data_5jtp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5jtp _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.8 m . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 108.252 -1.018 . . . . 73.42 108.252 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.592 ' HA ' HG23 ' A' ' 86' ' ' ILE . 72.8 t80 -130.41 114.13 15.19 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.695 -1.224 . . . . 74.22 107.695 170.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -134.18 134.58 42.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.418 -0.956 . . . . 72.25 108.418 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 mt -84.99 112.32 21.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 108.485 -0.932 . . . . 73.54 108.485 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.27 -39.77 65.13 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.515 -0.92 . . . . 73.13 108.515 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -172.17 148.28 2.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 116.591 -0.277 . . . . 71.21 110.622 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.7 mt -132.16 129.06 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.101 -1.074 . . . . 73.41 108.101 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.43 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 33.1 p90 -168.37 147.99 4.57 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 124.209 0.943 . . . . 73.21 110.562 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -75.68 112.53 12.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.865 -1.061 . . . . 64.21 109.121 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 37.7 mtpt -82.08 -27.51 32.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.955 0.407 . . . . 74.41 109.951 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.634 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 19.5 t70 -143.7 140.02 29.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.008 -0.997 . . . . 70.04 109.885 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.4 mt -137.15 140.91 41.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 107.204 -1.406 . . . . 70.34 107.204 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -147.77 134.5 19.99 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.78 -0.822 . . . . 70.14 108.78 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.582 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 55.2 t80 -140.09 121.6 15.15 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.834 -1.173 . . . . 73.42 107.834 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.98 110.2 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.809 -0.811 . . . . 70.33 108.809 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.772 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -126.05 76.14 71.85 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 107.246 -1.391 . . . . 72.33 107.246 170.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.45 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 72.7 Cg_endo -74.42 -30.87 7.79 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.33 2.02 . . . . 73.33 110.697 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.45 ' ND2' ' HG2' ' A' ' 26' ' ' PRO . 30.5 m-80 -101.16 19.57 17.32 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.216 1.006 . . . . 75.41 110.112 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.772 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -52.98 -48.26 92.44 Favored Pre-proline 0 CA--C 1.571 1.762 0 C-N-CA 123.694 0.798 . . . . 71.24 111.87 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.36 -17.38 16.71 Favored 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 121.88 1.72 . . . . 72.32 113.609 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -69.99 -49.21 53.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.974 0.509 . . . . 72.25 109.771 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.683 HG22 ' HA ' ' A' ' 73' ' ' ALA . 42.7 t -72.55 -20.18 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.861 0.864 . . . . 73.51 111.21 -175.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.405 ' HB2' ' NH1' ' B' ' 15' ' ' ARG . 81.3 t80 -60.21 -34.4 73.59 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.367 0.667 . . . . 73.03 110.447 168.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -94.18 -24.39 17.53 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.362 1.065 . . . . 72.34 110.977 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 32.9 mmtp -75.89 170.89 15.37 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.486 0.714 . . . . 75.51 110.304 172.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -81.31 138.43 35.7 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.973 -1.121 . . . . 54.32 107.973 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 41.5 t-105 -76.43 83.76 3.16 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.709 0.766 . . . . 75.3 110.443 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -129.82 77.63 76.5 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.863 1.265 . . . . 74.15 108.751 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.5 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 39.1 Cg_endo -93.03 146.38 2.42 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.55 2.167 . . . . 74.34 113.074 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 28.1 tt0 -97.87 95.73 7.72 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.766 -0.827 . . . . 72.42 108.766 172.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.36 91.21 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.499 0.666 . . . . 64.23 109.747 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -101.18 128.92 47.06 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.088 -0.708 . . . . 71.33 109.088 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 62' ' ' VAL . 45.6 tp -98.2 146.6 25.45 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.707 -0.849 . . . . 65.31 108.707 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.63 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.4 m-20 -134.46 109.35 8.68 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.269 -1.382 . . . . 73.32 107.269 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -96.99 120.37 37.21 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.847 -0.427 . . . . 75.35 109.847 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -128.37 143.97 51.07 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.991 -1.115 . . . . 53.14 107.991 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.1 m -133.44 142.22 48.21 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.104 0.562 . . . . 75.3 110.085 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -130.36 152.93 49.23 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.809 1.244 . . . . 53.03 109.217 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.3 t -127.49 151.61 48.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.622 0.769 . . . . 71.43 109.744 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 45.7 t -153.31 128.3 9.63 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.576 0.75 . . . . 64.24 110.176 -171.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -101.38 108.01 19.5 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.139 -0.689 . . . . 75.43 109.139 174.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.493 HD12 HG23 ' A' ' 83' ' ' ILE . 79.2 mt -88.43 -35.25 17.18 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.931 0.492 . . . . 65.11 110.696 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.408 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -159.62 -179.64 8.07 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 124.029 0.831 . . . . 72.14 110.461 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -67.41 116.65 8.4 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.721 -1.127 . . . . 73.35 109.136 171.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 67.54 11.21 8.26 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.728 1.211 . . . . 71.11 113.157 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.408 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 62.1 t -115.54 111.6 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.376 -1.342 . . . . 71.14 107.376 171.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -130.78 141.93 50.38 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.894 -0.78 . . . . 72.1 108.894 -171.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 41.7 tt0 -123.13 134.32 54.21 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.135 0.974 . . . . 75.04 109.213 -173.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.74 131.04 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 108.015 -1.106 . . . . 63.11 108.015 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 46.8 t -116.06 110.15 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.867 -0.79 . . . . 62.24 108.867 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.1 tp -90.26 105.71 17.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.487 -0.56 . . . . 75.24 109.487 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 51.8 ttt180 -85.07 101.69 12.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.504 0.722 . . . . 64.04 109.298 173.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.465 HG13 HD11 ' A' ' 42' ' ' LEU . 48.4 t -95.37 102.09 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.097 -1.075 . . . . 74.04 108.097 175.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.63 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 56.4 m -96.98 110.31 22.88 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.513 0.725 . . . . 75.33 109.051 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.488 HG22 HG21 ' A' ' 114' ' ' ILE . 41.9 t -102.92 137.28 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.392 -0.966 . . . . 73.32 108.392 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 t -143.09 150.5 39.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.863 -0.421 . . . . 73.33 109.863 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -138.67 109.61 6.75 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.823 -1.177 . . . . 71.1 107.823 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.8 p -135.04 127.04 29.65 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.416 0.687 . . . . 74.31 110.188 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.23 78.67 6.51 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.24 -1.393 . . . . 71.02 107.24 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.55 -91.42 0.66 Allowed Glycine 0 C--N 1.349 1.25 0 CA-C-N 115.142 -0.935 . . . . 73.11 112.783 173.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -91.91 -26.53 18.4 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.914 0.886 . . . . 71.34 111.823 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -113.55 129.92 56.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.721 0.408 . . . . 72.34 110.955 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 59.0 m -88.65 124.81 34.45 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.487 0.715 . . . . 64.3 110.289 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.683 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -70.59 -56.58 6.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.883 0.873 . . . . 75.45 110.071 175.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -155.83 158.77 38.64 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.617 -1.174 . . . . 73.35 111.128 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 tp -134.29 124.51 25.99 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.369 1.468 . . . . 75.44 107.217 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.45 ' SG ' HG13 ' A' ' 118' ' ' VAL . 61.6 m -132.22 99.96 4.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.111 0.964 . . . . 71.22 109.005 -174.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -123.68 127.39 48.13 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.527 0.731 . . . . 73.03 109.704 -171.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.2 t -135.63 113.85 15.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 123.445 0.698 . . . . 75.03 109.764 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.634 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.7 mt-30 -84.18 83.91 7.8 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.304 -0.998 . . . . 70.44 108.304 169.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.84 97.59 4.59 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.524 -1.216 . . . . 71.43 108.844 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.49 150.24 23.3 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.664 -0.574 . . . . 51.52 111.664 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.532 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -143.89 122.49 1.84 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.905 -0.878 . . . . 64.22 110.905 173.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.493 HG23 HD12 ' A' ' 51' ' ' LEU . 35.7 mt -82.02 130.52 35.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.801 -1.185 . . . . 74.14 107.801 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -127.67 122.64 33.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.85 -0.796 . . . . 74.53 108.85 -176.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -89.44 91.62 8.79 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.453 -0.943 . . . . 74.32 108.453 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.592 HG23 ' HA ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -126.74 155.62 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.175 0.59 . . . . 74.02 110.186 -175.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.56 170.72 8.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.156 0.982 . . . . 72.41 109.509 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.5 -32.34 6.08 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 123.675 0.61 . . . . 70.14 113.336 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.44 156.62 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.86 0.864 . . . . 74.05 109.748 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 14.5 tt0 -163.35 177.39 8.98 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.456 0.702 . . . . 71.12 109.403 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.403 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 69.66 -130.51 23.07 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 114.097 0.399 . . . . 73.42 114.097 177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.0 p -76.44 -35.57 58.43 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.56 1.144 . . . . 74.3 111.577 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -59.87 -43.92 94.46 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.963 0.905 . . . . 75.43 110.111 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.471 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 65.6 ttp -72.48 -36.01 68.32 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.005 -0.998 . . . . 74.41 110.848 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.23 -29.67 68.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.037 0.535 . . . . 70.41 110.883 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -69.15 -46.46 67.55 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.016 0.527 . . . . 70.3 110.94 168.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.5 m -59.98 -65.15 0.73 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 122.321 0.248 . . . . 63.23 110.824 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 94' ' ' MET . 2.0 pp -73.5 -21.64 60.35 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.028 0.751 . . . . 74.14 113.028 -176.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.415 ' N ' HD11 ' A' ' 98' ' ' LEU . . . -101.56 -4.53 52.47 Favored Glycine 0 N--CA 1.475 1.268 0 CA-C-O 119.599 -0.556 . . . . 65.22 113.577 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.32 -60.75 0.42 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.239 0.519 . . . . 53.55 111.612 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.58 -45.57 65.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.018 0.527 . . . . 74.45 111.991 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.3 m -67.76 -45.74 44.55 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.122 0.969 . . . . 73.22 111.943 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.95 -26.55 58.8 Favored 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 121.549 1.499 . . . . 74.24 112.576 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -70.09 -30.42 67.64 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.771 0.428 . . . . 73.34 110.307 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.7 mm -67.53 -41.43 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.79 0.836 . . . . 74.02 109.988 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.532 HD22 ' HA3' ' A' ' 82' ' ' GLY . 69.9 mt -74.99 -22.13 58.72 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.302 -0.863 . . . . 74.11 111.453 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -63.34 -43.49 79.85 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 117.464 -1.255 . . . . 74.14 114.233 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.1 -40.41 77.25 Favored 'Trans proline' 0 C--N 1.387 2.56 0 CA-C-N 122.093 1.783 . . . . 64.54 112.765 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -66.02 -44.64 84.13 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.453 0.701 . . . . 74.31 111.463 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.83 84.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.178 0.591 . . . . 73.41 110.711 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.453 ' NH1' HD13 ' C' ' 105' ' ' ILE . 26.8 ttm180 -50.79 -54.62 22.07 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.552 1.158 . . . . 73.52 109.76 174.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -67.01 -38.99 86.95 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.402 1.064 . . . . 75.43 111.833 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.557 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.2 t -62.06 -27.8 69.15 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.015 0.526 . . . . 72.4 111.019 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.488 HG21 HG22 ' A' ' 64' ' ' VAL . 97.5 mt -87.52 -41.09 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.227 1.411 . . . . 74.14 111.027 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 49.3 m -64.46 -44.48 90.95 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.482 0.713 . . . . 72.43 110.508 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.8 t -65.77 -40.89 92.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.794 -1.093 . . . . 73.35 109.93 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.582 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.7 ttm -59.58 -47.17 86.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.366 1.066 . . . . 74.34 111.903 -177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.45 HG13 ' SG ' ' A' ' 76' ' ' CYS . 20.5 m -66.02 -39.45 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.251 0.345 . . . . 73.45 110.317 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.0 m -67.45 -32.57 73.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.42 0.688 . . . . 73.01 111.362 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.616 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 86.5 mtt-85 -71.47 -31.5 67.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.518 0.727 . . . . 75.15 110.018 174.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.54 3.56 86.26 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.614 -0.721 . . . . 73.32 113.519 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.0 m 62.28 47.27 5.5 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 123.545 1.64 . . . . 75.11 110.797 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -116.75 137.64 23.89 Favored Pre-proline 0 C--O 1.246 0.92 0 CA-C-N 114.055 -1.429 . . . . 74.35 107.18 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.55 144.28 10.67 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.283 2.656 . . . . 73.33 113.705 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -55.98 132.38 49.76 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 124.357 1.036 . . . . 74.55 112.403 -173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 tp -118.97 100.69 7.52 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.143 -0.935 . . . . 72.12 109.68 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -98.03 107.3 19.74 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.839 -1.171 . . . . 74.44 107.839 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.46 139.31 58.76 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.169 0.587 . . . . 74.14 109.73 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.18 145.57 98.03 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 122.886 0.474 . . . . 52.35 110.673 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.84 107.84 0.67 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.083 1.855 . . . . 72.43 111.269 176.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 89.9 t -98.99 113.76 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.488 -0.93 . . . . 54.24 108.488 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -84.21 89.02 7.25 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.236 -1.024 . . . . 73.21 108.236 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -59.9 -29.67 68.5 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.645 0.778 . . . . 75.51 111.52 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.17 -44.39 72.31 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.699 1.2 . . . . 73.23 110.681 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.12 -45.36 92.38 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.992 0.808 . . . . 70.55 110.181 175.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.86 -37.04 80.74 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.164 -0.926 . . . . 73.11 111.212 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -68.86 -34.52 75.59 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.326 -0.852 . . . . 75.44 109.941 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.6 mmt . . . . . 0 N--CA 1.485 1.286 0 O-C-N 123.679 0.612 . . . . 74.44 111.124 177.48 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 60.5 m . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 109.382 -0.599 . . . . 74.33 109.382 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.422 ' HB3' ' HA ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -149.37 156.75 42.54 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.479 0.657 . . . . 74.13 110.039 155.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.31 135.15 51.15 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.639 -1.245 . . . . 52.13 107.639 173.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 51.0 mt -68.63 116.08 8.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.319 -0.993 . . . . 75.11 108.319 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -86.87 -36.41 18.44 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.235 -0.893 . . . . 71.42 109.45 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.405 ' NH1' ' HB2' ' A' ' 32' ' ' PHE . 75.2 ttt180 -167.33 133.71 2.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.894 -1.048 . . . . 72.23 109.715 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.451 ' H ' ' ND2' ' D' ' 127' ' ' ASN . 88.8 mt -115.61 135.08 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 105.809 -1.923 . . . . 74.25 105.809 166.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.47 ' HE2' ' HB2' ' A' ' 28' ' ' ALA . 10.0 p90 -168.4 151.04 5.32 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.213 0.53 . . . . 75.11 111.059 -174.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.8 m -82.62 129.84 35.01 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.942 -0.762 . . . . 75.33 108.942 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -97.89 -30.56 12.67 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.354 0.662 . . . . 72.51 110.721 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 11.8 t70 -145.09 139.11 27.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.428 -0.351 . . . . 72.55 110.232 -175.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.51 HD13 ' SG ' ' B' ' 113' ' ' CYS . 33.3 mm -131.17 139.53 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 106.768 -1.568 . . . . 74.33 106.768 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.8 t -147.6 138.25 23.29 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.32 -0.993 . . . . 72.24 108.32 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.0 t80 -154.71 110.38 3.15 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.662 -1.236 . . . . 72.44 107.662 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -117.95 114.42 23.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.627 1.171 . . . . 72.21 108.09 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.584 ' HB3' ' HB3' ' B' ' 28' ' ' ALA . . . -111.82 83.78 4.93 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.348 -0.982 . . . . 72.43 108.348 175.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.97 -34.26 6.69 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.775 2.316 . . . . 64.01 112.94 -170.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -98.14 -2.61 39.59 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.921 0.888 . . . . 64.22 111.426 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.584 ' HB3' ' HB3' ' B' ' 25' ' ' ALA . . . -35.83 -63.02 0.43 Allowed Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 125.867 1.667 . . . . 61.54 114.803 -165.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -54.97 -31.02 72.24 Favored 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 122.775 2.316 . . . . 75.0 113.794 -173.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -96.78 -34.49 11.3 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.692 -1.14 . . . . 74.51 111.404 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.667 HG21 HD13 ' B' ' 68' ' ' LEU . 5.6 p -74.45 -18.63 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 122.336 0.254 . . . . 75.32 111.672 -171.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.95 -15.49 62.24 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.619 0.768 . . . . 72.2 112.855 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -57.25 -29.98 64.26 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.425 0.69 . . . . 73.03 110.473 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.5 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 85.0 mttt -95.38 98.66 10.73 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 124.623 1.169 . . . . 74.23 109.025 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -83.36 92.92 7.64 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.41 0.684 . . . . 74.15 109.725 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -162.94 156.26 19.71 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.762 0.825 . . . . 75.03 109.347 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.05 105.44 0.85 Allowed Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 124.524 1.13 . . . . 74.45 110.676 170.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.533 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 40.3 Cg_endo -67.37 137.58 43.71 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.597 2.198 . . . . 62.53 112.115 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 11.9 tp10 -59.23 121.46 11.43 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 124.187 0.929 . . . . 72.22 112.099 -169.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 73.2 t -85.94 132.47 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.968 0.907 . . . . 73.1 110.23 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.546 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 12.9 tmtt? -131.9 117.29 18.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.275 -1.75 . . . . 74.13 106.275 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.455 HD23 HD13 ' B' ' 128' ' ' LEU . 40.4 tp -93.98 150.56 20.25 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.154 0.502 . . . . 74.42 111.188 -172.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.707 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.8 m-20 -140.59 143.64 35.39 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.694 -1.225 . . . . 63.55 107.694 171.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.0 125.94 16.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.926 -1.139 . . . . 73.13 107.926 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 12.2 m-20 -127.04 150.42 49.45 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.026 -1.102 . . . . 63.0 108.026 171.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.0 p -135.72 124.46 23.87 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.943 0.401 . . . . 72.3 110.817 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.19 164.08 16.77 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.542 1.537 . . . . 74.5 109.493 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 22.2 p -145.07 168.67 19.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.482 1.113 . . . . 74.04 109.104 170.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 97.4 p -151.23 168.47 24.63 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.156 0.582 . . . . 75.42 109.815 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -116.53 110.2 18.26 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.731 -1.211 . . . . 71.33 107.731 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 24.6 mt -88.02 -55.51 3.72 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.1 0.953 . . . . 73.2 108.777 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.67 -179.32 5.85 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 113.431 -1.713 . . . . 42.31 108.053 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.32 130.36 40.58 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 116.158 -0.474 . . . . 73.02 110.627 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 67.03 -1.19 1.48 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.969 1.708 . . . . 71.22 112.724 -172.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.2 t -103.61 104.11 16.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 108.074 -1.084 . . . . 74.31 108.074 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -114.19 140.45 48.53 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.026 -1.101 . . . . 75.11 108.026 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -119.87 104.67 10.39 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.212 -1.033 . . . . 71.42 108.212 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 72.3 t -89.08 140.09 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.358 0.663 . . . . 74.33 110.589 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 38.0 t -118.28 118.9 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.797 0.839 . . . . 75.15 109.403 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.5 OUTLIER -93.82 122.98 36.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.203 -1.406 . . . . 73.44 107.203 174.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.472 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 46.8 ttt180 -110.27 122.14 46.96 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.403 0.681 . . . . 72.11 109.486 175.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 13.6 t -117.62 131.36 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 107.67 -1.233 . . . . 72.54 107.67 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.707 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.1 m -127.07 130.28 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.758 -0.83 . . . . 74.52 108.758 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.33 116.39 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.844 -0.799 . . . . 73.24 108.844 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 89.2 m -99.05 138.46 36.13 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.917 -1.142 . . . . 71.11 107.917 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.17 147.36 30.42 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 122.437 0.295 . . . . 71.31 110.593 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 54.9 p -151.66 135.74 16.6 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 124.125 0.891 . . . . 72.45 111.383 -174.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.667 HD13 HG21 ' B' ' 31' ' ' VAL . 56.1 mt -95.45 110.44 22.49 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.947 0.899 . . . . 74.52 109.477 174.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.43 -111.12 3.43 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.581 -1.19 . . . . 73.13 111.764 -169.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -119.06 2.57 11.47 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.802 0.841 . . . . 73.22 110.905 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.5 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 10.5 pt-20 -112.66 148.96 33.56 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.888 -0.782 . . . . 75.23 108.888 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.6 m -61.6 140.42 58.14 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.55 0.531 . . . . 74.32 110.874 -176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.76 -67.14 0.86 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.676 -1.231 . . . . 70.43 107.676 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -148.1 158.07 43.86 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.969 -1.014 . . . . 64.5 109.862 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 41.7 mt -132.6 109.42 9.73 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 106.365 -1.717 . . . . 71.11 106.365 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 39.3 t -120.77 117.04 26.41 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.27 0.487 . . . . 54.42 110.05 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.4 tt0 -122.28 132.67 54.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.22 1.008 . . . . 65.11 108.736 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.508 HG12 HD11 ' B' ' 21' ' ' ILE . 75.5 t -128.48 147.64 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.111 -0.7 . . . . 74.24 109.111 173.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.8 mt-30 -125.36 102.99 7.68 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.094 -0.706 . . . . 73.34 109.094 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -90.44 104.78 17.32 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.658 -0.868 . . . . 74.1 108.658 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.59 171.11 37.62 Favored Glycine 0 C--O 1.243 0.68 0 N-CA-C 111.364 -0.694 . . . . 72.13 111.364 174.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.67 130.65 2.15 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 112.121 -0.392 . . . . 74.15 112.121 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 39.3 mt -89.89 127.47 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.334 0.653 . . . . 74.43 109.32 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -135.15 132.92 38.61 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.393 -1.336 . . . . 74.23 107.393 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m -101.62 90.97 4.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.705 0.402 . . . . 73.41 110.787 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.507 ' HB ' HD11 ' B' ' 89' ' ' ILE . 16.1 pt -96.25 145.25 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.494 0.718 . . . . 74.23 111.614 -167.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.77 157.16 32.85 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.279 1.031 . . . . 72.31 109.96 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.02 -39.31 2.94 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 123.378 0.513 . . . . 71.01 113.657 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.542 ' H ' HD12 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -79.12 146.65 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.062 0.545 . . . . 65.4 111.237 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -162.95 162.62 26.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.046 0.841 . . . . 74.42 109.506 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.99 -118.13 9.28 Favored Glycine 0 N--CA 1.474 1.171 0 CA-C-N 115.976 -0.556 . . . . 51.32 113.553 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 99.5 m -69.63 -33.48 72.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.663 0.785 . . . . 72.11 110.708 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -66.74 -38.98 87.74 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.264 0.625 . . . . 62.31 111.466 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -32.92 60.49 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.357 0.263 . . . . 75.22 111.29 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.27 75.13 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.495 -0.775 . . . . 62.23 110.103 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -72.36 -34.85 68.29 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.034 0.933 . . . . 71.14 110.677 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -68.11 -67.5 0.46 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.498 0.499 . . . . 64.12 110.812 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.407 HD22 HD12 ' B' ' 86' ' ' ILE . 68.2 mt -81.84 -16.51 50.57 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 111.873 0.323 . . . . 75.31 111.873 -173.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.13 -9.69 55.49 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 114.57 0.588 . . . . 70.41 114.57 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.99 -56.3 0.25 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.382 0.591 . . . . 73.22 111.722 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -71.7 -48.53 46.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.709 0.804 . . . . 72.41 112.06 -169.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 98.6 m -61.27 -47.23 94.81 Favored Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 124.158 0.983 . . . . 75.4 111.777 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.42 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 76.1 Cg_exo -56.03 -41.17 79.75 Favored 'Trans proline' 0 C--N 1.395 3.0 0 C-N-CA 122.406 2.071 . . . . 75.23 113.587 167.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -62.73 -29.37 70.62 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.482 0.713 . . . . 74.32 111.914 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.63 -41.65 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.85 0.86 . . . . 74.35 110.748 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.76 -19.52 57.52 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.981 -1.009 . . . . 74.44 112.255 -173.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -56.71 -48.58 96.99 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 114.872 1.434 . . . . 74.51 114.872 -170.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.77 -37.53 95.49 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.457 2.104 . . . . 74.2 113.828 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -71.25 -43.03 68.06 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.661 -0.699 . . . . 71.31 110.369 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -40.57 87.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.597 0.759 . . . . 74.33 110.776 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -60.53 -53.11 61.42 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.192 0.997 . . . . 64.33 111.212 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.23 -33.25 75.56 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.459 0.704 . . . . 72.22 110.397 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.616 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -67.89 -42.91 80.49 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.804 0.842 . . . . 74.14 111.658 177.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.63 -51.51 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.77 -0.456 . . . . 75.25 109.77 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.474 HG22 ' OG ' ' C' ' 119' ' ' SER . 19.8 m -60.13 -34.35 73.41 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.873 0.869 . . . . 73.54 111.646 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.4 t -60.34 -48.01 83.59 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.732 0.645 . . . . 64.31 110.075 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -74.77 -31.29 61.73 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.446 0.698 . . . . 70.44 111.524 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.08 -39.4 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.894 0.878 . . . . 70.01 110.559 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 30.4 t -65.28 -40.64 94.13 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.84 0.856 . . . . 75.14 111.065 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.557 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 78.0 mtt-85 -66.24 -33.49 75.87 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 114.843 -1.071 . . . . 72.45 110.128 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.12 7.42 75.34 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-O 119.361 -0.688 . . . . 73.03 113.677 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 80.6 p 56.12 29.68 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.905 1.682 . . . . 73.23 113.537 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -93.24 154.76 41.47 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.025 0.93 . . . . 75.24 110.787 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.23 165.94 1.91 Allowed 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 123.909 3.073 . . . . 75.34 115.556 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -63.58 137.62 58.19 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.461 1.104 . . . . 73.5 113.191 -168.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.99 112.31 15.09 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 107.753 -1.202 . . . . 75.51 107.753 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -130.53 109.54 10.76 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.589 -0.893 . . . . 75.43 108.589 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.455 HD13 HD23 ' B' ' 42' ' ' LEU . 33.6 tp -82.87 137.41 34.28 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.637 0.375 . . . . 65.24 110.397 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.32 144.75 92.47 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.148 0.979 . . . . 63.43 111.415 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.499 ' HG3' HD13 ' D' ' 16' ' ' ILE . 33.3 Cg_endo -61.64 109.2 0.72 Allowed 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.897 2.398 . . . . 75.22 112.298 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -89.83 111.9 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.615 -0.884 . . . . 74.43 108.615 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -78.5 87.93 4.47 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.22 -1.03 . . . . 72.5 108.22 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -59.06 -36.72 75.53 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.519 0.727 . . . . 73.43 111.339 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.12 -40.85 95.07 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.581 1.152 . . . . 73.25 111.998 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.85 -47.27 66.37 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.738 0.815 . . . . 73.31 110.855 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.89 -20.75 59.59 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.535 -0.757 . . . . 74.41 110.873 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 94.4 t80 . . . . . 0 N--CA 1.475 0.796 0 C-N-CA 123.588 0.755 . . . . 74.52 110.112 173.08 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 36.4 m . . . . . 0 C--O 1.223 -0.331 0 N-CA-C 108.613 -0.884 . . . . 72.42 108.613 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -115.57 126.48 54.28 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.801 -0.814 . . . . 75.53 108.801 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -140.68 125.45 18.11 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.875 -0.787 . . . . 71.14 108.875 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.407 ' HA ' ' HD2' ' C' ' 84' ' ' PHE . 56.1 mt -66.44 123.94 20.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.81 -0.811 . . . . 73.45 108.81 171.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -89.63 -48.74 7.09 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.157 -0.683 . . . . 71.32 109.157 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -174.33 125.89 0.33 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 115.565 -0.743 . . . . 74.13 110.404 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -109.46 143.22 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 107.919 -1.141 . . . . 73.33 107.919 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.44 ' HE1' HG12 ' C' ' 83' ' ' ILE . 25.1 p90 -176.25 169.58 2.73 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.406 0.622 . . . . 74.04 111.007 -173.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -93.02 114.59 27.18 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.318 -0.856 . . . . 61.44 109.533 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.638 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -68.34 -34.09 75.46 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.814 -0.81 . . . . 74.02 108.814 175.089 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -154.19 146.45 23.83 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.945 -1.479 . . . . 75.12 109.618 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.7 mt -140.61 144.37 27.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 125.607 1.563 . . . . 73.32 106.846 175.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -154.04 149.32 27.05 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.51 0.672 . . . . 73.0 110.116 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -153.68 125.16 7.57 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.159 -1.423 . . . . 71.55 107.159 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -132.23 109.96 10.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.062 0.545 . . . . 62.04 109.724 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.59 79.58 73.43 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 106.716 -1.587 . . . . 65.35 106.716 168.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.74 -25.34 28.8 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.767 2.311 . . . . 72.35 112.001 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -106.1 17.57 23.34 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.214 1.406 . . . . 72.42 110.932 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.89 -57.57 4.83 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 114.864 1.431 . . . . 52.12 114.864 -167.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.17 -36.63 68.22 Favored 'Trans proline' 0 C--N 1.391 2.774 0 CA-C-N 122.24 1.836 . . . . 74.34 112.529 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -69.09 -39.09 79.22 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.446 0.698 . . . . 74.12 111.637 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' C' ' 73' ' ' ALA . 2.9 p -79.39 -20.79 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 N-CA-C 112.412 0.523 . . . . 63.42 112.412 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -67.91 -31.71 71.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.545 0.572 . . . . 74.54 112.545 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -88.35 15.25 8.01 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.874 0.47 . . . . 75.14 111.057 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.43 161.34 13.83 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.954 0.902 . . . . 72.54 110.544 -176.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.92 126.85 30.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.624 0.77 . . . . 73.4 109.798 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 59.9 t90 -76.0 107.14 8.0 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.654 0.782 . . . . 74.32 109.847 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.56 73.16 2.87 Favored Pre-proline 0 CA--C 1.555 1.138 0 N-CA-C 107.328 -1.36 . . . . 64.52 107.328 173.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.59 134.18 8.59 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.092 2.528 . . . . 64.24 113.949 -174.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -87.38 95.13 9.9 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 106.345 -1.724 . . . . 75.43 106.345 168.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 m -75.88 96.23 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 122.275 1.036 . . . . 73.21 109.815 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.429 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 40.2 ttmt -100.8 103.09 14.3 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.582 -1.19 . . . . 75.44 108.082 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.8 mp -88.32 132.54 34.37 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 107.783 -1.191 . . . . 72.44 107.783 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.405 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.1 t70 -117.63 104.72 11.3 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.469 -1.308 . . . . 75.43 107.469 173.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 84.3 mt -95.58 143.23 27.05 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.305 -0.861 . . . . 72.54 109.236 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.605 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.2 t70 -148.33 144.27 27.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.993 0.917 . . . . 75.15 108.954 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 t -138.42 124.75 20.46 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.648 -0.871 . . . . 74.25 108.648 172.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.07 145.3 45.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.782 -0.821 . . . . 70.42 108.782 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -130.49 156.0 45.52 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.989 0.516 . . . . 74.01 111.115 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 29.5 t -144.8 139.84 28.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.369 1.067 . . . . 75.03 109.587 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -88.86 118.32 28.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.963 -1.125 . . . . 71.34 107.963 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.558 HD12 HD13 ' C' ' 83' ' ' ILE . 62.2 mt -90.0 -48.84 6.95 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.802 0.811 . . . . 72.03 109.362 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.18 -177.85 5.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 113.996 -1.456 . . . . 55.35 108.501 170.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.41 110.73 1.16 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.442 1.089 . . . . 75.1 110.703 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 22.6 m-20 68.3 9.28 7.14 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 125.386 1.474 . . . . 71.04 113.367 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.7 t -93.1 107.53 19.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 107.198 -1.408 . . . . 72.15 107.198 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -102.08 122.37 43.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.149 -1.387 . . . . 74.15 108.088 -164.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.525 ' HB2' HD12 ' C' ' 51' ' ' LEU . 36.3 tt0 -105.01 122.57 46.13 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.944 -1.132 . . . . 75.44 107.944 173.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -114.99 141.06 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 108.515 -0.92 . . . . 73.13 108.515 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.408 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 87.2 t -128.99 139.75 51.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.811 -0.811 . . . . 63.53 108.811 174.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.81 105.95 11.21 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.524 -1.287 . . . . 75.44 107.524 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.605 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 23.3 ttm-85 -93.58 107.7 19.52 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.603 -0.888 . . . . 72.31 108.603 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.438 ' HB ' HD11 ' C' ' 114' ' ' ILE . 24.1 t -107.11 120.42 58.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.438 -0.949 . . . . 74.34 108.438 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 43.6 m -117.68 131.53 56.62 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.23 -0.656 . . . . 65.44 109.23 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.569 HG23 HG21 ' C' ' 114' ' ' ILE . 60.2 t -108.41 125.28 65.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.972 -0.751 . . . . 72.21 108.972 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 6.6 m -118.38 123.93 46.47 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.515 -0.92 . . . . 72.12 108.515 173.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.92 99.65 7.23 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.493 -1.299 . . . . 64.43 107.493 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.9 m -108.18 120.6 42.83 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 109.7 -0.482 . . . . 72.5 109.7 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' C' ' 73' ' ' ALA . 8.7 mt -84.92 49.29 1.7 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.182 1.393 . . . . 75.43 109.589 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.79 -98.85 1.81 Allowed Glycine 0 C--N 1.35 1.317 0 N-CA-C 110.557 -1.017 . . . . 73.03 110.557 -174.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.39 -30.28 12.29 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.319 1.048 . . . . 72.15 109.97 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -79.78 120.07 23.55 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 124.348 1.059 . . . . 73.5 110.581 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 86.8 m -85.29 127.12 34.21 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 119.057 0.844 . . . . 72.33 109.764 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.648 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.85 -56.81 5.06 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.653 1.181 . . . . 72.42 110.101 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . 0.465 ' HZ ' HD23 ' C' ' 126' ' ' LEU . 33.0 p90 -157.4 164.52 37.43 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.287 -0.869 . . . . 75.04 112.284 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -128.25 105.29 8.25 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.636 -1.616 . . . . 73.33 106.636 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.9 t -109.41 148.69 30.7 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.974 -0.75 . . . . 74.24 108.974 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -156.42 136.81 13.04 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.414 -0.587 . . . . 73.22 109.414 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.0 t -133.93 135.02 55.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.89 -1.152 . . . . 72.23 107.89 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -111.5 89.42 3.05 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.952 -1.129 . . . . 65.02 107.952 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -78.99 100.27 7.23 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.061 -0.972 . . . . 74.5 110.04 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.638 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -89.24 169.07 35.79 Favored Glycine 0 C--O 1.242 0.636 0 CA-C-N 115.728 -0.669 . . . . 71.11 112.799 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.414 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -168.06 118.51 0.79 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.384 -0.686 . . . . 73.43 111.384 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.558 HD13 HD12 ' C' ' 51' ' ' LEU . 12.9 mm -84.01 133.44 29.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 108.821 -0.807 . . . . 73.31 108.821 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.407 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 45.3 m-85 -141.09 122.68 15.13 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.639 0.775 . . . . 72.23 109.337 -177.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 53.0 p -79.84 127.31 32.07 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.09 -1.078 . . . . 74.4 108.09 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.492 HD13 HD13 ' C' ' 89' ' ' ILE . 9.6 tt -141.91 143.09 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-O 121.036 0.446 . . . . 65.21 111.714 -170.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.78 169.18 24.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.344 1.058 . . . . 64.44 109.649 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.07 -46.34 1.19 Allowed Glycine 0 N--CA 1.471 1.012 0 CA-C-N 116.458 -0.337 . . . . 74.24 113.878 171.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.492 HD13 HD13 ' C' ' 86' ' ' ILE . 0.2 OUTLIER -113.39 146.77 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 122.935 0.494 . . . . 75.25 110.236 -176.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -146.83 -177.89 5.9 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.786 0.434 . . . . 73.11 111.008 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.25 -122.6 11.29 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 115.753 -0.658 . . . . 63.33 113.078 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 79.9 p -70.53 -23.79 62.7 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.589 0.756 . . . . 62.34 110.929 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -73.68 -32.16 63.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.661 0.785 . . . . 72.01 110.746 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 55.5 ttp -66.78 -40.64 88.24 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.086 -0.709 . . . . 74.12 109.086 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.27 -36.3 83.68 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.563 -0.744 . . . . 73.44 111.383 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.54 ' HE2' ' HA ' ' C' ' 134' ' ' ASP . 10.0 t-80 -76.86 -21.02 55.61 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.576 0.35 . . . . 74.14 111.607 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.9 t -61.28 -54.5 43.25 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.63 0.372 . . . . 72.43 110.097 173.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -75.66 -22.14 57.01 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.102 0.561 . . . . 75.12 111.147 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.55 -26.41 65.5 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 114.889 0.716 . . . . 71.43 114.889 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.56 -60.21 0.08 Allowed 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 112.494 0.553 . . . . 72.01 112.494 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -52.71 -47.76 67.08 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 124.154 0.909 . . . . 75.45 112.604 -167.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.9 m -78.4 -48.44 1.89 Allowed Pre-proline 0 CA--C 1.561 1.379 0 CA-C-O 117.78 -1.105 . . . . 71.3 112.422 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.57 -32.51 44.4 Favored 'Trans proline' 0 C--N 1.403 3.402 0 C-N-CA 122.197 1.931 . . . . 71.54 113.636 170.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -66.71 -38.04 85.91 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.278 1.031 . . . . 64.43 111.417 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.453 HD13 ' NH1' ' A' ' 111' ' ' ARG . 36.7 mm -64.5 -45.65 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 109.488 -0.56 . . . . 71.2 109.488 173.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.414 HD21 ' HA3' ' C' ' 82' ' ' GLY . 74.5 mt -78.48 -18.6 54.59 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.03 -0.987 . . . . 72.31 112.493 -172.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.412 ' HE1' HD13 ' C' ' 128' ' ' LEU . 79.0 t80 -59.0 -50.99 85.04 Favored Pre-proline 0 CA--C 1.56 1.358 0 N-CA-C 114.233 1.197 . . . . 74.3 114.233 -171.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.36 -32.48 72.13 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.789 1.659 . . . . 74.14 112.518 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -67.65 -45.15 76.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.15 0.58 . . . . 74.31 110.195 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.54 -45.2 89.39 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.918 0.887 . . . . 74.12 110.519 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -57.7 -54.74 43.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.634 1.174 . . . . 72.14 111.117 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -67.18 -33.05 74.57 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.299 0.64 . . . . 71.44 110.877 -173.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.2 t -69.5 -32.21 70.93 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.888 0.475 . . . . 53.14 110.932 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.569 HG21 HG23 ' C' ' 64' ' ' VAL . 74.7 mt -71.31 -53.32 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.59 -0.522 . . . . 64.34 109.59 173.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 14.5 m -60.73 -29.68 69.52 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.74 0.816 . . . . 75.33 111.326 -173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 31.7 t -61.78 -54.54 40.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.235 -0.893 . . . . 72.32 109.155 171.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.552 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.73 -37.66 79.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.794 1.238 . . . . 75.55 112.867 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.49 -46.7 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.59 0.756 . . . . 73.32 109.8 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.474 ' OG ' HG22 ' B' ' 115' ' ' THR . 34.7 t -66.28 -32.71 74.29 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.985 -1.007 . . . . 74.22 111.473 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 74.6 mtt-85 -66.49 -41.16 89.33 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.408 0.683 . . . . 72.32 109.481 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.23 7.81 62.85 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.706 -0.679 . . . . 75.22 112.989 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 77.4 p 57.96 33.32 23.06 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.906 1.682 . . . . 75.2 113.661 171.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -91.08 163.13 30.52 Favored Pre-proline 0 CA--C 1.565 1.526 0 C-N-CA 124.231 1.012 . . . . 61.22 108.86 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.11 172.75 3.75 Favored 'Trans proline' 0 C--N 1.39 2.729 0 C-N-CA 122.997 2.465 . . . . 61.31 113.82 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -62.48 112.74 2.59 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.945 0.898 . . . . 75.25 112.669 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.465 HD23 ' HZ ' ' C' ' 74' ' ' PHE . 8.9 mp -110.98 112.0 23.51 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.431 -0.952 . . . . 64.33 108.431 169.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -124.59 131.29 53.48 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.498 0.719 . . . . 73.41 109.223 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.412 HD13 ' HE1' ' C' ' 107' ' ' PHE . 1.4 tt -79.33 131.2 36.06 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.333 -0.617 . . . . 72.53 109.333 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.17 150.75 91.82 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.235 1.014 . . . . 70.11 111.433 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.07 103.29 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.382 2.055 . . . . 73.11 112.533 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 90.6 t -97.22 111.23 26.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.663 -0.866 . . . . 75.42 108.663 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -82.96 83.81 7.67 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 108.042 -1.096 . . . . 74.44 108.042 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -59.36 -22.47 61.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.11 0.564 . . . . 73.41 111.87 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.54 ' HA ' ' HE2' ' C' ' 96' ' ' HIS . 33.7 m-20 -63.19 -56.2 18.72 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.692 0.797 . . . . 74.1 110.848 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.11 -38.58 79.93 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.725 1.266 . . . . 71.43 110.641 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 74.8 mt -74.19 -29.5 61.78 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.493 -1.23 . . . . 71.4 111.675 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 19.5 t80 . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 110.142 -0.318 . . . . 75.22 110.142 179.928 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.413 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 89.3 m . . . . . 0 C--O 1.239 0.531 0 CA-C-O 120.945 0.402 . . . . 72.44 110.022 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -164.01 91.34 0.63 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.785 -1.561 . . . . 74.05 106.785 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -112.84 114.06 26.42 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.868 -1.16 . . . . 74.25 107.868 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.58 105.57 4.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.678 -0.86 . . . . 75.44 108.678 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -77.38 -37.85 51.23 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.172 -0.467 . . . . 63.11 111.892 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -166.2 144.1 5.48 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 111.786 0.291 . . . . 74.3 111.786 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.499 HD13 ' HG3' ' B' ' 130' ' ' PRO . 1.7 mp -121.86 134.12 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 106.016 -1.846 . . . . 75.33 106.016 167.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -161.44 163.18 30.64 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.9 0.857 . . . . 74.13 111.489 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -95.01 119.72 34.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.267 -1.333 . . . . 55.45 108.924 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -88.96 -22.34 23.1 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.568 -0.53 . . . . 73.35 109.568 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.613 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.2 t70 -155.67 139.4 16.11 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 114.933 -1.031 . . . . 64.22 109.8 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.552 HG23 ' HE1' ' C' ' 117' ' ' MET . 69.0 mt -143.62 136.78 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.938 1.295 . . . . 74.42 107.553 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.6 t -146.76 109.25 4.53 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.807 -0.812 . . . . 73.41 108.807 174.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.582 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.8 t80 -114.22 128.28 56.29 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.991 -1.114 . . . . 74.11 107.991 168.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.14 127.14 40.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.516 0.727 . . . . 75.11 109.324 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.31 87.42 2.05 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 106.559 -1.645 . . . . 64.54 106.559 165.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.55 -41.72 18.82 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.276 1.984 . . . . 73.4 112.505 -166.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -111.09 15.2 21.75 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.125 0.97 . . . . 75.24 109.979 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.428 ' O ' HG11 ' D' ' 31' ' ' VAL . . . -18.61 -70.26 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 117.227 2.306 . . . . 74.35 117.227 -168.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.439 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 64.6 Cg_endo -77.14 -23.75 10.15 Favored 'Trans proline' 0 C--N 1.382 2.329 0 CA-C-N 123.953 2.447 . . . . 74.13 113.772 -173.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -72.88 -36.54 67.37 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.631 0.772 . . . . 75.11 109.218 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.552 HG23 ' HA ' ' D' ' 73' ' ' ALA . 6.8 p -83.26 -19.13 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.229 0 CA-C-N 115.731 -0.668 . . . . 75.01 110.694 -176.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.439 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.6 m-85 -70.01 -19.02 63.34 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.835 0.454 . . . . 75.42 111.928 175.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -55.3 -34.09 63.84 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.817 0.698 . . . . 75.41 110.073 172.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.418 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 42.1 mtmt -91.88 78.02 5.42 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.583 -1.19 . . . . 75.52 109.095 168.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.01 82.0 3.53 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.836 0.827 . . . . 74.3 109.493 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -147.84 157.96 43.79 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.532 -1.213 . . . . 74.4 108.79 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -63.8 106.89 1.04 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.133 0.973 . . . . 74.31 108.979 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.469 ' HB2' ' HB2' ' D' ' 66' ' ' ALA . 23.1 Cg_exo -65.82 146.0 82.16 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.754 2.302 . . . . 73.11 112.196 -172.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -63.27 110.97 2.06 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.164 -1.05 . . . . 74.02 108.164 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.14 146.07 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-O 121.427 0.632 . . . . 74.15 111.225 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -129.59 118.94 22.8 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.401 -2.074 . . . . 73.44 105.401 172.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -97.01 145.37 26.01 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.633 -0.877 . . . . 75.43 108.633 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.568 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.8 m-20 -129.29 143.34 50.81 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.024 -0.732 . . . . 74.25 109.024 172.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -119.38 136.42 54.29 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.232 -1.025 . . . . 72.41 108.232 173.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 37.9 t70 -138.37 131.5 30.05 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.274 -1.38 . . . . 70.14 107.274 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -104.09 148.12 26.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.221 0.534 . . . . 62.44 109.57 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.58 165.41 33.4 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.897 -1.047 . . . . 73.13 108.536 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 31.1 p -164.77 155.97 15.01 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.179 0.592 . . . . 62.41 110.151 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 32.0 t -151.62 123.95 8.29 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.317 0.647 . . . . 71.35 110.626 -171.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -73.4 116.65 14.21 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.179 -1.045 . . . . 72.02 108.179 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' D' ' 57' ' ' GLU . 60.1 mt -91.79 -41.11 10.84 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.302 0.572 . . . . 75.51 110.11 -177.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.17 -175.09 5.25 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.449 -1.251 . . . . 41.32 109.261 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -66.27 124.91 23.97 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 123.731 0.644 . . . . 74.5 109.434 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 63.77 0.59 0.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.84 1.256 . . . . 74.21 113.887 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.9 t -108.29 114.11 45.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 107.728 -1.212 . . . . 72.41 107.728 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 129.33 37.12 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.195 -1.039 . . . . 75.14 108.195 -170.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.441 ' HB2' HD12 ' D' ' 51' ' ' LEU . 30.2 tt0 -99.82 147.47 25.46 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.325 1.05 . . . . 53.24 109.4 177.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.16 127.47 73.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.378 -1.342 . . . . 72.41 107.378 170.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.43 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 61.8 t -109.58 109.95 30.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.994 -0.743 . . . . 75.22 108.994 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.85 119.35 30.98 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.789 -0.819 . . . . 74.21 108.789 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 47.7 ttm-85 -98.74 109.98 22.66 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.88 -1.156 . . . . 73.55 107.88 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.535 HG23 ' HB1' ' D' ' 110' ' ' ALA . 38.8 t -115.06 118.77 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.787 -0.819 . . . . 72.51 108.787 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 12.0 m -115.46 144.31 44.02 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.487 1.115 . . . . 74.53 109.381 -171.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.495 HG21 HD22 ' D' ' 126' ' ' LEU . 58.5 t -139.01 103.82 2.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.18 0.992 . . . . 74.1 108.919 172.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 99.9 m -97.47 120.19 37.38 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.25 -1.019 . . . . 75.42 108.25 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' D' ' 38' ' ' PRO . . . -122.37 154.93 37.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.659 0.784 . . . . 74.34 110.925 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.406 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 54.7 m -150.6 139.69 21.1 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.562 0.539 . . . . 73.11 112.127 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 11.7 mt -110.7 121.05 44.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.054 1.342 . . . . 74.52 108.977 171.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.0 -113.28 4.27 Favored Glycine 0 C--N 1.341 0.829 0 O-C-N 123.338 0.399 . . . . 72.11 112.72 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.12 5.86 18.81 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.103 0.961 . . . . 74.11 110.898 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.418 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 15.8 pt-20 -132.13 158.75 40.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.86 0.464 . . . . 63.23 110.613 -174.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 65.4 m -71.39 138.48 49.19 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 116.061 -0.518 . . . . 74.0 110.603 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.552 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -91.19 -68.67 0.78 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.891 0.876 . . . . 71.54 109.624 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -146.36 145.96 30.49 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 121.551 0.691 . . . . 74.21 110.25 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -120.24 141.03 50.31 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.658 1.583 . . . . 74.33 106.956 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.571 ' SG ' HG22 ' D' ' 114' ' ' ILE . 42.4 t -153.79 139.0 17.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.56 -0.534 . . . . 72.44 109.56 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -156.9 132.16 9.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.41 -0.589 . . . . 75.33 109.41 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.06 120.15 46.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.756 0.823 . . . . 75.21 109.277 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.613 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.3 mt-30 -89.43 86.82 6.87 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.647 -0.872 . . . . 75.34 108.647 169.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -80.03 94.4 5.93 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.695 -1.139 . . . . 73.14 108.917 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.09 143.34 18.07 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.926 -0.47 . . . . 70.04 111.926 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.542 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -140.64 131.5 5.01 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.714 -0.554 . . . . 64.13 111.714 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -94.67 125.13 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.719 0.808 . . . . 73.23 109.447 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -132.18 125.11 30.4 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.052 0.941 . . . . 71.34 109.743 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.6 m -87.76 104.15 16.29 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.524 -0.547 . . . . 72.54 109.524 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.438 HD12 ' SD ' ' D' ' 94' ' ' MET . 39.9 pt -107.08 141.19 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.902 0.881 . . . . 75.53 110.807 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.413 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -169.14 165.96 10.95 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.976 0.91 . . . . 75.33 110.889 173.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.72 -19.62 19.39 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.197 -0.456 . . . . 73.34 112.925 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.409 HD12 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -118.97 149.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.084 0.953 . . . . 71.35 108.691 177.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -154.32 160.06 41.54 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.336 0.495 . . . . 73.42 112.336 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.36 -121.31 24.98 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 114.791 -1.095 . . . . 74.12 113.51 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.7 p -71.12 -31.98 68.44 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.892 0.877 . . . . 72.33 111.484 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -69.59 -40.34 76.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.761 0.425 . . . . 74.52 110.109 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.438 ' SD ' HD12 ' D' ' 86' ' ' ILE . 7.1 tmm? -72.45 -37.65 68.48 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.382 -0.826 . . . . 71.13 109.777 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.74 71.27 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.031 0.532 . . . . 72.34 111.507 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -69.49 -39.39 77.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.129 0.972 . . . . 72.13 110.16 175.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -68.85 -50.31 50.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.808 -0.633 . . . . 74.22 110.435 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.68 -25.21 44.78 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.554 0.742 . . . . 74.45 111.645 -168.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.12 11.23 37.22 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-O 119.607 -0.552 . . . . 74.3 113.543 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.36 -58.25 0.2 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.184 0.492 . . . . 74.21 111.227 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -70.7 -46.95 62.17 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.272 0.629 . . . . 64.53 111.689 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 55.1 m -67.37 -44.21 45.75 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.503 -0.76 . . . . 71.1 111.693 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -56.52 -32.82 90.96 Favored 'Trans proline' 0 C--N 1.394 2.922 0 C-N-CA 122.479 2.119 . . . . 74.35 113.423 165.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -71.34 -25.32 62.34 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.002 0.521 . . . . 72.32 111.216 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 64.0 mt -77.12 -34.47 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.894 0.877 . . . . 75.23 110.138 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.542 HD22 ' HA3' ' D' ' 82' ' ' GLY . 95.9 mt -76.77 -22.71 53.37 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.561 -0.745 . . . . 75.35 111.724 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -67.41 -42.05 35.74 Favored Pre-proline 0 CA--C 1.565 1.557 0 N-CA-C 113.941 1.089 . . . . 74.11 113.941 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -60.41 -40.49 57.32 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.097 1.865 . . . . 74.11 112.71 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -73.06 -33.71 65.83 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.586 0.754 . . . . 75.54 111.511 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.535 ' HB1' HG23 ' D' ' 62' ' ' VAL . . . -63.79 -53.12 55.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.641 0.776 . . . . 75.2 109.523 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -54.65 -48.57 72.15 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 124.895 1.372 . . . . 75.01 110.588 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -60.33 -46.3 90.4 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.155 0.909 . . . . 72.31 111.651 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.02 -42.08 93.59 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.788 0.68 . . . . 73.1 110.719 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.571 HG22 ' SG ' ' D' ' 76' ' ' CYS . 72.2 mt -64.17 -50.66 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 124.174 0.921 . . . . 74.45 110.988 174.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 41.5 m -57.32 -42.42 81.81 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.808 1.243 . . . . 74.34 110.831 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -65.31 -41.61 93.87 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.264 -1.334 . . . . 74.25 110.446 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.455 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 73.3 mtm -71.6 -31.06 66.51 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.198 0.444 . . . . 55.21 112.198 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.73 -42.06 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.328 0.651 . . . . 75.25 109.842 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 84.6 p -76.22 -27.08 56.67 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.876 0.47 . . . . 72.14 111.531 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -75.83 -34.2 60.1 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.002 0.521 . . . . 74.24 110.057 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.72 89.41 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.981 -0.554 . . . . 53.02 111.962 171.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 38.5 p 64.01 19.57 11.81 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.153 2.181 . . . . 75.11 114.077 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -78.4 149.39 75.4 Favored Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 108.549 -0.908 . . . . 72.54 108.549 170.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.34 137.35 71.4 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.817 2.345 . . . . 71.55 112.113 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -55.55 146.21 21.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.793 1.237 . . . . 71.2 113.247 -164.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.495 HD22 HG21 ' D' ' 64' ' ' VAL . 38.3 tp -116.48 94.21 4.53 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.256 -0.884 . . . . 75.42 109.328 -176.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.451 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 88.0 m-20 -104.82 91.48 3.85 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.563 -0.903 . . . . 74.52 108.563 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 23.6 tp -73.66 133.54 43.44 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.409 -0.814 . . . . 75.11 110.314 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.19 146.02 99.0 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.582 0.753 . . . . 73.44 111.167 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.4 124.33 3.63 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.329 2.019 . . . . 74.44 111.048 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 99.3 t -107.27 133.48 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.032 -0.531 . . . . 74.42 109.594 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -79.35 88.61 4.97 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.007 -0.738 . . . . 72.43 109.007 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -65.21 -24.87 67.48 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.759 -1.109 . . . . 73.22 111.469 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.95 -52.67 63.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.884 0.873 . . . . 71.53 110.593 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.02 -37.59 66.87 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.348 -0.842 . . . . 62.14 111.721 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.25 -31.33 72.07 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 115.616 -0.72 . . . . 75.42 110.162 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 84.4 t80 . . . . . 0 N--CA 1.485 1.312 0 C-N-CA 123.811 0.845 . . . . 75.1 110.653 176.581 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.6 m . . . . . 0 C--O 1.239 0.501 0 N-CA-C 108.732 -0.84 . . . . 71.13 108.732 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.485 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 35.9 t80 -136.31 111.91 9.34 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.32 -0.992 . . . . 74.35 108.32 170.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -136.47 124.56 22.96 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.549 -0.908 . . . . 61.44 108.549 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.488 HG12 ' HD2' ' A' ' 84' ' ' PHE . 50.3 mt -89.45 112.04 23.82 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.781 -0.822 . . . . 75.15 108.781 172.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -74.29 -38.59 63.32 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 124.412 1.07 . . . . 65.41 109.523 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -167.07 140.87 3.72 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.829 -0.623 . . . . 73.11 110.568 -169.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.427 HD13 ' HB3' ' C' ' 130' ' ' PRO . 79.6 mt -128.72 135.1 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.054 -1.091 . . . . 73.41 108.054 172.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -162.98 151.24 13.99 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 124.18 0.925 . . . . 74.34 110.249 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -74.64 121.93 22.39 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.842 -0.799 . . . . 74.41 108.842 172.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mtpt -82.07 -32.61 30.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.716 -0.475 . . . . 72.54 109.716 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.6 t70 -147.72 141.53 25.73 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.057 -0.974 . . . . 73.5 109.462 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 70.1 mt -136.67 147.67 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.138 1.375 . . . . 71.12 107.494 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.548 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 40.4 t -157.23 149.45 22.81 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.305 0.642 . . . . 75.24 109.699 172.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 88.8 t80 -151.53 124.53 8.65 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.368 -1.716 . . . . 75.4 106.368 177.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -129.41 114.27 15.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.73 0.412 . . . . 71.33 109.954 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.28 77.0 67.54 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 108.018 -1.105 . . . . 73.14 108.018 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.68 -29.01 20.13 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.203 1.935 . . . . 73.04 110.354 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.404 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 72.3 m-20 -100.94 24.64 9.0 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.139 1.376 . . . . 74.3 110.072 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.47 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -56.98 -42.59 97.17 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 124.536 1.134 . . . . 72.32 112.742 170.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.3 -24.61 14.24 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 121.87 1.713 . . . . 73.32 112.52 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -72.86 -33.7 66.27 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.223 0.609 . . . . 73.13 111.184 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.614 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 9.8 p -68.33 -25.36 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 123.52 0.513 . . . . 72.25 111.049 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -69.8 -33.66 72.66 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.241 1.016 . . . . 62.25 110.118 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -92.27 -33.73 14.53 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.76 0.824 . . . . 73.34 111.562 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.614 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -82.67 171.77 13.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.189 0.595 . . . . 73.42 110.364 176.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -86.2 138.96 31.48 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.009 0.524 . . . . 73.24 110.687 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.6 t-105 -76.26 87.0 3.08 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 121.506 0.669 . . . . 63.42 110.205 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -125.52 79.68 66.94 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 108.341 -0.985 . . . . 74.31 108.341 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -86.39 138.65 5.61 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.104 2.536 . . . . 70.34 114.248 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -112.04 110.71 21.16 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 106.334 -1.728 . . . . 74.13 106.334 166.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.7 m -112.97 134.87 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.917 0.887 . . . . 72.51 111.619 -165.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -121.69 149.18 43.61 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.719 0.808 . . . . 74.42 110.171 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -127.32 109.29 11.65 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.035 0.934 . . . . 73.22 108.505 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -106.58 118.5 36.82 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.673 -0.862 . . . . 73.43 108.673 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 60' ' ' LEU . 9.8 tt -116.04 141.62 47.88 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 122.788 0.435 . . . . 74.24 110.216 -177.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -143.23 132.56 23.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.934 1.293 . . . . 75.14 108.91 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.0 m -109.94 135.9 50.07 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.116 0.967 . . . . 75.01 108.631 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.01 129.67 40.41 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.716 0.806 . . . . 60.14 109.917 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.5 p -93.73 152.07 19.2 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.001 0.52 . . . . 73.44 110.545 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 43.3 t -150.03 151.96 34.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.19 0.996 . . . . 64.21 108.379 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -112.46 116.14 29.81 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.121 -0.696 . . . . 74.32 109.121 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.0 mt -92.04 -33.45 14.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.532 0.733 . . . . 73.35 110.421 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.67 178.67 10.07 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.32 -0.855 . . . . 73.45 109.968 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.59 121.77 14.7 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.198 -0.668 . . . . 73.04 109.198 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 69.25 9.53 7.38 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.602 1.161 . . . . 75.1 112.199 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.21 115.93 51.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 108.74 -0.837 . . . . 74.23 108.74 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -112.74 127.33 56.11 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.426 0.69 . . . . 72.43 110.022 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 44.9 tt0 -91.78 127.74 37.35 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.876 -1.056 . . . . 73.44 108.795 169.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.408 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 64.7 t -108.77 122.5 63.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.714 -1.217 . . . . 75.13 107.714 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.9 t -104.37 107.04 21.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.896 -1.15 . . . . 63.24 107.896 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 44' ' ' LEU . 43.6 tp -87.85 98.96 11.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.53 -0.915 . . . . 71.43 108.53 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -84.99 110.59 19.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.438 -0.801 . . . . 71.53 109.447 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.4 t -112.84 107.72 23.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.64 -0.874 . . . . 74.33 108.64 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.7 m -95.29 125.71 40.1 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.117 0.967 . . . . 75.44 108.984 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.695 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 26.5 t -118.43 135.52 58.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 124.721 1.209 . . . . 63.42 108.901 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 t -141.31 138.16 32.94 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.23 0.612 . . . . 74.32 109.542 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.58 103.3 6.79 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.947 0.899 . . . . 62.42 108.933 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.2 p -111.24 124.77 52.89 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.009 0.523 . . . . 65.23 109.92 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.598 HD13 ' HB1' ' A' ' 73' ' ' ALA . 8.6 mp -96.82 85.34 3.78 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.063 -1.088 . . . . 72.24 108.063 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.18 -105.62 2.91 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 114.413 -1.267 . . . . 54.55 110.472 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -105.85 -24.73 12.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.821 0.848 . . . . 75.24 110.402 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 22.4 tt0 -96.55 120.33 36.66 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.416 0.687 . . . . 74.44 111.088 -176.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 57.1 m -75.93 126.86 31.8 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.265 1.026 . . . . 75.04 110.959 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.598 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -69.61 -57.99 4.5 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.147 0.579 . . . . 63.23 109.806 174.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -145.77 157.67 43.91 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 114.719 -1.128 . . . . 75.15 111.419 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.0 tp -129.74 146.29 51.5 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.677 -1.601 . . . . 75.42 107.439 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.695 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.0 m -141.8 141.12 33.16 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.526 -0.916 . . . . 71.32 108.526 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.548 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 8.2 tp10 -147.22 120.96 9.22 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.792 -0.818 . . . . 61.52 108.792 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -135.23 110.22 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.706 -0.479 . . . . 75.55 109.706 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 68.5 mt-30 -91.48 82.87 5.35 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.183 -1.043 . . . . 72.53 108.183 172.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -75.74 106.88 7.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.834 -1.075 . . . . 73.14 109.386 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.98 151.83 20.08 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 112.02 -0.432 . . . . 51.45 112.02 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.02 141.58 10.05 Favored Glycine 0 C--O 1.239 0.442 0 N-CA-C 111.246 -0.742 . . . . 64.34 111.246 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mt -90.65 118.78 36.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.613 -0.884 . . . . 75.02 108.613 173.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.488 ' HD2' HG12 ' A' ' 13' ' ' ILE . 17.7 m-85 -124.08 118.91 28.01 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.559 -0.904 . . . . 63.25 108.559 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.4 p -90.56 110.23 21.36 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 108.473 -0.936 . . . . 74.34 108.473 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.433 ' HB ' HD13 ' A' ' 89' ' ' ILE . 2.8 pp -112.57 150.5 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.361 0.665 . . . . 74.13 111.422 -171.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.54 159.91 38.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.913 0.885 . . . . 72.54 109.534 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.27 4.94 84.89 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 123.533 0.52 . . . . 72.01 114.137 170.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.502 HG23 HE21 ' A' ' 93' ' ' GLN . 2.6 pp -134.42 148.65 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.97 0.908 . . . . 64.01 109.537 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.636 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 19.3 tt0 -166.89 175.5 7.67 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.962 0.505 . . . . 74.32 110.363 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.491 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 62.04 -134.89 46.14 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.44 0.543 . . . . 73.22 113.741 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.9 p -71.3 -24.6 62.17 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.618 0.767 . . . . 71.52 111.682 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.502 HE21 HG23 ' A' ' 89' ' ' ILE . 28.5 tt0 -72.28 -37.94 68.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.156 0.583 . . . . 74.43 110.07 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.636 ' HE1' ' HA ' ' A' ' 90' ' ' GLU . 48.2 ttm -62.6 -42.35 99.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.944 0.498 . . . . 71.22 110.374 172.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.11 -33.58 65.25 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.937 0.773 . . . . 70.22 111.143 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -76.03 -36.47 59.1 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 116.046 -0.524 . . . . 73.23 111.262 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 64.5 m -62.05 -57.58 11.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.798 0.439 . . . . 74.21 111.064 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 pp -91.11 -9.13 46.75 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.433 0.693 . . . . 70.24 112.583 -176.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.86 3.67 30.42 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 119.893 -0.393 . . . . 64.42 113.788 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.17 -63.13 0.35 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.318 0.559 . . . . 74.21 111.31 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.485 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 75.2 t80 -61.94 -58.78 6.58 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.25 -0.887 . . . . 73.43 111.886 -173.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.9 m -70.24 -34.92 4.43 Favored Pre-proline 0 CA--C 1.569 1.697 0 N-CA-C 114.128 1.159 . . . . 62.44 114.128 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -52.63 -42.9 59.28 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.24 1.96 . . . . 75.43 112.492 163.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -67.44 -28.32 67.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.247 0.619 . . . . 75.21 111.197 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.96 -45.44 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.814 0.845 . . . . 74.55 110.468 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.19 -18.07 60.81 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.838 -0.619 . . . . 75.02 111.63 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -62.35 -44.44 88.1 Favored Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 124.273 1.029 . . . . 74.34 113.715 -170.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.32 -36.43 79.14 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.1 1.867 . . . . 74.1 113.268 172.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.442 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 81.3 m-85 -68.22 -43.02 78.93 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.474 0.71 . . . . 70.11 111.516 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.24 83.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.092 0.557 . . . . 71.43 109.95 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -52.03 -51.43 57.47 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 124.164 0.915 . . . . 75.01 110.151 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.66 -45.85 84.97 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.036 0.935 . . . . 74.33 111.307 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.0 t -59.84 -34.13 72.69 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.047 0.539 . . . . 64.2 111.37 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.408 HG22 HG22 ' A' ' 64' ' ' VAL . 81.6 mt -74.41 -54.54 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.749 0.82 . . . . 65.43 109.848 175.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.439 HG22 ' HG3' ' A' ' 125' ' ' GLN . 89.3 m -48.81 -45.39 40.25 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.909 1.284 . . . . 65.5 111.66 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -63.48 -46.37 86.46 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.811 -1.086 . . . . 64.35 109.95 -175.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 64.1 mtm -64.38 -38.46 91.09 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.144 0.578 . . . . 75.55 111.201 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.69 -43.09 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.569 0.748 . . . . 74.52 110.391 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.8 m -73.61 -32.4 64.06 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.532 0.733 . . . . 74.12 111.159 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -72.33 -30.17 64.5 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.653 0.781 . . . . 74.04 109.672 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.67 -2.89 90.2 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 124.028 0.83 . . . . 74.22 112.788 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m 66.98 25.39 9.33 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 122.479 1.133 . . . . 74.34 110.838 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.421 ' CE1' HG12 ' A' ' 31' ' ' VAL . 96.6 m-85 -91.26 155.68 44.28 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 115.451 -0.795 . . . . 70.45 109.524 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.02 124.61 15.12 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.77 2.313 . . . . 65.52 112.024 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.439 ' HG3' HG22 ' A' ' 115' ' ' THR . 34.3 tt0 -54.76 134.81 47.78 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 124.214 0.947 . . . . 73.35 112.184 -173.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.0 tp -112.03 116.52 30.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.85 -1.068 . . . . 73.44 109.502 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -130.98 100.12 5.13 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.285 -1.005 . . . . 74.52 108.285 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.74 151.14 43.81 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.86 0.464 . . . . 74.43 110.255 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.55 150.61 89.11 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 123.139 0.576 . . . . 62.33 110.601 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.11 120.0 7.05 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.652 2.235 . . . . 74.43 110.472 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.56 124.43 54.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.657 -0.868 . . . . 75.45 108.657 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -77.02 88.53 3.55 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.982 0.801 . . . . 73.35 109.683 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -64.31 -24.12 67.54 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.146 -0.934 . . . . 72.32 111.05 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.2 -52.71 64.42 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 123.896 0.747 . . . . 71.44 110.107 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.8 -50.79 72.02 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 124.018 0.824 . . . . 74.32 110.285 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -54.36 -43.88 71.71 Favored 'General case' 0 C--O 1.243 0.726 0 O-C-N 124.503 1.127 . . . . 72.14 111.857 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -72.52 -41.45 65.87 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 116.113 -0.494 . . . . 65.34 109.868 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.3 mtp . . . . . 0 C--O 1.218 -0.603 0 CA-C-O 119.28 -0.391 . . . . 75.02 111.483 -175.022 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.4 m . . . . . 0 C--O 1.242 0.693 0 N-CA-C 107.936 -1.135 . . . . 72.34 107.936 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.11 156.76 43.67 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.083 0.468 . . . . 63.14 109.971 160.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -125.96 141.19 52.08 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.072 -0.967 . . . . 70.01 108.645 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.563 HD11 HD12 ' B' ' 105' ' ' ILE . 48.7 mt -84.69 121.5 36.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.525 -0.917 . . . . 75.11 108.525 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -88.06 -38.26 15.59 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.601 0.563 . . . . 75.34 110.196 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -170.52 131.14 0.9 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.986 -0.552 . . . . 75.31 109.92 -170.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.7 mt -114.94 140.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 107.153 -1.425 . . . . 72.31 107.153 170.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -167.34 145.54 4.81 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.353 0.597 . . . . 75.23 112.376 -174.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.1 m -75.02 124.88 27.77 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.475 -1.238 . . . . 75.21 109.158 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -98.08 -36.28 10.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.953 0.501 . . . . 74.3 110.391 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 17.8 t70 -147.76 133.66 19.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.51 -0.314 . . . . 70.21 110.643 -168.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.474 HD13 ' SG ' ' B' ' 113' ' ' CYS . 47.1 mm -133.55 145.95 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.756 1.222 . . . . 75.12 108.842 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.0 t -147.1 136.25 22.5 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.655 1.182 . . . . 65.2 108.147 173.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -147.84 113.91 5.83 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.925 -1.139 . . . . 74.55 107.925 172.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -119.07 119.25 33.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.071 0.948 . . . . 73.2 108.562 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.476 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -108.3 85.1 2.57 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 108.189 -1.041 . . . . 74.3 108.189 168.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -65.94 -35.94 32.8 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 122.997 2.465 . . . . 74.4 112.028 -173.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -106.28 9.86 31.89 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.856 -1.065 . . . . 71.15 110.68 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.532 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -25.2 -66.16 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.061 0 C-N-CA 126.287 1.835 . . . . 71.45 115.162 -174.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 10.5 Cg_exo -67.2 -30.79 37.24 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 122.362 2.042 . . . . 74.44 112.168 -169.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -96.57 -30.16 13.45 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.019 -0.991 . . . . 64.14 112.053 -170.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.634 HG23 HD13 ' B' ' 68' ' ' LEU . 10.7 p -72.4 -19.74 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 122.471 0.308 . . . . 63.13 111.132 -174.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -63.73 -14.11 49.51 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.574 0.75 . . . . 71.41 112.295 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -64.01 -22.93 67.14 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.57 0.748 . . . . 64.34 111.794 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.505 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 96.6 mttt -97.92 100.97 12.34 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.022 0.929 . . . . 75.44 109.353 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.47 95.98 4.6 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.636 -0.505 . . . . 72.33 109.636 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -166.61 155.86 11.05 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.67 0.788 . . . . 74.43 109.237 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -75.37 105.1 1.73 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.006 -0.738 . . . . 72.02 109.006 170.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.509 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 21.1 Cg_endo -58.89 127.48 24.52 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.692 2.261 . . . . 73.33 112.202 -171.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -51.56 126.16 16.67 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.376 1.047 . . . . 71.21 110.225 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.553 HG11 HG12 ' B' ' 64' ' ' VAL . 89.6 t -106.22 139.58 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.363 0.665 . . . . 75.43 110.911 -171.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -108.02 125.72 51.88 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.821 -1.178 . . . . 72.33 107.821 162.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -85.04 137.86 32.8 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.451 -0.944 . . . . 71.32 108.451 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.47 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.1 t70 -133.2 135.65 45.19 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.51 -1.293 . . . . 72.31 107.51 175.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.59 127.45 27.46 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.226 -1.028 . . . . 73.44 108.226 -177.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.49 145.75 34.02 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.069 -1.456 . . . . 73.14 107.069 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 34.6 p -127.86 120.1 27.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.012 -0.736 . . . . 75.21 109.012 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -119.95 116.14 25.19 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.747 0.819 . . . . 73.21 108.886 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -113.87 170.58 8.16 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.751 0.421 . . . . 72.01 111.616 -172.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 87.2 p -152.8 143.89 23.08 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.786 0.834 . . . . 74.34 110.251 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -83.13 136.14 34.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.198 0.599 . . . . 72.01 109.785 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 58.7 mt -101.67 -46.71 4.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.557 0.743 . . . . 64.52 110.645 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.07 -169.47 2.96 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.305 -0.862 . . . . 75.45 111.156 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -62.98 105.67 0.71 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.01 -0.996 . . . . 64.34 110.343 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 64.11 11.69 6.41 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.277 1.031 . . . . 73.31 112.026 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.4 112.2 37.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 106.567 -1.642 . . . . 74.22 106.567 173.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -133.85 137.94 45.32 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.491 -0.929 . . . . 75.11 108.491 -173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -107.89 137.09 46.51 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.483 0.713 . . . . 74.31 109.641 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.84 143.01 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.53 -0.915 . . . . 65.03 108.53 171.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 40.4 t -125.67 125.17 68.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 109.088 -0.708 . . . . 74.31 109.088 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.419 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -102.54 112.33 25.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.71 -1.132 . . . . 75.42 108.572 -174.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -97.62 110.98 23.44 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.587 0.755 . . . . 73.23 110.627 174.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.06 104.46 17.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.968 -1.123 . . . . 74.42 107.968 170.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 9.5 m -99.21 130.77 45.53 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.761 -0.829 . . . . 72.13 108.761 174.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.553 HG12 HG11 ' B' ' 40' ' ' VAL . 43.4 t -118.13 127.33 75.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 123.907 0.883 . . . . 73.55 108.93 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 87.9 m -109.75 137.85 46.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.403 -0.962 . . . . 75.11 108.403 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -146.61 145.86 30.22 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 122.844 0.457 . . . . 71.5 109.812 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.414 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.5 p -151.61 138.05 18.59 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.309 -0.86 . . . . 74.12 110.663 -172.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.634 HD13 HG23 ' B' ' 31' ' ' VAL . 60.4 mt -103.78 124.3 48.65 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.916 0.886 . . . . 74.03 109.923 174.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.51 -108.55 2.46 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 123.636 0.585 . . . . 74.32 112.733 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.61 5.0 12.36 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.854 0.862 . . . . 73.43 111.399 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.505 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 11.2 pt-20 -119.71 156.61 30.18 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.97 0.508 . . . . 71.54 110.019 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.2 m -68.3 137.84 55.0 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.595 0.56 . . . . 73.2 110.459 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.554 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -91.64 -65.01 1.04 Allowed 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.478 -1.304 . . . . 73.2 107.478 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -150.88 161.56 42.45 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.088 -0.96 . . . . 74.31 110.244 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.8 mt -132.85 111.56 11.19 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.047 -1.464 . . . . 74.35 107.047 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.2 t -118.86 153.45 34.52 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.005 -0.739 . . . . 74.41 109.005 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -160.64 131.39 5.44 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.875 -0.787 . . . . 75.42 108.875 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' B' ' 110' ' ' ALA . 86.2 t -128.09 145.29 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.679 -0.86 . . . . 73.41 108.679 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.531 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.0 mt-30 -126.37 95.96 4.54 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.999 -0.741 . . . . 73.42 108.999 172.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -86.2 104.01 15.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.167 -0.924 . . . . 73.14 109.895 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.44 153.85 25.55 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 111.673 -0.571 . . . . 52.33 111.673 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.44 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -154.02 127.11 2.06 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 111.417 -0.673 . . . . 75.12 111.417 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 62.7 mt -86.87 126.04 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.6 0.76 . . . . 73.14 109.68 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -131.74 132.07 43.54 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 107.713 -1.217 . . . . 72.41 107.713 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 31.6 m -102.95 91.66 4.23 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.194 -0.669 . . . . 73.2 109.194 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.521 HG13 ' HE2' ' B' ' 94' ' ' MET . 0.2 OUTLIER -94.79 142.58 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 115.859 -0.61 . . . . 72.35 110.939 -167.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.07 158.31 42.83 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.328 1.051 . . . . 73.44 109.399 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.47 -56.71 3.87 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.705 -0.68 . . . . 54.3 111.801 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.505 HD13 ' HB ' ' B' ' 86' ' ' ILE . 11.4 pt -69.13 149.7 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.81 0.844 . . . . 74.43 112.168 177.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -159.16 176.15 12.58 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 125.481 1.512 . . . . 72.22 107.588 171.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.09 -129.78 50.06 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.392 0.433 . . . . 74.22 112.716 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -83.38 -19.26 36.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.609 0.364 . . . . 70.44 111.719 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -72.89 -25.98 61.27 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.785 -0.45 . . . . 74.11 109.785 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.797 ' HE3' HD13 ' B' ' 98' ' ' LEU . 24.1 ttt -78.85 -33.57 45.78 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.127 -0.488 . . . . 71.52 110.12 170.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.17 -29.83 70.03 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.219 0.608 . . . . 64.13 111.001 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -69.2 -39.4 78.65 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.463 0.705 . . . . 72.11 111.414 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.8 t -66.87 -66.19 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.267 -0.879 . . . . 64.32 109.81 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.797 HD13 ' HE3' ' B' ' 94' ' ' MET . 38.8 mt -70.18 -27.31 64.42 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.555 0.742 . . . . 71.3 112.098 -172.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.25 -12.61 58.48 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.574 0.546 . . . . 64.3 114.298 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.51 -55.36 0.39 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.58 0.69 . . . . 74.24 112.282 -173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.435 ' OH ' ' HB3' ' D' ' 130' ' ' PRO . 66.2 t80 -75.86 -48.17 22.57 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.392 0.516 . . . . 75.44 112.392 -169.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.406 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 88.1 m -59.3 -50.09 89.31 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 123.676 0.791 . . . . 73.44 111.567 176.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.419 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 69.9 Cg_exo -55.22 -36.3 93.02 Favored 'Trans proline' 0 C--N 1.389 2.683 0 C-N-CA 121.968 1.779 . . . . 74.15 113.561 169.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.16 -40.63 90.58 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 123.185 0.594 . . . . 73.43 110.643 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.563 HD12 HD11 ' B' ' 13' ' ' ILE . 67.6 mt -63.79 -43.61 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.599 0.76 . . . . 74.45 110.404 175.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.44 HD21 ' HA3' ' B' ' 82' ' ' GLY . 65.9 mt -78.66 -18.89 53.72 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.064 -0.971 . . . . 75.22 112.034 -174.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -58.49 -51.83 79.01 Favored Pre-proline 0 N--CA 1.482 1.162 0 N-CA-C 113.963 1.097 . . . . 75.25 113.963 -170.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.95 -32.23 92.25 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 121.671 1.58 . . . . 73.22 113.312 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -66.05 -50.63 63.47 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.286 0.634 . . . . 74.33 110.472 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.428 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -59.16 -40.09 84.5 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.2 -0.909 . . . . 74.53 110.812 177.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -65.56 -49.02 70.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.506 1.523 . . . . 73.25 110.939 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -68.27 -34.53 76.34 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.81 -0.632 . . . . 72.31 109.842 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.484 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.7 t -67.99 -34.32 76.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.777 0.431 . . . . 74.01 111.223 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.464 ' O ' HG23 ' B' ' 118' ' ' VAL . 66.6 mt -63.83 -56.48 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.662 -0.495 . . . . 63.24 109.662 172.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.1 m -60.42 -26.02 66.39 Favored 'General case' 0 CA--C 1.554 1.131 0 O-C-N 123.973 0.796 . . . . 55.0 111.473 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.0 t -62.99 -50.45 70.69 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.225 0.61 . . . . 62.43 109.836 173.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -71.57 -32.1 67.7 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.414 0.686 . . . . 62.05 111.079 -176.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 114' ' ' ILE . 87.6 t -61.98 -44.62 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.65 0.78 . . . . 74.42 109.55 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.6 t -65.37 -35.76 81.93 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.039 -0.982 . . . . 72.42 111.368 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.0 mtt-85 -68.06 -32.17 72.32 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.475 -0.784 . . . . 74.55 110.323 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.87 8.12 77.29 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.952 0.783 . . . . 75.53 112.965 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 61.5 p 54.77 27.42 8.82 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.15 1.78 . . . . 74.14 113.626 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -83.43 154.74 66.16 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.397 0.679 . . . . 73.55 110.09 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -55.99 157.42 16.89 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.083 2.522 . . . . 55.33 113.223 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -64.56 113.77 3.92 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.369 -0.832 . . . . 73.23 111.38 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.1 mt -121.09 119.51 32.64 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.899 -0.778 . . . . 64.44 108.899 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -115.0 112.98 23.5 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.806 -0.813 . . . . 74.51 108.806 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.35 143.26 56.06 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.33 0.652 . . . . 72.2 111.353 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.56 150.9 64.16 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.843 0.857 . . . . 63.41 110.687 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.23 145.3 17.02 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.879 2.386 . . . . 72.11 111.775 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.31 118.59 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.246 -1.02 . . . . 72.53 108.246 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -79.8 83.37 5.75 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.618 -0.512 . . . . 64.21 109.618 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -64.45 -24.28 67.57 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.528 0.731 . . . . 74.1 111.962 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.56 -52.05 55.28 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.523 0.729 . . . . 74.51 110.268 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.16 95.26 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.937 0.895 . . . . 71.23 110.938 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 89.9 mt -74.07 -20.89 60.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.075 -0.966 . . . . 73.11 112.028 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 61.0 t80 . . . . . 0 N--CA 1.477 0.9 0 C-N-CA 122.625 0.37 . . . . 64.41 110.732 177.865 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 59.5 m . . . . . 0 N--CA 1.466 0.328 0 N-CA-C 108.206 -1.035 . . . . 74.35 108.206 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.61 ' HD1' ' HH ' ' C' ' 101' ' ' TYR . 1.1 t80 -120.23 126.32 50.34 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.808 -0.812 . . . . 75.01 108.808 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -142.51 109.05 5.34 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.385 -0.968 . . . . 74.02 108.385 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -73.82 122.11 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.158 -0.682 . . . . 73.34 109.158 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.567 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.8 mm-40 -86.47 -42.26 13.73 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.179 -0.919 . . . . 74.54 110.35 -175.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -175.56 139.93 0.45 Allowed 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.614 0.571 . . . . 74.55 109.523 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.418 HD11 HG21 ' C' ' 105' ' ' ILE . 72.0 mt -131.56 133.87 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.463 -0.94 . . . . 72.13 108.463 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.436 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 27.3 p90 -170.64 172.61 5.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.691 0.758 . . . . 73.13 111.565 -169.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -96.07 118.5 32.79 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.382 -0.827 . . . . 72.32 109.16 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.436 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.8 mmtp -65.78 -48.16 72.73 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 122.33 1.062 . . . . 71.1 108.156 169.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.5 t70 -139.82 146.25 39.16 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 113.814 -1.539 . . . . 74.04 109.884 -172.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.58 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 80.5 mt -140.39 140.93 33.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 106.701 -1.592 . . . . 75.22 106.701 174.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -159.25 149.84 19.51 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.173 0.511 . . . . 75.31 110.663 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.448 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.2 t80 -148.49 136.96 21.34 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.918 -1.141 . . . . 73.35 107.918 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.67 118.65 18.4 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.695 0.798 . . . . 63.41 109.754 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' C' ' 28' ' ' ALA . . . -136.92 76.87 45.2 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 106.356 -1.72 . . . . 62.51 106.356 165.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.07 -40.61 11.29 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.738 2.292 . . . . 74.33 111.199 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.03 21.12 3.27 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.628 -1.169 . . . . 73.22 111.417 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' C' ' 25' ' ' ALA . . . -44.65 -57.83 6.18 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 114.39 1.256 . . . . 65.33 114.39 -171.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.4 -36.43 66.67 Favored 'Trans proline' 0 C--N 1.385 2.459 0 CA-C-N 121.744 1.658 . . . . 70.43 112.397 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -70.07 -35.42 74.2 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.372 0.669 . . . . 74.31 112.135 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.658 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.5 p -79.6 -24.49 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 N-CA-C 111.886 0.328 . . . . 75.34 111.886 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.59 -30.2 69.75 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.617 0.367 . . . . 74.44 111.867 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -86.67 11.45 12.92 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.905 0.482 . . . . 74.45 111.12 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.742 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.99 160.05 14.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.231 1.012 . . . . 71.55 109.563 170.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -71.48 131.44 43.31 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.514 0.725 . . . . 63.14 110.561 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.531 ' NE1' ' HG3' ' C' ' 124' ' ' PRO . 31.5 t90 -73.86 91.91 2.02 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.424 -0.807 . . . . 75.41 111.297 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -147.04 74.43 11.98 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 107.444 -1.317 . . . . 75.33 107.444 169.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -85.15 137.14 6.04 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.732 2.288 . . . . 73.4 112.717 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -86.06 110.07 19.27 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.268 -1.012 . . . . 72.51 108.268 171.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -84.6 100.47 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-O 122.532 1.158 . . . . 74.14 110.978 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -95.74 103.29 15.16 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.784 -1.098 . . . . 74.52 108.279 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.52 134.75 36.73 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.25 -0.648 . . . . 74.31 109.25 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -127.67 136.08 51.1 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.352 -0.981 . . . . 73.41 108.352 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 tp -129.22 135.12 48.4 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.438 0.695 . . . . 72.22 109.683 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.401 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 27.5 t70 -149.04 153.06 37.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.883 0.873 . . . . 74.52 109.664 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -146.19 153.39 40.58 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.155 0.582 . . . . 73.21 109.441 170.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.55 160.54 39.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.248 1.019 . . . . 75.23 109.011 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -144.43 155.67 43.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.461 0.704 . . . . 72.32 109.223 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.5 p -157.4 153.78 27.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.601 0.76 . . . . 60.53 109.353 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -95.8 118.05 31.72 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.993 -0.743 . . . . 73.21 108.993 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' C' ' 57' ' ' GLU . 60.5 mt -89.37 -34.92 16.34 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.179 0.592 . . . . 75.43 110.337 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.3 -170.06 2.16 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.645 0.778 . . . . 63.02 111.004 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.91 111.44 1.66 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.85 0.86 . . . . 64.35 110.417 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 70.79 -5.75 1.4 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.344 1.458 . . . . 71.52 112.564 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.0 t -93.77 105.7 17.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.456 -0.942 . . . . 73.54 108.456 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -118.79 122.96 43.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.542 -0.754 . . . . 73.31 109.357 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.605 ' HB2' HD12 ' C' ' 51' ' ' LEU . 35.4 tt0 -84.36 144.7 28.65 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.532 0.733 . . . . 72.31 110.294 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -131.14 140.55 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.259 -1.015 . . . . 71.21 108.259 167.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 90.9 t -130.95 130.83 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.067 -1.086 . . . . 75.13 108.067 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.96 109.42 21.41 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.456 -1.313 . . . . 74.54 107.456 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.401 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.2 tmm_? -101.65 106.77 17.86 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.127 -1.064 . . . . 74.33 108.127 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.538 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.7 t -107.96 137.55 38.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.88 -1.156 . . . . 75.01 107.88 175.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -132.48 121.93 24.11 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.171 -0.678 . . . . 71.01 109.171 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 64.8 t -111.51 110.33 31.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 124.18 0.992 . . . . 75.13 108.9 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.475 HG23 HD22 ' C' ' 75' ' ' LEU . 4.0 m -108.85 108.28 19.0 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.226 0.61 . . . . 72.03 109.38 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.04 123.47 45.98 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.828 -0.804 . . . . 74.44 108.828 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.6 m -137.83 130.47 29.67 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.949 0.5 . . . . 65.23 111.046 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.742 HD11 ' HG2' ' C' ' 34' ' ' LYS . 6.6 mt -84.81 33.99 0.53 Allowed 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 125.255 1.422 . . . . 74.55 110.723 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.62 -100.13 1.84 Allowed Glycine 0 C--N 1.352 1.427 0 N-CA-C 111.052 -0.819 . . . . 74.22 111.052 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.61 -31.89 18.36 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.474 -0.565 . . . . 75.45 109.474 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.02 120.87 24.78 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.725 0.81 . . . . 63.31 109.13 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.5 m -76.73 128.7 35.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.981 -0.748 . . . . 75.14 108.981 169.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.658 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.08 -57.78 4.2 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.424 -0.954 . . . . 75.12 108.424 173.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -165.65 173.72 10.52 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.309 -0.86 . . . . 73.55 110.768 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.475 HD22 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -133.24 144.23 49.63 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.089 -1.448 . . . . 60.03 107.089 172.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.47 ' SG ' HG21 ' C' ' 114' ' ' ILE . 46.6 t -146.31 139.65 25.87 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.158 -1.053 . . . . 70.05 108.158 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -151.6 133.65 15.1 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.517 -0.549 . . . . 73.43 109.517 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.4 t -134.99 138.89 48.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.26 1.024 . . . . 75.12 108.474 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.437 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -114.17 88.17 2.79 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.258 -1.015 . . . . 72.42 108.258 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.414 ' HG3' HD22 ' C' ' 106' ' ' LEU . 9.5 tp-100 -79.1 97.77 6.27 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.175 -0.92 . . . . 74.43 110.197 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -98.74 144.13 17.03 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-O 121.199 0.333 . . . . 63.12 113.035 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.429 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -145.09 132.81 4.84 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.514 -1.034 . . . . 54.11 110.514 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 15.3 mm -88.97 123.7 41.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 108.394 -0.965 . . . . 71.35 108.394 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.6 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 51.2 m-85 -130.4 116.14 17.86 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.159 0.583 . . . . 71.51 109.787 -173.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 74.0 m -84.0 108.51 17.0 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.684 -0.487 . . . . 34.23 109.684 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.545 ' HB ' HD13 ' C' ' 89' ' ' ILE . 2.7 pp -117.06 138.61 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.949 0.899 . . . . 74.32 110.25 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -149.34 158.14 43.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.162 0.985 . . . . 72.54 109.554 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.39 -30.41 5.26 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 113.892 0.317 . . . . 73.22 113.892 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.545 HD13 ' HB ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -105.72 150.2 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 121.23 0.538 . . . . 75.43 111.792 -176.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.91 -170.79 3.73 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.784 -1.098 . . . . 75.55 108.505 166.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.05 -124.45 30.33 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 114.112 0.405 . . . . 74.3 114.112 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 74.1 p -76.35 -29.53 57.26 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.834 0.853 . . . . 71.22 111.806 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.87 -42.46 85.56 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.592 -0.521 . . . . 74.42 109.592 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 28.1 ttt -74.66 -33.12 62.45 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.857 -0.61 . . . . 75.22 110.807 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.62 -48.69 69.09 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.75 0.657 . . . . 63.15 109.706 174.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.57 ' HE2' ' HA ' ' C' ' 134' ' ' ASP . 11.6 t-80 -77.62 -35.16 52.99 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.857 0.723 . . . . 75.42 111.492 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.432 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 51.8 t -56.86 -36.79 70.46 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.849 0.718 . . . . 74.52 110.407 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 23.9 mt -101.07 -15.22 17.5 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.877 0.871 . . . . 71.52 110.917 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.76 -30.41 48.27 Favored Glycine 0 C--N 1.352 1.42 0 N-CA-C 114.842 0.697 . . . . 74.34 114.842 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.83 -36.88 0.06 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.938 0.495 . . . . 54.01 110.859 -172.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.61 ' HH ' ' HD1' ' C' ' 11' ' ' PHE . 70.4 t80 -66.88 -44.29 81.29 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.38 1.472 . . . . 74.42 112.282 -175.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 23.3 m -77.12 -47.91 2.6 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 123.394 0.678 . . . . 72.24 111.836 174.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -53.96 -28.85 51.37 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.138 1.892 . . . . 74.11 114.273 171.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -68.35 -39.56 81.81 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 123.109 0.564 . . . . 73.42 109.939 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.418 HG21 HD11 ' C' ' 16' ' ' ILE . 42.3 mm -59.92 -39.44 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.439 -0.578 . . . . 64.43 109.439 175.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.429 HD23 ' HA3' ' C' ' 82' ' ' GLY . 76.7 mt -85.52 -12.77 50.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.599 1.16 . . . . 75.33 112.501 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -63.37 -51.4 68.32 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 113.784 1.031 . . . . 73.42 113.784 -171.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -66.79 -30.99 40.26 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 121.731 1.621 . . . . 72.54 112.263 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.412 ' HE2' HG21 ' A' ' 115' ' ' THR . 93.3 m-85 -67.82 -46.25 72.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.457 0.703 . . . . 74.42 110.935 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.31 93.02 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.482 0.713 . . . . 63.5 109.806 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -53.15 -60.26 3.51 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.293 0.995 . . . . 71.31 110.938 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -62.56 -29.4 70.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.614 0.766 . . . . 74.15 110.945 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.444 ' SG ' HG12 ' C' ' 21' ' ' ILE . 8.3 t -72.55 -44.48 62.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.774 0.43 . . . . 75.21 110.832 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' C' ' 62' ' ' VAL . 85.5 mt -64.88 -50.09 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.31 0.644 . . . . 73.54 110.333 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.4 m -64.21 -29.34 70.45 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.413 -0.812 . . . . 75.25 110.741 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 28.1 t -65.54 -52.62 51.15 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.987 0.515 . . . . 74.03 109.71 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.601 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -54.15 -46.86 72.37 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.472 1.109 . . . . 73.03 112.026 178.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.443 HG11 HD13 ' C' ' 126' ' ' LEU . 71.2 t -65.97 -43.41 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.45 -0.796 . . . . 72.52 111.157 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.9 t -61.08 -36.94 81.0 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.445 0.698 . . . . 75.33 111.167 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.469 ' HD2' ' HE3' ' C' ' 117' ' ' MET . 86.4 mtt-85 -69.71 -32.02 70.36 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.134 -0.939 . . . . 65.12 110.329 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.08 7.05 76.98 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.894 0.746 . . . . 74.43 112.958 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 53.2 p 57.7 28.63 16.1 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 126.37 1.868 . . . . 72.11 113.751 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.462 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 93.2 m-85 -91.98 163.44 27.48 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 108.914 -0.772 . . . . 73.43 108.914 170.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.531 ' HG3' ' NE1' ' C' ' 36' ' ' TRP . 56.5 Cg_endo -64.06 -178.93 0.67 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.934 2.423 . . . . 74.52 114.641 -174.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -61.2 128.89 38.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.945 -1.025 . . . . 74.41 111.683 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.443 HD13 HG11 ' C' ' 118' ' ' VAL . 6.7 mp -134.81 86.49 2.26 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.445 -0.946 . . . . 74.43 108.445 170.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -99.77 123.68 44.27 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.089 -0.708 . . . . 64.14 109.089 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -64.93 118.87 9.69 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.782 -0.821 . . . . 70.32 108.782 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.02 141.25 93.75 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.727 0.811 . . . . 75.04 111.318 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.442 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 14.8 Cg_endo -58.05 103.74 0.16 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.436 2.091 . . . . 73.43 112.094 174.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 29.2 t -95.46 140.82 16.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.642 -1.614 . . . . 75.34 106.642 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -77.36 66.77 3.18 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.345 -0.613 . . . . 62.04 109.345 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -54.33 -43.12 70.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.912 0.885 . . . . 72.23 111.183 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.57 ' HA ' ' HE2' ' C' ' 96' ' ' HIS . 7.8 m-20 -66.49 -41.93 88.17 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.89 -1.05 . . . . 74.33 112.484 -175.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.91 -43.08 72.43 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.799 0.687 . . . . 64.42 110.398 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.05 -21.15 60.84 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.027 -0.988 . . . . 65.31 111.9 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.0 t80 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.902 -0.407 . . . . 72.2 109.902 172.76 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 121.18 0.515 . . . . 73.14 110.991 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -158.7 89.86 0.98 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.727 -1.582 . . . . 74.4 106.727 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -116.69 116.36 27.39 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.584 -0.895 . . . . 74.44 108.584 -176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.404 HG21 HD13 ' D' ' 16' ' ' ILE . 14.7 mt -82.48 117.55 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.569 -0.9 . . . . 75.13 108.569 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.56 -34.8 46.76 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.992 0.517 . . . . 73.13 111.37 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -169.2 130.92 1.17 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 111.631 0.234 . . . . 73.22 111.631 -168.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.404 HD13 HG21 ' D' ' 13' ' ' ILE . 2.6 mp -115.02 134.4 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.075 -1.454 . . . . 63.12 107.075 173.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -165.52 170.3 14.52 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.811 0.815 . . . . 75.13 111.868 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -102.52 123.15 45.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.265 -1.334 . . . . 73.34 108.817 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -93.25 -18.45 22.48 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.114 -0.494 . . . . 75.35 110.011 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -156.39 136.12 12.52 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.329 -0.989 . . . . 73.15 108.329 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.601 HG23 ' HE1' ' C' ' 117' ' ' MET . 17.5 mt -134.59 138.77 49.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.627 -1.249 . . . . 73.3 107.627 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -144.67 133.87 22.9 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.353 0.661 . . . . 73.54 109.773 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.58 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 70.5 t80 -144.67 127.48 16.3 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.56 -1.644 . . . . 74.3 106.56 167.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.5 mt-10 -134.89 126.64 29.13 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.638 0.775 . . . . 71.01 109.357 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.54 85.14 25.82 Favored Pre-proline 0 C--O 1.242 0.673 0 N-CA-C 107.953 -1.129 . . . . 73.44 107.953 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.22 -40.47 11.18 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.909 2.406 . . . . 72.02 112.482 -171.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -107.73 27.59 9.04 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 123.871 0.868 . . . . 74.32 109.789 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.437 ' HB2' ' HD3' ' D' ' 29' ' ' PRO . . . -37.74 -68.57 0.22 Allowed Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 115.284 1.586 . . . . 74.35 115.284 -161.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.493 ' HB3' HD11 ' C' ' 83' ' ' ILE . 89.4 Cg_endo -75.57 -19.97 16.2 Favored 'Trans proline' 0 C--N 1.382 2.299 0 CA-C-N 122.394 1.891 . . . . 72.35 113.385 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.417 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 8.5 t-160 -74.81 -38.79 61.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.534 1.133 . . . . 75.45 110.698 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.726 HG21 HD13 ' D' ' 68' ' ' LEU . 10.7 p -84.38 -25.24 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 122.789 0.435 . . . . 75.55 111.694 -172.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -58.43 -27.99 64.84 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.371 0.669 . . . . 75.13 112.359 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.417 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 72.1 mt-30 -53.73 -31.33 47.86 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.786 1.234 . . . . 74.11 111.541 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.545 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 83.7 mttt -87.51 96.95 10.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.984 0.913 . . . . 75.23 109.135 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -81.33 88.58 6.08 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.992 -0.549 . . . . 62.35 110.946 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -163.15 162.64 25.68 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.664 0.786 . . . . 74.53 109.153 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.407 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 1.3 mp0 -73.47 116.35 50.5 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 109.238 -0.652 . . . . 63.34 109.238 171.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.666 ' HB2' ' HB3' ' D' ' 66' ' ' ALA . 77.5 Cg_exo -56.55 138.97 86.61 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.94 3.094 . . . . 74.12 113.971 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.11 111.73 1.44 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.025 0.828 . . . . 71.12 109.372 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.487 HG22 HG13 ' D' ' 64' ' ' VAL . 7.3 p -103.79 135.35 41.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.357 -0.838 . . . . 73.45 110.917 -168.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -115.52 132.39 56.64 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.326 1.05 . . . . 74.34 108.346 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.413 HD23 ' HG ' ' D' ' 44' ' ' LEU . 8.5 tt -98.17 126.23 43.54 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.955 0.502 . . . . 73.44 109.746 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.511 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.8 m-20 -133.49 116.08 15.54 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.898 -1.149 . . . . 74.01 107.898 171.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.413 ' HG ' HD23 ' D' ' 42' ' ' LEU . 91.6 mt -113.88 142.34 46.23 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.153 0.581 . . . . 74.1 109.988 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.2 t70 -141.8 154.89 45.52 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.947 -1.131 . . . . 75.42 107.947 173.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -127.68 164.4 22.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.104 0.561 . . . . 55.14 109.712 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.24 161.79 42.1 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.784 0.834 . . . . 64.2 109.627 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 37.3 p -159.1 151.84 21.83 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.099 0.559 . . . . 73.2 109.726 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.4 p -157.93 139.23 13.51 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.36 0.664 . . . . 71.44 109.707 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -79.13 119.37 22.15 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.553 -0.536 . . . . 73.12 109.553 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.7 mt -90.15 -34.63 15.78 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.86 -0.793 . . . . 72.4 108.86 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.16 -178.95 5.36 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.224 1.01 . . . . 72.43 109.672 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.64 122.17 17.48 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.221 -0.899 . . . . 72.04 109.197 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 72.16 12.46 5.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.394 1.478 . . . . 74.41 112.402 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.6 t -128.98 117.6 44.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 123.972 0.909 . . . . 75.24 108.879 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -132.88 130.08 39.25 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.398 1.079 . . . . 74.1 108.703 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD11 ' D' ' 51' ' ' LEU . 18.5 tt0 -91.83 142.29 27.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.972 -0.751 . . . . 61.42 108.972 170.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -123.08 142.31 40.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.421 -1.326 . . . . 74.14 107.421 172.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 45.9 t -126.37 132.09 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.807 -0.812 . . . . 72.53 108.807 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.32 120.39 42.25 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.705 -0.85 . . . . 75.35 108.705 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 33.3 ttm-85 -102.94 98.45 8.41 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.312 -0.996 . . . . 64.4 108.312 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -100.2 123.37 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.859 -0.793 . . . . 71.54 108.859 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 15.4 m -119.13 141.82 48.47 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.496 0.718 . . . . 75.22 109.85 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.487 HG13 HG22 ' D' ' 40' ' ' VAL . 75.6 t -136.64 103.29 3.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.0 1.32 . . . . 72.33 108.561 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 83.4 m -100.9 113.72 26.93 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.349 -0.982 . . . . 64.0 108.349 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.666 ' HB3' ' HB2' ' D' ' 38' ' ' PRO . . . -122.55 142.82 50.21 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.726 0.811 . . . . 72.1 109.857 -174.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.455 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 23.5 m -144.13 134.39 24.41 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.652 0.595 . . . . 72.1 111.795 -176.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.726 HD13 HG21 ' D' ' 31' ' ' VAL . 48.9 mt -106.23 123.34 47.88 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.325 1.05 . . . . 74.15 109.198 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.56 -124.56 36.41 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 115.155 -0.93 . . . . 61.2 113.609 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.89 6.47 47.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 74.24 112.326 -175.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.545 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 11.7 pt-20 -137.0 165.1 26.79 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.668 0.387 . . . . 75.13 110.875 -172.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 34.7 m -68.23 138.07 55.28 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.762 0.663 . . . . 70.33 110.473 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.623 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -90.33 -70.69 0.66 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.342 -0.984 . . . . 60.14 108.342 173.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -147.63 140.6 24.96 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.576 -0.738 . . . . 72.33 109.605 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 88.1 mt -109.62 143.18 39.7 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.49 -1.3 . . . . 74.31 107.49 172.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.562 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 38.7 t -158.05 137.19 11.63 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.231 -0.285 . . . . 62.11 110.231 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.59 133.27 13.01 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.945 -0.761 . . . . 74.31 108.945 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.7 t -128.77 138.02 55.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.572 -0.899 . . . . 72.35 108.572 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -116.32 87.35 2.67 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.096 -1.075 . . . . 72.44 108.096 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.14 103.95 10.37 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.347 -1.297 . . . . 72.53 108.944 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.09 141.39 15.96 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.314 -0.714 . . . . 73.43 111.314 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.478 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -139.86 130.02 4.53 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.681 -0.968 . . . . 73.05 110.681 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 58.7 mt -92.57 115.95 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.717 -0.846 . . . . 75.33 108.717 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -116.33 125.55 52.28 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.931 0.892 . . . . 73.12 109.692 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -104.39 109.29 21.09 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.481 0.712 . . . . 73.34 109.353 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -110.78 144.14 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.244 0.617 . . . . 72.3 109.866 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.45 127.07 8.73 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.789 -0.819 . . . . 74.42 108.789 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.36 -20.51 42.25 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.398 -0.681 . . . . 64.35 111.398 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mp -98.41 130.75 46.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.231 1.013 . . . . 74.22 108.341 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -160.47 173.8 15.03 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.442 0.697 . . . . 74.13 110.7 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.01 -133.82 49.17 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 124.023 0.827 . . . . 72.32 113.879 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.1 m -63.35 -31.73 72.97 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.706 0.803 . . . . 74.21 110.73 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -69.34 -33.66 73.44 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.74 0.816 . . . . 73.03 110.945 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.465 ' SD ' HD12 ' D' ' 98' ' ' LEU . 17.5 tmm? -72.74 -37.61 67.66 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.263 0.625 . . . . 64.44 110.389 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.31 95.94 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.61 0.719 . . . . 75.53 110.55 171.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -71.53 -29.53 64.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.899 1.28 . . . . 74.22 111.405 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -81.12 -52.26 7.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.811 0.445 . . . . 71.54 110.874 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.465 HD12 ' SD ' ' D' ' 94' ' ' MET . 92.6 mt -84.35 -27.9 27.39 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.995 0.518 . . . . 74.44 111.697 -171.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.02 7.41 58.8 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.677 -0.513 . . . . 63.23 114.138 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.409 ' HB2' ' HA ' ' D' ' 134' ' ' ASP . . . -150.29 -61.3 0.2 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.393 0.597 . . . . 72.42 111.232 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -69.7 -41.65 75.1 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.034 0.534 . . . . 73.34 112.145 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.434 ' SG ' HD23 ' D' ' 98' ' ' LEU . 88.5 m -65.35 -45.97 70.48 Favored Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 123.62 0.768 . . . . 75.23 112.38 -178.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -53.1 -36.89 78.51 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.155 1.903 . . . . 73.44 113.177 167.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -67.77 -30.89 70.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.099 0.56 . . . . 64.24 111.438 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.0 -37.33 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.276 0.631 . . . . 73.41 110.584 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.478 HD22 ' HA3' ' D' ' 82' ' ' GLY . 92.7 mt -77.49 -19.77 55.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.057 0.943 . . . . 72.33 111.997 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.617 ' HZ ' HD23 ' D' ' 128' ' ' LEU . 40.5 t80 -64.65 -43.64 71.01 Favored Pre-proline 0 CA--C 1.56 1.327 0 N-CA-C 114.347 1.24 . . . . 73.11 114.347 -170.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -54.35 -45.51 40.42 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 121.952 1.768 . . . . 75.41 112.491 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -70.0 -35.59 74.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.041 0.936 . . . . 75.32 111.759 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.71 67.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.269 0.628 . . . . 72.14 110.502 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.2 ttp180 -58.48 -49.09 78.61 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.253 -0.885 . . . . 72.03 110.534 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.52 -46.63 87.53 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.136 0.897 . . . . 72.45 111.477 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.8 t -57.73 -42.15 83.28 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.739 0.65 . . . . 70.21 110.639 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.516 HG21 ' SG ' ' D' ' 76' ' ' CYS . 67.8 mt -61.67 -57.11 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.608 0.763 . . . . 73.01 110.56 174.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.569 HG21 ' HG3' ' D' ' 125' ' ' GLN . 86.4 m -51.67 -44.68 63.15 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.721 1.208 . . . . 75.31 112.061 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.402 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 33.7 t -63.95 -42.59 97.26 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.196 -0.911 . . . . 64.14 109.999 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.562 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 75.9 mtm -69.81 -34.39 73.62 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.999 0.52 . . . . 71.4 111.469 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 66.8 t -62.06 -44.89 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.612 0.765 . . . . 75.24 109.934 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.1 p -72.73 -30.48 64.21 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.981 0.512 . . . . 71.41 111.089 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' D' ' 116' ' ' SER . 73.6 mtt-85 -72.07 -29.76 64.45 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.466 0.706 . . . . 75.34 110.455 175.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.34 10.14 74.35 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.798 0.686 . . . . 72.41 112.556 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.421 HG22 ' HB3' ' C' ' 17' ' ' TYR . 73.0 p 56.85 20.78 5.49 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 126.68 1.992 . . . . 73.23 114.082 177.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.02 150.16 71.26 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 109.067 -0.716 . . . . 75.21 109.067 168.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.9 132.1 47.74 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.471 2.114 . . . . 75.41 111.202 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.569 ' HG3' HG21 ' D' ' 115' ' ' THR . 5.5 tt0 -51.78 127.19 20.1 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 124.464 1.102 . . . . 74.32 112.674 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.19 116.49 28.45 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.04 -1.096 . . . . 75.11 108.04 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -115.65 122.19 44.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.694 0.798 . . . . 73.13 109.524 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.617 HD23 ' HZ ' ' D' ' 107' ' ' PHE . 1.5 tt -74.9 129.71 38.13 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 108.967 -0.753 . . . . 75.4 108.967 173.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.18 157.75 79.91 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.395 1.078 . . . . 71.51 111.974 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.435 ' HB3' ' OH ' ' B' ' 101' ' ' TYR . 87.0 Cg_exo -50.01 107.82 0.18 Allowed 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 123.246 2.631 . . . . 73.32 113.284 172.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 84.0 t -109.59 116.24 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.542 0.737 . . . . 73.2 109.051 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -90.06 105.66 17.95 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.42 -0.585 . . . . 65.52 109.42 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -78.72 -20.18 50.64 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.571 0.748 . . . . 71.34 111.067 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . 0.409 ' HA ' ' HB2' ' D' ' 100' ' ' ALA . 6.5 t70 -65.17 -52.38 55.37 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.929 0.892 . . . . 74.12 110.66 -174.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.97 -34.89 76.06 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.288 -0.869 . . . . 71.22 111.034 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 47.3 tp -63.08 -35.26 79.65 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 114.986 -1.006 . . . . 73.21 111.407 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 89.2 t80 . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 123.573 0.749 . . . . 73.54 110.687 175.904 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.301 -0.629 . . . . 74.24 109.301 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.692 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 6.2 t80 -139.03 132.68 30.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.038 0.935 . . . . 73.01 108.62 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -149.98 103.56 3.22 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.528 -0.916 . . . . 74.24 108.528 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.553 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.3 mt -70.36 112.05 4.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.335 -0.987 . . . . 73.33 108.335 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -81.04 -31.14 34.65 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 124.237 0.961 . . . . 71.44 110.277 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -174.36 147.44 1.16 Allowed 'General case' 0 C--N 1.355 0.835 0 O-C-N 123.626 0.579 . . . . 74.11 110.228 -173.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.4 HD13 ' HG3' ' C' ' 130' ' ' PRO . 79.7 mt -137.02 133.6 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.878 -1.156 . . . . 74.34 107.878 172.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -168.59 154.39 6.71 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 123.915 0.759 . . . . 75.51 111.412 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -74.57 116.57 15.41 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.011 -0.737 . . . . 70.13 109.011 172.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -78.19 -42.86 30.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.368 -0.604 . . . . 74.11 109.368 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.608 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 7.0 m-20 -136.65 131.91 34.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.934 -1.03 . . . . 73.23 109.235 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.0 mt -128.18 141.06 47.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.09 -1.448 . . . . 73.23 107.09 172.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -152.51 120.78 6.29 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.199 -0.667 . . . . 75.32 109.199 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.581 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 87.3 t80 -123.78 130.6 52.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.274 -1.38 . . . . 75.45 107.274 174.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -126.48 153.01 45.68 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.023 -1.102 . . . . 74.54 108.023 172.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.51 79.16 10.6 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.486 -1.301 . . . . 74.3 107.486 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.21 -40.34 77.1 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.332 2.688 . . . . 74.02 112.843 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.554 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 39.0 m-80 -109.22 39.68 2.01 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.28 -0.873 . . . . 72.43 109.767 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.4 ' O ' HG13 ' A' ' 31' ' ' VAL . . . -59.54 -45.55 98.76 Favored Pre-proline 0 CA--C 1.565 1.536 0 C-N-CA 123.939 0.896 . . . . 70.42 113.079 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -71.79 -22.03 24.21 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 121.826 1.684 . . . . 75.13 112.29 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 42.0 m170 -86.91 -24.63 24.76 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.621 0.768 . . . . 64.01 112.333 -174.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 28' ' ' ALA . 7.7 p -72.19 -25.21 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.759 0.424 . . . . 72.45 110.409 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.1 -31.78 70.74 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.528 0.731 . . . . 72.11 110.607 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -78.57 -47.75 16.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.101 0.96 . . . . 72.1 110.424 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -83.02 151.53 25.79 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.856 0.862 . . . . 73.32 110.757 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.36 146.04 53.61 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.616 -0.512 . . . . 64.11 109.616 170.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -70.7 85.15 0.65 Allowed 'General case' 0 C--N 1.351 0.662 0 CA-C-O 121.468 0.651 . . . . 73.12 109.752 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.98 78.78 75.77 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 106.451 -1.685 . . . . 74.35 106.451 173.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -89.89 -173.44 0.71 Allowed 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.453 2.102 . . . . 71.2 112.543 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -141.03 108.81 5.65 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.811 -1.551 . . . . 71.34 106.811 167.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 65' ' ' THR . 22.1 m -96.5 135.81 29.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.317 0.58 . . . . 73.42 111.301 -172.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -120.71 145.47 47.45 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.284 -1.006 . . . . 73.24 108.284 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 tp -124.1 126.16 45.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.201 -0.666 . . . . 71.43 109.201 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.578 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.7 m-20 -113.95 144.1 43.62 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.106 -1.072 . . . . 54.02 108.106 170.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.18 146.65 37.22 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.353 -0.61 . . . . 74.42 109.353 169.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -152.06 147.96 27.11 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.195 0.598 . . . . 72.51 110.007 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.0 m -118.49 128.95 55.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.276 1.03 . . . . 73.33 109.353 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.55 151.55 51.89 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.411 0.684 . . . . 74.03 109.156 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.0 m -118.09 157.52 26.72 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.326 0.651 . . . . 73.12 109.967 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -149.27 121.09 8.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.736 0.814 . . . . 73.3 109.342 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -84.49 103.2 13.43 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.612 -0.884 . . . . 72.12 108.612 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.15 -34.77 23.97 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.414 -0.812 . . . . 72.05 110.373 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.42 -176.56 5.97 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 124.268 0.98 . . . . 72.54 109.723 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.48 115.15 4.38 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.702 0.626 . . . . 71.13 110.073 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 62.67 26.53 15.7 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.44 1.496 . . . . 73.34 112.78 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -117.79 118.36 58.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-N 114.706 -1.134 . . . . 72.12 108.743 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.572 ' HD2' HD13 ' A' ' 86' ' ' ILE . 23.8 m-85 -125.11 124.97 43.0 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.478 0.711 . . . . 71.41 109.991 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.26 126.44 37.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.277 -1.008 . . . . 74.2 108.277 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.415 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 92.7 t -100.78 130.35 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.33 -1.359 . . . . 74.15 107.33 171.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.1 t -107.56 107.68 23.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 107.874 -1.158 . . . . 63.03 107.874 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.27 99.86 12.02 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.381 -1.34 . . . . 73.33 107.381 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 37.8 ttt180 -85.74 119.61 26.25 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.22 -0.9 . . . . 75.21 109.641 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.5 t -112.13 140.77 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.561 -0.903 . . . . 74.23 108.561 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.578 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 17.9 m -130.92 129.31 42.03 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.739 -0.837 . . . . 74.45 108.739 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.55 HG21 HG22 ' A' ' 114' ' ' ILE . 74.2 t -127.84 126.32 66.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.958 -1.497 . . . . 74.32 106.958 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 14.7 t -136.71 145.97 45.32 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.593 -0.891 . . . . 73.34 108.593 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.07 123.81 13.37 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.548 -0.908 . . . . 73.34 108.548 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 p -127.18 133.67 50.26 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.447 0.699 . . . . 74.44 110.607 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 73' ' ' ALA . 7.6 mp -86.16 77.19 9.63 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.152 -1.795 . . . . 74.42 106.152 169.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.79 -115.69 4.81 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 114.515 -1.22 . . . . 65.31 111.082 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -87.98 -20.34 25.99 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.908 0.883 . . . . 72.33 110.319 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -80.06 100.98 8.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.754 0.822 . . . . 75.24 109.951 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.9 m -68.06 120.19 13.88 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 110.174 -0.306 . . . . 75.2 110.174 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.571 ' HB3' HD11 ' A' ' 68' ' ' LEU . . . -71.68 -55.42 7.74 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.84 -0.8 . . . . 63.41 108.84 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -160.64 165.79 30.03 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 115.524 -0.762 . . . . 74.21 111.708 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.7 tp -141.6 108.07 5.3 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.516 -1.22 . . . . 73.04 108.205 173.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.458 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 58.7 m -107.35 116.68 32.36 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.104 0.962 . . . . 74.2 109.898 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -134.0 126.04 29.41 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.151 -0.685 . . . . 72.54 109.151 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.4 t -133.38 110.28 14.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 124.292 1.037 . . . . 75.4 109.215 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 19.6 mt-30 -84.64 84.03 7.81 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.086 -1.079 . . . . 73.0 108.086 171.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -79.33 99.92 7.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.345 -1.298 . . . . 73.11 108.685 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.14 157.81 18.39 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 112.073 -0.411 . . . . 74.15 112.073 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.51 131.06 3.05 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 110.849 -0.9 . . . . 74.33 110.849 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -81.12 125.21 39.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.499 -0.926 . . . . 75.52 108.499 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.692 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 30.8 m-85 -131.06 119.95 22.73 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.845 -0.798 . . . . 65.55 108.845 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -91.8 108.63 20.05 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.286 -1.005 . . . . 64.0 108.286 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.572 HD13 ' HD2' ' A' ' 56' ' ' TYR . 2.6 pp -118.65 147.61 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.541 0.737 . . . . 75.34 110.533 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.34 176.92 6.36 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.137 0.975 . . . . 74.34 110.0 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.25 -24.58 21.61 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.854 -0.612 . . . . 61.4 113.583 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -136.39 148.83 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.501 0.72 . . . . 75.24 110.954 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.68 175.01 9.96 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.875 0.87 . . . . 70.21 109.365 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.37 -128.69 13.64 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 123.459 0.552 . . . . 63.13 112.386 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.4 p -68.84 -22.06 64.25 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.261 1.024 . . . . 65.34 111.958 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -68.45 -51.07 47.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.846 0.858 . . . . 74.33 110.68 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.451 ' SD ' HD11 ' A' ' 86' ' ' ILE . 41.5 ttp -78.08 -23.03 48.15 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 116.275 -0.42 . . . . 75.42 110.402 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -37.7 86.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.154 0.582 . . . . 74.32 110.199 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -67.72 -35.15 78.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.544 0.738 . . . . 73.24 110.85 174.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 76.8 m -62.1 -54.07 46.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.756 0.423 . . . . 73.25 110.582 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 pp -73.16 -34.5 66.08 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.771 0.428 . . . . 75.24 111.39 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.67 -2.0 56.39 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 114.905 0.722 . . . . 72.11 114.905 -168.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.75 -61.75 0.24 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.649 0.724 . . . . 74.3 112.727 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.401 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 89.5 t80 -72.17 -61.91 1.62 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.106 0.963 . . . . 75.22 112.709 -165.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 72.7 m -67.65 -34.96 7.24 Favored Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 114.026 1.121 . . . . 75.43 114.026 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 27.9 Cg_endo -64.64 -31.09 59.97 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 121.769 1.646 . . . . 74.13 113.357 167.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -67.89 -29.92 69.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.097 0.559 . . . . 64.52 110.206 178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.15 -42.81 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.845 0.858 . . . . 74.11 110.573 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.9 mt -82.16 -20.79 37.2 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.474 1.11 . . . . 74.23 112.575 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.77 -44.77 91.91 Favored Pre-proline 0 CA--C 1.572 1.805 0 C-N-CA 124.033 0.933 . . . . 75.13 113.437 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -64.73 -32.38 57.02 Favored 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 122.36 2.04 . . . . 75.44 113.434 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.415 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 97.3 m-85 -70.8 -40.66 72.4 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.144 0.577 . . . . 71.23 110.933 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.37 -38.8 78.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.968 0.507 . . . . 74.41 110.49 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.407 ' HB2' HD11 ' A' ' 128' ' ' LEU . 36.0 ttm180 -51.09 -56.25 13.58 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.088 0.867 . . . . 74.41 109.517 172.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -59.11 -47.74 84.16 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.609 1.164 . . . . 74.21 112.163 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.06 -44.89 87.71 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.999 0.812 . . . . 75.42 110.975 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.55 HG22 HG21 ' A' ' 64' ' ' VAL . 96.6 mt -67.53 -49.05 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.039 0.936 . . . . 72.31 110.586 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.492 HG23 ' HG3' ' A' ' 125' ' ' GLN . 36.3 m -53.25 -40.72 64.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.146 0.978 . . . . 75.41 111.208 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.28 -47.82 66.64 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.989 -1.005 . . . . 75.21 110.018 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 42.5 mtp -60.92 -41.09 95.51 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 124.077 0.951 . . . . 72.32 111.686 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.8 t -65.62 -44.15 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.17 0.988 . . . . 65.41 110.339 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.9 t -68.53 -31.82 71.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.6 0.76 . . . . 64.52 111.313 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -72.69 -29.94 63.82 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.38 0.672 . . . . 75.23 110.075 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.52 2.64 84.99 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 123.69 0.619 . . . . 71.44 112.896 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.3 m 68.0 22.9 8.35 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.768 1.227 . . . . 74.52 111.151 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -91.93 150.88 41.4 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 123.355 0.662 . . . . 71.3 109.222 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.46 139.48 90.8 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.577 2.184 . . . . 72.22 112.575 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.492 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.0 tt0 -57.73 150.04 20.63 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.814 1.246 . . . . 71.43 112.682 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 pp -126.65 137.46 53.29 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.846 -1.168 . . . . 75.02 107.846 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.45 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 86.6 m-20 -135.69 84.05 2.06 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.751 -1.203 . . . . 70.03 107.751 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 111' ' ' ARG . 2.7 pp -65.1 135.62 55.75 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.146 -0.479 . . . . 74.14 110.645 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.17 140.81 98.06 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 123.069 0.548 . . . . 75.25 110.068 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.75 126.92 22.63 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.196 1.931 . . . . 75.44 111.384 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 91.3 t -97.46 113.86 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 106.62 -1.622 . . . . 71.12 106.62 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -75.48 83.93 2.56 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.946 -1.131 . . . . 70.11 107.946 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -60.4 -33.41 72.45 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.108 -0.951 . . . . 74.04 110.589 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.05 -40.46 90.98 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.074 0.95 . . . . 63.12 110.98 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.06 -50.55 61.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.254 0.621 . . . . 75.51 110.259 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.0 mt -64.04 -42.15 97.17 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.22 -0.9 . . . . 71.41 111.573 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -66.49 -41.02 89.56 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.237 -0.892 . . . . 72.45 109.375 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.359 0.994 0 O-C-N 123.897 0.748 . . . . 73.25 109.774 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.636 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 70.6 m . . . . . 0 C--O 1.241 0.637 0 N-CA-C 107.122 -1.436 . . . . 73.31 107.122 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -139.39 141.49 37.55 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.759 0.423 . . . . 75.01 110.252 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -144.67 138.12 27.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.592 0.757 . . . . 71.13 109.906 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.94 126.78 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.048 -1.093 . . . . 73.43 108.048 171.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -95.35 -50.32 5.07 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.699 0.4 . . . . 72.24 110.079 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -161.72 131.07 4.56 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.531 -0.544 . . . . 74.33 109.531 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.2 mt -115.35 131.95 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 107.924 -1.139 . . . . 72.13 107.924 171.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -156.85 138.28 13.92 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.41 0.684 . . . . 71.43 110.144 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.5 m -72.23 121.84 20.04 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.478 -0.934 . . . . 74.44 108.478 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -95.33 -23.5 17.17 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.433 0.693 . . . . 71.01 111.042 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -161.69 141.03 9.97 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.399 0.437 . . . . 74.12 110.732 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.581 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 33.7 mm -134.23 144.46 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.159 1.384 . . . . 73.3 108.765 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -138.55 139.95 38.87 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.591 -1.186 . . . . 73.21 107.974 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.553 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 85.2 t80 -152.58 130.61 11.84 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.637 -1.246 . . . . 75.2 107.637 166.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 49.0 mt-10 -140.45 116.7 10.61 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.645 0.778 . . . . 73.32 108.918 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.486 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -105.29 84.29 1.07 Allowed Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 106.922 -1.51 . . . . 65.35 106.922 165.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.39 -23.83 20.03 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.954 2.436 . . . . 70.32 111.97 -170.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.492 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 78.3 m-20 -116.93 6.71 13.07 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 114.433 -1.258 . . . . 75.03 110.368 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.554 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -29.13 -66.05 0.15 Allowed Pre-proline 0 C--N 1.38 1.899 0 C-N-CA 126.163 1.785 . . . . 55.01 114.787 -171.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.8 Cg_exo -64.78 -29.46 59.29 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 122.585 2.19 . . . . 72.33 112.509 -169.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -46.47 14.52 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.364 -0.835 . . . . 72.44 110.752 176.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.406 HG21 HD11 ' B' ' 68' ' ' LEU . 2.7 p -70.31 -17.85 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.147 0.579 . . . . 72.51 111.986 -166.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -69.37 -11.64 60.99 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 112.654 0.613 . . . . 73.35 112.654 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -77.28 -3.42 39.74 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.191 0.596 . . . . 75.11 110.877 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.7 105.35 15.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.907 1.283 . . . . 75.01 110.093 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.93 91.91 7.7 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.842 0.857 . . . . 71.22 109.729 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -161.92 155.57 21.3 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.918 0.887 . . . . 75.43 108.922 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -81.97 102.95 1.78 Allowed Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 107.201 -1.407 . . . . 74.14 107.201 170.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.407 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 40.6 Cg_endo -66.67 133.35 31.54 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.555 2.17 . . . . 54.34 112.308 -171.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -69.23 129.54 40.11 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 123.855 0.722 . . . . 74.3 110.026 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.528 HG23 ' HB1' ' B' ' 66' ' ' ALA . 74.9 t -106.13 129.84 58.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.49 1.116 . . . . 74.31 109.968 -171.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -103.98 112.66 25.74 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 105.84 -1.911 . . . . 73.34 105.84 167.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.58 153.23 18.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.921 -1.036 . . . . 75.11 108.784 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.6 t70 -144.59 110.62 5.44 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.022 -0.732 . . . . 75.24 109.022 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -109.04 134.89 51.08 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.14 -1.059 . . . . 74.23 108.14 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -159.54 156.24 27.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.395 0.678 . . . . 75.35 109.377 170.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.6 p -124.82 128.33 48.54 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.352 0.661 . . . . 62.51 109.833 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.5 158.19 21.94 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.738 -1.208 . . . . 74.11 107.738 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.433 ' HB3' HD22 ' B' ' 98' ' ' LEU . 13.3 p -142.27 168.78 18.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.53 0.332 . . . . 60.13 111.107 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 2.1 m -148.53 136.06 20.52 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.424 -0.954 . . . . 72.04 108.424 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -90.36 100.53 13.35 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.416 -0.957 . . . . 73.13 108.416 170.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.461 HD12 HG22 ' B' ' 83' ' ' ILE . 82.2 mt -76.21 -33.44 59.26 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.637 -0.71 . . . . 75.43 109.911 174.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.02 -175.35 3.33 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.147 -0.933 . . . . 72.52 110.696 -177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.28 122.22 16.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.371 -1.286 . . . . 71.02 109.154 173.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 66.62 14.65 9.85 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.926 0.891 . . . . 72.13 112.379 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -118.5 119.78 62.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 123.642 0.777 . . . . 74.13 109.032 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -112.64 152.78 28.56 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.641 0.776 . . . . 72.41 110.172 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 6.8 tm-20 -124.66 97.18 5.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.508 -1.664 . . . . 75.21 106.508 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.437 HG21 ' HG ' ' B' ' 98' ' ' LEU . 90.4 t -86.51 143.99 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.048 -0.978 . . . . 71.34 109.792 -175.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -131.95 112.43 20.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.432 -0.951 . . . . 74.35 108.432 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.459 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -93.64 118.72 31.75 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.465 -1.309 . . . . 74.44 107.465 177.006 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 69.3 ttt-85 -107.43 110.07 21.94 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.975 0.51 . . . . 75.13 109.719 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.402 HG11 ' CD1' ' B' ' 114' ' ' ILE . 22.8 t -108.11 104.31 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.982 -1.118 . . . . 74.25 107.982 173.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 11.1 m -100.54 137.37 39.04 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.116 -0.698 . . . . 63.51 109.116 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.601 HG22 HG21 ' B' ' 114' ' ' ILE . 50.3 t -123.82 126.49 72.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.982 1.313 . . . . 70.11 108.822 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 52.4 m -125.09 139.01 54.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.476 -1.305 . . . . 74.23 107.476 170.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.528 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -146.03 151.6 38.01 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.605 -0.517 . . . . 73.14 109.605 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 27.7 p -149.07 139.57 22.51 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 123.699 0.624 . . . . 60.3 112.132 -174.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 86.3 mt -106.08 102.22 11.66 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.639 1.176 . . . . 73.12 108.328 172.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.02 -131.5 12.46 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.786 -0.643 . . . . 73.3 112.541 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -86.97 3.81 44.3 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.384 1.073 . . . . 70.2 112.446 -175.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.492 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.9 pt-20 -132.16 155.61 47.89 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.957 0.503 . . . . 73.1 111.095 -175.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.6 m -67.1 137.3 56.26 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.891 0.744 . . . . 74.24 110.85 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.06 -67.29 0.86 Allowed 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.697 -1.223 . . . . 75.35 107.697 173.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -144.3 145.59 32.1 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 121.407 0.622 . . . . 73.1 110.626 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.405 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 94.1 mt -117.14 149.46 40.32 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.309 1.444 . . . . 74.24 107.281 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.452 ' SG ' HG22 ' B' ' 114' ' ' ILE . 42.5 t -158.15 158.53 34.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.659 -0.867 . . . . 63.02 108.659 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -165.73 133.54 2.96 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.994 -1.113 . . . . 73.32 107.994 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.43 HG21 ' CD1' ' B' ' 21' ' ' ILE . 94.2 t -124.88 141.32 45.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.615 -0.883 . . . . 62.44 108.615 174.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -119.63 84.19 2.16 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.3 -1.37 . . . . 74.54 107.3 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.77 99.33 7.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.357 -1.292 . . . . 64.43 109.079 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.0 171.41 28.52 Favored Glycine 0 C--O 1.245 0.788 0 CA-C-N 115.774 -0.648 . . . . 72.25 112.006 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.54 130.88 1.94 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 112.029 -0.429 . . . . 73.15 112.029 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.461 HG22 HD12 ' B' ' 51' ' ' LEU . 63.8 mt -83.73 127.29 39.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 108.293 -1.003 . . . . 75.41 108.293 170.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -136.08 143.28 44.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.646 0.778 . . . . 72.01 109.163 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -104.05 125.3 50.29 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.691 0.796 . . . . 72.1 109.014 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.633 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.8 pp -119.23 145.01 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.217 1.007 . . . . 75.42 110.103 -176.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.636 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.04 162.11 41.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.584 0.754 . . . . 75.33 110.119 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.72 -57.13 5.05 Favored Glycine 0 C--N 1.354 1.567 0 O-C-N 123.683 0.614 . . . . 60.24 112.854 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.633 HD11 ' HB ' ' B' ' 86' ' ' ILE . 11.8 pt -58.19 148.39 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.762 1.225 . . . . 74.43 112.178 174.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.472 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 31.2 tt0 -160.84 152.52 19.56 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.999 -1.0 . . . . 74.4 109.843 -175.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.8 -112.76 4.08 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 112.206 -0.358 . . . . 74.44 112.206 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.9 m -92.51 -16.98 25.08 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.895 0.478 . . . . 74.24 111.139 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.472 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 45.6 mt-30 -59.76 -39.22 84.09 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.268 0.627 . . . . 64.4 110.725 175.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.564 ' HA ' HD13 ' B' ' 89' ' ' ILE . 26.2 ptt? -74.71 -25.25 59.01 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.647 -0.706 . . . . 52.04 110.993 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.33 -33.5 71.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.412 0.685 . . . . 64.11 110.466 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -65.4 -39.19 91.89 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.548 0.739 . . . . 73.32 110.685 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.459 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 44.5 t -70.42 -58.06 4.13 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.758 -0.655 . . . . 75.13 110.547 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.437 ' HG ' HG21 ' B' ' 58' ' ' VAL . 7.8 tt -65.13 -43.74 90.91 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.425 0.69 . . . . 74.32 111.38 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.19 -26.03 49.68 Favored Glycine 0 C--N 1.341 0.839 0 O-C-N 123.763 0.664 . . . . 64.34 114.238 -170.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.59 -53.17 1.25 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.215 0.508 . . . . 74.33 112.328 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.459 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 79.7 t80 -71.33 -45.72 62.29 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.565 0.746 . . . . 72.12 112.626 -169.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.501 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 81.0 m -67.82 -49.0 39.93 Favored Pre-proline 0 CA--C 1.565 1.551 0 C-N-CA 123.702 0.801 . . . . 73.13 110.424 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 66.8 Cg_exo -57.07 -30.04 85.36 Favored 'Trans proline' 0 C--N 1.399 3.229 0 C-N-CA 122.844 2.363 . . . . 75.0 113.898 169.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -62.55 -41.54 98.97 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.593 0.757 . . . . 73.3 109.803 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.79 -44.26 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.626 0.77 . . . . 75.4 110.063 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.3 mt -78.92 -15.76 57.9 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.029 0.932 . . . . 71.23 112.583 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -62.21 -51.82 71.34 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 118.102 -0.951 . . . . 73.32 113.348 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.27 -34.97 87.0 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 121.825 1.684 . . . . 74.12 112.515 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -62.73 -50.46 71.02 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.906 0.883 . . . . 75.32 110.911 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.41 97.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.789 0.836 . . . . 71.52 110.631 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -59.2 -54.34 48.03 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.636 1.574 . . . . 75.11 111.131 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.54 -30.66 70.36 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.193 0.597 . . . . 74.13 110.037 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.558 ' SG ' HD12 ' B' ' 21' ' ' ILE . 1.8 t -69.98 -28.42 65.52 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.745 0.418 . . . . 73.52 111.595 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.601 HG21 HG22 ' B' ' 64' ' ' VAL . 45.8 mt -76.03 -54.48 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 109.176 -0.676 . . . . 75.01 109.176 172.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.416 HG22 ' OG ' ' C' ' 119' ' ' SER . 23.5 m -54.2 -33.43 58.2 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.623 1.202 . . . . 71.01 111.568 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 24.8 t -60.42 -54.17 48.81 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 115.24 -0.891 . . . . 73.32 109.589 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.1 mmt -68.94 -35.33 76.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.7 0.8 . . . . 64.21 111.482 -173.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.3 t -60.63 -46.08 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.0 0.92 . . . . 74.33 109.811 174.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 34.8 t -72.59 -28.86 63.05 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.651 -1.159 . . . . 74.24 111.383 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.2 mtt-85 -68.75 -35.39 77.03 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.524 0.73 . . . . 74.4 109.533 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.71 11.13 57.73 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 124.119 0.887 . . . . 74.32 112.816 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 75.6 p 56.58 24.12 8.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.235 1.814 . . . . 74.13 113.631 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -84.52 154.81 62.55 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 123.326 0.65 . . . . 71.42 110.34 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.35 169.94 5.88 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.955 2.437 . . . . 75.22 113.778 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -63.62 131.18 47.18 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.01 -0.995 . . . . 74.04 112.211 -166.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.2 tp -135.11 111.54 9.81 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.859 0.863 . . . . 75.31 109.043 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -134.2 114.74 13.39 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.345 0.658 . . . . 73.34 109.272 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.27 141.75 55.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.794 0.837 . . . . 74.12 111.086 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.46 144.07 96.06 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.412 0.685 . . . . 75.44 110.365 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -69.32 100.54 0.77 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.405 2.07 . . . . 75.4 111.339 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.48 110.76 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.587 -0.894 . . . . 74.54 108.587 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -78.96 83.92 5.02 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.987 -1.116 . . . . 73.33 107.987 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -52.67 -39.11 61.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.578 1.151 . . . . 61.32 112.871 -172.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.41 -34.59 75.64 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.483 1.113 . . . . 74.12 112.396 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.79 -41.07 60.68 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.43 0.692 . . . . 72.51 110.863 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -70.13 -29.77 66.79 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.467 -0.788 . . . . 75.32 110.072 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 80.9 t80 . . . . . 0 N--CA 1.469 0.525 0 C-N-CA 123.976 0.91 . . . . 73.24 110.469 179.377 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 29.2 m . . . . . 0 C--O 1.236 0.362 0 N-CA-C 106.654 -1.61 . . . . 74.41 106.654 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.473 ' HD1' ' HH ' ' C' ' 101' ' ' TYR . 0.8 OUTLIER -104.04 122.33 45.05 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.831 -1.077 . . . . 74.3 109.479 -172.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -137.05 108.12 6.74 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 107.289 -1.374 . . . . 75.02 107.289 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 42.8 mt -67.73 119.17 12.94 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 108.112 -1.07 . . . . 64.23 108.112 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.654 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.7 mm-40 -78.34 -48.88 14.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.791 0.682 . . . . 73.14 109.431 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.45 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 25.2 ttt180 -172.24 138.65 0.98 Allowed 'General case' 0 C--N 1.349 0.58 0 CA-C-N 115.526 -0.761 . . . . 75.32 110.271 -169.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.3 mt -120.78 139.42 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.56 -1.274 . . . . 73.32 107.56 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -172.99 166.68 5.06 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.257 0.551 . . . . 73.1 111.015 -172.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -94.12 124.8 38.36 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.634 -0.712 . . . . 65.25 109.287 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.603 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.0 OUTLIER -81.61 -49.06 10.96 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.985 -1.487 . . . . 75.22 106.985 173.561 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.2 t70 -135.7 132.65 37.17 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.198 -1.819 . . . . 70.41 109.068 -168.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.5 mt -135.17 141.41 42.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.828 -1.545 . . . . 74.43 106.828 173.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.4 t -159.51 150.36 19.51 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.443 0.639 . . . . 73.32 110.597 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -145.71 139.8 26.78 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.336 -1.357 . . . . 74.15 107.336 174.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.84 120.3 12.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.644 0.778 . . . . 73.24 109.476 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.82 87.15 36.49 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 107.047 -1.464 . . . . 74.31 107.047 168.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.61 -38.34 25.28 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.077 2.518 . . . . 71.53 111.828 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -102.24 29.35 5.19 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.19 -1.368 . . . . 74.33 110.069 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.411 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -51.85 -55.6 28.85 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.457 1.103 . . . . 71.2 113.926 -171.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.411 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 33.5 Cg_exo -57.67 -44.9 37.27 Favored 'Trans proline' 0 C--N 1.39 2.747 0 CA-C-N 121.714 1.648 . . . . 73.43 112.927 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -69.95 -35.29 74.38 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.718 0.807 . . . . 74.42 112.238 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.714 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.9 p -78.23 -23.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.823 0.449 . . . . 73.21 111.874 -172.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -69.15 -33.27 73.17 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.627 0.251 . . . . 74.14 110.494 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -94.4 38.9 1.09 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.598 0.759 . . . . 73.42 110.374 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.705 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -119.96 141.71 49.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.749 1.22 . . . . 75.41 109.533 174.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.59 99.99 1.38 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.063 -1.088 . . . . 60.41 108.063 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.402 ' HA ' HD23 ' C' ' 68' ' ' LEU . 32.9 p90 -80.6 115.15 19.96 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.675 0.75 . . . . 75.23 112.548 -171.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -122.2 79.05 43.82 Favored Pre-proline 0 CA--C 1.555 1.137 0 N-CA-C 106.843 -1.54 . . . . 74.0 106.843 162.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.1 128.19 7.21 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.363 2.709 . . . . 65.41 112.946 -172.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -84.82 89.24 7.5 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.435 -1.32 . . . . 75.22 107.435 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.37 99.8 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.017 -1.447 . . . . 74.21 109.168 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.519 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 57.2 tttm -92.75 112.54 24.53 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.723 -0.843 . . . . 74.21 108.723 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.65 125.05 34.15 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.064 -0.717 . . . . 75.12 109.064 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.42 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.9 t70 -121.49 131.06 53.93 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.919 -1.141 . . . . 74.13 107.919 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 45.5 mt -120.6 147.04 45.74 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.827 -1.175 . . . . 74.33 107.827 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 22.8 t70 -157.48 152.77 26.09 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.235 0.614 . . . . 62.5 109.725 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 11.2 m -137.41 128.02 26.84 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.631 0.729 . . . . 72.51 110.045 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.83 161.68 16.66 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.151 -1.386 . . . . 72.24 108.554 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 20.3 p -159.31 151.36 20.87 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.858 0.361 . . . . 70.22 111.165 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 86.4 p -145.14 142.68 29.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.131 0.972 . . . . 64.55 108.747 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -82.87 118.06 23.17 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.426 -0.583 . . . . 71.43 109.426 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.539 HD12 HD13 ' C' ' 83' ' ' ILE . 38.6 mt -92.59 -40.05 10.99 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.609 0.763 . . . . 74.1 109.248 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.5 -175.73 5.49 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.263 1.025 . . . . 74.43 109.348 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.31 108.85 1.71 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.544 -0.753 . . . . 72.41 109.925 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 32.6 m-20 71.8 5.87 5.49 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.55 1.54 . . . . 74.43 112.668 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -103.23 97.78 6.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.964 -1.125 . . . . 70.14 107.964 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -103.43 137.82 41.0 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.46 0.704 . . . . 72.51 110.097 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.521 ' HB2' HD12 ' C' ' 51' ' ' LEU . 22.1 tt0 -81.9 108.99 15.85 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.745 -1.576 . . . . 71.21 106.745 164.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 50.9 t -96.97 137.26 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 108.166 -1.05 . . . . 72.43 108.166 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.411 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 52.1 t -127.4 129.88 70.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.235 -1.024 . . . . 71.52 108.235 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.7 104.5 13.51 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.831 -1.544 . . . . 74.15 106.831 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.544 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 9.2 ttm180 -90.27 120.79 31.71 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.862 -1.063 . . . . 73.02 108.326 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.28 123.93 71.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.836 -1.172 . . . . 74.32 107.836 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 27.0 m -126.03 123.67 38.95 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.612 -0.885 . . . . 62.3 108.612 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.526 HG12 HD23 ' C' ' 126' ' ' LEU . 34.2 t -114.03 120.87 64.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 108.795 -0.817 . . . . 55.32 108.795 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 30.8 m -101.19 143.86 30.76 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.641 0.776 . . . . 75.11 108.967 172.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.67 107.86 6.08 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.12 -1.437 . . . . 74.51 107.12 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.2 m -128.02 131.72 49.16 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.519 -0.549 . . . . 74.22 109.519 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.705 HD11 ' HG2' ' C' ' 34' ' ' LYS . 25.0 mt -85.15 43.18 0.99 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.281 1.832 . . . . 75.13 110.045 -176.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.62 -88.68 0.68 Allowed Glycine 0 C--N 1.343 0.919 0 N-CA-C 110.303 -1.119 . . . . 71.41 110.303 -170.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -118.5 -20.09 8.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.816 0.846 . . . . 71.53 110.746 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.417 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 5.5 tp10 -77.48 100.48 6.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.739 0.816 . . . . 74.23 109.143 172.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.7 m -66.85 120.26 13.26 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 118.922 0.783 . . . . 74.44 109.197 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.67 -52.36 18.3 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 124.095 0.872 . . . . 75.11 108.984 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -166.56 167.4 15.52 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.617 -1.174 . . . . 74.34 110.843 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -133.9 139.43 46.17 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 106.309 -1.737 . . . . 74.23 106.309 171.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.4 t -146.53 117.82 7.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.298 -0.631 . . . . 75.04 109.298 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -125.57 126.55 44.97 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 122.954 0.502 . . . . 73.43 109.909 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -120.46 132.46 70.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.338 -0.986 . . . . 73.4 108.338 167.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.544 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 69.0 mt-30 -106.08 94.66 5.29 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.587 -1.264 . . . . 75.0 107.587 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -84.2 105.73 15.28 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.532 -0.758 . . . . 64.03 109.701 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.603 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -95.64 163.73 23.86 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-O 121.609 0.56 . . . . 74.0 112.858 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.38 126.6 1.53 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.013 -1.235 . . . . 75.11 110.013 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.654 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 14.0 mm -85.23 128.77 38.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.125 -1.065 . . . . 74.43 108.125 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.11 119.41 20.91 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.392 -0.595 . . . . 75.14 109.392 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -83.95 107.58 16.41 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.162 -1.051 . . . . 74.31 108.162 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.44 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.4 pp -122.45 142.87 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.102 0.961 . . . . 73.24 110.144 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.92 169.53 21.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.628 0.771 . . . . 74.05 110.512 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.89 -44.21 1.52 Allowed Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.104 -0.498 . . . . 51.22 111.944 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.529 HD11 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -109.38 149.6 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.114 0.965 . . . . 63.03 109.234 178.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 11.7 pt-20 -143.01 172.59 12.5 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.652 0.263 . . . . 73.3 111.456 -171.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.81 -129.47 48.37 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.201 -0.909 . . . . 73.31 112.486 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -66.86 -19.32 65.71 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.671 0.788 . . . . 72.45 112.08 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -78.31 -35.26 48.0 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.404 0.681 . . . . 74.21 110.421 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.552 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 10.9 tmm? -72.63 -38.53 67.71 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.427 -0.953 . . . . 72.14 108.427 172.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.87 -32.8 71.05 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 115.248 -0.887 . . . . 64.34 110.558 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -77.37 -34.54 55.0 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.374 0.421 . . . . 73.12 110.918 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.416 ' SG ' HG22 ' C' ' 86' ' ' ILE . 15.2 t -63.29 -34.97 78.85 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.005 0.815 . . . . 74.4 109.913 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.402 ' HA ' ' HB2' ' C' ' 102' ' ' CYS . 3.8 pp -99.15 -12.46 20.45 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.99 0.516 . . . . 71.44 111.969 175.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.29 -31.51 59.2 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 114.562 0.585 . . . . 51.12 114.562 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.9 -38.09 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.797 0.439 . . . . 73.43 111.042 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.473 ' HH ' ' HD1' ' C' ' 11' ' ' PHE . 46.5 t80 -56.93 -41.81 78.91 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 125.419 1.488 . . . . 75.32 112.209 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.402 ' HB2' ' HA ' ' C' ' 98' ' ' LEU . 56.2 m -82.26 -48.59 0.89 Allowed Pre-proline 0 CA--C 1.569 1.708 0 N-CA-C 112.897 0.703 . . . . 74.34 112.897 174.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.98 -29.85 28.83 Favored 'Trans proline' 0 C--N 1.392 2.855 0 C-N-CA 123.21 2.607 . . . . 73.04 115.131 172.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.24 -35.41 80.74 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.907 0.883 . . . . 65.32 110.836 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.404 HG23 ' NH1' ' A' ' 111' ' ' ARG . 40.9 mm -64.71 -40.3 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 115.511 -0.768 . . . . 75.13 109.585 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 53.5 mt -83.55 -18.14 39.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.652 1.181 . . . . 71.32 112.14 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -56.75 -51.34 82.16 Favored Pre-proline 0 CA--C 1.56 1.352 0 N-CA-C 114.132 1.16 . . . . 75.51 114.132 -173.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.428 ' HA ' HH11 ' C' ' 111' ' ' ARG . 18.3 Cg_exo -66.15 -32.16 43.58 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 121.607 1.538 . . . . 72.21 112.778 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -65.63 -46.92 77.43 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.542 0.737 . . . . 74.45 110.503 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.04 -42.65 90.73 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.051 0.94 . . . . 73.32 110.679 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.428 HH11 ' HA ' ' C' ' 108' ' ' PRO . 27.6 mtp-105 -57.03 -55.93 28.33 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.333 1.02 . . . . 75.14 111.051 176.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.12 -29.91 70.8 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.139 0.576 . . . . 74.21 110.628 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 10.6 t -74.39 -33.13 62.96 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.265 0.626 . . . . 75.21 111.303 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 71.5 mt -72.76 -51.29 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.037 0.535 . . . . 75.25 109.654 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 25.8 m -59.99 -32.96 71.33 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.094 0.957 . . . . 75.13 111.349 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.0 t -61.57 -51.51 68.26 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.189 -0.671 . . . . 65.33 109.189 172.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.56 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.69 -35.54 78.3 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.703 1.201 . . . . 65.12 112.914 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.4 t -66.55 -47.13 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.52 0.728 . . . . 75.54 109.925 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.416 ' OG ' HG22 ' B' ' 115' ' ' THR . 48.4 t -66.18 -32.19 73.47 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.93 -1.032 . . . . 74.1 111.091 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.01 -35.53 74.44 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.73 0.812 . . . . 73.45 109.399 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 4.33 79.46 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.878 0.736 . . . . 74.33 112.873 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 60.0 p 59.38 25.55 14.28 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.509 1.924 . . . . 74.31 114.08 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -87.82 152.87 51.92 Favored Pre-proline 0 CA--C 1.557 1.237 0 N-CA-C 107.567 -1.272 . . . . 74.44 107.567 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.69 -179.81 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.729 2.286 . . . . 73.12 113.739 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -49.66 130.63 21.07 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.664 1.186 . . . . 71.44 112.89 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.526 HD23 HG12 ' C' ' 64' ' ' VAL . 14.3 tp -148.84 85.28 1.48 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.29 -1.004 . . . . 72.3 108.29 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -116.31 129.79 56.45 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.159 -1.052 . . . . 74.45 108.159 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 21.4 tp -76.18 132.69 40.11 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 109.78 -0.452 . . . . 74.04 109.78 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.1 154.91 75.78 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.243 1.017 . . . . 74.32 111.15 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.415 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 5.5 Cg_endo -50.11 101.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.907 2.405 . . . . 72.45 112.867 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 80.8 t -96.55 110.69 25.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.217 -1.031 . . . . 74.43 108.217 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -87.12 86.14 7.27 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.898 -1.149 . . . . 61.34 107.898 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -60.55 -31.4 70.51 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.303 0.641 . . . . 75.32 110.227 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.7 -36.94 79.13 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.336 1.054 . . . . 64.51 112.263 -165.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.45 74.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.98 0.912 . . . . 74.52 111.188 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.29 -23.97 34.92 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.182 -0.917 . . . . 74.55 111.452 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 3.3 t80 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.011 0.434 . . . . 73.24 109.997 173.083 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.6 m . . . . . 0 C--O 1.241 0.618 0 N-CA-C 107.506 -1.294 . . . . 73.52 107.506 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -148.53 110.77 4.64 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.077 -1.453 . . . . 74.35 107.077 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -132.81 141.67 48.59 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.183 -1.043 . . . . 75.1 108.183 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.588 HD12 HD12 ' D' ' 105' ' ' ILE . 19.4 mt -98.45 133.3 41.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.164 -1.05 . . . . 74.44 108.164 171.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -96.96 -45.65 6.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.403 0.681 . . . . 63.22 111.574 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -172.16 120.5 0.43 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 118.008 0.367 . . . . 73.52 111.874 -163.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.531 HD13 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -104.96 135.6 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.417 -1.327 . . . . 74.0 107.417 171.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -159.7 167.06 29.24 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.156 0.91 . . . . 62.52 111.205 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -99.53 117.16 33.31 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.078 -1.419 . . . . 74.22 109.327 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -88.06 -20.05 26.28 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.343 -0.844 . . . . 74.22 109.04 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.607 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.3 t70 -159.0 132.69 7.44 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.515 -1.22 . . . . 72.41 109.185 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.56 HG23 ' HE1' ' C' ' 117' ' ' MET . 79.7 mt -134.66 144.26 35.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 124.931 1.292 . . . . 75.45 107.553 174.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -147.46 136.6 22.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.337 1.055 . . . . 63.34 108.579 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.497 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.5 t80 -148.98 126.92 11.9 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.281 -1.748 . . . . 72.44 106.281 170.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -134.51 128.63 33.75 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.854 0.862 . . . . 74.15 109.372 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.67 81.27 60.91 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 107.881 -1.155 . . . . 70.43 107.881 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.92 -23.48 10.71 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.989 2.46 . . . . 73.24 113.604 -172.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -108.4 11.34 27.11 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.346 0.658 . . . . 65.22 109.966 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -36.85 -67.84 0.23 Allowed Pre-proline 0 CA--C 1.564 1.516 0 C-N-CA 126.371 1.868 . . . . 71.42 115.794 -161.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.403 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.0 Cg_endo -76.01 -19.18 16.03 Favored 'Trans proline' 0 C--N 1.38 2.196 0 CA-C-N 123.124 2.151 . . . . 75.53 113.839 -173.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -73.04 -43.06 62.48 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.917 0.887 . . . . 74.23 109.68 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.459 HG22 ' HA ' ' D' ' 73' ' ' ALA . 7.6 p -82.92 -16.12 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 CA-C-N 115.708 -0.678 . . . . 73.03 111.045 -172.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -68.4 -22.9 64.6 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.23 0.456 . . . . 71.24 112.23 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -65.94 -12.64 56.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.646 0.779 . . . . 75.54 110.744 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.4 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 82.7 mttt -98.44 92.91 5.89 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.396 1.078 . . . . 75.44 108.702 172.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -82.56 74.93 9.49 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.485 0.659 . . . . 75.21 109.697 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -137.43 156.23 48.41 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.129 -1.063 . . . . 73.44 108.129 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.436 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 1.8 mp0 -76.65 109.23 8.12 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.016 0.927 . . . . 72.43 108.921 174.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 21.6 Cg_exo -65.73 123.35 11.25 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 123.375 2.717 . . . . 63.31 113.432 -168.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -62.38 115.34 4.12 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.315 -0.624 . . . . 55.25 109.315 173.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.47 HG21 HG13 ' D' ' 64' ' ' VAL . 7.2 p -122.2 145.2 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.895 -1.048 . . . . 74.54 110.77 -170.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -117.26 147.9 42.13 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.978 0.911 . . . . 74.52 108.75 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.506 HD21 HG12 ' D' ' 62' ' ' VAL . 6.0 tt -121.34 125.61 47.43 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.339 -0.985 . . . . 75.52 108.339 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.607 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 29.3 t70 -108.11 137.49 46.01 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.941 0.896 . . . . 72.14 109.237 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 tp -113.14 140.45 47.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.651 0.78 . . . . 74.14 110.643 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.9 t70 -148.2 131.11 16.16 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.233 -1.395 . . . . 65.44 107.233 165.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.1 t -106.99 153.82 22.01 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.464 -0.939 . . . . 72.21 108.464 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.648 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.03 164.55 35.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.493 -0.929 . . . . 63.1 108.493 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 18.5 p -169.74 154.54 5.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.561 0.744 . . . . 75.1 109.806 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -154.22 142.61 20.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.784 0.834 . . . . 63.13 109.574 -166.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.11 118.66 28.99 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.644 -0.502 . . . . 75.3 109.644 175.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' D' ' 57' ' ' GLU . 49.6 mt -94.54 -42.02 9.04 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.351 0.66 . . . . 72.33 110.037 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.0 -174.75 4.89 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 124.013 0.925 . . . . 74.25 110.236 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -63.7 109.16 1.61 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.707 -1.133 . . . . 72.55 110.071 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 60.96 23.6 13.72 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.19 0.996 . . . . 63.34 111.906 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.52 121.79 67.9 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 124.758 1.223 . . . . 73.54 108.193 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -135.89 132.36 36.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.708 0.803 . . . . 65.05 109.311 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.537 ' HB2' HD11 ' D' ' 51' ' ' LEU . 30.4 tt0 -86.15 148.81 25.51 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 124.431 1.082 . . . . 63.31 108.98 169.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.2 t -125.96 124.77 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 107.653 -1.24 . . . . 75.33 107.653 168.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.4 t -99.64 128.29 51.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.26 -1.015 . . . . 70.35 108.26 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.54 115.58 30.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.502 -0.925 . . . . 74.44 108.502 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 45.9 ttm-85 -96.61 100.72 12.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.803 -1.184 . . . . 74.24 107.803 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.506 HG12 HD21 ' D' ' 42' ' ' LEU . 75.9 t -100.67 126.0 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.561 -0.903 . . . . 73.52 108.561 170.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 46.9 m -114.48 139.9 49.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.867 -0.79 . . . . 73.12 108.867 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.47 HG13 HG21 ' D' ' 40' ' ' VAL . 70.9 t -131.98 115.17 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.846 1.258 . . . . 75.1 108.213 -176.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 50.0 m -125.03 99.02 5.93 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.992 0.917 . . . . 75.23 109.227 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -101.59 158.84 15.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.669 0.787 . . . . 73.22 111.27 -175.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 50.8 p -149.92 133.31 16.51 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.669 -0.696 . . . . 70.41 111.548 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.419 HD11 HG21 ' D' ' 31' ' ' VAL . 34.9 mt -107.76 107.98 18.98 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.22 -1.4 . . . . 74.22 107.22 170.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.11 -133.3 12.35 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.934 -0.467 . . . . 72.4 111.934 -173.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -98.22 4.59 48.87 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.459 0.704 . . . . 75.43 111.401 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.4 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 12.9 pt-20 -120.23 165.23 15.09 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.922 0.489 . . . . 74.31 110.435 -175.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -61.64 131.0 48.57 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.198 -0.91 . . . . 70.04 111.449 175.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.459 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -87.49 -74.88 0.43 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.732 -1.21 . . . . 74.44 107.732 166.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . 0.476 ' HZ ' HD12 ' D' ' 126' ' ' LEU . 48.9 p90 -139.7 138.98 36.45 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.118 0.485 . . . . 73.31 109.875 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 83.3 mt -110.43 144.0 39.88 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.601 1.16 . . . . 75.15 108.159 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.594 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.2 t -159.05 146.61 17.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.848 0.459 . . . . 71.2 110.409 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -155.62 134.72 12.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.577 0.751 . . . . 74.01 108.984 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 89.5 t -133.31 121.57 42.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.892 -0.781 . . . . 73.4 108.892 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.607 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.9 mt-30 -88.11 83.25 7.01 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.812 -1.181 . . . . 71.3 107.812 167.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -79.52 93.44 5.43 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.702 -1.59 . . . . 71.42 108.663 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -84.3 157.32 33.14 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.624 -0.716 . . . . 73.44 112.059 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.455 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -152.47 130.06 2.95 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.198 -0.761 . . . . 74.22 111.198 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.1 mt -89.84 128.74 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 123.883 0.873 . . . . 73.24 108.646 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -126.8 152.46 46.91 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.211 1.005 . . . . 75.23 109.388 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 52.3 m -115.39 107.81 15.7 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.167 0.987 . . . . 75.43 108.423 170.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 28.5 pt -125.24 116.88 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.533 0.733 . . . . 75.44 109.444 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.07 136.39 38.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.54 0.736 . . . . 74.23 110.459 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.09 -19.82 13.26 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 115.47 0.948 . . . . 73.14 115.47 172.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.466 ' H ' HD11 ' D' ' 89' ' ' ILE . 0.2 OUTLIER -125.51 150.5 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 117.659 0.729 . . . . 74.32 110.979 -171.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 0.0 OUTLIER -151.57 166.09 32.27 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.237 0.458 . . . . 75.14 112.237 -172.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.48 -116.81 8.25 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 114.693 -1.139 . . . . 52.43 114.677 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.4 p -64.4 -47.43 79.22 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.96 0.904 . . . . 75.35 111.981 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -74.22 -24.08 59.28 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 116.306 -0.406 . . . . 62.2 111.014 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.652 ' HE2' HD22 ' D' ' 98' ' ' LEU . 0.8 OUTLIER -65.63 -49.2 69.58 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.695 -0.483 . . . . 74.01 109.695 174.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.96 -37.16 86.4 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.689 0.796 . . . . 63.54 110.861 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -65.91 -30.3 70.87 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.838 0.855 . . . . 75.21 111.392 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -82.57 -51.9 7.34 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.342 -0.39 . . . . 74.31 110.544 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.652 HD22 ' HE2' ' D' ' 94' ' ' MET . 8.1 tp -80.09 -31.13 39.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.798 0.439 . . . . 65.43 111.76 -168.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.04 13.96 55.81 Favored Glycine 0 N--CA 1.473 1.142 0 CA-C-N 115.982 -0.554 . . . . 72.02 113.362 -174.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' D' ' 134' ' ' ASP . . . -148.64 -63.67 0.24 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.812 0.445 . . . . 72.14 110.927 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -73.86 -43.0 59.97 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.242 0.617 . . . . 73.32 112.2 -172.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 97.3 m -63.55 -49.74 76.27 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 118.343 -0.836 . . . . 60.42 111.758 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.09 -20.74 43.68 Favored 'Trans proline' 0 C--N 1.399 3.213 0 C-N-CA 121.811 1.674 . . . . 71.2 113.131 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -71.18 -30.83 66.89 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.974 0.51 . . . . 61.12 110.769 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.588 HD12 HD12 ' D' ' 13' ' ' ILE . 63.7 mt -67.54 -39.27 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.943 0.897 . . . . 74.45 110.074 171.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.455 HD22 ' HA3' ' D' ' 82' ' ' GLY . 85.6 mt -77.19 -19.68 56.42 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.07 -0.968 . . . . 75.2 111.917 -175.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -70.38 -41.09 12.77 Favored Pre-proline 0 CA--C 1.563 1.449 0 N-CA-C 113.936 1.088 . . . . 75.41 113.936 -171.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.82 -40.96 82.54 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.192 1.928 . . . . 74.34 113.0 169.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -70.61 -35.49 73.01 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.742 0.817 . . . . 75.31 111.831 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -52.92 55.51 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.504 -0.554 . . . . 75.53 109.504 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.464 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 30.8 ttp-105 -52.27 -49.22 64.53 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.517 1.136 . . . . 71.54 111.098 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.79 -44.55 77.11 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.994 0.809 . . . . 74.15 111.252 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.95 -44.34 78.36 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.328 0.585 . . . . 62.05 110.636 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.594 HG12 ' SG ' ' D' ' 76' ' ' CYS . 78.3 mt -68.15 -51.37 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.582 -1.19 . . . . 72.33 110.959 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 52.7 m -51.56 -45.54 63.09 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.491 1.116 . . . . 73.22 111.174 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.7 t -62.26 -44.11 97.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.837 -1.074 . . . . 73.44 109.754 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.421 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 78.1 mtm -68.92 -31.38 70.25 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.222 0.609 . . . . 74.52 112.264 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' D' ' 123' ' ' PHE . 67.6 t -72.07 -38.83 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.85 0.86 . . . . 73.15 109.982 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.6 p -75.65 -29.49 59.14 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.112 0.565 . . . . 74.23 110.676 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -72.73 -34.91 67.38 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.697 0.799 . . . . 74.13 109.502 173.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 -1.71 88.0 Favored Glycine 0 C--N 1.356 1.688 0 CA-C-N 115.594 -0.73 . . . . 44.22 111.934 172.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p 64.84 19.3 11.8 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 127.219 2.207 . . . . 74.3 114.039 170.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.423 ' HB2' HG13 ' D' ' 118' ' ' VAL . 86.7 m-85 -78.97 152.98 77.5 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.163 0.585 . . . . 75.25 109.429 170.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.52 126.1 17.08 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.117 2.545 . . . . 74.52 112.756 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -60.43 120.33 9.71 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 123.804 0.842 . . . . 63.13 110.981 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.476 HD12 ' HZ ' ' D' ' 74' ' ' PHE . 80.7 mt -117.58 108.56 15.61 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.482 -0.933 . . . . 73.02 108.482 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.6 95.43 6.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.859 -1.163 . . . . 74.04 107.859 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.479 ' HG ' HD11 ' D' ' 42' ' ' LEU . 3.2 mm? -63.82 125.92 25.93 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.182 -0.917 . . . . 72.55 110.044 -175.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.6 139.86 58.82 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 124.072 0.857 . . . . 72.4 111.11 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.33 137.34 55.45 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.225 1.95 . . . . 73.42 110.923 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 67.0 t -106.17 110.85 32.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.4 -0.963 . . . . 72.12 108.4 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -72.76 88.81 1.32 Allowed 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.569 -0.9 . . . . 71.14 108.569 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -61.95 -31.23 71.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.773 -1.103 . . . . 72.03 110.86 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . 0.417 ' HA ' ' HB2' ' D' ' 100' ' ' ALA . 3.9 t70 -55.83 -50.25 71.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.143 1.377 . . . . 73.42 112.169 -173.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.36 -45.48 83.94 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.477 -0.783 . . . . 73.53 111.956 -174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -22.98 56.33 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.921 -0.581 . . . . 73.01 110.485 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 N--CA 1.479 1.011 0 C-N-CA 123.841 0.856 . . . . 72.43 111.004 178.541 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.6 m . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 108.959 -0.756 . . . . 74.21 108.959 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -136.86 130.06 31.18 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.166 0.986 . . . . 73.01 108.544 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -146.62 135.21 22.09 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.667 -0.864 . . . . 74.14 108.667 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 16' ' ' ILE . 13.0 mt -91.05 119.02 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.726 -0.842 . . . . 73.34 108.726 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -81.82 -40.65 22.22 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 123.525 0.516 . . . . 74.55 110.299 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -170.02 131.38 1.02 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.576 -0.283 . . . . 75.04 110.604 -169.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 13' ' ' ILE . 87.8 mt -121.32 132.88 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.728 -0.841 . . . . 74.34 108.728 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.428 ' HB3' HG21 ' B' ' 122' ' ' THR . 34.5 p90 -166.14 151.87 8.78 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.922 0.764 . . . . 64.13 110.812 -175.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -80.25 106.88 12.6 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.732 -1.122 . . . . 73.34 109.027 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -73.06 -28.59 62.4 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.223 -0.444 . . . . 72.23 110.395 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -148.57 140.06 23.48 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.065 -0.97 . . . . 71.11 109.226 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.13 142.81 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 107.537 -1.283 . . . . 74.3 107.537 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -143.13 147.86 35.65 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.115 0.483 . . . . 74.0 109.73 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 83.4 t80 -150.07 114.51 5.21 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.032 -1.469 . . . . 73.02 107.032 174.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -124.34 110.36 14.48 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.838 -0.43 . . . . 61.4 109.838 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.44 84.81 19.12 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 124.052 0.941 . . . . 64.52 108.559 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.49 -32.38 12.34 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.513 2.142 . . . . 75.51 110.826 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -102.62 28.87 5.68 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.604 1.162 . . . . 70.11 109.812 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.3 -46.34 99.09 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.529 0.731 . . . . 61.31 111.999 173.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -83.95 5.63 6.23 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.049 1.833 . . . . 53.45 112.756 172.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 54.7 m170 -104.47 -17.5 14.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.335 0.654 . . . . 73.22 111.903 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 28' ' ' ALA . 11.3 p -71.04 -31.07 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.47 0.544 . . . . 75.45 112.47 -170.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -80.15 -33.03 38.82 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.39 0.276 . . . . 73.12 110.813 -172.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -76.92 -24.36 52.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.939 -0.573 . . . . 74.32 110.167 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -83.53 151.61 25.32 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.758 0.823 . . . . 74.21 110.536 171.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.03 140.25 40.29 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.727 -0.842 . . . . 74.52 108.727 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -79.31 95.6 5.74 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.181 0.515 . . . . 74.52 111.083 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -126.92 83.81 64.86 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.41 1.084 . . . . 75.13 109.112 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.32 139.93 29.76 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.421 2.081 . . . . 74.21 112.726 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -106.82 100.52 10.02 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.252 -1.388 . . . . 71.43 107.252 172.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.8 m -76.26 101.25 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 CA-C-O 122.113 0.959 . . . . 74.31 111.432 -174.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -110.4 114.11 27.3 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.328 -1.36 . . . . 72.51 107.328 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 tp -120.43 136.84 54.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.085 0.554 . . . . 74.12 110.677 -172.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.592 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.1 m-20 -121.22 140.07 52.53 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.961 1.304 . . . . 64.23 108.22 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.536 HD21 ' HE1' ' A' ' 133' ' ' PHE . 7.7 tt -142.47 120.3 11.95 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.643 -0.873 . . . . 74.35 108.643 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -136.45 145.68 45.48 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.841 0.856 . . . . 74.11 110.243 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 m -113.19 135.07 54.22 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.291 1.036 . . . . 71.14 108.71 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.77 132.25 45.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.556 0.742 . . . . 75.13 109.433 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.4 m -90.99 152.49 20.67 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.597 0.759 . . . . 74.21 111.225 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 42.1 t -154.45 131.55 11.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.848 0.859 . . . . 75.31 109.329 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -112.18 111.92 23.15 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.748 -0.834 . . . . 74.53 108.748 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.5 mt -86.89 -39.68 15.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.257 0.623 . . . . 72.23 110.389 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.23 -174.99 4.33 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.008 0.923 . . . . 73.1 109.656 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.63 104.75 0.3 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.769 0.827 . . . . 72.21 109.744 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 66.54 9.75 6.82 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.125 1.37 . . . . 75.43 112.639 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.34 101.69 12.44 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 105.35 -2.093 . . . . 63.33 105.35 168.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -116.79 151.21 36.96 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.503 -1.226 . . . . 75.12 109.081 -164.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 43.7 tt0 -132.78 138.63 47.21 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.275 0.63 . . . . 72.32 110.031 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.6 t -119.85 130.98 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.106 -1.072 . . . . 70.03 108.106 171.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.4 t -115.69 109.6 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.134 0.973 . . . . 74.2 108.604 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.0 tp -89.2 101.42 14.08 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.055 -0.72 . . . . 71.42 109.055 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 ttp85 -85.4 107.51 17.41 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.051 -0.722 . . . . 75.43 109.051 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.458 HG11 ' HB1' ' A' ' 110' ' ' ALA . 3.1 p -113.52 121.87 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 108.93 -0.767 . . . . 73.3 108.93 176.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.6 m -116.49 135.45 53.82 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.586 0.754 . . . . 74.5 109.407 -177.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.46 ' O ' HD13 ' A' ' 75' ' ' LEU . 64.8 t -124.61 132.99 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 124.38 1.072 . . . . 70.24 108.634 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.3 m -131.21 120.55 23.43 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.049 -0.723 . . . . 75.02 109.049 173.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.41 122.52 44.02 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.677 -0.86 . . . . 75.33 108.677 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 t -130.18 146.72 51.83 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.916 0.886 . . . . 72.43 110.228 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.58 87.15 3.1 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 107.123 -1.436 . . . . 72.0 107.123 167.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.73 -105.09 3.23 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 114.835 -1.075 . . . . 73.14 110.518 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.54 -20.61 11.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.805 0.842 . . . . 74.55 110.616 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.05 104.89 9.99 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.831 0.853 . . . . 71.22 109.271 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.3 m -71.31 121.2 18.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.157 0.583 . . . . 72.34 110.732 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.01 -53.51 20.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.783 0.833 . . . . 72.41 109.38 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -150.22 158.08 43.77 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.502 -1.226 . . . . 75.12 111.618 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 64' ' ' VAL . 66.9 tp -125.57 140.89 52.36 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.371 1.468 . . . . 73.22 107.282 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.4 m -142.34 113.29 7.5 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.378 0.671 . . . . 74.32 109.585 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -127.05 120.52 29.18 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.272 -0.64 . . . . 65.14 109.272 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.4 t -127.63 110.64 22.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 123.665 0.786 . . . . 74.24 109.348 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -85.05 81.4 8.89 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.73 -1.211 . . . . 75.52 107.73 171.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -76.88 94.96 3.99 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.074 -0.967 . . . . 74.33 108.633 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.06 151.08 21.36 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 115.376 -0.829 . . . . 74.34 111.589 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.97 128.5 2.8 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.139 -0.784 . . . . 71.22 111.139 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -81.15 115.82 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.789 -0.819 . . . . 74.2 108.789 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -114.8 118.7 34.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.048 0.939 . . . . 75.33 109.586 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.9 m -85.36 103.7 14.51 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.63 -0.878 . . . . 73.11 108.63 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.9 pp -116.04 153.91 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.12 0.568 . . . . 72.31 110.812 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.55 149.98 5.89 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.615 1.166 . . . . 72.4 109.429 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.23 -26.75 23.45 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 122.856 0.265 . . . . 62.14 113.715 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.484 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.92 138.85 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.502 0.721 . . . . 74.43 110.321 -176.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 10.6 tt0 -152.59 174.4 14.0 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.89 0.476 . . . . 75.31 109.857 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.417 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 66.83 -127.7 28.33 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 116.344 -0.389 . . . . 63.25 112.248 -174.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -72.5 -21.07 61.25 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.464 0.706 . . . . 73.12 111.313 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -70.77 -45.26 65.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.503 0.721 . . . . 73.43 110.851 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.524 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 23.3 ttt -71.95 -37.34 69.99 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.347 -0.388 . . . . 71.32 110.013 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.88 72.19 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.346 0.404 . . . . 70.45 110.587 174.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -71.74 -33.74 68.96 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.381 0.672 . . . . 73.44 110.706 173.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -66.55 -61.81 1.79 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 110.047 -0.353 . . . . 61.22 110.047 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.424 HD23 ' HG2' ' A' ' 94' ' ' MET . 4.2 pp -74.13 -24.62 59.45 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.449 0.7 . . . . 72.25 112.547 -174.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.44 1.08 37.14 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-O 119.538 -0.59 . . . . 65.2 114.28 -173.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -141.36 -65.34 0.43 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 117.533 0.667 . . . . 72.34 111.052 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.439 ' O ' HG12 ' A' ' 105' ' ' ILE . 48.3 t80 -66.63 -46.49 75.63 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 112.797 0.666 . . . . 71.21 112.797 -171.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -68.66 -47.37 34.07 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 124.064 0.945 . . . . 73.53 112.723 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.51 -26.8 69.97 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 121.823 1.682 . . . . 73.55 112.185 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -65.91 -37.83 87.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.158 0.583 . . . . 74.14 110.937 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 101' ' ' TYR . 47.2 mm -66.34 -45.67 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.301 0.641 . . . . 72.41 110.046 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.6 mt -73.89 -23.37 59.56 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.381 -0.827 . . . . 73.34 111.918 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -60.69 -49.14 91.02 Favored Pre-proline 0 CA--C 1.563 1.451 0 N-CA-C 113.968 1.099 . . . . 64.34 113.968 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -63.11 -34.83 67.96 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.11 1.874 . . . . 75.42 112.841 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -67.52 -40.23 85.11 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.126 0.57 . . . . 75.54 110.872 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.458 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -69.77 -36.21 75.56 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.401 0.681 . . . . 65.33 110.79 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.581 ' HA ' HD23 ' A' ' 128' ' ' LEU . 38.1 ttm180 -57.15 -53.82 53.72 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 124.031 0.832 . . . . 72.32 109.715 176.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -57.76 -48.02 80.84 Favored 'General case' 0 C--N 1.348 0.531 0 O-C-N 124.563 1.164 . . . . 75.12 111.229 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 117' ' ' MET . 24.0 t -53.29 -47.84 68.87 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.334 1.021 . . . . 75.42 110.462 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.43 HD11 HG12 ' A' ' 62' ' ' VAL . 93.6 mt -68.55 -38.42 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.327 1.051 . . . . 74.41 111.176 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.2 m -64.34 -34.23 77.68 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.263 0.554 . . . . 75.43 110.115 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 t -74.24 -36.93 63.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.881 -0.599 . . . . 71.41 109.701 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 74.6 mmm -60.36 -46.98 88.03 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.98 0.512 . . . . 75.11 110.739 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.0 m -69.41 -39.68 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.571 -0.74 . . . . 74.22 110.826 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.8 m -67.23 -34.59 77.79 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.867 0.467 . . . . 73.31 111.639 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.526 HH12 ' HG3' ' B' ' 112' ' ' GLU . 86.8 mtt-85 -74.34 -28.92 61.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.225 0.61 . . . . 73.44 110.191 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.88 -4.74 88.49 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 123.758 0.661 . . . . 73.24 113.183 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.4 m 65.92 41.14 3.86 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 123.586 1.66 . . . . 73.32 111.132 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.89 151.61 43.62 Favored Pre-proline 0 C--O 1.244 0.772 0 CA-C-N 113.917 -1.492 . . . . 74.34 108.514 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -53.06 142.33 54.53 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.897 2.398 . . . . 74.05 112.697 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.06 145.88 24.39 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.987 0.804 . . . . 74.43 112.124 -177.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.4 ' CD2' HG13 ' A' ' 64' ' ' VAL . 18.4 tp -128.4 115.99 19.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.727 -1.124 . . . . 75.04 110.391 -175.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -120.8 89.29 3.1 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.248 -1.019 . . . . 64.41 108.248 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.611 HD21 ' H ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER -64.38 129.58 40.47 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 116.057 -0.519 . . . . 73.23 109.779 176.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.82 144.65 85.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.494 1.118 . . . . 73.14 112.077 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.402 ' HD3' HD13 ' C' ' 13' ' ' ILE . 15.5 Cg_exo -65.63 113.09 2.37 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.366 2.044 . . . . 71.43 110.844 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.05 127.56 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.595 -0.891 . . . . 73.24 108.595 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.421 ' ND2' ' HB3' ' A' ' 134' ' ' ASP . 0.2 OUTLIER -80.44 89.87 5.62 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.582 -0.735 . . . . 71.31 109.387 -172.212 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.536 ' HE1' HD21 ' A' ' 44' ' ' LEU . 97.3 m-85 -60.25 -37.43 80.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.147 0.979 . . . . 64.2 111.762 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.421 ' HB3' ' ND2' ' A' ' 132' ' ' ASN . 20.1 t70 -56.24 -51.14 69.18 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.975 0.797 . . . . 73.02 110.317 176.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.45 97.65 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 124.345 1.028 . . . . 71.43 111.28 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -57.53 -45.66 84.76 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.914 0.759 . . . . 72.31 111.215 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -67.69 -37.9 82.94 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.802 -0.635 . . . . 73.12 110.025 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.5 mmt . . . . . 0 N--CA 1.477 0.911 0 O-C-N 123.973 0.795 . . . . 75.13 111.763 -178.7 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.564 ' HB ' ' HB1' ' B' ' 87' ' ' ALA . 99.2 m . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 108.262 -1.014 . . . . 75.02 108.262 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -136.06 127.54 28.63 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.195 -1.039 . . . . 72.4 108.195 169.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -147.24 134.11 20.16 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.117 -0.697 . . . . 75.01 109.117 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.482 HD11 HD12 ' B' ' 105' ' ' ILE . 26.9 mt -86.84 122.03 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.439 -0.948 . . . . 74.5 108.439 172.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -95.23 -30.6 13.91 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.127 0.571 . . . . 73.14 110.177 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -172.72 138.05 0.82 Allowed 'General case' 0 C--N 1.353 0.725 0 O-C-N 123.642 0.589 . . . . 75.04 110.124 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.0 mt -118.74 137.66 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 106.922 -1.51 . . . . 74.11 106.922 171.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.452 ' HE1' HG13 ' B' ' 83' ' ' ILE . 10.8 p90 -167.17 143.61 4.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.249 0.547 . . . . 75.51 112.376 -173.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.4 m -73.56 125.64 28.44 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.134 -0.939 . . . . 72.44 108.73 169.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -97.52 -31.74 12.17 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.698 0.799 . . . . 75.2 110.698 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 21.1 t70 -155.72 143.2 19.47 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.45 -0.341 . . . . 71.14 111.025 -174.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.455 HD13 ' SG ' ' B' ' 113' ' ' CYS . 42.6 mm -139.54 143.3 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.988 1.315 . . . . 72.22 109.007 177.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.1 t -142.45 120.8 12.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.83 -1.077 . . . . 74.11 108.452 167.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -121.24 124.26 44.22 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.479 -1.304 . . . . 73.4 107.479 168.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.636 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 34.3 mt-10 -128.61 117.33 21.04 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.532 1.133 . . . . 70.31 108.381 -174.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.18 86.57 3.35 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 108.002 -1.11 . . . . 75.51 108.002 171.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -65.11 -47.88 4.19 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.057 2.504 . . . . 72.23 113.17 -167.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -107.34 28.19 8.34 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.035 0.934 . . . . 74.32 109.764 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.508 ' HB1' ' HD3' ' B' ' 29' ' ' PRO . . . -39.44 -63.15 0.68 Allowed Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 114.985 1.476 . . . . 72.25 114.985 -163.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.508 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 12.1 Cg_exo -68.45 -24.24 36.74 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.137 1.891 . . . . 71.15 112.896 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -92.69 -28.04 16.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.756 0.822 . . . . 74.12 112.555 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.731 HG21 ' HA ' ' B' ' 73' ' ' ALA . 13.4 p -81.95 -18.96 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 120.69 0.281 . . . . 73.44 111.472 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -64.89 -17.27 64.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 113.164 0.802 . . . . 75.45 113.164 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -66.93 -21.17 65.99 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.206 0.602 . . . . 71.13 111.385 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.514 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 86.1 mttt -94.05 107.38 19.3 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.813 0.845 . . . . 74.32 109.177 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -87.21 86.06 7.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.954 0.501 . . . . 74.02 110.566 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -164.64 158.11 17.55 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.902 0.881 . . . . 72.02 109.161 173.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.22 109.23 5.89 Favored Pre-proline 0 C--N 1.354 0.792 0 N-CA-C 109.087 -0.709 . . . . 75.3 109.087 169.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.643 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 13.1 Cg_endo -56.34 146.61 72.05 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.017 2.478 . . . . 61.12 111.842 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -61.32 102.51 0.23 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 123.826 0.704 . . . . 71.53 109.181 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.413 HG22 ' O ' ' B' ' 38' ' ' PRO . 85.1 t -92.81 120.31 41.94 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 115.607 -0.724 . . . . 73.33 109.576 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -121.08 119.19 31.73 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.904 -1.517 . . . . 75.15 106.904 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 pp -93.96 160.56 14.67 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.251 0.548 . . . . 74.14 111.065 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.7 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 3.2 m-20 -123.67 129.57 51.32 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.773 -1.195 . . . . 64.43 107.773 173.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 tt -100.38 128.62 46.4 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.36 -1.348 . . . . 73.31 107.36 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -145.93 121.43 10.38 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.496 0.718 . . . . 74.3 109.689 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 43.3 p -120.65 122.79 41.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.62 0.368 . . . . 75.0 110.255 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.78 154.77 33.72 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.523 1.129 . . . . 75.21 108.327 172.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.3 p -144.77 168.06 21.11 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.909 0.385 . . . . 74.23 111.061 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.2 p -153.47 169.91 22.02 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.354 1.061 . . . . 61.3 109.337 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -114.26 136.35 53.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.706 0.802 . . . . 73.11 110.339 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.505 HD12 HG22 ' B' ' 83' ' ' ILE . 86.4 mt -99.41 -39.22 8.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.281 0.633 . . . . 70.43 110.727 174.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.54 -177.09 5.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.637 0.775 . . . . 75.14 110.287 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -68.95 123.64 21.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.409 -0.814 . . . . 71.31 109.126 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 69.8 9.62 7.22 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.569 1.147 . . . . 75.21 112.161 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.7 t -124.34 110.72 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 107.862 -1.162 . . . . 73.3 107.862 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.435 ' CD2' HD11 ' B' ' 98' ' ' LEU . 5.8 t80 -125.28 154.13 42.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.769 -0.826 . . . . 75.33 108.769 -177.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -130.62 110.02 11.08 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.439 -0.949 . . . . 74.21 108.439 -168.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.48 145.26 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.961 0.904 . . . . 74.14 109.948 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.8 t -128.4 114.73 35.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 121.37 0.605 . . . . 72.22 109.537 176.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -94.15 111.51 23.24 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.578 -1.268 . . . . 75.23 107.578 176.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -105.31 129.72 53.59 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.274 0.559 . . . . 75.23 109.868 171.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.32 119.78 57.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.831 -1.174 . . . . 74.22 107.831 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.7 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 95.5 m -98.18 148.87 23.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.274 -1.01 . . . . 63.44 108.274 175.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.605 HG22 HG21 ' B' ' 114' ' ' ILE . 42.7 t -134.67 125.6 46.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.55 1.14 . . . . 72.22 108.284 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 99.5 m -123.97 139.69 53.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.589 -0.893 . . . . 63.44 108.589 172.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -136.62 145.49 44.94 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 123.652 0.595 . . . . 70.51 110.275 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.1 p -136.13 126.98 27.51 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.638 0.586 . . . . 65.21 111.153 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.643 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 19.8 mt -100.86 112.13 24.49 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.292 -1.003 . . . . 74.31 108.292 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.09 -114.16 5.89 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 124.003 0.815 . . . . 64.23 112.168 -174.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -110.58 4.39 20.25 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.316 0.646 . . . . 74.4 111.304 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.514 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.3 pt-20 -122.41 160.45 25.45 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.999 0.52 . . . . 73.4 110.438 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -75.2 138.15 41.76 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 123.501 0.501 . . . . 72.22 110.079 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.731 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.59 -64.07 1.15 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.371 0.668 . . . . 64.42 109.536 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -144.31 155.33 43.77 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.737 0.78 . . . . 74.21 110.877 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 82.1 mt -128.02 135.55 50.03 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.74 1.616 . . . . 74.32 106.761 173.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.429 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 38.9 t -145.07 148.4 33.63 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.993 -0.743 . . . . 54.23 108.993 175.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -158.98 126.97 5.06 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.215 -0.661 . . . . 74.31 109.215 -172.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 65.5 t -124.37 147.37 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 115.401 -0.818 . . . . 72.44 109.419 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -124.8 86.63 2.59 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.249 -1.019 . . . . 73.04 108.249 170.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -80.05 103.03 9.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.717 -0.674 . . . . 73.3 109.486 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.15 164.5 28.51 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 112.042 -0.423 . . . . 63.53 112.042 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.32 134.86 3.79 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.94 -0.464 . . . . 62.24 111.94 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.505 HG22 HD12 ' B' ' 51' ' ' LEU . 59.0 mt -91.93 124.52 44.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.982 0.913 . . . . 71.55 109.056 174.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -131.69 135.97 47.29 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.253 0.621 . . . . 72.13 110.029 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.7 m -91.36 115.05 27.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.428 1.091 . . . . 73.24 109.198 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.718 HD12 HD13 ' B' ' 98' ' ' LEU . 35.7 pt -115.96 130.37 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.665 0.786 . . . . 74.11 110.83 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.564 ' HB1' ' HB ' ' B' ' 10' ' ' THR . . . -157.78 167.4 30.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.599 0.76 . . . . 64.32 109.586 170.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.09 -56.77 5.08 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 111.5 -0.64 . . . . 74.44 111.5 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.441 HD13 ' HB ' ' B' ' 86' ' ' ILE . 2.8 pp -75.96 163.67 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.17 0.988 . . . . 73.23 111.246 175.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -168.59 157.32 8.58 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.628 0.58 . . . . 74.31 110.628 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.97 -116.03 7.37 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.533 0.521 . . . . 72.14 113.548 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 97.1 m -65.43 -36.1 82.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.88 0.872 . . . . 74.42 111.016 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -66.02 -41.79 90.53 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.689 0.796 . . . . 74.41 110.06 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 47.5 ttp -66.72 -36.65 82.97 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.608 -1.178 . . . . 73.4 110.931 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.19 -32.11 68.47 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.171 0.588 . . . . 63.02 110.572 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -69.96 -29.17 66.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.567 0.747 . . . . 61.14 110.676 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -77.57 -66.78 0.79 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.945 -0.57 . . . . 72.21 110.196 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.718 HD13 HD12 ' B' ' 86' ' ' ILE . 66.5 mt -78.43 -26.4 46.29 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.956 0.902 . . . . 71.32 112.92 -168.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.07 0.81 64.48 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-O 119.749 -0.473 . . . . 64.03 113.453 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 -66.21 0.25 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.28 0.54 . . . . 74.4 112.024 -174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -64.89 -42.39 94.82 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.769 0.827 . . . . 73.34 112.432 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.472 ' SG ' HD21 ' B' ' 98' ' ' LEU . 84.4 m -68.83 -47.44 32.0 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 124.288 1.035 . . . . 73.03 111.725 -177.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.453 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 86.8 Cg_exo -51.9 -39.75 68.02 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.321 2.014 . . . . 70.53 113.326 167.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -61.67 -31.96 72.11 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 112.709 0.633 . . . . 54.33 112.709 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.482 HD12 HD11 ' B' ' 13' ' ' ILE . 61.6 mt -67.85 -41.28 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.384 0.674 . . . . 73.23 110.156 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 66.8 mt -82.78 -19.47 37.7 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.871 -1.059 . . . . 73.41 111.867 -173.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.409 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 57.6 t80 -61.28 -45.22 95.14 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 114.166 1.173 . . . . 72.04 114.166 -170.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 18.2 Cg_endo -58.91 -38.01 90.54 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.089 1.859 . . . . 70.31 112.851 175.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -65.26 -46.26 81.24 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.374 0.67 . . . . 73.12 110.933 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.15 90.01 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.511 -0.768 . . . . 51.15 110.9 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -59.6 -60.52 3.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.495 1.118 . . . . 74.23 110.677 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.526 ' HG3' HH12 ' A' ' 120' ' ' ARG . 12.4 tp10 -58.45 -31.85 68.16 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.399 1.08 . . . . 62.04 111.075 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.531 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.4 t -71.67 -40.33 69.68 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 119.364 -0.351 . . . . 72.51 110.848 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.605 HG21 HG22 ' B' ' 64' ' ' VAL . 88.5 mt -65.1 -55.0 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 109.305 -0.628 . . . . 63.12 109.305 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 13.6 m -58.06 -34.61 70.29 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 124.367 1.042 . . . . 75.42 111.592 -173.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.7 t -61.52 -51.1 70.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 115.913 -0.585 . . . . 74.5 110.03 176.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.5 mmt -66.77 -38.64 86.98 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 123.645 0.59 . . . . 73.12 111.103 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 89.3 t -58.61 -44.56 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.998 0.919 . . . . 74.32 110.515 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 35.2 t -71.26 -30.54 66.42 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.011 -0.995 . . . . 73.32 111.56 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.7 mtt-85 -70.06 -28.91 65.83 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.515 0.726 . . . . 74.4 110.232 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -87.32 9.35 73.41 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 124.02 0.825 . . . . 64.4 112.737 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.428 HG21 ' HB3' ' A' ' 17' ' ' TYR . 58.9 p 55.84 31.65 18.08 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.018 1.727 . . . . 63.34 112.941 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -92.09 155.2 43.16 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 123.734 0.814 . . . . 73.21 109.971 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.17 156.96 6.98 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.713 2.942 . . . . 75.44 114.843 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.433 HE21 ' ND2' ' B' ' 127' ' ' ASN . 64.3 tp60 -60.39 130.43 46.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.095 0.958 . . . . 75.13 111.09 -174.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -141.61 95.36 2.81 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.601 -0.518 . . . . 74.21 109.601 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.433 ' ND2' HE21 ' B' ' 125' ' ' GLN . 55.3 m-80 -94.5 136.55 34.67 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.684 -0.858 . . . . 71.33 108.684 169.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.47 140.33 39.8 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.502 0.721 . . . . 75.54 110.508 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.86 146.1 92.76 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.066 0.946 . . . . 43.34 111.737 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.91 97.67 0.49 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.282 2.654 . . . . 73.42 111.71 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 62.1 t -91.01 110.39 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.142 -1.058 . . . . 75.4 108.142 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -84.87 98.46 10.33 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.805 -1.183 . . . . 75.14 107.805 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -57.99 -48.57 79.6 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.983 0.802 . . . . 75.1 111.357 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.97 -37.23 76.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.195 0.998 . . . . 74.3 112.547 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.66 -47.34 78.85 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.756 0.822 . . . . 64.4 111.549 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -81.81 -24.77 35.72 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.847 -0.615 . . . . 74.01 110.369 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 79.4 t80 . . . . . 0 N--CA 1.47 0.552 0 C-N-CA 123.511 0.724 . . . . 74.43 109.727 175.732 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 70.3 m . . . . . 0 C--O 1.236 0.359 0 N-CA-C 108.354 -0.98 . . . . 62.21 108.354 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.562 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.8 t80 -124.52 128.06 48.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.539 0.736 . . . . 74.42 109.101 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -146.54 128.04 15.04 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.82 0.7 . . . . 64.34 109.605 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.402 HD13 ' HD3' ' A' ' 130' ' ' PRO . 95.4 mt -68.46 124.66 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.416 -0.957 . . . . 74.12 108.416 168.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.578 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 36.4 mm-40 -93.28 -47.46 6.9 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.425 0.69 . . . . 74.05 110.192 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -175.24 124.44 0.24 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.59 -0.732 . . . . 65.42 110.013 -169.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.9 143.46 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 108.381 -0.97 . . . . 74.41 108.381 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.488 ' CE2' ' HD2' ' C' ' 19' ' ' LYS . 28.5 p90 -170.92 166.7 7.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.1 0.476 . . . . 72.43 110.77 -175.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.9 p -88.32 112.43 22.83 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.273 -0.876 . . . . 73.44 109.203 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.488 ' HD2' ' CE2' ' C' ' 17' ' ' TYR . 19.3 mmmt -64.97 -46.54 81.09 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.661 -1.237 . . . . 73.15 107.661 170.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.605 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.0 t70 -141.53 143.61 33.86 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 113.334 -1.757 . . . . 72.34 109.908 -170.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 59.0 mt -141.12 145.32 25.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 106.474 -1.676 . . . . 71.3 106.474 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.7 t -157.45 149.62 22.58 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.366 0.603 . . . . 75.04 109.984 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 84.1 t80 -149.55 116.72 6.03 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.017 -1.475 . . . . 72.21 107.017 172.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -120.78 111.1 17.15 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.162 0.585 . . . . 75.25 110.192 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.85 74.56 63.81 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.769 -1.567 . . . . 75.2 106.769 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.58 -15.87 30.53 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.652 2.234 . . . . 64.01 111.806 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -111.45 24.4 12.85 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.543 1.137 . . . . 74.15 109.623 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.485 ' HA ' HG11 ' C' ' 31' ' ' VAL . . . -51.27 -49.42 81.86 Favored Pre-proline 0 CA--C 1.562 1.404 0 N-CA-C 114.239 1.199 . . . . 72.41 114.239 -172.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.445 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 35.3 Cg_exo -60.13 -43.3 36.61 Favored 'Trans proline' 0 C--N 1.38 2.214 0 CA-C-N 122.021 1.757 . . . . 63.34 112.206 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -69.15 -30.0 68.14 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.826 -1.079 . . . . 71.51 112.053 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' C' ' 73' ' ' ALA . 5.4 p -79.78 -28.33 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 N-CA-C 111.858 0.318 . . . . 73.32 111.858 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -70.34 -31.68 69.06 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 120.791 0.329 . . . . 73.31 111.268 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -84.98 7.49 21.08 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.511 0.724 . . . . 74.21 111.228 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.706 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.07 164.43 13.95 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.343 1.057 . . . . 75.24 110.445 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.408 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 9.8 t70 -85.31 104.17 14.91 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.929 -1.138 . . . . 72.15 107.929 167.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.6 t90 -70.09 87.83 0.58 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.923 1.289 . . . . 74.34 111.335 -171.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -123.03 79.12 51.26 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 124.479 1.111 . . . . 72.52 108.55 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.57 138.98 30.47 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.638 2.226 . . . . 54.35 114.495 -171.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.12 115.94 22.65 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.606 -1.628 . . . . 71.32 106.606 164.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.13 118.63 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.489 -0.778 . . . . 75.54 110.079 -163.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.504 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 87.3 tttt -127.22 134.1 50.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.824 0.85 . . . . 73.32 109.102 176.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 50.9 tp -126.0 129.37 49.07 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.016 -0.735 . . . . 73.12 109.016 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.408 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.3 t70 -118.84 133.5 55.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.618 -1.252 . . . . 75.11 107.618 175.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.424 HD12 ' HE2' ' C' ' 133' ' ' PHE . 87.4 mt -124.8 136.01 53.46 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.836 -1.172 . . . . 72.53 107.836 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 15.6 t70 -141.96 151.29 42.41 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.503 0.721 . . . . 73.41 109.371 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -134.92 151.9 51.28 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.896 -0.779 . . . . 73.53 108.896 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.19 170.4 20.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.672 0.789 . . . . 73.32 109.273 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.411 ' HB2' ' CE2' ' C' ' 56' ' ' TYR . 78.0 p -159.64 153.09 22.43 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.265 0.226 . . . . 70.24 111.346 -176.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 84.2 p -149.59 147.44 28.14 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.943 0.897 . . . . 71.31 109.991 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -89.76 121.16 31.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.175 0.59 . . . . 65.22 109.587 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' C' ' 57' ' ' GLU . 20.5 mt -95.32 -39.26 10.13 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.329 0.652 . . . . 74.04 109.759 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.73 -172.45 3.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.77 0.828 . . . . 74.31 110.261 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.27 111.51 1.57 Allowed 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.255 0.972 . . . . 75.43 109.953 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 70.06 -6.02 1.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.711 1.205 . . . . 74.43 112.733 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 68.1 t -94.22 95.79 5.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 106.833 -1.543 . . . . 70.24 106.833 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' C' ' 48' ' ' SER . 12.1 t80 -118.17 124.59 48.34 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.141 -0.936 . . . . 74.21 108.845 -172.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.57 ' HB2' HD12 ' C' ' 51' ' ' LEU . 39.3 tt0 -85.5 138.95 31.87 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 123.263 0.625 . . . . 75.12 110.587 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 42.6 t -116.81 142.16 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.925 -1.139 . . . . 64.42 107.925 165.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 85.8 t -127.83 130.73 70.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.99 -1.115 . . . . 75.5 107.99 172.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.23 107.67 18.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.451 -0.944 . . . . 74.32 108.451 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.446 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 49.5 ttm-85 -86.56 134.95 33.61 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.795 -1.093 . . . . 73.1 109.192 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.04 118.54 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.029 -1.1 . . . . 72.34 108.029 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.1 m -121.46 122.42 39.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.635 -0.876 . . . . 65.22 108.635 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.578 HG11 HD13 ' C' ' 126' ' ' LEU . 14.5 t -115.55 129.35 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.52 -0.918 . . . . 73.32 108.52 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 5.6 m -121.7 115.94 23.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.787 0.835 . . . . 75.11 108.871 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.59 120.82 43.64 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.79 -1.189 . . . . 75.04 107.79 172.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 45.3 m -122.2 169.07 11.26 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.578 0.751 . . . . 74.44 109.605 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.706 HD11 ' HG2' ' C' ' 34' ' ' LYS . 85.1 mt -132.24 15.68 4.59 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.577 1.151 . . . . 65.22 109.818 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.44 -91.08 0.59 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.253 -0.739 . . . . 64.14 111.253 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -89.91 -27.98 19.51 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.438 0.695 . . . . 74.21 109.878 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 4.3 tp10 -94.96 121.91 37.07 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.912 1.285 . . . . 75.21 110.357 -175.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.7 m -77.56 126.06 30.3 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.369 -0.975 . . . . 72.21 108.369 165.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.563 ' HA ' HG23 ' C' ' 31' ' ' VAL . . . -64.75 -60.91 2.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.284 1.04 . . . . 75.02 108.809 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -161.65 161.82 29.7 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-N 112.707 -2.042 . . . . 74.45 108.989 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -126.3 140.71 52.31 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 105.855 -1.906 . . . . 72.35 105.855 167.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.8 t -138.09 132.41 32.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.833 -1.173 . . . . 71.31 107.833 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.62 136.45 27.46 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.67 -0.863 . . . . 74.02 108.67 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -146.25 132.97 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 124.603 1.161 . . . . 74.34 108.507 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.605 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 39.9 mt-30 -118.58 94.9 4.63 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.966 -1.124 . . . . 74.14 107.966 173.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -81.69 104.28 11.97 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.888 -1.051 . . . . 63.31 109.819 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.8 157.29 35.6 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.991 -0.444 . . . . 73.52 111.991 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.46 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -159.63 117.81 0.79 Allowed Glycine 0 CA--C 1.501 -0.795 0 N-CA-C 110.83 -0.908 . . . . 62.4 110.83 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 10.5 mm -84.84 121.29 36.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.175 -1.046 . . . . 75.14 108.175 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.562 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 53.0 m-85 -128.67 118.33 22.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.774 -0.824 . . . . 73.34 108.774 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 54.8 m -77.79 108.21 10.85 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.515 -0.92 . . . . 74.23 108.515 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 45.4 pt -114.94 131.25 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.65 0.78 . . . . 74.11 109.217 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -146.98 152.3 38.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.148 0.979 . . . . 64.34 109.312 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.59 -23.1 17.55 Favored Glycine 0 N--CA 1.479 1.502 0 N-CA-C 113.941 0.336 . . . . 73.22 113.941 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.433 HG21 HE21 ' C' ' 93' ' ' GLN . 28.7 pt -103.05 152.11 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.803 0.841 . . . . 73.22 110.532 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 15.8 pt-20 -166.44 177.97 6.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.697 0.799 . . . . 73.04 109.49 173.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.31 -125.67 34.4 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.592 0.557 . . . . 51.23 113.661 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 82.4 p -72.26 -28.35 63.07 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.498 0.719 . . . . 55.41 111.075 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.433 HE21 HG21 ' C' ' 89' ' ' ILE . 27.8 mt-30 -65.15 -44.55 88.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.588 0.755 . . . . 74.14 110.032 174.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.529 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 22.0 ttt -62.57 -46.17 89.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.214 -0.903 . . . . 65.3 110.472 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.83 -50.27 61.19 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 124.245 0.966 . . . . 73.14 111.613 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.443 ' HE2' ' HA ' ' C' ' 134' ' ' ASP . 10.6 t-160 -76.2 -32.38 58.94 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 123.377 0.423 . . . . 74.51 111.954 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.556 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.3 t -59.44 -36.13 75.34 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.312 0.383 . . . . 74.41 110.463 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 34.2 mt -96.13 -20.39 18.66 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.83 0.852 . . . . 74.22 110.882 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.93 -31.52 57.89 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.036 -0.529 . . . . 73.2 113.875 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.47 -39.48 0.06 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.628 0.251 . . . . 75.32 111.616 -169.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.556 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 42.6 t80 -65.39 -43.53 90.36 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.461 1.505 . . . . 75.34 113.158 -172.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 66.3 m -81.57 -44.89 1.11 Allowed Pre-proline 0 N--CA 1.486 1.336 0 CA-C-O 118.717 -0.659 . . . . 72.4 111.787 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.04 -27.0 34.39 Favored 'Trans proline' 0 C--N 1.394 2.954 0 C-N-CA 122.516 2.144 . . . . 73.31 113.738 169.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -59.76 -42.9 94.3 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.393 1.077 . . . . 74.23 111.027 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -66.1 -33.47 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 115.437 -0.801 . . . . 71.42 110.376 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.46 HD22 ' HA3' ' C' ' 82' ' ' GLY . 62.6 mt -91.25 -25.16 19.62 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.88 0.872 . . . . 72.15 112.389 -171.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -54.38 -50.53 84.5 Favored Pre-proline 0 CA--C 1.557 1.237 0 CA-C-O 117.966 -1.016 . . . . 73.53 113.682 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.35 -37.83 96.27 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.29 1.993 . . . . 75.35 113.184 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -68.24 -47.32 68.11 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.364 0.666 . . . . 75.41 110.974 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.51 79.56 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.258 -0.883 . . . . 72.3 110.612 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -60.72 -53.21 60.19 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.117 1.367 . . . . 74.14 111.026 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . 0.41 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.2 tm-20 -67.38 -34.02 76.42 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 123.656 0.598 . . . . 73.03 110.316 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.2 t -64.58 -36.76 85.28 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.481 0.488 . . . . 74.4 110.764 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.495 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 77.8 mt -67.67 -50.37 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.3 0.64 . . . . 73.45 110.31 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.6 m -62.47 -30.1 71.01 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.561 0.744 . . . . 72.45 111.374 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -69.68 -50.62 42.09 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 109.142 -0.688 . . . . 74.31 109.142 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.565 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.59 -44.62 66.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.21 1.004 . . . . 71.03 112.063 176.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 88.4 t -63.58 -46.58 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.915 0.886 . . . . 74.32 110.868 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 36.6 t -63.54 -33.49 75.71 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.873 0.869 . . . . 74.1 111.795 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -73.34 -39.35 65.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.838 0.855 . . . . 74.51 109.761 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.82 -2.15 69.61 Favored Glycine 0 C--N 1.352 1.468 0 O-C-N 123.832 0.707 . . . . 73.11 112.587 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 61.75 28.49 17.54 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 126.77 2.028 . . . . 75.1 113.302 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -81.84 156.62 69.97 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.272 -1.01 . . . . 74.52 108.272 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.26 171.25 2.48 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.727 2.285 . . . . 73.0 113.622 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -51.26 136.45 24.62 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.731 1.212 . . . . 71.03 114.036 -173.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.578 HD13 HG11 ' C' ' 64' ' ' VAL . 7.0 tt -127.32 91.73 3.37 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 106.764 -1.569 . . . . 72.44 106.764 171.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -100.5 105.61 17.07 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.851 -0.796 . . . . 72.24 108.851 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.02 125.58 25.9 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.144 -1.058 . . . . 74.13 108.144 175.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.07 148.64 98.34 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 122.84 0.456 . . . . 75.41 111.29 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.411 ' HG3' HD13 ' A' ' 16' ' ' ILE . 34.8 Cg_exo -57.55 106.78 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.872 2.381 . . . . 73.33 112.172 174.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 23.3 m -112.21 119.66 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.402 0.681 . . . . 72.45 109.924 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -91.87 93.61 8.91 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.904 -0.776 . . . . 73.33 108.904 -176.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.424 ' HE2' HD12 ' C' ' 44' ' ' LEU . 91.7 m-85 -61.09 -40.04 92.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.484 0.714 . . . . 74.1 111.026 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.443 ' HA ' ' HE2' ' C' ' 96' ' ' HIS . 9.7 m-20 -60.45 -43.9 96.39 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.342 -0.845 . . . . 71.13 112.226 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.91 -33.72 72.24 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.89 0.744 . . . . 75.14 111.396 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 2.1 tt -79.86 -46.07 17.52 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.69 -0.485 . . . . 74.33 109.69 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 22.7 t80 . . . . . 0 N--CA 1.489 1.479 0 C-N-CA 122.88 0.472 . . . . 74.55 111.364 -176.721 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.239 0.549 0 CA-C-O 121.486 0.66 . . . . 74.22 110.497 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.467 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 55.0 t80 -163.21 88.48 0.59 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.031 -1.84 . . . . 74.31 106.031 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -119.27 115.35 23.98 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.202 -1.407 . . . . 74.32 107.202 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.491 HG21 HD11 ' D' ' 16' ' ' ILE . 16.4 mt -72.63 120.58 21.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.75 -0.833 . . . . 63.2 108.75 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.417 HE22 HG12 ' D' ' 55' ' ' VAL . 51.8 mt-30 -86.22 -34.0 20.58 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.402 0.681 . . . . 75.44 110.825 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -171.38 134.01 0.86 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.1 0.25 . . . . 75.22 111.663 -172.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.491 HD11 HG21 ' D' ' 13' ' ' ILE . 3.7 mp -113.24 134.68 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 107.493 -1.299 . . . . 75.13 107.493 171.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.405 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 36.6 p90 -166.56 174.5 8.79 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.901 0.858 . . . . 72.13 112.022 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -102.64 120.04 39.87 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.196 -1.366 . . . . 73.53 109.049 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.445 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.4 mtpt -81.16 -36.96 29.56 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.127 -0.694 . . . . 73.4 109.127 175.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 12.5 t70 -144.89 145.27 31.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.951 -1.022 . . . . 71.21 109.436 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.565 HG21 ' HE1' ' C' ' 117' ' ' MET . 73.9 mt -139.2 150.44 23.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.819 1.248 . . . . 64.42 107.811 175.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 13.0 t -155.29 145.78 22.07 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.678 0.791 . . . . 73.44 109.422 174.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.412 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.2 t80 -150.1 124.1 9.37 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.948 -1.501 . . . . 73.31 106.948 170.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 2.2 mp0 -122.0 152.51 39.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.079 0.552 . . . . 75.01 109.595 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.67 82.21 16.05 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.799 -1.186 . . . . 75.35 107.799 175.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.79 -34.25 11.44 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.035 2.49 . . . . 73.02 113.608 -171.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -107.82 8.63 28.81 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.319 0.648 . . . . 71.04 110.523 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.424 ' HB3' ' HD3' ' D' ' 29' ' ' PRO . . . -36.69 -64.88 0.35 Allowed Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 116.416 2.006 . . . . 73.13 116.416 -156.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.475 ' HB3' HD11 ' C' ' 83' ' ' ILE . 39.2 Cg_endo -81.31 -13.41 11.13 Favored 'Trans proline' 0 C--N 1.371 1.756 0 CA-C-N 122.437 1.906 . . . . 74.24 113.65 -172.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -76.26 -42.88 44.26 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.182 0.993 . . . . 74.44 108.709 168.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 6.5 p -81.86 -18.37 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 123.36 0.664 . . . . 74.44 111.547 -173.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -67.63 -15.1 63.48 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.965 0.728 . . . . 73.43 112.965 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -66.98 -13.15 61.59 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.674 0.79 . . . . 75.32 110.548 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.459 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 88.4 mttt -103.59 80.25 1.77 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.357 1.463 . . . . 74.31 109.005 173.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.6 82.92 5.64 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.972 -0.751 . . . . 75.03 108.972 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 t-105 -149.46 157.66 43.48 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.595 1.158 . . . . 75.2 108.231 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -71.76 104.99 1.11 Allowed Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 108.963 -0.754 . . . . 74.34 108.963 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -66.23 140.91 60.7 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.928 2.418 . . . . 74.11 113.089 -169.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.41 112.83 1.36 Allowed 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.493 1.121 . . . . 73.51 109.24 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.6 HG23 HG13 ' D' ' 64' ' ' VAL . 2.5 p -98.18 115.0 37.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.626 -0.715 . . . . 73.01 110.752 -170.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -99.41 110.38 22.88 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.017 -1.475 . . . . 75.41 107.017 163.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -95.27 121.44 36.92 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.774 -1.195 . . . . 73.4 107.774 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.719 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 20.3 m-20 -106.05 145.61 31.19 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.064 -0.971 . . . . 75.53 108.38 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.5 130.07 39.97 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.424 -0.954 . . . . 75.31 108.424 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.7 t70 -132.05 143.42 50.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.109 -1.812 . . . . 72.33 106.109 170.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -135.72 155.93 49.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.649 -0.871 . . . . 71.41 108.649 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.07 173.29 14.04 Favored 'General case' 0 C--O 1.239 0.546 0 O-C-N 123.943 0.777 . . . . 71.21 109.854 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.567 ' HB2' ' HE1' ' D' ' 56' ' ' TYR . 19.9 p -155.61 151.23 27.27 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.655 0.782 . . . . 73.3 109.388 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 28.8 t -164.99 119.1 1.28 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.427 0.691 . . . . 64.35 109.545 -170.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -78.96 131.67 36.42 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.452 -0.573 . . . . 65.45 109.452 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' C' ' 29' ' ' PRO . 43.2 mt -102.24 -26.96 13.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.934 0.494 . . . . 74.44 111.101 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.417 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -168.09 -173.54 2.08 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.438 0.695 . . . . 61.21 110.629 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.05 111.98 10.82 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.984 -0.747 . . . . 72.44 108.984 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 76.09 4.01 3.73 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.777 1.631 . . . . 73.43 112.009 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 73.5 t -109.11 125.04 66.23 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 N-CA-C 108.032 -1.099 . . . . 75.43 108.032 169.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.567 ' HE1' ' HB2' ' D' ' 48' ' ' SER . 4.3 t80 -139.85 150.21 44.37 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.173 -1.047 . . . . 64.52 108.173 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -125.13 147.37 49.05 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.517 0.727 . . . . 74.43 109.973 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -124.3 141.83 43.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.959 -1.126 . . . . 73.42 107.959 171.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 53.4 t -118.37 139.17 46.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.185 -1.043 . . . . 74.41 108.185 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.449 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -123.69 113.68 18.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.652 -1.24 . . . . 74.03 107.652 179.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -96.4 97.4 9.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.994 -1.113 . . . . 74.3 107.994 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 t -98.1 118.67 45.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.133 -1.062 . . . . 75.14 108.133 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.719 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.8 m -119.73 143.78 47.6 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.27 1.028 . . . . 73.54 108.47 -172.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.6 HG13 HG23 ' D' ' 40' ' ' VAL . 92.9 t -130.78 103.23 7.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.55 -0.907 . . . . 73.14 108.55 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 52.3 m -92.87 111.99 23.79 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.392 -0.966 . . . . 72.33 108.392 169.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.05 154.47 29.86 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.071 0.549 . . . . 73.13 110.518 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.426 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.9 m -148.41 135.48 20.17 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.606 0.566 . . . . 72.54 111.421 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.91 99.55 10.04 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.377 1.071 . . . . 74.22 108.451 173.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.71 -114.23 5.51 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.727 -0.67 . . . . 75.51 113.724 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.21 3.44 49.37 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.878 0.695 . . . . 73.43 112.878 -172.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.459 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.3 pt-20 -151.87 161.45 42.64 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 122.298 -0.251 . . . . 62.44 110.953 -168.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.2 m -63.74 137.1 57.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.053 0.941 . . . . 61.54 111.482 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.426 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -93.01 -73.59 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.184 -1.043 . . . . 70.42 108.184 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -140.49 143.4 35.45 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 121.429 0.633 . . . . 74.53 110.513 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 75.8 mt -109.28 141.99 40.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.202 -1.406 . . . . 70.24 107.202 173.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.56 ' SG ' HG21 ' D' ' 114' ' ' ILE . 51.6 t -151.73 143.55 23.73 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.271 -0.64 . . . . 74.41 109.271 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -155.72 136.5 13.48 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.203 -0.665 . . . . 72.33 109.203 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.75 114.04 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.847 -0.797 . . . . 73.3 108.847 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -88.56 81.68 7.07 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.267 -1.012 . . . . 74.14 108.267 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -78.12 99.46 6.17 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.102 -1.408 . . . . 74.55 109.32 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.01 148.97 18.65 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 111.549 -0.62 . . . . 44.34 111.549 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.9 132.01 4.7 Favored Glycine 0 C--N 1.335 0.513 0 N-CA-C 111.746 -0.542 . . . . 74.34 111.746 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.4 mt -90.28 128.79 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.044 0.938 . . . . 73.24 108.871 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.99 123.43 25.86 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.273 1.029 . . . . 74.01 109.672 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -76.56 105.67 7.76 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.176 -0.676 . . . . 75.23 109.176 168.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.562 HD11 HD23 ' D' ' 98' ' ' LEU . 48.3 pt -116.62 144.37 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 122.922 0.489 . . . . 63.4 110.163 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.2 158.8 19.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.852 0.861 . . . . 72.3 109.371 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.75 21.7 79.52 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 116.486 -0.325 . . . . 63.51 113.621 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 23.9 pt -128.52 127.43 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.383 0.673 . . . . 74.35 110.0 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.81 154.1 46.09 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.483 1.113 . . . . 74.41 109.777 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.24 -117.84 11.62 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.43 -0.805 . . . . 72.44 114.562 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 19.2 m -65.56 -36.6 84.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.404 0.682 . . . . 75.25 111.612 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -77.09 -40.57 45.53 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.24 -0.436 . . . . 70.24 111.911 -172.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.494 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -64.8 -35.74 82.08 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 120.785 0.326 . . . . 75.25 110.465 178.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . 0.494 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -65.04 -49.48 69.98 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 115.381 -0.827 . . . . 63.31 109.736 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -59.97 -35.53 75.18 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.717 0.636 . . . . 73.5 111.391 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -64.82 -50.6 66.07 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.076 0.551 . . . . 71.52 111.239 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.562 HD23 HD11 ' D' ' 86' ' ' ILE . 75.7 mt -92.33 -28.42 16.95 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.801 0.667 . . . . 75.13 112.801 -169.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.81 -4.24 57.96 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-O 119.761 -0.466 . . . . 73.51 113.953 -174.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.423 ' HB2' ' HA ' ' D' ' 134' ' ' ASP . . . -142.9 -59.41 0.43 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.104 0.452 . . . . 65.15 111.365 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -70.56 -39.89 73.68 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.487 0.551 . . . . 74.24 112.487 -171.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.467 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 97.5 m -69.86 -46.84 23.98 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.313 -0.851 . . . . 71.31 111.611 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.449 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.4 Cg_exo -55.24 -34.19 87.34 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.004 1.803 . . . . 73.45 112.736 169.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -64.05 -40.83 97.16 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.404 0.681 . . . . 71.43 110.41 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.9 mm -63.2 -37.22 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.517 0.727 . . . . 74.15 110.659 174.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.23 -19.46 43.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.156 0.982 . . . . 72.23 112.237 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -65.91 -44.73 63.08 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 114.03 1.122 . . . . 74.14 114.03 -171.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.04 -44.62 38.02 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.282 1.988 . . . . 74.24 112.835 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -69.27 -34.72 75.2 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.384 -0.825 . . . . 65.32 111.263 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.55 -53.39 56.9 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.738 0.815 . . . . 73.41 110.341 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.469 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 30.0 ttp180 -53.39 -46.51 69.68 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 124.814 1.321 . . . . 74.11 111.292 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -63.38 -49.99 71.64 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.265 0.978 . . . . 53.22 111.29 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.7 t -57.22 -41.57 79.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.11 0.881 . . . . 74.22 111.018 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.56 HG21 ' SG ' ' D' ' 76' ' ' CYS . 70.2 mt -61.01 -56.41 18.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 123.788 0.835 . . . . 72.24 110.6 174.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.1 m -53.4 -43.57 68.02 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.437 1.095 . . . . 71.34 111.706 -175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 40.1 t -65.07 -43.07 93.4 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.947 -1.024 . . . . 70.01 110.478 -177.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.491 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.4 mtm -68.92 -32.6 72.34 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.833 0.453 . . . . 75.14 111.573 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 73.3 t -65.75 -42.41 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.675 0.79 . . . . 74.13 110.299 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -73.14 -27.73 61.84 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 122.686 0.394 . . . . 64.43 111.157 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' D' ' 116' ' ' SER . 80.3 mtt-85 -72.04 -33.95 68.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.595 0.758 . . . . 75.55 109.913 173.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.23 0.27 89.38 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.901 0.75 . . . . 60.41 112.0 174.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 19.2 p 64.4 19.82 11.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.599 1.959 . . . . 64.24 113.711 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -84.8 150.37 55.89 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 108.609 -0.886 . . . . 73.15 108.609 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.47 141.5 51.33 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 123.246 2.631 . . . . 74.11 113.546 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -51.0 140.44 15.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.905 1.282 . . . . 75.34 112.675 -172.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.459 HD13 HG22 ' D' ' 40' ' ' VAL . 0.3 OUTLIER -125.09 97.15 5.12 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.541 -0.911 . . . . 70.43 108.541 -175.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -99.0 110.37 22.99 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.868 -0.79 . . . . 71.24 108.868 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.469 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -69.39 113.41 6.69 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.656 -0.868 . . . . 73.01 108.656 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.73 140.6 97.84 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.042 0.537 . . . . 71.03 110.957 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.08 118.42 5.32 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.63 2.22 . . . . 54.0 111.778 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.73 123.17 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.522 0.729 . . . . 75.24 109.407 -176.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -85.17 79.32 9.61 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.572 -0.899 . . . . 65.52 108.572 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -83.56 -14.66 51.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.568 -0.742 . . . . 74.55 110.588 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . 0.423 ' HA ' ' HB2' ' D' ' 100' ' ' ALA . 2.3 m-20 -52.77 -53.55 46.58 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.969 0.908 . . . . 63.44 111.789 173.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.12 77.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.962 0.905 . . . . 72.55 111.691 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.1 -22.44 45.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.952 -1.022 . . . . 75.54 111.256 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 84.6 t80 . . . . . 0 N--CA 1.475 0.775 0 C-N-CA 123.403 0.681 . . . . 75.04 110.119 176.714 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.608 ' HB ' ' HB1' ' A' ' 87' ' ' ALA . 87.7 m . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 107.906 -1.146 . . . . 71.13 107.906 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -134.55 138.67 44.81 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.821 0.848 . . . . 74.0 108.758 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -152.8 127.61 9.54 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.429 0.692 . . . . 70.42 109.466 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.3 mt -83.39 115.74 26.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.302 -0.999 . . . . 75.41 108.302 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -81.51 -38.59 26.03 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.478 0.486 . . . . 63.22 109.864 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -170.11 124.07 0.73 Allowed 'General case' 0 C--N 1.356 0.875 0 CA-C-O 119.684 -0.198 . . . . 74.3 110.783 -167.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.487 HD13 ' HG3' ' C' ' 130' ' ' PRO . 46.8 mt -111.68 134.79 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.157 -1.053 . . . . 75.31 108.157 172.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.452 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 44.1 p90 -166.55 167.33 15.6 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.878 0.847 . . . . 70.24 111.272 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -91.3 110.69 21.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.732 -1.122 . . . . 73.14 108.138 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -70.95 -46.92 61.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.96 -0.756 . . . . 73.33 108.96 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.668 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 6.0 m-20 -133.5 132.97 41.63 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.598 -1.183 . . . . 75.2 109.256 -176.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -127.67 139.71 51.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 106.678 -1.601 . . . . 75.42 106.678 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -149.84 107.34 3.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 123.655 0.597 . . . . 70.21 109.718 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 60.0 t80 -111.2 113.7 26.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.707 -1.59 . . . . 73.2 106.707 171.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.0 114.37 22.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.319 -0.623 . . . . 75.31 109.319 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.72 80.56 70.26 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 107.613 -1.255 . . . . 72.41 107.613 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.76 -11.4 20.14 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.469 2.112 . . . . 72.42 111.214 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -107.72 20.84 18.29 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.874 1.269 . . . . 75.13 108.772 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.46 -45.02 99.71 Favored Pre-proline 0 CA--C 1.571 1.786 0 N-CA-C 114.43 1.271 . . . . 61.43 114.43 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -88.01 -8.44 5.78 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 121.678 1.585 . . . . 75.33 112.99 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.402 ' HA ' HE21 ' A' ' 33' ' ' GLN . 18.1 t-160 -94.88 -15.53 23.6 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.215 1.006 . . . . 75.41 110.354 -175.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.525 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 8.8 p -77.01 -25.93 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.731 0.812 . . . . 74.12 110.205 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -66.68 -29.82 69.91 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.801 0.84 . . . . 73.25 110.113 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.402 HE21 ' HA ' ' A' ' 30' ' ' HIS . 48.6 mt-30 -78.94 -34.95 44.01 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.025 0.93 . . . . 70.52 111.612 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.525 ' HE3' ' HA ' ' A' ' 31' ' ' VAL . 16.2 ptpt -82.87 169.2 16.33 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.115 0.413 . . . . 75.3 112.115 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -85.01 127.03 34.02 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.648 -0.871 . . . . 74.41 108.648 167.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -70.29 88.55 0.64 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.21 1.004 . . . . 75.31 111.594 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.444 ' HB2' HD13 ' A' ' 68' ' ' LEU . 98.5 mt-30 -132.88 76.78 70.01 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.141 0.976 . . . . 74.43 109.403 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -89.04 126.38 1.68 Allowed 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.339 2.026 . . . . 75.41 112.358 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.99 109.89 22.21 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.492 -1.299 . . . . 74.33 107.492 170.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.78 107.24 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 115.131 -0.94 . . . . 64.13 110.907 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -79.77 114.69 18.89 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.289 -1.004 . . . . 72.41 108.289 165.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.0 tp -98.24 111.55 23.84 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.302 -0.999 . . . . 74.35 108.302 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -116.11 129.49 56.36 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.055 -1.091 . . . . 62.12 108.055 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 tt -119.33 129.89 55.09 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.281 -1.007 . . . . 73.42 108.281 -171.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.689 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 18.7 t70 -130.34 155.28 46.62 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.13 0.972 . . . . 71.41 109.532 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.0 m -141.78 131.87 24.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.564 1.146 . . . . 75.32 109.207 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.1 148.64 45.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.973 0.909 . . . . 75.33 109.423 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.4 p -109.41 161.68 15.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.568 0.747 . . . . 51.31 109.313 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.1 p -152.95 138.08 17.35 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.134 0.574 . . . . 54.01 109.853 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.448 ' HA ' ' HD1' ' A' ' 56' ' ' TYR . 46.9 tt0 -91.25 114.83 27.47 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.944 0.498 . . . . 74.33 109.975 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.543 HD13 ' HB2' ' A' ' 57' ' ' GLU . 18.9 mt -89.25 -43.42 10.98 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.832 -0.803 . . . . 62.34 108.832 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.67 -179.33 7.16 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 113.989 -1.459 . . . . 71.14 108.662 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.57 113.64 6.26 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.39 -0.596 . . . . 75.53 109.39 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 66.3 21.55 10.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.337 1.455 . . . . 74.45 112.101 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.33 102.08 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 106.759 -1.571 . . . . 72.34 106.759 167.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.448 ' HD1' ' HA ' ' A' ' 50' ' ' GLN . 18.7 m-85 -127.05 143.35 51.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.951 0.501 . . . . 75.11 110.014 -170.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HB2' HD13 ' A' ' 51' ' ' LEU . 34.7 tt0 -114.89 137.91 51.41 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.782 0.833 . . . . 75.25 109.523 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.5 t -103.89 126.85 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.824 -1.176 . . . . 72.55 107.824 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.4 t -102.22 107.46 21.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.524 -0.917 . . . . 75.23 108.524 174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 tp -88.83 101.42 14.01 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.949 -0.759 . . . . 74.43 108.949 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.689 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 23.8 mtm105 -89.5 100.95 13.64 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.039 0.536 . . . . 75.22 109.619 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.541 HG23 ' HB1' ' A' ' 110' ' ' ALA . 2.5 m -113.25 108.48 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.154 0.581 . . . . 75.12 109.543 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -108.89 148.51 30.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.523 0.729 . . . . 65.14 110.741 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.41 ' O ' HD13 ' A' ' 75' ' ' LEU . 70.6 t -129.23 112.29 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 125.307 1.443 . . . . 73.14 108.067 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.7 m -102.6 104.2 14.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.562 -0.903 . . . . 75.3 108.562 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.84 109.57 21.35 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.562 -1.273 . . . . 74.1 107.562 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.7 p -147.39 140.93 25.49 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.18 0.514 . . . . 72.2 111.405 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.444 HD13 ' HB2' ' A' ' 37' ' ' GLN . 38.2 tp -90.39 68.64 6.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.828 1.251 . . . . 70.32 107.668 169.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.51 -89.71 0.63 Allowed Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.046 -0.979 . . . . 42.25 111.951 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.8 -26.01 14.17 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.2 1.0 . . . . 73.32 110.123 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -96.98 94.89 7.45 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.407 -0.815 . . . . 72.45 109.177 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.8 m -65.39 134.77 54.22 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.824 0.85 . . . . 63.51 111.99 -174.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.87 -64.54 1.16 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.874 -0.788 . . . . 70.51 108.874 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -157.06 174.14 15.96 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.166 -0.925 . . . . 75.14 110.937 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 64' ' ' VAL . 61.7 tp -140.2 130.36 25.02 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.973 1.309 . . . . 64.13 107.634 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.427 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 84.7 m -138.44 113.4 9.2 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.466 0.706 . . . . 63.25 110.204 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -132.74 126.76 33.21 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.897 -0.779 . . . . 73.1 108.897 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -129.17 119.15 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.513 -0.767 . . . . 75.04 109.362 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.668 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 44.9 mt-30 -91.05 89.77 7.56 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.877 -1.056 . . . . 64.3 108.286 172.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.433 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.9 tp-100 -78.73 105.71 10.22 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.149 -0.932 . . . . 70.04 109.29 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.97 160.03 27.03 Favored Glycine 0 C--O 1.242 0.613 0 N-CA-C 111.317 -0.713 . . . . 74.54 111.317 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.43 121.91 1.06 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.003 -1.239 . . . . 73.2 110.003 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.3 mt -79.23 123.74 36.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.625 -0.88 . . . . 72.14 108.625 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -126.41 119.0 26.14 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.081 -0.711 . . . . 73.22 109.081 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 p -91.62 119.2 31.31 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.066 -1.087 . . . . 73.01 108.066 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.711 HD12 HD12 ' A' ' 89' ' ' ILE . 2.4 pp -126.54 161.59 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.589 0.755 . . . . 71.54 111.559 -171.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.608 ' HB1' ' HB ' ' A' ' 10' ' ' THR . . . -167.72 155.28 8.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.376 1.071 . . . . 75.45 109.721 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.16 8.26 86.92 Favored Glycine 0 N--CA 1.475 1.249 0 N-CA-C 114.501 0.56 . . . . 73.52 114.501 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.711 HD12 HD12 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -114.99 153.85 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.2 1.0 . . . . 75.44 109.153 178.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.87 171.27 14.34 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.12 -1.067 . . . . 74.11 108.12 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.38 -114.54 1.47 Allowed Glycine 0 CA--C 1.542 1.721 0 N-CA-C 114.685 0.634 . . . . 74.14 114.685 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p -70.68 -29.72 66.12 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.267 1.027 . . . . 73.32 112.173 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.7 mm-40 -65.86 -44.63 84.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.45 0.7 . . . . 75.03 110.865 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -71.43 -34.17 70.06 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.22 -0.445 . . . . 73.45 110.467 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -33.51 76.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.099 0.56 . . . . 74.21 110.618 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.43 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 63.9 t-80 -71.49 -21.69 61.9 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.739 0.816 . . . . 71.44 110.728 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 78.3 m -79.12 -60.27 2.44 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.401 -0.592 . . . . 75.12 109.401 172.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.14 -32.84 73.48 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.169 0.987 . . . . 75.32 112.423 -173.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.47 4.13 29.56 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 119.356 -0.691 . . . . 64.1 114.055 -172.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.1 -66.73 0.34 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.882 0.841 . . . . 61.44 111.782 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -70.65 -58.32 3.79 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.241 0.616 . . . . 73.12 112.478 -169.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.65 -46.28 98.59 Favored Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 113.517 0.932 . . . . 74.32 113.517 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.09 -26.49 65.5 Favored 'Trans proline' 0 C--N 1.399 3.185 0 C-N-CA 121.846 1.697 . . . . 72.01 112.636 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -68.22 -39.76 82.29 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.382 0.673 . . . . 54.33 110.601 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.8 mm -61.7 -43.43 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.893 0.877 . . . . 73.52 110.13 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.433 HD23 ' HG3' ' A' ' 80' ' ' GLN . 83.0 mt -77.94 -22.22 49.89 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.889 -1.05 . . . . 74.22 112.219 -174.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -61.46 -47.25 93.87 Favored Pre-proline 0 CA--C 1.567 1.62 0 N-CA-C 113.788 1.033 . . . . 73.21 113.788 -170.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.12 -37.0 66.66 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.143 1.895 . . . . 75.31 113.139 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -70.37 -39.98 74.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.639 0.776 . . . . 75.23 110.418 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.541 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . -65.38 -43.11 91.77 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.388 -0.823 . . . . 72.13 110.549 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.488 ' NH1' HD13 ' C' ' 105' ' ' ILE . 31.8 ttm180 -55.14 -50.85 68.23 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 124.46 1.1 . . . . 70.3 110.33 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -59.86 -47.46 85.67 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.604 1.19 . . . . 75.35 111.343 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 117' ' ' MET . 36.1 t -61.7 -41.47 97.65 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 123.912 0.757 . . . . 71.04 110.643 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.499 HD11 HG21 ' A' ' 62' ' ' VAL . 96.1 mt -64.3 -50.23 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.895 0.878 . . . . 75.42 110.43 176.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 78.4 m -53.6 -45.03 69.91 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.839 0.855 . . . . 74.25 110.604 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -66.74 -38.77 87.3 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.165 -1.38 . . . . 73.54 110.228 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.472 ' HA ' ' HE1' ' A' ' 117' ' ' MET . 30.9 mmt -58.61 -47.13 85.38 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.283 0.633 . . . . 74.22 111.235 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.2 t -61.97 -43.64 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-N 114.897 -1.047 . . . . 74.31 110.408 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.1 m -73.29 -29.8 62.97 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.612 0.765 . . . . 60.24 111.917 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.486 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 93.9 mtt-85 -77.41 -25.31 50.67 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.207 0.603 . . . . 75.33 110.413 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.99 2.8 87.15 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.576 0.547 . . . . 74.22 112.758 171.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.9 m 68.01 16.79 9.56 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.908 1.283 . . . . 74.52 111.268 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -81.74 144.94 53.1 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 108.914 -0.773 . . . . 72.43 108.914 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.14 134.72 44.14 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.058 2.505 . . . . 71.24 112.226 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -52.75 141.95 19.94 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.369 1.068 . . . . 64.43 113.558 -171.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.0 tp -119.4 127.08 52.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.815 1.246 . . . . 75.32 109.766 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -135.9 102.39 5.04 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.492 -0.929 . . . . 71.33 108.492 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.534 ' H ' HD22 ' A' ' 128' ' ' LEU . 2.0 pt? -68.45 151.59 46.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.535 0.734 . . . . 75.13 111.031 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.94 146.46 98.27 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.196 0.999 . . . . 70.24 111.23 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -67.1 123.63 11.17 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.558 2.172 . . . . 74.12 112.347 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 98.7 t -101.25 113.56 37.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 123.971 0.908 . . . . 73.12 108.619 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -87.84 97.39 10.89 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.631 -0.878 . . . . 73.43 108.631 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -66.48 -21.14 66.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.315 1.046 . . . . 75.13 111.685 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.86 -48.77 62.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.413 1.085 . . . . 73.52 110.88 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.14 -40.02 88.34 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.83 0.707 . . . . 73.34 110.348 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.49 -39.9 85.22 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.081 -0.963 . . . . 72.43 111.369 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -67.08 -36.74 82.65 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.38 -0.6 . . . . 74.32 109.38 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.0 mmt . . . . . 0 N--CA 1.471 0.612 0 O-C-N 124.023 0.827 . . . . 75.33 111.176 177.234 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.238 0.481 0 N-CA-C 109.2 -0.667 . . . . 74.14 109.2 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -126.91 114.7 18.21 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.181 -1.415 . . . . 74.54 107.181 164.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.42 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -128.76 118.34 22.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.452 0.701 . . . . 75.52 109.268 -177.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 59.2 mt -77.77 116.48 21.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.902 -1.147 . . . . 65.24 107.902 169.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -85.72 -47.27 9.93 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.115 -0.698 . . . . 74.42 109.115 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -161.62 136.4 7.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.319 -0.855 . . . . 73.24 109.447 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 86.2 mt -115.89 140.76 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 106.392 -1.707 . . . . 71.25 106.392 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -166.3 171.18 12.37 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.392 0.615 . . . . 64.25 111.553 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.427 HG21 ' CD1' ' B' ' 21' ' ' ILE . 58.4 m -98.53 128.24 44.78 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.112 -0.949 . . . . 75.43 108.719 170.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.431 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 19.4 mtpp -86.96 -37.28 17.72 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.996 0.919 . . . . 75.13 109.465 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -151.93 139.45 19.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.178 -0.465 . . . . 75.44 112.059 -173.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.591 HD12 ' SG ' ' B' ' 113' ' ' CYS . 39.6 mm -124.24 141.1 45.57 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 124.965 1.306 . . . . 73.41 108.809 170.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.494 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.4 t -140.55 136.72 33.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.485 -1.234 . . . . 72.12 108.116 176.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.5 t80 -158.59 111.01 2.27 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 107.62 -1.252 . . . . 75.51 107.62 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -131.34 117.45 18.94 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.844 0.858 . . . . 73.14 109.269 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.481 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -109.94 85.83 4.42 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.166 0.987 . . . . 75.13 108.821 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.64 -32.38 24.23 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.759 2.306 . . . . 75.22 112.546 -170.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -108.9 8.41 26.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.535 0.734 . . . . 74.24 111.249 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.481 ' HB1' ' HB2' ' B' ' 25' ' ' ALA . . . -34.48 -65.25 0.26 Allowed Pre-proline 0 N--CA 1.503 2.204 0 C-N-CA 125.526 1.53 . . . . 74.52 114.852 -167.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -69.88 -19.41 35.58 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.284 1.99 . . . . 64.25 112.836 -168.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -95.48 -34.11 12.19 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.32 -0.854 . . . . 72.32 110.07 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.472 HG23 ' HA ' ' B' ' 73' ' ' ALA . 2.0 p -71.85 -24.29 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.859 0.464 . . . . 75.42 110.703 -173.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -67.62 -3.51 9.18 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.928 0.891 . . . . 73.25 112.989 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.56 -19.55 65.28 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 120.796 0.331 . . . . 75.45 110.294 170.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 86.3 mttt -105.35 92.74 4.33 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.581 1.153 . . . . 75.24 108.576 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.55 87.55 7.41 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.353 0.597 . . . . 75.32 110.221 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -165.43 159.08 16.6 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.803 1.241 . . . . 75.04 108.181 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.438 ' HG3' ' HB2' ' B' ' 124' ' ' PRO . 17.0 mp0 -59.5 110.65 2.9 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 123.852 0.861 . . . . 75.53 109.934 172.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.652 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.0 Cg_endo -60.24 140.71 93.48 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.908 2.405 . . . . 74.21 112.603 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -51.58 107.84 0.22 Allowed 'General case' 0 C--N 1.357 0.928 0 O-C-N 124.471 1.107 . . . . 71.41 110.561 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 31.3 m -87.5 155.04 3.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.157 -0.929 . . . . 65.02 111.454 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.61 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 48.9 tttp -139.39 107.69 5.8 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.308 -1.367 . . . . 72.44 107.308 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.26 124.37 33.8 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.502 -0.555 . . . . 74.14 109.502 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 23.6 t70 -130.18 154.45 47.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.242 1.417 . . . . 72.34 107.838 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.71 147.29 35.4 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.701 -0.481 . . . . 63.23 109.701 -170.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 23.4 t70 -146.91 114.14 6.24 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.912 -0.773 . . . . 71.52 108.912 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.2 p -114.95 108.29 16.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.23 0.612 . . . . 73.13 110.697 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.16 162.65 17.14 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.827 1.251 . . . . 64.22 108.689 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.0 p -137.44 162.28 34.08 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.271 0.628 . . . . 71.12 109.468 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 97.8 p -150.41 136.48 18.55 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.855 0.462 . . . . 75.13 110.199 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -87.02 110.41 20.04 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.311 -0.626 . . . . 71.12 109.311 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 27.5 mt -82.42 -41.94 19.23 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.908 -0.587 . . . . 72.31 109.669 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.73 -172.31 4.01 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.51 -1.223 . . . . 75.3 110.303 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.03 105.52 0.41 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.782 -1.099 . . . . 73.14 110.723 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 66.76 16.43 10.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.952 1.301 . . . . 75.51 112.322 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -105.49 110.05 29.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.765 -1.198 . . . . 74.42 107.765 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.52 140.23 52.48 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.508 0.67 . . . . 75.34 109.675 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -116.04 104.11 11.24 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.356 -1.35 . . . . 74.11 107.356 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 90.8 t -85.4 139.68 17.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 CA-C-N 114.632 -1.167 . . . . 75.23 109.635 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.83 120.04 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 123.585 0.754 . . . . 74.12 109.116 -176.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.42 106.29 16.62 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.78 -1.193 . . . . 71.32 107.78 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.586 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 34.6 ttm180 -98.87 118.81 36.46 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.157 0.583 . . . . 74.04 109.616 170.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.588 ' HB ' HD11 ' B' ' 114' ' ' ILE . 29.3 t -107.84 108.64 25.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.621 -1.251 . . . . 73.0 107.621 169.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 41.7 m -97.11 122.57 40.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.519 -0.549 . . . . 64.3 109.519 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.655 HG22 HG21 ' B' ' 114' ' ' ILE . 79.5 t -115.83 103.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 124.046 0.939 . . . . 63.22 110.111 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 99.7 m -91.23 145.09 24.95 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.559 -0.904 . . . . 71.32 108.559 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -145.85 148.73 33.19 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.463 0.305 . . . . 62.35 111.027 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.1 p -153.41 130.62 11.18 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.808 -0.633 . . . . 64.22 110.801 -175.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.652 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 35.0 mt -98.68 112.73 24.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.924 0.89 . . . . 75.01 108.978 175.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.48 -114.54 6.96 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 115.211 -0.904 . . . . 72.22 112.342 -172.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -109.09 11.65 25.57 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.226 0.611 . . . . 71.45 112.282 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.416 ' HG3' HG21 ' B' ' 31' ' ' VAL . 12.7 pt-20 -128.29 150.14 50.19 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.199 0.6 . . . . 74.41 110.079 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 37.5 m -66.38 135.19 53.98 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.474 0.484 . . . . 62.25 110.594 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.472 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -91.16 -62.32 1.47 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.283 -1.006 . . . . 74.1 108.283 174.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -151.4 162.88 40.16 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.202 -0.908 . . . . 74.42 110.17 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -132.91 109.35 9.53 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.976 -1.491 . . . . 75.42 106.976 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 51.2 t -118.3 156.43 28.89 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.69 0.796 . . . . 73.32 109.267 -174.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.0 tt0 -165.81 139.87 4.53 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.7 -0.852 . . . . 64.14 108.7 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 72.3 t -131.67 141.66 45.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.656 -1.239 . . . . 74.41 107.656 172.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -122.31 87.62 2.78 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.753 -0.832 . . . . 74.42 108.753 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.34 99.48 7.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.551 -0.75 . . . . 73.4 109.014 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.431 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.97 144.29 16.55 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.635 -0.986 . . . . 73.2 110.635 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.42 130.43 4.1 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.491 -0.644 . . . . 75.25 111.491 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.0 mt -85.15 125.77 40.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 123.945 0.898 . . . . 74.43 109.208 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -136.54 135.45 38.49 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.29 1.036 . . . . 64.22 108.565 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 41.9 m -101.99 106.6 17.54 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.802 -0.814 . . . . 62.33 108.802 176.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.429 HG23 ' SG ' ' B' ' 97' ' ' CYS . 31.2 pt -110.66 125.15 67.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.776 0.83 . . . . 74.14 109.906 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.45 162.06 41.65 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.753 0.821 . . . . 73.53 109.331 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.18 -47.8 3.9 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.476 0.485 . . . . 75.31 112.636 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 31.1 pt -70.18 152.28 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.838 0.855 . . . . 75.34 110.644 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -162.85 163.86 26.29 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.363 0.665 . . . . 74.31 109.96 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.4 -113.65 3.71 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.438 0.461 . . . . 71.4 112.407 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 87.7 m -84.97 -26.74 26.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.182 0.515 . . . . 72.31 110.745 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -73.43 -28.89 62.22 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.831 -0.622 . . . . 75.22 110.663 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.401 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 0.0 OUTLIER -72.7 -33.75 66.68 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 109.589 -0.522 . . . . 72.45 109.589 173.234 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.55 -39.08 84.96 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.905 0.882 . . . . 71.02 110.891 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -62.65 -31.23 72.06 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.681 -1.145 . . . . 74.24 110.808 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.429 ' SG ' HG23 ' B' ' 86' ' ' ILE . 25.2 t -72.06 -66.35 0.66 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.924 -0.58 . . . . 60.4 110.367 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.423 HD12 ' N ' ' B' ' 99' ' ' GLY . 1.6 pp -68.93 -26.74 65.23 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.589 0.959 . . . . 75.22 113.589 -171.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . 0.423 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -104.56 3.05 42.55 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-O 119.52 -0.6 . . . . 74.22 114.242 -171.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.86 -61.16 0.18 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 117.429 0.615 . . . . 71.31 111.176 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.426 ' HH ' ' HB2' ' D' ' 130' ' ' PRO . 52.9 t80 -66.92 -52.38 43.82 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.338 1.055 . . . . 75.35 111.908 -169.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 92.6 m -62.34 -50.38 79.68 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.371 1.068 . . . . 73.53 111.788 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.36 -36.65 97.4 Favored 'Trans proline' 0 C--N 1.401 3.305 0 C-N-CA 122.045 1.83 . . . . 73.43 113.295 170.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -66.59 -29.56 69.64 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.008 0.523 . . . . 75.44 111.004 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.423 HG22 ' NH2' ' D' ' 111' ' ' ARG . 93.0 mt -68.49 -45.51 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.87 0.868 . . . . 74.22 110.244 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 56.2 mt -76.39 -20.93 56.66 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.975 -1.011 . . . . 74.03 111.833 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -59.91 -48.79 93.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-O 117.661 -1.162 . . . . 73.0 113.419 -171.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -56.36 -38.69 94.73 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.124 1.882 . . . . 74.4 113.231 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -66.83 -47.64 71.38 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.158 0.583 . . . . 75.33 110.335 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.404 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -59.81 -40.27 87.81 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.593 0.757 . . . . 74.14 110.656 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.539 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 36.0 ttt180 -61.75 -52.3 64.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.334 1.454 . . . . 75.23 111.138 -176.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.74 -37.74 88.5 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.958 0.786 . . . . 62.22 109.916 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.591 ' SG ' HD12 ' B' ' 21' ' ' ILE . 5.1 t -67.38 -38.31 84.55 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.656 0.598 . . . . 75.42 111.796 -173.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.655 HG21 HG22 ' B' ' 64' ' ' VAL . 61.1 mt -66.74 -51.47 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 109.388 -0.597 . . . . 74.51 109.388 176.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.451 HG22 ' OG ' ' C' ' 119' ' ' SER . 88.9 m -54.91 -37.74 66.74 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.898 1.374 . . . . 75.52 110.848 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 46.7 t -63.43 -44.19 95.27 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 115.361 -0.836 . . . . 74.24 110.018 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 30.7 mmt -62.91 -43.07 99.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.337 0.398 . . . . 73.53 110.93 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.5 HG23 ' O ' ' B' ' 114' ' ' ILE . 48.4 t -58.96 -47.16 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.242 1.017 . . . . 71.44 109.605 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.522 ' HB3' HG21 ' C' ' 115' ' ' THR . 71.8 m -65.49 -34.54 78.51 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.261 -1.336 . . . . 70.15 112.062 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -68.87 -35.0 76.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.395 -0.821 . . . . 75.55 110.093 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -86.99 10.99 66.15 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 124.135 0.897 . . . . 52.51 112.957 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 67.0 p 56.74 23.61 8.12 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.992 1.717 . . . . 52.32 113.628 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.47 149.99 62.44 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 122.797 0.439 . . . . 64.12 109.996 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.438 ' HB2' ' HG3' ' B' ' 37' ' ' GLN . 51.2 Cg_exo -55.29 164.76 3.57 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.736 2.958 . . . . 74.51 114.906 -177.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -57.73 121.39 10.32 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.308 1.043 . . . . 71.23 112.895 -166.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 9.5 tt -128.54 123.85 34.52 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.075 -1.083 . . . . 70.41 108.075 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -134.98 127.1 29.89 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.611 0.764 . . . . 74.12 109.004 172.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.539 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -68.79 137.74 54.24 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.483 0.713 . . . . 62.03 109.919 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.03 138.4 61.07 Favored Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 123.625 0.578 . . . . 63.14 110.576 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.04 122.98 7.52 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.881 2.387 . . . . 72.41 112.847 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 t -116.2 112.08 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.42 -0.956 . . . . 75.32 108.42 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -76.68 88.71 3.35 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.461 -0.94 . . . . 74.53 108.461 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -59.51 -37.8 79.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.093 -0.958 . . . . 73.42 112.345 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.22 -43.59 87.79 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.978 0.911 . . . . 73.23 112.688 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.03 -53.64 29.28 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.537 0.735 . . . . 71.12 110.725 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.0 -14.72 61.07 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.282 -0.872 . . . . 74.12 111.433 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 84.2 t80 . . . . . 0 N--CA 1.476 0.837 0 O-C-N 123.396 0.435 . . . . 74.44 109.937 173.738 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 28.5 m . . . . . 0 CA--C 1.536 0.437 0 N-CA-C 107.632 -1.247 . . . . 74.31 107.632 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -97.44 128.45 44.24 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.491 -0.929 . . . . 74.33 108.491 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . 0.4 ' HB3' ' HG ' ' C' ' 85' ' ' SER . 27.5 tt0 -153.88 125.74 7.74 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.18 0.592 . . . . 65.21 109.723 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 50.1 mt -75.75 132.57 32.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.857 -0.794 . . . . 75.23 108.857 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.503 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 26.0 mm-40 -101.11 -39.52 7.64 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.593 0.757 . . . . 74.53 109.899 174.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -169.67 146.62 3.32 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.526 -0.546 . . . . 71.22 109.526 -172.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 89.8 mt -137.03 134.08 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.143 -1.058 . . . . 74.22 108.143 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.403 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 43.4 p90 -170.85 164.29 7.81 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.155 0.502 . . . . 74.24 110.904 -167.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -87.26 114.53 23.96 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.328 -0.851 . . . . 64.54 108.855 173.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.403 ' HD2' ' HE2' ' C' ' 17' ' ' TYR . 19.2 mmmt -64.02 -39.89 95.12 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.915 0.864 . . . . 75.13 109.139 172.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -160.4 144.98 14.38 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 113.696 -1.593 . . . . 75.22 108.349 -172.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 88.9 mt -133.78 146.99 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.585 -1.265 . . . . 73.41 107.585 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.8 t -151.92 149.76 29.29 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.471 0.653 . . . . 63.55 110.267 172.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 82.7 t80 -150.75 117.85 5.94 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 107.275 -1.38 . . . . 73.01 107.275 173.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.97 111.99 17.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.512 0.725 . . . . 75.53 109.882 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.88 82.34 60.94 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.25 -1.019 . . . . 64.12 108.25 169.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -65.17 -25.78 57.73 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.013 2.476 . . . . 75.32 112.712 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -102.31 13.02 35.73 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.154 0.982 . . . . 73.23 110.605 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.511 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -45.18 -58.42 5.74 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 114.703 1.371 . . . . 74.11 114.703 -165.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.522 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 23.5 Cg_endo -60.04 -43.22 37.78 Favored 'Trans proline' 0 C--N 1.383 2.382 0 CA-C-N 122.129 1.796 . . . . 74.22 111.817 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -71.67 -28.42 63.73 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.963 0.905 . . . . 75.35 112.674 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.701 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.7 p -80.25 -22.26 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.57 0.348 . . . . 72.44 111.567 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -72.91 -21.24 60.93 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.005 0.522 . . . . 74.24 111.783 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -102.1 6.5 40.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.734 0.814 . . . . 74.11 110.906 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.796 ' HG2' HD12 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -83.77 161.53 20.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.444 0.698 . . . . 74.52 110.546 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.428 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 7.2 m-20 -57.76 112.27 1.41 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.32 1.048 . . . . 74.33 109.646 168.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -73.57 88.45 1.67 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.028 0.531 . . . . 73.12 110.553 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -150.16 74.22 9.15 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.393 -0.966 . . . . 71.54 108.393 169.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -74.57 164.48 33.74 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.75 2.3 . . . . 74.22 112.87 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -115.8 94.38 4.66 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.374 -1.714 . . . . 74.14 106.374 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 90.9 t -73.38 98.4 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.548 -0.751 . . . . 73.44 109.256 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -101.5 107.39 18.68 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.912 -1.144 . . . . 73.12 107.912 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.07 138.48 31.41 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.273 0.559 . . . . 74.11 111.282 -174.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.561 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.2 t70 -130.74 132.86 45.58 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.11 1.364 . . . . 63.14 108.614 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.408 HD11 HG13 ' C' ' 131' ' ' VAL . 52.0 mt -123.05 131.9 53.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.845 -1.169 . . . . 74.45 107.845 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -144.4 144.58 31.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.322 0.649 . . . . 71.35 109.421 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -151.48 153.41 34.57 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 122.898 0.479 . . . . 55.33 110.101 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.95 168.86 24.97 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.432 -0.804 . . . . 61.11 109.564 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.4 p -129.9 151.22 50.7 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.882 0.873 . . . . 75.4 109.499 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 80.7 p -143.68 128.13 17.94 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.373 1.069 . . . . 73.1 108.197 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -76.94 116.43 17.6 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.36 -0.607 . . . . 72.33 109.36 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.53 HD13 HD13 ' C' ' 83' ' ' ILE . 75.3 mt -89.64 -39.7 13.05 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.0 -0.741 . . . . 63.04 109.0 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 -175.49 5.43 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.646 -1.161 . . . . 71.53 110.432 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.24 116.93 5.9 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.661 -1.154 . . . . 71.33 109.85 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 61.97 20.11 11.28 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.369 1.068 . . . . 63.53 112.136 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.8 t -119.72 116.43 50.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.535 -0.913 . . . . 74.13 108.535 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.38 125.9 44.15 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.077 0.951 . . . . 74.3 109.059 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.6 132.55 34.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.911 -1.144 . . . . 75.44 107.911 164.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 56.1 t -112.43 139.71 35.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.088 -1.078 . . . . 74.42 108.088 166.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -121.44 124.88 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.792 -0.818 . . . . 65.23 108.792 171.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.481 HD11 ' HA ' ' C' ' 107' ' ' PHE . 1.1 tm? -104.42 106.09 16.45 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.712 -1.218 . . . . 74.54 107.712 172.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.496 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 0.8 OUTLIER -101.16 115.13 29.78 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.72 -1.127 . . . . 74.2 109.492 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.543 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.7 t -101.91 134.95 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.375 -0.972 . . . . 61.42 108.375 174.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -121.87 136.88 54.95 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.665 -0.865 . . . . 72.23 108.665 172.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.454 HG12 HD12 ' C' ' 126' ' ' LEU . 46.5 t -127.83 118.37 48.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 123.655 0.782 . . . . 73.32 109.329 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.2 m -102.53 144.63 30.71 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.011 -0.737 . . . . 64.43 109.011 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.17 114.22 9.0 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.391 -0.966 . . . . 71.33 108.391 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -131.2 142.33 50.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.413 0.685 . . . . 73.21 109.868 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.796 HD12 ' HG2' ' C' ' 34' ' ' LYS . 4.7 mt -94.34 16.81 14.14 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.949 1.3 . . . . 75.43 110.779 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.27 -87.71 0.35 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.78 -1.328 . . . . 62.41 109.78 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.53 -26.68 8.93 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.133 0.973 . . . . 72.44 110.567 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -82.77 119.0 23.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.707 0.803 . . . . 71.01 109.344 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -73.83 127.14 32.03 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.601 -0.518 . . . . 72.31 109.601 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.701 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.13 -54.76 7.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.162 -0.681 . . . . 64.33 109.162 173.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -169.28 173.39 6.69 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.335 -0.848 . . . . 74.23 110.924 176.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -142.82 112.8 7.04 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.22 -1.4 . . . . 72.53 107.22 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -108.1 145.76 33.62 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.515 -0.92 . . . . 74.44 108.515 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -153.86 134.15 13.39 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.895 -0.78 . . . . 62.33 108.895 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 64.8 t -132.41 115.34 25.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.013 0.925 . . . . 75.41 108.898 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.496 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 57.8 mt-30 -93.53 89.9 6.46 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.32 -0.993 . . . . 71.22 108.32 174.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.7 102.16 13.96 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.152 0.581 . . . . 75.21 110.121 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.84 167.59 44.31 Favored Glycine 0 C--O 1.24 0.531 0 CA-C-O 121.175 0.319 . . . . 74.43 112.699 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.39 119.57 0.81 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.155 -0.778 . . . . 65.02 111.155 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.56 HD11 ' HB3' ' D' ' 29' ' ' PRO . 12.0 mm -82.9 132.35 31.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 109.129 -0.693 . . . . 74.43 109.129 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -134.28 119.89 19.28 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.322 0.649 . . . . 73.42 109.678 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.4 ' HG ' ' HB3' ' C' ' 12' ' ' GLN . 13.1 p -82.14 102.04 10.81 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.17 -1.048 . . . . 75.33 108.17 171.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' C' ' 10' ' ' THR . 2.5 pp -121.74 126.4 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 123.689 0.796 . . . . 74.32 110.982 -173.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.41 156.52 46.53 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.658 0.783 . . . . 65.34 109.899 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.42 -26.13 17.22 Favored Glycine 0 N--CA 1.476 1.314 0 N-CA-C 114.329 0.492 . . . . 71.12 114.329 172.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.563 HD11 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -87.28 145.81 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.056 0.543 . . . . 73.23 110.523 178.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.48 170.27 18.41 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.109 -0.95 . . . . 63.51 108.601 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.22 -119.27 6.86 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 124.118 0.887 . . . . 61.11 115.042 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 1.6 m -71.66 -32.35 67.79 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.641 1.176 . . . . 71.03 111.122 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -65.58 -43.16 90.64 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.466 0.707 . . . . 70.22 109.883 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 37.1 ttp -68.11 -40.73 82.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.17 -0.923 . . . . 74.41 110.593 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.8 -42.78 76.11 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 124.315 1.009 . . . . 64.23 110.697 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -83.14 -35.62 25.43 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.612 0.57 . . . . 74.14 111.956 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -58.0 -42.31 84.93 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.897 0.748 . . . . 73.53 110.62 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 21.9 mt -98.43 -24.91 14.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.266 -0.879 . . . . 72.53 110.686 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.61 -21.36 79.51 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.471 0.482 . . . . 55.45 114.174 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -158.26 -42.79 0.06 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.722 1.008 . . . . 75.45 113.722 -167.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.86 -46.63 74.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.915 0.486 . . . . 72.52 111.212 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.46 -49.06 54.3 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 124.254 1.022 . . . . 75.33 111.994 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -52.12 -34.44 58.15 Favored 'Trans proline' 0 C--N 1.399 3.186 0 C-N-CA 123.156 2.571 . . . . 72.14 114.654 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -60.23 -34.03 73.1 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.837 0.855 . . . . 71.11 111.722 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.488 HD13 ' NH1' ' A' ' 111' ' ' ARG . 47.9 mm -70.4 -37.33 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.183 0.593 . . . . 73.05 110.189 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 53.1 mt -87.73 -24.79 23.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.035 0.934 . . . . 74.02 112.587 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.481 ' HA ' HD11 ' C' ' 60' ' ' LEU . 63.7 t80 -56.63 -48.74 96.64 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 117.812 -1.089 . . . . 74.3 113.853 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -55.33 -38.03 94.12 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 122.388 2.059 . . . . 72.21 113.234 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -67.25 -46.29 74.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.696 0.798 . . . . 74.02 110.467 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.433 ' O ' HG13 ' C' ' 114' ' ' ILE . . . -63.14 -38.99 93.35 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.669 -0.696 . . . . 74.35 110.878 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -57.25 -49.41 76.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.731 1.212 . . . . 73.31 111.079 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.63 -37.6 82.71 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 123.603 0.564 . . . . 60.33 110.084 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.3 t -68.18 -29.58 68.48 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.087 0.555 . . . . 73.05 111.443 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.543 HD11 ' HB ' ' C' ' 62' ' ' VAL . 74.1 mt -71.28 -50.45 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 108.949 -0.76 . . . . 71.3 108.949 172.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.522 HG21 ' HB3' ' B' ' 119' ' ' SER . 23.2 m -58.64 -35.12 72.01 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.679 0.792 . . . . 64.11 111.179 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.0 t -67.0 -54.14 24.63 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 123.813 0.845 . . . . 75.21 109.124 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.659 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.24 -38.71 80.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.487 1.115 . . . . 75.35 112.89 -177.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.98 -46.28 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.75 0.82 . . . . 73.44 110.165 177.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.451 ' OG ' HG22 ' B' ' 115' ' ' THR . 45.1 t -71.12 -24.12 62.22 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.617 -0.72 . . . . 73.14 111.582 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -69.44 -44.08 72.01 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.546 -0.909 . . . . 72.3 108.546 173.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.67 -1.59 72.34 Favored Glycine 0 C--N 1.357 1.744 0 O-C-N 123.712 0.632 . . . . 74.32 112.901 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.477 HG21 ' HB3' ' D' ' 17' ' ' TYR . 26.7 p 60.65 37.2 19.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.656 1.982 . . . . 72.44 113.359 173.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -89.37 162.75 36.06 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-N 115.199 -0.909 . . . . 72.2 108.702 166.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.27 167.59 7.5 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.88 2.387 . . . . 75.44 113.301 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -51.66 131.69 30.19 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.706 1.202 . . . . 73.43 112.836 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.454 HD12 HG12 ' C' ' 64' ' ' VAL . 3.8 tt -136.3 85.08 2.12 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.306 -0.861 . . . . 64.3 108.918 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -95.48 124.22 39.41 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.818 -1.179 . . . . 64.15 107.818 171.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.05 134.9 47.44 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 108.487 -0.931 . . . . 71.42 108.487 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.5 152.39 34.32 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.311 1.044 . . . . 75.54 112.19 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.487 ' HG3' HD13 ' A' ' 16' ' ' ILE . 35.7 Cg_exo -56.33 92.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 122.566 2.177 . . . . 73.21 112.407 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . 0.408 HG13 HD11 ' C' ' 44' ' ' LEU . 54.8 t -98.57 109.86 24.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 108.833 -0.803 . . . . 74.14 108.833 177.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -93.44 88.54 5.98 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.124 -1.436 . . . . 74.23 107.124 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -58.07 -32.79 68.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.495 0.718 . . . . 73.24 110.647 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.511 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 16.0 t70 -61.0 -39.03 88.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.878 0.871 . . . . 64.52 111.395 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.2 -39.22 71.91 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.244 0.617 . . . . 72.34 110.948 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 97.2 mt -67.79 -33.82 75.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.814 0.845 . . . . 72.43 112.232 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.0 t80 . . . . . 0 N--CA 1.48 1.066 0 C-N-CA 122.434 0.294 . . . . 74.14 110.994 -177.315 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 C--O 1.236 0.385 0 N-CA-C 108.845 -0.798 . . . . 74.23 108.845 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -165.81 92.08 0.51 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.479 -1.304 . . . . 73.35 107.479 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -123.32 117.16 24.61 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.277 -1.379 . . . . 74.03 107.277 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.442 HG21 HD13 ' D' ' 16' ' ' ILE . 27.8 mt -65.89 117.28 6.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.511 0 N-CA-C 108.798 -0.815 . . . . 74.45 108.798 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -83.79 -32.94 25.1 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 123.628 0.58 . . . . 72.21 111.111 -170.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -178.73 129.05 0.11 Allowed 'General case' 0 C--N 1.363 1.188 0 O-C-N 123.032 0.207 . . . . 73.44 110.705 -167.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.442 HD13 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -108.53 136.06 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.313 -1.365 . . . . 62.21 107.313 166.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.477 ' HB3' HG21 ' C' ' 122' ' ' THR . 29.9 p90 -158.7 162.91 37.22 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.972 0.795 . . . . 75.33 111.055 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 56.9 p -97.8 114.39 26.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.033 -0.985 . . . . 62.24 109.442 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.522 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.5 mtpt -80.13 -22.85 41.62 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.592 -0.731 . . . . 75.43 109.786 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.2 t70 -163.04 139.49 7.27 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.755 -1.111 . . . . 73.33 109.236 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.659 HG21 ' HE1' ' C' ' 117' ' ' MET . 77.3 mt -134.9 146.67 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.565 1.146 . . . . 70.42 108.539 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -146.34 125.2 12.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.706 0.802 . . . . 74.54 109.801 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.478 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 80.7 t80 -123.85 132.65 53.8 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 106.889 -1.522 . . . . 75.44 106.889 163.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 41.6 mt-10 -131.82 134.9 46.29 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.033 -0.729 . . . . 72.33 109.033 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.73 82.29 68.98 Favored Pre-proline 0 C--O 1.242 0.703 0 N-CA-C 106.076 -1.824 . . . . 74.45 106.076 168.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.57 -36.02 35.49 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.515 2.143 . . . . 75.22 111.751 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.429 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 48.9 m-20 -105.76 11.21 32.3 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.106 0.962 . . . . 74.11 110.684 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.424 ' O ' HG11 ' D' ' 31' ' ' VAL . . . -18.53 -72.65 0.02 OUTLIER Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 116.287 1.958 . . . . 61.22 116.287 -166.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.56 ' HB3' HD11 ' C' ' 83' ' ' ILE . 49.1 Cg_endo -79.02 -16.42 12.52 Favored 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 123.771 2.383 . . . . 70.01 114.078 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.488 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 5.9 t-160 -76.45 -37.45 56.94 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.431 1.093 . . . . 74.51 109.793 174.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.721 HG22 ' HA ' ' D' ' 73' ' ' ALA . 7.4 p -83.51 -23.94 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 116.108 -0.496 . . . . 75.11 111.642 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -67.46 -18.16 64.97 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 122.537 0.335 . . . . 71.01 111.811 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.488 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 75.7 mt-30 -57.76 -29.66 64.98 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.303 1.041 . . . . 74.33 110.778 175.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -95.41 91.8 6.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.981 0.913 . . . . 73.43 109.279 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.56 70.92 10.35 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 122.531 1.157 . . . . 72.12 109.296 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -130.92 161.43 31.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.287 -1.324 . . . . 75.24 108.269 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.99 107.9 2.04 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.121 0.968 . . . . 74.33 109.411 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.44 ' HB2' ' HB3' ' D' ' 66' ' ' ALA . 35.5 Cg_exo -61.72 122.33 10.86 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.206 2.604 . . . . 74.32 112.667 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 40.8 tt0 -57.0 114.94 2.33 Favored 'General case' 0 C--N 1.359 0.995 0 O-C-N 124.092 0.87 . . . . 74.05 110.025 -177.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.3 135.27 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.525 0.73 . . . . 73.44 111.556 -170.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -114.19 132.63 56.03 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 106.975 -1.491 . . . . 72.55 106.975 170.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.87 129.59 55.07 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.086 0.554 . . . . 72.0 110.161 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 17.5 t70 -112.92 128.83 56.58 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.634 1.174 . . . . 72.24 108.864 173.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 41.2 tp -98.92 133.45 43.19 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.542 -0.54 . . . . 71.11 109.542 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.3 t0 -153.52 155.8 36.89 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.734 -1.209 . . . . 55.24 107.734 174.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.7 t -145.96 169.27 18.96 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 122.909 0.484 . . . . 74.23 110.116 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.565 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -156.05 166.56 33.11 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.711 1.204 . . . . 74.42 108.521 173.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.402 ' HB2' ' CE2' ' D' ' 56' ' ' TYR . 64.9 p -173.25 153.24 2.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.885 0.474 . . . . 64.45 111.058 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 45.5 p -168.78 143.29 3.18 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.317 1.047 . . . . 73.43 109.654 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -83.8 125.25 31.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.137 0.575 . . . . 74.4 110.333 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.0 mt -96.13 -35.36 11.36 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.266 0.626 . . . . 72.12 111.298 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.12 -177.21 6.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.064 0.545 . . . . 74.11 110.71 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.37 120.25 8.41 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 123.91 0.756 . . . . 72.25 109.914 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.54 3.52 1.5 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.114 1.366 . . . . 75.41 112.521 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -109.78 119.45 58.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.141 -1.059 . . . . 74.34 108.141 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.402 ' CE2' ' HB2' ' D' ' 48' ' ' SER . 28.6 t80 -134.41 131.24 37.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.407 -0.815 . . . . 75.34 108.969 -173.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.448 ' HB2' HD11 ' D' ' 51' ' ' LEU . 17.3 tt0 -96.64 132.26 42.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.625 -0.716 . . . . 64.14 109.189 173.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.437 HG12 ' HD3' ' D' ' 103' ' ' PRO . 64.0 t -116.6 125.46 73.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.225 -1.398 . . . . 74.32 107.225 167.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.565 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 44.1 t -102.64 138.54 26.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.862 -0.792 . . . . 72.21 108.862 172.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.2 127.23 54.05 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.619 -1.252 . . . . 72.43 107.619 170.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.495 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 3.9 tmm_? -111.42 95.95 5.82 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.831 -1.174 . . . . 75.31 107.831 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 65.7 t -96.51 132.83 39.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.006 -0.997 . . . . 64.31 108.967 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 16.7 m -127.39 133.91 49.97 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.283 0.563 . . . . 74.14 109.502 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.02 102.41 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.534 1.533 . . . . 74.21 107.999 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 42.1 m -105.32 98.37 8.08 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.851 0.86 . . . . 63.11 109.448 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' D' ' 38' ' ' PRO . . . -104.72 149.86 25.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.856 0.462 . . . . 70.44 111.033 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.42 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 53.3 p -147.5 134.5 20.3 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.604 -0.725 . . . . 55.22 110.556 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.573 HD11 HG21 ' D' ' 31' ' ' VAL . 27.3 mt -98.76 110.94 23.46 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.308 -0.997 . . . . 73.54 108.308 174.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.76 -112.66 4.37 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 123.634 0.584 . . . . 73.25 112.812 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.94 16.8 16.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.407 1.083 . . . . 74.45 110.409 -172.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.429 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 12.8 pt-20 -141.22 155.33 46.05 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.466 0.706 . . . . 70.32 109.366 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -68.06 138.3 55.7 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 120.949 0.404 . . . . 64.33 110.527 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.721 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -89.96 -68.84 0.76 Allowed 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.535 -0.913 . . . . 74.33 108.535 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . 0.461 ' HZ ' HD13 ' D' ' 126' ' ' LEU . 50.2 p90 -152.96 149.24 28.0 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.61 -0.723 . . . . 73.22 110.252 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.6 mt -119.05 119.45 34.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.333 1.053 . . . . 73.52 108.234 175.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.451 ' SG ' ' HD1' ' D' ' 23' ' ' PHE . 1.3 m -121.9 104.92 9.89 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.167 0.987 . . . . 75.24 109.692 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -127.19 120.8 29.63 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.407 -0.96 . . . . 74.41 108.407 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -131.88 126.34 56.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 109.616 -0.512 . . . . 74.41 109.616 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.495 ' HG2' ' HG2' ' D' ' 61' ' ' ARG . 52.1 mt-30 -88.41 81.5 7.2 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.15 -1.056 . . . . 73.44 108.15 168.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.56 92.4 5.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.316 -1.311 . . . . 64.13 109.194 -178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.89 147.17 20.24 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.843 -0.617 . . . . 54.31 112.18 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.514 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -142.2 129.29 3.84 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 111.321 -0.712 . . . . 41.42 111.321 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.461 HG13 ' HE1' ' D' ' 17' ' ' TYR . 48.2 mt -93.78 140.47 16.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.066 0.946 . . . . 73.14 108.55 173.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -139.86 132.03 28.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.541 0.736 . . . . 72.21 109.018 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.6 m -87.5 94.91 9.84 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.633 -0.877 . . . . 75.42 108.633 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 tt -126.68 139.31 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 124.56 1.144 . . . . 75.3 110.103 -173.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.93 168.39 26.9 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.525 0.73 . . . . 70.34 111.752 -173.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.1 22.37 65.8 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 115.397 -0.819 . . . . 72.41 113.9 174.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.82 144.03 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.006 0.923 . . . . 75.24 110.665 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -142.64 161.88 36.93 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.856 0.862 . . . . 73.13 111.385 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.41 -122.39 29.67 Favored Glycine 0 C--N 1.355 1.597 0 O-C-N 124.606 1.191 . . . . 74.44 115.075 169.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.1 p -67.64 -26.18 66.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.807 0.843 . . . . 74.32 111.443 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -80.76 -38.68 28.18 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.193 0.597 . . . . 75.15 111.667 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 28.0 ptm -68.19 -34.61 76.6 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.471 -0.566 . . . . 74.42 109.471 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.74 -45.77 85.06 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.108 0.563 . . . . 64.22 110.245 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -60.35 -44.51 95.49 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.655 1.182 . . . . 75.33 111.658 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 16.2 t -76.14 -45.09 35.31 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.862 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.61 -33.28 28.0 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.335 0.495 . . . . 74.3 112.335 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.21 -0.04 54.26 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 119.542 -0.588 . . . . 75.14 113.994 -173.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' D' ' 134' ' ' ASP . . . -141.99 -61.11 0.46 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.45 0.625 . . . . 74.24 111.429 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . 0.438 ' O ' HG12 ' D' ' 105' ' ' ILE . 72.6 t80 -66.21 -41.03 90.69 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.879 0.472 . . . . 71.1 112.202 -174.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.44 -45.87 19.24 Favored Pre-proline 0 CA--C 1.559 1.31 0 CA-C-O 118.277 -0.868 . . . . 62.24 111.091 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.437 ' HD3' HG12 ' D' ' 58' ' ' VAL . 86.5 Cg_exo -53.27 -33.74 66.78 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 122.358 2.039 . . . . 65.41 113.438 166.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -67.28 -35.29 79.18 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.441 0.697 . . . . 73.0 110.038 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.438 HG12 ' O ' ' D' ' 101' ' ' TYR . 40.7 mm -70.34 -36.15 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.092 0.957 . . . . 75.32 110.733 174.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.514 HD22 ' HA3' ' D' ' 82' ' ' GLY . 96.5 mt -78.73 -21.09 48.58 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.851 0.86 . . . . 75.52 112.276 -176.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -66.77 -42.4 43.98 Favored Pre-proline 0 CA--C 1.562 1.414 0 CA-C-O 117.939 -1.029 . . . . 73.45 113.515 -172.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.44 -39.41 87.79 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 122.163 1.909 . . . . 73.41 113.133 170.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -74.8 -36.74 62.46 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.721 0.808 . . . . 71.44 111.872 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.85 73.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.222 -0.658 . . . . 73.04 109.222 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.423 ' NH2' HG22 ' B' ' 105' ' ' ILE . 38.6 ttp180 -57.47 -45.14 85.14 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 114.17 -1.377 . . . . 74.43 110.668 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.93 -51.76 62.94 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.944 0.778 . . . . 75.33 111.652 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -55.62 -40.71 72.49 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 123.822 0.701 . . . . 71.33 110.591 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.428 ' O ' HG23 ' D' ' 118' ' ' VAL . 54.9 mt -64.36 -53.5 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.836 1.254 . . . . 65.31 111.407 174.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.9 m -59.08 -36.77 75.66 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.356 1.062 . . . . 74.03 111.037 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -65.78 -44.32 86.14 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.885 -1.052 . . . . 74.23 109.842 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.478 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 66.0 mtm -69.34 -29.84 67.75 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.825 0.45 . . . . 75.52 111.9 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.0 t -64.36 -47.85 87.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.585 0.754 . . . . 74.21 110.049 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.5 p -69.71 -34.24 73.62 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.081 -0.509 . . . . 75.21 110.71 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -68.72 -33.05 73.28 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.637 0.775 . . . . 73.2 110.293 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.98 11.04 73.34 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.67 0.606 . . . . 74.05 112.636 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 63.9 p 57.33 32.16 21.31 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 126.044 1.738 . . . . 74.14 114.53 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -95.89 150.8 37.8 Favored Pre-proline 0 N--CA 1.478 0.941 0 N-CA-C 108.323 -0.991 . . . . 64.41 108.323 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -59.94 147.37 93.03 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.659 2.239 . . . . 54.31 111.375 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -60.25 142.12 55.04 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 124.05 0.844 . . . . 73.54 112.794 -166.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.461 HD13 ' HZ ' ' D' ' 74' ' ' PHE . 0.8 OUTLIER -122.81 104.73 9.47 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.4 1.08 . . . . 64.13 109.263 -175.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -124.3 95.06 4.4 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.698 0.799 . . . . 71.35 109.665 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.35 139.38 54.21 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.803 -0.443 . . . . 72.13 109.803 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.73 136.94 93.04 Favored Pre-proline 0 CA--C 1.549 0.936 0 O-C-N 123.815 0.697 . . . . 45.22 109.669 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.426 ' HB2' ' HH ' ' B' ' 101' ' ' TYR . 4.2 Cg_exo -68.09 133.01 27.59 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.271 1.981 . . . . 72.43 110.244 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.88 131.94 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.251 -0.648 . . . . 75.01 109.251 -170.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -77.64 89.81 3.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.745 -0.835 . . . . 73.34 108.745 172.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -64.01 -28.71 69.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.653 0.781 . . . . 63.53 111.297 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . 0.425 ' HA ' ' HB2' ' D' ' 100' ' ' ALA . 2.0 m-20 -56.83 -55.88 28.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.295 1.438 . . . . 72.12 112.966 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.95 -47.23 87.39 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.279 0.632 . . . . 72.34 111.446 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 mp -66.31 -29.16 69.32 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.86 -1.064 . . . . 72.33 111.36 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 85.4 t80 . . . . . 0 N--CA 1.477 0.875 0 C-N-CA 124.038 0.935 . . . . 74.52 111.265 179.492 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 90.9 m . . . . . 0 C--O 1.24 0.563 0 N-CA-C 109.21 -0.663 . . . . 75.01 109.21 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.6 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.3 t80 -137.44 135.14 36.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.804 -0.813 . . . . 75.42 108.804 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -150.08 117.46 6.08 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.084 -1.08 . . . . 55.11 108.084 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.449 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.6 mt -80.87 118.24 28.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.813 -0.81 . . . . 71.51 108.813 175.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.9 -40.54 31.96 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.851 -0.796 . . . . 74.44 108.851 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -169.47 145.96 3.32 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.48 -0.327 . . . . 73.22 110.845 -176.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.512 HD13 ' HG3' ' C' ' 130' ' ' PRO . 84.4 mt -129.55 136.25 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 124.303 1.041 . . . . 73.15 108.726 172.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.504 ' HB3' HG23 ' B' ' 122' ' ' THR . 33.8 p90 -169.53 177.81 4.45 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.017 0.927 . . . . 75.04 111.029 -174.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -99.66 123.62 44.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.316 -0.624 . . . . 71.41 109.316 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -84.27 -28.86 26.89 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 110.011 -0.366 . . . . 74.21 110.011 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -152.75 146.27 24.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.502 -0.772 . . . . 74.5 109.692 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.06 142.44 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.391 1.476 . . . . 63.02 107.045 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -149.89 144.29 25.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.047 0.451 . . . . 75.11 110.181 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.565 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 92.7 t80 -150.21 129.42 12.79 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.888 -1.523 . . . . 62.54 106.888 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.62 127.83 39.76 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.608 0.763 . . . . 64.21 109.247 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.36 79.81 64.76 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 107.156 -1.424 . . . . 74.43 107.156 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.25 -16.6 24.89 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.485 2.123 . . . . 72.04 111.364 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -107.44 13.89 26.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.699 1.199 . . . . 75.41 109.533 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.71 99.9 Favored Pre-proline 0 CA--C 1.569 1.685 0 N-CA-C 114.258 1.207 . . . . 72.24 114.258 -170.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.62 -24.12 18.95 Favored 'Trans proline' 0 C--N 1.388 2.624 0 C-N-CA 121.818 1.679 . . . . 73.35 113.243 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -91.21 -21.88 20.9 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.62 0.768 . . . . 75.11 112.031 -171.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.455 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 12.0 p -69.77 -28.57 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.646 0.779 . . . . 75.11 111.722 -175.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -68.12 -36.21 79.36 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.828 0.851 . . . . 73.13 110.761 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -77.26 -46.45 23.06 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.328 -0.851 . . . . 74.33 111.346 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.62 ' HZ2' ' HG3' ' A' ' 71' ' ' GLU . 64.9 pttt -76.26 164.64 25.86 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.563 0.345 . . . . 74.23 110.165 176.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.98 141.21 36.19 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.869 0.467 . . . . 71.33 110.223 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -79.13 99.31 6.91 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.485 0.714 . . . . 65.42 109.593 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.453 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 35.6 tt0 -149.97 67.05 8.32 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.1 -0.704 . . . . 70.44 109.1 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.62 158.98 9.24 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.711 2.274 . . . . 74.43 113.162 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -94.67 99.68 11.75 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.194 -1.41 . . . . 71.41 107.194 170.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.4 m -78.06 93.72 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 114.576 -1.193 . . . . 65.33 110.816 -173.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 56.2 mttm -91.17 113.41 25.67 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.477 -1.238 . . . . 64.23 108.41 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.7 tp -116.67 119.01 34.15 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.145 -0.687 . . . . 74.24 109.145 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -130.06 151.05 51.02 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.64 0.776 . . . . 72.34 109.302 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.519 HD22 HG21 ' A' ' 62' ' ' VAL . 3.0 tm? -132.26 141.1 48.88 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.707 0.803 . . . . 74.2 109.208 -173.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -135.47 119.71 17.78 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.264 1.026 . . . . 62.53 109.145 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.2 m -111.72 130.17 55.87 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.126 0.97 . . . . 74.5 109.122 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.93 152.47 51.06 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.512 -0.921 . . . . 71.13 108.512 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.2 t -125.78 152.07 45.89 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.651 -0.5 . . . . 74.42 109.651 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 t -150.65 133.12 15.61 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.921 0.889 . . . . 71.25 109.084 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -77.85 131.45 37.54 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.501 -0.555 . . . . 74.23 109.501 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.8 mt -107.12 -41.98 5.0 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.865 0.866 . . . . 74.21 109.705 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.87 -175.01 4.64 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.678 -1.146 . . . . 74.21 109.272 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.69 114.11 3.11 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.427 0.691 . . . . 65.25 110.457 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.75 12.67 7.84 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.414 1.086 . . . . 75.2 112.105 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.1 t -101.68 112.56 35.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 124.909 1.284 . . . . 74.11 107.92 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -125.17 126.7 45.66 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.718 0.807 . . . . 73.42 109.292 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -101.94 126.91 48.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.74 -1.118 . . . . 75.11 108.477 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 m -100.89 133.33 44.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.99 -1.115 . . . . 73.05 107.99 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.62 110.68 26.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 107.972 -1.122 . . . . 73.44 107.972 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.0 tp -90.51 98.41 11.76 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.042 -0.725 . . . . 73.54 109.042 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.8 ttp85 -95.81 100.87 12.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.635 0.774 . . . . 73.32 109.712 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.519 HG21 HD22 ' A' ' 44' ' ' LEU . 12.3 t -97.15 117.29 41.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.219 -1.03 . . . . 75.04 108.219 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.0 t -107.55 141.89 38.29 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.734 0.778 . . . . 74.23 109.936 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 59.0 t -131.29 109.34 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.755 1.622 . . . . 72.12 107.641 -173.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 26.7 m -110.65 107.73 17.41 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.793 -0.818 . . . . 61.04 108.793 175.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.63 104.69 14.05 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 106.996 -1.483 . . . . 72.33 106.996 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.8 p -149.56 127.79 12.08 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.691 0.396 . . . . 74.3 110.569 -172.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.474 HD22 ' H ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -90.12 84.55 6.13 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.886 -0.783 . . . . 74.45 108.886 177.247 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.38 -104.8 1.81 Allowed Glycine 0 C--N 1.35 1.307 0 CA-C-N 115.065 -0.97 . . . . 71.23 112.283 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -97.28 -5.23 37.19 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.587 0.755 . . . . 74.45 110.314 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.62 ' HG3' ' HZ2' ' A' ' 34' ' ' LYS . 36.1 tp10 -112.22 94.65 5.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.606 1.162 . . . . 64.34 108.97 -169.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -71.45 138.41 49.0 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.424 0.289 . . . . 75.15 111.273 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.28 -59.45 2.25 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.944 0.898 . . . . 75.21 108.943 173.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -157.41 174.9 14.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.306 -0.861 . . . . 73.44 111.324 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -140.55 138.82 34.79 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.176 1.39 . . . . 75.25 107.896 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.9 m -141.28 139.51 33.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.96 0.904 . . . . 61.45 109.064 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -150.74 122.5 8.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.206 0.457 . . . . 72.33 109.826 174.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.3 t -122.35 132.85 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 123.875 0.87 . . . . 75.53 109.592 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.526 HE21 ' N ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -109.01 86.75 2.34 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.357 1.063 . . . . 74.03 108.293 174.413 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.09 103.18 8.85 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.96 -1.018 . . . . 75.31 108.462 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.39 142.84 16.38 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 111.368 -0.693 . . . . 72.2 111.368 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.535 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -140.61 123.51 2.38 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 111.142 -0.783 . . . . 65.54 111.142 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.1 mt -80.69 118.45 28.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.838 -0.801 . . . . 75.44 108.838 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.6 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 42.1 m-85 -125.22 119.35 28.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.887 0.475 . . . . 74.02 109.901 -176.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 m -86.82 105.0 16.71 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.845 -0.798 . . . . 73.53 108.845 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.524 ' HB ' HD11 ' A' ' 89' ' ' ILE . 43.5 pt -107.23 143.92 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.434 0.694 . . . . 73.44 110.75 -175.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.6 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -156.84 156.51 33.31 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.973 0.909 . . . . 74.32 109.778 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.0 7.04 87.63 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.897 0.719 . . . . 73.34 114.897 173.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.524 HD11 ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -122.31 156.21 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 108.686 -0.857 . . . . 73.05 108.686 172.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -157.61 173.95 16.09 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.242 0.617 . . . . 71.1 109.359 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.46 -136.64 47.38 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.514 0.509 . . . . 64.32 114.153 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -80.71 -16.14 54.69 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.537 0.735 . . . . 74.51 111.215 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -67.64 -36.45 80.8 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.002 0.921 . . . . 73.45 109.598 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.4 ' HE2' ' HB3' ' A' ' 94' ' ' MET . 34.2 ttp -76.83 -33.23 57.94 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.905 -1.043 . . . . 74.4 110.922 174.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -28.31 69.19 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.034 0.445 . . . . 71.54 110.583 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -64.57 -37.02 86.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.355 -0.839 . . . . 73.44 110.526 172.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.545 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 64.1 m -64.75 -35.74 82.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 122.871 0.469 . . . . 75.04 110.87 177.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 tt -72.96 -49.92 26.4 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.088 0.555 . . . . 74.54 109.983 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.15 4.8 52.28 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 115.059 0.784 . . . . 73.34 115.059 -165.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -145.57 -65.95 0.31 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.188 0.994 . . . . 74.2 112.201 -175.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.545 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 69.0 t80 -69.33 -66.6 0.56 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.927 -1.033 . . . . 71.42 113.402 -166.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 85.8 m -67.6 -35.06 7.46 Favored Pre-proline 0 CA--C 1.566 1.571 0 N-CA-C 114.079 1.14 . . . . 64.3 114.079 -174.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 27.9 Cg_endo -62.76 -30.15 77.76 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 122.015 1.81 . . . . 72.41 112.91 168.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -71.72 -27.86 63.3 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.091 0.556 . . . . 75.12 110.982 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.6 mm -59.31 -41.96 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-O 121.441 0.639 . . . . 75.32 109.872 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.535 HD22 ' HA3' ' A' ' 82' ' ' GLY . 84.1 mt -83.34 -16.24 46.89 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.035 -0.984 . . . . 73.23 112.581 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.79 -43.53 69.63 Favored Pre-proline 0 CA--C 1.561 1.366 0 N-CA-C 113.819 1.044 . . . . 75.42 113.819 -172.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -59.6 -37.55 87.65 Favored 'Trans proline' 0 C--N 1.387 2.574 0 CA-C-N 121.745 1.659 . . . . 71.14 112.7 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -69.89 -43.03 72.6 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.579 -0.737 . . . . 74.32 111.284 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.23 -39.24 82.37 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.13 0.572 . . . . 64.42 110.573 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.582 ' NH1' HD13 ' C' ' 105' ' ' ILE . 29.8 ttm180 -49.75 -55.1 15.23 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.645 1.215 . . . . 74.1 109.887 174.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -66.64 -44.09 82.9 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.055 -0.975 . . . . 71.5 111.569 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.1 t -60.43 -26.17 66.52 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.09 0.556 . . . . 74.35 111.844 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.479 HD11 ' HB ' ' A' ' 62' ' ' VAL . 95.6 mt -83.25 -52.23 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.75 0.82 . . . . 75.34 109.759 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.4 m -54.88 -50.88 67.62 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.818 0.847 . . . . 64.12 111.631 -173.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 47.1 t -59.6 -45.18 92.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.745 -1.116 . . . . 63.32 110.441 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.565 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 45.6 ttp -68.66 -35.05 76.72 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.073 0.949 . . . . 74.24 111.695 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.66 -41.26 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.096 0.958 . . . . 74.51 109.785 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.7 m -72.56 -24.41 61.11 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.334 -0.848 . . . . 70.12 111.467 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.444 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.8 mtt-85 -73.76 -30.95 63.07 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.521 0.729 . . . . 73.02 109.665 174.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.06 -1.64 80.28 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.658 -0.701 . . . . 44.14 112.637 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.8 m 69.16 21.0 7.4 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 125.161 1.384 . . . . 71.32 111.223 175.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.15 158.71 69.37 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 115.274 -0.875 . . . . 71.34 109.335 170.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.55 144.97 91.06 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.277 1.985 . . . . 72.02 111.54 173.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -59.35 134.53 57.09 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.621 0.768 . . . . 75.23 111.92 -173.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -117.32 102.46 9.27 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.211 -0.904 . . . . 71.41 109.803 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -102.03 108.04 19.35 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.12 -1.067 . . . . 73.14 108.12 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.16 117.34 10.68 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.066 -0.716 . . . . 72.52 109.066 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.33 139.14 96.39 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 122.841 0.456 . . . . 75.15 110.883 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -53.04 106.66 0.16 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.04 2.494 . . . . 75.21 111.877 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.46 133.06 42.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.578 0.704 . . . . 65.24 109.293 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -82.04 71.93 9.09 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.462 -1.245 . . . . 72.04 112.126 -170.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.484 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 35.2 m-85 -53.68 -41.05 66.47 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.612 0.765 . . . . 70.33 111.582 177.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 7.0 m-20 -68.85 -42.05 77.63 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.007 -0.997 . . . . 63.01 111.401 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.02 81.09 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.073 0.549 . . . . 62.53 110.981 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.53 -38.41 80.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.738 -1.119 . . . . 74.41 110.511 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -73.82 -37.64 64.81 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.539 -0.755 . . . . 73.2 110.347 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 N--CA 1.491 1.622 0 C-N-CA 123.357 0.663 . . . . 74.55 111.551 -178.238 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 72.3 m . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 108.041 -1.096 . . . . 74.42 108.041 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.34 157.63 44.59 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.73 0.3 . . . . 73.11 110.798 163.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.478 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -123.03 121.4 35.98 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 107.634 -1.247 . . . . 75.53 107.634 177.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 36.2 mt -71.71 119.87 18.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.572 -0.899 . . . . 74.13 108.572 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . 0.549 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 84.2 mm-40 -82.54 -39.33 22.49 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.185 -0.916 . . . . 74.3 109.913 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.5 ttt85 -174.06 134.89 0.45 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.101 -0.954 . . . . 74.31 109.583 -174.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -114.69 140.01 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 106.623 -1.621 . . . . 73.21 106.623 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -166.63 155.39 10.59 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.465 0.65 . . . . 73.3 111.639 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 96.2 m -83.19 127.01 33.24 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.684 -1.144 . . . . 73.44 109.059 171.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.443 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.0 mtpt -98.4 -22.22 16.17 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.68 0.792 . . . . 75.21 110.916 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -164.65 137.58 4.81 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 123.423 0.452 . . . . 70.02 110.86 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.714 HD12 ' SG ' ' B' ' 113' ' ' CYS . 46.2 mm -127.0 144.94 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.796 1.238 . . . . 73.31 109.276 173.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.1 t -145.04 138.88 27.03 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.464 -1.244 . . . . 74.52 107.66 174.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -153.98 123.03 6.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.277 -1.379 . . . . 74.44 107.277 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -124.21 138.22 54.43 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.144 -0.687 . . . . 75.34 109.144 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.31 83.87 64.05 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 106.723 -1.584 . . . . 73.35 106.723 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.15 -36.42 29.13 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.026 2.484 . . . . 74.12 112.998 -169.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -105.37 17.15 24.43 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.366 0.666 . . . . 73.34 110.588 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.561 ' HB2' ' HD3' ' B' ' 29' ' ' PRO . . . -36.28 -65.76 0.3 Allowed Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 115.002 1.482 . . . . 70.11 115.002 -164.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' B' ' 28' ' ' ALA . 23.1 Cg_exo -62.5 -24.99 75.61 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 122.527 2.151 . . . . 75.33 113.05 -174.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.454 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 63.4 m80 -95.25 -28.65 14.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.869 -1.06 . . . . 72.21 112.291 -173.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.676 HG23 HD13 ' B' ' 68' ' ' LEU . 8.2 p -78.85 -20.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 120.952 0.406 . . . . 75.13 111.34 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -67.75 -11.89 59.38 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.309 0.855 . . . . 72.22 113.309 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.9 pt20 -63.89 -34.48 78.05 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.016 0.527 . . . . 73.34 110.804 176.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.489 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 97.1 mttt -83.86 101.43 11.65 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.581 0.752 . . . . 74.01 109.582 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -85.51 90.08 7.87 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.092 -0.707 . . . . 74.33 109.092 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -157.85 158.46 35.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.706 1.202 . . . . 75.51 108.363 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -83.37 103.24 2.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.214 1.006 . . . . 73.35 108.476 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.89 135.37 66.38 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.373 2.715 . . . . 72.35 113.496 -168.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.3 125.8 25.05 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 123.908 0.755 . . . . 71.43 109.487 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.45 128.21 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.579 0.752 . . . . 73.23 112.078 -165.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -107.52 129.66 54.94 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.584 1.154 . . . . 74.44 108.458 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.5 146.67 23.61 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.314 -0.995 . . . . 71.1 108.314 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -140.21 112.31 7.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.342 -0.985 . . . . 73.21 108.342 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 74.0 mt -100.16 149.9 23.06 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.737 -0.468 . . . . 74.52 109.737 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.497 ' HB3' ' HD2' ' B' ' 61' ' ' ARG . 20.6 t70 -153.19 114.82 4.25 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.714 0.805 . . . . 74.04 109.275 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -110.38 114.41 27.84 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.209 0.604 . . . . 72.01 110.39 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.67 155.38 30.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.388 1.075 . . . . 55.52 108.729 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.3 p -144.19 164.45 30.68 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.439 0.296 . . . . 72.42 110.939 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -158.1 139.03 13.12 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.542 0.737 . . . . 72.44 109.939 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -80.83 113.89 19.34 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.46 0.704 . . . . 74.13 109.786 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.02 -42.68 37.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.835 0.454 . . . . 75.11 110.619 176.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.6 -175.32 5.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.273 -0.876 . . . . 73.43 110.25 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.03 117.22 3.78 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.376 -0.829 . . . . 73.33 109.862 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 71.3 1.0 3.65 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.708 1.203 . . . . 75.11 112.494 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 48.0 t -104.72 114.55 44.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 124.725 1.21 . . . . 73.02 107.927 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -123.29 140.57 52.88 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.039 -1.097 . . . . 74.1 108.039 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -116.12 107.47 14.95 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.353 -1.351 . . . . 74.23 107.353 -174.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 99.3 t -89.22 143.37 11.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 C-N-CA 124.467 1.107 . . . . 73.01 109.461 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 36.5 t -125.95 128.64 72.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.543 -0.91 . . . . 75.01 108.543 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -114.1 108.02 16.43 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.8 -1.185 . . . . 73.02 107.8 -177.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.497 ' HD2' ' HB3' ' B' ' 45' ' ' ASP . 38.1 ttm180 -93.44 123.59 36.84 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.676 -0.49 . . . . 74.33 109.676 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 44.2 t -118.29 103.12 14.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.284 -1.376 . . . . 73.3 107.284 168.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 15.7 m -98.33 126.52 43.87 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.967 -0.753 . . . . 73.35 108.967 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.432 HG22 HG22 ' B' ' 114' ' ' ILE . 58.0 t -113.75 120.2 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 123.975 0.91 . . . . 74.34 109.774 -176.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 77.9 m -109.74 135.74 50.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.631 -0.877 . . . . 75.22 108.631 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.27 142.88 27.66 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.278 0.631 . . . . 74.24 109.599 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.412 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 37.1 p -148.05 137.09 22.02 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.223 -0.444 . . . . 71.41 111.999 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.676 HD13 HG23 ' B' ' 31' ' ' VAL . 39.1 mt -96.2 104.83 16.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.039 0.936 . . . . 74.23 110.053 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.2 -113.46 5.9 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.151 -0.932 . . . . 62.21 113.143 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -107.98 21.89 16.75 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.713 0.805 . . . . 74.51 110.945 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.489 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 15.3 pt-20 -140.77 157.77 44.92 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.755 -0.591 . . . . 72.1 109.854 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 38.1 m -73.54 135.42 43.97 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.805 -0.443 . . . . 64.45 109.805 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.497 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -90.99 -66.2 0.95 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.56 -1.274 . . . . 73.32 107.56 174.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -150.18 161.87 41.57 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.844 0.83 . . . . 73.1 110.689 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.0 149.85 50.24 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.946 1.698 . . . . 74.12 106.76 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.417 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 48.6 t -154.91 159.82 40.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.551 -0.537 . . . . 70.23 109.551 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 38.7 tt0 -164.44 129.58 2.76 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.486 -0.931 . . . . 74.21 108.486 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.416 HG21 HD11 ' B' ' 21' ' ' ILE . 78.7 t -124.2 142.24 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 107.993 -1.114 . . . . 75.0 107.993 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -123.03 84.47 2.27 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.15 -1.055 . . . . 72.52 108.15 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.531 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.2 tp-100 -80.27 100.42 8.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.731 -1.122 . . . . 73.44 109.215 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.443 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -89.77 165.8 32.31 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.415 -0.674 . . . . 72.12 111.415 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.01 134.41 3.28 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.154 -0.779 . . . . 62.03 111.154 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 24.5 mt -97.87 127.35 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.955 0.902 . . . . 73.02 108.727 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -131.78 133.66 44.98 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 107.793 -1.188 . . . . 74.03 107.793 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 40.4 m -110.76 94.27 4.91 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.593 -0.521 . . . . 74.43 109.593 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.451 ' HB ' HD11 ' B' ' 89' ' ' ILE . 32.5 pt -95.88 138.42 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.396 0.678 . . . . 75.31 111.65 -167.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.54 149.87 33.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.386 1.074 . . . . 65.23 109.299 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.29 -31.21 8.92 Favored Glycine 0 N--CA 1.473 1.131 0 C-N-CA 123.256 0.455 . . . . 71.11 112.821 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' B' ' 94' ' ' MET . 9.7 pt -91.48 151.22 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.787 0.835 . . . . 63.45 111.7 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.96 148.83 17.44 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.655 -1.157 . . . . 74.34 108.749 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.17 -132.85 13.96 Favored Glycine 0 C--N 1.343 0.96 0 O-C-N 123.352 0.407 . . . . 62.23 112.608 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.4 m -74.54 -20.5 59.94 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.197 0.599 . . . . 73.15 112.183 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -59.87 -45.05 93.71 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.721 0.772 . . . . 74.34 109.804 170.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.5 ' HA ' HD13 ' B' ' 89' ' ' ILE . 9.8 tmm? -72.43 -38.07 68.44 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.37 -1.287 . . . . 72.42 110.57 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.0 -40.58 70.26 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.552 0.691 . . . . 74.24 110.593 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -71.38 -41.8 69.21 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.586 -1.188 . . . . 73.04 111.346 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.2 t -66.51 -60.1 3.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.955 0.502 . . . . 74.51 111.394 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.86 -41.18 78.78 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.824 0.849 . . . . 72.34 110.305 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.11 -34.39 41.87 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.318 0.387 . . . . 74.43 114.045 -171.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.43 -50.72 1.76 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 112.545 0.572 . . . . 71.24 112.545 -168.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -73.78 -35.78 64.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.692 0.797 . . . . 72.11 112.22 -171.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 97.1 m -70.83 -48.53 14.97 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 123.228 0.611 . . . . 71.04 111.053 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.495 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 75.3 Cg_exo -55.36 -34.82 90.17 Favored 'Trans proline' 0 C--N 1.399 3.232 0 C-N-CA 122.272 1.982 . . . . 72.15 113.542 168.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -58.72 -39.56 81.21 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.657 0.783 . . . . 75.12 110.758 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.61 -41.4 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.963 0.905 . . . . 75.1 110.791 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 59.8 mt -81.26 -16.15 53.47 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.683 0.793 . . . . 74.11 112.098 -173.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -61.8 -47.95 90.6 Favored Pre-proline 0 CA--C 1.558 1.285 0 N-CA-C 113.987 1.106 . . . . 74.32 113.987 -171.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.07 -34.46 89.9 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 121.744 1.63 . . . . 73.1 113.054 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.531 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 88.3 m-85 -65.05 -46.8 79.73 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.507 0.504 . . . . 73.24 110.32 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.6 96.92 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.532 0.733 . . . . 71.41 110.585 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -57.74 -55.93 28.54 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.203 1.001 . . . . 74.35 110.688 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.06 -34.56 77.85 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.866 0.728 . . . . 74.41 110.489 -175.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.714 ' SG ' HD12 ' B' ' 21' ' ' ILE . 2.7 t -69.96 -38.07 76.01 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.029 -0.532 . . . . 72.03 111.18 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.432 HG22 HG22 ' B' ' 64' ' ' VAL . 72.5 mt -65.73 -54.84 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.29 0.636 . . . . 72.15 109.665 174.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.9 m -61.6 -26.46 67.99 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 124.215 0.947 . . . . 62.11 111.647 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.6 t -61.73 -55.57 28.86 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.476 0.711 . . . . 75.32 109.199 171.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -66.45 -33.73 76.36 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.693 0.797 . . . . 74.12 111.716 -174.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.8 t -59.49 -48.65 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.048 0.939 . . . . 73.41 110.272 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.609 ' HB2' HE21 ' C' ' 125' ' ' GLN . 13.0 t -76.37 -21.0 56.63 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.277 -0.874 . . . . 71.2 111.216 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.7 mtt-85 -67.65 -41.71 83.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.852 -0.796 . . . . 75.13 108.852 172.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.7 -0.47 80.53 Favored Glycine 0 C--N 1.36 1.879 0 O-C-N 123.767 0.667 . . . . 72.41 113.018 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 17' ' ' TYR . 30.0 p 62.33 42.26 9.36 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.762 2.025 . . . . 72.34 113.061 173.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -97.65 159.66 30.51 Favored Pre-proline 0 CA--C 1.56 1.346 0 C-N-CA 124.04 0.936 . . . . 75.22 110.158 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -62.74 178.41 1.0 Allowed 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.516 2.81 . . . . 72.41 114.637 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.549 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 23.5 tp60 -66.17 114.94 5.66 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.875 -1.057 . . . . 71.31 112.491 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 7.4 mp -116.76 91.31 3.55 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.145 -0.687 . . . . 73.45 109.145 167.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -92.5 107.1 18.96 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.155 -1.054 . . . . 73.32 108.155 170.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 18.4 tp -71.71 126.02 28.62 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 123.64 0.587 . . . . 75.41 110.677 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.06 144.55 98.83 Favored Pre-proline 0 CA--C 1.55 0.954 0 O-C-N 124.702 1.251 . . . . 65.02 110.96 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.516 ' HG3' HD11 ' D' ' 16' ' ' ILE . 28.2 Cg_endo -61.67 112.39 1.46 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.239 2.626 . . . . 75.0 111.396 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.29 107.26 17.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 106.136 -1.801 . . . . 72.31 106.136 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -82.46 82.2 7.99 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 107.236 -1.394 . . . . 74.43 107.236 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -63.69 -27.59 69.32 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.695 -1.139 . . . . 74.54 110.068 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.43 -44.05 92.4 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.225 1.41 . . . . 63.1 111.424 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.32 -39.63 78.1 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.547 0.739 . . . . 55.13 110.322 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 85.7 mt -72.83 -23.84 60.82 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.381 -0.827 . . . . 73.25 110.734 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 51.3 t80 . . . . . 0 N--CA 1.48 1.026 0 C-N-CA 124.002 0.921 . . . . 75.11 110.889 -179.803 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 98.4 m . . . . . 0 C--O 1.241 0.608 0 N-CA-C 107.642 -1.244 . . . . 74.14 107.642 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.522 ' HD1' ' HH ' ' C' ' 101' ' ' TYR . 1.2 t80 -124.99 119.29 28.3 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.916 -1.142 . . . . 74.04 107.916 171.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -141.02 125.21 17.37 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 107.25 -1.389 . . . . 73.15 107.25 170.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.2 mt -74.35 120.53 23.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.103 -0.703 . . . . 75.22 109.103 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.573 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 16.3 mm-40 -86.94 -35.24 19.0 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.808 -1.087 . . . . 74.02 109.454 -176.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -174.16 147.79 1.26 Allowed 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.659 0.599 . . . . 63.44 109.987 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 92.1 mt -138.39 134.66 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.871 -1.159 . . . . 75.13 107.871 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -171.59 168.94 6.21 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.602 0.715 . . . . 71.33 111.728 -169.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -93.28 114.68 27.19 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.217 -0.901 . . . . 75.22 109.034 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -68.82 -39.82 79.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.037 0.922 . . . . 74.15 108.875 168.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.0 t70 -145.33 140.18 27.55 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 113.991 -1.459 . . . . 71.54 109.819 -173.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 81.2 mt -135.25 145.92 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.504 -1.665 . . . . 75.13 106.504 170.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -156.59 149.12 23.51 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.008 0.432 . . . . 73.54 110.242 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -141.97 131.11 23.33 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.705 -1.22 . . . . 72.22 107.705 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -135.28 115.9 13.79 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.507 1.123 . . . . 73.01 108.046 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.32 91.8 8.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 105.195 -2.15 . . . . 72.22 105.195 167.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.02 -36.52 97.98 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.244 2.629 . . . . 73.42 112.942 -167.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -125.41 43.16 3.12 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.762 -1.108 . . . . 73.14 108.915 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.506 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -42.61 -60.68 2.06 Favored Pre-proline 0 CA--C 1.568 1.671 0 N-CA-C 115.213 1.56 . . . . 72.03 115.213 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 19.2 Cg_exo -62.35 -39.14 48.82 Favored 'Trans proline' 0 C--N 1.391 2.801 0 CA-C-N 122.02 1.757 . . . . 75.43 112.088 -178.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -68.76 -33.77 74.45 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.033 -1.44 . . . . 73.52 111.991 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.679 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.5 p -81.82 -27.54 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 122.947 0.499 . . . . 70.25 111.99 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -68.24 -34.19 75.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.738 0.415 . . . . 74.01 111.758 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -86.55 7.06 27.77 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 122.894 0.477 . . . . 75.43 111.299 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.451 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.5 OUTLIER -95.91 170.2 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.88 0.872 . . . . 75.41 109.944 -179.022 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.45 129.25 37.89 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.676 0.791 . . . . 74.32 110.377 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 31.3 t90 -79.97 88.37 5.34 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.861 0.865 . . . . 74.54 110.186 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . 0.425 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.6 OUTLIER -144.35 73.39 15.88 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 107.353 -1.351 . . . . 74.03 107.353 174.177 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -76.67 119.05 5.03 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.05 2.5 . . . . 75.51 113.698 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.63 88.12 7.32 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.95 -1.5 . . . . 75.33 106.95 166.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.1 136.73 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 114.36 -1.291 . . . . 74.21 110.17 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -128.82 110.27 12.0 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.2 1.0 . . . . 75.21 108.864 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.78 122.56 29.3 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.146 -1.057 . . . . 73.41 108.146 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -120.23 132.05 55.19 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.101 -1.074 . . . . 75.21 108.101 174.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.557 HD22 ' HE1' ' C' ' 133' ' ' PHE . 15.3 tp -125.5 152.61 44.75 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.666 -0.865 . . . . 74.43 108.666 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.4 t70 -151.66 147.95 27.35 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.871 0.869 . . . . 75.31 108.982 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -146.22 133.2 20.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.82 0.848 . . . . 72.11 109.691 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.45 161.75 36.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.636 1.174 . . . . 64.31 107.978 171.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 16.7 m -138.55 151.58 47.44 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.866 -0.79 . . . . 74.12 108.866 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 17.9 p -142.19 128.62 20.08 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.733 0.813 . . . . 73.34 109.263 -170.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -73.88 118.26 16.63 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.728 -0.669 . . . . 73.2 110.146 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' C' ' 57' ' ' GLU . 32.8 mt -92.5 -31.69 15.15 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.081 -0.711 . . . . 74.11 109.081 172.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.85 -179.38 7.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.394 1.078 . . . . 75.52 110.457 176.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -62.87 119.11 8.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.214 -0.903 . . . . 64.33 109.467 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . 0.505 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 7.1 m-20 65.32 17.98 11.19 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.226 1.011 . . . . 71.1 112.234 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 74.1 t -124.41 115.65 45.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 108.218 -1.03 . . . . 72.14 108.218 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -128.82 131.48 47.74 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.935 0.894 . . . . 75.43 109.5 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.64 ' HB2' HD12 ' C' ' 51' ' ' LEU . 34.3 tt0 -83.75 114.94 21.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.775 -1.102 . . . . 75.53 108.135 166.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 76.2 t -96.03 137.87 22.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.671 -0.863 . . . . 72.23 108.671 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.95 131.8 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.171 -1.048 . . . . 73.22 108.171 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.538 HD21 HD13 ' C' ' 44' ' ' LEU . 1.0 OUTLIER -121.12 104.57 9.87 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.212 -1.403 . . . . 65.22 107.212 176.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 2.7 ttm180 -93.94 121.89 35.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.426 -1.261 . . . . 74.31 108.954 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.515 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.8 t -116.11 120.41 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.729 -1.212 . . . . 74.43 107.729 174.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 29.4 m -124.34 114.2 19.22 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.985 0.914 . . . . 73.22 108.714 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.657 HG12 HD13 ' C' ' 126' ' ' LEU . 43.8 t -107.56 120.1 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.857 -0.794 . . . . 73.43 108.857 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.4 m -104.54 150.6 24.48 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.669 -0.863 . . . . 75.34 108.669 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.86 137.16 31.23 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.361 -0.977 . . . . 73.42 108.361 172.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.2 m -145.1 133.47 21.8 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.23 0.612 . . . . 74.13 110.132 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.425 HD23 ' H ' ' C' ' 37' ' ' GLN . 18.2 mt -85.28 53.78 2.87 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.643 1.177 . . . . 64.33 108.999 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.82 -87.05 0.55 Allowed Glycine 0 C--N 1.342 0.867 0 N-CA-C 110.111 -1.195 . . . . 64.13 110.111 -167.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -125.55 -13.74 6.47 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.124 0.97 . . . . 62.34 111.664 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.451 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 3.7 tp10 -76.24 116.59 17.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.253 0.621 . . . . 72.25 109.721 174.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.5 m -74.85 122.26 23.1 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.416 0.553 . . . . 75.13 110.083 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.679 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.89 -61.9 1.73 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.788 -1.096 . . . . 73.25 108.709 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -155.03 173.95 15.86 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 114.574 -1.193 . . . . 70.43 111.768 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.51 139.59 26.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 104.958 -2.238 . . . . 74.23 104.958 169.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.9 t -149.04 111.55 4.74 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.026 -0.731 . . . . 72.42 109.026 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -117.84 127.39 53.82 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.0 0.52 . . . . 73.41 109.82 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.97 114.03 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.137 0.975 . . . . 74.31 108.6 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 74.1 mt-30 -92.34 91.0 7.48 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.864 -0.791 . . . . 71.34 108.864 173.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.429 ' HG3' HD22 ' C' ' 106' ' ' LEU . 7.9 tp-100 -80.95 99.71 8.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.122 -0.945 . . . . 75.42 109.76 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.8 145.61 17.86 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.786 -0.526 . . . . 74.33 111.786 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.407 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -150.14 133.22 4.28 Favored Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 110.775 -0.93 . . . . 74.04 110.775 -175.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 8.7 mm -87.52 120.57 36.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 108.452 -0.944 . . . . 63.54 108.452 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.443 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 63.1 m-85 -127.79 126.22 41.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.455 0.702 . . . . 51.12 109.184 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 59.2 p -82.81 122.95 28.88 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.596 -0.89 . . . . 72.33 108.596 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.61 ' HB ' HD13 ' C' ' 89' ' ' ILE . 47.0 pt -117.24 142.36 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.892 0.877 . . . . 72.14 109.983 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.54 159.4 21.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.73 0.812 . . . . 73.0 109.194 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.04 -38.19 3.16 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 121.401 0.445 . . . . 72.11 113.27 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.61 HD13 ' HB ' ' C' ' 86' ' ' ILE . 1.8 pp -78.72 149.13 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.258 1.023 . . . . 73.33 109.079 175.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.544 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 11.4 tp10 -146.17 146.02 30.68 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.968 0.507 . . . . 73.3 110.384 -172.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.34 -111.57 2.14 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 124.039 0.837 . . . . 64.12 113.903 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 7.1 m -63.7 -34.61 78.25 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.283 1.033 . . . . 75.43 111.219 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.544 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 38.8 mt-30 -70.85 -32.6 69.66 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.857 0.863 . . . . 75.22 111.158 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.422 ' SD ' HD12 ' C' ' 98' ' ' LEU . 17.4 tmm? -73.86 -43.78 57.52 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.689 -0.485 . . . . 73.05 109.689 176.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.65 70.64 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.224 -0.898 . . . . 74.43 110.806 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -67.49 -46.29 73.37 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.347 1.059 . . . . 72.42 110.651 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.567 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 44.7 t -64.4 -40.41 95.75 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 123.905 0.753 . . . . 72.13 111.157 -176.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.467 HD21 HD12 ' C' ' 86' ' ' ILE . 77.0 mt -90.27 -34.65 15.67 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.648 0.61 . . . . 74.15 112.648 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.87 -7.19 64.69 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-O 119.619 -0.545 . . . . 62.53 114.363 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.22 -55.22 0.16 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.718 0.771 . . . . 61.53 111.697 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.567 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 55.7 t80 -67.79 -35.73 79.18 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.326 1.45 . . . . 74.22 112.526 -172.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 35.1 m -80.52 -43.74 1.33 Allowed Pre-proline 0 N--CA 1.485 1.294 0 CA-C-O 118.924 -0.56 . . . . 74.04 112.377 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.33 -30.74 27.56 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.871 2.38 . . . . 72.31 114.257 166.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -60.95 -39.4 89.39 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.296 1.038 . . . . 75.44 110.334 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.582 HD13 ' NH1' ' A' ' 111' ' ' ARG . 40.8 mm -72.03 -40.3 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.719 0.807 . . . . 74.44 110.461 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.429 HD22 ' HG3' ' C' ' 80' ' ' GLN . 83.6 mt -78.93 -23.54 44.61 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.23 1.012 . . . . 74.52 112.644 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -59.67 -50.79 85.16 Favored Pre-proline 0 CA--C 1.556 1.173 0 N-CA-C 114.021 1.119 . . . . 64.22 114.021 -172.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.5 -35.44 96.74 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.088 1.859 . . . . 72.24 113.11 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -68.41 -50.04 55.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.587 0.755 . . . . 74.13 110.981 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.84 -37.44 84.48 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.532 -0.758 . . . . 73.11 111.042 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -58.15 -55.19 38.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.906 1.282 . . . . 73.43 110.817 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -66.97 -29.5 69.37 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.228 0.611 . . . . 75.12 110.58 -176.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.451 ' SG ' HG12 ' C' ' 21' ' ' ILE . 34.5 t -73.23 -32.19 64.6 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.23 0.612 . . . . 72.2 111.542 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.515 HD11 ' HB ' ' C' ' 62' ' ' VAL . 86.1 mt -71.23 -46.28 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.42 0.688 . . . . 74.22 109.483 172.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 23.1 m -61.34 -36.33 79.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.775 0.83 . . . . 74.24 111.33 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 37.7 t -60.19 -49.62 76.92 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.336 -0.847 . . . . 74.31 109.416 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.59 -32.62 74.3 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.586 1.155 . . . . 75.31 113.078 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.471 HG13 ' HB2' ' C' ' 123' ' ' PHE . 53.0 t -74.81 -35.39 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.437 0.695 . . . . 63.22 110.522 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 36.7 t -67.9 -35.86 79.2 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.576 0.75 . . . . 75.05 110.857 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' C' ' 116' ' ' SER . 71.7 mtt-85 -67.66 -43.76 79.48 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.435 -0.802 . . . . 73.33 109.613 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.87 1.21 84.88 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 123.737 0.648 . . . . 74.42 112.857 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 67.3 p 62.83 25.5 15.11 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.337 1.855 . . . . 61.22 114.823 167.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.471 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.8 m-85 -84.71 157.4 60.86 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 108.75 -0.833 . . . . 73.01 108.75 167.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.549 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 79.9 Cg_exo -51.61 142.28 40.51 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.93 2.42 . . . . 75.24 113.364 175.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.609 HE21 ' HB2' ' B' ' 119' ' ' SER . 14.7 mm100 -55.78 138.19 48.36 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.375 1.047 . . . . 73.11 113.015 -172.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.657 HD13 HG12 ' C' ' 64' ' ' VAL . 8.2 tt -104.58 114.79 29.24 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.5 -1.227 . . . . 71.14 108.778 -173.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -119.02 100.0 7.08 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.785 -0.821 . . . . 73.13 108.785 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.91 135.47 46.54 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.494 0.717 . . . . 75.34 109.946 -175.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.68 153.25 91.21 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.997 0.919 . . . . 71.43 111.411 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.512 ' HG3' HD13 ' A' ' 16' ' ' ILE . 31.6 Cg_exo -58.48 109.25 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.254 1.97 . . . . 75.31 112.06 172.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 91.0 t -96.28 110.73 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.031 -1.47 . . . . 73.04 107.031 173.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -83.01 94.1 7.7 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.916 -1.142 . . . . 74.44 107.916 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.557 ' HE1' HD22 ' C' ' 44' ' ' LEU . 84.8 m-85 -63.25 -38.79 92.54 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.151 0.98 . . . . 72.04 111.881 -175.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.21 -37.24 80.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.905 0.882 . . . . 74.34 111.35 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.93 -27.89 43.77 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.967 0.507 . . . . 71.12 110.373 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 54.0 tp -74.61 -26.25 59.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.257 0.623 . . . . 73.51 110.218 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 68.9 t80 . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 123.917 0.887 . . . . 74.53 111.775 -175.918 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 40.4 m . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 109.2 -0.667 . . . . 65.31 109.2 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.443 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 54.7 t80 -164.22 89.82 0.56 Allowed 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.013 -1.847 . . . . 72.44 106.013 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -128.41 130.67 47.99 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.725 -0.843 . . . . 74.42 108.725 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -90.83 110.98 22.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.123 -1.066 . . . . 61.44 108.123 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -73.86 -31.27 63.09 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.295 0.372 . . . . 75.24 110.711 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -168.68 131.68 1.4 Allowed 'General case' 0 C--N 1.349 0.547 0 O-C-N 123.268 0.355 . . . . 75.12 110.669 -169.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.516 HD11 ' HG3' ' B' ' 130' ' ' PRO . 2.0 mp -116.36 128.75 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 105.846 -1.909 . . . . 75.12 105.846 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.443 ' HE1' HG13 ' D' ' 83' ' ' ILE . 40.3 p90 -156.2 160.41 39.81 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.053 0.93 . . . . 75.34 112.477 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -91.33 118.43 30.51 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 113.738 -1.574 . . . . 73.42 108.887 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.414 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.0 mtpt -82.3 -37.37 25.89 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.632 -0.713 . . . . 72.52 109.404 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -150.24 139.06 20.85 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.106 -1.406 . . . . 61.1 109.125 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE1' ' C' ' 117' ' ' MET . 63.9 mt -137.92 147.75 25.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.919 1.287 . . . . 74.15 108.118 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.6 t -148.15 126.23 12.11 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.622 0.769 . . . . 75.1 109.48 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.515 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 66.6 t80 -121.19 133.19 55.17 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.205 -1.406 . . . . 75.03 107.205 164.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.717 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.7 mt-10 -134.84 136.7 42.66 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.34 1.056 . . . . 72.24 108.343 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.21 83.74 63.12 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.46 -1.311 . . . . 61.32 107.46 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.92 -52.95 2.41 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.05 2.5 . . . . 74.34 112.967 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.567 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 5.1 m-20 -102.18 19.69 18.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.287 0.635 . . . . 64.31 109.64 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.41 ' O ' HG11 ' D' ' 31' ' ' VAL . . . -23.85 -75.24 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 116.535 2.05 . . . . 64.41 116.535 -167.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.513 ' HB3' HD11 ' C' ' 83' ' ' ILE . 83.8 Cg_endo -77.28 -16.7 15.31 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 124.033 2.476 . . . . 72.14 113.539 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.42 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 0.2 OUTLIER -71.16 -44.45 65.49 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.209 1.004 . . . . 73.43 108.557 172.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.8 p -82.63 -20.74 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.466 0.706 . . . . 72.31 111.351 -168.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.84 -14.14 62.71 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.61 0.364 . . . . 71.15 111.599 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -67.27 -14.48 62.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.703 0.801 . . . . 71.22 110.925 174.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.617 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 97.4 mttt -97.79 101.63 13.18 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.855 1.262 . . . . 75.13 109.202 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -85.38 93.07 8.64 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.314 -0.625 . . . . 73.51 109.314 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -162.52 156.95 21.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.704 0.801 . . . . 72.45 109.192 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -76.52 105.45 2.33 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.386 -0.968 . . . . 72.5 108.386 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.05 124.97 17.16 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.002 2.468 . . . . 73.44 112.316 -170.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.52 114.83 4.62 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.864 0.727 . . . . 64.33 109.827 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.29 149.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.877 0.871 . . . . 73.4 112.018 -171.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' D' ' 64' ' ' VAL . 46.1 tptt -120.7 120.36 35.46 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.1 1.36 . . . . 73.41 107.866 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.501 HD23 HD12 ' D' ' 128' ' ' LEU . 7.2 mp -97.85 121.06 39.31 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.077 -0.712 . . . . 74.02 109.077 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.575 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 14.6 t70 -108.61 120.48 42.58 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.117 -1.068 . . . . 72.1 108.117 170.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 tt -106.43 127.79 53.56 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.506 -0.924 . . . . 72.14 108.506 -174.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.2 t70 -134.97 148.19 49.94 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.339 1.056 . . . . 73.12 108.434 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -120.19 152.21 38.01 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.999 0.52 . . . . 64.1 109.626 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.518 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -150.98 171.21 17.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.371 1.068 . . . . 71.14 108.252 174.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -174.62 161.66 3.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.065 0.546 . . . . 72.2 110.939 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.7 p -159.22 147.81 18.05 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.381 0.672 . . . . 64.42 109.93 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -87.0 127.06 35.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.474 -0.565 . . . . 74.1 109.474 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 67.6 mt -97.86 -38.62 9.37 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.289 0.635 . . . . 74.55 110.862 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.75 -173.74 4.66 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.567 0.747 . . . . 61.01 110.566 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.91 105.51 1.04 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.02 -0.991 . . . . 73.11 110.444 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 68.36 18.98 9.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.915 1.286 . . . . 71.2 111.554 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -110.77 123.08 66.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 N-CA-C 107.454 -1.313 . . . . 74.1 107.454 167.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -136.86 129.77 30.76 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.255 -0.646 . . . . 75.21 109.255 -176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -91.13 144.38 25.69 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.214 1.005 . . . . 74.52 109.624 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.0 t -123.12 145.64 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.079 1.352 . . . . 74.31 107.629 171.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.518 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 45.6 t -127.53 144.91 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.096 0.958 . . . . 74.1 108.914 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -127.7 122.09 32.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.863 -1.162 . . . . 72.1 107.863 178.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 37.0 ttm-85 -102.63 97.48 7.67 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.483 -0.932 . . . . 74.04 108.483 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.14 104.25 15.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.339 -0.985 . . . . 74.13 108.339 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.3 m -97.9 146.36 25.54 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.263 -0.88 . . . . 73.5 108.842 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 53.8 t -140.37 109.03 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.397 1.079 . . . . 75.35 108.841 -177.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -102.57 110.8 22.85 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.72 -0.845 . . . . 72.34 108.72 171.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.0 157.24 17.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.033 0.533 . . . . 73.33 110.48 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 21.6 p -154.64 130.97 10.43 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.449 0.642 . . . . 72.14 112.01 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 25.1 mt -97.91 101.62 13.16 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.384 -1.28 . . . . 75.24 107.876 170.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.97 -123.22 7.29 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.599 -0.728 . . . . 63.41 112.591 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.75 5.63 48.95 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.304 0.642 . . . . 72.13 112.341 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.617 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 13.0 pt-20 -129.09 160.14 33.75 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.207 0.603 . . . . 73.1 109.801 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -67.17 139.46 57.45 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.565 0.541 . . . . 75.13 110.412 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.578 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -92.89 -65.25 1.01 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.324 -0.853 . . . . 74.33 108.952 175.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -145.93 167.76 22.51 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.144 -0.935 . . . . 74.35 109.641 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.717 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.0 mt -132.14 140.38 48.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.404 -1.332 . . . . 73.45 107.404 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.508 ' SG ' HG21 ' D' ' 114' ' ' ILE . 1.2 m -144.91 139.51 27.67 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.022 0.929 . . . . 74.15 108.717 -177.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -158.2 130.19 6.88 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.007 -0.738 . . . . 74.41 109.007 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 62.8 t -134.87 117.5 22.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 109.258 -0.645 . . . . 73.22 109.258 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -89.58 85.48 6.5 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.612 0.72 . . . . 74.45 109.072 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -80.02 101.5 8.72 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.211 -1.359 . . . . 75.12 109.541 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.87 160.69 23.34 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.416 -0.673 . . . . 22.4 111.416 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.45 132.91 3.66 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.118 -0.793 . . . . 61.31 111.118 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.443 HG13 ' HE1' ' D' ' 17' ' ' TYR . 64.7 mt -87.69 124.56 41.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.152 0.981 . . . . 75.13 108.361 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -122.66 123.7 41.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.413 0.285 . . . . 71.31 110.368 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 48.5 m -83.49 110.19 17.99 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.745 -1.205 . . . . 61.1 107.745 164.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 15.6 pt -130.25 145.31 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.909 0.884 . . . . 74.32 110.617 -170.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.28 167.46 25.87 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.863 0.865 . . . . 42.25 109.913 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.73 -18.89 13.14 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 114.285 0.474 . . . . 64.33 114.285 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 pt -112.2 126.89 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.848 0.859 . . . . 74.14 109.113 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.53 164.33 30.44 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.068 0.547 . . . . 72.44 110.676 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.47 -129.29 30.93 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.582 0.552 . . . . 73.12 113.94 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.4 m -70.52 -29.4 65.88 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.501 0.721 . . . . 75.3 111.452 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.68 -43.57 98.48 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.978 0.911 . . . . 74.24 111.444 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.67 -31.83 63.66 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 116.244 -0.434 . . . . 72.41 110.746 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.64 88.06 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.998 0.519 . . . . 74.32 111.063 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -64.71 -31.79 73.17 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.786 0.835 . . . . 70.34 111.054 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.9 t -79.71 -49.6 11.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.516 0.326 . . . . 64.24 110.783 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.466 HD21 ' SG ' ' D' ' 102' ' ' CYS . 84.3 mt -79.28 -29.37 42.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.692 0.797 . . . . 73.35 112.238 -169.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.37 6.65 63.5 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 119.792 -0.449 . . . . 73.1 113.183 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.26 -67.94 0.23 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.258 0.529 . . . . 71.14 111.955 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . 0.403 ' O ' HG12 ' D' ' 105' ' ' ILE . 66.9 t80 -64.86 -37.77 88.74 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 112.467 0.544 . . . . 74.53 112.467 -172.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.466 ' SG ' HD21 ' D' ' 98' ' ' LEU . 85.9 m -70.65 -48.47 16.28 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-O 118.599 -0.715 . . . . 71.42 111.461 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.482 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 75.2 Cg_exo -55.96 -33.18 88.39 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.013 1.809 . . . . 75.12 113.185 167.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.56 -35.71 81.64 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.251 0.621 . . . . 73.43 111.169 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.403 HG12 ' O ' ' D' ' 101' ' ' TYR . 36.6 mm -67.84 -40.09 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.601 0.76 . . . . 74.14 110.523 174.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.7 mt -79.04 -16.93 56.14 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.642 -0.708 . . . . 75.44 111.514 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.31 -41.32 24.24 Favored Pre-proline 0 N--CA 1.485 1.317 0 N-CA-C 114.437 1.273 . . . . 71.51 114.437 -172.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.45 -39.21 92.85 Favored 'Trans proline' 0 C--N 1.385 2.476 0 CA-C-N 121.769 1.667 . . . . 75.25 112.74 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -71.16 -40.46 71.28 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.52 0.728 . . . . 75.43 110.95 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.79 -44.59 96.63 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.875 0.87 . . . . 64.32 110.639 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.51 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 19.8 ttp180 -59.92 -53.5 57.11 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.335 -1.302 . . . . 71.52 110.198 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.47 -42.77 99.72 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.28 0.988 . . . . 72.55 111.724 -172.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.8 t -58.52 -40.55 83.22 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.688 0.618 . . . . 64.23 110.875 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.508 HG21 ' SG ' ' D' ' 76' ' ' CYS . 84.3 mt -66.95 -50.3 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.626 0.77 . . . . 65.25 110.622 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -54.91 -43.86 73.67 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.213 1.005 . . . . 73.02 111.529 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.7 t -66.91 -42.02 86.11 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.48 -1.237 . . . . 74.51 110.519 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.515 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 71.9 mtm -66.12 -37.35 85.5 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.856 0.463 . . . . 73.32 111.638 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 72.0 t -63.21 -44.57 99.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.117 0.967 . . . . 73.13 110.479 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -73.57 -31.02 63.39 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 116.038 -0.528 . . . . 73.25 111.381 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -71.82 -30.3 65.34 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.205 0.602 . . . . 74.14 110.094 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.97 11.38 69.38 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.715 0.635 . . . . 72.13 112.663 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 66.2 p 58.15 21.93 8.54 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 126.446 1.899 . . . . 71.55 114.244 175.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -84.32 147.85 51.23 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 108.818 -0.808 . . . . 74.21 108.818 169.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.5 135.22 47.51 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 123.067 2.512 . . . . 74.33 112.488 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -50.63 140.91 13.52 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.957 1.303 . . . . 71.42 113.003 -170.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 55.2 tp -122.34 100.87 7.18 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.44 0.696 . . . . 73.2 110.713 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -99.67 101.16 12.26 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.093 -1.077 . . . . 64.51 108.093 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.51 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.7 mm? -69.23 114.27 7.34 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.338 0.655 . . . . 71.3 109.517 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.09 132.72 83.96 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.177 0.591 . . . . 72.01 111.414 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.472 ' HB3' HH12 ' D' ' 111' ' ' ARG . 58.6 Cg_endo -72.85 126.1 11.04 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.252 1.968 . . . . 72.44 111.185 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.82 141.79 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.797 0.839 . . . . 73.04 110.065 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -77.68 103.15 7.44 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.403 -0.962 . . . . 75.02 108.403 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -72.0 -40.56 68.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.801 0.441 . . . . 74.45 110.492 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.29 -53.46 56.53 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.905 0.882 . . . . 71.53 112.668 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.33 99.08 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.28 0.632 . . . . 63.31 111.165 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.41 -27.65 67.25 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.204 -0.907 . . . . 75.02 111.6 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 84.1 t80 . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 123.465 0.706 . . . . 73.24 110.423 177.607 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.24 0.589 0 N-CA-C 109.341 -0.614 . . . . 64.44 109.341 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.664 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 10.1 t80 -135.99 129.37 31.97 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.954 0.902 . . . . 75.24 108.607 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -149.68 127.56 11.82 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.706 0.803 . . . . 72.44 109.155 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.574 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.1 mt -95.34 119.21 43.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.896 -0.779 . . . . 73.22 108.896 173.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -88.69 -34.29 17.26 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 123.46 0.475 . . . . 70.43 110.184 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -166.87 126.16 1.45 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 116.414 -0.357 . . . . 74.43 111.141 -166.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.462 HD13 ' HG3' ' C' ' 130' ' ' PRO . 73.4 mt -120.3 138.51 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 124.37 1.068 . . . . 75.04 108.969 173.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -158.37 176.08 12.9 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.288 0.992 . . . . 74.25 111.511 -171.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.0 p -106.13 119.4 39.11 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.657 -1.238 . . . . 72.24 107.657 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -80.02 -48.58 13.09 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.841 -0.8 . . . . 71.41 108.841 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 22.7 m-20 -134.55 125.23 26.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.611 -1.177 . . . . 70.21 109.014 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 79.3 mt -117.62 144.28 25.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 106.775 -1.565 . . . . 73.23 106.775 173.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 43.2 t -152.41 142.16 21.95 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.102 0.477 . . . . 60.22 109.777 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.572 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 35.4 t80 -144.33 124.09 13.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.802 -1.555 . . . . 74.23 106.802 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.97 111.55 10.51 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.312 -0.996 . . . . 74.2 108.312 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.22 81.71 17.24 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.903 0.881 . . . . 74.41 109.274 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 72' ' ' THR . 22.0 Cg_exo -66.99 -14.46 43.76 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.077 2.518 . . . . 75.32 112.328 174.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.5 ' HB2' ' HA ' ' A' ' 73' ' ' ALA . 21.9 m-80 -117.35 30.15 7.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.853 0.861 . . . . 73.24 110.395 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.52 98.23 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 123.717 0.807 . . . . 64.31 113.006 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -85.12 -24.8 1.95 Allowed 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 121.644 1.563 . . . . 72.01 113.188 169.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.467 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 58.9 m170 -70.97 -34.72 71.7 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.123 0.569 . . . . 74.14 110.922 -173.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -55.86 -31.77 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.495 1.118 . . . . 72.44 112.388 -175.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.67 -32.82 70.22 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.652 0.781 . . . . 64.33 111.347 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -88.84 -45.2 9.93 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.132 0.973 . . . . 74.43 111.647 -174.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 16.1 ptpt -83.32 173.59 11.44 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.821 0.848 . . . . 74.43 111.548 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -74.27 142.7 45.24 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.565 0.746 . . . . 62.21 111.514 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -93.2 78.65 4.52 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.522 0.677 . . . . 71.41 109.832 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -125.86 79.98 67.83 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.363 -0.977 . . . . 74.43 108.363 169.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -84.15 136.23 6.72 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.354 2.036 . . . . 73.52 112.315 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -96.44 102.05 13.77 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.154 -1.424 . . . . 75.03 107.154 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.7 p -76.87 100.1 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 115.451 -0.795 . . . . 74.12 109.98 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.473 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 63.3 mttp -78.98 111.02 14.76 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.74 -1.208 . . . . 72.02 107.74 164.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.4 tp -109.48 133.31 53.23 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.895 -1.15 . . . . 74.45 107.895 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.404 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 24.4 t70 -135.93 129.42 32.18 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.91 -0.774 . . . . 75.41 108.91 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.2 mt -112.12 132.05 55.09 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.903 0.881 . . . . 73.5 109.013 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.76 147.73 52.46 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.709 0.803 . . . . 73.45 108.85 172.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.0 m -131.49 131.78 43.73 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.553 0.741 . . . . 61.55 109.825 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.82 154.34 50.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.144 0.978 . . . . 72.21 110.115 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 26.5 t -131.87 155.77 47.26 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.731 0.413 . . . . 74.23 110.284 174.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.7 p -148.76 141.21 24.27 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.572 0.749 . . . . 74.41 109.911 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -81.68 106.68 13.81 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.734 0.414 . . . . 74.35 110.479 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.6 HD12 ' HB2' ' A' ' 57' ' ' GLU . 34.1 mt -83.3 -36.3 24.58 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.263 -0.643 . . . . 74.42 109.263 173.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.42 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -155.82 177.27 11.6 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.765 1.226 . . . . 74.43 108.647 173.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -68.5 116.31 8.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.012 -0.736 . . . . 65.31 109.012 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 70.6 12.24 7.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.811 1.244 . . . . 75.1 112.476 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 42.8 t -120.38 112.41 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 107.71 -1.218 . . . . 70.44 107.71 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.81 134.43 45.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.464 0.706 . . . . 74.45 110.469 -169.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.6 ' HB2' HD12 ' A' ' 51' ' ' LEU . 33.5 tt0 -88.17 137.5 32.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.503 -0.925 . . . . 74.44 108.503 173.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.9 136.67 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.517 -1.29 . . . . 72.41 107.517 168.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.6 111.64 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.18 0.992 . . . . 74.53 108.69 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -92.23 102.3 14.81 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.168 -1.049 . . . . 74.52 108.168 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -84.33 106.76 16.19 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.002 -0.74 . . . . 75.3 109.002 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.0 t -104.35 103.97 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.834 -0.802 . . . . 61.44 108.834 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.573 HG22 ' HG3' ' A' ' 77' ' ' GLU . 74.9 p -100.35 111.96 24.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.487 0.715 . . . . 53.44 109.977 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.441 ' O ' HD13 ' A' ' 75' ' ' LEU . 92.3 t -102.9 113.83 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.059 0.944 . . . . 74.33 108.858 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 10.8 m -116.66 105.62 12.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.741 -0.837 . . . . 75.12 108.741 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.27 106.36 18.01 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 106.378 -1.712 . . . . 71.42 106.378 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 p -149.29 128.67 12.97 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.822 0.702 . . . . 74.4 110.171 -168.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.6 tp -91.3 87.22 6.39 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.678 -0.86 . . . . 72.14 108.678 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.45 -93.31 1.86 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 114.849 -1.069 . . . . 74.41 111.724 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -113.62 -27.24 7.92 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.031 0.532 . . . . 73.4 111.526 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.424 ' HG2' ' HZ2' ' A' ' 34' ' ' LYS . 5.1 mp0 -79.58 106.62 11.75 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 122.421 0.288 . . . . 73.24 110.226 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.424 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 26.8 m -76.1 116.53 16.89 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.682 -0.69 . . . . 73.44 109.327 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . . . -68.03 -50.87 52.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.911 0.884 . . . . 74.42 108.768 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.462 ' HB2' ' HE1' ' A' ' 23' ' ' PHE . 47.3 p90 -156.78 147.58 21.74 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.982 -1.463 . . . . 74.33 109.863 173.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 53.8 tp -123.02 107.85 12.26 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 107.622 -1.251 . . . . 75.33 107.622 175.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.423 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 79.8 m -106.85 99.31 8.88 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.296 0.639 . . . . 74.12 109.729 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.573 ' HG3' HG22 ' A' ' 63' ' ' THR . 32.4 tt0 -115.08 118.28 32.94 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.901 0.88 . . . . 72.52 109.309 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.4 t -130.2 109.27 17.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.617 0.722 . . . . 74.33 109.459 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -86.44 80.26 8.72 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.137 -1.392 . . . . 71.25 108.147 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -76.93 111.65 12.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.875 -1.057 . . . . 73.3 108.622 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.17 144.07 17.03 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.829 -0.508 . . . . 71.31 111.829 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.0 145.11 15.55 Favored Glycine 0 C--O 1.236 0.247 0 N-CA-C 111.283 -0.727 . . . . 63.5 111.283 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.4 mt -81.32 123.38 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 108.488 -0.93 . . . . 75.24 108.488 173.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.664 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.1 m-85 -130.18 116.35 18.31 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.804 -0.813 . . . . 74.43 108.804 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.7 p -85.7 102.98 14.08 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.203 -1.036 . . . . 75.53 108.203 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.0 pt -115.36 130.98 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.908 0.883 . . . . 74.41 109.096 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.22 147.0 30.99 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.908 0.883 . . . . 72.22 109.963 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.66 1.56 57.58 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 115.007 0.763 . . . . 62.44 115.007 171.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.53 154.72 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 118.105 0.952 . . . . 74.53 111.369 -176.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.599 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 10.8 tt0 -155.02 -174.68 5.08 Favored 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 123.931 0.892 . . . . 65.41 109.3 173.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.599 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 73.2 -139.02 26.24 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 123.331 0.491 . . . . 73.53 114.188 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.1 p -73.88 -20.88 60.28 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.441 0.696 . . . . 62.21 111.233 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -66.48 -48.14 70.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.854 0.862 . . . . 72.15 110.114 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 91' ' ' GLY . 24.7 ptt? -70.03 -30.95 68.37 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 116.136 -0.484 . . . . 73.22 110.342 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.24 -34.55 77.69 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.158 0.583 . . . . 64.45 110.56 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -71.85 -35.88 69.97 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.39 -0.823 . . . . 65.03 110.11 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.484 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 49.9 t -66.88 -43.29 83.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.962 0.505 . . . . 72.33 111.346 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.83 -38.19 23.37 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.258 -0.428 . . . . 74.43 110.785 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.91 3.03 57.06 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 114.365 0.506 . . . . 74.33 114.365 -169.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -146.87 -60.24 0.29 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.182 0.491 . . . . 75.44 111.577 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 77.2 t80 -68.89 -49.56 57.2 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.25 1.02 . . . . 71.33 113.126 -166.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.08 -34.46 0.95 Allowed Pre-proline 0 CA--C 1.565 1.55 0 N-CA-C 113.513 0.931 . . . . 74.11 113.513 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.24 -21.11 55.39 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 121.601 1.534 . . . . 74.25 113.184 165.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 3.6 m120 -62.1 -38.69 89.85 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 118.197 0.453 . . . . 75.33 110.211 169.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 13' ' ' ILE . 40.0 mm -63.04 -45.37 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 O-C-N 124.004 0.815 . . . . 74.13 110.138 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.56 -20.13 51.27 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.01 0.924 . . . . 74.43 112.781 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -62.8 -45.32 87.65 Favored Pre-proline 0 CA--C 1.569 1.705 0 N-CA-C 113.719 1.007 . . . . 75.32 113.719 -173.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -63.71 -36.15 53.65 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.1 1.867 . . . . 75.34 113.459 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -71.11 -40.45 71.46 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.018 0.527 . . . . 75.21 111.156 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.62 -43.97 83.33 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.307 0.643 . . . . 72.41 110.003 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.419 ' NH1' HD11 ' C' ' 105' ' ' ILE . 38.1 ttm180 -51.59 -51.43 55.64 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.612 1.195 . . . . 63.15 110.509 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.22 -41.9 96.81 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.439 1.087 . . . . 74.21 111.556 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.17 -29.42 69.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 116.095 -0.502 . . . . 72.44 111.412 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.6 mt -78.63 -40.14 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.359 1.063 . . . . 73.44 110.331 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.454 HG23 ' HG3' ' A' ' 125' ' ' GLN . 34.4 m -66.53 -43.55 84.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.46 0.648 . . . . 75.4 110.638 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.5 t -64.43 -44.44 91.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.033 -0.985 . . . . 74.52 109.519 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 76' ' ' CYS . 43.2 ttm -60.27 -46.53 89.48 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.229 1.012 . . . . 71.24 112.242 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 123' ' ' PHE . 7.2 p -69.71 -31.05 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.133 0.573 . . . . 62.45 110.616 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.2 m -77.06 -29.73 55.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.425 0.69 . . . . 71.41 111.213 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -70.77 -31.92 68.87 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.626 0.77 . . . . 74.44 109.832 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.23 -2.26 90.4 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-N 115.779 -0.646 . . . . 62.02 113.209 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.9 m 65.34 36.53 6.86 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-O 122.824 1.297 . . . . 75.43 110.939 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.406 ' HB2' HG21 ' A' ' 118' ' ' VAL . 95.9 m-85 -104.91 164.39 15.26 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.308 1.043 . . . . 64.43 108.904 171.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -59.59 153.35 55.83 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 122.322 2.014 . . . . 71.41 112.504 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.454 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.7 tt0 -63.77 139.12 58.74 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.447 0.699 . . . . 61.02 111.16 -177.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.6 tp -131.3 116.42 17.58 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.307 -0.861 . . . . 73.42 109.093 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -121.03 117.83 28.25 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.252 -1.018 . . . . 74.43 108.252 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.78 122.32 13.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.312 0.645 . . . . 65.45 110.082 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.57 128.65 90.4 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-O 119.17 -0.443 . . . . 63.12 109.881 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.18 100.23 0.31 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.657 2.238 . . . . 70.24 111.584 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.3 m -100.06 138.0 25.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-N 115.623 -0.717 . . . . 74.21 109.441 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -83.1 87.46 6.91 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.079 -0.964 . . . . 74.55 109.046 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.486 ' HA ' HD11 ' A' ' 136' ' ' LEU . 58.4 m-85 -56.03 -27.49 53.38 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.642 0.777 . . . . 75.13 112.559 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.21 -51.29 61.88 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.017 0.527 . . . . 73.44 110.25 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.52 85.63 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.007 0.817 . . . . 64.3 110.896 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.486 HD11 ' HA ' ' A' ' 133' ' ' PHE . 61.1 mt -67.52 -38.68 84.62 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.159 0.983 . . . . 75.0 111.06 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.7 -38.54 86.94 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.716 -0.675 . . . . 74.45 109.495 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 19.8 mmt . . . . . 0 C--N 1.348 0.517 0 O-C-N 124.221 0.951 . . . . 73.11 110.34 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 87.1 m . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.457 -0.572 . . . . 74.54 109.457 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -129.52 137.64 50.9 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.588 -0.893 . . . . 72.12 108.588 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -149.92 130.79 14.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.084 -0.71 . . . . 72.14 109.084 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.435 HD11 HD12 ' B' ' 105' ' ' ILE . 20.6 mt -76.52 118.09 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.738 -1.208 . . . . 74.34 107.738 166.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -86.22 -49.36 7.77 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.665 -0.865 . . . . 74.34 108.665 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.417 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 74.1 ttt180 -164.99 138.27 4.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.867 -1.061 . . . . 74.42 109.069 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.9 mt -115.6 141.92 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.321 -0.992 . . . . 74.13 108.321 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -164.12 147.2 9.45 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.767 0.427 . . . . 75.32 111.321 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.514 HG23 HD13 ' B' ' 21' ' ' ILE . 24.5 m -78.57 130.45 35.95 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.197 -1.038 . . . . 73.34 108.197 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -93.17 -47.48 6.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.58 0.752 . . . . 75.14 110.083 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.33 141.05 39.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.162 -0.927 . . . . 72.5 110.856 -171.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.517 HD13 ' SG ' ' B' ' 113' ' ' CYS . 48.4 mm -131.44 144.91 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.914 1.286 . . . . 74.03 108.26 171.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.7 t -145.63 129.12 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.077 -1.453 . . . . 75.51 107.077 173.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.57 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.3 t80 -143.31 107.04 4.63 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 106.517 -1.66 . . . . 74.42 106.517 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -118.1 112.51 20.3 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.079 -1.082 . . . . 73.34 108.079 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.3 85.46 2.15 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.939 -1.504 . . . . 61.54 106.939 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.96 -26.21 26.88 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.92 2.413 . . . . 75.11 112.156 -166.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -114.4 15.47 17.94 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.979 -1.009 . . . . 63.3 110.34 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.88 -61.99 0.97 Allowed Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 115.19 1.552 . . . . 71.14 115.19 -163.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.62 -27.05 39.14 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 121.831 1.687 . . . . 74.22 113.023 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -89.01 -38.87 14.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.994 0.518 . . . . 71.22 111.733 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' B' ' 73' ' ' ALA . 13.3 p -69.71 -16.09 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.209 0.604 . . . . 72.42 111.128 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -68.33 -4.07 13.18 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.483 0.713 . . . . 74.54 112.791 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.472 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.4 pt20 -68.34 -23.41 64.7 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.919 0.487 . . . . 72.12 110.219 168.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.472 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 86.7 mttt -107.88 79.02 1.23 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.829 1.251 . . . . 75.02 108.648 177.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -80.12 86.51 5.55 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.717 0.77 . . . . 75.34 109.35 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.0 t-105 -150.87 155.9 40.12 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.891 1.276 . . . . 72.44 107.594 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -70.76 99.99 0.26 Allowed Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 125.916 1.686 . . . . 74.55 110.576 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.615 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 49.0 Cg_endo -67.65 137.43 42.32 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.557 2.171 . . . . 73.23 112.535 -173.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -54.89 123.33 13.11 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.04 0.838 . . . . 73.54 109.764 173.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -104.33 157.19 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.443 0.64 . . . . 73.11 111.682 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -142.14 127.7 19.04 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.565 -1.643 . . . . 60.14 106.565 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.504 ' H ' HD22 ' B' ' 42' ' ' LEU . 2.6 pt? -104.41 151.88 22.98 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.834 0.453 . . . . 73.42 110.607 -175.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -143.19 116.19 8.85 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.603 -0.888 . . . . 75.45 108.603 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 mt -99.26 156.9 16.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.716 0.406 . . . . 64.42 110.166 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.483 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 11.6 m-20 -141.57 111.39 6.63 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.121 -1.066 . . . . 75.51 108.121 167.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -109.82 104.06 12.95 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.74 -0.467 . . . . 71.51 109.74 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.84 152.78 34.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.237 1.015 . . . . 75.31 109.434 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -137.58 161.84 35.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.033 0.533 . . . . 73.03 109.916 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -163.32 160.85 24.22 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.059 0.543 . . . . 73.41 110.241 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -91.47 123.03 34.58 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.124 0.57 . . . . 75.34 110.273 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.546 HD12 HG22 ' B' ' 83' ' ' ILE . 81.1 mt -87.33 -43.77 11.9 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.718 0.807 . . . . 72.34 109.107 167.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.61 -170.54 3.11 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.58 -1.191 . . . . 74.51 110.033 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.98 111.95 2.38 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.598 -0.728 . . . . 73.2 110.429 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 43.7 m-20 70.23 0.38 3.14 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.256 1.423 . . . . 74.0 112.838 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.8 t -104.18 102.88 14.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.526 -0.916 . . . . 62.4 108.526 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -99.73 146.99 25.92 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.64 -1.164 . . . . 74.31 109.643 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -109.4 116.55 32.03 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.465 -1.309 . . . . 70.34 107.465 165.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 52.3 t -96.01 143.37 12.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.526 -0.916 . . . . 75.32 108.526 172.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.2 t -131.89 137.36 55.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.959 -0.756 . . . . 74.21 108.959 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.411 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -122.85 109.59 14.38 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.176 -1.416 . . . . 75.44 107.176 -177.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 40.7 ttm180 -95.25 130.94 41.8 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.543 -0.54 . . . . 73.23 109.543 170.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.407 ' HB ' HD11 ' B' ' 114' ' ' ILE . 37.0 t -120.62 106.13 18.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.192 -1.41 . . . . 74.34 107.192 169.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -96.13 146.62 24.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.11 -1.07 . . . . 75.15 108.11 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 71.1 t -138.4 130.12 37.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.284 1.034 . . . . 75.01 108.466 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 98.3 m -117.39 136.95 52.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.385 -0.969 . . . . 72.51 108.385 172.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.12 143.79 50.25 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.473 0.483 . . . . 74.11 110.289 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 44.3 p -133.68 127.03 32.05 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 123.959 0.787 . . . . 74.31 110.771 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.615 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 34.1 mt -105.88 114.64 28.9 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.116 0.966 . . . . 74.4 108.697 171.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.37 -111.73 3.94 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.537 -1.025 . . . . 75.04 110.537 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.23 4.58 11.28 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.527 0.731 . . . . 72.13 111.027 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -114.47 160.64 18.97 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.424 0.69 . . . . 75.31 109.583 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.3 m -72.24 135.07 45.94 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.543 -0.54 . . . . 75.02 109.543 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.809 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -88.72 -59.62 2.18 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.411 -0.959 . . . . 61.41 108.411 175.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . 0.624 ' HZ ' HD11 ' B' ' 126' ' ' LEU . 52.5 p90 -151.96 170.08 20.74 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 113.973 -1.467 . . . . 74.32 109.821 176.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.7 mt -133.05 138.86 46.9 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.878 -1.897 . . . . 75.3 105.878 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.459 ' SG ' HG21 ' B' ' 114' ' ' ILE . 38.0 t -141.1 150.95 43.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.882 -0.784 . . . . 73.42 108.882 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.8 tt0 -164.37 132.55 3.45 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.034 -0.728 . . . . 62.21 109.034 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 98.6 t -128.94 147.67 33.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.474 -0.936 . . . . 74.33 108.474 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -123.15 93.13 3.86 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.293 -1.002 . . . . 74.3 108.293 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.461 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.9 tp-100 -82.79 100.89 10.58 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.702 -1.135 . . . . 72.4 109.014 177.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.51 163.73 31.36 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 111.02 -0.832 . . . . 74.44 111.02 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.3 128.23 1.73 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.936 -0.866 . . . . 72.42 110.936 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.546 HG22 HD12 ' B' ' 51' ' ' LEU . 30.8 mt -84.6 133.65 28.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.619 0.768 . . . . 72.41 109.077 173.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' B' ' 102' ' ' CYS . 22.8 m-85 -138.04 135.52 35.96 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.033 -0.728 . . . . 75.0 109.033 174.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -97.44 107.97 20.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.57 0.748 . . . . 73.3 108.995 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 43.0 pt -111.79 145.06 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.758 0.823 . . . . 74.14 110.377 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -144.32 158.1 43.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.702 0.801 . . . . 74.24 109.741 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.08 -65.14 4.12 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.557 0.536 . . . . 63.45 112.574 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.421 HD11 ' HB ' ' B' ' 86' ' ' ILE . 25.7 pt -58.15 144.01 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.225 1.01 . . . . 75.54 112.491 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -150.66 149.88 30.4 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.246 -0.888 . . . . 73.32 109.458 -171.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.3 -115.6 8.13 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.905 0.753 . . . . 63.24 113.013 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 24.7 m -67.14 -31.43 71.87 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.824 0.85 . . . . 74.42 112.003 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.93 -47.82 73.43 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.191 0.596 . . . . 74.11 110.81 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.528 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 12.3 ptp -72.91 -29.47 63.16 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-O 119.077 -0.487 . . . . 73.4 110.113 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.89 -32.16 71.63 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.824 0.45 . . . . 52.04 111.053 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.404 ' O ' ' HB1' ' B' ' 100' ' ' ALA . 28.0 t-80 -72.42 -30.44 64.62 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.961 0.504 . . . . 74.55 110.971 174.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.573 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 85.9 m -76.71 -71.69 0.38 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 110.385 -0.228 . . . . 75.32 110.385 176.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.4 pp -71.42 -14.41 62.15 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.384 0.883 . . . . 60.54 113.384 -171.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.89 0.33 36.04 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-O 119.488 -0.618 . . . . 75.04 113.93 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' B' ' 96' ' ' HIS . . . -152.42 -62.1 0.16 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.741 0.771 . . . . 74.33 112.4 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.573 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 90.0 t80 -70.18 -47.28 62.25 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.101 0.96 . . . . 74.52 112.205 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.424 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 71.5 m -62.7 -49.15 84.01 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.15 0.98 . . . . 65.23 111.428 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 86.3 Cg_exo -54.05 -35.33 81.0 Favored 'Trans proline' 0 C--N 1.397 3.099 0 C-N-CA 122.043 1.829 . . . . 64.35 114.128 167.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -62.9 -37.26 86.25 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 123.202 0.601 . . . . 75.13 110.468 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.435 HD12 HD11 ' B' ' 13' ' ' ILE . 68.1 mt -66.18 -41.83 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.958 0.903 . . . . 74.33 110.458 174.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 67.5 mt -78.73 -19.19 52.92 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.427 -0.806 . . . . 75.42 112.12 -175.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -58.79 -49.15 94.98 Favored Pre-proline 0 N--CA 1.483 1.214 0 CA-C-O 117.829 -1.081 . . . . 72.04 113.515 -171.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.41 -38.26 89.39 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.194 1.929 . . . . 74.55 113.723 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.461 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 83.4 m-85 -68.53 -48.66 63.75 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 123.516 0.51 . . . . 74.03 110.527 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.34 -42.25 91.04 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.557 0.743 . . . . 74.53 111.304 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.54 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 54.3 ttt-85 -61.58 -53.22 59.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.802 1.641 . . . . 73.25 110.946 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -68.27 -30.27 69.26 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.987 0.805 . . . . 74.33 110.198 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.517 ' SG ' HD13 ' B' ' 21' ' ' ILE . 5.4 t -69.0 -41.11 78.26 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.833 0.453 . . . . 73.43 111.131 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.459 HG21 ' SG ' ' B' ' 76' ' ' CYS . 73.0 mt -60.55 -52.4 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.609 -0.515 . . . . 74.54 109.609 172.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 62.9 m -56.12 -34.45 66.09 Favored 'General case' 0 CA--C 1.554 1.124 0 O-C-N 124.477 1.111 . . . . 71.45 111.988 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.6 t -66.72 -49.06 67.26 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 123.229 0.612 . . . . 65.4 109.873 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.485 ' SD ' HG21 ' A' ' 21' ' ' ILE . 34.5 mmt -61.5 -41.41 97.25 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.095 0.558 . . . . 74.44 111.155 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.407 HG23 ' O ' ' B' ' 114' ' ' ILE . 78.2 t -62.77 -43.7 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.427 1.091 . . . . 71.11 110.851 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.8 t -65.65 -36.84 84.83 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.821 -1.081 . . . . 72.0 111.607 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -67.69 -36.74 81.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.026 -0.988 . . . . 75.42 110.47 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.51 6.99 59.35 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.334 -0.703 . . . . 63.24 113.084 176.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 72.0 p 59.38 22.0 10.38 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.378 1.871 . . . . 70.41 113.332 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -85.13 151.79 57.56 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.61 0.764 . . . . 73.4 109.963 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.36 156.98 3.5 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 124.242 3.294 . . . . 73.44 116.328 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -65.86 117.8 8.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.229 -1.35 . . . . 73.11 111.844 -173.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.624 HD11 ' HZ ' ' B' ' 74' ' ' PHE . 22.5 mt -113.44 120.26 40.42 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.029 -0.73 . . . . 71.15 109.029 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -123.21 96.22 4.91 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 107.895 -1.15 . . . . 72.54 107.895 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.54 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.1 mm? -61.72 149.82 38.56 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.825 0.85 . . . . 75.11 112.334 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.63 151.25 87.02 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.987 0.915 . . . . 64.21 110.659 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.95 104.81 1.41 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.501 2.134 . . . . 72.13 111.634 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.0 t -90.57 108.66 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.277 -1.008 . . . . 73.44 108.277 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -90.07 98.36 11.73 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.1 -1.074 . . . . 71.01 108.1 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -61.92 -32.97 73.42 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.289 -0.869 . . . . 74.53 111.41 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.33 -39.3 78.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.716 1.207 . . . . 71.01 111.823 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.17 -41.17 90.67 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.312 0.645 . . . . 73.12 110.207 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.28 -37.27 85.05 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.685 -1.143 . . . . 74.24 110.965 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 60.3 t80 . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 123.64 0.776 . . . . 73.3 110.668 -178.268 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.718 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 64.4 m . . . . . 0 C--O 1.24 0.556 0 N-CA-C 108.04 -1.096 . . . . 70.24 108.04 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.498 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 44.9 t80 -102.02 128.93 48.24 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.556 -0.905 . . . . 72.11 108.556 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -137.56 126.35 23.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.949 -0.76 . . . . 72.11 108.949 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 83.8 mt -77.38 122.17 31.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.659 -0.867 . . . . 73.23 108.659 172.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -91.15 -39.22 12.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.228 -0.896 . . . . 65.44 109.712 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -172.59 144.75 1.48 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.101 -0.703 . . . . 73.34 109.101 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 92.3 mt -134.07 137.69 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.769 -1.197 . . . . 72.11 107.769 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.439 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 32.2 p90 -169.58 171.94 7.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.872 0.844 . . . . 73.51 111.458 -173.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.1 p -96.77 118.35 33.02 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.222 -0.899 . . . . 72.5 109.061 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.513 ' HE3' ' HA3' ' C' ' 81' ' ' GLY . 21.5 mmtp -67.37 -48.97 65.88 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.66 -1.237 . . . . 74.41 107.66 171.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -137.61 142.92 41.25 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 112.974 -1.921 . . . . 72.32 109.6 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 76.0 mt -136.5 144.07 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 106.283 -1.747 . . . . 74.41 106.283 172.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -160.51 146.92 15.39 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.372 0.606 . . . . 73.41 110.824 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -139.03 135.13 33.91 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.2 -1.407 . . . . 75.44 107.2 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 38.8 mt-10 -135.36 114.45 12.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.729 0.812 . . . . 64.21 109.988 -176.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.86 83.88 33.63 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 107.112 -1.44 . . . . 73.03 107.112 170.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -70.34 -19.85 32.83 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.048 2.499 . . . . 72.44 112.684 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -116.33 24.85 11.07 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.775 1.23 . . . . 72.52 110.06 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.87 -57.66 5.68 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 114.483 1.29 . . . . 73.43 114.483 -169.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.3 -36.56 55.74 Favored 'Trans proline' 0 C--N 1.388 2.655 0 CA-C-N 121.542 1.586 . . . . 73.33 112.172 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.519 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 68.3 t60 -69.9 -32.99 71.61 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.417 -0.81 . . . . 75.12 112.36 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.685 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.0 p -81.54 -22.12 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 N-CA-C 112.731 0.641 . . . . 75.23 112.731 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -64.33 -23.79 67.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.628 -0.67 . . . . 73.23 112.682 175.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.6 pt20 -88.48 8.32 28.56 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.952 0.501 . . . . 73.23 111.301 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' C' ' 31' ' ' VAL . 1.1 mptm? -92.52 177.87 5.99 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 122.255 1.026 . . . . 64.22 113.24 -172.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -87.47 114.04 23.72 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 112.905 -1.952 . . . . 74.44 108.074 168.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 51.5 t90 -84.48 71.32 10.73 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.742 0.782 . . . . 72.21 110.939 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -132.92 69.59 79.01 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 123.966 0.906 . . . . 74.22 109.034 170.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -87.95 158.05 7.3 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.046 2.497 . . . . 75.15 113.73 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.97 96.43 8.84 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 107.284 -1.376 . . . . 64.51 107.284 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 m -79.28 128.25 38.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-O 121.705 0.764 . . . . 63.35 110.373 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -132.65 113.54 13.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.503 1.121 . . . . 72.14 108.338 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 72.2 mt -86.0 158.79 19.78 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.825 -0.806 . . . . 75.23 108.825 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.581 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.7 t70 -137.4 105.14 5.58 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.602 -1.258 . . . . 73.32 107.602 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.27 129.49 43.58 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.044 -0.724 . . . . 75.33 109.044 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -144.24 125.01 14.16 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.57 -0.9 . . . . 74.32 108.57 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 5.2 t -116.46 139.78 50.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.447 -0.575 . . . . 72.33 109.447 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.45 135.61 37.03 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.106 0.962 . . . . 71.01 108.406 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 13.0 p -136.38 151.12 49.21 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 109.314 -0.625 . . . . 73.13 109.314 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 70.0 p -156.65 143.73 18.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.369 0.668 . . . . 74.03 109.765 -174.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -78.93 118.1 20.63 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.326 0.65 . . . . 64.52 109.991 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.652 HD12 ' HB2' ' C' ' 57' ' ' GLU . 68.8 mt -89.26 -29.73 19.0 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.05 0.54 . . . . 75.42 110.13 174.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.47 172.67 16.81 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.787 1.235 . . . . 45.53 109.034 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -57.37 128.58 37.75 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.842 -0.799 . . . . 72.11 108.842 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 69.48 -1.85 2.1 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.42 1.088 . . . . 73.05 113.015 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -111.95 117.56 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.338 0.655 . . . . 72.22 109.373 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -124.85 126.46 45.61 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.041 0.936 . . . . 60.32 109.983 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.652 ' HB2' HD12 ' C' ' 51' ' ' LEU . 21.5 tt0 -83.62 133.0 34.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.936 -1.135 . . . . 73.42 107.936 165.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.47 140.35 47.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 N-CA-C 108.842 -0.799 . . . . 75.53 108.842 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 81.6 t -124.56 133.18 70.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.838 1.255 . . . . 73.12 107.629 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' C' ' 107' ' ' PHE . 1.0 OUTLIER -125.2 104.81 8.71 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.237 -1.394 . . . . 73.24 107.237 174.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.45 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 1.9 ttm180 -86.69 130.01 34.65 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 113.886 -1.506 . . . . 70.43 109.127 177.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.1 124.81 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.458 -1.312 . . . . 73.01 107.458 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.581 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 32.7 m -124.52 131.18 53.49 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.855 -0.794 . . . . 75.15 108.855 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.426 HG23 HG21 ' C' ' 114' ' ' ILE . 23.4 t -107.49 126.65 63.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.003 -0.74 . . . . 72.24 109.003 173.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -116.25 145.43 43.15 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.935 -1.135 . . . . 75.43 107.935 173.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.54 128.02 20.08 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.053 -0.721 . . . . 73.24 109.053 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.8 m -128.01 126.03 40.54 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 123.196 0.598 . . . . 73.0 110.141 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 39.5 mt -88.47 37.7 0.84 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.589 1.156 . . . . 73.11 110.198 172.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.6 -96.08 1.52 Allowed Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.374 -1.09 . . . . 73.42 110.374 -173.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -107.1 -5.46 18.01 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.313 1.045 . . . . 72.31 110.839 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.447 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 4.0 tp10 -103.17 121.14 42.04 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.526 1.131 . . . . 70.11 109.062 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 35.6 m -69.32 126.95 31.36 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.779 0.718 . . . . 70.45 109.07 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.685 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.42 -54.64 6.44 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.093 -0.706 . . . . 73.32 109.093 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -169.08 168.87 9.79 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 114.836 -1.074 . . . . 74.24 111.097 175.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -140.08 143.83 36.51 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 106.883 -1.525 . . . . 74.15 106.883 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 43.8 t -153.24 116.19 4.55 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.726 -0.472 . . . . 74.45 109.726 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -117.6 133.01 56.41 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.722 0.409 . . . . 74.31 110.086 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 84.6 t -126.57 138.07 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.225 1.01 . . . . 64.34 108.39 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.45 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 66.7 mt-30 -115.11 97.14 6.04 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.349 -0.982 . . . . 72.32 108.349 173.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.418 ' HG3' HD22 ' C' ' 106' ' ' LEU . 8.7 tp-100 -86.63 104.52 16.13 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.572 0.749 . . . . 72.5 110.683 -174.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.513 ' HA3' ' HE3' ' C' ' 19' ' ' LYS . . . -110.42 143.78 16.96 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 121.532 -0.366 . . . . 73.32 112.729 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.03 142.06 10.22 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 111.361 -0.696 . . . . 53.3 111.361 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' D' ' 29' ' ' PRO . 14.4 mm -90.72 126.39 43.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.557 -0.905 . . . . 72.55 108.557 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -132.27 128.76 38.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.955 0.902 . . . . 55.13 109.19 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.8 p -96.78 126.1 41.7 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 109.225 -0.657 . . . . 55.33 109.225 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -115.48 143.9 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.89 1.276 . . . . 73.25 109.577 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.718 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -144.31 142.9 30.71 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.67 0.388 . . . . 65.34 110.953 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.71 -18.08 48.93 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 114.635 0.614 . . . . 73.13 114.635 175.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 38.5 pt -113.43 154.13 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 117.406 0.603 . . . . 75.42 112.227 -172.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.454 ' HA ' ' HE2' ' C' ' 94' ' ' MET . 12.7 pt-20 -164.57 -178.68 5.5 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.163 0.985 . . . . 71.4 109.798 173.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.12 -123.5 33.24 Favored Glycine 0 C--N 1.352 1.458 0 O-C-N 123.427 0.454 . . . . 44.43 114.005 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 74.0 p -70.64 -32.25 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.048 0.939 . . . . 75.24 111.258 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -69.09 -36.15 77.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.342 0.657 . . . . 73.32 110.987 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.454 ' HE2' ' HA ' ' C' ' 90' ' ' GLU . 46.8 ttm -76.81 -32.89 57.94 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.496 -0.32 . . . . 74.24 110.267 174.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.89 -41.02 73.84 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.55 0.532 . . . . 72.23 110.275 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.45 ' HE2' ' HA ' ' C' ' 134' ' ' ASP . 11.9 t-80 -81.24 -30.59 34.1 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.438 0.461 . . . . 74.51 111.705 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 23.0 t -62.09 -39.22 91.74 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.416 0.448 . . . . 74.42 110.666 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.32 -14.32 24.02 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.091 0.556 . . . . 62.1 110.718 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.05 -29.99 61.83 Favored Glycine 0 C--N 1.357 1.696 0 O-C-N 123.279 0.362 . . . . 75.13 113.886 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.09 -38.65 0.06 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.201 0.815 . . . . 65.04 113.201 -170.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -62.42 -52.45 63.5 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.906 0.482 . . . . 73.3 111.322 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.498 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 58.8 m -72.9 -46.19 8.7 Favored Pre-proline 0 CA--C 1.563 1.452 0 CA-C-O 118.732 -0.652 . . . . 74.14 112.289 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 64.6 Cg_exo -54.33 -28.5 53.48 Favored 'Trans proline' 0 C--N 1.398 3.14 0 C-N-CA 122.321 2.014 . . . . 73.45 114.306 171.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -69.65 -35.79 75.49 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.458 0.703 . . . . 75.22 109.774 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.419 HD11 ' NH1' ' A' ' 111' ' ' ARG . 27.8 mm -64.94 -41.8 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.509 -0.552 . . . . 63.31 109.509 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.418 HD22 ' HG3' ' C' ' 80' ' ' GLN . 39.8 mt -79.03 -27.95 43.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.063 0.945 . . . . 72.54 113.015 -173.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.4 ' HA ' HD11 ' C' ' 60' ' ' LEU . 81.4 t80 -57.67 -49.82 91.59 Favored Pre-proline 0 CA--C 1.564 1.503 0 N-CA-C 114.337 1.236 . . . . 75.43 114.337 -171.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.93 -33.93 95.47 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 121.944 1.763 . . . . 75.02 112.905 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -69.19 -45.59 69.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.983 0.513 . . . . 72.22 110.502 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.25 -37.45 77.63 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.255 -0.884 . . . . 73.34 110.665 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -61.89 -58.94 6.0 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.863 -1.062 . . . . 60.45 110.621 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.03 78.66 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 110.137 -0.32 . . . . 73.32 110.137 -175.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.3 t -66.74 -28.65 68.58 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.974 0.509 . . . . 74.34 111.609 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.426 HG21 HG23 ' C' ' 64' ' ' VAL . 83.4 mt -77.13 -55.43 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 109.707 -0.479 . . . . 75.24 109.707 170.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.1 m -60.81 -28.62 68.92 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.211 1.005 . . . . 74.12 111.782 -170.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -68.84 -49.75 55.74 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.834 -0.802 . . . . 74.53 108.834 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.565 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.21 -34.84 75.75 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.561 1.144 . . . . 71.55 112.639 178.205 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.52 -48.16 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.743 0.817 . . . . 72.14 109.193 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 41.9 t -67.85 -28.87 67.92 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.811 -1.086 . . . . 72.44 111.911 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -71.31 -43.95 66.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.578 -0.897 . . . . 73.33 108.578 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.86 3.27 61.34 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 123.901 0.751 . . . . 61.32 113.036 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.447 HG21 ' HB3' ' D' ' 17' ' ' TYR . 33.1 p 60.23 38.35 20.06 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.694 1.998 . . . . 72.2 113.898 170.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -94.4 149.8 37.21 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 108.655 -0.869 . . . . 75.21 108.655 166.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.31 176.71 0.35 Allowed 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.309 2.673 . . . . 72.1 115.376 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -59.85 122.16 13.54 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.325 1.05 . . . . 75.4 113.747 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 mp -112.66 86.26 2.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.218 1.007 . . . . 64.13 109.48 171.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -107.47 107.98 19.09 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.816 -0.809 . . . . 71.52 108.816 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 59.5 mt -73.38 142.83 46.98 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.643 -0.708 . . . . 74.35 110.519 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.67 148.32 94.95 Favored Pre-proline 0 CA--C 1.55 0.975 0 O-C-N 123.844 0.715 . . . . 75.12 110.111 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.462 ' HG3' HD13 ' A' ' 16' ' ' ILE . 37.4 Cg_exo -57.42 120.38 8.26 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.581 2.188 . . . . 75.34 112.221 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 98.7 t -97.52 119.51 45.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.296 -1.001 . . . . 75.43 108.296 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -77.93 73.12 4.5 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.761 0.663 . . . . 73.31 110.378 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -56.95 -41.05 77.6 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.558 0.743 . . . . 72.3 110.595 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.45 ' HA ' ' HE2' ' C' ' 96' ' ' HIS . 23.3 m-20 -66.0 -49.49 67.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.069 -0.969 . . . . 72.21 111.762 -176.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.02 96.22 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.959 0.787 . . . . 74.01 111.033 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.29 -29.32 66.04 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.376 -0.829 . . . . 75.31 111.665 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 15.3 t80 . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 110.062 -0.347 . . . . 75.33 110.062 177.873 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.238 0.463 0 N-CA-C 109.959 -0.386 . . . . 72.24 109.959 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -152.68 94.31 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.654 -1.239 . . . . 72.24 107.654 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -123.18 116.84 24.08 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.516 0.727 . . . . 75.25 109.04 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.16 113.79 17.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.221 -1.029 . . . . 75.22 108.221 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -81.99 -22.93 36.31 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.604 0.761 . . . . 75.15 111.059 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -170.61 141.28 1.85 Allowed 'General case' 0 C--N 1.361 1.065 0 O-C-N 123.536 0.522 . . . . 73.43 111.234 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.414 ' N ' HD13 ' D' ' 16' ' ' ILE . 3.3 mp -119.7 133.93 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.683 -1.599 . . . . 72.14 106.683 169.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.452 ' HE1' HG13 ' D' ' 83' ' ' ILE . 20.7 p90 -163.13 163.08 25.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.407 0.622 . . . . 75.32 111.499 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -95.47 120.91 36.53 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.704 -0.85 . . . . 65.41 108.704 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.423 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 41.0 mtpt -83.92 -35.2 24.24 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.19 -0.67 . . . . 75.23 109.19 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.4 t70 -146.9 137.18 23.55 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.506 -1.225 . . . . 74.25 109.303 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.565 HG23 ' HE1' ' C' ' 117' ' ' MET . 78.5 mt -136.9 145.31 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.532 1.133 . . . . 71.12 107.976 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -146.77 135.98 22.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.11 0.964 . . . . 75.24 108.831 172.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.497 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.3 t80 -136.65 129.54 30.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 106.453 -1.684 . . . . 64.53 106.453 166.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 33.1 mt-10 -137.65 112.73 9.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.114 -1.069 . . . . 72.13 108.114 -172.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.88 88.34 2.89 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.568 -1.271 . . . . 74.43 107.568 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.08 -32.26 43.99 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.418 2.079 . . . . 73.02 112.695 -167.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.493 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 70.4 m-20 -113.94 14.42 18.48 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.969 0.908 . . . . 74.45 110.7 -177.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.418 ' O ' HG11 ' D' ' 31' ' ' VAL . . . -18.6 -74.34 0.02 OUTLIER Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 116.566 2.061 . . . . 71.33 116.566 -166.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.547 ' HB3' HD11 ' C' ' 83' ' ' ILE . 84.3 Cg_endo -77.26 -20.08 12.94 Favored 'Trans proline' 0 C--N 1.382 2.324 0 CA-C-N 124.377 2.599 . . . . 74.3 114.246 -176.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -70.81 -39.16 73.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.192 0.997 . . . . 73.33 109.635 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.7 p -84.22 -24.34 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 115.675 -0.693 . . . . 74.12 112.172 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -66.68 -22.36 66.08 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 112.675 0.621 . . . . 71.3 112.675 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -61.71 -22.82 65.68 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.752 0.821 . . . . 64.52 110.849 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.53 ' HZ1' ' HG2' ' D' ' 71' ' ' GLU . 99.4 mttt -88.69 96.23 10.57 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.5 1.12 . . . . 72.12 110.157 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.35 88.12 2.57 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.152 -0.476 . . . . 64.41 109.776 170.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -154.5 158.03 39.26 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.321 -0.992 . . . . 74.31 108.321 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -76.26 110.04 10.14 Favored Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 108.267 -1.012 . . . . 73.41 108.267 172.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -54.29 127.69 26.89 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.425 2.75 . . . . 72.11 113.584 -174.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 24.2 tt0 -56.61 111.84 1.12 Allowed 'General case' 0 C--N 1.368 1.387 0 O-C-N 124.208 0.942 . . . . 74.11 108.81 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.72 138.26 45.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.638 0.732 . . . . 74.03 110.437 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -129.87 124.15 32.53 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 106.389 -1.708 . . . . 74.32 106.389 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 51.4 tp -95.19 120.45 35.43 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.163 -0.68 . . . . 75.14 109.163 -172.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.577 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 10.8 m-20 -106.23 140.09 39.72 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.617 1.167 . . . . 60.0 107.942 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.47 168.21 19.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.27 0.557 . . . . 63.04 109.852 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 7.8 t70 -157.75 142.16 16.24 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.743 1.217 . . . . 52.21 107.726 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -114.8 144.42 43.53 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.405 0.621 . . . . 71.24 109.416 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.97 164.36 34.79 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.833 1.253 . . . . 74.31 107.815 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.5 p -168.85 158.47 8.9 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 123.599 0.562 . . . . 75.15 110.49 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 94.6 p -150.7 155.66 39.76 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.832 0.853 . . . . 71.13 109.704 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -91.34 119.0 31.0 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.55 -0.908 . . . . 64.43 108.55 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' D' ' 57' ' ' GLU . 58.7 mt -89.75 -40.52 12.45 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.195 0.598 . . . . 72.24 109.613 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.72 -171.24 3.48 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.964 0.906 . . . . 75.31 110.284 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.48 106.89 1.0 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.241 -0.891 . . . . 72.13 110.784 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 64.7 17.63 11.03 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.609 1.163 . . . . 72.13 112.168 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 91.0 t -109.52 105.13 18.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 107.122 -1.436 . . . . 74.3 107.122 170.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -121.98 126.73 49.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.261 -1.014 . . . . 75.34 108.261 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.473 ' HB2' HD12 ' D' ' 51' ' ' LEU . 19.3 tt0 -89.85 151.1 21.93 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.452 1.101 . . . . 70.12 108.707 174.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 91.4 t -131.81 128.52 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 C-N-CA 124.516 1.126 . . . . 70.14 108.11 172.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -104.87 130.51 55.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.331 1.052 . . . . 60.04 108.503 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.87 114.47 24.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.548 -0.908 . . . . 74.45 108.548 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.557 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.0 ttm-85 -96.36 101.3 12.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.194 -1.039 . . . . 72.42 108.194 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.5 t -100.84 103.67 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.57 -0.9 . . . . 60.11 108.57 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.577 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 6.0 m -100.64 137.3 39.22 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.063 0.945 . . . . 64.01 109.171 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.475 HG21 HG23 ' D' ' 114' ' ' ILE . 61.9 t -125.6 113.44 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.855 0.862 . . . . 72.5 109.516 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 12.6 m -103.11 119.53 39.02 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.765 -0.828 . . . . 62.21 108.765 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -135.81 152.06 50.7 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.917 0.487 . . . . 74.15 111.32 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 57.2 p -148.92 136.03 20.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.083 -0.508 . . . . 71.31 112.013 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.563 HD11 HG23 ' D' ' 31' ' ' VAL . 50.1 mt -102.49 96.36 6.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.46 1.104 . . . . 75.22 108.103 171.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.63 -139.1 20.49 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.129 -0.487 . . . . 63.24 113.11 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.05 0.76 46.98 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.91 0.484 . . . . 74.45 111.362 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.53 ' HG2' ' HZ1' ' D' ' 34' ' ' LYS . 11.1 pt-20 -118.74 152.66 35.75 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.704 0.802 . . . . 73.31 109.286 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.7 m -73.63 139.68 45.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.75 0.42 . . . . 74.12 110.671 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.722 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.41 -69.83 0.66 Allowed 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.388 -0.824 . . . . 70.31 108.953 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -149.13 138.85 21.86 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.251 -0.886 . . . . 73.21 109.516 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.1 mt -111.78 132.43 54.67 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.359 1.463 . . . . 74.24 107.167 172.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.488 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.7 t -141.56 147.07 37.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.485 -0.561 . . . . 74.2 109.485 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -156.15 130.39 8.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.581 -0.526 . . . . 64.41 109.581 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.12 114.7 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.558 0.743 . . . . 74.32 109.127 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.27 86.56 6.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.567 -0.901 . . . . 72.01 108.567 170.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -78.7 100.76 7.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.237 -1.347 . . . . 72.14 108.901 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.07 146.57 20.46 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 116.1 -0.5 . . . . 73.55 112.16 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.405 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -141.9 130.45 4.34 Favored Glycine 0 CA--C 1.508 -0.358 0 N-CA-C 110.343 -1.103 . . . . 62.31 110.343 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.452 HG13 ' HE1' ' D' ' 17' ' ' TYR . 73.6 mt -89.41 122.85 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.722 -1.214 . . . . 72.4 107.722 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -118.2 145.28 45.09 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.906 0.882 . . . . 65.24 109.335 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 6.8 t -115.57 98.14 6.54 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.633 -1.247 . . . . 74.32 107.633 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 30.0 pt -129.92 137.12 57.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.18 -0.918 . . . . 72.15 110.099 -170.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.07 151.84 25.72 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.811 -0.631 . . . . 64.32 110.442 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.13 -13.17 60.41 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.131 -0.94 . . . . 65.31 113.444 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.488 HD12 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -95.71 136.86 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 121.463 0.649 . . . . 75.31 111.546 -170.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.508 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 44.8 mt-10 -143.02 -176.68 5.01 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.877 1.671 . . . . 75.14 109.685 -177.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.36 -128.06 27.22 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.347 -0.842 . . . . 55.52 113.425 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 46.0 m -85.45 -32.98 22.0 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.439 0.696 . . . . 71.14 111.031 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.33 -38.69 92.13 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.968 0.507 . . . . 75.1 111.977 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.508 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 26.1 ptt? -61.09 -45.09 96.13 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.348 0.405 . . . . 74.11 110.914 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.76 91.99 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.406 0.622 . . . . 75.41 110.137 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -68.33 -23.19 64.68 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.188 1.395 . . . . 74.24 111.757 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.0 t -79.02 -51.93 8.92 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.663 -0.495 . . . . 75.52 109.663 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.45 -29.54 62.61 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.306 0.642 . . . . 75.01 111.911 -176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.19 4.93 30.12 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.825 0.69 . . . . 74.24 114.825 -170.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.4 -55.91 0.24 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 117.929 0.864 . . . . 65.12 111.767 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -71.75 -51.85 20.67 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.058 0.392 . . . . 72.42 112.058 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 68.8 m -65.06 -42.48 61.62 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-O 118.401 -0.809 . . . . 74.11 112.256 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.56 -37.95 94.6 Favored 'Trans proline' 0 C--N 1.397 3.102 0 C-N-CA 122.227 1.951 . . . . 73.14 113.317 166.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -67.42 -30.04 69.69 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.199 0.6 . . . . 72.41 111.143 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 40.0 mm -66.54 -42.91 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.416 0.686 . . . . 65.42 110.225 171.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.405 HD22 ' HA3' ' D' ' 82' ' ' GLY . 87.5 mt -74.07 -20.83 60.16 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.056 -0.975 . . . . 65.34 111.906 -174.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -65.1 -43.12 65.48 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 114.192 1.182 . . . . 75.33 114.192 -172.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.01 -46.0 23.4 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.342 2.028 . . . . 73.2 114.073 169.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -72.13 -38.62 69.21 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.463 0.705 . . . . 75.43 111.597 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.85 89.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.369 0.668 . . . . 64.45 110.777 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -58.0 -48.99 78.37 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.392 1.077 . . . . 73.53 110.6 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -58.04 -46.81 84.75 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.201 0.938 . . . . 74.41 111.359 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -59.81 -44.5 93.98 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.027 0.829 . . . . 75.31 111.413 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.488 HG12 ' SG ' ' D' ' 76' ' ' CYS . 75.7 mt -65.35 -50.6 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.78 0.832 . . . . 73.41 111.046 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 57.3 m -55.14 -41.85 72.29 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 124.095 0.958 . . . . 75.22 111.402 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.9 t -67.26 -41.47 85.52 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.568 -1.196 . . . . 73.43 110.4 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -71.46 -28.96 64.32 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.845 0.458 . . . . 71.02 112.187 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' D' ' 123' ' ' PHE . 59.0 t -64.61 -46.44 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.204 0.602 . . . . 74.35 109.581 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.01 -27.24 62.6 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 116.076 -0.511 . . . . 74.33 110.998 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.2 mtt-85 -71.2 -35.04 71.42 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.332 0.653 . . . . 75.45 109.841 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.65 7.97 77.29 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 115.901 -0.59 . . . . 73.11 112.329 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p 59.14 25.34 13.83 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 126.35 1.86 . . . . 73.53 114.725 173.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.418 ' HB2' HG11 ' D' ' 118' ' ' VAL . 99.0 m-85 -87.52 155.69 53.77 Favored Pre-proline 0 CA--C 1.556 1.206 0 N-CA-C 108.607 -0.886 . . . . 75.54 108.607 169.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.72 146.92 96.49 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.635 2.223 . . . . 73.53 112.436 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -58.36 139.54 55.14 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.732 1.213 . . . . 74.23 113.026 -172.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 9.1 mp -114.47 112.36 22.86 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.705 0.802 . . . . 74.24 109.569 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.417 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.2 m-20 -102.35 92.67 4.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.35 -0.981 . . . . 74.13 108.35 172.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.18 115.45 7.66 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.374 -0.602 . . . . 74.12 109.374 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.3 138.99 97.31 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.306 0.642 . . . . 73.31 110.585 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -69.66 119.93 6.81 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.162 1.908 . . . . 65.42 111.073 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.7 150.74 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.325 0.65 . . . . 75.11 111.053 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -80.49 107.16 13.07 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.284 -0.871 . . . . 73.15 109.601 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -80.5 -31.68 37.11 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.321 0.648 . . . . 62.11 110.869 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.75 -52.35 65.81 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.194 1.398 . . . . 71.52 111.861 -168.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.33 79.54 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.136 0.898 . . . . 74.41 111.718 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.65 -25.6 56.98 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.258 -0.883 . . . . 73.52 111.285 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 88.3 t80 . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 123.36 0.664 . . . . 75.22 110.647 175.08 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.7 m . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 120.684 0.278 . . . . 75.33 110.986 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.646 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 12.6 t80 -137.08 121.84 18.67 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.849 0.859 . . . . 75.53 108.923 172.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -136.45 108.38 7.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.398 0.679 . . . . 75.24 109.292 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.617 HG12 ' HD2' ' A' ' 84' ' ' PHE . 59.5 mt -80.66 109.46 15.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.508 -0.923 . . . . 73.14 108.508 172.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -74.41 -34.91 63.4 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.556 -0.747 . . . . 73.05 110.572 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -174.61 138.0 0.49 Allowed 'General case' 0 C--N 1.362 1.127 0 O-C-N 123.544 0.527 . . . . 75.23 110.624 -170.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.565 HD12 ' HG3' ' C' ' 130' ' ' PRO . 75.4 mt -123.3 133.79 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.75 0.82 . . . . 74.53 109.423 175.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -167.78 151.01 5.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.821 0.848 . . . . 65.14 110.557 -171.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.4 p -79.44 114.75 18.62 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.938 -0.764 . . . . 75.33 108.938 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -78.51 -33.34 48.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.162 -0.681 . . . . 73.25 109.162 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.8 t70 -147.72 132.72 18.18 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.973 -1.012 . . . . 65.42 109.584 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.42 141.49 45.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 107.237 -1.394 . . . . 75.31 107.237 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -145.91 132.55 19.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.627 0.727 . . . . 71.24 109.719 171.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 79.1 t80 -133.19 130.51 39.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.768 -1.567 . . . . 73.34 106.768 172.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.58 122.26 16.38 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.204 0.602 . . . . 74.42 109.456 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.12 78.47 68.96 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.539 -1.282 . . . . 73.21 107.539 174.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.3 -43.35 8.53 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.492 2.128 . . . . 71.32 110.734 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -88.62 20.55 3.37 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.386 -1.279 . . . . 73.1 111.423 -177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.99 -45.93 88.03 Favored Pre-proline 0 CA--C 1.573 1.858 0 C-N-CA 123.71 0.804 . . . . 64.34 113.121 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.471 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 16.2 Cg_exo -68.82 -26.17 32.5 Favored 'Trans proline' 0 C--N 1.398 3.164 0 C-N-CA 121.666 1.577 . . . . 73.2 112.928 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -74.3 -37.42 63.66 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.292 0.637 . . . . 70.41 110.172 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.458 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 73.8 t -67.95 -32.94 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.229 1.012 . . . . 74.52 110.668 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -59.0 -27.95 65.92 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.198 0.999 . . . . 63.12 111.44 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -95.83 -48.62 5.67 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.677 0.791 . . . . 74.34 111.25 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 21.0 ptmt -81.66 164.68 21.65 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.909 0.483 . . . . 73.21 111.22 -175.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.55 141.24 43.74 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.511 0.725 . . . . 74.14 111.876 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -92.34 83.78 5.07 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.092 -0.707 . . . . 74.33 109.092 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.97 62.07 44.35 Favored Pre-proline 0 N--CA 1.482 1.146 0 N-CA-C 108.235 -1.024 . . . . 74.12 108.235 172.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.54 157.29 28.65 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.441 2.094 . . . . 63.24 112.681 -167.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.21 109.77 22.46 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.53 -0.915 . . . . 75.43 108.53 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -83.5 115.24 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.394 -0.821 . . . . 75.24 109.781 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -104.12 144.41 31.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.87 0.868 . . . . 75.53 108.749 170.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 23.7 tp -136.79 128.84 29.48 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.809 -1.182 . . . . 74.43 107.809 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -135.15 113.01 10.95 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.85 -1.167 . . . . 74.53 107.85 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.2 mt -98.08 121.72 40.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.263 0.625 . . . . 73.33 110.207 -173.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -126.76 147.69 49.97 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.201 1.001 . . . . 73.04 109.054 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.1 m -135.64 126.05 26.71 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.82 0.848 . . . . 75.13 109.761 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.57 109.72 8.86 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 122.941 0.496 . . . . 75.3 110.583 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 29.4 m -89.68 167.99 12.47 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.692 0.797 . . . . 75.12 109.928 175.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 57' ' ' GLU . 86.8 p -160.46 154.05 22.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.505 0.722 . . . . 72.53 109.616 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -89.58 117.46 28.49 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.654 0.382 . . . . 71.35 110.297 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 78.0 mt -87.27 -46.64 9.52 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.574 0.702 . . . . 75.22 109.42 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.43 -176.64 5.39 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 114.421 -1.263 . . . . 70.02 108.777 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -65.81 110.07 2.7 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 109.176 -0.676 . . . . 74.44 109.176 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 74.43 -0.98 3.2 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 125.505 1.522 . . . . 74.05 112.886 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -100.25 113.85 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.048 -1.093 . . . . 73.1 108.048 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -125.66 129.96 50.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.702 0.801 . . . . 74.21 110.642 -172.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 41.2 tp10 -89.94 114.72 26.58 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.506 -0.924 . . . . 73.54 108.506 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 61.9 t -100.89 129.49 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 107.985 -1.117 . . . . 72.03 107.985 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.5 105.66 19.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.126 -1.064 . . . . 74.51 108.126 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.7 97.78 11.0 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 106.918 -1.512 . . . . 71.41 106.918 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -92.32 105.64 17.8 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.994 1.318 . . . . 73.13 109.762 -174.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.511 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.7 t -98.84 105.46 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.869 -0.789 . . . . 64.53 108.869 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -98.94 107.51 19.97 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.091 0.556 . . . . 75.44 110.2 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.4 t -106.02 125.94 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.323 0.649 . . . . 72.12 109.443 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.4 m -127.75 107.92 10.3 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.038 -0.727 . . . . 71.54 109.038 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.4 117.86 35.63 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.358 -1.349 . . . . 74.23 107.358 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.8 p -144.82 145.38 31.61 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.089 0.556 . . . . 63.01 109.883 -173.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -129.09 90.22 2.99 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.112 0.965 . . . . 74.54 109.184 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.69 -114.89 3.95 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.383 -0.826 . . . . 72.33 111.269 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.92 -26.85 14.91 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.22 -0.659 . . . . 61.23 109.22 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -85.92 117.46 24.79 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.668 0.387 . . . . 72.04 110.374 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.6 m -73.71 131.04 41.2 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.076 -0.713 . . . . 65.32 109.076 168.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HA ' HG23 ' A' ' 31' ' ' VAL . . . -73.55 -58.27 3.42 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.999 -0.741 . . . . 72.02 108.999 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -156.62 159.05 38.11 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.133 -1.394 . . . . 73.42 110.191 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 32.3 tp -127.48 119.14 25.41 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 107.337 -1.357 . . . . 74.33 107.337 173.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 68.3 m -125.68 99.45 5.99 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.975 -0.75 . . . . 63.23 108.975 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -121.95 116.55 24.55 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.494 -0.928 . . . . 75.13 108.494 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.3 111.49 26.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 123.673 0.789 . . . . 75.41 109.392 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 43.0 mt-30 -85.21 86.22 7.4 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.499 -0.926 . . . . 74.25 108.499 171.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.475 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.5 tp-100 -76.55 118.34 19.11 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 114.78 -1.1 . . . . 75.12 108.172 178.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.17 160.22 13.49 Favored Glycine 0 C--O 1.24 0.512 0 O-C-N 123.533 0.521 . . . . 71.44 112.121 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.47 132.63 2.91 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.799 -0.92 . . . . 64.11 110.799 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.7 mt -81.19 115.69 24.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 174.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.646 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.5 m-85 -122.82 118.59 28.33 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.24 -0.652 . . . . 75.33 109.24 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 m -99.68 100.73 11.74 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.963 -0.755 . . . . 74.22 108.963 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.9 pt -108.95 125.36 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.665 0.786 . . . . 74.42 111.122 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.71 161.73 38.48 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.983 0.913 . . . . 73.31 109.937 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.17 2.0 88.55 Favored Glycine 0 N--CA 1.477 1.381 0 N-CA-C 114.674 0.629 . . . . 71.14 114.674 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.534 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -114.82 146.09 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 123.784 0.834 . . . . 72.04 109.73 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.47 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 15.9 tt0 -150.93 179.44 8.24 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.413 0.285 . . . . 74.14 110.494 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.47 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 71.83 -136.71 24.63 Favored Glycine 0 C--N 1.351 1.405 0 C-N-CA 123.374 0.512 . . . . 73.14 113.747 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.2 p -80.43 -15.85 55.82 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.034 0.934 . . . . 71.34 110.744 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -71.96 -37.24 69.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.326 1.051 . . . . 73.31 110.742 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -73.32 -25.05 60.48 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.312 0.245 . . . . 74.54 111.016 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.6 -35.72 70.59 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.97 0.508 . . . . 72.31 109.908 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -66.52 -31.26 71.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.51 0.724 . . . . 75.11 111.27 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.534 ' SG ' HG13 ' A' ' 89' ' ' ILE . 72.1 m -57.21 -60.03 4.22 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.496 0.498 . . . . 64.41 111.179 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -83.62 -12.06 56.51 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 112.541 0.571 . . . . 73.51 112.541 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.14 -15.2 26.56 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 119.476 -0.625 . . . . 51.52 114.399 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.29 -61.59 0.35 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.95 0.875 . . . . 72.23 111.725 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.17 -65.99 0.61 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.974 1.31 . . . . 72.45 112.759 -169.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.42 -39.39 19.9 Favored Pre-proline 0 CA--C 1.569 1.703 0 N-CA-C 113.379 0.881 . . . . 74.14 113.379 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.87 -29.57 88.38 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 121.683 1.589 . . . . 61.14 113.341 169.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -70.57 -28.09 64.63 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 122.6 0.36 . . . . 71.41 110.453 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 13' ' ' ILE . 36.3 mm -56.39 -40.35 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.462 0.705 . . . . 74.35 110.15 172.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.475 HD23 ' HG3' ' A' ' 80' ' ' GLN . 80.4 mt -80.39 -22.55 41.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.861 -1.063 . . . . 74.13 112.675 -173.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.46 -44.92 97.09 Favored Pre-proline 0 CA--C 1.572 1.825 0 N-CA-C 113.591 0.96 . . . . 74.12 113.591 -172.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -59.73 -43.64 36.85 Favored 'Trans proline' 0 C--N 1.394 2.954 0 C-N-CA 122.041 1.828 . . . . 75.02 112.954 173.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -65.48 -36.91 85.27 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.153 0.581 . . . . 73.35 111.037 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.69 -37.92 70.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.91 -0.586 . . . . 75.34 110.751 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.56 ' NH1' HD13 ' C' ' 105' ' ' ILE . 35.0 ttm180 -53.88 -52.87 59.11 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 123.943 0.777 . . . . 75.42 110.03 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -59.78 -49.14 78.87 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.572 1.17 . . . . 74.03 111.311 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 117' ' ' MET . 34.3 t -56.28 -40.85 74.92 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.317 1.011 . . . . 72.11 110.59 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.511 HD11 ' HB ' ' A' ' 62' ' ' VAL . 96.3 mt -70.37 -47.87 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.942 0.897 . . . . 71.24 111.076 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.481 HG23 ' HG3' ' A' ' 125' ' ' GLN . 33.5 m -54.66 -38.03 66.43 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.433 0.693 . . . . 73.43 110.349 177.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.6 t -69.42 -40.78 77.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.865 -1.061 . . . . 71.23 109.634 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 33.2 mmt -59.8 -44.56 93.9 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 120.957 0.408 . . . . 74.34 110.624 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 114' ' ' ILE . 57.3 t -67.79 -44.61 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.299 1.04 . . . . 70.45 111.118 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -72.97 -33.05 65.6 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.359 0.664 . . . . 62.51 111.642 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -71.36 -32.66 68.76 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.964 0.506 . . . . 63.41 109.658 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.79 -2.96 72.12 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 115.571 -0.741 . . . . 74.4 113.578 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.1 m 70.06 11.48 7.64 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.994 1.318 . . . . 73.54 111.487 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -82.86 142.9 45.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 N-CA-C 108.819 -0.808 . . . . 75.32 108.819 173.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -46.86 132.91 17.55 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.403 2.735 . . . . 74.55 113.592 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.481 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.3 tt0 -52.07 144.36 12.29 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.367 1.467 . . . . 75.32 114.108 -169.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.4 tp -121.1 104.12 9.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.281 1.432 . . . . 74.43 109.255 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -116.05 96.02 5.37 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.751 -0.833 . . . . 73.44 108.751 170.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.39 151.78 46.36 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.513 -0.767 . . . . 71.42 110.665 176.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.59 152.28 91.63 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.672 0.789 . . . . 74.12 110.964 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.9 126.78 18.81 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.006 1.804 . . . . 74.14 111.918 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.2 t -99.05 115.69 40.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.534 -0.913 . . . . 74.42 108.534 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -81.7 81.61 7.69 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.958 -0.756 . . . . 74.34 108.958 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -59.74 -27.15 66.24 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.478 0.711 . . . . 74.34 111.601 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.92 -49.42 65.6 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.549 1.139 . . . . 74.22 111.032 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.56 -42.45 95.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.224 0.61 . . . . 74.13 110.474 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.9 mt -67.66 -25.2 65.6 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.688 -1.142 . . . . 74.32 111.711 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -78.45 -43.69 26.53 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.46 -0.57 . . . . 74.2 109.46 175.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.5 mmt . . . . . 0 N--CA 1.485 1.29 0 O-C-N 123.687 0.617 . . . . 75.24 111.543 -177.323 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 91.2 m . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 107.903 -1.147 . . . . 75.54 107.903 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -138.46 137.22 36.96 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.257 -1.016 . . . . 75.22 108.257 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -145.13 142.51 29.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.16 0.584 . . . . 74.31 110.328 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.2 mt -94.16 123.16 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.809 -1.182 . . . . 74.22 107.809 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . 0.488 HE22 HG12 ' B' ' 55' ' ' VAL . 50.2 mt-30 -94.24 -31.45 14.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.075 0.55 . . . . 71.21 110.304 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -173.51 139.04 0.72 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 123.83 0.706 . . . . 74.45 109.458 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.411 HG21 HD22 ' B' ' 106' ' ' LEU . 90.2 mt -121.09 137.17 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 106.543 -1.651 . . . . 70.22 106.543 170.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -166.77 146.71 5.69 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.315 0.579 . . . . 63.52 111.397 -172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.9 m -74.0 126.97 31.68 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.223 -1.029 . . . . 73.43 108.223 168.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -95.16 -40.94 9.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.292 -0.633 . . . . 71.52 109.292 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.44 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 23.3 m-20 -144.55 133.49 22.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.776 -0.647 . . . . 73.45 110.375 -166.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.6 mm -127.85 142.96 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.248 1.019 . . . . 70.33 108.884 171.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.1 t -144.32 115.18 7.8 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.737 -1.209 . . . . 73.53 107.737 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -130.77 110.18 11.14 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 107.799 -1.185 . . . . 74.12 107.799 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.75 113.91 21.87 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.267 1.027 . . . . 75.14 108.921 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.99 82.67 7.09 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 106.958 -1.497 . . . . 61.51 106.958 169.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.13 -33.69 11.25 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.27 1.98 . . . . 74.25 112.176 -173.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.75 7.54 46.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.245 1.018 . . . . 74.44 110.544 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.413 ' HB1' ' HD3' ' B' ' 29' ' ' PRO . . . -37.6 -64.33 0.43 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 115.095 1.517 . . . . 72.01 115.095 -163.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 53.7 Cg_endo -70.17 -22.85 29.64 Favored 'Trans proline' 0 C--N 1.39 2.746 0 C-N-CA 121.64 1.56 . . . . 44.5 112.817 -170.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -96.78 -20.88 17.9 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.493 0.717 . . . . 73.34 111.002 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' B' ' 68' ' ' LEU . 2.7 p -84.19 -20.73 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.52 0.328 . . . . 74.2 110.445 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -68.08 -24.21 65.03 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.543 0.737 . . . . 74.53 112.886 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -64.36 -15.11 59.8 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.542 0.337 . . . . 73.22 110.779 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.426 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 89.1 mttt -89.38 106.88 18.74 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.748 1.219 . . . . 75.04 109.711 174.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.04 89.35 7.97 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.277 0.631 . . . . 73.1 109.432 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -161.11 161.25 31.12 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.25 1.02 . . . . 74.4 108.829 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.456 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 68.5 mt-30 -85.83 104.32 5.07 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 108.723 -0.843 . . . . 72.35 108.723 173.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.515 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 16.6 Cg_endo -55.94 122.62 12.09 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 122.978 2.452 . . . . 73.42 111.801 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -62.71 109.17 1.33 Allowed 'General case' 0 C--O 1.243 0.741 0 O-C-N 123.759 0.662 . . . . 74.12 110.177 -175.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.541 HG12 HG11 ' B' ' 64' ' ' VAL . 65.9 t -87.01 128.68 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-N 115.045 -0.98 . . . . 74.31 111.231 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -106.42 118.03 35.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.77 1.628 . . . . 75.1 108.356 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.32 135.87 36.39 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.247 0.619 . . . . 72.54 110.244 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.823 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.5 m-20 -129.94 156.19 44.84 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.78 1.232 . . . . 62.53 109.084 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.548 HD12 ' HE2' ' B' ' 133' ' ' PHE . 45.5 mt -134.43 159.55 40.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.759 0.823 . . . . 73.24 109.31 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.3 t70 -159.74 112.91 2.19 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.375 -1.343 . . . . 64.11 107.375 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.1 p -116.88 119.98 37.06 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.83 0.452 . . . . 70.13 110.182 -175.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.42 161.83 25.17 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.397 1.079 . . . . 71.44 109.188 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m -142.26 165.92 26.12 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.447 -0.946 . . . . 74.4 108.447 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.7 p -150.08 136.21 18.74 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.828 0.451 . . . . 63.1 109.83 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -80.95 109.94 16.0 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.911 -0.403 . . . . 72.53 109.911 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 86.2 mt -76.48 -50.59 13.65 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.518 0.675 . . . . 74.44 109.226 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.91 -172.99 4.24 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.082 -0.963 . . . . 70.21 110.054 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -63.82 107.71 1.28 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.028 -0.987 . . . . 74.52 109.863 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 49.4 m-20 72.82 15.2 4.79 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.4 1.48 . . . . 74.21 111.642 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.488 HG12 HE22 ' B' ' 14' ' ' GLN . 75.6 t -115.51 122.15 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.348 1.059 . . . . 72.52 108.708 173.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -129.93 143.16 50.65 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.192 0.597 . . . . 74.23 111.21 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.471 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 4.6 tm-20 -103.65 100.19 10.01 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 106.809 -1.552 . . . . 64.22 106.809 171.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.0 t -90.98 139.52 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.601 0.76 . . . . 74.44 110.265 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.467 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 18.4 t -120.77 135.92 59.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.788 0.835 . . . . 71.05 109.867 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -118.17 107.47 13.99 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.604 -1.258 . . . . 75.34 107.604 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.549 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 23.1 ttm-85 -96.57 125.5 41.09 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.217 0.607 . . . . 75.12 109.69 172.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' B' ' 114' ' ' ILE . 14.6 t -117.0 119.81 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.565 -1.272 . . . . 71.34 107.565 169.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.823 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 62.3 m -100.49 148.07 25.18 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.639 0.776 . . . . 71.55 109.216 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.541 HG11 HG12 ' B' ' 40' ' ' VAL . 73.6 t -135.67 108.29 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.297 1.039 . . . . 63.22 108.359 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.0 m -95.82 137.84 34.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.92 -1.141 . . . . 64.32 107.92 167.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.72 150.43 32.08 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.729 -0.471 . . . . 73.44 109.729 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 50.8 p -150.89 136.72 18.14 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.493 0.496 . . . . 73.44 112.106 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.539 ' HB2' HG23 ' B' ' 31' ' ' VAL . 34.2 mt -104.95 121.41 43.68 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.336 1.054 . . . . 71.01 108.608 170.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.82 -116.98 5.01 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 115.672 -0.694 . . . . 55.15 112.341 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -122.34 23.4 9.76 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.359 1.064 . . . . 73.41 110.116 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.426 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.8 pt-20 -146.09 159.93 42.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.952 0.901 . . . . 71.14 109.961 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 31.0 m -64.3 140.0 58.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.216 0.606 . . . . 70.34 111.292 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.97 -59.62 1.67 Allowed 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.665 -0.865 . . . . 75.23 108.665 171.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -154.35 152.29 30.05 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.788 -0.642 . . . . 74.12 110.684 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 33.3 mt -130.31 109.9 11.11 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 106.169 -1.789 . . . . 73.53 106.169 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 45.2 t -117.32 145.69 43.84 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.704 -0.85 . . . . 74.23 108.704 -175.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.3 tt0 -162.86 130.37 3.68 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.039 0.447 . . . . 74.54 110.046 -172.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 80.2 t -123.83 146.3 29.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.193 -0.912 . . . . 54.24 109.348 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.44 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 10.5 mt-30 -121.35 92.97 3.87 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 108.184 -1.043 . . . . 72.54 108.184 168.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.45 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.3 tp-100 -83.65 100.27 10.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.169 -1.048 . . . . 74.54 108.169 174.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.63 170.13 36.43 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.204 -0.758 . . . . 74.32 111.204 175.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.62 127.33 1.45 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 112.311 -0.316 . . . . 74.32 112.311 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 62.5 mt -86.81 131.79 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.778 0.831 . . . . 74.21 109.125 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -136.56 164.54 27.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.104 0.962 . . . . 71.21 109.9 -175.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -129.19 108.97 10.76 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.125 -1.065 . . . . 74.42 108.125 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 40.2 pt -101.25 145.2 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.47 0.708 . . . . 74.34 110.839 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.498 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -157.34 160.55 38.61 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.876 0.871 . . . . 71.24 110.014 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.07 -69.93 3.01 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 123.573 0.545 . . . . 74.41 112.044 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.431 HD12 ' HB2' ' B' ' 97' ' ' CYS . 19.4 pt -54.39 127.86 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.744 1.218 . . . . 74.43 110.854 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.471 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 30.5 tt0 -149.59 156.02 41.25 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 110.204 -0.295 . . . . 74.41 110.204 -171.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.72 -109.71 2.94 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 112.139 -0.384 . . . . 75.04 112.139 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 42.4 m -79.6 -27.46 41.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.982 0.513 . . . . 75.42 110.649 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.471 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 40.7 mt-30 -66.3 -39.88 89.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 122.795 0.438 . . . . 74.5 110.525 -177.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -76.24 -29.54 57.57 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.988 -0.551 . . . . 74.41 110.505 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.51 -33.17 75.09 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.533 0.733 . . . . 70.34 110.501 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.432 ' O ' ' HB1' ' B' ' 100' ' ' ALA . 17.6 t-80 -74.9 -20.35 59.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.826 1.25 . . . . 75.02 110.474 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.462 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 41.4 t -81.91 -68.51 0.69 Allowed 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.527 -0.546 . . . . 73.44 109.527 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 66.9 mt -66.95 -31.99 72.95 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.281 0.632 . . . . 73.24 112.567 -169.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.12 3.78 70.25 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-O 119.435 -0.647 . . . . 75.34 113.886 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' B' ' 96' ' ' HIS . . . -152.88 -65.95 0.16 Allowed 'General case' 0 C--N 1.357 0.895 0 CA-C-N 118.001 0.901 . . . . 64.41 112.553 -174.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.462 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 58.3 t80 -64.39 -47.42 79.3 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.725 0.81 . . . . 74.25 112.129 -174.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.408 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 87.7 m -60.17 -49.78 89.2 Favored Pre-proline 0 CA--C 1.566 1.562 0 C-N-CA 124.474 1.11 . . . . 65.44 111.908 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.494 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 50.8 Cg_exo -59.14 -34.77 98.63 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.068 1.846 . . . . 73.21 113.434 169.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -30.55 71.58 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.285 0.634 . . . . 71.32 110.874 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.93 -45.89 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.112 0.965 . . . . 75.01 110.565 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.411 HD22 HG21 ' B' ' 16' ' ' ILE . 49.8 mt -81.72 -12.71 58.5 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.908 -1.042 . . . . 72.4 112.065 -169.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.32 -49.08 94.51 Favored Pre-proline 0 CA--C 1.558 1.275 0 CA-C-O 117.645 -1.169 . . . . 74.13 113.502 -174.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.17 -35.84 98.37 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 121.951 1.768 . . . . 72.01 112.977 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.45 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 59.9 m-85 -68.96 -46.35 68.39 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.398 0.679 . . . . 74.5 109.851 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.03 88.59 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.611 0.764 . . . . 63.14 110.859 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.545 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 36.7 ttt180 -61.37 -54.81 38.9 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.174 1.389 . . . . 73.11 111.533 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.25 -36.05 82.84 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.541 0.736 . . . . 74.23 109.792 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.444 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.3 t -64.89 -39.31 93.33 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.526 -0.761 . . . . 55.41 111.171 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.517 HD11 ' HB ' ' B' ' 62' ' ' VAL . 70.3 mt -62.19 -54.57 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 109.633 -0.506 . . . . 75.52 109.633 174.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.457 HG22 ' OG ' ' C' ' 119' ' ' SER . 11.1 m -59.74 -30.67 68.99 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.33 1.019 . . . . 71.31 111.276 -173.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 41.7 t -60.63 -50.93 71.54 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 123.87 0.731 . . . . 74.03 109.541 173.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.446 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 7.9 mmt -68.19 -36.74 80.05 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.165 0.586 . . . . 74.15 111.453 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 114' ' ' ILE . 91.9 t -59.43 -43.42 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.056 0.942 . . . . 74.45 110.092 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.505 ' OG ' HG21 ' C' ' 115' ' ' THR . 45.9 t -71.46 -31.9 67.69 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.801 -1.09 . . . . 71.14 111.747 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.9 mtt-85 -65.8 -37.37 86.08 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 115.969 -0.56 . . . . 72.31 109.537 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.8 2.92 86.82 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.45 -0.639 . . . . 63.31 113.389 173.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.4 ' HA ' ' ND2' ' C' ' 127' ' ' ASN . 47.3 p 63.22 19.89 11.94 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 126.116 1.766 . . . . 70.32 114.182 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -81.75 153.51 70.33 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.249 0.62 . . . . 73.44 110.739 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.456 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 98.9 Cg_exo -48.77 162.62 0.36 Allowed 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 124.304 3.336 . . . . 63.12 115.67 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -61.62 128.9 38.49 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.701 1.2 . . . . 74.32 112.231 -169.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.406 HD22 HG22 ' B' ' 118' ' ' VAL . 35.5 tp -133.35 107.85 8.35 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.398 1.079 . . . . 72.52 109.202 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -124.37 134.72 53.06 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.457 0.703 . . . . 74.04 109.571 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.545 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.8 mm? -80.79 147.71 30.36 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.608 0.763 . . . . 65.11 111.075 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.87 146.63 46.5 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.738 0.815 . . . . 75.4 109.501 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.12 102.75 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.414 2.076 . . . . 72.44 112.465 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 64.3 t -89.42 110.64 21.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.746 -1.205 . . . . 70.44 107.746 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -82.27 86.18 6.72 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.953 -1.128 . . . . 75.24 107.953 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.548 ' HE2' HD12 ' B' ' 44' ' ' LEU . 91.0 m-85 -54.8 -37.84 66.58 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.87 0.868 . . . . 75.03 110.728 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' B' ' 100' ' ' ALA . 16.7 t70 -61.86 -43.77 98.17 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.104 -1.407 . . . . 75.42 111.109 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.19 -42.94 62.16 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.59 0.756 . . . . 65.51 111.116 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.42 -16.03 60.39 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.223 0.453 . . . . 71.52 112.223 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 63.4 t80 . . . . . 0 N--CA 1.483 1.205 0 C-N-CA 123.221 0.608 . . . . 71.55 109.817 171.641 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 24.9 m . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 108.707 -0.849 . . . . 71.12 108.707 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.608 ' HD1' ' HH ' ' C' ' 101' ' ' TYR . 1.1 t80 -122.41 123.21 40.81 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.264 0.626 . . . . 73.53 109.671 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -143.72 133.91 24.39 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.055 0.942 . . . . 70.32 108.492 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 36.5 mt -81.22 126.43 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.76 -0.829 . . . . 75.31 108.76 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.556 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 29.4 mm-40 -88.0 -47.02 8.85 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.646 -0.707 . . . . 73.32 110.148 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -174.81 138.88 0.49 Allowed 'General case' 0 C--N 1.352 0.706 0 CA-C-N 115.373 -0.83 . . . . 74.33 109.441 -168.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -128.31 141.0 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 107.824 -1.176 . . . . 73.15 107.824 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -170.41 171.14 6.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.469 0.652 . . . . 75.41 110.885 -170.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -96.26 110.91 23.13 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.758 -0.83 . . . . 65.53 108.758 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -71.81 -34.26 69.21 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.933 -0.766 . . . . 75.13 108.933 173.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.5 t70 -146.52 146.51 30.53 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.072 -0.967 . . . . 72.44 109.295 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.3 mt -141.86 144.26 25.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.815 1.646 . . . . 73.22 106.912 175.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t -155.05 151.05 27.94 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.641 0.734 . . . . 73.51 110.433 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -148.67 148.63 30.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.197 -1.365 . . . . 75.2 107.354 171.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.603 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.5 mt-10 -143.77 139.25 29.3 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.003 0.921 . . . . 74.42 109.29 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.06 73.42 5.67 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 106.263 -1.754 . . . . 43.44 106.263 169.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.29 -10.88 16.19 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.147 1.898 . . . . 74.32 111.766 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -114.98 20.7 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.984 1.314 . . . . 71.2 109.306 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.512 ' HA ' HG11 ' C' ' 31' ' ' VAL . . . -55.82 -53.49 62.35 Favored Pre-proline 0 CA--C 1.561 1.385 0 N-CA-C 113.348 0.869 . . . . 73.32 113.348 -168.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.38 -42.38 68.25 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 121.752 1.635 . . . . 73.21 113.015 177.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -70.84 -35.36 72.4 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.657 0.783 . . . . 74.42 112.444 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.672 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -79.5 -24.17 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 112.262 0.467 . . . . 65.24 112.262 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -68.99 -22.86 64.06 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.983 -0.448 . . . . 75.23 111.79 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -95.61 6.42 48.99 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.238 0.615 . . . . 72.33 111.048 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -92.89 142.5 27.24 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.756 0.822 . . . . 72.32 111.562 -172.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -71.2 134.14 46.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.748 1.219 . . . . 74.32 109.618 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -84.75 102.36 12.94 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.961 0.726 . . . . 73.41 112.961 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -121.16 67.84 17.32 Favored Pre-proline 0 N--CA 1.484 1.263 0 N-CA-C 107.507 -1.294 . . . . 73.52 107.507 160.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -84.15 118.75 2.35 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 122.969 2.446 . . . . 75.04 112.951 -171.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -86.35 99.16 11.41 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.953 -1.128 . . . . 74.13 107.953 167.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 p -76.83 98.82 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.688 0.756 . . . . 72.11 109.35 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.433 ' HB3' ' HZ3' ' C' ' 41' ' ' LYS . 0.0 OUTLIER -94.8 101.48 13.29 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.506 -2.035 . . . . 74.32 105.506 169.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 9.0 tt -86.38 142.3 28.55 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.305 -1.368 . . . . 75.01 107.305 174.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.559 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.1 t70 -119.58 133.63 55.58 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.685 -0.857 . . . . 73.21 108.685 -173.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.0 mt -112.71 123.36 50.14 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.467 -0.938 . . . . 71.41 108.467 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.3 t70 -135.78 126.6 27.47 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.397 -1.334 . . . . 51.1 107.397 172.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -137.58 128.17 26.76 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.583 0.706 . . . . 70.3 109.699 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.05 152.27 46.08 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 113.93 -1.486 . . . . 71.24 107.523 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -140.43 145.38 36.93 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.838 -0.43 . . . . 73.33 109.838 -174.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -143.84 135.71 26.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.492 0.717 . . . . 64.31 110.433 -168.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -72.75 122.67 21.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.471 0.708 . . . . 74.12 110.741 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' C' ' 57' ' ' GLU . 36.1 mt -91.71 -45.8 8.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.473 -0.936 . . . . 64.31 108.473 172.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.01 178.29 8.83 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.323 -1.308 . . . . 73.54 108.901 174.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -74.19 134.12 42.75 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.062 -0.718 . . . . 71.42 109.062 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 69.16 -0.21 2.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.478 1.511 . . . . 75.12 113.114 -171.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.1 t -123.35 94.82 3.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 123.961 0.904 . . . . 74.03 108.701 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -116.11 125.35 52.25 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.961 -1.125 . . . . 72.44 107.961 -176.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.56 ' HB2' HD12 ' C' ' 51' ' ' LEU . 37.1 tt0 -82.26 138.21 34.66 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.686 0.794 . . . . 73.01 109.519 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 63.6 t -115.45 130.05 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.916 -0.772 . . . . 74.31 108.916 170.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 97.0 t -111.76 133.73 56.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.542 -1.281 . . . . 73.43 107.542 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.06 104.31 8.8 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.455 -0.943 . . . . 73.32 108.455 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 33.1 ttm-85 -95.48 108.7 20.94 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.583 -0.895 . . . . 63.43 108.583 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.525 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.8 t -109.38 122.52 64.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.834 -1.173 . . . . 74.54 107.834 172.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.3 m -124.55 114.66 19.7 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.091 0.556 . . . . 71.31 109.837 -174.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.626 HG12 HD12 ' C' ' 126' ' ' LEU . 78.1 t -99.25 107.82 21.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.761 -0.829 . . . . 73.41 108.761 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.468 HG23 HD22 ' C' ' 75' ' ' LEU . 1.6 m -99.46 106.83 18.91 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.374 -1.343 . . . . 74.34 107.374 174.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.54 124.19 46.8 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.239 -1.023 . . . . 72.11 108.239 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 59.7 m -134.72 163.69 29.22 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.928 0.394 . . . . 65.34 110.651 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 30.7 mt -124.3 15.22 9.02 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.093 1.357 . . . . 73.23 109.785 -173.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.54 -93.04 0.42 Allowed Glycine 0 C--N 1.344 1.013 0 N-CA-C 110.381 -1.088 . . . . 71.43 110.381 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -100.04 -30.76 11.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.108 0.963 . . . . 71.12 109.599 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -75.34 122.68 24.12 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.592 1.157 . . . . 73.25 110.715 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 78.8 m -78.37 125.84 29.93 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.803 -1.184 . . . . 64.32 107.803 162.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.672 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.44 -64.74 0.86 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.549 -0.908 . . . . 55.24 108.549 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.69 168.72 24.14 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.28 -0.873 . . . . 74.23 109.675 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.603 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.1 tm? -128.36 142.28 51.17 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.515 -1.661 . . . . 74.23 106.515 169.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 47.4 t -144.23 145.47 32.08 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 107.817 -1.179 . . . . 75.1 107.817 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -157.61 128.14 6.41 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.891 -0.411 . . . . 74.12 109.891 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.58 125.29 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 123.855 0.862 . . . . 71.51 108.79 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.54 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.5 mt-30 -103.75 86.86 2.68 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.531 -0.914 . . . . 65.03 108.531 173.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -78.46 97.91 5.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.676 -1.147 . . . . 74.32 108.949 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.27 149.16 24.74 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.291 -0.868 . . . . 72.52 110.98 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.517 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -153.81 117.12 0.78 Allowed Glycine 0 CA--C 1.502 -0.723 0 N-CA-C 110.891 -0.884 . . . . 72.42 110.891 -176.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.6 mm -81.97 119.55 31.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.461 -0.941 . . . . 73.52 108.461 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -125.21 118.58 26.36 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.837 -0.801 . . . . 71.25 108.837 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.2 m -77.54 103.21 7.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.156 -0.683 . . . . 74.15 109.156 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.548 HG12 HD22 ' C' ' 98' ' ' LEU . 1.7 pp -122.63 123.52 68.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 123.762 0.825 . . . . 71.41 110.143 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.25 162.04 27.15 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.554 1.142 . . . . 72.05 109.225 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.68 -34.29 3.92 Favored Glycine 0 N--CA 1.473 1.133 0 N-CA-C 113.805 0.282 . . . . 73.11 113.805 173.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.452 HD13 ' HB ' ' C' ' 86' ' ' ILE . 28.0 pt -90.15 144.57 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.924 0.889 . . . . 74.43 111.07 -177.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -161.95 155.98 21.77 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.511 0.724 . . . . 74.25 110.079 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.72 -117.83 7.88 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.586 -0.734 . . . . 72.52 113.198 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 32.6 p -69.35 -25.07 64.01 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.001 0.92 . . . . 74.51 111.816 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.419 HE21 HG21 ' C' ' 89' ' ' ILE . 25.4 mt-30 -71.45 -52.34 19.0 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.591 0.757 . . . . 63.24 110.685 176.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -30.58 68.37 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.681 -0.69 . . . . 75.11 111.466 -174.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.13 -47.79 82.22 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 124.244 0.965 . . . . 74.3 110.692 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.439 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 10.5 t-160 -78.56 -35.56 45.82 Favored 'General case' 0 C--O 1.246 0.886 0 O-C-N 123.548 0.53 . . . . 72.23 111.994 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -58.65 -40.65 84.02 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.474 0.484 . . . . 74.54 110.665 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.548 HD22 HG12 ' C' ' 86' ' ' ILE . 31.0 mt -101.72 -10.68 19.75 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.994 0.518 . . . . 74.23 111.341 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.91 -30.55 63.31 Favored Glycine 0 C--N 1.355 1.584 0 N-CA-C 113.953 0.341 . . . . 54.43 113.953 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.63 -35.99 0.06 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.137 0.421 . . . . 71.22 112.137 -171.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.608 ' HH ' ' HD1' ' C' ' 11' ' ' PHE . 11.3 t80 -65.31 -43.49 90.91 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.318 1.447 . . . . 74.25 112.216 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -84.24 -42.59 0.74 Allowed Pre-proline 0 CA--C 1.567 1.601 0 CA-C-O 118.588 -0.72 . . . . 71.24 112.245 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -54.2 -25.55 38.5 Favored 'Trans proline' 0 C--N 1.397 3.113 0 C-N-CA 122.747 2.298 . . . . 72.12 114.095 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -61.37 -38.26 86.34 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.62 0.768 . . . . 74.24 110.822 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.56 HD13 ' NH1' ' A' ' 111' ' ' ARG . 47.5 mm -67.1 -39.88 84.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.196 -0.911 . . . . 73.24 110.306 177.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.517 HD22 ' HA3' ' C' ' 82' ' ' GLY . 60.5 mt -79.45 -22.75 43.73 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.943 0.897 . . . . 74.11 112.065 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -55.6 -52.8 69.02 Favored Pre-proline 0 CA--C 1.558 1.284 0 N-CA-C 114.08 1.141 . . . . 75.24 114.08 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.05 -29.01 65.85 Favored 'Trans proline' 0 C--N 1.386 2.531 0 CA-C-N 121.286 1.495 . . . . 74.24 112.637 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -70.29 -47.87 59.26 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.981 0.512 . . . . 75.34 109.674 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.82 -45.18 78.39 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.989 -1.005 . . . . 74.21 109.789 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.571 ' HG3' ' HB3' ' C' ' 128' ' ' LEU . 44.9 ttt-85 -56.21 -52.98 62.45 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.35 1.46 . . . . 71.12 111.708 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.28 -37.27 85.06 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.344 0.658 . . . . 75.31 110.483 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 21.1 t -71.36 -29.25 64.75 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 122.954 0.502 . . . . 73.32 111.628 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.525 HD11 ' HB ' ' C' ' 62' ' ' VAL . 98.0 mt -69.43 -52.34 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 109.342 -0.614 . . . . 74.43 109.342 173.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.505 HG21 ' OG ' ' B' ' 119' ' ' SER . 5.8 m -61.79 -31.16 71.36 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.58 0.752 . . . . 74.45 110.937 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.9 t -63.5 -52.68 60.2 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.433 0.693 . . . . 71.11 109.19 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.502 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.17 -38.01 84.97 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.263 1.025 . . . . 64.44 112.473 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' C' ' 114' ' ' ILE . 83.3 t -61.59 -48.35 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.656 0.783 . . . . 63.42 110.009 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.457 ' OG ' HG22 ' B' ' 115' ' ' THR . 41.7 t -67.23 -27.37 67.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.574 -1.194 . . . . 74.31 111.519 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -72.68 -40.75 66.02 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.181 0.592 . . . . 74.42 109.62 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -3.91 79.38 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.426 0.454 . . . . 62.43 112.747 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.443 HG21 ' HB3' ' D' ' 17' ' ' TYR . 31.1 p 62.95 33.78 14.66 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 126.853 2.061 . . . . 74.23 113.222 173.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.61 151.69 62.19 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.087 -1.079 . . . . 71.1 108.087 168.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -57.25 166.16 4.7 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.679 2.253 . . . . 75.23 113.6 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -46.44 138.24 5.89 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.344 1.457 . . . . 74.3 114.672 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.626 HD12 HG12 ' C' ' 64' ' ' VAL . 5.4 tt -119.84 85.29 2.35 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.91 -1.144 . . . . 75.22 107.91 169.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . 0.4 ' ND2' ' HA ' ' B' ' 122' ' ' THR . 18.9 m120 -92.17 94.59 9.28 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.225 -1.028 . . . . 74.23 108.225 175.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.571 ' HB3' ' HG3' ' C' ' 111' ' ' ARG . 16.7 tp -70.05 123.55 21.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.416 -0.811 . . . . 73.25 110.163 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.23 154.85 88.27 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 124.38 1.072 . . . . 73.44 111.402 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.565 ' HG3' HD12 ' A' ' 16' ' ' ILE . 45.9 Cg_exo -55.11 111.12 0.65 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.837 2.358 . . . . 73.42 113.291 172.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.55 115.74 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.443 -1.318 . . . . 63.35 107.443 167.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -82.13 86.62 6.58 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.775 -0.824 . . . . 72.12 108.775 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -62.63 -43.22 99.35 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.927 -1.033 . . . . 73.31 110.628 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.05 -42.99 93.73 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 114.049 -1.432 . . . . 70.52 111.27 -169.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.7 95.29 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 123.711 0.632 . . . . 75.14 111.676 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.04 -49.11 63.43 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.949 0.5 . . . . 74.24 110.021 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . 0.439 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 3.0 t80 . . . . . 0 CA--C 1.555 1.139 0 CA-C-N 116.087 -0.506 . . . . 73.44 110.107 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 27.9 m . . . . . 0 C--O 1.237 0.433 0 CA-C-O 120.993 0.425 . . . . 72.3 111.106 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -156.99 95.48 1.51 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.116 -1.439 . . . . 70.4 107.116 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -122.48 121.58 36.92 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.982 -0.747 . . . . 73.22 108.982 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.532 HD11 HG22 ' D' ' 105' ' ' ILE . 10.4 mt -84.75 121.61 37.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.046 -0.724 . . . . 63.31 109.046 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -87.04 -36.23 18.31 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 119.286 -0.387 . . . . 74.12 111.616 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -172.38 122.88 0.46 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 120.788 -0.365 . . . . 73.33 111.822 -164.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.41 137.91 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.886 -1.153 . . . . 72.21 107.886 166.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.492 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 30.8 p90 -161.43 177.06 10.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.151 0.907 . . . . 73.34 111.223 178.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.3 p -108.71 126.05 52.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.798 -1.092 . . . . 75.22 108.959 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.492 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 24.9 mtpt -93.88 -12.72 28.29 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.575 -0.528 . . . . 74.13 109.575 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.4 t70 -169.8 136.02 1.52 Allowed 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.516 1.126 . . . . 74.04 108.66 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.502 HG23 ' HE1' ' C' ' 117' ' ' MET . 69.4 mt -135.47 143.6 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.436 1.094 . . . . 75.04 108.403 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -142.69 134.98 27.56 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.249 1.02 . . . . 74.33 109.252 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.521 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.7 t80 -144.22 130.81 20.03 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.377 -1.712 . . . . 73.01 106.377 165.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.8 mt-10 -131.19 150.04 52.32 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.499 0.72 . . . . 73.42 109.377 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.12 76.86 10.21 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 106.939 -1.504 . . . . 74.11 106.939 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.78 -32.72 22.56 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.855 2.37 . . . . 74.12 112.326 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -96.62 0.09 49.38 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.078 -0.964 . . . . 72.22 110.864 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.14 -68.03 0.1 OUTLIER Pre-proline 0 CA--C 1.559 1.297 0 N-CA-C 115.64 1.718 . . . . 72.0 115.64 -160.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -78.04 -16.96 13.89 Favored 'Trans proline' 0 C--N 1.383 2.37 0 CA-C-N 122.655 1.984 . . . . 64.43 113.709 -172.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -74.7 -42.16 58.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.185 0.994 . . . . 74.33 109.394 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.568 HG23 HD11 ' D' ' 68' ' ' LEU . 9.2 p -83.82 -20.61 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 115.827 -0.624 . . . . 74.35 111.093 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -64.24 -16.92 63.0 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.208 0.603 . . . . 72.14 111.923 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -68.55 -2.93 9.96 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.83 0.852 . . . . 74.35 111.801 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.567 ' HZ2' ' HB3' ' D' ' 71' ' ' GLU . 89.1 mttt -109.92 101.67 10.49 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 125.125 1.37 . . . . 75.11 109.809 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -84.35 83.34 8.02 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.444 0.64 . . . . 71.44 109.518 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -146.41 157.2 43.74 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.571 1.149 . . . . 74.1 108.735 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -77.09 105.37 2.4 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.67 -0.863 . . . . 74.15 108.67 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.26 119.07 5.93 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.13 2.553 . . . . 74.14 113.909 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.15 116.22 7.7 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.089 0.956 . . . . 74.04 109.101 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.464 HG13 ' HB1' ' D' ' 66' ' ' ALA . 27.6 m -101.96 119.57 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 121.665 0.745 . . . . 73.13 112.069 -169.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 107.98 18.83 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.123 -1.806 . . . . 74.53 106.123 167.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.489 HD21 ' H ' ' D' ' 42' ' ' LEU . 1.3 pt? -98.14 156.08 16.85 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.418 0.627 . . . . 72.54 110.795 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -141.08 146.56 37.28 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.575 1.15 . . . . 73.21 108.522 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 26.4 tp -127.28 131.98 50.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.709 0.804 . . . . 63.54 109.397 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.0 t70 -141.58 144.43 34.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.473 -0.936 . . . . 72.1 108.473 173.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.5 t -134.55 158.84 42.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.676 -0.49 . . . . 74.1 109.676 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.12 157.2 35.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.033 -0.985 . . . . 73.44 108.384 174.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.7 p -153.96 148.2 25.89 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.596 -0.52 . . . . 64.44 109.596 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 57.2 p -162.58 142.23 9.35 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.124 0.569 . . . . 71.42 110.236 -171.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -71.52 125.41 26.98 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.998 0.919 . . . . 74.5 111.353 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 mt -94.63 -35.47 12.19 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.102 0.561 . . . . 73.43 109.917 172.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.75 -171.45 3.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.792 0.837 . . . . 74.01 110.381 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -59.68 113.22 2.13 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.701 0.626 . . . . 73.13 110.508 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 65.24 13.29 8.66 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.927 1.291 . . . . 70.43 111.677 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 81.8 t -109.43 118.92 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.496 -0.927 . . . . 71.43 108.496 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -127.93 127.55 43.52 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.329 -0.989 . . . . 71.31 108.329 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -94.03 122.54 36.65 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.214 1.006 . . . . 72.22 108.648 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.11 124.57 53.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.714 -1.217 . . . . 75.2 107.714 172.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.539 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.3 t -100.56 127.59 53.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.654 -0.869 . . . . 55.02 108.654 171.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.03 117.38 33.85 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.309 -0.997 . . . . 73.51 108.309 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.586 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.3 ttm-85 -96.73 114.28 25.91 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.881 -1.525 . . . . 73.43 106.881 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.472 HG23 ' HB1' ' D' ' 110' ' ' ALA . 64.4 t -118.03 116.84 52.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.977 -1.12 . . . . 75.42 107.977 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 74.1 m -119.17 134.61 55.11 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.615 -0.721 . . . . 74.23 109.461 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 78.1 t -131.01 118.07 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.49 0.716 . . . . 73.34 109.905 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -112.39 97.29 6.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.462 1.105 . . . . 72.01 108.279 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.464 ' HB1' HG13 ' D' ' 40' ' ' VAL . . . -96.2 161.72 13.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.321 0.649 . . . . 74.11 111.318 -173.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.401 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 28.4 p -154.66 137.33 15.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.221 -0.899 . . . . 54.32 111.663 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.568 HD11 HG23 ' D' ' 31' ' ' VAL . 65.8 mt -101.28 96.56 7.27 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.675 -1.148 . . . . 74.23 108.104 168.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.24 -130.48 10.86 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.892 -0.594 . . . . 55.41 112.671 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.26 4.86 21.94 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.109 0.964 . . . . 74.0 112.156 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.567 ' HB3' ' HZ2' ' D' ' 34' ' ' LYS . 6.4 tp10 -133.46 142.46 48.29 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.918 0.887 . . . . 75.33 110.742 -165.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.0 m -60.59 133.14 55.8 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.047 0.939 . . . . 75.55 111.309 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.507 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.06 -72.6 0.57 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.321 -0.992 . . . . 73.13 108.321 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -141.02 153.77 45.69 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 115.804 -0.635 . . . . 70.03 110.514 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 55.5 mt -114.68 151.09 34.2 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.397 1.079 . . . . 71.43 108.207 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.633 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.9 t -158.94 145.27 16.86 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.572 0.349 . . . . 71.42 110.721 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -155.75 122.7 5.35 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.448 0.699 . . . . 72.32 109.647 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.91 115.65 43.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 109.464 -0.569 . . . . 74.05 109.464 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -89.8 83.14 6.18 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.112 0.958 . . . . 73.32 108.775 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.42 91.87 5.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 113.619 -1.628 . . . . 63.51 108.997 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.23 141.95 17.15 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.635 -0.586 . . . . 74.03 111.635 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.533 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -140.07 130.14 4.54 Favored Glycine 0 C--O 1.228 -0.269 0 N-CA-C 111.49 -0.644 . . . . 62.02 111.49 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.7 mt -88.29 122.53 39.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.492 1.117 . . . . 73.53 108.977 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -123.74 156.98 35.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.303 0.641 . . . . 71.32 109.634 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.4 m -115.15 108.08 16.16 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.417 -0.957 . . . . 74.13 108.417 170.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.409 HD11 HD11 ' D' ' 98' ' ' LEU . 41.0 pt -105.75 139.84 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.486 0.714 . . . . 75.32 109.352 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.583 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -160.04 150.58 18.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.652 0.781 . . . . 60.03 109.74 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.43 -16.19 46.09 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.903 -0.387 . . . . 75.41 113.58 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.473 HD11 ' HA ' ' D' ' 94' ' ' MET . 43.2 pt -97.96 149.8 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.752 0.821 . . . . 74.13 109.822 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -168.3 177.68 5.29 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.165 0.586 . . . . 74.31 110.761 -168.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.07 -117.5 11.21 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.698 0.624 . . . . 74.32 112.817 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 19.3 m -92.27 -24.08 19.1 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.456 0.703 . . . . 71.45 110.861 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -61.16 -33.84 74.07 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.909 0.884 . . . . 74.35 111.164 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.473 ' HA ' HD11 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -63.85 -33.98 76.9 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.099 -0.5 . . . . 74.31 111.332 177.379 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.32 -32.61 55.39 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.018 0.527 . . . . 74.34 110.758 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . 0.408 ' O ' ' HB1' ' D' ' 100' ' ' ALA . 14.4 t-80 -72.62 -26.38 61.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.755 0.822 . . . . 74.44 111.264 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -90.54 -50.37 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.931 0.493 . . . . 72.24 110.877 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.603 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 13.9 tp -82.42 -27.21 32.13 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.117 0.567 . . . . 75.4 111.68 -170.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.62 14.13 42.36 Favored Glycine 0 N--CA 1.477 1.379 0 CA-C-O 119.879 -0.401 . . . . 73.5 113.46 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' D' ' 96' ' ' HIS . . . -144.41 -64.41 0.36 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.929 0.492 . . . . 54.1 110.642 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -69.95 -40.11 75.66 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.677 0.391 . . . . 74.34 111.644 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.603 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 85.6 m -66.35 -47.27 59.92 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.405 -0.807 . . . . 73.33 112.152 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.79 -32.62 92.14 Favored 'Trans proline' 0 C--N 1.4 3.237 0 C-N-CA 122.231 1.954 . . . . 73.24 113.386 168.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.46 -30.5 70.86 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.153 0.581 . . . . 74.44 111.678 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.532 HG22 HD11 ' D' ' 13' ' ' ILE . 95.2 mt -72.9 -37.25 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.72 0.808 . . . . 72.53 110.316 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.533 HD22 ' HA3' ' D' ' 82' ' ' GLY . 92.5 mt -75.66 -20.38 58.5 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.226 -0.897 . . . . 74.53 111.769 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -67.94 -43.47 37.09 Favored Pre-proline 0 CA--C 1.563 1.451 0 N-CA-C 113.763 1.023 . . . . 75.42 113.763 -171.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.69 -38.73 87.7 Favored 'Trans proline' 0 C--N 1.395 2.99 0 C-N-CA 121.931 1.754 . . . . 75.33 112.383 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -74.75 -32.74 62.17 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.902 0.751 . . . . 75.33 111.348 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.472 ' HB1' HG23 ' D' ' 62' ' ' VAL . . . -64.71 -53.93 39.46 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.224 -0.658 . . . . 64.52 109.224 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.441 HH12 ' HB3' ' D' ' 130' ' ' PRO . 40.5 ttp180 -58.14 -44.3 87.77 Favored 'General case' 0 C--O 1.212 -0.907 0 O-C-N 124.603 1.189 . . . . 75.03 110.509 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.17 -46.22 89.95 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.863 0.727 . . . . 74.3 111.137 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.82 -44.67 90.91 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.012 0.82 . . . . 73.51 110.339 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.633 HG12 ' SG ' ' D' ' 76' ' ' CYS . 69.0 mt -64.28 -52.29 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 124.033 0.833 . . . . 73.14 110.617 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 88.2 m -56.06 -43.68 78.14 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.679 1.192 . . . . 73.3 111.338 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.6 t -64.83 -41.63 95.58 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.995 -1.002 . . . . 74.33 109.978 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.8 mtm -69.85 -28.76 65.94 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.937 0.495 . . . . 61.34 111.917 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' D' ' 123' ' ' PHE . 54.7 t -70.72 -39.75 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.69 0.796 . . . . 75.44 110.419 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.2 p -76.66 -26.9 55.34 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.73 0.412 . . . . 54.12 110.729 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -73.78 -35.38 64.95 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.133 0.573 . . . . 74.15 109.475 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.95 -0.51 89.59 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 115.743 -0.662 . . . . 74.02 112.338 173.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.2 p 64.9 18.93 11.7 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.899 2.08 . . . . 71.44 114.327 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.45 ' HB2' HG13 ' D' ' 118' ' ' VAL . 96.3 m-85 -79.45 150.79 74.06 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 109.131 -0.692 . . . . 75.24 109.131 169.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.35 137.85 47.04 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.924 2.416 . . . . 62.23 112.771 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -55.74 143.36 31.11 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.915 1.286 . . . . 74.02 113.42 -168.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 50.0 tp -115.17 97.42 6.19 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.336 1.054 . . . . 70.41 109.716 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -104.16 89.65 3.33 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.731 -0.47 . . . . 72.53 109.731 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 36.4 tp -67.05 137.55 56.52 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.434 -0.803 . . . . 73.0 109.714 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.31 130.39 91.65 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.594 0.757 . . . . 74.22 111.113 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.441 ' HB3' HH12 ' D' ' 111' ' ' ARG . 56.6 Cg_endo -70.88 116.84 4.85 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.189 1.926 . . . . 72.03 110.756 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.03 124.39 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.554 0.742 . . . . 72.13 109.773 -171.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -73.9 96.28 2.59 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.659 -0.867 . . . . 73.24 108.659 171.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -68.38 -23.73 64.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.824 -0.625 . . . . 71.31 111.3 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.03 -54.85 41.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.277 1.031 . . . . 72.2 110.642 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.06 91.33 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.306 1.004 . . . . 74.03 111.144 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 16.6 tp -72.93 -22.18 60.77 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 115.85 -0.614 . . . . 73.33 111.634 -176.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 78.4 t80 . . . . . 0 N--CA 1.483 1.199 0 C-N-CA 123.852 0.861 . . . . 75.12 110.044 176.059 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 60.5 m . . . . . 0 C--O 1.244 0.787 0 N-CA-C 108.048 -1.093 . . . . 62.33 108.048 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.615 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.0 t80 -135.88 129.53 32.44 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.298 -0.63 . . . . 73.11 109.298 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -143.43 117.01 9.17 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.639 -1.245 . . . . 75.22 107.639 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.487 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.1 mt -87.07 125.28 40.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.934 -0.765 . . . . 74.43 108.934 176.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.433 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -79.62 -43.86 22.08 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 124.05 0.844 . . . . 74.11 108.901 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -173.38 128.79 0.44 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 119.495 -0.288 . . . . 72.14 111.096 -168.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.7 mt -113.04 124.05 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 123.665 0.786 . . . . 75.12 109.427 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HE1' HG13 ' A' ' 83' ' ' ILE . 25.3 p90 -152.96 141.33 20.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.31 1.044 . . . . 73.2 110.423 -169.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.8 p -75.53 110.98 10.36 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.552 -0.536 . . . . 74.22 109.552 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -75.96 -27.57 57.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.978 -0.378 . . . . 63.1 109.978 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.3 t70 -148.53 138.57 22.36 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.166 -0.924 . . . . 73.34 110.061 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 86.9 mt -134.77 142.32 40.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 125.629 1.572 . . . . 71.0 106.895 173.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -148.73 140.72 23.85 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 123.63 0.581 . . . . 64.32 109.972 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.516 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 77.0 t80 -143.05 127.07 17.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.255 -1.757 . . . . 75.21 106.255 173.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -137.64 121.37 17.47 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.91 -0.404 . . . . 75.21 109.91 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.83 77.24 77.15 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 107.997 -1.112 . . . . 73.44 107.997 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.43 -19.38 37.78 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.059 2.506 . . . . 72.33 112.188 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -120.17 28.91 7.78 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.88 0.872 . . . . 71.33 109.743 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.69 -46.84 99.67 Favored Pre-proline 0 CA--C 1.566 1.58 0 N-CA-C 113.45 0.907 . . . . 55.42 113.45 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.29 -13.23 18.88 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 122.2 1.933 . . . . 63.41 112.576 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -90.81 -34.27 15.37 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.745 0.818 . . . . 74.41 110.717 -173.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.538 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 35.9 m -77.78 -17.42 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.494 0.718 . . . . 75.34 111.416 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.57 ' HD1' HH11 ' B' ' 15' ' ' ARG . 75.2 t80 -60.26 -35.07 74.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.318 1.047 . . . . 74.13 110.145 165.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -86.73 -52.58 5.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.097 0.959 . . . . 74.43 111.65 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.662 ' HZ3' HD11 ' A' ' 68' ' ' LEU . 17.7 ptpt -73.89 170.77 14.68 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.735 0.414 . . . . 72.51 111.419 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.93 128.21 35.13 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.105 -0.498 . . . . 71.24 109.663 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.3 t-105 -72.34 94.2 1.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 O-C-N 123.793 0.683 . . . . 72.22 109.861 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -128.45 84.85 61.97 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.58 1.152 . . . . 70.43 108.706 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 49.2 Cg_endo -87.49 165.25 7.94 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.351 2.034 . . . . 73.4 112.451 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -121.99 106.71 11.46 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.83 -1.174 . . . . 74.43 107.83 168.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.8 m -73.7 92.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-O 122.764 1.268 . . . . 65.51 110.761 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -95.05 124.55 39.16 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.516 -1.22 . . . . 72.34 109.315 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.41 HD21 HD13 ' A' ' 128' ' ' LEU . 50.7 tp -120.52 115.56 23.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.412 0.685 . . . . 75.35 110.072 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 15.1 t70 -106.52 108.43 19.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.945 -1.132 . . . . 74.43 107.945 168.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.412 HD12 HD13 ' A' ' 60' ' ' LEU . 1.2 tm? -97.59 119.2 35.72 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.584 -1.265 . . . . 74.14 107.584 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -127.08 151.11 49.06 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.508 1.123 . . . . 73.04 109.561 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.8 m -134.9 139.78 45.26 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.05 0.94 . . . . 75.13 109.541 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.28 153.6 51.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.913 1.285 . . . . 73.41 108.387 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 m -133.0 151.63 52.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.235 0.614 . . . . 75.3 109.669 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -150.36 121.47 7.74 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.651 -0.87 . . . . 73.21 108.651 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -79.67 125.55 29.78 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.902 0.382 . . . . 73.34 110.762 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.3 mt -93.37 -34.7 13.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.964 0.906 . . . . 74.11 111.448 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -164.19 -172.49 2.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.534 0.734 . . . . 71.2 110.866 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.05 116.98 5.83 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.431 0.693 . . . . 70.22 109.558 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 71.47 -7.19 1.24 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 125.412 1.485 . . . . 75.42 112.419 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.419 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 60.6 t -104.69 125.06 59.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 124.45 1.1 . . . . 73.44 109.1 -174.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -143.0 171.3 14.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.018 -0.734 . . . . 74.44 109.018 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -125.12 152.0 45.0 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.776 -0.824 . . . . 73.44 108.776 167.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.7 t -115.62 126.73 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 107.876 -1.157 . . . . 75.15 107.876 168.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.3 t -97.96 105.48 17.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.046 -1.094 . . . . 74.53 108.046 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.412 HD13 HD12 ' A' ' 44' ' ' LEU . 42.7 tp -91.96 100.19 12.89 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.074 -0.714 . . . . 71.12 109.074 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -83.59 101.37 11.43 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.872 -0.788 . . . . 72.21 108.872 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.4 t -100.14 101.84 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.781 -1.192 . . . . 73.22 107.781 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.8 m -96.36 109.62 22.11 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.174 -0.676 . . . . 71.3 109.174 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.5 t -112.31 131.43 63.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.913 -1.143 . . . . 71.13 107.913 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -135.64 150.55 49.65 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.264 -1.013 . . . . 72.22 108.264 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -139.44 116.43 10.98 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.668 -1.234 . . . . 65.04 107.668 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.7 m -141.38 145.08 34.93 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.677 0.391 . . . . 71.42 111.793 -170.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.662 HD11 ' HZ3' ' A' ' 34' ' ' LYS . 3.2 tm? -94.79 87.53 5.04 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.708 -1.219 . . . . 75.22 107.708 170.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.5 -104.82 1.82 Allowed Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.791 -0.641 . . . . 53.44 112.583 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -95.36 -25.84 16.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.5 0.72 . . . . 71.32 110.771 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.55 123.08 29.39 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.789 0.435 . . . . 74.23 110.504 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 m -77.97 127.07 31.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.022 0.529 . . . . 72.34 110.121 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.43 -51.13 9.19 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.647 -0.871 . . . . 72.42 108.647 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -160.94 159.98 30.25 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.431 -1.259 . . . . 75.22 110.827 172.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 55.2 tp -129.84 143.03 50.6 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.289 1.435 . . . . 72.23 107.776 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.574 ' SG ' HG21 ' A' ' 118' ' ' VAL . 56.9 m -147.17 103.85 3.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.157 0.983 . . . . 71.55 109.099 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -128.54 127.46 42.42 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.654 -0.869 . . . . 73.43 108.654 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.5 t -128.75 110.96 22.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.732 -0.84 . . . . 74.23 108.732 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.666 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.3 mt-30 -85.26 85.67 7.44 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 108.449 -0.945 . . . . 74.2 108.449 171.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.514 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.1 tp-100 -76.51 102.17 5.93 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.096 -1.411 . . . . 75.34 109.035 -178.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.89 164.96 37.74 Favored Glycine 0 C--N 1.337 0.639 0 N-CA-C 111.334 -0.706 . . . . 61.51 111.334 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.05 124.94 1.1 Allowed Glycine 0 CA--C 1.51 -0.272 0 N-CA-C 111.765 -0.534 . . . . 75.15 111.765 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.464 HG13 ' HE1' ' A' ' 17' ' ' TYR . 46.5 mt -81.13 126.06 39.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.275 -0.639 . . . . 70.55 109.275 176.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.615 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 37.3 m-85 -128.56 137.72 51.87 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.388 1.075 . . . . 74.14 108.135 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.5 m -107.77 115.9 30.98 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.726 -0.842 . . . . 73.25 108.726 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.4 tt -105.52 143.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.628 0.771 . . . . 75.32 110.484 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.49 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -161.68 146.41 13.12 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.754 0.821 . . . . 74.51 109.701 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.36 -32.45 6.81 Favored Glycine 0 C--N 1.341 0.84 0 O-C-N 123.541 0.526 . . . . 63.15 113.713 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.29 146.11 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.947 0.499 . . . . 74.43 112.179 -165.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -135.71 173.07 12.12 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.279 1.031 . . . . 75.04 110.46 -174.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 56.95 -115.66 6.78 Favored Glycine 0 C--N 1.356 1.666 0 N-CA-C 115.61 1.004 . . . . 63.52 115.61 170.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.5 p -66.17 -33.98 77.0 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.671 0.789 . . . . 75.42 111.159 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -70.17 -43.43 70.82 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.199 -0.91 . . . . 71.31 110.874 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.501 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 13.2 ptt? -66.04 -37.23 85.34 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.132 -0.692 . . . . 75.31 109.132 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.78 81.58 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 123.542 0.737 . . . . 72.3 110.628 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -64.87 -35.8 82.31 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.646 -0.706 . . . . 75.1 110.639 174.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 61.0 m -69.0 -41.66 77.5 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.013 0.525 . . . . 71.24 111.331 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 94' ' ' MET . 65.3 mt -78.9 -43.69 24.32 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.513 0.725 . . . . 73.53 111.885 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.72 4.01 53.3 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-O 119.268 -0.74 . . . . 74.24 114.472 -169.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.48 -57.91 0.23 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 118.075 0.938 . . . . 74.4 112.611 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.596 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 81.3 t80 -66.51 -53.92 29.66 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.996 0.918 . . . . 72.04 112.005 -168.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.3 m -72.98 -36.42 3.36 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.611 -0.709 . . . . 72.52 112.842 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.404 ' HB3' HD11 ' A' ' 60' ' ' LEU . 77.0 Cg_exo -49.97 -41.35 48.31 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.405 2.07 . . . . 74.23 113.265 161.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -67.36 -32.96 74.25 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.652 0.781 . . . . 75.35 111.227 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.37 -45.25 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.225 0.61 . . . . 74.02 110.305 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.514 HD23 ' HG3' ' A' ' 80' ' ' GLN . 74.3 mt -74.85 -20.74 59.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.116 -0.947 . . . . 73.31 112.144 -175.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.552 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 61.9 t80 -62.3 -44.79 89.37 Favored Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 114.134 1.161 . . . . 74.43 114.134 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -59.54 -37.93 85.75 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 121.878 1.719 . . . . 75.21 112.988 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -70.15 -42.0 73.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.421 0.688 . . . . 75.24 111.029 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.07 -36.6 72.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.856 -0.611 . . . . 74.11 110.844 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.583 ' NH1' HD13 ' C' ' 105' ' ' ILE . 32.0 ttm180 -50.43 -56.41 11.57 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.353 1.033 . . . . 73.24 109.669 174.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -65.39 -43.39 90.81 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.345 1.028 . . . . 72.05 111.8 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.595 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.4 t -61.39 -24.82 66.77 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.048 0.539 . . . . 73.15 112.151 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.8 mt -84.93 -53.71 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.163 0.985 . . . . 72.2 109.821 172.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.546 HG23 ' HG3' ' A' ' 125' ' ' GLN . 85.5 m -53.33 -52.53 58.87 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.931 1.292 . . . . 71.51 112.521 -174.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.3 t -58.41 -44.55 89.09 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.398 -0.819 . . . . 75.51 110.646 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.516 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.3 ttp -66.15 -32.34 73.72 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.422 1.089 . . . . 62.05 111.644 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.574 HG21 ' SG ' ' A' ' 76' ' ' CYS . 87.1 t -70.39 -45.14 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.117 0.967 . . . . 75.11 110.423 174.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.8 m -68.08 -25.59 65.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.557 0.743 . . . . 71.42 111.596 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -72.55 -32.38 66.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.668 0.787 . . . . 75.33 109.541 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.93 0.34 83.08 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 124.005 0.816 . . . . 64.51 113.288 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.8 m 65.72 16.5 10.52 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.754 1.222 . . . . 74.5 111.199 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -86.8 153.83 55.3 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.79 0.836 . . . . 75.22 109.058 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -53.63 119.19 5.82 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 123.162 2.575 . . . . 75.51 112.343 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.546 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.9 tt0 -53.0 128.93 29.01 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.304 1.042 . . . . 74.15 111.627 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 pp -109.36 137.18 47.61 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.462 -0.94 . . . . 72.21 108.462 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -123.19 91.67 3.53 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.029 -1.471 . . . . 74.53 107.029 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.552 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -63.46 122.24 15.78 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.198 -0.91 . . . . 75.43 109.45 -173.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.64 140.17 96.96 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.223 0.609 . . . . 72.34 110.806 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.12 128.74 29.91 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.41 2.073 . . . . 75.44 111.754 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.3 t -97.82 137.01 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.972 -0.751 . . . . 73.34 108.972 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.431 HD21 ' HB1' ' A' ' 135' ' ' ALA . 1.8 p-10 -77.1 69.04 3.33 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.569 1.148 . . . . 71.14 111.249 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -53.21 -43.6 67.36 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.139 0.976 . . . . 73.12 111.621 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -58.86 -51.64 69.13 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.226 0.953 . . . . 74.14 111.201 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 132' ' ' ASN . . . -62.97 -41.15 99.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.872 0.733 . . . . 51.34 111.582 -176.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.29 -44.53 95.29 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.217 0.948 . . . . 73.0 110.269 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -72.99 -30.96 64.19 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 115.388 -0.824 . . . . 75.53 110.672 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 15.9 mmt . . . . . 0 N--CA 1.484 1.258 0 C-N-CA 123.26 0.624 . . . . 72.53 111.44 179.828 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 C--O 1.238 0.491 0 N-CA-C 107.946 -1.131 . . . . 74.11 107.946 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -137.46 142.94 41.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.014 0.525 . . . . 73.23 109.633 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -144.59 141.0 29.12 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.465 0.706 . . . . 74.34 109.755 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 31.6 mt -94.59 125.77 47.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 107.705 -1.22 . . . . 74.43 107.705 170.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -92.8 -41.25 10.2 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.618 -0.512 . . . . 75.24 109.618 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.57 HH11 ' HD1' ' A' ' 32' ' ' PHE . 58.9 ttt180 -168.92 132.86 1.43 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.613 -0.721 . . . . 74.32 109.562 -173.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.415 HD13 HD21 ' D' ' 127' ' ' ASN . 81.7 mt -114.84 135.32 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 106.595 -1.632 . . . . 74.4 106.595 170.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.447 ' HE1' HG13 ' B' ' 83' ' ' ILE . 19.2 p90 -165.52 139.97 4.79 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.229 0.538 . . . . 71.44 110.921 -172.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.4 m -73.4 125.57 28.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.052 -0.976 . . . . 73.32 108.929 174.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -98.35 -27.81 13.94 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.478 0.711 . . . . 74.4 110.855 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.7 t70 -157.16 137.7 13.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.62 0.368 . . . . 64.33 110.837 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.435 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.6 mm -133.37 145.03 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.644 1.178 . . . . 74.42 108.963 174.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -141.31 141.57 33.89 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.723 1.209 . . . . 73.24 108.427 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.409 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 71.8 t80 -156.07 113.98 3.32 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.143 -1.058 . . . . 73.43 108.143 170.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.18 115.91 20.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.825 0.85 . . . . 73.32 109.213 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.92 86.31 3.02 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.141 -1.059 . . . . 75.44 108.141 172.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.65 -27.64 26.75 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 122.869 2.38 . . . . 65.41 112.73 -172.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -108.75 15.85 23.28 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.564 -0.731 . . . . 65.1 110.574 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.06 -61.7 1.06 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 115.122 1.527 . . . . 62.41 115.122 -164.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.95 -31.06 56.88 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 121.837 1.692 . . . . 72.22 112.735 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -74.81 -49.23 21.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.681 0.792 . . . . 71.53 110.923 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.632 HG23 HD13 ' B' ' 68' ' ' LEU . 8.6 p -67.97 -21.98 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.771 0.828 . . . . 73.3 112.281 -164.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -66.38 -8.12 23.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.444 0.697 . . . . 70.35 112.822 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.568 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 27.7 pt20 -58.25 -26.03 62.42 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.439 0.696 . . . . 71.24 111.575 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.568 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 90.6 mttt -104.16 105.07 15.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.898 0.879 . . . . 75.43 109.077 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.29 81.31 8.76 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.426 0.631 . . . . 72.55 109.298 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -152.69 156.99 40.25 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.839 -1.171 . . . . 74.15 107.839 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -79.7 110.59 16.23 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 107.318 -1.364 . . . . 75.25 107.318 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.465 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 18.1 Cg_endo -58.03 139.67 91.25 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 123.079 2.519 . . . . 74.52 114.484 -170.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -65.89 124.15 21.71 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 124.236 0.96 . . . . 71.32 109.471 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.42 HG12 ' HB1' ' B' ' 66' ' ' ALA . 31.0 m -103.68 165.28 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.782 0.833 . . . . 72.54 112.459 -171.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -134.24 114.54 13.15 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 106.386 -1.709 . . . . 74.21 106.386 172.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 5.8 mp -86.27 133.97 33.79 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.405 1.082 . . . . 74.35 108.324 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -149.03 111.72 4.79 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.622 -1.251 . . . . 75.31 107.622 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.97 167.81 10.5 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.069 0.462 . . . . 75.0 109.893 -173.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 26.0 t70 -160.99 141.12 11.02 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.483 1.113 . . . . 64.03 109.139 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 22.8 p -136.28 125.13 24.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.414 0.686 . . . . 72.35 109.62 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.16 154.34 46.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.445 1.098 . . . . 64.24 108.318 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.2 p -142.36 170.51 15.56 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.963 0.411 . . . . 74.43 111.22 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.21 137.52 17.53 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.18 -0.918 . . . . 72.44 109.154 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -82.02 126.29 31.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.935 0.494 . . . . 73.11 109.947 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 91.1 mt -93.28 -34.2 13.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.203 0.601 . . . . 74.23 110.396 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.99 -173.53 2.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.641 0.776 . . . . 72.4 110.707 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.98 127.84 34.08 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.749 -1.114 . . . . 75.32 109.192 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 67.72 0.03 2.13 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.537 1.135 . . . . 74.21 112.612 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 109.9 30.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 123.66 0.784 . . . . 73.25 109.005 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -123.52 137.93 54.67 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.441 -0.948 . . . . 74.11 108.441 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -108.68 106.33 16.33 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.284 -1.376 . . . . 64.34 107.284 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.582 HG21 ' HG ' ' B' ' 98' ' ' LEU . 86.7 t -92.27 142.42 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 O-C-N 124.101 0.876 . . . . 54.31 109.925 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.73 141.54 42.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.731 -0.84 . . . . 74.32 108.731 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.437 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -124.29 105.51 9.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.284 -1.376 . . . . 75.51 107.284 178.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.537 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 36.4 ttm180 -92.68 123.87 36.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.794 0.438 . . . . 74.42 109.889 171.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.42 ' HB ' HD11 ' B' ' 114' ' ' ILE . 44.3 t -114.57 108.55 25.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.552 -1.277 . . . . 72.15 107.552 170.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 27.5 m -95.07 135.98 35.96 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.719 -0.845 . . . . 73.31 108.719 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.48 129.76 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.915 0.886 . . . . 73.14 109.146 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 28.8 m -118.01 142.43 47.38 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 107.961 -1.126 . . . . 72.03 107.961 169.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -144.79 155.51 43.56 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 117.803 0.274 . . . . 60.13 110.595 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 39.7 p -155.14 138.87 16.14 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 124.154 0.909 . . . . 74.32 111.007 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.632 HD13 HG23 ' B' ' 31' ' ' VAL . 67.7 mt -96.65 107.03 19.41 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.301 -0.863 . . . . 74.23 108.749 170.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.29 -111.56 4.18 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 114.885 -1.052 . . . . 64.51 112.847 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -108.58 0.03 20.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.64 0.776 . . . . 74.41 110.978 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.49 142.67 47.36 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.73 -0.606 . . . . 73.32 110.182 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.7 m -63.94 134.84 55.85 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 123.16 0.584 . . . . 72.14 111.238 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.11 -65.97 0.97 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.253 -0.885 . . . . 74.22 108.644 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -150.45 158.19 43.88 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.518 -0.765 . . . . 65.0 111.046 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 58.2 mt -128.3 108.98 11.04 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.105 -1.813 . . . . 74.25 106.105 172.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.8 t -119.26 148.34 43.25 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.344 -0.613 . . . . 75.33 109.344 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -160.4 134.71 7.35 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.152 -0.684 . . . . 65.21 109.152 -178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.416 HG21 HD12 ' B' ' 21' ' ' ILE . 94.9 t -125.79 144.0 37.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.163 -0.926 . . . . 71.12 108.636 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.4 mt-30 -122.9 85.94 2.5 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.891 -1.151 . . . . 74.4 107.891 172.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -80.01 101.08 8.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.199 -1.364 . . . . 74.3 108.623 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.74 167.92 27.35 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 111.558 -0.617 . . . . 71.11 111.558 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.41 130.76 2.2 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 112.099 -0.4 . . . . 72.12 112.099 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.447 HG13 ' HE1' ' B' ' 17' ' ' TYR . 61.1 mt -85.14 120.36 35.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.028 -1.101 . . . . 73.24 108.028 171.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -127.46 135.58 50.61 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.208 0.603 . . . . 64.52 109.54 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 68.2 m -97.93 109.33 22.11 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.019 0.527 . . . . 73.11 109.755 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.564 ' HB ' HG12 ' B' ' 89' ' ' ILE . 38.9 pt -102.47 122.66 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.316 1.046 . . . . 74.13 109.045 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.84 141.6 44.7 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.616 0.766 . . . . 73.35 109.612 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.53 -29.33 4.06 Favored Glycine 0 N--CA 1.473 1.157 0 CA-C-O 119.925 -0.375 . . . . 63.43 113.343 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.564 HG12 ' HB ' ' B' ' 86' ' ' ILE . 2.8 pp -56.23 132.53 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.874 0.87 . . . . 63.23 111.94 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -160.43 161.4 32.96 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 120.922 0.391 . . . . 72.12 111.688 176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.22 -95.65 1.56 Allowed Glycine 0 C--N 1.352 1.455 0 CA-C-N 115.484 -0.78 . . . . 75.24 111.286 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.2 m -105.22 -20.45 13.5 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.392 0.677 . . . . 73.55 110.247 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.66 -31.02 71.11 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.468 0.707 . . . . 71.51 111.319 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.506 ' HA ' HD12 ' B' ' 89' ' ' ILE . 21.5 ptt? -58.06 -44.88 87.72 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 123.985 0.803 . . . . 74.05 110.928 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . 0.42 ' HB3' ' HZ ' ' B' ' 137' ' ' PHE . . . -76.16 -50.28 15.0 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 123.988 0.915 . . . . 63.52 109.679 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -60.13 -31.6 70.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.674 0.79 . . . . 75.11 111.88 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 11.7 t -73.38 -63.15 1.25 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.353 0.408 . . . . 72.24 110.262 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.582 ' HG ' HG21 ' B' ' 58' ' ' VAL . 10.3 tt -67.6 -39.2 84.77 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.323 0.49 . . . . 73.11 112.323 -172.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.42 3.34 57.88 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 114.965 0.746 . . . . 64.2 114.965 -168.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.48 -56.1 0.27 Allowed 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 117.675 0.737 . . . . 61.12 111.381 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -71.39 -46.64 59.79 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.584 0.754 . . . . 73.31 111.85 -171.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.446 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 75.1 m -65.86 -47.85 63.65 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 123.728 0.811 . . . . 71.24 111.363 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.4 Cg_exo -58.42 -32.88 97.23 Favored 'Trans proline' 0 C--N 1.398 3.143 0 C-N-CA 122.337 2.025 . . . . 74.43 113.629 168.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -62.03 -39.27 91.73 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.209 0.603 . . . . 75.51 110.316 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.68 -45.03 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.576 0.75 . . . . 74.32 110.457 174.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.27 -18.36 60.09 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.891 -1.05 . . . . 74.12 112.192 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -60.91 -51.09 81.88 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 117.784 -1.103 . . . . 65.34 113.563 -171.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -59.16 -33.44 98.25 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 121.939 1.76 . . . . 75.32 112.949 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -69.54 -47.36 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.334 0.654 . . . . 75.34 110.556 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.97 88.73 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.549 0.74 . . . . 75.51 110.531 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.69 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 53.3 ttt180 -60.46 -55.99 26.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.627 1.571 . . . . 75.32 111.028 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.72 -34.79 79.01 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 124.053 0.846 . . . . 65.11 110.128 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.497 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.9 t -67.04 -35.3 79.59 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 122.768 0.427 . . . . 74.13 111.825 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.42 HD11 ' HB ' ' B' ' 62' ' ' VAL . 64.5 mt -64.26 -52.96 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.986 -0.746 . . . . 73.41 108.986 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -59.44 -30.68 68.67 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 124.498 1.124 . . . . 74.43 111.769 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.9 t -66.65 -46.54 75.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.615 0.766 . . . . 71.23 110.277 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.2 mmt -68.25 -35.16 77.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.993 0.517 . . . . 73.34 110.663 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 68.9 t -58.13 -48.18 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.278 1.031 . . . . 74.52 110.437 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.49 ' HB3' HG21 ' C' ' 115' ' ' THR . 65.5 m -61.23 -35.89 78.44 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.444 -1.253 . . . . 74.52 112.042 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.595 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 74.4 mtt-85 -69.15 -37.11 78.07 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.421 -0.809 . . . . 71.01 110.1 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.51 11.23 59.43 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.749 0.656 . . . . 61.15 113.297 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 57.5 p 64.2 18.79 11.47 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.317 1.847 . . . . 75.32 114.687 172.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -80.95 151.29 70.32 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 109.148 -0.686 . . . . 74.14 109.148 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.95 -160.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.68 2.92 . . . . 74.21 114.102 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -65.9 111.33 3.24 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 121.017 0.436 . . . . 75.11 110.76 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.421 HD23 ' HD2' ' B' ' 38' ' ' PRO . 4.0 mm? -122.63 84.7 2.3 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.392 -0.966 . . . . 74.4 108.392 171.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -92.7 128.04 38.41 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.328 -0.619 . . . . 73.43 109.328 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.69 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 32.9 tp -71.98 136.78 46.89 Favored 'General case' 0 CA--C 1.552 1.034 0 O-C-N 123.952 0.783 . . . . 70.32 109.785 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.06 151.98 92.69 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.127 0.571 . . . . 72.41 111.304 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.482 ' HG3' HD11 ' D' ' 16' ' ' ILE . 25.3 Cg_exo -61.3 102.9 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 122.311 2.007 . . . . 74.23 111.836 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.89 111.37 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.168 -1.049 . . . . 73.31 108.168 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -78.91 99.43 6.79 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.237 -1.023 . . . . 73.53 108.237 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -62.95 -48.03 80.62 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 123.371 0.42 . . . . 75.25 110.795 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.07 -41.74 90.35 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.369 1.068 . . . . 73.12 112.966 -166.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.29 -34.41 63.52 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.368 0.667 . . . . 75.54 111.347 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.8 mp -77.65 -32.15 53.12 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.232 0.613 . . . . 74.44 109.928 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . 0.42 ' HZ ' ' HB3' ' B' ' 95' ' ' ALA . 92.7 t80 . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 124.753 1.221 . . . . 74.1 110.452 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 58.5 m . . . . . 0 C--O 1.239 0.522 0 N-CA-C 108.194 -1.039 . . . . 75.11 108.194 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.577 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 4.5 t80 -123.6 125.48 44.92 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.968 -0.753 . . . . 74.42 108.968 176.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -147.02 119.99 8.75 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.065 -1.087 . . . . 71.45 108.065 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.5 mt -74.08 122.25 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.901 -0.777 . . . . 74.34 108.901 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.68 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.3 mm-40 -85.0 -45.74 11.86 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.173 -0.922 . . . . 72.23 110.508 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -174.16 126.02 0.34 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.032 -0.531 . . . . 75.22 110.31 -168.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.78 141.64 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 107.868 -1.16 . . . . 74.53 107.868 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -173.15 168.43 4.75 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.306 0.574 . . . . 75.24 111.941 -175.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -89.38 117.57 28.42 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.013 -0.736 . . . . 63.13 109.013 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -78.73 -35.47 44.73 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.506 -0.553 . . . . 75.5 109.506 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 13.9 t70 -146.62 147.83 31.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.127 -0.942 . . . . 71.14 109.323 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.0 mt -141.83 146.09 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.169 1.388 . . . . 75.45 107.394 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.7 t -158.11 149.35 21.13 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.355 0.597 . . . . 75.4 110.748 174.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -143.49 145.11 32.32 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.446 -1.316 . . . . 71.43 107.446 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.1 mt-10 -135.05 127.9 31.26 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.987 0.915 . . . . 75.24 109.926 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.72 72.7 7.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.591 1.557 . . . . 75.14 106.933 170.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.1 -39.94 21.96 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.763 2.309 . . . . 74.42 111.062 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -93.46 22.29 5.45 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 113.846 -1.525 . . . . 65.03 111.279 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.21 -56.08 5.79 Favored Pre-proline 0 CA--C 1.564 1.509 0 N-CA-C 114.135 1.161 . . . . 71.23 114.135 -173.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.42 -38.15 44.58 Favored 'Trans proline' 0 C--N 1.389 2.691 0 CA-C-N 121.77 1.668 . . . . 65.12 112.716 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -69.4 -38.42 77.94 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.596 0.759 . . . . 74.51 112.103 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.705 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.4 p -77.08 -22.26 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 N-CA-C 112.286 0.476 . . . . 75.02 112.286 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -68.1 -30.0 69.06 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.925 0.393 . . . . 74.33 110.87 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -99.82 31.67 3.17 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.255 0.622 . . . . 64.53 110.574 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.585 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.7 tppp? -108.86 157.79 18.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.83 0.852 . . . . 72.23 109.746 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -61.61 121.36 12.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.062 -0.718 . . . . 75.52 109.062 168.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 58.7 t-105 -86.55 96.6 10.13 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.146 0.578 . . . . 72.03 110.478 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . 0.401 ' H ' HD23 ' C' ' 68' ' ' LEU . 63.7 tt0 -144.72 78.48 12.88 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 108.585 -0.894 . . . . 74.44 108.585 170.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -85.67 139.96 6.89 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.74 2.293 . . . . 61.21 112.641 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . 0.423 ' HB3' ' HE3' ' C' ' 41' ' ' LYS . 36.6 mt-10 -87.28 85.43 7.17 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.15 -1.796 . . . . 73.51 106.15 169.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 48.1 t -63.13 107.99 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.504 0 CA-C-N 114.698 -1.137 . . . . 75.14 108.655 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' C' ' 39' ' ' GLU . 99.2 mttt -125.12 104.8 8.73 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.008 0.923 . . . . 73.32 109.763 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.51 HD12 HD22 ' C' ' 126' ' ' LEU . 4.0 mm? -86.09 125.6 33.58 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.159 -0.928 . . . . 74.54 109.194 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -118.25 105.31 11.63 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.812 -1.181 . . . . 71.01 107.812 173.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 tt -107.57 122.31 46.42 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.464 -0.569 . . . . 71.42 109.464 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -124.27 142.54 51.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.969 1.308 . . . . 74.21 108.654 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 1.5 m -123.48 126.6 47.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.465 0.65 . . . . 73.21 109.597 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.55 170.33 8.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.275 -1.329 . . . . 70.32 107.872 171.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -165.0 156.84 15.34 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.048 -0.723 . . . . 65.12 109.048 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 49.9 p -156.64 136.75 12.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.845 0.458 . . . . 74.4 110.713 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -70.2 126.35 29.41 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.415 -0.587 . . . . 74.13 109.415 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' C' ' 57' ' ' GLU . 57.6 mt -97.47 -35.93 10.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.421 0.688 . . . . 73.31 110.336 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.0 -174.08 4.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.031 0.933 . . . . 74.23 110.455 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -62.29 106.73 0.78 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.237 -0.892 . . . . 75.42 109.874 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 68.68 11.03 8.21 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.498 1.119 . . . . 72.21 112.876 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 99.4 t -105.94 105.76 19.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.62 -1.252 . . . . 74.31 107.62 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -117.73 123.88 47.12 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.722 -0.844 . . . . 75.13 108.722 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.682 ' HB2' HD12 ' C' ' 51' ' ' LEU . 43.6 tt0 -85.54 143.87 28.25 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.748 0.819 . . . . 75.05 109.218 171.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.564 HG11 HD12 ' C' ' 106' ' ' LEU . 43.7 t -119.26 139.08 47.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 108.102 -1.073 . . . . 74.51 108.102 166.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.76 123.36 65.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 107.43 -1.322 . . . . 71.43 107.43 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.4 107.7 18.82 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.629 -0.878 . . . . 75.02 108.629 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.15 102.96 14.81 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.706 -0.85 . . . . 71.23 108.706 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.416 ' HB ' HD11 ' C' ' 114' ' ' ILE . 58.7 t -103.59 108.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.344 -0.984 . . . . 74.31 108.344 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.7 m -98.1 137.1 37.39 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.853 -1.166 . . . . 71.13 107.853 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.52 HG12 HD21 ' C' ' 126' ' ' LEU . 61.3 t -132.24 108.82 14.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.591 -0.522 . . . . 71.25 109.591 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -103.9 142.93 33.55 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.117 -0.947 . . . . 74.11 109.737 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.26 123.23 15.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.874 -1.528 . . . . 62.23 106.874 173.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 7.9 m -130.45 128.42 41.23 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.492 0.495 . . . . 61.32 109.968 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.401 HD23 ' H ' ' C' ' 37' ' ' GLN . 18.3 mt -86.93 47.57 1.52 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.4 1.08 . . . . 75.43 108.752 175.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.22 -109.47 3.71 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 110.091 -1.204 . . . . 61.5 110.091 -172.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.29 -26.46 17.31 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.292 1.037 . . . . 72.43 110.418 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.585 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 3.9 tp10 -71.78 121.3 18.69 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.297 0.639 . . . . 72.41 110.028 173.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -68.63 126.37 29.47 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.65 -0.87 . . . . 75.03 108.65 168.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.705 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.6 -58.49 3.25 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.164 -1.05 . . . . 62.13 108.164 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.07 165.45 27.19 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.795 -1.093 . . . . 74.52 110.169 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.471 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.6 tm? -128.62 140.42 51.78 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.387 -1.708 . . . . 74.5 106.387 168.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.517 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.5 t -144.35 140.09 28.88 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.124 -1.065 . . . . 73.34 108.124 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -156.29 137.0 13.31 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 110.152 -0.314 . . . . 73.2 110.152 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -136.21 135.29 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.066 0.946 . . . . 74.22 108.833 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 41.9 mt-30 -107.07 94.62 5.2 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.259 1.023 . . . . 75.32 109.388 173.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -85.59 98.1 10.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.989 -1.005 . . . . 71.34 110.226 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.69 145.98 17.9 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 112.117 -0.393 . . . . 64.54 112.117 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.441 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.51 124.72 1.84 Allowed Glycine 0 CA--C 1.507 -0.441 0 N-CA-C 110.568 -1.013 . . . . 75.02 110.568 -174.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.68 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 4.8 mm -82.82 123.55 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.513 -0.921 . . . . 75.22 108.513 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.577 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 64.2 m-85 -129.32 120.7 26.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.222 0.609 . . . . 71.4 109.512 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -70.81 118.82 14.08 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.137 -0.69 . . . . 74.31 109.137 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.747 HD11 ' HB2' ' C' ' 94' ' ' MET . 4.7 tt -122.05 122.88 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.312 0.645 . . . . 71.03 110.313 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.609 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -156.57 168.89 26.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.493 0.717 . . . . 62.22 109.656 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.96 -54.45 4.3 Favored Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.045 0.355 . . . . 71.32 112.495 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 pt -83.01 156.1 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.408 1.083 . . . . 73.03 110.964 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.98 175.81 10.39 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.543 0.737 . . . . 70.5 110.635 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.11 -127.71 43.16 Favored Glycine 0 C--N 1.349 1.27 0 O-C-N 123.981 0.801 . . . . 73.14 114.128 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p -70.07 -26.95 64.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.017 0.927 . . . . 71.14 111.97 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -68.49 -44.65 74.29 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.869 0.868 . . . . 74.32 110.705 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.747 ' HB2' HD11 ' C' ' 86' ' ' ILE . 3.6 ppp? -74.13 -33.75 63.66 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.729 -0.471 . . . . 61.33 109.729 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.31 93.6 Favored 'General case' 0 C--N 1.36 1.046 0 O-C-N 124.242 0.964 . . . . 73.23 110.391 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.473 ' HE2' ' HA ' ' C' ' 134' ' ' ASP . 12.5 t-80 -80.97 -33.9 33.49 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.046 0.841 . . . . 72.51 112.301 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.9 t -55.4 -38.44 68.92 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.444 0.465 . . . . 74.32 110.053 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 30.6 mt -101.46 -13.29 18.0 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.74 0.816 . . . . 75.44 111.609 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.55 -30.54 56.32 Favored Glycine 0 C--N 1.354 1.58 0 N-CA-C 114.982 0.753 . . . . 74.33 114.982 -174.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.61 -35.38 0.07 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.814 0.445 . . . . 73.14 110.774 -171.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -68.45 -50.15 54.69 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.958 1.303 . . . . 75.45 112.467 -177.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 66.7 m -71.89 -41.39 9.02 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.877 -0.582 . . . . 63.02 112.354 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -53.84 -32.0 64.8 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 122.561 2.174 . . . . 71.51 113.927 166.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -69.24 -34.81 75.38 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.363 0.665 . . . . 63.15 109.904 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.583 HD13 ' NH1' ' A' ' 111' ' ' ARG . 34.2 mm -62.86 -40.45 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 109.37 -0.604 . . . . 73.23 109.37 174.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.564 HD12 HG11 ' C' ' 58' ' ' VAL . 69.1 mt -82.26 -17.98 44.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.296 1.038 . . . . 72.21 112.449 -177.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -60.07 -50.36 86.65 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-O 117.911 -1.043 . . . . 75.11 113.662 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.31 -31.51 62.88 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 121.955 1.77 . . . . 74.44 112.818 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -70.24 -47.76 59.91 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.178 0.591 . . . . 64.23 110.556 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.95 84.3 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.346 -0.843 . . . . 43.23 109.948 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -59.93 -49.35 78.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.021 1.329 . . . . 75.51 110.855 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.41 -39.1 91.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.375 0.67 . . . . 74.3 110.517 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 19.6 t -66.79 -27.53 67.65 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.826 0.45 . . . . 65.44 111.659 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.517 HG23 ' SG ' ' C' ' 76' ' ' CYS . 63.5 mt -80.78 -43.46 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.218 0.607 . . . . 71.32 110.067 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.49 HG21 ' HB3' ' B' ' 119' ' ' SER . 5.7 m -61.16 -29.33 69.73 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.321 0.582 . . . . 61.34 110.373 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -72.92 -53.5 11.14 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.754 -1.112 . . . . 72.14 109.818 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.534 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.37 -39.09 92.04 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.954 0.902 . . . . 65.42 113.167 -175.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 78.3 t -64.99 -42.17 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.689 0.795 . . . . 75.24 110.184 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -69.46 -29.95 67.75 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.26 -0.882 . . . . 73.42 111.244 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 86.4 mtt-85 -68.5 -39.24 81.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.636 0.775 . . . . 75.2 108.921 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.32 1.47 81.09 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 123.908 0.755 . . . . 64.25 113.17 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 38.4 p 64.03 27.31 14.22 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.543 1.937 . . . . 74.14 113.941 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -92.19 149.39 38.5 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 109.012 -0.736 . . . . 74.34 109.012 171.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -45.03 119.68 2.57 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.583 2.855 . . . . 74.12 113.128 170.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -59.9 155.9 15.51 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.81 1.244 . . . . 71.23 113.566 -170.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.52 HD21 HG12 ' C' ' 64' ' ' VAL . 34.3 tp -104.2 102.33 12.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.779 0.832 . . . . 75.51 109.89 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.76 89.77 4.46 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.951 -1.129 . . . . 73.31 107.951 168.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.03 134.39 43.01 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.628 -0.714 . . . . 75.11 110.282 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.96 151.6 96.14 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 124.111 0.964 . . . . 74.01 111.746 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.52 121.22 9.53 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.983 2.456 . . . . 73.22 112.683 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 t -102.95 137.6 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.966 -0.753 . . . . 74.45 108.966 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -82.27 73.4 9.31 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.541 -0.54 . . . . 73.44 109.541 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -61.53 -43.64 98.5 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.386 -0.824 . . . . 71.54 109.481 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.473 ' HA ' ' HE2' ' C' ' 96' ' ' HIS . 19.6 m-20 -64.07 -53.51 48.72 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 113.954 -1.475 . . . . 73.05 111.837 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.03 -38.4 70.51 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.487 1.117 . . . . 74.11 111.171 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.78 -45.0 79.84 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.213 -0.903 . . . . 75.32 110.693 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.488 1.458 0 C-N-CA 123.052 0.541 . . . . 71.24 110.422 179.466 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' D' ' 87' ' ' ALA . 90.0 m . . . . . 0 C--O 1.239 0.508 0 N-CA-C 108.79 -0.818 . . . . 72.21 108.79 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -159.95 90.13 0.9 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.56 -1.274 . . . . 75.23 107.56 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -118.78 116.91 27.53 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.24 -1.022 . . . . 72.33 108.24 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.445 HG22 HD13 ' D' ' 16' ' ' ILE . 13.7 mt -73.2 109.97 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.091 -0.707 . . . . 75.41 109.091 177.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -80.65 -37.85 30.18 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.449 0.7 . . . . 74.23 111.846 -173.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -168.9 139.01 2.3 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 117.414 0.097 . . . . 65.13 111.126 -168.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.482 HD11 ' HG3' ' B' ' 130' ' ' PRO . 2.4 mp -117.82 135.04 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.144 -1.428 . . . . 75.03 107.144 169.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -160.53 150.29 17.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.434 0.635 . . . . 74.21 111.798 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 64.3 p -86.5 113.56 22.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.949 -1.023 . . . . 74.2 109.18 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -81.31 -22.04 38.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.298 0.639 . . . . 74.51 110.554 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.476 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.6 t70 -160.39 142.39 12.74 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.151 -0.931 . . . . 74.34 109.042 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.534 HG23 ' HE1' ' C' ' 117' ' ' MET . 85.5 mt -138.65 143.54 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.116 -1.068 . . . . 74.35 108.116 175.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -143.54 133.12 23.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.754 0.822 . . . . 75.32 108.916 171.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.526 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.4 t80 -134.77 131.85 38.03 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.328 -1.73 . . . . 74.2 106.328 166.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.637 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 25.4 mt-10 -133.09 130.41 39.28 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.91 0.884 . . . . 75.44 108.83 -173.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.65 78.34 31.59 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.048 -1.093 . . . . 74.52 108.048 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.52 -31.29 21.87 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.896 2.397 . . . . 72.14 112.388 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -99.84 -1.29 37.86 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.457 -1.247 . . . . 72.31 110.971 -173.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -29.93 -67.2 0.14 Allowed Pre-proline 0 C--N 1.36 1.058 0 C-N-CA 126.517 1.927 . . . . 75.15 116.134 -160.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.531 ' HB3' HD11 ' C' ' 83' ' ' ILE . 80.9 Cg_endo -71.62 -29.64 15.83 Favored 'Trans proline' 0 C--N 1.375 1.959 0 CA-C-N 122.63 1.975 . . . . 72.13 113.318 -170.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.424 ' HA ' HE21 ' D' ' 33' ' ' GLN . 5.8 p-80 -84.91 -23.44 28.87 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 117.678 0.217 . . . . 74.22 111.137 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.474 HG23 HD11 ' D' ' 68' ' ' LEU . 8.9 p -80.6 -26.73 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 122.65 0.38 . . . . 74.34 110.444 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -61.71 -25.4 67.4 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.328 0.651 . . . . 74.22 112.436 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.424 HE21 ' HA ' ' D' ' 30' ' ' HIS . 74.3 mt-30 -53.21 -28.78 28.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.275 1.03 . . . . 75.23 111.509 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -84.1 101.52 11.87 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.139 0.975 . . . . 74.01 110.116 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.34 80.43 7.75 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.991 -1.004 . . . . 75.33 108.987 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.43 ' HD1' HD23 ' D' ' 68' ' ' LEU . 50.6 t-105 -142.98 156.47 44.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.85 1.26 . . . . 73.14 108.253 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -80.3 101.98 1.08 Allowed Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 108.066 -1.087 . . . . 72.34 108.066 174.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.92 119.72 6.5 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.084 2.523 . . . . 74.22 112.901 -167.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.84 112.86 2.73 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 123.957 0.785 . . . . 71.43 109.912 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.436 HG12 ' HB1' ' D' ' 66' ' ' ALA . 27.5 m -100.02 151.07 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.881 -1.054 . . . . 74.41 111.131 -172.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -118.08 117.96 30.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.118 -1.067 . . . . 73.13 108.118 173.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.0 tp -94.62 120.21 34.49 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.919 -0.771 . . . . 74.04 108.919 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.528 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.4 t70 -127.67 112.88 15.33 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.76 -1.2 . . . . 74.22 107.76 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 67.0 mt -96.16 129.08 43.56 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.003 0.521 . . . . 72.11 109.688 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -136.05 121.55 19.43 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.069 -0.715 . . . . 75.33 109.069 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -105.84 168.28 9.22 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.519 0.675 . . . . 72.41 110.512 -177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -161.05 162.73 31.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.286 -1.325 . . . . 72.2 108.539 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 24.4 p -156.88 153.32 28.0 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.868 -0.79 . . . . 71.41 108.868 172.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 37.3 p -155.69 131.36 9.76 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.543 0.737 . . . . 73.42 109.544 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -73.6 127.96 34.2 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.928 0.491 . . . . 75.14 110.073 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' D' ' 57' ' ' GLU . 61.4 mt -92.64 -35.08 13.72 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.625 -0.509 . . . . 70.41 109.625 175.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.28 -178.48 3.63 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.359 1.063 . . . . 74.12 109.512 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -65.67 127.64 32.75 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.983 -0.747 . . . . 71.43 108.983 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.81 19.3 11.32 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.39 1.076 . . . . 73.44 112.105 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.97 124.28 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.846 0.858 . . . . 74.51 109.173 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.404 ' HD1' HD11 ' D' ' 86' ' ' ILE . 15.0 m-85 -133.57 131.7 40.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.485 0.714 . . . . 74.5 109.751 176.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.524 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.0 tt0 -92.43 120.12 32.62 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.19 -1.041 . . . . 74.35 108.19 167.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -100.9 140.3 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.929 -1.137 . . . . 71.31 107.929 170.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.8 t -122.76 129.18 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.468 -0.938 . . . . 62.52 108.468 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.45 116.68 32.27 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.163 -1.421 . . . . 65.21 107.163 170.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -104.94 101.86 11.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.942 -1.133 . . . . 73.34 107.942 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.28 137.66 21.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.663 -0.699 . . . . 61.15 109.156 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 32.6 m -117.93 142.16 47.65 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.516 0.727 . . . . 73.53 109.805 177.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 59.3 t -136.5 113.08 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.058 0.943 . . . . 71.32 109.457 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 89.9 m -106.56 108.92 20.67 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.507 -0.553 . . . . 71.24 109.507 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.436 ' HB1' HG12 ' D' ' 40' ' ' VAL . . . -106.54 158.45 16.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.185 0.594 . . . . 74.53 110.368 -176.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 4.8 p -153.73 140.73 19.3 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-O 121.438 0.637 . . . . 72.42 112.404 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.474 HD11 HG23 ' D' ' 31' ' ' VAL . 70.5 mt -111.57 116.25 30.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.799 1.24 . . . . 72.41 107.764 169.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.76 -120.78 8.29 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 123.563 0.539 . . . . 74.0 113.112 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -102.84 6.66 39.33 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.82 0.848 . . . . 75.31 111.408 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -135.21 162.13 33.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.83 0.452 . . . . 72.15 110.725 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 30.4 m -57.61 142.9 43.2 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.175 0.99 . . . . 71.03 111.45 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.451 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -97.37 -68.58 0.79 Allowed 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.049 -1.093 . . . . 72.25 108.049 172.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -141.15 149.17 41.15 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.963 -1.017 . . . . 71.31 109.472 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.637 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.6 mt -112.55 146.27 38.83 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.681 -1.229 . . . . 72.44 107.681 169.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.8 t -153.97 133.45 12.79 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.765 -0.458 . . . . 70.14 109.765 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -154.26 126.61 7.94 Favored 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.97 -0.381 . . . . 73.43 109.97 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 97.9 t -131.09 125.02 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.783 0.833 . . . . 75.4 110.16 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 37.7 mt-30 -87.71 86.33 7.17 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.795 -0.817 . . . . 73.24 108.795 168.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -81.43 92.15 6.4 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.234 -0.893 . . . . 75.44 109.503 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.96 162.59 27.58 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 111.951 -0.46 . . . . 72.31 111.951 178.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.31 136.46 4.43 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.997 -0.441 . . . . 54.11 111.997 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.78 127.77 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.73 -0.841 . . . . 74.14 108.73 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.43 125.65 47.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.236 1.014 . . . . 75.34 108.915 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 6.4 t -87.98 97.16 10.8 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.086 -1.079 . . . . 64.43 108.086 176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.404 HD11 ' HD1' ' D' ' 56' ' ' TYR . 2.7 pp -111.32 139.03 37.3 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 C-N-CA 123.546 0.738 . . . . 75.31 110.154 -171.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.469 ' HB2' ' HB ' ' D' ' 10' ' ' THR . . . -157.82 157.18 32.82 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.06 0.544 . . . . 72.53 109.643 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.03 17.99 77.49 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.329 0.393 . . . . 73.11 113.512 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.68 134.41 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.817 0.847 . . . . 74.02 108.944 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.57 177.02 8.77 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.269 0.628 . . . . 64.4 111.136 -174.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.53 -111.36 2.06 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 124.284 0.99 . . . . 65.5 114.573 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.3 m -89.55 -27.05 20.52 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.712 0.805 . . . . 74.42 110.804 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -64.65 -41.03 96.4 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.314 0.645 . . . . 72.43 110.642 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -69.21 -34.04 74.26 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 116.036 -0.529 . . . . 74.14 111.08 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.32 -32.29 64.49 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.286 0.634 . . . . 65.12 110.968 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -77.65 -34.93 52.96 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.427 1.091 . . . . 74.51 110.262 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.2 -51.68 11.6 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.859 -0.61 . . . . 73.22 111.091 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.481 HD21 ' SG ' ' D' ' 102' ' ' CYS . 83.8 mt -85.86 -24.29 26.76 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.948 0.499 . . . . 71.25 112.03 -172.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.84 -14.06 55.63 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.751 -0.472 . . . . 72.32 113.668 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.604 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -135.81 -59.2 0.76 Allowed 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 117.354 0.577 . . . . 43.21 111.89 -173.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -67.8 -41.19 83.55 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.098 0.559 . . . . 71.31 112.295 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.481 ' SG ' HD21 ' D' ' 98' ' ' LEU . 70.4 m -67.86 -45.77 43.41 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 118.483 -0.77 . . . . 75.24 112.321 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -56.5 -36.2 97.44 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.184 1.923 . . . . 74.13 112.909 168.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -65.36 -30.66 71.51 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.606 0.763 . . . . 73.11 111.558 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 80.0 mt -71.3 -39.27 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.192 0.997 . . . . 71.1 110.463 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -76.0 -19.51 58.62 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.441 -0.799 . . . . 71.32 111.527 -176.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -64.88 -43.56 69.05 Favored Pre-proline 0 CA--C 1.562 1.409 0 CA-C-O 117.987 -1.006 . . . . 74.01 113.603 -174.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -51.48 -43.8 47.72 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.241 1.961 . . . . 62.12 113.923 170.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -72.83 -37.52 67.42 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.33 0.652 . . . . 74.15 111.2 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.33 -48.26 80.6 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.44 0.696 . . . . 73.24 109.674 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -54.38 -49.57 69.54 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.875 1.359 . . . . 73.34 110.942 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.16 -45.62 92.61 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.24 0.963 . . . . 75.5 111.372 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.7 t -58.51 -44.87 89.63 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.873 0.733 . . . . 75.45 110.697 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.492 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.0 mt -60.04 -56.56 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.184 0.994 . . . . 75.53 110.743 175.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.7 m -55.21 -42.78 73.77 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.932 1.293 . . . . 74.35 111.561 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 36.8 t -66.18 -40.63 90.6 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 114.561 -1.2 . . . . 74.25 110.047 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.472 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.5 mtm -70.57 -30.79 67.59 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.961 0.505 . . . . 64.13 111.869 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.433 HG23 ' O ' ' D' ' 114' ' ' ILE . 73.8 t -64.05 -45.89 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.484 0.714 . . . . 71.2 109.947 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -74.97 -28.13 60.44 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.648 -0.706 . . . . 63.04 111.28 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -70.85 -34.01 71.21 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.236 -0.653 . . . . 62.34 109.236 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.66 11.09 62.63 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.924 0.765 . . . . 71.33 112.919 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 78.9 p 58.51 16.84 4.48 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 126.499 1.92 . . . . 74.15 114.606 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -80.16 146.88 63.8 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.096 -0.705 . . . . 73.04 109.096 171.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.53 133.2 25.92 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.291 2.661 . . . . 72.55 112.428 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -53.34 136.93 36.33 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.346 1.029 . . . . 73.22 112.589 -168.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 51.6 tp -108.37 107.33 17.86 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.488 -0.778 . . . . 72.44 109.74 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.415 HD21 HD13 ' B' ' 16' ' ' ILE . 11.6 m120 -101.23 96.22 7.05 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.4 -0.963 . . . . 74.32 108.4 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.37 122.22 15.68 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.851 0.46 . . . . 75.33 110.05 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.71 123.06 80.18 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 122.993 0.517 . . . . 54.41 109.844 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.89 122.84 11.83 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.626 2.217 . . . . 75.33 112.031 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 75.0 t -106.78 123.27 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.854 -0.795 . . . . 73.22 108.854 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -80.29 93.32 5.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.019 -0.734 . . . . 75.1 109.019 174.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -60.81 -28.07 68.51 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.545 0.738 . . . . 73.45 111.292 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . 0.604 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 6.0 t70 -62.8 -50.08 72.42 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.423 1.089 . . . . 73.42 111.265 -173.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.66 -45.26 87.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.556 0.743 . . . . 73.45 111.408 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.66 -26.05 66.01 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.603 0.761 . . . . 74.23 111.603 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 90.5 t80 . . . . . 0 N--CA 1.478 0.973 0 C-N-CA 123.608 0.763 . . . . 75.51 110.447 175.591 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 92.3 m . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 108.845 -0.798 . . . . 74.2 108.845 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.582 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 13.7 t80 -137.93 126.83 24.01 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.958 0.503 . . . . 71.31 109.713 177.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -138.16 132.5 32.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.418 -1.327 . . . . 63.0 107.418 172.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.531 HG12 ' HD2' ' A' ' 84' ' ' PHE . 46.9 mt -92.76 116.82 34.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.188 -0.671 . . . . 71.41 109.188 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.6 -43.4 59.79 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 124.256 0.973 . . . . 70.11 108.909 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.401 ' NH1' ' HB3' ' B' ' 32' ' ' PHE . 39.6 ttt180 -173.71 129.73 0.42 Allowed 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.243 0.34 . . . . 74.0 111.007 -172.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 13' ' ' ILE . 77.1 mt -113.87 139.74 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.954 0.902 . . . . 72.31 109.097 172.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.458 ' HB3' HG23 ' B' ' 122' ' ' THR . 45.1 p90 -168.97 -179.78 3.79 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 124.537 1.148 . . . . 74.12 110.495 -170.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -110.15 126.38 54.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.42 -0.809 . . . . 65.23 109.466 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.414 ' HZ3' ' HG3' ' B' ' 29' ' ' PRO . 48.9 mttp -80.54 -48.8 12.22 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.338 -0.615 . . . . 74.11 109.338 171.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 19.3 t70 -135.58 132.27 36.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.652 -0.704 . . . . 72.44 109.481 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.3 mt -123.21 141.66 42.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.239 -1.393 . . . . 75.33 107.239 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.0 t -144.64 139.07 27.8 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 123.576 0.547 . . . . 74.54 109.586 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.449 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 87.6 t80 -146.36 126.3 13.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.632 -1.618 . . . . 74.42 106.632 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 22.5 mt-10 -129.6 127.75 41.27 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.438 0.695 . . . . 63.34 109.511 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.95 73.93 44.97 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.976 -1.12 . . . . 74.12 107.976 170.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.3 -16.19 13.85 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.664 2.243 . . . . 73.25 110.795 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -105.35 13.54 30.2 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.973 1.309 . . . . 74.15 108.96 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.41 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -53.12 -47.93 93.98 Favored Pre-proline 0 CA--C 1.566 1.589 0 C-N-CA 124.935 1.294 . . . . 73.45 113.568 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 37.5 Cg_exo -64.17 -24.39 65.94 Favored 'Trans proline' 0 C--N 1.397 3.107 0 C-N-CA 122.131 1.887 . . . . 71.43 113.608 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -74.07 -42.44 60.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.172 0.589 . . . . 71.1 110.597 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.404 HG23 ' HE1' ' A' ' 123' ' ' PHE . 90.3 t -50.37 -33.54 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.735 1.214 . . . . 74.42 112.356 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -58.02 -39.9 79.51 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.427 1.091 . . . . 74.0 111.694 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -91.67 -23.21 19.88 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.244 1.018 . . . . 74.21 111.628 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.402 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 32.0 mmmt -80.4 147.59 30.94 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.402 0.681 . . . . 73.23 111.654 -175.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.34 129.0 35.97 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.404 -0.961 . . . . 75.0 108.404 170.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -76.21 96.38 3.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.0 0.52 . . . . 74.44 110.85 -172.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -148.07 67.17 9.89 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 109.339 -0.615 . . . . 65.21 109.339 170.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.26 152.87 12.35 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.762 2.308 . . . . 74.1 111.589 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -97.0 106.44 18.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.452 -1.314 . . . . 73.52 107.452 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.07 98.19 4.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 116.016 -0.538 . . . . 72.3 109.984 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -78.73 113.45 16.8 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.09 -0.959 . . . . 73.52 108.478 170.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' A' ' 128' ' ' LEU . 46.1 tp -100.22 142.87 31.11 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.794 -1.188 . . . . 74.55 107.794 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.539 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 38.8 t70 -145.44 150.26 36.18 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.061 0.545 . . . . 74.23 109.834 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.2 mt -130.53 126.54 37.05 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.479 0.711 . . . . 74.35 110.49 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.662 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 10.5 m-20 -124.72 141.22 52.26 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.328 1.051 . . . . 64.34 109.499 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.5 m -134.8 131.12 37.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.008 0.523 . . . . 73.42 110.366 175.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.01 152.48 50.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.082 0.953 . . . . 64.34 109.383 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.434 ' HB2' HD12 ' A' ' 98' ' ' LEU . 22.4 t -123.45 153.92 39.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.452 0.701 . . . . 43.54 110.424 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.7 t -149.33 119.62 7.32 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.34 1.056 . . . . 72.33 108.695 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -78.42 106.59 10.46 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.482 -0.562 . . . . 74.14 109.482 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 57' ' ' GLU . 42.3 mt -82.0 -35.81 28.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.595 0.758 . . . . 71.33 110.224 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.48 -174.36 3.43 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.06 -0.973 . . . . 74.04 109.86 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.84 126.12 28.71 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.264 -1.013 . . . . 65.23 108.264 172.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 65.04 14.63 9.49 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.171 0.989 . . . . 74.23 111.4 -177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.406 HG13 ' HB2' ' A' ' 51' ' ' LEU . 57.9 t -128.64 104.88 12.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 N-CA-C 107.8 -1.185 . . . . 73.13 107.8 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.95 126.52 36.27 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.644 -0.707 . . . . 74.22 109.711 -170.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.465 ' HB2' HD12 ' A' ' 51' ' ' LEU . 21.0 tp10 -86.98 128.72 35.07 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 124.438 1.095 . . . . 73.21 109.225 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -128.02 120.32 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.379 -1.341 . . . . 71.43 107.379 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.5 t -110.97 118.51 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.778 0.831 . . . . 74.44 109.146 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.6 tp -100.06 108.11 20.2 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.88 -0.785 . . . . 74.34 108.88 172.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.662 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 27.5 ttp180 -87.18 104.98 16.88 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.543 -0.54 . . . . 75.34 109.543 173.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.1 t -94.39 104.75 16.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.119 -1.067 . . . . 74.31 108.119 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 30.7 m -96.27 135.87 37.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.728 0.811 . . . . 62.3 110.298 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.533 HG22 HG21 ' A' ' 114' ' ' ILE . 74.6 t -128.51 116.79 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.227 1.411 . . . . 75.13 108.544 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -120.95 123.36 42.27 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.209 -1.034 . . . . 74.22 108.209 172.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.84 113.78 21.1 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.839 -1.171 . . . . 71.41 107.839 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.6 t -144.76 143.85 30.88 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.902 0.481 . . . . 73.5 110.173 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -119.33 84.68 2.24 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.013 1.325 . . . . 74.51 108.961 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.14 -119.57 5.22 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.238 -0.892 . . . . 72.12 112.645 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -87.83 -18.98 28.09 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.435 0.694 . . . . 74.45 110.967 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.402 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 1.5 tp10 -94.07 120.27 34.09 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.468 -0.938 . . . . 72.21 108.468 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.3 m -87.35 143.5 27.22 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.114 0.415 . . . . 72.23 110.211 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.71 -66.41 0.89 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.356 -0.609 . . . . 72.12 109.356 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -161.49 174.23 13.71 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.199 -0.91 . . . . 75.42 110.985 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 64' ' ' VAL . 58.2 tp -137.81 137.41 38.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.852 1.261 . . . . 75.52 108.113 175.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.449 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 56.7 m -141.32 130.62 23.61 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.857 -1.164 . . . . 74.3 107.857 175.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -146.7 120.5 9.26 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.603 0.638 . . . . 73.53 109.739 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.84 113.39 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.36 0.664 . . . . 63.4 110.623 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -82.99 87.1 6.89 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.413 -0.958 . . . . 63.32 108.413 166.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.455 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.1 tp-100 -77.19 102.71 6.75 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.304 -0.999 . . . . 65.02 108.304 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.07 143.58 17.1 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.603 -0.599 . . . . 71.34 111.603 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.93 121.89 1.56 Allowed Glycine 0 N--CA 1.451 -0.336 0 N-CA-C 111.041 -0.824 . . . . 72.32 111.041 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.5 mt -82.02 122.26 36.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.107 -1.071 . . . . 74.31 108.107 171.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.582 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.6 m-85 -127.64 119.59 26.24 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.993 0.917 . . . . 74.25 108.962 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.4 m -81.07 91.63 6.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.584 0.754 . . . . 73.21 109.692 169.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.5 tt -96.61 135.64 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 114.555 -1.202 . . . . 74.54 109.232 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -161.05 163.56 31.47 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.091 0.956 . . . . 75.1 110.109 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.42 -33.61 5.71 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 116.259 -0.428 . . . . 73.43 113.879 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.474 ' H ' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.58 155.16 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.928 0.491 . . . . 74.45 111.043 -174.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.96 175.36 13.04 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.73 -1.123 . . . . 74.43 110.169 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.36 -142.49 34.15 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 116.022 -0.535 . . . . 72.24 111.892 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.1 p -70.17 -15.86 63.01 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.338 0.655 . . . . 73.33 111.581 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -75.18 -37.39 61.27 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.738 0.815 . . . . 74.53 111.137 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -28.64 58.79 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 110.132 -0.321 . . . . 74.21 110.132 173.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.92 -24.97 62.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.09 0.556 . . . . 72.41 110.458 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -68.17 -38.68 82.34 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 122.908 0.483 . . . . 71.22 109.847 171.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.599 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 68.8 m -65.86 -39.56 90.84 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.462 -0.335 . . . . 75.21 110.279 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 48' ' ' SER . 36.0 tp -66.69 -51.44 55.99 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.914 0.886 . . . . 75.23 111.91 -175.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.11 -26.84 10.76 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.558 -0.746 . . . . 70.22 114.075 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.551 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -111.41 -66.22 1.1 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.204 0.502 . . . . 75.21 112.034 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.599 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 72.2 t80 -68.77 -61.11 1.95 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.264 1.026 . . . . 74.04 112.766 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 94.2 m -67.6 -36.68 10.51 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 113.916 1.08 . . . . 71.31 113.916 -174.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.54 -31.34 50.92 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 121.548 1.499 . . . . 73.42 112.506 167.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.21 -28.47 68.77 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.521 0.328 . . . . 74.01 110.633 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.1 mm -62.53 -45.28 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.765 0.826 . . . . 75.3 109.86 171.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.455 HD23 ' HG3' ' A' ' 80' ' ' GLN . 80.0 mt -72.29 -27.0 62.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.977 0.911 . . . . 71.43 112.256 -175.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -57.7 -45.68 99.81 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 114.142 1.164 . . . . 73.03 114.142 -168.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -62.11 -38.81 53.67 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 121.978 1.785 . . . . 75.54 112.915 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -67.13 -39.38 86.59 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.302 0.641 . . . . 71.14 111.075 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.93 -43.49 71.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.31 0.644 . . . . 74.23 110.448 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -52.05 -48.07 64.8 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 124.421 1.075 . . . . 72.33 110.2 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.08 -47.94 75.5 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 124.089 0.868 . . . . 75.04 111.342 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.444 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.5 t -58.25 -27.68 64.21 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.833 0.708 . . . . 60.34 111.22 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.533 HG21 HG22 ' A' ' 64' ' ' VAL . 86.6 mt -77.46 -58.58 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.592 1.157 . . . . 73.22 110.287 174.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.7 m -57.36 -33.72 68.06 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 124.667 1.187 . . . . 74.54 111.344 -173.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -63.67 -49.02 74.81 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.848 0.859 . . . . 74.01 109.977 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.439 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 69.3 mtm -63.56 -34.12 77.1 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.389 0.676 . . . . 74.51 111.459 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.459 HG21 HD21 ' A' ' 126' ' ' LEU . 98.2 t -66.46 -46.0 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.196 0.998 . . . . 75.12 110.461 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.2 m -70.22 -28.67 65.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.442 0.697 . . . . 74.43 111.388 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -73.35 -31.69 64.1 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.428 0.691 . . . . 74.2 109.782 174.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.06 2.78 86.31 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.88 0.738 . . . . 75.0 112.735 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.5 m 68.5 16.73 9.13 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.918 1.287 . . . . 73.35 111.552 173.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.404 ' HE1' HG23 ' A' ' 31' ' ' VAL . 96.9 m-85 -78.85 156.29 77.44 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 109.011 -0.737 . . . . 74.03 109.011 171.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.73 163.8 17.75 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.486 2.124 . . . . 75.45 112.531 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -60.36 121.61 12.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.062 0.945 . . . . 75.52 110.998 -172.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.498 HD23 HG12 ' A' ' 64' ' ' VAL . 53.0 tp -106.16 93.92 4.88 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.743 -0.836 . . . . 73.35 108.743 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.423 HD22 ' N ' ' C' ' 16' ' ' ILE . 71.4 m-20 -107.1 85.27 2.11 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.889 -1.152 . . . . 73.15 107.889 173.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.434 ' HB2' HD22 ' A' ' 42' ' ' LEU . 4.0 pp -60.11 137.52 58.08 Favored 'General case' 0 C--O 1.251 1.178 0 CA-C-N 114.447 -1.251 . . . . 74.12 109.246 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.63 143.91 85.79 Favored Pre-proline 0 C--O 1.243 0.758 0 C-N-CA 123.162 0.585 . . . . 72.1 110.948 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.05 161.61 45.46 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 121.702 1.601 . . . . 75.33 110.214 170.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.86 130.22 18.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.675 -0.861 . . . . 73.04 108.675 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -75.07 92.03 2.6 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.888 -0.596 . . . . 74.2 110.071 -174.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.551 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 83.9 m-85 -58.09 -35.51 71.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.86 0.864 . . . . 73.11 111.91 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.46 -50.73 72.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.531 0.733 . . . . 72.01 110.302 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.47 94.43 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.135 0.897 . . . . 72.22 111.434 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.72 -41.91 91.7 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.859 -0.61 . . . . 71.12 111.15 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -68.37 -32.26 72.22 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.029 -0.532 . . . . 54.43 109.578 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 15.9 mmt . . . . . 0 N--CA 1.475 0.811 0 O-C-N 123.667 0.605 . . . . 71.31 110.835 177.676 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.5 m . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 108.63 -0.878 . . . . 65.33 108.63 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.93 156.71 48.35 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.533 -0.543 . . . . 74.32 109.533 157.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -124.24 137.52 54.5 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 107.442 -1.318 . . . . 74.44 107.442 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.495 HD11 HD12 ' B' ' 105' ' ' ILE . 27.4 mt -78.92 117.45 24.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 107.708 -1.219 . . . . 75.43 107.708 176.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -78.23 -42.47 31.13 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.874 -0.787 . . . . 75.45 108.874 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -164.9 135.71 4.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.022 -0.99 . . . . 74.1 110.155 -170.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 85.5 mt -114.46 139.15 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 106.619 -1.623 . . . . 71.54 106.619 167.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.424 ' HE2' ' HZ3' ' B' ' 19' ' ' LYS . 41.9 p90 -166.98 150.65 6.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.241 0.543 . . . . 75.03 111.524 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 75.9 m -78.24 128.98 34.53 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.935 -1.029 . . . . 72.24 109.084 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.424 ' HZ3' ' HE2' ' B' ' 17' ' ' TYR . 20.9 mttp -91.4 -46.24 8.12 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.661 0.784 . . . . 71.12 110.616 173.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 22.5 t70 -144.41 133.25 22.49 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.217 -0.447 . . . . 63.2 110.687 -165.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.419 HG22 ' HE2' ' B' ' 117' ' ' MET . 47.8 mm -130.82 142.15 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.157 0.983 . . . . 74.12 109.114 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 81.5 p -139.2 144.45 38.52 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.376 -0.972 . . . . 72.33 108.376 170.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.1 t80 -145.81 134.13 21.81 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.971 -1.492 . . . . 73.44 106.971 163.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 36.7 mt-10 -136.89 127.24 26.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.518 -0.919 . . . . 72.3 108.518 -175.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.432 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -124.55 84.94 56.75 Favored Pre-proline 0 C--O 1.24 0.571 0 N-CA-C 107.69 -1.226 . . . . 72.22 107.69 171.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.71 -32.93 46.13 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.701 2.268 . . . . 60.32 111.394 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -104.45 10.71 35.12 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 117.873 -1.06 . . . . 74.41 110.793 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.529 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -29.64 -68.7 0.11 Allowed Pre-proline 0 N--CA 1.5 2.06 0 C-N-CA 125.355 1.462 . . . . 73.21 114.869 -170.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 11.6 Cg_exo -67.49 -21.21 46.83 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 122.199 1.933 . . . . 73.23 113.042 -171.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -96.81 -32.68 11.99 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.296 1.039 . . . . 75.2 112.434 -172.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' B' ' 73' ' ' ALA . 9.8 p -82.69 -19.7 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 122.683 0.393 . . . . 72.31 111.327 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . 0.401 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . 11.5 m-30 -62.43 -25.41 67.95 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 113.976 1.102 . . . . 74.51 113.976 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -56.56 -25.62 52.83 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.081 0.552 . . . . 75.31 111.198 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.492 ' HB2' HD11 ' B' ' 68' ' ' LEU . 87.5 mttt -88.45 92.94 9.37 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.268 1.027 . . . . 74.14 109.435 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.24 91.25 6.17 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.099 -0.704 . . . . 73.43 109.099 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -163.32 156.82 19.4 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.837 0.855 . . . . 74.13 109.497 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -76.45 104.65 1.7 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.026 0.93 . . . . 74.54 108.649 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.609 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.2 Cg_endo -63.44 153.07 76.96 Favored 'Trans proline' 0 C--N 1.366 1.46 0 C-N-CA 123.137 2.558 . . . . 73.25 113.238 -176.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.8 118.6 7.38 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 123.778 0.674 . . . . 74.3 109.37 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.46 161.06 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 114.977 -1.011 . . . . 65.02 111.569 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -149.26 107.77 3.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.521 -1.659 . . . . 75.14 106.521 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 mp -100.27 148.69 24.37 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.164 0.585 . . . . 74.54 110.313 -171.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -131.74 113.44 13.54 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.708 -1.219 . . . . 71.14 107.708 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.2 127.25 45.14 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 106.02 -1.844 . . . . 74.03 106.02 176.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -144.99 148.64 33.99 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.797 0.839 . . . . 72.11 109.364 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 37.0 p -134.91 118.55 17.04 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.23 0.612 . . . . 74.03 109.995 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.48 153.31 31.36 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.766 1.226 . . . . 74.35 108.325 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 77.6 p -143.75 166.14 25.71 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.183 0.447 . . . . 73.34 111.34 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.0 p -152.33 149.97 29.22 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.25 1.02 . . . . 73.34 109.22 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -93.8 124.6 37.91 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.546 -0.539 . . . . 70.12 109.546 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.29 -52.42 5.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.128 -0.693 . . . . 73.31 109.128 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.41 -175.59 4.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.206 1.003 . . . . 62.2 109.646 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.46 116.33 8.09 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.577 -0.738 . . . . 75.42 109.218 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 83.0 m-20 74.08 -3.37 2.54 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.27 1.428 . . . . 74.4 112.887 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 48.4 t -106.04 110.41 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.521 -0.918 . . . . 72.12 108.521 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.496 ' HE2' ' HB ' ' B' ' 86' ' ' ILE . 1.3 p90 -119.97 173.34 7.13 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.88 0.872 . . . . 75.33 109.65 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -143.08 110.97 5.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.047 -1.094 . . . . 73.34 108.047 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 55.8 t -91.52 145.28 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.184 0.994 . . . . 74.22 109.817 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 39.5 t -129.33 115.13 34.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.263 -1.014 . . . . 75.05 108.263 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.51 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.4 OUTLIER -97.09 110.71 23.2 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.623 -0.88 . . . . 74.31 108.623 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -95.18 118.67 32.37 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.661 0.785 . . . . 73.34 110.746 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.479 ' HB ' HD11 ' B' ' 114' ' ' ILE . 26.3 t -116.54 103.19 14.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.53 -1.285 . . . . 74.21 107.53 168.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.546 HG22 ' HB2' ' B' ' 77' ' ' GLU . 2.8 m -99.6 131.3 45.69 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.222 -0.659 . . . . 73.12 109.222 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -125.21 116.99 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.342 0.657 . . . . 64.52 109.944 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.6 m -99.53 142.98 30.3 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.762 0.825 . . . . 60.23 108.957 167.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' B' ' 38' ' ' PRO . . . -149.22 147.04 27.93 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.033 0.533 . . . . 70.32 110.36 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.414 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 23.8 p -146.93 130.6 16.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.702 0.401 . . . . 73.44 111.93 -174.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.609 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 25.2 mt -95.84 118.85 33.27 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.679 1.191 . . . . 74.34 109.772 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.73 -108.8 2.6 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 123.742 0.651 . . . . 72.5 112.307 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -118.63 1.59 11.66 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.211 1.004 . . . . 74.24 110.384 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.45 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.4 pt-20 -122.51 155.2 36.69 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.993 0.517 . . . . 74.55 109.936 -175.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.1 m -63.37 134.98 56.66 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.82 0.7 . . . . 72.33 110.842 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.414 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -92.4 -64.84 1.06 Allowed 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.492 -1.299 . . . . 74.11 107.492 174.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -148.75 157.92 43.79 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.203 -0.908 . . . . 73.43 111.012 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.642 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 69.3 mt -130.18 143.57 50.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.589 -1.634 . . . . 64.23 106.589 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 41.9 t -155.28 156.67 35.96 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.644 -0.502 . . . . 75.53 109.644 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.546 ' HB2' HG22 ' B' ' 63' ' ' THR . 34.7 tt0 -160.27 136.17 8.46 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.123 -1.065 . . . . 74.4 108.123 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.416 HG21 HD12 ' B' ' 21' ' ' ILE . 93.4 t -124.06 141.53 43.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.622 -0.881 . . . . 74.05 108.622 172.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -120.57 89.6 3.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.581 -0.896 . . . . 73.52 108.581 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.6 tp-100 -83.3 99.09 9.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.678 -1.146 . . . . 73.02 108.821 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.84 169.95 35.9 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 116.19 -0.459 . . . . 53.51 111.968 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.36 129.86 1.97 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.68 -0.568 . . . . 61.12 111.68 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.3 mt -85.21 129.35 37.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.597 0.759 . . . . 73.53 109.227 172.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -131.92 139.76 48.82 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.947 -1.131 . . . . 74.23 107.947 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.3 m -112.71 97.87 6.85 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.867 -0.79 . . . . 73.45 108.867 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.496 ' HB ' ' HE2' ' B' ' 56' ' ' TYR . 17.4 tt -96.54 147.02 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.697 0.799 . . . . 75.42 111.097 -166.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.97 141.34 24.17 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.326 0.65 . . . . 65.33 110.396 -174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.57 -63.2 0.69 Allowed Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.617 -0.719 . . . . 64.13 114.488 169.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.468 HD11 ' HB3' ' B' ' 93' ' ' GLN . 17.2 tt -66.49 163.68 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.369 0 C-N-CA 124.042 0.937 . . . . 74.25 111.126 -173.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -158.91 175.47 13.53 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.085 0.402 . . . . 74.34 110.689 -172.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' B' ' 94' ' ' MET . . . 66.91 -132.2 31.26 Favored Glycine 0 C--N 1.355 1.59 0 C-N-CA 123.656 0.646 . . . . 61.14 114.446 169.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 46.3 m -75.9 -27.41 57.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.666 0.787 . . . . 72.42 110.947 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.468 ' HB3' HD11 ' B' ' 89' ' ' ILE . 52.1 mt-30 -68.63 -33.66 74.4 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.853 -0.612 . . . . 73.44 111.437 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' B' ' 91' ' ' GLY . 0.0 OUTLIER -71.26 -24.66 62.21 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.378 0.271 . . . . 63.14 110.734 176.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.52 78.28 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.114 0.566 . . . . 74.22 110.834 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -63.1 -29.95 71.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.3 -0.863 . . . . 75.44 110.976 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.465 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 49.2 t -74.67 -62.11 1.65 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.411 -0.359 . . . . 60.55 110.771 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.512 HD11 ' N ' ' B' ' 99' ' ' GLY . 3.0 pp -63.49 -32.79 74.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.126 0.788 . . . . 75.35 113.126 -173.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . 0.512 ' N ' HD11 ' B' ' 98' ' ' LEU . . . -92.25 -36.36 6.3 Favored Glycine 0 C--N 1.345 1.056 0 O-C-N 123.482 0.488 . . . . 62.44 113.273 -172.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.0 -53.76 2.15 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.615 0.598 . . . . 73.1 112.615 -167.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.465 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 51.7 t80 -72.03 -45.05 62.31 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.862 0.865 . . . . 75.1 111.617 -168.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.463 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 70.8 m -66.11 -49.68 54.86 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 123.6 0.76 . . . . 64.41 111.253 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.51 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 80.4 Cg_exo -53.63 -36.42 81.04 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 122.479 2.12 . . . . 74.23 114.203 168.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -57.44 -38.85 75.1 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 123.399 0.679 . . . . 73.21 110.709 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.495 HD12 HD11 ' B' ' 13' ' ' ILE . 80.5 mt -64.99 -43.4 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.117 0.967 . . . . 75.42 110.633 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 52.5 mt -83.23 -15.17 51.42 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.978 0.911 . . . . 75.22 112.043 -172.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -61.28 -49.32 88.46 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.023 -0.989 . . . . 72.31 113.558 -170.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.01 -31.01 83.85 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 121.729 1.619 . . . . 74.24 112.97 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.54 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 86.7 m-85 -67.92 -50.02 58.5 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.889 0.476 . . . . 71.11 110.207 176.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.41 -40.51 78.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.831 0.852 . . . . 74.3 110.582 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.739 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 30.8 ttt180 -58.08 -56.67 19.05 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.39 1.476 . . . . 75.3 111.065 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.54 -34.81 78.61 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.937 0.773 . . . . 73.45 110.51 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.46 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.7 t -69.88 -40.32 75.75 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.209 0.603 . . . . 72.44 111.417 -176.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.479 HD11 ' HB ' ' B' ' 62' ' ' VAL . 70.5 mt -62.22 -53.54 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 109.563 -0.532 . . . . 74.22 109.563 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.417 HG22 ' OG ' ' C' ' 119' ' ' SER . 12.0 m -60.07 -30.08 68.99 Favored 'General case' 0 CA--C 1.554 1.124 0 O-C-N 124.539 1.149 . . . . 72.11 111.403 -175.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.7 t -64.66 -54.09 37.18 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.555 0.742 . . . . 72.41 110.022 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.4 mmt -67.26 -34.59 77.75 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.411 0.684 . . . . 75.32 111.991 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.96 -38.31 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.134 0.974 . . . . 73.31 110.463 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.42 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 11.8 t -78.07 -20.64 51.92 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.886 -0.597 . . . . 74.1 111.139 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.444 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 92.7 mtt-85 -69.24 -33.79 73.81 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.422 -0.584 . . . . 74.54 109.422 171.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.29 11.3 58.63 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.595 0.559 . . . . 71.52 112.698 168.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.458 HG23 ' HB3' ' A' ' 17' ' ' TYR . 33.7 p 58.98 31.44 21.36 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.637 1.975 . . . . 62.3 114.18 170.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -84.81 157.93 59.89 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.133 0.573 . . . . 75.54 110.133 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.38 -175.29 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.994 2.463 . . . . 75.42 113.349 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -61.7 114.41 3.28 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.3 -0.864 . . . . 73.3 112.149 -170.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 35.9 tp -110.23 84.76 1.98 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.331 -0.989 . . . . 71.44 108.331 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.23 93.79 8.43 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.284 -0.636 . . . . 71.31 109.284 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.739 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 22.7 tp -57.68 127.77 33.69 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.737 0.815 . . . . 74.11 111.421 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.57 153.77 94.79 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 124.509 1.124 . . . . 74.32 111.813 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.19 100.56 0.46 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.836 2.357 . . . . 71.53 112.162 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.92 108.93 20.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.073 -1.084 . . . . 62.3 108.073 172.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . 0.429 ' ND2' ' HB1' ' B' ' 135' ' ' ALA . 60.9 t30 -94.08 95.21 8.86 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 107.686 -1.227 . . . . 71.41 107.686 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.78 -42.74 89.69 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 124.081 0.863 . . . . 65.41 109.501 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.36 -39.09 69.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.191 1.397 . . . . 73.54 112.843 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.429 ' HB1' ' ND2' ' B' ' 132' ' ' ASN . . . -63.92 -50.33 69.13 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.717 0.807 . . . . 73.14 111.304 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 82.6 mt -79.11 -28.91 43.01 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.254 -0.885 . . . . 65.41 111.305 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 78.5 t80 . . . . . 0 N--CA 1.479 0.982 0 C-N-CA 123.756 0.822 . . . . 74.42 109.947 179.629 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m . . . . . 0 C--O 1.237 0.41 0 N-CA-C 106.336 -1.727 . . . . 71.13 106.336 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.472 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 9.0 t80 -124.64 117.48 24.37 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.013 0.525 . . . . 74.43 110.893 -175.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -137.27 133.2 34.76 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.21 -1.404 . . . . 74.31 107.21 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.507 HD12 HG21 ' C' ' 105' ' ' ILE . 45.5 mt -74.36 118.57 20.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.567 -0.901 . . . . 73.34 108.567 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.528 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 1.4 mt-30 -77.09 -40.92 44.26 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.131 0.894 . . . . 73.3 109.892 -176.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -170.56 147.65 2.94 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 116.045 -0.525 . . . . 74.21 110.077 -173.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.423 ' N ' HD22 ' A' ' 127' ' ' ASN . 96.6 mt -135.46 137.4 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.791 -1.188 . . . . 72.44 107.791 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.412 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 29.8 p90 -176.01 173.78 2.2 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.903 0.752 . . . . 75.35 111.228 -171.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -100.03 123.82 44.71 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.615 0.766 . . . . 64.4 109.594 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.412 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.0 mmtp -70.67 -48.94 52.28 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.821 -1.177 . . . . 75.44 107.821 168.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -135.37 143.12 45.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 113.863 -1.517 . . . . 72.24 110.283 -172.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.0 mt -137.89 146.97 26.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 126.077 1.751 . . . . 74.11 106.359 174.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -162.21 149.95 14.31 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.423 0.63 . . . . 71.43 110.405 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.476 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 93.7 t80 -140.35 139.19 35.32 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.661 -1.237 . . . . 75.33 107.661 171.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -136.23 128.83 30.61 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.509 0.724 . . . . 72.44 110.061 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.92 82.65 11.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 106.838 -1.541 . . . . 71.42 106.838 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.85 -26.1 38.53 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.974 2.449 . . . . 65.14 112.268 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -112.28 27.23 9.83 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 114.822 -1.081 . . . . 75.21 109.641 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.414 ' HA ' HG13 ' C' ' 31' ' ' VAL . . . -50.19 -58.62 9.08 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 114.449 1.277 . . . . 71.43 114.449 -170.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.57 -31.49 79.82 Favored 'Trans proline' 0 C--N 1.388 2.624 0 CA-C-N 121.891 1.711 . . . . 74.31 112.092 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -69.75 -43.06 73.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.354 1.062 . . . . 73.43 112.031 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.644 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.7 p -77.81 -24.87 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 123.04 0.536 . . . . 64.21 111.644 -173.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.0 -29.11 70.29 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.354 0.262 . . . . 72.21 111.664 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -104.78 36.18 2.52 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.202 0.601 . . . . 74.33 110.615 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.472 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 2.9 tppp? -111.07 169.46 8.76 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.235 1.014 . . . . 71.23 109.969 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -68.42 130.57 43.28 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.03 0.532 . . . . 63.23 110.147 173.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -73.99 93.37 2.22 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.324 1.049 . . . . 75.24 109.224 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -150.24 59.25 3.54 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.302 0.641 . . . . 71.42 109.712 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.4 110.28 3.03 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.643 2.229 . . . . 74.12 111.768 -175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -86.52 108.51 18.58 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.522 -0.918 . . . . 71.24 108.522 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.53 142.33 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.308 1.043 . . . . 71.12 111.257 -171.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -130.57 119.45 22.55 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.875 -1.528 . . . . 74.21 106.875 174.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 30.1 tp -101.38 124.79 47.63 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 109.635 -0.506 . . . . 74.14 109.635 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.469 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.7 t70 -117.24 112.2 20.47 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.258 -1.016 . . . . 74.42 108.258 -176.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.434 HD11 ' HE1' ' C' ' 133' ' ' PHE . 79.9 mt -110.86 111.1 22.01 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.963 -0.754 . . . . 73.32 108.963 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 12.8 t70 -122.63 139.78 53.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.34 1.056 . . . . 75.12 108.674 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 m -126.8 126.37 43.28 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.511 0.672 . . . . 34.24 110.258 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.76 154.91 25.46 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.108 -1.406 . . . . 63.25 107.975 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.528 ' HB2' ' HE1' ' C' ' 56' ' ' TYR . 13.4 p -149.5 142.71 25.07 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.87 0.468 . . . . 72.32 109.871 -177.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.7 t -149.74 146.65 27.32 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.896 0.878 . . . . 75.31 110.162 -171.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -82.95 133.82 35.09 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.486 -0.561 . . . . 74.31 109.486 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.58 HD12 ' HB2' ' C' ' 57' ' ' GLU . 43.7 mt -106.53 -41.29 5.31 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.052 -0.722 . . . . 71.4 109.052 173.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.01 -175.65 5.54 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.731 -1.122 . . . . 73.51 109.963 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -67.22 119.08 11.52 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 114.973 -1.012 . . . . 64.44 109.679 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 65.34 8.21 4.79 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.017 1.327 . . . . 75.23 112.584 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -113.18 96.96 5.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 107.657 -1.238 . . . . 72.02 107.657 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.528 ' HE1' ' HB2' ' C' ' 48' ' ' SER . 1.6 t80 -114.87 129.51 56.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.652 -0.704 . . . . 71.05 109.597 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.58 ' HB2' HD12 ' C' ' 51' ' ' LEU . 33.7 tt0 -88.77 135.02 33.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.983 -1.008 . . . . 62.53 110.218 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.85 141.59 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.704 -1.221 . . . . 70.11 107.704 166.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -128.66 123.43 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.614 -1.254 . . . . 74.44 107.614 173.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.97 102.83 12.23 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.424 -1.325 . . . . 64.44 107.424 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.4 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 33.8 ttm-85 -85.86 122.85 30.51 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.947 -1.478 . . . . 75.2 108.443 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.6 t -117.73 126.04 74.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 107.735 -1.209 . . . . 73.43 107.735 169.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 13.0 m -126.75 115.88 20.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.61 -0.885 . . . . 72.5 108.61 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.488 HG12 HD13 ' C' ' 126' ' ' LEU . 65.2 t -102.67 120.57 52.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 109.012 -0.736 . . . . 72.24 109.012 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 16.3 m -103.52 142.83 33.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.382 -0.97 . . . . 75.33 108.382 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.44 118.25 13.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.545 -1.28 . . . . 73.35 107.545 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -132.29 134.01 44.75 Favored 'General case' 0 C--O 1.224 -0.262 0 O-C-N 123.855 0.722 . . . . 72.3 109.575 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.434 HD11 HG22 ' C' ' 31' ' ' VAL . 12.1 mt -86.2 28.01 0.87 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.809 1.243 . . . . 75.14 111.081 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.7 -104.84 1.53 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 110.453 -1.059 . . . . 32.34 110.453 -169.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -90.57 -30.89 16.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.908 0.883 . . . . 70.32 110.587 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.472 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 4.5 tp10 -75.45 124.3 26.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.284 1.034 . . . . 72.33 110.206 172.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 18.0 m -80.68 125.61 30.25 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.789 -0.819 . . . . 74.52 108.789 167.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.644 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.82 -61.22 2.07 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.374 -0.602 . . . . 63.02 109.374 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -151.34 156.83 41.57 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.475 0.655 . . . . 75.14 111.237 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.423 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -127.79 142.2 51.37 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 106.75 -1.574 . . . . 73.03 106.75 172.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.423 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.4 t -148.07 141.07 24.87 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.597 -0.89 . . . . 74.31 108.597 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -147.35 133.72 19.62 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.123 -0.695 . . . . 74.41 109.123 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' C' ' 110' ' ' ALA . 59.8 t -135.97 113.75 14.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.569 1.147 . . . . 74.34 108.145 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -95.5 89.11 5.28 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.769 -0.826 . . . . 72.12 108.769 174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -79.78 98.77 7.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.268 -0.878 . . . . 64.11 110.144 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.65 144.82 17.99 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-O 121.177 0.321 . . . . 52.53 112.45 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.488 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -146.2 128.17 2.98 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.346 -1.102 . . . . 73.52 110.346 -176.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 11.0 mm -88.32 122.68 40.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.36 -0.978 . . . . 71.45 108.36 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.472 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 62.0 m-85 -127.24 119.51 26.54 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.108 -0.701 . . . . 72.41 109.108 -175.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 31.2 p -82.96 109.64 17.25 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.797 -0.816 . . . . 73.45 108.797 176.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.564 HD11 HD23 ' C' ' 98' ' ' LEU . 32.9 pt -116.12 102.53 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-O 122.151 0.976 . . . . 74.45 110.276 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.16 158.65 30.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.106 0.962 . . . . 74.13 108.9 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.11 -18.67 34.96 Favored Glycine 0 C--N 1.344 0.986 0 N-CA-C 114.06 0.384 . . . . 72.52 114.06 173.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.19 158.74 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.381 1.072 . . . . 74.13 110.608 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -161.25 -177.26 5.91 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.119 0.567 . . . . 72.3 110.94 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.45 -116.19 8.83 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-N 115.308 -0.86 . . . . 73.02 113.78 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.6 p -70.23 -34.49 72.94 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.096 0.959 . . . . 74.44 111.24 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -70.25 -38.72 75.22 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.68 -0.691 . . . . 72.2 111.207 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 22.0 ptm -78.97 -25.55 43.44 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 119.588 -0.244 . . . . 72.54 110.697 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.47 85.53 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.646 -0.502 . . . . 63.23 109.646 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -75.73 -34.66 60.34 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.394 0.434 . . . . 73.33 111.673 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 40.3 t -59.0 -35.89 74.0 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.654 0.596 . . . . 73.54 110.661 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.564 HD23 HD11 ' C' ' 86' ' ' ILE . 51.3 mt -100.49 -16.3 17.59 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.273 0.629 . . . . 74.52 111.308 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.79 -30.5 57.72 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 114.491 0.556 . . . . 74.22 114.491 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.18 -39.09 0.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.861 0.464 . . . . 52.21 110.866 -168.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.467 ' HH ' ' HD1' ' C' ' 11' ' ' PHE . 59.6 t80 -66.07 -48.95 69.3 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.143 1.777 . . . . 73.13 112.718 -175.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 51.0 m -73.12 -45.65 8.17 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 118.57 -0.728 . . . . 74.12 112.133 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -53.37 -30.78 54.24 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 122.602 2.201 . . . . 65.35 113.528 170.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -64.82 -40.69 95.61 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.862 0.865 . . . . 70.51 110.364 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.507 HG21 HD12 ' C' ' 13' ' ' ILE . 47.9 mm -60.71 -44.15 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.056 0.542 . . . . 74.53 109.795 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.488 HD21 ' HA3' ' C' ' 82' ' ' GLY . 88.0 mt -80.08 -26.81 39.46 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.907 -1.042 . . . . 75.43 112.764 -170.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -57.36 -48.55 97.12 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 117.575 -1.203 . . . . 72.13 113.534 -172.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.74 -37.96 94.92 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.356 2.037 . . . . 74.42 113.732 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -68.27 -44.68 75.03 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.844 0.458 . . . . 72.32 110.587 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -64.64 -38.3 90.53 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.803 -0.635 . . . . 71.34 110.78 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -57.16 -48.58 78.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.477 1.511 . . . . 74.21 110.834 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.35 -34.59 68.13 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.398 0.679 . . . . 73.31 110.69 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.5 t -69.11 -30.71 69.05 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.031 0.532 . . . . 64.4 111.287 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.548 HD11 ' HB ' ' C' ' 62' ' ' VAL . 97.7 mt -68.47 -51.36 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.439 0.696 . . . . 74.51 109.541 173.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.406 HG21 ' OG ' ' B' ' 119' ' ' SER . 10.5 m -60.25 -31.95 70.69 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.166 0.916 . . . . 71.43 111.104 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.9 t -64.51 -54.78 27.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.722 0.809 . . . . 61.21 109.465 174.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.599 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.56 -42.52 83.19 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.741 1.216 . . . . 73.13 112.84 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -66.27 -41.74 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.105 0.962 . . . . 74.12 110.422 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.417 ' OG ' HG22 ' B' ' 115' ' ' THR . 32.7 t -70.64 -26.51 63.5 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.954 -0.567 . . . . 74.15 111.011 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.5 mtt-85 -70.93 -40.45 72.07 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.211 0.605 . . . . 75.25 109.439 175.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.57 1.26 88.22 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.87 0.731 . . . . 64.01 112.934 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.433 HG21 ' HB3' ' D' ' 17' ' ' TYR . 16.5 p 66.1 24.83 10.89 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.479 1.912 . . . . 75.5 113.931 170.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -85.27 163.76 43.83 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.018 0.927 . . . . 74.01 110.056 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -54.67 124.18 15.54 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.979 2.453 . . . . 75.22 112.721 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.42 ' NE2' ' HB2' ' B' ' 119' ' ' SER . 47.1 mt-30 -60.49 137.89 58.09 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.074 0.549 . . . . 74.52 110.855 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.488 HD13 HG12 ' C' ' 64' ' ' VAL . 2.5 pt? -130.22 127.52 39.8 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.895 -0.593 . . . . 74.54 110.049 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -110.1 110.24 21.05 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.267 -1.012 . . . . 75.54 108.267 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.31 134.53 56.62 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 124.134 0.896 . . . . 71.44 110.99 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.81 147.07 94.05 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 123.857 0.723 . . . . 73.42 111.499 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.428 ' HG3' HD13 ' A' ' 16' ' ' ILE . 9.7 Cg_exo -69.4 109.7 2.3 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.601 2.201 . . . . 72.41 111.905 176.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 m -106.07 138.95 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.756 -0.831 . . . . 74.02 108.756 170.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -75.85 88.34 2.86 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.91 0.484 . . . . 75.12 110.204 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.434 ' HE1' HD11 ' C' ' 44' ' ' LEU . 98.5 m-85 -62.05 -48.32 80.76 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.664 -0.698 . . . . 75.31 110.429 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.12 -44.64 68.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.667 -1.151 . . . . 71.14 112.455 -170.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.65 87.85 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.242 0.964 . . . . 75.01 111.307 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 -50.4 70.92 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 124.439 1.087 . . . . 73.35 109.852 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 4.5 t80 . . . . . 0 CA--C 1.554 1.132 0 CA-C-N 115.834 -0.621 . . . . 75.54 110.282 -178.488 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.544 0.724 0 N-CA-C 109.8 -0.444 . . . . 71.42 109.8 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -152.5 113.29 4.15 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.115 -1.069 . . . . 74.41 108.115 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -131.57 121.48 24.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.871 0.868 . . . . 65.35 108.751 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.425 HG21 HD11 ' D' ' 16' ' ' ILE . 23.7 mt -75.35 121.29 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.544 -0.91 . . . . 70.2 108.544 174.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -88.57 -31.49 18.61 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.188 0.595 . . . . 63.23 111.584 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -169.08 142.63 2.86 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.587 0.232 . . . . 73.23 111.526 -174.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.425 HD11 HG21 ' D' ' 13' ' ' ILE . 3.9 mp -121.4 132.85 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 107.188 -1.412 . . . . 74.33 107.188 169.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.472 ' HE1' HG13 ' D' ' 83' ' ' ILE . 36.9 p90 -161.15 152.28 18.69 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.925 0.869 . . . . 75.22 111.438 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -88.47 116.13 26.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.428 -1.26 . . . . 74.53 108.975 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -83.56 -26.42 30.1 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.407 -0.59 . . . . 74.34 109.407 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -154.31 139.97 17.97 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.967 -1.015 . . . . 61.33 109.352 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.599 HG23 ' HE1' ' C' ' 117' ' ' MET . 38.5 mt -137.33 147.31 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.865 1.266 . . . . 74.21 107.851 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -156.27 143.29 18.91 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.348 0.595 . . . . 73.3 110.068 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.451 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.9 t80 -138.05 133.58 33.71 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.401 -1.703 . . . . 73.02 106.401 170.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.2 mt-10 -129.2 141.13 51.24 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.887 0.875 . . . . 73.13 109.061 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.98 81.27 39.86 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.166 -1.42 . . . . 75.35 107.166 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.79 -36.15 8.51 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.006 2.471 . . . . 73.25 113.012 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -104.84 17.66 23.74 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.709 0.804 . . . . 75.22 110.793 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -32.49 -64.79 0.23 Allowed Pre-proline 0 CA--C 1.564 1.488 0 N-CA-C 116.11 1.892 . . . . 65.05 116.11 -164.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.416 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 68.8 Cg_endo -77.91 -20.88 11.41 Favored 'Trans proline' 0 C--N 1.382 2.295 0 CA-C-N 122.896 2.07 . . . . 64.41 113.732 -176.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -72.9 -40.09 65.84 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.759 1.223 . . . . 72.2 109.884 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.729 HG23 ' HA ' ' D' ' 73' ' ' ALA . 14.6 p -83.59 -14.54 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.485 -0.78 . . . . 72.31 111.807 -175.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 20.0 m-85 -68.15 -15.99 63.81 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.666 -0.646 . . . . 73.12 111.862 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -67.29 -19.16 65.44 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.74 0.816 . . . . 74.41 110.971 173.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -84.96 87.61 7.37 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.034 0.934 . . . . 64.23 108.847 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.54 68.06 10.3 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.737 0.78 . . . . 71.44 108.919 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 48.3 t-105 -142.19 158.46 43.71 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.984 0.913 . . . . 65.45 109.251 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -72.95 111.1 10.07 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.676 1.19 . . . . 73.32 110.031 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.83 141.73 55.07 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.927 2.418 . . . . 60.41 112.33 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.67 124.72 27.71 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.153 -0.684 . . . . 75.45 109.153 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.652 HG12 HG13 ' D' ' 64' ' ' VAL . 59.2 t -97.93 107.67 20.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.831 -0.803 . . . . 74.32 108.831 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -95.28 118.5 32.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.433 -1.321 . . . . 75.03 107.433 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.57 143.2 28.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.238 0.615 . . . . 75.1 110.326 -175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.723 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.7 m-20 -127.45 112.36 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.576 -1.268 . . . . 71.13 107.576 169.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 88.2 mt -99.72 130.2 45.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.433 0.693 . . . . 70.54 110.114 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.2 t0 -144.87 149.76 35.9 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.51 1.124 . . . . 74.35 108.373 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -125.12 159.65 30.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.519 0.676 . . . . 75.41 110.257 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.96 154.28 37.99 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.818 -1.549 . . . . 72.23 106.818 172.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.7 p -167.64 152.97 7.13 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.853 0.297 . . . . 62.14 111.223 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.7 p -163.74 142.47 7.82 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.91 0.884 . . . . 73.35 109.707 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -75.92 121.05 22.11 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.231 -0.655 . . . . 64.01 109.231 176.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 49.4 mt -89.93 -38.61 13.55 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.855 0.36 . . . . 75.44 110.436 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.42 -176.07 5.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.053 -0.522 . . . . 73.22 110.438 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -69.49 118.51 12.45 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.229 0.611 . . . . 64.12 109.594 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 67.99 9.2 7.0 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.907 1.283 . . . . 72.25 111.856 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 66.2 t -113.44 119.1 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.327 0.651 . . . . 63.42 109.693 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -128.41 129.56 46.36 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.009 0.924 . . . . 75.24 108.79 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -96.53 138.96 33.33 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.953 0.901 . . . . 73.42 109.072 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -126.42 122.76 61.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 N-CA-C 108.113 -1.069 . . . . 75.24 108.113 173.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.544 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 23.6 t -99.11 137.62 26.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 123.693 0.797 . . . . 75.01 108.903 171.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.41 123.32 44.95 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.67 -0.863 . . . . 73.32 108.67 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.44 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.4 ttm-85 -98.6 113.67 25.82 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.086 -0.709 . . . . 74.42 109.086 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.8 t -112.74 113.35 43.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.778 -1.193 . . . . 65.15 107.778 170.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.723 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 48.5 m -111.74 136.8 50.51 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.817 0.847 . . . . 70.55 109.141 -177.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.652 HG13 HG12 ' D' ' 40' ' ' VAL . 78.0 t -130.13 108.34 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.419 1.088 . . . . 65.43 109.635 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 38.1 m -107.58 114.67 28.81 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.371 -0.974 . . . . 64.03 108.371 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.4 145.13 48.22 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.328 0.651 . . . . 72.32 110.533 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 50.6 p -129.67 147.76 51.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.972 0.909 . . . . 75.34 109.246 173.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.467 HD11 HG22 ' D' ' 31' ' ' VAL . 25.6 mt -118.5 108.75 15.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.389 1.076 . . . . 72.53 108.243 171.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.42 -126.11 15.18 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 123.686 0.617 . . . . 74.12 112.447 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -90.61 2.36 55.92 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.31 0.644 . . . . 74.13 112.602 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -134.06 158.98 42.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.551 0.34 . . . . 72.42 111.354 -166.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.7 m -65.17 124.35 21.92 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.17 -0.923 . . . . 63.14 109.651 174.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.729 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -80.81 -72.8 0.4 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.158 -1.052 . . . . 70.13 108.158 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -155.45 139.48 16.41 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.477 -0.783 . . . . 72.45 110.036 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 37.0 mt -105.47 150.76 25.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.326 -1.306 . . . . 74.23 107.795 176.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.478 ' SG ' HG22 ' D' ' 114' ' ' ILE . 49.1 t -158.38 147.63 19.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.909 -0.404 . . . . 63.01 109.909 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.01 134.13 10.39 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.917 -0.771 . . . . 73.3 108.917 172.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.2 t -128.46 137.23 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.406 -0.961 . . . . 73.52 108.406 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -117.86 81.55 1.68 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.73 -1.211 . . . . 74.2 107.73 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -80.06 96.48 6.49 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 112.961 -1.927 . . . . 64.34 109.802 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.63 143.17 17.58 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.676 -0.569 . . . . 74.21 111.676 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.66 130.81 5.38 Favored Glycine 0 C--O 1.228 -0.243 0 N-CA-C 111.214 -0.755 . . . . 74.1 111.214 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.472 HG13 ' HE1' ' D' ' 17' ' ' TYR . 70.8 mt -90.3 122.74 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.95 -1.13 . . . . 73.23 107.95 172.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -124.15 149.54 46.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.035 0.934 . . . . 70.32 109.049 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t -115.01 102.7 10.2 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.981 -1.118 . . . . 74.11 107.981 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.531 HG21 HD12 ' D' ' 89' ' ' ILE . 46.1 mt -108.81 128.03 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.988 0.915 . . . . 71.31 110.443 -171.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.18 157.31 42.51 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.961 0.905 . . . . 74.25 110.272 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.87 11.96 81.03 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.331 -0.395 . . . . 62.1 113.933 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.531 HD12 HG21 ' D' ' 86' ' ' ILE . 15.8 mt -111.42 127.65 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.062 0.945 . . . . 74.22 110.443 -173.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.04 164.1 34.12 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.228 1.011 . . . . 75.53 111.039 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.18 -131.57 11.34 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.54 -0.754 . . . . 43.5 113.569 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -75.79 -24.43 55.97 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.813 0.845 . . . . 75.33 111.487 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -65.15 -26.37 68.15 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.44 0.696 . . . . 75.21 110.724 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 54.3 mtp -54.31 -55.15 31.24 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.489 1.116 . . . . 73.12 110.831 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.71 -41.43 83.57 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.952 -1.022 . . . . 65.21 110.648 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -65.9 -24.89 66.93 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.88 0.872 . . . . 74.14 111.742 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -80.38 -48.85 12.3 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.832 -0.432 . . . . 65.41 109.832 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 28.5 tp -67.72 -56.01 10.95 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.729 0.812 . . . . 75.14 112.452 -171.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.88 -0.1 51.98 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 114.654 0.621 . . . . 41.3 114.654 -168.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' D' ' 134' ' ' ASP . . . -124.84 -66.07 0.99 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.673 0.737 . . . . 71.05 110.88 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -65.88 -54.21 29.59 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.536 0.734 . . . . 75.43 111.763 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.2 m -62.69 -46.35 88.52 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.305 -0.855 . . . . 74.42 112.387 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.32 -36.6 97.21 Favored 'Trans proline' 0 C--N 1.393 2.909 0 C-N-CA 122.523 2.149 . . . . 70.32 113.378 168.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . 0.414 ' HB2' ' HB2' ' D' ' 133' ' ' PHE . 64.3 t30 -71.09 -23.86 62.19 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.213 0.605 . . . . 73.54 110.77 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 29.7 mm -76.68 -36.51 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.961 0.904 . . . . 75.2 110.252 171.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.88 -18.62 53.63 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.31 0.644 . . . . 74.04 111.862 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -71.34 -37.94 6.2 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 113.901 1.074 . . . . 74.42 113.901 -173.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.99 -45.63 37.52 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 121.883 1.722 . . . . 71.21 112.281 168.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -70.61 -33.49 71.1 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.32 -0.855 . . . . 65.43 111.764 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.85 -51.48 54.99 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.301 0.64 . . . . 64.24 110.084 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.413 ' HG3' HD23 ' D' ' 128' ' ' LEU . 22.0 ttp180 -51.2 -52.32 45.52 Favored 'General case' 0 C--N 1.358 0.942 0 O-C-N 124.797 1.311 . . . . 75.44 110.309 175.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.38 -46.23 91.06 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.383 1.052 . . . . 73.45 111.839 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.6 t -58.97 -41.9 88.62 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.863 0.727 . . . . 64.44 110.659 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.478 HG22 ' SG ' ' D' ' 76' ' ' CYS . 80.4 mt -64.33 -56.08 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 123.996 0.81 . . . . 73.21 110.411 174.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 61.4 m -51.89 -44.55 63.79 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.816 1.247 . . . . 75.41 111.574 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.5 t -65.29 -42.0 93.58 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.912 -1.04 . . . . 74.31 110.201 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.4 mtm -68.58 -34.25 75.48 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.028 0.531 . . . . 65.4 111.772 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -66.99 -40.85 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.002 0.921 . . . . 71.34 110.099 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 77.7 p -76.66 -28.47 55.99 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.979 0.512 . . . . 74.35 111.012 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -73.68 -28.53 61.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.222 0.609 . . . . 75.1 109.633 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.18 3.64 86.66 Favored Glycine 0 C--N 1.351 1.381 0 O-C-N 123.837 0.71 . . . . 71.3 112.378 172.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 45.2 p 60.09 20.0 9.23 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 126.845 2.058 . . . . 74.3 114.181 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -79.61 157.23 74.9 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 123.13 0.572 . . . . 74.34 109.853 171.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.53 126.34 17.69 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.946 2.431 . . . . 74.4 112.367 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -56.05 138.99 48.3 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.425 1.09 . . . . 73.43 112.041 -174.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 32.5 mt -107.92 101.41 10.68 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.557 -0.535 . . . . 74.23 109.557 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -100.65 84.83 2.8 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.615 -1.254 . . . . 74.14 107.615 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.413 HD23 ' HG3' ' D' ' 111' ' ' ARG . 3.4 mm? -59.18 115.68 3.36 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 114.775 -1.102 . . . . 74.54 109.991 -175.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.79 136.06 86.87 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 124.189 0.931 . . . . 71.04 110.191 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 24.3 Cg_exo -61.7 114.31 2.21 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.802 2.335 . . . . 73.33 112.55 -172.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.1 m -108.02 128.38 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.483 0.713 . . . . 75.01 109.243 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -85.84 103.98 15.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.632 0.773 . . . . 43.23 110.544 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.414 ' HB2' ' HB2' ' D' ' 104' ' ' ASN . 63.9 m-85 -66.5 -25.63 66.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.205 0.602 . . . . 73.13 112.041 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . 0.495 ' HA ' ' HB3' ' D' ' 100' ' ' ALA . 2.5 m-20 -57.42 -58.67 7.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.892 0.877 . . . . 71.31 111.258 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.17 90.19 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.815 0.846 . . . . 72.12 111.713 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.88 -29.76 68.95 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.181 -0.918 . . . . 74.25 112.067 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.7 t80 . . . . . 0 N--CA 1.485 1.283 0 C-N-CA 123.537 0.735 . . . . 74.44 110.66 178.434 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.9 m . . . . . 0 C--O 1.24 0.565 0 N-CA-C 108.704 -0.85 . . . . 73.23 108.704 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.696 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 11.5 t80 -123.09 124.71 43.7 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.329 -0.989 . . . . 74.24 108.329 170.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -141.7 112.07 6.99 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.73 -0.668 . . . . 73.23 109.851 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.584 HG12 ' HD2' ' A' ' 84' ' ' PHE . 52.7 mt -83.05 113.87 22.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.804 -0.813 . . . . 72.3 108.804 173.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -81.34 -31.97 33.21 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.792 -0.64 . . . . 74.43 109.843 -177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -171.53 143.54 1.78 Allowed 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.008 0.193 . . . . 75.5 111.108 -173.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.86 126.92 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 124.251 1.02 . . . . 73.43 108.384 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.521 ' HB3' HG23 ' B' ' 122' ' ' THR . 23.2 p90 -160.54 168.71 24.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.028 0.931 . . . . 75.12 110.698 -170.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.6 p -93.39 121.06 34.39 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.083 -0.71 . . . . 72.55 109.083 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -85.76 -26.07 26.03 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.037 -0.529 . . . . 73.13 109.675 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.2 t70 -152.77 142.59 22.06 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.934 -1.03 . . . . 75.53 110.197 -175.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 88.2 mt -146.19 141.72 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.728 1.611 . . . . 72.55 107.057 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -151.82 132.14 13.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.579 -0.526 . . . . 74.45 109.579 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 82.9 t80 -130.99 122.6 27.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.74 -1.578 . . . . 63.41 106.74 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -129.99 118.42 21.59 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.36 -0.607 . . . . 73.15 109.36 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.12 79.03 70.11 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.826 -1.175 . . . . 75.11 107.826 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.26 -33.05 40.61 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.052 2.501 . . . . 74.34 111.686 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 47.5 m-80 -107.03 36.73 2.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.779 -1.1 . . . . 74.44 109.631 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.488 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -60.39 -44.58 96.28 Favored Pre-proline 0 CA--C 1.57 1.743 0 C-N-CA 124.537 1.135 . . . . 61.22 113.967 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.88 -20.85 11.46 Favored 'Trans proline' 0 C--N 1.385 2.468 0 CA-C-N 121.522 1.579 . . . . 74.13 112.876 172.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 61.7 m170 -77.67 -38.97 46.47 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.143 0.577 . . . . 73.22 110.876 -176.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.628 HG21 HD13 ' A' ' 68' ' ' LEU . 10.6 p -63.48 -27.7 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.989 0.916 . . . . 54.34 110.998 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.592 ' HD1' HH11 ' B' ' 15' ' ' ARG . 91.7 t80 -62.44 -35.57 79.7 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.315 1.046 . . . . 74.55 110.907 174.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -93.03 -25.43 17.95 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.641 0.776 . . . . 63.44 111.264 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HE2' HD21 ' A' ' 68' ' ' LEU . 53.9 mtpt -82.87 165.31 19.89 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.463 0.705 . . . . 73.44 111.489 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.464 ' O ' HD22 ' A' ' 68' ' ' LEU . 10.3 m-20 -80.77 128.66 33.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.178 0.991 . . . . 72.14 108.919 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -69.28 85.92 0.4 Allowed 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.37 0.605 . . . . 75.44 111.245 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -127.25 82.28 68.47 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.543 1.137 . . . . 74.32 108.647 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -85.11 152.52 10.95 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.418 2.079 . . . . 64.31 113.117 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.436 ' HB3' ' NZ ' ' A' ' 41' ' ' LYS . 63.1 mm-40 -105.6 85.49 2.25 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.865 -1.161 . . . . 70.25 107.865 176.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -82.5 93.83 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 122.323 1.059 . . . . 62.42 111.357 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.436 ' NZ ' ' HB3' ' A' ' 39' ' ' GLU . 13.7 mptt -98.17 136.05 38.94 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.912 -1.04 . . . . 74.43 108.61 169.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.411 HD12 HG21 ' A' ' 64' ' ' VAL . 37.2 tp -119.57 114.8 22.79 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.009 -0.737 . . . . 70.4 109.009 172.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -102.67 128.55 49.32 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.028 -1.101 . . . . 70.25 108.028 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.1 mt -107.35 143.03 36.22 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.625 -0.88 . . . . 73.12 108.625 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 26.2 t70 -143.29 130.46 20.79 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.987 -0.746 . . . . 74.32 108.987 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -105.77 131.09 53.54 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.065 -0.717 . . . . 74.33 109.065 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.6 127.37 38.86 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.658 0.783 . . . . 74.0 109.664 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.404 ' HB2' ' HH ' ' A' ' 56' ' ' TYR . 28.1 p -94.83 153.22 17.83 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.143 0.977 . . . . 61.24 110.214 -178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 28.9 t -150.39 127.39 11.15 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.872 -0.788 . . . . 72.21 108.872 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -103.01 106.7 17.27 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.282 -0.636 . . . . 75.3 109.282 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.622 HD12 ' HB2' ' A' ' 57' ' ' GLU . 65.6 mt -83.37 -30.47 27.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.047 0.539 . . . . 70.34 110.505 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.426 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -163.73 -177.98 5.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.12 -0.946 . . . . 74.21 109.748 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.43 126.27 28.76 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.518 -1.29 . . . . 64.5 107.518 164.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 74.19 -3.85 2.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.272 1.029 . . . . 74.55 112.85 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.426 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 50.5 t -115.64 111.4 35.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 107.403 -1.332 . . . . 72.1 107.403 177.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.404 ' HH ' ' HB2' ' A' ' 48' ' ' SER . 2.7 t80 -130.99 123.73 29.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.39 -0.596 . . . . 53.41 109.39 -172.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.622 ' HB2' HD12 ' A' ' 51' ' ' LEU . 45.3 tt0 -93.95 140.34 29.82 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.762 0.825 . . . . 73.15 109.404 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -119.29 143.43 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.483 -1.302 . . . . 73.42 107.483 170.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.03 117.74 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.967 -1.123 . . . . 73.3 107.967 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.52 HD13 HG23 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -99.54 106.8 18.84 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.215 -1.031 . . . . 73.22 108.215 178.221 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 62.9 ttt180 -84.34 105.89 15.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.063 0.945 . . . . 72.54 109.29 176.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.52 HG23 HD13 ' A' ' 60' ' ' LEU . 15.9 t -104.71 115.84 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.869 0.868 . . . . 72.31 109.003 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.3 m -110.71 112.71 24.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.091 0.957 . . . . 74.43 110.511 -175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.429 HG22 HG21 ' A' ' 114' ' ' ILE . 53.0 t -102.89 107.35 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.888 0.875 . . . . 74.43 109.176 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.1 m -105.13 109.91 22.08 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.531 -0.915 . . . . 74.45 108.531 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.71 104.1 9.96 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.611 -0.885 . . . . 64.42 108.611 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.8 m -107.76 127.15 53.44 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.563 0.745 . . . . 71.1 109.13 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.628 HD13 HG21 ' A' ' 31' ' ' VAL . 2.2 tt -86.62 87.14 7.38 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 106.781 -1.563 . . . . 72.4 106.781 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.86 -98.7 1.32 Allowed Glycine 0 C--N 1.343 0.926 0 CA-C-N 114.51 -1.223 . . . . 70.44 110.632 -172.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -115.5 -12.54 11.65 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.124 0.97 . . . . 73.15 110.443 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -99.48 119.5 38.12 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.227 1.011 . . . . 74.22 109.671 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.3 m -61.82 122.44 15.39 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 123.459 0.474 . . . . 75.42 111.409 -178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.93 -55.67 5.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.045 -1.095 . . . . 75.13 108.045 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -158.95 150.43 20.56 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.854 -1.066 . . . . 73.43 110.601 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.0 tp -131.1 107.57 9.14 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 107.741 -1.207 . . . . 70.41 107.741 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 60.4 m -109.74 99.78 8.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.659 0.784 . . . . 64.13 109.715 -177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -119.71 116.04 25.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.636 -0.876 . . . . 60.5 108.636 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.24 132.3 68.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 123.992 0.917 . . . . 72.44 109.29 -173.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 44.9 mt-30 -104.55 101.13 10.79 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 109.232 -0.655 . . . . 74.12 109.232 168.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -86.82 105.4 16.99 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.107 -1.072 . . . . 74.4 108.107 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.44 144.6 17.15 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 111.756 -0.538 . . . . 73.35 111.756 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.4 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -141.23 137.09 7.89 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.078 -0.809 . . . . 63.33 111.078 177.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.4 mt -89.08 123.58 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.844 -0.799 . . . . 75.3 108.844 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.696 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 34.8 m-85 -128.18 133.59 48.93 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.264 0.626 . . . . 74.32 109.654 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.3 t -100.89 114.31 28.05 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.67 -0.863 . . . . 74.24 108.67 176.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.31 142.31 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.831 0.852 . . . . 72.32 109.25 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.49 152.35 19.97 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.088 0.955 . . . . 64.15 109.792 173.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.2 -17.19 57.82 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.558 0.536 . . . . 54.01 114.398 173.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.542 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -132.18 152.95 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.483 0.713 . . . . 73.31 109.874 178.586 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.477 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 17.9 tt0 -150.27 -179.05 6.88 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.845 0.858 . . . . 64.44 108.866 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 71.9 -135.58 23.2 Favored Glycine 0 C--N 1.35 1.359 0 C-N-CA 123.003 0.335 . . . . 71.1 113.888 176.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.2 p -79.32 -15.13 58.43 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.075 0.55 . . . . 73.12 110.918 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -74.96 -36.84 62.07 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.151 0.98 . . . . 75.31 110.532 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 91' ' ' GLY . 12.9 ptt? -74.94 -25.13 58.67 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 110.259 -0.274 . . . . 74.24 110.259 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.45 -26.53 62.76 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.294 0.637 . . . . 73.2 110.26 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -71.88 -34.56 69.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.069 0.548 . . . . 75.51 110.494 171.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.542 ' SG ' HG13 ' A' ' 89' ' ' ILE . 79.3 m -69.58 -61.27 1.85 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.454 0.302 . . . . 73.22 110.769 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -76.21 -24.23 54.65 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.676 0.39 . . . . 70.33 111.194 -173.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.0 3.75 38.53 Favored Glycine 0 N--CA 1.476 1.325 0 CA-C-O 119.762 -0.466 . . . . 73.35 114.251 -171.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -147.49 -59.0 0.26 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 117.375 0.588 . . . . 70.34 111.755 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.42 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 84.6 t80 -70.74 -51.05 29.74 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.776 0.831 . . . . 75.35 112.511 -173.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.432 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 74.5 m -76.18 -34.2 1.38 Allowed Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 113.876 1.065 . . . . 75.14 113.876 -173.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 42.8 Cg_endo -69.12 -22.38 35.08 Favored 'Trans proline' 0 C--N 1.379 2.143 0 CA-C-N 121.596 1.606 . . . . 71.02 112.92 167.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -70.35 -31.36 68.6 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.389 0.676 . . . . 73.22 109.721 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 35.9 mm -57.08 -39.09 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.185 0.994 . . . . 74.12 110.962 171.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.4 HD22 ' HA3' ' A' ' 82' ' ' GLY . 54.0 mt -86.23 -16.99 35.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.788 0.835 . . . . 73.32 112.748 -172.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -64.79 -43.14 68.17 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 113.453 0.909 . . . . 73.15 113.453 -175.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.46 -36.25 78.44 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.058 1.839 . . . . 52.43 113.243 173.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.449 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 96.2 m-85 -70.5 -40.06 73.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.347 0.659 . . . . 74.42 111.223 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.11 -40.55 86.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.299 0.64 . . . . 75.3 110.149 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.543 ' NH1' HD13 ' C' ' 105' ' ' ILE . 36.9 ttm180 -51.56 -55.52 18.68 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 124.334 1.021 . . . . 71.25 110.143 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.37 -47.31 86.41 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.367 1.042 . . . . 52.43 111.537 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.3 t -55.14 -45.01 75.6 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.93 0.769 . . . . 70.21 110.987 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.429 HG21 HG22 ' A' ' 64' ' ' VAL . 83.9 mt -64.69 -55.68 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.773 -1.103 . . . . 73.04 110.758 176.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -55.58 -37.35 67.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.985 0.914 . . . . 63.43 111.799 -175.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -66.79 -49.89 64.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.88 -1.055 . . . . 63.01 109.912 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 38.8 mtp -58.44 -37.18 74.89 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.773 0.829 . . . . 73.25 111.847 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 114' ' ' ILE . 98.2 t -65.69 -47.86 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.851 0.86 . . . . 73.14 110.263 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 p -74.98 -21.61 59.05 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.18 0.592 . . . . 73.32 111.876 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -73.0 -34.27 66.29 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.519 0.728 . . . . 74.11 109.362 172.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.82 0.66 76.95 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.894 0.746 . . . . 63.24 113.1 172.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.4 m 69.25 19.63 7.76 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 124.648 1.179 . . . . 75.31 111.141 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -86.97 150.46 50.08 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.627 0.771 . . . . 72.1 109.987 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.48 152.6 15.61 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.722 2.948 . . . . 71.32 114.374 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -57.67 140.92 50.05 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.238 1.015 . . . . 73.14 112.413 -172.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.8 tp -127.14 113.36 16.28 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.853 0.461 . . . . 75.23 110.558 -176.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -122.41 86.7 2.62 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.387 0.675 . . . . 71.25 109.206 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.617 ' H ' HD22 ' A' ' 128' ' ' LEU . 0.5 OUTLIER -65.61 131.06 45.44 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.278 0.631 . . . . 71.1 110.028 175.22 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.38 146.39 81.09 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 123.756 0.822 . . . . 72.42 111.847 -170.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.51 121.99 7.9 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 122.942 2.428 . . . . 75.21 112.548 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -108.39 134.73 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 109.217 -0.661 . . . . 71.25 109.217 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.4 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 52.5 t-20 -80.76 101.94 9.64 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.701 0.8 . . . . 75.53 109.355 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -66.9 -27.15 67.27 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.275 0.63 . . . . 75.44 111.596 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.53 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 5.1 m-20 -67.87 -37.49 81.88 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.836 0.855 . . . . 65.52 110.816 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.48 -37.24 84.66 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.893 0.746 . . . . 64.13 110.589 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 132' ' ' ASN . 84.3 mt -67.07 -45.14 78.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.655 0.782 . . . . 75.11 111.396 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -64.0 -39.49 94.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.507 -0.769 . . . . 74.41 109.322 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 CA--C 1.543 0.69 0 O-C-N 124.211 0.944 . . . . 74.32 110.668 -178.355 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 95.5 m . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 106.608 -1.627 . . . . 74.33 106.608 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -133.49 132.83 41.48 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.686 0.395 . . . . 74.41 110.317 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -140.09 142.08 36.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.34 0.656 . . . . 75.12 109.732 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.456 HD11 HD12 ' B' ' 105' ' ' ILE . 32.1 mt -95.64 120.68 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 107.989 -1.115 . . . . 73.35 107.989 170.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -85.2 -50.86 7.04 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.334 -0.617 . . . . 74.51 109.334 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.592 HH11 ' HD1' ' A' ' 32' ' ' PHE . 46.0 ttt180 -162.03 137.99 7.68 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.364 -0.834 . . . . 75.42 109.508 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 91.4 mt -114.99 145.46 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 106.77 -1.567 . . . . 74.33 106.77 171.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.403 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 13.0 p90 -165.61 141.24 5.1 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.931 0.396 . . . . 74.2 111.416 -178.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 59.0 m -72.92 120.92 19.21 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.108 -1.071 . . . . 74.45 108.108 171.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.488 ' HE3' ' HB2' ' A' ' 28' ' ' ALA . 46.8 mtpt -92.67 -32.42 14.76 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.221 0.608 . . . . 73.53 111.267 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.9 t70 -153.93 137.8 16.25 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.064 0.228 . . . . 73.55 110.689 -171.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.446 HD13 ' SG ' ' B' ' 113' ' ' CYS . 47.8 mm -134.87 141.3 43.47 Favored 'Isoleucine or valine' 0 C--N 1.348 0.533 0 C-N-CA 124.834 1.254 . . . . 74.02 108.223 173.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.3 t -139.16 127.07 22.2 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.526 -1.286 . . . . 74.23 107.526 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.582 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.0 t80 -143.39 114.35 7.74 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.478 -0.934 . . . . 64.1 108.478 173.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -119.48 137.94 53.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.031 0.933 . . . . 65.35 108.817 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.01 81.04 71.17 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.461 -1.311 . . . . 74.54 107.461 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.87 -44.39 16.61 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.25 2.633 . . . . 71.33 113.356 -166.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.521 ' HB2' ' HB ' ' B' ' 31' ' ' VAL . 33.5 m-80 -100.25 15.49 27.41 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 117.905 -1.045 . . . . 74.24 110.792 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -30.17 -72.26 0.06 OUTLIER Pre-proline 0 N--CA 1.511 2.59 0 C-N-CA 125.927 1.691 . . . . 65.03 115.048 -165.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.3 -21.61 54.25 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.462 2.108 . . . . 65.2 113.166 -172.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -83.11 -49.53 9.42 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.383 -0.826 . . . . 71.11 111.308 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.72 HG22 HD13 ' B' ' 68' ' ' LEU . 8.1 p -64.37 -19.61 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.133 0.973 . . . . 65.55 112.056 -166.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -61.37 -11.77 11.49 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 123.821 0.848 . . . . 75.35 112.319 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.597 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 24.7 pt20 -55.34 -40.27 71.03 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.08 1.352 . . . . 51.41 111.574 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.597 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 90.0 mttt -94.54 89.65 5.89 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.622 0.769 . . . . 71.42 108.925 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.32 86.91 2.51 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.388 -0.824 . . . . 64.25 109.641 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -154.16 155.15 34.81 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.087 1.355 . . . . 73.34 107.377 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -76.2 102.91 0.87 Allowed Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.559 -0.904 . . . . 72.4 108.559 170.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.545 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 34.6 Cg_endo -60.06 142.06 97.59 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 123.136 2.558 . . . . 62.53 113.098 -170.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.41 121.58 13.57 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 123.701 0.625 . . . . 74.41 109.441 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' B' ' 65' ' ' THR . 18.3 m -104.05 135.5 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.587 -0.733 . . . . 65.25 112.314 -171.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.588 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 54.1 tttp -106.1 103.48 12.97 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.597 -1.26 . . . . 75.33 107.597 170.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.573 ' H ' HD23 ' B' ' 42' ' ' LEU . 2.2 pt? -95.81 132.31 41.19 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.81 -0.811 . . . . 73.03 108.81 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 19.5 t70 -131.77 146.96 52.44 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.14 1.376 . . . . 73.32 109.123 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 tp -125.04 131.4 53.38 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.106 0.962 . . . . 75.45 109.724 -172.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -148.87 155.89 41.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.643 1.177 . . . . 72.41 108.822 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.5 p -134.93 130.41 35.81 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.452 0.701 . . . . 71.34 109.753 173.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.79 122.71 46.26 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.97 -1.122 . . . . 74.52 107.97 174.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.3 m -124.8 160.79 27.89 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 122.915 0.486 . . . . 75.54 109.865 -175.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 94.6 p -152.35 139.82 19.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.493 0.717 . . . . 73.13 110.064 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -82.19 105.26 13.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.27 0.628 . . . . 63.04 110.067 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 78.4 mt -72.23 -42.77 65.32 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.62 0.724 . . . . 74.11 109.603 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.37 -179.16 7.92 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.269 -1.332 . . . . 63.33 108.782 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.25 123.12 22.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.291 -1.003 . . . . 65.31 108.291 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 72.82 -5.4 1.89 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.517 1.527 . . . . 65.03 113.288 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -111.49 109.83 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 107.59 -1.263 . . . . 75.32 107.59 173.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.72 140.5 52.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.183 -0.673 . . . . 74.34 109.183 -173.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -99.7 133.65 43.74 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.149 -1.056 . . . . 74.31 108.149 172.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -115.69 139.58 41.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.2 -1.037 . . . . 75.41 108.2 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 33.0 t -126.54 120.83 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.62 -0.881 . . . . 65.1 108.62 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.7 OUTLIER -93.66 113.13 25.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.125 -1.065 . . . . 74.34 108.125 -178.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -100.65 122.43 43.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.806 0.442 . . . . 73.14 110.315 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -116.09 114.61 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 107.783 -1.192 . . . . 63.34 107.783 171.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 48.7 m -96.4 137.72 35.06 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.474 -0.935 . . . . 72.11 108.474 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 85.5 t -131.99 133.08 61.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.998 -0.742 . . . . 75.52 108.998 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.588 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 91.4 m -120.09 148.88 43.05 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.767 1.227 . . . . 72.23 107.721 175.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.45 134.65 21.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 122.858 0.463 . . . . 71.43 110.077 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.6 p -132.62 126.69 33.28 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.308 0.643 . . . . 75.54 110.751 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.72 HD13 HG22 ' B' ' 31' ' ' VAL . 41.2 mt -95.13 103.15 15.0 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 108.149 -1.056 . . . . 74.2 108.149 170.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.48 -109.78 3.1 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.008 -0.996 . . . . 73.34 111.206 -170.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -117.37 5.15 12.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.928 0.891 . . . . 75.41 111.583 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.537 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 13.0 pt-20 -116.17 149.21 39.44 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.185 -0.672 . . . . 75.4 109.185 175.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 65.7 m -72.89 134.0 44.63 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.192 0.308 . . . . 75.0 111.097 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.59 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -82.97 -68.21 0.72 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.249 -1.019 . . . . 71.32 108.249 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -144.25 158.94 43.46 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.811 -1.086 . . . . 75.03 110.395 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 94.8 mt -131.2 120.82 23.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.08 -1.822 . . . . 73.33 106.08 174.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 36.9 t -132.35 145.24 51.11 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.194 -0.669 . . . . 74.41 109.194 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -160.19 133.96 7.11 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.865 -0.791 . . . . 71.53 108.865 -175.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.422 HG21 HD12 ' B' ' 21' ' ' ILE . 86.0 t -128.01 146.39 33.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.87 0.868 . . . . 74.02 108.918 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 17.6 mt-30 -124.96 93.32 3.85 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.233 -1.025 . . . . 72.33 108.233 170.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -85.57 101.0 12.32 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.845 -1.071 . . . . 71.53 109.155 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.07 160.26 29.52 Favored Glycine 0 C--N 1.339 0.748 0 O-C-N 123.435 0.459 . . . . 73.04 112.047 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.18 130.42 2.34 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 119.952 -0.36 . . . . 73.11 112.22 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -84.54 126.09 40.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 108.806 -0.813 . . . . 74.24 108.806 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -132.37 134.18 44.86 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.282 1.033 . . . . 75.33 108.972 -176.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.6 m -102.06 103.08 13.65 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.822 0.849 . . . . 74.13 109.51 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.655 ' HB ' HD12 ' B' ' 89' ' ' ILE . 46.2 pt -103.92 135.33 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.496 0.719 . . . . 74.21 109.794 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.486 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -146.69 151.81 37.81 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.863 -0.792 . . . . 44.11 108.863 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.93 -62.16 3.66 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 112.109 -0.396 . . . . 61.11 112.109 -176.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.655 HD12 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -62.12 142.07 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.679 0.392 . . . . 72.44 111.781 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.84 167.73 26.61 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.969 0.907 . . . . 72.45 109.526 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.07 -113.62 5.28 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.794 0.684 . . . . 74.15 113.042 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 2.2 m -87.17 -17.49 32.57 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.609 -0.348 . . . . 61.23 111.26 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -65.61 -46.75 78.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.982 0.513 . . . . 72.31 110.262 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -24.42 57.03 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 116.058 -0.519 . . . . 74.44 110.529 177.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.77 98.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.33 0.586 . . . . 62.43 109.918 169.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -70.25 -30.91 68.08 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.31 1.044 . . . . 73.21 111.203 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.482 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 69.2 m -70.76 -67.68 0.49 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 110.247 -0.279 . . . . 63.32 110.247 174.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 59.3 mt -74.34 -21.93 59.46 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.585 0.587 . . . . 75.41 112.585 -168.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.95 3.09 41.2 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-O 119.522 -0.599 . . . . 64.34 114.302 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.48 -62.85 0.2 Allowed 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.789 0.795 . . . . 70.41 111.909 -177.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.482 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 89.4 t80 -68.18 -39.18 82.61 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.915 0.886 . . . . 75.22 112.372 -172.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 91.3 m -73.08 -46.36 8.22 Favored Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 123.693 0.797 . . . . 64.24 111.103 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.402 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 78.5 Cg_exo -55.87 -34.05 90.39 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.025 1.817 . . . . 64.41 113.727 167.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -59.6 -38.77 82.13 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.231 0.613 . . . . 72.24 110.799 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.456 HD12 HD11 ' B' ' 13' ' ' ILE . 70.4 mt -64.12 -42.99 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.06 0.944 . . . . 75.22 110.836 175.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.419 HD11 ' O ' ' B' ' 80' ' ' GLN . 74.1 mt -79.03 -19.73 50.73 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.657 -1.156 . . . . 73.3 112.399 -173.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -59.7 -47.41 97.59 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.179 1.177 . . . . 73.15 114.179 -171.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.96 -42.78 61.84 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.373 2.048 . . . . 73.13 113.788 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.527 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 82.5 m-85 -66.27 -48.63 69.81 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.839 -0.619 . . . . 64.43 110.421 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.96 -42.12 84.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.742 0.817 . . . . 71.33 110.908 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.423 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 49.5 ttt180 -61.86 -54.71 38.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.245 1.418 . . . . 72.24 110.995 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -67.17 -34.16 76.95 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 123.998 0.811 . . . . 73.24 110.147 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.486 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.6 t -68.18 -33.93 75.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.71 0.404 . . . . 74.24 111.088 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 70.9 mt -65.28 -52.01 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.415 -0.587 . . . . 75.31 109.415 171.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.0 m -60.01 -30.62 69.27 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 123.979 0.8 . . . . 75.53 111.543 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.2 t -63.63 -51.86 63.36 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 123.454 0.702 . . . . 52.23 109.858 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -68.59 -34.91 76.6 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.148 0.579 . . . . 74.42 110.985 -174.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.05 -43.04 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.736 0.815 . . . . 64.03 110.312 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.3 t -68.75 -30.19 68.75 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.393 -0.821 . . . . 63.4 111.598 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.8 mtt-85 -69.59 -43.4 72.88 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.547 -0.751 . . . . 75.54 109.612 176.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.21 -3.09 64.24 Favored Glycine 0 C--N 1.357 1.708 0 O-C-N 124.072 0.857 . . . . 65.12 112.924 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 17' ' ' TYR . 28.2 p 62.18 25.87 15.5 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 126.506 1.922 . . . . 72.14 112.86 174.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -80.34 161.51 64.64 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 123.837 0.855 . . . . 64.43 110.729 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -49.41 157.86 1.95 Allowed 'Trans proline' 0 C--N 1.387 2.581 0 C-N-CA 123.742 2.961 . . . . 71.41 115.178 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -59.61 114.17 2.6 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.226 1.01 . . . . 74.23 111.306 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -119.1 108.97 15.35 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.657 -0.868 . . . . 71.51 108.657 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -124.02 134.44 53.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.511 -0.922 . . . . 75.22 108.511 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.423 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.3 mm? -77.02 147.42 36.78 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.299 0.639 . . . . 75.23 109.848 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.23 147.23 53.04 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 123.092 0.557 . . . . 62.52 109.667 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.33 110.78 0.85 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.151 2.568 . . . . 73.23 112.322 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.0 t -90.11 112.63 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.435 -0.95 . . . . 74.4 108.435 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -82.08 83.83 7.2 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.968 -1.123 . . . . 74.22 107.968 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -54.41 -42.26 70.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.288 1.035 . . . . 64.42 111.302 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.73 -43.09 80.79 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.408 1.083 . . . . 75.23 111.888 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.52 -54.25 45.64 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.316 0.646 . . . . 74.2 110.271 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.4 -29.37 70.43 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.613 -1.176 . . . . 62.11 111.47 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 75.2 t80 . . . . . 0 C--N 1.349 0.559 0 C-N-CA 123.151 0.58 . . . . 74.33 110.433 177.774 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 31.4 m . . . . . 0 C--O 1.237 0.395 0 N-CA-C 108.368 -0.975 . . . . 74.01 108.368 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.567 ' HD1' ' HH ' ' C' ' 101' ' ' TYR . 0.9 OUTLIER -90.56 122.93 33.8 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.79 -1.095 . . . . 75.42 109.155 179.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . 0.425 ' HA ' HE21 ' C' ' 12' ' ' GLN . 0.1 OUTLIER -137.21 108.41 6.81 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.593 -1.262 . . . . 74.22 107.593 168.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.409 HD11 HG22 ' C' ' 105' ' ' ILE . 74.2 mt -63.9 118.62 6.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.071 -1.085 . . . . 74.45 108.071 172.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.488 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.1 mm-40 -82.74 -48.84 10.4 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.705 0.628 . . . . 54.33 109.415 -178.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -170.19 124.46 0.74 Allowed 'General case' 0 C--N 1.354 0.78 0 CA-C-N 115.947 -0.569 . . . . 62.43 110.677 -172.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.1 mt -112.35 139.27 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 107.736 -1.209 . . . . 72.55 107.736 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -173.5 153.12 2.26 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.094 0.474 . . . . 74.45 110.435 -168.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.9 p -82.32 116.64 21.91 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.96 -0.755 . . . . 71.42 108.96 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.42 ' HG3' ' HA3' ' C' ' 81' ' ' GLY . 15.2 mtmt -83.58 -29.79 27.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.09 0.472 . . . . 75.53 109.947 176.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 27.4 t70 -144.37 138.68 27.97 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.132 -0.94 . . . . 75.42 109.354 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.478 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 87.0 mt -136.51 140.24 43.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.924 -1.509 . . . . 74.44 106.924 171.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -157.05 141.23 16.39 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.842 0.353 . . . . 72.31 110.155 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.415 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 86.8 t80 -136.44 148.2 47.62 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.489 -1.3 . . . . 75.42 107.489 171.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -145.08 118.12 8.84 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.0 0.92 . . . . 74.33 110.062 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.83 83.78 51.7 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 107.222 -1.399 . . . . 74.53 107.222 163.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.01 -27.89 19.94 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.331 2.021 . . . . 73.51 111.394 175.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -92.25 12.2 23.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.579 1.151 . . . . 74.22 110.747 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.81 -58.76 7.63 Favored Pre-proline 0 C--N 1.37 1.463 0 N-CA-C 114.698 1.37 . . . . 74.43 114.698 -165.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -62.98 -39.77 38.44 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 121.503 1.468 . . . . 51.14 112.171 -174.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -70.3 -34.96 73.36 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.787 -1.097 . . . . 73.4 112.233 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.3 p -80.6 -26.06 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 112.906 0.706 . . . . 72.32 112.906 -170.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -64.77 -20.48 66.39 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 113.29 0.848 . . . . 73.02 113.29 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -99.11 12.07 37.18 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.302 0.641 . . . . 75.12 111.286 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.792 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -88.06 146.32 25.52 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.276 -0.638 . . . . 74.52 109.276 172.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -57.98 119.18 6.3 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.116 -0.698 . . . . 73.44 109.116 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -67.8 93.17 0.38 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.803 0.841 . . . . 73.42 111.283 -173.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -148.99 69.1 9.81 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 124.839 1.255 . . . . 73.41 108.251 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -80.16 133.27 9.78 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.573 2.182 . . . . 73.44 111.152 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.09 105.11 15.59 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.107 -1.072 . . . . 74.42 108.107 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.55 113.56 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.36 -0.836 . . . . 70.21 110.329 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -111.17 110.7 21.34 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.183 -1.414 . . . . 73.34 107.183 170.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 40.4 tp -91.28 142.26 27.9 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.124 0.569 . . . . 72.15 109.7 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 20.1 t70 -131.95 117.75 18.86 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.823 -1.177 . . . . 75.34 107.823 175.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.6 mt -108.72 151.67 25.87 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.607 0.763 . . . . 71.22 109.953 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 30.0 t70 -157.6 150.19 22.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.198 0.599 . . . . 64.13 109.949 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -144.45 123.36 12.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.629 0.772 . . . . 65.12 110.117 176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.78 135.11 54.44 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.619 -0.882 . . . . 73.14 108.619 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.4 p -131.2 142.31 50.17 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.239 0.616 . . . . 74.42 109.623 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 29.6 t -145.79 150.8 36.88 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.137 0.975 . . . . 73.13 109.532 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.75 138.77 41.46 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.957 -0.565 . . . . 74.44 109.829 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' C' ' 57' ' ' GLU . 62.6 mt -106.22 -43.26 4.85 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.681 -0.859 . . . . 74.34 108.681 169.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.66 -176.34 5.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.63 -1.168 . . . . 75.15 109.525 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -66.18 126.1 27.63 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.511 -0.768 . . . . 62.23 109.684 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 72.2 -1.82 2.78 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.31 1.444 . . . . 73.35 112.032 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -114.89 114.12 45.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 123.264 0.625 . . . . 61.31 109.418 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -124.84 135.3 52.78 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.063 0.945 . . . . 74.34 109.192 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.605 ' HB2' HD12 ' C' ' 51' ' ' LEU . 42.8 tt0 -92.6 123.97 36.29 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 124.154 0.909 . . . . 70.23 108.877 168.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 85.3 t -103.79 136.95 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.293 -1.003 . . . . 71.03 108.293 168.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -121.17 130.58 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.303 -1.369 . . . . 75.5 107.303 174.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.26 104.26 11.64 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.818 -1.178 . . . . 71.14 107.818 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 30.4 ttm-85 -88.39 126.19 35.09 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.241 -1.345 . . . . 75.4 108.297 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.567 ' HB ' HD11 ' C' ' 114' ' ' ILE . 21.5 t -123.58 128.22 74.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.583 -1.266 . . . . 73.53 107.583 173.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 9.8 m -128.37 112.0 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.746 -0.835 . . . . 72.45 108.746 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.431 HG22 HG22 ' C' ' 114' ' ' ILE . 51.7 t -104.84 116.02 47.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.92 -1.036 . . . . 72.31 108.788 -173.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.9 m -105.8 141.37 37.34 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.07 -0.715 . . . . 72.41 109.07 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.15 115.15 8.74 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.85 -1.167 . . . . 73.13 107.85 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.9 m -137.17 134.25 36.11 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.483 0.49 . . . . 54.53 109.833 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.663 HD11 ' HG2' ' C' ' 34' ' ' LYS . 0.5 OUTLIER -87.88 42.03 1.03 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.936 1.294 . . . . 71.55 108.596 177.135 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.27 -112.62 4.17 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.209 -0.756 . . . . 70.54 111.209 -171.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.56 -30.71 19.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.326 0.65 . . . . 71.25 109.485 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.15 110.53 3.02 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 115.222 -0.899 . . . . 71.23 109.032 173.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -77.95 125.49 29.42 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.001 -0.74 . . . . 74.05 109.001 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.621 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.85 -57.87 3.75 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.421 -1.325 . . . . 65.22 107.421 171.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -167.4 169.23 12.45 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 121.885 0.85 . . . . 71.13 111.939 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -133.77 141.63 47.57 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 105.947 -1.872 . . . . 73.43 105.947 170.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 47.4 t -151.34 113.44 4.53 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.963 -0.384 . . . . 72.35 109.963 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -117.02 127.62 54.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.478 0.311 . . . . 73.21 110.309 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.5 t -118.24 138.33 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.953 -1.129 . . . . 74.51 107.953 167.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.6 mt-30 -116.05 94.96 4.88 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 108.68 -0.859 . . . . 72.12 108.68 173.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.41 ' HG3' HD22 ' C' ' 106' ' ' LEU . 9.4 tp-100 -79.79 102.64 9.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.954 -1.021 . . . . 73.2 109.903 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.42 ' HA3' ' HG3' ' C' ' 19' ' ' LYS . . . -85.58 151.85 25.75 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 111.759 -0.536 . . . . 74.13 111.759 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.561 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -154.37 118.47 0.86 Allowed Glycine 0 CA--C 1.506 -0.475 0 N-CA-C 111.697 -0.561 . . . . 71.34 111.697 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.541 HD13 HD12 ' C' ' 51' ' ' LEU . 8.8 mm -84.71 125.91 40.29 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 N-CA-C 108.764 -0.828 . . . . 72.52 108.764 173.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -134.24 120.08 19.55 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.673 -0.862 . . . . 73.22 108.673 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 61.1 p -91.07 118.82 30.71 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.189 -0.671 . . . . 71.44 109.189 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.741 HG22 ' SG ' ' C' ' 97' ' ' CYS . 1.8 pp -125.61 141.13 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.594 1.158 . . . . 72.43 111.356 -174.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -149.53 167.46 26.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.333 0.653 . . . . 75.43 110.326 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.64 -54.41 3.78 Favored Glycine 0 N--CA 1.475 1.269 0 N-CA-C 112.43 -0.268 . . . . 55.0 112.43 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.414 HD12 ' HB ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -81.42 157.54 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.254 0.622 . . . . 75.12 110.564 177.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.79 178.63 8.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.851 0.46 . . . . 73.34 110.418 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.54 -114.1 5.58 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.718 0.637 . . . . 64.25 113.533 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -82.55 -20.08 37.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.672 0.789 . . . . 64.5 112.087 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.56 -42.92 61.01 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.513 -0.551 . . . . 74.34 109.513 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 23.9 ptm -74.23 -30.11 62.02 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 110.248 -0.278 . . . . 74.33 110.248 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.69 93.59 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 123.489 0.493 . . . . 75.15 110.118 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -74.72 -35.83 62.67 Favored 'General case' 0 C--O 1.245 0.832 0 O-C-N 123.477 0.485 . . . . 75.1 111.78 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.741 ' SG ' HG22 ' C' ' 86' ' ' ILE . 53.3 t -56.6 -36.37 69.32 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.644 0.59 . . . . 70.41 110.558 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 24.4 mt -98.31 -18.06 18.56 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.856 0.862 . . . . 75.42 111.18 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.43 -29.62 55.44 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 115.015 0.766 . . . . 51.1 115.015 -172.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.94 -36.0 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.654 0.382 . . . . 63.14 111.081 -170.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.567 ' HH ' ' HD1' ' C' ' 11' ' ' PHE . 84.6 t80 -67.61 -45.8 74.39 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.216 1.406 . . . . 74.42 112.677 -175.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.0 m -79.79 -40.41 1.37 Allowed Pre-proline 0 CA--C 1.557 1.247 0 CA-C-O 118.475 -0.774 . . . . 61.12 112.481 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -54.0 -27.58 45.92 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 122.249 1.966 . . . . 74.54 114.078 166.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -68.28 -37.9 81.14 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.679 0.792 . . . . 74.15 109.768 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.543 HD13 ' NH1' ' A' ' 111' ' ' ARG . 43.8 mm -68.94 -34.01 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.008 0.523 . . . . 73.11 109.983 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.561 HD23 ' HA3' ' C' ' 82' ' ' GLY . 95.4 mt -81.34 -27.3 35.01 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.917 0.887 . . . . 75.35 112.756 -177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -57.8 -48.52 97.03 Favored Pre-proline 0 CA--C 1.559 1.31 0 N-CA-C 113.959 1.096 . . . . 73.41 113.959 -174.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.94 -37.15 79.29 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 121.992 1.795 . . . . 74.42 113.056 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -66.69 -42.46 86.43 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.103 0.561 . . . . 61.12 110.895 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.56 99.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.539 0.736 . . . . 62.52 110.461 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.601 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 35.9 ttt180 -54.12 -56.47 17.85 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.464 1.506 . . . . 63.5 111.412 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.23 -35.43 77.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.733 0.413 . . . . 75.31 110.543 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 20.0 t -64.75 -33.58 76.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.957 0.503 . . . . 73.11 111.973 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.567 HD11 ' HB ' ' C' ' 62' ' ' VAL . 75.4 mt -76.75 -52.7 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.585 0.754 . . . . 74.4 110.231 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -60.94 -28.67 69.12 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.356 0.662 . . . . 72.1 111.38 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.2 t -67.31 -52.07 44.86 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.779 0.832 . . . . 70.33 109.156 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.541 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.37 -36.84 78.97 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.226 1.011 . . . . 74.22 112.338 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 78.3 t -66.53 -44.84 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.633 0.773 . . . . 72.33 109.904 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 40.4 t -69.2 -22.92 63.86 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.262 -0.881 . . . . 71.11 111.645 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.3 mtt-85 -75.65 -41.05 55.13 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.49 0.716 . . . . 75.15 109.082 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.01 -2.87 62.89 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 123.83 0.706 . . . . 63.44 112.498 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p 67.03 27.76 8.62 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.88 2.072 . . . . 74.12 113.611 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -83.8 153.45 64.13 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 108.813 -0.81 . . . . 73.53 108.813 168.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -60.67 178.49 0.47 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.149 2.566 . . . . 74.24 114.75 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -60.8 114.33 2.98 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 114.171 1.174 . . . . 62.13 114.171 -174.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 7.2 mp -112.2 89.49 3.08 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.81 -0.811 . . . . 74.05 108.81 163.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -91.32 112.68 24.69 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.513 -0.921 . . . . 53.54 108.513 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.601 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -65.0 126.29 27.55 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.618 0.767 . . . . 75.4 110.587 -177.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.21 149.18 81.82 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 124.423 1.089 . . . . 72.4 111.887 -173.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.449 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 20.7 Cg_endo -61.07 105.3 0.32 Allowed 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.11 2.54 . . . . 73.32 113.212 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.6 111.33 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.707 -0.849 . . . . 73.54 108.707 171.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -87.22 90.31 8.31 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 108.622 -0.881 . . . . 65.11 108.622 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -60.36 -29.95 69.24 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.251 1.021 . . . . 74.32 111.261 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.56 -43.93 68.88 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.415 1.486 . . . . 75.01 112.915 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.61 82.97 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.348 1.03 . . . . 74.24 110.604 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 20.6 tp -71.72 -29.31 64.41 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.142 -0.935 . . . . 74.41 111.152 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 12.2 t80 . . . . . 0 N--CA 1.487 1.396 0 C-N-CA 122.639 0.375 . . . . 72.04 110.344 177.008 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' D' ' 87' ' ' ALA . 21.0 m . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.403 0.621 . . . . 75.04 110.905 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.543 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 71.1 t80 -162.58 97.7 0.98 Allowed 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.063 -1.458 . . . . 73.42 107.063 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -112.22 115.01 28.11 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.394 -1.336 . . . . 75.24 107.394 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.585 HD11 HD12 ' D' ' 105' ' ' ILE . 59.7 mt -73.59 119.31 20.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.384 -0.969 . . . . 75.43 108.384 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.461 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 9.5 mm100 -85.34 -41.77 15.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.693 -0.685 . . . . 75.24 109.219 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -174.67 144.27 0.83 Allowed 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.251 0.345 . . . . 71.31 111.164 -167.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.495 HD11 HG21 ' D' ' 13' ' ' ILE . 4.1 mp -120.66 142.39 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.112 -1.44 . . . . 72.11 107.112 170.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -164.87 160.44 19.4 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.405 0.682 . . . . 75.54 111.121 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.8 p -93.15 116.48 29.07 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.325 -0.621 . . . . 72.13 109.325 173.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -85.38 -19.88 30.73 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.965 0.506 . . . . 75.42 110.105 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.1 t70 -160.31 140.03 11.15 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.782 0.833 . . . . 75.15 109.261 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.541 HG23 ' HE1' ' C' ' 117' ' ' MET . 98.6 mt -137.95 142.86 34.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.859 1.263 . . . . 75.41 107.701 175.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -141.6 136.23 30.81 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.957 0.903 . . . . 75.43 108.807 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.483 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 82.4 t80 -143.53 124.87 14.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.587 -1.634 . . . . 71.33 106.587 168.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 27.0 mt-10 -135.13 118.02 16.25 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.612 -0.884 . . . . 63.45 108.612 -173.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.59 82.39 9.97 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.729 -1.212 . . . . 72.23 107.729 174.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.47 -33.74 10.45 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.681 2.254 . . . . 75.45 113.183 -170.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -103.52 11.06 36.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.542 0.737 . . . . 70.24 110.666 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -30.66 -70.57 0.09 OUTLIER Pre-proline 0 CA--C 1.565 1.521 0 N-CA-C 116.276 1.954 . . . . 55.11 116.276 -160.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.401 ' HB3' HD11 ' C' ' 83' ' ' ILE . 86.7 Cg_endo -75.46 -15.42 19.77 Favored 'Trans proline' 0 C--N 1.375 1.946 0 CA-C-N 123.55 2.304 . . . . 74.04 113.829 -173.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -79.79 -41.1 27.21 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.485 1.114 . . . . 54.21 110.044 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.5 p -79.96 -23.46 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 116.235 -0.439 . . . . 72.25 111.34 -173.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -63.19 -19.81 64.85 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.127 0.417 . . . . 73.34 112.127 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -61.47 -17.1 52.94 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.877 0.871 . . . . 75.32 111.947 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.419 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 37.6 mtmt -99.83 110.75 23.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.772 0.829 . . . . 72.34 111.09 174.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.49 93.85 9.47 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.576 -0.738 . . . . 72.15 109.722 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -157.39 157.07 33.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.432 1.093 . . . . 73.11 108.235 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -76.44 106.38 3.24 Favored Pre-proline 0 N--CA 1.477 0.908 0 N-CA-C 107.374 -1.343 . . . . 72.23 107.374 171.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.565 ' HB2' ' HB2' ' D' ' 66' ' ' ALA . 24.5 Cg_exo -63.21 137.31 60.5 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.796 2.331 . . . . 74.22 112.452 -167.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 7.4 mm-40 -56.93 109.72 0.69 Allowed 'General case' 0 C--N 1.361 1.075 0 O-C-N 124.082 0.864 . . . . 73.41 109.692 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.588 HG21 HG11 ' D' ' 64' ' ' VAL . 2.1 p -99.63 111.71 29.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 115.198 -0.91 . . . . 74.24 110.586 -171.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -86.49 111.86 20.97 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.366 -1.346 . . . . 72.21 107.366 169.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -95.79 151.86 19.0 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 108.961 -0.755 . . . . 73.44 108.961 173.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -151.44 154.12 35.99 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.438 -0.949 . . . . 70.0 108.438 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 89.6 mt -131.14 144.04 51.09 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.725 0.81 . . . . 75.34 109.711 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.651 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.8 t70 -141.41 125.48 17.29 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.61 1.164 . . . . 73.32 108.234 175.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -104.66 145.38 30.42 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 109.215 -0.661 . . . . 74.32 109.215 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.99 142.69 24.61 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.158 -1.053 . . . . 74.44 108.158 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 47.6 p -141.94 159.92 41.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.602 0.637 . . . . 75.14 111.35 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -163.39 125.91 2.59 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.893 0.877 . . . . 74.1 109.668 -173.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -74.99 121.87 22.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.576 -0.528 . . . . 73.12 109.576 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' D' ' 57' ' ' GLU . 55.9 mt -96.36 -29.65 13.84 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.139 0.576 . . . . 74.32 111.283 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.452 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -162.21 -173.01 3.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.391 0.677 . . . . 43.23 110.45 -177.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.89 120.84 18.06 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.968 -1.014 . . . . 75.44 110.762 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 65.05 3.74 2.26 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.487 1.115 . . . . 75.33 112.005 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 51.5 t -117.0 124.2 72.73 Favored 'Isoleucine or valine' 0 C--N 1.349 0.575 0 C-N-CA 123.369 0.668 . . . . 64.51 109.572 -173.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -120.81 173.13 7.41 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.957 1.303 . . . . 74.2 109.99 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.528 ' HB2' HD11 ' D' ' 51' ' ' LEU . 33.4 tt0 -131.3 133.84 45.77 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.733 -1.576 . . . . 74.24 107.008 168.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.6 t -120.63 141.77 39.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.004 -1.11 . . . . 64.13 108.004 168.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.473 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 39.8 t -120.77 131.32 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.718 -1.216 . . . . 65.05 107.718 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.44 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -115.16 119.75 37.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.464 -0.939 . . . . 72.2 108.464 178.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.651 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.2 ttm180 -104.77 102.37 11.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.129 -1.063 . . . . 74.43 108.129 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.2 t -94.48 102.51 13.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.693 -1.225 . . . . 72.45 107.693 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 28.4 m -100.32 140.0 35.2 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.544 -0.753 . . . . 74.54 109.588 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.74 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 52.0 t -132.35 133.68 59.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.628 1.571 . . . . 72.32 108.6 -172.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.0 m -134.66 100.77 4.72 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.117 -1.068 . . . . 74.03 108.117 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.565 ' HB2' ' HB2' ' D' ' 38' ' ' PRO . . . -104.2 153.14 21.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.644 0.778 . . . . 62.24 110.868 -176.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 65.1 p -146.08 137.96 25.06 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.29 0.567 . . . . 70.13 111.909 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.564 HD11 HG23 ' D' ' 31' ' ' VAL . 53.3 mt -105.69 125.7 51.29 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.586 1.154 . . . . 72.21 108.131 170.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.03 -113.29 5.5 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.454 0.471 . . . . 75.23 112.728 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.96 5.32 13.94 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.346 0.659 . . . . 75.24 110.706 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.419 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 12.4 pt-20 -127.11 159.9 32.81 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.151 0.58 . . . . 73.52 110.276 -174.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -68.92 130.72 43.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.598 0.759 . . . . 71.31 111.95 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.99 -77.46 0.3 Allowed 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.82 -0.807 . . . . 74.32 108.82 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -141.33 147.57 38.32 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 121.227 0.537 . . . . 75.31 110.859 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 55.8 mt -117.85 140.03 50.27 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.805 -1.183 . . . . 61.15 107.805 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.74 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 33.0 m -141.21 144.7 34.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.118 0.967 . . . . 72.21 109.035 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -156.94 118.07 3.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.16 -1.052 . . . . 74.01 108.16 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.83 113.05 25.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 109.361 -0.607 . . . . 75.43 109.361 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -89.73 85.88 6.54 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.649 -0.871 . . . . 74.23 108.649 172.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -79.09 94.66 5.38 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.618 -1.174 . . . . 73.42 108.509 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.83 145.95 21.12 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.781 -0.528 . . . . 55.03 111.781 177.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.47 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -145.67 131.41 4.15 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.445 -0.662 . . . . 71.21 111.445 -176.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.525 HG22 HD13 ' D' ' 51' ' ' LEU . 43.6 mt -89.0 128.73 40.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 N-CA-C 108.248 -1.019 . . . . 75.15 108.248 176.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -135.08 123.9 23.91 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.175 0.59 . . . . 73.4 110.1 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' D' ' 55' ' ' VAL . 57.8 m -74.19 108.46 7.0 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.081 -0.711 . . . . 64.54 109.081 166.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.512 HD11 HD22 ' D' ' 98' ' ' LEU . 45.1 pt -105.22 138.29 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.355 0.662 . . . . 71.11 109.271 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.415 ' HB2' ' HB ' ' D' ' 10' ' ' THR . . . -167.76 170.43 10.86 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.377 1.071 . . . . 73.23 108.934 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.19 -15.1 29.93 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-O 119.899 -0.39 . . . . 63.32 112.718 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 pp -128.49 134.97 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.401 1.08 . . . . 75.22 109.631 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -132.42 158.36 42.21 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.851 0.861 . . . . 73.43 109.726 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.08 -127.05 39.87 Favored Glycine 0 C--N 1.355 1.587 0 O-C-N 124.366 1.041 . . . . 62.42 114.426 172.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 75.1 p -63.17 -39.86 95.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.699 0.8 . . . . 75.31 111.257 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -73.76 -27.11 60.99 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.578 -0.737 . . . . 71.12 111.623 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 18.3 tmm? -70.93 -44.72 65.54 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 109.516 -0.549 . . . . 74.31 109.516 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.04 -25.04 66.63 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.519 0.728 . . . . 64.22 111.462 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . 0.49 ' HE2' ' HB3' ' D' ' 134' ' ' ASP . 14.2 t-160 -78.67 -38.51 39.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.785 0.834 . . . . 74.04 110.713 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -73.69 -27.29 61.14 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.258 0.623 . . . . 73.15 111.506 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.512 HD22 HD11 ' D' ' 86' ' ' ILE . 2.3 tm? -100.1 -54.01 2.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.311 1.044 . . . . 75.31 109.819 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.9 14.42 58.72 Favored Glycine 0 N--CA 1.472 1.065 0 CA-C-O 119.557 -0.579 . . . . 61.23 114.433 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.51 ' HA ' ' HD2' ' D' ' 133' ' ' PHE . . . -149.74 -55.44 0.17 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.574 0.687 . . . . 75.41 112.016 -178.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -72.6 -37.85 68.0 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 112.233 0.457 . . . . 74.13 112.233 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.543 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 96.6 m -61.94 -46.93 92.28 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 118.687 -0.673 . . . . 70.45 112.392 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.44 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 82.4 Cg_exo -52.06 -35.29 61.13 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.285 1.99 . . . . 74.41 114.325 167.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -68.67 -25.34 64.76 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 122.909 0.484 . . . . 64.32 112.079 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.585 HD12 HD11 ' D' ' 13' ' ' ILE . 23.8 mm -73.01 -40.05 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.706 0.765 . . . . 74.1 109.813 171.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.47 HD22 ' HA3' ' D' ' 82' ' ' GLY . 91.8 mt -77.27 -26.8 52.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.776 -1.102 . . . . 64.53 112.839 -173.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -62.83 -43.5 83.08 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 113.725 1.009 . . . . 74.11 113.725 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.42 -45.87 34.86 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.051 1.834 . . . . 75.33 113.949 171.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -72.26 -37.15 69.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.584 0.754 . . . . 73.0 111.342 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.41 90.2 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.906 0.882 . . . . 74.44 110.43 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.468 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 29.4 ttp180 -55.22 -52.71 62.48 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 114.523 -1.217 . . . . 75.22 110.181 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -60.16 -43.41 95.79 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.295 0.997 . . . . 74.12 111.629 -174.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.2 t -59.41 -43.97 92.93 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.512 0.508 . . . . 73.31 110.771 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.445 HG21 ' SG ' ' D' ' 76' ' ' CYS . 80.6 mt -64.8 -49.68 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.918 0.887 . . . . 74.22 110.987 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 23.2 m -56.31 -40.82 74.99 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.414 1.086 . . . . 63.25 111.192 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 14.4 t -66.59 -44.24 82.71 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 114.447 -1.251 . . . . 64.32 110.045 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.488 ' HE2' ' HG ' ' D' ' 76' ' ' CYS . 75.1 mtm -67.87 -32.01 72.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.904 0.482 . . . . 73.43 111.82 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.408 HG23 ' O ' ' D' ' 114' ' ' ILE . 61.9 t -67.65 -42.7 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.681 0.793 . . . . 75.03 110.216 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.2 p -74.87 -29.95 61.17 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.829 0.451 . . . . 75.13 111.181 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -72.3 -36.73 69.02 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.622 0.769 . . . . 64.21 109.893 174.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.96 2.7 79.65 Favored Glycine 0 C--N 1.356 1.657 0 O-C-N 123.696 0.622 . . . . 74.44 112.427 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.3 p 62.28 23.26 13.75 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.819 2.048 . . . . 73.22 113.964 171.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.401 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.2 m-85 -83.54 155.85 65.62 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 109.029 -0.73 . . . . 70.35 109.029 167.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.79 142.24 97.15 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 122.39 2.06 . . . . 73.44 111.405 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -51.6 147.67 6.14 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.256 1.422 . . . . 72.2 113.669 -167.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.412 HD13 HG23 ' D' ' 40' ' ' VAL . 23.2 tp -122.61 98.82 6.09 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.003 0.521 . . . . 74.11 110.477 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -101.73 92.18 4.73 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.696 0.798 . . . . 74.21 109.849 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.468 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -64.38 118.52 8.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.453 0.701 . . . . 71.31 110.397 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -60.57 132.9 91.26 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 123.466 0.707 . . . . 72.0 111.021 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 4.7 Cg_exo -73.09 117.59 5.18 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.795 2.33 . . . . 72.44 111.287 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.61 145.36 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.016 0.526 . . . . 74.12 110.926 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -89.27 97.9 11.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.019 0.928 . . . . 75.41 109.946 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.51 ' HD2' ' HA ' ' D' ' 100' ' ' ALA . 7.5 t80 -76.19 -16.97 59.74 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.263 0.625 . . . . 70.23 111.183 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . 0.49 ' HB3' ' HE2' ' D' ' 96' ' ' HIS . 13.1 m-20 -62.65 -49.23 75.96 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.325 0.65 . . . . 74.13 110.924 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.92 -45.87 89.29 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.643 0.59 . . . . 72.02 110.597 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' D' ' 133' ' ' PHE . 82.4 mt -58.56 -42.18 87.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.629 -1.169 . . . . 74.54 111.925 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 85.1 t80 . . . . . 0 N--CA 1.475 0.819 0 C-N-CA 123.649 0.78 . . . . 75.4 110.973 -178.227 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.466 0.373 0 N-CA-C 108.13 -1.063 . . . . 62.43 108.13 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.648 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.6 t80 -138.48 129.88 27.45 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.826 0.346 . . . . 74.11 110.472 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -153.23 108.64 3.24 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 107.811 -1.181 . . . . 75.24 107.811 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.425 HG12 ' HD2' ' A' ' 84' ' ' PHE . 52.8 mt -74.51 116.32 16.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.815 -0.439 . . . . 74.43 109.815 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -74.13 -42.11 60.52 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.072 0.858 . . . . 74.23 110.781 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -178.31 121.39 0.1 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.162 0.289 . . . . 75.01 110.734 -169.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 82.4 mt -106.96 129.56 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.717 0.807 . . . . 75.32 108.878 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -163.06 148.39 11.7 Favored 'General case' 0 C--N 1.346 0.418 0 O-C-N 123.646 0.591 . . . . 74.44 111.653 -174.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.1 p -75.02 112.39 11.2 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.863 -0.608 . . . . 63.42 109.406 175.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 35.7 mtpt -80.79 -23.78 39.03 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.421 -0.354 . . . . 74.31 110.192 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.2 t70 -153.24 142.08 21.11 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.964 0.906 . . . . 75.51 110.393 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.6 mt -135.03 141.73 42.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 125.64 1.576 . . . . 74.12 107.574 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.7 t -145.72 112.42 5.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.141 0.576 . . . . 71.31 110.026 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.504 ' HB2' ' HE1' ' A' ' 117' ' ' MET . 87.5 t80 -125.83 119.92 29.15 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.3 -1.0 . . . . 75.34 108.3 174.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -118.42 136.2 53.91 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.927 -0.768 . . . . 74.41 108.927 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.731 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -148.67 78.78 8.97 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 107.813 -1.18 . . . . 74.31 107.813 170.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.35 -29.93 5.76 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.698 2.265 . . . . 75.43 111.253 175.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -102.7 23.55 11.88 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.943 1.297 . . . . 73.55 109.909 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.731 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -58.82 -45.06 99.64 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 125.26 1.424 . . . . 75.34 112.327 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -64.81 -34.11 50.82 Favored 'Trans proline' 0 C--N 1.399 3.217 0 CA-C-N 120.995 1.391 . . . . 73.51 112.713 172.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.427 ' HA ' ' OE1' ' A' ' 33' ' ' GLN . 30.4 m170 -68.76 -16.23 63.74 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.527 0.731 . . . . 75.2 112.616 -171.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 28' ' ' ALA . 9.3 p -72.73 -19.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 122.438 0.295 . . . . 73.22 110.665 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -78.5 -29.03 46.41 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 108.412 -0.959 . . . . 74.2 108.412 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.427 ' OE1' ' HA ' ' A' ' 30' ' ' HIS . 1.0 OUTLIER -80.95 -54.78 5.27 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.931 -1.031 . . . . 73.21 110.737 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 30' ' ' HIS . 54.5 mtmt -84.78 171.43 12.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.093 0.957 . . . . 73.35 112.577 -173.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.29 153.2 21.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.848 0.859 . . . . 64.44 109.819 172.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -85.2 94.05 8.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.42 0.688 . . . . 74.14 110.756 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -127.37 83.56 65.71 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.175 0.99 . . . . 74.21 108.868 172.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -86.54 149.75 8.84 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.61 2.207 . . . . 75.24 112.72 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -99.09 91.66 5.11 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.613 -1.254 . . . . 64.3 107.613 168.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -66.34 99.06 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 CA-C-O 121.701 0.762 . . . . 75.11 110.388 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -108.16 113.35 26.42 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.531 -0.914 . . . . 72.1 108.531 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -107.06 145.23 32.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.54 0.736 . . . . 63.44 109.059 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -139.42 133.21 30.69 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.498 1.119 . . . . 54.53 108.484 174.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -119.48 123.15 43.32 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 109.059 -0.719 . . . . 74.23 109.059 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 24.3 m-20 -119.81 121.7 39.71 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.764 -0.828 . . . . 71.21 108.764 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.4 m -106.95 122.87 47.28 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.767 -0.827 . . . . 74.43 108.767 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.68 151.33 49.15 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.945 0.898 . . . . 62.21 108.66 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.5 m -132.8 155.87 48.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.178 -0.675 . . . . 75.23 109.178 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -148.03 128.96 14.41 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.78 0.432 . . . . 74.3 110.378 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -73.7 107.7 6.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.91 0.884 . . . . 72.42 109.839 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.1 mt -78.37 -41.26 33.88 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.751 -0.659 . . . . 71.21 109.512 175.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.65 -179.18 7.86 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.647 1.179 . . . . 65.22 108.752 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -61.98 113.26 2.71 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.672 0.389 . . . . 73.53 110.243 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 68.39 12.23 8.65 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.89 1.276 . . . . 64.12 112.28 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.48 110.7 33.16 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 N-CA-C 107.485 -1.302 . . . . 74.23 107.485 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -126.24 152.88 45.51 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.812 -0.81 . . . . 75.01 108.812 -174.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -117.84 153.58 33.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.658 -0.867 . . . . 73.42 108.658 167.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.5 t -117.98 125.24 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.24 -1.392 . . . . 75.43 107.24 167.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.86 107.61 22.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 124.099 0.96 . . . . 64.35 108.681 174.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.7 tp -99.78 101.85 13.13 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.871 -0.788 . . . . 74.03 108.871 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.489 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 14.4 ttm180 -84.42 102.75 13.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.187 -0.672 . . . . 75.02 109.187 175.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.8 t -95.32 102.33 13.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.279 -1.008 . . . . 74.15 108.279 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.4 m -98.25 119.46 36.95 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.047 0.939 . . . . 72.03 110.322 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.502 ' O ' HD13 ' A' ' 75' ' ' LEU . 97.9 t -115.51 123.84 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.926 0.89 . . . . 74.23 108.874 175.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 t -132.2 126.63 34.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.516 -0.92 . . . . 52.15 108.516 169.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -124.13 107.13 10.93 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.633 -0.877 . . . . 71.05 108.633 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.6 p -113.85 143.02 45.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.653 0.781 . . . . 65.32 111.021 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.509 HD21 ' H ' ' A' ' 68' ' ' LEU . 1.3 pt? -110.61 85.87 2.2 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.103 -1.073 . . . . 70.33 108.103 171.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.89 -125.57 8.03 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 114.66 -1.155 . . . . 73.13 110.932 -173.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -87.72 -26.87 22.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.593 0.697 . . . . 71.11 109.621 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -76.23 118.97 19.5 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 123.006 0.522 . . . . 53.23 110.779 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.7 m -77.19 132.42 38.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.192 -0.67 . . . . 73.54 109.192 171.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.03 -57.08 3.99 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.616 -0.883 . . . . 74.4 108.616 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -149.39 152.59 36.02 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.88 -1.055 . . . . 73.41 111.223 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 64' ' ' VAL . 40.9 tp -114.3 135.19 54.35 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.147 -1.427 . . . . 71.13 107.147 166.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.1 m -135.96 98.1 3.8 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.481 -0.933 . . . . 72.23 108.481 170.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -125.11 116.04 21.43 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.717 1.207 . . . . 75.43 108.379 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.4 t -128.73 115.69 38.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.765 0.826 . . . . 61.02 109.466 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 72.0 mt-30 -85.51 84.98 7.46 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 107.973 -1.121 . . . . 75.13 107.973 170.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.479 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.4 tp-100 -76.47 99.58 4.96 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.715 -1.13 . . . . 74.4 108.186 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.86 155.79 29.37 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 110.683 -0.967 . . . . 73.22 110.683 176.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.34 120.63 0.98 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.351 -1.1 . . . . 73.31 110.351 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.9 mt -81.5 122.22 36.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.109 -1.071 . . . . 73.44 108.109 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.648 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 43.8 m-85 -123.46 118.15 26.78 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.834 -1.173 . . . . 74.22 107.834 -176.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.0 t -84.69 104.0 14.28 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.52 -1.289 . . . . 64.41 107.52 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.85 139.97 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 116.118 -0.492 . . . . 75.22 110.874 -170.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.82 176.05 13.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.357 1.063 . . . . 64.32 110.239 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.02 -7.11 62.41 Favored Glycine 0 N--CA 1.475 1.235 0 N-CA-C 114.961 0.744 . . . . 71.23 114.961 172.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.577 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -138.75 158.21 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 117.885 0.843 . . . . 74.13 110.859 -177.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 94' ' ' MET . 0.9 OUTLIER -154.37 174.48 14.8 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.965 0.506 . . . . 75.25 109.989 179.472 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.34 -127.52 26.72 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 114.528 0.571 . . . . 75.32 114.528 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.5 p -68.78 -20.89 64.36 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.196 0.598 . . . . 75.2 111.234 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -75.9 -42.99 47.41 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.659 0.784 . . . . 71.35 109.893 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.417 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 25.6 ptt? -72.97 -27.94 62.11 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 110.038 -0.356 . . . . 72.53 110.038 175.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.12 -27.71 65.81 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 115.803 -0.635 . . . . 72.02 110.269 173.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -78.31 -30.14 48.12 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.218 0.607 . . . . 74.03 111.125 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.577 ' SG ' HG13 ' A' ' 89' ' ' ILE . 70.9 m -61.86 -46.59 88.8 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.875 -0.602 . . . . 74.31 111.09 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -81.26 -24.57 37.23 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.096 -0.502 . . . . 73.0 110.605 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.24 -33.21 49.84 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 114.772 0.669 . . . . 75.35 114.772 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.53 -45.75 0.17 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.379 0.589 . . . . 71.22 112.091 -169.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -62.54 -64.47 0.91 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.512 1.125 . . . . 72.45 112.035 -168.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 92.7 m -78.6 -33.61 0.93 Allowed Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.428 1.27 . . . . 73.53 114.428 -174.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 35.4 Cg_endo -64.18 -30.77 64.91 Favored 'Trans proline' 0 C--N 1.394 2.959 0 CA-C-N 122.23 1.832 . . . . 73.11 112.841 171.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -69.29 -26.57 64.81 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.677 0.391 . . . . 75.34 110.882 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.61 -40.9 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 73.43 110.125 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.479 HD23 ' HG3' ' A' ' 80' ' ' GLN . 79.7 mt -80.6 -21.82 41.22 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.067 0.947 . . . . 71.15 112.613 -174.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -63.57 -44.27 80.58 Favored Pre-proline 0 CA--C 1.567 1.605 0 CA-C-O 117.64 -1.171 . . . . 74.54 113.229 -172.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.4 -34.48 76.55 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.112 1.874 . . . . 63.55 113.474 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.455 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 93.3 m-85 -72.97 -41.25 64.58 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.211 0.605 . . . . 75.4 111.329 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.45 -38.2 74.47 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.994 0.518 . . . . 71.35 110.182 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.523 ' HA ' HD21 ' A' ' 128' ' ' LEU . 29.7 ttm180 -54.44 -51.15 65.86 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.203 1.001 . . . . 73.23 109.888 174.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.63 -48.39 77.49 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.485 1.116 . . . . 75.25 111.361 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.41 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.1 t -55.91 -44.58 78.41 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.047 0.842 . . . . 64.11 110.538 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.473 ' O ' HG21 ' A' ' 118' ' ' VAL . 74.5 mt -65.22 -50.5 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.526 1.13 . . . . 71.24 110.747 176.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.455 HG21 ' HE2' ' C' ' 109' ' ' TYR . 95.0 m -53.17 -46.07 68.77 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.835 0.854 . . . . 75.22 110.322 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -65.13 -46.23 81.84 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.922 -1.49 . . . . 74.22 109.527 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.504 ' HE1' ' HB2' ' A' ' 23' ' ' PHE . 37.5 mtp -59.43 -41.18 88.96 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.696 0.798 . . . . 71.32 111.865 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 114' ' ' ILE . 93.4 t -62.94 -45.61 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.912 0.885 . . . . 71.33 110.236 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.3 m -72.58 -27.45 62.19 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.447 -0.797 . . . . 74.24 111.831 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.596 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.9 mtt-85 -75.12 -31.72 61.18 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.492 0.717 . . . . 73.22 109.723 175.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.13 -0.7 86.62 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.58 -0.736 . . . . 64.11 112.878 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m 69.53 20.12 7.24 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.763 1.225 . . . . 73.03 111.047 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -89.67 146.87 36.44 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 123.45 0.7 . . . . 75.11 109.657 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.64 133.09 31.98 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.52 2.813 . . . . 74.41 113.517 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.452 ' HG3' HG22 ' A' ' 115' ' ' THR . 31.6 tt0 -54.93 137.44 45.71 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.238 1.015 . . . . 73.41 113.24 -170.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.7 tp -119.82 102.4 8.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.859 1.264 . . . . 74.45 109.349 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -99.34 114.65 27.64 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.213 -1.403 . . . . 64.04 107.213 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 111' ' ' ARG . 3.7 mm? -62.53 132.9 54.0 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.099 0.559 . . . . 74.24 110.476 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.8 146.01 91.47 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.213 0.605 . . . . 62.54 110.776 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.56 ' HG3' ' HD2' ' C' ' 11' ' ' PHE . 34.2 Cg_endo -60.74 112.16 1.26 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.382 2.054 . . . . 64.13 111.323 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 80.6 t -99.92 113.91 36.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 108.473 -0.936 . . . . 74.44 108.473 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -78.79 85.95 4.75 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 108.767 -0.827 . . . . 75.34 108.767 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -64.02 -27.82 69.38 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.649 -0.705 . . . . 74.01 111.144 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.07 -48.45 76.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.801 0.84 . . . . 72.22 110.224 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.43 -57.01 12.8 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.003 -0.999 . . . . 73.01 110.463 175.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.2 mt -58.05 -36.73 73.19 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.562 1.145 . . . . 74.44 112.812 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -61.62 -50.81 71.08 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.772 0.67 . . . . 73.11 110.381 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 95.2 mmm . . . . . 0 CA--C 1.551 0.987 0 CA-C-N 115.909 -0.587 . . . . 62.2 110.612 -174.348 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 66.2 m . . . . . 0 C--O 1.239 0.537 0 N-CA-C 108.932 -0.766 . . . . 74.24 108.932 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -136.11 137.35 40.94 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.712 -0.847 . . . . 72.51 108.712 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -148.5 140.8 24.16 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.562 0.745 . . . . 72.44 109.258 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.5 mt -90.32 113.55 26.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.434 -1.321 . . . . 73.33 107.434 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -76.22 -43.57 41.63 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.446 -0.576 . . . . 64.23 109.446 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -164.78 139.63 5.36 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.719 -0.673 . . . . 74.45 110.071 -175.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 88.2 mt -115.7 144.12 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 106.212 -1.773 . . . . 74.44 106.212 168.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.515 ' HE1' HG13 ' B' ' 83' ' ' ILE . 32.5 p90 -170.08 149.36 3.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.449 0.642 . . . . 75.11 111.648 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -77.81 125.71 29.76 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.872 -1.058 . . . . 74.32 109.347 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.424 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.3 mtpt -99.4 -21.51 15.96 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.872 0.869 . . . . 75.33 111.57 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -160.78 133.41 6.25 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.495 0.318 . . . . 74.43 110.441 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.507 HG22 ' HE2' ' B' ' 117' ' ' MET . 40.8 mm -126.33 137.91 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.273 -1.01 . . . . 74.44 108.273 168.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 37.2 t -139.48 134.21 31.98 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.746 -1.205 . . . . 72.11 107.746 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -150.32 109.48 3.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.895 -1.15 . . . . 63.14 107.895 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -119.71 115.0 23.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.278 1.031 . . . . 74.02 108.895 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.39 86.64 4.44 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 108.486 -0.931 . . . . 73.1 108.486 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.41 -32.45 8.02 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.742 2.295 . . . . 73.15 113.011 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -104.2 14.68 29.93 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.713 0.805 . . . . 75.13 110.403 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.484 ' HB1' ' HD3' ' B' ' 29' ' ' PRO . . . -38.39 -60.79 0.97 Allowed Pre-proline 0 CA--C 1.562 1.437 0 N-CA-C 114.758 1.392 . . . . 64.11 114.758 -165.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.484 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 20.4 Cg_exo -63.24 -35.28 64.2 Favored 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 122.101 1.867 . . . . 74.44 112.504 -175.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -78.84 -47.01 17.43 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.168 -0.923 . . . . 72.15 111.593 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.587 HG23 HD13 ' B' ' 68' ' ' LEU . 9.1 p -62.4 -22.4 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.583 0.753 . . . . 73.12 112.332 -167.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -63.34 -13.95 44.64 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.988 0.915 . . . . 73.12 112.993 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.51 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 25.6 pt20 -60.36 -33.14 72.01 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.422 1.089 . . . . 72.42 111.585 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.51 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.3 mttt -96.18 86.18 4.18 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.585 0.754 . . . . 74.0 108.993 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -74.22 97.36 2.95 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 115.806 -0.634 . . . . 74.03 110.902 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -163.43 157.3 19.69 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.32 1.448 . . . . 74.25 108.179 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.425 ' HG2' ' HB2' ' B' ' 124' ' ' PRO . 14.4 mt-30 -72.85 108.74 4.85 Favored Pre-proline 0 C--N 1.356 0.861 0 N-CA-C 107.827 -1.175 . . . . 74.04 107.827 169.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.446 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.0 Cg_endo -60.18 147.06 94.85 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.796 2.331 . . . . 73.41 113.702 -167.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 11.3 tp10 -53.31 109.33 0.42 Allowed 'General case' 0 N--CA 1.484 1.246 0 O-C-N 124.349 1.031 . . . . 75.14 110.42 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.87 131.03 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 O-C-N 123.7 0.625 . . . . 73.12 110.625 -172.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -121.23 121.75 38.45 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.597 -1.26 . . . . 71.02 107.597 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -106.05 124.88 50.28 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.763 -0.828 . . . . 74.03 108.763 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.511 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.5 m-20 -122.16 111.33 16.84 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.398 -1.705 . . . . 72.25 106.398 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 87.3 mt -101.38 127.21 48.13 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.157 -1.053 . . . . 75.42 108.157 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -140.02 136.5 33.77 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.384 -1.339 . . . . 75.24 107.384 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.5 p -128.96 115.85 18.46 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.827 -0.434 . . . . 71.14 109.827 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.7 134.82 54.65 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.443 -1.317 . . . . 74.31 107.443 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.0 m -138.89 162.88 33.74 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.316 0.507 . . . . 74.12 111.312 -172.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.0 p -157.8 143.3 17.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.744 0.818 . . . . 75.1 110.888 -172.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -83.4 135.21 34.78 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.711 0.804 . . . . 75.03 109.77 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 mt -99.26 -40.88 7.72 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.205 0.526 . . . . 75.34 109.891 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.85 -178.45 7.32 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.906 -1.043 . . . . 75.34 109.997 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -71.63 122.28 20.28 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.468 -0.787 . . . . 74.32 109.289 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 74.0 -4.76 2.19 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 125.765 1.626 . . . . 75.3 112.04 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.3 110.16 30.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.51 -0.922 . . . . 75.03 108.51 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -125.25 140.22 53.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.617 -0.883 . . . . 73.21 108.617 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -122.78 115.05 21.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.243 -1.021 . . . . 71.33 108.243 -171.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 83.5 t -99.37 141.98 15.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 123.815 0.846 . . . . 75.51 109.617 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.15 119.34 58.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 109.046 -0.724 . . . . 71.2 109.046 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.94 129.42 40.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.013 -1.476 . . . . 74.11 107.013 175.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -121.75 109.9 15.27 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.818 0.847 . . . . 72.11 109.04 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 56.0 t -104.76 102.81 14.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.257 -1.386 . . . . 74.34 107.257 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 24.4 m -97.86 126.06 43.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.886 -0.783 . . . . 74.31 108.886 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.606 HG22 HG21 ' B' ' 114' ' ' ILE . 70.2 t -116.31 121.9 68.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 124.792 1.237 . . . . 73.51 108.27 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 62.9 m -113.29 137.1 52.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.815 -0.809 . . . . 75.11 108.815 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -144.03 146.15 32.68 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 122.628 0.371 . . . . 71.21 110.602 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.456 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 76.0 p -150.32 140.63 22.28 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.656 0.598 . . . . 74.33 111.306 -174.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.587 HD13 HG23 ' B' ' 31' ' ' VAL . 76.5 mt -102.51 109.66 21.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.198 -1.038 . . . . 74.43 108.198 170.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.75 -131.61 37.22 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 116.001 -0.545 . . . . 74.15 112.389 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -95.92 14.7 22.65 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.477 0.547 . . . . 72.02 112.477 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.427 ' HG2' ' HZ3' ' B' ' 34' ' ' LYS . 12.6 pt-20 -126.7 141.0 51.98 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.961 0.505 . . . . 73.45 109.915 178.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 48.2 m -70.51 127.51 32.95 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 123.289 0.635 . . . . 71.3 111.233 -175.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.456 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -80.28 -67.36 0.77 Allowed 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.454 -0.943 . . . . 73.52 108.454 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . 0.506 ' HZ ' HD13 ' B' ' 126' ' ' LEU . 51.5 p90 -150.25 155.37 39.58 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-O 121.619 0.723 . . . . 72.51 111.869 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 33.7 mt -122.86 109.52 14.27 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.124 -1.806 . . . . 72.2 106.124 172.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 37.6 t -120.75 115.39 23.22 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.449 -0.574 . . . . 72.23 109.449 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -121.36 123.84 43.09 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.645 -1.242 . . . . 64.2 107.645 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.51 143.42 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.667 -0.864 . . . . 54.02 108.667 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -124.66 100.65 6.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.312 -0.858 . . . . 72.01 108.813 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.473 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.7 tp-100 -90.25 105.81 18.06 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.224 -0.658 . . . . 72.43 109.224 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.424 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.13 164.74 26.17 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.799 -0.521 . . . . 74.2 111.799 175.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.67 128.3 1.92 Allowed Glycine 0 CA--C 1.52 0.365 0 CA-C-O 120.024 -0.32 . . . . 72.44 112.497 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.515 HG13 ' HE1' ' B' ' 17' ' ' TYR . 48.5 mt -84.37 123.83 39.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.966 -0.753 . . . . 71.05 108.966 172.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -133.12 136.55 45.88 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.015 . . . . 65.24 108.795 -175.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.9 m -103.51 108.57 19.89 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.346 0.659 . . . . 72.42 110.047 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.61 HD11 HD23 ' B' ' 98' ' ' LEU . 41.0 pt -100.11 132.03 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.251 1.02 . . . . 74.13 109.912 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.555 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -155.47 144.12 20.45 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 122.721 0.409 . . . . 72.13 110.057 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.75 -55.06 1.66 Allowed Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.808 -0.633 . . . . 74.31 112.164 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.443 HD12 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -72.57 155.06 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 75.45 111.255 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.27 167.37 28.85 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.127 -0.942 . . . . 74.41 109.502 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.07 -121.74 27.13 Favored Glycine 0 C--N 1.346 1.09 0 O-C-N 124.103 0.877 . . . . 70.33 114.589 172.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 89.8 m -71.89 -35.05 69.63 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.399 1.079 . . . . 74.5 111.784 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -70.51 -31.88 69.14 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 120.986 0.422 . . . . 73.44 110.373 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 49.3 ttp -74.08 -34.22 63.91 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.637 -0.71 . . . . 74.14 110.382 173.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.93 93.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.198 0.599 . . . . 61.12 110.25 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -64.17 -25.36 68.05 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.578 1.151 . . . . 71.34 111.39 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -78.83 -59.2 2.88 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.993 0.517 . . . . 64.32 110.282 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.61 HD23 HD11 ' B' ' 86' ' ' ILE . 66.3 mt -72.63 -40.53 66.35 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.856 0.688 . . . . 74.42 112.856 -167.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.32 3.97 61.98 Favored Glycine 0 N--CA 1.469 0.859 0 CA-C-O 119.728 -0.484 . . . . 64.4 114.073 -173.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -143.37 -69.65 0.33 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.33 0.565 . . . . 62.21 111.386 -175.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.34 -43.49 96.42 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.702 1.201 . . . . 74.14 112.049 -172.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 94.4 m -66.39 -50.43 48.28 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 124.206 1.003 . . . . 74.31 111.562 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.18 -35.17 90.27 Favored 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.187 1.925 . . . . 74.31 113.995 169.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -63.27 -33.59 75.84 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 118.159 0.436 . . . . 74.44 111.825 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 77.4 mt -66.06 -40.94 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.362 0.665 . . . . 74.42 110.408 175.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.7 mt -82.61 -20.82 35.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.192 0.997 . . . . 74.12 112.851 -172.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.2 -47.98 97.24 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-O 117.864 -1.065 . . . . 75.04 113.822 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.36 -32.78 89.7 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 121.993 1.796 . . . . 73.43 113.166 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.473 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 91.7 m-85 -70.37 -48.96 53.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.842 0.457 . . . . 75.42 110.133 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.62 -43.35 72.15 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.95 0.9 . . . . 71.11 110.251 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.546 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 35.9 ttt-85 -59.97 -55.03 39.1 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.322 1.449 . . . . 74.42 111.824 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.56 -33.81 76.78 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.766 0.827 . . . . 72.31 110.065 -175.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.596 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.1 t -72.16 -43.3 64.83 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.8 -0.636 . . . . 75.12 111.355 -176.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.606 HG21 HG22 ' B' ' 64' ' ' VAL . 99.1 mt -60.0 -53.59 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 109.819 -0.437 . . . . 72.1 109.819 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 86.8 m -59.32 -32.82 70.42 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 124.084 0.865 . . . . 74.12 111.41 -176.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.3 t -61.98 -47.42 84.89 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.297 0.639 . . . . 74.42 109.674 174.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.511 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.8 mmt -69.24 -34.42 74.77 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.17 0.588 . . . . 74.23 111.368 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.443 HG21 ' O ' ' B' ' 114' ' ' ILE . 92.4 t -60.83 -43.15 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.148 0.979 . . . . 75.14 109.924 174.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.0 t -68.22 -33.77 75.02 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.634 -1.166 . . . . 72.44 111.471 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.464 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 85.1 mtt-85 -66.95 -35.93 81.09 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.518 0.727 . . . . 75.53 110.152 177.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.09 9.51 60.44 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-O 119.483 -0.62 . . . . 63.43 113.361 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 70.4 p 57.06 22.14 7.07 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 126.158 1.783 . . . . 74.01 113.72 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -78.79 149.26 73.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.796 -0.446 . . . . 74.2 109.796 175.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.425 ' HB2' ' HG2' ' B' ' 37' ' ' GLN . 28.7 Cg_endo -59.57 171.57 2.56 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.306 2.67 . . . . 74.44 113.672 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.402 ' NE2' HD22 ' B' ' 127' ' ' ASN . 51.9 tp60 -62.91 114.77 3.85 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.038 -0.983 . . . . 64.52 111.88 -167.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.506 HD13 ' HZ ' ' B' ' 74' ' ' PHE . 8.6 tt -135.78 106.64 6.62 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.961 -0.755 . . . . 71.55 108.961 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.402 HD22 ' NE2' ' B' ' 125' ' ' GLN . 12.9 m120 -114.26 135.14 54.39 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.847 0.859 . . . . 75.12 109.843 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.546 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.5 mm? -72.24 124.73 25.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.198 -0.667 . . . . 74.35 109.198 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.72 152.25 89.21 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.296 0.639 . . . . 74.22 110.962 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.17 110.1 1.28 Allowed 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 122.402 2.068 . . . . 65.35 112.947 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 31.2 t -100.71 111.0 29.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.106 -1.072 . . . . 75.53 108.106 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -85.05 90.29 7.81 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.459 -0.941 . . . . 73.53 108.459 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -57.04 -31.53 65.27 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.45 0.7 . . . . 74.31 111.321 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . 0.644 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 11.7 t70 -73.11 -44.92 59.68 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.259 1.024 . . . . 72.31 111.054 -173.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.53 -39.0 93.27 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.075 0.95 . . . . 74.41 111.48 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.5 mp -75.1 -33.54 61.63 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.105 -0.952 . . . . 74.42 110.866 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 69.3 t80 . . . . . 0 N--CA 1.48 1.031 0 C-N-CA 124.05 0.94 . . . . 73.34 111.645 -177.248 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.623 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 51.6 m . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 108.062 -1.088 . . . . 62.23 108.062 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.56 ' HD2' ' HG3' ' A' ' 130' ' ' PRO . 64.4 t80 -107.81 122.95 47.81 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.354 -0.98 . . . . 73.24 108.354 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -139.1 117.85 12.3 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.382 0.673 . . . . 74.33 109.644 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.2 mt -73.22 127.11 34.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 108.856 -0.794 . . . . 74.24 108.856 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.6 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.3 mm-40 -94.0 -46.22 7.24 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.466 -0.568 . . . . 72.03 109.466 173.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -170.97 141.32 1.69 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.602 -0.726 . . . . 75.34 109.418 -167.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.0 mt -136.13 130.25 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.295 -1.372 . . . . 72.14 107.295 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -166.34 157.81 13.34 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.154 0.502 . . . . 73.12 110.611 -164.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.8 p -88.56 117.29 27.41 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.45 -0.796 . . . . 74.51 109.047 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -86.88 -37.6 17.54 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.144 0.497 . . . . 71.24 109.893 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -138.35 127.72 24.59 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.13 -0.941 . . . . 75.44 109.137 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.5 mt -129.8 139.5 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.398 -1.334 . . . . 72.13 107.398 175.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -147.71 145.38 28.85 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.529 0.731 . . . . 74.01 109.678 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -143.12 134.44 26.05 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.469 -1.308 . . . . 74.02 107.469 168.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.4 mt-10 -129.11 126.98 40.53 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 124.326 1.05 . . . . 73.15 108.421 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.76 81.04 23.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 106.664 -1.606 . . . . 74.54 106.664 169.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -64.29 -31.58 62.96 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.966 2.444 . . . . 75.25 112.233 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -105.7 19.28 20.81 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.232 -0.895 . . . . 74.44 111.215 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.451 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -41.28 -62.15 1.14 Allowed Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 117.598 -1.191 . . . . 74.32 114.199 -167.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.0 -44.1 26.52 Favored 'Trans proline' 0 C--N 1.391 2.788 0 CA-C-N 121.977 1.742 . . . . 73.03 111.628 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -68.81 -31.71 70.91 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.016 0.926 . . . . 65.03 112.514 -174.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.676 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.5 p -80.5 -16.59 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 C-N-CA 122.731 0.413 . . . . 73.11 111.322 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -75.39 -22.55 57.39 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.563 0.345 . . . . 75.43 111.683 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -95.74 4.49 52.9 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.452 0.301 . . . . 64.12 111.113 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.429 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.2 tppp? -91.5 151.64 20.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.444 0.697 . . . . 74.44 110.337 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -56.87 124.33 18.19 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 124.092 0.87 . . . . 65.23 110.303 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.9 t90 -84.58 93.39 8.35 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.784 -0.644 . . . . 74.31 110.273 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -145.24 76.98 13.12 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.182 -1.044 . . . . 63.13 108.182 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.8 128.88 6.09 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.687 2.258 . . . . 75.14 112.867 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -85.28 109.43 18.35 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.072 -1.455 . . . . 71.34 107.072 161.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 m -96.48 113.27 30.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.045 0.938 . . . . 75.14 110.571 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -119.65 112.41 19.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.892 1.277 . . . . 75.33 108.186 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.06 168.62 12.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.424 0.69 . . . . 72.34 111.632 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 29.5 t70 -145.5 105.52 4.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.19 0.596 . . . . 72.14 109.976 173.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.42 130.36 55.5 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.576 1.15 . . . . 74.12 109.38 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -156.49 153.88 29.48 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.461 0.705 . . . . 75.14 109.946 171.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -129.81 152.46 49.27 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.947 0.899 . . . . 72.21 110.239 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.7 167.43 22.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.257 1.023 . . . . 71.22 108.84 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.441 ' HB3' HG21 ' C' ' 58' ' ' VAL . 93.1 p -148.15 152.75 37.81 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.046 0.538 . . . . 71.0 109.912 174.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 27.4 p -143.87 135.05 25.67 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.493 0.717 . . . . 64.24 109.545 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -64.91 116.25 6.18 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.941 0.775 . . . . 74.22 109.59 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.528 HD13 HD13 ' C' ' 83' ' ' ILE . 94.5 mt -84.38 -39.72 18.71 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.349 0.595 . . . . 74.52 109.44 174.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.18 -174.84 5.02 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.291 -1.322 . . . . 72.15 109.663 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.84 113.75 2.67 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.986 -1.006 . . . . 71.45 109.954 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 69.97 4.43 4.79 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.94 1.296 . . . . 75.24 112.975 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -105.86 123.0 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.04 0.936 . . . . 65.11 109.444 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -111.91 161.43 16.41 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.694 0.759 . . . . 74.54 110.37 172.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.464 ' HB2' HD13 ' C' ' 51' ' ' LEU . 32.9 tt0 -123.67 111.82 16.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.949 -1.5 . . . . 71.23 106.949 166.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.441 HG21 ' HB3' ' C' ' 48' ' ' SER . 74.0 t -94.07 121.29 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.026 -1.102 . . . . 74.04 108.026 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.33 133.51 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.502 -0.925 . . . . 72.54 108.502 173.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -119.45 109.06 15.3 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.247 -1.02 . . . . 75.33 108.247 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -99.77 112.97 25.17 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.685 0.794 . . . . 73.34 109.784 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.48 ' HB ' HD11 ' C' ' 114' ' ' ILE . 23.3 t -106.4 130.93 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.259 1.024 . . . . 70.32 108.357 175.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 4.9 m -125.31 146.42 49.57 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.725 -0.843 . . . . 72.21 108.725 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -136.35 109.46 8.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.506 1.122 . . . . 75.31 108.644 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 22.1 m -99.25 140.83 32.83 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.512 -0.921 . . . . 74.2 108.512 171.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.11 105.71 5.83 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.825 -1.176 . . . . 71.45 107.825 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 52.3 m -119.67 133.17 55.75 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.698 -0.852 . . . . 74.34 108.698 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 mt -82.68 51.34 1.86 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.263 1.425 . . . . 74.31 110.303 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.81 -76.68 0.31 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.504 -1.038 . . . . 64.14 110.504 -175.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.99 -31.7 2.12 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.701 1.2 . . . . 61.52 109.809 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.429 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 38.5 tp10 -70.88 100.32 1.92 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.344 1.057 . . . . 75.14 110.257 174.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 49.8 m -66.64 125.13 24.82 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 118.007 0.367 . . . . 72.15 110.273 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.676 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -82.0 -55.02 4.84 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 114.982 -1.008 . . . . 64.31 109.161 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -161.14 176.08 11.69 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.259 1.028 . . . . 75.01 112.448 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.2 tm? -137.88 146.53 43.48 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 113.001 -1.909 . . . . 74.1 106.212 172.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.427 ' N ' HD13 ' C' ' 75' ' ' LEU . 44.1 t -148.3 143.39 26.89 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.614 -0.884 . . . . 74.41 108.614 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -155.89 137.12 13.84 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.718 0.294 . . . . 74.0 110.345 -177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.9 t -135.62 137.84 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.466 1.106 . . . . 72.34 108.751 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -115.31 94.55 4.77 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.329 -0.989 . . . . 64.41 108.329 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -79.44 98.55 6.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.489 -0.778 . . . . 74.5 109.452 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.24 143.4 22.87 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.208 -1.157 . . . . 70.22 110.208 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.402 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.84 117.23 0.88 Allowed Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 111.53 -0.628 . . . . 53.14 111.53 -174.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.6 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 6.4 mm -82.61 128.79 38.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 108.638 -0.875 . . . . 74.12 108.638 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -135.85 122.03 20.3 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.43 0.457 . . . . 72.03 110.109 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 22.1 m -79.48 107.55 12.33 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.059 -1.089 . . . . 72.33 108.059 169.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.68 143.83 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.069 0.547 . . . . 73.23 110.637 -175.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.623 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -158.5 166.28 32.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.314 1.046 . . . . 73.12 109.652 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.46 -34.58 4.4 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.984 -0.553 . . . . 75.4 112.896 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.17 140.42 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.731 0.813 . . . . 73.33 110.531 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -148.3 156.65 42.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.585 0.754 . . . . 75.4 109.712 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.81 -117.54 8.21 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 116.209 -0.45 . . . . 43.44 113.248 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 5.2 m -70.6 -33.53 71.16 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.036 0.934 . . . . 74.31 110.501 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -67.14 -39.9 86.66 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.732 -1.122 . . . . 73.4 110.085 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 39.6 ttp -78.11 -24.64 47.41 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.272 -0.876 . . . . 63.13 110.741 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.39 95.65 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 122.752 0.421 . . . . 74.0 110.435 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -75.94 -41.19 52.42 Favored 'General case' 0 C--O 1.248 0.979 0 N-CA-C 111.927 0.343 . . . . 75.32 111.927 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -55.61 -48.89 74.16 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.069 0.856 . . . . 73.41 110.543 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.443 HD21 ' SG ' ' C' ' 102' ' ' CYS . 34.9 mt -92.88 -14.26 27.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.277 0.631 . . . . 75.42 111.076 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.93 -29.39 65.07 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 123.329 0.49 . . . . 73.42 113.835 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -156.5 -39.83 0.08 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 113.13 0.789 . . . . 72.43 113.13 -166.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -66.04 -55.82 14.68 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.453 0.471 . . . . 72.54 111.184 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.545 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 37.8 m -64.52 -46.28 77.35 Favored Pre-proline 0 CA--C 1.563 1.478 0 C-N-CA 123.643 0.777 . . . . 65.24 112.943 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.418 ' HD3' HG12 ' C' ' 58' ' ' VAL . 41.5 Cg_endo -66.56 -19.81 54.15 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 121.967 1.778 . . . . 74.54 113.967 174.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' C' ' 100' ' ' ALA . 0.2 OUTLIER -71.98 -28.41 63.4 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.714 -0.476 . . . . 71.31 109.714 176.189 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.71 -43.21 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.673 0.789 . . . . 73.31 109.67 171.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.402 HD21 ' HA3' ' C' ' 82' ' ' GLY . 66.0 mt -74.95 -28.2 60.49 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 114.886 -1.052 . . . . 52.22 112.133 -172.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -56.7 -50.2 89.31 Favored Pre-proline 0 CA--C 1.566 1.578 0 CA-C-O 117.34 -1.314 . . . . 74.43 114.243 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.54 -39.14 55.58 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 122.4 2.067 . . . . 72.11 113.367 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.455 ' HE2' HG21 ' A' ' 115' ' ' THR . 20.1 m-85 -67.94 -48.34 66.19 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.781 0.832 . . . . 72.51 110.405 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.15 -34.84 75.66 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.011 -0.995 . . . . 73.53 110.843 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -61.33 -56.53 19.42 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 124.12 0.968 . . . . 75.43 109.988 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.01 -30.33 71.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 123.724 0.64 . . . . 71.1 110.717 -175.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.5 t -73.91 -31.24 63.0 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.142 0.577 . . . . 73.32 110.884 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.48 HD11 ' HB ' ' C' ' 62' ' ' VAL . 58.7 mt -74.0 -50.33 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.945 0.498 . . . . 63.32 109.724 173.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 5.2 m -62.62 -30.27 71.23 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.013 0.925 . . . . 75.24 110.887 -175.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.3 t -65.5 -51.75 57.75 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.999 -0.741 . . . . 74.44 108.999 172.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.672 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.59 -36.65 76.67 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.541 1.136 . . . . 73.14 112.926 -179.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.686 HG12 HD21 ' C' ' 126' ' ' LEU . 95.0 t -71.72 -39.36 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.473 0.709 . . . . 74.23 109.775 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.5 t -70.77 -26.45 63.36 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.655 0.782 . . . . 74.35 111.234 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 78.2 mtt-85 -72.93 -42.49 63.41 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.744 -0.836 . . . . 75.43 108.744 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.1 -4.17 82.93 Favored Glycine 0 C--N 1.356 1.649 0 O-C-N 123.706 0.629 . . . . 72.53 112.942 173.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.406 HG21 ' HB3' ' D' ' 17' ' ' TYR . 23.4 p 66.83 25.84 9.48 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.633 1.973 . . . . 72.3 113.62 171.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.503 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 98.6 m-85 -86.49 166.08 29.7 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 123.841 0.857 . . . . 74.14 109.115 169.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 51.3 Cg_endo -62.67 178.31 1.01 Allowed 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 123.139 2.559 . . . . 72.43 114.708 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -59.67 112.22 1.73 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.877 1.271 . . . . 72.51 111.742 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.686 HD21 HG12 ' C' ' 118' ' ' VAL . 4.1 mm? -106.62 96.78 6.69 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.211 -0.663 . . . . 74.05 109.211 172.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -124.79 122.48 37.54 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.708 1.203 . . . . 74.01 108.539 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 14.8 tp -79.96 135.4 36.39 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.932 -0.395 . . . . 75.43 109.932 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.13 140.44 78.14 Favored Pre-proline 0 CA--C 1.547 0.849 0 O-C-N 124.45 1.094 . . . . 75.33 110.304 173.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.455 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 9.8 Cg_endo -53.84 102.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.582 2.188 . . . . 70.22 112.676 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 50.0 t -95.74 111.17 25.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 106.675 -1.602 . . . . 71.31 106.675 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -76.24 83.22 3.03 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.633 -1.247 . . . . 74.53 107.633 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -56.43 -36.64 69.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.731 0.812 . . . . 73.23 110.825 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.7 -43.13 99.45 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 114.857 -1.065 . . . . 70.34 111.213 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.02 91.53 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.637 0.586 . . . . 62.52 110.952 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.1 mp -57.48 -50.66 72.33 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 123.97 0.794 . . . . 75.35 111.409 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 123.347 0.659 . . . . 74.21 110.396 -177.834 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 C--O 1.236 0.39 0 N-CA-C 109.737 -0.468 . . . . 73.44 109.737 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -175.13 102.01 0.08 Allowed 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.458 -2.053 . . . . 74.21 105.458 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -144.2 134.47 24.39 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.243 -0.89 . . . . 73.34 108.799 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.3 mt -84.25 122.6 38.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 115.203 -0.908 . . . . 73.15 109.182 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -90.07 -39.8 12.69 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 122.617 0.367 . . . . 74.13 111.315 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -166.56 127.79 1.71 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 111.755 0.28 . . . . 74.1 111.755 -167.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.75 136.13 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.343 -1.354 . . . . 73.42 107.343 167.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.417 ' HE1' HG13 ' D' ' 83' ' ' ILE . 25.1 p90 -156.51 164.38 38.29 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.771 0.796 . . . . 74.02 111.334 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 65.3 p -100.15 123.27 44.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.043 -0.981 . . . . 75.14 108.839 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -87.24 -36.01 18.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.67 0.748 . . . . 62.51 109.132 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.621 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 2.6 t70 -142.07 138.88 32.05 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.233 -1.349 . . . . 72.04 108.942 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.672 HG21 ' HE1' ' C' ' 117' ' ' MET . 82.3 mt -134.25 145.89 32.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.63 -1.248 . . . . 63.53 107.63 169.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -148.11 137.87 22.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.886 -0.783 . . . . 65.1 108.886 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.5 t80 -146.12 124.06 12.03 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.239 -1.393 . . . . 74.31 107.239 170.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -121.75 148.49 44.57 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.079 -0.711 . . . . 75.4 109.079 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.78 84.19 27.27 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 106.738 -1.578 . . . . 70.25 106.738 171.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.4 -46.08 6.16 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.198 2.598 . . . . 74.45 113.586 -167.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -104.95 28.0 7.6 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.703 0.801 . . . . 74.54 109.591 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.419 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -40.27 -66.72 0.34 Allowed Pre-proline 0 CA--C 1.565 1.528 0 N-CA-C 114.908 1.447 . . . . 75.31 114.908 -161.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.552 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.7 Cg_endo -73.8 -20.13 20.24 Favored 'Trans proline' 0 C--N 1.382 2.324 0 CA-C-N 122.533 1.94 . . . . 75.15 113.3 -174.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -73.88 -40.44 63.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.595 1.158 . . . . 71.42 110.328 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.441 HG22 ' HA ' ' D' ' 73' ' ' ALA . 4.0 p -85.54 -23.95 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 123.341 0.657 . . . . 65.22 111.803 -171.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -60.64 -22.09 63.46 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 123.286 0.634 . . . . 74.52 112.428 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -68.17 -10.3 53.19 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.579 0.752 . . . . 73.34 111.052 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.522 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 93.2 mttt -100.95 107.73 19.29 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.737 1.215 . . . . 73.24 110.246 177.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -93.27 91.87 7.44 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.293 0.637 . . . . 72.31 110.423 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.514 ' HZ3' ' H ' ' D' ' 69' ' ' GLY . 22.0 t90 -161.62 158.41 26.13 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.937 1.295 . . . . 73.31 108.127 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -69.31 108.03 2.74 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 107.999 -1.111 . . . . 74.03 107.999 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.74 124.23 15.75 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.967 2.444 . . . . 64.41 112.495 -173.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -57.28 110.98 0.94 Allowed 'General case' 0 C--N 1.359 0.996 0 O-C-N 124.442 1.088 . . . . 74.11 110.244 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.68 112.39 34.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 115.283 -0.871 . . . . 75.32 110.269 -172.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.74 ' HZ3' ' HB2' ' D' ' 43' ' ' ASP . 0.5 OUTLIER -85.55 109.82 18.79 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 104.908 -2.256 . . . . 75.33 104.908 165.313 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.431 HD13 HD13 ' D' ' 128' ' ' LEU . 5.4 tt -95.49 127.9 41.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.36 -1.348 . . . . 70.25 107.36 -170.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.74 ' HB2' ' HZ3' ' D' ' 41' ' ' LYS . 10.0 t70 -130.17 147.0 51.85 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 123.542 0.527 . . . . 72.31 109.915 -176.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -127.99 153.02 47.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.584 0.753 . . . . 75.34 109.682 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -157.69 147.78 20.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.055 0.942 . . . . 73.41 108.828 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -127.73 160.85 30.42 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.409 -0.589 . . . . 72.33 109.409 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.472 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -158.05 166.77 31.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.755 -1.112 . . . . 75.44 108.661 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 21.8 p -165.72 161.31 18.01 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.609 0.764 . . . . 71.33 109.557 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.2 p -151.98 160.47 43.47 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.282 1.033 . . . . 72.45 109.238 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -98.81 120.65 39.6 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.995 -0.742 . . . . 72.35 108.995 171.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' D' ' 57' ' ' GLU . 59.2 mt -91.0 -41.3 11.18 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.124 0.488 . . . . 73.31 110.198 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.55 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -153.51 -172.44 4.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.754 0.822 . . . . 73.12 110.896 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.37 105.96 1.59 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 114.968 -1.015 . . . . 70.33 109.53 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 64.11 18.59 11.33 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.517 1.127 . . . . 74.23 112.404 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 98.1 t -117.83 120.44 64.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.587 0 N-CA-C 107.843 -1.169 . . . . 74.41 107.843 169.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -125.46 163.8 21.86 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.671 0.788 . . . . 73.35 109.411 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' D' ' 51' ' ' LEU . 22.2 tt0 -121.52 148.38 44.55 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 124.746 1.218 . . . . 72.51 107.714 169.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.1 t -129.75 119.28 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 106.896 -1.52 . . . . 75.31 106.896 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.508 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 41.4 t -99.38 125.29 52.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.987 -0.746 . . . . 73.4 108.987 176.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.64 124.86 49.61 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.702 -1.221 . . . . 74.14 107.702 175.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -118.98 95.66 4.91 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.987 -0.746 . . . . 75.12 108.987 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -91.24 123.1 43.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.078 -1.082 . . . . 75.4 108.078 174.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 24.0 m -111.15 144.06 40.9 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.25 0.548 . . . . 72.14 110.041 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 93.9 t -137.44 120.28 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.111 0.964 . . . . 74.22 109.503 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 100.0 m -113.39 121.03 43.12 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 107.912 -1.144 . . . . 74.54 107.912 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.88 145.49 48.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.333 0.653 . . . . 63.23 110.319 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.8 m -146.83 129.96 16.48 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 123.526 0.516 . . . . 74.33 111.129 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 mt -92.86 92.6 7.98 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.945 -1.132 . . . . 74.31 107.945 173.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . 0.514 ' H ' ' HZ3' ' D' ' 36' ' ' TRP . . . 70.22 -114.77 5.67 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 114.571 -1.195 . . . . 54.31 113.382 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.15 6.37 40.36 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.299 0.852 . . . . 74.15 113.299 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.522 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.2 pt-20 -148.91 156.94 43.02 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.11 0.414 . . . . 65.51 110.222 -177.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.5 m -67.29 136.89 55.59 Favored 'General case' 0 C--O 1.242 0.697 0 O-C-N 123.633 0.583 . . . . 73.23 110.694 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.441 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -89.34 -69.57 0.71 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.252 -1.34 . . . . 75.44 108.522 175.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -145.58 157.46 43.98 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 121.319 0.58 . . . . 72.22 109.958 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -131.96 144.58 50.91 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.255 -1.387 . . . . 74.23 107.255 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.549 ' SG ' HG12 ' D' ' 114' ' ' ILE . 43.6 t -158.22 136.68 11.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.336 0.254 . . . . 75.21 110.589 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -154.07 128.35 9.1 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.387 0.675 . . . . 73.21 109.32 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.2 118.39 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.382 0.673 . . . . 72.3 109.905 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.621 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.6 mt-30 -89.77 82.97 6.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.34 0.656 . . . . 63.54 109.307 169.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -80.37 91.86 5.73 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.963 1.305 . . . . 63.31 109.359 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.25 142.18 17.98 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.713 -0.555 . . . . 65.13 111.713 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.93 132.31 5.5 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 119.716 -0.491 . . . . 70.43 112.064 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.417 HG13 ' HE1' ' D' ' 17' ' ' TYR . 61.9 mt -89.17 131.23 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.379 0.672 . . . . 70.55 109.99 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -131.22 124.55 30.81 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.886 0.875 . . . . 70.31 109.341 175.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 71.5 m -83.75 111.7 19.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.088 -1.078 . . . . 73.12 108.088 168.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.418 HD11 ' SG ' ' D' ' 97' ' ' CYS . 5.5 tt -138.06 127.99 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 122.902 0.481 . . . . 70.14 111.117 -172.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.68 167.66 27.86 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.398 1.479 . . . . 64.22 109.099 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.05 11.51 63.11 Favored Glycine 0 N--CA 1.473 1.128 0 CA-C-O 119.463 -0.632 . . . . 75.42 113.66 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.8 169.22 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 125.079 1.352 . . . . 74.25 109.661 171.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -153.91 175.82 12.91 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.723 0.409 . . . . 74.23 111.912 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.89 -107.42 0.71 Allowed Glycine 0 C--N 1.36 1.868 0 O-C-N 124.757 1.285 . . . . 64.31 115.263 164.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.0 p -66.04 -41.54 90.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.816 0.847 . . . . 72.13 110.974 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -74.72 -38.03 62.41 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.344 0.657 . . . . 73.43 111.685 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -66.63 -34.46 77.92 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.867 0.365 . . . . 75.24 110.671 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.98 -42.65 69.4 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.907 -0.588 . . . . 73.22 109.646 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -66.25 -26.41 67.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.421 1.088 . . . . 70.53 111.817 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' D' ' 86' ' ' ILE . 25.3 t -91.12 -54.14 4.07 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.844 -0.122 . . . . 73.33 110.864 -176.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -72.31 -29.77 64.16 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.391 0.276 . . . . 73.41 111.494 -176.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.5 12.91 27.98 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.122 -0.821 . . . . 73.01 114.532 -172.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.656 ' HB3' ' HA ' ' D' ' 134' ' ' ASP . . . -154.46 -59.65 0.12 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.983 0.891 . . . . 72.41 112.207 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -68.59 -50.41 51.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.006 0.523 . . . . 73.43 111.499 -173.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 83.7 m -62.6 -45.71 88.78 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.11 0.964 . . . . 73.32 112.243 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -52.56 -40.79 71.58 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.203 1.935 . . . . 74.0 112.967 167.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -66.07 -29.87 70.28 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.256 0.622 . . . . 75.54 111.328 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.7 mm -69.59 -42.4 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.894 0.878 . . . . 74.12 110.436 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 62.8 mt -74.83 -16.28 60.7 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.224 -0.898 . . . . 74.43 111.67 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.452 ' HE2' ' HA ' ' D' ' 130' ' ' PRO . 27.6 t80 -68.07 -40.37 21.73 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.916 -1.04 . . . . 75.24 113.74 -169.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.39 -44.84 45.6 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.011 1.807 . . . . 75.01 112.895 167.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -69.24 -36.64 77.37 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.692 0.797 . . . . 73.12 111.783 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.07 -49.46 69.95 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.241 0.616 . . . . 73.42 109.717 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.497 HH12 ' HB3' ' D' ' 130' ' ' PRO . 26.5 ttp180 -55.99 -47.62 77.37 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 124.357 1.036 . . . . 74.14 110.946 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -62.13 -49.03 77.49 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.073 0.858 . . . . 75.52 111.534 -174.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.0 -41.86 83.98 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.053 0.846 . . . . 72.44 110.636 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.549 HG12 ' SG ' ' D' ' 76' ' ' CYS . 81.1 mt -60.4 -56.51 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 O-C-N 124.293 0.996 . . . . 73.24 110.79 173.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -58.21 -37.55 75.04 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.588 1.155 . . . . 75.52 111.372 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -66.78 -42.15 86.5 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.155 -0.93 . . . . 75.45 110.079 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.485 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.4 mtm -72.52 -27.11 62.04 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.809 0.444 . . . . 65.53 111.766 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.97 -42.14 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.458 0.703 . . . . 64.35 110.078 173.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.6 p -75.62 -29.44 59.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.813 0.445 . . . . 72.43 111.108 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -74.26 -33.84 63.41 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.245 0.618 . . . . 75.4 109.599 174.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.68 -2.25 90.62 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-N 115.746 -0.661 . . . . 75.43 112.237 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p 66.57 21.3 10.73 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.876 2.07 . . . . 52.43 113.904 170.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -82.62 156.77 67.95 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.452 0.701 . . . . 75.12 110.348 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.97 137.23 44.23 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.298 2.666 . . . . 64.44 112.138 173.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -54.66 136.77 45.18 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.359 1.037 . . . . 75.21 111.929 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -113.44 102.32 10.2 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.568 -0.901 . . . . 74.02 108.568 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -98.29 95.08 7.13 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.221 -1.4 . . . . 73.53 107.221 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.431 HD13 HD13 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -57.11 113.89 1.9 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.566 -1.197 . . . . 65.24 108.273 -176.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.88 122.65 70.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 123.963 0.789 . . . . 75.53 110.632 -171.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.497 ' HB3' HH12 ' D' ' 111' ' ' ARG . 59.1 Cg_endo -72.64 112.52 3.5 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.944 1.763 . . . . 72.22 111.427 -176.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.0 m -105.81 138.52 30.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 108.317 -0.994 . . . . 70.43 108.317 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -79.25 77.11 5.78 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.872 0.844 . . . . 73.44 109.726 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -56.71 -29.39 62.39 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.623 1.569 . . . . 72.14 111.64 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . 0.656 ' HA ' ' HB3' ' D' ' 100' ' ' ALA . 21.7 t70 -60.51 -45.1 95.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.13 1.372 . . . . 75.54 110.747 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.07 -37.84 57.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.807 0.843 . . . . 63.31 111.329 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 9.8 mp -58.93 -31.23 68.48 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.33 0.652 . . . . 65.54 111.043 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.6 t80 . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 123.986 0.914 . . . . 74.22 110.8 177.715 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.1 m . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.865 -0.42 . . . . 75.24 109.865 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.653 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.4 t80 -133.25 132.87 41.96 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.647 -0.872 . . . . 75.22 108.647 173.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -147.39 116.64 6.94 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.682 -0.858 . . . . 74.52 108.682 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.461 HG12 ' HD2' ' A' ' 84' ' ' PHE . 50.7 mt -81.19 117.4 27.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.87 -0.789 . . . . 74.35 108.87 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -86.34 -40.37 15.52 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 123.742 0.651 . . . . 74.42 110.757 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -168.12 137.46 2.48 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 122.969 0.168 . . . . 74.55 110.744 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.533 HD12 ' HG3' ' C' ' 130' ' ' PRO . 88.6 mt -125.44 133.48 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.378 1.071 . . . . 74.34 108.584 177.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.412 ' HB3' HG21 ' B' ' 122' ' ' THR . 41.4 p90 -168.97 177.32 4.99 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 123.97 0.794 . . . . 75.44 111.355 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -102.2 122.96 45.19 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.05 -0.977 . . . . 74.3 108.749 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HE3' ' HB1' ' B' ' 28' ' ' ALA . 31.3 mtpt -88.07 -45.21 10.36 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.316 -0.624 . . . . 73.32 109.316 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.3 t70 -134.34 125.67 28.08 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.507 -1.224 . . . . 72.02 108.288 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 58.9 mt -124.91 140.39 48.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.696 -1.594 . . . . 73.15 106.696 173.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -156.09 121.12 4.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.17 0.509 . . . . 74.53 109.727 171.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.438 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 86.8 t80 -116.3 118.54 33.05 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 106.36 -1.718 . . . . 74.44 106.36 173.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -119.56 126.48 51.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.058 0.39 . . . . 51.43 110.145 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.17 75.64 23.15 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.685 -1.228 . . . . 54.33 107.685 169.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.56 -28.68 25.91 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.26 1.974 . . . . 62.42 110.405 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.419 ' O ' HG22 ' A' ' 31' ' ' VAL . 43.1 m-20 -93.33 12.41 24.81 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.196 -1.365 . . . . 75.15 110.898 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.73 -46.88 80.19 Favored Pre-proline 0 CA--C 1.571 1.752 0 C-N-CA 124.185 0.994 . . . . 72.52 113.607 -176.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.13 -21.77 20.05 Favored 'Trans proline' 0 C--N 1.396 3.073 0 C-N-CA 122.082 1.855 . . . . 75.31 113.651 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -71.65 -47.57 53.53 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.623 -0.51 . . . . 70.02 109.623 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.625 HG23 HD21 ' A' ' 68' ' ' LEU . 88.1 t -60.91 -33.88 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.738 1.215 . . . . 72.33 110.936 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.432 ' HD1' HH11 ' B' ' 15' ' ' ARG . 90.9 t80 -56.46 -39.52 73.3 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.643 1.177 . . . . 74.41 111.918 176.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -96.43 -35.15 11.26 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.652 0.781 . . . . 73.1 111.87 -172.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.597 ' HZ2' ' HB2' ' A' ' 71' ' ' GLU . 57.9 mtpt -83.15 170.63 14.54 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.596 0.758 . . . . 74.55 112.88 -172.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.63 115.86 9.36 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.825 0.85 . . . . 43.52 111.101 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -79.63 92.65 5.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.022 0.929 . . . . 73.52 109.966 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -140.51 75.83 26.09 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 107.38 -1.341 . . . . 72.2 107.38 172.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -90.52 163.85 4.35 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.095 2.53 . . . . 74.34 113.98 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -126.32 118.39 24.97 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.04 -0.982 . . . . 72.04 108.534 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.69 110.05 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.602 0.761 . . . . 74.32 110.831 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -103.24 140.07 37.86 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.679 -0.86 . . . . 74.25 108.679 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 63' ' ' THR . 64.7 tp -132.09 124.76 29.83 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.491 0.716 . . . . 74.24 109.701 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.479 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 64.4 m-20 -102.95 124.33 48.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.152 -1.055 . . . . 75.53 108.152 175.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.35 115.21 29.82 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.788 -1.56 . . . . 74.35 106.788 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.701 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 12.0 m-20 -132.07 124.6 29.53 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.096 -1.075 . . . . 63.43 108.096 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.9 m -115.35 121.94 44.36 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.404 -0.591 . . . . 72.15 109.404 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.76 140.86 48.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.182 0.993 . . . . 71.22 108.614 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.533 ' HB2' HD23 ' A' ' 98' ' ' LEU . 37.0 t -130.59 163.92 26.06 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.358 0.599 . . . . 65.31 111.628 -173.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.2 t -148.91 121.62 8.64 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.198 -1.365 . . . . 74.44 108.256 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -71.67 107.89 4.74 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.822 0.849 . . . . 72.34 109.279 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.43 HD12 HG22 ' A' ' 83' ' ' ILE . 86.9 mt -78.52 -34.51 47.24 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.221 0.608 . . . . 71.45 110.281 -178.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.54 -177.71 6.59 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.939 0.895 . . . . 72.4 109.878 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.72 119.44 14.86 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.412 -0.588 . . . . 75.33 109.412 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 67.34 20.15 10.04 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.084 1.354 . . . . 73.41 112.151 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.12 124.05 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.414 1.086 . . . . 75.31 108.35 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.506 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -142.43 169.22 17.99 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.337 -0.616 . . . . 73.54 109.337 174.337 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -128.75 130.51 47.17 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.498 -0.927 . . . . 74.3 108.498 174.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.8 m -102.42 132.06 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.586 -0.894 . . . . 73.43 108.586 169.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.51 106.92 21.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 125.194 1.397 . . . . 74.34 107.68 177.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.7 tp -87.57 99.14 11.82 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.693 -0.685 . . . . 73.03 109.155 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.701 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 52.6 ttt-85 -84.38 105.24 15.06 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.805 -0.813 . . . . 75.14 108.805 174.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.587 HG21 ' HB1' ' A' ' 110' ' ' ALA . 1.7 m -112.95 106.58 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 108.37 -0.974 . . . . 74.32 108.37 175.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 25.6 m -109.83 112.01 23.79 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.451 1.1 . . . . 74.32 110.716 -167.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 78.2 t -101.74 110.97 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.52 0.728 . . . . 74.42 109.656 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -115.44 108.29 16.29 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.735 -0.839 . . . . 71.13 108.735 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.79 133.49 53.08 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.312 -0.995 . . . . 72.11 108.312 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 t -140.27 134.38 30.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.905 0.482 . . . . 74.11 110.595 -176.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.625 HD21 HG23 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -94.78 80.17 3.74 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.432 1.093 . . . . 74.43 108.436 172.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.06 -118.86 5.48 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.311 -0.858 . . . . 74.44 112.593 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -89.41 5.97 42.82 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.61 0.764 . . . . 74.53 111.368 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.597 ' HB2' ' HZ2' ' A' ' 34' ' ' LYS . 6.3 tp10 -116.84 112.92 21.77 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.636 -0.876 . . . . 73.23 108.636 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.0 m -73.75 130.08 39.24 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.541 0.609 . . . . 72.25 109.864 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.484 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.81 -59.96 2.53 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.433 0.693 . . . . 74.21 109.789 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -159.28 163.35 35.85 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 115.157 -0.928 . . . . 73.31 110.782 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 34.6 tp -135.68 106.38 6.55 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.751 -1.113 . . . . 74.23 108.172 175.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.438 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 57.2 m -107.69 97.36 7.1 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.241 -0.651 . . . . 74.51 109.241 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -113.06 117.16 31.23 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.671 -1.233 . . . . 74.53 107.671 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 113' ' ' CYS . 90.4 t -126.3 109.55 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.492 -0.776 . . . . 73.0 109.119 -175.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.574 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.3 mt-30 -90.34 86.23 6.42 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.866 -1.061 . . . . 72.23 108.608 171.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.494 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.1 tp-100 -76.42 109.05 9.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.156 -1.384 . . . . 73.34 108.104 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.37 144.83 17.53 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.429 -0.668 . . . . 74.32 111.429 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.59 122.46 1.49 Allowed Glycine 0 CA--C 1.502 -0.746 0 N-CA-C 110.869 -0.892 . . . . 72.43 110.869 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.43 HG22 HD12 ' A' ' 51' ' ' LEU . 57.9 mt -80.93 121.77 35.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 108.406 -0.961 . . . . 75.25 108.406 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.653 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.2 m-85 -130.37 135.53 48.13 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.511 -0.922 . . . . 74.02 108.511 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.4 p -112.62 98.02 6.96 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.325 -0.62 . . . . 61.33 109.325 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.41 HD13 HD13 ' A' ' 89' ' ' ILE . 39.3 pt -99.52 149.8 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 115.733 -0.667 . . . . 74.22 109.469 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.58 147.73 14.02 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.413 0.685 . . . . 74.13 110.121 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.24 9.75 64.93 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 114.873 0.709 . . . . 63.1 114.873 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.509 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -123.39 153.36 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.748 0.819 . . . . 74.22 110.085 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 14.2 tt0 -160.78 179.4 8.55 Favored 'General case' 0 CA--C 1.557 1.228 0 O-C-N 123.251 0.345 . . . . 74.43 111.085 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 73.61 -133.62 17.85 Favored Glycine 0 C--N 1.351 1.38 0 C-N-CA 123.907 0.765 . . . . 71.32 113.838 177.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.0 p -64.86 -35.25 80.51 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.934 0.894 . . . . 72.44 110.961 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -64.96 -35.58 81.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.994 0.918 . . . . 75.04 110.846 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.574 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 28.1 ttt -62.37 -47.06 85.82 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.635 0.774 . . . . 75.1 110.904 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.71 -39.24 91.02 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.777 -0.647 . . . . 73.13 110.865 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -67.24 -31.86 72.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.287 1.035 . . . . 71.14 111.633 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 24.6 t -69.95 -29.27 66.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.991 0.424 . . . . 75.31 110.899 -175.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' A' ' 48' ' ' SER . 1.8 tt -95.09 -32.68 12.99 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.75 -0.659 . . . . 74.42 110.235 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.2 -1.93 66.51 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-O 119.578 -0.568 . . . . 74.2 113.942 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -147.82 -64.54 0.26 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 117.827 0.813 . . . . 75.31 111.967 -176.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 51.1 t80 -56.22 -70.83 0.1 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.252 1.421 . . . . 73.33 113.607 -169.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 86.6 m -72.35 -35.64 3.4 Favored Pre-proline 0 CA--C 1.565 1.541 0 N-CA-C 114.894 1.442 . . . . 73.31 114.894 -173.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 37.8 Cg_endo -64.65 -26.12 61.38 Favored 'Trans proline' 0 C--N 1.392 2.866 0 CA-C-N 121.99 1.746 . . . . 73.42 113.103 173.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -72.53 -23.1 60.95 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.847 0.459 . . . . 74.21 111.217 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.45 HG23 HD11 ' A' ' 13' ' ' ILE . 47.3 mm -61.91 -40.58 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.092 0.472 . . . . 75.1 109.759 171.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.494 HD23 ' HG3' ' A' ' 80' ' ' GLN . 83.7 mt -82.82 -13.45 56.18 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.298 -0.864 . . . . 73.54 112.507 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.422 ' HE2' ' HA ' ' A' ' 130' ' ' PRO . 49.2 t80 -63.94 -43.23 74.73 Favored Pre-proline 0 CA--C 1.567 1.613 0 C-N-CA 123.709 0.804 . . . . 75.23 113.101 -174.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.56 -35.77 57.59 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 122.215 1.943 . . . . 64.35 113.904 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.2 -40.54 64.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.918 0.487 . . . . 74.11 110.79 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.587 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -69.81 -36.12 75.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.528 -0.76 . . . . 65.44 110.514 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.489 ' NH1' HD13 ' C' ' 105' ' ' ILE . 36.5 ttm180 -52.95 -53.07 55.09 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.292 0.995 . . . . 74.42 109.66 171.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.75 -44.61 95.74 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 124.385 1.053 . . . . 74.11 111.701 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.401 ' HB3' HG12 ' A' ' 78' ' ' VAL . 17.1 t -62.2 -45.3 93.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.474 0.71 . . . . 65.13 110.555 -176.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.417 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.3 mt -60.97 -54.66 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.799 0.84 . . . . 74.22 110.016 175.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.528 HG22 ' HG3' ' A' ' 125' ' ' GLN . 85.0 m -48.55 -48.0 38.92 Favored 'General case' 0 C--O 1.248 1.024 0 C-N-CA 124.515 1.126 . . . . 72.31 111.585 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -64.31 -47.69 78.48 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.272 -1.331 . . . . 62.43 110.034 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.41 ' SD ' HG22 ' A' ' 21' ' ' ILE . 39.0 mtp -61.07 -41.04 95.9 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.183 0.993 . . . . 73.2 112.32 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 114' ' ' ILE . 98.3 t -62.2 -45.94 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.691 0.796 . . . . 73.25 109.954 177.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.0 m -70.68 -27.77 64.27 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.386 -0.825 . . . . 73.33 111.978 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -72.55 -30.14 64.17 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.505 0.722 . . . . 72.05 110.186 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.82 7.07 75.9 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.541 0.525 . . . . 52.33 112.981 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.1 m 69.41 12.23 8.24 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.772 1.229 . . . . 74.11 111.791 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.533 ' HE1' HG13 ' A' ' 31' ' ' VAL . 89.3 m-85 -81.1 152.35 71.14 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.177 0.591 . . . . 73.34 109.792 173.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.4 138.16 79.31 Favored 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 123.162 2.575 . . . . 71.44 112.224 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.528 ' HG3' HG22 ' A' ' 115' ' ' THR . 32.5 tt0 -55.39 129.48 38.78 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 123.875 0.734 . . . . 75.23 111.654 -176.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.4 tp -110.4 116.76 32.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.945 -1.025 . . . . 71.23 109.566 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -118.84 101.87 8.38 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.723 -1.214 . . . . 63.42 107.723 172.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 pp -64.4 134.24 54.16 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 109.8 -0.445 . . . . 63.34 109.8 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.28 146.9 94.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.058 0.543 . . . . 62.04 110.46 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HA ' ' HE2' ' A' ' 107' ' ' PHE . 36.3 Cg_exo -61.83 115.18 2.64 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.54 2.16 . . . . 75.03 111.38 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.35 121.08 48.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.986 -1.116 . . . . 75.01 107.986 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -71.98 95.81 1.63 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.801 -0.815 . . . . 73.34 108.801 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 94.3 m-85 -60.51 -31.61 70.66 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.67 0.788 . . . . 71.43 111.996 -177.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.66 -50.74 70.02 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.911 0.757 . . . . 65.43 109.921 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.11 90.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.574 0.75 . . . . 65.25 111.064 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.41 -34.18 77.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.738 0.815 . . . . 75.1 111.42 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -73.19 -34.6 66.07 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.187 0.595 . . . . 75.14 110.036 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 123.041 0.536 . . . . 72.22 111.306 -179.539 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.564 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 87.7 m . . . . . 0 C--O 1.235 0.321 0 N-CA-C 107.663 -1.236 . . . . 75.13 107.663 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -139.32 138.96 37.13 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.546 -0.909 . . . . 65.43 108.546 174.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -158.93 141.12 13.88 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.215 0.606 . . . . 73.31 109.674 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.486 HD11 HD11 ' B' ' 16' ' ' ILE . 54.1 mt -83.69 121.98 37.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.989 -1.115 . . . . 74.43 107.989 172.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -94.11 -43.8 8.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.204 0.602 . . . . 75.33 109.401 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.438 ' HG2' ' HD1' ' B' ' 17' ' ' TYR . 50.0 ttt180 -163.89 132.69 3.77 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.515 -0.766 . . . . 75.5 109.314 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.486 HD11 HD11 ' B' ' 13' ' ' ILE . 96.0 mt -115.02 141.29 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.237 -1.394 . . . . 73.3 107.237 169.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.438 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 33.1 p90 -164.73 157.27 16.44 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.837 0.711 . . . . 74.21 110.735 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 22.6 m -83.72 122.92 29.29 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.635 -1.246 . . . . 72.15 107.635 168.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.403 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 19.4 mtpp -84.15 -52.82 5.96 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.917 -0.772 . . . . 75.41 108.917 176.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 28.9 t70 -134.96 149.43 50.22 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.687 -0.688 . . . . 75.04 111.256 -170.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.542 HD13 ' SG ' ' B' ' 113' ' ' CYS . 25.7 mm -139.81 144.74 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.528 1.531 . . . . 74.53 108.575 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -147.73 110.99 4.88 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.098 0.873 . . . . 75.44 108.667 166.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.459 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 85.7 t80 -119.81 113.06 20.03 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.204 -1.406 . . . . 75.4 107.204 170.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -122.95 124.23 42.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.611 0.764 . . . . 72.41 109.203 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.49 85.0 12.78 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.162 -1.421 . . . . 71.02 107.162 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.44 -36.83 19.02 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.886 2.39 . . . . 73.34 112.811 -169.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -105.5 17.26 24.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.887 0.875 . . . . 64.33 110.378 -176.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.433 ' HB1' ' HE3' ' A' ' 19' ' ' LYS . . . -41.59 -61.97 1.25 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 115.349 1.611 . . . . 75.13 115.349 -164.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -66.97 -16.06 48.61 Favored 'Trans proline' 0 C--N 1.4 3.287 0 C-N-CA 122.314 2.01 . . . . 72.44 112.372 -170.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -97.73 -49.04 4.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.19 0.996 . . . . 74.11 111.408 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' B' ' 73' ' ' ALA . 9.8 p -64.38 -20.49 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.563 0.745 . . . . 63.41 112.333 -166.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -65.04 -17.76 64.73 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.45 0.908 . . . . 72.23 113.45 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -59.3 -25.52 64.21 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.114 0.566 . . . . 71.34 110.901 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.511 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 91.1 mttt -94.46 80.11 3.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.512 1.125 . . . . 65.35 108.674 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.3 93.25 3.4 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.294 0.569 . . . . 75.1 109.59 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -161.74 158.26 25.56 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.752 1.221 . . . . 74.54 107.988 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -60.43 106.15 0.71 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.903 0.881 . . . . 72.05 110.032 169.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.555 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 35.5 Cg_endo -64.35 124.71 13.79 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.872 1.714 . . . . 75.43 110.497 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -58.15 107.23 0.45 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 123.724 0.64 . . . . 61.42 110.126 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.495 HG12 ' HB1' ' B' ' 66' ' ' ALA . 28.5 m -96.68 150.52 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.744 0.783 . . . . 74.33 112.535 -173.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -119.42 115.12 23.44 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.253 -1.34 . . . . 74.43 107.657 170.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 mp -85.15 132.22 34.33 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.421 -1.326 . . . . 71.22 107.421 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.462 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 14.4 t70 -147.38 110.96 4.95 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 110.135 -0.32 . . . . 75.3 110.135 -177.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 mp -100.57 163.79 12.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.995 0.426 . . . . 72.31 110.211 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 17.7 t70 -158.43 139.25 12.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.712 1.205 . . . . 61.24 108.397 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 47.8 p -133.6 117.73 17.4 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.938 0.495 . . . . 71.53 110.452 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.64 162.8 17.44 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.632 1.173 . . . . 73.22 108.662 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.437 ' HB2' ' HD2' ' B' ' 56' ' ' TYR . 64.1 p -143.22 160.93 39.54 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.184 -0.672 . . . . 71.31 109.184 170.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.0 p -152.16 135.6 16.02 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.509 0.724 . . . . 64.33 109.426 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.33 124.95 29.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.08 0.552 . . . . 71.23 110.215 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 64.6 mt -86.96 -44.68 11.44 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.672 -0.492 . . . . 74.43 109.672 172.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.96 -175.63 5.47 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.675 -0.693 . . . . 64.5 111.098 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.48 124.32 21.02 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.524 -1.216 . . . . 73.04 109.443 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 67.29 19.59 10.2 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.563 1.145 . . . . 72.13 111.663 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -131.27 125.82 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.166 0.986 . . . . 73.42 109.464 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.437 ' HD2' ' HB2' ' B' ' 48' ' ' SER . 0.2 OUTLIER -131.81 140.51 49.18 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.977 -0.749 . . . . 74.34 108.977 174.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -112.41 106.67 15.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.982 -1.488 . . . . 73.43 106.982 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.4 t -93.74 140.66 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.921 0.488 . . . . 73.53 109.924 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.77 135.34 57.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 124.41 1.084 . . . . 72.3 109.062 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.07 109.87 16.41 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.82 -1.178 . . . . 74.23 107.82 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.497 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.2 ttt180 -95.38 123.64 39.01 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.813 0.845 . . . . 75.12 109.727 173.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.474 ' HB ' HD11 ' B' ' 114' ' ' ILE . 15.2 t -118.34 123.85 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.347 -0.982 . . . . 70.03 108.347 171.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 39.6 m -107.85 140.78 40.43 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.676 1.19 . . . . 73.31 109.455 -178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.549 HG22 HG21 ' B' ' 114' ' ' ILE . 97.8 t -133.13 100.59 3.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 124.155 0.982 . . . . 72.24 108.715 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 70.8 m -84.0 138.88 32.88 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.023 -1.102 . . . . 54.45 108.023 167.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.495 ' HB1' HG12 ' B' ' 40' ' ' VAL . . . -147.69 149.39 32.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.985 0.357 . . . . 70.32 110.459 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 62.5 p -152.11 135.91 16.3 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.834 0.709 . . . . 70.51 111.541 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 43.6 mt -103.21 117.35 34.34 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.182 0.993 . . . . 75.12 108.942 173.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.04 -112.69 5.13 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.244 -0.889 . . . . 65.03 112.189 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -115.88 4.21 13.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.691 0.796 . . . . 75.31 111.703 -175.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.511 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.8 pt-20 -118.96 158.72 25.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.591 0.756 . . . . 73.25 110.012 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.5 m -64.56 138.25 58.3 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.615 0.572 . . . . 74.34 110.792 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.428 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -96.71 -65.11 0.99 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.337 -0.847 . . . . 72.21 108.811 171.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -149.82 155.29 39.83 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.368 -0.833 . . . . 74.05 109.721 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 41.4 mt -131.98 108.56 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.232 -1.766 . . . . 74.23 106.232 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.457 ' SG ' HG22 ' B' ' 114' ' ' ILE . 49.4 t -118.82 139.46 51.57 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.693 -0.854 . . . . 63.45 108.693 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -159.69 133.78 7.47 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.29 -0.633 . . . . 65.11 109.29 -173.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.7 t -124.62 146.48 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.126 -0.943 . . . . 73.33 109.019 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.441 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 29.1 mt-30 -122.3 84.12 2.21 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.076 -1.083 . . . . 71.22 108.076 171.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -81.75 101.06 9.88 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.721 -1.127 . . . . 73.31 109.473 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.2 167.78 30.58 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 111.9 -0.48 . . . . 44.35 111.9 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.87 126.81 1.66 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.109 -0.796 . . . . 62.2 111.109 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.414 HG13 ' HE1' ' B' ' 17' ' ' TYR . 65.6 mt -84.83 127.78 39.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.605 -0.887 . . . . 73.42 108.605 174.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -134.87 146.36 49.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.153 0.981 . . . . 75.13 108.618 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -99.94 106.9 18.76 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.883 -0.784 . . . . 72.35 108.883 170.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.6 ' HB ' HD12 ' B' ' 89' ' ' ILE . 48.4 pt -116.06 130.41 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.171 0.588 . . . . 64.01 110.239 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.564 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -149.52 159.9 43.92 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.559 0.744 . . . . 63.22 110.304 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.99 -54.32 4.73 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.741 -0.663 . . . . 63.0 112.692 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.6 HD12 ' HB ' ' B' ' 86' ' ' ILE . 17.6 pt -54.23 138.56 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.736 1.214 . . . . 73.54 112.798 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -162.8 172.5 15.11 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.793 -1.094 . . . . 71.43 109.749 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.42 -109.93 2.94 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.994 -0.548 . . . . 61.32 112.282 -173.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.2 m -89.61 -26.62 20.68 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.481 0.712 . . . . 75.5 110.946 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.464 ' HB3' HG23 ' B' ' 89' ' ' ILE . 48.5 mt-30 -58.52 -46.08 87.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.394 0.616 . . . . 71.35 110.049 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.407 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 0.0 OUTLIER -70.32 -35.29 73.55 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.584 -1.189 . . . . 71.14 110.507 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.72 -47.85 84.03 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 124.119 0.887 . . . . 62.42 109.954 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -62.24 -27.8 69.25 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.263 -1.335 . . . . 74.43 111.306 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 t -76.06 -66.93 0.73 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.008 0.523 . . . . 73.12 110.888 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' B' ' 94' ' ' MET . 1.5 pp -71.83 -22.54 61.53 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 112.92 0.711 . . . . 64.41 112.92 -173.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.6 -1.21 53.04 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.553 -0.582 . . . . 74.34 114.058 -175.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.98 -64.43 0.19 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.608 0.704 . . . . 73.01 111.755 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.535 ' HH ' ' HG2' ' D' ' 130' ' ' PRO . 35.1 t80 -59.91 -55.03 39.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.314 1.045 . . . . 75.33 112.021 -168.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.442 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 92.1 m -59.52 -52.09 76.6 Favored Pre-proline 0 CA--C 1.568 1.665 0 C-N-CA 124.397 1.079 . . . . 72.05 112.097 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 71.1 Cg_exo -54.92 -40.5 85.23 Favored 'Trans proline' 0 C--N 1.404 3.485 0 C-N-CA 122.433 2.089 . . . . 74.2 114.393 172.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -63.89 -24.18 67.64 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.888 0.699 . . . . 73.43 112.888 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.53 -43.98 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.603 -0.517 . . . . 71.01 109.603 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 60.8 mt -76.71 -21.99 54.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.55 -1.205 . . . . 71.52 112.015 -173.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -60.57 -48.38 93.58 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 118.073 -0.965 . . . . 74.42 113.283 -171.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.28 -39.5 86.54 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.987 1.791 . . . . 74.53 113.277 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -66.57 -45.83 78.03 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.193 0.597 . . . . 75.32 110.684 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.88 -34.75 78.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.278 0.631 . . . . 64.2 111.045 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.706 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 39.1 ttt180 -63.62 -54.33 37.55 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.143 1.377 . . . . 64.11 111.178 -177.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.39 -33.9 76.74 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.716 0.635 . . . . 73.53 109.821 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.542 ' SG ' HD13 ' B' ' 21' ' ' ILE . 7.4 t -66.73 -31.52 72.23 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.146 0.578 . . . . 72.3 111.907 -177.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.565 HD13 HD22 ' B' ' 128' ' ' LEU . 80.5 mt -70.45 -58.66 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 109.033 -0.729 . . . . 75.51 109.033 172.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.6 m -59.02 -26.63 64.72 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 124.29 0.994 . . . . 75.41 111.825 -173.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 36.3 t -60.52 -56.6 19.36 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.205 1.002 . . . . 64.54 109.268 173.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.3 mmt -67.48 -34.21 76.69 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.655 0.782 . . . . 75.31 111.375 -173.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 114' ' ' ILE . 94.0 t -59.71 -49.69 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.958 0.903 . . . . 70.34 110.121 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.7 t -66.31 -34.75 78.7 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.651 -1.158 . . . . 73.22 111.363 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -65.46 -35.84 82.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.388 0.675 . . . . 74.45 110.337 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.52 15.07 53.13 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 123.923 0.764 . . . . 70.0 112.96 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.412 HG21 ' HB3' ' A' ' 17' ' ' TYR . 69.3 p 54.37 26.78 7.33 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.959 1.704 . . . . 73.44 113.608 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -85.3 151.16 56.11 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.357 0.663 . . . . 63.22 110.906 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.61 167.71 1.34 Allowed 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 124.049 3.166 . . . . 64.12 115.315 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -63.85 114.83 4.31 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.036 -0.984 . . . . 75.22 112.548 -167.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 17.0 tp -116.28 98.49 6.62 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 115.432 -0.804 . . . . 72.41 109.501 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -97.37 95.96 8.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.25 -1.018 . . . . 75.43 108.25 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.706 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 31.8 tp -55.18 116.87 3.04 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.352 0.661 . . . . 74.34 110.69 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.62 146.18 88.17 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.886 0.874 . . . . 64.3 111.582 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -76.61 110.71 3.1 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.328 2.685 . . . . 75.5 111.923 -173.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.2 t -90.82 111.0 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 108.576 -0.898 . . . . 74.24 108.576 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -78.75 110.81 14.25 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -69.5 -48.66 59.86 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.581 0.55 . . . . 72.51 110.619 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -56.95 -40.78 77.08 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.187 0.995 . . . . 73.54 112.442 -171.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.43 -53.84 53.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.211 1.004 . . . . 71.12 111.384 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.5 mp -84.64 -11.98 54.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.493 -0.776 . . . . 74.1 111.664 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 66.7 t80 . . . . . 0 N--CA 1.48 1.026 0 C-N-CA 123.16 0.584 . . . . 65.02 110.272 -179.921 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 32.4 m . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 109.029 -0.73 . . . . 73.31 109.029 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.549 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 3.5 t80 -121.14 124.2 44.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.487 0.715 . . . . 74.1 109.896 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -140.61 140.16 35.03 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.165 -1.05 . . . . 74.12 108.165 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 68.0 mt -85.96 129.74 37.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.159 -0.682 . . . . 74.22 109.159 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.495 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.1 mm-40 -87.94 -45.43 10.24 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.64 0.776 . . . . 75.35 109.727 178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -169.7 148.21 3.59 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.024 -0.534 . . . . 73.14 109.667 -172.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.4 mt -137.58 136.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.747 -1.205 . . . . 73.24 107.747 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -169.74 161.03 9.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.007 0.432 . . . . 75.22 111.838 -172.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.9 p -80.39 108.06 13.7 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.095 -0.705 . . . . 75.54 109.095 170.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -68.34 -37.3 80.39 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.445 -0.576 . . . . 73.14 109.445 172.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 12.8 t70 -149.78 150.27 31.78 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.49 -0.777 . . . . 70.25 109.83 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.5 mt -141.63 146.94 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.34 1.456 . . . . 61.32 107.62 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -152.19 142.37 22.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.484 0.714 . . . . 73.2 109.563 173.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -142.9 137.86 29.8 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.618 -1.253 . . . . 75.45 107.618 170.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.08 121.68 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.365 1.066 . . . . 74.33 109.293 -172.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.34 69.11 13.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 106.12 -1.807 . . . . 74.41 106.12 165.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.22 -10.35 27.09 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.555 2.17 . . . . 74.25 112.178 -174.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -123.23 26.38 8.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.664 1.585 . . . . 70.35 109.774 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.61 -58.12 4.06 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 114.64 1.348 . . . . 72.31 114.64 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.57 -33.32 46.18 Favored 'Trans proline' 0 C--N 1.388 2.609 0 CA-C-N 121.844 1.694 . . . . 73.03 112.362 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -69.41 -37.53 77.51 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.846 0.859 . . . . 75.11 111.575 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -79.31 -26.33 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 112.513 0.56 . . . . 74.5 112.513 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.25 -31.87 73.24 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 112.212 0.449 . . . . 75.12 112.212 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -85.79 9.55 16.23 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.542 0.337 . . . . 72.04 111.881 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.62 166.1 11.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.484 0.714 . . . . 74.55 111.037 -175.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -58.2 127.53 32.58 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.003 0.921 . . . . 65.33 110.018 170.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.456 ' NE1' ' HG2' ' C' ' 124' ' ' PRO . 32.9 t90 -84.95 93.24 8.51 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.613 0.765 . . . . 73.21 109.831 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -150.47 78.73 7.59 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 108.51 -0.922 . . . . 74.23 108.51 164.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.56 136.95 37.85 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.681 2.254 . . . . 72.01 112.183 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -86.21 93.43 9.04 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 105.359 -2.089 . . . . 61.23 105.359 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 17.0 m -68.6 131.41 33.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 115.368 -0.833 . . . . 75.21 109.755 -176.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 tptt -134.9 129.62 34.64 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.526 -1.657 . . . . 74.23 106.526 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.552 HD21 HD13 ' C' ' 128' ' ' LEU . 2.8 tm? -116.32 139.68 50.13 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.508 -0.923 . . . . 75.35 108.508 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.525 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.2 t70 -134.4 141.2 46.76 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.453 1.101 . . . . 61.05 108.971 -177.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 79.6 mt -132.11 137.15 47.61 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.309 1.044 . . . . 73.33 108.917 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 27.3 t70 -144.81 155.23 43.39 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.11 0.964 . . . . 74.24 109.201 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 5.1 m -151.1 138.55 19.51 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.29 1.036 . . . . 62.43 109.577 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.67 173.92 10.17 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.742 1.217 . . . . 62.12 108.926 175.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -159.95 153.95 23.18 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.65 0.78 . . . . 71.21 110.039 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.8 p -155.3 137.54 14.8 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.258 0.623 . . . . 65.54 109.434 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -77.32 118.8 20.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.053 -0.721 . . . . 74.3 109.053 174.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' C' ' 57' ' ' GLU . 54.1 mt -93.35 -43.16 8.92 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.348 -0.612 . . . . 72.33 109.348 176.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.423 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -148.79 -177.89 6.05 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.227 -0.897 . . . . 75.12 110.919 -177.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.91 123.8 21.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.722 -1.126 . . . . 74.21 109.101 175.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 61.27 18.81 9.55 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.444 1.098 . . . . 65.01 112.056 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 77.4 t -127.88 103.67 10.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 124.351 1.06 . . . . 73.02 109.238 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.496 ' HD1' HD13 ' C' ' 86' ' ' ILE . 24.7 m-85 -102.3 146.49 27.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.489 -0.778 . . . . 74.34 108.986 169.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.65 ' HB2' HD12 ' C' ' 51' ' ' LEU . 35.0 tt0 -94.35 129.07 41.18 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.408 -1.33 . . . . 71.04 107.408 160.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 42.4 t -106.27 143.4 17.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.993 -1.114 . . . . 74.3 107.993 165.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.0 t -121.28 140.66 44.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 107.931 -1.137 . . . . 75.25 107.931 172.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -129.71 106.97 9.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.553 -1.277 . . . . 73.41 107.553 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 58.7 ttt-85 -95.41 122.64 38.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.993 -1.458 . . . . 74.23 108.83 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.9 t -117.27 132.35 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.013 -1.106 . . . . 74.11 108.013 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.8 m -134.12 128.95 35.18 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.3 0.64 . . . . 74.22 109.715 -174.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.571 HG21 HD12 ' C' ' 114' ' ' ILE . 61.6 t -115.64 121.03 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.839 0.856 . . . . 74.54 109.712 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.7 m -100.81 145.36 28.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.476 0.71 . . . . 74.53 109.179 170.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.98 131.37 32.85 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.792 -1.188 . . . . 62.01 107.792 169.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.7 m -139.95 129.17 23.83 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 123.598 0.561 . . . . 72.45 110.266 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 37.1 mt -85.22 41.5 0.89 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.319 1.048 . . . . 72.3 109.704 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.73 -104.17 2.54 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 110.053 -1.219 . . . . 75.12 110.053 -170.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -93.8 -29.72 15.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.263 1.025 . . . . 74.43 110.003 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -73.14 120.17 18.4 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.823 0.849 . . . . 71.14 110.268 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 35.7 m -75.88 129.64 37.29 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.568 -0.53 . . . . 73.44 109.568 173.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.605 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.27 -60.95 2.07 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.398 -0.964 . . . . 73.22 108.398 170.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -158.09 173.77 16.23 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 114.417 -1.265 . . . . 73.44 111.436 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -138.89 130.04 26.79 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.572 -1.64 . . . . 74.23 106.572 162.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 46.0 t -128.35 138.73 52.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.946 -1.131 . . . . 74.43 107.946 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -154.54 129.07 9.19 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.522 -0.548 . . . . 75.52 109.522 -170.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' C' ' 61' ' ' ARG . 97.2 t -135.03 114.3 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.689 0.796 . . . . 72.01 109.921 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.402 ' OE1' ' HG3' ' C' ' 61' ' ' ARG . 1.7 mp0 -90.08 87.84 7.04 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.531 -0.915 . . . . 75.15 108.531 174.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -83.21 98.77 9.55 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.308 -0.86 . . . . 72.43 109.662 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.42 159.49 38.86 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.441 -0.664 . . . . 72.33 111.441 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.46 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -161.25 118.83 0.85 Allowed Glycine 0 CA--C 1.504 -0.614 0 N-CA-C 111.047 -0.821 . . . . 74.31 111.047 -177.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.524 HD13 HD12 ' C' ' 51' ' ' LEU . 6.9 mm -84.1 121.13 36.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.334 -0.987 . . . . 74.2 108.334 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.549 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 57.6 m-85 -126.58 118.46 24.89 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.421 -0.955 . . . . 75.32 108.421 -177.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 54.5 p -87.95 105.87 17.74 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.688 -0.856 . . . . 64.0 108.688 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.529 HD11 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -116.97 125.9 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.038 0.935 . . . . 73.22 109.341 -176.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.96 163.93 32.05 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.473 0.709 . . . . 61.34 110.697 -172.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.04 -41.99 2.88 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 115.519 -0.764 . . . . 71.14 113.111 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 46.9 mm -122.73 150.4 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.901 0.88 . . . . 73.44 110.421 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.52 -174.22 4.34 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.179 0.992 . . . . 73.41 111.544 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.64 -138.17 25.62 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 115.414 -0.812 . . . . 74.13 113.778 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 53.5 p -61.87 -29.12 69.98 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.152 0.981 . . . . 73.51 111.113 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -70.04 -44.71 68.66 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.471 -1.24 . . . . 75.53 111.326 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -73.7 -30.45 62.88 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 110.17 -0.307 . . . . 74.25 110.17 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.4 81.11 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.134 0.574 . . . . 64.22 109.615 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.402 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 11.3 t-160 -72.17 -41.05 67.49 Favored 'General case' 0 C--O 1.241 0.636 0 O-C-N 123.464 0.478 . . . . 71.14 110.935 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -59.5 -38.18 80.23 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.272 0.983 . . . . 72.32 111.119 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 37.4 mt -101.13 -23.48 14.46 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.356 0.662 . . . . 74.1 112.417 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.78 -23.74 57.2 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 116.138 -0.483 . . . . 70.23 114.107 -170.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.64 -43.47 0.1 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.148 0.499 . . . . 74.33 111.034 -171.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.465 ' HH ' ' HD1' ' C' ' 11' ' ' PHE . 55.8 t80 -66.34 -42.79 87.61 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.425 1.49 . . . . 75.11 112.729 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 33.8 m -73.76 -43.48 6.61 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-O 118.832 -0.604 . . . . 53.33 112.277 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -51.22 -31.83 38.2 Favored 'Trans proline' 0 C--N 1.393 2.873 0 C-N-CA 122.361 2.041 . . . . 73.13 114.201 167.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' C' ' 134' ' ' ASP . 74.7 m-20 -64.17 -35.18 79.95 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.854 0.862 . . . . 74.42 111.712 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.489 HD13 ' NH1' ' A' ' 111' ' ' ARG . 50.8 mm -68.43 -38.69 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.281 0.563 . . . . 73.52 109.723 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.46 HD21 ' HA3' ' C' ' 82' ' ' GLY . 90.9 mt -80.56 -22.71 40.53 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.725 -1.125 . . . . 73.55 112.736 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.475 ' HZ ' HD22 ' C' ' 128' ' ' LEU . 45.7 t80 -59.48 -49.73 90.84 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-O 117.75 -1.119 . . . . 75.14 113.631 -173.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -53.02 -36.68 76.91 Favored 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 122.44 2.094 . . . . 72.42 114.006 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.44 ' HE2' HG21 ' A' ' 115' ' ' THR . 61.8 m-85 -69.3 -52.88 23.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.763 0.825 . . . . 71.32 110.763 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.3 81.66 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.148 -0.933 . . . . 62.21 111.142 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -59.11 -54.96 41.05 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.657 1.583 . . . . 72.51 110.814 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -67.75 -33.72 75.4 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.554 0.742 . . . . 75.41 110.251 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 28.1 t -68.58 -31.84 71.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.03 0.532 . . . . 74.11 111.496 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.571 HD12 HG21 ' C' ' 64' ' ' VAL . 64.2 mt -68.92 -52.44 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.129 -0.487 . . . . 65.14 109.993 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 3.6 m -65.49 -28.83 69.48 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 123.741 0.651 . . . . 72.42 111.24 -174.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 46.3 t -66.53 -49.31 66.92 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 123.771 0.828 . . . . 51.4 109.413 171.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.621 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.09 -40.72 86.16 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.804 1.242 . . . . 75.01 112.917 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 39.2 t -67.75 -42.48 86.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.323 1.049 . . . . 71.54 110.351 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.0 t -70.0 -27.22 64.51 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.716 -0.675 . . . . 52.44 111.154 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.479 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.1 mtt-85 -68.38 -36.85 79.78 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.807 0.843 . . . . 74.44 108.93 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.39 9.26 67.98 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 124.052 0.845 . . . . 74.31 112.834 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 57.0 p 55.52 36.61 27.5 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.614 1.565 . . . . 73.31 113.759 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.64 158.03 34.32 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.916 0.887 . . . . 72.23 109.243 172.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.456 ' HG2' ' NE1' ' C' ' 36' ' ' TRP . 34.6 Cg_exo -61.52 157.7 40.21 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 122.993 2.462 . . . . 73.12 113.882 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -60.18 141.24 56.25 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.448 1.099 . . . . 73.23 113.184 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.534 HD21 HG12 ' C' ' 64' ' ' VAL . 0.5 OUTLIER -134.72 96.7 3.6 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.961 -1.018 . . . . 75.3 109.816 170.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -90.65 95.62 10.24 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.288 -1.005 . . . . 75.53 108.288 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.552 HD13 HD21 ' C' ' 42' ' ' LEU . 1.3 tt -60.49 129.36 41.21 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.498 1.119 . . . . 74.24 110.628 -172.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.86 148.72 98.44 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.373 0.669 . . . . 72.54 111.284 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.533 ' HG3' HD12 ' A' ' 16' ' ' ILE . 50.1 Cg_exo -54.29 117.56 4.06 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.783 2.322 . . . . 64.43 112.693 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.35 118.21 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.822 -0.807 . . . . 74.41 108.822 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.91 88.56 4.71 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.089 0.556 . . . . 73.44 109.935 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -73.82 -45.25 52.49 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.072 -0.714 . . . . 73.14 109.072 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.501 ' HB2' ' ND2' ' C' ' 104' ' ' ASN . 20.6 t70 -66.98 -41.64 86.44 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.277 -1.328 . . . . 72.45 111.707 -168.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.86 94.19 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.755 -1.111 . . . . 63.12 112.075 -177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.31 -26.44 46.93 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 116.035 -0.53 . . . . 71.12 112.378 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . 0.402 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 11.2 t80 . . . . . 0 N--CA 1.484 1.263 0 C-N-CA 122.717 0.407 . . . . 71.04 110.742 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 57.5 m . . . . . 0 C--O 1.238 0.461 0 N-CA-C 109.371 -0.603 . . . . 72.33 109.371 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -157.46 96.21 1.52 Allowed 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.879 -1.156 . . . . 73.34 107.879 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -113.67 130.15 56.45 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.292 -1.373 . . . . 75.4 107.292 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.408 HG21 HD13 ' D' ' 16' ' ' ILE . 39.9 mt -73.21 119.28 19.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.503 -0.925 . . . . 73.45 108.503 176.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -87.06 -30.97 20.76 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.462 0.476 . . . . 72.35 110.651 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -176.55 139.59 0.33 Allowed 'General case' 0 C--N 1.369 1.443 0 C-N-CA 122.483 0.313 . . . . 75.53 110.53 -170.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.408 HD13 HG21 ' D' ' 13' ' ' ILE . 3.1 mp -120.89 134.58 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.76 -1.2 . . . . 71.22 107.76 172.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -161.3 172.42 16.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.948 0.88 . . . . 71.0 111.919 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 45.7 p -104.34 124.3 48.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.758 -1.11 . . . . 72.21 109.221 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -94.55 -20.04 19.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.334 0.654 . . . . 75.33 110.186 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.715 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 3.7 t70 -158.66 135.18 9.39 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.139 -1.06 . . . . 40.11 108.139 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.621 HG21 ' HE1' ' C' ' 117' ' ' MET . 72.6 mt -135.9 145.33 31.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.068 -1.086 . . . . 73.33 108.068 175.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -151.21 144.1 24.51 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.897 0.748 . . . . 73.35 109.325 172.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.0 t80 -145.13 115.61 7.62 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 105.939 -1.875 . . . . 73.55 105.939 168.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.575 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 22.9 mt-10 -119.86 110.65 16.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.934 -0.765 . . . . 72.11 108.934 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.52 88.36 4.1 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.842 -1.17 . . . . 61.45 107.842 172.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.88 -28.78 7.48 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.744 2.296 . . . . 64.22 112.754 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -114.67 17.97 16.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.517 1.127 . . . . 73.13 109.96 -171.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.63 -67.53 0.33 Allowed Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 114.85 1.426 . . . . 52.12 114.85 -160.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.509 ' HB3' HD11 ' C' ' 83' ' ' ILE . 87.7 Cg_endo -73.82 -15.62 23.81 Favored 'Trans proline' 0 C--N 1.39 2.722 0 CA-C-N 122.426 1.902 . . . . 65.44 113.54 -173.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -78.45 -45.2 22.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.45 1.1 . . . . 72.53 110.736 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.04 -24.59 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 CA-C-N 115.986 -0.552 . . . . 71.55 111.617 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -52.87 -31.27 38.61 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 123.797 0.839 . . . . 73.41 113.004 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -53.01 -24.28 9.21 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.627 1.171 . . . . 72.42 111.916 -176.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -83.41 96.38 8.53 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.441 1.096 . . . . 73.4 110.066 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -74.88 83.54 2.19 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.52 0.676 . . . . 63.41 110.078 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.402 ' HD1' HD21 ' D' ' 68' ' ' LEU . 61.1 t-105 -155.89 156.94 35.5 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.017 1.327 . . . . 73.05 107.915 -176.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -82.21 112.2 34.02 Favored Pre-proline 0 N--CA 1.483 1.198 0 N-CA-C 109.147 -0.686 . . . . 72.35 109.147 173.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.1 124.85 16.87 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.416 2.744 . . . . 73.54 113.917 -173.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -62.1 120.36 10.73 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.021 1.329 . . . . 74.35 110.894 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.527 HG23 HG13 ' D' ' 64' ' ' VAL . 7.2 p -95.43 127.44 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.466 0.65 . . . . 74.41 110.882 -170.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -119.61 106.78 12.51 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 105.988 -1.856 . . . . 72.54 105.988 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.477 ' H ' HD22 ' D' ' 42' ' ' LEU . 1.3 pt? -110.72 134.44 52.47 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.945 0.498 . . . . 75.13 110.612 -170.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.72 126.4 52.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.455 0.702 . . . . 74.3 109.198 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -100.81 137.09 39.67 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.162 0.985 . . . . 74.51 109.75 -175.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.9 t70 -153.9 139.13 17.49 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.437 -0.949 . . . . 72.32 108.437 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.7 t -117.24 155.65 29.09 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.094 0.473 . . . . 71.12 110.095 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.425 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -151.54 176.22 11.54 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.42 1.088 . . . . 75.43 108.866 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.5 p -174.21 161.36 3.51 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.82 0.448 . . . . 44.51 111.989 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 28.4 t -157.04 124.04 5.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.605 1.162 . . . . 63.03 109.806 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -78.73 123.72 27.46 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.454 -0.573 . . . . 74.54 109.454 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 38.5 mt -94.08 -32.8 13.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.16 0.584 . . . . 72.31 109.954 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.62 -176.73 4.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.775 1.23 . . . . 64.3 108.922 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.71 135.05 36.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.093 -1.077 . . . . 73.03 108.093 171.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 74.28 -0.19 3.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.412 1.485 . . . . 74.1 111.605 -174.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.0 t -129.79 118.54 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.125 0.97 . . . . 72.51 108.782 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -141.86 128.55 20.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.702 -0.481 . . . . 74.31 109.702 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -94.23 140.26 30.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.893 0.877 . . . . 75.25 109.316 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -122.75 138.56 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.971 -1.122 . . . . 73.45 107.971 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 59.6 t -111.55 143.19 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.541 1.136 . . . . 74.01 108.388 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.51 123.58 41.58 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.506 -0.924 . . . . 71.02 108.506 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.537 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.4 ttm-85 -102.57 96.0 6.61 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.108 -1.071 . . . . 75.34 108.108 176.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 78.2 t -99.47 128.94 50.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.327 -0.99 . . . . 71.24 108.327 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 3.6 m -120.93 144.06 48.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.226 -1.027 . . . . 73.42 108.226 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.527 HG13 HG23 ' D' ' 40' ' ' VAL . 53.3 t -136.66 101.83 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.443 -1.317 . . . . 74.14 107.443 -174.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 88.5 m -107.33 97.69 7.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.17 0.988 . . . . 74.53 108.571 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.08 152.83 18.38 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.817 -0.628 . . . . 75.12 110.958 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.442 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.7 m -144.05 130.68 20.11 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.715 -0.675 . . . . 73.41 110.518 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.402 HD21 ' HD1' ' D' ' 36' ' ' TRP . 32.5 mt -91.82 101.09 13.68 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.833 -1.543 . . . . 73.13 106.833 171.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.71 -128.64 12.74 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.625 0.578 . . . . 61.44 112.383 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.3 5.73 43.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.826 0.85 . . . . 74.11 111.804 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -123.88 140.94 52.49 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.592 0.757 . . . . 73.34 110.604 -171.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.2 m -58.16 125.73 24.44 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.106 0.962 . . . . 75.2 110.721 175.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.442 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.14 -74.72 0.43 Allowed 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.908 -1.145 . . . . 75.35 107.908 175.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . 0.496 ' HZ ' HD23 ' D' ' 126' ' ' LEU . 54.4 p90 -140.86 154.3 46.12 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-O 121.543 0.687 . . . . 72.04 110.221 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 39.7 mt -115.86 147.25 41.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.352 -1.722 . . . . 71.44 106.352 172.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.612 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 23.5 t -160.25 127.79 4.53 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 109.681 -0.488 . . . . 75.22 109.681 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -142.27 124.14 15.21 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.623 -0.51 . . . . 73.45 109.623 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.19 122.7 62.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 C-N-CA 123.464 0.706 . . . . 73.35 109.641 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.715 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 21.1 mt-30 -88.12 88.92 7.79 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.159 -1.052 . . . . 73.2 108.159 164.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.13 101.0 8.52 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.406 -1.27 . . . . 72.33 108.903 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.74 148.25 20.3 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.853 -0.499 . . . . 53.42 111.853 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.521 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -147.54 128.99 3.07 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 111.371 -0.692 . . . . 62.11 111.371 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.9 mt -91.76 141.75 14.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.547 -0.909 . . . . 73.05 108.547 174.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -139.43 129.47 25.07 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.459 0.703 . . . . 74.12 110.09 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -74.24 99.12 3.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.145 0.578 . . . . 65.45 109.687 168.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 9.4 tt -122.02 118.63 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-O 121.364 0.602 . . . . 74.11 110.9 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.0 167.92 21.03 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.454 1.102 . . . . 74.44 109.31 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.4 24.94 66.88 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-O 119.906 -0.386 . . . . 74.1 113.439 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.28 156.41 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.981 0.912 . . . . 74.25 111.682 -175.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.28 171.73 4.71 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.412 1.085 . . . . 72.32 110.717 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.21 -118.65 12.9 Favored Glycine 0 C--N 1.355 1.629 0 N-CA-C 114.894 0.718 . . . . 74.03 114.894 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.2 m -82.64 -28.96 30.37 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.234 0.614 . . . . 74.02 110.599 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -66.76 -42.36 86.29 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.269 0.628 . . . . 71.32 111.335 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.4 ' O ' ' HB2' ' D' ' 98' ' ' LEU . 25.9 ptt? -62.5 -39.45 93.52 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.878 -0.601 . . . . 73.44 110.244 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.77 74.53 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.543 0.737 . . . . 73.31 110.954 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -67.08 -30.36 70.38 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.76 0.824 . . . . 74.21 110.9 -176.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -79.92 -47.09 15.6 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.717 -0.674 . . . . 72.33 110.304 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' D' ' 94' ' ' MET . 4.7 tt -69.58 -55.25 10.63 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.29 1.036 . . . . 74.04 111.575 -168.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.97 10.82 73.65 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.964 -0.562 . . . . 64.32 114.09 -171.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.704 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -140.14 -65.85 0.45 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 117.346 0.573 . . . . 71.45 111.306 -175.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -70.8 -43.86 67.77 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.376 -0.829 . . . . 72.42 111.776 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -63.51 -50.02 75.11 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 124.012 0.925 . . . . 74.42 112.614 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.21 -21.9 30.78 Favored 'Trans proline' 0 C--N 1.397 3.114 0 C-N-CA 121.865 1.71 . . . . 75.13 112.907 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' D' ' 100' ' ' ALA . 0.2 OUTLIER -68.53 -32.8 73.0 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.989 0.516 . . . . 72.51 110.21 178.279 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 57.6 mt -67.6 -36.76 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 124.324 1.05 . . . . 72.32 110.643 173.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.521 HD22 ' HA3' ' D' ' 82' ' ' GLY . 89.2 mt -76.11 -18.17 59.28 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.126 -0.943 . . . . 75.33 112.392 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -68.21 -45.36 39.35 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 113.662 0.986 . . . . 74.43 113.662 -173.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -53.24 -38.87 82.1 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.324 2.016 . . . . 71.53 113.702 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -77.99 -33.35 51.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.703 0.801 . . . . 74.42 111.935 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.08 64.58 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.067 -0.716 . . . . 75.12 109.067 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -53.7 -48.08 69.9 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 124.813 1.321 . . . . 72.12 110.602 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.49 -52.13 66.52 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.329 0.652 . . . . 72.52 111.305 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.76 -44.33 77.55 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 124.081 0.863 . . . . 75.24 110.99 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.496 HG12 ' SG ' ' D' ' 76' ' ' CYS . 32.7 mt -62.26 -60.12 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.929 0.892 . . . . 70.01 110.855 174.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 93.7 m -51.67 -39.55 58.44 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.113 1.365 . . . . 75.11 112.214 -173.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 48.4 t -67.08 -44.49 79.92 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.018 -0.992 . . . . 74.11 110.022 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.612 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.9 mtm -68.02 -26.41 65.88 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.174 0.59 . . . . 74.3 112.184 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.459 HG22 ' O ' ' D' ' 114' ' ' ILE . 80.0 t -67.81 -45.59 83.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.75 0.82 . . . . 73.21 109.784 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.9 p -73.84 -26.85 60.79 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.843 -0.617 . . . . 74.12 111.054 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -70.16 -37.16 75.14 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.613 0.765 . . . . 74.11 109.481 173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.48 11.2 61.92 Favored Glycine 0 C--N 1.357 1.704 0 O-C-N 123.986 0.804 . . . . 74.24 112.732 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 67.5 p 58.17 16.93 4.21 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 126.815 2.046 . . . . 73.0 115.093 174.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -79.49 146.98 66.97 Favored Pre-proline 0 C--O 1.243 0.719 0 N-CA-C 107.961 -1.125 . . . . 73.42 107.961 166.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.67 138.43 14.67 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 123.534 2.823 . . . . 74.35 112.757 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -64.68 120.04 11.68 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 123.767 0.667 . . . . 74.04 110.49 -174.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.496 HD23 ' HZ ' ' D' ' 74' ' ' PHE . 4.8 mp -104.63 101.96 11.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.959 -0.756 . . . . 74.43 108.959 -176.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -100.64 93.51 5.62 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.437 -0.949 . . . . 74.15 108.437 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.29 133.48 47.03 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.914 0.886 . . . . 71.31 110.23 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.3 137.65 95.6 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.885 0.474 . . . . 75.15 110.657 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.535 ' HG2' ' HH ' ' B' ' 101' ' ' TYR . 72.7 Cg_endo -70.79 130.04 17.45 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.841 2.361 . . . . 71.44 112.339 -173.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.71 140.74 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.423 0.689 . . . . 74.43 110.268 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -97.01 108.37 21.09 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.095 0.958 . . . . 75.33 109.73 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -76.51 -21.11 56.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.371 0.668 . . . . 64.35 111.401 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . 0.704 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 9.9 t70 -65.81 -49.91 66.53 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.527 0.731 . . . . 75.12 111.744 -171.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.1 89.87 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.842 0.714 . . . . 74.41 111.372 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.7 mp -81.01 -17.19 51.15 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.535 -1.212 . . . . 75.41 111.732 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 81.8 t80 . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 109.439 -0.578 . . . . 74.42 109.439 173.136 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.707 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 31.3 m . . . . . 0 C--O 1.239 0.538 0 N-CA-C 108.711 -0.848 . . . . 74.21 108.711 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.439 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 16.8 t80 -133.68 121.23 21.66 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.898 -1.149 . . . . 73.05 107.898 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -136.97 112.59 9.4 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.037 -0.727 . . . . 75.54 109.037 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.534 HG12 ' HD2' ' A' ' 84' ' ' PHE . 46.3 mt -81.98 114.96 23.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.42 -0.955 . . . . 72.4 108.42 171.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -80.34 -39.26 28.97 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.475 -0.784 . . . . 74.2 109.686 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -168.16 133.16 1.77 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 116.236 -0.438 . . . . 74.12 111.035 -167.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.45 HD13 ' HG3' ' C' ' 130' ' ' PRO . 91.5 mt -119.47 132.13 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.289 1.036 . . . . 63.55 108.304 173.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HB3' HG23 ' B' ' 122' ' ' THR . 24.7 p90 -164.22 176.72 8.94 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.709 0.766 . . . . 73.15 111.427 -171.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.6 p -109.3 118.07 35.72 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.978 -1.01 . . . . 73.32 109.112 177.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -84.87 -26.69 27.18 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.441 -0.345 . . . . 75.41 110.328 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -152.28 132.33 13.45 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.507 -0.769 . . . . 65.25 109.083 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 62.7 mt -128.93 141.81 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.505 -1.294 . . . . 75.31 107.505 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.4 t -151.79 144.21 24.12 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 123.494 0.496 . . . . 74.33 110.831 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.485 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 59.1 t80 -144.6 128.83 17.75 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 106.712 -1.588 . . . . 74.11 106.712 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -135.83 110.72 8.78 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.638 -0.875 . . . . 63.33 108.638 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.84 85.97 8.33 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.99 -1.115 . . . . 75.24 107.99 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.67 -25.76 20.31 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.562 2.175 . . . . 71.42 111.939 -174.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -107.91 31.09 5.77 Favored 'General case' 0 C--O 1.206 -1.2 0 C-N-CA 123.784 0.834 . . . . 72.42 109.846 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.432 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -50.95 -53.98 42.12 Favored Pre-proline 0 CA--C 1.577 2.015 0 N-CA-C 113.64 0.978 . . . . 72.52 113.64 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 2.6 Cg_exo -79.58 -20.54 9.31 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.004 1.803 . . . . 75.41 113.106 173.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -88.0 -29.96 20.35 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.786 0.834 . . . . 72.14 112.131 -167.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.406 HG13 ' HE1' ' A' ' 123' ' ' PHE . 9.2 p -76.52 -13.83 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.101 0.96 . . . . 72.44 110.404 -175.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.49 -37.52 75.7 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.104 0.962 . . . . 74.41 110.857 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -73.54 -27.8 61.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.484 -0.78 . . . . 75.42 111.715 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.504 ' HZ2' ' HG2' ' A' ' 71' ' ' GLU . 31.7 mmtp -81.98 151.89 26.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.418 0.687 . . . . 74.24 112.219 -176.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -64.04 140.48 58.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.617 0.767 . . . . 74.41 109.157 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -80.28 80.66 6.68 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.74 0.781 . . . . 74.11 109.474 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -132.84 72.9 76.64 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.862 -1.063 . . . . 73.23 108.716 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -89.67 149.0 5.07 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.535 2.157 . . . . 72.11 112.002 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -96.41 117.73 31.47 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.259 -1.386 . . . . 73.53 107.259 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.79 112.33 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 123.423 0.689 . . . . 75.43 110.376 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HE3' ' HB2' ' A' ' 43' ' ' ASP . 25.7 ttpt -114.23 130.78 56.63 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.662 -0.866 . . . . 73.12 108.662 172.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.417 HD23 HD23 ' A' ' 128' ' ' LEU . 69.2 tp -96.46 109.98 22.43 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.663 -1.236 . . . . 73.52 107.663 173.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.445 ' HB2' ' HE3' ' A' ' 41' ' ' LYS . 21.9 t70 -102.99 107.71 18.61 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.086 -1.079 . . . . 70.1 108.086 -177.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -96.64 161.36 13.92 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.675 -0.491 . . . . 75.33 109.675 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.598 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 8.9 t0 -153.34 127.11 8.84 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.141 -0.689 . . . . 63.12 109.141 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -105.74 120.45 41.73 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.868 -0.79 . . . . 73.11 108.868 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.17 153.31 51.91 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.052 0.941 . . . . 71.14 108.759 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.0 m -127.2 156.9 41.11 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.856 0.462 . . . . 72.02 110.874 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.1 t -149.23 133.17 17.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.317 0.647 . . . . 72.4 110.139 -171.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -88.05 117.45 26.94 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.83 -0.433 . . . . 63.21 109.83 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 57' ' ' GLU . 48.8 mt -95.57 -36.19 11.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.373 0.669 . . . . 73.24 110.89 -176.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.76 -168.0 0.73 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.984 0.913 . . . . 55.35 111.016 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.26 112.83 3.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.504 1.122 . . . . 74.51 110.856 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 65.39 3.77 2.44 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 124.817 1.247 . . . . 74.1 112.792 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.7 t -104.44 115.28 46.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.051 -1.092 . . . . 73.3 108.051 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.07 168.15 12.73 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.445 -0.946 . . . . 73.11 108.445 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.538 ' HB2' HD12 ' A' ' 51' ' ' LEU . 44.7 tt0 -132.04 147.38 52.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.059 -0.973 . . . . 70.24 108.885 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.432 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 65.4 t -120.87 125.52 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.006 -1.479 . . . . 73.45 107.006 164.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.86 114.62 47.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.123 -1.066 . . . . 75.34 108.123 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.581 HD23 HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -96.69 109.5 22.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.377 -0.972 . . . . 74.33 108.377 178.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.598 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 66.1 ttp85 -83.17 103.86 12.9 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.592 -0.892 . . . . 72.5 108.592 172.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.704 HG21 ' HB1' ' A' ' 110' ' ' ALA . 2.5 m -103.5 103.81 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.631 0.729 . . . . 73.5 109.228 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 m -103.12 117.05 33.68 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.449 1.1 . . . . 71.43 110.096 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 56.1 t -101.09 109.44 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.834 0.854 . . . . 74.11 109.629 176.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.1 m -103.28 108.49 19.73 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.321 -0.622 . . . . 65.45 109.321 175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.47 106.91 14.51 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.017 0.927 . . . . 64.35 108.763 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 m -140.92 148.33 40.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.939 0.496 . . . . 75.32 110.519 -175.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.15 85.68 2.45 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.982 0.896 . . . . 71.11 109.083 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.14 -106.58 2.4 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 114.421 -1.263 . . . . 62.2 112.424 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -96.4 -26.08 15.47 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.331 1.052 . . . . 74.43 110.6 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.504 ' HG2' ' HZ2' ' A' ' 34' ' ' LYS . 8.1 mp0 -92.73 109.17 20.59 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.821 0.849 . . . . 75.13 109.682 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.8 m -72.7 123.88 24.19 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.323 -0.621 . . . . 74.1 109.323 171.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -58.33 5.7 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.065 0.853 . . . . 74.23 108.8 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -158.85 155.77 28.41 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.233 -1.349 . . . . 75.33 109.721 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 64' ' ' VAL . 64.0 tp -126.92 138.21 53.26 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.789 -1.189 . . . . 75.33 107.789 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.565 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 73.7 m -134.43 139.99 45.94 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.095 -1.076 . . . . 73.34 108.095 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -149.35 125.59 10.78 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 117.818 0.281 . . . . 65.23 110.251 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.88 112.0 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.771 0.829 . . . . 72.21 109.819 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.405 ' OE1' ' HG3' ' A' ' 61' ' ' ARG . 2.4 mp0 -87.29 84.32 7.24 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.473 -0.936 . . . . 74.11 108.473 173.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.421 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.2 tp-100 -76.65 95.31 3.94 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 114.629 -1.169 . . . . 75.15 108.678 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.28 143.92 17.21 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.073 -0.811 . . . . 70.24 111.073 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.54 130.87 4.25 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.115 -0.794 . . . . 62.23 111.115 -177.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.0 mt -81.93 123.36 38.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.73 -0.841 . . . . 74.12 108.73 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.534 ' HD2' HG12 ' A' ' 13' ' ' ILE . 32.1 m-85 -130.81 137.38 49.4 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.852 -0.796 . . . . 75.31 108.852 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 m -97.19 116.46 29.44 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.037 -0.727 . . . . 75.33 109.037 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.78 135.15 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.062 -1.088 . . . . 74.42 108.062 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.707 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -164.0 136.72 5.1 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.001 0.921 . . . . 64.02 109.182 169.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.65 -16.38 60.89 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 114.664 0.626 . . . . 50.14 114.664 173.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.511 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -114.03 135.4 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 117.645 0.722 . . . . 72.3 109.734 178.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.604 ' HA ' ' HE2' ' A' ' 94' ' ' MET . 49.4 mt-10 -140.53 172.47 12.68 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.104 0.962 . . . . 73.01 109.998 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.69 -123.78 33.1 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.036 0.835 . . . . 64.2 114.57 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.1 p -78.35 -27.59 47.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.216 1.007 . . . . 71.22 111.583 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -68.34 -36.57 79.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.813 0.845 . . . . 75.3 109.97 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.604 ' HE2' ' HA ' ' A' ' 90' ' ' GLU . 48.3 ttm -69.44 -41.98 75.55 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 116.056 -0.52 . . . . 71.02 110.203 171.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.54 -30.12 69.56 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.988 0.515 . . . . 73.02 111.421 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -71.63 -36.43 70.75 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.244 0.618 . . . . 75.3 110.97 173.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.542 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 99.6 m -67.12 -63.09 1.13 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.815 0.446 . . . . 70.11 111.59 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.15 -17.92 61.33 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.273 0.471 . . . . 73.1 112.273 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.01 -11.96 38.23 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.262 -0.743 . . . . 63.11 114.415 -175.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.04 -52.56 0.19 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.153 0.976 . . . . 74.43 112.965 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.542 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 28.2 t80 -63.37 -56.37 16.9 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.752 1.221 . . . . 74.24 111.491 -172.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.8 m -77.67 -35.41 1.27 Allowed Pre-proline 0 CA--C 1.565 1.555 0 N-CA-C 113.245 0.832 . . . . 73.24 113.245 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.83 -39.73 57.85 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.364 2.043 . . . . 74.11 113.19 163.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -64.06 -35.16 79.82 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.073 0.549 . . . . 75.53 111.376 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -63.25 -42.24 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.787 0.835 . . . . 73.1 110.645 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.421 HD23 ' HG3' ' A' ' 80' ' ' GLN . 85.5 mt -72.57 -30.06 64.09 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.08 -0.964 . . . . 72.21 112.068 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -58.36 -44.21 98.94 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 114.6 1.334 . . . . 72.12 114.6 -170.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.68 -39.84 84.5 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.191 1.927 . . . . 74.43 114.115 173.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.41 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 96.7 m-85 -72.88 -40.0 65.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.231 0.613 . . . . 74.42 111.228 -178.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.704 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.68 -40.1 88.4 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.525 -0.761 . . . . 74.43 110.489 176.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.472 ' NH1' HD13 ' C' ' 105' ' ' ILE . 29.3 ttm180 -54.15 -50.66 66.44 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.554 1.159 . . . . 75.21 110.292 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -66.86 -42.69 85.26 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.14 0.9 . . . . 72.41 111.559 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.574 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.2 t -61.46 -24.66 66.71 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.228 0.611 . . . . 74.01 111.622 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -87.29 -44.19 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.4 1.08 . . . . 71.03 110.897 174.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.7 m -62.64 -40.58 97.45 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.451 0.643 . . . . 75.14 111.244 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.0 t -70.72 -41.01 72.46 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.191 -0.913 . . . . 73.53 109.595 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.485 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.2 ttm -58.4 -48.94 79.05 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.598 1.159 . . . . 73.35 112.079 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.73 -33.78 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.523 0.729 . . . . 64.31 110.734 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.4 t -72.71 -28.44 62.67 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.755 0.822 . . . . 71.5 111.191 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.458 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.1 mtt-85 -75.17 -30.24 60.66 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.545 0.738 . . . . 73.13 110.138 175.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.54 -2.17 79.27 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.794 0.684 . . . . 43.14 112.703 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.9 m 69.4 14.67 8.44 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.057 1.343 . . . . 54.43 111.596 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.406 ' HE1' HG13 ' A' ' 31' ' ' VAL . 94.0 m-85 -82.35 152.59 67.75 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 108.572 -0.899 . . . . 73.23 108.572 169.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.12 150.1 10.96 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.266 2.644 . . . . 74.25 114.064 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -61.37 136.46 58.05 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.763 -0.653 . . . . 63.34 111.438 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.8 tp -117.01 102.02 8.99 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.824 -1.08 . . . . 73.24 108.857 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -97.96 104.33 16.35 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.948 -1.131 . . . . 74.1 107.948 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.417 HD23 HD23 ' A' ' 42' ' ' LEU . 89.8 mt -64.08 130.29 43.39 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.575 0.547 . . . . 64.32 109.797 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.28 138.53 97.18 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 119.086 -0.483 . . . . 74.21 110.268 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.07 115.52 2.55 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.472 2.115 . . . . 71.03 112.403 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.65 113.21 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.671 -1.233 . . . . 74.32 107.671 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 135' ' ' ALA . 5.4 t30 -88.97 85.25 6.68 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.677 -0.86 . . . . 73.42 108.677 -175.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.491 ' HA ' HD11 ' A' ' 136' ' ' LEU . 93.1 m-85 -58.57 -32.64 69.11 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.52 1.128 . . . . 74.42 112.607 -174.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.41 -47.75 80.68 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.455 -0.793 . . . . 75.34 111.319 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.421 ' H ' ' ND2' ' A' ' 132' ' ' ASN . . . -59.06 -49.46 77.78 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.636 0.585 . . . . 74.4 109.997 176.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.491 HD11 ' HA ' ' A' ' 133' ' ' PHE . 76.2 mt -54.95 -41.14 70.74 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 124.731 1.269 . . . . 75.35 112.238 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -74.78 -34.64 62.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.99 -0.55 . . . . 65.01 110.437 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.444 ' HE2' ' HA ' ' A' ' 138' ' ' MET . 8.5 mmt . . . . . 0 N--CA 1.48 1.062 0 C-N-CA 122.567 0.347 . . . . 74.13 110.49 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 87.7 m . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 108.054 -1.091 . . . . 75.14 108.054 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -144.76 135.36 24.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.012 0.525 . . . . 73.13 109.939 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -154.45 125.46 7.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.819 0.848 . . . . 75.24 109.053 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 17.9 mt -77.97 118.4 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.606 -0.887 . . . . 73.33 108.606 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -91.49 -39.52 11.9 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.868 -0.419 . . . . 74.41 109.868 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -166.88 138.29 3.32 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.756 0.66 . . . . 74.32 109.731 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.73 145.24 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 106.878 -1.527 . . . . 72.22 106.878 169.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -169.52 168.24 9.41 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.578 0.704 . . . . 73.31 111.578 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 86.4 m -96.51 131.92 42.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.251 -0.886 . . . . 62.41 108.668 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -96.58 -36.31 10.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.497 0.719 . . . . 74.22 109.979 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -152.48 145.25 24.33 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.024 -0.534 . . . . 71.2 110.91 -172.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.707 HD12 ' SG ' ' B' ' 113' ' ' CYS . 41.3 mm -134.46 145.18 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.755 1.222 . . . . 73.0 109.104 175.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 23.0 t -145.94 134.63 22.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.128 -0.942 . . . . 75.1 108.896 172.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.447 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.4 t80 -149.3 109.77 4.21 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.885 -1.154 . . . . 74.22 107.885 170.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -117.3 114.77 24.07 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.542 -0.91 . . . . 74.14 108.542 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.7 87.61 2.92 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 107.848 -1.167 . . . . 74.54 107.848 169.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.65 -51.76 4.63 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.905 2.403 . . . . 75.41 112.462 -171.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.494 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 72.3 m-20 -98.2 23.17 8.57 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.578 0.751 . . . . 74.3 110.957 -176.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -33.17 -67.06 0.2 Allowed Pre-proline 0 N--CA 1.498 1.925 0 C-N-CA 125.327 1.451 . . . . 73.45 114.64 -168.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.93 -20.78 57.75 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.348 2.032 . . . . 70.24 113.013 -172.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -96.57 -28.47 14.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.889 0.876 . . . . 73.2 112.16 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.611 HG23 HD13 ' B' ' 68' ' ' LEU . 10.7 p -83.22 -18.35 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 122.633 0.373 . . . . 73.24 111.117 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -66.39 -15.34 63.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.102 0.779 . . . . 72.31 113.102 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.459 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -62.64 -24.52 67.65 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 120.935 0.398 . . . . 73.4 110.753 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.512 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 89.8 mttt -96.17 101.39 13.03 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.477 1.111 . . . . 75.33 109.498 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.61 80.9 5.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.498 0.719 . . . . 71.41 109.692 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -154.17 158.91 41.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.113 -0.949 . . . . 75.54 108.682 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -75.79 108.5 6.03 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 124.081 0.952 . . . . 64.13 109.929 174.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.599 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 43.3 Cg_endo -66.72 150.02 83.61 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.918 2.412 . . . . 74.33 112.778 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -58.66 108.11 0.6 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.686 0.616 . . . . 73.23 110.771 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.468 HG12 HG11 ' B' ' 64' ' ' VAL . 81.4 t -89.86 120.99 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.975 -1.011 . . . . 74.12 110.28 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -108.07 128.95 55.13 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.703 -1.221 . . . . 70.21 107.703 168.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.562 HD23 HD12 ' B' ' 128' ' ' LEU . 40.5 tp -90.7 148.44 22.6 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.831 -0.433 . . . . 73.12 109.831 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -148.11 141.11 24.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.393 1.077 . . . . 74.35 108.167 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 96.0 mt -135.42 142.74 45.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.484 0.714 . . . . 74.25 109.783 -175.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 6.2 m-20 -132.08 110.29 10.6 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.898 -1.149 . . . . 73.31 107.898 165.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 23.6 p -109.84 100.07 9.11 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.767 -0.827 . . . . 74.51 108.767 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.63 116.36 23.7 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.473 0.709 . . . . 61.41 109.28 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 20.2 p -100.84 162.78 12.67 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.949 0.9 . . . . 75.01 109.282 176.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.5 p -150.11 170.63 18.46 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.504 0.721 . . . . 61.31 109.641 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -113.45 107.67 16.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.499 0.72 . . . . 72.33 109.719 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.97 -38.15 64.28 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.955 0.502 . . . . 74.35 110.06 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.69 177.78 9.63 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.66 -1.154 . . . . 72.32 109.991 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -63.48 119.21 9.32 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.704 -0.48 . . . . 63.13 109.704 174.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 71.99 -3.01 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.854 1.262 . . . . 73.34 112.779 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 97.8 t -105.09 112.5 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.812 -0.81 . . . . 74.23 108.812 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -126.94 139.64 52.91 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.151 0.58 . . . . 74.43 109.748 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -120.53 106.94 12.27 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.867 -0.79 . . . . 74.41 108.867 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 96.7 t -92.91 122.44 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.656 1.182 . . . . 74.13 111.028 -177.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.83 115.03 45.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.726 -0.472 . . . . 74.35 109.726 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.425 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -97.22 120.27 37.27 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.579 -1.267 . . . . 74.1 107.579 174.392 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 13.4 ttm180 -109.0 127.74 54.34 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.23 -0.655 . . . . 71.44 109.23 172.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.49 103.73 14.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.038 -1.097 . . . . 72.14 108.038 174.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -102.61 130.81 49.6 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.393 -0.595 . . . . 64.43 109.393 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.531 HG13 HD21 ' B' ' 126' ' ' LEU . 92.1 t -122.37 112.48 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.359 1.063 . . . . 72.34 109.241 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.2 m -92.8 138.15 31.74 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.568 0.747 . . . . 74.52 109.361 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.76 142.88 24.09 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.813 0.445 . . . . 71.0 111.249 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.456 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 21.5 p -153.36 133.69 13.5 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.571 0.582 . . . . 73.13 112.571 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.611 HD13 HG23 ' B' ' 31' ' ' VAL . 52.8 mt -100.12 122.4 42.92 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.531 1.132 . . . . 64.23 111.183 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.25 -110.84 3.72 Favored Glycine 0 C--N 1.342 0.892 0 O-C-N 123.906 0.754 . . . . 62.24 113.042 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.09 5.27 20.04 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.616 0.766 . . . . 73.52 111.551 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.512 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.9 pt-20 -129.13 159.25 36.59 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.851 0.46 . . . . 72.01 110.74 -175.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 61.9 m -75.38 138.26 41.6 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.131 0.491 . . . . 72.55 110.706 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.456 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -92.57 -71.46 0.65 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.114 -1.069 . . . . 72.12 108.114 176.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -146.4 144.39 29.69 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.761 -0.654 . . . . 74.14 110.203 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.9 mt -123.41 112.46 17.57 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 106.656 -1.609 . . . . 73.31 106.656 174.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.489 ' SG ' HG21 ' B' ' 114' ' ' ILE . 35.6 t -116.93 154.95 29.94 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.071 -0.715 . . . . 74.34 109.071 -178.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.412 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.7 tt0 -163.97 137.22 5.31 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.012 -0.736 . . . . 71.43 109.012 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 75.4 t -133.71 146.01 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.267 1.027 . . . . 73.25 108.744 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -122.2 95.8 4.79 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.905 -0.776 . . . . 75.14 108.905 170.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -85.56 98.98 10.95 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.92 -0.771 . . . . 74.31 108.92 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.08 143.1 16.28 Favored Glycine 0 C--N 1.343 0.952 0 N-CA-C 111.187 -0.765 . . . . 72.32 111.187 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.403 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -143.52 127.0 2.93 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 112.165 -0.374 . . . . 62.5 112.165 -173.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 51.3 mt -85.93 127.91 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 109.11 -0.7 . . . . 74.44 109.11 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.33 157.21 47.49 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.818 1.247 . . . . 64.25 108.465 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 68.5 m -117.75 100.36 7.55 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.392 0.677 . . . . 71.34 109.41 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.563 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.5 pp -111.11 137.36 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.862 0.465 . . . . 75.25 110.001 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.549 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -154.53 166.91 31.82 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.015 0.926 . . . . 73.25 110.12 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.27 -59.27 4.81 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 111.46 -0.656 . . . . 75.33 111.46 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.563 HD11 ' HB ' ' B' ' 86' ' ' ILE . 15.4 pt -63.2 139.45 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 124.428 1.091 . . . . 74.14 110.892 171.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -152.14 151.41 31.01 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.315 0.646 . . . . 73.3 110.2 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.65 -111.86 4.11 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.959 -0.456 . . . . 42.33 111.959 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -80.53 -25.01 38.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.379 0.672 . . . . 71.04 110.812 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -68.79 -35.64 77.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.765 -0.652 . . . . 74.13 110.133 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -85.92 -23.57 26.94 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.598 -0.728 . . . . 75.21 110.598 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.02 77.19 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.967 0.413 . . . . 73.32 110.769 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 30.4 t-80 -68.3 -27.05 65.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.33 0.652 . . . . 74.35 110.823 176.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.462 ' SG ' HG21 ' B' ' 86' ' ' ILE . 18.9 t -81.19 -68.5 0.68 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.479 -0.563 . . . . 71.11 109.479 176.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.506 HD21 HG12 ' B' ' 86' ' ' ILE . 23.9 mt -69.57 -22.44 63.54 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.888 0.699 . . . . 73.34 112.888 -171.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.89 -11.17 47.41 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-O 119.53 -0.594 . . . . 73.2 113.772 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -138.37 -58.86 0.64 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.659 0.73 . . . . 73.5 112.317 -173.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -72.51 -41.69 65.63 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.941 0.496 . . . . 74.14 111.935 -172.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 86.3 m -68.66 -47.65 33.43 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.066 0.947 . . . . 72.14 111.489 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.425 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 77.4 Cg_exo -56.78 -31.33 87.94 Favored 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 122.143 1.895 . . . . 70.42 113.582 168.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -62.34 -38.74 90.65 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 123.373 0.669 . . . . 73.45 110.673 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 68.0 mt -69.34 -44.11 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.789 0.836 . . . . 73.23 110.617 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.403 HD21 ' HA3' ' B' ' 82' ' ' GLY . 59.5 mt -73.64 -20.17 60.65 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.327 -0.851 . . . . 74.34 111.776 -176.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -62.33 -49.44 84.04 Favored Pre-proline 0 N--CA 1.481 1.105 0 N-CA-C 114.748 1.388 . . . . 71.51 114.748 -169.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.27 -32.19 82.07 Favored 'Trans proline' 0 C--N 1.377 2.077 0 CA-C-N 121.384 1.53 . . . . 75.22 112.474 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -66.58 -48.49 69.43 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.069 0.548 . . . . 72.13 110.363 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.05 -41.15 87.19 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.203 -0.908 . . . . 74.54 110.747 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -60.35 -56.29 23.22 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.487 1.115 . . . . 75.35 111.102 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.88 -35.29 80.67 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.032 0.533 . . . . 74.43 110.266 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.707 ' SG ' HD12 ' B' ' 21' ' ' ILE . 6.6 t -66.87 -37.44 84.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.879 0.472 . . . . 72.11 111.209 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.489 HG21 ' SG ' ' B' ' 76' ' ' CYS . 50.3 mt -63.22 -52.32 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.879 0.472 . . . . 74.13 110.05 172.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.439 HG22 ' OG ' ' C' ' 119' ' ' SER . 21.0 m -59.83 -31.94 70.2 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.885 0.874 . . . . 74.32 111.591 -177.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.8 t -64.8 -49.13 71.86 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.406 -0.816 . . . . 73.12 109.766 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -68.88 -31.77 70.94 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.078 0.551 . . . . 74.41 111.342 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.52 -43.71 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.776 0.83 . . . . 74.4 110.065 172.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.1 t -68.45 -31.91 71.56 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.642 -0.708 . . . . 74.11 111.499 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.574 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 76.1 mtt-85 -68.03 -41.85 81.47 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.894 -0.593 . . . . 73.05 109.728 176.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.62 1.24 86.55 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.704 0.627 . . . . 73.15 113.12 173.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 17' ' ' TYR . 26.4 p 60.87 26.64 16.5 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.404 1.882 . . . . 74.0 113.822 171.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -80.09 162.3 62.41 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 123.819 0.848 . . . . 73.55 111.443 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -55.22 158.51 11.86 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 123.263 2.642 . . . . 72.34 113.242 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -58.81 134.51 56.94 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.148 -0.933 . . . . 64.43 112.528 -171.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.531 HD21 HG13 ' B' ' 64' ' ' VAL . 30.9 tp -130.2 109.99 11.23 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.314 -0.857 . . . . 65.12 108.976 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -122.11 120.05 33.13 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.303 -0.999 . . . . 74.54 108.303 171.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.562 HD12 HD23 ' B' ' 42' ' ' LEU . 39.6 tp -84.72 136.22 33.81 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.71 0.404 . . . . 74.42 109.975 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.35 145.08 84.95 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.885 0.874 . . . . 60.52 111.462 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.77 130.16 35.6 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.159 2.573 . . . . 75.22 113.064 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.15 113.16 28.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 114.807 -1.088 . . . . 72.21 108.381 172.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -74.47 79.83 1.93 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.163 -1.421 . . . . 72.42 107.163 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -54.7 -38.59 67.22 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.481 0.713 . . . . 74.33 111.24 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.94 -43.13 77.12 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.354 1.062 . . . . 75.52 111.742 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.97 38.83 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.935 0.894 . . . . 75.5 111.437 -176.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -79.54 -22.28 44.08 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 116.4 -0.364 . . . . 73.52 111.203 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 73.1 t80 . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 109.943 -0.392 . . . . 74.31 109.943 178.914 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 89.5 m . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 108.125 -1.065 . . . . 74.1 108.125 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.494 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.5 t80 -108.6 122.87 47.99 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.735 -0.839 . . . . 75.04 108.735 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -136.67 128.28 28.74 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.493 -0.929 . . . . 75.04 108.493 172.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.1 mt -71.64 124.45 28.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.645 -0.872 . . . . 74.02 108.645 171.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -88.84 -46.42 8.96 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.098 0.559 . . . . 73.53 109.558 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -172.31 125.57 0.52 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.95 -0.568 . . . . 72.2 110.329 -171.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 91.3 mt -109.93 141.37 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 107.946 -1.131 . . . . 72.43 107.946 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.494 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 25.8 p90 -175.71 174.99 2.12 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.421 0.629 . . . . 71.31 110.775 -171.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -104.09 124.97 50.02 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.569 -0.741 . . . . 74.43 109.065 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.494 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 27.4 mmtp -69.88 -49.72 49.52 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.755 -1.202 . . . . 74.24 107.755 168.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -139.2 142.46 37.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 113.253 -1.794 . . . . 72.14 109.172 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.6 mt -138.79 142.67 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.292 -1.373 . . . . 73.21 107.292 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.1 t -156.81 150.44 24.54 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.459 0.647 . . . . 63.24 110.624 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.448 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 89.4 t80 -141.75 124.94 16.37 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.433 -1.321 . . . . 74.51 107.433 172.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 39.3 mt-10 -122.21 111.74 17.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.664 0.786 . . . . 74.23 109.516 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.92 82.04 69.18 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 107.641 -1.244 . . . . 71.45 107.641 170.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.1 -29.55 11.64 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.388 2.059 . . . . 73.41 111.824 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -99.38 19.41 15.59 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.842 0.857 . . . . 73.3 110.04 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.427 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -47.84 -55.16 18.62 Favored Pre-proline 0 CA--C 1.561 1.366 0 N-CA-C 113.793 1.034 . . . . 65.21 113.793 -171.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.525 ' HB3' HD12 ' D' ' 51' ' ' LEU . 36.3 Cg_exo -60.62 -43.39 32.94 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 121.644 1.562 . . . . 71.31 112.284 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -69.84 -30.09 67.5 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 113.861 -1.518 . . . . 74.44 112.663 -174.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.684 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.6 p -82.0 -22.06 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 112.282 0.475 . . . . 75.21 112.282 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -71.44 -23.94 61.93 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 122.246 -0.284 . . . . 74.32 111.706 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -87.19 10.58 16.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.33 0.652 . . . . 72.11 110.946 174.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.712 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -106.56 159.93 15.81 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.929 0.892 . . . . 65.23 109.818 176.081 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -73.11 121.24 19.9 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.503 0.721 . . . . 74.53 109.479 167.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -84.87 95.84 9.14 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.019 0.528 . . . . 74.24 110.171 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -142.74 75.98 17.85 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 108.162 -1.051 . . . . 75.14 108.162 166.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -87.24 156.18 8.19 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.898 2.398 . . . . 70.13 113.569 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.37 118.89 27.11 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 113.731 -1.577 . . . . 74.42 108.386 173.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.41 101.59 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 122.934 0.494 . . . . 73.04 110.003 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 2.3 mptp? -91.39 102.69 15.38 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 106.427 -1.694 . . . . 74.45 106.427 169.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 50.1 tp -97.26 126.22 42.33 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.112 0.565 . . . . 74.13 110.086 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -120.38 136.13 54.81 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.366 1.066 . . . . 72.44 108.963 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.78 132.28 54.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.048 0.939 . . . . 74.03 108.657 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -130.76 151.65 50.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.176 0.991 . . . . 75.33 108.852 169.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -149.89 144.14 25.73 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.073 -0.714 . . . . 74.12 109.073 169.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.55 149.05 43.42 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.617 0.767 . . . . 73.04 108.939 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 28.5 p -127.21 142.78 51.4 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.346 0.658 . . . . 73.21 110.397 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.7 t -145.2 128.06 16.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.955 0.902 . . . . 72.31 109.369 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -70.34 119.68 14.89 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.522 0.729 . . . . 70.1 109.728 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.577 HD12 ' HB2' ' C' ' 57' ' ' GLU . 51.1 mt -92.3 -29.9 16.13 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.999 0.519 . . . . 71.23 109.753 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.35 179.22 7.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.429 1.092 . . . . 73.35 110.097 176.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.68 123.32 17.62 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.597 -0.729 . . . . 70.41 109.292 175.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.99 19.42 11.85 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.177 0.923 . . . . 74.04 111.706 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.69 115.31 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.695 -0.854 . . . . 74.35 108.695 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.527 ' HD2' HD13 ' C' ' 86' ' ' ILE . 1.0 OUTLIER -115.38 157.94 23.17 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.578 0.751 . . . . 73.33 109.057 175.182 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.577 ' HB2' HD12 ' C' ' 51' ' ' LEU . 22.5 tt0 -116.34 120.45 38.91 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.334 -1.303 . . . . 75.41 107.506 170.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.4 t -107.75 135.22 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.606 -0.887 . . . . 71.22 108.606 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.57 108.45 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.918 -0.771 . . . . 74.35 108.918 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.559 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -86.45 108.7 18.63 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.519 -1.289 . . . . 75.4 107.519 175.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.491 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 24.0 ttm180 -95.94 119.64 34.8 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.435 -0.95 . . . . 74.44 108.435 173.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.486 ' HB ' HD11 ' C' ' 114' ' ' ILE . 29.1 t -111.94 130.95 64.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.01 -1.107 . . . . 74.33 108.01 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 13.3 m -126.92 121.73 32.58 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.654 -0.869 . . . . 71.43 108.654 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.503 HG12 HD22 ' C' ' 126' ' ' LEU . 22.1 t -112.19 116.7 53.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.244 -0.65 . . . . 65.55 109.244 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 3.5 m -102.1 137.32 40.52 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.543 -0.91 . . . . 74.24 108.543 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.1 118.62 21.78 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.307 -0.997 . . . . 64.32 108.307 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 13.3 m -133.58 130.64 38.67 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.521 0.513 . . . . 74.34 110.664 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.712 HD11 ' HG2' ' C' ' 34' ' ' LYS . 25.6 mt -86.81 45.63 1.28 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.238 1.415 . . . . 74.31 109.796 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.09 -85.21 0.49 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 110.476 -1.05 . . . . 65.25 110.476 -171.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.42 -29.13 5.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.486 0.715 . . . . 63.04 110.496 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.42 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 8.2 tp10 -63.17 118.72 8.33 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.072 0.949 . . . . 73.11 109.918 175.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -74.31 117.72 16.44 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.532 -0.914 . . . . 71.44 108.532 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.684 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.68 -55.05 7.4 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.333 -0.988 . . . . 74.23 108.333 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -164.99 163.46 20.76 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.91 -1.041 . . . . 74.34 110.288 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.407 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -130.31 142.43 50.54 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 105.803 -1.925 . . . . 74.21 105.803 172.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 50.1 t -144.63 142.91 30.47 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.316 -0.994 . . . . 73.31 108.316 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -150.29 127.82 11.53 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.433 -0.58 . . . . 74.23 109.433 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 74.8 t -127.73 136.23 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.559 1.144 . . . . 74.24 108.267 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.491 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 69.7 mt-30 -109.59 87.35 2.48 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.121 -1.066 . . . . 74.33 108.121 174.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -78.21 96.9 5.33 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.341 -0.845 . . . . 72.2 109.251 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.2 146.45 21.09 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.327 -0.851 . . . . 73.2 112.399 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.27 118.11 0.9 Allowed Glycine 0 C--O 1.238 0.373 0 N-CA-C 110.958 -0.857 . . . . 71.1 110.958 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.543 HD13 HD12 ' C' ' 51' ' ' LEU . 15.5 mm -82.22 131.29 34.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.725 -0.843 . . . . 73.51 108.725 176.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -134.75 120.06 18.98 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 123.615 0.572 . . . . 75.45 110.083 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.0 p -79.72 106.16 11.54 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.153 -1.055 . . . . 62.52 108.153 170.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.527 HD13 ' HD2' ' C' ' 56' ' ' TYR . 2.3 pp -116.11 142.82 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.178 0.991 . . . . 74.04 109.98 -172.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -149.88 158.21 43.94 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.884 0.474 . . . . 63.2 110.607 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.55 -29.01 6.46 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.218 -0.447 . . . . 74.12 113.963 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.568 HD11 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -84.67 164.68 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.123 0.569 . . . . 74.43 111.401 -176.306 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -164.55 148.48 9.28 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.879 0.872 . . . . 73.45 109.205 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.88 -115.07 7.43 Favored Glycine 0 C--N 1.351 1.389 0 O-C-N 123.79 0.681 . . . . 73.13 114.516 170.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 70.4 p -79.88 -26.99 40.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.783 0.833 . . . . 63.4 110.906 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -67.34 -38.8 85.45 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.455 0.702 . . . . 73.22 109.746 173.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 40.4 ttp -73.11 -38.99 66.14 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.811 -0.632 . . . . 65.3 110.464 174.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 -40.69 85.51 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 123.776 0.672 . . . . 53.15 110.588 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.493 ' HE2' ' HA ' ' C' ' 134' ' ' ASP . 12.7 t-80 -79.1 -34.1 43.83 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 123.576 0.548 . . . . 72.13 112.029 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -53.96 -41.76 68.16 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.634 0.584 . . . . 74.21 110.533 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.99 -14.65 17.76 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.309 -0.859 . . . . 74.32 110.954 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.16 -21.9 64.25 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 114.086 0.395 . . . . 62.12 114.086 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.27 -45.03 0.09 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.489 0.552 . . . . 72.52 112.489 -171.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -67.54 -48.99 65.4 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.315 0.385 . . . . 72.33 111.439 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.494 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 94.5 m -64.58 -49.56 69.95 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 118.714 -0.66 . . . . 75.43 111.895 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.559 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 75.1 Cg_exo -56.55 -30.22 81.93 Favored 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 122.259 1.973 . . . . 63.24 114.309 170.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -64.64 -41.03 96.42 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.594 0.758 . . . . 71.01 110.589 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.472 HD13 ' NH1' ' A' ' 111' ' ' ARG . 39.3 mm -61.08 -45.23 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.557 -0.747 . . . . 74.04 110.173 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 71.8 mt -79.23 -16.6 56.26 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.193 -0.912 . . . . 74.22 112.418 -172.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -62.68 -48.32 86.12 Favored Pre-proline 0 CA--C 1.561 1.372 0 N-CA-C 114.194 1.183 . . . . 75.44 114.194 -172.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -59.06 -34.72 99.0 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 121.833 1.689 . . . . 72.54 112.94 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -71.2 -44.95 64.42 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.504 0.721 . . . . 75.25 110.831 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.14 -44.7 87.98 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.333 -0.848 . . . . 73.22 109.925 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -54.1 -54.62 36.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.705 1.202 . . . . 75.52 111.305 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.62 -29.39 68.7 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.269 0.628 . . . . 73.41 110.872 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.1 t -73.9 -37.0 64.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.998 0.519 . . . . 72.44 110.973 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.486 HD11 ' HB ' ' C' ' 62' ' ' VAL . 89.4 mt -67.81 -51.72 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.342 -0.614 . . . . 75.1 109.342 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 14.5 m -58.36 -31.84 67.99 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.613 0.765 . . . . 71.41 111.404 -177.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -62.42 -57.73 10.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.328 0.651 . . . . 75.1 109.599 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.577 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.77 -41.89 61.98 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.715 1.206 . . . . 71.34 112.843 177.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 95.7 t -67.48 -46.26 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.067 0.947 . . . . 73.24 110.758 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.439 ' OG ' HG22 ' B' ' 115' ' ' THR . 39.5 t -69.72 -26.42 64.32 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.556 -0.747 . . . . 72.35 111.281 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.482 ' HD2' ' HE3' ' C' ' 117' ' ' MET . 78.1 mtt-85 -71.63 -42.11 68.02 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.467 0.707 . . . . 74.13 109.339 174.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.03 -3.11 67.6 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 123.759 0.662 . . . . 74.2 112.852 170.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p 65.5 30.82 10.56 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.828 2.051 . . . . 71.31 113.506 171.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -88.79 142.18 30.43 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 108.078 -1.082 . . . . 74.53 108.078 167.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.49 172.39 0.48 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 123.213 2.609 . . . . 73.53 115.732 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -46.19 135.0 8.16 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.746 1.619 . . . . 75.43 114.83 -169.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.503 HD22 HG12 ' C' ' 64' ' ' VAL . 43.7 tp -137.15 86.86 2.23 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.183 -1.371 . . . . 74.4 108.631 176.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -116.21 114.94 25.12 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.004 0.922 . . . . 73.13 109.105 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.09 137.3 38.15 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 122.588 0.355 . . . . 61.23 110.562 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.66 157.98 88.72 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 124.744 1.217 . . . . 74.33 111.272 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.45 ' HG3' HD13 ' A' ' 16' ' ' ILE . 9.4 Cg_endo -51.73 111.67 0.65 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.233 2.622 . . . . 72.23 112.835 176.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.5 t -97.52 112.07 28.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.193 -0.669 . . . . 73.44 109.193 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.64 77.94 7.42 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.392 0.677 . . . . 75.15 109.744 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -60.14 -38.96 84.68 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.689 -0.687 . . . . 71.33 109.414 171.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.493 ' HA ' ' HE2' ' C' ' 96' ' ' HIS . 8.6 m-20 -57.46 -35.28 69.95 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 114.095 -1.411 . . . . 64.12 112.745 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.64 -51.98 67.08 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 124.122 0.889 . . . . 74.35 111.134 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.8 mp -74.83 -35.01 62.43 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.836 -0.62 . . . . 63.45 111.435 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . 0.411 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 2.2 t80 . . . . . 0 CA--C 1.551 1.011 0 C-N-CA 122.678 0.391 . . . . 74.42 110.566 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 C--O 1.239 0.542 0 N-CA-C 109.652 -0.499 . . . . 71.22 109.652 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -148.53 96.46 2.6 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.306 -1.368 . . . . 73.53 107.306 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -119.25 122.42 41.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.378 -0.971 . . . . 64.14 108.378 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.474 HD12 HD11 ' D' ' 105' ' ' ILE . 41.2 mt -78.49 114.66 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.841 -1.17 . . . . 74.54 107.841 169.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -84.86 -38.73 19.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.356 0.262 . . . . 74.43 111.504 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -169.3 127.22 0.96 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 119.757 -0.163 . . . . 75.24 111.248 -166.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.4 mp -105.33 134.59 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.144 -1.428 . . . . 73.45 107.144 164.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.433 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 36.2 p90 -154.87 165.45 36.63 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.975 0.893 . . . . 70.42 111.033 174.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -98.54 117.97 34.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.337 -1.301 . . . . 72.13 109.46 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.433 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 33.2 mtpt -82.25 -33.68 29.12 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.729 -0.841 . . . . 74.21 108.729 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -143.95 144.53 31.74 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.535 -1.211 . . . . 64.35 109.398 173.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.577 HG23 ' HE1' ' C' ' 117' ' ' MET . 47.2 mt -133.73 141.25 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.41 -1.33 . . . . 73.23 107.41 172.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -144.1 137.1 27.3 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.955 0.902 . . . . 71.34 108.917 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.573 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.0 t80 -152.33 128.66 10.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.237 -1.764 . . . . 74.23 106.237 172.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -138.41 125.66 21.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.67 0.788 . . . . 74.33 109.354 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.29 83.8 60.59 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.257 -1.016 . . . . 73.03 108.257 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.42 -23.55 20.25 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.692 2.262 . . . . 62.24 112.62 -173.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 -106.84 1.69 24.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.569 0.748 . . . . 72.32 111.075 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -27.27 -66.64 0.11 Allowed Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 116.702 2.112 . . . . 72.15 116.702 -161.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.75 -22.29 9.12 Favored 'Trans proline' 0 C--N 1.38 2.229 0 CA-C-N 123.544 2.301 . . . . 72.14 113.718 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -70.73 -38.09 73.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.213 1.005 . . . . 73.22 109.291 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.9 p -84.92 -21.86 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 115.801 -0.636 . . . . 64.23 111.738 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -65.95 -20.36 66.18 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 112.418 0.525 . . . . 73.53 112.418 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.54 -22.15 64.89 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.296 0.638 . . . . 74.41 110.439 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -88.6 83.52 6.77 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.43 1.092 . . . . 70.12 108.396 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.23 93.2 5.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.552 -0.749 . . . . 44.42 110.099 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -160.36 158.28 29.36 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.3 1.04 . . . . 75.53 109.102 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -65.92 107.42 1.53 Allowed Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 124.007 0.923 . . . . 63.31 109.548 171.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.92 117.29 4.3 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 122.964 2.443 . . . . 73.44 112.867 -167.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.84 121.61 21.16 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.103 -0.703 . . . . 64.24 109.103 -175.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' D' ' 66' ' ' ALA . 14.5 m -107.86 151.05 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.492 0.717 . . . . 73.34 112.309 -168.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -109.37 125.3 52.23 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.709 -1.219 . . . . 75.24 107.709 164.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 65.4 mt -97.03 133.89 41.11 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.796 -0.446 . . . . 74.44 109.796 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -145.65 128.45 16.31 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.452 -1.314 . . . . 64.53 107.452 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.85 159.18 42.21 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.418 0.627 . . . . 75.1 111.071 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.0 t70 -136.48 128.96 30.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.479 1.512 . . . . 74.33 108.304 -170.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.6 t -106.06 146.77 29.71 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.28 -0.637 . . . . 72.22 109.28 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.99 170.48 19.77 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.709 0.804 . . . . 72.55 109.032 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 88.9 p -162.9 155.2 18.59 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 123.163 0.289 . . . . 74.41 110.83 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 22.2 t -153.44 153.88 33.34 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.489 1.116 . . . . 72.23 109.726 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.96 136.99 32.72 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 109.542 -0.54 . . . . 74.55 109.542 172.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.525 HD12 ' HB3' ' C' ' 29' ' ' PRO . 26.7 mt -109.5 -34.64 6.45 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.156 0.583 . . . . 75.54 110.138 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.01 -178.62 7.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.937 0.895 . . . . 71.43 110.243 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.72 118.62 10.52 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.474 -0.785 . . . . 74.33 110.082 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 56.79 17.22 3.09 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 124.998 1.319 . . . . 73.31 113.036 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 77.9 t -118.51 110.29 29.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 106.696 -1.594 . . . . 73.4 106.696 171.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.433 ' HB2' HD11 ' D' ' 86' ' ' ILE . 6.0 t80 -120.7 161.26 21.72 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.431 -0.952 . . . . 74.01 108.431 -170.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -129.74 145.42 51.54 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.306 -0.861 . . . . 72.01 109.516 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.71 125.05 66.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.064 -1.458 . . . . 72.11 107.064 172.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.52 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 43.6 t -103.26 133.2 47.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.935 -0.765 . . . . 64.42 108.935 176.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.57 118.42 31.62 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.665 -0.865 . . . . 74.45 108.665 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.2 ttm-85 -104.27 96.05 6.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.253 -1.018 . . . . 74.41 108.253 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.35 125.21 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.874 -0.787 . . . . 60.31 108.874 174.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 5.9 m -118.07 134.01 55.38 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 123.633 0.583 . . . . 73.04 109.669 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.417 HG23 HG21 ' D' ' 114' ' ' ILE . 64.4 t -119.58 117.66 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.305 1.042 . . . . 74.32 108.914 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 31.9 m -105.91 94.1 5.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.885 0.874 . . . . 74.44 108.652 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -96.2 151.31 19.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.013 0.525 . . . . 61.4 111.337 -172.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 56.7 p -147.0 135.62 22.02 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.35 -0.841 . . . . 74.34 111.449 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 22.6 mt -96.56 94.42 7.35 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.518 -1.29 . . . . 75.11 107.518 167.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.77 -117.01 8.76 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.313 -0.858 . . . . 74.2 112.577 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -93.69 4.77 53.42 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.851 0.86 . . . . 74.15 111.914 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -118.9 140.29 50.22 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.013 0.525 . . . . 74.45 110.183 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.6 m -63.57 116.15 5.36 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 123.456 0.472 . . . . 70.33 110.255 174.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.542 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -77.24 -72.12 0.37 Allowed 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.949 -0.759 . . . . 73.12 108.949 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -142.03 153.42 44.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.573 -0.739 . . . . 74.54 109.935 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 79.2 mt -115.48 148.52 39.35 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.935 -1.506 . . . . 72.23 106.935 169.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.511 ' SG ' HG12 ' D' ' 114' ' ' ILE . 47.4 t -155.1 143.12 20.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.27 -0.641 . . . . 74.23 109.27 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -155.8 127.28 7.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.61 -0.515 . . . . 74.14 109.61 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.31 120.52 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 122.863 0.465 . . . . 74.24 110.125 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -89.48 83.57 6.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.977 -0.749 . . . . 72.3 108.977 171.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -79.7 91.55 5.28 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.789 -1.096 . . . . 75.32 108.78 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.84 143.23 18.92 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 110.96 -0.856 . . . . 75.12 110.96 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.481 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -135.31 130.77 5.54 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 112.059 -0.416 . . . . 74.25 112.059 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.431 HG13 ' HE1' ' D' ' 17' ' ' TYR . 43.5 mt -89.44 126.15 42.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 124.028 0.931 . . . . 72.43 109.026 174.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -127.76 125.57 40.15 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.532 -0.914 . . . . 73.53 108.532 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.5 t -86.45 111.17 20.29 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.652 -1.24 . . . . 73.41 107.652 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.433 HD11 ' HB2' ' D' ' 56' ' ' TYR . 0.9 OUTLIER -130.24 136.7 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.288 0.566 . . . . 74.02 110.538 -173.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.4 156.3 40.4 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.8 1.24 . . . . 74.4 107.882 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.28 20.92 79.46 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 121.117 -0.564 . . . . 71.4 112.322 -175.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 45.5 pt -109.8 152.35 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.057 0.943 . . . . 75.44 109.24 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -163.16 146.04 10.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.903 0.481 . . . . 74.01 110.912 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.91 -120.81 11.41 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.17 0.828 . . . . 51.02 115.17 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 24.2 p -70.08 -24.06 63.16 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.482 1.113 . . . . 73.51 112.272 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -64.19 -36.11 82.99 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.443 0.697 . . . . 72.02 110.211 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.436 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 19.4 mtm -68.25 -51.88 40.19 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.52 0.513 . . . . 72.3 110.318 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.33 70.92 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.067 0.547 . . . . 71.11 111.915 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . 0.433 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 28.9 t-80 -72.68 -32.17 65.6 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.887 0.875 . . . . 75.23 111.161 176.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.4 t -78.31 -53.52 7.21 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.491 0.316 . . . . 63.41 111.258 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' D' ' 94' ' ' MET . 4.6 pp -95.3 -18.98 20.36 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.308 0.643 . . . . 74.31 112.163 -169.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.4 13.23 56.95 Favored Glycine 0 N--CA 1.473 1.152 0 CA-C-O 120.051 -0.305 . . . . 55.31 112.693 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.627 ' HB2' ' HA ' ' D' ' 134' ' ' ASP . . . -152.63 -71.03 0.15 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 111.969 0.359 . . . . 73.25 111.969 -176.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -73.11 -32.74 65.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 112.378 0.51 . . . . 73.33 112.378 -171.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -71.71 -43.89 11.73 Favored Pre-proline 0 CA--C 1.561 1.365 0 CA-C-O 118.48 -0.771 . . . . 74.34 111.791 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -52.95 -36.1 73.92 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.194 1.929 . . . . 75.14 113.287 164.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -67.84 -22.31 65.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.517 0.727 . . . . 74.31 111.586 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.474 HD11 HD12 ' D' ' 13' ' ' ILE . 87.1 mt -81.1 -40.24 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.415 1.086 . . . . 72.44 110.463 172.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.481 HD22 ' HA3' ' D' ' 82' ' ' GLY . 93.9 mt -73.03 -22.75 60.58 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.246 -0.888 . . . . 74.02 111.82 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -71.68 -40.34 8.31 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 124.263 1.025 . . . . 75.31 113.308 -171.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -52.58 -42.66 60.57 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.292 1.994 . . . . 74.51 114.243 166.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -74.82 -35.72 62.43 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.167 0.587 . . . . 71.13 111.482 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.65 -42.42 86.71 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.562 -0.533 . . . . 64.3 109.562 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.638 HH12 ' HB3' ' D' ' 130' ' ' PRO . 21.2 ttp180 -51.49 -56.71 11.85 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 124.805 1.316 . . . . 74.5 110.708 173.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -67.17 -37.76 84.27 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.346 1.028 . . . . 73.34 111.584 -171.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.39 -45.25 94.22 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.467 0.479 . . . . 74.01 110.445 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.511 HG12 ' SG ' ' D' ' 76' ' ' CYS . 96.6 mt -61.8 -53.64 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.036 -0.984 . . . . 71.2 110.706 174.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -56.39 -40.35 74.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.305 1.042 . . . . 63.23 111.525 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.4 t -66.48 -43.4 85.51 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 114.783 -1.099 . . . . 74.12 110.6 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.408 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.3 mtm -70.17 -26.24 63.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.705 0.402 . . . . 72.32 111.66 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.423 HG23 ' O ' ' D' ' 114' ' ' ILE . 69.2 t -68.06 -45.23 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.566 0.746 . . . . 73.44 110.019 173.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.9 p -74.84 -26.21 59.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.816 0.446 . . . . 74.1 111.473 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -75.65 -34.71 60.52 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.204 0.601 . . . . 75.45 109.646 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.36 1.65 84.68 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.651 0.595 . . . . 74.51 112.303 171.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 44.6 p 61.04 21.23 11.62 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.073 2.149 . . . . 64.02 114.458 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.414 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.1 m-85 -78.44 142.7 62.83 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 107.86 -1.163 . . . . 73.3 107.86 168.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -50.18 137.74 37.52 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.245 2.63 . . . . 71.24 113.192 176.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -50.22 135.49 21.19 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.842 1.257 . . . . 72.3 114.04 -164.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 18.7 tp -108.84 102.0 11.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.196 0.599 . . . . 71.34 110.675 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -100.35 96.91 7.75 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.368 0.604 . . . . 75.34 109.931 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.94 123.2 19.18 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.122 1.369 . . . . 65.22 111.357 -175.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.07 122.84 88.14 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.396 0.679 . . . . 73.13 110.385 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.638 ' HB3' HH12 ' D' ' 111' ' ' ARG . 74.2 Cg_endo -80.87 128.85 6.81 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.304 2.003 . . . . 64.22 112.674 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.39 146.1 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.497 0.719 . . . . 72.33 109.807 176.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -85.6 89.83 7.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.029 0.532 . . . . 75.13 109.566 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -59.21 -24.08 62.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.61 0.764 . . . . 72.24 112.344 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . 0.627 ' HA ' ' HB2' ' D' ' 100' ' ' ALA . 9.8 t70 -60.23 -52.47 65.16 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.075 0.95 . . . . 73.43 110.7 -176.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.77 -40.04 69.55 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.127 -0.942 . . . . 71.12 111.359 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 91.4 mt -58.17 -34.5 70.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.627 0.771 . . . . 75.41 112.111 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.4 t80 . . . . . 0 N--CA 1.474 0.767 0 C-N-CA 123.377 0.671 . . . . 74.1 110.57 178.5 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.236 0.371 0 N-CA-C 109.137 -0.69 . . . . 74.45 109.137 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.483 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 21.6 t80 -134.28 125.0 26.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.7 0.8 . . . . 74.05 109.32 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -137.93 135.71 36.33 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.145 -1.057 . . . . 75.11 108.145 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.58 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.5 mt -92.83 118.31 38.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.22 -1.03 . . . . 75.52 108.22 174.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -88.83 -30.21 19.12 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 124.003 0.814 . . . . 64.44 110.272 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -171.28 147.61 2.51 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 123.275 0.359 . . . . 74.15 110.721 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.411 HD13 ' HG3' ' C' ' 130' ' ' PRO . 84.6 mt -137.05 134.16 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.503 1.121 . . . . 75.34 108.058 173.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' HB3' HG21 ' B' ' 122' ' ' THR . 25.1 p90 -166.54 169.2 13.97 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.773 0.797 . . . . 75.24 112.193 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -89.36 122.75 32.89 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.303 -0.862 . . . . 74.44 108.778 170.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.6 mtpt -87.7 -18.65 29.03 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.926 -0.398 . . . . 74.22 109.926 173.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.1 t70 -161.73 144.73 12.09 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.102 0.961 . . . . 75.21 109.297 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 82.0 mt -140.49 142.52 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.813 1.645 . . . . 74.33 107.172 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -146.32 139.99 26.1 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.176 0.513 . . . . 73.23 110.147 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 89.1 t80 -141.44 127.15 19.1 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.204 -1.406 . . . . 71.22 107.204 173.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -133.87 122.43 23.18 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.734 -0.469 . . . . 74.54 109.734 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.02 74.53 79.72 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.278 -1.378 . . . . 74.34 107.278 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.57 -22.09 51.66 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.662 2.241 . . . . 74.15 112.543 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 42.6 m-80 -120.01 34.81 5.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.124 0.97 . . . . 73.33 109.314 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.45 -54.21 37.39 Favored Pre-proline 0 CA--C 1.565 1.522 0 CA-C-O 118.128 -0.939 . . . . 62.03 113.4 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.97 -22.02 31.68 Favored 'Trans proline' 0 C--N 1.387 2.599 0 CA-C-N 121.607 1.609 . . . . 74.45 113.147 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 6.0 t-160 -82.03 -38.83 24.41 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.99 0.916 . . . . 63.13 110.885 -171.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 73' ' ' ALA . 34.2 m -69.43 -25.92 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.311 0.644 . . . . 74.24 111.957 -175.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -72.43 -24.51 61.23 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.192 0.597 . . . . 73.31 111.004 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -77.09 -49.07 16.12 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.687 0.795 . . . . 72.33 110.905 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -75.36 172.77 11.89 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.372 0.669 . . . . 75.12 111.779 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.56 116.96 4.74 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 123.444 0.698 . . . . 75.25 110.525 176.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -73.65 90.41 1.8 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.455 -0.793 . . . . 74.41 109.549 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -131.4 72.0 81.13 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.092 -1.077 . . . . 74.54 108.092 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.57 116.77 2.96 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.396 2.064 . . . . 72.3 111.245 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -94.78 111.46 23.24 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.658 -1.238 . . . . 74.33 107.658 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 m -85.71 127.82 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 114.458 -1.246 . . . . 71.51 112.013 -170.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -122.01 114.54 21.1 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.334 1.453 . . . . 75.02 107.805 177.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.6 tp -110.44 113.73 26.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.032 0.533 . . . . 71.25 109.823 -175.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -113.11 110.05 19.8 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.744 0.818 . . . . 64.11 108.902 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mp -97.88 155.35 17.1 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.179 -0.674 . . . . 75.03 109.179 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.9 t70 -148.83 146.76 28.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.432 1.093 . . . . 73.23 108.437 -174.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.2 m -141.89 134.44 28.25 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.614 0.765 . . . . 74.44 110.175 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.2 140.51 46.55 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.807 0.843 . . . . 74.32 110.61 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.435 ' HB3' HD23 ' A' ' 98' ' ' LEU . 39.5 p -92.16 152.97 19.62 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.029 0.932 . . . . 63.12 109.834 176.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -151.85 145.25 24.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.946 0.898 . . . . 72.21 109.178 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -113.44 137.76 51.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.976 -0.75 . . . . 64.13 108.976 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.406 HD12 HG22 ' A' ' 83' ' ' ILE . 69.3 mt -110.96 -36.42 5.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.496 0.718 . . . . 74.25 110.469 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.45 -176.85 5.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.388 0.675 . . . . 74.11 110.828 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.28 120.54 12.95 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.166 -1.05 . . . . 74.32 108.166 170.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 72.46 -5.91 1.71 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.778 1.231 . . . . 71.5 112.702 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.3 t -109.25 116.38 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.081 0.952 . . . . 75.2 108.832 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.78 162.56 28.17 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.26 0.624 . . . . 72.41 109.549 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -134.88 145.74 48.55 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.063 0.945 . . . . 74.04 109.732 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -131.6 147.57 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.5 -0.926 . . . . 75.1 108.5 166.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.13 117.3 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.728 0.811 . . . . 72.4 109.382 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.7 tp -97.91 103.28 15.2 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.874 -0.787 . . . . 73.44 108.874 173.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.613 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 27.3 ttp180 -88.26 112.99 23.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.3 0.64 . . . . 74.35 109.673 172.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.85 123.2 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.598 -0.89 . . . . 73.53 108.598 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -115.77 120.65 39.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.748 0.819 . . . . 72.12 110.061 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.43 ' O ' HD13 ' A' ' 75' ' ' LEU . 86.0 t -111.39 113.46 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.992 0.917 . . . . 71.23 110.007 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.2 m -112.06 105.6 14.03 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.82 -0.807 . . . . 73.2 108.82 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -111.38 105.36 13.97 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.198 -1.038 . . . . 73.11 108.198 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.3 p -128.85 131.29 47.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.49 0.716 . . . . 73.43 110.753 -174.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.624 HD21 ' H ' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -91.83 87.15 6.14 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.564 -0.902 . . . . 71.4 108.564 175.371 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.15 -102.88 2.32 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 114.981 -1.009 . . . . 75.13 111.902 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.43 -26.12 12.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.994 0.517 . . . . 72.2 110.327 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -91.68 127.4 37.12 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.894 0.878 . . . . 61.34 109.159 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.7 m -87.4 134.56 33.56 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 122.643 0.377 . . . . 75.34 110.751 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.648 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -76.48 -61.09 2.07 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 124.283 0.989 . . . . 74.5 108.668 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -152.88 153.79 33.76 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.554 -1.203 . . . . 62.22 110.725 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 58.6 tp -122.18 136.73 54.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.849 -1.537 . . . . 73.24 106.849 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 85.8 m -140.05 103.39 4.61 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.187 0.595 . . . . 72.55 109.445 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.22 117.68 24.37 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.216 -0.661 . . . . 74.13 109.216 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -126.11 113.79 35.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 123.862 0.865 . . . . 74.34 109.683 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.613 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 50.0 mt-30 -85.38 84.86 7.51 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.65 -0.871 . . . . 73.12 108.65 170.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.84 100.87 8.21 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.367 -0.975 . . . . 72.33 108.367 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.12 144.79 17.36 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 111.335 -0.706 . . . . 73.03 111.335 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.521 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -138.02 128.43 4.22 Favored Glycine 0 CA--C 1.504 -0.639 0 N-CA-C 111.369 -0.692 . . . . 74.13 111.369 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.406 HG22 HD12 ' A' ' 51' ' ' LEU . 55.0 mt -82.22 119.63 32.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.406 -0.961 . . . . 74.53 108.406 172.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.58 ' HD2' HG12 ' A' ' 13' ' ' ILE . 26.9 m-85 -130.31 117.73 20.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.954 -1.128 . . . . 70.03 107.954 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 p -78.75 108.42 12.16 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.973 -1.121 . . . . 73.25 107.973 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.508 ' HB ' HD13 ' A' ' 89' ' ' ILE . 42.9 pt -119.19 139.45 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.361 0.664 . . . . 75.12 109.943 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.32 159.68 28.75 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.478 1.111 . . . . 73.11 109.522 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.54 4.0 89.05 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.926 -0.375 . . . . 51.21 113.879 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.508 HD13 ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -120.46 136.58 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.284 -1.006 . . . . 72.22 108.284 172.268 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -141.22 173.6 11.33 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.34 1.056 . . . . 74.13 109.659 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.83 -133.14 51.33 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 123.948 0.78 . . . . 74.15 114.198 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.5 p -71.55 -24.82 62.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.01 0.924 . . . . 73.42 111.854 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -68.82 -44.11 74.18 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.582 0.753 . . . . 71.33 110.17 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 52.3 ttp -63.33 -48.4 78.18 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.956 -0.387 . . . . 72.21 109.956 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.9 -31.6 68.76 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.171 0.919 . . . . 61.41 112.034 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -73.98 -45.08 52.26 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.95 0.5 . . . . 75.43 110.62 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 78.7 m -66.55 -25.04 66.46 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.177 0.591 . . . . 40.14 111.575 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.435 HD23 ' HB3' ' A' ' 48' ' ' SER . 6.0 tt -95.72 -42.5 8.34 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.459 1.103 . . . . 74.44 110.159 -173.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.77 4.31 53.3 Favored Glycine 0 N--CA 1.472 1.045 0 CA-C-N 115.945 -0.57 . . . . 74.24 113.681 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.6 -57.79 0.32 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.224 0.512 . . . . 74.42 111.772 -176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.483 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 67.2 t80 -70.68 -62.43 1.4 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.118 0.567 . . . . 75.11 112.395 -170.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.3 m -68.71 -33.09 4.06 Favored Pre-proline 0 CA--C 1.567 1.618 0 N-CA-C 114.369 1.248 . . . . 73.34 114.369 -173.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.02 -24.77 44.93 Favored 'Trans proline' 0 C--N 1.39 2.742 0 CA-C-N 121.725 1.652 . . . . 72.15 112.776 167.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -73.41 -26.56 61.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.776 -0.453 . . . . 73.34 109.776 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.5 mm -63.63 -36.52 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.466 0.707 . . . . 73.03 109.818 169.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.521 HD22 ' HA3' ' A' ' 82' ' ' GLY . 76.5 mt -79.97 -17.61 52.5 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.899 0.88 . . . . 75.21 111.932 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -64.69 -46.17 76.17 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 117.755 -1.117 . . . . 71.44 113.684 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.47 -33.88 67.24 Favored 'Trans proline' 0 C--N 1.389 2.675 0 CA-C-N 122.071 1.776 . . . . 74.14 112.838 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.449 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 86.3 m-85 -70.53 -41.16 72.91 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.37 0.668 . . . . 74.51 111.239 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.98 -39.68 79.28 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.925 0.49 . . . . 75.21 110.405 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.453 ' NH1' HG23 ' C' ' 105' ' ' ILE . 36.5 ttm180 -53.2 -51.54 61.76 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 124.402 1.064 . . . . 73.2 109.611 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -66.59 -44.21 82.81 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.023 -0.989 . . . . 75.31 111.653 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.411 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.9 t -62.2 -33.99 75.6 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.174 0.59 . . . . 75.14 111.306 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 118' ' ' VAL . 83.3 mt -70.63 -55.97 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.112 0.965 . . . . 72.24 110.092 173.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.8 m -51.67 -43.43 62.69 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.697 1.199 . . . . 75.43 111.466 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -63.37 -47.07 83.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.906 -1.497 . . . . 61.32 110.268 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.418 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 69.0 mtm -63.13 -36.96 85.34 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.053 0.541 . . . . 62.31 111.722 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 114' ' ' ILE . 86.1 t -62.83 -47.2 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 123.507 0.723 . . . . 73.24 110.298 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.4 p -76.75 -20.25 56.71 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.153 0.581 . . . . 75.12 112.089 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -75.59 -34.89 60.66 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.005 -0.739 . . . . 74.04 109.005 172.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.43 -0.88 80.35 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.457 -0.792 . . . . 73.43 112.291 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.8 m 70.92 14.22 6.94 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 125.246 1.418 . . . . 71.33 111.578 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -77.91 157.43 79.02 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 123.619 0.767 . . . . 74.52 110.027 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.63 131.19 44.35 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.214 2.609 . . . . 74.5 111.897 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -55.24 126.41 24.78 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 124.414 1.071 . . . . 72.32 112.148 -170.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.8 tp -106.16 97.63 7.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.553 -0.748 . . . . 74.01 109.295 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.4 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 80.4 m-20 -95.78 107.63 19.88 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.389 -1.337 . . . . 73.02 107.389 174.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.432 ' HB3' ' HG3' ' A' ' 111' ' ' ARG . 30.5 tp -72.03 126.81 30.71 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.441 -0.799 . . . . 70.24 110.213 -176.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.1 139.02 92.5 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.401 0.68 . . . . 74.33 110.441 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.58 128.46 28.36 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.906 2.404 . . . . 74.14 113.192 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 96.8 t -100.22 120.88 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.858 -0.793 . . . . 72.5 108.858 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.436 HD21 ' HB1' ' A' ' 135' ' ' ALA . 1.3 p-10 -76.7 74.01 3.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.515 1.126 . . . . 65.03 110.932 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -56.36 -39.54 73.05 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.406 0.682 . . . . 74.34 111.862 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.8 -33.35 72.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.509 1.124 . . . . 75.44 111.864 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.436 ' HB1' HD21 ' A' ' 132' ' ' ASN . . . -75.46 -43.01 51.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.158 0.583 . . . . 74.25 110.168 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.5 -38.19 90.15 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.333 -0.849 . . . . 74.44 110.131 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -69.22 -38.62 78.64 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.294 -0.866 . . . . 72.02 109.949 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 C-N-CA 124.213 1.005 . . . . 64.44 110.599 176.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 C--O 1.243 0.748 0 N-CA-C 108.367 -0.975 . . . . 74.23 108.367 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -148.27 157.05 43.26 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.444 0.64 . . . . 73.41 111.389 161.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -124.1 133.33 53.63 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.116 -1.439 . . . . 74.43 107.116 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.419 HD11 HD12 ' B' ' 105' ' ' ILE . 27.7 mt -77.0 123.96 34.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.902 -0.777 . . . . 73.42 108.902 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -83.01 -45.48 14.01 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.818 0.698 . . . . 74.12 109.911 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -170.32 130.98 0.94 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.931 -0.577 . . . . 74.14 110.279 -171.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 77.6 mt -113.91 139.47 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 107.408 -1.33 . . . . 75.52 107.408 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -161.93 152.73 17.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.576 0.703 . . . . 65.24 111.762 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 81.7 m -77.47 121.36 23.74 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.165 -1.379 . . . . 73.13 108.195 171.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.565 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.1 mtpt -93.62 -29.53 15.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.528 0.731 . . . . 71.22 110.453 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -160.69 139.25 10.1 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.363 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.532 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.6 mm -133.21 142.01 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.867 1.267 . . . . 73.1 108.802 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -138.56 129.99 27.41 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.493 -1.299 . . . . 75.41 107.493 171.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.7 t80 -142.78 132.4 23.84 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.294 -1.373 . . . . 65.25 107.294 170.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.29 148.43 51.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.686 -0.857 . . . . 73.45 108.686 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.643 ' HB3' ' HB3' ' B' ' 28' ' ' ALA . . . -142.85 77.67 16.25 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 107.538 -1.282 . . . . 74.23 107.538 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.83 -36.83 17.27 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.928 2.419 . . . . 72.33 112.265 -171.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -100.37 -0.94 37.27 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.598 0.759 . . . . 72.32 111.346 -174.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.643 ' HB3' ' HB3' ' B' ' 25' ' ' ALA . . . -36.67 -66.08 0.29 Allowed Pre-proline 0 N--CA 1.494 1.728 0 C-N-CA 125.834 1.653 . . . . 72.31 115.013 -165.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.09 -24.42 73.32 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.332 2.021 . . . . 75.21 113.305 -170.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -93.12 -32.21 14.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.367 0.667 . . . . 75.34 111.262 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.468 HG22 HD13 ' B' ' 68' ' ' LEU . 1.5 p -75.56 -20.81 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 122.895 0.478 . . . . 74.34 110.922 -172.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -66.4 -10.11 40.45 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.633 0.773 . . . . 74.23 112.952 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -61.73 -28.72 69.63 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.231 0.612 . . . . 72.34 110.266 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -90.44 96.84 10.85 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 124.34 1.056 . . . . 73.23 109.536 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.08 94.99 1.97 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.507 -0.923 . . . . 71.4 108.507 171.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.414 ' HZ3' ' H ' ' B' ' 69' ' ' GLY . 26.9 t90 -169.35 154.96 6.05 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.372 1.069 . . . . 74.45 108.844 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.426 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 0.1 OUTLIER -87.07 110.59 34.35 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.046 -1.094 . . . . 72.23 108.046 170.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.441 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 53.8 Cg_endo -68.69 143.24 55.52 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.817 2.345 . . . . 73.15 113.407 -170.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.5 107.96 0.75 Allowed 'General case' 0 C--O 1.242 0.663 0 O-C-N 124.281 0.988 . . . . 74.03 110.066 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.5 m -86.34 161.2 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.207 -0.906 . . . . 75.35 110.972 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.463 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 60.3 tttp -134.16 104.29 6.14 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.612 -1.255 . . . . 72.04 107.612 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.17 124.22 31.58 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.523 -0.917 . . . . 74.15 108.523 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -140.81 109.82 6.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.214 -1.402 . . . . 75.13 107.214 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.61 155.09 17.78 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.876 -0.787 . . . . 75.31 108.876 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -155.71 149.89 25.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.452 -1.249 . . . . 72.44 108.374 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -140.65 143.12 34.98 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.352 0.596 . . . . 72.34 111.099 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.43 148.48 37.85 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.942 1.297 . . . . 63.31 107.915 172.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 72.4 p -145.03 162.92 35.76 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.114 0.416 . . . . 74.1 111.456 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -151.84 147.82 27.08 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.906 0.882 . . . . 44.53 109.833 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -84.04 131.36 34.82 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.331 0.652 . . . . 74.22 109.566 172.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 43.3 mt -93.66 -44.31 8.24 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.333 0.653 . . . . 74.35 109.509 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.62 -176.35 5.89 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.369 1.068 . . . . 74.05 110.177 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -69.47 120.35 15.13 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.713 -1.131 . . . . 64.3 109.346 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.77 16.75 10.62 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.3 1.04 . . . . 73.2 112.072 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 67.1 t -130.15 104.06 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.221 -1.029 . . . . 74.41 108.221 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -112.55 167.25 10.61 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.922 -1.14 . . . . 74.31 107.922 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -143.38 121.37 12.07 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.202 -1.036 . . . . 74.25 108.202 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -106.5 143.29 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.173 0.989 . . . . 75.14 109.39 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.49 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 35.6 t -116.78 144.53 24.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.977 -0.749 . . . . 75.01 108.977 176.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.441 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -127.71 110.06 12.28 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.143 -1.058 . . . . 72.32 108.143 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.424 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 36.1 ttm180 -94.36 122.3 36.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.841 0.856 . . . . 73.54 110.162 171.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 47.7 t -116.44 103.43 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.387 -1.338 . . . . 72.34 107.387 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.2 m -98.9 131.7 44.78 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.302 0.641 . . . . 73.11 109.542 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.421 HG23 HD12 ' B' ' 114' ' ' ILE . 91.5 t -123.49 130.02 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.023 0.929 . . . . 61.34 109.631 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.5 m -119.25 136.88 54.01 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 108.85 -0.796 . . . . 73.32 108.85 172.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.49 151.95 43.76 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.057 0.389 . . . . 65.42 110.917 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.5 p -152.22 132.77 13.87 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.175 0.922 . . . . 75.1 111.515 -173.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.468 HD13 HG22 ' B' ' 31' ' ' VAL . 77.4 mt -93.51 104.17 16.32 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.682 -1.229 . . . . 64.21 107.682 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.414 ' H ' ' HZ3' ' B' ' 36' ' ' TRP . . . 85.57 -110.7 3.47 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.462 -0.655 . . . . 54.03 111.462 -174.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.77 1.17 9.93 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.888 0.875 . . . . 73.52 110.419 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -113.55 150.87 32.36 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.034 -0.728 . . . . 71.01 109.034 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -62.16 139.11 58.48 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.822 0.702 . . . . 74.33 110.908 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.465 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -97.4 -67.78 0.83 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.545 -1.279 . . . . 74.5 107.545 170.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -145.18 160.61 41.18 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.005 -0.998 . . . . 74.54 109.993 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -135.0 138.64 44.16 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.471 -1.677 . . . . 70.44 106.471 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -150.04 157.87 43.58 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.876 0.369 . . . . 74.14 110.084 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -164.62 135.55 4.18 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.03 -1.1 . . . . 63.5 108.03 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 95.8 t -126.2 145.88 32.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.572 -0.899 . . . . 75.12 108.572 172.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.424 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 45.3 mt-30 -123.29 86.69 2.62 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.739 -0.837 . . . . 75.45 108.739 171.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.594 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.0 tp-100 -83.26 101.43 11.25 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.955 -1.021 . . . . 73.43 109.424 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.565 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.55 169.9 34.74 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.894 -0.482 . . . . 55.42 111.894 175.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.26 137.12 4.57 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 111.304 -0.718 . . . . 43.45 111.304 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.3 mt -96.87 125.91 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.044 0.938 . . . . 75.43 108.529 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -128.3 131.26 48.67 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.662 -1.236 . . . . 72.11 107.662 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 45.0 m -97.96 89.82 4.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.463 -0.569 . . . . 72.21 109.463 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.435 ' HB ' HD12 ' B' ' 89' ' ' ILE . 1.6 pp -94.42 139.67 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.424 0.69 . . . . 74.42 111.527 -166.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.29 138.49 21.43 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.37 1.068 . . . . 75.42 109.294 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.4 -35.87 4.02 Favored Glycine 0 C--N 1.345 1.033 0 O-C-N 123.642 0.589 . . . . 62.41 113.307 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.435 HD12 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -54.64 137.48 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 C-N-CA 124.805 1.242 . . . . 71.41 112.752 -175.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -158.9 142.34 14.89 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.563 0.345 . . . . 75.44 111.282 175.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' B' ' 94' ' ' MET . . . 67.04 -121.92 17.57 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 114.573 0.589 . . . . 72.04 114.573 173.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 84.8 m -65.66 -33.21 75.36 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.645 0.778 . . . . 75.03 110.193 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -68.29 -39.26 82.14 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.34 -0.845 . . . . 74.41 110.202 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' B' ' 91' ' ' GLY . 17.5 ptm -78.79 -28.9 44.68 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 116.314 -0.403 . . . . 64.02 110.72 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.91 -30.55 62.65 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.2 0.6 . . . . 70.33 110.916 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -79.61 -33.48 41.48 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.092 0.957 . . . . 72.53 109.994 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.6 t -71.37 -65.15 0.79 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.587 0.755 . . . . 62.14 110.298 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 50.6 mt -80.45 -20.24 44.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.823 0.849 . . . . 71.23 112.395 -171.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.65 -13.16 41.75 Favored Glycine 0 N--CA 1.477 1.383 0 CA-C-O 119.646 -0.53 . . . . 74.14 114.363 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.93 -52.86 0.52 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 117.612 0.706 . . . . 74.43 111.688 -172.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -73.58 -38.47 65.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.047 0.539 . . . . 75.14 111.601 -173.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 84.4 m -70.43 -48.23 18.1 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-O 118.655 -0.688 . . . . 74.13 111.246 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.441 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 53.5 Cg_exo -55.86 -33.26 87.97 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.107 1.872 . . . . 70.4 113.701 168.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -59.52 -39.21 83.16 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.332 0.653 . . . . 72.12 111.644 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.419 HD12 HD11 ' B' ' 13' ' ' ILE . 79.8 mt -66.11 -41.06 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.09 0.956 . . . . 62.54 110.844 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 52.6 mt -80.13 -16.04 55.78 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.404 -0.817 . . . . 70.32 111.887 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -60.21 -48.8 93.26 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.198 0.999 . . . . 73.02 113.589 -172.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.558 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 33.3 Cg_endo -61.34 -34.08 88.0 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.141 1.894 . . . . 75.12 113.498 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.594 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 94.3 m-85 -67.39 -46.86 72.01 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.692 0.397 . . . . 75.3 110.234 177.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.45 86.08 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.47 -0.786 . . . . 53.45 111.112 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.565 ' HA ' HD21 ' B' ' 128' ' ' LEU . 29.0 mtp-105 -55.16 -61.39 2.35 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.376 1.07 . . . . 74.23 111.36 175.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.37 -27.85 69.29 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.07 0.856 . . . . 74.44 110.781 -173.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.532 ' SG ' HD13 ' B' ' 21' ' ' ILE . 4.5 t -73.32 -37.94 65.97 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.108 0.563 . . . . 73.02 111.048 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.421 HD12 HG23 ' B' ' 64' ' ' VAL . 71.2 mt -64.89 -51.86 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.449 -0.574 . . . . 74.33 109.449 173.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.52 HG22 ' OG ' ' C' ' 119' ' ' SER . 14.4 m -58.19 -34.63 70.56 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 124.406 1.067 . . . . 74.44 111.902 -176.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 25.7 t -58.86 -52.25 66.55 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 124.028 0.83 . . . . 74.53 109.46 175.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.2 mmt -69.28 -33.46 73.24 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.496 0.719 . . . . 75.32 111.417 -174.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.04 -44.33 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.974 0.91 . . . . 63.31 110.496 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -69.48 -32.17 70.9 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.178 -0.919 . . . . 61.45 111.209 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.1 mtt-85 -67.7 -37.97 83.02 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.393 -0.821 . . . . 72.32 109.357 175.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.43 4.14 64.86 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 124.161 0.913 . . . . 73.32 113.237 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.461 HG21 ' HB3' ' A' ' 17' ' ' TYR . 82.1 p 58.8 32.07 21.85 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.169 1.787 . . . . 71.21 113.12 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -95.47 154.25 39.36 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 124.203 1.001 . . . . 71.44 110.972 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.426 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 81.2 Cg_exo -49.92 158.77 1.97 Allowed 'Trans proline' 0 C--N 1.39 2.731 0 C-N-CA 124.299 3.333 . . . . 64.42 115.652 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.431 HE21 ' ND2' ' B' ' 127' ' ' ASN . 67.6 tp60 -63.94 130.75 45.34 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 114.636 -1.166 . . . . 75.01 112.251 -172.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 68.6 tp -141.53 123.77 15.63 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.938 0.895 . . . . 71.0 109.709 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.431 ' ND2' HE21 ' B' ' 125' ' ' GLN . 51.0 m-80 -130.49 136.36 48.9 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.209 -1.034 . . . . 74.43 108.209 168.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' B' ' 111' ' ' ARG . 1.9 mm? -82.93 119.66 24.7 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.457 -0.942 . . . . 75.54 108.457 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.02 150.37 71.64 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.183 0.593 . . . . 72.43 111.054 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.09 140.58 41.78 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.061 2.508 . . . . 75.14 112.817 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.38 145.6 34.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.446 -1.316 . . . . 71.44 107.446 167.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -66.61 101.51 0.79 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.605 0.762 . . . . 73.0 110.902 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -61.11 -32.58 72.26 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.004 0.521 . . . . 75.11 110.126 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -69.78 -52.61 23.75 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.407 1.083 . . . . 60.13 111.193 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.19 -44.4 95.12 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 123.707 0.63 . . . . 64.43 111.184 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 66.7 mt -61.2 -37.48 83.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.959 0.504 . . . . 74.21 111.44 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 72.4 t80 . . . . . 0 N--CA 1.472 0.627 0 O-C-N 123.53 0.519 . . . . 73.43 110.733 -176.913 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.604 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 43.6 m . . . . . 0 C--O 1.242 0.674 0 N-CA-C 108.84 -0.8 . . . . 73.04 108.84 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.562 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 6.0 t80 -110.03 124.81 52.11 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.827 -0.805 . . . . 75.43 108.827 174.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -145.83 134.19 21.87 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.601 0.76 . . . . 72.15 109.162 171.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.406 HG21 HD13 ' C' ' 16' ' ' ILE . 67.2 mt -78.17 122.44 33.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.323 -0.991 . . . . 73.31 108.323 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.621 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 82.4 mm-40 -89.77 -42.19 11.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.217 -0.901 . . . . 74.42 110.639 -175.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.4 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 17.6 ttt180 -175.6 129.82 0.26 Allowed 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.384 0.427 . . . . 74.04 110.214 -168.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.406 HD13 HG21 ' C' ' 13' ' ' ILE . 66.5 mt -121.77 131.8 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.636 -0.876 . . . . 70.04 108.636 -177.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.478 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 32.6 p90 -171.36 173.09 4.96 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.706 0.765 . . . . 73.44 111.311 -169.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.3 p -95.88 119.58 34.64 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.32 -0.855 . . . . 71.04 109.572 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.478 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 21.8 mmtp -65.32 -47.74 75.49 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 107.581 -1.266 . . . . 73.0 107.581 169.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 21.9 t70 -144.04 143.84 31.36 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 113.352 -1.749 . . . . 70.32 109.936 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.3 mt -129.96 144.36 38.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.475 -1.676 . . . . 73.4 106.475 172.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -152.53 147.25 25.98 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.35 0.595 . . . . 71.13 109.712 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -144.55 137.06 26.53 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.451 -1.314 . . . . 75.23 107.451 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -135.22 131.43 36.67 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.858 0.863 . . . . 74.51 109.352 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.28 76.63 5.65 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 106.799 -1.556 . . . . 62.13 106.799 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.66 -42.0 5.38 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.229 1.953 . . . . 75.31 111.429 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -96.96 29.04 3.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.525 1.13 . . . . 74.51 110.595 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.401 ' HB2' ' HE2' ' D' ' 17' ' ' TYR . . . -51.63 -55.87 25.97 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.201 -0.904 . . . . 74.13 113.408 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.5 -32.9 70.18 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 121.723 1.615 . . . . 73.34 112.684 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -67.99 -44.48 76.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.081 0.553 . . . . 72.31 110.859 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.8 p -77.17 -22.65 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 112.708 0.632 . . . . 74.01 112.708 -173.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -63.72 -33.6 76.02 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.22 0.452 . . . . 74.42 112.22 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -85.79 11.18 11.68 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.471 0.308 . . . . 71.13 111.572 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.791 ' HG2' HD12 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -89.95 158.51 17.36 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.505 0.722 . . . . 74.43 109.978 175.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -65.17 129.0 38.11 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.942 0.897 . . . . 73.53 109.791 165.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 58.9 t90 -82.03 94.16 7.12 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.386 0.674 . . . . 74.14 111.312 -172.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -141.39 76.15 21.65 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.644 0.778 . . . . 74.12 108.934 172.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -83.54 126.98 4.25 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.118 2.545 . . . . 54.1 113.252 -175.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.37 103.38 13.49 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.271 -1.381 . . . . 74.05 107.271 168.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 19.6 m -88.33 103.56 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.155 0.979 . . . . 74.41 110.855 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.543 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 82.7 tttt -93.87 104.11 16.19 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.802 -1.09 . . . . 75.2 108.644 177.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.13 136.72 32.82 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.351 -0.981 . . . . 74.21 108.351 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -130.88 105.34 7.7 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.927 -0.768 . . . . 73.02 108.927 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mp -103.19 135.02 45.63 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.239 -1.023 . . . . 73.45 108.239 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -151.44 155.48 38.67 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.515 0.726 . . . . 72.34 110.061 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -139.04 146.72 41.16 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.128 0.571 . . . . 75.34 109.719 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.84 146.66 43.71 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.153 0.981 . . . . 71.22 108.949 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.1 p -137.0 151.78 49.38 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.111 0.564 . . . . 73.14 110.297 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 86.4 p -149.41 157.94 43.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.854 0.862 . . . . 72.33 109.76 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -89.36 118.77 29.27 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.982 -0.747 . . . . 74.5 108.982 174.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.525 HD12 HD13 ' C' ' 83' ' ' ILE . 57.5 mt -90.8 -40.3 11.87 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.299 0.571 . . . . 63.24 109.779 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.71 177.82 10.28 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 114.395 -1.275 . . . . 62.12 108.95 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.64 119.56 14.06 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 109.264 -0.643 . . . . 73.31 109.264 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 66.92 21.81 10.27 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.545 1.138 . . . . 74.4 111.15 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 65.9 t -126.69 101.61 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.855 1.262 . . . . 73.14 108.158 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.584 ' HB2' HD13 ' C' ' 86' ' ' ILE . 0.2 OUTLIER -104.23 138.04 41.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.173 -0.677 . . . . 73.51 109.173 177.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.49 ' HB2' HD12 ' C' ' 51' ' ' LEU . 29.1 tt0 -85.57 137.75 32.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.577 -1.192 . . . . 73.31 108.667 166.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 t -122.18 139.54 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.682 -1.229 . . . . 72.42 107.682 167.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 49.6 t -131.79 131.94 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 108.545 -0.909 . . . . 73.54 108.545 175.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.21 109.35 21.01 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.802 -1.555 . . . . 73.51 106.802 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.408 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 5.8 tmm_? -99.5 105.73 17.67 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.748 -1.204 . . . . 74.34 107.748 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.474 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.3 t -107.77 138.37 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.478 -0.934 . . . . 64.44 108.478 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 35.7 m -134.04 121.22 21.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.35 -0.611 . . . . 74.03 109.35 171.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.547 HG12 HD13 ' C' ' 126' ' ' LEU . 59.7 t -106.35 111.72 36.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 114.885 -1.052 . . . . 73.45 109.014 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 7.0 m -103.36 142.72 33.74 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.213 -0.903 . . . . 72.11 109.42 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.88 120.71 19.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.716 -1.216 . . . . 74.32 107.716 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.6 m -140.44 128.0 21.5 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.565 0.541 . . . . 71.34 110.816 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.791 HD12 ' HG2' ' C' ' 34' ' ' LYS . 8.5 mt -89.27 31.63 0.89 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.174 1.39 . . . . 74.1 110.813 -176.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.67 -105.42 0.95 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 109.808 -1.317 . . . . 64.21 109.808 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.13 -18.08 17.87 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.981 0.913 . . . . 64.44 110.053 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.671 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 5.7 tp10 -76.37 119.17 19.88 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.898 0.879 . . . . 75.14 109.515 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 44.8 m -76.98 128.42 34.48 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.261 -0.644 . . . . 74.24 109.261 172.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.562 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -78.39 -56.39 4.49 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.287 -1.005 . . . . 73.34 108.287 170.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . 0.541 ' HZ ' HD12 ' C' ' 126' ' ' LEU . 41.5 p90 -163.83 174.31 11.71 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.359 0.663 . . . . 74.33 110.716 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.12 107.68 5.07 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.37 -1.344 . . . . 74.25 107.37 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -110.58 143.43 41.0 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.827 -0.805 . . . . 63.43 108.827 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.81 134.39 15.44 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.348 0.659 . . . . 63.24 109.646 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.1 t -135.89 119.54 24.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 124.281 1.032 . . . . 64.01 109.19 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.408 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 54.3 mt-30 -92.17 88.27 6.43 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.58 -0.896 . . . . 72.3 108.58 170.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -79.64 99.49 7.39 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.736 -0.665 . . . . 60.12 109.785 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.22 144.2 16.97 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 116.416 -0.356 . . . . 71.52 112.518 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.562 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -149.23 135.4 5.35 Favored Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 110.536 -1.026 . . . . 42.54 110.536 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 8.8 mm -94.8 127.01 47.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.429 -0.952 . . . . 72.54 108.429 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.562 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 47.0 m-85 -134.22 118.38 17.55 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.251 -0.648 . . . . 75.12 109.251 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 53.8 m -75.7 132.92 40.84 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.219 -0.66 . . . . 74.4 109.219 175.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.584 HD13 ' HB2' ' C' ' 56' ' ' TYR . 1.1 pp -134.38 107.23 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.189 0.996 . . . . 74.35 109.219 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.604 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -130.25 157.71 41.75 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.898 -0.779 . . . . 72.42 108.898 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.22 -42.8 3.02 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 123.15 0.281 . . . . 74.13 113.22 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 46.4 pt -93.26 169.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.544 0.738 . . . . 71.54 110.445 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -170.47 171.88 6.29 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 124.012 0.82 . . . . 73.33 109.622 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.87 -123.64 7.53 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.777 -0.457 . . . . 65.42 112.755 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 69.1 p -68.44 -29.24 67.84 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.418 0.687 . . . . 62.14 111.234 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -64.16 -51.23 64.85 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.244 1.017 . . . . 72.23 110.645 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 21.2 ptm -74.01 -28.18 61.32 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.284 0.365 . . . . 74.4 110.564 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.11 -43.98 87.45 Favored 'General case' 0 C--N 1.362 1.135 0 O-C-N 123.682 0.614 . . . . 73.2 109.594 173.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -77.61 -42.05 36.38 Favored 'General case' 0 C--O 1.245 0.863 0 O-C-N 123.562 0.539 . . . . 71.11 111.809 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -61.79 -39.03 90.25 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.058 0.849 . . . . 71.24 110.693 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.47 HD12 HG12 ' C' ' 86' ' ' ILE . 33.5 mt -101.3 -17.01 16.75 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 122.888 0.475 . . . . 75.11 111.74 -177.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' C' ' 137' ' ' PHE . . . -77.2 -29.2 56.9 Favored Glycine 0 C--N 1.354 1.583 0 N-CA-C 114.558 0.583 . . . . 55.21 114.558 -175.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.12 -36.09 0.09 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 120.805 0.336 . . . . 63.54 111.736 -169.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.53 -45.88 74.43 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.267 1.427 . . . . 75.31 112.125 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 55.5 m -76.68 -42.56 2.98 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 118.625 -0.702 . . . . 71.01 112.734 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.31 -27.35 57.03 Favored 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 122.194 1.929 . . . . 73.43 113.832 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -66.74 -36.92 83.6 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.519 0.727 . . . . 64.01 110.845 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.453 HG23 ' NH1' ' A' ' 111' ' ' ARG . 44.2 mm -63.18 -38.28 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.352 0.661 . . . . 73.02 109.617 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.562 HD23 ' HA3' ' C' ' 82' ' ' GLY . 90.9 mt -81.83 -18.12 45.04 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.808 -1.087 . . . . 74.42 112.765 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -60.49 -48.67 92.99 Favored Pre-proline 0 CA--C 1.561 1.371 0 N-CA-C 114.133 1.16 . . . . 74.24 114.133 -172.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -62.85 -34.11 73.26 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.845 1.697 . . . . 63.23 112.7 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -70.05 -45.64 66.67 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.47 0.708 . . . . 74.51 111.013 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.38 95.79 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 115.834 -0.621 . . . . 72.43 109.613 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.541 ' HG3' HD23 ' C' ' 128' ' ' LEU . 65.3 ttt180 -57.45 -52.85 63.73 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 124.599 1.187 . . . . 75.32 111.341 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.43 -31.33 71.44 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.921 0.488 . . . . 71.33 110.584 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.8 t -73.06 -34.5 66.3 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.965 0.506 . . . . 72.23 111.132 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.474 HD11 ' HB ' ' C' ' 62' ' ' VAL . 83.8 mt -68.59 -53.71 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.261 0.624 . . . . 64.45 109.591 174.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.3 m -63.19 -28.27 69.93 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.205 1.002 . . . . 72.24 111.389 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.8 t -64.05 -51.93 61.79 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.359 0.663 . . . . 72.44 109.417 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.572 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.55 -32.13 73.04 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.3 1.04 . . . . 70.21 112.766 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.549 HG22 HD11 ' C' ' 126' ' ' LEU . 71.7 t -67.02 -46.59 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.664 0.786 . . . . 70.3 110.095 174.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.52 ' OG ' HG22 ' B' ' 115' ' ' THR . 36.9 t -63.51 -34.86 78.71 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.045 -0.979 . . . . 74.54 111.445 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -69.29 -43.57 73.57 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.305 -0.861 . . . . 74.43 109.355 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.75 -4.87 72.41 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.783 0.677 . . . . 71.12 112.802 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.463 HG21 ' HB3' ' D' ' 17' ' ' TYR . 27.5 p 61.9 34.83 16.7 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.776 2.03 . . . . 73.41 113.138 174.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -88.09 159.74 47.56 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.397 1.079 . . . . 73.22 109.704 171.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.1 164.34 8.53 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 123.373 2.715 . . . . 71.41 114.639 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -55.32 133.22 49.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.871 1.268 . . . . 73.34 113.001 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.549 HD11 HG22 ' C' ' 118' ' ' VAL . 36.2 mt -117.38 108.77 15.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.794 0.837 . . . . 71.53 109.607 170.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.7 110.97 22.52 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.491 -0.929 . . . . 75.45 108.491 174.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.541 HD23 ' HG3' ' C' ' 111' ' ' ARG . 3.7 mm? -76.6 133.14 39.74 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.627 -0.509 . . . . 75.41 109.627 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.08 139.6 82.45 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 124.054 0.846 . . . . 74.12 111.133 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.449 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 43.0 Cg_endo -67.58 96.43 0.42 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.647 2.231 . . . . 74.53 111.99 173.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.23 116.05 39.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.482 -1.303 . . . . 74.34 107.482 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -78.19 79.28 4.65 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.584 -0.895 . . . . 71.25 108.584 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -55.8 -34.22 65.12 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.867 0.867 . . . . 73.53 110.814 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -60.48 -51.29 70.09 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.854 1.262 . . . . 62.24 111.451 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.1 -38.8 92.39 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.046 0.539 . . . . 62.1 111.088 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.35 -27.8 67.43 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.374 -0.83 . . . . 71.15 111.338 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . 0.417 ' CE2' ' HA3' ' C' ' 99' ' ' GLY . 3.4 t80 . . . . . 0 N--CA 1.486 1.362 0 C-N-CA 123.283 0.633 . . . . 71.2 110.179 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.482 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 86.5 m . . . . . 0 CA--C 1.538 0.481 0 CA-C-O 121.237 0.541 . . . . 74.13 110.207 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -156.25 103.83 2.2 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.355 -1.35 . . . . 74.41 107.355 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -125.86 147.28 49.5 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.417 -0.957 . . . . 74.52 108.417 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.44 HG21 HD13 ' D' ' 16' ' ' ILE . 8.7 mt -95.85 129.51 45.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.71 -0.848 . . . . 74.21 108.71 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -87.08 -37.35 17.5 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.457 0.703 . . . . 73.12 111.711 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -167.82 124.71 1.12 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.004 0.372 . . . . 75.25 112.004 -170.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.44 HD13 HG21 ' D' ' 13' ' ' ILE . 2.0 mp -104.15 132.49 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.133 -1.432 . . . . 63.51 107.133 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.463 ' HB3' HG21 ' C' ' 122' ' ' THR . 21.6 p90 -162.91 153.21 16.32 Favored 'General case' 0 C--N 1.337 0.061 0 O-C-N 123.652 0.595 . . . . 75.43 110.908 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -84.32 123.33 30.06 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.874 -0.787 . . . . 72.54 108.874 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.8 mtpt -92.25 -22.91 19.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.46 -0.57 . . . . 73.31 109.46 175.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.3 t70 -152.52 140.24 19.9 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.612 0.765 . . . . 75.24 109.496 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.572 HG23 ' HE1' ' C' ' 117' ' ' MET . 78.0 mt -139.83 145.6 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.805 -1.183 . . . . 74.24 107.805 174.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 58.6 m -148.5 121.45 8.78 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.431 1.093 . . . . 72.51 109.718 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.526 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 92.6 t80 -124.13 117.68 25.18 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.296 -1.742 . . . . 74.2 106.296 166.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.59 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 31.6 mt-10 -127.92 109.29 11.45 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.62 -0.511 . . . . 73.1 109.62 -174.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.41 85.91 17.04 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 108.099 -1.075 . . . . 73.52 108.099 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.83 -26.93 15.19 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.502 2.134 . . . . 75.34 112.092 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -104.24 8.37 36.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.884 0.874 . . . . 74.31 110.259 -174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -32.99 -68.68 0.15 Allowed Pre-proline 0 CA--C 1.567 1.617 0 N-CA-C 116.32 1.97 . . . . 73.32 116.32 -165.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.533 ' HB3' HD11 ' C' ' 83' ' ' ILE . 75.7 Cg_endo -73.06 -21.49 20.55 Favored 'Trans proline' 0 C--N 1.384 2.423 0 CA-C-N 123.598 2.321 . . . . 65.44 113.699 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -74.47 -39.84 62.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.823 1.249 . . . . 72.5 110.004 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' D' ' 73' ' ' ALA . 7.4 p -83.67 -24.74 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.076 0.55 . . . . 74.15 112.274 -170.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.92 -19.03 63.84 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 122.867 0.467 . . . . 73.5 112.157 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -69.03 0.06 5.07 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.348 1.059 . . . . 73.14 111.933 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -110.72 100.85 9.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.881 1.272 . . . . 74.21 109.949 168.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.31 90.01 4.96 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.341 0.591 . . . . 74.44 109.598 171.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.453 ' CH2' ' HB2' ' D' ' 39' ' ' GLU . 19.7 t90 -154.32 156.11 36.34 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.1 -1.444 . . . . 71.55 107.1 174.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -70.58 107.88 2.98 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.398 -1.334 . . . . 75.41 107.398 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.423 ' O ' HG13 ' D' ' 40' ' ' VAL . 50.6 Cg_exo -55.21 125.55 19.53 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.89 2.394 . . . . 70.42 111.473 -171.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.453 ' HB2' ' CH2' ' D' ' 36' ' ' TRP . 34.1 tt0 -58.48 110.66 1.02 Allowed 'General case' 0 C--N 1.353 0.756 0 O-C-N 124.172 0.92 . . . . 75.24 109.667 -177.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.423 HG13 ' O ' ' D' ' 38' ' ' PRO . 16.2 m -98.25 122.36 49.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 121.607 0.717 . . . . 74.23 110.455 -171.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.407 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 53.3 tttm -86.27 132.28 34.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 106.392 -1.707 . . . . 63.22 106.392 165.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.21 109.15 12.0 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.326 -0.99 . . . . 74.15 108.326 -169.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -127.41 149.75 49.94 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.387 1.075 . . . . 64.04 108.387 -176.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.499 HD21 HD23 ' D' ' 60' ' ' LEU . 8.4 tt -139.43 139.25 37.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.076 -0.713 . . . . 75.53 109.076 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -133.54 139.7 46.75 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.384 1.474 . . . . 74.3 107.31 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -105.82 164.73 11.71 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.074 -0.713 . . . . 74.1 109.074 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.54 160.55 40.61 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.879 0.872 . . . . 73.11 108.899 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -159.15 151.22 20.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.053 0.541 . . . . 73.33 110.046 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.2 p -160.64 129.84 4.88 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.053 0.941 . . . . 74.33 109.167 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -73.93 133.64 43.09 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.19 0.596 . . . . 73.25 110.251 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 54.2 mt -100.76 -34.5 9.81 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.248 0.619 . . . . 74.45 110.717 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.96 -176.24 5.38 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.807 0.843 . . . . 73.25 109.974 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.85 121.62 14.48 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.108 -0.951 . . . . 74.41 109.933 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 65.61 2.93 2.23 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.886 1.275 . . . . 75.22 113.101 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.0 t -112.67 116.41 52.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.327 -0.99 . . . . 72.34 108.327 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -133.53 130.48 38.53 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.091 -1.077 . . . . 74.42 108.091 -171.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -98.65 143.81 28.62 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.923 0.889 . . . . 74.52 109.48 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 54.8 t -120.04 137.66 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.78 -1.193 . . . . 75.41 107.78 166.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.455 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.3 t -116.0 126.58 73.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.788 -1.19 . . . . 71.51 107.788 175.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.499 HD23 HD21 ' D' ' 44' ' ' LEU . 0.0 OUTLIER -104.17 117.41 34.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.619 -0.882 . . . . 71.44 108.619 -177.268 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -102.84 96.35 6.78 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.66 -0.867 . . . . 73.52 108.66 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 50.7 t -96.31 130.22 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.21 -1.033 . . . . 73.01 108.21 170.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 19.2 m -128.9 132.99 47.73 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.273 0.629 . . . . 73.13 110.446 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 69.1 t -126.29 112.39 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.736 1.214 . . . . 74.43 109.555 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 30.7 m -103.1 96.04 6.52 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.493 0.717 . . . . 75.14 109.301 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.13 153.83 17.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.95 0.5 . . . . 71.22 111.2 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.6 p -152.37 127.63 9.86 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.925 -0.579 . . . . 73.14 111.276 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 25.2 mt -95.76 101.71 13.43 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.967 -1.123 . . . . 73.41 107.967 170.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . 0.42 ' H ' ' HZ3' ' D' ' 36' ' ' TRP . . . 68.14 -118.6 9.63 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 123.63 0.581 . . . . 75.45 113.797 177.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.76 5.3 46.63 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.629 0.771 . . . . 71.34 113.053 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.21 164.49 32.11 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 120.89 0.376 . . . . 75.14 110.791 -174.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.1 m -68.15 132.03 46.47 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.045 -0.98 . . . . 73.13 110.697 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.588 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -86.74 -71.98 0.53 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.711 -1.218 . . . . 75.33 107.711 174.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -141.43 151.37 43.35 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 121.318 0.58 . . . . 73.35 110.436 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.59 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 72.2 mt -111.41 146.37 37.29 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.565 -1.272 . . . . 75.03 107.565 171.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.488 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.2 m -146.69 132.46 18.97 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.876 0.87 . . . . 74.34 108.686 -174.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -155.7 126.24 6.81 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.138 -1.06 . . . . 73.03 108.138 170.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.1 t -131.15 115.28 29.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 108.911 -0.774 . . . . 75.34 108.911 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 70.7 mt-30 -93.1 85.59 5.12 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.966 -0.753 . . . . 73.02 108.966 173.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.09 97.11 6.71 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.516 -1.22 . . . . 73.12 109.022 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.7 144.03 20.22 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.862 -0.495 . . . . 71.23 111.862 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.425 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -140.06 130.04 4.5 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 111.037 -0.825 . . . . 70.21 111.037 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.412 HG13 ' HE1' ' D' ' 17' ' ' TYR . 54.5 mt -90.54 123.95 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.989 -1.115 . . . . 75.34 107.989 177.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -123.95 136.06 54.07 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.638 0.775 . . . . 75.35 110.13 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 20.8 m -93.3 112.08 23.91 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.442 -0.947 . . . . 73.42 108.442 171.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 31.4 pt -108.19 122.27 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-O 121.19 0.519 . . . . 73.24 110.211 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.482 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -147.47 154.41 40.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.529 1.132 . . . . 51.32 109.072 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.23 -19.63 7.98 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 114.054 0.382 . . . . 71.2 114.054 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -127.3 154.49 37.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 124.448 1.099 . . . . 72.13 109.332 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.49 159.39 22.03 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 123.632 0.582 . . . . 75.34 110.695 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.61 -99.16 0.08 OUTLIER Glycine 0 C--N 1.355 1.597 0 O-C-N 124.218 0.949 . . . . 71.35 114.763 170.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 25.6 m -68.42 -44.38 75.12 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.246 1.018 . . . . 74.33 111.453 -174.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -72.61 -29.54 63.58 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.056 -0.52 . . . . 73.34 110.563 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 35.1 ttp -60.25 -34.97 74.45 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 123.662 0.601 . . . . 75.03 110.35 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.16 82.07 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 122.306 -0.247 . . . . 73.24 111.438 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -80.08 -43.94 20.9 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.284 0.634 . . . . 74.45 111.945 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 43.8 t -74.29 -42.57 59.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.361 0.664 . . . . 75.25 110.703 -172.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.543 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 15.0 tp -87.93 -33.84 18.32 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.362 1.065 . . . . 73.2 110.45 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.22 -26.09 29.37 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-N 116.356 -0.383 . . . . 73.34 113.948 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.18 -57.88 2.04 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 117.186 0.493 . . . . 71.15 111.389 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -70.13 -33.83 72.3 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.553 0.575 . . . . 73.51 112.553 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 69.4 m -67.36 -49.55 42.49 Favored Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 118.477 -0.773 . . . . 60.11 111.825 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.38 -30.06 90.13 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 121.864 1.71 . . . . 62.41 113.727 168.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -64.78 -37.98 89.44 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.516 0.726 . . . . 75.03 110.118 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 30.5 mm -62.94 -45.48 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.722 0.809 . . . . 75.32 110.873 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.425 HD22 ' HA3' ' D' ' 82' ' ' GLY . 83.2 mt -77.25 -18.18 57.82 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.926 -1.034 . . . . 71.22 112.399 -170.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -69.69 -42.12 18.15 Favored Pre-proline 0 N--CA 1.486 1.329 0 N-CA-C 113.914 1.079 . . . . 73.01 113.914 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.69 -41.75 60.12 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.033 1.822 . . . . 52.23 113.107 169.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -75.36 -35.15 61.17 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.975 0.91 . . . . 73.41 111.6 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.24 -46.55 67.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.01 0.524 . . . . 71.43 110.192 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -53.67 -49.12 68.67 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.751 1.282 . . . . 75.03 110.73 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.72 -45.77 92.54 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.308 1.005 . . . . 75.33 111.977 -175.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.4 t -63.15 -39.57 95.06 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.63 0.581 . . . . 64.34 111.231 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.432 ' O ' HG23 ' D' ' 118' ' ' VAL . 86.2 mt -59.76 -55.49 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.554 0.741 . . . . 73.31 110.093 172.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 38.3 m -56.68 -40.16 75.08 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.804 1.242 . . . . 74.41 112.005 -174.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -68.35 -40.62 81.48 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.06 -0.973 . . . . 74.33 110.561 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.526 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 68.5 mtm -68.33 -33.2 73.88 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.611 0.365 . . . . 71.21 111.524 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.432 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.8 t -63.65 -43.46 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.601 0.761 . . . . 64.43 110.36 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.89 -30.93 61.45 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 116.178 -0.464 . . . . 71.14 111.206 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -74.18 -26.15 60.12 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.205 0.602 . . . . 75.22 110.32 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.44 7.96 74.94 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.646 0.591 . . . . 71.55 112.404 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 44.3 p 61.11 17.21 7.84 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.514 1.926 . . . . 72.03 114.81 174.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.09 150.97 72.44 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 109.558 -0.534 . . . . 73.35 109.558 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.6 127.87 22.04 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.116 2.544 . . . . 71.52 111.448 171.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -51.65 145.31 9.39 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.676 1.235 . . . . 74.41 113.007 -171.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 56.8 tp -117.05 106.19 13.11 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.692 -0.686 . . . . 73.44 109.538 -175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -101.95 104.19 14.87 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.037 -0.727 . . . . 74.41 109.037 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.82 118.35 13.5 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.156 -0.683 . . . . 70.31 109.156 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 135.76 89.24 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.214 0.605 . . . . 75.31 110.137 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.84 119.34 6.35 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.63 2.22 . . . . 72.32 112.314 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 82.8 t -108.85 115.55 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.083 0.953 . . . . 74.32 108.916 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -77.79 113.2 15.42 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.943 0.497 . . . . 70.43 110.037 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -72.22 -35.88 68.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.684 0.793 . . . . 72.24 111.509 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.47 -50.35 74.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.412 1.085 . . . . 73.22 111.739 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.31 71.51 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.156 0.582 . . . . 64.25 110.636 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 34.4 mt -63.3 -23.76 67.56 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.41 0.684 . . . . 72.34 112.571 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 88.4 t80 . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 123.654 0.782 . . . . 71.43 110.238 178.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 109.82 -0.437 . . . . 74.14 109.82 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.7 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 17.3 t80 -127.14 131.07 50.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.303 1.041 . . . . 73.33 109.191 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 26.5 tp60 -147.79 107.34 3.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.276 0.631 . . . . 71.45 110.052 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.588 HG12 ' HD2' ' A' ' 84' ' ' PHE . 60.7 mt -75.02 120.58 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.586 -0.524 . . . . 72.44 109.586 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -89.63 -36.99 14.96 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 124.079 0.862 . . . . 73.04 110.027 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -169.15 146.0 3.52 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 110.454 -0.202 . . . . 73.23 110.454 -171.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.448 HD13 ' HG3' ' C' ' 130' ' ' PRO . 97.6 mt -137.9 128.37 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 124.544 1.138 . . . . 73.35 108.058 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -167.83 154.63 8.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.716 0.806 . . . . 74.02 111.205 -172.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.7 p -75.14 112.82 11.79 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.238 -0.652 . . . . 73.22 109.238 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HG3' ' HA3' ' A' ' 81' ' ' GLY . 32.6 mtpt -71.61 -34.35 69.78 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.251 -0.431 . . . . 63.53 110.481 174.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -153.79 148.65 26.57 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.056 -0.974 . . . . 74.52 109.111 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 22' ' ' SER . 80.9 mt -138.19 148.77 24.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 C-N-CA 124.947 1.299 . . . . 74.14 108.043 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.58 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 17.9 t -147.14 142.3 27.19 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.892 0.877 . . . . 74.42 109.93 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.538 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.3 t80 -153.06 132.88 13.2 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.625 1.17 . . . . 71.41 107.859 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -139.85 135.1 32.59 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.499 1.119 . . . . 72.0 108.34 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.06 87.46 48.39 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 108.32 -0.993 . . . . 74.13 108.32 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 37.3 Cg_exo -64.09 -48.65 4.7 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.608 2.872 . . . . 74.1 113.107 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -91.96 24.43 3.24 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.784 0.834 . . . . 74.13 111.169 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.473 ' HB1' ' HE2' ' B' ' 17' ' ' TYR . . . -53.07 -48.91 90.23 Favored Pre-proline 0 CA--C 1.568 1.638 0 N-CA-C 114.837 1.421 . . . . 65.14 114.837 -173.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.47 -19.73 16.62 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 121.742 1.628 . . . . 75.3 111.94 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -100.64 -13.42 18.56 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.074 -0.966 . . . . 75.1 112.29 -170.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.56 -26.04 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.798 0.839 . . . . 61.15 112.055 -169.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -78.9 -33.77 45.28 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.988 -1.006 . . . . 71.51 110.413 176.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -82.43 -32.19 29.14 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.917 0.887 . . . . 74.34 111.568 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.43 ' HZ1' ' HB2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -78.97 161.1 26.89 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.299 -0.63 . . . . 75.23 109.299 175.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.36 134.67 56.16 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.145 0.578 . . . . 74.53 110.059 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -95.69 85.88 4.26 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.343 0.657 . . . . 73.04 110.715 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.468 ' H ' HD12 ' A' ' 68' ' ' LEU . 79.7 mt-30 -135.58 68.53 66.74 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 123.648 0.779 . . . . 75.24 109.005 169.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -78.72 159.21 28.18 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.169 1.913 . . . . 74.24 111.867 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -106.73 105.69 15.85 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.042 -1.095 . . . . 75.35 108.042 173.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 p -74.62 93.35 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 122.363 1.078 . . . . 73.13 110.274 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 49.4 mtpt -85.82 115.56 23.54 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.347 -1.297 . . . . 74.41 108.279 172.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.3 tp -116.05 134.8 54.56 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.146 -0.687 . . . . 75.22 109.146 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.669 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 32.4 t70 -128.62 146.68 50.79 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.301 1.04 . . . . 75.11 109.168 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.2 mt -128.45 125.09 37.79 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.184 0.994 . . . . 74.55 108.496 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 21.8 t0 -129.2 148.97 51.18 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.101 0.96 . . . . 70.12 109.413 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.0 m -144.14 138.42 28.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.252 1.021 . . . . 73.11 109.923 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.9 138.59 18.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.02 0.928 . . . . 64.34 109.324 169.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.6 m -90.36 162.42 15.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.138 0.575 . . . . 73.45 110.199 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.8 t -148.8 119.61 7.58 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.384 1.073 . . . . 63.42 108.231 -174.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -78.65 120.31 23.15 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.808 -0.442 . . . . 74.31 109.808 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.0 mt -92.17 -44.99 8.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.738 -0.838 . . . . 73.31 108.738 171.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.12 -178.88 6.75 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.157 -1.383 . . . . 74.43 108.88 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -74.57 133.34 42.24 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.897 -1.149 . . . . 73.31 107.897 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 70.27 -8.66 0.83 Allowed 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 125.489 1.516 . . . . 72.21 112.871 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.7 t -110.76 106.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 N-CA-C 108.863 -0.791 . . . . 74.23 108.863 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -130.36 121.65 26.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.732 0.777 . . . . 74.51 109.202 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -93.37 121.83 35.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 124.903 1.281 . . . . 64.32 109.396 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.07 132.97 45.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.898 -1.149 . . . . 61.42 107.898 176.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.6 t -120.1 115.59 47.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.585 -0.895 . . . . 64.34 108.585 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 tt -94.33 116.64 29.05 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.277 -1.008 . . . . 62.1 108.277 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.723 ' HG3' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -93.01 102.13 14.48 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.816 -0.809 . . . . 75.13 108.816 172.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.542 HG12 ' HB1' ' A' ' 110' ' ' ALA . 2.4 p -99.61 110.17 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 108.998 -0.742 . . . . 74.14 108.998 176.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.669 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 33.8 m -95.99 133.58 40.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.282 1.033 . . . . 75.45 109.055 -176.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.4 t -130.99 115.72 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 107.981 -1.118 . . . . 74.32 107.981 -174.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 16.8 m -127.39 108.24 10.67 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.732 -0.84 . . . . 74.32 108.732 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.61 103.44 14.26 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 106.828 -1.545 . . . . 75.24 106.828 171.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.4 p -136.71 127.4 27.14 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.181 0.592 . . . . 75.41 110.39 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.468 HD12 ' H ' ' A' ' 37' ' ' GLN . 6.4 tt -89.71 88.22 7.3 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 106.844 -1.539 . . . . 73.34 106.844 173.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.29 -83.86 0.97 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.257 -0.737 . . . . 73.02 111.257 178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -119.84 -26.25 5.68 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.87 0.868 . . . . 62.31 110.866 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -82.26 101.65 10.65 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.372 0.269 . . . . 72.44 111.016 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.46 ' HB ' ' HG2' ' A' ' 26' ' ' PRO . 61.6 m -70.35 112.8 6.93 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.334 0.654 . . . . 64.23 109.842 173.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.61 -59.4 4.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.174 0.989 . . . . 74.21 109.476 171.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -149.16 160.92 42.93 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.997 -1.002 . . . . 73.24 111.029 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 64' ' ' VAL . 49.1 tp -141.33 133.66 28.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.548 1.539 . . . . 73.15 107.3 -175.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 35.0 m -147.28 120.29 8.79 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 118.807 0.73 . . . . 71.04 110.381 -171.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 9.5 mp0 -128.09 128.8 45.56 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.012 -1.107 . . . . 74.23 108.012 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.7 t -131.24 110.67 18.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.34 -0.615 . . . . 73.31 109.34 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.723 ' HG3' ' HG3' ' A' ' 61' ' ' ARG . 15.5 mp0 -85.04 79.43 9.63 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.474 -1.306 . . . . 75.22 107.474 174.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.454 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.4 tp-100 -78.21 97.27 5.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.801 -1.185 . . . . 74.34 107.801 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.472 ' HA3' ' HG3' ' A' ' 19' ' ' LYS . . . -93.91 147.2 18.49 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.041 -0.823 . . . . 34.14 111.041 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.78 126.87 2.37 Favored Glycine 0 CA--C 1.499 -0.929 0 N-CA-C 110.264 -1.134 . . . . 64.32 110.264 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 60.6 mt -82.38 114.28 23.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.653 -0.869 . . . . 74.03 108.653 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.7 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.6 m-85 -122.46 119.14 30.08 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.66 -0.867 . . . . 75.32 108.66 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 23.1 t -84.63 91.13 7.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.064 -0.717 . . . . 73.13 109.064 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -100.39 128.48 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.502 0.668 . . . . 72.15 109.23 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.89 154.75 44.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.939 1.296 . . . . 61.44 108.496 -175.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.19 9.54 81.93 Favored Glycine 0 N--CA 1.48 1.618 0 C-N-CA 121.673 -0.299 . . . . 41.31 113.715 172.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.511 HG23 ' HB3' ' A' ' 93' ' ' GLN . 0.9 OUTLIER -127.17 138.2 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.269 1.028 . . . . 62.32 110.772 -174.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -142.43 173.26 11.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.226 1.011 . . . . 73.12 109.707 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.92 -117.16 10.67 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.703 -0.681 . . . . 70.32 113.524 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.3 p -86.64 -26.63 24.27 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.702 0.801 . . . . 74.12 112.365 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.511 ' HB3' HG23 ' A' ' 89' ' ' ILE . 16.5 mm100 -60.09 -43.97 95.15 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.44 0.696 . . . . 73.34 110.512 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -62.85 -40.37 97.24 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.249 -0.887 . . . . 74.13 110.888 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.7 -26.04 62.34 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.616 0.766 . . . . 71.04 110.568 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -78.09 -30.47 49.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.243 0.617 . . . . 73.31 110.514 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.47 ' SG ' HG21 ' A' ' 89' ' ' ILE . 72.0 m -70.74 -64.84 0.82 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.48 -0.327 . . . . 74.23 110.531 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.51 -9.19 53.26 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.206 0.817 . . . . 75.45 113.206 -171.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.6 3.53 32.49 Favored Glycine 0 N--CA 1.48 1.631 0 CA-C-O 119.791 -0.449 . . . . 74.11 113.635 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.648 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -146.25 -64.05 0.31 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.287 0.543 . . . . 75.14 111.414 -176.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.472 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 84.2 t80 -70.5 -51.65 27.44 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.244 -0.889 . . . . 72.44 111.588 -172.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -72.9 -36.11 3.26 Favored Pre-proline 0 CA--C 1.566 1.564 0 N-CA-C 113.859 1.059 . . . . 75.05 113.859 -172.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.509 ' HA ' HD13 ' A' ' 106' ' ' LEU . 30.4 Cg_endo -65.39 -26.9 55.24 Favored 'Trans proline' 0 C--N 1.39 2.727 0 CA-C-N 121.732 1.654 . . . . 73.05 112.507 167.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.469 HD22 ' HA ' ' A' ' 132' ' ' ASN . 25.8 t-20 -71.84 -25.86 62.14 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.505 0.322 . . . . 71.34 110.252 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -62.84 -36.49 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.467 0.707 . . . . 74.2 109.926 170.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.509 HD13 ' HA ' ' A' ' 103' ' ' PRO . 65.5 mt -78.11 -23.23 47.96 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.298 1.039 . . . . 70.1 112.36 -178.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -61.81 -43.48 87.59 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 117.797 -1.097 . . . . 73.33 113.672 -172.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.56 -38.75 60.08 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.124 1.883 . . . . 74.35 113.076 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -69.44 -41.45 76.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.374 0.669 . . . . 75.14 111.057 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.542 ' HB1' HG12 ' A' ' 62' ' ' VAL . . . -67.61 -42.41 82.42 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.499 0.719 . . . . 73.14 110.128 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.558 ' HA ' HD23 ' A' ' 128' ' ' LEU . 29.8 ttm180 -51.17 -53.33 35.77 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.833 1.333 . . . . 71.03 110.256 175.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -66.16 -42.33 89.13 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.436 1.085 . . . . 73.12 111.214 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 41.9 t -60.88 -34.77 75.15 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.249 0.619 . . . . 75.14 111.398 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 81.0 mt -73.75 -51.66 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.815 0.846 . . . . 60.32 109.837 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.534 HG21 ' HG3' ' A' ' 125' ' ' GLN . 95.4 m -52.35 -51.28 59.71 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.334 1.054 . . . . 64.25 111.359 -174.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -65.42 -44.0 88.75 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.117 -1.401 . . . . 73.13 110.461 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.538 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 43.0 ttp -67.2 -35.45 79.64 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.03 0.932 . . . . 72.43 111.9 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.91 -40.39 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.246 1.018 . . . . 71.34 110.037 174.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -71.71 -25.42 62.07 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.952 0.901 . . . . 73.53 111.304 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -76.29 -25.92 55.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.756 0.822 . . . . 74.2 109.605 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.04 0.12 88.95 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.826 0.704 . . . . 75.23 112.712 171.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.3 m 67.88 15.98 9.61 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.848 1.259 . . . . 74.15 111.679 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.96 156.71 69.62 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.373 0.669 . . . . 73.13 109.365 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.85 141.96 92.76 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.476 2.117 . . . . 71.22 111.554 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.534 ' HG3' HG21 ' A' ' 115' ' ' THR . 29.7 tt0 -55.03 134.77 49.25 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.192 0.933 . . . . 72.43 111.78 -175.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.7 tp -118.69 98.97 6.49 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.492 -0.776 . . . . 74.34 110.287 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -100.18 113.21 25.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.379 -1.341 . . . . 64.33 107.379 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 111' ' ' ARG . 2.6 mm? -72.85 128.41 35.43 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.149 0.58 . . . . 71.2 109.522 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.03 135.48 73.92 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.632 0.773 . . . . 54.13 111.235 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.532 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 42.8 Cg_exo -58.08 98.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.727 2.285 . . . . 74.15 112.762 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 95.3 t -100.18 113.99 37.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.371 -0.974 . . . . 73.24 108.371 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.469 ' HA ' HD22 ' A' ' 104' ' ' ASN . 53.6 t30 -84.74 102.4 12.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.671 0.388 . . . . 73.43 110.045 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -63.67 -25.28 68.14 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.927 0.891 . . . . 70.21 111.468 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.648 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 7.2 t70 -65.96 -48.71 70.42 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.111 0.882 . . . . 74.52 110.432 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.37 -39.57 94.89 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.61 0.764 . . . . 70.52 111.334 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.94 -40.73 83.22 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.15 -0.932 . . . . 74.04 111.081 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -68.0 -38.45 82.65 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.191 -0.913 . . . . 72.32 109.5 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.354 0.765 0 O-C-N 124.228 0.955 . . . . 73.32 110.624 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 108.579 -0.897 . . . . 72.52 108.579 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.97 157.42 43.41 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.485 0.66 . . . . 75.33 110.21 160.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -125.45 139.11 53.92 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 107.757 -1.201 . . . . 74.34 107.757 172.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.504 HD11 HD12 ' B' ' 105' ' ' ILE . 50.4 mt -76.66 120.41 26.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.482 -0.932 . . . . 75.02 108.482 173.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -83.5 -39.61 20.25 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.075 -0.713 . . . . 75.01 109.075 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -165.73 135.78 3.51 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.597 -0.729 . . . . 74.45 110.277 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.423 HG13 HG21 ' B' ' 13' ' ' ILE . 79.9 mt -114.96 140.73 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 106.411 -1.7 . . . . 73.52 106.411 168.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.473 ' HE2' ' HB1' ' A' ' 28' ' ' ALA . 36.4 p90 -171.49 170.62 5.74 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.597 0.713 . . . . 73.15 112.041 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.467 HG23 HD13 ' B' ' 21' ' ' ILE . 24.8 m -98.11 130.72 44.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.546 -1.206 . . . . 71.3 108.792 174.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -96.26 -34.47 11.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.875 0.87 . . . . 73.11 110.407 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -148.98 136.34 20.19 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.792 -0.64 . . . . 71.02 110.555 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.615 HD13 ' SG ' ' B' ' 113' ' ' CYS . 47.0 mm -127.98 138.62 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.222 1.009 . . . . 71.43 108.915 171.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.522 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 39.8 t -135.66 129.55 32.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.228 1.411 . . . . 71.23 107.217 174.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -139.7 119.79 13.65 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 107.155 -1.424 . . . . 74.35 107.155 168.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.52 113.83 19.26 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.249 -0.648 . . . . 72.54 109.249 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.434 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -107.59 84.55 1.95 Allowed Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 107.556 -1.276 . . . . 74.11 107.556 166.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.19 -22.83 18.66 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.748 2.299 . . . . 71.14 111.385 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 89.2 m-20 -116.55 7.81 13.78 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.664 1.186 . . . . 62.23 110.898 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.551 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -29.02 -62.62 0.21 Allowed Pre-proline 0 N--CA 1.491 1.576 0 C-N-CA 126.244 1.817 . . . . 75.14 115.186 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 21.2 Cg_exo -61.9 -49.47 6.69 Favored 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 122.183 1.922 . . . . 75.2 112.122 -170.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.431 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 77.4 m80 -88.92 -11.9 43.19 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.052 -0.977 . . . . 73.31 112.251 -171.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.569 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.4 p -81.08 -23.36 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 CA-C-N 118.303 0.501 . . . . 75.32 110.525 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -64.77 -18.96 65.53 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.929 0.892 . . . . 64.45 113.331 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.9 pt20 -66.21 -23.3 66.41 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.882 0.473 . . . . 75.15 111.043 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -83.98 95.67 8.61 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.295 0.638 . . . . 75.31 109.589 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.38 83.32 1.93 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.922 0.889 . . . . 75.53 109.352 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -159.08 155.93 28.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.947 -1.024 . . . . 72.34 109.156 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -83.03 108.31 12.22 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.057 0.943 . . . . 73.0 108.502 169.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.575 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 55.6 Cg_endo -68.66 129.53 18.97 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.418 2.079 . . . . 72.32 112.294 -173.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.89 123.48 18.14 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 123.897 0.748 . . . . 73.4 110.164 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.506 HG12 HD23 ' B' ' 126' ' ' LEU . 33.0 m -104.0 150.68 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.463 0.705 . . . . 75.3 111.785 -169.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -133.57 119.85 20.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.542 -0.91 . . . . 74.42 108.542 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.22 144.26 25.47 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.782 0.833 . . . . 73.4 109.625 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.66 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 10.2 m-20 -136.08 115.32 12.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.716 1.207 . . . . 65.21 108.368 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.9 149.47 23.37 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.415 -0.587 . . . . 74.11 109.415 177.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.9 t70 -155.62 114.23 3.48 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.353 -0.98 . . . . 74.12 108.353 177.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -113.7 103.85 11.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.23 0.612 . . . . 75.2 109.656 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.24 118.46 32.35 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.638 0.775 . . . . 62.34 109.281 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 14.0 p -102.82 162.28 13.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.983 0.513 . . . . 72.31 110.755 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -151.82 136.84 17.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.057 0.943 . . . . 73.52 109.33 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -80.87 112.25 18.08 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.358 0.663 . . . . 75.12 109.721 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' B' ' 57' ' ' GLU . 75.3 mt -81.39 -54.06 5.78 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.31 0.576 . . . . 74.54 111.023 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.34 -163.74 1.75 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.372 1.069 . . . . 74.3 109.362 -176.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.42 100.95 0.53 Allowed 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.966 0.791 . . . . 74.04 109.432 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 22.1 m-20 62.13 15.7 7.65 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.582 1.153 . . . . 64.12 112.839 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 95.5 t -104.39 123.89 58.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 106.085 -1.82 . . . . 73.03 106.085 169.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.91 167.22 21.61 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.944 -0.761 . . . . 74.14 108.944 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.501 ' HB2' HD13 ' B' ' 51' ' ' LEU . 12.1 tt0 -124.38 120.7 32.87 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.608 -0.886 . . . . 71.51 108.608 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.1 t -88.19 137.72 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.714 -0.847 . . . . 64.51 108.714 170.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 56.3 t -120.88 110.39 28.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.484 -0.932 . . . . 72.23 108.484 175.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.05 99.08 11.45 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.712 -1.218 . . . . 75.13 107.712 177.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.487 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 13.2 ttm180 -87.27 113.11 22.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.595 -0.729 . . . . 73.45 109.429 170.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.54 123.84 63.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.764 -1.198 . . . . 73.13 107.764 170.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.66 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 6.9 m -118.55 134.75 54.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.926 -0.768 . . . . 70.35 108.926 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.464 HG23 HD12 ' B' ' 114' ' ' ILE . 88.1 t -122.45 127.92 75.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 123.964 0.906 . . . . 72.33 108.636 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 53.5 m -112.22 147.57 35.92 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 124.265 1.026 . . . . 74.5 108.739 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.23 147.21 33.29 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.439 0.696 . . . . 74.45 109.831 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.1 p -137.48 125.99 23.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.408 0.683 . . . . 72.11 110.381 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.575 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 42.2 mt -93.18 99.88 12.37 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 106.979 -1.489 . . . . 75.53 106.979 171.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.58 -118.55 5.06 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.492 -0.776 . . . . 75.03 112.651 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -103.33 14.77 30.77 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.128 0.971 . . . . 74.51 111.076 -171.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.418 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.9 pt-20 -147.84 156.49 42.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.721 0.808 . . . . 74.43 110.209 -173.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 86.7 m -66.26 135.83 55.0 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.698 0.624 . . . . 61.32 110.755 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.569 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -89.68 -62.57 1.44 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.584 -0.895 . . . . 73.43 108.584 174.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -150.92 157.88 43.46 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.095 -1.411 . . . . 64.55 109.96 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -132.34 138.63 47.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.766 -1.568 . . . . 72.34 106.766 175.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.432 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 49.8 t -142.65 151.01 40.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.467 -0.938 . . . . 72.13 108.467 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 44.8 tt0 -161.96 126.91 3.4 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.717 -0.845 . . . . 72.54 108.717 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.68 144.07 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 123.84 0.856 . . . . 71.43 108.934 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -115.16 91.2 3.54 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.36 -0.978 . . . . 73.53 108.36 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -81.19 97.63 7.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.545 -0.909 . . . . 73.03 108.545 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.96 142.7 16.14 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.129 -0.788 . . . . 74.25 111.129 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.85 128.86 3.58 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.123 -0.791 . . . . 74.33 111.123 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.7 mt -87.98 126.86 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.843 0.857 . . . . 70.25 109.837 175.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -134.47 134.6 41.72 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.501 -1.296 . . . . 72.33 107.501 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -109.38 93.02 4.29 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.036 0.535 . . . . 74.13 110.205 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.443 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 30.0 pt -94.38 144.85 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.327 0.584 . . . . 73.01 112.445 -167.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.79 146.86 19.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.915 1.286 . . . . 75.45 107.926 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.4 -25.85 26.21 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-O 119.884 -0.398 . . . . 64.41 113.761 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' B' ' 94' ' ' MET . 5.4 pt -84.31 165.56 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 117.48 0.64 . . . . 74.15 111.664 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -171.8 175.32 3.96 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.047 1.339 . . . . 74.41 108.726 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.21 -125.6 8.25 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.931 -0.468 . . . . 54.24 111.931 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.2 m -103.32 -13.14 16.81 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.511 0.724 . . . . 71.24 109.434 170.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -62.34 -27.78 69.29 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.148 0.979 . . . . 74.01 109.971 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.612 ' HA ' HD12 ' B' ' 89' ' ' ILE . 25.4 ptt? -71.06 -37.39 72.49 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.54 -0.754 . . . . 75.23 110.789 171.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.04 -21.24 59.17 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 115.451 -0.795 . . . . 74.02 110.766 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -76.99 -28.43 55.08 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.12 0.568 . . . . 73.23 111.425 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.24 -37.69 75.39 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.834 0.709 . . . . 72.15 110.052 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -102.8 -9.12 20.23 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.736 0.814 . . . . 74.52 111.819 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.32 -25.39 57.26 Favored Glycine 0 N--CA 1.475 1.265 0 C-N-CA 123.677 0.656 . . . . 75.12 112.728 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.47 -56.52 0.11 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.096 -0.552 . . . . 74.11 110.975 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.458 ' HH ' ' HB2' ' D' ' 130' ' ' PRO . 28.1 t80 -55.24 -54.81 38.7 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.604 1.162 . . . . 73.21 112.187 -168.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 78.9 m -69.62 -48.74 23.23 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 118.191 -0.909 . . . . 72.33 112.032 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -50.81 -35.79 49.83 Favored 'Trans proline' 0 C--N 1.399 3.195 0 C-N-CA 122.61 2.207 . . . . 73.22 113.929 170.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -75.15 -23.87 57.87 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.531 0.732 . . . . 72.1 111.701 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.504 HD12 HD11 ' B' ' 13' ' ' ILE . 83.2 mt -70.01 -44.14 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.089 -0.708 . . . . 73.45 109.089 168.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -80.6 -21.46 41.57 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.831 -1.077 . . . . 74.11 112.448 -173.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -62.48 -46.11 89.49 Favored Pre-proline 0 N--CA 1.487 1.394 0 N-CA-C 113.754 1.02 . . . . 63.23 113.754 -169.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.83 -35.71 98.17 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.859 1.706 . . . . 74.52 112.817 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -68.66 -45.31 72.11 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.991 0.517 . . . . 74.43 110.066 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.52 -37.53 78.56 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.689 0.796 . . . . 73.11 110.487 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -62.33 -57.88 9.71 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.29 1.036 . . . . 72.12 110.694 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -65.34 -28.88 69.61 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.988 0.805 . . . . 70.11 110.655 -173.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.615 ' SG ' HD13 ' B' ' 21' ' ' ILE . 4.3 t -75.09 -36.05 61.74 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.903 0.481 . . . . 74.42 111.377 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.464 HD12 HG23 ' B' ' 64' ' ' VAL . 81.7 mt -66.96 -52.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.671 -0.492 . . . . 74.32 109.671 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.432 HG22 ' OG ' ' C' ' 119' ' ' SER . 28.6 m -58.24 -33.56 69.49 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 124.339 1.024 . . . . 75.41 111.568 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 22.7 t -58.49 -53.94 52.62 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 123.813 0.696 . . . . 63.33 109.85 175.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.6 mmt -69.64 -35.22 75.03 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.493 0.717 . . . . 75.1 111.723 -171.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.98 -45.58 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.635 0.774 . . . . 71.51 110.428 174.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.408 ' OG ' HG21 ' C' ' 115' ' ' THR . 47.0 t -68.6 -32.58 72.56 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.969 -1.014 . . . . 65.42 111.357 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.7 mtt-85 -65.62 -37.2 85.93 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.552 -0.749 . . . . 74.0 109.389 175.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.37 5.0 65.2 Favored Glycine 0 C--N 1.357 1.72 0 O-C-N 124.213 0.946 . . . . 72.54 113.511 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 82.3 p 57.28 35.63 26.34 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.827 1.651 . . . . 72.34 112.96 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -95.26 162.53 24.43 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.83 0.852 . . . . 73.3 110.214 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.24 159.84 7.37 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 123.717 2.944 . . . . 74.2 114.19 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.429 HE21 ' ND2' ' B' ' 127' ' ' ASN . 67.9 tp60 -66.4 117.39 8.57 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.058 -0.973 . . . . 72.54 111.757 -176.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.506 HD23 HG12 ' B' ' 40' ' ' VAL . 10.2 mp -120.13 127.42 52.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.146 0.978 . . . . 73.3 109.455 173.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.429 ' ND2' HE21 ' B' ' 125' ' ' GLN . 50.7 m-80 -123.75 134.8 53.61 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.539 -0.911 . . . . 61.33 108.539 168.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.08 125.72 27.57 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.004 0.922 . . . . 75.31 109.892 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.28 151.14 87.75 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 124.011 0.924 . . . . 70.41 111.5 -176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.23 120.33 7.47 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.008 2.472 . . . . 74.14 112.431 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.9 t -118.33 112.7 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.941 -1.133 . . . . 71.54 107.941 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -79.13 84.86 5.07 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.838 -0.801 . . . . 72.11 108.838 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.72 -23.55 67.22 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.571 0.748 . . . . 75.45 111.83 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.07 -48.66 62.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.771 0.828 . . . . 71.11 110.696 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.43 95.39 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.683 -1.144 . . . . 75.3 110.306 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -71.53 -31.21 66.79 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.254 -1.339 . . . . 74.54 111.868 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 51.4 t80 . . . . . 0 N--CA 1.48 1.036 0 C-N-CA 122.717 0.407 . . . . 74.21 110.723 -176.622 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 10.6 m . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 107.943 -1.132 . . . . 64.4 107.943 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.59 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 62.5 t80 -123.41 121.33 35.48 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.655 -1.239 . . . . 72.31 107.655 174.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -137.21 122.76 19.69 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.168 -0.679 . . . . 73.41 109.168 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.04 125.35 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.807 -0.812 . . . . 73.05 108.807 172.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.573 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 29.3 mm-40 -91.97 -42.85 9.78 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.695 0.798 . . . . 71.31 109.306 175.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -175.61 138.58 0.39 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.63 -0.878 . . . . 70.32 108.63 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -127.91 141.67 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.862 -1.162 . . . . 65.41 107.862 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -170.57 161.18 7.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.714 0.768 . . . . 74.1 111.582 -171.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.3 p -83.95 107.47 16.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.753 -1.112 . . . . 71.3 108.338 172.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -68.81 -41.67 78.31 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.309 -0.996 . . . . 74.52 108.309 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 26.8 t70 -139.27 142.32 37.76 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 114.381 -1.282 . . . . 74.01 109.555 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.602 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.4 mt -135.99 145.35 31.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.548 1.539 . . . . 73.51 106.911 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -154.28 149.36 26.87 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.463 0.705 . . . . 73.42 109.504 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -155.82 109.01 2.71 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.2 -1.037 . . . . 74.21 108.2 174.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -119.3 111.9 18.78 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.266 0.626 . . . . 72.51 110.352 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.64 87.64 6.85 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 106.732 -1.581 . . . . 73.35 106.732 169.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.15 -23.65 24.39 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.698 2.266 . . . . 72.42 112.299 -170.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -121.39 29.71 7.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.367 1.067 . . . . 73.21 109.546 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.68 -53.54 40.54 Favored Pre-proline 0 CA--C 1.562 1.426 0 N-CA-C 114.031 1.123 . . . . 53.12 114.031 -171.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.437 ' HB3' HD12 ' D' ' 51' ' ' LEU . 26.3 Cg_exo -60.52 -48.72 10.55 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 121.671 1.581 . . . . 74.45 112.091 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -69.99 -27.08 64.42 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.244 -1.344 . . . . 72.24 112.27 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -79.54 -26.95 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 112.557 0.577 . . . . 72.53 112.557 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -68.19 -27.39 66.35 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.01 0.374 . . . . 73.21 112.01 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -89.9 9.62 26.95 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.441 0.696 . . . . 72.42 111.797 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.6 176.57 5.97 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.585 0.754 . . . . 73.43 110.065 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -76.93 124.37 27.65 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.47 0.708 . . . . 74.51 109.367 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 50.7 t90 -85.15 84.84 7.56 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.711 0.804 . . . . 75.14 111.157 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -142.56 79.92 14.88 Favored Pre-proline 0 N--CA 1.478 0.943 0 N-CA-C 107.334 -1.358 . . . . 74.54 107.334 164.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.414 ' HA ' HD22 ' C' ' 68' ' ' LEU . 6.0 Cg_exo -79.42 139.95 14.9 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.678 2.252 . . . . 75.51 112.922 -177.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.73 104.92 14.23 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 106.19 -1.781 . . . . 74.03 106.19 165.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.46 102.74 13.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.197 -1.365 . . . . 73.3 110.791 -169.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.548 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 54.4 mttp -91.84 111.13 22.54 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.489 -0.778 . . . . 75.23 109.005 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 pp -86.41 157.22 19.89 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.515 -0.55 . . . . 75.55 109.515 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.624 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.6 t70 -151.75 137.32 17.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.044 -1.095 . . . . 74.54 108.044 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 tt -137.97 137.2 37.7 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.556 -0.905 . . . . 73.32 108.556 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -148.21 125.58 11.6 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.973 1.309 . . . . 74.43 108.596 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m -114.22 126.35 54.95 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.431 0.634 . . . . 74.44 110.342 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.23 141.05 52.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.862 1.265 . . . . 73.25 107.805 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -152.24 143.68 23.39 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.851 0.46 . . . . 73.15 110.46 -170.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 80.5 p -148.43 151.93 36.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.211 0.605 . . . . 60.51 111.23 -171.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -79.22 136.89 37.2 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.466 0.706 . . . . 73.21 110.269 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.674 HD12 ' HB2' ' C' ' 57' ' ' GLU . 29.8 mt -110.12 -34.42 6.39 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.53 0.732 . . . . 71.04 110.245 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.47 179.82 8.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.36 0.664 . . . . 61.12 110.242 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -58.46 112.93 1.75 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.719 0.808 . . . . 64.51 109.907 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 64.12 9.82 5.0 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.672 1.189 . . . . 63.15 113.473 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 94.2 t -105.59 116.25 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.558 -1.275 . . . . 73.52 107.558 172.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -134.09 124.21 25.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.013 -0.736 . . . . 73.53 109.013 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.674 ' HB2' HD12 ' C' ' 51' ' ' LEU . 38.3 tt0 -83.42 139.01 33.23 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.92 0.888 . . . . 74.41 109.635 175.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.409 HG12 ' HD3' ' C' ' 103' ' ' PRO . 42.0 t -120.05 135.33 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 124.185 0.994 . . . . 64.55 108.496 166.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.561 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 59.1 t -115.84 144.55 23.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.543 -0.91 . . . . 74.04 108.543 175.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.4 104.64 8.56 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.197 -1.038 . . . . 75.02 108.197 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -88.16 117.46 27.07 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.79 -1.189 . . . . 64.42 107.79 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.439 HG11 HD22 ' C' ' 128' ' ' LEU . 21.4 t -118.88 118.85 59.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.741 -1.207 . . . . 74.12 107.741 175.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.9 m -122.3 122.32 38.81 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.579 0.752 . . . . 71.35 109.54 -173.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.607 HG23 HG21 ' C' ' 114' ' ' ILE . 99.5 t -110.36 122.16 64.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.083 1.353 . . . . 71.23 109.258 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.6 m -117.55 144.17 45.38 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.446 -0.946 . . . . 74.11 108.446 175.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.28 128.47 19.81 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.482 -0.933 . . . . 74.21 108.482 176.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 21.4 m -142.91 129.3 20.03 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.092 0.557 . . . . 60.35 110.586 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' C' ' 38' ' ' PRO . 49.0 mt -87.67 32.95 0.71 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.174 1.39 . . . . 74.54 111.334 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 -100.72 1.41 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.41 -1.076 . . . . 74.55 110.41 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.64 -31.09 17.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.808 0.843 . . . . 72.24 109.953 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -76.62 120.23 21.53 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.276 1.03 . . . . 74.23 110.092 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.2 m -78.14 126.18 30.44 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.561 -0.903 . . . . 71.51 108.561 168.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -60.98 2.06 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.589 -0.893 . . . . 74.41 108.589 173.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -163.61 172.49 14.25 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.068 0.937 . . . . 74.24 111.83 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -135.8 145.57 46.65 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 105.863 -1.902 . . . . 75.52 105.863 172.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.8 t -147.98 150.42 33.96 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.059 -1.089 . . . . 74.32 108.059 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.99 132.83 8.5 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.759 -0.46 . . . . 74.41 109.759 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.52 114.1 22.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.263 -1.014 . . . . 62.53 108.263 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.512 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 68.4 mt-30 -94.15 85.12 4.59 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.401 -0.963 . . . . 75.02 108.401 173.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -78.33 97.4 5.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.053 -1.431 . . . . 74.51 110.324 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -89.37 161.13 29.81 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 116.465 -0.334 . . . . 71.01 112.382 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.16 123.06 1.15 Allowed Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 111.058 -0.817 . . . . 73.24 111.058 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 6.2 mm -82.26 125.92 39.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.532 -0.914 . . . . 74.42 108.532 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -131.6 119.74 21.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.166 0.587 . . . . 73.43 110.257 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 71.9 m -80.66 111.89 17.52 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.934 -0.765 . . . . 52.25 108.934 170.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.699 HG12 HD21 ' C' ' 98' ' ' LEU . 1.2 pp -117.06 139.31 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.225 1.01 . . . . 70.32 110.317 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.07 172.68 13.46 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.409 1.084 . . . . 73.23 110.514 -172.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.93 -59.67 3.55 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 116.179 -0.464 . . . . 71.24 112.086 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.81 157.57 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.756 0.823 . . . . 75.11 109.475 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.602 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 13.3 pt-20 -145.53 -170.8 3.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.0 0.52 . . . . 75.24 109.925 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.82 -121.73 24.26 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 114.621 0.608 . . . . 72.15 114.621 174.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 62.6 p -73.33 -34.27 65.58 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.792 0.837 . . . . 73.51 110.555 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -70.14 -32.7 70.81 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.243 1.017 . . . . 64.25 109.981 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.602 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 39.4 ttp -79.61 -33.13 41.8 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.836 -1.074 . . . . 72.31 110.838 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.45 84.17 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.369 0.604 . . . . 72.3 109.913 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.417 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 49.2 t-80 -65.42 -29.21 69.88 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.562 -1.199 . . . . 73.4 111.478 175.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.3 -60.81 2.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.057 0.543 . . . . 73.21 110.448 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.699 HD21 HG12 ' C' ' 86' ' ' ILE . 92.9 mt -74.16 -33.81 63.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.074 0.95 . . . . 75.05 112.696 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.35 8.79 77.08 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-O 119.475 -0.625 . . . . 72.04 113.551 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -156.87 -66.23 0.1 Allowed 'General case' 0 C--N 1.357 0.916 0 CA-C-N 117.724 0.762 . . . . 60.24 112.874 -172.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.408 ' O ' ' HB2' ' C' ' 104' ' ' ASN . 87.9 t80 -63.89 -34.8 78.76 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.286 0.634 . . . . 75.42 112.328 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.59 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 56.2 m -72.75 -46.28 9.18 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.69 -0.671 . . . . 74.04 111.148 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.409 ' HD3' HG12 ' C' ' 58' ' ' VAL . 83.2 Cg_exo -52.99 -32.95 60.25 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.312 2.008 . . . . 75.54 113.791 164.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' C' ' 101' ' ' TYR . 5.1 m-20 -60.09 -39.83 87.49 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 123.158 0.583 . . . . 65.35 110.911 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.47 HD13 ' NH1' ' A' ' 111' ' ' ARG . 40.2 mm -66.5 -45.22 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 115.954 -0.567 . . . . 64.51 110.198 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 42.3 mt -75.88 -16.39 60.06 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.433 -0.803 . . . . 74.53 111.986 -174.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -59.92 -52.7 71.76 Favored Pre-proline 0 CA--C 1.566 1.583 0 C-N-CA 125.035 1.334 . . . . 62.43 113.811 -172.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.18 -31.38 64.34 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 121.948 1.765 . . . . 71.23 112.784 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.407 ' HE2' HG23 ' A' ' 115' ' ' THR . 90.3 m-85 -69.09 -47.6 64.78 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.188 0.595 . . . . 75.12 110.546 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.37 -41.85 85.66 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.179 -0.918 . . . . 71.13 109.925 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -56.08 -57.72 10.97 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 124.437 1.086 . . . . 74.11 111.126 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -66.93 -30.93 71.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.181 0.593 . . . . 64.04 111.036 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.6 t -70.5 -34.1 71.95 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.779 0.432 . . . . 72.34 110.971 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.607 HG21 HG23 ' C' ' 64' ' ' VAL . 88.4 mt -69.34 -51.24 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.277 -0.638 . . . . 63.42 109.277 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.408 HG21 ' OG ' ' B' ' 119' ' ' SER . 13.7 m -58.43 -33.53 69.79 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.05 0.94 . . . . 72.12 111.286 -174.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 28.3 t -62.9 -54.85 32.32 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.834 -1.075 . . . . 72.21 109.13 173.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.54 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.96 -40.05 72.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.91 1.284 . . . . 75.24 112.639 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.34 -47.72 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.956 0.902 . . . . 73.45 109.691 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.432 ' OG ' HG22 ' B' ' 115' ' ' THR . 48.4 t -69.95 -27.98 65.19 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.238 -0.892 . . . . 72.14 111.93 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' C' ' 116' ' ' SER . 84.3 mtt-85 -70.65 -43.68 68.67 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.688 0.795 . . . . 75.42 109.29 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.15 5.86 65.39 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.955 -1.02 . . . . 65.3 112.522 172.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 64.8 p 61.66 29.76 18.28 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.175 1.79 . . . . 74.21 113.757 168.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -86.62 152.53 54.56 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 108.981 -0.748 . . . . 75.31 108.981 169.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.43 173.26 3.58 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.258 2.639 . . . . 71.32 114.649 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -50.79 130.92 25.75 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.308 1.443 . . . . 75.31 114.043 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -133.88 112.6 11.43 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.388 -1.338 . . . . 75.14 107.388 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -133.16 132.15 41.26 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.497 0.719 . . . . 75.4 109.99 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.439 HD22 HG11 ' C' ' 62' ' ' VAL . 6.8 mp -86.07 125.93 33.81 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.765 0.826 . . . . 74.41 110.11 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.86 155.67 75.32 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 124.75 1.22 . . . . 62.04 111.18 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.448 ' HG3' HD13 ' A' ' 16' ' ' ILE . 30.7 Cg_endo -59.03 113.93 1.79 Allowed 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 123.361 2.708 . . . . 74.32 113.522 -177.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.39 113.38 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.786 0.834 . . . . 74.22 109.279 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -76.38 91.05 3.25 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.689 0.795 . . . . 74.32 110.473 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -68.55 -33.06 73.43 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 110.062 -0.348 . . . . 72.55 110.062 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.461 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 12.7 p-10 -65.02 -45.83 83.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.527 1.131 . . . . 74.52 111.447 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.53 -37.09 71.18 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.372 0.669 . . . . 75.31 110.897 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.26 -18.45 55.32 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.23 -0.895 . . . . 74.44 112.347 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 57.1 t80 . . . . . 0 N--CA 1.493 1.721 0 C-N-CA 123.096 0.558 . . . . 71.33 111.626 -178.887 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.237 0.433 0 N-CA-C 108.072 -1.085 . . . . 75.11 108.072 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -157.19 91.28 1.17 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.951 -1.5 . . . . 74.51 106.951 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -113.43 114.71 26.96 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.341 -0.985 . . . . 65.21 108.341 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.401 HG22 HD11 ' D' ' 16' ' ' ILE . 12.6 mt -75.27 114.76 15.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.014 -1.106 . . . . 70.31 108.014 174.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -89.96 -32.27 16.88 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.423 0.452 . . . . 72.43 111.096 -178.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -172.76 146.42 1.61 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.062 0.226 . . . . 74.22 111.555 -170.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.401 HD11 HG22 ' D' ' 13' ' ' ILE . 2.9 mp -126.56 132.27 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 105.79 -1.929 . . . . 72.33 105.79 170.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.419 ' HE1' HG13 ' D' ' 83' ' ' ILE . 28.8 p90 -158.53 150.92 21.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.203 1.001 . . . . 74.44 111.03 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -84.23 119.22 24.78 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.222 -1.808 . . . . 73.52 108.487 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -95.08 -28.53 15.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.34 -0.615 . . . . 74.52 109.34 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.1 t70 -145.16 128.74 17.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.583 -1.189 . . . . 73.03 108.232 175.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.54 HG23 ' HE1' ' C' ' 117' ' ' MET . 73.4 mt -129.92 137.72 55.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.401 -1.333 . . . . 74.24 107.401 172.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -138.24 139.42 39.22 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.438 1.095 . . . . 75.24 108.312 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.602 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -150.61 129.45 12.46 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.093 -1.447 . . . . 74.21 107.093 170.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.7 mt-10 -131.26 150.98 51.92 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.895 0.878 . . . . 75.31 109.178 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.23 78.21 19.2 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 106.946 -1.501 . . . . 75.33 106.946 173.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.8 -22.88 17.18 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.78 2.32 . . . . 75.44 113.596 -170.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -108.15 16.34 23.39 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.102 0.561 . . . . 73.13 110.256 176.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.418 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -39.1 -66.92 0.29 Allowed Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 115.581 1.697 . . . . 72.0 115.581 -160.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.558 ' HB3' HD11 ' C' ' 83' ' ' ILE . 96.2 Cg_endo -74.15 -20.51 18.93 Favored 'Trans proline' 0 C--N 1.387 2.568 0 CA-C-N 122.435 1.905 . . . . 73.14 112.717 -173.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -74.26 -41.05 61.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.148 1.379 . . . . 74.14 110.445 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' D' ' 73' ' ' ALA . 3.6 p -84.04 -20.92 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 115.883 -0.599 . . . . 73.13 111.066 -170.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -62.74 -22.08 66.29 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.076 0.551 . . . . 74.42 112.433 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -65.75 -18.0 65.02 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.489 0.715 . . . . 70.51 111.06 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -84.09 102.55 12.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.489 1.115 . . . . 74.43 108.972 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -84.56 89.42 7.44 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.373 -0.603 . . . . 71.41 109.373 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.1 t-105 -168.5 158.85 9.84 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.618 1.167 . . . . 71.43 109.368 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -72.13 109.8 6.56 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 108.315 -0.994 . . . . 71.41 108.315 169.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.52 125.91 20.07 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.307 2.671 . . . . 64.34 113.329 -173.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.02 115.66 2.75 Favored 'General case' 0 C--N 1.361 1.101 0 O-C-N 124.484 1.115 . . . . 70.04 109.61 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.603 HG23 HG13 ' D' ' 64' ' ' VAL . 3.0 p -96.66 112.76 29.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-O 121.86 0.838 . . . . 75.03 110.562 -170.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -101.91 151.24 22.34 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.846 -1.07 . . . . 75.33 108.258 167.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.49 136.12 47.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.771 0.428 . . . . 73.42 110.637 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.654 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 30.4 m-20 -107.79 150.28 27.19 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 107.376 -1.342 . . . . 74.55 107.376 165.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.439 HD23 ' HE2' ' D' ' 133' ' ' PHE . 18.8 tp -137.36 131.27 31.87 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.584 0.23 . . . . 70.33 110.993 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 34.3 m-20 -138.87 158.42 44.24 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.61 1.164 . . . . 73.21 108.711 170.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.0 t -124.48 175.35 7.2 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.601 0.761 . . . . 72.34 109.189 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.54 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -161.34 163.99 30.38 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.9 0.88 . . . . 74.44 109.448 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 71.9 p -150.26 153.0 35.42 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.617 0.767 . . . . 74.21 109.264 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.7 p -156.62 140.41 16.11 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.485 0.714 . . . . 72.11 110.262 -174.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -91.56 116.43 28.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.511 0.724 . . . . 75.23 109.064 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' C' ' 29' ' ' PRO . 26.8 mt -98.5 -42.17 7.43 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.093 0.473 . . . . 71.23 110.297 -173.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.16 176.02 10.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.431 1.093 . . . . 71.41 108.097 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.08 130.61 41.33 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.581 -0.526 . . . . 75.21 109.581 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 61.42 11.0 3.45 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 124.425 1.09 . . . . 64.44 112.813 -171.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.67 114.37 43.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 108.211 -1.033 . . . . 75.22 108.211 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.12 164.66 12.61 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.175 -1.046 . . . . 73.04 108.175 -175.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.418 ' HB2' HD11 ' D' ' 51' ' ' LEU . 62.3 tt0 -131.04 150.89 51.94 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.838 -0.801 . . . . 74.35 108.838 169.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.61 141.87 42.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.795 1.238 . . . . 70.32 107.874 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 47.2 t -128.1 126.41 66.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.778 -1.194 . . . . 75.22 107.778 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.08 120.9 43.35 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.074 -1.084 . . . . 70.41 108.074 -175.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.41 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 22.3 ttm-85 -100.99 97.63 8.18 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.583 -0.895 . . . . 74.34 108.583 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.19 123.93 47.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.619 -1.252 . . . . 74.4 107.619 167.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.654 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 12.9 m -118.74 130.37 55.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.959 -0.756 . . . . 72.43 108.959 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.603 HG13 HG23 ' D' ' 40' ' ' VAL . 94.2 t -117.48 121.1 66.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.106 0.962 . . . . 63.13 109.157 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.1 m -116.01 104.0 11.15 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.083 -1.08 . . . . 62.22 108.083 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.27 150.57 24.32 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.641 -0.709 . . . . 72.11 110.493 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.405 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 55.1 p -143.96 142.19 30.6 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.705 0.628 . . . . 73.03 111.053 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 21.4 mt -110.32 104.37 13.15 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 124.633 1.173 . . . . 70.14 109.191 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.03 -112.9 3.55 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.443 -0.663 . . . . 71.41 111.443 -177.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -117.52 14.32 14.53 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.249 0.619 . . . . 75.54 111.488 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.58 156.04 45.52 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.071 0.548 . . . . 74.4 110.59 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.5 m -63.4 127.28 30.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.09 0.956 . . . . 63.24 111.502 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.566 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -86.03 -75.78 0.36 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.842 -0.799 . . . . 74.44 108.842 174.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.29 139.46 35.5 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-O 121.349 0.595 . . . . 75.55 110.03 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 80.6 mt -103.54 147.37 27.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.912 -1.144 . . . . 74.03 107.912 171.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.538 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.6 t -158.02 146.66 19.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 122.914 0.486 . . . . 73.02 109.859 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -156.2 134.28 11.29 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 108.858 -0.793 . . . . 64.32 108.858 171.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.32 114.75 24.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 109.104 -0.702 . . . . 75.12 109.104 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.457 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 72.3 mt-30 -89.08 83.23 6.54 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.295 -1.002 . . . . 62.22 108.295 171.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -80.96 99.22 8.29 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.457 -1.702 . . . . 75.25 109.946 -175.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.08 163.62 29.3 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.441 -0.345 . . . . 73.44 112.483 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.465 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -161.96 132.87 2.94 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 111.883 -0.487 . . . . 73.13 111.883 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.419 HG13 ' HE1' ' D' ' 17' ' ' TYR . 43.7 mt -88.93 130.41 38.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 123.822 0.849 . . . . 71.12 109.311 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -133.85 124.23 26.13 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.356 0.662 . . . . 74.42 110.04 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -83.41 105.5 14.41 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.594 -0.891 . . . . 64.52 108.594 170.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.427 HD12 HD12 ' D' ' 98' ' ' LEU . 47.8 pt -109.78 141.93 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 122.985 0.514 . . . . 75.35 110.855 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.35 159.88 41.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.309 1.044 . . . . 52.24 109.354 176.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.04 10.59 81.16 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 115.009 0.764 . . . . 54.43 115.009 173.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 24.0 pt -124.06 135.07 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.596 0.758 . . . . 75.24 109.549 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.73 164.9 28.95 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.517 0.727 . . . . 73.14 110.682 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.14 -121.9 25.57 Favored Glycine 0 C--N 1.353 1.481 0 O-C-N 124.091 0.87 . . . . 75.24 114.393 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 12.5 t -72.04 -32.4 67.07 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.691 0.796 . . . . 73.01 111.44 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -71.62 -35.28 70.39 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.167 0.587 . . . . 74.33 110.706 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -66.56 -47.48 72.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.295 -0.866 . . . . 73.35 110.154 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.54 -28.37 69.89 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.21 -0.905 . . . . 74.1 111.479 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -76.47 -46.51 26.5 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.939 0.896 . . . . 75.24 110.869 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.71 -42.48 73.97 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.013 -0.54 . . . . 75.23 111.296 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.427 HD12 HD12 ' D' ' 86' ' ' ILE . 12.4 tp -84.51 -36.21 22.38 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 122.68 0.392 . . . . 73.42 111.195 -173.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.0 -23.09 42.65 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.036 -0.529 . . . . 61.12 113.705 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' D' ' 134' ' ' ASP . . . -122.17 -56.34 1.83 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.23 0.515 . . . . 74.13 111.949 -175.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . 0.402 ' O ' HG12 ' D' ' 105' ' ' ILE . 63.7 t80 -66.76 -43.36 84.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 111.841 0.312 . . . . 75.43 111.841 -173.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 98.8 m -65.85 -47.83 63.88 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.053 -0.975 . . . . 72.14 112.912 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.464 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.3 Cg_exo -57.0 -36.22 99.25 Favored 'Trans proline' 0 C--N 1.4 3.263 0 C-N-CA 121.847 1.698 . . . . 72.31 112.7 170.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -65.1 -31.22 72.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.851 0.86 . . . . 71.34 111.119 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.402 HG12 ' O ' ' D' ' 101' ' ' TYR . 46.3 mm -68.25 -40.89 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.502 0.721 . . . . 75.32 110.164 173.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.465 HD22 ' HA3' ' D' ' 82' ' ' GLY . 63.3 mt -77.96 -21.82 50.4 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.252 -0.886 . . . . 75.2 111.856 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -64.27 -41.29 59.44 Favored Pre-proline 0 CA--C 1.566 1.562 0 N-CA-C 114.098 1.147 . . . . 72.1 114.098 -172.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -51.19 -43.38 49.05 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.263 1.975 . . . . 73.54 113.56 170.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -72.51 -37.89 68.26 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.57 -0.741 . . . . 74.32 111.03 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.22 -45.11 93.16 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.498 0.719 . . . . 73.13 110.528 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -57.28 -51.85 67.71 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.416 1.072 . . . . 74.13 110.395 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.02 -44.65 96.25 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.175 0.922 . . . . 74.4 112.009 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -54.59 -48.14 72.5 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.91 0.756 . . . . 70.52 110.359 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.538 HG12 ' SG ' ' D' ' 76' ' ' CYS . 82.2 mt -60.4 -54.85 29.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 CA-C-N 114.502 -1.226 . . . . 72.33 110.38 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.0 m -55.39 -39.92 70.75 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.301 1.04 . . . . 74.33 111.806 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -68.05 -41.93 81.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.005 -0.998 . . . . 73.21 110.566 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -70.01 -29.19 66.19 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.8 0.44 . . . . 73.01 111.828 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.426 HG21 ' O ' ' D' ' 114' ' ' ILE . 65.9 t -66.12 -45.1 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 123.961 0.904 . . . . 72.44 109.834 175.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.0 p -74.49 -28.93 61.22 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.992 -0.549 . . . . 73.12 111.251 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 -72.86 -33.5 66.14 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.429 0.692 . . . . 75.05 109.809 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.47 2.01 86.28 Favored Glycine 0 C--N 1.355 1.603 0 CA-C-N 115.769 -0.65 . . . . 75.45 112.165 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.8 p 64.37 18.98 11.62 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 127.142 2.177 . . . . 63.23 113.984 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -80.02 147.38 65.57 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 108.587 -0.894 . . . . 71.22 108.587 168.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.87 148.8 91.19 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.083 1.855 . . . . 73.01 111.463 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -57.8 139.84 53.09 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.723 1.209 . . . . 71.04 113.883 -165.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.479 HD13 HG22 ' D' ' 40' ' ' VAL . 42.2 tp -109.09 102.59 11.55 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.055 -0.975 . . . . 74.02 109.678 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -100.91 104.39 15.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.266 0.626 . . . . 74.11 109.385 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -74.56 118.62 17.72 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.16 0.584 . . . . 74.51 109.441 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.9 136.35 72.89 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.691 0.796 . . . . 72.4 111.368 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.458 ' HB2' ' HH ' ' B' ' 101' ' ' TYR . 72.5 Cg_endo -72.83 118.97 5.81 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.217 1.945 . . . . 75.14 110.76 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.5 p -107.38 136.75 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.521 0.728 . . . . 74.23 110.028 -173.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . 0.571 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 55.0 t30 -76.73 76.27 3.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.688 -1.227 . . . . 73.44 107.688 169.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.439 ' HE2' HD23 ' D' ' 44' ' ' LEU . 87.4 t80 -59.98 -33.15 71.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.075 -1.421 . . . . 74.41 112.006 -172.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . 0.575 ' HA ' ' HB2' ' D' ' 100' ' ' ALA . 17.4 t70 -60.27 -34.8 74.24 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.656 1.182 . . . . 72.54 111.392 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.571 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -67.18 -37.92 84.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.16 -0.927 . . . . 64.13 111.716 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.6 mp -64.21 -33.34 75.58 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.707 0.803 . . . . 72.01 110.956 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 N--CA 1.482 1.162 0 C-N-CA 124.121 0.969 . . . . 75.34 111.808 -178.109 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m . . . . . 0 N--CA 1.462 0.173 0 N-CA-C 107.985 -1.117 . . . . 52.11 107.985 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.511 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -137.81 134.92 35.76 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.529 -0.915 . . . . 73.35 108.529 172.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -149.96 110.96 4.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.215 -1.032 . . . . 65.42 108.215 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 mt -78.14 110.38 13.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.59 -0.892 . . . . 73.55 108.59 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -80.08 -32.62 39.26 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.957 -1.02 . . . . 74.0 110.175 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -177.44 126.25 0.14 Allowed 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.375 0.422 . . . . 75.42 110.415 -172.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.454 HD13 ' CG ' ' C' ' 130' ' ' PRO . 93.8 mt -113.52 130.99 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.424 -0.954 . . . . 72.15 108.424 169.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.459 ' HB3' HG23 ' B' ' 122' ' ' THR . 29.5 p90 -160.18 154.31 23.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.334 1.054 . . . . 64.23 109.561 -172.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.5 p -79.84 120.27 23.86 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.937 -0.764 . . . . 74.01 108.937 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -81.0 -31.23 34.74 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.04 0.448 . . . . 72.14 109.855 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -153.26 143.57 22.41 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.774 -1.103 . . . . 64.2 109.537 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -133.86 145.1 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.852 1.261 . . . . 74.03 108.122 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -144.82 134.38 23.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.346 0.593 . . . . 73.21 109.471 171.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -134.56 131.13 37.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.184 -1.784 . . . . 75.1 106.184 162.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -134.33 142.07 47.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.974 -0.75 . . . . 73.04 108.974 171.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.45 79.08 55.39 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 106.459 -1.682 . . . . 73.54 106.459 169.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.2 -15.23 35.39 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.486 2.124 . . . . 53.34 110.329 174.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -112.44 28.01 9.15 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.848 1.259 . . . . 74.15 111.139 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.491 ' HB2' ' CE2' ' B' ' 17' ' ' TYR . . . -60.12 -54.54 54.27 Favored Pre-proline 0 CA--C 1.575 1.907 0 CA-C-O 118.933 -0.556 . . . . 72.43 111.344 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 11.6 Cg_exo -76.48 -14.93 17.85 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 122.192 1.928 . . . . 75.4 113.373 173.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -69.88 -53.28 18.75 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 109.633 -0.506 . . . . 73.53 109.633 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.558 HG11 ' HE1' ' A' ' 123' ' ' PHE . 12.1 p -64.44 -23.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.783 0.833 . . . . 64.14 111.424 -175.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -58.09 -40.4 81.03 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.607 0.763 . . . . 72.41 110.4 171.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -90.64 -30.3 17.24 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.327 1.051 . . . . 72.02 111.021 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.565 ' HZ2' ' HG3' ' A' ' 71' ' ' GLU . 14.1 mmmm -84.0 172.16 12.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.275 1.03 . . . . 74.42 111.38 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.23 148.59 23.52 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.675 0.79 . . . . 71.54 109.818 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -79.59 90.94 5.15 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.234 0.614 . . . . 74.42 109.761 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -132.37 42.03 0.81 Allowed Pre-proline 0 CA--C 1.574 1.869 0 C-N-CA 123.313 0.645 . . . . 75.52 112.69 -176.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -81.47 140.03 11.76 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.308 2.006 . . . . 72.4 113.564 -171.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -98.69 99.96 11.13 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.764 -1.199 . . . . 65.23 107.764 168.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.13 93.33 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 115.619 -0.719 . . . . 74.42 109.999 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -78.4 153.03 31.91 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.869 0.366 . . . . 75.22 110.375 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.1 tp -122.2 130.2 52.98 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.387 -0.824 . . . . 64.05 109.969 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -130.98 146.84 52.51 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.562 1.145 . . . . 71.44 107.916 172.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.538 HD21 HD21 ' A' ' 60' ' ' LEU . 85.2 mt -129.53 148.53 51.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.468 0.707 . . . . 74.43 109.845 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.708 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 14.9 m-20 -132.48 140.14 48.25 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.183 0.993 . . . . 72.13 109.1 172.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.0 m -108.22 126.2 52.53 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.062 1.345 . . . . 71.3 108.488 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.16 146.16 51.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.593 0.757 . . . . 72.11 109.163 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.5 m -134.45 158.51 43.72 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.847 0.459 . . . . 70.11 111.045 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 40.2 t -154.44 129.49 9.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.451 1.1 . . . . 72.34 108.605 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -84.48 107.75 16.9 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.15 -0.685 . . . . 74.23 109.15 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.0 mt -79.57 -38.43 34.1 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.986 0.515 . . . . 73.32 110.372 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.19 -177.03 6.25 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.495 -0.775 . . . . 74.22 110.315 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.13 111.82 2.37 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.875 0.87 . . . . 64.45 109.95 174.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 65.28 17.23 10.92 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.053 1.341 . . . . 75.11 112.873 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.79 116.7 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.223 -1.029 . . . . 73.14 108.223 169.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -110.7 167.57 10.13 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.603 1.192 . . . . 73.22 111.501 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 9.6 tp10 -128.78 126.43 39.92 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 112.393 -2.185 . . . . 54.34 105.661 169.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.24 131.27 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 107.482 -1.303 . . . . 72.52 107.482 173.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 21.9 t -119.49 115.52 47.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 124.128 0.971 . . . . 74.12 108.656 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.538 HD21 HD21 ' A' ' 44' ' ' LEU . 3.7 tt -88.19 98.01 11.32 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.322 -1.733 . . . . 72.32 106.322 167.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.708 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 46.8 ttt-85 -85.61 101.97 13.16 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.952 -1.129 . . . . 72.25 107.952 174.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.528 HG12 ' HB1' ' A' ' 110' ' ' ALA . 2.3 p -105.02 124.26 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.294 0.637 . . . . 74.21 110.291 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.0 m -108.13 130.84 55.09 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 123.846 0.858 . . . . 74.32 109.593 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.402 ' O ' HD13 ' A' ' 75' ' ' LEU . 45.9 t -126.32 122.65 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.02 1.328 . . . . 74.13 107.973 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 t -128.88 120.59 26.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.018 0.527 . . . . 71.54 109.68 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.15 110.18 22.45 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.589 -0.893 . . . . 73.21 108.589 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.3 p -124.88 126.89 46.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.862 0.465 . . . . 75.14 111.403 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -104.62 84.78 2.22 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.806 -1.183 . . . . 73.34 107.806 166.843 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.94 -117.32 5.08 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.386 -0.824 . . . . 31.43 111.846 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -87.94 -23.22 23.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.056 0.542 . . . . 71.23 109.889 175.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.565 ' HG3' ' HZ2' ' A' ' 34' ' ' LYS . 7.1 mm-40 -81.53 134.87 35.57 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.026 0.93 . . . . 74.32 110.725 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.3 m -83.15 154.37 24.33 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.072 0.949 . . . . 73.5 109.148 168.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.9 -61.18 1.4 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.197 -1.038 . . . . 61.03 108.197 164.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -151.07 170.36 19.58 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.53 -1.214 . . . . 73.51 110.722 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 64' ' ' VAL . 51.2 tp -138.83 129.22 25.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.043 1.337 . . . . 65.21 107.729 177.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.3 m -136.07 117.6 14.83 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.809 0.844 . . . . 74.15 108.761 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -138.79 115.38 10.59 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.274 -0.639 . . . . 61.33 109.274 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.7 t -123.99 115.72 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.202 1.001 . . . . 74.13 109.498 -171.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.625 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 17.3 mt-30 -87.85 82.43 7.3 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.156 -1.053 . . . . 73.44 108.156 169.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.4 115.5 16.2 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.022 -1.103 . . . . 73.2 108.022 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.14 170.85 13.59 Favored Glycine 0 C--O 1.242 0.618 0 CA-C-O 121.227 0.348 . . . . 64.1 112.255 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.51 136.05 3.97 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.144 -0.528 . . . . 74.33 112.0 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.5 mt -81.1 122.84 36.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 108.131 -1.063 . . . . 72.43 108.131 169.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.511 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.3 m-85 -130.95 118.49 20.74 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.717 -0.846 . . . . 71.12 108.717 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.5 p -94.98 118.11 31.27 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.896 -0.779 . . . . 74.24 108.896 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.55 157.11 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.137 0.975 . . . . 64.41 110.624 -174.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.48 154.01 13.71 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.975 0.91 . . . . 74.32 109.947 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.4 9.63 61.51 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 113.752 0.261 . . . . 73.32 113.752 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.617 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -133.19 145.09 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.937 0.895 . . . . 65.21 109.934 178.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.541 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.6 tt0 -156.13 174.13 15.82 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.15 0.58 . . . . 74.33 109.819 177.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.541 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 60.07 -116.94 9.81 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.678 0.656 . . . . 65.34 113.444 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.4 p -71.55 -27.01 62.87 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.745 0.818 . . . . 75.41 110.934 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -71.02 -36.2 72.3 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.762 0.825 . . . . 73.33 110.432 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.462 ' HE2' ' HA ' ' A' ' 90' ' ' GLU . 49.3 ttm -73.11 -37.17 66.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.068 0.547 . . . . 72.43 110.09 175.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 -24.69 66.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.792 -0.64 . . . . 73.1 110.231 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.472 ' NE2' ' HB3' ' A' ' 100' ' ' ALA . 9.8 t-160 -83.38 -25.95 30.91 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.562 0.745 . . . . 63.03 111.204 176.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.617 ' SG ' HG13 ' A' ' 89' ' ' ILE . 74.0 m -56.86 -43.21 80.98 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.004 0.431 . . . . 73.44 110.492 175.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -90.73 -20.74 22.09 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.567 -0.742 . . . . 70.24 111.268 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -38.56 41.8 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 114.071 0.388 . . . . 74.11 114.071 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.472 ' HB3' ' NE2' ' A' ' 96' ' ' HIS . . . -150.88 -47.12 0.12 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 117.508 0.654 . . . . 63.2 112.004 -175.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.425 ' HH ' ' HB2' ' A' ' 11' ' ' PHE . 31.2 t80 -45.08 -70.24 0.11 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 126.053 1.741 . . . . 74.42 112.865 -175.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.1 m -81.29 -34.53 0.73 Allowed Pre-proline 0 CA--C 1.572 1.79 0 N-CA-C 115.462 1.653 . . . . 64.24 115.462 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.436 ' O ' HD13 ' A' ' 60' ' ' LEU . 37.4 Cg_endo -63.88 -34.74 59.27 Favored 'Trans proline' 0 C--N 1.399 3.231 0 CA-C-N 122.701 2.0 . . . . 72.21 112.619 175.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -66.56 -26.62 67.21 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 120.716 0.293 . . . . 65.15 111.299 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.06 -43.44 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.67 0.788 . . . . 75.53 110.18 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.03 -14.66 59.42 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.061 0.944 . . . . 74.34 112.479 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.16 -49.38 84.93 Favored Pre-proline 0 CA--C 1.565 1.555 0 N-CA-C 113.486 0.921 . . . . 74.44 113.486 -171.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.1 -32.3 75.09 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 121.929 1.753 . . . . 72.35 112.572 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -74.48 -37.63 63.13 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.694 0.798 . . . . 71.02 111.58 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.528 ' HB1' HG12 ' A' ' 62' ' ' VAL . . . -70.26 -45.15 67.02 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.843 0.457 . . . . 61.3 110.099 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.408 ' NH1' HD13 ' C' ' 105' ' ' ILE . 31.9 ttm180 -54.2 -47.73 71.79 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.365 1.041 . . . . 75.24 110.342 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.27 -46.38 89.06 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.139 0.9 . . . . 74.02 111.725 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 117' ' ' MET . 37.1 t -59.81 -38.39 81.82 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.408 0.683 . . . . 75.24 110.537 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.2 mt -70.82 -47.84 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.034 0.934 . . . . 73.35 110.896 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -54.41 -38.16 65.91 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.791 0.836 . . . . 74.1 110.343 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.6 t -65.86 -47.01 76.34 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.325 -1.307 . . . . 75.53 110.253 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 34.0 mmt -57.18 -48.21 79.32 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.159 0.583 . . . . 71.32 111.246 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 114' ' ' ILE . 58.6 t -64.27 -48.63 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.443 1.097 . . . . 72.03 111.046 -175.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -69.97 -29.57 66.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.33 0.652 . . . . 74.23 112.209 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -71.11 -28.33 64.23 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.832 0.453 . . . . 75.4 110.255 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.48 7.97 66.65 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-O 119.755 -0.469 . . . . 55.34 113.126 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.404 ' HB ' HH21 ' B' ' 15' ' ' ARG . 15.7 m 68.28 15.01 9.3 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.776 1.231 . . . . 72.32 111.245 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.558 ' HE1' HG11 ' A' ' 31' ' ' VAL . 63.6 m-85 -89.54 144.5 32.12 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.451 -0.944 . . . . 74.11 108.451 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.37 142.89 88.12 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.822 2.348 . . . . 74.33 111.898 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.25 138.45 16.47 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.391 1.076 . . . . 72.34 112.486 -175.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.1 tp -115.6 103.03 10.31 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.732 -1.122 . . . . 62.23 110.062 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -111.47 96.85 6.35 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.044 -1.095 . . . . 73.41 108.044 168.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.9 151.28 47.86 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.422 -0.808 . . . . 74.31 110.056 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.69 145.72 95.21 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.745 0.818 . . . . 74.3 111.73 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -57.68 127.62 26.0 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.832 2.355 . . . . 73.44 112.657 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 93.8 t -102.04 115.97 44.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 124.457 1.103 . . . . 71.14 109.243 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -84.86 93.62 8.55 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.521 -0.918 . . . . 72.53 108.521 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -65.06 -27.36 68.73 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.657 0.783 . . . . 74.44 111.801 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -66.72 -47.15 73.21 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.935 0.494 . . . . 72.53 110.175 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.04 -50.88 71.92 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.114 0.884 . . . . 73.24 109.912 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.2 mt -62.29 -38.42 89.3 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.647 -1.16 . . . . 74.24 112.343 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -65.82 -46.78 77.33 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.361 0.665 . . . . 74.41 110.472 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 CA--C 1.543 0.699 0 CA-C-N 115.913 -0.585 . . . . 72.22 110.624 -175.626 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 56.0 m . . . . . 0 N--CA 1.468 0.442 0 N-CA-C 107.875 -1.157 . . . . 73.04 107.875 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -147.37 140.97 25.54 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.801 -0.814 . . . . 72.3 108.801 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -153.0 141.21 20.5 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.17 -0.678 . . . . 72.21 109.17 175.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 mt -85.86 121.26 37.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.179 -1.045 . . . . 73.41 108.179 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -88.08 -42.45 12.38 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.527 0.517 . . . . 72.13 109.931 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.438 ' HG2' ' HD1' ' B' ' 17' ' ' TYR . 65.5 ttt180 -167.8 133.76 2.01 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.765 -0.652 . . . . 75.04 109.695 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.0 mt -115.15 140.48 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.025 -1.472 . . . . 73.04 107.025 168.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.491 ' CE2' ' HB2' ' A' ' 28' ' ' ALA . 34.8 p90 -164.25 158.34 18.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.881 0.848 . . . . 74.24 111.544 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 96.9 m -83.6 120.84 26.45 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.43 -1.259 . . . . 74.24 108.545 171.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.401 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 35.8 mtpt -88.43 -33.38 17.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.44 0.696 . . . . 74.32 110.423 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.5 t70 -150.82 135.94 17.62 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.739 -0.664 . . . . 72.3 110.826 -171.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.539 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.2 mm -127.98 139.79 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.617 1.167 . . . . 74.12 108.678 166.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 43.5 t -140.93 131.34 25.21 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.077 -1.083 . . . . 72.54 108.077 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -141.89 115.4 9.01 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.861 -1.163 . . . . 73.24 107.861 170.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 36.5 mt-10 -118.26 112.54 20.22 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.902 -1.148 . . . . 60.24 107.902 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' B' ' 28' ' ' ALA . . . -106.83 83.23 1.22 Allowed Pre-proline 0 C--O 1.24 0.575 0 N-CA-C 106.311 -1.737 . . . . 72.1 106.311 164.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.91 -13.74 29.25 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 122.459 2.106 . . . . 74.23 112.139 -171.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -123.59 12.48 9.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.075 0.95 . . . . 71.31 110.774 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.417 ' HB3' ' HB1' ' B' ' 25' ' ' ALA . . . -34.86 -62.7 0.4 Allowed Pre-proline 0 N--CA 1.501 2.096 0 N-CA-C 114.456 1.28 . . . . 74.1 114.456 -170.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.18 -36.3 81.35 Favored 'Trans proline' 0 C--N 1.396 3.067 0 C-N-CA 122.154 1.903 . . . . 65.1 113.429 -174.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -92.1 -18.8 23.06 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.891 0.7 . . . . 74.4 112.891 -173.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.684 HG23 HD13 ' B' ' 68' ' ' LEU . 8.6 p -83.12 -19.91 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 118.69 0.677 . . . . 72.14 111.422 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -67.91 -14.38 62.92 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 112.94 0.719 . . . . 74.3 112.94 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.469 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.8 pt20 -60.49 -26.32 66.73 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.125 0.488 . . . . 71.51 110.371 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.558 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 88.2 mttt -101.66 87.65 3.21 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.535 1.134 . . . . 74.42 108.728 175.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -79.54 101.98 8.57 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.315 -0.624 . . . . 71.33 109.315 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -172.66 158.01 3.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.48 1.112 . . . . 74.11 108.877 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' B' ' 124' ' ' PRO . 47.6 mt-30 -64.65 107.59 1.47 Allowed Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.948 0.899 . . . . 74.14 109.123 168.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.616 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.7 Cg_endo -59.14 160.86 17.67 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 123.351 2.7 . . . . 71.55 113.653 -176.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -59.81 103.02 0.18 Allowed 'General case' 0 C--N 1.35 0.614 0 N-CA-C 107.722 -1.214 . . . . 71.32 107.722 169.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.0 m -91.55 161.22 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.3 -0.864 . . . . 65.04 110.509 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -135.71 113.75 11.27 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.398 -1.334 . . . . 75.12 107.398 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 tt -85.2 126.2 33.46 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.692 -1.595 . . . . 73.33 106.692 173.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.72 144.79 26.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.942 -1.132 . . . . 64.13 107.942 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -146.63 160.02 42.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.061 0.544 . . . . 74.11 110.145 174.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -143.65 150.17 38.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.037 0.935 . . . . 63.3 109.335 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -125.52 115.26 19.93 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.007 0.923 . . . . 73.51 109.85 -174.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.02 161.66 19.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.479 1.112 . . . . 73.34 108.501 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 77.4 p -145.37 162.84 36.3 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.538 0.335 . . . . 73.14 110.351 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -154.49 136.19 14.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.684 0.794 . . . . 75.24 109.543 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -89.89 116.06 27.68 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.924 -0.398 . . . . 73.13 109.924 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 24.5 mt -80.25 -52.15 8.07 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.146 0.978 . . . . 72.54 110.741 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.32 -168.53 2.56 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.42 1.088 . . . . 73.42 109.013 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -63.05 100.8 0.23 Allowed 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.492 0.495 . . . . 75.15 110.205 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 63.62 16.16 9.47 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.064 1.345 . . . . 75.25 113.227 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 69.1 t -103.44 101.12 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 105.065 -2.198 . . . . 65.22 105.065 167.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -118.97 168.93 10.34 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.388 -0.967 . . . . 73.3 108.388 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -144.9 111.86 5.91 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.433 -0.951 . . . . 72.2 108.433 -171.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -96.27 137.78 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 O-C-N 124.029 0.831 . . . . 64.25 109.471 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 37.3 t -113.48 117.64 56.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.808 0.843 . . . . 75.44 109.274 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.39 110.73 23.23 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.317 -1.364 . . . . 75.32 107.317 173.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -100.31 128.85 46.28 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.794 -0.817 . . . . 74.13 108.794 173.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.475 ' HB ' HD11 ' B' ' 114' ' ' ILE . 11.4 t -126.91 123.7 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.024 -1.102 . . . . 70.23 108.024 172.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -118.81 134.52 55.1 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.704 0.802 . . . . 73.12 110.807 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.571 HG22 HG21 ' B' ' 114' ' ' ILE . 66.8 t -120.26 101.77 11.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.488 1.515 . . . . 74.31 108.452 177.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 90.5 m -84.65 135.28 34.24 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.883 -1.155 . . . . 75.42 107.883 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.22 141.48 26.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.935 0.334 . . . . 74.42 111.325 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 58.2 p -148.84 135.3 19.49 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.226 0.61 . . . . 70.33 111.341 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.684 HD13 HG23 ' B' ' 31' ' ' VAL . 24.1 mt -96.67 115.3 27.21 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 124.395 1.078 . . . . 73.53 109.995 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.32 -108.44 2.36 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 115.477 -0.783 . . . . 61.51 112.492 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -116.19 2.1 13.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.404 0.681 . . . . 55.32 110.982 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.558 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 14.7 pt-20 -116.2 145.28 43.23 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.438 -0.578 . . . . 73.21 109.438 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 51.2 m -64.74 135.91 56.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.972 0.509 . . . . 63.35 110.778 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.554 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.29 -64.26 1.13 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.339 -0.986 . . . . 64.03 108.339 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -154.11 154.7 34.07 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.79 -1.096 . . . . 73.22 109.827 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 41.6 mt -131.95 108.7 9.55 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.917 -1.883 . . . . 73.54 105.917 176.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.4 t -118.26 143.38 46.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.48 -0.933 . . . . 74.2 108.48 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -157.14 129.31 7.29 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.627 -0.879 . . . . 73.1 108.627 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 81.1 t -123.42 146.35 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.638 0.775 . . . . 73.01 109.148 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.2 mt-30 -123.58 96.17 4.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.405 -0.961 . . . . 72.42 108.405 169.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.517 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.0 tp-100 -86.47 99.52 11.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.503 -0.925 . . . . 74.15 108.503 174.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.23 167.96 33.34 Favored Glycine 0 C--O 1.244 0.734 0 N-CA-C 110.906 -0.877 . . . . 54.24 110.906 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.19 125.46 1.42 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 112.299 -0.32 . . . . 74.11 112.299 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 53.0 mt -85.85 128.91 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.02 0.928 . . . . 75.12 108.982 172.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -134.62 158.87 42.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.617 1.167 . . . . 74.42 108.366 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.6 m -131.83 129.26 40.23 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.854 -0.795 . . . . 74.52 108.854 171.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 13.9 tt -139.9 145.54 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.093 0.557 . . . . 73.11 110.686 -175.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.17 164.24 34.54 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.45 1.1 . . . . 72.23 109.162 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.21 -25.23 15.3 Favored Glycine 0 N--CA 1.475 1.264 0 CA-C-O 121.039 0.244 . . . . 62.24 112.502 -175.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 17.3 tt -88.91 133.03 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.722 1.209 . . . . 74.31 111.849 -167.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -149.6 -176.47 5.42 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.193 1.397 . . . . 74.54 109.219 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.05 -134.11 27.01 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 114.897 -1.047 . . . . 64.11 113.162 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 61.0 m -73.39 -29.19 62.44 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.175 0.99 . . . . 74.25 111.417 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -57.96 -33.34 68.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.562 0.745 . . . . 64.11 111.863 -171.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 22.9 ptm -60.4 -39.84 88.78 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.705 0.802 . . . . 74.4 111.194 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.81 -32.45 59.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.834 0.854 . . . . 65.25 110.319 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -68.57 -28.3 66.84 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.014 -0.994 . . . . 74.01 111.303 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.485 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 48.9 t -75.4 -66.61 0.75 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.089 0.555 . . . . 74.2 110.162 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.95 -26.42 65.05 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.123 0.569 . . . . 73.3 111.967 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.87 -9.8 62.1 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-O 119.489 -0.617 . . . . 60.03 114.462 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.59 -56.21 0.13 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.818 0.809 . . . . 60.21 113.177 -167.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 92.7 t80 -67.6 -49.48 62.91 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.366 0.667 . . . . 72.32 111.899 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.45 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.1 m -61.96 -51.51 74.66 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.646 0.779 . . . . 74.2 111.604 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 89.0 Cg_exo -53.5 -35.34 75.97 Favored 'Trans proline' 0 C--N 1.4 3.262 0 C-N-CA 122.547 2.165 . . . . 73.14 114.332 172.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -58.63 -43.87 89.83 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 123.359 0.664 . . . . 71.13 110.612 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mt -59.71 -41.0 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.167 0.987 . . . . 74.55 110.912 177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 46.9 mt -84.5 -17.05 40.29 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.236 1.014 . . . . 73.45 112.207 -172.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -58.83 -50.07 89.97 Favored Pre-proline 0 CA--C 1.556 1.182 0 N-CA-C 114.02 1.119 . . . . 75.11 114.02 -170.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.49 -34.33 92.95 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.03 1.82 . . . . 72.03 113.12 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.517 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 74.4 m-85 -65.69 -50.45 64.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.001 0.52 . . . . 75.01 110.091 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.16 81.47 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.818 0.847 . . . . 70.13 111.197 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.42 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 36.0 ttt180 -63.89 -53.5 49.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.409 1.483 . . . . 73.21 111.18 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.92 -38.43 90.96 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.874 0.734 . . . . 75.12 109.71 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' B' ' 21' ' ' ILE . 3.2 t -66.63 -36.66 83.11 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.511 -0.768 . . . . 71.32 111.958 -174.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.571 HG21 HG22 ' B' ' 64' ' ' VAL . 66.3 mt -62.11 -56.59 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 109.104 -0.702 . . . . 73.51 109.104 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.8 m -60.85 -25.61 66.78 Favored 'General case' 0 CA--C 1.556 1.21 0 O-C-N 124.334 1.021 . . . . 71.1 111.648 -173.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.9 t -68.3 -46.19 70.98 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.7 0.8 . . . . 75.11 110.261 175.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 7.9 mmt -72.54 -34.65 67.69 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.89 0.476 . . . . 74.3 111.063 -177.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 114' ' ' ILE . 93.8 t -57.53 -44.22 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.231 1.013 . . . . 74.53 109.567 171.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.5 t -70.74 -30.88 67.53 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.427 -1.26 . . . . 74.33 112.07 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' ' 116' ' ' SER . 89.1 mtt-85 -69.8 -36.03 75.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.983 0.513 . . . . 73.45 110.036 177.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.64 1.95 84.34 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.592 0.558 . . . . 72.25 112.559 171.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 17' ' ' TYR . 26.7 p 62.18 30.77 17.75 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.687 1.995 . . . . 73.24 113.0 172.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -85.16 155.05 60.63 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.667 0.787 . . . . 74.2 110.095 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.505 ' HB2' ' HG2' ' B' ' 37' ' ' GLN . 48.0 Cg_exo -57.15 168.82 2.38 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.231 2.621 . . . . 74.1 114.537 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.416 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 63.9 tp60 -56.85 133.42 54.44 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.573 1.149 . . . . 75.14 112.065 -172.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.47 102.48 6.65 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.269 -1.012 . . . . 75.23 108.269 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.53 101.31 12.21 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.611 0.764 . . . . 74.5 109.553 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.42 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 0.2 OUTLIER -61.28 129.35 40.83 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 109.259 -0.645 . . . . 75.25 109.259 179.451 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.64 152.13 80.47 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 123.625 0.77 . . . . 73.24 111.941 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.423 ' HG2' ' HB ' ' D' ' 13' ' ' ILE . 6.2 Cg_endo -81.26 109.69 2.16 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.25 2.633 . . . . 63.44 112.137 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 t -115.06 112.4 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.19 -0.67 . . . . 72.11 109.19 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' B' ' 136' ' ' LEU . 56.2 t-20 -85.24 112.85 21.12 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.905 -0.776 . . . . 75.11 108.905 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -89.86 -27.47 19.9 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.01 0.744 . . . . 72.21 113.01 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -73.77 -42.71 60.68 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 118.602 0.637 . . . . 73.42 111.416 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.2 89.25 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.542 0.737 . . . . 61.41 110.307 172.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' B' ' 132' ' ' ASN . 0.9 OUTLIER -68.78 -33.5 73.98 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.079 0.951 . . . . 75.32 110.25 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 80.3 t80 . . . . . 0 N--CA 1.475 0.79 0 C-N-CA 123.429 0.692 . . . . 74.44 110.767 -175.643 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 90.9 m . . . . . 0 C--O 1.239 0.51 0 N-CA-C 108.93 -0.766 . . . . 74.31 108.93 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -94.31 140.83 29.29 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.535 -0.757 . . . . 74.35 109.387 175.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.63 136.05 15.92 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.536 -0.542 . . . . 73.43 109.536 172.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.14 127.84 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.517 -0.92 . . . . 74.51 108.517 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.504 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.8 mm-40 -89.8 -47.47 7.88 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.207 -0.664 . . . . 75.31 109.207 174.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -175.0 134.41 0.34 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.798 -0.637 . . . . 62.23 109.836 -170.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.8 mt -117.34 144.98 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.791 -1.189 . . . . 74.44 107.791 176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.433 ' CE2' ' HG2' ' C' ' 19' ' ' LYS . 36.7 p90 -171.53 161.72 6.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.506 0.669 . . . . 73.24 111.301 -174.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.9 p -88.63 112.51 23.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.876 -1.157 . . . . 73.43 107.876 169.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.433 ' HG2' ' CE2' ' C' ' 17' ' ' TYR . 18.1 mttt -67.44 -48.97 65.67 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 122.24 1.019 . . . . 73.21 108.345 171.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.34 133.37 36.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 113.599 -1.637 . . . . 74.13 109.045 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 79.6 mt -124.49 141.31 45.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.692 -1.596 . . . . 72.24 106.692 172.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -153.92 147.61 25.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.398 0.618 . . . . 62.33 110.997 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 81.7 t80 -146.37 132.12 18.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 106.899 -1.519 . . . . 71.42 106.899 169.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -132.54 124.93 29.4 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.729 0.811 . . . . 73.14 109.35 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.41 79.87 29.03 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.06 -1.459 . . . . 72.54 107.06 172.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.72 -26.74 19.05 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.748 2.299 . . . . 74.22 111.569 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -102.43 17.6 23.16 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.283 1.033 . . . . 73.41 110.218 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.437 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -47.96 -59.63 5.53 Favored Pre-proline 0 C--N 1.371 1.512 0 N-CA-C 114.774 1.398 . . . . 62.4 114.774 -166.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.14 -42.36 36.53 Favored 'Trans proline' 0 C--N 1.393 2.917 0 CA-C-N 121.834 1.691 . . . . 55.04 111.919 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -69.73 -33.16 72.1 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.402 -1.272 . . . . 71.13 112.232 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.639 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.0 p -79.43 -21.6 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 O-C-N 122.094 -0.379 . . . . 75.43 111.867 -176.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -69.83 -22.18 63.31 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.762 0.425 . . . . 71.33 111.742 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -97.29 19.46 13.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.671 0.388 . . . . 75.23 111.295 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.749 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -91.76 149.83 21.41 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.902 -0.777 . . . . 75.33 108.902 170.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -69.41 129.7 40.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.88 -0.785 . . . . 70.45 108.88 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -68.51 109.72 3.85 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.165 0.586 . . . . 75.04 111.418 -172.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -163.08 70.19 1.93 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.948 0.899 . . . . 54.41 108.879 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -88.52 128.5 2.12 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.94 2.427 . . . . 62.3 112.818 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . 0.436 ' HB3' ' HE2' ' C' ' 41' ' ' LYS . 26.4 mt-10 -84.68 94.96 8.76 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.381 -0.97 . . . . 74.14 108.381 168.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 m -74.7 99.17 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-N 114.419 -1.264 . . . . 64.53 110.314 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.436 ' HE2' ' HB3' ' C' ' 39' ' ' GLU . 73.4 mmtt -92.76 103.35 15.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.76 -1.109 . . . . 72.14 108.497 177.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.477 HD11 HD12 ' C' ' 128' ' ' LEU . 7.3 tt -95.04 136.71 35.03 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.913 -0.773 . . . . 74.41 108.913 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -118.4 112.73 20.37 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.253 1.421 . . . . 73.2 107.739 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.407 HD12 HD21 ' C' ' 60' ' ' LEU . 14.7 tp -104.14 133.96 48.2 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.926 -0.768 . . . . 75.11 108.926 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.4 t70 -140.47 149.33 42.4 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.045 0.938 . . . . 74.13 109.153 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 7.9 m -132.57 130.36 40.21 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 123.505 0.722 . . . . 74.22 109.301 169.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.37 153.23 26.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.933 1.293 . . . . 72.14 108.241 175.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 17.8 p -149.85 140.92 22.97 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.711 -0.477 . . . . 74.4 109.711 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -161.16 150.81 16.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.878 0.871 . . . . 73.31 109.453 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -86.08 132.7 33.98 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.936 -0.394 . . . . 74.02 109.936 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' C' ' 57' ' ' GLU . 50.0 mt -98.88 -38.41 9.04 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.426 0.69 . . . . 74.32 109.269 173.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.63 178.0 10.77 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.229 1.012 . . . . 72.34 109.635 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.89 123.17 17.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.94 0.496 . . . . 73.34 109.891 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 71.38 -8.77 0.98 Allowed 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 126.316 1.846 . . . . 72.35 113.311 -173.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -95.27 97.5 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.77 -0.826 . . . . 74.31 108.77 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.66 124.54 49.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.132 -0.692 . . . . 72.41 109.132 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.57 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.4 tt0 -90.16 135.4 33.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.163 0.585 . . . . 74.1 109.715 173.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.34 141.34 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.502 1.121 . . . . 73.35 107.979 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.7 t -127.49 129.27 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 107.662 -1.236 . . . . 74.21 107.662 172.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.407 HD21 HD12 ' C' ' 44' ' ' LEU . 0.6 OUTLIER -110.17 102.81 11.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.575 -1.269 . . . . 74.4 107.575 -179.029 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -84.22 127.83 34.19 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.037 -0.983 . . . . 74.54 108.388 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.498 ' HB ' HD11 ' C' ' 114' ' ' ILE . 40.9 t -124.45 121.06 60.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 107.123 -1.436 . . . . 75.23 107.123 168.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 9.5 m -124.98 115.36 20.44 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.479 -0.563 . . . . 71.14 109.479 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.439 HG22 HG23 ' C' ' 114' ' ' ILE . 81.2 t -99.92 107.96 21.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.298 -1.001 . . . . 71.44 108.298 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 55.6 m -96.18 139.82 31.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.276 -1.75 . . . . 75.22 106.276 169.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.75 116.19 11.99 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.527 -1.286 . . . . 63.25 107.527 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.6 m -127.08 168.39 14.67 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.031 -0.729 . . . . 70.53 109.031 175.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.709 HD11 ' HG2' ' C' ' 34' ' ' LYS . 5.6 mt -123.47 21.41 9.43 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.535 1.134 . . . . 75.12 109.004 -174.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.72 -99.76 1.0 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.66 -1.376 . . . . 64.42 109.66 -166.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -90.89 -31.62 16.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.418 0.687 . . . . 74.15 110.64 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -85.36 120.17 26.54 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.059 0.943 . . . . 63.53 110.875 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 40.5 m -73.55 125.78 28.76 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.744 -0.465 . . . . 71.4 109.744 170.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.639 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.0 -61.86 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.091 0.869 . . . . 72.4 109.003 171.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . 0.452 ' HZ ' HD22 ' C' ' 126' ' ' LEU . 54.6 p90 -164.86 176.08 9.03 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.708 0.766 . . . . 71.23 111.739 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.436 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -130.41 144.77 51.6 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 106.508 -1.664 . . . . 74.24 106.508 168.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.436 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.8 t -152.47 111.65 3.86 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.085 -0.709 . . . . 73.01 109.085 174.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.69 133.86 55.5 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.822 -0.436 . . . . 73.01 109.822 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 56.1 t -124.95 135.05 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.735 0.814 . . . . 63.2 108.846 168.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -111.99 90.4 3.33 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.835 -1.172 . . . . 65.32 107.835 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.05 96.59 6.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.427 -0.806 . . . . 65.41 109.403 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.63 146.8 20.92 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.218 -0.753 . . . . 73.05 111.218 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.429 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.36 117.5 0.85 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.312 -1.115 . . . . 74.32 110.312 -175.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.538 HD13 HD12 ' C' ' 51' ' ' LEU . 10.7 mm -82.88 126.54 40.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 107.714 -1.217 . . . . 75.05 107.714 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -133.13 121.28 22.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.481 0.713 . . . . 74.44 109.378 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.6 p -85.24 111.07 19.51 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.204 -0.665 . . . . 63.15 109.204 174.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 49.4 pt -114.68 141.17 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.088 0.955 . . . . 74.23 108.975 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.95 164.42 31.19 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.399 0.68 . . . . 72.13 110.004 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.75 -55.8 0.72 Allowed Glycine 0 C--N 1.341 0.82 0 O-C-N 123.512 0.508 . . . . 70.25 113.137 172.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.48 170.52 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 112.577 0.584 . . . . 74.13 112.577 -173.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.487 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 17.1 pt-20 -151.97 -172.64 4.28 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.941 0.897 . . . . 74.25 109.819 172.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.49 -137.92 16.96 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-O 119.338 -0.701 . . . . 52.43 113.231 172.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 25.3 p -63.49 -33.58 75.89 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.895 0.878 . . . . 73.32 111.402 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -59.65 -48.53 81.32 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.242 1.017 . . . . 74.35 110.064 176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.487 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 35.8 ttp -72.97 -30.09 63.57 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.613 -1.176 . . . . 74.31 110.845 176.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.58 -35.13 73.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.912 0.485 . . . . 74.12 110.23 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.577 ' HE2' ' HA ' ' C' ' 134' ' ' ASP . 10.1 t-160 -78.67 -33.16 47.26 Favored 'General case' 0 C--O 1.242 0.702 0 O-C-N 123.693 0.621 . . . . 65.52 111.827 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 39.8 t -57.23 -39.28 75.18 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.412 0.445 . . . . 34.31 110.442 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.8 mt -95.21 -19.54 19.96 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.794 0.837 . . . . 71.13 110.348 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.99 -29.4 54.32 Favored Glycine 0 C--N 1.349 1.252 0 C-N-CA 123.559 0.6 . . . . 74.31 114.036 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.03 -41.94 0.08 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.601 0.593 . . . . 65.11 112.601 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -61.85 -57.54 11.4 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.222 0.609 . . . . 73.43 111.961 -173.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 97.0 m -66.64 -46.6 57.35 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.927 0.891 . . . . 71.1 112.45 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.58 -35.92 69.14 Favored 'Trans proline' 0 C--N 1.401 3.328 0 C-N-CA 122.428 2.085 . . . . 75.53 113.388 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -67.75 -35.65 79.09 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.763 0.825 . . . . 74.52 110.463 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.408 HD13 ' NH1' ' A' ' 111' ' ' ARG . 46.8 mm -63.73 -39.5 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 122.863 0.465 . . . . 74.21 109.995 174.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.429 HD21 ' HA3' ' C' ' 82' ' ' GLY . 83.2 mt -85.78 -22.82 27.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.098 0.959 . . . . 74.43 112.847 -173.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -60.29 -46.59 97.69 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 124.984 1.314 . . . . 74.52 113.787 -172.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.618 ' HA ' ' HD3' ' C' ' 111' ' ' ARG . 35.2 Cg_exo -63.55 -34.53 63.95 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 122.307 2.005 . . . . 73.31 113.463 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -67.49 -44.59 78.15 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.752 0.421 . . . . 75.43 110.142 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.37 78.49 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 115.285 -0.871 . . . . 73.14 110.891 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.721 ' HG2' ' HG ' ' C' ' 128' ' ' LEU . 21.3 mtp-105 -56.88 -62.32 1.82 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.784 0.833 . . . . 65.42 110.707 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.51 -30.13 71.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.243 0.617 . . . . 75.44 111.286 -172.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.5 t -74.07 -32.85 63.46 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.073 0.549 . . . . 73.2 111.502 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.498 HD11 ' HB ' ' C' ' 62' ' ' VAL . 66.4 mt -73.71 -49.81 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.274 0.63 . . . . 74.22 109.846 172.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 90.6 m -57.26 -37.79 72.88 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.343 1.057 . . . . 75.34 111.407 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -63.72 -48.07 78.54 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.34 -0.846 . . . . 75.21 109.622 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.548 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.59 -37.89 88.0 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.617 1.167 . . . . 72.24 112.991 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.414 HG23 HD11 ' C' ' 126' ' ' LEU . 78.5 t -68.36 -43.28 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.657 0.783 . . . . 74.31 110.611 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -66.19 -30.42 70.89 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 115.018 -0.992 . . . . 72.34 110.604 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -71.86 -34.29 69.1 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 123.69 0.796 . . . . 74.03 109.455 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.69 5.58 77.8 Favored Glycine 0 C--N 1.353 1.484 0 O-C-N 123.73 0.644 . . . . 74.12 113.04 174.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.416 HG22 ' HB3' ' D' ' 17' ' ' TYR . 75.5 p 60.62 23.36 13.13 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.524 1.93 . . . . 72.21 113.974 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -85.06 156.56 60.41 Favored Pre-proline 0 CA--C 1.555 1.145 0 N-CA-C 108.739 -0.837 . . . . 73.24 108.739 170.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.11 155.35 40.05 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.195 2.597 . . . . 53.2 113.129 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.416 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 52.3 mm-40 -60.13 131.39 50.68 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.978 0.911 . . . . 75.12 112.017 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.452 HD22 ' HZ ' ' C' ' 74' ' ' PHE . 2.9 pp -144.67 126.82 15.63 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.819 0.848 . . . . 73.14 108.809 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -127.7 124.88 38.95 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.537 -1.653 . . . . 63.32 106.537 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.721 ' HG ' ' HG2' ' C' ' 111' ' ' ARG . 0.0 OUTLIER -75.82 130.12 38.08 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.475 -0.565 . . . . 71.5 109.475 -171.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.57 154.39 93.31 Favored Pre-proline 0 CA--C 1.551 1.001 0 O-C-N 124.726 1.266 . . . . 72.31 112.589 -170.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.454 ' CG ' HD13 ' A' ' 16' ' ' ILE . 7.6 Cg_exo -68.79 115.2 3.83 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.372 2.048 . . . . 73.01 111.749 175.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 51.0 t -99.12 134.28 38.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.084 -1.45 . . . . 63.33 107.084 168.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -73.65 73.34 1.49 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.219 0.608 . . . . 65.23 110.358 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -60.75 -39.63 89.45 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.448 0.699 . . . . 74.21 110.656 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.577 ' HA ' ' HE2' ' C' ' 96' ' ' HIS . 10.7 m-20 -61.61 -49.36 76.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.299 -0.864 . . . . 71.14 111.606 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.49 87.67 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.88 0.737 . . . . 54.2 111.183 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 93.8 mt -67.71 -34.8 77.6 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.543 -0.753 . . . . 74.41 111.894 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 10.6 t80 . . . . . 0 N--CA 1.486 1.327 0 C-N-CA 122.663 0.385 . . . . 62.55 110.677 -178.663 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 61.6 m . . . . . 0 C--O 1.236 0.354 0 CA-C-O 121.463 0.649 . . . . 74.32 111.066 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -154.47 93.01 1.55 Allowed 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.579 -1.637 . . . . 74.51 106.579 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -113.23 126.87 55.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.177 -0.675 . . . . 71.42 109.177 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.423 ' HB ' ' HG2' ' B' ' 130' ' ' PRO . 10.2 mt -87.56 119.87 35.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.062 -1.088 . . . . 74.3 108.062 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -85.62 -28.52 24.72 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 123.643 0.589 . . . . 65.0 111.125 -175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -172.4 121.03 0.42 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 110.399 -0.223 . . . . 73.42 110.399 -166.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.02 133.49 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 107.328 -1.36 . . . . 74.05 107.328 169.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.426 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 42.6 p90 -162.63 174.18 12.93 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 122.007 0.908 . . . . 75.44 112.045 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.9 p -104.57 124.18 48.86 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.188 -1.369 . . . . 71.21 109.188 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.426 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 36.4 mtpt -93.86 -18.49 21.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.418 0.687 . . . . 72.24 109.559 177.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.7 t70 -162.12 135.17 6.06 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 124.377 1.071 . . . . 74.2 108.989 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.548 HG23 ' HE1' ' C' ' 117' ' ' MET . 86.8 mt -136.16 133.86 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.602 1.161 . . . . 74.43 108.076 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 57.8 m -137.59 113.46 9.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.413 1.085 . . . . 64.4 109.655 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.498 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 83.8 t80 -116.82 117.12 28.86 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.353 -1.721 . . . . 73.53 106.353 163.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.4 mt-10 -126.3 111.33 14.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.422 0.689 . . . . 72.01 109.357 -175.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.17 87.31 7.17 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.272 -1.01 . . . . 74.02 108.272 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -75.54 -32.61 4.67 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.7 2.267 . . . . 72.31 113.01 -171.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -100.42 9.09 43.11 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.557 0.743 . . . . 75.4 110.161 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.06 -69.79 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 116.18 1.919 . . . . 75.44 116.18 -161.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.434 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 68.4 Cg_endo -77.41 -19.6 13.08 Favored 'Trans proline' 0 C--N 1.383 2.353 0 CA-C-N 123.558 2.306 . . . . 70.22 113.765 -174.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -70.18 -43.07 71.54 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.366 1.066 . . . . 62.13 109.13 173.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.538 HG21 ' HA ' ' D' ' 73' ' ' ALA . 6.3 p -84.28 -15.65 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.81 0.844 . . . . 71.32 111.398 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.434 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.8 m-85 -70.4 -19.69 62.99 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 120.784 0.325 . . . . 73.23 111.38 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -72.66 -12.44 61.04 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.413 -0.812 . . . . 73.04 111.069 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -83.26 84.51 7.47 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.208 1.003 . . . . 64.23 108.885 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -77.46 80.43 3.95 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.457 0.646 . . . . 75.05 109.282 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -156.23 163.8 39.12 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.501 -1.227 . . . . 73.24 108.842 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.467 ' NE2' HD23 ' D' ' 126' ' ' LEU . 23.7 tp60 -89.99 108.18 24.23 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.204 1.002 . . . . 74.12 109.65 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.413 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 34.8 Cg_exo -59.85 158.09 30.51 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 123.329 2.686 . . . . 73.34 114.302 -174.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -79.82 157.31 27.06 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.356 1.062 . . . . 74.45 110.736 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.83 118.47 57.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.178 -0.675 . . . . 74.42 109.178 172.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -117.65 114.04 22.79 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.819 0.847 . . . . 63.23 108.832 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.35 126.33 43.82 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.113 0.565 . . . . 72.41 111.034 -172.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -124.97 120.09 30.6 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.959 1.304 . . . . 65.52 107.654 170.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt -110.95 146.03 37.33 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.728 0.411 . . . . 73.41 110.093 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 34.5 t70 -147.82 151.5 36.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.651 1.18 . . . . 75.51 108.342 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -132.16 163.73 27.88 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.735 0.414 . . . . 75.3 110.432 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.667 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -153.93 175.21 13.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.371 1.068 . . . . 60.1 109.512 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.531 ' HB3' HD23 ' D' ' 98' ' ' LEU . 50.5 p -168.5 157.25 8.69 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.81 0.844 . . . . 71.3 110.573 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 88.5 p -153.2 154.56 34.95 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.962 0.905 . . . . 72.11 109.038 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -94.59 116.97 29.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.728 -0.842 . . . . 75.22 108.728 170.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.521 HD13 HG22 ' D' ' 83' ' ' ILE . 42.7 mt -93.38 -30.01 15.32 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 110.02 -0.363 . . . . 73.44 110.02 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.425 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -162.83 -174.84 4.1 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.444 0.698 . . . . 72.42 111.2 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -67.09 116.47 7.94 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.661 -1.154 . . . . 71.44 109.455 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 66.02 5.5 3.56 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.867 1.267 . . . . 73.12 112.567 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 78.8 t -110.18 120.05 60.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 108.545 -0.909 . . . . 75.35 108.545 176.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -135.26 131.27 36.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.752 -0.833 . . . . 73.52 108.752 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -89.81 148.01 23.46 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.698 0.799 . . . . 73.52 109.355 173.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.46 HG21 ' HG ' ' D' ' 98' ' ' LEU . 90.8 t -125.49 139.87 50.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 124.737 1.215 . . . . 74.23 107.867 170.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 77.8 t -118.69 135.37 59.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.282 -1.007 . . . . 73.32 108.282 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -118.25 121.01 39.39 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.785 -0.82 . . . . 74.54 108.785 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 24.8 ttm-85 -103.38 96.0 6.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.048 -1.093 . . . . 72.34 108.048 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 74.5 t -97.81 119.0 45.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.295 -1.002 . . . . 65.32 108.295 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 14.2 m -119.77 129.87 54.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.846 -1.07 . . . . 74.12 108.541 -172.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 67.2 t -122.47 128.97 75.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 124.837 1.255 . . . . 73.24 108.261 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 95.9 m -122.34 120.63 34.58 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.199 -1.037 . . . . 63.43 108.199 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.71 151.94 39.95 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.472 -0.785 . . . . 75.31 110.08 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.433 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 19.7 p -149.6 125.37 10.47 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.293 -0.867 . . . . 73.12 109.368 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 12.0 mt -92.83 114.21 26.7 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.221 1.008 . . . . 74.31 108.931 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.92 -110.1 2.94 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.966 -0.854 . . . . 75.01 110.966 -174.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 5.94 8.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.013 0.925 . . . . 74.42 110.844 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -123.02 155.41 36.91 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.539 0.736 . . . . 74.32 109.788 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -60.51 129.98 44.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.851 0.86 . . . . 75.41 111.979 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.538 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.96 -72.74 0.55 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.756 -1.201 . . . . 74.32 107.756 176.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -145.57 146.36 31.36 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.216 -0.902 . . . . 73.4 110.217 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.7 mt -114.34 143.58 44.65 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.534 1.134 . . . . 73.45 108.134 175.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.542 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 23.7 m -142.09 137.49 31.03 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.832 0.853 . . . . 72.23 109.232 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -154.41 121.0 5.45 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.799 -1.186 . . . . 72.44 107.799 170.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.7 t -130.8 115.23 29.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.684 -0.858 . . . . 74.35 108.684 -175.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.461 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -88.49 85.37 6.84 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.431 -0.952 . . . . 72.43 108.431 172.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -78.61 96.77 5.58 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.248 -1.342 . . . . 74.11 108.771 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.85 143.12 17.4 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 115.827 -0.624 . . . . 74.43 111.867 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.446 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -140.75 129.64 4.22 Favored Glycine 0 C--N 1.329 0.187 0 N-CA-C 110.685 -0.966 . . . . 73.52 110.685 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.521 HG22 HD13 ' D' ' 51' ' ' LEU . 61.0 mt -90.15 129.43 41.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.321 -0.992 . . . . 73.14 108.321 177.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -128.92 153.46 47.49 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.71 0.404 . . . . 74.15 111.06 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -114.88 105.65 13.25 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.806 1.242 . . . . 65.23 108.097 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.35 122.76 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.125 0.57 . . . . 74.34 110.305 -175.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.08 141.94 24.67 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.316 1.046 . . . . 74.22 108.48 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.94 -20.13 29.35 Favored Glycine 0 N--CA 1.468 0.825 0 O-C-N 123.116 0.26 . . . . 61.3 112.59 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 32.9 pt -131.95 147.0 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.414 0.686 . . . . 74.44 109.17 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.07 163.48 33.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.807 0.843 . . . . 74.02 111.317 -176.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.64 -127.52 31.37 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.173 -0.921 . . . . 65.14 114.264 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.1 m -74.32 -30.63 62.14 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.192 0.997 . . . . 75.33 111.135 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -65.46 -34.83 79.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.32 0.648 . . . . 75.34 109.977 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.438 ' HE3' HD12 ' D' ' 98' ' ' LEU . 1.2 tmt? -83.62 -26.17 30.18 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.534 -0.757 . . . . 71.41 110.817 175.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.08 -23.16 67.09 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.86 0.362 . . . . 73.11 110.612 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -70.48 -43.6 69.42 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.672 0.789 . . . . 72.34 110.557 168.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -63.59 -46.83 84.03 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.933 0.493 . . . . 72.42 110.966 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.531 HD23 ' HB3' ' D' ' 48' ' ' SER . 7.3 tt -77.2 -46.26 23.88 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.838 0.855 . . . . 73.53 109.785 -175.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.37 -12.69 83.58 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.83 -0.623 . . . . 71.34 114.149 -172.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.49 -61.03 0.65 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.424 0.612 . . . . 74.4 112.546 -172.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -67.06 -39.7 86.95 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 112.639 0.607 . . . . 75.14 112.639 -172.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.414 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 97.7 m -68.91 -48.94 28.15 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 118.547 -0.739 . . . . 71.25 111.086 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.422 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 71.0 Cg_exo -55.74 -35.11 92.81 Favored 'Trans proline' 0 C--N 1.399 3.209 0 C-N-CA 122.413 2.075 . . . . 70.21 113.169 168.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -63.36 -37.37 87.02 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.338 0.655 . . . . 74.25 110.276 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.41 HG21 HD12 ' D' ' 13' ' ' ILE . 36.5 mm -67.58 -43.42 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.664 0.786 . . . . 75.23 110.703 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.446 HD22 ' HA3' ' D' ' 82' ' ' GLY . 95.1 mt -75.08 -16.71 60.55 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.382 -0.826 . . . . 74.24 111.809 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -69.64 -43.08 21.07 Favored Pre-proline 0 CA--C 1.56 1.334 0 CA-C-O 118.209 -0.9 . . . . 75.23 113.274 -170.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -53.15 -44.74 46.37 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.2 1.934 . . . . 74.52 112.964 168.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.49 -36.09 76.19 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.665 0.786 . . . . 71.05 111.817 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.94 -54.66 31.11 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.49 0.716 . . . . 63.1 109.678 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -49.56 -49.46 46.28 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 125.068 1.48 . . . . 65.44 111.038 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -64.79 -44.0 91.39 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 124.132 0.895 . . . . 64.0 111.608 -173.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.0 t -60.33 -43.7 96.18 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.511 0.507 . . . . 75.44 110.717 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.542 HG21 HG22 ' D' ' 64' ' ' VAL . 77.3 mt -59.42 -56.97 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.399 1.08 . . . . 74.04 110.057 173.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.3 m -59.07 -35.35 73.22 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.205 1.402 . . . . 73.12 112.053 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -69.27 -43.85 73.06 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.643 -0.708 . . . . 72.44 109.753 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 72.3 mtm -67.38 -31.82 72.3 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.974 0.51 . . . . 72.4 111.875 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.46 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.6 t -62.69 -45.37 98.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.976 0.91 . . . . 72.53 110.334 175.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.8 p -73.59 -32.08 63.93 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 116.126 -0.488 . . . . 71.32 111.136 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -70.67 -31.78 68.82 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.633 0.773 . . . . 75.13 110.509 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.06 8.84 76.96 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-N 115.491 -0.777 . . . . 73.42 112.419 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 28.3 p 63.94 18.45 11.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.494 1.918 . . . . 74.54 114.231 171.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.82 147.69 49.28 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.198 0.599 . . . . 74.01 109.446 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.42 124.07 13.43 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.358 2.705 . . . . 72.42 112.932 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -61.86 130.09 44.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.955 1.302 . . . . 75.25 112.092 -173.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.467 HD23 ' NE2' ' D' ' 37' ' ' GLN . 71.2 mt -119.09 112.5 19.62 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.015 0.926 . . . . 74.45 109.12 -176.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -100.79 103.06 14.27 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.749 -0.834 . . . . 72.52 108.749 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 29.2 tp -68.91 135.85 51.67 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.679 -1.146 . . . . 70.33 112.053 -169.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.31 135.9 93.46 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 122.989 0.516 . . . . 74.21 110.428 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -64.04 136.41 52.23 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.719 2.279 . . . . 75.44 111.925 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.85 123.19 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.563 0.745 . . . . 73.53 109.211 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -82.66 92.59 7.19 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.954 -0.758 . . . . 71.33 108.954 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -67.23 -35.76 80.26 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.982 -0.554 . . . . 70.23 110.555 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.62 -53.51 57.25 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.575 1.15 . . . . 71.41 112.789 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.82 93.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.116 0.566 . . . . 41.14 110.973 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 33.4 tp -76.2 -17.77 59.37 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.592 -0.731 . . . . 71.52 111.951 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 89.8 t80 . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 109.398 -0.593 . . . . 74.14 109.398 171.569 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 87' ' ' ALA . 68.9 m . . . . . 0 C--O 1.241 0.611 0 N-CA-C 109.388 -0.597 . . . . 74.55 109.388 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.669 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.6 t80 -136.44 131.63 34.33 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.745 1.218 . . . . 72.4 108.951 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -138.93 117.93 12.5 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.013 0.925 . . . . 73.34 108.652 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.526 HG12 ' HD2' ' A' ' 84' ' ' PHE . 39.1 mt -84.19 110.91 19.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.549 -0.908 . . . . 74.15 108.549 172.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -78.07 -40.03 39.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.991 0.807 . . . . 73.11 110.132 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.404 ' HB3' HD12 ' A' ' 83' ' ' ILE . 14.6 ttt180 -169.84 143.77 2.68 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 121.137 -0.225 . . . . 73.04 111.125 -171.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.48 HD13 ' HG3' ' C' ' 130' ' ' PRO . 94.2 mt -135.71 128.31 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.121 -1.066 . . . . 75.1 108.121 175.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.423 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.7 p90 -165.62 150.21 8.57 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.177 0.991 . . . . 70.31 110.37 -169.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -75.32 114.91 14.4 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.978 -0.749 . . . . 71.12 108.978 173.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HZ3' ' HG2' ' A' ' 57' ' ' GLU . 37.5 mtpt -81.74 -28.36 33.39 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.297 -0.631 . . . . 75.45 109.297 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.1 t70 -149.08 138.52 21.67 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.235 -0.893 . . . . 74.23 109.723 174.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.459 HG21 ' SD ' ' B' ' 117' ' ' MET . 61.9 mt -131.11 150.43 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 107.257 -1.386 . . . . 74.15 107.257 173.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.0 t -158.23 146.4 18.62 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.387 0.429 . . . . 72.2 109.972 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 82.4 t80 -137.72 141.07 41.02 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.262 -1.384 . . . . 75.51 107.262 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 50.7 mt-10 -139.13 133.55 31.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.374 0.67 . . . . 74.02 109.39 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.32 73.39 11.88 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 107.235 -1.394 . . . . 74.31 107.235 171.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.51 -22.25 18.57 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.63 2.22 . . . . 74.44 111.779 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.408 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 94.2 m-20 -112.27 32.8 5.29 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.019 1.328 . . . . 50.43 109.367 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.412 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -60.47 -46.75 97.44 Favored Pre-proline 0 CA--C 1.571 1.763 0 N-CA-C 113.054 0.761 . . . . 74.02 113.054 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 25.4 Cg_exo -66.61 -19.28 54.26 Favored 'Trans proline' 0 C--N 1.393 2.909 0 C-N-CA 122.002 1.801 . . . . 72.31 113.216 172.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -79.93 -48.86 12.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.398 0.679 . . . . 71.25 110.892 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.449 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 7.8 p -68.43 -18.93 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.963 0.505 . . . . 64.14 110.71 -178.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -62.2 -39.63 93.39 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.108 0.963 . . . . 74.02 111.29 175.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -95.06 -13.14 25.44 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.591 0.756 . . . . 72.11 111.552 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 31.9 mmtp -83.19 167.93 17.26 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.24 0.616 . . . . 74.43 111.928 177.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -83.85 137.27 33.77 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.92 0.888 . . . . 73.43 109.819 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -77.68 86.77 3.96 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.469 0.652 . . . . 74.24 109.86 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -138.34 73.77 42.63 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 107.652 -1.24 . . . . 75.04 107.652 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 37.2 Cg_endo -91.05 166.06 3.75 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.48 2.12 . . . . 72.22 113.506 -174.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -99.58 105.51 17.39 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.06 -1.459 . . . . 74.54 107.06 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.13 90.87 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-O 122.728 1.251 . . . . 72.41 110.78 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 65' ' ' THR . 29.8 mmmt -94.91 118.09 31.21 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.899 -1.046 . . . . 74.23 108.887 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.9 tp -116.77 127.2 54.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.25 -1.389 . . . . 74.4 107.25 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.432 ' HB2' HG21 ' A' ' 63' ' ' THR . 6.7 m-20 -123.54 122.91 39.41 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.334 -1.358 . . . . 71.3 107.334 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.412 ' HG ' HG22 ' A' ' 62' ' ' VAL . 6.3 tt -128.75 136.46 50.59 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.75 -0.833 . . . . 75.42 108.75 -169.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 28.8 t70 -143.75 145.35 32.33 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.993 1.317 . . . . 74.23 108.431 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.0 m -114.35 133.77 55.45 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.262 -1.014 . . . . 74.14 108.262 171.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.96 143.15 50.65 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.881 -0.785 . . . . 73.4 108.881 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.8 m -127.8 152.54 47.66 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.077 0.551 . . . . 74.51 111.017 -170.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.6 p -159.44 140.36 12.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.724 0.64 . . . . 72.11 110.123 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -87.18 109.22 19.32 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.304 -0.628 . . . . 74.31 109.304 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.601 HD12 ' HB2' ' A' ' 57' ' ' GLU . 82.7 mt -78.95 -41.63 28.87 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.229 0.538 . . . . 71.44 109.984 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.99 176.86 10.72 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.228 -1.027 . . . . 73.31 108.228 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -60.58 117.54 5.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.13 -0.693 . . . . 63.52 109.13 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 72.58 13.1 5.39 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.731 1.212 . . . . 72.45 112.317 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.93 125.17 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.395 -0.965 . . . . 73.3 108.395 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -123.55 153.34 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.549 0.69 . . . . 74.24 111.582 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.601 ' HB2' HD12 ' A' ' 51' ' ' LEU . 8.4 tp10 -118.05 114.15 22.69 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.186 -1.783 . . . . 73.22 106.186 166.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.74 122.37 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 107.782 -1.192 . . . . 75.43 107.782 169.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -99.31 123.21 51.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.175 -1.046 . . . . 75.32 108.175 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 tp -86.74 96.83 10.3 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 106.754 -1.572 . . . . 73.4 106.754 173.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.587 ' HG2' ' HG3' ' A' ' 79' ' ' GLN . 0.8 OUTLIER -85.77 101.95 13.23 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.526 -1.216 . . . . 74.02 107.908 -175.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.412 HG22 ' HG ' ' A' ' 44' ' ' LEU . 62.1 t -125.08 137.97 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.067 0.547 . . . . 73.04 109.689 -174.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.432 HG21 ' HB2' ' A' ' 43' ' ' ASP . 7.5 t -138.53 145.63 40.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.348 0.659 . . . . 73.23 110.003 172.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 93.2 t -120.11 111.57 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.915 0.886 . . . . 75.11 108.614 177.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 20.7 m -105.52 107.91 19.15 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.199 -0.667 . . . . 74.41 109.199 173.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.64 104.64 15.02 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.736 -1.209 . . . . 74.22 107.736 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 25.0 m -117.27 123.53 46.81 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.954 -0.387 . . . . 75.54 109.954 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.631 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -90.26 86.33 6.48 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.049 0.928 . . . . 74.14 108.895 -178.372 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.29 -95.94 1.8 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 114.434 -1.257 . . . . 62.51 110.853 -174.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -114.73 -25.78 8.12 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.277 0.631 . . . . 75.34 111.455 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.408 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 29.8 tt0 -87.72 134.07 33.73 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.772 0.829 . . . . 71.21 110.693 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 49.4 m -84.96 135.07 34.2 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 120.923 0.392 . . . . 71.41 110.74 174.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.21 -61.61 1.85 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.83 1.252 . . . . 71.44 109.425 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -147.07 165.16 30.75 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.888 -1.051 . . . . 73.24 111.456 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 61.6 tp -135.65 108.79 7.71 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.028 -1.442 . . . . 72.31 107.561 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.0 m -108.35 104.38 13.74 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.269 0.628 . . . . 65.14 109.596 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.442 ' HG2' HE22 ' A' ' 79' ' ' GLN . 37.9 tt0 -124.13 117.28 24.29 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.171 0.988 . . . . 73.44 110.269 -169.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.1 t -133.69 112.83 17.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 123.7 0.8 . . . . 73.12 109.808 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.587 ' HG3' ' HG2' ' A' ' 61' ' ' ARG . 2.7 mp0 -89.68 84.22 6.3 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.657 1.183 . . . . 72.33 107.953 173.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -82.68 100.85 10.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.754 -1.112 . . . . 73.11 109.387 -175.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.13 151.91 20.99 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.45 0.469 . . . . 73.34 112.33 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.509 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -146.3 125.49 2.26 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.657 -0.577 . . . . 62.03 111.657 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.404 HD12 ' HB3' ' A' ' 15' ' ' ARG . 56.8 mt -81.45 118.13 28.68 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.252 -1.018 . . . . 72.34 108.252 169.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.669 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 41.1 m-85 -131.27 126.97 36.79 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.793 0.837 . . . . 74.3 108.971 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.3 m -83.75 115.64 22.31 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.379 1.072 . . . . 64.43 109.878 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.45 HD13 ' HB2' ' A' ' 94' ' ' MET . 6.0 tt -97.14 136.68 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.246 1.019 . . . . 74.32 109.063 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.477 ' HB2' ' HB ' ' A' ' 10' ' ' THR . . . -160.72 137.56 8.91 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.359 0.264 . . . . 71.52 111.368 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.97 -32.2 6.51 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.86 -0.609 . . . . 65.21 114.515 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.15 148.03 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 116.931 0.366 . . . . 70.41 111.693 -165.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 9.5 tt0 -134.99 -176.8 4.37 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.042 0.937 . . . . 72.33 109.18 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.522 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.94 -130.67 36.22 Favored Glycine 0 C--N 1.353 1.501 0 C-N-CA 123.178 0.418 . . . . 73.05 113.951 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.0 p -74.08 -21.71 59.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.537 0.735 . . . . 54.42 111.472 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.24 -49.68 47.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.446 0.698 . . . . 73.43 109.841 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.45 ' HB2' HD13 ' A' ' 86' ' ' ILE . 25.7 ptm -65.71 -32.13 73.52 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 116.189 -0.46 . . . . 63.54 110.269 177.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.79 88.66 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 124.044 0.84 . . . . 75.12 111.388 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -69.43 -36.53 76.74 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.562 0.745 . . . . 75.24 111.301 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.8 m -73.27 -43.49 60.98 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.213 0.53 . . . . 70.25 111.008 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 tt -83.05 -38.38 22.63 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.337 1.055 . . . . 73.12 110.495 -169.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.97 3.78 52.31 Favored Glycine 0 N--CA 1.473 1.12 0 CA-C-N 116.111 -0.495 . . . . 74.43 114.259 -171.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.574 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -139.76 -62.77 0.51 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 117.452 0.626 . . . . 43.43 111.573 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.478 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 83.5 t80 -68.38 -55.28 12.51 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.977 0.911 . . . . 75.44 112.508 -170.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 76.0 m -72.05 -36.35 4.1 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 114.605 1.335 . . . . 74.03 114.605 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.56 -21.34 46.23 Favored 'Trans proline' 0 C--N 1.386 2.536 0 CA-C-N 121.787 1.674 . . . . 74.44 112.921 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -75.1 -28.64 60.33 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.069 0.548 . . . . 72.0 110.658 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 13' ' ' ILE . 26.7 mm -59.9 -37.53 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.566 0.747 . . . . 74.15 109.9 172.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.509 HD22 ' HA3' ' A' ' 82' ' ' GLY . 83.5 mt -78.35 -21.19 49.88 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.308 1.043 . . . . 74.04 112.527 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -61.22 -45.62 95.5 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.936 -1.03 . . . . 75.3 113.636 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.99 -34.57 80.48 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 121.929 1.753 . . . . 73.51 113.27 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.42 -43.4 66.82 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.573 0.749 . . . . 73.14 111.193 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.9 -41.08 75.18 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.095 0.558 . . . . 73.51 110.333 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.46 ' NH1' HG23 ' C' ' 105' ' ' ILE . 30.8 ttm180 -52.38 -52.81 51.55 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.158 0.983 . . . . 74.32 109.494 174.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.15 -52.52 65.37 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 124.637 1.211 . . . . 75.1 111.471 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 117' ' ' MET . 40.4 t -55.82 -50.09 71.48 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 124.38 1.05 . . . . 71.03 110.621 -176.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.468 ' O ' HG21 ' A' ' 118' ' ' VAL . 96.4 mt -58.77 -50.64 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 124.07 0.948 . . . . 73.22 110.985 177.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.5 m -51.92 -46.06 64.52 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.814 0.846 . . . . 72.42 110.65 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -64.09 -41.51 97.28 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 113.967 -1.469 . . . . 75.45 109.579 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.511 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 64.4 mmm -61.4 -42.5 98.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.182 0.593 . . . . 64.45 111.1 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 114' ' ' ILE . 57.8 t -62.05 -48.69 87.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.807 0.843 . . . . 72.13 110.091 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.0 p -71.75 -26.51 62.48 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.342 0.657 . . . . 72.51 111.956 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -70.76 -32.36 69.48 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.158 0.583 . . . . 72.12 109.996 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.75 -0.44 87.97 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.543 0.527 . . . . 71.24 112.987 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m 69.36 19.42 7.7 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 125.207 1.403 . . . . 71.42 111.217 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -86.06 150.8 53.33 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.542 -0.91 . . . . 73.1 108.542 171.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.91 143.12 92.78 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.721 2.281 . . . . 74.13 111.482 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -57.63 136.67 56.83 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.469 0.708 . . . . 74.42 112.398 -171.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.456 ' HB3' HG23 ' A' ' 118' ' ' VAL . 29.1 tp -120.42 99.93 6.85 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.656 1.182 . . . . 73.23 109.335 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -99.8 101.47 12.63 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.606 -0.887 . . . . 74.14 108.606 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.415 HD21 HG21 ' A' ' 114' ' ' ILE . 2.9 mm? -61.17 117.72 5.91 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.057 -0.72 . . . . 73.14 109.057 -177.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.23 142.58 86.01 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.373 0.669 . . . . 73.4 110.744 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.68 119.22 6.34 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.85 2.366 . . . . 74.15 112.826 -174.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.2 t -99.21 112.76 32.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 107.626 -1.25 . . . . 64.13 107.626 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -83.39 91.34 7.32 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 108.339 -0.985 . . . . 74.15 108.339 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -64.93 -24.58 67.57 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.659 -0.7 . . . . 74.34 111.489 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.574 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 8.6 t70 -69.7 -50.29 45.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.73 0.812 . . . . 73.41 110.066 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.16 -45.68 93.65 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.541 1.136 . . . . 70.32 110.87 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.24 -30.89 70.04 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.925 -1.034 . . . . 64.02 111.919 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -70.66 -35.43 72.86 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 123.366 0.416 . . . . 73.53 109.914 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 32.4 tpp . . . . . 0 N--CA 1.483 1.22 0 O-C-N 123.719 0.637 . . . . 71.23 110.492 176.315 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 89.6 m . . . . . 0 N--CA 1.472 0.657 0 CA-C-O 119.169 -0.443 . . . . 71.05 110.011 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . 0.266 0.3 OUTLIER -154.96 155.29 33.96 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.265 0.353 . . . . 74.12 110.951 147.246 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -126.88 140.86 52.03 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 107.702 -1.222 . . . . 73.03 107.702 170.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.495 HD11 HD12 ' B' ' 105' ' ' ILE . 30.4 mt -78.47 122.85 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.618 -0.719 . . . . 70.03 109.32 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -86.42 -49.92 7.26 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.883 0.74 . . . . 74.42 109.69 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -158.53 129.88 6.47 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.605 -0.725 . . . . 75.21 110.074 -171.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.8 mt -116.45 119.15 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 106.807 -1.553 . . . . 72.32 106.807 172.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -151.89 143.54 23.59 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.246 0.546 . . . . 74.2 110.942 -168.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -72.46 124.62 25.55 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.937 -1.029 . . . . 75.0 108.714 172.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.485 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.7 mtpt -95.01 -36.76 11.43 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.533 0.733 . . . . 74.5 110.319 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.0 t70 -157.07 141.08 16.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.602 -0.272 . . . . 72.52 110.984 -167.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.423 HD12 HG21 ' B' ' 78' ' ' VAL . 40.7 mm -141.13 148.08 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.118 1.367 . . . . 75.42 108.866 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 41.6 t -144.42 139.15 28.2 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.555 1.142 . . . . 64.34 108.13 170.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -145.01 114.21 7.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.665 -1.606 . . . . 72.12 106.665 170.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -124.85 112.51 16.74 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.825 0.45 . . . . 75.43 109.893 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.35 86.65 8.31 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 108.225 -1.028 . . . . 70.0 108.225 172.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.1 -35.29 11.92 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.916 2.41 . . . . 74.24 113.033 -173.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -102.87 19.33 19.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.587 0.755 . . . . 72.34 110.611 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.537 ' HB2' ' HD3' ' B' ' 29' ' ' PRO . . . -40.31 -65.48 0.44 Allowed Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 125.183 1.393 . . . . 75.25 113.836 -166.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' B' ' 28' ' ' ALA . 52.6 Cg_exo -53.54 -38.56 83.73 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.838 2.359 . . . . 75.24 114.018 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.408 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 52.8 m80 -87.48 -35.77 18.04 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.317 -0.856 . . . . 74.34 112.406 -170.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.574 HG21 HD11 ' B' ' 68' ' ' LEU . 11.1 p -69.99 -17.44 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.699 0.4 . . . . 75.3 111.425 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -68.7 -10.73 58.07 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 113.512 0.93 . . . . 73.41 113.512 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.7 pt20 -66.52 -25.13 66.53 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 122.811 0.444 . . . . 73.21 110.843 174.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.473 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 95.4 mttt -91.81 88.97 6.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.161 0.984 . . . . 74.12 108.747 177.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.51 76.79 6.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.823 0.849 . . . . 73.51 109.712 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -154.39 160.9 41.92 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.556 1.142 . . . . 75.22 108.37 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -75.15 107.41 3.93 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 124.833 1.253 . . . . 71.22 109.634 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.601 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 12.5 Cg_endo -59.95 133.71 52.19 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.103 2.536 . . . . 73.25 112.834 -175.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -57.7 114.59 2.34 Favored 'General case' 0 C--N 1.361 1.091 0 O-C-N 124.138 0.899 . . . . 74.42 111.051 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.23 156.75 3.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 114.775 -1.102 . . . . 74.11 111.485 -173.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -145.87 121.49 10.45 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.943 -1.503 . . . . 74.21 106.943 169.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.2 mp -86.22 155.39 20.73 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.11 -0.7 . . . . 73.02 109.11 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.553 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 27.2 t70 -144.6 145.2 31.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.981 -1.489 . . . . 75.44 106.981 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.89 135.85 29.89 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.146 -0.687 . . . . 75.3 109.146 -169.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.457 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.0 t70 -145.69 140.0 26.95 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.2 1.4 . . . . 73.4 108.254 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 74.8 p -134.26 141.31 46.94 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.987 -0.746 . . . . 73.52 108.987 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.44 120.68 4.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.41 0.684 . . . . 71.04 109.881 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 57.3 p -99.4 168.75 9.8 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.981 0.513 . . . . 74.54 109.911 176.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 86.5 p -151.15 135.87 17.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.06 0.544 . . . . 73.33 109.927 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -82.5 103.44 12.04 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.297 -0.631 . . . . 71.33 109.297 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.593 HD13 ' HB2' ' B' ' 57' ' ' GLU . 58.8 mt -75.02 -53.79 8.3 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.418 0.628 . . . . 71.3 110.629 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.88 -170.61 3.57 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.754 -1.112 . . . . 72.3 109.375 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -64.73 109.84 2.18 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.815 0.697 . . . . 54.32 109.72 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 13.3 m-20 71.97 1.55 3.96 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.123 1.369 . . . . 72.04 112.667 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -104.69 122.63 57.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.08 -1.081 . . . . 75.4 108.08 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.5 ' HE2' ' HB3' ' B' ' 98' ' ' LEU . 0.1 OUTLIER -135.98 154.64 51.02 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.034 -0.728 . . . . 71.45 109.034 178.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.593 ' HB2' HD13 ' B' ' 51' ' ' LEU . 12.5 tm-20 -123.29 110.53 15.31 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.672 -1.233 . . . . 75.43 107.672 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 95.0 t -89.81 141.35 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 O-C-N 123.777 0.673 . . . . 73.15 109.446 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 39.5 t -117.22 145.45 22.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 108.675 -0.861 . . . . 74.02 108.675 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -128.66 104.72 7.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.619 -1.252 . . . . 73.01 107.619 178.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 33.1 ttt180 -94.03 113.47 25.45 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.582 0.753 . . . . 73.52 110.596 173.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.19 104.36 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.258 -1.016 . . . . 71.12 108.258 171.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 41.3 m -96.34 142.0 28.99 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.534 -0.913 . . . . 63.44 108.534 175.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.4 HG11 HD23 ' B' ' 126' ' ' LEU . 90.4 t -136.5 136.01 48.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.507 -0.923 . . . . 75.4 108.507 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 74.6 m -122.48 137.7 54.79 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.599 -0.889 . . . . 73.41 108.599 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -141.64 141.83 33.4 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.617 0.767 . . . . 73.24 109.684 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.469 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 57.5 p -145.03 133.5 21.91 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.959 -0.564 . . . . 75.11 111.908 -173.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.601 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.1 mt -94.06 106.89 18.85 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.17 0.988 . . . . 74.14 109.033 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.49 -111.8 4.34 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 114.887 -1.051 . . . . 65.52 111.909 -173.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -107.64 5.36 26.8 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.81 0.844 . . . . 73.52 111.813 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.473 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 13.0 pt-20 -124.72 144.8 50.03 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.039 0.382 . . . . 74.44 111.237 -176.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 99.8 m -64.72 119.92 11.48 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 123.817 0.698 . . . . 74.43 110.524 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -81.55 -65.63 0.99 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.712 -1.131 . . . . 73.12 108.02 176.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -144.2 150.75 38.49 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-O 121.723 0.773 . . . . 74.13 111.457 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 74.7 mt -115.03 142.19 46.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.086 -1.82 . . . . 73.1 106.086 166.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.566 ' SG ' HG21 ' B' ' 114' ' ' ILE . 49.7 t -147.55 146.8 29.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.804 -0.813 . . . . 73.01 108.804 176.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -160.7 136.39 8.14 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.512 -0.551 . . . . 74.23 109.512 -173.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.437 HG11 ' HA ' ' B' ' 110' ' ' ALA . 98.1 t -131.23 145.15 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 123.863 0.865 . . . . 73.43 109.203 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 42.2 mt-30 -122.71 88.49 2.94 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.076 -1.083 . . . . 74.54 108.076 171.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 11.2 tp-100 -81.24 101.62 9.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.783 -1.099 . . . . 61.25 109.157 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.485 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -95.75 163.06 23.44 Favored Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.677 -0.569 . . . . 73.44 111.677 176.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.74 127.41 1.9 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.114 -0.795 . . . . 74.14 111.114 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.89 127.2 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 109.045 -0.724 . . . . 73.23 109.045 172.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . 0.411 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 24.0 m-85 -132.02 153.93 49.88 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 107.227 -1.397 . . . . 61.15 107.227 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 59.0 m -122.48 91.21 3.45 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.825 0.45 . . . . 72.14 110.41 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.439 HD11 HD13 ' B' ' 89' ' ' ILE . 15.4 tt -94.82 145.81 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.844 0.858 . . . . 73.43 112.474 -166.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.47 161.14 40.07 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 124.709 1.204 . . . . 75.03 108.999 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.06 -68.17 0.39 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.095 -0.502 . . . . 64.33 113.207 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.562 ' H ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -90.38 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 121.418 0.628 . . . . 72.21 112.03 -173.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.43 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 33.2 tt0 -156.94 179.38 9.35 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.826 1.25 . . . . 54.15 108.26 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.43 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 72.4 -123.55 9.27 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 117.676 0.217 . . . . 63.24 112.621 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 32.2 m -93.41 -18.16 22.67 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.323 0.649 . . . . 70.11 111.436 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -68.08 -33.87 75.35 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 122.081 -0.387 . . . . 75.32 110.289 173.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -29.31 52.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.26 0.224 . . . . 75.33 110.477 173.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.14 -40.78 91.01 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-O 121.403 0.621 . . . . 72.45 109.922 176.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.419 ' O ' ' HB1' ' B' ' 100' ' ' ALA . 40.6 t-80 -64.12 -29.51 70.63 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.713 -1.13 . . . . 74.31 111.395 175.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 37.9 t -70.83 -66.11 0.65 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 110.312 -0.255 . . . . 75.41 110.312 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.5 ' HB3' ' HE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -72.23 -23.83 61.29 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.56 0.948 . . . . 73.44 113.56 -174.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.92 1.07 56.45 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 119.651 -0.527 . . . . 61.11 113.346 -174.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.597 ' HA ' ' HB3' ' B' ' 133' ' ' PHE . . . -152.06 -62.43 0.17 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.413 0.523 . . . . 72.3 112.413 -175.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -66.65 -42.52 86.52 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.187 0.995 . . . . 75.13 111.89 -170.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.459 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 73.2 m -71.25 -50.58 11.07 Favored Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 124.332 1.053 . . . . 74.34 111.069 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.471 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 65.3 Cg_exo -57.16 -30.86 88.7 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.115 1.876 . . . . 75.55 114.014 170.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -59.13 -43.01 91.98 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 123.65 0.78 . . . . 75.33 110.298 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.495 HD12 HD11 ' B' ' 13' ' ' ILE . 73.8 mt -62.9 -41.37 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 115.09 -0.959 . . . . 75.25 110.889 176.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.15 -22.93 38.62 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.953 -1.022 . . . . 72.02 112.314 -172.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -58.72 -49.03 95.66 Favored Pre-proline 0 N--CA 1.486 1.333 0 N-CA-C 114.205 1.187 . . . . 71.32 114.205 -170.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -55.95 -36.82 96.36 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.029 1.819 . . . . 74.23 113.937 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.401 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 78.7 m-85 -67.43 -46.59 72.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.158 0.583 . . . . 73.51 110.601 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.437 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -59.68 -40.54 88.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.686 0.794 . . . . 71.23 110.856 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.656 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 34.6 ttt180 -61.21 -54.69 41.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.632 1.573 . . . . 75.43 111.014 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -38.12 89.9 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.36 0.664 . . . . 75.13 110.021 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.463 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.8 t -66.63 -33.89 76.66 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 116.18 -0.464 . . . . 73.3 111.535 -176.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.566 HG21 ' SG ' ' B' ' 76' ' ' CYS . 62.6 mt -66.46 -52.05 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 109.896 -0.409 . . . . 75.31 109.896 175.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.434 HG22 ' OG ' ' C' ' 119' ' ' SER . 5.1 m -62.5 -30.57 71.37 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.732 0.645 . . . . 72.41 111.487 -176.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.5 t -61.3 -49.92 75.09 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.449 0.7 . . . . 74.23 109.376 174.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.0 mmt -58.44 -44.87 89.33 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.637 0.775 . . . . 73.13 111.03 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.11 -45.49 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.291 1.036 . . . . 64.54 111.269 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.0 t -63.45 -37.48 87.44 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.307 -0.86 . . . . 63.41 111.476 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.5 mtt-85 -66.16 -36.19 82.46 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.751 -1.113 . . . . 72.21 109.949 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.43 9.74 66.52 Favored Glycine 0 C--N 1.356 1.678 0 O-C-N 123.93 0.769 . . . . 65.31 113.898 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 72.4 p 54.76 35.38 23.89 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.781 1.632 . . . . 75.41 113.222 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -99.31 153.58 37.71 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.171 0.588 . . . . 73.55 110.342 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -50.82 158.6 2.89 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 123.868 3.046 . . . . 72.42 115.187 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -63.33 119.66 10.09 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.655 1.182 . . . . 75.45 112.699 -170.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.414 HD21 HG22 ' B' ' 114' ' ' ILE . 55.9 tp -108.54 102.75 11.8 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.064 -0.717 . . . . 74.53 109.064 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -100.21 105.29 16.86 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.22 -0.659 . . . . 73.42 109.22 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.656 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -73.33 113.0 9.92 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.037 -0.727 . . . . 71.53 109.037 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.09 149.94 96.18 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.922 0.889 . . . . 74.33 110.752 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.479 ' HG3' HD11 ' D' ' 16' ' ' ILE . 55.6 Cg_endo -66.37 123.35 11.04 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.441 2.094 . . . . 64.53 112.383 -175.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.8 111.61 24.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.306 -1.368 . . . . 74.34 107.306 172.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -76.97 86.56 3.5 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.63 -1.248 . . . . 73.51 107.63 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.597 ' HB3' ' HA ' ' B' ' 100' ' ' ALA . 97.7 m-85 -55.37 -42.65 74.22 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.895 0.878 . . . . 74.43 111.529 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . 0.425 ' HA ' ' HB3' ' B' ' 100' ' ' ALA . 5.5 m-20 -63.72 -42.43 97.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.361 1.064 . . . . 74.44 111.696 -174.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.04 -52.81 31.14 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.586 0.754 . . . . 74.33 110.283 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.25 -18.62 61.8 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.112 -0.949 . . . . 72.43 112.282 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 72.1 t80 . . . . . 0 N--CA 1.471 0.582 0 C-N-CA 123.329 0.651 . . . . 71.12 109.757 174.758 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 40.2 m . . . . . 0 C--O 1.24 0.576 0 N-CA-C 107.711 -1.218 . . . . 73.21 107.711 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.526 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 3.2 t80 -116.14 119.85 37.12 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.127 -0.942 . . . . 74.21 108.578 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -136.47 131.9 34.64 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 107.981 -1.118 . . . . 74.35 107.981 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.425 HG21 HD13 ' C' ' 16' ' ' ILE . 63.8 mt -76.59 120.33 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.556 -0.905 . . . . 71.03 108.556 173.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.652 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.6 mm-40 -82.71 -42.31 18.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.075 -0.966 . . . . 71.31 109.106 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -170.94 149.31 2.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.639 -0.71 . . . . 74.22 109.703 -170.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.438 HG22 HD21 ' C' ' 106' ' ' LEU . 70.5 mt -138.3 133.77 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.645 -1.243 . . . . 75.12 107.645 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.408 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 31.5 p90 -169.77 172.04 6.98 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.847 0.832 . . . . 74.01 111.77 -172.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -97.27 123.14 40.98 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.094 -0.957 . . . . 74.32 109.101 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.408 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.9 mmtp -71.21 -50.46 32.85 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 122.755 1.264 . . . . 75.24 107.631 168.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -134.92 141.88 46.41 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 112.517 -2.129 . . . . 75.33 108.889 -168.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 74.2 mt -137.95 142.03 36.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 106.024 -1.843 . . . . 72.12 106.024 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -155.99 150.15 25.49 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.316 0.579 . . . . 74.54 110.439 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -150.87 134.95 16.77 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.526 -1.287 . . . . 71.2 107.526 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.69 124.27 19.58 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.737 0.815 . . . . 75.34 109.499 -171.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.62 79.02 7.37 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 107.517 -1.29 . . . . 74.15 107.517 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.93 -42.71 61.5 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.026 2.484 . . . . 73.35 111.494 174.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -91.53 29.76 1.44 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.11 -1.404 . . . . 72.51 110.362 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.94 -58.91 8.71 Favored Pre-proline 0 N--CA 1.487 1.405 0 CA-C-O 118.084 -0.96 . . . . 75.34 113.046 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.33 -33.41 58.97 Favored 'Trans proline' 0 C--N 1.388 2.62 0 CA-C-N 121.735 1.655 . . . . 71.21 111.898 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.496 ' NE2' ' HZ3' ' C' ' 34' ' ' LYS . 75.7 t60 -68.48 -37.63 80.3 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.202 1.401 . . . . 64.41 112.496 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.9 p -82.02 -23.51 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.372 0.269 . . . . 72.2 111.68 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -68.07 -35.83 78.85 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.877 0.37 . . . . 73.43 110.561 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -89.37 12.38 16.42 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.815 0.846 . . . . 71.43 111.062 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.57 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.7 tppp? -101.27 160.51 14.35 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.154 0.982 . . . . 73.34 109.621 177.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.48 114.19 9.29 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.461 0.704 . . . . 72.54 109.91 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -78.84 100.95 7.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.879 0.872 . . . . 74.13 111.155 -174.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . 0.451 ' H ' HD23 ' C' ' 68' ' ' LEU . 10.8 pt20 -149.9 78.42 8.14 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 124.107 0.963 . . . . 75.0 109.535 171.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -87.3 128.31 2.6 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.351 2.034 . . . . 73.31 112.571 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -86.27 91.5 8.49 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 106.075 -1.824 . . . . 72.31 106.075 165.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 18.0 m -72.49 131.81 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.737 -1.119 . . . . 73.13 111.831 -171.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -113.77 102.89 10.66 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.548 -1.279 . . . . 62.44 107.548 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -87.98 152.49 22.01 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.167 -0.679 . . . . 72.13 109.167 170.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.5 t70 -137.45 104.65 5.42 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.584 -0.895 . . . . 75.44 108.584 177.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 85.6 mt -92.65 113.09 25.28 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.839 -1.171 . . . . 73.43 107.839 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.3 t70 -122.27 153.7 38.55 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.856 1.262 . . . . 74.25 109.399 178.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 5.3 t -143.87 154.2 43.12 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.119 -0.697 . . . . 73.22 109.119 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.12 135.93 15.37 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.16 0.984 . . . . 73.41 109.097 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.426 ' HB3' HG21 ' C' ' 58' ' ' VAL . 29.6 p -125.71 142.18 51.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.363 0.665 . . . . 72.4 109.665 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.7 p -153.43 140.33 19.16 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.393 0.677 . . . . 73.14 110.766 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -72.18 127.14 31.62 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.955 0.902 . . . . 72.22 111.104 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.609 HD12 ' HB2' ' C' ' 57' ' ' GLU . 55.7 mt -96.06 -44.3 7.39 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.018 0.927 . . . . 75.43 109.708 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.25 -176.57 5.28 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.771 -1.104 . . . . 65.54 109.807 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.73 108.07 0.93 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.689 0.796 . . . . 72.2 110.369 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 70.63 1.6 3.76 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.745 1.618 . . . . 73.43 112.974 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 68.5 t -98.16 118.43 44.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.86 -0.793 . . . . 74.45 108.86 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -108.83 158.74 17.38 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.182 0.992 . . . . 73.04 110.28 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.609 ' HB2' HD12 ' C' ' 51' ' ' LEU . 24.6 tt0 -119.41 130.81 55.48 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 112.884 -1.962 . . . . 75.44 107.285 169.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.426 HG21 ' HB3' ' C' ' 48' ' ' SER . 76.0 t -115.28 126.4 72.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.877 -0.786 . . . . 73.0 108.877 170.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.484 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 88.0 t -105.79 130.36 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 107.788 -1.19 . . . . 73.03 107.788 171.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.41 103.75 10.43 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.837 -1.542 . . . . 74.42 106.837 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.423 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.9 ttm-85 -84.27 123.18 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.15 -1.386 . . . . 71.44 108.47 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -116.46 118.58 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.973 -1.121 . . . . 73.21 107.973 169.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 42.3 m -110.72 141.81 43.5 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.087 0.955 . . . . 64.03 108.628 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.674 HG12 HD13 ' C' ' 126' ' ' LEU . 55.8 t -126.1 127.65 71.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 108.663 -0.866 . . . . 53.42 108.663 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -115.81 137.37 52.15 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.22 -1.4 . . . . 74.44 107.22 167.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.51 114.39 14.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.187 -1.412 . . . . 71.34 107.187 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.6 m -134.75 134.08 40.6 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.562 0.539 . . . . 71.53 110.027 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.451 HD23 ' H ' ' C' ' 37' ' ' GLN . 12.5 mt -90.91 23.04 3.33 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 126.005 1.722 . . . . 73.42 110.133 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.39 -87.8 0.51 Allowed Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.024 -0.83 . . . . 65.53 111.024 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.2 -30.51 18.49 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.572 0.749 . . . . 71.31 110.326 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.57 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 15.8 tp10 -92.97 118.36 31.07 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.455 0.702 . . . . 55.33 110.429 -173.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -77.44 122.4 25.14 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.614 -0.884 . . . . 71.13 108.614 169.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.72 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.5 -54.24 7.91 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.298 -0.865 . . . . 73.21 109.461 176.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -167.24 157.05 10.8 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.283 -0.871 . . . . 75.04 110.909 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -118.0 144.99 45.08 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 106.365 -1.717 . . . . 73.01 106.365 168.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.4 ' SG ' HG22 ' C' ' 114' ' ' ILE . 42.8 t -148.78 149.45 31.4 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.504 -0.924 . . . . 63.14 108.504 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -159.22 130.25 6.08 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.374 0.421 . . . . 54.32 110.073 175.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.5 t -125.54 131.6 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.891 0.876 . . . . 73.1 108.646 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -109.32 87.53 2.52 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.605 -1.257 . . . . 74.35 107.605 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.424 ' HG3' HD22 ' C' ' 106' ' ' LEU . 8.8 tp-100 -79.42 96.77 6.14 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.483 -0.78 . . . . 70.53 110.357 -175.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -97.7 143.23 16.58 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 112.306 -0.317 . . . . 61.22 112.306 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.99 140.62 8.53 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 110.357 -1.097 . . . . 71.1 110.357 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.7 mm -91.39 122.7 43.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.553 -0.906 . . . . 70.54 108.553 -178.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.526 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 63.8 m-85 -127.46 119.33 25.85 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.201 -1.037 . . . . 71.22 108.201 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 39.9 p -84.46 125.49 32.41 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.066 0.546 . . . . 75.33 109.563 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.618 HD11 HD13 ' C' ' 98' ' ' LEU . 39.0 pt -116.51 135.33 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.214 0.606 . . . . 74.45 109.776 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.444 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -153.45 151.29 29.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.947 0.899 . . . . 74.14 109.321 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.15 -57.74 4.26 Favored Glycine 0 N--CA 1.474 1.188 0 N-CA-C 112.243 -0.343 . . . . 72.43 112.243 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -85.48 156.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.869 0.868 . . . . 75.32 111.834 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.539 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 11.9 pt-20 -161.42 -175.74 4.97 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.416 -0.811 . . . . 74.34 110.421 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.1 -119.75 18.43 Favored Glycine 0 C--N 1.352 1.47 0 O-C-N 123.902 0.751 . . . . 75.21 113.845 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.3 p -72.94 -33.32 65.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.246 1.019 . . . . 72.51 111.171 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -67.9 -34.9 77.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.736 0.815 . . . . 72.04 110.903 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.539 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 55.3 ttp -75.35 -41.77 55.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.837 0.855 . . . . 73.25 110.396 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.37 -41.04 75.54 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.076 0.86 . . . . 61.2 110.086 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 18.7 t-160 -76.39 -43.2 41.68 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 124.05 0.844 . . . . 74.24 111.811 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -55.68 -40.25 72.06 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 123.956 0.785 . . . . 72.55 110.648 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.618 HD13 HD11 ' C' ' 86' ' ' ILE . 22.0 mt -101.71 -14.9 17.17 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.748 0.819 . . . . 73.23 111.632 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.87 -30.89 55.24 Favored Glycine 0 C--N 1.355 1.615 0 N-CA-C 114.77 0.668 . . . . 62.55 114.77 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.2 -36.32 0.06 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.07 0.396 . . . . 62.41 112.07 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.521 ' HH ' ' HD1' ' C' ' 11' ' ' PHE . 74.4 t80 -59.2 -49.59 77.29 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 125.231 1.412 . . . . 75.32 112.535 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 88.1 m -77.94 -41.99 2.17 Favored Pre-proline 0 CA--C 1.563 1.464 0 CA-C-O 118.727 -0.654 . . . . 63.21 112.575 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.08 -33.44 34.98 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.449 2.099 . . . . 74.44 114.558 168.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.33 -26.68 63.87 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.581 0.752 . . . . 71.23 110.458 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.46 HG23 ' NH1' ' A' ' 111' ' ' ARG . 48.0 mm -68.71 -39.36 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.829 0.852 . . . . 70.21 109.725 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.438 HD21 HG22 ' C' ' 16' ' ' ILE . 35.8 mt -80.64 -23.82 39.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.668 1.187 . . . . 75.23 112.597 -174.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -57.3 -49.25 94.95 Favored Pre-proline 0 CA--C 1.563 1.45 0 N-CA-C 114.212 1.19 . . . . 75.12 114.212 -173.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.41 -37.64 96.82 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 121.945 1.764 . . . . 72.14 113.223 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -66.36 -49.01 68.34 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.837 0.855 . . . . 73.43 111.178 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.09 -38.97 84.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.289 -0.868 . . . . 75.13 110.628 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -58.54 -55.71 31.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.564 1.146 . . . . 74.54 110.8 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.29 -33.08 75.13 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.852 0.461 . . . . 75.13 110.39 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 33.4 t -71.16 -31.4 67.64 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.009 0.524 . . . . 73.04 111.48 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.55 HG21 HG23 ' C' ' 64' ' ' VAL . 76.9 mt -73.2 -54.04 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.523 -0.547 . . . . 75.21 109.523 172.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 4.7 m -62.46 -27.82 69.39 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.166 0.587 . . . . 73.34 111.271 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.6 t -61.33 -53.66 53.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.626 0.771 . . . . 74.3 109.094 169.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.602 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.28 -35.23 75.06 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.791 1.236 . . . . 73.44 112.46 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.67 -45.27 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.683 0.793 . . . . 73.5 109.622 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.434 ' OG ' HG22 ' B' ' 115' ' ' THR . 42.3 t -68.69 -28.55 66.95 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.001 0.813 . . . . 61.01 111.449 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.478 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 82.7 mtt-85 -70.74 -43.11 69.52 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.503 0.721 . . . . 72.21 109.211 176.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.09 -3.79 82.13 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 124.287 0.992 . . . . 74.11 112.24 172.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 65.82 26.55 11.18 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 127.026 2.13 . . . . 74.44 113.588 170.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -82.8 156.62 67.56 Favored Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 109.021 -0.733 . . . . 73.25 109.021 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.14 175.1 2.72 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.909 2.406 . . . . 73.25 114.285 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -56.84 137.56 54.78 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.784 1.031 . . . . 75.52 113.784 -171.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.674 HD13 HG12 ' C' ' 64' ' ' VAL . 3.0 tt -126.9 87.03 2.59 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.662 -1.154 . . . . 72.41 108.278 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -107.89 109.66 21.23 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.21 0.604 . . . . 73.4 109.846 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -74.73 135.63 41.79 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 122.918 0.487 . . . . 74.22 110.762 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.26 151.38 87.86 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.894 0.877 . . . . 74.1 110.241 174.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.48 ' HG3' HD13 ' A' ' 16' ' ' ILE . 24.6 Cg_exo -60.93 103.34 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.816 2.344 . . . . 53.31 112.794 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 17.9 m -98.46 111.13 27.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.244 -1.021 . . . . 72.1 108.244 168.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -75.72 84.57 2.72 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.32 -0.854 . . . . 74.41 109.196 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -54.39 -44.82 72.61 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.752 0.658 . . . . 75.55 110.121 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.74 -47.53 85.29 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.574 -1.194 . . . . 61.52 111.682 -174.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.27 87.01 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.345 0.658 . . . . 75.05 111.209 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.96 -42.49 99.84 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.776 -0.647 . . . . 74.02 111.422 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . 0.416 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 10.1 t80 . . . . . 0 N--CA 1.487 1.405 0 C-N-CA 122.935 0.494 . . . . 74.51 110.807 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 37.1 m . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.067 0.46 . . . . 75.42 110.024 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -158.14 97.01 1.49 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.87 -1.529 . . . . 74.12 106.87 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -134.46 149.82 50.77 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.828 -0.805 . . . . 74.22 108.828 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 mt -92.87 130.48 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.404 -0.591 . . . . 70.32 109.404 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -86.73 -35.22 19.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.055 0.542 . . . . 61.44 110.5 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -174.54 130.56 0.35 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.488 0.315 . . . . 75.22 111.091 -172.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.479 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.5 mp -107.47 140.78 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.747 -1.205 . . . . 74.13 107.747 172.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -162.65 158.62 23.44 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.733 0.646 . . . . 75.12 111.679 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.8 p -93.59 118.85 31.89 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.169 -0.923 . . . . 73.13 109.56 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -90.28 -20.59 22.76 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 116.045 -0.525 . . . . 75.41 109.923 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.609 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.1 t70 -157.02 132.36 9.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.517 -0.765 . . . . 75.3 109.821 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.602 HG21 ' HE1' ' C' ' 117' ' ' MET . 60.4 mt -135.9 147.06 28.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 124.548 1.139 . . . . 74.5 107.982 171.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -153.52 115.68 4.35 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.82 0.7 . . . . 73.52 110.142 171.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -110.21 134.22 52.44 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.487 -1.671 . . . . 74.22 106.487 166.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.71 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 31.4 mt-10 -140.0 120.21 13.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.777 0.831 . . . . 72.02 108.959 -173.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.05 89.43 50.75 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.845 -1.169 . . . . 75.34 107.845 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.3 -46.8 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.103 2.536 . . . . 73.13 111.795 -174.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 26.3 m-20 -98.2 34.93 1.85 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.256 1.023 . . . . 73.52 109.01 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.8 -66.86 0.53 Allowed Pre-proline 0 CA--C 1.567 1.614 0 N-CA-C 114.101 1.149 . . . . 73.42 114.101 -162.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.518 ' HB3' HD11 ' C' ' 83' ' ' ILE . 95.1 Cg_endo -76.03 -20.28 15.04 Favored 'Trans proline' 0 C--N 1.384 2.447 0 CA-C-N 122.705 2.002 . . . . 75.34 113.02 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 6.6 t-160 -64.49 -47.65 78.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.575 1.55 . . . . 73.51 109.746 176.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.651 HG22 ' HA ' ' D' ' 73' ' ' ALA . 5.1 p -85.26 -23.94 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 CA-C-N 114.821 -1.081 . . . . 73.01 112.194 -168.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -60.79 -30.45 70.05 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 123.355 0.662 . . . . 73.4 112.765 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -60.08 -24.06 64.3 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.931 -1.031 . . . . 64.23 111.166 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.469 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 84.8 mttt -86.84 85.14 7.25 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.365 1.066 . . . . 75.44 108.775 173.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.15 82.08 3.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.419 0.628 . . . . 72.33 110.414 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -142.17 157.88 44.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.012 1.325 . . . . 73.41 107.759 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -68.22 107.69 2.15 Favored Pre-proline 0 CA--C 1.555 1.139 0 N-CA-C 108.635 -0.876 . . . . 74.3 108.635 172.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.401 ' O ' HG12 ' D' ' 40' ' ' VAL . 35.8 Cg_exo -59.93 120.96 9.06 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.122 2.548 . . . . 73.41 112.157 -168.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.15 111.78 4.1 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 123.943 0.777 . . . . 63.33 109.983 -175.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.591 HG13 ' HB1' ' D' ' 66' ' ' ALA . 35.9 m -104.5 142.49 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.109 -0.951 . . . . 75.23 110.745 -173.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.49 136.93 40.51 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.912 -1.144 . . . . 72.05 107.912 162.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.4 112.42 24.35 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.168 -1.049 . . . . 72.12 108.168 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -127.54 123.13 35.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.331 -0.989 . . . . 73.1 108.331 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.05 160.81 19.79 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.446 0.641 . . . . 72.43 110.047 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -149.73 151.6 33.92 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.202 -1.407 . . . . 64.23 107.202 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -128.37 154.18 46.26 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.464 -0.569 . . . . 75.13 109.464 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.69 157.75 43.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.983 0.913 . . . . 72.51 109.402 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.4 m -149.01 153.44 37.91 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.332 0.653 . . . . 50.52 109.968 175.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.8 t -152.67 126.01 8.69 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.669 0.788 . . . . 75.22 109.757 -169.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -78.01 118.33 20.19 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.78 0.432 . . . . 75.32 109.842 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' D' ' 57' ' ' GLU . 67.0 mt -91.72 -42.09 10.34 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.579 -0.526 . . . . 73.43 109.579 176.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.62 -174.95 5.09 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.872 -1.058 . . . . 73.33 110.05 -176.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.11 117.86 9.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.924 -1.035 . . . . 64.24 110.031 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 64.39 18.01 11.09 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.501 1.126 . . . . 71.01 111.68 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.98 119.25 59.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 124.228 1.011 . . . . 73.11 108.356 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -132.44 127.33 35.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.501 -0.926 . . . . 74.11 108.501 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.473 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.1 tt0 -90.21 121.65 32.43 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.656 1.183 . . . . 74.3 108.897 169.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 74.3 t -102.27 142.37 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.542 -0.91 . . . . 64.41 108.542 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.449 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.6 t -121.91 130.76 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.463 -0.94 . . . . 72.42 108.463 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -110.59 119.85 40.52 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.442 -1.318 . . . . 75.11 107.442 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -98.02 96.6 8.26 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.034 -1.099 . . . . 74.42 108.034 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.9 t -93.44 120.01 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.012 -1.107 . . . . 75.5 108.012 171.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -119.18 140.87 49.46 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.432 0.693 . . . . 75.51 109.601 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.446 HG12 HD13 ' D' ' 126' ' ' LEU . 91.5 t -136.51 122.26 28.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 125.031 1.333 . . . . 65.41 108.276 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 93.3 m -119.51 112.63 19.6 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.743 -0.836 . . . . 55.21 108.743 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.591 ' HB1' HG13 ' D' ' 40' ' ' VAL . . . -111.02 154.82 23.64 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.855 0.862 . . . . 64.13 110.293 -172.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 34.0 p -149.8 134.14 17.35 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.783 0.677 . . . . 63.43 111.415 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.422 ' HB2' HG21 ' D' ' 31' ' ' VAL . 48.1 mt -113.19 122.62 48.04 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.933 1.293 . . . . 72.22 107.855 171.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.4 -112.46 3.48 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.999 -0.44 . . . . 63.32 111.999 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 4.08 9.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.118 0.967 . . . . 73.52 110.036 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.469 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.8 pt-20 -126.15 163.0 24.08 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.64 0.776 . . . . 72.24 110.392 -170.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.0 m -61.91 125.41 23.76 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 124.22 0.95 . . . . 74.03 111.801 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.651 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -81.13 -72.87 0.4 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.339 -0.985 . . . . 73.41 108.339 171.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . 0.51 ' HZ ' HD12 ' D' ' 126' ' ' LEU . 48.1 p90 -144.7 160.45 41.18 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.559 0.695 . . . . 73.01 110.311 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.71 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 64.8 mt -122.58 141.4 51.74 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.451 -1.685 . . . . 74.15 106.451 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.567 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.8 t -153.49 136.66 15.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.782 -0.451 . . . . 65.0 109.782 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.8 130.82 11.02 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.619 0.768 . . . . 75.2 108.936 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.8 t -129.44 114.19 30.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.532 -0.914 . . . . 74.13 108.532 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.609 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.0 mt-30 -89.9 84.75 6.24 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 122.045 0.926 . . . . 73.53 109.07 171.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.86 101.41 8.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 113.474 -1.694 . . . . 75.0 110.146 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.87 161.37 29.36 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.957 -0.457 . . . . 71.01 111.957 175.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.22 134.92 3.58 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.942 -0.863 . . . . 43.03 110.942 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.1 mt -87.33 128.51 39.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 124.101 0.96 . . . . 73.23 108.93 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -128.12 126.59 41.42 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.237 0.615 . . . . 63.3 110.175 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.4 m -81.13 102.45 10.28 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.984 -0.747 . . . . 73.4 108.984 169.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.522 HD11 HD11 ' D' ' 89' ' ' ILE . 44.7 pt -109.7 140.99 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.195 0.998 . . . . 74.34 110.689 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.9 159.16 34.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.836 0.854 . . . . 65.34 109.448 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.98 -0.36 89.08 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 114.349 0.499 . . . . 51.14 114.349 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.522 HD11 HD11 ' D' ' 86' ' ' ILE . 29.0 pt -105.37 147.86 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.473 0.709 . . . . 74.04 110.389 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.1 146.65 28.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.117 0.567 . . . . 73.21 111.588 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.65 -113.5 2.78 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 124.254 0.931 . . . . 74.35 115.143 175.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.9 p -64.43 -33.22 75.36 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.693 1.197 . . . . 71.23 111.6 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -65.64 -31.11 71.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.486 0.715 . . . . 75.05 111.032 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 55.9 mtm -67.97 -45.79 73.19 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.614 0.365 . . . . 75.21 110.128 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.12 -37.36 82.53 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.074 0.55 . . . . 74.42 111.317 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . 0.483 ' HE2' ' HB3' ' D' ' 134' ' ' ASP . 28.8 t-80 -71.15 -38.8 72.2 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.86 0.864 . . . . 53.43 111.078 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -72.75 -51.11 20.47 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.377 -0.374 . . . . 53.31 111.632 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.592 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.2 mm? -86.06 -28.52 24.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.422 0.689 . . . . 74.52 111.041 -174.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.95 -22.97 47.35 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 114.242 0.457 . . . . 71.51 114.242 -176.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.04 -56.6 1.18 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.983 0.513 . . . . 75.23 111.479 -172.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . 0.491 ' HA ' HD21 ' D' ' 104' ' ' ASN . 63.2 t80 -70.63 -34.88 72.57 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 112.839 0.681 . . . . 73.13 112.839 -172.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.592 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 75.7 m -69.57 -49.45 21.77 Favored Pre-proline 0 CA--C 1.569 1.679 0 CA-C-O 118.562 -0.732 . . . . 63.12 111.625 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.483 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 84.1 Cg_exo -55.25 -30.3 71.14 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 122.565 2.176 . . . . 53.14 114.48 170.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . 0.491 HD21 ' HA ' ' D' ' 101' ' ' TYR . 72.9 m-20 -53.96 -40.26 66.69 Favored 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 123.584 0.754 . . . . 75.24 111.857 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.2 mt -78.69 -40.65 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.899 0.88 . . . . 73.54 110.761 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.2 mt -72.36 -20.82 61.39 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.506 -0.77 . . . . 73.45 111.973 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -68.22 -45.3 39.23 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.035 0.934 . . . . 73.24 113.119 -173.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -50.05 -45.77 31.4 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.591 2.194 . . . . 73.54 114.415 169.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.16 -41.57 77.07 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.446 0.698 . . . . 73.11 111.32 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.34 95.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.723 0.809 . . . . 73.23 110.51 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.443 ' HA ' HD21 ' D' ' 128' ' ' LEU . 29.5 ttp180 -59.72 -51.23 70.68 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.41 -1.268 . . . . 74.54 110.385 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.64 -45.81 92.45 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 124.528 1.143 . . . . 75.53 111.154 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.55 -41.34 80.77 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.01 0.819 . . . . 73.45 110.856 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.567 HG12 ' SG ' ' D' ' 76' ' ' CYS . 76.3 mt -63.05 -56.34 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 123.74 0.65 . . . . 75.14 110.262 173.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.3 m -53.7 -39.38 65.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.409 1.083 . . . . 72.3 111.682 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -66.15 -46.28 78.01 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.83 -1.077 . . . . 73.02 109.867 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.425 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.3 mtm -69.34 -30.21 68.19 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.002 0.521 . . . . 74.21 112.317 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.02 -45.32 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.461 0.704 . . . . 71.52 109.209 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -71.51 -33.03 68.87 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 123.391 0.432 . . . . 72.13 110.822 -178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -69.97 -33.03 71.54 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.927 0.891 . . . . 74.22 110.089 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.8 3.28 86.08 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 123.884 0.74 . . . . 73.53 112.463 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 36.4 p 63.1 23.77 14.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.721 2.008 . . . . 71.04 114.446 171.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -86.74 151.5 52.68 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 108.924 -0.769 . . . . 74.33 108.924 170.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.07 145.92 31.97 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.352 2.701 . . . . 74.44 113.792 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -54.76 140.19 36.95 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.352 1.061 . . . . 72.22 113.668 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.51 HD12 ' HZ ' ' D' ' 74' ' ' PHE . 4.8 tt -119.75 106.69 12.36 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.482 -0.932 . . . . 73.12 108.482 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -108.95 111.57 23.31 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.843 -0.799 . . . . 75.51 108.843 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.443 HD21 ' HA ' ' D' ' 111' ' ' ARG . 3.1 mm? -73.69 120.28 19.06 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.97 -0.752 . . . . 75.13 108.97 171.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.28 137.93 94.14 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 109.812 -0.44 . . . . 64.12 109.812 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.85 115.03 3.26 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.385 2.056 . . . . 74.5 111.548 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.7 m -108.04 152.8 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.436 0.694 . . . . 75.32 110.09 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -81.51 96.18 7.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.399 -0.819 . . . . 73.02 109.121 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -63.49 -31.64 72.86 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.653 0.381 . . . . 74.53 111.22 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . 0.483 ' HB3' ' HE2' ' D' ' 96' ' ' HIS . 54.9 m-20 -62.09 -57.82 10.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.531 0.732 . . . . 74.33 111.564 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.61 96.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.642 0.777 . . . . 74.21 111.17 -176.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 5.0 mp -67.23 -28.18 67.85 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.16 -0.927 . . . . 73.24 111.797 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.7 t80 . . . . . 0 N--CA 1.486 1.352 0 C-N-CA 124.004 0.922 . . . . 75.43 111.333 175.691 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 109.071 -0.714 . . . . 74.22 109.071 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.638 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.6 t80 -136.21 129.71 32.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.062 -0.718 . . . . 75.23 109.062 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 48.1 tp60 -149.87 109.6 4.05 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.947 0.899 . . . . 73.53 109.04 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.548 HG22 ' HG2' ' C' ' 130' ' ' PRO . 32.4 mt -78.59 112.53 16.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.408 -0.96 . . . . 74.53 108.408 174.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.9 -41.83 25.35 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.825 -0.625 . . . . 72.54 109.317 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -171.19 123.57 0.59 Allowed 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.157 0.286 . . . . 75.31 111.185 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.572 HD13 ' HG3' ' C' ' 130' ' ' PRO . 72.2 mt -111.95 136.26 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.74 0.816 . . . . 74.11 109.166 174.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.501 ' HB3' HG23 ' B' ' 122' ' ' THR . 24.9 p90 -166.52 177.8 6.45 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.204 0.94 . . . . 73.44 110.928 -171.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -103.08 120.23 40.3 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.459 -0.791 . . . . 61.22 109.01 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 27.2 mtpt -84.77 -38.42 19.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.404 -0.591 . . . . 73.2 109.404 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.7 t70 -138.97 136.28 35.22 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.063 -0.971 . . . . 74.31 109.534 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 49.7 mt -133.55 146.68 31.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.116 -1.438 . . . . 74.11 107.116 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.1 t -155.16 145.71 22.17 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.636 0.585 . . . . 62.12 109.811 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.438 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.6 t80 -145.89 131.72 19.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.926 -1.509 . . . . 73.22 106.926 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -138.72 129.96 27.05 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.721 -0.844 . . . . 72.41 108.721 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.43 81.41 70.1 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.316 -0.994 . . . . 74.51 108.316 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.26 -25.91 25.8 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.024 2.482 . . . . 70.22 112.986 -172.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.495 ' O ' HG21 ' A' ' 31' ' ' VAL . 51.4 m-80 -114.67 24.11 12.1 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.411 0.685 . . . . 64.15 110.445 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -52.1 -49.31 85.13 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 113.705 1.002 . . . . 73.24 113.705 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 6.8 Cg_exo -73.54 -21.83 18.99 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 121.982 1.788 . . . . 74.22 111.964 176.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -80.1 -23.04 41.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.98 -1.009 . . . . 74.34 111.006 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.534 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 86.2 t -59.96 -24.65 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.637 0.775 . . . . 74.21 111.3 177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -56.96 -38.85 73.54 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.852 0.861 . . . . 70.15 111.188 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -93.11 -20.92 20.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.497 0.719 . . . . 72.44 110.921 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 30.7 mmmt -79.86 143.41 34.34 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.62 0.768 . . . . 75.03 111.468 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.27 121.12 20.8 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.34 -0.985 . . . . 75.04 108.34 168.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -68.88 89.91 0.42 Allowed 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.472 0.482 . . . . 71.52 110.689 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -144.13 81.55 11.48 Favored Pre-proline 0 C--O 1.245 0.834 0 N-CA-C 107.519 -1.289 . . . . 74.5 107.519 167.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 95.5 Cg_endo -81.94 157.66 18.13 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.693 2.262 . . . . 73.43 112.798 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -95.74 99.97 11.74 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.084 -1.08 . . . . 75.55 108.084 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.2 m -71.21 94.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-O 122.292 1.044 . . . . 72.21 110.776 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -110.03 135.63 50.56 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.753 -1.112 . . . . 74.12 109.443 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.5 tp -136.15 126.6 26.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.076 0.55 . . . . 74.13 110.737 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -126.42 131.29 51.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.83 0.852 . . . . 71.2 109.397 173.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.625 HD23 HG13 ' A' ' 62' ' ' VAL . 54.5 mt -119.69 134.33 55.27 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.413 0.685 . . . . 74.23 110.518 -175.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 8.2 m-20 -125.8 141.15 52.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.799 1.24 . . . . 74.43 108.188 173.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.5 m -126.32 129.85 49.66 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.006 -0.739 . . . . 74.53 109.006 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.58 153.95 50.5 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.438 1.095 . . . . 71.13 108.491 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.7 t -126.72 152.95 46.14 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 120.911 0.386 . . . . 70.21 110.17 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.5 t -149.45 121.41 8.22 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.386 1.074 . . . . 63.5 108.766 -176.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -74.28 125.85 29.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.092 0.557 . . . . 73.31 109.69 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.5 mt -95.49 -34.42 12.08 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.316 0.646 . . . . 75.41 110.421 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.0 177.36 10.83 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.08 0.952 . . . . 74.33 109.268 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -66.22 125.75 26.53 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.287 -0.634 . . . . 73.35 109.287 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 70.82 3.59 4.67 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.056 1.343 . . . . 73.42 112.142 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.75 115.0 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.251 1.021 . . . . 63.4 108.621 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -126.77 156.29 41.46 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.59 0.756 . . . . 74.1 109.604 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -130.19 142.85 50.54 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.266 -1.013 . . . . 74.42 108.266 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.51 139.91 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 108.241 -1.022 . . . . 75.31 108.241 165.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -112.41 107.34 22.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 107.824 -1.176 . . . . 65.34 107.824 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.8 tp -88.94 100.76 13.45 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.332 -0.849 . . . . 62.25 109.11 178.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 14.0 ttm-85 -84.46 107.89 16.96 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.65 -0.704 . . . . 75.25 109.155 175.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.625 HG13 HD23 ' A' ' 44' ' ' LEU . 19.8 m -103.96 130.22 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 123.857 0.863 . . . . 70.13 109.559 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.1 m -121.26 116.36 24.74 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.641 0.777 . . . . 73.15 110.075 -176.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.3 t -116.14 121.45 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.486 1.114 . . . . 64.43 108.83 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.6 m -126.71 124.9 40.85 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.347 -0.983 . . . . 74.23 108.347 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -125.56 105.24 8.89 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.163 -0.68 . . . . 72.32 109.163 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 42.4 t -116.73 128.86 55.73 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.377 0.671 . . . . 75.02 111.207 -173.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.491 HD12 ' HB1' ' A' ' 73' ' ' ALA . 5.1 mp -89.92 86.37 6.6 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.223 -1.399 . . . . 75.3 107.223 175.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.08 -104.88 2.07 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.512 -1.035 . . . . 73.41 110.512 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -109.23 -14.02 14.55 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.179 0.592 . . . . 75.34 110.534 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -85.48 95.97 9.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.934 0.894 . . . . 75.43 110.118 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 26.5 m -67.44 125.46 26.21 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 123.441 0.463 . . . . 71.22 110.535 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.491 ' HB1' HD12 ' A' ' 68' ' ' LEU . . . -78.01 -54.06 6.72 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.318 -0.856 . . . . 61.01 109.003 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -146.59 155.47 42.5 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.429 -1.26 . . . . 72.45 110.878 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.7 tp -133.48 132.07 40.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.527 -1.657 . . . . 73.4 106.527 176.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 85.1 m -133.92 110.44 9.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.342 -0.614 . . . . 74.22 109.342 -174.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -124.38 117.07 23.63 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.044 0.938 . . . . 74.01 109.118 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.3 t -132.91 111.33 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.221 0.608 . . . . 75.21 109.817 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.713 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 26.3 mt-30 -87.81 87.12 7.27 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 108.609 -0.886 . . . . 75.4 108.609 167.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -76.91 116.63 17.75 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.919 -1.037 . . . . 73.33 108.448 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.84 144.25 18.35 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.56 -0.616 . . . . 71.2 111.56 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.468 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -141.99 134.22 6.06 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 111.167 -0.773 . . . . 74.51 111.167 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.3 mt -82.89 115.43 25.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.645 -0.872 . . . . 71.44 108.645 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.638 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.4 m-85 -122.29 117.7 26.74 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.857 0.863 . . . . 74.23 108.937 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.449 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 12.6 m -90.81 89.94 7.7 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.321 -0.992 . . . . 70.12 108.321 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.7 pt -109.74 139.72 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.347 -0.842 . . . . 75.41 110.766 -172.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.8 168.95 25.56 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.846 -1.07 . . . . 64.11 109.695 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.11 9.61 85.93 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.606 0.566 . . . . 74.05 114.039 174.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.447 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.15 153.69 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.126 0.57 . . . . 73.32 110.603 -176.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -160.43 -172.48 3.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.669 0.788 . . . . 73.23 110.506 -171.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.1 -143.34 48.47 Favored Glycine 0 C--N 1.359 1.824 0 O-C-N 123.537 0.523 . . . . 53.15 112.636 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.9 t -86.44 -11.24 52.39 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 122.866 0.466 . . . . 74.45 111.038 166.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -33.99 74.83 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.925 0.89 . . . . 73.51 109.827 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -31.71 70.8 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.375 0.27 . . . . 73.25 110.966 173.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.68 -28.18 55.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.65 0.78 . . . . 61.21 110.826 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -69.73 -29.36 66.71 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.136 0.574 . . . . 64.5 110.313 170.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 78.0 m -69.69 -49.34 54.39 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.489 0.316 . . . . 72.13 110.928 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 pp -85.16 -18.93 32.65 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.017 0.527 . . . . 64.21 112.339 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.69 3.87 27.63 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-O 119.782 -0.455 . . . . 73.2 114.117 -173.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -148.09 -63.57 0.26 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.33 0.565 . . . . 74.45 111.378 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -61.66 -66.0 0.6 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.367 1.467 . . . . 74.31 112.826 -168.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 95.9 m -73.9 -37.98 3.6 Favored Pre-proline 0 CA--C 1.569 1.675 0 N-CA-C 114.701 1.371 . . . . 72.15 114.701 -175.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.55 -24.53 63.18 Favored 'Trans proline' 0 C--N 1.388 2.626 0 CA-C-N 121.837 1.692 . . . . 71.34 113.369 173.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -69.43 -29.78 67.57 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.017 0.527 . . . . 72.55 110.13 177.656 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.4 mm -62.66 -40.66 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.443 0.697 . . . . 64.11 110.184 176.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.468 HD22 ' HA3' ' A' ' 82' ' ' GLY . 96.3 mt -79.53 -19.24 50.06 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.166 0.986 . . . . 75.05 112.967 -175.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -59.4 -47.74 97.38 Favored Pre-proline 0 CA--C 1.569 1.693 0 N-CA-C 113.584 0.957 . . . . 74.44 113.584 -172.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.9 -37.05 57.08 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.061 1.841 . . . . 74.33 113.096 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -67.31 -40.22 85.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.319 0.648 . . . . 74.12 111.153 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.466 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . -66.59 -42.65 86.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.151 0.58 . . . . 64.44 110.137 177.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -50.31 -53.68 26.92 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.475 1.11 . . . . 75.42 110.506 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -68.65 -38.05 80.14 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.394 -0.821 . . . . 74.35 111.433 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.37 -34.18 74.89 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.107 0.48 . . . . 74.14 111.095 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.434 ' O ' HG22 ' A' ' 118' ' ' VAL . 60.7 mt -69.49 -57.25 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.132 -0.94 . . . . 72.51 109.624 172.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.401 HG22 ' HE2' ' C' ' 109' ' ' TYR . 28.5 m -55.35 -37.07 67.01 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.869 1.268 . . . . 74.34 111.923 -172.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.4 t -65.38 -50.3 66.05 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.117 -0.947 . . . . 73.51 109.903 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.438 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 67.6 mtm -62.27 -37.84 87.04 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.173 0.589 . . . . 74.34 111.454 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 114' ' ' ILE . 99.3 t -59.57 -49.12 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.676 0.79 . . . . 75.41 110.062 176.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.3 m -69.74 -29.78 67.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.537 -0.756 . . . . 72.54 111.615 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -72.8 -26.96 61.7 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.638 0.775 . . . . 74.32 110.126 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.87 6.64 77.84 Favored Glycine 0 C--N 1.354 1.563 0 O-C-N 123.685 0.616 . . . . 34.24 112.913 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.9 m 67.66 15.48 9.72 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.534 1.134 . . . . 71.01 111.175 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.442 ' HE1' HG23 ' A' ' 31' ' ' VAL . 63.6 m-85 -87.82 140.93 31.36 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 108.546 -0.909 . . . . 62.32 108.546 174.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -49.45 148.23 11.4 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.267 2.645 . . . . 75.32 113.25 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -59.63 129.46 42.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.5 0.72 . . . . 73.11 112.236 -173.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -110.18 101.55 10.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.121 0.968 . . . . 74.14 109.844 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -102.25 103.79 14.3 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.142 -1.059 . . . . 71.31 108.142 171.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.61 154.58 41.31 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.661 0.384 . . . . 75.13 110.575 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.56 142.84 92.17 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.363 0.665 . . . . 61.41 111.079 -175.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.33 127.91 13.14 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.343 2.029 . . . . 72.44 112.771 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 76.8 t -102.28 115.06 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.856 0.862 . . . . 75.03 108.878 175.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -92.14 85.91 5.62 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.671 -1.233 . . . . 70.23 107.671 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.463 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 91.8 m-85 -59.05 -31.6 69.01 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.745 -1.116 . . . . 73.12 113.203 -169.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.405 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 5.5 p-10 -66.12 -36.67 83.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.351 0.26 . . . . 74.34 111.419 -178.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.62 -38.17 89.19 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.109 0.563 . . . . 73.34 110.895 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.5 -39.38 88.69 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.211 -0.904 . . . . 74.2 111.311 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -68.61 -25.91 65.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.998 -0.546 . . . . 75.24 110.833 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.508 ' HE2' ' HA ' ' A' ' 138' ' ' MET . 17.0 mmt . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 123.04 0.536 . . . . 64.44 111.665 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.644 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 81.0 m . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 107.415 -1.328 . . . . 73.42 107.415 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -150.79 142.14 23.33 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.991 -0.374 . . . . 71.2 109.991 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -159.11 141.94 14.28 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 123.919 0.762 . . . . 71.33 109.644 169.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.441 HD12 HD11 ' B' ' 16' ' ' ILE . 45.8 mt -80.26 125.39 39.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.877 -0.786 . . . . 74.44 108.877 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -96.3 -35.52 11.2 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.343 0.657 . . . . 74.45 109.609 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -170.66 131.92 0.91 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.529 -0.76 . . . . 72.33 109.557 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.441 HD11 HD12 ' B' ' 13' ' ' ILE . 87.2 mt -114.89 136.33 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 106.641 -1.614 . . . . 64.32 106.641 168.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -166.48 162.97 17.17 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.695 0.622 . . . . 61.14 111.306 -174.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.444 HG23 HD13 ' B' ' 21' ' ' ILE . 27.5 m -98.32 127.4 44.24 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.444 -0.947 . . . . 74.41 108.444 176.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -98.05 -23.72 15.64 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.745 0.818 . . . . 74.41 111.018 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 9.3 t70 -158.78 139.33 12.55 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.142 0.276 . . . . 70.3 111.188 -170.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.637 HD13 ' SG ' ' B' ' 113' ' ' CYS . 40.8 mm -135.79 149.15 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.598 1.159 . . . . 74.14 108.754 175.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 17.7 m -146.89 143.62 28.67 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.524 1.13 . . . . 73.23 109.082 165.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -152.2 108.77 3.45 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.662 -1.236 . . . . 72.33 107.662 169.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -122.08 118.18 28.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.262 1.025 . . . . 72.12 108.399 -174.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.45 84.22 14.41 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.264 1.026 . . . . 72.13 108.549 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.23 -40.49 19.34 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.872 2.381 . . . . 74.42 112.585 -174.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 87.3 m-20 -96.67 13.8 27.09 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.987 -1.006 . . . . 70.11 111.078 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.406 ' HB1' ' HD3' ' B' ' 29' ' ' PRO . . . -40.29 -62.75 0.85 Allowed Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 115.086 1.513 . . . . 74.43 115.086 -164.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 6.7 Cg_exo -69.4 -25.58 30.13 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 121.721 1.614 . . . . 73.11 112.204 -171.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -95.44 -25.43 16.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.865 -1.061 . . . . 74.11 111.731 -170.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.741 HG23 HD13 ' B' ' 68' ' ' LEU . 8.7 p -83.9 -18.25 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.995 0.518 . . . . 65.21 110.981 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -61.11 -30.91 70.64 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.309 0.855 . . . . 73.34 113.309 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -61.27 -18.12 56.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.831 0.452 . . . . 72.12 111.608 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -92.29 82.87 4.97 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.146 0.978 . . . . 74.01 108.865 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -86.52 90.83 8.36 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.281 -0.637 . . . . 72.53 109.281 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.7 t-105 -158.15 156.12 30.32 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.898 1.279 . . . . 73.51 107.988 174.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -59.79 104.76 0.47 Allowed Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.991 1.316 . . . . 73.52 111.295 173.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.617 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 60.9 Cg_endo -74.45 128.17 11.71 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.689 2.26 . . . . 70.02 112.415 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.88 125.74 24.81 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 123.565 0.541 . . . . 74.52 109.911 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.586 HG11 ' HB1' ' B' ' 66' ' ' ALA . 25.2 m -104.67 153.32 6.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.848 -0.615 . . . . 71.02 111.014 -176.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.459 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 79.4 tttt -108.71 117.98 35.59 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.789 -1.189 . . . . 75.33 107.789 169.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.38 140.67 30.7 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.877 0.471 . . . . 74.21 110.23 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 6.1 t70 -145.42 155.85 43.4 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.616 -0.883 . . . . 74.23 108.616 -177.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.4 ' H ' HD21 ' B' ' 44' ' ' LEU . 1.5 pt? -115.51 163.12 16.22 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.596 0.712 . . . . 75.34 110.771 -175.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.578 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.0 t70 -163.64 111.3 1.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.19 -1.411 . . . . 74.31 107.19 167.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.6 p -128.73 125.34 37.74 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.167 0.587 . . . . 74.51 110.239 -172.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.66 159.47 41.89 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.034 0.934 . . . . 42.32 109.932 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.9 p -133.29 159.24 40.84 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.138 0.575 . . . . 73.41 109.678 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 98.1 p -153.1 140.75 19.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.173 0.589 . . . . 71.34 109.582 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -89.01 115.84 26.86 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.882 0.473 . . . . 72.42 109.996 176.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.96 -39.91 17.56 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.682 0.793 . . . . 75.34 109.207 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.43 -176.51 5.83 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.594 1.158 . . . . 74.31 109.717 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -67.43 126.15 28.37 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.851 -0.613 . . . . 64.31 110.033 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' B' ' 85' ' ' SER . 7.2 m-20 69.02 -9.95 0.55 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.093 1.757 . . . . 74.34 112.487 -173.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.9 t -105.63 104.13 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.789 -0.819 . . . . 74.51 108.789 -172.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -115.18 168.08 10.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.413 -1.267 . . . . 74.4 108.979 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -143.64 117.43 9.3 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.848 -1.168 . . . . 74.14 107.848 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.88 144.71 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.591 1.156 . . . . 75.54 109.247 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.5 t -127.82 119.82 52.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.088 -0.708 . . . . 72.32 109.088 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.468 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -98.28 114.7 27.08 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.642 -1.614 . . . . 75.53 106.642 172.109 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 3.7 ttt180 -111.56 125.89 54.4 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.409 -0.589 . . . . 75.04 109.409 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 49.5 t -114.3 116.21 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.681 1.192 . . . . 74.25 108.429 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.8 m -97.61 137.03 37.14 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.18 -0.674 . . . . 75.44 109.18 173.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 76.9 t -133.02 126.22 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.859 0.864 . . . . 73.31 109.529 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 91.9 m -124.66 107.16 10.7 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.373 0.669 . . . . 75.11 110.236 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.586 ' HB1' HG11 ' B' ' 40' ' ' VAL . . . -106.5 151.83 24.47 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.217 0.607 . . . . 75.23 110.992 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 57.0 p -153.24 139.86 18.85 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.051 -0.977 . . . . 73.24 110.497 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.741 HD13 HG23 ' B' ' 31' ' ' VAL . 48.5 mt -107.87 102.33 11.54 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.28 1.032 . . . . 74.23 109.201 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.08 -110.18 3.2 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.609 -0.723 . . . . 72.12 112.733 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.94 2.81 46.81 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.637 0.775 . . . . 74.14 111.138 -169.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.408 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.1 pt-20 -144.07 158.13 43.9 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.967 0.507 . . . . 75.11 110.875 -170.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -65.82 143.71 57.31 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.955 0.785 . . . . 75.12 111.171 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -96.18 -70.22 0.72 Allowed 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.508 -0.923 . . . . 74.33 108.508 169.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -148.6 153.03 37.77 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.167 -0.924 . . . . 74.24 109.466 -173.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 23.4 mt -131.12 109.44 10.46 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.538 -1.282 . . . . 60.23 107.538 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.0 t -119.96 147.32 44.9 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.816 -0.439 . . . . 63.44 109.816 -175.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -157.6 133.69 9.47 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 109.486 -0.561 . . . . 73.35 109.486 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 89.6 t -129.62 148.52 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.4 0.68 . . . . 73.22 109.474 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.531 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.0 mt-30 -118.33 98.9 6.51 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.75 -1.204 . . . . 73.53 107.75 166.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -85.89 99.55 11.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.1 -1.074 . . . . 74.1 108.1 171.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.68 169.81 35.98 Favored Glycine 0 C--O 1.242 0.626 0 N-CA-C 111.228 -0.749 . . . . 72.41 111.228 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.42 127.74 1.59 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 112.111 -0.396 . . . . 73.22 112.111 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 46.8 mt -84.53 120.78 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 107.727 -1.212 . . . . 72.33 107.727 171.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -128.41 135.11 49.06 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.84 0.856 . . . . 75.35 109.211 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 67.5 m -93.91 117.25 29.84 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 110.045 -0.354 . . . . 54.32 110.045 172.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.593 HD12 HD23 ' B' ' 98' ' ' LEU . 45.3 pt -117.11 146.81 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.821 1.248 . . . . 75.05 110.025 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.644 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -152.69 161.37 42.65 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.391 1.077 . . . . 75.55 108.62 170.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.86 -28.76 4.38 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 113.794 0.278 . . . . 71.42 113.794 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.89 140.06 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 124.608 1.163 . . . . 73.22 112.209 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.465 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 36.0 tt0 -162.71 144.81 10.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.25 0.62 . . . . 73.54 110.175 -177.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.39 -113.3 5.58 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.578 0.548 . . . . 61.24 113.768 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 88.4 m -82.14 -24.32 35.13 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.609 0.764 . . . . 73.35 111.17 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.465 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 44.2 mt-30 -60.52 -43.87 96.66 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.044 0.537 . . . . 74.21 111.271 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -65.02 -36.49 84.55 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.41 0.444 . . . . 75.33 110.269 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.67 -37.35 86.26 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.229 1.012 . . . . 75.13 111.157 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -82.68 -29.36 29.99 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.234 0.614 . . . . 75.32 110.858 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -67.09 -64.39 0.86 Allowed 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.661 0.601 . . . . 74.51 110.177 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.593 HD23 HD12 ' B' ' 86' ' ' ILE . 60.2 mt -81.76 -18.57 43.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.837 0.455 . . . . 75.11 111.173 -176.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.46 -35.53 11.85 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.427 0.454 . . . . 65.23 113.955 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.99 -41.16 0.75 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.033 0.753 . . . . 75.13 113.033 -167.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -77.44 -48.61 16.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.659 0.784 . . . . 74.43 111.277 -170.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.447 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 86.5 m -64.88 -48.0 73.17 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.684 0.794 . . . . 71.53 110.859 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.468 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 53.4 Cg_exo -58.05 -30.29 89.69 Favored 'Trans proline' 0 C--N 1.397 3.105 0 C-N-CA 122.085 1.856 . . . . 74.51 114.339 170.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -61.06 -42.17 97.98 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 123.084 0.554 . . . . 64.24 110.856 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.88 -40.94 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 115.357 -0.838 . . . . 65.41 110.105 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.3 mt -77.65 -20.99 52.89 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.729 -1.123 . . . . 73.2 112.125 -174.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -59.71 -50.65 85.8 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 114.269 1.211 . . . . 75.13 114.269 -171.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.87 -31.74 95.96 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 121.755 1.637 . . . . 72.54 113.087 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -73.32 -47.21 44.4 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.462 0.705 . . . . 73.34 110.965 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.99 -43.07 81.34 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.287 0.635 . . . . 60.42 110.291 175.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -60.08 -51.2 70.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.371 1.468 . . . . 75.14 111.204 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.82 -34.91 79.24 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.12 0.568 . . . . 65.31 109.794 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.637 ' SG ' HD13 ' B' ' 21' ' ' ILE . 4.8 t -70.71 -34.85 72.37 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.962 0.505 . . . . 73.33 111.665 -177.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 118' ' ' VAL . 58.8 mt -65.34 -55.87 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 109.178 -0.675 . . . . 72.41 109.178 173.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 15.5 m -59.76 -27.5 66.58 Favored 'General case' 0 CA--C 1.552 1.043 0 O-C-N 124.001 0.813 . . . . 71.0 111.557 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -64.07 -51.02 66.05 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.341 0.657 . . . . 65.42 109.77 174.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -69.24 -35.04 75.72 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.082 0.553 . . . . 73.01 111.125 -175.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.9 t -59.16 -46.75 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.554 0.741 . . . . 75.23 109.697 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.4 t -67.12 -30.83 70.94 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.749 -1.114 . . . . 62.42 111.811 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.444 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -70.21 -38.65 75.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.834 -0.621 . . . . 74.44 110.12 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.06 1.88 83.17 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.85 0.719 . . . . 75.12 112.695 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.501 HG23 ' HB3' ' A' ' 17' ' ' TYR . 27.1 p 61.84 25.47 15.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.69 1.996 . . . . 63.11 113.302 173.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -80.51 155.01 74.09 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 123.568 0.747 . . . . 75.23 110.953 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -50.48 158.6 2.57 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.809 3.006 . . . . 74.12 115.042 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -61.16 119.58 8.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.536 1.134 . . . . 75.21 112.531 -168.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.4 tp -110.18 127.15 54.77 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.269 0.628 . . . . 73.1 109.854 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -129.06 126.13 38.76 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.587 0.755 . . . . 73.21 109.093 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.9 131.1 34.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.419 -0.585 . . . . 72.51 109.419 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.62 152.02 96.37 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.748 0.819 . . . . 75.3 111.365 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.09 109.12 0.87 Allowed 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.621 2.214 . . . . 72.44 111.464 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 24.1 t -91.21 115.53 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.39 -0.596 . . . . 72.24 109.39 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . 0.427 ' O ' HD12 ' B' ' 136' ' ' LEU . 57.4 t-20 -72.7 90.72 1.41 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.198 0.599 . . . . 74.02 109.561 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -57.22 -32.93 67.01 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.97 0.908 . . . . 75.13 112.708 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -82.87 -41.31 19.13 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.389 0.676 . . . . 72.42 112.387 -168.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.33 61.99 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.125 0.57 . . . . 75.43 110.944 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . 0.427 HD12 ' O ' ' B' ' 132' ' ' ASN . 6.7 mp -74.92 -30.67 61.32 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.672 -0.695 . . . . 73.12 109.868 172.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 59.6 t80 . . . . . 0 CA--C 1.552 1.027 0 CA-C-N 115.46 -0.791 . . . . 72.44 110.159 173.293 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 107.9 -1.148 . . . . 60.4 107.9 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -93.55 118.64 31.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.16 -0.927 . . . . 75.14 108.637 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -138.12 135.37 35.68 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.48 -1.304 . . . . 72.4 107.48 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.2 mt -74.81 121.17 25.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.401 -0.963 . . . . 74.54 108.401 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.518 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 19.6 mm-40 -83.68 -44.05 14.9 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 123.888 0.743 . . . . 71.2 109.051 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -177.42 137.52 0.21 Allowed 'General case' 0 C--N 1.359 1.001 0 CA-C-N 115.491 -0.777 . . . . 74.11 109.72 -173.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.3 mt -124.46 143.8 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.008 -1.108 . . . . 75.04 108.008 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.41 ' OH ' HD11 ' C' ' 83' ' ' ILE . 30.7 p90 -171.43 165.13 7.02 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.36 0.6 . . . . 65.15 111.923 -172.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -92.64 107.67 19.39 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.967 -1.015 . . . . 74.35 109.191 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -68.38 -39.97 81.56 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.672 0.749 . . . . 75.54 109.548 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 19.3 t70 -143.28 139.36 30.12 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 113.918 -1.492 . . . . 75.5 109.192 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 96.4 mt -137.05 143.13 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 106.704 -1.591 . . . . 75.31 106.704 172.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -149.44 147.84 28.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.096 0.474 . . . . 75.44 110.001 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -147.46 135.32 21.18 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.45 -1.315 . . . . 72.2 107.45 169.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.59 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 33.7 mt-10 -138.13 111.3 7.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.561 0.745 . . . . 73.22 109.742 -170.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.11 74.02 11.0 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.445 -1.316 . . . . 73.32 107.445 166.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.46 -28.72 21.51 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.58 2.187 . . . . 73.42 111.163 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -88.22 14.49 9.25 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.957 -1.474 . . . . 72.43 111.787 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.505 ' HA ' HG11 ' C' ' 31' ' ' VAL . . . -44.83 -54.49 12.95 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 114.184 1.179 . . . . 63.42 114.184 -174.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.23 -37.08 85.55 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 121.916 1.744 . . . . 65.25 113.175 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -69.05 -45.1 71.26 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.836 0.854 . . . . 73.52 111.818 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.693 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -76.53 -22.28 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 113.156 0.798 . . . . 74.25 113.156 -174.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -65.49 -31.53 72.65 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.58 0.585 . . . . 72.24 112.58 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -94.84 11.55 31.19 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.355 0.662 . . . . 73.34 111.667 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.624 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.5 tppp? -85.14 160.55 19.91 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.981 0.912 . . . . 74.54 110.688 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.92 115.38 3.37 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.339 0.656 . . . . 72.03 109.372 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -84.72 91.75 8.03 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.355 0.597 . . . . 72.22 110.01 -177.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -143.46 79.95 13.49 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 106.756 -1.572 . . . . 73.4 106.756 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -80.35 149.92 19.48 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 123.029 2.486 . . . . 74.44 113.619 -177.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -108.03 110.79 22.58 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 107.064 -1.458 . . . . 74.31 107.064 169.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 m -80.43 124.11 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.334 0.588 . . . . 73.22 110.292 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.508 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 1.8 tmtp? -125.03 102.52 7.55 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.376 -1.713 . . . . 74.21 106.376 171.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.667 HD13 HD12 ' C' ' 128' ' ' LEU . 4.2 tt -108.44 121.71 45.52 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.968 -1.864 . . . . 72.3 105.968 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -122.72 117.06 24.83 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.88 -0.415 . . . . 74.41 109.88 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.416 HD12 HG22 ' C' ' 131' ' ' VAL . 89.4 mt -92.23 150.93 20.61 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.677 0.791 . . . . 75.53 109.322 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 12.7 t70 -151.32 142.77 23.48 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.235 -1.024 . . . . 61.34 108.235 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -126.75 139.51 53.07 Favored 'General case' 0 C--O 1.249 1.072 0 N-CA-C 108.607 -0.886 . . . . 75.15 108.607 172.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.91 141.92 21.27 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.896 -1.149 . . . . 62.41 107.896 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 16.5 p -148.1 156.8 43.03 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 120.853 0.359 . . . . 74.3 110.844 -171.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 95.5 p -144.12 158.64 43.6 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.723 0.809 . . . . 72.33 110.014 -172.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -94.46 130.91 40.65 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.797 -0.816 . . . . 75.5 108.797 172.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.571 HD13 HD13 ' C' ' 83' ' ' ILE . 39.1 mt -99.79 -42.6 6.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.335 0.654 . . . . 73.54 110.489 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -152.67 -172.25 4.18 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.322 -0.853 . . . . 74.51 110.245 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.67 105.87 1.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.013 -0.994 . . . . 70.1 109.826 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 70.06 3.69 4.48 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.01 1.324 . . . . 71.23 113.13 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 56.1 t -100.76 122.78 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.109 -1.071 . . . . 73.54 108.109 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -138.25 124.39 20.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.01 -0.541 . . . . 74.33 109.736 -166.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -84.83 137.8 32.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.561 0.745 . . . . 73.53 109.496 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.51 129.57 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.791 -1.189 . . . . 73.5 107.791 170.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.4 148.24 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.693 0.797 . . . . 75.1 109.109 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.09 111.92 14.02 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.481 -1.303 . . . . 74.41 107.481 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.59 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.6 tmm_? -98.42 107.13 19.52 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 107.731 -1.211 . . . . 75.43 107.731 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 t -103.62 123.11 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.186 -1.042 . . . . 74.11 108.186 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -111.83 141.55 45.32 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.021 -0.733 . . . . 74.13 109.021 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.66 HG23 HG21 ' C' ' 114' ' ' ILE . 91.1 t -131.84 123.21 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.515 1.126 . . . . 75.1 108.146 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 12.8 m -124.69 141.84 51.82 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.795 0.838 . . . . 75.04 108.764 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.69 123.98 16.72 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.235 -1.394 . . . . 63.0 107.235 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 60.4 m -133.3 158.22 43.49 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.6 0.714 . . . . 71.34 111.312 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 mt -121.35 39.85 3.73 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.356 1.463 . . . . 72.55 107.338 -171.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.29 -111.6 3.88 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 109.507 -1.437 . . . . 75.35 109.507 -166.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -90.48 -31.08 16.93 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.105 0.562 . . . . 74.12 110.389 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.624 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 4.4 tp10 -70.67 106.91 3.69 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.026 0.93 . . . . 71.32 109.911 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.7 m -72.83 126.73 30.61 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.94 -0.763 . . . . 75.01 108.94 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.693 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.92 -58.23 4.1 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.029 -0.73 . . . . 64.34 109.029 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -159.43 163.8 35.1 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.536 -0.756 . . . . 74.41 110.897 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.59 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -128.27 144.84 51.16 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 106.517 -1.66 . . . . 72.13 106.517 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.433 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.3 t -149.42 147.11 27.87 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.334 -0.987 . . . . 75.02 108.334 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.43 135.28 10.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.72 0.295 . . . . 74.14 110.48 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' C' ' 110' ' ' ALA . 50.4 t -135.33 114.77 17.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 124.332 1.053 . . . . 74.33 108.704 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 65.4 mt-30 -97.35 89.9 4.89 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.143 -0.688 . . . . 73.14 109.143 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.39 102.47 8.72 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.053 -0.976 . . . . 70.55 110.498 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.96 157.14 31.89 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 116.202 -0.454 . . . . 51.31 112.035 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.518 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -160.81 116.64 0.73 Allowed Glycine 0 CA--C 1.508 -0.369 0 N-CA-C 111.72 -0.552 . . . . 74.24 111.72 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.571 HD13 HD13 ' C' ' 51' ' ' LEU . 7.4 mm -82.7 127.28 39.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.727 -0.842 . . . . 65.25 108.727 177.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -132.12 141.05 49.01 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.758 0.823 . . . . 72.44 109.082 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 13.5 p -83.73 122.92 29.29 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.142 -0.688 . . . . 65.3 109.142 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 46.6 pt -120.86 133.14 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.602 0.761 . . . . 74.2 109.804 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.63 159.68 21.99 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.302 1.041 . . . . 61.33 108.704 176.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.33 -57.6 4.22 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 112.713 -0.155 . . . . 70.54 112.713 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -88.57 163.76 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.184 0.594 . . . . 74.14 111.687 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -165.85 163.21 18.71 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.673 0.789 . . . . 55.45 110.392 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.92 -114.96 7.03 Favored Glycine 0 C--N 1.355 1.594 0 C-N-CA 123.44 0.543 . . . . 64.3 113.703 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -63.34 -40.47 97.37 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.731 0.812 . . . . 63.31 111.574 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -76.59 -32.1 57.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.675 0.39 . . . . 74.15 110.861 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 41.5 ttm -76.99 -28.71 55.19 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.274 0.358 . . . . 65.53 110.817 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.63 91.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.441 -0.577 . . . . 51.14 109.441 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.596 ' HE2' ' HA ' ' C' ' 134' ' ' ASP . 7.5 t-160 -77.33 -25.22 50.92 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.308 0.38 . . . . 71.53 111.718 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.05 -52.18 66.47 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.542 0.526 . . . . 74.31 109.733 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 pp -81.99 -20.53 38.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.931 0.492 . . . . 75.13 110.882 176.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.27 -29.19 56.74 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 114.482 0.553 . . . . 75.24 114.482 -173.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.14 -43.52 0.06 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.918 0.71 . . . . 73.32 112.918 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -59.42 -46.08 89.73 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.477 0.711 . . . . 74.24 112.309 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 81.1 m -78.92 -46.87 1.74 Allowed Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.699 0.8 . . . . 71.31 111.396 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.86 -26.3 56.92 Favored 'Trans proline' 0 C--N 1.399 3.185 0 C-N-CA 122.402 2.068 . . . . 74.3 113.831 169.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.33 -43.37 97.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.561 1.145 . . . . 73.53 109.936 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.0 mm -64.05 -45.21 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 114.84 -1.073 . . . . 71.32 109.789 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.518 HD21 ' HA3' ' C' ' 82' ' ' GLY . 86.4 mt -75.72 -25.18 56.39 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.149 -0.932 . . . . 72.0 112.812 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -56.22 -53.42 63.87 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 113.78 1.029 . . . . 75.34 113.78 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.69 -29.63 88.77 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 121.725 1.617 . . . . 75.52 113.387 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.401 ' HE2' HG22 ' A' ' 115' ' ' THR . 90.6 m-85 -68.94 -48.71 62.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.781 0.433 . . . . 75.41 110.478 176.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.51 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -63.23 -31.11 72.17 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.461 -0.791 . . . . 71.31 110.773 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.667 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 46.6 ttt180 -63.42 -58.86 5.71 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.472 1.509 . . . . 64.24 111.146 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -31.91 73.36 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.686 0.394 . . . . 74.21 110.262 -177.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -65.29 -31.34 72.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.141 0.576 . . . . 62.11 111.579 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.66 HG21 HG23 ' C' ' 64' ' ' VAL . 84.8 mt -74.89 -56.61 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 116.154 -0.475 . . . . 71.54 109.933 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 3.3 m -62.7 -27.72 69.45 Favored 'General case' 0 CA--C 1.553 1.066 0 O-C-N 123.688 0.617 . . . . 74.1 111.412 -172.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -62.39 -51.34 67.98 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.349 0.66 . . . . 74.32 109.304 170.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.669 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.79 -39.61 89.53 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.333 1.053 . . . . 75.33 112.435 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.403 HG23 ' O ' ' C' ' 114' ' ' ILE . 60.4 t -59.91 -47.88 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.436 0.694 . . . . 73.52 109.422 176.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -66.31 -32.42 73.81 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.494 -1.23 . . . . 65.43 111.755 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -67.8 -35.02 77.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.31 0.644 . . . . 75.43 109.879 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.39 10.84 69.91 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.928 0.767 . . . . 54.21 112.888 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 46.6 p 54.84 37.26 28.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.058 1.743 . . . . 73.34 113.752 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -95.65 153.48 39.41 Favored Pre-proline 0 N--CA 1.477 0.911 0 N-CA-C 108.196 -1.038 . . . . 74.22 108.196 168.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -64.76 168.9 12.47 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.5 2.134 . . . . 75.12 112.688 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -54.44 113.33 1.24 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.353 1.061 . . . . 75.53 113.412 -174.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 5.5 tt -113.87 87.03 2.53 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.307 -1.368 . . . . 72.13 107.307 167.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -95.47 127.47 41.54 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.23 -1.026 . . . . 73.34 108.23 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.667 HD12 HD13 ' C' ' 42' ' ' LEU . 2.3 mm? -73.62 132.15 42.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.552 0.741 . . . . 75.2 109.546 -174.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.62 153.47 75.91 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.518 0.727 . . . . 63.23 110.606 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.572 ' HG3' HD13 ' A' ' 16' ' ' ILE . 50.2 Cg_exo -51.58 115.68 2.25 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.771 2.314 . . . . 71.41 112.73 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . 0.416 HG22 HD12 ' C' ' 44' ' ' LEU . 85.0 t -97.95 122.58 49.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.199 -0.667 . . . . 74.04 109.199 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -83.88 76.11 10.05 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.17 0.588 . . . . 75.11 109.497 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -60.51 -44.67 95.77 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 122.116 0.96 . . . . 73.44 109.038 170.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.596 ' HA ' ' HE2' ' C' ' 96' ' ' HIS . 7.4 m-20 -65.09 -50.0 67.81 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 113.184 -1.825 . . . . 75.23 112.366 -172.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.67 88.32 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.814 0.696 . . . . 75.12 111.825 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -42.93 74.38 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.762 -1.108 . . . . 70.34 109.82 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 4.8 t80 . . . . . 0 N--CA 1.483 1.199 0 C-N-CA 122.739 0.416 . . . . 75.41 111.285 -175.719 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.6 m . . . . . 0 C--O 1.241 0.62 0 N-CA-C 108.733 -0.84 . . . . 75.55 108.733 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -148.23 102.21 3.34 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.506 -1.294 . . . . 71.35 107.506 172.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -126.1 115.91 20.56 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.763 -1.199 . . . . 73.02 107.763 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 mt -72.33 115.76 13.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 N-CA-C 108.247 -1.02 . . . . 75.41 108.247 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -88.01 -29.53 20.65 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.722 -0.672 . . . . 75.35 110.783 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -179.54 141.13 0.15 Allowed 'General case' 0 C--N 1.366 1.315 0 C-N-CA 122.34 0.256 . . . . 74.22 110.411 -170.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.46 135.79 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.256 -1.387 . . . . 71.22 107.256 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -165.86 174.02 10.0 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-O 121.654 0.74 . . . . 75.13 112.258 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -105.06 120.17 40.84 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.735 -1.12 . . . . 71.1 108.912 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.401 ' HZ2' ' CD ' ' D' ' 57' ' ' GLU . 28.7 mtpt -89.91 -21.47 22.47 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.307 0.643 . . . . 74.12 109.805 177.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.668 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.0 t70 -155.37 139.36 16.37 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.081 -0.963 . . . . 71.14 108.856 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.669 HG21 ' HE1' ' C' ' 117' ' ' MET . 81.3 mt -137.53 142.77 35.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.56 -1.274 . . . . 74.43 107.56 172.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -149.07 130.09 14.39 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.543 -0.91 . . . . 73.11 108.543 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -136.78 126.23 25.09 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.992 -1.484 . . . . 75.11 106.992 170.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.5 mt-10 -130.82 138.3 49.82 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.74 -0.837 . . . . 74.34 108.74 -175.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.77 82.86 67.81 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 106.97 -1.492 . . . . 74.51 106.97 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.08 -32.4 27.92 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.196 2.597 . . . . 71.51 113.034 -169.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -111.77 26.53 10.53 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.308 0.643 . . . . 75.52 109.385 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.432 ' HB2' ' HD3' ' D' ' 29' ' ' PRO . . . -37.04 -70.09 0.16 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 114.746 1.387 . . . . 50.41 114.746 -161.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.547 ' HB3' HD11 ' C' ' 83' ' ' ILE . 65.2 Cg_endo -77.04 -16.35 15.91 Favored 'Trans proline' 0 C--N 1.38 2.198 0 CA-C-N 122.401 1.893 . . . . 73.11 113.612 -172.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -76.13 -41.71 49.2 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.597 1.159 . . . . 75.43 110.327 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' D' ' 73' ' ' ALA . 6.6 p -82.66 -25.29 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 115.649 -0.705 . . . . 73.22 111.138 -170.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -61.5 -20.78 63.59 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.761 0.824 . . . . 75.34 113.004 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -60.86 -26.29 67.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.425 0.69 . . . . 75.01 110.945 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.421 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 41.2 mtmt -91.72 86.4 5.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.941 0.897 . . . . 70.15 109.113 168.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -76.91 88.73 3.48 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.664 -0.698 . . . . 74.33 109.631 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -155.78 158.34 37.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.515 1.126 . . . . 75.44 108.489 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -69.09 106.1 1.32 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.891 0.876 . . . . 74.11 108.966 174.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' D' ' 66' ' ' ALA . 35.4 Cg_exo -63.17 141.15 81.6 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.664 2.243 . . . . 73.12 113.287 -171.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 8.5 mm-40 -58.73 111.35 1.24 Allowed 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.051 0.844 . . . . 74.15 110.2 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.47 HG13 ' O ' ' D' ' 38' ' ' PRO . 16.1 m -101.4 128.02 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.656 0.741 . . . . 75.33 111.83 -170.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -106.55 112.76 25.9 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.821 1.248 . . . . 72.01 107.913 171.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.565 HD21 ' H ' ' D' ' 42' ' ' LEU . 1.8 pt? -95.98 112.92 24.52 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.039 -1.097 . . . . 75.11 108.039 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -114.84 113.21 23.91 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.667 -1.235 . . . . 71.23 107.667 174.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.529 HD11 ' H ' ' D' ' 44' ' ' LEU . 0.0 OUTLIER -110.34 155.48 22.06 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.904 0.882 . . . . 75.01 109.247 -176.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -158.64 152.65 23.7 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.528 0.731 . . . . 75.03 109.983 -177.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -109.87 167.59 10.05 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.617 -0.512 . . . . 73.11 109.617 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.544 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.47 160.52 36.85 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.795 0.838 . . . . 71.55 108.866 173.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -146.4 151.52 37.59 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.656 0.382 . . . . 72.12 110.736 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.7 t -165.55 122.13 1.42 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.582 0.753 . . . . 71.31 109.873 -171.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -82.42 117.71 22.67 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.809 -0.441 . . . . 71.23 109.809 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.549 HD13 HG22 ' D' ' 83' ' ' ILE . 32.2 mt -97.63 -24.98 15.28 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.162 0.585 . . . . 72.33 110.71 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.43 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -162.62 -178.54 6.27 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.482 0.713 . . . . 70.43 111.037 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.51 114.3 4.78 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.475 -1.239 . . . . 35.3 109.791 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.14 21.18 11.62 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.302 1.041 . . . . 63.3 111.795 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 66.3 t -118.82 128.72 75.65 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 N-CA-C 108.159 -1.052 . . . . 72.11 108.159 170.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.442 ' HB2' HD13 ' D' ' 86' ' ' ILE . 0.4 OUTLIER -122.27 172.7 8.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.054 0.93 . . . . 65.11 110.287 174.386 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.492 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.9 tt0 -132.31 138.54 47.86 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.255 -1.793 . . . . 74.11 107.577 169.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.27 138.63 47.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.513 -1.292 . . . . 75.35 107.513 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 47.6 t -119.57 128.67 75.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.077 -1.083 . . . . 54.25 108.077 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.403 HD21 ' O ' ' D' ' 45' ' ' ASP . 0.1 OUTLIER -99.1 116.45 31.35 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.25 -1.019 . . . . 74.2 108.25 175.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.592 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 2.4 tmm_? -99.71 96.29 7.51 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.652 -1.61 . . . . 75.44 106.652 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.584 HG23 ' HB1' ' D' ' 110' ' ' ALA . 37.0 t -107.96 125.63 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.599 -0.889 . . . . 74.44 108.599 -177.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 20.8 m -130.26 135.29 47.96 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.366 0.667 . . . . 52.15 109.398 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 63.9 t -122.3 109.33 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.858 0.863 . . . . 73.34 109.257 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.1 m -95.39 111.54 23.4 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.832 -0.803 . . . . 72.44 108.832 170.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' D' ' 38' ' ' PRO . . . -115.28 149.84 37.18 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.48 0.712 . . . . 74.11 110.771 -173.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 15.1 m -149.32 132.28 16.17 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 123.778 0.674 . . . . 71.21 111.603 -177.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.513 HD11 HG23 ' D' ' 31' ' ' VAL . 30.5 mt -96.24 109.35 21.84 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.554 -0.906 . . . . 71.51 108.554 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.38 -114.57 4.99 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 123.678 0.612 . . . . 64.0 113.02 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.57 16.53 20.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.57 0.748 . . . . 75.52 111.386 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.421 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 12.4 pt-20 -137.23 161.22 36.78 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.219 0.607 . . . . 75.44 109.785 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 19.5 m -69.62 138.9 53.47 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.561 0.538 . . . . 74.22 111.239 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.525 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -95.72 -70.64 0.7 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.955 0.902 . . . . 73.24 109.375 173.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -144.72 138.45 27.23 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 121.136 0.493 . . . . 74.3 110.286 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.7 mt -111.37 109.83 20.0 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.027 -1.101 . . . . 74.23 108.027 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.533 ' SG ' HG22 ' D' ' 114' ' ' ILE . 53.3 t -118.78 140.64 49.62 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.473 0.709 . . . . 71.11 109.406 -177.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -155.57 134.5 12.06 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.28 0.632 . . . . 75.31 109.629 175.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.18 119.06 18.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.929 0.892 . . . . 65.05 108.873 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.668 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.7 83.71 6.26 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.2 -1.037 . . . . 73.44 108.2 168.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.31 94.35 5.46 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.29 -1.323 . . . . 74.52 109.0 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.9 142.67 16.67 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.985 -0.446 . . . . 64.14 111.985 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.509 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -142.15 130.02 4.14 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.542 -1.023 . . . . 73.41 110.542 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.549 HG22 HD13 ' D' ' 51' ' ' LEU . 39.0 mt -90.82 136.75 23.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.422 -0.955 . . . . 74.23 108.422 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -138.86 131.83 29.51 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.26 0.624 . . . . 72.42 109.84 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -80.17 109.31 14.51 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.772 -0.825 . . . . 54.43 108.772 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.442 HD13 ' HB2' ' D' ' 56' ' ' TYR . 1.6 pp -119.83 133.88 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.648 0.779 . . . . 74.34 111.81 -171.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.24 169.0 9.49 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.434 1.094 . . . . 72.42 109.207 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.18 11.46 84.89 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 115.368 0.907 . . . . 74.5 115.368 169.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.81 143.35 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 117.837 0.819 . . . . 75.22 110.059 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.2 -174.42 4.37 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.717 0.807 . . . . 73.41 111.072 -176.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.93 -120.85 14.86 Favored Glycine 0 C--N 1.357 1.728 0 O-C-N 123.455 0.472 . . . . 70.43 113.0 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 29.7 m -88.82 -28.65 20.28 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.213 0.605 . . . . 74.13 110.333 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -62.85 -30.23 71.35 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.273 1.029 . . . . 73.03 111.857 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 12.1 ptm -68.65 -29.39 67.87 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.079 0.552 . . . . 74.51 111.574 177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.54 -36.26 24.15 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.586 0.754 . . . . 74.34 110.651 174.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . 0.462 ' HE2' ' HB3' ' D' ' 134' ' ' ASP . 25.9 t-80 -70.02 -41.32 74.46 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.214 1.005 . . . . 74.22 111.61 -174.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.6 t -65.94 -50.33 64.76 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.099 0.56 . . . . 74.52 110.66 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 18.2 tp -76.95 -31.36 56.53 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 115.715 -0.675 . . . . 73.04 111.104 -173.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.28 -26.94 10.47 Favored Glycine 0 C--N 1.354 1.541 0 N-CA-C 114.931 0.732 . . . . 61.53 114.931 -170.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.37 -49.63 1.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 117.609 0.704 . . . . 72.42 112.118 -171.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -69.95 -48.29 58.96 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.26 0.624 . . . . 75.44 111.932 -173.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 92.6 m -61.44 -48.18 91.5 Favored Pre-proline 0 CA--C 1.564 1.502 0 CA-C-O 118.509 -0.758 . . . . 74.01 112.15 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.3 -35.68 91.96 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.113 1.875 . . . . 70.11 113.765 170.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -63.85 -39.74 94.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.993 0.517 . . . . 73.55 110.424 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.0 mm -60.51 -40.64 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.568 0.699 . . . . 75.34 110.544 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.509 HD22 ' HA3' ' D' ' 82' ' ' GLY . 96.1 mt -76.34 -19.17 58.47 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.84 -1.073 . . . . 75.04 112.061 -175.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -65.33 -43.8 65.68 Favored Pre-proline 0 CA--C 1.564 1.498 0 N-CA-C 114.189 1.181 . . . . 72.22 114.189 -170.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.63 -42.06 71.77 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 122.1 1.867 . . . . 71.31 113.432 172.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -73.68 -35.2 65.17 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.742 0.817 . . . . 72.32 111.808 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.584 ' HB1' HG23 ' D' ' 62' ' ' VAL . . . -61.51 -51.03 70.33 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.519 0.728 . . . . 63.02 109.592 176.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -54.92 -52.22 63.63 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 113.891 -1.504 . . . . 75.42 110.586 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.84 -48.0 81.05 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 124.023 0.827 . . . . 75.24 111.703 -174.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.9 t -59.9 -42.56 94.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.898 0.479 . . . . 61.2 111.169 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.533 HG22 ' SG ' ' D' ' 76' ' ' CYS . 70.3 mt -60.5 -52.53 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.927 0.891 . . . . 63.44 110.528 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 39.5 m -56.55 -44.88 81.33 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 125.063 1.345 . . . . 75.13 111.573 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 25.7 t -64.54 -41.36 96.4 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.696 -1.138 . . . . 74.11 110.457 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.452 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.8 mtm -70.56 -34.02 71.76 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.698 0.399 . . . . 64.22 111.749 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.12 -43.62 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.304 0.642 . . . . 74.31 110.044 176.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.4 p -72.45 -31.17 65.22 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 116.054 -0.521 . . . . 74.5 111.196 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.3 mtt-85 -71.46 -32.56 68.46 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.494 0.718 . . . . 74.5 110.411 175.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.29 7.22 79.42 Favored Glycine 0 C--N 1.351 1.405 0 O-C-N 123.67 0.606 . . . . 55.35 112.072 175.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 66.2 p 63.08 13.59 6.91 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.88 2.072 . . . . 73.12 114.309 173.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -79.26 149.82 73.21 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 108.543 -0.91 . . . . 75.41 108.543 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -48.25 122.08 7.05 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.075 2.517 . . . . 74.14 112.755 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -49.49 135.87 17.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.395 1.478 . . . . 71.41 112.345 -171.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 29.5 tp -108.16 95.9 5.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.941 0.496 . . . . 64.41 110.736 -169.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -103.4 87.74 2.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.674 0.79 . . . . 71.52 109.062 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.414 HD12 HD13 ' D' ' 42' ' ' LEU . 39.1 tp -71.68 133.63 45.77 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.014 -0.993 . . . . 73.12 110.549 -176.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.05 141.07 98.01 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 123.131 0.573 . . . . 75.01 110.892 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -61.4 130.98 33.98 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.666 2.244 . . . . 74.31 111.868 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 80.0 t -108.58 120.84 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.424 0.689 . . . . 75.14 109.77 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -82.99 91.37 7.15 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.591 -0.892 . . . . 73.41 108.591 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -66.72 -35.1 79.33 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.798 -0.637 . . . . 72.41 110.632 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . 0.462 ' HB3' ' HE2' ' D' ' 96' ' ' HIS . 6.0 m-20 -52.39 -52.14 55.24 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.201 1.4 . . . . 52.51 112.743 -173.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.68 75.26 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.19 0.596 . . . . 64.0 111.518 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -68.46 -28.5 67.1 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.569 -0.741 . . . . 73.32 111.19 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 90.4 t80 . . . . . 0 N--CA 1.475 0.816 0 C-N-CA 123.968 0.907 . . . . 73.33 110.555 176.634 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 C--O 1.237 0.438 0 N-CA-C 106.125 -1.806 . . . . 75.43 106.125 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.616 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.6 t80 -114.49 129.96 56.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.001 -1.0 . . . . 75.42 109.213 -171.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -140.99 108.84 5.67 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.36 -0.978 . . . . 75.11 108.36 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.555 HG12 ' HD2' ' A' ' 84' ' ' PHE . 55.0 mt -81.16 116.94 26.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.971 -0.751 . . . . 72.3 108.971 173.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.478 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -73.82 -40.77 63.11 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.634 -0.712 . . . . 75.24 109.301 -178.683 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -173.64 122.96 0.35 Allowed 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.299 0.374 . . . . 72.52 111.384 -171.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.562 HD13 ' HG3' ' C' ' 130' ' ' PRO . 71.3 mt -106.43 133.83 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.067 -0.716 . . . . 75.12 109.067 173.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.433 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 33.2 p90 -163.76 178.86 7.53 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.882 0.873 . . . . 54.41 110.901 -173.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.9 p -106.2 116.26 31.63 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.951 -0.759 . . . . 75.24 108.951 176.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 22.7 mtpt -81.26 -29.71 34.31 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.422 -0.585 . . . . 73.13 109.422 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.583 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.3 t70 -146.84 141.75 26.95 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.719 -1.128 . . . . 70.22 109.697 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 88.0 mt -139.05 141.26 36.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 125.616 1.566 . . . . 74.32 106.807 171.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -147.96 136.85 21.94 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.184 0.516 . . . . 62.43 109.986 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.585 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.4 t80 -135.26 126.23 27.69 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.682 -1.229 . . . . 75.45 107.682 171.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.81 119.88 24.1 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.885 0.474 . . . . 74.14 110.159 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -132.93 80.4 60.71 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 107.367 -1.345 . . . . 73.44 107.367 170.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.66 -19.38 12.87 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.68 2.253 . . . . 74.34 111.192 175.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.479 ' O ' HG21 ' A' ' 31' ' ' VAL . 91.0 m-20 -103.94 16.98 25.08 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.294 1.038 . . . . 75.45 110.56 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.527 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -55.25 -46.6 99.66 Favored Pre-proline 0 CA--C 1.57 1.725 0 C-N-CA 123.54 0.736 . . . . 72.33 112.277 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.52 6.1 4.69 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 122.318 2.012 . . . . 72.43 113.383 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -100.78 -40.25 7.42 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.125 0.57 . . . . 75.2 109.8 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 27' ' ' ASN . 98.6 t -66.78 -34.39 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.716 0.806 . . . . 74.01 111.34 -175.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.441 ' CE1' ' HG3' ' A' ' 33' ' ' GLN . 1.1 p90 -65.82 -26.14 67.54 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 120.898 0.38 . . . . 75.12 111.029 -177.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.441 ' HG3' ' CE1' ' A' ' 32' ' ' PHE . 49.2 mt-30 -87.08 -44.11 11.79 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.372 0.669 . . . . 75.22 111.068 177.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.415 ' HE3' HD13 ' A' ' 68' ' ' LEU . 53.4 mtmt -82.86 168.55 17.0 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.086 0.47 . . . . 75.11 112.251 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.24 131.96 41.69 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.009 -0.996 . . . . 75.32 110.535 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -77.44 98.62 5.35 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.589 1.156 . . . . 73.1 110.256 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -139.01 75.66 34.78 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 108.879 -0.786 . . . . 75.45 108.879 172.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -84.96 152.81 11.19 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.554 2.169 . . . . 72.54 112.863 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -118.33 108.76 15.48 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.603 -1.258 . . . . 73.41 107.603 172.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.6 m -82.54 135.41 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.609 0.764 . . . . 74.24 111.649 -171.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -123.28 113.28 18.67 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.895 -1.15 . . . . 74.03 107.895 174.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.7 tp -110.46 116.72 31.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.045 0.538 . . . . 75.51 110.078 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.507 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 31.5 t70 -103.15 132.93 49.04 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 109.029 -0.73 . . . . 75.14 109.029 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.5 mt -110.47 132.4 54.21 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.459 -0.941 . . . . 74.43 108.459 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.74 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 16.9 t70 -145.39 153.17 40.92 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.907 0.483 . . . . 74.24 110.068 177.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.6 m -127.71 139.39 52.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.667 1.187 . . . . 71.21 108.659 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.57 123.69 25.58 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.491 -0.559 . . . . 72.41 109.491 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.6 m -88.11 152.21 22.17 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.333 -0.617 . . . . 72.24 109.333 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -160.42 122.52 3.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.368 0.667 . . . . 75.45 109.819 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -81.04 139.12 35.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.026 0.53 . . . . 73.43 110.239 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.465 HD12 HG23 ' A' ' 83' ' ' ILE . 83.7 mt -117.49 -28.76 5.99 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.522 0.729 . . . . 72.52 110.138 176.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.2 -177.35 4.92 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.08 0.952 . . . . 64.31 109.374 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.18 128.22 35.57 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.269 -0.641 . . . . 63.42 109.269 173.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 69.38 2.42 3.7 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.204 1.402 . . . . 74.33 112.309 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.87 116.43 52.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 123.923 0.889 . . . . 74.12 109.389 -177.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.16 125.59 23.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.987 0.915 . . . . 74.24 108.678 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -93.83 145.39 24.64 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.632 -0.877 . . . . 63.22 108.632 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -111.58 138.26 40.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.995 -1.113 . . . . 71.44 107.995 172.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -114.73 106.78 21.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.021 -1.103 . . . . 72.4 108.021 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.7 tp -88.09 105.91 17.81 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.656 -0.868 . . . . 74.35 108.656 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.74 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 59.1 mtt85 -83.75 121.94 27.98 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.838 -0.801 . . . . 74.44 108.838 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.613 HG23 ' HB1' ' A' ' 110' ' ' ALA . 2.1 m -127.61 101.52 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.644 -0.873 . . . . 75.03 108.644 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 86.6 m -98.13 108.54 21.27 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.344 1.057 . . . . 75.32 109.87 -175.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.0 t -103.03 113.65 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.42 -0.585 . . . . 54.31 109.42 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.9 m -123.6 107.05 11.09 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.071 -0.714 . . . . 72.1 109.071 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.25 125.1 53.79 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.977 -0.749 . . . . 64.43 108.977 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.4 p -120.95 130.38 53.83 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.535 0.734 . . . . 70.44 110.161 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.477 HD21 ' H ' ' A' ' 68' ' ' LEU . 2.7 pt? -90.4 48.31 1.54 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 122.278 1.037 . . . . 72.04 109.661 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.78 -125.34 6.36 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 114.915 -1.039 . . . . 52.52 111.071 -170.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.27 -28.34 23.83 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 117.48 0.64 . . . . 75.31 109.73 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -86.12 134.5 33.81 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.85 0.86 . . . . 74.12 110.571 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 m -74.72 133.4 42.04 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.649 0.593 . . . . 62.33 109.869 172.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.83 -51.88 9.1 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.891 0.877 . . . . 71.3 108.963 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -155.92 157.08 35.7 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.447 -1.252 . . . . 74.44 111.551 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 62.8 tp -121.97 109.76 14.99 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.403 -1.332 . . . . 75.2 107.403 166.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 80.1 m -107.28 97.36 7.13 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.939 -1.134 . . . . 72.33 107.939 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -122.13 115.8 23.08 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.36 -0.978 . . . . 61.44 108.36 -173.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.7 t -126.22 136.11 61.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.49 -0.777 . . . . 73.13 109.184 -172.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 24.5 mt-30 -110.28 91.17 3.55 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.826 -0.805 . . . . 64.24 108.826 167.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -77.18 113.17 14.63 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.867 -1.16 . . . . 63.15 107.867 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.72 142.19 16.12 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 112.198 -0.361 . . . . 60.11 112.198 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.41 141.54 10.86 Favored Glycine 0 CA--C 1.505 -0.557 0 N-CA-C 110.743 -0.943 . . . . 75.02 110.743 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.478 ' HB ' ' HB3' ' A' ' 14' ' ' GLN . 36.2 mt -88.63 124.45 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.868 -0.79 . . . . 74.44 108.868 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.616 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 39.0 m-85 -129.3 128.97 44.27 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.706 0.802 . . . . 74.04 109.522 -171.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.2 t -89.05 120.84 30.82 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.912 -0.774 . . . . 64.13 108.912 174.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.1 pt -95.84 129.24 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.437 0.695 . . . . 74.25 109.898 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.03 158.9 7.34 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.934 0.894 . . . . 71.41 111.164 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.18 -33.38 6.63 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 115.771 -0.649 . . . . 72.15 113.494 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.62 170.7 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.837 0.855 . . . . 72.3 109.905 -177.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.95 173.33 11.61 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.524 0.73 . . . . 70.14 109.449 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.28 -145.09 43.81 Favored Glycine 0 C--N 1.351 1.387 0 C-N-CA 122.648 0.166 . . . . 53.41 113.498 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.517 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 23.3 p -72.64 -14.85 61.69 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.802 0.841 . . . . 73.15 111.921 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -68.07 -38.36 82.3 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.968 -0.753 . . . . 70.44 108.968 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 38.1 ttp -82.93 -35.49 26.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.485 0.714 . . . . 70.15 111.054 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.517 ' HB1' ' HA ' ' A' ' 92' ' ' THR . . . -63.21 -26.5 68.83 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.942 0.497 . . . . 73.51 110.631 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -66.38 -50.35 63.78 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.502 1.121 . . . . 74.31 110.506 169.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 71.0 m -67.2 -27.31 67.15 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.852 0.461 . . . . 73.03 112.1 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.88 -41.82 12.95 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.14 0.976 . . . . 74.02 109.589 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.84 2.18 56.9 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-O 119.469 -0.628 . . . . 75.43 114.585 -171.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -138.37 -62.06 0.58 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.608 0.704 . . . . 73.02 111.262 -177.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -62.75 -49.72 73.91 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.729 0.812 . . . . 73.22 111.736 -175.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 89.6 m -71.1 -39.64 8.49 Favored Pre-proline 0 CA--C 1.571 1.76 0 N-CA-C 114.101 1.148 . . . . 62.13 114.101 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.38 -24.4 50.09 Favored 'Trans proline' 0 C--N 1.387 2.571 0 CA-C-N 121.742 1.658 . . . . 74.53 112.826 167.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -27.57 61.76 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.907 -0.405 . . . . 75.05 109.907 177.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.8 mm -60.25 -40.7 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.911 0.884 . . . . 73.44 109.818 170.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.5 mt -80.07 -17.22 53.25 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.066 0.947 . . . . 74.03 112.338 -175.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -63.75 -45.22 81.78 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 113.916 1.08 . . . . 71.44 113.916 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.46 -39.51 65.36 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 121.596 1.53 . . . . 73.34 112.701 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -69.47 -38.48 77.73 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.379 0.672 . . . . 75.14 111.085 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.613 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . -66.85 -41.73 86.87 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.816 -0.629 . . . . 63.24 110.39 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.561 ' HA ' HD21 ' A' ' 128' ' ' LEU . 40.9 ttm180 -54.78 -50.47 68.41 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 124.7 1.25 . . . . 74.13 110.29 177.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -63.65 -42.69 98.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.485 1.116 . . . . 73.32 111.397 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 117' ' ' MET . 27.6 t -60.93 -37.4 82.18 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 123.695 0.622 . . . . 71.35 110.61 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.61 -43.05 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.483 1.113 . . . . 74.42 110.561 176.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 125' ' ' GLN . 24.0 m -61.6 -33.99 74.86 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.731 0.776 . . . . 74.04 109.94 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.7 t -70.93 -40.09 72.27 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.712 -1.131 . . . . 74.33 109.864 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.585 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 18.4 mmt -59.08 -48.38 81.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.308 0.643 . . . . 74.21 111.626 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.1 m -68.13 -42.14 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 O-C-N 123.448 0.467 . . . . 74.34 111.43 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.9 m -69.01 -35.71 76.97 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.054 0.541 . . . . 72.22 111.692 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.506 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 95.2 mtt-85 -70.55 -35.19 72.98 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.896 0.479 . . . . 72.13 110.029 175.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.14 19.72 20.65 Favored Glycine 0 C--N 1.354 1.57 0 CA-C-O 119.14 -0.811 . . . . 75.05 114.32 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' B' ' 17' ' ' TYR . 2.4 t 61.4 10.73 3.3 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 127.16 2.184 . . . . 63.44 114.311 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -86.52 150.54 51.5 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 108.542 -0.91 . . . . 72.21 108.542 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.55 159.03 21.29 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.395 2.063 . . . . 74.13 112.2 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.409 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.1 tt0 -60.83 142.97 55.65 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.071 0.549 . . . . 72.03 112.308 -177.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.3 tp -128.15 121.8 30.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.117 0.967 . . . . 74.34 109.938 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -124.7 109.66 13.4 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.681 -0.859 . . . . 74.04 108.681 173.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.649 ' H ' HD22 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -73.23 126.34 29.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 109.101 -0.703 . . . . 75.42 109.101 173.662 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.13 151.22 27.1 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 124.895 1.278 . . . . 63.13 112.715 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 110.23 0.65 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.805 2.337 . . . . 73.14 112.54 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 81.7 t -99.37 113.09 33.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.072 -1.084 . . . . 75.02 108.072 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -85.27 81.65 8.7 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.433 -0.951 . . . . 73.5 108.433 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -56.27 -31.9 64.02 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.456 0.702 . . . . 72.3 111.407 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 9.8 t70 -63.31 -48.3 78.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.546 1.138 . . . . 73.3 110.706 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.69 92.61 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.994 0.918 . . . . 72.1 111.445 176.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.7 mt -69.53 -34.6 74.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.731 0.812 . . . . 70.02 111.878 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.96 -38.48 79.44 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.652 -0.87 . . . . 72.03 108.652 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 10.4 mmt . . . . . 0 CA--C 1.545 0.764 0 O-C-N 124.109 0.881 . . . . 75.22 111.195 177.129 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 85.0 m . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 108.544 -0.91 . . . . 64.21 108.544 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -114.42 143.25 45.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.215 0.606 . . . . 65.14 109.848 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -149.72 140.81 22.99 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.289 0.636 . . . . 75.34 109.749 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.64 123.49 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.75 -1.204 . . . . 65.23 107.75 172.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 14.0 mm100 -86.23 -50.65 6.81 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.233 -0.654 . . . . 75.41 109.233 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -170.12 133.24 1.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.508 -0.769 . . . . 74.51 109.704 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.04 138.76 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 107.87 -1.159 . . . . 74.32 107.87 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.413 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 33.7 p90 -165.11 164.65 20.27 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 122.304 1.049 . . . . 73.03 112.379 -177.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 74.3 m -87.73 130.08 34.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.938 -1.483 . . . . 73.41 108.063 169.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -98.02 -36.62 10.06 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.381 0.672 . . . . 72.02 110.302 178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -149.99 132.21 15.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.814 -0.63 . . . . 72.11 110.545 -170.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.45 HD12 HG21 ' B' ' 78' ' ' VAL . 48.8 mm -128.3 141.97 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.116 0.966 . . . . 75.43 108.553 171.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -142.34 130.67 22.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.227 -1.397 . . . . 73.41 107.227 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.404 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.0 t80 -144.99 109.85 5.06 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.585 -1.265 . . . . 74.51 107.585 170.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -120.89 123.42 42.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.54 -0.911 . . . . 72.03 108.54 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.96 87.16 2.25 Favored Pre-proline 0 C--O 1.242 0.68 0 N-CA-C 106.722 -1.584 . . . . 53.13 106.722 171.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.85 -36.1 19.26 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.639 2.226 . . . . 74.02 112.735 -165.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -110.83 22.25 15.57 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.86 0.864 . . . . 64.13 110.423 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.522 ' HB1' ' HD3' ' B' ' 29' ' ' PRO . . . -36.29 -64.93 0.34 Allowed Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 115.195 1.554 . . . . 54.22 115.195 -162.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.522 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 16.7 Cg_exo -66.21 -30.28 46.28 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 121.828 1.685 . . . . 75.44 112.682 -173.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.417 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 65.8 m80 -93.32 -15.87 25.29 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.373 -0.831 . . . . 74.42 112.284 -174.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.609 HG23 HD13 ' B' ' 68' ' ' LEU . 7.5 p -85.93 -30.12 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 117.93 0.332 . . . . 74.52 110.529 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -61.2 -19.54 61.73 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.742 0.817 . . . . 75.12 113.081 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.1 pt20 -64.85 -15.7 62.22 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.99 0.516 . . . . 75.43 111.594 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.621 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 94.3 mttt -99.57 97.58 8.55 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.109 0.964 . . . . 73.14 109.024 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -79.65 91.72 5.28 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.281 0.563 . . . . 74.05 109.796 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -164.36 159.81 20.13 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.322 1.049 . . . . 72.43 108.993 -174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.42 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 13.8 pm0 -82.52 109.74 17.93 Favored Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 109.217 -0.661 . . . . 72.21 109.217 173.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.507 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 35.3 Cg_endo -62.41 127.38 20.75 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.815 2.343 . . . . 64.24 113.074 -171.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -56.73 120.16 7.37 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.294 0.996 . . . . 74.31 110.969 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.458 HG13 HD12 ' B' ' 126' ' ' LEU . 29.6 m -96.18 163.03 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.159 -0.928 . . . . 72.41 113.19 -168.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.543 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 81.8 tttt -148.88 137.46 21.19 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.982 1.713 . . . . 75.24 107.512 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.25 131.41 52.74 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.119 -0.697 . . . . 73.35 109.119 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.557 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.8 t70 -124.29 110.71 14.95 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 106.697 -1.594 . . . . 73.43 106.697 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.98 129.26 56.68 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.832 -0.803 . . . . 74.21 108.832 -165.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 20.7 m-20 -130.65 112.79 13.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.035 0.534 . . . . 73.12 109.841 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 28.6 p -107.15 102.27 11.61 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.217 -1.031 . . . . 74.24 108.217 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.19 119.15 26.74 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.241 1.016 . . . . 73.23 109.321 -174.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.485 ' HB3' HG23 ' B' ' 58' ' ' VAL . 16.6 p -100.3 161.62 13.49 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.615 0.766 . . . . 73.01 109.931 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 81.2 p -151.07 137.21 18.35 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.5 0.72 . . . . 64.11 109.355 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -81.9 118.35 22.87 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.206 0.602 . . . . 74.42 109.788 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.17 -43.72 15.86 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.959 -0.756 . . . . 73.15 108.959 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.64 177.37 11.3 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.186 -1.37 . . . . 63.23 108.923 174.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.92 130.78 43.76 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.895 -0.78 . . . . 65.22 108.895 178.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 75.28 -4.45 2.37 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 125.056 1.343 . . . . 71.54 112.424 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -117.56 109.18 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.759 0.824 . . . . 75.41 109.332 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -125.56 138.61 53.96 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.401 -0.592 . . . . 74.35 109.401 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -119.07 107.09 13.07 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.092 -1.077 . . . . 72.32 108.092 -172.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' B' ' 48' ' ' SER . 85.8 t -94.3 135.13 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.991 0.916 . . . . 74.21 110.617 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.15 130.08 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.385 -0.969 . . . . 74.33 108.385 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.84 112.81 23.34 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.112 -1.07 . . . . 74.34 108.112 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.4 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 36.8 ttm180 -99.83 127.49 45.99 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.412 0.685 . . . . 73.12 109.829 173.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.456 ' HB ' HD11 ' B' ' 114' ' ' ILE . 46.0 t -123.12 102.64 11.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 106.67 -1.604 . . . . 75.42 106.67 167.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.5 m -99.44 126.25 45.32 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.346 -0.613 . . . . 75.32 109.346 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.556 HG22 HG21 ' B' ' 114' ' ' ILE . 60.3 t -108.94 105.43 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 123.298 0.639 . . . . 70.31 109.721 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 42.0 m -84.02 137.42 33.61 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.966 -1.124 . . . . 62.22 107.966 167.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.434 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -149.02 143.43 26.09 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.51 0.324 . . . . 54.3 110.182 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 49.4 p -146.0 134.23 21.7 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.579 0.549 . . . . 71.21 111.373 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.609 HD13 HG23 ' B' ' 31' ' ' VAL . 39.2 mt -93.35 109.94 21.49 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.511 -0.922 . . . . 62.21 108.511 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.67 -108.8 2.6 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.866 -1.061 . . . . 71.03 111.713 -170.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.95 3.97 10.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.045 0.938 . . . . 75.53 111.905 -175.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.621 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 10.5 pt-20 -115.03 149.78 36.92 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.436 -0.579 . . . . 74.53 109.436 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.2 m -67.31 133.26 49.33 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.936 0.398 . . . . 54.35 111.161 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.471 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -90.46 -64.07 1.19 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.962 -1.017 . . . . 74.53 109.234 176.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -150.02 154.68 38.6 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.316 -0.856 . . . . 73.34 110.393 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.0 mt -128.79 110.77 12.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.669 -1.604 . . . . 74.45 106.669 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.9 t -117.57 155.69 29.38 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.856 -0.794 . . . . 75.22 108.856 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -163.55 130.67 3.39 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.836 -0.801 . . . . 74.54 108.836 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.45 HG21 HD12 ' B' ' 21' ' ' ILE . 88.3 t -124.07 141.32 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.593 -0.891 . . . . 73.32 108.593 172.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -123.04 88.42 2.92 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.89 -0.782 . . . . 64.13 108.89 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -79.76 100.82 8.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.141 -0.936 . . . . 72.13 109.102 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.31 143.69 16.88 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.744 -0.542 . . . . 74.42 111.744 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.546 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -145.81 127.13 2.72 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.135 -0.786 . . . . 70.51 111.135 -172.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 14.3 mt -91.2 129.68 41.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 123.918 0.887 . . . . 72.01 108.617 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -137.71 133.68 34.47 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.889 -0.782 . . . . 63.35 108.889 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.8 m -93.42 109.19 20.77 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.953 -0.758 . . . . 71.3 108.953 172.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 pt -112.92 117.83 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.228 1.011 . . . . 71.22 109.118 -174.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.549 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -129.84 152.72 49.02 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.18 0.592 . . . . 61.21 110.791 -175.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.43 -60.22 4.32 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.824 0.702 . . . . 73.31 112.522 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -67.12 145.29 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.351 0.661 . . . . 74.33 112.391 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.402 ' HA ' ' HB3' ' B' ' 94' ' ' MET . 16.2 tt0 -166.32 174.51 9.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.186 0.595 . . . . 74.54 109.561 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.6 -112.29 3.91 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 112.217 -0.353 . . . . 75.55 112.217 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' B' ' 95' ' ' ALA . 31.6 m -78.13 -29.53 48.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.142 0.496 . . . . 74.4 110.742 176.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -69.99 -33.81 72.53 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.34 -0.391 . . . . 74.02 110.575 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.402 ' HB3' ' HA ' ' B' ' 90' ' ' GLU . 0.0 OUTLIER -74.86 -30.81 61.46 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.957 -0.565 . . . . 71.25 110.212 178.391 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' B' ' 92' ' ' THR . . . -59.83 -38.45 82.05 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.45 0.7 . . . . 74.52 110.032 171.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -76.08 -36.31 59.01 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.284 1.034 . . . . 71.35 111.608 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.64 -57.36 6.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 123.593 0.558 . . . . 65.13 109.846 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.3 mp -79.62 -15.83 56.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.94 0.496 . . . . 75.22 111.521 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.39 -15.02 48.98 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.41 0.524 . . . . 65.24 114.41 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.35 -56.74 0.32 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 117.341 0.57 . . . . 64.23 111.879 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -68.5 -52.56 30.97 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.835 0.854 . . . . 73.52 112.001 -167.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.414 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 92.2 m -63.04 -49.07 83.05 Favored Pre-proline 0 CA--C 1.565 1.542 0 C-N-CA 124.319 1.047 . . . . 74.31 112.13 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.0 Cg_exo -58.49 -34.07 98.48 Favored 'Trans proline' 0 C--N 1.398 3.15 0 C-N-CA 122.095 1.864 . . . . 74.33 113.559 171.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.24 -37.62 83.72 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.374 0.67 . . . . 75.25 111.747 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 45.4 mt -63.9 -41.72 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.843 0.857 . . . . 73.41 110.759 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.546 HD21 ' HA3' ' B' ' 82' ' ' GLY . 51.2 mt -80.19 -19.91 45.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.348 1.059 . . . . 63.44 112.311 -173.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -59.7 -49.38 92.1 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.278 1.214 . . . . 75.51 114.278 -171.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -61.67 -33.7 85.58 Favored 'Trans proline' 0 C--N 1.381 2.258 0 CA-C-N 121.452 1.554 . . . . 73.34 112.618 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.411 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 84.5 m-85 -68.06 -46.0 72.3 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 123.662 0.601 . . . . 74.35 110.087 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.25 -47.1 84.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.521 0.729 . . . . 73.24 110.22 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -54.26 -55.36 28.97 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.129 1.372 . . . . 75.32 111.581 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.02 -35.04 79.48 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.854 0.721 . . . . 75.01 110.389 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.506 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 6.8 t -69.03 -37.63 78.73 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.95 -0.568 . . . . 74.32 111.227 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.556 HG21 HG22 ' B' ' 64' ' ' VAL . 58.5 mt -63.2 -55.33 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.715 -0.476 . . . . 74.14 109.715 174.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.509 HG22 ' OG ' ' C' ' 119' ' ' SER . 18.9 m -59.0 -34.01 71.36 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 124.468 1.105 . . . . 74.42 111.404 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.5 t -57.98 -52.21 66.46 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.423 -0.808 . . . . 75.24 109.503 174.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 9.9 mmt -66.83 -38.19 85.95 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.333 0.653 . . . . 74.44 111.748 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 114' ' ' ILE . 91.2 t -58.9 -46.12 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.087 0.955 . . . . 73.32 110.303 176.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 45.3 t -70.99 -33.06 70.05 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.605 -1.18 . . . . 74.23 111.433 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' B' ' 116' ' ' SER . 90.8 mtt-85 -63.84 -36.84 85.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.106 0.563 . . . . 74.44 110.089 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.1 14.32 53.94 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-O 119.43 -0.65 . . . . 73.31 113.322 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 82.5 p 55.93 26.9 10.35 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.917 1.687 . . . . 73.1 113.636 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -87.06 153.01 54.07 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 123.609 0.764 . . . . 74.22 110.55 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.42 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 89.1 Cg_exo -51.55 161.06 2.16 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 124.17 3.247 . . . . 72.44 115.271 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.441 HE21 ' ND2' ' B' ' 127' ' ' ASN . 63.7 tp60 -63.05 140.56 58.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.925 0.89 . . . . 74.53 111.982 -171.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.551 HD23 HG13 ' B' ' 64' ' ' VAL . 13.7 tp -146.05 117.67 8.07 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.906 -0.588 . . . . 75.12 109.433 -173.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.441 ' ND2' HE21 ' B' ' 125' ' ' GLN . 26.4 m-80 -130.98 135.12 47.34 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.422 0.689 . . . . 74.35 110.06 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.73 130.87 34.31 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.825 0.85 . . . . 72.13 110.012 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.75 152.53 59.89 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.247 1.019 . . . . 63.54 111.285 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.436 ' HB2' HD13 ' D' ' 13' ' ' ILE . 20.5 Cg_exo -65.94 133.58 34.09 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.701 2.267 . . . . 74.01 112.81 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.1 t -121.22 115.12 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.126 -1.064 . . . . 73.34 108.126 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . 0.418 ' ND2' ' HB3' ' B' ' 135' ' ' ALA . 64.1 t30 -80.45 82.23 6.53 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 109.684 -0.487 . . . . 75.12 109.684 -178.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -60.15 -27.24 66.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.882 0.873 . . . . 74.31 111.325 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -54.6 -47.74 73.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.986 1.314 . . . . 72.44 111.365 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.418 ' HB3' ' ND2' ' B' ' 132' ' ' ASN . . . -66.87 -37.95 85.41 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.706 -0.679 . . . . 64.55 111.274 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.19 -19.06 60.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.551 0.74 . . . . 74.35 111.317 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 66.3 t80 . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 122.932 0.493 . . . . 73.33 111.51 -176.517 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 108.268 -1.012 . . . . 52.13 108.268 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.5 ' HD1' ' HH ' ' C' ' 101' ' ' TYR . 1.7 t80 -118.77 126.69 52.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.413 0.685 . . . . 64.43 109.743 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -146.59 133.58 20.28 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 109.111 -0.7 . . . . 73.4 109.111 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -71.95 118.73 17.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.351 -0.981 . . . . 75.23 108.351 170.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.628 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 29.8 mm-40 -83.49 -49.22 9.49 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.415 0.447 . . . . 71.43 109.969 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -169.51 127.15 0.93 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 116.382 -0.372 . . . . 75.52 110.524 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -107.85 148.76 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 107.867 -1.161 . . . . 73.33 107.867 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.419 ' CE2' ' HG2' ' C' ' 19' ' ' LYS . 32.1 p90 -174.53 167.8 3.85 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.401 0.619 . . . . 74.44 111.223 -174.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.1 p -96.55 111.62 23.68 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.135 -1.061 . . . . 64.14 108.135 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.419 ' HG2' ' CE2' ' C' ' 17' ' ' TYR . 19.0 mttt -68.77 -47.6 65.79 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.812 -1.181 . . . . 71.33 107.812 170.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.631 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.2 t70 -133.55 139.68 46.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 113.558 -1.655 . . . . 65.23 109.69 -169.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 75.6 mt -140.97 143.78 27.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.898 -1.89 . . . . 72.23 105.898 174.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.0 t -158.09 148.46 20.42 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.278 -0.638 . . . . 72.41 109.278 173.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -147.64 130.95 16.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.122 -1.436 . . . . 70.2 107.122 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -133.47 126.47 31.2 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.001 0.52 . . . . 64.34 109.731 -176.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.39 80.86 18.56 Favored Pre-proline 0 C--O 1.242 0.705 0 N-CA-C 106.683 -1.599 . . . . 74.42 106.683 168.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.48 -12.49 29.5 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.73 2.286 . . . . 64.53 112.083 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -121.11 25.0 9.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.474 1.51 . . . . 72.43 109.628 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.447 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -46.38 -55.78 12.94 Favored Pre-proline 0 CA--C 1.563 1.46 0 N-CA-C 114.093 1.146 . . . . 71.44 114.093 -168.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 51.4 Cg_exo -56.67 -41.24 77.87 Favored 'Trans proline' 0 C--N 1.385 2.485 0 CA-C-N 121.829 1.689 . . . . 75.0 112.888 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -69.3 -33.76 73.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.082 -0.508 . . . . 74.43 112.091 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.4 p -79.03 -24.52 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 112.716 0.636 . . . . 75.15 112.716 176.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -67.34 -30.64 70.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.877 -0.514 . . . . 74.55 112.278 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -87.5 34.11 0.7 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.245 0.618 . . . . 72.25 111.071 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.404 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.1 OUTLIER -124.54 153.8 41.56 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.568 0.747 . . . . 73.41 111.534 -172.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.5 118.06 13.84 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.709 -0.849 . . . . 73.55 108.709 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -77.8 99.15 5.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.438 0.695 . . . . 73.11 110.681 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -156.21 74.6 4.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.851 -0.796 . . . . 63.42 108.851 171.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -92.36 161.76 3.04 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.882 2.388 . . . . 75.34 114.029 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.37 95.38 10.18 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.766 -1.198 . . . . 63.23 107.766 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.4 t -80.26 98.48 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 115.358 -0.837 . . . . 74.15 109.841 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -106.77 110.11 22.19 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.405 -0.961 . . . . 74.22 108.405 174.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 mp -85.77 144.65 27.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.249 -1.76 . . . . 74.12 106.249 167.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -123.88 111.94 16.66 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.708 -0.849 . . . . 73.22 108.708 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 90.8 mt -93.88 142.01 27.86 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.082 0.553 . . . . 72.0 110.032 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.2 t70 -157.79 161.14 38.4 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.65 1.18 . . . . 71.21 108.343 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.1 t -146.57 135.0 21.95 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.028 0.442 . . . . 72.42 110.491 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.83 156.25 32.33 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.221 1.008 . . . . 72.02 108.738 172.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.458 ' HB2' ' CE2' ' C' ' 56' ' ' TYR . 63.8 p -160.74 151.99 19.1 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.334 0.253 . . . . 74.44 111.563 -173.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -161.21 142.66 11.7 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.847 0.859 . . . . 73.55 110.307 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.24 136.34 39.68 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.776 -0.453 . . . . 72.54 109.776 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.599 HD12 ' HB2' ' C' ' 57' ' ' GLU . 39.8 mt -108.95 -44.97 3.87 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.346 0.658 . . . . 74.32 109.701 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.41 -173.07 3.84 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.669 -0.696 . . . . 71.11 111.045 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -67.86 108.59 3.05 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.136 -0.938 . . . . 74.44 110.392 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 63.42 24.65 14.24 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.792 1.237 . . . . 70.34 111.512 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.29 114.47 45.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.361 -0.977 . . . . 74.23 108.361 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' C' ' 48' ' ' SER . 35.5 t80 -126.22 124.99 41.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.564 -0.902 . . . . 74.12 108.564 -176.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.599 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.9 tt0 -82.09 141.64 32.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.027 -0.988 . . . . 74.32 109.929 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.28 142.22 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.487 1.115 . . . . 70.25 108.196 169.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.08 133.33 60.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.836 -0.801 . . . . 65.42 108.836 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.43 114.88 29.33 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.911 -1.144 . . . . 75.34 107.911 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 41.5 ttm-85 -99.29 117.53 33.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.033 -0.729 . . . . 74.42 109.033 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.4 t -118.57 133.57 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.299 -1.001 . . . . 75.22 108.299 172.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 14.8 m -131.55 114.85 15.36 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.258 -0.645 . . . . 72.43 109.258 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.526 HG11 HD21 ' C' ' 126' ' ' LEU . 21.8 t -99.51 128.84 50.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.847 -0.798 . . . . 73.45 108.847 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.1 m -122.87 140.4 53.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.803 -1.184 . . . . 74.53 107.803 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . 0.435 ' HB3' ' HB1' ' C' ' 73' ' ' ALA . . . -132.03 113.13 13.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.763 -1.199 . . . . 71.31 107.763 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.2 m -113.69 122.58 47.57 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.356 0.598 . . . . 74.13 110.173 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.4 HD11 ' HG2' ' C' ' 34' ' ' LYS . 18.7 mt -92.1 24.63 3.2 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.042 1.337 . . . . 75.32 109.52 175.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.1 -108.52 2.6 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 110.569 -1.012 . . . . 71.43 110.569 -170.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.63 -27.37 20.22 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.587 0.755 . . . . 73.33 110.276 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.404 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 7.5 tp10 -79.42 119.26 22.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.685 0.794 . . . . 74.13 109.331 174.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 39.4 m -87.53 130.81 34.59 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.159 -0.682 . . . . 74.0 109.159 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.585 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.79 -61.61 1.75 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.249 0.619 . . . . 74.22 110.613 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -156.92 170.52 22.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.54 -0.755 . . . . 74.35 110.858 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -142.47 116.82 9.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.216 -1.401 . . . . 71.2 107.216 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.43 ' SG ' HG21 ' C' ' 114' ' ' ILE . 48.9 t -124.78 119.35 28.64 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.079 0.552 . . . . 74.04 109.751 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -121.94 125.67 46.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.684 0.394 . . . . 71.04 110.019 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.87 137.19 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.01 0.924 . . . . 65.5 108.817 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.631 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.9 mt-30 -115.56 95.41 5.14 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.635 -0.876 . . . . 74.03 108.635 172.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -79.71 100.25 7.8 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.626 -1.17 . . . . 74.21 110.081 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.45 149.34 27.32 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 116.194 -0.457 . . . . 75.55 112.071 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.481 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -157.03 122.2 1.15 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 111.713 -0.555 . . . . 72.22 111.713 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.628 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.9 mm -88.99 124.52 41.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.788 -0.819 . . . . 75.23 108.788 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.492 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 53.0 m-85 -131.44 118.82 20.75 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.074 0.549 . . . . 74.41 109.945 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 66.8 m -80.9 118.72 22.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.777 -0.823 . . . . 75.5 108.777 171.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 pp -135.05 141.32 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.849 0.86 . . . . 74.23 110.119 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.0 142.87 17.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.176 0.59 . . . . 53.41 110.522 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.94 -23.43 35.65 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.506 0.504 . . . . 75.23 114.264 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.461 HD11 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -89.82 153.55 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.451 0.7 . . . . 73.24 110.813 178.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -160.06 -179.07 7.46 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.344 -0.844 . . . . 72.54 110.221 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.85 -112.44 3.81 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.864 0.728 . . . . 52.24 114.249 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 21.2 p -68.89 -43.02 76.14 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.178 0.991 . . . . 72.3 111.292 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.47 -37.44 85.13 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.856 -0.611 . . . . 73.44 111.418 -174.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -72.86 -39.96 66.07 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 110.364 -0.235 . . . . 74.35 110.364 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.13 -44.27 92.04 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 123.533 0.52 . . . . 74.44 110.81 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -80.39 -34.05 36.61 Favored 'General case' 0 C--O 1.245 0.864 0 O-C-N 123.411 0.444 . . . . 73.54 112.128 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.467 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 42.4 t -59.3 -37.16 77.03 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 123.425 0.453 . . . . 72.53 110.101 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 32.1 mt -93.94 -22.83 18.34 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.866 0.866 . . . . 75.11 111.033 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -31.65 57.98 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 115.077 0.791 . . . . 72.14 115.077 -172.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.65 -35.43 0.05 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.217 0.451 . . . . 61.21 112.217 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.5 ' HH ' ' HD1' ' C' ' 11' ' ' PHE . 45.5 t80 -60.18 -50.96 71.61 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.442 1.497 . . . . 71.52 112.567 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 61.4 m -75.41 -44.24 4.37 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-O 118.319 -0.848 . . . . 52.4 112.258 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -53.91 -26.71 41.13 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 122.001 1.801 . . . . 72.41 113.66 170.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -68.33 -34.91 76.97 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.514 0.725 . . . . 74.23 111.166 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -64.01 -36.51 77.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.356 0.662 . . . . 72.43 109.983 175.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.481 HD21 ' HA3' ' C' ' 82' ' ' GLY . 63.4 mt -84.94 -15.3 44.85 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.058 . . . . 71.52 112.265 -176.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.33 -48.57 90.88 Favored Pre-proline 0 CA--C 1.56 1.36 0 N-CA-C 114.115 1.154 . . . . 74.11 114.115 -173.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.82 -33.13 76.89 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 121.877 1.718 . . . . 71.3 112.767 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -71.5 -46.69 59.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.612 -0.722 . . . . 71.21 110.327 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.23 -41.9 76.43 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 115.321 -0.854 . . . . 64.24 109.847 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -56.21 -60.34 3.64 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.47 1.106 . . . . 74.41 111.718 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.02 -29.08 68.79 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.941 0.496 . . . . 70.04 111.237 -173.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 24.3 t -69.95 -35.87 74.84 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.009 0.524 . . . . 75.31 111.219 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' C' ' 62' ' ' VAL . 94.9 mt -72.92 -47.24 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.631 0.772 . . . . 74.41 110.036 174.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.0 m -61.0 -34.58 75.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.022 0.929 . . . . 75.54 111.125 -177.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -62.49 -51.72 66.32 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 115.351 -0.84 . . . . 72.43 109.59 174.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.564 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.46 -35.56 76.16 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.626 1.17 . . . . 72.32 112.867 -179.074 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 68.3 t -67.1 -44.99 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.548 0.739 . . . . 74.42 110.465 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.509 ' OG ' HG22 ' B' ' 115' ' ' THR . 47.3 t -66.8 -31.35 71.92 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.733 -0.667 . . . . 71.43 111.186 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -67.29 -46.06 74.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.414 0.686 . . . . 74.31 109.391 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.21 -0.8 67.13 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.683 0.614 . . . . 65.04 113.24 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 34.2 p 64.6 27.96 13.27 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.742 2.017 . . . . 75.31 114.19 170.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -83.73 155.67 65.04 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.529 0.731 . . . . 75.53 109.737 172.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -53.16 173.58 0.15 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 124.072 3.181 . . . . 75.5 115.573 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -55.6 132.97 50.13 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.728 1.211 . . . . 70.43 112.851 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.526 HD21 HG11 ' C' ' 64' ' ' VAL . 17.4 tp -135.14 102.48 5.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.929 -1.137 . . . . 73.04 107.929 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -123.42 126.81 47.46 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.105 0.562 . . . . 73.23 110.221 -175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mp -77.01 117.11 18.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.312 0.645 . . . . 72.04 109.379 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.79 162.36 58.82 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.507 1.123 . . . . 75.12 111.506 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.562 ' HG3' HD13 ' A' ' 16' ' ' ILE . 51.2 Cg_exo -55.19 103.61 0.11 Allowed 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.407 2.071 . . . . 71.3 112.152 169.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 89.0 t -97.99 113.24 32.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.57 0.748 . . . . 75.35 109.533 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -90.68 59.81 4.32 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.669 0.747 . . . . 64.35 110.025 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.415 ' HD1' ' H ' ' C' ' 133' ' ' PHE . 1.2 p90 -78.44 -14.21 59.48 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.214 -0.903 . . . . 64.41 110.066 175.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -75.47 -49.04 20.03 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.642 0.777 . . . . 71.45 109.818 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.66 74.17 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.524 -0.762 . . . . 73.32 110.622 174.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.17 -42.8 83.65 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.311 -0.859 . . . . 71.13 110.415 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 16.9 t80 . . . . . 0 N--CA 1.487 1.423 0 C-N-CA 122.488 0.315 . . . . 71.5 110.81 179.762 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.546 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 94.3 m . . . . . 0 C--O 1.24 0.559 0 N-CA-C 109.749 -0.463 . . . . 71.3 109.749 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -151.81 88.21 1.39 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.297 -1.372 . . . . 74.31 107.297 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -114.05 121.84 45.08 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.103 -1.073 . . . . 74.55 108.103 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' B' ' 130' ' ' PRO . 9.4 mt -86.98 128.47 39.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 116.213 -0.449 . . . . 65.12 110.117 -171.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.41 ' NE2' HG21 ' D' ' 83' ' ' ILE . 51.0 mt-30 -90.79 -39.74 12.2 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.437 0.695 . . . . 74.4 112.096 -173.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -175.08 122.19 0.22 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 112.219 0.452 . . . . 71.21 112.219 -167.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.422 HD13 ' HG2' ' B' ' 130' ' ' PRO . 1.5 mp -108.9 134.23 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.708 -0.849 . . . . 75.15 108.708 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.494 ' HE1' HG13 ' D' ' 83' ' ' ILE . 27.8 p90 -159.65 159.43 33.05 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 124.16 0.912 . . . . 75.31 110.487 -172.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -94.78 114.24 26.11 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.638 -0.71 . . . . 72.23 109.552 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.452 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 3.8 mtpp -77.84 -26.71 49.63 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.23 -0.656 . . . . 75.14 109.23 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.457 ' HB3' HE21 ' D' ' 79' ' ' GLN . 20.2 t70 -160.74 144.74 13.71 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.847 -1.069 . . . . 74.15 109.864 177.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.564 HG21 ' HE1' ' C' ' 117' ' ' MET . 68.0 mt -140.16 148.62 22.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 125.549 1.54 . . . . 74.32 107.388 174.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 26.9 t -156.08 119.44 4.3 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.226 0.61 . . . . 71.4 109.612 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -125.63 118.38 25.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.849 1.26 . . . . 75.31 107.879 173.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -124.16 135.96 53.86 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.124 -0.695 . . . . 74.12 109.124 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.48 86.36 39.21 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.442 -1.318 . . . . 70.34 107.442 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -66.61 -39.04 16.84 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.803 2.336 . . . . 72.3 113.115 -170.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 82.1 m-20 -101.3 17.33 22.86 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.869 0.868 . . . . 72.23 110.732 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.24 -70.81 0.12 Allowed Pre-proline 0 CA--C 1.562 1.424 0 N-CA-C 115.69 1.737 . . . . 61.43 115.69 -162.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.406 ' HB3' HD11 ' C' ' 83' ' ' ILE . 56.5 Cg_endo -76.69 -18.79 14.96 Favored 'Trans proline' 0 C--N 1.382 2.328 0 CA-C-N 123.531 2.297 . . . . 62.2 113.198 -172.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.439 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 11.2 t-160 -68.1 -47.64 67.65 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.794 1.238 . . . . 73.21 109.347 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.556 HG22 ' HA ' ' D' ' 73' ' ' ALA . 8.6 p -83.17 -20.21 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.241 1.016 . . . . 74.12 111.838 -172.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -63.52 -32.19 73.57 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.175 0.512 . . . . 71.41 111.431 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -67.42 -10.48 51.75 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.969 -1.014 . . . . 71.32 111.544 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.427 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 5.1 ttmt -96.17 84.74 3.84 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.119 0.967 . . . . 73.44 109.17 173.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.89 82.79 5.91 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.679 0.792 . . . . 71.31 109.866 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.4 t-105 -147.46 163.1 37.59 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.821 0.848 . . . . 75.12 109.665 -175.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -70.95 109.26 4.86 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.474 1.11 . . . . 75.54 110.438 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.39 144.04 25.44 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.795 2.33 . . . . 74.01 112.242 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -90.03 135.62 33.54 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.874 -0.787 . . . . 75.35 108.874 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.533 ' HB ' HG13 ' D' ' 64' ' ' VAL . 32.9 m -105.78 127.67 60.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 123.045 0.538 . . . . 75.34 109.555 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -87.42 114.03 23.66 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.923 -1.51 . . . . 74.43 106.923 172.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.458 HD13 ' O ' ' D' ' 42' ' ' LEU . 2.9 pp -94.75 117.81 30.73 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.011 0.91 . . . . 75.33 109.28 -174.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -122.96 112.54 17.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.726 -1.583 . . . . 73.41 106.726 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.93 152.34 22.09 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.159 0.584 . . . . 72.44 109.712 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.0 t70 -151.02 156.28 40.81 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.756 1.222 . . . . 74.24 108.367 174.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -138.95 156.71 47.03 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.372 0.669 . . . . 74.41 109.464 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.405 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -158.47 177.86 10.78 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.283 0.633 . . . . 72.21 110.282 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.6 p -163.19 164.82 25.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.485 0.714 . . . . 62.55 111.2 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 91.1 p -156.36 132.71 10.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.402 1.081 . . . . 54.32 108.744 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -86.37 117.99 25.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.404 -0.591 . . . . 73.21 109.404 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.08 -25.42 16.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.084 0.554 . . . . 72.32 110.629 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.49 -178.68 5.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.392 1.077 . . . . 74.22 109.496 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.49 137.05 49.92 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.88 -0.785 . . . . 73.42 108.88 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 61.2 10.8 3.16 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.095 0.958 . . . . 72.23 112.772 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -123.78 124.79 70.03 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 C-N-CA 124.63 1.172 . . . . 62.21 108.47 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.54 ' HD2' HD13 ' D' ' 86' ' ' ILE . 8.1 m-85 -128.29 158.59 37.76 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.399 -0.963 . . . . 75.43 108.399 171.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -125.9 128.04 46.95 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 105.729 -1.952 . . . . 72.55 105.729 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.45 141.23 31.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.598 -0.89 . . . . 73.21 108.598 -174.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 48.2 t -121.3 134.04 65.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 O-C-N 123.852 0.72 . . . . 74.04 109.136 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.489 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -117.49 121.89 42.23 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.18 -1.415 . . . . 74.35 107.18 174.139 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.558 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 15.7 ttm-85 -105.6 102.65 12.1 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.765 -0.828 . . . . 73.04 108.765 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 71.9 t -99.76 113.39 34.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.549 -0.908 . . . . 63.14 108.549 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 11.8 m -114.61 134.36 55.11 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.263 0.625 . . . . 73.03 109.377 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.533 HG13 ' HB ' ' D' ' 40' ' ' VAL . 78.8 t -131.67 102.44 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.344 1.457 . . . . 74.22 108.623 -171.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 96.5 m -103.36 95.8 6.33 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.323 -0.991 . . . . 74.23 108.323 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.56 159.94 14.62 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.059 0.456 . . . . 63.13 111.843 -172.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.421 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 53.3 p -145.47 142.93 29.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.135 -0.939 . . . . 72.12 110.912 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.449 HD11 HG21 ' D' ' 31' ' ' VAL . 14.9 mt -113.09 114.59 27.06 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.597 1.159 . . . . 64.41 108.711 169.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.96 -112.39 4.55 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.672 0.608 . . . . 63.3 112.857 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -106.94 3.75 26.49 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.289 0.636 . . . . 74.34 112.092 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.427 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.4 pt-20 -135.81 167.6 20.86 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.654 0.381 . . . . 74.43 110.677 -172.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.0 m -70.06 132.18 45.47 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.608 -0.724 . . . . 74.2 110.942 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.556 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -90.32 -76.46 0.43 Allowed 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.913 -1.143 . . . . 73.3 107.913 174.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -142.22 136.84 30.28 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 121.242 0.544 . . . . 72.45 111.641 -176.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 63.3 mt -104.34 140.29 38.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.124 1.369 . . . . 71.52 107.63 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.666 ' SG ' HG12 ' D' ' 114' ' ' ILE . 50.5 t -154.15 143.09 21.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.038 0.535 . . . . 71.13 109.615 -175.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -155.89 131.84 9.91 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.262 -1.014 . . . . 75.33 108.262 172.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.0 t -131.94 114.78 25.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.248 -0.649 . . . . 74.53 109.248 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.457 HE21 ' HB3' ' D' ' 20' ' ' ASP . 5.0 mt-30 -88.17 82.48 7.12 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.094 -1.076 . . . . 75.14 108.094 169.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -79.86 96.43 6.34 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.694 -1.594 . . . . 71.14 108.744 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.11 164.24 25.92 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.132 -0.486 . . . . 55.35 112.075 177.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.2 135.06 3.71 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 112.562 -0.215 . . . . 73.22 112.562 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.494 HG13 ' HE1' ' D' ' 17' ' ' TYR . 45.3 mt -89.79 129.66 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.343 1.057 . . . . 74.0 108.875 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -129.84 147.21 51.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.395 1.078 . . . . 75.4 110.321 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.1 m -108.01 109.78 21.33 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.555 -0.906 . . . . 74.22 108.555 171.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.54 HD13 ' HD2' ' D' ' 56' ' ' TYR . 19.2 pt -115.94 136.64 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.529 0.732 . . . . 74.4 110.942 -173.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.546 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -154.54 159.54 40.99 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.195 0.998 . . . . 75.34 109.115 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.01 -12.37 30.78 Favored Glycine 0 N--CA 1.478 1.457 0 N-CA-C 114.257 0.463 . . . . 75.14 114.257 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.6 pt -123.09 142.1 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.424 1.089 . . . . 74.41 109.165 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 6.3 pt-20 -165.83 164.55 18.66 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.506 0.722 . . . . 74.51 110.781 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.89 -114.72 7.11 Favored Glycine 0 C--N 1.354 1.56 0 O-C-N 123.851 0.719 . . . . 75.4 112.254 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.9 m -67.85 -37.79 82.3 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.492 0.717 . . . . 73.34 110.421 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -70.22 -28.78 65.54 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.602 0.761 . . . . 75.1 112.572 -177.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.51 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 18.5 tmm? -83.54 -32.03 26.08 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.25 -0.278 . . . . 73.04 110.25 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 -33.92 76.92 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.276 0.56 . . . . 72.45 110.379 169.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . 0.415 ' O ' ' HB1' ' D' ' 100' ' ' ALA . 14.1 t-80 -73.58 -20.28 60.66 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.994 1.317 . . . . 74.44 111.14 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -88.01 -53.83 4.54 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.435 0.294 . . . . 64.33 110.712 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.428 HD11 ' SD ' ' D' ' 94' ' ' MET . 9.8 mp -74.57 -32.92 62.55 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.659 0.783 . . . . 75.13 111.77 -173.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.19 14.54 61.13 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 119.072 -0.849 . . . . 75.32 113.311 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' D' ' 96' ' ' HIS . . . -157.58 -69.66 0.1 Allowed 'General case' 0 C--N 1.356 0.871 0 CA-C-N 118.212 1.006 . . . . 71.23 112.846 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -68.14 -39.61 82.62 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.818 0.447 . . . . 73.42 112.057 -171.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 74.8 m -69.5 -46.3 26.73 Favored Pre-proline 0 CA--C 1.557 1.242 0 CA-C-O 118.372 -0.823 . . . . 73.52 111.516 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.489 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 97.9 Cg_exo -51.29 -36.97 58.94 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 122.314 2.01 . . . . 75.22 113.373 165.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -65.83 -29.81 70.33 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.025 0.53 . . . . 75.14 111.792 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -68.96 -44.81 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.521 -0.548 . . . . 73.33 109.521 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -77.05 -14.98 59.75 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.99 -1.005 . . . . 74.31 112.021 -173.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -73.73 -40.1 4.94 Favored Pre-proline 0 CA--C 1.561 1.395 0 N-CA-C 113.924 1.083 . . . . 62.33 113.924 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.7 -39.35 88.38 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 121.742 1.628 . . . . 74.34 112.782 169.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -72.67 -35.33 67.68 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.612 0.765 . . . . 73.31 110.985 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.1 -51.46 67.81 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.657 -0.701 . . . . 73.42 109.359 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.483 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 29.7 ttp-105 -54.34 -50.24 67.87 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.794 1.309 . . . . 73.22 110.874 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -64.11 -46.04 85.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.861 0.865 . . . . 71.45 111.898 -173.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.7 t -59.47 -40.42 86.86 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.994 0.809 . . . . 75.02 110.507 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.666 HG12 ' SG ' ' D' ' 76' ' ' CYS . 95.4 mt -63.01 -56.06 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.111 0.964 . . . . 75.51 110.35 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -55.36 -37.01 66.95 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.574 1.15 . . . . 64.11 111.376 -174.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.4 t -68.73 -46.23 69.43 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.009 -0.996 . . . . 73.4 110.144 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.8 mtm -68.21 -29.24 68.03 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.783 0.433 . . . . 71.22 111.897 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' D' ' 123' ' ' PHE . 54.7 t -68.7 -41.75 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.788 0.835 . . . . 63.54 110.266 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.6 p -74.88 -32.11 61.77 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.615 0.366 . . . . 64.3 110.909 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -70.43 -34.8 72.88 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.469 0.708 . . . . 75.13 109.82 174.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.51 5.61 82.89 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 115.345 -0.843 . . . . 64.5 112.537 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 26.6 p 63.04 16.32 9.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.407 1.883 . . . . 75.0 114.84 171.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.434 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.8 m-85 -80.71 153.82 73.22 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.462 0.705 . . . . 75.13 109.292 170.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.02 141.83 94.08 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.73 2.287 . . . . 71.42 113.083 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.76 134.92 47.85 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.865 1.266 . . . . 74.24 112.555 -174.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -110.01 107.13 16.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.109 -1.071 . . . . 75.33 108.109 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -99.22 89.06 4.1 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.911 -0.774 . . . . 74.24 108.911 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.483 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 44.0 tp -70.53 115.83 10.15 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.936 -1.029 . . . . 75.11 109.787 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.96 133.44 87.14 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 123.459 0.704 . . . . 70.4 111.396 -176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.71 113.35 2.71 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.626 2.217 . . . . 63.43 111.161 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 61.1 t -106.43 128.11 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.532 0.733 . . . . 74.14 109.045 -175.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -78.29 98.23 5.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.529 0.732 . . . . 73.42 109.713 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -63.46 -22.42 66.88 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.169 0.588 . . . . 73.32 111.855 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' D' ' 100' ' ' ALA . 10.9 m-20 -61.87 -48.56 79.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.321 0.648 . . . . 72.4 111.689 177.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.41 -45.77 89.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.551 0.74 . . . . 72.4 111.702 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.49 -31.8 72.19 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.934 -0.575 . . . . 74.52 111.128 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 89.4 t80 . . . . . 0 N--CA 1.485 1.3 0 C-N-CA 123.248 0.619 . . . . 75.21 110.179 176.311 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 110.104 -0.332 . . . . 74.12 110.104 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m -70.31 86.47 0.6 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.515 0.726 . . . . 73.44 110.45 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.74 115.72 28.97 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.495 -1.298 . . . . 74.53 107.495 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -124.76 13.75 8.61 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.141 0.576 . . . . 74.31 112.199 -167.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -151.45 -84.82 0.08 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.976 -0.379 . . . . 61.31 109.976 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 171.63 108.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.376 1.47 . . . . 63.34 107.056 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -66.14 128.68 37.04 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 108.996 -0.742 . . . . 65.51 108.996 170.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -88.52 158.44 18.31 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.178 0.591 . . . . 65.15 110.433 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.443 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 15.5 ptp -49.59 133.94 20.3 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 124.416 1.086 . . . . 74.31 113.061 -176.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.8 m -152.67 138.64 18.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.142 1.377 . . . . 73.42 108.252 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.592 ' HA ' HG23 ' A' ' 86' ' ' ILE . 72.8 t80 -130.41 114.13 15.19 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.695 -1.224 . . . . 74.22 107.695 170.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -134.18 134.58 42.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.418 -0.956 . . . . 72.25 108.418 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 mt -84.99 112.32 21.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 108.485 -0.932 . . . . 73.54 108.485 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.27 -39.77 65.13 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.515 -0.92 . . . . 73.13 108.515 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -172.17 148.28 2.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 116.591 -0.277 . . . . 71.21 110.622 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.7 mt -132.16 129.06 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.101 -1.074 . . . . 73.41 108.101 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.43 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 33.1 p90 -168.37 147.99 4.57 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 124.209 0.943 . . . . 73.21 110.562 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -75.68 112.53 12.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.865 -1.061 . . . . 64.21 109.121 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 37.7 mtpt -82.08 -27.51 32.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.955 0.407 . . . . 74.41 109.951 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.634 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 19.5 t70 -143.7 140.02 29.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.008 -0.997 . . . . 70.04 109.885 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.4 mt -137.15 140.91 41.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 107.204 -1.406 . . . . 70.34 107.204 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -147.77 134.5 19.99 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.78 -0.822 . . . . 70.14 108.78 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.582 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 55.2 t80 -140.09 121.6 15.15 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.834 -1.173 . . . . 73.42 107.834 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.98 110.2 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.809 -0.811 . . . . 70.33 108.809 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.772 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -126.05 76.14 71.85 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 107.246 -1.391 . . . . 72.33 107.246 170.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.45 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 72.7 Cg_endo -74.42 -30.87 7.79 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.33 2.02 . . . . 73.33 110.697 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.45 ' ND2' ' HG2' ' A' ' 26' ' ' PRO . 30.5 m-80 -101.16 19.57 17.32 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.216 1.006 . . . . 75.41 110.112 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.772 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -52.98 -48.26 92.44 Favored Pre-proline 0 CA--C 1.571 1.762 0 C-N-CA 123.694 0.798 . . . . 71.24 111.87 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.36 -17.38 16.71 Favored 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 121.88 1.72 . . . . 72.32 113.609 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -69.99 -49.21 53.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.974 0.509 . . . . 72.25 109.771 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.683 HG22 ' HA ' ' A' ' 73' ' ' ALA . 42.7 t -72.55 -20.18 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.861 0.864 . . . . 73.51 111.21 -175.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.405 ' HB2' ' NH1' ' B' ' 15' ' ' ARG . 81.3 t80 -60.21 -34.4 73.59 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.367 0.667 . . . . 73.03 110.447 168.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -94.18 -24.39 17.53 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.362 1.065 . . . . 72.34 110.977 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 32.9 mmtp -75.89 170.89 15.37 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.486 0.714 . . . . 75.51 110.304 172.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -81.31 138.43 35.7 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.973 -1.121 . . . . 54.32 107.973 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 41.5 t-105 -76.43 83.76 3.16 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.709 0.766 . . . . 75.3 110.443 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -129.82 77.63 76.5 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.863 1.265 . . . . 74.15 108.751 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.5 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 39.1 Cg_endo -93.03 146.38 2.42 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.55 2.167 . . . . 74.34 113.074 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 28.1 tt0 -97.87 95.73 7.72 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.766 -0.827 . . . . 72.42 108.766 172.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.36 91.21 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.499 0.666 . . . . 64.23 109.747 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -101.18 128.92 47.06 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.088 -0.708 . . . . 71.33 109.088 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 62' ' ' VAL . 45.6 tp -98.2 146.6 25.45 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.707 -0.849 . . . . 65.31 108.707 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.63 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.4 m-20 -134.46 109.35 8.68 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.269 -1.382 . . . . 73.32 107.269 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -96.99 120.37 37.21 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.847 -0.427 . . . . 75.35 109.847 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -128.37 143.97 51.07 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.991 -1.115 . . . . 53.14 107.991 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.1 m -133.44 142.22 48.21 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.104 0.562 . . . . 75.3 110.085 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -130.36 152.93 49.23 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.809 1.244 . . . . 53.03 109.217 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.3 t -127.49 151.61 48.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.622 0.769 . . . . 71.43 109.744 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 45.7 t -153.31 128.3 9.63 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.576 0.75 . . . . 64.24 110.176 -171.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -101.38 108.01 19.5 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.139 -0.689 . . . . 75.43 109.139 174.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.493 HD12 HG23 ' A' ' 83' ' ' ILE . 79.2 mt -88.43 -35.25 17.18 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.931 0.492 . . . . 65.11 110.696 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.408 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -159.62 -179.64 8.07 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 124.029 0.831 . . . . 72.14 110.461 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -67.41 116.65 8.4 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.721 -1.127 . . . . 73.35 109.136 171.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.669 ' HA ' HG11 ' E' ' 451' ' ' VAL . 3.5 m-20 67.54 11.21 8.26 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.728 1.211 . . . . 71.11 113.157 -177.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.408 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 62.1 t -115.54 111.6 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.376 -1.342 . . . . 71.14 107.376 171.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -130.78 141.93 50.38 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.894 -0.78 . . . . 72.1 108.894 -171.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 41.7 tt0 -123.13 134.32 54.21 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.135 0.974 . . . . 75.04 109.213 -173.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.74 131.04 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 108.015 -1.106 . . . . 63.11 108.015 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 46.8 t -116.06 110.15 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.867 -0.79 . . . . 62.24 108.867 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.1 tp -90.26 105.71 17.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.487 -0.56 . . . . 75.24 109.487 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 51.8 ttt180 -85.07 101.69 12.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.504 0.722 . . . . 64.04 109.298 173.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.465 HG13 HD11 ' A' ' 42' ' ' LEU . 48.4 t -95.37 102.09 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.097 -1.075 . . . . 74.04 108.097 175.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.63 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 56.4 m -96.98 110.31 22.88 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.513 0.725 . . . . 75.33 109.051 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.488 HG22 HG21 ' A' ' 114' ' ' ILE . 41.9 t -102.92 137.28 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.392 -0.966 . . . . 73.32 108.392 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 t -143.09 150.5 39.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.863 -0.421 . . . . 73.33 109.863 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -138.67 109.61 6.75 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.823 -1.177 . . . . 71.1 107.823 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.8 p -135.04 127.04 29.65 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.416 0.687 . . . . 74.31 110.188 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.23 78.67 6.51 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.24 -1.393 . . . . 71.02 107.24 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.55 -91.42 0.66 Allowed Glycine 0 C--N 1.349 1.25 0 CA-C-N 115.142 -0.935 . . . . 73.11 112.783 173.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -91.91 -26.53 18.4 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.914 0.886 . . . . 71.34 111.823 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -113.55 129.92 56.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.721 0.408 . . . . 72.34 110.955 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 59.0 m -88.65 124.81 34.45 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.487 0.715 . . . . 64.3 110.289 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.683 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -70.59 -56.58 6.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.883 0.873 . . . . 75.45 110.071 175.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -155.83 158.77 38.64 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.617 -1.174 . . . . 73.35 111.128 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 tp -134.29 124.51 25.99 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.369 1.468 . . . . 75.44 107.217 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.45 ' SG ' HG13 ' A' ' 118' ' ' VAL . 61.6 m -132.22 99.96 4.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.111 0.964 . . . . 71.22 109.005 -174.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -123.68 127.39 48.13 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.527 0.731 . . . . 73.03 109.704 -171.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.2 t -135.63 113.85 15.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 123.445 0.698 . . . . 75.03 109.764 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.634 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.7 mt-30 -84.18 83.91 7.8 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.304 -0.998 . . . . 70.44 108.304 169.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.84 97.59 4.59 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.524 -1.216 . . . . 71.43 108.844 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.49 150.24 23.3 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.664 -0.574 . . . . 51.52 111.664 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.532 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -143.89 122.49 1.84 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.905 -0.878 . . . . 64.22 110.905 173.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.493 HG23 HD12 ' A' ' 51' ' ' LEU . 35.7 mt -82.02 130.52 35.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.801 -1.185 . . . . 74.14 107.801 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -127.67 122.64 33.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.85 -0.796 . . . . 74.53 108.85 -176.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -89.44 91.62 8.79 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.453 -0.943 . . . . 74.32 108.453 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.592 HG23 ' HA ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -126.74 155.62 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.175 0.59 . . . . 74.02 110.186 -175.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 9' ' ' MET . . . -169.56 170.72 8.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.156 0.982 . . . . 72.41 109.509 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.5 -32.34 6.08 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 123.675 0.61 . . . . 70.14 113.336 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.425 ' O ' HG23 ' E' ' 451' ' ' VAL . 0.2 OUTLIER -113.44 156.62 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.86 0.864 . . . . 74.05 109.748 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 14.5 tt0 -163.35 177.39 8.98 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.456 0.702 . . . . 71.12 109.403 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.403 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 69.66 -130.51 23.07 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 114.097 0.399 . . . . 73.42 114.097 177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.0 p -76.44 -35.57 58.43 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.56 1.144 . . . . 74.3 111.577 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -59.87 -43.92 94.46 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.963 0.905 . . . . 75.43 110.111 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.471 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 65.6 ttp -72.48 -36.01 68.32 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.005 -0.998 . . . . 74.41 110.848 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.23 -29.67 68.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.037 0.535 . . . . 70.41 110.883 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -69.15 -46.46 67.55 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.016 0.527 . . . . 70.3 110.94 168.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.5 m -59.98 -65.15 0.73 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 122.321 0.248 . . . . 63.23 110.824 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 94' ' ' MET . 2.0 pp -73.5 -21.64 60.35 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.028 0.751 . . . . 74.14 113.028 -176.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.415 ' N ' HD11 ' A' ' 98' ' ' LEU . . . -101.56 -4.53 52.47 Favored Glycine 0 N--CA 1.475 1.268 0 CA-C-O 119.599 -0.556 . . . . 65.22 113.577 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.32 -60.75 0.42 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.239 0.519 . . . . 53.55 111.612 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.58 -45.57 65.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.018 0.527 . . . . 74.45 111.991 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.3 m -67.76 -45.74 44.55 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.122 0.969 . . . . 73.22 111.943 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.95 -26.55 58.8 Favored 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 121.549 1.499 . . . . 74.24 112.576 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -70.09 -30.42 67.64 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.771 0.428 . . . . 73.34 110.307 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.7 mm -67.53 -41.43 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.79 0.836 . . . . 74.02 109.988 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.532 HD22 ' HA3' ' A' ' 82' ' ' GLY . 69.9 mt -74.99 -22.13 58.72 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.302 -0.863 . . . . 74.11 111.453 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -63.34 -43.49 79.85 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 117.464 -1.255 . . . . 74.14 114.233 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.1 -40.41 77.25 Favored 'Trans proline' 0 C--N 1.387 2.56 0 CA-C-N 122.093 1.783 . . . . 64.54 112.765 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -66.02 -44.64 84.13 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.453 0.701 . . . . 74.31 111.463 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.83 84.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.178 0.591 . . . . 73.41 110.711 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.453 ' NH1' HD13 ' C' ' 105' ' ' ILE . 26.8 ttm180 -50.79 -54.62 22.07 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.552 1.158 . . . . 73.52 109.76 174.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -67.01 -38.99 86.95 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.402 1.064 . . . . 75.43 111.833 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.557 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.2 t -62.06 -27.8 69.15 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.015 0.526 . . . . 72.4 111.019 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.488 HG21 HG22 ' A' ' 64' ' ' VAL . 97.5 mt -87.52 -41.09 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.227 1.411 . . . . 74.14 111.027 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 49.3 m -64.46 -44.48 90.95 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.482 0.713 . . . . 72.43 110.508 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.8 t -65.77 -40.89 92.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.794 -1.093 . . . . 73.35 109.93 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.582 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.7 ttm -59.58 -47.17 86.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.366 1.066 . . . . 74.34 111.903 -177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.45 HG13 ' SG ' ' A' ' 76' ' ' CYS . 20.5 m -66.02 -39.45 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.251 0.345 . . . . 73.45 110.317 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.0 m -67.45 -32.57 73.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.42 0.688 . . . . 73.01 111.362 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.616 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 86.5 mtt-85 -71.47 -31.5 67.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.518 0.727 . . . . 75.15 110.018 174.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.54 3.56 86.26 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.614 -0.721 . . . . 73.32 113.519 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.0 m 62.28 47.27 5.5 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 123.545 1.64 . . . . 75.11 110.797 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -116.75 137.64 23.89 Favored Pre-proline 0 C--O 1.246 0.92 0 CA-C-N 114.055 -1.429 . . . . 74.35 107.18 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.55 144.28 10.67 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.283 2.656 . . . . 73.33 113.705 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -55.98 132.38 49.76 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 124.357 1.036 . . . . 74.55 112.403 -173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 tp -118.97 100.69 7.52 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.143 -0.935 . . . . 72.12 109.68 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -98.03 107.3 19.74 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.839 -1.171 . . . . 74.44 107.839 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.46 139.31 58.76 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.169 0.587 . . . . 74.14 109.73 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.18 145.57 98.03 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 122.886 0.474 . . . . 52.35 110.673 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.84 107.84 0.67 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.083 1.855 . . . . 72.43 111.269 176.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 89.9 t -98.99 113.76 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.488 -0.93 . . . . 54.24 108.488 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -84.21 89.02 7.25 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.236 -1.024 . . . . 73.21 108.236 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -59.9 -29.67 68.5 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.645 0.778 . . . . 75.51 111.52 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.466 ' HB3' ' HG2' ' C' ' 147' ' ' GLU . 5.2 m-20 -69.17 -44.39 72.31 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.699 1.2 . . . . 73.23 110.681 -177.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.12 -45.36 92.38 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.992 0.808 . . . . 70.55 110.181 175.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.86 -37.04 80.74 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.164 -0.926 . . . . 73.11 111.212 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -68.86 -34.52 75.59 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.326 -0.852 . . . . 75.44 109.941 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.6 mmt -61.89 -35.46 78.42 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.679 0.612 . . . . 74.44 111.124 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.52 ' HA ' ' H ' ' A' ' 144' ' ' GLN . 61.7 m-80 -66.29 -40.25 89.93 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.943 -0.571 . . . . 74.31 110.888 176.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -73.54 -31.63 63.76 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.181 0.592 . . . . 72.11 111.113 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.8 tp -66.89 -49.45 65.58 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.892 1.277 . . . . 74.52 111.006 -171.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -172.14 30.75 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 108.91 -0.774 . . . . 74.44 108.91 -174.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 59.81 78.75 0.26 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.441 0.697 . . . . 72.13 110.184 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.52 ' H ' ' HA ' ' A' ' 139' ' ' ASN . 91.2 mt-30 76.1 -43.77 0.48 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.573 1.549 . . . . 72.32 111.689 -176.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 67.56 -77.48 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.382 1.473 . . . . 63.05 111.344 172.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.72 -93.97 0.66 Allowed Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.34 -1.104 . . . . 73.43 110.34 173.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 66.55 157.79 0.12 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.727 1.611 . . . . 74.22 112.059 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.34 32.53 62.37 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.247 -0.433 . . . . 62.14 112.487 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.1 t -84.0 10.33 10.18 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.92 0.888 . . . . 75.43 111.22 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.559 ' HA ' ' HB2' ' C' ' 145' ' ' ALA . 0.2 OUTLIER -63.13 92.24 0.05 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.038 0.935 . . . . 73.33 109.449 -177.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -56.94 -39.33 74.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.113 1.365 . . . . 73.23 111.272 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.407 ' HE1' ' HG3' ' C' ' 93' ' ' GLN . 55.4 t60 62.55 82.51 0.18 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.603 1.189 . . . . 74.04 111.506 173.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -127.77 123.5 35.45 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.278 -1.008 . . . . 73.24 108.278 170.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.668 ' HA ' ' HA ' ' C' ' 142' ' ' GLN . 7.8 p-10 -75.64 165.6 24.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.11 0.564 . . . . 74.22 110.488 176.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 N-CA-C 108.427 -0.953 . . . . 72.34 108.427 173.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.418 -0.216 . . . . 74.42 110.418 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 24.7 m -74.66 83.03 2.07 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.534 0.733 . . . . 70.14 110.48 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -96.08 60.58 2.04 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.572 0.701 . . . . 74.11 109.685 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -130.24 135.49 48.18 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.942 -1.026 . . . . 73.22 108.306 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -130.77 -171.82 2.66 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.584 0.754 . . . . 64.33 110.248 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 37.3 t30 65.08 106.38 0.03 OUTLIER 'General case' 0 C--N 1.362 1.122 0 C-N-CA 124.61 1.164 . . . . 75.43 110.628 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 37.8 p -77.68 76.84 4.21 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.681 0.753 . . . . 65.55 110.631 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -99.76 -71.56 0.69 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.909 -1.515 . . . . 72.44 106.909 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 7.9 ptm 47.45 167.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 127.804 2.441 . . . . 73.02 114.398 -172.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 60.5 m -165.09 134.37 3.51 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.382 -0.599 . . . . 74.33 109.382 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.422 ' HB3' ' HA ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -149.37 156.75 42.54 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.479 0.657 . . . . 74.13 110.039 155.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.31 135.15 51.15 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.639 -1.245 . . . . 52.13 107.639 173.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 51.0 mt -68.63 116.08 8.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.319 -0.993 . . . . 75.11 108.319 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -86.87 -36.41 18.44 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.235 -0.893 . . . . 71.42 109.45 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.405 ' NH1' ' HB2' ' A' ' 32' ' ' PHE . 75.2 ttt180 -167.33 133.71 2.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.894 -1.048 . . . . 72.23 109.715 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.451 ' H ' ' ND2' ' D' ' 127' ' ' ASN . 88.8 mt -115.61 135.08 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 105.809 -1.923 . . . . 74.25 105.809 166.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.47 ' HE2' ' HB2' ' A' ' 28' ' ' ALA . 10.0 p90 -168.4 151.04 5.32 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.213 0.53 . . . . 75.11 111.059 -174.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.8 m -82.62 129.84 35.01 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.942 -0.762 . . . . 75.33 108.942 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -97.89 -30.56 12.67 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.354 0.662 . . . . 72.51 110.721 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 11.8 t70 -145.09 139.11 27.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.428 -0.351 . . . . 72.55 110.232 -175.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.51 HD13 ' SG ' ' B' ' 113' ' ' CYS . 33.3 mm -131.17 139.53 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 106.768 -1.568 . . . . 74.33 106.768 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.8 t -147.6 138.25 23.29 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.32 -0.993 . . . . 72.24 108.32 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.0 t80 -154.71 110.38 3.15 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.662 -1.236 . . . . 72.44 107.662 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -117.95 114.42 23.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.627 1.171 . . . . 72.21 108.09 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.584 ' HB3' ' HB3' ' B' ' 28' ' ' ALA . . . -111.82 83.78 4.93 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.348 -0.982 . . . . 72.43 108.348 175.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.97 -34.26 6.69 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.775 2.316 . . . . 64.01 112.94 -170.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -98.14 -2.61 39.59 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.921 0.888 . . . . 64.22 111.426 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.584 ' HB3' ' HB3' ' B' ' 25' ' ' ALA . . . -35.83 -63.02 0.43 Allowed Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 125.867 1.667 . . . . 61.54 114.803 -165.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -54.97 -31.02 72.24 Favored 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 122.775 2.316 . . . . 75.0 113.794 -173.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -96.78 -34.49 11.3 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.692 -1.14 . . . . 74.51 111.404 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.667 HG21 HD13 ' B' ' 68' ' ' LEU . 5.6 p -74.45 -18.63 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 122.336 0.254 . . . . 75.32 111.672 -171.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.95 -15.49 62.24 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.619 0.768 . . . . 72.2 112.855 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -57.25 -29.98 64.26 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.425 0.69 . . . . 73.03 110.473 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.5 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 85.0 mttt -95.38 98.66 10.73 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 124.623 1.169 . . . . 74.23 109.025 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -83.36 92.92 7.64 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.41 0.684 . . . . 74.15 109.725 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -162.94 156.26 19.71 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.762 0.825 . . . . 75.03 109.347 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.443 ' HB3' HD21 ' F' ' 470' ' ' LEU . 0.0 OUTLIER -67.05 105.44 0.85 Allowed Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 124.524 1.13 . . . . 74.45 110.676 170.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.533 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 40.3 Cg_endo -67.37 137.58 43.71 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.597 2.198 . . . . 62.53 112.115 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 11.9 tp10 -59.23 121.46 11.43 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 124.187 0.929 . . . . 72.22 112.099 -169.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.639 HG21 HD13 ' F' ' 470' ' ' LEU . 73.2 t -85.94 132.47 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.968 0.907 . . . . 73.1 110.23 -172.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.546 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 12.9 tmtt? -131.9 117.29 18.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.275 -1.75 . . . . 74.13 106.275 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.455 HD23 HD13 ' B' ' 128' ' ' LEU . 40.4 tp -93.98 150.56 20.25 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.154 0.502 . . . . 74.42 111.188 -172.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.707 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.8 m-20 -140.59 143.64 35.39 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.694 -1.225 . . . . 63.55 107.694 171.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.496 HD13 ' HG ' ' F' ' 460' ' ' LEU . 0.4 OUTLIER -143.0 125.94 16.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.926 -1.139 . . . . 73.13 107.926 -177.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 12.2 m-20 -127.04 150.42 49.45 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.026 -1.102 . . . . 63.0 108.026 171.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.0 p -135.72 124.46 23.87 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.943 0.401 . . . . 72.3 110.817 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.19 164.08 16.77 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.542 1.537 . . . . 74.5 109.493 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 22.2 p -145.07 168.67 19.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.482 1.113 . . . . 74.04 109.104 170.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 97.4 p -151.23 168.47 24.63 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.156 0.582 . . . . 75.42 109.815 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -116.53 110.2 18.26 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.731 -1.211 . . . . 71.33 107.731 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 24.6 mt -88.02 -55.51 3.72 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.1 0.953 . . . . 73.2 108.777 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.67 -179.32 5.85 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 113.431 -1.713 . . . . 42.31 108.053 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.32 130.36 40.58 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 116.158 -0.474 . . . . 73.02 110.627 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 67.03 -1.19 1.48 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.969 1.708 . . . . 71.22 112.724 -172.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.2 t -103.61 104.11 16.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 108.074 -1.084 . . . . 74.31 108.074 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -114.19 140.45 48.53 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.026 -1.101 . . . . 75.11 108.026 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -119.87 104.67 10.39 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.212 -1.033 . . . . 71.42 108.212 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 72.3 t -89.08 140.09 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.358 0.663 . . . . 74.33 110.589 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 38.0 t -118.28 118.9 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.797 0.839 . . . . 75.15 109.403 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.5 OUTLIER -93.82 122.98 36.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.203 -1.406 . . . . 73.44 107.203 174.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.472 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 46.8 ttt180 -110.27 122.14 46.96 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.403 0.681 . . . . 72.11 109.486 175.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 13.6 t -117.62 131.36 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 107.67 -1.233 . . . . 72.54 107.67 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.707 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.1 m -127.07 130.28 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.758 -0.83 . . . . 74.52 108.758 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.33 116.39 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.844 -0.799 . . . . 73.24 108.844 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 89.2 m -99.05 138.46 36.13 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.917 -1.142 . . . . 71.11 107.917 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.17 147.36 30.42 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 122.437 0.295 . . . . 71.31 110.593 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 54.9 p -151.66 135.74 16.6 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 124.125 0.891 . . . . 72.45 111.383 -174.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.667 HD13 HG21 ' B' ' 31' ' ' VAL . 56.1 mt -95.45 110.44 22.49 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.947 0.899 . . . . 74.52 109.477 174.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.43 -111.12 3.43 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.581 -1.19 . . . . 73.13 111.764 -169.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -119.06 2.57 11.47 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.802 0.841 . . . . 73.22 110.905 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.5 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 10.5 pt-20 -112.66 148.96 33.56 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.888 -0.782 . . . . 75.23 108.888 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.6 m -61.6 140.42 58.14 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.55 0.531 . . . . 74.32 110.874 -176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.76 -67.14 0.86 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.676 -1.231 . . . . 70.43 107.676 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -148.1 158.07 43.86 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.969 -1.014 . . . . 64.5 109.862 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 41.7 mt -132.6 109.42 9.73 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 106.365 -1.717 . . . . 71.11 106.365 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 39.3 t -120.77 117.04 26.41 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.27 0.487 . . . . 54.42 110.05 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.4 tt0 -122.28 132.67 54.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.22 1.008 . . . . 65.11 108.736 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.508 HG12 HD11 ' B' ' 21' ' ' ILE . 75.5 t -128.48 147.64 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.111 -0.7 . . . . 74.24 109.111 173.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.8 mt-30 -125.36 102.99 7.68 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.094 -0.706 . . . . 73.34 109.094 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -90.44 104.78 17.32 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.658 -0.868 . . . . 74.1 108.658 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.59 171.11 37.62 Favored Glycine 0 C--O 1.243 0.68 0 N-CA-C 111.364 -0.694 . . . . 72.13 111.364 174.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.67 130.65 2.15 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 112.121 -0.392 . . . . 74.15 112.121 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 39.3 mt -89.89 127.47 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.334 0.653 . . . . 74.43 109.32 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -135.15 132.92 38.61 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.393 -1.336 . . . . 74.23 107.393 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m -101.62 90.97 4.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.705 0.402 . . . . 73.41 110.787 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.507 ' HB ' HD11 ' B' ' 89' ' ' ILE . 16.1 pt -96.25 145.25 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.494 0.718 . . . . 74.23 111.614 -167.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.77 157.16 32.85 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.279 1.031 . . . . 72.31 109.96 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.02 -39.31 2.94 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 123.378 0.513 . . . . 71.01 113.657 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.542 ' H ' HD12 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -79.12 146.65 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.062 0.545 . . . . 65.4 111.237 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -162.95 162.62 26.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.046 0.841 . . . . 74.42 109.506 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.99 -118.13 9.28 Favored Glycine 0 N--CA 1.474 1.171 0 CA-C-N 115.976 -0.556 . . . . 51.32 113.553 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 99.5 m -69.63 -33.48 72.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.663 0.785 . . . . 72.11 110.708 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -66.74 -38.98 87.74 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.264 0.625 . . . . 62.31 111.466 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -32.92 60.49 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.357 0.263 . . . . 75.22 111.29 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.27 75.13 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.495 -0.775 . . . . 62.23 110.103 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -72.36 -34.85 68.29 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.034 0.933 . . . . 71.14 110.677 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -68.11 -67.5 0.46 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.498 0.499 . . . . 64.12 110.812 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.427 HD13 HD12 ' F' ' 454' ' ' LEU . 68.2 mt -81.84 -16.51 50.57 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 111.873 0.323 . . . . 75.31 111.873 -173.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . 0.51 ' HA2' ' NE2' ' F' ' 457' ' ' GLN . . . -97.13 -9.69 55.49 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 114.57 0.588 . . . . 70.41 114.57 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.99 -56.3 0.25 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.382 0.591 . . . . 73.22 111.722 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -71.7 -48.53 46.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.709 0.804 . . . . 72.41 112.06 -169.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 98.6 m -61.27 -47.23 94.81 Favored Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 124.158 0.983 . . . . 75.4 111.777 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.42 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 76.1 Cg_exo -56.03 -41.17 79.75 Favored 'Trans proline' 0 C--N 1.395 3.0 0 C-N-CA 122.406 2.071 . . . . 75.23 113.587 167.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -62.73 -29.37 70.62 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.482 0.713 . . . . 74.32 111.914 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.63 -41.65 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.85 0.86 . . . . 74.35 110.748 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.76 -19.52 57.52 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.981 -1.009 . . . . 74.44 112.255 -173.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -56.71 -48.58 96.99 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 114.872 1.434 . . . . 74.51 114.872 -170.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.77 -37.53 95.49 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.457 2.104 . . . . 74.2 113.828 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -71.25 -43.03 68.06 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.661 -0.699 . . . . 71.31 110.369 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -40.57 87.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.597 0.759 . . . . 74.33 110.776 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -60.53 -53.11 61.42 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.192 0.997 . . . . 64.33 111.212 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.23 -33.25 75.56 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.459 0.704 . . . . 72.22 110.397 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.616 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -67.89 -42.91 80.49 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.804 0.842 . . . . 74.14 111.658 177.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.63 -51.51 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.77 -0.456 . . . . 75.25 109.77 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.474 HG22 ' OG ' ' C' ' 119' ' ' SER . 19.8 m -60.13 -34.35 73.41 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.873 0.869 . . . . 73.54 111.646 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.4 t -60.34 -48.01 83.59 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.732 0.645 . . . . 64.31 110.075 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -74.77 -31.29 61.73 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.446 0.698 . . . . 70.44 111.524 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.08 -39.4 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.894 0.878 . . . . 70.01 110.559 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 30.4 t -65.28 -40.64 94.13 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.84 0.856 . . . . 75.14 111.065 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.557 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 78.0 mtt-85 -66.24 -33.49 75.87 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 114.843 -1.071 . . . . 72.45 110.128 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.12 7.42 75.34 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-O 119.361 -0.688 . . . . 73.03 113.677 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 80.6 p 56.12 29.68 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.905 1.682 . . . . 73.23 113.537 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -93.24 154.76 41.47 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.025 0.93 . . . . 75.24 110.787 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.23 165.94 1.91 Allowed 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 123.909 3.073 . . . . 75.34 115.556 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -63.58 137.62 58.19 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.461 1.104 . . . . 73.5 113.191 -168.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.99 112.31 15.09 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 107.753 -1.202 . . . . 75.51 107.753 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -130.53 109.54 10.76 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.589 -0.893 . . . . 75.43 108.589 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.455 HD13 HD23 ' B' ' 42' ' ' LEU . 33.6 tp -82.87 137.41 34.28 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.637 0.375 . . . . 65.24 110.397 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.32 144.75 92.47 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.148 0.979 . . . . 63.43 111.415 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.499 ' HG3' HD13 ' D' ' 16' ' ' ILE . 33.3 Cg_endo -61.64 109.2 0.72 Allowed 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.897 2.398 . . . . 75.22 112.298 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -89.83 111.9 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.615 -0.884 . . . . 74.43 108.615 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -78.5 87.93 4.47 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.22 -1.03 . . . . 72.5 108.22 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -59.06 -36.72 75.53 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.519 0.727 . . . . 73.43 111.339 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.12 -40.85 95.07 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.581 1.152 . . . . 73.25 111.998 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.85 -47.27 66.37 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.738 0.815 . . . . 73.31 110.855 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.89 -20.75 59.59 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.535 -0.757 . . . . 74.41 110.873 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.433 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 94.4 t80 -66.9 -44.26 81.27 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.588 0.755 . . . . 74.52 110.112 173.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.75 -36.71 74.79 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.83 0.852 . . . . 73.33 110.633 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -76.61 -28.21 56.03 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.282 -0.872 . . . . 74.04 111.45 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -65.36 -33.9 77.05 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.999 0.92 . . . . 75.0 111.336 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 31.4 mt -76.21 -3.47 36.58 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.596 0.759 . . . . 72.12 111.48 -174.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -122.33 -37.2 2.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.388 1.075 . . . . 74.53 109.587 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 50.99 64.99 1.61 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.806 1.242 . . . . 74.04 110.425 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -166.58 161.73 16.14 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.757 -1.11 . . . . 74.42 110.212 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.26 151.36 36.81 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.452 0.701 . . . . 74.54 111.017 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.97 139.44 32.73 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 123.582 0.551 . . . . 54.12 113.202 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -97.76 107.57 20.09 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.785 -0.82 . . . . 74.41 108.785 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -144.78 37.79 1.33 Allowed Glycine 0 C--N 1.342 0.899 0 N-CA-C 111.471 -0.651 . . . . 75.2 111.471 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 28.0 m -58.17 106.21 0.35 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.428 1.091 . . . . 74.25 110.936 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.7 173.71 11.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.928 0.491 . . . . 74.3 110.424 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -132.14 85.12 2.21 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.732 0.777 . . . . 65.25 109.158 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -68.45 -46.43 69.86 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.434 -0.803 . . . . 75.42 109.754 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 50.5 80.33 0.08 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.024 1.33 . . . . 71.24 111.809 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -108.31 109.44 20.77 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.46 -1.246 . . . . 73.03 108.769 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.735 0 C-N-CA 123.537 0.735 . . . . 73.21 109.141 -177.968 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.921 0.391 . . . . 73.33 110.676 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 39.8 m -146.33 150.24 35.35 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.881 0.873 . . . . 75.34 109.365 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -78.6 88.47 4.52 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.684 0.793 . . . . 72.42 109.102 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -96.28 108.11 20.56 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.735 0.814 . . . . 73.11 111.272 -171.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 9.6 t30 57.33 92.52 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.42 1.488 . . . . 75.33 112.348 174.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -64.41 -36.13 83.16 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.068 0.947 . . . . 60.21 111.991 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 25.1 m -84.69 79.9 9.44 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.602 0.715 . . . . 75.32 110.795 -170.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -118.93 -31.79 4.66 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.289 1.035 . . . . 73.21 109.537 171.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.456 ' HG3' HD12 ' C' ' 89' ' ' ILE . 24.8 ttt 64.05 112.61 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.269 1.428 . . . . 74.4 111.948 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 36.4 m -88.07 91.15 8.66 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 108.613 -0.884 . . . . 72.42 108.613 174.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -115.57 126.48 54.28 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.801 -0.814 . . . . 75.53 108.801 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -140.68 125.45 18.11 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.875 -0.787 . . . . 71.14 108.875 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.407 ' HA ' ' HD2' ' C' ' 84' ' ' PHE . 56.1 mt -66.44 123.94 20.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.81 -0.811 . . . . 73.45 108.81 171.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -89.63 -48.74 7.09 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.157 -0.683 . . . . 71.32 109.157 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -174.33 125.89 0.33 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 115.565 -0.743 . . . . 74.13 110.404 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -109.46 143.22 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 107.919 -1.141 . . . . 73.33 107.919 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.44 ' HE1' HG12 ' C' ' 83' ' ' ILE . 25.1 p90 -176.25 169.58 2.73 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.406 0.622 . . . . 74.04 111.007 -173.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -93.02 114.59 27.18 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.318 -0.856 . . . . 61.44 109.533 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.638 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -68.34 -34.09 75.46 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.814 -0.81 . . . . 74.02 108.814 175.089 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -154.19 146.45 23.83 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.945 -1.479 . . . . 75.12 109.618 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.7 mt -140.61 144.37 27.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 125.607 1.563 . . . . 73.32 106.846 175.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -154.04 149.32 27.05 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.51 0.672 . . . . 73.0 110.116 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -153.68 125.16 7.57 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.159 -1.423 . . . . 71.55 107.159 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -132.23 109.96 10.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.062 0.545 . . . . 62.04 109.724 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.59 79.58 73.43 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 106.716 -1.587 . . . . 65.35 106.716 168.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.74 -25.34 28.8 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.767 2.311 . . . . 72.35 112.001 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -106.1 17.57 23.34 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.214 1.406 . . . . 72.42 110.932 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.89 -57.57 4.83 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 114.864 1.431 . . . . 52.12 114.864 -167.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.17 -36.63 68.22 Favored 'Trans proline' 0 C--N 1.391 2.774 0 CA-C-N 122.24 1.836 . . . . 74.34 112.529 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -69.09 -39.09 79.22 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.446 0.698 . . . . 74.12 111.637 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' C' ' 73' ' ' ALA . 2.9 p -79.39 -20.79 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 N-CA-C 112.412 0.523 . . . . 63.42 112.412 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -67.91 -31.71 71.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.545 0.572 . . . . 74.54 112.545 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -88.35 15.25 8.01 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.874 0.47 . . . . 75.14 111.057 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.43 161.34 13.83 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.954 0.902 . . . . 72.54 110.544 -176.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.92 126.85 30.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.624 0.77 . . . . 73.4 109.798 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 59.9 t90 -76.0 107.14 8.0 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.654 0.782 . . . . 74.32 109.847 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.56 73.16 2.87 Favored Pre-proline 0 CA--C 1.555 1.138 0 N-CA-C 107.328 -1.36 . . . . 64.52 107.328 173.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' G' ' 470' ' ' LEU . 2.7 Cg_endo -81.59 134.18 8.59 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.092 2.528 . . . . 64.24 113.949 -174.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -87.38 95.13 9.9 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 106.345 -1.724 . . . . 75.43 106.345 168.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 m -75.88 96.23 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 122.275 1.036 . . . . 73.21 109.815 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.429 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 40.2 ttmt -100.8 103.09 14.3 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.582 -1.19 . . . . 75.44 108.082 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.614 HD23 HD23 ' G' ' 468' ' ' LEU . 5.8 mp -88.32 132.54 34.37 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 107.783 -1.191 . . . . 72.44 107.783 174.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.405 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.1 t70 -117.63 104.72 11.3 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.469 -1.308 . . . . 75.43 107.469 173.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 84.3 mt -95.58 143.23 27.05 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.305 -0.861 . . . . 72.54 109.236 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.605 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.2 t70 -148.33 144.27 27.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.993 0.917 . . . . 75.15 108.954 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 t -138.42 124.75 20.46 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.648 -0.871 . . . . 74.25 108.648 172.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.07 145.3 45.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.782 -0.821 . . . . 70.42 108.782 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.408 ' HB2' HD13 ' G' ' 454' ' ' LEU . 44.3 p -130.49 156.0 45.52 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.989 0.516 . . . . 74.01 111.115 -176.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 29.5 t -144.8 139.84 28.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.369 1.067 . . . . 75.03 109.587 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . 0.408 ' HB2' ' HB2' ' G' ' 454' ' ' LEU . 37.5 tp60 -88.86 118.32 28.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.963 -1.125 . . . . 71.34 107.963 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.558 HD12 HD13 ' C' ' 83' ' ' ILE . 62.2 mt -90.0 -48.84 6.95 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.802 0.811 . . . . 72.03 109.362 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.18 -177.85 5.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 113.996 -1.456 . . . . 55.35 108.501 170.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.41 110.73 1.16 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.442 1.089 . . . . 75.1 110.703 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 22.6 m-20 68.3 9.28 7.14 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 125.386 1.474 . . . . 71.04 113.367 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.7 t -93.1 107.53 19.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 107.198 -1.408 . . . . 72.15 107.198 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.412 ' CD1' HG13 ' G' ' 452' ' ' VAL . 2.5 t80 -102.08 122.37 43.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.149 -1.387 . . . . 74.15 108.088 -164.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.525 ' HB2' HD12 ' C' ' 51' ' ' LEU . 36.3 tt0 -105.01 122.57 46.13 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.944 -1.132 . . . . 75.44 107.944 173.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -114.99 141.06 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 108.515 -0.92 . . . . 73.13 108.515 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.408 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 87.2 t -128.99 139.75 51.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.811 -0.811 . . . . 63.53 108.811 174.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.81 105.95 11.21 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.524 -1.287 . . . . 75.44 107.524 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.605 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 23.3 ttm-85 -93.58 107.7 19.52 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.603 -0.888 . . . . 72.31 108.603 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.438 ' HB ' HD11 ' C' ' 114' ' ' ILE . 24.1 t -107.11 120.42 58.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.438 -0.949 . . . . 74.34 108.438 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 43.6 m -117.68 131.53 56.62 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.23 -0.656 . . . . 65.44 109.23 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.569 HG23 HG21 ' C' ' 114' ' ' ILE . 60.2 t -108.41 125.28 65.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.972 -0.751 . . . . 72.21 108.972 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 6.6 m -118.38 123.93 46.47 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.515 -0.92 . . . . 72.12 108.515 173.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.92 99.65 7.23 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.493 -1.299 . . . . 64.43 107.493 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.9 m -108.18 120.6 42.83 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 109.7 -0.482 . . . . 72.5 109.7 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' C' ' 73' ' ' ALA . 8.7 mt -84.92 49.29 1.7 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.182 1.393 . . . . 75.43 109.589 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.79 -98.85 1.81 Allowed Glycine 0 C--N 1.35 1.317 0 N-CA-C 110.557 -1.017 . . . . 73.03 110.557 -174.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.39 -30.28 12.29 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.319 1.048 . . . . 72.15 109.97 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -79.78 120.07 23.55 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 124.348 1.059 . . . . 73.5 110.581 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 86.8 m -85.29 127.12 34.21 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 119.057 0.844 . . . . 72.33 109.764 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.648 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.85 -56.81 5.06 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.653 1.181 . . . . 72.42 110.101 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . 0.465 ' HZ ' HD23 ' C' ' 126' ' ' LEU . 33.0 p90 -157.4 164.52 37.43 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.287 -0.869 . . . . 75.04 112.284 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -128.25 105.29 8.25 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.636 -1.616 . . . . 73.33 106.636 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.9 t -109.41 148.69 30.7 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.974 -0.75 . . . . 74.24 108.974 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -156.42 136.81 13.04 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.414 -0.587 . . . . 73.22 109.414 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.0 t -133.93 135.02 55.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.89 -1.152 . . . . 72.23 107.89 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -111.5 89.42 3.05 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.952 -1.129 . . . . 65.02 107.952 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -78.99 100.27 7.23 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.061 -0.972 . . . . 74.5 110.04 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.638 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -89.24 169.07 35.79 Favored Glycine 0 C--O 1.242 0.636 0 CA-C-N 115.728 -0.669 . . . . 71.11 112.799 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.414 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -168.06 118.51 0.79 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.384 -0.686 . . . . 73.43 111.384 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.558 HD13 HD12 ' C' ' 51' ' ' LEU . 12.9 mm -84.01 133.44 29.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 108.821 -0.807 . . . . 73.31 108.821 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.407 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 45.3 m-85 -141.09 122.68 15.13 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.639 0.775 . . . . 72.23 109.337 -177.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 53.0 p -79.84 127.31 32.07 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.09 -1.078 . . . . 74.4 108.09 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.492 HD13 HD13 ' C' ' 89' ' ' ILE . 9.6 tt -141.91 143.09 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-O 121.036 0.446 . . . . 65.21 111.714 -170.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.78 169.18 24.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.344 1.058 . . . . 64.44 109.649 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.07 -46.34 1.19 Allowed Glycine 0 N--CA 1.471 1.012 0 CA-C-N 116.458 -0.337 . . . . 74.24 113.878 171.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.492 HD13 HD13 ' C' ' 86' ' ' ILE . 0.2 OUTLIER -113.39 146.77 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 122.935 0.494 . . . . 75.25 110.236 -176.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -146.83 -177.89 5.9 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.786 0.434 . . . . 73.11 111.008 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.25 -122.6 11.29 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 115.753 -0.658 . . . . 63.33 113.078 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 79.9 p -70.53 -23.79 62.7 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.589 0.756 . . . . 62.34 110.929 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.407 ' HG3' ' HE1' ' A' ' 152' ' ' HIS . 19.7 mt-30 -73.68 -32.16 63.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.661 0.785 . . . . 72.01 110.746 176.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 55.5 ttp -66.78 -40.64 88.24 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.086 -0.709 . . . . 74.12 109.086 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.27 -36.3 83.68 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.563 -0.744 . . . . 73.44 111.383 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.54 ' HE2' ' HA ' ' C' ' 134' ' ' ASP . 10.0 t-80 -76.86 -21.02 55.61 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.576 0.35 . . . . 74.14 111.607 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.9 t -61.28 -54.5 43.25 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.63 0.372 . . . . 72.43 110.097 173.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.475 HD13 ' HG3' ' G' ' 457' ' ' GLN . 4.5 pp -75.66 -22.14 57.01 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.102 0.561 . . . . 75.12 111.147 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.55 -26.41 65.5 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 114.889 0.716 . . . . 71.43 114.889 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.56 -60.21 0.08 Allowed 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 112.494 0.553 . . . . 72.01 112.494 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -52.71 -47.76 67.08 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 124.154 0.909 . . . . 75.45 112.604 -167.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.9 m -78.4 -48.44 1.89 Allowed Pre-proline 0 CA--C 1.561 1.379 0 CA-C-O 117.78 -1.105 . . . . 71.3 112.422 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.57 -32.51 44.4 Favored 'Trans proline' 0 C--N 1.403 3.402 0 C-N-CA 122.197 1.931 . . . . 71.54 113.636 170.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -66.71 -38.04 85.91 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.278 1.031 . . . . 64.43 111.417 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.453 HD13 ' NH1' ' A' ' 111' ' ' ARG . 36.7 mm -64.5 -45.65 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 109.488 -0.56 . . . . 71.2 109.488 173.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.414 HD21 ' HA3' ' C' ' 82' ' ' GLY . 74.5 mt -78.48 -18.6 54.59 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.03 -0.987 . . . . 72.31 112.493 -172.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.412 ' HE1' HD13 ' C' ' 128' ' ' LEU . 79.0 t80 -59.0 -50.99 85.04 Favored Pre-proline 0 CA--C 1.56 1.358 0 N-CA-C 114.233 1.197 . . . . 74.3 114.233 -171.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.36 -32.48 72.13 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.789 1.659 . . . . 74.14 112.518 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -67.65 -45.15 76.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.15 0.58 . . . . 74.31 110.195 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.54 -45.2 89.39 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.918 0.887 . . . . 74.12 110.519 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -57.7 -54.74 43.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.634 1.174 . . . . 72.14 111.117 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -67.18 -33.05 74.57 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.299 0.64 . . . . 71.44 110.877 -173.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.2 t -69.5 -32.21 70.93 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.888 0.475 . . . . 53.14 110.932 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.569 HG21 HG23 ' C' ' 64' ' ' VAL . 74.7 mt -71.31 -53.32 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.59 -0.522 . . . . 64.34 109.59 173.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 14.5 m -60.73 -29.68 69.52 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.74 0.816 . . . . 75.33 111.326 -173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 31.7 t -61.78 -54.54 40.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.235 -0.893 . . . . 72.32 109.155 171.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.552 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.73 -37.66 79.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.794 1.238 . . . . 75.55 112.867 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.49 -46.7 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.59 0.756 . . . . 73.32 109.8 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.474 ' OG ' HG22 ' B' ' 115' ' ' THR . 34.7 t -66.28 -32.71 74.29 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.985 -1.007 . . . . 74.22 111.473 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 74.6 mtt-85 -66.49 -41.16 89.33 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.408 0.683 . . . . 72.32 109.481 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.23 7.81 62.85 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.706 -0.679 . . . . 75.22 112.989 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 77.4 p 57.96 33.32 23.06 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.906 1.682 . . . . 75.2 113.661 171.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -91.08 163.13 30.52 Favored Pre-proline 0 CA--C 1.565 1.526 0 C-N-CA 124.231 1.012 . . . . 61.22 108.86 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.11 172.75 3.75 Favored 'Trans proline' 0 C--N 1.39 2.729 0 C-N-CA 122.997 2.465 . . . . 61.31 113.82 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -62.48 112.74 2.59 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.945 0.898 . . . . 75.25 112.669 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.49 HD11 HD11 ' G' ' 470' ' ' LEU . 8.9 mp -110.98 112.0 23.51 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.431 -0.952 . . . . 64.33 108.431 169.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -124.59 131.29 53.48 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.498 0.719 . . . . 73.41 109.223 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.412 HD13 ' HE1' ' C' ' 107' ' ' PHE . 1.4 tt -79.33 131.2 36.06 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.333 -0.617 . . . . 72.53 109.333 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.17 150.75 91.82 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.235 1.014 . . . . 70.11 111.433 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.07 103.29 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.382 2.055 . . . . 73.11 112.533 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 90.6 t -97.22 111.23 26.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.663 -0.866 . . . . 75.42 108.663 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -82.96 83.81 7.67 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 108.042 -1.096 . . . . 74.44 108.042 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -59.36 -22.47 61.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.11 0.564 . . . . 73.41 111.87 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.54 ' HA ' ' HE2' ' C' ' 96' ' ' HIS . 33.7 m-20 -63.19 -56.2 18.72 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.692 0.797 . . . . 74.1 110.848 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.11 -38.58 79.93 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.725 1.266 . . . . 71.43 110.641 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 74.8 mt -74.19 -29.5 61.78 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.493 -1.23 . . . . 71.4 111.675 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -75.45 -28.69 59.41 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 110.142 -0.318 . . . . 75.22 110.142 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 60.7 mtt -63.95 -34.86 78.92 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.252 0.621 . . . . 63.13 111.876 -176.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -71.7 -37.11 70.71 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.204 0.315 . . . . 73.04 110.383 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -67.2 -81.7 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.552 1.141 . . . . 75.33 110.064 176.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 52.4 tp -127.06 135.42 50.76 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.575 0.75 . . . . 74.43 110.26 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.668 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 45.0 tt0 65.26 93.94 0.06 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.181 1.393 . . . . 73.25 112.407 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -69.34 88.14 0.45 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.281 -1.007 . . . . 75.42 108.281 166.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -77.37 136.76 38.46 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.455 -1.248 . . . . 75.11 110.443 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.559 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . . . -84.23 159.8 20.91 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.085 0.554 . . . . 71.35 110.447 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.67 -151.73 5.86 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 114.27 0.468 . . . . 74.02 114.27 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 3.5 mp0 -81.81 152.23 27.03 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.213 0.605 . . . . 64.55 109.544 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.54 62.86 4.5 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.744 -0.542 . . . . 70.0 111.744 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 58.3 p -78.4 112.92 15.92 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.236 1.015 . . . . 73.34 111.176 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -89.57 159.03 17.39 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.291 0.636 . . . . 74.14 109.709 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -92.32 107.13 18.98 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.513 -1.291 . . . . 75.32 107.513 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -171.16 133.37 0.86 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.297 0.639 . . . . 74.33 110.867 171.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -157.09 131.89 8.8 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.109 -0.701 . . . . 74.12 109.109 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -138.59 133.35 32.39 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.699 0.8 . . . . 73.32 109.042 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 N-CA-C 108.894 -0.78 . . . . 72.03 108.894 -176.719 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.748 -0.464 . . . . 71.23 109.748 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 40.4 m -84.39 69.02 10.45 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.878 0.847 . . . . 75.1 109.661 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -99.6 142.89 30.49 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.37 -1.286 . . . . 71.45 110.874 -172.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 53.04 71.19 0.51 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.233 1.413 . . . . 75.34 111.819 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -69.93 109.01 4.26 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.226 -0.897 . . . . 75.52 109.47 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -111.93 79.12 1.18 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.48 0.712 . . . . 70.34 109.637 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.8 t -155.89 66.4 0.6 Allowed 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.425 -1.324 . . . . 74.44 107.425 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 67.03 147.42 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.56 1.544 . . . . 73.04 110.842 -168.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.3 ttp -34.43 125.45 0.5 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.864 1.266 . . . . 74.44 112.654 171.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.413 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 89.3 m -114.81 139.73 49.5 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.034 0.534 . . . . 72.44 110.022 176.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -164.01 91.34 0.63 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.785 -1.561 . . . . 74.05 106.785 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -112.84 114.06 26.42 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.868 -1.16 . . . . 74.25 107.868 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.58 105.57 4.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.678 -0.86 . . . . 75.44 108.678 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -77.38 -37.85 51.23 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.172 -0.467 . . . . 63.11 111.892 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -166.2 144.1 5.48 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 111.786 0.291 . . . . 74.3 111.786 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.499 HD13 ' HG3' ' B' ' 130' ' ' PRO . 1.7 mp -121.86 134.12 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 106.016 -1.846 . . . . 75.33 106.016 167.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -161.44 163.18 30.64 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.9 0.857 . . . . 74.13 111.489 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -95.01 119.72 34.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.267 -1.333 . . . . 55.45 108.924 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -88.96 -22.34 23.1 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.568 -0.53 . . . . 73.35 109.568 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.613 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.2 t70 -155.67 139.4 16.11 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 114.933 -1.031 . . . . 64.22 109.8 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.552 HG23 ' HE1' ' C' ' 117' ' ' MET . 69.0 mt -143.62 136.78 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.938 1.295 . . . . 74.42 107.553 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.6 t -146.76 109.25 4.53 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.807 -0.812 . . . . 73.41 108.807 174.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.582 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.8 t80 -114.22 128.28 56.29 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.991 -1.114 . . . . 74.11 107.991 168.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.14 127.14 40.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.516 0.727 . . . . 75.11 109.324 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.31 87.42 2.05 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 106.559 -1.645 . . . . 64.54 106.559 165.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.55 -41.72 18.82 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.276 1.984 . . . . 73.4 112.505 -166.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -111.09 15.2 21.75 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.125 0.97 . . . . 75.24 109.979 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.428 ' O ' HG11 ' D' ' 31' ' ' VAL . . . -18.61 -70.26 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 117.227 2.306 . . . . 74.35 117.227 -168.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.439 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 64.6 Cg_endo -77.14 -23.75 10.15 Favored 'Trans proline' 0 C--N 1.382 2.329 0 CA-C-N 123.953 2.447 . . . . 74.13 113.772 -173.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -72.88 -36.54 67.37 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.631 0.772 . . . . 75.11 109.218 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.552 HG23 ' HA ' ' D' ' 73' ' ' ALA . 6.8 p -83.26 -19.13 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.229 0 CA-C-N 115.731 -0.668 . . . . 75.01 110.694 -176.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.439 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.6 m-85 -70.01 -19.02 63.34 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.835 0.454 . . . . 75.42 111.928 175.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -55.3 -34.09 63.84 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.817 0.698 . . . . 75.41 110.073 172.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.418 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 42.1 mtmt -91.88 78.02 5.42 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.583 -1.19 . . . . 75.52 109.095 168.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.01 82.0 3.53 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.836 0.827 . . . . 74.3 109.493 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -147.84 157.96 43.79 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.532 -1.213 . . . . 74.4 108.79 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -63.8 106.89 1.04 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.133 0.973 . . . . 74.31 108.979 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.469 ' HB2' ' HB2' ' D' ' 66' ' ' ALA . 23.1 Cg_exo -65.82 146.0 82.16 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.754 2.302 . . . . 73.11 112.196 -172.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -63.27 110.97 2.06 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.164 -1.05 . . . . 74.02 108.164 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.14 146.07 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-O 121.427 0.632 . . . . 74.15 111.225 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' H' ' 465' ' ' LYS . 8.0 tmtt? -129.59 118.94 22.8 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.401 -2.074 . . . . 73.44 105.401 172.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -97.01 145.37 26.01 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.633 -0.877 . . . . 75.43 108.633 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.568 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.8 m-20 -129.29 143.34 50.81 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.024 -0.732 . . . . 74.25 109.024 172.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -119.38 136.42 54.29 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.232 -1.025 . . . . 72.41 108.232 173.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 37.9 t70 -138.37 131.5 30.05 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.274 -1.38 . . . . 70.14 107.274 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -104.09 148.12 26.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.221 0.534 . . . . 62.44 109.57 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.58 165.41 33.4 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.897 -1.047 . . . . 73.13 108.536 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 31.1 p -164.77 155.97 15.01 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.179 0.592 . . . . 62.41 110.151 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 32.0 t -151.62 123.95 8.29 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.317 0.647 . . . . 71.35 110.626 -171.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -73.4 116.65 14.21 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.179 -1.045 . . . . 72.02 108.179 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' D' ' 57' ' ' GLU . 60.1 mt -91.79 -41.11 10.84 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.302 0.572 . . . . 75.51 110.11 -177.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.17 -175.09 5.25 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.449 -1.251 . . . . 41.32 109.261 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -66.27 124.91 23.97 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 123.731 0.644 . . . . 74.5 109.434 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 63.77 0.59 0.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.84 1.256 . . . . 74.21 113.887 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.9 t -108.29 114.11 45.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 107.728 -1.212 . . . . 72.41 107.728 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 129.33 37.12 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.195 -1.039 . . . . 75.14 108.195 -170.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.441 ' HB2' HD12 ' D' ' 51' ' ' LEU . 30.2 tt0 -99.82 147.47 25.46 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.325 1.05 . . . . 53.24 109.4 177.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.16 127.47 73.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.378 -1.342 . . . . 72.41 107.378 170.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.43 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 61.8 t -109.58 109.95 30.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.994 -0.743 . . . . 75.22 108.994 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.85 119.35 30.98 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.789 -0.819 . . . . 74.21 108.789 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 47.7 ttm-85 -98.74 109.98 22.66 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.88 -1.156 . . . . 73.55 107.88 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.535 HG23 ' HB1' ' D' ' 110' ' ' ALA . 38.8 t -115.06 118.77 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.787 -0.819 . . . . 72.51 108.787 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 12.0 m -115.46 144.31 44.02 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.487 1.115 . . . . 74.53 109.381 -171.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.495 HG21 HD22 ' D' ' 126' ' ' LEU . 58.5 t -139.01 103.82 2.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.18 0.992 . . . . 74.1 108.919 172.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 99.9 m -97.47 120.19 37.38 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.25 -1.019 . . . . 75.42 108.25 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' D' ' 38' ' ' PRO . . . -122.37 154.93 37.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.659 0.784 . . . . 74.34 110.925 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.406 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 54.7 m -150.6 139.69 21.1 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.562 0.539 . . . . 73.11 112.127 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 11.7 mt -110.7 121.05 44.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.054 1.342 . . . . 74.52 108.977 171.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.0 -113.28 4.27 Favored Glycine 0 C--N 1.341 0.829 0 O-C-N 123.338 0.399 . . . . 72.11 112.72 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.12 5.86 18.81 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.103 0.961 . . . . 74.11 110.898 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.418 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 15.8 pt-20 -132.13 158.75 40.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.86 0.464 . . . . 63.23 110.613 -174.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 65.4 m -71.39 138.48 49.19 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 116.061 -0.518 . . . . 74.0 110.603 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.552 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -91.19 -68.67 0.78 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.891 0.876 . . . . 71.54 109.624 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -146.36 145.96 30.49 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 121.551 0.691 . . . . 74.21 110.25 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -120.24 141.03 50.31 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.658 1.583 . . . . 74.33 106.956 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.571 ' SG ' HG22 ' D' ' 114' ' ' ILE . 42.4 t -153.79 139.0 17.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.56 -0.534 . . . . 72.44 109.56 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -156.9 132.16 9.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.41 -0.589 . . . . 75.33 109.41 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.06 120.15 46.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.756 0.823 . . . . 75.21 109.277 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.613 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.3 mt-30 -89.43 86.82 6.87 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.647 -0.872 . . . . 75.34 108.647 169.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -80.03 94.4 5.93 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.695 -1.139 . . . . 73.14 108.917 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.09 143.34 18.07 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.926 -0.47 . . . . 70.04 111.926 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.542 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -140.64 131.5 5.01 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.714 -0.554 . . . . 64.13 111.714 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -94.67 125.13 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.719 0.808 . . . . 73.23 109.447 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -132.18 125.11 30.4 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.052 0.941 . . . . 71.34 109.743 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.6 m -87.76 104.15 16.29 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.524 -0.547 . . . . 72.54 109.524 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.438 HD12 ' SD ' ' D' ' 94' ' ' MET . 39.9 pt -107.08 141.19 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.902 0.881 . . . . 75.53 110.807 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.413 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -169.14 165.96 10.95 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.976 0.91 . . . . 75.33 110.889 173.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.72 -19.62 19.39 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.197 -0.456 . . . . 73.34 112.925 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.409 HD12 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -118.97 149.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.084 0.953 . . . . 71.35 108.691 177.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -154.32 160.06 41.54 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.336 0.495 . . . . 73.42 112.336 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.36 -121.31 24.98 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 114.791 -1.095 . . . . 74.12 113.51 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.7 p -71.12 -31.98 68.44 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.892 0.877 . . . . 72.33 111.484 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -69.59 -40.34 76.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.761 0.425 . . . . 74.52 110.109 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.571 ' HE2' ' HA ' ' H' ' 452' ' ' VAL . 7.1 tmm? -72.45 -37.65 68.48 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.382 -0.826 . . . . 71.13 109.777 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.74 71.27 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.031 0.532 . . . . 72.34 111.507 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -69.49 -39.39 77.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.129 0.972 . . . . 72.13 110.16 175.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -68.85 -50.31 50.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.808 -0.633 . . . . 74.22 110.435 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.68 -25.21 44.78 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.554 0.742 . . . . 74.45 111.645 -168.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.12 11.23 37.22 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-O 119.607 -0.552 . . . . 74.3 113.543 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.36 -58.25 0.2 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.184 0.492 . . . . 74.21 111.227 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -70.7 -46.95 62.17 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.272 0.629 . . . . 64.53 111.689 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 55.1 m -67.37 -44.21 45.75 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.503 -0.76 . . . . 71.1 111.693 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -56.52 -32.82 90.96 Favored 'Trans proline' 0 C--N 1.394 2.922 0 C-N-CA 122.479 2.119 . . . . 74.35 113.423 165.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -71.34 -25.32 62.34 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.002 0.521 . . . . 72.32 111.216 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 64.0 mt -77.12 -34.47 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.894 0.877 . . . . 75.23 110.138 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.542 HD22 ' HA3' ' D' ' 82' ' ' GLY . 95.9 mt -76.77 -22.71 53.37 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.561 -0.745 . . . . 75.35 111.724 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -67.41 -42.05 35.74 Favored Pre-proline 0 CA--C 1.565 1.557 0 N-CA-C 113.941 1.089 . . . . 74.11 113.941 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -60.41 -40.49 57.32 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.097 1.865 . . . . 74.11 112.71 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -73.06 -33.71 65.83 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.586 0.754 . . . . 75.54 111.511 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.535 ' HB1' HG23 ' D' ' 62' ' ' VAL . . . -63.79 -53.12 55.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.641 0.776 . . . . 75.2 109.523 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -54.65 -48.57 72.15 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 124.895 1.372 . . . . 75.01 110.588 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -60.33 -46.3 90.4 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.155 0.909 . . . . 72.31 111.651 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.02 -42.08 93.59 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.788 0.68 . . . . 73.1 110.719 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.571 HG22 ' SG ' ' D' ' 76' ' ' CYS . 72.2 mt -64.17 -50.66 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 124.174 0.921 . . . . 74.45 110.988 174.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 41.5 m -57.32 -42.42 81.81 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.808 1.243 . . . . 74.34 110.831 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -65.31 -41.61 93.87 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.264 -1.334 . . . . 74.25 110.446 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.455 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 73.3 mtm -71.6 -31.06 66.51 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.198 0.444 . . . . 55.21 112.198 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.73 -42.06 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.328 0.651 . . . . 75.25 109.842 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 84.6 p -76.22 -27.08 56.67 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.876 0.47 . . . . 72.14 111.531 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -75.83 -34.2 60.1 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.002 0.521 . . . . 74.24 110.057 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.72 89.41 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.981 -0.554 . . . . 53.02 111.962 171.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 38.5 p 64.01 19.57 11.81 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.153 2.181 . . . . 75.11 114.077 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -78.4 149.39 75.4 Favored Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 108.549 -0.908 . . . . 72.54 108.549 170.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.34 137.35 71.4 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.817 2.345 . . . . 71.55 112.113 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -55.55 146.21 21.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.793 1.237 . . . . 71.2 113.247 -164.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.495 HD22 HG21 ' D' ' 64' ' ' VAL . 38.3 tp -116.48 94.21 4.53 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.256 -0.884 . . . . 75.42 109.328 -176.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.451 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 88.0 m-20 -104.82 91.48 3.85 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.563 -0.903 . . . . 74.52 108.563 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 23.6 tp -73.66 133.54 43.44 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.409 -0.814 . . . . 75.11 110.314 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.19 146.02 99.0 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.582 0.753 . . . . 73.44 111.167 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.4 124.33 3.63 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.329 2.019 . . . . 74.44 111.048 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 99.3 t -107.27 133.48 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.032 -0.531 . . . . 74.42 109.594 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -79.35 88.61 4.97 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.007 -0.738 . . . . 72.43 109.007 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -65.21 -24.87 67.48 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.759 -1.109 . . . . 73.22 111.469 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.95 -52.67 63.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.884 0.873 . . . . 71.53 110.593 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.02 -37.59 66.87 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.348 -0.842 . . . . 62.14 111.721 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.25 -31.33 72.07 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 115.616 -0.72 . . . . 75.42 110.162 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -63.68 -39.88 95.41 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.811 0.845 . . . . 75.1 110.653 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 30.8 mtt -63.44 -46.16 87.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.222 0.609 . . . . 75.12 109.708 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.407 ' HA ' HE21 ' D' ' 142' ' ' GLN . 79.5 m-20 -74.15 -20.82 60.1 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.167 -0.924 . . . . 72.11 111.674 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -73.27 -39.98 64.96 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.915 0.886 . . . . 74.42 110.247 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.6 mp -65.41 -38.01 88.66 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.323 0.649 . . . . 75.43 111.794 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.407 HE21 ' HA ' ' D' ' 139' ' ' ASN . 23.2 pt20 -86.73 32.96 0.65 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.579 0.585 . . . . 75.41 112.579 -174.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -119.15 91.39 3.54 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.319 0.648 . . . . 75.52 110.33 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -147.87 85.62 1.56 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.095 0.958 . . . . 72.33 108.513 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.57 141.57 18.24 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.565 -0.743 . . . . 61.11 110.195 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -116.14 8.03 18.64 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.735 -0.48 . . . . 72.3 113.669 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -84.5 149.92 25.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.552 0.741 . . . . 73.25 110.848 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.82 90.04 2.15 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 116.559 -0.291 . . . . 61.05 112.384 176.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 26.4 m -68.35 99.04 0.89 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.618 0.767 . . . . 74.54 110.642 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -80.96 97.53 7.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.411 0.684 . . . . 71.33 109.515 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -88.16 -68.02 0.79 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.021 0.928 . . . . 74.14 110.931 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 60.6 99.84 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.311 1.044 . . . . 73.04 110.585 -173.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -129.22 101.35 5.97 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.913 0.885 . . . . 74.42 109.014 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -79.36 155.41 28.44 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.815 -0.439 . . . . 74.14 109.815 172.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 N-CA-C 108.37 -0.974 . . . . 73.44 108.37 -178.846 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 110.15 -0.315 . . . . 65.34 110.15 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . 0.669 HG11 ' HA ' ' A' ' 54' ' ' ASP . 8.9 p -168.0 29.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.391 0 CA-C-O 122.785 1.279 . . . . 62.21 108.52 -174.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.53 -171.73 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 115.056 -0.974 . . . . 72.53 111.736 -162.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 99.7 21.59 14.06 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 114.346 0.498 . . . . 43.35 114.346 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 6.2 mp -99.39 -175.87 3.13 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 117.477 0.639 . . . . 74.43 111.074 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 12.9 t -141.4 178.79 7.18 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.967 0.907 . . . . 71.14 109.367 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -81.81 165.53 20.8 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.937 0.895 . . . . 74.43 109.817 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . 0.441 ' NE2' ' HA ' ' E' ' 460' ' ' LEU . 17.1 pt20 -154.04 131.87 11.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.068 0.547 . . . . 75.13 110.008 174.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 53.0 p -69.66 94.83 0.82 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.784 0.834 . . . . 64.2 109.454 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 7.5 t70 73.47 146.69 0.08 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.381 1.472 . . . . 64.21 111.587 -172.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . 0.441 ' HA ' ' NE2' ' E' ' 457' ' ' GLN . 95.2 mt -74.69 -71.87 0.32 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.599 -0.728 . . . . 74.43 109.363 170.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -175.37 18.86 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.884 0.874 . . . . 74.21 111.504 -171.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -162.12 130.99 4.28 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 111.667 0.247 . . . . 75.42 111.667 -168.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 4.7 p -95.46 -60.19 1.72 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.894 0.878 . . . . 73.14 110.782 175.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 464' ' ' MET . . . . . 0.405 ' HB3' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER 82.11 125.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 126.509 1.924 . . . . 75.41 109.874 -170.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.44 98.67 7.42 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.579 -0.897 . . . . 75.41 108.579 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -81.46 152.5 27.34 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.043 0.537 . . . . 70.14 110.852 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -158.82 93.96 1.2 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.43 -0.582 . . . . 71.25 109.43 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . 0.568 ' HB2' ' HG ' ' E' ' 470' ' ' LEU . 77.1 mt -82.95 -179.98 7.6 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.543 -0.753 . . . . 74.05 109.65 175.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -82.27 55.75 4.96 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.752 -0.539 . . . . 63.34 111.752 173.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . 0.568 ' HG ' ' HB2' ' E' ' 468' ' ' LEU . 62.7 mt -85.11 86.86 7.35 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 123.443 0.697 . . . . 72.01 109.575 -175.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt . . . . . 0 C--O 1.247 0.939 0 CA-C-N 114.721 -1.127 . . . . 75.11 108.52 -178.294 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 109.593 -0.521 . . . . 71.52 109.593 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.29 -30.27 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 120.656 0.265 . . . . 62.23 110.654 171.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 23.1 m -139.18 170.42 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.647 1.179 . . . . 75.4 109.563 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -174.54 118.16 0.66 Allowed Glycine 0 C--N 1.344 1.003 0 N-CA-C 111.358 -0.697 . . . . 63.3 111.358 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . 0.427 HD12 HD13 ' B' ' 98' ' ' LEU . 7.6 mp -86.67 167.38 14.55 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.532 0.733 . . . . 74.11 110.999 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 6.2 m -70.86 -15.99 62.67 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.856 0.863 . . . . 73.42 110.512 173.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 5.9 t70 74.11 68.82 0.1 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 125.707 1.603 . . . . 75.13 108.831 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . 0.51 ' NE2' ' HA2' ' B' ' 99' ' ' GLY . 4.5 pm0 -58.8 93.76 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.013 -1.449 . . . . 74.03 112.001 -171.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 29.6 m -67.1 -44.09 80.85 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.593 -1.185 . . . . 73.24 109.075 171.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -87.67 115.31 25.02 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.754 -1.112 . . . . 73.04 109.637 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . 0.496 ' HG ' HD13 ' B' ' 44' ' ' LEU . 4.6 mm? -92.88 -169.73 2.25 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.672 0.789 . . . . 75.33 111.622 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -134.0 14.08 3.93 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.684 1.194 . . . . 75.32 111.579 -168.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . 0.414 ' OH ' ' HA ' ' B' ' 43' ' ' ASP . 24.5 p90 -73.05 112.61 9.24 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 121.412 0.625 . . . . 70.43 110.731 -174.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 20.7 p -126.21 137.92 53.59 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.268 1.027 . . . . 63.05 109.548 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 49.5 ttm -151.44 122.31 7.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.599 0.76 . . . . 75.01 109.656 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -85.22 72.53 10.73 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.455 -0.943 . . . . 75.05 108.455 171.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . 179.79 -178.4 0.4 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.828 1.251 . . . . 74.5 109.783 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -133.87 -169.44 2.31 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.227 1.011 . . . . 62.12 109.3 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . 0.443 HD11 HG23 ' B' ' 40' ' ' VAL . 8.5 tt -65.33 -35.81 82.11 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.875 0.47 . . . . 74.53 110.243 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.12 54.47 1.87 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 110.792 -0.923 . . . . 72.1 110.792 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . 0.639 HD13 HG21 ' B' ' 40' ' ' VAL . 77.5 mt -67.36 95.75 0.46 Allowed 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.893 0.877 . . . . 74.5 110.848 -178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--O 1.25 1.085 0 N-CA-C 108.242 -1.021 . . . . 74.45 108.242 175.621 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 110.207 -0.294 . . . . 75.14 110.207 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.29 -63.75 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 123.949 0.9 . . . . 74.43 111.142 -174.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . 0.412 HG13 ' CD1' ' C' ' 56' ' ' TYR . 52.4 t -94.59 131.69 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.509 0.723 . . . . 73.42 112.232 -167.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . -135.42 79.62 0.32 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 110.879 -0.888 . . . . 63.03 110.879 172.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' C' ' 48' ' ' SER . 92.5 mt -66.76 131.04 45.09 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.605 0.762 . . . . 74.5 112.207 -178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 34.0 p -100.53 -73.16 0.65 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.779 0.832 . . . . 75.41 109.182 171.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -167.19 173.44 9.04 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.557 0.743 . . . . 72.23 109.843 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . 0.475 ' HG3' HD13 ' C' ' 98' ' ' LEU . 0.0 OUTLIER -146.08 128.07 15.52 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 107.421 -1.326 . . . . 62.11 107.421 -178.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 22.7 p -135.02 11.79 3.6 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.297 0.851 . . . . 75.3 113.297 -173.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -121.1 122.62 40.45 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 118.431 0.559 . . . . 75.32 111.365 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.54 85.69 2.38 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.866 -0.79 . . . . 65.43 108.866 167.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -51.54 -33.56 32.62 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.068 1.347 . . . . 73.21 112.667 171.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -78.27 102.02 7.44 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.39 -0.596 . . . . 64.12 109.39 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 81.3 p -86.04 -6.16 59.08 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.197 0.999 . . . . 74.32 111.904 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 464' ' ' MET . . . . . 0.531 ' HE1' HD22 ' C' ' 42' ' ' LEU . 0.0 OUTLIER 74.43 123.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.56 1.544 . . . . 74.14 111.07 174.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -131.77 25.06 4.69 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.361 0.664 . . . . 72.54 110.571 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . 0.404 ' HB2' ' HE3' ' G' ' 464' ' ' MET . . . -138.46 154.47 48.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.96 0.504 . . . . 63.23 110.984 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -102.31 175.36 5.54 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.214 -0.903 . . . . 72.52 110.615 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . 0.614 HD23 HD23 ' C' ' 42' ' ' LEU . 96.1 mt -97.34 24.49 6.45 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.03 0.932 . . . . 74.13 111.835 -176.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 85.67 -8.14 73.6 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.185 -0.461 . . . . 75.04 112.922 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . 0.552 HD12 ' HG2' ' C' ' 38' ' ' PRO . 42.9 mt -82.78 156.19 23.82 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 122.792 0.437 . . . . 74.14 110.537 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt . . . . . 0 C--O 1.246 0.9 0 C-N-CA 124.474 1.11 . . . . 74.35 108.976 172.802 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.326 -0.62 . . . . 62.13 109.326 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.95 -65.56 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.494 0.718 . . . . 74.05 109.14 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.571 ' HA ' ' HE2' ' D' ' 94' ' ' MET . 33.7 m -87.39 -176.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.205 0.602 . . . . 70.22 111.553 -175.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 152.43 57.01 0.01 OUTLIER Glycine 0 C--N 1.35 1.324 0 N-CA-C 111.576 -0.61 . . . . 73.11 111.576 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.44 160.52 15.99 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.632 0.773 . . . . 72.23 111.828 -174.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 4.7 t -159.32 74.75 0.64 Allowed 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 114.304 -1.317 . . . . 72.42 108.327 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -86.26 150.88 24.06 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.014 -0.994 . . . . 62.3 111.726 -172.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -134.76 156.78 48.24 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.508 1.123 . . . . 65.55 108.948 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 77.0 p -72.83 -28.0 62.28 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.893 0.477 . . . . 73.23 110.859 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -89.73 132.49 35.16 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.331 -0.988 . . . . 61.15 108.331 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -157.76 135.15 10.34 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 122.943 0.497 . . . . 71.3 109.863 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 64.51 -80.75 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.159 1.383 . . . . 75.35 113.715 168.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -152.9 176.93 11.3 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.74 0.816 . . . . 72.24 111.094 -173.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 44.6 p -119.16 -57.62 2.0 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.892 0.877 . . . . 74.45 110.995 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 64.4 mtt 59.2 104.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.405 1.482 . . . . 64.11 113.255 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . 0.431 ' HA ' ' HG2' ' D' ' 41' ' ' LYS . 40.1 ttmt -113.95 59.38 0.67 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.543 -0.91 . . . . 74.21 108.543 174.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -176.27 -75.47 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.698 -1.137 . . . . 72.5 108.676 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . 56.14 -174.1 0.06 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.297 1.039 . . . . 72.3 112.284 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 84.3 mt 56.32 -81.59 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.277 1.431 . . . . 65.53 113.547 172.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 134.57 72.31 0.08 OUTLIER Glycine 0 C--N 1.345 1.052 0 N-CA-C 108.696 -1.762 . . . . 73.42 108.696 -167.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.43 115.75 5.43 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.603 0.761 . . . . 74.55 109.204 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 13.3 mptt . . . . . 0 N--CA 1.483 1.198 0 C-N-CA 123.899 0.88 . . . . 65.11 110.495 -178.155 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.487 1.375 0 N-CA-C 108.914 -0.773 . . . . 74.32 108.914 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.4 p 56.59 97.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.708 1.603 . . . . 70.11 112.471 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -84.81 149.77 25.49 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 116.169 -0.469 . . . . 73.52 110.382 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -100.26 56.07 0.92 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.749 -0.834 . . . . 63.44 108.749 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 9' ' ' MET . 8.7 t30 -67.0 105.74 1.73 Allowed 'General case' 0 C--N 1.347 0.476 0 CA-C-N 115.323 -0.853 . . . . 74.12 109.224 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -69.16 -79.41 0.06 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.781 -0.822 . . . . 71.12 108.781 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.0 p -146.04 0.36 0.83 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.105 0.562 . . . . 73.12 110.931 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.14 -45.39 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.119 0.568 . . . . 74.33 110.379 -174.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.485 ' O ' ' HA ' ' A' ' 5' ' ' ASN . 20.3 ptp -85.32 144.03 28.32 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.123 0.569 . . . . 73.5 109.868 -174.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.6 m -140.94 134.28 29.72 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.732 -0.84 . . . . 71.13 108.732 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.485 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 35.9 t80 -136.31 111.91 9.34 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.32 -0.992 . . . . 74.35 108.32 170.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.744 ' HG2' ' HB3' ' C' ' 150' ' ' GLU . 41.1 tp60 -136.47 124.56 22.96 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.549 -0.908 . . . . 61.44 108.549 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.488 HG12 ' HD2' ' A' ' 84' ' ' PHE . 50.3 mt -89.45 112.04 23.82 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.781 -0.822 . . . . 75.15 108.781 172.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -74.29 -38.59 63.32 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 124.412 1.07 . . . . 65.41 109.523 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -167.07 140.87 3.72 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.829 -0.623 . . . . 73.11 110.568 -169.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.427 HD13 ' HB3' ' C' ' 130' ' ' PRO . 79.6 mt -128.72 135.1 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.054 -1.091 . . . . 73.41 108.054 172.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -162.98 151.24 13.99 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 124.18 0.925 . . . . 74.34 110.249 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -74.64 121.93 22.39 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.842 -0.799 . . . . 74.41 108.842 172.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mtpt -82.07 -32.61 30.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.716 -0.475 . . . . 72.54 109.716 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.6 t70 -147.72 141.53 25.73 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.057 -0.974 . . . . 73.5 109.462 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 70.1 mt -136.67 147.67 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.138 1.375 . . . . 71.12 107.494 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.548 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 40.4 t -157.23 149.45 22.81 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.305 0.642 . . . . 75.24 109.699 172.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 88.8 t80 -151.53 124.53 8.65 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.368 -1.716 . . . . 75.4 106.368 177.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -129.41 114.27 15.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.73 0.412 . . . . 71.33 109.954 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.28 77.0 67.54 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 108.018 -1.105 . . . . 73.14 108.018 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.68 -29.01 20.13 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.203 1.935 . . . . 73.04 110.354 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.404 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 72.3 m-20 -100.94 24.64 9.0 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.139 1.376 . . . . 74.3 110.072 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.47 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -56.98 -42.59 97.17 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 124.536 1.134 . . . . 72.32 112.742 170.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.3 -24.61 14.24 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 121.87 1.713 . . . . 73.32 112.52 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -72.86 -33.7 66.27 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.223 0.609 . . . . 73.13 111.184 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.614 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 9.8 p -68.33 -25.36 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 123.52 0.513 . . . . 72.25 111.049 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -69.8 -33.66 72.66 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.241 1.016 . . . . 62.25 110.118 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -92.27 -33.73 14.53 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.76 0.824 . . . . 73.34 111.562 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.614 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -82.67 171.77 13.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.189 0.595 . . . . 73.42 110.364 176.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -86.2 138.96 31.48 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.009 0.524 . . . . 73.24 110.687 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.412 ' HZ2' HD13 ' E' ' 470' ' ' LEU . 77.6 t-105 -76.26 87.0 3.08 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 121.506 0.669 . . . . 63.42 110.205 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -125.52 79.68 66.94 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 108.341 -0.985 . . . . 74.31 108.341 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -86.39 138.65 5.61 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.104 2.536 . . . . 70.34 114.248 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -112.04 110.71 21.16 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 106.334 -1.728 . . . . 74.13 106.334 166.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.446 HG11 HD12 ' E' ' 470' ' ' LEU . 16.7 m -112.97 134.87 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.917 0.887 . . . . 72.51 111.619 -165.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -121.69 149.18 43.61 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.719 0.808 . . . . 74.42 110.171 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.483 ' HB2' ' HG ' ' E' ' 468' ' ' LEU . 46.9 tp -127.32 109.29 11.65 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.035 0.934 . . . . 73.22 108.505 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -106.58 118.5 36.82 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.673 -0.862 . . . . 73.43 108.673 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 60' ' ' LEU . 9.8 tt -116.04 141.62 47.88 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 122.788 0.435 . . . . 74.24 110.216 -177.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -143.23 132.56 23.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.934 1.293 . . . . 75.14 108.91 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.427 ' H ' HD21 ' E' ' 460' ' ' LEU . 90.0 m -109.94 135.9 50.07 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.116 0.967 . . . . 75.01 108.631 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.01 129.67 40.41 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.716 0.806 . . . . 60.14 109.917 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.5 p -93.73 152.07 19.2 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.001 0.52 . . . . 73.44 110.545 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 43.3 t -150.03 151.96 34.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.19 0.996 . . . . 64.21 108.379 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -112.46 116.14 29.81 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.121 -0.696 . . . . 74.32 109.121 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.0 mt -92.04 -33.45 14.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.532 0.733 . . . . 73.35 110.421 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.67 178.67 10.07 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.32 -0.855 . . . . 73.45 109.968 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.59 121.77 14.7 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.198 -0.668 . . . . 73.04 109.198 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 69.25 9.53 7.38 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.602 1.161 . . . . 75.1 112.199 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.21 115.93 51.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 108.74 -0.837 . . . . 74.23 108.74 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -112.74 127.33 56.11 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.426 0.69 . . . . 72.43 110.022 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 44.9 tt0 -91.78 127.74 37.35 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.876 -1.056 . . . . 73.44 108.795 169.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.408 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 64.7 t -108.77 122.5 63.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.714 -1.217 . . . . 75.13 107.714 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.9 t -104.37 107.04 21.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.896 -1.15 . . . . 63.24 107.896 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 44' ' ' LEU . 43.6 tp -87.85 98.96 11.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.53 -0.915 . . . . 71.43 108.53 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -84.99 110.59 19.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.438 -0.801 . . . . 71.53 109.447 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.4 t -112.84 107.72 23.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.64 -0.874 . . . . 74.33 108.64 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.7 m -95.29 125.71 40.1 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.117 0.967 . . . . 75.44 108.984 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.695 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 26.5 t -118.43 135.52 58.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 124.721 1.209 . . . . 63.42 108.901 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 t -141.31 138.16 32.94 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.23 0.612 . . . . 74.32 109.542 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.58 103.3 6.79 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.947 0.899 . . . . 62.42 108.933 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.2 p -111.24 124.77 52.89 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.009 0.523 . . . . 65.23 109.92 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.598 HD13 ' HB1' ' A' ' 73' ' ' ALA . 8.6 mp -96.82 85.34 3.78 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.063 -1.088 . . . . 72.24 108.063 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.18 -105.62 2.91 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 114.413 -1.267 . . . . 54.55 110.472 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -105.85 -24.73 12.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.821 0.848 . . . . 75.24 110.402 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 22.4 tt0 -96.55 120.33 36.66 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.416 0.687 . . . . 74.44 111.088 -176.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 57.1 m -75.93 126.86 31.8 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.265 1.026 . . . . 75.04 110.959 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.598 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -69.61 -57.99 4.5 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.147 0.579 . . . . 63.23 109.806 174.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -145.77 157.67 43.91 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 114.719 -1.128 . . . . 75.15 111.419 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.0 tp -129.74 146.29 51.5 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.677 -1.601 . . . . 75.42 107.439 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.695 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.0 m -141.8 141.12 33.16 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.526 -0.916 . . . . 71.32 108.526 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.548 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 8.2 tp10 -147.22 120.96 9.22 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.792 -0.818 . . . . 61.52 108.792 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -135.23 110.22 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.706 -0.479 . . . . 75.55 109.706 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 68.5 mt-30 -91.48 82.87 5.35 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.183 -1.043 . . . . 72.53 108.183 172.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -75.74 106.88 7.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.834 -1.075 . . . . 73.14 109.386 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.98 151.83 20.08 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 112.02 -0.432 . . . . 51.45 112.02 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.02 141.58 10.05 Favored Glycine 0 C--O 1.239 0.442 0 N-CA-C 111.246 -0.742 . . . . 64.34 111.246 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mt -90.65 118.78 36.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.613 -0.884 . . . . 75.02 108.613 173.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.488 ' HD2' HG12 ' A' ' 13' ' ' ILE . 17.7 m-85 -124.08 118.91 28.01 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.559 -0.904 . . . . 63.25 108.559 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.4 p -90.56 110.23 21.36 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 108.473 -0.936 . . . . 74.34 108.473 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.433 ' HB ' HD13 ' A' ' 89' ' ' ILE . 2.8 pp -112.57 150.5 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.361 0.665 . . . . 74.13 111.422 -171.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.454 ' HA ' HG23 ' E' ' 451' ' ' VAL . . . -156.54 159.91 38.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.913 0.885 . . . . 72.54 109.534 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 77.27 4.94 84.89 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 123.533 0.52 . . . . 72.01 114.137 170.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.502 HG23 HE21 ' A' ' 93' ' ' GLN . 2.6 pp -134.42 148.65 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.97 0.908 . . . . 64.01 109.537 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.636 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 19.3 tt0 -166.89 175.5 7.67 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.962 0.505 . . . . 74.32 110.363 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.491 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 62.04 -134.89 46.14 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.44 0.543 . . . . 73.22 113.741 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.9 p -71.3 -24.6 62.17 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.618 0.767 . . . . 71.52 111.682 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.502 HE21 HG23 ' A' ' 89' ' ' ILE . 28.5 tt0 -72.28 -37.94 68.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.156 0.583 . . . . 74.43 110.07 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.636 ' HE1' ' HA ' ' A' ' 90' ' ' GLU . 48.2 ttm -62.6 -42.35 99.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.944 0.498 . . . . 71.22 110.374 172.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.11 -33.58 65.25 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.937 0.773 . . . . 70.22 111.143 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -76.03 -36.47 59.1 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 116.046 -0.524 . . . . 73.23 111.262 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 64.5 m -62.05 -57.58 11.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.798 0.439 . . . . 74.21 111.064 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.496 HD23 HD11 ' E' ' 454' ' ' LEU . 1.7 pp -91.11 -9.13 46.75 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.433 0.693 . . . . 70.24 112.583 -176.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.86 3.67 30.42 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 119.893 -0.393 . . . . 64.42 113.788 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.17 -63.13 0.35 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.318 0.559 . . . . 74.21 111.31 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.485 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 75.2 t80 -61.94 -58.78 6.58 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.25 -0.887 . . . . 73.43 111.886 -173.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.9 m -70.24 -34.92 4.43 Favored Pre-proline 0 CA--C 1.569 1.697 0 N-CA-C 114.128 1.159 . . . . 62.44 114.128 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -52.63 -42.9 59.28 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.24 1.96 . . . . 75.43 112.492 163.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -67.44 -28.32 67.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.247 0.619 . . . . 75.21 111.197 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.96 -45.44 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.814 0.845 . . . . 74.55 110.468 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.19 -18.07 60.81 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.838 -0.619 . . . . 75.02 111.63 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -62.35 -44.44 88.1 Favored Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 124.273 1.029 . . . . 74.34 113.715 -170.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.32 -36.43 79.14 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.1 1.867 . . . . 74.1 113.268 172.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.442 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 81.3 m-85 -68.22 -43.02 78.93 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.474 0.71 . . . . 70.11 111.516 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.24 83.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.092 0.557 . . . . 71.43 109.95 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -52.03 -51.43 57.47 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 124.164 0.915 . . . . 75.01 110.151 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.66 -45.85 84.97 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.036 0.935 . . . . 74.33 111.307 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.0 t -59.84 -34.13 72.69 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.047 0.539 . . . . 64.2 111.37 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.408 HG22 HG22 ' A' ' 64' ' ' VAL . 81.6 mt -74.41 -54.54 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.749 0.82 . . . . 65.43 109.848 175.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.439 HG22 ' HG3' ' A' ' 125' ' ' GLN . 89.3 m -48.81 -45.39 40.25 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.909 1.284 . . . . 65.5 111.66 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -63.48 -46.37 86.46 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.811 -1.086 . . . . 64.35 109.95 -175.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 64.1 mtm -64.38 -38.46 91.09 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.144 0.578 . . . . 75.55 111.201 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.69 -43.09 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.569 0.748 . . . . 74.52 110.391 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.8 m -73.61 -32.4 64.06 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.532 0.733 . . . . 74.12 111.159 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -72.33 -30.17 64.5 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.653 0.781 . . . . 74.04 109.672 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.67 -2.89 90.2 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 124.028 0.83 . . . . 74.22 112.788 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m 66.98 25.39 9.33 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 122.479 1.133 . . . . 74.34 110.838 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.421 ' CE1' HG12 ' A' ' 31' ' ' VAL . 96.6 m-85 -91.26 155.68 44.28 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 115.451 -0.795 . . . . 70.45 109.524 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.02 124.61 15.12 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.77 2.313 . . . . 65.52 112.024 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.439 ' HG3' HG22 ' A' ' 115' ' ' THR . 34.3 tt0 -54.76 134.81 47.78 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 124.214 0.947 . . . . 73.35 112.184 -173.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.497 HD11 HD23 ' E' ' 470' ' ' LEU . 19.0 tp -112.03 116.52 30.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.85 -1.068 . . . . 73.44 109.502 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -130.98 100.12 5.13 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.285 -1.005 . . . . 74.52 108.285 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.74 151.14 43.81 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.86 0.464 . . . . 74.43 110.255 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.55 150.61 89.11 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 123.139 0.576 . . . . 62.33 110.601 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.11 120.0 7.05 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.652 2.235 . . . . 74.43 110.472 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.56 124.43 54.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.657 -0.868 . . . . 75.45 108.657 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -77.02 88.53 3.55 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.982 0.801 . . . . 73.35 109.683 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -64.31 -24.12 67.54 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.146 -0.934 . . . . 72.32 111.05 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.2 -52.71 64.42 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 123.896 0.747 . . . . 71.44 110.107 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.8 -50.79 72.02 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 124.018 0.824 . . . . 74.32 110.285 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -54.36 -43.88 71.71 Favored 'General case' 0 C--O 1.243 0.726 0 O-C-N 124.503 1.127 . . . . 72.14 111.857 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -72.52 -41.45 65.87 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 116.113 -0.494 . . . . 65.34 109.868 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.632 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 22.3 mtp -69.08 -25.91 64.67 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-O 119.28 -0.391 . . . . 75.02 111.483 -175.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -59.57 -31.69 69.67 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.596 0.758 . . . . 72.41 110.3 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -85.85 -41.52 14.92 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.204 1.001 . . . . 71.33 110.758 174.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.632 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 63.3 tp -67.88 -50.65 55.17 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.359 1.063 . . . . 74.55 112.431 -169.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.417 ' HG3' ' HB1' ' A' ' 145' ' ' ALA . 6.4 tp-100 -163.83 25.33 0.08 Allowed 'General case' 0 CA--C 1.556 1.19 0 CA-C-O 121.597 0.713 . . . . 65.31 109.85 -173.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 64.67 -74.88 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.519 1.528 . . . . 74.32 112.451 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.4 tm0? -134.39 -38.26 0.84 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.237 0.615 . . . . 73.43 109.366 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.417 ' HB1' ' HG3' ' A' ' 142' ' ' GLN . . . -60.05 138.28 57.9 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.287 0.635 . . . . 63.23 111.375 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.551 ' HA3' ' HE3' ' A' ' 138' ' ' MET . . . 177.23 70.46 0.06 OUTLIER Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.137 -0.785 . . . . 72.25 111.137 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -148.18 154.13 39.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.697 0.799 . . . . 73.11 109.018 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 174.01 75.2 0.05 OUTLIER Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.042 -0.823 . . . . 74.14 111.042 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 35.7 p -60.66 94.49 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.825 0.85 . . . . 74.41 111.227 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -103.01 100.21 10.13 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.245 1.018 . . . . 75.43 108.526 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.27 158.36 36.01 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.424 0.689 . . . . 75.15 110.906 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -115.21 94.29 4.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.733 -0.667 . . . . 73.43 109.546 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -79.21 124.61 28.52 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.405 -0.816 . . . . 75.33 109.567 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -66.86 -24.94 66.19 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.304 0.642 . . . . 74.41 111.344 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 C-N-CA 124.543 1.137 . . . . 75.44 111.055 175.578 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.952 0.405 . . . . 74.23 110.8 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.8 p -142.68 139.43 31.17 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.858 -0.526 . . . . 72.44 110.536 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.98 134.14 34.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.881 0.472 . . . . 73.33 110.126 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.88 118.79 3.13 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.38 -0.97 . . . . 73.03 108.38 176.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -134.29 -7.19 2.61 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.031 0.933 . . . . 75.42 110.918 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -69.18 122.98 19.9 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.719 0.807 . . . . 72.24 109.89 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 35.1 p -69.8 95.3 0.89 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.382 0.673 . . . . 50.43 111.47 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -131.64 172.35 12.36 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.877 0.871 . . . . 72.33 110.802 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.2 ptm 52.9 167.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 127.698 2.399 . . . . 74.55 114.04 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.4 m -167.4 140.26 3.4 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.767 1.227 . . . . 72.34 107.936 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.11 156.76 43.67 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.083 0.468 . . . . 63.14 109.971 160.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -125.96 141.19 52.08 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.072 -0.967 . . . . 70.01 108.645 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.563 HD11 HD12 ' B' ' 105' ' ' ILE . 48.7 mt -84.69 121.5 36.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.525 -0.917 . . . . 75.11 108.525 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -88.06 -38.26 15.59 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.601 0.563 . . . . 75.34 110.196 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -170.52 131.14 0.9 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.986 -0.552 . . . . 75.31 109.92 -170.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.7 mt -114.94 140.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 107.153 -1.425 . . . . 72.31 107.153 170.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -167.34 145.54 4.81 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.353 0.597 . . . . 75.23 112.376 -174.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.1 m -75.02 124.88 27.77 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.475 -1.238 . . . . 75.21 109.158 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -98.08 -36.28 10.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.953 0.501 . . . . 74.3 110.391 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 17.8 t70 -147.76 133.66 19.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.51 -0.314 . . . . 70.21 110.643 -168.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.474 HD13 ' SG ' ' B' ' 113' ' ' CYS . 47.1 mm -133.55 145.95 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.756 1.222 . . . . 75.12 108.842 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.0 t -147.1 136.25 22.5 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.655 1.182 . . . . 65.2 108.147 173.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -147.84 113.91 5.83 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.925 -1.139 . . . . 74.55 107.925 172.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -119.07 119.25 33.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.071 0.948 . . . . 73.2 108.562 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.476 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -108.3 85.1 2.57 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 108.189 -1.041 . . . . 74.3 108.189 168.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -65.94 -35.94 32.8 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 122.997 2.465 . . . . 74.4 112.028 -173.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -106.28 9.86 31.89 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.856 -1.065 . . . . 71.15 110.68 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.532 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -25.2 -66.16 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.061 0 C-N-CA 126.287 1.835 . . . . 71.45 115.162 -174.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 10.5 Cg_exo -67.2 -30.79 37.24 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 122.362 2.042 . . . . 74.44 112.168 -169.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -96.57 -30.16 13.45 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.019 -0.991 . . . . 64.14 112.053 -170.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.634 HG23 HD13 ' B' ' 68' ' ' LEU . 10.7 p -72.4 -19.74 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 122.471 0.308 . . . . 63.13 111.132 -174.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -63.73 -14.11 49.51 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.574 0.75 . . . . 71.41 112.295 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -64.01 -22.93 67.14 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.57 0.748 . . . . 64.34 111.794 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.505 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 96.6 mttt -97.92 100.97 12.34 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.022 0.929 . . . . 75.44 109.353 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.47 95.98 4.6 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.636 -0.505 . . . . 72.33 109.636 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -166.61 155.86 11.05 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.67 0.788 . . . . 74.43 109.237 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -75.37 105.1 1.73 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.006 -0.738 . . . . 72.02 109.006 170.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.509 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 21.1 Cg_endo -58.89 127.48 24.52 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.692 2.261 . . . . 73.33 112.202 -171.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -51.56 126.16 16.67 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.376 1.047 . . . . 71.21 110.225 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.553 HG11 HG12 ' B' ' 64' ' ' VAL . 89.6 t -106.22 139.58 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.363 0.665 . . . . 75.43 110.911 -171.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -108.02 125.72 51.88 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.821 -1.178 . . . . 72.33 107.821 162.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -85.04 137.86 32.8 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.451 -0.944 . . . . 71.32 108.451 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.47 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.1 t70 -133.2 135.65 45.19 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.51 -1.293 . . . . 72.31 107.51 175.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.529 HD13 HD12 ' F' ' 460' ' ' LEU . 0.2 OUTLIER -136.59 127.45 27.46 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.226 -1.028 . . . . 73.44 108.226 -177.404 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.49 145.75 34.02 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.069 -1.456 . . . . 73.14 107.069 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 34.6 p -127.86 120.1 27.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.012 -0.736 . . . . 75.21 109.012 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -119.95 116.14 25.19 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.747 0.819 . . . . 73.21 108.886 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -113.87 170.58 8.16 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.751 0.421 . . . . 72.01 111.616 -172.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 87.2 p -152.8 143.89 23.08 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.786 0.834 . . . . 74.34 110.251 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -83.13 136.14 34.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.198 0.599 . . . . 72.01 109.785 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 58.7 mt -101.67 -46.71 4.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.557 0.743 . . . . 64.52 110.645 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.07 -169.47 2.96 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.305 -0.862 . . . . 75.45 111.156 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -62.98 105.67 0.71 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.01 -0.996 . . . . 64.34 110.343 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 64.11 11.69 6.41 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.277 1.031 . . . . 73.31 112.026 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.4 112.2 37.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 106.567 -1.642 . . . . 74.22 106.567 173.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -133.85 137.94 45.32 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.491 -0.929 . . . . 75.11 108.491 -173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -107.89 137.09 46.51 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.483 0.713 . . . . 74.31 109.641 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.84 143.01 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.53 -0.915 . . . . 65.03 108.53 171.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 40.4 t -125.67 125.17 68.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 109.088 -0.708 . . . . 74.31 109.088 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.419 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -102.54 112.33 25.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.71 -1.132 . . . . 75.42 108.572 -174.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -97.62 110.98 23.44 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.587 0.755 . . . . 73.23 110.627 174.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.06 104.46 17.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.968 -1.123 . . . . 74.42 107.968 170.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 9.5 m -99.21 130.77 45.53 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.761 -0.829 . . . . 72.13 108.761 174.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.553 HG12 HG11 ' B' ' 40' ' ' VAL . 43.4 t -118.13 127.33 75.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 123.907 0.883 . . . . 73.55 108.93 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 87.9 m -109.75 137.85 46.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.403 -0.962 . . . . 75.11 108.403 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -146.61 145.86 30.22 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 122.844 0.457 . . . . 71.5 109.812 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.414 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.5 p -151.61 138.05 18.59 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.309 -0.86 . . . . 74.12 110.663 -172.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.634 HD13 HG23 ' B' ' 31' ' ' VAL . 60.4 mt -103.78 124.3 48.65 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.916 0.886 . . . . 74.03 109.923 174.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.51 -108.55 2.46 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 123.636 0.585 . . . . 74.32 112.733 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.61 5.0 12.36 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.854 0.862 . . . . 73.43 111.399 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.505 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 11.2 pt-20 -119.71 156.61 30.18 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.97 0.508 . . . . 71.54 110.019 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.2 m -68.3 137.84 55.0 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.595 0.56 . . . . 73.2 110.459 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.554 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -91.64 -65.01 1.04 Allowed 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.478 -1.304 . . . . 73.2 107.478 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -150.88 161.56 42.45 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.088 -0.96 . . . . 74.31 110.244 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.8 mt -132.85 111.56 11.19 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.047 -1.464 . . . . 74.35 107.047 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.2 t -118.86 153.45 34.52 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.005 -0.739 . . . . 74.41 109.005 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -160.64 131.39 5.44 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.875 -0.787 . . . . 75.42 108.875 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' B' ' 110' ' ' ALA . 86.2 t -128.09 145.29 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.679 -0.86 . . . . 73.41 108.679 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.531 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.0 mt-30 -126.37 95.96 4.54 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.999 -0.741 . . . . 73.42 108.999 172.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -86.2 104.01 15.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.167 -0.924 . . . . 73.14 109.895 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.44 153.85 25.55 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 111.673 -0.571 . . . . 52.33 111.673 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.44 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -154.02 127.11 2.06 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 111.417 -0.673 . . . . 75.12 111.417 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 62.7 mt -86.87 126.04 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.6 0.76 . . . . 73.14 109.68 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -131.74 132.07 43.54 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 107.713 -1.217 . . . . 72.41 107.713 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 31.6 m -102.95 91.66 4.23 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.194 -0.669 . . . . 73.2 109.194 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.521 HG13 ' HE2' ' B' ' 94' ' ' MET . 0.2 OUTLIER -94.79 142.58 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 115.859 -0.61 . . . . 72.35 110.939 -167.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.07 158.31 42.83 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.328 1.051 . . . . 73.44 109.399 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.47 -56.71 3.87 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.705 -0.68 . . . . 54.3 111.801 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.505 HD13 ' HB ' ' B' ' 86' ' ' ILE . 11.4 pt -69.13 149.7 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.81 0.844 . . . . 74.43 112.168 177.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -159.16 176.15 12.58 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 125.481 1.512 . . . . 72.22 107.588 171.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.09 -129.78 50.06 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.392 0.433 . . . . 74.22 112.716 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -83.38 -19.26 36.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.609 0.364 . . . . 70.44 111.719 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -72.89 -25.98 61.27 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.785 -0.45 . . . . 74.11 109.785 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.797 ' HE3' HD13 ' B' ' 98' ' ' LEU . 24.1 ttt -78.85 -33.57 45.78 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.127 -0.488 . . . . 71.52 110.12 170.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.17 -29.83 70.03 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.219 0.608 . . . . 64.13 111.001 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -69.2 -39.4 78.65 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.463 0.705 . . . . 72.11 111.414 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.8 t -66.87 -66.19 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.267 -0.879 . . . . 64.32 109.81 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.797 HD13 ' HE3' ' B' ' 94' ' ' MET . 38.8 mt -70.18 -27.31 64.42 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.555 0.742 . . . . 71.3 112.098 -172.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.25 -12.61 58.48 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.574 0.546 . . . . 64.3 114.298 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.51 -55.36 0.39 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.58 0.69 . . . . 74.24 112.282 -173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.435 ' OH ' ' HB3' ' D' ' 130' ' ' PRO . 66.2 t80 -75.86 -48.17 22.57 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.392 0.516 . . . . 75.44 112.392 -169.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.406 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 88.1 m -59.3 -50.09 89.31 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 123.676 0.791 . . . . 73.44 111.567 176.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.419 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 69.9 Cg_exo -55.22 -36.3 93.02 Favored 'Trans proline' 0 C--N 1.389 2.683 0 C-N-CA 121.968 1.779 . . . . 74.15 113.561 169.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.16 -40.63 90.58 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 123.185 0.594 . . . . 73.43 110.643 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.563 HD12 HD11 ' B' ' 13' ' ' ILE . 67.6 mt -63.79 -43.61 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.599 0.76 . . . . 74.45 110.404 175.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.44 HD21 ' HA3' ' B' ' 82' ' ' GLY . 65.9 mt -78.66 -18.89 53.72 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.064 -0.971 . . . . 75.22 112.034 -174.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -58.49 -51.83 79.01 Favored Pre-proline 0 N--CA 1.482 1.162 0 N-CA-C 113.963 1.097 . . . . 75.25 113.963 -170.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.95 -32.23 92.25 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 121.671 1.58 . . . . 73.22 113.312 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -66.05 -50.63 63.47 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.286 0.634 . . . . 74.33 110.472 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.428 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -59.16 -40.09 84.5 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.2 -0.909 . . . . 74.53 110.812 177.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -65.56 -49.02 70.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.506 1.523 . . . . 73.25 110.939 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -68.27 -34.53 76.34 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.81 -0.632 . . . . 72.31 109.842 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.484 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.7 t -67.99 -34.32 76.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.777 0.431 . . . . 74.01 111.223 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.464 ' O ' HG23 ' B' ' 118' ' ' VAL . 66.6 mt -63.83 -56.48 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.662 -0.495 . . . . 63.24 109.662 172.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.1 m -60.42 -26.02 66.39 Favored 'General case' 0 CA--C 1.554 1.131 0 O-C-N 123.973 0.796 . . . . 55.0 111.473 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.0 t -62.99 -50.45 70.69 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.225 0.61 . . . . 62.43 109.836 173.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -71.57 -32.1 67.7 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.414 0.686 . . . . 62.05 111.079 -176.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 114' ' ' ILE . 87.6 t -61.98 -44.62 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.65 0.78 . . . . 74.42 109.55 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.6 t -65.37 -35.76 81.93 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.039 -0.982 . . . . 72.42 111.368 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.0 mtt-85 -68.06 -32.17 72.32 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.475 -0.784 . . . . 74.55 110.323 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.87 8.12 77.29 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.952 0.783 . . . . 75.53 112.965 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 61.5 p 54.77 27.42 8.82 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.15 1.78 . . . . 74.14 113.626 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -83.43 154.74 66.16 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.397 0.679 . . . . 73.55 110.09 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -55.99 157.42 16.89 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.083 2.522 . . . . 55.33 113.223 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -64.56 113.77 3.92 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.369 -0.832 . . . . 73.23 111.38 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.428 HD23 HD23 ' F' ' 470' ' ' LEU . 49.1 mt -121.09 119.51 32.64 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.899 -0.778 . . . . 64.44 108.899 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.411 ' O ' HD22 ' F' ' 468' ' ' LEU . 29.1 m-80 -115.0 112.98 23.5 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.806 -0.813 . . . . 74.51 108.806 -177.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.35 143.26 56.06 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.33 0.652 . . . . 72.2 111.353 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.56 150.9 64.16 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.843 0.857 . . . . 63.41 110.687 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.23 145.3 17.02 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.879 2.386 . . . . 72.11 111.775 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.31 118.59 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.246 -1.02 . . . . 72.53 108.246 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -79.8 83.37 5.75 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.618 -0.512 . . . . 64.21 109.618 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -64.45 -24.28 67.57 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.528 0.731 . . . . 74.1 111.962 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.56 -52.05 55.28 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.523 0.729 . . . . 74.51 110.268 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.16 95.26 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.937 0.895 . . . . 71.23 110.938 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 89.9 mt -74.07 -20.89 60.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.075 -0.966 . . . . 73.11 112.028 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.626 ' CE1' HD12 ' B' ' 141' ' ' LEU . 61.0 t80 -65.96 -29.91 70.39 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.625 0.37 . . . . 64.41 110.732 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 53.8 mtt -72.03 -30.63 65.39 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 109.732 -0.47 . . . . 74.51 109.732 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -80.88 -23.17 39.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.788 0.835 . . . . 72.32 110.694 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . 0.48 ' HB3' ' O ' ' B' ' 137' ' ' PHE . 39.5 t80 -62.08 -21.06 64.65 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.749 1.219 . . . . 71.52 111.236 171.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.626 HD12 ' CE1' ' B' ' 137' ' ' PHE . 30.2 mt -118.28 12.4 13.42 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.35 1.06 . . . . 75.21 110.806 -172.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -140.7 173.95 11.0 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.107 0.963 . . . . 75.14 110.095 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -144.71 8.19 1.29 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.813 0.845 . . . . 73.13 109.843 168.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -82.22 119.72 24.44 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 123.618 0.767 . . . . 74.1 109.86 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.18 124.4 31.13 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.407 -0.59 . . . . 62.14 109.407 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.7 72.85 2.71 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.322 0.389 . . . . 72.43 112.926 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -76.5 108.93 9.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.299 0.639 . . . . 73.13 109.712 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -111.03 -131.62 5.93 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.178 -0.769 . . . . 72.45 111.178 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.579 ' H ' ' HB ' ' D' ' 7' ' ' THR . 86.3 m -156.81 92.18 1.27 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.833 0.853 . . . . 71.54 108.903 173.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' D' ' 8' ' ' GLU . 0.0 OUTLIER -77.7 163.27 26.33 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.723 -0.473 . . . . 63.12 109.723 173.103 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -163.96 130.67 3.2 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.121 -0.696 . . . . 71.14 109.121 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -90.92 132.65 35.81 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.836 0.454 . . . . 75.23 110.377 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -110.93 158.01 19.23 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.913 -1.143 . . . . 71.13 107.913 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -138.6 129.18 26.22 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.501 -0.555 . . . . 74.35 109.501 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 C-N-CA 123.625 0.77 . . . . 75.42 110.212 179.838 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.732 0.301 . . . . 72.24 110.818 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -145.03 95.45 2.69 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 106.874 -1.528 . . . . 74.33 106.874 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -62.86 -55.77 23.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.977 0.911 . . . . 72.54 110.213 -174.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -165.45 86.93 0.39 Allowed 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.694 -1.139 . . . . 73.23 108.57 172.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -74.17 90.85 2.08 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.842 -0.799 . . . . 74.42 108.842 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -62.37 91.6 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.015 0.926 . . . . 71.13 110.146 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 31.2 m -98.72 97.84 9.03 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.415 -0.958 . . . . 64.11 108.415 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.92 120.21 13.84 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 106.82 -1.548 . . . . 72.3 106.82 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 26.7 ttt 63.98 113.41 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.591 1.182 . . . . 71.14 110.12 -162.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 59.5 m -127.93 117.56 21.98 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.206 -1.035 . . . . 74.35 108.206 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.61 ' HD1' ' HH ' ' C' ' 101' ' ' TYR . 1.1 t80 -120.23 126.32 50.34 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.808 -0.812 . . . . 75.01 108.808 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -142.51 109.05 5.34 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.385 -0.968 . . . . 74.02 108.385 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -73.82 122.11 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.158 -0.682 . . . . 73.34 109.158 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.567 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.8 mm-40 -86.47 -42.26 13.73 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.179 -0.919 . . . . 74.54 110.35 -175.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -175.56 139.93 0.45 Allowed 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.614 0.571 . . . . 74.55 109.523 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.418 HD11 HG21 ' C' ' 105' ' ' ILE . 72.0 mt -131.56 133.87 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.463 -0.94 . . . . 72.13 108.463 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.436 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 27.3 p90 -170.64 172.61 5.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.691 0.758 . . . . 73.13 111.565 -169.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -96.07 118.5 32.79 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.382 -0.827 . . . . 72.32 109.16 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.436 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.8 mmtp -65.78 -48.16 72.73 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 122.33 1.062 . . . . 71.1 108.156 169.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.5 t70 -139.82 146.25 39.16 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 113.814 -1.539 . . . . 74.04 109.884 -172.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.58 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 80.5 mt -140.39 140.93 33.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 106.701 -1.592 . . . . 75.22 106.701 174.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -159.25 149.84 19.51 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.173 0.511 . . . . 75.31 110.663 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.448 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.2 t80 -148.49 136.96 21.34 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.918 -1.141 . . . . 73.35 107.918 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.67 118.65 18.4 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.695 0.798 . . . . 63.41 109.754 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' C' ' 28' ' ' ALA . . . -136.92 76.87 45.2 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 106.356 -1.72 . . . . 62.51 106.356 165.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.07 -40.61 11.29 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.738 2.292 . . . . 74.33 111.199 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.03 21.12 3.27 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.628 -1.169 . . . . 73.22 111.417 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' C' ' 25' ' ' ALA . . . -44.65 -57.83 6.18 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 114.39 1.256 . . . . 65.33 114.39 -171.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.4 -36.43 66.67 Favored 'Trans proline' 0 C--N 1.385 2.459 0 CA-C-N 121.744 1.658 . . . . 70.43 112.397 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -70.07 -35.42 74.2 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.372 0.669 . . . . 74.31 112.135 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.658 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.5 p -79.6 -24.49 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 N-CA-C 111.886 0.328 . . . . 75.34 111.886 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.59 -30.2 69.75 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.617 0.367 . . . . 74.44 111.867 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -86.67 11.45 12.92 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.905 0.482 . . . . 74.45 111.12 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.742 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.99 160.05 14.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.231 1.012 . . . . 71.55 109.563 170.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -71.48 131.44 43.31 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.514 0.725 . . . . 63.14 110.561 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.531 ' NE1' ' HG3' ' C' ' 124' ' ' PRO . 31.5 t90 -73.86 91.91 2.02 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.424 -0.807 . . . . 75.41 111.297 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.507 ' HG2' ' HD2' ' G' ' 471' ' ' LYS . 9.1 tm0? -147.04 74.43 11.98 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 107.444 -1.317 . . . . 75.33 107.444 169.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -85.15 137.14 6.04 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.732 2.288 . . . . 73.4 112.717 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -86.06 110.07 19.27 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.268 -1.012 . . . . 72.51 108.268 171.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.499 HG23 ' HB2' ' G' ' 468' ' ' LEU . 15.9 m -84.6 100.47 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-O 122.532 1.158 . . . . 74.14 110.978 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -95.74 103.29 15.16 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.784 -1.098 . . . . 74.52 108.279 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.52 134.75 36.73 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.25 -0.648 . . . . 74.31 109.25 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -127.67 136.08 51.1 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.352 -0.981 . . . . 73.41 108.352 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 tp -129.22 135.12 48.4 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.438 0.695 . . . . 72.22 109.683 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.401 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 27.5 t70 -149.04 153.06 37.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.883 0.873 . . . . 74.52 109.664 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -146.19 153.39 40.58 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.155 0.582 . . . . 73.21 109.441 170.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.55 160.54 39.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.248 1.019 . . . . 75.23 109.011 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -144.43 155.67 43.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.461 0.704 . . . . 72.32 109.223 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.5 p -157.4 153.78 27.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.601 0.76 . . . . 60.53 109.353 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -95.8 118.05 31.72 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.993 -0.743 . . . . 73.21 108.993 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' C' ' 57' ' ' GLU . 60.5 mt -89.37 -34.92 16.34 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.179 0.592 . . . . 75.43 110.337 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.3 -170.06 2.16 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.645 0.778 . . . . 63.02 111.004 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.91 111.44 1.66 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.85 0.86 . . . . 64.35 110.417 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 70.79 -5.75 1.4 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.344 1.458 . . . . 71.52 112.564 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.0 t -93.77 105.7 17.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.456 -0.942 . . . . 73.54 108.456 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -118.79 122.96 43.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.542 -0.754 . . . . 73.31 109.357 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.605 ' HB2' HD12 ' C' ' 51' ' ' LEU . 35.4 tt0 -84.36 144.7 28.65 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.532 0.733 . . . . 72.31 110.294 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -131.14 140.55 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.259 -1.015 . . . . 71.21 108.259 167.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 90.9 t -130.95 130.83 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.067 -1.086 . . . . 75.13 108.067 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.96 109.42 21.41 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.456 -1.313 . . . . 74.54 107.456 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.401 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.2 tmm_? -101.65 106.77 17.86 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.127 -1.064 . . . . 74.33 108.127 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.538 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.7 t -107.96 137.55 38.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.88 -1.156 . . . . 75.01 107.88 175.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -132.48 121.93 24.11 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.171 -0.678 . . . . 71.01 109.171 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 64.8 t -111.51 110.33 31.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 124.18 0.992 . . . . 75.13 108.9 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.475 HG23 HD22 ' C' ' 75' ' ' LEU . 4.0 m -108.85 108.28 19.0 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.226 0.61 . . . . 72.03 109.38 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.04 123.47 45.98 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.828 -0.804 . . . . 74.44 108.828 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.6 m -137.83 130.47 29.67 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.949 0.5 . . . . 65.23 111.046 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.742 HD11 ' HG2' ' C' ' 34' ' ' LYS . 6.6 mt -84.81 33.99 0.53 Allowed 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 125.255 1.422 . . . . 74.55 110.723 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.62 -100.13 1.84 Allowed Glycine 0 C--N 1.352 1.427 0 N-CA-C 111.052 -0.819 . . . . 74.22 111.052 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.61 -31.89 18.36 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.474 -0.565 . . . . 75.45 109.474 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.02 120.87 24.78 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.725 0.81 . . . . 63.31 109.13 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.5 m -76.73 128.7 35.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.981 -0.748 . . . . 75.14 108.981 169.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.658 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.08 -57.78 4.2 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.424 -0.954 . . . . 75.12 108.424 173.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -165.65 173.72 10.52 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.309 -0.86 . . . . 73.55 110.768 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.475 HD22 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -133.24 144.23 49.63 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.089 -1.448 . . . . 60.03 107.089 172.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.47 ' SG ' HG21 ' C' ' 114' ' ' ILE . 46.6 t -146.31 139.65 25.87 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.158 -1.053 . . . . 70.05 108.158 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -151.6 133.65 15.1 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.517 -0.549 . . . . 73.43 109.517 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.4 t -134.99 138.89 48.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.26 1.024 . . . . 75.12 108.474 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.437 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -114.17 88.17 2.79 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.258 -1.015 . . . . 72.42 108.258 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.414 ' HG3' HD22 ' C' ' 106' ' ' LEU . 9.5 tp-100 -79.1 97.77 6.27 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.175 -0.92 . . . . 74.43 110.197 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -98.74 144.13 17.03 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-O 121.199 0.333 . . . . 63.12 113.035 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.429 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -145.09 132.81 4.84 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.514 -1.034 . . . . 54.11 110.514 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 15.3 mm -88.97 123.7 41.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 108.394 -0.965 . . . . 71.35 108.394 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.6 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 51.2 m-85 -130.4 116.14 17.86 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.159 0.583 . . . . 71.51 109.787 -173.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 74.0 m -84.0 108.51 17.0 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.684 -0.487 . . . . 34.23 109.684 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.545 ' HB ' HD13 ' C' ' 89' ' ' ILE . 2.7 pp -117.06 138.61 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.949 0.899 . . . . 74.32 110.25 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -149.34 158.14 43.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.162 0.985 . . . . 72.54 109.554 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.39 -30.41 5.26 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 113.892 0.317 . . . . 73.22 113.892 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.545 HD13 ' HB ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -105.72 150.2 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 121.23 0.538 . . . . 75.43 111.792 -176.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.91 -170.79 3.73 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.784 -1.098 . . . . 75.55 108.505 166.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.402 ' HA2' HG21 ' G' ' 455' ' ' THR . . . 64.05 -124.45 30.33 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 114.112 0.405 . . . . 74.3 114.112 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.51 ' HB ' HD23 ' C' ' 141' ' ' LEU . 74.1 p -76.35 -29.53 57.26 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.834 0.853 . . . . 71.22 111.806 -175.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.87 -42.46 85.56 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.592 -0.521 . . . . 74.42 109.592 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.548 ' SD ' ' HA ' ' G' ' 452' ' ' VAL . 28.1 ttt -74.66 -33.12 62.45 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.857 -0.61 . . . . 75.22 110.807 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.62 -48.69 69.09 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.75 0.657 . . . . 63.15 109.706 174.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.57 ' HE2' ' HA ' ' C' ' 134' ' ' ASP . 11.6 t-80 -77.62 -35.16 52.99 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.857 0.723 . . . . 75.42 111.492 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.432 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 51.8 t -56.86 -36.79 70.46 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.849 0.718 . . . . 74.52 110.407 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.421 HD13 HD13 ' G' ' 454' ' ' LEU . 23.9 mt -101.07 -15.22 17.5 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.877 0.871 . . . . 71.52 110.917 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.76 -30.41 48.27 Favored Glycine 0 C--N 1.352 1.42 0 N-CA-C 114.842 0.697 . . . . 74.34 114.842 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.83 -36.88 0.06 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.938 0.495 . . . . 54.01 110.859 -172.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.61 ' HH ' ' HD1' ' C' ' 11' ' ' PHE . 70.4 t80 -66.88 -44.29 81.29 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.38 1.472 . . . . 74.42 112.282 -175.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 23.3 m -77.12 -47.91 2.6 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 123.394 0.678 . . . . 72.24 111.836 174.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -53.96 -28.85 51.37 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.138 1.892 . . . . 74.11 114.273 171.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -68.35 -39.56 81.81 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 123.109 0.564 . . . . 73.42 109.939 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.418 HG21 HD11 ' C' ' 16' ' ' ILE . 42.3 mm -59.92 -39.44 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.439 -0.578 . . . . 64.43 109.439 175.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.429 HD23 ' HA3' ' C' ' 82' ' ' GLY . 76.7 mt -85.52 -12.77 50.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.599 1.16 . . . . 75.33 112.501 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -63.37 -51.4 68.32 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 113.784 1.031 . . . . 73.42 113.784 -171.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -66.79 -30.99 40.26 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 121.731 1.621 . . . . 72.54 112.263 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.412 ' HE2' HG21 ' A' ' 115' ' ' THR . 93.3 m-85 -67.82 -46.25 72.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.457 0.703 . . . . 74.42 110.935 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.31 93.02 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.482 0.713 . . . . 63.5 109.806 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -53.15 -60.26 3.51 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.293 0.995 . . . . 71.31 110.938 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -62.56 -29.4 70.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.614 0.766 . . . . 74.15 110.945 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.444 ' SG ' HG12 ' C' ' 21' ' ' ILE . 8.3 t -72.55 -44.48 62.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.774 0.43 . . . . 75.21 110.832 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' C' ' 62' ' ' VAL . 85.5 mt -64.88 -50.09 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.31 0.644 . . . . 73.54 110.333 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.4 m -64.21 -29.34 70.45 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.413 -0.812 . . . . 75.25 110.741 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 28.1 t -65.54 -52.62 51.15 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.987 0.515 . . . . 74.03 109.71 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.601 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -54.15 -46.86 72.37 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.472 1.109 . . . . 73.03 112.026 178.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.443 HG11 HD13 ' C' ' 126' ' ' LEU . 71.2 t -65.97 -43.41 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.45 -0.796 . . . . 72.52 111.157 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.9 t -61.08 -36.94 81.0 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.445 0.698 . . . . 75.33 111.167 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.469 ' HD2' ' HE3' ' C' ' 117' ' ' MET . 86.4 mtt-85 -69.71 -32.02 70.36 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.134 -0.939 . . . . 65.12 110.329 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.08 7.05 76.98 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.894 0.746 . . . . 74.43 112.958 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 53.2 p 57.7 28.63 16.1 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 126.37 1.868 . . . . 72.11 113.751 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.462 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 93.2 m-85 -91.98 163.44 27.48 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 108.914 -0.772 . . . . 73.43 108.914 170.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.531 ' HG3' ' NE1' ' C' ' 36' ' ' TRP . 56.5 Cg_endo -64.06 -178.93 0.67 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.934 2.423 . . . . 74.52 114.641 -174.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -61.2 128.89 38.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.945 -1.025 . . . . 74.41 111.683 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.443 HD13 HG11 ' C' ' 118' ' ' VAL . 6.7 mp -134.81 86.49 2.26 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.445 -0.946 . . . . 74.43 108.445 170.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -99.77 123.68 44.27 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.089 -0.708 . . . . 64.14 109.089 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -64.93 118.87 9.69 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.782 -0.821 . . . . 70.32 108.782 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.02 141.25 93.75 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.727 0.811 . . . . 75.04 111.318 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.442 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 14.8 Cg_endo -58.05 103.74 0.16 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.436 2.091 . . . . 73.43 112.094 174.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.467 HG22 ' SD ' ' G' ' 464' ' ' MET . 29.2 t -95.46 140.82 16.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.642 -1.614 . . . . 75.34 106.642 174.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -77.36 66.77 3.18 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.345 -0.613 . . . . 62.04 109.345 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -54.33 -43.12 70.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.912 0.885 . . . . 72.23 111.183 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.57 ' HA ' ' HE2' ' C' ' 96' ' ' HIS . 7.8 m-20 -66.49 -41.93 88.17 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.89 -1.05 . . . . 74.33 112.484 -175.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.91 -43.08 72.43 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.799 0.687 . . . . 64.42 110.398 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.05 -21.15 60.84 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.027 -0.988 . . . . 65.31 111.9 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -82.48 -34.6 27.98 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.902 -0.407 . . . . 72.2 109.902 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 37.1 tpp -64.86 -46.64 80.97 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.206 -0.452 . . . . 70.02 110.938 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -72.15 -35.18 68.98 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.47 -0.786 . . . . 74.14 110.933 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -56.5 -86.93 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.149 0.979 . . . . 74.45 109.81 171.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.51 HD23 ' HB ' ' C' ' 92' ' ' THR . 1.1 tm? 62.74 -75.44 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.977 1.311 . . . . 73.42 109.838 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -151.4 42.06 0.73 Allowed 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 107.78 -1.193 . . . . 73.13 107.78 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -152.25 168.08 26.51 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.048 1.339 . . . . 75.22 108.091 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -78.73 146.57 33.84 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 122.797 0.439 . . . . 75.54 110.567 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.579 ' HB3' HG22 ' G' ' 463' ' ' THR . . . -82.07 171.1 14.75 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.556 0.742 . . . . 72.14 110.656 175.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.97 -106.55 2.34 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 111.301 -0.72 . . . . 63.52 111.301 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 59.72 -171.3 0.13 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.831 1.252 . . . . 74.45 112.838 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.02 -111.02 0.44 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.623 -1.391 . . . . 73.31 109.623 170.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.3 t 177.65 169.54 0.66 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.73 1.212 . . . . 72.44 109.905 170.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.744 ' HB3' ' HG2' ' A' ' 12' ' ' GLN . 31.7 tt0 -155.5 100.78 2.14 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.92 0.888 . . . . 64.45 108.939 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 62.24 178.88 0.13 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.585 1.154 . . . . 74.54 112.796 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -168.04 178.65 4.99 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.581 1.153 . . . . 74.15 109.684 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.9 pm0 -67.88 178.13 1.88 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.812 0.845 . . . . 74.24 110.824 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -64.15 -64.8 0.79 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 120.925 0.393 . . . . 72.33 110.422 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.824 0 CA-C-N 115.427 -0.806 . . . . 74.31 109.208 -174.349 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.784 0.326 . . . . 62.15 110.946 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 56.0 m -126.93 95.88 4.45 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.389 0.675 . . . . 72.53 109.6 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.13 151.13 28.43 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.546 -0.538 . . . . 74.33 109.546 176.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -167.07 157.43 11.4 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.983 0.913 . . . . 73.34 109.812 -173.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -157.65 144.38 18.0 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.994 -0.743 . . . . 64.23 108.994 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.41 ' N ' HD21 ' D' ' 6' ' ' ASN . 0.9 OUTLIER -98.86 99.2 10.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.351 -0.981 . . . . 72.41 108.351 178.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' THR . . . . . 0.579 ' HB ' ' H ' ' B' ' 149' ' ' THR . 18.1 p -66.01 -60.97 2.32 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.112 0.565 . . . . 61.33 109.908 174.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.57 ' HB2' ' HB3' ' B' ' 150' ' ' GLU . 50.7 mt-10 -128.64 74.04 1.54 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.88 0.872 . . . . 73.22 108.821 171.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 7.0 ttp -33.21 126.39 0.35 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.026 1.33 . . . . 75.01 112.759 170.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 87.9 m -124.95 135.6 52.97 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.18 0.515 . . . . 73.14 110.991 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -158.7 89.86 0.98 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.727 -1.582 . . . . 74.4 106.727 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -116.69 116.36 27.39 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.584 -0.895 . . . . 74.44 108.584 -176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.404 HG21 HD13 ' D' ' 16' ' ' ILE . 14.7 mt -82.48 117.55 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.569 -0.9 . . . . 75.13 108.569 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.56 -34.8 46.76 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.992 0.517 . . . . 73.13 111.37 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -169.2 130.92 1.17 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 111.631 0.234 . . . . 73.22 111.631 -168.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.404 HD13 HG21 ' D' ' 13' ' ' ILE . 2.6 mp -115.02 134.4 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.075 -1.454 . . . . 63.12 107.075 173.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -165.52 170.3 14.52 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.811 0.815 . . . . 75.13 111.868 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -102.52 123.15 45.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.265 -1.334 . . . . 73.34 108.817 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -93.25 -18.45 22.48 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.114 -0.494 . . . . 75.35 110.011 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -156.39 136.12 12.52 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.329 -0.989 . . . . 73.15 108.329 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.601 HG23 ' HE1' ' C' ' 117' ' ' MET . 17.5 mt -134.59 138.77 49.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.627 -1.249 . . . . 73.3 107.627 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -144.67 133.87 22.9 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.353 0.661 . . . . 73.54 109.773 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.58 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 70.5 t80 -144.67 127.48 16.3 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.56 -1.644 . . . . 74.3 106.56 167.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.5 mt-10 -134.89 126.64 29.13 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.638 0.775 . . . . 71.01 109.357 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.54 85.14 25.82 Favored Pre-proline 0 C--O 1.242 0.673 0 N-CA-C 107.953 -1.129 . . . . 73.44 107.953 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.22 -40.47 11.18 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.909 2.406 . . . . 72.02 112.482 -171.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -107.73 27.59 9.04 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 123.871 0.868 . . . . 74.32 109.789 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.437 ' HB2' ' HD3' ' D' ' 29' ' ' PRO . . . -37.74 -68.57 0.22 Allowed Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 115.284 1.586 . . . . 74.35 115.284 -161.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.493 ' HB3' HD11 ' C' ' 83' ' ' ILE . 89.4 Cg_endo -75.57 -19.97 16.2 Favored 'Trans proline' 0 C--N 1.382 2.299 0 CA-C-N 122.394 1.891 . . . . 72.35 113.385 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.417 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 8.5 t-160 -74.81 -38.79 61.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.534 1.133 . . . . 75.45 110.698 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.726 HG21 HD13 ' D' ' 68' ' ' LEU . 10.7 p -84.38 -25.24 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 122.789 0.435 . . . . 75.55 111.694 -172.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -58.43 -27.99 64.84 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.371 0.669 . . . . 75.13 112.359 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.417 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 72.1 mt-30 -53.73 -31.33 47.86 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.786 1.234 . . . . 74.11 111.541 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.545 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 83.7 mttt -87.51 96.95 10.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.984 0.913 . . . . 75.23 109.135 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -81.33 88.58 6.08 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.992 -0.549 . . . . 62.35 110.946 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -163.15 162.64 25.68 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.664 0.786 . . . . 74.53 109.153 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.407 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 1.3 mp0 -73.47 116.35 50.5 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 109.238 -0.652 . . . . 63.34 109.238 171.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.666 ' HB2' ' HB3' ' D' ' 66' ' ' ALA . 77.5 Cg_exo -56.55 138.97 86.61 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.94 3.094 . . . . 74.12 113.971 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.11 111.73 1.44 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.025 0.828 . . . . 71.12 109.372 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.487 HG22 HG13 ' D' ' 64' ' ' VAL . 7.3 p -103.79 135.35 41.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.357 -0.838 . . . . 73.45 110.917 -168.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -115.52 132.39 56.64 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.326 1.05 . . . . 74.34 108.346 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.64 ' HB2' HD21 ' H' ' 468' ' ' LEU . 8.5 tt -98.17 126.23 43.54 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.955 0.502 . . . . 73.44 109.746 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.511 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.8 m-20 -133.49 116.08 15.54 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.898 -1.149 . . . . 74.01 107.898 171.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.413 ' HG ' HD23 ' D' ' 42' ' ' LEU . 91.6 mt -113.88 142.34 46.23 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.153 0.581 . . . . 74.1 109.988 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.2 t70 -141.8 154.89 45.52 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.947 -1.131 . . . . 75.42 107.947 173.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.474 ' HB ' HD23 ' H' ' 460' ' ' LEU . 13.4 t -127.68 164.4 22.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.104 0.561 . . . . 55.14 109.712 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.24 161.79 42.1 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.784 0.834 . . . . 64.2 109.627 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 37.3 p -159.1 151.84 21.83 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.099 0.559 . . . . 73.2 109.726 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.4 p -157.93 139.23 13.51 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.36 0.664 . . . . 71.44 109.707 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -79.13 119.37 22.15 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.553 -0.536 . . . . 73.12 109.553 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.7 mt -90.15 -34.63 15.78 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.86 -0.793 . . . . 72.4 108.86 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.16 -178.95 5.36 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.224 1.01 . . . . 72.43 109.672 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.64 122.17 17.48 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.221 -0.899 . . . . 72.04 109.197 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 72.16 12.46 5.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.394 1.478 . . . . 74.41 112.402 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.6 t -128.98 117.6 44.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 123.972 0.909 . . . . 75.24 108.879 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' H' ' 454' ' ' LEU . 5.5 m-85 -132.88 130.08 39.25 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.398 1.079 . . . . 74.1 108.703 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD11 ' D' ' 51' ' ' LEU . 18.5 tt0 -91.83 142.29 27.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.972 -0.751 . . . . 61.42 108.972 170.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -123.08 142.31 40.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.421 -1.326 . . . . 74.14 107.421 172.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 45.9 t -126.37 132.09 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.807 -0.812 . . . . 72.53 108.807 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.32 120.39 42.25 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.705 -0.85 . . . . 75.35 108.705 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 33.3 ttm-85 -102.94 98.45 8.41 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.312 -0.996 . . . . 64.4 108.312 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -100.2 123.37 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.859 -0.793 . . . . 71.54 108.859 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 15.4 m -119.13 141.82 48.47 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.496 0.718 . . . . 75.22 109.85 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.487 HG13 HG22 ' D' ' 40' ' ' VAL . 75.6 t -136.64 103.29 3.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.0 1.32 . . . . 72.33 108.561 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 83.4 m -100.9 113.72 26.93 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.349 -0.982 . . . . 64.0 108.349 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.666 ' HB3' ' HB2' ' D' ' 38' ' ' PRO . . . -122.55 142.82 50.21 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.726 0.811 . . . . 72.1 109.857 -174.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.455 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 23.5 m -144.13 134.39 24.41 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.652 0.595 . . . . 72.1 111.795 -176.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.726 HD13 HG21 ' D' ' 31' ' ' VAL . 48.9 mt -106.23 123.34 47.88 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.325 1.05 . . . . 74.15 109.198 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.56 -124.56 36.41 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 115.155 -0.93 . . . . 61.2 113.609 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.89 6.47 47.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 74.24 112.326 -175.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.545 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 11.7 pt-20 -137.0 165.1 26.79 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.668 0.387 . . . . 75.13 110.875 -172.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 34.7 m -68.23 138.07 55.28 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.762 0.663 . . . . 70.33 110.473 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.623 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -90.33 -70.69 0.66 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.342 -0.984 . . . . 60.14 108.342 173.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -147.63 140.6 24.96 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.576 -0.738 . . . . 72.33 109.605 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 88.1 mt -109.62 143.18 39.7 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.49 -1.3 . . . . 74.31 107.49 172.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.562 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 38.7 t -158.05 137.19 11.63 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.231 -0.285 . . . . 62.11 110.231 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.59 133.27 13.01 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.945 -0.761 . . . . 74.31 108.945 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.7 t -128.77 138.02 55.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.572 -0.899 . . . . 72.35 108.572 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -116.32 87.35 2.67 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.096 -1.075 . . . . 72.44 108.096 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.14 103.95 10.37 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.347 -1.297 . . . . 72.53 108.944 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.09 141.39 15.96 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.314 -0.714 . . . . 73.43 111.314 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.478 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -139.86 130.02 4.53 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.681 -0.968 . . . . 73.05 110.681 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 58.7 mt -92.57 115.95 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.717 -0.846 . . . . 75.33 108.717 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -116.33 125.55 52.28 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.931 0.892 . . . . 73.12 109.692 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -104.39 109.29 21.09 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.481 0.712 . . . . 73.34 109.353 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.435 HD11 HG13 ' H' ' 452' ' ' VAL . 2.4 pp -110.78 144.14 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.244 0.617 . . . . 72.3 109.866 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.45 127.07 8.73 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.789 -0.819 . . . . 74.42 108.789 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.36 -20.51 42.25 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.398 -0.681 . . . . 64.35 111.398 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mp -98.41 130.75 46.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.231 1.013 . . . . 74.22 108.341 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.688 ' HB3' HG22 ' H' ' 451' ' ' VAL . 8.4 pt-20 -160.47 173.8 15.03 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.442 0.697 . . . . 74.13 110.7 -174.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.01 -133.82 49.17 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 124.023 0.827 . . . . 72.32 113.879 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.1 m -63.35 -31.73 72.97 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.706 0.803 . . . . 74.21 110.73 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -69.34 -33.66 73.44 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.74 0.816 . . . . 73.03 110.945 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.465 ' SD ' HD12 ' D' ' 98' ' ' LEU . 17.5 tmm? -72.74 -37.61 67.66 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.263 0.625 . . . . 64.44 110.389 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.31 95.94 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.61 0.719 . . . . 75.53 110.55 171.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -71.53 -29.53 64.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.899 1.28 . . . . 74.22 111.405 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -81.12 -52.26 7.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.811 0.445 . . . . 71.54 110.874 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.465 HD12 ' SD ' ' D' ' 94' ' ' MET . 92.6 mt -84.35 -27.9 27.39 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.995 0.518 . . . . 74.44 111.697 -171.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.02 7.41 58.8 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.677 -0.513 . . . . 63.23 114.138 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.409 ' HB2' ' HA ' ' D' ' 134' ' ' ASP . . . -150.29 -61.3 0.2 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.393 0.597 . . . . 72.42 111.232 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -69.7 -41.65 75.1 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.034 0.534 . . . . 73.34 112.145 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.434 ' SG ' HD23 ' D' ' 98' ' ' LEU . 88.5 m -65.35 -45.97 70.48 Favored Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 123.62 0.768 . . . . 75.23 112.38 -178.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -53.1 -36.89 78.51 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.155 1.903 . . . . 73.44 113.177 167.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -67.77 -30.89 70.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.099 0.56 . . . . 64.24 111.438 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.0 -37.33 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.276 0.631 . . . . 73.41 110.584 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.478 HD22 ' HA3' ' D' ' 82' ' ' GLY . 92.7 mt -77.49 -19.77 55.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.057 0.943 . . . . 72.33 111.997 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.617 ' HZ ' HD23 ' D' ' 128' ' ' LEU . 40.5 t80 -64.65 -43.64 71.01 Favored Pre-proline 0 CA--C 1.56 1.327 0 N-CA-C 114.347 1.24 . . . . 73.11 114.347 -170.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -54.35 -45.51 40.42 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 121.952 1.768 . . . . 75.41 112.491 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -70.0 -35.59 74.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.041 0.936 . . . . 75.32 111.759 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.71 67.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.269 0.628 . . . . 72.14 110.502 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.2 ttp180 -58.48 -49.09 78.61 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.253 -0.885 . . . . 72.03 110.534 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.52 -46.63 87.53 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.136 0.897 . . . . 72.45 111.477 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.8 t -57.73 -42.15 83.28 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.739 0.65 . . . . 70.21 110.639 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.516 HG21 ' SG ' ' D' ' 76' ' ' CYS . 67.8 mt -61.67 -57.11 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.608 0.763 . . . . 73.01 110.56 174.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.569 HG21 ' HG3' ' D' ' 125' ' ' GLN . 86.4 m -51.67 -44.68 63.15 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.721 1.208 . . . . 75.31 112.061 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.402 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 33.7 t -63.95 -42.59 97.26 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.196 -0.911 . . . . 64.14 109.999 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.562 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 75.9 mtm -69.81 -34.39 73.62 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.999 0.52 . . . . 71.4 111.469 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 66.8 t -62.06 -44.89 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.612 0.765 . . . . 75.24 109.934 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.1 p -72.73 -30.48 64.21 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.981 0.512 . . . . 71.41 111.089 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' D' ' 116' ' ' SER . 73.6 mtt-85 -72.07 -29.76 64.45 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.466 0.706 . . . . 75.34 110.455 175.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.34 10.14 74.35 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.798 0.686 . . . . 72.41 112.556 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.421 HG22 ' HB3' ' C' ' 17' ' ' TYR . 73.0 p 56.85 20.78 5.49 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 126.68 1.992 . . . . 73.23 114.082 177.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.02 150.16 71.26 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 109.067 -0.716 . . . . 75.21 109.067 168.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.9 132.1 47.74 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.471 2.114 . . . . 75.41 111.202 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.569 ' HG3' HG21 ' D' ' 115' ' ' THR . 5.5 tt0 -51.78 127.19 20.1 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 124.464 1.102 . . . . 74.32 112.674 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.19 116.49 28.45 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.04 -1.096 . . . . 75.11 108.04 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -115.65 122.19 44.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.694 0.798 . . . . 73.13 109.524 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.617 HD23 ' HZ ' ' D' ' 107' ' ' PHE . 1.5 tt -74.9 129.71 38.13 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 108.967 -0.753 . . . . 75.4 108.967 173.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.18 157.75 79.91 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.395 1.078 . . . . 71.51 111.974 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.435 ' HB3' ' OH ' ' B' ' 101' ' ' TYR . 87.0 Cg_exo -50.01 107.82 0.18 Allowed 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 123.246 2.631 . . . . 73.32 113.284 172.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 84.0 t -109.59 116.24 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.542 0.737 . . . . 73.2 109.051 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -90.06 105.66 17.95 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.42 -0.585 . . . . 65.52 109.42 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -78.72 -20.18 50.64 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.571 0.748 . . . . 71.34 111.067 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.409 ' HA ' ' HB2' ' D' ' 100' ' ' ALA . 6.5 t70 -65.17 -52.38 55.37 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.929 0.892 . . . . 74.12 110.66 -174.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.487 ' HA ' ' SD ' ' D' ' 138' ' ' MET . . . -68.97 -34.89 76.06 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.288 -0.869 . . . . 71.22 111.034 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.472 HD22 ' HB2' ' H' ' 462' ' ' TYR . 47.3 tp -63.08 -35.26 79.65 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 114.986 -1.006 . . . . 73.21 111.407 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -64.26 -37.33 87.11 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.573 0.749 . . . . 73.54 110.687 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.487 ' SD ' ' HA ' ' D' ' 135' ' ' ALA . 35.5 mtt -63.49 -39.57 94.79 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.671 -0.695 . . . . 73.12 109.596 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -61.68 -39.75 92.54 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.993 0.917 . . . . 74.4 111.389 176.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -64.41 -34.95 79.37 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.86 0.864 . . . . 73.54 111.021 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.5 mp -76.62 -30.93 57.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.336 0.654 . . . . 73.55 111.877 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -91.3 44.16 1.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.51 0.671 . . . . 75.04 111.081 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -119.56 49.17 1.4 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.857 0.863 . . . . 74.31 108.767 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -170.86 -52.0 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.302 -1.317 . . . . 73.21 109.723 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -174.85 96.6 0.08 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.549 1.14 . . . . 73.45 108.793 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -153.78 41.04 0.66 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 112.094 -0.403 . . . . 65.41 112.094 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.41 179.92 6.07 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.172 0.989 . . . . 74.24 109.388 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.73 22.67 71.97 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 112.323 -0.311 . . . . 53.43 112.323 -174.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 47.6 p -81.8 88.09 6.32 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.436 1.094 . . . . 72.03 110.63 -173.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -144.7 103.1 3.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.457 1.103 . . . . 74.44 108.596 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -85.1 -22.47 28.89 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.232 0.613 . . . . 74.11 110.051 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 23.7 m170 71.71 162.89 0.26 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.333 1.453 . . . . 75.33 111.306 -176.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.6 106.87 5.55 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.654 -0.703 . . . . 64.11 110.157 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -77.61 -32.68 53.67 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.783 -0.644 . . . . 72.34 110.444 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 C-N-CA 124.077 0.951 . . . . 74.22 108.759 -174.297 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 121.037 0.446 . . . . 74.34 110.115 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . 0.454 HG23 ' HA ' ' A' ' 87' ' ' ALA . 15.5 m -118.72 87.99 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.346 -1.724 . . . . 75.34 106.346 161.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.95 169.76 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.016 1.326 . . . . 72.43 108.626 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 158.44 -82.82 0.14 Allowed Glycine 0 C--N 1.344 0.983 0 C-N-CA 121.437 -0.411 . . . . 32.51 113.313 172.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . 0.496 HD11 HD23 ' A' ' 98' ' ' LEU . 6.8 mp 58.62 -98.53 0.09 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.306 1.042 . . . . 75.21 110.335 -170.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 3.6 m 63.78 -3.42 0.43 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 124.818 1.247 . . . . 64.15 113.491 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -85.91 -25.1 26.33 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.135 0.974 . . . . 52.43 110.877 -172.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 72.86 141.55 0.06 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.725 1.61 . . . . 75.54 111.12 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 8.6 t -132.18 137.11 47.49 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.715 0.806 . . . . 74.02 108.836 175.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -118.23 5.48 11.93 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.693 0.797 . . . . 54.11 110.121 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . 0.427 HD21 ' H ' ' A' ' 46' ' ' THR . 3.9 mm? 68.83 160.88 0.19 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.044 1.338 . . . . 72.42 112.534 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -147.31 26.45 1.06 Allowed 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.411 -1.268 . . . . 75.51 109.38 -169.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -72.85 91.88 1.55 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.762 -0.829 . . . . 73.4 108.762 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 32.4 p -71.32 -81.56 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.462 -0.79 . . . . 72.13 111.051 -174.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 82.9 mmm 51.19 87.18 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.403 1.081 . . . . 71.32 111.663 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -63.29 -38.01 89.49 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.774 0.429 . . . . 74.25 110.407 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -94.21 101.23 13.2 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.492 -1.299 . . . . 70.41 107.492 163.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -68.41 -58.71 3.94 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.478 0.711 . . . . 63.53 111.31 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . 0.483 ' HG ' ' HB2' ' A' ' 42' ' ' LEU . 81.7 mt -130.03 156.84 43.83 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.967 0.907 . . . . 74.11 109.066 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -131.85 105.34 0.61 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.981 -0.847 . . . . 73.12 110.981 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . 0.497 HD23 HD11 ' A' ' 126' ' ' LEU . 2.1 pp -151.79 153.31 34.01 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.549 0.739 . . . . 62.15 109.985 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 26.6 tptp . . . . . 0 C--O 1.253 1.269 0 N-CA-C 108.434 -0.95 . . . . 73.53 108.434 174.683 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 121.151 0.501 . . . . 74.03 110.147 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' B' ' 89' ' ' ILE . 18.7 m -81.03 -15.38 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.971 0.908 . . . . 75.01 112.609 -171.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . 0.64 ' HA ' ' HE1' ' B' ' 94' ' ' MET . 13.7 m -70.05 140.92 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 122.688 0.395 . . . . 72.43 111.938 -171.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 163.96 76.19 0.03 OUTLIER Glycine 0 C--N 1.345 1.076 0 N-CA-C 111.737 -0.545 . . . . 65.11 111.737 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 65.9 tp -147.17 143.25 28.09 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.74 0.816 . . . . 75.0 110.023 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 41.2 m -96.32 133.2 40.99 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.799 -0.815 . . . . 72.43 108.799 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -138.15 -171.85 3.13 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.81 -0.811 . . . . 70.51 108.81 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 72.1 66.08 0.13 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.043 1.337 . . . . 72.54 109.215 -175.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 32.7 m -146.52 141.71 27.3 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.247 -1.342 . . . . 74.45 108.397 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.72 120.36 7.7 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.29 0.636 . . . . 74.31 110.175 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . 0.529 HD12 HD13 ' B' ' 44' ' ' LEU . 40.7 mt -83.66 162.89 20.6 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.706 0.765 . . . . 73.34 112.111 -174.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -80.33 153.72 28.22 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.063 -1.426 . . . . 64.35 112.025 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -129.89 -177.44 4.29 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.745 1.218 . . . . 71.41 110.057 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 15.3 t -151.13 -1.13 0.36 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.932 -1.031 . . . . 74.11 109.949 171.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 464' ' ' MET . . . . . 0.504 ' SD ' ' HB3' ' F' ' 466' ' ' ALA . 15.0 tmm? -80.49 84.71 6.04 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.562 -0.903 . . . . 73.34 108.562 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -75.87 79.09 2.78 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.676 -0.693 . . . . 72.21 109.527 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . 0.504 ' HB3' ' SD ' ' F' ' 464' ' ' MET . . . -175.26 178.23 1.73 Allowed 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.563 1.145 . . . . 74.03 110.094 -177.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -75.35 -57.26 4.0 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.035 -0.728 . . . . 75.14 109.035 172.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . 0.572 HD12 HD21 ' F' ' 470' ' ' LEU . 6.1 tt -162.73 -48.58 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.421 -0.955 . . . . 72.41 108.421 175.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 106.71 50.99 0.82 Allowed Glycine 0 N--CA 1.469 0.856 0 N-CA-C 110.413 -1.075 . . . . 55.42 110.413 -172.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . 0.572 HD21 HD12 ' F' ' 468' ' ' LEU . 90.2 mt -75.82 -67.64 0.65 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.734 0.814 . . . . 62.2 110.488 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? . . . . . 0 CA--C 1.56 1.336 0 C-N-CA 125.079 1.352 . . . . 75.22 110.086 179.276 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 109.253 -0.647 . . . . 74.44 109.253 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . 0.63 HG23 HG21 ' G' ' 452' ' ' VAL . 7.1 p -164.07 136.48 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 124.503 1.121 . . . . 71.12 109.29 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . 0.63 HG21 HG23 ' G' ' 451' ' ' VAL . 95.9 t 56.66 92.15 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 125.064 1.345 . . . . 73.52 111.818 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . 0.446 ' N ' ' SD ' ' C' ' 94' ' ' MET . . . -157.6 70.23 0.26 Allowed Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.769 -0.932 . . . . 45.34 110.769 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . 0.421 HD13 HD13 ' C' ' 98' ' ' LEU . 62.3 tp -63.39 109.37 1.58 Allowed 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.229 0.612 . . . . 62.44 110.067 178.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 455' ' ' THR . . . . . 0.402 HG21 ' HA2' ' C' ' 91' ' ' GLY . 23.6 p -69.2 167.52 16.06 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.815 -0.63 . . . . 72.31 111.217 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.63 107.77 17.68 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.871 -0.604 . . . . 74.32 109.861 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -109.18 134.95 51.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.728 -0.842 . . . . 73.42 108.728 171.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 30.5 p -78.06 78.93 4.54 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 123.861 0.865 . . . . 75.33 110.242 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 62.19 -174.23 0.14 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.703 1.201 . . . . 62.31 111.968 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 77.8 mt -79.1 138.21 37.83 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.305 -0.628 . . . . 74.41 109.305 171.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -47.01 -53.48 12.37 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.714 1.206 . . . . 73.12 111.077 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 33.7 t80 38.55 51.48 1.69 Allowed 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 125.634 1.574 . . . . 75.44 111.567 -173.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 463' ' ' THR . . . . . 0.579 HG22 ' HB3' ' C' ' 145' ' ' ALA . 10.4 p -80.81 15.22 1.84 Allowed 'General case' 0 CA--C 1.555 1.173 0 CA-C-N 114.773 -1.103 . . . . 71.45 112.302 -173.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 464' ' ' MET . . . . . 0.467 ' SD ' HG22 ' C' ' 131' ' ' VAL . 55.4 ttp -82.28 -14.75 54.93 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.023 0.929 . . . . 75.3 111.237 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 10.6 mptt 70.35 -73.79 0.09 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.3 1.44 . . . . 74.41 109.645 -174.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -149.6 174.37 12.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.629 1.172 . . . . 43.43 109.552 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -144.13 -171.39 3.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.658 0.783 . . . . 73.11 110.28 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . 0.499 ' HB2' HG23 ' C' ' 40' ' ' VAL . 91.3 mt 68.78 -171.11 0.18 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.751 1.22 . . . . 72.15 112.007 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.61 82.48 0.05 OUTLIER Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.148 -1.181 . . . . 74.53 110.148 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 71.5 mt -86.67 54.87 3.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.399 0.679 . . . . 71.04 111.571 -175.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . 0.507 ' HD2' ' HG2' ' C' ' 37' ' ' GLN . 62.7 tttp . . . . . 0 CA--C 1.551 0.99 0 C-N-CA 125.25 1.42 . . . . 71.12 108.064 173.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 119.558 -0.258 . . . . 73.42 110.634 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' D' ' 90' ' ' GLU . 4.1 p -65.73 -16.43 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 123.625 0.77 . . . . 75.41 112.898 -166.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.435 HG13 HD11 ' D' ' 86' ' ' ILE . 15.5 m -79.27 175.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.932 0.893 . . . . 75.12 113.253 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 158.11 60.78 0.01 OUTLIER Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.177 -0.92 . . . . 74.35 111.732 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . 0.47 ' HB3' ' CE1' ' D' ' 56' ' ' TYR . 62.3 tp -94.14 139.94 30.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.153 0.581 . . . . 74.22 110.978 -176.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 11.8 t -153.31 153.2 32.16 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.659 1.184 . . . . 74.44 109.27 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 60.8 85.98 0.11 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.745 1.218 . . . . 64.42 111.981 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -96.89 103.04 14.93 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.183 -1.043 . . . . 73.03 108.183 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 30.5 m -64.76 150.3 47.65 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.63 0.772 . . . . 75.52 110.514 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.36 146.28 7.26 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.618 0.767 . . . . 72.32 110.762 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . 0.474 HD23 ' HB ' ' D' ' 46' ' ' THR . 0.7 OUTLIER -64.96 107.2 1.42 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 108.189 -1.041 . . . . 75.54 108.189 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -80.26 66.24 5.68 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.752 -1.567 . . . . 72.34 111.307 -173.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . 0.472 ' HB2' HD22 ' D' ' 136' ' ' LEU . 57.8 t80 -157.53 111.85 2.64 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.918 -0.771 . . . . 74.31 108.918 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 68.3 p -109.45 16.69 22.1 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.759 0.824 . . . . 73.4 110.783 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 464' ' ' MET . . . . . 0.539 ' HB2' HD12 ' D' ' 42' ' ' LEU . 34.9 tpp 70.4 144.3 0.06 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.248 1.419 . . . . 74.14 111.871 -176.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.19 -53.15 27.01 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.343 -0.844 . . . . 74.11 110.582 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -150.85 -74.23 0.15 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.798 0.439 . . . . 71.44 110.815 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -129.11 136.34 50.08 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.503 0.721 . . . . 75.22 109.908 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . 0.64 HD21 ' HB2' ' D' ' 42' ' ' LEU . 2.8 pp -91.11 -17.34 26.33 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.259 0.466 . . . . 75.24 112.259 -177.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.38 54.46 0.04 OUTLIER Glycine 0 N--CA 1.464 0.539 0 N-CA-C 111.546 -0.622 . . . . 73.55 111.546 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 6.5 tt -159.3 118.45 2.94 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.38 -1.341 . . . . 71.14 107.38 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt . . . . . 0 C--O 1.25 1.112 0 N-CA-C 108.789 -0.819 . . . . 74.31 108.789 175.034 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HE1' ' HA ' ' A' ' 1' ' ' MET . 3.5 tpt . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.674 0.273 . . . . 73.51 110.486 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t -119.58 70.53 0.85 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.944 0.897 . . . . 51.11 108.676 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -74.17 108.09 6.75 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.786 -1.097 . . . . 70.34 109.769 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -100.32 109.93 22.14 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.272 1.029 . . . . 72.24 108.977 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -78.56 133.12 37.37 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.062 -0.718 . . . . 74.21 109.062 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.586 ' ND2' ' HA ' ' C' ' 147' ' ' GLU . 1.2 p-10 -154.1 108.07 2.99 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.534 0.734 . . . . 73.14 110.55 -175.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 p -142.11 92.52 2.44 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.831 0.852 . . . . 75.33 108.961 171.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.37 -41.71 10.74 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.426 -0.583 . . . . 72.32 109.426 174.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.413 ' HE1' HG21 ' A' ' 89' ' ' ILE . 1.7 mpt? -95.78 165.73 12.15 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.279 0.632 . . . . 74.5 110.036 175.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.5 m -147.35 128.3 14.5 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.972 0.909 . . . . 74.24 109.301 169.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.692 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 6.2 t80 -139.03 132.68 30.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.038 0.935 . . . . 73.01 108.62 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -149.98 103.56 3.22 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.528 -0.916 . . . . 74.24 108.528 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.553 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.3 mt -70.36 112.05 4.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.335 -0.987 . . . . 73.33 108.335 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -81.04 -31.14 34.65 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 124.237 0.961 . . . . 71.44 110.277 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -174.36 147.44 1.16 Allowed 'General case' 0 C--N 1.355 0.835 0 O-C-N 123.626 0.579 . . . . 74.11 110.228 -173.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.4 HD13 ' HG3' ' C' ' 130' ' ' PRO . 79.7 mt -137.02 133.6 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.878 -1.156 . . . . 74.34 107.878 172.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -168.59 154.39 6.71 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 123.915 0.759 . . . . 75.51 111.412 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -74.57 116.57 15.41 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.011 -0.737 . . . . 70.13 109.011 172.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -78.19 -42.86 30.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.368 -0.604 . . . . 74.11 109.368 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.608 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 7.0 m-20 -136.65 131.91 34.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.934 -1.03 . . . . 73.23 109.235 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.0 mt -128.18 141.06 47.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.09 -1.448 . . . . 73.23 107.09 172.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -152.51 120.78 6.29 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.199 -0.667 . . . . 75.32 109.199 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.581 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 87.3 t80 -123.78 130.6 52.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.274 -1.38 . . . . 75.45 107.274 174.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -126.48 153.01 45.68 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.023 -1.102 . . . . 74.54 108.023 172.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.51 79.16 10.6 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.486 -1.301 . . . . 74.3 107.486 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.21 -40.34 77.1 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.332 2.688 . . . . 74.02 112.843 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.554 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 39.0 m-80 -109.22 39.68 2.01 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.28 -0.873 . . . . 72.43 109.767 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.4 ' O ' HG13 ' A' ' 31' ' ' VAL . . . -59.54 -45.55 98.76 Favored Pre-proline 0 CA--C 1.565 1.536 0 C-N-CA 123.939 0.896 . . . . 70.42 113.079 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -71.79 -22.03 24.21 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 121.826 1.684 . . . . 75.13 112.29 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 42.0 m170 -86.91 -24.63 24.76 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.621 0.768 . . . . 64.01 112.333 -174.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 28' ' ' ALA . 7.7 p -72.19 -25.21 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.759 0.424 . . . . 72.45 110.409 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.1 -31.78 70.74 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.528 0.731 . . . . 72.11 110.607 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -78.57 -47.75 16.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.101 0.96 . . . . 72.1 110.424 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -83.02 151.53 25.79 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.856 0.862 . . . . 73.32 110.757 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.36 146.04 53.61 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.616 -0.512 . . . . 64.11 109.616 170.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.43 ' HE1' HD23 ' E' ' 470' ' ' LEU . 65.0 t-105 -70.7 85.15 0.65 Allowed 'General case' 0 C--N 1.351 0.662 0 CA-C-O 121.468 0.651 . . . . 73.12 109.752 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.98 78.78 75.77 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 106.451 -1.685 . . . . 74.35 106.451 173.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -89.89 -173.44 0.71 Allowed 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.453 2.102 . . . . 71.2 112.543 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -141.03 108.81 5.65 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.811 -1.551 . . . . 71.34 106.811 167.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.435 HG12 ' HB2' ' E' ' 470' ' ' LEU . 22.1 m -96.5 135.81 29.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.317 0.58 . . . . 73.42 111.301 -172.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -120.71 145.47 47.45 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.284 -1.006 . . . . 73.24 108.284 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.661 ' HB3' ' HH ' ' E' ' 462' ' ' TYR . 37.9 tp -124.1 126.16 45.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.201 -0.666 . . . . 71.43 109.201 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.578 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.7 m-20 -113.95 144.1 43.62 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.106 -1.072 . . . . 54.02 108.106 170.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.18 146.65 37.22 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.353 -0.61 . . . . 74.42 109.353 169.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -152.06 147.96 27.11 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.195 0.598 . . . . 72.51 110.007 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.442 ' HB ' HD12 ' E' ' 460' ' ' LEU . 80.0 m -118.49 128.95 55.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.276 1.03 . . . . 73.33 109.353 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.55 151.55 51.89 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.411 0.684 . . . . 74.03 109.156 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.0 m -118.09 157.52 26.72 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.326 0.651 . . . . 73.12 109.967 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -149.27 121.09 8.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.736 0.814 . . . . 73.3 109.342 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -84.49 103.2 13.43 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.612 -0.884 . . . . 72.12 108.612 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.15 -34.77 23.97 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.414 -0.812 . . . . 72.05 110.373 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.42 -176.56 5.97 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 124.268 0.98 . . . . 72.54 109.723 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.48 115.15 4.38 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.702 0.626 . . . . 71.13 110.073 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 62.67 26.53 15.7 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.44 1.496 . . . . 73.34 112.78 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -117.79 118.36 58.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-N 114.706 -1.134 . . . . 72.12 108.743 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.572 ' HD2' HD13 ' A' ' 86' ' ' ILE . 23.8 m-85 -125.11 124.97 43.0 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.478 0.711 . . . . 71.41 109.991 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.26 126.44 37.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.277 -1.008 . . . . 74.2 108.277 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.415 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 92.7 t -100.78 130.35 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.33 -1.359 . . . . 74.15 107.33 171.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.1 t -107.56 107.68 23.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 107.874 -1.158 . . . . 63.03 107.874 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.27 99.86 12.02 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.381 -1.34 . . . . 73.33 107.381 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 37.8 ttt180 -85.74 119.61 26.25 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.22 -0.9 . . . . 75.21 109.641 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.5 t -112.13 140.77 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.561 -0.903 . . . . 74.23 108.561 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.578 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 17.9 m -130.92 129.31 42.03 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.739 -0.837 . . . . 74.45 108.739 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.55 HG21 HG22 ' A' ' 114' ' ' ILE . 74.2 t -127.84 126.32 66.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.958 -1.497 . . . . 74.32 106.958 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 14.7 t -136.71 145.97 45.32 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.593 -0.891 . . . . 73.34 108.593 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.07 123.81 13.37 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.548 -0.908 . . . . 73.34 108.548 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 p -127.18 133.67 50.26 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.447 0.699 . . . . 74.44 110.607 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 73' ' ' ALA . 7.6 mp -86.16 77.19 9.63 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.152 -1.795 . . . . 74.42 106.152 169.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.79 -115.69 4.81 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 114.515 -1.22 . . . . 65.31 111.082 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -87.98 -20.34 25.99 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.908 0.883 . . . . 72.33 110.319 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -80.06 100.98 8.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.754 0.822 . . . . 75.24 109.951 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.9 m -68.06 120.19 13.88 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 110.174 -0.306 . . . . 75.2 110.174 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.571 ' HB3' HD11 ' A' ' 68' ' ' LEU . . . -71.68 -55.42 7.74 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.84 -0.8 . . . . 63.41 108.84 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -160.64 165.79 30.03 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 115.524 -0.762 . . . . 74.21 111.708 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.7 tp -141.6 108.07 5.3 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.516 -1.22 . . . . 73.04 108.205 173.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.458 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 58.7 m -107.35 116.68 32.36 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.104 0.962 . . . . 74.2 109.898 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -134.0 126.04 29.41 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.151 -0.685 . . . . 72.54 109.151 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.4 t -133.38 110.28 14.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 124.292 1.037 . . . . 75.4 109.215 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 19.6 mt-30 -84.64 84.03 7.81 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.086 -1.079 . . . . 73.0 108.086 171.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -79.33 99.92 7.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.345 -1.298 . . . . 73.11 108.685 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.14 157.81 18.39 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 112.073 -0.411 . . . . 74.15 112.073 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.51 131.06 3.05 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 110.849 -0.9 . . . . 74.33 110.849 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -81.12 125.21 39.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.499 -0.926 . . . . 75.52 108.499 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.692 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 30.8 m-85 -131.06 119.95 22.73 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.845 -0.798 . . . . 65.55 108.845 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -91.8 108.63 20.05 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.286 -1.005 . . . . 64.0 108.286 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.572 HD13 ' HD2' ' A' ' 56' ' ' TYR . 2.6 pp -118.65 147.61 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.541 0.737 . . . . 75.34 110.533 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.34 176.92 6.36 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.137 0.975 . . . . 74.34 110.0 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.25 -24.58 21.61 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.854 -0.612 . . . . 61.4 113.583 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.413 HG21 ' HE1' ' A' ' 9' ' ' MET . 2.0 pp -136.39 148.83 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.501 0.72 . . . . 75.24 110.954 -175.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.68 175.01 9.96 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.875 0.87 . . . . 70.21 109.365 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.37 -128.69 13.64 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 123.459 0.552 . . . . 63.13 112.386 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.579 ' HB ' HD11 ' A' ' 141' ' ' LEU . 61.4 p -68.84 -22.06 64.25 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.261 1.024 . . . . 65.34 111.958 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -68.45 -51.07 47.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.846 0.858 . . . . 74.33 110.68 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.451 ' SD ' HD11 ' A' ' 86' ' ' ILE . 41.5 ttp -78.08 -23.03 48.15 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 116.275 -0.42 . . . . 75.42 110.402 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -37.7 86.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.154 0.582 . . . . 74.32 110.199 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -67.72 -35.15 78.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.544 0.738 . . . . 73.24 110.85 174.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 76.8 m -62.1 -54.07 46.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.756 0.423 . . . . 73.25 110.582 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 pp -73.16 -34.5 66.08 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.771 0.428 . . . . 75.24 111.39 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.67 -2.0 56.39 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 114.905 0.722 . . . . 72.11 114.905 -168.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.75 -61.75 0.24 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.649 0.724 . . . . 74.3 112.727 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.401 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 89.5 t80 -72.17 -61.91 1.62 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.106 0.963 . . . . 75.22 112.709 -165.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 72.7 m -67.65 -34.96 7.24 Favored Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 114.026 1.121 . . . . 75.43 114.026 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 27.9 Cg_endo -64.64 -31.09 59.97 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 121.769 1.646 . . . . 74.13 113.357 167.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -67.89 -29.92 69.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.097 0.559 . . . . 64.52 110.206 178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.15 -42.81 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.845 0.858 . . . . 74.11 110.573 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.9 mt -82.16 -20.79 37.2 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.474 1.11 . . . . 74.23 112.575 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.77 -44.77 91.91 Favored Pre-proline 0 CA--C 1.572 1.805 0 C-N-CA 124.033 0.933 . . . . 75.13 113.437 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -64.73 -32.38 57.02 Favored 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 122.36 2.04 . . . . 75.44 113.434 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.415 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 97.3 m-85 -70.8 -40.66 72.4 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.144 0.577 . . . . 71.23 110.933 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.37 -38.8 78.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.968 0.507 . . . . 74.41 110.49 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.407 ' HB2' HD11 ' A' ' 128' ' ' LEU . 36.0 ttm180 -51.09 -56.25 13.58 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.088 0.867 . . . . 74.41 109.517 172.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -59.11 -47.74 84.16 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.609 1.164 . . . . 74.21 112.163 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.06 -44.89 87.71 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.999 0.812 . . . . 75.42 110.975 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.55 HG22 HG21 ' A' ' 64' ' ' VAL . 96.6 mt -67.53 -49.05 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.039 0.936 . . . . 72.31 110.586 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.492 HG23 ' HG3' ' A' ' 125' ' ' GLN . 36.3 m -53.25 -40.72 64.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.146 0.978 . . . . 75.41 111.208 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.28 -47.82 66.64 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.989 -1.005 . . . . 75.21 110.018 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 42.5 mtp -60.92 -41.09 95.51 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 124.077 0.951 . . . . 72.32 111.686 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.8 t -65.62 -44.15 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.17 0.988 . . . . 65.41 110.339 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.9 t -68.53 -31.82 71.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.6 0.76 . . . . 64.52 111.313 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -72.69 -29.94 63.82 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.38 0.672 . . . . 75.23 110.075 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.52 2.64 84.99 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 123.69 0.619 . . . . 71.44 112.896 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.3 m 68.0 22.9 8.35 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.768 1.227 . . . . 74.52 111.151 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -91.93 150.88 41.4 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 123.355 0.662 . . . . 71.3 109.222 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.46 139.48 90.8 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.577 2.184 . . . . 72.22 112.575 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.492 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.0 tt0 -57.73 150.04 20.63 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.814 1.246 . . . . 71.43 112.682 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.534 ' HA ' ' HA3' ' E' ' 469' ' ' GLY . 2.9 pp -126.65 137.46 53.29 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.846 -1.168 . . . . 75.02 107.846 173.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.45 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 86.6 m-20 -135.69 84.05 2.06 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.751 -1.203 . . . . 70.03 107.751 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 111' ' ' ARG . 2.7 pp -65.1 135.62 55.75 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.146 -0.479 . . . . 74.14 110.645 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.17 140.81 98.06 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 123.069 0.548 . . . . 75.25 110.068 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.75 126.92 22.63 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.196 1.931 . . . . 75.44 111.384 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 91.3 t -97.46 113.86 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 106.62 -1.622 . . . . 71.12 106.62 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -75.48 83.93 2.56 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.946 -1.131 . . . . 70.11 107.946 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -60.4 -33.41 72.45 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.108 -0.951 . . . . 74.04 110.589 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.05 -40.46 90.98 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.074 0.95 . . . . 63.12 110.98 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.06 -50.55 61.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.254 0.621 . . . . 75.51 110.259 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.0 mt -64.04 -42.15 97.17 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.22 -0.9 . . . . 71.41 111.573 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -66.49 -41.02 89.56 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.237 -0.892 . . . . 72.45 109.375 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.43 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -66.05 -36.64 83.77 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 123.897 0.748 . . . . 73.25 109.774 -177.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -57.55 -39.57 76.97 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.019 0.528 . . . . 74.53 111.214 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -73.64 -39.67 64.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.137 0.575 . . . . 75.44 110.738 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.579 HD11 ' HB ' ' A' ' 92' ' ' THR . 64.5 tp -61.69 -46.48 89.53 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.744 1.218 . . . . 74.43 111.814 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -175.45 -18.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.285 0.634 . . . . 74.23 110.941 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 54.67 75.23 0.31 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.047 1.739 . . . . 74.31 110.909 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -144.01 88.92 1.99 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.358 -0.837 . . . . 71.1 109.193 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.0 160.16 20.09 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 124.479 1.112 . . . . 71.11 110.349 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -144.99 147.53 18.76 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 111.7 -0.56 . . . . 74.45 111.7 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.2 133.36 29.6 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 107.899 -1.148 . . . . 72.41 107.899 -177.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.41 41.15 0.28 Allowed Glycine 0 C--N 1.345 1.028 0 CA-C-O 119.711 -0.494 . . . . 62.42 113.426 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.3 p -69.49 98.75 1.16 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.975 0.387 . . . . 75.23 111.081 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -81.02 163.89 22.91 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.079 0.951 . . . . 75.24 109.318 171.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.59 139.62 39.55 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 109.31 -0.626 . . . . 74.13 109.31 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -89.1 3.61 51.23 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.797 0.839 . . . . 73.11 112.293 -173.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 67.23 -168.38 0.2 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.58 1.152 . . . . 74.34 110.619 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -76.52 128.42 34.73 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.972 -0.751 . . . . 53.04 108.972 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 N-CA-C 108.921 -0.77 . . . . 71.13 108.921 -177.325 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 109.196 -0.668 . . . . 75.24 109.196 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 37.5 p -135.21 62.89 1.63 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.76 0.824 . . . . 73.11 110.457 -176.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -78.28 104.07 8.63 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 107.857 -1.164 . . . . 65.41 107.857 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -122.62 79.05 1.59 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.334 0.654 . . . . 75.51 109.549 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -73.99 138.98 44.49 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.466 -0.568 . . . . 70.34 109.466 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -81.24 136.44 35.82 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.175 0.59 . . . . 74.15 109.583 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.4 t -78.23 149.51 33.63 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 123.549 0.531 . . . . 71.32 109.855 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.18 -143.84 0.32 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 107.779 -1.193 . . . . 72.44 107.779 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.54 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 12.2 ptm 59.41 171.26 0.07 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.548 1.939 . . . . 72.14 114.435 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.636 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 70.6 m -150.85 136.86 18.3 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 125.346 1.458 . . . . 73.31 107.122 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -139.39 141.49 37.55 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.759 0.423 . . . . 75.01 110.252 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -144.67 138.12 27.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.592 0.757 . . . . 71.13 109.906 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.94 126.78 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.048 -1.093 . . . . 73.43 108.048 171.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -95.35 -50.32 5.07 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.699 0.4 . . . . 72.24 110.079 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -161.72 131.07 4.56 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.531 -0.544 . . . . 74.33 109.531 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.2 mt -115.35 131.95 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 107.924 -1.139 . . . . 72.13 107.924 171.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -156.85 138.28 13.92 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.41 0.684 . . . . 71.43 110.144 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.5 m -72.23 121.84 20.04 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.478 -0.934 . . . . 74.44 108.478 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -95.33 -23.5 17.17 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.433 0.693 . . . . 71.01 111.042 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -161.69 141.03 9.97 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.399 0.437 . . . . 74.12 110.732 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.581 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 33.7 mm -134.23 144.46 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.159 1.384 . . . . 73.3 108.765 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -138.55 139.95 38.87 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.591 -1.186 . . . . 73.21 107.974 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.553 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 85.2 t80 -152.58 130.61 11.84 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.637 -1.246 . . . . 75.2 107.637 166.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 49.0 mt-10 -140.45 116.7 10.61 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.645 0.778 . . . . 73.32 108.918 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.486 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -105.29 84.29 1.07 Allowed Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 106.922 -1.51 . . . . 65.35 106.922 165.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.39 -23.83 20.03 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.954 2.436 . . . . 70.32 111.97 -170.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.492 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 78.3 m-20 -116.93 6.71 13.07 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 114.433 -1.258 . . . . 75.03 110.368 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.554 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -29.13 -66.05 0.15 Allowed Pre-proline 0 C--N 1.38 1.899 0 C-N-CA 126.163 1.785 . . . . 55.01 114.787 -171.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.8 Cg_exo -64.78 -29.46 59.29 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 122.585 2.19 . . . . 72.33 112.509 -169.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -46.47 14.52 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.364 -0.835 . . . . 72.44 110.752 176.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.406 HG21 HD11 ' B' ' 68' ' ' LEU . 2.7 p -70.31 -17.85 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.147 0.579 . . . . 72.51 111.986 -166.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -69.37 -11.64 60.99 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 112.654 0.613 . . . . 73.35 112.654 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -77.28 -3.42 39.74 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.191 0.596 . . . . 75.11 110.877 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.7 105.35 15.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.907 1.283 . . . . 75.01 110.093 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.93 91.91 7.7 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.842 0.857 . . . . 71.22 109.729 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -161.92 155.57 21.3 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.918 0.887 . . . . 75.43 108.922 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.437 ' HG3' HD12 ' F' ' 470' ' ' LEU . 7.9 tp60 -81.97 102.95 1.78 Allowed Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 107.201 -1.407 . . . . 74.14 107.201 170.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.407 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 40.6 Cg_endo -66.67 133.35 31.54 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.555 2.17 . . . . 54.34 112.308 -171.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -69.23 129.54 40.11 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 123.855 0.722 . . . . 74.3 110.026 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.631 ' H ' HD21 ' F' ' 470' ' ' LEU . 74.9 t -106.13 129.84 58.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.49 1.116 . . . . 74.31 109.968 -171.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -103.98 112.66 25.74 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 105.84 -1.911 . . . . 73.34 105.84 167.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.58 153.23 18.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.921 -1.036 . . . . 75.11 108.784 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.6 t70 -144.59 110.62 5.44 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.022 -0.732 . . . . 75.24 109.022 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -109.04 134.89 51.08 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.14 -1.059 . . . . 74.23 108.14 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -159.54 156.24 27.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.395 0.678 . . . . 75.35 109.377 170.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.6 p -124.82 128.33 48.54 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.352 0.661 . . . . 62.51 109.833 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.5 158.19 21.94 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.738 -1.208 . . . . 74.11 107.738 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.433 ' HB3' HD22 ' B' ' 98' ' ' LEU . 13.3 p -142.27 168.78 18.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.53 0.332 . . . . 60.13 111.107 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 2.1 m -148.53 136.06 20.52 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.424 -0.954 . . . . 72.04 108.424 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -90.36 100.53 13.35 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.416 -0.957 . . . . 73.13 108.416 170.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.461 HD12 HG22 ' B' ' 83' ' ' ILE . 82.2 mt -76.21 -33.44 59.26 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.637 -0.71 . . . . 75.43 109.911 174.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.02 -175.35 3.33 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.147 -0.933 . . . . 72.52 110.696 -177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.28 122.22 16.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.371 -1.286 . . . . 71.02 109.154 173.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 66.62 14.65 9.85 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.926 0.891 . . . . 72.13 112.379 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -118.5 119.78 62.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 123.642 0.777 . . . . 74.13 109.032 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -112.64 152.78 28.56 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.641 0.776 . . . . 72.41 110.172 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 6.8 tm-20 -124.66 97.18 5.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.508 -1.664 . . . . 75.21 106.508 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.437 HG21 ' HG ' ' B' ' 98' ' ' LEU . 90.4 t -86.51 143.99 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.048 -0.978 . . . . 71.34 109.792 -175.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -131.95 112.43 20.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.432 -0.951 . . . . 74.35 108.432 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.459 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -93.64 118.72 31.75 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.465 -1.309 . . . . 74.44 107.465 177.006 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 69.3 ttt-85 -107.43 110.07 21.94 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.975 0.51 . . . . 75.13 109.719 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.402 HG11 ' CD1' ' B' ' 114' ' ' ILE . 22.8 t -108.11 104.31 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.982 -1.118 . . . . 74.25 107.982 173.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 11.1 m -100.54 137.37 39.04 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.116 -0.698 . . . . 63.51 109.116 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.601 HG22 HG21 ' B' ' 114' ' ' ILE . 50.3 t -123.82 126.49 72.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.982 1.313 . . . . 70.11 108.822 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 52.4 m -125.09 139.01 54.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.476 -1.305 . . . . 74.23 107.476 170.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.528 ' HB1' HG23 ' B' ' 40' ' ' VAL . . . -146.03 151.6 38.01 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.605 -0.517 . . . . 73.14 109.605 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 27.7 p -149.07 139.57 22.51 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 123.699 0.624 . . . . 60.3 112.132 -174.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 86.3 mt -106.08 102.22 11.66 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.639 1.176 . . . . 73.12 108.328 172.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.02 -131.5 12.46 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.786 -0.643 . . . . 73.3 112.541 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -86.97 3.81 44.3 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.384 1.073 . . . . 70.2 112.446 -175.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.492 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.9 pt-20 -132.16 155.61 47.89 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.957 0.503 . . . . 73.1 111.095 -175.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.6 m -67.1 137.3 56.26 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.891 0.744 . . . . 74.24 110.85 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.06 -67.29 0.86 Allowed 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.697 -1.223 . . . . 75.35 107.697 173.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -144.3 145.59 32.1 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 121.407 0.622 . . . . 73.1 110.626 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.405 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 94.1 mt -117.14 149.46 40.32 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.309 1.444 . . . . 74.24 107.281 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.452 ' SG ' HG22 ' B' ' 114' ' ' ILE . 42.5 t -158.15 158.53 34.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.659 -0.867 . . . . 63.02 108.659 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -165.73 133.54 2.96 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.994 -1.113 . . . . 73.32 107.994 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.43 HG21 ' CD1' ' B' ' 21' ' ' ILE . 94.2 t -124.88 141.32 45.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.615 -0.883 . . . . 62.44 108.615 174.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -119.63 84.19 2.16 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.3 -1.37 . . . . 74.54 107.3 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.77 99.33 7.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.357 -1.292 . . . . 64.43 109.079 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.0 171.41 28.52 Favored Glycine 0 C--O 1.245 0.788 0 CA-C-N 115.774 -0.648 . . . . 72.25 112.006 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.54 130.88 1.94 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 112.029 -0.429 . . . . 73.15 112.029 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.461 HG22 HD12 ' B' ' 51' ' ' LEU . 63.8 mt -83.73 127.29 39.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 108.293 -1.003 . . . . 75.41 108.293 170.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -136.08 143.28 44.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.646 0.778 . . . . 72.01 109.163 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -104.05 125.3 50.29 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.691 0.796 . . . . 72.1 109.014 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.633 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.8 pp -119.23 145.01 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.217 1.007 . . . . 75.42 110.103 -176.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.636 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.04 162.11 41.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.584 0.754 . . . . 75.33 110.119 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.72 -57.13 5.05 Favored Glycine 0 C--N 1.354 1.567 0 O-C-N 123.683 0.614 . . . . 60.24 112.854 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.633 HD11 ' HB ' ' B' ' 86' ' ' ILE . 11.8 pt -58.19 148.39 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.762 1.225 . . . . 74.43 112.178 174.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.472 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 31.2 tt0 -160.84 152.52 19.56 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.999 -1.0 . . . . 74.4 109.843 -175.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.8 -112.76 4.08 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 112.206 -0.358 . . . . 74.44 112.206 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.9 m -92.51 -16.98 25.08 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.895 0.478 . . . . 74.24 111.139 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.472 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 45.6 mt-30 -59.76 -39.22 84.09 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.268 0.627 . . . . 64.4 110.725 175.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.564 ' HA ' HD13 ' B' ' 89' ' ' ILE . 26.2 ptt? -74.71 -25.25 59.01 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.647 -0.706 . . . . 52.04 110.993 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.33 -33.5 71.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.412 0.685 . . . . 64.11 110.466 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -65.4 -39.19 91.89 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.548 0.739 . . . . 73.32 110.685 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.459 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 44.5 t -70.42 -58.06 4.13 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.758 -0.655 . . . . 75.13 110.547 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.437 ' HG ' HG21 ' B' ' 58' ' ' VAL . 7.8 tt -65.13 -43.74 90.91 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.425 0.69 . . . . 74.32 111.38 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.19 -26.03 49.68 Favored Glycine 0 C--N 1.341 0.839 0 O-C-N 123.763 0.664 . . . . 64.34 114.238 -170.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.59 -53.17 1.25 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.215 0.508 . . . . 74.33 112.328 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.459 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 79.7 t80 -71.33 -45.72 62.29 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.565 0.746 . . . . 72.12 112.626 -169.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.501 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 81.0 m -67.82 -49.0 39.93 Favored Pre-proline 0 CA--C 1.565 1.551 0 C-N-CA 123.702 0.801 . . . . 73.13 110.424 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 66.8 Cg_exo -57.07 -30.04 85.36 Favored 'Trans proline' 0 C--N 1.399 3.229 0 C-N-CA 122.844 2.363 . . . . 75.0 113.898 169.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -62.55 -41.54 98.97 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.593 0.757 . . . . 73.3 109.803 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.79 -44.26 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.626 0.77 . . . . 75.4 110.063 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.3 mt -78.92 -15.76 57.9 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.029 0.932 . . . . 71.23 112.583 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -62.21 -51.82 71.34 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 118.102 -0.951 . . . . 73.32 113.348 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.27 -34.97 87.0 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 121.825 1.684 . . . . 74.12 112.515 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -62.73 -50.46 71.02 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.906 0.883 . . . . 75.32 110.911 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.41 97.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.789 0.836 . . . . 71.52 110.631 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -59.2 -54.34 48.03 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.636 1.574 . . . . 75.11 111.131 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.54 -30.66 70.36 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.193 0.597 . . . . 74.13 110.037 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.558 ' SG ' HD12 ' B' ' 21' ' ' ILE . 1.8 t -69.98 -28.42 65.52 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.745 0.418 . . . . 73.52 111.595 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.601 HG21 HG22 ' B' ' 64' ' ' VAL . 45.8 mt -76.03 -54.48 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 109.176 -0.676 . . . . 75.01 109.176 172.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.416 HG22 ' OG ' ' C' ' 119' ' ' SER . 23.5 m -54.2 -33.43 58.2 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.623 1.202 . . . . 71.01 111.568 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 24.8 t -60.42 -54.17 48.81 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 115.24 -0.891 . . . . 73.32 109.589 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.1 mmt -68.94 -35.33 76.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.7 0.8 . . . . 64.21 111.482 -173.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.3 t -60.63 -46.08 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.0 0.92 . . . . 74.33 109.811 174.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 34.8 t -72.59 -28.86 63.05 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.651 -1.159 . . . . 74.24 111.383 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.2 mtt-85 -68.75 -35.39 77.03 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.524 0.73 . . . . 74.4 109.533 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.71 11.13 57.73 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 124.119 0.887 . . . . 74.32 112.816 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 75.6 p 56.58 24.12 8.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.235 1.814 . . . . 74.13 113.631 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -84.52 154.81 62.55 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 123.326 0.65 . . . . 71.42 110.34 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.35 169.94 5.88 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.955 2.437 . . . . 75.22 113.778 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -63.62 131.18 47.18 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.01 -0.995 . . . . 74.04 112.211 -166.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.2 tp -135.11 111.54 9.81 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.859 0.863 . . . . 75.31 109.043 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -134.2 114.74 13.39 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.345 0.658 . . . . 73.34 109.272 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.27 141.75 55.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.794 0.837 . . . . 74.12 111.086 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.46 144.07 96.06 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.412 0.685 . . . . 75.44 110.365 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -69.32 100.54 0.77 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.405 2.07 . . . . 75.4 111.339 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.48 110.76 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.587 -0.894 . . . . 74.54 108.587 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -78.96 83.92 5.02 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.987 -1.116 . . . . 73.33 107.987 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -52.67 -39.11 61.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.578 1.151 . . . . 61.32 112.871 -172.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.41 -34.59 75.64 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.483 1.113 . . . . 74.12 112.396 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.79 -41.07 60.68 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.43 0.692 . . . . 72.51 110.863 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -70.13 -29.77 66.79 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.467 -0.788 . . . . 75.32 110.072 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.463 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 80.9 t80 -68.76 -33.35 73.75 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.976 0.91 . . . . 73.24 110.469 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -39.34 83.78 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.437 0.637 . . . . 75.51 109.837 177.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -88.57 -12.09 43.73 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.922 -1.035 . . . . 65.54 110.704 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -71.07 -33.99 70.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.397 0.679 . . . . 75.32 110.193 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 40.7 mt -82.71 -6.23 59.28 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 114.914 -1.039 . . . . 73.44 111.901 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.493 ' HG3' ' HG2' ' B' ' 144' ' ' GLN . 7.1 tp60 -151.2 115.73 5.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.81 -0.811 . . . . 64.52 108.81 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -84.46 49.84 1.76 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.46 1.104 . . . . 74.31 111.602 -168.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.493 ' HG2' ' HG3' ' B' ' 142' ' ' GLN . 20.2 pt20 -158.49 170.81 21.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.449 1.1 . . . . 75.25 109.519 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.92 138.33 50.84 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.865 0.866 . . . . 71.21 109.145 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.52 137.74 23.06 Favored Glycine 0 C--N 1.348 1.227 0 O-C-N 123.531 0.519 . . . . 74.35 111.848 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.53 106.21 1.38 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.643 0.777 . . . . 73.22 110.346 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.4 148.71 46.58 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.782 0.676 . . . . 74.4 112.355 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.2 t -84.38 49.71 1.73 Allowed 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 122.304 1.049 . . . . 65.02 109.959 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -67.41 95.48 0.45 Allowed 'General case' 0 C--O 1.244 0.764 0 CA-C-N 114.276 -1.329 . . . . 73.01 110.865 -168.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.7 118.79 14.97 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 123.56 0.538 . . . . 74.14 109.661 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -88.27 -13.98 39.55 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.314 -0.857 . . . . 70.44 110.731 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -81.71 109.22 15.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.69 0.796 . . . . 75.33 109.768 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.36 158.84 33.24 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.946 0.898 . . . . 75.52 110.834 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.165 0 C-N-CA 124.479 1.112 . . . . 74.24 111.311 -177.053 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.419 ' H3 ' HG21 ' E' ' 463' ' ' THR . 26.4 ttt . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.405 -0.591 . . . . 74.53 109.405 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 35.2 m -72.64 125.89 28.56 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.565 0.746 . . . . 61.54 111.277 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.24 90.28 3.3 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.994 0.917 . . . . 72.42 110.535 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -95.32 126.81 40.89 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.087 0.555 . . . . 74.55 110.242 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -124.25 114.23 19.33 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.106 0.962 . . . . 75.32 108.652 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -131.1 -81.41 0.53 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.376 0.67 . . . . 64.12 111.106 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 27.1 p -106.17 -4.31 20.4 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.347 0.659 . . . . 72.32 112.766 -170.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -86.49 53.2 2.72 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.312 0.645 . . . . 74.14 111.432 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.481 ' HG3' HD12 ' C' ' 89' ' ' ILE . 1.4 mpt? 61.31 126.13 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.286 1.434 . . . . 75.53 112.352 -175.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 29.2 m -85.78 78.72 9.49 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.654 -1.61 . . . . 74.41 106.654 167.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.473 ' HD1' ' HH ' ' C' ' 101' ' ' TYR . 0.8 OUTLIER -104.04 122.33 45.05 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.831 -1.077 . . . . 74.3 109.479 -172.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -137.05 108.12 6.74 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 107.289 -1.374 . . . . 75.02 107.289 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 42.8 mt -67.73 119.17 12.94 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 108.112 -1.07 . . . . 64.23 108.112 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.654 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.7 mm-40 -78.34 -48.88 14.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.791 0.682 . . . . 73.14 109.431 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.45 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 25.2 ttt180 -172.24 138.65 0.98 Allowed 'General case' 0 C--N 1.349 0.58 0 CA-C-N 115.526 -0.761 . . . . 75.32 110.271 -169.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.3 mt -120.78 139.42 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.56 -1.274 . . . . 73.32 107.56 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -172.99 166.68 5.06 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.257 0.551 . . . . 73.1 111.015 -172.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -94.12 124.8 38.36 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.634 -0.712 . . . . 65.25 109.287 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.603 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.0 OUTLIER -81.61 -49.06 10.96 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.985 -1.487 . . . . 75.22 106.985 173.561 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.2 t70 -135.7 132.65 37.17 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.198 -1.819 . . . . 70.41 109.068 -168.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.5 mt -135.17 141.41 42.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.828 -1.545 . . . . 74.43 106.828 173.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.4 t -159.51 150.36 19.51 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.443 0.639 . . . . 73.32 110.597 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -145.71 139.8 26.78 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.336 -1.357 . . . . 74.15 107.336 174.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.84 120.3 12.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.644 0.778 . . . . 73.24 109.476 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.82 87.15 36.49 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 107.047 -1.464 . . . . 74.31 107.047 168.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.61 -38.34 25.28 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.077 2.518 . . . . 71.53 111.828 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -102.24 29.35 5.19 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.19 -1.368 . . . . 74.33 110.069 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.411 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -51.85 -55.6 28.85 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.457 1.103 . . . . 71.2 113.926 -171.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.411 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 33.5 Cg_exo -57.67 -44.9 37.27 Favored 'Trans proline' 0 C--N 1.39 2.747 0 CA-C-N 121.714 1.648 . . . . 73.43 112.927 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -69.95 -35.29 74.38 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.718 0.807 . . . . 74.42 112.238 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.714 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.9 p -78.23 -23.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.823 0.449 . . . . 73.21 111.874 -172.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -69.15 -33.27 73.17 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.627 0.251 . . . . 74.14 110.494 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -94.4 38.9 1.09 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.598 0.759 . . . . 73.42 110.374 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.705 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -119.96 141.71 49.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.749 1.22 . . . . 75.41 109.533 174.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.59 99.99 1.38 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.063 -1.088 . . . . 60.41 108.063 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.402 ' HA ' HD23 ' C' ' 68' ' ' LEU . 32.9 p90 -80.6 115.15 19.96 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.675 0.75 . . . . 75.23 112.548 -171.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -122.2 79.05 43.82 Favored Pre-proline 0 CA--C 1.555 1.137 0 N-CA-C 106.843 -1.54 . . . . 74.0 106.843 162.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.1 128.19 7.21 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.363 2.709 . . . . 65.41 112.946 -172.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -84.82 89.24 7.5 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.435 -1.32 . . . . 75.22 107.435 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.37 99.8 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.017 -1.447 . . . . 74.21 109.168 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.519 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 57.2 tttm -92.75 112.54 24.53 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.723 -0.843 . . . . 74.21 108.723 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.739 HD13 HD11 ' G' ' 468' ' ' LEU . 3.0 mm? -87.65 125.05 34.15 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.064 -0.717 . . . . 75.12 109.064 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.42 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.9 t70 -121.49 131.06 53.93 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.919 -1.141 . . . . 74.13 107.919 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.563 ' HB2' HD13 ' G' ' 460' ' ' LEU . 45.5 mt -120.6 147.04 45.74 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.827 -1.175 . . . . 74.33 107.827 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 22.8 t70 -157.48 152.77 26.09 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.235 0.614 . . . . 62.5 109.725 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 11.2 m -137.41 128.02 26.84 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.631 0.729 . . . . 72.51 110.045 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.83 161.68 16.66 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.151 -1.386 . . . . 72.24 108.554 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 20.3 p -159.31 151.36 20.87 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.858 0.361 . . . . 70.22 111.165 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 86.4 p -145.14 142.68 29.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.131 0.972 . . . . 64.55 108.747 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -82.87 118.06 23.17 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.426 -0.583 . . . . 71.43 109.426 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.539 HD12 HD13 ' C' ' 83' ' ' ILE . 38.6 mt -92.59 -40.05 10.99 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.609 0.763 . . . . 74.1 109.248 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.5 -175.73 5.49 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.263 1.025 . . . . 74.43 109.348 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.31 108.85 1.71 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.544 -0.753 . . . . 72.41 109.925 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 32.6 m-20 71.8 5.87 5.49 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.55 1.54 . . . . 74.43 112.668 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -103.23 97.78 6.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.964 -1.125 . . . . 70.14 107.964 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.426 ' HE2' HG13 ' G' ' 452' ' ' VAL . 51.0 m-85 -103.43 137.82 41.0 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.46 0.704 . . . . 72.51 110.097 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.521 ' HB2' HD12 ' C' ' 51' ' ' LEU . 22.1 tt0 -81.9 108.99 15.85 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.745 -1.576 . . . . 71.21 106.745 164.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 50.9 t -96.97 137.26 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 108.166 -1.05 . . . . 72.43 108.166 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.411 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 52.1 t -127.4 129.88 70.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.235 -1.024 . . . . 71.52 108.235 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.7 104.5 13.51 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.831 -1.544 . . . . 74.15 106.831 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.544 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 9.2 ttm180 -90.27 120.79 31.71 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.862 -1.063 . . . . 73.02 108.326 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.28 123.93 71.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.836 -1.172 . . . . 74.32 107.836 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 27.0 m -126.03 123.67 38.95 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.612 -0.885 . . . . 62.3 108.612 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.526 HG12 HD23 ' C' ' 126' ' ' LEU . 34.2 t -114.03 120.87 64.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 108.795 -0.817 . . . . 55.32 108.795 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 30.8 m -101.19 143.86 30.76 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.641 0.776 . . . . 75.11 108.967 172.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.67 107.86 6.08 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.12 -1.437 . . . . 74.51 107.12 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.2 m -128.02 131.72 49.16 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.519 -0.549 . . . . 74.22 109.519 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.705 HD11 ' HG2' ' C' ' 34' ' ' LYS . 25.0 mt -85.15 43.18 0.99 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.281 1.832 . . . . 75.13 110.045 -176.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.62 -88.68 0.68 Allowed Glycine 0 C--N 1.343 0.919 0 N-CA-C 110.303 -1.119 . . . . 71.41 110.303 -170.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -118.5 -20.09 8.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.816 0.846 . . . . 71.53 110.746 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.417 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 5.5 tp10 -77.48 100.48 6.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.739 0.816 . . . . 74.23 109.143 172.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.7 m -66.85 120.26 13.26 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 118.922 0.783 . . . . 74.44 109.197 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.67 -52.36 18.3 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 124.095 0.872 . . . . 75.11 108.984 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -166.56 167.4 15.52 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.617 -1.174 . . . . 74.34 110.843 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -133.9 139.43 46.17 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 106.309 -1.737 . . . . 74.23 106.309 171.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.4 t -146.53 117.82 7.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.298 -0.631 . . . . 75.04 109.298 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -125.57 126.55 44.97 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 122.954 0.502 . . . . 73.43 109.909 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -120.46 132.46 70.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.338 -0.986 . . . . 73.4 108.338 167.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.544 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 69.0 mt-30 -106.08 94.66 5.29 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.587 -1.264 . . . . 75.0 107.587 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -84.2 105.73 15.28 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.532 -0.758 . . . . 64.03 109.701 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.603 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -95.64 163.73 23.86 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-O 121.609 0.56 . . . . 74.0 112.858 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.38 126.6 1.53 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.013 -1.235 . . . . 75.11 110.013 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.654 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 14.0 mm -85.23 128.77 38.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.125 -1.065 . . . . 74.43 108.125 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.11 119.41 20.91 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.392 -0.595 . . . . 75.14 109.392 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -83.95 107.58 16.41 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.162 -1.051 . . . . 74.31 108.162 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.44 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.4 pp -122.45 142.87 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.102 0.961 . . . . 73.24 110.144 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.463 ' HA ' HG21 ' G' ' 451' ' ' VAL . . . -161.92 169.53 21.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.628 0.771 . . . . 74.05 110.512 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.89 -44.21 1.52 Allowed Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.104 -0.498 . . . . 51.22 111.944 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.529 HD11 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -109.38 149.6 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.114 0.965 . . . . 63.03 109.234 178.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 11.7 pt-20 -143.01 172.59 12.5 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.652 0.263 . . . . 73.3 111.456 -171.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.81 -129.47 48.37 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.201 -0.909 . . . . 73.31 112.486 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -66.86 -19.32 65.71 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.671 0.788 . . . . 72.45 112.08 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -78.31 -35.26 48.0 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.404 0.681 . . . . 74.21 110.421 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.552 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 10.9 tmm? -72.63 -38.53 67.71 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.427 -0.953 . . . . 72.14 108.427 172.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.87 -32.8 71.05 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 115.248 -0.887 . . . . 64.34 110.558 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -77.37 -34.54 55.0 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.374 0.421 . . . . 73.12 110.918 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.416 ' SG ' HG22 ' C' ' 86' ' ' ILE . 15.2 t -63.29 -34.97 78.85 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.005 0.815 . . . . 74.4 109.913 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.402 ' HA ' ' HB2' ' C' ' 102' ' ' CYS . 3.8 pp -99.15 -12.46 20.45 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.99 0.516 . . . . 71.44 111.969 175.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.29 -31.51 59.2 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 114.562 0.585 . . . . 51.12 114.562 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.9 -38.09 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.797 0.439 . . . . 73.43 111.042 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.473 ' HH ' ' HD1' ' C' ' 11' ' ' PHE . 46.5 t80 -56.93 -41.81 78.91 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 125.419 1.488 . . . . 75.32 112.209 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.402 ' HB2' ' HA ' ' C' ' 98' ' ' LEU . 56.2 m -82.26 -48.59 0.89 Allowed Pre-proline 0 CA--C 1.569 1.708 0 N-CA-C 112.897 0.703 . . . . 74.34 112.897 174.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.98 -29.85 28.83 Favored 'Trans proline' 0 C--N 1.392 2.855 0 C-N-CA 123.21 2.607 . . . . 73.04 115.131 172.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.24 -35.41 80.74 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.907 0.883 . . . . 65.32 110.836 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.404 HG23 ' NH1' ' A' ' 111' ' ' ARG . 40.9 mm -64.71 -40.3 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 115.511 -0.768 . . . . 75.13 109.585 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 53.5 mt -83.55 -18.14 39.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.652 1.181 . . . . 71.32 112.14 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -56.75 -51.34 82.16 Favored Pre-proline 0 CA--C 1.56 1.352 0 N-CA-C 114.132 1.16 . . . . 75.51 114.132 -173.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.428 ' HA ' HH11 ' C' ' 111' ' ' ARG . 18.3 Cg_exo -66.15 -32.16 43.58 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 121.607 1.538 . . . . 72.21 112.778 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -65.63 -46.92 77.43 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.542 0.737 . . . . 74.45 110.503 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.04 -42.65 90.73 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.051 0.94 . . . . 73.32 110.679 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.428 HH11 ' HA ' ' C' ' 108' ' ' PRO . 27.6 mtp-105 -57.03 -55.93 28.33 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.333 1.02 . . . . 75.14 111.051 176.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.12 -29.91 70.8 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.139 0.576 . . . . 74.21 110.628 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 10.6 t -74.39 -33.13 62.96 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.265 0.626 . . . . 75.21 111.303 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 71.5 mt -72.76 -51.29 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.037 0.535 . . . . 75.25 109.654 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 25.8 m -59.99 -32.96 71.33 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.094 0.957 . . . . 75.13 111.349 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.0 t -61.57 -51.51 68.26 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.189 -0.671 . . . . 65.33 109.189 172.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.56 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.69 -35.54 78.3 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.703 1.201 . . . . 65.12 112.914 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.4 t -66.55 -47.13 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.52 0.728 . . . . 75.54 109.925 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.416 ' OG ' HG22 ' B' ' 115' ' ' THR . 48.4 t -66.18 -32.19 73.47 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.93 -1.032 . . . . 74.1 111.091 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.01 -35.53 74.44 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.73 0.812 . . . . 73.45 109.399 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 4.33 79.46 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.878 0.736 . . . . 74.33 112.873 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 60.0 p 59.38 25.55 14.28 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.509 1.924 . . . . 74.31 114.08 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -87.82 152.87 51.92 Favored Pre-proline 0 CA--C 1.557 1.237 0 N-CA-C 107.567 -1.272 . . . . 74.44 107.567 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.69 -179.81 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.729 2.286 . . . . 73.12 113.739 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -49.66 130.63 21.07 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.664 1.186 . . . . 71.44 112.89 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.526 HD23 HG12 ' C' ' 64' ' ' VAL . 14.3 tp -148.84 85.28 1.48 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.29 -1.004 . . . . 72.3 108.29 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -116.31 129.79 56.45 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.159 -1.052 . . . . 74.45 108.159 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 21.4 tp -76.18 132.69 40.11 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 109.78 -0.452 . . . . 74.04 109.78 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.1 154.91 75.78 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.243 1.017 . . . . 74.32 111.15 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.415 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 5.5 Cg_endo -50.11 101.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.907 2.405 . . . . 72.45 112.867 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 80.8 t -96.55 110.69 25.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.217 -1.031 . . . . 74.43 108.217 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -87.12 86.14 7.27 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.898 -1.149 . . . . 61.34 107.898 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -60.55 -31.4 70.51 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.303 0.641 . . . . 75.32 110.227 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' C' ' 138' ' ' MET . 6.8 t70 -68.7 -36.94 79.13 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.336 1.054 . . . . 64.51 112.263 -165.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.45 74.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.98 0.912 . . . . 74.52 111.188 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.29 -23.97 34.92 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.182 -0.917 . . . . 74.55 111.452 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -81.73 -15.17 55.21 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.011 0.434 . . . . 73.24 109.997 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.547 ' HB3' HE21 ' C' ' 142' ' ' GLN . 67.2 mtt -71.66 -32.1 67.53 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.577 -0.527 . . . . 74.2 109.577 168.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -65.33 -34.92 79.45 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.183 0.593 . . . . 71.34 110.347 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -56.35 -82.74 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 109.005 -0.739 . . . . 74.53 109.005 168.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 8.0 tt -134.25 107.16 7.51 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.127 0.489 . . . . 64.23 109.978 172.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.547 HE21 ' HB3' ' C' ' 138' ' ' MET . 8.1 tt0 -110.67 -56.04 2.4 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 106.861 -1.533 . . . . 65.41 106.861 160.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -174.72 -49.83 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.071 -1.422 . . . . 72.22 109.217 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -169.13 -60.77 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.888 -1.523 . . . . 71.54 106.888 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.88 164.78 0.18 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.052 1.341 . . . . 75.25 113.222 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.77 -36.03 0.18 Allowed Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.763 -0.653 . . . . 64.13 111.604 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . 0.586 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 1.9 tm-20 -72.19 139.16 48.07 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 109.181 -0.674 . . . . 62.33 109.181 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.59 -10.68 8.03 Favored Glycine 0 C--N 1.345 1.051 0 O-C-N 123.663 0.602 . . . . 64.3 112.584 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 45.3 p 54.16 -170.88 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.836 1.655 . . . . 74.11 113.858 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -147.88 -172.37 4.03 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.026 0.93 . . . . 74.32 110.388 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -153.5 83.48 1.18 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.283 0.633 . . . . 71.2 110.015 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -175.75 139.95 0.43 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.321 1.448 . . . . 74.15 108.473 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -100.76 32.54 3.1 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.531 0.732 . . . . 61.04 111.857 -171.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -76.21 78.97 3.0 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.96 -0.756 . . . . 70.31 108.96 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 N-CA-C 108.618 -0.882 . . . . 64.02 108.618 177.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.417 ' HG3' ' HA ' ' D' ' 151' ' ' GLU . 1.5 mpt? . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 108.344 -0.984 . . . . 74.41 108.344 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 12.8 p -176.55 7.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.078 0.951 . . . . 73.15 111.955 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -79.11 131.43 36.24 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.514 0.725 . . . . 62.13 109.394 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.433 ' HA ' ' ND2' ' H' ' 450' ' ' ASN . 25.7 pt20 -138.83 27.79 2.41 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.806 0.669 . . . . 72.23 112.806 -161.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.76 128.47 35.63 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.472 -0.566 . . . . 74.23 109.472 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -158.2 151.51 23.13 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.196 0.522 . . . . 63.44 110.848 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' THR . . . . . 0.514 HG22 ' H ' ' D' ' 8' ' ' GLU . 2.6 m -134.96 -161.05 1.11 Allowed 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 125.481 1.512 . . . . 60.32 106.955 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.514 ' H ' HG22 ' D' ' 7' ' ' THR . 42.7 tt0 -65.44 136.32 56.32 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.135 0.88 . . . . 74.14 109.452 167.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 11.3 ttp -33.71 127.0 0.39 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.977 1.311 . . . . 75.0 113.247 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.6 m -130.05 140.92 50.78 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.506 -1.294 . . . . 73.52 107.506 172.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -148.53 110.77 4.64 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.077 -1.453 . . . . 74.35 107.077 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -132.81 141.67 48.59 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.183 -1.043 . . . . 75.1 108.183 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.588 HD12 HD12 ' D' ' 105' ' ' ILE . 19.4 mt -98.45 133.3 41.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.164 -1.05 . . . . 74.44 108.164 171.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -96.96 -45.65 6.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.403 0.681 . . . . 63.22 111.574 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -172.16 120.5 0.43 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 118.008 0.367 . . . . 73.52 111.874 -163.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.531 HD13 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -104.96 135.6 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.417 -1.327 . . . . 74.0 107.417 171.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -159.7 167.06 29.24 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.156 0.91 . . . . 62.52 111.205 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -99.53 117.16 33.31 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.078 -1.419 . . . . 74.22 109.327 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -88.06 -20.05 26.28 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.343 -0.844 . . . . 74.22 109.04 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.607 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.3 t70 -159.0 132.69 7.44 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.515 -1.22 . . . . 72.41 109.185 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.56 HG23 ' HE1' ' C' ' 117' ' ' MET . 79.7 mt -134.66 144.26 35.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 124.931 1.292 . . . . 75.45 107.553 174.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -147.46 136.6 22.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.337 1.055 . . . . 63.34 108.579 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.497 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.5 t80 -148.98 126.92 11.9 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.281 -1.748 . . . . 72.44 106.281 170.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -134.51 128.63 33.75 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.854 0.862 . . . . 74.15 109.372 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.67 81.27 60.91 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 107.881 -1.155 . . . . 70.43 107.881 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.92 -23.48 10.71 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.989 2.46 . . . . 73.24 113.604 -172.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -108.4 11.34 27.11 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.346 0.658 . . . . 65.22 109.966 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -36.85 -67.84 0.23 Allowed Pre-proline 0 CA--C 1.564 1.516 0 C-N-CA 126.371 1.868 . . . . 71.42 115.794 -161.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.403 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.0 Cg_endo -76.01 -19.18 16.03 Favored 'Trans proline' 0 C--N 1.38 2.196 0 CA-C-N 123.124 2.151 . . . . 75.53 113.839 -173.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -73.04 -43.06 62.48 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.917 0.887 . . . . 74.23 109.68 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.459 HG22 ' HA ' ' D' ' 73' ' ' ALA . 7.6 p -82.92 -16.12 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 CA-C-N 115.708 -0.678 . . . . 73.03 111.045 -172.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -68.4 -22.9 64.6 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.23 0.456 . . . . 71.24 112.23 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -65.94 -12.64 56.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.646 0.779 . . . . 75.54 110.744 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.4 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 82.7 mttt -98.44 92.91 5.89 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.396 1.078 . . . . 75.44 108.702 172.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -82.56 74.93 9.49 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.485 0.659 . . . . 75.21 109.697 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -137.43 156.23 48.41 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.129 -1.063 . . . . 73.44 108.129 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.666 ' HB3' HD13 ' H' ' 470' ' ' LEU . 1.8 mp0 -76.65 109.23 8.12 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.016 0.927 . . . . 72.43 108.921 174.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 21.6 Cg_exo -65.73 123.35 11.25 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 123.375 2.717 . . . . 63.31 113.432 -168.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -62.38 115.34 4.12 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.315 -0.624 . . . . 55.25 109.315 173.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.47 HG21 HG13 ' D' ' 64' ' ' VAL . 7.2 p -122.2 145.2 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.895 -1.048 . . . . 74.54 110.77 -170.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -117.26 147.9 42.13 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.978 0.911 . . . . 74.52 108.75 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.506 HD21 HG12 ' D' ' 62' ' ' VAL . 6.0 tt -121.34 125.61 47.43 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.339 -0.985 . . . . 75.52 108.339 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.607 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 29.3 t70 -108.11 137.49 46.01 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.941 0.896 . . . . 72.14 109.237 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 tp -113.14 140.45 47.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.651 0.78 . . . . 74.14 110.643 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.9 t70 -148.2 131.11 16.16 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.233 -1.395 . . . . 65.44 107.233 165.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.1 t -106.99 153.82 22.01 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.464 -0.939 . . . . 72.21 108.464 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.648 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.03 164.55 35.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.493 -0.929 . . . . 63.1 108.493 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 18.5 p -169.74 154.54 5.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.561 0.744 . . . . 75.1 109.806 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -154.22 142.61 20.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.784 0.834 . . . . 63.13 109.574 -166.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.11 118.66 28.99 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.644 -0.502 . . . . 75.3 109.644 175.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' D' ' 57' ' ' GLU . 49.6 mt -94.54 -42.02 9.04 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.351 0.66 . . . . 72.33 110.037 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.0 -174.75 4.89 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 124.013 0.925 . . . . 74.25 110.236 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -63.7 109.16 1.61 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.707 -1.133 . . . . 72.55 110.071 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 60.96 23.6 13.72 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.19 0.996 . . . . 63.34 111.906 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.52 121.79 67.9 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 124.758 1.223 . . . . 73.54 108.193 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -135.89 132.36 36.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.708 0.803 . . . . 65.05 109.311 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.537 ' HB2' HD11 ' D' ' 51' ' ' LEU . 30.4 tt0 -86.15 148.81 25.51 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 124.431 1.082 . . . . 63.31 108.98 169.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.2 t -125.96 124.77 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 107.653 -1.24 . . . . 75.33 107.653 168.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.4 t -99.64 128.29 51.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.26 -1.015 . . . . 70.35 108.26 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.54 115.58 30.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.502 -0.925 . . . . 74.44 108.502 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 45.9 ttm-85 -96.61 100.72 12.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.803 -1.184 . . . . 74.24 107.803 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.506 HG12 HD21 ' D' ' 42' ' ' LEU . 75.9 t -100.67 126.0 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.561 -0.903 . . . . 73.52 108.561 170.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 46.9 m -114.48 139.9 49.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.867 -0.79 . . . . 73.12 108.867 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.47 HG13 HG21 ' D' ' 40' ' ' VAL . 70.9 t -131.98 115.17 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.846 1.258 . . . . 75.1 108.213 -176.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 50.0 m -125.03 99.02 5.93 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.992 0.917 . . . . 75.23 109.227 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -101.59 158.84 15.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.669 0.787 . . . . 73.22 111.27 -175.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 50.8 p -149.92 133.31 16.51 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.669 -0.696 . . . . 70.41 111.548 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.419 HD11 HG21 ' D' ' 31' ' ' VAL . 34.9 mt -107.76 107.98 18.98 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.22 -1.4 . . . . 74.22 107.22 170.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.11 -133.3 12.35 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.934 -0.467 . . . . 72.4 111.934 -173.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -98.22 4.59 48.87 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.459 0.704 . . . . 75.43 111.401 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.4 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 12.9 pt-20 -120.23 165.23 15.09 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.922 0.489 . . . . 74.31 110.435 -175.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -61.64 131.0 48.57 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.198 -0.91 . . . . 70.04 111.449 175.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.459 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -87.49 -74.88 0.43 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.732 -1.21 . . . . 74.44 107.732 166.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . 0.476 ' HZ ' HD12 ' D' ' 126' ' ' LEU . 48.9 p90 -139.7 138.98 36.45 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.118 0.485 . . . . 73.31 109.875 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 83.3 mt -110.43 144.0 39.88 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.601 1.16 . . . . 75.15 108.159 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.594 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.2 t -159.05 146.61 17.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.848 0.459 . . . . 71.2 110.409 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -155.62 134.72 12.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.577 0.751 . . . . 74.01 108.984 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 89.5 t -133.31 121.57 42.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.892 -0.781 . . . . 73.4 108.892 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.607 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.9 mt-30 -88.11 83.25 7.01 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.812 -1.181 . . . . 71.3 107.812 167.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -79.52 93.44 5.43 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.702 -1.59 . . . . 71.42 108.663 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -84.3 157.32 33.14 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.624 -0.716 . . . . 73.44 112.059 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.455 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -152.47 130.06 2.95 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.198 -0.761 . . . . 74.22 111.198 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.1 mt -89.84 128.74 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 123.883 0.873 . . . . 73.24 108.646 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -126.8 152.46 46.91 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.211 1.005 . . . . 75.23 109.388 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 52.3 m -115.39 107.81 15.7 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.167 0.987 . . . . 75.43 108.423 170.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 28.5 pt -125.24 116.88 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.533 0.733 . . . . 75.44 109.444 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.49 ' HA ' HG21 ' H' ' 451' ' ' VAL . . . -137.07 136.39 38.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.54 0.736 . . . . 74.23 110.459 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.09 -19.82 13.26 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 115.47 0.948 . . . . 73.14 115.47 172.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.466 ' H ' HD11 ' D' ' 89' ' ' ILE . 0.2 OUTLIER -125.51 150.5 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 117.659 0.729 . . . . 74.32 110.979 -171.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 0.0 OUTLIER -151.57 166.09 32.27 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.237 0.458 . . . . 75.14 112.237 -172.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.48 -116.81 8.25 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 114.693 -1.139 . . . . 52.43 114.677 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.4 p -64.4 -47.43 79.22 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.96 0.904 . . . . 75.35 111.981 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -74.22 -24.08 59.28 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 116.306 -0.406 . . . . 62.2 111.014 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.652 ' HE2' HD22 ' D' ' 98' ' ' LEU . 0.8 OUTLIER -65.63 -49.2 69.58 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.695 -0.483 . . . . 74.01 109.695 174.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.96 -37.16 86.4 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.689 0.796 . . . . 63.54 110.861 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -65.91 -30.3 70.87 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.838 0.855 . . . . 75.21 111.392 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -82.57 -51.9 7.34 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.342 -0.39 . . . . 74.31 110.544 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.652 HD22 ' HE2' ' D' ' 94' ' ' MET . 8.1 tp -80.09 -31.13 39.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.798 0.439 . . . . 65.43 111.76 -168.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.04 13.96 55.81 Favored Glycine 0 N--CA 1.473 1.142 0 CA-C-N 115.982 -0.554 . . . . 72.02 113.362 -174.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' D' ' 134' ' ' ASP . . . -148.64 -63.67 0.24 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.812 0.445 . . . . 72.14 110.927 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -73.86 -43.0 59.97 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.242 0.617 . . . . 73.32 112.2 -172.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 97.3 m -63.55 -49.74 76.27 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 118.343 -0.836 . . . . 60.42 111.758 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.09 -20.74 43.68 Favored 'Trans proline' 0 C--N 1.399 3.213 0 C-N-CA 121.811 1.674 . . . . 71.2 113.131 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -71.18 -30.83 66.89 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.974 0.51 . . . . 61.12 110.769 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.588 HD12 HD12 ' D' ' 13' ' ' ILE . 63.7 mt -67.54 -39.27 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.943 0.897 . . . . 74.45 110.074 171.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.455 HD22 ' HA3' ' D' ' 82' ' ' GLY . 85.6 mt -77.19 -19.68 56.42 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.07 -0.968 . . . . 75.2 111.917 -175.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -70.38 -41.09 12.77 Favored Pre-proline 0 CA--C 1.563 1.449 0 N-CA-C 113.936 1.088 . . . . 75.41 113.936 -171.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.82 -40.96 82.54 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.192 1.928 . . . . 74.34 113.0 169.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -70.61 -35.49 73.01 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.742 0.817 . . . . 75.31 111.831 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -52.92 55.51 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.504 -0.554 . . . . 75.53 109.504 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.464 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 30.8 ttp-105 -52.27 -49.22 64.53 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.517 1.136 . . . . 71.54 111.098 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.79 -44.55 77.11 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.994 0.809 . . . . 74.15 111.252 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.95 -44.34 78.36 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.328 0.585 . . . . 62.05 110.636 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.594 HG12 ' SG ' ' D' ' 76' ' ' CYS . 78.3 mt -68.15 -51.37 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.582 -1.19 . . . . 72.33 110.959 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 52.7 m -51.56 -45.54 63.09 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.491 1.116 . . . . 73.22 111.174 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.7 t -62.26 -44.11 97.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.837 -1.074 . . . . 73.44 109.754 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.421 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 78.1 mtm -68.92 -31.38 70.25 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.222 0.609 . . . . 74.52 112.264 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' D' ' 123' ' ' PHE . 67.6 t -72.07 -38.83 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.85 0.86 . . . . 73.15 109.982 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.6 p -75.65 -29.49 59.14 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.112 0.565 . . . . 74.23 110.676 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -72.73 -34.91 67.38 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.697 0.799 . . . . 74.13 109.502 173.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 -1.71 88.0 Favored Glycine 0 C--N 1.356 1.688 0 CA-C-N 115.594 -0.73 . . . . 44.22 111.934 172.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p 64.84 19.3 11.8 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 127.219 2.207 . . . . 74.3 114.039 170.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.423 ' HB2' HG13 ' D' ' 118' ' ' VAL . 86.7 m-85 -78.97 152.98 77.5 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.163 0.585 . . . . 75.25 109.429 170.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.52 126.1 17.08 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.117 2.545 . . . . 74.52 112.756 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -60.43 120.33 9.71 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 123.804 0.842 . . . . 63.13 110.981 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.476 HD12 ' HZ ' ' D' ' 74' ' ' PHE . 80.7 mt -117.58 108.56 15.61 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.482 -0.933 . . . . 73.02 108.482 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.6 95.43 6.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.859 -1.163 . . . . 74.04 107.859 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.479 ' HG ' HD11 ' D' ' 42' ' ' LEU . 3.2 mm? -63.82 125.92 25.93 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.182 -0.917 . . . . 72.55 110.044 -175.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.6 139.86 58.82 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 124.072 0.857 . . . . 72.4 111.11 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.33 137.34 55.45 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.225 1.95 . . . . 73.42 110.923 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 67.0 t -106.17 110.85 32.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.4 -0.963 . . . . 72.12 108.4 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -72.76 88.81 1.32 Allowed 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.569 -0.9 . . . . 71.14 108.569 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -61.95 -31.23 71.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.773 -1.103 . . . . 72.03 110.86 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.417 ' HA ' ' HB2' ' D' ' 100' ' ' ALA . 3.9 t70 -55.83 -50.25 71.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.143 1.377 . . . . 73.42 112.169 -173.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.36 -45.48 83.94 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.477 -0.783 . . . . 73.53 111.956 -174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -22.98 56.33 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.921 -0.581 . . . . 73.01 110.485 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -68.89 -31.88 71.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.841 0.856 . . . . 72.43 111.004 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.419 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 33.5 mtt -59.06 -47.31 85.7 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.48 -0.782 . . . . 74.22 109.593 174.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -63.22 -40.57 97.85 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.982 0.913 . . . . 52.41 111.608 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -58.55 -39.88 81.48 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.091 0.956 . . . . 70.2 111.266 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.56 -28.34 62.76 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.476 0.711 . . . . 72.32 111.796 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' D' ' 138' ' ' MET . 20.5 mt-30 -81.8 -1.01 45.86 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.91 0.484 . . . . 72.1 111.988 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -140.49 45.23 1.84 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.888 0.475 . . . . 72.42 110.284 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -173.54 120.8 0.33 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.392 0.677 . . . . 72.21 109.879 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.88 168.93 10.0 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.87 0.868 . . . . 74.53 110.224 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.91 134.89 3.38 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.802 -0.519 . . . . 42.54 111.802 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -111.17 132.04 54.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.426 0.691 . . . . 74.24 111.2 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -113.81 -148.38 9.95 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.141 -1.184 . . . . 75.45 110.141 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 10.6 t -170.7 176.67 4.16 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 124.075 0.95 . . . . 75.32 109.503 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.5 177.4 4.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.573 0.349 . . . . 71.52 110.523 169.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' D' ' 1' ' ' MET . 0.5 OUTLIER -140.22 79.16 1.69 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.918 -0.401 . . . . 74.53 109.918 -177.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -160.45 159.53 31.01 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.783 1.233 . . . . 74.41 109.619 164.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -141.86 0.7 1.43 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.161 0.985 . . . . 71.22 108.401 164.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.77 115.71 8.43 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.544 1.138 . . . . 74.33 110.373 -174.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 C-N-CA 124.173 0.989 . . . . 53.41 108.446 177.437 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.996 0.427 . . . . 73.51 110.944 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.92 -30.69 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 124.233 1.013 . . . . 74.01 112.059 -173.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . 0.429 HG12 ' CE2' ' A' ' 56' ' ' TYR . 31.2 m -55.49 162.14 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 115.416 1.636 . . . . 73.33 115.416 -172.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 158.15 -71.36 0.24 Allowed Glycine 0 C--N 1.342 0.888 0 CA-C-N 114.029 -1.441 . . . . 64.45 110.314 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 20.6 mt 64.18 175.0 0.18 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.992 1.717 . . . . 70.31 112.823 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 21.3 p -108.4 138.55 44.51 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.427 1.091 . . . . 74.41 109.058 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -63.27 -44.58 94.7 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.929 0.768 . . . . 75.12 109.755 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -70.25 122.04 18.76 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.76 -1.109 . . . . 74.43 109.477 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 72.4 m -124.59 -56.53 1.59 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.144 0.578 . . . . 72.3 109.643 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 34.8 t70 60.95 98.96 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.836 1.254 . . . . 74.43 111.219 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . 0.442 HD12 ' HB ' ' A' ' 46' ' ' THR . 4.2 mm? -81.6 169.89 16.5 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.641 0.734 . . . . 74.13 111.178 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -133.38 144.6 49.69 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 114.284 -1.325 . . . . 71.03 109.31 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . 0.661 ' HH ' ' HB3' ' A' ' 42' ' ' LEU . 77.4 t80 -150.67 109.3 3.83 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.684 0.794 . . . . 72.32 109.525 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 463' ' ' THR . . . . . 0.419 HG21 ' H3 ' ' C' ' 1' ' ' MET . 18.4 p -143.91 100.56 3.6 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.855 0.862 . . . . 75.54 109.473 171.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 27.2 ptm -156.77 166.59 32.96 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.501 -0.925 . . . . 74.51 108.501 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' E' ' 465' ' ' LYS . 0.3 OUTLIER -81.44 106.06 13.1 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.721 -1.214 . . . . 74.2 107.721 177.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -70.98 78.04 0.65 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.373 1.069 . . . . 74.51 110.126 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -103.92 -51.21 3.21 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.039 -1.097 . . . . 63.32 108.039 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 45.3 mt 69.79 -75.11 0.07 Allowed 'General case' 0 C--N 1.367 1.33 0 C-N-CA 125.46 1.504 . . . . 74.33 110.002 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 126' ' ' LEU . . . -162.16 16.05 0.15 Allowed Glycine 0 N--CA 1.48 1.581 0 N-CA-C 110.013 -1.235 . . . . 63.21 110.013 170.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . 0.435 ' HB2' HG12 ' A' ' 40' ' ' VAL . 51.1 mt -138.69 -163.26 1.44 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.51 1.924 . . . . 75.14 107.447 -170.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 117.736 -1.125 . . . . 71.12 108.442 172.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 10.4 t30 . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 122.072 0.939 . . . . 74.41 109.296 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.6 146.54 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.15 0.98 . . . . 73.45 108.632 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 75.6 t 71.13 118.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.681 1.192 . . . . 74.12 111.64 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 154.45 60.71 0.01 OUTLIER Glycine 0 C--N 1.346 1.102 0 CA-C-N 116.018 -0.537 . . . . 55.4 112.365 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 2.6 pp -137.99 130.99 30.09 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 109.567 -0.531 . . . . 61.32 109.567 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 32.8 m -155.95 85.34 1.02 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.662 1.185 . . . . 71.22 108.03 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -126.27 98.51 5.49 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.644 0.778 . . . . 75.01 109.954 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -74.09 100.39 3.61 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.202 -1.407 . . . . 74.23 107.202 170.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 20.1 m -143.92 167.16 22.98 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.272 1.029 . . . . 72.23 108.653 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -49.59 109.61 0.29 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.571 1.148 . . . . 71.41 111.163 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.11 119.67 12.43 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.98 -0.748 . . . . 73.11 108.98 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -52.83 111.65 0.7 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.839 1.256 . . . . 71.03 111.414 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -149.34 49.63 0.96 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.047 -0.524 . . . . 75.14 109.924 -174.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 67.0 m -65.71 91.12 0.13 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.51 -0.552 . . . . 73.02 109.51 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 16.8 tmm? -164.92 -55.59 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.338 -1.356 . . . . 74.12 107.338 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp 73.01 -26.22 0.19 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 125.301 1.44 . . . . 75.13 114.239 168.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -75.9 179.03 5.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.336 0.655 . . . . 61.12 110.505 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -98.82 -95.73 0.23 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 119.392 -0.337 . . . . 65.01 110.403 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 1.2 pp -172.29 43.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.497 0.719 . . . . 63.21 110.856 -169.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 95.8 -34.21 5.04 Favored Glycine 0 N--CA 1.483 1.788 0 CA-C-N 115.745 -0.662 . . . . 53.45 111.689 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . 0.631 HD21 ' H ' ' B' ' 40' ' ' VAL . 16.1 tp -49.1 -51.09 33.8 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.172 1.789 . . . . 71.52 112.244 169.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.248 1.013 0 N-CA-C 108.944 -0.761 . . . . 74.01 108.944 -173.287 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 . . . . . 0 CA--C 1.54 0.572 0 CA-C-O 119.43 -0.319 . . . . 53.51 111.311 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . 0.463 HG21 ' HA ' ' C' ' 87' ' ' ALA . 19.1 m -89.66 4.83 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 122.847 0.459 . . . . 74.52 111.883 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . 0.426 HG13 ' HE2' ' C' ' 56' ' ' TYR . 27.2 m -52.0 139.41 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 C-N-CA 123.522 0.729 . . . . 74.51 111.351 174.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 163.83 108.98 0.22 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.928 -0.869 . . . . 73.53 110.928 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 22.8 tp -136.77 100.17 4.25 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.318 0.647 . . . . 71.35 109.468 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 7.8 p -78.79 118.64 21.04 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.205 -1.035 . . . . 64.52 108.205 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -76.81 160.44 29.26 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.402 0.681 . . . . 74.31 111.657 -173.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . 0.426 ' HG2' ' HB3' ' G' ' 459' ' ' ASP . 53.6 tt0 -158.18 100.73 1.71 Allowed 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.453 -1.314 . . . . 73.5 107.453 166.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 27.3 p -73.89 77.98 1.63 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.701 0.763 . . . . 73.42 109.413 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . 0.426 ' HB3' ' HG2' ' G' ' 457' ' ' GLN . 25.7 t70 -162.75 119.68 1.95 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.482 -1.235 . . . . 62.11 108.119 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . 0.563 HD13 ' HB2' ' C' ' 44' ' ' LEU . 0.5 OUTLIER -97.46 126.77 42.92 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.054 -0.721 . . . . 74.44 109.054 -176.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -94.71 -172.09 2.64 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.06 1.344 . . . . 74.1 111.476 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 86.1 t80 68.92 103.58 0.06 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.829 1.252 . . . . 74.2 111.362 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 28.9 p -82.46 98.04 8.7 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.153 0.581 . . . . 72.31 109.676 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 15.2 tpt -77.19 146.21 37.17 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.987 0.515 . . . . 73.44 110.193 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -143.64 162.7 35.25 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.373 1.069 . . . . 74.43 109.591 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . 71.01 147.5 0.08 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.26 1.424 . . . . 70.53 112.768 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -76.22 143.21 41.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.573 0.749 . . . . 72.54 109.977 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . 0.739 HD11 HD13 ' C' ' 42' ' ' LEU . 65.4 mt -68.17 -56.09 10.01 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.649 0.78 . . . . 74.43 111.901 -174.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -162.17 28.16 0.26 Allowed Glycine 0 N--CA 1.469 0.866 0 CA-C-N 115.755 -0.657 . . . . 75.04 111.647 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -110.05 125.69 53.21 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.646 0.778 . . . . 75.51 109.502 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 59.2 tttm . . . . . 0 C--O 1.249 1.032 0 N-CA-C 107.211 -1.403 . . . . 75.54 107.211 -179.178 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' D' ' 4' ' ' GLN . 21.6 t-20 . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 112.193 0.442 . . . . 65.44 112.193 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . 0.49 HG21 ' HA ' ' D' ' 87' ' ' ALA . 47.2 t -76.39 70.81 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-O 121.946 0.879 . . . . 71.15 111.088 -175.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.522 ' HA ' ' HE3' ' D' ' 94' ' ' MET . 0.1 OUTLIER -155.49 145.0 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.882 1.273 . . . . 74.45 108.041 174.242 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 178.85 43.82 0.07 OUTLIER Glycine 0 N--CA 1.461 0.361 0 N-CA-C 110.356 -1.098 . . . . 53.33 110.356 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 66.5 mt -82.23 148.08 28.6 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.2 0.6 . . . . 74.3 110.229 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 27.3 p -92.02 -54.73 3.72 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.985 0.914 . . . . 72.21 109.198 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -164.41 161.12 21.36 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.903 0.881 . . . . 74.02 109.637 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -129.77 98.49 4.82 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.17 0.988 . . . . 74.12 110.308 -177.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 2.4 p -145.83 -152.22 0.42 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.045 1.338 . . . . 74.44 108.025 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.15 135.87 57.85 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.122 -0.696 . . . . 74.22 109.122 167.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 95.0 mt -85.22 -56.67 3.42 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.586 -0.734 . . . . 74.32 110.866 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -175.56 18.75 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 123.391 0.676 . . . . 65.33 111.836 -168.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -76.44 89.64 3.23 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.849 -0.426 . . . . 74.43 109.849 -169.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 29.4 m -96.67 -73.85 0.59 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.904 0.881 . . . . 64.23 110.667 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 59.4 mtt 63.9 146.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.897 1.279 . . . . 75.21 111.442 -166.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -89.39 -9.78 49.02 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 111.98 0.363 . . . . 75.31 111.98 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -152.68 -178.26 6.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.831 0.852 . . . . 72.32 110.072 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -63.64 -64.51 0.88 Allowed 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.215 -0.661 . . . . 75.35 109.215 173.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -172.2 -31.24 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.244 0.965 . . . . 75.34 110.347 170.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 72.91 70.47 1.22 Allowed Glycine 0 C--N 1.359 1.858 0 O-C-N 123.19 0.306 . . . . 74.11 112.388 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . 0.666 HD13 ' HB3' ' D' ' 37' ' ' GLN . 23.7 mt -70.62 98.2 1.46 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.932 0.893 . . . . 74.23 111.71 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt . . . . . 0 C--O 1.254 1.301 0 C-N-CA 124.94 1.296 . . . . 73.04 110.774 176.288 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.035 -0.358 . . . . 74.52 110.035 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.7 p -81.72 143.11 32.08 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.094 0.957 . . . . 73.2 110.221 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -124.32 148.35 47.52 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.855 0.462 . . . . 71.42 109.941 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.18 85.79 3.02 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.456 -0.942 . . . . 64.33 108.456 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -132.01 86.34 2.33 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.296 -1.372 . . . . 73.52 107.296 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -67.93 -17.15 64.37 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.751 -1.113 . . . . 72.11 111.342 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 m -67.41 123.64 20.95 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.289 0.635 . . . . 74.05 109.911 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.76 -55.97 26.8 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.852 0.72 . . . . 75.43 110.968 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.5 mtp -72.07 134.67 45.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.233 -0.44 . . . . 74.25 109.883 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.6 m -141.81 121.86 13.74 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.959 -0.756 . . . . 74.21 108.959 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -136.86 130.06 31.18 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.166 0.986 . . . . 73.01 108.544 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -146.62 135.21 22.09 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.667 -0.864 . . . . 74.14 108.667 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 16' ' ' ILE . 13.0 mt -91.05 119.02 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.726 -0.842 . . . . 73.34 108.726 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -81.82 -40.65 22.22 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 123.525 0.516 . . . . 74.55 110.299 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -170.02 131.38 1.02 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.576 -0.283 . . . . 75.04 110.604 -169.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.421 HD11 HD11 ' A' ' 13' ' ' ILE . 87.8 mt -121.32 132.88 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.728 -0.841 . . . . 74.34 108.728 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.428 ' HB3' HG21 ' B' ' 122' ' ' THR . 34.5 p90 -166.14 151.87 8.78 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.922 0.764 . . . . 64.13 110.812 -175.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -80.25 106.88 12.6 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.732 -1.122 . . . . 73.34 109.027 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -73.06 -28.59 62.4 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.223 -0.444 . . . . 72.23 110.395 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -148.57 140.06 23.48 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.065 -0.97 . . . . 71.11 109.226 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.13 142.81 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 107.537 -1.283 . . . . 74.3 107.537 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -143.13 147.86 35.65 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.115 0.483 . . . . 74.0 109.73 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 83.4 t80 -150.07 114.51 5.21 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.032 -1.469 . . . . 73.02 107.032 174.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -124.34 110.36 14.48 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.838 -0.43 . . . . 61.4 109.838 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.44 84.81 19.12 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 124.052 0.941 . . . . 64.52 108.559 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.49 -32.38 12.34 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.513 2.142 . . . . 75.51 110.826 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -102.62 28.87 5.68 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.604 1.162 . . . . 70.11 109.812 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.3 -46.34 99.09 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.529 0.731 . . . . 61.31 111.999 173.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -83.95 5.63 6.23 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.049 1.833 . . . . 53.45 112.756 172.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 54.7 m170 -104.47 -17.5 14.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.335 0.654 . . . . 73.22 111.903 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 28' ' ' ALA . 11.3 p -71.04 -31.07 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.47 0.544 . . . . 75.45 112.47 -170.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -80.15 -33.03 38.82 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.39 0.276 . . . . 73.12 110.813 -172.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -76.92 -24.36 52.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.939 -0.573 . . . . 74.32 110.167 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -83.53 151.61 25.32 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.758 0.823 . . . . 74.21 110.536 171.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.03 140.25 40.29 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.727 -0.842 . . . . 74.52 108.727 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -79.31 95.6 5.74 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.181 0.515 . . . . 74.52 111.083 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -126.92 83.81 64.86 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.41 1.084 . . . . 75.13 109.112 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.32 139.93 29.76 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.421 2.081 . . . . 74.21 112.726 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -106.82 100.52 10.02 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.252 -1.388 . . . . 71.43 107.252 172.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.8 m -76.26 101.25 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 CA-C-O 122.113 0.959 . . . . 74.31 111.432 -174.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -110.4 114.11 27.3 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.328 -1.36 . . . . 72.51 107.328 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.457 HD21 HD23 ' E' ' 468' ' ' LEU . 52.6 tp -120.43 136.84 54.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.085 0.554 . . . . 74.12 110.677 -172.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.592 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.1 m-20 -121.22 140.07 52.53 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.961 1.304 . . . . 64.23 108.22 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.536 HD21 ' HE1' ' A' ' 133' ' ' PHE . 7.7 tt -142.47 120.3 11.95 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.643 -0.873 . . . . 74.35 108.643 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -136.45 145.68 45.48 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.841 0.856 . . . . 74.11 110.243 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 m -113.19 135.07 54.22 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.291 1.036 . . . . 71.14 108.71 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.77 132.25 45.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.556 0.742 . . . . 75.13 109.433 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.4 m -90.99 152.49 20.67 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.597 0.759 . . . . 74.21 111.225 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 42.1 t -154.45 131.55 11.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.848 0.859 . . . . 75.31 109.329 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -112.18 111.92 23.15 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.748 -0.834 . . . . 74.53 108.748 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.5 mt -86.89 -39.68 15.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.257 0.623 . . . . 72.23 110.389 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.23 -174.99 4.33 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.008 0.923 . . . . 73.1 109.656 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.63 104.75 0.3 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.769 0.827 . . . . 72.21 109.744 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 66.54 9.75 6.82 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.125 1.37 . . . . 75.43 112.639 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.34 101.69 12.44 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 105.35 -2.093 . . . . 63.33 105.35 168.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -116.79 151.21 36.96 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.503 -1.226 . . . . 75.12 109.081 -164.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 43.7 tt0 -132.78 138.63 47.21 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.275 0.63 . . . . 72.32 110.031 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.6 t -119.85 130.98 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.106 -1.072 . . . . 70.03 108.106 171.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.4 t -115.69 109.6 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.134 0.973 . . . . 74.2 108.604 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.0 tp -89.2 101.42 14.08 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.055 -0.72 . . . . 71.42 109.055 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 ttp85 -85.4 107.51 17.41 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.051 -0.722 . . . . 75.43 109.051 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.458 HG11 ' HB1' ' A' ' 110' ' ' ALA . 3.1 p -113.52 121.87 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 108.93 -0.767 . . . . 73.3 108.93 176.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.6 m -116.49 135.45 53.82 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.586 0.754 . . . . 74.5 109.407 -177.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.46 ' O ' HD13 ' A' ' 75' ' ' LEU . 64.8 t -124.61 132.99 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 124.38 1.072 . . . . 70.24 108.634 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.3 m -131.21 120.55 23.43 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.049 -0.723 . . . . 75.02 109.049 173.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.41 122.52 44.02 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.677 -0.86 . . . . 75.33 108.677 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 t -130.18 146.72 51.83 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.916 0.886 . . . . 72.43 110.228 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.58 87.15 3.1 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 107.123 -1.436 . . . . 72.0 107.123 167.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.73 -105.09 3.23 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 114.835 -1.075 . . . . 73.14 110.518 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.54 -20.61 11.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.805 0.842 . . . . 74.55 110.616 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.05 104.89 9.99 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.831 0.853 . . . . 71.22 109.271 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.3 m -71.31 121.2 18.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.157 0.583 . . . . 72.34 110.732 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.01 -53.51 20.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.783 0.833 . . . . 72.41 109.38 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -150.22 158.08 43.77 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.502 -1.226 . . . . 75.12 111.618 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 64' ' ' VAL . 66.9 tp -125.57 140.89 52.36 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.371 1.468 . . . . 73.22 107.282 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.4 m -142.34 113.29 7.5 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.378 0.671 . . . . 74.32 109.585 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -127.05 120.52 29.18 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.272 -0.64 . . . . 65.14 109.272 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.4 t -127.63 110.64 22.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 123.665 0.786 . . . . 74.24 109.348 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -85.05 81.4 8.89 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.73 -1.211 . . . . 75.52 107.73 171.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -76.88 94.96 3.99 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.074 -0.967 . . . . 74.33 108.633 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.06 151.08 21.36 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 115.376 -0.829 . . . . 74.34 111.589 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.97 128.5 2.8 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.139 -0.784 . . . . 71.22 111.139 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -81.15 115.82 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.789 -0.819 . . . . 74.2 108.789 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -114.8 118.7 34.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.048 0.939 . . . . 75.33 109.586 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.9 m -85.36 103.7 14.51 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.63 -0.878 . . . . 73.11 108.63 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.9 pp -116.04 153.91 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.12 0.568 . . . . 72.31 110.812 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.55 149.98 5.89 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.615 1.166 . . . . 72.4 109.429 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.23 -26.75 23.45 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 122.856 0.265 . . . . 62.14 113.715 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.484 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.92 138.85 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.502 0.721 . . . . 74.43 110.321 -176.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 10.6 tt0 -152.59 174.4 14.0 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.89 0.476 . . . . 75.31 109.857 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.417 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 66.83 -127.7 28.33 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 116.344 -0.389 . . . . 63.25 112.248 -174.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -72.5 -21.07 61.25 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.464 0.706 . . . . 73.12 111.313 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -70.77 -45.26 65.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.503 0.721 . . . . 73.43 110.851 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.524 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 23.3 ttt -71.95 -37.34 69.99 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.347 -0.388 . . . . 71.32 110.013 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.88 72.19 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.346 0.404 . . . . 70.45 110.587 174.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -71.74 -33.74 68.96 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.381 0.672 . . . . 73.44 110.706 173.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -66.55 -61.81 1.79 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 110.047 -0.353 . . . . 61.22 110.047 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.424 HD23 ' HG2' ' A' ' 94' ' ' MET . 4.2 pp -74.13 -24.62 59.45 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.449 0.7 . . . . 72.25 112.547 -174.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.44 1.08 37.14 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-O 119.538 -0.59 . . . . 65.2 114.28 -173.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -141.36 -65.34 0.43 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 117.533 0.667 . . . . 72.34 111.052 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.439 ' O ' HG12 ' A' ' 105' ' ' ILE . 48.3 t80 -66.63 -46.49 75.63 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 112.797 0.666 . . . . 71.21 112.797 -171.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -68.66 -47.37 34.07 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 124.064 0.945 . . . . 73.53 112.723 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.51 -26.8 69.97 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 121.823 1.682 . . . . 73.55 112.185 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -65.91 -37.83 87.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.158 0.583 . . . . 74.14 110.937 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 101' ' ' TYR . 47.2 mm -66.34 -45.67 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.301 0.641 . . . . 72.41 110.046 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.6 mt -73.89 -23.37 59.56 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.381 -0.827 . . . . 73.34 111.918 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -60.69 -49.14 91.02 Favored Pre-proline 0 CA--C 1.563 1.451 0 N-CA-C 113.968 1.099 . . . . 64.34 113.968 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -63.11 -34.83 67.96 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.11 1.874 . . . . 75.42 112.841 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -67.52 -40.23 85.11 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.126 0.57 . . . . 75.54 110.872 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.458 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -69.77 -36.21 75.56 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.401 0.681 . . . . 65.33 110.79 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.581 ' HA ' HD23 ' A' ' 128' ' ' LEU . 38.1 ttm180 -57.15 -53.82 53.72 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 124.031 0.832 . . . . 72.32 109.715 176.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -57.76 -48.02 80.84 Favored 'General case' 0 C--N 1.348 0.531 0 O-C-N 124.563 1.164 . . . . 75.12 111.229 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 117' ' ' MET . 24.0 t -53.29 -47.84 68.87 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.334 1.021 . . . . 75.42 110.462 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.43 HD11 HG12 ' A' ' 62' ' ' VAL . 93.6 mt -68.55 -38.42 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.327 1.051 . . . . 74.41 111.176 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.2 m -64.34 -34.23 77.68 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.263 0.554 . . . . 75.43 110.115 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 t -74.24 -36.93 63.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.881 -0.599 . . . . 71.41 109.701 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 74.6 mmm -60.36 -46.98 88.03 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.98 0.512 . . . . 75.11 110.739 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.0 m -69.41 -39.68 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.571 -0.74 . . . . 74.22 110.826 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.8 m -67.23 -34.59 77.79 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.867 0.467 . . . . 73.31 111.639 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.526 HH12 ' HG3' ' B' ' 112' ' ' GLU . 86.8 mtt-85 -74.34 -28.92 61.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.225 0.61 . . . . 73.44 110.191 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.88 -4.74 88.49 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 123.758 0.661 . . . . 73.24 113.183 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.4 m 65.92 41.14 3.86 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 123.586 1.66 . . . . 73.32 111.132 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.89 151.61 43.62 Favored Pre-proline 0 C--O 1.244 0.772 0 CA-C-N 113.917 -1.492 . . . . 74.34 108.514 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -53.06 142.33 54.53 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.897 2.398 . . . . 74.05 112.697 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.06 145.88 24.39 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.987 0.804 . . . . 74.43 112.124 -177.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.4 ' CD2' HG13 ' A' ' 64' ' ' VAL . 18.4 tp -128.4 115.99 19.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.727 -1.124 . . . . 75.04 110.391 -175.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -120.8 89.29 3.1 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.248 -1.019 . . . . 64.41 108.248 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.611 HD21 ' H ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER -64.38 129.58 40.47 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 116.057 -0.519 . . . . 73.23 109.779 176.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.82 144.65 85.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.494 1.118 . . . . 73.14 112.077 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.402 ' HD3' HD13 ' C' ' 13' ' ' ILE . 15.5 Cg_exo -65.63 113.09 2.37 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.366 2.044 . . . . 71.43 110.844 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.05 127.56 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.595 -0.891 . . . . 73.24 108.595 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.421 ' ND2' ' HB3' ' A' ' 134' ' ' ASP . 0.2 OUTLIER -80.44 89.87 5.62 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.582 -0.735 . . . . 71.31 109.387 -172.212 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.536 ' HE1' HD21 ' A' ' 44' ' ' LEU . 97.3 m-85 -60.25 -37.43 80.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.147 0.979 . . . . 64.2 111.762 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.421 ' HB3' ' ND2' ' A' ' 132' ' ' ASN . 20.1 t70 -56.24 -51.14 69.18 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.975 0.797 . . . . 73.02 110.317 176.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.45 97.65 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 124.345 1.028 . . . . 71.43 111.28 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -57.53 -45.66 84.76 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.914 0.759 . . . . 72.31 111.215 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -67.69 -37.9 82.94 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.802 -0.635 . . . . 73.12 110.025 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.5 mmt -58.16 -35.43 71.53 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.973 0.795 . . . . 75.13 111.763 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -60.77 -47.42 86.41 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 123.713 0.633 . . . . 74.51 110.999 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -73.93 -32.93 63.75 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.623 -0.717 . . . . 74.54 111.247 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.06 -46.52 77.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.232 1.013 . . . . 72.24 110.738 -173.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -167.32 -14.22 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.895 -0.593 . . . . 75.22 110.129 -174.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.569 ' HG2' ' HG2' ' C' ' 151' ' ' GLU . 57.7 tt0 59.07 92.45 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.482 1.513 . . . . 72.34 110.154 -164.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.551 ' HA ' ' HB3' ' C' ' 151' ' ' GLU . 14.1 pt20 -171.84 172.81 4.71 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.277 0.56 . . . . 73.43 111.633 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.457 ' HB2' ' H ' ' C' ' 150' ' ' GLU . . . -81.26 143.67 32.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.521 -1.218 . . . . 74.32 108.343 165.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.51 45.43 0.92 Allowed Glycine 0 N--CA 1.467 0.716 0 N-CA-C 112.255 -0.338 . . . . 61.42 112.255 -175.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -159.93 134.93 7.94 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.083 0.553 . . . . 74.1 110.629 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -115.89 -147.26 8.94 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 110.702 -0.959 . . . . 61.12 110.702 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.1 m -124.97 146.79 49.22 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.455 -0.943 . . . . 74.2 108.455 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.76 133.74 49.78 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.244 -0.65 . . . . 72.45 109.244 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -58.97 -28.31 66.2 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.199 0.999 . . . . 73.22 111.624 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -65.08 97.58 0.25 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.676 0.751 . . . . 73.2 110.089 168.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -79.06 -175.72 4.72 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.847 -1.07 . . . . 72.4 109.441 168.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -136.51 143.16 43.6 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.079 -0.712 . . . . 72.43 109.079 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 C-N-CA 123.309 0.643 . . . . 72.25 109.498 178.917 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 86.8 mtp . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 109.291 -0.633 . . . . 74.22 109.291 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 44.6 p -80.27 92.13 5.71 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.598 0.759 . . . . 74.41 110.224 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -77.62 86.73 3.93 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.457 -1.312 . . . . 71.33 107.457 174.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.44 136.32 56.97 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.815 -0.629 . . . . 70.31 110.802 -171.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -125.23 99.93 6.3 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.015 -1.106 . . . . 73.43 108.015 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -89.44 -33.8 16.69 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.3 -0.864 . . . . 65.11 110.986 -172.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.2 t -64.2 -24.07 67.54 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.302 0.641 . . . . 75.34 111.297 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -92.64 -37.93 12.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.415 0.686 . . . . 71.23 110.148 175.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 24.5 ptm 43.52 -156.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.628 1.571 . . . . 74.31 112.491 -176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.564 ' HB ' ' HB1' ' B' ' 87' ' ' ALA . 99.2 m -152.27 120.11 6.15 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.262 -1.014 . . . . 75.02 108.262 168.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -136.06 127.54 28.63 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.195 -1.039 . . . . 72.4 108.195 169.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -147.24 134.11 20.16 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.117 -0.697 . . . . 75.01 109.117 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.482 HD11 HD12 ' B' ' 105' ' ' ILE . 26.9 mt -86.84 122.03 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.439 -0.948 . . . . 74.5 108.439 172.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -95.23 -30.6 13.91 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.127 0.571 . . . . 73.14 110.177 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -172.72 138.05 0.82 Allowed 'General case' 0 C--N 1.353 0.725 0 O-C-N 123.642 0.589 . . . . 75.04 110.124 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.0 mt -118.74 137.66 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 106.922 -1.51 . . . . 74.11 106.922 171.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.452 ' HE1' HG13 ' B' ' 83' ' ' ILE . 10.8 p90 -167.17 143.61 4.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.249 0.547 . . . . 75.51 112.376 -173.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.4 m -73.56 125.64 28.44 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.134 -0.939 . . . . 72.44 108.73 169.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -97.52 -31.74 12.17 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.698 0.799 . . . . 75.2 110.698 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 21.1 t70 -155.72 143.2 19.47 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.45 -0.341 . . . . 71.14 111.025 -174.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.455 HD13 ' SG ' ' B' ' 113' ' ' CYS . 42.6 mm -139.54 143.3 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.988 1.315 . . . . 72.22 109.007 177.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.1 t -142.45 120.8 12.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.83 -1.077 . . . . 74.11 108.452 167.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -121.24 124.26 44.22 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.479 -1.304 . . . . 73.4 107.479 168.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.636 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 34.3 mt-10 -128.61 117.33 21.04 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.532 1.133 . . . . 70.31 108.381 -174.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.18 86.57 3.35 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 108.002 -1.11 . . . . 75.51 108.002 171.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -65.11 -47.88 4.19 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.057 2.504 . . . . 72.23 113.17 -167.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -107.34 28.19 8.34 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.035 0.934 . . . . 74.32 109.764 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.508 ' HB1' ' HD3' ' B' ' 29' ' ' PRO . . . -39.44 -63.15 0.68 Allowed Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 114.985 1.476 . . . . 72.25 114.985 -163.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.508 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 12.1 Cg_exo -68.45 -24.24 36.74 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.137 1.891 . . . . 71.15 112.896 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -92.69 -28.04 16.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.756 0.822 . . . . 74.12 112.555 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.731 HG21 ' HA ' ' B' ' 73' ' ' ALA . 13.4 p -81.95 -18.96 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 120.69 0.281 . . . . 73.44 111.472 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -64.89 -17.27 64.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 113.164 0.802 . . . . 75.45 113.164 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -66.93 -21.17 65.99 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.206 0.602 . . . . 71.13 111.385 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.514 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 86.1 mttt -94.05 107.38 19.3 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.813 0.845 . . . . 74.32 109.177 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -87.21 86.06 7.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.954 0.501 . . . . 74.02 110.566 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -164.64 158.11 17.55 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.902 0.881 . . . . 72.02 109.161 173.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.498 ' HB3' HD21 ' F' ' 470' ' ' LEU . 42.0 mt-30 -73.22 109.23 5.89 Favored Pre-proline 0 C--N 1.354 0.792 0 N-CA-C 109.087 -0.709 . . . . 75.3 109.087 169.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.643 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 13.1 Cg_endo -56.34 146.61 72.05 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.017 2.478 . . . . 61.12 111.842 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -61.32 102.51 0.23 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 123.826 0.704 . . . . 71.53 109.181 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.413 HG22 ' O ' ' B' ' 38' ' ' PRO . 85.1 t -92.81 120.31 41.94 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 115.607 -0.724 . . . . 73.33 109.576 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -121.08 119.19 31.73 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.904 -1.517 . . . . 75.15 106.904 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 pp -93.96 160.56 14.67 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.251 0.548 . . . . 74.14 111.065 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.7 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 3.2 m-20 -123.67 129.57 51.32 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.773 -1.195 . . . . 64.43 107.773 173.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 tt -100.38 128.62 46.4 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.36 -1.348 . . . . 73.31 107.36 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -145.93 121.43 10.38 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.496 0.718 . . . . 74.3 109.689 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 43.3 p -120.65 122.79 41.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.62 0.368 . . . . 75.0 110.255 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.78 154.77 33.72 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.523 1.129 . . . . 75.21 108.327 172.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.3 p -144.77 168.06 21.11 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.909 0.385 . . . . 74.23 111.061 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.2 p -153.47 169.91 22.02 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.354 1.061 . . . . 61.3 109.337 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -114.26 136.35 53.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.706 0.802 . . . . 73.11 110.339 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.505 HD12 HG22 ' B' ' 83' ' ' ILE . 86.4 mt -99.41 -39.22 8.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.281 0.633 . . . . 70.43 110.727 174.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.54 -177.09 5.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.637 0.775 . . . . 75.14 110.287 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -68.95 123.64 21.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.409 -0.814 . . . . 71.31 109.126 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 69.8 9.62 7.22 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.569 1.147 . . . . 75.21 112.161 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.7 t -124.34 110.72 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 107.862 -1.162 . . . . 73.3 107.862 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.435 ' CD2' HD11 ' B' ' 98' ' ' LEU . 5.8 t80 -125.28 154.13 42.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.769 -0.826 . . . . 75.33 108.769 -177.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -130.62 110.02 11.08 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.439 -0.949 . . . . 74.21 108.439 -168.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.48 145.26 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.961 0.904 . . . . 74.14 109.948 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.8 t -128.4 114.73 35.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 121.37 0.605 . . . . 72.22 109.537 176.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -94.15 111.51 23.24 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.578 -1.268 . . . . 75.23 107.578 176.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -105.31 129.72 53.59 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.274 0.559 . . . . 75.23 109.868 171.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.32 119.78 57.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.831 -1.174 . . . . 74.22 107.831 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.7 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 95.5 m -98.18 148.87 23.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.274 -1.01 . . . . 63.44 108.274 175.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.605 HG22 HG21 ' B' ' 114' ' ' ILE . 42.7 t -134.67 125.6 46.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.55 1.14 . . . . 72.22 108.284 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 99.5 m -123.97 139.69 53.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.589 -0.893 . . . . 63.44 108.589 172.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -136.62 145.49 44.94 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 123.652 0.595 . . . . 70.51 110.275 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.1 p -136.13 126.98 27.51 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.638 0.586 . . . . 65.21 111.153 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.643 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 19.8 mt -100.86 112.13 24.49 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.292 -1.003 . . . . 74.31 108.292 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.09 -114.16 5.89 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 124.003 0.815 . . . . 64.23 112.168 -174.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -110.58 4.39 20.25 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.316 0.646 . . . . 74.4 111.304 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.514 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.3 pt-20 -122.41 160.45 25.45 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.999 0.52 . . . . 73.4 110.438 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -75.2 138.15 41.76 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 123.501 0.501 . . . . 72.22 110.079 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.731 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.59 -64.07 1.15 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.371 0.668 . . . . 64.42 109.536 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -144.31 155.33 43.77 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.737 0.78 . . . . 74.21 110.877 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 82.1 mt -128.02 135.55 50.03 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.74 1.616 . . . . 74.32 106.761 173.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.429 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 38.9 t -145.07 148.4 33.63 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.993 -0.743 . . . . 54.23 108.993 175.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -158.98 126.97 5.06 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.215 -0.661 . . . . 74.31 109.215 -172.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 65.5 t -124.37 147.37 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 115.401 -0.818 . . . . 72.44 109.419 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -124.8 86.63 2.59 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.249 -1.019 . . . . 73.04 108.249 170.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -80.05 103.03 9.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.717 -0.674 . . . . 73.3 109.486 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.15 164.5 28.51 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 112.042 -0.423 . . . . 63.53 112.042 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.32 134.86 3.79 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.94 -0.464 . . . . 62.24 111.94 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.505 HG22 HD12 ' B' ' 51' ' ' LEU . 59.0 mt -91.93 124.52 44.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.982 0.913 . . . . 71.55 109.056 174.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -131.69 135.97 47.29 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.253 0.621 . . . . 72.13 110.029 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.7 m -91.36 115.05 27.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.428 1.091 . . . . 73.24 109.198 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.718 HD12 HD13 ' B' ' 98' ' ' LEU . 35.7 pt -115.96 130.37 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.665 0.786 . . . . 74.11 110.83 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.564 ' HB1' ' HB ' ' B' ' 10' ' ' THR . . . -157.78 167.4 30.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.599 0.76 . . . . 64.32 109.586 170.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.09 -56.77 5.08 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 111.5 -0.64 . . . . 74.44 111.5 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.441 HD13 ' HB ' ' B' ' 86' ' ' ILE . 2.8 pp -75.96 163.67 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.17 0.988 . . . . 73.23 111.246 175.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -168.59 157.32 8.58 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.628 0.58 . . . . 74.31 110.628 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.97 -116.03 7.37 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.533 0.521 . . . . 72.14 113.548 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 97.1 m -65.43 -36.1 82.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.88 0.872 . . . . 74.42 111.016 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -66.02 -41.79 90.53 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.689 0.796 . . . . 74.41 110.06 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 47.5 ttp -66.72 -36.65 82.97 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.608 -1.178 . . . . 73.4 110.931 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.19 -32.11 68.47 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.171 0.588 . . . . 63.02 110.572 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -69.96 -29.17 66.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.567 0.747 . . . . 61.14 110.676 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -77.57 -66.78 0.79 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.945 -0.57 . . . . 72.21 110.196 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.718 HD13 HD12 ' B' ' 86' ' ' ILE . 66.5 mt -78.43 -26.4 46.29 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.956 0.902 . . . . 71.32 112.92 -168.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.07 0.81 64.48 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-O 119.749 -0.473 . . . . 64.03 113.453 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 -66.21 0.25 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.28 0.54 . . . . 74.4 112.024 -174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -64.89 -42.39 94.82 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.769 0.827 . . . . 73.34 112.432 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.472 ' SG ' HD21 ' B' ' 98' ' ' LEU . 84.4 m -68.83 -47.44 32.0 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 124.288 1.035 . . . . 73.03 111.725 -177.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.453 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 86.8 Cg_exo -51.9 -39.75 68.02 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.321 2.014 . . . . 70.53 113.326 167.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -61.67 -31.96 72.11 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 112.709 0.633 . . . . 54.33 112.709 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.482 HD12 HD11 ' B' ' 13' ' ' ILE . 61.6 mt -67.85 -41.28 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.384 0.674 . . . . 73.23 110.156 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 66.8 mt -82.78 -19.47 37.7 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.871 -1.059 . . . . 73.41 111.867 -173.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.409 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 57.6 t80 -61.28 -45.22 95.14 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 114.166 1.173 . . . . 72.04 114.166 -170.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 18.2 Cg_endo -58.91 -38.01 90.54 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.089 1.859 . . . . 70.31 112.851 175.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -65.26 -46.26 81.24 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.374 0.67 . . . . 73.12 110.933 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.15 90.01 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.511 -0.768 . . . . 51.15 110.9 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -59.6 -60.52 3.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.495 1.118 . . . . 74.23 110.677 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.526 ' HG3' HH12 ' A' ' 120' ' ' ARG . 12.4 tp10 -58.45 -31.85 68.16 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.399 1.08 . . . . 62.04 111.075 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.531 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.4 t -71.67 -40.33 69.68 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 119.364 -0.351 . . . . 72.51 110.848 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.605 HG21 HG22 ' B' ' 64' ' ' VAL . 88.5 mt -65.1 -55.0 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 109.305 -0.628 . . . . 63.12 109.305 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 13.6 m -58.06 -34.61 70.29 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 124.367 1.042 . . . . 75.42 111.592 -173.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.7 t -61.52 -51.1 70.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 115.913 -0.585 . . . . 74.5 110.03 176.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.5 mmt -66.77 -38.64 86.98 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 123.645 0.59 . . . . 73.12 111.103 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 89.3 t -58.61 -44.56 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.998 0.919 . . . . 74.32 110.515 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 35.2 t -71.26 -30.54 66.42 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.011 -0.995 . . . . 73.32 111.56 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.7 mtt-85 -70.06 -28.91 65.83 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.515 0.726 . . . . 74.4 110.232 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -87.32 9.35 73.41 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 124.02 0.825 . . . . 64.4 112.737 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.428 HG21 ' HB3' ' A' ' 17' ' ' TYR . 58.9 p 55.84 31.65 18.08 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.018 1.727 . . . . 63.34 112.941 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -92.09 155.2 43.16 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 123.734 0.814 . . . . 73.21 109.971 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.17 156.96 6.98 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.713 2.942 . . . . 75.44 114.843 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.433 HE21 ' ND2' ' B' ' 127' ' ' ASN . 64.3 tp60 -60.39 130.43 46.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.095 0.958 . . . . 75.13 111.09 -174.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.454 HD21 HD11 ' F' ' 468' ' ' LEU . 2.9 tm? -141.61 95.36 2.81 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.601 -0.518 . . . . 74.21 109.601 -174.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.433 ' ND2' HE21 ' B' ' 125' ' ' GLN . 55.3 m-80 -94.5 136.55 34.67 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.684 -0.858 . . . . 71.33 108.684 169.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.47 140.33 39.8 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.502 0.721 . . . . 75.54 110.508 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.86 146.1 92.76 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.066 0.946 . . . . 43.34 111.737 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.91 97.67 0.49 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.282 2.654 . . . . 73.42 111.71 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 62.1 t -91.01 110.39 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.142 -1.058 . . . . 75.4 108.142 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -84.87 98.46 10.33 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.805 -1.183 . . . . 75.14 107.805 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -57.99 -48.57 79.6 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.983 0.802 . . . . 75.1 111.357 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.97 -37.23 76.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.195 0.998 . . . . 74.3 112.547 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.66 -47.34 78.85 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.756 0.822 . . . . 64.4 111.549 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -81.81 -24.77 35.72 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.847 -0.615 . . . . 74.01 110.369 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 79.4 t80 -69.61 -30.06 67.72 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.511 0.724 . . . . 74.43 109.727 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -63.41 -37.55 87.72 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.194 0.521 . . . . 54.33 109.692 175.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -79.66 -11.23 59.87 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.309 -0.859 . . . . 62.12 111.543 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -72.26 -36.46 69.05 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.199 -0.667 . . . . 75.13 109.199 169.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 12.5 mt -86.99 -10.93 51.95 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.396 -0.82 . . . . 74.1 110.928 -175.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 176.26 94.31 0.01 OUTLIER 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.266 1.426 . . . . 74.11 107.836 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -70.89 97.52 1.43 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.473 -0.566 . . . . 64.12 109.473 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -159.98 110.23 1.87 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.415 -0.812 . . . . 74.41 109.059 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.59 105.43 11.83 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 109.712 -0.477 . . . . 73.35 109.712 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.28 178.34 52.82 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 116.503 -0.317 . . . . 75.34 112.986 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.415 ' HG2' HG23 ' B' ' 149' ' ' THR . 37.0 tt0 -151.09 97.94 2.51 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.377 -0.601 . . . . 75.33 109.377 -177.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.5 77.99 2.05 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.744 -0.662 . . . . 73.22 113.054 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.415 HG23 ' HG2' ' B' ' 147' ' ' GLU . 46.1 p -96.2 127.49 42.26 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.175 0.59 . . . . 75.04 109.914 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.36 -178.52 5.26 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.849 0.859 . . . . 74.14 109.971 175.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -150.35 108.31 3.72 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.982 0.513 . . . . 54.53 110.258 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -104.41 92.48 4.34 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 109.175 -0.676 . . . . 75.03 109.175 176.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -61.88 134.19 56.37 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.828 0.851 . . . . 63.41 110.804 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -64.33 126.31 27.38 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 123.172 0.589 . . . . 73.24 110.696 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 C-N-CA 125.165 1.386 . . . . 73.1 108.354 176.02 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' C' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.837 0.351 . . . . 75.51 110.677 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 33.4 t -174.83 129.17 0.31 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.738 0.815 . . . . 74.11 109.216 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -133.46 86.26 2.28 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.723 0.809 . . . . 74.14 109.266 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -78.81 104.14 9.23 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.153 0.502 . . . . 71.22 110.266 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -148.05 51.72 1.03 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.281 1.032 . . . . 75.45 108.366 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -90.07 55.25 3.05 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.105 -0.702 . . . . 64.13 109.105 176.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.3 p -63.8 -30.07 71.2 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.524 1.129 . . . . 75.44 112.245 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -83.8 80.37 9.16 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.081 -0.711 . . . . 73.41 109.081 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.46 ' HE1' HD12 ' C' ' 89' ' ' ILE . 27.5 ttt 64.8 115.21 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.445 1.498 . . . . 75.33 112.922 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 70.3 m -103.1 109.14 20.6 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.354 -0.98 . . . . 62.21 108.354 170.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.562 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.8 t80 -124.52 128.06 48.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.539 0.736 . . . . 74.42 109.101 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -146.54 128.04 15.04 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.82 0.7 . . . . 64.34 109.605 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.402 HD13 ' HD3' ' A' ' 130' ' ' PRO . 95.4 mt -68.46 124.66 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.416 -0.957 . . . . 74.12 108.416 168.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.578 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 36.4 mm-40 -93.28 -47.46 6.9 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.425 0.69 . . . . 74.05 110.192 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -175.24 124.44 0.24 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.59 -0.732 . . . . 65.42 110.013 -169.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.9 143.46 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 108.381 -0.97 . . . . 74.41 108.381 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.488 ' CE2' ' HD2' ' C' ' 19' ' ' LYS . 28.5 p90 -170.92 166.7 7.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.1 0.476 . . . . 72.43 110.77 -175.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.9 p -88.32 112.43 22.83 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.273 -0.876 . . . . 73.44 109.203 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.488 ' HD2' ' CE2' ' C' ' 17' ' ' TYR . 19.3 mmmt -64.97 -46.54 81.09 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.661 -1.237 . . . . 73.15 107.661 170.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.605 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.0 t70 -141.53 143.61 33.86 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 113.334 -1.757 . . . . 72.34 109.908 -170.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 59.0 mt -141.12 145.32 25.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 106.474 -1.676 . . . . 71.3 106.474 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.7 t -157.45 149.62 22.58 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.366 0.603 . . . . 75.04 109.984 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 84.1 t80 -149.55 116.72 6.03 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.017 -1.475 . . . . 72.21 107.017 172.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -120.78 111.1 17.15 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.162 0.585 . . . . 75.25 110.192 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.85 74.56 63.81 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.769 -1.567 . . . . 75.2 106.769 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.58 -15.87 30.53 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.652 2.234 . . . . 64.01 111.806 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -111.45 24.4 12.85 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.543 1.137 . . . . 74.15 109.623 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.485 ' HA ' HG11 ' C' ' 31' ' ' VAL . . . -51.27 -49.42 81.86 Favored Pre-proline 0 CA--C 1.562 1.404 0 N-CA-C 114.239 1.199 . . . . 72.41 114.239 -172.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.445 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 35.3 Cg_exo -60.13 -43.3 36.61 Favored 'Trans proline' 0 C--N 1.38 2.214 0 CA-C-N 122.021 1.757 . . . . 63.34 112.206 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -69.15 -30.0 68.14 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.826 -1.079 . . . . 71.51 112.053 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' C' ' 73' ' ' ALA . 5.4 p -79.78 -28.33 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 N-CA-C 111.858 0.318 . . . . 73.32 111.858 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -70.34 -31.68 69.06 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 120.791 0.329 . . . . 73.31 111.268 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -84.98 7.49 21.08 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.511 0.724 . . . . 74.21 111.228 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.706 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.07 164.43 13.95 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.343 1.057 . . . . 75.24 110.445 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.408 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 9.8 t70 -85.31 104.17 14.91 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.929 -1.138 . . . . 72.15 107.929 167.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.6 t90 -70.09 87.83 0.58 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.923 1.289 . . . . 74.34 111.335 -171.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -123.03 79.12 51.26 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 124.479 1.111 . . . . 72.52 108.55 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.57 138.98 30.47 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.638 2.226 . . . . 54.35 114.495 -171.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.12 115.94 22.65 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.606 -1.628 . . . . 71.32 106.606 164.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.436 HG23 HD23 ' G' ' 470' ' ' LEU . 2.6 t -95.13 118.63 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.489 -0.778 . . . . 75.54 110.079 -163.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.504 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 87.3 tttt -127.22 134.1 50.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.824 0.85 . . . . 73.32 109.102 176.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' G' ' 464' ' ' MET . 50.9 tp -126.0 129.37 49.07 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.016 -0.735 . . . . 73.12 109.016 175.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.408 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.3 t70 -118.84 133.5 55.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.618 -1.252 . . . . 75.11 107.618 175.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.553 ' HB3' HD13 ' G' ' 460' ' ' LEU . 87.4 mt -124.8 136.01 53.46 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.836 -1.172 . . . . 72.53 107.836 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 15.6 t70 -141.96 151.29 42.41 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.503 0.721 . . . . 73.41 109.371 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -134.92 151.9 51.28 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.896 -0.779 . . . . 73.53 108.896 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.19 170.4 20.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.672 0.789 . . . . 73.32 109.273 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.411 ' HB2' ' CE2' ' C' ' 56' ' ' TYR . 78.0 p -159.64 153.09 22.43 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.265 0.226 . . . . 70.24 111.346 -176.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 84.2 p -149.59 147.44 28.14 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.943 0.897 . . . . 71.31 109.991 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -89.76 121.16 31.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.175 0.59 . . . . 65.22 109.587 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' C' ' 57' ' ' GLU . 20.5 mt -95.32 -39.26 10.13 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.329 0.652 . . . . 74.04 109.759 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.73 -172.45 3.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.77 0.828 . . . . 74.31 110.261 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.27 111.51 1.57 Allowed 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.255 0.972 . . . . 75.43 109.953 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 70.06 -6.02 1.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.711 1.205 . . . . 74.43 112.733 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 68.1 t -94.22 95.79 5.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 106.833 -1.543 . . . . 70.24 106.833 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' C' ' 48' ' ' SER . 12.1 t80 -118.17 124.59 48.34 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.141 -0.936 . . . . 74.21 108.845 -172.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.57 ' HB2' HD12 ' C' ' 51' ' ' LEU . 39.3 tt0 -85.5 138.95 31.87 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 123.263 0.625 . . . . 75.12 110.587 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 42.6 t -116.81 142.16 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.925 -1.139 . . . . 64.42 107.925 165.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 85.8 t -127.83 130.73 70.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.99 -1.115 . . . . 75.5 107.99 172.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.23 107.67 18.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.451 -0.944 . . . . 74.32 108.451 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.446 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 49.5 ttm-85 -86.56 134.95 33.61 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.795 -1.093 . . . . 73.1 109.192 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.04 118.54 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.029 -1.1 . . . . 72.34 108.029 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.1 m -121.46 122.42 39.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.635 -0.876 . . . . 65.22 108.635 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.578 HG11 HD13 ' C' ' 126' ' ' LEU . 14.5 t -115.55 129.35 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.52 -0.918 . . . . 73.32 108.52 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 5.6 m -121.7 115.94 23.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.787 0.835 . . . . 75.11 108.871 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.59 120.82 43.64 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.79 -1.189 . . . . 75.04 107.79 172.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 45.3 m -122.2 169.07 11.26 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.578 0.751 . . . . 74.44 109.605 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.706 HD11 ' HG2' ' C' ' 34' ' ' LYS . 85.1 mt -132.24 15.68 4.59 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.577 1.151 . . . . 65.22 109.818 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.44 -91.08 0.59 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.253 -0.739 . . . . 64.14 111.253 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -89.91 -27.98 19.51 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.438 0.695 . . . . 74.21 109.878 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 4.3 tp10 -94.96 121.91 37.07 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.912 1.285 . . . . 75.21 110.357 -175.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.7 m -77.56 126.06 30.3 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.369 -0.975 . . . . 72.21 108.369 165.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.563 ' HA ' HG23 ' C' ' 31' ' ' VAL . . . -64.75 -60.91 2.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.284 1.04 . . . . 75.02 108.809 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -161.65 161.82 29.7 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-N 112.707 -2.042 . . . . 74.45 108.989 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -126.3 140.71 52.31 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 105.855 -1.906 . . . . 72.35 105.855 167.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.8 t -138.09 132.41 32.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.833 -1.173 . . . . 71.31 107.833 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.62 136.45 27.46 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.67 -0.863 . . . . 74.02 108.67 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -146.25 132.97 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 124.603 1.161 . . . . 74.34 108.507 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.605 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 39.9 mt-30 -118.58 94.9 4.63 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.966 -1.124 . . . . 74.14 107.966 173.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -81.69 104.28 11.97 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.888 -1.051 . . . . 63.31 109.819 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.8 157.29 35.6 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.991 -0.444 . . . . 73.52 111.991 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.46 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -159.63 117.81 0.79 Allowed Glycine 0 CA--C 1.501 -0.795 0 N-CA-C 110.83 -0.908 . . . . 62.4 110.83 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 10.5 mm -84.84 121.29 36.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.175 -1.046 . . . . 75.14 108.175 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.562 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 53.0 m-85 -128.67 118.33 22.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.774 -0.824 . . . . 73.34 108.774 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 54.8 m -77.79 108.21 10.85 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.515 -0.92 . . . . 74.23 108.515 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 45.4 pt -114.94 131.25 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.65 0.78 . . . . 74.11 109.217 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -146.98 152.3 38.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.148 0.979 . . . . 64.34 109.312 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.59 -23.1 17.55 Favored Glycine 0 N--CA 1.479 1.502 0 N-CA-C 113.941 0.336 . . . . 73.22 113.941 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.46 HD12 ' HE1' ' C' ' 9' ' ' MET . 28.7 pt -103.05 152.11 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.803 0.841 . . . . 73.22 110.532 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 15.8 pt-20 -166.44 177.97 6.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.697 0.799 . . . . 73.04 109.49 173.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.31 -125.67 34.4 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.592 0.557 . . . . 51.23 113.661 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.416 HG22 ' HG2' ' C' ' 142' ' ' GLN . 82.4 p -72.26 -28.35 63.07 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.498 0.719 . . . . 55.41 111.075 -177.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.433 HE21 HG21 ' C' ' 89' ' ' ILE . 27.8 mt-30 -65.15 -44.55 88.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.588 0.755 . . . . 74.14 110.032 174.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.529 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 22.0 ttt -62.57 -46.17 89.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.214 -0.903 . . . . 65.3 110.472 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.83 -50.27 61.19 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 124.245 0.966 . . . . 73.14 111.613 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.443 ' HE2' ' HA ' ' C' ' 134' ' ' ASP . 10.6 t-160 -76.2 -32.38 58.94 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 123.377 0.423 . . . . 74.51 111.954 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.556 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.3 t -59.44 -36.13 75.34 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.312 0.383 . . . . 74.41 110.463 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 34.2 mt -96.13 -20.39 18.66 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.83 0.852 . . . . 74.22 110.882 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.93 -31.52 57.89 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.036 -0.529 . . . . 73.2 113.875 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.47 -39.48 0.06 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.628 0.251 . . . . 75.32 111.616 -169.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.556 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 42.6 t80 -65.39 -43.53 90.36 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.461 1.505 . . . . 75.34 113.158 -172.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 66.3 m -81.57 -44.89 1.11 Allowed Pre-proline 0 N--CA 1.486 1.336 0 CA-C-O 118.717 -0.659 . . . . 72.4 111.787 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.04 -27.0 34.39 Favored 'Trans proline' 0 C--N 1.394 2.954 0 C-N-CA 122.516 2.144 . . . . 73.31 113.738 169.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -59.76 -42.9 94.3 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.393 1.077 . . . . 74.23 111.027 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -66.1 -33.47 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 115.437 -0.801 . . . . 71.42 110.376 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.46 HD22 ' HA3' ' C' ' 82' ' ' GLY . 62.6 mt -91.25 -25.16 19.62 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.88 0.872 . . . . 72.15 112.389 -171.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -54.38 -50.53 84.5 Favored Pre-proline 0 CA--C 1.557 1.237 0 CA-C-O 117.966 -1.016 . . . . 73.53 113.682 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.35 -37.83 96.27 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.29 1.993 . . . . 75.35 113.184 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -68.24 -47.32 68.11 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.364 0.666 . . . . 75.41 110.974 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.51 79.56 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.258 -0.883 . . . . 72.3 110.612 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -60.72 -53.21 60.19 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.117 1.367 . . . . 74.14 111.026 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . 0.41 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.2 tm-20 -67.38 -34.02 76.42 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 123.656 0.598 . . . . 73.03 110.316 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.2 t -64.58 -36.76 85.28 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.481 0.488 . . . . 74.4 110.764 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.495 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 77.8 mt -67.67 -50.37 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.3 0.64 . . . . 73.45 110.31 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.6 m -62.47 -30.1 71.01 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.561 0.744 . . . . 72.45 111.374 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -69.68 -50.62 42.09 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 109.142 -0.688 . . . . 74.31 109.142 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.565 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.59 -44.62 66.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.21 1.004 . . . . 71.03 112.063 176.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 88.4 t -63.58 -46.58 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.915 0.886 . . . . 74.32 110.868 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 36.6 t -63.54 -33.49 75.71 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.873 0.869 . . . . 74.1 111.795 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -73.34 -39.35 65.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.838 0.855 . . . . 74.51 109.761 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.82 -2.15 69.61 Favored Glycine 0 C--N 1.352 1.468 0 O-C-N 123.832 0.707 . . . . 73.11 112.587 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 61.75 28.49 17.54 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 126.77 2.028 . . . . 75.1 113.302 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -81.84 156.62 69.97 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.272 -1.01 . . . . 74.52 108.272 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.26 171.25 2.48 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.727 2.285 . . . . 73.0 113.622 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -51.26 136.45 24.62 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.731 1.212 . . . . 71.03 114.036 -173.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.578 HD13 HG11 ' C' ' 64' ' ' VAL . 7.0 tt -127.32 91.73 3.37 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 106.764 -1.569 . . . . 72.44 106.764 171.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -100.5 105.61 17.07 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.851 -0.796 . . . . 72.24 108.851 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.02 125.58 25.9 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.144 -1.058 . . . . 74.13 108.144 175.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.07 148.64 98.34 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 122.84 0.456 . . . . 75.41 111.29 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.411 ' HG3' HD13 ' A' ' 16' ' ' ILE . 34.8 Cg_exo -57.55 106.78 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.872 2.381 . . . . 73.33 112.172 174.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 23.3 m -112.21 119.66 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.402 0.681 . . . . 72.45 109.924 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -91.87 93.61 8.91 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.904 -0.776 . . . . 73.33 108.904 -176.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.424 ' HE2' HD12 ' C' ' 44' ' ' LEU . 91.7 m-85 -61.09 -40.04 92.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.484 0.714 . . . . 74.1 111.026 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.443 ' HA ' ' HE2' ' C' ' 96' ' ' HIS . 9.7 m-20 -60.45 -43.9 96.39 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.342 -0.845 . . . . 71.13 112.226 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.91 -33.72 72.24 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.89 0.744 . . . . 75.14 111.396 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.456 ' HA ' HD22 ' C' ' 139' ' ' ASN . 2.1 tt -79.86 -46.07 17.52 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.69 -0.485 . . . . 74.33 109.69 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.412 ' HD2' ' CE2' ' G' ' 461' ' ' PHE . 22.7 t80 -59.71 -31.38 69.54 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.88 0.472 . . . . 74.55 111.364 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 66.7 mtt -63.04 -60.42 3.46 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.736 -0.665 . . . . 74.14 111.512 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . 0.456 HD22 ' HA ' ' C' ' 136' ' ' LEU . 12.0 p30 -63.05 -33.72 76.03 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.571 0.348 . . . . 73.43 111.243 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -51.63 -84.57 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.468 1.507 . . . . 74.21 110.406 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 pp -175.93 160.76 2.37 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.716 0.806 . . . . 75.12 111.755 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.416 ' HG2' HG22 ' C' ' 92' ' ' THR . 79.2 mt-30 62.47 98.46 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.145 1.378 . . . . 63.44 113.173 171.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -121.48 175.71 6.05 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.651 0.78 . . . . 73.14 111.516 -174.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -73.01 140.08 47.08 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 114.703 -1.135 . . . . 63.55 109.53 169.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.23 97.9 11.27 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.954 0.502 . . . . 70.31 110.088 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.72 132.47 13.12 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.262 -0.735 . . . . 60.32 111.262 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -76.62 -19.78 57.44 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.702 0.801 . . . . 74.24 112.651 -172.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.04 -111.51 1.92 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.372 -0.291 . . . . 72.44 112.372 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 3.6 t -148.69 83.65 1.47 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.949 0.881 . . . . 74.23 110.2 -175.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.457 ' H ' ' HB2' ' A' ' 145' ' ' ALA . 1.6 mp0 -92.56 174.49 7.25 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.862 0.865 . . . . 61.33 110.501 174.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . 0.569 ' HG2' ' HG2' ' A' ' 143' ' ' GLN . 10.1 tp10 69.14 109.76 0.05 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.356 1.462 . . . . 63.31 109.502 -172.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -73.64 -95.79 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.763 0.825 . . . . 70.14 112.126 -170.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 174.47 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.132 -1.432 . . . . 73.25 107.132 -166.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -79.22 105.08 10.29 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.102 -0.703 . . . . 74.11 109.102 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.305 0 C-N-CA 123.918 0.887 . . . . 72.51 110.637 -178.894 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 43.3 tpp . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.762 -0.458 . . . . 72.25 109.762 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 58.6 m -137.06 129.26 29.58 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.065 0.946 . . . . 73.33 110.038 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.17 152.75 40.51 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.551 0.741 . . . . 63.24 109.728 174.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -128.71 143.27 50.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.044 0.538 . . . . 63.53 110.642 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -133.63 150.61 51.59 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.504 0.722 . . . . 71.33 109.84 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -141.23 103.89 4.52 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.807 -0.812 . . . . 73.25 108.807 174.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 78.1 p -105.04 -172.1 2.04 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.148 0.979 . . . . 74.33 108.718 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.49 158.23 12.57 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 118.56 -0.733 . . . . 72.35 110.046 169.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 3.5 ttp 19.61 118.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 126.395 1.878 . . . . 74.34 114.483 -168.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 23.7 m -107.08 139.34 41.64 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.252 -0.905 . . . . 74.22 110.497 -174.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.467 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 55.0 t80 -163.21 88.48 0.59 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.031 -1.84 . . . . 74.31 106.031 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -119.27 115.35 23.98 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.202 -1.407 . . . . 74.32 107.202 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.491 HG21 HD11 ' D' ' 16' ' ' ILE . 16.4 mt -72.63 120.58 21.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.75 -0.833 . . . . 63.2 108.75 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.417 HE22 HG12 ' D' ' 55' ' ' VAL . 51.8 mt-30 -86.22 -34.0 20.58 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.402 0.681 . . . . 75.44 110.825 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -171.38 134.01 0.86 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.1 0.25 . . . . 75.22 111.663 -172.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.491 HD11 HG21 ' D' ' 13' ' ' ILE . 3.7 mp -113.24 134.68 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 107.493 -1.299 . . . . 75.13 107.493 171.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.405 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 36.6 p90 -166.56 174.5 8.79 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.901 0.858 . . . . 72.13 112.022 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -102.64 120.04 39.87 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.196 -1.366 . . . . 73.53 109.049 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.445 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.4 mtpt -81.16 -36.96 29.56 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.127 -0.694 . . . . 73.4 109.127 175.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 12.5 t70 -144.89 145.27 31.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.951 -1.022 . . . . 71.21 109.436 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.565 HG21 ' HE1' ' C' ' 117' ' ' MET . 73.9 mt -139.2 150.44 23.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.819 1.248 . . . . 64.42 107.811 175.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 13.0 t -155.29 145.78 22.07 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.678 0.791 . . . . 73.44 109.422 174.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.412 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.2 t80 -150.1 124.1 9.37 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.948 -1.501 . . . . 73.31 106.948 170.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 2.2 mp0 -122.0 152.51 39.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.079 0.552 . . . . 75.01 109.595 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.67 82.21 16.05 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.799 -1.186 . . . . 75.35 107.799 175.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.79 -34.25 11.44 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.035 2.49 . . . . 73.02 113.608 -171.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -107.82 8.63 28.81 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.319 0.648 . . . . 71.04 110.523 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.424 ' HB3' ' HD3' ' D' ' 29' ' ' PRO . . . -36.69 -64.88 0.35 Allowed Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 116.416 2.006 . . . . 73.13 116.416 -156.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.475 ' HB3' HD11 ' C' ' 83' ' ' ILE . 39.2 Cg_endo -81.31 -13.41 11.13 Favored 'Trans proline' 0 C--N 1.371 1.756 0 CA-C-N 122.437 1.906 . . . . 74.24 113.65 -172.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -76.26 -42.88 44.26 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.182 0.993 . . . . 74.44 108.709 168.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 6.5 p -81.86 -18.37 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 123.36 0.664 . . . . 74.44 111.547 -173.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -67.63 -15.1 63.48 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.965 0.728 . . . . 73.43 112.965 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -66.98 -13.15 61.59 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.674 0.79 . . . . 75.32 110.548 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.459 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 88.4 mttt -103.59 80.25 1.77 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.357 1.463 . . . . 74.31 109.005 173.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.6 82.92 5.64 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.972 -0.751 . . . . 75.03 108.972 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 t-105 -149.46 157.66 43.48 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.595 1.158 . . . . 75.2 108.231 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.606 ' HG3' HD11 ' H' ' 470' ' ' LEU . 30.5 tp60 -71.76 104.99 1.11 Allowed Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 108.963 -0.754 . . . . 74.34 108.963 176.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -66.23 140.91 60.7 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.928 2.418 . . . . 74.11 113.089 -169.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.41 112.83 1.36 Allowed 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.493 1.121 . . . . 73.51 109.24 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.6 HG23 HG13 ' D' ' 64' ' ' VAL . 2.5 p -98.18 115.0 37.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.626 -0.715 . . . . 73.01 110.752 -170.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -99.41 110.38 22.88 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.017 -1.475 . . . . 75.41 107.017 163.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -95.27 121.44 36.92 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.774 -1.195 . . . . 73.4 107.774 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.719 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 20.3 m-20 -106.05 145.61 31.19 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.064 -0.971 . . . . 75.53 108.38 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.5 130.07 39.97 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.424 -0.954 . . . . 75.31 108.424 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.7 t70 -132.05 143.42 50.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.109 -1.812 . . . . 72.33 106.109 170.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -135.72 155.93 49.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.649 -0.871 . . . . 71.41 108.649 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.07 173.29 14.04 Favored 'General case' 0 C--O 1.239 0.546 0 O-C-N 123.943 0.777 . . . . 71.21 109.854 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.567 ' HB2' ' HE1' ' D' ' 56' ' ' TYR . 19.9 p -155.61 151.23 27.27 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.655 0.782 . . . . 73.3 109.388 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 28.8 t -164.99 119.1 1.28 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.427 0.691 . . . . 64.35 109.545 -170.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -78.96 131.67 36.42 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.452 -0.573 . . . . 65.45 109.452 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' C' ' 29' ' ' PRO . 43.2 mt -102.24 -26.96 13.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.934 0.494 . . . . 74.44 111.101 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.417 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -168.09 -173.54 2.08 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.438 0.695 . . . . 61.21 110.629 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.05 111.98 10.82 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.984 -0.747 . . . . 72.44 108.984 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 76.09 4.01 3.73 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.777 1.631 . . . . 73.43 112.009 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 73.5 t -109.11 125.04 66.23 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 N-CA-C 108.032 -1.099 . . . . 75.43 108.032 169.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.567 ' HE1' ' HB2' ' D' ' 48' ' ' SER . 4.3 t80 -139.85 150.21 44.37 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.173 -1.047 . . . . 64.52 108.173 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -125.13 147.37 49.05 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.517 0.727 . . . . 74.43 109.973 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -124.3 141.83 43.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.959 -1.126 . . . . 73.42 107.959 171.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 53.4 t -118.37 139.17 46.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.185 -1.043 . . . . 74.41 108.185 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.449 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -123.69 113.68 18.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.652 -1.24 . . . . 74.03 107.652 179.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -96.4 97.4 9.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.994 -1.113 . . . . 74.3 107.994 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 t -98.1 118.67 45.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.133 -1.062 . . . . 75.14 108.133 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.719 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.8 m -119.73 143.78 47.6 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.27 1.028 . . . . 73.54 108.47 -172.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.6 HG13 HG23 ' D' ' 40' ' ' VAL . 92.9 t -130.78 103.23 7.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.55 -0.907 . . . . 73.14 108.55 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 52.3 m -92.87 111.99 23.79 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.392 -0.966 . . . . 72.33 108.392 169.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.05 154.47 29.86 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.071 0.549 . . . . 73.13 110.518 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.426 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.9 m -148.41 135.48 20.17 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.606 0.566 . . . . 72.54 111.421 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.91 99.55 10.04 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.377 1.071 . . . . 74.22 108.451 173.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.71 -114.23 5.51 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.727 -0.67 . . . . 75.51 113.724 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.21 3.44 49.37 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.878 0.695 . . . . 73.43 112.878 -172.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.459 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.3 pt-20 -151.87 161.45 42.64 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 122.298 -0.251 . . . . 62.44 110.953 -168.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.2 m -63.74 137.1 57.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.053 0.941 . . . . 61.54 111.482 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.426 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -93.01 -73.59 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.184 -1.043 . . . . 70.42 108.184 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -140.49 143.4 35.45 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 121.429 0.633 . . . . 74.53 110.513 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 75.8 mt -109.28 141.99 40.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.202 -1.406 . . . . 70.24 107.202 173.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.56 ' SG ' HG21 ' D' ' 114' ' ' ILE . 51.6 t -151.73 143.55 23.73 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.271 -0.64 . . . . 74.41 109.271 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -155.72 136.5 13.48 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.203 -0.665 . . . . 72.33 109.203 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.75 114.04 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.847 -0.797 . . . . 73.3 108.847 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -88.56 81.68 7.07 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.267 -1.012 . . . . 74.14 108.267 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -78.12 99.46 6.17 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.102 -1.408 . . . . 74.55 109.32 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.01 148.97 18.65 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 111.549 -0.62 . . . . 44.34 111.549 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.9 132.01 4.7 Favored Glycine 0 C--N 1.335 0.513 0 N-CA-C 111.746 -0.542 . . . . 74.34 111.746 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.4 mt -90.28 128.79 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.044 0.938 . . . . 73.24 108.871 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.99 123.43 25.86 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.273 1.029 . . . . 74.01 109.672 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -76.56 105.67 7.76 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.176 -0.676 . . . . 75.23 109.176 168.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.562 HD11 HD23 ' D' ' 98' ' ' LEU . 48.3 pt -116.62 144.37 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 122.922 0.489 . . . . 63.4 110.163 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.2 158.8 19.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.852 0.861 . . . . 72.3 109.371 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.75 21.7 79.52 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 116.486 -0.325 . . . . 63.51 113.621 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 23.9 pt -128.52 127.43 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.383 0.673 . . . . 74.35 110.0 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.81 154.1 46.09 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.483 1.113 . . . . 74.41 109.777 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.24 -117.84 11.62 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.43 -0.805 . . . . 72.44 114.562 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 19.2 m -65.56 -36.6 84.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.404 0.682 . . . . 75.25 111.612 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -77.09 -40.57 45.53 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.24 -0.436 . . . . 70.24 111.911 -172.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.708 ' SD ' HG21 ' H' ' 452' ' ' VAL . 0.0 OUTLIER -64.8 -35.74 82.08 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 120.785 0.326 . . . . 75.25 110.465 178.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.494 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -65.04 -49.48 69.98 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 115.381 -0.827 . . . . 63.31 109.736 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -59.97 -35.53 75.18 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.717 0.636 . . . . 73.5 111.391 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -64.82 -50.6 66.07 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.076 0.551 . . . . 71.52 111.239 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.562 HD23 HD11 ' D' ' 86' ' ' ILE . 75.7 mt -92.33 -28.42 16.95 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.801 0.667 . . . . 75.13 112.801 -169.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.81 -4.24 57.96 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-O 119.761 -0.466 . . . . 73.51 113.953 -174.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.423 ' HB2' ' HA ' ' D' ' 134' ' ' ASP . . . -142.9 -59.41 0.43 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.104 0.452 . . . . 65.15 111.365 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -70.56 -39.89 73.68 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.487 0.551 . . . . 74.24 112.487 -171.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.467 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 97.5 m -69.86 -46.84 23.98 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.313 -0.851 . . . . 71.31 111.611 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.449 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.4 Cg_exo -55.24 -34.19 87.34 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.004 1.803 . . . . 73.45 112.736 169.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -64.05 -40.83 97.16 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.404 0.681 . . . . 71.43 110.41 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.9 mm -63.2 -37.22 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.517 0.727 . . . . 74.15 110.659 174.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.23 -19.46 43.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.156 0.982 . . . . 72.23 112.237 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -65.91 -44.73 63.08 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 114.03 1.122 . . . . 74.14 114.03 -171.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.04 -44.62 38.02 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.282 1.988 . . . . 74.24 112.835 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -69.27 -34.72 75.2 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.384 -0.825 . . . . 65.32 111.263 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.55 -53.39 56.9 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.738 0.815 . . . . 73.41 110.341 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.469 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 30.0 ttp180 -53.39 -46.51 69.68 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 124.814 1.321 . . . . 74.11 111.292 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -63.38 -49.99 71.64 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.265 0.978 . . . . 53.22 111.29 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.7 t -57.22 -41.57 79.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.11 0.881 . . . . 74.22 111.018 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.56 HG21 ' SG ' ' D' ' 76' ' ' CYS . 70.2 mt -61.01 -56.41 18.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 123.788 0.835 . . . . 72.24 110.6 174.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.1 m -53.4 -43.57 68.02 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.437 1.095 . . . . 71.34 111.706 -175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 40.1 t -65.07 -43.07 93.4 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.947 -1.024 . . . . 70.01 110.478 -177.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.491 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.4 mtm -68.92 -32.6 72.34 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.833 0.453 . . . . 75.14 111.573 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 73.3 t -65.75 -42.41 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.675 0.79 . . . . 74.13 110.299 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -73.14 -27.73 61.84 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 122.686 0.394 . . . . 64.43 111.157 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' D' ' 116' ' ' SER . 80.3 mtt-85 -72.04 -33.95 68.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.595 0.758 . . . . 75.55 109.913 173.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.23 0.27 89.38 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.901 0.75 . . . . 60.41 112.0 174.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 19.2 p 64.4 19.82 11.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.599 1.959 . . . . 64.24 113.711 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -84.8 150.37 55.89 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 108.609 -0.886 . . . . 73.15 108.609 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.47 141.5 51.33 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 123.246 2.631 . . . . 74.11 113.546 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -51.0 140.44 15.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.905 1.282 . . . . 75.34 112.675 -172.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.459 HD13 HG22 ' D' ' 40' ' ' VAL . 0.3 OUTLIER -125.09 97.15 5.12 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.541 -0.911 . . . . 70.43 108.541 -175.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -99.0 110.37 22.99 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.868 -0.79 . . . . 71.24 108.868 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.469 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -69.39 113.41 6.69 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.656 -0.868 . . . . 73.01 108.656 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.73 140.6 97.84 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.042 0.537 . . . . 71.03 110.957 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.08 118.42 5.32 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.63 2.22 . . . . 54.0 111.778 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.73 123.17 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.522 0.729 . . . . 75.24 109.407 -176.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -85.17 79.32 9.61 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.572 -0.899 . . . . 65.52 108.572 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -83.56 -14.66 51.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.568 -0.742 . . . . 74.55 110.588 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' D' ' 138' ' ' MET . 2.3 m-20 -52.77 -53.55 46.58 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.969 0.908 . . . . 63.44 111.789 173.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.12 77.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.962 0.905 . . . . 72.55 111.691 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.1 -22.44 45.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.952 -1.022 . . . . 75.54 111.256 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.431 ' O ' HD13 ' D' ' 141' ' ' LEU . 84.6 t80 -70.51 -40.21 73.67 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.403 0.681 . . . . 75.04 110.119 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 35.0 mtt -62.55 -35.76 80.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.467 0.707 . . . . 64.11 110.137 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -76.12 -40.18 53.45 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.131 -0.94 . . . . 74.25 110.434 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -58.59 -35.14 71.95 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.009 1.323 . . . . 74.04 110.874 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.431 HD13 ' O ' ' D' ' 137' ' ' PHE . 2.8 mp -62.93 -37.14 85.84 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.232 1.013 . . . . 75.34 111.342 176.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -85.1 3.22 39.88 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.099 0.559 . . . . 74.5 111.751 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -119.37 49.11 1.39 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.828 0.823 . . . . 70.25 109.714 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -157.85 -171.22 3.45 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.361 -1.29 . . . . 70.52 108.789 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.17 58.52 3.55 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.312 0.645 . . . . 60.43 110.787 178.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.46 39.39 3.0 Favored Glycine 0 C--N 1.354 1.537 0 C-N-CA 123.341 0.496 . . . . 42.31 113.049 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -152.36 134.45 14.96 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.382 -1.34 . . . . 72.4 107.382 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.11 62.79 0.2 Allowed Glycine 0 C--N 1.342 0.893 0 O-C-N 123.24 0.337 . . . . 70.21 112.313 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 6.3 t -79.02 167.48 21.03 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 109.605 -0.517 . . . . 64.33 109.605 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -102.74 146.06 28.8 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.577 0.751 . . . . 75.25 109.926 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -71.03 125.25 26.35 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.43 -0.952 . . . . 70.44 108.43 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.52 154.97 37.09 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.567 0.542 . . . . 72.24 110.742 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -63.1 91.57 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.836 0.826 . . . . 73.3 110.848 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -143.12 73.88 1.42 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.121 1.368 . . . . 62.44 107.999 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-N 114.965 -1.016 . . . . 72.4 109.035 -175.826 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 121.275 0.559 . . . . 74.23 110.106 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 79.7 t -135.89 -45.48 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.992 1.717 . . . . 74.21 107.847 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . 0.402 ' HA ' ' HE3' ' A' ' 94' ' ' MET . 31.4 m -64.78 147.47 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 114.751 -1.113 . . . . 73.52 111.857 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 167.79 -43.94 0.24 Allowed Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.44 -0.345 . . . . 64.4 112.443 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 7.3 mp 66.29 -177.99 0.2 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.01 1.324 . . . . 73.32 112.11 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 5.2 t -155.69 87.35 1.08 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.818 0.847 . . . . 73.4 109.242 175.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 66.17 103.76 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.587 1.155 . . . . 73.14 111.814 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -63.43 -43.4 97.56 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.244 -0.65 . . . . 71.41 109.244 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 27.0 m 65.78 -77.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.816 1.646 . . . . 74.24 113.301 169.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -142.47 140.73 32.0 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.156 0.982 . . . . 70.41 109.838 -171.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -99.75 111.85 24.15 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 106.702 -1.592 . . . . 74.02 106.702 169.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -77.25 66.22 2.99 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.62 1.168 . . . . 74.22 111.59 -173.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -86.81 124.6 33.22 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.432 -0.803 . . . . 73.13 109.101 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 12.6 t -153.12 128.57 9.95 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.736 -0.838 . . . . 72.4 108.736 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 55.8 ttp -172.32 149.8 2.28 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.216 1.006 . . . . 73.32 108.397 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -64.84 132.66 50.08 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.047 0.539 . . . . 65.43 110.555 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -68.68 88.66 0.36 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.352 0.596 . . . . 73.05 109.97 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -152.66 103.67 2.81 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.139 -0.937 . . . . 72.34 108.89 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . 0.457 HD23 HD21 ' A' ' 42' ' ' LEU . 59.1 mt -114.15 150.32 34.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.437 0.695 . . . . 75.13 109.947 -177.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -76.6 78.65 1.31 Allowed Glycine 0 C--N 1.349 1.285 0 O-C-N 123.401 0.438 . . . . 72.33 112.18 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 6.8 tt -145.1 132.0 20.19 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.528 -1.286 . . . . 73.41 107.528 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.559 1.32 0 C-N-CA 123.797 0.839 . . . . 73.23 109.995 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 110.348 -0.242 . . . . 71.42 110.348 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 33.3 t -81.79 72.63 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.891 0.876 . . . . 71.41 110.041 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 15.8 m -155.42 -179.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 125.205 1.402 . . . . 64.22 110.004 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 105.61 40.46 2.03 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-N 116.576 -0.284 . . . . 63.33 112.662 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.57 109.84 16.39 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.383 0.673 . . . . 74.3 109.33 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 70.1 p -76.35 149.29 37.01 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.766 0.827 . . . . 75.24 110.449 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.74 167.56 20.6 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.12 0.568 . . . . 73.53 109.711 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . 0.552 ' HA ' HE21 ' F' ' 457' ' ' GLN . 0.0 OUTLIER -133.49 121.56 22.36 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.636 -0.505 . . . . 73.02 109.636 -177.436 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 5.2 t -64.15 -39.09 93.27 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.85 0.86 . . . . 73.52 111.324 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.47 102.59 5.58 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.013 0.925 . . . . 74.33 108.989 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.76 144.27 49.27 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.23 0.538 . . . . 73.02 109.934 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -74.48 112.37 10.59 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.674 -1.148 . . . . 73.34 110.695 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -162.76 151.64 14.85 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.821 0.849 . . . . 73.33 108.96 169.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 8.5 t -140.77 130.59 24.38 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.748 -0.834 . . . . 74.31 108.748 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 464' ' ' MET . . . . . 0.587 ' SD ' ' HA ' ' F' ' 468' ' ' LEU . 31.5 ttp -162.61 90.91 0.73 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.795 -0.817 . . . . 74.41 108.795 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -90.19 26.96 1.75 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.473 1.109 . . . . 74.0 111.797 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -131.89 25.28 4.65 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.359 1.063 . . . . 71.11 109.86 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . 69.47 -68.53 0.19 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.711 1.604 . . . . 75.42 110.507 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . 0.587 ' HA ' ' SD ' ' F' ' 464' ' ' MET . 6.0 tt -151.95 -61.08 0.16 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.577 -1.268 . . . . 75.43 107.577 173.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 175.34 41.03 0.05 OUTLIER Glycine 0 C--N 1.349 1.294 0 CA-C-N 116.126 -0.488 . . . . 64.21 112.077 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . 0.498 HD21 ' HB3' ' B' ' 37' ' ' GLN . 2.7 pp -153.2 21.84 0.56 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.009 0.924 . . . . 73.24 110.222 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? . . . . . 0 C--O 1.25 1.11 0 N-CA-C 107.375 -1.342 . . . . 74.21 107.375 -174.822 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.59 -0.152 . . . . 73.01 110.59 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . 0.424 HG13 HG12 ' G' ' 452' ' ' VAL . 7.5 p -72.12 -32.24 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.662 0.785 . . . . 75.4 110.944 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . 0.424 HG12 HG13 ' G' ' 451' ' ' VAL . 27.3 m -126.81 150.87 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.454 1.102 . . . . 75.2 110.237 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 119.28 43.53 0.51 Allowed Glycine 0 C--N 1.348 1.215 0 N-CA-C 114.003 0.361 . . . . 71.25 114.003 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 44.4 tp -77.1 88.68 3.6 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.822 -0.807 . . . . 73.32 108.822 172.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 31.2 p -85.61 -8.08 58.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.721 0.808 . . . . 73.2 110.986 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -68.52 97.02 0.74 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.935 0.894 . . . . 73.54 110.176 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -73.43 83.62 1.47 Allowed 'General case' 0 C--N 1.349 0.557 0 N-CA-C 109.099 -0.704 . . . . 74.14 109.099 173.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 40.0 p -99.83 128.42 45.93 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.179 -0.919 . . . . 72.02 109.374 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.65 144.38 52.04 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.658 -0.868 . . . . 73.1 108.658 170.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . 0.553 HD13 ' HB3' ' C' ' 44' ' ' LEU . 2.4 tt -68.79 103.49 1.78 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 107.902 -1.147 . . . . 73.12 107.902 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . 0.412 ' CE2' ' HD2' ' C' ' 137' ' ' PHE . 31.0 p90 -33.76 -36.25 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 128.112 2.565 . . . . 74.51 114.646 175.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -76.28 105.37 7.29 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.942 -0.762 . . . . 72.5 108.942 -178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 26.3 m -76.24 -52.93 9.01 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.316 0.646 . . . . 74.1 110.069 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 464' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' G' ' 466' ' ' ALA . 0.0 OUTLIER 70.71 133.6 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.579 1.552 . . . . 73.42 110.315 -175.606 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -75.15 4.18 7.33 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.926 0.713 . . . . 75.13 112.926 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . 0.416 ' N ' ' SD ' ' G' ' 464' ' ' MET . . . 57.53 57.89 4.09 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.705 1.202 . . . . 71.24 111.469 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -109.28 105.24 14.57 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.632 -0.713 . . . . 71.04 109.348 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . 0.707 ' HB2' HD22 ' G' ' 470' ' ' LEU . 42.9 mt -116.32 -11.44 11.24 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.81 0.844 . . . . 64.31 111.549 -173.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 71.11 60.62 4.38 Favored Glycine 0 C--N 1.356 1.654 0 O-C-N 123.523 0.514 . . . . 74.43 111.932 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . 0.707 HD22 ' HB2' ' G' ' 468' ' ' LEU . 2.4 pt? -126.8 18.5 7.29 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.628 0.771 . . . . 73.51 110.654 -172.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp . . . . . 0 CA--C 1.564 1.5 0 CA-C-O 117.555 -1.212 . . . . 73.31 110.9 175.965 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.008 -0.368 . . . . 73.03 110.008 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.78 -47.35 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 124.111 0.964 . . . . 61.1 110.041 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.708 HG21 ' SD ' ' D' ' 94' ' ' MET . 7.4 p -168.72 151.03 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 114.191 -1.368 . . . . 74.42 110.39 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -143.64 58.34 0.54 Allowed Glycine 0 C--N 1.335 0.514 0 N-CA-C 109.077 -1.609 . . . . 73.32 109.077 167.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . 0.483 ' H ' HG23 ' H' ' 452' ' ' VAL . 2.3 pt? -58.94 159.7 6.76 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.34 1.056 . . . . 73.44 111.496 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 90.6 m -57.69 121.56 10.69 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 109.574 -0.528 . . . . 75.55 109.574 173.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -56.64 104.95 0.17 Allowed 'General case' 0 CA--C 1.541 0.617 0 O-C-N 124.161 0.913 . . . . 75.13 109.87 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -68.98 106.81 2.88 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.616 0.766 . . . . 65.33 109.018 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 60.7 p -81.4 -45.43 16.1 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.705 0.802 . . . . 75.23 110.646 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.48 148.93 21.94 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.03 0.932 . . . . 74.02 110.35 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.67 54.96 1.89 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.763 -0.828 . . . . 73.43 108.763 173.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 23.1 p90 29.24 -60.44 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 129.189 2.996 . . . . 74.5 118.059 168.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 77.13 170.42 0.23 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.649 1.58 . . . . 75.04 111.604 -170.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 9.7 t -162.15 -9.71 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.755 0.65 . . . . 64.11 112.755 -169.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -103.33 -167.69 1.41 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.77 0.428 . . . . 75.24 111.104 -171.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . 0.43 ' HG2' ' H ' ' H' ' 466' ' ' ALA . 30.7 ttmt -123.91 -156.36 0.71 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 107.846 -1.168 . . . . 75.31 107.846 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . 0.43 ' H ' ' HG2' ' H' ' 465' ' ' LYS . . . -62.4 97.41 0.09 Allowed 'General case' 0 C--N 1.363 1.159 0 CA-C-N 118.89 0.768 . . . . 71.41 110.539 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -60.36 -42.74 96.41 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.231 1.013 . . . . 72.1 112.943 -170.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . 0.41 HD21 ' HG ' ' H' ' 470' ' ' LEU . 4.9 tt -77.15 -35.33 56.15 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 109.164 -0.68 . . . . 74.14 109.164 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 103.72 15.45 22.52 Favored Glycine 0 N--CA 1.472 1.096 0 CA-C-O 119.84 -0.422 . . . . 73.35 113.256 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . 0.606 HD11 ' HG3' ' D' ' 37' ' ' GLN . 84.2 mt -79.7 84.6 5.5 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.738 -0.838 . . . . 72.54 108.738 173.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 92.1 mttt . . . . . 0 C--O 1.248 1.018 0 C-N-CA 123.802 0.841 . . . . 70.52 109.006 -176.691 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 109.699 -0.482 . . . . 71.15 109.699 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.3 m -82.24 124.15 29.67 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.412 0.685 . . . . 70.24 110.742 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -145.08 34.23 1.1 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.799 0.84 . . . . 72.44 109.576 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.71 136.14 47.09 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.42 0.688 . . . . 73.33 109.406 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -74.32 85.38 1.95 Allowed 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.746 0.784 . . . . 74.22 110.637 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -84.44 87.47 7.23 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.169 -0.923 . . . . 72.22 108.961 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 m -75.61 -46.72 30.08 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.714 0.805 . . . . 64.35 111.804 -167.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -122.7 -52.81 1.9 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.612 0.765 . . . . 74.12 109.084 171.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.2 mtt -90.44 176.5 6.68 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.412 -1.267 . . . . 72.14 110.632 -172.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.608 ' HB ' ' HB1' ' A' ' 87' ' ' ALA . 87.7 m -148.84 124.19 10.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.666 1.186 . . . . 71.13 107.906 173.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -134.55 138.67 44.81 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.821 0.848 . . . . 74.0 108.758 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -152.8 127.61 9.54 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.429 0.692 . . . . 70.42 109.466 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.3 mt -83.39 115.74 26.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.302 -0.999 . . . . 75.41 108.302 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -81.51 -38.59 26.03 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.478 0.486 . . . . 63.22 109.864 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -170.11 124.07 0.73 Allowed 'General case' 0 C--N 1.356 0.875 0 CA-C-O 119.684 -0.198 . . . . 74.3 110.783 -167.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.487 HD13 ' HG3' ' C' ' 130' ' ' PRO . 46.8 mt -111.68 134.79 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.157 -1.053 . . . . 75.31 108.157 172.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.452 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 44.1 p90 -166.55 167.33 15.6 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.878 0.847 . . . . 70.24 111.272 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -91.3 110.69 21.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.732 -1.122 . . . . 73.14 108.138 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -70.95 -46.92 61.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.96 -0.756 . . . . 73.33 108.96 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.668 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 6.0 m-20 -133.5 132.97 41.63 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.598 -1.183 . . . . 75.2 109.256 -176.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -127.67 139.71 51.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 106.678 -1.601 . . . . 75.42 106.678 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -149.84 107.34 3.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 123.655 0.597 . . . . 70.21 109.718 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 60.0 t80 -111.2 113.7 26.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.707 -1.59 . . . . 73.2 106.707 171.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.0 114.37 22.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.319 -0.623 . . . . 75.31 109.319 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.72 80.56 70.26 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 107.613 -1.255 . . . . 72.41 107.613 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.76 -11.4 20.14 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.469 2.112 . . . . 72.42 111.214 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -107.72 20.84 18.29 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.874 1.269 . . . . 75.13 108.772 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.46 -45.02 99.71 Favored Pre-proline 0 CA--C 1.571 1.786 0 N-CA-C 114.43 1.271 . . . . 61.43 114.43 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -88.01 -8.44 5.78 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 121.678 1.585 . . . . 75.33 112.99 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.402 ' HA ' HE21 ' A' ' 33' ' ' GLN . 18.1 t-160 -94.88 -15.53 23.6 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.215 1.006 . . . . 75.41 110.354 -175.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.525 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 8.8 p -77.01 -25.93 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.731 0.812 . . . . 74.12 110.205 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -66.68 -29.82 69.91 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.801 0.84 . . . . 73.25 110.113 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.402 HE21 ' HA ' ' A' ' 30' ' ' HIS . 48.6 mt-30 -78.94 -34.95 44.01 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.025 0.93 . . . . 70.52 111.612 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.525 ' HE3' ' HA ' ' A' ' 31' ' ' VAL . 16.2 ptpt -82.87 169.2 16.33 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.115 0.413 . . . . 75.3 112.115 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -85.01 127.03 34.02 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.648 -0.871 . . . . 74.41 108.648 167.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -70.29 88.55 0.64 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.21 1.004 . . . . 75.31 111.594 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.444 ' HB2' HD13 ' A' ' 68' ' ' LEU . 98.5 mt-30 -132.88 76.78 70.01 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.141 0.976 . . . . 74.43 109.403 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -89.04 126.38 1.68 Allowed 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.339 2.026 . . . . 75.41 112.358 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.99 109.89 22.21 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.492 -1.299 . . . . 74.33 107.492 170.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.78 107.24 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 115.131 -0.94 . . . . 64.13 110.907 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -79.77 114.69 18.89 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.289 -1.004 . . . . 72.41 108.289 165.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.482 HD23 ' HE2' ' E' ' 464' ' ' MET . 50.0 tp -98.24 111.55 23.84 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.302 -0.999 . . . . 74.35 108.302 171.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -116.11 129.49 56.36 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.055 -1.091 . . . . 62.12 108.055 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 tt -119.33 129.89 55.09 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.281 -1.007 . . . . 73.42 108.281 -171.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.689 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 18.7 t70 -130.34 155.28 46.62 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.13 0.972 . . . . 71.41 109.532 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.59 ' H ' HD21 ' E' ' 460' ' ' LEU . 90.0 m -141.78 131.87 24.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.564 1.146 . . . . 75.32 109.207 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.1 148.64 45.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.973 0.909 . . . . 75.33 109.423 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.4 p -109.41 161.68 15.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.568 0.747 . . . . 51.31 109.313 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.1 p -152.95 138.08 17.35 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.134 0.574 . . . . 54.01 109.853 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.448 ' HA ' ' HD1' ' A' ' 56' ' ' TYR . 46.9 tt0 -91.25 114.83 27.47 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.944 0.498 . . . . 74.33 109.975 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.543 HD13 ' HB2' ' A' ' 57' ' ' GLU . 18.9 mt -89.25 -43.42 10.98 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.832 -0.803 . . . . 62.34 108.832 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.67 -179.33 7.16 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 113.989 -1.459 . . . . 71.14 108.662 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' E' ' 450' ' ' ASN . 2.4 m-20 -68.57 113.64 6.26 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.39 -0.596 . . . . 75.53 109.39 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 66.3 21.55 10.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.337 1.455 . . . . 74.45 112.101 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.33 102.08 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 106.759 -1.571 . . . . 72.34 106.759 167.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.448 ' HD1' ' HA ' ' A' ' 50' ' ' GLN . 18.7 m-85 -127.05 143.35 51.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.951 0.501 . . . . 75.11 110.014 -170.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HB2' HD13 ' A' ' 51' ' ' LEU . 34.7 tt0 -114.89 137.91 51.41 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.782 0.833 . . . . 75.25 109.523 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.5 t -103.89 126.85 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.824 -1.176 . . . . 72.55 107.824 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.4 t -102.22 107.46 21.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.524 -0.917 . . . . 75.23 108.524 174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 tp -88.83 101.42 14.01 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.949 -0.759 . . . . 74.43 108.949 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.689 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 23.8 mtm105 -89.5 100.95 13.64 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.039 0.536 . . . . 75.22 109.619 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.541 HG23 ' HB1' ' A' ' 110' ' ' ALA . 2.5 m -113.25 108.48 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.154 0.581 . . . . 75.12 109.543 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -108.89 148.51 30.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.523 0.729 . . . . 65.14 110.741 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.41 ' O ' HD13 ' A' ' 75' ' ' LEU . 70.6 t -129.23 112.29 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 125.307 1.443 . . . . 73.14 108.067 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.7 m -102.6 104.2 14.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.562 -0.903 . . . . 75.3 108.562 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.84 109.57 21.35 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.562 -1.273 . . . . 74.1 107.562 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.7 p -147.39 140.93 25.49 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.18 0.514 . . . . 72.2 111.405 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.444 HD13 ' HB2' ' A' ' 37' ' ' GLN . 38.2 tp -90.39 68.64 6.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.828 1.251 . . . . 70.32 107.668 169.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.51 -89.71 0.63 Allowed Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.046 -0.979 . . . . 42.25 111.951 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.8 -26.01 14.17 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.2 1.0 . . . . 73.32 110.123 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -96.98 94.89 7.45 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.407 -0.815 . . . . 72.45 109.177 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.8 m -65.39 134.77 54.22 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.824 0.85 . . . . 63.51 111.99 -174.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.87 -64.54 1.16 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.874 -0.788 . . . . 70.51 108.874 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -157.06 174.14 15.96 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.166 -0.925 . . . . 75.14 110.937 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 64' ' ' VAL . 61.7 tp -140.2 130.36 25.02 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.973 1.309 . . . . 64.13 107.634 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.427 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 84.7 m -138.44 113.4 9.2 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.466 0.706 . . . . 63.25 110.204 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -132.74 126.76 33.21 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.897 -0.779 . . . . 73.1 108.897 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -129.17 119.15 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.513 -0.767 . . . . 75.04 109.362 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.668 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 44.9 mt-30 -91.05 89.77 7.56 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.877 -1.056 . . . . 64.3 108.286 172.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.433 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.9 tp-100 -78.73 105.71 10.22 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.149 -0.932 . . . . 70.04 109.29 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.97 160.03 27.03 Favored Glycine 0 C--O 1.242 0.613 0 N-CA-C 111.317 -0.713 . . . . 74.54 111.317 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.43 121.91 1.06 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.003 -1.239 . . . . 73.2 110.003 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.3 mt -79.23 123.74 36.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.625 -0.88 . . . . 72.14 108.625 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -126.41 119.0 26.14 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.081 -0.711 . . . . 73.22 109.081 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 p -91.62 119.2 31.31 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.066 -1.087 . . . . 73.01 108.066 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.711 HD12 HD12 ' A' ' 89' ' ' ILE . 2.4 pp -126.54 161.59 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.589 0.755 . . . . 71.54 111.559 -171.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.608 ' HB1' ' HB ' ' A' ' 10' ' ' THR . . . -167.72 155.28 8.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.376 1.071 . . . . 75.45 109.721 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.16 8.26 86.92 Favored Glycine 0 N--CA 1.475 1.249 0 N-CA-C 114.501 0.56 . . . . 73.52 114.501 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.711 HD12 HD12 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -114.99 153.85 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.2 1.0 . . . . 75.44 109.153 178.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.87 171.27 14.34 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.12 -1.067 . . . . 74.11 108.12 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.38 -114.54 1.47 Allowed Glycine 0 CA--C 1.542 1.721 0 N-CA-C 114.685 0.634 . . . . 74.14 114.685 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p -70.68 -29.72 66.12 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.267 1.027 . . . . 73.32 112.173 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.7 mm-40 -65.86 -44.63 84.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.45 0.7 . . . . 75.03 110.865 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -71.43 -34.17 70.06 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.22 -0.445 . . . . 73.45 110.467 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -33.51 76.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.099 0.56 . . . . 74.21 110.618 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.43 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 63.9 t-80 -71.49 -21.69 61.9 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.739 0.816 . . . . 71.44 110.728 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 78.3 m -79.12 -60.27 2.44 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.401 -0.592 . . . . 75.12 109.401 172.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.14 -32.84 73.48 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.169 0.987 . . . . 75.32 112.423 -173.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.47 4.13 29.56 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 119.356 -0.691 . . . . 64.1 114.055 -172.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.1 -66.73 0.34 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.882 0.841 . . . . 61.44 111.782 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -70.65 -58.32 3.79 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.241 0.616 . . . . 73.12 112.478 -169.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.65 -46.28 98.59 Favored Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 113.517 0.932 . . . . 74.32 113.517 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.09 -26.49 65.5 Favored 'Trans proline' 0 C--N 1.399 3.185 0 C-N-CA 121.846 1.697 . . . . 72.01 112.636 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -68.22 -39.76 82.29 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.382 0.673 . . . . 54.33 110.601 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.8 mm -61.7 -43.43 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.893 0.877 . . . . 73.52 110.13 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.433 HD23 ' HG3' ' A' ' 80' ' ' GLN . 83.0 mt -77.94 -22.22 49.89 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.889 -1.05 . . . . 74.22 112.219 -174.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -61.46 -47.25 93.87 Favored Pre-proline 0 CA--C 1.567 1.62 0 N-CA-C 113.788 1.033 . . . . 73.21 113.788 -170.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.12 -37.0 66.66 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.143 1.895 . . . . 75.31 113.139 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -70.37 -39.98 74.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.639 0.776 . . . . 75.23 110.418 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.541 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . -65.38 -43.11 91.77 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.388 -0.823 . . . . 72.13 110.549 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.488 ' NH1' HD13 ' C' ' 105' ' ' ILE . 31.8 ttm180 -55.14 -50.85 68.23 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 124.46 1.1 . . . . 70.3 110.33 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -59.86 -47.46 85.67 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.604 1.19 . . . . 75.35 111.343 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 117' ' ' MET . 36.1 t -61.7 -41.47 97.65 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 123.912 0.757 . . . . 71.04 110.643 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.499 HD11 HG21 ' A' ' 62' ' ' VAL . 96.1 mt -64.3 -50.23 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.895 0.878 . . . . 75.42 110.43 176.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 78.4 m -53.6 -45.03 69.91 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.839 0.855 . . . . 74.25 110.604 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -66.74 -38.77 87.3 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.165 -1.38 . . . . 73.54 110.228 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.472 ' HA ' ' HE1' ' A' ' 117' ' ' MET . 30.9 mmt -58.61 -47.13 85.38 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.283 0.633 . . . . 74.22 111.235 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.2 t -61.97 -43.64 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-N 114.897 -1.047 . . . . 74.31 110.408 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.1 m -73.29 -29.8 62.97 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.612 0.765 . . . . 60.24 111.917 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.486 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 93.9 mtt-85 -77.41 -25.31 50.67 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.207 0.603 . . . . 75.33 110.413 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.99 2.8 87.15 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.576 0.547 . . . . 74.22 112.758 171.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.9 m 68.01 16.79 9.56 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.908 1.283 . . . . 74.52 111.268 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -81.74 144.94 53.1 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 108.914 -0.773 . . . . 72.43 108.914 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.14 134.72 44.14 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.058 2.505 . . . . 71.24 112.226 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -52.75 141.95 19.94 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.369 1.068 . . . . 64.43 113.558 -171.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.0 tp -119.4 127.08 52.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.815 1.246 . . . . 75.32 109.766 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -135.9 102.39 5.04 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.492 -0.929 . . . . 71.33 108.492 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.534 ' H ' HD22 ' A' ' 128' ' ' LEU . 2.0 pt? -68.45 151.59 46.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.535 0.734 . . . . 75.13 111.031 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.94 146.46 98.27 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.196 0.999 . . . . 70.24 111.23 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -67.1 123.63 11.17 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.558 2.172 . . . . 74.12 112.347 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 98.7 t -101.25 113.56 37.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 123.971 0.908 . . . . 73.12 108.619 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -87.84 97.39 10.89 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.631 -0.878 . . . . 73.43 108.631 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -66.48 -21.14 66.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.315 1.046 . . . . 75.13 111.685 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.86 -48.77 62.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.413 1.085 . . . . 73.52 110.88 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.14 -40.02 88.34 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.83 0.707 . . . . 73.34 110.348 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.49 -39.9 85.22 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.081 -0.963 . . . . 72.43 111.369 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -67.08 -36.74 82.65 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.38 -0.6 . . . . 74.32 109.38 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.0 mmt -64.46 -35.11 79.87 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.023 0.827 . . . . 75.33 111.176 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 42.2 m-80 -60.0 -45.1 93.84 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.993 0.517 . . . . 64.12 110.787 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -68.26 -42.82 79.05 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.066 0.546 . . . . 71.33 110.759 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.51 -47.26 70.48 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.323 1.049 . . . . 72.32 111.568 -167.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -163.71 17.77 0.07 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.888 -0.596 . . . . 73.0 111.53 -172.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.653 ' HG2' ' HG3' ' A' ' 144' ' ' GLN . 50.6 tt0 64.97 -77.27 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.429 1.092 . . . . 51.15 110.189 -170.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.653 ' HG3' ' HG2' ' A' ' 143' ' ' GLN . 0.9 OUTLIER -163.28 155.5 18.03 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.827 0.851 . . . . 74.03 110.795 177.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -168.84 -77.25 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.12 0.968 . . . . 73.41 108.853 172.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 52.95 -121.12 14.32 Favored Glycine 0 C--N 1.36 1.864 0 O-C-N 124.115 0.885 . . . . 63.43 113.148 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -118.76 -178.54 3.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.307 1.043 . . . . 62.4 109.247 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 151.81 51.08 0.01 OUTLIER Glycine 0 C--N 1.345 1.053 0 C-N-CA 121.674 -0.298 . . . . 53.42 113.211 177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.3 t -161.96 156.97 23.04 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 122.946 0.499 . . . . 73.31 110.338 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -161.82 102.89 1.17 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.11 -1.07 . . . . 73.32 108.11 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -67.43 114.77 6.37 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.638 0.775 . . . . 74.44 111.672 -170.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -114.87 127.32 55.64 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.492 -1.299 . . . . 63.15 107.492 168.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -66.97 85.66 0.13 Allowed 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.961 0.886 . . . . 73.43 111.118 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -92.54 125.77 37.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.862 -1.063 . . . . 73.14 109.474 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 C-N-CA 123.653 0.781 . . . . 73.33 109.822 -176.358 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.504 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 108.44 -0.948 . . . . 74.54 108.44 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 28.8 p -141.68 81.21 1.76 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.13 0.572 . . . . 74.32 110.467 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -156.68 162.2 39.83 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.846 0.858 . . . . 75.01 109.325 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -157.05 162.82 39.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.394 0.678 . . . . 74.42 110.298 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -77.05 88.87 3.57 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.825 -0.805 . . . . 74.11 108.825 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -154.99 157.67 38.01 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.9 0.381 . . . . 71.12 110.92 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 38.9 p -63.97 -11.18 26.32 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.931 1.293 . . . . 74.22 112.214 174.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -55.55 -47.46 76.31 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.703 0.801 . . . . 73.23 110.935 169.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.544 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 19.7 ptm 53.8 177.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.174 1.79 . . . . 72.51 114.765 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 63.7 m -149.05 130.68 14.95 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.641 -1.163 . . . . 74.14 109.2 170.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -126.91 114.7 18.21 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.181 -1.415 . . . . 74.54 107.181 164.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.42 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -128.76 118.34 22.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.452 0.701 . . . . 75.52 109.268 -177.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 59.2 mt -77.77 116.48 21.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.902 -1.147 . . . . 65.24 107.902 169.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -85.72 -47.27 9.93 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.115 -0.698 . . . . 74.42 109.115 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -161.62 136.4 7.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.319 -0.855 . . . . 73.24 109.447 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 86.2 mt -115.89 140.76 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 106.392 -1.707 . . . . 71.25 106.392 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -166.3 171.18 12.37 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.392 0.615 . . . . 64.25 111.553 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.427 HG21 ' CD1' ' B' ' 21' ' ' ILE . 58.4 m -98.53 128.24 44.78 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.112 -0.949 . . . . 75.43 108.719 170.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.431 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 19.4 mtpp -86.96 -37.28 17.72 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.996 0.919 . . . . 75.13 109.465 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -151.93 139.45 19.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.178 -0.465 . . . . 75.44 112.059 -173.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.591 HD12 ' SG ' ' B' ' 113' ' ' CYS . 39.6 mm -124.24 141.1 45.57 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 124.965 1.306 . . . . 73.41 108.809 170.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.494 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.4 t -140.55 136.72 33.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.485 -1.234 . . . . 72.12 108.116 176.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.5 t80 -158.59 111.01 2.27 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 107.62 -1.252 . . . . 75.51 107.62 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -131.34 117.45 18.94 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.844 0.858 . . . . 73.14 109.269 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.481 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -109.94 85.83 4.42 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.166 0.987 . . . . 75.13 108.821 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.64 -32.38 24.23 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.759 2.306 . . . . 75.22 112.546 -170.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -108.9 8.41 26.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.535 0.734 . . . . 74.24 111.249 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.481 ' HB1' ' HB2' ' B' ' 25' ' ' ALA . . . -34.48 -65.25 0.26 Allowed Pre-proline 0 N--CA 1.503 2.204 0 C-N-CA 125.526 1.53 . . . . 74.52 114.852 -167.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -69.88 -19.41 35.58 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.284 1.99 . . . . 64.25 112.836 -168.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -95.48 -34.11 12.19 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.32 -0.854 . . . . 72.32 110.07 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.472 HG23 ' HA ' ' B' ' 73' ' ' ALA . 2.0 p -71.85 -24.29 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.859 0.464 . . . . 75.42 110.703 -173.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -67.62 -3.51 9.18 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.928 0.891 . . . . 73.25 112.989 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.56 -19.55 65.28 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 120.796 0.331 . . . . 75.45 110.294 170.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 86.3 mttt -105.35 92.74 4.33 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.581 1.153 . . . . 75.24 108.576 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.55 87.55 7.41 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.353 0.597 . . . . 75.32 110.221 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -165.43 159.08 16.6 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.803 1.241 . . . . 75.04 108.181 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.438 ' HG3' ' HB2' ' B' ' 124' ' ' PRO . 17.0 mp0 -59.5 110.65 2.9 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 123.852 0.861 . . . . 75.53 109.934 172.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.652 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.0 Cg_endo -60.24 140.71 93.48 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.908 2.405 . . . . 74.21 112.603 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -51.58 107.84 0.22 Allowed 'General case' 0 C--N 1.357 0.928 0 O-C-N 124.471 1.107 . . . . 71.41 110.561 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 31.3 m -87.5 155.04 3.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.157 -0.929 . . . . 65.02 111.454 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.61 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 48.9 tttp -139.39 107.69 5.8 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.308 -1.367 . . . . 72.44 107.308 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.26 124.37 33.8 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.502 -0.555 . . . . 74.14 109.502 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 23.6 t70 -130.18 154.45 47.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.242 1.417 . . . . 72.34 107.838 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.427 ' HB2' ' CD2' ' F' ' 462' ' ' TYR . 0.2 OUTLIER -142.71 147.29 35.4 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.701 -0.481 . . . . 63.23 109.701 -170.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 23.4 t70 -146.91 114.14 6.24 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.912 -0.773 . . . . 71.52 108.912 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.2 p -114.95 108.29 16.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.23 0.612 . . . . 73.13 110.697 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.16 162.65 17.14 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.827 1.251 . . . . 64.22 108.689 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.0 p -137.44 162.28 34.08 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.271 0.628 . . . . 71.12 109.468 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 97.8 p -150.41 136.48 18.55 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.855 0.462 . . . . 75.13 110.199 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -87.02 110.41 20.04 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.311 -0.626 . . . . 71.12 109.311 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 27.5 mt -82.42 -41.94 19.23 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.908 -0.587 . . . . 72.31 109.669 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.73 -172.31 4.01 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.51 -1.223 . . . . 75.3 110.303 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.03 105.52 0.41 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.782 -1.099 . . . . 73.14 110.723 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 66.76 16.43 10.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.952 1.301 . . . . 75.51 112.322 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -105.49 110.05 29.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.765 -1.198 . . . . 74.42 107.765 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.52 140.23 52.48 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.508 0.67 . . . . 75.34 109.675 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -116.04 104.11 11.24 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.356 -1.35 . . . . 74.11 107.356 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 90.8 t -85.4 139.68 17.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 CA-C-N 114.632 -1.167 . . . . 75.23 109.635 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.83 120.04 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 123.585 0.754 . . . . 74.12 109.116 -176.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.42 106.29 16.62 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.78 -1.193 . . . . 71.32 107.78 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.586 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 34.6 ttm180 -98.87 118.81 36.46 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.157 0.583 . . . . 74.04 109.616 170.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.588 ' HB ' HD11 ' B' ' 114' ' ' ILE . 29.3 t -107.84 108.64 25.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.621 -1.251 . . . . 73.0 107.621 169.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 41.7 m -97.11 122.57 40.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.519 -0.549 . . . . 64.3 109.519 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.655 HG22 HG21 ' B' ' 114' ' ' ILE . 79.5 t -115.83 103.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 124.046 0.939 . . . . 63.22 110.111 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 99.7 m -91.23 145.09 24.95 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.559 -0.904 . . . . 71.32 108.559 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -145.85 148.73 33.19 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.463 0.305 . . . . 62.35 111.027 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.1 p -153.41 130.62 11.18 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.808 -0.633 . . . . 64.22 110.801 -175.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.652 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 35.0 mt -98.68 112.73 24.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.924 0.89 . . . . 75.01 108.978 175.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.48 -114.54 6.96 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 115.211 -0.904 . . . . 72.22 112.342 -172.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -109.09 11.65 25.57 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.226 0.611 . . . . 71.45 112.282 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.416 ' HG3' HG21 ' B' ' 31' ' ' VAL . 12.7 pt-20 -128.29 150.14 50.19 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.199 0.6 . . . . 74.41 110.079 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 37.5 m -66.38 135.19 53.98 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.474 0.484 . . . . 62.25 110.594 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.472 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -91.16 -62.32 1.47 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.283 -1.006 . . . . 74.1 108.283 174.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -151.4 162.88 40.16 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.202 -0.908 . . . . 74.42 110.17 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -132.91 109.35 9.53 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.976 -1.491 . . . . 75.42 106.976 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 51.2 t -118.3 156.43 28.89 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.69 0.796 . . . . 73.32 109.267 -174.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.0 tt0 -165.81 139.87 4.53 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.7 -0.852 . . . . 64.14 108.7 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 72.3 t -131.67 141.66 45.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.656 -1.239 . . . . 74.41 107.656 172.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -122.31 87.62 2.78 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.753 -0.832 . . . . 74.42 108.753 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.34 99.48 7.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.551 -0.75 . . . . 73.4 109.014 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.431 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.97 144.29 16.55 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.635 -0.986 . . . . 73.2 110.635 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.42 130.43 4.1 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.491 -0.644 . . . . 75.25 111.491 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.0 mt -85.15 125.77 40.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 123.945 0.898 . . . . 74.43 109.208 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -136.54 135.45 38.49 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.29 1.036 . . . . 64.22 108.565 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 41.9 m -101.99 106.6 17.54 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.802 -0.814 . . . . 62.33 108.802 176.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.429 HG23 ' SG ' ' B' ' 97' ' ' CYS . 31.2 pt -110.66 125.15 67.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.776 0.83 . . . . 74.14 109.906 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.45 162.06 41.65 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.753 0.821 . . . . 73.53 109.331 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.18 -47.8 3.9 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.476 0.485 . . . . 75.31 112.636 -177.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 31.1 pt -70.18 152.28 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.838 0.855 . . . . 75.34 110.644 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -162.85 163.86 26.29 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.363 0.665 . . . . 74.31 109.96 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.4 -113.65 3.71 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.438 0.461 . . . . 71.4 112.407 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 87.7 m -84.97 -26.74 26.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.182 0.515 . . . . 72.31 110.745 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -73.43 -28.89 62.22 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.831 -0.622 . . . . 75.22 110.663 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.512 ' SD ' HG21 ' F' ' 452' ' ' VAL . 0.0 OUTLIER -72.7 -33.75 66.68 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 109.589 -0.522 . . . . 72.45 109.589 173.234 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.55 -39.08 84.96 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.905 0.882 . . . . 71.02 110.891 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -62.65 -31.23 72.06 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.681 -1.145 . . . . 74.24 110.808 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.429 ' SG ' HG23 ' B' ' 86' ' ' ILE . 25.2 t -72.06 -66.35 0.66 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.924 -0.58 . . . . 60.4 110.367 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.423 HD12 ' N ' ' B' ' 99' ' ' GLY . 1.6 pp -68.93 -26.74 65.23 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.589 0.959 . . . . 75.22 113.589 -171.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . 0.423 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -104.56 3.05 42.55 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-O 119.52 -0.6 . . . . 74.22 114.242 -171.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.86 -61.16 0.18 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 117.429 0.615 . . . . 71.31 111.176 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.426 ' HH ' ' HB2' ' D' ' 130' ' ' PRO . 52.9 t80 -66.92 -52.38 43.82 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.338 1.055 . . . . 75.35 111.908 -169.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 92.6 m -62.34 -50.38 79.68 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.371 1.068 . . . . 73.53 111.788 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.36 -36.65 97.4 Favored 'Trans proline' 0 C--N 1.401 3.305 0 C-N-CA 122.045 1.83 . . . . 73.43 113.295 170.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -66.59 -29.56 69.64 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.008 0.523 . . . . 75.44 111.004 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.423 HG22 ' NH2' ' D' ' 111' ' ' ARG . 93.0 mt -68.49 -45.51 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.87 0.868 . . . . 74.22 110.244 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 56.2 mt -76.39 -20.93 56.66 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.975 -1.011 . . . . 74.03 111.833 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -59.91 -48.79 93.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-O 117.661 -1.162 . . . . 73.0 113.419 -171.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -56.36 -38.69 94.73 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.124 1.882 . . . . 74.4 113.231 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -66.83 -47.64 71.38 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.158 0.583 . . . . 75.33 110.335 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.404 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -59.81 -40.27 87.81 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.593 0.757 . . . . 74.14 110.656 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.539 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 36.0 ttt180 -61.75 -52.3 64.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.334 1.454 . . . . 75.23 111.138 -176.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.74 -37.74 88.5 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.958 0.786 . . . . 62.22 109.916 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.591 ' SG ' HD12 ' B' ' 21' ' ' ILE . 5.1 t -67.38 -38.31 84.55 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.656 0.598 . . . . 75.42 111.796 -173.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.655 HG21 HG22 ' B' ' 64' ' ' VAL . 61.1 mt -66.74 -51.47 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 109.388 -0.597 . . . . 74.51 109.388 176.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.451 HG22 ' OG ' ' C' ' 119' ' ' SER . 88.9 m -54.91 -37.74 66.74 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.898 1.374 . . . . 75.52 110.848 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 46.7 t -63.43 -44.19 95.27 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 115.361 -0.836 . . . . 74.24 110.018 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 30.7 mmt -62.91 -43.07 99.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.337 0.398 . . . . 73.53 110.93 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.5 HG23 ' O ' ' B' ' 114' ' ' ILE . 48.4 t -58.96 -47.16 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.242 1.017 . . . . 71.44 109.605 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.522 ' HB3' HG21 ' C' ' 115' ' ' THR . 71.8 m -65.49 -34.54 78.51 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.261 -1.336 . . . . 70.15 112.062 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -68.87 -35.0 76.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.395 -0.821 . . . . 75.55 110.093 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -86.99 10.99 66.15 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 124.135 0.897 . . . . 52.51 112.957 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 67.0 p 56.74 23.61 8.12 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.992 1.717 . . . . 52.32 113.628 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.47 149.99 62.44 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 122.797 0.439 . . . . 64.12 109.996 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.438 ' HB2' ' HG3' ' B' ' 37' ' ' GLN . 51.2 Cg_exo -55.29 164.76 3.57 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.736 2.958 . . . . 74.51 114.906 -177.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -57.73 121.39 10.32 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.308 1.043 . . . . 71.23 112.895 -166.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.611 ' HG ' HD13 ' F' ' 468' ' ' LEU . 9.5 tt -128.54 123.85 34.52 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.075 -1.083 . . . . 70.41 108.075 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -134.98 127.1 29.89 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.611 0.764 . . . . 74.12 109.004 172.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.539 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -68.79 137.74 54.24 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.483 0.713 . . . . 62.03 109.919 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.03 138.4 61.07 Favored Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 123.625 0.578 . . . . 63.14 110.576 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.04 122.98 7.52 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.881 2.387 . . . . 72.41 112.847 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 t -116.2 112.08 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.42 -0.956 . . . . 75.32 108.42 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -76.68 88.71 3.35 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.461 -0.94 . . . . 74.53 108.461 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -59.51 -37.8 79.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.093 -0.958 . . . . 73.42 112.345 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.22 -43.59 87.79 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.978 0.911 . . . . 73.23 112.688 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.03 -53.64 29.28 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.537 0.735 . . . . 71.12 110.725 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.0 -14.72 61.07 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.282 -0.872 . . . . 74.12 111.433 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.488 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 84.2 t80 -71.67 -42.95 66.86 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.396 0.435 . . . . 74.44 109.937 173.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 61.9 mtt -62.16 -33.78 75.15 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.024 0.53 . . . . 75.01 110.601 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -79.38 -25.7 42.11 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.582 -0.735 . . . . 72.22 111.272 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . 0.463 ' HH ' ' HB2' ' F' ' 459' ' ' ASP . 62.8 t80 -64.03 -28.5 69.84 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.289 0.636 . . . . 75.02 111.334 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 17.5 mt -83.56 5.83 22.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.478 0.711 . . . . 74.33 111.453 -174.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -143.78 153.34 42.31 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.386 1.074 . . . . 75.25 108.819 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -89.46 11.75 18.44 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.735 0.414 . . . . 72.53 111.598 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -113.37 151.85 30.74 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.505 0.722 . . . . 74.23 109.89 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.98 160.22 43.0 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.645 0.778 . . . . 64.34 110.226 -177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.95 171.78 28.95 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.745 -0.661 . . . . 74.45 112.589 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -152.66 102.22 2.69 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.569 -0.9 . . . . 73.31 108.569 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -134.46 52.23 0.81 Allowed Glycine 0 CA--C 1.504 -0.628 0 N-CA-C 109.661 -1.376 . . . . 73.35 109.661 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 1.8 m -118.76 30.54 7.13 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.638 -0.781 . . . . 75.31 109.839 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.82 174.65 11.12 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.879 -0.6 . . . . 62.04 109.783 175.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.32 133.43 35.23 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.288 0.565 . . . . 70.54 110.475 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -163.51 137.64 5.92 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.7 1.2 . . . . 75.01 108.428 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -129.18 117.92 21.56 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.25 0.62 . . . . 74.32 110.087 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -143.7 99.17 3.36 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.802 0.841 . . . . 74.44 109.217 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . 0.4 ' HA ' ' NE2' ' D' ' 50' ' ' GLN . . . . . . . . 0 C--O 1.256 1.415 0 C-N-CA 123.675 0.79 . . . . 72.33 109.745 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.77 -0.456 . . . . 74.54 109.77 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m 72.63 20.42 3.8 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.369 1.467 . . . . 74.42 111.808 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.35 102.32 6.72 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.895 0.878 . . . . 73.33 110.546 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -140.45 116.68 10.59 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.652 0.781 . . . . 74.32 109.397 168.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -103.58 120.87 41.74 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.131 0.972 . . . . 73.14 108.873 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -76.74 86.78 3.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.851 -0.796 . . . . 71.12 108.851 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 37.7 p -65.07 -29.28 70.16 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.99 0.916 . . . . 72.55 112.049 -174.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.69 77.95 4.2 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.63 0.772 . . . . 75.12 109.634 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.413 ' HE1' ' HB2' ' C' ' 11' ' ' PHE . 27.6 ttt 65.42 111.73 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 126.13 1.772 . . . . 71.32 112.299 -173.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 28.5 m -103.69 96.58 6.81 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.632 -1.247 . . . . 74.31 107.632 170.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.413 ' HB2' ' HE1' ' C' ' 9' ' ' MET . 53.1 t80 -97.44 128.45 44.24 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.491 -0.929 . . . . 74.33 108.491 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.4 ' HB3' ' HG ' ' C' ' 85' ' ' SER . 27.5 tt0 -153.88 125.74 7.74 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.18 0.592 . . . . 65.21 109.723 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 50.1 mt -75.75 132.57 32.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.857 -0.794 . . . . 75.23 108.857 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.503 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 26.0 mm-40 -101.11 -39.52 7.64 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.593 0.757 . . . . 74.53 109.899 174.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -169.67 146.62 3.32 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.526 -0.546 . . . . 71.22 109.526 -172.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 89.8 mt -137.03 134.08 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.143 -1.058 . . . . 74.22 108.143 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.403 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 43.4 p90 -170.85 164.29 7.81 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.155 0.502 . . . . 74.24 110.904 -167.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -87.26 114.53 23.96 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.328 -0.851 . . . . 64.54 108.855 173.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.403 ' HD2' ' HE2' ' C' ' 17' ' ' TYR . 19.2 mmmt -64.02 -39.89 95.12 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.915 0.864 . . . . 75.13 109.139 172.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -160.4 144.98 14.38 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 113.696 -1.593 . . . . 75.22 108.349 -172.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 88.9 mt -133.78 146.99 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.585 -1.265 . . . . 73.41 107.585 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.8 t -151.92 149.76 29.29 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.471 0.653 . . . . 63.55 110.267 172.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 82.7 t80 -150.75 117.85 5.94 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 107.275 -1.38 . . . . 73.01 107.275 173.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.97 111.99 17.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.512 0.725 . . . . 75.53 109.882 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.88 82.34 60.94 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.25 -1.019 . . . . 64.12 108.25 169.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -65.17 -25.78 57.73 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.013 2.476 . . . . 75.32 112.712 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -102.31 13.02 35.73 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.154 0.982 . . . . 73.23 110.605 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.511 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -45.18 -58.42 5.74 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 114.703 1.371 . . . . 74.11 114.703 -165.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.522 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 23.5 Cg_endo -60.04 -43.22 37.78 Favored 'Trans proline' 0 C--N 1.383 2.382 0 CA-C-N 122.129 1.796 . . . . 74.22 111.817 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -71.67 -28.42 63.73 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.963 0.905 . . . . 75.35 112.674 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.701 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.7 p -80.25 -22.26 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.57 0.348 . . . . 72.44 111.567 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -72.91 -21.24 60.93 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.005 0.522 . . . . 74.24 111.783 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -102.1 6.5 40.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.734 0.814 . . . . 74.11 110.906 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.796 ' HG2' HD12 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -83.77 161.53 20.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.444 0.698 . . . . 74.52 110.546 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.428 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 7.2 m-20 -57.76 112.27 1.41 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.32 1.048 . . . . 74.33 109.646 168.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -73.57 88.45 1.67 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.028 0.531 . . . . 73.12 110.553 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -150.16 74.22 9.15 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.393 -0.966 . . . . 71.54 108.393 169.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.542 ' HD2' HD23 ' G' ' 470' ' ' LEU . 9.5 Cg_exo -74.57 164.48 33.74 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.75 2.3 . . . . 74.22 112.87 173.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -115.8 94.38 4.66 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.374 -1.714 . . . . 74.14 106.374 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 90.9 t -73.38 98.4 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.548 -0.751 . . . . 73.44 109.256 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -101.5 107.39 18.68 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.912 -1.144 . . . . 73.12 107.912 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.07 138.48 31.41 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.273 0.559 . . . . 74.11 111.282 -174.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.561 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.2 t70 -130.74 132.86 45.58 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.11 1.364 . . . . 63.14 108.614 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.408 HD11 HG13 ' C' ' 131' ' ' VAL . 52.0 mt -123.05 131.9 53.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.845 -1.169 . . . . 74.45 107.845 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.524 ' HA ' ' HG ' ' G' ' 460' ' ' LEU . 19.2 t70 -144.4 144.58 31.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.322 0.649 . . . . 71.35 109.421 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -151.48 153.41 34.57 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 122.898 0.479 . . . . 55.33 110.101 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.95 168.86 24.97 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.432 -0.804 . . . . 61.11 109.564 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.4 p -129.9 151.22 50.7 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.882 0.873 . . . . 75.4 109.499 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 80.7 p -143.68 128.13 17.94 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.373 1.069 . . . . 73.1 108.197 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -76.94 116.43 17.6 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.36 -0.607 . . . . 72.33 109.36 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.53 HD13 HD13 ' C' ' 83' ' ' ILE . 75.3 mt -89.64 -39.7 13.05 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.0 -0.741 . . . . 63.04 109.0 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 -175.49 5.43 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.646 -1.161 . . . . 71.53 110.432 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.24 116.93 5.9 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.661 -1.154 . . . . 71.33 109.85 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 61.97 20.11 11.28 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.369 1.068 . . . . 63.53 112.136 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.8 t -119.72 116.43 50.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.535 -0.913 . . . . 74.13 108.535 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.617 ' HE2' ' HB ' ' G' ' 452' ' ' VAL . 0.6 OUTLIER -125.38 125.9 44.15 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.077 0.951 . . . . 74.3 109.059 -179.263 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -83.6 132.55 34.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.911 -1.144 . . . . 75.44 107.911 164.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 56.1 t -112.43 139.71 35.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.088 -1.078 . . . . 74.42 108.088 166.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -121.44 124.88 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.792 -0.818 . . . . 65.23 108.792 171.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.481 HD11 ' HA ' ' C' ' 107' ' ' PHE . 1.1 tm? -104.42 106.09 16.45 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.712 -1.218 . . . . 74.54 107.712 172.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.496 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 0.8 OUTLIER -101.16 115.13 29.78 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.72 -1.127 . . . . 74.2 109.492 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.543 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.7 t -101.91 134.95 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.375 -0.972 . . . . 61.42 108.375 174.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -121.87 136.88 54.95 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.665 -0.865 . . . . 72.23 108.665 172.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.454 HG12 HD12 ' C' ' 126' ' ' LEU . 46.5 t -127.83 118.37 48.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 123.655 0.782 . . . . 73.32 109.329 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.2 m -102.53 144.63 30.71 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.011 -0.737 . . . . 64.43 109.011 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.17 114.22 9.0 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.391 -0.966 . . . . 71.33 108.391 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -131.2 142.33 50.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.413 0.685 . . . . 73.21 109.868 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.796 HD12 ' HG2' ' C' ' 34' ' ' LYS . 4.7 mt -94.34 16.81 14.14 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.949 1.3 . . . . 75.43 110.779 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.27 -87.71 0.35 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.78 -1.328 . . . . 62.41 109.78 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.53 -26.68 8.93 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.133 0.973 . . . . 72.44 110.567 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -82.77 119.0 23.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.707 0.803 . . . . 71.01 109.344 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -73.83 127.14 32.03 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.601 -0.518 . . . . 72.31 109.601 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.701 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.13 -54.76 7.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.162 -0.681 . . . . 64.33 109.162 173.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -169.28 173.39 6.69 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.335 -0.848 . . . . 74.23 110.924 176.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -142.82 112.8 7.04 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.22 -1.4 . . . . 72.53 107.22 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -108.1 145.76 33.62 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.515 -0.92 . . . . 74.44 108.515 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -153.86 134.15 13.39 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.895 -0.78 . . . . 62.33 108.895 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 64.8 t -132.41 115.34 25.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.013 0.925 . . . . 75.41 108.898 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.496 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 57.8 mt-30 -93.53 89.9 6.46 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.32 -0.993 . . . . 71.22 108.32 174.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.7 102.16 13.96 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.152 0.581 . . . . 75.21 110.121 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.84 167.59 44.31 Favored Glycine 0 C--O 1.24 0.531 0 CA-C-O 121.175 0.319 . . . . 74.43 112.699 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.39 119.57 0.81 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.155 -0.778 . . . . 65.02 111.155 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.56 HD11 ' HB3' ' D' ' 29' ' ' PRO . 12.0 mm -82.9 132.35 31.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 109.129 -0.693 . . . . 74.43 109.129 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -134.28 119.89 19.28 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.322 0.649 . . . . 73.42 109.678 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.4 ' HG ' ' HB3' ' C' ' 12' ' ' GLN . 13.1 p -82.14 102.04 10.81 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.17 -1.048 . . . . 75.33 108.17 171.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' C' ' 10' ' ' THR . 2.5 pp -121.74 126.4 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 123.689 0.796 . . . . 74.32 110.982 -173.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.41 156.52 46.53 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.658 0.783 . . . . 65.34 109.899 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.42 -26.13 17.22 Favored Glycine 0 N--CA 1.476 1.314 0 N-CA-C 114.329 0.492 . . . . 71.12 114.329 172.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.563 HD11 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -87.28 145.81 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.056 0.543 . . . . 73.23 110.523 178.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.48 170.27 18.41 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.109 -0.95 . . . . 63.51 108.601 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.22 -119.27 6.86 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 124.118 0.887 . . . . 61.11 115.042 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 1.6 m -71.66 -32.35 67.79 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.641 1.176 . . . . 71.03 111.122 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -65.58 -43.16 90.64 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.466 0.707 . . . . 70.22 109.883 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.677 ' SD ' ' HA ' ' G' ' 452' ' ' VAL . 37.1 ttp -68.11 -40.73 82.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.17 -0.923 . . . . 74.41 110.593 175.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.8 -42.78 76.11 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 124.315 1.009 . . . . 64.23 110.697 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -83.14 -35.62 25.43 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.612 0.57 . . . . 74.14 111.956 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -58.0 -42.31 84.93 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.897 0.748 . . . . 73.53 110.62 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 21.9 mt -98.43 -24.91 14.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.266 -0.879 . . . . 72.53 110.686 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.61 -21.36 79.51 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.471 0.482 . . . . 55.45 114.174 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -158.26 -42.79 0.06 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.722 1.008 . . . . 75.45 113.722 -167.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.86 -46.63 74.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.915 0.486 . . . . 72.52 111.212 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.46 -49.06 54.3 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 124.254 1.022 . . . . 75.33 111.994 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -52.12 -34.44 58.15 Favored 'Trans proline' 0 C--N 1.399 3.186 0 C-N-CA 123.156 2.571 . . . . 72.14 114.654 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -60.23 -34.03 73.1 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.837 0.855 . . . . 71.11 111.722 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.488 HD13 ' NH1' ' A' ' 111' ' ' ARG . 47.9 mm -70.4 -37.33 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.183 0.593 . . . . 73.05 110.189 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 53.1 mt -87.73 -24.79 23.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.035 0.934 . . . . 74.02 112.587 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.481 ' HA ' HD11 ' C' ' 60' ' ' LEU . 63.7 t80 -56.63 -48.74 96.64 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 117.812 -1.089 . . . . 74.3 113.853 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -55.33 -38.03 94.12 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 122.388 2.059 . . . . 72.21 113.234 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -67.25 -46.29 74.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.696 0.798 . . . . 74.02 110.467 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.433 ' O ' HG13 ' C' ' 114' ' ' ILE . . . -63.14 -38.99 93.35 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.669 -0.696 . . . . 74.35 110.878 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -57.25 -49.41 76.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.731 1.212 . . . . 73.31 111.079 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.63 -37.6 82.71 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 123.603 0.564 . . . . 60.33 110.084 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.3 t -68.18 -29.58 68.48 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.087 0.555 . . . . 73.05 111.443 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.543 HD11 ' HB ' ' C' ' 62' ' ' VAL . 74.1 mt -71.28 -50.45 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 108.949 -0.76 . . . . 71.3 108.949 172.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.522 HG21 ' HB3' ' B' ' 119' ' ' SER . 23.2 m -58.64 -35.12 72.01 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.679 0.792 . . . . 64.11 111.179 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.0 t -67.0 -54.14 24.63 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 123.813 0.845 . . . . 75.21 109.124 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.659 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.24 -38.71 80.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.487 1.115 . . . . 75.35 112.89 -177.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.98 -46.28 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.75 0.82 . . . . 73.44 110.165 177.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.451 ' OG ' HG22 ' B' ' 115' ' ' THR . 45.1 t -71.12 -24.12 62.22 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.617 -0.72 . . . . 73.14 111.582 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -69.44 -44.08 72.01 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.546 -0.909 . . . . 72.3 108.546 173.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.67 -1.59 72.34 Favored Glycine 0 C--N 1.357 1.744 0 O-C-N 123.712 0.632 . . . . 74.32 112.901 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.477 HG21 ' HB3' ' D' ' 17' ' ' TYR . 26.7 p 60.65 37.2 19.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.656 1.982 . . . . 72.44 113.359 173.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -89.37 162.75 36.06 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-N 115.199 -0.909 . . . . 72.2 108.702 166.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.27 167.59 7.5 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.88 2.387 . . . . 75.44 113.301 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -51.66 131.69 30.19 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.706 1.202 . . . . 73.43 112.836 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.454 HD12 HG12 ' C' ' 64' ' ' VAL . 3.8 tt -136.3 85.08 2.12 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.306 -0.861 . . . . 64.3 108.918 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . 0.469 ' H ' HD23 ' G' ' 468' ' ' LEU . 14.2 m120 -95.48 124.22 39.41 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.818 -1.179 . . . . 64.15 107.818 171.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.05 134.9 47.44 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 108.487 -0.931 . . . . 71.42 108.487 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' G' ' 467' ' ' ALA . . . -57.5 152.39 34.32 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.311 1.044 . . . . 75.54 112.19 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.487 ' HG3' HD13 ' A' ' 16' ' ' ILE . 35.7 Cg_exo -56.33 92.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 122.566 2.177 . . . . 73.21 112.407 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.408 HG13 HD11 ' C' ' 44' ' ' LEU . 54.8 t -98.57 109.86 24.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 108.833 -0.803 . . . . 74.14 108.833 177.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -93.44 88.54 5.98 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.124 -1.436 . . . . 74.23 107.124 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -58.07 -32.79 68.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.495 0.718 . . . . 73.24 110.647 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.511 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 16.0 t70 -61.0 -39.03 88.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.878 0.871 . . . . 64.52 111.395 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.2 -39.22 71.91 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.244 0.617 . . . . 72.34 110.948 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 97.2 mt -67.79 -33.82 75.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.814 0.845 . . . . 72.43 112.232 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -74.3 -16.29 60.93 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.434 0.294 . . . . 74.14 110.994 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 91.4 mtp -73.27 -30.22 63.29 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.525 0.33 . . . . 73.2 111.003 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -71.35 -35.76 71.27 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 110.012 -0.366 . . . . 74.33 110.012 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.443 ' OH ' ' HA ' ' G' ' 458' ' ' THR . 75.5 t80 -71.51 -84.93 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 123.676 0.79 . . . . 74.3 110.129 169.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 23.0 tp 70.45 -77.1 0.06 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.819 1.648 . . . . 75.13 111.146 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -153.48 -67.49 0.15 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.554 0.742 . . . . 71.43 109.342 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -108.94 22.02 16.46 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.816 0.847 . . . . 75.22 109.848 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . 0.281 0.7 OUTLIER 58.21 163.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 127.114 2.166 . . . . 65.31 115.461 179.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -163.2 162.94 25.67 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.076 1.35 . . . . 54.21 109.352 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.17 65.5 0.01 OUTLIER Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.512 -0.635 . . . . 73.44 111.512 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.89 173.41 11.54 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.948 0.899 . . . . 75.22 110.715 -176.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 123.51 -168.87 15.67 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.607 -0.724 . . . . 73.12 111.773 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 14.0 t -137.59 173.56 11.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.758 0.823 . . . . 74.02 109.303 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -146.13 156.56 43.52 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.101 0.561 . . . . 72.52 111.131 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -162.22 150.09 14.4 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.351 1.06 . . . . 73.21 108.715 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . 0.458 ' CD2' ' HB2' ' C' ' 154' ' ' ASP . 18.5 t60 -167.15 96.5 0.5 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.633 -0.506 . . . . 63.21 109.633 -176.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -98.97 86.25 3.43 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 122.07 0.938 . . . . 74.03 108.49 170.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . 0.458 ' HB2' ' CD2' ' C' ' 152' ' ' HIS . 12.4 t70 -78.01 155.93 30.43 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.369 -0.832 . . . . 71.25 110.916 -172.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . 0.467 ' HB2' HG13 ' E' ' 451' ' ' VAL . . . . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.262 -0.875 . . . . 74.32 109.869 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.805 -0.443 . . . . 74.21 109.805 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 41.5 m -136.57 161.36 36.11 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.323 1.049 . . . . 63.42 109.035 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.01 167.54 23.76 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.94 0.896 . . . . 73.52 109.963 -175.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -68.85 139.92 55.2 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.441 0.697 . . . . 75.15 110.869 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -89.22 79.94 7.0 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.873 0.844 . . . . 72.24 109.726 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -59.84 112.01 1.68 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.089 -0.96 . . . . 64.21 108.886 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.8 m -143.28 114.79 8.04 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 122.412 0.285 . . . . 74.44 110.701 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -84.55 133.09 34.45 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 105.387 -2.079 . . . . 61.21 105.387 151.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 4.9 ttp -29.54 122.78 0.15 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 125.101 1.501 . . . . 62.0 113.503 -173.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.1 m -111.55 146.49 37.24 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.845 -0.798 . . . . 74.23 108.845 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -165.81 92.08 0.51 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.479 -1.304 . . . . 73.35 107.479 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -123.32 117.16 24.61 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.277 -1.379 . . . . 74.03 107.277 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.442 HG21 HD13 ' D' ' 16' ' ' ILE . 27.8 mt -65.89 117.28 6.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.511 0 N-CA-C 108.798 -0.815 . . . . 74.45 108.798 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -83.79 -32.94 25.1 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 123.628 0.58 . . . . 72.21 111.111 -170.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -178.73 129.05 0.11 Allowed 'General case' 0 C--N 1.363 1.188 0 O-C-N 123.032 0.207 . . . . 73.44 110.705 -167.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.442 HD13 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -108.53 136.06 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.313 -1.365 . . . . 62.21 107.313 166.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.477 ' HB3' HG21 ' C' ' 122' ' ' THR . 29.9 p90 -158.7 162.91 37.22 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.972 0.795 . . . . 75.33 111.055 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 56.9 p -97.8 114.39 26.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.033 -0.985 . . . . 62.24 109.442 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.522 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.5 mtpt -80.13 -22.85 41.62 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.592 -0.731 . . . . 75.43 109.786 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.2 t70 -163.04 139.49 7.27 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.755 -1.111 . . . . 73.33 109.236 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.659 HG21 ' HE1' ' C' ' 117' ' ' MET . 77.3 mt -134.9 146.67 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.565 1.146 . . . . 70.42 108.539 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -146.34 125.2 12.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.706 0.802 . . . . 74.54 109.801 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.478 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 80.7 t80 -123.85 132.65 53.8 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 106.889 -1.522 . . . . 75.44 106.889 163.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 41.6 mt-10 -131.82 134.9 46.29 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.033 -0.729 . . . . 72.33 109.033 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.73 82.29 68.98 Favored Pre-proline 0 C--O 1.242 0.703 0 N-CA-C 106.076 -1.824 . . . . 74.45 106.076 168.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.57 -36.02 35.49 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.515 2.143 . . . . 75.22 111.751 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.429 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 48.9 m-20 -105.76 11.21 32.3 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.106 0.962 . . . . 74.11 110.684 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.424 ' O ' HG11 ' D' ' 31' ' ' VAL . . . -18.53 -72.65 0.02 OUTLIER Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 116.287 1.958 . . . . 61.22 116.287 -166.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.56 ' HB3' HD11 ' C' ' 83' ' ' ILE . 49.1 Cg_endo -79.02 -16.42 12.52 Favored 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 123.771 2.383 . . . . 70.01 114.078 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.488 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 5.9 t-160 -76.45 -37.45 56.94 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.431 1.093 . . . . 74.51 109.793 174.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.721 HG22 ' HA ' ' D' ' 73' ' ' ALA . 7.4 p -83.51 -23.94 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 116.108 -0.496 . . . . 75.11 111.642 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -67.46 -18.16 64.97 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 122.537 0.335 . . . . 71.01 111.811 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.488 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 75.7 mt-30 -57.76 -29.66 64.98 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.303 1.041 . . . . 74.33 110.778 175.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -95.41 91.8 6.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.981 0.913 . . . . 73.43 109.279 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.56 70.92 10.35 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 122.531 1.157 . . . . 72.12 109.296 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -130.92 161.43 31.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.287 -1.324 . . . . 75.24 108.269 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.524 ' HB3' HD22 ' H' ' 470' ' ' LEU . 2.0 mp0 -66.99 107.9 2.04 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.121 0.968 . . . . 74.33 109.411 174.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.44 ' HB2' ' HB3' ' D' ' 66' ' ' ALA . 35.5 Cg_exo -61.72 122.33 10.86 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.206 2.604 . . . . 74.32 112.667 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 40.8 tt0 -57.0 114.94 2.33 Favored 'General case' 0 C--N 1.359 0.995 0 O-C-N 124.092 0.87 . . . . 74.05 110.025 -177.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.486 HG13 HD13 ' H' ' 468' ' ' LEU . 7.6 p -98.3 135.27 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.525 0.73 . . . . 73.44 111.556 -170.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -114.19 132.63 56.03 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 106.975 -1.491 . . . . 72.55 106.975 170.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.87 129.59 55.07 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.086 0.554 . . . . 72.0 110.161 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 17.5 t70 -112.92 128.83 56.58 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.634 1.174 . . . . 72.24 108.864 173.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 41.2 tp -98.92 133.45 43.19 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.542 -0.54 . . . . 71.11 109.542 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.3 t0 -153.52 155.8 36.89 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.734 -1.209 . . . . 55.24 107.734 174.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.636 HG21 ' HB2' ' H' ' 456' ' ' ASP . 13.7 t -145.96 169.27 18.96 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 122.909 0.484 . . . . 74.23 110.116 -177.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.565 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -156.05 166.56 33.11 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.711 1.204 . . . . 74.42 108.521 173.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.402 ' HB2' ' CE2' ' D' ' 56' ' ' TYR . 64.9 p -173.25 153.24 2.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.885 0.474 . . . . 64.45 111.058 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 45.5 p -168.78 143.29 3.18 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.317 1.047 . . . . 73.43 109.654 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.4 ' NE2' ' HA ' ' B' ' 155' ' ' ALA . 61.4 tt0 -83.8 125.25 31.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.137 0.575 . . . . 74.4 110.333 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.0 mt -96.13 -35.36 11.36 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.266 0.626 . . . . 72.12 111.298 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.12 -177.21 6.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.064 0.545 . . . . 74.11 110.71 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.37 120.25 8.41 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 123.91 0.756 . . . . 72.25 109.914 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.54 3.52 1.5 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.114 1.366 . . . . 75.41 112.521 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -109.78 119.45 58.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.141 -1.059 . . . . 74.34 108.141 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.402 ' CE2' ' HB2' ' D' ' 48' ' ' SER . 28.6 t80 -134.41 131.24 37.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.407 -0.815 . . . . 75.34 108.969 -173.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.448 ' HB2' HD11 ' D' ' 51' ' ' LEU . 17.3 tt0 -96.64 132.26 42.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.625 -0.716 . . . . 64.14 109.189 173.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.437 HG12 ' HD3' ' D' ' 103' ' ' PRO . 64.0 t -116.6 125.46 73.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.225 -1.398 . . . . 74.32 107.225 167.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.565 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 44.1 t -102.64 138.54 26.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.862 -0.792 . . . . 72.21 108.862 172.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.2 127.23 54.05 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.619 -1.252 . . . . 72.43 107.619 170.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.495 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 3.9 tmm_? -111.42 95.95 5.82 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.831 -1.174 . . . . 75.31 107.831 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 65.7 t -96.51 132.83 39.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.006 -0.997 . . . . 64.31 108.967 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 16.7 m -127.39 133.91 49.97 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.283 0.563 . . . . 74.14 109.502 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.02 102.41 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.534 1.533 . . . . 74.21 107.999 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 42.1 m -105.32 98.37 8.08 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.851 0.86 . . . . 63.11 109.448 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' D' ' 38' ' ' PRO . . . -104.72 149.86 25.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.856 0.462 . . . . 70.44 111.033 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.42 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 53.3 p -147.5 134.5 20.3 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.604 -0.725 . . . . 55.22 110.556 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.573 HD11 HG21 ' D' ' 31' ' ' VAL . 27.3 mt -98.76 110.94 23.46 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.308 -0.997 . . . . 73.54 108.308 174.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.76 -112.66 4.37 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 123.634 0.584 . . . . 73.25 112.812 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.94 16.8 16.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.407 1.083 . . . . 74.45 110.409 -172.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.429 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 12.8 pt-20 -141.22 155.33 46.05 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.466 0.706 . . . . 70.32 109.366 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -68.06 138.3 55.7 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 120.949 0.404 . . . . 64.33 110.527 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.721 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -89.96 -68.84 0.76 Allowed 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.535 -0.913 . . . . 74.33 108.535 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . 0.461 ' HZ ' HD13 ' D' ' 126' ' ' LEU . 50.2 p90 -152.96 149.24 28.0 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.61 -0.723 . . . . 73.22 110.252 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.6 mt -119.05 119.45 34.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.333 1.053 . . . . 73.52 108.234 175.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.451 ' SG ' ' HD1' ' D' ' 23' ' ' PHE . 1.3 m -121.9 104.92 9.89 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.167 0.987 . . . . 75.24 109.692 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -127.19 120.8 29.63 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.407 -0.96 . . . . 74.41 108.407 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -131.88 126.34 56.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 109.616 -0.512 . . . . 74.41 109.616 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.495 ' HG2' ' HG2' ' D' ' 61' ' ' ARG . 52.1 mt-30 -88.41 81.5 7.2 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.15 -1.056 . . . . 73.44 108.15 168.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.56 92.4 5.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.316 -1.311 . . . . 64.13 109.194 -178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.89 147.17 20.24 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.843 -0.617 . . . . 54.31 112.18 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.514 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -142.2 129.29 3.84 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 111.321 -0.712 . . . . 41.42 111.321 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.461 HG13 ' HE1' ' D' ' 17' ' ' TYR . 48.2 mt -93.78 140.47 16.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.066 0.946 . . . . 73.14 108.55 173.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -139.86 132.03 28.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.541 0.736 . . . . 72.21 109.018 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.6 m -87.5 94.91 9.84 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.633 -0.877 . . . . 75.42 108.633 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.601 HG23 HG11 ' H' ' 452' ' ' VAL . 2.3 tt -126.68 139.31 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 124.56 1.144 . . . . 75.3 110.103 -173.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.93 168.39 26.9 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.525 0.73 . . . . 70.34 111.752 -173.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.1 22.37 65.8 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 115.397 -0.819 . . . . 72.41 113.9 174.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.82 144.03 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.006 0.923 . . . . 75.24 110.665 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -142.64 161.88 36.93 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.856 0.862 . . . . 73.13 111.385 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.41 -122.39 29.67 Favored Glycine 0 C--N 1.355 1.597 0 O-C-N 124.606 1.191 . . . . 74.44 115.075 169.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.1 p -67.64 -26.18 66.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.807 0.843 . . . . 74.32 111.443 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -80.76 -38.68 28.18 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.193 0.597 . . . . 75.15 111.667 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 28.0 ptm -68.19 -34.61 76.6 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.471 -0.566 . . . . 74.42 109.471 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.74 -45.77 85.06 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.108 0.563 . . . . 64.22 110.245 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -60.35 -44.51 95.49 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.655 1.182 . . . . 75.33 111.658 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 16.2 t -76.14 -45.09 35.31 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.862 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.61 -33.28 28.0 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.335 0.495 . . . . 74.3 112.335 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.21 -0.04 54.26 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 119.542 -0.588 . . . . 75.14 113.994 -173.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' D' ' 134' ' ' ASP . . . -141.99 -61.11 0.46 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.45 0.625 . . . . 74.24 111.429 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . 0.438 ' O ' HG12 ' D' ' 105' ' ' ILE . 72.6 t80 -66.21 -41.03 90.69 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.879 0.472 . . . . 71.1 112.202 -174.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.44 -45.87 19.24 Favored Pre-proline 0 CA--C 1.559 1.31 0 CA-C-O 118.277 -0.868 . . . . 62.24 111.091 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.437 ' HD3' HG12 ' D' ' 58' ' ' VAL . 86.5 Cg_exo -53.27 -33.74 66.78 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 122.358 2.039 . . . . 65.41 113.438 166.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -67.28 -35.29 79.18 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.441 0.697 . . . . 73.0 110.038 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.438 HG12 ' O ' ' D' ' 101' ' ' TYR . 40.7 mm -70.34 -36.15 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.092 0.957 . . . . 75.32 110.733 174.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.514 HD22 ' HA3' ' D' ' 82' ' ' GLY . 96.5 mt -78.73 -21.09 48.58 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.851 0.86 . . . . 75.52 112.276 -176.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -66.77 -42.4 43.98 Favored Pre-proline 0 CA--C 1.562 1.414 0 CA-C-O 117.939 -1.029 . . . . 73.45 113.515 -172.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.44 -39.41 87.79 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 122.163 1.909 . . . . 73.41 113.133 170.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -74.8 -36.74 62.46 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.721 0.808 . . . . 71.44 111.872 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.85 73.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.222 -0.658 . . . . 73.04 109.222 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.423 ' NH2' HG22 ' B' ' 105' ' ' ILE . 38.6 ttp180 -57.47 -45.14 85.14 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 114.17 -1.377 . . . . 74.43 110.668 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.93 -51.76 62.94 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.944 0.778 . . . . 75.33 111.652 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -55.62 -40.71 72.49 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 123.822 0.701 . . . . 71.33 110.591 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.428 ' O ' HG23 ' D' ' 118' ' ' VAL . 54.9 mt -64.36 -53.5 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.836 1.254 . . . . 65.31 111.407 174.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.9 m -59.08 -36.77 75.66 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.356 1.062 . . . . 74.03 111.037 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -65.78 -44.32 86.14 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.885 -1.052 . . . . 74.23 109.842 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.478 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 66.0 mtm -69.34 -29.84 67.75 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.825 0.45 . . . . 75.52 111.9 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.0 t -64.36 -47.85 87.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.585 0.754 . . . . 74.21 110.049 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.5 p -69.71 -34.24 73.62 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.081 -0.509 . . . . 75.21 110.71 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -68.72 -33.05 73.28 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.637 0.775 . . . . 73.2 110.293 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.98 11.04 73.34 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.67 0.606 . . . . 74.05 112.636 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 63.9 p 57.33 32.16 21.31 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 126.044 1.738 . . . . 74.14 114.53 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -95.89 150.8 37.8 Favored Pre-proline 0 N--CA 1.478 0.941 0 N-CA-C 108.323 -0.991 . . . . 64.41 108.323 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -59.94 147.37 93.03 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.659 2.239 . . . . 54.31 111.375 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -60.25 142.12 55.04 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 124.05 0.844 . . . . 73.54 112.794 -166.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.461 HD13 ' HZ ' ' D' ' 74' ' ' PHE . 0.8 OUTLIER -122.81 104.73 9.47 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.4 1.08 . . . . 64.13 109.263 -175.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -124.3 95.06 4.4 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.698 0.799 . . . . 71.35 109.665 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.35 139.38 54.21 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.803 -0.443 . . . . 72.13 109.803 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.73 136.94 93.04 Favored Pre-proline 0 CA--C 1.549 0.936 0 O-C-N 123.815 0.697 . . . . 45.22 109.669 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.426 ' HB2' ' HH ' ' B' ' 101' ' ' TYR . 4.2 Cg_exo -68.09 133.01 27.59 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.271 1.981 . . . . 72.43 110.244 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.88 131.94 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.251 -0.648 . . . . 75.01 109.251 -170.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -77.64 89.81 3.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.745 -0.835 . . . . 73.34 108.745 172.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -64.01 -28.71 69.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.653 0.781 . . . . 63.53 111.297 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.425 ' HA ' ' HB2' ' D' ' 100' ' ' ALA . 2.0 m-20 -56.83 -55.88 28.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.295 1.438 . . . . 72.12 112.966 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.95 -47.23 87.39 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.279 0.632 . . . . 72.34 111.446 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 mp -66.31 -29.16 69.32 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.86 -1.064 . . . . 72.33 111.36 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.429 ' HD1' ' HE1' ' H' ' 461' ' ' PHE . 85.4 t80 -67.48 -38.99 85.21 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.038 0.935 . . . . 74.52 111.265 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 38.1 mtt -63.24 -37.41 87.13 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.621 -0.718 . . . . 72.35 110.112 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -65.31 -44.22 88.55 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.959 -1.019 . . . . 74.15 110.429 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -62.87 -36.33 82.92 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.136 0.975 . . . . 71.42 111.937 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.4 mp -67.41 -27.4 67.05 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.423 0.689 . . . . 73.15 111.644 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -84.0 9.63 11.91 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.357 0.663 . . . . 64.3 111.388 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -129.99 46.11 2.7 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.07 0.948 . . . . 74.24 109.943 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -162.42 121.53 2.27 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.565 0.746 . . . . 74.23 109.913 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.32 173.06 6.96 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.262 1.025 . . . . 63.31 110.233 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.67 122.57 0.92 Allowed Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.249 -0.741 . . . . 74.13 111.249 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -81.81 166.66 19.8 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.642 0.777 . . . . 75.51 110.659 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.8 159.24 52.6 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 115.939 -0.573 . . . . 70.44 113.431 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 41.3 m -112.04 98.72 7.54 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.963 0.905 . . . . 62.22 109.501 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.12 177.58 4.81 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.5 0.72 . . . . 65.53 110.318 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -135.05 170.6 15.66 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.264 1.026 . . . . 75.53 109.548 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -157.47 116.08 3.21 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.308 0.643 . . . . 74.33 109.781 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -75.38 105.68 6.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.19 0.596 . . . . 72.52 109.424 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.7 133.0 38.84 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.778 -0.823 . . . . 74.21 108.778 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.398 0 N-CA-C 109.033 -0.728 . . . . 70.22 109.033 177.783 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 53' ' ' ASP . 47.6 t30 . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.996 -0.372 . . . . 73.11 109.996 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' C' ' 155' ' ' ALA . 10.2 m -77.36 -26.44 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.37 0.605 . . . . 71.2 109.492 172.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 10.9 p -143.03 164.52 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 124.572 1.149 . . . . 74.12 108.722 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -144.41 151.42 23.47 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 111.261 -0.736 . . . . 72.11 111.261 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 67.6 mt -85.52 13.37 6.95 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.803 0.841 . . . . 70.13 113.159 -172.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 41.5 p -77.86 72.22 4.38 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 121.351 0.596 . . . . 72.44 110.701 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -170.12 157.27 6.34 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.893 1.277 . . . . 70.43 108.278 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 16.1 mp0 -97.96 149.71 22.13 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.241 0.616 . . . . 74.44 109.96 -173.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 59.1 m -123.06 -64.19 1.19 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.466 0.706 . . . . 64.35 110.209 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 30.1 t70 63.17 163.15 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.824 1.25 . . . . 75.22 112.422 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . 0.59 HD21 ' H ' ' A' ' 46' ' ' THR . 3.8 mm? -88.72 128.45 35.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.482 0.713 . . . . 74.42 110.099 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -123.85 16.17 9.38 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.704 1.202 . . . . 74.13 110.349 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -76.2 143.47 41.05 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.252 0.621 . . . . 75.41 110.001 -176.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 24.6 m -84.5 -75.31 0.35 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.806 -0.813 . . . . 65.13 108.806 174.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 464' ' ' MET . . . . . 0.482 ' HE2' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER 60.19 113.27 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.528 1.531 . . . . 73.32 112.353 -179.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -152.43 85.47 1.26 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.439 -0.949 . . . . 72.02 108.439 173.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -151.23 106.7 3.35 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.486 -0.779 . . . . 72.43 109.527 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -75.93 172.78 12.13 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.401 0.681 . . . . 74.52 110.496 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 3.1 pp -151.98 166.04 32.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.143 0.577 . . . . 75.33 110.656 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -120.55 154.65 16.39 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.757 -0.656 . . . . 42.01 111.762 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -96.44 142.29 28.72 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.516 1.126 . . . . 75.12 109.101 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 54.5 tptt . . . . . 0 CA--C 1.558 1.264 0 N-CA-C 108.223 -1.028 . . . . 75.51 108.223 178.757 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.608 0.242 . . . . 75.22 111.484 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . 0.516 HG11 HG23 ' F' ' 452' ' ' VAL . 46.9 t -73.61 144.8 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.609 0.764 . . . . 75.31 109.371 176.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . 0.516 HG23 HG11 ' F' ' 451' ' ' VAL . 92.4 t 72.68 142.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 125.068 1.347 . . . . 71.21 111.986 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -146.65 36.43 1.25 Allowed Glycine 0 C--N 1.342 0.902 0 N-CA-C 110.764 -0.934 . . . . 32.43 110.764 172.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 36.3 tp -92.11 140.98 29.1 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.335 0.654 . . . . 74.2 111.277 -173.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 25.6 p -100.41 -65.83 0.94 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.123 0.969 . . . . 73.13 110.144 172.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -163.06 5.13 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.326 0.65 . . . . 74.22 111.699 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -63.62 -28.74 70.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.119 0.968 . . . . 74.04 113.212 -167.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 10.9 p -61.17 120.21 9.89 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.665 0.786 . . . . 71.42 111.823 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . 0.463 ' HB2' ' HH ' ' B' ' 140' ' ' TYR . 17.5 m-20 -85.74 136.62 33.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.38 0.672 . . . . 74.2 109.202 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 37.9 tp -99.99 123.12 43.88 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.694 -0.484 . . . . 71.13 109.694 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -51.89 -58.22 7.11 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.754 1.622 . . . . 74.35 111.888 176.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . 0.427 ' CD2' ' HB2' ' B' ' 44' ' ' LEU . 1.0 OUTLIER 42.04 -141.52 0.11 Allowed 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 125.723 1.609 . . . . 74.11 111.596 -178.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 3.4 m 58.18 43.06 21.09 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.36 1.064 . . . . 74.31 111.768 166.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.8 151.74 40.49 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.781 0.832 . . . . 75.22 111.14 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.54 -37.67 81.98 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.045 0.938 . . . . 73.13 112.015 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -81.49 85.41 6.5 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.459 -0.941 . . . . 72.53 108.459 172.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -70.08 -42.5 72.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.193 0.597 . . . . 73.22 110.784 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . 0.611 HD13 ' HG ' ' B' ' 126' ' ' LEU . 5.0 tt -167.73 -59.1 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.095 -1.076 . . . . 72.01 108.095 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 87.82 57.66 1.91 Allowed Glycine 0 C--N 1.348 1.206 0 N-CA-C 110.555 -1.018 . . . . 72.34 110.555 -169.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . 0.517 ' H ' HD23 ' F' ' 470' ' ' LEU . 1.5 pt? -97.68 -8.08 29.51 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.02 0.928 . . . . 75.34 111.268 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? . . . . . 0 C--O 1.249 1.076 0 C-N-CA 124.043 0.937 . . . . 74.21 109.511 175.408 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.112 -0.699 . . . . 71.23 109.112 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 85.9 t 70.49 -71.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 124.948 1.299 . . . . 71.1 111.227 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . 0.677 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 27.5 m -83.59 158.25 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.181 0.992 . . . . 72.23 111.733 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 140.95 68.33 0.03 OUTLIER Glycine 0 C--N 1.347 1.15 0 N-CA-C 111.702 -0.559 . . . . 74.54 111.702 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 6.8 tt -78.53 -48.45 15.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.403 0.681 . . . . 75.44 110.738 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 11.4 m -56.9 93.05 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 O-C-N 124.293 0.996 . . . . 74.53 112.448 -167.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 29.1 t70 177.51 131.23 0.06 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.572 1.949 . . . . 74.34 106.903 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 59.96 -156.29 0.34 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.807 0.843 . . . . 74.5 110.187 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 458' ' ' THR . . . . . 0.443 ' HA ' ' OH ' ' C' ' 140' ' ' TYR . 34.6 m 76.43 126.82 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.952 1.301 . . . . 75.43 112.205 170.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.82 147.12 42.4 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.865 0.866 . . . . 65.11 109.335 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . 0.524 ' HG ' ' HA ' ' C' ' 45' ' ' ASP . 0.1 OUTLIER -82.59 140.24 33.34 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.043 -1.095 . . . . 75.4 108.043 173.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -133.03 175.65 9.19 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.305 1.042 . . . . 75.12 110.231 -173.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 7.4 t80 73.2 107.74 0.07 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.305 1.442 . . . . 74.53 111.515 171.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 86.2 m -89.59 -71.22 0.62 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.433 0.693 . . . . 75.24 110.133 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 39.0 ttp 69.0 153.76 0.11 Allowed 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.059 1.344 . . . . 64.54 112.171 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -159.86 5.44 0.09 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.8 0.84 . . . . 75.32 111.003 168.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -75.95 80.04 2.83 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.186 0.594 . . . . 70.24 109.649 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' C' ' 129' ' ' ALA . . . -161.46 157.15 24.62 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.272 -0.877 . . . . 74.14 110.425 -176.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . 0.469 HD23 ' H ' ' C' ' 127' ' ' ASN . 79.1 mt 70.26 161.22 0.22 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.269 1.428 . . . . 75.2 113.108 170.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -90.19 46.9 3.08 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-N 115.139 -0.937 . . . . 70.21 111.312 171.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . 0.542 HD23 ' HD2' ' C' ' 38' ' ' PRO . 6.2 tt -138.95 -69.15 0.43 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.406 -1.331 . . . . 73.54 107.406 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 58.2 mttp . . . . . 0 CA--C 1.562 1.405 0 O-C-N 124.671 1.232 . . . . 74.32 110.92 -177.351 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 108.801 -0.814 . . . . 71.21 108.801 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 13.6 p -70.42 -28.46 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.72 0.771 . . . . 73.33 109.711 172.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.601 HG11 HG23 ' D' ' 86' ' ' ILE . 11.9 m -134.91 124.95 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.718 1.207 . . . . 74.43 109.374 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 159.74 116.78 0.45 Allowed Glycine 0 C--N 1.349 1.254 0 CA-C-O 119.662 -0.521 . . . . 74.25 112.409 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.86 158.43 36.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.474 0.71 . . . . 74.22 109.935 173.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 22.8 m -85.24 137.9 32.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.226 0.611 . . . . 55.41 109.592 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . 0.636 ' HB2' HG21 ' D' ' 46' ' ' THR . 5.0 p-10 -98.67 149.86 22.37 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.362 1.065 . . . . 61.31 110.391 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -131.8 155.29 48.01 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.741 0.816 . . . . 71.14 109.565 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 68.6 p -73.22 -59.38 2.73 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.285 0.634 . . . . 73.02 110.887 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -85.83 88.07 7.5 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.705 0.802 . . . . 72.32 110.142 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . 0.428 HD11 HG23 ' D' ' 46' ' ' THR . 94.5 mt -90.48 -66.32 0.94 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.709 -0.678 . . . . 73.25 110.129 175.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . 0.429 ' HE1' ' HD1' ' D' ' 137' ' ' PHE . 13.3 p90 -171.11 146.25 2.38 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.195 0.998 . . . . 74.33 109.624 -171.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -167.6 87.98 0.27 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.906 0.384 . . . . 73.23 110.512 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 9.0 t -113.04 105.33 13.34 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 107.711 -1.218 . . . . 72.41 107.711 166.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 464' ' ' MET . . . . . 0.502 ' HG3' ' HB3' ' H' ' 467' ' ' ALA . 14.4 tpt -110.47 124.69 52.25 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.45 -0.796 . . . . 63.02 109.707 -169.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -133.12 145.83 51.05 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.07 -1.085 . . . . 72.23 108.07 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . 63.4 40.26 8.58 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.262 1.025 . . . . 55.32 110.131 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . 0.502 ' HB3' ' HG3' ' H' ' 464' ' ' MET . . . -77.84 -164.6 0.53 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.723 -1.126 . . . . 74.44 110.365 175.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . 0.486 HD13 HG13 ' D' ' 40' ' ' VAL . 94.7 mt -68.23 -56.83 7.28 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.585 -0.524 . . . . 72.34 109.585 171.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 54.91 32.07 55.55 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 124.119 0.887 . . . . 73.45 113.22 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' D' ' 37' ' ' GLN . 2.3 pp -76.04 -30.92 58.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.558 0.743 . . . . 73.3 111.802 -168.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . 0.485 ' HZ1' ' HB3' ' H' ' 471' ' ' LYS . 2.6 ttpm? . . . . . 0 CA--C 1.569 1.679 0 C-N-CA 124.681 1.192 . . . . 72.34 112.07 171.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptp . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 109.861 -0.422 . . . . 72.34 109.861 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 p -164.17 92.78 0.67 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.411 1.085 . . . . 62.43 108.498 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -82.22 163.45 21.87 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.785 0.834 . . . . 74.12 111.17 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 64.04 -179.39 0.16 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.885 1.274 . . . . 73.42 112.336 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -70.05 170.36 11.55 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.593 -0.521 . . . . 72.24 109.593 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.1 t30 73.08 82.72 0.13 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.349 1.06 . . . . 74.54 108.67 -171.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -99.2 158.57 15.6 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.087 0.955 . . . . 72.31 110.335 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 54.53 -84.93 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.707 1.203 . . . . 74.25 111.464 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -69.66 150.25 47.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.734 0.813 . . . . 74.3 110.208 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 90.9 m -145.65 131.29 18.89 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.893 0.877 . . . . 75.01 109.21 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.6 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.3 t80 -137.44 135.14 36.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.804 -0.813 . . . . 75.42 108.804 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -150.08 117.46 6.08 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.084 -1.08 . . . . 55.11 108.084 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.449 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.6 mt -80.87 118.24 28.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.813 -0.81 . . . . 71.51 108.813 175.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.9 -40.54 31.96 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.851 -0.796 . . . . 74.44 108.851 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -169.47 145.96 3.32 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.48 -0.327 . . . . 73.22 110.845 -176.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.512 HD13 ' HG3' ' C' ' 130' ' ' PRO . 84.4 mt -129.55 136.25 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 124.303 1.041 . . . . 73.15 108.726 172.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' HB3' HG23 ' B' ' 122' ' ' THR . 33.8 p90 -169.53 177.81 4.45 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.017 0.927 . . . . 75.04 111.029 -174.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -99.66 123.62 44.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.316 -0.624 . . . . 71.41 109.316 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -84.27 -28.86 26.89 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 110.011 -0.366 . . . . 74.21 110.011 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -152.75 146.27 24.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.502 -0.772 . . . . 74.5 109.692 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.06 142.44 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.391 1.476 . . . . 63.02 107.045 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -149.89 144.29 25.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.047 0.451 . . . . 75.11 110.181 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.565 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 92.7 t80 -150.21 129.42 12.79 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.888 -1.523 . . . . 62.54 106.888 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.62 127.83 39.76 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.608 0.763 . . . . 64.21 109.247 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.36 79.81 64.76 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 107.156 -1.424 . . . . 74.43 107.156 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.25 -16.6 24.89 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.485 2.123 . . . . 72.04 111.364 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -107.44 13.89 26.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.699 1.199 . . . . 75.41 109.533 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.71 99.9 Favored Pre-proline 0 CA--C 1.569 1.685 0 N-CA-C 114.258 1.207 . . . . 72.24 114.258 -170.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.62 -24.12 18.95 Favored 'Trans proline' 0 C--N 1.388 2.624 0 C-N-CA 121.818 1.679 . . . . 73.35 113.243 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -91.21 -21.88 20.9 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.62 0.768 . . . . 75.11 112.031 -171.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.455 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 12.0 p -69.77 -28.57 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.646 0.779 . . . . 75.11 111.722 -175.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -68.12 -36.21 79.36 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.828 0.851 . . . . 73.13 110.761 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -77.26 -46.45 23.06 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.328 -0.851 . . . . 74.33 111.346 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.62 ' HZ2' ' HG3' ' A' ' 71' ' ' GLU . 64.9 pttt -76.26 164.64 25.86 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.563 0.345 . . . . 74.23 110.165 176.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.98 141.21 36.19 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.869 0.467 . . . . 71.33 110.223 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -79.13 99.31 6.91 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.485 0.714 . . . . 65.42 109.593 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.453 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 35.6 tt0 -149.97 67.05 8.32 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.1 -0.704 . . . . 70.44 109.1 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.62 158.98 9.24 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.711 2.274 . . . . 74.43 113.162 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -94.67 99.68 11.75 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.194 -1.41 . . . . 71.41 107.194 170.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.417 HG13 HD13 ' E' ' 468' ' ' LEU . 18.4 m -78.06 93.72 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 114.576 -1.193 . . . . 65.33 110.816 -173.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 56.2 mttm -91.17 113.41 25.67 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.477 -1.238 . . . . 64.23 108.41 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.608 HD23 ' SD ' ' E' ' 464' ' ' MET . 58.7 tp -116.67 119.01 34.15 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.145 -0.687 . . . . 74.24 109.145 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -130.06 151.05 51.02 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.64 0.776 . . . . 72.34 109.302 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.519 HD22 HG21 ' A' ' 62' ' ' VAL . 3.0 tm? -132.26 141.1 48.88 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.707 0.803 . . . . 74.2 109.208 -173.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -135.47 119.71 17.78 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.264 1.026 . . . . 62.53 109.145 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.445 ' H ' HD23 ' E' ' 460' ' ' LEU . 67.2 m -111.72 130.17 55.87 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.126 0.97 . . . . 74.5 109.122 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.93 152.47 51.06 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.512 -0.921 . . . . 71.13 108.512 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.2 t -125.78 152.07 45.89 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.651 -0.5 . . . . 74.42 109.651 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 t -150.65 133.12 15.61 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.921 0.889 . . . . 71.25 109.084 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -77.85 131.45 37.54 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.501 -0.555 . . . . 74.23 109.501 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.8 mt -107.12 -41.98 5.0 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.865 0.866 . . . . 74.21 109.705 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.87 -175.01 4.64 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.678 -1.146 . . . . 74.21 109.272 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.69 114.11 3.11 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.427 0.691 . . . . 65.25 110.457 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.75 12.67 7.84 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.414 1.086 . . . . 75.2 112.105 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.1 t -101.68 112.56 35.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 124.909 1.284 . . . . 74.11 107.92 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -125.17 126.7 45.66 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.718 0.807 . . . . 73.42 109.292 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -101.94 126.91 48.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.74 -1.118 . . . . 75.11 108.477 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 m -100.89 133.33 44.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.99 -1.115 . . . . 73.05 107.99 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.62 110.68 26.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 107.972 -1.122 . . . . 73.44 107.972 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.0 tp -90.51 98.41 11.76 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.042 -0.725 . . . . 73.54 109.042 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.8 ttp85 -95.81 100.87 12.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.635 0.774 . . . . 73.32 109.712 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.519 HG21 HD22 ' A' ' 44' ' ' LEU . 12.3 t -97.15 117.29 41.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.219 -1.03 . . . . 75.04 108.219 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.0 t -107.55 141.89 38.29 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.734 0.778 . . . . 74.23 109.936 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 59.0 t -131.29 109.34 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.755 1.622 . . . . 72.12 107.641 -173.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 26.7 m -110.65 107.73 17.41 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.793 -0.818 . . . . 61.04 108.793 175.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.63 104.69 14.05 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 106.996 -1.483 . . . . 72.33 106.996 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.8 p -149.56 127.79 12.08 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.691 0.396 . . . . 74.3 110.569 -172.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.474 HD22 ' H ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -90.12 84.55 6.13 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.886 -0.783 . . . . 74.45 108.886 177.247 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.38 -104.8 1.81 Allowed Glycine 0 C--N 1.35 1.307 0 CA-C-N 115.065 -0.97 . . . . 71.23 112.283 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -97.28 -5.23 37.19 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.587 0.755 . . . . 74.45 110.314 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.62 ' HG3' ' HZ2' ' A' ' 34' ' ' LYS . 36.1 tp10 -112.22 94.65 5.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.606 1.162 . . . . 64.34 108.97 -169.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -71.45 138.41 49.0 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.424 0.289 . . . . 75.15 111.273 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.28 -59.45 2.25 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.944 0.898 . . . . 75.21 108.943 173.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -157.41 174.9 14.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.306 -0.861 . . . . 73.44 111.324 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -140.55 138.82 34.79 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.176 1.39 . . . . 75.25 107.896 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.9 m -141.28 139.51 33.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.96 0.904 . . . . 61.45 109.064 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -150.74 122.5 8.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.206 0.457 . . . . 72.33 109.826 174.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.3 t -122.35 132.85 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 123.875 0.87 . . . . 75.53 109.592 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.526 HE21 ' N ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -109.01 86.75 2.34 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.357 1.063 . . . . 74.03 108.293 174.413 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.09 103.18 8.85 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.96 -1.018 . . . . 75.31 108.462 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.39 142.84 16.38 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 111.368 -0.693 . . . . 72.2 111.368 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.535 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -140.61 123.51 2.38 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 111.142 -0.783 . . . . 65.54 111.142 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.1 mt -80.69 118.45 28.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.838 -0.801 . . . . 75.44 108.838 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.6 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 42.1 m-85 -125.22 119.35 28.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.887 0.475 . . . . 74.02 109.901 -176.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 m -86.82 105.0 16.71 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.845 -0.798 . . . . 73.53 108.845 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.524 ' HB ' HD11 ' A' ' 89' ' ' ILE . 43.5 pt -107.23 143.92 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.434 0.694 . . . . 73.44 110.75 -175.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.6 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -156.84 156.51 33.31 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.973 0.909 . . . . 74.32 109.778 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.0 7.04 87.63 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.897 0.719 . . . . 73.34 114.897 173.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.524 HD11 ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -122.31 156.21 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 108.686 -0.857 . . . . 73.05 108.686 172.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -157.61 173.95 16.09 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.242 0.617 . . . . 71.1 109.359 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.46 -136.64 47.38 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.514 0.509 . . . . 64.32 114.153 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -80.71 -16.14 54.69 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.537 0.735 . . . . 74.51 111.215 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -67.64 -36.45 80.8 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.002 0.921 . . . . 73.45 109.598 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.4 ' HE2' ' HB3' ' A' ' 94' ' ' MET . 34.2 ttp -76.83 -33.23 57.94 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.905 -1.043 . . . . 74.4 110.922 174.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -28.31 69.19 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.034 0.445 . . . . 71.54 110.583 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -64.57 -37.02 86.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.355 -0.839 . . . . 73.44 110.526 172.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.545 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 64.1 m -64.75 -35.74 82.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 122.871 0.469 . . . . 75.04 110.87 177.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.418 HD11 ' HB2' ' E' ' 457' ' ' GLN . 6.8 tt -72.96 -49.92 26.4 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.088 0.555 . . . . 74.54 109.983 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.15 4.8 52.28 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 115.059 0.784 . . . . 73.34 115.059 -165.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -145.57 -65.95 0.31 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.188 0.994 . . . . 74.2 112.201 -175.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.545 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 69.0 t80 -69.33 -66.6 0.56 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.927 -1.033 . . . . 71.42 113.402 -166.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 85.8 m -67.6 -35.06 7.46 Favored Pre-proline 0 CA--C 1.566 1.571 0 N-CA-C 114.079 1.14 . . . . 64.3 114.079 -174.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 27.9 Cg_endo -62.76 -30.15 77.76 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 122.015 1.81 . . . . 72.41 112.91 168.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -71.72 -27.86 63.3 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.091 0.556 . . . . 75.12 110.982 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.6 mm -59.31 -41.96 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-O 121.441 0.639 . . . . 75.32 109.872 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.535 HD22 ' HA3' ' A' ' 82' ' ' GLY . 84.1 mt -83.34 -16.24 46.89 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.035 -0.984 . . . . 73.23 112.581 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.79 -43.53 69.63 Favored Pre-proline 0 CA--C 1.561 1.366 0 N-CA-C 113.819 1.044 . . . . 75.42 113.819 -172.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -59.6 -37.55 87.65 Favored 'Trans proline' 0 C--N 1.387 2.574 0 CA-C-N 121.745 1.659 . . . . 71.14 112.7 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -69.89 -43.03 72.6 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.579 -0.737 . . . . 74.32 111.284 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.23 -39.24 82.37 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.13 0.572 . . . . 64.42 110.573 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.582 ' NH1' HD13 ' C' ' 105' ' ' ILE . 29.8 ttm180 -49.75 -55.1 15.23 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.645 1.215 . . . . 74.1 109.887 174.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -66.64 -44.09 82.9 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.055 -0.975 . . . . 71.5 111.569 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.1 t -60.43 -26.17 66.52 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.09 0.556 . . . . 74.35 111.844 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.479 HD11 ' HB ' ' A' ' 62' ' ' VAL . 95.6 mt -83.25 -52.23 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.75 0.82 . . . . 75.34 109.759 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.4 m -54.88 -50.88 67.62 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.818 0.847 . . . . 64.12 111.631 -173.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 47.1 t -59.6 -45.18 92.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.745 -1.116 . . . . 63.32 110.441 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.565 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 45.6 ttp -68.66 -35.05 76.72 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.073 0.949 . . . . 74.24 111.695 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.66 -41.26 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.096 0.958 . . . . 74.51 109.785 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.7 m -72.56 -24.41 61.11 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.334 -0.848 . . . . 70.12 111.467 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.444 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.8 mtt-85 -73.76 -30.95 63.07 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.521 0.729 . . . . 73.02 109.665 174.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.06 -1.64 80.28 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.658 -0.701 . . . . 44.14 112.637 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.8 m 69.16 21.0 7.4 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 125.161 1.384 . . . . 71.32 111.223 175.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.15 158.71 69.37 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 115.274 -0.875 . . . . 71.34 109.335 170.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.55 144.97 91.06 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.277 1.985 . . . . 72.02 111.54 173.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -59.35 134.53 57.09 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.621 0.768 . . . . 75.23 111.92 -173.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -117.32 102.46 9.27 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.211 -0.904 . . . . 71.41 109.803 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -102.03 108.04 19.35 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.12 -1.067 . . . . 73.14 108.12 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.16 117.34 10.68 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.066 -0.716 . . . . 72.52 109.066 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.33 139.14 96.39 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 122.841 0.456 . . . . 75.15 110.883 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -53.04 106.66 0.16 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.04 2.494 . . . . 75.21 111.877 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.46 133.06 42.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.578 0.704 . . . . 65.24 109.293 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -82.04 71.93 9.09 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.462 -1.245 . . . . 72.04 112.126 -170.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.484 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 35.2 m-85 -53.68 -41.05 66.47 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.612 0.765 . . . . 70.33 111.582 177.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 7.0 m-20 -68.85 -42.05 77.63 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.007 -0.997 . . . . 63.01 111.401 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.02 81.09 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.073 0.549 . . . . 62.53 110.981 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.53 -38.41 80.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.738 -1.119 . . . . 74.41 110.511 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -73.82 -37.64 64.81 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.539 -0.755 . . . . 73.2 110.347 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.49 ' SD ' HD22 ' A' ' 141' ' ' LEU . 20.1 mmt -61.26 -33.52 73.67 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.357 0.663 . . . . 74.55 111.551 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -54.35 -45.9 72.83 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.09 0.956 . . . . 63.4 110.575 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -77.36 -37.45 52.19 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.108 -0.951 . . . . 74.03 110.983 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.49 HD22 ' SD ' ' A' ' 138' ' ' MET . 32.7 tp -65.87 -49.68 67.24 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.871 0.868 . . . . 74.23 111.564 -168.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.494 ' OE1' ' HA ' ' C' ' 153' ' ' GLN . 35.5 tt0 -168.89 25.38 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 O-C-N 123.92 0.762 . . . . 72.24 109.646 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 71.53 -64.89 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.426 1.49 . . . . 73.11 111.861 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -139.43 132.79 30.05 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.497 1.119 . . . . 74.14 109.323 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.492 ' HA ' ' HB3' ' C' ' 152' ' ' HIS . . . -165.23 107.14 0.8 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.665 0.786 . . . . 74.21 110.046 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -174.37 -172.32 39.42 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.114 -0.394 . . . . 74.23 112.114 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.724 ' HG2' ' HA ' ' C' ' 149' ' ' THR . 10.5 tp10 -161.3 156.17 23.6 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.151 0.98 . . . . 71.22 109.857 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.89 151.46 39.15 Favored Glycine 0 C--N 1.353 1.483 0 N-CA-C 112.262 -0.335 . . . . 73.35 112.262 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.7 p -85.64 148.84 25.71 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.707 0.803 . . . . 74.01 110.676 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -68.05 130.25 42.37 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.386 0.674 . . . . 75.34 110.175 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -117.97 119.88 36.15 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.859 0.864 . . . . 75.42 111.229 -174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -151.09 90.6 1.62 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.03 1.332 . . . . 70.11 107.872 168.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -81.15 69.47 7.76 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 108.675 -0.861 . . . . 73.35 108.675 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -83.06 -22.99 33.35 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.918 -1.037 . . . . 75.43 110.535 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.96 0 C-N-CA 124.439 1.096 . . . . 73.33 108.723 177.903 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 110.281 -0.266 . . . . 72.24 110.281 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 23.9 m -77.46 99.96 5.84 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.705 0.802 . . . . 74.42 110.058 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -92.77 126.18 37.73 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.292 1.037 . . . . 75.41 111.102 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -89.58 91.22 8.59 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.193 0.597 . . . . 75.35 109.793 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -85.02 97.15 9.67 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.772 -0.455 . . . . 75.14 109.772 174.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -81.31 147.14 30.03 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.605 -0.887 . . . . 72.51 108.605 175.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.7 t -65.69 134.73 53.83 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 109.956 -0.387 . . . . 70.53 109.956 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -105.49 156.26 18.38 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.718 0.807 . . . . 63.51 110.295 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 5.1 ptm 65.1 168.2 0.19 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 127.727 2.411 . . . . 72.32 114.382 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 72.3 m -169.36 143.23 2.83 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.685 1.594 . . . . 74.42 108.041 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.34 157.63 44.59 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.73 0.3 . . . . 73.11 110.798 163.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.478 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -123.03 121.4 35.98 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 107.634 -1.247 . . . . 75.53 107.634 177.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 36.2 mt -71.71 119.87 18.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.572 -0.899 . . . . 74.13 108.572 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.549 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 84.2 mm-40 -82.54 -39.33 22.49 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.185 -0.916 . . . . 74.3 109.913 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.5 ttt85 -174.06 134.89 0.45 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.101 -0.954 . . . . 74.31 109.583 -174.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -114.69 140.01 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 106.623 -1.621 . . . . 73.21 106.623 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -166.63 155.39 10.59 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.465 0.65 . . . . 73.3 111.639 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 96.2 m -83.19 127.01 33.24 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.684 -1.144 . . . . 73.44 109.059 171.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.443 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.0 mtpt -98.4 -22.22 16.17 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.68 0.792 . . . . 75.21 110.916 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -164.65 137.58 4.81 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 123.423 0.452 . . . . 70.02 110.86 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.714 HD12 ' SG ' ' B' ' 113' ' ' CYS . 46.2 mm -127.0 144.94 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.796 1.238 . . . . 73.31 109.276 173.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.1 t -145.04 138.88 27.03 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.464 -1.244 . . . . 74.52 107.66 174.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -153.98 123.03 6.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.277 -1.379 . . . . 74.44 107.277 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -124.21 138.22 54.43 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.144 -0.687 . . . . 75.34 109.144 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.31 83.87 64.05 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 106.723 -1.584 . . . . 73.35 106.723 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.15 -36.42 29.13 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.026 2.484 . . . . 74.12 112.998 -169.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -105.37 17.15 24.43 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.366 0.666 . . . . 73.34 110.588 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.561 ' HB2' ' HD3' ' B' ' 29' ' ' PRO . . . -36.28 -65.76 0.3 Allowed Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 115.002 1.482 . . . . 70.11 115.002 -164.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' B' ' 28' ' ' ALA . 23.1 Cg_exo -62.5 -24.99 75.61 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 122.527 2.151 . . . . 75.33 113.05 -174.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.454 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 63.4 m80 -95.25 -28.65 14.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.869 -1.06 . . . . 72.21 112.291 -173.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.676 HG23 HD13 ' B' ' 68' ' ' LEU . 8.2 p -78.85 -20.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 120.952 0.406 . . . . 75.13 111.34 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -67.75 -11.89 59.38 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.309 0.855 . . . . 72.22 113.309 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.9 pt20 -63.89 -34.48 78.05 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.016 0.527 . . . . 73.34 110.804 176.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.489 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 97.1 mttt -83.86 101.43 11.65 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.581 0.752 . . . . 74.01 109.582 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -85.51 90.08 7.87 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.092 -0.707 . . . . 74.33 109.092 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -157.85 158.46 35.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.706 1.202 . . . . 75.51 108.363 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -83.37 103.24 2.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.214 1.006 . . . . 73.35 108.476 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.89 135.37 66.38 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.373 2.715 . . . . 72.35 113.496 -168.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.3 125.8 25.05 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 123.908 0.755 . . . . 71.43 109.487 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.541 HG11 ' HG ' ' F' ' 468' ' ' LEU . 2.4 p -123.45 128.21 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.579 0.752 . . . . 73.23 112.078 -165.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -107.52 129.66 54.94 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.584 1.154 . . . . 74.44 108.458 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.5 146.67 23.61 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.314 -0.995 . . . . 71.1 108.314 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -140.21 112.31 7.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.342 -0.985 . . . . 73.21 108.342 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 74.0 mt -100.16 149.9 23.06 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.737 -0.468 . . . . 74.52 109.737 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.497 ' HB3' ' HD2' ' B' ' 61' ' ' ARG . 20.6 t70 -153.19 114.82 4.25 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.714 0.805 . . . . 74.04 109.275 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -110.38 114.41 27.84 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.209 0.604 . . . . 72.01 110.39 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.67 155.38 30.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.388 1.075 . . . . 55.52 108.729 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.3 p -144.19 164.45 30.68 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.439 0.296 . . . . 72.42 110.939 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -158.1 139.03 13.12 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.542 0.737 . . . . 72.44 109.939 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -80.83 113.89 19.34 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.46 0.704 . . . . 74.13 109.786 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.02 -42.68 37.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.835 0.454 . . . . 75.11 110.619 176.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.6 -175.32 5.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.273 -0.876 . . . . 73.43 110.25 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.03 117.22 3.78 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.376 -0.829 . . . . 73.33 109.862 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 71.3 1.0 3.65 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.708 1.203 . . . . 75.11 112.494 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 48.0 t -104.72 114.55 44.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 124.725 1.21 . . . . 73.02 107.927 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -123.29 140.57 52.88 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.039 -1.097 . . . . 74.1 108.039 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -116.12 107.47 14.95 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.353 -1.351 . . . . 74.23 107.353 -174.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 99.3 t -89.22 143.37 11.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 C-N-CA 124.467 1.107 . . . . 73.01 109.461 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 36.5 t -125.95 128.64 72.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.543 -0.91 . . . . 75.01 108.543 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -114.1 108.02 16.43 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.8 -1.185 . . . . 73.02 107.8 -177.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.497 ' HD2' ' HB3' ' B' ' 45' ' ' ASP . 38.1 ttm180 -93.44 123.59 36.84 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.676 -0.49 . . . . 74.33 109.676 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 44.2 t -118.29 103.12 14.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.284 -1.376 . . . . 73.3 107.284 168.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 15.7 m -98.33 126.52 43.87 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.967 -0.753 . . . . 73.35 108.967 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.432 HG22 HG22 ' B' ' 114' ' ' ILE . 58.0 t -113.75 120.2 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 123.975 0.91 . . . . 74.34 109.774 -176.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 77.9 m -109.74 135.74 50.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.631 -0.877 . . . . 75.22 108.631 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.27 142.88 27.66 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.278 0.631 . . . . 74.24 109.599 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.412 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 37.1 p -148.05 137.09 22.02 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.223 -0.444 . . . . 71.41 111.999 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.676 HD13 HG23 ' B' ' 31' ' ' VAL . 39.1 mt -96.2 104.83 16.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.039 0.936 . . . . 74.23 110.053 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.2 -113.46 5.9 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.151 -0.932 . . . . 62.21 113.143 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -107.98 21.89 16.75 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.713 0.805 . . . . 74.51 110.945 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.489 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 15.3 pt-20 -140.77 157.77 44.92 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.755 -0.591 . . . . 72.1 109.854 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 38.1 m -73.54 135.42 43.97 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.805 -0.443 . . . . 64.45 109.805 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.497 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -90.99 -66.2 0.95 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.56 -1.274 . . . . 73.32 107.56 174.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -150.18 161.87 41.57 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.844 0.83 . . . . 73.1 110.689 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.0 149.85 50.24 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.946 1.698 . . . . 74.12 106.76 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.417 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 48.6 t -154.91 159.82 40.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.551 -0.537 . . . . 70.23 109.551 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 38.7 tt0 -164.44 129.58 2.76 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.486 -0.931 . . . . 74.21 108.486 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.416 HG21 HD11 ' B' ' 21' ' ' ILE . 78.7 t -124.2 142.24 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 107.993 -1.114 . . . . 75.0 107.993 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -123.03 84.47 2.27 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.15 -1.055 . . . . 72.52 108.15 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.531 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.2 tp-100 -80.27 100.42 8.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.731 -1.122 . . . . 73.44 109.215 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.443 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -89.77 165.8 32.31 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.415 -0.674 . . . . 72.12 111.415 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.01 134.41 3.28 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.154 -0.779 . . . . 62.03 111.154 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 24.5 mt -97.87 127.35 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.955 0.902 . . . . 73.02 108.727 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -131.78 133.66 44.98 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 107.793 -1.188 . . . . 74.03 107.793 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 40.4 m -110.76 94.27 4.91 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.593 -0.521 . . . . 74.43 109.593 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.451 ' HB ' HD11 ' B' ' 89' ' ' ILE . 32.5 pt -95.88 138.42 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.396 0.678 . . . . 75.31 111.65 -167.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.54 149.87 33.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.386 1.074 . . . . 65.23 109.299 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.29 -31.21 8.92 Favored Glycine 0 N--CA 1.473 1.131 0 C-N-CA 123.256 0.455 . . . . 71.11 112.821 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' B' ' 94' ' ' MET . 9.7 pt -91.48 151.22 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.787 0.835 . . . . 63.45 111.7 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.96 148.83 17.44 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.655 -1.157 . . . . 74.34 108.749 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.17 -132.85 13.96 Favored Glycine 0 C--N 1.343 0.96 0 O-C-N 123.352 0.407 . . . . 62.23 112.608 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.4 m -74.54 -20.5 59.94 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.197 0.599 . . . . 73.15 112.183 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -59.87 -45.05 93.71 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.721 0.772 . . . . 74.34 109.804 170.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.541 ' HE3' HD12 ' F' ' 454' ' ' LEU . 9.8 tmm? -72.43 -38.07 68.44 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.37 -1.287 . . . . 72.42 110.57 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.0 -40.58 70.26 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.552 0.691 . . . . 74.24 110.593 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -71.38 -41.8 69.21 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.586 -1.188 . . . . 73.04 111.346 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.2 t -66.51 -60.1 3.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.955 0.502 . . . . 74.51 111.394 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.491 HD21 HD23 ' F' ' 454' ' ' LEU . 6.9 tt -68.86 -41.18 78.78 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.824 0.849 . . . . 72.34 110.305 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.11 -34.39 41.87 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.318 0.387 . . . . 74.43 114.045 -171.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.43 -50.72 1.76 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 112.545 0.572 . . . . 71.24 112.545 -168.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -73.78 -35.78 64.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.692 0.797 . . . . 72.11 112.22 -171.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 97.1 m -70.83 -48.53 14.97 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 123.228 0.611 . . . . 71.04 111.053 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.495 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 75.3 Cg_exo -55.36 -34.82 90.17 Favored 'Trans proline' 0 C--N 1.399 3.232 0 C-N-CA 122.272 1.982 . . . . 72.15 113.542 168.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -58.72 -39.56 81.21 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.657 0.783 . . . . 75.12 110.758 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.61 -41.4 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.963 0.905 . . . . 75.1 110.791 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 59.8 mt -81.26 -16.15 53.47 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.683 0.793 . . . . 74.11 112.098 -173.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -61.8 -47.95 90.6 Favored Pre-proline 0 CA--C 1.558 1.285 0 N-CA-C 113.987 1.106 . . . . 74.32 113.987 -171.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.07 -34.46 89.9 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 121.744 1.63 . . . . 73.1 113.054 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.531 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 88.3 m-85 -65.05 -46.8 79.73 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.507 0.504 . . . . 73.24 110.32 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.6 96.92 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.532 0.733 . . . . 71.41 110.585 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -57.74 -55.93 28.54 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.203 1.001 . . . . 74.35 110.688 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.06 -34.56 77.85 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.866 0.728 . . . . 74.41 110.489 -175.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.714 ' SG ' HD12 ' B' ' 21' ' ' ILE . 2.7 t -69.96 -38.07 76.01 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.029 -0.532 . . . . 72.03 111.18 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.432 HG22 HG22 ' B' ' 64' ' ' VAL . 72.5 mt -65.73 -54.84 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.29 0.636 . . . . 72.15 109.665 174.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.9 m -61.6 -26.46 67.99 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 124.215 0.947 . . . . 62.11 111.647 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.6 t -61.73 -55.57 28.86 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.476 0.711 . . . . 75.32 109.199 171.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -66.45 -33.73 76.36 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.693 0.797 . . . . 74.12 111.716 -174.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.8 t -59.49 -48.65 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.048 0.939 . . . . 73.41 110.272 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.609 ' HB2' HE21 ' C' ' 125' ' ' GLN . 13.0 t -76.37 -21.0 56.63 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.277 -0.874 . . . . 71.2 111.216 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.7 mtt-85 -67.65 -41.71 83.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.852 -0.796 . . . . 75.13 108.852 172.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.7 -0.47 80.53 Favored Glycine 0 C--N 1.36 1.879 0 O-C-N 123.767 0.667 . . . . 72.41 113.018 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 17' ' ' TYR . 30.0 p 62.33 42.26 9.36 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.762 2.025 . . . . 72.34 113.061 173.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -97.65 159.66 30.51 Favored Pre-proline 0 CA--C 1.56 1.346 0 C-N-CA 124.04 0.936 . . . . 75.22 110.158 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -62.74 178.41 1.0 Allowed 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.516 2.81 . . . . 72.41 114.637 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.549 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 23.5 tp60 -66.17 114.94 5.66 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.875 -1.057 . . . . 71.31 112.491 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.454 ' HA ' HD13 ' F' ' 468' ' ' LEU . 7.4 mp -116.76 91.31 3.55 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.145 -0.687 . . . . 73.45 109.145 167.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -92.5 107.1 18.96 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.155 -1.054 . . . . 73.32 108.155 170.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 18.4 tp -71.71 126.02 28.62 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 123.64 0.587 . . . . 75.41 110.677 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.06 144.55 98.83 Favored Pre-proline 0 CA--C 1.55 0.954 0 O-C-N 124.702 1.251 . . . . 65.02 110.96 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.516 ' HG3' HD11 ' D' ' 16' ' ' ILE . 28.2 Cg_endo -61.67 112.39 1.46 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.239 2.626 . . . . 75.0 111.396 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.29 107.26 17.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 106.136 -1.801 . . . . 72.31 106.136 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -82.46 82.2 7.99 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 107.236 -1.394 . . . . 74.43 107.236 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -63.69 -27.59 69.32 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.695 -1.139 . . . . 74.54 110.068 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.43 -44.05 92.4 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.225 1.41 . . . . 63.1 111.424 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.32 -39.63 78.1 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.547 0.739 . . . . 55.13 110.322 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 85.7 mt -72.83 -23.84 60.82 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.381 -0.827 . . . . 73.25 110.734 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.488 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 51.3 t80 -69.82 -24.56 63.49 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.002 0.921 . . . . 75.11 110.889 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 68.0 mtm -61.79 -31.59 71.82 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.395 0.678 . . . . 73.31 110.869 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.47 ' HA ' HE21 ' B' ' 142' ' ' GLN . 19.8 m-80 -76.88 -18.5 58.28 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.386 1.074 . . . . 75.03 111.296 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -76.41 -30.3 57.4 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.477 0.711 . . . . 73.45 110.25 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 21.2 mt -95.82 18.61 12.8 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.115 -0.948 . . . . 72.33 111.977 -169.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.47 HE21 ' HA ' ' B' ' 139' ' ' ASN . 86.6 mm-40 -68.97 84.66 0.33 Allowed 'General case' 0 C--N 1.353 0.743 0 CA-C-O 121.341 0.591 . . . . 74.14 110.05 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -172.9 -50.65 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.909 1.284 . . . . 75.31 108.306 -176.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.18 75.2 1.06 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.337 -0.986 . . . . 74.04 108.337 175.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.44 38.67 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.731 1.212 . . . . 74.23 109.21 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.27 77.14 1.21 Allowed Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.502 -0.772 . . . . 74.51 111.971 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.71 96.17 1.57 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.136 0.974 . . . . 64.44 110.39 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.83 132.42 9.87 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.844 -0.616 . . . . 73.32 111.717 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.9 t -166.37 136.01 3.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.072 0.949 . . . . 74.21 109.556 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.24 131.35 53.58 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.304 -0.628 . . . . 70.21 109.304 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -157.37 132.91 9.16 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.536 -1.283 . . . . 72.33 107.536 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -172.22 77.09 0.05 OUTLIER 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.581 -1.266 . . . . 74.55 107.581 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.9 84.43 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 122.178 0.99 . . . . 73.23 111.633 173.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -101.69 130.22 48.02 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.197 0.999 . . . . 72.12 109.001 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 C-N-CA 124.203 1.001 . . . . 74.41 108.87 -178.947 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 108.228 -1.026 . . . . 74.22 108.228 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 69.3 m 60.78 -175.87 0.11 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.775 1.23 . . . . 71.54 111.399 -168.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -149.91 77.62 1.33 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.923 -0.769 . . . . 73.14 108.923 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -95.47 90.2 5.69 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.981 -1.859 . . . . 75.21 105.981 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -56.07 124.88 19.28 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.623 0.769 . . . . 65.32 110.541 -174.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -66.62 98.37 0.51 Allowed 'General case' 0 CA--C 1.547 0.859 0 O-C-N 123.896 0.748 . . . . 74.21 109.769 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 12.7 t -86.9 0.22 55.38 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.234 1.014 . . . . 74.33 110.839 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -102.28 55.06 0.79 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.302 1.041 . . . . 74.52 108.879 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 89.8 mtp 64.82 114.67 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.344 1.858 . . . . 75.2 113.52 -176.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 98.4 m -123.28 113.67 19.19 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.015 -1.448 . . . . 74.14 107.642 170.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.522 ' HD1' ' HH ' ' C' ' 101' ' ' TYR . 1.2 t80 -124.99 119.29 28.3 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.916 -1.142 . . . . 74.04 107.916 171.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -141.02 125.21 17.37 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 107.25 -1.389 . . . . 73.15 107.25 170.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.2 mt -74.35 120.53 23.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.103 -0.703 . . . . 75.22 109.103 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.573 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 16.3 mm-40 -86.94 -35.24 19.0 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.808 -1.087 . . . . 74.02 109.454 -176.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -174.16 147.79 1.26 Allowed 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.659 0.599 . . . . 63.44 109.987 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 92.1 mt -138.39 134.66 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.871 -1.159 . . . . 75.13 107.871 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -171.59 168.94 6.21 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.602 0.715 . . . . 71.33 111.728 -169.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -93.28 114.68 27.19 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.217 -0.901 . . . . 75.22 109.034 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -68.82 -39.82 79.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.037 0.922 . . . . 74.15 108.875 168.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.0 t70 -145.33 140.18 27.55 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 113.991 -1.459 . . . . 71.54 109.819 -173.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 81.2 mt -135.25 145.92 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.504 -1.665 . . . . 75.13 106.504 170.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -156.59 149.12 23.51 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.008 0.432 . . . . 73.54 110.242 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -141.97 131.11 23.33 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.705 -1.22 . . . . 72.22 107.705 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -135.28 115.9 13.79 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.507 1.123 . . . . 73.01 108.046 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.32 91.8 8.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 105.195 -2.15 . . . . 72.22 105.195 167.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.02 -36.52 97.98 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.244 2.629 . . . . 73.42 112.942 -167.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -125.41 43.16 3.12 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.762 -1.108 . . . . 73.14 108.915 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.506 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -42.61 -60.68 2.06 Favored Pre-proline 0 CA--C 1.568 1.671 0 N-CA-C 115.213 1.56 . . . . 72.03 115.213 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 19.2 Cg_exo -62.35 -39.14 48.82 Favored 'Trans proline' 0 C--N 1.391 2.801 0 CA-C-N 122.02 1.757 . . . . 75.43 112.088 -178.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -68.76 -33.77 74.45 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.033 -1.44 . . . . 73.52 111.991 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.679 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.5 p -81.82 -27.54 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 122.947 0.499 . . . . 70.25 111.99 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -68.24 -34.19 75.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.738 0.415 . . . . 74.01 111.758 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -86.55 7.06 27.77 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 122.894 0.477 . . . . 75.43 111.299 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.451 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.5 OUTLIER -95.91 170.2 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.88 0.872 . . . . 75.41 109.944 -179.022 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.45 129.25 37.89 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.676 0.791 . . . . 74.32 110.377 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 31.3 t90 -79.97 88.37 5.34 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.861 0.865 . . . . 74.54 110.186 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.425 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.6 OUTLIER -144.35 73.39 15.88 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 107.353 -1.351 . . . . 74.03 107.353 174.177 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.421 ' HG2' HD13 ' G' ' 470' ' ' LEU . 8.7 Cg_exo -76.67 119.05 5.03 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.05 2.5 . . . . 75.51 113.698 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.63 88.12 7.32 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.95 -1.5 . . . . 75.33 106.95 166.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.653 HG21 HD11 ' G' ' 468' ' ' LEU . 14.4 p -79.1 136.73 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 114.36 -1.291 . . . . 74.21 110.17 -175.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -128.82 110.27 12.0 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.2 1.0 . . . . 75.21 108.864 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.465 HD13 ' O ' ' G' ' 465' ' ' LYS . 6.4 mp -84.78 122.56 29.3 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.146 -1.057 . . . . 73.41 108.146 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -120.23 132.05 55.19 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.101 -1.074 . . . . 75.21 108.101 174.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.557 HD22 ' HE1' ' C' ' 133' ' ' PHE . 15.3 tp -125.5 152.61 44.75 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.666 -0.865 . . . . 74.43 108.666 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.4 t70 -151.66 147.95 27.35 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.871 0.869 . . . . 75.31 108.982 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -146.22 133.2 20.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.82 0.848 . . . . 72.11 109.691 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.45 161.75 36.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.636 1.174 . . . . 64.31 107.978 171.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.413 ' HB2' ' HG ' ' G' ' 454' ' ' LEU . 16.7 m -138.55 151.58 47.44 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.866 -0.79 . . . . 74.12 108.866 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 17.9 p -142.19 128.62 20.08 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.733 0.813 . . . . 73.34 109.263 -170.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -73.88 118.26 16.63 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.728 -0.669 . . . . 73.2 110.146 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' C' ' 57' ' ' GLU . 32.8 mt -92.5 -31.69 15.15 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.081 -0.711 . . . . 74.11 109.081 172.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.85 -179.38 7.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.394 1.078 . . . . 75.52 110.457 176.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -62.87 119.11 8.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.214 -0.903 . . . . 64.33 109.467 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.505 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 7.1 m-20 65.32 17.98 11.19 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.226 1.011 . . . . 71.1 112.234 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 74.1 t -124.41 115.65 45.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 108.218 -1.03 . . . . 72.14 108.218 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -128.82 131.48 47.74 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.935 0.894 . . . . 75.43 109.5 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.64 ' HB2' HD12 ' C' ' 51' ' ' LEU . 34.3 tt0 -83.75 114.94 21.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.775 -1.102 . . . . 75.53 108.135 166.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 76.2 t -96.03 137.87 22.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.671 -0.863 . . . . 72.23 108.671 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.95 131.8 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.171 -1.048 . . . . 73.22 108.171 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.538 HD21 HD13 ' C' ' 44' ' ' LEU . 1.0 OUTLIER -121.12 104.57 9.87 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.212 -1.403 . . . . 65.22 107.212 176.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 2.7 ttm180 -93.94 121.89 35.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.426 -1.261 . . . . 74.31 108.954 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.515 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.8 t -116.11 120.41 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.729 -1.212 . . . . 74.43 107.729 174.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 29.4 m -124.34 114.2 19.22 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.985 0.914 . . . . 73.22 108.714 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.657 HG12 HD13 ' C' ' 126' ' ' LEU . 43.8 t -107.56 120.1 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.857 -0.794 . . . . 73.43 108.857 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.4 m -104.54 150.6 24.48 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.669 -0.863 . . . . 75.34 108.669 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.86 137.16 31.23 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.361 -0.977 . . . . 73.42 108.361 172.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.2 m -145.1 133.47 21.8 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.23 0.612 . . . . 74.13 110.132 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.425 HD23 ' H ' ' C' ' 37' ' ' GLN . 18.2 mt -85.28 53.78 2.87 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.643 1.177 . . . . 64.33 108.999 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.82 -87.05 0.55 Allowed Glycine 0 C--N 1.342 0.867 0 N-CA-C 110.111 -1.195 . . . . 64.13 110.111 -167.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -125.55 -13.74 6.47 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.124 0.97 . . . . 62.34 111.664 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.451 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 3.7 tp10 -76.24 116.59 17.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.253 0.621 . . . . 72.25 109.721 174.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.5 m -74.85 122.26 23.1 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.416 0.553 . . . . 75.13 110.083 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.679 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.89 -61.9 1.73 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.788 -1.096 . . . . 73.25 108.709 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -155.03 173.95 15.86 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 114.574 -1.193 . . . . 70.43 111.768 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.51 139.59 26.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 104.958 -2.238 . . . . 74.23 104.958 169.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.9 t -149.04 111.55 4.74 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.026 -0.731 . . . . 72.42 109.026 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -117.84 127.39 53.82 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.0 0.52 . . . . 73.41 109.82 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.97 114.03 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.137 0.975 . . . . 74.31 108.6 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 74.1 mt-30 -92.34 91.0 7.48 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.864 -0.791 . . . . 71.34 108.864 173.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.429 ' HG3' HD22 ' C' ' 106' ' ' LEU . 7.9 tp-100 -80.95 99.71 8.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.122 -0.945 . . . . 75.42 109.76 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.8 145.61 17.86 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.786 -0.526 . . . . 74.33 111.786 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.407 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -150.14 133.22 4.28 Favored Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 110.775 -0.93 . . . . 74.04 110.775 -175.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 8.7 mm -87.52 120.57 36.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 108.452 -0.944 . . . . 63.54 108.452 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.443 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 63.1 m-85 -127.79 126.22 41.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.455 0.702 . . . . 51.12 109.184 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 59.2 p -82.81 122.95 28.88 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.596 -0.89 . . . . 72.33 108.596 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.61 ' HB ' HD13 ' C' ' 89' ' ' ILE . 47.0 pt -117.24 142.36 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.892 0.877 . . . . 72.14 109.983 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -163.54 159.4 21.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.73 0.812 . . . . 73.0 109.194 175.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.04 -38.19 3.16 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 121.401 0.445 . . . . 72.11 113.27 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.61 HD13 ' HB ' ' C' ' 86' ' ' ILE . 1.8 pp -78.72 149.13 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.258 1.023 . . . . 73.33 109.079 175.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.544 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 11.4 tp10 -146.17 146.02 30.68 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.968 0.507 . . . . 73.3 110.384 -172.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.34 -111.57 2.14 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 124.039 0.837 . . . . 64.12 113.903 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 7.1 m -63.7 -34.61 78.25 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.283 1.033 . . . . 75.43 111.219 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.544 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 38.8 mt-30 -70.85 -32.6 69.66 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.857 0.863 . . . . 75.22 111.158 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.544 ' HG3' HG22 ' G' ' 451' ' ' VAL . 17.4 tmm? -73.86 -43.78 57.52 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.689 -0.485 . . . . 73.05 109.689 176.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.65 70.64 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.224 -0.898 . . . . 74.43 110.806 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -67.49 -46.29 73.37 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.347 1.059 . . . . 72.42 110.651 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.567 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 44.7 t -64.4 -40.41 95.75 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 123.905 0.753 . . . . 72.13 111.157 -176.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.467 HD21 HD12 ' C' ' 86' ' ' ILE . 77.0 mt -90.27 -34.65 15.67 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.648 0.61 . . . . 74.15 112.648 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.87 -7.19 64.69 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-O 119.619 -0.545 . . . . 62.53 114.363 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.22 -55.22 0.16 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.718 0.771 . . . . 61.53 111.697 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.567 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 55.7 t80 -67.79 -35.73 79.18 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.326 1.45 . . . . 74.22 112.526 -172.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 35.1 m -80.52 -43.74 1.33 Allowed Pre-proline 0 N--CA 1.485 1.294 0 CA-C-O 118.924 -0.56 . . . . 74.04 112.377 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.33 -30.74 27.56 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.871 2.38 . . . . 72.31 114.257 166.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -60.95 -39.4 89.39 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.296 1.038 . . . . 75.44 110.334 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.582 HD13 ' NH1' ' A' ' 111' ' ' ARG . 40.8 mm -72.03 -40.3 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.719 0.807 . . . . 74.44 110.461 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.429 HD22 ' HG3' ' C' ' 80' ' ' GLN . 83.6 mt -78.93 -23.54 44.61 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.23 1.012 . . . . 74.52 112.644 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -59.67 -50.79 85.16 Favored Pre-proline 0 CA--C 1.556 1.173 0 N-CA-C 114.021 1.119 . . . . 64.22 114.021 -172.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.5 -35.44 96.74 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.088 1.859 . . . . 72.24 113.11 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -68.41 -50.04 55.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.587 0.755 . . . . 74.13 110.981 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.84 -37.44 84.48 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.532 -0.758 . . . . 73.11 111.042 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -58.15 -55.19 38.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.906 1.282 . . . . 73.43 110.817 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -66.97 -29.5 69.37 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.228 0.611 . . . . 75.12 110.58 -176.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.451 ' SG ' HG12 ' C' ' 21' ' ' ILE . 34.5 t -73.23 -32.19 64.6 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.23 0.612 . . . . 72.2 111.542 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.515 HD11 ' HB ' ' C' ' 62' ' ' VAL . 86.1 mt -71.23 -46.28 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.42 0.688 . . . . 74.22 109.483 172.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 23.1 m -61.34 -36.33 79.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.775 0.83 . . . . 74.24 111.33 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 37.7 t -60.19 -49.62 76.92 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.336 -0.847 . . . . 74.31 109.416 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.59 -32.62 74.3 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.586 1.155 . . . . 75.31 113.078 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.471 HG13 ' HB2' ' C' ' 123' ' ' PHE . 53.0 t -74.81 -35.39 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.437 0.695 . . . . 63.22 110.522 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 36.7 t -67.9 -35.86 79.2 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.576 0.75 . . . . 75.05 110.857 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' C' ' 116' ' ' SER . 71.7 mtt-85 -67.66 -43.76 79.48 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.435 -0.802 . . . . 73.33 109.613 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.87 1.21 84.88 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 123.737 0.648 . . . . 74.42 112.857 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 67.3 p 62.83 25.5 15.11 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.337 1.855 . . . . 61.22 114.823 167.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.471 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.8 m-85 -84.71 157.4 60.86 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 108.75 -0.833 . . . . 73.01 108.75 167.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.549 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 79.9 Cg_exo -51.61 142.28 40.51 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.93 2.42 . . . . 75.24 113.364 175.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.609 HE21 ' HB2' ' B' ' 119' ' ' SER . 14.7 mm100 -55.78 138.19 48.36 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.375 1.047 . . . . 73.11 113.015 -172.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.657 HD13 HG12 ' C' ' 64' ' ' VAL . 8.2 tt -104.58 114.79 29.24 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.5 -1.227 . . . . 71.14 108.778 -173.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -119.02 100.0 7.08 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.785 -0.821 . . . . 73.13 108.785 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.438 HD23 HD22 ' G' ' 468' ' ' LEU . 0.1 OUTLIER -71.91 135.47 46.54 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.494 0.717 . . . . 75.34 109.946 -175.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.68 153.25 91.21 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.997 0.919 . . . . 71.43 111.411 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.512 ' HG3' HD13 ' A' ' 16' ' ' ILE . 31.6 Cg_exo -58.48 109.25 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.254 1.97 . . . . 75.31 112.06 172.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 91.0 t -96.28 110.73 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.031 -1.47 . . . . 73.04 107.031 173.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -83.01 94.1 7.7 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.916 -1.142 . . . . 74.44 107.916 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.557 ' HE1' HD22 ' C' ' 44' ' ' LEU . 84.8 m-85 -63.25 -38.79 92.54 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.151 0.98 . . . . 72.04 111.881 -175.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.21 -37.24 80.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.905 0.882 . . . . 74.34 111.35 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.93 -27.89 43.77 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.967 0.507 . . . . 71.12 110.373 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 54.0 tp -74.61 -26.25 59.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.257 0.623 . . . . 73.51 110.218 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.427 ' HA ' ' HE1' ' G' ' 461' ' ' PHE . 68.9 t80 -61.05 -51.07 70.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.917 0.887 . . . . 74.53 111.775 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 26.5 ptm -57.12 -27.28 61.68 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.349 0.66 . . . . 73.44 112.705 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -56.96 -30.72 64.32 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.968 1.307 . . . . 71.35 113.286 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -155.23 0.02 OUTLIER 'General case' 0 CA--C 1.573 1.857 0 C-N-CA 123.205 0.602 . . . . 74.52 111.463 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' C' ' 144' ' ' GLN . 16.3 tp 71.82 131.56 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.689 1.195 . . . . 74.23 112.25 167.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -69.88 -61.26 1.85 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.206 -0.664 . . . . 71.11 109.206 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -98.05 87.79 4.05 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.871 -0.604 . . . . 72.03 110.069 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.451 ' HA ' HD23 ' C' ' 141' ' ' LEU . 73.0 mt-30 -73.79 158.45 34.56 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.706 0.402 . . . . 70.02 110.509 172.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.25 151.64 45.3 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.591 0.756 . . . . 73.55 109.645 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.94 167.52 51.17 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.736 0.648 . . . . 70.1 112.554 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -134.99 99.15 4.2 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.289 0.545 . . . . 72.33 110.321 -171.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.65 91.83 1.09 Allowed Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.823 -0.626 . . . . 65.11 112.018 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.724 ' HA ' ' HG2' ' A' ' 147' ' ' GLU . 40.0 p -90.01 105.6 17.92 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.263 0.625 . . . . 75.41 110.176 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -76.56 124.55 27.77 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.515 -0.55 . . . . 73.3 109.515 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.8 108.48 2.99 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.585 -0.895 . . . . 73.22 108.585 171.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . 0.492 ' HB3' ' HA ' ' A' ' 145' ' ' ALA . 54.1 t-80 -74.93 82.31 2.19 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.516 -0.92 . . . . 73.21 108.516 174.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.494 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 59.7 tt0 -99.38 103.34 15.14 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.015 0.526 . . . . 62.55 109.725 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -84.04 86.31 7.22 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.637 -0.875 . . . . 64.42 108.637 172.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.213 0 CA-C-N 115.081 -0.963 . . . . 74.34 110.162 179.313 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 109.854 -0.424 . . . . 64.1 109.854 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -82.46 85.59 6.9 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.21 -0.663 . . . . 55.12 109.21 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.56 131.49 34.37 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.243 -0.651 . . . . 74.22 109.243 -175.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -139.07 161.59 37.0 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.016 0.526 . . . . 75.4 112.076 -170.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -170.68 112.33 0.4 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 106.632 -1.618 . . . . 74.41 106.632 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -78.58 147.56 33.67 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.195 0.452 . . . . 71.31 111.097 -172.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' THR . . . . . 0.485 HG23 ' H ' ' D' ' 8' ' ' GLU . 0.8 OUTLIER -99.46 -166.02 1.3 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 124.256 1.022 . . . . 72.41 108.773 178.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.485 ' H ' HG23 ' D' ' 7' ' ' THR . 42.9 mm-40 -62.67 -86.88 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 109.246 -0.65 . . . . 53.41 109.246 171.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -37.15 136.47 0.42 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.275 0.63 . . . . 74.14 112.067 157.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 40.4 m -143.29 140.89 30.82 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.2 -0.667 . . . . 65.31 109.2 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.443 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 54.7 t80 -164.22 89.82 0.56 Allowed 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.013 -1.847 . . . . 72.44 106.013 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -128.41 130.67 47.99 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.725 -0.843 . . . . 74.42 108.725 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -90.83 110.98 22.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.123 -1.066 . . . . 61.44 108.123 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -73.86 -31.27 63.09 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.295 0.372 . . . . 75.24 110.711 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -168.68 131.68 1.4 Allowed 'General case' 0 C--N 1.349 0.547 0 O-C-N 123.268 0.355 . . . . 75.12 110.669 -169.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.516 HD11 ' HG3' ' B' ' 130' ' ' PRO . 2.0 mp -116.36 128.75 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 105.846 -1.909 . . . . 75.12 105.846 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.443 ' HE1' HG13 ' D' ' 83' ' ' ILE . 40.3 p90 -156.2 160.41 39.81 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.053 0.93 . . . . 75.34 112.477 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -91.33 118.43 30.51 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 113.738 -1.574 . . . . 73.42 108.887 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.414 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.0 mtpt -82.3 -37.37 25.89 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.632 -0.713 . . . . 72.52 109.404 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -150.24 139.06 20.85 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.106 -1.406 . . . . 61.1 109.125 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE1' ' C' ' 117' ' ' MET . 63.9 mt -137.92 147.75 25.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.919 1.287 . . . . 74.15 108.118 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.6 t -148.15 126.23 12.11 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.622 0.769 . . . . 75.1 109.48 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.515 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 66.6 t80 -121.19 133.19 55.17 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.205 -1.406 . . . . 75.03 107.205 164.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.717 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.7 mt-10 -134.84 136.7 42.66 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.34 1.056 . . . . 72.24 108.343 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.21 83.74 63.12 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.46 -1.311 . . . . 61.32 107.46 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.92 -52.95 2.41 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.05 2.5 . . . . 74.34 112.967 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.567 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 5.1 m-20 -102.18 19.69 18.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.287 0.635 . . . . 64.31 109.64 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.41 ' O ' HG11 ' D' ' 31' ' ' VAL . . . -23.85 -75.24 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 116.535 2.05 . . . . 64.41 116.535 -167.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.513 ' HB3' HD11 ' C' ' 83' ' ' ILE . 83.8 Cg_endo -77.28 -16.7 15.31 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 124.033 2.476 . . . . 72.14 113.539 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.42 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 0.2 OUTLIER -71.16 -44.45 65.49 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.209 1.004 . . . . 73.43 108.557 172.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.8 p -82.63 -20.74 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.466 0.706 . . . . 72.31 111.351 -168.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.84 -14.14 62.71 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.61 0.364 . . . . 71.15 111.599 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -67.27 -14.48 62.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.703 0.801 . . . . 71.22 110.925 174.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.617 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 97.4 mttt -97.79 101.63 13.18 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.855 1.262 . . . . 75.13 109.202 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -85.38 93.07 8.64 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.314 -0.625 . . . . 73.51 109.314 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -162.52 156.95 21.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.704 0.801 . . . . 72.45 109.192 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -76.52 105.45 2.33 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.386 -0.968 . . . . 72.5 108.386 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.05 124.97 17.16 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.002 2.468 . . . . 73.44 112.316 -170.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.52 114.83 4.62 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.864 0.727 . . . . 64.33 109.827 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.29 149.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.877 0.871 . . . . 73.4 112.018 -171.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' D' ' 64' ' ' VAL . 46.1 tptt -120.7 120.36 35.46 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.1 1.36 . . . . 73.41 107.866 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.501 HD23 HD12 ' D' ' 128' ' ' LEU . 7.2 mp -97.85 121.06 39.31 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.077 -0.712 . . . . 74.02 109.077 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.575 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 14.6 t70 -108.61 120.48 42.58 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.117 -1.068 . . . . 72.1 108.117 170.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 tt -106.43 127.79 53.56 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.506 -0.924 . . . . 72.14 108.506 -174.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.2 t70 -134.97 148.19 49.94 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.339 1.056 . . . . 73.12 108.434 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -120.19 152.21 38.01 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.999 0.52 . . . . 64.1 109.626 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.518 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -150.98 171.21 17.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.371 1.068 . . . . 71.14 108.252 174.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -174.62 161.66 3.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.065 0.546 . . . . 72.2 110.939 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.7 p -159.22 147.81 18.05 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.381 0.672 . . . . 64.42 109.93 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -87.0 127.06 35.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.474 -0.565 . . . . 74.1 109.474 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 67.6 mt -97.86 -38.62 9.37 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.289 0.635 . . . . 74.55 110.862 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.75 -173.74 4.66 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.567 0.747 . . . . 61.01 110.566 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.91 105.51 1.04 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.02 -0.991 . . . . 73.11 110.444 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 68.36 18.98 9.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.915 1.286 . . . . 71.2 111.554 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -110.77 123.08 66.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 N-CA-C 107.454 -1.313 . . . . 74.1 107.454 167.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -136.86 129.77 30.76 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.255 -0.646 . . . . 75.21 109.255 -176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -91.13 144.38 25.69 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.214 1.005 . . . . 74.52 109.624 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.0 t -123.12 145.64 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.079 1.352 . . . . 74.31 107.629 171.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.518 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 45.6 t -127.53 144.91 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.096 0.958 . . . . 74.1 108.914 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -127.7 122.09 32.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.863 -1.162 . . . . 72.1 107.863 178.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 37.0 ttm-85 -102.63 97.48 7.67 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.483 -0.932 . . . . 74.04 108.483 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.14 104.25 15.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.339 -0.985 . . . . 74.13 108.339 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.3 m -97.9 146.36 25.54 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.263 -0.88 . . . . 73.5 108.842 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 53.8 t -140.37 109.03 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.397 1.079 . . . . 75.35 108.841 -177.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -102.57 110.8 22.85 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.72 -0.845 . . . . 72.34 108.72 171.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.0 157.24 17.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.033 0.533 . . . . 73.33 110.48 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 21.6 p -154.64 130.97 10.43 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.449 0.642 . . . . 72.14 112.01 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 25.1 mt -97.91 101.62 13.16 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.384 -1.28 . . . . 75.24 107.876 170.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.97 -123.22 7.29 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.599 -0.728 . . . . 63.41 112.591 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.75 5.63 48.95 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.304 0.642 . . . . 72.13 112.341 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.617 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 13.0 pt-20 -129.09 160.14 33.75 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.207 0.603 . . . . 73.1 109.801 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -67.17 139.46 57.45 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.565 0.541 . . . . 75.13 110.412 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.578 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -92.89 -65.25 1.01 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.324 -0.853 . . . . 74.33 108.952 175.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -145.93 167.76 22.51 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.144 -0.935 . . . . 74.35 109.641 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.717 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.0 mt -132.14 140.38 48.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.404 -1.332 . . . . 73.45 107.404 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.508 ' SG ' HG21 ' D' ' 114' ' ' ILE . 1.2 m -144.91 139.51 27.67 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.022 0.929 . . . . 74.15 108.717 -177.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -158.2 130.19 6.88 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.007 -0.738 . . . . 74.41 109.007 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 62.8 t -134.87 117.5 22.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 109.258 -0.645 . . . . 73.22 109.258 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -89.58 85.48 6.5 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.612 0.72 . . . . 74.45 109.072 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -80.02 101.5 8.72 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.211 -1.359 . . . . 75.12 109.541 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.87 160.69 23.34 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.416 -0.673 . . . . 22.4 111.416 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.45 132.91 3.66 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.118 -0.793 . . . . 61.31 111.118 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.443 HG13 ' HE1' ' D' ' 17' ' ' TYR . 64.7 mt -87.69 124.56 41.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.152 0.981 . . . . 75.13 108.361 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -122.66 123.7 41.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.413 0.285 . . . . 71.31 110.368 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 48.5 m -83.49 110.19 17.99 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.745 -1.205 . . . . 61.1 107.745 164.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.452 HG13 HG11 ' H' ' 451' ' ' VAL . 15.6 pt -130.25 145.31 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.909 0.884 . . . . 74.32 110.617 -170.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.28 167.46 25.87 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.863 0.865 . . . . 42.25 109.913 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.73 -18.89 13.14 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 114.285 0.474 . . . . 64.33 114.285 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 pt -112.2 126.89 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.848 0.859 . . . . 74.14 109.113 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.53 164.33 30.44 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.068 0.547 . . . . 72.44 110.676 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.47 -129.29 30.93 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.582 0.552 . . . . 73.12 113.94 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.4 m -70.52 -29.4 65.88 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.501 0.721 . . . . 75.3 111.452 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.68 -43.57 98.48 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.978 0.911 . . . . 74.24 111.444 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.4 ' HG2' ' O ' ' H' ' 451' ' ' VAL . 0.0 OUTLIER -73.67 -31.83 63.66 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 116.244 -0.434 . . . . 72.41 110.746 179.103 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.64 88.06 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.998 0.519 . . . . 74.32 111.063 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -64.71 -31.79 73.17 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.786 0.835 . . . . 70.34 111.054 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.9 t -79.71 -49.6 11.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.516 0.326 . . . . 64.24 110.783 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.466 HD21 ' SG ' ' D' ' 102' ' ' CYS . 84.3 mt -79.28 -29.37 42.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.692 0.797 . . . . 73.35 112.238 -169.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.37 6.65 63.5 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 119.792 -0.449 . . . . 73.1 113.183 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.26 -67.94 0.23 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.258 0.529 . . . . 71.14 111.955 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . 0.403 ' O ' HG12 ' D' ' 105' ' ' ILE . 66.9 t80 -64.86 -37.77 88.74 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 112.467 0.544 . . . . 74.53 112.467 -172.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.466 ' SG ' HD21 ' D' ' 98' ' ' LEU . 85.9 m -70.65 -48.47 16.28 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-O 118.599 -0.715 . . . . 71.42 111.461 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.482 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 75.2 Cg_exo -55.96 -33.18 88.39 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.013 1.809 . . . . 75.12 113.185 167.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.56 -35.71 81.64 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.251 0.621 . . . . 73.43 111.169 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.403 HG12 ' O ' ' D' ' 101' ' ' TYR . 36.6 mm -67.84 -40.09 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.601 0.76 . . . . 74.14 110.523 174.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.7 mt -79.04 -16.93 56.14 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.642 -0.708 . . . . 75.44 111.514 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.31 -41.32 24.24 Favored Pre-proline 0 N--CA 1.485 1.317 0 N-CA-C 114.437 1.273 . . . . 71.51 114.437 -172.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.45 -39.21 92.85 Favored 'Trans proline' 0 C--N 1.385 2.476 0 CA-C-N 121.769 1.667 . . . . 75.25 112.74 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -71.16 -40.46 71.28 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.52 0.728 . . . . 75.43 110.95 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.79 -44.59 96.63 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.875 0.87 . . . . 64.32 110.639 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.51 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 19.8 ttp180 -59.92 -53.5 57.11 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.335 -1.302 . . . . 71.52 110.198 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.47 -42.77 99.72 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.28 0.988 . . . . 72.55 111.724 -172.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.8 t -58.52 -40.55 83.22 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.688 0.618 . . . . 64.23 110.875 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.508 HG21 ' SG ' ' D' ' 76' ' ' CYS . 84.3 mt -66.95 -50.3 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.626 0.77 . . . . 65.25 110.622 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -54.91 -43.86 73.67 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.213 1.005 . . . . 73.02 111.529 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.7 t -66.91 -42.02 86.11 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.48 -1.237 . . . . 74.51 110.519 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.515 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 71.9 mtm -66.12 -37.35 85.5 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.856 0.463 . . . . 73.32 111.638 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 72.0 t -63.21 -44.57 99.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.117 0.967 . . . . 73.13 110.479 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -73.57 -31.02 63.39 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 116.038 -0.528 . . . . 73.25 111.381 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -71.82 -30.3 65.34 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.205 0.602 . . . . 74.14 110.094 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.97 11.38 69.38 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.715 0.635 . . . . 72.13 112.663 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 66.2 p 58.15 21.93 8.54 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 126.446 1.899 . . . . 71.55 114.244 175.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -84.32 147.85 51.23 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 108.818 -0.808 . . . . 74.21 108.818 169.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.5 135.22 47.51 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 123.067 2.512 . . . . 74.33 112.488 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -50.63 140.91 13.52 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.957 1.303 . . . . 71.42 113.003 -170.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.443 ' HA ' HD11 ' H' ' 468' ' ' LEU . 55.2 tp -122.34 100.87 7.18 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.44 0.696 . . . . 73.2 110.713 -176.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.544 ' H ' HD11 ' H' ' 468' ' ' LEU . 74.0 m-20 -99.67 101.16 12.26 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.093 -1.077 . . . . 64.51 108.093 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.51 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.7 mm? -69.23 114.27 7.34 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.338 0.655 . . . . 71.3 109.517 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.415 ' HB1' ' SD ' ' H' ' 464' ' ' MET . . . -58.09 132.72 83.96 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.177 0.591 . . . . 72.01 111.414 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.472 ' HB3' HH12 ' D' ' 111' ' ' ARG . 58.6 Cg_endo -72.85 126.1 11.04 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.252 1.968 . . . . 72.44 111.185 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.82 141.79 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.797 0.839 . . . . 73.04 110.065 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -77.68 103.15 7.44 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.403 -0.962 . . . . 75.02 108.403 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -72.0 -40.56 68.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.801 0.441 . . . . 74.45 110.492 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.423 ' O ' ' HG3' ' D' ' 138' ' ' MET . 5.8 m-20 -61.29 -53.46 56.53 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.905 0.882 . . . . 71.53 112.668 -172.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.33 99.08 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.28 0.632 . . . . 63.31 111.165 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.41 -27.65 67.25 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.204 -0.907 . . . . 75.02 111.6 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.424 ' O ' HD13 ' D' ' 141' ' ' LEU . 84.1 t80 -72.02 -40.06 68.72 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.465 0.706 . . . . 73.24 110.423 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.423 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 36.6 mtt -64.16 -36.76 85.11 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.272 0.629 . . . . 73.03 110.11 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -70.56 -41.6 72.24 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.2 -0.909 . . . . 74.11 110.402 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -61.42 -34.63 75.71 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.215 1.006 . . . . 75.31 111.427 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.424 HD13 ' O ' ' D' ' 137' ' ' PHE . 1.2 mp -59.45 -34.33 72.39 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.722 0.809 . . . . 75.33 111.339 175.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -87.98 0.71 55.57 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.855 0.862 . . . . 72.5 111.567 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -121.71 90.66 3.35 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.001 0.92 . . . . 75.15 109.647 -175.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.04 160.07 42.39 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.789 0.836 . . . . 73.13 109.521 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.57 91.43 1.42 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.311 0.644 . . . . 72.0 110.248 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.08 -156.32 31.48 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.828 -0.624 . . . . 45.03 112.001 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -129.3 123.35 31.63 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.843 0.857 . . . . 72.43 109.874 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.1 61.58 4.28 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 111.283 -0.727 . . . . 73.12 111.283 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.3 t -62.04 142.84 57.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.072 0.949 . . . . 71.41 111.089 -175.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.74 141.29 19.84 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.004 0.522 . . . . 72.45 109.872 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -105.73 134.35 48.99 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.328 -1.36 . . . . 64.31 107.328 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -137.13 94.86 3.0 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.637 0.775 . . . . 73.25 108.958 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -64.49 129.45 39.91 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 122.877 0.471 . . . . 74.22 110.653 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -108.6 6.47 25.96 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.554 0.741 . . . . 73.15 110.753 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.217 0 C-N-CA 123.622 0.769 . . . . 74.14 109.992 179.759 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.444 0.164 . . . . 74.11 110.624 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . 0.601 HG13 HG12 ' E' ' 452' ' ' VAL . 7.4 p -76.23 -42.79 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 122.835 0.454 . . . . 73.14 111.226 -177.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . 0.601 HG12 HG13 ' E' ' 451' ' ' VAL . 15.6 m -99.89 111.11 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.051 0.54 . . . . 75.51 111.511 -171.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -73.88 -62.11 3.09 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-N 115.739 -0.664 . . . . 61.12 111.728 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 2.2 tm? 56.21 92.69 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.489 1.516 . . . . 72.04 112.084 170.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 15.2 t -77.57 171.36 15.03 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.989 0.515 . . . . 73.01 110.414 174.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -73.06 81.12 1.23 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.187 0.595 . . . . 73.41 110.026 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . 0.418 ' HB2' HD11 ' A' ' 98' ' ' LEU . 79.2 mt-30 -81.68 130.63 35.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.029 -0.73 . . . . 54.51 109.029 175.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 15.0 t -137.34 -174.82 3.86 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.923 0.889 . . . . 60.53 109.189 -174.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 31.0 t70 70.25 112.54 0.05 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.52 1.128 . . . . 72.43 110.429 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 46' ' ' THR . 4.3 mm? -98.42 132.64 43.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.357 0.663 . . . . 70.15 109.677 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -86.17 27.36 0.92 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.02 1.328 . . . . 72.14 110.503 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -74.87 130.94 40.3 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.46 0.704 . . . . 74.15 110.552 -174.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 8.9 t -167.73 143.78 4.04 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.519 1.127 . . . . 63.44 108.602 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 464' ' ' MET . . . . . 0.608 ' SD ' HD23 ' A' ' 42' ' ' LEU . 22.7 ptm -144.51 113.23 6.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.513 0.725 . . . . 62.34 109.173 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -107.32 99.36 8.89 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.359 -0.978 . . . . 71.5 108.359 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -167.52 -33.94 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.788 0.835 . . . . 74.3 110.554 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . 69.68 173.22 0.3 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.036 1.334 . . . . 73.01 112.205 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . 0.417 HD13 HG13 ' A' ' 40' ' ' VAL . 88.8 mt -90.12 -62.1 1.54 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.134 0.574 . . . . 71.51 110.894 -174.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 93.91 40.96 4.49 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 115.528 -0.76 . . . . 71.13 112.63 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 91.3 mt -68.71 -53.82 19.81 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.718 -1.216 . . . . 73.34 107.718 167.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt . . . . . 0 CA--C 1.549 0.928 0 C-N-CA 125.757 1.623 . . . . 75.11 107.46 169.827 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 57.9 t30 . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 108.364 -0.976 . . . . 72.41 108.364 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . 0.555 HG21 HG23 ' F' ' 452' ' ' VAL . 21.6 m -61.6 -44.61 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 123.404 0.44 . . . . 71.22 111.78 -177.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . 0.555 HG23 HG21 ' F' ' 451' ' ' VAL . 23.5 m -138.95 -59.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 112.706 0.632 . . . . 74.1 112.706 -172.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . 0.455 ' N ' HG22 ' F' ' 452' ' ' VAL . . . 72.48 63.19 2.99 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.236 -1.146 . . . . 51.11 110.236 -163.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . 0.541 HD12 ' HE3' ' B' ' 94' ' ' MET . 58.4 tp -66.8 131.09 45.21 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 122.761 0.425 . . . . 71.42 110.431 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 7.3 t -145.22 126.29 14.62 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.957 0.903 . . . . 72.4 108.934 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -169.05 136.75 1.9 Allowed 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.125 -1.435 . . . . 75.45 107.125 173.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -147.64 72.78 1.25 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.829 0.823 . . . . 75.41 109.606 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 7.6 p -106.45 -75.75 0.62 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.703 -1.135 . . . . 73.12 108.44 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -178.54 -174.9 0.41 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 125.502 1.521 . . . . 72.44 108.161 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . 0.41 HD21 ' HA ' ' B' ' 45' ' ' ASP . 2.0 pt? -137.65 148.79 46.05 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.237 0.615 . . . . 75.44 109.451 177.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -72.89 146.16 46.36 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.588 1.155 . . . . 74.23 111.697 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -132.13 67.4 1.53 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.288 -1.375 . . . . 74.4 107.288 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 28.8 m -80.26 84.34 5.95 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.014 -0.994 . . . . 75.44 108.37 174.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 464' ' ' MET . . . . . 0.475 ' SD ' ' HA ' ' F' ' 467' ' ' ALA . 39.0 tpp -91.01 146.85 23.5 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.101 -0.954 . . . . 75.2 110.796 -172.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.5 -63.11 0.9 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.169 0.988 . . . . 75.41 109.435 -175.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -82.94 -30.6 28.22 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.271 0.628 . . . . 72.41 111.565 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . 0.475 ' HA ' ' SD ' ' F' ' 464' ' ' MET . . . 68.84 -77.49 0.05 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.321 1.448 . . . . 75.4 111.569 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . 0.541 ' HG ' HG11 ' B' ' 40' ' ' VAL . 2.6 tm? -147.43 -25.49 0.38 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.093 0.957 . . . . 74.21 108.948 -174.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 94.11 -58.55 2.05 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 110.009 -1.236 . . . . 72.2 110.009 -168.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 10.4 tp 55.9 74.97 0.36 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.034 1.334 . . . . 74.22 109.578 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--O 1.253 1.239 0 CA-C-O 118.562 -0.732 . . . . 65.55 109.959 -174.546 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 110.284 -0.265 . . . . 73.24 110.284 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . 0.544 HG22 ' HG3' ' C' ' 94' ' ' MET . 15.0 p -87.21 114.97 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 122.01 0.91 . . . . 72.32 111.312 -170.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 19.7 m -141.03 -168.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.806 1.242 . . . . 63.33 109.305 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 86.81 58.53 1.9 Allowed Glycine 0 C--N 1.342 0.909 0 CA-C-O 121.125 0.292 . . . . 63.21 112.733 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . 0.413 ' HG ' ' HB2' ' C' ' 48' ' ' SER . 3.4 tm? -88.38 121.26 30.58 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.616 -1.253 . . . . 71.43 107.616 173.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 9.9 t -89.11 136.23 33.13 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 109.938 -0.393 . . . . 72.05 109.938 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -77.44 98.76 5.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.235 -0.439 . . . . 62.51 110.375 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -88.77 88.19 7.51 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.763 -1.199 . . . . 73.44 107.763 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 31.5 p -63.49 -37.65 88.13 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.423 1.089 . . . . 64.21 112.069 -173.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -78.73 84.59 4.8 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 109.109 -0.7 . . . . 74.32 109.109 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.28 110.39 5.22 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.615 -0.883 . . . . 75.53 108.615 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . 0.427 ' HE1' ' HA ' ' C' ' 137' ' ' PHE . 16.6 p90 -52.74 83.76 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 126.117 1.767 . . . . 65.11 111.941 173.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -137.89 90.95 2.53 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.682 -0.859 . . . . 75.1 108.682 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 41.6 p -92.48 82.63 4.87 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.995 -0.742 . . . . 73.24 108.995 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 52.3 ttm -163.74 117.16 1.49 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.172 -1.048 . . . . 73.32 108.172 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . 0.465 ' O ' HD13 ' C' ' 42' ' ' LEU . 65.1 mttm -129.56 -60.03 1.06 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.208 0.603 . . . . 74.43 109.847 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -90.07 85.33 6.28 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.955 -0.757 . . . . 71.5 108.955 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -129.41 6.4 5.27 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.633 0.773 . . . . 62.21 111.209 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . 0.653 HD11 HG21 ' C' ' 40' ' ' VAL . 82.3 mt -117.78 124.04 47.44 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.632 0.773 . . . . 71.41 109.059 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -80.86 61.92 4.47 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 110.919 -0.872 . . . . 61.53 110.919 172.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . 0.421 HD13 ' HG2' ' C' ' 38' ' ' PRO . 0.2 OUTLIER -95.14 31.13 1.97 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.541 1.136 . . . . 74.15 108.215 -176.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt . . . . . 0 C--O 1.255 1.36 0 C-N-CA 125.024 1.33 . . . . 72.44 108.904 -172.205 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 20.2 m120 . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.628 -0.508 . . . . 72.25 109.628 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . 0.714 HG12 HG12 ' H' ' 452' ' ' VAL . 9.7 p -54.55 -32.77 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 124.182 0.993 . . . . 75.12 112.789 -174.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.714 HG12 HG12 ' H' ' 451' ' ' VAL . 20.1 m -114.37 151.7 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.629 0.728 . . . . 73.12 112.449 -172.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -158.82 28.71 0.42 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-N 114.115 -1.402 . . . . 71.12 111.065 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.55 127.52 42.62 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.253 0.621 . . . . 74.31 109.847 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 38.2 p -78.02 -4.79 48.93 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.917 0.887 . . . . 74.44 111.658 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 31.8 t70 73.46 148.94 0.09 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.71 1.604 . . . . 74.03 111.059 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' H' ' 458' ' ' THR . 17.6 tt0 -152.53 141.11 20.8 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.333 0.653 . . . . 75.44 109.381 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 458' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' H' ' 457' ' ' GLN . 13.4 t -86.77 151.36 23.45 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.392 -0.966 . . . . 75.14 108.392 166.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 71.66 155.7 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.035 1.334 . . . . 72.41 111.456 -174.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . 0.427 ' HG ' ' H ' ' H' ' 461' ' ' PHE . 1.8 pt? -162.17 -73.57 0.05 Allowed 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.62 -0.718 . . . . 74.34 109.833 175.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . 0.427 ' H ' ' HG ' ' H' ' 460' ' ' LEU . 30.3 p90 -176.8 157.42 1.51 Allowed 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.561 1.144 . . . . 73.13 109.362 -171.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -162.56 120.02 2.04 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.726 0.81 . . . . 74.04 109.476 167.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 34.5 m -152.16 106.52 3.17 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.72 0.808 . . . . 72.52 109.017 170.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 464' ' ' MET . . . . . 0.415 ' SD ' ' HB1' ' D' ' 129' ' ' ALA . 16.4 tmm? -149.48 113.86 5.24 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.21 -1.033 . . . . 74.31 108.21 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -90.25 118.85 30.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.363 0.665 . . . . 74.24 110.48 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . 72.32 97.39 0.07 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.005 1.322 . . . . 75.32 112.424 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -72.85 -53.83 10.4 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.847 -0.615 . . . . 61.13 109.85 174.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . 0.544 HD11 ' H ' ' D' ' 127' ' ' ASN . 87.6 mt -132.28 28.18 4.41 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.154 1.382 . . . . 74.23 108.676 173.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 79.08 -73.57 2.31 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.763 -0.535 . . . . 74.24 111.763 -170.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 64.19 95.77 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.091 1.356 . . . . 73.52 110.986 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 23.1 tptm . . . . . 0 CA--C 1.559 1.325 0 C-N-CA 124.534 1.134 . . . . 75.35 111.246 173.557 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptm . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.183 -0.303 . . . . 74.41 110.183 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.9 m -94.6 78.95 3.78 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.604 0.762 . . . . 54.21 109.38 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -99.21 81.89 2.63 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.296 -0.866 . . . . 74.23 108.805 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.83 88.58 6.78 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.721 -1.127 . . . . 74.01 109.242 174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -66.27 116.22 7.08 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.035 -0.529 . . . . 71.55 110.824 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.9 t30 60.91 -90.47 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.407 1.483 . . . . 71.41 112.587 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 m -78.99 80.8 5.31 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.761 0.791 . . . . 73.44 110.352 -168.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -80.98 104.05 11.22 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.686 -1.143 . . . . 75.14 109.023 176.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.27 174.06 12.39 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.633 -1.167 . . . . 75.03 109.717 -175.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m -141.56 137.25 31.83 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.432 0.693 . . . . 64.44 109.341 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.664 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 10.1 t80 -135.99 129.37 31.97 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.954 0.902 . . . . 75.24 108.607 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -149.68 127.56 11.82 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.706 0.803 . . . . 72.44 109.155 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.574 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.1 mt -95.34 119.21 43.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.896 -0.779 . . . . 73.22 108.896 173.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -88.69 -34.29 17.26 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 123.46 0.475 . . . . 70.43 110.184 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -166.87 126.16 1.45 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 116.414 -0.357 . . . . 74.43 111.141 -166.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.462 HD13 ' HG3' ' C' ' 130' ' ' PRO . 73.4 mt -120.3 138.51 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 124.37 1.068 . . . . 75.04 108.969 173.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -158.37 176.08 12.9 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.288 0.992 . . . . 74.25 111.511 -171.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.0 p -106.13 119.4 39.11 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.657 -1.238 . . . . 72.24 107.657 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -80.02 -48.58 13.09 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.841 -0.8 . . . . 71.41 108.841 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 22.7 m-20 -134.55 125.23 26.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.611 -1.177 . . . . 70.21 109.014 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 79.3 mt -117.62 144.28 25.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 106.775 -1.565 . . . . 73.23 106.775 173.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 43.2 t -152.41 142.16 21.95 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.102 0.477 . . . . 60.22 109.777 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.572 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 35.4 t80 -144.33 124.09 13.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.802 -1.555 . . . . 74.23 106.802 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.97 111.55 10.51 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.312 -0.996 . . . . 74.2 108.312 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.22 81.71 17.24 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.903 0.881 . . . . 74.41 109.274 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 72' ' ' THR . 22.0 Cg_exo -66.99 -14.46 43.76 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.077 2.518 . . . . 75.32 112.328 174.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.5 ' HB2' ' HA ' ' A' ' 73' ' ' ALA . 21.9 m-80 -117.35 30.15 7.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.853 0.861 . . . . 73.24 110.395 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.52 98.23 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 123.717 0.807 . . . . 64.31 113.006 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -85.12 -24.8 1.95 Allowed 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 121.644 1.563 . . . . 72.01 113.188 169.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.467 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 58.9 m170 -70.97 -34.72 71.7 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.123 0.569 . . . . 74.14 110.922 -173.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -55.86 -31.77 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.495 1.118 . . . . 72.44 112.388 -175.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.67 -32.82 70.22 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.652 0.781 . . . . 64.33 111.347 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -88.84 -45.2 9.93 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.132 0.973 . . . . 74.43 111.647 -174.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 16.1 ptpt -83.32 173.59 11.44 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.821 0.848 . . . . 74.43 111.548 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -74.27 142.7 45.24 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.565 0.746 . . . . 62.21 111.514 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -93.2 78.65 4.52 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.522 0.677 . . . . 71.41 109.832 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -125.86 79.98 67.83 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.363 -0.977 . . . . 74.43 108.363 169.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -84.15 136.23 6.72 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.354 2.036 . . . . 73.52 112.315 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -96.44 102.05 13.77 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.154 -1.424 . . . . 75.03 107.154 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.7 p -76.87 100.1 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 115.451 -0.795 . . . . 74.12 109.98 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.473 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 63.3 mttp -78.98 111.02 14.76 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.74 -1.208 . . . . 72.02 107.74 164.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.428 HD23 ' SD ' ' E' ' 464' ' ' MET . 33.4 tp -109.48 133.31 53.23 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.895 -1.15 . . . . 74.45 107.895 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.404 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 24.4 t70 -135.93 129.42 32.18 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.91 -0.774 . . . . 75.41 108.91 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.45 HD11 ' HE2' ' E' ' 464' ' ' MET . 64.2 mt -112.12 132.05 55.09 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.903 0.881 . . . . 73.5 109.013 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.76 147.73 52.46 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.709 0.803 . . . . 73.45 108.85 172.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.0 m -131.49 131.78 43.73 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.553 0.741 . . . . 61.55 109.825 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.82 154.34 50.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.144 0.978 . . . . 72.21 110.115 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.653 ' HB3' HD11 ' E' ' 454' ' ' LEU . 26.5 t -131.87 155.77 47.26 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.731 0.413 . . . . 74.23 110.284 174.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.7 p -148.76 141.21 24.27 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.572 0.749 . . . . 74.41 109.911 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -81.68 106.68 13.81 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.734 0.414 . . . . 74.35 110.479 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.6 HD12 ' HB2' ' A' ' 57' ' ' GLU . 34.1 mt -83.3 -36.3 24.58 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.263 -0.643 . . . . 74.42 109.263 173.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.42 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -155.82 177.27 11.6 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.765 1.226 . . . . 74.43 108.647 173.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -68.5 116.31 8.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.012 -0.736 . . . . 65.31 109.012 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 70.6 12.24 7.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.811 1.244 . . . . 75.1 112.476 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 42.8 t -120.38 112.41 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 107.71 -1.218 . . . . 70.44 107.71 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.81 134.43 45.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.464 0.706 . . . . 74.45 110.469 -169.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.6 ' HB2' HD12 ' A' ' 51' ' ' LEU . 33.5 tt0 -88.17 137.5 32.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.503 -0.925 . . . . 74.44 108.503 173.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.9 136.67 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.517 -1.29 . . . . 72.41 107.517 168.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.6 111.64 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.18 0.992 . . . . 74.53 108.69 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -92.23 102.3 14.81 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.168 -1.049 . . . . 74.52 108.168 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -84.33 106.76 16.19 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.002 -0.74 . . . . 75.3 109.002 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.0 t -104.35 103.97 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.834 -0.802 . . . . 61.44 108.834 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.573 HG22 ' HG3' ' A' ' 77' ' ' GLU . 74.9 p -100.35 111.96 24.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.487 0.715 . . . . 53.44 109.977 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.441 ' O ' HD13 ' A' ' 75' ' ' LEU . 92.3 t -102.9 113.83 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.059 0.944 . . . . 74.33 108.858 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 10.8 m -116.66 105.62 12.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.741 -0.837 . . . . 75.12 108.741 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.27 106.36 18.01 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 106.378 -1.712 . . . . 71.42 106.378 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 p -149.29 128.67 12.97 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.822 0.702 . . . . 74.4 110.171 -168.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.6 tp -91.3 87.22 6.39 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.678 -0.86 . . . . 72.14 108.678 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.45 -93.31 1.86 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 114.849 -1.069 . . . . 74.41 111.724 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -113.62 -27.24 7.92 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.031 0.532 . . . . 73.4 111.526 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.424 ' HG2' ' HZ2' ' A' ' 34' ' ' LYS . 5.1 mp0 -79.58 106.62 11.75 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 122.421 0.288 . . . . 73.24 110.226 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.424 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 26.8 m -76.1 116.53 16.89 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.682 -0.69 . . . . 73.44 109.327 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . . . -68.03 -50.87 52.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.911 0.884 . . . . 74.42 108.768 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.462 ' HB2' ' HE1' ' A' ' 23' ' ' PHE . 47.3 p90 -156.78 147.58 21.74 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.982 -1.463 . . . . 74.33 109.863 173.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 53.8 tp -123.02 107.85 12.26 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 107.622 -1.251 . . . . 75.33 107.622 175.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.423 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 79.8 m -106.85 99.31 8.88 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.296 0.639 . . . . 74.12 109.729 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.573 ' HG3' HG22 ' A' ' 63' ' ' THR . 32.4 tt0 -115.08 118.28 32.94 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.901 0.88 . . . . 72.52 109.309 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.4 t -130.2 109.27 17.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.617 0.722 . . . . 74.33 109.459 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -86.44 80.26 8.72 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.137 -1.392 . . . . 71.25 108.147 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -76.93 111.65 12.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.875 -1.057 . . . . 73.3 108.622 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.17 144.07 17.03 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.829 -0.508 . . . . 71.31 111.829 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.0 145.11 15.55 Favored Glycine 0 C--O 1.236 0.247 0 N-CA-C 111.283 -0.727 . . . . 63.5 111.283 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.4 mt -81.32 123.38 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 108.488 -0.93 . . . . 75.24 108.488 173.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.664 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.1 m-85 -130.18 116.35 18.31 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.804 -0.813 . . . . 74.43 108.804 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.7 p -85.7 102.98 14.08 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.203 -1.036 . . . . 75.53 108.203 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.0 pt -115.36 130.98 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.908 0.883 . . . . 74.41 109.096 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.22 147.0 30.99 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.908 0.883 . . . . 72.22 109.963 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.66 1.56 57.58 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 115.007 0.763 . . . . 62.44 115.007 171.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.53 154.72 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 118.105 0.952 . . . . 74.53 111.369 -176.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.599 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 10.8 tt0 -155.02 -174.68 5.08 Favored 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 123.931 0.892 . . . . 65.41 109.3 173.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.599 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 73.2 -139.02 26.24 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 123.331 0.491 . . . . 73.53 114.188 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.1 p -73.88 -20.88 60.28 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.441 0.696 . . . . 62.21 111.233 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -66.48 -48.14 70.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.854 0.862 . . . . 72.15 110.114 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 91' ' ' GLY . 24.7 ptt? -70.03 -30.95 68.37 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 116.136 -0.484 . . . . 73.22 110.342 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.24 -34.55 77.69 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.158 0.583 . . . . 64.45 110.56 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -71.85 -35.88 69.97 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.39 -0.823 . . . . 65.03 110.11 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.484 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 49.9 t -66.88 -43.29 83.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.962 0.505 . . . . 72.33 111.346 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.83 -38.19 23.37 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.258 -0.428 . . . . 74.43 110.785 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.91 3.03 57.06 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 114.365 0.506 . . . . 74.33 114.365 -169.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -146.87 -60.24 0.29 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.182 0.491 . . . . 75.44 111.577 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 77.2 t80 -68.89 -49.56 57.2 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.25 1.02 . . . . 71.33 113.126 -166.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.08 -34.46 0.95 Allowed Pre-proline 0 CA--C 1.565 1.55 0 N-CA-C 113.513 0.931 . . . . 74.11 113.513 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.24 -21.11 55.39 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 121.601 1.534 . . . . 74.25 113.184 165.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 3.6 m120 -62.1 -38.69 89.85 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 118.197 0.453 . . . . 75.33 110.211 169.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 13' ' ' ILE . 40.0 mm -63.04 -45.37 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 O-C-N 124.004 0.815 . . . . 74.13 110.138 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.56 -20.13 51.27 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.01 0.924 . . . . 74.43 112.781 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -62.8 -45.32 87.65 Favored Pre-proline 0 CA--C 1.569 1.705 0 N-CA-C 113.719 1.007 . . . . 75.32 113.719 -173.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -63.71 -36.15 53.65 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.1 1.867 . . . . 75.34 113.459 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -71.11 -40.45 71.46 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.018 0.527 . . . . 75.21 111.156 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.62 -43.97 83.33 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.307 0.643 . . . . 72.41 110.003 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.419 ' NH1' HD11 ' C' ' 105' ' ' ILE . 38.1 ttm180 -51.59 -51.43 55.64 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.612 1.195 . . . . 63.15 110.509 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.22 -41.9 96.81 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.439 1.087 . . . . 74.21 111.556 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.17 -29.42 69.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 116.095 -0.502 . . . . 72.44 111.412 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.6 mt -78.63 -40.14 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.359 1.063 . . . . 73.44 110.331 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.454 HG23 ' HG3' ' A' ' 125' ' ' GLN . 34.4 m -66.53 -43.55 84.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.46 0.648 . . . . 75.4 110.638 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.5 t -64.43 -44.44 91.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.033 -0.985 . . . . 74.52 109.519 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 76' ' ' CYS . 43.2 ttm -60.27 -46.53 89.48 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.229 1.012 . . . . 71.24 112.242 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 123' ' ' PHE . 7.2 p -69.71 -31.05 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.133 0.573 . . . . 62.45 110.616 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.2 m -77.06 -29.73 55.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.425 0.69 . . . . 71.41 111.213 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -70.77 -31.92 68.87 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.626 0.77 . . . . 74.44 109.832 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.23 -2.26 90.4 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-N 115.779 -0.646 . . . . 62.02 113.209 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.9 m 65.34 36.53 6.86 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-O 122.824 1.297 . . . . 75.43 110.939 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.406 ' HB2' HG21 ' A' ' 118' ' ' VAL . 95.9 m-85 -104.91 164.39 15.26 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.308 1.043 . . . . 64.43 108.904 171.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -59.59 153.35 55.83 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 122.322 2.014 . . . . 71.41 112.504 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.454 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.7 tt0 -63.77 139.12 58.74 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.447 0.699 . . . . 61.02 111.16 -177.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.6 tp -131.3 116.42 17.58 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.307 -0.861 . . . . 73.42 109.093 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -121.03 117.83 28.25 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.252 -1.018 . . . . 74.43 108.252 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.78 122.32 13.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.312 0.645 . . . . 65.45 110.082 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.57 128.65 90.4 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-O 119.17 -0.443 . . . . 63.12 109.881 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.18 100.23 0.31 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.657 2.238 . . . . 70.24 111.584 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.3 m -100.06 138.0 25.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-N 115.623 -0.717 . . . . 74.21 109.441 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -83.1 87.46 6.91 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.079 -0.964 . . . . 74.55 109.046 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.486 ' HA ' HD11 ' A' ' 136' ' ' LEU . 58.4 m-85 -56.03 -27.49 53.38 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.642 0.777 . . . . 75.13 112.559 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.21 -51.29 61.88 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.017 0.527 . . . . 73.44 110.25 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.52 85.63 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.007 0.817 . . . . 64.3 110.896 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.486 HD11 ' HA ' ' A' ' 133' ' ' PHE . 61.1 mt -67.52 -38.68 84.62 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.159 0.983 . . . . 75.0 111.06 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.7 -38.54 86.94 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.716 -0.675 . . . . 74.45 109.495 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 19.8 mmt -63.18 -41.6 99.24 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 124.221 0.951 . . . . 73.11 110.34 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 143' ' ' GLN . 52.9 m-80 -54.22 -47.25 72.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 123.743 0.652 . . . . 73.32 110.403 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -67.36 -37.11 82.68 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.177 -0.92 . . . . 52.01 111.303 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.02 -56.03 8.01 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.992 0.917 . . . . 64.42 112.304 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -166.06 -11.62 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 123.955 0.902 . . . . 75.44 112.479 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.634 ' HB3' ' HA ' ' A' ' 139' ' ' ASN . 0.8 OUTLIER -65.59 107.36 1.7 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.519 0.728 . . . . 74.42 109.609 -174.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -134.98 -163.87 1.44 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.938 1.295 . . . . 63.12 109.025 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.3 94.16 0.08 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.041 0.448 . . . . 75.31 110.4 175.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.72 119.29 0.69 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 110.923 -0.871 . . . . 64.44 110.923 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -110.12 133.19 53.47 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.233 0.613 . . . . 73.25 111.627 -171.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -92.53 93.64 1.8 Allowed Glycine 0 C--N 1.351 1.393 0 N-CA-C 112.161 -0.376 . . . . 73.02 112.161 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.3 m -134.09 161.0 36.07 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.959 0.903 . . . . 71.34 110.099 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.18 175.87 5.67 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.336 0.654 . . . . 74.24 111.236 175.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -124.2 -15.41 6.77 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.592 0.757 . . . . 74.54 111.787 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -166.12 141.37 4.68 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.833 -0.803 . . . . 75.44 108.833 -174.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -166.24 94.11 0.53 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.299 -1.0 . . . . 75.35 108.299 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -122.94 -71.47 0.72 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.658 0.783 . . . . 71.35 109.06 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.883 0 N-CA-C 107.751 -1.203 . . . . 55.12 107.751 175.272 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.438 -0.579 . . . . 74.5 109.438 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 65.5 p -136.14 160.28 39.13 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.203 0.601 . . . . 75.14 111.071 -176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.11 117.82 35.07 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.026 -0.731 . . . . 70.34 109.026 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -80.27 -25.64 39.36 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.486 0.715 . . . . 73.23 111.368 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -80.43 88.78 5.59 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.401 0.62 . . . . 65.44 109.559 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -102.27 82.65 2.22 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.461 -0.94 . . . . 63.34 108.461 173.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -84.29 -42.73 15.53 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.288 -0.869 . . . . 73.41 109.76 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -119.19 -42.8 2.66 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.798 -0.637 . . . . 64.34 112.393 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.417 ' SD ' HG21 ' B' ' 89' ' ' ILE . 0.8 OUTLIER 66.48 164.62 0.19 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.437 1.095 . . . . 74.45 111.287 -167.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 87.1 m -155.28 133.9 11.92 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.199 0.999 . . . . 74.54 109.457 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -129.52 137.64 50.9 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.588 -0.893 . . . . 72.12 108.588 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -149.92 130.79 14.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.084 -0.71 . . . . 72.14 109.084 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.435 HD11 HD12 ' B' ' 105' ' ' ILE . 20.6 mt -76.52 118.09 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.738 -1.208 . . . . 74.34 107.738 166.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -86.22 -49.36 7.77 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.665 -0.865 . . . . 74.34 108.665 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.417 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 74.1 ttt180 -164.99 138.27 4.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.867 -1.061 . . . . 74.42 109.069 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.9 mt -115.6 141.92 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.321 -0.992 . . . . 74.13 108.321 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -164.12 147.2 9.45 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.767 0.427 . . . . 75.32 111.321 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.514 HG23 HD13 ' B' ' 21' ' ' ILE . 24.5 m -78.57 130.45 35.95 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.197 -1.038 . . . . 73.34 108.197 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -93.17 -47.48 6.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.58 0.752 . . . . 75.14 110.083 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.33 141.05 39.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.162 -0.927 . . . . 72.5 110.856 -171.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.517 HD13 ' SG ' ' B' ' 113' ' ' CYS . 48.4 mm -131.44 144.91 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.914 1.286 . . . . 74.03 108.26 171.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.7 t -145.63 129.12 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.077 -1.453 . . . . 75.51 107.077 173.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.57 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.3 t80 -143.31 107.04 4.63 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 106.517 -1.66 . . . . 74.42 106.517 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -118.1 112.51 20.3 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.079 -1.082 . . . . 73.34 108.079 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.3 85.46 2.15 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.939 -1.504 . . . . 61.54 106.939 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.96 -26.21 26.88 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.92 2.413 . . . . 75.11 112.156 -166.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -114.4 15.47 17.94 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.979 -1.009 . . . . 63.3 110.34 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.88 -61.99 0.97 Allowed Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 115.19 1.552 . . . . 71.14 115.19 -163.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.62 -27.05 39.14 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 121.831 1.687 . . . . 74.22 113.023 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -89.01 -38.87 14.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.994 0.518 . . . . 71.22 111.733 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' B' ' 73' ' ' ALA . 13.3 p -69.71 -16.09 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.209 0.604 . . . . 72.42 111.128 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -68.33 -4.07 13.18 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.483 0.713 . . . . 74.54 112.791 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.472 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.4 pt20 -68.34 -23.41 64.7 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.919 0.487 . . . . 72.12 110.219 168.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.472 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 86.7 mttt -107.88 79.02 1.23 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.829 1.251 . . . . 75.02 108.648 177.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -80.12 86.51 5.55 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.717 0.77 . . . . 75.34 109.35 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.0 t-105 -150.87 155.9 40.12 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.891 1.276 . . . . 72.44 107.594 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -70.76 99.99 0.26 Allowed Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 125.916 1.686 . . . . 74.55 110.576 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.615 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 49.0 Cg_endo -67.65 137.43 42.32 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.557 2.171 . . . . 73.23 112.535 -173.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -54.89 123.33 13.11 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.04 0.838 . . . . 73.54 109.764 173.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -104.33 157.19 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.443 0.64 . . . . 73.11 111.682 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -142.14 127.7 19.04 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.565 -1.643 . . . . 60.14 106.565 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.504 ' H ' HD22 ' B' ' 42' ' ' LEU . 2.6 pt? -104.41 151.88 22.98 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.834 0.453 . . . . 73.42 110.607 -175.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.45 ' HA ' ' OH ' ' F' ' 462' ' ' TYR . 13.0 t70 -143.19 116.19 8.85 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.603 -0.888 . . . . 75.45 108.603 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' F' ' 460' ' ' LEU . 63.7 mt -99.26 156.9 16.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.716 0.406 . . . . 64.42 110.166 -174.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.483 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 11.6 m-20 -141.57 111.39 6.63 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.121 -1.066 . . . . 75.51 108.121 167.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -109.82 104.06 12.95 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.74 -0.467 . . . . 71.51 109.74 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.84 152.78 34.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.237 1.015 . . . . 75.31 109.434 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -137.58 161.84 35.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.033 0.533 . . . . 73.03 109.916 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -163.32 160.85 24.22 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.059 0.543 . . . . 73.41 110.241 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -91.47 123.03 34.58 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.124 0.57 . . . . 75.34 110.273 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.546 HD12 HG22 ' B' ' 83' ' ' ILE . 81.1 mt -87.33 -43.77 11.9 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.718 0.807 . . . . 72.34 109.107 167.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.61 -170.54 3.11 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.58 -1.191 . . . . 74.51 110.033 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.98 111.95 2.38 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.598 -0.728 . . . . 73.2 110.429 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 43.7 m-20 70.23 0.38 3.14 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.256 1.423 . . . . 74.0 112.838 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.8 t -104.18 102.88 14.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.526 -0.916 . . . . 62.4 108.526 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -99.73 146.99 25.92 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.64 -1.164 . . . . 74.31 109.643 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -109.4 116.55 32.03 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.465 -1.309 . . . . 70.34 107.465 165.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 52.3 t -96.01 143.37 12.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.526 -0.916 . . . . 75.32 108.526 172.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.2 t -131.89 137.36 55.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.959 -0.756 . . . . 74.21 108.959 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.411 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -122.85 109.59 14.38 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.176 -1.416 . . . . 75.44 107.176 -177.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 40.7 ttm180 -95.25 130.94 41.8 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.543 -0.54 . . . . 73.23 109.543 170.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.407 ' HB ' HD11 ' B' ' 114' ' ' ILE . 37.0 t -120.62 106.13 18.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.192 -1.41 . . . . 74.34 107.192 169.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -96.13 146.62 24.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.11 -1.07 . . . . 75.15 108.11 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 71.1 t -138.4 130.12 37.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.284 1.034 . . . . 75.01 108.466 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 98.3 m -117.39 136.95 52.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.385 -0.969 . . . . 72.51 108.385 172.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.12 143.79 50.25 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.473 0.483 . . . . 74.11 110.289 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 44.3 p -133.68 127.03 32.05 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 123.959 0.787 . . . . 74.31 110.771 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.615 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 34.1 mt -105.88 114.64 28.9 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.116 0.966 . . . . 74.4 108.697 171.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.37 -111.73 3.94 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.537 -1.025 . . . . 75.04 110.537 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.23 4.58 11.28 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.527 0.731 . . . . 72.13 111.027 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -114.47 160.64 18.97 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.424 0.69 . . . . 75.31 109.583 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.3 m -72.24 135.07 45.94 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.543 -0.54 . . . . 75.02 109.543 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.809 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -88.72 -59.62 2.18 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.411 -0.959 . . . . 61.41 108.411 175.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . 0.624 ' HZ ' HD11 ' B' ' 126' ' ' LEU . 52.5 p90 -151.96 170.08 20.74 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 113.973 -1.467 . . . . 74.32 109.821 176.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.7 mt -133.05 138.86 46.9 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.878 -1.897 . . . . 75.3 105.878 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.459 ' SG ' HG21 ' B' ' 114' ' ' ILE . 38.0 t -141.1 150.95 43.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.882 -0.784 . . . . 73.42 108.882 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.8 tt0 -164.37 132.55 3.45 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.034 -0.728 . . . . 62.21 109.034 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 98.6 t -128.94 147.67 33.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.474 -0.936 . . . . 74.33 108.474 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -123.15 93.13 3.86 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.293 -1.002 . . . . 74.3 108.293 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.461 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.9 tp-100 -82.79 100.89 10.58 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.702 -1.135 . . . . 72.4 109.014 177.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.51 163.73 31.36 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 111.02 -0.832 . . . . 74.44 111.02 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.3 128.23 1.73 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.936 -0.866 . . . . 72.42 110.936 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.546 HG22 HD12 ' B' ' 51' ' ' LEU . 30.8 mt -84.6 133.65 28.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.619 0.768 . . . . 72.41 109.077 173.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' B' ' 102' ' ' CYS . 22.8 m-85 -138.04 135.52 35.96 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.033 -0.728 . . . . 75.0 109.033 174.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -97.44 107.97 20.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.57 0.748 . . . . 73.3 108.995 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 43.0 pt -111.79 145.06 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.758 0.823 . . . . 74.14 110.377 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.533 ' HA ' HG11 ' F' ' 451' ' ' VAL . . . -144.32 158.1 43.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.702 0.801 . . . . 74.24 109.741 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.08 -65.14 4.12 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.557 0.536 . . . . 63.45 112.574 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.421 HD11 ' HB ' ' B' ' 86' ' ' ILE . 25.7 pt -58.15 144.01 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.225 1.01 . . . . 75.54 112.491 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -150.66 149.88 30.4 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.246 -0.888 . . . . 73.32 109.458 -171.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.3 -115.6 8.13 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.905 0.753 . . . . 63.24 113.013 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 24.7 m -67.14 -31.43 71.87 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.824 0.85 . . . . 74.42 112.003 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.93 -47.82 73.43 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.191 0.596 . . . . 74.11 110.81 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.528 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 12.3 ptp -72.91 -29.47 63.16 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-O 119.077 -0.487 . . . . 73.4 110.113 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.89 -32.16 71.63 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.824 0.45 . . . . 52.04 111.053 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.404 ' O ' ' HB1' ' B' ' 100' ' ' ALA . 28.0 t-80 -72.42 -30.44 64.62 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.961 0.504 . . . . 74.55 110.971 174.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.573 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 85.9 m -76.71 -71.69 0.38 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 110.385 -0.228 . . . . 75.32 110.385 176.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.4 pp -71.42 -14.41 62.15 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.384 0.883 . . . . 60.54 113.384 -171.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.89 0.33 36.04 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-O 119.488 -0.618 . . . . 75.04 113.93 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' B' ' 96' ' ' HIS . . . -152.42 -62.1 0.16 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.741 0.771 . . . . 74.33 112.4 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.573 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 90.0 t80 -70.18 -47.28 62.25 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.101 0.96 . . . . 74.52 112.205 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.424 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 71.5 m -62.7 -49.15 84.01 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.15 0.98 . . . . 65.23 111.428 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 86.3 Cg_exo -54.05 -35.33 81.0 Favored 'Trans proline' 0 C--N 1.397 3.099 0 C-N-CA 122.043 1.829 . . . . 64.35 114.128 167.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -62.9 -37.26 86.25 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 123.202 0.601 . . . . 75.13 110.468 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.435 HD12 HD11 ' B' ' 13' ' ' ILE . 68.1 mt -66.18 -41.83 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.958 0.903 . . . . 74.33 110.458 174.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 67.5 mt -78.73 -19.19 52.92 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.427 -0.806 . . . . 75.42 112.12 -175.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -58.79 -49.15 94.98 Favored Pre-proline 0 N--CA 1.483 1.214 0 CA-C-O 117.829 -1.081 . . . . 72.04 113.515 -171.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.41 -38.26 89.39 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.194 1.929 . . . . 74.55 113.723 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.461 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 83.4 m-85 -68.53 -48.66 63.75 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 123.516 0.51 . . . . 74.03 110.527 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.34 -42.25 91.04 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.557 0.743 . . . . 74.53 111.304 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.54 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 54.3 ttt-85 -61.58 -53.22 59.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.802 1.641 . . . . 73.25 110.946 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -68.27 -30.27 69.26 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.987 0.805 . . . . 74.33 110.198 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.517 ' SG ' HD13 ' B' ' 21' ' ' ILE . 5.4 t -69.0 -41.11 78.26 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.833 0.453 . . . . 73.43 111.131 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.459 HG21 ' SG ' ' B' ' 76' ' ' CYS . 73.0 mt -60.55 -52.4 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.609 -0.515 . . . . 74.54 109.609 172.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 62.9 m -56.12 -34.45 66.09 Favored 'General case' 0 CA--C 1.554 1.124 0 O-C-N 124.477 1.111 . . . . 71.45 111.988 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.6 t -66.72 -49.06 67.26 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 123.229 0.612 . . . . 65.4 109.873 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.485 ' SD ' HG21 ' A' ' 21' ' ' ILE . 34.5 mmt -61.5 -41.41 97.25 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.095 0.558 . . . . 74.44 111.155 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.407 HG23 ' O ' ' B' ' 114' ' ' ILE . 78.2 t -62.77 -43.7 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.427 1.091 . . . . 71.11 110.851 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.8 t -65.65 -36.84 84.83 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.821 -1.081 . . . . 72.0 111.607 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -67.69 -36.74 81.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.026 -0.988 . . . . 75.42 110.47 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.51 6.99 59.35 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.334 -0.703 . . . . 63.24 113.084 176.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 72.0 p 59.38 22.0 10.38 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.378 1.871 . . . . 70.41 113.332 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -85.13 151.79 57.56 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.61 0.764 . . . . 73.4 109.963 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.36 156.98 3.5 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 124.242 3.294 . . . . 73.44 116.328 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -65.86 117.8 8.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.229 -1.35 . . . . 73.11 111.844 -173.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.624 HD11 ' HZ ' ' B' ' 74' ' ' PHE . 22.5 mt -113.44 120.26 40.42 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.029 -0.73 . . . . 71.15 109.029 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -123.21 96.22 4.91 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 107.895 -1.15 . . . . 72.54 107.895 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.54 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.1 mm? -61.72 149.82 38.56 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.825 0.85 . . . . 75.11 112.334 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.63 151.25 87.02 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.987 0.915 . . . . 64.21 110.659 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.95 104.81 1.41 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.501 2.134 . . . . 72.13 111.634 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.0 t -90.57 108.66 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.277 -1.008 . . . . 73.44 108.277 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -90.07 98.36 11.73 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.1 -1.074 . . . . 71.01 108.1 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -61.92 -32.97 73.42 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.289 -0.869 . . . . 74.53 111.41 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.33 -39.3 78.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.716 1.207 . . . . 71.01 111.823 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.17 -41.17 90.67 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.312 0.645 . . . . 73.12 110.207 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.28 -37.27 85.05 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.685 -1.143 . . . . 74.24 110.965 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.457 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 60.3 t80 -69.32 -36.49 77.02 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.64 0.776 . . . . 73.3 110.668 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -62.37 -38.27 88.9 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.116 0.567 . . . . 74.14 110.291 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -75.44 -28.24 59.24 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.475 -0.784 . . . . 74.43 110.854 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -61.36 -44.75 96.64 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.074 0.549 . . . . 62.44 110.501 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 15.5 mt -83.63 -9.63 58.76 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.549 -0.75 . . . . 71.23 111.756 -171.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -139.76 111.29 7.18 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.299 0.639 . . . . 74.41 109.947 -172.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -70.4 -28.47 65.1 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.42 -0.585 . . . . 74.32 109.42 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -57.01 97.79 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.088 0.955 . . . . 74.43 110.155 173.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.69 130.18 36.48 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.748 -0.834 . . . . 71.12 108.748 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.71 146.37 4.4 Favored Glycine 0 C--O 1.241 0.542 0 N-CA-C 111.072 -0.811 . . . . 70.52 111.072 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -164.78 175.83 9.31 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.116 0.566 . . . . 73.43 110.158 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 141.99 176.94 16.62 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 116.065 -0.516 . . . . 74.05 112.179 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.58 HG21 ' HB3' ' D' ' 6' ' ' ASN . 3.0 t -141.97 144.54 33.76 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.428 0.691 . . . . 73.41 110.727 -173.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.46 130.22 34.96 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.803 -0.814 . . . . 74.3 108.803 172.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.523 ' HG2' ' H ' ' B' ' 152' ' ' HIS . 29.6 tt0 -155.01 -176.41 5.92 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.534 -0.914 . . . . 62.44 108.534 -172.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . 0.523 ' H ' ' HG2' ' B' ' 151' ' ' GLU . 68.9 m80 -132.24 135.09 46.04 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.636 -0.665 . . . . 73.15 109.679 175.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -75.75 113.86 13.69 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.977 0.911 . . . . 75.22 109.353 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -65.03 -70.27 0.24 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 109.172 -0.677 . . . . 74.32 109.172 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 N-CA-C 108.326 -0.99 . . . . 74.52 108.326 -178.06 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 109.931 -0.396 . . . . 73.24 109.931 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 10.4 m -68.15 97.17 0.68 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.847 0.859 . . . . 71.12 110.295 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -119.35 156.69 29.6 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.837 0.855 . . . . 73.21 109.972 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -154.72 -70.12 0.13 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.042 -0.526 . . . . 62.55 110.03 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -91.53 58.64 3.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.549 0.739 . . . . 72.12 110.411 -173.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -79.95 -47.21 15.37 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.922 0.889 . . . . 75.3 108.978 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -157.93 150.76 22.79 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 114.262 -1.336 . . . . 73.45 108.545 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.04 140.27 48.92 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.931 -0.766 . . . . 75.53 108.931 172.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.4 ' SD ' HD11 ' C' ' 89' ' ' ILE . 45.7 ttp 63.26 112.53 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.977 1.311 . . . . 74.52 110.875 -167.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.718 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 64.4 m -101.0 97.26 7.85 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.04 -1.096 . . . . 70.24 108.04 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.498 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 44.9 t80 -102.02 128.93 48.24 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.556 -0.905 . . . . 72.11 108.556 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -137.56 126.35 23.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.949 -0.76 . . . . 72.11 108.949 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 83.8 mt -77.38 122.17 31.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.659 -0.867 . . . . 73.23 108.659 172.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -91.15 -39.22 12.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.228 -0.896 . . . . 65.44 109.712 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -172.59 144.75 1.48 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.101 -0.703 . . . . 73.34 109.101 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 92.3 mt -134.07 137.69 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.769 -1.197 . . . . 72.11 107.769 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.439 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 32.2 p90 -169.58 171.94 7.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.872 0.844 . . . . 73.51 111.458 -173.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.1 p -96.77 118.35 33.02 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.222 -0.899 . . . . 72.5 109.061 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.513 ' HE3' ' HA3' ' C' ' 81' ' ' GLY . 21.5 mmtp -67.37 -48.97 65.88 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.66 -1.237 . . . . 74.41 107.66 171.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -137.61 142.92 41.25 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 112.974 -1.921 . . . . 72.32 109.6 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 76.0 mt -136.5 144.07 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 106.283 -1.747 . . . . 74.41 106.283 172.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -160.51 146.92 15.39 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.372 0.606 . . . . 73.41 110.824 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -139.03 135.13 33.91 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.2 -1.407 . . . . 75.44 107.2 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 38.8 mt-10 -135.36 114.45 12.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.729 0.812 . . . . 64.21 109.988 -176.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.86 83.88 33.63 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 107.112 -1.44 . . . . 73.03 107.112 170.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -70.34 -19.85 32.83 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.048 2.499 . . . . 72.44 112.684 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -116.33 24.85 11.07 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.775 1.23 . . . . 72.52 110.06 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.87 -57.66 5.68 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 114.483 1.29 . . . . 73.43 114.483 -169.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.3 -36.56 55.74 Favored 'Trans proline' 0 C--N 1.388 2.655 0 CA-C-N 121.542 1.586 . . . . 73.33 112.172 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.519 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 68.3 t60 -69.9 -32.99 71.61 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.417 -0.81 . . . . 75.12 112.36 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.685 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.0 p -81.54 -22.12 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 N-CA-C 112.731 0.641 . . . . 75.23 112.731 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -64.33 -23.79 67.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.628 -0.67 . . . . 73.23 112.682 175.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.6 pt20 -88.48 8.32 28.56 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.952 0.501 . . . . 73.23 111.301 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' C' ' 31' ' ' VAL . 1.1 mptm? -92.52 177.87 5.99 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 122.255 1.026 . . . . 64.22 113.24 -172.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -87.47 114.04 23.72 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 112.905 -1.952 . . . . 74.44 108.074 168.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.456 ' CZ2' HD13 ' G' ' 470' ' ' LEU . 51.5 t90 -84.48 71.32 10.73 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.742 0.782 . . . . 72.21 110.939 -174.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -132.92 69.59 79.01 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 123.966 0.906 . . . . 74.22 109.034 170.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.498 ' HD2' HD11 ' G' ' 470' ' ' LEU . 9.8 Cg_endo -87.95 158.05 7.3 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.046 2.497 . . . . 75.15 113.73 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.97 96.43 8.84 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 107.284 -1.376 . . . . 64.51 107.284 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 m -79.28 128.25 38.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-O 121.705 0.764 . . . . 63.35 110.373 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -132.65 113.54 13.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.503 1.121 . . . . 72.14 108.338 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.612 HD12 ' SD ' ' G' ' 464' ' ' MET . 72.2 mt -86.0 158.79 19.78 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.825 -0.806 . . . . 75.23 108.825 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.581 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.7 t70 -137.4 105.14 5.58 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.602 -1.258 . . . . 73.32 107.602 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.27 129.49 43.58 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.044 -0.724 . . . . 75.33 109.044 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -144.24 125.01 14.16 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.57 -0.9 . . . . 74.32 108.57 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' THR . . . . . 0.428 ' H ' HD21 ' G' ' 460' ' ' LEU . 5.2 t -116.46 139.78 50.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.447 -0.575 . . . . 72.33 109.447 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.45 135.61 37.03 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.106 0.962 . . . . 71.01 108.406 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 13.0 p -136.38 151.12 49.21 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 109.314 -0.625 . . . . 73.13 109.314 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 70.0 p -156.65 143.73 18.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.369 0.668 . . . . 74.03 109.765 -174.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -78.93 118.1 20.63 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.326 0.65 . . . . 64.52 109.991 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.652 HD12 ' HB2' ' C' ' 57' ' ' GLU . 68.8 mt -89.26 -29.73 19.0 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.05 0.54 . . . . 75.42 110.13 174.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.47 172.67 16.81 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.787 1.235 . . . . 45.53 109.034 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -57.37 128.58 37.75 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.842 -0.799 . . . . 72.11 108.842 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 69.48 -1.85 2.1 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.42 1.088 . . . . 73.05 113.015 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -111.95 117.56 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.338 0.655 . . . . 72.22 109.373 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -124.85 126.46 45.61 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.041 0.936 . . . . 60.32 109.983 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.652 ' HB2' HD12 ' C' ' 51' ' ' LEU . 21.5 tt0 -83.62 133.0 34.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.936 -1.135 . . . . 73.42 107.936 165.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.47 140.35 47.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 N-CA-C 108.842 -0.799 . . . . 75.53 108.842 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 81.6 t -124.56 133.18 70.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.838 1.255 . . . . 73.12 107.629 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' C' ' 107' ' ' PHE . 1.0 OUTLIER -125.2 104.81 8.71 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.237 -1.394 . . . . 73.24 107.237 174.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.45 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 1.9 ttm180 -86.69 130.01 34.65 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 113.886 -1.506 . . . . 70.43 109.127 177.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.1 124.81 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.458 -1.312 . . . . 73.01 107.458 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.581 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 32.7 m -124.52 131.18 53.49 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.855 -0.794 . . . . 75.15 108.855 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.426 HG23 HG21 ' C' ' 114' ' ' ILE . 23.4 t -107.49 126.65 63.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.003 -0.74 . . . . 72.24 109.003 173.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -116.25 145.43 43.15 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.935 -1.135 . . . . 75.43 107.935 173.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.54 128.02 20.08 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.053 -0.721 . . . . 73.24 109.053 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.8 m -128.01 126.03 40.54 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 123.196 0.598 . . . . 73.0 110.141 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 39.5 mt -88.47 37.7 0.84 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.589 1.156 . . . . 73.11 110.198 172.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.6 -96.08 1.52 Allowed Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.374 -1.09 . . . . 73.42 110.374 -173.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -107.1 -5.46 18.01 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.313 1.045 . . . . 72.31 110.839 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.447 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 4.0 tp10 -103.17 121.14 42.04 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.526 1.131 . . . . 70.11 109.062 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 35.6 m -69.32 126.95 31.36 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.779 0.718 . . . . 70.45 109.07 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.685 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.42 -54.64 6.44 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.093 -0.706 . . . . 73.32 109.093 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -169.08 168.87 9.79 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 114.836 -1.074 . . . . 74.24 111.097 175.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -140.08 143.83 36.51 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 106.883 -1.525 . . . . 74.15 106.883 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 43.8 t -153.24 116.19 4.55 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.726 -0.472 . . . . 74.45 109.726 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -117.6 133.01 56.41 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.722 0.409 . . . . 74.31 110.086 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 84.6 t -126.57 138.07 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.225 1.01 . . . . 64.34 108.39 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.45 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 66.7 mt-30 -115.11 97.14 6.04 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.349 -0.982 . . . . 72.32 108.349 173.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.418 ' HG3' HD22 ' C' ' 106' ' ' LEU . 8.7 tp-100 -86.63 104.52 16.13 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.572 0.749 . . . . 72.5 110.683 -174.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.513 ' HA3' ' HE3' ' C' ' 19' ' ' LYS . . . -110.42 143.78 16.96 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 121.532 -0.366 . . . . 73.32 112.729 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.03 142.06 10.22 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 111.361 -0.696 . . . . 53.3 111.361 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' D' ' 29' ' ' PRO . 14.4 mm -90.72 126.39 43.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.557 -0.905 . . . . 72.55 108.557 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -132.27 128.76 38.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.955 0.902 . . . . 55.13 109.19 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.8 p -96.78 126.1 41.7 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 109.225 -0.657 . . . . 55.33 109.225 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -115.48 143.9 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.89 1.276 . . . . 73.25 109.577 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.718 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -144.31 142.9 30.71 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.67 0.388 . . . . 65.34 110.953 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.71 -18.08 48.93 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 114.635 0.614 . . . . 73.13 114.635 175.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.4 HD11 ' SD ' ' C' ' 9' ' ' MET . 38.5 pt -113.43 154.13 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 117.406 0.603 . . . . 75.42 112.227 -172.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.454 ' HA ' ' HE2' ' C' ' 94' ' ' MET . 12.7 pt-20 -164.57 -178.68 5.5 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.163 0.985 . . . . 71.4 109.798 173.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.12 -123.5 33.24 Favored Glycine 0 C--N 1.352 1.458 0 O-C-N 123.427 0.454 . . . . 44.43 114.005 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 74.0 p -70.64 -32.25 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.048 0.939 . . . . 75.24 111.258 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -69.09 -36.15 77.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.342 0.657 . . . . 73.32 110.987 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.454 ' HE2' ' HA ' ' C' ' 90' ' ' GLU . 46.8 ttm -76.81 -32.89 57.94 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.496 -0.32 . . . . 74.24 110.267 174.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.89 -41.02 73.84 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.55 0.532 . . . . 72.23 110.275 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.45 ' HE2' ' HA ' ' C' ' 134' ' ' ASP . 11.9 t-80 -81.24 -30.59 34.1 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.438 0.461 . . . . 74.51 111.705 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 23.0 t -62.09 -39.22 91.74 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.416 0.448 . . . . 74.42 110.666 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.32 -14.32 24.02 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.091 0.556 . . . . 62.1 110.718 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.05 -29.99 61.83 Favored Glycine 0 C--N 1.357 1.696 0 O-C-N 123.279 0.362 . . . . 75.13 113.886 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.09 -38.65 0.06 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.201 0.815 . . . . 65.04 113.201 -170.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -62.42 -52.45 63.5 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.906 0.482 . . . . 73.3 111.322 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.498 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 58.8 m -72.9 -46.19 8.7 Favored Pre-proline 0 CA--C 1.563 1.452 0 CA-C-O 118.732 -0.652 . . . . 74.14 112.289 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 64.6 Cg_exo -54.33 -28.5 53.48 Favored 'Trans proline' 0 C--N 1.398 3.14 0 C-N-CA 122.321 2.014 . . . . 73.45 114.306 171.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -69.65 -35.79 75.49 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.458 0.703 . . . . 75.22 109.774 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.419 HD11 ' NH1' ' A' ' 111' ' ' ARG . 27.8 mm -64.94 -41.8 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.509 -0.552 . . . . 63.31 109.509 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.418 HD22 ' HG3' ' C' ' 80' ' ' GLN . 39.8 mt -79.03 -27.95 43.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.063 0.945 . . . . 72.54 113.015 -173.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.4 ' HA ' HD11 ' C' ' 60' ' ' LEU . 81.4 t80 -57.67 -49.82 91.59 Favored Pre-proline 0 CA--C 1.564 1.503 0 N-CA-C 114.337 1.236 . . . . 75.43 114.337 -171.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.93 -33.93 95.47 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 121.944 1.763 . . . . 75.02 112.905 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -69.19 -45.59 69.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.983 0.513 . . . . 72.22 110.502 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.25 -37.45 77.63 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.255 -0.884 . . . . 73.34 110.665 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -61.89 -58.94 6.0 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.863 -1.062 . . . . 60.45 110.621 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.03 78.66 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 110.137 -0.32 . . . . 73.32 110.137 -175.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.3 t -66.74 -28.65 68.58 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.974 0.509 . . . . 74.34 111.609 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.426 HG21 HG23 ' C' ' 64' ' ' VAL . 83.4 mt -77.13 -55.43 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 109.707 -0.479 . . . . 75.24 109.707 170.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.1 m -60.81 -28.62 68.92 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.211 1.005 . . . . 74.12 111.782 -170.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -68.84 -49.75 55.74 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.834 -0.802 . . . . 74.53 108.834 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.565 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.21 -34.84 75.75 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.561 1.144 . . . . 71.55 112.639 178.205 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.52 -48.16 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.743 0.817 . . . . 72.14 109.193 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 41.9 t -67.85 -28.87 67.92 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.811 -1.086 . . . . 72.44 111.911 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -71.31 -43.95 66.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.578 -0.897 . . . . 73.33 108.578 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.86 3.27 61.34 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 123.901 0.751 . . . . 61.32 113.036 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.447 HG21 ' HB3' ' D' ' 17' ' ' TYR . 33.1 p 60.23 38.35 20.06 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.694 1.998 . . . . 72.2 113.898 170.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -94.4 149.8 37.21 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 108.655 -0.869 . . . . 75.21 108.655 166.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.31 176.71 0.35 Allowed 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.309 2.673 . . . . 72.1 115.376 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -59.85 122.16 13.54 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.325 1.05 . . . . 75.4 113.747 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 mp -112.66 86.26 2.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.218 1.007 . . . . 64.13 109.48 171.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -107.47 107.98 19.09 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.816 -0.809 . . . . 71.52 108.816 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 59.5 mt -73.38 142.83 46.98 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.643 -0.708 . . . . 74.35 110.519 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.67 148.32 94.95 Favored Pre-proline 0 CA--C 1.55 0.975 0 O-C-N 123.844 0.715 . . . . 75.12 110.111 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.462 ' HG3' HD13 ' A' ' 16' ' ' ILE . 37.4 Cg_exo -57.42 120.38 8.26 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.581 2.188 . . . . 75.34 112.221 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 98.7 t -97.52 119.51 45.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.296 -1.001 . . . . 75.43 108.296 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -77.93 73.12 4.5 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.761 0.663 . . . . 73.31 110.378 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -56.95 -41.05 77.6 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.558 0.743 . . . . 72.3 110.595 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.45 ' HA ' ' HE2' ' C' ' 96' ' ' HIS . 23.3 m-20 -66.0 -49.49 67.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.069 -0.969 . . . . 72.21 111.762 -176.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.02 96.22 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.959 0.787 . . . . 74.01 111.033 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.29 -29.32 66.04 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.376 -0.829 . . . . 75.31 111.665 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.409 ' HA ' ' HB3' ' C' ' 140' ' ' TYR . 15.3 t80 -77.26 -25.99 52.05 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 110.062 -0.347 . . . . 75.33 110.062 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 94.2 mtp -72.03 -30.82 65.57 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.916 0.487 . . . . 62.04 110.118 172.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -70.19 -37.42 75.12 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 109.508 -0.553 . . . . 74.0 109.508 170.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' C' ' 143' ' ' GLN . 57.3 t80 -70.04 -88.35 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.394 1.077 . . . . 74.55 112.726 -175.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 55.93 -79.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.231 1.012 . . . . 75.2 111.527 -164.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -129.59 9.51 5.51 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.95 0.9 . . . . 72.44 112.003 -175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' C' ' 140' ' ' TYR . 10.4 pt20 -135.94 122.82 21.26 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.815 0.846 . . . . 75.34 109.878 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -65.96 84.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.06 0.544 . . . . 72.04 110.708 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.75 68.09 0.67 Allowed 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.962 0.905 . . . . 71.55 110.065 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.48 67.62 0.59 Allowed Glycine 0 C--N 1.341 0.842 0 CA-C-N 114.99 -1.005 . . . . 63.41 111.161 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.7 111.61 17.3 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.709 -0.478 . . . . 73.33 109.709 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.08 121.43 5.47 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 123.578 0.549 . . . . 65.31 112.275 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 23.4 p -139.04 41.2 2.12 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.084 0.954 . . . . 75.23 109.922 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -91.78 114.58 27.15 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.225 0.61 . . . . 74.45 110.167 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -79.29 142.27 36.29 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.202 0.601 . . . . 74.43 109.679 170.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -157.92 152.06 24.36 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.769 0.828 . . . . 73.32 108.9 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -65.63 98.02 0.35 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.225 0.61 . . . . 74.11 110.927 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -72.57 101.73 3.08 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.582 -0.896 . . . . 70.31 108.582 174.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.244 0 C-N-CA 125.05 1.34 . . . . 63.33 111.823 -173.406 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.461 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.392 -0.596 . . . . 64.24 109.392 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -115.83 89.18 3.05 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.657 0.783 . . . . 62.0 110.339 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.04 113.45 6.43 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.943 -0.762 . . . . 75.03 108.943 170.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -130.76 126.6 36.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.065 0.546 . . . . 75.22 110.592 -172.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -84.55 103.21 13.48 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.675 -0.861 . . . . 74.4 108.675 171.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.58 ' HB3' HG21 ' B' ' 149' ' ' THR . 64.6 t-20 -81.47 70.87 8.43 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.841 0.829 . . . . 73.42 108.877 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -93.21 -12.76 29.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.667 0.787 . . . . 75.32 111.225 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.4 -21.96 41.74 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.85 0.86 . . . . 74.45 110.892 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 4.7 ttp -28.9 122.94 0.13 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 126.077 1.751 . . . . 74.12 113.594 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.1 m -116.6 147.38 41.92 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 122.967 0.507 . . . . 72.24 109.959 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -152.68 94.31 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.654 -1.239 . . . . 72.24 107.654 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -123.18 116.84 24.08 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.516 0.727 . . . . 75.25 109.04 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.16 113.79 17.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.221 -1.029 . . . . 75.22 108.221 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -81.99 -22.93 36.31 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.604 0.761 . . . . 75.15 111.059 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -170.61 141.28 1.85 Allowed 'General case' 0 C--N 1.361 1.065 0 O-C-N 123.536 0.522 . . . . 73.43 111.234 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.414 ' N ' HD13 ' D' ' 16' ' ' ILE . 3.3 mp -119.7 133.93 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.683 -1.599 . . . . 72.14 106.683 169.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.452 ' HE1' HG13 ' D' ' 83' ' ' ILE . 20.7 p90 -163.13 163.08 25.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.407 0.622 . . . . 75.32 111.499 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -95.47 120.91 36.53 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.704 -0.85 . . . . 65.41 108.704 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.423 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 41.0 mtpt -83.92 -35.2 24.24 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.19 -0.67 . . . . 75.23 109.19 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.4 t70 -146.9 137.18 23.55 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.506 -1.225 . . . . 74.25 109.303 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.565 HG23 ' HE1' ' C' ' 117' ' ' MET . 78.5 mt -136.9 145.31 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.532 1.133 . . . . 71.12 107.976 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -146.77 135.98 22.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.11 0.964 . . . . 75.24 108.831 172.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.497 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.3 t80 -136.65 129.54 30.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 106.453 -1.684 . . . . 64.53 106.453 166.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 33.1 mt-10 -137.65 112.73 9.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.114 -1.069 . . . . 72.13 108.114 -172.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.88 88.34 2.89 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.568 -1.271 . . . . 74.43 107.568 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.08 -32.26 43.99 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.418 2.079 . . . . 73.02 112.695 -167.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.493 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 70.4 m-20 -113.94 14.42 18.48 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.969 0.908 . . . . 74.45 110.7 -177.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.418 ' O ' HG11 ' D' ' 31' ' ' VAL . . . -18.6 -74.34 0.02 OUTLIER Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 116.566 2.061 . . . . 71.33 116.566 -166.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.547 ' HB3' HD11 ' C' ' 83' ' ' ILE . 84.3 Cg_endo -77.26 -20.08 12.94 Favored 'Trans proline' 0 C--N 1.382 2.324 0 CA-C-N 124.377 2.599 . . . . 74.3 114.246 -176.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -70.81 -39.16 73.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.192 0.997 . . . . 73.33 109.635 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.7 p -84.22 -24.34 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 115.675 -0.693 . . . . 74.12 112.172 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -66.68 -22.36 66.08 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 112.675 0.621 . . . . 71.3 112.675 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -61.71 -22.82 65.68 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.752 0.821 . . . . 64.52 110.849 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.53 ' HZ1' ' HG2' ' D' ' 71' ' ' GLU . 99.4 mttt -88.69 96.23 10.57 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.5 1.12 . . . . 72.12 110.157 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.35 88.12 2.57 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.152 -0.476 . . . . 64.41 109.776 170.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -154.5 158.03 39.26 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.321 -0.992 . . . . 74.31 108.321 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -76.26 110.04 10.14 Favored Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 108.267 -1.012 . . . . 73.41 108.267 172.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -54.29 127.69 26.89 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.425 2.75 . . . . 72.11 113.584 -174.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 24.2 tt0 -56.61 111.84 1.12 Allowed 'General case' 0 C--N 1.368 1.387 0 O-C-N 124.208 0.942 . . . . 74.11 108.81 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.462 HG13 ' HB1' ' H' ' 467' ' ' ALA . 4.2 p -114.72 138.26 45.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.638 0.732 . . . . 74.03 110.437 -169.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -129.87 124.15 32.53 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 106.389 -1.708 . . . . 74.32 106.389 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 51.4 tp -95.19 120.45 35.43 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.163 -0.68 . . . . 75.14 109.163 -172.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.577 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 10.8 m-20 -106.23 140.09 39.72 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.617 1.167 . . . . 60.0 107.942 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.487 ' HB2' HD22 ' H' ' 460' ' ' LEU . 4.7 mp -134.47 168.21 19.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.27 0.557 . . . . 63.04 109.852 171.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 7.8 t70 -157.75 142.16 16.24 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.743 1.217 . . . . 52.21 107.726 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -114.8 144.42 43.53 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.405 0.621 . . . . 71.24 109.416 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.97 164.36 34.79 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.833 1.253 . . . . 74.31 107.815 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.5 p -168.85 158.47 8.9 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 123.599 0.562 . . . . 75.15 110.49 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 94.6 p -150.7 155.66 39.76 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.832 0.853 . . . . 71.13 109.704 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -91.34 119.0 31.0 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.55 -0.908 . . . . 64.43 108.55 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' D' ' 57' ' ' GLU . 58.7 mt -89.75 -40.52 12.45 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.195 0.598 . . . . 72.24 109.613 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.72 -171.24 3.48 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.964 0.906 . . . . 75.31 110.284 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . 0.413 ' HA ' ' OD1' ' H' ' 450' ' ' ASN . 3.4 m-20 -63.48 106.89 1.0 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.241 -0.891 . . . . 72.13 110.784 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 64.7 17.63 11.03 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.609 1.163 . . . . 72.13 112.168 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 91.0 t -109.52 105.13 18.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 107.122 -1.436 . . . . 74.3 107.122 170.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -121.98 126.73 49.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.261 -1.014 . . . . 75.34 108.261 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.473 ' HB2' HD12 ' D' ' 51' ' ' LEU . 19.3 tt0 -89.85 151.1 21.93 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.452 1.101 . . . . 70.12 108.707 174.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 91.4 t -131.81 128.52 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 C-N-CA 124.516 1.126 . . . . 70.14 108.11 172.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -104.87 130.51 55.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.331 1.052 . . . . 60.04 108.503 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.87 114.47 24.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.548 -0.908 . . . . 74.45 108.548 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.557 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.0 ttm-85 -96.36 101.3 12.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.194 -1.039 . . . . 72.42 108.194 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.5 t -100.84 103.67 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.57 -0.9 . . . . 60.11 108.57 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.577 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 6.0 m -100.64 137.3 39.22 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.063 0.945 . . . . 64.01 109.171 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.475 HG21 HG23 ' D' ' 114' ' ' ILE . 61.9 t -125.6 113.44 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.855 0.862 . . . . 72.5 109.516 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 12.6 m -103.11 119.53 39.02 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.765 -0.828 . . . . 62.21 108.765 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -135.81 152.06 50.7 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.917 0.487 . . . . 74.15 111.32 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 57.2 p -148.92 136.03 20.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.083 -0.508 . . . . 71.31 112.013 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.563 HD11 HG23 ' D' ' 31' ' ' VAL . 50.1 mt -102.49 96.36 6.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.46 1.104 . . . . 75.22 108.103 171.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.63 -139.1 20.49 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.129 -0.487 . . . . 63.24 113.11 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.05 0.76 46.98 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.91 0.484 . . . . 74.45 111.362 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.53 ' HG2' ' HZ1' ' D' ' 34' ' ' LYS . 11.1 pt-20 -118.74 152.66 35.75 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.704 0.802 . . . . 73.31 109.286 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.7 m -73.63 139.68 45.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.75 0.42 . . . . 74.12 110.671 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.722 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.41 -69.83 0.66 Allowed 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.388 -0.824 . . . . 70.31 108.953 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -149.13 138.85 21.86 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.251 -0.886 . . . . 73.21 109.516 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.1 mt -111.78 132.43 54.67 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.359 1.463 . . . . 74.24 107.167 172.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.488 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.7 t -141.56 147.07 37.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.485 -0.561 . . . . 74.2 109.485 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -156.15 130.39 8.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.581 -0.526 . . . . 64.41 109.581 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.12 114.7 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.558 0.743 . . . . 74.32 109.127 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.27 86.56 6.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.567 -0.901 . . . . 72.01 108.567 170.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -78.7 100.76 7.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.237 -1.347 . . . . 72.14 108.901 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.07 146.57 20.46 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 116.1 -0.5 . . . . 73.55 112.16 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.405 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -141.9 130.45 4.34 Favored Glycine 0 CA--C 1.508 -0.358 0 N-CA-C 110.343 -1.103 . . . . 62.31 110.343 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.452 HG13 ' HE1' ' D' ' 17' ' ' TYR . 73.6 mt -89.41 122.85 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.722 -1.214 . . . . 72.4 107.722 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -118.2 145.28 45.09 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.906 0.882 . . . . 65.24 109.335 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 6.8 t -115.57 98.14 6.54 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.633 -1.247 . . . . 74.32 107.633 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 30.0 pt -129.92 137.12 57.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.18 -0.918 . . . . 72.15 110.099 -170.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.07 151.84 25.72 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.811 -0.631 . . . . 64.32 110.442 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.13 -13.17 60.41 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.131 -0.94 . . . . 65.31 113.444 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.488 HD12 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -95.71 136.86 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 121.463 0.649 . . . . 75.31 111.546 -170.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.508 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 44.8 mt-10 -143.02 -176.68 5.01 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.877 1.671 . . . . 75.14 109.685 -177.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.36 -128.06 27.22 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.347 -0.842 . . . . 55.52 113.425 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 46.0 m -85.45 -32.98 22.0 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.439 0.696 . . . . 71.14 111.031 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.546 HE22 HG23 ' B' ' 149' ' ' THR . 50.1 tt0 -63.33 -38.69 92.13 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.968 0.507 . . . . 75.1 111.977 -174.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.508 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 26.1 ptt? -61.09 -45.09 96.13 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.348 0.405 . . . . 74.11 110.914 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.76 91.99 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.406 0.622 . . . . 75.41 110.137 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -68.33 -23.19 64.68 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.188 1.395 . . . . 74.24 111.757 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.0 t -79.02 -51.93 8.92 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.663 -0.495 . . . . 75.52 109.663 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.45 -29.54 62.61 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.306 0.642 . . . . 75.01 111.911 -176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.19 4.93 30.12 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.825 0.69 . . . . 74.24 114.825 -170.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.4 -55.91 0.24 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 117.929 0.864 . . . . 65.12 111.767 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -71.75 -51.85 20.67 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.058 0.392 . . . . 72.42 112.058 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 68.8 m -65.06 -42.48 61.62 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-O 118.401 -0.809 . . . . 74.11 112.256 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.56 -37.95 94.6 Favored 'Trans proline' 0 C--N 1.397 3.102 0 C-N-CA 122.227 1.951 . . . . 73.14 113.317 166.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -67.42 -30.04 69.69 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.199 0.6 . . . . 72.41 111.143 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 40.0 mm -66.54 -42.91 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.416 0.686 . . . . 65.42 110.225 171.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.405 HD22 ' HA3' ' D' ' 82' ' ' GLY . 87.5 mt -74.07 -20.83 60.16 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.056 -0.975 . . . . 65.34 111.906 -174.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -65.1 -43.12 65.48 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 114.192 1.182 . . . . 75.33 114.192 -172.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.01 -46.0 23.4 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.342 2.028 . . . . 73.2 114.073 169.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -72.13 -38.62 69.21 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.463 0.705 . . . . 75.43 111.597 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.85 89.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.369 0.668 . . . . 64.45 110.777 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -58.0 -48.99 78.37 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.392 1.077 . . . . 73.53 110.6 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -58.04 -46.81 84.75 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.201 0.938 . . . . 74.41 111.359 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -59.81 -44.5 93.98 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.027 0.829 . . . . 75.31 111.413 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.488 HG12 ' SG ' ' D' ' 76' ' ' CYS . 75.7 mt -65.35 -50.6 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.78 0.832 . . . . 73.41 111.046 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 57.3 m -55.14 -41.85 72.29 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 124.095 0.958 . . . . 75.22 111.402 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.9 t -67.26 -41.47 85.52 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.568 -1.196 . . . . 73.43 110.4 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -71.46 -28.96 64.32 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.845 0.458 . . . . 71.02 112.187 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' D' ' 123' ' ' PHE . 59.0 t -64.61 -46.44 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.204 0.602 . . . . 74.35 109.581 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.01 -27.24 62.6 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 116.076 -0.511 . . . . 74.33 110.998 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.2 mtt-85 -71.2 -35.04 71.42 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.332 0.653 . . . . 75.45 109.841 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.65 7.97 77.29 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 115.901 -0.59 . . . . 73.11 112.329 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p 59.14 25.34 13.83 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 126.35 1.86 . . . . 73.53 114.725 173.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.418 ' HB2' HG11 ' D' ' 118' ' ' VAL . 99.0 m-85 -87.52 155.69 53.77 Favored Pre-proline 0 CA--C 1.556 1.206 0 N-CA-C 108.607 -0.886 . . . . 75.54 108.607 169.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.72 146.92 96.49 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.635 2.223 . . . . 73.53 112.436 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -58.36 139.54 55.14 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.732 1.213 . . . . 74.23 113.026 -172.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.434 ' HG ' HD22 ' H' ' 468' ' ' LEU . 9.1 mp -114.47 112.36 22.86 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.705 0.802 . . . . 74.24 109.569 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.417 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.2 m-20 -102.35 92.67 4.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.35 -0.981 . . . . 74.13 108.35 172.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.18 115.45 7.66 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.374 -0.602 . . . . 74.12 109.374 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.3 138.99 97.31 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.306 0.642 . . . . 73.31 110.585 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -69.66 119.93 6.81 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.162 1.908 . . . . 65.42 111.073 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.7 150.74 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.325 0.65 . . . . 75.11 111.053 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -80.49 107.16 13.07 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.284 -0.871 . . . . 73.15 109.601 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -80.5 -31.68 37.11 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.321 0.648 . . . . 62.11 110.869 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.75 -52.35 65.81 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.194 1.398 . . . . 71.52 111.861 -168.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.33 79.54 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.136 0.898 . . . . 74.41 111.718 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.507 ' HA ' HD21 ' D' ' 139' ' ' ASN . 3.2 mm? -75.65 -25.6 56.98 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.258 -0.883 . . . . 73.52 111.285 -174.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -61.45 -36.81 81.44 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.36 0.664 . . . . 75.22 110.647 175.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 32.9 mtt -67.32 -32.19 72.99 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.482 -0.781 . . . . 74.45 110.21 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.507 HD21 ' HA ' ' D' ' 136' ' ' LEU . 50.0 m-80 -72.79 -29.82 63.59 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.534 -0.757 . . . . 74.3 111.023 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . 0.673 ' HB2' ' HB3' ' H' ' 461' ' ' PHE . 85.6 t80 -66.48 -39.65 88.87 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.88 0.872 . . . . 72.11 111.823 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 5.7 mp -67.54 -33.15 74.48 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.892 0.877 . . . . 73.05 111.689 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -91.64 33.79 1.01 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.785 0.834 . . . . 75.33 111.701 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 32.4 mm-40 -116.29 85.47 2.31 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.766 -0.827 . . . . 73.03 108.766 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -175.02 142.9 0.67 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.418 1.487 . . . . 74.12 108.127 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.75 0.92 20.73 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.073 0.397 . . . . 72.4 112.073 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.9 20.78 74.82 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.374 0.421 . . . . 44.0 112.502 -176.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -51.59 134.75 29.37 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.6 1.56 . . . . 65.22 113.231 -175.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.66 129.13 9.61 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.344 -0.844 . . . . 75.53 112.654 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 85.2 m -70.69 125.47 26.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.281 0.632 . . . . 73.0 110.593 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.18 159.87 15.76 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.199 1.4 . . . . 73.03 109.965 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -158.08 163.51 37.59 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.175 0.59 . . . . 75.12 110.843 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -156.14 120.39 4.51 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.713 0.805 . . . . 75.33 109.121 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -137.31 138.27 39.82 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.676 0.79 . . . . 74.15 109.638 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -133.52 -175.36 3.79 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 107.796 -1.187 . . . . 72.03 107.796 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 C-N-CA 123.429 0.691 . . . . 54.15 111.648 177.679 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 9.4 t30 . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 110.178 -0.304 . . . . 65.52 110.178 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . 0.567 HG11 HG12 ' E' ' 452' ' ' VAL . 68.9 t -127.04 -75.12 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.093 0.957 . . . . 75.44 108.896 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . 0.567 HG12 HG11 ' E' ' 451' ' ' VAL . 22.5 m -106.83 -177.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.201 0.6 . . . . 73.34 110.682 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 176.14 84.13 0.06 OUTLIER Glycine 0 C--N 1.343 0.924 0 N-CA-C 111.31 -0.716 . . . . 64.51 111.31 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 48' ' ' SER . 10.1 mp -85.66 169.12 13.78 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.393 0.677 . . . . 74.32 110.894 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 40.5 p -111.84 -172.46 2.04 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.271 1.028 . . . . 72.43 110.336 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.12 -49.83 74.33 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.842 0.857 . . . . 75.31 110.867 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -80.24 106.27 12.13 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.44 -0.8 . . . . 72.42 109.152 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 50.1 p -118.96 165.99 13.4 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.789 0.836 . . . . 74.55 109.215 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -143.12 -178.12 5.68 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.551 0.74 . . . . 74.43 109.659 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -154.07 129.81 10.07 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 106.84 -1.541 . . . . 73.45 106.84 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -73.16 19.87 0.09 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.616 1.566 . . . . 72.5 113.563 -173.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -158.82 110.13 2.12 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.122 -0.695 . . . . 75.04 109.122 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 9.5 t -87.25 -13.94 42.37 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.324 0.65 . . . . 50.03 110.865 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 464' ' ' MET . . . . . 0.45 ' HE2' HD11 ' A' ' 44' ' ' LEU . 42.0 ttm 77.71 145.18 0.09 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.341 1.856 . . . . 74.44 110.799 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -52.88 -37.1 60.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.417 1.087 . . . . 74.5 111.742 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . 63.25 78.67 0.28 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.788 1.235 . . . . 74.25 110.802 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -148.87 149.19 30.86 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.918 -1.037 . . . . 75.13 110.055 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 tt -161.04 -60.36 0.05 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 107.58 -1.267 . . . . 63.0 107.58 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 96.14 56.24 1.22 Allowed Glycine 0 C--N 1.346 1.109 0 CA-C-N 115.289 -0.869 . . . . 75.41 111.858 -176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.71 137.24 45.83 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.201 0.6 . . . . 75.45 109.895 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt . . . . . 0 C--O 1.248 1.007 0 C-N-CA 124.071 0.948 . . . . 75.0 109.796 -171.39 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 51.8 t30 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 121.203 0.525 . . . . 73.22 110.178 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . 0.533 HG11 ' HA ' ' B' ' 87' ' ' ALA . 7.1 p -132.9 5.87 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.196 0.998 . . . . 73.02 109.944 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 25.9 m -68.81 79.06 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.393 0 CA-C-O 122.626 1.203 . . . . 73.04 112.959 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -115.59 64.95 0.31 Allowed Glycine 0 C--N 1.34 0.755 0 CA-C-N 114.742 -1.117 . . . . 73.52 110.865 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . 0.537 ' HG ' ' HB3' ' F' ' 456' ' ' ASP . 43.0 tp -68.31 101.2 1.16 Allowed 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.571 0.748 . . . . 75.22 110.728 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 23.9 p -76.15 82.79 2.97 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.441 -0.948 . . . . 73.52 108.441 166.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . 0.537 ' HB3' ' HG ' ' F' ' 454' ' ' LEU . 9.7 p-10 -89.96 -170.62 2.86 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.571 -1.195 . . . . 73.3 110.643 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 68.76 88.82 0.11 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.332 1.453 . . . . 74.32 110.489 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 6.5 t -155.61 133.69 11.45 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.215 1.006 . . . . 75.23 109.113 174.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.11 154.34 40.42 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 109.355 -0.609 . . . . 75.21 109.355 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' B' ' 44' ' ' LEU . 4.6 mm? -70.88 95.26 1.13 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.803 0.811 . . . . 74.33 109.876 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -85.32 14.27 5.54 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.141 1.376 . . . . 72.43 112.521 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . 0.45 ' OH ' ' HA ' ' B' ' 43' ' ' ASP . 13.2 p90 -70.54 139.5 51.57 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 109.231 -0.655 . . . . 75.55 109.231 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 76.7 m -140.33 120.81 14.12 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.179 -0.675 . . . . 74.33 109.179 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 49.4 ttp -141.1 130.42 23.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.107 0.963 . . . . 71.11 108.524 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -72.9 -41.34 64.72 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.658 0.783 . . . . 73.12 112.293 -169.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -140.0 111.75 7.39 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.562 0.745 . . . . 75.42 109.513 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . 0.419 ' HB1' HD23 ' B' ' 42' ' ' LEU . . . -67.83 -40.5 83.74 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.36 0.664 . . . . 73.44 110.747 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 96.3 mt -137.58 151.63 48.57 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.331 1.052 . . . . 73.14 109.668 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . -86.0 60.21 4.64 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 111.666 -0.574 . . . . 72.23 111.666 174.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 4.4 pp -161.29 139.33 9.4 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.245 1.018 . . . . 74.41 108.736 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt . . . . . 0 C--O 1.251 1.141 0 C-N-CA 124.681 1.192 . . . . 74.32 108.312 -178.326 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 66.1 t30 . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 108.794 -0.817 . . . . 74.44 108.794 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.47 124.75 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 121.717 0.77 . . . . 55.44 110.375 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.1 133.96 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 106.985 -1.487 . . . . 74.44 106.985 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . 0.421 ' N ' ' SD ' ' C' ' 94' ' ' MET . . . -141.57 -15.5 0.41 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 115.074 0.79 . . . . 64.42 115.074 -169.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 3.8 tt -68.82 96.49 0.75 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.29 -1.004 . . . . 71.2 108.29 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 4.8 m -124.46 10.19 8.52 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.11 0.964 . . . . 74.22 109.421 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -153.3 136.13 15.38 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.578 0.751 . . . . 75.25 109.393 -175.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -124.82 103.57 8.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.281 1.033 . . . . 74.45 109.086 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 458' ' ' THR . . . . . 0.442 HG23 ' HH ' ' C' ' 140' ' ' TYR . 63.3 p -97.9 167.94 10.6 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.485 0.714 . . . . 73.4 111.141 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -84.2 162.48 20.18 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 109.016 -0.735 . . . . 53.14 109.016 171.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . 0.428 HD21 ' H ' ' C' ' 46' ' ' THR . 0.1 OUTLIER -66.45 125.83 26.92 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.417 -0.957 . . . . 75.31 108.417 174.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -88.22 13.11 12.13 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.097 0.959 . . . . 74.35 111.651 -177.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -163.39 111.39 1.22 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.035 0.534 . . . . 72.34 110.233 -171.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 26.3 m -83.58 -30.33 27.08 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.585 0.754 . . . . 75.42 111.895 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 464' ' ' MET . . . . . 0.612 ' SD ' HD12 ' C' ' 42' ' ' LEU . 0.0 OUTLIER 73.16 112.99 0.06 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.647 1.579 . . . . 74.42 110.515 -174.002 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -135.7 30.43 3.14 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.69 0.796 . . . . 73.24 109.367 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -78.02 131.76 37.5 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.755 -0.831 . . . . 74.42 108.755 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -65.54 105.46 1.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.22 0.608 . . . . 73.53 110.867 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -15.76 63.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.528 0.731 . . . . 73.5 111.57 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.91 -11.32 0.12 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.308 -0.717 . . . . 71.21 111.308 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . 0.498 HD11 ' HD2' ' C' ' 38' ' ' PRO . 77.2 mt -134.54 158.99 42.54 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.079 1.352 . . . . 74.55 109.818 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.555 1.148 0 N-CA-C 108.79 -0.818 . . . . 74.03 108.79 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' D' ' 53' ' ' ASP . 86.8 m-20 . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.735 0.303 . . . . 71.13 110.625 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.84 166.07 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.802 1.241 . . . . 73.24 108.82 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.442 ' HA ' ' SD ' ' D' ' 94' ' ' MET 0.261 7.1 p 46.29 -73.1 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 C-N-CA 126.059 1.744 . . . . 73.42 115.595 178.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 77.01 43.32 17.34 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 118.44 0.564 . . . . 42.44 112.133 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.91 178.01 7.24 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.743 0.817 . . . . 71.1 112.906 -174.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 11.8 t -163.88 170.55 16.63 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 114.021 -1.445 . . . . 75.25 108.109 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 30.1 t70 70.42 160.03 0.2 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 124.374 1.07 . . . . 70.24 112.585 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -156.82 -156.68 0.63 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.79 1.236 . . . . 74.24 109.029 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 25.2 m 80.45 137.51 0.06 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.487 1.515 . . . . 74.11 111.619 175.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 27.1 t70 74.68 112.81 0.07 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.708 1.603 . . . . 65.31 111.416 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . 0.487 HD22 ' HB2' ' D' ' 44' ' ' LEU . 30.2 tp -77.21 161.4 28.2 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.933 -0.576 . . . . 75.4 110.352 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . 0.673 ' HB3' ' HB2' ' D' ' 140' ' ' TYR . 1.9 p90 -94.2 8.11 42.87 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 125.119 1.368 . . . . 74.05 111.99 177.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -148.79 159.74 43.86 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.175 0.99 . . . . 74.24 109.118 -173.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 87.5 m -151.53 110.58 3.89 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.244 -1.021 . . . . 73.25 108.244 173.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 464' ' ' MET . . . . . 0.409 ' HG2' ' HA ' ' H' ' 467' ' ' ALA . 36.1 ttp -82.86 96.06 8.13 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.597 -0.519 . . . . 74.44 109.597 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -65.41 132.23 48.45 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.669 -1.151 . . . . 74.11 109.305 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . 78.44 -32.92 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.398 1.479 . . . . 75.05 112.205 -173.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . 0.462 ' HB1' HG13 ' D' ' 40' ' ' VAL . . . 68.26 -72.72 0.09 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.015 1.726 . . . . 74.41 112.425 172.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . 0.434 HD22 ' HG ' ' D' ' 126' ' ' LEU . 11.8 tp -84.38 6.31 23.68 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.887 0.875 . . . . 74.14 112.006 -175.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 78.45 32.64 41.73 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.064 -0.815 . . . . 71.1 111.064 -167.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 5.1 tt -99.12 85.97 3.34 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.916 -1.142 . . . . 75.12 107.916 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? . . . . . 0 CA--C 1.552 1.037 0 C-N-CA 123.57 0.748 . . . . 74.33 109.467 -178.222 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.489 ' SD ' ' HG2' ' A' ' 3' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.685 0.278 . . . . 75.44 110.339 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.1 m -147.37 89.51 1.79 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.774 -1.195 . . . . 74.1 107.774 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.489 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 16.4 mm-40 -89.45 59.53 4.83 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.833 0.825 . . . . 71.02 110.325 -173.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -115.68 68.29 0.72 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.87 -1.059 . . . . 73.31 109.589 -170.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -161.25 84.28 0.65 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.488 0.715 . . . . 71.51 110.085 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.536 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 3.4 t-20 -166.62 113.47 0.83 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.417 0.687 . . . . 73.44 110.495 173.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -157.13 121.09 4.25 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.016 0.926 . . . . 73.05 109.25 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 64.64 -75.58 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.166 1.387 . . . . 70.3 110.264 -172.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.584 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -140.8 165.55 27.19 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.687 1.195 . . . . 74.42 108.799 171.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.536 ' OG1' ' HA ' ' A' ' 6' ' ' ASN . 94.7 m -153.11 136.05 15.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.55 0.34 . . . . 75.33 110.986 -173.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.646 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 12.6 t80 -137.08 121.84 18.67 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.849 0.859 . . . . 75.53 108.923 172.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -136.45 108.38 7.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.398 0.679 . . . . 75.24 109.292 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.617 HG12 ' HD2' ' A' ' 84' ' ' PHE . 59.5 mt -80.66 109.46 15.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.508 -0.923 . . . . 73.14 108.508 172.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -74.41 -34.91 63.4 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.556 -0.747 . . . . 73.05 110.572 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -174.61 138.0 0.49 Allowed 'General case' 0 C--N 1.362 1.127 0 O-C-N 123.544 0.527 . . . . 75.23 110.624 -170.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.565 HD12 ' HG3' ' C' ' 130' ' ' PRO . 75.4 mt -123.3 133.79 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.75 0.82 . . . . 74.53 109.423 175.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -167.78 151.01 5.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.821 0.848 . . . . 65.14 110.557 -171.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.4 p -79.44 114.75 18.62 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.938 -0.764 . . . . 75.33 108.938 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -78.51 -33.34 48.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.162 -0.681 . . . . 73.25 109.162 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.8 t70 -147.72 132.72 18.18 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.973 -1.012 . . . . 65.42 109.584 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.42 141.49 45.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 107.237 -1.394 . . . . 75.31 107.237 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -145.91 132.55 19.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.627 0.727 . . . . 71.24 109.719 171.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 79.1 t80 -133.19 130.51 39.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.768 -1.567 . . . . 73.34 106.768 172.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.58 122.26 16.38 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.204 0.602 . . . . 74.42 109.456 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.12 78.47 68.96 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.539 -1.282 . . . . 73.21 107.539 174.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.3 -43.35 8.53 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.492 2.128 . . . . 71.32 110.734 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -88.62 20.55 3.37 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.386 -1.279 . . . . 73.1 111.423 -177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.99 -45.93 88.03 Favored Pre-proline 0 CA--C 1.573 1.858 0 C-N-CA 123.71 0.804 . . . . 64.34 113.121 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.471 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 16.2 Cg_exo -68.82 -26.17 32.5 Favored 'Trans proline' 0 C--N 1.398 3.164 0 C-N-CA 121.666 1.577 . . . . 73.2 112.928 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -74.3 -37.42 63.66 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.292 0.637 . . . . 70.41 110.172 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.458 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 73.8 t -67.95 -32.94 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.229 1.012 . . . . 74.52 110.668 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -59.0 -27.95 65.92 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.198 0.999 . . . . 63.12 111.44 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -95.83 -48.62 5.67 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.677 0.791 . . . . 74.34 111.25 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 21.0 ptmt -81.66 164.68 21.65 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.909 0.483 . . . . 73.21 111.22 -175.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.55 141.24 43.74 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.511 0.725 . . . . 74.14 111.876 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -92.34 83.78 5.07 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.092 -0.707 . . . . 74.33 109.092 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.97 62.07 44.35 Favored Pre-proline 0 N--CA 1.482 1.146 0 N-CA-C 108.235 -1.024 . . . . 74.12 108.235 172.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.54 157.29 28.65 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.441 2.094 . . . . 63.24 112.681 -167.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.21 109.77 22.46 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.53 -0.915 . . . . 75.43 108.53 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -83.5 115.24 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.394 -0.821 . . . . 75.24 109.781 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -104.12 144.41 31.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.87 0.868 . . . . 75.53 108.749 170.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.513 HD21 ' SD ' ' E' ' 464' ' ' MET . 23.7 tp -136.79 128.84 29.48 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.809 -1.182 . . . . 74.43 107.809 175.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -135.15 113.01 10.95 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.85 -1.167 . . . . 74.53 107.85 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.2 mt -98.08 121.72 40.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.263 0.625 . . . . 73.33 110.207 -173.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -126.76 147.69 49.97 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.201 1.001 . . . . 73.04 109.054 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.1 m -135.64 126.05 26.71 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.82 0.848 . . . . 75.13 109.761 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.57 109.72 8.86 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 122.941 0.496 . . . . 75.3 110.583 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 29.4 m -89.68 167.99 12.47 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.692 0.797 . . . . 75.12 109.928 175.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 57' ' ' GLU . 86.8 p -160.46 154.05 22.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.505 0.722 . . . . 72.53 109.616 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -89.58 117.46 28.49 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.654 0.382 . . . . 71.35 110.297 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 78.0 mt -87.27 -46.64 9.52 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.574 0.702 . . . . 75.22 109.42 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.43 -176.64 5.39 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 114.421 -1.263 . . . . 70.02 108.777 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -65.81 110.07 2.7 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 109.176 -0.676 . . . . 74.44 109.176 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 74.43 -0.98 3.2 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 125.505 1.522 . . . . 74.05 112.886 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -100.25 113.85 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.048 -1.093 . . . . 73.1 108.048 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -125.66 129.96 50.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.702 0.801 . . . . 74.21 110.642 -172.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 41.2 tp10 -89.94 114.72 26.58 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.506 -0.924 . . . . 73.54 108.506 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 61.9 t -100.89 129.49 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 107.985 -1.117 . . . . 72.03 107.985 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.5 105.66 19.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.126 -1.064 . . . . 74.51 108.126 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.7 97.78 11.0 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 106.918 -1.512 . . . . 71.41 106.918 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -92.32 105.64 17.8 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.994 1.318 . . . . 73.13 109.762 -174.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.511 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.7 t -98.84 105.46 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.869 -0.789 . . . . 64.53 108.869 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -98.94 107.51 19.97 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.091 0.556 . . . . 75.44 110.2 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.4 t -106.02 125.94 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.323 0.649 . . . . 72.12 109.443 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.4 m -127.75 107.92 10.3 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.038 -0.727 . . . . 71.54 109.038 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.4 117.86 35.63 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.358 -1.349 . . . . 74.23 107.358 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.8 p -144.82 145.38 31.61 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.089 0.556 . . . . 63.01 109.883 -173.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -129.09 90.22 2.99 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.112 0.965 . . . . 74.54 109.184 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.69 -114.89 3.95 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.383 -0.826 . . . . 72.33 111.269 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.92 -26.85 14.91 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.22 -0.659 . . . . 61.23 109.22 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -85.92 117.46 24.79 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.668 0.387 . . . . 72.04 110.374 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.6 m -73.71 131.04 41.2 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.076 -0.713 . . . . 65.32 109.076 168.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HA ' HG23 ' A' ' 31' ' ' VAL . . . -73.55 -58.27 3.42 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.999 -0.741 . . . . 72.02 108.999 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -156.62 159.05 38.11 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.133 -1.394 . . . . 73.42 110.191 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 32.3 tp -127.48 119.14 25.41 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 107.337 -1.357 . . . . 74.33 107.337 173.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 68.3 m -125.68 99.45 5.99 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.975 -0.75 . . . . 63.23 108.975 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -121.95 116.55 24.55 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.494 -0.928 . . . . 75.13 108.494 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.3 111.49 26.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 123.673 0.789 . . . . 75.41 109.392 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 43.0 mt-30 -85.21 86.22 7.4 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.499 -0.926 . . . . 74.25 108.499 171.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.475 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.5 tp-100 -76.55 118.34 19.11 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 114.78 -1.1 . . . . 75.12 108.172 178.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.17 160.22 13.49 Favored Glycine 0 C--O 1.24 0.512 0 O-C-N 123.533 0.521 . . . . 71.44 112.121 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.47 132.63 2.91 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.799 -0.92 . . . . 64.11 110.799 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.7 mt -81.19 115.69 24.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 174.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.646 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.5 m-85 -122.82 118.59 28.33 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.24 -0.652 . . . . 75.33 109.24 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 m -99.68 100.73 11.74 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.963 -0.755 . . . . 74.22 108.963 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.9 pt -108.95 125.36 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.665 0.786 . . . . 74.42 111.122 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.71 161.73 38.48 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.983 0.913 . . . . 73.31 109.937 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 80.17 2.0 88.55 Favored Glycine 0 N--CA 1.477 1.381 0 N-CA-C 114.674 0.629 . . . . 71.14 114.674 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.534 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -114.82 146.09 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 123.784 0.834 . . . . 72.04 109.73 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.47 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 15.9 tt0 -150.93 179.44 8.24 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.413 0.285 . . . . 74.14 110.494 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.47 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 71.83 -136.71 24.63 Favored Glycine 0 C--N 1.351 1.405 0 C-N-CA 123.374 0.512 . . . . 73.14 113.747 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.2 p -80.43 -15.85 55.82 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.034 0.934 . . . . 71.34 110.744 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -71.96 -37.24 69.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.326 1.051 . . . . 73.31 110.742 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.563 ' SD ' HG22 ' E' ' 451' ' ' VAL . 27.3 ptt? -73.32 -25.05 60.48 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.312 0.245 . . . . 74.54 111.016 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.6 -35.72 70.59 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.97 0.508 . . . . 72.31 109.908 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -66.52 -31.26 71.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.51 0.724 . . . . 75.11 111.27 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.534 ' SG ' HG13 ' A' ' 89' ' ' ILE . 72.1 m -57.21 -60.03 4.22 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.496 0.498 . . . . 64.41 111.179 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.445 HD22 HD12 ' E' ' 454' ' ' LEU . 3.8 pp -83.62 -12.06 56.51 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 112.541 0.571 . . . . 73.51 112.541 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.14 -15.2 26.56 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 119.476 -0.625 . . . . 51.52 114.399 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.29 -61.59 0.35 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.95 0.875 . . . . 72.23 111.725 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.17 -65.99 0.61 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.974 1.31 . . . . 72.45 112.759 -169.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.42 -39.39 19.9 Favored Pre-proline 0 CA--C 1.569 1.703 0 N-CA-C 113.379 0.881 . . . . 74.14 113.379 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.87 -29.57 88.38 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 121.683 1.589 . . . . 61.14 113.341 169.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -70.57 -28.09 64.63 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 122.6 0.36 . . . . 71.41 110.453 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 13' ' ' ILE . 36.3 mm -56.39 -40.35 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.462 0.705 . . . . 74.35 110.15 172.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.475 HD23 ' HG3' ' A' ' 80' ' ' GLN . 80.4 mt -80.39 -22.55 41.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.861 -1.063 . . . . 74.13 112.675 -173.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.46 -44.92 97.09 Favored Pre-proline 0 CA--C 1.572 1.825 0 N-CA-C 113.591 0.96 . . . . 74.12 113.591 -172.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -59.73 -43.64 36.85 Favored 'Trans proline' 0 C--N 1.394 2.954 0 C-N-CA 122.041 1.828 . . . . 75.02 112.954 173.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -65.48 -36.91 85.27 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.153 0.581 . . . . 73.35 111.037 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.69 -37.92 70.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.91 -0.586 . . . . 75.34 110.751 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.56 ' NH1' HD13 ' C' ' 105' ' ' ILE . 35.0 ttm180 -53.88 -52.87 59.11 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 123.943 0.777 . . . . 75.42 110.03 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -59.78 -49.14 78.87 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.572 1.17 . . . . 74.03 111.311 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 117' ' ' MET . 34.3 t -56.28 -40.85 74.92 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.317 1.011 . . . . 72.11 110.59 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.511 HD11 ' HB ' ' A' ' 62' ' ' VAL . 96.3 mt -70.37 -47.87 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.942 0.897 . . . . 71.24 111.076 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.481 HG23 ' HG3' ' A' ' 125' ' ' GLN . 33.5 m -54.66 -38.03 66.43 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.433 0.693 . . . . 73.43 110.349 177.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.6 t -69.42 -40.78 77.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.865 -1.061 . . . . 71.23 109.634 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 33.2 mmt -59.8 -44.56 93.9 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 120.957 0.408 . . . . 74.34 110.624 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 114' ' ' ILE . 57.3 t -67.79 -44.61 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.299 1.04 . . . . 70.45 111.118 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -72.97 -33.05 65.6 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.359 0.664 . . . . 62.51 111.642 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -71.36 -32.66 68.76 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.964 0.506 . . . . 63.41 109.658 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.79 -2.96 72.12 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 115.571 -0.741 . . . . 74.4 113.578 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.1 m 70.06 11.48 7.64 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.994 1.318 . . . . 73.54 111.487 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -82.86 142.9 45.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 N-CA-C 108.819 -0.808 . . . . 75.32 108.819 173.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -46.86 132.91 17.55 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.403 2.735 . . . . 74.55 113.592 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.481 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.3 tt0 -52.07 144.36 12.29 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.367 1.467 . . . . 75.32 114.108 -169.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.4 tp -121.1 104.12 9.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.281 1.432 . . . . 74.43 109.255 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -116.05 96.02 5.37 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.751 -0.833 . . . . 73.44 108.751 170.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.39 151.78 46.36 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.513 -0.767 . . . . 71.42 110.665 176.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.421 ' H ' ' HB2' ' E' ' 467' ' ' ALA . . . -72.59 152.28 91.63 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.672 0.789 . . . . 74.12 110.964 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.9 126.78 18.81 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.006 1.804 . . . . 74.14 111.918 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.2 t -99.05 115.69 40.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.534 -0.913 . . . . 74.42 108.534 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -81.7 81.61 7.69 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.958 -0.756 . . . . 74.34 108.958 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -59.74 -27.15 66.24 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.478 0.711 . . . . 74.34 111.601 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.92 -49.42 65.6 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.549 1.139 . . . . 74.22 111.032 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.56 -42.45 95.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.224 0.61 . . . . 74.13 110.474 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.9 mt -67.66 -25.2 65.6 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.688 -1.142 . . . . 74.32 111.711 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -78.45 -43.69 26.53 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.46 -0.57 . . . . 74.2 109.46 175.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.5 mmt -59.75 -49.11 79.01 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.687 0.617 . . . . 75.24 111.543 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 28.8 p30 -64.36 -35.81 82.08 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.806 0.691 . . . . 73.32 111.154 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -69.98 -40.3 75.43 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.415 0.686 . . . . 75.54 110.953 174.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.2 tp -66.9 -50.58 61.98 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.693 0.797 . . . . 72.14 111.874 -168.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -168.83 14.96 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.749 0.655 . . . . 70.54 109.865 -176.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 29.3 tt0 66.55 -71.88 0.09 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.092 1.357 . . . . 74.34 110.827 -173.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -116.76 108.19 15.57 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.386 0.674 . . . . 74.33 109.426 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.02 164.42 30.95 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.826 0.85 . . . . 71.21 110.406 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.28 72.76 0.06 OUTLIER Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.956 -0.458 . . . . 70.34 111.956 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -124.8 168.52 13.12 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.898 0.879 . . . . 74.45 110.675 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.13 -23.93 4.57 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.045 -0.525 . . . . 70.31 112.616 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 41.8 p -83.51 93.97 7.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.272 0.629 . . . . 72.02 110.292 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.81 -177.5 6.38 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.191 0.596 . . . . 72.43 110.909 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -159.86 -52.12 0.06 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.305 -0.998 . . . . 63.23 108.305 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -112.04 170.72 7.96 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.374 -1.284 . . . . 74.43 108.504 172.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -76.58 153.83 35.0 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.451 -0.574 . . . . 73.21 109.451 168.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.32 146.02 54.53 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.041 0.536 . . . . 71.21 111.058 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 C-N-CA 123.968 0.907 . . . . 74.21 110.776 -173.548 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.507 ' H3 ' ' HB3' ' B' ' 53' ' ' ASP . 26.1 ptm . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.638 -0.504 . . . . 75.44 109.638 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p -71.93 89.2 1.08 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.19 -1.041 . . . . 72.43 108.19 168.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -90.77 82.29 5.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.997 0.903 . . . . 73.33 111.818 -173.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -100.67 120.72 40.48 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 105.088 -2.19 . . . . 74.11 105.088 162.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -121.6 63.15 0.91 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.826 0.822 . . . . 74.22 109.089 -172.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -164.01 167.99 19.78 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.29 1.436 . . . . 74.52 108.753 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -76.97 -2.54 34.32 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 122.118 -0.364 . . . . 72.22 111.729 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -61.62 -33.25 73.59 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.226 0.61 . . . . 73.31 110.494 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.464 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 24.5 ptm 55.77 171.68 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 126.572 1.949 . . . . 74.11 114.501 176.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 91.2 m -143.98 132.3 22.0 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.903 -1.147 . . . . 75.54 107.903 170.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -138.46 137.22 36.96 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.257 -1.016 . . . . 75.22 108.257 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -145.13 142.51 29.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.16 0.584 . . . . 74.31 110.328 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.2 mt -94.16 123.16 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.809 -1.182 . . . . 74.22 107.809 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.488 HE22 HG12 ' B' ' 55' ' ' VAL . 50.2 mt-30 -94.24 -31.45 14.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.075 0.55 . . . . 71.21 110.304 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -173.51 139.04 0.72 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 123.83 0.706 . . . . 74.45 109.458 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.411 HG21 HD22 ' B' ' 106' ' ' LEU . 90.2 mt -121.09 137.17 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 106.543 -1.651 . . . . 70.22 106.543 170.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -166.77 146.71 5.69 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.315 0.579 . . . . 63.52 111.397 -172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.9 m -74.0 126.97 31.68 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.223 -1.029 . . . . 73.43 108.223 168.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -95.16 -40.94 9.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.292 -0.633 . . . . 71.52 109.292 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.44 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 23.3 m-20 -144.55 133.49 22.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.776 -0.647 . . . . 73.45 110.375 -166.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.6 mm -127.85 142.96 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.248 1.019 . . . . 70.33 108.884 171.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.1 t -144.32 115.18 7.8 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.737 -1.209 . . . . 73.53 107.737 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -130.77 110.18 11.14 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 107.799 -1.185 . . . . 74.12 107.799 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.75 113.91 21.87 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.267 1.027 . . . . 75.14 108.921 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.99 82.67 7.09 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 106.958 -1.497 . . . . 61.51 106.958 169.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.13 -33.69 11.25 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.27 1.98 . . . . 74.25 112.176 -173.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.75 7.54 46.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.245 1.018 . . . . 74.44 110.544 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.413 ' HB1' ' HD3' ' B' ' 29' ' ' PRO . . . -37.6 -64.33 0.43 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 115.095 1.517 . . . . 72.01 115.095 -163.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 53.7 Cg_endo -70.17 -22.85 29.64 Favored 'Trans proline' 0 C--N 1.39 2.746 0 C-N-CA 121.64 1.56 . . . . 44.5 112.817 -170.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -96.78 -20.88 17.9 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.493 0.717 . . . . 73.34 111.002 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' B' ' 68' ' ' LEU . 2.7 p -84.19 -20.73 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.52 0.328 . . . . 74.2 110.445 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -68.08 -24.21 65.03 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.543 0.737 . . . . 74.53 112.886 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -64.36 -15.11 59.8 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.542 0.337 . . . . 73.22 110.779 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.426 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 89.1 mttt -89.38 106.88 18.74 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.748 1.219 . . . . 75.04 109.711 174.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.04 89.35 7.97 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.277 0.631 . . . . 73.1 109.432 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -161.11 161.25 31.12 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.25 1.02 . . . . 74.4 108.829 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.456 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 68.5 mt-30 -85.83 104.32 5.07 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 108.723 -0.843 . . . . 72.35 108.723 173.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.515 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 16.6 Cg_endo -55.94 122.62 12.09 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 122.978 2.452 . . . . 73.42 111.801 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -62.71 109.17 1.33 Allowed 'General case' 0 C--O 1.243 0.741 0 O-C-N 123.759 0.662 . . . . 74.12 110.177 -175.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.541 HG12 HG11 ' B' ' 64' ' ' VAL . 65.9 t -87.01 128.68 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-N 115.045 -0.98 . . . . 74.31 111.231 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -106.42 118.03 35.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.77 1.628 . . . . 75.1 108.356 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.32 135.87 36.39 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.247 0.619 . . . . 72.54 110.244 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.823 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.5 m-20 -129.94 156.19 44.84 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.78 1.232 . . . . 62.53 109.084 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.548 HD12 ' HE2' ' B' ' 133' ' ' PHE . 45.5 mt -134.43 159.55 40.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.759 0.823 . . . . 73.24 109.31 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.3 t70 -159.74 112.91 2.19 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.375 -1.343 . . . . 64.11 107.375 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.1 p -116.88 119.98 37.06 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.83 0.452 . . . . 70.13 110.182 -175.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.42 161.83 25.17 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.397 1.079 . . . . 71.44 109.188 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m -142.26 165.92 26.12 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.447 -0.946 . . . . 74.4 108.447 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.7 p -150.08 136.21 18.74 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.828 0.451 . . . . 63.1 109.83 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -80.95 109.94 16.0 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.911 -0.403 . . . . 72.53 109.911 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 86.2 mt -76.48 -50.59 13.65 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.518 0.675 . . . . 74.44 109.226 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.91 -172.99 4.24 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.082 -0.963 . . . . 70.21 110.054 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . 0.507 ' HB3' ' H3 ' ' B' ' 1' ' ' MET . 52.4 m-20 -63.82 107.71 1.28 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.028 -0.987 . . . . 74.52 109.863 177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 49.4 m-20 72.82 15.2 4.79 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.4 1.48 . . . . 74.21 111.642 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.488 HG12 HE22 ' B' ' 14' ' ' GLN . 75.6 t -115.51 122.15 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.348 1.059 . . . . 72.52 108.708 173.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -129.93 143.16 50.65 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.192 0.597 . . . . 74.23 111.21 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.471 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 4.6 tm-20 -103.65 100.19 10.01 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 106.809 -1.552 . . . . 64.22 106.809 171.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.0 t -90.98 139.52 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.601 0.76 . . . . 74.44 110.265 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.467 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 18.4 t -120.77 135.92 59.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.788 0.835 . . . . 71.05 109.867 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -118.17 107.47 13.99 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.604 -1.258 . . . . 75.34 107.604 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.549 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 23.1 ttm-85 -96.57 125.5 41.09 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.217 0.607 . . . . 75.12 109.69 172.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' B' ' 114' ' ' ILE . 14.6 t -117.0 119.81 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.565 -1.272 . . . . 71.34 107.565 169.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.823 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 62.3 m -100.49 148.07 25.18 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.639 0.776 . . . . 71.55 109.216 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.541 HG11 HG12 ' B' ' 40' ' ' VAL . 73.6 t -135.67 108.29 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.297 1.039 . . . . 63.22 108.359 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.0 m -95.82 137.84 34.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.92 -1.141 . . . . 64.32 107.92 167.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.72 150.43 32.08 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.729 -0.471 . . . . 73.44 109.729 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 50.8 p -150.89 136.72 18.14 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.493 0.496 . . . . 73.44 112.106 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.539 ' HB2' HG23 ' B' ' 31' ' ' VAL . 34.2 mt -104.95 121.41 43.68 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.336 1.054 . . . . 71.01 108.608 170.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.82 -116.98 5.01 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 115.672 -0.694 . . . . 55.15 112.341 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -122.34 23.4 9.76 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.359 1.064 . . . . 73.41 110.116 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.426 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.8 pt-20 -146.09 159.93 42.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.952 0.901 . . . . 71.14 109.961 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 31.0 m -64.3 140.0 58.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.216 0.606 . . . . 70.34 111.292 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.97 -59.62 1.67 Allowed 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.665 -0.865 . . . . 75.23 108.665 171.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -154.35 152.29 30.05 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.788 -0.642 . . . . 74.12 110.684 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 33.3 mt -130.31 109.9 11.11 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 106.169 -1.789 . . . . 73.53 106.169 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 45.2 t -117.32 145.69 43.84 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.704 -0.85 . . . . 74.23 108.704 -175.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.3 tt0 -162.86 130.37 3.68 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.039 0.447 . . . . 74.54 110.046 -172.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 80.2 t -123.83 146.3 29.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.193 -0.912 . . . . 54.24 109.348 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.44 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 10.5 mt-30 -121.35 92.97 3.87 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 108.184 -1.043 . . . . 72.54 108.184 168.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.45 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.3 tp-100 -83.65 100.27 10.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.169 -1.048 . . . . 74.54 108.169 174.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.63 170.13 36.43 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.204 -0.758 . . . . 74.32 111.204 175.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.62 127.33 1.45 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 112.311 -0.316 . . . . 74.32 112.311 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 62.5 mt -86.81 131.79 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.778 0.831 . . . . 74.21 109.125 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -136.56 164.54 27.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.104 0.962 . . . . 71.21 109.9 -175.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -129.19 108.97 10.76 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.125 -1.065 . . . . 74.42 108.125 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 40.2 pt -101.25 145.2 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.47 0.708 . . . . 74.34 110.839 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.498 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -157.34 160.55 38.61 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.876 0.871 . . . . 71.24 110.014 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 80.07 -69.93 3.01 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 123.573 0.545 . . . . 74.41 112.044 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.431 HD12 ' HB2' ' B' ' 97' ' ' CYS . 19.4 pt -54.39 127.86 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.744 1.218 . . . . 74.43 110.854 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.471 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 30.5 tt0 -149.59 156.02 41.25 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 110.204 -0.295 . . . . 74.41 110.204 -171.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.72 -109.71 2.94 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 112.139 -0.384 . . . . 75.04 112.139 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 42.4 m -79.6 -27.46 41.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.982 0.513 . . . . 75.42 110.649 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.471 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 40.7 mt-30 -66.3 -39.88 89.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 122.795 0.438 . . . . 74.5 110.525 -177.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -76.24 -29.54 57.57 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.988 -0.551 . . . . 74.41 110.505 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.51 -33.17 75.09 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.533 0.733 . . . . 70.34 110.501 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.432 ' O ' ' HB1' ' B' ' 100' ' ' ALA . 17.6 t-80 -74.9 -20.35 59.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.826 1.25 . . . . 75.02 110.474 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.462 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 41.4 t -81.91 -68.51 0.69 Allowed 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.527 -0.546 . . . . 73.44 109.527 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 66.9 mt -66.95 -31.99 72.95 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.281 0.632 . . . . 73.24 112.567 -169.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.12 3.78 70.25 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-O 119.435 -0.647 . . . . 75.34 113.886 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' B' ' 96' ' ' HIS . . . -152.88 -65.95 0.16 Allowed 'General case' 0 C--N 1.357 0.895 0 CA-C-N 118.001 0.901 . . . . 64.41 112.553 -174.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.462 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 58.3 t80 -64.39 -47.42 79.3 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.725 0.81 . . . . 74.25 112.129 -174.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.408 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 87.7 m -60.17 -49.78 89.2 Favored Pre-proline 0 CA--C 1.566 1.562 0 C-N-CA 124.474 1.11 . . . . 65.44 111.908 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.494 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 50.8 Cg_exo -59.14 -34.77 98.63 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.068 1.846 . . . . 73.21 113.434 169.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -30.55 71.58 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.285 0.634 . . . . 71.32 110.874 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.93 -45.89 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.112 0.965 . . . . 75.01 110.565 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.411 HD22 HG21 ' B' ' 16' ' ' ILE . 49.8 mt -81.72 -12.71 58.5 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.908 -1.042 . . . . 72.4 112.065 -169.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.32 -49.08 94.51 Favored Pre-proline 0 CA--C 1.558 1.275 0 CA-C-O 117.645 -1.169 . . . . 74.13 113.502 -174.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.17 -35.84 98.37 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 121.951 1.768 . . . . 72.01 112.977 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.45 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 59.9 m-85 -68.96 -46.35 68.39 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.398 0.679 . . . . 74.5 109.851 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.03 88.59 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.611 0.764 . . . . 63.14 110.859 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.545 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 36.7 ttt180 -61.37 -54.81 38.9 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.174 1.389 . . . . 73.11 111.533 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.25 -36.05 82.84 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.541 0.736 . . . . 74.23 109.792 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.444 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.3 t -64.89 -39.31 93.33 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.526 -0.761 . . . . 55.41 111.171 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.517 HD11 ' HB ' ' B' ' 62' ' ' VAL . 70.3 mt -62.19 -54.57 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 109.633 -0.506 . . . . 75.52 109.633 174.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.457 HG22 ' OG ' ' C' ' 119' ' ' SER . 11.1 m -59.74 -30.67 68.99 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.33 1.019 . . . . 71.31 111.276 -173.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 41.7 t -60.63 -50.93 71.54 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 123.87 0.731 . . . . 74.03 109.541 173.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.446 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 7.9 mmt -68.19 -36.74 80.05 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.165 0.586 . . . . 74.15 111.453 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 114' ' ' ILE . 91.9 t -59.43 -43.42 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.056 0.942 . . . . 74.45 110.092 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.505 ' OG ' HG21 ' C' ' 115' ' ' THR . 45.9 t -71.46 -31.9 67.69 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.801 -1.09 . . . . 71.14 111.747 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.9 mtt-85 -65.8 -37.37 86.08 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 115.969 -0.56 . . . . 72.31 109.537 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.8 2.92 86.82 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.45 -0.639 . . . . 63.31 113.389 173.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.4 ' HA ' ' ND2' ' C' ' 127' ' ' ASN . 47.3 p 63.22 19.89 11.94 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 126.116 1.766 . . . . 70.32 114.182 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -81.75 153.51 70.33 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.249 0.62 . . . . 73.44 110.739 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.456 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 98.9 Cg_exo -48.77 162.62 0.36 Allowed 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 124.304 3.336 . . . . 63.12 115.67 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -61.62 128.9 38.49 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.701 1.2 . . . . 74.32 112.231 -169.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.406 HD22 HG22 ' B' ' 118' ' ' VAL . 35.5 tp -133.35 107.85 8.35 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.398 1.079 . . . . 72.52 109.202 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -124.37 134.72 53.06 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.457 0.703 . . . . 74.04 109.571 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.545 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.8 mm? -80.79 147.71 30.36 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.608 0.763 . . . . 65.11 111.075 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.87 146.63 46.5 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.738 0.815 . . . . 75.4 109.501 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.12 102.75 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.414 2.076 . . . . 72.44 112.465 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 64.3 t -89.42 110.64 21.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.746 -1.205 . . . . 70.44 107.746 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -82.27 86.18 6.72 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.953 -1.128 . . . . 75.24 107.953 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.548 ' HE2' HD12 ' B' ' 44' ' ' LEU . 91.0 m-85 -54.8 -37.84 66.58 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.87 0.868 . . . . 75.03 110.728 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' B' ' 100' ' ' ALA . 16.7 t70 -61.86 -43.77 98.17 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.104 -1.407 . . . . 75.42 111.109 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.19 -42.94 62.16 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.59 0.756 . . . . 65.51 111.116 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.42 -16.03 60.39 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.223 0.453 . . . . 71.52 112.223 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -65.32 -33.84 76.91 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.221 0.608 . . . . 71.55 109.817 171.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 52.3 mtt -69.13 -37.19 78.19 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.538 0.735 . . . . 73.2 110.589 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -88.92 -13.41 39.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.224 0.61 . . . . 72.25 111.614 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -60.43 -45.76 92.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.96 0.904 . . . . 74.24 110.951 175.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.67 21.89 10.7 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.88 -1.055 . . . . 74.4 112.138 -169.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -164.96 164.0 20.73 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.264 0.626 . . . . 72.31 109.751 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -73.98 -179.38 3.72 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.646 0.778 . . . . 73.24 111.616 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -139.0 117.83 12.35 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.966 -0.753 . . . . 74.25 108.966 173.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -75.42 85.65 2.55 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.217 -0.66 . . . . 73.55 109.217 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.81 81.61 1.0 Allowed Glycine 0 C--N 1.342 0.893 0 CA-C-N 115.531 -0.759 . . . . 72.53 111.554 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -126.12 142.43 51.53 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.683 0.793 . . . . 73.53 109.647 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.12 161.07 14.32 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.044 -0.98 . . . . 73.32 110.727 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 17.8 p -144.14 139.95 29.11 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.979 0.912 . . . . 74.03 109.32 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.88 126.93 29.73 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.875 -1.528 . . . . 74.14 106.875 169.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.76 96.73 1.9 Allowed 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.82 -1.548 . . . . 73.14 106.82 171.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . 0.461 ' O ' ' HB2' ' H' ' 450' ' ' ASN . 62.3 t60 -138.29 75.14 1.51 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.109 -1.441 . . . . 74.0 107.109 169.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -66.51 100.13 0.64 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.386 0.612 . . . . 73.02 109.505 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -89.9 -177.1 5.13 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 114.737 -1.12 . . . . 73.42 109.063 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.994 0 C-N-CA 123.471 0.708 . . . . 70.43 110.905 177.026 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 110.104 -0.332 . . . . 71.43 110.104 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' SER . . . . . 0.435 ' HB2' ' OD1' ' C' ' 5' ' ' ASN . 42.2 p -82.47 82.8 7.76 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.881 0.872 . . . . 72.2 109.555 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -74.88 -45.11 45.11 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.028 -0.987 . . . . 72.43 112.288 -171.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -128.04 95.11 4.09 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.803 -0.814 . . . . 73.11 108.803 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' C' ' 2' ' ' SER . 60.9 m-20 -96.98 6.57 48.39 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.982 0.913 . . . . 75.34 111.447 -173.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . 0.505 ' HB3' ' HA2' ' C' ' 88' ' ' GLY . 53.4 t-20 68.34 -84.93 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.201 1.0 . . . . 74.25 110.827 174.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 10.6 p -148.46 179.8 7.53 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.986 1.314 . . . . 75.33 109.066 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.446 ' HB2' HG23 ' C' ' 149' ' ' THR . 21.1 mm-40 -86.74 57.62 4.6 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.379 0.672 . . . . 74.41 110.591 176.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.466 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 27.7 ttt 53.88 112.37 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 126.139 1.775 . . . . 74.35 112.584 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 24.9 m -117.28 117.19 28.87 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.707 -0.849 . . . . 71.12 108.707 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.608 ' HD1' ' HH ' ' C' ' 101' ' ' TYR . 1.1 t80 -122.41 123.21 40.81 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.264 0.626 . . . . 73.53 109.671 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -143.72 133.91 24.39 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.055 0.942 . . . . 70.32 108.492 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 36.5 mt -81.22 126.43 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.76 -0.829 . . . . 75.31 108.76 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.556 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 29.4 mm-40 -88.0 -47.02 8.85 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.646 -0.707 . . . . 73.32 110.148 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -174.81 138.88 0.49 Allowed 'General case' 0 C--N 1.352 0.706 0 CA-C-N 115.373 -0.83 . . . . 74.33 109.441 -168.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -128.31 141.0 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 107.824 -1.176 . . . . 73.15 107.824 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -170.41 171.14 6.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.469 0.652 . . . . 75.41 110.885 -170.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -96.26 110.91 23.13 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.758 -0.83 . . . . 65.53 108.758 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -71.81 -34.26 69.21 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.933 -0.766 . . . . 75.13 108.933 173.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.5 t70 -146.52 146.51 30.53 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.072 -0.967 . . . . 72.44 109.295 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.3 mt -141.86 144.26 25.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.815 1.646 . . . . 73.22 106.912 175.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t -155.05 151.05 27.94 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.641 0.734 . . . . 73.51 110.433 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -148.67 148.63 30.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.197 -1.365 . . . . 75.2 107.354 171.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.603 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.5 mt-10 -143.77 139.25 29.3 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.003 0.921 . . . . 74.42 109.29 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.06 73.42 5.67 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 106.263 -1.754 . . . . 43.44 106.263 169.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.29 -10.88 16.19 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.147 1.898 . . . . 74.32 111.766 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -114.98 20.7 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.984 1.314 . . . . 71.2 109.306 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.512 ' HA ' HG11 ' C' ' 31' ' ' VAL . . . -55.82 -53.49 62.35 Favored Pre-proline 0 CA--C 1.561 1.385 0 N-CA-C 113.348 0.869 . . . . 73.32 113.348 -168.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.38 -42.38 68.25 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 121.752 1.635 . . . . 73.21 113.015 177.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -70.84 -35.36 72.4 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.657 0.783 . . . . 74.42 112.444 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.672 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -79.5 -24.17 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 112.262 0.467 . . . . 65.24 112.262 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -68.99 -22.86 64.06 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.983 -0.448 . . . . 75.23 111.79 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -95.61 6.42 48.99 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.238 0.615 . . . . 72.33 111.048 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -92.89 142.5 27.24 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.756 0.822 . . . . 72.32 111.562 -172.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -71.2 134.14 46.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.748 1.219 . . . . 74.32 109.618 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -84.75 102.36 12.94 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.961 0.726 . . . . 73.41 112.961 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -121.16 67.84 17.32 Favored Pre-proline 0 N--CA 1.484 1.263 0 N-CA-C 107.507 -1.294 . . . . 73.52 107.507 160.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -84.15 118.75 2.35 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 122.969 2.446 . . . . 75.04 112.951 -171.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -86.35 99.16 11.41 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.953 -1.128 . . . . 74.13 107.953 167.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 p -76.83 98.82 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.688 0.756 . . . . 72.11 109.35 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.433 ' HB3' ' HZ3' ' C' ' 41' ' ' LYS . 0.0 OUTLIER -94.8 101.48 13.29 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.506 -2.035 . . . . 74.32 105.506 169.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 9.0 tt -86.38 142.3 28.55 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.305 -1.368 . . . . 75.01 107.305 174.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.559 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.1 t70 -119.58 133.63 55.58 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.685 -0.857 . . . . 73.21 108.685 -173.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.0 mt -112.71 123.36 50.14 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.467 -0.938 . . . . 71.41 108.467 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.3 t70 -135.78 126.6 27.47 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.397 -1.334 . . . . 51.1 107.397 172.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -137.58 128.17 26.76 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.583 0.706 . . . . 70.3 109.699 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.05 152.27 46.08 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 113.93 -1.486 . . . . 71.24 107.523 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -140.43 145.38 36.93 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.838 -0.43 . . . . 73.33 109.838 -174.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -143.84 135.71 26.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.492 0.717 . . . . 64.31 110.433 -168.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . 0.451 HE22 ' HA ' ' G' ' 450' ' ' ASN . 61.4 tt0 -72.75 122.67 21.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.471 0.708 . . . . 74.12 110.741 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' C' ' 57' ' ' GLU . 36.1 mt -91.71 -45.8 8.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.473 -0.936 . . . . 64.31 108.473 172.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.01 178.29 8.83 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.323 -1.308 . . . . 73.54 108.901 174.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -74.19 134.12 42.75 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.062 -0.718 . . . . 71.42 109.062 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.469 ' HA ' HG13 ' G' ' 451' ' ' VAL . 63.4 m-20 69.16 -0.21 2.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.478 1.511 . . . . 75.12 113.114 -171.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.1 t -123.35 94.82 3.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 123.961 0.904 . . . . 74.03 108.701 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -116.11 125.35 52.25 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.961 -1.125 . . . . 72.44 107.961 -176.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.56 ' HB2' HD12 ' C' ' 51' ' ' LEU . 37.1 tt0 -82.26 138.21 34.66 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.686 0.794 . . . . 73.01 109.519 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 63.6 t -115.45 130.05 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.916 -0.772 . . . . 74.31 108.916 170.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 97.0 t -111.76 133.73 56.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.542 -1.281 . . . . 73.43 107.542 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.06 104.31 8.8 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.455 -0.943 . . . . 73.32 108.455 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 33.1 ttm-85 -95.48 108.7 20.94 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.583 -0.895 . . . . 63.43 108.583 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.525 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.8 t -109.38 122.52 64.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.834 -1.173 . . . . 74.54 107.834 172.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.3 m -124.55 114.66 19.7 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.091 0.556 . . . . 71.31 109.837 -174.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.626 HG12 HD12 ' C' ' 126' ' ' LEU . 78.1 t -99.25 107.82 21.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.761 -0.829 . . . . 73.41 108.761 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.468 HG23 HD22 ' C' ' 75' ' ' LEU . 1.6 m -99.46 106.83 18.91 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.374 -1.343 . . . . 74.34 107.374 174.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.54 124.19 46.8 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.239 -1.023 . . . . 72.11 108.239 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 59.7 m -134.72 163.69 29.22 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.928 0.394 . . . . 65.34 110.651 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 30.7 mt -124.3 15.22 9.02 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.093 1.357 . . . . 73.23 109.785 -173.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.54 -93.04 0.42 Allowed Glycine 0 C--N 1.344 1.013 0 N-CA-C 110.381 -1.088 . . . . 71.43 110.381 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -100.04 -30.76 11.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.108 0.963 . . . . 71.12 109.599 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -75.34 122.68 24.12 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.592 1.157 . . . . 73.25 110.715 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 78.8 m -78.37 125.84 29.93 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.803 -1.184 . . . . 64.32 107.803 162.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.672 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.44 -64.74 0.86 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.549 -0.908 . . . . 55.24 108.549 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.69 168.72 24.14 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.28 -0.873 . . . . 74.23 109.675 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.603 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.1 tm? -128.36 142.28 51.17 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.515 -1.661 . . . . 74.23 106.515 169.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 47.4 t -144.23 145.47 32.08 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 107.817 -1.179 . . . . 75.1 107.817 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -157.61 128.14 6.41 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.891 -0.411 . . . . 74.12 109.891 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.58 125.29 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 123.855 0.862 . . . . 71.51 108.79 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.54 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.5 mt-30 -103.75 86.86 2.68 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.531 -0.914 . . . . 65.03 108.531 173.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -78.46 97.91 5.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.676 -1.147 . . . . 74.32 108.949 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.27 149.16 24.74 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.291 -0.868 . . . . 72.52 110.98 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.517 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -153.81 117.12 0.78 Allowed Glycine 0 CA--C 1.502 -0.723 0 N-CA-C 110.891 -0.884 . . . . 72.42 110.891 -176.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.6 mm -81.97 119.55 31.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.461 -0.941 . . . . 73.52 108.461 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -125.21 118.58 26.36 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.837 -0.801 . . . . 71.25 108.837 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.2 m -77.54 103.21 7.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.156 -0.683 . . . . 74.15 109.156 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.548 HG12 HD22 ' C' ' 98' ' ' LEU . 1.7 pp -122.63 123.52 68.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 123.762 0.825 . . . . 71.41 110.143 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -127.25 162.04 27.15 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.554 1.142 . . . . 72.05 109.225 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' C' ' 6' ' ' ASN . . . 88.68 -34.29 3.92 Favored Glycine 0 N--CA 1.473 1.133 0 N-CA-C 113.805 0.282 . . . . 73.11 113.805 173.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.452 HD13 ' HB ' ' C' ' 86' ' ' ILE . 28.0 pt -90.15 144.57 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.924 0.889 . . . . 74.43 111.07 -177.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -161.95 155.98 21.77 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.511 0.724 . . . . 74.25 110.079 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.72 -117.83 7.88 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.586 -0.734 . . . . 72.52 113.198 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.48 HG21 HD11 ' C' ' 141' ' ' LEU . 32.6 p -69.35 -25.07 64.01 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.001 0.92 . . . . 74.51 111.816 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.419 HE21 HG21 ' C' ' 89' ' ' ILE . 25.4 mt-30 -71.45 -52.34 19.0 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.591 0.757 . . . . 63.24 110.685 176.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.598 ' SD ' HG12 ' G' ' 452' ' ' VAL . 0.0 OUTLIER -69.59 -30.58 68.37 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.681 -0.69 . . . . 75.11 111.466 -174.382 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.13 -47.79 82.22 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 124.244 0.965 . . . . 74.3 110.692 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.439 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 10.5 t-160 -78.56 -35.56 45.82 Favored 'General case' 0 C--O 1.246 0.886 0 O-C-N 123.548 0.53 . . . . 72.23 111.994 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -58.65 -40.65 84.02 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.474 0.484 . . . . 74.54 110.665 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.548 HD22 HG12 ' C' ' 86' ' ' ILE . 31.0 mt -101.72 -10.68 19.75 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.994 0.518 . . . . 74.23 111.341 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.91 -30.55 63.31 Favored Glycine 0 C--N 1.355 1.584 0 N-CA-C 113.953 0.341 . . . . 54.43 113.953 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.63 -35.99 0.06 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.137 0.421 . . . . 71.22 112.137 -171.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.608 ' HH ' ' HD1' ' C' ' 11' ' ' PHE . 11.3 t80 -65.31 -43.49 90.91 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.318 1.447 . . . . 74.25 112.216 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -84.24 -42.59 0.74 Allowed Pre-proline 0 CA--C 1.567 1.601 0 CA-C-O 118.588 -0.72 . . . . 71.24 112.245 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -54.2 -25.55 38.5 Favored 'Trans proline' 0 C--N 1.397 3.113 0 C-N-CA 122.747 2.298 . . . . 72.12 114.095 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -61.37 -38.26 86.34 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.62 0.768 . . . . 74.24 110.822 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.56 HD13 ' NH1' ' A' ' 111' ' ' ARG . 47.5 mm -67.1 -39.88 84.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.196 -0.911 . . . . 73.24 110.306 177.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.517 HD22 ' HA3' ' C' ' 82' ' ' GLY . 60.5 mt -79.45 -22.75 43.73 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.943 0.897 . . . . 74.11 112.065 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -55.6 -52.8 69.02 Favored Pre-proline 0 CA--C 1.558 1.284 0 N-CA-C 114.08 1.141 . . . . 75.24 114.08 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.05 -29.01 65.85 Favored 'Trans proline' 0 C--N 1.386 2.531 0 CA-C-N 121.286 1.495 . . . . 74.24 112.637 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -70.29 -47.87 59.26 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.981 0.512 . . . . 75.34 109.674 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.82 -45.18 78.39 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.989 -1.005 . . . . 74.21 109.789 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.571 ' HG3' ' HB3' ' C' ' 128' ' ' LEU . 44.9 ttt-85 -56.21 -52.98 62.45 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.35 1.46 . . . . 71.12 111.708 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.28 -37.27 85.06 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.344 0.658 . . . . 75.31 110.483 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 21.1 t -71.36 -29.25 64.75 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 122.954 0.502 . . . . 73.32 111.628 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.525 HD11 ' HB ' ' C' ' 62' ' ' VAL . 98.0 mt -69.43 -52.34 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 109.342 -0.614 . . . . 74.43 109.342 173.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.505 HG21 ' OG ' ' B' ' 119' ' ' SER . 5.8 m -61.79 -31.16 71.36 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.58 0.752 . . . . 74.45 110.937 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.9 t -63.5 -52.68 60.2 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.433 0.693 . . . . 71.11 109.19 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.502 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.17 -38.01 84.97 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.263 1.025 . . . . 64.44 112.473 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' C' ' 114' ' ' ILE . 83.3 t -61.59 -48.35 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.656 0.783 . . . . 63.42 110.009 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.457 ' OG ' HG22 ' B' ' 115' ' ' THR . 41.7 t -67.23 -27.37 67.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.574 -1.194 . . . . 74.31 111.519 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -72.68 -40.75 66.02 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.181 0.592 . . . . 74.42 109.62 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -3.91 79.38 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.426 0.454 . . . . 62.43 112.747 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.443 HG21 ' HB3' ' D' ' 17' ' ' TYR . 31.1 p 62.95 33.78 14.66 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 126.853 2.061 . . . . 74.23 113.222 173.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.61 151.69 62.19 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.087 -1.079 . . . . 71.1 108.087 168.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -57.25 166.16 4.7 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.679 2.253 . . . . 75.23 113.6 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -46.44 138.24 5.89 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.344 1.457 . . . . 74.3 114.672 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.626 HD12 HG12 ' C' ' 64' ' ' VAL . 5.4 tt -119.84 85.29 2.35 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.91 -1.144 . . . . 75.22 107.91 169.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . 0.4 ' ND2' ' HA ' ' B' ' 122' ' ' THR . 18.9 m120 -92.17 94.59 9.28 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.225 -1.028 . . . . 74.23 108.225 175.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.571 ' HB3' ' HG3' ' C' ' 111' ' ' ARG . 16.7 tp -70.05 123.55 21.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.416 -0.811 . . . . 73.25 110.163 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.23 154.85 88.27 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 124.38 1.072 . . . . 73.44 111.402 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.565 ' HG3' HD12 ' A' ' 16' ' ' ILE . 45.9 Cg_exo -55.11 111.12 0.65 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.837 2.358 . . . . 73.42 113.291 172.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.55 115.74 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.443 -1.318 . . . . 63.35 107.443 167.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -82.13 86.62 6.58 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.775 -0.824 . . . . 72.12 108.775 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.465 ' HA ' ' HZ ' ' G' ' 461' ' ' PHE . 80.2 m-85 -62.63 -43.22 99.35 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.927 -1.033 . . . . 73.31 110.628 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.05 -42.99 93.73 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 114.049 -1.432 . . . . 70.52 111.27 -169.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.7 95.29 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 123.711 0.632 . . . . 75.14 111.676 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.04 -49.11 63.43 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.949 0.5 . . . . 74.24 110.021 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.439 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 3.0 t80 -69.49 -21.28 63.7 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 116.087 -0.506 . . . . 73.44 110.107 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 25.9 ttt -69.03 -32.25 71.63 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.717 0.407 . . . . 72.44 110.251 173.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -70.95 -38.83 72.85 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 110.068 -0.345 . . . . 73.34 110.068 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -64.23 -84.2 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.486 0.714 . . . . 74.24 110.696 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.48 HD11 HG21 ' C' ' 92' ' ' THR . 18.8 tp -125.22 134.66 52.26 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 120.861 0.362 . . . . 75.21 111.227 -175.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -145.3 168.62 20.02 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.616 1.166 . . . . 74.41 111.041 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.06 127.48 15.93 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 106.375 -1.713 . . . . 74.53 106.375 169.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -75.51 87.44 2.64 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.697 0.761 . . . . 74.05 110.232 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.66 159.58 35.51 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.064 1.346 . . . . 75.1 108.335 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.85 -124.02 1.86 Allowed Glycine 0 C--N 1.334 0.439 0 N-CA-C 111.344 -0.702 . . . . 62.04 111.344 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 62.12 -176.81 0.13 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.432 1.093 . . . . 72.55 111.461 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 168.55 138.19 2.41 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.913 -0.475 . . . . 51.45 111.913 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.446 HG23 ' HB2' ' C' ' 8' ' ' GLU . 23.2 p -90.65 169.51 10.94 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 123.469 0.708 . . . . 73.24 110.313 171.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.14 -177.87 4.18 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.014 0.926 . . . . 72.25 111.353 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -71.94 179.64 3.13 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.633 0.773 . . . . 74.51 111.089 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -59.84 -45.79 91.32 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.892 -0.595 . . . . 74.34 110.418 171.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.23 153.98 0.12 Allowed 'General case' 0 CA--C 1.561 1.375 0 O-C-N 124.906 1.379 . . . . 72.22 109.892 -177.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 72.88 128.49 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.548 1.539 . . . . 74.45 111.596 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.948 0 C-N-CA 123.537 0.735 . . . . 44.43 109.56 178.742 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 109.558 -0.534 . . . . 74.22 109.558 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 17.8 m -84.63 173.58 10.65 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.806 0.843 . . . . 74.14 110.222 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -80.97 160.59 24.58 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.001 0.521 . . . . 75.1 110.238 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -79.93 97.32 6.69 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.304 0.642 . . . . 74.31 109.548 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -65.9 149.88 49.5 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.882 0.473 . . . . 64.45 110.484 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -101.46 24.53 9.53 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.593 0.711 . . . . 73.45 111.214 -166.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -93.04 167.28 11.89 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.812 0.845 . . . . 73.44 109.707 170.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 61.89 104.65 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.643 1.177 . . . . 71.13 110.157 -171.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 2.9 ttp -32.95 122.79 0.38 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.901 0.88 . . . . 71.13 111.481 172.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 27.9 m -108.32 141.82 39.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.993 0.425 . . . . 72.3 111.106 -172.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -156.99 95.48 1.51 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.116 -1.439 . . . . 70.4 107.116 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -122.48 121.58 36.92 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.982 -0.747 . . . . 73.22 108.982 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.532 HD11 HG22 ' D' ' 105' ' ' ILE . 10.4 mt -84.75 121.61 37.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.046 -0.724 . . . . 63.31 109.046 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -87.04 -36.23 18.31 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 119.286 -0.387 . . . . 74.12 111.616 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -172.38 122.88 0.46 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 120.788 -0.365 . . . . 73.33 111.822 -164.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.41 137.91 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.886 -1.153 . . . . 72.21 107.886 166.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.492 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 30.8 p90 -161.43 177.06 10.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.151 0.907 . . . . 73.34 111.223 178.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.3 p -108.71 126.05 52.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.798 -1.092 . . . . 75.22 108.959 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.492 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 24.9 mtpt -93.88 -12.72 28.29 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.575 -0.528 . . . . 74.13 109.575 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.4 t70 -169.8 136.02 1.52 Allowed 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.516 1.126 . . . . 74.04 108.66 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.502 HG23 ' HE1' ' C' ' 117' ' ' MET . 69.4 mt -135.47 143.6 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.436 1.094 . . . . 75.04 108.403 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -142.69 134.98 27.56 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.249 1.02 . . . . 74.33 109.252 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.521 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.7 t80 -144.22 130.81 20.03 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.377 -1.712 . . . . 73.01 106.377 165.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.8 mt-10 -131.19 150.04 52.32 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.499 0.72 . . . . 73.42 109.377 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.12 76.86 10.21 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 106.939 -1.504 . . . . 74.11 106.939 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.78 -32.72 22.56 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.855 2.37 . . . . 74.12 112.326 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -96.62 0.09 49.38 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.078 -0.964 . . . . 72.22 110.864 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.14 -68.03 0.1 OUTLIER Pre-proline 0 CA--C 1.559 1.297 0 N-CA-C 115.64 1.718 . . . . 72.0 115.64 -160.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -78.04 -16.96 13.89 Favored 'Trans proline' 0 C--N 1.383 2.37 0 CA-C-N 122.655 1.984 . . . . 64.43 113.709 -172.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -74.7 -42.16 58.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.185 0.994 . . . . 74.33 109.394 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.568 HG23 HD11 ' D' ' 68' ' ' LEU . 9.2 p -83.82 -20.61 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 115.827 -0.624 . . . . 74.35 111.093 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -64.24 -16.92 63.0 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.208 0.603 . . . . 72.14 111.923 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -68.55 -2.93 9.96 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.83 0.852 . . . . 74.35 111.801 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.567 ' HZ2' ' HB3' ' D' ' 71' ' ' GLU . 89.1 mttt -109.92 101.67 10.49 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 125.125 1.37 . . . . 75.11 109.809 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -84.35 83.34 8.02 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.444 0.64 . . . . 71.44 109.518 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -146.41 157.2 43.74 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.571 1.149 . . . . 74.1 108.735 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -77.09 105.37 2.4 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.67 -0.863 . . . . 74.15 108.67 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.26 119.07 5.93 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.13 2.553 . . . . 74.14 113.909 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.15 116.22 7.7 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.089 0.956 . . . . 74.04 109.101 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.464 HG13 ' HB1' ' D' ' 66' ' ' ALA . 27.6 m -101.96 119.57 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 121.665 0.745 . . . . 73.13 112.069 -169.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 107.98 18.83 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.123 -1.806 . . . . 74.53 106.123 167.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.489 HD21 ' H ' ' D' ' 42' ' ' LEU . 1.3 pt? -98.14 156.08 16.85 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.418 0.627 . . . . 72.54 110.795 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -141.08 146.56 37.28 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.575 1.15 . . . . 73.21 108.522 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.401 ' HB2' ' CE2' ' H' ' 462' ' ' TYR . 26.4 tp -127.28 131.98 50.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.709 0.804 . . . . 63.54 109.397 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.0 t70 -141.58 144.43 34.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.473 -0.936 . . . . 72.1 108.473 173.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.436 HG22 HD21 ' H' ' 460' ' ' LEU . 8.5 t -134.55 158.84 42.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.676 -0.49 . . . . 74.1 109.676 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.12 157.2 35.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.033 -0.985 . . . . 73.44 108.384 174.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.7 p -153.96 148.2 25.89 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.596 -0.52 . . . . 64.44 109.596 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 57.2 p -162.58 142.23 9.35 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.124 0.569 . . . . 71.42 110.236 -171.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -71.52 125.41 26.98 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.998 0.919 . . . . 74.5 111.353 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 mt -94.63 -35.47 12.19 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.102 0.561 . . . . 73.43 109.917 172.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.75 -171.45 3.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.792 0.837 . . . . 74.01 110.381 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -59.68 113.22 2.13 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.701 0.626 . . . . 73.13 110.508 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 65.24 13.29 8.66 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.927 1.291 . . . . 70.43 111.677 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 81.8 t -109.43 118.92 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.496 -0.927 . . . . 71.43 108.496 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -127.93 127.55 43.52 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.329 -0.989 . . . . 71.31 108.329 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -94.03 122.54 36.65 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.214 1.006 . . . . 72.22 108.648 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.11 124.57 53.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.714 -1.217 . . . . 75.2 107.714 172.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.539 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.3 t -100.56 127.59 53.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.654 -0.869 . . . . 55.02 108.654 171.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.03 117.38 33.85 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.309 -0.997 . . . . 73.51 108.309 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.586 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.3 ttm-85 -96.73 114.28 25.91 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.881 -1.525 . . . . 73.43 106.881 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.472 HG23 ' HB1' ' D' ' 110' ' ' ALA . 64.4 t -118.03 116.84 52.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.977 -1.12 . . . . 75.42 107.977 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 74.1 m -119.17 134.61 55.11 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.615 -0.721 . . . . 74.23 109.461 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 78.1 t -131.01 118.07 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.49 0.716 . . . . 73.34 109.905 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -112.39 97.29 6.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.462 1.105 . . . . 72.01 108.279 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.464 ' HB1' HG13 ' D' ' 40' ' ' VAL . . . -96.2 161.72 13.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.321 0.649 . . . . 74.11 111.318 -173.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.401 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 28.4 p -154.66 137.33 15.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.221 -0.899 . . . . 54.32 111.663 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.568 HD11 HG23 ' D' ' 31' ' ' VAL . 65.8 mt -101.28 96.56 7.27 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.675 -1.148 . . . . 74.23 108.104 168.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.24 -130.48 10.86 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.892 -0.594 . . . . 55.41 112.671 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.26 4.86 21.94 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.109 0.964 . . . . 74.0 112.156 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.567 ' HB3' ' HZ2' ' D' ' 34' ' ' LYS . 6.4 tp10 -133.46 142.46 48.29 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.918 0.887 . . . . 75.33 110.742 -165.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.0 m -60.59 133.14 55.8 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.047 0.939 . . . . 75.55 111.309 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.507 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.06 -72.6 0.57 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.321 -0.992 . . . . 73.13 108.321 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -141.02 153.77 45.69 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 115.804 -0.635 . . . . 70.03 110.514 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 55.5 mt -114.68 151.09 34.2 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.397 1.079 . . . . 71.43 108.207 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.633 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.9 t -158.94 145.27 16.86 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.572 0.349 . . . . 71.42 110.721 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -155.75 122.7 5.35 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.448 0.699 . . . . 72.32 109.647 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.91 115.65 43.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 109.464 -0.569 . . . . 74.05 109.464 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -89.8 83.14 6.18 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.112 0.958 . . . . 73.32 108.775 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.42 91.87 5.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 113.619 -1.628 . . . . 63.51 108.997 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.23 141.95 17.15 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.635 -0.586 . . . . 74.03 111.635 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.533 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -140.07 130.14 4.54 Favored Glycine 0 C--O 1.228 -0.269 0 N-CA-C 111.49 -0.644 . . . . 62.02 111.49 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.7 mt -88.29 122.53 39.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.492 1.117 . . . . 73.53 108.977 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -123.74 156.98 35.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.303 0.641 . . . . 71.32 109.634 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.4 m -115.15 108.08 16.16 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.417 -0.957 . . . . 74.13 108.417 170.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.409 HD11 HD11 ' D' ' 98' ' ' LEU . 41.0 pt -105.75 139.84 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.486 0.714 . . . . 75.32 109.352 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.583 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -160.04 150.58 18.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.652 0.781 . . . . 60.03 109.74 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.43 -16.19 46.09 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.903 -0.387 . . . . 75.41 113.58 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.473 HD11 ' HA ' ' D' ' 94' ' ' MET . 43.2 pt -97.96 149.8 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.752 0.821 . . . . 74.13 109.822 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -168.3 177.68 5.29 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.165 0.586 . . . . 74.31 110.761 -168.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.07 -117.5 11.21 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.698 0.624 . . . . 74.32 112.817 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 19.3 m -92.27 -24.08 19.1 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.456 0.703 . . . . 71.45 110.861 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -61.16 -33.84 74.07 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.909 0.884 . . . . 74.35 111.164 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.503 ' HG2' HG12 ' H' ' 452' ' ' VAL . 0.0 OUTLIER -63.85 -33.98 76.9 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.099 -0.5 . . . . 74.31 111.332 177.379 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.461 ' HA ' HD21 ' H' ' 454' ' ' LEU . . . -77.32 -32.61 55.39 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.018 0.527 . . . . 74.34 110.758 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.408 ' O ' ' HB1' ' D' ' 100' ' ' ALA . 14.4 t-80 -72.62 -26.38 61.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.755 0.822 . . . . 74.44 111.264 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -90.54 -50.37 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.931 0.493 . . . . 72.24 110.877 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.603 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 13.9 tp -82.42 -27.21 32.13 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.117 0.567 . . . . 75.4 111.68 -170.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.62 14.13 42.36 Favored Glycine 0 N--CA 1.477 1.379 0 CA-C-O 119.879 -0.401 . . . . 73.5 113.46 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' D' ' 96' ' ' HIS . . . -144.41 -64.41 0.36 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.929 0.492 . . . . 54.1 110.642 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -69.95 -40.11 75.66 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.677 0.391 . . . . 74.34 111.644 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.603 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 85.6 m -66.35 -47.27 59.92 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.405 -0.807 . . . . 73.33 112.152 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.79 -32.62 92.14 Favored 'Trans proline' 0 C--N 1.4 3.237 0 C-N-CA 122.231 1.954 . . . . 73.24 113.386 168.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.46 -30.5 70.86 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.153 0.581 . . . . 74.44 111.678 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.532 HG22 HD11 ' D' ' 13' ' ' ILE . 95.2 mt -72.9 -37.25 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.72 0.808 . . . . 72.53 110.316 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.533 HD22 ' HA3' ' D' ' 82' ' ' GLY . 92.5 mt -75.66 -20.38 58.5 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.226 -0.897 . . . . 74.53 111.769 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -67.94 -43.47 37.09 Favored Pre-proline 0 CA--C 1.563 1.451 0 N-CA-C 113.763 1.023 . . . . 75.42 113.763 -171.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.69 -38.73 87.7 Favored 'Trans proline' 0 C--N 1.395 2.99 0 C-N-CA 121.931 1.754 . . . . 75.33 112.383 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -74.75 -32.74 62.17 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.902 0.751 . . . . 75.33 111.348 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.472 ' HB1' HG23 ' D' ' 62' ' ' VAL . . . -64.71 -53.93 39.46 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.224 -0.658 . . . . 64.52 109.224 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.441 HH12 ' HB3' ' D' ' 130' ' ' PRO . 40.5 ttp180 -58.14 -44.3 87.77 Favored 'General case' 0 C--O 1.212 -0.907 0 O-C-N 124.603 1.189 . . . . 75.03 110.509 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.17 -46.22 89.95 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.863 0.727 . . . . 74.3 111.137 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.82 -44.67 90.91 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.012 0.82 . . . . 73.51 110.339 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.633 HG12 ' SG ' ' D' ' 76' ' ' CYS . 69.0 mt -64.28 -52.29 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 124.033 0.833 . . . . 73.14 110.617 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 88.2 m -56.06 -43.68 78.14 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.679 1.192 . . . . 73.3 111.338 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.6 t -64.83 -41.63 95.58 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.995 -1.002 . . . . 74.33 109.978 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.8 mtm -69.85 -28.76 65.94 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.937 0.495 . . . . 61.34 111.917 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' D' ' 123' ' ' PHE . 54.7 t -70.72 -39.75 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.69 0.796 . . . . 75.44 110.419 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.2 p -76.66 -26.9 55.34 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.73 0.412 . . . . 54.12 110.729 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -73.78 -35.38 64.95 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.133 0.573 . . . . 74.15 109.475 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.95 -0.51 89.59 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 115.743 -0.662 . . . . 74.02 112.338 173.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.2 p 64.9 18.93 11.7 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.899 2.08 . . . . 71.44 114.327 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.45 ' HB2' HG13 ' D' ' 118' ' ' VAL . 96.3 m-85 -79.45 150.79 74.06 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 109.131 -0.692 . . . . 75.24 109.131 169.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.35 137.85 47.04 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.924 2.416 . . . . 62.23 112.771 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -55.74 143.36 31.11 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.915 1.286 . . . . 74.02 113.42 -168.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 50.0 tp -115.17 97.42 6.19 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.336 1.054 . . . . 70.41 109.716 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -104.16 89.65 3.33 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.731 -0.47 . . . . 72.53 109.731 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 36.4 tp -67.05 137.55 56.52 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.434 -0.803 . . . . 73.0 109.714 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.31 130.39 91.65 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.594 0.757 . . . . 74.22 111.113 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.441 ' HB3' HH12 ' D' ' 111' ' ' ARG . 56.6 Cg_endo -70.88 116.84 4.85 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.189 1.926 . . . . 72.03 110.756 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.03 124.39 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.554 0.742 . . . . 72.13 109.773 -171.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -73.9 96.28 2.59 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.659 -0.867 . . . . 73.24 108.659 171.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -68.38 -23.73 64.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.824 -0.625 . . . . 71.31 111.3 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.03 -54.85 41.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.277 1.031 . . . . 72.2 110.642 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.06 91.33 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.306 1.004 . . . . 74.03 111.144 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 16.6 tp -72.93 -22.18 60.77 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 115.85 -0.614 . . . . 73.33 111.634 -176.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.444 ' CZ ' HD13 ' D' ' 141' ' ' LEU . 78.4 t80 -71.5 -35.94 70.94 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.852 0.861 . . . . 75.12 110.044 176.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 32.5 mtt -60.21 -43.25 96.13 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.546 0.738 . . . . 74.14 109.817 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -60.32 -45.95 91.62 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.847 0.859 . . . . 75.41 111.231 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -61.09 -41.22 96.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.069 0.948 . . . . 72.22 112.231 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.444 HD13 ' CZ ' ' D' ' 137' ' ' PHE . 5.5 mp -65.96 -29.66 70.1 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.762 0.825 . . . . 74.3 111.286 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -78.81 0.53 26.65 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.408 0.683 . . . . 71.41 111.938 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -123.01 42.46 3.19 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.256 0.622 . . . . 73.01 109.713 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -171.53 150.18 2.76 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.741 0.816 . . . . 72.52 110.403 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.49 159.3 20.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.695 0.798 . . . . 75.34 110.761 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.08 102.72 1.03 Allowed Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.492 -0.776 . . . . 63.12 111.788 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.62 152.11 48.07 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 123.632 0.773 . . . . 72.41 109.831 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -75.74 91.91 0.89 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.748 -0.941 . . . . 72.31 110.748 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 75.2 m -56.11 139.43 47.2 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.75 0.82 . . . . 73.01 110.797 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -58.06 87.81 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 O-C-N 124.609 1.193 . . . . 75.13 112.816 -172.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -142.93 160.27 40.66 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.824 1.65 . . . . 73.04 107.918 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -85.92 76.42 9.86 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 108.638 -0.875 . . . . 71.21 108.638 175.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -89.45 174.99 7.49 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.887 0.875 . . . . 71.44 111.535 -173.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -93.36 96.26 9.83 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.36 -0.978 . . . . 75.33 108.36 170.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.388 0 C-N-CA 124.996 1.318 . . . . 74.3 111.213 179.807 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 109.125 -0.695 . . . . 75.21 109.125 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . 0.563 HG22 ' SD ' ' A' ' 94' ' ' MET . 7.2 p -74.49 -53.66 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 122.585 0.354 . . . . 73.24 111.857 -176.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . 0.427 HG21 HD23 ' A' ' 98' ' ' LEU . 6.6 p -88.87 133.57 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.779 -0.822 . . . . 65.32 108.779 177.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -85.67 -15.24 66.19 Favored Glycine 0 N--CA 1.472 1.092 0 CA-C-O 119.796 -0.447 . . . . 73.32 113.299 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . 0.445 HD12 HD22 ' A' ' 98' ' ' LEU . 34.0 tp 65.07 36.81 7.1 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.412 1.085 . . . . 75.45 109.427 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 24.5 m -65.87 96.42 0.3 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.409 -1.268 . . . . 74.12 111.028 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 32.9 t70 59.11 95.89 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.282 1.433 . . . . 74.24 111.573 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -98.96 17.13 20.36 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.393 -0.821 . . . . 75.41 110.977 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 11.7 m -76.08 78.49 2.92 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.287 0.635 . . . . 72.21 109.819 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -171.89 130.17 0.64 Allowed 'General case' 0 C--N 1.348 0.521 0 C-N-CA 124.668 1.187 . . . . 75.22 108.287 -177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.56 108.05 6.93 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.838 -1.171 . . . . 73.5 107.838 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -60.36 -31.15 70.05 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.204 1.187 . . . . 75.53 114.204 -172.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -160.41 116.78 2.38 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.192 0.597 . . . . 74.0 109.674 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 14.1 t -93.89 -13.0 27.66 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.478 0.711 . . . . 74.14 112.167 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 464' ' ' MET . . . . . 0.513 ' SD ' HD21 ' A' ' 42' ' ' LEU . 24.5 ttt 72.31 153.0 0.13 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.253 1.421 . . . . 71.52 112.274 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -81.41 -68.24 0.71 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.381 -0.97 . . . . 74.22 108.381 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . 168.64 174.12 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.814 1.646 . . . . 64.43 109.814 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . 0.421 ' HB2' ' H ' ' A' ' 129' ' ' ALA . . . -157.36 121.82 4.35 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.006 0.522 . . . . 52.21 110.597 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . 0.456 HD11 HD12 ' E' ' 470' ' ' LEU . 0.5 OUTLIER -172.35 129.24 0.57 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.729 -1.212 . . . . 74.53 107.729 174.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -88.46 50.89 3.87 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 111.201 -0.76 . . . . 74.22 111.201 172.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . 0.456 HD12 HD11 ' E' ' 468' ' ' LEU . 5.6 tt -79.67 108.25 13.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.922 0.889 . . . . 74.43 109.51 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 79.0 tttt . . . . . 0 C--O 1.251 1.158 0 N-CA-C 108.829 -0.804 . . . . 74.01 108.829 170.878 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 54.3 t30 . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 121.334 0.588 . . . . 73.44 109.947 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . 0.437 ' HA ' ' HG3' ' B' ' 90' ' ' GLU . 15.6 m -96.61 16.11 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-N 115.127 -0.942 . . . . 73.14 112.559 -169.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.56 157.14 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 112.211 0.449 . . . . 63.22 112.211 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -178.49 -139.31 3.45 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.495 -0.775 . . . . 72.43 112.136 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 11.2 mp 56.83 72.68 0.49 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.362 1.065 . . . . 72.54 111.265 -173.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 14.6 t -113.18 0.4 14.9 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.835 -1.075 . . . . 75.51 109.844 172.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -123.4 152.69 41.31 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.13 0.972 . . . . 75.21 109.834 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -100.25 105.69 17.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.47 0.708 . . . . 73.22 111.012 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 40.0 p -78.46 126.52 30.88 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.552 0.741 . . . . 61.54 109.703 171.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -63.59 152.5 38.64 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.627 0.771 . . . . 74.14 110.942 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 42.6 tp -71.25 157.39 38.2 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.603 0.761 . . . . 73.24 110.238 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -144.14 142.85 30.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.206 0.603 . . . . 71.15 111.137 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -134.04 137.49 44.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.316 1.046 . . . . 74.3 110.088 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 29.2 m -140.71 79.39 1.7 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.713 -1.218 . . . . 74.11 107.713 170.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 26.5 ptm -150.74 136.11 17.84 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.09 -0.959 . . . . 75.41 109.653 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -107.59 133.38 52.13 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.248 1.019 . . . . 74.44 108.691 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . 67.91 125.79 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.755 1.222 . . . . 62.53 110.82 -169.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -64.12 -57.68 8.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.21 0.604 . . . . 60.3 110.556 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . 0.436 HD12 ' HB ' ' B' ' 40' ' ' VAL . 61.4 mt -136.27 -61.77 0.69 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.998 0.919 . . . . 73.52 109.557 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 103.4 56.09 0.79 Allowed Glycine 0 C--N 1.344 0.993 0 CA-C-N 114.862 -1.063 . . . . 73.33 110.506 -169.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 97.2 mt -69.94 141.08 53.11 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.216 0.606 . . . . 75.14 110.327 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' F' ' 471' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.256 1.421 0 C-N-CA 123.199 0.6 . . . . 74.22 110.857 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . 0.451 ' HA ' HE22 ' C' ' 50' ' ' GLN . 77.5 m-20 . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 110.246 -0.279 . . . . 71.44 110.246 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' C' ' 54' ' ' ASP . 9.8 p -83.83 146.36 6.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.353 -0.98 . . . . 64.43 108.353 166.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . 0.598 HG12 ' SD ' ' C' ' 94' ' ' MET . 61.1 t 68.23 141.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 124.329 1.052 . . . . 71.03 112.853 176.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . -131.17 45.06 1.16 Allowed Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.125 -0.489 . . . . 73.31 112.566 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . 0.498 ' HG ' ' SD ' ' C' ' 94' ' ' MET . 18.1 mt -78.34 125.26 29.1 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.933 0.397 . . . . 74.33 110.819 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 10.1 t -153.92 28.64 0.47 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.467 1.107 . . . . 51.51 108.766 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -153.4 -65.17 0.15 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.741 -1.118 . . . . 74.24 109.219 -170.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.37 8.06 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 125.062 1.345 . . . . 70.43 113.58 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 6.9 m 65.81 163.12 0.16 Allowed 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 125.217 1.407 . . . . 72.42 111.663 -176.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.48 44.48 0.89 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.818 0.818 . . . . 65.23 110.059 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 51.12 -140.29 0.88 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.286 1.435 . . . . 75.03 111.312 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . 0.465 ' HZ ' ' HA ' ' C' ' 133' ' ' PHE . 33.2 p90 -163.54 -48.52 0.03 OUTLIER 'General case' 0 C--N 1.356 0.88 0 C-N-CA 122.932 0.493 . . . . 74.32 110.502 -177.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 34.7 t80 51.55 70.63 0.52 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.787 1.235 . . . . 74.12 111.066 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 11.5 t -75.84 -10.25 59.27 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.53 0.567 . . . . 71.53 112.53 -170.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 27.2 ptm -94.56 154.43 17.39 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.117 0.567 . . . . 73.32 110.409 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -150.76 12.27 0.69 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.894 0.878 . . . . 74.22 110.228 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -140.42 172.86 12.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.994 0.918 . . . . 73.45 110.337 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . 73.68 139.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.424 1.49 . . . . 74.03 111.944 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . 0.414 HD12 ' HG ' ' C' ' 126' ' ' LEU . 24.2 tp -150.6 -52.38 0.14 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.949 0.9 . . . . 74.44 109.912 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 119.83 -48.64 0.93 Allowed Glycine 0 N--CA 1.474 1.181 0 N-CA-C 109.703 -1.359 . . . . 53.45 109.703 -173.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 6.3 tt -66.37 -48.51 69.94 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.841 -1.54 . . . . 72.14 106.841 163.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . 0.431 ' HA ' ' HE3' ' G' ' 471' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.55 0.956 0 CA-C-N 115.119 -0.946 . . . . 75.55 108.948 173.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' B' ' 152' ' ' HIS . 2.3 m-20 . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 121.282 0.563 . . . . 60.12 110.151 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 26.8 m -81.17 -174.07 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.4 -0.818 . . . . 70.11 111.14 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.503 HG12 ' HG2' ' D' ' 94' ' ' MET . 14.8 p -124.33 159.63 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.956 0.902 . . . . 73.33 109.787 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -133.31 158.84 23.38 Favored Glycine 0 C--O 1.243 0.668 0 N-CA-C 110.966 -0.854 . . . . 62.04 110.966 170.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' D' ' 95' ' ' ALA . 2.5 pt? -66.8 131.64 46.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.536 0.334 . . . . 71.45 110.686 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 10.4 t -115.86 -11.87 11.5 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.868 0.867 . . . . 73.41 110.467 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.56 126.35 27.23 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.076 0.95 . . . . 55.33 110.635 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -73.92 76.46 1.66 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.459 0.704 . . . . 75.14 109.169 175.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 12.8 t -92.98 141.93 27.86 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 108.921 -0.77 . . . . 72.24 108.921 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.04 153.53 41.69 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.68 0.392 . . . . 74.22 110.965 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . 0.436 HD21 HG22 ' D' ' 46' ' ' THR . 4.3 mm? -90.22 166.65 13.23 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.36 0.6 . . . . 70.52 111.124 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -135.79 133.64 38.11 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.148 -0.933 . . . . 75.01 111.161 -164.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . 0.401 ' CE2' ' HB2' ' D' ' 44' ' ' LEU . 10.5 m-85 -135.05 98.83 4.1 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.309 1.043 . . . . 73.13 109.486 172.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 6.1 m -92.35 -3.37 55.44 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 121.288 0.566 . . . . 53.2 109.694 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 60.7 ttp -71.39 118.88 14.76 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 124.068 0.947 . . . . 72.15 109.834 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -93.75 30.79 1.72 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.823 0.849 . . . . 75.44 111.426 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -149.04 -179.8 7.3 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.954 0.902 . . . . 71.34 110.739 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -150.22 -63.83 0.21 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.807 0.843 . . . . 65.15 108.791 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.93 0.29 0.63 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.817 0.847 . . . . 74.32 110.432 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.01 -36.69 3.58 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 123.007 0.337 . . . . 61.23 113.071 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 63.67 67.42 0.63 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.878 1.271 . . . . 75.25 109.885 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm . . . . . 0 C--O 1.247 0.955 0 N-CA-C 108.875 -0.787 . . . . 73.33 108.875 177.034 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptp . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.455 -0.202 . . . . 75.33 110.455 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.3 t -165.57 116.6 1.08 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.024 -1.102 . . . . 71.25 108.024 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.08 112.34 7.16 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.407 0.622 . . . . 75.13 109.52 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -75.44 143.53 42.63 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.469 -0.787 . . . . 73.23 109.444 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -65.49 128.94 37.93 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.039 -0.726 . . . . 74.42 109.039 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -65.3 -69.34 0.3 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.048 -1.093 . . . . 73.25 108.048 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.0 m -156.16 83.36 1.0 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 107.416 -1.327 . . . . 71.11 107.416 163.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -160.16 153.86 22.63 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.78 0.832 . . . . 75.53 109.237 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 9' ' ' MET . 1.3 mpt? -65.47 158.41 26.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.41 1.084 . . . . 75.04 111.495 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 60.5 m -151.68 136.31 17.04 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.586 1.154 . . . . 62.33 108.048 170.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.615 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.0 t80 -135.88 129.53 32.44 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.298 -0.63 . . . . 73.11 109.298 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -143.43 117.01 9.17 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.639 -1.245 . . . . 75.22 107.639 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.487 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.1 mt -87.07 125.28 40.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.934 -0.765 . . . . 74.43 108.934 176.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.433 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -79.62 -43.86 22.08 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 124.05 0.844 . . . . 74.11 108.901 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -173.38 128.79 0.44 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 119.495 -0.288 . . . . 72.14 111.096 -168.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.7 mt -113.04 124.05 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 123.665 0.786 . . . . 75.12 109.427 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HE1' HG13 ' A' ' 83' ' ' ILE . 25.3 p90 -152.96 141.33 20.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.31 1.044 . . . . 73.2 110.423 -169.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.8 p -75.53 110.98 10.36 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.552 -0.536 . . . . 74.22 109.552 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -75.96 -27.57 57.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.978 -0.378 . . . . 63.1 109.978 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.3 t70 -148.53 138.57 22.36 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.166 -0.924 . . . . 73.34 110.061 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 86.9 mt -134.77 142.32 40.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 125.629 1.572 . . . . 71.0 106.895 173.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -148.73 140.72 23.85 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 123.63 0.581 . . . . 64.32 109.972 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.516 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 77.0 t80 -143.05 127.07 17.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.255 -1.757 . . . . 75.21 106.255 173.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -137.64 121.37 17.47 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.91 -0.404 . . . . 75.21 109.91 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.83 77.24 77.15 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 107.997 -1.112 . . . . 73.44 107.997 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.43 -19.38 37.78 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.059 2.506 . . . . 72.33 112.188 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -120.17 28.91 7.78 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.88 0.872 . . . . 71.33 109.743 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.69 -46.84 99.67 Favored Pre-proline 0 CA--C 1.566 1.58 0 N-CA-C 113.45 0.907 . . . . 55.42 113.45 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.29 -13.23 18.88 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 122.2 1.933 . . . . 63.41 112.576 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -90.81 -34.27 15.37 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.745 0.818 . . . . 74.41 110.717 -173.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.538 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 35.9 m -77.78 -17.42 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.494 0.718 . . . . 75.34 111.416 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.57 ' HD1' HH11 ' B' ' 15' ' ' ARG . 75.2 t80 -60.26 -35.07 74.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.318 1.047 . . . . 74.13 110.145 165.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -86.73 -52.58 5.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.097 0.959 . . . . 74.43 111.65 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.662 ' HZ3' HD11 ' A' ' 68' ' ' LEU . 17.7 ptpt -73.89 170.77 14.68 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.735 0.414 . . . . 72.51 111.419 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.93 128.21 35.13 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.105 -0.498 . . . . 71.24 109.663 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.3 t-105 -72.34 94.2 1.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 O-C-N 123.793 0.683 . . . . 72.22 109.861 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -128.45 84.85 61.97 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.58 1.152 . . . . 70.43 108.706 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 49.2 Cg_endo -87.49 165.25 7.94 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.351 2.034 . . . . 73.4 112.451 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -121.99 106.71 11.46 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.83 -1.174 . . . . 74.43 107.83 168.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.8 m -73.7 92.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-O 122.764 1.268 . . . . 65.51 110.761 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -95.05 124.55 39.16 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.516 -1.22 . . . . 72.34 109.315 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.589 ' H ' ' HB2' ' E' ' 465' ' ' LYS . 50.7 tp -120.52 115.56 23.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.412 0.685 . . . . 75.35 110.072 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 15.1 t70 -106.52 108.43 19.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.945 -1.132 . . . . 74.43 107.945 168.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.412 HD12 HD13 ' A' ' 60' ' ' LEU . 1.2 tm? -97.59 119.2 35.72 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.584 -1.265 . . . . 74.14 107.584 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -127.08 151.11 49.06 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.508 1.123 . . . . 73.04 109.561 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.8 m -134.9 139.78 45.26 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.05 0.94 . . . . 75.13 109.541 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.28 153.6 51.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.913 1.285 . . . . 73.41 108.387 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 m -133.0 151.63 52.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.235 0.614 . . . . 75.3 109.669 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -150.36 121.47 7.74 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.651 -0.87 . . . . 73.21 108.651 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -79.67 125.55 29.78 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.902 0.382 . . . . 73.34 110.762 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.3 mt -93.37 -34.7 13.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.964 0.906 . . . . 74.11 111.448 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -164.19 -172.49 2.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.534 0.734 . . . . 71.2 110.866 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.05 116.98 5.83 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.431 0.693 . . . . 70.22 109.558 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 71.47 -7.19 1.24 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 125.412 1.485 . . . . 75.42 112.419 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.419 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 60.6 t -104.69 125.06 59.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 124.45 1.1 . . . . 73.44 109.1 -174.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -143.0 171.3 14.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.018 -0.734 . . . . 74.44 109.018 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -125.12 152.0 45.0 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.776 -0.824 . . . . 73.44 108.776 167.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.7 t -115.62 126.73 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 107.876 -1.157 . . . . 75.15 107.876 168.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.3 t -97.96 105.48 17.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.046 -1.094 . . . . 74.53 108.046 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.412 HD13 HD12 ' A' ' 44' ' ' LEU . 42.7 tp -91.96 100.19 12.89 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.074 -0.714 . . . . 71.12 109.074 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -83.59 101.37 11.43 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.872 -0.788 . . . . 72.21 108.872 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.4 t -100.14 101.84 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.781 -1.192 . . . . 73.22 107.781 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.8 m -96.36 109.62 22.11 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.174 -0.676 . . . . 71.3 109.174 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.5 t -112.31 131.43 63.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.913 -1.143 . . . . 71.13 107.913 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -135.64 150.55 49.65 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.264 -1.013 . . . . 72.22 108.264 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -139.44 116.43 10.98 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.668 -1.234 . . . . 65.04 107.668 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.7 m -141.38 145.08 34.93 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.677 0.391 . . . . 71.42 111.793 -170.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.662 HD11 ' HZ3' ' A' ' 34' ' ' LYS . 3.2 tm? -94.79 87.53 5.04 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.708 -1.219 . . . . 75.22 107.708 170.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.5 -104.82 1.82 Allowed Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.791 -0.641 . . . . 53.44 112.583 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -95.36 -25.84 16.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.5 0.72 . . . . 71.32 110.771 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.55 123.08 29.39 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.789 0.435 . . . . 74.23 110.504 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 m -77.97 127.07 31.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.022 0.529 . . . . 72.34 110.121 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.43 -51.13 9.19 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.647 -0.871 . . . . 72.42 108.647 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -160.94 159.98 30.25 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.431 -1.259 . . . . 75.22 110.827 172.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 55.2 tp -129.84 143.03 50.6 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.289 1.435 . . . . 72.23 107.776 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.574 ' SG ' HG21 ' A' ' 118' ' ' VAL . 56.9 m -147.17 103.85 3.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.157 0.983 . . . . 71.55 109.099 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -128.54 127.46 42.42 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.654 -0.869 . . . . 73.43 108.654 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.5 t -128.75 110.96 22.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.732 -0.84 . . . . 74.23 108.732 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.666 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.3 mt-30 -85.26 85.67 7.44 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 108.449 -0.945 . . . . 74.2 108.449 171.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.514 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.1 tp-100 -76.51 102.17 5.93 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.096 -1.411 . . . . 75.34 109.035 -178.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.89 164.96 37.74 Favored Glycine 0 C--N 1.337 0.639 0 N-CA-C 111.334 -0.706 . . . . 61.51 111.334 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.05 124.94 1.1 Allowed Glycine 0 CA--C 1.51 -0.272 0 N-CA-C 111.765 -0.534 . . . . 75.15 111.765 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.464 HG13 ' HE1' ' A' ' 17' ' ' TYR . 46.5 mt -81.13 126.06 39.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.275 -0.639 . . . . 70.55 109.275 176.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.615 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 37.3 m-85 -128.56 137.72 51.87 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.388 1.075 . . . . 74.14 108.135 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.5 m -107.77 115.9 30.98 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.726 -0.842 . . . . 73.25 108.726 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.4 tt -105.52 143.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.628 0.771 . . . . 75.32 110.484 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.49 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -161.68 146.41 13.12 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.754 0.821 . . . . 74.51 109.701 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.36 -32.45 6.81 Favored Glycine 0 C--N 1.341 0.84 0 O-C-N 123.541 0.526 . . . . 63.15 113.713 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.29 146.11 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.947 0.499 . . . . 74.43 112.179 -165.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -135.71 173.07 12.12 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.279 1.031 . . . . 75.04 110.46 -174.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 56.95 -115.66 6.78 Favored Glycine 0 C--N 1.356 1.666 0 N-CA-C 115.61 1.004 . . . . 63.52 115.61 170.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.5 p -66.17 -33.98 77.0 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.671 0.789 . . . . 75.42 111.159 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -70.17 -43.43 70.82 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.199 -0.91 . . . . 71.31 110.874 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.547 ' SD ' ' HA ' ' E' ' 452' ' ' VAL . 13.2 ptt? -66.04 -37.23 85.34 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.132 -0.692 . . . . 75.31 109.132 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.78 81.58 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 123.542 0.737 . . . . 72.3 110.628 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -64.87 -35.8 82.31 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.646 -0.706 . . . . 75.1 110.639 174.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 61.0 m -69.0 -41.66 77.5 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.013 0.525 . . . . 71.24 111.331 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 94' ' ' MET . 65.3 mt -78.9 -43.69 24.32 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.513 0.725 . . . . 73.53 111.885 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.72 4.01 53.3 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-O 119.268 -0.74 . . . . 74.24 114.472 -169.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.48 -57.91 0.23 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 118.075 0.938 . . . . 74.4 112.611 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.596 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 81.3 t80 -66.51 -53.92 29.66 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.996 0.918 . . . . 72.04 112.005 -168.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.3 m -72.98 -36.42 3.36 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.611 -0.709 . . . . 72.52 112.842 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.404 ' HB3' HD11 ' A' ' 60' ' ' LEU . 77.0 Cg_exo -49.97 -41.35 48.31 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.405 2.07 . . . . 74.23 113.265 161.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -67.36 -32.96 74.25 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.652 0.781 . . . . 75.35 111.227 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.37 -45.25 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.225 0.61 . . . . 74.02 110.305 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.514 HD23 ' HG3' ' A' ' 80' ' ' GLN . 74.3 mt -74.85 -20.74 59.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.116 -0.947 . . . . 73.31 112.144 -175.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.552 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 61.9 t80 -62.3 -44.79 89.37 Favored Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 114.134 1.161 . . . . 74.43 114.134 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -59.54 -37.93 85.75 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 121.878 1.719 . . . . 75.21 112.988 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -70.15 -42.0 73.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.421 0.688 . . . . 75.24 111.029 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.07 -36.6 72.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.856 -0.611 . . . . 74.11 110.844 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.583 ' NH1' HD13 ' C' ' 105' ' ' ILE . 32.0 ttm180 -50.43 -56.41 11.57 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.353 1.033 . . . . 73.24 109.669 174.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -65.39 -43.39 90.81 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.345 1.028 . . . . 72.05 111.8 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.595 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.4 t -61.39 -24.82 66.77 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.048 0.539 . . . . 73.15 112.151 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.8 mt -84.93 -53.71 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.163 0.985 . . . . 72.2 109.821 172.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.546 HG23 ' HG3' ' A' ' 125' ' ' GLN . 85.5 m -53.33 -52.53 58.87 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.931 1.292 . . . . 71.51 112.521 -174.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.3 t -58.41 -44.55 89.09 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.398 -0.819 . . . . 75.51 110.646 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.516 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.3 ttp -66.15 -32.34 73.72 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.422 1.089 . . . . 62.05 111.644 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.574 HG21 ' SG ' ' A' ' 76' ' ' CYS . 87.1 t -70.39 -45.14 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.117 0.967 . . . . 75.11 110.423 174.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.8 m -68.08 -25.59 65.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.557 0.743 . . . . 71.42 111.596 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -72.55 -32.38 66.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.668 0.787 . . . . 75.33 109.541 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.93 0.34 83.08 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 124.005 0.816 . . . . 64.51 113.288 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.8 m 65.72 16.5 10.52 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.754 1.222 . . . . 74.5 111.199 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -86.8 153.83 55.3 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.79 0.836 . . . . 75.22 109.058 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -53.63 119.19 5.82 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 123.162 2.575 . . . . 75.51 112.343 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.546 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.9 tt0 -53.0 128.93 29.01 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.304 1.042 . . . . 74.15 111.627 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.401 ' HB2' HD11 ' E' ' 468' ' ' LEU . 3.4 pp -109.36 137.18 47.61 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.462 -0.94 . . . . 72.21 108.462 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -123.19 91.67 3.53 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.029 -1.471 . . . . 74.53 107.029 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.552 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -63.46 122.24 15.78 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.198 -0.91 . . . . 75.43 109.45 -173.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.64 140.17 96.96 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.223 0.609 . . . . 72.34 110.806 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.12 128.74 29.91 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.41 2.073 . . . . 75.44 111.754 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.3 t -97.82 137.01 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.972 -0.751 . . . . 73.34 108.972 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.431 HD21 ' HB1' ' A' ' 135' ' ' ALA . 1.8 p-10 -77.1 69.04 3.33 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.569 1.148 . . . . 71.14 111.249 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -53.21 -43.6 67.36 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.139 0.976 . . . . 73.12 111.621 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -58.86 -51.64 69.13 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.226 0.953 . . . . 74.14 111.201 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 132' ' ' ASN . . . -62.97 -41.15 99.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.872 0.733 . . . . 51.34 111.582 -176.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.29 -44.53 95.29 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.217 0.948 . . . . 73.0 110.269 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -72.99 -30.96 64.19 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 115.388 -0.824 . . . . 75.53 110.672 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.673 ' SD ' HD23 ' A' ' 141' ' ' LEU . 15.9 mmt -66.34 -26.04 67.1 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.26 0.624 . . . . 72.53 111.44 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -63.57 -31.09 72.15 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.745 0.818 . . . . 71.01 110.7 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.403 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 76.4 t80 -93.2 -36.64 12.51 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.375 1.07 . . . . 74.35 110.785 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.673 HD23 ' SD ' ' A' ' 138' ' ' MET . 20.4 tp -70.72 -21.32 62.57 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.348 1.059 . . . . 75.43 111.467 -172.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -142.83 29.01 1.54 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.073 0.949 . . . . 64.44 110.009 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -61.87 -30.82 71.12 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 120.906 0.384 . . . . 61.43 111.479 173.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -88.37 -45.76 9.73 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.221 1.008 . . . . 62.22 109.51 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.78 2.34 10.34 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.662 -0.699 . . . . 52.51 112.705 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.45 3.89 85.36 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.878 -0.401 . . . . 55.53 113.585 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.68 -55.68 7.25 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.356 0.663 . . . . 71.15 110.539 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.27 149.75 8.0 Favored Glycine 0 C--N 1.348 1.194 0 CA-C-N 115.959 -0.564 . . . . 63.03 112.714 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.7 m -94.5 -81.46 0.38 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.003 -0.74 . . . . 71.05 109.003 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 54.01 -161.8 0.13 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.368 1.067 . . . . 73.14 113.055 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 65.3 51.49 1.59 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.578 1.151 . . . . 75.4 109.212 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -148.92 3.82 0.63 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.615 -1.175 . . . . 75.24 110.76 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -72.34 -10.38 59.72 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 112.079 0.399 . . . . 75.05 112.079 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -112.89 157.44 21.42 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.783 0.833 . . . . 73.21 108.811 167.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.321 0 C-N-CA 123.623 0.769 . . . . 74.4 108.945 -178.676 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.553 ' SD ' ' HB2' ' B' ' 3' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 108.821 -0.807 . . . . 73.51 108.821 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 31.4 m -78.94 81.77 5.19 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.36 0.6 . . . . 72.44 109.841 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.553 ' HB2' ' SD ' ' B' ' 1' ' ' MET . 33.9 tt0 -134.96 173.9 11.2 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.106 0.963 . . . . 74.45 108.563 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -59.6 116.7 4.2 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.052 0.941 . . . . 75.33 111.345 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -67.88 -27.07 66.35 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.171 0.589 . . . . 70.11 110.971 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -72.05 92.3 1.3 Allowed 'General case' 0 C--N 1.352 0.691 0 N-CA-C 109.307 -0.627 . . . . 75.04 109.307 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.471 HG21 ' H ' ' B' ' 9' ' ' MET . 27.0 m -136.71 147.51 46.8 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.085 0.954 . . . . 73.22 108.514 176.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.03 -26.81 67.69 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.497 0.719 . . . . 72.43 111.476 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.471 ' H ' HG21 ' B' ' 7' ' ' THR . 15.8 ptm 54.55 170.78 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 127.485 2.314 . . . . 74.31 114.739 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.0 m -149.87 139.19 21.36 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.826 1.25 . . . . 74.11 107.946 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -137.46 142.94 41.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.014 0.525 . . . . 73.23 109.633 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -144.59 141.0 29.12 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.465 0.706 . . . . 74.34 109.755 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 31.6 mt -94.59 125.77 47.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 107.705 -1.22 . . . . 74.43 107.705 170.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -92.8 -41.25 10.2 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.618 -0.512 . . . . 75.24 109.618 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.57 HH11 ' HD1' ' A' ' 32' ' ' PHE . 58.9 ttt180 -168.92 132.86 1.43 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.613 -0.721 . . . . 74.32 109.562 -173.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.415 HD13 HD21 ' D' ' 127' ' ' ASN . 81.7 mt -114.84 135.32 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 106.595 -1.632 . . . . 74.4 106.595 170.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.447 ' HE1' HG13 ' B' ' 83' ' ' ILE . 19.2 p90 -165.52 139.97 4.79 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.229 0.538 . . . . 71.44 110.921 -172.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.4 m -73.4 125.57 28.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.052 -0.976 . . . . 73.32 108.929 174.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -98.35 -27.81 13.94 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.478 0.711 . . . . 74.4 110.855 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.7 t70 -157.16 137.7 13.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.62 0.368 . . . . 64.33 110.837 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.435 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.6 mm -133.37 145.03 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.644 1.178 . . . . 74.42 108.963 174.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -141.31 141.57 33.89 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.723 1.209 . . . . 73.24 108.427 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.409 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 71.8 t80 -156.07 113.98 3.32 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.143 -1.058 . . . . 73.43 108.143 170.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.18 115.91 20.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.825 0.85 . . . . 73.32 109.213 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.92 86.31 3.02 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.141 -1.059 . . . . 75.44 108.141 172.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.65 -27.64 26.75 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 122.869 2.38 . . . . 65.41 112.73 -172.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -108.75 15.85 23.28 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.564 -0.731 . . . . 65.1 110.574 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.06 -61.7 1.06 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 115.122 1.527 . . . . 62.41 115.122 -164.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.95 -31.06 56.88 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 121.837 1.692 . . . . 72.22 112.735 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -74.81 -49.23 21.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.681 0.792 . . . . 71.53 110.923 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.632 HG23 HD13 ' B' ' 68' ' ' LEU . 8.6 p -67.97 -21.98 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.771 0.828 . . . . 73.3 112.281 -164.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -66.38 -8.12 23.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.444 0.697 . . . . 70.35 112.822 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.568 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 27.7 pt20 -58.25 -26.03 62.42 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.439 0.696 . . . . 71.24 111.575 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.568 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 90.6 mttt -104.16 105.07 15.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.898 0.879 . . . . 75.43 109.077 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.29 81.31 8.76 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.426 0.631 . . . . 72.55 109.298 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -152.69 156.99 40.25 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.839 -1.171 . . . . 74.15 107.839 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.434 ' HB2' HD22 ' F' ' 470' ' ' LEU . 8.3 mt-30 -79.7 110.59 16.23 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 107.318 -1.364 . . . . 75.25 107.318 175.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.465 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 18.1 Cg_endo -58.03 139.67 91.25 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 123.079 2.519 . . . . 74.52 114.484 -170.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -65.89 124.15 21.71 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 124.236 0.96 . . . . 71.32 109.471 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.479 HG23 HD12 ' F' ' 468' ' ' LEU . 31.0 m -103.68 165.28 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.782 0.833 . . . . 72.54 112.459 -171.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -134.24 114.54 13.15 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 106.386 -1.709 . . . . 74.21 106.386 172.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 5.8 mp -86.27 133.97 33.79 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.405 1.082 . . . . 74.35 108.324 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -149.03 111.72 4.79 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.622 -1.251 . . . . 75.31 107.622 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.97 167.81 10.5 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.069 0.462 . . . . 75.0 109.893 -173.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 26.0 t70 -160.99 141.12 11.02 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.483 1.113 . . . . 64.03 109.139 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 22.8 p -136.28 125.13 24.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.414 0.686 . . . . 72.35 109.62 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.16 154.34 46.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.445 1.098 . . . . 64.24 108.318 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.2 p -142.36 170.51 15.56 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.963 0.411 . . . . 74.43 111.22 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.21 137.52 17.53 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.18 -0.918 . . . . 72.44 109.154 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -82.02 126.29 31.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.935 0.494 . . . . 73.11 109.947 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 91.1 mt -93.28 -34.2 13.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.203 0.601 . . . . 74.23 110.396 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.99 -173.53 2.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.641 0.776 . . . . 72.4 110.707 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.98 127.84 34.08 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.749 -1.114 . . . . 75.32 109.192 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.579 ' HA ' HG23 ' F' ' 451' ' ' VAL . 5.4 m-20 67.72 0.03 2.13 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.537 1.135 . . . . 74.21 112.612 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 109.9 30.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 123.66 0.784 . . . . 73.25 109.005 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -123.52 137.93 54.67 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.441 -0.948 . . . . 74.11 108.441 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -108.68 106.33 16.33 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.284 -1.376 . . . . 64.34 107.284 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.582 HG21 ' HG ' ' B' ' 98' ' ' LEU . 86.7 t -92.27 142.42 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 O-C-N 124.101 0.876 . . . . 54.31 109.925 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.73 141.54 42.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.731 -0.84 . . . . 74.32 108.731 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.437 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -124.29 105.51 9.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.284 -1.376 . . . . 75.51 107.284 178.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.537 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 36.4 ttm180 -92.68 123.87 36.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.794 0.438 . . . . 74.42 109.889 171.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.42 ' HB ' HD11 ' B' ' 114' ' ' ILE . 44.3 t -114.57 108.55 25.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.552 -1.277 . . . . 72.15 107.552 170.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 27.5 m -95.07 135.98 35.96 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.719 -0.845 . . . . 73.31 108.719 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.48 129.76 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.915 0.886 . . . . 73.14 109.146 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 28.8 m -118.01 142.43 47.38 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 107.961 -1.126 . . . . 72.03 107.961 169.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -144.79 155.51 43.56 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 117.803 0.274 . . . . 60.13 110.595 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 39.7 p -155.14 138.87 16.14 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 124.154 0.909 . . . . 74.32 111.007 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.632 HD13 HG23 ' B' ' 31' ' ' VAL . 67.7 mt -96.65 107.03 19.41 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.301 -0.863 . . . . 74.23 108.749 170.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.29 -111.56 4.18 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 114.885 -1.052 . . . . 64.51 112.847 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -108.58 0.03 20.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.64 0.776 . . . . 74.41 110.978 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.49 142.67 47.36 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.73 -0.606 . . . . 73.32 110.182 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.7 m -63.94 134.84 55.85 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 123.16 0.584 . . . . 72.14 111.238 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.11 -65.97 0.97 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.253 -0.885 . . . . 74.22 108.644 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -150.45 158.19 43.88 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.518 -0.765 . . . . 65.0 111.046 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 58.2 mt -128.3 108.98 11.04 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.105 -1.813 . . . . 74.25 106.105 172.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.8 t -119.26 148.34 43.25 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.344 -0.613 . . . . 75.33 109.344 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -160.4 134.71 7.35 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.152 -0.684 . . . . 65.21 109.152 -178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.416 HG21 HD12 ' B' ' 21' ' ' ILE . 94.9 t -125.79 144.0 37.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.163 -0.926 . . . . 71.12 108.636 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.4 mt-30 -122.9 85.94 2.5 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.891 -1.151 . . . . 74.4 107.891 172.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -80.01 101.08 8.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.199 -1.364 . . . . 74.3 108.623 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.74 167.92 27.35 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 111.558 -0.617 . . . . 71.11 111.558 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.41 130.76 2.2 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 112.099 -0.4 . . . . 72.12 112.099 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.447 HG13 ' HE1' ' B' ' 17' ' ' TYR . 61.1 mt -85.14 120.36 35.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.028 -1.101 . . . . 73.24 108.028 171.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -127.46 135.58 50.61 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.208 0.603 . . . . 64.52 109.54 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 68.2 m -97.93 109.33 22.11 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.019 0.527 . . . . 73.11 109.755 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.564 ' HB ' HG12 ' B' ' 89' ' ' ILE . 38.9 pt -102.47 122.66 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.316 1.046 . . . . 74.13 109.045 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.84 141.6 44.7 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.616 0.766 . . . . 73.35 109.612 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.53 -29.33 4.06 Favored Glycine 0 N--CA 1.473 1.157 0 CA-C-O 119.925 -0.375 . . . . 63.43 113.343 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.564 HG12 ' HB ' ' B' ' 86' ' ' ILE . 2.8 pp -56.23 132.53 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.874 0.87 . . . . 63.23 111.94 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.408 ' HG2' ' HB3' ' B' ' 3' ' ' GLU . 5.8 tp10 -160.43 161.4 32.96 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 120.922 0.391 . . . . 72.12 111.688 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.22 -95.65 1.56 Allowed Glycine 0 C--N 1.352 1.455 0 CA-C-N 115.484 -0.78 . . . . 75.24 111.286 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.2 m -105.22 -20.45 13.5 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.392 0.677 . . . . 73.55 110.247 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.66 -31.02 71.11 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.468 0.707 . . . . 71.51 111.319 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.506 ' HA ' HD12 ' B' ' 89' ' ' ILE . 21.5 ptt? -58.06 -44.88 87.72 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 123.985 0.803 . . . . 74.05 110.928 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.42 ' HB3' ' HZ ' ' B' ' 137' ' ' PHE . . . -76.16 -50.28 15.0 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 123.988 0.915 . . . . 63.52 109.679 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -60.13 -31.6 70.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.674 0.79 . . . . 75.11 111.88 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 11.7 t -73.38 -63.15 1.25 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.353 0.408 . . . . 72.24 110.262 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.648 HD11 ' HA3' ' F' ' 453' ' ' GLY . 10.3 tt -67.6 -39.2 84.77 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.323 0.49 . . . . 73.11 112.323 -172.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.42 3.34 57.88 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 114.965 0.746 . . . . 64.2 114.965 -168.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.48 -56.1 0.27 Allowed 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 117.675 0.737 . . . . 61.12 111.381 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -71.39 -46.64 59.79 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.584 0.754 . . . . 73.31 111.85 -171.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.446 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 75.1 m -65.86 -47.85 63.65 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 123.728 0.811 . . . . 71.24 111.363 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.4 Cg_exo -58.42 -32.88 97.23 Favored 'Trans proline' 0 C--N 1.398 3.143 0 C-N-CA 122.337 2.025 . . . . 74.43 113.629 168.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -62.03 -39.27 91.73 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.209 0.603 . . . . 75.51 110.316 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.68 -45.03 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.576 0.75 . . . . 74.32 110.457 174.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.27 -18.36 60.09 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.891 -1.05 . . . . 74.12 112.192 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -60.91 -51.09 81.88 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 117.784 -1.103 . . . . 65.34 113.563 -171.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -59.16 -33.44 98.25 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 121.939 1.76 . . . . 75.32 112.949 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -69.54 -47.36 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.334 0.654 . . . . 75.34 110.556 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.97 88.73 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.549 0.74 . . . . 75.51 110.531 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.69 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 53.3 ttt180 -60.46 -55.99 26.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.627 1.571 . . . . 75.32 111.028 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.72 -34.79 79.01 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 124.053 0.846 . . . . 65.11 110.128 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.497 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.9 t -67.04 -35.3 79.59 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 122.768 0.427 . . . . 74.13 111.825 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.42 HD11 ' HB ' ' B' ' 62' ' ' VAL . 64.5 mt -64.26 -52.96 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.986 -0.746 . . . . 73.41 108.986 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -59.44 -30.68 68.67 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 124.498 1.124 . . . . 74.43 111.769 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.9 t -66.65 -46.54 75.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.615 0.766 . . . . 71.23 110.277 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.2 mmt -68.25 -35.16 77.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.993 0.517 . . . . 73.34 110.663 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 68.9 t -58.13 -48.18 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.278 1.031 . . . . 74.52 110.437 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.49 ' HB3' HG21 ' C' ' 115' ' ' THR . 65.5 m -61.23 -35.89 78.44 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.444 -1.253 . . . . 74.52 112.042 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.595 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 74.4 mtt-85 -69.15 -37.11 78.07 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.421 -0.809 . . . . 71.01 110.1 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.51 11.23 59.43 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.749 0.656 . . . . 61.15 113.297 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 57.5 p 64.2 18.79 11.47 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.317 1.847 . . . . 75.32 114.687 172.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -80.95 151.29 70.32 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 109.148 -0.686 . . . . 74.14 109.148 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.95 -160.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.68 2.92 . . . . 74.21 114.102 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -65.9 111.33 3.24 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 121.017 0.436 . . . . 75.11 110.76 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.421 HD23 ' HD2' ' B' ' 38' ' ' PRO . 4.0 mm? -122.63 84.7 2.3 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.392 -0.966 . . . . 74.4 108.392 171.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -92.7 128.04 38.41 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.328 -0.619 . . . . 73.43 109.328 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.69 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 32.9 tp -71.98 136.78 46.89 Favored 'General case' 0 CA--C 1.552 1.034 0 O-C-N 123.952 0.783 . . . . 70.32 109.785 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.06 151.98 92.69 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.127 0.571 . . . . 72.41 111.304 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.482 ' HG3' HD11 ' D' ' 16' ' ' ILE . 25.3 Cg_exo -61.3 102.9 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 122.311 2.007 . . . . 74.23 111.836 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.89 111.37 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.168 -1.049 . . . . 73.31 108.168 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -78.91 99.43 6.79 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.237 -1.023 . . . . 73.53 108.237 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -62.95 -48.03 80.62 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 123.371 0.42 . . . . 75.25 110.795 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.07 -41.74 90.35 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.369 1.068 . . . . 73.12 112.966 -166.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.29 -34.41 63.52 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.368 0.667 . . . . 75.54 111.347 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.591 ' HB3' ' HB2' ' F' ' 461' ' ' PHE . 8.8 mp -77.65 -32.15 53.12 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.232 0.613 . . . . 74.44 109.928 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.42 ' HZ ' ' HB3' ' B' ' 95' ' ' ALA . 92.7 t80 -70.69 -28.84 65.06 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.753 1.221 . . . . 74.1 110.452 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 21.1 ttt -53.73 -37.76 63.67 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.264 1.025 . . . . 72.24 110.85 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -78.26 -33.37 49.7 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.082 -1.417 . . . . 73.33 110.676 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -63.05 -26.43 68.84 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.22 1.008 . . . . 74.31 112.497 -175.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.408 HD22 ' CZ ' ' B' ' 137' ' ' PHE . 20.1 mt -77.88 -6.03 52.94 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.086 0.773 . . . . 75.23 113.086 -166.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.435 HE21 ' HA ' ' B' ' 145' ' ' ALA . 8.6 pt20 -161.27 157.65 25.93 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.868 0.867 . . . . 64.15 109.673 -175.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -79.82 -19.19 49.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.978 0.511 . . . . 71.01 111.344 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -131.14 107.45 9.04 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.32 1.048 . . . . 74.43 108.882 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . 0.435 ' HA ' HE21 ' B' ' 142' ' ' GLN . . . -126.52 110.5 13.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.651 0.78 . . . . 74.44 109.931 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -152.86 155.25 26.02 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.555 -0.618 . . . . 73.54 111.555 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.9 140.47 29.65 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.028 -1.101 . . . . 74.32 108.028 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.49 54.12 0.34 Allowed Glycine 0 C--N 1.35 1.319 0 C-N-CA 121.505 -0.379 . . . . 63.12 113.652 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 12.7 t -98.26 145.05 27.04 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.435 0.618 . . . . 75.31 109.634 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -100.98 92.47 5.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.097 -0.705 . . . . 75.32 109.097 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -70.64 96.73 1.24 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.928 -0.578 . . . . 72.12 109.874 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -142.28 98.15 3.26 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.579 -0.897 . . . . 73.42 108.579 173.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -144.06 112.44 6.45 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.466 -0.939 . . . . 70.24 108.466 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -100.84 146.04 27.8 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.388 0.675 . . . . 74.11 109.482 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.319 0 C-N-CA 123.896 0.879 . . . . 75.21 109.192 176.834 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.444 ' HG2' ' H ' ' C' ' 2' ' ' SER . 48.6 ttm . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 108.767 -0.827 . . . . 73.55 108.767 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' SER . . . . . 0.444 ' H ' ' HG2' ' C' ' 1' ' ' MET . 15.3 m -43.76 -46.09 7.49 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.923 1.689 . . . . 74.52 115.002 -171.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -89.66 24.09 2.44 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.082 0.553 . . . . 63.41 112.051 -173.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 69.54 0.51 2.97 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.877 1.271 . . . . 74.3 111.08 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -75.8 127.74 33.67 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 124.797 1.239 . . . . 71.34 109.812 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -162.48 -39.91 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.043 0.537 . . . . 74.45 109.885 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m 72.59 155.89 0.16 Allowed 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 125.439 1.496 . . . . 73.14 110.936 -177.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -59.05 -66.12 0.56 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.839 0.855 . . . . 75.11 109.476 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.9 ttt 56.14 115.06 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.753 1.621 . . . . 73.23 113.068 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 58.5 m -120.57 104.36 9.89 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.194 -1.039 . . . . 75.11 108.194 173.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.577 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 4.5 t80 -123.6 125.48 44.92 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.968 -0.753 . . . . 74.42 108.968 176.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -147.02 119.99 8.75 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.065 -1.087 . . . . 71.45 108.065 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.5 mt -74.08 122.25 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.901 -0.777 . . . . 74.34 108.901 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.68 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.3 mm-40 -85.0 -45.74 11.86 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.173 -0.922 . . . . 72.23 110.508 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -174.16 126.02 0.34 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.032 -0.531 . . . . 75.22 110.31 -168.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.78 141.64 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 107.868 -1.16 . . . . 74.53 107.868 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -173.15 168.43 4.75 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.306 0.574 . . . . 75.24 111.941 -175.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -89.38 117.57 28.42 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.013 -0.736 . . . . 63.13 109.013 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -78.73 -35.47 44.73 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.506 -0.553 . . . . 75.5 109.506 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 13.9 t70 -146.62 147.83 31.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.127 -0.942 . . . . 71.14 109.323 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.0 mt -141.83 146.09 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.169 1.388 . . . . 75.45 107.394 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.7 t -158.11 149.35 21.13 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.355 0.597 . . . . 75.4 110.748 174.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -143.49 145.11 32.32 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.446 -1.316 . . . . 71.43 107.446 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.1 mt-10 -135.05 127.9 31.26 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.987 0.915 . . . . 75.24 109.926 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.72 72.7 7.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.591 1.557 . . . . 75.14 106.933 170.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.1 -39.94 21.96 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.763 2.309 . . . . 74.42 111.062 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -93.46 22.29 5.45 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 113.846 -1.525 . . . . 65.03 111.279 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.21 -56.08 5.79 Favored Pre-proline 0 CA--C 1.564 1.509 0 N-CA-C 114.135 1.161 . . . . 71.23 114.135 -173.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.42 -38.15 44.58 Favored 'Trans proline' 0 C--N 1.389 2.691 0 CA-C-N 121.77 1.668 . . . . 65.12 112.716 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -69.4 -38.42 77.94 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.596 0.759 . . . . 74.51 112.103 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.705 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.4 p -77.08 -22.26 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 N-CA-C 112.286 0.476 . . . . 75.02 112.286 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -68.1 -30.0 69.06 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.925 0.393 . . . . 74.33 110.87 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -99.82 31.67 3.17 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.255 0.622 . . . . 64.53 110.574 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.585 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.7 tppp? -108.86 157.79 18.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.83 0.852 . . . . 72.23 109.746 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -61.61 121.36 12.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.062 -0.718 . . . . 75.52 109.062 168.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 58.7 t-105 -86.55 96.6 10.13 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.146 0.578 . . . . 72.03 110.478 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.401 ' H ' HD23 ' C' ' 68' ' ' LEU . 63.7 tt0 -144.72 78.48 12.88 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 108.585 -0.894 . . . . 74.44 108.585 170.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -85.67 139.96 6.89 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.74 2.293 . . . . 61.21 112.641 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.423 ' HB3' ' HE3' ' C' ' 41' ' ' LYS . 36.6 mt-10 -87.28 85.43 7.17 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.15 -1.796 . . . . 73.51 106.15 169.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.655 HG11 ' HB2' ' G' ' 468' ' ' LEU . 48.1 t -63.13 107.99 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.504 0 CA-C-N 114.698 -1.137 . . . . 75.14 108.655 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' C' ' 39' ' ' GLU . 99.2 mttt -125.12 104.8 8.73 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.008 0.923 . . . . 73.32 109.763 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.51 HD12 HD22 ' C' ' 126' ' ' LEU . 4.0 mm? -86.09 125.6 33.58 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.159 -0.928 . . . . 74.54 109.194 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -118.25 105.31 11.63 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.812 -1.181 . . . . 71.01 107.812 173.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 tt -107.57 122.31 46.42 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.464 -0.569 . . . . 71.42 109.464 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -124.27 142.54 51.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.969 1.308 . . . . 74.21 108.654 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 1.5 m -123.48 126.6 47.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.465 0.65 . . . . 73.21 109.597 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.55 170.33 8.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.275 -1.329 . . . . 70.32 107.872 171.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -165.0 156.84 15.34 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.048 -0.723 . . . . 65.12 109.048 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 49.9 p -156.64 136.75 12.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.845 0.458 . . . . 74.4 110.713 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -70.2 126.35 29.41 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.415 -0.587 . . . . 74.13 109.415 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' C' ' 57' ' ' GLU . 57.6 mt -97.47 -35.93 10.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.421 0.688 . . . . 73.31 110.336 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.0 -174.08 4.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.031 0.933 . . . . 74.23 110.455 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -62.29 106.73 0.78 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.237 -0.892 . . . . 75.42 109.874 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 68.68 11.03 8.21 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.498 1.119 . . . . 72.21 112.876 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 99.4 t -105.94 105.76 19.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.62 -1.252 . . . . 74.31 107.62 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -117.73 123.88 47.12 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.722 -0.844 . . . . 75.13 108.722 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.682 ' HB2' HD12 ' C' ' 51' ' ' LEU . 43.6 tt0 -85.54 143.87 28.25 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.748 0.819 . . . . 75.05 109.218 171.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.564 HG11 HD12 ' C' ' 106' ' ' LEU . 43.7 t -119.26 139.08 47.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 108.102 -1.073 . . . . 74.51 108.102 166.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.76 123.36 65.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 107.43 -1.322 . . . . 71.43 107.43 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.4 107.7 18.82 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.629 -0.878 . . . . 75.02 108.629 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.15 102.96 14.81 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.706 -0.85 . . . . 71.23 108.706 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.416 ' HB ' HD11 ' C' ' 114' ' ' ILE . 58.7 t -103.59 108.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.344 -0.984 . . . . 74.31 108.344 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.7 m -98.1 137.1 37.39 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.853 -1.166 . . . . 71.13 107.853 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.52 HG12 HD21 ' C' ' 126' ' ' LEU . 61.3 t -132.24 108.82 14.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.591 -0.522 . . . . 71.25 109.591 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -103.9 142.93 33.55 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.117 -0.947 . . . . 74.11 109.737 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.26 123.23 15.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.874 -1.528 . . . . 62.23 106.874 173.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 7.9 m -130.45 128.42 41.23 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.492 0.495 . . . . 61.32 109.968 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.401 HD23 ' H ' ' C' ' 37' ' ' GLN . 18.3 mt -86.93 47.57 1.52 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.4 1.08 . . . . 75.43 108.752 175.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.22 -109.47 3.71 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 110.091 -1.204 . . . . 61.5 110.091 -172.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.29 -26.46 17.31 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.292 1.037 . . . . 72.43 110.418 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.585 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 3.9 tp10 -71.78 121.3 18.69 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.297 0.639 . . . . 72.41 110.028 173.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -68.63 126.37 29.47 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.65 -0.87 . . . . 75.03 108.65 168.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.705 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.6 -58.49 3.25 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.164 -1.05 . . . . 62.13 108.164 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.07 165.45 27.19 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.795 -1.093 . . . . 74.52 110.169 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.471 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.6 tm? -128.62 140.42 51.78 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.387 -1.708 . . . . 74.5 106.387 168.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.517 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.5 t -144.35 140.09 28.88 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.124 -1.065 . . . . 73.34 108.124 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -156.29 137.0 13.31 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 110.152 -0.314 . . . . 73.2 110.152 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -136.21 135.29 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.066 0.946 . . . . 74.22 108.833 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 41.9 mt-30 -107.07 94.62 5.2 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.259 1.023 . . . . 75.32 109.388 173.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -85.59 98.1 10.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.989 -1.005 . . . . 71.34 110.226 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.69 145.98 17.9 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 112.117 -0.393 . . . . 64.54 112.117 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.441 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.51 124.72 1.84 Allowed Glycine 0 CA--C 1.507 -0.441 0 N-CA-C 110.568 -1.013 . . . . 75.02 110.568 -174.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.68 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 4.8 mm -82.82 123.55 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.513 -0.921 . . . . 75.22 108.513 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.577 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 64.2 m-85 -129.32 120.7 26.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.222 0.609 . . . . 71.4 109.512 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -70.81 118.82 14.08 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.137 -0.69 . . . . 74.31 109.137 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.747 HD11 ' HB2' ' C' ' 94' ' ' MET . 4.7 tt -122.05 122.88 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.312 0.645 . . . . 71.03 110.313 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.609 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -156.57 168.89 26.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.493 0.717 . . . . 62.22 109.656 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.96 -54.45 4.3 Favored Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.045 0.355 . . . . 71.32 112.495 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 pt -83.01 156.1 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.408 1.083 . . . . 73.03 110.964 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.98 175.81 10.39 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.543 0.737 . . . . 70.5 110.635 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.11 -127.71 43.16 Favored Glycine 0 C--N 1.349 1.27 0 O-C-N 123.981 0.801 . . . . 73.14 114.128 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.681 ' HB ' ' HA ' ' C' ' 142' ' ' GLN . 41.4 p -70.07 -26.95 64.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.017 0.927 . . . . 71.14 111.97 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -68.49 -44.65 74.29 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.869 0.868 . . . . 74.32 110.705 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.747 ' HB2' HD11 ' C' ' 86' ' ' ILE . 3.6 ppp? -74.13 -33.75 63.66 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.729 -0.471 . . . . 61.33 109.729 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.49 ' HA ' HD23 ' G' ' 454' ' ' LEU . . . -60.4 -41.31 93.6 Favored 'General case' 0 C--N 1.36 1.046 0 O-C-N 124.242 0.964 . . . . 73.23 110.391 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.473 ' HE2' ' HA ' ' C' ' 134' ' ' ASP . 12.5 t-80 -80.97 -33.9 33.49 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.046 0.841 . . . . 72.51 112.301 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.9 t -55.4 -38.44 68.92 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.444 0.465 . . . . 74.32 110.053 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.582 ' HB2' HD12 ' G' ' 454' ' ' LEU . 30.6 mt -101.46 -13.29 18.0 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.74 0.816 . . . . 75.44 111.609 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.55 -30.54 56.32 Favored Glycine 0 C--N 1.354 1.58 0 N-CA-C 114.982 0.753 . . . . 74.33 114.982 -174.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.61 -35.38 0.07 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.814 0.445 . . . . 73.14 110.774 -171.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -68.45 -50.15 54.69 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.958 1.303 . . . . 75.45 112.467 -177.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 66.7 m -71.89 -41.39 9.02 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.877 -0.582 . . . . 63.02 112.354 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -53.84 -32.0 64.8 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 122.561 2.174 . . . . 71.51 113.927 166.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -69.24 -34.81 75.38 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.363 0.665 . . . . 63.15 109.904 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.583 HD13 ' NH1' ' A' ' 111' ' ' ARG . 34.2 mm -62.86 -40.45 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 109.37 -0.604 . . . . 73.23 109.37 174.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.564 HD12 HG11 ' C' ' 58' ' ' VAL . 69.1 mt -82.26 -17.98 44.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.296 1.038 . . . . 72.21 112.449 -177.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -60.07 -50.36 86.65 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-O 117.911 -1.043 . . . . 75.11 113.662 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.31 -31.51 62.88 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 121.955 1.77 . . . . 74.44 112.818 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -70.24 -47.76 59.91 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.178 0.591 . . . . 64.23 110.556 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.95 84.3 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.346 -0.843 . . . . 43.23 109.948 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -59.93 -49.35 78.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.021 1.329 . . . . 75.51 110.855 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.41 -39.1 91.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.375 0.67 . . . . 74.3 110.517 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 19.6 t -66.79 -27.53 67.65 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.826 0.45 . . . . 65.44 111.659 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.517 HG23 ' SG ' ' C' ' 76' ' ' CYS . 63.5 mt -80.78 -43.46 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.218 0.607 . . . . 71.32 110.067 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.49 HG21 ' HB3' ' B' ' 119' ' ' SER . 5.7 m -61.16 -29.33 69.73 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.321 0.582 . . . . 61.34 110.373 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -72.92 -53.5 11.14 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.754 -1.112 . . . . 72.14 109.818 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.534 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.37 -39.09 92.04 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.954 0.902 . . . . 65.42 113.167 -175.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 78.3 t -64.99 -42.17 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.689 0.795 . . . . 75.24 110.184 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -69.46 -29.95 67.75 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.26 -0.882 . . . . 73.42 111.244 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 86.4 mtt-85 -68.5 -39.24 81.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.636 0.775 . . . . 75.2 108.921 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.32 1.47 81.09 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 123.908 0.755 . . . . 64.25 113.17 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 38.4 p 64.03 27.31 14.22 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.543 1.937 . . . . 74.14 113.941 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -92.19 149.39 38.5 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 109.012 -0.736 . . . . 74.34 109.012 171.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -45.03 119.68 2.57 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.583 2.855 . . . . 74.12 113.128 170.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -59.9 155.9 15.51 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.81 1.244 . . . . 71.23 113.566 -170.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.52 HD21 HG12 ' C' ' 64' ' ' VAL . 34.3 tp -104.2 102.33 12.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.779 0.832 . . . . 75.51 109.89 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.76 89.77 4.46 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.951 -1.129 . . . . 73.31 107.951 168.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.405 HD21 ' HH ' ' G' ' 462' ' ' TYR . 27.4 tp -74.03 134.39 43.01 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.628 -0.714 . . . . 75.11 110.282 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.96 151.6 96.14 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 124.111 0.964 . . . . 74.01 111.746 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.52 121.22 9.53 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.983 2.456 . . . . 73.22 112.683 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.451 HG22 ' HE1' ' G' ' 462' ' ' TYR . 11.5 t -102.95 137.6 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.966 -0.753 . . . . 74.45 108.966 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -82.27 73.4 9.31 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.541 -0.54 . . . . 73.44 109.541 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -61.53 -43.64 98.5 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.386 -0.824 . . . . 71.54 109.481 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.473 ' HA ' ' HE2' ' C' ' 96' ' ' HIS . 19.6 m-20 -64.07 -53.51 48.72 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 113.954 -1.475 . . . . 73.05 111.837 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.03 -38.4 70.51 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.487 1.117 . . . . 74.11 111.171 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.78 -45.0 79.84 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.213 -0.903 . . . . 75.32 110.693 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.522 ' HA ' ' HB3' ' C' ' 140' ' ' TYR . 13.3 t80 -70.26 -28.79 65.51 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.052 0.541 . . . . 71.24 110.422 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.763 ' HA ' ' HB3' ' C' ' 142' ' ' GLN . 49.3 mtp -72.74 -32.97 66.08 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.228 0.611 . . . . 73.24 110.834 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -74.71 -36.91 62.7 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.721 0.808 . . . . 64.24 110.986 170.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' C' ' 137' ' ' PHE . 31.1 t80 -67.19 -84.63 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.234 1.414 . . . . 74.34 111.081 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.438 ' HG ' HG23 ' C' ' 92' ' ' THR . 32.7 tp -133.28 83.45 2.06 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.416 0.627 . . . . 75.22 110.093 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.763 ' HB3' ' HA ' ' C' ' 138' ' ' MET . 19.9 tp60 -169.25 -44.6 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.949 1.3 . . . . 71.44 108.279 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 60.39 81.53 0.18 Allowed 'General case' 0 C--N 1.357 0.9 0 O-C-N 124.852 1.345 . . . . 75.41 109.578 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -146.93 -47.53 0.18 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.962 -0.563 . . . . 73.43 110.556 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 69.19 138.94 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.046 1.338 . . . . 73.52 112.64 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -178.68 73.39 0.07 OUTLIER Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.268 -0.423 . . . . 75.43 112.059 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -160.82 -44.1 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.471 0.708 . . . . 74.32 110.369 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 88.14 -151.81 23.13 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 115.553 -0.748 . . . . 61.21 111.599 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 44.2 p -79.05 102.06 8.18 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 118.022 0.911 . . . . 72.55 109.182 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -67.03 149.36 50.72 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.953 -0.758 . . . . 74.31 108.953 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.82 102.04 0.09 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.626 0.77 . . . . 73.02 111.327 -173.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -85.55 150.97 24.29 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.627 -0.715 . . . . 74.43 109.637 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -83.31 -176.83 6.51 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.683 0.793 . . . . 73.15 110.233 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.89 -40.8 91.9 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.565 0.746 . . . . 75.24 110.251 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 124.783 1.233 . . . . 74.44 111.046 178.049 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.417 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.265 -0.643 . . . . 71.52 109.265 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 57.7 m -70.86 82.83 0.65 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.33 0.652 . . . . 71.54 110.017 172.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -67.35 124.4 23.06 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.25 -0.886 . . . . 72.41 111.111 -173.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -69.34 89.31 0.48 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.051 -1.462 . . . . 72.21 107.051 162.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -66.5 161.22 23.37 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.896 -0.593 . . . . 72.35 110.469 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -53.69 150.9 6.66 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.166 0.986 . . . . 74.31 112.513 -172.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 42.5 p -76.97 9.64 2.82 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.355 1.062 . . . . 75.34 113.017 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -68.93 89.69 0.42 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.888 0.875 . . . . 72.3 109.45 171.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.0 ttp -33.63 125.86 0.41 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.409 1.484 . . . . 71.55 113.336 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' D' ' 87' ' ' ALA . 90.0 m -133.05 143.26 49.25 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.003 0.921 . . . . 72.21 108.79 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -159.95 90.13 0.9 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.56 -1.274 . . . . 75.23 107.56 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -118.78 116.91 27.53 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.24 -1.022 . . . . 72.33 108.24 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.445 HG22 HD13 ' D' ' 16' ' ' ILE . 13.7 mt -73.2 109.97 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.091 -0.707 . . . . 75.41 109.091 177.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -80.65 -37.85 30.18 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.449 0.7 . . . . 74.23 111.846 -173.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -168.9 139.01 2.3 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 117.414 0.097 . . . . 65.13 111.126 -168.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.482 HD11 ' HG3' ' B' ' 130' ' ' PRO . 2.4 mp -117.82 135.04 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.144 -1.428 . . . . 75.03 107.144 169.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -160.53 150.29 17.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.434 0.635 . . . . 74.21 111.798 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 64.3 p -86.5 113.56 22.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.949 -1.023 . . . . 74.2 109.18 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -81.31 -22.04 38.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.298 0.639 . . . . 74.51 110.554 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.476 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.6 t70 -160.39 142.39 12.74 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.151 -0.931 . . . . 74.34 109.042 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.534 HG23 ' HE1' ' C' ' 117' ' ' MET . 85.5 mt -138.65 143.54 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.116 -1.068 . . . . 74.35 108.116 175.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -143.54 133.12 23.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.754 0.822 . . . . 75.32 108.916 171.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.526 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.4 t80 -134.77 131.85 38.03 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.328 -1.73 . . . . 74.2 106.328 166.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.637 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 25.4 mt-10 -133.09 130.41 39.28 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.91 0.884 . . . . 75.44 108.83 -173.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.65 78.34 31.59 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.048 -1.093 . . . . 74.52 108.048 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.52 -31.29 21.87 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.896 2.397 . . . . 72.14 112.388 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -99.84 -1.29 37.86 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.457 -1.247 . . . . 72.31 110.971 -173.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -29.93 -67.2 0.14 Allowed Pre-proline 0 C--N 1.36 1.058 0 C-N-CA 126.517 1.927 . . . . 75.15 116.134 -160.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.531 ' HB3' HD11 ' C' ' 83' ' ' ILE . 80.9 Cg_endo -71.62 -29.64 15.83 Favored 'Trans proline' 0 C--N 1.375 1.959 0 CA-C-N 122.63 1.975 . . . . 72.13 113.318 -170.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.424 ' HA ' HE21 ' D' ' 33' ' ' GLN . 5.8 p-80 -84.91 -23.44 28.87 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 117.678 0.217 . . . . 74.22 111.137 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.474 HG23 HD11 ' D' ' 68' ' ' LEU . 8.9 p -80.6 -26.73 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 122.65 0.38 . . . . 74.34 110.444 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -61.71 -25.4 67.4 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.328 0.651 . . . . 74.22 112.436 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.424 HE21 ' HA ' ' D' ' 30' ' ' HIS . 74.3 mt-30 -53.21 -28.78 28.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.275 1.03 . . . . 75.23 111.509 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -84.1 101.52 11.87 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.139 0.975 . . . . 74.01 110.116 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.34 80.43 7.75 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.991 -1.004 . . . . 75.33 108.987 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.43 ' HD1' HD23 ' D' ' 68' ' ' LEU . 50.6 t-105 -142.98 156.47 44.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.85 1.26 . . . . 73.14 108.253 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -80.3 101.98 1.08 Allowed Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 108.066 -1.087 . . . . 72.34 108.066 174.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.92 119.72 6.5 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.084 2.523 . . . . 74.22 112.901 -167.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.84 112.86 2.73 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 123.957 0.785 . . . . 71.43 109.912 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.436 HG12 ' HB1' ' D' ' 66' ' ' ALA . 27.5 m -100.02 151.07 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.881 -1.054 . . . . 74.41 111.131 -172.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' H' ' 465' ' ' LYS . 23.5 tptp -118.08 117.96 30.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.118 -1.067 . . . . 73.13 108.118 173.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.0 tp -94.62 120.21 34.49 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.919 -0.771 . . . . 74.04 108.919 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.528 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.4 t70 -127.67 112.88 15.33 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.76 -1.2 . . . . 74.22 107.76 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 67.0 mt -96.16 129.08 43.56 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.003 0.521 . . . . 72.11 109.688 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.593 ' HA ' ' HG ' ' H' ' 460' ' ' LEU . 30.1 t70 -136.05 121.55 19.43 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.069 -0.715 . . . . 75.33 109.069 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.46 ' H ' HD21 ' H' ' 460' ' ' LEU . 10.1 t -105.84 168.28 9.22 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.519 0.675 . . . . 72.41 110.512 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -161.05 162.73 31.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.286 -1.325 . . . . 72.2 108.539 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 24.4 p -156.88 153.32 28.0 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.868 -0.79 . . . . 71.41 108.868 172.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 37.3 p -155.69 131.36 9.76 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.543 0.737 . . . . 73.42 109.544 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -73.6 127.96 34.2 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.928 0.491 . . . . 75.14 110.073 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' D' ' 57' ' ' GLU . 61.4 mt -92.64 -35.08 13.72 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.625 -0.509 . . . . 70.41 109.625 175.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.28 -178.48 3.63 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.359 1.063 . . . . 74.12 109.512 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -65.67 127.64 32.75 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.983 -0.747 . . . . 71.43 108.983 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.81 19.3 11.32 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.39 1.076 . . . . 73.44 112.105 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.97 124.28 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.846 0.858 . . . . 74.51 109.173 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.404 ' HD1' HD11 ' D' ' 86' ' ' ILE . 15.0 m-85 -133.57 131.7 40.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.485 0.714 . . . . 74.5 109.751 176.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.524 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.0 tt0 -92.43 120.12 32.62 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.19 -1.041 . . . . 74.35 108.19 167.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -100.9 140.3 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.929 -1.137 . . . . 71.31 107.929 170.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.8 t -122.76 129.18 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.468 -0.938 . . . . 62.52 108.468 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.45 116.68 32.27 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.163 -1.421 . . . . 65.21 107.163 170.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -104.94 101.86 11.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.942 -1.133 . . . . 73.34 107.942 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.28 137.66 21.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.663 -0.699 . . . . 61.15 109.156 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 32.6 m -117.93 142.16 47.65 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.516 0.727 . . . . 73.53 109.805 177.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 59.3 t -136.5 113.08 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.058 0.943 . . . . 71.32 109.457 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 89.9 m -106.56 108.92 20.67 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.507 -0.553 . . . . 71.24 109.507 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.436 ' HB1' HG12 ' D' ' 40' ' ' VAL . . . -106.54 158.45 16.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.185 0.594 . . . . 74.53 110.368 -176.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 4.8 p -153.73 140.73 19.3 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-O 121.438 0.637 . . . . 72.42 112.404 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.474 HD11 HG23 ' D' ' 31' ' ' VAL . 70.5 mt -111.57 116.25 30.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.799 1.24 . . . . 72.41 107.764 169.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.76 -120.78 8.29 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 123.563 0.539 . . . . 74.0 113.112 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -102.84 6.66 39.33 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.82 0.848 . . . . 75.31 111.408 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -135.21 162.13 33.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.83 0.452 . . . . 72.15 110.725 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 30.4 m -57.61 142.9 43.2 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.175 0.99 . . . . 71.03 111.45 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.451 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -97.37 -68.58 0.79 Allowed 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.049 -1.093 . . . . 72.25 108.049 172.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -141.15 149.17 41.15 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.963 -1.017 . . . . 71.31 109.472 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.637 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.6 mt -112.55 146.27 38.83 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.681 -1.229 . . . . 72.44 107.681 169.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.8 t -153.97 133.45 12.79 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.765 -0.458 . . . . 70.14 109.765 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -154.26 126.61 7.94 Favored 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.97 -0.381 . . . . 73.43 109.97 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 97.9 t -131.09 125.02 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.783 0.833 . . . . 75.4 110.16 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 37.7 mt-30 -87.71 86.33 7.17 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.795 -0.817 . . . . 73.24 108.795 168.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -81.43 92.15 6.4 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.234 -0.893 . . . . 75.44 109.503 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.96 162.59 27.58 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 111.951 -0.46 . . . . 72.31 111.951 178.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.31 136.46 4.43 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.997 -0.441 . . . . 54.11 111.997 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.78 127.77 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.73 -0.841 . . . . 74.14 108.73 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.43 125.65 47.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.236 1.014 . . . . 75.34 108.915 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 6.4 t -87.98 97.16 10.8 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.086 -1.079 . . . . 64.43 108.086 176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.557 HD12 HG12 ' H' ' 452' ' ' VAL . 2.7 pp -111.32 139.03 37.3 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 C-N-CA 123.546 0.738 . . . . 75.31 110.154 -171.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.469 ' HB2' ' HB ' ' D' ' 10' ' ' THR . . . -157.82 157.18 32.82 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.06 0.544 . . . . 72.53 109.643 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.03 17.99 77.49 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.329 0.393 . . . . 73.11 113.512 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.68 134.41 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.817 0.847 . . . . 74.02 108.944 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.57 177.02 8.77 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.269 0.628 . . . . 64.4 111.136 -174.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.53 -111.36 2.06 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 124.284 0.99 . . . . 65.5 114.573 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.3 m -89.55 -27.05 20.52 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.712 0.805 . . . . 74.42 110.804 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -64.65 -41.03 96.4 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.314 0.645 . . . . 72.43 110.642 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.675 ' SD ' ' HA ' ' H' ' 452' ' ' VAL . 26.9 ptt? -69.21 -34.04 74.26 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 116.036 -0.529 . . . . 74.14 111.08 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.32 -32.29 64.49 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.286 0.634 . . . . 65.12 110.968 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -77.65 -34.93 52.96 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.427 1.091 . . . . 74.51 110.262 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.2 -51.68 11.6 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.859 -0.61 . . . . 73.22 111.091 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.481 HD21 ' SG ' ' D' ' 102' ' ' CYS . 83.8 mt -85.86 -24.29 26.76 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.948 0.499 . . . . 71.25 112.03 -172.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.84 -14.06 55.63 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.751 -0.472 . . . . 72.32 113.668 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.604 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -135.81 -59.2 0.76 Allowed 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 117.354 0.577 . . . . 43.21 111.89 -173.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -67.8 -41.19 83.55 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.098 0.559 . . . . 71.31 112.295 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.481 ' SG ' HD21 ' D' ' 98' ' ' LEU . 70.4 m -67.86 -45.77 43.41 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 118.483 -0.77 . . . . 75.24 112.321 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -56.5 -36.2 97.44 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.184 1.923 . . . . 74.13 112.909 168.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -65.36 -30.66 71.51 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.606 0.763 . . . . 73.11 111.558 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 80.0 mt -71.3 -39.27 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.192 0.997 . . . . 71.1 110.463 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -76.0 -19.51 58.62 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.441 -0.799 . . . . 71.32 111.527 -176.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -64.88 -43.56 69.05 Favored Pre-proline 0 CA--C 1.562 1.409 0 CA-C-O 117.987 -1.006 . . . . 74.01 113.603 -174.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -51.48 -43.8 47.72 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.241 1.961 . . . . 62.12 113.923 170.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -72.83 -37.52 67.42 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.33 0.652 . . . . 74.15 111.2 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.33 -48.26 80.6 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.44 0.696 . . . . 73.24 109.674 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -54.38 -49.57 69.54 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.875 1.359 . . . . 73.34 110.942 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.16 -45.62 92.61 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.24 0.963 . . . . 75.5 111.372 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.7 t -58.51 -44.87 89.63 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.873 0.733 . . . . 75.45 110.697 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.492 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.0 mt -60.04 -56.56 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.184 0.994 . . . . 75.53 110.743 175.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.7 m -55.21 -42.78 73.77 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.932 1.293 . . . . 74.35 111.561 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 36.8 t -66.18 -40.63 90.6 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 114.561 -1.2 . . . . 74.25 110.047 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.472 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.5 mtm -70.57 -30.79 67.59 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.961 0.505 . . . . 64.13 111.869 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.433 HG23 ' O ' ' D' ' 114' ' ' ILE . 73.8 t -64.05 -45.89 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.484 0.714 . . . . 71.2 109.947 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -74.97 -28.13 60.44 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.648 -0.706 . . . . 63.04 111.28 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -70.85 -34.01 71.21 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.236 -0.653 . . . . 62.34 109.236 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.66 11.09 62.63 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.924 0.765 . . . . 71.33 112.919 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 78.9 p 58.51 16.84 4.48 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 126.499 1.92 . . . . 74.15 114.606 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -80.16 146.88 63.8 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.096 -0.705 . . . . 73.04 109.096 171.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.53 133.2 25.92 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.291 2.661 . . . . 72.55 112.428 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -53.34 136.93 36.33 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.346 1.029 . . . . 73.22 112.589 -168.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.402 HD12 HD11 ' H' ' 468' ' ' LEU . 51.6 tp -108.37 107.33 17.86 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.488 -0.778 . . . . 72.44 109.74 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.415 HD21 HD13 ' B' ' 16' ' ' ILE . 11.6 m120 -101.23 96.22 7.05 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.4 -0.963 . . . . 74.32 108.4 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.37 122.22 15.68 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.851 0.46 . . . . 75.33 110.05 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.71 123.06 80.18 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 122.993 0.517 . . . . 54.41 109.844 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.89 122.84 11.83 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.626 2.217 . . . . 75.33 112.031 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 75.0 t -106.78 123.27 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.854 -0.795 . . . . 73.22 108.854 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -80.29 93.32 5.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.019 -0.734 . . . . 75.1 109.019 174.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -60.81 -28.07 68.51 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.545 0.738 . . . . 73.45 111.292 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.604 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 6.0 t70 -62.8 -50.08 72.42 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.423 1.089 . . . . 73.42 111.265 -173.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.66 -45.26 87.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.556 0.743 . . . . 73.45 111.408 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.66 -26.05 66.01 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.603 0.761 . . . . 74.23 111.603 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -67.27 -39.53 86.06 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.608 0.763 . . . . 75.51 110.447 175.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 31.0 mtt -61.28 -39.11 89.17 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.517 0.727 . . . . 74.41 109.821 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.456 ' HA ' ' HG3' ' D' ' 142' ' ' GLN . 19.3 m120 -63.9 -46.86 82.97 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.129 0.893 . . . . 75.22 111.052 175.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -54.57 -38.47 66.72 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.095 0.958 . . . . 73.15 111.256 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.9 mp -74.55 -39.85 62.06 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.203 0.601 . . . . 72.44 111.622 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.456 ' HG3' ' HA ' ' D' ' 139' ' ' ASN . 0.0 OUTLIER -86.33 11.4 12.33 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.093 0.775 . . . . 74.3 113.093 -174.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -118.99 87.83 2.81 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.469 0.652 . . . . 60.55 110.256 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -162.23 168.29 22.64 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.452 -1.249 . . . . 64.24 109.114 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.85 82.23 2.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.057 0.543 . . . . 63.52 110.151 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.34 65.72 3.78 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 115.687 -0.688 . . . . 72.53 111.707 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -157.63 -149.03 0.22 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.761 0.825 . . . . 75.31 109.298 -171.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -47.25 109.51 0.43 Allowed Glycine 0 C--N 1.364 2.123 0 C-N-CA 123.723 0.678 . . . . 73.51 113.529 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 17.5 m -73.78 87.06 1.72 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.68 1.192 . . . . 75.01 110.55 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -161.55 -168.45 1.99 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.209 1.004 . . . . 73.52 108.982 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.23 71.69 1.71 Allowed 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 121.914 0.864 . . . . 74.54 110.53 174.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -72.31 98.17 2.15 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.311 -0.859 . . . . 72.51 109.407 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -75.98 141.11 42.28 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 116.037 -0.529 . . . . 73.44 110.237 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -174.47 162.52 3.51 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.199 1.399 . . . . 74.15 108.517 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 N-CA-C 108.784 -0.821 . . . . 74.31 108.784 178.41 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 110.175 -0.305 . . . . 75.13 110.175 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . 0.442 HG13 HG23 ' E' ' 452' ' ' VAL . 9.8 p -75.61 163.37 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 C-N-CA 123.354 0.661 . . . . 64.41 111.278 -172.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . 0.547 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 88.4 t 75.15 -76.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.837 0 C-N-CA 125.768 1.627 . . . . 74.23 111.398 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 60.81 46.67 94.06 Favored Glycine 0 C--N 1.343 0.951 0 O-C-N 123.19 0.306 . . . . 53.14 112.804 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.26 151.11 48.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.356 0.662 . . . . 74.12 111.708 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 14.1 p -113.97 -33.71 5.65 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.943 0.897 . . . . 64.2 109.577 168.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 26.1 t70 68.45 154.17 0.1 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.758 1.223 . . . . 74.41 112.154 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -124.16 -11.83 7.47 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.989 0.916 . . . . 62.13 111.549 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 30.7 m 58.62 88.01 0.07 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 124.533 1.133 . . . . 74.33 109.859 -173.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -161.65 137.05 7.56 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 116.311 -0.404 . . . . 75.12 110.301 -171.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 45.5 mt -138.91 177.37 7.94 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.772 0.829 . . . . 73.04 110.533 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.75 50.55 2.23 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.776 1.23 . . . . 74.1 110.419 -171.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -82.68 144.38 30.29 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.695 -0.684 . . . . 74.43 110.93 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 4.9 m -138.38 49.54 1.91 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 108.272 -1.01 . . . . 70.55 108.272 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 26.2 ptm -163.89 170.78 16.29 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.685 -1.143 . . . . 72.42 109.828 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . 0.646 ' HG2' ' H ' ' E' ' 466' ' ' ALA . 0.0 OUTLIER -127.5 -95.96 0.42 Allowed 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 108.698 -0.853 . . . . 74.51 108.698 167.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . 0.646 ' H ' ' HG2' ' E' ' 465' ' ' LYS . . . -163.79 164.36 23.65 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.767 0.827 . . . . 75.32 109.637 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -164.37 87.96 0.49 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.135 -1.061 . . . . 63.52 108.135 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 126' ' ' LEU . 50.0 mt -93.41 -68.64 0.79 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.477 0.711 . . . . 74.4 110.568 -170.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 134.19 42.69 0.14 Allowed Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.404 -0.816 . . . . 75.31 111.326 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 43.1 mt -87.43 19.61 3.22 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.384 0.673 . . . . 71.42 111.985 -176.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? . . . . . 0 CA--C 1.555 1.172 0 N-CA-C 107.301 -1.37 . . . . 72.53 107.301 -178.413 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.081 -0.711 . . . . 71.34 109.081 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . 0.579 HG23 ' HA ' ' B' ' 54' ' ' ASP . 14.8 p -158.2 143.12 7.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 C-N-CA 122.86 0.464 . . . . 75.51 110.395 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 12.1 p -173.03 166.34 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.69 1.196 . . . . 73.34 108.075 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . 0.648 ' HA3' HD11 ' B' ' 98' ' ' LEU . . . -104.23 -90.64 2.18 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.046 -0.822 . . . . 73.25 111.046 168.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . 0.401 ' HG ' HD21 ' B' ' 98' ' ' LEU . 2.9 pp -160.17 -174.57 4.6 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.149 0.979 . . . . 74.03 109.726 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 12.1 t -145.0 30.22 1.17 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.987 0.899 . . . . 73.33 108.698 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -112.45 130.13 56.09 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.832 -1.076 . . . . 73.31 110.071 -169.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -161.28 29.81 0.14 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.129 0.972 . . . . 64.45 108.803 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 85.4 m -63.02 -44.98 94.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.167 0.987 . . . . 73.54 111.225 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -159.51 135.81 9.0 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.549 0.74 . . . . 74.5 109.491 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.54 123.69 27.81 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.414 0.685 . . . . 74.12 110.218 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . 0.591 ' HB2' ' HB3' ' B' ' 136' ' ' LEU . 6.3 p90 -62.35 114.37 3.45 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.653 -1.158 . . . . 71.44 110.518 175.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -135.4 106.66 6.77 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.123 -0.695 . . . . 73.34 109.123 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 74.9 m -148.45 112.14 5.07 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.797 -1.186 . . . . 73.24 107.797 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 46.8 ttp -147.16 142.29 27.16 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.258 -0.645 . . . . 73.42 109.258 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -73.82 -17.79 61.03 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.21 1.004 . . . . 74.25 112.07 -170.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -126.55 167.63 15.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.971 0.908 . . . . 71.35 109.38 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -81.94 -40.4 22.32 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.678 0.391 . . . . 60.12 111.313 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . 0.479 HD12 HG23 ' B' ' 40' ' ' VAL . 21.3 tp -155.64 -45.73 0.08 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.983 0.513 . . . . 74.21 111.463 -174.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 95.71 41.92 3.74 Favored Glycine 0 N--CA 1.472 1.092 0 N-CA-C 110.599 -1.0 . . . . 64.41 110.599 -166.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' B' ' 37' ' ' GLN . 10.4 tt -78.51 -47.86 16.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.351 1.06 . . . . 71.34 109.811 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt . . . . . 0 C--O 1.252 1.232 0 N-CA-C 107.3 -1.37 . . . . 73.33 107.3 177.524 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 109.561 -0.533 . . . . 75.11 109.561 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 6.1 p -70.13 101.39 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 CA-C-O 121.835 0.826 . . . . 74.24 111.05 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 24.0 m -136.25 162.98 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.375 1.07 . . . . 73.13 110.5 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 148.55 69.65 0.01 OUTLIER Glycine 0 C--N 1.356 1.674 0 O-C-N 123.054 0.221 . . . . 74.23 113.167 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' C' ' 98' ' ' LEU . 94.4 mt -131.84 170.96 14.12 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.675 0.79 . . . . 72.51 111.06 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 9.9 t -70.28 137.6 50.87 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 116.194 -0.457 . . . . 73.03 110.444 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -89.29 49.95 1.85 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.957 0.903 . . . . 72.44 109.973 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 71.04 112.52 0.06 Allowed 'General case' 0 C--N 1.363 1.167 0 C-N-CA 125.903 1.681 . . . . 71.53 109.973 -174.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 15.3 t -141.15 -47.26 0.39 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.443 0.697 . . . . 74.1 109.897 168.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -175.27 166.78 3.41 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.245 1.018 . . . . 74.31 110.12 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -137.7 135.59 36.59 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.219 -1.03 . . . . 75.11 108.219 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -58.42 113.09 1.81 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.489 1.116 . . . . 72.41 111.408 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . 0.451 ' HE1' HG22 ' C' ' 131' ' ' VAL . 54.0 t80 -158.2 110.39 2.3 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.956 -0.386 . . . . 73.21 109.956 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 463' ' ' THR . . . . . 0.447 ' HA ' ' HE2' ' G' ' 465' ' ' LYS . 38.1 p -133.65 82.71 2.0 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.835 0.854 . . . . 72.53 110.748 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 31.5 mtm -135.99 -64.05 0.63 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.869 -0.789 . . . . 75.3 108.869 168.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' G' ' 463' ' ' THR . 0.0 OUTLIER 64.92 -79.08 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.907 1.283 . . . . 74.44 111.368 -177.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -72.99 86.37 1.31 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.763 -0.458 . . . . 72.5 109.763 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -151.21 31.19 0.61 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.26 0.624 . . . . 73.43 111.811 -171.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . 0.655 ' HB2' HG11 ' C' ' 40' ' ' VAL . 4.7 tt -97.98 -66.8 0.88 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.222 -1.029 . . . . 73.41 108.222 175.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 132.19 2.2 4.23 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.495 -0.775 . . . . 75.41 113.048 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . 0.407 ' HG ' HD23 ' G' ' 468' ' ' LEU . 80.9 mt -69.0 133.04 47.62 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.589 0.694 . . . . 75.02 110.044 174.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 26.0 tptp . . . . . 0 C--O 1.249 1.072 0 C-N-CA 123.629 0.772 . . . . 75.02 109.059 -175.609 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.742 -0.466 . . . . 74.34 109.742 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 96.4 t -75.08 -67.82 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 107.348 -1.353 . . . . 71.01 107.348 168.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.675 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 16.7 m -100.73 144.94 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 115.364 -0.834 . . . . 72.23 110.052 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -176.25 81.33 0.07 OUTLIER Glycine 0 C--N 1.34 0.804 0 O-C-N 123.478 0.486 . . . . 75.44 111.897 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . 0.408 HD22 HD11 ' D' ' 98' ' ' LEU . 1.5 pt? -147.64 133.7 19.28 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.929 0.892 . . . . 61.52 109.005 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 14.8 t -133.69 -1.52 3.07 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.875 0.47 . . . . 71.11 111.028 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -82.68 142.85 31.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.264 0.626 . . . . 64.42 110.099 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -74.88 -20.61 59.66 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.36 0.664 . . . . 74.41 111.376 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 27.8 m 72.62 128.76 0.04 OUTLIER 'General case' 0 C--N 1.364 1.23 0 C-N-CA 125.296 1.439 . . . . 75.11 111.045 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.88 121.19 14.51 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 122.756 0.422 . . . . 74.4 109.89 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . 0.593 ' HG ' ' HA ' ' D' ' 45' ' ' ASP . 4.5 mm? -65.23 149.4 50.0 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.164 0.983 . . . . 73.25 111.981 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -135.27 136.76 41.92 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 113.618 -1.628 . . . . 71.24 108.553 -172.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 90.2 t80 69.38 134.39 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.945 1.298 . . . . 72.11 112.176 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 14.3 t -156.11 133.03 10.48 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 108.783 -0.821 . . . . 75.53 108.783 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -134.59 159.86 39.88 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.783 0.433 . . . . 74.0 111.437 -170.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . 0.524 ' HZ3' ' HB2' ' H' ' 465' ' ' LYS . 4.3 ttmp? -83.16 -66.28 0.91 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.504 0.722 . . . . 72.14 109.702 173.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -69.5 90.49 0.54 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.596 0.758 . . . . 73.31 111.976 -171.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -102.83 33.49 3.2 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 114.798 -1.092 . . . . 75.5 109.876 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . 0.402 HD11 HD12 ' D' ' 126' ' ' LEU . 6.6 tt -166.98 -52.56 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 106.978 -1.49 . . . . 74.21 106.978 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.13 -30.83 3.8 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 114.418 -1.265 . . . . 65.2 110.443 -173.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 59.27 81.01 0.18 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 124.917 1.287 . . . . 74.32 110.815 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 94.6 mttt . . . . . 0 C--O 1.248 1.015 0 CA-C-N 115.247 -0.888 . . . . 70.21 109.676 -179.381 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 110.53 -0.174 . . . . 64.32 110.53 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m 57.81 37.81 27.13 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.26 1.024 . . . . 73.35 111.434 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 66.25 90.73 0.09 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.078 1.351 . . . . 72.44 111.204 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.02 134.55 40.96 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 107.499 -1.297 . . . . 75.04 107.499 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 73.29 117.38 0.05 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.183 1.393 . . . . 75.24 109.977 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -61.93 -64.95 0.77 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.442 0.697 . . . . 54.2 109.795 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 p -144.34 168.26 20.5 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.485 1.114 . . . . 74.22 109.409 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -157.04 133.01 9.54 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.328 -0.99 . . . . 65.33 108.328 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 83.7 mtp -145.24 137.91 26.1 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.264 1.026 . . . . 75.14 109.356 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 92.3 m -147.15 120.02 8.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.784 0.834 . . . . 74.2 108.845 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.582 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 13.7 t80 -137.93 126.83 24.01 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.958 0.503 . . . . 71.31 109.713 177.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -138.16 132.5 32.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.418 -1.327 . . . . 63.0 107.418 172.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.531 HG12 ' HD2' ' A' ' 84' ' ' PHE . 46.9 mt -92.76 116.82 34.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.188 -0.671 . . . . 71.41 109.188 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.6 -43.4 59.79 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 124.256 0.973 . . . . 70.11 108.909 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.401 ' NH1' ' HB3' ' B' ' 32' ' ' PHE . 39.6 ttt180 -173.71 129.73 0.42 Allowed 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.243 0.34 . . . . 74.0 111.007 -172.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 13' ' ' ILE . 77.1 mt -113.87 139.74 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.954 0.902 . . . . 72.31 109.097 172.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.458 ' HB3' HG23 ' B' ' 122' ' ' THR . 45.1 p90 -168.97 -179.78 3.79 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 124.537 1.148 . . . . 74.12 110.495 -170.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -110.15 126.38 54.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.42 -0.809 . . . . 65.23 109.466 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.414 ' HZ3' ' HG3' ' B' ' 29' ' ' PRO . 48.9 mttp -80.54 -48.8 12.22 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.338 -0.615 . . . . 74.11 109.338 171.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 19.3 t70 -135.58 132.27 36.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.652 -0.704 . . . . 72.44 109.481 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.3 mt -123.21 141.66 42.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.239 -1.393 . . . . 75.33 107.239 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.0 t -144.64 139.07 27.8 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 123.576 0.547 . . . . 74.54 109.586 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.449 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 87.6 t80 -146.36 126.3 13.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.632 -1.618 . . . . 74.42 106.632 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 22.5 mt-10 -129.6 127.75 41.27 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.438 0.695 . . . . 63.34 109.511 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.95 73.93 44.97 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.976 -1.12 . . . . 74.12 107.976 170.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.3 -16.19 13.85 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.664 2.243 . . . . 73.25 110.795 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -105.35 13.54 30.2 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.973 1.309 . . . . 74.15 108.96 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.41 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -53.12 -47.93 93.98 Favored Pre-proline 0 CA--C 1.566 1.589 0 C-N-CA 124.935 1.294 . . . . 73.45 113.568 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 37.5 Cg_exo -64.17 -24.39 65.94 Favored 'Trans proline' 0 C--N 1.397 3.107 0 C-N-CA 122.131 1.887 . . . . 71.43 113.608 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -74.07 -42.44 60.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.172 0.589 . . . . 71.1 110.597 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.404 HG23 ' HE1' ' A' ' 123' ' ' PHE . 90.3 t -50.37 -33.54 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.735 1.214 . . . . 74.42 112.356 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -58.02 -39.9 79.51 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.427 1.091 . . . . 74.0 111.694 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -91.67 -23.21 19.88 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.244 1.018 . . . . 74.21 111.628 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 32.0 mmmt -80.4 147.59 30.94 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.402 0.681 . . . . 73.23 111.654 -175.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.34 129.0 35.97 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.404 -0.961 . . . . 75.0 108.404 170.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.502 ' HE1' ' HB3' ' E' ' 470' ' ' LEU . 69.8 t-105 -76.21 96.38 3.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.0 0.52 . . . . 74.44 110.85 -172.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -148.07 67.17 9.89 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 109.339 -0.615 . . . . 65.21 109.339 170.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.26 152.87 12.35 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.762 2.308 . . . . 74.1 111.589 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -97.0 106.44 18.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.452 -1.314 . . . . 73.52 107.452 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.07 98.19 4.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 116.016 -0.538 . . . . 72.3 109.984 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -78.73 113.45 16.8 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.09 -0.959 . . . . 73.52 108.478 170.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' E' ' 467' ' ' ALA . 46.1 tp -100.22 142.87 31.11 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.794 -1.188 . . . . 74.55 107.794 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.539 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 38.8 t70 -145.44 150.26 36.18 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.061 0.545 . . . . 74.23 109.834 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.2 mt -130.53 126.54 37.05 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.479 0.711 . . . . 74.35 110.49 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.662 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 10.5 m-20 -124.72 141.22 52.26 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.328 1.051 . . . . 64.34 109.499 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.458 ' HB ' HD22 ' E' ' 460' ' ' LEU . 87.5 m -134.8 131.12 37.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.008 0.523 . . . . 73.42 110.366 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.01 152.48 50.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.082 0.953 . . . . 64.34 109.383 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.434 ' HB2' HD12 ' A' ' 98' ' ' LEU . 22.4 t -123.45 153.92 39.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.452 0.701 . . . . 43.54 110.424 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.7 t -149.33 119.62 7.32 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.34 1.056 . . . . 72.33 108.695 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -78.42 106.59 10.46 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.482 -0.562 . . . . 74.14 109.482 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 57' ' ' GLU . 42.3 mt -82.0 -35.81 28.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.595 0.758 . . . . 71.33 110.224 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.48 -174.36 3.43 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.06 -0.973 . . . . 74.04 109.86 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.84 126.12 28.71 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.264 -1.013 . . . . 65.23 108.264 172.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 65.04 14.63 9.49 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.171 0.989 . . . . 74.23 111.4 -177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.406 HG13 ' HB2' ' A' ' 51' ' ' LEU . 57.9 t -128.64 104.88 12.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 N-CA-C 107.8 -1.185 . . . . 73.13 107.8 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.95 126.52 36.27 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.644 -0.707 . . . . 74.22 109.711 -170.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.465 ' HB2' HD12 ' A' ' 51' ' ' LEU . 21.0 tp10 -86.98 128.72 35.07 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 124.438 1.095 . . . . 73.21 109.225 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -128.02 120.32 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.379 -1.341 . . . . 71.43 107.379 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.5 t -110.97 118.51 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.778 0.831 . . . . 74.44 109.146 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.6 tp -100.06 108.11 20.2 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.88 -0.785 . . . . 74.34 108.88 172.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.662 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 27.5 ttp180 -87.18 104.98 16.88 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.543 -0.54 . . . . 75.34 109.543 173.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.1 t -94.39 104.75 16.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.119 -1.067 . . . . 74.31 108.119 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 30.7 m -96.27 135.87 37.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.728 0.811 . . . . 62.3 110.298 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.533 HG22 HG21 ' A' ' 114' ' ' ILE . 74.6 t -128.51 116.79 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.227 1.411 . . . . 75.13 108.544 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -120.95 123.36 42.27 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.209 -1.034 . . . . 74.22 108.209 172.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.84 113.78 21.1 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.839 -1.171 . . . . 71.41 107.839 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.6 t -144.76 143.85 30.88 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.902 0.481 . . . . 73.5 110.173 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -119.33 84.68 2.24 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.013 1.325 . . . . 74.51 108.961 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.14 -119.57 5.22 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.238 -0.892 . . . . 72.12 112.645 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -87.83 -18.98 28.09 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.435 0.694 . . . . 74.45 110.967 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.402 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 1.5 tp10 -94.07 120.27 34.09 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.468 -0.938 . . . . 72.21 108.468 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.3 m -87.35 143.5 27.22 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.114 0.415 . . . . 72.23 110.211 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.71 -66.41 0.89 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.356 -0.609 . . . . 72.12 109.356 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -161.49 174.23 13.71 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.199 -0.91 . . . . 75.42 110.985 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 64' ' ' VAL . 58.2 tp -137.81 137.41 38.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.852 1.261 . . . . 75.52 108.113 175.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.449 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 56.7 m -141.32 130.62 23.61 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.857 -1.164 . . . . 74.3 107.857 175.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -146.7 120.5 9.26 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.603 0.638 . . . . 73.53 109.739 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.84 113.39 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.36 0.664 . . . . 63.4 110.623 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -82.99 87.1 6.89 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.413 -0.958 . . . . 63.32 108.413 166.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.455 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.1 tp-100 -77.19 102.71 6.75 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.304 -0.999 . . . . 65.02 108.304 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.07 143.58 17.1 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.603 -0.599 . . . . 71.34 111.603 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.93 121.89 1.56 Allowed Glycine 0 N--CA 1.451 -0.336 0 N-CA-C 111.041 -0.824 . . . . 72.32 111.041 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.5 mt -82.02 122.26 36.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.107 -1.071 . . . . 74.31 108.107 171.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.582 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.6 m-85 -127.64 119.59 26.24 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.993 0.917 . . . . 74.25 108.962 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.4 m -81.07 91.63 6.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.584 0.754 . . . . 73.21 109.692 169.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.5 tt -96.61 135.64 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 114.555 -1.202 . . . . 74.54 109.232 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -161.05 163.56 31.47 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.091 0.956 . . . . 75.1 110.109 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.42 -33.61 5.71 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 116.259 -0.428 . . . . 73.43 113.879 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.474 ' H ' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.58 155.16 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.928 0.491 . . . . 74.45 111.043 -174.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.96 175.36 13.04 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.73 -1.123 . . . . 74.43 110.169 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.36 -142.49 34.15 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 116.022 -0.535 . . . . 72.24 111.892 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.1 p -70.17 -15.86 63.01 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.338 0.655 . . . . 73.33 111.581 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -75.18 -37.39 61.27 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.738 0.815 . . . . 74.53 111.137 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.618 ' SD ' HD21 ' E' ' 454' ' ' LEU . 0.0 OUTLIER -75.67 -28.64 58.79 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 110.132 -0.321 . . . . 74.21 110.132 173.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.92 -24.97 62.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.09 0.556 . . . . 72.41 110.458 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -68.17 -38.68 82.34 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 122.908 0.483 . . . . 71.22 109.847 171.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.599 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 68.8 m -65.86 -39.56 90.84 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.462 -0.335 . . . . 75.21 110.279 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.491 HD21 HD22 ' E' ' 454' ' ' LEU . 36.0 tp -66.69 -51.44 55.99 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.914 0.886 . . . . 75.23 111.91 -175.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.11 -26.84 10.76 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.558 -0.746 . . . . 70.22 114.075 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.551 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -111.41 -66.22 1.1 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.204 0.502 . . . . 75.21 112.034 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.599 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 72.2 t80 -68.77 -61.11 1.95 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.264 1.026 . . . . 74.04 112.766 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 94.2 m -67.6 -36.68 10.51 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 113.916 1.08 . . . . 71.31 113.916 -174.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.54 -31.34 50.92 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 121.548 1.499 . . . . 73.42 112.506 167.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.21 -28.47 68.77 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.521 0.328 . . . . 74.01 110.633 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.1 mm -62.53 -45.28 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.765 0.826 . . . . 75.3 109.86 171.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.455 HD23 ' HG3' ' A' ' 80' ' ' GLN . 80.0 mt -72.29 -27.0 62.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.977 0.911 . . . . 71.43 112.256 -175.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -57.7 -45.68 99.81 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 114.142 1.164 . . . . 73.03 114.142 -168.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -62.11 -38.81 53.67 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 121.978 1.785 . . . . 75.54 112.915 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -67.13 -39.38 86.59 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.302 0.641 . . . . 71.14 111.075 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.93 -43.49 71.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.31 0.644 . . . . 74.23 110.448 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -52.05 -48.07 64.8 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 124.421 1.075 . . . . 72.33 110.2 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.08 -47.94 75.5 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 124.089 0.868 . . . . 75.04 111.342 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.444 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.5 t -58.25 -27.68 64.21 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.833 0.708 . . . . 60.34 111.22 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.533 HG21 HG22 ' A' ' 64' ' ' VAL . 86.6 mt -77.46 -58.58 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.592 1.157 . . . . 73.22 110.287 174.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.7 m -57.36 -33.72 68.06 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 124.667 1.187 . . . . 74.54 111.344 -173.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -63.67 -49.02 74.81 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.848 0.859 . . . . 74.01 109.977 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.439 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 69.3 mtm -63.56 -34.12 77.1 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.389 0.676 . . . . 74.51 111.459 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.459 HG21 HD21 ' A' ' 126' ' ' LEU . 98.2 t -66.46 -46.0 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.196 0.998 . . . . 75.12 110.461 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.2 m -70.22 -28.67 65.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.442 0.697 . . . . 74.43 111.388 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -73.35 -31.69 64.1 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.428 0.691 . . . . 74.2 109.782 174.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.06 2.78 86.31 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.88 0.738 . . . . 75.0 112.735 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.5 m 68.5 16.73 9.13 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.918 1.287 . . . . 73.35 111.552 173.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.404 ' HE1' HG23 ' A' ' 31' ' ' VAL . 96.9 m-85 -78.85 156.29 77.44 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 109.011 -0.737 . . . . 74.03 109.011 171.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.73 163.8 17.75 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.486 2.124 . . . . 75.45 112.531 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -60.36 121.61 12.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.062 0.945 . . . . 75.52 110.998 -172.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.498 HD23 HG12 ' A' ' 64' ' ' VAL . 53.0 tp -106.16 93.92 4.88 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.743 -0.836 . . . . 73.35 108.743 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.423 HD22 ' N ' ' C' ' 16' ' ' ILE . 71.4 m-20 -107.1 85.27 2.11 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.889 -1.152 . . . . 73.15 107.889 173.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.434 ' HB2' HD22 ' A' ' 42' ' ' LEU . 4.0 pp -60.11 137.52 58.08 Favored 'General case' 0 C--O 1.251 1.178 0 CA-C-N 114.447 -1.251 . . . . 74.12 109.246 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.63 143.91 85.79 Favored Pre-proline 0 C--O 1.243 0.758 0 C-N-CA 123.162 0.585 . . . . 72.1 110.948 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.05 161.61 45.46 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 121.702 1.601 . . . . 75.33 110.214 170.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.86 130.22 18.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.675 -0.861 . . . . 73.04 108.675 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.468 ' HB2' ' HG3' ' C' ' 147' ' ' GLU . 37.4 t-20 -75.07 92.03 2.6 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.888 -0.596 . . . . 74.2 110.071 -174.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.551 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 83.9 m-85 -58.09 -35.51 71.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.86 0.864 . . . . 73.11 111.91 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.46 -50.73 72.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.531 0.733 . . . . 72.01 110.302 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.47 94.43 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.135 0.897 . . . . 72.22 111.434 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.72 -41.91 91.7 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.859 -0.61 . . . . 71.12 111.15 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -68.37 -32.26 72.22 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.029 -0.532 . . . . 54.43 109.578 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 15.9 mmt -59.55 -41.78 90.87 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.667 0.605 . . . . 71.31 110.835 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -56.34 -38.67 71.67 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 123.667 0.605 . . . . 73.11 111.134 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -75.38 -40.1 58.41 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.73 0.812 . . . . 73.43 111.036 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.8 tp -70.05 -51.28 33.35 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.491 1.116 . . . . 74.52 112.805 -168.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -168.83 2.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.873 -0.603 . . . . 74.34 111.616 -169.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 59.51 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.696 1.598 . . . . 75.53 111.806 -168.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -152.9 179.07 9.0 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.135 0.974 . . . . 75.2 108.42 -176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 67.61 11.72 8.51 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.505 1.122 . . . . 74.03 113.114 170.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.37 -10.17 86.22 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 112.652 -0.179 . . . . 61.24 112.652 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.31 114.64 6.94 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.845 0.858 . . . . 74.44 108.722 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -148.02 38.34 1.05 Allowed Glycine 0 C--N 1.343 0.933 0 N-CA-C 112.107 -0.397 . . . . 65.21 112.107 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.6 m -84.64 87.43 7.28 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.794 -0.817 . . . . 74.2 108.794 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -80.27 93.8 5.97 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.432 -0.804 . . . . 75.41 109.56 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.46 -22.21 65.5 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.008 0.923 . . . . 74.43 110.532 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -64.77 99.54 0.34 Allowed 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.87 0.868 . . . . 72.33 110.053 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -122.71 18.84 10.31 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.374 1.07 . . . . 62.35 110.153 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -143.67 124.15 13.97 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.062 0.545 . . . . 72.44 109.998 -174.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 N-CA-C 108.228 -1.027 . . . . 75.12 108.228 174.29 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.7 mtm . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 108.788 -0.819 . . . . 64.45 108.788 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 23.3 p -157.31 76.26 0.83 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.702 0.801 . . . . 73.31 108.849 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.579 ' HA ' ' HB2' ' B' ' 87' ' ' ALA . 4.5 mp0 -84.4 78.07 9.88 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.982 -1.008 . . . . 72.01 110.154 -176.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.643 HE22 ' HB3' ' B' ' 6' ' ' ASN . 0.2 OUTLIER -93.33 103.14 15.39 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.65 -1.241 . . . . 75.13 107.65 177.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . 0.481 ' HA ' ' HA2' ' B' ' 88' ' ' GLY . 3.6 p-10 -67.48 -30.54 70.27 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 113.687 0.995 . . . . 75.42 113.687 -166.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.643 ' HB3' HE22 ' B' ' 4' ' ' GLN . 46.3 t-20 -65.25 152.33 43.97 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.163 0.585 . . . . 71.14 109.471 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 43.4 m -60.25 80.68 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.481 1.112 . . . . 74.42 111.93 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -147.15 -41.22 0.18 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.796 1.638 . . . . 74.45 106.807 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.515 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 23.2 ptm 54.92 170.5 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 127.342 2.257 . . . . 75.34 114.583 172.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.5 m -159.13 133.48 7.8 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.169 -0.923 . . . . 65.33 108.63 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.93 156.71 48.35 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.533 -0.543 . . . . 74.32 109.533 157.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -124.24 137.52 54.5 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 107.442 -1.318 . . . . 74.44 107.442 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.495 HD11 HD12 ' B' ' 105' ' ' ILE . 27.4 mt -78.92 117.45 24.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 107.708 -1.219 . . . . 75.43 107.708 176.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -78.23 -42.47 31.13 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.874 -0.787 . . . . 75.45 108.874 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -164.9 135.71 4.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.022 -0.99 . . . . 74.1 110.155 -170.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 85.5 mt -114.46 139.15 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 106.619 -1.623 . . . . 71.54 106.619 167.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.424 ' HE2' ' HZ3' ' B' ' 19' ' ' LYS . 41.9 p90 -166.98 150.65 6.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.241 0.543 . . . . 75.03 111.524 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 75.9 m -78.24 128.98 34.53 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.935 -1.029 . . . . 72.24 109.084 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.424 ' HZ3' ' HE2' ' B' ' 17' ' ' TYR . 20.9 mttp -91.4 -46.24 8.12 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.661 0.784 . . . . 71.12 110.616 173.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 22.5 t70 -144.41 133.25 22.49 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.217 -0.447 . . . . 63.2 110.687 -165.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.419 HG22 ' HE2' ' B' ' 117' ' ' MET . 47.8 mm -130.82 142.15 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.157 0.983 . . . . 74.12 109.114 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 81.5 p -139.2 144.45 38.52 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.376 -0.972 . . . . 72.33 108.376 170.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.1 t80 -145.81 134.13 21.81 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.971 -1.492 . . . . 73.44 106.971 163.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 36.7 mt-10 -136.89 127.24 26.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.518 -0.919 . . . . 72.3 108.518 -175.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.432 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -124.55 84.94 56.75 Favored Pre-proline 0 C--O 1.24 0.571 0 N-CA-C 107.69 -1.226 . . . . 72.22 107.69 171.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.71 -32.93 46.13 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.701 2.268 . . . . 60.32 111.394 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -104.45 10.71 35.12 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 117.873 -1.06 . . . . 74.41 110.793 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.529 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -29.64 -68.7 0.11 Allowed Pre-proline 0 N--CA 1.5 2.06 0 C-N-CA 125.355 1.462 . . . . 73.21 114.869 -170.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 11.6 Cg_exo -67.49 -21.21 46.83 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 122.199 1.933 . . . . 73.23 113.042 -171.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -96.81 -32.68 11.99 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.296 1.039 . . . . 75.2 112.434 -172.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' B' ' 73' ' ' ALA . 9.8 p -82.69 -19.7 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 122.683 0.393 . . . . 72.31 111.327 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . 0.401 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . 11.5 m-30 -62.43 -25.41 67.95 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 113.976 1.102 . . . . 74.51 113.976 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -56.56 -25.62 52.83 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.081 0.552 . . . . 75.31 111.198 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.492 ' HB2' HD11 ' B' ' 68' ' ' LEU . 87.5 mttt -88.45 92.94 9.37 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.268 1.027 . . . . 74.14 109.435 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.24 91.25 6.17 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.099 -0.704 . . . . 73.43 109.099 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -163.32 156.82 19.4 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.837 0.855 . . . . 74.13 109.497 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.578 ' HB2' HD23 ' F' ' 470' ' ' LEU . 38.4 mt-30 -76.45 104.65 1.7 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.026 0.93 . . . . 74.54 108.649 171.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.609 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.2 Cg_endo -63.44 153.07 76.96 Favored 'Trans proline' 0 C--N 1.366 1.46 0 C-N-CA 123.137 2.558 . . . . 73.25 113.238 -176.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.8 118.6 7.38 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 123.778 0.674 . . . . 74.3 109.37 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.522 HG23 HD11 ' F' ' 468' ' ' LEU . 29.9 m -87.46 161.06 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 114.977 -1.011 . . . . 65.02 111.569 -176.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -149.26 107.77 3.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.521 -1.659 . . . . 75.14 106.521 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 mp -100.27 148.69 24.37 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.164 0.585 . . . . 74.54 110.313 -171.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -131.74 113.44 13.54 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.708 -1.219 . . . . 71.14 107.708 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.2 127.25 45.14 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 106.02 -1.844 . . . . 74.03 106.02 176.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.59 ' HA ' ' HG ' ' F' ' 460' ' ' LEU . 24.8 t70 -144.99 148.64 33.99 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.797 0.839 . . . . 72.11 109.364 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 37.0 p -134.91 118.55 17.04 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.23 0.612 . . . . 74.03 109.995 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.48 153.31 31.36 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.766 1.226 . . . . 74.35 108.325 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 77.6 p -143.75 166.14 25.71 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.183 0.447 . . . . 73.34 111.34 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.0 p -152.33 149.97 29.22 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.25 1.02 . . . . 73.34 109.22 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -93.8 124.6 37.91 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.546 -0.539 . . . . 70.12 109.546 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.29 -52.42 5.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.128 -0.693 . . . . 73.31 109.128 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.41 -175.59 4.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.206 1.003 . . . . 62.2 109.646 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.46 116.33 8.09 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.577 -0.738 . . . . 75.42 109.218 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 83.0 m-20 74.08 -3.37 2.54 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.27 1.428 . . . . 74.4 112.887 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 48.4 t -106.04 110.41 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.521 -0.918 . . . . 72.12 108.521 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.496 ' HE2' ' HB ' ' B' ' 86' ' ' ILE . 1.3 p90 -119.97 173.34 7.13 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.88 0.872 . . . . 75.33 109.65 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -143.08 110.97 5.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.047 -1.094 . . . . 73.34 108.047 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 55.8 t -91.52 145.28 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.184 0.994 . . . . 74.22 109.817 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 39.5 t -129.33 115.13 34.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.263 -1.014 . . . . 75.05 108.263 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.51 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.4 OUTLIER -97.09 110.71 23.2 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.623 -0.88 . . . . 74.31 108.623 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -95.18 118.67 32.37 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.661 0.785 . . . . 73.34 110.746 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.479 ' HB ' HD11 ' B' ' 114' ' ' ILE . 26.3 t -116.54 103.19 14.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.53 -1.285 . . . . 74.21 107.53 168.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.546 HG22 ' HB2' ' B' ' 77' ' ' GLU . 2.8 m -99.6 131.3 45.69 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.222 -0.659 . . . . 73.12 109.222 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -125.21 116.99 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.342 0.657 . . . . 64.52 109.944 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.6 m -99.53 142.98 30.3 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.762 0.825 . . . . 60.23 108.957 167.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' B' ' 38' ' ' PRO . . . -149.22 147.04 27.93 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.033 0.533 . . . . 70.32 110.36 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.414 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 23.8 p -146.93 130.6 16.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.702 0.401 . . . . 73.44 111.93 -174.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.609 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 25.2 mt -95.84 118.85 33.27 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.679 1.191 . . . . 74.34 109.772 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.73 -108.8 2.6 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 123.742 0.651 . . . . 72.5 112.307 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -118.63 1.59 11.66 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.211 1.004 . . . . 74.24 110.384 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.45 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.4 pt-20 -122.51 155.2 36.69 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.993 0.517 . . . . 74.55 109.936 -175.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.1 m -63.37 134.98 56.66 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.82 0.7 . . . . 72.33 110.842 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.414 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -92.4 -64.84 1.06 Allowed 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.492 -1.299 . . . . 74.11 107.492 174.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -148.75 157.92 43.79 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.203 -0.908 . . . . 73.43 111.012 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.642 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 69.3 mt -130.18 143.57 50.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.589 -1.634 . . . . 64.23 106.589 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 41.9 t -155.28 156.67 35.96 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.644 -0.502 . . . . 75.53 109.644 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.546 ' HB2' HG22 ' B' ' 63' ' ' THR . 34.7 tt0 -160.27 136.17 8.46 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.123 -1.065 . . . . 74.4 108.123 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.416 HG21 HD12 ' B' ' 21' ' ' ILE . 93.4 t -124.06 141.53 43.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.622 -0.881 . . . . 74.05 108.622 172.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -120.57 89.6 3.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.581 -0.896 . . . . 73.52 108.581 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.6 tp-100 -83.3 99.09 9.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.678 -1.146 . . . . 73.02 108.821 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.84 169.95 35.9 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 116.19 -0.459 . . . . 53.51 111.968 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.36 129.86 1.97 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.68 -0.568 . . . . 61.12 111.68 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.3 mt -85.21 129.35 37.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.597 0.759 . . . . 73.53 109.227 172.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -131.92 139.76 48.82 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.947 -1.131 . . . . 74.23 107.947 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.3 m -112.71 97.87 6.85 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.867 -0.79 . . . . 73.45 108.867 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.499 HG23 HG12 ' F' ' 452' ' ' VAL . 17.4 tt -96.54 147.02 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.697 0.799 . . . . 75.42 111.097 -166.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' B' ' 3' ' ' GLU . . . -148.97 141.34 24.17 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.326 0.65 . . . . 65.33 110.396 -174.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' B' ' 5' ' ' ASN . . . 99.57 -63.2 0.69 Allowed Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.617 -0.719 . . . . 64.13 114.488 169.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' B' ' 9' ' ' MET . 17.2 tt -66.49 163.68 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.369 0 C-N-CA 124.042 0.937 . . . . 74.25 111.126 -173.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -158.91 175.47 13.53 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.085 0.402 . . . . 74.34 110.689 -172.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' B' ' 94' ' ' MET . . . 66.91 -132.2 31.26 Favored Glycine 0 C--N 1.355 1.59 0 C-N-CA 123.656 0.646 . . . . 61.14 114.446 169.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 46.3 m -75.9 -27.41 57.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.666 0.787 . . . . 72.42 110.947 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.468 ' HB3' HD11 ' B' ' 89' ' ' ILE . 52.1 mt-30 -68.63 -33.66 74.4 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.853 -0.612 . . . . 73.44 111.437 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.498 ' SD ' ' HA ' ' F' ' 452' ' ' VAL . 0.0 OUTLIER -71.26 -24.66 62.21 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.378 0.271 . . . . 63.14 110.734 176.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.52 78.28 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.114 0.566 . . . . 74.22 110.834 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -63.1 -29.95 71.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.3 -0.863 . . . . 75.44 110.976 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.465 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 49.2 t -74.67 -62.11 1.65 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.411 -0.359 . . . . 60.55 110.771 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.512 HD11 ' N ' ' B' ' 99' ' ' GLY . 3.0 pp -63.49 -32.79 74.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.126 0.788 . . . . 75.35 113.126 -173.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . 0.512 ' N ' HD11 ' B' ' 98' ' ' LEU . . . -92.25 -36.36 6.3 Favored Glycine 0 C--N 1.345 1.056 0 O-C-N 123.482 0.488 . . . . 62.44 113.273 -172.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.0 -53.76 2.15 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.615 0.598 . . . . 73.1 112.615 -167.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.465 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 51.7 t80 -72.03 -45.05 62.31 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.862 0.865 . . . . 75.1 111.617 -168.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.463 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 70.8 m -66.11 -49.68 54.86 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 123.6 0.76 . . . . 64.41 111.253 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.51 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 80.4 Cg_exo -53.63 -36.42 81.04 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 122.479 2.12 . . . . 74.23 114.203 168.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -57.44 -38.85 75.1 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 123.399 0.679 . . . . 73.21 110.709 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.495 HD12 HD11 ' B' ' 13' ' ' ILE . 80.5 mt -64.99 -43.4 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.117 0.967 . . . . 75.42 110.633 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 52.5 mt -83.23 -15.17 51.42 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.978 0.911 . . . . 75.22 112.043 -172.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -61.28 -49.32 88.46 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.023 -0.989 . . . . 72.31 113.558 -170.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.01 -31.01 83.85 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 121.729 1.619 . . . . 74.24 112.97 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.54 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 86.7 m-85 -67.92 -50.02 58.5 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.889 0.476 . . . . 71.11 110.207 176.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.41 -40.51 78.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.831 0.852 . . . . 74.3 110.582 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.739 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 30.8 ttt180 -58.08 -56.67 19.05 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.39 1.476 . . . . 75.3 111.065 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.54 -34.81 78.61 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.937 0.773 . . . . 73.45 110.51 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.46 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.7 t -69.88 -40.32 75.75 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.209 0.603 . . . . 72.44 111.417 -176.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.479 HD11 ' HB ' ' B' ' 62' ' ' VAL . 70.5 mt -62.22 -53.54 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 109.563 -0.532 . . . . 74.22 109.563 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.417 HG22 ' OG ' ' C' ' 119' ' ' SER . 12.0 m -60.07 -30.08 68.99 Favored 'General case' 0 CA--C 1.554 1.124 0 O-C-N 124.539 1.149 . . . . 72.11 111.403 -175.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.7 t -64.66 -54.09 37.18 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.555 0.742 . . . . 72.41 110.022 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.4 mmt -67.26 -34.59 77.75 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.411 0.684 . . . . 75.32 111.991 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.96 -38.31 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.134 0.974 . . . . 73.31 110.463 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.42 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 11.8 t -78.07 -20.64 51.92 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.886 -0.597 . . . . 74.1 111.139 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.444 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 92.7 mtt-85 -69.24 -33.79 73.81 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.422 -0.584 . . . . 74.54 109.422 171.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.29 11.3 58.63 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.595 0.559 . . . . 71.52 112.698 168.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.458 HG23 ' HB3' ' A' ' 17' ' ' TYR . 33.7 p 58.98 31.44 21.36 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.637 1.975 . . . . 62.3 114.18 170.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -84.81 157.93 59.89 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.133 0.573 . . . . 75.54 110.133 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.38 -175.29 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.994 2.463 . . . . 75.42 113.349 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -61.7 114.41 3.28 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.3 -0.864 . . . . 73.3 112.149 -170.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 35.9 tp -110.23 84.76 1.98 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.331 -0.989 . . . . 71.44 108.331 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.23 93.79 8.43 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.284 -0.636 . . . . 71.31 109.284 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.739 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 22.7 tp -57.68 127.77 33.69 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.737 0.815 . . . . 74.11 111.421 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.57 153.77 94.79 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 124.509 1.124 . . . . 74.32 111.813 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.19 100.56 0.46 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.836 2.357 . . . . 71.53 112.162 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.92 108.93 20.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.073 -1.084 . . . . 62.3 108.073 172.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.429 ' ND2' ' HB1' ' B' ' 135' ' ' ALA . 60.9 t30 -94.08 95.21 8.86 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 107.686 -1.227 . . . . 71.41 107.686 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.78 -42.74 89.69 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 124.081 0.863 . . . . 65.41 109.501 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.36 -39.09 69.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.191 1.397 . . . . 73.54 112.843 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.429 ' HB1' ' ND2' ' B' ' 132' ' ' ASN . . . -63.92 -50.33 69.13 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.717 0.807 . . . . 73.14 111.304 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 82.6 mt -79.11 -28.91 43.01 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.254 -0.885 . . . . 65.41 111.305 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.51 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 78.5 t80 -69.88 -35.66 74.83 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.756 0.822 . . . . 74.42 109.947 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 14.4 tmm? -59.23 -34.11 71.81 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.073 0.949 . . . . 64.51 110.742 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -75.42 -35.58 60.96 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.612 0.765 . . . . 73.32 110.931 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . 0.6 ' HH ' ' HB3' ' F' ' 459' ' ' ASP . 64.1 t80 -60.48 -29.41 69.04 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.594 1.158 . . . . 75.53 111.932 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 22.9 mt -85.16 -9.29 58.01 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.859 0.464 . . . . 75.31 111.781 -174.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -124.04 103.86 8.55 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.79 0.836 . . . . 75.14 108.94 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -83.83 58.37 4.62 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.142 0.973 . . . . 73.41 110.09 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -154.7 165.35 36.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.099 -0.955 . . . . 71.45 109.818 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.56 121.52 35.01 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.539 0.735 . . . . 73.24 110.432 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.65 173.7 53.93 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 123.393 0.433 . . . . 62.45 112.996 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -89.67 122.8 33.12 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.516 0.726 . . . . 75.12 110.55 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.27 111.33 0.52 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.887 -0.885 . . . . 64.33 110.887 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 12.1 t -113.86 -179.0 3.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.528 0.731 . . . . 74.1 110.632 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -111.3 124.1 51.55 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.101 -1.074 . . . . 62.23 108.101 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -74.78 146.51 42.05 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.513 -0.551 . . . . 73.5 109.513 174.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -65.6 87.99 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.124 0.97 . . . . 74.13 109.074 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -73.69 96.04 2.44 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.681 0.792 . . . . 74.11 109.852 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -117.46 144.51 44.96 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.744 0.817 . . . . 75.23 109.454 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.855 0 C-N-CA 123.909 0.884 . . . . 62.03 108.869 178.415 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.428 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 109.402 -0.592 . . . . 74.13 109.402 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 43.0 t -148.59 129.04 13.92 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.739 0.816 . . . . 62.21 108.989 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -149.34 146.44 27.52 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.062 0.545 . . . . 73.34 109.707 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -138.23 144.8 40.77 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.502 1.121 . . . . 74.22 108.344 175.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -88.89 -57.99 2.71 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.796 -0.446 . . . . 64.35 109.796 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -166.91 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.096 0.558 . . . . 73.12 110.54 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 28.7 m -73.91 84.13 1.71 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.304 0.642 . . . . 72.34 110.19 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -78.79 -59.91 2.59 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.743 -0.662 . . . . 74.51 109.289 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.498 ' SD ' ' HA ' ' C' ' 147' ' ' GLU . 53.7 ttm 61.44 116.02 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.729 1.611 . . . . 72.4 112.602 -178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m -127.43 97.06 4.75 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.336 -1.727 . . . . 71.13 106.336 172.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.472 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 9.0 t80 -124.64 117.48 24.37 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.013 0.525 . . . . 74.43 110.893 -175.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.47 ' HB2' ' HG3' ' C' ' 153' ' ' GLN . 49.5 tp60 -137.27 133.2 34.76 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.21 -1.404 . . . . 74.31 107.21 173.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.507 HD12 HG21 ' C' ' 105' ' ' ILE . 45.5 mt -74.36 118.57 20.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.567 -0.901 . . . . 73.34 108.567 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.528 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 1.4 mt-30 -77.09 -40.92 44.26 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.131 0.894 . . . . 73.3 109.892 -176.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -170.56 147.65 2.94 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 116.045 -0.525 . . . . 74.21 110.077 -173.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.423 ' N ' HD22 ' A' ' 127' ' ' ASN . 96.6 mt -135.46 137.4 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.791 -1.188 . . . . 72.44 107.791 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.412 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 29.8 p90 -176.01 173.78 2.2 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.903 0.752 . . . . 75.35 111.228 -171.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -100.03 123.82 44.71 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.615 0.766 . . . . 64.4 109.594 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.412 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.0 mmtp -70.67 -48.94 52.28 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.821 -1.177 . . . . 75.44 107.821 168.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -135.37 143.12 45.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 113.863 -1.517 . . . . 72.24 110.283 -172.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.0 mt -137.89 146.97 26.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 126.077 1.751 . . . . 74.11 106.359 174.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -162.21 149.95 14.31 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.423 0.63 . . . . 71.43 110.405 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.476 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 93.7 t80 -140.35 139.19 35.32 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.661 -1.237 . . . . 75.33 107.661 171.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -136.23 128.83 30.61 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.509 0.724 . . . . 72.44 110.061 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.92 82.65 11.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 106.838 -1.541 . . . . 71.42 106.838 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.85 -26.1 38.53 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.974 2.449 . . . . 65.14 112.268 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -112.28 27.23 9.83 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 114.822 -1.081 . . . . 75.21 109.641 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.414 ' HA ' HG13 ' C' ' 31' ' ' VAL . . . -50.19 -58.62 9.08 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 114.449 1.277 . . . . 71.43 114.449 -170.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.57 -31.49 79.82 Favored 'Trans proline' 0 C--N 1.388 2.624 0 CA-C-N 121.891 1.711 . . . . 74.31 112.092 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -69.75 -43.06 73.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.354 1.062 . . . . 73.43 112.031 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.644 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.7 p -77.81 -24.87 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 123.04 0.536 . . . . 64.21 111.644 -173.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.0 -29.11 70.29 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.354 0.262 . . . . 72.21 111.664 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -104.78 36.18 2.52 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.202 0.601 . . . . 74.33 110.615 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.472 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 2.9 tppp? -111.07 169.46 8.76 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.235 1.014 . . . . 71.23 109.969 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -68.42 130.57 43.28 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.03 0.532 . . . . 63.23 110.147 173.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -73.99 93.37 2.22 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.324 1.049 . . . . 75.24 109.224 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -150.24 59.25 3.54 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.302 0.641 . . . . 71.42 109.712 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.4 110.28 3.03 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.643 2.229 . . . . 74.12 111.768 -175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -86.52 108.51 18.58 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.522 -0.918 . . . . 71.24 108.522 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.53 142.33 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.308 1.043 . . . . 71.12 111.257 -171.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -130.57 119.45 22.55 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.875 -1.528 . . . . 74.21 106.875 174.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 30.1 tp -101.38 124.79 47.63 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 109.635 -0.506 . . . . 74.14 109.635 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.469 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.7 t70 -117.24 112.2 20.47 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.258 -1.016 . . . . 74.42 108.258 -176.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.434 HD11 ' HE1' ' C' ' 133' ' ' PHE . 79.9 mt -110.86 111.1 22.01 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.963 -0.754 . . . . 73.32 108.963 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 12.8 t70 -122.63 139.78 53.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.34 1.056 . . . . 75.12 108.674 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 m -126.8 126.37 43.28 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.511 0.672 . . . . 34.24 110.258 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.76 154.91 25.46 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.108 -1.406 . . . . 63.25 107.975 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.528 ' HB2' ' HE1' ' C' ' 56' ' ' TYR . 13.4 p -149.5 142.71 25.07 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.87 0.468 . . . . 72.32 109.871 -177.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.7 t -149.74 146.65 27.32 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.896 0.878 . . . . 75.31 110.162 -171.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -82.95 133.82 35.09 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.486 -0.561 . . . . 74.31 109.486 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.58 HD12 ' HB2' ' C' ' 57' ' ' GLU . 43.7 mt -106.53 -41.29 5.31 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.052 -0.722 . . . . 71.4 109.052 173.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.01 -175.65 5.54 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.731 -1.122 . . . . 73.51 109.963 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -67.22 119.08 11.52 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 114.973 -1.012 . . . . 64.44 109.679 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 65.34 8.21 4.79 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.017 1.327 . . . . 75.23 112.584 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -113.18 96.96 5.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 107.657 -1.238 . . . . 72.02 107.657 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.528 ' HE1' ' HB2' ' C' ' 48' ' ' SER . 1.6 t80 -114.87 129.51 56.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.652 -0.704 . . . . 71.05 109.597 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.58 ' HB2' HD12 ' C' ' 51' ' ' LEU . 33.7 tt0 -88.77 135.02 33.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.983 -1.008 . . . . 62.53 110.218 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.85 141.59 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.704 -1.221 . . . . 70.11 107.704 166.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -128.66 123.43 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.614 -1.254 . . . . 74.44 107.614 173.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.97 102.83 12.23 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.424 -1.325 . . . . 64.44 107.424 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.4 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 33.8 ttm-85 -85.86 122.85 30.51 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.947 -1.478 . . . . 75.2 108.443 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.6 t -117.73 126.04 74.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 107.735 -1.209 . . . . 73.43 107.735 169.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 13.0 m -126.75 115.88 20.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.61 -0.885 . . . . 72.5 108.61 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.488 HG12 HD13 ' C' ' 126' ' ' LEU . 65.2 t -102.67 120.57 52.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 109.012 -0.736 . . . . 72.24 109.012 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 16.3 m -103.52 142.83 33.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.382 -0.97 . . . . 75.33 108.382 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.44 118.25 13.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.545 -1.28 . . . . 73.35 107.545 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -132.29 134.01 44.75 Favored 'General case' 0 C--O 1.224 -0.262 0 O-C-N 123.855 0.722 . . . . 72.3 109.575 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.434 HD11 HG22 ' C' ' 31' ' ' VAL . 12.1 mt -86.2 28.01 0.87 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.809 1.243 . . . . 75.14 111.081 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.7 -104.84 1.53 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 110.453 -1.059 . . . . 32.34 110.453 -169.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -90.57 -30.89 16.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.908 0.883 . . . . 70.32 110.587 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.472 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 4.5 tp10 -75.45 124.3 26.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.284 1.034 . . . . 72.33 110.206 172.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 18.0 m -80.68 125.61 30.25 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.789 -0.819 . . . . 74.52 108.789 167.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.644 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.82 -61.22 2.07 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.374 -0.602 . . . . 63.02 109.374 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -151.34 156.83 41.57 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.475 0.655 . . . . 75.14 111.237 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.423 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -127.79 142.2 51.37 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 106.75 -1.574 . . . . 73.03 106.75 172.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.423 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.4 t -148.07 141.07 24.87 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.597 -0.89 . . . . 74.31 108.597 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -147.35 133.72 19.62 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.123 -0.695 . . . . 74.41 109.123 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' C' ' 110' ' ' ALA . 59.8 t -135.97 113.75 14.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.569 1.147 . . . . 74.34 108.145 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -95.5 89.11 5.28 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.769 -0.826 . . . . 72.12 108.769 174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -79.78 98.77 7.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.268 -0.878 . . . . 64.11 110.144 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.65 144.82 17.99 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-O 121.177 0.321 . . . . 52.53 112.45 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.488 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -146.2 128.17 2.98 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.346 -1.102 . . . . 73.52 110.346 -176.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 11.0 mm -88.32 122.68 40.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.36 -0.978 . . . . 71.45 108.36 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.472 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 62.0 m-85 -127.24 119.51 26.54 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.108 -0.701 . . . . 72.41 109.108 -175.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 31.2 p -82.96 109.64 17.25 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.797 -0.816 . . . . 73.45 108.797 176.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.564 HD11 HD23 ' C' ' 98' ' ' LEU . 32.9 pt -116.12 102.53 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-O 122.151 0.976 . . . . 74.45 110.276 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.16 158.65 30.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.106 0.962 . . . . 74.13 108.9 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.11 -18.67 34.96 Favored Glycine 0 C--N 1.344 0.986 0 N-CA-C 114.06 0.384 . . . . 72.52 114.06 173.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.19 158.74 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.381 1.072 . . . . 74.13 110.608 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -161.25 -177.26 5.91 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.119 0.567 . . . . 72.3 110.94 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.45 -116.19 8.83 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-N 115.308 -0.86 . . . . 73.02 113.78 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.6 p -70.23 -34.49 72.94 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.096 0.959 . . . . 74.44 111.24 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -70.25 -38.72 75.22 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.68 -0.691 . . . . 72.2 111.207 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.554 ' HE3' ' HA ' ' G' ' 452' ' ' VAL . 22.0 ptm -78.97 -25.55 43.44 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 119.588 -0.244 . . . . 72.54 110.697 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.47 85.53 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.646 -0.502 . . . . 63.23 109.646 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -75.73 -34.66 60.34 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.394 0.434 . . . . 73.33 111.673 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 40.3 t -59.0 -35.89 74.0 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.654 0.596 . . . . 73.54 110.661 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.564 HD23 HD11 ' C' ' 86' ' ' ILE . 51.3 mt -100.49 -16.3 17.59 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.273 0.629 . . . . 74.52 111.308 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.79 -30.5 57.72 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 114.491 0.556 . . . . 74.22 114.491 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.18 -39.09 0.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.861 0.464 . . . . 52.21 110.866 -168.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.467 ' HH ' ' HD1' ' C' ' 11' ' ' PHE . 59.6 t80 -66.07 -48.95 69.3 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.143 1.777 . . . . 73.13 112.718 -175.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 51.0 m -73.12 -45.65 8.17 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 118.57 -0.728 . . . . 74.12 112.133 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -53.37 -30.78 54.24 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 122.602 2.201 . . . . 65.35 113.528 170.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -64.82 -40.69 95.61 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.862 0.865 . . . . 70.51 110.364 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.507 HG21 HD12 ' C' ' 13' ' ' ILE . 47.9 mm -60.71 -44.15 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.056 0.542 . . . . 74.53 109.795 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.488 HD21 ' HA3' ' C' ' 82' ' ' GLY . 88.0 mt -80.08 -26.81 39.46 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.907 -1.042 . . . . 75.43 112.764 -170.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -57.36 -48.55 97.12 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 117.575 -1.203 . . . . 72.13 113.534 -172.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.74 -37.96 94.92 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.356 2.037 . . . . 74.42 113.732 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -68.27 -44.68 75.03 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.844 0.458 . . . . 72.32 110.587 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -64.64 -38.3 90.53 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.803 -0.635 . . . . 71.34 110.78 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -57.16 -48.58 78.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.477 1.511 . . . . 74.21 110.834 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.35 -34.59 68.13 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.398 0.679 . . . . 73.31 110.69 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.5 t -69.11 -30.71 69.05 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.031 0.532 . . . . 64.4 111.287 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.548 HD11 ' HB ' ' C' ' 62' ' ' VAL . 97.7 mt -68.47 -51.36 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.439 0.696 . . . . 74.51 109.541 173.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.406 HG21 ' OG ' ' B' ' 119' ' ' SER . 10.5 m -60.25 -31.95 70.69 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.166 0.916 . . . . 71.43 111.104 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.9 t -64.51 -54.78 27.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.722 0.809 . . . . 61.21 109.465 174.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.599 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.56 -42.52 83.19 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.741 1.216 . . . . 73.13 112.84 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -66.27 -41.74 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.105 0.962 . . . . 74.12 110.422 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.417 ' OG ' HG22 ' B' ' 115' ' ' THR . 32.7 t -70.64 -26.51 63.5 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.954 -0.567 . . . . 74.15 111.011 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.5 mtt-85 -70.93 -40.45 72.07 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.211 0.605 . . . . 75.25 109.439 175.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.57 1.26 88.22 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.87 0.731 . . . . 64.01 112.934 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.433 HG21 ' HB3' ' D' ' 17' ' ' TYR . 16.5 p 66.1 24.83 10.89 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.479 1.912 . . . . 75.5 113.931 170.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -85.27 163.76 43.83 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.018 0.927 . . . . 74.01 110.056 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -54.67 124.18 15.54 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.979 2.453 . . . . 75.22 112.721 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.42 ' NE2' ' HB2' ' B' ' 119' ' ' SER . 47.1 mt-30 -60.49 137.89 58.09 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.074 0.549 . . . . 74.52 110.855 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.488 HD13 HG12 ' C' ' 64' ' ' VAL . 2.5 pt? -130.22 127.52 39.8 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.895 -0.593 . . . . 74.54 110.049 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -110.1 110.24 21.05 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.267 -1.012 . . . . 75.54 108.267 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.31 134.53 56.62 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 124.134 0.896 . . . . 71.44 110.99 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.81 147.07 94.05 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 123.857 0.723 . . . . 73.42 111.499 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.428 ' HG3' HD13 ' A' ' 16' ' ' ILE . 9.7 Cg_exo -69.4 109.7 2.3 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.601 2.201 . . . . 72.41 111.905 176.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.473 HG11 ' SD ' ' G' ' 464' ' ' MET . 26.3 m -106.07 138.95 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.756 -0.831 . . . . 74.02 108.756 170.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -75.85 88.34 2.86 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.91 0.484 . . . . 75.12 110.204 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.434 ' HE1' HD11 ' C' ' 44' ' ' LEU . 98.5 m-85 -62.05 -48.32 80.76 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.664 -0.698 . . . . 75.31 110.429 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.12 -44.64 68.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.667 -1.151 . . . . 71.14 112.455 -170.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.65 87.85 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.242 0.964 . . . . 75.01 111.307 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 -50.4 70.92 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 124.439 1.087 . . . . 73.35 109.852 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -72.92 -24.58 60.84 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.834 -0.621 . . . . 75.54 110.282 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 26.6 ttt -75.35 -43.26 51.43 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.317 0.647 . . . . 74.22 111.124 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -69.15 -36.93 77.95 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.603 -0.517 . . . . 73.13 109.603 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -64.91 -84.58 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.78 1.232 . . . . 74.23 110.917 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -99.17 102.05 13.59 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.091 0.956 . . . . 75.32 108.933 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 66.0 108.87 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.594 1.558 . . . . 75.32 112.88 175.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -75.12 79.74 2.27 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.709 0.804 . . . . 73.35 109.049 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -163.1 141.61 8.27 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.513 0.725 . . . . 73.42 110.672 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.35 175.05 11.78 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.641 1.176 . . . . 73.5 108.719 172.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.19 99.97 1.08 Allowed Glycine 0 C--N 1.343 0.918 0 N-CA-C 112.001 -0.44 . . . . 72.14 112.001 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . 0.498 ' HA ' ' SD ' ' C' ' 9' ' ' MET . 7.0 pt-20 -72.0 144.53 48.8 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.76 0.824 . . . . 71.33 111.464 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -102.92 42.03 1.99 Allowed Glycine 0 C--N 1.348 1.228 0 CA-C-N 115.753 -0.658 . . . . 65.03 112.589 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 40.3 p -75.8 131.78 39.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.227 0.611 . . . . 73.04 109.942 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -135.38 96.76 3.53 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.795 0.438 . . . . 72.13 111.732 -170.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 59.87 -87.48 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.524 1.53 . . . . 75.11 111.544 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -80.97 -42.17 21.66 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.106 0.562 . . . . 75.34 110.606 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.47 ' HG3' ' HB2' ' C' ' 12' ' ' GLN . 22.6 tp60 62.78 58.84 1.5 Allowed 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 122.462 1.125 . . . . 74.21 108.9 -171.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 65.83 14.27 9.46 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 113.501 -1.681 . . . . 71.15 112.658 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 C-N-CA 123.267 0.627 . . . . 73.43 109.835 178.559 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.449 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.472 -0.566 . . . . 73.22 109.472 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 69.4 p -149.96 118.26 6.42 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.917 -0.771 . . . . 75.25 108.917 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.62 162.73 40.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.525 0.73 . . . . 74.24 110.046 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -141.87 99.23 3.49 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.17 0.588 . . . . 70.31 110.032 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -112.62 81.61 1.51 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.086 -1.079 . . . . 73.04 108.086 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -89.12 30.34 0.97 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.636 -0.711 . . . . 71.01 111.039 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.1 t -67.54 -18.53 65.06 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.591 0.756 . . . . 74.42 111.121 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -79.06 -23.48 44.2 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.741 1.216 . . . . 75.32 111.617 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.542 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 11.8 tpt -27.63 125.07 0.09 Allowed 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 126.302 1.841 . . . . 74.22 115.18 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.6 m -146.26 144.33 29.79 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.007 0.923 . . . . 71.42 109.8 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -152.5 113.29 4.15 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.115 -1.069 . . . . 74.41 108.115 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -131.57 121.48 24.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.871 0.868 . . . . 65.35 108.751 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.425 HG21 HD11 ' D' ' 16' ' ' ILE . 23.7 mt -75.35 121.29 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.544 -0.91 . . . . 70.2 108.544 174.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -88.57 -31.49 18.61 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.188 0.595 . . . . 63.23 111.584 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -169.08 142.63 2.86 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.587 0.232 . . . . 73.23 111.526 -174.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.425 HD11 HG21 ' D' ' 13' ' ' ILE . 3.9 mp -121.4 132.85 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 107.188 -1.412 . . . . 74.33 107.188 169.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.472 ' HE1' HG13 ' D' ' 83' ' ' ILE . 36.9 p90 -161.15 152.28 18.69 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.925 0.869 . . . . 75.22 111.438 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -88.47 116.13 26.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.428 -1.26 . . . . 74.53 108.975 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -83.56 -26.42 30.1 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.407 -0.59 . . . . 74.34 109.407 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -154.31 139.97 17.97 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.967 -1.015 . . . . 61.33 109.352 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.599 HG23 ' HE1' ' C' ' 117' ' ' MET . 38.5 mt -137.33 147.31 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.865 1.266 . . . . 74.21 107.851 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -156.27 143.29 18.91 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.348 0.595 . . . . 73.3 110.068 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.451 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.9 t80 -138.05 133.58 33.71 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.401 -1.703 . . . . 73.02 106.401 170.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.2 mt-10 -129.2 141.13 51.24 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.887 0.875 . . . . 73.13 109.061 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.98 81.27 39.86 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.166 -1.42 . . . . 75.35 107.166 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.79 -36.15 8.51 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.006 2.471 . . . . 73.25 113.012 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -104.84 17.66 23.74 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.709 0.804 . . . . 75.22 110.793 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -32.49 -64.79 0.23 Allowed Pre-proline 0 CA--C 1.564 1.488 0 N-CA-C 116.11 1.892 . . . . 65.05 116.11 -164.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.416 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 68.8 Cg_endo -77.91 -20.88 11.41 Favored 'Trans proline' 0 C--N 1.382 2.295 0 CA-C-N 122.896 2.07 . . . . 64.41 113.732 -176.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -72.9 -40.09 65.84 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.759 1.223 . . . . 72.2 109.884 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.729 HG23 ' HA ' ' D' ' 73' ' ' ALA . 14.6 p -83.59 -14.54 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.485 -0.78 . . . . 72.31 111.807 -175.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 20.0 m-85 -68.15 -15.99 63.81 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.666 -0.646 . . . . 73.12 111.862 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -67.29 -19.16 65.44 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.74 0.816 . . . . 74.41 110.971 173.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -84.96 87.61 7.37 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.034 0.934 . . . . 64.23 108.847 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.54 68.06 10.3 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.737 0.78 . . . . 71.44 108.919 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 48.3 t-105 -142.19 158.46 43.71 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.984 0.913 . . . . 65.45 109.251 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -72.95 111.1 10.07 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.676 1.19 . . . . 73.32 110.031 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.83 141.73 55.07 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.927 2.418 . . . . 60.41 112.33 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' H' ' 470' ' ' LEU . 35.9 tt0 -75.67 124.72 27.71 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.153 -0.684 . . . . 75.45 109.153 173.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.652 HG12 HG13 ' D' ' 64' ' ' VAL . 59.2 t -97.93 107.67 20.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.831 -0.803 . . . . 74.32 108.831 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -95.28 118.5 32.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.433 -1.321 . . . . 75.03 107.433 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.569 HD23 ' SD ' ' H' ' 464' ' ' MET . 3.2 mm? -97.57 143.2 28.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.238 0.615 . . . . 75.1 110.326 -175.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.723 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.7 m-20 -127.45 112.36 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.576 -1.268 . . . . 71.13 107.576 169.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 88.2 mt -99.72 130.2 45.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.433 0.693 . . . . 70.54 110.114 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.2 t0 -144.87 149.76 35.9 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.51 1.124 . . . . 74.35 108.373 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -125.12 159.65 30.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.519 0.676 . . . . 75.41 110.257 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.96 154.28 37.99 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.818 -1.549 . . . . 72.23 106.818 172.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.7 p -167.64 152.97 7.13 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.853 0.297 . . . . 62.14 111.223 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.7 p -163.74 142.47 7.82 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.91 0.884 . . . . 73.35 109.707 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -75.92 121.05 22.11 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.231 -0.655 . . . . 64.01 109.231 176.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 49.4 mt -89.93 -38.61 13.55 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.855 0.36 . . . . 75.44 110.436 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.42 -176.07 5.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.053 -0.522 . . . . 73.22 110.438 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -69.49 118.51 12.45 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.229 0.611 . . . . 64.12 109.594 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 67.99 9.2 7.0 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.907 1.283 . . . . 72.25 111.856 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 66.2 t -113.44 119.1 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.327 0.651 . . . . 63.42 109.693 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -128.41 129.56 46.36 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.009 0.924 . . . . 75.24 108.79 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -96.53 138.96 33.33 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.953 0.901 . . . . 73.42 109.072 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -126.42 122.76 61.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 N-CA-C 108.113 -1.069 . . . . 75.24 108.113 173.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.544 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 23.6 t -99.11 137.62 26.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 123.693 0.797 . . . . 75.01 108.903 171.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.41 123.32 44.95 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.67 -0.863 . . . . 73.32 108.67 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.44 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.4 ttm-85 -98.6 113.67 25.82 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.086 -0.709 . . . . 74.42 109.086 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.8 t -112.74 113.35 43.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.778 -1.193 . . . . 65.15 107.778 170.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.723 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 48.5 m -111.74 136.8 50.51 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.817 0.847 . . . . 70.55 109.141 -177.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.652 HG13 HG12 ' D' ' 40' ' ' VAL . 78.0 t -130.13 108.34 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.419 1.088 . . . . 65.43 109.635 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 38.1 m -107.58 114.67 28.81 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.371 -0.974 . . . . 64.03 108.371 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.4 145.13 48.22 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.328 0.651 . . . . 72.32 110.533 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 50.6 p -129.67 147.76 51.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.972 0.909 . . . . 75.34 109.246 173.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.467 HD11 HG22 ' D' ' 31' ' ' VAL . 25.6 mt -118.5 108.75 15.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.389 1.076 . . . . 72.53 108.243 171.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . 0.427 ' H ' HD21 ' H' ' 470' ' ' LEU . . . 70.42 -126.11 15.18 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 123.686 0.617 . . . . 74.12 112.447 -176.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -90.61 2.36 55.92 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.31 0.644 . . . . 74.13 112.602 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -134.06 158.98 42.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.551 0.34 . . . . 72.42 111.354 -166.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.7 m -65.17 124.35 21.92 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.17 -0.923 . . . . 63.14 109.651 174.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.729 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -80.81 -72.8 0.4 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.158 -1.052 . . . . 70.13 108.158 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -155.45 139.48 16.41 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.477 -0.783 . . . . 72.45 110.036 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 37.0 mt -105.47 150.76 25.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.326 -1.306 . . . . 74.23 107.795 176.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.478 ' SG ' HG22 ' D' ' 114' ' ' ILE . 49.1 t -158.38 147.63 19.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.909 -0.404 . . . . 63.01 109.909 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.01 134.13 10.39 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.917 -0.771 . . . . 73.3 108.917 172.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.2 t -128.46 137.23 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.406 -0.961 . . . . 73.52 108.406 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -117.86 81.55 1.68 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.73 -1.211 . . . . 74.2 107.73 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -80.06 96.48 6.49 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 112.961 -1.927 . . . . 64.34 109.802 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.63 143.17 17.58 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.676 -0.569 . . . . 74.21 111.676 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.66 130.81 5.38 Favored Glycine 0 C--O 1.228 -0.243 0 N-CA-C 111.214 -0.755 . . . . 74.1 111.214 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.472 HG13 ' HE1' ' D' ' 17' ' ' TYR . 70.8 mt -90.3 122.74 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.95 -1.13 . . . . 73.23 107.95 172.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -124.15 149.54 46.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.035 0.934 . . . . 70.32 109.049 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t -115.01 102.7 10.2 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.981 -1.118 . . . . 74.11 107.981 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.531 HG21 HD12 ' D' ' 89' ' ' ILE . 46.1 mt -108.81 128.03 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.988 0.915 . . . . 71.31 110.443 -171.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.18 157.31 42.51 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.961 0.905 . . . . 74.25 110.272 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.87 11.96 81.03 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.331 -0.395 . . . . 62.1 113.933 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.531 HD12 HG21 ' D' ' 86' ' ' ILE . 15.8 mt -111.42 127.65 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.062 0.945 . . . . 74.22 110.443 -173.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.04 164.1 34.12 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.228 1.011 . . . . 75.53 111.039 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.18 -131.57 11.34 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.54 -0.754 . . . . 43.5 113.569 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -75.79 -24.43 55.97 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.813 0.845 . . . . 75.33 111.487 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -65.15 -26.37 68.15 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.44 0.696 . . . . 75.21 110.724 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 54.3 mtp -54.31 -55.15 31.24 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.489 1.116 . . . . 73.12 110.831 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.71 -41.43 83.57 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.952 -1.022 . . . . 65.21 110.648 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -65.9 -24.89 66.93 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.88 0.872 . . . . 74.14 111.742 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -80.38 -48.85 12.3 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.832 -0.432 . . . . 65.41 109.832 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.563 ' HB2' HG13 ' H' ' 452' ' ' VAL . 28.5 tp -67.72 -56.01 10.95 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.729 0.812 . . . . 75.14 112.452 -171.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.88 -0.1 51.98 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 114.654 0.621 . . . . 41.3 114.654 -168.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' D' ' 134' ' ' ASP . . . -124.84 -66.07 0.99 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.673 0.737 . . . . 71.05 110.88 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -65.88 -54.21 29.59 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.536 0.734 . . . . 75.43 111.763 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.2 m -62.69 -46.35 88.52 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.305 -0.855 . . . . 74.42 112.387 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.32 -36.6 97.21 Favored 'Trans proline' 0 C--N 1.393 2.909 0 C-N-CA 122.523 2.149 . . . . 70.32 113.378 168.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . 0.414 ' HB2' ' HB2' ' D' ' 133' ' ' PHE . 64.3 t30 -71.09 -23.86 62.19 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.213 0.605 . . . . 73.54 110.77 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 29.7 mm -76.68 -36.51 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.961 0.904 . . . . 75.2 110.252 171.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.88 -18.62 53.63 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.31 0.644 . . . . 74.04 111.862 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -71.34 -37.94 6.2 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 113.901 1.074 . . . . 74.42 113.901 -173.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.99 -45.63 37.52 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 121.883 1.722 . . . . 71.21 112.281 168.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -70.61 -33.49 71.1 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.32 -0.855 . . . . 65.43 111.764 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.85 -51.48 54.99 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.301 0.64 . . . . 64.24 110.084 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.413 ' HG3' HD23 ' D' ' 128' ' ' LEU . 22.0 ttp180 -51.2 -52.32 45.52 Favored 'General case' 0 C--N 1.358 0.942 0 O-C-N 124.797 1.311 . . . . 75.44 110.309 175.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.38 -46.23 91.06 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.383 1.052 . . . . 73.45 111.839 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.6 t -58.97 -41.9 88.62 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.863 0.727 . . . . 64.44 110.659 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.478 HG22 ' SG ' ' D' ' 76' ' ' CYS . 80.4 mt -64.33 -56.08 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 123.996 0.81 . . . . 73.21 110.411 174.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 61.4 m -51.89 -44.55 63.79 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.816 1.247 . . . . 75.41 111.574 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.5 t -65.29 -42.0 93.58 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.912 -1.04 . . . . 74.31 110.201 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.4 mtm -68.58 -34.25 75.48 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.028 0.531 . . . . 65.4 111.772 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -66.99 -40.85 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.002 0.921 . . . . 71.34 110.099 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 77.7 p -76.66 -28.47 55.99 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.979 0.512 . . . . 74.35 111.012 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -73.68 -28.53 61.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.222 0.609 . . . . 75.1 109.633 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.18 3.64 86.66 Favored Glycine 0 C--N 1.351 1.381 0 O-C-N 123.837 0.71 . . . . 71.3 112.378 172.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 45.2 p 60.09 20.0 9.23 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 126.845 2.058 . . . . 74.3 114.181 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -79.61 157.23 74.9 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 123.13 0.572 . . . . 74.34 109.853 171.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.53 126.34 17.69 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.946 2.431 . . . . 74.4 112.367 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -56.05 138.99 48.3 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.425 1.09 . . . . 73.43 112.041 -174.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 32.5 mt -107.92 101.41 10.68 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.557 -0.535 . . . . 74.23 109.557 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -100.65 84.83 2.8 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.615 -1.254 . . . . 74.14 107.615 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.413 HD23 ' HG3' ' D' ' 111' ' ' ARG . 3.4 mm? -59.18 115.68 3.36 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 114.775 -1.102 . . . . 74.54 109.991 -175.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.79 136.06 86.87 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 124.189 0.931 . . . . 71.04 110.191 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 24.3 Cg_exo -61.7 114.31 2.21 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.802 2.335 . . . . 73.33 112.55 -172.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.1 m -108.02 128.38 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.483 0.713 . . . . 75.01 109.243 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -85.84 103.98 15.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.632 0.773 . . . . 43.23 110.544 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.414 ' HB2' ' HB2' ' D' ' 104' ' ' ASN . 63.9 m-85 -66.5 -25.63 66.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.205 0.602 . . . . 73.13 112.041 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.495 ' HA ' ' HB3' ' D' ' 100' ' ' ALA . 2.5 m-20 -57.42 -58.67 7.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.892 0.877 . . . . 71.31 111.258 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.17 90.19 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.815 0.846 . . . . 72.12 111.713 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.88 -29.76 68.95 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.181 -0.918 . . . . 74.25 112.067 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -72.92 -34.94 66.91 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.537 0.735 . . . . 74.44 110.66 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 45.2 mtt -60.83 -39.77 90.28 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.528 -0.545 . . . . 74.43 109.528 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.442 ' HA ' HE21 ' D' ' 142' ' ' GLN . 84.7 m-20 -64.92 -43.26 93.38 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.172 0.92 . . . . 73.42 110.843 175.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -55.38 -31.87 62.16 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.141 0.976 . . . . 73.21 111.398 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.95 -47.19 12.03 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.82 0.848 . . . . 74.4 111.969 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.442 HE21 ' HA ' ' D' ' 139' ' ' ASN . 5.0 pp0? -89.89 9.09 28.94 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.698 0.629 . . . . 74.24 112.698 -171.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -117.87 87.25 2.68 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.545 -0.909 . . . . 74.13 108.545 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.35 157.61 17.75 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 113.795 -1.548 . . . . 75.44 108.596 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.64 -35.82 77.13 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.472 0.709 . . . . 70.45 111.637 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.0 158.88 9.56 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.955 -0.566 . . . . 70.01 112.009 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.72 118.13 26.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.94 0.896 . . . . 74.22 108.797 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.29 83.65 0.16 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.953 -0.859 . . . . 70.31 110.953 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 41.0 m -73.37 99.1 2.85 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.368 0.667 . . . . 74.4 110.499 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.12 131.3 44.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.739 0.816 . . . . 72.02 109.87 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -125.5 150.47 47.37 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.712 0.805 . . . . 70.14 110.903 -171.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 74.85 88.63 0.09 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.442 1.497 . . . . 74.24 111.496 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -139.04 27.71 2.36 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.27 -1.381 . . . . 71.23 107.27 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.78 95.42 0.67 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.667 1.187 . . . . 64.31 110.84 -167.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 124.053 0.941 . . . . 53.14 109.088 -177.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 108.861 -0.792 . . . . 71.14 108.861 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . 0.521 HG13 ' HA ' ' A' ' 87' ' ' ALA . 48.0 t -120.96 89.86 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.178 0.591 . . . . 75.45 110.764 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 59.3 t 65.53 133.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.443 1.097 . . . . 71.51 113.775 163.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -146.17 58.16 0.5 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.825 -0.51 . . . . 74.13 111.825 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . 0.618 HD21 ' SD ' ' A' ' 94' ' ' MET . 4.5 pp -117.06 155.65 28.9 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.395 0.678 . . . . 70.4 110.97 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 2.0 p -147.97 -48.66 0.16 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.797 1.239 . . . . 65.3 108.725 167.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.41 137.11 50.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.993 0.517 . . . . 74.41 110.8 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -157.94 97.41 1.54 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.914 0.886 . . . . 64.44 108.89 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 59.8 p -72.49 -67.47 0.55 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.667 -0.697 . . . . 70.25 111.265 -175.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -167.74 159.17 11.56 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.079 0.951 . . . . 74.2 109.045 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . 0.458 HD22 ' HB ' ' A' ' 46' ' ' THR . 1.4 tm? -68.39 122.96 19.49 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 108.787 -0.82 . . . . 75.23 108.787 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -44.04 -32.73 1.25 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 126.194 1.798 . . . . 73.14 115.123 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -136.86 111.58 8.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.311 0.645 . . . . 72.44 109.728 175.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 40.8 p -72.87 124.62 25.76 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.23 -1.026 . . . . 71.21 108.23 167.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 12.4 tpt -62.6 161.11 12.67 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.423 -0.584 . . . . 71.34 109.423 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.45 -65.44 0.68 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.227 -0.657 . . . . 74.42 109.227 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -86.62 174.48 8.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.19 0.596 . . . . 61.32 111.293 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . . . -154.81 -56.7 0.1 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.547 0.739 . . . . 72.25 109.707 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -171.64 160.89 5.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.696 0.798 . . . . 74.15 109.839 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -99.54 82.6 0.56 Allowed Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.703 -0.559 . . . . 74.14 111.703 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . 0.502 ' HB3' ' HE1' ' A' ' 36' ' ' TRP . 35.2 mt -70.49 106.32 3.4 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.76 0.424 . . . . 72.25 110.313 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt . . . . . 0 C--O 1.25 1.091 0 N-CA-C 108.118 -1.067 . . . . 73.33 108.118 179.747 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 110.004 -0.369 . . . . 74.21 110.004 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . 0.445 HG11 ' O ' ' B' ' 89' ' ' ILE . 40.9 t -67.9 -62.43 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 109.41 -0.589 . . . . 73.3 109.41 172.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . 0.499 HG12 HG23 ' B' ' 86' ' ' ILE . 19.2 m -83.26 156.98 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.083 -0.962 . . . . 75.34 111.671 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -164.58 56.99 0.27 Allowed Glycine 0 C--N 1.344 1.002 0 CA-C-N 115.846 -0.615 . . . . 61.43 112.939 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . 0.437 HD11 HD13 ' B' ' 98' ' ' LEU . 4.9 tt -72.17 111.97 7.85 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.665 -1.235 . . . . 75.44 107.665 172.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 43.0 m -147.06 -47.52 0.18 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.548 0.739 . . . . 72.4 109.622 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -115.45 173.11 6.69 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.655 0.782 . . . . 75.5 111.781 -173.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 58.58 26.48 14.45 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.415 1.486 . . . . 75.41 111.455 174.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 27.9 m -79.11 86.24 4.95 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.477 0.711 . . . . 74.13 110.053 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . 0.6 ' HB3' ' HH ' ' B' ' 140' ' ' TYR . 21.5 t70 -125.84 113.68 17.56 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.151 -0.932 . . . . 61.25 108.814 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . 0.59 ' HG ' ' HA ' ' B' ' 45' ' ' ASP . 3.7 mm? -87.28 120.42 28.54 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.808 0.843 . . . . 73.12 108.804 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -88.66 44.82 1.23 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.069 1.347 . . . . 72.41 111.18 -173.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.63 112.31 18.29 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.666 0.786 . . . . 74.31 111.61 -173.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 18.9 p -139.34 105.97 5.35 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 107.047 -1.464 . . . . 75.53 107.047 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 26.6 ptm -141.68 153.42 44.68 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.03 0.443 . . . . 75.23 111.919 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -134.8 -75.14 0.46 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.641 1.176 . . . . 74.44 109.19 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . 0.667 ' HB2' ' HA ' ' F' ' 471' ' ' LYS . . . -91.58 112.06 23.82 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.07 0.948 . . . . 71.12 110.82 -171.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -164.41 -53.85 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.217 0.607 . . . . 74.42 111.946 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . 0.522 HD11 HG23 ' B' ' 40' ' ' VAL . 0.7 OUTLIER -85.16 63.94 8.39 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.935 0.874 . . . . 73.03 112.899 -167.052 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 90.61 -57.11 3.43 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.417 -1.073 . . . . 61.23 110.417 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . 0.578 HD23 ' HB2' ' B' ' 37' ' ' GLN . 95.1 mt -65.43 113.07 3.86 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.06 -0.719 . . . . 74.12 109.06 169.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . 0.667 ' HA ' ' HB2' ' F' ' 466' ' ' ALA . 86.9 tttt . . . . . 0 C--O 1.25 1.098 0 C-N-CA 123.233 0.613 . . . . 74.22 109.467 -175.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.409 -0.589 . . . . 74.34 109.409 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 8.2 p -71.45 144.81 12.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 C-N-CA 123.148 0.579 . . . . 75.01 109.631 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . 0.554 ' HA ' ' HE3' ' C' ' 94' ' ' MET . 73.3 t 68.3 85.68 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 124.038 0.935 . . . . 75.33 109.851 -173.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 174.4 99.37 0.12 Allowed Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.288 -0.869 . . . . 71.42 111.837 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 5.9 mp -82.31 148.02 28.55 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.087 -0.708 . . . . 72.12 109.087 174.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 13.3 t -82.07 -28.77 32.19 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.765 0.426 . . . . 72.12 110.557 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -170.01 161.49 8.74 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.263 1.025 . . . . 65.43 109.374 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -97.44 -50.48 4.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.611 0.765 . . . . 75.21 112.008 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 23.3 m 66.86 157.86 0.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.636 1.174 . . . . 74.21 111.397 -171.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -74.92 73.15 2.14 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.241 -0.652 . . . . 74.05 109.241 173.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 22.7 tp 55.62 -93.82 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.866 1.266 . . . . 72.44 109.544 -168.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 33.5 p90 173.55 -27.25 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.503 1.521 . . . . 73.21 109.259 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -142.34 159.23 42.64 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.664 0.786 . . . . 63.5 110.33 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 12.3 t -151.65 164.49 36.8 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.666 1.186 . . . . 73.45 108.297 171.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 464' ' ' MET . . . . . 0.473 ' SD ' HG11 ' C' ' 131' ' ' VAL . 24.2 ptm -156.67 148.69 22.98 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.426 0.69 . . . . 75.4 109.612 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -102.82 -64.49 1.07 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.103 -0.703 . . . . 73.31 109.103 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -75.19 82.41 2.35 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.781 -1.099 . . . . 74.21 110.955 -173.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -77.32 -37.29 52.91 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.489 -0.778 . . . . 74.42 110.042 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 93.9 mt -140.19 169.35 17.84 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.498 1.119 . . . . 74.11 109.955 177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -137.05 110.61 0.79 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 109.454 -1.458 . . . . 53.01 109.454 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -137.45 148.9 46.46 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.007 0.523 . . . . 75.32 111.225 -169.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? . . . . . 0 C--O 1.251 1.176 0 N-CA-C 107.04 -1.467 . . . . 75.14 107.04 179.073 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 109.727 -0.471 . . . . 75.12 109.727 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.11 -35.7 29.26 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 N-CA-C 109.546 -0.539 . . . . 74.12 109.546 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.563 HG13 ' HB2' ' D' ' 98' ' ' LEU . 35.4 m -133.75 143.32 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 122.004 -0.435 . . . . 70.01 110.341 175.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -86.43 -14.26 66.37 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.371 -0.832 . . . . 64.32 112.939 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 91.6 mt 58.52 -144.99 0.57 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.004 0.922 . . . . 74.54 110.841 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 11.0 m 65.5 25.39 11.83 Favored 'General case' 0 C--N 1.364 1.199 0 CA-C-O 122.293 1.044 . . . . 62.51 110.056 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.57 -177.57 4.83 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.045 -0.979 . . . . 74.01 110.434 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -110.6 157.95 19.11 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.296 0.639 . . . . 75.31 111.493 -171.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 27.0 m -82.6 71.36 9.68 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.077 -0.965 . . . . 73.12 109.963 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 35.5 t70 179.46 127.85 0.07 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.531 -1.213 . . . . 65.13 109.336 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.52 -104.42 0.06 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.66 -0.496 . . . . 75.12 109.66 170.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -176.85 179.94 1.02 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.963 1.305 . . . . 74.13 108.108 -166.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 30.4 t80 58.2 78.09 0.26 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.352 1.061 . . . . 72.51 111.306 175.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 29.9 m -60.52 -26.36 66.81 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.185 -0.916 . . . . 41.3 110.545 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 464' ' ' MET . . . . . 0.569 ' SD ' HD23 ' D' ' 42' ' ' LEU . 17.2 ttt 75.07 151.68 0.12 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 125.879 1.671 . . . . 73.32 110.937 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' H' ' 465' ' ' LYS . 0.2 OUTLIER -88.51 28.89 1.05 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.356 1.062 . . . . 73.02 110.493 -173.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . 64.51 102.67 0.04 OUTLIER 'General case' 0 C--N 1.363 1.173 0 C-N-CA 125.399 1.48 . . . . 64.34 111.055 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . 0.582 ' HB2' ' HB ' ' D' ' 40' ' ' VAL . . . -65.66 138.34 57.92 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.326 0.65 . . . . 75.33 110.947 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . 0.412 HD12 HG23 ' D' ' 40' ' ' VAL . 70.5 mt 76.53 -59.48 0.5 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.539 1.535 . . . . 61.41 112.053 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 91.56 119.88 2.43 Favored Glycine 0 C--N 1.344 0.988 0 N-CA-C 112.402 -0.279 . . . . 74.14 112.402 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . 0.564 ' HB2' ' HB2' ' D' ' 39' ' ' GLU . 13.0 tp -89.82 101.18 13.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.156 0.583 . . . . 74.52 110.379 -175.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt . . . . . 0 C--O 1.252 1.226 0 N-CA-C 108.227 -1.027 . . . . 74.1 108.227 170.309 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.482 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.027 0 CA-C-O 121.477 0.656 . . . . 75.31 109.935 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 t -174.15 -54.07 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.904 0.881 . . . . 72.14 109.958 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -150.59 156.9 42.28 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.125 -0.943 . . . . 75.45 109.943 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -81.22 104.02 11.4 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 107.667 -1.235 . . . . 64.21 107.667 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -67.37 90.88 0.24 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.239 0.615 . . . . 74.41 110.244 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -101.43 -45.9 5.17 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.155 0.582 . . . . 62.12 109.708 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -76.18 93.84 3.43 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 109.309 -0.626 . . . . 62.11 109.309 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -63.13 -29.44 70.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.218 1.007 . . . . 74.12 110.191 174.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.0 ttp -73.64 134.07 43.57 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 114.86 -1.064 . . . . 74.31 110.348 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.9 m -150.79 125.82 9.87 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.904 0.882 . . . . 73.23 108.704 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.696 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 11.5 t80 -123.09 124.71 43.7 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.329 -0.989 . . . . 74.24 108.329 170.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -141.7 112.07 6.99 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.73 -0.668 . . . . 73.23 109.851 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.584 HG12 ' HD2' ' A' ' 84' ' ' PHE . 52.7 mt -83.05 113.87 22.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.804 -0.813 . . . . 72.3 108.804 173.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -81.34 -31.97 33.21 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.792 -0.64 . . . . 74.43 109.843 -177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -171.53 143.54 1.78 Allowed 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.008 0.193 . . . . 75.5 111.108 -173.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.86 126.92 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 124.251 1.02 . . . . 73.43 108.384 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.521 ' HB3' HG23 ' B' ' 122' ' ' THR . 23.2 p90 -160.54 168.71 24.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.028 0.931 . . . . 75.12 110.698 -170.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.6 p -93.39 121.06 34.39 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.083 -0.71 . . . . 72.55 109.083 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -85.76 -26.07 26.03 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.037 -0.529 . . . . 73.13 109.675 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.2 t70 -152.77 142.59 22.06 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.934 -1.03 . . . . 75.53 110.197 -175.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 88.2 mt -146.19 141.72 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.728 1.611 . . . . 72.55 107.057 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -151.82 132.14 13.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.579 -0.526 . . . . 74.45 109.579 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 82.9 t80 -130.99 122.6 27.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.74 -1.578 . . . . 63.41 106.74 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -129.99 118.42 21.59 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.36 -0.607 . . . . 73.15 109.36 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.12 79.03 70.11 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.826 -1.175 . . . . 75.11 107.826 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.26 -33.05 40.61 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.052 2.501 . . . . 74.34 111.686 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 47.5 m-80 -107.03 36.73 2.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.779 -1.1 . . . . 74.44 109.631 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.488 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -60.39 -44.58 96.28 Favored Pre-proline 0 CA--C 1.57 1.743 0 C-N-CA 124.537 1.135 . . . . 61.22 113.967 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.88 -20.85 11.46 Favored 'Trans proline' 0 C--N 1.385 2.468 0 CA-C-N 121.522 1.579 . . . . 74.13 112.876 172.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 61.7 m170 -77.67 -38.97 46.47 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.143 0.577 . . . . 73.22 110.876 -176.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.628 HG21 HD13 ' A' ' 68' ' ' LEU . 10.6 p -63.48 -27.7 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.989 0.916 . . . . 54.34 110.998 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.592 ' HD1' HH11 ' B' ' 15' ' ' ARG . 91.7 t80 -62.44 -35.57 79.7 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.315 1.046 . . . . 74.55 110.907 174.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -93.03 -25.43 17.95 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.641 0.776 . . . . 63.44 111.264 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HE2' HD21 ' A' ' 68' ' ' LEU . 53.9 mtpt -82.87 165.31 19.89 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.463 0.705 . . . . 73.44 111.489 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.464 ' O ' HD22 ' A' ' 68' ' ' LEU . 10.3 m-20 -80.77 128.66 33.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.178 0.991 . . . . 72.14 108.919 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -69.28 85.92 0.4 Allowed 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.37 0.605 . . . . 75.44 111.245 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -127.25 82.28 68.47 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.543 1.137 . . . . 74.32 108.647 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -85.11 152.52 10.95 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.418 2.079 . . . . 64.31 113.117 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.436 ' HB3' ' NZ ' ' A' ' 41' ' ' LYS . 63.1 mm-40 -105.6 85.49 2.25 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.865 -1.161 . . . . 70.25 107.865 176.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.466 HG22 ' HE3' ' E' ' 471' ' ' LYS . 27.6 m -82.5 93.83 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 122.323 1.059 . . . . 62.42 111.357 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.436 ' NZ ' ' HB3' ' A' ' 39' ' ' GLU . 13.7 mptt -98.17 136.05 38.94 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.912 -1.04 . . . . 74.43 108.61 169.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.477 ' HB2' ' HG ' ' E' ' 468' ' ' LEU . 37.2 tp -119.57 114.8 22.79 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.009 -0.737 . . . . 70.4 109.009 172.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -102.67 128.55 49.32 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.028 -1.101 . . . . 70.25 108.028 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.449 ' HB2' ' HG ' ' E' ' 460' ' ' LEU . 91.1 mt -107.35 143.03 36.22 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.625 -0.88 . . . . 73.12 108.625 175.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 26.2 t70 -143.29 130.46 20.79 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.987 -0.746 . . . . 74.32 108.987 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -105.77 131.09 53.54 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.065 -0.717 . . . . 74.33 109.065 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.6 127.37 38.86 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.658 0.783 . . . . 74.0 109.664 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.404 ' HB2' ' HH ' ' A' ' 56' ' ' TYR . 28.1 p -94.83 153.22 17.83 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.143 0.977 . . . . 61.24 110.214 -178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 28.9 t -150.39 127.39 11.15 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.872 -0.788 . . . . 72.21 108.872 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -103.01 106.7 17.27 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.282 -0.636 . . . . 75.3 109.282 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.622 HD12 ' HB2' ' A' ' 57' ' ' GLU . 65.6 mt -83.37 -30.47 27.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.047 0.539 . . . . 70.34 110.505 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.426 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -163.73 -177.98 5.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.12 -0.946 . . . . 74.21 109.748 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.43 126.27 28.76 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.518 -1.29 . . . . 64.5 107.518 164.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.406 ' HA ' HG11 ' E' ' 451' ' ' VAL . 0.8 OUTLIER 74.19 -3.85 2.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.272 1.029 . . . . 74.55 112.85 175.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.426 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 50.5 t -115.64 111.4 35.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 107.403 -1.332 . . . . 72.1 107.403 177.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.404 ' HH ' ' HB2' ' A' ' 48' ' ' SER . 2.7 t80 -130.99 123.73 29.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.39 -0.596 . . . . 53.41 109.39 -172.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.622 ' HB2' HD12 ' A' ' 51' ' ' LEU . 45.3 tt0 -93.95 140.34 29.82 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.762 0.825 . . . . 73.15 109.404 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -119.29 143.43 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.483 -1.302 . . . . 73.42 107.483 170.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.03 117.74 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.967 -1.123 . . . . 73.3 107.967 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.52 HD13 HG23 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -99.54 106.8 18.84 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.215 -1.031 . . . . 73.22 108.215 178.221 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 62.9 ttt180 -84.34 105.89 15.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.063 0.945 . . . . 72.54 109.29 176.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.52 HG23 HD13 ' A' ' 60' ' ' LEU . 15.9 t -104.71 115.84 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.869 0.868 . . . . 72.31 109.003 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.3 m -110.71 112.71 24.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.091 0.957 . . . . 74.43 110.511 -175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.429 HG22 HG21 ' A' ' 114' ' ' ILE . 53.0 t -102.89 107.35 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.888 0.875 . . . . 74.43 109.176 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.1 m -105.13 109.91 22.08 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.531 -0.915 . . . . 74.45 108.531 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.71 104.1 9.96 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.611 -0.885 . . . . 64.42 108.611 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.8 m -107.76 127.15 53.44 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.563 0.745 . . . . 71.1 109.13 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.628 HD13 HG21 ' A' ' 31' ' ' VAL . 2.2 tt -86.62 87.14 7.38 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 106.781 -1.563 . . . . 72.4 106.781 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.86 -98.7 1.32 Allowed Glycine 0 C--N 1.343 0.926 0 CA-C-N 114.51 -1.223 . . . . 70.44 110.632 -172.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -115.5 -12.54 11.65 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.124 0.97 . . . . 73.15 110.443 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -99.48 119.5 38.12 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.227 1.011 . . . . 74.22 109.671 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.3 m -61.82 122.44 15.39 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 123.459 0.474 . . . . 75.42 111.409 -178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.93 -55.67 5.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.045 -1.095 . . . . 75.13 108.045 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -158.95 150.43 20.56 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.854 -1.066 . . . . 73.43 110.601 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.0 tp -131.1 107.57 9.14 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 107.741 -1.207 . . . . 70.41 107.741 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 60.4 m -109.74 99.78 8.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.659 0.784 . . . . 64.13 109.715 -177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -119.71 116.04 25.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.636 -0.876 . . . . 60.5 108.636 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.24 132.3 68.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 123.992 0.917 . . . . 72.44 109.29 -173.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 44.9 mt-30 -104.55 101.13 10.79 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 109.232 -0.655 . . . . 74.12 109.232 168.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -86.82 105.4 16.99 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.107 -1.072 . . . . 74.4 108.107 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.44 144.6 17.15 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 111.756 -0.538 . . . . 73.35 111.756 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.4 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -141.23 137.09 7.89 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.078 -0.809 . . . . 63.33 111.078 177.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.4 mt -89.08 123.58 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.844 -0.799 . . . . 75.3 108.844 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.696 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 34.8 m-85 -128.18 133.59 48.93 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.264 0.626 . . . . 74.32 109.654 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.3 t -100.89 114.31 28.05 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.67 -0.863 . . . . 74.24 108.67 176.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.31 142.31 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.831 0.852 . . . . 72.32 109.25 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.458 ' HA ' HG23 ' E' ' 451' ' ' VAL . . . -160.49 152.35 19.97 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.088 0.955 . . . . 64.15 109.792 173.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.2 -17.19 57.82 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.558 0.536 . . . . 54.01 114.398 173.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.542 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -132.18 152.95 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.483 0.713 . . . . 73.31 109.874 178.586 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.477 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 17.9 tt0 -150.27 -179.05 6.88 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.845 0.858 . . . . 64.44 108.866 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 71.9 -135.58 23.2 Favored Glycine 0 C--N 1.35 1.359 0 C-N-CA 123.003 0.335 . . . . 71.1 113.888 176.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.2 p -79.32 -15.13 58.43 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.075 0.55 . . . . 73.12 110.918 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -74.96 -36.84 62.07 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.151 0.98 . . . . 75.31 110.532 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.63 ' SD ' ' HA ' ' E' ' 452' ' ' VAL . 12.9 ptt? -74.94 -25.13 58.67 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 110.259 -0.274 . . . . 74.24 110.259 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.45 -26.53 62.76 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.294 0.637 . . . . 73.2 110.26 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -71.88 -34.56 69.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.069 0.548 . . . . 75.51 110.494 171.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.542 ' SG ' HG13 ' A' ' 89' ' ' ILE . 79.3 m -69.58 -61.27 1.85 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.454 0.302 . . . . 73.22 110.769 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.431 HD11 ' HB3' ' E' ' 454' ' ' LEU . 1.1 pp -76.21 -24.23 54.65 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.676 0.39 . . . . 70.33 111.194 -173.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.0 3.75 38.53 Favored Glycine 0 N--CA 1.476 1.325 0 CA-C-O 119.762 -0.466 . . . . 73.35 114.251 -171.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -147.49 -59.0 0.26 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 117.375 0.588 . . . . 70.34 111.755 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.42 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 84.6 t80 -70.74 -51.05 29.74 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.776 0.831 . . . . 75.35 112.511 -173.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.432 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 74.5 m -76.18 -34.2 1.38 Allowed Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 113.876 1.065 . . . . 75.14 113.876 -173.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 42.8 Cg_endo -69.12 -22.38 35.08 Favored 'Trans proline' 0 C--N 1.379 2.143 0 CA-C-N 121.596 1.606 . . . . 71.02 112.92 167.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -70.35 -31.36 68.6 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.389 0.676 . . . . 73.22 109.721 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 35.9 mm -57.08 -39.09 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.185 0.994 . . . . 74.12 110.962 171.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.4 HD22 ' HA3' ' A' ' 82' ' ' GLY . 54.0 mt -86.23 -16.99 35.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.788 0.835 . . . . 73.32 112.748 -172.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -64.79 -43.14 68.17 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 113.453 0.909 . . . . 73.15 113.453 -175.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.46 -36.25 78.44 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.058 1.839 . . . . 52.43 113.243 173.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.449 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 96.2 m-85 -70.5 -40.06 73.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.347 0.659 . . . . 74.42 111.223 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.11 -40.55 86.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.299 0.64 . . . . 75.3 110.149 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.543 ' NH1' HD13 ' C' ' 105' ' ' ILE . 36.9 ttm180 -51.56 -55.52 18.68 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 124.334 1.021 . . . . 71.25 110.143 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.37 -47.31 86.41 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.367 1.042 . . . . 52.43 111.537 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.3 t -55.14 -45.01 75.6 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.93 0.769 . . . . 70.21 110.987 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.429 HG21 HG22 ' A' ' 64' ' ' VAL . 83.9 mt -64.69 -55.68 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.773 -1.103 . . . . 73.04 110.758 176.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -55.58 -37.35 67.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.985 0.914 . . . . 63.43 111.799 -175.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -66.79 -49.89 64.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.88 -1.055 . . . . 63.01 109.912 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 38.8 mtp -58.44 -37.18 74.89 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.773 0.829 . . . . 73.25 111.847 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 114' ' ' ILE . 98.2 t -65.69 -47.86 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.851 0.86 . . . . 73.14 110.263 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 p -74.98 -21.61 59.05 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.18 0.592 . . . . 73.32 111.876 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -73.0 -34.27 66.29 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.519 0.728 . . . . 74.11 109.362 172.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.82 0.66 76.95 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.894 0.746 . . . . 63.24 113.1 172.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.4 m 69.25 19.63 7.76 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 124.648 1.179 . . . . 75.31 111.141 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -86.97 150.46 50.08 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.627 0.771 . . . . 72.1 109.987 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.48 152.6 15.61 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.722 2.948 . . . . 71.32 114.374 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -57.67 140.92 50.05 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.238 1.015 . . . . 73.14 112.413 -172.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' E' ' 468' ' ' LEU . 16.8 tp -127.14 113.36 16.28 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.853 0.461 . . . . 75.23 110.558 -176.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -122.41 86.7 2.62 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.387 0.675 . . . . 71.25 109.206 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.617 ' H ' HD22 ' A' ' 128' ' ' LEU . 0.5 OUTLIER -65.61 131.06 45.44 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.278 0.631 . . . . 71.1 110.028 175.22 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.639 ' HB2' ' HB1' ' E' ' 466' ' ' ALA . . . -75.38 146.39 81.09 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 123.756 0.822 . . . . 72.42 111.847 -170.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.51 121.99 7.9 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 122.942 2.428 . . . . 75.21 112.548 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -108.39 134.73 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 109.217 -0.661 . . . . 71.25 109.217 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.4 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 52.5 t-20 -80.76 101.94 9.64 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.701 0.8 . . . . 75.53 109.355 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -66.9 -27.15 67.27 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.275 0.63 . . . . 75.44 111.596 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.53 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 5.1 m-20 -67.87 -37.49 81.88 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.836 0.855 . . . . 65.52 110.816 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.48 -37.24 84.66 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.893 0.746 . . . . 64.13 110.589 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 132' ' ' ASN . 84.3 mt -67.07 -45.14 78.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.655 0.782 . . . . 75.11 111.396 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -64.0 -39.49 94.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.507 -0.769 . . . . 74.41 109.322 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.43 ' SD ' HD22 ' A' ' 141' ' ' LEU . 13.7 tpt -64.39 -31.65 72.94 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 124.211 0.944 . . . . 74.32 110.668 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.657 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 88.8 m-20 -60.24 -42.36 95.12 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.316 0.646 . . . . 75.21 110.995 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -70.74 -39.24 73.44 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.632 -0.713 . . . . 74.1 110.998 174.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.43 HD22 ' SD ' ' A' ' 138' ' ' MET . 28.3 tp -68.56 -48.51 64.07 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.109 0.964 . . . . 75.33 111.99 -170.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -167.71 10.02 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 123.581 0.752 . . . . 75.23 110.937 -170.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.657 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 96.1 mt-30 61.76 -171.88 0.15 Allowed 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 124.411 1.084 . . . . 75.03 110.855 -167.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -67.12 95.05 0.38 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.03 -0.73 . . . . 75.53 109.03 174.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.6 123.08 41.08 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.452 -0.944 . . . . 72.34 108.452 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.96 106.28 0.64 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.344 -0.702 . . . . 75.34 111.344 -173.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -109.41 121.05 44.32 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.545 -0.909 . . . . 72.23 108.545 173.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -142.89 142.0 11.1 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.677 -0.569 . . . . 52.52 111.677 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -149.79 156.79 42.42 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.747 0.819 . . . . 71.55 109.881 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -128.21 110.74 12.71 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.521 0.677 . . . . 64.33 111.015 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -131.28 77.6 1.79 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 106.907 -1.516 . . . . 74.44 106.907 175.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -121.21 62.42 0.89 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.65 0.738 . . . . 74.23 109.775 -177.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -169.5 124.71 0.84 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 113.791 -1.549 . . . . 73.11 108.694 171.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -94.89 106.85 18.86 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.281 -1.378 . . . . 72.13 107.281 167.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.432 0 O-C-N 123.815 0.697 . . . . 61.41 110.785 -175.252 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.132 0.492 . . . . 62.15 110.838 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 51.1 p -131.92 147.06 52.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.459 1.104 . . . . 62.31 108.448 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.73 132.52 49.58 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.864 -0.791 . . . . 75.23 108.864 -172.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -138.1 116.27 11.79 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.66 0.384 . . . . 74.2 110.624 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -140.02 133.71 30.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.444 1.098 . . . . 72.44 108.444 170.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -90.09 14.8 11.48 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.404 0.682 . . . . 72.03 111.11 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 28.3 m -55.1 116.23 2.67 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.276 1.031 . . . . 70.23 110.326 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.06 87.16 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 124.357 1.036 . . . . 74.02 111.082 178.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.582 ' HE2' HD11 ' B' ' 89' ' ' ILE . 14.3 ptm 60.71 170.21 0.09 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.333 2.253 . . . . 72.11 114.87 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 95.5 m -158.05 127.92 6.02 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.28 1.832 . . . . 74.33 106.608 175.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -133.49 132.83 41.48 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.686 0.395 . . . . 74.41 110.317 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -140.09 142.08 36.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.34 0.656 . . . . 75.12 109.732 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.456 HD11 HD12 ' B' ' 105' ' ' ILE . 32.1 mt -95.64 120.68 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 107.989 -1.115 . . . . 73.35 107.989 170.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -85.2 -50.86 7.04 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.334 -0.617 . . . . 74.51 109.334 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.592 HH11 ' HD1' ' A' ' 32' ' ' PHE . 46.0 ttt180 -162.03 137.99 7.68 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.364 -0.834 . . . . 75.42 109.508 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 91.4 mt -114.99 145.46 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 106.77 -1.567 . . . . 74.33 106.77 171.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.403 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 13.0 p90 -165.61 141.24 5.1 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.931 0.396 . . . . 74.2 111.416 -178.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 59.0 m -72.92 120.92 19.21 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.108 -1.071 . . . . 74.45 108.108 171.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.488 ' HE3' ' HB2' ' A' ' 28' ' ' ALA . 46.8 mtpt -92.67 -32.42 14.76 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.221 0.608 . . . . 73.53 111.267 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.9 t70 -153.93 137.8 16.25 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.064 0.228 . . . . 73.55 110.689 -171.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.446 HD13 ' SG ' ' B' ' 113' ' ' CYS . 47.8 mm -134.87 141.3 43.47 Favored 'Isoleucine or valine' 0 C--N 1.348 0.533 0 C-N-CA 124.834 1.254 . . . . 74.02 108.223 173.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.3 t -139.16 127.07 22.2 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.526 -1.286 . . . . 74.23 107.526 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.582 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.0 t80 -143.39 114.35 7.74 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.478 -0.934 . . . . 64.1 108.478 173.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -119.48 137.94 53.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.031 0.933 . . . . 65.35 108.817 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.01 81.04 71.17 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.461 -1.311 . . . . 74.54 107.461 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.87 -44.39 16.61 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.25 2.633 . . . . 71.33 113.356 -166.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.521 ' HB2' ' HB ' ' B' ' 31' ' ' VAL . 33.5 m-80 -100.25 15.49 27.41 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 117.905 -1.045 . . . . 74.24 110.792 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -30.17 -72.26 0.06 OUTLIER Pre-proline 0 N--CA 1.511 2.59 0 C-N-CA 125.927 1.691 . . . . 65.03 115.048 -165.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.3 -21.61 54.25 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.462 2.108 . . . . 65.2 113.166 -172.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -83.11 -49.53 9.42 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.383 -0.826 . . . . 71.11 111.308 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.72 HG22 HD13 ' B' ' 68' ' ' LEU . 8.1 p -64.37 -19.61 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.133 0.973 . . . . 65.55 112.056 -166.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -61.37 -11.77 11.49 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 123.821 0.848 . . . . 75.35 112.319 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.597 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 24.7 pt20 -55.34 -40.27 71.03 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.08 1.352 . . . . 51.41 111.574 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.597 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 90.0 mttt -94.54 89.65 5.89 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.622 0.769 . . . . 71.42 108.925 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.32 86.91 2.51 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.388 -0.824 . . . . 64.25 109.641 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -154.16 155.15 34.81 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.087 1.355 . . . . 73.34 107.377 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -76.2 102.91 0.87 Allowed Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.559 -0.904 . . . . 72.4 108.559 170.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.545 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 34.6 Cg_endo -60.06 142.06 97.59 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 123.136 2.558 . . . . 62.53 113.098 -170.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.41 121.58 13.57 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 123.701 0.625 . . . . 74.41 109.441 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' B' ' 65' ' ' THR . 18.3 m -104.05 135.5 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.587 -0.733 . . . . 65.25 112.314 -171.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.588 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 54.1 tttp -106.1 103.48 12.97 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.597 -1.26 . . . . 75.33 107.597 170.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.573 ' H ' HD23 ' B' ' 42' ' ' LEU . 2.2 pt? -95.81 132.31 41.19 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.81 -0.811 . . . . 73.03 108.81 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 19.5 t70 -131.77 146.96 52.44 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.14 1.376 . . . . 73.32 109.123 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 tp -125.04 131.4 53.38 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.106 0.962 . . . . 75.45 109.724 -172.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -148.87 155.89 41.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.643 1.177 . . . . 72.41 108.822 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.5 p -134.93 130.41 35.81 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.452 0.701 . . . . 71.34 109.753 173.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.79 122.71 46.26 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.97 -1.122 . . . . 74.52 107.97 174.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.3 m -124.8 160.79 27.89 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 122.915 0.486 . . . . 75.54 109.865 -175.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 94.6 p -152.35 139.82 19.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.493 0.717 . . . . 73.13 110.064 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -82.19 105.26 13.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.27 0.628 . . . . 63.04 110.067 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 78.4 mt -72.23 -42.77 65.32 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.62 0.724 . . . . 74.11 109.603 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.37 -179.16 7.92 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.269 -1.332 . . . . 63.33 108.782 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.25 123.12 22.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.291 -1.003 . . . . 65.31 108.291 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 72.82 -5.4 1.89 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.517 1.527 . . . . 65.03 113.288 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -111.49 109.83 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 107.59 -1.263 . . . . 75.32 107.59 173.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.72 140.5 52.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.183 -0.673 . . . . 74.34 109.183 -173.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -99.7 133.65 43.74 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.149 -1.056 . . . . 74.31 108.149 172.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -115.69 139.58 41.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.2 -1.037 . . . . 75.41 108.2 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 33.0 t -126.54 120.83 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.62 -0.881 . . . . 65.1 108.62 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.7 OUTLIER -93.66 113.13 25.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.125 -1.065 . . . . 74.34 108.125 -178.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -100.65 122.43 43.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.806 0.442 . . . . 73.14 110.315 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -116.09 114.61 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 107.783 -1.192 . . . . 63.34 107.783 171.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 48.7 m -96.4 137.72 35.06 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.474 -0.935 . . . . 72.11 108.474 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 85.5 t -131.99 133.08 61.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.998 -0.742 . . . . 75.52 108.998 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.588 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 91.4 m -120.09 148.88 43.05 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.767 1.227 . . . . 72.23 107.721 175.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.45 134.65 21.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 122.858 0.463 . . . . 71.43 110.077 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.6 p -132.62 126.69 33.28 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.308 0.643 . . . . 75.54 110.751 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.72 HD13 HG22 ' B' ' 31' ' ' VAL . 41.2 mt -95.13 103.15 15.0 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 108.149 -1.056 . . . . 74.2 108.149 170.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.48 -109.78 3.1 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.008 -0.996 . . . . 73.34 111.206 -170.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -117.37 5.15 12.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.928 0.891 . . . . 75.41 111.583 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.537 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 13.0 pt-20 -116.17 149.21 39.44 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.185 -0.672 . . . . 75.4 109.185 175.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 65.7 m -72.89 134.0 44.63 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.192 0.308 . . . . 75.0 111.097 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.59 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -82.97 -68.21 0.72 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.249 -1.019 . . . . 71.32 108.249 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -144.25 158.94 43.46 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.811 -1.086 . . . . 75.03 110.395 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 94.8 mt -131.2 120.82 23.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.08 -1.822 . . . . 73.33 106.08 174.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 36.9 t -132.35 145.24 51.11 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.194 -0.669 . . . . 74.41 109.194 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -160.19 133.96 7.11 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.865 -0.791 . . . . 71.53 108.865 -175.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.422 HG21 HD12 ' B' ' 21' ' ' ILE . 86.0 t -128.01 146.39 33.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.87 0.868 . . . . 74.02 108.918 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 17.6 mt-30 -124.96 93.32 3.85 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.233 -1.025 . . . . 72.33 108.233 170.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -85.57 101.0 12.32 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.845 -1.071 . . . . 71.53 109.155 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.07 160.26 29.52 Favored Glycine 0 C--N 1.339 0.748 0 O-C-N 123.435 0.459 . . . . 73.04 112.047 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.18 130.42 2.34 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 119.952 -0.36 . . . . 73.11 112.22 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -84.54 126.09 40.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 108.806 -0.813 . . . . 74.24 108.806 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -132.37 134.18 44.86 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.282 1.033 . . . . 75.33 108.972 -176.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.6 m -102.06 103.08 13.65 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.822 0.849 . . . . 74.13 109.51 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.655 ' HB ' HD12 ' B' ' 89' ' ' ILE . 46.2 pt -103.92 135.33 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.496 0.719 . . . . 74.21 109.794 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.486 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -146.69 151.81 37.81 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.863 -0.792 . . . . 44.11 108.863 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.93 -62.16 3.66 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 112.109 -0.396 . . . . 61.11 112.109 -176.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.655 HD12 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -62.12 142.07 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.679 0.392 . . . . 72.44 111.781 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.84 167.73 26.61 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.969 0.907 . . . . 72.45 109.526 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.07 -113.62 5.28 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.794 0.684 . . . . 74.15 113.042 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 2.2 m -87.17 -17.49 32.57 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.609 -0.348 . . . . 61.23 111.26 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -65.61 -46.75 78.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.982 0.513 . . . . 72.31 110.262 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -24.42 57.03 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 116.058 -0.519 . . . . 74.44 110.529 177.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.77 98.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.33 0.586 . . . . 62.43 109.918 169.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -70.25 -30.91 68.08 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.31 1.044 . . . . 73.21 111.203 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.482 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 69.2 m -70.76 -67.68 0.49 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 110.247 -0.279 . . . . 63.32 110.247 174.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 59.3 mt -74.34 -21.93 59.46 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.585 0.587 . . . . 75.41 112.585 -168.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.95 3.09 41.2 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-O 119.522 -0.599 . . . . 64.34 114.302 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.48 -62.85 0.2 Allowed 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.789 0.795 . . . . 70.41 111.909 -177.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.482 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 89.4 t80 -68.18 -39.18 82.61 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.915 0.886 . . . . 75.22 112.372 -172.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 91.3 m -73.08 -46.36 8.22 Favored Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 123.693 0.797 . . . . 64.24 111.103 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.402 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 78.5 Cg_exo -55.87 -34.05 90.39 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.025 1.817 . . . . 64.41 113.727 167.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -59.6 -38.77 82.13 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.231 0.613 . . . . 72.24 110.799 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.456 HD12 HD11 ' B' ' 13' ' ' ILE . 70.4 mt -64.12 -42.99 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.06 0.944 . . . . 75.22 110.836 175.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.419 HD11 ' O ' ' B' ' 80' ' ' GLN . 74.1 mt -79.03 -19.73 50.73 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.657 -1.156 . . . . 73.3 112.399 -173.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -59.7 -47.41 97.59 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.179 1.177 . . . . 73.15 114.179 -171.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.96 -42.78 61.84 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.373 2.048 . . . . 73.13 113.788 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.527 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 82.5 m-85 -66.27 -48.63 69.81 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.839 -0.619 . . . . 64.43 110.421 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.96 -42.12 84.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.742 0.817 . . . . 71.33 110.908 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.423 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 49.5 ttt180 -61.86 -54.71 38.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.245 1.418 . . . . 72.24 110.995 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -67.17 -34.16 76.95 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 123.998 0.811 . . . . 73.24 110.147 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.486 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.6 t -68.18 -33.93 75.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.71 0.404 . . . . 74.24 111.088 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 70.9 mt -65.28 -52.01 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.415 -0.587 . . . . 75.31 109.415 171.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.0 m -60.01 -30.62 69.27 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 123.979 0.8 . . . . 75.53 111.543 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.2 t -63.63 -51.86 63.36 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 123.454 0.702 . . . . 52.23 109.858 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -68.59 -34.91 76.6 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.148 0.579 . . . . 74.42 110.985 -174.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.05 -43.04 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.736 0.815 . . . . 64.03 110.312 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.3 t -68.75 -30.19 68.75 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.393 -0.821 . . . . 63.4 111.598 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.8 mtt-85 -69.59 -43.4 72.88 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.547 -0.751 . . . . 75.54 109.612 176.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.21 -3.09 64.24 Favored Glycine 0 C--N 1.357 1.708 0 O-C-N 124.072 0.857 . . . . 65.12 112.924 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 17' ' ' TYR . 28.2 p 62.18 25.87 15.5 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 126.506 1.922 . . . . 72.14 112.86 174.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -80.34 161.51 64.64 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 123.837 0.855 . . . . 64.43 110.729 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -49.41 157.86 1.95 Allowed 'Trans proline' 0 C--N 1.387 2.581 0 C-N-CA 123.742 2.961 . . . . 71.41 115.178 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -59.61 114.17 2.6 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.226 1.01 . . . . 74.23 111.306 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -119.1 108.97 15.35 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.657 -0.868 . . . . 71.51 108.657 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -124.02 134.44 53.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.511 -0.922 . . . . 75.22 108.511 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.423 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.3 mm? -77.02 147.42 36.78 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.299 0.639 . . . . 75.23 109.848 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.523 ' HB1' ' HE1' ' F' ' 464' ' ' MET . . . -83.23 147.23 53.04 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 123.092 0.557 . . . . 62.52 109.667 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.33 110.78 0.85 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.151 2.568 . . . . 73.23 112.322 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.0 t -90.11 112.63 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.435 -0.95 . . . . 74.4 108.435 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -82.08 83.83 7.2 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.968 -1.123 . . . . 74.22 107.968 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -54.41 -42.26 70.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.288 1.035 . . . . 64.42 111.302 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.73 -43.09 80.79 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.408 1.083 . . . . 75.23 111.888 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.52 -54.25 45.64 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.316 0.646 . . . . 74.2 110.271 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.4 -29.37 70.43 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.613 -1.176 . . . . 62.11 111.47 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.448 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 75.2 t80 -65.54 -43.21 90.67 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.151 0.58 . . . . 74.33 110.433 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 60.4 mtt -64.83 -36.2 83.55 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.888 0.475 . . . . 73.2 110.674 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -82.96 -4.61 58.45 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.767 0.827 . . . . 72.25 111.464 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -83.12 -34.27 26.12 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.081 0.552 . . . . 74.12 109.668 173.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 12.7 mt -77.68 -6.27 53.33 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.621 -0.718 . . . . 75.35 111.38 -172.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -144.35 132.75 21.99 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.464 1.106 . . . . 72.11 108.153 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -79.44 68.75 5.54 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.713 0.768 . . . . 71.42 109.709 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -143.29 177.19 8.59 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.198 1.399 . . . . 72.51 108.541 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.38 97.59 2.88 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.014 0.526 . . . . 75.42 110.647 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.97 149.88 21.13 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 111.764 -0.534 . . . . 73.14 111.764 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -160.85 165.65 29.84 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.671 0.789 . . . . 71.01 110.412 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.31 85.45 0.14 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 111.393 -0.683 . . . . 75.1 111.393 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.6 p -85.15 110.44 19.0 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.164 0.586 . . . . 75.32 109.616 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -137.41 144.73 42.54 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.122 -1.807 . . . . 75.32 106.122 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -169.44 125.53 0.88 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.086 0.554 . . . . 75.44 109.75 -176.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -168.9 94.57 0.33 Allowed 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.54 0.736 . . . . 73.13 111.501 174.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.21 61.99 2.1 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 106.759 -1.571 . . . . 73.12 106.759 163.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.48 117.66 18.37 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.481 -1.236 . . . . 74.51 109.722 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 C-N-CA 123.733 0.813 . . . . 72.22 108.946 -178.648 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.844 -0.428 . . . . 74.24 109.844 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -139.08 -176.54 4.54 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 108.075 -1.083 . . . . 75.12 108.075 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.73 77.33 3.36 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.199 0.6 . . . . 54.25 109.691 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 57.15 68.7 0.82 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.083 1.353 . . . . 71.02 111.777 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -74.77 80.84 2.08 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.688 -0.856 . . . . 74.34 108.688 172.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -172.71 123.68 0.45 Allowed 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.769 -1.197 . . . . 61.21 107.769 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 45.8 p -72.68 -67.87 0.52 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.24 -0.652 . . . . 75.13 109.24 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 56.72 65.31 1.43 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.061 1.344 . . . . 74.24 111.896 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.457 ' HG3' HD11 ' C' ' 89' ' ' ILE . 54.4 ttm 57.33 113.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.817 1.647 . . . . 74.31 113.352 177.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 31.4 m -87.81 80.49 7.84 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.368 -0.975 . . . . 74.01 108.368 173.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.567 ' HD1' ' HH ' ' C' ' 101' ' ' TYR . 0.9 OUTLIER -90.56 122.93 33.8 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.79 -1.095 . . . . 75.42 109.155 179.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.425 ' HA ' HE21 ' C' ' 12' ' ' GLN . 0.1 OUTLIER -137.21 108.41 6.81 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.593 -1.262 . . . . 74.22 107.593 168.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.409 HD11 HG22 ' C' ' 105' ' ' ILE . 74.2 mt -63.9 118.62 6.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.071 -1.085 . . . . 74.45 108.071 172.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.488 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.1 mm-40 -82.74 -48.84 10.4 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.705 0.628 . . . . 54.33 109.415 -178.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -170.19 124.46 0.74 Allowed 'General case' 0 C--N 1.354 0.78 0 CA-C-N 115.947 -0.569 . . . . 62.43 110.677 -172.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.1 mt -112.35 139.27 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 107.736 -1.209 . . . . 72.55 107.736 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -173.5 153.12 2.26 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.094 0.474 . . . . 74.45 110.435 -168.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.9 p -82.32 116.64 21.91 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.96 -0.755 . . . . 71.42 108.96 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.42 ' HG3' ' HA3' ' C' ' 81' ' ' GLY . 15.2 mtmt -83.58 -29.79 27.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.09 0.472 . . . . 75.53 109.947 176.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 27.4 t70 -144.37 138.68 27.97 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.132 -0.94 . . . . 75.42 109.354 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.478 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 87.0 mt -136.51 140.24 43.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.924 -1.509 . . . . 74.44 106.924 171.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -157.05 141.23 16.39 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.842 0.353 . . . . 72.31 110.155 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.415 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 86.8 t80 -136.44 148.2 47.62 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.489 -1.3 . . . . 75.42 107.489 171.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -145.08 118.12 8.84 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.0 0.92 . . . . 74.33 110.062 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.83 83.78 51.7 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 107.222 -1.399 . . . . 74.53 107.222 163.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.01 -27.89 19.94 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.331 2.021 . . . . 73.51 111.394 175.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -92.25 12.2 23.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.579 1.151 . . . . 74.22 110.747 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.81 -58.76 7.63 Favored Pre-proline 0 C--N 1.37 1.463 0 N-CA-C 114.698 1.37 . . . . 74.43 114.698 -165.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -62.98 -39.77 38.44 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 121.503 1.468 . . . . 51.14 112.171 -174.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -70.3 -34.96 73.36 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.787 -1.097 . . . . 73.4 112.233 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.3 p -80.6 -26.06 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 112.906 0.706 . . . . 72.32 112.906 -170.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -64.77 -20.48 66.39 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 113.29 0.848 . . . . 73.02 113.29 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -99.11 12.07 37.18 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.302 0.641 . . . . 75.12 111.286 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.792 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -88.06 146.32 25.52 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.276 -0.638 . . . . 74.52 109.276 172.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -57.98 119.18 6.3 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.116 -0.698 . . . . 73.44 109.116 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -67.8 93.17 0.38 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.803 0.841 . . . . 73.42 111.283 -173.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -148.99 69.1 9.81 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 124.839 1.255 . . . . 73.41 108.251 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -80.16 133.27 9.78 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.573 2.182 . . . . 73.44 111.152 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.09 105.11 15.59 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.107 -1.072 . . . . 74.42 108.107 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.55 113.56 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.36 -0.836 . . . . 70.21 110.329 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -111.17 110.7 21.34 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.183 -1.414 . . . . 73.34 107.183 170.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 40.4 tp -91.28 142.26 27.9 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.124 0.569 . . . . 72.15 109.7 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 20.1 t70 -131.95 117.75 18.86 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.823 -1.177 . . . . 75.34 107.823 175.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.6 mt -108.72 151.67 25.87 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.607 0.763 . . . . 71.22 109.953 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 30.0 t70 -157.6 150.19 22.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.198 0.599 . . . . 64.13 109.949 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -144.45 123.36 12.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.629 0.772 . . . . 65.12 110.117 176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.78 135.11 54.44 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.619 -0.882 . . . . 73.14 108.619 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.4 p -131.2 142.31 50.17 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.239 0.616 . . . . 74.42 109.623 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 29.6 t -145.79 150.8 36.88 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.137 0.975 . . . . 73.13 109.532 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . 0.535 ' NE2' HG12 ' G' ' 452' ' ' VAL . 55.2 tt0 -75.75 138.77 41.46 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.957 -0.565 . . . . 74.44 109.829 174.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' C' ' 57' ' ' GLU . 62.6 mt -106.22 -43.26 4.85 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.681 -0.859 . . . . 74.34 108.681 169.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.66 -176.34 5.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.63 -1.168 . . . . 75.15 109.525 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . 0.49 ' HB3' ' HA ' ' G' ' 450' ' ' ASN . 12.2 m-20 -66.18 126.1 27.63 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.511 -0.768 . . . . 62.23 109.684 176.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 72.2 -1.82 2.78 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.31 1.444 . . . . 73.35 112.032 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -114.89 114.12 45.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 123.264 0.625 . . . . 61.31 109.418 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -124.84 135.3 52.78 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.063 0.945 . . . . 74.34 109.192 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.605 ' HB2' HD12 ' C' ' 51' ' ' LEU . 42.8 tt0 -92.6 123.97 36.29 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 124.154 0.909 . . . . 70.23 108.877 168.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 85.3 t -103.79 136.95 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.293 -1.003 . . . . 71.03 108.293 168.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -121.17 130.58 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.303 -1.369 . . . . 75.5 107.303 174.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.26 104.26 11.64 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.818 -1.178 . . . . 71.14 107.818 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 30.4 ttm-85 -88.39 126.19 35.09 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.241 -1.345 . . . . 75.4 108.297 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.567 ' HB ' HD11 ' C' ' 114' ' ' ILE . 21.5 t -123.58 128.22 74.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.583 -1.266 . . . . 73.53 107.583 173.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 9.8 m -128.37 112.0 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.746 -0.835 . . . . 72.45 108.746 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.431 HG22 HG22 ' C' ' 114' ' ' ILE . 51.7 t -104.84 116.02 47.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.92 -1.036 . . . . 72.31 108.788 -173.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.9 m -105.8 141.37 37.34 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.07 -0.715 . . . . 72.41 109.07 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.15 115.15 8.74 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.85 -1.167 . . . . 73.13 107.85 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.9 m -137.17 134.25 36.11 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.483 0.49 . . . . 54.53 109.833 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.663 HD11 ' HG2' ' C' ' 34' ' ' LYS . 0.5 OUTLIER -87.88 42.03 1.03 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.936 1.294 . . . . 71.55 108.596 177.135 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.27 -112.62 4.17 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.209 -0.756 . . . . 70.54 111.209 -171.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.56 -30.71 19.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.326 0.65 . . . . 71.25 109.485 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.15 110.53 3.02 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 115.222 -0.899 . . . . 71.23 109.032 173.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -77.95 125.49 29.42 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.001 -0.74 . . . . 74.05 109.001 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.621 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.85 -57.87 3.75 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.421 -1.325 . . . . 65.22 107.421 171.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -167.4 169.23 12.45 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 121.885 0.85 . . . . 71.13 111.939 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -133.77 141.63 47.57 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 105.947 -1.872 . . . . 73.43 105.947 170.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 47.4 t -151.34 113.44 4.53 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.963 -0.384 . . . . 72.35 109.963 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -117.02 127.62 54.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.478 0.311 . . . . 73.21 110.309 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.5 t -118.24 138.33 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.953 -1.129 . . . . 74.51 107.953 167.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.6 mt-30 -116.05 94.96 4.88 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 108.68 -0.859 . . . . 72.12 108.68 173.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.41 ' HG3' HD22 ' C' ' 106' ' ' LEU . 9.4 tp-100 -79.79 102.64 9.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.954 -1.021 . . . . 73.2 109.903 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.42 ' HA3' ' HG3' ' C' ' 19' ' ' LYS . . . -85.58 151.85 25.75 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 111.759 -0.536 . . . . 74.13 111.759 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.561 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -154.37 118.47 0.86 Allowed Glycine 0 CA--C 1.506 -0.475 0 N-CA-C 111.697 -0.561 . . . . 71.34 111.697 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.541 HD13 HD12 ' C' ' 51' ' ' LEU . 8.8 mm -84.71 125.91 40.29 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 N-CA-C 108.764 -0.828 . . . . 72.52 108.764 173.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -134.24 120.08 19.55 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.673 -0.862 . . . . 73.22 108.673 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 61.1 p -91.07 118.82 30.71 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.189 -0.671 . . . . 71.44 109.189 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.741 HG22 ' SG ' ' C' ' 97' ' ' CYS . 1.8 pp -125.61 141.13 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.594 1.158 . . . . 72.43 111.356 -174.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.648 ' HA ' HG21 ' G' ' 451' ' ' VAL . . . -149.53 167.46 26.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.333 0.653 . . . . 75.43 110.326 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.64 -54.41 3.78 Favored Glycine 0 N--CA 1.475 1.269 0 N-CA-C 112.43 -0.268 . . . . 55.0 112.43 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.457 HD11 ' HG3' ' C' ' 9' ' ' MET . 0.2 OUTLIER -81.42 157.54 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.254 0.622 . . . . 75.12 110.564 177.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.79 178.63 8.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.851 0.46 . . . . 73.34 110.418 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.54 -114.1 5.58 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.718 0.637 . . . . 64.25 113.533 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -82.55 -20.08 37.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.672 0.789 . . . . 64.5 112.087 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.56 -42.92 61.01 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.513 -0.551 . . . . 74.34 109.513 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.41 ' HE3' ' HA ' ' G' ' 452' ' ' VAL . 23.9 ptm -74.23 -30.11 62.02 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 110.248 -0.278 . . . . 74.33 110.248 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.548 ' HA ' HD21 ' G' ' 454' ' ' LEU . . . -59.59 -43.69 93.59 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 123.489 0.493 . . . . 75.15 110.118 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -74.72 -35.83 62.67 Favored 'General case' 0 C--O 1.245 0.832 0 O-C-N 123.477 0.485 . . . . 75.1 111.78 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.741 ' SG ' HG22 ' C' ' 86' ' ' ILE . 53.3 t -56.6 -36.37 69.32 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.644 0.59 . . . . 70.41 110.558 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 24.4 mt -98.31 -18.06 18.56 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.856 0.862 . . . . 75.42 111.18 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.43 -29.62 55.44 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 115.015 0.766 . . . . 51.1 115.015 -172.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.94 -36.0 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.654 0.382 . . . . 63.14 111.081 -170.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.567 ' HH ' ' HD1' ' C' ' 11' ' ' PHE . 84.6 t80 -67.61 -45.8 74.39 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.216 1.406 . . . . 74.42 112.677 -175.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.0 m -79.79 -40.41 1.37 Allowed Pre-proline 0 CA--C 1.557 1.247 0 CA-C-O 118.475 -0.774 . . . . 61.12 112.481 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -54.0 -27.58 45.92 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 122.249 1.966 . . . . 74.54 114.078 166.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -68.28 -37.9 81.14 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.679 0.792 . . . . 74.15 109.768 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.543 HD13 ' NH1' ' A' ' 111' ' ' ARG . 43.8 mm -68.94 -34.01 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.008 0.523 . . . . 73.11 109.983 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.561 HD23 ' HA3' ' C' ' 82' ' ' GLY . 95.4 mt -81.34 -27.3 35.01 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.917 0.887 . . . . 75.35 112.756 -177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -57.8 -48.52 97.03 Favored Pre-proline 0 CA--C 1.559 1.31 0 N-CA-C 113.959 1.096 . . . . 73.41 113.959 -174.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.94 -37.15 79.29 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 121.992 1.795 . . . . 74.42 113.056 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -66.69 -42.46 86.43 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.103 0.561 . . . . 61.12 110.895 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.56 99.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.539 0.736 . . . . 62.52 110.461 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.601 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 35.9 ttt180 -54.12 -56.47 17.85 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.464 1.506 . . . . 63.5 111.412 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.23 -35.43 77.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.733 0.413 . . . . 75.31 110.543 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 20.0 t -64.75 -33.58 76.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.957 0.503 . . . . 73.11 111.973 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.567 HD11 ' HB ' ' C' ' 62' ' ' VAL . 75.4 mt -76.75 -52.7 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.585 0.754 . . . . 74.4 110.231 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -60.94 -28.67 69.12 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.356 0.662 . . . . 72.1 111.38 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.2 t -67.31 -52.07 44.86 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.779 0.832 . . . . 70.33 109.156 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.541 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.37 -36.84 78.97 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.226 1.011 . . . . 74.22 112.338 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 78.3 t -66.53 -44.84 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.633 0.773 . . . . 72.33 109.904 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 40.4 t -69.2 -22.92 63.86 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.262 -0.881 . . . . 71.11 111.645 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.3 mtt-85 -75.65 -41.05 55.13 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.49 0.716 . . . . 75.15 109.082 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.01 -2.87 62.89 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 123.83 0.706 . . . . 63.44 112.498 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p 67.03 27.76 8.62 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.88 2.072 . . . . 74.12 113.611 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -83.8 153.45 64.13 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 108.813 -0.81 . . . . 73.53 108.813 168.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -60.67 178.49 0.47 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.149 2.566 . . . . 74.24 114.75 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -60.8 114.33 2.98 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 114.171 1.174 . . . . 62.13 114.171 -174.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.426 ' HG ' HD11 ' G' ' 470' ' ' LEU . 7.2 mp -112.2 89.49 3.08 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.81 -0.811 . . . . 74.05 108.81 163.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -91.32 112.68 24.69 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.513 -0.921 . . . . 53.54 108.513 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.601 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -65.0 126.29 27.55 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.618 0.767 . . . . 75.4 110.587 -177.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.21 149.18 81.82 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 124.423 1.089 . . . . 72.4 111.887 -173.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.449 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 20.7 Cg_endo -61.07 105.3 0.32 Allowed 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.11 2.54 . . . . 73.32 113.212 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.6 111.33 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.707 -0.849 . . . . 73.54 108.707 171.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -87.22 90.31 8.31 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 108.622 -0.881 . . . . 65.11 108.622 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -60.36 -29.95 69.24 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.251 1.021 . . . . 74.32 111.261 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.56 -43.93 68.88 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.415 1.486 . . . . 75.01 112.915 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.61 82.97 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.348 1.03 . . . . 74.24 110.604 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 20.6 tp -71.72 -29.31 64.41 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.142 -0.935 . . . . 74.41 111.152 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -74.21 -26.13 60.08 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.639 0.375 . . . . 72.04 110.344 177.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 91.5 mtp -71.97 -32.28 67.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.582 0.353 . . . . 74.12 110.5 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -71.22 -46.51 61.0 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.882 0.473 . . . . 73.55 109.967 174.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -56.51 -82.87 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 124.651 1.18 . . . . 75.11 110.743 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' C' ' 145' ' ' ALA . 17.9 tp 64.52 -81.98 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.759 1.624 . . . . 70.24 108.997 -174.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 11.7 tm0? 179.3 -57.63 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.227 1.411 . . . . 74.11 107.397 166.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -93.53 -76.02 0.48 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.399 -0.819 . . . . 70.42 109.395 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -176.71 160.72 1.98 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.846 0.858 . . . . 74.53 110.45 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.483 ' HB2' HD21 ' C' ' 141' ' ' LEU . . . -126.15 153.5 44.51 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.058 0.943 . . . . 73.44 109.567 175.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.31 43.21 0.52 Allowed Glycine 0 C--N 1.347 1.163 0 O-C-N 123.043 0.215 . . . . 52.5 113.2 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -156.71 147.42 21.67 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.812 0.445 . . . . 63.32 110.48 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -142.67 -177.09 17.37 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 110.754 -0.938 . . . . 64.21 110.754 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 92.6 m -113.42 -96.69 0.44 Allowed 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.111 -0.7 . . . . 72.22 109.111 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 38.84 69.22 0.28 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.559 1.543 . . . . 71.54 113.608 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -93.4 142.88 26.83 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.119 -1.067 . . . . 75.14 108.119 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -150.12 117.25 5.99 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.597 0.359 . . . . 71.51 111.127 -170.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -95.5 129.37 42.69 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.505 -0.924 . . . . 75.34 108.505 160.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -79.47 74.43 6.1 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.826 0.822 . . . . 75.12 109.206 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-N 114.605 -1.18 . . . . 72.2 108.783 -178.18 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.45 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 109.99 -0.374 . . . . 73.42 109.99 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 18.0 m -91.92 -179.38 5.28 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.512 1.125 . . . . 71.23 110.941 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -78.1 83.23 4.4 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.409 0.624 . . . . 73.11 109.418 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.42 ' HG3' ' H ' ' D' ' 5' ' ' ASN . 15.7 tp60 -149.82 -175.36 5.0 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 106.819 -1.549 . . . . 74.03 106.819 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . 0.42 ' H ' ' HG3' ' D' ' 4' ' ' GLN . 25.5 p-10 -64.2 -28.23 69.6 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 118.922 0.783 . . . . 74.05 109.687 167.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.522 HD21 ' HB3' ' D' ' 9' ' ' MET . 4.3 t30 70.13 103.17 0.06 Allowed 'General case' 0 C--N 1.36 1.05 0 C-N-CA 125.979 1.712 . . . . 72.04 109.66 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -72.93 146.26 46.23 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.501 -0.772 . . . . 74.54 110.46 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 73.21 -1.73 2.96 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.797 1.239 . . . . 75.15 113.318 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.59 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 6.1 ptm -36.46 153.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.313 1.227 . . . . 74.34 114.313 165.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' D' ' 87' ' ' ALA . 21.0 m -117.27 143.55 45.78 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.592 0.757 . . . . 75.04 110.905 177.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.543 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 71.1 t80 -162.58 97.7 0.98 Allowed 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.063 -1.458 . . . . 73.42 107.063 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -112.22 115.01 28.11 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.394 -1.336 . . . . 75.24 107.394 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.585 HD11 HD12 ' D' ' 105' ' ' ILE . 59.7 mt -73.59 119.31 20.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.384 -0.969 . . . . 75.43 108.384 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.461 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 9.5 mm100 -85.34 -41.77 15.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.693 -0.685 . . . . 75.24 109.219 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -174.67 144.27 0.83 Allowed 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.251 0.345 . . . . 71.31 111.164 -167.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.495 HD11 HG21 ' D' ' 13' ' ' ILE . 4.1 mp -120.66 142.39 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.112 -1.44 . . . . 72.11 107.112 170.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -164.87 160.44 19.4 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.405 0.682 . . . . 75.54 111.121 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.8 p -93.15 116.48 29.07 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.325 -0.621 . . . . 72.13 109.325 173.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -85.38 -19.88 30.73 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.965 0.506 . . . . 75.42 110.105 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.1 t70 -160.31 140.03 11.15 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.782 0.833 . . . . 75.15 109.261 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.541 HG23 ' HE1' ' C' ' 117' ' ' MET . 98.6 mt -137.95 142.86 34.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.859 1.263 . . . . 75.41 107.701 175.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -141.6 136.23 30.81 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.957 0.903 . . . . 75.43 108.807 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.483 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 82.4 t80 -143.53 124.87 14.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.587 -1.634 . . . . 71.33 106.587 168.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 27.0 mt-10 -135.13 118.02 16.25 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.612 -0.884 . . . . 63.45 108.612 -173.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.59 82.39 9.97 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.729 -1.212 . . . . 72.23 107.729 174.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.47 -33.74 10.45 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.681 2.254 . . . . 75.45 113.183 -170.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -103.52 11.06 36.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.542 0.737 . . . . 70.24 110.666 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -30.66 -70.57 0.09 OUTLIER Pre-proline 0 CA--C 1.565 1.521 0 N-CA-C 116.276 1.954 . . . . 55.11 116.276 -160.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.401 ' HB3' HD11 ' C' ' 83' ' ' ILE . 86.7 Cg_endo -75.46 -15.42 19.77 Favored 'Trans proline' 0 C--N 1.375 1.946 0 CA-C-N 123.55 2.304 . . . . 74.04 113.829 -173.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -79.79 -41.1 27.21 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.485 1.114 . . . . 54.21 110.044 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.5 p -79.96 -23.46 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 116.235 -0.439 . . . . 72.25 111.34 -173.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -63.19 -19.81 64.85 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.127 0.417 . . . . 73.34 112.127 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -61.47 -17.1 52.94 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.877 0.871 . . . . 75.32 111.947 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.419 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 37.6 mtmt -99.83 110.75 23.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.772 0.829 . . . . 72.34 111.09 174.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.49 93.85 9.47 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.576 -0.738 . . . . 72.15 109.722 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -157.39 157.07 33.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.432 1.093 . . . . 73.11 108.235 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.468 ' HG3' HD13 ' H' ' 470' ' ' LEU . 30.3 tp60 -76.44 106.38 3.24 Favored Pre-proline 0 N--CA 1.477 0.908 0 N-CA-C 107.374 -1.343 . . . . 72.23 107.374 171.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.565 ' HB2' ' HB2' ' D' ' 66' ' ' ALA . 24.5 Cg_exo -63.21 137.31 60.5 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.796 2.331 . . . . 74.22 112.452 -167.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 7.4 mm-40 -56.93 109.72 0.69 Allowed 'General case' 0 C--N 1.361 1.075 0 O-C-N 124.082 0.864 . . . . 73.41 109.692 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.588 HG21 HG11 ' D' ' 64' ' ' VAL . 2.1 p -99.63 111.71 29.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 115.198 -0.91 . . . . 74.24 110.586 -171.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -86.49 111.86 20.97 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.366 -1.346 . . . . 72.21 107.366 169.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -95.79 151.86 19.0 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 108.961 -0.755 . . . . 73.44 108.961 173.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -151.44 154.12 35.99 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.438 -0.949 . . . . 70.0 108.438 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.651 ' HB2' HD11 ' H' ' 460' ' ' LEU . 89.6 mt -131.14 144.04 51.09 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.725 0.81 . . . . 75.34 109.711 -176.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.651 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.8 t70 -141.41 125.48 17.29 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.61 1.164 . . . . 73.32 108.234 175.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -104.66 145.38 30.42 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 109.215 -0.661 . . . . 74.32 109.215 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.99 142.69 24.61 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.158 -1.053 . . . . 74.44 108.158 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 47.6 p -141.94 159.92 41.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.602 0.637 . . . . 75.14 111.35 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -163.39 125.91 2.59 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.893 0.877 . . . . 74.1 109.668 -173.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -74.99 121.87 22.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.576 -0.528 . . . . 73.12 109.576 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' D' ' 57' ' ' GLU . 55.9 mt -96.36 -29.65 13.84 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.139 0.576 . . . . 74.32 111.283 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.452 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -162.21 -173.01 3.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.391 0.677 . . . . 43.23 110.45 -177.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.89 120.84 18.06 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.968 -1.014 . . . . 75.44 110.762 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 65.05 3.74 2.26 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.487 1.115 . . . . 75.33 112.005 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 51.5 t -117.0 124.2 72.73 Favored 'Isoleucine or valine' 0 C--N 1.349 0.575 0 C-N-CA 123.369 0.668 . . . . 64.51 109.572 -173.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -120.81 173.13 7.41 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.957 1.303 . . . . 74.2 109.99 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.528 ' HB2' HD11 ' D' ' 51' ' ' LEU . 33.4 tt0 -131.3 133.84 45.77 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.733 -1.576 . . . . 74.24 107.008 168.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.6 t -120.63 141.77 39.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.004 -1.11 . . . . 64.13 108.004 168.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.473 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 39.8 t -120.77 131.32 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.718 -1.216 . . . . 65.05 107.718 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.44 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -115.16 119.75 37.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.464 -0.939 . . . . 72.2 108.464 178.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.651 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.2 ttm180 -104.77 102.37 11.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.129 -1.063 . . . . 74.43 108.129 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.2 t -94.48 102.51 13.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.693 -1.225 . . . . 72.45 107.693 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 28.4 m -100.32 140.0 35.2 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.544 -0.753 . . . . 74.54 109.588 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.74 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 52.0 t -132.35 133.68 59.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.628 1.571 . . . . 72.32 108.6 -172.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.0 m -134.66 100.77 4.72 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.117 -1.068 . . . . 74.03 108.117 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.565 ' HB2' ' HB2' ' D' ' 38' ' ' PRO . . . -104.2 153.14 21.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.644 0.778 . . . . 62.24 110.868 -176.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 65.1 p -146.08 137.96 25.06 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.29 0.567 . . . . 70.13 111.909 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.564 HD11 HG23 ' D' ' 31' ' ' VAL . 53.3 mt -105.69 125.7 51.29 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.586 1.154 . . . . 72.21 108.131 170.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.03 -113.29 5.5 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.454 0.471 . . . . 75.23 112.728 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.96 5.32 13.94 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.346 0.659 . . . . 75.24 110.706 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.419 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 12.4 pt-20 -127.11 159.9 32.81 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.151 0.58 . . . . 73.52 110.276 -174.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -68.92 130.72 43.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.598 0.759 . . . . 71.31 111.95 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.99 -77.46 0.3 Allowed 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.82 -0.807 . . . . 74.32 108.82 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -141.33 147.57 38.32 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 121.227 0.537 . . . . 75.31 110.859 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 55.8 mt -117.85 140.03 50.27 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.805 -1.183 . . . . 61.15 107.805 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.74 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 33.0 m -141.21 144.7 34.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.118 0.967 . . . . 72.21 109.035 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -156.94 118.07 3.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.16 -1.052 . . . . 74.01 108.16 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.83 113.05 25.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 109.361 -0.607 . . . . 75.43 109.361 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -89.73 85.88 6.54 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.649 -0.871 . . . . 74.23 108.649 172.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -79.09 94.66 5.38 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.618 -1.174 . . . . 73.42 108.509 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.83 145.95 21.12 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.781 -0.528 . . . . 55.03 111.781 177.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.47 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -145.67 131.41 4.15 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.445 -0.662 . . . . 71.21 111.445 -176.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.525 HG22 HD13 ' D' ' 51' ' ' LEU . 43.6 mt -89.0 128.73 40.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 N-CA-C 108.248 -1.019 . . . . 75.15 108.248 176.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -135.08 123.9 23.91 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.175 0.59 . . . . 73.4 110.1 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' D' ' 55' ' ' VAL . 57.8 m -74.19 108.46 7.0 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.081 -0.711 . . . . 64.54 109.081 166.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.512 HD11 HD22 ' D' ' 98' ' ' LEU . 45.1 pt -105.22 138.29 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.355 0.662 . . . . 71.11 109.271 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.554 ' HA ' HG23 ' H' ' 451' ' ' VAL . . . -167.76 170.43 10.86 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.377 1.071 . . . . 73.23 108.934 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.19 -15.1 29.93 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-O 119.899 -0.39 . . . . 63.32 112.718 -177.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 pp -128.49 134.97 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.401 1.08 . . . . 75.22 109.631 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -132.42 158.36 42.21 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.851 0.861 . . . . 73.43 109.726 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.08 -127.05 39.87 Favored Glycine 0 C--N 1.355 1.587 0 O-C-N 124.366 1.041 . . . . 62.42 114.426 172.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 75.1 p -63.17 -39.86 95.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.699 0.8 . . . . 75.31 111.257 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -73.76 -27.11 60.99 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.578 -0.737 . . . . 71.12 111.623 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.497 ' HG3' ' O ' ' H' ' 451' ' ' VAL . 18.3 tmm? -70.93 -44.72 65.54 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 109.516 -0.549 . . . . 74.31 109.516 172.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.04 -25.04 66.63 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.519 0.728 . . . . 64.22 111.462 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.49 ' HE2' ' HB3' ' D' ' 134' ' ' ASP . 14.2 t-160 -78.67 -38.51 39.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.785 0.834 . . . . 74.04 110.713 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -73.69 -27.29 61.14 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.258 0.623 . . . . 73.15 111.506 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.512 HD22 HD11 ' D' ' 86' ' ' ILE . 2.3 tm? -100.1 -54.01 2.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.311 1.044 . . . . 75.31 109.819 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.9 14.42 58.72 Favored Glycine 0 N--CA 1.472 1.065 0 CA-C-O 119.557 -0.579 . . . . 61.23 114.433 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.51 ' HA ' ' HD2' ' D' ' 133' ' ' PHE . . . -149.74 -55.44 0.17 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.574 0.687 . . . . 75.41 112.016 -178.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -72.6 -37.85 68.0 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 112.233 0.457 . . . . 74.13 112.233 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.543 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 96.6 m -61.94 -46.93 92.28 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 118.687 -0.673 . . . . 70.45 112.392 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.44 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 82.4 Cg_exo -52.06 -35.29 61.13 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.285 1.99 . . . . 74.41 114.325 167.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -68.67 -25.34 64.76 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 122.909 0.484 . . . . 64.32 112.079 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.585 HD12 HD11 ' D' ' 13' ' ' ILE . 23.8 mm -73.01 -40.05 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.706 0.765 . . . . 74.1 109.813 171.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.47 HD22 ' HA3' ' D' ' 82' ' ' GLY . 91.8 mt -77.27 -26.8 52.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.776 -1.102 . . . . 64.53 112.839 -173.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -62.83 -43.5 83.08 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 113.725 1.009 . . . . 74.11 113.725 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.42 -45.87 34.86 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.051 1.834 . . . . 75.33 113.949 171.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -72.26 -37.15 69.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.584 0.754 . . . . 73.0 111.342 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.41 90.2 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.906 0.882 . . . . 74.44 110.43 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.468 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 29.4 ttp180 -55.22 -52.71 62.48 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 114.523 -1.217 . . . . 75.22 110.181 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -60.16 -43.41 95.79 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.295 0.997 . . . . 74.12 111.629 -174.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.2 t -59.41 -43.97 92.93 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.512 0.508 . . . . 73.31 110.771 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.445 HG21 ' SG ' ' D' ' 76' ' ' CYS . 80.6 mt -64.8 -49.68 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.918 0.887 . . . . 74.22 110.987 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 23.2 m -56.31 -40.82 74.99 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.414 1.086 . . . . 63.25 111.192 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 14.4 t -66.59 -44.24 82.71 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 114.447 -1.251 . . . . 64.32 110.045 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.488 ' HE2' ' HG ' ' D' ' 76' ' ' CYS . 75.1 mtm -67.87 -32.01 72.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.904 0.482 . . . . 73.43 111.82 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.408 HG23 ' O ' ' D' ' 114' ' ' ILE . 61.9 t -67.65 -42.7 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.681 0.793 . . . . 75.03 110.216 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.2 p -74.87 -29.95 61.17 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.829 0.451 . . . . 75.13 111.181 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -72.3 -36.73 69.02 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.622 0.769 . . . . 64.21 109.893 174.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.96 2.7 79.65 Favored Glycine 0 C--N 1.356 1.657 0 O-C-N 123.696 0.622 . . . . 74.44 112.427 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.3 p 62.28 23.26 13.75 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.819 2.048 . . . . 73.22 113.964 171.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.401 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.2 m-85 -83.54 155.85 65.62 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 109.029 -0.73 . . . . 70.35 109.029 167.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.79 142.24 97.15 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 122.39 2.06 . . . . 73.44 111.405 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -51.6 147.67 6.14 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.256 1.422 . . . . 72.2 113.669 -167.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.582 ' HA ' HD12 ' H' ' 468' ' ' LEU . 23.2 tp -122.61 98.82 6.09 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.003 0.521 . . . . 74.11 110.477 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -101.73 92.18 4.73 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.696 0.798 . . . . 74.21 109.849 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.468 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -64.38 118.52 8.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.453 0.701 . . . . 71.31 110.397 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -60.57 132.9 91.26 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 123.466 0.707 . . . . 72.0 111.021 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 4.7 Cg_exo -73.09 117.59 5.18 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.795 2.33 . . . . 72.44 111.287 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.61 145.36 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.016 0.526 . . . . 74.12 110.926 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -89.27 97.9 11.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.019 0.928 . . . . 75.41 109.946 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.51 ' HD2' ' HA ' ' D' ' 100' ' ' ALA . 7.5 t80 -76.19 -16.97 59.74 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.263 0.625 . . . . 70.23 111.183 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.49 ' HB3' ' HE2' ' D' ' 96' ' ' HIS . 13.1 m-20 -62.65 -49.23 75.96 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.325 0.65 . . . . 74.13 110.924 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.92 -45.87 89.29 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.643 0.59 . . . . 72.02 110.597 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' D' ' 133' ' ' PHE . 82.4 mt -58.56 -42.18 87.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.629 -1.169 . . . . 74.54 111.925 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -67.69 -43.76 79.38 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.649 0.78 . . . . 75.4 110.973 -178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 73.7 mtm -65.94 -27.83 68.46 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.591 0.356 . . . . 73.25 110.76 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -74.22 -34.12 63.59 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.044 -0.525 . . . . 73.4 110.779 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -66.13 -36.85 84.22 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.105 0.562 . . . . 74.52 111.095 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.6 mp -70.31 -30.4 67.38 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.065 0.546 . . . . 73.12 111.765 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.41 ' NE2' ' HA2' ' D' ' 148' ' ' GLY . 13.3 pt20 -91.3 10.06 28.87 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.753 0.421 . . . . 75.33 112.07 174.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -120.2 89.87 3.21 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.964 0.888 . . . . 74.14 110.069 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -144.86 -62.79 0.36 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 106.238 -1.764 . . . . 74.23 106.238 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.9 -14.61 25.85 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.242 1.017 . . . . 75.13 110.913 171.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.15 97.86 1.46 Allowed Glycine 0 C--N 1.352 1.435 0 O-C-N 123.532 0.52 . . . . 50.32 111.837 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.32 -179.82 5.87 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.08 0.952 . . . . 55.45 110.651 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . 0.41 ' HA2' ' NE2' ' D' ' 142' ' ' GLN . . . -146.5 124.76 2.07 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-O 119.879 -0.4 . . . . 61.22 112.341 -176.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 12.9 t -70.56 -20.15 62.81 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.591 0.756 . . . . 73.11 111.864 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 66.36 101.42 0.04 OUTLIER 'General case' 0 C--N 1.358 0.969 0 C-N-CA 125.425 1.49 . . . . 75.44 111.449 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.13 87.46 1.08 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.947 -0.76 . . . . 74.45 108.947 171.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -150.89 155.63 39.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 108.498 -0.927 . . . . 73.4 108.498 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 72.28 142.01 0.06 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.081 1.352 . . . . 75.53 110.159 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -69.98 81.33 0.48 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.509 -0.552 . . . . 71.11 109.509 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.864 0 C-N-CA 124.139 0.975 . . . . 73.01 109.741 -176.249 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.257 -0.275 . . . . 73.42 110.257 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 87' ' ' ALA . 7.9 p -176.92 -22.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 124.909 1.284 . . . . 71.51 109.573 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . 0.63 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 12.5 p -147.05 147.48 17.6 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 123.818 0.847 . . . . 64.01 109.951 -171.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . 0.44 ' N ' ' HE1' ' A' ' 94' ' ' MET . . . 175.81 145.86 5.67 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.052 -0.522 . . . . 71.45 112.616 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . 0.431 ' HB3' HD11 ' A' ' 98' ' ' LEU . 9.6 tt -162.01 108.43 1.31 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 106.414 -1.698 . . . . 73.25 106.414 173.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 4.8 m -104.97 -10.41 17.26 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.603 0.761 . . . . 71.13 110.16 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -94.45 62.04 2.82 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.114 0.966 . . . . 74.12 110.244 -177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -86.84 -163.33 0.89 Allowed 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 115.33 -0.85 . . . . 72.53 110.644 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 11.3 m 69.23 52.0 0.49 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.765 1.226 . . . . 75.21 111.109 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -161.65 134.47 6.1 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.95 -1.477 . . . . 74.53 107.946 171.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . 0.449 ' HG ' ' HB2' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -113.56 107.53 15.92 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 106.397 -1.705 . . . . 74.43 106.397 169.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -81.49 44.43 0.8 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.685 1.194 . . . . 73.44 111.912 -175.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . 0.484 ' HE2' ' SD ' ' E' ' 464' ' ' MET . 29.5 t80 -162.98 128.79 3.26 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.996 0.918 . . . . 75.33 109.205 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 1.7 t -80.45 110.42 15.9 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.255 -1.017 . . . . 74.15 108.255 171.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 464' ' ' MET . . . . . 0.505 ' HG3' ' HA ' ' E' ' 467' ' ' ALA . 12.8 tpt -65.87 87.23 0.09 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 121.986 0.898 . . . . 70.12 110.812 -173.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -77.79 -43.74 29.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.046 -1.434 . . . . 74.44 110.813 -174.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 129' ' ' ALA . . . -61.52 -43.25 99.2 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.124 -0.944 . . . . 72.53 110.226 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . 0.505 ' HA ' ' HG3' ' E' ' 464' ' ' MET . . . 49.76 -103.03 0.11 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.572 1.549 . . . . 70.52 113.303 177.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . 0.613 ' HB3' HD13 ' A' ' 126' ' ' LEU . 95.3 mt -134.69 119.97 18.93 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.596 0.758 . . . . 73.54 109.439 -166.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -83.52 92.26 1.66 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 111.45 -0.66 . . . . 71.24 111.45 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 6.4 tt -138.48 -59.77 0.62 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.557 -0.905 . . . . 73.34 108.557 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . 0.466 ' HE3' HG22 ' A' ' 40' ' ' VAL . 7.8 mtmp? . . . . . 0 C--O 1.256 1.404 0 C-N-CA 123.789 0.836 . . . . 73.21 110.022 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.657 -0.127 . . . . 74.43 110.657 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.75 -29.64 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 122.983 0.513 . . . . 75.12 111.334 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . 0.523 HG11 HD13 ' B' ' 86' ' ' ILE . 34.1 m -74.91 174.66 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.207 1.003 . . . . 74.11 113.425 -173.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 176.05 -94.67 0.1 OUTLIER Glycine 0 C--N 1.35 1.344 0 CA-C-O 119.368 -0.684 . . . . 75.51 111.713 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 64.89 98.44 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 124.976 1.31 . . . . 72.03 112.029 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 23.8 m -116.24 90.73 3.4 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.363 -0.606 . . . . 75.0 109.363 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -102.07 159.31 15.49 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.823 0.849 . . . . 70.22 110.572 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -167.96 150.59 5.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.504 1.122 . . . . 74.14 108.635 176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 18.7 m 74.56 161.89 0.25 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.633 1.173 . . . . 70.3 110.385 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -56.52 137.2 53.8 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.482 0.713 . . . . 74.3 110.395 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 74.3 mt -74.65 165.75 24.7 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.057 0.543 . . . . 74.1 111.662 -175.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -52.18 138.72 25.29 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.262 -1.335 . . . . 72.15 111.272 171.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.9 -56.19 0.77 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 109.106 -0.702 . . . . 73.32 109.106 175.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 14.7 m 73.18 -40.96 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.272 1.429 . . . . 75.21 113.617 172.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 464' ' ' MET . . . . . 0.523 ' HE1' ' HB1' ' B' ' 129' ' ' ALA . 3.0 ppp? -74.79 82.47 2.12 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 122.333 1.064 . . . . 64.2 111.366 -174.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.14 -23.05 62.0 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.8 -1.091 . . . . 74.5 109.109 171.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -78.03 83.1 4.34 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.277 -1.009 . . . . 73.44 108.277 165.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -86.81 -146.0 0.12 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.411 1.084 . . . . 75.53 110.255 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 6.3 tt -53.16 -43.42 67.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.758 0.823 . . . . 74.32 109.824 174.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 99.62 -21.11 46.7 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 115.825 -0.625 . . . . 74.43 112.74 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 61.73 -84.96 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.021 1.328 . . . . 74.3 110.715 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.16 0 N-CA-C 108.36 -0.978 . . . . 74.13 108.36 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . 0.49 ' HA ' ' HB3' ' C' ' 53' ' ' ASP . 16.2 p-10 . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 118.722 -0.656 . . . . 72.11 110.268 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' C' ' 87' ' ' ALA . 62.2 t 26.18 75.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 126.622 1.969 . . . . 73.13 114.455 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . 0.535 HG12 ' NE2' ' C' ' 50' ' ' GLN . 17.2 m -137.15 153.45 29.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 113.871 -1.513 . . . . 73.22 109.053 176.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 169.96 -49.07 0.2 Allowed Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.918 -0.473 . . . . 61.24 111.918 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' C' ' 95' ' ' ALA . 49.6 tp -68.94 105.61 2.44 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 122.769 0.428 . . . . 73.35 109.942 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 2.9 m -126.5 28.57 5.92 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.46 1.104 . . . . 74.22 109.52 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.81 141.71 50.8 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.934 0.894 . . . . 73.13 108.825 173.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -85.35 -36.95 20.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.001 0.921 . . . . 74.13 109.895 -177.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 32.6 m 68.19 0.04 2.31 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.87 1.268 . . . . 74.41 111.248 -171.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 55.09 -85.4 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.921 1.288 . . . . 71.13 109.273 -164.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 56.7 tp -177.31 130.64 0.16 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.535 -1.654 . . . . 73.01 106.535 165.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -87.66 29.82 0.87 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.077 0.951 . . . . 72.35 111.008 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -144.13 104.44 4.12 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.877 -0.786 . . . . 74.5 108.877 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 53.3 p -63.39 -38.27 90.51 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 124.255 0.972 . . . . 74.32 110.189 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 464' ' ' MET . . . . . 0.425 ' SD ' ' HB2' ' G' ' 466' ' ' ALA . 0.3 OUTLIER 78.97 -43.14 0.32 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.59 1.956 . . . . 75.53 111.091 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 58.6 tttp 76.09 -70.26 0.15 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.964 1.706 . . . . 75.33 110.331 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . 0.425 ' HB2' ' SD ' ' G' ' 464' ' ' MET . . . 63.83 146.86 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.543 1.537 . . . . 74.2 112.704 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -159.74 89.9 0.9 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.516 -1.661 . . . . 71.32 106.516 170.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.67 147.86 47.06 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.582 -0.525 . . . . 74.41 109.582 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -80.64 61.11 4.53 Favored Glycine 0 C--N 1.346 1.086 0 O-C-N 123.536 0.523 . . . . 62.52 112.289 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . 0.426 HD11 ' HG ' ' C' ' 126' ' ' LEU . 60.2 mt -92.96 54.31 2.15 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.174 0.99 . . . . 74.43 108.776 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? . . . . . 0 C--O 1.249 1.04 0 N-CA-C 107.941 -1.133 . . . . 74.04 107.941 -169.33 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 . . . . . 0 N--CA 1.486 1.325 0 N-CA-C 108.856 -0.794 . . . . 73.54 108.856 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . 0.635 HG12 HG11 ' H' ' 452' ' ' VAL . 9.7 p -77.51 -41.76 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 122.311 0.244 . . . . 74.43 111.136 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.635 HG11 HG12 ' H' ' 451' ' ' VAL . 25.1 m -94.5 -177.03 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 122.818 0.447 . . . . 70.42 111.988 -174.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 101.46 79.94 1.45 Allowed Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.661 -0.699 . . . . 72.25 112.623 169.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 1.4 pp -148.22 172.56 14.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.699 0.762 . . . . 74.3 111.845 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 19.8 p -139.51 143.21 37.35 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.376 1.87 . . . . 74.41 106.443 168.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.5 -57.98 10.42 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.176 0.591 . . . . 60.11 109.873 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 59.01 19.95 7.74 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.856 1.262 . . . . 73.52 112.653 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 15.2 t -144.92 158.1 43.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.973 0.509 . . . . 70.03 110.427 -175.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -111.66 -70.32 0.82 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.793 0.837 . . . . 72.35 109.253 -175.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' D' ' 44' ' ' LEU . 42.7 tp -161.92 146.47 12.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.39 1.076 . . . . 71.54 108.904 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . 0.4 ' H ' HD12 ' H' ' 460' ' ' LEU . 4.2 p90 -142.13 43.59 1.67 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.497 1.119 . . . . 75.22 109.29 -177.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . 0.46 ' HB3' HD13 ' H' ' 460' ' ' LEU . 54.2 t80 -150.88 145.67 25.8 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.946 -1.024 . . . . 75.12 110.2 -175.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 90.5 m -140.9 139.48 34.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.198 0.999 . . . . 70.51 109.465 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 60.0 ttp -154.92 -46.32 0.08 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.63 0.772 . . . . 75.52 109.705 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . 0.59 ' HG2' ' H ' ' H' ' 466' ' ' ALA . 14.9 ttpt 68.98 -174.05 0.19 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.95 1.3 . . . . 73.43 108.568 -171.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . 0.59 ' H ' ' HG2' ' H' ' 465' ' ' LYS . . . 71.02 -170.77 0.16 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.819 0.848 . . . . 70.53 112.333 168.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . 0.41 ' HB1' HD11 ' H' ' 468' ' ' LEU . . . -167.15 -67.17 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.66 0.784 . . . . 74.31 109.743 177.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . 0.582 HD12 ' HA ' ' D' ' 126' ' ' LEU . 2.9 mp -88.3 -45.05 10.36 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.812 -0.631 . . . . 63.05 109.874 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.65 -23.46 0.64 Allowed Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.242 -0.89 . . . . 74.32 112.292 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . 0.468 HD13 ' HG3' ' D' ' 37' ' ' GLN . 3.1 mm? 63.15 63.71 0.9 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.348 1.059 . . . . 74.44 109.657 176.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp . . . . . 0 C--O 1.253 1.267 0 CA-C-N 114.9 -1.046 . . . . 74.4 109.153 -174.7 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 121.12 0.486 . . . . 74.05 109.809 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -147.88 144.96 28.46 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.879 1.271 . . . . 74.32 108.063 175.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.597 ' HG2' ' H ' ' A' ' 4' ' ' GLN . 33.6 tt0 65.88 -171.3 0.19 Allowed 'General case' 0 CA--C 1.567 1.602 0 O-C-N 124.242 0.964 . . . . 74.24 109.231 -176.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.597 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 24.3 tt0 -59.15 93.1 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.946 0.899 . . . . 73.45 110.014 170.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.02 -51.39 2.12 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.158 0.983 . . . . 73.15 108.921 -175.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -78.8 85.15 4.82 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.19 -0.67 . . . . 63.14 109.19 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.9 m -143.96 106.39 4.41 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.707 -1.22 . . . . 70.42 107.707 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -63.78 88.94 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 O-C-N 123.828 0.705 . . . . 62.43 109.859 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 mpt? 65.16 154.97 0.07 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.016 1.327 . . . . 73.3 111.824 -176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.4 m -145.61 123.43 11.94 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.13 -1.063 . . . . 62.43 108.13 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.648 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.6 t80 -138.48 129.88 27.45 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.826 0.346 . . . . 74.11 110.472 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -153.23 108.64 3.24 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 107.811 -1.181 . . . . 75.24 107.811 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.425 HG12 ' HD2' ' A' ' 84' ' ' PHE . 52.8 mt -74.51 116.32 16.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.815 -0.439 . . . . 74.43 109.815 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -74.13 -42.11 60.52 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.072 0.858 . . . . 74.23 110.781 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -178.31 121.39 0.1 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.162 0.289 . . . . 75.01 110.734 -169.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 82.4 mt -106.96 129.56 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.717 0.807 . . . . 75.32 108.878 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -163.06 148.39 11.7 Favored 'General case' 0 C--N 1.346 0.418 0 O-C-N 123.646 0.591 . . . . 74.44 111.653 -174.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.1 p -75.02 112.39 11.2 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.863 -0.608 . . . . 63.42 109.406 175.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 35.7 mtpt -80.79 -23.78 39.03 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.421 -0.354 . . . . 74.31 110.192 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.2 t70 -153.24 142.08 21.11 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.964 0.906 . . . . 75.51 110.393 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.6 mt -135.03 141.73 42.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 125.64 1.576 . . . . 74.12 107.574 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.7 t -145.72 112.42 5.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.141 0.576 . . . . 71.31 110.026 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.504 ' HB2' ' HE1' ' A' ' 117' ' ' MET . 87.5 t80 -125.83 119.92 29.15 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.3 -1.0 . . . . 75.34 108.3 174.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -118.42 136.2 53.91 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.927 -0.768 . . . . 74.41 108.927 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.731 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -148.67 78.78 8.97 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 107.813 -1.18 . . . . 74.31 107.813 170.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.35 -29.93 5.76 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.698 2.265 . . . . 75.43 111.253 175.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -102.7 23.55 11.88 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.943 1.297 . . . . 73.55 109.909 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.731 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -58.82 -45.06 99.64 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 125.26 1.424 . . . . 75.34 112.327 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -64.81 -34.11 50.82 Favored 'Trans proline' 0 C--N 1.399 3.217 0 CA-C-N 120.995 1.391 . . . . 73.51 112.713 172.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.427 ' HA ' ' OE1' ' A' ' 33' ' ' GLN . 30.4 m170 -68.76 -16.23 63.74 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.527 0.731 . . . . 75.2 112.616 -171.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 28' ' ' ALA . 9.3 p -72.73 -19.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 122.438 0.295 . . . . 73.22 110.665 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -78.5 -29.03 46.41 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 108.412 -0.959 . . . . 74.2 108.412 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.427 ' OE1' ' HA ' ' A' ' 30' ' ' HIS . 1.0 OUTLIER -80.95 -54.78 5.27 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.931 -1.031 . . . . 73.21 110.737 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 30' ' ' HIS . 54.5 mtmt -84.78 171.43 12.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.093 0.957 . . . . 73.35 112.577 -173.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.29 153.2 21.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.848 0.859 . . . . 64.44 109.819 172.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.602 ' HE1' ' HB3' ' E' ' 470' ' ' LEU . 66.3 t-105 -85.2 94.05 8.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.42 0.688 . . . . 74.14 110.756 -173.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -127.37 83.56 65.71 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.175 0.99 . . . . 74.21 108.868 172.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -86.54 149.75 8.84 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.61 2.207 . . . . 75.24 112.72 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -99.09 91.66 5.11 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.613 -1.254 . . . . 64.3 107.613 168.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -66.34 99.06 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 CA-C-O 121.701 0.762 . . . . 75.11 110.388 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -108.16 113.35 26.42 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.531 -0.914 . . . . 72.1 108.531 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -107.06 145.23 32.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.54 0.736 . . . . 63.44 109.059 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -139.42 133.21 30.69 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.498 1.119 . . . . 54.53 108.484 174.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -119.48 123.15 43.32 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 109.059 -0.719 . . . . 74.23 109.059 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 24.3 m-20 -119.81 121.7 39.71 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.764 -0.828 . . . . 71.21 108.764 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.633 ' HB ' HD22 ' E' ' 460' ' ' LEU . 31.4 m -106.95 122.87 47.28 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.767 -0.827 . . . . 74.43 108.767 175.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.68 151.33 49.15 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.945 0.898 . . . . 62.21 108.66 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.5 m -132.8 155.87 48.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.178 -0.675 . . . . 75.23 109.178 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -148.03 128.96 14.41 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.78 0.432 . . . . 74.3 110.378 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -73.7 107.7 6.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.91 0.884 . . . . 72.42 109.839 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.1 mt -78.37 -41.26 33.88 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.751 -0.659 . . . . 71.21 109.512 175.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.65 -179.18 7.86 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.647 1.179 . . . . 65.22 108.752 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -61.98 113.26 2.71 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.672 0.389 . . . . 73.53 110.243 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 68.39 12.23 8.65 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.89 1.276 . . . . 64.12 112.28 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.48 110.7 33.16 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 N-CA-C 107.485 -1.302 . . . . 74.23 107.485 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -126.24 152.88 45.51 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.812 -0.81 . . . . 75.01 108.812 -174.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -117.84 153.58 33.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.658 -0.867 . . . . 73.42 108.658 167.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.5 t -117.98 125.24 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.24 -1.392 . . . . 75.43 107.24 167.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.86 107.61 22.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 124.099 0.96 . . . . 64.35 108.681 174.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.7 tp -99.78 101.85 13.13 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.871 -0.788 . . . . 74.03 108.871 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.489 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 14.4 ttm180 -84.42 102.75 13.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.187 -0.672 . . . . 75.02 109.187 175.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.8 t -95.32 102.33 13.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.279 -1.008 . . . . 74.15 108.279 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.4 m -98.25 119.46 36.95 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.047 0.939 . . . . 72.03 110.322 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.502 ' O ' HD13 ' A' ' 75' ' ' LEU . 97.9 t -115.51 123.84 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.926 0.89 . . . . 74.23 108.874 175.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 t -132.2 126.63 34.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.516 -0.92 . . . . 52.15 108.516 169.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -124.13 107.13 10.93 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.633 -0.877 . . . . 71.05 108.633 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.6 p -113.85 143.02 45.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.653 0.781 . . . . 65.32 111.021 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.509 HD21 ' H ' ' A' ' 68' ' ' LEU . 1.3 pt? -110.61 85.87 2.2 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.103 -1.073 . . . . 70.33 108.103 171.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.89 -125.57 8.03 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 114.66 -1.155 . . . . 73.13 110.932 -173.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -87.72 -26.87 22.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.593 0.697 . . . . 71.11 109.621 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -76.23 118.97 19.5 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 123.006 0.522 . . . . 53.23 110.779 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.7 m -77.19 132.42 38.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.192 -0.67 . . . . 73.54 109.192 171.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.03 -57.08 3.99 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.616 -0.883 . . . . 74.4 108.616 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -149.39 152.59 36.02 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.88 -1.055 . . . . 73.41 111.223 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 64' ' ' VAL . 40.9 tp -114.3 135.19 54.35 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.147 -1.427 . . . . 71.13 107.147 166.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.1 m -135.96 98.1 3.8 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.481 -0.933 . . . . 72.23 108.481 170.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -125.11 116.04 21.43 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.717 1.207 . . . . 75.43 108.379 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.4 t -128.73 115.69 38.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.765 0.826 . . . . 61.02 109.466 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 72.0 mt-30 -85.51 84.98 7.46 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 107.973 -1.121 . . . . 75.13 107.973 170.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.479 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.4 tp-100 -76.47 99.58 4.96 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.715 -1.13 . . . . 74.4 108.186 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.86 155.79 29.37 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 110.683 -0.967 . . . . 73.22 110.683 176.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.34 120.63 0.98 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.351 -1.1 . . . . 73.31 110.351 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.9 mt -81.5 122.22 36.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.109 -1.071 . . . . 73.44 108.109 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.648 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 43.8 m-85 -123.46 118.15 26.78 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.834 -1.173 . . . . 74.22 107.834 -176.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.0 t -84.69 104.0 14.28 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.52 -1.289 . . . . 64.41 107.52 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.85 139.97 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 116.118 -0.492 . . . . 75.22 110.874 -170.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.685 ' HA ' HG23 ' E' ' 451' ' ' VAL . . . -156.82 176.05 13.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.357 1.063 . . . . 64.32 110.239 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.02 -7.11 62.41 Favored Glycine 0 N--CA 1.475 1.235 0 N-CA-C 114.961 0.744 . . . . 71.23 114.961 172.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.577 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -138.75 158.21 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 117.885 0.843 . . . . 74.13 110.859 -177.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 94' ' ' MET . 0.9 OUTLIER -154.37 174.48 14.8 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.965 0.506 . . . . 75.25 109.989 179.472 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.34 -127.52 26.72 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 114.528 0.571 . . . . 75.32 114.528 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.562 HG21 ' HB2' ' C' ' 153' ' ' GLN . 16.5 p -68.78 -20.89 64.36 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.196 0.598 . . . . 75.2 111.234 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -75.9 -42.99 47.41 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.659 0.784 . . . . 71.35 109.893 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.479 ' SD ' ' HA ' ' E' ' 452' ' ' VAL . 25.6 ptt? -72.97 -27.94 62.11 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 110.038 -0.356 . . . . 72.53 110.038 175.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.12 -27.71 65.81 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 115.803 -0.635 . . . . 72.02 110.269 173.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -78.31 -30.14 48.12 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.218 0.607 . . . . 74.03 111.125 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.577 ' SG ' HG13 ' A' ' 89' ' ' ILE . 70.9 m -61.86 -46.59 88.8 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.875 -0.602 . . . . 74.31 111.09 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -81.26 -24.57 37.23 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.096 -0.502 . . . . 73.0 110.605 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.24 -33.21 49.84 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 114.772 0.669 . . . . 75.35 114.772 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.53 -45.75 0.17 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.379 0.589 . . . . 71.22 112.091 -169.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -62.54 -64.47 0.91 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.512 1.125 . . . . 72.45 112.035 -168.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 92.7 m -78.6 -33.61 0.93 Allowed Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.428 1.27 . . . . 73.53 114.428 -174.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 35.4 Cg_endo -64.18 -30.77 64.91 Favored 'Trans proline' 0 C--N 1.394 2.959 0 CA-C-N 122.23 1.832 . . . . 73.11 112.841 171.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -69.29 -26.57 64.81 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.677 0.391 . . . . 75.34 110.882 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.61 -40.9 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 73.43 110.125 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.479 HD23 ' HG3' ' A' ' 80' ' ' GLN . 79.7 mt -80.6 -21.82 41.22 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.067 0.947 . . . . 71.15 112.613 -174.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -63.57 -44.27 80.58 Favored Pre-proline 0 CA--C 1.567 1.605 0 CA-C-O 117.64 -1.171 . . . . 74.54 113.229 -172.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.4 -34.48 76.55 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.112 1.874 . . . . 63.55 113.474 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.455 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 93.3 m-85 -72.97 -41.25 64.58 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.211 0.605 . . . . 75.4 111.329 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.45 -38.2 74.47 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.994 0.518 . . . . 71.35 110.182 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.523 ' HA ' HD21 ' A' ' 128' ' ' LEU . 29.7 ttm180 -54.44 -51.15 65.86 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.203 1.001 . . . . 73.23 109.888 174.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.63 -48.39 77.49 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.485 1.116 . . . . 75.25 111.361 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.41 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.1 t -55.91 -44.58 78.41 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.047 0.842 . . . . 64.11 110.538 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.473 ' O ' HG21 ' A' ' 118' ' ' VAL . 74.5 mt -65.22 -50.5 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.526 1.13 . . . . 71.24 110.747 176.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.455 HG21 ' HE2' ' C' ' 109' ' ' TYR . 95.0 m -53.17 -46.07 68.77 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.835 0.854 . . . . 75.22 110.322 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -65.13 -46.23 81.84 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.922 -1.49 . . . . 74.22 109.527 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.504 ' HE1' ' HB2' ' A' ' 23' ' ' PHE . 37.5 mtp -59.43 -41.18 88.96 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.696 0.798 . . . . 71.32 111.865 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 114' ' ' ILE . 93.4 t -62.94 -45.61 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.912 0.885 . . . . 71.33 110.236 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.3 m -72.58 -27.45 62.19 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.447 -0.797 . . . . 74.24 111.831 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.596 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.9 mtt-85 -75.12 -31.72 61.18 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.492 0.717 . . . . 73.22 109.723 175.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.13 -0.7 86.62 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.58 -0.736 . . . . 64.11 112.878 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m 69.53 20.12 7.24 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.763 1.225 . . . . 73.03 111.047 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -89.67 146.87 36.44 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 123.45 0.7 . . . . 75.11 109.657 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.64 133.09 31.98 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.52 2.813 . . . . 74.41 113.517 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.452 ' HG3' HG22 ' A' ' 115' ' ' THR . 31.6 tt0 -54.93 137.44 45.71 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.238 1.015 . . . . 73.41 113.24 -170.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.7 tp -119.82 102.4 8.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.859 1.264 . . . . 74.45 109.349 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -99.34 114.65 27.64 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.213 -1.403 . . . . 64.04 107.213 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 111' ' ' ARG . 3.7 mm? -62.53 132.9 54.0 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.099 0.559 . . . . 74.24 110.476 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.8 146.01 91.47 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.213 0.605 . . . . 62.54 110.776 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.56 ' HG3' ' HD2' ' C' ' 11' ' ' PHE . 34.2 Cg_endo -60.74 112.16 1.26 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.382 2.054 . . . . 64.13 111.323 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 80.6 t -99.92 113.91 36.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 108.473 -0.936 . . . . 74.44 108.473 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -78.79 85.95 4.75 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 108.767 -0.827 . . . . 75.34 108.767 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -64.02 -27.82 69.38 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.649 -0.705 . . . . 74.01 111.144 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.07 -48.45 76.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.801 0.84 . . . . 72.22 110.224 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.43 -57.01 12.8 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.003 -0.999 . . . . 73.01 110.463 175.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.2 mt -58.05 -36.73 73.19 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.562 1.145 . . . . 74.44 112.812 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.48 ' CZ ' HD21 ' A' ' 141' ' ' LEU . 42.6 t80 -61.62 -50.81 71.08 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.772 0.67 . . . . 73.11 110.381 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 95.2 mmm -68.33 -26.39 65.58 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.909 -0.587 . . . . 62.2 110.612 -174.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 55.3 m-80 -63.07 -42.7 99.71 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.288 0.635 . . . . 74.41 110.659 170.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.604 ' HB2' ' HB3' ' E' ' 461' ' ' PHE . 0.1 OUTLIER -61.32 -46.23 91.13 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.147 0.979 . . . . 75.44 110.524 174.194 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.48 HD21 ' CZ ' ' A' ' 137' ' ' PHE . 19.9 tp -70.21 -50.25 41.88 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.37 -1.286 . . . . 75.34 112.926 -165.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.23 9.94 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.383 0.427 . . . . 74.15 110.162 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 75.5 mt-30 58.85 -171.83 0.11 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.312 1.045 . . . . 74.23 112.432 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.8 -174.03 4.66 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.594 1.158 . . . . 70.42 108.883 171.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.37 -59.95 0.09 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.321 0.648 . . . . 71.32 109.559 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.26 125.63 0.79 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 111.341 -0.703 . . . . 73.32 111.341 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -113.58 -29.44 7.16 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.081 0.953 . . . . 73.34 110.784 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.25 -104.14 3.12 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-O 119.058 -0.857 . . . . 72.41 112.012 -176.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.5 m 70.18 128.88 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.068 1.347 . . . . 74.43 109.735 -169.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -58.52 5.98 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 109.345 -0.613 . . . . 73.54 109.345 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.14 110.71 21.99 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.467 -0.938 . . . . 73.31 108.467 -177.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -164.92 172.11 13.23 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.482 1.113 . . . . 74.23 109.309 -176.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -81.28 -42.43 20.65 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.066 0.546 . . . . 74.44 110.666 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -73.93 170.88 14.49 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.937 0.895 . . . . 74.21 111.387 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.059 0 C-N-CA 123.581 0.752 . . . . 71.34 111.47 -173.477 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 95.0 mmm . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.267 -0.272 . . . . 74.14 110.267 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 44.3 p -75.5 78.68 2.53 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.54 -0.911 . . . . 60.13 108.54 170.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -166.34 140.78 4.33 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.692 -1.14 . . . . 75.41 109.465 -166.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -146.92 163.73 35.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.686 0.794 . . . . 75.53 109.094 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -115.31 171.85 7.44 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.348 0.659 . . . . 74.15 110.482 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -129.25 136.17 49.74 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.158 -1.053 . . . . 75.22 108.158 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -154.7 170.72 20.9 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.231 0.612 . . . . 73.5 110.294 -172.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.45 137.32 54.38 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.948 -0.76 . . . . 73.2 108.948 167.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.501 ' HE1' ' HB2' ' B' ' 11' ' ' PHE . 21.3 ptm 48.86 -174.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 126.823 2.049 . . . . 75.13 114.364 -177.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 66.2 m -136.81 114.33 11.01 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.932 -0.766 . . . . 74.24 108.932 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.501 ' HB2' ' HE1' ' B' ' 9' ' ' MET . 59.0 t80 -136.11 137.35 40.94 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.712 -0.847 . . . . 72.51 108.712 175.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -148.5 140.8 24.16 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.562 0.745 . . . . 72.44 109.258 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.5 mt -90.32 113.55 26.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.434 -1.321 . . . . 73.33 107.434 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -76.22 -43.57 41.63 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.446 -0.576 . . . . 64.23 109.446 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -164.78 139.63 5.36 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.719 -0.673 . . . . 74.45 110.071 -175.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 88.2 mt -115.7 144.12 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 106.212 -1.773 . . . . 74.44 106.212 168.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.515 ' HE1' HG13 ' B' ' 83' ' ' ILE . 32.5 p90 -170.08 149.36 3.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.449 0.642 . . . . 75.11 111.648 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -77.81 125.71 29.76 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.872 -1.058 . . . . 74.32 109.347 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.424 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.3 mtpt -99.4 -21.51 15.96 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.872 0.869 . . . . 75.33 111.57 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -160.78 133.41 6.25 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.495 0.318 . . . . 74.43 110.441 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.507 HG22 ' HE2' ' B' ' 117' ' ' MET . 40.8 mm -126.33 137.91 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.273 -1.01 . . . . 74.44 108.273 168.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 37.2 t -139.48 134.21 31.98 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.746 -1.205 . . . . 72.11 107.746 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -150.32 109.48 3.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.895 -1.15 . . . . 63.14 107.895 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -119.71 115.0 23.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.278 1.031 . . . . 74.02 108.895 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.39 86.64 4.44 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 108.486 -0.931 . . . . 73.1 108.486 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.41 -32.45 8.02 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.742 2.295 . . . . 73.15 113.011 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -104.2 14.68 29.93 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.713 0.805 . . . . 75.13 110.403 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.484 ' HB1' ' HD3' ' B' ' 29' ' ' PRO . . . -38.39 -60.79 0.97 Allowed Pre-proline 0 CA--C 1.562 1.437 0 N-CA-C 114.758 1.392 . . . . 64.11 114.758 -165.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.484 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 20.4 Cg_exo -63.24 -35.28 64.2 Favored 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 122.101 1.867 . . . . 74.44 112.504 -175.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -78.84 -47.01 17.43 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.168 -0.923 . . . . 72.15 111.593 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.587 HG23 HD13 ' B' ' 68' ' ' LEU . 9.1 p -62.4 -22.4 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.583 0.753 . . . . 73.12 112.332 -167.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -63.34 -13.95 44.64 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.988 0.915 . . . . 73.12 112.993 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.51 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 25.6 pt20 -60.36 -33.14 72.01 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.422 1.089 . . . . 72.42 111.585 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.51 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.3 mttt -96.18 86.18 4.18 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.585 0.754 . . . . 74.0 108.993 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -74.22 97.36 2.95 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 115.806 -0.634 . . . . 74.03 110.902 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -163.43 157.3 19.69 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.32 1.448 . . . . 74.25 108.179 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.436 HE21 ' HA ' ' F' ' 470' ' ' LEU . 14.4 mt-30 -72.85 108.74 4.85 Favored Pre-proline 0 C--N 1.356 0.861 0 N-CA-C 107.827 -1.175 . . . . 74.04 107.827 169.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.446 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.0 Cg_endo -60.18 147.06 94.85 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.796 2.331 . . . . 73.41 113.702 -167.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 11.3 tp10 -53.31 109.33 0.42 Allowed 'General case' 0 N--CA 1.484 1.246 0 O-C-N 124.349 1.031 . . . . 75.14 110.42 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.526 HG11 HD21 ' F' ' 470' ' ' LEU . 14.9 p -88.87 131.03 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 O-C-N 123.7 0.625 . . . . 73.12 110.625 -172.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -121.23 121.75 38.45 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.597 -1.26 . . . . 71.02 107.597 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.562 ' HB2' ' HH ' ' F' ' 462' ' ' TYR . 1.9 mm? -106.05 124.88 50.28 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.763 -0.828 . . . . 74.03 108.763 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.511 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.5 m-20 -122.16 111.33 16.84 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.398 -1.705 . . . . 72.25 106.398 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 87.3 mt -101.38 127.21 48.13 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.157 -1.053 . . . . 75.42 108.157 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -140.02 136.5 33.77 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.384 -1.339 . . . . 75.24 107.384 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.5 p -128.96 115.85 18.46 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.827 -0.434 . . . . 71.14 109.827 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.7 134.82 54.65 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.443 -1.317 . . . . 74.31 107.443 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.0 m -138.89 162.88 33.74 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.316 0.507 . . . . 74.12 111.312 -172.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.0 p -157.8 143.3 17.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.744 0.818 . . . . 75.1 110.888 -172.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -83.4 135.21 34.78 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.711 0.804 . . . . 75.03 109.77 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 mt -99.26 -40.88 7.72 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.205 0.526 . . . . 75.34 109.891 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.85 -178.45 7.32 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.906 -1.043 . . . . 75.34 109.997 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -71.63 122.28 20.28 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.468 -0.787 . . . . 74.32 109.289 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 74.0 -4.76 2.19 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 125.765 1.626 . . . . 75.3 112.04 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.3 110.16 30.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.51 -0.922 . . . . 75.03 108.51 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -125.25 140.22 53.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.617 -0.883 . . . . 73.21 108.617 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -122.78 115.05 21.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.243 -1.021 . . . . 71.33 108.243 -171.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 83.5 t -99.37 141.98 15.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 123.815 0.846 . . . . 75.51 109.617 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.15 119.34 58.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 109.046 -0.724 . . . . 71.2 109.046 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.94 129.42 40.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.013 -1.476 . . . . 74.11 107.013 175.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -121.75 109.9 15.27 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.818 0.847 . . . . 72.11 109.04 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 56.0 t -104.76 102.81 14.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.257 -1.386 . . . . 74.34 107.257 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 24.4 m -97.86 126.06 43.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.886 -0.783 . . . . 74.31 108.886 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.606 HG22 HG21 ' B' ' 114' ' ' ILE . 70.2 t -116.31 121.9 68.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 124.792 1.237 . . . . 73.51 108.27 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 62.9 m -113.29 137.1 52.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.815 -0.809 . . . . 75.11 108.815 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -144.03 146.15 32.68 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 122.628 0.371 . . . . 71.21 110.602 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.456 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 76.0 p -150.32 140.63 22.28 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.656 0.598 . . . . 74.33 111.306 -174.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.587 HD13 HG23 ' B' ' 31' ' ' VAL . 76.5 mt -102.51 109.66 21.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.198 -1.038 . . . . 74.43 108.198 170.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.75 -131.61 37.22 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 116.001 -0.545 . . . . 74.15 112.389 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -95.92 14.7 22.65 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.477 0.547 . . . . 72.02 112.477 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.427 ' HG2' ' HZ3' ' B' ' 34' ' ' LYS . 12.6 pt-20 -126.7 141.0 51.98 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.961 0.505 . . . . 73.45 109.915 178.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 48.2 m -70.51 127.51 32.95 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 123.289 0.635 . . . . 71.3 111.233 -175.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.456 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -80.28 -67.36 0.77 Allowed 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.454 -0.943 . . . . 73.52 108.454 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . 0.506 ' HZ ' HD13 ' B' ' 126' ' ' LEU . 51.5 p90 -150.25 155.37 39.58 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-O 121.619 0.723 . . . . 72.51 111.869 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 33.7 mt -122.86 109.52 14.27 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.124 -1.806 . . . . 72.2 106.124 172.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 37.6 t -120.75 115.39 23.22 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.449 -0.574 . . . . 72.23 109.449 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -121.36 123.84 43.09 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.645 -1.242 . . . . 64.2 107.645 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.51 143.42 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.667 -0.864 . . . . 54.02 108.667 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -124.66 100.65 6.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.312 -0.858 . . . . 72.01 108.813 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.473 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.7 tp-100 -90.25 105.81 18.06 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.224 -0.658 . . . . 72.43 109.224 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.424 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.13 164.74 26.17 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.799 -0.521 . . . . 74.2 111.799 175.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.67 128.3 1.92 Allowed Glycine 0 CA--C 1.52 0.365 0 CA-C-O 120.024 -0.32 . . . . 72.44 112.497 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.515 HG13 ' HE1' ' B' ' 17' ' ' TYR . 48.5 mt -84.37 123.83 39.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.966 -0.753 . . . . 71.05 108.966 172.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -133.12 136.55 45.88 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.015 . . . . 65.24 108.795 -175.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.9 m -103.51 108.57 19.89 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.346 0.659 . . . . 72.42 110.047 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.61 HD11 HD23 ' B' ' 98' ' ' LEU . 41.0 pt -100.11 132.03 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.251 1.02 . . . . 74.13 109.912 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.555 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -155.47 144.12 20.45 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 122.721 0.409 . . . . 72.13 110.057 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.75 -55.06 1.66 Allowed Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.808 -0.633 . . . . 74.31 112.164 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.443 HD12 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -72.57 155.06 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 75.45 111.255 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.27 167.37 28.85 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.127 -0.942 . . . . 74.41 109.502 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.07 -121.74 27.13 Favored Glycine 0 C--N 1.346 1.09 0 O-C-N 124.103 0.877 . . . . 70.33 114.589 172.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' THR . . . . . 0.412 HG23 HD12 ' B' ' 141' ' ' LEU . 89.8 m -71.89 -35.05 69.63 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.399 1.079 . . . . 74.5 111.784 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -70.51 -31.88 69.14 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 120.986 0.422 . . . . 73.44 110.373 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' F' ' 452' ' ' VAL . 49.3 ttp -74.08 -34.22 63.91 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.637 -0.71 . . . . 74.14 110.382 173.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.411 ' HA ' HD13 ' F' ' 454' ' ' LEU . . . -60.03 -41.93 93.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.198 0.599 . . . . 61.12 110.25 174.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -64.17 -25.36 68.05 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.578 1.151 . . . . 71.34 111.39 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -78.83 -59.2 2.88 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.993 0.517 . . . . 64.32 110.282 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.61 HD23 HD11 ' B' ' 86' ' ' ILE . 66.3 mt -72.63 -40.53 66.35 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.856 0.688 . . . . 74.42 112.856 -167.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.32 3.97 61.98 Favored Glycine 0 N--CA 1.469 0.859 0 CA-C-O 119.728 -0.484 . . . . 64.4 114.073 -173.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -143.37 -69.65 0.33 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.33 0.565 . . . . 62.21 111.386 -175.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.34 -43.49 96.42 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.702 1.201 . . . . 74.14 112.049 -172.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 94.4 m -66.39 -50.43 48.28 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 124.206 1.003 . . . . 74.31 111.562 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.18 -35.17 90.27 Favored 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.187 1.925 . . . . 74.31 113.995 169.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -63.27 -33.59 75.84 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 118.159 0.436 . . . . 74.44 111.825 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 77.4 mt -66.06 -40.94 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.362 0.665 . . . . 74.42 110.408 175.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.7 mt -82.61 -20.82 35.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.192 0.997 . . . . 74.12 112.851 -172.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.2 -47.98 97.24 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-O 117.864 -1.065 . . . . 75.04 113.822 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.36 -32.78 89.7 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 121.993 1.796 . . . . 73.43 113.166 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.473 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 91.7 m-85 -70.37 -48.96 53.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.842 0.457 . . . . 75.42 110.133 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.62 -43.35 72.15 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.95 0.9 . . . . 71.11 110.251 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.546 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 35.9 ttt-85 -59.97 -55.03 39.1 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.322 1.449 . . . . 74.42 111.824 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.56 -33.81 76.78 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.766 0.827 . . . . 72.31 110.065 -175.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.596 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.1 t -72.16 -43.3 64.83 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.8 -0.636 . . . . 75.12 111.355 -176.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.606 HG21 HG22 ' B' ' 64' ' ' VAL . 99.1 mt -60.0 -53.59 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 109.819 -0.437 . . . . 72.1 109.819 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 86.8 m -59.32 -32.82 70.42 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 124.084 0.865 . . . . 74.12 111.41 -176.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.3 t -61.98 -47.42 84.89 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.297 0.639 . . . . 74.42 109.674 174.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.511 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.8 mmt -69.24 -34.42 74.77 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.17 0.588 . . . . 74.23 111.368 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.443 HG21 ' O ' ' B' ' 114' ' ' ILE . 92.4 t -60.83 -43.15 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.148 0.979 . . . . 75.14 109.924 174.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.0 t -68.22 -33.77 75.02 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.634 -1.166 . . . . 72.44 111.471 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.464 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 85.1 mtt-85 -66.95 -35.93 81.09 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.518 0.727 . . . . 75.53 110.152 177.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.09 9.51 60.44 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-O 119.483 -0.62 . . . . 63.43 113.361 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 70.4 p 57.06 22.14 7.07 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 126.158 1.783 . . . . 74.01 113.72 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -78.79 149.26 73.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.796 -0.446 . . . . 74.2 109.796 175.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.425 ' HB2' ' HG2' ' B' ' 37' ' ' GLN . 28.7 Cg_endo -59.57 171.57 2.56 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.306 2.67 . . . . 74.44 113.672 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.402 ' NE2' HD22 ' B' ' 127' ' ' ASN . 51.9 tp60 -62.91 114.77 3.85 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.038 -0.983 . . . . 64.52 111.88 -167.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.506 HD13 ' HZ ' ' B' ' 74' ' ' PHE . 8.6 tt -135.78 106.64 6.62 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.961 -0.755 . . . . 71.55 108.961 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.402 HD22 ' NE2' ' B' ' 125' ' ' GLN . 12.9 m120 -114.26 135.14 54.39 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.847 0.859 . . . . 75.12 109.843 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.546 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.5 mm? -72.24 124.73 25.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.198 -0.667 . . . . 74.35 109.198 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.604 ' HB1' ' SD ' ' F' ' 464' ' ' MET . . . -73.72 152.25 89.21 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.296 0.639 . . . . 74.22 110.962 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.17 110.1 1.28 Allowed 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 122.402 2.068 . . . . 65.35 112.947 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 31.2 t -100.71 111.0 29.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.106 -1.072 . . . . 75.53 108.106 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -85.05 90.29 7.81 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.459 -0.941 . . . . 73.53 108.459 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -57.04 -31.53 65.27 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.45 0.7 . . . . 74.31 111.321 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.644 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 11.7 t70 -73.11 -44.92 59.68 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.259 1.024 . . . . 72.31 111.054 -173.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.53 -39.0 93.27 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.075 0.95 . . . . 74.41 111.48 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.441 ' HB3' ' HB2' ' F' ' 461' ' ' PHE . 8.5 mp -75.1 -33.54 61.63 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.105 -0.952 . . . . 74.42 110.866 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.438 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 69.3 t80 -64.82 -30.02 71.0 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.05 0.94 . . . . 73.34 111.645 -177.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 56.7 mtt -56.35 -36.43 68.76 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.693 0.797 . . . . 75.01 111.229 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -88.79 -19.04 26.51 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.218 1.007 . . . . 65.13 110.876 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -73.03 -19.79 61.13 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.609 0.764 . . . . 74.44 111.195 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 40.0 mt -92.85 -8.3 43.84 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.886 0.699 . . . . 75.14 112.886 -172.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.54 130.15 1.64 Allowed 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.445 -0.946 . . . . 72.54 108.445 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -57.38 -40.05 77.36 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.195 0.998 . . . . 72.44 112.64 -172.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -116.01 86.79 2.55 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.753 0.787 . . . . 74.54 110.19 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.62 139.94 47.7 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.836 -0.62 . . . . 64.32 110.196 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.46 160.6 54.09 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 114.993 0.757 . . . . 73.15 114.993 -170.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -73.93 171.82 12.74 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.607 1.163 . . . . 71.24 112.318 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.15 110.19 1.06 Allowed Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.289 -0.869 . . . . 72.31 111.179 177.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 71.4 p -110.29 127.53 55.06 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.814 0.846 . . . . 64.04 109.776 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -160.52 160.11 31.52 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.988 0.915 . . . . 72.13 109.004 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.31 111.88 1.93 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.956 0.502 . . . . 74.11 110.775 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . 0.564 ' HA ' ' HG2' ' D' ' 90' ' ' GLU . 28.8 p80 -142.96 114.01 7.71 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.022 -0.536 . . . . 75.23 110.698 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -160.49 76.76 0.6 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.425 1.49 . . . . 74.22 107.661 168.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -93.01 -179.76 5.2 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.241 -0.891 . . . . 73.54 109.291 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 C-N-CA 123.75 0.82 . . . . 71.33 109.191 -179.159 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 46.7 ttm . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.768 -0.456 . . . . 73.31 109.768 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 48.5 t -74.86 104.48 5.49 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.336 0.654 . . . . 74.04 110.529 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.0 100.18 0.3 Allowed 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.798 -0.637 . . . . 71.55 110.09 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -67.13 82.06 0.13 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.856 0.862 . . . . 64.04 109.048 172.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -91.21 151.5 20.91 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.337 -0.847 . . . . 64.2 109.618 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -66.45 149.06 50.98 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.285 0.634 . . . . 75.41 110.327 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 14.4 m -50.66 130.78 25.01 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.654 1.181 . . . . 71.11 110.94 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -55.86 97.03 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.845 0.858 . . . . 72.22 110.441 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 52.1 ttm 64.94 149.49 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 125.384 1.473 . . . . 73.14 112.281 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.623 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 51.6 m -127.11 89.93 3.06 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.062 -1.088 . . . . 62.23 108.062 171.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.56 ' HD2' ' HG3' ' A' ' 130' ' ' PRO . 64.4 t80 -107.81 122.95 47.81 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.354 -0.98 . . . . 73.24 108.354 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -139.1 117.85 12.3 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.382 0.673 . . . . 74.33 109.644 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.2 mt -73.22 127.11 34.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 108.856 -0.794 . . . . 74.24 108.856 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.6 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.3 mm-40 -94.0 -46.22 7.24 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.466 -0.568 . . . . 72.03 109.466 173.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -170.97 141.32 1.69 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.602 -0.726 . . . . 75.34 109.418 -167.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.0 mt -136.13 130.25 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.295 -1.372 . . . . 72.14 107.295 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -166.34 157.81 13.34 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.154 0.502 . . . . 73.12 110.611 -164.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.8 p -88.56 117.29 27.41 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.45 -0.796 . . . . 74.51 109.047 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -86.88 -37.6 17.54 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.144 0.497 . . . . 71.24 109.893 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -138.35 127.72 24.59 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.13 -0.941 . . . . 75.44 109.137 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.5 mt -129.8 139.5 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.398 -1.334 . . . . 72.13 107.398 175.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -147.71 145.38 28.85 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.529 0.731 . . . . 74.01 109.678 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -143.12 134.44 26.05 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.469 -1.308 . . . . 74.02 107.469 168.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.4 mt-10 -129.11 126.98 40.53 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 124.326 1.05 . . . . 73.15 108.421 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.76 81.04 23.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 106.664 -1.606 . . . . 74.54 106.664 169.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -64.29 -31.58 62.96 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.966 2.444 . . . . 75.25 112.233 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -105.7 19.28 20.81 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.232 -0.895 . . . . 74.44 111.215 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.451 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -41.28 -62.15 1.14 Allowed Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 117.598 -1.191 . . . . 74.32 114.199 -167.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.0 -44.1 26.52 Favored 'Trans proline' 0 C--N 1.391 2.788 0 CA-C-N 121.977 1.742 . . . . 73.03 111.628 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -68.81 -31.71 70.91 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.016 0.926 . . . . 65.03 112.514 -174.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.676 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.5 p -80.5 -16.59 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 C-N-CA 122.731 0.413 . . . . 73.11 111.322 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -75.39 -22.55 57.39 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.563 0.345 . . . . 75.43 111.683 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -95.74 4.49 52.9 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.452 0.301 . . . . 64.12 111.113 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.429 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.2 tppp? -91.5 151.64 20.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.444 0.697 . . . . 74.44 110.337 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -56.87 124.33 18.19 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 124.092 0.87 . . . . 65.23 110.303 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.9 t90 -84.58 93.39 8.35 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.784 -0.644 . . . . 74.31 110.273 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -145.24 76.98 13.12 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.182 -1.044 . . . . 63.13 108.182 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.8 128.88 6.09 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.687 2.258 . . . . 75.14 112.867 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -85.28 109.43 18.35 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.072 -1.455 . . . . 71.34 107.072 161.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 m -96.48 113.27 30.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.045 0.938 . . . . 75.14 110.571 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -119.65 112.41 19.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.892 1.277 . . . . 75.33 108.186 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.06 168.62 12.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.424 0.69 . . . . 72.34 111.632 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 29.5 t70 -145.5 105.52 4.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.19 0.596 . . . . 72.14 109.976 173.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.42 130.36 55.5 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.576 1.15 . . . . 74.12 109.38 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -156.49 153.88 29.48 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.461 0.705 . . . . 75.14 109.946 171.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -129.81 152.46 49.27 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.947 0.899 . . . . 72.21 110.239 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.7 167.43 22.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.257 1.023 . . . . 71.22 108.84 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.441 ' HB3' HG21 ' C' ' 58' ' ' VAL . 93.1 p -148.15 152.75 37.81 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.046 0.538 . . . . 71.0 109.912 174.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 27.4 p -143.87 135.05 25.67 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.493 0.717 . . . . 64.24 109.545 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -64.91 116.25 6.18 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.941 0.775 . . . . 74.22 109.59 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.528 HD13 HD13 ' C' ' 83' ' ' ILE . 94.5 mt -84.38 -39.72 18.71 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.349 0.595 . . . . 74.52 109.44 174.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.18 -174.84 5.02 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.291 -1.322 . . . . 72.15 109.663 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.84 113.75 2.67 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.986 -1.006 . . . . 71.45 109.954 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 69.97 4.43 4.79 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.94 1.296 . . . . 75.24 112.975 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -105.86 123.0 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.04 0.936 . . . . 65.11 109.444 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -111.91 161.43 16.41 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.694 0.759 . . . . 74.54 110.37 172.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.464 ' HB2' HD13 ' C' ' 51' ' ' LEU . 32.9 tt0 -123.67 111.82 16.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.949 -1.5 . . . . 71.23 106.949 166.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.441 HG21 ' HB3' ' C' ' 48' ' ' SER . 74.0 t -94.07 121.29 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.026 -1.102 . . . . 74.04 108.026 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.33 133.51 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.502 -0.925 . . . . 72.54 108.502 173.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -119.45 109.06 15.3 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.247 -1.02 . . . . 75.33 108.247 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -99.77 112.97 25.17 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.685 0.794 . . . . 73.34 109.784 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.48 ' HB ' HD11 ' C' ' 114' ' ' ILE . 23.3 t -106.4 130.93 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.259 1.024 . . . . 70.32 108.357 175.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 4.9 m -125.31 146.42 49.57 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.725 -0.843 . . . . 72.21 108.725 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -136.35 109.46 8.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.506 1.122 . . . . 75.31 108.644 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 22.1 m -99.25 140.83 32.83 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.512 -0.921 . . . . 74.2 108.512 171.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.11 105.71 5.83 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.825 -1.176 . . . . 71.45 107.825 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 52.3 m -119.67 133.17 55.75 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.698 -0.852 . . . . 74.34 108.698 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 mt -82.68 51.34 1.86 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.263 1.425 . . . . 74.31 110.303 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.81 -76.68 0.31 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.504 -1.038 . . . . 64.14 110.504 -175.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.99 -31.7 2.12 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.701 1.2 . . . . 61.52 109.809 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.429 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 38.5 tp10 -70.88 100.32 1.92 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.344 1.057 . . . . 75.14 110.257 174.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 49.8 m -66.64 125.13 24.82 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 118.007 0.367 . . . . 72.15 110.273 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.676 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -82.0 -55.02 4.84 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 114.982 -1.008 . . . . 64.31 109.161 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -161.14 176.08 11.69 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.259 1.028 . . . . 75.01 112.448 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.465 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.2 tm? -137.88 146.53 43.48 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 113.001 -1.909 . . . . 74.1 106.212 172.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.427 ' N ' HD13 ' C' ' 75' ' ' LEU . 44.1 t -148.3 143.39 26.89 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.614 -0.884 . . . . 74.41 108.614 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -155.89 137.12 13.84 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.718 0.294 . . . . 74.0 110.345 -177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.9 t -135.62 137.84 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.466 1.106 . . . . 72.34 108.751 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -115.31 94.55 4.77 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.329 -0.989 . . . . 64.41 108.329 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -79.44 98.55 6.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.489 -0.778 . . . . 74.5 109.452 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.24 143.4 22.87 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.208 -1.157 . . . . 70.22 110.208 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.402 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.84 117.23 0.88 Allowed Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 111.53 -0.628 . . . . 53.14 111.53 -174.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.6 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 6.4 mm -82.61 128.79 38.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 108.638 -0.875 . . . . 74.12 108.638 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -135.85 122.03 20.3 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.43 0.457 . . . . 72.03 110.109 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 22.1 m -79.48 107.55 12.33 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.059 -1.089 . . . . 72.33 108.059 169.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.68 143.83 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.069 0.547 . . . . 73.23 110.637 -175.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.623 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -158.5 166.28 32.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.314 1.046 . . . . 73.12 109.652 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.46 -34.58 4.4 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.984 -0.553 . . . . 75.4 112.896 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.17 140.42 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.731 0.813 . . . . 73.33 110.531 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -148.3 156.65 42.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.585 0.754 . . . . 75.4 109.712 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.81 -117.54 8.21 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 116.209 -0.45 . . . . 43.44 113.248 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 5.2 m -70.6 -33.53 71.16 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.036 0.934 . . . . 74.31 110.501 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -67.14 -39.9 86.66 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.732 -1.122 . . . . 73.4 110.085 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 39.6 ttp -78.11 -24.64 47.41 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.272 -0.876 . . . . 63.13 110.741 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.39 95.65 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 122.752 0.421 . . . . 74.0 110.435 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -75.94 -41.19 52.42 Favored 'General case' 0 C--O 1.248 0.979 0 N-CA-C 111.927 0.343 . . . . 75.32 111.927 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -55.61 -48.89 74.16 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.069 0.856 . . . . 73.41 110.543 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.443 HD21 ' SG ' ' C' ' 102' ' ' CYS . 34.9 mt -92.88 -14.26 27.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.277 0.631 . . . . 75.42 111.076 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.93 -29.39 65.07 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 123.329 0.49 . . . . 73.42 113.835 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -156.5 -39.83 0.08 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 113.13 0.789 . . . . 72.43 113.13 -166.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -66.04 -55.82 14.68 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.453 0.471 . . . . 72.54 111.184 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.545 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 37.8 m -64.52 -46.28 77.35 Favored Pre-proline 0 CA--C 1.563 1.478 0 C-N-CA 123.643 0.777 . . . . 65.24 112.943 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.418 ' HD3' HG12 ' C' ' 58' ' ' VAL . 41.5 Cg_endo -66.56 -19.81 54.15 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 121.967 1.778 . . . . 74.54 113.967 174.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' C' ' 100' ' ' ALA . 0.2 OUTLIER -71.98 -28.41 63.4 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.714 -0.476 . . . . 71.31 109.714 176.189 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.71 -43.21 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.673 0.789 . . . . 73.31 109.67 171.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.402 HD21 ' HA3' ' C' ' 82' ' ' GLY . 66.0 mt -74.95 -28.2 60.49 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 114.886 -1.052 . . . . 52.22 112.133 -172.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -56.7 -50.2 89.31 Favored Pre-proline 0 CA--C 1.566 1.578 0 CA-C-O 117.34 -1.314 . . . . 74.43 114.243 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.54 -39.14 55.58 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 122.4 2.067 . . . . 72.11 113.367 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.455 ' HE2' HG21 ' A' ' 115' ' ' THR . 20.1 m-85 -67.94 -48.34 66.19 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.781 0.832 . . . . 72.51 110.405 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.15 -34.84 75.66 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.011 -0.995 . . . . 73.53 110.843 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -61.33 -56.53 19.42 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 124.12 0.968 . . . . 75.43 109.988 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.01 -30.33 71.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 123.724 0.64 . . . . 71.1 110.717 -175.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.5 t -73.91 -31.24 63.0 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.142 0.577 . . . . 73.32 110.884 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.48 HD11 ' HB ' ' C' ' 62' ' ' VAL . 58.7 mt -74.0 -50.33 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.945 0.498 . . . . 63.32 109.724 173.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 5.2 m -62.62 -30.27 71.23 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.013 0.925 . . . . 75.24 110.887 -175.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.3 t -65.5 -51.75 57.75 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.999 -0.741 . . . . 74.44 108.999 172.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.672 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.59 -36.65 76.67 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.541 1.136 . . . . 73.14 112.926 -179.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.686 HG12 HD21 ' C' ' 126' ' ' LEU . 95.0 t -71.72 -39.36 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.473 0.709 . . . . 74.23 109.775 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.5 t -70.77 -26.45 63.36 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.655 0.782 . . . . 74.35 111.234 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 78.2 mtt-85 -72.93 -42.49 63.41 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.744 -0.836 . . . . 75.43 108.744 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.1 -4.17 82.93 Favored Glycine 0 C--N 1.356 1.649 0 O-C-N 123.706 0.629 . . . . 72.53 112.942 173.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.406 HG21 ' HB3' ' D' ' 17' ' ' TYR . 23.4 p 66.83 25.84 9.48 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.633 1.973 . . . . 72.3 113.62 171.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.503 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 98.6 m-85 -86.49 166.08 29.7 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 123.841 0.857 . . . . 74.14 109.115 169.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 51.3 Cg_endo -62.67 178.31 1.01 Allowed 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 123.139 2.559 . . . . 72.43 114.708 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -59.67 112.22 1.73 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.877 1.271 . . . . 72.51 111.742 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.686 HD21 HG12 ' C' ' 118' ' ' VAL . 4.1 mm? -106.62 96.78 6.69 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.211 -0.663 . . . . 74.05 109.211 172.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -124.79 122.48 37.54 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.708 1.203 . . . . 74.01 108.539 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 14.8 tp -79.96 135.4 36.39 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.932 -0.395 . . . . 75.43 109.932 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.13 140.44 78.14 Favored Pre-proline 0 CA--C 1.547 0.849 0 O-C-N 124.45 1.094 . . . . 75.33 110.304 173.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.455 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 9.8 Cg_endo -53.84 102.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.582 2.188 . . . . 70.22 112.676 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 50.0 t -95.74 111.17 25.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 106.675 -1.602 . . . . 71.31 106.675 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -76.24 83.22 3.03 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.633 -1.247 . . . . 74.53 107.633 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -56.43 -36.64 69.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.731 0.812 . . . . 73.23 110.825 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.7 -43.13 99.45 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 114.857 -1.065 . . . . 70.34 111.213 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.02 91.53 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.637 0.586 . . . . 62.52 110.952 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.1 mp -57.48 -50.66 72.33 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 123.97 0.794 . . . . 75.35 111.409 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.417 ' HA ' ' HB3' ' C' ' 140' ' ' TYR . 8.0 t80 -74.93 -20.82 59.53 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.347 0.659 . . . . 74.21 110.396 -177.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.415 ' O ' ' HB3' ' C' ' 142' ' ' GLN . 52.3 ttm -68.42 -55.4 12.03 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 122.806 0.442 . . . . 72.14 110.017 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -65.22 -35.06 79.89 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 122.443 0.297 . . . . 73.53 111.27 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.417 ' HB3' ' HA ' ' C' ' 137' ' ' PHE . 61.5 t80 -54.91 -83.67 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.807 1.243 . . . . 74.12 111.063 174.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 10.0 tp -98.67 87.3 3.75 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 109.546 -0.539 . . . . 74.32 109.546 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' C' ' 138' ' ' MET . 11.3 pt20 -133.63 133.9 42.53 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.646 0.778 . . . . 73.24 111.241 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -143.57 -56.37 0.39 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.389 -1.338 . . . . 63.02 107.389 169.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -79.5 104.32 10.02 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.963 -1.017 . . . . 74.12 109.382 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.31 -162.0 1.04 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.648 0.779 . . . . 72.44 111.007 -173.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.48 -143.04 3.83 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 110.556 -1.018 . . . . 70.52 110.556 175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.54 147.56 27.61 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.6 -0.889 . . . . 74.45 108.6 175.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.87 121.84 17.77 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 123.745 0.653 . . . . 71.42 112.799 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 60.8 m -101.55 93.97 5.64 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.781 0.832 . . . . 61.5 110.53 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -87.55 160.57 18.17 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.551 0.74 . . . . 62.03 109.726 172.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -102.55 -174.87 2.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.266 0.626 . . . . 71.44 110.116 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -123.36 115.37 21.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.066 1.346 . . . . 75.22 108.714 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.562 ' HB2' HG21 ' A' ' 92' ' ' THR . 8.6 tt0 -83.17 140.5 32.55 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.965 0.506 . . . . 71.23 110.567 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -148.83 135.33 19.53 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.045 -1.095 . . . . 65.21 108.045 171.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.383 0 N-CA-C 108.921 -0.77 . . . . 71.21 108.921 -176.797 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 109.283 -0.636 . . . . 74.25 109.283 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 32.8 t -74.75 85.38 2.16 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.014 -0.736 . . . . 75.14 109.014 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.65 178.68 7.86 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.231 -0.895 . . . . 73.45 111.307 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -117.67 75.73 1.01 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.951 0.882 . . . . 73.31 110.715 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -68.37 104.74 1.95 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.325 -0.852 . . . . 75.11 109.056 171.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -71.05 115.54 10.31 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.638 0.733 . . . . 64.23 109.987 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -99.1 -164.36 1.12 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.165 0.986 . . . . 71.4 108.712 172.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -72.3 165.77 23.8 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 109.056 -0.72 . . . . 75.33 109.056 167.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.555 ' HG3' HG21 ' D' ' 89' ' ' ILE . 4.9 ttp -32.26 123.56 0.32 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.132 0.973 . . . . 73.0 112.235 173.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 45.1 m -112.14 141.6 45.62 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.277 0.631 . . . . 73.44 109.737 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -175.13 102.01 0.08 Allowed 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.458 -2.053 . . . . 74.21 105.458 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -144.2 134.47 24.39 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.243 -0.89 . . . . 73.34 108.799 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.3 mt -84.25 122.6 38.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 115.203 -0.908 . . . . 73.15 109.182 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -90.07 -39.8 12.69 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 122.617 0.367 . . . . 74.13 111.315 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -166.56 127.79 1.71 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 111.755 0.28 . . . . 74.1 111.755 -167.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.75 136.13 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.343 -1.354 . . . . 73.42 107.343 167.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.417 ' HE1' HG13 ' D' ' 83' ' ' ILE . 25.1 p90 -156.51 164.38 38.29 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.771 0.796 . . . . 74.02 111.334 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 65.3 p -100.15 123.27 44.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.043 -0.981 . . . . 75.14 108.839 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -87.24 -36.01 18.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.67 0.748 . . . . 62.51 109.132 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.621 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 2.6 t70 -142.07 138.88 32.05 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.233 -1.349 . . . . 72.04 108.942 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.672 HG21 ' HE1' ' C' ' 117' ' ' MET . 82.3 mt -134.25 145.89 32.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.63 -1.248 . . . . 63.53 107.63 169.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -148.11 137.87 22.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.886 -0.783 . . . . 65.1 108.886 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.413 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.5 t80 -146.12 124.06 12.03 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.239 -1.393 . . . . 74.31 107.239 170.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -121.75 148.49 44.57 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.079 -0.711 . . . . 75.4 109.079 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.78 84.19 27.27 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 106.738 -1.578 . . . . 70.25 106.738 171.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.4 -46.08 6.16 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.198 2.598 . . . . 74.45 113.586 -167.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -104.95 28.0 7.6 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.703 0.801 . . . . 74.54 109.591 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.419 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -40.27 -66.72 0.34 Allowed Pre-proline 0 CA--C 1.565 1.528 0 N-CA-C 114.908 1.447 . . . . 75.31 114.908 -161.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.552 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.7 Cg_endo -73.8 -20.13 20.24 Favored 'Trans proline' 0 C--N 1.382 2.324 0 CA-C-N 122.533 1.94 . . . . 75.15 113.3 -174.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -73.88 -40.44 63.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.595 1.158 . . . . 71.42 110.328 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.441 HG22 ' HA ' ' D' ' 73' ' ' ALA . 4.0 p -85.54 -23.95 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 123.341 0.657 . . . . 65.22 111.803 -171.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -60.64 -22.09 63.46 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 123.286 0.634 . . . . 74.52 112.428 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -68.17 -10.3 53.19 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.579 0.752 . . . . 73.34 111.052 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.522 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 93.2 mttt -100.95 107.73 19.29 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.737 1.215 . . . . 73.24 110.246 177.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -93.27 91.87 7.44 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.293 0.637 . . . . 72.31 110.423 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.514 ' HZ3' ' H ' ' D' ' 69' ' ' GLY . 22.0 t90 -161.62 158.41 26.13 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.937 1.295 . . . . 73.31 108.127 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -69.31 108.03 2.74 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 107.999 -1.111 . . . . 74.03 107.999 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.74 124.23 15.75 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.967 2.444 . . . . 64.41 112.495 -173.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.638 ' HA ' ' HG ' ' H' ' 470' ' ' LEU . 44.5 tt0 -57.28 110.98 0.94 Allowed 'General case' 0 C--N 1.359 0.996 0 O-C-N 124.442 1.088 . . . . 74.11 110.244 -174.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.645 HG13 HD12 ' H' ' 470' ' ' LEU . 2.8 p -101.68 112.39 34.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 115.283 -0.871 . . . . 75.32 110.269 -172.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.74 ' HZ3' ' HB2' ' D' ' 43' ' ' ASP . 0.5 OUTLIER -85.55 109.82 18.79 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 104.908 -2.256 . . . . 75.33 104.908 165.313 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.594 HD11 ' HE3' ' H' ' 464' ' ' MET . 5.4 tt -95.49 127.9 41.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.36 -1.348 . . . . 70.25 107.36 -170.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.74 ' HB2' ' HZ3' ' D' ' 41' ' ' LYS . 10.0 t70 -130.17 147.0 51.85 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 123.542 0.527 . . . . 72.31 109.915 -176.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -127.99 153.02 47.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.584 0.753 . . . . 75.34 109.682 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -157.69 147.78 20.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.055 0.942 . . . . 73.41 108.828 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -127.73 160.85 30.42 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.409 -0.589 . . . . 72.33 109.409 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.472 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -158.05 166.77 31.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.755 -1.112 . . . . 75.44 108.661 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 21.8 p -165.72 161.31 18.01 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.609 0.764 . . . . 71.33 109.557 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.2 p -151.98 160.47 43.47 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.282 1.033 . . . . 72.45 109.238 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -98.81 120.65 39.6 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.995 -0.742 . . . . 72.35 108.995 171.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' D' ' 57' ' ' GLU . 59.2 mt -91.0 -41.3 11.18 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.124 0.488 . . . . 73.31 110.198 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.55 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -153.51 -172.44 4.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.754 0.822 . . . . 73.12 110.896 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.37 105.96 1.59 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 114.968 -1.015 . . . . 70.33 109.53 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 64.11 18.59 11.33 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.517 1.127 . . . . 74.23 112.404 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 98.1 t -117.83 120.44 64.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.587 0 N-CA-C 107.843 -1.169 . . . . 74.41 107.843 169.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -125.46 163.8 21.86 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.671 0.788 . . . . 73.35 109.411 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' D' ' 51' ' ' LEU . 22.2 tt0 -121.52 148.38 44.55 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 124.746 1.218 . . . . 72.51 107.714 169.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.1 t -129.75 119.28 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 106.896 -1.52 . . . . 75.31 106.896 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.508 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 41.4 t -99.38 125.29 52.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.987 -0.746 . . . . 73.4 108.987 176.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.64 124.86 49.61 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.702 -1.221 . . . . 74.14 107.702 175.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -118.98 95.66 4.91 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.987 -0.746 . . . . 75.12 108.987 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -91.24 123.1 43.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.078 -1.082 . . . . 75.4 108.078 174.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 24.0 m -111.15 144.06 40.9 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.25 0.548 . . . . 72.14 110.041 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 93.9 t -137.44 120.28 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.111 0.964 . . . . 74.22 109.503 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 100.0 m -113.39 121.03 43.12 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 107.912 -1.144 . . . . 74.54 107.912 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.88 145.49 48.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.333 0.653 . . . . 63.23 110.319 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.8 m -146.83 129.96 16.48 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 123.526 0.516 . . . . 74.33 111.129 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 mt -92.86 92.6 7.98 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.945 -1.132 . . . . 74.31 107.945 173.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . 0.514 ' H ' ' HZ3' ' D' ' 36' ' ' TRP . . . 70.22 -114.77 5.67 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 114.571 -1.195 . . . . 54.31 113.382 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.15 6.37 40.36 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.299 0.852 . . . . 74.15 113.299 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.522 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.2 pt-20 -148.91 156.94 43.02 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.11 0.414 . . . . 65.51 110.222 -177.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.5 m -67.29 136.89 55.59 Favored 'General case' 0 C--O 1.242 0.697 0 O-C-N 123.633 0.583 . . . . 73.23 110.694 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.441 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -89.34 -69.57 0.71 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.252 -1.34 . . . . 75.44 108.522 175.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -145.58 157.46 43.98 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 121.319 0.58 . . . . 72.22 109.958 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -131.96 144.58 50.91 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.255 -1.387 . . . . 74.23 107.255 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.549 ' SG ' HG12 ' D' ' 114' ' ' ILE . 43.6 t -158.22 136.68 11.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.336 0.254 . . . . 75.21 110.589 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -154.07 128.35 9.1 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.387 0.675 . . . . 73.21 109.32 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.2 118.39 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.382 0.673 . . . . 72.3 109.905 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.621 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.6 mt-30 -89.77 82.97 6.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.34 0.656 . . . . 63.54 109.307 169.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -80.37 91.86 5.73 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.963 1.305 . . . . 63.31 109.359 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.25 142.18 17.98 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.713 -0.555 . . . . 65.13 111.713 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.93 132.31 5.5 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 119.716 -0.491 . . . . 70.43 112.064 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.417 HG13 ' HE1' ' D' ' 17' ' ' TYR . 61.9 mt -89.17 131.23 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.379 0.672 . . . . 70.55 109.99 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -131.22 124.55 30.81 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.886 0.875 . . . . 70.31 109.341 175.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 71.5 m -83.75 111.7 19.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.088 -1.078 . . . . 73.12 108.088 168.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.418 HD11 ' SG ' ' D' ' 97' ' ' CYS . 5.5 tt -138.06 127.99 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 122.902 0.481 . . . . 70.14 111.117 -172.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.68 167.66 27.86 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.398 1.479 . . . . 64.22 109.099 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.05 11.51 63.11 Favored Glycine 0 N--CA 1.473 1.128 0 CA-C-O 119.463 -0.632 . . . . 75.42 113.66 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.555 HG21 ' HG3' ' D' ' 9' ' ' MET . 0.2 OUTLIER -141.8 169.22 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 125.079 1.352 . . . . 74.25 109.661 171.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' B' ' 152' ' ' HIS . 3.8 pt-20 -153.91 175.82 12.91 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.723 0.409 . . . . 74.23 111.912 -173.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.89 -107.42 0.71 Allowed Glycine 0 C--N 1.36 1.868 0 O-C-N 124.757 1.285 . . . . 64.31 115.263 164.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.0 p -66.04 -41.54 90.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.816 0.847 . . . . 72.13 110.974 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -74.72 -38.03 62.41 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.344 0.657 . . . . 73.43 111.685 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.605 ' SD ' ' HB ' ' H' ' 452' ' ' VAL . 23.9 ptt? -66.63 -34.46 77.92 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.867 0.365 . . . . 75.24 110.671 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.98 -42.65 69.4 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.907 -0.588 . . . . 73.22 109.646 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -66.25 -26.41 67.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.421 1.088 . . . . 70.53 111.817 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' D' ' 86' ' ' ILE . 25.3 t -91.12 -54.14 4.07 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.844 -0.122 . . . . 73.33 110.864 -176.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -72.31 -29.77 64.16 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.391 0.276 . . . . 73.41 111.494 -176.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.5 12.91 27.98 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.122 -0.821 . . . . 73.01 114.532 -172.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.656 ' HB3' ' HA ' ' D' ' 134' ' ' ASP . . . -154.46 -59.65 0.12 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.983 0.891 . . . . 72.41 112.207 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -68.59 -50.41 51.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.006 0.523 . . . . 73.43 111.499 -173.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 83.7 m -62.6 -45.71 88.78 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.11 0.964 . . . . 73.32 112.243 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -52.56 -40.79 71.58 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.203 1.935 . . . . 74.0 112.967 167.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -66.07 -29.87 70.28 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.256 0.622 . . . . 75.54 111.328 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.7 mm -69.59 -42.4 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.894 0.878 . . . . 74.12 110.436 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 62.8 mt -74.83 -16.28 60.7 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.224 -0.898 . . . . 74.43 111.67 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.452 ' HE2' ' HA ' ' D' ' 130' ' ' PRO . 27.6 t80 -68.07 -40.37 21.73 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.916 -1.04 . . . . 75.24 113.74 -169.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.39 -44.84 45.6 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.011 1.807 . . . . 75.01 112.895 167.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -69.24 -36.64 77.37 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.692 0.797 . . . . 73.12 111.783 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.07 -49.46 69.95 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.241 0.616 . . . . 73.42 109.717 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.497 HH12 ' HB3' ' D' ' 130' ' ' PRO . 26.5 ttp180 -55.99 -47.62 77.37 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 124.357 1.036 . . . . 74.14 110.946 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -62.13 -49.03 77.49 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.073 0.858 . . . . 75.52 111.534 -174.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.0 -41.86 83.98 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.053 0.846 . . . . 72.44 110.636 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.549 HG12 ' SG ' ' D' ' 76' ' ' CYS . 81.1 mt -60.4 -56.51 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 O-C-N 124.293 0.996 . . . . 73.24 110.79 173.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -58.21 -37.55 75.04 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.588 1.155 . . . . 75.52 111.372 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -66.78 -42.15 86.5 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.155 -0.93 . . . . 75.45 110.079 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.485 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.4 mtm -72.52 -27.11 62.04 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.809 0.444 . . . . 65.53 111.766 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.97 -42.14 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.458 0.703 . . . . 64.35 110.078 173.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.6 p -75.62 -29.44 59.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.813 0.445 . . . . 72.43 111.108 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -74.26 -33.84 63.41 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.245 0.618 . . . . 75.4 109.599 174.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.68 -2.25 90.62 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-N 115.746 -0.661 . . . . 75.43 112.237 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p 66.57 21.3 10.73 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.876 2.07 . . . . 52.43 113.904 170.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -82.62 156.77 67.95 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.452 0.701 . . . . 75.12 110.348 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.97 137.23 44.23 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.298 2.666 . . . . 64.44 112.138 173.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -54.66 136.77 45.18 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.359 1.037 . . . . 75.21 111.929 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -113.44 102.32 10.2 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.568 -0.901 . . . . 74.02 108.568 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -98.29 95.08 7.13 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.221 -1.4 . . . . 73.53 107.221 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.431 HD13 HD13 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -57.11 113.89 1.9 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.566 -1.197 . . . . 65.24 108.273 -176.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.88 122.65 70.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 123.963 0.789 . . . . 75.53 110.632 -171.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.497 ' HB3' HH12 ' D' ' 111' ' ' ARG . 59.1 Cg_endo -72.64 112.52 3.5 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.944 1.763 . . . . 72.22 111.427 -176.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.0 m -105.81 138.52 30.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 108.317 -0.994 . . . . 70.43 108.317 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -79.25 77.11 5.78 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.872 0.844 . . . . 73.44 109.726 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.535 ' HE2' HD12 ' H' ' 460' ' ' LEU . 86.5 t80 -56.71 -29.39 62.39 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.623 1.569 . . . . 72.14 111.64 -178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.656 ' HA ' ' HB3' ' D' ' 100' ' ' ALA . 21.7 t70 -60.51 -45.1 95.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.13 1.372 . . . . 75.54 110.747 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.07 -37.84 57.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.807 0.843 . . . . 63.31 111.329 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.422 HD21 ' HA ' ' H' ' 462' ' ' TYR . 9.8 mp -58.93 -31.23 68.48 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.33 0.652 . . . . 65.54 111.043 174.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -69.53 -41.77 75.52 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.986 0.914 . . . . 74.22 110.8 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 30.8 mtt -62.79 -36.28 82.61 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.393 0.677 . . . . 72.24 109.89 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.28 -36.15 78.95 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.938 -1.028 . . . . 74.24 111.176 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -68.5 -40.47 80.86 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.777 0.831 . . . . 75.41 111.748 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.88 -36.33 80.95 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.313 0.645 . . . . 73.53 111.537 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -89.47 37.55 0.87 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.074 0.549 . . . . 73.02 111.28 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -127.03 84.8 2.3 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.436 1.094 . . . . 64.11 109.641 172.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -143.07 13.71 1.85 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.47 1.108 . . . . 75.15 109.531 170.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.89 -58.68 0.32 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.797 0.839 . . . . 74.12 110.368 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 129.57 120.01 2.2 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-O 119.947 -0.363 . . . . 44.22 112.358 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -141.51 126.66 18.47 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.445 0.698 . . . . 74.3 110.176 -177.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.0 -84.83 0.07 OUTLIER Glycine 0 C--N 1.35 1.331 0 O-C-N 124.322 1.014 . . . . 65.2 112.804 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 4.4 t -69.76 97.69 1.12 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.133 0.973 . . . . 63.24 110.461 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -126.38 -37.92 2.16 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.653 1.181 . . . . 71.13 109.116 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -81.69 119.34 23.71 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.928 0.891 . . . . 73.25 109.138 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -82.83 95.86 8.05 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.043 -0.725 . . . . 72.24 109.043 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -63.71 88.93 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.83 1.252 . . . . 63.52 111.221 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -142.88 111.41 6.25 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.407 -0.96 . . . . 75.34 108.407 -176.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 N-CA-C 109.541 -0.54 . . . . 65.32 109.541 -174.463 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.444 -0.576 . . . . 74.13 109.444 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . 0.685 HG23 ' HA ' ' A' ' 87' ' ' ALA . 3.9 p -119.07 -63.1 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.113 0.565 . . . . 75.4 111.492 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . 0.479 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 43.3 t -92.11 89.8 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.256 -1.016 . . . . 62.23 108.256 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -80.29 60.08 4.53 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.367 -0.833 . . . . 74.34 113.197 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 65.2 tp -82.2 122.52 28.0 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 109.442 -0.577 . . . . 74.34 109.442 176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 44.6 m -139.65 136.11 33.96 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.243 -1.021 . . . . 71.31 108.243 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 10.7 t70 76.21 163.16 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.37 1.468 . . . . 74.41 111.501 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -83.96 161.86 20.65 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.948 0.899 . . . . 73.11 112.209 -174.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 51.2 m -147.51 141.16 25.57 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.227 1.011 . . . . 70.32 109.446 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.3 142.64 58.31 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.703 0.801 . . . . 71.4 111.026 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . 0.633 HD22 ' HB ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -89.0 144.51 26.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.698 0.761 . . . . 71.42 109.932 -177.116 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . 0.604 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 18.9 p90 -92.79 13.36 20.53 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.0 1.32 . . . . 65.13 112.956 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -66.19 108.15 2.19 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 120.744 0.307 . . . . 74.45 110.857 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 10.0 t -153.96 117.94 4.75 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.405 -0.816 . . . . 74.13 109.664 173.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 464' ' ' MET . . . . . 0.449 ' HE1' ' HB1' ' E' ' 466' ' ' ALA . 25.4 ptt? -158.07 149.94 21.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.014 0.926 . . . . 75.24 109.352 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -85.23 80.91 9.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.695 -0.854 . . . . 74.53 108.695 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . 0.449 ' HB1' ' HE1' ' E' ' 464' ' ' MET . . . -80.34 152.73 28.79 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.343 -0.844 . . . . 72.43 111.549 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -155.83 166.61 32.99 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.723 0.809 . . . . 71.04 110.049 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . 0.504 HD21 ' HG ' ' E' ' 470' ' ' LEU . 2.0 tt -157.67 -61.18 0.09 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 108.586 -0.894 . . . . 63.42 108.586 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 121.26 -107.61 1.25 Allowed Glycine 0 C--N 1.341 0.822 0 N-CA-C 110.043 -1.223 . . . . 73.42 110.043 -172.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . 0.602 ' HB3' ' HE1' ' A' ' 36' ' ' TRP . 75.8 mt 53.7 72.32 0.45 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 124.619 1.168 . . . . 75.34 110.456 -176.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? . . . . . 0 C--O 1.253 1.255 0 N-CA-C 107.94 -1.134 . . . . 75.43 107.94 -174.748 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 108.899 -0.778 . . . . 75.0 108.899 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . 0.448 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 28.2 m -97.94 165.37 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 122.781 0.432 . . . . 70.32 110.603 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . 0.47 ' N ' ' SD ' ' B' ' 94' ' ' MET . 56.7 t 66.84 136.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 124.782 1.233 . . . . 63.51 111.251 -176.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -178.04 -157.68 19.3 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 111.678 -0.569 . . . . 44.44 111.678 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' B' ' 95' ' ' ALA . 6.6 mp 64.93 -173.21 0.18 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.211 1.004 . . . . 71.53 111.248 178.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 11.7 t -157.3 179.32 9.37 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.707 0.403 . . . . 74.1 110.089 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -68.4 107.38 2.84 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.583 -0.895 . . . . 75.44 108.583 175.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -110.09 126.46 54.05 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.02 0.528 . . . . 65.01 110.654 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 16.7 p -92.19 -45.38 8.28 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.361 1.064 . . . . 61.24 110.797 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -75.39 80.68 2.45 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.33 0.586 . . . . 71.23 109.706 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 85.5 mt -97.1 157.58 15.85 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.356 -0.838 . . . . 74.53 111.001 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' B' ' 136' ' ' LEU . 6.0 p90 -59.06 139.04 57.27 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 113.477 -1.692 . . . . 75.42 110.83 165.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . 0.562 ' HH ' ' HB2' ' B' ' 42' ' ' LEU . 90.6 t80 -160.16 107.97 1.65 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.59 0.756 . . . . 73.23 109.043 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 4.3 t -151.37 66.85 0.89 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 122.866 1.317 . . . . 65.32 108.19 174.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 464' ' ' MET . . . . . 0.604 ' SD ' ' HB1' ' B' ' 129' ' ' ALA . 54.0 ttp -76.73 92.82 3.59 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.041 -1.436 . . . . 72.21 109.138 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -66.94 -32.55 73.88 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.07 0.948 . . . . 75.11 111.561 -176.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -66.47 -59.74 3.38 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.427 0.691 . . . . 74.32 110.869 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . 0.484 ' HA ' ' HE1' ' F' ' 464' ' ' MET . . . 56.58 -170.29 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.821 1.248 . . . . 72.22 112.089 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -132.65 134.86 45.39 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.503 -0.554 . . . . 70.11 109.503 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . -81.91 119.12 4.78 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.587 -0.733 . . . . 71.3 112.005 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . 0.526 HD21 HG11 ' B' ' 40' ' ' VAL . 3.2 mm? -76.95 85.82 3.49 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.135 -0.691 . . . . 74.04 109.135 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . 0.417 ' H ' ' NE2' ' B' ' 37' ' ' GLN . 19.2 tptp . . . . . 0 CA--C 1.561 1.376 0 C-N-CA 125.767 1.627 . . . . 72.23 110.012 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . 0.471 ' HB3' HG21 ' G' ' 452' ' ' VAL . 86.6 m-20 . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.849 -0.426 . . . . 74.53 109.849 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 4.0 p -73.89 -10.69 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.561 0.744 . . . . 74.2 111.554 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . 0.471 HG21 ' HB3' ' G' ' 450' ' ' ASN . 35.2 m -67.86 -179.33 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 124.136 0.974 . . . . 73.22 111.786 173.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 98.47 68.62 0.92 Allowed Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.421 -0.809 . . . . 73.35 112.082 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' G' ' 457' ' ' GLN . 4.1 pp -87.44 138.17 31.71 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.333 -0.988 . . . . 74.15 108.333 169.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 63.0 m -83.56 -60.47 2.12 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 110.36 -0.237 . . . . 73.53 110.36 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -107.31 140.91 39.48 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.337 0.655 . . . . 64.3 111.473 -174.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . 0.576 ' HG2' ' H ' ' G' ' 458' ' ' THR . 31.6 tt0 -174.87 -175.88 0.93 Allowed 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 124.986 1.315 . . . . 74.54 108.098 175.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 458' ' ' THR . . . . . 0.576 ' H ' ' HG2' ' G' ' 457' ' ' GLN . 62.6 p 69.03 158.39 0.16 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 126.763 2.025 . . . . 73.03 112.147 -176.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 30.2 t70 59.11 76.19 0.36 Allowed 'General case' 0 C--N 1.355 0.831 0 C-N-CA 124.134 0.974 . . . . 75.42 108.869 -170.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.64 114.24 6.1 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.341 -1.355 . . . . 72.11 107.341 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -41.3 -48.14 3.57 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.913 1.285 . . . . 74.23 112.49 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 58.3 t80 48.91 81.17 0.05 Allowed 'General case' 0 C--N 1.362 1.11 0 C-N-CA 125.351 1.46 . . . . 75.23 111.672 175.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 14.8 t -86.19 -0.28 55.37 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.803 -0.635 . . . . 70.14 111.652 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 13.2 tpt -61.34 119.25 8.14 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.274 1.029 . . . . 71.04 110.299 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.23 -63.08 1.35 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.194 0.998 . . . . 72.24 110.634 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -61.52 109.71 1.26 Allowed 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.512 0.725 . . . . 74.35 110.287 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -69.6 -82.83 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 O-C-N 124.049 0.843 . . . . 72.13 109.842 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . 0.42 HD11 HD13 ' C' ' 126' ' ' LEU . 50.5 mt -141.58 178.24 7.59 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.195 0.998 . . . . 72.53 108.838 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -146.51 129.7 3.42 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-O 119.325 -0.708 . . . . 65.11 111.797 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . 0.476 HD22 HD22 ' C' ' 126' ' ' LEU . 24.0 mt -124.55 114.45 19.43 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 117.328 0.564 . . . . 74.14 110.605 177.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 N-CA-C 106.853 -1.536 . . . . 75.12 106.853 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 42.6 t30 . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.115 -0.698 . . . . 62.44 109.115 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 46.5 t -55.46 -57.81 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.943 0.897 . . . . 62.32 111.808 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.605 ' HB ' ' SD ' ' D' ' 94' ' ' MET . 2.1 p -143.04 -80.93 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 122.89 0.476 . . . . 75.41 112.046 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . 0.517 ' H ' HG12 ' H' ' 452' ' ' VAL . . . 79.73 100.33 0.27 Allowed Glycine 0 C--N 1.35 1.35 0 N-CA-C 111.598 -0.601 . . . . 61.54 111.598 -168.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -140.83 144.03 35.13 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.33 0.565 . . . . 64.21 110.402 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 26.8 p -140.84 99.52 3.63 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.111 1.364 . . . . 63.44 108.852 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -147.89 133.79 19.11 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.549 0.34 . . . . 73.43 110.168 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -134.8 36.32 3.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.272 1.029 . . . . 72.41 109.651 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 21.4 m -80.98 87.43 5.99 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 122.176 -0.328 . . . . 73.22 110.259 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 12.7 t70 62.53 -171.5 0.16 Allowed 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.887 1.275 . . . . 74.2 110.463 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . 0.535 HD12 ' HE2' ' D' ' 133' ' ' PHE . 0.4 OUTLIER -139.41 137.73 35.9 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.828 -0.805 . . . . 65.22 108.828 175.257 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -87.04 18.67 3.45 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.116 1.366 . . . . 72.51 113.269 -172.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . 0.422 ' HA ' HD21 ' D' ' 136' ' ' LEU . 6.0 p90 -77.11 139.91 40.1 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.031 0.378 . . . . 73.44 110.444 -177.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 33.4 p -127.75 124.62 38.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.521 0.729 . . . . 64.41 109.756 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 464' ' ' MET . . . . . 0.594 ' HE3' HD11 ' D' ' 42' ' ' LEU . 40.4 ttp -160.96 -81.74 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.585 0.754 . . . . 74.43 109.853 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . 0.494 ' HB3' ' HZ2' ' H' ' 465' ' ' LYS . 8.1 mtpm? 58.04 75.75 0.37 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.048 0.939 . . . . 74.04 111.05 -172.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -167.87 -51.33 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.785 0.834 . . . . 65.32 109.553 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . 66.1 -80.9 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.389 1.476 . . . . 70.53 112.251 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 95.6 mt -133.51 -9.66 2.84 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.472 0.709 . . . . 75.3 112.132 -175.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.19 -37.36 3.41 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 111.785 -0.526 . . . . 51.2 111.785 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . 0.645 HD12 HG13 ' D' ' 40' ' ' VAL . 3.6 mm? 69.35 84.34 0.15 Allowed 'General case' 0 C--N 1.355 0.817 0 C-N-CA 125.497 1.519 . . . . 72.14 112.466 169.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . 0.61 ' HZ2' ' HB3' ' H' ' 471' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.126 0 N-CA-C 106.801 -1.555 . . . . 73.34 106.801 175.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HB3' ' HB3' ' A' ' 6' ' ' ASN . 1.7 mpt? . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.78 0.324 . . . . 74.34 110.391 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 m -72.93 91.45 1.54 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.597 0.759 . . . . 72.44 109.007 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 64.76 -164.97 0.24 Allowed 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 124.522 1.129 . . . . 71.34 111.345 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 67.41 -81.26 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.613 1.565 . . . . 72.43 111.425 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -126.72 92.03 3.47 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.422 -0.955 . . . . 71.34 108.422 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.444 ' HB2' ' HG3' ' A' ' 8' ' ' GLU . 25.9 p-10 -155.36 -50.68 0.09 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.006 0.522 . . . . 74.44 110.176 176.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m 52.12 29.97 7.07 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.882 1.273 . . . . 52.14 111.902 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 6' ' ' ASN . 42.7 mt-10 -65.05 -38.59 91.34 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.895 0.878 . . . . 74.32 111.103 -172.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.3 mtm -84.51 143.44 29.35 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.66 -0.7 . . . . 74.21 109.233 172.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.1 m -146.62 132.02 18.6 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.614 0.765 . . . . 75.24 109.865 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.653 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.4 t80 -133.25 132.87 41.96 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.647 -0.872 . . . . 75.22 108.647 173.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -147.39 116.64 6.94 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.682 -0.858 . . . . 74.52 108.682 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.461 HG12 ' HD2' ' A' ' 84' ' ' PHE . 50.7 mt -81.19 117.4 27.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.87 -0.789 . . . . 74.35 108.87 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -86.34 -40.37 15.52 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 123.742 0.651 . . . . 74.42 110.757 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -168.12 137.46 2.48 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 122.969 0.168 . . . . 74.55 110.744 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.533 HD12 ' HG3' ' C' ' 130' ' ' PRO . 88.6 mt -125.44 133.48 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.378 1.071 . . . . 74.34 108.584 177.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.412 ' HB3' HG21 ' B' ' 122' ' ' THR . 41.4 p90 -168.97 177.32 4.99 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 123.97 0.794 . . . . 75.44 111.355 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -102.2 122.96 45.19 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.05 -0.977 . . . . 74.3 108.749 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HE3' ' HB1' ' B' ' 28' ' ' ALA . 31.3 mtpt -88.07 -45.21 10.36 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.316 -0.624 . . . . 73.32 109.316 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.3 t70 -134.34 125.67 28.08 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.507 -1.224 . . . . 72.02 108.288 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 58.9 mt -124.91 140.39 48.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.696 -1.594 . . . . 73.15 106.696 173.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -156.09 121.12 4.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.17 0.509 . . . . 74.53 109.727 171.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.438 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 86.8 t80 -116.3 118.54 33.05 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 106.36 -1.718 . . . . 74.44 106.36 173.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -119.56 126.48 51.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.058 0.39 . . . . 51.43 110.145 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.17 75.64 23.15 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.685 -1.228 . . . . 54.33 107.685 169.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.56 -28.68 25.91 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.26 1.974 . . . . 62.42 110.405 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.419 ' O ' HG22 ' A' ' 31' ' ' VAL . 43.1 m-20 -93.33 12.41 24.81 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.196 -1.365 . . . . 75.15 110.898 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.73 -46.88 80.19 Favored Pre-proline 0 CA--C 1.571 1.752 0 C-N-CA 124.185 0.994 . . . . 72.52 113.607 -176.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.13 -21.77 20.05 Favored 'Trans proline' 0 C--N 1.396 3.073 0 C-N-CA 122.082 1.855 . . . . 75.31 113.651 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -71.65 -47.57 53.53 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.623 -0.51 . . . . 70.02 109.623 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.625 HG23 HD21 ' A' ' 68' ' ' LEU . 88.1 t -60.91 -33.88 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.738 1.215 . . . . 72.33 110.936 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.432 ' HD1' HH11 ' B' ' 15' ' ' ARG . 90.9 t80 -56.46 -39.52 73.3 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.643 1.177 . . . . 74.41 111.918 176.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -96.43 -35.15 11.26 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.652 0.781 . . . . 73.1 111.87 -172.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.597 ' HZ2' ' HB2' ' A' ' 71' ' ' GLU . 57.9 mtpt -83.15 170.63 14.54 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.596 0.758 . . . . 74.55 112.88 -172.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.63 115.86 9.36 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.825 0.85 . . . . 43.52 111.101 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -79.63 92.65 5.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.022 0.929 . . . . 73.52 109.966 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -140.51 75.83 26.09 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 107.38 -1.341 . . . . 72.2 107.38 172.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -90.52 163.85 4.35 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.095 2.53 . . . . 74.34 113.98 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -126.32 118.39 24.97 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.04 -0.982 . . . . 72.04 108.534 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.69 110.05 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.602 0.761 . . . . 74.32 110.831 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -103.24 140.07 37.86 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.679 -0.86 . . . . 74.25 108.679 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.54 HD22 ' SD ' ' E' ' 464' ' ' MET . 64.7 tp -132.09 124.76 29.83 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.491 0.716 . . . . 74.24 109.701 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.479 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 64.4 m-20 -102.95 124.33 48.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.152 -1.055 . . . . 75.53 108.152 175.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.35 115.21 29.82 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.788 -1.56 . . . . 74.35 106.788 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.701 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 12.0 m-20 -132.07 124.6 29.53 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.096 -1.075 . . . . 63.43 108.096 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.519 ' HB ' HD22 ' E' ' 460' ' ' LEU . 53.9 m -115.35 121.94 44.36 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.404 -0.591 . . . . 72.15 109.404 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.76 140.86 48.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.182 0.993 . . . . 71.22 108.614 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.543 ' HB3' ' H ' ' E' ' 454' ' ' LEU . 37.0 t -130.59 163.92 26.06 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.358 0.599 . . . . 65.31 111.628 -173.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.2 t -148.91 121.62 8.64 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.198 -1.365 . . . . 74.44 108.256 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -71.67 107.89 4.74 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.822 0.849 . . . . 72.34 109.279 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.43 HD12 HG22 ' A' ' 83' ' ' ILE . 86.9 mt -78.52 -34.51 47.24 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.221 0.608 . . . . 71.45 110.281 -178.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.54 -177.71 6.59 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.939 0.895 . . . . 72.4 109.878 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.72 119.44 14.86 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.412 -0.588 . . . . 75.33 109.412 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.757 ' HA ' ' HB ' ' E' ' 451' ' ' VAL . 42.7 m-20 67.34 20.15 10.04 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.084 1.354 . . . . 73.41 112.151 -174.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.12 124.05 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.414 1.086 . . . . 75.31 108.35 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.506 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -142.43 169.22 17.99 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.337 -0.616 . . . . 73.54 109.337 174.337 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -128.75 130.51 47.17 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.498 -0.927 . . . . 74.3 108.498 174.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.8 m -102.42 132.06 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.586 -0.894 . . . . 73.43 108.586 169.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.51 106.92 21.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 125.194 1.397 . . . . 74.34 107.68 177.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.7 tp -87.57 99.14 11.82 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.693 -0.685 . . . . 73.03 109.155 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.701 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 52.6 ttt-85 -84.38 105.24 15.06 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.805 -0.813 . . . . 75.14 108.805 174.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.587 HG21 ' HB1' ' A' ' 110' ' ' ALA . 1.7 m -112.95 106.58 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 108.37 -0.974 . . . . 74.32 108.37 175.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 25.6 m -109.83 112.01 23.79 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.451 1.1 . . . . 74.32 110.716 -167.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 78.2 t -101.74 110.97 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.52 0.728 . . . . 74.42 109.656 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -115.44 108.29 16.29 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.735 -0.839 . . . . 71.13 108.735 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.79 133.49 53.08 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.312 -0.995 . . . . 72.11 108.312 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 t -140.27 134.38 30.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.905 0.482 . . . . 74.11 110.595 -176.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.625 HD21 HG23 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -94.78 80.17 3.74 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.432 1.093 . . . . 74.43 108.436 172.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.06 -118.86 5.48 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.311 -0.858 . . . . 74.44 112.593 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -89.41 5.97 42.82 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.61 0.764 . . . . 74.53 111.368 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.597 ' HB2' ' HZ2' ' A' ' 34' ' ' LYS . 6.3 tp10 -116.84 112.92 21.77 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.636 -0.876 . . . . 73.23 108.636 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.0 m -73.75 130.08 39.24 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.541 0.609 . . . . 72.25 109.864 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.484 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.81 -59.96 2.53 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.433 0.693 . . . . 74.21 109.789 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -159.28 163.35 35.85 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 115.157 -0.928 . . . . 73.31 110.782 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 34.6 tp -135.68 106.38 6.55 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.751 -1.113 . . . . 74.23 108.172 175.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.438 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 57.2 m -107.69 97.36 7.1 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.241 -0.651 . . . . 74.51 109.241 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -113.06 117.16 31.23 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.671 -1.233 . . . . 74.53 107.671 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 113' ' ' CYS . 90.4 t -126.3 109.55 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.492 -0.776 . . . . 73.0 109.119 -175.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.574 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.3 mt-30 -90.34 86.23 6.42 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.866 -1.061 . . . . 72.23 108.608 171.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.494 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.1 tp-100 -76.42 109.05 9.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.156 -1.384 . . . . 73.34 108.104 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.37 144.83 17.53 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.429 -0.668 . . . . 74.32 111.429 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.59 122.46 1.49 Allowed Glycine 0 CA--C 1.502 -0.746 0 N-CA-C 110.869 -0.892 . . . . 72.43 110.869 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.43 HG22 HD12 ' A' ' 51' ' ' LEU . 57.9 mt -80.93 121.77 35.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 108.406 -0.961 . . . . 75.25 108.406 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.653 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.2 m-85 -130.37 135.53 48.13 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.511 -0.922 . . . . 74.02 108.511 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.4 p -112.62 98.02 6.96 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.325 -0.62 . . . . 61.33 109.325 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.41 HD13 HD13 ' A' ' 89' ' ' ILE . 39.3 pt -99.52 149.8 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 115.733 -0.667 . . . . 74.22 109.469 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.58 147.73 14.02 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.413 0.685 . . . . 74.13 110.121 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.24 9.75 64.93 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 114.873 0.709 . . . . 63.1 114.873 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.509 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -123.39 153.36 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.748 0.819 . . . . 74.22 110.085 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 14.2 tt0 -160.78 179.4 8.55 Favored 'General case' 0 CA--C 1.557 1.228 0 O-C-N 123.251 0.345 . . . . 74.43 111.085 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 73.61 -133.62 17.85 Favored Glycine 0 C--N 1.351 1.38 0 C-N-CA 123.907 0.765 . . . . 71.32 113.838 177.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.0 p -64.86 -35.25 80.51 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.934 0.894 . . . . 72.44 110.961 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -64.96 -35.58 81.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.994 0.918 . . . . 75.04 110.846 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.574 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 28.1 ttt -62.37 -47.06 85.82 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.635 0.774 . . . . 75.1 110.904 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.71 -39.24 91.02 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.777 -0.647 . . . . 73.13 110.865 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -67.24 -31.86 72.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.287 1.035 . . . . 71.14 111.633 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 24.6 t -69.95 -29.27 66.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.991 0.424 . . . . 75.31 110.899 -175.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.585 HD11 ' HG ' ' E' ' 454' ' ' LEU . 1.8 tt -95.09 -32.68 12.99 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.75 -0.659 . . . . 74.42 110.235 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.2 -1.93 66.51 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-O 119.578 -0.568 . . . . 74.2 113.942 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -147.82 -64.54 0.26 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 117.827 0.813 . . . . 75.31 111.967 -176.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 51.1 t80 -56.22 -70.83 0.1 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.252 1.421 . . . . 73.33 113.607 -169.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 86.6 m -72.35 -35.64 3.4 Favored Pre-proline 0 CA--C 1.565 1.541 0 N-CA-C 114.894 1.442 . . . . 73.31 114.894 -173.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 37.8 Cg_endo -64.65 -26.12 61.38 Favored 'Trans proline' 0 C--N 1.392 2.866 0 CA-C-N 121.99 1.746 . . . . 73.42 113.103 173.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -72.53 -23.1 60.95 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.847 0.459 . . . . 74.21 111.217 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.45 HG23 HD11 ' A' ' 13' ' ' ILE . 47.3 mm -61.91 -40.58 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.092 0.472 . . . . 75.1 109.759 171.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.494 HD23 ' HG3' ' A' ' 80' ' ' GLN . 83.7 mt -82.82 -13.45 56.18 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.298 -0.864 . . . . 73.54 112.507 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.422 ' HE2' ' HA ' ' A' ' 130' ' ' PRO . 49.2 t80 -63.94 -43.23 74.73 Favored Pre-proline 0 CA--C 1.567 1.613 0 C-N-CA 123.709 0.804 . . . . 75.23 113.101 -174.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.56 -35.77 57.59 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 122.215 1.943 . . . . 64.35 113.904 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.2 -40.54 64.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.918 0.487 . . . . 74.11 110.79 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.587 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -69.81 -36.12 75.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.528 -0.76 . . . . 65.44 110.514 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.489 ' NH1' HD13 ' C' ' 105' ' ' ILE . 36.5 ttm180 -52.95 -53.07 55.09 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.292 0.995 . . . . 74.42 109.66 171.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.75 -44.61 95.74 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 124.385 1.053 . . . . 74.11 111.701 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.401 ' HB3' HG12 ' A' ' 78' ' ' VAL . 17.1 t -62.2 -45.3 93.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.474 0.71 . . . . 65.13 110.555 -176.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.417 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.3 mt -60.97 -54.66 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.799 0.84 . . . . 74.22 110.016 175.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.528 HG22 ' HG3' ' A' ' 125' ' ' GLN . 85.0 m -48.55 -48.0 38.92 Favored 'General case' 0 C--O 1.248 1.024 0 C-N-CA 124.515 1.126 . . . . 72.31 111.585 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -64.31 -47.69 78.48 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.272 -1.331 . . . . 62.43 110.034 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.41 ' SD ' HG22 ' A' ' 21' ' ' ILE . 39.0 mtp -61.07 -41.04 95.9 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.183 0.993 . . . . 73.2 112.32 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 114' ' ' ILE . 98.3 t -62.2 -45.94 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.691 0.796 . . . . 73.25 109.954 177.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.0 m -70.68 -27.77 64.27 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.386 -0.825 . . . . 73.33 111.978 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -72.55 -30.14 64.17 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.505 0.722 . . . . 72.05 110.186 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.82 7.07 75.9 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.541 0.525 . . . . 52.33 112.981 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.1 m 69.41 12.23 8.24 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.772 1.229 . . . . 74.11 111.791 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.533 ' HE1' HG13 ' A' ' 31' ' ' VAL . 89.3 m-85 -81.1 152.35 71.14 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.177 0.591 . . . . 73.34 109.792 173.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.4 138.16 79.31 Favored 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 123.162 2.575 . . . . 71.44 112.224 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.528 ' HG3' HG22 ' A' ' 115' ' ' THR . 32.5 tt0 -55.39 129.48 38.78 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 123.875 0.734 . . . . 75.23 111.654 -176.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.418 HD11 HD12 ' E' ' 468' ' ' LEU . 22.4 tp -110.4 116.76 32.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.945 -1.025 . . . . 71.23 109.566 176.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -118.84 101.87 8.38 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.723 -1.214 . . . . 63.42 107.723 172.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 pp -64.4 134.24 54.16 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 109.8 -0.445 . . . . 63.34 109.8 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.28 146.9 94.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.058 0.543 . . . . 62.04 110.46 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HA ' ' HE2' ' A' ' 107' ' ' PHE . 36.3 Cg_exo -61.83 115.18 2.64 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.54 2.16 . . . . 75.03 111.38 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.35 121.08 48.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.986 -1.116 . . . . 75.01 107.986 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -71.98 95.81 1.63 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.801 -0.815 . . . . 73.34 108.801 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 94.3 m-85 -60.51 -31.61 70.66 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.67 0.788 . . . . 71.43 111.996 -177.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.66 -50.74 70.02 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.911 0.757 . . . . 65.43 109.921 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.11 90.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.574 0.75 . . . . 65.25 111.064 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.41 -34.18 77.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.738 0.815 . . . . 75.1 111.42 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -73.19 -34.6 66.07 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.187 0.595 . . . . 75.14 110.036 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.458 ' SD ' ' HA3' ' A' ' 146' ' ' GLY . 24.1 mmt -74.68 -23.73 58.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.041 0.536 . . . . 72.22 111.306 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -66.95 -31.12 71.48 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.26 0.624 . . . . 71.12 110.061 171.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -85.76 -45.11 11.93 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.312 -0.858 . . . . 74.43 110.474 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.4 tp -69.14 -45.96 68.79 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.617 1.167 . . . . 75.12 111.575 -170.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -146.77 12.37 1.13 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 120.968 0.413 . . . . 73.14 111.335 -172.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 69.04 -75.97 0.06 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.489 1.516 . . . . 75.32 112.689 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -128.95 65.75 1.44 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.47 0.652 . . . . 75.41 109.819 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -165.45 -160.73 0.48 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.572 -1.194 . . . . 63.44 109.704 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.458 ' HA3' ' SD ' ' A' ' 138' ' ' MET . . . 89.65 8.2 68.01 Favored Glycine 0 C--N 1.355 1.633 0 O-C-N 122.943 0.152 . . . . 74.42 113.316 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -81.57 134.44 35.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.246 1.018 . . . . 62.43 111.141 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.58 -147.62 25.56 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 116.31 -0.405 . . . . 72.33 112.667 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.1 m -139.71 160.32 40.14 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.921 0.888 . . . . 75.13 109.396 -176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -82.2 -159.05 0.28 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.926 0.891 . . . . 63.12 110.618 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 65.22 83.87 0.16 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.565 1.146 . . . . 64.14 110.438 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -141.03 32.17 1.76 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.311 -1.313 . . . . 74.42 108.524 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -83.2 72.36 10.16 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 108.371 -0.974 . . . . 73.44 108.371 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -66.11 -64.54 0.84 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.458 0.703 . . . . 63.42 111.337 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.048 0 CA-C-O 118.15 -0.928 . . . . 64.03 109.095 -179.597 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' F' ' 452' ' ' VAL . 90.5 mtp . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.192 -0.67 . . . . 63.01 109.192 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 42.4 t -163.17 -64.74 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.202 1.001 . . . . 72.32 108.969 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -166.42 133.73 2.65 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.132 -1.062 . . . . 73.52 108.132 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -75.13 87.56 2.42 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.536 1.16 . . . . 72.11 110.796 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -110.14 -32.64 6.93 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.154 -0.93 . . . . 64.21 110.903 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -77.68 90.9 4.0 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.16 -0.682 . . . . 74.21 109.16 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 17.4 m -75.77 -37.64 59.06 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.514 -1.221 . . . . 71.45 110.674 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -76.54 -20.62 56.69 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.742 -1.117 . . . . 75.04 111.089 -174.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.563 ' HE1' ' HB2' ' B' ' 11' ' ' PHE . 22.9 ptm 51.67 -168.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 126.507 1.923 . . . . 73.31 113.353 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.564 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 87.7 m -141.62 121.26 13.37 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.663 -1.236 . . . . 75.13 107.663 174.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.563 ' HB2' ' HE1' ' B' ' 9' ' ' MET . 30.8 t80 -139.32 138.96 37.13 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.546 -0.909 . . . . 65.43 108.546 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -158.93 141.12 13.88 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.215 0.606 . . . . 73.31 109.674 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.486 HD11 HD11 ' B' ' 16' ' ' ILE . 54.1 mt -83.69 121.98 37.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.989 -1.115 . . . . 74.43 107.989 172.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -94.11 -43.8 8.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.204 0.602 . . . . 75.33 109.401 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.438 ' HG2' ' HD1' ' B' ' 17' ' ' TYR . 50.0 ttt180 -163.89 132.69 3.77 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.515 -0.766 . . . . 75.5 109.314 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.486 HD11 HD11 ' B' ' 13' ' ' ILE . 96.0 mt -115.02 141.29 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.237 -1.394 . . . . 73.3 107.237 169.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.438 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 33.1 p90 -164.73 157.27 16.44 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.837 0.711 . . . . 74.21 110.735 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 22.6 m -83.72 122.92 29.29 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.635 -1.246 . . . . 72.15 107.635 168.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.403 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 19.4 mtpp -84.15 -52.82 5.96 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.917 -0.772 . . . . 75.41 108.917 176.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 28.9 t70 -134.96 149.43 50.22 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.687 -0.688 . . . . 75.04 111.256 -170.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.542 HD13 ' SG ' ' B' ' 113' ' ' CYS . 25.7 mm -139.81 144.74 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.528 1.531 . . . . 74.53 108.575 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -147.73 110.99 4.88 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.098 0.873 . . . . 75.44 108.667 166.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.459 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 85.7 t80 -119.81 113.06 20.03 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.204 -1.406 . . . . 75.4 107.204 170.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -122.95 124.23 42.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.611 0.764 . . . . 72.41 109.203 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.49 85.0 12.78 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.162 -1.421 . . . . 71.02 107.162 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.44 -36.83 19.02 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.886 2.39 . . . . 73.34 112.811 -169.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -105.5 17.26 24.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.887 0.875 . . . . 64.33 110.378 -176.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.433 ' HB1' ' HE3' ' A' ' 19' ' ' LYS . . . -41.59 -61.97 1.25 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 115.349 1.611 . . . . 75.13 115.349 -164.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -66.97 -16.06 48.61 Favored 'Trans proline' 0 C--N 1.4 3.287 0 C-N-CA 122.314 2.01 . . . . 72.44 112.372 -170.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -97.73 -49.04 4.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.19 0.996 . . . . 74.11 111.408 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.428 HG23 ' HA ' ' B' ' 73' ' ' ALA . 9.8 p -64.38 -20.49 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.563 0.745 . . . . 63.41 112.333 -166.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -65.04 -17.76 64.73 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.45 0.908 . . . . 72.23 113.45 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -59.3 -25.52 64.21 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.114 0.566 . . . . 71.34 110.901 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.511 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 91.1 mttt -94.46 80.11 3.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.512 1.125 . . . . 65.35 108.674 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.3 93.25 3.4 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.294 0.569 . . . . 75.1 109.59 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -161.74 158.26 25.56 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.752 1.221 . . . . 74.54 107.988 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -60.43 106.15 0.71 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.903 0.881 . . . . 72.05 110.032 169.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.555 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 35.5 Cg_endo -64.35 124.71 13.79 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.872 1.714 . . . . 75.43 110.497 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -58.15 107.23 0.45 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 123.724 0.64 . . . . 61.42 110.126 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.533 HG22 HD22 ' F' ' 470' ' ' LEU . 28.5 m -96.68 150.52 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.744 0.783 . . . . 74.33 112.535 -173.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -119.42 115.12 23.44 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.253 -1.34 . . . . 74.43 107.657 170.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.532 HD21 HD21 ' F' ' 468' ' ' LEU . 3.9 mp -85.15 132.22 34.33 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.421 -1.326 . . . . 71.22 107.421 176.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.462 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 14.4 t70 -147.38 110.96 4.95 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 110.135 -0.32 . . . . 75.3 110.135 -177.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 mp -100.57 163.79 12.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.995 0.426 . . . . 72.31 110.211 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 17.7 t70 -158.43 139.25 12.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.712 1.205 . . . . 61.24 108.397 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 47.8 p -133.6 117.73 17.4 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.938 0.495 . . . . 71.53 110.452 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.64 162.8 17.44 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.632 1.173 . . . . 73.22 108.662 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.437 ' HB2' ' HD2' ' B' ' 56' ' ' TYR . 64.1 p -143.22 160.93 39.54 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.184 -0.672 . . . . 71.31 109.184 170.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.0 p -152.16 135.6 16.02 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.509 0.724 . . . . 64.33 109.426 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.33 124.95 29.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.08 0.552 . . . . 71.23 110.215 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 64.6 mt -86.96 -44.68 11.44 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.672 -0.492 . . . . 74.43 109.672 172.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.96 -175.63 5.47 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.675 -0.693 . . . . 64.5 111.098 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.48 124.32 21.02 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.524 -1.216 . . . . 73.04 109.443 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 67.29 19.59 10.2 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.563 1.145 . . . . 72.13 111.663 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -131.27 125.82 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.166 0.986 . . . . 73.42 109.464 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.437 ' HD2' ' HB2' ' B' ' 48' ' ' SER . 0.2 OUTLIER -131.81 140.51 49.18 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.977 -0.749 . . . . 74.34 108.977 174.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -112.41 106.67 15.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.982 -1.488 . . . . 73.43 106.982 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.4 t -93.74 140.66 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.921 0.488 . . . . 73.53 109.924 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.77 135.34 57.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 124.41 1.084 . . . . 72.3 109.062 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.07 109.87 16.41 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.82 -1.178 . . . . 74.23 107.82 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.497 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.2 ttt180 -95.38 123.64 39.01 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.813 0.845 . . . . 75.12 109.727 173.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.474 ' HB ' HD11 ' B' ' 114' ' ' ILE . 15.2 t -118.34 123.85 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.347 -0.982 . . . . 70.03 108.347 171.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 39.6 m -107.85 140.78 40.43 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.676 1.19 . . . . 73.31 109.455 -178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.549 HG22 HG21 ' B' ' 114' ' ' ILE . 97.8 t -133.13 100.59 3.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 124.155 0.982 . . . . 72.24 108.715 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 70.8 m -84.0 138.88 32.88 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.023 -1.102 . . . . 54.45 108.023 167.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.495 ' HB1' HG12 ' B' ' 40' ' ' VAL . . . -147.69 149.39 32.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.985 0.357 . . . . 70.32 110.459 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 62.5 p -152.11 135.91 16.3 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.834 0.709 . . . . 70.51 111.541 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 43.6 mt -103.21 117.35 34.34 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.182 0.993 . . . . 75.12 108.942 173.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.04 -112.69 5.13 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.244 -0.889 . . . . 65.03 112.189 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -115.88 4.21 13.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.691 0.796 . . . . 75.31 111.703 -175.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.511 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.8 pt-20 -118.96 158.72 25.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.591 0.756 . . . . 73.25 110.012 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.5 m -64.56 138.25 58.3 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.615 0.572 . . . . 74.34 110.792 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.428 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -96.71 -65.11 0.99 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.337 -0.847 . . . . 72.21 108.811 171.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -149.82 155.29 39.83 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.368 -0.833 . . . . 74.05 109.721 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 41.4 mt -131.98 108.56 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.232 -1.766 . . . . 74.23 106.232 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.457 ' SG ' HG22 ' B' ' 114' ' ' ILE . 49.4 t -118.82 139.46 51.57 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.693 -0.854 . . . . 63.45 108.693 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -159.69 133.78 7.47 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.29 -0.633 . . . . 65.11 109.29 -173.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.7 t -124.62 146.48 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.126 -0.943 . . . . 73.33 109.019 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.441 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 29.1 mt-30 -122.3 84.12 2.21 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.076 -1.083 . . . . 71.22 108.076 171.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -81.75 101.06 9.88 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.721 -1.127 . . . . 73.31 109.473 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.2 167.78 30.58 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 111.9 -0.48 . . . . 44.35 111.9 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.87 126.81 1.66 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.109 -0.796 . . . . 62.2 111.109 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.414 HG13 ' HE1' ' B' ' 17' ' ' TYR . 65.6 mt -84.83 127.78 39.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.605 -0.887 . . . . 73.42 108.605 174.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -134.87 146.36 49.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.153 0.981 . . . . 75.13 108.618 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -99.94 106.9 18.76 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.883 -0.784 . . . . 72.35 108.883 170.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.6 ' HB ' HD12 ' B' ' 89' ' ' ILE . 48.4 pt -116.06 130.41 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.171 0.588 . . . . 64.01 110.239 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.564 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -149.52 159.9 43.92 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.559 0.744 . . . . 63.22 110.304 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.99 -54.32 4.73 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.741 -0.663 . . . . 63.0 112.692 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.6 HD12 ' HB ' ' B' ' 86' ' ' ILE . 17.6 pt -54.23 138.56 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.736 1.214 . . . . 73.54 112.798 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -162.8 172.5 15.11 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.793 -1.094 . . . . 71.43 109.749 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.42 -109.93 2.94 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.994 -0.548 . . . . 61.32 112.282 -173.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.2 m -89.61 -26.62 20.68 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.481 0.712 . . . . 75.5 110.946 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.464 ' HB3' HG23 ' B' ' 89' ' ' ILE . 48.5 mt-30 -58.52 -46.08 87.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.394 0.616 . . . . 71.35 110.049 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.553 ' HB2' HG21 ' F' ' 452' ' ' VAL . 0.0 OUTLIER -70.32 -35.29 73.55 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.584 -1.189 . . . . 71.14 110.507 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.72 -47.85 84.03 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 124.119 0.887 . . . . 62.42 109.954 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -62.24 -27.8 69.25 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.263 -1.335 . . . . 74.43 111.306 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 t -76.06 -66.93 0.73 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.008 0.523 . . . . 73.12 110.888 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' B' ' 94' ' ' MET . 1.5 pp -71.83 -22.54 61.53 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 112.92 0.711 . . . . 64.41 112.92 -173.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.6 -1.21 53.04 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.553 -0.582 . . . . 74.34 114.058 -175.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.98 -64.43 0.19 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.608 0.704 . . . . 73.01 111.755 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.535 ' HH ' ' HG2' ' D' ' 130' ' ' PRO . 35.1 t80 -59.91 -55.03 39.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.314 1.045 . . . . 75.33 112.021 -168.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.442 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 92.1 m -59.52 -52.09 76.6 Favored Pre-proline 0 CA--C 1.568 1.665 0 C-N-CA 124.397 1.079 . . . . 72.05 112.097 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 71.1 Cg_exo -54.92 -40.5 85.23 Favored 'Trans proline' 0 C--N 1.404 3.485 0 C-N-CA 122.433 2.089 . . . . 74.2 114.393 172.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -63.89 -24.18 67.64 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.888 0.699 . . . . 73.43 112.888 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.53 -43.98 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.603 -0.517 . . . . 71.01 109.603 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 60.8 mt -76.71 -21.99 54.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.55 -1.205 . . . . 71.52 112.015 -173.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -60.57 -48.38 93.58 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 118.073 -0.965 . . . . 74.42 113.283 -171.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.28 -39.5 86.54 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.987 1.791 . . . . 74.53 113.277 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -66.57 -45.83 78.03 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.193 0.597 . . . . 75.32 110.684 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.88 -34.75 78.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.278 0.631 . . . . 64.2 111.045 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.706 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 39.1 ttt180 -63.62 -54.33 37.55 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.143 1.377 . . . . 64.11 111.178 -177.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.39 -33.9 76.74 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.716 0.635 . . . . 73.53 109.821 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.542 ' SG ' HD13 ' B' ' 21' ' ' ILE . 7.4 t -66.73 -31.52 72.23 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.146 0.578 . . . . 72.3 111.907 -177.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.565 HD13 HD22 ' B' ' 128' ' ' LEU . 80.5 mt -70.45 -58.66 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 109.033 -0.729 . . . . 75.51 109.033 172.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.6 m -59.02 -26.63 64.72 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 124.29 0.994 . . . . 75.41 111.825 -173.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 36.3 t -60.52 -56.6 19.36 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.205 1.002 . . . . 64.54 109.268 173.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.3 mmt -67.48 -34.21 76.69 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.655 0.782 . . . . 75.31 111.375 -173.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 114' ' ' ILE . 94.0 t -59.71 -49.69 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.958 0.903 . . . . 70.34 110.121 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.7 t -66.31 -34.75 78.7 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.651 -1.158 . . . . 73.22 111.363 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -65.46 -35.84 82.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.388 0.675 . . . . 74.45 110.337 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.52 15.07 53.13 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 123.923 0.764 . . . . 70.0 112.96 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.412 HG21 ' HB3' ' A' ' 17' ' ' TYR . 69.3 p 54.37 26.78 7.33 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.959 1.704 . . . . 73.44 113.608 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -85.3 151.16 56.11 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.357 0.663 . . . . 63.22 110.906 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.61 167.71 1.34 Allowed 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 124.049 3.166 . . . . 64.12 115.315 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -63.85 114.83 4.31 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.036 -0.984 . . . . 75.22 112.548 -167.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 17.0 tp -116.28 98.49 6.62 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 115.432 -0.804 . . . . 72.41 109.501 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -97.37 95.96 8.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.25 -1.018 . . . . 75.43 108.25 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.706 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 31.8 tp -55.18 116.87 3.04 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.352 0.661 . . . . 74.34 110.69 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.62 146.18 88.17 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.886 0.874 . . . . 64.3 111.582 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -76.61 110.71 3.1 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.328 2.685 . . . . 75.5 111.923 -173.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.2 t -90.82 111.0 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 108.576 -0.898 . . . . 74.24 108.576 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -78.75 110.81 14.25 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -69.5 -48.66 59.86 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.581 0.55 . . . . 72.51 110.619 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -56.95 -40.78 77.08 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.187 0.995 . . . . 73.54 112.442 -171.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.43 -53.84 53.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.211 1.004 . . . . 71.12 111.384 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' F' ' 462' ' ' TYR . 6.5 mp -84.64 -11.98 54.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.493 -0.776 . . . . 74.1 111.664 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.4 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 66.7 t80 -71.38 -33.1 69.21 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.16 0.584 . . . . 65.02 110.272 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 59.9 mtm -63.47 -35.38 80.25 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.957 -0.565 . . . . 74.53 109.518 172.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.429 ' N ' HD21 ' B' ' 139' ' ' ASN . 0.7 OUTLIER -74.59 -16.44 60.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.774 0.83 . . . . 72.53 110.661 176.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -82.46 -34.97 27.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.263 0.625 . . . . 74.55 111.056 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 75.4 mt -81.86 -12.27 58.55 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 111.983 0.364 . . . . 74.53 111.983 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -156.94 130.51 8.1 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.317 1.047 . . . . 63.52 108.387 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -64.74 90.53 0.08 Allowed 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 121.903 0.858 . . . . 75.23 109.494 172.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -171.83 134.0 0.77 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.387 -1.278 . . . . 72.44 107.83 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.09 142.64 27.52 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.966 0.506 . . . . 61.35 110.596 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.01 46.24 1.2 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 110.871 -0.892 . . . . 70.44 110.871 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -65.46 149.1 50.6 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.51 1.124 . . . . 64.24 112.018 -176.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -122.68 147.34 16.83 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 110.759 -0.937 . . . . 72.42 110.759 174.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 67.1 p -71.86 93.55 1.34 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.19 -0.67 . . . . 64.4 109.19 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.54 71.23 2.45 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.375 1.083 . . . . 74.25 110.667 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -88.02 173.45 8.87 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.751 -1.113 . . . . 74.22 111.13 -175.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -150.2 104.43 3.26 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.648 -0.705 . . . . 73.12 109.617 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -111.48 115.39 29.15 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.63 -0.878 . . . . 75.13 108.63 174.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.18 163.48 28.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.767 0.827 . . . . 71.02 110.856 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.26 0 C-N-CA 123.805 0.842 . . . . 62.11 110.032 177.524 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttp . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.508 -0.553 . . . . 62.13 109.508 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 45.6 m 62.38 82.85 0.17 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.797 1.239 . . . . 65.02 111.265 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.93 34.92 0.51 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.268 1.027 . . . . 74.44 111.858 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -70.6 2.42 4.08 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.405 1.082 . . . . 73.22 112.446 174.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 65.0 t30 70.04 23.93 5.22 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.355 1.462 . . . . 71.13 110.939 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -83.71 -14.09 52.5 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.418 -0.81 . . . . 71.52 110.415 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 14.9 t -78.69 159.8 27.8 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 123.417 0.687 . . . . 73.42 110.382 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -99.4 72.78 1.83 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.411 0.684 . . . . 75.22 109.342 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.676 ' HE2' ' HB ' ' C' ' 86' ' ' ILE . 24.1 ttt 65.36 145.62 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.011 1.324 . . . . 74.51 112.949 175.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 32.4 m -85.56 95.9 9.47 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.029 -0.73 . . . . 73.31 109.029 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.549 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 3.5 t80 -121.14 124.2 44.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.487 0.715 . . . . 74.1 109.896 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -140.61 140.16 35.03 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.165 -1.05 . . . . 74.12 108.165 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 68.0 mt -85.96 129.74 37.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.159 -0.682 . . . . 74.22 109.159 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.495 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.1 mm-40 -87.94 -45.43 10.24 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.64 0.776 . . . . 75.35 109.727 178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -169.7 148.21 3.59 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.024 -0.534 . . . . 73.14 109.667 -172.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.4 mt -137.58 136.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.747 -1.205 . . . . 73.24 107.747 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -169.74 161.03 9.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.007 0.432 . . . . 75.22 111.838 -172.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.9 p -80.39 108.06 13.7 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.095 -0.705 . . . . 75.54 109.095 170.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -68.34 -37.3 80.39 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.445 -0.576 . . . . 73.14 109.445 172.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 12.8 t70 -149.78 150.27 31.78 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.49 -0.777 . . . . 70.25 109.83 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.5 mt -141.63 146.94 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.34 1.456 . . . . 61.32 107.62 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -152.19 142.37 22.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.484 0.714 . . . . 73.2 109.563 173.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -142.9 137.86 29.8 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.618 -1.253 . . . . 75.45 107.618 170.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.08 121.68 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.365 1.066 . . . . 74.33 109.293 -172.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.34 69.11 13.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 106.12 -1.807 . . . . 74.41 106.12 165.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.22 -10.35 27.09 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.555 2.17 . . . . 74.25 112.178 -174.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -123.23 26.38 8.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.664 1.585 . . . . 70.35 109.774 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.61 -58.12 4.06 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 114.64 1.348 . . . . 72.31 114.64 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.57 -33.32 46.18 Favored 'Trans proline' 0 C--N 1.388 2.609 0 CA-C-N 121.844 1.694 . . . . 73.03 112.362 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -69.41 -37.53 77.51 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.846 0.859 . . . . 75.11 111.575 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.605 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -79.31 -26.33 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 112.513 0.56 . . . . 74.5 112.513 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.25 -31.87 73.24 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 112.212 0.449 . . . . 75.12 112.212 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -85.79 9.55 16.23 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.542 0.337 . . . . 72.04 111.881 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.62 166.1 11.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.484 0.714 . . . . 74.55 111.037 -175.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -58.2 127.53 32.58 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.003 0.921 . . . . 65.33 110.018 170.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.456 ' NE1' ' HG2' ' C' ' 124' ' ' PRO . 32.9 t90 -84.95 93.24 8.51 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.613 0.765 . . . . 73.21 109.831 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -150.47 78.73 7.59 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 108.51 -0.922 . . . . 74.23 108.51 164.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.56 136.95 37.85 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.681 2.254 . . . . 72.01 112.183 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -86.21 93.43 9.04 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 105.359 -2.089 . . . . 61.23 105.359 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 17.0 m -68.6 131.41 33.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 115.368 -0.833 . . . . 75.21 109.755 -176.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 tptt -134.9 129.62 34.64 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.526 -1.657 . . . . 74.23 106.526 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.552 HD21 HD13 ' C' ' 128' ' ' LEU . 2.8 tm? -116.32 139.68 50.13 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.508 -0.923 . . . . 75.35 108.508 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.525 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.2 t70 -134.4 141.2 46.76 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.453 1.101 . . . . 61.05 108.971 -177.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 79.6 mt -132.11 137.15 47.61 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.309 1.044 . . . . 73.33 108.917 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 27.3 t70 -144.81 155.23 43.39 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.11 0.964 . . . . 74.24 109.201 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' THR . . . . . 0.638 ' H ' HD21 ' G' ' 460' ' ' LEU . 5.1 m -151.1 138.55 19.51 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.29 1.036 . . . . 62.43 109.577 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.67 173.92 10.17 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.742 1.217 . . . . 62.12 108.926 175.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -159.95 153.95 23.18 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.65 0.78 . . . . 71.21 110.039 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.8 p -155.3 137.54 14.8 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.258 0.623 . . . . 65.54 109.434 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . 0.431 ' NE2' HG22 ' G' ' 452' ' ' VAL . 58.3 tt0 -77.32 118.8 20.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.053 -0.721 . . . . 74.3 109.053 174.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' C' ' 57' ' ' GLU . 54.1 mt -93.35 -43.16 8.92 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.348 -0.612 . . . . 72.33 109.348 176.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.423 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -148.79 -177.89 6.05 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.227 -0.897 . . . . 75.12 110.919 -177.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.91 123.8 21.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.722 -1.126 . . . . 74.21 109.101 175.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 61.27 18.81 9.55 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.444 1.098 . . . . 65.01 112.056 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 77.4 t -127.88 103.67 10.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 124.351 1.06 . . . . 73.02 109.238 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.496 ' HD1' HD13 ' C' ' 86' ' ' ILE . 24.7 m-85 -102.3 146.49 27.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.489 -0.778 . . . . 74.34 108.986 169.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.65 ' HB2' HD12 ' C' ' 51' ' ' LEU . 35.0 tt0 -94.35 129.07 41.18 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.408 -1.33 . . . . 71.04 107.408 160.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 42.4 t -106.27 143.4 17.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.993 -1.114 . . . . 74.3 107.993 165.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.0 t -121.28 140.66 44.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 107.931 -1.137 . . . . 75.25 107.931 172.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -129.71 106.97 9.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.553 -1.277 . . . . 73.41 107.553 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 58.7 ttt-85 -95.41 122.64 38.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.993 -1.458 . . . . 74.23 108.83 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.9 t -117.27 132.35 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.013 -1.106 . . . . 74.11 108.013 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.8 m -134.12 128.95 35.18 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.3 0.64 . . . . 74.22 109.715 -174.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.571 HG21 HD12 ' C' ' 114' ' ' ILE . 61.6 t -115.64 121.03 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.839 0.856 . . . . 74.54 109.712 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.7 m -100.81 145.36 28.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.476 0.71 . . . . 74.53 109.179 170.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.98 131.37 32.85 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.792 -1.188 . . . . 62.01 107.792 169.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.7 m -139.95 129.17 23.83 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 123.598 0.561 . . . . 72.45 110.266 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 37.1 mt -85.22 41.5 0.89 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.319 1.048 . . . . 72.3 109.704 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.73 -104.17 2.54 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 110.053 -1.219 . . . . 75.12 110.053 -170.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -93.8 -29.72 15.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.263 1.025 . . . . 74.43 110.003 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -73.14 120.17 18.4 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.823 0.849 . . . . 71.14 110.268 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 35.7 m -75.88 129.64 37.29 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.568 -0.53 . . . . 73.44 109.568 173.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.605 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.27 -60.95 2.07 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.398 -0.964 . . . . 73.22 108.398 170.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -158.09 173.77 16.23 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 114.417 -1.265 . . . . 73.44 111.436 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -138.89 130.04 26.79 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.572 -1.64 . . . . 74.23 106.572 162.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 46.0 t -128.35 138.73 52.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.946 -1.131 . . . . 74.43 107.946 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -154.54 129.07 9.19 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.522 -0.548 . . . . 75.52 109.522 -170.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' C' ' 61' ' ' ARG . 97.2 t -135.03 114.3 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.689 0.796 . . . . 72.01 109.921 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.402 ' OE1' ' HG3' ' C' ' 61' ' ' ARG . 1.7 mp0 -90.08 87.84 7.04 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.531 -0.915 . . . . 75.15 108.531 174.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -83.21 98.77 9.55 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.308 -0.86 . . . . 72.43 109.662 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.42 159.49 38.86 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.441 -0.664 . . . . 72.33 111.441 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.46 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -161.25 118.83 0.85 Allowed Glycine 0 CA--C 1.504 -0.614 0 N-CA-C 111.047 -0.821 . . . . 74.31 111.047 -177.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.524 HD13 HD12 ' C' ' 51' ' ' LEU . 6.9 mm -84.1 121.13 36.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.334 -0.987 . . . . 74.2 108.334 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.549 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 57.6 m-85 -126.58 118.46 24.89 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.421 -0.955 . . . . 75.32 108.421 -177.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 54.5 p -87.95 105.87 17.74 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.688 -0.856 . . . . 64.0 108.688 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.676 ' HB ' ' HE2' ' C' ' 9' ' ' MET . 0.2 OUTLIER -116.97 125.9 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.038 0.935 . . . . 73.22 109.341 -176.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.96 163.93 32.05 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.473 0.709 . . . . 61.34 110.697 -172.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.04 -41.99 2.88 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 115.519 -0.764 . . . . 71.14 113.111 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 46.9 mm -122.73 150.4 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.901 0.88 . . . . 73.44 110.421 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.425 ' HB3' ' HB ' ' G' ' 451' ' ' VAL . 12.5 pt-20 -145.52 -174.22 4.34 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.179 0.992 . . . . 73.41 111.544 -168.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.64 -138.17 25.62 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 115.414 -0.812 . . . . 74.13 113.778 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' C' ' 141' ' ' LEU . 53.5 p -61.87 -29.12 69.98 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.152 0.981 . . . . 73.51 111.113 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -70.04 -44.71 68.66 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.471 -1.24 . . . . 75.53 111.326 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -73.7 -30.45 62.88 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 110.17 -0.307 . . . . 74.25 110.17 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.4 81.11 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.134 0.574 . . . . 64.22 109.615 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.402 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 11.3 t-160 -72.17 -41.05 67.49 Favored 'General case' 0 C--O 1.241 0.636 0 O-C-N 123.464 0.478 . . . . 71.14 110.935 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -59.5 -38.18 80.23 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.272 0.983 . . . . 72.32 111.119 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 37.4 mt -101.13 -23.48 14.46 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.356 0.662 . . . . 74.1 112.417 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.78 -23.74 57.2 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 116.138 -0.483 . . . . 70.23 114.107 -170.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.64 -43.47 0.1 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.148 0.499 . . . . 74.33 111.034 -171.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.465 ' HH ' ' HD1' ' C' ' 11' ' ' PHE . 55.8 t80 -66.34 -42.79 87.61 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.425 1.49 . . . . 75.11 112.729 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 33.8 m -73.76 -43.48 6.61 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-O 118.832 -0.604 . . . . 53.33 112.277 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -51.22 -31.83 38.2 Favored 'Trans proline' 0 C--N 1.393 2.873 0 C-N-CA 122.361 2.041 . . . . 73.13 114.201 167.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' C' ' 134' ' ' ASP . 74.7 m-20 -64.17 -35.18 79.95 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.854 0.862 . . . . 74.42 111.712 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.489 HD13 ' NH1' ' A' ' 111' ' ' ARG . 50.8 mm -68.43 -38.69 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.281 0.563 . . . . 73.52 109.723 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.46 HD21 ' HA3' ' C' ' 82' ' ' GLY . 90.9 mt -80.56 -22.71 40.53 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.725 -1.125 . . . . 73.55 112.736 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.475 ' HZ ' HD22 ' C' ' 128' ' ' LEU . 45.7 t80 -59.48 -49.73 90.84 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-O 117.75 -1.119 . . . . 75.14 113.631 -173.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -53.02 -36.68 76.91 Favored 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 122.44 2.094 . . . . 72.42 114.006 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.44 ' HE2' HG21 ' A' ' 115' ' ' THR . 61.8 m-85 -69.3 -52.88 23.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.763 0.825 . . . . 71.32 110.763 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.3 81.66 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.148 -0.933 . . . . 62.21 111.142 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -59.11 -54.96 41.05 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.657 1.583 . . . . 72.51 110.814 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -67.75 -33.72 75.4 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.554 0.742 . . . . 75.41 110.251 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 28.1 t -68.58 -31.84 71.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.03 0.532 . . . . 74.11 111.496 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.571 HD12 HG21 ' C' ' 64' ' ' VAL . 64.2 mt -68.92 -52.44 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.129 -0.487 . . . . 65.14 109.993 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 3.6 m -65.49 -28.83 69.48 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 123.741 0.651 . . . . 72.42 111.24 -174.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 46.3 t -66.53 -49.31 66.92 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 123.771 0.828 . . . . 51.4 109.413 171.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.621 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.09 -40.72 86.16 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.804 1.242 . . . . 75.01 112.917 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 39.2 t -67.75 -42.48 86.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.323 1.049 . . . . 71.54 110.351 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.0 t -70.0 -27.22 64.51 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.716 -0.675 . . . . 52.44 111.154 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.479 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.1 mtt-85 -68.38 -36.85 79.78 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.807 0.843 . . . . 74.44 108.93 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.39 9.26 67.98 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 124.052 0.845 . . . . 74.31 112.834 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 57.0 p 55.52 36.61 27.5 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.614 1.565 . . . . 73.31 113.759 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.64 158.03 34.32 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.916 0.887 . . . . 72.23 109.243 172.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.456 ' HG2' ' NE1' ' C' ' 36' ' ' TRP . 34.6 Cg_exo -61.52 157.7 40.21 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 122.993 2.462 . . . . 73.12 113.882 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -60.18 141.24 56.25 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.448 1.099 . . . . 73.23 113.184 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' G' ' 470' ' ' LEU . 0.5 OUTLIER -134.72 96.7 3.6 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.961 -1.018 . . . . 75.3 109.816 170.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -90.65 95.62 10.24 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.288 -1.005 . . . . 75.53 108.288 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.552 HD13 HD21 ' C' ' 42' ' ' LEU . 1.3 tt -60.49 129.36 41.21 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.498 1.119 . . . . 74.24 110.628 -172.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.86 148.72 98.44 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.373 0.669 . . . . 72.54 111.284 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.533 ' HG3' HD12 ' A' ' 16' ' ' ILE . 50.1 Cg_exo -54.29 117.56 4.06 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.783 2.322 . . . . 64.43 112.693 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.35 118.21 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.822 -0.807 . . . . 74.41 108.822 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.91 88.56 4.71 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.089 0.556 . . . . 73.44 109.935 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -73.82 -45.25 52.49 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.072 -0.714 . . . . 73.14 109.072 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.501 ' HB2' ' ND2' ' C' ' 104' ' ' ASN . 20.6 t70 -66.98 -41.64 86.44 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.277 -1.328 . . . . 72.45 111.707 -168.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.86 94.19 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.755 -1.111 . . . . 63.12 112.075 -177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.31 -26.44 46.93 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 116.035 -0.53 . . . . 71.12 112.378 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.402 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 11.2 t80 -68.92 -25.51 64.62 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.717 0.407 . . . . 71.04 110.742 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 65.7 mtt -59.72 -41.61 91.24 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.336 0.655 . . . . 75.33 110.46 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -60.79 -37.3 81.46 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.655 0.782 . . . . 72.22 111.13 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -66.15 -85.06 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.306 1.043 . . . . 75.34 110.052 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' C' ' 92' ' ' THR . 72.2 mt -131.83 134.52 45.86 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.238 0.615 . . . . 74.54 110.25 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -160.43 163.55 32.97 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.547 1.139 . . . . 74.13 109.265 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -95.26 102.07 13.85 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.979 -0.749 . . . . 72.23 108.979 171.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -76.17 101.56 5.42 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.161 -1.051 . . . . 74.11 108.161 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -174.63 144.56 0.86 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.65 1.18 . . . . 72.03 109.007 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -165.75 142.11 7.46 Favored Glycine 0 C--N 1.343 0.972 0 O-C-N 123.407 0.442 . . . . 52.44 112.477 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -78.74 -178.41 5.94 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.563 0.745 . . . . 72.05 111.618 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -102.13 133.76 11.5 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 111.205 -0.758 . . . . 73.53 111.205 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 12.6 t -135.81 175.23 9.79 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.732 0.813 . . . . 74.34 108.986 173.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -134.4 146.19 49.64 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 109.359 -0.608 . . . . 74.32 109.359 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.64 126.67 28.28 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.754 0.822 . . . . 73.34 109.066 171.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -141.36 86.75 2.03 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.387 -0.968 . . . . 74.34 108.387 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -71.8 104.76 3.53 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.241 -0.651 . . . . 74.41 109.241 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -151.23 132.41 14.44 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.258 1.023 . . . . 73.11 108.512 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 C-N-CA 123.711 0.805 . . . . 54.31 108.997 -178.848 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' D' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 120.767 0.317 . . . . 73.34 110.499 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 19.0 m -90.63 76.69 6.48 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.793 0.837 . . . . 71.11 109.672 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.93 104.68 11.6 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.644 -0.707 . . . . 74.4 109.889 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -73.68 -178.92 3.34 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.414 1.085 . . . . 75.24 111.733 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -136.68 145.61 44.95 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.754 0.822 . . . . 63.32 110.008 170.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -83.07 96.99 8.54 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-O 121.596 0.712 . . . . 75.34 110.454 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 98.2 m -145.0 146.84 32.09 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.533 1.133 . . . . 74.12 109.107 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -66.08 108.87 2.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.331 -1.359 . . . . 74.4 107.331 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 4.0 ttp -29.15 120.49 0.14 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 125.653 1.846 . . . . 75.41 112.907 -168.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 57.5 m -121.37 139.82 52.93 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.669 0.787 . . . . 72.33 109.371 -176.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -157.46 96.21 1.52 Allowed 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.879 -1.156 . . . . 73.34 107.879 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -113.67 130.15 56.45 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.292 -1.373 . . . . 75.4 107.292 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.408 HG21 HD13 ' D' ' 16' ' ' ILE . 39.9 mt -73.21 119.28 19.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.503 -0.925 . . . . 73.45 108.503 176.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -87.06 -30.97 20.76 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.462 0.476 . . . . 72.35 110.651 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -176.55 139.59 0.33 Allowed 'General case' 0 C--N 1.369 1.443 0 C-N-CA 122.483 0.313 . . . . 75.53 110.53 -170.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.408 HD13 HG21 ' D' ' 13' ' ' ILE . 3.1 mp -120.89 134.58 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.76 -1.2 . . . . 71.22 107.76 172.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -161.3 172.42 16.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.948 0.88 . . . . 71.0 111.919 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 45.7 p -104.34 124.3 48.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.758 -1.11 . . . . 72.21 109.221 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -94.55 -20.04 19.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.334 0.654 . . . . 75.33 110.186 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.715 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 3.7 t70 -158.66 135.18 9.39 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.139 -1.06 . . . . 40.11 108.139 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.621 HG21 ' HE1' ' C' ' 117' ' ' MET . 72.6 mt -135.9 145.33 31.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.068 -1.086 . . . . 73.33 108.068 175.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -151.21 144.1 24.51 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.897 0.748 . . . . 73.35 109.325 172.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.0 t80 -145.13 115.61 7.62 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 105.939 -1.875 . . . . 73.55 105.939 168.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.575 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 22.9 mt-10 -119.86 110.65 16.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.934 -0.765 . . . . 72.11 108.934 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.52 88.36 4.1 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.842 -1.17 . . . . 61.45 107.842 172.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.88 -28.78 7.48 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.744 2.296 . . . . 64.22 112.754 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -114.67 17.97 16.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.517 1.127 . . . . 73.13 109.96 -171.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.63 -67.53 0.33 Allowed Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 114.85 1.426 . . . . 52.12 114.85 -160.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.509 ' HB3' HD11 ' C' ' 83' ' ' ILE . 87.7 Cg_endo -73.82 -15.62 23.81 Favored 'Trans proline' 0 C--N 1.39 2.722 0 CA-C-N 122.426 1.902 . . . . 65.44 113.54 -173.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -78.45 -45.2 22.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.45 1.1 . . . . 72.53 110.736 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.04 -24.59 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 CA-C-N 115.986 -0.552 . . . . 71.55 111.617 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -52.87 -31.27 38.61 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 123.797 0.839 . . . . 73.41 113.004 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -53.01 -24.28 9.21 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.627 1.171 . . . . 72.42 111.916 -176.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -83.41 96.38 8.53 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.441 1.096 . . . . 73.4 110.066 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -74.88 83.54 2.19 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.52 0.676 . . . . 63.41 110.078 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.402 ' HD1' HD21 ' D' ' 68' ' ' LEU . 61.1 t-105 -155.89 156.94 35.5 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.017 1.327 . . . . 73.05 107.915 -176.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -82.21 112.2 34.02 Favored Pre-proline 0 N--CA 1.483 1.198 0 N-CA-C 109.147 -0.686 . . . . 72.35 109.147 173.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.1 124.85 16.87 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.416 2.744 . . . . 73.54 113.917 -173.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.665 ' HA ' ' HG ' ' H' ' 470' ' ' LEU . 38.5 mt-10 -62.1 120.36 10.73 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.021 1.329 . . . . 74.35 110.894 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.527 HG23 HG13 ' D' ' 64' ' ' VAL . 7.2 p -95.43 127.44 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.466 0.65 . . . . 74.41 110.882 -170.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -119.61 106.78 12.51 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 105.988 -1.856 . . . . 72.54 105.988 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.477 ' H ' HD22 ' D' ' 42' ' ' LEU . 1.3 pt? -110.72 134.44 52.47 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.945 0.498 . . . . 75.13 110.612 -170.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.72 126.4 52.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.455 0.702 . . . . 74.3 109.198 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -100.81 137.09 39.67 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.162 0.985 . . . . 74.51 109.75 -175.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.561 ' HA ' ' HG ' ' H' ' 460' ' ' LEU . 26.9 t70 -153.9 139.13 17.49 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.437 -0.949 . . . . 72.32 108.437 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.7 t -117.24 155.65 29.09 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.094 0.473 . . . . 71.12 110.095 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.425 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -151.54 176.22 11.54 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.42 1.088 . . . . 75.43 108.866 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.5 p -174.21 161.36 3.51 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.82 0.448 . . . . 44.51 111.989 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 28.4 t -157.04 124.04 5.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.605 1.162 . . . . 63.03 109.806 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -78.73 123.72 27.46 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.454 -0.573 . . . . 74.54 109.454 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 38.5 mt -94.08 -32.8 13.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.16 0.584 . . . . 72.31 109.954 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.62 -176.73 4.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.775 1.23 . . . . 64.3 108.922 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.71 135.05 36.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.093 -1.077 . . . . 73.03 108.093 171.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 74.28 -0.19 3.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.412 1.485 . . . . 74.1 111.605 -174.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.0 t -129.79 118.54 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.125 0.97 . . . . 72.51 108.782 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -141.86 128.55 20.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.702 -0.481 . . . . 74.31 109.702 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -94.23 140.26 30.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.893 0.877 . . . . 75.25 109.316 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -122.75 138.56 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.971 -1.122 . . . . 73.45 107.971 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 59.6 t -111.55 143.19 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.541 1.136 . . . . 74.01 108.388 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.51 123.58 41.58 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.506 -0.924 . . . . 71.02 108.506 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.537 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.4 ttm-85 -102.57 96.0 6.61 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.108 -1.071 . . . . 75.34 108.108 176.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 78.2 t -99.47 128.94 50.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.327 -0.99 . . . . 71.24 108.327 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 3.6 m -120.93 144.06 48.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.226 -1.027 . . . . 73.42 108.226 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.527 HG13 HG23 ' D' ' 40' ' ' VAL . 53.3 t -136.66 101.83 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.443 -1.317 . . . . 74.14 107.443 -174.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 88.5 m -107.33 97.69 7.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.17 0.988 . . . . 74.53 108.571 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.08 152.83 18.38 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.817 -0.628 . . . . 75.12 110.958 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.442 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.7 m -144.05 130.68 20.11 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.715 -0.675 . . . . 73.41 110.518 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.402 HD21 ' HD1' ' D' ' 36' ' ' TRP . 32.5 mt -91.82 101.09 13.68 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.833 -1.543 . . . . 73.13 106.833 171.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.71 -128.64 12.74 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.625 0.578 . . . . 61.44 112.383 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.3 5.73 43.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.826 0.85 . . . . 74.11 111.804 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -123.88 140.94 52.49 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.592 0.757 . . . . 73.34 110.604 -171.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.2 m -58.16 125.73 24.44 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.106 0.962 . . . . 75.2 110.721 175.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.442 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.14 -74.72 0.43 Allowed 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.908 -1.145 . . . . 75.35 107.908 175.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . 0.496 ' HZ ' HD23 ' D' ' 126' ' ' LEU . 54.4 p90 -140.86 154.3 46.12 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-O 121.543 0.687 . . . . 72.04 110.221 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 39.7 mt -115.86 147.25 41.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.352 -1.722 . . . . 71.44 106.352 172.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.612 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 23.5 t -160.25 127.79 4.53 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 109.681 -0.488 . . . . 75.22 109.681 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -142.27 124.14 15.21 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.623 -0.51 . . . . 73.45 109.623 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.19 122.7 62.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 C-N-CA 123.464 0.706 . . . . 73.35 109.641 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.715 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 21.1 mt-30 -88.12 88.92 7.79 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.159 -1.052 . . . . 73.2 108.159 164.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.13 101.0 8.52 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.406 -1.27 . . . . 72.33 108.903 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.74 148.25 20.3 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.853 -0.499 . . . . 53.42 111.853 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.521 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -147.54 128.99 3.07 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 111.371 -0.692 . . . . 62.11 111.371 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.9 mt -91.76 141.75 14.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.547 -0.909 . . . . 73.05 108.547 174.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -139.43 129.47 25.07 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.459 0.703 . . . . 74.12 110.09 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -74.24 99.12 3.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.145 0.578 . . . . 65.45 109.687 168.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 9.4 tt -122.02 118.63 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-O 121.364 0.602 . . . . 74.11 110.9 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.0 167.92 21.03 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.454 1.102 . . . . 74.44 109.31 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.4 24.94 66.88 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-O 119.906 -0.386 . . . . 74.1 113.439 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.28 156.41 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.981 0.912 . . . . 74.25 111.682 -175.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.28 171.73 4.71 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.412 1.085 . . . . 72.32 110.717 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.21 -118.65 12.9 Favored Glycine 0 C--N 1.355 1.629 0 N-CA-C 114.894 0.718 . . . . 74.03 114.894 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.2 m -82.64 -28.96 30.37 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.234 0.614 . . . . 74.02 110.599 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -66.76 -42.36 86.29 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.269 0.628 . . . . 71.32 111.335 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.587 ' SD ' ' HA ' ' H' ' 452' ' ' VAL . 25.9 ptt? -62.5 -39.45 93.52 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.878 -0.601 . . . . 73.44 110.244 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.77 74.53 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.543 0.737 . . . . 73.31 110.954 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -67.08 -30.36 70.38 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.76 0.824 . . . . 74.21 110.9 -176.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -79.92 -47.09 15.6 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.717 -0.674 . . . . 72.33 110.304 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' D' ' 94' ' ' MET . 4.7 tt -69.58 -55.25 10.63 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.29 1.036 . . . . 74.04 111.575 -168.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.97 10.82 73.65 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.964 -0.562 . . . . 64.32 114.09 -171.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.704 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -140.14 -65.85 0.45 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 117.346 0.573 . . . . 71.45 111.306 -175.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -70.8 -43.86 67.77 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.376 -0.829 . . . . 72.42 111.776 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -63.51 -50.02 75.11 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 124.012 0.925 . . . . 74.42 112.614 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.21 -21.9 30.78 Favored 'Trans proline' 0 C--N 1.397 3.114 0 C-N-CA 121.865 1.71 . . . . 75.13 112.907 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' D' ' 100' ' ' ALA . 0.2 OUTLIER -68.53 -32.8 73.0 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.989 0.516 . . . . 72.51 110.21 178.279 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 57.6 mt -67.6 -36.76 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 124.324 1.05 . . . . 72.32 110.643 173.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.521 HD22 ' HA3' ' D' ' 82' ' ' GLY . 89.2 mt -76.11 -18.17 59.28 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.126 -0.943 . . . . 75.33 112.392 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -68.21 -45.36 39.35 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 113.662 0.986 . . . . 74.43 113.662 -173.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -53.24 -38.87 82.1 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.324 2.016 . . . . 71.53 113.702 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -77.99 -33.35 51.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.703 0.801 . . . . 74.42 111.935 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.08 64.58 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.067 -0.716 . . . . 75.12 109.067 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -53.7 -48.08 69.9 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 124.813 1.321 . . . . 72.12 110.602 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.49 -52.13 66.52 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.329 0.652 . . . . 72.52 111.305 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.76 -44.33 77.55 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 124.081 0.863 . . . . 75.24 110.99 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.496 HG12 ' SG ' ' D' ' 76' ' ' CYS . 32.7 mt -62.26 -60.12 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.929 0.892 . . . . 70.01 110.855 174.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 93.7 m -51.67 -39.55 58.44 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.113 1.365 . . . . 75.11 112.214 -173.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 48.4 t -67.08 -44.49 79.92 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.018 -0.992 . . . . 74.11 110.022 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.612 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.9 mtm -68.02 -26.41 65.88 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.174 0.59 . . . . 74.3 112.184 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.459 HG22 ' O ' ' D' ' 114' ' ' ILE . 80.0 t -67.81 -45.59 83.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.75 0.82 . . . . 73.21 109.784 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.9 p -73.84 -26.85 60.79 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.843 -0.617 . . . . 74.12 111.054 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -70.16 -37.16 75.14 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.613 0.765 . . . . 74.11 109.481 173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.48 11.2 61.92 Favored Glycine 0 C--N 1.357 1.704 0 O-C-N 123.986 0.804 . . . . 74.24 112.732 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 67.5 p 58.17 16.93 4.21 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 126.815 2.046 . . . . 73.0 115.093 174.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -79.49 146.98 66.97 Favored Pre-proline 0 C--O 1.243 0.719 0 N-CA-C 107.961 -1.125 . . . . 73.42 107.961 166.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.67 138.43 14.67 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 123.534 2.823 . . . . 74.35 112.757 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -64.68 120.04 11.68 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 123.767 0.667 . . . . 74.04 110.49 -174.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.496 HD23 ' HZ ' ' D' ' 74' ' ' PHE . 4.8 mp -104.63 101.96 11.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.959 -0.756 . . . . 74.43 108.959 -176.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -100.64 93.51 5.62 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.437 -0.949 . . . . 74.15 108.437 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.29 133.48 47.03 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.914 0.886 . . . . 71.31 110.23 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.656 ' HB2' ' HB1' ' H' ' 467' ' ' ALA . . . -66.3 137.65 95.6 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.885 0.474 . . . . 75.15 110.657 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.535 ' HG2' ' HH ' ' B' ' 101' ' ' TYR . 72.7 Cg_endo -70.79 130.04 17.45 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.841 2.361 . . . . 71.44 112.339 -173.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.71 140.74 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.423 0.689 . . . . 74.43 110.268 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -97.01 108.37 21.09 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.095 0.958 . . . . 75.33 109.73 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -76.51 -21.11 56.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.371 0.668 . . . . 64.35 111.401 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.704 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 9.9 t70 -65.81 -49.91 66.53 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.527 0.731 . . . . 75.12 111.744 -171.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.4 ' HA ' ' HE2' ' D' ' 138' ' ' MET . . . -61.55 -39.1 89.87 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.842 0.714 . . . . 74.41 111.372 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.7 mp -81.01 -17.19 51.15 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.535 -1.212 . . . . 75.41 111.732 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -77.19 -43.98 31.76 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.439 -0.578 . . . . 74.42 109.439 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.4 ' HE2' ' HA ' ' D' ' 135' ' ' ALA . 73.8 mtm -64.37 -32.31 73.87 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.79 -0.641 . . . . 74.14 110.775 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -71.49 -42.68 67.75 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.955 0.902 . . . . 74.21 109.54 172.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -59.49 -41.88 90.85 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.717 0.807 . . . . 74.22 112.296 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.71 -35.02 79.56 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.437 0.695 . . . . 74.22 112.02 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -88.3 10.8 18.5 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.792 0.437 . . . . 74.2 111.26 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -120.29 85.04 2.32 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.721 0.809 . . . . 74.34 109.346 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -162.18 134.17 5.52 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.112 1.365 . . . . 72.21 108.218 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.71 91.09 1.87 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 122.978 0.511 . . . . 72.11 109.759 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.7 176.79 45.98 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.28 -0.873 . . . . 71.14 113.248 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -171.52 136.35 0.98 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.081 0.953 . . . . 71.52 109.465 177.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -134.24 162.64 24.57 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.706 -0.558 . . . . 74.03 111.706 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 14.8 t -158.95 153.1 23.7 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.759 0.824 . . . . 72.52 109.362 176.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -155.81 116.89 3.87 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.519 0.327 . . . . 73.0 110.591 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -80.22 65.23 5.31 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.604 1.162 . . . . 74.2 110.234 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -68.23 113.19 5.64 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.586 1.154 . . . . 75.2 110.897 -174.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -119.75 114.39 22.08 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.324 0.65 . . . . 64.14 110.988 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -84.14 83.48 7.95 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.329 0.651 . . . . 53.52 111.231 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.295 0 C-N-CA 124.547 1.139 . . . . 74.34 108.797 175.342 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 55.8 t30 . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 109.753 -0.462 . . . . 74.24 109.753 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . 0.757 ' HB ' ' HA ' ' A' ' 54' ' ' ASP . 8.4 p -115.44 160.38 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.398 1.079 . . . . 74.13 108.94 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . 0.519 HG11 HD12 ' A' ' 98' ' ' LEU . 6.9 p -111.25 153.59 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.592 0.757 . . . . 64.13 110.468 -174.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -152.5 112.8 0.55 Allowed Glycine 0 C--N 1.357 1.703 0 CA-C-O 119.902 -0.388 . . . . 74.04 112.279 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . 0.585 ' HG ' HD11 ' A' ' 98' ' ' LEU . 73.0 mt -85.08 84.47 7.69 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 117.385 0.592 . . . . 73.13 109.612 173.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 8.9 m -77.43 -17.73 57.84 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-N 115.344 -0.844 . . . . 71.22 109.917 172.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -74.92 152.1 38.86 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.2 1.0 . . . . 75.41 110.563 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.07 91.64 3.55 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.631 0.772 . . . . 74.24 110.824 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 19.9 p -140.23 173.81 11.14 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.589 1.155 . . . . 72.11 108.998 170.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -68.99 152.57 45.1 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.086 -0.709 . . . . 70.44 109.086 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . 0.519 HD22 ' HB ' ' A' ' 46' ' ' THR . 79.2 mt -76.39 -62.83 1.49 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.192 0.52 . . . . 70.55 110.302 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -173.04 -9.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 114.952 -1.022 . . . . 73.11 112.241 -169.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -168.34 122.24 0.9 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.125 0.421 . . . . 73.24 111.066 -168.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 31.8 m -97.18 131.32 44.04 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 107.816 -1.179 . . . . 71.54 107.816 165.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 464' ' ' MET . . . . . 0.54 ' SD ' HD22 ' A' ' 42' ' ' LEU . 28.4 ttt -96.45 114.26 25.91 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.922 0.489 . . . . 72.33 111.665 -171.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -96.82 110.74 23.16 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.393 -0.966 . . . . 72.11 108.393 167.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -83.31 -48.57 10.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.164 0.586 . . . . 72.51 110.929 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . 68.84 -63.03 0.37 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.821 1.648 . . . . 71.33 111.966 -173.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . 0.418 HD12 HD11 ' A' ' 126' ' ' LEU . 2.0 tt 75.6 -64.98 0.34 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.212 1.805 . . . . 72.35 109.823 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 96.78 53.3 1.42 Allowed Glycine 0 C--N 1.342 0.876 0 N-CA-C 111.205 -0.758 . . . . 72.11 111.205 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.44 135.69 45.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.232 0.613 . . . . 71.23 110.424 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 59.7 pttt . . . . . 0 CA--C 1.565 1.546 0 C-N-CA 124.346 1.058 . . . . 75.44 109.26 177.929 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 14.6 m120 . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.718 0.294 . . . . 73.45 111.099 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 11.8 p -133.5 160.9 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.822 0.849 . . . . 74.04 109.194 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . 0.553 HG21 ' HB2' ' B' ' 94' ' ' MET . 32.1 m -67.64 173.86 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.466 1.106 . . . . 71.13 112.597 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -115.54 154.24 17.06 Favored Glycine 0 C--N 1.345 1.034 0 N-CA-C 111.495 -0.642 . . . . 74.35 111.495 173.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 67.2 tp -88.59 139.66 30.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.97 0.508 . . . . 74.22 109.812 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 17.6 p -76.8 159.03 30.43 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.257 1.023 . . . . 73.35 111.548 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.92 146.44 46.11 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.973 -1.012 . . . . 72.53 109.957 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . 0.426 ' HG2' ' HB2' ' F' ' 459' ' ' ASP . 35.0 tt0 59.2 87.7 0.08 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.088 1.355 . . . . 65.24 110.936 -175.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 32.0 p -66.55 -47.1 73.93 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.945 -0.57 . . . . 74.14 110.085 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . 0.426 ' HB2' ' HG2' ' F' ' 457' ' ' GLN . 34.8 t70 51.88 93.94 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 O-C-N 125.076 1.485 . . . . 75.13 112.15 169.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.12 108.89 2.82 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 122.427 1.108 . . . . 73.5 109.887 -174.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -67.35 0.67 2.71 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.396 2.278 . . . . 75.33 114.396 -175.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . 0.557 ' HA ' HD21 ' B' ' 136' ' ' LEU . 4.5 p90 -68.34 129.49 40.08 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-N 118.565 0.62 . . . . 72.2 110.2 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 33.8 m -96.48 -55.25 2.98 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.84 -1.17 . . . . 74.35 107.84 170.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 464' ' ' MET . . . . . 0.465 ' HE3' HD23 ' B' ' 42' ' ' LEU . 26.3 ttt 58.37 99.06 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.792 1.637 . . . . 75.5 112.595 173.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -79.57 -15.1 58.28 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.586 0.755 . . . . 74.43 112.708 -173.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -112.79 160.36 18.06 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.574 0.749 . . . . 62.14 110.223 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -96.62 -86.93 0.31 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.241 -0.652 . . . . 71.24 109.241 175.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . 0.532 HD21 HD21 ' B' ' 42' ' ' LEU . 2.3 pp -172.28 -30.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.627 0.771 . . . . 75.33 112.138 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 148.97 80.52 0.03 OUTLIER Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.518 -0.633 . . . . 61.01 111.518 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . 0.533 HD22 HG22 ' B' ' 40' ' ' VAL . 4.0 mm? -102.0 -65.7 0.97 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.175 0.59 . . . . 74.43 109.711 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 21.2 tptm . . . . . 0 CA--C 1.551 1.006 0 C-N-CA 123.2 0.6 . . . . 71.32 109.446 -176.86 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 43.1 t30 . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 121.221 0.534 . . . . 73.11 110.704 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' C' ' 90' ' ' GLU . 20.8 m -110.44 -12.44 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.702 1.201 . . . . 52.11 108.409 160.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . 0.431 HG22 ' NE2' ' C' ' 50' ' ' GLN . 18.2 m -68.22 163.56 3.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 C-N-CA 124.886 1.274 . . . . 63.45 112.035 -174.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 139.21 70.1 0.04 OUTLIER Glycine 0 C--N 1.342 0.899 0 CA-C-N 116.015 -0.539 . . . . 73.43 112.232 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 4.0 pp -134.66 154.21 51.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.711 0.805 . . . . 73.42 109.273 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 8.7 t -90.73 135.61 33.6 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 109.311 -0.625 . . . . 74.13 109.311 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -78.19 97.33 5.46 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.835 -0.802 . . . . 74.43 108.835 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -159.19 179.55 8.91 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.218 1.007 . . . . 72.32 108.708 -172.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 21.8 m 80.12 118.58 0.05 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.131 1.772 . . . . 75.51 109.134 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -84.8 46.9 1.31 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.135 0.974 . . . . 71.24 111.269 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . 0.638 HD21 ' H ' ' C' ' 46' ' ' THR . 3.3 mm? 71.51 179.45 0.24 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.781 1.233 . . . . 75.13 112.745 174.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -142.73 178.15 7.84 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 125.638 1.575 . . . . 75.45 107.969 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 92.7 t80 67.14 102.32 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.358 1.063 . . . . 74.44 111.838 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 83.0 m -84.2 109.91 18.12 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.97 -1.122 . . . . 63.12 107.97 168.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 464' ' ' MET . . . . . 0.546 ' SD ' HD11 ' C' ' 42' ' ' LEU . 24.5 ttt -71.83 142.33 49.62 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.323 -0.621 . . . . 74.54 109.323 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -82.49 11.77 5.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.742 0.817 . . . . 75.05 111.738 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . 61.79 81.67 0.19 Allowed 'General case' 0 C--N 1.36 1.043 0 C-N-CA 124.907 1.283 . . . . 62.42 111.189 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -147.66 83.36 1.53 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.853 -0.795 . . . . 61.32 108.853 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' C' ' 42' ' ' LEU . 1.2 pp -124.62 17.95 8.79 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.009 0.924 . . . . 72.33 112.53 -170.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 101.95 -40.54 2.39 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-O 120.002 -0.332 . . . . 64.23 113.92 173.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . 0.62 ' HB2' ' HB3' ' C' ' 126' ' ' LEU . 61.5 tp -67.85 140.92 56.58 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.07 0.548 . . . . 72.24 110.567 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt . . . . . 0 C--O 1.251 1.153 0 C-N-CA 124.142 0.977 . . . . 75.5 110.174 -174.808 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 46.4 t30 . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.876 -0.416 . . . . 75.23 109.876 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . 0.476 HG21 HG12 ' H' ' 452' ' ' VAL . 17.5 m -108.95 -26.32 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.921 0.889 . . . . 75.32 110.966 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.587 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 23.7 m -103.79 174.2 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.441 0.696 . . . . 75.03 112.073 -174.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -143.37 110.17 0.58 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 110.707 -0.957 . . . . 74.33 110.707 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.45 94.21 6.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.641 0.776 . . . . 74.1 110.134 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 5.8 t -91.82 61.9 4.24 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.499 1.142 . . . . 64.21 109.11 173.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.93 -127.41 0.05 Allowed 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 114.424 -1.262 . . . . 65.22 109.82 -177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 58.58 14.66 3.18 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 126.522 1.929 . . . . 75.52 114.047 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 19.5 p -107.39 -81.35 0.56 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.481 0.712 . . . . 72.23 111.054 -174.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -173.81 -174.38 0.94 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.236 1.015 . . . . 62.32 109.836 -176.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . 0.561 ' HG ' ' HA ' ' D' ' 45' ' ' ASP . 2.5 tm? -120.78 110.38 16.29 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.655 -1.239 . . . . 75.44 107.655 175.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . 0.4 ' O ' HD13 ' H' ' 460' ' ' LEU . 53.1 p90 -64.83 162.03 17.0 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.009 0.924 . . . . 71.4 111.578 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 18.2 t80 68.4 92.5 0.08 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.293 1.037 . . . . 73.13 110.295 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 23.4 m -72.02 -42.25 66.6 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.342 -0.845 . . . . 74.04 110.557 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 464' ' ' MET . . . . . 0.66 ' HE1' ' HB3' ' H' ' 467' ' ' ALA . 11.2 tpt 72.18 149.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.687 1.195 . . . . 73.4 112.871 170.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -140.61 -66.79 0.43 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.932 0.893 . . . . 74.12 110.463 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -133.47 153.98 51.17 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.139 0.576 . . . . 62.02 111.699 -173.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . 0.66 ' HB3' ' HE1' ' H' ' 464' ' ' MET . . . -148.15 -49.81 0.17 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.764 1.226 . . . . 73.44 108.357 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . 0.435 HD23 ' N ' ' H' ' 469' ' ' GLY . 5.0 tt -74.15 142.9 45.47 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.08 -1.418 . . . . 65.01 107.35 169.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . 0.435 ' N ' HD23 ' H' ' 468' ' ' LEU . . . -81.52 81.83 1.62 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-O 120.006 -0.33 . . . . 61.51 112.619 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . 0.665 ' HG ' ' HA ' ' D' ' 39' ' ' GLU . 3.2 mm? -78.68 72.72 5.22 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.897 -0.779 . . . . 70.34 108.897 173.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt . . . . . 0 CA--C 1.549 0.919 0 CA-C-N 114.914 -1.039 . . . . 70.12 109.071 -173.336 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tpt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.77 0.319 . . . . 75.45 111.003 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.6 p -143.22 54.67 1.36 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.643 -0.873 . . . . 72.53 108.643 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.33 84.89 5.21 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.752 -1.113 . . . . 75.34 108.802 -168.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -131.09 -177.68 4.49 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.202 1.001 . . . . 75.44 110.113 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 63.03 43.75 6.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.187 0.995 . . . . 74.21 110.343 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -106.48 87.77 2.62 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.255 -0.884 . . . . 74.12 109.219 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 t -158.81 -50.22 0.06 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 116.088 -0.505 . . . . 71.55 111.742 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.33 -59.98 2.17 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.468 -0.938 . . . . 75.55 108.468 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.8 ttt -131.61 152.56 50.72 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.662 1.185 . . . . 75.2 107.982 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.707 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 31.3 m -140.48 127.99 21.42 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.848 0.859 . . . . 74.21 108.711 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.439 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 16.8 t80 -133.68 121.23 21.66 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.898 -1.149 . . . . 73.05 107.898 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -136.97 112.59 9.4 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.037 -0.727 . . . . 75.54 109.037 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.534 HG12 ' HD2' ' A' ' 84' ' ' PHE . 46.3 mt -81.98 114.96 23.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.42 -0.955 . . . . 72.4 108.42 171.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -80.34 -39.26 28.97 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.475 -0.784 . . . . 74.2 109.686 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -168.16 133.16 1.77 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 116.236 -0.438 . . . . 74.12 111.035 -167.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.45 HD13 ' HG3' ' C' ' 130' ' ' PRO . 91.5 mt -119.47 132.13 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.289 1.036 . . . . 63.55 108.304 173.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HB3' HG23 ' B' ' 122' ' ' THR . 24.7 p90 -164.22 176.72 8.94 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.709 0.766 . . . . 73.15 111.427 -171.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.6 p -109.3 118.07 35.72 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.978 -1.01 . . . . 73.32 109.112 177.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -84.87 -26.69 27.18 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.441 -0.345 . . . . 75.41 110.328 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -152.28 132.33 13.45 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.507 -0.769 . . . . 65.25 109.083 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 62.7 mt -128.93 141.81 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.505 -1.294 . . . . 75.31 107.505 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.4 t -151.79 144.21 24.12 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 123.494 0.496 . . . . 74.33 110.831 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 59.1 t80 -144.6 128.83 17.75 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 106.712 -1.588 . . . . 74.11 106.712 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -135.83 110.72 8.78 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.638 -0.875 . . . . 63.33 108.638 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.84 85.97 8.33 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.99 -1.115 . . . . 75.24 107.99 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.67 -25.76 20.31 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.562 2.175 . . . . 71.42 111.939 -174.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -107.91 31.09 5.77 Favored 'General case' 0 C--O 1.206 -1.2 0 C-N-CA 123.784 0.834 . . . . 72.42 109.846 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.432 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -50.95 -53.98 42.12 Favored Pre-proline 0 CA--C 1.577 2.015 0 N-CA-C 113.64 0.978 . . . . 72.52 113.64 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 2.6 Cg_exo -79.58 -20.54 9.31 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.004 1.803 . . . . 75.41 113.106 173.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -88.0 -29.96 20.35 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.786 0.834 . . . . 72.14 112.131 -167.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.406 HG13 ' HE1' ' A' ' 123' ' ' PHE . 9.2 p -76.52 -13.83 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.101 0.96 . . . . 72.44 110.404 -175.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.49 -37.52 75.7 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.104 0.962 . . . . 74.41 110.857 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -73.54 -27.8 61.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.484 -0.78 . . . . 75.42 111.715 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.504 ' HZ2' ' HG2' ' A' ' 71' ' ' GLU . 31.7 mmtp -81.98 151.89 26.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.418 0.687 . . . . 74.24 112.219 -176.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -64.04 140.48 58.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.617 0.767 . . . . 74.41 109.157 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.537 ' NE1' ' HB3' ' E' ' 470' ' ' LEU . 57.8 t-105 -80.28 80.66 6.68 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.74 0.781 . . . . 74.11 109.474 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -132.84 72.9 76.64 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.862 -1.063 . . . . 73.23 108.716 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -89.67 149.0 5.07 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.535 2.157 . . . . 72.11 112.002 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -96.41 117.73 31.47 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.259 -1.386 . . . . 73.53 107.259 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.79 112.33 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 123.423 0.689 . . . . 75.43 110.376 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HE3' ' HB2' ' A' ' 43' ' ' ASP . 25.7 ttpt -114.23 130.78 56.63 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.662 -0.866 . . . . 73.12 108.662 172.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.417 HD23 HD23 ' A' ' 128' ' ' LEU . 69.2 tp -96.46 109.98 22.43 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.663 -1.236 . . . . 73.52 107.663 173.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.445 ' HB2' ' HE3' ' A' ' 41' ' ' LYS . 21.9 t70 -102.99 107.71 18.61 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.086 -1.079 . . . . 70.1 108.086 -177.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -96.64 161.36 13.92 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.675 -0.491 . . . . 75.33 109.675 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.677 ' HA ' HD23 ' E' ' 460' ' ' LEU . 8.9 t0 -153.34 127.11 8.84 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.141 -0.689 . . . . 63.12 109.141 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -105.74 120.45 41.73 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.868 -0.79 . . . . 73.11 108.868 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.17 153.31 51.91 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.052 0.941 . . . . 71.14 108.759 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.0 m -127.2 156.9 41.11 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.856 0.462 . . . . 72.02 110.874 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.1 t -149.23 133.17 17.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.317 0.647 . . . . 72.4 110.139 -171.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -88.05 117.45 26.94 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.83 -0.433 . . . . 63.21 109.83 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 57' ' ' GLU . 48.8 mt -95.57 -36.19 11.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.373 0.669 . . . . 73.24 110.89 -176.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.76 -168.0 0.73 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.984 0.913 . . . . 55.35 111.016 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.26 112.83 3.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.504 1.122 . . . . 74.51 110.856 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 65.39 3.77 2.44 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 124.817 1.247 . . . . 74.1 112.792 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.7 t -104.44 115.28 46.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.051 -1.092 . . . . 73.3 108.051 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.07 168.15 12.73 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.445 -0.946 . . . . 73.11 108.445 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.538 ' HB2' HD12 ' A' ' 51' ' ' LEU . 44.7 tt0 -132.04 147.38 52.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.059 -0.973 . . . . 70.24 108.885 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.432 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 65.4 t -120.87 125.52 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.006 -1.479 . . . . 73.45 107.006 164.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.86 114.62 47.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.123 -1.066 . . . . 75.34 108.123 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.581 HD23 HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -96.69 109.5 22.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.377 -0.972 . . . . 74.33 108.377 178.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.598 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 66.1 ttp85 -83.17 103.86 12.9 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.592 -0.892 . . . . 72.5 108.592 172.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.704 HG21 ' HB1' ' A' ' 110' ' ' ALA . 2.5 m -103.5 103.81 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.631 0.729 . . . . 73.5 109.228 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 m -103.12 117.05 33.68 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.449 1.1 . . . . 71.43 110.096 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 56.1 t -101.09 109.44 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.834 0.854 . . . . 74.11 109.629 176.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.1 m -103.28 108.49 19.73 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.321 -0.622 . . . . 65.45 109.321 175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.47 106.91 14.51 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.017 0.927 . . . . 64.35 108.763 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 m -140.92 148.33 40.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.939 0.496 . . . . 75.32 110.519 -175.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.15 85.68 2.45 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.982 0.896 . . . . 71.11 109.083 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.14 -106.58 2.4 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 114.421 -1.263 . . . . 62.2 112.424 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -96.4 -26.08 15.47 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.331 1.052 . . . . 74.43 110.6 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.504 ' HG2' ' HZ2' ' A' ' 34' ' ' LYS . 8.1 mp0 -92.73 109.17 20.59 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.821 0.849 . . . . 75.13 109.682 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.8 m -72.7 123.88 24.19 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.323 -0.621 . . . . 74.1 109.323 171.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -58.33 5.7 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.065 0.853 . . . . 74.23 108.8 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -158.85 155.77 28.41 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.233 -1.349 . . . . 75.33 109.721 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 64' ' ' VAL . 64.0 tp -126.92 138.21 53.26 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.789 -1.189 . . . . 75.33 107.789 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.565 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 73.7 m -134.43 139.99 45.94 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.095 -1.076 . . . . 73.34 108.095 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -149.35 125.59 10.78 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 117.818 0.281 . . . . 65.23 110.251 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.88 112.0 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.771 0.829 . . . . 72.21 109.819 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.405 ' OE1' ' HG3' ' A' ' 61' ' ' ARG . 2.4 mp0 -87.29 84.32 7.24 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.473 -0.936 . . . . 74.11 108.473 173.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.421 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.2 tp-100 -76.65 95.31 3.94 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 114.629 -1.169 . . . . 75.15 108.678 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.28 143.92 17.21 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.073 -0.811 . . . . 70.24 111.073 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.54 130.87 4.25 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.115 -0.794 . . . . 62.23 111.115 -177.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.0 mt -81.93 123.36 38.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.73 -0.841 . . . . 74.12 108.73 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.534 ' HD2' HG12 ' A' ' 13' ' ' ILE . 32.1 m-85 -130.81 137.38 49.4 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.852 -0.796 . . . . 75.31 108.852 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 m -97.19 116.46 29.44 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.037 -0.727 . . . . 75.33 109.037 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.78 135.15 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.062 -1.088 . . . . 74.42 108.062 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.707 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -164.0 136.72 5.1 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.001 0.921 . . . . 64.02 109.182 169.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.65 -16.38 60.89 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 114.664 0.626 . . . . 50.14 114.664 173.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.511 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -114.03 135.4 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 117.645 0.722 . . . . 72.3 109.734 178.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.604 ' HA ' ' HE2' ' A' ' 94' ' ' MET . 49.4 mt-10 -140.53 172.47 12.68 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.104 0.962 . . . . 73.01 109.998 -178.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.69 -123.78 33.1 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.036 0.835 . . . . 64.2 114.57 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.1 p -78.35 -27.59 47.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.216 1.007 . . . . 71.22 111.583 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -68.34 -36.57 79.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.813 0.845 . . . . 75.3 109.97 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.604 ' HE2' ' HA ' ' A' ' 90' ' ' GLU . 48.3 ttm -69.44 -41.98 75.55 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 116.056 -0.52 . . . . 71.02 110.203 171.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.54 -30.12 69.56 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.988 0.515 . . . . 73.02 111.421 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -71.63 -36.43 70.75 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.244 0.618 . . . . 75.3 110.97 173.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.542 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 99.6 m -67.12 -63.09 1.13 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.815 0.446 . . . . 70.11 111.59 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.15 -17.92 61.33 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.273 0.471 . . . . 73.1 112.273 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.01 -11.96 38.23 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.262 -0.743 . . . . 63.11 114.415 -175.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.04 -52.56 0.19 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.153 0.976 . . . . 74.43 112.965 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.542 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 28.2 t80 -63.37 -56.37 16.9 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.752 1.221 . . . . 74.24 111.491 -172.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.8 m -77.67 -35.41 1.27 Allowed Pre-proline 0 CA--C 1.565 1.555 0 N-CA-C 113.245 0.832 . . . . 73.24 113.245 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.83 -39.73 57.85 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.364 2.043 . . . . 74.11 113.19 163.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -64.06 -35.16 79.82 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.073 0.549 . . . . 75.53 111.376 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -63.25 -42.24 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.787 0.835 . . . . 73.1 110.645 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.421 HD23 ' HG3' ' A' ' 80' ' ' GLN . 85.5 mt -72.57 -30.06 64.09 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.08 -0.964 . . . . 72.21 112.068 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -58.36 -44.21 98.94 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 114.6 1.334 . . . . 72.12 114.6 -170.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.68 -39.84 84.5 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.191 1.927 . . . . 74.43 114.115 173.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.41 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 96.7 m-85 -72.88 -40.0 65.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.231 0.613 . . . . 74.42 111.228 -178.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.704 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.68 -40.1 88.4 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.525 -0.761 . . . . 74.43 110.489 176.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.472 ' NH1' HD13 ' C' ' 105' ' ' ILE . 29.3 ttm180 -54.15 -50.66 66.44 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.554 1.159 . . . . 75.21 110.292 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -66.86 -42.69 85.26 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.14 0.9 . . . . 72.41 111.559 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.574 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.2 t -61.46 -24.66 66.71 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.228 0.611 . . . . 74.01 111.622 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -87.29 -44.19 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.4 1.08 . . . . 71.03 110.897 174.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.7 m -62.64 -40.58 97.45 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.451 0.643 . . . . 75.14 111.244 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.0 t -70.72 -41.01 72.46 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.191 -0.913 . . . . 73.53 109.595 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.485 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.2 ttm -58.4 -48.94 79.05 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.598 1.159 . . . . 73.35 112.079 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.73 -33.78 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.523 0.729 . . . . 64.31 110.734 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.4 t -72.71 -28.44 62.67 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.755 0.822 . . . . 71.5 111.191 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.458 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.1 mtt-85 -75.17 -30.24 60.66 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.545 0.738 . . . . 73.13 110.138 175.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.54 -2.17 79.27 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.794 0.684 . . . . 43.14 112.703 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.9 m 69.4 14.67 8.44 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.057 1.343 . . . . 54.43 111.596 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.406 ' HE1' HG13 ' A' ' 31' ' ' VAL . 94.0 m-85 -82.35 152.59 67.75 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 108.572 -0.899 . . . . 73.23 108.572 169.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.12 150.1 10.96 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.266 2.644 . . . . 74.25 114.064 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -61.37 136.46 58.05 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.763 -0.653 . . . . 63.34 111.438 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.8 tp -117.01 102.02 8.99 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.824 -1.08 . . . . 73.24 108.857 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -97.96 104.33 16.35 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.948 -1.131 . . . . 74.1 107.948 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.417 HD23 HD23 ' A' ' 42' ' ' LEU . 89.8 mt -64.08 130.29 43.39 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.575 0.547 . . . . 64.32 109.797 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.28 138.53 97.18 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 119.086 -0.483 . . . . 74.21 110.268 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.07 115.52 2.55 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.472 2.115 . . . . 71.03 112.403 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.65 113.21 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.671 -1.233 . . . . 74.32 107.671 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 135' ' ' ALA . 5.4 t30 -88.97 85.25 6.68 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.677 -0.86 . . . . 73.42 108.677 -175.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.491 ' HA ' HD11 ' A' ' 136' ' ' LEU . 93.1 m-85 -58.57 -32.64 69.11 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.52 1.128 . . . . 74.42 112.607 -174.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.41 -47.75 80.68 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.455 -0.793 . . . . 75.34 111.319 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.421 ' H ' ' ND2' ' A' ' 132' ' ' ASN . . . -59.06 -49.46 77.78 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.636 0.585 . . . . 74.4 109.997 176.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.491 HD11 ' HA ' ' A' ' 133' ' ' PHE . 76.2 mt -54.95 -41.14 70.74 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 124.731 1.269 . . . . 75.35 112.238 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.407 ' HE2' HD22 ' A' ' 141' ' ' LEU . 44.5 t80 -74.78 -34.64 62.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.99 -0.55 . . . . 65.01 110.437 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.444 ' HE2' ' HA ' ' A' ' 138' ' ' MET . 8.5 mmt -67.65 -32.96 74.01 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.567 0.347 . . . . 74.13 110.49 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -65.69 -26.53 67.82 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.59 0.756 . . . . 63.31 111.141 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -85.48 -57.66 2.98 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.799 0.44 . . . . 73.41 110.064 172.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.407 HD22 ' HE2' ' A' ' 137' ' ' PHE . 36.7 tp -63.63 -33.32 75.36 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.266 1.026 . . . . 73.22 112.546 -165.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.93 -6.06 0.6 Allowed 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 109.557 -0.534 . . . . 71.2 109.557 -164.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 67.72 -70.68 0.12 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.734 1.614 . . . . 73.22 111.263 -174.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -165.1 -69.33 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.695 0.398 . . . . 74.5 110.179 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 48.35 -155.41 0.08 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.637 1.175 . . . . 70.31 111.606 -170.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 123.19 95.41 1.2 Allowed Glycine 0 C--N 1.34 0.779 0 O-C-N 122.175 -0.328 . . . . 54.0 113.031 172.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -93.12 139.87 30.1 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 106.815 -1.55 . . . . 75.0 106.815 167.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.31 47.88 0.62 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 114.941 0.736 . . . . 72.32 114.941 -171.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.0 p -87.39 136.95 32.74 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.613 -0.884 . . . . 75.22 108.613 164.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.22 120.74 17.23 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.531 -0.914 . . . . 73.42 108.531 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -80.63 -70.57 0.52 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.678 0.391 . . . . 71.21 111.367 -174.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -59.58 97.48 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.02 0.825 . . . . 75.22 112.277 -166.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -68.91 119.11 12.72 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 115.634 -0.712 . . . . 63.32 109.631 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.29 94.63 0.11 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.834 0.854 . . . . 73.14 110.675 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 N-CA-C 108.485 -0.931 . . . . 64.43 108.485 174.073 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 108.69 -0.856 . . . . 61.43 108.69 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t -66.57 95.81 0.35 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.363 0.665 . . . . 74.15 111.329 -172.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -84.03 -64.22 1.2 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.205 0.602 . . . . 72.34 110.226 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -91.6 83.72 5.39 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.045 0.45 . . . . 74.44 110.256 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -87.97 25.88 1.47 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.297 0.639 . . . . 55.32 110.53 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -130.5 117.98 20.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.753 0.821 . . . . 72.24 108.838 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -167.52 158.51 11.46 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.104 0.962 . . . . 74.23 110.0 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -74.31 -30.16 61.93 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.747 0.819 . . . . 73.25 109.731 173.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 12.4 ptm 56.19 172.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 126.843 2.057 . . . . 71.2 113.67 -173.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 87.7 m -151.22 135.14 16.56 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.054 -1.091 . . . . 75.14 108.054 175.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -144.76 135.36 24.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.012 0.525 . . . . 73.13 109.939 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -154.45 125.46 7.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.819 0.848 . . . . 75.24 109.053 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 17.9 mt -77.97 118.4 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.606 -0.887 . . . . 73.33 108.606 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -91.49 -39.52 11.9 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.868 -0.419 . . . . 74.41 109.868 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -166.88 138.29 3.32 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.756 0.66 . . . . 74.32 109.731 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.73 145.24 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 106.878 -1.527 . . . . 72.22 106.878 169.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -169.52 168.24 9.41 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.578 0.704 . . . . 73.31 111.578 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 86.4 m -96.51 131.92 42.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.251 -0.886 . . . . 62.41 108.668 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -96.58 -36.31 10.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.497 0.719 . . . . 74.22 109.979 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -152.48 145.25 24.33 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.024 -0.534 . . . . 71.2 110.91 -172.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.707 HD12 ' SG ' ' B' ' 113' ' ' CYS . 41.3 mm -134.46 145.18 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.755 1.222 . . . . 73.0 109.104 175.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 23.0 t -145.94 134.63 22.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.128 -0.942 . . . . 75.1 108.896 172.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.447 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.4 t80 -149.3 109.77 4.21 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.885 -1.154 . . . . 74.22 107.885 170.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -117.3 114.77 24.07 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.542 -0.91 . . . . 74.14 108.542 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.7 87.61 2.92 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 107.848 -1.167 . . . . 74.54 107.848 169.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.65 -51.76 4.63 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.905 2.403 . . . . 75.41 112.462 -171.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.494 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 72.3 m-20 -98.2 23.17 8.57 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.578 0.751 . . . . 74.3 110.957 -176.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -33.17 -67.06 0.2 Allowed Pre-proline 0 N--CA 1.498 1.925 0 C-N-CA 125.327 1.451 . . . . 73.45 114.64 -168.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.93 -20.78 57.75 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.348 2.032 . . . . 70.24 113.013 -172.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -96.57 -28.47 14.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.889 0.876 . . . . 73.2 112.16 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.611 HG23 HD13 ' B' ' 68' ' ' LEU . 10.7 p -83.22 -18.35 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 122.633 0.373 . . . . 73.24 111.117 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -66.39 -15.34 63.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.102 0.779 . . . . 72.31 113.102 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.459 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -62.64 -24.52 67.65 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 120.935 0.398 . . . . 73.4 110.753 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.512 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 89.8 mttt -96.17 101.39 13.03 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.477 1.111 . . . . 75.33 109.498 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.61 80.9 5.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.498 0.719 . . . . 71.41 109.692 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -154.17 158.91 41.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.113 -0.949 . . . . 75.54 108.682 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -75.79 108.5 6.03 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 124.081 0.952 . . . . 64.13 109.929 174.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.599 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 43.3 Cg_endo -66.72 150.02 83.61 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.918 2.412 . . . . 74.33 112.778 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -58.66 108.11 0.6 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.686 0.616 . . . . 73.23 110.771 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.547 ' H ' HD23 ' F' ' 470' ' ' LEU . 81.4 t -89.86 120.99 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.975 -1.011 . . . . 74.12 110.28 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -108.07 128.95 55.13 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.703 -1.221 . . . . 70.21 107.703 168.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.739 ' HB2' ' HB2' ' F' ' 467' ' ' ALA . 40.5 tp -90.7 148.44 22.6 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.831 -0.433 . . . . 73.12 109.831 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -148.11 141.11 24.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.393 1.077 . . . . 74.35 108.167 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 96.0 mt -135.42 142.74 45.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.484 0.714 . . . . 74.25 109.783 -175.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 6.2 m-20 -132.08 110.29 10.6 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.898 -1.149 . . . . 73.31 107.898 165.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 23.6 p -109.84 100.07 9.11 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.767 -0.827 . . . . 74.51 108.767 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.63 116.36 23.7 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.473 0.709 . . . . 61.41 109.28 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 20.2 p -100.84 162.78 12.67 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.949 0.9 . . . . 75.01 109.282 176.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.5 p -150.11 170.63 18.46 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.504 0.721 . . . . 61.31 109.641 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -113.45 107.67 16.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.499 0.72 . . . . 72.33 109.719 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.97 -38.15 64.28 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.955 0.502 . . . . 74.35 110.06 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.69 177.78 9.63 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.66 -1.154 . . . . 72.32 109.991 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -63.48 119.21 9.32 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.704 -0.48 . . . . 63.13 109.704 174.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 71.99 -3.01 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.854 1.262 . . . . 73.34 112.779 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 97.8 t -105.09 112.5 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.812 -0.81 . . . . 74.23 108.812 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -126.94 139.64 52.91 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.151 0.58 . . . . 74.43 109.748 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -120.53 106.94 12.27 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.867 -0.79 . . . . 74.41 108.867 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 96.7 t -92.91 122.44 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.656 1.182 . . . . 74.13 111.028 -177.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.83 115.03 45.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.726 -0.472 . . . . 74.35 109.726 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.425 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -97.22 120.27 37.27 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.579 -1.267 . . . . 74.1 107.579 174.392 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 13.4 ttm180 -109.0 127.74 54.34 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.23 -0.655 . . . . 71.44 109.23 172.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.49 103.73 14.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.038 -1.097 . . . . 72.14 108.038 174.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -102.61 130.81 49.6 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.393 -0.595 . . . . 64.43 109.393 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.531 HG13 HD21 ' B' ' 126' ' ' LEU . 92.1 t -122.37 112.48 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.359 1.063 . . . . 72.34 109.241 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.2 m -92.8 138.15 31.74 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.568 0.747 . . . . 74.52 109.361 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.76 142.88 24.09 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.813 0.445 . . . . 71.0 111.249 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.456 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 21.5 p -153.36 133.69 13.5 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.571 0.582 . . . . 73.13 112.571 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.611 HD13 HG23 ' B' ' 31' ' ' VAL . 52.8 mt -100.12 122.4 42.92 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.531 1.132 . . . . 64.23 111.183 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.25 -110.84 3.72 Favored Glycine 0 C--N 1.342 0.892 0 O-C-N 123.906 0.754 . . . . 62.24 113.042 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.09 5.27 20.04 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.616 0.766 . . . . 73.52 111.551 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.512 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.9 pt-20 -129.13 159.25 36.59 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.851 0.46 . . . . 72.01 110.74 -175.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 61.9 m -75.38 138.26 41.6 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.131 0.491 . . . . 72.55 110.706 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.456 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -92.57 -71.46 0.65 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.114 -1.069 . . . . 72.12 108.114 176.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -146.4 144.39 29.69 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.761 -0.654 . . . . 74.14 110.203 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.9 mt -123.41 112.46 17.57 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 106.656 -1.609 . . . . 73.31 106.656 174.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.489 ' SG ' HG21 ' B' ' 114' ' ' ILE . 35.6 t -116.93 154.95 29.94 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.071 -0.715 . . . . 74.34 109.071 -178.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.412 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.7 tt0 -163.97 137.22 5.31 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.012 -0.736 . . . . 71.43 109.012 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 75.4 t -133.71 146.01 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.267 1.027 . . . . 73.25 108.744 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -122.2 95.8 4.79 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.905 -0.776 . . . . 75.14 108.905 170.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -85.56 98.98 10.95 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.92 -0.771 . . . . 74.31 108.92 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.08 143.1 16.28 Favored Glycine 0 C--N 1.343 0.952 0 N-CA-C 111.187 -0.765 . . . . 72.32 111.187 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.403 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -143.52 127.0 2.93 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 112.165 -0.374 . . . . 62.5 112.165 -173.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 51.3 mt -85.93 127.91 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 109.11 -0.7 . . . . 74.44 109.11 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.33 157.21 47.49 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.818 1.247 . . . . 64.25 108.465 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 68.5 m -117.75 100.36 7.55 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.392 0.677 . . . . 71.34 109.41 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.563 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.5 pp -111.11 137.36 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.862 0.465 . . . . 75.25 110.001 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.549 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -154.53 166.91 31.82 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.015 0.926 . . . . 73.25 110.12 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.27 -59.27 4.81 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 111.46 -0.656 . . . . 75.33 111.46 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.563 HD11 ' HB ' ' B' ' 86' ' ' ILE . 15.4 pt -63.2 139.45 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 124.428 1.091 . . . . 74.14 110.892 171.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' F' ' 451' ' ' VAL . 32.2 tt0 -152.14 151.41 31.01 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.315 0.646 . . . . 73.3 110.2 -177.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.65 -111.86 4.11 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.959 -0.456 . . . . 42.33 111.959 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -80.53 -25.01 38.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.379 0.672 . . . . 71.04 110.812 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -68.79 -35.64 77.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.765 -0.652 . . . . 74.13 110.133 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -85.92 -23.57 26.94 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.598 -0.728 . . . . 75.21 110.598 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.02 77.19 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.967 0.413 . . . . 73.32 110.769 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 30.4 t-80 -68.3 -27.05 65.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.33 0.652 . . . . 74.35 110.823 176.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.462 ' SG ' HG21 ' B' ' 86' ' ' ILE . 18.9 t -81.19 -68.5 0.68 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.479 -0.563 . . . . 71.11 109.479 176.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.506 HD21 HG12 ' B' ' 86' ' ' ILE . 23.9 mt -69.57 -22.44 63.54 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.888 0.699 . . . . 73.34 112.888 -171.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.89 -11.17 47.41 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-O 119.53 -0.594 . . . . 73.2 113.772 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -138.37 -58.86 0.64 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.659 0.73 . . . . 73.5 112.317 -173.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -72.51 -41.69 65.63 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.941 0.496 . . . . 74.14 111.935 -172.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 86.3 m -68.66 -47.65 33.43 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.066 0.947 . . . . 72.14 111.489 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.425 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 77.4 Cg_exo -56.78 -31.33 87.94 Favored 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 122.143 1.895 . . . . 70.42 113.582 168.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -62.34 -38.74 90.65 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 123.373 0.669 . . . . 73.45 110.673 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 68.0 mt -69.34 -44.11 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.789 0.836 . . . . 73.23 110.617 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.403 HD21 ' HA3' ' B' ' 82' ' ' GLY . 59.5 mt -73.64 -20.17 60.65 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.327 -0.851 . . . . 74.34 111.776 -176.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -62.33 -49.44 84.04 Favored Pre-proline 0 N--CA 1.481 1.105 0 N-CA-C 114.748 1.388 . . . . 71.51 114.748 -169.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.27 -32.19 82.07 Favored 'Trans proline' 0 C--N 1.377 2.077 0 CA-C-N 121.384 1.53 . . . . 75.22 112.474 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -66.58 -48.49 69.43 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.069 0.548 . . . . 72.13 110.363 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.05 -41.15 87.19 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.203 -0.908 . . . . 74.54 110.747 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -60.35 -56.29 23.22 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.487 1.115 . . . . 75.35 111.102 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.88 -35.29 80.67 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.032 0.533 . . . . 74.43 110.266 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.707 ' SG ' HD12 ' B' ' 21' ' ' ILE . 6.6 t -66.87 -37.44 84.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.879 0.472 . . . . 72.11 111.209 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.489 HG21 ' SG ' ' B' ' 76' ' ' CYS . 50.3 mt -63.22 -52.32 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.879 0.472 . . . . 74.13 110.05 172.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.439 HG22 ' OG ' ' C' ' 119' ' ' SER . 21.0 m -59.83 -31.94 70.2 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.885 0.874 . . . . 74.32 111.591 -177.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.8 t -64.8 -49.13 71.86 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.406 -0.816 . . . . 73.12 109.766 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -68.88 -31.77 70.94 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.078 0.551 . . . . 74.41 111.342 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.52 -43.71 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.776 0.83 . . . . 74.4 110.065 172.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.1 t -68.45 -31.91 71.56 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.642 -0.708 . . . . 74.11 111.499 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.574 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 76.1 mtt-85 -68.03 -41.85 81.47 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.894 -0.593 . . . . 73.05 109.728 176.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.62 1.24 86.55 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.704 0.627 . . . . 73.15 113.12 173.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 17' ' ' TYR . 26.4 p 60.87 26.64 16.5 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.404 1.882 . . . . 74.0 113.822 171.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -80.09 162.3 62.41 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 123.819 0.848 . . . . 73.55 111.443 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -55.22 158.51 11.86 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 123.263 2.642 . . . . 72.34 113.242 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -58.81 134.51 56.94 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.148 -0.933 . . . . 64.43 112.528 -171.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.531 HD21 HG13 ' B' ' 64' ' ' VAL . 30.9 tp -130.2 109.99 11.23 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.314 -0.857 . . . . 65.12 108.976 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -122.11 120.05 33.13 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.303 -0.999 . . . . 74.54 108.303 171.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.562 HD12 HD23 ' B' ' 42' ' ' LEU . 39.6 tp -84.72 136.22 33.81 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.71 0.404 . . . . 74.42 109.975 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.35 145.08 84.95 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.885 0.874 . . . . 60.52 111.462 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.77 130.16 35.6 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.159 2.573 . . . . 75.22 113.064 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.15 113.16 28.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 114.807 -1.088 . . . . 72.21 108.381 172.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -74.47 79.83 1.93 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.163 -1.421 . . . . 72.42 107.163 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -54.7 -38.59 67.22 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.481 0.713 . . . . 74.33 111.24 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.94 -43.13 77.12 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.354 1.062 . . . . 75.52 111.742 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.434 ' HA ' ' HE2' ' B' ' 138' ' ' MET . . . -60.68 -54.97 38.83 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.935 0.894 . . . . 75.5 111.437 -176.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.541 ' HB2' ' HD2' ' F' ' 461' ' ' PHE . 1.5 mm? -79.54 -22.28 44.08 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 116.4 -0.364 . . . . 73.52 111.203 -174.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.468 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 73.1 t80 -65.11 -36.68 85.05 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.943 -0.392 . . . . 74.31 109.943 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.434 ' HE2' ' HA ' ' B' ' 135' ' ' ALA . 71.0 mtm -60.4 -36.04 77.17 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.416 0.448 . . . . 72.13 110.833 175.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -85.62 -18.62 32.77 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.644 0.778 . . . . 75.25 111.457 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -68.01 -32.8 73.43 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.285 1.034 . . . . 73.42 111.189 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 12.8 mt -89.37 9.26 26.83 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.034 -0.985 . . . . 75.03 111.232 -172.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -160.24 -159.36 0.7 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.837 1.255 . . . . 73.5 108.16 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -136.44 88.52 2.38 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 121.29 0.567 . . . . 70.21 109.546 167.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -135.54 174.87 10.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.056 0.942 . . . . 74.54 108.952 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -141.8 147.37 37.17 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.2 0.6 . . . . 71.53 110.548 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.55 177.4 45.31 Favored Glycine 0 C--N 1.35 1.319 0 O-C-N 123.593 0.558 . . . . 74.22 112.366 175.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -160.36 -179.04 7.36 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.63 0.772 . . . . 74.13 110.327 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.54 107.61 0.24 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.805 -0.442 . . . . 72.31 113.113 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 28.0 m -69.34 99.77 1.25 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.314 0.646 . . . . 72.4 109.821 171.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.49 ' HG2' HG22 ' D' ' 10' ' ' THR . 47.6 mt-10 -78.45 87.34 4.45 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.578 -0.737 . . . . 74.24 110.808 -176.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -71.1 126.45 29.63 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.613 -0.721 . . . . 74.25 110.302 171.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -170.48 137.36 1.39 Allowed 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.671 1.188 . . . . 63.23 108.573 -177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.71 168.77 18.41 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.932 0.893 . . . . 73.42 110.355 178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -83.57 92.04 7.55 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.232 -0.655 . . . . 73.41 109.232 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-N 115.321 -0.854 . . . . 75.04 110.948 179.023 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 109.374 -0.602 . . . . 74.22 109.374 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 55.9 m -144.88 93.46 2.41 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.586 0.754 . . . . 75.11 110.26 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -120.91 124.97 46.26 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.306 -0.998 . . . . 75.54 108.306 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -80.24 107.18 12.83 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.477 -0.934 . . . . 74.24 108.477 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -69.92 -39.74 75.97 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.292 1.037 . . . . 74.31 110.675 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -78.3 87.6 4.35 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.399 -0.819 . . . . 74.23 108.932 174.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 6.8 t -148.61 116.95 6.49 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.85 0.86 . . . . 74.51 109.59 -175.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -81.46 132.41 35.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.044 0.538 . . . . 74.31 111.117 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.495 ' HE2' ' SG ' ' C' ' 97' ' ' CYS . 27.6 ttt 63.6 110.98 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.436 1.494 . . . . 74.34 111.756 -177.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 89.5 m -101.29 101.32 11.97 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.125 -1.065 . . . . 74.1 108.125 171.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.494 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.5 t80 -108.6 122.87 47.99 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.735 -0.839 . . . . 75.04 108.735 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -136.67 128.28 28.74 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.493 -0.929 . . . . 75.04 108.493 172.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.1 mt -71.64 124.45 28.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.645 -0.872 . . . . 74.02 108.645 171.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -88.84 -46.42 8.96 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.098 0.559 . . . . 73.53 109.558 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -172.31 125.57 0.52 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.95 -0.568 . . . . 72.2 110.329 -171.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 91.3 mt -109.93 141.37 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 107.946 -1.131 . . . . 72.43 107.946 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.494 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 25.8 p90 -175.71 174.99 2.12 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.421 0.629 . . . . 71.31 110.775 -171.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -104.09 124.97 50.02 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.569 -0.741 . . . . 74.43 109.065 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.494 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 27.4 mmtp -69.88 -49.72 49.52 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.755 -1.202 . . . . 74.24 107.755 168.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -139.2 142.46 37.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 113.253 -1.794 . . . . 72.14 109.172 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.6 mt -138.79 142.67 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.292 -1.373 . . . . 73.21 107.292 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.1 t -156.81 150.44 24.54 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.459 0.647 . . . . 63.24 110.624 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.448 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 89.4 t80 -141.75 124.94 16.37 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.433 -1.321 . . . . 74.51 107.433 172.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 39.3 mt-10 -122.21 111.74 17.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.664 0.786 . . . . 74.23 109.516 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.92 82.04 69.18 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 107.641 -1.244 . . . . 71.45 107.641 170.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.1 -29.55 11.64 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.388 2.059 . . . . 73.41 111.824 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -99.38 19.41 15.59 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.842 0.857 . . . . 73.3 110.04 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.427 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -47.84 -55.16 18.62 Favored Pre-proline 0 CA--C 1.561 1.366 0 N-CA-C 113.793 1.034 . . . . 65.21 113.793 -171.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.525 ' HB3' HD12 ' D' ' 51' ' ' LEU . 36.3 Cg_exo -60.62 -43.39 32.94 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 121.644 1.562 . . . . 71.31 112.284 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -69.84 -30.09 67.5 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 113.861 -1.518 . . . . 74.44 112.663 -174.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.684 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.6 p -82.0 -22.06 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 112.282 0.475 . . . . 75.21 112.282 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -71.44 -23.94 61.93 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 122.246 -0.284 . . . . 74.32 111.706 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -87.19 10.58 16.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.33 0.652 . . . . 72.11 110.946 174.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.712 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -106.56 159.93 15.81 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.929 0.892 . . . . 65.23 109.818 176.081 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -73.11 121.24 19.9 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.503 0.721 . . . . 74.53 109.479 167.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -84.87 95.84 9.14 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.019 0.528 . . . . 74.24 110.171 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -142.74 75.98 17.85 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 108.162 -1.051 . . . . 75.14 108.162 166.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -87.24 156.18 8.19 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.898 2.398 . . . . 70.13 113.569 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.37 118.89 27.11 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 113.731 -1.577 . . . . 74.42 108.386 173.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.41 101.59 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 122.934 0.494 . . . . 73.04 110.003 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 2.3 mptp? -91.39 102.69 15.38 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 106.427 -1.694 . . . . 74.45 106.427 169.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' G' ' 464' ' ' MET . 50.1 tp -97.26 126.22 42.33 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.112 0.565 . . . . 74.13 110.086 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -120.38 136.13 54.81 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.366 1.066 . . . . 72.44 108.963 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.78 132.28 54.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.048 0.939 . . . . 74.03 108.657 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -130.76 151.65 50.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.176 0.991 . . . . 75.33 108.852 169.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -149.89 144.14 25.73 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.073 -0.714 . . . . 74.12 109.073 169.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.55 149.05 43.42 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.617 0.767 . . . . 73.04 108.939 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 28.5 p -127.21 142.78 51.4 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.346 0.658 . . . . 73.21 110.397 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.7 t -145.2 128.06 16.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.955 0.902 . . . . 72.31 109.369 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -70.34 119.68 14.89 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.522 0.729 . . . . 70.1 109.728 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.577 HD12 ' HB2' ' C' ' 57' ' ' GLU . 51.1 mt -92.3 -29.9 16.13 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.999 0.519 . . . . 71.23 109.753 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.35 179.22 7.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.429 1.092 . . . . 73.35 110.097 176.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.68 123.32 17.62 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.597 -0.729 . . . . 70.41 109.292 175.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.99 19.42 11.85 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.177 0.923 . . . . 74.04 111.706 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.69 115.31 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.695 -0.854 . . . . 74.35 108.695 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.527 ' HD2' HD13 ' C' ' 86' ' ' ILE . 1.0 OUTLIER -115.38 157.94 23.17 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.578 0.751 . . . . 73.33 109.057 175.182 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.577 ' HB2' HD12 ' C' ' 51' ' ' LEU . 22.5 tt0 -116.34 120.45 38.91 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.334 -1.303 . . . . 75.41 107.506 170.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.4 t -107.75 135.22 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.606 -0.887 . . . . 71.22 108.606 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.57 108.45 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.918 -0.771 . . . . 74.35 108.918 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.559 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -86.45 108.7 18.63 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.519 -1.289 . . . . 75.4 107.519 175.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.491 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 24.0 ttm180 -95.94 119.64 34.8 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.435 -0.95 . . . . 74.44 108.435 173.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.486 ' HB ' HD11 ' C' ' 114' ' ' ILE . 29.1 t -111.94 130.95 64.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.01 -1.107 . . . . 74.33 108.01 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 13.3 m -126.92 121.73 32.58 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.654 -0.869 . . . . 71.43 108.654 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.503 HG12 HD22 ' C' ' 126' ' ' LEU . 22.1 t -112.19 116.7 53.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.244 -0.65 . . . . 65.55 109.244 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 3.5 m -102.1 137.32 40.52 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.543 -0.91 . . . . 74.24 108.543 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.1 118.62 21.78 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.307 -0.997 . . . . 64.32 108.307 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 13.3 m -133.58 130.64 38.67 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.521 0.513 . . . . 74.34 110.664 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.712 HD11 ' HG2' ' C' ' 34' ' ' LYS . 25.6 mt -86.81 45.63 1.28 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.238 1.415 . . . . 74.31 109.796 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.09 -85.21 0.49 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 110.476 -1.05 . . . . 65.25 110.476 -171.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.42 -29.13 5.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.486 0.715 . . . . 63.04 110.496 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.42 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 8.2 tp10 -63.17 118.72 8.33 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.072 0.949 . . . . 73.11 109.918 175.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -74.31 117.72 16.44 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.532 -0.914 . . . . 71.44 108.532 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.684 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.68 -55.05 7.4 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.333 -0.988 . . . . 74.23 108.333 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -164.99 163.46 20.76 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.91 -1.041 . . . . 74.34 110.288 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.407 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -130.31 142.43 50.54 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 105.803 -1.925 . . . . 74.21 105.803 172.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 50.1 t -144.63 142.91 30.47 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.316 -0.994 . . . . 73.31 108.316 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -150.29 127.82 11.53 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.433 -0.58 . . . . 74.23 109.433 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 74.8 t -127.73 136.23 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.559 1.144 . . . . 74.24 108.267 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.491 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 69.7 mt-30 -109.59 87.35 2.48 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.121 -1.066 . . . . 74.33 108.121 174.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -78.21 96.9 5.33 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.341 -0.845 . . . . 72.2 109.251 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.2 146.45 21.09 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.327 -0.851 . . . . 73.2 112.399 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.27 118.11 0.9 Allowed Glycine 0 C--O 1.238 0.373 0 N-CA-C 110.958 -0.857 . . . . 71.1 110.958 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.543 HD13 HD12 ' C' ' 51' ' ' LEU . 15.5 mm -82.22 131.29 34.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.725 -0.843 . . . . 73.51 108.725 176.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -134.75 120.06 18.98 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 123.615 0.572 . . . . 75.45 110.083 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.0 p -79.72 106.16 11.54 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.153 -1.055 . . . . 62.52 108.153 170.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.527 HD13 ' HD2' ' C' ' 56' ' ' TYR . 2.3 pp -116.11 142.82 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.178 0.991 . . . . 74.04 109.98 -172.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -149.88 158.21 43.94 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.884 0.474 . . . . 63.2 110.607 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.55 -29.01 6.46 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.218 -0.447 . . . . 74.12 113.963 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.568 HD11 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -84.67 164.68 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.123 0.569 . . . . 74.43 111.401 -176.306 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -164.55 148.48 9.28 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.879 0.872 . . . . 73.45 109.205 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.88 -115.07 7.43 Favored Glycine 0 C--N 1.351 1.389 0 O-C-N 123.79 0.681 . . . . 73.13 114.516 170.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 70.4 p -79.88 -26.99 40.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.783 0.833 . . . . 63.4 110.906 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -67.34 -38.8 85.45 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.455 0.702 . . . . 73.22 109.746 173.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.442 ' SD ' ' O ' ' G' ' 451' ' ' VAL . 40.4 ttp -73.11 -38.99 66.14 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.811 -0.632 . . . . 65.3 110.464 174.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 -40.69 85.51 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 123.776 0.672 . . . . 53.15 110.588 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.493 ' HE2' ' HA ' ' C' ' 134' ' ' ASP . 12.7 t-80 -79.1 -34.1 43.83 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 123.576 0.548 . . . . 72.13 112.029 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.495 ' SG ' ' HE2' ' C' ' 9' ' ' MET . 44.1 t -53.96 -41.76 68.16 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.634 0.584 . . . . 74.21 110.533 176.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.99 -14.65 17.76 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.309 -0.859 . . . . 74.32 110.954 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.16 -21.9 64.25 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 114.086 0.395 . . . . 62.12 114.086 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.27 -45.03 0.09 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.489 0.552 . . . . 72.52 112.489 -171.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -67.54 -48.99 65.4 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.315 0.385 . . . . 72.33 111.439 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.494 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 94.5 m -64.58 -49.56 69.95 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 118.714 -0.66 . . . . 75.43 111.895 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.559 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 75.1 Cg_exo -56.55 -30.22 81.93 Favored 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 122.259 1.973 . . . . 63.24 114.309 170.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -64.64 -41.03 96.42 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.594 0.758 . . . . 71.01 110.589 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.472 HD13 ' NH1' ' A' ' 111' ' ' ARG . 39.3 mm -61.08 -45.23 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.557 -0.747 . . . . 74.04 110.173 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 71.8 mt -79.23 -16.6 56.26 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.193 -0.912 . . . . 74.22 112.418 -172.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -62.68 -48.32 86.12 Favored Pre-proline 0 CA--C 1.561 1.372 0 N-CA-C 114.194 1.183 . . . . 75.44 114.194 -172.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -59.06 -34.72 99.0 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 121.833 1.689 . . . . 72.54 112.94 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -71.2 -44.95 64.42 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.504 0.721 . . . . 75.25 110.831 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.14 -44.7 87.98 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.333 -0.848 . . . . 73.22 109.925 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -54.1 -54.62 36.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.705 1.202 . . . . 75.52 111.305 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.62 -29.39 68.7 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.269 0.628 . . . . 73.41 110.872 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.1 t -73.9 -37.0 64.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.998 0.519 . . . . 72.44 110.973 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.486 HD11 ' HB ' ' C' ' 62' ' ' VAL . 89.4 mt -67.81 -51.72 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.342 -0.614 . . . . 75.1 109.342 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 14.5 m -58.36 -31.84 67.99 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.613 0.765 . . . . 71.41 111.404 -177.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -62.42 -57.73 10.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.328 0.651 . . . . 75.1 109.599 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.577 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.77 -41.89 61.98 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.715 1.206 . . . . 71.34 112.843 177.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 95.7 t -67.48 -46.26 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.067 0.947 . . . . 73.24 110.758 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.439 ' OG ' HG22 ' B' ' 115' ' ' THR . 39.5 t -69.72 -26.42 64.32 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.556 -0.747 . . . . 72.35 111.281 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.482 ' HD2' ' HE3' ' C' ' 117' ' ' MET . 78.1 mtt-85 -71.63 -42.11 68.02 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.467 0.707 . . . . 74.13 109.339 174.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.03 -3.11 67.6 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 123.759 0.662 . . . . 74.2 112.852 170.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p 65.5 30.82 10.56 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.828 2.051 . . . . 71.31 113.506 171.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -88.79 142.18 30.43 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 108.078 -1.082 . . . . 74.53 108.078 167.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.49 172.39 0.48 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 123.213 2.609 . . . . 73.53 115.732 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -46.19 135.0 8.16 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.746 1.619 . . . . 75.43 114.83 -169.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.503 HD22 HG12 ' C' ' 64' ' ' VAL . 43.7 tp -137.15 86.86 2.23 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.183 -1.371 . . . . 74.4 108.631 176.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -116.21 114.94 25.12 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.004 0.922 . . . . 73.13 109.105 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.09 137.3 38.15 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 122.588 0.355 . . . . 61.23 110.562 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.66 157.98 88.72 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 124.744 1.217 . . . . 74.33 111.272 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.45 ' HG3' HD13 ' A' ' 16' ' ' ILE . 9.4 Cg_endo -51.73 111.67 0.65 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.233 2.622 . . . . 72.23 112.835 176.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.5 t -97.52 112.07 28.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.193 -0.669 . . . . 73.44 109.193 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.64 77.94 7.42 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.392 0.677 . . . . 75.15 109.744 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -60.14 -38.96 84.68 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.689 -0.687 . . . . 71.33 109.414 171.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.493 ' HA ' ' HE2' ' C' ' 96' ' ' HIS . 8.6 m-20 -57.46 -35.28 69.95 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 114.095 -1.411 . . . . 64.12 112.745 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.64 -51.98 67.08 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 124.122 0.889 . . . . 74.35 111.134 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.8 mp -74.83 -35.01 62.43 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.836 -0.62 . . . . 63.45 111.435 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.411 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 2.2 t80 -75.5 -28.39 59.14 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.678 0.391 . . . . 74.42 110.566 -177.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -73.63 -31.39 63.5 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.455 0.702 . . . . 73.22 110.23 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -60.79 -38.39 85.16 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.081 0.552 . . . . 71.22 110.646 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -70.36 -87.21 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.699 -0.682 . . . . 74.4 109.399 169.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.483 ' HG ' ' HG2' ' C' ' 142' ' ' GLN . 56.4 tp 49.49 -89.63 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.862 1.265 . . . . 63.42 110.873 -171.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.483 ' HG2' ' HG ' ' C' ' 141' ' ' LEU . 30.0 pt20 179.99 167.69 1.27 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.969 1.308 . . . . 74.15 108.645 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -79.3 113.53 17.51 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.381 -0.599 . . . . 74.3 109.381 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -158.88 152.2 22.68 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.621 0.368 . . . . 74.41 111.531 -176.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.6 143.73 32.67 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.617 0.767 . . . . 64.12 109.915 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -119.26 179.37 16.7 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.336 0.397 . . . . 63.4 112.42 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.5 168.28 20.21 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.049 0.939 . . . . 73.5 109.403 177.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.9 107.66 0.48 Allowed Glycine 0 C--N 1.339 0.706 0 N-CA-C 111.13 -0.788 . . . . 61.14 111.13 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 82.2 m -149.66 91.45 1.81 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.446 1.099 . . . . 74.51 108.262 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.06 114.22 20.47 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.281 0.562 . . . . 73.25 109.967 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.49 103.98 16.15 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 106.728 -1.582 . . . . 74.23 106.728 168.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -108.74 85.8 2.17 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.311 0.577 . . . . 72.14 110.673 -175.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -81.69 148.56 28.93 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.645 -0.707 . . . . 75.14 109.096 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -158.2 126.11 5.25 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.866 -0.79 . . . . 74.41 108.866 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 C-N-CA 123.803 0.841 . . . . 73.31 109.502 -174.049 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.482 ' SD ' ' N ' ' D' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 110.518 -0.178 . . . . 71.51 110.518 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 37.2 t -161.21 179.29 8.48 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.046 0.938 . . . . 65.25 108.857 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.84 100.09 7.84 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.533 -0.914 . . . . 73.43 108.533 172.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -135.47 14.99 3.44 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.026 -0.988 . . . . 72.34 110.926 -171.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -112.31 19.88 17.26 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.989 0.915 . . . . 74.2 110.151 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -59.14 -44.21 92.05 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.32 1.048 . . . . 73.14 111.561 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' THR . . . . . 0.521 HG21 ' H ' ' D' ' 9' ' ' MET . 9.4 t -160.62 -166.23 1.59 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.375 1.07 . . . . 75.05 108.652 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -76.0 14.81 0.63 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.623 0.769 . . . . 74.35 111.562 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.521 ' H ' HG21 ' D' ' 7' ' ' THR . 5.3 ttp -30.16 136.41 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.745 1.618 . . . . 71.31 113.25 165.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.49 HG22 ' HG2' ' B' ' 150' ' ' GLU . 5.2 m -105.62 143.55 33.61 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.089 0.556 . . . . 71.22 109.652 176.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -148.53 96.46 2.6 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.306 -1.368 . . . . 73.53 107.306 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -119.25 122.42 41.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.378 -0.971 . . . . 64.14 108.378 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.474 HD12 HD11 ' D' ' 105' ' ' ILE . 41.2 mt -78.49 114.66 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.841 -1.17 . . . . 74.54 107.841 169.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -84.86 -38.73 19.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.356 0.262 . . . . 74.43 111.504 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -169.3 127.22 0.96 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 119.757 -0.163 . . . . 75.24 111.248 -166.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.4 mp -105.33 134.59 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.144 -1.428 . . . . 73.45 107.144 164.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.433 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 36.2 p90 -154.87 165.45 36.63 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.975 0.893 . . . . 70.42 111.033 174.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -98.54 117.97 34.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.337 -1.301 . . . . 72.13 109.46 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.433 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 33.2 mtpt -82.25 -33.68 29.12 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.729 -0.841 . . . . 74.21 108.729 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -143.95 144.53 31.74 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.535 -1.211 . . . . 64.35 109.398 173.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.577 HG23 ' HE1' ' C' ' 117' ' ' MET . 47.2 mt -133.73 141.25 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.41 -1.33 . . . . 73.23 107.41 172.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -144.1 137.1 27.3 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.955 0.902 . . . . 71.34 108.917 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.573 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.0 t80 -152.33 128.66 10.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.237 -1.764 . . . . 74.23 106.237 172.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -138.41 125.66 21.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.67 0.788 . . . . 74.33 109.354 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.29 83.8 60.59 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.257 -1.016 . . . . 73.03 108.257 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.42 -23.55 20.25 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.692 2.262 . . . . 62.24 112.62 -173.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 -106.84 1.69 24.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.569 0.748 . . . . 72.32 111.075 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -27.27 -66.64 0.11 Allowed Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 116.702 2.112 . . . . 72.15 116.702 -161.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.75 -22.29 9.12 Favored 'Trans proline' 0 C--N 1.38 2.229 0 CA-C-N 123.544 2.301 . . . . 72.14 113.718 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -70.73 -38.09 73.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.213 1.005 . . . . 73.22 109.291 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.9 p -84.92 -21.86 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 115.801 -0.636 . . . . 64.23 111.738 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -65.95 -20.36 66.18 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 112.418 0.525 . . . . 73.53 112.418 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.54 -22.15 64.89 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.296 0.638 . . . . 74.41 110.439 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -88.6 83.52 6.77 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.43 1.092 . . . . 70.12 108.396 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.23 93.2 5.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.552 -0.749 . . . . 44.42 110.099 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -160.36 158.28 29.36 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.3 1.04 . . . . 75.53 109.102 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.793 ' HG3' HD13 ' H' ' 470' ' ' LEU . 67.9 tp60 -65.92 107.42 1.53 Allowed Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 124.007 0.923 . . . . 63.31 109.548 171.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.92 117.29 4.3 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 122.964 2.443 . . . . 73.44 112.867 -167.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.409 ' HA ' HD11 ' H' ' 470' ' ' LEU . 0.4 OUTLIER -73.84 121.61 21.16 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.103 -0.703 . . . . 64.24 109.103 -175.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' D' ' 66' ' ' ALA . 14.5 m -107.86 151.05 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.492 0.717 . . . . 73.34 112.309 -168.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -109.37 125.3 52.23 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.709 -1.219 . . . . 75.24 107.709 164.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.554 ' HB2' ' SD ' ' H' ' 464' ' ' MET . 65.4 mt -97.03 133.89 41.11 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.796 -0.446 . . . . 74.44 109.796 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -145.65 128.45 16.31 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.452 -1.314 . . . . 64.53 107.452 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.412 ' HG ' HD21 ' H' ' 460' ' ' LEU . 1.2 pt? -134.85 159.18 42.21 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.418 0.627 . . . . 75.1 111.071 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.0 t70 -136.48 128.96 30.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.479 1.512 . . . . 74.33 108.304 -170.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.6 t -106.06 146.77 29.71 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.28 -0.637 . . . . 72.22 109.28 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.99 170.48 19.77 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.709 0.804 . . . . 72.55 109.032 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 88.9 p -162.9 155.2 18.59 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 123.163 0.289 . . . . 74.41 110.83 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 22.2 t -153.44 153.88 33.34 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.489 1.116 . . . . 72.23 109.726 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.96 136.99 32.72 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 109.542 -0.54 . . . . 74.55 109.542 172.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.525 HD12 ' HB3' ' C' ' 29' ' ' PRO . 26.7 mt -109.5 -34.64 6.45 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.156 0.583 . . . . 75.54 110.138 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.01 -178.62 7.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.937 0.895 . . . . 71.43 110.243 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.72 118.62 10.52 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.474 -0.785 . . . . 74.33 110.082 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 56.79 17.22 3.09 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 124.998 1.319 . . . . 73.31 113.036 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 77.9 t -118.51 110.29 29.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 106.696 -1.594 . . . . 73.4 106.696 171.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.433 ' HB2' HD11 ' D' ' 86' ' ' ILE . 6.0 t80 -120.7 161.26 21.72 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.431 -0.952 . . . . 74.01 108.431 -170.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -129.74 145.42 51.54 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.306 -0.861 . . . . 72.01 109.516 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.71 125.05 66.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.064 -1.458 . . . . 72.11 107.064 172.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.52 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 43.6 t -103.26 133.2 47.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.935 -0.765 . . . . 64.42 108.935 176.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.57 118.42 31.62 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.665 -0.865 . . . . 74.45 108.665 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.2 ttm-85 -104.27 96.05 6.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.253 -1.018 . . . . 74.41 108.253 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.35 125.21 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.874 -0.787 . . . . 60.31 108.874 174.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 5.9 m -118.07 134.01 55.38 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 123.633 0.583 . . . . 73.04 109.669 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.417 HG23 HG21 ' D' ' 114' ' ' ILE . 64.4 t -119.58 117.66 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.305 1.042 . . . . 74.32 108.914 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 31.9 m -105.91 94.1 5.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.885 0.874 . . . . 74.44 108.652 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -96.2 151.31 19.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.013 0.525 . . . . 61.4 111.337 -172.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 56.7 p -147.0 135.62 22.02 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.35 -0.841 . . . . 74.34 111.449 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 22.6 mt -96.56 94.42 7.35 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.518 -1.29 . . . . 75.11 107.518 167.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.77 -117.01 8.76 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.313 -0.858 . . . . 74.2 112.577 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -93.69 4.77 53.42 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.851 0.86 . . . . 74.15 111.914 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -118.9 140.29 50.22 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.013 0.525 . . . . 74.45 110.183 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.6 m -63.57 116.15 5.36 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 123.456 0.472 . . . . 70.33 110.255 174.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.542 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -77.24 -72.12 0.37 Allowed 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.949 -0.759 . . . . 73.12 108.949 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -142.03 153.42 44.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.573 -0.739 . . . . 74.54 109.935 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 79.2 mt -115.48 148.52 39.35 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.935 -1.506 . . . . 72.23 106.935 169.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.511 ' SG ' HG12 ' D' ' 114' ' ' ILE . 47.4 t -155.1 143.12 20.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.27 -0.641 . . . . 74.23 109.27 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -155.8 127.28 7.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.61 -0.515 . . . . 74.14 109.61 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.31 120.52 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 122.863 0.465 . . . . 74.24 110.125 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -89.48 83.57 6.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.977 -0.749 . . . . 72.3 108.977 171.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -79.7 91.55 5.28 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.789 -1.096 . . . . 75.32 108.78 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.84 143.23 18.92 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 110.96 -0.856 . . . . 75.12 110.96 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.481 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -135.31 130.77 5.54 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 112.059 -0.416 . . . . 74.25 112.059 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.431 HG13 ' HE1' ' D' ' 17' ' ' TYR . 43.5 mt -89.44 126.15 42.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 124.028 0.931 . . . . 72.43 109.026 174.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -127.76 125.57 40.15 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.532 -0.914 . . . . 73.53 108.532 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.5 t -86.45 111.17 20.29 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.652 -1.24 . . . . 73.41 107.652 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.433 HD11 ' HB2' ' D' ' 56' ' ' TYR . 0.9 OUTLIER -130.24 136.7 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.288 0.566 . . . . 74.02 110.538 -173.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.4 156.3 40.4 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.8 1.24 . . . . 74.4 107.882 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.28 20.92 79.46 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 121.117 -0.564 . . . . 71.4 112.322 -175.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 45.5 pt -109.8 152.35 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.057 0.943 . . . . 75.44 109.24 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -163.16 146.04 10.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.903 0.481 . . . . 74.01 110.912 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.91 -120.81 11.41 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.17 0.828 . . . . 51.02 115.17 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 24.2 p -70.08 -24.06 63.16 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.482 1.113 . . . . 73.51 112.272 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -64.19 -36.11 82.99 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.443 0.697 . . . . 72.02 110.211 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.664 ' SD ' ' HA ' ' H' ' 452' ' ' VAL . 19.4 mtm -68.25 -51.88 40.19 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.52 0.513 . . . . 72.3 110.318 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.33 70.92 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.067 0.547 . . . . 71.11 111.915 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.433 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 28.9 t-80 -72.68 -32.17 65.6 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.887 0.875 . . . . 75.23 111.161 176.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.4 t -78.31 -53.52 7.21 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.491 0.316 . . . . 63.41 111.258 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' D' ' 94' ' ' MET . 4.6 pp -95.3 -18.98 20.36 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.308 0.643 . . . . 74.31 112.163 -169.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.4 13.23 56.95 Favored Glycine 0 N--CA 1.473 1.152 0 CA-C-O 120.051 -0.305 . . . . 55.31 112.693 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.627 ' HB2' ' HA ' ' D' ' 134' ' ' ASP . . . -152.63 -71.03 0.15 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 111.969 0.359 . . . . 73.25 111.969 -176.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -73.11 -32.74 65.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 112.378 0.51 . . . . 73.33 112.378 -171.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -71.71 -43.89 11.73 Favored Pre-proline 0 CA--C 1.561 1.365 0 CA-C-O 118.48 -0.771 . . . . 74.34 111.791 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -52.95 -36.1 73.92 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.194 1.929 . . . . 75.14 113.287 164.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -67.84 -22.31 65.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.517 0.727 . . . . 74.31 111.586 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.474 HD11 HD12 ' D' ' 13' ' ' ILE . 87.1 mt -81.1 -40.24 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.415 1.086 . . . . 72.44 110.463 172.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.481 HD22 ' HA3' ' D' ' 82' ' ' GLY . 93.9 mt -73.03 -22.75 60.58 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.246 -0.888 . . . . 74.02 111.82 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -71.68 -40.34 8.31 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 124.263 1.025 . . . . 75.31 113.308 -171.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -52.58 -42.66 60.57 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.292 1.994 . . . . 74.51 114.243 166.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -74.82 -35.72 62.43 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.167 0.587 . . . . 71.13 111.482 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.65 -42.42 86.71 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.562 -0.533 . . . . 64.3 109.562 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.638 HH12 ' HB3' ' D' ' 130' ' ' PRO . 21.2 ttp180 -51.49 -56.71 11.85 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 124.805 1.316 . . . . 74.5 110.708 173.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -67.17 -37.76 84.27 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.346 1.028 . . . . 73.34 111.584 -171.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.39 -45.25 94.22 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.467 0.479 . . . . 74.01 110.445 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.511 HG12 ' SG ' ' D' ' 76' ' ' CYS . 96.6 mt -61.8 -53.64 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.036 -0.984 . . . . 71.2 110.706 174.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -56.39 -40.35 74.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.305 1.042 . . . . 63.23 111.525 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.4 t -66.48 -43.4 85.51 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 114.783 -1.099 . . . . 74.12 110.6 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.408 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.3 mtm -70.17 -26.24 63.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.705 0.402 . . . . 72.32 111.66 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.423 HG23 ' O ' ' D' ' 114' ' ' ILE . 69.2 t -68.06 -45.23 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.566 0.746 . . . . 73.44 110.019 173.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.9 p -74.84 -26.21 59.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.816 0.446 . . . . 74.1 111.473 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -75.65 -34.71 60.52 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.204 0.601 . . . . 75.45 109.646 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.36 1.65 84.68 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.651 0.595 . . . . 74.51 112.303 171.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 44.6 p 61.04 21.23 11.62 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.073 2.149 . . . . 64.02 114.458 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.414 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.1 m-85 -78.44 142.7 62.83 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 107.86 -1.163 . . . . 73.3 107.86 168.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -50.18 137.74 37.52 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.245 2.63 . . . . 71.24 113.192 176.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -50.22 135.49 21.19 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.842 1.257 . . . . 72.3 114.04 -164.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 18.7 tp -108.84 102.0 11.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.196 0.599 . . . . 71.34 110.675 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -100.35 96.91 7.75 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.368 0.604 . . . . 75.34 109.931 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.94 123.2 19.18 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.122 1.369 . . . . 65.22 111.357 -175.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.07 122.84 88.14 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.396 0.679 . . . . 73.13 110.385 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.638 ' HB3' HH12 ' D' ' 111' ' ' ARG . 74.2 Cg_endo -80.87 128.85 6.81 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.304 2.003 . . . . 64.22 112.674 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.39 146.1 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.497 0.719 . . . . 72.33 109.807 176.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -85.6 89.83 7.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.029 0.532 . . . . 75.13 109.566 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -59.21 -24.08 62.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.61 0.764 . . . . 72.24 112.344 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.627 ' HA ' ' HB2' ' D' ' 100' ' ' ALA . 9.8 t70 -60.23 -52.47 65.16 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.075 0.95 . . . . 73.43 110.7 -176.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.559 ' HA ' ' HE2' ' D' ' 138' ' ' MET . . . -71.77 -40.04 69.55 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.127 -0.942 . . . . 71.12 111.359 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 91.4 mt -58.17 -34.5 70.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.627 0.771 . . . . 75.41 112.111 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -71.97 -49.06 40.47 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.377 0.671 . . . . 74.1 110.57 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.559 ' HE2' ' HA ' ' D' ' 135' ' ' ALA . 74.5 mtm -63.21 -34.53 77.84 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.76 0.424 . . . . 74.12 110.869 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -70.7 -35.96 73.01 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.964 0.506 . . . . 71.51 111.017 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -61.73 -42.88 99.54 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.702 0.401 . . . . 75.34 110.8 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.39 -30.22 71.27 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.563 0.745 . . . . 75.22 112.248 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -93.0 20.23 6.95 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.045 0.538 . . . . 75.12 112.328 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -122.2 81.65 1.86 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.025 0.53 . . . . 75.11 111.598 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -145.43 84.73 1.7 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.983 1.313 . . . . 75.44 108.278 166.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.82 137.04 9.56 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.356 0.663 . . . . 74.11 110.454 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.86 -14.79 82.22 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 111.779 -0.528 . . . . 73.35 111.779 170.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.27 138.2 41.71 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.125 0.97 . . . . 75.51 109.184 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.58 -178.65 29.98 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.669 0.605 . . . . 64.14 113.896 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 12.5 t -148.91 -152.07 0.42 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.502 -0.925 . . . . 73.4 108.502 -173.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -54.76 147.17 15.38 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.557 0.743 . . . . 73.44 110.758 172.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -77.61 78.15 4.12 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.485 0.659 . . . . 71.12 109.811 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -149.65 140.17 22.47 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.973 -1.012 . . . . 74.33 109.019 174.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -160.52 133.89 6.76 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.668 -0.864 . . . . 75.32 108.668 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -109.93 138.89 45.67 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.693 0.797 . . . . 72.23 109.332 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.919 0 C-N-CA 123.337 0.655 . . . . 74.15 111.506 -172.248 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 58.6 t30 . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.618 -0.512 . . . . 73.13 109.618 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 87' ' ' ALA . 11.5 p -113.12 -23.65 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.118 0.967 . . . . 73.11 109.899 176.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 18.9 m -63.08 150.12 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.706 1.202 . . . . 71.24 114.066 -167.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -168.75 -174.79 37.7 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.193 -0.912 . . . . 52.21 112.127 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -160.78 102.96 1.33 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 106.679 -1.6 . . . . 72.35 106.679 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 6.4 t -130.32 59.68 1.64 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 122.09 0.948 . . . . 73.12 110.223 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -160.13 129.79 5.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.987 -1.006 . . . . 74.11 109.608 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -131.37 106.47 8.28 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.353 -0.98 . . . . 75.44 108.353 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 15.3 t -148.33 150.35 33.44 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.456 -0.572 . . . . 75.32 109.456 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -85.01 66.01 9.54 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.601 -0.888 . . . . 74.23 108.601 174.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' A' ' 45' ' ' ASP . 3.5 mm? 61.95 -171.55 0.16 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.753 1.221 . . . . 71.4 111.671 -176.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . 0.445 ' HD1' ' HB3' ' A' ' 136' ' ' LEU . 6.0 p90 -157.36 8.32 0.17 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.446 0.698 . . . . 71.4 111.04 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . 0.439 ' OH ' ' HA ' ' A' ' 43' ' ' ASP . 34.2 p90 -84.78 172.83 11.15 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.152 0.501 . . . . 73.3 110.856 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 9.9 t -121.43 -22.33 5.99 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.806 0.842 . . . . 65.3 110.262 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.07 -79.53 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.717 1.607 . . . . 75.13 109.129 -171.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 87.2 tttt 74.66 -24.55 0.21 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.608 1.563 . . . . 73.32 113.753 167.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -81.54 85.24 6.54 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.138 0.494 . . . . 61.33 110.201 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -73.66 120.41 19.22 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.457 -0.792 . . . . 73.4 109.401 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . 0.438 ' HB3' HD22 ' E' ' 470' ' ' LEU . 4.1 tt -69.89 -43.15 72.35 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.562 -0.903 . . . . 73.53 108.562 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.29 -48.14 2.64 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.826 -0.624 . . . . 70.12 112.027 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . 0.537 ' HB3' ' NE1' ' A' ' 36' ' ' TRP . 4.0 mm? 70.92 102.94 0.06 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.219 1.407 . . . . 72.21 110.86 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 96.2 mttt . . . . . 0 C--O 1.251 1.163 0 C-N-CA 124.702 1.201 . . . . 74.34 108.881 -177.832 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 14.2 m120 . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 108.626 -0.879 . . . . 73.35 108.626 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . 0.497 ' HA ' ' HG3' ' B' ' 90' ' ' GLU . 88.0 t -64.35 -46.01 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.39 0.676 . . . . 74.45 111.309 -173.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 15.5 m -52.44 134.03 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 113.916 1.08 . . . . 75.24 113.916 -173.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -163.93 47.16 0.31 Allowed Glycine 0 C--N 1.341 0.818 0 CA-C-N 115.046 -0.979 . . . . 73.43 110.858 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.15 124.01 26.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.401 0.68 . . . . 74.13 109.801 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 18.5 m -68.67 125.34 26.24 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 109.208 -0.664 . . . . 73.53 109.208 172.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -58.44 143.9 43.87 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.957 0.903 . . . . 61.31 112.529 -173.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -70.31 88.57 0.64 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.305 1.042 . . . . 70.34 111.881 -171.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 41.0 p -102.52 -144.43 0.36 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.165 0.986 . . . . 73.43 108.867 172.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.17 85.09 0.05 Allowed 'General case' 0 C--N 1.358 0.94 0 N-CA-C 108.962 -0.755 . . . . 71.43 108.962 170.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . 0.452 HD22 ' H ' ' F' ' 460' ' ' LEU . 2.2 pt? -75.65 127.62 33.46 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.803 -0.635 . . . . 74.21 110.708 -174.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . 0.541 ' HD2' ' HB2' ' B' ' 136' ' ' LEU . 93.7 m-85 69.09 -77.33 0.05 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.917 1.287 . . . . 73.42 113.289 170.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -132.54 173.01 11.76 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.551 0.691 . . . . 74.55 111.366 -171.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 12.0 m -132.57 54.44 1.95 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 107.659 -1.237 . . . . 73.24 107.659 171.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 53.1 mtm -70.7 -21.31 62.58 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.215 -0.902 . . . . 74.01 110.753 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 48.8 tttp 70.59 -76.08 0.07 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.557 1.143 . . . . 72.52 110.486 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -86.34 164.79 16.87 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.873 0.869 . . . . 72.33 110.746 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . 0.739 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -121.18 160.26 24.16 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.505 0.722 . . . . 73.4 109.834 174.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 7.3 mp 66.89 -76.4 0.05 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.667 1.187 . . . . 72.3 110.013 -173.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 132.41 -18.14 4.69 Favored Glycine 0 N--CA 1.476 1.35 0 N-CA-C 111.813 -0.515 . . . . 52.51 111.813 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . 0.547 HD23 ' H ' ' B' ' 40' ' ' VAL . 3.2 mm? 60.93 32.24 19.99 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.028 1.331 . . . . 75.45 111.063 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 C--O 1.252 1.195 0 C-N-CA 124.968 1.307 . . . . 62.02 107.77 -179.239 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 121.603 0.716 . . . . 63.15 109.246 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . 0.442 ' O ' ' SD ' ' C' ' 94' ' ' MET . 8.9 p -72.56 -11.66 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 114.695 -1.139 . . . . 74.14 111.423 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . 0.476 ' HA ' ' HE2' ' C' ' 56' ' ' TYR . 33.6 m -126.73 173.06 13.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 124.531 1.132 . . . . 72.53 110.001 174.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 109.76 79.31 1.08 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.735 -0.546 . . . . 74.15 111.735 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 79.8 mt -124.96 126.38 45.38 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.321 1.048 . . . . 74.14 108.232 169.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 58.5 p -78.85 -60.73 2.26 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 122.805 0.442 . . . . 70.03 111.162 -175.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -164.64 154.8 14.13 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.095 0.558 . . . . 74.14 110.172 -175.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -153.4 52.54 0.73 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.472 -0.936 . . . . 62.15 108.472 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 14.5 t -72.55 142.43 48.46 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.308 -0.86 . . . . 70.12 110.177 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 21.4 t70 66.11 108.11 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.383 1.073 . . . . 75.43 111.243 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 56.7 mt -93.48 166.59 12.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.277 0.561 . . . . 74.52 111.128 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -77.28 177.39 7.95 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.956 -1.02 . . . . 64.44 110.17 168.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 70.2 t80 64.23 76.57 0.34 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.215 1.006 . . . . 63.01 110.467 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 16.6 p -94.0 88.72 5.79 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.719 -0.845 . . . . 73.21 108.719 169.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 464' ' ' MET . . . . . 0.631 ' HB3' ' HB3' ' C' ' 42' ' ' LEU . 39.7 tpp -72.19 132.17 43.76 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.505 -0.771 . . . . 73.42 110.262 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -124.81 12.85 8.53 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.94 0.896 . . . . 75.52 111.378 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -144.69 -67.36 0.32 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.109 0.564 . . . . 54.24 110.474 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . 60.93 -79.93 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.228 1.411 . . . . 64.31 111.866 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . 0.419 HD12 HD12 ' C' ' 126' ' ' LEU . 84.3 mt -110.94 125.04 53.27 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.123 0.969 . . . . 73.22 109.654 -177.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -76.84 74.78 1.76 Allowed Glycine 0 C--N 1.345 1.057 0 N-CA-C 110.785 -0.926 . . . . 63.1 110.785 170.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 85.2 mt -73.29 90.66 1.65 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.978 0.911 . . . . 73.23 109.913 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.055 -0.974 . . . . 73.23 108.813 -178.229 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.533 0.206 . . . . 75.34 111.027 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 11.8 p -96.5 -29.21 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 109.472 -0.566 . . . . 72.11 109.472 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.664 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 11.0 p -82.04 147.8 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.524 0.73 . . . . 72.54 110.741 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 147.34 114.66 0.82 Allowed Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.843 -0.42 . . . . 45.42 112.621 174.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . 0.552 ' HG ' ' H ' ' H' ' 455' ' ' THR . 0.3 OUTLIER -123.13 -84.55 0.66 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.245 0.618 . . . . 72.42 109.365 174.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' H' H ' 455' ' ' THR . . . . . 0.552 ' H ' ' HG ' ' H' ' 454' ' ' LEU . 14.1 t 174.2 175.69 0.15 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.579 1.152 . . . . 73.24 109.275 -172.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -72.37 136.78 46.21 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.815 -0.809 . . . . 74.24 108.815 167.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 15.3 pm0 -136.33 39.1 2.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.738 0.415 . . . . 74.52 110.336 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 10.9 p -50.02 96.64 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.887 0.875 . . . . 74.34 112.242 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -176.62 174.52 1.84 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.166 1.786 . . . . 74.02 107.325 -174.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . 0.412 HD21 ' HG ' ' D' ' 44' ' ' LEU . 14.8 tp -149.19 156.82 42.74 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.424 0.63 . . . . 74.4 110.843 173.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -101.59 -158.97 0.7 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.019 1.328 . . . . 74.13 108.911 167.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 28.3 t80 70.07 151.4 0.09 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.602 0.761 . . . . 75.45 112.555 169.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 51.4 m -131.66 125.28 31.74 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.743 0.817 . . . . 74.23 109.971 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 464' ' ' MET . . . . . 0.554 ' SD ' ' HB2' ' D' ' 42' ' ' LEU . 5.8 ptp -129.15 109.75 11.43 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.666 0.786 . . . . 64.41 110.016 175.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . 0.429 ' O ' ' HE2' ' H' ' 471' ' ' LYS . 30.9 ttmt -73.66 -46.7 44.97 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 107.319 -1.363 . . . . 73.4 107.319 164.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -72.18 160.87 31.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.195 -1.366 . . . . 74.43 111.837 -178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -118.08 -85.61 0.64 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.161 0.584 . . . . 74.41 111.303 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -163.02 56.14 0.19 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.876 0.846 . . . . 75.35 111.213 -167.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 96.04 -52.8 1.65 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.235 -1.146 . . . . 74.31 110.235 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . 0.793 HD13 ' HG3' ' D' ' 37' ' ' GLN . 83.8 mt -69.92 112.82 6.6 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 108.235 -1.024 . . . . 72.44 108.235 167.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . 0.715 ' HZ2' ' HB3' ' H' ' 471' ' ' LYS . 5.1 ttpm? . . . . . 0 CA--C 1.56 1.364 0 O-C-N 124.255 0.972 . . . . 73.14 110.68 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.5 mpp? . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.897 -0.409 . . . . 74.32 109.897 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 m 64.6 -80.82 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.91 1.284 . . . . 72.11 111.364 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -102.43 93.17 5.02 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.813 -0.81 . . . . 73.52 108.813 172.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -84.3 -41.74 16.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.198 -1.038 . . . . 74.2 108.198 167.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -80.92 85.37 6.23 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 124.183 0.993 . . . . 72.42 109.113 174.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -78.99 132.8 36.79 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.968 -0.56 . . . . 73.1 109.772 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -141.61 155.36 45.74 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.181 0.992 . . . . 64.24 109.137 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -67.55 175.47 2.84 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.293 0.637 . . . . 74.21 109.907 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.4 mtt -61.64 129.15 39.67 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.633 -0.506 . . . . 72.52 109.633 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.421 ' HA ' ' HB3' ' C' ' 150' ' ' GLU . 75.6 m -141.42 121.09 13.4 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.482 0.713 . . . . 74.45 109.137 -170.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.51 ' HD1' HG21 ' C' ' 149' ' ' THR . 21.6 t80 -134.28 125.0 26.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.7 0.8 . . . . 74.05 109.32 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -137.93 135.71 36.33 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.145 -1.057 . . . . 75.11 108.145 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.58 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.5 mt -92.83 118.31 38.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.22 -1.03 . . . . 75.52 108.22 174.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -88.83 -30.21 19.12 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 124.003 0.814 . . . . 64.44 110.272 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -171.28 147.61 2.51 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 123.275 0.359 . . . . 74.15 110.721 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.411 HD13 ' HG3' ' C' ' 130' ' ' PRO . 84.6 mt -137.05 134.16 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.503 1.121 . . . . 75.34 108.058 173.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.461 ' HB3' HG21 ' B' ' 122' ' ' THR . 25.1 p90 -166.54 169.2 13.97 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.773 0.797 . . . . 75.24 112.193 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -89.36 122.75 32.89 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.303 -0.862 . . . . 74.44 108.778 170.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.6 mtpt -87.7 -18.65 29.03 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.926 -0.398 . . . . 74.22 109.926 173.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.1 t70 -161.73 144.73 12.09 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.102 0.961 . . . . 75.21 109.297 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 82.0 mt -140.49 142.52 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.813 1.645 . . . . 74.33 107.172 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -146.32 139.99 26.1 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.176 0.513 . . . . 73.23 110.147 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 89.1 t80 -141.44 127.15 19.1 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.204 -1.406 . . . . 71.22 107.204 173.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -133.87 122.43 23.18 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.734 -0.469 . . . . 74.54 109.734 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.02 74.53 79.72 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.278 -1.378 . . . . 74.34 107.278 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.57 -22.09 51.66 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.662 2.241 . . . . 74.15 112.543 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 42.6 m-80 -120.01 34.81 5.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.124 0.97 . . . . 73.33 109.314 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.45 -54.21 37.39 Favored Pre-proline 0 CA--C 1.565 1.522 0 CA-C-O 118.128 -0.939 . . . . 62.03 113.4 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.97 -22.02 31.68 Favored 'Trans proline' 0 C--N 1.387 2.599 0 CA-C-N 121.607 1.609 . . . . 74.45 113.147 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 6.0 t-160 -82.03 -38.83 24.41 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.99 0.916 . . . . 63.13 110.885 -171.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 73' ' ' ALA . 34.2 m -69.43 -25.92 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.311 0.644 . . . . 74.24 111.957 -175.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -72.43 -24.51 61.23 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.192 0.597 . . . . 73.31 111.004 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -77.09 -49.07 16.12 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.687 0.795 . . . . 72.33 110.905 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -75.36 172.77 11.89 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.372 0.669 . . . . 75.12 111.779 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.56 116.96 4.74 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 123.444 0.698 . . . . 75.25 110.525 176.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -73.65 90.41 1.8 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.455 -0.793 . . . . 74.41 109.549 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -131.4 72.0 81.13 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.092 -1.077 . . . . 74.54 108.092 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.57 116.77 2.96 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.396 2.064 . . . . 72.3 111.245 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -94.78 111.46 23.24 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.658 -1.238 . . . . 74.33 107.658 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 m -85.71 127.82 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 114.458 -1.246 . . . . 71.51 112.013 -170.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -122.01 114.54 21.1 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.334 1.453 . . . . 75.02 107.805 177.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.571 ' HB3' ' HB3' ' E' ' 464' ' ' MET . 22.6 tp -110.44 113.73 26.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.032 0.533 . . . . 71.25 109.823 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -113.11 110.05 19.8 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.744 0.818 . . . . 64.11 108.902 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mp -97.88 155.35 17.1 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.179 -0.674 . . . . 75.03 109.179 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.9 t70 -148.83 146.76 28.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.432 1.093 . . . . 73.23 108.437 -174.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.2 m -141.89 134.44 28.25 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.614 0.765 . . . . 74.44 110.175 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.2 140.51 46.55 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.807 0.843 . . . . 74.32 110.61 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.435 ' HB3' HD23 ' A' ' 98' ' ' LEU . 39.5 p -92.16 152.97 19.62 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.029 0.932 . . . . 63.12 109.834 176.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -151.85 145.25 24.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.946 0.898 . . . . 72.21 109.178 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -113.44 137.76 51.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.976 -0.75 . . . . 64.13 108.976 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.406 HD12 HG22 ' A' ' 83' ' ' ILE . 69.3 mt -110.96 -36.42 5.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.496 0.718 . . . . 74.25 110.469 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.45 -176.85 5.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.388 0.675 . . . . 74.11 110.828 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.28 120.54 12.95 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.166 -1.05 . . . . 74.32 108.166 170.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 72.46 -5.91 1.71 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.778 1.231 . . . . 71.5 112.702 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.3 t -109.25 116.38 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.081 0.952 . . . . 75.2 108.832 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.78 162.56 28.17 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.26 0.624 . . . . 72.41 109.549 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -134.88 145.74 48.55 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.063 0.945 . . . . 74.04 109.732 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -131.6 147.57 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.5 -0.926 . . . . 75.1 108.5 166.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.13 117.3 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.728 0.811 . . . . 72.4 109.382 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.7 tp -97.91 103.28 15.2 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.874 -0.787 . . . . 73.44 108.874 173.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.613 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 27.3 ttp180 -88.26 112.99 23.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.3 0.64 . . . . 74.35 109.673 172.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.85 123.2 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.598 -0.89 . . . . 73.53 108.598 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -115.77 120.65 39.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.748 0.819 . . . . 72.12 110.061 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.43 ' O ' HD13 ' A' ' 75' ' ' LEU . 86.0 t -111.39 113.46 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.992 0.917 . . . . 71.23 110.007 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.2 m -112.06 105.6 14.03 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.82 -0.807 . . . . 73.2 108.82 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -111.38 105.36 13.97 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.198 -1.038 . . . . 73.11 108.198 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.3 p -128.85 131.29 47.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.49 0.716 . . . . 73.43 110.753 -174.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.624 HD21 ' H ' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -91.83 87.15 6.14 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.564 -0.902 . . . . 71.4 108.564 175.371 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.15 -102.88 2.32 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 114.981 -1.009 . . . . 75.13 111.902 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.43 -26.12 12.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.994 0.517 . . . . 72.2 110.327 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -91.68 127.4 37.12 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.894 0.878 . . . . 61.34 109.159 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.7 m -87.4 134.56 33.56 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 122.643 0.377 . . . . 75.34 110.751 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.648 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -76.48 -61.09 2.07 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 124.283 0.989 . . . . 74.5 108.668 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -152.88 153.79 33.76 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.554 -1.203 . . . . 62.22 110.725 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 58.6 tp -122.18 136.73 54.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.849 -1.537 . . . . 73.24 106.849 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 85.8 m -140.05 103.39 4.61 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.187 0.595 . . . . 72.55 109.445 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.22 117.68 24.37 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.216 -0.661 . . . . 74.13 109.216 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -126.11 113.79 35.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 123.862 0.865 . . . . 74.34 109.683 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.613 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 50.0 mt-30 -85.38 84.86 7.51 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.65 -0.871 . . . . 73.12 108.65 170.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.84 100.87 8.21 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.367 -0.975 . . . . 72.33 108.367 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.12 144.79 17.36 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 111.335 -0.706 . . . . 73.03 111.335 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.521 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -138.02 128.43 4.22 Favored Glycine 0 CA--C 1.504 -0.639 0 N-CA-C 111.369 -0.692 . . . . 74.13 111.369 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.406 HG22 HD12 ' A' ' 51' ' ' LEU . 55.0 mt -82.22 119.63 32.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.406 -0.961 . . . . 74.53 108.406 172.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.58 ' HD2' HG12 ' A' ' 13' ' ' ILE . 26.9 m-85 -130.31 117.73 20.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.954 -1.128 . . . . 70.03 107.954 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 p -78.75 108.42 12.16 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.973 -1.121 . . . . 73.25 107.973 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.508 ' HB ' HD13 ' A' ' 89' ' ' ILE . 42.9 pt -119.19 139.45 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.361 0.664 . . . . 75.12 109.943 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.32 159.68 28.75 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.478 1.111 . . . . 73.11 109.522 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.54 4.0 89.05 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.926 -0.375 . . . . 51.21 113.879 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.508 HD13 ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -120.46 136.58 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.284 -1.006 . . . . 72.22 108.284 172.268 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -141.22 173.6 11.33 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.34 1.056 . . . . 74.13 109.659 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.83 -133.14 51.33 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 123.948 0.78 . . . . 74.15 114.198 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.627 ' HB ' HD11 ' A' ' 141' ' ' LEU . 55.5 p -71.55 -24.82 62.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.01 0.924 . . . . 73.42 111.854 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -68.82 -44.11 74.18 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.582 0.753 . . . . 71.33 110.17 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 52.3 ttp -63.33 -48.4 78.18 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.956 -0.387 . . . . 72.21 109.956 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.9 -31.6 68.76 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.171 0.919 . . . . 61.41 112.034 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -73.98 -45.08 52.26 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.95 0.5 . . . . 75.43 110.62 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 78.7 m -66.55 -25.04 66.46 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.177 0.591 . . . . 40.14 111.575 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.435 HD23 ' HB3' ' A' ' 48' ' ' SER . 6.0 tt -95.72 -42.5 8.34 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.459 1.103 . . . . 74.44 110.159 -173.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.77 4.31 53.3 Favored Glycine 0 N--CA 1.472 1.045 0 CA-C-N 115.945 -0.57 . . . . 74.24 113.681 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.6 -57.79 0.32 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.224 0.512 . . . . 74.42 111.772 -176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.483 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 67.2 t80 -70.68 -62.43 1.4 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.118 0.567 . . . . 75.11 112.395 -170.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.3 m -68.71 -33.09 4.06 Favored Pre-proline 0 CA--C 1.567 1.618 0 N-CA-C 114.369 1.248 . . . . 73.34 114.369 -173.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.02 -24.77 44.93 Favored 'Trans proline' 0 C--N 1.39 2.742 0 CA-C-N 121.725 1.652 . . . . 72.15 112.776 167.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -73.41 -26.56 61.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.776 -0.453 . . . . 73.34 109.776 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.5 mm -63.63 -36.52 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.466 0.707 . . . . 73.03 109.818 169.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.521 HD22 ' HA3' ' A' ' 82' ' ' GLY . 76.5 mt -79.97 -17.61 52.5 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.899 0.88 . . . . 75.21 111.932 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -64.69 -46.17 76.17 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 117.755 -1.117 . . . . 71.44 113.684 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.47 -33.88 67.24 Favored 'Trans proline' 0 C--N 1.389 2.675 0 CA-C-N 122.071 1.776 . . . . 74.14 112.838 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.449 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 86.3 m-85 -70.53 -41.16 72.91 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.37 0.668 . . . . 74.51 111.239 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.98 -39.68 79.28 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.925 0.49 . . . . 75.21 110.405 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.453 ' NH1' HG23 ' C' ' 105' ' ' ILE . 36.5 ttm180 -53.2 -51.54 61.76 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 124.402 1.064 . . . . 73.2 109.611 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -66.59 -44.21 82.81 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.023 -0.989 . . . . 75.31 111.653 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.411 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.9 t -62.2 -33.99 75.6 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.174 0.59 . . . . 75.14 111.306 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 118' ' ' VAL . 83.3 mt -70.63 -55.97 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.112 0.965 . . . . 72.24 110.092 173.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.8 m -51.67 -43.43 62.69 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.697 1.199 . . . . 75.43 111.466 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -63.37 -47.07 83.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.906 -1.497 . . . . 61.32 110.268 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.418 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 69.0 mtm -63.13 -36.96 85.34 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.053 0.541 . . . . 62.31 111.722 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 114' ' ' ILE . 86.1 t -62.83 -47.2 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 123.507 0.723 . . . . 73.24 110.298 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.4 p -76.75 -20.25 56.71 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.153 0.581 . . . . 75.12 112.089 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -75.59 -34.89 60.66 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.005 -0.739 . . . . 74.04 109.005 172.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.43 -0.88 80.35 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.457 -0.792 . . . . 73.43 112.291 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.8 m 70.92 14.22 6.94 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 125.246 1.418 . . . . 71.33 111.578 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -77.91 157.43 79.02 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 123.619 0.767 . . . . 74.52 110.027 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.63 131.19 44.35 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.214 2.609 . . . . 74.5 111.897 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -55.24 126.41 24.78 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 124.414 1.071 . . . . 72.32 112.148 -170.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.8 tp -106.16 97.63 7.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.553 -0.748 . . . . 74.01 109.295 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.402 ' H ' ' HA3' ' E' ' 469' ' ' GLY . 80.4 m-20 -95.78 107.63 19.88 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.389 -1.337 . . . . 73.02 107.389 174.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.432 ' HB3' ' HG3' ' A' ' 111' ' ' ARG . 30.5 tp -72.03 126.81 30.71 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.441 -0.799 . . . . 70.24 110.213 -176.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.1 139.02 92.5 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.401 0.68 . . . . 74.33 110.441 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.58 128.46 28.36 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.906 2.404 . . . . 74.14 113.192 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 96.8 t -100.22 120.88 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.858 -0.793 . . . . 72.5 108.858 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.436 HD21 ' HB1' ' A' ' 135' ' ' ALA . 1.3 p-10 -76.7 74.01 3.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.515 1.126 . . . . 65.03 110.932 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -56.36 -39.54 73.05 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.406 0.682 . . . . 74.34 111.862 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.8 -33.35 72.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.509 1.124 . . . . 75.44 111.864 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.436 ' HB1' HD21 ' A' ' 132' ' ' ASN . . . -75.46 -43.01 51.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.158 0.583 . . . . 74.25 110.168 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.5 -38.19 90.15 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.333 -0.849 . . . . 74.44 110.131 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -69.22 -38.62 78.64 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.294 -0.866 . . . . 72.02 109.949 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -41.06 85.87 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.213 1.005 . . . . 64.44 110.599 176.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.508 ' HA ' ' HB2' ' A' ' 143' ' ' GLN . 82.4 m-20 -66.76 -23.8 66.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.21 1.004 . . . . 75.53 112.048 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -91.9 -34.86 14.33 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.166 0.987 . . . . 73.34 110.896 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.627 HD11 ' HB ' ' A' ' 92' ' ' THR . 41.7 tp -67.93 -48.64 65.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.58 1.152 . . . . 74.45 112.829 -165.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -146.97 4.07 0.83 Allowed 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.225 0.328 . . . . 74.13 111.029 -174.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.508 ' HB2' ' HA ' ' A' ' 139' ' ' ASN . 21.1 mm-40 -107.39 175.74 5.39 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.736 0.814 . . . . 53.33 109.841 173.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -144.93 -32.9 0.39 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.349 -0.842 . . . . 74.23 109.516 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 68.55 -175.23 0.2 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.931 1.292 . . . . 72.33 111.398 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 72.97 -97.04 0.8 Allowed Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.73 -0.548 . . . . 73.24 111.73 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.59 81.88 5.32 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 122.355 1.074 . . . . 74.12 109.838 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.4 134.69 3.37 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 114.922 -1.035 . . . . 64.0 111.309 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 46.6 m -136.14 124.14 22.85 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.864 0.866 . . . . 75.43 108.956 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 70.07 151.37 0.09 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.615 1.166 . . . . 73.01 111.744 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.25 110.85 3.54 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.962 -1.125 . . . . 65.25 107.962 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -54.74 112.14 0.97 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.873 0.869 . . . . 65.22 111.428 -177.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -123.36 125.76 45.58 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.945 0.898 . . . . 73.32 108.752 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -142.45 120.58 12.17 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.242 1.017 . . . . 65.21 108.658 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.025 0 C-N-CA 123.51 0.724 . . . . 62.13 110.279 -177.561 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 110.23 -0.285 . . . . 75.32 110.23 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.4 p -90.21 110.18 21.23 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.322 -0.621 . . . . 74.12 109.322 175.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.64 107.45 2.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.252 0.621 . . . . 73.21 109.896 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -71.08 134.39 47.0 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.97 0.908 . . . . 71.21 111.304 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -98.31 145.65 26.46 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.545 -1.28 . . . . 71.45 107.545 171.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -64.33 116.28 5.89 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.946 0.499 . . . . 75.43 110.433 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -113.56 152.93 29.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.068 0.947 . . . . 71.02 110.236 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.7 -29.43 58.97 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.936 0.894 . . . . 73.31 110.503 171.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 6.0 ptm 50.76 168.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 127.692 2.397 . . . . 74.32 114.379 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 58.3 m -162.04 143.41 10.84 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.278 1.031 . . . . 74.23 108.367 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -148.27 157.05 43.26 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.444 0.64 . . . . 73.41 111.389 161.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -124.1 133.33 53.63 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.116 -1.439 . . . . 74.43 107.116 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.419 HD11 HD12 ' B' ' 105' ' ' ILE . 27.7 mt -77.0 123.96 34.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.902 -0.777 . . . . 73.42 108.902 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -83.01 -45.48 14.01 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.818 0.698 . . . . 74.12 109.911 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -170.32 130.98 0.94 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.931 -0.577 . . . . 74.14 110.279 -171.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 77.6 mt -113.91 139.47 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 107.408 -1.33 . . . . 75.52 107.408 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -161.93 152.73 17.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.576 0.703 . . . . 65.24 111.762 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 81.7 m -77.47 121.36 23.74 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.165 -1.379 . . . . 73.13 108.195 171.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.565 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.1 mtpt -93.62 -29.53 15.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.528 0.731 . . . . 71.22 110.453 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -160.69 139.25 10.1 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.363 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.532 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.6 mm -133.21 142.01 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.867 1.267 . . . . 73.1 108.802 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -138.56 129.99 27.41 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.493 -1.299 . . . . 75.41 107.493 171.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.7 t80 -142.78 132.4 23.84 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.294 -1.373 . . . . 65.25 107.294 170.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.29 148.43 51.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.686 -0.857 . . . . 73.45 108.686 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.643 ' HB3' ' HB3' ' B' ' 28' ' ' ALA . . . -142.85 77.67 16.25 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 107.538 -1.282 . . . . 74.23 107.538 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.83 -36.83 17.27 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.928 2.419 . . . . 72.33 112.265 -171.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -100.37 -0.94 37.27 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.598 0.759 . . . . 72.32 111.346 -174.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.643 ' HB3' ' HB3' ' B' ' 25' ' ' ALA . . . -36.67 -66.08 0.29 Allowed Pre-proline 0 N--CA 1.494 1.728 0 C-N-CA 125.834 1.653 . . . . 72.31 115.013 -165.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.09 -24.42 73.32 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.332 2.021 . . . . 75.21 113.305 -170.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -93.12 -32.21 14.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.367 0.667 . . . . 75.34 111.262 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.468 HG22 HD13 ' B' ' 68' ' ' LEU . 1.5 p -75.56 -20.81 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 122.895 0.478 . . . . 74.34 110.922 -172.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -66.4 -10.11 40.45 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.633 0.773 . . . . 74.23 112.952 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -61.73 -28.72 69.63 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.231 0.612 . . . . 72.34 110.266 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -90.44 96.84 10.85 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 124.34 1.056 . . . . 73.23 109.536 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.08 94.99 1.97 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.507 -0.923 . . . . 71.4 108.507 171.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.414 ' HZ3' ' H ' ' B' ' 69' ' ' GLY . 26.9 t90 -169.35 154.96 6.05 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.372 1.069 . . . . 74.45 108.844 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.426 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 0.1 OUTLIER -87.07 110.59 34.35 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.046 -1.094 . . . . 72.23 108.046 170.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.441 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 53.8 Cg_endo -68.69 143.24 55.52 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.817 2.345 . . . . 73.15 113.407 -170.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.5 107.96 0.75 Allowed 'General case' 0 C--O 1.242 0.663 0 O-C-N 124.281 0.988 . . . . 74.03 110.066 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.5 m -86.34 161.2 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.207 -0.906 . . . . 75.35 110.972 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.463 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 60.3 tttp -134.16 104.29 6.14 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.612 -1.255 . . . . 72.04 107.612 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.461 HD22 ' HG3' ' F' ' 464' ' ' MET . 5.5 mp -85.17 124.22 31.58 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.523 -0.917 . . . . 74.15 108.523 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -140.81 109.82 6.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.214 -1.402 . . . . 75.13 107.214 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.61 155.09 17.78 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.876 -0.787 . . . . 75.31 108.876 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -155.71 149.89 25.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.452 -1.249 . . . . 72.44 108.374 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -140.65 143.12 34.98 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.352 0.596 . . . . 72.34 111.099 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.43 148.48 37.85 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.942 1.297 . . . . 63.31 107.915 172.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 72.4 p -145.03 162.92 35.76 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.114 0.416 . . . . 74.1 111.456 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -151.84 147.82 27.08 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.906 0.882 . . . . 44.53 109.833 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.465 ' HB2' HG11 ' F' ' 452' ' ' VAL . 58.1 tt0 -84.04 131.36 34.82 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.331 0.652 . . . . 74.22 109.566 172.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 43.3 mt -93.66 -44.31 8.24 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.333 0.653 . . . . 74.35 109.509 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.62 -176.35 5.89 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.369 1.068 . . . . 74.05 110.177 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -69.47 120.35 15.13 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.713 -1.131 . . . . 64.3 109.346 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.77 16.75 10.62 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.3 1.04 . . . . 73.2 112.072 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 67.1 t -130.15 104.06 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.221 -1.029 . . . . 74.41 108.221 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -112.55 167.25 10.61 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.922 -1.14 . . . . 74.31 107.922 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -143.38 121.37 12.07 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.202 -1.036 . . . . 74.25 108.202 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -106.5 143.29 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.173 0.989 . . . . 75.14 109.39 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.49 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 35.6 t -116.78 144.53 24.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.977 -0.749 . . . . 75.01 108.977 176.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.441 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -127.71 110.06 12.28 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.143 -1.058 . . . . 72.32 108.143 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.424 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 36.1 ttm180 -94.36 122.3 36.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.841 0.856 . . . . 73.54 110.162 171.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 47.7 t -116.44 103.43 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.387 -1.338 . . . . 72.34 107.387 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.2 m -98.9 131.7 44.78 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.302 0.641 . . . . 73.11 109.542 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.421 HG23 HD12 ' B' ' 114' ' ' ILE . 91.5 t -123.49 130.02 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.023 0.929 . . . . 61.34 109.631 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.5 m -119.25 136.88 54.01 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 108.85 -0.796 . . . . 73.32 108.85 172.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.49 151.95 43.76 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.057 0.389 . . . . 65.42 110.917 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.5 p -152.22 132.77 13.87 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.175 0.922 . . . . 75.1 111.515 -173.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.468 HD13 HG22 ' B' ' 31' ' ' VAL . 77.4 mt -93.51 104.17 16.32 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.682 -1.229 . . . . 64.21 107.682 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.414 ' H ' ' HZ3' ' B' ' 36' ' ' TRP . . . 85.57 -110.7 3.47 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.462 -0.655 . . . . 54.03 111.462 -174.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.77 1.17 9.93 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.888 0.875 . . . . 73.52 110.419 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -113.55 150.87 32.36 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.034 -0.728 . . . . 71.01 109.034 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -62.16 139.11 58.48 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.822 0.702 . . . . 74.33 110.908 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.465 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -97.4 -67.78 0.83 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.545 -1.279 . . . . 74.5 107.545 170.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -145.18 160.61 41.18 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.005 -0.998 . . . . 74.54 109.993 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -135.0 138.64 44.16 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.471 -1.677 . . . . 70.44 106.471 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -150.04 157.87 43.58 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.876 0.369 . . . . 74.14 110.084 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -164.62 135.55 4.18 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.03 -1.1 . . . . 63.5 108.03 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 95.8 t -126.2 145.88 32.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.572 -0.899 . . . . 75.12 108.572 172.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.424 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 45.3 mt-30 -123.29 86.69 2.62 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.739 -0.837 . . . . 75.45 108.739 171.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.594 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.0 tp-100 -83.26 101.43 11.25 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.955 -1.021 . . . . 73.43 109.424 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.565 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.55 169.9 34.74 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.894 -0.482 . . . . 55.42 111.894 175.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.26 137.12 4.57 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 111.304 -0.718 . . . . 43.45 111.304 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.3 mt -96.87 125.91 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.044 0.938 . . . . 75.43 108.529 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -128.3 131.26 48.67 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.662 -1.236 . . . . 72.11 107.662 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 45.0 m -97.96 89.82 4.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.463 -0.569 . . . . 72.21 109.463 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.435 ' HB ' HD12 ' B' ' 89' ' ' ILE . 1.6 pp -94.42 139.67 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.424 0.69 . . . . 74.42 111.527 -166.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.29 138.49 21.43 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.37 1.068 . . . . 75.42 109.294 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.4 -35.87 4.02 Favored Glycine 0 C--N 1.345 1.033 0 O-C-N 123.642 0.589 . . . . 62.41 113.307 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.435 HD12 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -54.64 137.48 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 C-N-CA 124.805 1.242 . . . . 71.41 112.752 -175.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -158.9 142.34 14.89 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.563 0.345 . . . . 75.44 111.282 175.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' B' ' 94' ' ' MET . . . 67.04 -121.92 17.57 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 114.573 0.589 . . . . 72.04 114.573 173.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 84.8 m -65.66 -33.21 75.36 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.645 0.778 . . . . 75.03 110.193 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -68.29 -39.26 82.14 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.34 -0.845 . . . . 74.41 110.202 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.615 ' HE2' HD22 ' F' ' 454' ' ' LEU . 17.5 ptm -78.79 -28.9 44.68 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 116.314 -0.403 . . . . 64.02 110.72 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.91 -30.55 62.65 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.2 0.6 . . . . 70.33 110.916 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -79.61 -33.48 41.48 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.092 0.957 . . . . 72.53 109.994 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.6 t -71.37 -65.15 0.79 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.587 0.755 . . . . 62.14 110.298 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 50.6 mt -80.45 -20.24 44.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.823 0.849 . . . . 71.23 112.395 -171.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.65 -13.16 41.75 Favored Glycine 0 N--CA 1.477 1.383 0 CA-C-O 119.646 -0.53 . . . . 74.14 114.363 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.93 -52.86 0.52 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 117.612 0.706 . . . . 74.43 111.688 -172.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -73.58 -38.47 65.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.047 0.539 . . . . 75.14 111.601 -173.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 84.4 m -70.43 -48.23 18.1 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-O 118.655 -0.688 . . . . 74.13 111.246 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.441 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 53.5 Cg_exo -55.86 -33.26 87.97 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.107 1.872 . . . . 70.4 113.701 168.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -59.52 -39.21 83.16 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.332 0.653 . . . . 72.12 111.644 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.419 HD12 HD11 ' B' ' 13' ' ' ILE . 79.8 mt -66.11 -41.06 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.09 0.956 . . . . 62.54 110.844 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 52.6 mt -80.13 -16.04 55.78 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.404 -0.817 . . . . 70.32 111.887 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -60.21 -48.8 93.26 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.198 0.999 . . . . 73.02 113.589 -172.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.558 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 33.3 Cg_endo -61.34 -34.08 88.0 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.141 1.894 . . . . 75.12 113.498 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.594 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 94.3 m-85 -67.39 -46.86 72.01 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.692 0.397 . . . . 75.3 110.234 177.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.45 86.08 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.47 -0.786 . . . . 53.45 111.112 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.565 ' HA ' HD21 ' B' ' 128' ' ' LEU . 29.0 mtp-105 -55.16 -61.39 2.35 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.376 1.07 . . . . 74.23 111.36 175.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.37 -27.85 69.29 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.07 0.856 . . . . 74.44 110.781 -173.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.532 ' SG ' HD13 ' B' ' 21' ' ' ILE . 4.5 t -73.32 -37.94 65.97 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.108 0.563 . . . . 73.02 111.048 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.421 HD12 HG23 ' B' ' 64' ' ' VAL . 71.2 mt -64.89 -51.86 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.449 -0.574 . . . . 74.33 109.449 173.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.52 HG22 ' OG ' ' C' ' 119' ' ' SER . 14.4 m -58.19 -34.63 70.56 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 124.406 1.067 . . . . 74.44 111.902 -176.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 25.7 t -58.86 -52.25 66.55 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 124.028 0.83 . . . . 74.53 109.46 175.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.2 mmt -69.28 -33.46 73.24 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.496 0.719 . . . . 75.32 111.417 -174.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.04 -44.33 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.974 0.91 . . . . 63.31 110.496 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -69.48 -32.17 70.9 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.178 -0.919 . . . . 61.45 111.209 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.1 mtt-85 -67.7 -37.97 83.02 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.393 -0.821 . . . . 72.32 109.357 175.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.43 4.14 64.86 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 124.161 0.913 . . . . 73.32 113.237 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.461 HG21 ' HB3' ' A' ' 17' ' ' TYR . 82.1 p 58.8 32.07 21.85 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.169 1.787 . . . . 71.21 113.12 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -95.47 154.25 39.36 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 124.203 1.001 . . . . 71.44 110.972 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.426 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 81.2 Cg_exo -49.92 158.77 1.97 Allowed 'Trans proline' 0 C--N 1.39 2.731 0 C-N-CA 124.299 3.333 . . . . 64.42 115.652 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.431 HE21 ' ND2' ' B' ' 127' ' ' ASN . 67.6 tp60 -63.94 130.75 45.34 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 114.636 -1.166 . . . . 75.01 112.251 -172.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 68.6 tp -141.53 123.77 15.63 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.938 0.895 . . . . 71.0 109.709 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.431 ' ND2' HE21 ' B' ' 125' ' ' GLN . 51.0 m-80 -130.49 136.36 48.9 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.209 -1.034 . . . . 74.43 108.209 168.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' B' ' 111' ' ' ARG . 1.9 mm? -82.93 119.66 24.7 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.457 -0.942 . . . . 75.54 108.457 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.02 150.37 71.64 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.183 0.593 . . . . 72.43 111.054 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.09 140.58 41.78 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.061 2.508 . . . . 75.14 112.817 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' F' ' 464' ' ' MET . 61.6 t -127.38 145.6 34.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.446 -1.316 . . . . 71.44 107.446 167.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -66.61 101.51 0.79 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.605 0.762 . . . . 73.0 110.902 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -61.11 -32.58 72.26 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.004 0.521 . . . . 75.11 110.126 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -69.78 -52.61 23.75 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.407 1.083 . . . . 60.13 111.193 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.19 -44.4 95.12 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 123.707 0.63 . . . . 64.43 111.184 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 66.7 mt -61.2 -37.48 83.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.959 0.504 . . . . 74.21 111.44 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' B' ' 140' ' ' TYR . 72.4 t80 -68.17 -46.35 70.99 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.53 0.519 . . . . 73.43 110.733 -176.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 26.0 ptm -69.51 -25.42 64.03 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 117.772 0.26 . . . . 72.54 110.953 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.406 ' ND2' ' HG2' ' B' ' 144' ' ' GLN . 0.9 OUTLIER -74.84 -29.26 61.0 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.63 0.772 . . . . 72.33 110.621 175.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' B' ' 137' ' ' PHE . 24.0 t80 -62.63 -38.24 89.49 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.445 0.698 . . . . 73.54 109.893 171.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 8.1 mt -81.21 -2.45 48.76 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.189 -0.914 . . . . 74.42 110.929 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 71.52 6.67 5.8 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.645 1.578 . . . . 74.53 111.89 -177.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -89.48 87.83 7.22 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.962 -0.755 . . . . 75.42 108.962 176.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.406 ' HG2' ' ND2' ' B' ' 139' ' ' ASN . 5.0 tm0? -120.11 98.35 6.03 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.802 -1.185 . . . . 74.33 107.802 -176.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.86 86.68 2.95 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.859 0.463 . . . . 64.31 110.163 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . 0.556 ' HA3' ' HG2' ' D' ' 8' ' ' GLU . . . 85.46 132.99 2.9 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.716 -0.675 . . . . 51.21 113.2 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -102.19 153.78 19.64 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.455 0.702 . . . . 73.4 109.948 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -73.48 109.6 2.85 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.968 -0.56 . . . . 53.15 112.053 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.1 t -80.79 172.0 14.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.943 0.897 . . . . 75.13 110.424 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -145.41 80.01 1.59 Allowed 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.694 0.759 . . . . 75.13 112.813 -170.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -75.01 84.1 2.26 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.629 0.771 . . . . 75.03 109.919 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -80.74 94.0 6.31 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.598 -0.728 . . . . 64.43 109.106 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . 0.665 ' HG3' ' HB3' ' D' ' 1' ' ' MET . 22.8 tm0? -66.47 130.96 44.96 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.475 -0.935 . . . . 74.12 108.475 173.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.95 111.31 6.24 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.062 0.545 . . . . 53.53 110.102 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 C-N-CA 124.022 0.929 . . . . 63.34 109.143 -177.012 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.343 0.592 . . . . 71.44 109.423 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -163.96 106.28 0.93 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.338 1.055 . . . . 71.22 108.631 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -151.57 -44.06 0.11 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.585 0.754 . . . . 71.55 109.988 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -119.69 21.08 12.17 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.229 1.012 . . . . 74.14 109.24 175.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -71.17 104.09 2.97 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.418 1.087 . . . . 63.32 110.3 -172.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 t30 65.72 95.65 0.06 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.861 0.865 . . . . 72.32 109.742 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 29.5 m -126.19 101.04 6.58 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.362 0.665 . . . . 74.23 110.622 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -71.79 105.97 3.97 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.241 -0.651 . . . . 74.41 109.241 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.428 ' SD ' HD11 ' C' ' 89' ' ' ILE . 60.6 ttp 64.75 113.82 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.214 1.406 . . . . 72.54 111.453 -172.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.604 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 43.6 m -93.28 91.38 7.21 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.84 -0.8 . . . . 73.04 108.84 173.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.562 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 6.0 t80 -110.03 124.81 52.11 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.827 -0.805 . . . . 75.43 108.827 174.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -145.83 134.19 21.87 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.601 0.76 . . . . 72.15 109.162 171.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.406 HG21 HD13 ' C' ' 16' ' ' ILE . 67.2 mt -78.17 122.44 33.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.323 -0.991 . . . . 73.31 108.323 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.621 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 82.4 mm-40 -89.77 -42.19 11.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.217 -0.901 . . . . 74.42 110.639 -175.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.4 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 17.6 ttt180 -175.6 129.82 0.26 Allowed 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.384 0.427 . . . . 74.04 110.214 -168.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.406 HD13 HG21 ' C' ' 13' ' ' ILE . 66.5 mt -121.77 131.8 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.636 -0.876 . . . . 70.04 108.636 -177.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.478 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 32.6 p90 -171.36 173.09 4.96 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.706 0.765 . . . . 73.44 111.311 -169.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.3 p -95.88 119.58 34.64 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.32 -0.855 . . . . 71.04 109.572 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.478 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 21.8 mmtp -65.32 -47.74 75.49 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 107.581 -1.266 . . . . 73.0 107.581 169.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 21.9 t70 -144.04 143.84 31.36 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 113.352 -1.749 . . . . 70.32 109.936 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.3 mt -129.96 144.36 38.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.475 -1.676 . . . . 73.4 106.475 172.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -152.53 147.25 25.98 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.35 0.595 . . . . 71.13 109.712 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -144.55 137.06 26.53 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.451 -1.314 . . . . 75.23 107.451 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -135.22 131.43 36.67 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.858 0.863 . . . . 74.51 109.352 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.28 76.63 5.65 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 106.799 -1.556 . . . . 62.13 106.799 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.66 -42.0 5.38 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.229 1.953 . . . . 75.31 111.429 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -96.96 29.04 3.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.525 1.13 . . . . 74.51 110.595 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.401 ' HB2' ' HE2' ' D' ' 17' ' ' TYR . . . -51.63 -55.87 25.97 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.201 -0.904 . . . . 74.13 113.408 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.5 -32.9 70.18 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 121.723 1.615 . . . . 73.34 112.684 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -67.99 -44.48 76.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.081 0.553 . . . . 72.31 110.859 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.8 p -77.17 -22.65 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 112.708 0.632 . . . . 74.01 112.708 -173.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -63.72 -33.6 76.02 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.22 0.452 . . . . 74.42 112.22 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -85.79 11.18 11.68 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.471 0.308 . . . . 71.13 111.572 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.791 ' HG2' HD12 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -89.95 158.51 17.36 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.505 0.722 . . . . 74.43 109.978 175.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -65.17 129.0 38.11 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.942 0.897 . . . . 73.53 109.791 165.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 58.9 t90 -82.03 94.16 7.12 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.386 0.674 . . . . 74.14 111.312 -172.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -141.39 76.15 21.65 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.644 0.778 . . . . 74.12 108.934 172.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -83.54 126.98 4.25 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.118 2.545 . . . . 54.1 113.252 -175.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.37 103.38 13.49 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.271 -1.381 . . . . 74.05 107.271 168.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 19.6 m -88.33 103.56 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.155 0.979 . . . . 74.41 110.855 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.543 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 82.7 tttt -93.87 104.11 16.19 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.802 -1.09 . . . . 75.2 108.644 177.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.51 ' HG ' ' HE1' ' G' ' 464' ' ' MET . 3.1 mm? -87.13 136.72 32.82 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.351 -0.981 . . . . 74.21 108.351 176.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -130.88 105.34 7.7 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.927 -0.768 . . . . 73.02 108.927 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mp -103.19 135.02 45.63 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.239 -1.023 . . . . 73.45 108.239 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.446 ' HA ' ' HG ' ' G' ' 460' ' ' LEU . 24.6 t70 -151.44 155.48 38.67 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.515 0.726 . . . . 72.34 110.061 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -139.04 146.72 41.16 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.128 0.571 . . . . 75.34 109.719 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.84 146.66 43.71 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.153 0.981 . . . . 71.22 108.949 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.1 p -137.0 151.78 49.38 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.111 0.564 . . . . 73.14 110.297 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 86.4 p -149.41 157.94 43.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.854 0.862 . . . . 72.33 109.76 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -89.36 118.77 29.27 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.982 -0.747 . . . . 74.5 108.982 174.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.525 HD12 HD13 ' C' ' 83' ' ' ILE . 57.5 mt -90.8 -40.3 11.87 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.299 0.571 . . . . 63.24 109.779 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.71 177.82 10.28 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 114.395 -1.275 . . . . 62.12 108.95 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.64 119.56 14.06 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 109.264 -0.643 . . . . 73.31 109.264 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 66.92 21.81 10.27 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.545 1.138 . . . . 74.4 111.15 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 65.9 t -126.69 101.61 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.855 1.262 . . . . 73.14 108.158 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.584 ' HB2' HD13 ' C' ' 86' ' ' ILE . 0.2 OUTLIER -104.23 138.04 41.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.173 -0.677 . . . . 73.51 109.173 177.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.49 ' HB2' HD12 ' C' ' 51' ' ' LEU . 29.1 tt0 -85.57 137.75 32.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.577 -1.192 . . . . 73.31 108.667 166.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 t -122.18 139.54 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.682 -1.229 . . . . 72.42 107.682 167.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 49.6 t -131.79 131.94 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 108.545 -0.909 . . . . 73.54 108.545 175.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.21 109.35 21.01 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.802 -1.555 . . . . 73.51 106.802 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.408 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 5.8 tmm_? -99.5 105.73 17.67 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.748 -1.204 . . . . 74.34 107.748 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.474 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.3 t -107.77 138.37 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.478 -0.934 . . . . 64.44 108.478 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 35.7 m -134.04 121.22 21.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.35 -0.611 . . . . 74.03 109.35 171.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.547 HG12 HD13 ' C' ' 126' ' ' LEU . 59.7 t -106.35 111.72 36.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 114.885 -1.052 . . . . 73.45 109.014 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 7.0 m -103.36 142.72 33.74 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.213 -0.903 . . . . 72.11 109.42 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.88 120.71 19.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.716 -1.216 . . . . 74.32 107.716 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.6 m -140.44 128.0 21.5 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.565 0.541 . . . . 71.34 110.816 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.791 HD12 ' HG2' ' C' ' 34' ' ' LYS . 8.5 mt -89.27 31.63 0.89 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.174 1.39 . . . . 74.1 110.813 -176.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.67 -105.42 0.95 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 109.808 -1.317 . . . . 64.21 109.808 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.13 -18.08 17.87 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.981 0.913 . . . . 64.44 110.053 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.671 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 5.7 tp10 -76.37 119.17 19.88 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.898 0.879 . . . . 75.14 109.515 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 44.8 m -76.98 128.42 34.48 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.261 -0.644 . . . . 74.24 109.261 172.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.562 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -78.39 -56.39 4.49 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.287 -1.005 . . . . 73.34 108.287 170.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . 0.541 ' HZ ' HD12 ' C' ' 126' ' ' LEU . 41.5 p90 -163.83 174.31 11.71 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.359 0.663 . . . . 74.33 110.716 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.12 107.68 5.07 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.37 -1.344 . . . . 74.25 107.37 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -110.58 143.43 41.0 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.827 -0.805 . . . . 63.43 108.827 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.81 134.39 15.44 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.348 0.659 . . . . 63.24 109.646 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.1 t -135.89 119.54 24.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 124.281 1.032 . . . . 64.01 109.19 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.408 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 54.3 mt-30 -92.17 88.27 6.43 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.58 -0.896 . . . . 72.3 108.58 170.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -79.64 99.49 7.39 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.736 -0.665 . . . . 60.12 109.785 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.22 144.2 16.97 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 116.416 -0.356 . . . . 71.52 112.518 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.562 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -149.23 135.4 5.35 Favored Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 110.536 -1.026 . . . . 42.54 110.536 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 8.8 mm -94.8 127.01 47.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.429 -0.952 . . . . 72.54 108.429 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.562 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 47.0 m-85 -134.22 118.38 17.55 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.251 -0.648 . . . . 75.12 109.251 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 53.8 m -75.7 132.92 40.84 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.219 -0.66 . . . . 74.4 109.219 175.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.584 HD13 ' HB2' ' C' ' 56' ' ' TYR . 1.1 pp -134.38 107.23 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.189 0.996 . . . . 74.35 109.219 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.604 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -130.25 157.71 41.75 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.898 -0.779 . . . . 72.42 108.898 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.22 -42.8 3.02 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 123.15 0.281 . . . . 74.13 113.22 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.428 HD11 ' SD ' ' C' ' 9' ' ' MET . 46.4 pt -93.26 169.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.544 0.738 . . . . 71.54 110.445 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -170.47 171.88 6.29 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 124.012 0.82 . . . . 73.33 109.622 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.87 -123.64 7.53 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.777 -0.457 . . . . 65.42 112.755 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 69.1 p -68.44 -29.24 67.84 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.418 0.687 . . . . 62.14 111.234 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -64.16 -51.23 64.85 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.244 1.017 . . . . 72.23 110.645 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.671 ' HE2' HD12 ' G' ' 454' ' ' LEU . 21.2 ptm -74.01 -28.18 61.32 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.284 0.365 . . . . 74.4 110.564 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.528 ' HA ' HD22 ' G' ' 454' ' ' LEU . . . -58.11 -43.98 87.45 Favored 'General case' 0 C--N 1.362 1.135 0 O-C-N 123.682 0.614 . . . . 73.2 109.594 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -77.61 -42.05 36.38 Favored 'General case' 0 C--O 1.245 0.863 0 O-C-N 123.562 0.539 . . . . 71.11 111.809 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -61.79 -39.03 90.25 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.058 0.849 . . . . 71.24 110.693 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.47 HD12 HG12 ' C' ' 86' ' ' ILE . 33.5 mt -101.3 -17.01 16.75 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 122.888 0.475 . . . . 75.11 111.74 -177.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' C' ' 137' ' ' PHE . . . -77.2 -29.2 56.9 Favored Glycine 0 C--N 1.354 1.583 0 N-CA-C 114.558 0.583 . . . . 55.21 114.558 -175.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.12 -36.09 0.09 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 120.805 0.336 . . . . 63.54 111.736 -169.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.53 -45.88 74.43 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.267 1.427 . . . . 75.31 112.125 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 55.5 m -76.68 -42.56 2.98 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 118.625 -0.702 . . . . 71.01 112.734 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.31 -27.35 57.03 Favored 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 122.194 1.929 . . . . 73.43 113.832 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -66.74 -36.92 83.6 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.519 0.727 . . . . 64.01 110.845 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.453 HG23 ' NH1' ' A' ' 111' ' ' ARG . 44.2 mm -63.18 -38.28 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.352 0.661 . . . . 73.02 109.617 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.562 HD23 ' HA3' ' C' ' 82' ' ' GLY . 90.9 mt -81.83 -18.12 45.04 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.808 -1.087 . . . . 74.42 112.765 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -60.49 -48.67 92.99 Favored Pre-proline 0 CA--C 1.561 1.371 0 N-CA-C 114.133 1.16 . . . . 74.24 114.133 -172.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -62.85 -34.11 73.26 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.845 1.697 . . . . 63.23 112.7 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -70.05 -45.64 66.67 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.47 0.708 . . . . 74.51 111.013 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.38 95.79 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 115.834 -0.621 . . . . 72.43 109.613 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.541 ' HG3' HD23 ' C' ' 128' ' ' LEU . 65.3 ttt180 -57.45 -52.85 63.73 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 124.599 1.187 . . . . 75.32 111.341 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.43 -31.33 71.44 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.921 0.488 . . . . 71.33 110.584 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.8 t -73.06 -34.5 66.3 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.965 0.506 . . . . 72.23 111.132 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.474 HD11 ' HB ' ' C' ' 62' ' ' VAL . 83.8 mt -68.59 -53.71 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.261 0.624 . . . . 64.45 109.591 174.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.3 m -63.19 -28.27 69.93 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.205 1.002 . . . . 72.24 111.389 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.8 t -64.05 -51.93 61.79 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.359 0.663 . . . . 72.44 109.417 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.572 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.55 -32.13 73.04 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.3 1.04 . . . . 70.21 112.766 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.549 HG22 HD11 ' C' ' 126' ' ' LEU . 71.7 t -67.02 -46.59 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.664 0.786 . . . . 70.3 110.095 174.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.52 ' OG ' HG22 ' B' ' 115' ' ' THR . 36.9 t -63.51 -34.86 78.71 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.045 -0.979 . . . . 74.54 111.445 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -69.29 -43.57 73.57 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.305 -0.861 . . . . 74.43 109.355 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.75 -4.87 72.41 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.783 0.677 . . . . 71.12 112.802 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.463 HG21 ' HB3' ' D' ' 17' ' ' TYR . 27.5 p 61.9 34.83 16.7 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.776 2.03 . . . . 73.41 113.138 174.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -88.09 159.74 47.56 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.397 1.079 . . . . 73.22 109.704 171.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.1 164.34 8.53 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 123.373 2.715 . . . . 71.41 114.639 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -55.32 133.22 49.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.871 1.268 . . . . 73.34 113.001 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.549 HD11 HG22 ' C' ' 118' ' ' VAL . 36.2 mt -117.38 108.77 15.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.794 0.837 . . . . 71.53 109.607 170.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.7 110.97 22.52 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.491 -0.929 . . . . 75.45 108.491 174.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.541 HD23 ' HG3' ' C' ' 111' ' ' ARG . 3.7 mm? -76.6 133.14 39.74 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.627 -0.509 . . . . 75.41 109.627 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.08 139.6 82.45 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 124.054 0.846 . . . . 74.12 111.133 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.449 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 43.0 Cg_endo -67.58 96.43 0.42 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.647 2.231 . . . . 74.53 111.99 173.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.23 116.05 39.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.482 -1.303 . . . . 74.34 107.482 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -78.19 79.28 4.65 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.584 -0.895 . . . . 71.25 108.584 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -55.8 -34.22 65.12 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.867 0.867 . . . . 73.53 110.814 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -60.48 -51.29 70.09 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.854 1.262 . . . . 62.24 111.451 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.1 -38.8 92.39 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.046 0.539 . . . . 62.1 111.088 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.35 -27.8 67.43 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.374 -0.83 . . . . 71.15 111.338 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.417 ' CE2' ' HA3' ' C' ' 99' ' ' GLY . 3.4 t80 -81.93 -31.28 31.41 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.283 0.633 . . . . 71.2 110.179 176.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 26.1 ttt -71.22 -39.59 71.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.384 0.674 . . . . 62.13 110.61 -173.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -73.1 -35.93 66.68 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.637 -0.711 . . . . 64.4 110.818 171.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -63.2 -85.13 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.816 1.246 . . . . 75.52 111.089 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -119.58 81.89 1.79 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.753 0.821 . . . . 74.43 109.146 -177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -166.54 -91.56 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 107.832 -1.173 . . . . 74.12 107.832 169.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -138.91 -78.3 0.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.036 -0.728 . . . . 75.41 109.036 169.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -149.83 158.62 44.34 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.522 0.729 . . . . 75.21 110.237 -171.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -163.5 -177.4 5.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.656 0.782 . . . . 73.43 110.76 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.24 29.37 45.65 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 115.669 -0.696 . . . . 75.24 112.828 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.25 -66.82 0.68 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.111 0.964 . . . . 74.12 111.361 -173.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.25 19.2 44.55 Favored Glycine 0 C--N 1.355 1.594 0 CA-C-N 116.648 -0.251 . . . . 71.3 113.121 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.51 HG21 ' HD1' ' A' ' 11' ' ' PHE . 59.1 p -126.2 160.65 29.68 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.055 0.942 . . . . 71.11 110.01 -177.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 8.5 tp10 -153.88 128.32 9.22 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.335 -0.987 . . . . 73.11 108.335 173.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.13 101.95 0.96 Allowed 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.24 -1.022 . . . . 65.23 108.24 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -70.71 88.31 0.71 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.521 -0.918 . . . . 71.44 108.521 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -140.72 83.11 1.88 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.296 -2.113 . . . . 72.51 105.296 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -69.53 137.78 52.75 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.039 -0.982 . . . . 72.44 110.364 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 C-N-CA 123.345 0.658 . . . . 70.42 110.157 -176.384 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.665 ' HB3' ' HG3' ' B' ' 153' ' ' GLN . 12.0 tpt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 108.591 -0.892 . . . . 74.04 108.591 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -78.77 80.82 5.11 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.777 0.831 . . . . 74.21 110.335 -176.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.63 99.63 1.7 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 107.485 -1.302 . . . . 63.0 107.485 174.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -56.17 99.03 0.03 OUTLIER 'General case' 0 C--N 1.359 0.995 0 C-N-CA 124.098 0.959 . . . . 73.41 111.984 -168.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -67.7 101.59 1.07 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.732 -1.122 . . . . 73.22 109.032 173.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -79.06 70.97 5.5 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.593 0.757 . . . . 72.23 109.509 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -171.87 -156.46 0.1 Allowed 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.723 1.209 . . . . 73.43 107.992 -169.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.556 ' HG2' ' HA3' ' B' ' 146' ' ' GLY . 9.2 mp0 -77.08 131.68 38.49 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.007 0.923 . . . . 64.34 109.87 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.571 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 20.9 ptm -33.59 147.72 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.392 1.477 . . . . 73.35 114.476 168.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.482 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 86.5 m -118.15 141.83 48.08 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.365 0.666 . . . . 74.13 110.207 175.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -156.25 103.83 2.2 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.355 -1.35 . . . . 74.41 107.355 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -125.86 147.28 49.5 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.417 -0.957 . . . . 74.52 108.417 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.44 HG21 HD13 ' D' ' 16' ' ' ILE . 8.7 mt -95.85 129.51 45.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.71 -0.848 . . . . 74.21 108.71 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -87.08 -37.35 17.5 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.457 0.703 . . . . 73.12 111.711 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -167.82 124.71 1.12 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.004 0.372 . . . . 75.25 112.004 -170.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.44 HD13 HG21 ' D' ' 13' ' ' ILE . 2.0 mp -104.15 132.49 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.133 -1.432 . . . . 63.51 107.133 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.463 ' HB3' HG21 ' C' ' 122' ' ' THR . 21.6 p90 -162.91 153.21 16.32 Favored 'General case' 0 C--N 1.337 0.061 0 O-C-N 123.652 0.595 . . . . 75.43 110.908 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -84.32 123.33 30.06 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.874 -0.787 . . . . 72.54 108.874 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.8 mtpt -92.25 -22.91 19.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.46 -0.57 . . . . 73.31 109.46 175.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.3 t70 -152.52 140.24 19.9 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.612 0.765 . . . . 75.24 109.496 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.572 HG23 ' HE1' ' C' ' 117' ' ' MET . 78.0 mt -139.83 145.6 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.805 -1.183 . . . . 74.24 107.805 174.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 58.6 m -148.5 121.45 8.78 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.431 1.093 . . . . 72.51 109.718 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.526 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 92.6 t80 -124.13 117.68 25.18 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.296 -1.742 . . . . 74.2 106.296 166.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.59 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 31.6 mt-10 -127.92 109.29 11.45 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.62 -0.511 . . . . 73.1 109.62 -174.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.41 85.91 17.04 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 108.099 -1.075 . . . . 73.52 108.099 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.83 -26.93 15.19 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.502 2.134 . . . . 75.34 112.092 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -104.24 8.37 36.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.884 0.874 . . . . 74.31 110.259 -174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -32.99 -68.68 0.15 Allowed Pre-proline 0 CA--C 1.567 1.617 0 N-CA-C 116.32 1.97 . . . . 73.32 116.32 -165.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.533 ' HB3' HD11 ' C' ' 83' ' ' ILE . 75.7 Cg_endo -73.06 -21.49 20.55 Favored 'Trans proline' 0 C--N 1.384 2.423 0 CA-C-N 123.598 2.321 . . . . 65.44 113.699 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -74.47 -39.84 62.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.823 1.249 . . . . 72.5 110.004 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' D' ' 73' ' ' ALA . 7.4 p -83.67 -24.74 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.076 0.55 . . . . 74.15 112.274 -170.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.92 -19.03 63.84 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 122.867 0.467 . . . . 73.5 112.157 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -69.03 0.06 5.07 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.348 1.059 . . . . 73.14 111.933 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -110.72 100.85 9.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.881 1.272 . . . . 74.21 109.949 168.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.31 90.01 4.96 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.341 0.591 . . . . 74.44 109.598 171.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.453 ' CH2' ' HB2' ' D' ' 39' ' ' GLU . 19.7 t90 -154.32 156.11 36.34 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.1 -1.444 . . . . 71.55 107.1 174.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -70.58 107.88 2.98 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.398 -1.334 . . . . 75.41 107.398 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.423 ' O ' HG13 ' D' ' 40' ' ' VAL . 50.6 Cg_exo -55.21 125.55 19.53 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.89 2.394 . . . . 70.42 111.473 -171.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.453 ' HB2' ' CH2' ' D' ' 36' ' ' TRP . 34.1 tt0 -58.48 110.66 1.02 Allowed 'General case' 0 C--N 1.353 0.756 0 O-C-N 124.172 0.92 . . . . 75.24 109.667 -177.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.52 HG22 HD11 ' H' ' 470' ' ' LEU . 16.2 m -98.25 122.36 49.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 121.607 0.717 . . . . 74.23 110.455 -171.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.407 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 53.3 tttm -86.27 132.28 34.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 106.392 -1.707 . . . . 63.22 106.392 165.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.589 HD22 ' SD ' ' H' ' 464' ' ' MET . 0.4 OUTLIER -126.21 109.15 12.0 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.326 -0.99 . . . . 74.15 108.326 -169.008 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -127.41 149.75 49.94 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.387 1.075 . . . . 64.04 108.387 -176.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.499 HD21 HD23 ' D' ' 60' ' ' LEU . 8.4 tt -139.43 139.25 37.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.076 -0.713 . . . . 75.53 109.076 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -133.54 139.7 46.75 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.384 1.474 . . . . 74.3 107.31 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -105.82 164.73 11.71 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.074 -0.713 . . . . 74.1 109.074 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.54 160.55 40.61 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.879 0.872 . . . . 73.11 108.899 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -159.15 151.22 20.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.053 0.541 . . . . 73.33 110.046 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.2 p -160.64 129.84 4.88 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.053 0.941 . . . . 74.33 109.167 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -73.93 133.64 43.09 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.19 0.596 . . . . 73.25 110.251 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 54.2 mt -100.76 -34.5 9.81 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.248 0.619 . . . . 74.45 110.717 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.96 -176.24 5.38 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.807 0.843 . . . . 73.25 109.974 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.85 121.62 14.48 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.108 -0.951 . . . . 74.41 109.933 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 65.61 2.93 2.23 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.886 1.275 . . . . 75.22 113.101 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.0 t -112.67 116.41 52.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.327 -0.99 . . . . 72.34 108.327 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -133.53 130.48 38.53 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.091 -1.077 . . . . 74.42 108.091 -171.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -98.65 143.81 28.62 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.923 0.889 . . . . 74.52 109.48 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 54.8 t -120.04 137.66 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.78 -1.193 . . . . 75.41 107.78 166.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.455 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.3 t -116.0 126.58 73.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.788 -1.19 . . . . 71.51 107.788 175.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.499 HD23 HD21 ' D' ' 44' ' ' LEU . 0.0 OUTLIER -104.17 117.41 34.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.619 -0.882 . . . . 71.44 108.619 -177.268 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -102.84 96.35 6.78 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.66 -0.867 . . . . 73.52 108.66 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 50.7 t -96.31 130.22 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.21 -1.033 . . . . 73.01 108.21 170.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 19.2 m -128.9 132.99 47.73 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.273 0.629 . . . . 73.13 110.446 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 69.1 t -126.29 112.39 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.736 1.214 . . . . 74.43 109.555 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 30.7 m -103.1 96.04 6.52 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.493 0.717 . . . . 75.14 109.301 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.13 153.83 17.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.95 0.5 . . . . 71.22 111.2 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.6 p -152.37 127.63 9.86 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.925 -0.579 . . . . 73.14 111.276 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 25.2 mt -95.76 101.71 13.43 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.967 -1.123 . . . . 73.41 107.967 170.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . 0.42 ' H ' ' HZ3' ' D' ' 36' ' ' TRP . . . 68.14 -118.6 9.63 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 123.63 0.581 . . . . 75.45 113.797 177.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.76 5.3 46.63 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.629 0.771 . . . . 71.34 113.053 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.21 164.49 32.11 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 120.89 0.376 . . . . 75.14 110.791 -174.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.1 m -68.15 132.03 46.47 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.045 -0.98 . . . . 73.13 110.697 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.588 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -86.74 -71.98 0.53 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.711 -1.218 . . . . 75.33 107.711 174.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -141.43 151.37 43.35 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 121.318 0.58 . . . . 73.35 110.436 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.59 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 72.2 mt -111.41 146.37 37.29 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.565 -1.272 . . . . 75.03 107.565 171.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.488 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.2 m -146.69 132.46 18.97 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.876 0.87 . . . . 74.34 108.686 -174.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -155.7 126.24 6.81 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.138 -1.06 . . . . 73.03 108.138 170.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.1 t -131.15 115.28 29.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 108.911 -0.774 . . . . 75.34 108.911 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 70.7 mt-30 -93.1 85.59 5.12 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.966 -0.753 . . . . 73.02 108.966 173.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.09 97.11 6.71 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.516 -1.22 . . . . 73.12 109.022 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.7 144.03 20.22 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.862 -0.495 . . . . 71.23 111.862 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.425 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -140.06 130.04 4.5 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 111.037 -0.825 . . . . 70.21 111.037 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.412 HG13 ' HE1' ' D' ' 17' ' ' TYR . 54.5 mt -90.54 123.95 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.989 -1.115 . . . . 75.34 107.989 177.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -123.95 136.06 54.07 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.638 0.775 . . . . 75.35 110.13 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 20.8 m -93.3 112.08 23.91 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.442 -0.947 . . . . 73.42 108.442 171.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 31.4 pt -108.19 122.27 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-O 121.19 0.519 . . . . 73.24 110.211 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.482 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -147.47 154.41 40.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.529 1.132 . . . . 51.32 109.072 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 81.23 -19.63 7.98 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 114.054 0.382 . . . . 71.2 114.054 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -127.3 154.49 37.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 124.448 1.099 . . . . 72.13 109.332 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' H' ' 450' ' ' ASN . 0.0 OUTLIER -163.49 159.39 22.03 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 123.632 0.582 . . . . 75.34 110.695 -174.013 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.61 -99.16 0.08 OUTLIER Glycine 0 C--N 1.355 1.597 0 O-C-N 124.218 0.949 . . . . 71.35 114.763 170.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 25.6 m -68.42 -44.38 75.12 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.246 1.018 . . . . 74.33 111.453 -174.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.507 HE21 ' HB2' ' D' ' 152' ' ' HIS . 7.2 tp-100 -72.61 -29.54 63.58 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.056 -0.52 . . . . 73.34 110.563 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.443 ' SD ' ' HA ' ' H' ' 452' ' ' VAL . 35.1 ttp -60.25 -34.97 74.45 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 123.662 0.601 . . . . 75.03 110.35 174.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.16 82.07 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 122.306 -0.247 . . . . 73.24 111.438 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -80.08 -43.94 20.9 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.284 0.634 . . . . 74.45 111.945 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 43.8 t -74.29 -42.57 59.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.361 0.664 . . . . 75.25 110.703 -172.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.543 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 15.0 tp -87.93 -33.84 18.32 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.362 1.065 . . . . 73.2 110.45 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.22 -26.09 29.37 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-N 116.356 -0.383 . . . . 73.34 113.948 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.18 -57.88 2.04 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 117.186 0.493 . . . . 71.15 111.389 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -70.13 -33.83 72.3 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.553 0.575 . . . . 73.51 112.553 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 69.4 m -67.36 -49.55 42.49 Favored Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 118.477 -0.773 . . . . 60.11 111.825 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.38 -30.06 90.13 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 121.864 1.71 . . . . 62.41 113.727 168.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -64.78 -37.98 89.44 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.516 0.726 . . . . 75.03 110.118 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 30.5 mm -62.94 -45.48 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.722 0.809 . . . . 75.32 110.873 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.425 HD22 ' HA3' ' D' ' 82' ' ' GLY . 83.2 mt -77.25 -18.18 57.82 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.926 -1.034 . . . . 71.22 112.399 -170.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -69.69 -42.12 18.15 Favored Pre-proline 0 N--CA 1.486 1.329 0 N-CA-C 113.914 1.079 . . . . 73.01 113.914 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.69 -41.75 60.12 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.033 1.822 . . . . 52.23 113.107 169.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -75.36 -35.15 61.17 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.975 0.91 . . . . 73.41 111.6 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.24 -46.55 67.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.01 0.524 . . . . 71.43 110.192 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -53.67 -49.12 68.67 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.751 1.282 . . . . 75.03 110.73 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.72 -45.77 92.54 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.308 1.005 . . . . 75.33 111.977 -175.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.4 t -63.15 -39.57 95.06 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.63 0.581 . . . . 64.34 111.231 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.432 ' O ' HG23 ' D' ' 118' ' ' VAL . 86.2 mt -59.76 -55.49 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.554 0.741 . . . . 73.31 110.093 172.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 38.3 m -56.68 -40.16 75.08 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.804 1.242 . . . . 74.41 112.005 -174.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -68.35 -40.62 81.48 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.06 -0.973 . . . . 74.33 110.561 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.526 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 68.5 mtm -68.33 -33.2 73.88 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.611 0.365 . . . . 71.21 111.524 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.432 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.8 t -63.65 -43.46 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.601 0.761 . . . . 64.43 110.36 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.89 -30.93 61.45 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 116.178 -0.464 . . . . 71.14 111.206 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -74.18 -26.15 60.12 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.205 0.602 . . . . 75.22 110.32 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.44 7.96 74.94 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.646 0.591 . . . . 71.55 112.404 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 44.3 p 61.11 17.21 7.84 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.514 1.926 . . . . 72.03 114.81 174.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.09 150.97 72.44 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 109.558 -0.534 . . . . 73.35 109.558 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.6 127.87 22.04 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.116 2.544 . . . . 71.52 111.448 171.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -51.65 145.31 9.39 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.676 1.235 . . . . 74.41 113.007 -171.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 56.8 tp -117.05 106.19 13.11 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.692 -0.686 . . . . 73.44 109.538 -175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -101.95 104.19 14.87 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.037 -0.727 . . . . 74.41 109.037 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.82 118.35 13.5 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.156 -0.683 . . . . 70.31 109.156 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 135.76 89.24 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.214 0.605 . . . . 75.31 110.137 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.84 119.34 6.35 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.63 2.22 . . . . 72.32 112.314 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 82.8 t -108.85 115.55 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.083 0.953 . . . . 74.32 108.916 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -77.79 113.2 15.42 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.943 0.497 . . . . 70.43 110.037 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -72.22 -35.88 68.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.684 0.793 . . . . 72.24 111.509 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.47 -50.35 74.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.412 1.085 . . . . 73.22 111.739 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.31 71.51 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.156 0.582 . . . . 64.25 110.636 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 34.4 mt -63.3 -23.76 67.56 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.41 0.684 . . . . 72.34 112.571 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -69.11 -39.45 78.93 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.654 0.782 . . . . 71.43 110.238 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 32.2 mtt -65.84 -28.9 69.32 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.135 -0.939 . . . . 73.25 110.131 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -70.31 -38.46 74.94 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.345 0.658 . . . . 60.12 110.662 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -62.36 -41.31 98.5 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.354 0.662 . . . . 70.35 111.288 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.9 mp -74.88 -29.02 60.88 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.552 0.741 . . . . 74.21 112.243 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -83.49 0.72 45.16 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 117.61 0.186 . . . . 74.34 111.19 177.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -121.23 46.91 1.94 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.13 0.572 . . . . 72.14 109.787 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -167.59 145.31 4.55 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.707 0.803 . . . . 74.24 109.859 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.39 78.38 5.91 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.508 0.67 . . . . 71.12 109.48 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.51 57.16 0.06 OUTLIER Glycine 0 C--N 1.344 1.026 0 CA-C-N 114.868 -1.06 . . . . 64.34 110.778 -177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -73.82 90.23 1.87 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 121.879 0.847 . . . . 74.35 110.983 -178.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -121.53 79.9 0.34 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.1 -1.2 . . . . 73.4 110.1 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 76.1 p -108.53 151.91 25.46 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.582 0.753 . . . . 73.52 110.133 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -144.12 154.12 42.86 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.794 0.838 . . . . 72.21 108.85 174.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.37 -87.6 0.3 Allowed 'General case' 0 CA--C 1.558 1.266 0 CA-C-O 118.17 -0.919 . . . . 74.2 111.114 -175.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . 0.507 ' HB2' HE21 ' D' ' 93' ' ' GLN . 57.0 m170 43.45 67.58 0.63 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.282 1.433 . . . . 75.21 112.983 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.26 14.09 0.99 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.674 -0.693 . . . . 71.01 111.385 -175.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -64.6 102.95 0.61 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.697 0.799 . . . . 75.55 110.659 -172.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 C-N-CA 124.291 1.036 . . . . 75.35 108.209 -176.38 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 109.123 -0.695 . . . . 71.11 109.123 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 62.0 t -140.21 -48.58 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.561 1.144 . . . . 75.42 108.571 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.4 150.53 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.401 1.08 . . . . 73.5 109.486 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -153.65 -71.82 0.01 OUTLIER Glycine 0 C--N 1.339 0.704 0 N-CA-C 110.494 -1.042 . . . . 73.25 110.494 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 10.6 mp 67.88 146.02 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.543 1.537 . . . . 73.21 112.145 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 61.6 p -70.44 110.46 5.36 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.265 -0.879 . . . . 64.04 108.694 170.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.69 178.29 5.53 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.218 0.607 . . . . 75.4 110.138 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 62.59 16.69 9.02 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 124.292 1.037 . . . . 75.13 112.221 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 48.6 m -90.13 -33.44 16.25 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.957 0.903 . . . . 74.12 110.539 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.47 -163.86 0.26 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.408 1.083 . . . . 74.52 110.355 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 53.6 tp -80.26 141.84 35.16 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.123 -1.066 . . . . 74.31 108.123 165.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -85.27 35.27 0.59 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.433 1.093 . . . . 75.31 111.229 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -168.73 143.89 3.36 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.967 0.907 . . . . 71.41 109.698 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 27.1 p -132.27 127.65 36.14 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.314 1.046 . . . . 75.14 108.232 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 464' ' ' MET . . . . . 0.571 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 52.8 tpp -80.16 136.46 36.51 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.858 0.463 . . . . 63.3 111.158 -174.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -142.47 86.54 1.96 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.262 -1.385 . . . . 74.5 107.262 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -159.29 169.51 23.9 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.296 -0.866 . . . . 72.2 110.241 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -67.42 113.21 5.1 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.789 0.835 . . . . 73.14 110.985 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 79.0 mt -94.9 -175.42 3.55 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.265 1.026 . . . . 75.22 109.691 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . 0.402 ' HA3' ' H ' ' A' ' 127' ' ' ASN . . . -48.35 -83.62 0.03 OUTLIER Glycine 0 N--CA 1.483 1.814 0 N-CA-C 115.429 0.932 . . . . 74.22 115.429 -173.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 58.14 20.14 6.73 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.371 1.069 . . . . 75.35 112.486 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 25.3 pttm . . . . . 0 C--O 1.262 1.734 0 C-N-CA 124.584 1.154 . . . . 75.41 109.427 179.595 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 109.853 -0.425 . . . . 74.04 109.853 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 33.4 m -82.04 -24.16 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 122.98 0.512 . . . . 72.43 110.063 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . 0.465 HG11 ' HB2' ' B' ' 50' ' ' GLN . 86.1 t -92.39 133.12 34.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.998 0.919 . . . . 74.55 109.534 174.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 171.72 62.44 0.04 OUTLIER Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.362 -0.695 . . . . 74.14 111.362 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . 0.615 HD22 ' HE2' ' B' ' 94' ' ' MET . 2.4 pt? -148.6 155.39 41.02 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.324 0.65 . . . . 75.52 109.755 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 41.7 p -108.87 122.65 47.63 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.969 -1.123 . . . . 74.14 107.969 171.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -73.42 151.03 41.28 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.491 0.317 . . . . 71.21 110.291 176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -92.77 122.76 35.49 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 109.166 -0.679 . . . . 72.22 109.166 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 28.8 m -86.84 54.43 3.17 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.457 1.122 . . . . 75.25 108.638 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -168.96 90.1 0.22 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.183 -1.371 . . . . 74.34 107.943 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' F' ' 462' ' ' TYR . 0.2 OUTLIER -77.57 121.96 24.62 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.725 -1.213 . . . . 73.15 107.725 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -81.04 48.05 1.07 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.907 1.283 . . . . 71.33 110.662 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . 0.714 ' HB2' HD12 ' F' ' 460' ' ' LEU . 7.2 t80 -85.3 94.55 8.96 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.94 -1.133 . . . . 74.32 107.94 -175.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 37.0 p -59.29 -57.96 10.72 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.979 0.8 . . . . 74.43 110.593 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 464' ' ' MET . . . . . 0.564 ' HA ' HG23 ' B' ' 131' ' ' VAL . 0.0 OUTLIER 67.88 111.03 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.198 1.399 . . . . 74.25 111.474 174.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -113.82 -25.18 8.75 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.275 0.63 . . . . 74.11 111.796 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -84.14 67.54 9.77 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.405 0.622 . . . . 75.44 111.475 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -72.88 151.2 42.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.467 0.707 . . . . 75.21 110.158 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . 0.525 HD21 ' H ' ' F' ' 468' ' ' LEU . 1.9 pt? -73.29 -1.9 19.8 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.008 0.523 . . . . 73.11 111.731 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 96.64 -41.09 2.43 Favored Glycine 0 C--N 1.357 1.744 0 C-N-CA 123.053 0.359 . . . . 75.43 113.134 171.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 61.13 29.82 19.05 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.66 1.184 . . . . 75.53 111.95 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . 0.6 ' HZ3' ' HB3' ' F' ' 471' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.078 0 N-CA-C 107.862 -1.162 . . . . 74.4 107.862 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 110.195 -0.298 . . . . 73.32 110.195 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 4.4 t 58.45 71.07 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.997 0 C-N-CA 124.806 1.242 . . . . 74.54 110.352 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.32 147.9 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.459 1.103 . . . . 74.24 110.387 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 141.01 32.79 0.14 Allowed Glycine 0 C--N 1.354 1.535 0 N-CA-C 114.462 0.545 . . . . 64.31 114.462 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . 0.671 HD12 ' HE2' ' C' ' 94' ' ' MET . 8.4 mp -110.0 165.18 11.93 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 117.565 0.683 . . . . 74.22 111.403 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 9.7 m 53.41 51.64 14.97 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.12 1.368 . . . . 74.52 110.411 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -93.47 -34.41 13.42 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 114.763 -1.108 . . . . 73.44 108.589 172.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -116.25 129.52 56.33 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.495 1.118 . . . . 74.43 108.306 166.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 89.2 m -84.0 95.93 8.7 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.275 0.63 . . . . 75.25 109.51 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -139.26 118.71 12.91 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.749 0.82 . . . . 75.52 109.028 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' C' ' 45' ' ' ASP . 1.0 OUTLIER -118.51 110.82 17.85 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.08 -1.452 . . . . 75.31 107.08 176.714 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -76.69 140.48 40.89 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.761 0.824 . . . . 75.41 110.085 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 72.5 t80 72.77 143.19 0.06 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.885 1.274 . . . . 74.01 112.571 172.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 12.8 t -157.7 170.57 22.08 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.255 1.022 . . . . 75.21 109.219 172.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 464' ' ' MET . . . . . 0.51 ' HE1' ' HG ' ' C' ' 42' ' ' LEU . 71.2 mtm -121.18 120.04 34.08 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.658 0.783 . . . . 63.43 110.43 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -113.39 124.26 52.03 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.537 -1.283 . . . . 73.52 107.537 172.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . 71.55 -17.14 0.35 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 124.882 1.273 . . . . 75.04 113.425 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -92.43 95.4 9.63 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.587 0.755 . . . . 54.1 110.817 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 1.4 tt -156.26 144.2 19.6 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 107.23 -1.396 . . . . 72.32 107.23 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -62.56 82.92 0.03 OUTLIER Glycine 0 C--N 1.35 1.332 0 O-C-N 123.581 0.55 . . . . 71.11 111.867 170.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 4.5 tt -158.93 -48.86 0.06 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.782 1.633 . . . . 70.4 107.323 -175.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 63.3 tttp . . . . . 0 C--O 1.247 0.966 0 C-N-CA 124.687 1.195 . . . . 75.44 107.995 179.545 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' D' ' 90' ' ' GLU . 53.8 t-20 . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 109.143 -0.688 . . . . 73.14 109.143 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . 0.572 HG12 HG11 ' H' ' 452' ' ' VAL . 14.3 p -60.57 -32.32 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.716 1.206 . . . . 73.41 111.028 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.572 HG11 HG12 ' H' ' 451' ' ' VAL . 32.1 m -113.79 158.84 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.321 1.048 . . . . 75.52 110.56 177.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 160.09 10.83 0.04 OUTLIER Glycine 0 N--CA 1.471 0.988 0 CA-C-N 115.821 -0.627 . . . . 61.43 112.966 -176.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . 0.412 ' HB2' ' HE1' ' D' ' 94' ' ' MET . 56.3 tp -91.55 128.87 37.55 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.787 0.835 . . . . 70.43 108.83 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 35.5 p -85.6 28.25 0.78 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.945 0.898 . . . . 73.34 111.334 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 19.1 t70 66.91 154.94 0.09 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.309 1.444 . . . . 74.14 112.153 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -108.11 114.48 28.42 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.502 0.721 . . . . 72.44 109.569 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 20.7 p -90.5 152.08 21.09 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 123.918 0.887 . . . . 75.32 108.913 172.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 23.4 t70 67.31 174.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.224 0.952 . . . . 73.1 109.435 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.72 144.48 20.44 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.809 -0.812 . . . . 74.51 108.809 169.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -80.08 40.1 0.46 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 126.803 2.041 . . . . 73.31 111.737 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -72.14 90.34 1.2 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.004 0.922 . . . . 72.52 110.613 -170.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 24.0 m -102.15 82.67 2.24 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.204 1.001 . . . . 72.45 109.165 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 464' ' ' MET . . . . . 0.589 ' SD ' HD22 ' D' ' 42' ' ' LEU . 27.4 ttt -84.71 99.48 10.87 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.696 -0.853 . . . . 51.35 108.696 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -72.1 -32.3 66.87 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.955 0.902 . . . . 75.3 112.161 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -130.14 139.11 50.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.198 0.599 . . . . 73.34 110.273 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -118.04 175.3 5.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.803 1.241 . . . . 63.32 108.369 173.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -58.19 -28.21 64.58 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.837 0.855 . . . . 75.35 112.588 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 108.07 115.19 3.87 Favored Glycine 0 C--N 1.354 1.556 0 N-CA-C 110.831 -0.907 . . . . 71.22 110.831 -176.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . 0.52 HD11 HG22 ' D' ' 40' ' ' VAL . 3.5 mm? -88.66 74.33 8.43 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.403 0.681 . . . . 75.33 111.074 -174.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 124.602 1.161 . . . . 75.1 108.199 173.604 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.431 ' N ' ' HA ' ' C' ' 150' ' ' GLU . 66.0 mtt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.211 -0.292 . . . . 73.14 110.211 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 p -162.57 -47.72 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.906 0.482 . . . . 75.21 112.036 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 67.97 29.72 6.35 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.483 1.113 . . . . 62.34 110.431 -162.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -101.77 99.58 9.83 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.472 0.709 . . . . 73.53 110.015 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -86.54 160.71 18.87 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 108.125 -1.065 . . . . 72.51 108.125 170.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.25 -38.26 88.57 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.457 0.703 . . . . 73.5 111.112 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 9' ' ' MET . 13.4 m 70.68 156.74 0.16 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.358 1.463 . . . . 75.03 111.791 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.56 -27.54 68.7 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.278 0.631 . . . . 71.22 111.024 173.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.566 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -110.79 168.12 9.72 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.845 0.858 . . . . 74.43 109.501 170.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.7 m -145.69 139.79 26.8 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.0 0.52 . . . . 74.14 109.82 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.7 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 17.3 t80 -127.14 131.07 50.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.303 1.041 . . . . 73.33 109.191 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 26.5 tp60 -147.79 107.34 3.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.276 0.631 . . . . 71.45 110.052 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.588 HG12 ' HD2' ' A' ' 84' ' ' PHE . 60.7 mt -75.02 120.58 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.586 -0.524 . . . . 72.44 109.586 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -89.63 -36.99 14.96 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 124.079 0.862 . . . . 73.04 110.027 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -169.15 146.0 3.52 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 110.454 -0.202 . . . . 73.23 110.454 -171.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.448 HD13 ' HG3' ' C' ' 130' ' ' PRO . 97.6 mt -137.9 128.37 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 124.544 1.138 . . . . 73.35 108.058 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -167.83 154.63 8.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.716 0.806 . . . . 74.02 111.205 -172.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.7 p -75.14 112.82 11.79 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.238 -0.652 . . . . 73.22 109.238 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HG3' ' HA3' ' A' ' 81' ' ' GLY . 32.6 mtpt -71.61 -34.35 69.78 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.251 -0.431 . . . . 63.53 110.481 174.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -153.79 148.65 26.57 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.056 -0.974 . . . . 74.52 109.111 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 22' ' ' SER . 80.9 mt -138.19 148.77 24.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 C-N-CA 124.947 1.299 . . . . 74.14 108.043 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.58 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 17.9 t -147.14 142.3 27.19 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.892 0.877 . . . . 74.42 109.93 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.538 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.3 t80 -153.06 132.88 13.2 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.625 1.17 . . . . 71.41 107.859 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -139.85 135.1 32.59 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.499 1.119 . . . . 72.0 108.34 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.06 87.46 48.39 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 108.32 -0.993 . . . . 74.13 108.32 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 37.3 Cg_exo -64.09 -48.65 4.7 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.608 2.872 . . . . 74.1 113.107 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -91.96 24.43 3.24 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.784 0.834 . . . . 74.13 111.169 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.473 ' HB1' ' HE2' ' B' ' 17' ' ' TYR . . . -53.07 -48.91 90.23 Favored Pre-proline 0 CA--C 1.568 1.638 0 N-CA-C 114.837 1.421 . . . . 65.14 114.837 -173.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.47 -19.73 16.62 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 121.742 1.628 . . . . 75.3 111.94 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -100.64 -13.42 18.56 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.074 -0.966 . . . . 75.1 112.29 -170.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.56 -26.04 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.798 0.839 . . . . 61.15 112.055 -169.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -78.9 -33.77 45.28 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.988 -1.006 . . . . 71.51 110.413 176.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -82.43 -32.19 29.14 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.917 0.887 . . . . 74.34 111.568 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.43 ' HZ1' ' HB2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -78.97 161.1 26.89 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.299 -0.63 . . . . 75.23 109.299 175.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.36 134.67 56.16 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.145 0.578 . . . . 74.53 110.059 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -95.69 85.88 4.26 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.343 0.657 . . . . 73.04 110.715 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.468 ' H ' HD12 ' A' ' 68' ' ' LEU . 79.7 mt-30 -135.58 68.53 66.74 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 123.648 0.779 . . . . 75.24 109.005 169.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -78.72 159.21 28.18 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.169 1.913 . . . . 74.24 111.867 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -106.73 105.69 15.85 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.042 -1.095 . . . . 75.35 108.042 173.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 p -74.62 93.35 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 122.363 1.078 . . . . 73.13 110.274 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 49.4 mtpt -85.82 115.56 23.54 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.347 -1.297 . . . . 74.41 108.279 172.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.541 HD22 ' HG3' ' E' ' 464' ' ' MET . 67.3 tp -116.05 134.8 54.56 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.146 -0.687 . . . . 75.22 109.146 174.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.669 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 32.4 t70 -128.62 146.68 50.79 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.301 1.04 . . . . 75.11 109.168 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.2 mt -128.45 125.09 37.79 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.184 0.994 . . . . 74.55 108.496 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 21.8 t0 -129.2 148.97 51.18 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.101 0.96 . . . . 70.12 109.413 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.561 ' HB ' HD22 ' E' ' 460' ' ' LEU . 59.0 m -144.14 138.42 28.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.252 1.021 . . . . 73.11 109.923 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.9 138.59 18.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.02 0.928 . . . . 64.34 109.324 169.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.6 m -90.36 162.42 15.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.138 0.575 . . . . 73.45 110.199 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.8 t -148.8 119.61 7.58 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.384 1.073 . . . . 63.42 108.231 -174.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -78.65 120.31 23.15 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.808 -0.442 . . . . 74.31 109.808 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.0 mt -92.17 -44.99 8.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.738 -0.838 . . . . 73.31 108.738 171.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.12 -178.88 6.75 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.157 -1.383 . . . . 74.43 108.88 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -74.57 133.34 42.24 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.897 -1.149 . . . . 73.31 107.897 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 70.27 -8.66 0.83 Allowed 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 125.489 1.516 . . . . 72.21 112.871 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.7 t -110.76 106.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 N-CA-C 108.863 -0.791 . . . . 74.23 108.863 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -130.36 121.65 26.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.732 0.777 . . . . 74.51 109.202 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -93.37 121.83 35.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 124.903 1.281 . . . . 64.32 109.396 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.07 132.97 45.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.898 -1.149 . . . . 61.42 107.898 176.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.6 t -120.1 115.59 47.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.585 -0.895 . . . . 64.34 108.585 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 tt -94.33 116.64 29.05 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.277 -1.008 . . . . 62.1 108.277 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.723 ' HG3' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -93.01 102.13 14.48 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.816 -0.809 . . . . 75.13 108.816 172.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.542 HG12 ' HB1' ' A' ' 110' ' ' ALA . 2.4 p -99.61 110.17 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 108.998 -0.742 . . . . 74.14 108.998 176.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.669 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 33.8 m -95.99 133.58 40.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.282 1.033 . . . . 75.45 109.055 -176.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.4 t -130.99 115.72 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 107.981 -1.118 . . . . 74.32 107.981 -174.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 16.8 m -127.39 108.24 10.67 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.732 -0.84 . . . . 74.32 108.732 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.61 103.44 14.26 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 106.828 -1.545 . . . . 75.24 106.828 171.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.4 p -136.71 127.4 27.14 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.181 0.592 . . . . 75.41 110.39 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.468 HD12 ' H ' ' A' ' 37' ' ' GLN . 6.4 tt -89.71 88.22 7.3 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 106.844 -1.539 . . . . 73.34 106.844 173.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.29 -83.86 0.97 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.257 -0.737 . . . . 73.02 111.257 178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -119.84 -26.25 5.68 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.87 0.868 . . . . 62.31 110.866 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -82.26 101.65 10.65 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.372 0.269 . . . . 72.44 111.016 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.46 ' HB ' ' HG2' ' A' ' 26' ' ' PRO . 61.6 m -70.35 112.8 6.93 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.334 0.654 . . . . 64.23 109.842 173.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.61 -59.4 4.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.174 0.989 . . . . 74.21 109.476 171.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -149.16 160.92 42.93 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.997 -1.002 . . . . 73.24 111.029 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 64' ' ' VAL . 49.1 tp -141.33 133.66 28.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.548 1.539 . . . . 73.15 107.3 -175.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 35.0 m -147.28 120.29 8.79 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 118.807 0.73 . . . . 71.04 110.381 -171.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 9.5 mp0 -128.09 128.8 45.56 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.012 -1.107 . . . . 74.23 108.012 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.7 t -131.24 110.67 18.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.34 -0.615 . . . . 73.31 109.34 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.723 ' HG3' ' HG3' ' A' ' 61' ' ' ARG . 15.5 mp0 -85.04 79.43 9.63 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.474 -1.306 . . . . 75.22 107.474 174.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.454 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.4 tp-100 -78.21 97.27 5.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.801 -1.185 . . . . 74.34 107.801 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.472 ' HA3' ' HG3' ' A' ' 19' ' ' LYS . . . -93.91 147.2 18.49 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.041 -0.823 . . . . 34.14 111.041 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.78 126.87 2.37 Favored Glycine 0 CA--C 1.499 -0.929 0 N-CA-C 110.264 -1.134 . . . . 64.32 110.264 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 60.6 mt -82.38 114.28 23.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.653 -0.869 . . . . 74.03 108.653 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.7 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.6 m-85 -122.46 119.14 30.08 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.66 -0.867 . . . . 75.32 108.66 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 23.1 t -84.63 91.13 7.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.064 -0.717 . . . . 73.13 109.064 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -100.39 128.48 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.502 0.668 . . . . 72.15 109.23 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.89 154.75 44.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.939 1.296 . . . . 61.44 108.496 -175.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 84.19 9.54 81.93 Favored Glycine 0 N--CA 1.48 1.618 0 C-N-CA 121.673 -0.299 . . . . 41.31 113.715 172.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.511 HG23 ' HB3' ' A' ' 93' ' ' GLN . 0.9 OUTLIER -127.17 138.2 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.269 1.028 . . . . 62.32 110.772 -174.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -142.43 173.26 11.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.226 1.011 . . . . 73.12 109.707 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.92 -117.16 10.67 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.703 -0.681 . . . . 70.32 113.524 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.626 ' HB ' HD13 ' A' ' 141' ' ' LEU . 29.3 p -86.64 -26.63 24.27 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.702 0.801 . . . . 74.12 112.365 175.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.511 ' HB3' HG23 ' A' ' 89' ' ' ILE . 16.5 mm100 -60.09 -43.97 95.15 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.44 0.696 . . . . 73.34 110.512 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.556 ' SD ' ' HB ' ' E' ' 452' ' ' VAL . 24.7 ptt? -62.85 -40.37 97.24 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.249 -0.887 . . . . 74.13 110.888 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.7 -26.04 62.34 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.616 0.766 . . . . 71.04 110.568 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -78.09 -30.47 49.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.243 0.617 . . . . 73.31 110.514 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.47 ' SG ' HG21 ' A' ' 89' ' ' ILE . 72.0 m -70.74 -64.84 0.82 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.48 -0.327 . . . . 74.23 110.531 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.51 -9.19 53.26 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.206 0.817 . . . . 75.45 113.206 -171.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.6 3.53 32.49 Favored Glycine 0 N--CA 1.48 1.631 0 CA-C-O 119.791 -0.449 . . . . 74.11 113.635 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.648 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -146.25 -64.05 0.31 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.287 0.543 . . . . 75.14 111.414 -176.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.472 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 84.2 t80 -70.5 -51.65 27.44 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.244 -0.889 . . . . 72.44 111.588 -172.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -72.9 -36.11 3.26 Favored Pre-proline 0 CA--C 1.566 1.564 0 N-CA-C 113.859 1.059 . . . . 75.05 113.859 -172.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.509 ' HA ' HD13 ' A' ' 106' ' ' LEU . 30.4 Cg_endo -65.39 -26.9 55.24 Favored 'Trans proline' 0 C--N 1.39 2.727 0 CA-C-N 121.732 1.654 . . . . 73.05 112.507 167.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.469 HD22 ' HA ' ' A' ' 132' ' ' ASN . 25.8 t-20 -71.84 -25.86 62.14 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.505 0.322 . . . . 71.34 110.252 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -62.84 -36.49 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.467 0.707 . . . . 74.2 109.926 170.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.509 HD13 ' HA ' ' A' ' 103' ' ' PRO . 65.5 mt -78.11 -23.23 47.96 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.298 1.039 . . . . 70.1 112.36 -178.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -61.81 -43.48 87.59 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 117.797 -1.097 . . . . 73.33 113.672 -172.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.56 -38.75 60.08 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.124 1.883 . . . . 74.35 113.076 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -69.44 -41.45 76.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.374 0.669 . . . . 75.14 111.057 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.542 ' HB1' HG12 ' A' ' 62' ' ' VAL . . . -67.61 -42.41 82.42 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.499 0.719 . . . . 73.14 110.128 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.558 ' HA ' HD23 ' A' ' 128' ' ' LEU . 29.8 ttm180 -51.17 -53.33 35.77 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.833 1.333 . . . . 71.03 110.256 175.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -66.16 -42.33 89.13 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.436 1.085 . . . . 73.12 111.214 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 41.9 t -60.88 -34.77 75.15 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.249 0.619 . . . . 75.14 111.398 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 81.0 mt -73.75 -51.66 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.815 0.846 . . . . 60.32 109.837 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.534 HG21 ' HG3' ' A' ' 125' ' ' GLN . 95.4 m -52.35 -51.28 59.71 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.334 1.054 . . . . 64.25 111.359 -174.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -65.42 -44.0 88.75 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.117 -1.401 . . . . 73.13 110.461 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.538 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 43.0 ttp -67.2 -35.45 79.64 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.03 0.932 . . . . 72.43 111.9 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.91 -40.39 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.246 1.018 . . . . 71.34 110.037 174.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -71.71 -25.42 62.07 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.952 0.901 . . . . 73.53 111.304 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -76.29 -25.92 55.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.756 0.822 . . . . 74.2 109.605 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.04 0.12 88.95 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.826 0.704 . . . . 75.23 112.712 171.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.3 m 67.88 15.98 9.61 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.848 1.259 . . . . 74.15 111.679 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.96 156.71 69.62 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.373 0.669 . . . . 73.13 109.365 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.85 141.96 92.76 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.476 2.117 . . . . 71.22 111.554 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.534 ' HG3' HG21 ' A' ' 115' ' ' THR . 29.7 tt0 -55.03 134.77 49.25 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.192 0.933 . . . . 72.43 111.78 -175.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.7 tp -118.69 98.97 6.49 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.492 -0.776 . . . . 74.34 110.287 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -100.18 113.21 25.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.379 -1.341 . . . . 64.33 107.379 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 111' ' ' ARG . 2.6 mm? -72.85 128.41 35.43 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.149 0.58 . . . . 71.2 109.522 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.03 135.48 73.92 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.632 0.773 . . . . 54.13 111.235 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.532 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 42.8 Cg_exo -58.08 98.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.727 2.285 . . . . 74.15 112.762 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 95.3 t -100.18 113.99 37.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.371 -0.974 . . . . 73.24 108.371 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.469 ' HA ' HD22 ' A' ' 104' ' ' ASN . 53.6 t30 -84.74 102.4 12.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.671 0.388 . . . . 73.43 110.045 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -63.67 -25.28 68.14 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.927 0.891 . . . . 70.21 111.468 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.648 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 7.2 t70 -65.96 -48.71 70.42 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.111 0.882 . . . . 74.52 110.432 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.37 -39.57 94.89 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.61 0.764 . . . . 70.52 111.334 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.94 -40.73 83.22 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.15 -0.932 . . . . 74.04 111.081 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -68.0 -38.45 82.65 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.191 -0.913 . . . . 72.32 109.5 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.464 ' HE1' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -56.77 -39.58 74.31 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 124.228 0.955 . . . . 73.32 110.624 177.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 88.7 m-20 -59.24 -52.24 66.55 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.684 0.794 . . . . 73.53 111.08 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -64.83 -36.36 84.07 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.778 0.831 . . . . 73.53 111.416 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.626 HD13 ' HB ' ' A' ' 92' ' ' THR . 48.7 tp -69.93 -50.91 37.4 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.593 1.157 . . . . 71.3 111.888 -171.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -162.96 -3.14 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.312 0.645 . . . . 74.11 110.776 -169.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 36.1 tt0 69.94 133.56 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.623 1.569 . . . . 73.34 110.378 -165.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.83 178.5 8.15 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 122.043 -0.41 . . . . 70.44 111.27 176.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.63 143.89 26.06 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.417 0.687 . . . . 75.21 109.993 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.99 79.94 0.37 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.647 -0.581 . . . . 63.5 111.647 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -79.7 135.78 36.62 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.801 0.84 . . . . 73.52 111.517 -171.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.76 105.3 0.27 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 110.068 -1.213 . . . . 51.12 110.068 175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -98.47 131.19 44.92 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.0 0.52 . . . . 73.22 110.829 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -80.29 154.37 27.87 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.528 0.731 . . . . 74.01 110.817 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' C' ' 90' ' ' GLU . 5.0 tp10 -176.03 139.2 0.37 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.997 1.319 . . . . 72.24 108.698 176.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -155.42 124.5 6.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.947 0.403 . . . . 75.02 111.447 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -115.92 -158.02 0.67 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.161 1.385 . . . . 73.12 108.399 173.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -143.63 114.93 7.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.159 0.584 . . . . 53.21 109.579 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 C-N-CA 123.906 0.882 . . . . 65.23 110.665 -178.566 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 44.9 ttm . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.568 -0.531 . . . . 74.32 109.568 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 34.5 t -73.39 130.69 40.69 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.237 -0.653 . . . . 73.45 109.237 174.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -76.68 128.53 34.85 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.682 -0.488 . . . . 74.15 109.682 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -78.17 143.66 37.04 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.554 -0.536 . . . . 73.43 109.554 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -70.59 148.82 47.73 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.732 0.813 . . . . 75.51 110.766 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' B' ' 88' ' ' GLY . 4.1 m-20 -63.34 123.59 19.1 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.561 1.144 . . . . 74.03 110.305 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -126.4 160.28 30.9 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.576 0.75 . . . . 75.24 110.429 -174.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 82.39 -59.65 0.18 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 126.387 1.875 . . . . 75.52 112.41 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.492 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 8.8 ptm 59.11 168.93 0.06 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 127.064 2.146 . . . . 71.42 113.471 -171.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m -159.01 138.16 11.34 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.439 1.096 . . . . 72.52 108.579 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.97 157.42 43.41 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.485 0.66 . . . . 75.33 110.21 160.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -125.45 139.11 53.92 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 107.757 -1.201 . . . . 74.34 107.757 172.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.504 HD11 HD12 ' B' ' 105' ' ' ILE . 50.4 mt -76.66 120.41 26.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.482 -0.932 . . . . 75.02 108.482 173.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -83.5 -39.61 20.25 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.075 -0.713 . . . . 75.01 109.075 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -165.73 135.78 3.51 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.597 -0.729 . . . . 74.45 110.277 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.423 HG13 HG21 ' B' ' 13' ' ' ILE . 79.9 mt -114.96 140.73 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 106.411 -1.7 . . . . 73.52 106.411 168.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.473 ' HE2' ' HB1' ' A' ' 28' ' ' ALA . 36.4 p90 -171.49 170.62 5.74 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.597 0.713 . . . . 73.15 112.041 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.467 HG23 HD13 ' B' ' 21' ' ' ILE . 24.8 m -98.11 130.72 44.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.546 -1.206 . . . . 71.3 108.792 174.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -96.26 -34.47 11.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.875 0.87 . . . . 73.11 110.407 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -148.98 136.34 20.19 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.792 -0.64 . . . . 71.02 110.555 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.615 HD13 ' SG ' ' B' ' 113' ' ' CYS . 47.0 mm -127.98 138.62 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.222 1.009 . . . . 71.43 108.915 171.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.522 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 39.8 t -135.66 129.55 32.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.228 1.411 . . . . 71.23 107.217 174.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -139.7 119.79 13.65 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 107.155 -1.424 . . . . 74.35 107.155 168.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.52 113.83 19.26 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.249 -0.648 . . . . 72.54 109.249 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.434 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -107.59 84.55 1.95 Allowed Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 107.556 -1.276 . . . . 74.11 107.556 166.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.19 -22.83 18.66 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.748 2.299 . . . . 71.14 111.385 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 89.2 m-20 -116.55 7.81 13.78 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.664 1.186 . . . . 62.23 110.898 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.551 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -29.02 -62.62 0.21 Allowed Pre-proline 0 N--CA 1.491 1.576 0 C-N-CA 126.244 1.817 . . . . 75.14 115.186 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 21.2 Cg_exo -61.9 -49.47 6.69 Favored 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 122.183 1.922 . . . . 75.2 112.122 -170.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.431 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 77.4 m80 -88.92 -11.9 43.19 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.052 -0.977 . . . . 73.31 112.251 -171.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.569 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.4 p -81.08 -23.36 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 CA-C-N 118.303 0.501 . . . . 75.32 110.525 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -64.77 -18.96 65.53 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.929 0.892 . . . . 64.45 113.331 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.9 pt20 -66.21 -23.3 66.41 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.882 0.473 . . . . 75.15 111.043 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -83.98 95.67 8.61 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.295 0.638 . . . . 75.31 109.589 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.38 83.32 1.93 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.922 0.889 . . . . 75.53 109.352 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -159.08 155.93 28.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.947 -1.024 . . . . 72.34 109.156 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -83.03 108.31 12.22 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.057 0.943 . . . . 73.0 108.502 169.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.575 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 55.6 Cg_endo -68.66 129.53 18.97 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.418 2.079 . . . . 72.32 112.294 -173.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.89 123.48 18.14 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 123.897 0.748 . . . . 73.4 110.164 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.506 HG12 HD23 ' B' ' 126' ' ' LEU . 33.0 m -104.0 150.68 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.463 0.705 . . . . 75.3 111.785 -169.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -133.57 119.85 20.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.542 -0.91 . . . . 74.42 108.542 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.468 HD22 ' HE2' ' F' ' 464' ' ' MET . 6.0 mp -93.22 144.26 25.47 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.782 0.833 . . . . 73.4 109.625 -177.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.66 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 10.2 m-20 -136.08 115.32 12.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.716 1.207 . . . . 65.21 108.368 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.9 149.47 23.37 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.415 -0.587 . . . . 74.11 109.415 177.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.9 t70 -155.62 114.23 3.48 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.353 -0.98 . . . . 74.12 108.353 177.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -113.7 103.85 11.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.23 0.612 . . . . 75.2 109.656 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.24 118.46 32.35 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.638 0.775 . . . . 62.34 109.281 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 14.0 p -102.82 162.28 13.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.983 0.513 . . . . 72.31 110.755 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -151.82 136.84 17.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.057 0.943 . . . . 73.52 109.33 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -80.87 112.25 18.08 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.358 0.663 . . . . 75.12 109.721 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' B' ' 57' ' ' GLU . 75.3 mt -81.39 -54.06 5.78 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.31 0.576 . . . . 74.54 111.023 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.34 -163.74 1.75 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.372 1.069 . . . . 74.3 109.362 -176.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.42 100.95 0.53 Allowed 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.966 0.791 . . . . 74.04 109.432 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 22.1 m-20 62.13 15.7 7.65 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.582 1.153 . . . . 64.12 112.839 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 95.5 t -104.39 123.89 58.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 106.085 -1.82 . . . . 73.03 106.085 169.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.91 167.22 21.61 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.944 -0.761 . . . . 74.14 108.944 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.501 ' HB2' HD13 ' B' ' 51' ' ' LEU . 12.1 tt0 -124.38 120.7 32.87 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.608 -0.886 . . . . 71.51 108.608 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.1 t -88.19 137.72 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.714 -0.847 . . . . 64.51 108.714 170.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 56.3 t -120.88 110.39 28.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.484 -0.932 . . . . 72.23 108.484 175.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.05 99.08 11.45 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.712 -1.218 . . . . 75.13 107.712 177.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.487 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 13.2 ttm180 -87.27 113.11 22.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.595 -0.729 . . . . 73.45 109.429 170.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.54 123.84 63.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.764 -1.198 . . . . 73.13 107.764 170.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.66 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 6.9 m -118.55 134.75 54.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.926 -0.768 . . . . 70.35 108.926 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.464 HG23 HD12 ' B' ' 114' ' ' ILE . 88.1 t -122.45 127.92 75.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 123.964 0.906 . . . . 72.33 108.636 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 53.5 m -112.22 147.57 35.92 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 124.265 1.026 . . . . 74.5 108.739 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.23 147.21 33.29 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.439 0.696 . . . . 74.45 109.831 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.1 p -137.48 125.99 23.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.408 0.683 . . . . 72.11 110.381 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.575 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 42.2 mt -93.18 99.88 12.37 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 106.979 -1.489 . . . . 75.53 106.979 171.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.58 -118.55 5.06 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.492 -0.776 . . . . 75.03 112.651 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -103.33 14.77 30.77 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.128 0.971 . . . . 74.51 111.076 -171.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.418 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.9 pt-20 -147.84 156.49 42.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.721 0.808 . . . . 74.43 110.209 -173.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 86.7 m -66.26 135.83 55.0 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.698 0.624 . . . . 61.32 110.755 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.569 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -89.68 -62.57 1.44 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.584 -0.895 . . . . 73.43 108.584 174.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -150.92 157.88 43.46 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.095 -1.411 . . . . 64.55 109.96 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -132.34 138.63 47.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.766 -1.568 . . . . 72.34 106.766 175.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.432 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 49.8 t -142.65 151.01 40.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.467 -0.938 . . . . 72.13 108.467 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 44.8 tt0 -161.96 126.91 3.4 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.717 -0.845 . . . . 72.54 108.717 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.68 144.07 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 123.84 0.856 . . . . 71.43 108.934 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -115.16 91.2 3.54 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.36 -0.978 . . . . 73.53 108.36 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -81.19 97.63 7.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.545 -0.909 . . . . 73.03 108.545 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.96 142.7 16.14 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.129 -0.788 . . . . 74.25 111.129 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.85 128.86 3.58 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.123 -0.791 . . . . 74.33 111.123 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.7 mt -87.98 126.86 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.843 0.857 . . . . 70.25 109.837 175.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -134.47 134.6 41.72 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.501 -1.296 . . . . 72.33 107.501 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -109.38 93.02 4.29 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.036 0.535 . . . . 74.13 110.205 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.443 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 30.0 pt -94.38 144.85 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.327 0.584 . . . . 73.01 112.445 -167.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.79 146.86 19.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.915 1.286 . . . . 75.45 107.926 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 102.4 -25.85 26.21 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-O 119.884 -0.398 . . . . 64.41 113.761 176.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' B' ' 94' ' ' MET . 5.4 pt -84.31 165.56 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 117.48 0.64 . . . . 74.15 111.664 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -171.8 175.32 3.96 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.047 1.339 . . . . 74.41 108.726 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.21 -125.6 8.25 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.931 -0.468 . . . . 54.24 111.931 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.2 m -103.32 -13.14 16.81 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.511 0.724 . . . . 71.24 109.434 170.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -62.34 -27.78 69.29 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.148 0.979 . . . . 74.01 109.971 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.697 ' SD ' HG11 ' F' ' 451' ' ' VAL . 25.4 ptt? -71.06 -37.39 72.49 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.54 -0.754 . . . . 75.23 110.789 171.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.04 -21.24 59.17 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 115.451 -0.795 . . . . 74.02 110.766 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -76.99 -28.43 55.08 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.12 0.568 . . . . 73.23 111.425 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.24 -37.69 75.39 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.834 0.709 . . . . 72.15 110.052 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -102.8 -9.12 20.23 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.736 0.814 . . . . 74.52 111.819 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.32 -25.39 57.26 Favored Glycine 0 N--CA 1.475 1.265 0 C-N-CA 123.677 0.656 . . . . 75.12 112.728 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.47 -56.52 0.11 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.096 -0.552 . . . . 74.11 110.975 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.458 ' HH ' ' HB2' ' D' ' 130' ' ' PRO . 28.1 t80 -55.24 -54.81 38.7 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.604 1.162 . . . . 73.21 112.187 -168.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 78.9 m -69.62 -48.74 23.23 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 118.191 -0.909 . . . . 72.33 112.032 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -50.81 -35.79 49.83 Favored 'Trans proline' 0 C--N 1.399 3.195 0 C-N-CA 122.61 2.207 . . . . 73.22 113.929 170.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -75.15 -23.87 57.87 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.531 0.732 . . . . 72.1 111.701 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.504 HD12 HD11 ' B' ' 13' ' ' ILE . 83.2 mt -70.01 -44.14 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.089 -0.708 . . . . 73.45 109.089 168.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -80.6 -21.46 41.57 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.831 -1.077 . . . . 74.11 112.448 -173.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -62.48 -46.11 89.49 Favored Pre-proline 0 N--CA 1.487 1.394 0 N-CA-C 113.754 1.02 . . . . 63.23 113.754 -169.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.83 -35.71 98.17 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.859 1.706 . . . . 74.52 112.817 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -68.66 -45.31 72.11 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.991 0.517 . . . . 74.43 110.066 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.52 -37.53 78.56 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.689 0.796 . . . . 73.11 110.487 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -62.33 -57.88 9.71 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.29 1.036 . . . . 72.12 110.694 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -65.34 -28.88 69.61 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.988 0.805 . . . . 70.11 110.655 -173.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.615 ' SG ' HD13 ' B' ' 21' ' ' ILE . 4.3 t -75.09 -36.05 61.74 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.903 0.481 . . . . 74.42 111.377 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.464 HD12 HG23 ' B' ' 64' ' ' VAL . 81.7 mt -66.96 -52.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.671 -0.492 . . . . 74.32 109.671 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.432 HG22 ' OG ' ' C' ' 119' ' ' SER . 28.6 m -58.24 -33.56 69.49 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 124.339 1.024 . . . . 75.41 111.568 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 22.7 t -58.49 -53.94 52.62 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 123.813 0.696 . . . . 63.33 109.85 175.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.6 mmt -69.64 -35.22 75.03 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.493 0.717 . . . . 75.1 111.723 -171.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.98 -45.58 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.635 0.774 . . . . 71.51 110.428 174.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.408 ' OG ' HG21 ' C' ' 115' ' ' THR . 47.0 t -68.6 -32.58 72.56 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.969 -1.014 . . . . 65.42 111.357 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.7 mtt-85 -65.62 -37.2 85.93 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.552 -0.749 . . . . 74.0 109.389 175.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.37 5.0 65.2 Favored Glycine 0 C--N 1.357 1.72 0 O-C-N 124.213 0.946 . . . . 72.54 113.511 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 82.3 p 57.28 35.63 26.34 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.827 1.651 . . . . 72.34 112.96 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -95.26 162.53 24.43 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.83 0.852 . . . . 73.3 110.214 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.24 159.84 7.37 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 123.717 2.944 . . . . 74.2 114.19 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.429 HE21 ' ND2' ' B' ' 127' ' ' ASN . 67.9 tp60 -66.4 117.39 8.57 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.058 -0.973 . . . . 72.54 111.757 -176.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.506 HD23 HG12 ' B' ' 40' ' ' VAL . 10.2 mp -120.13 127.42 52.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.146 0.978 . . . . 73.3 109.455 173.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.429 ' ND2' HE21 ' B' ' 125' ' ' GLN . 50.7 m-80 -123.75 134.8 53.61 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.539 -0.911 . . . . 61.33 108.539 168.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.08 125.72 27.57 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.004 0.922 . . . . 75.31 109.892 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.28 151.14 87.75 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 124.011 0.924 . . . . 70.41 111.5 -176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.23 120.33 7.47 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.008 2.472 . . . . 74.14 112.431 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.9 t -118.33 112.7 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.941 -1.133 . . . . 71.54 107.941 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -79.13 84.86 5.07 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.838 -0.801 . . . . 72.11 108.838 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.72 -23.55 67.22 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.571 0.748 . . . . 75.45 111.83 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.07 -48.66 62.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.771 0.828 . . . . 71.11 110.696 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.43 95.39 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.683 -1.144 . . . . 75.3 110.306 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -71.53 -31.21 66.79 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.254 -1.339 . . . . 74.54 111.868 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.622 ' CE1' HD12 ' B' ' 141' ' ' LEU . 51.4 t80 -69.77 -23.03 63.3 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.717 0.407 . . . . 74.21 110.723 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 82.8 mtp -71.69 -35.81 70.39 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.089 0.471 . . . . 74.12 110.09 174.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.8 -15.55 59.7 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.805 0.842 . . . . 74.22 110.882 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -67.54 -32.83 73.88 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.561 1.145 . . . . 75.52 110.724 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.622 HD12 ' CE1' ' B' ' 137' ' ' PHE . 24.4 mt -111.66 -6.26 14.38 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.912 0.885 . . . . 74.21 112.71 -163.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -154.18 170.01 22.23 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.489 -0.93 . . . . 74.03 108.489 -172.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -48.37 119.94 3.32 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.175 0.99 . . . . 75.41 110.295 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -49.96 99.5 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.963 1.305 . . . . 65.33 111.691 -172.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.51 40.42 1.16 Allowed 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.116 0.967 . . . . 71.35 109.844 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.94 57.45 5.07 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.751 -0.659 . . . . 62.53 111.463 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -76.29 89.31 3.14 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.965 0.906 . . . . 73.13 108.991 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.32 69.1 2.83 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 114.756 -1.111 . . . . 45.12 110.833 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.3 m -70.5 83.11 0.59 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.776 -0.824 . . . . 64.0 108.776 175.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -80.34 83.77 6.12 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.965 -1.016 . . . . 51.51 109.764 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -87.49 120.5 28.86 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.675 -1.232 . . . . 74.42 107.675 170.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -83.68 -9.38 58.9 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.78 0.432 . . . . 74.44 111.63 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 57.43 -168.7 0.11 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.423 1.089 . . . . 65.41 110.851 -174.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -139.79 92.96 2.6 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.55 -0.908 . . . . 74.52 108.55 171.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.907 0 C-N-CA 124.623 1.169 . . . . 74.21 110.751 -174.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.4 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 109.99 -0.374 . . . . 63.54 109.99 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 63.0 m -150.91 101.23 2.88 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.47 1.108 . . . . 75.1 108.456 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.76 135.84 41.73 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.966 0.506 . . . . 70.2 109.684 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -102.16 105.72 16.46 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.443 0.697 . . . . 72.03 109.993 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -152.27 142.49 22.39 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.055 0.942 . . . . 60.41 108.902 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -146.71 9.93 1.04 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.668 0.787 . . . . 75.52 110.173 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 77.3 p -74.71 -16.12 60.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.542 0.737 . . . . 72.14 111.366 -176.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.64 60.15 6.05 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 108.199 -1.037 . . . . 73.05 108.199 175.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 58.3 ttp 53.95 113.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 126.09 1.756 . . . . 74.3 113.351 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 10.6 m -92.55 108.35 19.91 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.943 -1.132 . . . . 64.4 107.943 167.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.59 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 62.5 t80 -123.41 121.33 35.48 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.655 -1.239 . . . . 72.31 107.655 174.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -137.21 122.76 19.69 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.168 -0.679 . . . . 73.41 109.168 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.04 125.35 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.807 -0.812 . . . . 73.05 108.807 172.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.573 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 29.3 mm-40 -91.97 -42.85 9.78 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.695 0.798 . . . . 71.31 109.306 175.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -175.61 138.58 0.39 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.63 -0.878 . . . . 70.32 108.63 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -127.91 141.67 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.862 -1.162 . . . . 65.41 107.862 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -170.57 161.18 7.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.714 0.768 . . . . 74.1 111.582 -171.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.3 p -83.95 107.47 16.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.753 -1.112 . . . . 71.3 108.338 172.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -68.81 -41.67 78.31 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.309 -0.996 . . . . 74.52 108.309 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 26.8 t70 -139.27 142.32 37.76 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 114.381 -1.282 . . . . 74.01 109.555 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.602 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.4 mt -135.99 145.35 31.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.548 1.539 . . . . 73.51 106.911 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -154.28 149.36 26.87 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.463 0.705 . . . . 73.42 109.504 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -155.82 109.01 2.71 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.2 -1.037 . . . . 74.21 108.2 174.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -119.3 111.9 18.78 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.266 0.626 . . . . 72.51 110.352 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.64 87.64 6.85 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 106.732 -1.581 . . . . 73.35 106.732 169.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.15 -23.65 24.39 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.698 2.266 . . . . 72.42 112.299 -170.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -121.39 29.71 7.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.367 1.067 . . . . 73.21 109.546 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.68 -53.54 40.54 Favored Pre-proline 0 CA--C 1.562 1.426 0 N-CA-C 114.031 1.123 . . . . 53.12 114.031 -171.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.437 ' HB3' HD12 ' D' ' 51' ' ' LEU . 26.3 Cg_exo -60.52 -48.72 10.55 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 121.671 1.581 . . . . 74.45 112.091 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -69.99 -27.08 64.42 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.244 -1.344 . . . . 72.24 112.27 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -79.54 -26.95 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 112.557 0.577 . . . . 72.53 112.557 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -68.19 -27.39 66.35 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.01 0.374 . . . . 73.21 112.01 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -89.9 9.62 26.95 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.441 0.696 . . . . 72.42 111.797 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.6 176.57 5.97 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.585 0.754 . . . . 73.43 110.065 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -76.93 124.37 27.65 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.47 0.708 . . . . 74.51 109.367 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.409 ' HE1' HD13 ' G' ' 470' ' ' LEU . 50.7 t90 -85.15 84.84 7.56 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.711 0.804 . . . . 75.14 111.157 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -142.56 79.92 14.88 Favored Pre-proline 0 N--CA 1.478 0.943 0 N-CA-C 107.334 -1.358 . . . . 74.54 107.334 164.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.414 ' HA ' HD22 ' C' ' 68' ' ' LEU . 6.0 Cg_exo -79.42 139.95 14.9 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.678 2.252 . . . . 75.51 112.922 -177.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.73 104.92 14.23 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 106.19 -1.781 . . . . 74.03 106.19 165.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.469 ' HB ' HD13 ' G' ' 468' ' ' LEU . 5.8 m -93.46 102.74 13.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.197 -1.365 . . . . 73.3 110.791 -169.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.548 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 54.4 mttp -91.84 111.13 22.54 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.489 -0.778 . . . . 75.23 109.005 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.545 ' HB3' ' HG ' ' G' ' 468' ' ' LEU . 3.5 pp -86.41 157.22 19.89 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.515 -0.55 . . . . 75.55 109.515 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.624 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.6 t70 -151.75 137.32 17.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.044 -1.095 . . . . 74.54 108.044 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 tt -137.97 137.2 37.7 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.556 -0.905 . . . . 73.32 108.556 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -148.21 125.58 11.6 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.973 1.309 . . . . 74.43 108.596 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m -114.22 126.35 54.95 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.431 0.634 . . . . 74.44 110.342 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.23 141.05 52.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.862 1.265 . . . . 73.25 107.805 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -152.24 143.68 23.39 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.851 0.46 . . . . 73.15 110.46 -170.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 80.5 p -148.43 151.93 36.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.211 0.605 . . . . 60.51 111.23 -171.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -79.22 136.89 37.2 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.466 0.706 . . . . 73.21 110.269 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.674 HD12 ' HB2' ' C' ' 57' ' ' GLU . 29.8 mt -110.12 -34.42 6.39 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.53 0.732 . . . . 71.04 110.245 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.47 179.82 8.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.36 0.664 . . . . 61.12 110.242 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -58.46 112.93 1.75 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.719 0.808 . . . . 64.51 109.907 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 64.12 9.82 5.0 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.672 1.189 . . . . 63.15 113.473 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 94.2 t -105.59 116.25 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.558 -1.275 . . . . 73.52 107.558 172.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -134.09 124.21 25.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.013 -0.736 . . . . 73.53 109.013 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.674 ' HB2' HD12 ' C' ' 51' ' ' LEU . 38.3 tt0 -83.42 139.01 33.23 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.92 0.888 . . . . 74.41 109.635 175.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.409 HG12 ' HD3' ' C' ' 103' ' ' PRO . 42.0 t -120.05 135.33 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 124.185 0.994 . . . . 64.55 108.496 166.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.561 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 59.1 t -115.84 144.55 23.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.543 -0.91 . . . . 74.04 108.543 175.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.4 104.64 8.56 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.197 -1.038 . . . . 75.02 108.197 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -88.16 117.46 27.07 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.79 -1.189 . . . . 64.42 107.79 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.439 HG11 HD22 ' C' ' 128' ' ' LEU . 21.4 t -118.88 118.85 59.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.741 -1.207 . . . . 74.12 107.741 175.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.9 m -122.3 122.32 38.81 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.579 0.752 . . . . 71.35 109.54 -173.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.672 HG13 HD12 ' G' ' 468' ' ' LEU . 99.5 t -110.36 122.16 64.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.083 1.353 . . . . 71.23 109.258 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.6 m -117.55 144.17 45.38 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.446 -0.946 . . . . 74.11 108.446 175.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.28 128.47 19.81 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.482 -0.933 . . . . 74.21 108.482 176.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 21.4 m -142.91 129.3 20.03 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.092 0.557 . . . . 60.35 110.586 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' C' ' 38' ' ' PRO . 49.0 mt -87.67 32.95 0.71 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.174 1.39 . . . . 74.54 111.334 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 -100.72 1.41 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.41 -1.076 . . . . 74.55 110.41 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.64 -31.09 17.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.808 0.843 . . . . 72.24 109.953 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -76.62 120.23 21.53 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.276 1.03 . . . . 74.23 110.092 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.2 m -78.14 126.18 30.44 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.561 -0.903 . . . . 71.51 108.561 168.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -60.98 2.06 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.589 -0.893 . . . . 74.41 108.589 173.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -163.61 172.49 14.25 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.068 0.937 . . . . 74.24 111.83 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -135.8 145.57 46.65 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 105.863 -1.902 . . . . 75.52 105.863 172.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.8 t -147.98 150.42 33.96 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.059 -1.089 . . . . 74.32 108.059 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.99 132.83 8.5 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.759 -0.46 . . . . 74.41 109.759 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.52 114.1 22.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.263 -1.014 . . . . 62.53 108.263 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.512 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 68.4 mt-30 -94.15 85.12 4.59 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.401 -0.963 . . . . 75.02 108.401 173.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -78.33 97.4 5.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.053 -1.431 . . . . 74.51 110.324 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -89.37 161.13 29.81 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 116.465 -0.334 . . . . 71.01 112.382 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.16 123.06 1.15 Allowed Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 111.058 -0.817 . . . . 73.24 111.058 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 6.2 mm -82.26 125.92 39.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.532 -0.914 . . . . 74.42 108.532 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -131.6 119.74 21.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.166 0.587 . . . . 73.43 110.257 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 71.9 m -80.66 111.89 17.52 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.934 -0.765 . . . . 52.25 108.934 170.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.699 HG12 HD21 ' C' ' 98' ' ' LEU . 1.2 pp -117.06 139.31 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.225 1.01 . . . . 70.32 110.317 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.07 172.68 13.46 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.409 1.084 . . . . 73.23 110.514 -172.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.93 -59.67 3.55 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 116.179 -0.464 . . . . 71.24 112.086 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.81 157.57 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.756 0.823 . . . . 75.11 109.475 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.602 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 13.3 pt-20 -145.53 -170.8 3.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.0 0.52 . . . . 75.24 109.925 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.82 -121.73 24.26 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 114.621 0.608 . . . . 72.15 114.621 174.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 62.6 p -73.33 -34.27 65.58 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.792 0.837 . . . . 73.51 110.555 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -70.14 -32.7 70.81 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.243 1.017 . . . . 64.25 109.981 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.602 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 39.4 ttp -79.61 -33.13 41.8 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.836 -1.074 . . . . 72.31 110.838 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.45 84.17 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.369 0.604 . . . . 72.3 109.913 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.417 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 49.2 t-80 -65.42 -29.21 69.88 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.562 -1.199 . . . . 73.4 111.478 175.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.3 -60.81 2.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.057 0.543 . . . . 73.21 110.448 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.699 HD21 HG12 ' C' ' 86' ' ' ILE . 92.9 mt -74.16 -33.81 63.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.074 0.95 . . . . 75.05 112.696 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.35 8.79 77.08 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-O 119.475 -0.625 . . . . 72.04 113.551 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -156.87 -66.23 0.1 Allowed 'General case' 0 C--N 1.357 0.916 0 CA-C-N 117.724 0.762 . . . . 60.24 112.874 -172.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.408 ' O ' ' HB2' ' C' ' 104' ' ' ASN . 87.9 t80 -63.89 -34.8 78.76 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.286 0.634 . . . . 75.42 112.328 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.59 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 56.2 m -72.75 -46.28 9.18 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.69 -0.671 . . . . 74.04 111.148 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.409 ' HD3' HG12 ' C' ' 58' ' ' VAL . 83.2 Cg_exo -52.99 -32.95 60.25 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.312 2.008 . . . . 75.54 113.791 164.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' C' ' 101' ' ' TYR . 5.1 m-20 -60.09 -39.83 87.49 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 123.158 0.583 . . . . 65.35 110.911 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.47 HD13 ' NH1' ' A' ' 111' ' ' ARG . 40.2 mm -66.5 -45.22 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 115.954 -0.567 . . . . 64.51 110.198 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 42.3 mt -75.88 -16.39 60.06 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.433 -0.803 . . . . 74.53 111.986 -174.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -59.92 -52.7 71.76 Favored Pre-proline 0 CA--C 1.566 1.583 0 C-N-CA 125.035 1.334 . . . . 62.43 113.811 -172.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.18 -31.38 64.34 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 121.948 1.765 . . . . 71.23 112.784 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.407 ' HE2' HG23 ' A' ' 115' ' ' THR . 90.3 m-85 -69.09 -47.6 64.78 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.188 0.595 . . . . 75.12 110.546 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.37 -41.85 85.66 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.179 -0.918 . . . . 71.13 109.925 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -56.08 -57.72 10.97 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 124.437 1.086 . . . . 74.11 111.126 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -66.93 -30.93 71.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.181 0.593 . . . . 64.04 111.036 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.6 t -70.5 -34.1 71.95 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.779 0.432 . . . . 72.34 110.971 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.607 HG21 HG23 ' C' ' 64' ' ' VAL . 88.4 mt -69.34 -51.24 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.277 -0.638 . . . . 63.42 109.277 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.408 HG21 ' OG ' ' B' ' 119' ' ' SER . 13.7 m -58.43 -33.53 69.79 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.05 0.94 . . . . 72.12 111.286 -174.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 28.3 t -62.9 -54.85 32.32 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.834 -1.075 . . . . 72.21 109.13 173.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.54 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.96 -40.05 72.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.91 1.284 . . . . 75.24 112.639 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.34 -47.72 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.956 0.902 . . . . 73.45 109.691 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.432 ' OG ' HG22 ' B' ' 115' ' ' THR . 48.4 t -69.95 -27.98 65.19 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.238 -0.892 . . . . 72.14 111.93 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' C' ' 116' ' ' SER . 84.3 mtt-85 -70.65 -43.68 68.67 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.688 0.795 . . . . 75.42 109.29 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.15 5.86 65.39 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.955 -1.02 . . . . 65.3 112.522 172.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 64.8 p 61.66 29.76 18.28 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.175 1.79 . . . . 74.21 113.757 168.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -86.62 152.53 54.56 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 108.981 -0.748 . . . . 75.31 108.981 169.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.43 173.26 3.58 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.258 2.639 . . . . 71.32 114.649 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -50.79 130.92 25.75 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.308 1.443 . . . . 75.31 114.043 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.566 HD23 ' HB3' ' G' ' 468' ' ' LEU . 3.1 tm? -133.88 112.6 11.43 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.388 -1.338 . . . . 75.14 107.388 177.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -133.16 132.15 41.26 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.497 0.719 . . . . 75.4 109.99 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.439 HD22 HG11 ' C' ' 62' ' ' VAL . 6.8 mp -86.07 125.93 33.81 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.765 0.826 . . . . 74.41 110.11 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.406 ' HB1' ' SD ' ' G' ' 464' ' ' MET . . . -79.86 155.67 75.32 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 124.75 1.22 . . . . 62.04 111.18 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.448 ' HG3' HD13 ' A' ' 16' ' ' ILE . 30.7 Cg_endo -59.03 113.93 1.79 Allowed 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 123.361 2.708 . . . . 74.32 113.522 -177.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.39 113.38 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.786 0.834 . . . . 74.22 109.279 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -76.38 91.05 3.25 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.689 0.795 . . . . 74.32 110.473 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -68.55 -33.06 73.43 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 110.062 -0.348 . . . . 72.55 110.062 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.461 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 12.7 p-10 -65.02 -45.83 83.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.527 1.131 . . . . 74.52 111.447 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.53 -37.09 71.18 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.372 0.669 . . . . 75.31 110.897 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.26 -18.45 55.32 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.23 -0.895 . . . . 74.44 112.347 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -59.84 -17.78 39.05 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.096 0.558 . . . . 71.33 111.626 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 22.3 mmt -51.25 -42.27 60.91 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.688 0.795 . . . . 73.44 111.185 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -66.83 -36.39 82.25 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.153 0.581 . . . . 74.44 111.43 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -68.87 -86.52 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.827 0.851 . . . . 71.33 110.69 174.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.454 HD11 HE21 ' C' ' 144' ' ' GLN . 88.3 mt 56.1 -84.7 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.588 1.155 . . . . 72.25 110.861 -172.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -167.11 -83.39 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.727 -0.842 . . . . 75.23 108.727 176.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.45 -50.6 3.11 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 107.521 -1.288 . . . . 73.33 107.521 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.454 HE21 HD11 ' C' ' 141' ' ' LEU . 17.9 pt20 -55.58 124.09 16.18 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.249 -1.341 . . . . 70.32 110.636 172.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.3 108.6 21.18 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.571 0.748 . . . . 75.01 109.96 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.3 93.0 1.2 Allowed Glycine 0 C--N 1.337 0.639 0 N-CA-C 110.239 -1.144 . . . . 75.13 110.239 171.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.04 142.95 32.91 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.073 0.549 . . . . 74.53 109.764 -175.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.1 -33.15 0.1 OUTLIER Glycine 0 C--N 1.347 1.163 0 CA-C-N 115.943 -0.571 . . . . 74.4 112.463 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 28.3 p -133.19 108.77 9.0 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.771 0.828 . . . . 74.32 109.779 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.431 ' HA ' ' N ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -89.78 126.66 35.76 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 109.278 -0.638 . . . . 72.31 109.278 178.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.58 13.01 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.06 1.344 . . . . 75.14 110.855 -172.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.01 142.02 35.54 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.627 0.771 . . . . 72.15 111.003 -172.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -78.92 89.76 4.73 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.345 1.058 . . . . 72.15 109.872 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -129.88 123.0 29.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.306 1.042 . . . . 75.41 108.917 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 N-CA-C 109.54 -0.541 . . . . 75.13 109.54 -177.261 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.74 0.305 . . . . 74.0 110.563 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 47.3 t -129.72 94.17 3.68 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.414 0.685 . . . . 63.12 109.241 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.85 114.52 23.56 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.151 -0.685 . . . . 73.2 109.151 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -89.31 83.13 6.43 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.248 -1.019 . . . . 73.44 108.248 175.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -65.33 114.3 4.68 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.026 -0.988 . . . . 74.4 110.125 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -74.06 79.27 1.72 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 122.348 1.07 . . . . 62.41 110.509 -176.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 33.4 m -108.04 140.94 40.47 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.824 -1.08 . . . . 73.14 109.355 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -70.88 109.11 4.84 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.116 -1.068 . . . . 74.14 108.116 170.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.8 ttp -30.41 123.93 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 125.325 1.641 . . . . 75.22 113.783 -173.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 22.5 m -114.16 142.36 46.34 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.072 -1.085 . . . . 75.11 108.072 171.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -157.19 91.28 1.17 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.951 -1.5 . . . . 74.51 106.951 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -113.43 114.71 26.96 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.341 -0.985 . . . . 65.21 108.341 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.401 HG22 HD11 ' D' ' 16' ' ' ILE . 12.6 mt -75.27 114.76 15.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.014 -1.106 . . . . 70.31 108.014 174.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -89.96 -32.27 16.88 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.423 0.452 . . . . 72.43 111.096 -178.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -172.76 146.42 1.61 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.062 0.226 . . . . 74.22 111.555 -170.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.401 HD11 HG22 ' D' ' 13' ' ' ILE . 2.9 mp -126.56 132.27 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 105.79 -1.929 . . . . 72.33 105.79 170.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.419 ' HE1' HG13 ' D' ' 83' ' ' ILE . 28.8 p90 -158.53 150.92 21.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.203 1.001 . . . . 74.44 111.03 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -84.23 119.22 24.78 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.222 -1.808 . . . . 73.52 108.487 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -95.08 -28.53 15.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.34 -0.615 . . . . 74.52 109.34 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.1 t70 -145.16 128.74 17.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.583 -1.189 . . . . 73.03 108.232 175.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.54 HG23 ' HE1' ' C' ' 117' ' ' MET . 73.4 mt -129.92 137.72 55.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.401 -1.333 . . . . 74.24 107.401 172.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -138.24 139.42 39.22 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.438 1.095 . . . . 75.24 108.312 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.602 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -150.61 129.45 12.46 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.093 -1.447 . . . . 74.21 107.093 170.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.7 mt-10 -131.26 150.98 51.92 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.895 0.878 . . . . 75.31 109.178 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.23 78.21 19.2 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 106.946 -1.501 . . . . 75.33 106.946 173.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.8 -22.88 17.18 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.78 2.32 . . . . 75.44 113.596 -170.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -108.15 16.34 23.39 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.102 0.561 . . . . 73.13 110.256 176.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.418 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -39.1 -66.92 0.29 Allowed Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 115.581 1.697 . . . . 72.0 115.581 -160.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.558 ' HB3' HD11 ' C' ' 83' ' ' ILE . 96.2 Cg_endo -74.15 -20.51 18.93 Favored 'Trans proline' 0 C--N 1.387 2.568 0 CA-C-N 122.435 1.905 . . . . 73.14 112.717 -173.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -74.26 -41.05 61.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.148 1.379 . . . . 74.14 110.445 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' D' ' 73' ' ' ALA . 3.6 p -84.04 -20.92 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 115.883 -0.599 . . . . 73.13 111.066 -170.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -62.74 -22.08 66.29 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.076 0.551 . . . . 74.42 112.433 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -65.75 -18.0 65.02 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.489 0.715 . . . . 70.51 111.06 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -84.09 102.55 12.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.489 1.115 . . . . 74.43 108.972 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -84.56 89.42 7.44 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.373 -0.603 . . . . 71.41 109.373 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.412 ' HZ2' ' H ' ' H' ' 471' ' ' LYS . 39.1 t-105 -168.5 158.85 9.84 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.618 1.167 . . . . 71.43 109.368 176.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -72.13 109.8 6.56 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 108.315 -0.994 . . . . 71.41 108.315 169.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.52 125.91 20.07 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.307 2.671 . . . . 64.34 113.329 -173.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.02 115.66 2.75 Favored 'General case' 0 C--N 1.361 1.101 0 O-C-N 124.484 1.115 . . . . 70.04 109.61 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.603 HG23 HG13 ' D' ' 64' ' ' VAL . 3.0 p -96.66 112.76 29.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-O 121.86 0.838 . . . . 75.03 110.562 -170.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -101.91 151.24 22.34 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.846 -1.07 . . . . 75.33 108.258 167.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.49 136.12 47.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.771 0.428 . . . . 73.42 110.637 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.654 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 30.4 m-20 -107.79 150.28 27.19 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 107.376 -1.342 . . . . 74.55 107.376 165.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.439 HD23 ' HE2' ' D' ' 133' ' ' PHE . 18.8 tp -137.36 131.27 31.87 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.584 0.23 . . . . 70.33 110.993 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 34.3 m-20 -138.87 158.42 44.24 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.61 1.164 . . . . 73.21 108.711 170.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.0 t -124.48 175.35 7.2 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.601 0.761 . . . . 72.34 109.189 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.54 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -161.34 163.99 30.38 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.9 0.88 . . . . 74.44 109.448 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 71.9 p -150.26 153.0 35.42 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.617 0.767 . . . . 74.21 109.264 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.7 p -156.62 140.41 16.11 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.485 0.714 . . . . 72.11 110.262 -174.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.63 HE22 HG11 ' H' ' 452' ' ' VAL . 45.9 tp60 -91.56 116.43 28.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.511 0.724 . . . . 75.23 109.064 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' C' ' 29' ' ' PRO . 26.8 mt -98.5 -42.17 7.43 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.093 0.473 . . . . 71.23 110.297 -173.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.16 176.02 10.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.431 1.093 . . . . 71.41 108.097 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.08 130.61 41.33 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.581 -0.526 . . . . 75.21 109.581 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 61.42 11.0 3.45 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 124.425 1.09 . . . . 64.44 112.813 -171.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.67 114.37 43.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 108.211 -1.033 . . . . 75.22 108.211 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.452 ' HE2' ' H ' ' H' ' 453' ' ' GLY . 0.1 OUTLIER -111.12 164.66 12.61 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.175 -1.046 . . . . 73.04 108.175 -175.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.418 ' HB2' HD11 ' D' ' 51' ' ' LEU . 62.3 tt0 -131.04 150.89 51.94 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.838 -0.801 . . . . 74.35 108.838 169.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.61 141.87 42.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.795 1.238 . . . . 70.32 107.874 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 47.2 t -128.1 126.41 66.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.778 -1.194 . . . . 75.22 107.778 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.08 120.9 43.35 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.074 -1.084 . . . . 70.41 108.074 -175.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.41 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 22.3 ttm-85 -100.99 97.63 8.18 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.583 -0.895 . . . . 74.34 108.583 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.19 123.93 47.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.619 -1.252 . . . . 74.4 107.619 167.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.654 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 12.9 m -118.74 130.37 55.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.959 -0.756 . . . . 72.43 108.959 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.603 HG13 HG23 ' D' ' 40' ' ' VAL . 94.2 t -117.48 121.1 66.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.106 0.962 . . . . 63.13 109.157 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.1 m -116.01 104.0 11.15 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.083 -1.08 . . . . 62.22 108.083 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.27 150.57 24.32 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.641 -0.709 . . . . 72.11 110.493 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.405 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 55.1 p -143.96 142.19 30.6 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.705 0.628 . . . . 73.03 111.053 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 21.4 mt -110.32 104.37 13.15 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 124.633 1.173 . . . . 70.14 109.191 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.03 -112.9 3.55 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.443 -0.663 . . . . 71.41 111.443 -177.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -117.52 14.32 14.53 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.249 0.619 . . . . 75.54 111.488 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.58 156.04 45.52 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.071 0.548 . . . . 74.4 110.59 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.5 m -63.4 127.28 30.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.09 0.956 . . . . 63.24 111.502 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.566 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -86.03 -75.78 0.36 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.842 -0.799 . . . . 74.44 108.842 174.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.29 139.46 35.5 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-O 121.349 0.595 . . . . 75.55 110.03 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 80.6 mt -103.54 147.37 27.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.912 -1.144 . . . . 74.03 107.912 171.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.538 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.6 t -158.02 146.66 19.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 122.914 0.486 . . . . 73.02 109.859 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -156.2 134.28 11.29 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 108.858 -0.793 . . . . 64.32 108.858 171.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.32 114.75 24.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 109.104 -0.702 . . . . 75.12 109.104 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.457 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 72.3 mt-30 -89.08 83.23 6.54 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.295 -1.002 . . . . 62.22 108.295 171.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -80.96 99.22 8.29 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.457 -1.702 . . . . 75.25 109.946 -175.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.08 163.62 29.3 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.441 -0.345 . . . . 73.44 112.483 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.465 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -161.96 132.87 2.94 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 111.883 -0.487 . . . . 73.13 111.883 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.419 HG13 ' HE1' ' D' ' 17' ' ' TYR . 43.7 mt -88.93 130.41 38.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 123.822 0.849 . . . . 71.12 109.311 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -133.85 124.23 26.13 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.356 0.662 . . . . 74.42 110.04 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -83.41 105.5 14.41 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.594 -0.891 . . . . 64.52 108.594 170.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.427 HD12 HD12 ' D' ' 98' ' ' LEU . 47.8 pt -109.78 141.93 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 122.985 0.514 . . . . 75.35 110.855 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.436 ' HA ' HG21 ' H' ' 451' ' ' VAL . . . -154.35 159.88 41.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.309 1.044 . . . . 52.24 109.354 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.04 10.59 81.16 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 115.009 0.764 . . . . 54.43 115.009 173.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 24.0 pt -124.06 135.07 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.596 0.758 . . . . 75.24 109.549 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.73 164.9 28.95 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.517 0.727 . . . . 73.14 110.682 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.14 -121.9 25.57 Favored Glycine 0 C--N 1.353 1.481 0 O-C-N 124.091 0.87 . . . . 75.24 114.393 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 12.5 t -72.04 -32.4 67.07 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.691 0.796 . . . . 73.01 111.44 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -71.62 -35.28 70.39 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.167 0.587 . . . . 74.33 110.706 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.543 ' HE1' ' HB2' ' H' ' 454' ' ' LEU . 1.6 tmt? -66.56 -47.48 72.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.295 -0.866 . . . . 73.35 110.154 175.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.54 -28.37 69.89 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.21 -0.905 . . . . 74.1 111.479 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -76.47 -46.51 26.5 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.939 0.896 . . . . 75.24 110.869 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.71 -42.48 73.97 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.013 -0.54 . . . . 75.23 111.296 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.5 HD21 HD23 ' H' ' 454' ' ' LEU . 12.4 tp -84.51 -36.21 22.38 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 122.68 0.392 . . . . 73.42 111.195 -173.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.0 -23.09 42.65 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.036 -0.529 . . . . 61.12 113.705 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' D' ' 134' ' ' ASP . . . -122.17 -56.34 1.83 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.23 0.515 . . . . 74.13 111.949 -175.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . 0.402 ' O ' HG12 ' D' ' 105' ' ' ILE . 63.7 t80 -66.76 -43.36 84.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 111.841 0.312 . . . . 75.43 111.841 -173.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 98.8 m -65.85 -47.83 63.88 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.053 -0.975 . . . . 72.14 112.912 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.464 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.3 Cg_exo -57.0 -36.22 99.25 Favored 'Trans proline' 0 C--N 1.4 3.263 0 C-N-CA 121.847 1.698 . . . . 72.31 112.7 170.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -65.1 -31.22 72.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.851 0.86 . . . . 71.34 111.119 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.402 HG12 ' O ' ' D' ' 101' ' ' TYR . 46.3 mm -68.25 -40.89 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.502 0.721 . . . . 75.32 110.164 173.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.465 HD22 ' HA3' ' D' ' 82' ' ' GLY . 63.3 mt -77.96 -21.82 50.4 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.252 -0.886 . . . . 75.2 111.856 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -64.27 -41.29 59.44 Favored Pre-proline 0 CA--C 1.566 1.562 0 N-CA-C 114.098 1.147 . . . . 72.1 114.098 -172.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -51.19 -43.38 49.05 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.263 1.975 . . . . 73.54 113.56 170.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -72.51 -37.89 68.26 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.57 -0.741 . . . . 74.32 111.03 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.22 -45.11 93.16 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.498 0.719 . . . . 73.13 110.528 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -57.28 -51.85 67.71 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.416 1.072 . . . . 74.13 110.395 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.02 -44.65 96.25 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.175 0.922 . . . . 74.4 112.009 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -54.59 -48.14 72.5 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.91 0.756 . . . . 70.52 110.359 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.538 HG12 ' SG ' ' D' ' 76' ' ' CYS . 82.2 mt -60.4 -54.85 29.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 CA-C-N 114.502 -1.226 . . . . 72.33 110.38 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.0 m -55.39 -39.92 70.75 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.301 1.04 . . . . 74.33 111.806 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -68.05 -41.93 81.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.005 -0.998 . . . . 73.21 110.566 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -70.01 -29.19 66.19 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.8 0.44 . . . . 73.01 111.828 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.426 HG21 ' O ' ' D' ' 114' ' ' ILE . 65.9 t -66.12 -45.1 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 123.961 0.904 . . . . 72.44 109.834 175.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.0 p -74.49 -28.93 61.22 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.992 -0.549 . . . . 73.12 111.251 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 -72.86 -33.5 66.14 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.429 0.692 . . . . 75.05 109.809 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.47 2.01 86.28 Favored Glycine 0 C--N 1.355 1.603 0 CA-C-N 115.769 -0.65 . . . . 75.45 112.165 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.8 p 64.37 18.98 11.62 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 127.142 2.177 . . . . 63.23 113.984 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -80.02 147.38 65.57 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 108.587 -0.894 . . . . 71.22 108.587 168.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.87 148.8 91.19 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.083 1.855 . . . . 73.01 111.463 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -57.8 139.84 53.09 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.723 1.209 . . . . 71.04 113.883 -165.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.479 HD13 HG22 ' D' ' 40' ' ' VAL . 42.2 tp -109.09 102.59 11.55 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.055 -0.975 . . . . 74.02 109.678 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -100.91 104.39 15.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.266 0.626 . . . . 74.11 109.385 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -74.56 118.62 17.72 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.16 0.584 . . . . 74.51 109.441 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.9 136.35 72.89 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.691 0.796 . . . . 72.4 111.368 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.458 ' HB2' ' HH ' ' B' ' 101' ' ' TYR . 72.5 Cg_endo -72.83 118.97 5.81 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.217 1.945 . . . . 75.14 110.76 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.5 p -107.38 136.75 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.521 0.728 . . . . 74.23 110.028 -173.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . 0.571 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 55.0 t30 -76.73 76.27 3.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.688 -1.227 . . . . 73.44 107.688 169.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.439 ' HE2' HD23 ' D' ' 44' ' ' LEU . 87.4 t80 -59.98 -33.15 71.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.075 -1.421 . . . . 74.41 112.006 -172.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.575 ' HA ' ' HB2' ' D' ' 100' ' ' ALA . 17.4 t70 -60.27 -34.8 74.24 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.656 1.182 . . . . 72.54 111.392 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.571 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -67.18 -37.92 84.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.16 -0.927 . . . . 64.13 111.716 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.6 mp -64.21 -33.34 75.58 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.707 0.803 . . . . 72.01 110.956 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.445 ' HD1' ' HZ ' ' H' ' 461' ' ' PHE . 61.3 t80 -65.9 -30.73 71.37 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.121 0.969 . . . . 75.34 111.808 -178.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.55 ' HE3' ' HA ' ' D' ' 135' ' ' ALA . 49.6 mtt -60.71 -23.82 65.19 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.826 0.85 . . . . 62.23 112.136 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -75.59 -42.13 52.82 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.266 0.626 . . . . 72.33 110.847 176.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -58.66 -38.06 77.34 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.026 0.93 . . . . 74.33 111.329 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 5.2 mp -60.4 -31.05 70.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.97 0.908 . . . . 75.04 111.767 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -89.21 1.32 55.85 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.554 0.741 . . . . 64.22 111.586 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -138.15 77.19 1.62 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.057 0.943 . . . . 74.33 109.574 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -162.05 139.52 8.55 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.613 0.765 . . . . 74.55 110.015 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.88 178.33 8.42 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.543 0.737 . . . . 75.04 110.232 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 98.72 175.61 32.34 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 116.01 -0.541 . . . . 71.54 111.965 -174.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -166.53 152.04 8.22 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.278 0.631 . . . . 72.34 111.155 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -92.94 85.65 1.15 Allowed Glycine 0 C--N 1.342 0.915 0 N-CA-C 110.524 -1.03 . . . . 61.02 110.524 172.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 11.4 m -76.27 79.44 3.05 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.358 0.599 . . . . 73.42 110.303 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -86.88 104.06 15.86 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.7 -0.682 . . . . 72.21 109.308 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -82.92 72.78 9.99 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.845 -1.169 . . . . 63.24 107.845 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -78.4 80.13 4.81 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.379 -0.828 . . . . 73.32 109.831 -171.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -96.66 102.62 14.43 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.924 -0.769 . . . . 73.41 108.924 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -65.85 140.34 58.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.632 0.773 . . . . 75.12 109.645 173.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 C-N-CA 123.455 0.702 . . . . 63.44 109.786 -174.382 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.172 -0.677 . . . . 70.43 109.172 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 28.3 m -82.23 -35.21 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 122.943 0.497 . . . . 73.44 111.333 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . 0.556 ' HB ' ' SD ' ' A' ' 94' ' ' MET . 5.2 m -137.34 149.39 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.223 0.609 . . . . 73.43 109.748 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -130.84 83.45 0.31 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.038 -0.825 . . . . 73.52 111.038 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . 0.419 HD22 ' HE3' ' A' ' 94' ' ' MET . 2.4 pp -131.99 141.59 49.33 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.684 0.794 . . . . 74.14 110.279 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 40.6 p -131.16 66.99 1.52 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.084 0.954 . . . . 71.03 109.669 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -78.62 134.78 37.15 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.431 -0.804 . . . . 74.31 109.201 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -108.93 -70.19 0.82 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.553 0.741 . . . . 75.42 111.174 -173.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 52.6 m -148.97 162.01 40.76 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.095 0.958 . . . . 73.34 110.088 -175.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 87.98 142.38 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 127.193 2.197 . . . . 71.32 111.481 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . 0.561 HD22 ' HB ' ' A' ' 46' ' ' THR . 49.5 mt -126.08 175.64 7.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.219 1.008 . . . . 75.34 109.199 168.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -95.37 24.54 5.01 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.884 1.274 . . . . 74.13 110.79 -177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -141.58 135.58 30.21 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.099 0.56 . . . . 75.02 110.265 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 10.2 t -125.05 146.95 49.2 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.705 1.202 . . . . 75.22 108.251 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 464' ' ' MET . . . . . 0.541 ' HG3' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -99.54 105.26 17.13 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.358 -0.608 . . . . 74.34 109.358 -176.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -115.33 -2.12 12.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.267 1.027 . . . . 73.3 111.133 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.03 72.07 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.495 0.718 . . . . 64.53 111.541 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . 62.42 178.69 0.13 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.542 1.137 . . . . 74.02 112.517 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 90.1 mt -133.61 -50.76 0.85 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.436 0.694 . . . . 73.1 110.2 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 79.25 63.5 2.04 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 110.882 -0.887 . . . . 74.24 110.882 -172.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.8 122.71 17.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.692 0.797 . . . . 65.32 110.978 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.556 1.18 0 N-CA-C 108.131 -1.063 . . . . 74.14 108.131 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 108.958 -0.756 . . . . 72.41 108.958 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . 0.697 HG11 ' SD ' ' B' ' 94' ' ' MET . 59.0 t -67.96 -61.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 122.876 0.47 . . . . 73.41 110.862 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 29.9 m -72.18 157.53 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.269 0.628 . . . . 74.32 111.338 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -147.02 -66.06 0.01 OUTLIER Glycine 0 C--N 1.353 1.514 0 N-CA-C 111.594 -0.602 . . . . 62.23 111.594 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 11.0 mp 69.6 -178.52 0.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 125.112 1.365 . . . . 65.11 113.953 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 9.7 t -154.02 164.63 38.13 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 113.952 -1.476 . . . . 65.32 108.885 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.42 113.55 5.38 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.042 0.937 . . . . 74.01 110.678 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -129.71 137.9 50.84 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.985 0.914 . . . . 74.51 109.97 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 47.2 m -102.97 124.54 48.67 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.988 0.915 . . . . 74.24 109.779 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 69.87 146.33 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.083 1.353 . . . . 73.25 111.967 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 91.2 mt -128.76 -61.9 1.04 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.275 -1.009 . . . . 73.14 108.275 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -176.52 161.38 2.16 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.27 1.428 . . . . 72.21 109.534 -173.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.21 -71.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.85 -0.796 . . . . 74.35 108.85 172.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 5.6 m 57.77 39.31 27.22 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.405 1.082 . . . . 60.41 110.723 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 464' ' ' MET . . . . . 0.468 ' HE2' HD22 ' B' ' 42' ' ' LEU . 41.7 ttm -73.16 110.21 7.28 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.137 -0.938 . . . . 74.3 109.458 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -69.53 -51.6 34.17 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.084 0.954 . . . . 71.44 111.489 -171.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -127.4 164.94 20.74 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.871 0.868 . . . . 73.41 109.155 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -59.27 168.63 1.39 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.111 0.964 . . . . 64.21 113.551 -172.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . 0.462 HD12 ' N ' ' F' ' 469' ' ' GLY . 2.2 pp -55.94 -25.15 42.07 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.931 0.892 . . . . 75.14 112.254 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . 0.462 ' N ' HD12 ' F' ' 468' ' ' LEU . . . -168.77 -80.9 0.05 OUTLIER Glycine 0 C--N 1.344 0.979 0 N-CA-C 109.862 -1.295 . . . . 72.21 109.862 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 19.0 tp 59.56 73.02 0.5 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.536 1.135 . . . . 70.3 110.517 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 62.2 tttp . . . . . 0 C--O 1.254 1.303 0 C-N-CA 123.14 0.576 . . . . 74.32 109.95 -173.692 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 121.679 0.752 . . . . 74.12 109.46 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . 0.533 HG21 HG23 ' G' ' 452' ' ' VAL . 7.9 m -153.78 -165.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.775 1.23 . . . . 73.41 109.97 -173.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . 0.533 HG23 HG21 ' G' ' 451' ' ' VAL . 60.4 t 67.69 116.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.28 0 C-N-CA 126.219 1.807 . . . . 75.15 111.124 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 162.7 63.55 0.02 OUTLIER Glycine 0 C--N 1.345 1.066 0 N-CA-C 111.67 -0.572 . . . . 73.14 111.67 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 7.1 mp -95.5 109.76 21.92 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.21 -1.033 . . . . 72.1 108.21 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 23.0 p -58.92 -48.62 80.8 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.622 0.769 . . . . 75.45 111.693 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -119.4 156.29 30.41 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.17 0.588 . . . . 74.25 110.598 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -122.22 2.99 9.82 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.951 1.3 . . . . 74.02 109.952 168.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 20.5 m -76.33 140.96 41.69 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.27 1.028 . . . . 75.02 110.817 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 70.77 131.4 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.663 1.585 . . . . 75.42 111.931 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.19 101.41 2.85 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 106.833 -1.543 . . . . 74.35 106.833 166.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.85 154.1 12.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.152 1.381 . . . . 72.14 113.312 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -149.55 87.29 1.5 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.458 -1.312 . . . . 75.15 107.458 171.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 11.9 t -85.43 14.32 5.61 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.854 0.861 . . . . 73.13 112.363 -168.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 464' ' ' MET . . . . . 0.406 ' SD ' ' HB1' ' C' ' 129' ' ' ALA . 55.4 ttp -66.75 95.4 0.35 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.482 -0.562 . . . . 65.22 109.482 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -66.07 -20.82 66.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.638 1.175 . . . . 75.14 111.372 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -59.02 -21.4 59.01 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 124.026 0.931 . . . . 74.41 111.519 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . 53.71 83.01 0.08 Allowed 'General case' 0 C--N 1.364 1.207 0 C-N-CA 125.189 1.395 . . . . 72.1 111.506 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . 0.672 HD12 HG13 ' C' ' 64' ' ' VAL . 96.1 mt 56.75 -83.02 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.462 1.105 . . . . 73.33 112.54 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.72 -148.14 11.61 Favored Glycine 0 C--O 1.239 0.41 0 N-CA-C 109.653 -1.379 . . . . 72.12 109.653 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . 0.409 HD13 ' HE1' ' C' ' 36' ' ' TRP . 2.6 mm? 70.36 -21.56 0.18 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 125.289 1.436 . . . . 72.21 114.009 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 125.369 1.468 . . . . 72.24 112.108 171.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 7.7 p30 . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 121.345 0.593 . . . . 72.23 109.929 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' D' ' 87' ' ' ALA . 69.6 t -99.49 -13.27 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.729 0.811 . . . . 73.31 109.4 170.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.63 HG11 HE22 ' D' ' 50' ' ' GLN . 25.3 m -112.17 159.0 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.505 0.722 . . . . 75.13 111.126 -176.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . 0.452 ' H ' ' HE2' ' D' ' 56' ' ' TYR . . . 116.22 50.89 0.41 Allowed Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.706 -0.679 . . . . 70.52 112.294 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . 0.543 ' HB2' ' HE1' ' D' ' 94' ' ' MET . 59.9 tp -73.38 142.43 47.0 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.917 0.487 . . . . 71.22 110.341 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 22.5 p -73.04 82.77 1.25 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.849 -0.797 . . . . 72.1 108.849 168.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.35 131.13 47.27 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.442 -0.799 . . . . 64.43 110.918 -176.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.98 128.31 11.3 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.119 -1.437 . . . . 75.02 107.119 -175.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 47.7 p -73.31 -54.1 9.19 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.922 0.489 . . . . 64.31 111.417 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.85 117.55 5.15 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.017 0.927 . . . . 71.32 110.757 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.99 128.1 35.64 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.09 0.472 . . . . 75.32 110.075 -170.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . 0.445 ' HZ ' ' HD1' ' D' ' 137' ' ' PHE . 21.3 p90 -51.82 144.39 11.44 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.256 1.823 . . . . 70.53 112.23 173.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . 0.438 ' CD1' HD22 ' D' ' 44' ' ' LEU . 14.8 t80 -147.94 63.14 1.12 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.368 -0.975 . . . . 72.22 108.368 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 42.8 p -77.56 80.93 4.03 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.752 -1.113 . . . . 71.52 109.778 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 59.8 mtp -126.98 153.47 45.84 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.99 0.916 . . . . 74.24 110.396 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -131.44 174.89 9.62 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 114.249 -1.341 . . . . 75.32 108.626 174.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . 64.49 -77.19 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.568 1.147 . . . . 75.23 110.9 -173.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . 70.78 -64.48 0.37 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.516 1.526 . . . . 63.24 111.777 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . 0.52 ' HB3' HD21 ' H' ' 470' ' ' LEU . 7.2 tt -147.49 147.58 30.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 106.364 -1.717 . . . . 75.44 106.364 171.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . 0.458 ' N ' HD21 ' H' ' 468' ' ' LEU . . . -76.47 75.05 1.65 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 123.073 0.233 . . . . 72.14 113.127 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' H' ' 468' ' ' LEU . 1.7 pt? -146.33 150.62 36.08 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.582 0.753 . . . . 65.02 110.065 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . 0.61 ' HB2' ' HZ1' ' H' ' 471' ' ' LYS . 10.0 mtmp? . . . . . 0 C--O 1.253 1.266 0 N-CA-C 107.02 -1.474 . . . . 73.04 107.02 168.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.6 mpp? . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.399 -0.593 . . . . 64.34 109.399 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.4 m -84.66 15.24 3.95 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.481 0.919 . . . . 65.24 113.481 -168.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -72.18 90.53 1.22 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.662 -0.496 . . . . 75.34 109.662 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -89.46 161.36 16.3 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.404 -0.816 . . . . 75.44 109.696 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -72.98 -70.9 0.33 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.275 -1.009 . . . . 72.22 108.275 171.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 61.35 -65.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.856 1.662 . . . . 74.51 114.028 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 m -39.43 125.64 1.72 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.055 1.742 . . . . 71.32 112.491 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -61.63 -37.38 83.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.449 1.1 . . . . 75.4 110.435 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.411 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.4 mpt? -74.58 164.0 27.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.549 -1.205 . . . . 73.41 109.921 171.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m -140.21 127.7 21.46 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.985 -1.117 . . . . 52.11 107.985 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.511 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -137.81 134.92 35.76 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.529 -0.915 . . . . 73.35 108.529 172.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -149.96 110.96 4.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.215 -1.032 . . . . 65.42 108.215 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 mt -78.14 110.38 13.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.59 -0.892 . . . . 73.55 108.59 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -80.08 -32.62 39.26 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.957 -1.02 . . . . 74.0 110.175 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -177.44 126.25 0.14 Allowed 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.375 0.422 . . . . 75.42 110.415 -172.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.454 HD13 ' CG ' ' C' ' 130' ' ' PRO . 93.8 mt -113.52 130.99 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.424 -0.954 . . . . 72.15 108.424 169.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.459 ' HB3' HG23 ' B' ' 122' ' ' THR . 29.5 p90 -160.18 154.31 23.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.334 1.054 . . . . 64.23 109.561 -172.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.5 p -79.84 120.27 23.86 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.937 -0.764 . . . . 74.01 108.937 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -81.0 -31.23 34.74 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.04 0.448 . . . . 72.14 109.855 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -153.26 143.57 22.41 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.774 -1.103 . . . . 64.2 109.537 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -133.86 145.1 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.852 1.261 . . . . 74.03 108.122 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -144.82 134.38 23.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.346 0.593 . . . . 73.21 109.471 171.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -134.56 131.13 37.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.184 -1.784 . . . . 75.1 106.184 162.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -134.33 142.07 47.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.974 -0.75 . . . . 73.04 108.974 171.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.45 79.08 55.39 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 106.459 -1.682 . . . . 73.54 106.459 169.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.2 -15.23 35.39 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.486 2.124 . . . . 53.34 110.329 174.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -112.44 28.01 9.15 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.848 1.259 . . . . 74.15 111.139 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.491 ' HB2' ' CE2' ' B' ' 17' ' ' TYR . . . -60.12 -54.54 54.27 Favored Pre-proline 0 CA--C 1.575 1.907 0 CA-C-O 118.933 -0.556 . . . . 72.43 111.344 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 11.6 Cg_exo -76.48 -14.93 17.85 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 122.192 1.928 . . . . 75.4 113.373 173.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -69.88 -53.28 18.75 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 109.633 -0.506 . . . . 73.53 109.633 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.558 HG11 ' HE1' ' A' ' 123' ' ' PHE . 12.1 p -64.44 -23.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.783 0.833 . . . . 64.14 111.424 -175.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -58.09 -40.4 81.03 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.607 0.763 . . . . 72.41 110.4 171.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -90.64 -30.3 17.24 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.327 1.051 . . . . 72.02 111.021 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.565 ' HZ2' ' HG3' ' A' ' 71' ' ' GLU . 14.1 mmmm -84.0 172.16 12.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.275 1.03 . . . . 74.42 111.38 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.23 148.59 23.52 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.675 0.79 . . . . 71.54 109.818 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -79.59 90.94 5.15 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.234 0.614 . . . . 74.42 109.761 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.645 HE21 ' HE3' ' E' ' 471' ' ' LYS . 50.6 mt-30 -132.37 42.03 0.81 Allowed Pre-proline 0 CA--C 1.574 1.869 0 C-N-CA 123.313 0.645 . . . . 75.52 112.69 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.481 ' HG2' ' HB2' ' E' ' 470' ' ' LEU . 45.0 Cg_endo -81.47 140.03 11.76 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.308 2.006 . . . . 72.4 113.564 -171.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -98.69 99.96 11.13 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.764 -1.199 . . . . 65.23 107.764 168.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' E' ' 467' ' ' ALA . 48.8 t -83.13 93.33 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 115.619 -0.719 . . . . 74.42 109.999 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -78.4 153.03 31.91 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.869 0.366 . . . . 75.22 110.375 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.1 tp -122.2 130.2 52.98 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.387 -0.824 . . . . 64.05 109.969 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -130.98 146.84 52.51 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.562 1.145 . . . . 71.44 107.916 172.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.538 HD21 HD21 ' A' ' 60' ' ' LEU . 85.2 mt -129.53 148.53 51.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.468 0.707 . . . . 74.43 109.845 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.708 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 14.9 m-20 -132.48 140.14 48.25 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.183 0.993 . . . . 72.13 109.1 172.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.677 ' H ' HD21 ' E' ' 460' ' ' LEU . 24.0 m -108.22 126.2 52.53 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.062 1.345 . . . . 71.3 108.488 174.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.16 146.16 51.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.593 0.757 . . . . 72.11 109.163 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.5 m -134.45 158.51 43.72 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.847 0.459 . . . . 70.11 111.045 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 40.2 t -154.44 129.49 9.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.451 1.1 . . . . 72.34 108.605 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -84.48 107.75 16.9 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.15 -0.685 . . . . 74.23 109.15 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.0 mt -79.57 -38.43 34.1 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.986 0.515 . . . . 73.32 110.372 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.19 -177.03 6.25 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.495 -0.775 . . . . 74.22 110.315 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.13 111.82 2.37 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.875 0.87 . . . . 64.45 109.95 174.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 65.28 17.23 10.92 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.053 1.341 . . . . 75.11 112.873 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.79 116.7 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.223 -1.029 . . . . 73.14 108.223 169.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -110.7 167.57 10.13 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.603 1.192 . . . . 73.22 111.501 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 9.6 tp10 -128.78 126.43 39.92 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 112.393 -2.185 . . . . 54.34 105.661 169.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.24 131.27 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 107.482 -1.303 . . . . 72.52 107.482 173.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 21.9 t -119.49 115.52 47.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 124.128 0.971 . . . . 74.12 108.656 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.538 HD21 HD21 ' A' ' 44' ' ' LEU . 3.7 tt -88.19 98.01 11.32 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.322 -1.733 . . . . 72.32 106.322 167.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.708 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 46.8 ttt-85 -85.61 101.97 13.16 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.952 -1.129 . . . . 72.25 107.952 174.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.528 HG12 ' HB1' ' A' ' 110' ' ' ALA . 2.3 p -105.02 124.26 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.294 0.637 . . . . 74.21 110.291 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.0 m -108.13 130.84 55.09 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 123.846 0.858 . . . . 74.32 109.593 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.402 ' O ' HD13 ' A' ' 75' ' ' LEU . 45.9 t -126.32 122.65 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.02 1.328 . . . . 74.13 107.973 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 t -128.88 120.59 26.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.018 0.527 . . . . 71.54 109.68 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.15 110.18 22.45 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.589 -0.893 . . . . 73.21 108.589 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.3 p -124.88 126.89 46.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.862 0.465 . . . . 75.14 111.403 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -104.62 84.78 2.22 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.806 -1.183 . . . . 73.34 107.806 166.843 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.94 -117.32 5.08 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.386 -0.824 . . . . 31.43 111.846 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -87.94 -23.22 23.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.056 0.542 . . . . 71.23 109.889 175.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.565 ' HG3' ' HZ2' ' A' ' 34' ' ' LYS . 7.1 mm-40 -81.53 134.87 35.57 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.026 0.93 . . . . 74.32 110.725 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.3 m -83.15 154.37 24.33 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.072 0.949 . . . . 73.5 109.148 168.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.9 -61.18 1.4 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.197 -1.038 . . . . 61.03 108.197 164.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -151.07 170.36 19.58 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.53 -1.214 . . . . 73.51 110.722 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 64' ' ' VAL . 51.2 tp -138.83 129.22 25.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.043 1.337 . . . . 65.21 107.729 177.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.3 m -136.07 117.6 14.83 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.809 0.844 . . . . 74.15 108.761 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -138.79 115.38 10.59 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.274 -0.639 . . . . 61.33 109.274 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.7 t -123.99 115.72 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.202 1.001 . . . . 74.13 109.498 -171.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.625 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 17.3 mt-30 -87.85 82.43 7.3 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.156 -1.053 . . . . 73.44 108.156 169.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.4 115.5 16.2 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.022 -1.103 . . . . 73.2 108.022 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.14 170.85 13.59 Favored Glycine 0 C--O 1.242 0.618 0 CA-C-O 121.227 0.348 . . . . 64.1 112.255 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.51 136.05 3.97 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.144 -0.528 . . . . 74.33 112.0 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.5 mt -81.1 122.84 36.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 108.131 -1.063 . . . . 72.43 108.131 169.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.511 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.3 m-85 -130.95 118.49 20.74 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.717 -0.846 . . . . 71.12 108.717 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.5 p -94.98 118.11 31.27 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.896 -0.779 . . . . 74.24 108.896 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.55 157.11 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.137 0.975 . . . . 64.41 110.624 -174.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.48 154.01 13.71 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.975 0.91 . . . . 74.32 109.947 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.4 9.63 61.51 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 113.752 0.261 . . . . 73.32 113.752 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.617 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -133.19 145.09 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.937 0.895 . . . . 65.21 109.934 178.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.541 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.6 tt0 -156.13 174.13 15.82 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.15 0.58 . . . . 74.33 109.819 177.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.541 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 60.07 -116.94 9.81 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.678 0.656 . . . . 65.34 113.444 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.4 p -71.55 -27.01 62.87 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.745 0.818 . . . . 75.41 110.934 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -71.02 -36.2 72.3 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.762 0.825 . . . . 73.33 110.432 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.462 ' HE2' ' HA ' ' A' ' 90' ' ' GLU . 49.3 ttm -73.11 -37.17 66.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.068 0.547 . . . . 72.43 110.09 175.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 -24.69 66.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.792 -0.64 . . . . 73.1 110.231 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.472 ' NE2' ' HB3' ' A' ' 100' ' ' ALA . 9.8 t-160 -83.38 -25.95 30.91 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.562 0.745 . . . . 63.03 111.204 176.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.617 ' SG ' HG13 ' A' ' 89' ' ' ILE . 74.0 m -56.86 -43.21 80.98 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.004 0.431 . . . . 73.44 110.492 175.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -90.73 -20.74 22.09 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.567 -0.742 . . . . 70.24 111.268 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -38.56 41.8 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 114.071 0.388 . . . . 74.11 114.071 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.472 ' HB3' ' NE2' ' A' ' 96' ' ' HIS . . . -150.88 -47.12 0.12 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 117.508 0.654 . . . . 63.2 112.004 -175.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.425 ' HH ' ' HB2' ' A' ' 11' ' ' PHE . 31.2 t80 -45.08 -70.24 0.11 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 126.053 1.741 . . . . 74.42 112.865 -175.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.1 m -81.29 -34.53 0.73 Allowed Pre-proline 0 CA--C 1.572 1.79 0 N-CA-C 115.462 1.653 . . . . 64.24 115.462 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.436 ' O ' HD13 ' A' ' 60' ' ' LEU . 37.4 Cg_endo -63.88 -34.74 59.27 Favored 'Trans proline' 0 C--N 1.399 3.231 0 CA-C-N 122.701 2.0 . . . . 72.21 112.619 175.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -66.56 -26.62 67.21 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 120.716 0.293 . . . . 65.15 111.299 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.06 -43.44 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.67 0.788 . . . . 75.53 110.18 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.03 -14.66 59.42 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.061 0.944 . . . . 74.34 112.479 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.16 -49.38 84.93 Favored Pre-proline 0 CA--C 1.565 1.555 0 N-CA-C 113.486 0.921 . . . . 74.44 113.486 -171.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.1 -32.3 75.09 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 121.929 1.753 . . . . 72.35 112.572 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -74.48 -37.63 63.13 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.694 0.798 . . . . 71.02 111.58 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.528 ' HB1' HG12 ' A' ' 62' ' ' VAL . . . -70.26 -45.15 67.02 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.843 0.457 . . . . 61.3 110.099 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.408 ' NH1' HD13 ' C' ' 105' ' ' ILE . 31.9 ttm180 -54.2 -47.73 71.79 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.365 1.041 . . . . 75.24 110.342 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.27 -46.38 89.06 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.139 0.9 . . . . 74.02 111.725 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 117' ' ' MET . 37.1 t -59.81 -38.39 81.82 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.408 0.683 . . . . 75.24 110.537 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.2 mt -70.82 -47.84 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.034 0.934 . . . . 73.35 110.896 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -54.41 -38.16 65.91 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.791 0.836 . . . . 74.1 110.343 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.6 t -65.86 -47.01 76.34 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.325 -1.307 . . . . 75.53 110.253 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 34.0 mmt -57.18 -48.21 79.32 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.159 0.583 . . . . 71.32 111.246 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 114' ' ' ILE . 58.6 t -64.27 -48.63 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.443 1.097 . . . . 72.03 111.046 -175.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -69.97 -29.57 66.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.33 0.652 . . . . 74.23 112.209 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -71.11 -28.33 64.23 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.832 0.453 . . . . 75.4 110.255 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.48 7.97 66.65 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-O 119.755 -0.469 . . . . 55.34 113.126 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.404 ' HB ' HH21 ' B' ' 15' ' ' ARG . 15.7 m 68.28 15.01 9.3 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.776 1.231 . . . . 72.32 111.245 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.558 ' HE1' HG11 ' A' ' 31' ' ' VAL . 63.6 m-85 -89.54 144.5 32.12 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.451 -0.944 . . . . 74.11 108.451 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.37 142.89 88.12 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.822 2.348 . . . . 74.33 111.898 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.25 138.45 16.47 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.391 1.076 . . . . 72.34 112.486 -175.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.1 tp -115.6 103.03 10.31 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.732 -1.122 . . . . 62.23 110.062 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -111.47 96.85 6.35 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.044 -1.095 . . . . 73.41 108.044 168.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.9 151.28 47.86 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.422 -0.808 . . . . 74.31 110.056 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.69 145.72 95.21 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.745 0.818 . . . . 74.3 111.73 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -57.68 127.62 26.0 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.832 2.355 . . . . 73.44 112.657 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.442 HG22 ' HE3' ' E' ' 464' ' ' MET . 93.8 t -102.04 115.97 44.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 124.457 1.103 . . . . 71.14 109.243 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -84.86 93.62 8.55 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.521 -0.918 . . . . 72.53 108.521 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -65.06 -27.36 68.73 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.657 0.783 . . . . 74.44 111.801 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -66.72 -47.15 73.21 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.935 0.494 . . . . 72.53 110.175 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.04 -50.88 71.92 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.114 0.884 . . . . 73.24 109.912 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.47 ' HB3' ' CD1' ' E' ' 461' ' ' PHE . 52.2 mt -62.29 -38.42 89.3 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.647 -1.16 . . . . 74.24 112.343 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.493 ' CE1' HD21 ' A' ' 141' ' ' LEU . 30.2 t80 -65.82 -46.78 77.33 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.361 0.665 . . . . 74.41 110.472 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.47 ' SD ' HD23 ' A' ' 141' ' ' LEU . 94.2 mmm -70.62 -26.76 63.63 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.913 -0.585 . . . . 72.22 110.624 -175.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.559 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 93.4 m-20 -58.57 -38.9 78.86 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.719 0.808 . . . . 74.21 111.014 171.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.541 ' HB2' ' HB3' ' E' ' 461' ' ' PHE . 0.4 OUTLIER -70.61 -48.01 57.27 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.522 1.129 . . . . 73.42 111.048 173.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.493 HD21 ' CE1' ' A' ' 137' ' ' PHE . 23.0 tp -70.13 -38.89 75.65 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 113.941 -1.481 . . . . 74.53 113.626 -166.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.477 ' NE2' ' HB3' ' C' ' 150' ' ' GLU . 11.8 pt20 -158.24 5.02 0.12 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.442 0.697 . . . . 74.24 111.442 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.559 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 28.6 tt0 62.92 -153.29 0.34 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.222 1.009 . . . . 75.45 108.957 -165.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.508 ' H ' ' HG2' ' A' ' 143' ' ' GLN . 13.8 mt-30 65.49 82.98 0.17 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.823 0.849 . . . . 74.42 111.221 171.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.22 62.91 7.71 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 122.172 0.987 . . . . 73.23 109.135 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.33 -163.56 31.66 Favored Glycine 0 C--O 1.243 0.69 0 CA-C-N 114.307 -1.315 . . . . 73.13 111.322 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 56.53 -90.7 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.502 1.121 . . . . 73.03 109.813 -170.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 55.92 27.6 51.08 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 115.047 0.779 . . . . 64.45 115.047 172.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -147.19 160.57 42.31 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.383 0.673 . . . . 74.31 110.185 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -152.29 138.52 18.37 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.807 0.843 . . . . 75.14 109.251 175.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -107.09 139.93 40.73 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.994 0.918 . . . . 75.53 109.163 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -132.02 21.95 4.52 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.829 0.852 . . . . 73.01 112.081 -169.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -84.51 55.39 3.37 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.546 0.689 . . . . 71.41 112.042 -177.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.81 104.37 2.88 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.037 0.535 . . . . 64.24 109.95 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.274 0 C-N-CA 123.942 0.897 . . . . 74.33 110.414 179.224 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 109.873 -0.417 . . . . 72.51 109.873 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.9 m -146.66 -171.31 3.72 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.537 1.135 . . . . 60.13 109.702 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' B' ' 4' ' ' GLN . 14.6 tt0 -138.9 172.15 13.28 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.643 0.777 . . . . 75.11 109.058 175.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.491 ' H ' ' HG2' ' B' ' 3' ' ' GLU . 37.0 mt-30 -81.24 -23.69 37.88 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.446 0.698 . . . . 73.23 109.949 175.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 17.8 m120 70.38 95.3 0.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.559 1.544 . . . . 75.22 113.1 172.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -77.09 86.64 3.58 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.294 0.638 . . . . 74.31 109.505 172.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 14.4 t -161.7 176.7 10.67 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.677 0.791 . . . . 73.13 109.898 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.7 123.11 17.04 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.192 -1.04 . . . . 71.33 108.192 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.6 ptm 46.74 -168.46 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.548 1.539 . . . . 75.44 112.784 -171.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 56.0 m -147.57 129.09 14.98 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.875 -1.157 . . . . 73.04 107.875 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -147.37 140.97 25.54 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.801 -0.814 . . . . 72.3 108.801 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -153.0 141.21 20.5 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.17 -0.678 . . . . 72.21 109.17 175.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 mt -85.86 121.26 37.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.179 -1.045 . . . . 73.41 108.179 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -88.08 -42.45 12.38 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.527 0.517 . . . . 72.13 109.931 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.438 ' HG2' ' HD1' ' B' ' 17' ' ' TYR . 65.5 ttt180 -167.8 133.76 2.01 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.765 -0.652 . . . . 75.04 109.695 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.0 mt -115.15 140.48 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.025 -1.472 . . . . 73.04 107.025 168.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.491 ' CE2' ' HB2' ' A' ' 28' ' ' ALA . 34.8 p90 -164.25 158.34 18.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.881 0.848 . . . . 74.24 111.544 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 96.9 m -83.6 120.84 26.45 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.43 -1.259 . . . . 74.24 108.545 171.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.401 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 35.8 mtpt -88.43 -33.38 17.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.44 0.696 . . . . 74.32 110.423 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.5 t70 -150.82 135.94 17.62 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.739 -0.664 . . . . 72.3 110.826 -171.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.539 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.2 mm -127.98 139.79 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.617 1.167 . . . . 74.12 108.678 166.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 43.5 t -140.93 131.34 25.21 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.077 -1.083 . . . . 72.54 108.077 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -141.89 115.4 9.01 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.861 -1.163 . . . . 73.24 107.861 170.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 36.5 mt-10 -118.26 112.54 20.22 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.902 -1.148 . . . . 60.24 107.902 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' B' ' 28' ' ' ALA . . . -106.83 83.23 1.22 Allowed Pre-proline 0 C--O 1.24 0.575 0 N-CA-C 106.311 -1.737 . . . . 72.1 106.311 164.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.91 -13.74 29.25 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 122.459 2.106 . . . . 74.23 112.139 -171.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -123.59 12.48 9.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.075 0.95 . . . . 71.31 110.774 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.417 ' HB3' ' HB1' ' B' ' 25' ' ' ALA . . . -34.86 -62.7 0.4 Allowed Pre-proline 0 N--CA 1.501 2.096 0 N-CA-C 114.456 1.28 . . . . 74.1 114.456 -170.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.18 -36.3 81.35 Favored 'Trans proline' 0 C--N 1.396 3.067 0 C-N-CA 122.154 1.903 . . . . 65.1 113.429 -174.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -92.1 -18.8 23.06 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.891 0.7 . . . . 74.4 112.891 -173.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.684 HG23 HD13 ' B' ' 68' ' ' LEU . 8.6 p -83.12 -19.91 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 118.69 0.677 . . . . 72.14 111.422 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -67.91 -14.38 62.92 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 112.94 0.719 . . . . 74.3 112.94 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.469 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.8 pt20 -60.49 -26.32 66.73 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.125 0.488 . . . . 71.51 110.371 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.558 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 88.2 mttt -101.66 87.65 3.21 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.535 1.134 . . . . 74.42 108.728 175.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -79.54 101.98 8.57 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.315 -0.624 . . . . 71.33 109.315 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -172.66 158.01 3.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.48 1.112 . . . . 74.11 108.877 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' B' ' 124' ' ' PRO . 47.6 mt-30 -64.65 107.59 1.47 Allowed Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.948 0.899 . . . . 74.14 109.123 168.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.616 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.7 Cg_endo -59.14 160.86 17.67 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 123.351 2.7 . . . . 71.55 113.653 -176.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -59.81 103.02 0.18 Allowed 'General case' 0 C--N 1.35 0.614 0 N-CA-C 107.722 -1.214 . . . . 71.32 107.722 169.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.0 m -91.55 161.22 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.3 -0.864 . . . . 65.04 110.509 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -135.71 113.75 11.27 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.398 -1.334 . . . . 75.12 107.398 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.587 HD12 ' HB3' ' F' ' 468' ' ' LEU . 4.1 tt -85.2 126.2 33.46 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.692 -1.595 . . . . 73.33 106.692 173.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.72 144.79 26.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.942 -1.132 . . . . 64.13 107.942 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -146.63 160.02 42.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.061 0.544 . . . . 74.11 110.145 174.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -143.65 150.17 38.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.037 0.935 . . . . 63.3 109.335 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -125.52 115.26 19.93 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.007 0.923 . . . . 73.51 109.85 -174.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.02 161.66 19.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.479 1.112 . . . . 73.34 108.501 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 77.4 p -145.37 162.84 36.3 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.538 0.335 . . . . 73.14 110.351 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -154.49 136.19 14.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.684 0.794 . . . . 75.24 109.543 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -89.89 116.06 27.68 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.924 -0.398 . . . . 73.13 109.924 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 24.5 mt -80.25 -52.15 8.07 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.146 0.978 . . . . 72.54 110.741 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.32 -168.53 2.56 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.42 1.088 . . . . 73.42 109.013 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -63.05 100.8 0.23 Allowed 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.492 0.495 . . . . 75.15 110.205 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 63.62 16.16 9.47 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.064 1.345 . . . . 75.25 113.227 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 69.1 t -103.44 101.12 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 105.065 -2.198 . . . . 65.22 105.065 167.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -118.97 168.93 10.34 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.388 -0.967 . . . . 73.3 108.388 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -144.9 111.86 5.91 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.433 -0.951 . . . . 72.2 108.433 -171.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -96.27 137.78 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 O-C-N 124.029 0.831 . . . . 64.25 109.471 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 37.3 t -113.48 117.64 56.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.808 0.843 . . . . 75.44 109.274 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.39 110.73 23.23 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.317 -1.364 . . . . 75.32 107.317 173.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -100.31 128.85 46.28 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.794 -0.817 . . . . 74.13 108.794 173.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.475 ' HB ' HD11 ' B' ' 114' ' ' ILE . 11.4 t -126.91 123.7 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.024 -1.102 . . . . 70.23 108.024 172.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -118.81 134.52 55.1 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.704 0.802 . . . . 73.12 110.807 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.571 HG22 HG21 ' B' ' 114' ' ' ILE . 66.8 t -120.26 101.77 11.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.488 1.515 . . . . 74.31 108.452 177.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 90.5 m -84.65 135.28 34.24 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.883 -1.155 . . . . 75.42 107.883 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.22 141.48 26.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.935 0.334 . . . . 74.42 111.325 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 58.2 p -148.84 135.3 19.49 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.226 0.61 . . . . 70.33 111.341 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.684 HD13 HG23 ' B' ' 31' ' ' VAL . 24.1 mt -96.67 115.3 27.21 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 124.395 1.078 . . . . 73.53 109.995 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.32 -108.44 2.36 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 115.477 -0.783 . . . . 61.51 112.492 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -116.19 2.1 13.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.404 0.681 . . . . 55.32 110.982 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.558 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 14.7 pt-20 -116.2 145.28 43.23 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.438 -0.578 . . . . 73.21 109.438 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 51.2 m -64.74 135.91 56.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.972 0.509 . . . . 63.35 110.778 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.554 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.29 -64.26 1.13 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.339 -0.986 . . . . 64.03 108.339 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -154.11 154.7 34.07 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.79 -1.096 . . . . 73.22 109.827 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 41.6 mt -131.95 108.7 9.55 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.917 -1.883 . . . . 73.54 105.917 176.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.4 t -118.26 143.38 46.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.48 -0.933 . . . . 74.2 108.48 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -157.14 129.31 7.29 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.627 -0.879 . . . . 73.1 108.627 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 81.1 t -123.42 146.35 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.638 0.775 . . . . 73.01 109.148 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.2 mt-30 -123.58 96.17 4.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.405 -0.961 . . . . 72.42 108.405 169.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.517 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.0 tp-100 -86.47 99.52 11.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.503 -0.925 . . . . 74.15 108.503 174.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.23 167.96 33.34 Favored Glycine 0 C--O 1.244 0.734 0 N-CA-C 110.906 -0.877 . . . . 54.24 110.906 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.19 125.46 1.42 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 112.299 -0.32 . . . . 74.11 112.299 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 53.0 mt -85.85 128.91 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.02 0.928 . . . . 75.12 108.982 172.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -134.62 158.87 42.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.617 1.167 . . . . 74.42 108.366 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.6 m -131.83 129.26 40.23 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.854 -0.795 . . . . 74.52 108.854 171.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 13.9 tt -139.9 145.54 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.093 0.557 . . . . 73.11 110.686 -175.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.17 164.24 34.54 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.45 1.1 . . . . 72.23 109.162 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.21 -25.23 15.3 Favored Glycine 0 N--CA 1.475 1.264 0 CA-C-O 121.039 0.244 . . . . 62.24 112.502 -175.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 17.3 tt -88.91 133.03 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.722 1.209 . . . . 74.31 111.849 -167.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -149.6 -176.47 5.42 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.193 1.397 . . . . 74.54 109.219 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.05 -134.11 27.01 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 114.897 -1.047 . . . . 64.11 113.162 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 61.0 m -73.39 -29.19 62.44 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.175 0.99 . . . . 74.25 111.417 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -57.96 -33.34 68.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.562 0.745 . . . . 64.11 111.863 -171.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 22.9 ptm -60.4 -39.84 88.78 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.705 0.802 . . . . 74.4 111.194 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.81 -32.45 59.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.834 0.854 . . . . 65.25 110.319 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -68.57 -28.3 66.84 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.014 -0.994 . . . . 74.01 111.303 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.485 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 48.9 t -75.4 -66.61 0.75 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.089 0.555 . . . . 74.2 110.162 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.95 -26.42 65.05 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.123 0.569 . . . . 73.3 111.967 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.87 -9.8 62.1 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-O 119.489 -0.617 . . . . 60.03 114.462 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.59 -56.21 0.13 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.818 0.809 . . . . 60.21 113.177 -167.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 92.7 t80 -67.6 -49.48 62.91 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.366 0.667 . . . . 72.32 111.899 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.45 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.1 m -61.96 -51.51 74.66 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.646 0.779 . . . . 74.2 111.604 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 89.0 Cg_exo -53.5 -35.34 75.97 Favored 'Trans proline' 0 C--N 1.4 3.262 0 C-N-CA 122.547 2.165 . . . . 73.14 114.332 172.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -58.63 -43.87 89.83 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 123.359 0.664 . . . . 71.13 110.612 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mt -59.71 -41.0 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.167 0.987 . . . . 74.55 110.912 177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 46.9 mt -84.5 -17.05 40.29 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.236 1.014 . . . . 73.45 112.207 -172.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -58.83 -50.07 89.97 Favored Pre-proline 0 CA--C 1.556 1.182 0 N-CA-C 114.02 1.119 . . . . 75.11 114.02 -170.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.49 -34.33 92.95 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.03 1.82 . . . . 72.03 113.12 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.517 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 74.4 m-85 -65.69 -50.45 64.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.001 0.52 . . . . 75.01 110.091 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.16 81.47 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.818 0.847 . . . . 70.13 111.197 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.42 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 36.0 ttt180 -63.89 -53.5 49.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.409 1.483 . . . . 73.21 111.18 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.92 -38.43 90.96 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.874 0.734 . . . . 75.12 109.71 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' B' ' 21' ' ' ILE . 3.2 t -66.63 -36.66 83.11 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.511 -0.768 . . . . 71.32 111.958 -174.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.571 HG21 HG22 ' B' ' 64' ' ' VAL . 66.3 mt -62.11 -56.59 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 109.104 -0.702 . . . . 73.51 109.104 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.8 m -60.85 -25.61 66.78 Favored 'General case' 0 CA--C 1.556 1.21 0 O-C-N 124.334 1.021 . . . . 71.1 111.648 -173.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.9 t -68.3 -46.19 70.98 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.7 0.8 . . . . 75.11 110.261 175.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 7.9 mmt -72.54 -34.65 67.69 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.89 0.476 . . . . 74.3 111.063 -177.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 114' ' ' ILE . 93.8 t -57.53 -44.22 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.231 1.013 . . . . 74.53 109.567 171.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.5 t -70.74 -30.88 67.53 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.427 -1.26 . . . . 74.33 112.07 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' ' 116' ' ' SER . 89.1 mtt-85 -69.8 -36.03 75.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.983 0.513 . . . . 73.45 110.036 177.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.64 1.95 84.34 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.592 0.558 . . . . 72.25 112.559 171.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 17' ' ' TYR . 26.7 p 62.18 30.77 17.75 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.687 1.995 . . . . 73.24 113.0 172.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -85.16 155.05 60.63 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.667 0.787 . . . . 74.2 110.095 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.505 ' HB2' ' HG2' ' B' ' 37' ' ' GLN . 48.0 Cg_exo -57.15 168.82 2.38 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.231 2.621 . . . . 74.1 114.537 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.416 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 63.9 tp60 -56.85 133.42 54.44 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.573 1.149 . . . . 75.14 112.065 -172.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.47 102.48 6.65 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.269 -1.012 . . . . 75.23 108.269 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.53 101.31 12.21 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.611 0.764 . . . . 74.5 109.553 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.42 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 0.2 OUTLIER -61.28 129.35 40.83 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 109.259 -0.645 . . . . 75.25 109.259 179.451 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.69 ' HB3' ' SD ' ' F' ' 464' ' ' MET . . . -77.64 152.13 80.47 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 123.625 0.77 . . . . 73.24 111.941 -173.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.423 ' HG2' ' HB ' ' D' ' 13' ' ' ILE . 6.2 Cg_endo -81.26 109.69 2.16 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.25 2.633 . . . . 63.44 112.137 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 t -115.06 112.4 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.19 -0.67 . . . . 72.11 109.19 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' B' ' 136' ' ' LEU . 56.2 t-20 -85.24 112.85 21.12 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.905 -0.776 . . . . 75.11 108.905 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -89.86 -27.47 19.9 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.01 0.744 . . . . 72.21 113.01 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -73.77 -42.71 60.68 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 118.602 0.637 . . . . 73.42 111.416 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.2 89.25 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.542 0.737 . . . . 61.41 110.307 172.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' B' ' 132' ' ' ASN . 0.9 OUTLIER -68.78 -33.5 73.98 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.079 0.951 . . . . 75.32 110.25 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.514 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 80.3 t80 -60.69 -35.57 76.61 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.429 0.692 . . . . 74.44 110.767 -175.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 23.4 mmt -62.24 -36.88 83.37 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.044 0.449 . . . . 75.52 111.242 176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -76.28 -29.43 57.4 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.79 0.836 . . . . 72.3 111.017 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -60.13 -32.1 70.69 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.39 1.076 . . . . 75.34 110.965 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 7.0 mt -89.02 11.19 19.0 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.9 0.88 . . . . 72.35 110.864 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 61.85 19.44 10.64 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.071 1.348 . . . . 74.11 111.953 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -85.46 135.09 33.99 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.966 0.507 . . . . 74.31 110.695 -176.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -116.4 105.13 12.17 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.478 -1.304 . . . . 74.54 107.478 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.11 123.91 14.08 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.691 1.196 . . . . 72.11 111.004 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.47 76.2 0.51 Allowed Glycine 0 C--N 1.351 1.385 0 O-C-N 123.958 0.786 . . . . 54.03 112.776 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -164.05 63.55 0.15 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.909 1.284 . . . . 74.14 108.999 -175.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.13 56.84 4.86 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.468 -0.787 . . . . 62.45 112.094 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 5.7 t -116.34 132.97 56.52 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.637 1.175 . . . . 72.34 108.564 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -169.34 158.96 8.42 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.273 -0.64 . . . . 74.33 109.273 -171.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.35 151.74 44.91 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.668 0.747 . . . . 73.35 110.595 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -126.94 4.84 6.54 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.657 -1.156 . . . . 72.32 108.691 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -162.78 149.96 13.25 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 125.034 1.334 . . . . 74.33 108.307 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -74.68 86.77 2.16 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.731 0.776 . . . . 75.15 109.713 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.854 0 CA-C-N 115.541 -0.754 . . . . 70.41 109.491 179.115 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 35.1 ttm . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 108.907 -0.775 . . . . 65.13 108.907 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.1 p -111.6 83.84 1.85 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 107.877 -1.157 . . . . 73.52 107.877 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -102.47 -27.23 12.91 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.849 -1.069 . . . . 73.44 111.719 -169.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -149.31 110.35 4.36 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.252 0.621 . . . . 74.5 109.632 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -152.37 146.63 25.49 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.452 1.101 . . . . 73.15 109.477 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 63.52 15.17 8.62 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.051 1.34 . . . . 73.33 112.837 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 32.2 p -74.31 100.07 3.65 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.605 0.762 . . . . 74.12 109.1 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.55 87.96 0.67 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.851 0.86 . . . . 63.14 111.018 -173.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.423 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 27.6 ttt 64.2 114.86 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.681 1.592 . . . . 75.24 112.648 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 90.9 m -101.88 99.67 9.9 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.93 -0.766 . . . . 74.31 108.93 171.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -94.31 140.83 29.29 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.535 -0.757 . . . . 74.35 109.387 175.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.63 136.05 15.92 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.536 -0.542 . . . . 73.43 109.536 172.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.14 127.84 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.517 -0.92 . . . . 74.51 108.517 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.504 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.8 mm-40 -89.8 -47.47 7.88 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.207 -0.664 . . . . 75.31 109.207 174.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -175.0 134.41 0.34 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.798 -0.637 . . . . 62.23 109.836 -170.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.8 mt -117.34 144.98 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.791 -1.189 . . . . 74.44 107.791 176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.433 ' CE2' ' HG2' ' C' ' 19' ' ' LYS . 36.7 p90 -171.53 161.72 6.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.506 0.669 . . . . 73.24 111.301 -174.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.9 p -88.63 112.51 23.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.876 -1.157 . . . . 73.43 107.876 169.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.433 ' HG2' ' CE2' ' C' ' 17' ' ' TYR . 18.1 mttt -67.44 -48.97 65.67 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 122.24 1.019 . . . . 73.21 108.345 171.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.34 133.37 36.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 113.599 -1.637 . . . . 74.13 109.045 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 79.6 mt -124.49 141.31 45.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.692 -1.596 . . . . 72.24 106.692 172.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -153.92 147.61 25.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.398 0.618 . . . . 62.33 110.997 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 81.7 t80 -146.37 132.12 18.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 106.899 -1.519 . . . . 71.42 106.899 169.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -132.54 124.93 29.4 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.729 0.811 . . . . 73.14 109.35 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.41 79.87 29.03 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.06 -1.459 . . . . 72.54 107.06 172.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.72 -26.74 19.05 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.748 2.299 . . . . 74.22 111.569 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -102.43 17.6 23.16 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.283 1.033 . . . . 73.41 110.218 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.437 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -47.96 -59.63 5.53 Favored Pre-proline 0 C--N 1.371 1.512 0 N-CA-C 114.774 1.398 . . . . 62.4 114.774 -166.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.14 -42.36 36.53 Favored 'Trans proline' 0 C--N 1.393 2.917 0 CA-C-N 121.834 1.691 . . . . 55.04 111.919 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -69.73 -33.16 72.1 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.402 -1.272 . . . . 71.13 112.232 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.639 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.0 p -79.43 -21.6 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 O-C-N 122.094 -0.379 . . . . 75.43 111.867 -176.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -69.83 -22.18 63.31 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.762 0.425 . . . . 71.33 111.742 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -97.29 19.46 13.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.671 0.388 . . . . 75.23 111.295 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.749 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -91.76 149.83 21.41 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.902 -0.777 . . . . 75.33 108.902 170.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -69.41 129.7 40.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.88 -0.785 . . . . 70.45 108.88 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -68.51 109.72 3.85 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.165 0.586 . . . . 75.04 111.418 -172.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -163.08 70.19 1.93 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.948 0.899 . . . . 54.41 108.879 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -88.52 128.5 2.12 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.94 2.427 . . . . 62.3 112.818 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.436 ' HB3' ' HE2' ' C' ' 41' ' ' LYS . 26.4 mt-10 -84.68 94.96 8.76 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.381 -0.97 . . . . 74.14 108.381 168.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 m -74.7 99.17 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-N 114.419 -1.264 . . . . 64.53 110.314 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.436 ' HE2' ' HB3' ' C' ' 39' ' ' GLU . 73.4 mmtt -92.76 103.35 15.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.76 -1.109 . . . . 72.14 108.497 177.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.477 HD11 HD12 ' C' ' 128' ' ' LEU . 7.3 tt -95.04 136.71 35.03 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.913 -0.773 . . . . 74.41 108.913 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -118.4 112.73 20.37 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.253 1.421 . . . . 73.2 107.739 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.534 HD23 HD13 ' G' ' 460' ' ' LEU . 14.7 tp -104.14 133.96 48.2 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.926 -0.768 . . . . 75.11 108.926 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.4 t70 -140.47 149.33 42.4 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.045 0.938 . . . . 74.13 109.153 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' THR . . . . . 0.517 ' O ' ' HB3' ' G' ' 457' ' ' GLN . 7.9 m -132.57 130.36 40.21 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 123.505 0.722 . . . . 74.22 109.301 169.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.37 153.23 26.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.933 1.293 . . . . 72.14 108.241 175.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 17.8 p -149.85 140.92 22.97 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.711 -0.477 . . . . 74.4 109.711 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -161.16 150.81 16.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.878 0.871 . . . . 73.31 109.453 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -86.08 132.7 33.98 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.936 -0.394 . . . . 74.02 109.936 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' C' ' 57' ' ' GLU . 50.0 mt -98.88 -38.41 9.04 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.426 0.69 . . . . 74.32 109.269 173.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.63 178.0 10.77 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.229 1.012 . . . . 72.34 109.635 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.89 123.17 17.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.94 0.496 . . . . 73.34 109.891 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 71.38 -8.77 0.98 Allowed 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 126.316 1.846 . . . . 72.35 113.311 -173.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -95.27 97.5 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.77 -0.826 . . . . 74.31 108.77 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.609 ' HE1' ' HA ' ' G' ' 452' ' ' VAL . 0.2 OUTLIER -105.66 124.54 49.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.132 -0.692 . . . . 72.41 109.132 -179.227 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.57 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.4 tt0 -90.16 135.4 33.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.163 0.585 . . . . 74.1 109.715 173.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.34 141.34 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.502 1.121 . . . . 73.35 107.979 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.7 t -127.49 129.27 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 107.662 -1.236 . . . . 74.21 107.662 172.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.407 HD21 HD12 ' C' ' 44' ' ' LEU . 0.6 OUTLIER -110.17 102.81 11.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.575 -1.269 . . . . 74.4 107.575 -179.029 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -84.22 127.83 34.19 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.037 -0.983 . . . . 74.54 108.388 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.498 ' HB ' HD11 ' C' ' 114' ' ' ILE . 40.9 t -124.45 121.06 60.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 107.123 -1.436 . . . . 75.23 107.123 168.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 9.5 m -124.98 115.36 20.44 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.479 -0.563 . . . . 71.14 109.479 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.439 HG22 HG23 ' C' ' 114' ' ' ILE . 81.2 t -99.92 107.96 21.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.298 -1.001 . . . . 71.44 108.298 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 55.6 m -96.18 139.82 31.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.276 -1.75 . . . . 75.22 106.276 169.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.75 116.19 11.99 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.527 -1.286 . . . . 63.25 107.527 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.6 m -127.08 168.39 14.67 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.031 -0.729 . . . . 70.53 109.031 175.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.709 HD11 ' HG2' ' C' ' 34' ' ' LYS . 5.6 mt -123.47 21.41 9.43 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.535 1.134 . . . . 75.12 109.004 -174.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.72 -99.76 1.0 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.66 -1.376 . . . . 64.42 109.66 -166.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -90.89 -31.62 16.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.418 0.687 . . . . 74.15 110.64 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -85.36 120.17 26.54 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.059 0.943 . . . . 63.53 110.875 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 40.5 m -73.55 125.78 28.76 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.744 -0.465 . . . . 71.4 109.744 170.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.639 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.0 -61.86 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.091 0.869 . . . . 72.4 109.003 171.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . 0.452 ' HZ ' HD22 ' C' ' 126' ' ' LEU . 54.6 p90 -164.86 176.08 9.03 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.708 0.766 . . . . 71.23 111.739 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.436 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -130.41 144.77 51.6 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 106.508 -1.664 . . . . 74.24 106.508 168.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.436 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.8 t -152.47 111.65 3.86 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.085 -0.709 . . . . 73.01 109.085 174.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.69 133.86 55.5 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.822 -0.436 . . . . 73.01 109.822 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 56.1 t -124.95 135.05 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.735 0.814 . . . . 63.2 108.846 168.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -111.99 90.4 3.33 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.835 -1.172 . . . . 65.32 107.835 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.05 96.59 6.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.427 -0.806 . . . . 65.41 109.403 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.63 146.8 20.92 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.218 -0.753 . . . . 73.05 111.218 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.429 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.36 117.5 0.85 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.312 -1.115 . . . . 74.32 110.312 -175.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.538 HD13 HD12 ' C' ' 51' ' ' LEU . 10.7 mm -82.88 126.54 40.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 107.714 -1.217 . . . . 75.05 107.714 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -133.13 121.28 22.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.481 0.713 . . . . 74.44 109.378 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.6 p -85.24 111.07 19.51 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.204 -0.665 . . . . 63.15 109.204 174.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 49.4 pt -114.68 141.17 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.088 0.955 . . . . 74.23 108.975 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -144.95 164.42 31.19 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.399 0.68 . . . . 72.13 110.004 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.75 -55.8 0.72 Allowed Glycine 0 C--N 1.341 0.82 0 O-C-N 123.512 0.508 . . . . 70.25 113.137 172.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.48 170.52 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 112.577 0.584 . . . . 74.13 112.577 -173.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.487 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 17.1 pt-20 -151.97 -172.64 4.28 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.941 0.897 . . . . 74.25 109.819 172.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.49 -137.92 16.96 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-O 119.338 -0.701 . . . . 52.43 113.231 172.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 25.3 p -63.49 -33.58 75.89 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.895 0.878 . . . . 73.32 111.402 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -59.65 -48.53 81.32 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.242 1.017 . . . . 74.35 110.064 176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.487 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 35.8 ttp -72.97 -30.09 63.57 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.613 -1.176 . . . . 74.31 110.845 176.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.58 -35.13 73.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.912 0.485 . . . . 74.12 110.23 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.577 ' HE2' ' HA ' ' C' ' 134' ' ' ASP . 10.1 t-160 -78.67 -33.16 47.26 Favored 'General case' 0 C--O 1.242 0.702 0 O-C-N 123.693 0.621 . . . . 65.52 111.827 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 39.8 t -57.23 -39.28 75.18 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.412 0.445 . . . . 34.31 110.442 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.8 mt -95.21 -19.54 19.96 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.794 0.837 . . . . 71.13 110.348 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.99 -29.4 54.32 Favored Glycine 0 C--N 1.349 1.252 0 C-N-CA 123.559 0.6 . . . . 74.31 114.036 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.03 -41.94 0.08 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.601 0.593 . . . . 65.11 112.601 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -61.85 -57.54 11.4 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.222 0.609 . . . . 73.43 111.961 -173.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 97.0 m -66.64 -46.6 57.35 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.927 0.891 . . . . 71.1 112.45 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.58 -35.92 69.14 Favored 'Trans proline' 0 C--N 1.401 3.328 0 C-N-CA 122.428 2.085 . . . . 75.53 113.388 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -67.75 -35.65 79.09 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.763 0.825 . . . . 74.52 110.463 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.408 HD13 ' NH1' ' A' ' 111' ' ' ARG . 46.8 mm -63.73 -39.5 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 122.863 0.465 . . . . 74.21 109.995 174.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.429 HD21 ' HA3' ' C' ' 82' ' ' GLY . 83.2 mt -85.78 -22.82 27.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.098 0.959 . . . . 74.43 112.847 -173.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -60.29 -46.59 97.69 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 124.984 1.314 . . . . 74.52 113.787 -172.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.618 ' HA ' ' HD3' ' C' ' 111' ' ' ARG . 35.2 Cg_exo -63.55 -34.53 63.95 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 122.307 2.005 . . . . 73.31 113.463 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -67.49 -44.59 78.15 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.752 0.421 . . . . 75.43 110.142 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.37 78.49 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 115.285 -0.871 . . . . 73.14 110.891 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.721 ' HG2' ' HG ' ' C' ' 128' ' ' LEU . 21.3 mtp-105 -56.88 -62.32 1.82 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.784 0.833 . . . . 65.42 110.707 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.51 -30.13 71.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.243 0.617 . . . . 75.44 111.286 -172.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.5 t -74.07 -32.85 63.46 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.073 0.549 . . . . 73.2 111.502 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.498 HD11 ' HB ' ' C' ' 62' ' ' VAL . 66.4 mt -73.71 -49.81 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.274 0.63 . . . . 74.22 109.846 172.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 90.6 m -57.26 -37.79 72.88 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.343 1.057 . . . . 75.34 111.407 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -63.72 -48.07 78.54 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.34 -0.846 . . . . 75.21 109.622 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.548 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.59 -37.89 88.0 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.617 1.167 . . . . 72.24 112.991 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.414 HG23 HD11 ' C' ' 126' ' ' LEU . 78.5 t -68.36 -43.28 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.657 0.783 . . . . 74.31 110.611 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -66.19 -30.42 70.89 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 115.018 -0.992 . . . . 72.34 110.604 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -71.86 -34.29 69.1 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 123.69 0.796 . . . . 74.03 109.455 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.69 5.58 77.8 Favored Glycine 0 C--N 1.353 1.484 0 O-C-N 123.73 0.644 . . . . 74.12 113.04 174.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.416 HG22 ' HB3' ' D' ' 17' ' ' TYR . 75.5 p 60.62 23.36 13.13 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.524 1.93 . . . . 72.21 113.974 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -85.06 156.56 60.41 Favored Pre-proline 0 CA--C 1.555 1.145 0 N-CA-C 108.739 -0.837 . . . . 73.24 108.739 170.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.11 155.35 40.05 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.195 2.597 . . . . 53.2 113.129 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.416 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 52.3 mm-40 -60.13 131.39 50.68 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.978 0.911 . . . . 75.12 112.017 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.535 ' HB3' ' HG ' ' G' ' 470' ' ' LEU . 2.9 pp -144.67 126.82 15.63 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.819 0.848 . . . . 73.14 108.809 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -127.7 124.88 38.95 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.537 -1.653 . . . . 63.32 106.537 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.721 ' HG ' ' HG2' ' C' ' 111' ' ' ARG . 0.0 OUTLIER -75.82 130.12 38.08 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.475 -0.565 . . . . 71.5 109.475 -171.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.57 154.39 93.31 Favored Pre-proline 0 CA--C 1.551 1.001 0 O-C-N 124.726 1.266 . . . . 72.31 112.589 -170.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.454 ' CG ' HD13 ' A' ' 16' ' ' ILE . 7.6 Cg_exo -68.79 115.2 3.83 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.372 2.048 . . . . 73.01 111.749 175.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 51.0 t -99.12 134.28 38.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.084 -1.45 . . . . 63.33 107.084 168.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -73.65 73.34 1.49 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.219 0.608 . . . . 65.23 110.358 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -60.75 -39.63 89.45 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.448 0.699 . . . . 74.21 110.656 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.577 ' HA ' ' HE2' ' C' ' 96' ' ' HIS . 10.7 m-20 -61.61 -49.36 76.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.299 -0.864 . . . . 71.14 111.606 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.49 87.67 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.88 0.737 . . . . 54.2 111.183 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.436 ' HB2' ' HE1' ' G' ' 461' ' ' PHE . 93.8 mt -67.71 -34.8 77.6 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.543 -0.753 . . . . 74.41 111.894 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -79.72 -22.01 43.86 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.663 0.385 . . . . 62.55 110.677 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 66.1 mtt -65.54 -26.54 67.93 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.361 0.664 . . . . 74.33 110.921 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -63.45 -37.79 88.66 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.53 0.732 . . . . 71.41 111.177 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -56.02 -81.0 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.025 0.93 . . . . 74.11 110.674 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 2.3 pp -67.8 -179.6 1.19 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.385 0.674 . . . . 73.33 111.668 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.86 159.3 37.0 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.969 0.508 . . . . 73.11 110.227 176.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.68 -179.73 7.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.884 0.874 . . . . 73.43 110.312 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -146.05 156.17 43.29 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.102 0.961 . . . . 74.14 108.967 171.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.99 147.8 11.55 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.635 0.774 . . . . 73.45 110.015 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.0 60.49 0.48 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.94 -0.464 . . . . 74.0 111.94 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.04 135.54 47.31 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.265 -1.013 . . . . 75.1 108.265 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 169.5 43.13 0.03 OUTLIER Glycine 0 C--N 1.338 0.679 0 N-CA-C 111.066 -0.814 . . . . 72.41 111.066 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.1 t -139.94 132.95 29.46 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.165 0.586 . . . . 74.31 109.969 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.477 ' HB3' ' NE2' ' A' ' 142' ' ' GLN . 0.1 OUTLIER -158.29 -172.04 3.72 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.355 1.062 . . . . 73.14 109.498 178.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -157.71 112.88 2.72 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.046 -0.724 . . . . 73.24 109.046 172.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -73.57 86.98 1.61 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.974 -0.75 . . . . 71.15 108.974 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -107.69 101.18 10.5 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.331 -0.618 . . . . 74.41 109.331 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -149.51 104.97 3.41 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.46 -0.941 . . . . 64.32 108.46 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 C-N-CA 123.892 0.877 . . . . 74.35 110.011 -179.156 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.823 -0.436 . . . . 74.23 109.823 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 42.0 p -167.95 112.79 0.66 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.31 1.044 . . . . 64.43 109.631 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -66.4 114.78 5.68 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.473 -0.566 . . . . 74.43 109.473 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -172.33 -76.91 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.012 0.925 . . . . 74.21 108.59 -173.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -168.96 0.91 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.12 1.768 . . . . 71.05 108.744 173.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -61.41 152.26 30.19 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 124.249 1.02 . . . . 71.11 108.948 167.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 19.2 m -65.38 88.34 0.08 Allowed 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 121.442 0.639 . . . . 71.35 112.285 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -98.29 -13.66 20.64 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.501 1.12 . . . . 73.31 108.394 166.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.9 tpt -28.44 126.42 0.09 Allowed 'General case' 0 C--N 1.37 1.472 0 C-N-CA 127.318 2.247 . . . . 72.51 113.663 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 61.6 m -129.23 138.79 51.89 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.676 0.79 . . . . 74.32 111.066 -173.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -154.47 93.01 1.55 Allowed 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.579 -1.637 . . . . 74.51 106.579 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -113.23 126.87 55.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.177 -0.675 . . . . 71.42 109.177 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.423 ' HB ' ' HG2' ' B' ' 130' ' ' PRO . 10.2 mt -87.56 119.87 35.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.062 -1.088 . . . . 74.3 108.062 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -85.62 -28.52 24.72 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 123.643 0.589 . . . . 65.0 111.125 -175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -172.4 121.03 0.42 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 110.399 -0.223 . . . . 73.42 110.399 -166.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.02 133.49 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 107.328 -1.36 . . . . 74.05 107.328 169.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.426 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 42.6 p90 -162.63 174.18 12.93 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 122.007 0.908 . . . . 75.44 112.045 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.9 p -104.57 124.18 48.86 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.188 -1.369 . . . . 71.21 109.188 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.426 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 36.4 mtpt -93.86 -18.49 21.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.418 0.687 . . . . 72.24 109.559 177.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.7 t70 -162.12 135.17 6.06 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 124.377 1.071 . . . . 74.2 108.989 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.548 HG23 ' HE1' ' C' ' 117' ' ' MET . 86.8 mt -136.16 133.86 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.602 1.161 . . . . 74.43 108.076 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 57.8 m -137.59 113.46 9.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.413 1.085 . . . . 64.4 109.655 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.498 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 83.8 t80 -116.82 117.12 28.86 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.353 -1.721 . . . . 73.53 106.353 163.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.4 mt-10 -126.3 111.33 14.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.422 0.689 . . . . 72.01 109.357 -175.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.17 87.31 7.17 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.272 -1.01 . . . . 74.02 108.272 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -75.54 -32.61 4.67 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.7 2.267 . . . . 72.31 113.01 -171.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -100.42 9.09 43.11 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.557 0.743 . . . . 75.4 110.161 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.06 -69.79 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 116.18 1.919 . . . . 75.44 116.18 -161.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.434 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 68.4 Cg_endo -77.41 -19.6 13.08 Favored 'Trans proline' 0 C--N 1.383 2.353 0 CA-C-N 123.558 2.306 . . . . 70.22 113.765 -174.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -70.18 -43.07 71.54 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.366 1.066 . . . . 62.13 109.13 173.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.538 HG21 ' HA ' ' D' ' 73' ' ' ALA . 6.3 p -84.28 -15.65 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.81 0.844 . . . . 71.32 111.398 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.434 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.8 m-85 -70.4 -19.69 62.99 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 120.784 0.325 . . . . 73.23 111.38 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -72.66 -12.44 61.04 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.413 -0.812 . . . . 73.04 111.069 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -83.26 84.51 7.47 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.208 1.003 . . . . 64.23 108.885 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -77.46 80.43 3.95 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.457 0.646 . . . . 75.05 109.282 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -156.23 163.8 39.12 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.501 -1.227 . . . . 73.24 108.842 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.467 ' NE2' HD23 ' D' ' 126' ' ' LEU . 23.7 tp60 -89.99 108.18 24.23 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.204 1.002 . . . . 74.12 109.65 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.413 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 34.8 Cg_exo -59.85 158.09 30.51 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 123.329 2.686 . . . . 73.34 114.302 -174.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.584 ' HB2' ' HB3' ' H' ' 470' ' ' LEU . 8.7 tp10 -79.82 157.31 27.06 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.356 1.062 . . . . 74.45 110.736 177.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.83 118.47 57.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.178 -0.675 . . . . 74.42 109.178 172.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -117.65 114.04 22.79 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.819 0.847 . . . . 63.23 108.832 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.35 126.33 43.82 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.113 0.565 . . . . 72.41 111.034 -172.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.493 ' HA ' ' HH ' ' H' ' 462' ' ' TYR . 20.6 t70 -124.97 120.09 30.6 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.959 1.304 . . . . 65.52 107.654 170.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt -110.95 146.03 37.33 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.728 0.411 . . . . 73.41 110.093 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 34.5 t70 -147.82 151.5 36.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.651 1.18 . . . . 75.51 108.342 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -132.16 163.73 27.88 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.735 0.414 . . . . 75.3 110.432 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.667 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -153.93 175.21 13.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.371 1.068 . . . . 60.1 109.512 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.531 ' HB3' HD23 ' D' ' 98' ' ' LEU . 50.5 p -168.5 157.25 8.69 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.81 0.844 . . . . 71.3 110.573 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 88.5 p -153.2 154.56 34.95 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.962 0.905 . . . . 72.11 109.038 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -94.59 116.97 29.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.728 -0.842 . . . . 75.22 108.728 170.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.521 HD13 HG22 ' D' ' 83' ' ' ILE . 42.7 mt -93.38 -30.01 15.32 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 110.02 -0.363 . . . . 73.44 110.02 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.425 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -162.83 -174.84 4.1 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.444 0.698 . . . . 72.42 111.2 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -67.09 116.47 7.94 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.661 -1.154 . . . . 71.44 109.455 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 66.02 5.5 3.56 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.867 1.267 . . . . 73.12 112.567 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 78.8 t -110.18 120.05 60.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 108.545 -0.909 . . . . 75.35 108.545 176.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -135.26 131.27 36.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.752 -0.833 . . . . 73.52 108.752 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -89.81 148.01 23.46 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.698 0.799 . . . . 73.52 109.355 173.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.46 HG21 ' HG ' ' D' ' 98' ' ' LEU . 90.8 t -125.49 139.87 50.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 124.737 1.215 . . . . 74.23 107.867 170.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 77.8 t -118.69 135.37 59.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.282 -1.007 . . . . 73.32 108.282 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -118.25 121.01 39.39 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.785 -0.82 . . . . 74.54 108.785 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 24.8 ttm-85 -103.38 96.0 6.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.048 -1.093 . . . . 72.34 108.048 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 74.5 t -97.81 119.0 45.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.295 -1.002 . . . . 65.32 108.295 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 14.2 m -119.77 129.87 54.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.846 -1.07 . . . . 74.12 108.541 -172.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 67.2 t -122.47 128.97 75.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 124.837 1.255 . . . . 73.24 108.261 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 95.9 m -122.34 120.63 34.58 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.199 -1.037 . . . . 63.43 108.199 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.71 151.94 39.95 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.472 -0.785 . . . . 75.31 110.08 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.433 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 19.7 p -149.6 125.37 10.47 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.293 -0.867 . . . . 73.12 109.368 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 12.0 mt -92.83 114.21 26.7 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.221 1.008 . . . . 74.31 108.931 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.92 -110.1 2.94 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.966 -0.854 . . . . 75.01 110.966 -174.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 5.94 8.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.013 0.925 . . . . 74.42 110.844 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -123.02 155.41 36.91 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.539 0.736 . . . . 74.32 109.788 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -60.51 129.98 44.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.851 0.86 . . . . 75.41 111.979 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.538 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.96 -72.74 0.55 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.756 -1.201 . . . . 74.32 107.756 176.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -145.57 146.36 31.36 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.216 -0.902 . . . . 73.4 110.217 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.7 mt -114.34 143.58 44.65 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.534 1.134 . . . . 73.45 108.134 175.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.542 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 23.7 m -142.09 137.49 31.03 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.832 0.853 . . . . 72.23 109.232 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -154.41 121.0 5.45 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.799 -1.186 . . . . 72.44 107.799 170.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.7 t -130.8 115.23 29.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.684 -0.858 . . . . 74.35 108.684 -175.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.461 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -88.49 85.37 6.84 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.431 -0.952 . . . . 72.43 108.431 172.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -78.61 96.77 5.58 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.248 -1.342 . . . . 74.11 108.771 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.85 143.12 17.4 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 115.827 -0.624 . . . . 74.43 111.867 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.446 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -140.75 129.64 4.22 Favored Glycine 0 C--N 1.329 0.187 0 N-CA-C 110.685 -0.966 . . . . 73.52 110.685 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.521 HG22 HD13 ' D' ' 51' ' ' LEU . 61.0 mt -90.15 129.43 41.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.321 -0.992 . . . . 73.14 108.321 177.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -128.92 153.46 47.49 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.71 0.404 . . . . 74.15 111.06 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -114.88 105.65 13.25 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.806 1.242 . . . . 65.23 108.097 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.35 122.76 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.125 0.57 . . . . 74.34 110.305 -175.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.08 141.94 24.67 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.316 1.046 . . . . 74.22 108.48 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.94 -20.13 29.35 Favored Glycine 0 N--CA 1.468 0.825 0 O-C-N 123.116 0.26 . . . . 61.3 112.59 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 32.9 pt -131.95 147.0 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.414 0.686 . . . . 74.44 109.17 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.07 163.48 33.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.807 0.843 . . . . 74.02 111.317 -176.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.64 -127.52 31.37 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.173 -0.921 . . . . 65.14 114.264 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.1 m -74.32 -30.63 62.14 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.192 0.997 . . . . 75.33 111.135 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -65.46 -34.83 79.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.32 0.648 . . . . 75.34 109.977 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.668 ' HG3' HG13 ' H' ' 451' ' ' VAL . 1.2 tmt? -83.62 -26.17 30.18 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.534 -0.757 . . . . 71.41 110.817 175.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.08 -23.16 67.09 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.86 0.362 . . . . 73.11 110.612 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -70.48 -43.6 69.42 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.672 0.789 . . . . 72.34 110.557 168.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -63.59 -46.83 84.03 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.933 0.493 . . . . 72.42 110.966 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.531 HD23 ' HB3' ' D' ' 48' ' ' SER . 7.3 tt -77.2 -46.26 23.88 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.838 0.855 . . . . 73.53 109.785 -175.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.37 -12.69 83.58 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.83 -0.623 . . . . 71.34 114.149 -172.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.49 -61.03 0.65 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.424 0.612 . . . . 74.4 112.546 -172.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -67.06 -39.7 86.95 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 112.639 0.607 . . . . 75.14 112.639 -172.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.414 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 97.7 m -68.91 -48.94 28.15 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 118.547 -0.739 . . . . 71.25 111.086 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.422 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 71.0 Cg_exo -55.74 -35.11 92.81 Favored 'Trans proline' 0 C--N 1.399 3.209 0 C-N-CA 122.413 2.075 . . . . 70.21 113.169 168.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -63.36 -37.37 87.02 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.338 0.655 . . . . 74.25 110.276 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.41 HG21 HD12 ' D' ' 13' ' ' ILE . 36.5 mm -67.58 -43.42 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.664 0.786 . . . . 75.23 110.703 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.446 HD22 ' HA3' ' D' ' 82' ' ' GLY . 95.1 mt -75.08 -16.71 60.55 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.382 -0.826 . . . . 74.24 111.809 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -69.64 -43.08 21.07 Favored Pre-proline 0 CA--C 1.56 1.334 0 CA-C-O 118.209 -0.9 . . . . 75.23 113.274 -170.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -53.15 -44.74 46.37 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.2 1.934 . . . . 74.52 112.964 168.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.49 -36.09 76.19 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.665 0.786 . . . . 71.05 111.817 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.94 -54.66 31.11 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.49 0.716 . . . . 63.1 109.678 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -49.56 -49.46 46.28 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 125.068 1.48 . . . . 65.44 111.038 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -64.79 -44.0 91.39 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 124.132 0.895 . . . . 64.0 111.608 -173.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.0 t -60.33 -43.7 96.18 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.511 0.507 . . . . 75.44 110.717 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.542 HG21 HG22 ' D' ' 64' ' ' VAL . 77.3 mt -59.42 -56.97 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.399 1.08 . . . . 74.04 110.057 173.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.3 m -59.07 -35.35 73.22 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.205 1.402 . . . . 73.12 112.053 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -69.27 -43.85 73.06 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.643 -0.708 . . . . 72.44 109.753 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 72.3 mtm -67.38 -31.82 72.3 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.974 0.51 . . . . 72.4 111.875 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.46 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.6 t -62.69 -45.37 98.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.976 0.91 . . . . 72.53 110.334 175.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.8 p -73.59 -32.08 63.93 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 116.126 -0.488 . . . . 71.32 111.136 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -70.67 -31.78 68.82 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.633 0.773 . . . . 75.13 110.509 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.06 8.84 76.96 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-N 115.491 -0.777 . . . . 73.42 112.419 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 28.3 p 63.94 18.45 11.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.494 1.918 . . . . 74.54 114.231 171.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.82 147.69 49.28 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.198 0.599 . . . . 74.01 109.446 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.42 124.07 13.43 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.358 2.705 . . . . 72.42 112.932 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -61.86 130.09 44.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.955 1.302 . . . . 75.25 112.092 -173.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.467 HD23 ' NE2' ' D' ' 37' ' ' GLN . 71.2 mt -119.09 112.5 19.62 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.015 0.926 . . . . 74.45 109.12 -176.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -100.79 103.06 14.27 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.749 -0.834 . . . . 72.52 108.749 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 29.2 tp -68.91 135.85 51.67 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.679 -1.146 . . . . 70.33 112.053 -169.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.31 135.9 93.46 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 122.989 0.516 . . . . 74.21 110.428 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -64.04 136.41 52.23 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.719 2.279 . . . . 75.44 111.925 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.85 123.19 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.563 0.745 . . . . 73.53 109.211 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -82.66 92.59 7.19 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.954 -0.758 . . . . 71.33 108.954 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -67.23 -35.76 80.26 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.982 -0.554 . . . . 70.23 110.555 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.62 -53.51 57.25 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.575 1.15 . . . . 71.41 112.789 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.82 93.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.116 0.566 . . . . 41.14 110.973 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.414 HD13 ' HB2' ' D' ' 139' ' ' ASN . 33.4 tp -76.2 -17.77 59.37 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.592 -0.731 . . . . 71.52 111.951 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -64.48 -40.42 95.64 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.398 -0.593 . . . . 74.14 109.398 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 30.8 mtt -68.39 -37.01 79.99 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.999 -1.0 . . . . 75.13 109.981 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.414 ' HB2' HD13 ' D' ' 136' ' ' LEU . 2.5 m-20 -69.64 -34.17 73.64 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.36 -0.836 . . . . 71.34 110.661 176.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -69.22 -40.66 77.83 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.412 0.685 . . . . 71.41 111.059 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.4 mp -63.73 -30.86 71.91 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.399 0.68 . . . . 75.1 111.911 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -91.67 18.09 7.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.926 0.49 . . . . 75.43 111.841 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -119.01 90.5 3.35 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.9 0.88 . . . . 74.32 109.114 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.5 113.07 6.29 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 106.112 -1.81 . . . . 75.02 106.112 175.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.5 87.45 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.092 0.957 . . . . 62.04 111.397 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.44 -171.34 23.77 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 111.014 -0.834 . . . . 73.21 111.014 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -166.76 117.88 0.94 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.032 0.533 . . . . 72.25 110.037 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.54 152.27 37.26 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.647 0.592 . . . . 45.13 111.851 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 35.9 p -66.93 154.35 41.28 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.874 0.87 . . . . 74.14 111.553 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -57.05 136.73 56.33 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.646 1.179 . . . . 72.14 112.373 -175.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -110.29 66.59 0.63 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.625 0.77 . . . . 74.1 109.632 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -66.74 97.75 0.48 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.538 -0.755 . . . . 73.25 109.756 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.48 179.39 5.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.978 0.911 . . . . 71.43 109.596 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -134.71 84.03 2.07 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.664 -0.865 . . . . 74.15 108.664 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.887 0 C-N-CA 123.993 0.917 . . . . 74.2 109.26 -179.658 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 53.0 t30 . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 108.993 -0.743 . . . . 73.11 108.993 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 65.5 t -90.91 -31.3 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 115.351 -0.84 . . . . 75.42 109.396 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 31.3 m -54.53 144.97 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.203 1.001 . . . . 74.21 113.229 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -140.86 -40.9 0.08 OUTLIER Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.171 -0.922 . . . . 71.13 111.378 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 1.5 tt 66.01 99.33 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.062 1.345 . . . . 74.5 109.861 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 71.8 p -75.98 168.62 19.7 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.277 0.631 . . . . 74.34 110.162 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -58.88 115.66 3.26 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.24 0.616 . . . . 65.31 109.514 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -63.04 100.77 0.23 Allowed 'General case' 0 C--N 1.353 0.723 0 CA-C-O 121.598 0.713 . . . . 74.12 109.412 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 21.7 m -61.35 148.74 40.42 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 114.812 -1.085 . . . . 75.23 110.32 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -51.13 147.65 5.19 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.504 0.722 . . . . 70.14 109.972 174.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . 0.677 HD21 ' H ' ' A' ' 46' ' ' THR . 4.0 mm? -65.05 126.04 26.79 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.972 0.891 . . . . 73.02 112.849 -166.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 3.2 p90 -70.58 -3.97 20.8 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.308 -1.769 . . . . 75.21 112.165 170.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -60.45 98.0 0.06 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.029 0.932 . . . . 75.01 109.722 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 14.7 p -121.14 61.35 0.91 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.018 1.327 . . . . 73.41 109.372 -176.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 464' ' ' MET . . . . . 0.51 ' HE1' ' HB3' ' E' ' 466' ' ' ALA . 50.9 ttp -154.01 105.58 2.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.514 -1.221 . . . . 73.23 108.72 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -82.63 84.7 7.19 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.407 -0.96 . . . . 74.05 108.407 172.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . 0.51 ' HB3' ' HE1' ' E' ' 464' ' ' MET . . . -77.7 72.34 4.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.754 0.822 . . . . 74.25 109.858 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 40' ' ' VAL . . . -96.69 115.27 27.15 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.328 -0.851 . . . . 64.43 109.048 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.91 -38.25 90.21 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.656 0.598 . . . . 73.23 110.938 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 64.92 65.52 2.91 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.451 -0.795 . . . . 72.42 111.852 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . 0.481 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . 90.8 mt -64.01 113.91 3.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.553 0.741 . . . . 71.14 109.465 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . 0.645 ' HE3' HE21 ' A' ' 37' ' ' GLN . 23.3 tptm . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.439 -0.791 . . . . 73.41 109.394 -170.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.219 0.533 . . . . 60.15 109.843 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.29 -3.78 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.656 1.183 . . . . 75.44 111.602 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 35.5 m -101.83 165.55 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.054 0.942 . . . . 73.35 111.383 -177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 151.67 173.28 21.29 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 116.22 -0.446 . . . . 74.41 111.986 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 92.2 mt -122.77 165.39 16.66 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.943 0.897 . . . . 74.54 110.843 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 40.9 p -71.09 -57.08 4.87 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.663 -0.699 . . . . 73.15 109.427 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 26.6 t70 171.49 -41.91 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.201 1.8 . . . . 64.51 108.056 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.29 78.44 0.21 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.561 1.545 . . . . 74.21 109.161 -176.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 25.2 m -93.39 118.94 31.92 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.344 1.058 . . . . 73.42 108.842 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 64.92 104.92 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.431 1.092 . . . . 70.24 110.721 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.3 108.98 0.77 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.28 0.632 . . . . 75.11 111.476 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . 0.415 ' HB2' HD23 ' B' ' 136' ' ' LEU . 14.2 p90 -61.11 108.09 0.84 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.961 -1.018 . . . . 73.04 109.319 172.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -146.58 107.34 4.12 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.834 -0.621 . . . . 74.24 109.329 -172.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 47.0 p -124.8 87.27 2.69 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.806 0.843 . . . . 75.21 109.396 176.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 464' ' ' MET . . . . . 0.69 ' SD ' ' HB3' ' B' ' 129' ' ' ALA . 64.0 ttp -102.68 112.12 24.74 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.344 -0.984 . . . . 73.45 108.344 175.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -70.13 -50.28 42.2 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.886 0.875 . . . . 75.23 110.434 -172.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -89.85 170.72 10.16 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.147 0.579 . . . . 74.14 111.039 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -86.77 169.37 12.67 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.903 0.481 . . . . 63.04 110.08 173.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . 0.599 ' H ' HD23 ' F' ' 468' ' ' LEU . 1.3 pt? -84.79 71.45 10.85 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.753 0.787 . . . . 74.22 110.872 -176.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 79.55 -56.03 4.45 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.255 -0.884 . . . . 71.21 112.805 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 4.6 tt -62.62 107.43 0.95 Allowed 'General case' 0 C--N 1.348 0.513 0 N-CA-C 107.825 -1.176 . . . . 72.5 107.825 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 53.8 pttt . . . . . 0 C--O 1.249 1.029 0 C-N-CA 124.268 1.027 . . . . 74.14 109.528 176.514 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 59.8 t30 . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.998 -0.371 . . . . 74.53 109.998 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . 0.441 ' O ' ' SD ' ' C' ' 94' ' ' MET . 8.9 p -157.64 13.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 122.608 0.363 . . . . 74.31 110.542 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . 0.609 ' HA ' ' HE1' ' C' ' 56' ' ' TYR . 27.4 m -130.01 154.02 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 113.098 0.777 . . . . 64.42 113.098 -174.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . -168.2 -147.37 5.31 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 113.938 -1.483 . . . . 70.11 110.108 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 7.7 mp 53.87 90.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.474 1.11 . . . . 73.44 112.642 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 42.9 p -108.63 8.7 27.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.138 0.975 . . . . 62.32 110.471 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.92 96.37 2.92 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.013 0.925 . . . . 71.01 108.912 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . 0.517 ' HB3' ' O ' ' C' ' 46' ' ' THR . 23.0 mp0 -113.13 61.47 0.64 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.793 0.837 . . . . 74.21 108.943 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 73.0 p -117.83 136.12 53.63 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.256 0.622 . . . . 70.55 110.182 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 53.74 80.95 0.1 Allowed 'General case' 0 C--O 1.243 0.741 0 C-N-CA 125.02 1.328 . . . . 73.25 111.78 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . 0.534 HD13 HD23 ' C' ' 44' ' ' LEU . 1.5 tm? -71.9 120.65 17.79 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.984 -1.488 . . . . 75.12 106.984 174.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . 0.436 ' HE1' ' HB2' ' C' ' 136' ' ' LEU . 15.1 p90 -51.65 116.08 1.94 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.851 1.26 . . . . 64.14 110.943 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -141.18 95.36 2.82 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.84 -1.17 . . . . 72.15 107.84 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 42.6 m -121.88 115.41 22.55 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.651 0.78 . . . . 73.15 109.998 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 52.1 mtt -111.19 -175.01 2.6 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.239 1.016 . . . . 74.31 109.295 170.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -81.18 -6.57 59.0 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.444 -0.798 . . . . 75.01 111.39 174.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -142.32 -77.05 0.26 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.434 0.694 . . . . 52.54 109.777 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -171.34 -55.45 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.449 1.1 . . . . 73.42 108.607 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 tt -148.46 -64.36 0.24 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 106.445 -1.687 . . . . 72.5 106.445 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 97.9 -178.91 32.47 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.018 -0.992 . . . . 74.12 111.804 -174.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . 0.535 ' HG ' ' HB3' ' C' ' 126' ' ' LEU . 6.0 tt -167.13 -61.02 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 106.833 -1.543 . . . . 62.34 106.833 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.554 1.097 0 N-CA-C 106.562 -1.644 . . . . 71.24 106.562 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 . . . . . 0 C--O 1.243 0.715 0 N-CA-C 110.226 -0.287 . . . . 71.14 110.226 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . 0.668 HG13 ' HG3' ' D' ' 94' ' ' MET . 40.1 t -60.33 -53.86 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.219 0.949 . . . . 75.32 109.442 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . . . . . . . . . 18.2 m -71.93 154.96 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 115.973 -0.558 . . . . 73.44 111.625 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -150.96 57.42 0.45 Allowed Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.023 -0.535 . . . . 72.05 111.998 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . 0.468 HD12 HD22 ' D' ' 98' ' ' LEU . 2.4 mm? -77.29 107.59 9.81 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.399 -0.593 . . . . 74.4 109.399 177.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 14.8 m -66.45 -54.83 19.74 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 123.793 0.683 . . . . 70.42 110.644 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -174.93 149.1 1.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.062 0.945 . . . . 73.44 109.91 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -81.84 77.9 8.61 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.625 0.726 . . . . 74.33 109.388 173.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 13.8 p -76.34 -66.78 0.76 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.8 -1.091 . . . . 70.44 111.291 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -164.66 149.46 9.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.646 0.779 . . . . 75.34 109.931 -171.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . 0.536 ' HG ' ' HA ' ' D' ' 45' ' ' ASP . 4.4 mm? -87.6 100.07 12.52 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 123.559 0.744 . . . . 74.43 109.656 175.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -59.42 108.6 0.73 Allowed 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 114.813 -1.085 . . . . 74.24 110.024 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . 0.493 ' HH ' ' HA ' ' D' ' 43' ' ' ASP . 29.5 p90 -159.16 126.0 4.66 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.44 -0.948 . . . . 72.51 108.44 168.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 23.6 m -83.35 -69.96 0.6 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.407 -1.331 . . . . 75.31 107.407 171.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 464' ' ' MET . . . . . 0.529 ' HE3' ' HB2' ' H' ' 466' ' ' ALA . 0.0 OUTLIER 65.61 138.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.079 1.352 . . . . 74.34 112.132 172.833 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . 0.411 ' N ' ' SD ' ' H' ' 464' ' ' MET . 39.4 ttpt -159.89 105.96 1.6 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.716 0.407 . . . . 73.44 110.593 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . 0.529 ' HB2' ' HE3' ' H' ' 464' ' ' MET . . . -164.01 32.64 0.08 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.779 0.831 . . . . 63.42 110.816 174.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -68.34 140.61 55.91 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.009 0.524 . . . . 63.13 110.163 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 4.2 mp -83.89 -6.96 59.53 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.443 0.697 . . . . 73.1 112.04 -174.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 76.01 39.87 31.63 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.132 0.27 . . . . 63.33 113.186 173.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . 0.584 ' HB3' ' HB2' ' D' ' 39' ' ' GLU . 7.7 tt -73.0 -54.28 9.0 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.307 -0.997 . . . . 73.33 108.307 168.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . 0.475 ' HE2' ' HA ' ' H' ' 471' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-N 114.15 -1.386 . . . . 75.43 108.999 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptm . . . . . 0 C--O 1.24 0.568 0 CA-C-O 121.429 0.633 . . . . 74.22 110.126 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m -146.43 155.46 42.58 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.217 1.007 . . . . 63.53 109.271 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.02 145.29 26.33 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.872 0.869 . . . . 61.22 109.695 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -73.8 109.06 7.01 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.943 0.497 . . . . 70.21 109.844 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -77.14 153.46 34.19 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.347 -0.612 . . . . 73.04 109.347 172.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -68.42 -20.54 64.66 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.603 0.761 . . . . 71.02 111.261 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 p -86.78 7.38 27.13 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.865 0.866 . . . . 72.22 112.584 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.554 ' HG3' ' HG3' ' A' ' 9' ' ' MET . 10.2 pt-20 -54.94 -39.52 68.95 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.888 0.875 . . . . 74.23 112.722 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.554 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 58.0 mtt -84.72 137.61 33.12 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.7 0.8 . . . . 73.13 109.718 -177.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 87' ' ' ALA . 68.9 m -143.43 132.81 23.37 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.655 0.782 . . . . 74.55 109.388 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.669 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.6 t80 -136.44 131.63 34.33 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.745 1.218 . . . . 72.4 108.951 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.494 HE22 ' HB2' ' C' ' 151' ' ' GLU . 43.9 tp60 -138.93 117.93 12.5 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.013 0.925 . . . . 73.34 108.652 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.526 HG12 ' HD2' ' A' ' 84' ' ' PHE . 39.1 mt -84.19 110.91 19.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.549 -0.908 . . . . 74.15 108.549 172.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -78.07 -40.03 39.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.991 0.807 . . . . 73.11 110.132 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.404 ' HB3' HD12 ' A' ' 83' ' ' ILE . 14.6 ttt180 -169.84 143.77 2.68 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 121.137 -0.225 . . . . 73.04 111.125 -171.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.48 HD13 ' HG3' ' C' ' 130' ' ' PRO . 94.2 mt -135.71 128.31 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.121 -1.066 . . . . 75.1 108.121 175.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.423 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.7 p90 -165.62 150.21 8.57 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.177 0.991 . . . . 70.31 110.37 -169.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -75.32 114.91 14.4 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.978 -0.749 . . . . 71.12 108.978 173.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HZ3' ' HG2' ' A' ' 57' ' ' GLU . 37.5 mtpt -81.74 -28.36 33.39 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.297 -0.631 . . . . 75.45 109.297 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.1 t70 -149.08 138.52 21.67 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.235 -0.893 . . . . 74.23 109.723 174.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.459 HG21 ' SD ' ' B' ' 117' ' ' MET . 61.9 mt -131.11 150.43 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 107.257 -1.386 . . . . 74.15 107.257 173.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.0 t -158.23 146.4 18.62 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.387 0.429 . . . . 72.2 109.972 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 82.4 t80 -137.72 141.07 41.02 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.262 -1.384 . . . . 75.51 107.262 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 50.7 mt-10 -139.13 133.55 31.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.374 0.67 . . . . 74.02 109.39 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.32 73.39 11.88 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 107.235 -1.394 . . . . 74.31 107.235 171.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.51 -22.25 18.57 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.63 2.22 . . . . 74.44 111.779 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.408 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 94.2 m-20 -112.27 32.8 5.29 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.019 1.328 . . . . 50.43 109.367 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.412 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -60.47 -46.75 97.44 Favored Pre-proline 0 CA--C 1.571 1.763 0 N-CA-C 113.054 0.761 . . . . 74.02 113.054 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 25.4 Cg_exo -66.61 -19.28 54.26 Favored 'Trans proline' 0 C--N 1.393 2.909 0 C-N-CA 122.002 1.801 . . . . 72.31 113.216 172.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -79.93 -48.86 12.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.398 0.679 . . . . 71.25 110.892 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.449 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 7.8 p -68.43 -18.93 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.963 0.505 . . . . 64.14 110.71 -178.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -62.2 -39.63 93.39 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.108 0.963 . . . . 74.02 111.29 175.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -95.06 -13.14 25.44 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.591 0.756 . . . . 72.11 111.552 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 31.9 mmtp -83.19 167.93 17.26 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.24 0.616 . . . . 74.43 111.928 177.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -83.85 137.27 33.77 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.92 0.888 . . . . 73.43 109.819 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -77.68 86.77 3.96 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.469 0.652 . . . . 74.24 109.86 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -138.34 73.77 42.63 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 107.652 -1.24 . . . . 75.04 107.652 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 37.2 Cg_endo -91.05 166.06 3.75 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.48 2.12 . . . . 72.22 113.506 -174.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -99.58 105.51 17.39 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.06 -1.459 . . . . 74.54 107.06 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' E' ' 467' ' ' ALA . 16.4 m -73.13 90.87 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-O 122.728 1.251 . . . . 72.41 110.78 -178.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 65' ' ' THR . 29.8 mmmt -94.91 118.09 31.21 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.899 -1.046 . . . . 74.23 108.887 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.696 ' HB3' ' HH ' ' E' ' 462' ' ' TYR . 58.9 tp -116.77 127.2 54.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.25 -1.389 . . . . 74.4 107.25 169.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.432 ' HB2' HG21 ' A' ' 63' ' ' THR . 6.7 m-20 -123.54 122.91 39.41 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.334 -1.358 . . . . 71.3 107.334 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.412 ' HG ' HG22 ' A' ' 62' ' ' VAL . 6.3 tt -128.75 136.46 50.59 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.75 -0.833 . . . . 75.42 108.75 -169.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 28.8 t70 -143.75 145.35 32.33 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.993 1.317 . . . . 74.23 108.431 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.0 m -114.35 133.77 55.45 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.262 -1.014 . . . . 74.14 108.262 171.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.96 143.15 50.65 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.881 -0.785 . . . . 73.4 108.881 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.8 m -127.8 152.54 47.66 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.077 0.551 . . . . 74.51 111.017 -170.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.6 p -159.44 140.36 12.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.724 0.64 . . . . 72.11 110.123 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -87.18 109.22 19.32 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.304 -0.628 . . . . 74.31 109.304 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.601 HD12 ' HB2' ' A' ' 57' ' ' GLU . 82.7 mt -78.95 -41.63 28.87 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.229 0.538 . . . . 71.44 109.984 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.99 176.86 10.72 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.228 -1.027 . . . . 73.31 108.228 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -60.58 117.54 5.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.13 -0.693 . . . . 63.52 109.13 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 72.58 13.1 5.39 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.731 1.212 . . . . 72.45 112.317 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.93 125.17 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.395 -0.965 . . . . 73.3 108.395 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -123.55 153.34 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.549 0.69 . . . . 74.24 111.582 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.601 ' HB2' HD12 ' A' ' 51' ' ' LEU . 8.4 tp10 -118.05 114.15 22.69 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.186 -1.783 . . . . 73.22 106.186 166.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.74 122.37 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 107.782 -1.192 . . . . 75.43 107.782 169.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -99.31 123.21 51.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.175 -1.046 . . . . 75.32 108.175 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 tp -86.74 96.83 10.3 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 106.754 -1.572 . . . . 73.4 106.754 173.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.587 ' HG2' ' HG3' ' A' ' 79' ' ' GLN . 0.8 OUTLIER -85.77 101.95 13.23 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.526 -1.216 . . . . 74.02 107.908 -175.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.412 HG22 ' HG ' ' A' ' 44' ' ' LEU . 62.1 t -125.08 137.97 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.067 0.547 . . . . 73.04 109.689 -174.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.432 HG21 ' HB2' ' A' ' 43' ' ' ASP . 7.5 t -138.53 145.63 40.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.348 0.659 . . . . 73.23 110.003 172.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 93.2 t -120.11 111.57 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.915 0.886 . . . . 75.11 108.614 177.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 20.7 m -105.52 107.91 19.15 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.199 -0.667 . . . . 74.41 109.199 173.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.64 104.64 15.02 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.736 -1.209 . . . . 74.22 107.736 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 25.0 m -117.27 123.53 46.81 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.954 -0.387 . . . . 75.54 109.954 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.631 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -90.26 86.33 6.48 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.049 0.928 . . . . 74.14 108.895 -178.372 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.29 -95.94 1.8 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 114.434 -1.257 . . . . 62.51 110.853 -174.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -114.73 -25.78 8.12 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.277 0.631 . . . . 75.34 111.455 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.408 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 29.8 tt0 -87.72 134.07 33.73 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.772 0.829 . . . . 71.21 110.693 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 49.4 m -84.96 135.07 34.2 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 120.923 0.392 . . . . 71.41 110.74 174.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.21 -61.61 1.85 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.83 1.252 . . . . 71.44 109.425 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -147.07 165.16 30.75 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.888 -1.051 . . . . 73.24 111.456 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 61.6 tp -135.65 108.79 7.71 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.028 -1.442 . . . . 72.31 107.561 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.0 m -108.35 104.38 13.74 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.269 0.628 . . . . 65.14 109.596 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.442 ' HG2' HE22 ' A' ' 79' ' ' GLN . 37.9 tt0 -124.13 117.28 24.29 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.171 0.988 . . . . 73.44 110.269 -169.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.1 t -133.69 112.83 17.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 123.7 0.8 . . . . 73.12 109.808 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.587 ' HG3' ' HG2' ' A' ' 61' ' ' ARG . 2.7 mp0 -89.68 84.22 6.3 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.657 1.183 . . . . 72.33 107.953 173.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -82.68 100.85 10.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.754 -1.112 . . . . 73.11 109.387 -175.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.13 151.91 20.99 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.45 0.469 . . . . 73.34 112.33 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.509 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -146.3 125.49 2.26 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.657 -0.577 . . . . 62.03 111.657 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.404 HD12 ' HB3' ' A' ' 15' ' ' ARG . 56.8 mt -81.45 118.13 28.68 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.252 -1.018 . . . . 72.34 108.252 169.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.669 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 41.1 m-85 -131.27 126.97 36.79 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.793 0.837 . . . . 74.3 108.971 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.3 m -83.75 115.64 22.31 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.379 1.072 . . . . 64.43 109.878 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.45 HD13 ' HB2' ' A' ' 94' ' ' MET . 6.0 tt -97.14 136.68 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.246 1.019 . . . . 74.32 109.063 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.477 ' HB2' ' HB ' ' A' ' 10' ' ' THR . . . -160.72 137.56 8.91 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.359 0.264 . . . . 71.52 111.368 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.97 -32.2 6.51 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.86 -0.609 . . . . 65.21 114.515 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.15 148.03 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 116.931 0.366 . . . . 70.41 111.693 -165.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 9.5 tt0 -134.99 -176.8 4.37 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.042 0.937 . . . . 72.33 109.18 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.522 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.94 -130.67 36.22 Favored Glycine 0 C--N 1.353 1.501 0 C-N-CA 123.178 0.418 . . . . 73.05 113.951 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.0 p -74.08 -21.71 59.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.537 0.735 . . . . 54.42 111.472 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.24 -49.68 47.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.446 0.698 . . . . 73.43 109.841 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.45 ' HB2' HD13 ' A' ' 86' ' ' ILE . 25.7 ptm -65.71 -32.13 73.52 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 116.189 -0.46 . . . . 63.54 110.269 177.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.621 ' HA ' HD12 ' E' ' 454' ' ' LEU . . . -63.68 -37.79 88.66 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 124.044 0.84 . . . . 75.12 111.388 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -69.43 -36.53 76.74 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.562 0.745 . . . . 75.24 111.301 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.8 m -73.27 -43.49 60.98 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.213 0.53 . . . . 70.25 111.008 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.459 HD22 HD11 ' E' ' 454' ' ' LEU . 6.9 tt -83.05 -38.38 22.63 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.337 1.055 . . . . 73.12 110.495 -169.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.97 3.78 52.31 Favored Glycine 0 N--CA 1.473 1.12 0 CA-C-N 116.111 -0.495 . . . . 74.43 114.259 -171.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.574 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -139.76 -62.77 0.51 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 117.452 0.626 . . . . 43.43 111.573 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.478 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 83.5 t80 -68.38 -55.28 12.51 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.977 0.911 . . . . 75.44 112.508 -170.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 76.0 m -72.05 -36.35 4.1 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 114.605 1.335 . . . . 74.03 114.605 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.56 -21.34 46.23 Favored 'Trans proline' 0 C--N 1.386 2.536 0 CA-C-N 121.787 1.674 . . . . 74.44 112.921 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -75.1 -28.64 60.33 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.069 0.548 . . . . 72.0 110.658 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 13' ' ' ILE . 26.7 mm -59.9 -37.53 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.566 0.747 . . . . 74.15 109.9 172.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.509 HD22 ' HA3' ' A' ' 82' ' ' GLY . 83.5 mt -78.35 -21.19 49.88 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.308 1.043 . . . . 74.04 112.527 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -61.22 -45.62 95.5 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.936 -1.03 . . . . 75.3 113.636 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.99 -34.57 80.48 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 121.929 1.753 . . . . 73.51 113.27 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.42 -43.4 66.82 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.573 0.749 . . . . 73.14 111.193 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.9 -41.08 75.18 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.095 0.558 . . . . 73.51 110.333 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.46 ' NH1' HG23 ' C' ' 105' ' ' ILE . 30.8 ttm180 -52.38 -52.81 51.55 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.158 0.983 . . . . 74.32 109.494 174.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.15 -52.52 65.37 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 124.637 1.211 . . . . 75.1 111.471 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 117' ' ' MET . 40.4 t -55.82 -50.09 71.48 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 124.38 1.05 . . . . 71.03 110.621 -176.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.468 ' O ' HG21 ' A' ' 118' ' ' VAL . 96.4 mt -58.77 -50.64 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 124.07 0.948 . . . . 73.22 110.985 177.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.5 m -51.92 -46.06 64.52 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.814 0.846 . . . . 72.42 110.65 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -64.09 -41.51 97.28 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 113.967 -1.469 . . . . 75.45 109.579 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.511 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 64.4 mmm -61.4 -42.5 98.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.182 0.593 . . . . 64.45 111.1 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 114' ' ' ILE . 57.8 t -62.05 -48.69 87.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.807 0.843 . . . . 72.13 110.091 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.0 p -71.75 -26.51 62.48 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.342 0.657 . . . . 72.51 111.956 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -70.76 -32.36 69.48 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.158 0.583 . . . . 72.12 109.996 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.75 -0.44 87.97 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.543 0.527 . . . . 71.24 112.987 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m 69.36 19.42 7.7 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 125.207 1.403 . . . . 71.42 111.217 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -86.06 150.8 53.33 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.542 -0.91 . . . . 73.1 108.542 171.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.91 143.12 92.78 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.721 2.281 . . . . 74.13 111.482 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -57.63 136.67 56.83 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.469 0.708 . . . . 74.42 112.398 -171.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.618 HD13 ' HG ' ' E' ' 470' ' ' LEU . 29.1 tp -120.42 99.93 6.85 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.656 1.182 . . . . 73.23 109.335 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -99.8 101.47 12.63 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.606 -0.887 . . . . 74.14 108.606 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.415 HD21 HG21 ' A' ' 114' ' ' ILE . 2.9 mm? -61.17 117.72 5.91 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.057 -0.72 . . . . 73.14 109.057 -177.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.407 ' HB2' ' HE3' ' E' ' 464' ' ' MET . . . -59.23 142.58 86.01 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.373 0.669 . . . . 73.4 110.744 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.68 119.22 6.34 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.85 2.366 . . . . 74.15 112.826 -174.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.2 t -99.21 112.76 32.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 107.626 -1.25 . . . . 64.13 107.626 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -83.39 91.34 7.32 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 108.339 -0.985 . . . . 74.15 108.339 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -64.93 -24.58 67.57 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.659 -0.7 . . . . 74.34 111.489 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.574 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 8.6 t70 -69.7 -50.29 45.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.73 0.812 . . . . 73.41 110.066 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.16 -45.68 93.65 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.541 1.136 . . . . 70.32 110.87 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.24 -30.89 70.04 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.925 -1.034 . . . . 64.02 111.919 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -70.66 -35.43 72.86 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 123.366 0.416 . . . . 73.53 109.914 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 32.4 tpp -63.1 -38.94 93.18 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 123.719 0.637 . . . . 71.23 110.492 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -63.87 -33.46 75.74 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.163 -0.926 . . . . 73.03 110.906 175.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -81.65 -32.99 31.6 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.197 0.999 . . . . 71.31 111.113 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 42.9 tp -67.24 -49.52 64.16 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.916 0.886 . . . . 74.32 111.969 -164.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -159.07 5.08 0.1 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.678 0.621 . . . . 75.53 112.678 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -73.95 -17.51 61.0 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 109.152 -0.685 . . . . 74.22 109.152 168.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -59.23 164.06 3.41 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 125.162 1.385 . . . . 72.11 110.853 169.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.19 -24.08 25.21 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.358 1.063 . . . . 63.31 112.705 176.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.04 67.86 2.93 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-N 116.075 -0.511 . . . . 72.35 112.348 172.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.78 -172.86 2.42 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.321 1.048 . . . . 72.33 110.717 177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 148.87 91.79 0.1 OUTLIER Glycine 0 C--N 1.344 1.023 0 C-N-CA 121.215 -0.517 . . . . 62.23 113.649 174.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.6 m -133.02 -91.42 0.38 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.657 -1.238 . . . . 75.32 107.657 171.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 165.69 -70.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 126.044 1.738 . . . . 72.14 107.61 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -171.59 -154.59 0.09 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 106.877 -1.527 . . . . 75.24 106.877 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -124.51 86.06 2.51 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.431 -0.952 . . . . 74.2 108.431 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -81.32 105.48 12.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.784 0.834 . . . . 73.52 109.562 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -83.49 -54.66 4.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.2 0.6 . . . . 74.44 111.008 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.239 0 CA-C-O 118.329 -0.843 . . . . 43.41 109.226 179.642 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.608 -0.516 . . . . 72.04 109.608 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 23.8 t -166.34 159.11 14.49 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.581 0.752 . . . . 65.01 109.645 176.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.504 ' HG3' ' H ' ' B' ' 4' ' ' GLN . 4.1 pt-20 -153.46 -92.6 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.81 0.844 . . . . 71.04 109.883 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.504 ' H ' ' HG3' ' B' ' 3' ' ' GLU . 26.9 tp60 57.15 90.98 0.04 OUTLIER 'General case' 0 C--N 1.364 1.202 0 C-N-CA 125.216 1.407 . . . . 74.04 111.771 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -79.3 163.87 24.56 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.957 -0.565 . . . . 74.41 109.716 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -68.28 106.07 2.34 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.212 -1.033 . . . . 70.13 108.212 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -132.81 156.33 47.33 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 123.905 0.882 . . . . 60.22 109.451 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -72.18 -41.06 67.44 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.197 -0.91 . . . . 70.53 109.238 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.418 ' HB2' HD12 ' B' ' 89' ' ' ILE . 18.3 ptm 50.85 -177.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 126.287 1.835 . . . . 62.41 112.384 -170.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 89.6 m -155.54 117.37 4.06 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 119.169 -0.443 . . . . 71.05 110.011 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . 0.266 0.3 OUTLIER -154.96 155.29 33.96 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.265 0.353 . . . . 74.12 110.951 147.246 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -126.88 140.86 52.03 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 107.702 -1.222 . . . . 73.03 107.702 170.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.495 HD11 HD12 ' B' ' 105' ' ' ILE . 30.4 mt -78.47 122.85 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.618 -0.719 . . . . 70.03 109.32 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -86.42 -49.92 7.26 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.883 0.74 . . . . 74.42 109.69 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -158.53 129.88 6.47 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.605 -0.725 . . . . 75.21 110.074 -171.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.8 mt -116.45 119.15 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 106.807 -1.553 . . . . 72.32 106.807 172.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -151.89 143.54 23.59 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.246 0.546 . . . . 74.2 110.942 -168.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -72.46 124.62 25.55 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.937 -1.029 . . . . 75.0 108.714 172.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.485 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.7 mtpt -95.01 -36.76 11.43 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.533 0.733 . . . . 74.5 110.319 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.0 t70 -157.07 141.08 16.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.602 -0.272 . . . . 72.52 110.984 -167.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.423 HD12 HG21 ' B' ' 78' ' ' VAL . 40.7 mm -141.13 148.08 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.118 1.367 . . . . 75.42 108.866 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 41.6 t -144.42 139.15 28.2 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.555 1.142 . . . . 64.34 108.13 170.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -145.01 114.21 7.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.665 -1.606 . . . . 72.12 106.665 170.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -124.85 112.51 16.74 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.825 0.45 . . . . 75.43 109.893 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.35 86.65 8.31 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 108.225 -1.028 . . . . 70.0 108.225 172.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.1 -35.29 11.92 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.916 2.41 . . . . 74.24 113.033 -173.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -102.87 19.33 19.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.587 0.755 . . . . 72.34 110.611 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.537 ' HB2' ' HD3' ' B' ' 29' ' ' PRO . . . -40.31 -65.48 0.44 Allowed Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 125.183 1.393 . . . . 75.25 113.836 -166.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' B' ' 28' ' ' ALA . 52.6 Cg_exo -53.54 -38.56 83.73 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.838 2.359 . . . . 75.24 114.018 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.408 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 52.8 m80 -87.48 -35.77 18.04 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.317 -0.856 . . . . 74.34 112.406 -170.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.574 HG21 HD11 ' B' ' 68' ' ' LEU . 11.1 p -69.99 -17.44 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.699 0.4 . . . . 75.3 111.425 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -68.7 -10.73 58.07 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 113.512 0.93 . . . . 73.41 113.512 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.7 pt20 -66.52 -25.13 66.53 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 122.811 0.444 . . . . 73.21 110.843 174.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.473 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 95.4 mttt -91.81 88.97 6.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.161 0.984 . . . . 74.12 108.747 177.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.51 76.79 6.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.823 0.849 . . . . 73.51 109.712 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -154.39 160.9 41.92 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.556 1.142 . . . . 75.22 108.37 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -75.15 107.41 3.93 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 124.833 1.253 . . . . 71.22 109.634 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.601 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 12.5 Cg_endo -59.95 133.71 52.19 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.103 2.536 . . . . 73.25 112.834 -175.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -57.7 114.59 2.34 Favored 'General case' 0 C--N 1.361 1.091 0 O-C-N 124.138 0.899 . . . . 74.42 111.051 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.23 156.75 3.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 114.775 -1.102 . . . . 74.11 111.485 -173.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -145.87 121.49 10.45 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.943 -1.503 . . . . 74.21 106.943 169.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.2 mp -86.22 155.39 20.73 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.11 -0.7 . . . . 73.02 109.11 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.553 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 27.2 t70 -144.6 145.2 31.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.981 -1.489 . . . . 75.44 106.981 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.89 135.85 29.89 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.146 -0.687 . . . . 75.3 109.146 -169.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.457 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.0 t70 -145.69 140.0 26.95 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.2 1.4 . . . . 73.4 108.254 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 74.8 p -134.26 141.31 46.94 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.987 -0.746 . . . . 73.52 108.987 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.44 120.68 4.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.41 0.684 . . . . 71.04 109.881 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 57.3 p -99.4 168.75 9.8 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.981 0.513 . . . . 74.54 109.911 176.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 86.5 p -151.15 135.87 17.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.06 0.544 . . . . 73.33 109.927 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -82.5 103.44 12.04 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.297 -0.631 . . . . 71.33 109.297 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.593 HD13 ' HB2' ' B' ' 57' ' ' GLU . 58.8 mt -75.02 -53.79 8.3 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.418 0.628 . . . . 71.3 110.629 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.88 -170.61 3.57 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.754 -1.112 . . . . 72.3 109.375 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -64.73 109.84 2.18 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.815 0.697 . . . . 54.32 109.72 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 13.3 m-20 71.97 1.55 3.96 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.123 1.369 . . . . 72.04 112.667 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -104.69 122.63 57.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.08 -1.081 . . . . 75.4 108.08 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.5 ' HE2' ' HB3' ' B' ' 98' ' ' LEU . 0.1 OUTLIER -135.98 154.64 51.02 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.034 -0.728 . . . . 71.45 109.034 178.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.593 ' HB2' HD13 ' B' ' 51' ' ' LEU . 12.5 tm-20 -123.29 110.53 15.31 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.672 -1.233 . . . . 75.43 107.672 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 95.0 t -89.81 141.35 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 O-C-N 123.777 0.673 . . . . 73.15 109.446 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 39.5 t -117.22 145.45 22.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 108.675 -0.861 . . . . 74.02 108.675 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -128.66 104.72 7.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.619 -1.252 . . . . 73.01 107.619 178.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 33.1 ttt180 -94.03 113.47 25.45 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.582 0.753 . . . . 73.52 110.596 173.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.19 104.36 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.258 -1.016 . . . . 71.12 108.258 171.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 41.3 m -96.34 142.0 28.99 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.534 -0.913 . . . . 63.44 108.534 175.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.4 HG11 HD23 ' B' ' 126' ' ' LEU . 90.4 t -136.5 136.01 48.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.507 -0.923 . . . . 75.4 108.507 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 74.6 m -122.48 137.7 54.79 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.599 -0.889 . . . . 73.41 108.599 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -141.64 141.83 33.4 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.617 0.767 . . . . 73.24 109.684 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.469 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 57.5 p -145.03 133.5 21.91 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.959 -0.564 . . . . 75.11 111.908 -173.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.601 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.1 mt -94.06 106.89 18.85 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.17 0.988 . . . . 74.14 109.033 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.49 -111.8 4.34 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 114.887 -1.051 . . . . 65.52 111.909 -173.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -107.64 5.36 26.8 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.81 0.844 . . . . 73.52 111.813 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.473 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 13.0 pt-20 -124.72 144.8 50.03 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.039 0.382 . . . . 74.44 111.237 -176.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 99.8 m -64.72 119.92 11.48 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 123.817 0.698 . . . . 74.43 110.524 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -81.55 -65.63 0.99 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.712 -1.131 . . . . 73.12 108.02 176.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -144.2 150.75 38.49 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-O 121.723 0.773 . . . . 74.13 111.457 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 74.7 mt -115.03 142.19 46.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.086 -1.82 . . . . 73.1 106.086 166.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.566 ' SG ' HG21 ' B' ' 114' ' ' ILE . 49.7 t -147.55 146.8 29.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.804 -0.813 . . . . 73.01 108.804 176.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -160.7 136.39 8.14 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.512 -0.551 . . . . 74.23 109.512 -173.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.437 HG11 ' HA ' ' B' ' 110' ' ' ALA . 98.1 t -131.23 145.15 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 123.863 0.865 . . . . 73.43 109.203 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 42.2 mt-30 -122.71 88.49 2.94 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.076 -1.083 . . . . 74.54 108.076 171.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 11.2 tp-100 -81.24 101.62 9.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.783 -1.099 . . . . 61.25 109.157 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.485 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -95.75 163.06 23.44 Favored Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.677 -0.569 . . . . 73.44 111.677 176.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.74 127.41 1.9 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.114 -0.795 . . . . 74.14 111.114 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.89 127.2 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 109.045 -0.724 . . . . 73.23 109.045 172.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . 0.411 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 24.0 m-85 -132.02 153.93 49.88 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 107.227 -1.397 . . . . 61.15 107.227 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 59.0 m -122.48 91.21 3.45 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.825 0.45 . . . . 72.14 110.41 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.439 HD11 HD13 ' B' ' 89' ' ' ILE . 15.4 tt -94.82 145.81 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.844 0.858 . . . . 73.43 112.474 -166.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.47 161.14 40.07 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 124.709 1.204 . . . . 75.03 108.999 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.06 -68.17 0.39 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.095 -0.502 . . . . 64.33 113.207 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.562 ' H ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -90.38 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 121.418 0.628 . . . . 72.21 112.03 -173.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.43 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 33.2 tt0 -156.94 179.38 9.35 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.826 1.25 . . . . 54.15 108.26 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.43 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 72.4 -123.55 9.27 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 117.676 0.217 . . . . 63.24 112.621 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 32.2 m -93.41 -18.16 22.67 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.323 0.649 . . . . 70.11 111.436 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -68.08 -33.87 75.35 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 122.081 -0.387 . . . . 75.32 110.289 173.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.556 ' SD ' ' HA ' ' F' ' 452' ' ' VAL . 0.0 OUTLIER -77.56 -29.31 52.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.26 0.224 . . . . 75.33 110.477 173.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.14 -40.78 91.01 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-O 121.403 0.621 . . . . 72.45 109.922 176.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.419 ' O ' ' HB1' ' B' ' 100' ' ' ALA . 40.6 t-80 -64.12 -29.51 70.63 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.713 -1.13 . . . . 74.31 111.395 175.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 37.9 t -70.83 -66.11 0.65 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 110.312 -0.255 . . . . 75.41 110.312 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.65 HD23 ' HB ' ' F' ' 452' ' ' VAL . 0.4 OUTLIER -72.23 -23.83 61.29 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.56 0.948 . . . . 73.44 113.56 -174.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.92 1.07 56.45 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 119.651 -0.527 . . . . 61.11 113.346 -174.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.597 ' HA ' ' HB3' ' B' ' 133' ' ' PHE . . . -152.06 -62.43 0.17 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.413 0.523 . . . . 72.3 112.413 -175.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -66.65 -42.52 86.52 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.187 0.995 . . . . 75.13 111.89 -170.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.459 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 73.2 m -71.25 -50.58 11.07 Favored Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 124.332 1.053 . . . . 74.34 111.069 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.471 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 65.3 Cg_exo -57.16 -30.86 88.7 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.115 1.876 . . . . 75.55 114.014 170.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -59.13 -43.01 91.98 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 123.65 0.78 . . . . 75.33 110.298 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.495 HD12 HD11 ' B' ' 13' ' ' ILE . 73.8 mt -62.9 -41.37 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 115.09 -0.959 . . . . 75.25 110.889 176.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.15 -22.93 38.62 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.953 -1.022 . . . . 72.02 112.314 -172.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -58.72 -49.03 95.66 Favored Pre-proline 0 N--CA 1.486 1.333 0 N-CA-C 114.205 1.187 . . . . 71.32 114.205 -170.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -55.95 -36.82 96.36 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.029 1.819 . . . . 74.23 113.937 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.401 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 78.7 m-85 -67.43 -46.59 72.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.158 0.583 . . . . 73.51 110.601 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.437 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -59.68 -40.54 88.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.686 0.794 . . . . 71.23 110.856 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.656 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 34.6 ttt180 -61.21 -54.69 41.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.632 1.573 . . . . 75.43 111.014 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -38.12 89.9 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.36 0.664 . . . . 75.13 110.021 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.463 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.8 t -66.63 -33.89 76.66 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 116.18 -0.464 . . . . 73.3 111.535 -176.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.566 HG21 ' SG ' ' B' ' 76' ' ' CYS . 62.6 mt -66.46 -52.05 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 109.896 -0.409 . . . . 75.31 109.896 175.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.434 HG22 ' OG ' ' C' ' 119' ' ' SER . 5.1 m -62.5 -30.57 71.37 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.732 0.645 . . . . 72.41 111.487 -176.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.5 t -61.3 -49.92 75.09 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.449 0.7 . . . . 74.23 109.376 174.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.0 mmt -58.44 -44.87 89.33 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.637 0.775 . . . . 73.13 111.03 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.11 -45.49 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.291 1.036 . . . . 64.54 111.269 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.0 t -63.45 -37.48 87.44 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.307 -0.86 . . . . 63.41 111.476 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.5 mtt-85 -66.16 -36.19 82.46 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.751 -1.113 . . . . 72.21 109.949 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.43 9.74 66.52 Favored Glycine 0 C--N 1.356 1.678 0 O-C-N 123.93 0.769 . . . . 65.31 113.898 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 72.4 p 54.76 35.38 23.89 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.781 1.632 . . . . 75.41 113.222 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -99.31 153.58 37.71 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.171 0.588 . . . . 73.55 110.342 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -50.82 158.6 2.89 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 123.868 3.046 . . . . 72.42 115.187 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -63.33 119.66 10.09 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.655 1.182 . . . . 75.45 112.699 -170.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.414 HD21 HG22 ' B' ' 114' ' ' ILE . 55.9 tp -108.54 102.75 11.8 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.064 -0.717 . . . . 74.53 109.064 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -100.21 105.29 16.86 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.22 -0.659 . . . . 73.42 109.22 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.656 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -73.33 113.0 9.92 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.037 -0.727 . . . . 71.53 109.037 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.09 149.94 96.18 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.922 0.889 . . . . 74.33 110.752 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.479 ' HG3' HD11 ' D' ' 16' ' ' ILE . 55.6 Cg_endo -66.37 123.35 11.04 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.441 2.094 . . . . 64.53 112.383 -175.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.8 111.61 24.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.306 -1.368 . . . . 74.34 107.306 172.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -76.97 86.56 3.5 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.63 -1.248 . . . . 73.51 107.63 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.597 ' HB3' ' HA ' ' B' ' 100' ' ' ALA . 97.7 m-85 -55.37 -42.65 74.22 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.895 0.878 . . . . 74.43 111.529 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.425 ' HA ' ' HB3' ' B' ' 100' ' ' ALA . 5.5 m-20 -63.72 -42.43 97.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.361 1.064 . . . . 74.44 111.696 -174.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.04 -52.81 31.14 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.586 0.754 . . . . 74.33 110.283 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.4 HD23 ' HG1' ' F' ' 463' ' ' THR . 88.7 mt -72.25 -18.62 61.8 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.112 -0.949 . . . . 72.43 112.282 -173.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.484 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 72.1 t80 -70.75 -40.52 72.66 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.329 0.651 . . . . 71.12 109.757 174.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 65.6 mtt -65.84 -26.44 67.66 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.739 0.416 . . . . 75.4 110.571 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.445 ' N ' HD21 ' B' ' 139' ' ' ASN . 0.7 OUTLIER -73.75 -29.18 62.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.835 0.854 . . . . 75.02 109.529 176.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . 0.423 ' HD1' ' HB3' ' F' ' 461' ' ' PHE . 47.5 t80 -71.94 -32.63 67.51 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.421 1.088 . . . . 73.41 110.874 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 32.4 mt -80.08 0.1 33.42 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.73 0.812 . . . . 74.41 112.546 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -151.67 -168.41 3.07 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.415 -0.957 . . . . 72.11 108.415 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -123.95 22.01 8.91 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.104 0.562 . . . . 72.52 110.675 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -142.41 147.95 37.02 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.186 0.594 . . . . 75.1 110.666 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -173.43 -170.59 0.62 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.129 1.371 . . . . 75.24 108.991 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.83 -178.04 20.9 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 112.701 -0.16 . . . . 74.11 112.701 174.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.99 129.41 27.83 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.364 1.066 . . . . 72.02 108.964 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.16 100.83 0.52 Allowed Glycine 0 C--N 1.338 0.658 0 N-CA-C 111.004 -0.838 . . . . 64.02 111.004 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 14.4 t -148.48 157.02 43.2 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.145 0.578 . . . . 73.11 109.838 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -94.08 122.85 37.03 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.861 -0.609 . . . . 75.42 109.394 174.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -70.96 83.27 0.67 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 107.573 -1.269 . . . . 75.12 107.573 167.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -94.48 128.73 41.25 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.644 -0.707 . . . . 72.13 110.379 -173.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.49 -178.25 4.17 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.165 0.986 . . . . 71.43 110.018 174.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.06 -76.82 0.6 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.921 0.888 . . . . 72.33 109.044 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 C-N-CA 124.476 1.11 . . . . 72.43 108.487 -176.766 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.473 -0.566 . . . . 72.42 109.473 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 26.9 t -159.57 78.49 0.71 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.217 -1.031 . . . . 73.0 108.217 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -90.14 58.72 4.21 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.812 0.845 . . . . 64.24 109.496 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 63.97 -79.36 0.03 OUTLIER 'General case' 0 C--N 1.357 0.893 0 C-N-CA 125.212 1.405 . . . . 64.4 110.727 -176.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -159.92 -56.09 0.06 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.742 -1.207 . . . . 72.42 107.742 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 63.29 -163.94 0.26 Allowed 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 124.776 1.23 . . . . 72.2 109.394 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.417 HG23 ' HG3' ' C' ' 8' ' ' GLU . 54.2 m 69.29 151.1 0.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.467 1.107 . . . . 72.04 111.677 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.417 ' HG3' HG23 ' C' ' 7' ' ' THR . 49.6 mt-10 73.84 173.33 0.28 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.071 1.348 . . . . 73.15 111.798 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 28.0 ttt 63.67 112.25 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.183 1.393 . . . . 73.31 110.149 -171.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 40.2 m -126.3 105.16 8.61 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.711 -1.218 . . . . 73.21 107.711 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.526 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 3.2 t80 -116.14 119.85 37.12 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.127 -0.942 . . . . 74.21 108.578 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -136.47 131.9 34.64 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 107.981 -1.118 . . . . 74.35 107.981 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.425 HG21 HD13 ' C' ' 16' ' ' ILE . 63.8 mt -76.59 120.33 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.556 -0.905 . . . . 71.03 108.556 173.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.652 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.6 mm-40 -82.71 -42.31 18.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.075 -0.966 . . . . 71.31 109.106 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -170.94 149.31 2.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.639 -0.71 . . . . 74.22 109.703 -170.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.438 HG22 HD21 ' C' ' 106' ' ' LEU . 70.5 mt -138.3 133.77 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.645 -1.243 . . . . 75.12 107.645 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.408 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 31.5 p90 -169.77 172.04 6.98 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.847 0.832 . . . . 74.01 111.77 -172.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -97.27 123.14 40.98 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.094 -0.957 . . . . 74.32 109.101 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.408 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.9 mmtp -71.21 -50.46 32.85 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 122.755 1.264 . . . . 75.24 107.631 168.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -134.92 141.88 46.41 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 112.517 -2.129 . . . . 75.33 108.889 -168.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 74.2 mt -137.95 142.03 36.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 106.024 -1.843 . . . . 72.12 106.024 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -155.99 150.15 25.49 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.316 0.579 . . . . 74.54 110.439 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -150.87 134.95 16.77 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.526 -1.287 . . . . 71.2 107.526 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.69 124.27 19.58 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.737 0.815 . . . . 75.34 109.499 -171.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.62 79.02 7.37 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 107.517 -1.29 . . . . 74.15 107.517 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.93 -42.71 61.5 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.026 2.484 . . . . 73.35 111.494 174.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -91.53 29.76 1.44 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.11 -1.404 . . . . 72.51 110.362 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.94 -58.91 8.71 Favored Pre-proline 0 N--CA 1.487 1.405 0 CA-C-O 118.084 -0.96 . . . . 75.34 113.046 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.33 -33.41 58.97 Favored 'Trans proline' 0 C--N 1.388 2.62 0 CA-C-N 121.735 1.655 . . . . 71.21 111.898 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.496 ' NE2' ' HZ3' ' C' ' 34' ' ' LYS . 75.7 t60 -68.48 -37.63 80.3 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.202 1.401 . . . . 64.41 112.496 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.9 p -82.02 -23.51 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.372 0.269 . . . . 72.2 111.68 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -68.07 -35.83 78.85 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.877 0.37 . . . . 73.43 110.561 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -89.37 12.38 16.42 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.815 0.846 . . . . 71.43 111.062 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.57 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.7 tppp? -101.27 160.51 14.35 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.154 0.982 . . . . 73.34 109.621 177.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.48 114.19 9.29 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.461 0.704 . . . . 72.54 109.91 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -78.84 100.95 7.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.879 0.872 . . . . 74.13 111.155 -174.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.451 ' H ' HD23 ' C' ' 68' ' ' LEU . 10.8 pt20 -149.9 78.42 8.14 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 124.107 0.963 . . . . 75.0 109.535 171.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -87.3 128.31 2.6 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.351 2.034 . . . . 73.31 112.571 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -86.27 91.5 8.49 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 106.075 -1.824 . . . . 72.31 106.075 165.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 18.0 m -72.49 131.81 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.737 -1.119 . . . . 73.13 111.831 -171.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -113.77 102.89 10.66 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.548 -1.279 . . . . 62.44 107.548 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -87.98 152.49 22.01 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.167 -0.679 . . . . 72.13 109.167 170.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.5 t70 -137.45 104.65 5.42 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.584 -0.895 . . . . 75.44 108.584 177.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 85.6 mt -92.65 113.09 25.28 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.839 -1.171 . . . . 73.43 107.839 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.3 t70 -122.27 153.7 38.55 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.856 1.262 . . . . 74.25 109.399 178.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 5.3 t -143.87 154.2 43.12 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.119 -0.697 . . . . 73.22 109.119 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.12 135.93 15.37 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.16 0.984 . . . . 73.41 109.097 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.426 ' HB3' HG21 ' C' ' 58' ' ' VAL . 29.6 p -125.71 142.18 51.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.363 0.665 . . . . 72.4 109.665 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.7 p -153.43 140.33 19.16 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.393 0.677 . . . . 73.14 110.766 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -72.18 127.14 31.62 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.955 0.902 . . . . 72.22 111.104 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.609 HD12 ' HB2' ' C' ' 57' ' ' GLU . 55.7 mt -96.06 -44.3 7.39 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.018 0.927 . . . . 75.43 109.708 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.25 -176.57 5.28 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.771 -1.104 . . . . 65.54 109.807 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.73 108.07 0.93 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.689 0.796 . . . . 72.2 110.369 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 70.63 1.6 3.76 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.745 1.618 . . . . 73.43 112.974 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 68.5 t -98.16 118.43 44.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.86 -0.793 . . . . 74.45 108.86 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -108.83 158.74 17.38 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.182 0.992 . . . . 73.04 110.28 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.609 ' HB2' HD12 ' C' ' 51' ' ' LEU . 24.6 tt0 -119.41 130.81 55.48 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 112.884 -1.962 . . . . 75.44 107.285 169.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.426 HG21 ' HB3' ' C' ' 48' ' ' SER . 76.0 t -115.28 126.4 72.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.877 -0.786 . . . . 73.0 108.877 170.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.484 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 88.0 t -105.79 130.36 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 107.788 -1.19 . . . . 73.03 107.788 171.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.41 103.75 10.43 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.837 -1.542 . . . . 74.42 106.837 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.423 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.9 ttm-85 -84.27 123.18 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.15 -1.386 . . . . 71.44 108.47 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -116.46 118.58 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.973 -1.121 . . . . 73.21 107.973 169.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 42.3 m -110.72 141.81 43.5 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.087 0.955 . . . . 64.03 108.628 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.674 HG12 HD13 ' C' ' 126' ' ' LEU . 55.8 t -126.1 127.65 71.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 108.663 -0.866 . . . . 53.42 108.663 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -115.81 137.37 52.15 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.22 -1.4 . . . . 74.44 107.22 167.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.51 114.39 14.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.187 -1.412 . . . . 71.34 107.187 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.6 m -134.75 134.08 40.6 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.562 0.539 . . . . 71.53 110.027 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.451 HD23 ' H ' ' C' ' 37' ' ' GLN . 12.5 mt -90.91 23.04 3.33 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 126.005 1.722 . . . . 73.42 110.133 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.39 -87.8 0.51 Allowed Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.024 -0.83 . . . . 65.53 111.024 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.2 -30.51 18.49 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.572 0.749 . . . . 71.31 110.326 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.57 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 15.8 tp10 -92.97 118.36 31.07 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.455 0.702 . . . . 55.33 110.429 -173.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -77.44 122.4 25.14 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.614 -0.884 . . . . 71.13 108.614 169.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.72 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.5 -54.24 7.91 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.298 -0.865 . . . . 73.21 109.461 176.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -167.24 157.05 10.8 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.283 -0.871 . . . . 75.04 110.909 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -118.0 144.99 45.08 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 106.365 -1.717 . . . . 73.01 106.365 168.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.4 ' SG ' HG22 ' C' ' 114' ' ' ILE . 42.8 t -148.78 149.45 31.4 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.504 -0.924 . . . . 63.14 108.504 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -159.22 130.25 6.08 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.374 0.421 . . . . 54.32 110.073 175.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.5 t -125.54 131.6 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.891 0.876 . . . . 73.1 108.646 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -109.32 87.53 2.52 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.605 -1.257 . . . . 74.35 107.605 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.424 ' HG3' HD22 ' C' ' 106' ' ' LEU . 8.8 tp-100 -79.42 96.77 6.14 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.483 -0.78 . . . . 70.53 110.357 -175.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -97.7 143.23 16.58 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 112.306 -0.317 . . . . 61.22 112.306 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.99 140.62 8.53 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 110.357 -1.097 . . . . 71.1 110.357 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.7 mm -91.39 122.7 43.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.553 -0.906 . . . . 70.54 108.553 -178.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.526 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 63.8 m-85 -127.46 119.33 25.85 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.201 -1.037 . . . . 71.22 108.201 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 39.9 p -84.46 125.49 32.41 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.066 0.546 . . . . 75.33 109.563 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.618 HD11 HD13 ' C' ' 98' ' ' LEU . 39.0 pt -116.51 135.33 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.214 0.606 . . . . 74.45 109.776 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.444 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -153.45 151.29 29.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.947 0.899 . . . . 74.14 109.321 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.15 -57.74 4.26 Favored Glycine 0 N--CA 1.474 1.188 0 N-CA-C 112.243 -0.343 . . . . 72.43 112.243 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -85.48 156.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.869 0.868 . . . . 75.32 111.834 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.539 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 11.9 pt-20 -161.42 -175.74 4.97 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.416 -0.811 . . . . 74.34 110.421 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.1 -119.75 18.43 Favored Glycine 0 C--N 1.352 1.47 0 O-C-N 123.902 0.751 . . . . 75.21 113.845 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.474 ' HB ' HD12 ' C' ' 141' ' ' LEU . 47.3 p -72.94 -33.32 65.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.246 1.019 . . . . 72.51 111.171 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -67.9 -34.9 77.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.736 0.815 . . . . 72.04 110.903 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.539 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 55.3 ttp -75.35 -41.77 55.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.837 0.855 . . . . 73.25 110.396 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.37 -41.04 75.54 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.076 0.86 . . . . 61.2 110.086 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 18.7 t-160 -76.39 -43.2 41.68 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 124.05 0.844 . . . . 74.24 111.811 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -55.68 -40.25 72.06 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 123.956 0.785 . . . . 72.55 110.648 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.618 HD13 HD11 ' C' ' 86' ' ' ILE . 22.0 mt -101.71 -14.9 17.17 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.748 0.819 . . . . 73.23 111.632 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . 0.604 ' HA2' HG23 ' G' ' 458' ' ' THR . . . -76.87 -30.89 55.24 Favored Glycine 0 C--N 1.355 1.615 0 N-CA-C 114.77 0.668 . . . . 62.55 114.77 -176.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.2 -36.32 0.06 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.07 0.396 . . . . 62.41 112.07 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.521 ' HH ' ' HD1' ' C' ' 11' ' ' PHE . 74.4 t80 -59.2 -49.59 77.29 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 125.231 1.412 . . . . 75.32 112.535 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 88.1 m -77.94 -41.99 2.17 Favored Pre-proline 0 CA--C 1.563 1.464 0 CA-C-O 118.727 -0.654 . . . . 63.21 112.575 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.08 -33.44 34.98 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.449 2.099 . . . . 74.44 114.558 168.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.33 -26.68 63.87 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.581 0.752 . . . . 71.23 110.458 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.46 HG23 ' NH1' ' A' ' 111' ' ' ARG . 48.0 mm -68.71 -39.36 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.829 0.852 . . . . 70.21 109.725 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.438 HD21 HG22 ' C' ' 16' ' ' ILE . 35.8 mt -80.64 -23.82 39.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.668 1.187 . . . . 75.23 112.597 -174.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -57.3 -49.25 94.95 Favored Pre-proline 0 CA--C 1.563 1.45 0 N-CA-C 114.212 1.19 . . . . 75.12 114.212 -173.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.41 -37.64 96.82 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 121.945 1.764 . . . . 72.14 113.223 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -66.36 -49.01 68.34 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.837 0.855 . . . . 73.43 111.178 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.09 -38.97 84.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.289 -0.868 . . . . 75.13 110.628 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -58.54 -55.71 31.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.564 1.146 . . . . 74.54 110.8 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.29 -33.08 75.13 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.852 0.461 . . . . 75.13 110.39 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 33.4 t -71.16 -31.4 67.64 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.009 0.524 . . . . 73.04 111.48 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.55 HG21 HG23 ' C' ' 64' ' ' VAL . 76.9 mt -73.2 -54.04 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.523 -0.547 . . . . 75.21 109.523 172.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 4.7 m -62.46 -27.82 69.39 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.166 0.587 . . . . 73.34 111.271 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.6 t -61.33 -53.66 53.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.626 0.771 . . . . 74.3 109.094 169.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.602 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.28 -35.23 75.06 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.791 1.236 . . . . 73.44 112.46 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.67 -45.27 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.683 0.793 . . . . 73.5 109.622 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.434 ' OG ' HG22 ' B' ' 115' ' ' THR . 42.3 t -68.69 -28.55 66.95 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.001 0.813 . . . . 61.01 111.449 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.478 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 82.7 mtt-85 -70.74 -43.11 69.52 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.503 0.721 . . . . 72.21 109.211 176.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.09 -3.79 82.13 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 124.287 0.992 . . . . 74.11 112.24 172.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 65.82 26.55 11.18 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 127.026 2.13 . . . . 74.44 113.588 170.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -82.8 156.62 67.56 Favored Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 109.021 -0.733 . . . . 73.25 109.021 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.14 175.1 2.72 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.909 2.406 . . . . 73.25 114.285 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -56.84 137.56 54.78 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.784 1.031 . . . . 75.52 113.784 -171.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.674 HD13 HG12 ' C' ' 64' ' ' VAL . 3.0 tt -126.9 87.03 2.59 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.662 -1.154 . . . . 72.41 108.278 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -107.89 109.66 21.23 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.21 0.604 . . . . 73.4 109.846 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -74.73 135.63 41.79 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 122.918 0.487 . . . . 74.22 110.762 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.26 151.38 87.86 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.894 0.877 . . . . 74.1 110.241 174.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.48 ' HG3' HD13 ' A' ' 16' ' ' ILE . 24.6 Cg_exo -60.93 103.34 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.816 2.344 . . . . 53.31 112.794 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.416 HG13 ' HG3' ' G' ' 464' ' ' MET . 17.9 m -98.46 111.13 27.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.244 -1.021 . . . . 72.1 108.244 168.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -75.72 84.57 2.72 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.32 -0.854 . . . . 74.41 109.196 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -54.39 -44.82 72.61 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.752 0.658 . . . . 75.55 110.121 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.74 -47.53 85.29 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.574 -1.194 . . . . 61.52 111.682 -174.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.27 87.01 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.345 0.658 . . . . 75.05 111.209 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' G' ' 462' ' ' TYR . 87.5 mt -62.96 -42.49 99.84 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.776 -0.647 . . . . 74.02 111.422 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.598 ' HA ' ' HB3' ' C' ' 140' ' ' TYR . 10.1 t80 -71.89 -26.48 62.34 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.935 0.494 . . . . 74.51 110.807 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 25.3 ttt -60.09 -45.77 91.83 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 122.769 0.428 . . . . 74.41 109.943 174.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -72.04 -35.61 69.4 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.974 0.91 . . . . 73.02 111.474 175.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.598 ' HB3' ' HA ' ' C' ' 137' ' ' PHE . 84.8 t80 -66.32 -84.81 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.082 0.953 . . . . 74.54 109.801 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.474 HD12 ' HB ' ' C' ' 92' ' ' THR . 23.2 tp 70.09 -76.4 0.06 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.697 1.599 . . . . 70.15 109.696 -175.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -138.05 2.04 2.31 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 124.067 0.947 . . . . 73.42 110.859 170.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -117.83 169.0 9.96 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.639 1.176 . . . . 72.4 109.067 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -52.75 148.48 7.33 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.171 0.989 . . . . 74.14 112.892 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.5 ' HB3' ' HB2' ' C' ' 140' ' ' TYR . . . -115.22 127.61 55.62 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.331 1.052 . . . . 62.42 109.999 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -155.72 70.08 0.28 Allowed Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.956 -0.458 . . . . 72.41 111.956 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -147.91 123.13 10.21 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.468 0.707 . . . . 73.43 109.708 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.32 147.3 5.16 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.391 0.432 . . . . 60.42 112.715 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 18.0 p -89.65 172.09 9.19 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.119 0.968 . . . . 74.2 110.657 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -119.49 159.07 25.0 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.796 0.838 . . . . 74.1 111.796 -170.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . 0.494 ' HB2' HE22 ' A' ' 12' ' ' GLN . 13.9 tp10 -145.24 146.57 31.75 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.925 0.49 . . . . 73.11 110.888 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -119.78 27.35 8.76 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.434 1.094 . . . . 74.43 112.25 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -64.92 132.69 50.03 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.192 0.451 . . . . 54.51 111.066 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -92.0 114.17 26.63 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.461 0.704 . . . . 74.15 109.332 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . 0.481 ' H ' ' HA3' ' G' ' 469' ' ' GLY . . . . . . . . 0 CA--C 1.562 1.418 0 C-N-CA 124.339 1.055 . . . . 73.22 109.096 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 109.108 -0.701 . . . . 64.12 109.108 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 23.4 m -119.88 147.74 44.34 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.044 0.937 . . . . 72.44 110.006 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -131.05 106.64 8.52 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.533 0.733 . . . . 63.34 109.374 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -94.18 80.98 4.03 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.739 -0.837 . . . . 64.12 108.739 171.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -158.46 147.33 18.93 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.723 -1.214 . . . . 71.04 107.723 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -71.92 84.21 0.95 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.537 0.684 . . . . 74.5 109.739 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -118.16 -170.63 1.92 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.952 1.301 . . . . 73.21 108.119 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -68.08 -14.87 63.31 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.169 0.803 . . . . 71.31 113.169 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 10.4 tpt -34.31 123.79 0.5 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.714 0.805 . . . . 72.32 111.46 159.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 37.1 m -133.55 142.34 48.13 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.088 0.555 . . . . 75.42 110.024 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -158.14 97.01 1.49 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.87 -1.529 . . . . 74.12 106.87 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -134.46 149.82 50.77 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.828 -0.805 . . . . 74.22 108.828 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 mt -92.87 130.48 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.404 -0.591 . . . . 70.32 109.404 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -86.73 -35.22 19.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.055 0.542 . . . . 61.44 110.5 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -174.54 130.56 0.35 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.488 0.315 . . . . 75.22 111.091 -172.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.479 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.5 mp -107.47 140.78 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.747 -1.205 . . . . 74.13 107.747 172.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -162.65 158.62 23.44 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.733 0.646 . . . . 75.12 111.679 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.8 p -93.59 118.85 31.89 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.169 -0.923 . . . . 73.13 109.56 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -90.28 -20.59 22.76 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 116.045 -0.525 . . . . 75.41 109.923 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.609 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.1 t70 -157.02 132.36 9.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.517 -0.765 . . . . 75.3 109.821 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.602 HG21 ' HE1' ' C' ' 117' ' ' MET . 60.4 mt -135.9 147.06 28.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 124.548 1.139 . . . . 74.5 107.982 171.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -153.52 115.68 4.35 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.82 0.7 . . . . 73.52 110.142 171.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -110.21 134.22 52.44 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.487 -1.671 . . . . 74.22 106.487 166.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.71 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 31.4 mt-10 -140.0 120.21 13.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.777 0.831 . . . . 72.02 108.959 -173.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.05 89.43 50.75 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.845 -1.169 . . . . 75.34 107.845 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.3 -46.8 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.103 2.536 . . . . 73.13 111.795 -174.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 26.3 m-20 -98.2 34.93 1.85 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.256 1.023 . . . . 73.52 109.01 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.8 -66.86 0.53 Allowed Pre-proline 0 CA--C 1.567 1.614 0 N-CA-C 114.101 1.149 . . . . 73.42 114.101 -162.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.518 ' HB3' HD11 ' C' ' 83' ' ' ILE . 95.1 Cg_endo -76.03 -20.28 15.04 Favored 'Trans proline' 0 C--N 1.384 2.447 0 CA-C-N 122.705 2.002 . . . . 75.34 113.02 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 6.6 t-160 -64.49 -47.65 78.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.575 1.55 . . . . 73.51 109.746 176.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.651 HG22 ' HA ' ' D' ' 73' ' ' ALA . 5.1 p -85.26 -23.94 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 CA-C-N 114.821 -1.081 . . . . 73.01 112.194 -168.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -60.79 -30.45 70.05 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 123.355 0.662 . . . . 73.4 112.765 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -60.08 -24.06 64.3 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.931 -1.031 . . . . 64.23 111.166 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.469 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 84.8 mttt -86.84 85.14 7.25 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.365 1.066 . . . . 75.44 108.775 173.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.15 82.08 3.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.419 0.628 . . . . 72.33 110.414 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -142.17 157.88 44.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.012 1.325 . . . . 73.41 107.759 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -68.22 107.69 2.15 Favored Pre-proline 0 CA--C 1.555 1.139 0 N-CA-C 108.635 -0.876 . . . . 74.3 108.635 172.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.401 ' O ' HG12 ' D' ' 40' ' ' VAL . 35.8 Cg_exo -59.93 120.96 9.06 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.122 2.548 . . . . 73.41 112.157 -168.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.49 ' HA ' ' HG ' ' H' ' 470' ' ' LEU . 46.9 mt-10 -67.15 111.78 4.1 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 123.943 0.777 . . . . 63.33 109.983 -175.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.591 HG13 ' HB1' ' D' ' 66' ' ' ALA . 35.9 m -104.5 142.49 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.109 -0.951 . . . . 75.23 110.745 -173.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.49 136.93 40.51 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.912 -1.144 . . . . 72.05 107.912 162.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.4 112.42 24.35 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.168 -1.049 . . . . 72.12 108.168 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -127.54 123.13 35.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.331 -0.989 . . . . 73.1 108.331 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.05 160.81 19.79 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.446 0.641 . . . . 72.43 110.047 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -149.73 151.6 33.92 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.202 -1.407 . . . . 64.23 107.202 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -128.37 154.18 46.26 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.464 -0.569 . . . . 75.13 109.464 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.69 157.75 43.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.983 0.913 . . . . 72.51 109.402 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.4 m -149.01 153.44 37.91 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.332 0.653 . . . . 50.52 109.968 175.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.8 t -152.67 126.01 8.69 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.669 0.788 . . . . 75.22 109.757 -169.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -78.01 118.33 20.19 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.78 0.432 . . . . 75.32 109.842 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' D' ' 57' ' ' GLU . 67.0 mt -91.72 -42.09 10.34 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.579 -0.526 . . . . 73.43 109.579 176.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.62 -174.95 5.09 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.872 -1.058 . . . . 73.33 110.05 -176.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.11 117.86 9.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.924 -1.035 . . . . 64.24 110.031 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 64.39 18.01 11.09 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.501 1.126 . . . . 71.01 111.68 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.98 119.25 59.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 124.228 1.011 . . . . 73.11 108.356 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -132.44 127.33 35.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.501 -0.926 . . . . 74.11 108.501 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.473 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.1 tt0 -90.21 121.65 32.43 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.656 1.183 . . . . 74.3 108.897 169.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 74.3 t -102.27 142.37 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.542 -0.91 . . . . 64.41 108.542 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.449 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.6 t -121.91 130.76 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.463 -0.94 . . . . 72.42 108.463 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -110.59 119.85 40.52 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.442 -1.318 . . . . 75.11 107.442 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -98.02 96.6 8.26 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.034 -1.099 . . . . 74.42 108.034 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.9 t -93.44 120.01 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.012 -1.107 . . . . 75.5 108.012 171.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -119.18 140.87 49.46 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.432 0.693 . . . . 75.51 109.601 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.446 HG12 HD13 ' D' ' 126' ' ' LEU . 91.5 t -136.51 122.26 28.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 125.031 1.333 . . . . 65.41 108.276 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 93.3 m -119.51 112.63 19.6 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.743 -0.836 . . . . 55.21 108.743 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.591 ' HB1' HG13 ' D' ' 40' ' ' VAL . . . -111.02 154.82 23.64 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.855 0.862 . . . . 64.13 110.293 -172.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 34.0 p -149.8 134.14 17.35 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.783 0.677 . . . . 63.43 111.415 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.422 ' HB2' HG21 ' D' ' 31' ' ' VAL . 48.1 mt -113.19 122.62 48.04 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.933 1.293 . . . . 72.22 107.855 171.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.4 -112.46 3.48 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.999 -0.44 . . . . 63.32 111.999 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 4.08 9.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.118 0.967 . . . . 73.52 110.036 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.469 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.8 pt-20 -126.15 163.0 24.08 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.64 0.776 . . . . 72.24 110.392 -170.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.0 m -61.91 125.41 23.76 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 124.22 0.95 . . . . 74.03 111.801 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.651 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -81.13 -72.87 0.4 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.339 -0.985 . . . . 73.41 108.339 171.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . 0.51 ' HZ ' HD12 ' D' ' 126' ' ' LEU . 48.1 p90 -144.7 160.45 41.18 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.559 0.695 . . . . 73.01 110.311 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.71 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 64.8 mt -122.58 141.4 51.74 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.451 -1.685 . . . . 74.15 106.451 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.567 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.8 t -153.49 136.66 15.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.782 -0.451 . . . . 65.0 109.782 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.8 130.82 11.02 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.619 0.768 . . . . 75.2 108.936 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.8 t -129.44 114.19 30.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.532 -0.914 . . . . 74.13 108.532 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.609 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.0 mt-30 -89.9 84.75 6.24 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 122.045 0.926 . . . . 73.53 109.07 171.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.86 101.41 8.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 113.474 -1.694 . . . . 75.0 110.146 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.87 161.37 29.36 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.957 -0.457 . . . . 71.01 111.957 175.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.22 134.92 3.58 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.942 -0.863 . . . . 43.03 110.942 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.1 mt -87.33 128.51 39.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 124.101 0.96 . . . . 73.23 108.93 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -128.12 126.59 41.42 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.237 0.615 . . . . 63.3 110.175 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.4 m -81.13 102.45 10.28 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.984 -0.747 . . . . 73.4 108.984 169.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.522 HD11 HD11 ' D' ' 89' ' ' ILE . 44.7 pt -109.7 140.99 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.195 0.998 . . . . 74.34 110.689 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.9 159.16 34.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.836 0.854 . . . . 65.34 109.448 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.98 -0.36 89.08 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 114.349 0.499 . . . . 51.14 114.349 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.522 HD11 HD11 ' D' ' 86' ' ' ILE . 29.0 pt -105.37 147.86 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.473 0.709 . . . . 74.04 110.389 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.1 146.65 28.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.117 0.567 . . . . 73.21 111.588 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.65 -113.5 2.78 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 124.254 0.931 . . . . 74.35 115.143 175.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.9 p -64.43 -33.22 75.36 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.693 1.197 . . . . 71.23 111.6 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -65.64 -31.11 71.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.486 0.715 . . . . 75.05 111.032 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.664 ' HB3' HD22 ' H' ' 454' ' ' LEU . 55.9 mtm -67.97 -45.79 73.19 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.614 0.365 . . . . 75.21 110.128 174.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.12 -37.36 82.53 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.074 0.55 . . . . 74.42 111.317 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.483 ' HE2' ' HB3' ' D' ' 134' ' ' ASP . 28.8 t-80 -71.15 -38.8 72.2 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.86 0.864 . . . . 53.43 111.078 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -72.75 -51.11 20.47 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.377 -0.374 . . . . 53.31 111.632 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.592 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.2 mm? -86.06 -28.52 24.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.422 0.689 . . . . 74.52 111.041 -174.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.95 -22.97 47.35 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 114.242 0.457 . . . . 71.51 114.242 -176.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.04 -56.6 1.18 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.983 0.513 . . . . 75.23 111.479 -172.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . 0.491 ' HA ' HD21 ' D' ' 104' ' ' ASN . 63.2 t80 -70.63 -34.88 72.57 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 112.839 0.681 . . . . 73.13 112.839 -172.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.592 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 75.7 m -69.57 -49.45 21.77 Favored Pre-proline 0 CA--C 1.569 1.679 0 CA-C-O 118.562 -0.732 . . . . 63.12 111.625 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.483 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 84.1 Cg_exo -55.25 -30.3 71.14 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 122.565 2.176 . . . . 53.14 114.48 170.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . 0.491 HD21 ' HA ' ' D' ' 101' ' ' TYR . 72.9 m-20 -53.96 -40.26 66.69 Favored 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 123.584 0.754 . . . . 75.24 111.857 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.2 mt -78.69 -40.65 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.899 0.88 . . . . 73.54 110.761 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.2 mt -72.36 -20.82 61.39 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.506 -0.77 . . . . 73.45 111.973 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -68.22 -45.3 39.23 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.035 0.934 . . . . 73.24 113.119 -173.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -50.05 -45.77 31.4 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.591 2.194 . . . . 73.54 114.415 169.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.16 -41.57 77.07 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.446 0.698 . . . . 73.11 111.32 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.34 95.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.723 0.809 . . . . 73.23 110.51 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.443 ' HA ' HD21 ' D' ' 128' ' ' LEU . 29.5 ttp180 -59.72 -51.23 70.68 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.41 -1.268 . . . . 74.54 110.385 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.64 -45.81 92.45 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 124.528 1.143 . . . . 75.53 111.154 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.55 -41.34 80.77 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.01 0.819 . . . . 73.45 110.856 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.567 HG12 ' SG ' ' D' ' 76' ' ' CYS . 76.3 mt -63.05 -56.34 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 123.74 0.65 . . . . 75.14 110.262 173.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.3 m -53.7 -39.38 65.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.409 1.083 . . . . 72.3 111.682 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -66.15 -46.28 78.01 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.83 -1.077 . . . . 73.02 109.867 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.425 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.3 mtm -69.34 -30.21 68.19 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.002 0.521 . . . . 74.21 112.317 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.02 -45.32 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.461 0.704 . . . . 71.52 109.209 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -71.51 -33.03 68.87 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 123.391 0.432 . . . . 72.13 110.822 -178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -69.97 -33.03 71.54 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.927 0.891 . . . . 74.22 110.089 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.8 3.28 86.08 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 123.884 0.74 . . . . 73.53 112.463 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 36.4 p 63.1 23.77 14.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.721 2.008 . . . . 71.04 114.446 171.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -86.74 151.5 52.68 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 108.924 -0.769 . . . . 74.33 108.924 170.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.07 145.92 31.97 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.352 2.701 . . . . 74.44 113.792 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -54.76 140.19 36.95 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.352 1.061 . . . . 72.22 113.668 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.511 ' HA ' HD12 ' H' ' 468' ' ' LEU . 4.8 tt -119.75 106.69 12.36 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.482 -0.932 . . . . 73.12 108.482 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -108.95 111.57 23.31 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.843 -0.799 . . . . 75.51 108.843 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.443 HD21 ' HA ' ' D' ' 111' ' ' ARG . 3.1 mm? -73.69 120.28 19.06 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.97 -0.752 . . . . 75.13 108.97 171.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.28 137.93 94.14 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 109.812 -0.44 . . . . 64.12 109.812 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.85 115.03 3.26 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.385 2.056 . . . . 74.5 111.548 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.7 m -108.04 152.8 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.436 0.694 . . . . 75.32 110.09 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -81.51 96.18 7.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.399 -0.819 . . . . 73.02 109.121 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -63.49 -31.64 72.86 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.653 0.381 . . . . 74.53 111.22 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.483 ' HB3' ' HE2' ' D' ' 96' ' ' HIS . 54.9 m-20 -62.09 -57.82 10.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.531 0.732 . . . . 74.33 111.564 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.61 96.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.642 0.777 . . . . 74.21 111.17 -176.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.453 ' HA ' HD21 ' D' ' 139' ' ' ASN . 5.0 mp -67.23 -28.18 67.85 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.16 -0.927 . . . . 73.24 111.797 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -68.72 -34.4 75.56 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.004 0.922 . . . . 75.43 111.333 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 44.4 mtt -68.1 -26.18 65.69 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.169 0.588 . . . . 71.12 110.852 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.453 HD21 ' HA ' ' D' ' 136' ' ' LEU . 46.7 m-80 -73.99 -19.78 60.54 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.093 0.557 . . . . 73.44 111.674 176.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' H' ' 461' ' ' PHE . 68.8 t80 -80.81 -40.03 25.66 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.047 0.539 . . . . 75.24 111.56 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.0 -27.95 69.18 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.223 1.009 . . . . 74.32 111.554 -177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -90.23 17.47 7.06 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 123.876 0.87 . . . . 72.4 112.105 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 53.4 mt-30 -119.23 88.59 2.96 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.839 0.856 . . . . 54.12 108.76 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -165.3 103.12 0.74 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.269 -0.878 . . . . 75.11 109.292 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 64.5 -74.25 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.79 1.636 . . . . 62.55 113.157 175.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.8 -140.57 2.96 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 111.852 -0.499 . . . . 74.23 111.852 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -143.88 172.15 13.24 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.737 0.815 . . . . 73.53 110.829 -175.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.05 -135.14 2.48 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.871 -0.604 . . . . 73.4 111.706 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.2 m -99.17 25.87 6.43 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.547 0.739 . . . . 74.34 109.864 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 56.43 77.58 0.24 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.715 1.206 . . . . 62.52 111.21 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.82 79.39 0.87 Allowed 'General case' 0 CA--C 1.549 0.942 0 CA-C-O 122.696 1.236 . . . . 61.13 108.737 171.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -80.75 97.1 7.16 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.059 -1.428 . . . . 75.24 109.578 -171.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -72.3 126.73 30.53 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.333 -0.988 . . . . 73.25 108.333 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -121.26 150.35 41.49 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.521 0.728 . . . . 71.43 110.532 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.834 0 C-N-CA 124.06 0.944 . . . . 55.2 108.483 -179.264 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 109.343 -0.614 . . . . 62.52 109.343 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 13.1 m -114.7 86.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-O 122.326 1.06 . . . . 72.34 108.773 171.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.03 144.25 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 115.096 -0.956 . . . . 73.11 110.255 -172.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 163.25 -169.23 38.29 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 115.602 -0.727 . . . . 62.34 111.639 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . 0.621 HD12 ' HA ' ' A' ' 95' ' ' ALA . 2.7 tt 65.66 66.31 0.52 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.969 1.307 . . . . 74.34 109.975 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 85.3 m -157.58 110.05 2.41 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.417 1.087 . . . . 65.14 108.834 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -158.22 -54.97 0.07 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.239 -1.022 . . . . 72.03 108.239 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -150.1 129.08 12.59 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.563 -0.902 . . . . 74.42 108.563 173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 76.3 p -92.56 27.27 2.35 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.087 0.955 . . . . 72.23 111.948 -174.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -70.39 106.84 3.54 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.55 0.74 . . . . 70.35 109.205 178.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . 0.472 HD22 ' H ' ' E' ' 460' ' ' LEU . 2.6 pt? -120.35 -178.61 3.73 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.602 0.715 . . . . 74.34 111.744 -167.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -86.13 158.05 19.88 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.164 1.386 . . . . 73.12 111.119 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . 0.696 ' HH ' ' HB3' ' A' ' 42' ' ' LEU . 59.3 t80 -166.45 134.46 2.78 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.463 1.105 . . . . 74.54 109.147 175.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 28.8 p -132.96 -77.95 0.49 Allowed 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 123.126 0.571 . . . . 64.33 111.267 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 464' ' ' MET . . . . . 0.407 ' HE3' ' HB2' ' A' ' 129' ' ' ALA . 94.8 mmm 66.66 -75.41 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.515 1.526 . . . . 61.44 111.501 -171.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 61.21 41.97 12.73 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.626 1.17 . . . . 73.44 111.269 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -151.68 176.87 10.95 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.705 0.802 . . . . 62.45 110.359 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . 0.573 ' HA ' HG23 ' A' ' 40' ' ' VAL . . . -81.02 17.42 1.23 Allowed 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.892 0.877 . . . . 74.24 112.106 177.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 53.1 mt 68.37 -71.67 0.11 Allowed 'General case' 0 C--N 1.368 1.397 0 C-N-CA 126.413 1.885 . . . . 72.22 110.568 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -171.54 26.15 0.09 OUTLIER Glycine 0 C--N 1.341 0.828 0 O-C-N 123.922 0.764 . . . . 64.31 112.053 175.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . 0.618 ' HG ' HD13 ' A' ' 126' ' ' LEU . 70.4 mt -105.72 139.02 40.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.779 0.832 . . . . 70.2 109.936 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 58.4 pttt . . . . . 0 C--O 1.256 1.409 0 C-N-CA 123.526 0.73 . . . . 74.21 109.416 171.347 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 108.944 -0.762 . . . . 74.01 108.944 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . 0.422 HG12 HG22 ' F' ' 452' ' ' VAL . 14.5 p -60.36 -24.38 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.604 0.762 . . . . 74.11 112.248 -173.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . 0.65 ' HB ' HD23 ' B' ' 98' ' ' LEU . 2.8 m -148.67 159.08 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.107 0.963 . . . . 75.23 111.371 176.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . 0.49 ' H ' HD22 ' B' ' 98' ' ' LEU . . . 179.03 91.96 0.08 OUTLIER Glycine 0 C--N 1.357 1.736 0 CA-C-N 115.342 -0.844 . . . . 63.34 112.187 176.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' B' ' 98' ' ' LEU . 30.0 tp -88.16 132.14 34.45 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.45 0.7 . . . . 74.21 110.418 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 41.0 m -149.52 144.54 26.33 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.193 0.997 . . . . 75.31 108.467 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -100.01 143.65 29.97 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.34 0.656 . . . . 72.3 110.309 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -72.37 -39.75 67.82 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.589 0.756 . . . . 72.21 110.263 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 19.6 p -145.86 -59.09 0.32 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.401 1.08 . . . . 73.3 109.015 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -151.75 165.94 32.89 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.534 1.134 . . . . 71.0 108.49 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.85 140.16 39.34 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.177 -0.675 . . . . 74.23 109.177 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . 0.423 ' HB3' ' HD1' ' B' ' 140' ' ' TYR . 48.7 p90 -67.19 135.75 53.97 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.534 0.734 . . . . 70.4 112.06 -174.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -141.33 119.49 12.08 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.869 -1.16 . . . . 75.52 107.869 172.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 463' ' ' THR . . . . . 0.4 ' HG1' HD23 ' B' ' 136' ' ' LEU . 22.3 p -134.8 -41.04 0.76 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.007 0.923 . . . . 71.11 108.901 173.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 25.8 ttt 69.54 -78.75 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.443 1.497 . . . . 73.45 110.181 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -172.66 -58.92 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.872 1.269 . . . . 65.3 108.153 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -163.19 -63.38 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.827 0.851 . . . . 75.3 108.873 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -155.71 -178.27 7.17 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.845 1.258 . . . . 70.42 109.059 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 5.8 tt -80.34 -47.52 14.36 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.175 -0.676 . . . . 75.24 109.175 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.61 72.41 1.21 Allowed Glycine 0 C--N 1.341 0.832 0 N-CA-C 110.799 -0.92 . . . . 64.25 110.799 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 88.4 mt -80.95 96.73 7.17 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.25 0.62 . . . . 72.44 109.623 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? . . . . . 0 CA--C 1.56 1.337 0 C-N-CA 125.048 1.339 . . . . 75.52 108.924 -177.028 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 16.5 m120 . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 109.935 -0.394 . . . . 74.42 109.935 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.43 160.14 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 N-CA-C 108.287 -1.005 . . . . 73.42 108.287 171.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . 0.465 ' N ' ' SD ' ' C' ' 94' ' ' MET . 60.8 t 71.3 120.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.207 1.403 . . . . 71.44 111.603 -174.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 139.74 80.33 0.07 OUTLIER Glycine 0 C--N 1.35 1.352 0 N-CA-C 112.382 -0.287 . . . . 73.45 112.382 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . 0.492 HD21 ' HB2' ' C' ' 98' ' ' LEU . 8.6 mp -102.0 -175.96 2.99 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.99 0.916 . . . . 64.41 110.774 177.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 22.3 p -80.58 156.67 26.33 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.714 1.206 . . . . 75.45 110.431 175.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -58.91 122.41 13.57 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.568 0.747 . . . . 75.2 111.166 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 78.19 -48.02 0.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.44 1.896 . . . . 74.32 112.744 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 458' ' ' THR . . . . . 0.604 HG23 ' HA2' ' C' ' 99' ' ' GLY . 27.6 m 68.31 89.22 0.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.713 1.205 . . . . 75.34 108.829 -163.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.24 156.5 37.17 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.283 -0.872 . . . . 75.21 111.233 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . 0.489 ' HB3' ' HD1' ' G' ' 462' ' ' TYR . 4.2 mm? -100.37 168.67 9.61 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.872 0.844 . . . . 74.52 111.197 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -164.0 26.37 0.08 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 113.958 -1.474 . . . . 73.32 109.06 -162.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . 0.528 ' HA ' HD12 ' C' ' 136' ' ' LEU . 19.0 p90 -74.37 83.75 1.94 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.335 1.064 . . . . 75.21 110.96 -170.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 36.0 p -85.01 85.12 7.52 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.24 -0.891 . . . . 63.42 109.797 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 464' ' ' MET . . . . . 0.416 ' HG3' HG13 ' C' ' 131' ' ' VAL . 16.3 tmm? -121.84 147.27 46.19 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.939 -0.763 . . . . 75.44 108.939 177.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . 0.445 ' HA ' ' HE3' ' G' ' 465' ' ' LYS . 1.4 tpmt? -58.48 -60.87 3.12 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.712 1.205 . . . . 74.55 112.981 -168.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -110.64 -147.05 0.41 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.784 0.834 . . . . 64.44 110.447 -171.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -150.33 -55.86 0.17 Allowed 'General case' 0 C--O 1.242 0.685 0 N-CA-C 107.961 -1.126 . . . . 70.52 107.961 175.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -167.58 -164.23 0.56 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.807 -1.542 . . . . 71.11 108.494 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . 0.481 ' HA3' ' H ' ' C' ' 155' ' ' ALA . . . -83.76 -97.62 0.59 Allowed Glycine 0 C--N 1.349 1.297 0 CA-C-O 119.587 -0.563 . . . . 74.02 112.333 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 60.8 mt 55.8 77.06 0.25 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.94 1.296 . . . . 72.31 112.187 -173.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.35 0 CA-C-O 118.532 -0.747 . . . . 74.34 109.452 172.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . 0.474 ' ND2' HG11 ' H' ' 451' ' ' VAL . 1.7 t30 . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 109.972 -0.381 . . . . 71.55 109.972 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . 0.66 HG21 HG22 ' H' ' 452' ' ' VAL . 27.7 m -114.78 -179.87 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 123.005 0.522 . . . . 72.42 111.175 175.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.66 HG22 HG21 ' H' ' 451' ' ' VAL . 22.4 t 74.01 132.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.388 1.875 . . . . 71.05 112.114 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -161.82 95.36 0.13 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.185 -1.166 . . . . 63.2 110.185 174.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . 0.664 HD22 ' HB3' ' D' ' 94' ' ' MET . 3.1 pp -127.72 170.13 13.06 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.311 0.577 . . . . 75.21 111.083 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 40.1 p -97.35 162.86 13.14 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.556 -1.202 . . . . 72.43 109.439 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.57 81.46 1.09 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.182 0.993 . . . . 60.01 111.386 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 51.38 -150.94 0.26 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.882 1.273 . . . . 75.31 113.445 168.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 4.4 t -158.84 -54.31 0.06 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.543 0.337 . . . . 72.42 111.422 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -175.56 166.61 3.24 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.597 0.759 . . . . 73.35 109.674 -171.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 39.1 tp -66.99 151.48 47.57 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.13 0.572 . . . . 71.44 109.847 172.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' D' ' 140' ' ' TYR . 17.2 p90 -124.27 16.38 9.07 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.373 0.879 . . . . 73.32 113.373 -168.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . 0.429 ' HE2' ' SD ' ' H' ' 464' ' ' MET . 21.3 p90 -165.65 156.77 13.88 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 120.807 0.337 . . . . 74.32 111.323 178.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 56.8 m -91.59 103.66 16.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.588 0.755 . . . . 73.34 109.343 173.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 464' ' ' MET . . . . . 0.506 ' HE1' ' HB1' ' H' ' 467' ' ' ALA . 14.2 tpt -77.44 105.56 8.65 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.359 0.663 . . . . 73.14 110.073 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -117.42 -50.72 2.53 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.587 1.155 . . . . 72.05 109.252 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -72.6 98.24 2.29 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 114.339 -1.301 . . . . 75.11 110.177 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . 0.506 ' HB1' ' HE1' ' H' ' 464' ' ' MET . . . -153.72 -67.48 0.14 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.536 -0.757 . . . . 73.14 109.594 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' D' ' 126' ' ' LEU . 3.4 mm? -99.37 -53.24 3.28 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.125 0.97 . . . . 75.25 109.584 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.04 -36.08 3.79 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.551 -0.749 . . . . 71.05 112.66 -174.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . 0.49 ' HG ' ' HA ' ' D' ' 39' ' ' GLU . 2.8 mm? 58.5 39.96 24.43 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.213 1.405 . . . . 73.25 110.562 -178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? . . . . . 0 CA--C 1.555 1.173 0 CA-C-N 114.401 -1.272 . . . . 73.25 110.366 -177.356 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.5 mtp . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 109.386 -0.598 . . . . 72.11 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.0 p -150.84 113.15 4.61 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.297 -1.001 . . . . 73.4 108.297 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.85 157.0 34.16 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.806 0.842 . . . . 75.33 111.402 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -138.86 136.53 35.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.416 0.686 . . . . 74.44 109.749 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -135.39 -7.94 2.24 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.607 0.763 . . . . 73.23 111.184 -169.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -70.85 88.43 0.74 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.217 0.532 . . . . 74.45 110.457 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -81.87 -38.07 25.96 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.859 0.863 . . . . 65.12 109.597 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -73.27 139.07 45.89 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.063 -0.971 . . . . 71.45 110.154 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.504 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 4.5 ppp? -72.33 158.59 35.52 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.658 -0.701 . . . . 74.14 111.614 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.3 m -143.99 136.76 27.16 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.896 0.879 . . . . 74.22 109.071 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.638 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.6 t80 -136.21 129.71 32.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.062 -0.718 . . . . 75.23 109.062 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 48.1 tp60 -149.87 109.6 4.05 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.947 0.899 . . . . 73.53 109.04 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.548 HG22 ' HG2' ' C' ' 130' ' ' PRO . 32.4 mt -78.59 112.53 16.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.408 -0.96 . . . . 74.53 108.408 174.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.9 -41.83 25.35 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.825 -0.625 . . . . 72.54 109.317 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -171.19 123.57 0.59 Allowed 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.157 0.286 . . . . 75.31 111.185 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.572 HD13 ' HG3' ' C' ' 130' ' ' PRO . 72.2 mt -111.95 136.26 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.74 0.816 . . . . 74.11 109.166 174.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' HB3' HG23 ' B' ' 122' ' ' THR . 24.9 p90 -166.52 177.8 6.45 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.204 0.94 . . . . 73.44 110.928 -171.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -103.08 120.23 40.3 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.459 -0.791 . . . . 61.22 109.01 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 27.2 mtpt -84.77 -38.42 19.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.404 -0.591 . . . . 73.2 109.404 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.7 t70 -138.97 136.28 35.22 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.063 -0.971 . . . . 74.31 109.534 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 49.7 mt -133.55 146.68 31.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.116 -1.438 . . . . 74.11 107.116 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.1 t -155.16 145.71 22.17 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.636 0.585 . . . . 62.12 109.811 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.438 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.6 t80 -145.89 131.72 19.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.926 -1.509 . . . . 73.22 106.926 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -138.72 129.96 27.05 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.721 -0.844 . . . . 72.41 108.721 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.43 81.41 70.1 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.316 -0.994 . . . . 74.51 108.316 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.26 -25.91 25.8 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.024 2.482 . . . . 70.22 112.986 -172.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.495 ' O ' HG21 ' A' ' 31' ' ' VAL . 51.4 m-80 -114.67 24.11 12.1 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.411 0.685 . . . . 64.15 110.445 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -52.1 -49.31 85.13 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 113.705 1.002 . . . . 73.24 113.705 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 6.8 Cg_exo -73.54 -21.83 18.99 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 121.982 1.788 . . . . 74.22 111.964 176.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -80.1 -23.04 41.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.98 -1.009 . . . . 74.34 111.006 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.534 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 86.2 t -59.96 -24.65 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.637 0.775 . . . . 74.21 111.3 177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -56.96 -38.85 73.54 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.852 0.861 . . . . 70.15 111.188 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -93.11 -20.92 20.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.497 0.719 . . . . 72.44 110.921 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 30.7 mmmt -79.86 143.41 34.34 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.62 0.768 . . . . 75.03 111.468 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.27 121.12 20.8 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.34 -0.985 . . . . 75.04 108.34 168.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -68.88 89.91 0.42 Allowed 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.472 0.482 . . . . 71.52 110.689 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -144.13 81.55 11.48 Favored Pre-proline 0 C--O 1.245 0.834 0 N-CA-C 107.519 -1.289 . . . . 74.5 107.519 167.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 95.5 Cg_endo -81.94 157.66 18.13 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.693 2.262 . . . . 73.43 112.798 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -95.74 99.97 11.74 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.084 -1.08 . . . . 75.55 108.084 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.2 m -71.21 94.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-O 122.292 1.044 . . . . 72.21 110.776 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -110.03 135.63 50.56 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.753 -1.112 . . . . 74.12 109.443 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.468 HD21 HD22 ' E' ' 468' ' ' LEU . 39.5 tp -136.15 126.6 26.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.076 0.55 . . . . 74.13 110.737 -175.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.614 ' HA ' ' HH ' ' E' ' 462' ' ' TYR . 16.7 m-20 -126.42 131.29 51.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.83 0.852 . . . . 71.2 109.397 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.625 HD23 HG13 ' A' ' 62' ' ' VAL . 54.5 mt -119.69 134.33 55.27 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.413 0.685 . . . . 74.23 110.518 -175.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 8.2 m-20 -125.8 141.15 52.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.799 1.24 . . . . 74.43 108.188 173.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.5 m -126.32 129.85 49.66 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.006 -0.739 . . . . 74.53 109.006 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.58 153.95 50.5 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.438 1.095 . . . . 71.13 108.491 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.427 ' HB3' HD13 ' E' ' 454' ' ' LEU . 26.7 t -126.72 152.95 46.14 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 120.911 0.386 . . . . 70.21 110.17 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.5 t -149.45 121.41 8.22 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.386 1.074 . . . . 63.5 108.766 -176.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -74.28 125.85 29.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.092 0.557 . . . . 73.31 109.69 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.5 mt -95.49 -34.42 12.08 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.316 0.646 . . . . 75.41 110.421 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.0 177.36 10.83 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.08 0.952 . . . . 74.33 109.268 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -66.22 125.75 26.53 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.287 -0.634 . . . . 73.35 109.287 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 70.82 3.59 4.67 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.056 1.343 . . . . 73.42 112.142 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.75 115.0 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.251 1.021 . . . . 63.4 108.621 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -126.77 156.29 41.46 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.59 0.756 . . . . 74.1 109.604 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -130.19 142.85 50.54 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.266 -1.013 . . . . 74.42 108.266 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.51 139.91 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 108.241 -1.022 . . . . 75.31 108.241 165.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -112.41 107.34 22.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 107.824 -1.176 . . . . 65.34 107.824 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.8 tp -88.94 100.76 13.45 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.332 -0.849 . . . . 62.25 109.11 178.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 14.0 ttm-85 -84.46 107.89 16.96 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.65 -0.704 . . . . 75.25 109.155 175.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.625 HG13 HD23 ' A' ' 44' ' ' LEU . 19.8 m -103.96 130.22 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 123.857 0.863 . . . . 70.13 109.559 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.1 m -121.26 116.36 24.74 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.641 0.777 . . . . 73.15 110.075 -176.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.3 t -116.14 121.45 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.486 1.114 . . . . 64.43 108.83 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.6 m -126.71 124.9 40.85 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.347 -0.983 . . . . 74.23 108.347 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -125.56 105.24 8.89 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.163 -0.68 . . . . 72.32 109.163 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 42.4 t -116.73 128.86 55.73 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.377 0.671 . . . . 75.02 111.207 -173.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.491 HD12 ' HB1' ' A' ' 73' ' ' ALA . 5.1 mp -89.92 86.37 6.6 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.223 -1.399 . . . . 75.3 107.223 175.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.08 -104.88 2.07 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.512 -1.035 . . . . 73.41 110.512 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -109.23 -14.02 14.55 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.179 0.592 . . . . 75.34 110.534 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -85.48 95.97 9.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.934 0.894 . . . . 75.43 110.118 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 26.5 m -67.44 125.46 26.21 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 123.441 0.463 . . . . 71.22 110.535 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.491 ' HB1' HD12 ' A' ' 68' ' ' LEU . . . -78.01 -54.06 6.72 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.318 -0.856 . . . . 61.01 109.003 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -146.59 155.47 42.5 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.429 -1.26 . . . . 72.45 110.878 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.7 tp -133.48 132.07 40.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.527 -1.657 . . . . 73.4 106.527 176.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 85.1 m -133.92 110.44 9.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.342 -0.614 . . . . 74.22 109.342 -174.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -124.38 117.07 23.63 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.044 0.938 . . . . 74.01 109.118 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.3 t -132.91 111.33 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.221 0.608 . . . . 75.21 109.817 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.713 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 26.3 mt-30 -87.81 87.12 7.27 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 108.609 -0.886 . . . . 75.4 108.609 167.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -76.91 116.63 17.75 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.919 -1.037 . . . . 73.33 108.448 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.84 144.25 18.35 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.56 -0.616 . . . . 71.2 111.56 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.468 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -141.99 134.22 6.06 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 111.167 -0.773 . . . . 74.51 111.167 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.3 mt -82.89 115.43 25.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.645 -0.872 . . . . 71.44 108.645 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.638 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.4 m-85 -122.29 117.7 26.74 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.857 0.863 . . . . 74.23 108.937 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.449 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 12.6 m -90.81 89.94 7.7 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.321 -0.992 . . . . 70.12 108.321 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.7 pt -109.74 139.72 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.347 -0.842 . . . . 75.41 110.766 -172.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.8 168.95 25.56 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.846 -1.07 . . . . 64.11 109.695 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 81.11 9.61 85.93 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.606 0.566 . . . . 74.05 114.039 174.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.447 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.15 153.69 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.126 0.57 . . . . 73.32 110.603 -176.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -160.43 -172.48 3.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.669 0.788 . . . . 73.23 110.506 -171.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.1 -143.34 48.47 Favored Glycine 0 C--N 1.359 1.824 0 O-C-N 123.537 0.523 . . . . 53.15 112.636 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.9 t -86.44 -11.24 52.39 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 122.866 0.466 . . . . 74.45 111.038 166.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -33.99 74.83 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.925 0.89 . . . . 73.51 109.827 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -31.71 70.8 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.375 0.27 . . . . 73.25 110.966 173.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.68 -28.18 55.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.65 0.78 . . . . 61.21 110.826 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -69.73 -29.36 66.71 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.136 0.574 . . . . 64.5 110.313 170.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 78.0 m -69.69 -49.34 54.39 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.489 0.316 . . . . 72.13 110.928 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 pp -85.16 -18.93 32.65 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.017 0.527 . . . . 64.21 112.339 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.69 3.87 27.63 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-O 119.782 -0.455 . . . . 73.2 114.117 -173.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -148.09 -63.57 0.26 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.33 0.565 . . . . 74.45 111.378 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -61.66 -66.0 0.6 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.367 1.467 . . . . 74.31 112.826 -168.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 95.9 m -73.9 -37.98 3.6 Favored Pre-proline 0 CA--C 1.569 1.675 0 N-CA-C 114.701 1.371 . . . . 72.15 114.701 -175.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.55 -24.53 63.18 Favored 'Trans proline' 0 C--N 1.388 2.626 0 CA-C-N 121.837 1.692 . . . . 71.34 113.369 173.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -69.43 -29.78 67.57 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.017 0.527 . . . . 72.55 110.13 177.656 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.4 mm -62.66 -40.66 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.443 0.697 . . . . 64.11 110.184 176.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.468 HD22 ' HA3' ' A' ' 82' ' ' GLY . 96.3 mt -79.53 -19.24 50.06 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.166 0.986 . . . . 75.05 112.967 -175.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -59.4 -47.74 97.38 Favored Pre-proline 0 CA--C 1.569 1.693 0 N-CA-C 113.584 0.957 . . . . 74.44 113.584 -172.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.9 -37.05 57.08 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.061 1.841 . . . . 74.33 113.096 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -67.31 -40.22 85.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.319 0.648 . . . . 74.12 111.153 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.466 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . -66.59 -42.65 86.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.151 0.58 . . . . 64.44 110.137 177.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -50.31 -53.68 26.92 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.475 1.11 . . . . 75.42 110.506 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -68.65 -38.05 80.14 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.394 -0.821 . . . . 74.35 111.433 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.37 -34.18 74.89 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.107 0.48 . . . . 74.14 111.095 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.434 ' O ' HG22 ' A' ' 118' ' ' VAL . 60.7 mt -69.49 -57.25 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.132 -0.94 . . . . 72.51 109.624 172.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.401 HG22 ' HE2' ' C' ' 109' ' ' TYR . 28.5 m -55.35 -37.07 67.01 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.869 1.268 . . . . 74.34 111.923 -172.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.4 t -65.38 -50.3 66.05 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.117 -0.947 . . . . 73.51 109.903 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.438 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 67.6 mtm -62.27 -37.84 87.04 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.173 0.589 . . . . 74.34 111.454 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 114' ' ' ILE . 99.3 t -59.57 -49.12 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.676 0.79 . . . . 75.41 110.062 176.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.3 m -69.74 -29.78 67.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.537 -0.756 . . . . 72.54 111.615 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -72.8 -26.96 61.7 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.638 0.775 . . . . 74.32 110.126 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.87 6.64 77.84 Favored Glycine 0 C--N 1.354 1.563 0 O-C-N 123.685 0.616 . . . . 34.24 112.913 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.9 m 67.66 15.48 9.72 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.534 1.134 . . . . 71.01 111.175 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.442 ' HE1' HG23 ' A' ' 31' ' ' VAL . 63.6 m-85 -87.82 140.93 31.36 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 108.546 -0.909 . . . . 62.32 108.546 174.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -49.45 148.23 11.4 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.267 2.645 . . . . 75.32 113.25 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -59.63 129.46 42.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.5 0.72 . . . . 73.11 112.236 -173.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' E' ' 470' ' ' LEU . 41.8 tp -110.18 101.55 10.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.121 0.968 . . . . 74.14 109.844 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -102.25 103.79 14.3 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.142 -1.059 . . . . 71.31 108.142 171.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.61 154.58 41.31 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.661 0.384 . . . . 75.13 110.575 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.414 ' HB3' ' SD ' ' E' ' 464' ' ' MET . . . -69.56 142.84 92.17 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.363 0.665 . . . . 61.41 111.079 -175.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.33 127.91 13.14 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.343 2.029 . . . . 72.44 112.771 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.566 HG23 ' HB3' ' E' ' 464' ' ' MET . 76.8 t -102.28 115.06 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.856 0.862 . . . . 75.03 108.878 175.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -92.14 85.91 5.62 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.671 -1.233 . . . . 70.23 107.671 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.463 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 91.8 m-85 -59.05 -31.6 69.01 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.745 -1.116 . . . . 73.12 113.203 -169.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.405 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 5.5 p-10 -66.12 -36.67 83.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.351 0.26 . . . . 74.34 111.419 -178.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.62 -38.17 89.19 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.109 0.563 . . . . 73.34 110.895 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.578 HD13 ' HA ' ' E' ' 462' ' ' TYR . 97.6 mt -66.5 -39.38 88.69 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.211 -0.904 . . . . 74.2 111.311 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -68.61 -25.91 65.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.998 -0.546 . . . . 75.24 110.833 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.508 ' HE2' ' HA ' ' A' ' 138' ' ' MET . 17.0 mmt -60.71 -34.3 74.18 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.04 0.536 . . . . 64.44 111.665 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -66.32 -24.09 66.47 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.841 0.856 . . . . 74.44 111.612 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -91.84 -44.64 8.83 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.837 0.855 . . . . 73.14 110.78 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.4 tp -68.18 -46.08 71.67 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.484 1.114 . . . . 74.12 112.361 -171.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.531 ' HB3' ' HG2' ' A' ' 144' ' ' GLN . 1.4 mm-40 -145.62 4.06 1.0 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.949 0.499 . . . . 74.54 110.555 -172.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 62.68 20.63 12.19 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.654 1.181 . . . . 74.5 111.567 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.531 ' HG2' ' HB3' ' A' ' 142' ' ' GLN . 73.0 mm-40 -95.19 163.45 13.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.211 0.604 . . . . 75.13 110.18 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.41 33.55 1.23 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.023 0.929 . . . . 72.14 110.817 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.2 -61.49 4.71 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 116.027 -0.533 . . . . 71.43 111.921 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 62.57 97.36 0.03 OUTLIER 'General case' 0 C--N 1.357 0.907 0 C-N-CA 125.251 1.42 . . . . 75.43 110.773 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -108.05 113.69 3.95 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.095 -0.802 . . . . 72.34 111.095 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.9 m -68.15 101.91 1.25 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.146 0.578 . . . . 72.41 110.23 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.74 133.15 35.16 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.145 -0.934 . . . . 74.42 109.478 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.417 ' HB3' HE22 ' C' ' 142' ' ' GLN . 39.0 tt0 -144.57 139.63 28.26 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.53 -1.285 . . . . 75.4 107.53 171.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -71.3 87.68 0.84 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.621 0.768 . . . . 72.12 111.824 -170.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.508 ' HG2' ' HA ' ' C' ' 141' ' ' LEU . 59.6 tp60 -84.76 105.45 15.56 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.5 -1.296 . . . . 74.21 107.5 163.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -78.36 84.91 4.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.175 0.59 . . . . 75.14 109.601 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.289 0 CA-C-N 115.443 -0.799 . . . . 72.23 109.585 178.603 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.7 mtt . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.575 -0.528 . . . . 73.43 109.575 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 44.8 m -140.74 -49.13 0.43 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.471 0.708 . . . . 75.42 110.233 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.18 135.32 54.35 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 109.866 -0.42 . . . . 72.21 109.866 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -150.36 103.18 3.12 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.979 0.419 . . . . 71.35 110.64 -177.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -104.59 163.63 12.34 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.95 1.3 . . . . 73.42 108.65 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -148.61 172.72 14.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.836 0.854 . . . . 73.25 109.743 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.8 m -82.55 84.97 7.05 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.346 -0.983 . . . . 73.22 108.346 167.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -74.59 -66.9 0.68 Allowed 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.241 -0.891 . . . . 74.14 108.863 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.53 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 23.2 ptm 42.55 -165.14 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.989 1.715 . . . . 73.41 112.663 -171.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.644 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 81.0 m -153.78 137.88 16.45 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.415 -1.328 . . . . 73.42 107.415 173.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -150.79 142.14 23.33 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.991 -0.374 . . . . 71.2 109.991 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -159.11 141.94 14.28 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 123.919 0.762 . . . . 71.33 109.644 169.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.441 HD12 HD11 ' B' ' 16' ' ' ILE . 45.8 mt -80.26 125.39 39.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.877 -0.786 . . . . 74.44 108.877 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -96.3 -35.52 11.2 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.343 0.657 . . . . 74.45 109.609 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -170.66 131.92 0.91 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.529 -0.76 . . . . 72.33 109.557 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.441 HD11 HD12 ' B' ' 13' ' ' ILE . 87.2 mt -114.89 136.33 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 106.641 -1.614 . . . . 64.32 106.641 168.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -166.48 162.97 17.17 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.695 0.622 . . . . 61.14 111.306 -174.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.444 HG23 HD13 ' B' ' 21' ' ' ILE . 27.5 m -98.32 127.4 44.24 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.444 -0.947 . . . . 74.41 108.444 176.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -98.05 -23.72 15.64 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.745 0.818 . . . . 74.41 111.018 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 9.3 t70 -158.78 139.33 12.55 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.142 0.276 . . . . 70.3 111.188 -170.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.637 HD13 ' SG ' ' B' ' 113' ' ' CYS . 40.8 mm -135.79 149.15 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.598 1.159 . . . . 74.14 108.754 175.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 17.7 m -146.89 143.62 28.67 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.524 1.13 . . . . 73.23 109.082 165.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -152.2 108.77 3.45 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.662 -1.236 . . . . 72.33 107.662 169.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -122.08 118.18 28.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.262 1.025 . . . . 72.12 108.399 -174.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.45 84.22 14.41 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.264 1.026 . . . . 72.13 108.549 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.23 -40.49 19.34 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.872 2.381 . . . . 74.42 112.585 -174.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 87.3 m-20 -96.67 13.8 27.09 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.987 -1.006 . . . . 70.11 111.078 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.406 ' HB1' ' HD3' ' B' ' 29' ' ' PRO . . . -40.29 -62.75 0.85 Allowed Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 115.086 1.513 . . . . 74.43 115.086 -164.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 6.7 Cg_exo -69.4 -25.58 30.13 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 121.721 1.614 . . . . 73.11 112.204 -171.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -95.44 -25.43 16.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.865 -1.061 . . . . 74.11 111.731 -170.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.741 HG23 HD13 ' B' ' 68' ' ' LEU . 8.7 p -83.9 -18.25 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.995 0.518 . . . . 65.21 110.981 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -61.11 -30.91 70.64 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.309 0.855 . . . . 73.34 113.309 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -61.27 -18.12 56.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.831 0.452 . . . . 72.12 111.608 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -92.29 82.87 4.97 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.146 0.978 . . . . 74.01 108.865 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -86.52 90.83 8.36 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.281 -0.637 . . . . 72.53 109.281 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.7 t-105 -158.15 156.12 30.32 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.898 1.279 . . . . 73.51 107.988 174.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.543 ' HB3' HD23 ' F' ' 470' ' ' LEU . 20.9 mm-40 -59.79 104.76 0.47 Allowed Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.991 1.316 . . . . 73.52 111.295 173.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.617 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 60.9 Cg_endo -74.45 128.17 11.71 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.689 2.26 . . . . 70.02 112.415 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.88 125.74 24.81 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 123.565 0.541 . . . . 74.52 109.911 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.586 HG11 ' HB1' ' B' ' 66' ' ' ALA . 25.2 m -104.67 153.32 6.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.848 -0.615 . . . . 71.02 111.014 -176.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.459 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 79.4 tttt -108.71 117.98 35.59 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.789 -1.189 . . . . 75.33 107.789 169.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.476 HD23 ' HB3' ' F' ' 467' ' ' ALA . 0.6 OUTLIER -96.38 140.67 30.7 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.877 0.471 . . . . 74.21 110.23 176.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 6.1 t70 -145.42 155.85 43.4 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.616 -0.883 . . . . 74.23 108.616 -177.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.563 HD13 ' HB2' ' F' ' 461' ' ' PHE . 1.5 pt? -115.51 163.12 16.22 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.596 0.712 . . . . 75.34 110.771 -175.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.578 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.0 t70 -163.64 111.3 1.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.19 -1.411 . . . . 74.31 107.19 167.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.6 p -128.73 125.34 37.74 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.167 0.587 . . . . 74.51 110.239 -172.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.66 159.47 41.89 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.034 0.934 . . . . 42.32 109.932 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.9 p -133.29 159.24 40.84 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.138 0.575 . . . . 73.41 109.678 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 98.1 p -153.1 140.75 19.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.173 0.589 . . . . 71.34 109.582 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -89.01 115.84 26.86 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.882 0.473 . . . . 72.42 109.996 176.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.96 -39.91 17.56 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.682 0.793 . . . . 75.34 109.207 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.43 -176.51 5.83 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.594 1.158 . . . . 74.31 109.717 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -67.43 126.15 28.37 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.851 -0.613 . . . . 64.31 110.033 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' B' ' 85' ' ' SER . 7.2 m-20 69.02 -9.95 0.55 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.093 1.757 . . . . 74.34 112.487 -173.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.9 t -105.63 104.13 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.789 -0.819 . . . . 74.51 108.789 -172.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -115.18 168.08 10.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.413 -1.267 . . . . 74.4 108.979 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -143.64 117.43 9.3 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.848 -1.168 . . . . 74.14 107.848 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.88 144.71 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.591 1.156 . . . . 75.54 109.247 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.5 t -127.82 119.82 52.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.088 -0.708 . . . . 72.32 109.088 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.468 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -98.28 114.7 27.08 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.642 -1.614 . . . . 75.53 106.642 172.109 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 3.7 ttt180 -111.56 125.89 54.4 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.409 -0.589 . . . . 75.04 109.409 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 49.5 t -114.3 116.21 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.681 1.192 . . . . 74.25 108.429 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.8 m -97.61 137.03 37.14 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.18 -0.674 . . . . 75.44 109.18 173.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 76.9 t -133.02 126.22 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.859 0.864 . . . . 73.31 109.529 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 91.9 m -124.66 107.16 10.7 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.373 0.669 . . . . 75.11 110.236 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.586 ' HB1' HG11 ' B' ' 40' ' ' VAL . . . -106.5 151.83 24.47 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.217 0.607 . . . . 75.23 110.992 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 57.0 p -153.24 139.86 18.85 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.051 -0.977 . . . . 73.24 110.497 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.741 HD13 HG23 ' B' ' 31' ' ' VAL . 48.5 mt -107.87 102.33 11.54 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.28 1.032 . . . . 74.23 109.201 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.08 -110.18 3.2 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.609 -0.723 . . . . 72.12 112.733 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.94 2.81 46.81 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.637 0.775 . . . . 74.14 111.138 -169.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.408 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.1 pt-20 -144.07 158.13 43.9 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.967 0.507 . . . . 75.11 110.875 -170.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -65.82 143.71 57.31 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.955 0.785 . . . . 75.12 111.171 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -96.18 -70.22 0.72 Allowed 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.508 -0.923 . . . . 74.33 108.508 169.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -148.6 153.03 37.77 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.167 -0.924 . . . . 74.24 109.466 -173.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 23.4 mt -131.12 109.44 10.46 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.538 -1.282 . . . . 60.23 107.538 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.0 t -119.96 147.32 44.9 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.816 -0.439 . . . . 63.44 109.816 -175.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -157.6 133.69 9.47 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 109.486 -0.561 . . . . 73.35 109.486 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 89.6 t -129.62 148.52 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.4 0.68 . . . . 73.22 109.474 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.531 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.0 mt-30 -118.33 98.9 6.51 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.75 -1.204 . . . . 73.53 107.75 166.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -85.89 99.55 11.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.1 -1.074 . . . . 74.1 108.1 171.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.68 169.81 35.98 Favored Glycine 0 C--O 1.242 0.626 0 N-CA-C 111.228 -0.749 . . . . 72.41 111.228 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.42 127.74 1.59 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 112.111 -0.396 . . . . 73.22 112.111 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 46.8 mt -84.53 120.78 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 107.727 -1.212 . . . . 72.33 107.727 171.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -128.41 135.11 49.06 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.84 0.856 . . . . 75.35 109.211 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 67.5 m -93.91 117.25 29.84 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 110.045 -0.354 . . . . 54.32 110.045 172.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.593 HD12 HD23 ' B' ' 98' ' ' LEU . 45.3 pt -117.11 146.81 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.821 1.248 . . . . 75.05 110.025 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.644 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -152.69 161.37 42.65 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.391 1.077 . . . . 75.55 108.62 170.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 84.86 -28.76 4.38 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 113.794 0.278 . . . . 71.42 113.794 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.89 140.06 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 124.608 1.163 . . . . 73.22 112.209 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.465 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 36.0 tt0 -162.71 144.81 10.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.25 0.62 . . . . 73.54 110.175 -177.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.39 -113.3 5.58 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.578 0.548 . . . . 61.24 113.768 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 88.4 m -82.14 -24.32 35.13 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.609 0.764 . . . . 73.35 111.17 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.465 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 44.2 mt-30 -60.52 -43.87 96.66 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.044 0.537 . . . . 74.21 111.271 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -65.02 -36.49 84.55 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.41 0.444 . . . . 75.33 110.269 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.67 -37.35 86.26 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.229 1.012 . . . . 75.13 111.157 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -82.68 -29.36 29.99 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.234 0.614 . . . . 75.32 110.858 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -67.09 -64.39 0.86 Allowed 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.661 0.601 . . . . 74.51 110.177 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.593 HD23 HD12 ' B' ' 86' ' ' ILE . 60.2 mt -81.76 -18.57 43.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.837 0.455 . . . . 75.11 111.173 -176.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.46 -35.53 11.85 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.427 0.454 . . . . 65.23 113.955 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.99 -41.16 0.75 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.033 0.753 . . . . 75.13 113.033 -167.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -77.44 -48.61 16.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.659 0.784 . . . . 74.43 111.277 -170.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.447 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 86.5 m -64.88 -48.0 73.17 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.684 0.794 . . . . 71.53 110.859 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.468 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 53.4 Cg_exo -58.05 -30.29 89.69 Favored 'Trans proline' 0 C--N 1.397 3.105 0 C-N-CA 122.085 1.856 . . . . 74.51 114.339 170.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -61.06 -42.17 97.98 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 123.084 0.554 . . . . 64.24 110.856 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.88 -40.94 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 115.357 -0.838 . . . . 65.41 110.105 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.3 mt -77.65 -20.99 52.89 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.729 -1.123 . . . . 73.2 112.125 -174.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -59.71 -50.65 85.8 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 114.269 1.211 . . . . 75.13 114.269 -171.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.87 -31.74 95.96 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 121.755 1.637 . . . . 72.54 113.087 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -73.32 -47.21 44.4 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.462 0.705 . . . . 73.34 110.965 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.99 -43.07 81.34 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.287 0.635 . . . . 60.42 110.291 175.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -60.08 -51.2 70.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.371 1.468 . . . . 75.14 111.204 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.82 -34.91 79.24 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.12 0.568 . . . . 65.31 109.794 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.637 ' SG ' HD13 ' B' ' 21' ' ' ILE . 4.8 t -70.71 -34.85 72.37 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.962 0.505 . . . . 73.33 111.665 -177.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 118' ' ' VAL . 58.8 mt -65.34 -55.87 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 109.178 -0.675 . . . . 72.41 109.178 173.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 15.5 m -59.76 -27.5 66.58 Favored 'General case' 0 CA--C 1.552 1.043 0 O-C-N 124.001 0.813 . . . . 71.0 111.557 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -64.07 -51.02 66.05 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.341 0.657 . . . . 65.42 109.77 174.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -69.24 -35.04 75.72 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.082 0.553 . . . . 73.01 111.125 -175.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.9 t -59.16 -46.75 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.554 0.741 . . . . 75.23 109.697 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.4 t -67.12 -30.83 70.94 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.749 -1.114 . . . . 62.42 111.811 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.444 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -70.21 -38.65 75.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.834 -0.621 . . . . 74.44 110.12 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.06 1.88 83.17 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.85 0.719 . . . . 75.12 112.695 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.501 HG23 ' HB3' ' A' ' 17' ' ' TYR . 27.1 p 61.84 25.47 15.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.69 1.996 . . . . 63.11 113.302 173.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -80.51 155.01 74.09 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 123.568 0.747 . . . . 75.23 110.953 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -50.48 158.6 2.57 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.809 3.006 . . . . 74.12 115.042 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -61.16 119.58 8.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.536 1.134 . . . . 75.21 112.531 -168.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.4 tp -110.18 127.15 54.77 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.269 0.628 . . . . 73.1 109.854 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -129.06 126.13 38.76 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.587 0.755 . . . . 73.21 109.093 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.9 131.1 34.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.419 -0.585 . . . . 72.51 109.419 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.62 152.02 96.37 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.748 0.819 . . . . 75.3 111.365 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.09 109.12 0.87 Allowed 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.621 2.214 . . . . 72.44 111.464 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 24.1 t -91.21 115.53 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.39 -0.596 . . . . 72.24 109.39 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.427 ' O ' HD12 ' B' ' 136' ' ' LEU . 57.4 t-20 -72.7 90.72 1.41 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.198 0.599 . . . . 74.02 109.561 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -57.22 -32.93 67.01 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.97 0.908 . . . . 75.13 112.708 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -82.87 -41.31 19.13 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.389 0.676 . . . . 72.42 112.387 -168.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.33 61.99 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.125 0.57 . . . . 75.43 110.944 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.664 ' HG ' ' HB ' ' F' ' 463' ' ' THR . 6.7 mp -74.92 -30.67 61.32 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.672 -0.695 . . . . 73.12 109.868 172.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.617 ' CE1' HD12 ' B' ' 141' ' ' LEU . 59.6 t80 -70.79 -25.93 63.1 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.46 -0.791 . . . . 72.44 110.159 173.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 18.5 ttt -65.19 -36.51 84.43 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.939 0.496 . . . . 73.44 110.283 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -73.07 -32.22 64.88 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.729 -0.669 . . . . 75.54 110.502 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . 0.497 ' HE1' ' HB2' ' F' ' 457' ' ' GLN . 81.4 t80 -56.57 -34.24 66.94 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.367 1.067 . . . . 75.45 111.23 176.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.617 HD12 ' CE1' ' B' ' 137' ' ' PHE . 7.8 mt -105.81 -11.19 16.34 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.528 0.566 . . . . 74.3 112.528 -173.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.01 141.41 18.69 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.602 -0.518 . . . . 72.24 109.602 -169.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.31 -48.67 69.58 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.107 1.363 . . . . 74.3 111.448 -170.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -114.71 92.59 4.0 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.826 0.851 . . . . 74.22 110.328 -171.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.19 137.63 36.71 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.193 -0.669 . . . . 54.11 109.193 170.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.14 74.43 1.22 Allowed Glycine 0 C--N 1.35 1.359 0 O-C-N 123.495 0.497 . . . . 73.11 112.54 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -73.22 155.5 39.49 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.688 0.795 . . . . 75.44 110.919 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 158.09 177.46 31.2 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 116.199 -0.455 . . . . 65.21 113.263 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 2.6 t -145.96 88.2 1.8 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.324 1.049 . . . . 75.51 108.509 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.438 ' HG3' ' HD1' ' B' ' 152' ' ' HIS . 10.3 tp10 -94.56 99.27 11.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.506 -0.77 . . . . 72.32 109.655 -177.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.44 ' HA ' ' OG1' ' D' ' 10' ' ' THR . 48.1 mt-10 -89.47 121.4 31.67 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.295 -0.866 . . . . 75.35 109.664 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . 0.438 ' HD1' ' HG3' ' B' ' 150' ' ' GLU . 4.6 m80 -123.5 83.05 2.08 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.335 0.654 . . . . 73.42 111.239 -178.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -80.08 118.43 21.79 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.307 -0.86 . . . . 75.25 108.965 169.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -129.97 145.0 51.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.621 0.769 . . . . 54.31 109.079 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 C-N-CA 124.278 1.031 . . . . 73.34 108.969 179.248 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 60.4 mtt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.185 -0.672 . . . . 74.42 109.185 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -105.87 73.26 0.99 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.69 -0.855 . . . . 73.13 108.69 176.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -88.86 103.59 16.14 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.29 -0.868 . . . . 75.22 110.609 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 61.22 91.03 0.06 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.751 1.22 . . . . 75.41 112.287 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -93.07 -76.59 0.47 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.005 -1.109 . . . . 74.1 108.005 170.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.06 35.84 17.3 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.048 1.339 . . . . 73.24 111.268 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 23.9 m -80.87 80.53 7.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.633 0.773 . . . . 75.34 109.743 -175.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -102.86 82.39 2.11 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.096 -0.957 . . . . 71.52 108.595 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 26.4 ttt 62.11 111.0 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.512 1.525 . . . . 72.2 111.459 -173.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 27.0 m -111.35 84.09 1.88 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.9 -1.148 . . . . 60.4 107.9 174.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -93.55 118.64 31.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.16 -0.927 . . . . 75.14 108.637 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -138.12 135.37 35.68 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.48 -1.304 . . . . 72.4 107.48 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.2 mt -74.81 121.17 25.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.401 -0.963 . . . . 74.54 108.401 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.518 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 19.6 mm-40 -83.68 -44.05 14.9 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 123.888 0.743 . . . . 71.2 109.051 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -177.42 137.52 0.21 Allowed 'General case' 0 C--N 1.359 1.001 0 CA-C-N 115.491 -0.777 . . . . 74.11 109.72 -173.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.3 mt -124.46 143.8 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.008 -1.108 . . . . 75.04 108.008 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.41 ' OH ' HD11 ' C' ' 83' ' ' ILE . 30.7 p90 -171.43 165.13 7.02 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.36 0.6 . . . . 65.15 111.923 -172.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -92.64 107.67 19.39 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.967 -1.015 . . . . 74.35 109.191 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -68.38 -39.97 81.56 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.672 0.749 . . . . 75.54 109.548 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 19.3 t70 -143.28 139.36 30.12 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 113.918 -1.492 . . . . 75.5 109.192 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 96.4 mt -137.05 143.13 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 106.704 -1.591 . . . . 75.31 106.704 172.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -149.44 147.84 28.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.096 0.474 . . . . 75.44 110.001 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -147.46 135.32 21.18 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.45 -1.315 . . . . 72.2 107.45 169.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.59 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 33.7 mt-10 -138.13 111.3 7.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.561 0.745 . . . . 73.22 109.742 -170.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.11 74.02 11.0 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.445 -1.316 . . . . 73.32 107.445 166.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.46 -28.72 21.51 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.58 2.187 . . . . 73.42 111.163 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -88.22 14.49 9.25 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.957 -1.474 . . . . 72.43 111.787 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.505 ' HA ' HG11 ' C' ' 31' ' ' VAL . . . -44.83 -54.49 12.95 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 114.184 1.179 . . . . 63.42 114.184 -174.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.23 -37.08 85.55 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 121.916 1.744 . . . . 65.25 113.175 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -69.05 -45.1 71.26 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.836 0.854 . . . . 73.52 111.818 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.693 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -76.53 -22.28 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 113.156 0.798 . . . . 74.25 113.156 -174.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -65.49 -31.53 72.65 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.58 0.585 . . . . 72.24 112.58 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -94.84 11.55 31.19 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.355 0.662 . . . . 73.34 111.667 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.624 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.5 tppp? -85.14 160.55 19.91 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.981 0.912 . . . . 74.54 110.688 -178.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.92 115.38 3.37 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.339 0.656 . . . . 72.03 109.372 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -84.72 91.75 8.03 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.355 0.597 . . . . 72.22 110.01 -177.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -143.46 79.95 13.49 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 106.756 -1.572 . . . . 73.4 106.756 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -80.35 149.92 19.48 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 123.029 2.486 . . . . 74.44 113.619 -177.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -108.03 110.79 22.58 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 107.064 -1.458 . . . . 74.31 107.064 169.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 m -80.43 124.11 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.334 0.588 . . . . 73.22 110.292 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.508 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 1.8 tmtp? -125.03 102.52 7.55 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.376 -1.713 . . . . 74.21 106.376 171.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' G' ' 464' ' ' MET . 4.2 tt -108.44 121.71 45.52 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.968 -1.864 . . . . 72.3 105.968 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -122.72 117.06 24.83 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.88 -0.415 . . . . 74.41 109.88 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.522 ' HB3' HD21 ' G' ' 460' ' ' LEU . 89.4 mt -92.23 150.93 20.61 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.677 0.791 . . . . 75.53 109.322 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 12.7 t70 -151.32 142.77 23.48 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.235 -1.024 . . . . 61.34 108.235 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -126.75 139.51 53.07 Favored 'General case' 0 C--O 1.249 1.072 0 N-CA-C 108.607 -0.886 . . . . 75.15 108.607 172.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.91 141.92 21.27 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.896 -1.149 . . . . 62.41 107.896 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 16.5 p -148.1 156.8 43.03 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 120.853 0.359 . . . . 74.3 110.844 -171.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 95.5 p -144.12 158.64 43.6 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.723 0.809 . . . . 72.33 110.014 -172.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -94.46 130.91 40.65 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.797 -0.816 . . . . 75.5 108.797 172.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.571 HD13 HD13 ' C' ' 83' ' ' ILE . 39.1 mt -99.79 -42.6 6.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.335 0.654 . . . . 73.54 110.489 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -152.67 -172.25 4.18 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.322 -0.853 . . . . 74.51 110.245 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.67 105.87 1.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.013 -0.994 . . . . 70.1 109.826 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 70.06 3.69 4.48 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.01 1.324 . . . . 71.23 113.13 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 56.1 t -100.76 122.78 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.109 -1.071 . . . . 73.54 108.109 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -138.25 124.39 20.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.01 -0.541 . . . . 74.33 109.736 -166.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -84.83 137.8 32.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.561 0.745 . . . . 73.53 109.496 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.51 129.57 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.791 -1.189 . . . . 73.5 107.791 170.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.4 148.24 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.693 0.797 . . . . 75.1 109.109 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.09 111.92 14.02 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.481 -1.303 . . . . 74.41 107.481 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.59 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.6 tmm_? -98.42 107.13 19.52 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 107.731 -1.211 . . . . 75.43 107.731 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 t -103.62 123.11 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.186 -1.042 . . . . 74.11 108.186 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -111.83 141.55 45.32 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.021 -0.733 . . . . 74.13 109.021 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.66 HG23 HG21 ' C' ' 114' ' ' ILE . 91.1 t -131.84 123.21 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.515 1.126 . . . . 75.1 108.146 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 12.8 m -124.69 141.84 51.82 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.795 0.838 . . . . 75.04 108.764 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.69 123.98 16.72 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.235 -1.394 . . . . 63.0 107.235 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 60.4 m -133.3 158.22 43.49 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.6 0.714 . . . . 71.34 111.312 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 mt -121.35 39.85 3.73 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.356 1.463 . . . . 72.55 107.338 -171.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.29 -111.6 3.88 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 109.507 -1.437 . . . . 75.35 109.507 -166.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -90.48 -31.08 16.93 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.105 0.562 . . . . 74.12 110.389 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.624 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 4.4 tp10 -70.67 106.91 3.69 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.026 0.93 . . . . 71.32 109.911 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.7 m -72.83 126.73 30.61 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.94 -0.763 . . . . 75.01 108.94 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.693 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.92 -58.23 4.1 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.029 -0.73 . . . . 64.34 109.029 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -159.43 163.8 35.1 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.536 -0.756 . . . . 74.41 110.897 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.59 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -128.27 144.84 51.16 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 106.517 -1.66 . . . . 72.13 106.517 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.433 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.3 t -149.42 147.11 27.87 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.334 -0.987 . . . . 75.02 108.334 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.43 135.28 10.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.72 0.295 . . . . 74.14 110.48 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' C' ' 110' ' ' ALA . 50.4 t -135.33 114.77 17.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 124.332 1.053 . . . . 74.33 108.704 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 65.4 mt-30 -97.35 89.9 4.89 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.143 -0.688 . . . . 73.14 109.143 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.39 102.47 8.72 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.053 -0.976 . . . . 70.55 110.498 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.96 157.14 31.89 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 116.202 -0.454 . . . . 51.31 112.035 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.518 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -160.81 116.64 0.73 Allowed Glycine 0 CA--C 1.508 -0.369 0 N-CA-C 111.72 -0.552 . . . . 74.24 111.72 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.571 HD13 HD13 ' C' ' 51' ' ' LEU . 7.4 mm -82.7 127.28 39.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.727 -0.842 . . . . 65.25 108.727 177.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -132.12 141.05 49.01 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.758 0.823 . . . . 72.44 109.082 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 13.5 p -83.73 122.92 29.29 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.142 -0.688 . . . . 65.3 109.142 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 46.6 pt -120.86 133.14 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.602 0.761 . . . . 74.2 109.804 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -163.63 159.68 21.99 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.302 1.041 . . . . 61.33 108.704 176.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.33 -57.6 4.22 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 112.713 -0.155 . . . . 70.54 112.713 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -88.57 163.76 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.184 0.594 . . . . 74.14 111.687 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -165.85 163.21 18.71 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.673 0.789 . . . . 55.45 110.392 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.92 -114.96 7.03 Favored Glycine 0 C--N 1.355 1.594 0 C-N-CA 123.44 0.543 . . . . 64.3 113.703 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -63.34 -40.47 97.37 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.731 0.812 . . . . 63.31 111.574 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -76.59 -32.1 57.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.675 0.39 . . . . 74.15 110.861 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 41.5 ttm -76.99 -28.71 55.19 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.274 0.358 . . . . 65.53 110.817 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.63 91.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.441 -0.577 . . . . 51.14 109.441 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.596 ' HE2' ' HA ' ' C' ' 134' ' ' ASP . 7.5 t-160 -77.33 -25.22 50.92 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.308 0.38 . . . . 71.53 111.718 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.05 -52.18 66.47 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.542 0.526 . . . . 74.31 109.733 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 pp -81.99 -20.53 38.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.931 0.492 . . . . 75.13 110.882 176.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.27 -29.19 56.74 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 114.482 0.553 . . . . 75.24 114.482 -173.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.14 -43.52 0.06 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.918 0.71 . . . . 73.32 112.918 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -59.42 -46.08 89.73 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.477 0.711 . . . . 74.24 112.309 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 81.1 m -78.92 -46.87 1.74 Allowed Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.699 0.8 . . . . 71.31 111.396 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.86 -26.3 56.92 Favored 'Trans proline' 0 C--N 1.399 3.185 0 C-N-CA 122.402 2.068 . . . . 74.3 113.831 169.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.33 -43.37 97.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.561 1.145 . . . . 73.53 109.936 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.0 mm -64.05 -45.21 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 114.84 -1.073 . . . . 71.32 109.789 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.518 HD21 ' HA3' ' C' ' 82' ' ' GLY . 86.4 mt -75.72 -25.18 56.39 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.149 -0.932 . . . . 72.0 112.812 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -56.22 -53.42 63.87 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 113.78 1.029 . . . . 75.34 113.78 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.69 -29.63 88.77 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 121.725 1.617 . . . . 75.52 113.387 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.401 ' HE2' HG22 ' A' ' 115' ' ' THR . 90.6 m-85 -68.94 -48.71 62.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.781 0.433 . . . . 75.41 110.478 176.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.51 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -63.23 -31.11 72.17 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.461 -0.791 . . . . 71.31 110.773 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.667 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 46.6 ttt180 -63.42 -58.86 5.71 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.472 1.509 . . . . 64.24 111.146 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -31.91 73.36 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.686 0.394 . . . . 74.21 110.262 -177.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -65.29 -31.34 72.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.141 0.576 . . . . 62.11 111.579 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.66 HG21 HG23 ' C' ' 64' ' ' VAL . 84.8 mt -74.89 -56.61 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 116.154 -0.475 . . . . 71.54 109.933 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 3.3 m -62.7 -27.72 69.45 Favored 'General case' 0 CA--C 1.553 1.066 0 O-C-N 123.688 0.617 . . . . 74.1 111.412 -172.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -62.39 -51.34 67.98 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.349 0.66 . . . . 74.32 109.304 170.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.669 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.79 -39.61 89.53 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.333 1.053 . . . . 75.33 112.435 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.403 HG23 ' O ' ' C' ' 114' ' ' ILE . 60.4 t -59.91 -47.88 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.436 0.694 . . . . 73.52 109.422 176.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -66.31 -32.42 73.81 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.494 -1.23 . . . . 65.43 111.755 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -67.8 -35.02 77.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.31 0.644 . . . . 75.43 109.879 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.39 10.84 69.91 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.928 0.767 . . . . 54.21 112.888 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 46.6 p 54.84 37.26 28.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.058 1.743 . . . . 73.34 113.752 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -95.65 153.48 39.41 Favored Pre-proline 0 N--CA 1.477 0.911 0 N-CA-C 108.196 -1.038 . . . . 74.22 108.196 168.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -64.76 168.9 12.47 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.5 2.134 . . . . 75.12 112.688 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -54.44 113.33 1.24 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.353 1.061 . . . . 75.53 113.412 -174.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.692 HD11 HD12 ' G' ' 470' ' ' LEU . 5.5 tt -113.87 87.03 2.53 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.307 -1.368 . . . . 72.13 107.307 167.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -95.47 127.47 41.54 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.23 -1.026 . . . . 73.34 108.23 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.667 HD12 HD13 ' C' ' 42' ' ' LEU . 2.3 mm? -73.62 132.15 42.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.552 0.741 . . . . 75.2 109.546 -174.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.62 153.47 75.91 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.518 0.727 . . . . 63.23 110.606 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.572 ' HG3' HD13 ' A' ' 16' ' ' ILE . 50.2 Cg_exo -51.58 115.68 2.25 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.771 2.314 . . . . 71.41 112.73 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.416 HG22 HD12 ' C' ' 44' ' ' LEU . 85.0 t -97.95 122.58 49.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.199 -0.667 . . . . 74.04 109.199 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -83.88 76.11 10.05 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.17 0.588 . . . . 75.11 109.497 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -60.51 -44.67 95.77 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 122.116 0.96 . . . . 73.44 109.038 170.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.596 ' HA ' ' HE2' ' C' ' 96' ' ' HIS . 7.4 m-20 -65.09 -50.0 67.81 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 113.184 -1.825 . . . . 75.23 112.366 -172.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.67 88.32 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.814 0.696 . . . . 75.12 111.825 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -42.93 74.38 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.762 -1.108 . . . . 70.34 109.82 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.47 -23.92 61.12 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.739 0.416 . . . . 75.41 111.285 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 67.4 mtt -70.63 -46.84 62.57 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.049 -0.722 . . . . 73.23 109.049 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -57.71 -37.62 73.83 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.871 0.868 . . . . 74.52 111.117 175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -53.5 -77.44 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.39 1.476 . . . . 71.41 109.96 172.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.508 ' HA ' ' HG2' ' A' ' 153' ' ' GLN . 96.4 mt -49.63 -88.29 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.411 1.084 . . . . 74.42 113.007 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.417 HE22 ' HB3' ' A' ' 151' ' ' GLU . 20.3 pt20 -176.48 21.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.361 1.065 . . . . 75.24 110.101 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 59.58 88.24 0.07 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.702 1.601 . . . . 73.24 112.293 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -85.23 101.25 12.35 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.871 0.868 . . . . 73.04 108.677 175.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.55 116.49 14.19 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.996 0.518 . . . . 72.55 110.56 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.67 78.89 1.45 Allowed Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.453 -0.659 . . . . 74.44 111.453 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -74.97 145.37 42.6 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.166 0.586 . . . . 73.41 111.009 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -122.16 123.13 5.33 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 111.111 -0.796 . . . . 74.4 111.111 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 40.9 p -66.06 126.03 27.33 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.313 0.645 . . . . 61.52 110.251 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -84.93 145.62 27.67 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.453 0.644 . . . . 71.34 110.858 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -136.1 153.65 51.24 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 107.16 -1.422 . . . . 74.34 107.16 165.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -78.84 75.74 5.34 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.337 0.589 . . . . 74.22 109.541 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -139.39 142.24 37.53 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.916 1.286 . . . . 74.2 108.689 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -141.45 154.58 45.65 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.859 0.864 . . . . 70.13 108.828 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.374 0 N-CA-C 109.321 -0.622 . . . . 73.41 109.321 179.26 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 CA--C 1.551 0.991 0 CA-C-O 121.54 0.686 . . . . 74.51 111.321 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -89.84 109.39 20.4 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.408 -0.96 . . . . 74.24 108.408 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -159.76 -58.89 0.06 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.063 0.545 . . . . 64.15 110.32 -174.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -76.88 103.26 6.73 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.543 -0.753 . . . . 73.05 110.817 -172.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -147.74 138.7 23.4 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.12 0.968 . . . . 71.31 108.893 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.586 ' HB2' ' HB2' ' D' ' 9' ' ' MET . 28.3 p-10 -133.84 99.59 4.5 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.879 0.847 . . . . 71.15 110.545 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -120.05 -22.83 6.53 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.926 0.89 . . . . 74.43 109.417 170.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -91.32 -25.86 19.22 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.323 1.049 . . . . 74.43 111.285 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.586 ' HB2' ' HB2' ' D' ' 6' ' ' ASN . 8.1 ttp -31.84 130.56 0.14 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.579 1.952 . . . . 73.32 114.187 175.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' B' ' 151' ' ' GLU . 24.6 m -120.79 119.98 34.3 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.232 1.013 . . . . 75.55 108.733 172.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -148.23 102.21 3.34 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.506 -1.294 . . . . 71.35 107.506 172.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -126.1 115.91 20.56 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.763 -1.199 . . . . 73.02 107.763 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 mt -72.33 115.76 13.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 N-CA-C 108.247 -1.02 . . . . 75.41 108.247 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -88.01 -29.53 20.65 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.722 -0.672 . . . . 75.35 110.783 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -179.54 141.13 0.15 Allowed 'General case' 0 C--N 1.366 1.315 0 C-N-CA 122.34 0.256 . . . . 74.22 110.411 -170.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.46 135.79 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.256 -1.387 . . . . 71.22 107.256 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -165.86 174.02 10.0 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-O 121.654 0.74 . . . . 75.13 112.258 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -105.06 120.17 40.84 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.735 -1.12 . . . . 71.1 108.912 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.401 ' HZ2' ' CD ' ' D' ' 57' ' ' GLU . 28.7 mtpt -89.91 -21.47 22.47 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.307 0.643 . . . . 74.12 109.805 177.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.668 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.0 t70 -155.37 139.36 16.37 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.081 -0.963 . . . . 71.14 108.856 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.669 HG21 ' HE1' ' C' ' 117' ' ' MET . 81.3 mt -137.53 142.77 35.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.56 -1.274 . . . . 74.43 107.56 172.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -149.07 130.09 14.39 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.543 -0.91 . . . . 73.11 108.543 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -136.78 126.23 25.09 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.992 -1.484 . . . . 75.11 106.992 170.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.5 mt-10 -130.82 138.3 49.82 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.74 -0.837 . . . . 74.34 108.74 -175.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.77 82.86 67.81 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 106.97 -1.492 . . . . 74.51 106.97 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.08 -32.4 27.92 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.196 2.597 . . . . 71.51 113.034 -169.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -111.77 26.53 10.53 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.308 0.643 . . . . 75.52 109.385 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.432 ' HB2' ' HD3' ' D' ' 29' ' ' PRO . . . -37.04 -70.09 0.16 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 114.746 1.387 . . . . 50.41 114.746 -161.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.547 ' HB3' HD11 ' C' ' 83' ' ' ILE . 65.2 Cg_endo -77.04 -16.35 15.91 Favored 'Trans proline' 0 C--N 1.38 2.198 0 CA-C-N 122.401 1.893 . . . . 73.11 113.612 -172.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -76.13 -41.71 49.2 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.597 1.159 . . . . 75.43 110.327 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' D' ' 73' ' ' ALA . 6.6 p -82.66 -25.29 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 115.649 -0.705 . . . . 73.22 111.138 -170.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -61.5 -20.78 63.59 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.761 0.824 . . . . 75.34 113.004 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -60.86 -26.29 67.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.425 0.69 . . . . 75.01 110.945 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.421 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 41.2 mtmt -91.72 86.4 5.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.941 0.897 . . . . 70.15 109.113 168.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -76.91 88.73 3.48 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.664 -0.698 . . . . 74.33 109.631 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -155.78 158.34 37.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.515 1.126 . . . . 75.44 108.489 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.541 ' HG3' HD12 ' H' ' 470' ' ' LEU . 29.8 tp60 -69.09 106.1 1.32 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.891 0.876 . . . . 74.11 108.966 174.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' D' ' 66' ' ' ALA . 35.4 Cg_exo -63.17 141.15 81.6 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.664 2.243 . . . . 73.12 113.287 -171.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 8.5 mm-40 -58.73 111.35 1.24 Allowed 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.051 0.844 . . . . 74.15 110.2 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.47 HG13 ' O ' ' D' ' 38' ' ' PRO . 16.1 m -101.4 128.02 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.656 0.741 . . . . 75.33 111.83 -170.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -106.55 112.76 25.9 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.821 1.248 . . . . 72.01 107.913 171.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.565 HD21 ' H ' ' D' ' 42' ' ' LEU . 1.8 pt? -95.98 112.92 24.52 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.039 -1.097 . . . . 75.11 108.039 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -114.84 113.21 23.91 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.667 -1.235 . . . . 71.23 107.667 174.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.529 HD11 ' H ' ' D' ' 44' ' ' LEU . 0.0 OUTLIER -110.34 155.48 22.06 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.904 0.882 . . . . 75.01 109.247 -176.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -158.64 152.65 23.7 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.528 0.731 . . . . 75.03 109.983 -177.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -109.87 167.59 10.05 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.617 -0.512 . . . . 73.11 109.617 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.544 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.47 160.52 36.85 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.795 0.838 . . . . 71.55 108.866 173.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -146.4 151.52 37.59 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.656 0.382 . . . . 72.12 110.736 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.7 t -165.55 122.13 1.42 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.582 0.753 . . . . 71.31 109.873 -171.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -82.42 117.71 22.67 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.809 -0.441 . . . . 71.23 109.809 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.549 HD13 HG22 ' D' ' 83' ' ' ILE . 32.2 mt -97.63 -24.98 15.28 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.162 0.585 . . . . 72.33 110.71 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.43 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -162.62 -178.54 6.27 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.482 0.713 . . . . 70.43 111.037 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.51 114.3 4.78 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.475 -1.239 . . . . 35.3 109.791 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.14 21.18 11.62 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.302 1.041 . . . . 63.3 111.795 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 66.3 t -118.82 128.72 75.65 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 N-CA-C 108.159 -1.052 . . . . 72.11 108.159 170.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.442 ' HB2' HD13 ' D' ' 86' ' ' ILE . 0.4 OUTLIER -122.27 172.7 8.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.054 0.93 . . . . 65.11 110.287 174.386 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.492 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.9 tt0 -132.31 138.54 47.86 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.255 -1.793 . . . . 74.11 107.577 169.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.27 138.63 47.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.513 -1.292 . . . . 75.35 107.513 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 47.6 t -119.57 128.67 75.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.077 -1.083 . . . . 54.25 108.077 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.403 HD21 ' O ' ' D' ' 45' ' ' ASP . 0.1 OUTLIER -99.1 116.45 31.35 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.25 -1.019 . . . . 74.2 108.25 175.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.592 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 2.4 tmm_? -99.71 96.29 7.51 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.652 -1.61 . . . . 75.44 106.652 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.584 HG23 ' HB1' ' D' ' 110' ' ' ALA . 37.0 t -107.96 125.63 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.599 -0.889 . . . . 74.44 108.599 -177.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 20.8 m -130.26 135.29 47.96 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.366 0.667 . . . . 52.15 109.398 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 63.9 t -122.3 109.33 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.858 0.863 . . . . 73.34 109.257 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.1 m -95.39 111.54 23.4 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.832 -0.803 . . . . 72.44 108.832 170.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' D' ' 38' ' ' PRO . . . -115.28 149.84 37.18 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.48 0.712 . . . . 74.11 110.771 -173.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 15.1 m -149.32 132.28 16.17 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 123.778 0.674 . . . . 71.21 111.603 -177.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.513 HD11 HG23 ' D' ' 31' ' ' VAL . 30.5 mt -96.24 109.35 21.84 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.554 -0.906 . . . . 71.51 108.554 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.38 -114.57 4.99 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 123.678 0.612 . . . . 64.0 113.02 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.57 16.53 20.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.57 0.748 . . . . 75.52 111.386 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.421 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 12.4 pt-20 -137.23 161.22 36.78 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.219 0.607 . . . . 75.44 109.785 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 19.5 m -69.62 138.9 53.47 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.561 0.538 . . . . 74.22 111.239 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.525 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -95.72 -70.64 0.7 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.955 0.902 . . . . 73.24 109.375 173.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -144.72 138.45 27.23 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 121.136 0.493 . . . . 74.3 110.286 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.7 mt -111.37 109.83 20.0 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.027 -1.101 . . . . 74.23 108.027 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.533 ' SG ' HG22 ' D' ' 114' ' ' ILE . 53.3 t -118.78 140.64 49.62 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.473 0.709 . . . . 71.11 109.406 -177.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -155.57 134.5 12.06 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.28 0.632 . . . . 75.31 109.629 175.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.18 119.06 18.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.929 0.892 . . . . 65.05 108.873 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.668 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.7 83.71 6.26 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.2 -1.037 . . . . 73.44 108.2 168.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.31 94.35 5.46 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.29 -1.323 . . . . 74.52 109.0 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.9 142.67 16.67 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.985 -0.446 . . . . 64.14 111.985 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.509 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -142.15 130.02 4.14 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.542 -1.023 . . . . 73.41 110.542 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.549 HG22 HD13 ' D' ' 51' ' ' LEU . 39.0 mt -90.82 136.75 23.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.422 -0.955 . . . . 74.23 108.422 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -138.86 131.83 29.51 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.26 0.624 . . . . 72.42 109.84 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -80.17 109.31 14.51 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.772 -0.825 . . . . 54.43 108.772 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.515 HD11 HG11 ' H' ' 451' ' ' VAL . 1.6 pp -119.83 133.88 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.648 0.779 . . . . 74.34 111.81 -171.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.24 169.0 9.49 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.434 1.094 . . . . 72.42 109.207 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.18 11.46 84.89 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 115.368 0.907 . . . . 74.5 115.368 169.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.81 143.35 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 117.837 0.819 . . . . 75.22 110.059 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.2 -174.42 4.37 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.717 0.807 . . . . 73.41 111.072 -176.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.93 -120.85 14.86 Favored Glycine 0 C--N 1.357 1.728 0 O-C-N 123.455 0.472 . . . . 70.43 113.0 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 29.7 m -88.82 -28.65 20.28 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.213 0.605 . . . . 74.13 110.333 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -62.85 -30.23 71.35 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.273 1.029 . . . . 73.03 111.857 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 12.1 ptm -68.65 -29.39 67.87 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.079 0.552 . . . . 74.51 111.574 177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.54 -36.26 24.15 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.586 0.754 . . . . 74.34 110.651 174.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.462 ' HE2' ' HB3' ' D' ' 134' ' ' ASP . 25.9 t-80 -70.02 -41.32 74.46 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.214 1.005 . . . . 74.22 111.61 -174.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.6 t -65.94 -50.33 64.76 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.099 0.56 . . . . 74.52 110.66 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 18.2 tp -76.95 -31.36 56.53 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 115.715 -0.675 . . . . 73.04 111.104 -173.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.28 -26.94 10.47 Favored Glycine 0 C--N 1.354 1.541 0 N-CA-C 114.931 0.732 . . . . 61.53 114.931 -170.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.37 -49.63 1.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 117.609 0.704 . . . . 72.42 112.118 -171.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -69.95 -48.29 58.96 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.26 0.624 . . . . 75.44 111.932 -173.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 92.6 m -61.44 -48.18 91.5 Favored Pre-proline 0 CA--C 1.564 1.502 0 CA-C-O 118.509 -0.758 . . . . 74.01 112.15 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.3 -35.68 91.96 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.113 1.875 . . . . 70.11 113.765 170.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -63.85 -39.74 94.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.993 0.517 . . . . 73.55 110.424 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.0 mm -60.51 -40.64 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.568 0.699 . . . . 75.34 110.544 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.509 HD22 ' HA3' ' D' ' 82' ' ' GLY . 96.1 mt -76.34 -19.17 58.47 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.84 -1.073 . . . . 75.04 112.061 -175.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -65.33 -43.8 65.68 Favored Pre-proline 0 CA--C 1.564 1.498 0 N-CA-C 114.189 1.181 . . . . 72.22 114.189 -170.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.63 -42.06 71.77 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 122.1 1.867 . . . . 71.31 113.432 172.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -73.68 -35.2 65.17 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.742 0.817 . . . . 72.32 111.808 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.584 ' HB1' HG23 ' D' ' 62' ' ' VAL . . . -61.51 -51.03 70.33 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.519 0.728 . . . . 63.02 109.592 176.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -54.92 -52.22 63.63 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 113.891 -1.504 . . . . 75.42 110.586 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.84 -48.0 81.05 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 124.023 0.827 . . . . 75.24 111.703 -174.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.9 t -59.9 -42.56 94.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.898 0.479 . . . . 61.2 111.169 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.533 HG22 ' SG ' ' D' ' 76' ' ' CYS . 70.3 mt -60.5 -52.53 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.927 0.891 . . . . 63.44 110.528 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 39.5 m -56.55 -44.88 81.33 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 125.063 1.345 . . . . 75.13 111.573 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 25.7 t -64.54 -41.36 96.4 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.696 -1.138 . . . . 74.11 110.457 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.452 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.8 mtm -70.56 -34.02 71.76 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.698 0.399 . . . . 64.22 111.749 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.12 -43.62 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.304 0.642 . . . . 74.31 110.044 176.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.4 p -72.45 -31.17 65.22 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 116.054 -0.521 . . . . 74.5 111.196 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.3 mtt-85 -71.46 -32.56 68.46 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.494 0.718 . . . . 74.5 110.411 175.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.29 7.22 79.42 Favored Glycine 0 C--N 1.351 1.405 0 O-C-N 123.67 0.606 . . . . 55.35 112.072 175.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 66.2 p 63.08 13.59 6.91 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.88 2.072 . . . . 73.12 114.309 173.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -79.26 149.82 73.21 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 108.543 -0.91 . . . . 75.41 108.543 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -48.25 122.08 7.05 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.075 2.517 . . . . 74.14 112.755 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -49.49 135.87 17.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.395 1.478 . . . . 71.41 112.345 -171.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 29.5 tp -108.16 95.9 5.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.941 0.496 . . . . 64.41 110.736 -169.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.606 ' H ' HD21 ' H' ' 468' ' ' LEU . 85.6 m-20 -103.4 87.74 2.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.674 0.79 . . . . 71.52 109.062 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.414 HD12 HD13 ' D' ' 42' ' ' LEU . 39.1 tp -71.68 133.63 45.77 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.014 -0.993 . . . . 73.12 110.549 -176.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.05 141.07 98.01 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 123.131 0.573 . . . . 75.01 110.892 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -61.4 130.98 33.98 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.666 2.244 . . . . 74.31 111.868 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 80.0 t -108.58 120.84 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.424 0.689 . . . . 75.14 109.77 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -82.99 91.37 7.15 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.591 -0.892 . . . . 73.41 108.591 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -66.72 -35.1 79.33 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.798 -0.637 . . . . 72.41 110.632 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.462 ' HB3' ' HE2' ' D' ' 96' ' ' HIS . 6.0 m-20 -52.39 -52.14 55.24 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.201 1.4 . . . . 52.51 112.743 -173.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.68 75.26 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.19 0.596 . . . . 64.0 111.518 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -68.46 -28.5 67.1 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.569 -0.741 . . . . 73.32 111.19 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -62.17 -42.76 99.57 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.968 0.907 . . . . 73.33 110.555 176.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.446 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 37.5 mtt -66.55 -40.49 89.09 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.118 0.567 . . . . 74.55 110.87 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -72.88 -33.08 65.84 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.897 -0.592 . . . . 75.32 110.523 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -62.65 -38.13 89.06 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.208 1.003 . . . . 72.54 111.764 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.93 -37.09 72.86 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.365 0.666 . . . . 74.41 111.997 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -87.39 39.64 0.88 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.185 0.594 . . . . 63.12 112.002 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -118.66 87.67 2.77 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.676 0.79 . . . . 72.2 109.578 -175.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -172.58 162.82 5.24 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.184 0.994 . . . . 74.0 110.093 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.21 139.96 58.14 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.898 0.479 . . . . 63.25 111.028 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 153.83 59.91 0.01 OUTLIER Glycine 0 C--N 1.345 1.046 0 CA-C-N 116.353 -0.385 . . . . 53.21 112.16 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.25 144.14 30.85 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.015 0.526 . . . . 75.1 110.538 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -93.71 48.56 2.3 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.173 -0.467 . . . . 70.22 112.081 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 48.1 p -95.63 87.09 4.6 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.49 0.716 . . . . 73.1 109.48 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.41 159.38 42.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.366 -0.833 . . . . 71.22 110.346 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -167.64 -64.13 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.866 -1.161 . . . . 72.54 107.866 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -178.1 143.38 0.3 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.496 1.518 . . . . 70.22 107.736 174.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -107.82 -72.58 0.72 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 106.327 -1.731 . . . . 70.12 106.327 169.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 41.92 70.14 0.3 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.748 1.619 . . . . 64.35 113.675 163.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.207 0 C-N-CA 122.724 0.41 . . . . 74.2 109.968 -177.51 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 111.594 0.22 . . . . 71.54 111.594 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.0 -57.82 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.367 0.667 . . . . 73.42 110.794 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 29.2 m -113.86 112.93 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-O 121.374 0.607 . . . . 74.23 111.675 -171.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -87.3 65.78 3.59 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 116.238 -0.437 . . . . 54.32 112.274 -176.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . 0.427 HD13 ' HB3' ' A' ' 48' ' ' SER . 75.4 mt -72.5 114.1 10.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.035 0.534 . . . . 74.34 109.942 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 8.9 t -138.87 -40.94 0.48 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.302 0.641 . . . . 74.01 110.055 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -91.08 -24.96 19.86 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.985 0.914 . . . . 73.4 111.3 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -56.9 114.72 2.22 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.317 1.047 . . . . 74.53 110.352 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 85.0 m -139.82 -51.43 0.51 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.399 1.08 . . . . 73.44 109.886 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.11 132.1 35.12 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.487 0.715 . . . . 72.44 111.002 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -105.9 122.74 46.75 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.764 -1.198 . . . . 65.12 107.764 172.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -88.5 136.7 32.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.415 0.686 . . . . 73.3 109.741 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . 0.614 ' HH ' ' HA ' ' A' ' 43' ' ' ASP . 13.6 p90 -163.29 120.21 1.84 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.074 0.95 . . . . 74.1 108.586 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 36.3 m -69.52 -45.83 67.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.026 0.53 . . . . 72.03 110.797 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 464' ' ' MET . . . . . 0.566 ' HB3' HG23 ' A' ' 131' ' ' VAL . 5.2 tmm? -72.89 96.77 2.15 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.472 -0.936 . . . . 74.34 108.472 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -130.02 131.0 45.67 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.856 -1.164 . . . . 75.05 107.856 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . 0.441 ' H ' ' HB3' ' A' ' 42' ' ' LEU . . . 61.11 -158.12 0.33 Allowed 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.344 1.028 . . . . 74.1 110.169 -174.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . 58.68 31.31 21.0 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.499 0.72 . . . . 51.32 111.219 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . 0.468 HD22 HD21 ' A' ' 42' ' ' LEU . 38.1 mt -67.46 148.77 51.1 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.06 -0.973 . . . . 74.41 109.566 -177.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -52.21 -84.81 0.02 OUTLIER Glycine 0 C--N 1.354 1.543 0 O-C-N 124.551 1.157 . . . . 52.3 113.444 -173.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . 0.501 ' HB2' HD13 ' A' ' 126' ' ' LEU . 24.9 tp 63.82 150.64 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.974 1.309 . . . . 74.01 112.219 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? . . . . . 0 CA--C 1.554 1.119 0 N-CA-C 107.499 -1.297 . . . . 71.53 107.499 173.887 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 110.387 -0.227 . . . . 74.13 110.387 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.56 -69.06 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.44 0.696 . . . . 74.22 109.201 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 35.0 m -128.49 157.61 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.844 1.257 . . . . 75.44 108.603 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -98.95 -49.64 1.59 Allowed Glycine 0 N--CA 1.468 0.785 0 N-CA-C 111.164 -0.774 . . . . 72.43 111.164 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 25.5 tp 48.27 62.42 2.53 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.662 1.585 . . . . 75.4 111.415 -173.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 46.3 p -102.34 35.23 2.48 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.543 -1.208 . . . . 74.35 109.461 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.7 -156.33 0.13 Allowed 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.359 1.064 . . . . 44.23 109.07 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . 0.497 ' HB2' ' HE1' ' B' ' 140' ' ' TYR . 23.1 mt-30 -62.31 -56.34 19.4 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.167 0.587 . . . . 73.21 109.803 174.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 12.8 m 62.26 8.92 2.95 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.83 1.252 . . . . 72.41 111.166 -172.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.27 103.65 16.3 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 124.534 1.134 . . . . 75.35 109.461 -173.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 1.6 pp -167.6 103.16 0.5 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.981 0.912 . . . . 72.11 108.8 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . 0.563 ' HB2' HD13 ' B' ' 44' ' ' LEU . 3.2 m-85 179.01 154.56 0.43 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.52 1.528 . . . . 74.02 109.577 170.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . 0.459 ' HB3' HD11 ' B' ' 42' ' ' LEU . 59.3 m-85 64.15 10.2 5.31 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.335 1.454 . . . . 75.2 113.155 173.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 463' ' ' THR . . . . . 0.664 ' HB ' ' HG ' ' B' ' 136' ' ' LEU . 9.0 m -76.65 72.4 3.3 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.178 -1.045 . . . . 72.03 108.178 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -151.83 163.21 39.68 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.932 -1.031 . . . . 75.41 109.779 -168.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -115.55 145.44 42.64 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.131 0.972 . . . . 65.53 108.462 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . 58.95 69.96 0.69 Allowed 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.125 0.89 . . . . 74.0 109.179 -168.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . 0.476 ' HB3' HD23 ' B' ' 42' ' ' LEU . . . -66.3 -16.36 63.98 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.749 -1.114 . . . . 71.11 113.389 -169.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 2.7 tt -154.28 -71.78 0.13 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.927 -0.768 . . . . 70.2 108.927 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 87.99 66.73 1.31 Allowed Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.589 -0.604 . . . . 74.2 111.589 -174.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . 0.543 HD23 ' HB3' ' B' ' 37' ' ' GLN . 91.3 mt -67.59 98.0 0.65 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.801 0.84 . . . . 75.54 110.824 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 62.1 tttm . . . . . 0 C--O 1.252 1.217 0 N-CA-C 108.579 -0.897 . . . . 70.5 108.579 -175.942 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 37.7 t30 . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 109.083 -0.71 . . . . 74.15 109.083 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.46 -59.94 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.273 0.629 . . . . 74.11 109.645 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 11.3 p -157.87 149.24 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 115.821 -0.627 . . . . 73.43 110.597 -171.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . -119.71 111.4 2.02 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 109.039 -1.624 . . . . 74.33 109.039 169.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 38.6 tp -75.12 130.53 39.4 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.485 0.642 . . . . 75.45 111.322 -172.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 37.7 m -67.82 149.41 49.92 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.696 0.799 . . . . 74.54 109.576 170.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -61.35 87.49 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.011 0.524 . . . . 70.52 110.93 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.61 -60.07 2.52 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.476 -0.935 . . . . 73.42 108.476 175.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 29.7 m 58.86 79.43 0.22 Allowed 'General case' 0 C--O 1.247 0.957 0 O-C-N 124.525 1.141 . . . . 65.43 110.739 174.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -171.13 151.03 3.11 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.706 -1.133 . . . . 75.5 109.438 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' C' ' 44' ' ' LEU . 24.9 tp -153.8 123.83 6.88 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.493 -0.928 . . . . 74.13 108.493 169.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -52.91 -28.51 23.65 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.679 1.591 . . . . 70.14 113.87 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -85.09 89.18 7.56 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 122.743 0.417 . . . . 75.44 110.663 -171.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 86.0 m -99.57 127.8 45.67 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.569 -0.9 . . . . 74.0 108.569 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 464' ' ' MET . . . . . 0.682 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . 63.4 mtp -107.05 126.83 52.86 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.012 0.925 . . . . 73.34 110.296 -173.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -112.5 -8.32 13.86 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 108.494 -0.928 . . . . 75.44 108.494 162.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -117.06 129.57 56.08 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.202 1.001 . . . . 72.34 109.291 175.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -160.66 -47.25 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.088 0.955 . . . . 74.44 109.606 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.64 -49.35 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 116.08 -0.509 . . . . 75.24 110.956 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 105.95 -33.9 6.15 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 119.495 -0.614 . . . . 71.01 114.084 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . 0.692 HD12 HD11 ' C' ' 126' ' ' LEU . 88.2 mt 67.59 9.23 6.91 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 124.848 1.259 . . . . 74.11 112.053 -174.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 94.7 mttt . . . . . 0 C--O 1.254 1.317 0 C-N-CA 124.056 0.942 . . . . 74.14 109.193 -176.647 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 108.579 -0.897 . . . . 74.04 108.579 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . 0.515 HG11 HD11 ' D' ' 86' ' ' ILE . 21.2 t -61.73 -45.81 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 124.153 0.981 . . . . 73.15 109.68 175.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . 0.413 ' HA ' ' CE1' ' D' ' 56' ' ' TYR . 2.6 p -133.31 141.93 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 114.309 -1.314 . . . . 74.24 110.338 -173.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 112.11 -7.01 27.11 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.894 -0.594 . . . . 73.41 112.932 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 39.3 tp -94.21 131.92 39.3 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.203 -0.666 . . . . 74.43 109.203 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 13.5 t -139.35 10.86 2.54 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.023 0.44 . . . . 75.23 110.496 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -147.02 163.92 34.69 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.002 0.521 . . . . 73.13 109.939 -169.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.99 120.06 41.13 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.759 1.224 . . . . 75.54 109.067 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 25.5 p -69.72 -69.17 0.36 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.987 0.515 . . . . 72.15 110.635 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -169.94 150.67 3.9 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.484 0.713 . . . . 73.43 110.11 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.54 -169.47 2.65 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.272 1.029 . . . . 74.11 111.029 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -159.16 7.46 0.11 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.47 0.708 . . . . 74.23 112.305 -171.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -119.12 134.84 54.96 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.886 0.766 . . . . 70.23 112.182 -175.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 30.4 p -138.75 153.85 48.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.728 1.611 . . . . 72.32 108.224 174.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 464' ' ' MET . . . . . 0.459 ' HB3' HD23 ' D' ' 42' ' ' LEU . 55.6 ttp -155.94 141.77 18.01 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.621 -0.511 . . . . 74.15 109.621 173.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -67.73 -58.65 4.28 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.607 0.763 . . . . 75.43 111.633 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -151.43 167.05 29.17 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.084 0.554 . . . . 74.3 110.726 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -129.43 166.9 18.66 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.17 0.988 . . . . 73.41 110.157 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . 0.606 HD21 ' H ' ' D' ' 127' ' ' ASN . 6.0 mp 59.27 -157.71 0.32 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.375 1.07 . . . . 71.44 111.206 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . -80.79 27.83 2.91 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 113.607 0.203 . . . . 73.22 113.607 173.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . 0.541 HD12 ' HG3' ' D' ' 37' ' ' GLN . 4.8 tt -89.92 101.16 13.86 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 107.882 -1.155 . . . . 74.45 107.882 177.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? . . . . . 0 C--O 1.253 1.266 0 N-CA-C 107.324 -1.361 . . . . 75.42 107.324 171.323 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptm . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 111.093 0.034 . . . . 75.2 111.093 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 t 178.66 115.23 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.088 1.355 . . . . 74.03 107.546 164.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.61 88.16 2.28 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.87 -1.159 . . . . 73.34 107.87 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -145.18 103.68 3.88 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.871 1.268 . . . . 72.01 108.197 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -121.13 170.54 9.45 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.863 0.865 . . . . 73.42 110.469 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -153.26 21.45 0.56 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.912 0.863 . . . . 74.32 109.411 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.8 p -78.88 82.86 5.04 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.264 -0.88 . . . . 74.24 110.892 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.26 130.84 44.58 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.083 -0.962 . . . . 74.5 109.867 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.556 ' HG2' HD13 ' A' ' 89' ' ' ILE . 80.3 mtp -134.39 171.31 14.46 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.809 0.814 . . . . 74.41 111.651 -174.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.7 m -139.26 102.16 4.43 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 106.125 -1.806 . . . . 75.43 106.125 164.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.616 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.6 t80 -114.49 129.96 56.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.001 -1.0 . . . . 75.42 109.213 -171.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -140.99 108.84 5.67 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.36 -0.978 . . . . 75.11 108.36 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.555 HG12 ' HD2' ' A' ' 84' ' ' PHE . 55.0 mt -81.16 116.94 26.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.971 -0.751 . . . . 72.3 108.971 173.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.478 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -73.82 -40.77 63.11 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.634 -0.712 . . . . 75.24 109.301 -178.683 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -173.64 122.96 0.35 Allowed 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.299 0.374 . . . . 72.52 111.384 -171.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.562 HD13 ' HG3' ' C' ' 130' ' ' PRO . 71.3 mt -106.43 133.83 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.067 -0.716 . . . . 75.12 109.067 173.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.433 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 33.2 p90 -163.76 178.86 7.53 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.882 0.873 . . . . 54.41 110.901 -173.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.9 p -106.2 116.26 31.63 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.951 -0.759 . . . . 75.24 108.951 176.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 22.7 mtpt -81.26 -29.71 34.31 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.422 -0.585 . . . . 73.13 109.422 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.583 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.3 t70 -146.84 141.75 26.95 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.719 -1.128 . . . . 70.22 109.697 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 88.0 mt -139.05 141.26 36.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 125.616 1.566 . . . . 74.32 106.807 171.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -147.96 136.85 21.94 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.184 0.516 . . . . 62.43 109.986 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.585 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.4 t80 -135.26 126.23 27.69 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.682 -1.229 . . . . 75.45 107.682 171.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.81 119.88 24.1 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.885 0.474 . . . . 74.14 110.159 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -132.93 80.4 60.71 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 107.367 -1.345 . . . . 73.44 107.367 170.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.66 -19.38 12.87 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.68 2.253 . . . . 74.34 111.192 175.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.479 ' O ' HG21 ' A' ' 31' ' ' VAL . 91.0 m-20 -103.94 16.98 25.08 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.294 1.038 . . . . 75.45 110.56 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.527 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -55.25 -46.6 99.66 Favored Pre-proline 0 CA--C 1.57 1.725 0 C-N-CA 123.54 0.736 . . . . 72.33 112.277 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.52 6.1 4.69 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 122.318 2.012 . . . . 72.43 113.383 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -100.78 -40.25 7.42 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.125 0.57 . . . . 75.2 109.8 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 27' ' ' ASN . 98.6 t -66.78 -34.39 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.716 0.806 . . . . 74.01 111.34 -175.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.441 ' CE1' ' HG3' ' A' ' 33' ' ' GLN . 1.1 p90 -65.82 -26.14 67.54 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 120.898 0.38 . . . . 75.12 111.029 -177.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.441 ' HG3' ' CE1' ' A' ' 32' ' ' PHE . 49.2 mt-30 -87.08 -44.11 11.79 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.372 0.669 . . . . 75.22 111.068 177.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.415 ' HE3' HD13 ' A' ' 68' ' ' LEU . 53.4 mtmt -82.86 168.55 17.0 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.086 0.47 . . . . 75.11 112.251 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.24 131.96 41.69 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.009 -0.996 . . . . 75.32 110.535 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -77.44 98.62 5.35 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.589 1.156 . . . . 73.1 110.256 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -139.01 75.66 34.78 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 108.879 -0.786 . . . . 75.45 108.879 172.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -84.96 152.81 11.19 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.554 2.169 . . . . 72.54 112.863 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -118.33 108.76 15.48 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.603 -1.258 . . . . 73.41 107.603 172.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.522 HG21 ' HG ' ' E' ' 468' ' ' LEU . 22.6 m -82.54 135.41 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.609 0.764 . . . . 74.24 111.649 -171.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -123.28 113.28 18.67 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.895 -1.15 . . . . 74.03 107.895 174.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.41 HD21 ' HB3' ' E' ' 464' ' ' MET . 64.7 tp -110.46 116.72 31.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.045 0.538 . . . . 75.51 110.078 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.507 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 31.5 t70 -103.15 132.93 49.04 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 109.029 -0.73 . . . . 75.14 109.029 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' E' ' 464' ' ' MET . 85.5 mt -110.47 132.4 54.21 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.459 -0.941 . . . . 74.43 108.459 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.74 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 16.9 t70 -145.39 153.17 40.92 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.907 0.483 . . . . 74.24 110.068 177.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.407 ' O ' HG22 ' E' ' 458' ' ' THR . 26.6 m -127.71 139.39 52.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.667 1.187 . . . . 71.21 108.659 177.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.57 123.69 25.58 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.491 -0.559 . . . . 72.41 109.491 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.452 ' HB2' ' HA ' ' E' ' 456' ' ' ASP . 17.6 m -88.11 152.21 22.17 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.333 -0.617 . . . . 72.24 109.333 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -160.42 122.52 3.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.368 0.667 . . . . 75.45 109.819 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -81.04 139.12 35.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.026 0.53 . . . . 73.43 110.239 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.465 HD12 HG23 ' A' ' 83' ' ' ILE . 83.7 mt -117.49 -28.76 5.99 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.522 0.729 . . . . 72.52 110.138 176.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.2 -177.35 4.92 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.08 0.952 . . . . 64.31 109.374 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.18 128.22 35.57 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.269 -0.641 . . . . 63.42 109.269 173.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 69.38 2.42 3.7 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.204 1.402 . . . . 74.33 112.309 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.87 116.43 52.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 123.923 0.889 . . . . 74.12 109.389 -177.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.16 125.59 23.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.987 0.915 . . . . 74.24 108.678 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -93.83 145.39 24.64 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.632 -0.877 . . . . 63.22 108.632 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -111.58 138.26 40.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.995 -1.113 . . . . 71.44 107.995 172.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -114.73 106.78 21.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.021 -1.103 . . . . 72.4 108.021 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.7 tp -88.09 105.91 17.81 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.656 -0.868 . . . . 74.35 108.656 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.74 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 59.1 mtt85 -83.75 121.94 27.98 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.838 -0.801 . . . . 74.44 108.838 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.613 HG23 ' HB1' ' A' ' 110' ' ' ALA . 2.1 m -127.61 101.52 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.644 -0.873 . . . . 75.03 108.644 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 86.6 m -98.13 108.54 21.27 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.344 1.057 . . . . 75.32 109.87 -175.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.0 t -103.03 113.65 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.42 -0.585 . . . . 54.31 109.42 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.9 m -123.6 107.05 11.09 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.071 -0.714 . . . . 72.1 109.071 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.25 125.1 53.79 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.977 -0.749 . . . . 64.43 108.977 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.4 p -120.95 130.38 53.83 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.535 0.734 . . . . 70.44 110.161 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.477 HD21 ' H ' ' A' ' 68' ' ' LEU . 2.7 pt? -90.4 48.31 1.54 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 122.278 1.037 . . . . 72.04 109.661 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.78 -125.34 6.36 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 114.915 -1.039 . . . . 52.52 111.071 -170.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.27 -28.34 23.83 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 117.48 0.64 . . . . 75.31 109.73 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -86.12 134.5 33.81 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.85 0.86 . . . . 74.12 110.571 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 m -74.72 133.4 42.04 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.649 0.593 . . . . 62.33 109.869 172.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.83 -51.88 9.1 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.891 0.877 . . . . 71.3 108.963 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -155.92 157.08 35.7 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.447 -1.252 . . . . 74.44 111.551 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 62.8 tp -121.97 109.76 14.99 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.403 -1.332 . . . . 75.2 107.403 166.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 80.1 m -107.28 97.36 7.13 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.939 -1.134 . . . . 72.33 107.939 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -122.13 115.8 23.08 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.36 -0.978 . . . . 61.44 108.36 -173.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.7 t -126.22 136.11 61.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.49 -0.777 . . . . 73.13 109.184 -172.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 24.5 mt-30 -110.28 91.17 3.55 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.826 -0.805 . . . . 64.24 108.826 167.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -77.18 113.17 14.63 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.867 -1.16 . . . . 63.15 107.867 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.72 142.19 16.12 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 112.198 -0.361 . . . . 60.11 112.198 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.41 141.54 10.86 Favored Glycine 0 CA--C 1.505 -0.557 0 N-CA-C 110.743 -0.943 . . . . 75.02 110.743 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.478 ' HB ' ' HB3' ' A' ' 14' ' ' GLN . 36.2 mt -88.63 124.45 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.868 -0.79 . . . . 74.44 108.868 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.616 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 39.0 m-85 -129.3 128.97 44.27 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.706 0.802 . . . . 74.04 109.522 -171.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.2 t -89.05 120.84 30.82 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.912 -0.774 . . . . 64.13 108.912 174.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.1 pt -95.84 129.24 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.437 0.695 . . . . 74.25 109.898 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.03 158.9 7.34 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.934 0.894 . . . . 71.41 111.164 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.513 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 103.18 -33.38 6.63 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 115.771 -0.649 . . . . 72.15 113.494 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.556 HD13 ' HG2' ' A' ' 9' ' ' MET . 0.2 OUTLIER -137.62 170.7 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.837 0.855 . . . . 72.3 109.905 -177.25 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.95 173.33 11.61 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.524 0.73 . . . . 70.14 109.449 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.28 -145.09 43.81 Favored Glycine 0 C--N 1.351 1.387 0 C-N-CA 122.648 0.166 . . . . 53.41 113.498 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.517 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 23.3 p -72.64 -14.85 61.69 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.802 0.841 . . . . 73.15 111.921 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -68.07 -38.36 82.3 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.968 -0.753 . . . . 70.44 108.968 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.464 ' SD ' HG22 ' E' ' 451' ' ' VAL . 38.1 ttp -82.93 -35.49 26.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.485 0.714 . . . . 70.15 111.054 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.517 ' HB1' ' HA ' ' A' ' 92' ' ' THR . . . -63.21 -26.5 68.83 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.942 0.497 . . . . 73.51 110.631 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -66.38 -50.35 63.78 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.502 1.121 . . . . 74.31 110.506 169.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 71.0 m -67.2 -27.31 67.15 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.852 0.461 . . . . 73.03 112.1 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.88 -41.82 12.95 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.14 0.976 . . . . 74.02 109.589 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.84 2.18 56.9 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-O 119.469 -0.628 . . . . 75.43 114.585 -171.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.417 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -138.37 -62.06 0.58 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.608 0.704 . . . . 73.02 111.262 -177.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -62.75 -49.72 73.91 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.729 0.812 . . . . 73.22 111.736 -175.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 89.6 m -71.1 -39.64 8.49 Favored Pre-proline 0 CA--C 1.571 1.76 0 N-CA-C 114.101 1.148 . . . . 62.13 114.101 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.38 -24.4 50.09 Favored 'Trans proline' 0 C--N 1.387 2.571 0 CA-C-N 121.742 1.658 . . . . 74.53 112.826 167.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -27.57 61.76 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.907 -0.405 . . . . 75.05 109.907 177.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.8 mm -60.25 -40.7 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.911 0.884 . . . . 73.44 109.818 170.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.5 mt -80.07 -17.22 53.25 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.066 0.947 . . . . 74.03 112.338 -175.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -63.75 -45.22 81.78 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 113.916 1.08 . . . . 71.44 113.916 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.46 -39.51 65.36 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 121.596 1.53 . . . . 73.34 112.701 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -69.47 -38.48 77.73 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.379 0.672 . . . . 75.14 111.085 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.613 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . -66.85 -41.73 86.87 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.816 -0.629 . . . . 63.24 110.39 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.561 ' HA ' HD21 ' A' ' 128' ' ' LEU . 40.9 ttm180 -54.78 -50.47 68.41 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 124.7 1.25 . . . . 74.13 110.29 177.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -63.65 -42.69 98.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.485 1.116 . . . . 73.32 111.397 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 117' ' ' MET . 27.6 t -60.93 -37.4 82.18 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 123.695 0.622 . . . . 71.35 110.61 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.61 -43.05 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.483 1.113 . . . . 74.42 110.561 176.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 125' ' ' GLN . 24.0 m -61.6 -33.99 74.86 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.731 0.776 . . . . 74.04 109.94 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.7 t -70.93 -40.09 72.27 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.712 -1.131 . . . . 74.33 109.864 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.585 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 18.4 mmt -59.08 -48.38 81.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.308 0.643 . . . . 74.21 111.626 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.1 m -68.13 -42.14 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 O-C-N 123.448 0.467 . . . . 74.34 111.43 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.9 m -69.01 -35.71 76.97 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.054 0.541 . . . . 72.22 111.692 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.506 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 95.2 mtt-85 -70.55 -35.19 72.98 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.896 0.479 . . . . 72.13 110.029 175.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.14 19.72 20.65 Favored Glycine 0 C--N 1.354 1.57 0 CA-C-O 119.14 -0.811 . . . . 75.05 114.32 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' B' ' 17' ' ' TYR . 2.4 t 61.4 10.73 3.3 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 127.16 2.184 . . . . 63.44 114.311 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -86.52 150.54 51.5 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 108.542 -0.91 . . . . 72.21 108.542 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.55 159.03 21.29 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.395 2.063 . . . . 74.13 112.2 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.409 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.1 tt0 -60.83 142.97 55.65 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.071 0.549 . . . . 72.03 112.308 -177.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.3 tp -128.15 121.8 30.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.117 0.967 . . . . 74.34 109.938 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -124.7 109.66 13.4 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.681 -0.859 . . . . 74.04 108.681 173.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.649 ' H ' HD22 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -73.23 126.34 29.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 109.101 -0.703 . . . . 75.42 109.101 173.662 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.13 151.22 27.1 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 124.895 1.278 . . . . 63.13 112.715 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 110.23 0.65 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.805 2.337 . . . . 73.14 112.54 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 81.7 t -99.37 113.09 33.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.072 -1.084 . . . . 75.02 108.072 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -85.27 81.65 8.7 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.433 -0.951 . . . . 73.5 108.433 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -56.27 -31.9 64.02 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.456 0.702 . . . . 72.3 111.407 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 9.8 t70 -63.31 -48.3 78.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.546 1.138 . . . . 73.3 110.706 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.69 92.61 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.994 0.918 . . . . 72.1 111.445 176.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.7 mt -69.53 -34.6 74.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.731 0.812 . . . . 70.02 111.878 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.96 -38.48 79.44 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.652 -0.87 . . . . 72.03 108.652 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.414 ' SD ' HD23 ' A' ' 141' ' ' LEU . 10.4 mmt -60.35 -43.58 96.37 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 124.109 0.881 . . . . 75.22 111.195 177.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -58.47 -36.96 74.52 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.279 0.632 . . . . 72.31 110.853 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -77.87 -33.25 52.18 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.652 1.181 . . . . 71.4 111.216 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.414 HD23 ' SD ' ' A' ' 138' ' ' MET . 56.0 tp -69.6 -52.17 28.5 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.556 1.143 . . . . 74.14 111.6 -173.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 172.12 -15.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.747 1.219 . . . . 74.23 110.899 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -69.92 159.65 33.31 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 122.032 0.92 . . . . 74.35 111.771 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -147.69 -32.7 0.27 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 113.837 -1.529 . . . . 74.03 108.811 -173.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.77 -42.54 33.69 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.451 -1.25 . . . . 61.13 112.081 -173.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.28 -133.27 2.85 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.974 -0.348 . . . . 71.31 113.092 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -65.64 -43.99 87.78 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.155 0.982 . . . . 65.35 110.332 -176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.74 151.52 12.58 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 114.635 -1.166 . . . . 70.24 111.138 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.1 m -125.26 9.89 7.99 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 121.489 0.661 . . . . 74.32 109.281 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -80.25 151.7 29.47 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.844 0.858 . . . . 75.33 111.007 -170.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 71.53 178.5 0.25 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.066 1.346 . . . . 75.42 113.326 -175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -141.65 177.89 7.84 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.647 -1.615 . . . . 73.02 108.403 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -75.01 85.64 2.3 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.896 -1.15 . . . . 72.2 107.896 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.28 -48.2 44.22 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.594 -0.73 . . . . 72.33 109.759 -177.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-N 115.205 -0.907 . . . . 72.04 108.942 170.495 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.504 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.556 0.217 . . . . 74.22 110.594 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.7 t -120.01 128.22 53.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.457 0.703 . . . . 52.51 109.679 176.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.559 ' HG3' HE21 ' B' ' 4' ' ' GLN . 11.7 pt-20 -57.0 -25.96 59.38 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.469 1.108 . . . . 72.45 112.479 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.559 HE21 ' HG3' ' B' ' 3' ' ' GLU . 31.4 mm-40 -70.93 -24.67 62.49 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.992 0.917 . . . . 70.55 112.336 -176.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 32.99 78.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 125.923 1.689 . . . . 75.11 113.679 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -72.6 -171.63 0.85 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.069 1.347 . . . . 75.44 109.528 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.403 HG23 ' HB1' ' D' ' 135' ' ' ALA . 9.9 t -77.26 63.41 2.48 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 123.27 1.51 . . . . 71.41 109.162 169.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -110.13 -149.65 0.45 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.874 -1.512 . . . . 75.31 108.763 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.592 ' HB3' HG22 ' B' ' 89' ' ' ILE . 23.2 ptm 57.18 -173.73 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 125.594 1.558 . . . . 75.45 114.396 170.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 85.0 m -135.4 108.62 7.75 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.544 -0.91 . . . . 64.21 108.544 172.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -114.42 143.25 45.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.215 0.606 . . . . 65.14 109.848 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -149.72 140.81 22.99 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.289 0.636 . . . . 75.34 109.749 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.64 123.49 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.75 -1.204 . . . . 65.23 107.75 172.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 14.0 mm100 -86.23 -50.65 6.81 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.233 -0.654 . . . . 75.41 109.233 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -170.12 133.24 1.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.508 -0.769 . . . . 74.51 109.704 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.04 138.76 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 107.87 -1.159 . . . . 74.32 107.87 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.413 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 33.7 p90 -165.11 164.65 20.27 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 122.304 1.049 . . . . 73.03 112.379 -177.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 74.3 m -87.73 130.08 34.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.938 -1.483 . . . . 73.41 108.063 169.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -98.02 -36.62 10.06 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.381 0.672 . . . . 72.02 110.302 178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -149.99 132.21 15.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.814 -0.63 . . . . 72.11 110.545 -170.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.45 HD12 HG21 ' B' ' 78' ' ' VAL . 48.8 mm -128.3 141.97 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.116 0.966 . . . . 75.43 108.553 171.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -142.34 130.67 22.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.227 -1.397 . . . . 73.41 107.227 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.404 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.0 t80 -144.99 109.85 5.06 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.585 -1.265 . . . . 74.51 107.585 170.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -120.89 123.42 42.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.54 -0.911 . . . . 72.03 108.54 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.96 87.16 2.25 Favored Pre-proline 0 C--O 1.242 0.68 0 N-CA-C 106.722 -1.584 . . . . 53.13 106.722 171.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.85 -36.1 19.26 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.639 2.226 . . . . 74.02 112.735 -165.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -110.83 22.25 15.57 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.86 0.864 . . . . 64.13 110.423 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.522 ' HB1' ' HD3' ' B' ' 29' ' ' PRO . . . -36.29 -64.93 0.34 Allowed Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 115.195 1.554 . . . . 54.22 115.195 -162.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.522 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 16.7 Cg_exo -66.21 -30.28 46.28 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 121.828 1.685 . . . . 75.44 112.682 -173.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.417 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 65.8 m80 -93.32 -15.87 25.29 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.373 -0.831 . . . . 74.42 112.284 -174.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.609 HG23 HD13 ' B' ' 68' ' ' LEU . 7.5 p -85.93 -30.12 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 117.93 0.332 . . . . 74.52 110.529 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -61.2 -19.54 61.73 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.742 0.817 . . . . 75.12 113.081 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.1 pt20 -64.85 -15.7 62.22 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.99 0.516 . . . . 75.43 111.594 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.621 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 94.3 mttt -99.57 97.58 8.55 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.109 0.964 . . . . 73.14 109.024 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -79.65 91.72 5.28 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.281 0.563 . . . . 74.05 109.796 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -164.36 159.81 20.13 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.322 1.049 . . . . 72.43 108.993 -174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.42 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 13.8 pm0 -82.52 109.74 17.93 Favored Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 109.217 -0.661 . . . . 72.21 109.217 173.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.507 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 35.3 Cg_endo -62.41 127.38 20.75 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.815 2.343 . . . . 64.24 113.074 -171.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -56.73 120.16 7.37 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.294 0.996 . . . . 74.31 110.969 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.458 HG13 HD12 ' B' ' 126' ' ' LEU . 29.6 m -96.18 163.03 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.159 -0.928 . . . . 72.41 113.19 -168.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.543 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 81.8 tttt -148.88 137.46 21.19 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.982 1.713 . . . . 75.24 107.512 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.25 131.41 52.74 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.119 -0.697 . . . . 73.35 109.119 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.557 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.8 t70 -124.29 110.71 14.95 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 106.697 -1.594 . . . . 73.43 106.697 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.42 ' HB2' HD22 ' F' ' 460' ' ' LEU . 0.5 OUTLIER -114.98 129.26 56.68 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.832 -0.803 . . . . 74.21 108.832 -165.422 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 20.7 m-20 -130.65 112.79 13.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.035 0.534 . . . . 73.12 109.841 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 28.6 p -107.15 102.27 11.61 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.217 -1.031 . . . . 74.24 108.217 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.19 119.15 26.74 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.241 1.016 . . . . 73.23 109.321 -174.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.58 ' HG ' HD11 ' F' ' 454' ' ' LEU . 16.6 p -100.3 161.62 13.49 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.615 0.766 . . . . 73.01 109.931 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 81.2 p -151.07 137.21 18.35 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.5 0.72 . . . . 64.11 109.355 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -81.9 118.35 22.87 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.206 0.602 . . . . 74.42 109.788 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.17 -43.72 15.86 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.959 -0.756 . . . . 73.15 108.959 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.64 177.37 11.3 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.186 -1.37 . . . . 63.23 108.923 174.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.92 130.78 43.76 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.895 -0.78 . . . . 65.22 108.895 178.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 75.28 -4.45 2.37 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 125.056 1.343 . . . . 71.54 112.424 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -117.56 109.18 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.759 0.824 . . . . 75.41 109.332 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -125.56 138.61 53.96 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.401 -0.592 . . . . 74.35 109.401 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -119.07 107.09 13.07 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.092 -1.077 . . . . 72.32 108.092 -172.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' B' ' 48' ' ' SER . 85.8 t -94.3 135.13 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.991 0.916 . . . . 74.21 110.617 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.15 130.08 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.385 -0.969 . . . . 74.33 108.385 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.84 112.81 23.34 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.112 -1.07 . . . . 74.34 108.112 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.4 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 36.8 ttm180 -99.83 127.49 45.99 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.412 0.685 . . . . 73.12 109.829 173.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.456 ' HB ' HD11 ' B' ' 114' ' ' ILE . 46.0 t -123.12 102.64 11.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 106.67 -1.604 . . . . 75.42 106.67 167.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.5 m -99.44 126.25 45.32 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.346 -0.613 . . . . 75.32 109.346 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.556 HG22 HG21 ' B' ' 114' ' ' ILE . 60.3 t -108.94 105.43 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 123.298 0.639 . . . . 70.31 109.721 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 42.0 m -84.02 137.42 33.61 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.966 -1.124 . . . . 62.22 107.966 167.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.434 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -149.02 143.43 26.09 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.51 0.324 . . . . 54.3 110.182 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 49.4 p -146.0 134.23 21.7 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.579 0.549 . . . . 71.21 111.373 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.609 HD13 HG23 ' B' ' 31' ' ' VAL . 39.2 mt -93.35 109.94 21.49 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.511 -0.922 . . . . 62.21 108.511 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.67 -108.8 2.6 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.866 -1.061 . . . . 71.03 111.713 -170.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.95 3.97 10.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.045 0.938 . . . . 75.53 111.905 -175.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.621 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 10.5 pt-20 -115.03 149.78 36.92 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.436 -0.579 . . . . 74.53 109.436 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.2 m -67.31 133.26 49.33 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.936 0.398 . . . . 54.35 111.161 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.471 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -90.46 -64.07 1.19 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.962 -1.017 . . . . 74.53 109.234 176.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -150.02 154.68 38.6 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.316 -0.856 . . . . 73.34 110.393 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.0 mt -128.79 110.77 12.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.669 -1.604 . . . . 74.45 106.669 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.9 t -117.57 155.69 29.38 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.856 -0.794 . . . . 75.22 108.856 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -163.55 130.67 3.39 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.836 -0.801 . . . . 74.54 108.836 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.45 HG21 HD12 ' B' ' 21' ' ' ILE . 88.3 t -124.07 141.32 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.593 -0.891 . . . . 73.32 108.593 172.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -123.04 88.42 2.92 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.89 -0.782 . . . . 64.13 108.89 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -79.76 100.82 8.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.141 -0.936 . . . . 72.13 109.102 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.31 143.69 16.88 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.744 -0.542 . . . . 74.42 111.744 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.546 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -145.81 127.13 2.72 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.135 -0.786 . . . . 70.51 111.135 -172.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 14.3 mt -91.2 129.68 41.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 123.918 0.887 . . . . 72.01 108.617 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -137.71 133.68 34.47 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.889 -0.782 . . . . 63.35 108.889 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.8 m -93.42 109.19 20.77 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.953 -0.758 . . . . 71.3 108.953 172.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 pt -112.92 117.83 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.228 1.011 . . . . 71.22 109.118 -174.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.549 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -129.84 152.72 49.02 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.18 0.592 . . . . 61.21 110.791 -175.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.43 -60.22 4.32 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.824 0.702 . . . . 73.31 112.522 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.592 HG22 ' HB3' ' B' ' 9' ' ' MET . 2.8 pp -67.12 145.29 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.351 0.661 . . . . 74.33 112.391 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.402 ' HA ' ' HB3' ' B' ' 94' ' ' MET . 16.2 tt0 -166.32 174.51 9.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.186 0.595 . . . . 74.54 109.561 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.6 -112.29 3.91 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 112.217 -0.353 . . . . 75.55 112.217 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' B' ' 95' ' ' ALA . 31.6 m -78.13 -29.53 48.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.142 0.496 . . . . 74.4 110.742 176.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -69.99 -33.81 72.53 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.34 -0.391 . . . . 74.02 110.575 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.503 ' HB2' HG12 ' F' ' 452' ' ' VAL . 0.0 OUTLIER -74.86 -30.81 61.46 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.957 -0.565 . . . . 71.25 110.212 178.391 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' B' ' 92' ' ' THR . . . -59.83 -38.45 82.05 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.45 0.7 . . . . 74.52 110.032 171.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -76.08 -36.31 59.01 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.284 1.034 . . . . 71.35 111.608 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.64 -57.36 6.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 123.593 0.558 . . . . 65.13 109.846 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.3 mp -79.62 -15.83 56.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.94 0.496 . . . . 75.22 111.521 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.39 -15.02 48.98 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.41 0.524 . . . . 65.24 114.41 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.35 -56.74 0.32 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 117.341 0.57 . . . . 64.23 111.879 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -68.5 -52.56 30.97 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.835 0.854 . . . . 73.52 112.001 -167.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.414 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 92.2 m -63.04 -49.07 83.05 Favored Pre-proline 0 CA--C 1.565 1.542 0 C-N-CA 124.319 1.047 . . . . 74.31 112.13 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.0 Cg_exo -58.49 -34.07 98.48 Favored 'Trans proline' 0 C--N 1.398 3.15 0 C-N-CA 122.095 1.864 . . . . 74.33 113.559 171.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.24 -37.62 83.72 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.374 0.67 . . . . 75.25 111.747 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 45.4 mt -63.9 -41.72 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.843 0.857 . . . . 73.41 110.759 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.546 HD21 ' HA3' ' B' ' 82' ' ' GLY . 51.2 mt -80.19 -19.91 45.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.348 1.059 . . . . 63.44 112.311 -173.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -59.7 -49.38 92.1 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.278 1.214 . . . . 75.51 114.278 -171.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -61.67 -33.7 85.58 Favored 'Trans proline' 0 C--N 1.381 2.258 0 CA-C-N 121.452 1.554 . . . . 73.34 112.618 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.411 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 84.5 m-85 -68.06 -46.0 72.3 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 123.662 0.601 . . . . 74.35 110.087 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.25 -47.1 84.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.521 0.729 . . . . 73.24 110.22 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -54.26 -55.36 28.97 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.129 1.372 . . . . 75.32 111.581 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.02 -35.04 79.48 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.854 0.721 . . . . 75.01 110.389 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.506 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 6.8 t -69.03 -37.63 78.73 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.95 -0.568 . . . . 74.32 111.227 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.556 HG21 HG22 ' B' ' 64' ' ' VAL . 58.5 mt -63.2 -55.33 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.715 -0.476 . . . . 74.14 109.715 174.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.509 HG22 ' OG ' ' C' ' 119' ' ' SER . 18.9 m -59.0 -34.01 71.36 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 124.468 1.105 . . . . 74.42 111.404 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.5 t -57.98 -52.21 66.46 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.423 -0.808 . . . . 75.24 109.503 174.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 9.9 mmt -66.83 -38.19 85.95 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.333 0.653 . . . . 74.44 111.748 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 114' ' ' ILE . 91.2 t -58.9 -46.12 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.087 0.955 . . . . 73.32 110.303 176.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 45.3 t -70.99 -33.06 70.05 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.605 -1.18 . . . . 74.23 111.433 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' B' ' 116' ' ' SER . 90.8 mtt-85 -63.84 -36.84 85.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.106 0.563 . . . . 74.44 110.089 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.1 14.32 53.94 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-O 119.43 -0.65 . . . . 73.31 113.322 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 82.5 p 55.93 26.9 10.35 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.917 1.687 . . . . 73.1 113.636 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -87.06 153.01 54.07 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 123.609 0.764 . . . . 74.22 110.55 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.42 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 89.1 Cg_exo -51.55 161.06 2.16 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 124.17 3.247 . . . . 72.44 115.271 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.441 HE21 ' ND2' ' B' ' 127' ' ' ASN . 63.7 tp60 -63.05 140.56 58.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.925 0.89 . . . . 74.53 111.982 -171.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.551 HD23 HG13 ' B' ' 64' ' ' VAL . 13.7 tp -146.05 117.67 8.07 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.906 -0.588 . . . . 75.12 109.433 -173.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.441 ' ND2' HE21 ' B' ' 125' ' ' GLN . 26.4 m-80 -130.98 135.12 47.34 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.422 0.689 . . . . 74.35 110.06 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.73 130.87 34.31 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.825 0.85 . . . . 72.13 110.012 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.75 152.53 59.89 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.247 1.019 . . . . 63.54 111.285 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.436 ' HB2' HD13 ' D' ' 13' ' ' ILE . 20.5 Cg_exo -65.94 133.58 34.09 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.701 2.267 . . . . 74.01 112.81 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.1 t -121.22 115.12 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.126 -1.064 . . . . 73.34 108.126 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.418 ' ND2' ' HB3' ' B' ' 135' ' ' ALA . 64.1 t30 -80.45 82.23 6.53 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 109.684 -0.487 . . . . 75.12 109.684 -178.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -60.15 -27.24 66.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.882 0.873 . . . . 74.31 111.325 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -54.6 -47.74 73.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.986 1.314 . . . . 72.44 111.365 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.418 ' HB3' ' ND2' ' B' ' 132' ' ' ASN . . . -66.87 -37.95 85.41 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.706 -0.679 . . . . 64.55 111.274 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.19 -19.06 60.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.551 0.74 . . . . 74.35 111.317 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.654 ' CE1' HD12 ' B' ' 141' ' ' LEU . 66.3 t80 -67.16 -26.4 66.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.932 0.493 . . . . 73.33 111.51 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 26.2 mmt -63.08 -35.96 81.99 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.348 0.594 . . . . 73.12 110.248 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.455 ' N ' HD21 ' B' ' 139' ' ' ASN . 0.7 OUTLIER -79.06 -17.43 55.25 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.129 -0.941 . . . . 75.04 110.717 -178.352 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . 0.572 ' HB2' ' HE1' ' F' ' 461' ' ' PHE . 46.2 t80 -68.43 -25.94 65.27 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.841 0.856 . . . . 75.4 111.496 174.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.654 HD12 ' CE1' ' B' ' 137' ' ' PHE . 15.3 mt -110.66 -6.58 14.8 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.97 0.908 . . . . 75.32 111.771 -168.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -155.61 137.09 14.09 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 123.415 0.447 . . . . 72.2 109.809 -173.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -70.48 80.72 0.57 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.794 0.807 . . . . 73.14 109.807 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -144.38 179.01 7.52 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.587 0.755 . . . . 72.35 110.647 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.42 151.82 29.45 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.335 -0.848 . . . . 74.23 109.719 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.07 174.63 51.15 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 116.084 -0.507 . . . . 74.54 112.197 171.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -100.82 152.79 20.09 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.448 0.699 . . . . 73.3 110.259 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.34 -163.47 34.67 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.099 -0.5 . . . . 72.21 113.445 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 58.6 m -140.03 -60.02 0.54 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.444 -0.947 . . . . 64.41 108.444 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 68.05 -65.16 0.26 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.713 1.605 . . . . 75.02 112.378 174.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -70.17 132.83 46.38 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.562 0.745 . . . . 73.24 110.105 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -130.16 151.79 50.3 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.266 0.626 . . . . 72.31 109.454 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -76.08 92.66 3.22 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.433 0.635 . . . . 73.22 109.762 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -81.72 92.89 6.69 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.769 -1.105 . . . . 73.02 109.675 -175.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 C-N-CA 123.896 0.879 . . . . 73.13 108.988 -177.603 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.632 -0.507 . . . . 75.11 109.632 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m -145.32 121.82 11.03 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.877 0.871 . . . . 73.02 109.158 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.03 33.46 0.91 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.377 0.671 . . . . 53.11 109.795 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.431 ' HB2' ' HA ' ' C' ' 7' ' ' THR . 42.3 mt-30 69.67 -165.77 0.17 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.979 1.312 . . . . 75.22 110.633 -172.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -101.07 -72.06 0.69 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.37 0.668 . . . . 75.0 109.4 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -86.51 -12.83 47.75 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.457 0.703 . . . . 73.54 110.512 175.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.431 ' HA ' ' HB2' ' C' ' 4' ' ' GLN . 2.7 m 63.22 32.92 14.67 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 124.569 1.148 . . . . 71.54 112.359 173.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.06 26.57 9.41 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.618 0.767 . . . . 63.43 112.112 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 55.4 ttp 66.39 136.63 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.823 1.249 . . . . 74.24 113.252 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -86.96 99.7 12.07 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 108.268 -1.012 . . . . 52.13 108.268 170.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.5 ' HD1' ' HH ' ' C' ' 101' ' ' TYR . 1.7 t80 -118.77 126.69 52.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.413 0.685 . . . . 64.43 109.743 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -146.59 133.58 20.28 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 109.111 -0.7 . . . . 73.4 109.111 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -71.95 118.73 17.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.351 -0.981 . . . . 75.23 108.351 170.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.628 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 29.8 mm-40 -83.49 -49.22 9.49 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.415 0.447 . . . . 71.43 109.969 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -169.51 127.15 0.93 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 116.382 -0.372 . . . . 75.52 110.524 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -107.85 148.76 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 107.867 -1.161 . . . . 73.33 107.867 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.419 ' CE2' ' HG2' ' C' ' 19' ' ' LYS . 32.1 p90 -174.53 167.8 3.85 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.401 0.619 . . . . 74.44 111.223 -174.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.1 p -96.55 111.62 23.68 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.135 -1.061 . . . . 64.14 108.135 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.419 ' HG2' ' CE2' ' C' ' 17' ' ' TYR . 19.0 mttt -68.77 -47.6 65.79 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.812 -1.181 . . . . 71.33 107.812 170.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.631 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.2 t70 -133.55 139.68 46.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 113.558 -1.655 . . . . 65.23 109.69 -169.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 75.6 mt -140.97 143.78 27.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.898 -1.89 . . . . 72.23 105.898 174.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.0 t -158.09 148.46 20.42 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.278 -0.638 . . . . 72.41 109.278 173.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -147.64 130.95 16.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.122 -1.436 . . . . 70.2 107.122 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -133.47 126.47 31.2 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.001 0.52 . . . . 64.34 109.731 -176.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.39 80.86 18.56 Favored Pre-proline 0 C--O 1.242 0.705 0 N-CA-C 106.683 -1.599 . . . . 74.42 106.683 168.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.48 -12.49 29.5 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.73 2.286 . . . . 64.53 112.083 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -121.11 25.0 9.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.474 1.51 . . . . 72.43 109.628 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.447 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -46.38 -55.78 12.94 Favored Pre-proline 0 CA--C 1.563 1.46 0 N-CA-C 114.093 1.146 . . . . 71.44 114.093 -168.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 51.4 Cg_exo -56.67 -41.24 77.87 Favored 'Trans proline' 0 C--N 1.385 2.485 0 CA-C-N 121.829 1.689 . . . . 75.0 112.888 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -69.3 -33.76 73.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.082 -0.508 . . . . 74.43 112.091 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.4 p -79.03 -24.52 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 112.716 0.636 . . . . 75.15 112.716 176.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -67.34 -30.64 70.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.877 -0.514 . . . . 74.55 112.278 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -87.5 34.11 0.7 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.245 0.618 . . . . 72.25 111.071 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.404 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.1 OUTLIER -124.54 153.8 41.56 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.568 0.747 . . . . 73.41 111.534 -172.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.5 118.06 13.84 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.709 -0.849 . . . . 73.55 108.709 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.513 ' HE1' ' HB3' ' G' ' 470' ' ' LEU . 74.9 t-105 -77.8 99.15 5.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.438 0.695 . . . . 73.11 110.681 -176.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -156.21 74.6 4.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.851 -0.796 . . . . 63.42 108.851 171.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -92.36 161.76 3.04 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.882 2.388 . . . . 75.34 114.029 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.37 95.38 10.18 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.766 -1.198 . . . . 63.23 107.766 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.4 t -80.26 98.48 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 115.358 -0.837 . . . . 74.15 109.841 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -106.77 110.11 22.19 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.405 -0.961 . . . . 74.22 108.405 174.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 mp -85.77 144.65 27.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.249 -1.76 . . . . 74.12 106.249 167.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -123.88 111.94 16.66 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.708 -0.849 . . . . 73.22 108.708 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 90.8 mt -93.88 142.01 27.86 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.082 0.553 . . . . 72.0 110.032 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.2 t70 -157.79 161.14 38.4 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.65 1.18 . . . . 71.21 108.343 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.1 t -146.57 135.0 21.95 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.028 0.442 . . . . 72.42 110.491 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.83 156.25 32.33 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.221 1.008 . . . . 72.02 108.738 172.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.458 ' HB2' ' CE2' ' C' ' 56' ' ' TYR . 63.8 p -160.74 151.99 19.1 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.334 0.253 . . . . 74.44 111.563 -173.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -161.21 142.66 11.7 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.847 0.859 . . . . 73.55 110.307 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.24 136.34 39.68 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.776 -0.453 . . . . 72.54 109.776 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.599 HD12 ' HB2' ' C' ' 57' ' ' GLU . 39.8 mt -108.95 -44.97 3.87 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.346 0.658 . . . . 74.32 109.701 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.41 -173.07 3.84 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.669 -0.696 . . . . 71.11 111.045 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -67.86 108.59 3.05 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.136 -0.938 . . . . 74.44 110.392 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 63.42 24.65 14.24 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.792 1.237 . . . . 70.34 111.512 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.29 114.47 45.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.361 -0.977 . . . . 74.23 108.361 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' C' ' 48' ' ' SER . 35.5 t80 -126.22 124.99 41.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.564 -0.902 . . . . 74.12 108.564 -176.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.599 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.9 tt0 -82.09 141.64 32.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.027 -0.988 . . . . 74.32 109.929 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.28 142.22 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.487 1.115 . . . . 70.25 108.196 169.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.08 133.33 60.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.836 -0.801 . . . . 65.42 108.836 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.43 114.88 29.33 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.911 -1.144 . . . . 75.34 107.911 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 41.5 ttm-85 -99.29 117.53 33.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.033 -0.729 . . . . 74.42 109.033 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.4 t -118.57 133.57 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.299 -1.001 . . . . 75.22 108.299 172.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 14.8 m -131.55 114.85 15.36 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.258 -0.645 . . . . 72.43 109.258 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.526 HG11 HD21 ' C' ' 126' ' ' LEU . 21.8 t -99.51 128.84 50.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.847 -0.798 . . . . 73.45 108.847 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.1 m -122.87 140.4 53.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.803 -1.184 . . . . 74.53 107.803 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . 0.435 ' HB3' ' HB1' ' C' ' 73' ' ' ALA . . . -132.03 113.13 13.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.763 -1.199 . . . . 71.31 107.763 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.2 m -113.69 122.58 47.57 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.356 0.598 . . . . 74.13 110.173 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.4 HD11 ' HG2' ' C' ' 34' ' ' LYS . 18.7 mt -92.1 24.63 3.2 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.042 1.337 . . . . 75.32 109.52 175.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.1 -108.52 2.6 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 110.569 -1.012 . . . . 71.43 110.569 -170.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.63 -27.37 20.22 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.587 0.755 . . . . 73.33 110.276 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.404 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 7.5 tp10 -79.42 119.26 22.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.685 0.794 . . . . 74.13 109.331 174.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 39.4 m -87.53 130.81 34.59 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.159 -0.682 . . . . 74.0 109.159 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.585 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.79 -61.61 1.75 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.249 0.619 . . . . 74.22 110.613 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -156.92 170.52 22.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.54 -0.755 . . . . 74.35 110.858 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -142.47 116.82 9.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.216 -1.401 . . . . 71.2 107.216 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.43 ' SG ' HG21 ' C' ' 114' ' ' ILE . 48.9 t -124.78 119.35 28.64 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.079 0.552 . . . . 74.04 109.751 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -121.94 125.67 46.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.684 0.394 . . . . 71.04 110.019 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.87 137.19 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.01 0.924 . . . . 65.5 108.817 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.631 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.9 mt-30 -115.56 95.41 5.14 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.635 -0.876 . . . . 74.03 108.635 172.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -79.71 100.25 7.8 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.626 -1.17 . . . . 74.21 110.081 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.45 149.34 27.32 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 116.194 -0.457 . . . . 75.55 112.071 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.481 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -157.03 122.2 1.15 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 111.713 -0.555 . . . . 72.22 111.713 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.628 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.9 mm -88.99 124.52 41.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.788 -0.819 . . . . 75.23 108.788 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.492 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 53.0 m-85 -131.44 118.82 20.75 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.074 0.549 . . . . 74.41 109.945 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 66.8 m -80.9 118.72 22.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.777 -0.823 . . . . 75.5 108.777 171.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 pp -135.05 141.32 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.849 0.86 . . . . 74.23 110.119 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.0 142.87 17.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.176 0.59 . . . . 53.41 110.522 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.94 -23.43 35.65 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.506 0.504 . . . . 75.23 114.264 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.461 HD11 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -89.82 153.55 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.451 0.7 . . . . 73.24 110.813 178.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -160.06 -179.07 7.46 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.344 -0.844 . . . . 72.54 110.221 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.85 -112.44 3.81 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.864 0.728 . . . . 52.24 114.249 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.422 HG21 ' HB2' ' C' ' 145' ' ' ALA . 21.2 p -68.89 -43.02 76.14 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.178 0.991 . . . . 72.3 111.292 178.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.47 -37.44 85.13 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.856 -0.611 . . . . 73.44 111.418 -174.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -72.86 -39.96 66.07 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 110.364 -0.235 . . . . 74.35 110.364 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.13 -44.27 92.04 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 123.533 0.52 . . . . 74.44 110.81 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -80.39 -34.05 36.61 Favored 'General case' 0 C--O 1.245 0.864 0 O-C-N 123.411 0.444 . . . . 73.54 112.128 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.467 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 42.4 t -59.3 -37.16 77.03 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 123.425 0.453 . . . . 72.53 110.101 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 32.1 mt -93.94 -22.83 18.34 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.866 0.866 . . . . 75.11 111.033 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -31.65 57.98 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 115.077 0.791 . . . . 72.14 115.077 -172.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.65 -35.43 0.05 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.217 0.451 . . . . 61.21 112.217 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.5 ' HH ' ' HD1' ' C' ' 11' ' ' PHE . 45.5 t80 -60.18 -50.96 71.61 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.442 1.497 . . . . 71.52 112.567 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 61.4 m -75.41 -44.24 4.37 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-O 118.319 -0.848 . . . . 52.4 112.258 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -53.91 -26.71 41.13 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 122.001 1.801 . . . . 72.41 113.66 170.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -68.33 -34.91 76.97 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.514 0.725 . . . . 74.23 111.166 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -64.01 -36.51 77.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.356 0.662 . . . . 72.43 109.983 175.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.481 HD21 ' HA3' ' C' ' 82' ' ' GLY . 63.4 mt -84.94 -15.3 44.85 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.058 . . . . 71.52 112.265 -176.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.33 -48.57 90.88 Favored Pre-proline 0 CA--C 1.56 1.36 0 N-CA-C 114.115 1.154 . . . . 74.11 114.115 -173.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.82 -33.13 76.89 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 121.877 1.718 . . . . 71.3 112.767 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -71.5 -46.69 59.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.612 -0.722 . . . . 71.21 110.327 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.23 -41.9 76.43 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 115.321 -0.854 . . . . 64.24 109.847 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -56.21 -60.34 3.64 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.47 1.106 . . . . 74.41 111.718 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.02 -29.08 68.79 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.941 0.496 . . . . 70.04 111.237 -173.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 24.3 t -69.95 -35.87 74.84 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.009 0.524 . . . . 75.31 111.219 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' C' ' 62' ' ' VAL . 94.9 mt -72.92 -47.24 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.631 0.772 . . . . 74.41 110.036 174.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.0 m -61.0 -34.58 75.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.022 0.929 . . . . 75.54 111.125 -177.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -62.49 -51.72 66.32 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 115.351 -0.84 . . . . 72.43 109.59 174.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.564 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.46 -35.56 76.16 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.626 1.17 . . . . 72.32 112.867 -179.074 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 68.3 t -67.1 -44.99 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.548 0.739 . . . . 74.42 110.465 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.509 ' OG ' HG22 ' B' ' 115' ' ' THR . 47.3 t -66.8 -31.35 71.92 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.733 -0.667 . . . . 71.43 111.186 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -67.29 -46.06 74.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.414 0.686 . . . . 74.31 109.391 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.21 -0.8 67.13 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.683 0.614 . . . . 65.04 113.24 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 34.2 p 64.6 27.96 13.27 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.742 2.017 . . . . 75.31 114.19 170.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -83.73 155.67 65.04 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.529 0.731 . . . . 75.53 109.737 172.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -53.16 173.58 0.15 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 124.072 3.181 . . . . 75.5 115.573 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -55.6 132.97 50.13 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.728 1.211 . . . . 70.43 112.851 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.526 HD21 HG11 ' C' ' 64' ' ' VAL . 17.4 tp -135.14 102.48 5.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.929 -1.137 . . . . 73.04 107.929 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -123.42 126.81 47.46 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.105 0.562 . . . . 73.23 110.221 -175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mp -77.01 117.11 18.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.312 0.645 . . . . 72.04 109.379 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.79 162.36 58.82 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.507 1.123 . . . . 75.12 111.506 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.562 ' HG3' HD13 ' A' ' 16' ' ' ILE . 51.2 Cg_exo -55.19 103.61 0.11 Allowed 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.407 2.071 . . . . 71.3 112.152 169.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 89.0 t -97.99 113.24 32.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.57 0.748 . . . . 75.35 109.533 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -90.68 59.81 4.32 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.669 0.747 . . . . 64.35 110.025 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.415 ' HD1' ' H ' ' C' ' 133' ' ' PHE . 1.2 p90 -78.44 -14.21 59.48 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.214 -0.903 . . . . 64.41 110.066 175.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -75.47 -49.04 20.03 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.642 0.777 . . . . 71.45 109.818 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.66 74.17 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.524 -0.762 . . . . 73.32 110.622 174.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.481 ' HA ' ' ND2' ' C' ' 139' ' ' ASN . 1.2 tt -67.17 -42.8 83.65 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.311 -0.859 . . . . 71.13 110.415 176.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -64.97 -31.45 72.7 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.488 0.315 . . . . 71.5 110.81 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -49.38 65.56 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 122.876 0.471 . . . . 72.41 110.195 -177.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . 0.481 ' ND2' ' HA ' ' C' ' 136' ' ' LEU . 10.4 p30 -71.99 -33.67 68.29 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 122.672 0.389 . . . . 72.43 111.697 177.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -51.41 -80.8 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.318 1.047 . . . . 73.12 109.515 169.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' C' ' 143' ' ' GLN . 27.4 tp 68.66 158.47 0.16 Allowed 'General case' 0 C--N 1.36 1.039 0 C-N-CA 124.889 1.276 . . . . 74.44 111.048 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -152.11 20.54 0.67 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.286 0.565 . . . . 75.12 109.975 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.426 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 9.1 tp-100 -161.86 110.87 1.5 Allowed 'General case' 0 C--N 1.35 0.602 0 CA-C-N 115.621 -0.718 . . . . 75.24 109.675 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -74.94 97.05 3.26 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-O 121.687 0.756 . . . . 75.54 110.04 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' C' ' 92' ' ' THR . . . -158.71 -172.63 3.9 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.334 -0.848 . . . . 72.01 110.531 -172.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 122.43 6.26 8.17 Favored Glycine 0 N--CA 1.474 1.21 0 C-N-CA 123.207 0.432 . . . . 73.42 112.478 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -75.62 94.39 3.19 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.401 0.68 . . . . 71.2 109.411 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 167.5 95.79 0.1 Allowed Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.762 -0.654 . . . . 63.21 111.903 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 84.8 m -141.15 107.16 5.17 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.141 0.976 . . . . 73.12 109.118 176.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -149.31 135.18 18.83 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 122.928 0.491 . . . . 71.25 109.835 175.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.61 101.64 2.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.464 1.106 . . . . 75.23 110.669 -170.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -127.31 116.57 20.74 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.784 0.834 . . . . 74.41 109.241 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -165.26 102.74 0.74 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 106.726 -1.583 . . . . 73.3 106.726 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -104.43 -0.24 28.22 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.957 0.903 . . . . 74.33 110.96 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 C-N-CA 125.468 1.507 . . . . 74.22 111.365 -178.976 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.603 -0.518 . . . . 62.42 109.603 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -173.63 75.65 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.93 -1.137 . . . . 73.32 107.93 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -80.45 119.11 22.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.749 -0.66 . . . . 71.24 110.412 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -135.37 116.21 14.06 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.961 0.905 . . . . 71.35 108.695 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -146.03 137.8 25.02 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.532 0.733 . . . . 75.01 109.702 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -126.8 120.07 28.42 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.232 -1.025 . . . . 73.13 108.232 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -66.51 -28.11 68.3 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.33 0.652 . . . . 73.33 111.322 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.02 1.93 11.79 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.089 0.956 . . . . 70.01 111.199 -178.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.514 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.3 tpt -33.26 124.94 0.39 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.549 1.14 . . . . 75.2 112.698 163.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.546 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 94.3 m -148.86 140.88 23.84 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.844 0.857 . . . . 71.3 109.749 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -151.81 88.21 1.39 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.297 -1.372 . . . . 74.31 107.297 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -114.05 121.84 45.08 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.103 -1.073 . . . . 74.55 108.103 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' B' ' 130' ' ' PRO . 9.4 mt -86.98 128.47 39.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 116.213 -0.449 . . . . 65.12 110.117 -171.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.41 ' NE2' HG21 ' D' ' 83' ' ' ILE . 51.0 mt-30 -90.79 -39.74 12.2 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.437 0.695 . . . . 74.4 112.096 -173.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -175.08 122.19 0.22 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 112.219 0.452 . . . . 71.21 112.219 -167.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.422 HD13 ' HG2' ' B' ' 130' ' ' PRO . 1.5 mp -108.9 134.23 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.708 -0.849 . . . . 75.15 108.708 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.494 ' HE1' HG13 ' D' ' 83' ' ' ILE . 27.8 p90 -159.65 159.43 33.05 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 124.16 0.912 . . . . 75.31 110.487 -172.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -94.78 114.24 26.11 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.638 -0.71 . . . . 72.23 109.552 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.452 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 3.8 mtpp -77.84 -26.71 49.63 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.23 -0.656 . . . . 75.14 109.23 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.457 ' HB3' HE21 ' D' ' 79' ' ' GLN . 20.2 t70 -160.74 144.74 13.71 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.847 -1.069 . . . . 74.15 109.864 177.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.564 HG21 ' HE1' ' C' ' 117' ' ' MET . 68.0 mt -140.16 148.62 22.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 125.549 1.54 . . . . 74.32 107.388 174.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 26.9 t -156.08 119.44 4.3 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.226 0.61 . . . . 71.4 109.612 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -125.63 118.38 25.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.849 1.26 . . . . 75.31 107.879 173.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -124.16 135.96 53.86 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.124 -0.695 . . . . 74.12 109.124 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.48 86.36 39.21 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.442 -1.318 . . . . 70.34 107.442 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -66.61 -39.04 16.84 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.803 2.336 . . . . 72.3 113.115 -170.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 82.1 m-20 -101.3 17.33 22.86 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.869 0.868 . . . . 72.23 110.732 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.24 -70.81 0.12 Allowed Pre-proline 0 CA--C 1.562 1.424 0 N-CA-C 115.69 1.737 . . . . 61.43 115.69 -162.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.406 ' HB3' HD11 ' C' ' 83' ' ' ILE . 56.5 Cg_endo -76.69 -18.79 14.96 Favored 'Trans proline' 0 C--N 1.382 2.328 0 CA-C-N 123.531 2.297 . . . . 62.2 113.198 -172.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.439 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 11.2 t-160 -68.1 -47.64 67.65 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.794 1.238 . . . . 73.21 109.347 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.556 HG22 ' HA ' ' D' ' 73' ' ' ALA . 8.6 p -83.17 -20.21 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.241 1.016 . . . . 74.12 111.838 -172.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -63.52 -32.19 73.57 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.175 0.512 . . . . 71.41 111.431 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -67.42 -10.48 51.75 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.969 -1.014 . . . . 71.32 111.544 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.427 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 5.1 ttmt -96.17 84.74 3.84 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.119 0.967 . . . . 73.44 109.17 173.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.89 82.79 5.91 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.679 0.792 . . . . 71.31 109.866 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.4 t-105 -147.46 163.1 37.59 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.821 0.848 . . . . 75.12 109.665 -175.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -70.95 109.26 4.86 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.474 1.11 . . . . 75.54 110.438 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.39 144.04 25.44 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.795 2.33 . . . . 74.01 112.242 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' H' ' 470' ' ' LEU . 44.5 tt0 -90.03 135.62 33.54 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.874 -0.787 . . . . 75.35 108.874 171.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.533 ' HB ' HG13 ' D' ' 64' ' ' VAL . 32.9 m -105.78 127.67 60.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 123.045 0.538 . . . . 75.34 109.555 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -87.42 114.03 23.66 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.923 -1.51 . . . . 74.43 106.923 172.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.458 HD13 ' O ' ' D' ' 42' ' ' LEU . 2.9 pp -94.75 117.81 30.73 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.011 0.91 . . . . 75.33 109.28 -174.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -122.96 112.54 17.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.726 -1.583 . . . . 73.41 106.726 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.93 152.34 22.09 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.159 0.584 . . . . 72.44 109.712 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.0 t70 -151.02 156.28 40.81 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.756 1.222 . . . . 74.24 108.367 174.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -138.95 156.71 47.03 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.372 0.669 . . . . 74.41 109.464 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.405 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -158.47 177.86 10.78 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.283 0.633 . . . . 72.21 110.282 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.6 p -163.19 164.82 25.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.485 0.714 . . . . 62.55 111.2 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 91.1 p -156.36 132.71 10.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.402 1.081 . . . . 54.32 108.744 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -86.37 117.99 25.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.404 -0.591 . . . . 73.21 109.404 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.08 -25.42 16.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.084 0.554 . . . . 72.32 110.629 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.49 -178.68 5.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.392 1.077 . . . . 74.22 109.496 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.49 137.05 49.92 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.88 -0.785 . . . . 73.42 108.88 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.686 ' HA ' HG12 ' H' ' 451' ' ' VAL . 17.4 m-20 61.2 10.8 3.16 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.095 0.958 . . . . 72.23 112.772 -177.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -123.78 124.79 70.03 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 C-N-CA 124.63 1.172 . . . . 62.21 108.47 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.54 ' HD2' HD13 ' D' ' 86' ' ' ILE . 8.1 m-85 -128.29 158.59 37.76 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.399 -0.963 . . . . 75.43 108.399 171.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -125.9 128.04 46.95 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 105.729 -1.952 . . . . 72.55 105.729 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.45 141.23 31.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.598 -0.89 . . . . 73.21 108.598 -174.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 48.2 t -121.3 134.04 65.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 O-C-N 123.852 0.72 . . . . 74.04 109.136 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.489 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -117.49 121.89 42.23 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.18 -1.415 . . . . 74.35 107.18 174.139 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.558 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 15.7 ttm-85 -105.6 102.65 12.1 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.765 -0.828 . . . . 73.04 108.765 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 71.9 t -99.76 113.39 34.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.549 -0.908 . . . . 63.14 108.549 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 11.8 m -114.61 134.36 55.11 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.263 0.625 . . . . 73.03 109.377 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.533 HG13 ' HB ' ' D' ' 40' ' ' VAL . 78.8 t -131.67 102.44 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.344 1.457 . . . . 74.22 108.623 -171.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 96.5 m -103.36 95.8 6.33 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.323 -0.991 . . . . 74.23 108.323 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.56 159.94 14.62 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.059 0.456 . . . . 63.13 111.843 -172.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.421 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 53.3 p -145.47 142.93 29.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.135 -0.939 . . . . 72.12 110.912 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.47 ' HA ' HD11 ' H' ' 470' ' ' LEU . 14.9 mt -113.09 114.59 27.06 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.597 1.159 . . . . 64.41 108.711 169.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.96 -112.39 4.55 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.672 0.608 . . . . 63.3 112.857 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -106.94 3.75 26.49 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.289 0.636 . . . . 74.34 112.092 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.427 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.4 pt-20 -135.81 167.6 20.86 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.654 0.381 . . . . 74.43 110.677 -172.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.0 m -70.06 132.18 45.47 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.608 -0.724 . . . . 74.2 110.942 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.556 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -90.32 -76.46 0.43 Allowed 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.913 -1.143 . . . . 73.3 107.913 174.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -142.22 136.84 30.28 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 121.242 0.544 . . . . 72.45 111.641 -176.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 63.3 mt -104.34 140.29 38.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.124 1.369 . . . . 71.52 107.63 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.666 ' SG ' HG12 ' D' ' 114' ' ' ILE . 50.5 t -154.15 143.09 21.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.038 0.535 . . . . 71.13 109.615 -175.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -155.89 131.84 9.91 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.262 -1.014 . . . . 75.33 108.262 172.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.0 t -131.94 114.78 25.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.248 -0.649 . . . . 74.53 109.248 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.457 HE21 ' HB3' ' D' ' 20' ' ' ASP . 5.0 mt-30 -88.17 82.48 7.12 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.094 -1.076 . . . . 75.14 108.094 169.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -79.86 96.43 6.34 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.694 -1.594 . . . . 71.14 108.744 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.11 164.24 25.92 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.132 -0.486 . . . . 55.35 112.075 177.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.2 135.06 3.71 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 112.562 -0.215 . . . . 73.22 112.562 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.494 HG13 ' HE1' ' D' ' 17' ' ' TYR . 45.3 mt -89.79 129.66 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.343 1.057 . . . . 74.0 108.875 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -129.84 147.21 51.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.395 1.078 . . . . 75.4 110.321 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.1 m -108.01 109.78 21.33 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.555 -0.906 . . . . 74.22 108.555 171.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.54 HD13 ' HD2' ' D' ' 56' ' ' TYR . 19.2 pt -115.94 136.64 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.529 0.732 . . . . 74.4 110.942 -173.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.546 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -154.54 159.54 40.99 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.195 0.998 . . . . 75.34 109.115 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 80.01 -12.37 30.78 Favored Glycine 0 N--CA 1.478 1.457 0 N-CA-C 114.257 0.463 . . . . 75.14 114.257 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.453 ' O ' HG22 ' H' ' 451' ' ' VAL . 10.6 pt -123.09 142.1 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.424 1.089 . . . . 74.41 109.165 -178.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.573 ' HB3' ' HA ' ' H' ' 451' ' ' VAL . 6.3 pt-20 -165.83 164.55 18.66 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.506 0.722 . . . . 74.51 110.781 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.89 -114.72 7.11 Favored Glycine 0 C--N 1.354 1.56 0 O-C-N 123.851 0.719 . . . . 75.4 112.254 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.9 m -67.85 -37.79 82.3 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.492 0.717 . . . . 73.34 110.421 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -70.22 -28.78 65.54 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.602 0.761 . . . . 75.1 112.572 -177.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.515 ' HE3' HD23 ' H' ' 454' ' ' LEU . 18.5 tmm? -83.54 -32.03 26.08 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.25 -0.278 . . . . 73.04 110.25 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 -33.92 76.92 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.276 0.56 . . . . 72.45 110.379 169.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.415 ' O ' ' HB1' ' D' ' 100' ' ' ALA . 14.1 t-80 -73.58 -20.28 60.66 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.994 1.317 . . . . 74.44 111.14 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -88.01 -53.83 4.54 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.435 0.294 . . . . 64.33 110.712 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.428 HD11 ' SD ' ' D' ' 94' ' ' MET . 9.8 mp -74.57 -32.92 62.55 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.659 0.783 . . . . 75.13 111.77 -173.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.19 14.54 61.13 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 119.072 -0.849 . . . . 75.32 113.311 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' D' ' 96' ' ' HIS . . . -157.58 -69.66 0.1 Allowed 'General case' 0 C--N 1.356 0.871 0 CA-C-N 118.212 1.006 . . . . 71.23 112.846 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -68.14 -39.61 82.62 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.818 0.447 . . . . 73.42 112.057 -171.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 74.8 m -69.5 -46.3 26.73 Favored Pre-proline 0 CA--C 1.557 1.242 0 CA-C-O 118.372 -0.823 . . . . 73.52 111.516 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.489 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 97.9 Cg_exo -51.29 -36.97 58.94 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 122.314 2.01 . . . . 75.22 113.373 165.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -65.83 -29.81 70.33 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.025 0.53 . . . . 75.14 111.792 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -68.96 -44.81 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.521 -0.548 . . . . 73.33 109.521 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -77.05 -14.98 59.75 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.99 -1.005 . . . . 74.31 112.021 -173.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -73.73 -40.1 4.94 Favored Pre-proline 0 CA--C 1.561 1.395 0 N-CA-C 113.924 1.083 . . . . 62.33 113.924 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.7 -39.35 88.38 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 121.742 1.628 . . . . 74.34 112.782 169.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -72.67 -35.33 67.68 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.612 0.765 . . . . 73.31 110.985 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.1 -51.46 67.81 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.657 -0.701 . . . . 73.42 109.359 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.483 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 29.7 ttp-105 -54.34 -50.24 67.87 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.794 1.309 . . . . 73.22 110.874 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -64.11 -46.04 85.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.861 0.865 . . . . 71.45 111.898 -173.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.7 t -59.47 -40.42 86.86 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.994 0.809 . . . . 75.02 110.507 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.666 HG12 ' SG ' ' D' ' 76' ' ' CYS . 95.4 mt -63.01 -56.06 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.111 0.964 . . . . 75.51 110.35 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -55.36 -37.01 66.95 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.574 1.15 . . . . 64.11 111.376 -174.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.4 t -68.73 -46.23 69.43 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.009 -0.996 . . . . 73.4 110.144 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.8 mtm -68.21 -29.24 68.03 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.783 0.433 . . . . 71.22 111.897 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' D' ' 123' ' ' PHE . 54.7 t -68.7 -41.75 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.788 0.835 . . . . 63.54 110.266 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.6 p -74.88 -32.11 61.77 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.615 0.366 . . . . 64.3 110.909 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -70.43 -34.8 72.88 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.469 0.708 . . . . 75.13 109.82 174.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.51 5.61 82.89 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 115.345 -0.843 . . . . 64.5 112.537 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 26.6 p 63.04 16.32 9.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.407 1.883 . . . . 75.0 114.84 171.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.434 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.8 m-85 -80.71 153.82 73.22 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.462 0.705 . . . . 75.13 109.292 170.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.02 141.83 94.08 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.73 2.287 . . . . 71.42 113.083 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.76 134.92 47.85 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.865 1.266 . . . . 74.24 112.555 -174.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -110.01 107.13 16.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.109 -1.071 . . . . 75.33 108.109 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -99.22 89.06 4.1 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.911 -0.774 . . . . 74.24 108.911 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.483 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 44.0 tp -70.53 115.83 10.15 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.936 -1.029 . . . . 75.11 109.787 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.96 133.44 87.14 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 123.459 0.704 . . . . 70.4 111.396 -176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.71 113.35 2.71 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.626 2.217 . . . . 63.43 111.161 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 61.1 t -106.43 128.11 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.532 0.733 . . . . 74.14 109.045 -175.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -78.29 98.23 5.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.529 0.732 . . . . 73.42 109.713 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -63.46 -22.42 66.88 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.169 0.588 . . . . 73.32 111.855 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' D' ' 138' ' ' MET . 10.9 m-20 -61.87 -48.56 79.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.321 0.648 . . . . 72.4 111.689 177.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.403 ' HB1' HG23 ' B' ' 7' ' ' THR . . . -63.41 -45.77 89.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.551 0.74 . . . . 72.4 111.702 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.49 -31.8 72.19 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.934 -0.575 . . . . 74.52 111.128 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -65.29 -43.19 91.92 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.248 0.619 . . . . 75.21 110.179 176.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 35.2 mtt -63.59 -40.4 96.84 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.278 0.631 . . . . 74.42 110.1 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.36 -40.59 96.93 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 124.026 0.829 . . . . 74.4 110.842 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -63.16 -40.08 96.53 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.337 0.655 . . . . 75.44 111.507 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -66.22 -36.26 82.58 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.541 0.736 . . . . 72.14 111.6 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -89.55 9.14 27.79 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.107 0.563 . . . . 74.52 111.307 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -121.22 87.51 2.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.207 1.003 . . . . 73.4 109.513 -176.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -148.39 23.68 1.02 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.76 0.791 . . . . 75.55 109.746 174.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.91 -44.04 0.07 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.084 1.354 . . . . 63.32 107.603 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -163.92 176.22 39.97 Favored Glycine 0 C--O 1.241 0.564 0 CA-C-N 113.716 -1.583 . . . . 72.32 109.528 169.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.64 100.65 0.92 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.582 -0.525 . . . . 71.15 109.582 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.51 158.04 46.88 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.631 -0.713 . . . . 73.02 112.777 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 24.3 m -129.44 80.25 1.95 Allowed 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.852 -0.795 . . . . 74.15 108.852 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.03 137.17 24.61 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.77 -1.105 . . . . 75.41 108.664 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -155.87 111.12 2.96 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.604 -1.628 . . . . 60.4 106.604 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -147.24 72.85 1.27 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.782 -1.192 . . . . 61.54 107.782 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -84.04 9.0 13.55 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.083 -0.962 . . . . 72.3 111.181 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -52.9 107.99 0.28 Allowed 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.513 1.125 . . . . 43.03 110.633 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.868 0.867 . . . . 75.21 109.787 -173.527 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 67.0 t30 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.974 0.416 . . . . 75.45 110.074 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' 451' ' ' VAL . . . . . 0.464 HG22 ' SD ' ' A' ' 94' ' ' MET . 8.1 p -67.62 121.13 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 121.521 0.677 . . . . 75.3 109.819 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.72 142.79 19.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 C-N-CA 124.822 1.249 . . . . 71.55 108.96 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -157.11 172.33 34.61 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.562 -1.015 . . . . 73.33 110.562 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 35.8 tp 64.24 113.4 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.672 1.189 . . . . 71.24 110.784 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 5.7 m -63.45 142.38 58.41 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.863 0.465 . . . . 73.15 110.262 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 456' ' ' ASP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 48' ' ' SER . 6.9 m-20 -61.94 153.12 30.21 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.906 0.482 . . . . 71.42 110.336 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 71.13 166.75 0.3 Allowed 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.727 1.211 . . . . 75.22 110.227 -164.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 458' ' ' THR . . . . . 0.585 HG21 HD21 ' E' ' 460' ' ' LEU . 12.5 t -158.87 154.45 26.06 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.239 0.543 . . . . 74.42 111.13 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.82 7.69 44.78 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 124.318 1.047 . . . . 74.04 109.507 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 460' ' ' LEU . . . . . 0.585 HD21 HG21 ' E' ' 458' ' ' THR . 4.1 mm? 67.02 -176.33 0.2 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.255 1.422 . . . . 54.41 112.407 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -137.46 -13.49 1.53 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.853 1.261 . . . . 75.13 110.174 176.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -167.79 137.89 2.73 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 124.012 0.925 . . . . 74.24 109.73 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 80.6 p -116.01 134.96 54.41 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.229 -1.397 . . . . 72.4 107.229 169.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 464' ' ' MET . . . . . 0.459 ' HB2' HD12 ' A' ' 44' ' ' LEU . 7.2 tmm? -72.41 -75.43 0.14 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.597 -0.89 . . . . 75.41 108.597 -178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 42.6 tttm 47.52 -87.42 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.332 1.453 . . . . 73.31 113.147 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . 49.66 -87.98 0.01 OUTLIER 'General case' 0 C--N 1.363 1.185 0 C-N-CA 125.058 1.343 . . . . 74.55 112.738 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . 171.5 152.74 0.06 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.431 1.892 . . . . 73.43 108.57 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 468' ' ' LEU . . . . . 0.522 ' HG ' HG21 ' A' ' 40' ' ' VAL . 4.4 pp -168.09 168.2 11.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.007 0.923 . . . . 74.42 109.344 168.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -126.18 140.22 11.94 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.769 -0.65 . . . . 75.13 111.553 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 5.3 mp -78.42 -62.16 1.77 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.306 -1.368 . . . . 73.35 107.306 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 471' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' E' ' 471' ' ' LYS . 33.3 mmtt . . . . . 0 C--O 1.252 1.219 0 C-N-CA 128.469 2.708 . . . . 72.5 106.367 163.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.796 -0.446 . . . . 73.04 109.796 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 50.6 t 58.75 90.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 124.421 1.076 . . . . 62.05 108.992 -170.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 452' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' B' ' 94' ' ' MET . 60.0 t 73.52 165.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.767 1.227 . . . . 75.51 109.569 -169.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 170.4 149.79 6.59 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 121.916 -0.49 . . . . 73.55 113.625 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 454' ' ' LEU . . . . . 0.58 HD11 ' HG ' ' B' ' 48' ' ' SER . 3.9 pp -167.04 155.61 9.98 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.931 1.293 . . . . 75.3 109.312 174.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 14.1 m -99.68 -67.42 0.85 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 122.893 0.477 . . . . 63.43 109.781 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -167.58 96.44 0.46 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.327 -0.852 . . . . 75.31 110.633 -170.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 178.89 63.2 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.572 1.549 . . . . 61.42 107.488 166.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 60.4 p -118.36 106.08 12.38 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.2 -0.909 . . . . 75.24 110.251 -174.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -143.18 130.4 20.86 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.165 -1.05 . . . . 74.34 108.165 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 460' ' ' LEU . . . . . 0.434 ' H ' HD23 ' F' ' 460' ' ' LEU . 2.6 pt? -80.37 -173.0 3.81 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.616 0.766 . . . . 72.03 110.588 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 461' ' ' PHE . . . . . 0.572 ' HE1' ' HB2' ' B' ' 140' ' ' TYR . 8.2 m-85 -72.34 -72.41 0.24 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.786 0.834 . . . . 74.02 108.944 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 15.0 t80 178.18 134.55 0.08 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.03 1.332 . . . . 73.32 107.42 176.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 17.9 m -91.34 74.01 6.12 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.342 0.591 . . . . 64.1 110.346 176.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 33.7 tpp -177.24 152.26 0.85 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.025 1.33 . . . . 65.43 109.018 168.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -64.79 -56.67 12.09 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.573 0.749 . . . . 74.45 109.846 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -152.06 -66.82 0.17 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.432 -0.951 . . . . 72.31 108.432 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -118.35 160.05 22.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.241 1.016 . . . . 71.42 108.67 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 7.2 tt -66.96 -35.17 79.38 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.153 0.581 . . . . 75.23 110.34 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.19 -55.77 0.35 Allowed Glycine 0 CA--C 1.507 -0.413 0 N-CA-C 110.051 -1.22 . . . . 74.3 110.051 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 470' ' ' LEU . . . . . 0.563 HD21 ' H ' ' F' ' 470' ' ' LEU . 1.3 pt? -76.81 100.11 5.38 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.664 -0.768 . . . . 74.33 110.219 176.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.244 0.809 0 N-CA-C 107.07 -1.455 . . . . 73.35 107.07 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 34.4 t30 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 110.124 -0.324 . . . . 72.14 110.124 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 9.2 p -71.17 -40.99 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 123.419 0.688 . . . . 72.14 111.69 -174.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 27.6 m -144.28 144.8 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.211 0.605 . . . . 72.43 111.046 -175.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 144.27 77.08 0.03 OUTLIER Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.638 -0.585 . . . . 74.04 111.638 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.14 123.72 29.23 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.229 0.612 . . . . 64.43 110.441 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 17.6 p -82.68 -61.01 1.99 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.823 0.849 . . . . 74.03 110.036 175.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 18.2 t70 68.02 120.52 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.13 1.372 . . . . 61.32 113.149 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -140.12 23.5 2.38 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.507 1.123 . . . . 71.14 110.711 175.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 87.1 m -144.03 136.01 26.37 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.07 0.548 . . . . 73.54 110.176 -174.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.47 171.17 7.79 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.995 0.518 . . . . 75.11 110.266 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.17 122.08 17.04 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.65 -0.87 . . . . 73.33 108.65 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -68.07 4.01 1.39 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.762 1.225 . . . . 75.44 114.097 -175.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 462' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' G' ' 464' ' ' MET . 21.5 t80 -148.36 122.94 9.8 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.139 -0.689 . . . . 74.32 109.139 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 8.9 t -104.61 -43.66 5.09 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.336 0.655 . . . . 73.53 109.701 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 464' ' ' MET . . . . . 0.413 ' HB2' ' CE2' ' G' ' 462' ' ' TYR . 53.4 ttp 68.53 93.78 0.08 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.078 1.351 . . . . 73.41 111.753 -174.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -106.54 -51.53 2.93 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.598 -0.89 . . . . 75.32 108.598 170.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -73.0 83.7 1.25 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.326 -0.852 . . . . 54.42 110.447 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -159.33 -63.05 0.07 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.124 0.97 . . . . 55.43 108.827 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 77.5 mt -101.26 110.79 22.86 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.576 -1.193 . . . . 74.14 108.555 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -74.68 -51.51 8.03 Favored Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.365 -0.694 . . . . 73.43 111.365 175.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 470' ' ' LEU . . . . . 0.513 ' HB3' ' HE1' ' C' ' 36' ' ' TRP . 30.2 mt 57.69 103.69 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.89 1.676 . . . . 72.25 111.593 -176.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.376 -0.829 . . . . 72.5 111.064 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 108.2 -1.037 . . . . 74.33 108.2 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' H' H ' 451' ' ' VAL . . . . . 0.686 HG12 ' HA ' ' D' ' 54' ' ' ASP . 11.3 p -59.07 -38.24 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.1 0.96 . . . . 73.25 111.292 -177.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 452' ' ' VAL . . . . . . . . . . . . . 33.3 m -67.78 163.28 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.578 1.151 . . . . 73.5 112.526 -175.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 94.78 97.92 1.67 Allowed Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.623 -0.717 . . . . 74.02 112.64 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 454' ' ' LEU . . . . . 0.515 HD23 ' HE3' ' D' ' 94' ' ' MET . 2.5 pt? -137.34 170.26 16.38 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.807 0.843 . . . . 74.24 109.403 173.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 26.9 m -70.47 144.96 51.26 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 109.443 -0.577 . . . . 75.44 109.443 172.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -58.47 103.82 0.18 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.67 -0.492 . . . . 70.04 109.67 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -69.83 83.74 0.47 Allowed 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 122.504 1.145 . . . . 74.43 110.833 -176.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 31.4 p -116.04 12.23 15.56 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.908 -1.497 . . . . 62.33 109.681 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -111.54 108.22 17.66 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.088 0.955 . . . . 74.33 109.629 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.16 84.89 6.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.201 1.0 . . . . 61.42 109.793 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -57.03 -19.9 21.34 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 113.42 -1.718 . . . . 74.04 112.217 169.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -65.67 101.7 0.65 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.185 -1.043 . . . . 74.45 108.185 171.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 4.8 t -140.35 76.23 1.55 Allowed 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 122.046 0.927 . . . . 65.35 110.048 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.47 166.43 33.3 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.266 -0.879 . . . . 75.45 110.002 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -160.32 134.49 7.29 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.003 -1.11 . . . . 74.24 108.003 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -161.39 -159.42 0.64 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.509 0.724 . . . . 70.33 110.395 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . 78.05 -77.05 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.425 1.49 . . . . 74.41 112.131 172.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 468' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' D' ' 39' ' ' GLU . 0.6 OUTLIER -131.46 136.68 48.14 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.343 0.657 . . . . 75.41 110.451 -174.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . -127.18 19.07 6.08 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.44 -0.645 . . . . 62.32 114.254 -173.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 470' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' D' ' 39' ' ' GLU . 12.7 tp 63.14 18.16 10.73 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 124.795 1.238 . . . . 71.13 111.337 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 23.4 tptm . . . . . 0 C--O 1.248 1.006 0 N-CA-C 107.527 -1.286 . . . . 74.22 107.527 -170.567 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.8 m . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 108.252 -1.018 . . . . 72.31 108.252 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.612 ' HA ' HG22 ' A' ' 86' ' ' ILE . 72.8 t80 -130.41 114.13 15.19 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.695 -1.224 . . . . 74.22 107.695 170.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -134.18 134.58 42.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.418 -0.956 . . . . 71.52 108.418 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.429 ' CD1' HG21 ' A' ' 105' ' ' ILE . 14.6 mt -84.99 112.32 21.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 108.485 -0.932 . . . . 73.54 108.485 174.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.27 -39.77 65.13 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.515 -0.92 . . . . 63.54 108.515 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -172.17 148.28 2.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 116.591 -0.277 . . . . 55.43 110.622 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.7 mt -132.16 129.06 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.101 -1.074 . . . . 73.41 108.101 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.437 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 33.1 p90 -168.37 147.99 4.57 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 124.209 0.943 . . . . 73.21 110.562 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -75.68 112.53 12.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.865 -1.061 . . . . 33.05 109.121 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 37.7 mtpt -82.08 -27.51 32.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.955 0.407 . . . . 71.13 109.951 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.642 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 19.5 t70 -143.7 140.02 29.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.008 -0.997 . . . . 70.04 109.885 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.4 mt -137.15 140.91 41.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 107.204 -1.406 . . . . 70.34 107.204 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -147.77 134.5 19.99 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.78 -0.822 . . . . 70.14 108.78 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.575 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 55.2 t80 -140.09 121.6 15.15 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.834 -1.173 . . . . 73.42 107.834 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.98 110.2 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.809 -0.811 . . . . 53.44 108.809 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.726 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -126.05 76.14 71.85 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 107.246 -1.391 . . . . 72.33 107.246 170.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.42 -30.87 7.79 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.33 2.02 . . . . 70.15 110.697 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 72' ' ' THR . 16.4 m120 -101.16 19.57 17.32 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.216 1.006 . . . . 71.3 110.112 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.726 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -52.98 -48.26 92.44 Favored Pre-proline 0 CA--C 1.571 1.762 0 C-N-CA 123.694 0.798 . . . . 54.22 111.87 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.36 -17.38 16.71 Favored 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 121.88 1.72 . . . . 72.32 113.609 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -69.99 -49.21 53.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.974 0.509 . . . . 72.25 109.771 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.66 HG21 ' HA ' ' A' ' 73' ' ' ALA . 42.7 t -72.55 -20.18 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.861 0.864 . . . . 73.21 111.21 -175.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.406 ' HB2' ' NH1' ' B' ' 15' ' ' ARG . 81.3 t80 -60.21 -34.4 73.59 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.367 0.667 . . . . 73.03 110.447 168.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -94.18 -24.39 17.53 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.362 1.065 . . . . 72.34 110.977 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 32.9 mmtp -75.89 170.89 15.37 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.486 0.714 . . . . 71.31 110.304 172.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -81.31 138.43 35.7 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.973 -1.121 . . . . 54.32 107.973 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 41.5 t-105 -76.43 83.76 3.16 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.709 0.766 . . . . 75.3 110.443 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -129.82 77.63 76.5 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.863 1.265 . . . . 70.01 108.751 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 39.1 Cg_endo -93.03 146.38 2.42 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.55 2.167 . . . . 62.44 113.074 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 28.1 tt0 -97.87 95.73 7.72 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.766 -0.827 . . . . 72.42 108.766 172.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.36 91.21 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.499 0.666 . . . . 62.12 109.747 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -101.18 128.92 47.06 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.088 -0.708 . . . . 71.33 109.088 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.476 HD11 HG13 ' A' ' 62' ' ' VAL . 45.6 tp -98.2 146.6 25.45 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.707 -0.849 . . . . 45.14 108.707 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.653 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.4 m-20 -134.46 109.35 8.68 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.269 -1.382 . . . . 73.32 107.269 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -96.99 120.37 37.21 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.847 -0.427 . . . . 75.35 109.847 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -128.37 143.97 51.07 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.991 -1.115 . . . . 53.14 107.991 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.1 m -133.44 142.22 48.21 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.104 0.562 . . . . 64.33 110.085 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -130.36 152.93 49.23 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.809 1.244 . . . . 53.03 109.217 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.3 t -127.49 151.61 48.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.622 0.769 . . . . 54.55 109.744 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.7 t -153.31 128.3 9.63 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.576 0.75 . . . . 64.24 110.176 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -101.38 108.01 19.5 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.139 -0.689 . . . . 75.43 109.139 174.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.464 HD12 HG23 ' A' ' 83' ' ' ILE . 79.2 mt -88.43 -35.25 17.18 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.931 0.492 . . . . 64.04 110.696 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -159.62 -179.64 8.07 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 124.029 0.831 . . . . 41.44 110.461 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -67.41 116.65 8.4 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.721 -1.127 . . . . 73.35 109.136 171.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 67.54 11.21 8.26 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.728 1.211 . . . . 71.11 113.157 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 62.1 t -115.54 111.6 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.376 -1.342 . . . . 61.01 107.376 171.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -130.78 141.93 50.38 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.894 -0.78 . . . . 72.1 108.894 -171.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -123.13 134.32 54.21 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.135 0.974 . . . . 73.03 109.213 -173.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.74 131.04 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 108.015 -1.106 . . . . 62.2 108.015 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 46.8 t -116.06 110.15 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.867 -0.79 . . . . 62.24 108.867 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.1 tp -90.26 105.71 17.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.487 -0.56 . . . . 75.24 109.487 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.451 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 51.8 ttt180 -85.07 101.69 12.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.504 0.722 . . . . 63.1 109.298 173.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.476 HG13 HD11 ' A' ' 42' ' ' LEU . 48.4 t -95.37 102.09 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.097 -1.075 . . . . 51.43 108.097 175.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.653 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 56.4 m -96.98 110.31 22.88 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.513 0.725 . . . . 63.43 109.051 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.615 HG21 HG21 ' A' ' 114' ' ' ILE . 41.9 t -102.92 137.28 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.392 -0.966 . . . . 72.05 108.392 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 t -143.09 150.5 39.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.863 -0.421 . . . . 73.33 109.863 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -138.67 109.61 6.75 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.823 -1.177 . . . . 71.1 107.823 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.8 p -135.04 127.04 29.65 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.416 0.687 . . . . 74.31 110.188 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.23 78.67 6.51 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.24 -1.393 . . . . 64.23 107.24 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.55 -91.42 0.66 Allowed Glycine 0 C--N 1.349 1.25 0 CA-C-N 115.142 -0.935 . . . . 73.11 112.783 173.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -91.91 -26.53 18.4 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.914 0.886 . . . . 71.02 111.823 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -113.55 129.92 56.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.721 0.408 . . . . 72.34 110.955 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 59.0 m -88.65 124.81 34.45 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.487 0.715 . . . . 64.3 110.289 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.66 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -70.59 -56.58 6.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.883 0.873 . . . . 75.45 110.071 175.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -155.83 158.77 38.64 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.617 -1.174 . . . . 73.35 111.128 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 tp -134.29 124.51 25.99 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.369 1.468 . . . . 75.44 107.217 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.441 ' SG ' HG12 ' A' ' 118' ' ' VAL . 61.6 m -132.22 99.96 4.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.111 0.964 . . . . 55.41 109.005 -174.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -123.68 127.39 48.13 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.527 0.731 . . . . 53.22 109.704 -171.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.2 t -135.63 113.85 15.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 123.445 0.698 . . . . 72.23 109.764 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.642 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.7 mt-30 -84.18 83.91 7.8 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.304 -0.998 . . . . 70.44 108.304 169.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -76.84 97.59 4.59 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.524 -1.216 . . . . 71.43 108.844 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.49 150.24 23.3 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.664 -0.574 . . . . 33.33 111.664 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.542 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -143.89 122.49 1.84 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.905 -0.878 . . . . 64.22 110.905 173.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.464 HG23 HD12 ' A' ' 51' ' ' LEU . 35.7 mt -82.02 130.52 35.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.801 -1.185 . . . . 74.14 107.801 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -127.67 122.64 33.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.85 -0.796 . . . . 64.41 108.85 -176.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -89.44 91.62 8.79 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.453 -0.943 . . . . 74.32 108.453 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.612 HG22 ' HA ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -126.74 155.62 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.175 0.59 . . . . 73.41 110.186 -175.447 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.56 170.72 8.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.156 0.982 . . . . 70.41 109.509 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.5 -32.34 6.08 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 123.675 0.61 . . . . 70.14 113.336 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.58 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.44 156.62 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.86 0.864 . . . . 74.05 109.748 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -163.35 177.39 8.98 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.456 0.702 . . . . 71.12 109.403 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.66 -130.51 23.07 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 114.097 0.399 . . . . 62.13 114.097 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.0 p -76.44 -35.57 58.43 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.56 1.144 . . . . 71.2 111.577 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -59.87 -43.92 94.46 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.963 0.905 . . . . 73.21 110.111 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.482 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 65.6 ttp -72.48 -36.01 68.32 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.005 -0.998 . . . . 63.52 110.848 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.23 -29.67 68.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.037 0.535 . . . . 55.21 110.883 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -69.15 -46.46 67.55 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.016 0.527 . . . . 64.25 110.94 168.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.5 m -59.98 -65.15 0.73 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 122.321 0.248 . . . . 60.24 110.824 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 94' ' ' MET . 2.0 pp -73.5 -21.64 60.35 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.028 0.751 . . . . 74.14 113.028 -176.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.419 ' N ' HD12 ' A' ' 98' ' ' LEU . . . -101.56 -4.53 52.47 Favored Glycine 0 N--CA 1.475 1.268 0 CA-C-O 119.599 -0.556 . . . . 63.41 113.577 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.32 -60.75 0.42 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.239 0.519 . . . . 41.25 111.612 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.58 -45.57 65.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.018 0.527 . . . . 74.45 111.991 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.3 m -67.76 -45.74 44.55 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.122 0.969 . . . . 73.22 111.943 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.95 -26.55 58.8 Favored 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 121.549 1.499 . . . . 74.24 112.576 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -70.09 -30.42 67.64 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.771 0.428 . . . . 73.34 110.307 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.429 HG21 ' CD1' ' A' ' 13' ' ' ILE . 41.7 mm -67.53 -41.43 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.79 0.836 . . . . 74.02 109.988 171.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.542 HD21 ' HA3' ' A' ' 82' ' ' GLY . 69.9 mt -74.99 -22.13 58.72 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.302 -0.863 . . . . 71.51 111.453 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -63.34 -43.49 79.85 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 117.464 -1.255 . . . . 72.13 114.233 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.1 -40.41 77.25 Favored 'Trans proline' 0 C--N 1.387 2.56 0 CA-C-N 122.093 1.783 . . . . 64.54 112.765 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -66.02 -44.64 84.13 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.453 0.701 . . . . 74.31 111.463 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.83 84.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.178 0.591 . . . . 73.41 110.711 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.414 ' NH1' HD12 ' C' ' 105' ' ' ILE . 26.8 ttm180 -50.79 -54.62 22.07 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.552 1.158 . . . . 72.21 109.76 174.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -67.01 -38.99 86.95 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.402 1.064 . . . . 53.05 111.833 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.561 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.2 t -62.06 -27.8 69.15 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.015 0.526 . . . . 72.4 111.019 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.615 HG21 HG21 ' A' ' 64' ' ' VAL . 97.5 mt -87.52 -41.09 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.227 1.411 . . . . 64.11 111.027 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 49.3 m -64.46 -44.48 90.95 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.482 0.713 . . . . 72.43 110.508 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.8 t -65.77 -40.89 92.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.794 -1.093 . . . . 51.24 109.93 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.575 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.7 ttm -59.58 -47.17 86.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.366 1.066 . . . . 63.02 111.903 -177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.441 HG12 ' SG ' ' A' ' 76' ' ' CYS . 20.5 m -66.02 -39.45 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.251 0.345 . . . . 61.43 110.317 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.0 m -67.45 -32.57 73.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.42 0.688 . . . . 73.01 111.362 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.622 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 86.5 mtt-85 -71.47 -31.5 67.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.518 0.727 . . . . 74.12 110.018 174.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.54 3.56 86.26 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.614 -0.721 . . . . 63.44 113.519 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.0 m 62.28 47.27 5.5 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 123.545 1.64 . . . . 73.34 110.797 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -116.75 137.64 23.89 Favored Pre-proline 0 C--O 1.246 0.92 0 CA-C-N 114.055 -1.429 . . . . 74.35 107.18 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.55 144.28 10.67 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.283 2.656 . . . . 73.33 113.705 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -55.98 132.38 49.76 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 124.357 1.036 . . . . 54.05 112.403 -173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 tp -118.97 100.69 7.52 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.143 -0.935 . . . . 72.12 109.68 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -98.03 107.3 19.74 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.839 -1.171 . . . . 74.44 107.839 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.46 139.31 58.76 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.169 0.587 . . . . 63.41 109.73 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.18 145.57 98.03 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 122.886 0.474 . . . . 52.35 110.673 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.406 ' HG3' ' HD2' ' C' ' 11' ' ' PHE . 37.0 Cg_endo -62.84 107.84 0.67 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.083 1.855 . . . . 64.2 111.269 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 89.9 t -98.99 113.76 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.488 -0.93 . . . . 54.24 108.488 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -84.21 89.02 7.25 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.236 -1.024 . . . . 73.21 108.236 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -59.9 -29.67 68.5 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.645 0.778 . . . . 75.51 111.52 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.17 -44.39 72.31 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.699 1.2 . . . . 73.23 110.681 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.12 -45.36 92.38 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.992 0.808 . . . . 70.55 110.181 175.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.86 -37.04 80.74 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.164 -0.926 . . . . 73.11 111.212 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -68.86 -34.52 75.59 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.326 -0.852 . . . . 75.44 109.941 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.6 mmt . . . . . 0 N--CA 1.485 1.286 0 O-C-N 123.679 0.612 . . . . 71.53 111.124 177.48 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 60.5 m . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 109.382 -0.599 . . . . 73.43 109.382 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.37 156.75 42.54 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.479 0.657 . . . . 72.51 110.039 155.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -126.31 135.15 51.15 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.639 -1.245 . . . . 52.13 107.639 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.459 HD13 HD11 ' B' ' 16' ' ' ILE . 51.0 mt -68.63 116.08 8.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.319 -0.993 . . . . 75.11 108.319 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -86.87 -36.41 18.44 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.235 -0.893 . . . . 71.42 109.45 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.406 ' NH1' ' HB2' ' A' ' 32' ' ' PHE . 75.2 ttt180 -167.33 133.71 2.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.894 -1.048 . . . . 62.33 109.715 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.489 ' H ' ' ND2' ' D' ' 127' ' ' ASN . 88.8 mt -115.61 135.08 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 105.809 -1.923 . . . . 73.22 105.809 166.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.402 ' HE1' HG13 ' B' ' 83' ' ' ILE . 10.0 p90 -168.4 151.04 5.32 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.213 0.53 . . . . 75.11 111.059 -174.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.669 HG21 HD11 ' B' ' 21' ' ' ILE . 17.8 m -82.62 129.84 35.01 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.942 -0.762 . . . . 75.33 108.942 175.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -97.89 -30.56 12.67 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.354 0.662 . . . . 72.51 110.721 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 11.8 t70 -145.09 139.11 27.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.428 -0.351 . . . . 72.24 110.232 -175.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.669 HD11 HG21 ' B' ' 18' ' ' THR . 33.3 mm -131.17 139.53 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 106.768 -1.568 . . . . 74.33 106.768 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.8 t -147.6 138.25 23.29 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.32 -0.993 . . . . 52.11 108.32 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.0 t80 -154.71 110.38 3.15 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.662 -1.236 . . . . 72.44 107.662 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -117.95 114.42 23.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.627 1.171 . . . . 72.21 108.09 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.727 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -111.82 83.78 4.93 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.348 -0.982 . . . . 72.43 108.348 175.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.97 -34.26 6.69 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.775 2.316 . . . . 64.01 112.94 -170.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -98.14 -2.61 39.59 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.921 0.888 . . . . 54.15 111.426 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.727 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -35.83 -63.02 0.43 Allowed Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 125.867 1.667 . . . . 61.54 114.803 -165.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 37.9 Cg_exo -54.97 -31.02 72.24 Favored 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 122.775 2.316 . . . . 75.0 113.794 -173.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -96.78 -34.49 11.3 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.692 -1.14 . . . . 74.51 111.404 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.592 HG22 HD12 ' B' ' 68' ' ' LEU . 5.6 p -74.45 -18.63 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 122.336 0.254 . . . . 75.32 111.672 -171.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.95 -15.49 62.24 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.619 0.768 . . . . 72.2 112.855 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -57.25 -29.98 64.26 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.425 0.69 . . . . 73.03 110.473 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -95.38 98.66 10.73 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 124.623 1.169 . . . . 74.23 109.025 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -83.36 92.92 7.64 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.41 0.684 . . . . 74.15 109.725 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -162.94 156.26 19.71 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.762 0.825 . . . . 75.03 109.347 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -67.05 105.44 0.85 Allowed Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 124.524 1.13 . . . . 74.45 110.676 170.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.523 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 40.3 Cg_endo -67.37 137.58 43.71 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.597 2.198 . . . . 62.53 112.115 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 11.9 tp10 -59.23 121.46 11.43 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 124.187 0.929 . . . . 72.22 112.099 -169.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 73.2 t -85.94 132.47 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.968 0.907 . . . . 73.1 110.23 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.563 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 12.9 tmtt? -131.9 117.29 18.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.275 -1.75 . . . . 74.13 106.275 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.463 HD22 HD11 ' B' ' 128' ' ' LEU . 40.4 tp -93.98 150.56 20.25 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.154 0.502 . . . . 73.24 111.188 -172.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.722 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.8 m-20 -140.59 143.64 35.39 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.694 -1.225 . . . . 63.55 107.694 171.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.0 125.94 16.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.926 -1.139 . . . . 73.13 107.926 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 12.2 m-20 -127.04 150.42 49.45 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.026 -1.102 . . . . 63.0 108.026 171.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.0 p -135.72 124.46 23.87 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.943 0.401 . . . . 72.3 110.817 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.19 164.08 16.77 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.542 1.537 . . . . 74.5 109.493 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 22.2 p -145.07 168.67 19.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.482 1.113 . . . . 70.53 109.104 170.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 97.4 p -151.23 168.47 24.63 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.156 0.582 . . . . 75.42 109.815 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -116.53 110.2 18.26 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.731 -1.211 . . . . 64.14 107.731 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 24.6 mt -88.02 -55.51 3.72 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.1 0.953 . . . . 73.2 108.777 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.67 -179.32 5.85 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 113.431 -1.713 . . . . 42.31 108.053 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.32 130.36 40.58 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 116.158 -0.474 . . . . 73.02 110.627 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 67.03 -1.19 1.48 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.969 1.708 . . . . 64.23 112.724 -172.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.2 t -103.61 104.11 16.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 108.074 -1.084 . . . . 74.31 108.074 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -114.19 140.45 48.53 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.026 -1.101 . . . . 71.42 108.026 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -119.87 104.67 10.39 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.212 -1.033 . . . . 71.42 108.212 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 72.3 t -89.08 140.09 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.358 0.663 . . . . 62.42 110.589 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.464 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 38.0 t -118.28 118.9 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.797 0.839 . . . . 75.15 109.403 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.5 OUTLIER -93.82 122.98 36.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.203 -1.406 . . . . 73.44 107.203 174.264 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 46.8 ttt180 -110.27 122.14 46.96 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.403 0.681 . . . . 72.11 109.486 175.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 13.6 t -117.62 131.36 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 107.67 -1.233 . . . . 72.54 107.67 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.722 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.1 m -127.07 130.28 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.758 -0.83 . . . . 74.52 108.758 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.33 116.39 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.844 -0.799 . . . . 73.24 108.844 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 89.2 m -99.05 138.46 36.13 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.917 -1.142 . . . . 70.12 107.917 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.17 147.36 30.42 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 122.437 0.295 . . . . 71.31 110.593 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 54.9 p -151.66 135.74 16.6 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 124.125 0.891 . . . . 72.45 111.383 -174.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.592 HD12 HG22 ' B' ' 31' ' ' VAL . 56.1 mt -95.45 110.44 22.49 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.947 0.899 . . . . 62.33 109.477 174.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.43 -111.12 3.43 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.581 -1.19 . . . . 73.13 111.764 -169.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -119.06 2.57 11.47 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.802 0.841 . . . . 73.22 110.905 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -112.66 148.96 33.56 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.888 -0.782 . . . . 75.23 108.888 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.6 m -61.6 140.42 58.14 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.55 0.531 . . . . 53.11 110.874 -176.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.76 -67.14 0.86 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.676 -1.231 . . . . 63.12 107.676 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -148.1 158.07 43.86 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.969 -1.014 . . . . 64.5 109.862 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 41.7 mt -132.6 109.42 9.73 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 106.365 -1.717 . . . . 61.31 106.365 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 39.3 t -120.77 117.04 26.41 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.27 0.487 . . . . 50.14 110.05 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.4 tt0 -122.28 132.67 54.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.22 1.008 . . . . 65.11 108.736 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 75.5 t -128.48 147.64 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.111 -0.7 . . . . 74.01 109.111 173.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.534 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 80.2 mt-30 -125.36 102.99 7.68 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.094 -0.706 . . . . 62.53 109.094 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -90.44 104.78 17.32 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.658 -0.868 . . . . 64.25 108.658 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.59 171.11 37.62 Favored Glycine 0 C--O 1.243 0.68 0 N-CA-C 111.364 -0.694 . . . . 71.34 111.364 174.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.67 130.65 2.15 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 112.121 -0.392 . . . . 71.45 112.121 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.402 HG13 ' HE1' ' B' ' 17' ' ' TYR . 39.3 mt -89.89 127.47 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.334 0.653 . . . . 74.43 109.32 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -135.15 132.92 38.61 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.393 -1.336 . . . . 71.44 107.393 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m -101.62 90.97 4.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.705 0.402 . . . . 72.55 110.787 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.532 ' HB ' HD11 ' B' ' 89' ' ' ILE . 16.1 pt -96.25 145.25 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.494 0.718 . . . . 64.44 111.614 -167.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.77 157.16 32.85 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.279 1.031 . . . . 72.31 109.96 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.02 -39.31 2.94 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 123.378 0.513 . . . . 71.01 113.657 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.64 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -79.12 146.65 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.062 0.545 . . . . 65.4 111.237 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -162.95 162.62 26.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.046 0.841 . . . . 74.42 109.506 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.99 -118.13 9.28 Favored Glycine 0 N--CA 1.474 1.171 0 CA-C-N 115.976 -0.556 . . . . 44.12 113.553 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 99.5 m -69.63 -33.48 72.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.663 0.785 . . . . 72.11 110.708 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -66.74 -38.98 87.74 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.264 0.625 . . . . 62.31 111.466 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -32.92 60.49 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.357 0.263 . . . . 75.22 111.29 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.27 75.13 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.495 -0.775 . . . . 44.12 110.103 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -72.36 -34.85 68.29 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.034 0.933 . . . . 63.24 110.677 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -68.11 -67.5 0.46 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.498 0.499 . . . . 64.12 110.812 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.417 HD21 HD13 ' B' ' 86' ' ' ILE . 68.2 mt -81.84 -16.51 50.57 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 111.873 0.323 . . . . 61.34 111.873 -173.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.13 -9.69 55.49 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 114.57 0.588 . . . . 70.41 114.57 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.99 -56.3 0.25 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.382 0.591 . . . . 73.22 111.722 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -71.7 -48.53 46.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.709 0.804 . . . . 71.43 112.06 -169.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 98.6 m -61.27 -47.23 94.81 Favored Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 124.158 0.983 . . . . 63.23 111.777 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.421 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 76.1 Cg_exo -56.03 -41.17 79.75 Favored 'Trans proline' 0 C--N 1.395 3.0 0 C-N-CA 122.406 2.071 . . . . 70.32 113.587 167.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -62.73 -29.37 70.62 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.482 0.713 . . . . 74.22 111.914 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.52 HG23 ' NH2' ' D' ' 111' ' ' ARG . 77.7 mt -69.63 -41.65 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.85 0.86 . . . . 74.35 110.748 173.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.76 -19.52 57.52 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.981 -1.009 . . . . 62.12 112.255 -173.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -56.71 -48.58 96.99 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 114.872 1.434 . . . . 74.51 114.872 -170.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.77 -37.53 95.49 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.457 2.104 . . . . 72.11 113.828 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -71.25 -43.03 68.06 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.661 -0.699 . . . . 54.21 110.369 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -40.57 87.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.597 0.759 . . . . 74.33 110.776 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -60.53 -53.11 61.42 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.192 0.997 . . . . 45.33 111.212 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.23 -33.25 75.56 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.459 0.704 . . . . 61.31 110.397 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.622 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -67.89 -42.91 80.49 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.804 0.842 . . . . 74.14 111.658 177.389 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.63 -51.51 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.77 -0.456 . . . . 45.02 109.77 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.48 HG21 ' OG ' ' C' ' 119' ' ' SER . 19.8 m -60.13 -34.35 73.41 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.873 0.869 . . . . 32.23 111.646 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.4 t -60.34 -48.01 83.59 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.732 0.645 . . . . 54.21 110.075 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -74.77 -31.29 61.73 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.446 0.698 . . . . 63.52 111.524 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.08 -39.4 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.894 0.878 . . . . 64.04 110.559 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.407 ' OG ' HG21 ' C' ' 115' ' ' THR . 30.4 t -65.28 -40.64 94.13 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.84 0.856 . . . . 75.14 111.065 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.561 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 78.0 mtt-85 -66.24 -33.49 75.87 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 114.843 -1.071 . . . . 52.14 110.128 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.12 7.42 75.34 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-O 119.361 -0.688 . . . . 54.53 113.677 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.437 HG23 ' HB3' ' A' ' 17' ' ' TYR . 80.6 p 56.12 29.68 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.905 1.682 . . . . 73.23 113.537 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -93.24 154.76 41.47 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.025 0.93 . . . . 75.24 110.787 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.23 165.94 1.91 Allowed 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 123.909 3.073 . . . . 71.23 115.556 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -63.58 137.62 58.19 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.461 1.104 . . . . 73.31 113.191 -168.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.99 112.31 15.09 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 107.753 -1.202 . . . . 75.51 107.753 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -130.53 109.54 10.76 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.589 -0.893 . . . . 53.54 108.589 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.463 HD11 HD22 ' B' ' 42' ' ' LEU . 33.6 tp -82.87 137.41 34.28 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.637 0.375 . . . . 65.24 110.397 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.32 144.75 92.47 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.148 0.979 . . . . 63.43 111.415 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.449 ' HG3' HD13 ' D' ' 16' ' ' ILE . 33.3 Cg_endo -61.64 109.2 0.72 Allowed 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.897 2.398 . . . . 75.22 112.298 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -89.83 111.9 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.615 -0.884 . . . . 74.43 108.615 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -78.5 87.93 4.47 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.22 -1.03 . . . . 45.42 108.22 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -59.06 -36.72 75.53 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.519 0.727 . . . . 73.43 111.339 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.12 -40.85 95.07 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.581 1.152 . . . . 73.25 111.998 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.85 -47.27 66.37 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.738 0.815 . . . . 62.13 110.855 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.89 -20.75 59.59 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.535 -0.757 . . . . 73.02 110.873 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 94.4 t80 . . . . . 0 N--CA 1.475 0.796 0 C-N-CA 123.588 0.755 . . . . 74.52 110.112 173.08 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 36.4 m . . . . . 0 C--O 1.223 -0.331 0 N-CA-C 108.613 -0.884 . . . . 72.42 108.613 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.406 ' HD2' ' HG3' ' A' ' 130' ' ' PRO . 60.2 t80 -115.57 126.48 54.28 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.801 -0.814 . . . . 75.53 108.801 176.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -140.68 125.45 18.11 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.875 -0.787 . . . . 71.14 108.875 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.418 ' HA ' ' HD2' ' C' ' 84' ' ' PHE . 56.1 mt -66.44 123.94 20.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.81 -0.811 . . . . 73.45 108.81 171.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -89.63 -48.74 7.09 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.157 -0.683 . . . . 71.32 109.157 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -174.33 125.89 0.33 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 115.565 -0.743 . . . . 74.13 110.404 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -109.46 143.22 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 107.919 -1.141 . . . . 63.12 107.919 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.432 ' HE1' HG12 ' C' ' 83' ' ' ILE . 25.1 p90 -176.25 169.58 2.73 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.406 0.622 . . . . 70.03 111.007 -173.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -93.02 114.59 27.18 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.318 -0.856 . . . . 61.14 109.533 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.633 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -68.34 -34.09 75.46 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.814 -0.81 . . . . 72.33 108.814 175.089 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -154.19 146.45 23.83 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.945 -1.479 . . . . 75.12 109.618 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.7 mt -140.61 144.37 27.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 125.607 1.563 . . . . 73.14 106.846 175.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -154.04 149.32 27.05 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.51 0.672 . . . . 65.23 110.116 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -153.68 125.16 7.57 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.159 -1.423 . . . . 41.52 107.159 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -132.23 109.96 10.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.062 0.545 . . . . 62.04 109.724 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.59 79.58 73.43 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 106.716 -1.587 . . . . 53.13 106.716 168.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.74 -25.34 28.8 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.767 2.311 . . . . 71.51 112.001 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -106.1 17.57 23.34 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.214 1.406 . . . . 72.42 110.932 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.404 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -42.89 -57.57 4.83 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 114.864 1.431 . . . . 15.15 114.864 -167.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.17 -36.63 68.22 Favored 'Trans proline' 0 C--N 1.391 2.774 0 CA-C-N 122.24 1.836 . . . . 74.34 112.529 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -69.09 -39.09 79.22 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.446 0.698 . . . . 74.12 111.637 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.813 HG21 ' HA ' ' C' ' 73' ' ' ALA . 2.9 p -79.39 -20.79 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 N-CA-C 112.412 0.523 . . . . 63.42 112.412 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -67.91 -31.71 71.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.545 0.572 . . . . 74.33 112.545 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -88.35 15.25 8.01 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.874 0.47 . . . . 73.54 111.057 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.43 161.34 13.83 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.954 0.902 . . . . 71.33 110.544 -176.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.92 126.85 30.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.624 0.77 . . . . 63.1 109.798 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 59.9 t90 -76.0 107.14 8.0 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.654 0.782 . . . . 74.32 109.847 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.56 73.16 2.87 Favored Pre-proline 0 CA--C 1.555 1.138 0 N-CA-C 107.328 -1.36 . . . . 54.04 107.328 173.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.59 134.18 8.59 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.092 2.528 . . . . 64.24 113.949 -174.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -87.38 95.13 9.9 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 106.345 -1.724 . . . . 74.24 106.345 168.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 m -75.88 96.23 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 122.275 1.036 . . . . 73.21 109.815 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.428 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 40.2 ttmt -100.8 103.09 14.3 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.582 -1.19 . . . . 64.01 108.082 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.8 mp -88.32 132.54 34.37 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 107.783 -1.191 . . . . 63.42 107.783 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.4 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.1 t70 -117.63 104.72 11.3 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.469 -1.308 . . . . 73.31 107.469 173.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 84.3 mt -95.58 143.23 27.05 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.305 -0.861 . . . . 60.42 109.236 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.2 t70 -148.33 144.27 27.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.993 0.917 . . . . 65.24 108.954 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 t -138.42 124.75 20.46 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.648 -0.871 . . . . 64.42 108.648 172.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.07 145.3 45.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.782 -0.821 . . . . 70.42 108.782 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -130.49 156.0 45.52 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.989 0.516 . . . . 63.31 111.115 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 29.5 t -144.8 139.84 28.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.369 1.067 . . . . 75.03 109.587 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -88.86 118.32 28.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.963 -1.125 . . . . 71.34 107.963 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.625 HD11 HD12 ' C' ' 83' ' ' ILE . 62.2 mt -90.0 -48.84 6.95 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.802 0.811 . . . . 72.03 109.362 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.18 -177.85 5.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 113.996 -1.456 . . . . 50.01 108.501 170.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.41 110.73 1.16 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.442 1.089 . . . . 72.14 110.703 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 22.6 m-20 68.3 9.28 7.14 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 125.386 1.474 . . . . 71.04 113.367 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.7 t -93.1 107.53 19.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 107.198 -1.408 . . . . 72.0 107.198 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -102.08 122.37 43.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.149 -1.387 . . . . 74.15 108.088 -164.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -105.01 122.57 46.13 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.944 -1.132 . . . . 75.44 107.944 173.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -114.99 141.06 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 108.515 -0.92 . . . . 73.13 108.515 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.417 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 87.2 t -128.99 139.75 51.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.811 -0.811 . . . . 63.53 108.811 174.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.81 105.95 11.21 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.524 -1.287 . . . . 73.42 107.524 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.615 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 23.3 ttm-85 -93.58 107.7 19.52 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.603 -0.888 . . . . 72.31 108.603 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.448 ' HB ' HD11 ' C' ' 114' ' ' ILE . 24.1 t -107.11 120.42 58.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.438 -0.949 . . . . 74.34 108.438 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 43.6 m -117.68 131.53 56.62 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.23 -0.656 . . . . 45.4 109.23 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.405 HG23 HD13 ' C' ' 114' ' ' ILE . 60.2 t -108.41 125.28 65.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.972 -0.751 . . . . 54.03 108.972 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 6.6 m -118.38 123.93 46.47 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.515 -0.92 . . . . 72.12 108.515 173.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.92 99.65 7.23 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.493 -1.299 . . . . 62.13 107.493 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.9 m -108.18 120.6 42.83 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 109.7 -0.482 . . . . 72.5 109.7 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 8.7 mt -84.92 49.29 1.7 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.182 1.393 . . . . 75.43 109.589 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.79 -98.85 1.81 Allowed Glycine 0 C--N 1.35 1.317 0 N-CA-C 110.557 -1.017 . . . . 50.22 110.557 -174.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.39 -30.28 12.29 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.319 1.048 . . . . 61.23 109.97 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -79.78 120.07 23.55 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 124.348 1.059 . . . . 73.5 110.581 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 86.8 m -85.29 127.12 34.21 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 119.057 0.844 . . . . 72.33 109.764 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.813 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.85 -56.81 5.06 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.653 1.181 . . . . 70.53 110.101 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 74' ' ' PHE . . . . . 0.437 ' HZ ' HD22 ' C' ' 126' ' ' LEU . 33.0 p90 -157.4 164.52 37.43 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.287 -0.869 . . . . 75.04 112.284 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -128.25 105.29 8.25 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.636 -1.616 . . . . 73.33 106.636 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.9 t -109.41 148.69 30.7 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.974 -0.75 . . . . 74.24 108.974 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -156.42 136.81 13.04 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.414 -0.587 . . . . 71.22 109.414 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.0 t -133.93 135.02 55.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.89 -1.152 . . . . 70.24 107.89 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -111.5 89.42 3.05 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.952 -1.129 . . . . 65.02 107.952 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -78.99 100.27 7.23 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.061 -0.972 . . . . 74.5 110.04 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.633 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -89.24 169.07 35.79 Favored Glycine 0 C--O 1.242 0.636 0 CA-C-N 115.728 -0.669 . . . . 71.11 112.799 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.448 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -168.06 118.51 0.79 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.384 -0.686 . . . . 41.22 111.384 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.625 HD12 HD11 ' C' ' 51' ' ' LEU . 12.9 mm -84.01 133.44 29.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 108.821 -0.807 . . . . 61.43 108.821 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.418 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 45.3 m-85 -141.09 122.68 15.13 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.639 0.775 . . . . 72.23 109.337 -177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 53.0 p -79.84 127.31 32.07 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.09 -1.078 . . . . 62.12 108.09 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.54 HD11 HD11 ' C' ' 89' ' ' ILE . 9.6 tt -141.91 143.09 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-O 121.036 0.446 . . . . 54.02 111.714 -170.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.78 169.18 24.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.344 1.058 . . . . 64.44 109.649 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.07 -46.34 1.19 Allowed Glycine 0 N--CA 1.471 1.012 0 CA-C-N 116.458 -0.337 . . . . 74.24 113.878 171.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.54 HD11 HD11 ' C' ' 86' ' ' ILE . 0.2 OUTLIER -113.39 146.77 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 122.935 0.494 . . . . 75.25 110.236 -176.253 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -146.83 -177.89 5.9 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.786 0.434 . . . . 73.11 111.008 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.25 -122.6 11.29 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 115.753 -0.658 . . . . 61.42 113.078 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 79.9 p -70.53 -23.79 62.7 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.589 0.756 . . . . 62.34 110.929 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -73.68 -32.16 63.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.661 0.785 . . . . 72.01 110.746 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 55.5 ttp -66.78 -40.64 88.24 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.086 -0.709 . . . . 71.12 109.086 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.27 -36.3 83.68 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.563 -0.744 . . . . 73.05 111.383 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -76.86 -21.02 55.61 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.576 0.35 . . . . 74.14 111.607 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.9 t -61.28 -54.5 43.25 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.63 0.372 . . . . 35.15 110.097 173.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -75.66 -22.14 57.01 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.102 0.561 . . . . 75.12 111.147 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.55 -26.41 65.5 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 114.889 0.716 . . . . 34.43 114.889 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.56 -60.21 0.08 Allowed 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 112.494 0.553 . . . . 72.01 112.494 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -52.71 -47.76 67.08 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 124.154 0.909 . . . . 73.12 112.604 -167.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.9 m -78.4 -48.44 1.89 Allowed Pre-proline 0 CA--C 1.561 1.379 0 CA-C-O 117.78 -1.105 . . . . 63.51 112.422 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.57 -32.51 44.4 Favored 'Trans proline' 0 C--N 1.403 3.402 0 C-N-CA 122.197 1.931 . . . . 62.03 113.636 170.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -66.71 -38.04 85.91 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.278 1.031 . . . . 64.43 111.417 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.414 HD12 ' NH1' ' A' ' 111' ' ' ARG . 36.7 mm -64.5 -45.65 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 109.488 -0.56 . . . . 65.02 109.488 173.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.448 HD21 ' HA3' ' C' ' 82' ' ' GLY . 74.5 mt -78.48 -18.6 54.59 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.03 -0.987 . . . . 64.41 112.493 -172.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.404 ' HE1' HD13 ' C' ' 128' ' ' LEU . 79.0 t80 -59.0 -50.99 85.04 Favored Pre-proline 0 CA--C 1.56 1.358 0 N-CA-C 114.233 1.197 . . . . 71.54 114.233 -171.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.36 -32.48 72.13 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.789 1.659 . . . . 74.14 112.518 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -67.65 -45.15 76.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.15 0.58 . . . . 70.53 110.195 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.54 -45.2 89.39 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.918 0.887 . . . . 45.34 110.519 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -57.7 -54.74 43.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.634 1.174 . . . . 72.14 111.117 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -67.18 -33.05 74.57 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.299 0.64 . . . . 71.44 110.877 -173.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.2 t -69.5 -32.21 70.93 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.888 0.475 . . . . 53.14 110.932 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.448 HD11 ' HB ' ' C' ' 62' ' ' VAL . 74.7 mt -71.31 -53.32 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.59 -0.522 . . . . 51.42 109.59 173.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.407 HG21 ' OG ' ' B' ' 119' ' ' SER . 14.5 m -60.73 -29.68 69.52 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.74 0.816 . . . . 70.25 111.326 -173.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 31.7 t -61.78 -54.54 40.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.235 -0.893 . . . . 72.31 109.155 171.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.492 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.73 -37.66 79.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.794 1.238 . . . . 72.01 112.867 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.485 HG11 HD13 ' C' ' 126' ' ' LEU . 85.6 t -64.49 -46.7 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.59 0.756 . . . . 73.32 109.8 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.48 ' OG ' HG21 ' B' ' 115' ' ' THR . 34.7 t -66.28 -32.71 74.29 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.985 -1.007 . . . . 50.1 111.473 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.421 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 74.6 mtt-85 -66.49 -41.16 89.33 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.408 0.683 . . . . 71.33 109.481 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.23 7.81 62.85 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.706 -0.679 . . . . 75.22 112.989 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 77.4 p 57.96 33.32 23.06 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.906 1.682 . . . . 74.05 113.661 171.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -91.08 163.13 30.52 Favored Pre-proline 0 CA--C 1.565 1.526 0 C-N-CA 124.231 1.012 . . . . 61.22 108.86 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.11 172.75 3.75 Favored 'Trans proline' 0 C--N 1.39 2.729 0 C-N-CA 122.997 2.465 . . . . 60.1 113.82 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -62.48 112.74 2.59 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.945 0.898 . . . . 75.25 112.669 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.485 HD13 HG11 ' C' ' 118' ' ' VAL . 8.9 mp -110.98 112.0 23.51 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.431 -0.952 . . . . 64.2 108.431 169.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -124.59 131.29 53.48 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.498 0.719 . . . . 53.04 109.223 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.404 HD13 ' HE1' ' C' ' 107' ' ' PHE . 1.4 tt -79.33 131.2 36.06 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.333 -0.617 . . . . 65.31 109.333 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.17 150.75 91.82 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.235 1.014 . . . . 51.15 111.433 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.07 103.29 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.382 2.055 . . . . 73.11 112.533 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 90.6 t -97.22 111.23 26.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.663 -0.866 . . . . 75.42 108.663 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -82.96 83.81 7.67 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 108.042 -1.096 . . . . 74.44 108.042 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -59.36 -22.47 61.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.11 0.564 . . . . 73.41 111.87 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -63.19 -56.2 18.72 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.692 0.797 . . . . 64.44 110.848 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.11 -38.58 79.93 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.725 1.266 . . . . 71.43 110.641 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 74.8 mt -74.19 -29.5 61.78 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.493 -1.23 . . . . 63.43 111.675 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 19.5 t80 . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 110.142 -0.318 . . . . 75.22 110.142 179.928 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 89.3 m . . . . . 0 C--O 1.239 0.531 0 CA-C-O 120.945 0.402 . . . . 62.13 110.022 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -164.01 91.34 0.63 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.785 -1.561 . . . . 74.05 106.785 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -112.84 114.06 26.42 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.868 -1.16 . . . . 71.01 107.868 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.58 105.57 4.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.678 -0.86 . . . . 64.44 108.678 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -77.38 -37.85 51.23 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.172 -0.467 . . . . 63.11 111.892 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -166.2 144.1 5.48 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 111.786 0.291 . . . . 71.44 111.786 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.449 HD13 ' HG3' ' B' ' 130' ' ' PRO . 1.7 mp -121.86 134.12 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 106.016 -1.846 . . . . 62.14 106.016 167.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -161.44 163.18 30.64 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.9 0.857 . . . . 74.13 111.489 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -95.01 119.72 34.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.267 -1.333 . . . . 55.45 108.924 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -88.96 -22.34 23.1 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.568 -0.53 . . . . 70.11 109.568 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.609 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.2 t70 -155.67 139.4 16.11 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 114.933 -1.031 . . . . 64.22 109.8 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.492 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.0 mt -143.62 136.78 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.938 1.295 . . . . 74.42 107.553 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.6 t -146.76 109.25 4.53 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.807 -0.812 . . . . 63.2 108.807 174.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.601 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.8 t80 -114.22 128.28 56.29 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.991 -1.114 . . . . 73.41 107.991 168.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.14 127.14 40.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.516 0.727 . . . . 75.11 109.324 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.31 87.42 2.05 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 106.559 -1.645 . . . . 62.22 106.559 165.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.55 -41.72 18.82 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.276 1.984 . . . . 72.42 112.505 -166.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -111.09 15.2 21.75 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.125 0.97 . . . . 75.24 109.979 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.488 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -18.61 -70.26 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 117.227 2.306 . . . . 74.35 117.227 -168.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 64.6 Cg_endo -77.14 -23.75 10.15 Favored 'Trans proline' 0 C--N 1.382 2.329 0 CA-C-N 123.953 2.447 . . . . 74.13 113.772 -173.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -72.88 -36.54 67.37 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.631 0.772 . . . . 74.44 109.218 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' D' ' 73' ' ' ALA . 6.8 p -83.26 -19.13 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.229 0 CA-C-N 115.731 -0.668 . . . . 62.13 110.694 -176.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.6 m-85 -70.01 -19.02 63.34 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.835 0.454 . . . . 75.42 111.928 175.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -55.3 -34.09 63.84 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.817 0.698 . . . . 64.14 110.073 172.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.425 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 42.1 mtmt -91.88 78.02 5.42 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.583 -1.19 . . . . 75.33 109.095 168.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.01 82.0 3.53 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.836 0.827 . . . . 73.14 109.493 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -147.84 157.96 43.79 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.532 -1.213 . . . . 74.4 108.79 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -63.8 106.89 1.04 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.133 0.973 . . . . 74.31 108.979 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.506 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 23.1 Cg_exo -65.82 146.0 82.16 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.754 2.302 . . . . 62.45 112.196 -172.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -63.27 110.97 2.06 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.164 -1.05 . . . . 74.02 108.164 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.14 146.07 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-O 121.427 0.632 . . . . 74.15 111.225 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -129.59 118.94 22.8 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.401 -2.074 . . . . 70.42 105.401 172.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -97.01 145.37 26.01 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.633 -0.877 . . . . 75.43 108.633 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.558 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.8 m-20 -129.29 143.34 50.81 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.024 -0.732 . . . . 74.25 109.024 172.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -119.38 136.42 54.29 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.232 -1.025 . . . . 71.12 108.232 173.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 37.9 t70 -138.37 131.5 30.05 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.274 -1.38 . . . . 70.14 107.274 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -104.09 148.12 26.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.221 0.534 . . . . 62.44 109.57 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.58 165.41 33.4 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.897 -1.047 . . . . 53.31 108.536 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 31.1 p -164.77 155.97 15.01 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.179 0.592 . . . . 62.41 110.151 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 32.0 t -151.62 123.95 8.29 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.317 0.647 . . . . 71.35 110.626 -171.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -73.4 116.65 14.21 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.179 -1.045 . . . . 72.02 108.179 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' D' ' 57' ' ' GLU . 60.1 mt -91.79 -41.11 10.84 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.302 0.572 . . . . 75.51 110.11 -177.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.17 -175.09 5.25 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.449 -1.251 . . . . 41.32 109.261 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -66.27 124.91 23.97 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 123.731 0.644 . . . . 74.5 109.434 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 63.77 0.59 0.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.84 1.256 . . . . 50.11 113.887 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.9 t -108.29 114.11 45.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 107.728 -1.212 . . . . 61.44 107.728 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 129.33 37.12 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.195 -1.039 . . . . 75.14 108.195 -170.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.48 ' HB2' HD11 ' D' ' 51' ' ' LEU . 30.2 tt0 -99.82 147.47 25.46 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.325 1.05 . . . . 53.24 109.4 177.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.16 127.47 73.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.378 -1.342 . . . . 72.41 107.378 170.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.433 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 61.8 t -109.58 109.95 30.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.994 -0.743 . . . . 73.22 108.994 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.85 119.35 30.98 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.789 -0.819 . . . . 74.21 108.789 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.539 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 47.7 ttm-85 -98.74 109.98 22.66 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.88 -1.156 . . . . 73.55 107.88 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.51 HG21 ' HB1' ' D' ' 110' ' ' ALA . 38.8 t -115.06 118.77 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.787 -0.819 . . . . 72.51 108.787 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 12.0 m -115.46 144.31 44.02 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.487 1.115 . . . . 74.53 109.381 -171.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.483 HG21 HD21 ' D' ' 126' ' ' LEU . 58.5 t -139.01 103.82 2.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.18 0.992 . . . . 72.04 108.919 172.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 99.9 m -97.47 120.19 37.38 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.25 -1.019 . . . . 71.51 108.25 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -122.37 154.93 37.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.659 0.784 . . . . 72.4 110.925 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 54.7 m -150.6 139.69 21.1 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.562 0.539 . . . . 70.12 112.127 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.433 HD12 HG22 ' D' ' 31' ' ' VAL . 11.7 mt -110.7 121.05 44.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.054 1.342 . . . . 64.12 108.977 171.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.0 -113.28 4.27 Favored Glycine 0 C--N 1.341 0.829 0 O-C-N 123.338 0.399 . . . . 72.11 112.72 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.12 5.86 18.81 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.103 0.961 . . . . 74.11 110.898 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.425 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 15.8 pt-20 -132.13 158.75 40.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.86 0.464 . . . . 63.23 110.613 -174.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 65.4 m -71.39 138.48 49.19 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 116.061 -0.518 . . . . 41.32 110.603 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.624 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.19 -68.67 0.78 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.891 0.876 . . . . 43.24 109.624 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -146.36 145.96 30.49 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 121.551 0.691 . . . . 74.21 110.25 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -120.24 141.03 50.31 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.658 1.583 . . . . 74.22 106.956 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.564 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.4 t -153.79 139.0 17.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.56 -0.534 . . . . 72.43 109.56 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -156.9 132.16 9.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.41 -0.589 . . . . 75.33 109.41 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.06 120.15 46.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.756 0.823 . . . . 75.21 109.277 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.609 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.3 mt-30 -89.43 86.82 6.87 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.647 -0.872 . . . . 72.31 108.647 169.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -80.03 94.4 5.93 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.695 -1.139 . . . . 63.12 108.917 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.09 143.34 18.07 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.926 -0.47 . . . . 34.4 111.926 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.558 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -140.64 131.5 5.01 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.714 -0.554 . . . . 64.13 111.714 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -94.67 125.13 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.719 0.808 . . . . 73.23 109.447 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -132.18 125.11 30.4 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.052 0.941 . . . . 71.34 109.743 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.6 m -87.76 104.15 16.29 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.524 -0.547 . . . . 72.54 109.524 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.438 HD12 ' SD ' ' D' ' 94' ' ' MET . 39.9 pt -107.08 141.19 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.902 0.881 . . . . 63.43 110.807 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -169.14 165.96 10.95 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.976 0.91 . . . . 75.33 110.889 173.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.72 -19.62 19.39 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.197 -0.456 . . . . 71.13 112.925 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.489 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -118.97 149.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.084 0.953 . . . . 71.24 108.691 177.246 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -154.32 160.06 41.54 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.336 0.495 . . . . 73.42 112.336 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.36 -121.31 24.98 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 114.791 -1.095 . . . . 74.12 113.51 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.7 p -71.12 -31.98 68.44 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.892 0.877 . . . . 72.33 111.484 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -69.59 -40.34 76.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.761 0.425 . . . . 70.33 110.109 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.438 ' SD ' HD12 ' D' ' 86' ' ' ILE . 7.1 tmm? -72.45 -37.65 68.48 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.382 -0.826 . . . . 64.11 109.777 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.74 71.27 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.031 0.532 . . . . 70.34 111.507 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.408 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.7 t-160 -69.49 -39.39 77.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.129 0.972 . . . . 63.23 110.16 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -68.85 -50.31 50.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.808 -0.633 . . . . 74.22 110.435 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.68 -25.21 44.78 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.554 0.742 . . . . 73.12 111.645 -168.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.12 11.23 37.22 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-O 119.607 -0.552 . . . . 42.43 113.543 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -149.36 -58.25 0.2 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.184 0.492 . . . . 74.21 111.227 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -70.7 -46.95 62.17 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.272 0.629 . . . . 64.53 111.689 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.401 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 55.1 m -67.37 -44.21 45.75 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.503 -0.76 . . . . 71.1 111.693 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 76.9 Cg_exo -56.52 -32.82 90.96 Favored 'Trans proline' 0 C--N 1.394 2.922 0 C-N-CA 122.479 2.119 . . . . 63.13 113.423 165.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -71.34 -25.32 62.34 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.002 0.521 . . . . 72.32 111.216 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 64.0 mt -77.12 -34.47 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.894 0.877 . . . . 75.23 110.138 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.558 HD21 ' HA3' ' D' ' 82' ' ' GLY . 95.9 mt -76.77 -22.71 53.37 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.561 -0.745 . . . . 73.51 111.724 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -67.41 -42.05 35.74 Favored Pre-proline 0 CA--C 1.565 1.557 0 N-CA-C 113.941 1.089 . . . . 74.11 113.941 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -60.41 -40.49 57.32 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.097 1.865 . . . . 60.21 112.71 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -73.06 -33.71 65.83 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.586 0.754 . . . . 72.33 111.511 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.51 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -63.79 -53.12 55.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.641 0.776 . . . . 75.2 109.523 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.52 ' NH2' HG23 ' B' ' 105' ' ' ILE . 28.5 ttp180 -54.65 -48.57 72.15 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 124.895 1.372 . . . . 75.01 110.588 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -60.33 -46.3 90.4 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.155 0.909 . . . . 72.31 111.651 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.02 -42.08 93.59 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.788 0.68 . . . . 73.1 110.719 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.564 HG23 ' SG ' ' D' ' 76' ' ' CYS . 72.2 mt -64.17 -50.66 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 124.174 0.921 . . . . 72.23 110.988 174.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 41.5 m -57.32 -42.42 81.81 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.808 1.243 . . . . 74.34 110.831 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -65.31 -41.61 93.87 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.264 -1.334 . . . . 74.25 110.446 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.41 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 73.3 mtm -71.6 -31.06 66.51 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.198 0.444 . . . . 52.33 112.198 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.73 -42.06 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.328 0.651 . . . . 74.42 109.842 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 84.6 p -76.22 -27.08 56.67 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.876 0.47 . . . . 54.02 111.531 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -75.83 -34.2 60.1 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.002 0.521 . . . . 72.15 110.057 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.72 89.41 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.981 -0.554 . . . . 53.02 111.962 171.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 38.5 p 64.01 19.57 11.81 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.153 2.181 . . . . 62.14 114.077 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -78.4 149.39 75.4 Favored Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 108.549 -0.908 . . . . 71.13 108.549 170.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.34 137.35 71.4 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.817 2.345 . . . . 71.55 112.113 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -55.55 146.21 21.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.793 1.237 . . . . 71.2 113.247 -164.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.483 HD21 HG21 ' D' ' 64' ' ' VAL . 38.3 tp -116.48 94.21 4.53 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.256 -0.884 . . . . 71.13 109.328 -176.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 127' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 88.0 m-20 -104.82 91.48 3.85 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.563 -0.903 . . . . 74.52 108.563 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 23.6 tp -73.66 133.54 43.44 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.409 -0.814 . . . . 75.11 110.314 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.19 146.02 99.0 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.582 0.753 . . . . 55.34 111.167 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.4 124.33 3.63 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.329 2.019 . . . . 74.44 111.048 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 99.3 t -107.27 133.48 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.032 -0.531 . . . . 73.41 109.594 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -79.35 88.61 4.97 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.007 -0.738 . . . . 72.23 109.007 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -65.21 -24.87 67.48 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.759 -1.109 . . . . 72.24 111.469 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.95 -52.67 63.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.884 0.873 . . . . 71.53 110.593 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.02 -37.59 66.87 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.348 -0.842 . . . . 60.23 111.721 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.25 -31.33 72.07 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 115.616 -0.72 . . . . 75.42 110.162 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 84.4 t80 . . . . . 0 N--CA 1.485 1.312 0 C-N-CA 123.811 0.845 . . . . 63.44 110.653 176.581 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.6 m . . . . . 0 C--O 1.239 0.501 0 N-CA-C 108.732 -0.84 . . . . 61.52 108.732 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.488 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 35.9 t80 -136.31 111.91 9.34 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.32 -0.992 . . . . 71.24 108.32 170.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -136.47 124.56 22.96 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.549 -0.908 . . . . 41.32 108.549 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.568 HD11 HG21 ' A' ' 105' ' ' ILE . 50.3 mt -89.45 112.04 23.82 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.781 -0.822 . . . . 73.14 108.781 172.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -74.29 -38.59 63.32 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 124.412 1.07 . . . . 65.41 109.523 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -167.07 140.87 3.72 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.829 -0.623 . . . . 73.01 110.568 -169.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.484 HD11 HD13 ' A' ' 13' ' ' ILE . 79.6 mt -128.72 135.1 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.054 -1.091 . . . . 73.41 108.054 172.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.413 ' HB3' HG23 ' B' ' 122' ' ' THR . 33.0 p90 -162.98 151.24 13.99 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 124.18 0.925 . . . . 74.34 110.249 -176.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -74.64 121.93 22.39 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.842 -0.799 . . . . 74.15 108.842 172.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 27.7 mtpt -82.07 -32.61 30.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.716 -0.475 . . . . 72.54 109.716 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.6 t70 -147.72 141.53 25.73 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.057 -0.974 . . . . 73.31 109.462 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.52 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 70.1 mt -136.67 147.67 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.138 1.375 . . . . 53.13 107.494 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.554 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 40.4 t -157.23 149.45 22.81 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.305 0.642 . . . . 44.22 109.699 172.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.482 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 88.8 t80 -151.53 124.53 8.65 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.368 -1.716 . . . . 71.43 106.368 177.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -129.41 114.27 15.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.73 0.412 . . . . 71.33 109.954 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.28 77.0 67.54 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 108.018 -1.105 . . . . 53.43 108.018 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.68 -29.01 20.13 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.203 1.935 . . . . 73.04 110.354 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.403 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 72.3 m-20 -100.94 24.64 9.0 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.139 1.376 . . . . 74.3 110.072 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -56.98 -42.59 97.17 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 124.536 1.134 . . . . 72.32 112.742 170.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.3 -24.61 14.24 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 121.87 1.713 . . . . 71.02 112.52 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -72.86 -33.7 66.27 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.223 0.609 . . . . 73.13 111.184 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.621 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 9.8 p -68.33 -25.36 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 123.52 0.513 . . . . 54.01 111.049 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -69.8 -33.66 72.66 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.241 1.016 . . . . 43.43 110.118 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -92.27 -33.73 14.53 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.76 0.824 . . . . 73.34 111.562 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.621 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -82.67 171.77 13.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.189 0.595 . . . . 73.42 110.364 176.334 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -86.2 138.96 31.48 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.009 0.524 . . . . 70.44 110.687 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.6 t-105 -76.26 87.0 3.08 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 121.506 0.669 . . . . 63.13 110.205 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -125.52 79.68 66.94 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 108.341 -0.985 . . . . 63.42 108.341 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -86.39 138.65 5.61 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.104 2.536 . . . . 54.32 114.248 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -112.04 110.71 21.16 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 106.334 -1.728 . . . . 73.41 106.334 166.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.7 m -112.97 134.87 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.917 0.887 . . . . 72.51 111.619 -165.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -121.69 149.18 43.61 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.719 0.808 . . . . 64.23 110.171 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -127.32 109.29 11.65 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.035 0.934 . . . . 65.33 108.505 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -106.58 118.5 36.82 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.673 -0.862 . . . . 73.43 108.673 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.409 HD11 HD11 ' A' ' 60' ' ' LEU . 9.8 tt -116.04 141.62 47.88 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 122.788 0.435 . . . . 61.5 110.216 -177.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -143.23 132.56 23.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.934 1.293 . . . . 72.12 108.91 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.0 m -109.94 135.9 50.07 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.116 0.967 . . . . 75.01 108.631 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.01 129.67 40.41 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.716 0.806 . . . . 60.14 109.917 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.5 p -93.73 152.07 19.2 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.001 0.52 . . . . 73.44 110.545 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 43.3 t -150.03 151.96 34.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.19 0.996 . . . . 64.21 108.379 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -112.46 116.14 29.81 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.121 -0.696 . . . . 73.52 109.121 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.0 mt -92.04 -33.45 14.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.532 0.733 . . . . 71.24 110.421 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.67 178.67 10.07 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.32 -0.855 . . . . 70.43 109.968 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.59 121.77 14.7 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.198 -0.668 . . . . 73.04 109.198 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 69.25 9.53 7.38 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.602 1.161 . . . . 75.1 112.199 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.21 115.93 51.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 108.74 -0.837 . . . . 73.31 108.74 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -112.74 127.33 56.11 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.426 0.69 . . . . 72.43 110.022 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 44.9 tt0 -91.78 127.74 37.35 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.876 -1.056 . . . . 73.44 108.795 169.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.412 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 64.7 t -108.77 122.5 63.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.714 -1.217 . . . . 71.14 107.714 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.9 t -104.37 107.04 21.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.896 -1.15 . . . . 63.24 107.896 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.409 HD11 HD11 ' A' ' 44' ' ' LEU . 43.6 tp -87.85 98.96 11.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.53 -0.915 . . . . 64.34 108.53 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -84.99 110.59 19.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.438 -0.801 . . . . 71.02 109.447 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.4 t -112.84 107.72 23.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.64 -0.874 . . . . 72.22 108.64 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.7 m -95.29 125.71 40.1 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.117 0.967 . . . . 75.44 108.984 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.727 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 26.5 t -118.43 135.52 58.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 124.721 1.209 . . . . 60.01 108.901 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 t -141.31 138.16 32.94 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.23 0.612 . . . . 74.32 109.542 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.58 103.3 6.79 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.947 0.899 . . . . 62.42 108.933 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.2 p -111.24 124.77 52.89 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.009 0.523 . . . . 65.23 109.92 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 73' ' ' ALA . 8.6 mp -96.82 85.34 3.78 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.063 -1.088 . . . . 64.01 108.063 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.18 -105.62 2.91 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 114.413 -1.267 . . . . 54.55 110.472 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -105.85 -24.73 12.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.821 0.848 . . . . 75.24 110.402 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.403 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 22.4 tt0 -96.55 120.33 36.66 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.416 0.687 . . . . 65.54 111.088 -176.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.624 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 57.1 m -75.93 126.86 31.8 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.265 1.026 . . . . 73.2 110.959 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -69.61 -57.99 4.5 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.147 0.579 . . . . 31.15 109.806 174.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -145.77 157.67 43.91 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 114.719 -1.128 . . . . 75.15 111.419 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 64' ' ' VAL . 66.0 tp -129.74 146.29 51.5 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.677 -1.601 . . . . 70.21 107.439 177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.727 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.0 m -141.8 141.12 33.16 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.526 -0.916 . . . . 71.32 108.526 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 8.2 tp10 -147.22 120.96 9.22 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.792 -0.818 . . . . 61.52 108.792 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -135.23 110.22 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.706 -0.479 . . . . 75.55 109.706 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 68.5 mt-30 -91.48 82.87 5.35 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.183 -1.043 . . . . 72.21 108.183 172.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -75.74 106.88 7.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.834 -1.075 . . . . 73.14 109.386 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.98 151.83 20.08 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 112.02 -0.432 . . . . 51.45 112.02 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.02 141.58 10.05 Favored Glycine 0 C--O 1.239 0.442 0 N-CA-C 111.246 -0.742 . . . . 54.13 111.246 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mt -90.65 118.78 36.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.613 -0.884 . . . . 75.02 108.613 173.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.491 ' HD2' HG12 ' A' ' 13' ' ' ILE . 17.7 m-85 -124.08 118.91 28.01 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.559 -0.904 . . . . 63.25 108.559 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.4 p -90.56 110.23 21.36 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 108.473 -0.936 . . . . 51.34 108.473 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.468 ' HB ' HD11 ' A' ' 89' ' ' ILE . 2.8 pp -112.57 150.5 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.361 0.665 . . . . 74.13 111.422 -171.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.54 159.91 38.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.913 0.885 . . . . 72.54 109.534 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.27 4.94 84.89 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 123.533 0.52 . . . . 72.01 114.137 170.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.468 HD11 ' HB ' ' A' ' 86' ' ' ILE . 2.6 pp -134.42 148.65 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.97 0.908 . . . . 64.01 109.537 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.47 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 19.3 tt0 -166.89 175.5 7.67 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.962 0.505 . . . . 74.14 110.363 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.47 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 62.04 -134.89 46.14 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.44 0.543 . . . . 73.22 113.741 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.9 p -71.3 -24.6 62.17 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.618 0.767 . . . . 65.31 111.682 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -72.28 -37.94 68.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.156 0.583 . . . . 74.42 110.07 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.428 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 48.2 ttm -62.6 -42.35 99.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.944 0.498 . . . . 71.22 110.374 172.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.11 -33.58 65.25 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.937 0.773 . . . . 70.22 111.143 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -76.03 -36.47 59.1 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 116.046 -0.524 . . . . 73.23 111.262 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 64.5 m -62.05 -57.58 11.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.798 0.439 . . . . 61.43 111.064 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 pp -91.11 -9.13 46.75 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.433 0.693 . . . . 70.24 112.583 -176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.86 3.67 30.42 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 119.893 -0.393 . . . . 64.42 113.788 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.17 -63.13 0.35 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.318 0.559 . . . . 62.35 111.31 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.488 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 75.2 t80 -61.94 -58.78 6.58 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.25 -0.887 . . . . 73.43 111.886 -173.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.9 m -70.24 -34.92 4.43 Favored Pre-proline 0 CA--C 1.569 1.697 0 N-CA-C 114.128 1.159 . . . . 62.44 114.128 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -52.63 -42.9 59.28 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.24 1.96 . . . . 53.12 112.492 163.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -67.44 -28.32 67.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.247 0.619 . . . . 75.21 111.197 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.568 HG21 HD11 ' A' ' 13' ' ' ILE . 47.4 mm -67.96 -45.44 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.814 0.845 . . . . 73.5 110.468 173.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.19 -18.07 60.81 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.838 -0.619 . . . . 75.02 111.63 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -62.35 -44.44 88.1 Favored Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 124.273 1.029 . . . . 74.34 113.715 -170.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.32 -36.43 79.14 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.1 1.867 . . . . 65.45 113.268 172.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -68.22 -43.02 78.93 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.474 0.71 . . . . 63.13 111.516 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.24 83.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.092 0.557 . . . . 71.43 109.95 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -52.03 -51.43 57.47 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 124.164 0.915 . . . . 75.01 110.151 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.66 -45.85 84.97 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.036 0.935 . . . . 64.12 111.307 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.0 t -59.84 -34.13 72.69 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.047 0.539 . . . . 51.41 111.37 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.462 HG21 HG21 ' A' ' 64' ' ' VAL . 81.6 mt -74.41 -54.54 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.749 0.82 . . . . 65.43 109.848 175.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.496 HG23 ' HG3' ' A' ' 125' ' ' GLN . 89.3 m -48.81 -45.39 40.25 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.909 1.284 . . . . 65.5 111.66 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -63.48 -46.37 86.46 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.811 -1.086 . . . . 45.53 109.95 -175.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 64.1 mtm -64.38 -38.46 91.09 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.144 0.578 . . . . 71.23 111.201 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.8 t -64.69 -43.09 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.569 0.748 . . . . 72.3 110.391 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.8 m -73.61 -32.4 64.06 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.532 0.733 . . . . 74.12 111.159 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -72.33 -30.17 64.5 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.653 0.781 . . . . 70.5 109.672 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.67 -2.89 90.2 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 124.028 0.83 . . . . 74.22 112.788 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m 66.98 25.39 9.33 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 122.479 1.133 . . . . 74.13 110.838 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.425 ' CE1' HG11 ' A' ' 31' ' ' VAL . 96.6 m-85 -91.26 155.68 44.28 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 115.451 -0.795 . . . . 70.45 109.524 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.02 124.61 15.12 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.77 2.313 . . . . 62.1 112.024 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.496 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.3 tt0 -54.76 134.81 47.78 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 124.214 0.947 . . . . 73.35 112.184 -173.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.0 tp -112.03 116.52 30.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.85 -1.068 . . . . 73.44 109.502 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -130.98 100.12 5.13 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.285 -1.005 . . . . 74.52 108.285 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.74 151.14 43.81 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.86 0.464 . . . . 64.24 110.255 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.55 150.61 89.11 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 123.139 0.576 . . . . 62.33 110.601 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.11 120.0 7.05 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.652 2.235 . . . . 71.01 110.472 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.56 124.43 54.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.657 -0.868 . . . . 70.32 108.657 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 135' ' ' ALA . 58.4 t30 -77.02 88.53 3.55 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.982 0.801 . . . . 73.34 109.683 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -64.31 -24.12 67.54 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.146 -0.934 . . . . 72.32 111.05 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.2 -52.71 64.42 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 123.896 0.747 . . . . 71.44 110.107 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.422 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -60.8 -50.79 72.02 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 124.018 0.824 . . . . 70.55 110.285 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -54.36 -43.88 71.71 Favored 'General case' 0 C--O 1.243 0.726 0 O-C-N 124.503 1.127 . . . . 70.43 111.857 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -72.52 -41.45 65.87 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 116.113 -0.494 . . . . 65.34 109.868 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.3 mtp . . . . . 0 C--O 1.218 -0.603 0 CA-C-O 119.28 -0.391 . . . . 71.31 111.483 -175.022 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.4 m . . . . . 0 C--O 1.242 0.693 0 N-CA-C 107.936 -1.135 . . . . 72.34 107.936 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.11 156.76 43.67 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.083 0.468 . . . . 63.14 109.971 160.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -125.96 141.19 52.08 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.072 -0.967 . . . . 70.01 108.645 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.604 HD11 HD13 ' B' ' 105' ' ' ILE . 48.7 mt -84.69 121.5 36.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.525 -0.917 . . . . 75.11 108.525 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -88.06 -38.26 15.59 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.601 0.563 . . . . 75.34 110.196 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -170.52 131.14 0.9 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.986 -0.552 . . . . 75.31 109.92 -170.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.7 mt -114.94 140.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 107.153 -1.425 . . . . 53.43 107.153 170.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -167.34 145.54 4.81 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.353 0.597 . . . . 64.3 112.376 -174.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.1 m -75.02 124.88 27.77 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.475 -1.238 . . . . 75.21 109.158 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -98.08 -36.28 10.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.953 0.501 . . . . 74.04 110.391 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 17.8 t70 -147.76 133.66 19.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.51 -0.314 . . . . 70.21 110.643 -168.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.1 mm -133.55 145.95 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.756 1.222 . . . . 72.1 108.842 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.0 t -147.1 136.25 22.5 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.655 1.182 . . . . 50.21 108.147 173.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.52 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -147.84 113.91 5.83 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.925 -1.139 . . . . 71.42 107.925 172.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -119.07 119.25 33.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.071 0.948 . . . . 73.2 108.562 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.629 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.3 85.1 2.57 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 108.189 -1.041 . . . . 72.53 108.189 168.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -65.94 -35.94 32.8 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 122.997 2.465 . . . . 53.12 112.028 -173.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -106.28 9.86 31.89 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.856 -1.065 . . . . 61.15 110.68 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.629 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -25.2 -66.16 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.061 0 C-N-CA 126.287 1.835 . . . . 70.32 115.162 -174.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 10.5 Cg_exo -67.2 -30.79 37.24 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 122.362 2.042 . . . . 74.44 112.168 -169.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -96.57 -30.16 13.45 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.019 -0.991 . . . . 64.14 112.053 -170.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.684 HG21 ' HA ' ' B' ' 73' ' ' ALA . 10.7 p -72.4 -19.74 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 122.471 0.308 . . . . 45.31 111.132 -174.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -63.73 -14.11 49.51 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.574 0.75 . . . . 71.41 112.295 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -64.01 -22.93 67.14 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.57 0.748 . . . . 60.0 111.794 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.92 100.97 12.34 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.022 0.929 . . . . 74.03 109.353 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.47 95.98 4.6 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.636 -0.505 . . . . 72.33 109.636 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -166.61 155.86 11.05 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.67 0.788 . . . . 74.43 109.237 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -75.37 105.1 1.73 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.006 -0.738 . . . . 72.02 109.006 170.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.492 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 21.1 Cg_endo -58.89 127.48 24.52 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.692 2.261 . . . . 73.33 112.202 -171.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -51.56 126.16 16.67 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.376 1.047 . . . . 71.21 110.225 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.635 HG13 HG13 ' B' ' 64' ' ' VAL . 89.6 t -106.22 139.58 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.363 0.665 . . . . 75.43 110.911 -171.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -108.02 125.72 51.88 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.821 -1.178 . . . . 63.23 107.821 162.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -85.04 137.86 32.8 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.451 -0.944 . . . . 71.32 108.451 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.1 t70 -133.2 135.65 45.19 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.51 -1.293 . . . . 72.31 107.51 175.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.59 127.45 27.46 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.226 -1.028 . . . . 34.31 108.226 -177.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.49 145.75 34.02 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.069 -1.456 . . . . 73.14 107.069 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 34.6 p -127.86 120.1 27.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.012 -0.736 . . . . 75.21 109.012 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.43 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -119.95 116.14 25.19 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.747 0.819 . . . . 73.21 108.886 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -113.87 170.58 8.16 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.751 0.421 . . . . 64.24 111.616 -172.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 87.2 p -152.8 143.89 23.08 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.786 0.834 . . . . 74.34 110.251 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -83.13 136.14 34.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.198 0.599 . . . . 70.25 109.785 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 58.7 mt -101.67 -46.71 4.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.557 0.743 . . . . 60.01 110.645 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.07 -169.47 2.96 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.305 -0.862 . . . . 51.41 111.156 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -62.98 105.67 0.71 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.01 -0.996 . . . . 64.34 110.343 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 64.11 11.69 6.41 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.277 1.031 . . . . 73.31 112.026 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.4 112.2 37.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 106.567 -1.642 . . . . 74.22 106.567 173.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -133.85 137.94 45.32 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.491 -0.929 . . . . 75.11 108.491 -173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -107.89 137.09 46.51 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.483 0.713 . . . . 74.31 109.641 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.84 143.01 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.53 -0.915 . . . . 55.33 108.53 171.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 40.4 t -125.67 125.17 68.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 109.088 -0.708 . . . . 74.31 109.088 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.4 HD22 HG23 ' B' ' 62' ' ' VAL . 0.2 OUTLIER -102.54 112.33 25.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.71 -1.132 . . . . 72.14 108.572 -174.377 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -97.62 110.98 23.44 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.587 0.755 . . . . 71.23 110.627 174.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.4 HG23 HD22 ' B' ' 60' ' ' LEU . 39.2 t -107.06 104.46 17.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.968 -1.123 . . . . 73.33 107.968 170.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 9.5 m -99.21 130.77 45.53 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.761 -0.829 . . . . 72.13 108.761 174.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.635 HG13 HG13 ' B' ' 40' ' ' VAL . 43.4 t -118.13 127.33 75.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 123.907 0.883 . . . . 73.51 108.93 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 87.9 m -109.75 137.85 46.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.403 -0.962 . . . . 75.11 108.403 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -146.61 145.86 30.22 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 122.844 0.457 . . . . 60.23 109.812 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.5 p -151.61 138.05 18.59 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.309 -0.86 . . . . 52.14 110.663 -172.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.667 HD12 HG22 ' B' ' 31' ' ' VAL . 60.4 mt -103.78 124.3 48.65 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.916 0.886 . . . . 71.14 109.923 174.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.51 -108.55 2.46 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 123.636 0.585 . . . . 61.51 112.733 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.61 5.0 12.36 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.854 0.862 . . . . 71.45 111.399 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -119.71 156.61 30.18 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.97 0.508 . . . . 71.54 110.019 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.2 m -68.3 137.84 55.0 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.595 0.56 . . . . 73.2 110.459 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.684 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -91.64 -65.01 1.04 Allowed 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.478 -1.304 . . . . 62.42 107.478 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -150.88 161.56 42.45 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.088 -0.96 . . . . 74.0 110.244 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.8 mt -132.85 111.56 11.19 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.047 -1.464 . . . . 64.44 107.047 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.2 t -118.86 153.45 34.52 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.005 -0.739 . . . . 51.44 109.005 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -160.64 131.39 5.44 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.875 -0.787 . . . . 75.42 108.875 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.2 t -128.09 145.29 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.679 -0.86 . . . . 51.54 108.679 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.54 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.0 mt-30 -126.37 95.96 4.54 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.999 -0.741 . . . . 73.42 108.999 172.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -86.2 104.01 15.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.167 -0.924 . . . . 73.14 109.895 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -87.44 153.85 25.55 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 111.673 -0.571 . . . . 52.33 111.673 176.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -154.02 127.11 2.06 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 111.417 -0.673 . . . . 75.12 111.417 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 62.7 mt -86.87 126.04 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.6 0.76 . . . . 73.14 109.68 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -131.74 132.07 43.54 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 107.713 -1.217 . . . . 54.33 107.713 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 31.6 m -102.95 91.66 4.23 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.194 -0.669 . . . . 73.2 109.194 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.572 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -94.79 142.58 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 115.859 -0.61 . . . . 72.35 110.939 -167.64 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.07 158.31 42.83 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.328 1.051 . . . . 73.44 109.399 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.47 -56.71 3.87 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.705 -0.68 . . . . 54.3 111.801 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.494 HD11 ' HB ' ' B' ' 86' ' ' ILE . 11.4 pt -69.13 149.7 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.81 0.844 . . . . 74.43 112.168 177.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -159.16 176.15 12.58 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 125.481 1.512 . . . . 72.22 107.588 171.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.09 -129.78 50.06 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.392 0.433 . . . . 62.53 112.716 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -83.38 -19.26 36.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.609 0.364 . . . . 52.21 111.719 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -72.89 -25.98 61.27 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.785 -0.45 . . . . 71.41 109.785 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 24.1 ttt -78.85 -33.57 45.78 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.127 -0.488 . . . . 71.52 110.12 170.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.17 -29.83 70.03 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.219 0.608 . . . . 54.03 111.001 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -69.2 -39.4 78.65 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.463 0.705 . . . . 63.21 111.414 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.8 t -66.87 -66.19 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.267 -0.879 . . . . 42.53 109.81 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 38.8 mt -70.18 -27.31 64.42 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.555 0.742 . . . . 71.3 112.098 -172.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.25 -12.61 58.48 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.574 0.546 . . . . 64.3 114.298 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.51 -55.36 0.39 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.58 0.69 . . . . 72.04 112.282 -173.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.431 ' OH ' ' HB3' ' D' ' 130' ' ' PRO . 66.2 t80 -75.86 -48.17 22.57 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.392 0.516 . . . . 75.44 112.392 -169.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.434 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 88.1 m -59.3 -50.09 89.31 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 123.676 0.791 . . . . 73.44 111.567 176.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 69.9 Cg_exo -55.22 -36.3 93.02 Favored 'Trans proline' 0 C--N 1.389 2.683 0 C-N-CA 121.968 1.779 . . . . 62.14 113.561 169.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.16 -40.63 90.58 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 123.185 0.594 . . . . 73.43 110.643 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.604 HD13 HD11 ' B' ' 13' ' ' ILE . 67.6 mt -63.79 -43.61 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.599 0.76 . . . . 63.33 110.404 175.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.449 HD21 ' HA3' ' B' ' 82' ' ' GLY . 65.9 mt -78.66 -18.89 53.72 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.064 -0.971 . . . . 74.34 112.034 -174.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -58.49 -51.83 79.01 Favored Pre-proline 0 N--CA 1.482 1.162 0 N-CA-C 113.963 1.097 . . . . 75.25 113.963 -170.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.95 -32.23 92.25 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 121.671 1.58 . . . . 62.22 113.312 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -66.05 -50.63 63.47 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.286 0.634 . . . . 74.33 110.472 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.16 -40.09 84.5 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.2 -0.909 . . . . 74.53 110.812 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -65.56 -49.02 70.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.506 1.523 . . . . 53.53 110.939 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -68.27 -34.53 76.34 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.81 -0.632 . . . . 53.54 109.842 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.7 t -67.99 -34.32 76.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.777 0.431 . . . . 74.01 111.223 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.465 ' O ' HG23 ' B' ' 118' ' ' VAL . 66.6 mt -63.83 -56.48 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.662 -0.495 . . . . 53.03 109.662 172.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.1 m -60.42 -26.02 66.39 Favored 'General case' 0 CA--C 1.554 1.131 0 O-C-N 123.973 0.796 . . . . 55.0 111.473 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.0 t -62.99 -50.45 70.69 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.225 0.61 . . . . 62.43 109.836 173.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -71.57 -32.1 67.7 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.414 0.686 . . . . 62.05 111.079 -176.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 114' ' ' ILE . 87.6 t -61.98 -44.62 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.65 0.78 . . . . 64.32 109.55 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.6 t -65.37 -35.76 81.93 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.039 -0.982 . . . . 60.14 111.368 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.0 mtt-85 -68.06 -32.17 72.32 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.475 -0.784 . . . . 62.42 110.323 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.87 8.12 77.29 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.952 0.783 . . . . 75.53 112.965 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 17' ' ' TYR . 61.5 p 54.77 27.42 8.82 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.15 1.78 . . . . 74.14 113.626 176.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -83.43 154.74 66.16 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.397 0.679 . . . . 73.55 110.09 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -55.99 157.42 16.89 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.083 2.522 . . . . 55.33 113.223 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -64.56 113.77 3.92 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.369 -0.832 . . . . 73.23 111.38 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.1 mt -121.09 119.51 32.64 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.899 -0.778 . . . . 53.21 108.899 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -115.0 112.98 23.5 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.806 -0.813 . . . . 64.32 108.806 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.35 143.26 56.06 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.33 0.652 . . . . 55.34 111.353 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.56 150.9 64.16 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.843 0.857 . . . . 63.41 110.687 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.23 145.3 17.02 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.879 2.386 . . . . 71.43 111.775 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.31 118.59 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.246 -1.02 . . . . 63.52 108.246 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -79.8 83.37 5.75 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.618 -0.512 . . . . 61.14 109.618 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -64.45 -24.28 67.57 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.528 0.731 . . . . 74.1 111.962 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.56 -52.05 55.28 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.523 0.729 . . . . 74.51 110.268 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.16 95.26 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.937 0.895 . . . . 71.23 110.938 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 89.9 mt -74.07 -20.89 60.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.075 -0.966 . . . . 61.53 112.028 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 61.0 t80 . . . . . 0 N--CA 1.477 0.9 0 C-N-CA 122.625 0.37 . . . . 64.02 110.732 177.865 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.466 0.328 0 N-CA-C 108.206 -1.035 . . . . 74.35 108.206 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.611 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.1 t80 -120.23 126.32 50.34 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.808 -0.812 . . . . 74.02 108.808 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -142.51 109.05 5.34 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.385 -0.968 . . . . 74.02 108.385 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -73.82 122.11 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.158 -0.682 . . . . 64.45 109.158 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.569 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.8 mm-40 -86.47 -42.26 13.73 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.179 -0.919 . . . . 74.54 110.35 -175.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -175.56 139.93 0.45 Allowed 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.614 0.571 . . . . 74.55 109.523 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.0 mt -131.56 133.87 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.463 -0.94 . . . . 71.21 108.463 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.522 ' HB3' HG23 ' D' ' 122' ' ' THR . 27.3 p90 -170.64 172.61 5.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.691 0.758 . . . . 73.13 111.565 -169.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -96.07 118.5 32.79 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.382 -0.827 . . . . 72.32 109.16 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.454 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.8 mmtp -65.78 -48.16 72.73 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 122.33 1.062 . . . . 61.02 108.156 169.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.438 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.5 t70 -139.82 146.25 39.16 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 113.814 -1.539 . . . . 74.04 109.884 -172.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.59 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 80.5 mt -140.39 140.93 33.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 106.701 -1.592 . . . . 74.01 106.701 174.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -159.25 149.84 19.51 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.173 0.511 . . . . 75.31 110.663 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.2 t80 -148.49 136.96 21.34 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.918 -1.141 . . . . 70.32 107.918 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.67 118.65 18.4 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.695 0.798 . . . . 63.41 109.754 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.92 76.87 45.2 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 106.356 -1.72 . . . . 62.51 106.356 165.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.07 -40.61 11.29 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.738 2.292 . . . . 74.33 111.199 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.03 21.12 3.27 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.628 -1.169 . . . . 73.22 111.417 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.412 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -44.65 -57.83 6.18 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 114.39 1.256 . . . . 65.33 114.39 -171.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.4 -36.43 66.67 Favored 'Trans proline' 0 C--N 1.385 2.459 0 CA-C-N 121.744 1.658 . . . . 60.31 112.397 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -70.07 -35.42 74.2 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.372 0.669 . . . . 74.31 112.135 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.5 p -79.6 -24.49 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 N-CA-C 111.886 0.328 . . . . 72.41 111.886 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.59 -30.2 69.75 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.617 0.367 . . . . 72.35 111.867 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -86.67 11.45 12.92 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.905 0.482 . . . . 74.45 111.12 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.799 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.99 160.05 14.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.231 1.012 . . . . 65.41 109.563 170.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -71.48 131.44 43.31 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.514 0.725 . . . . 63.14 110.561 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.532 ' NE1' ' HG3' ' C' ' 124' ' ' PRO . 31.5 t90 -73.86 91.91 2.02 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.424 -0.807 . . . . 72.22 111.297 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -147.04 74.43 11.98 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 107.444 -1.317 . . . . 75.33 107.444 169.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -85.15 137.14 6.04 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.732 2.288 . . . . 54.45 112.717 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -86.06 110.07 19.27 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.268 -1.012 . . . . 72.51 108.268 171.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -84.6 100.47 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-O 122.532 1.158 . . . . 74.14 110.978 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -95.74 103.29 15.16 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.784 -1.098 . . . . 74.52 108.279 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.52 134.75 36.73 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.25 -0.648 . . . . 72.32 109.25 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -127.67 136.08 51.1 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.352 -0.981 . . . . 55.42 108.352 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 tp -129.22 135.12 48.4 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.438 0.695 . . . . 72.04 109.683 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.412 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 27.5 t70 -149.04 153.06 37.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.883 0.873 . . . . 72.25 109.664 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -146.19 153.39 40.58 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.155 0.582 . . . . 72.21 109.441 170.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.55 160.54 39.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.248 1.019 . . . . 63.01 109.011 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -144.43 155.67 43.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.461 0.704 . . . . 54.24 109.223 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.5 p -157.4 153.78 27.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.601 0.76 . . . . 60.53 109.353 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -95.8 118.05 31.72 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.993 -0.743 . . . . 60.24 108.993 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' C' ' 57' ' ' GLU . 60.5 mt -89.37 -34.92 16.34 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.179 0.592 . . . . 75.43 110.337 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.3 -170.06 2.16 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.645 0.778 . . . . 50.2 111.004 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.91 111.44 1.66 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.85 0.86 . . . . 42.14 110.417 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 70.79 -5.75 1.4 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.344 1.458 . . . . 71.52 112.564 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.0 t -93.77 105.7 17.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.456 -0.942 . . . . 73.54 108.456 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -118.79 122.96 43.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.542 -0.754 . . . . 73.31 109.357 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.486 ' HB2' HD11 ' C' ' 51' ' ' LEU . 35.4 tt0 -84.36 144.7 28.65 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.532 0.733 . . . . 72.31 110.294 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -131.14 140.55 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.259 -1.015 . . . . 70.12 108.259 167.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.427 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 90.9 t -130.95 130.83 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.067 -1.086 . . . . 75.13 108.067 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.96 109.42 21.41 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.456 -1.313 . . . . 63.51 107.456 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.412 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.2 tmm_? -101.65 106.77 17.86 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.127 -1.064 . . . . 65.14 108.127 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.621 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.7 t -107.96 137.55 38.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.88 -1.156 . . . . 75.01 107.88 175.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -132.48 121.93 24.11 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.171 -0.678 . . . . 71.01 109.171 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 64.8 t -111.51 110.33 31.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 124.18 0.992 . . . . 73.11 108.9 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.487 HG23 HD23 ' C' ' 75' ' ' LEU . 4.0 m -108.85 108.28 19.0 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.226 0.61 . . . . 72.03 109.38 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.04 123.47 45.98 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.828 -0.804 . . . . 74.44 108.828 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.6 m -137.83 130.47 29.67 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.949 0.5 . . . . 65.23 111.046 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.799 HD13 ' HG2' ' C' ' 34' ' ' LYS . 6.6 mt -84.81 33.99 0.53 Allowed 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 125.255 1.422 . . . . 74.55 110.723 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.62 -100.13 1.84 Allowed Glycine 0 C--N 1.352 1.427 0 N-CA-C 111.052 -0.819 . . . . 74.22 111.052 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.61 -31.89 18.36 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.474 -0.565 . . . . 75.45 109.474 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.02 120.87 24.78 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.725 0.81 . . . . 63.31 109.13 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.5 m -76.73 128.7 35.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.981 -0.748 . . . . 61.13 108.981 169.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.747 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.08 -57.78 4.2 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.424 -0.954 . . . . 75.12 108.424 173.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -165.65 173.72 10.52 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.309 -0.86 . . . . 73.55 110.768 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.487 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -133.24 144.23 49.63 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.089 -1.448 . . . . 60.03 107.089 172.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.454 ' SG ' HG23 ' C' ' 114' ' ' ILE . 46.6 t -146.31 139.65 25.87 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.158 -1.053 . . . . 70.05 108.158 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -151.6 133.65 15.1 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.517 -0.549 . . . . 73.43 109.517 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.4 t -134.99 138.89 48.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.26 1.024 . . . . 75.12 108.474 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -114.17 88.17 2.79 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.258 -1.015 . . . . 72.42 108.258 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.401 ' HG3' HD22 ' C' ' 106' ' ' LEU . 71.9 tp60 -79.1 97.77 6.27 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.175 -0.92 . . . . 74.43 110.197 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -98.74 144.13 17.03 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-O 121.199 0.333 . . . . 51.13 113.035 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.432 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -145.09 132.81 4.84 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.514 -1.034 . . . . 52.44 110.514 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 15.3 mm -88.97 123.7 41.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 108.394 -0.965 . . . . 71.35 108.394 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.611 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 51.2 m-85 -130.4 116.14 17.86 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.159 0.583 . . . . 71.51 109.787 -173.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 74.0 m -84.0 108.51 17.0 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.684 -0.487 . . . . 31.33 109.684 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.523 ' HB ' HD11 ' C' ' 89' ' ' ILE . 2.7 pp -117.06 138.61 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.949 0.899 . . . . 74.32 110.25 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.34 158.14 43.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.162 0.985 . . . . 64.33 109.554 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.39 -30.41 5.26 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 113.892 0.317 . . . . 73.22 113.892 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.567 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -105.72 150.2 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 121.23 0.538 . . . . 75.1 111.792 -176.697 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.91 -170.79 3.73 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.784 -1.098 . . . . 75.55 108.505 166.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.05 -124.45 30.33 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 114.112 0.405 . . . . 74.22 114.112 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 74.1 p -76.35 -29.53 57.26 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.834 0.853 . . . . 63.03 111.806 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.87 -42.46 85.56 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.592 -0.521 . . . . 74.42 109.592 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 28.1 ttt -74.66 -33.12 62.45 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.857 -0.61 . . . . 72.12 110.807 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.62 -48.69 69.09 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.75 0.657 . . . . 52.23 109.706 174.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.434 ' NE2' ' HA ' ' C' ' 134' ' ' ASP . 11.6 t-80 -77.62 -35.16 52.99 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.857 0.723 . . . . 75.42 111.492 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.412 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 51.8 t -56.86 -36.79 70.46 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.849 0.718 . . . . 74.52 110.407 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 23.9 mt -101.07 -15.22 17.5 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.877 0.871 . . . . 71.52 110.917 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.76 -30.41 48.27 Favored Glycine 0 C--N 1.352 1.42 0 N-CA-C 114.842 0.697 . . . . 74.34 114.842 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.83 -36.88 0.06 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.938 0.495 . . . . 54.01 110.859 -172.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.412 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 70.4 t80 -66.88 -44.29 81.29 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.38 1.472 . . . . 74.42 112.282 -175.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 23.3 m -77.12 -47.91 2.6 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 123.394 0.678 . . . . 72.24 111.836 174.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -53.96 -28.85 51.37 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.138 1.892 . . . . 74.1 114.273 171.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -68.35 -39.56 81.81 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 123.109 0.564 . . . . 62.43 109.939 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 42.3 mm -59.92 -39.44 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.439 -0.578 . . . . 63.22 109.439 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.432 HD21 ' HA3' ' C' ' 82' ' ' GLY . 76.7 mt -85.52 -12.77 50.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.599 1.16 . . . . 75.33 112.501 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -63.37 -51.4 68.32 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 113.784 1.031 . . . . 73.42 113.784 -171.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -66.79 -30.99 40.26 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 121.731 1.621 . . . . 51.22 112.263 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -67.82 -46.25 72.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.457 0.703 . . . . 74.42 110.935 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.31 93.02 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.482 0.713 . . . . 60.13 109.806 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -53.15 -60.26 3.51 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.293 0.995 . . . . 62.33 110.938 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -62.56 -29.4 70.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.614 0.766 . . . . 74.15 110.945 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.432 ' SG ' HG12 ' C' ' 21' ' ' ILE . 8.3 t -72.55 -44.48 62.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.774 0.43 . . . . 74.11 110.832 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.621 HD11 ' HB ' ' C' ' 62' ' ' VAL . 85.5 mt -64.88 -50.09 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.31 0.644 . . . . 73.54 110.333 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.4 m -64.21 -29.34 70.45 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.413 -0.812 . . . . 75.1 110.741 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 28.1 t -65.54 -52.62 51.15 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.987 0.515 . . . . 74.03 109.71 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.436 ' HB3' ' HB2' ' C' ' 23' ' ' PHE . 0.0 OUTLIER -54.15 -46.86 72.37 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.472 1.109 . . . . 54.5 112.026 178.58 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.576 HG11 HD13 ' C' ' 126' ' ' LEU . 71.2 t -65.97 -43.41 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.45 -0.796 . . . . 72.21 111.157 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.9 t -61.08 -36.94 81.0 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.445 0.698 . . . . 63.43 111.167 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -69.71 -32.02 70.36 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.134 -0.939 . . . . 65.12 110.329 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.08 7.05 76.98 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.894 0.746 . . . . 61.53 112.958 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.412 HG23 ' HB3' ' D' ' 17' ' ' TYR . 53.2 p 57.7 28.63 16.1 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 126.37 1.868 . . . . 71.14 113.751 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.5 ' HB2' HG13 ' C' ' 118' ' ' VAL . 93.2 m-85 -91.98 163.44 27.48 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 108.914 -0.772 . . . . 65.43 108.914 170.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.532 ' HG3' ' NE1' ' C' ' 36' ' ' TRP . 56.5 Cg_endo -64.06 -178.93 0.67 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.934 2.423 . . . . 73.33 114.641 -174.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -61.2 128.89 38.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.945 -1.025 . . . . 74.41 111.683 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.576 HD13 HG11 ' C' ' 118' ' ' VAL . 6.7 mp -134.81 86.49 2.26 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.445 -0.946 . . . . 72.14 108.445 170.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -99.77 123.68 44.27 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.089 -0.708 . . . . 64.14 109.089 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -64.93 118.87 9.69 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.782 -0.821 . . . . 63.43 108.782 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.02 141.25 93.75 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.727 0.811 . . . . 75.04 111.318 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.442 ' HB3' HD12 ' A' ' 16' ' ' ILE . 14.8 Cg_endo -58.05 103.74 0.16 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.436 2.091 . . . . 73.43 112.094 174.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 29.2 t -95.46 140.82 16.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.642 -1.614 . . . . 75.32 106.642 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -77.36 66.77 3.18 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.345 -0.613 . . . . 34.33 109.345 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -54.33 -43.12 70.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.912 0.885 . . . . 72.22 111.183 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.434 ' HA ' ' NE2' ' C' ' 96' ' ' HIS . 7.8 m-20 -66.49 -41.93 88.17 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.89 -1.05 . . . . 61.42 112.484 -175.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.91 -43.08 72.43 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.799 0.687 . . . . 64.42 110.398 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.05 -21.15 60.84 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.027 -0.988 . . . . 63.31 111.9 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.0 t80 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.902 -0.407 . . . . 72.01 109.902 172.76 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 121.18 0.515 . . . . 73.14 110.991 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -158.7 89.86 0.98 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.727 -1.582 . . . . 74.4 106.727 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -116.69 116.36 27.39 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.584 -0.895 . . . . 74.44 108.584 -176.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.42 HG21 HD11 ' D' ' 16' ' ' ILE . 14.7 mt -82.48 117.55 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.569 -0.9 . . . . 74.21 108.569 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -78.56 -34.8 46.76 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.992 0.517 . . . . 73.13 111.37 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -169.2 130.92 1.17 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 111.631 0.234 . . . . 73.22 111.631 -168.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.446 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.6 mp -115.02 134.4 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.075 -1.454 . . . . 62.02 107.075 173.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.412 ' HB3' HG23 ' C' ' 122' ' ' THR . 36.4 p90 -165.52 170.3 14.52 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.811 0.815 . . . . 75.13 111.868 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -102.52 123.15 45.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.265 -1.334 . . . . 73.34 108.817 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -93.25 -18.45 22.48 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.114 -0.494 . . . . 75.35 110.011 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -156.39 136.12 12.52 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.329 -0.989 . . . . 73.15 108.329 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.426 ' CD1' ' HE3' ' C' ' 117' ' ' MET . 17.5 mt -134.59 138.77 49.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.627 -1.249 . . . . 70.54 107.627 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -144.67 133.87 22.9 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.353 0.661 . . . . 54.33 109.773 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.59 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 70.5 t80 -144.67 127.48 16.3 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.56 -1.644 . . . . 72.44 106.56 167.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.5 mt-10 -134.89 126.64 29.13 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.638 0.775 . . . . 71.01 109.357 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.54 85.14 25.82 Favored Pre-proline 0 C--O 1.242 0.673 0 N-CA-C 107.953 -1.129 . . . . 73.44 107.953 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.22 -40.47 11.18 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.909 2.406 . . . . 70.22 112.482 -171.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -107.73 27.59 9.04 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 123.871 0.868 . . . . 74.32 109.789 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.74 -68.57 0.22 Allowed Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 115.284 1.586 . . . . 73.14 115.284 -161.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.57 -19.97 16.2 Favored 'Trans proline' 0 C--N 1.382 2.299 0 CA-C-N 122.394 1.891 . . . . 72.35 113.385 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -74.81 -38.79 61.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.534 1.133 . . . . 71.42 110.698 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' D' ' 73' ' ' ALA . 10.7 p -84.38 -25.24 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 122.789 0.435 . . . . 70.22 111.694 -172.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -58.43 -27.99 64.84 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.371 0.669 . . . . 75.13 112.359 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -53.73 -31.33 47.86 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.786 1.234 . . . . 74.11 111.541 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -87.51 96.95 10.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.984 0.913 . . . . 74.45 109.135 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -81.33 88.58 6.08 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.992 -0.549 . . . . 53.54 110.946 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -163.15 162.64 25.68 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.664 0.786 . . . . 71.33 109.153 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 37' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 1.5 mp0 -73.47 116.35 50.5 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 109.238 -0.652 . . . . 63.34 109.238 171.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.716 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 77.5 Cg_exo -56.55 138.97 86.61 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.94 3.094 . . . . 74.12 113.971 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.11 111.73 1.44 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.025 0.828 . . . . 71.12 109.372 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.496 HG23 HG13 ' D' ' 64' ' ' VAL . 7.3 p -103.79 135.35 41.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.357 -0.838 . . . . 73.45 110.917 -168.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -115.52 132.39 56.64 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.326 1.05 . . . . 72.44 108.346 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.408 HD21 ' HG ' ' D' ' 44' ' ' LEU . 8.5 tt -98.17 126.23 43.54 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.955 0.502 . . . . 73.44 109.746 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.521 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.8 m-20 -133.49 116.08 15.54 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.898 -1.149 . . . . 74.01 107.898 171.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.408 ' HG ' HD21 ' D' ' 42' ' ' LEU . 91.6 mt -113.88 142.34 46.23 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.153 0.581 . . . . 73.2 109.988 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.459 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.2 t70 -141.8 154.89 45.52 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.947 -1.131 . . . . 75.42 107.947 173.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -127.68 164.4 22.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.104 0.561 . . . . 55.14 109.712 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.542 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.24 161.79 42.1 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.784 0.834 . . . . 52.3 109.627 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 37.3 p -159.1 151.84 21.83 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.099 0.559 . . . . 72.53 109.726 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.4 p -157.93 139.23 13.51 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.36 0.664 . . . . 71.44 109.707 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -79.13 119.37 22.15 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.553 -0.536 . . . . 72.24 109.553 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.7 mt -90.15 -34.63 15.78 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.86 -0.793 . . . . 72.4 108.86 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.16 -178.95 5.36 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.224 1.01 . . . . 63.22 109.672 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.64 122.17 17.48 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.221 -0.899 . . . . 65.21 109.197 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 72.16 12.46 5.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.394 1.478 . . . . 74.41 112.402 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.6 t -128.98 117.6 44.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 123.972 0.909 . . . . 41.32 108.879 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -132.88 130.08 39.25 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.398 1.079 . . . . 74.1 108.703 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.5 ' HB2' HD11 ' D' ' 51' ' ' LEU . 18.5 tt0 -91.83 142.29 27.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.972 -0.751 . . . . 61.42 108.972 170.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -123.08 142.31 40.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.421 -1.326 . . . . 74.14 107.421 172.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 45.9 t -126.37 132.09 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.807 -0.812 . . . . 72.53 108.807 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.32 120.39 42.25 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.705 -0.85 . . . . 75.35 108.705 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.459 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 33.3 ttm-85 -102.94 98.45 8.41 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.312 -0.996 . . . . 64.4 108.312 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -100.2 123.37 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.859 -0.793 . . . . 51.44 108.859 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 15.4 m -119.13 141.82 48.47 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.496 0.718 . . . . 75.22 109.85 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.496 HG13 HG23 ' D' ' 40' ' ' VAL . 75.6 t -136.64 103.29 3.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.0 1.32 . . . . 55.25 108.561 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 83.4 m -100.9 113.72 26.93 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.349 -0.982 . . . . 61.33 108.349 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -122.55 142.82 50.21 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.726 0.811 . . . . 72.1 109.857 -174.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 23.5 m -144.13 134.39 24.41 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.652 0.595 . . . . 72.1 111.795 -176.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.621 HD12 HG22 ' D' ' 31' ' ' VAL . 48.9 mt -106.23 123.34 47.88 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.325 1.05 . . . . 63.15 109.198 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.56 -124.56 36.41 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 115.155 -0.93 . . . . 61.2 113.609 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.89 6.47 47.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 71.02 112.326 -175.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.0 165.1 26.79 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.668 0.387 . . . . 75.13 110.875 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 34.7 m -68.23 138.07 55.28 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.762 0.663 . . . . 70.33 110.473 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.775 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -90.33 -70.69 0.66 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.342 -0.984 . . . . 60.14 108.342 173.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -147.63 140.6 24.96 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.576 -0.738 . . . . 72.33 109.605 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 88.1 mt -109.62 143.18 39.7 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.49 -1.3 . . . . 63.52 107.49 172.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.545 ' SG ' HG23 ' D' ' 114' ' ' ILE . 38.7 t -158.05 137.19 11.63 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.231 -0.285 . . . . 53.22 110.231 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.59 133.27 13.01 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.945 -0.761 . . . . 74.31 108.945 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.7 t -128.77 138.02 55.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.572 -0.899 . . . . 72.35 108.572 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -116.32 87.35 2.67 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.096 -1.075 . . . . 65.22 108.096 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.14 103.95 10.37 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.347 -1.297 . . . . 72.24 108.944 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.09 141.39 15.96 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.314 -0.714 . . . . 73.43 111.314 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.475 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -139.86 130.02 4.53 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.681 -0.968 . . . . 73.05 110.681 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 58.7 mt -92.57 115.95 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.717 -0.846 . . . . 54.1 108.717 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -116.33 125.55 52.28 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.931 0.892 . . . . 53.12 109.692 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -104.39 109.29 21.09 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.481 0.712 . . . . 73.34 109.353 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -110.78 144.14 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.244 0.617 . . . . 54.34 109.866 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.45 127.07 8.73 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.789 -0.819 . . . . 74.42 108.789 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.36 -20.51 42.25 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.398 -0.681 . . . . 64.35 111.398 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mp -98.41 130.75 46.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.231 1.013 . . . . 74.22 108.341 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -160.47 173.8 15.03 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.442 0.697 . . . . 74.13 110.7 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.01 -133.82 49.17 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 124.023 0.827 . . . . 72.32 113.879 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.1 m -63.35 -31.73 72.97 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.706 0.803 . . . . 52.22 110.73 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -69.34 -33.66 73.44 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.74 0.816 . . . . 73.03 110.945 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.488 ' SD ' HD12 ' D' ' 98' ' ' LEU . 17.5 tmm? -72.74 -37.61 67.66 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.263 0.625 . . . . 63.3 110.389 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.31 95.94 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.61 0.719 . . . . 40.15 110.55 171.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -71.53 -29.53 64.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.899 1.28 . . . . 61.22 111.405 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -81.12 -52.26 7.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.811 0.445 . . . . 62.14 110.874 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.488 HD12 ' SD ' ' D' ' 94' ' ' MET . 92.6 mt -84.35 -27.9 27.39 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.995 0.518 . . . . 70.42 111.697 -171.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.02 7.41 58.8 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.677 -0.513 . . . . 63.23 114.138 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -150.29 -61.3 0.2 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.393 0.597 . . . . 72.42 111.232 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -69.7 -41.65 75.1 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.034 0.534 . . . . 73.34 112.145 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.444 ' SG ' HD23 ' D' ' 98' ' ' LEU . 88.5 m -65.35 -45.97 70.48 Favored Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 123.62 0.768 . . . . 64.42 112.38 -178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -53.1 -36.89 78.51 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.155 1.903 . . . . 70.03 113.177 167.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -67.77 -30.89 70.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.099 0.56 . . . . 64.24 111.438 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.0 -37.33 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.276 0.631 . . . . 63.12 110.584 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.475 HD21 ' HA3' ' D' ' 82' ' ' GLY . 92.7 mt -77.49 -19.77 55.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.057 0.943 . . . . 72.33 111.997 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.64 ' HZ ' HD22 ' D' ' 128' ' ' LEU . 40.5 t80 -64.65 -43.64 71.01 Favored Pre-proline 0 CA--C 1.56 1.327 0 N-CA-C 114.347 1.24 . . . . 73.11 114.347 -170.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -54.35 -45.51 40.42 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 121.952 1.768 . . . . 74.33 112.491 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -70.0 -35.59 74.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.041 0.936 . . . . 75.32 111.759 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.71 67.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.269 0.628 . . . . 60.32 110.502 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.445 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.2 ttp180 -58.48 -49.09 78.61 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.253 -0.885 . . . . 54.42 110.534 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.52 -46.63 87.53 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.136 0.897 . . . . 72.45 111.477 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.8 t -57.73 -42.15 83.28 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.739 0.65 . . . . 63.15 110.639 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.545 HG23 ' SG ' ' D' ' 76' ' ' CYS . 67.8 mt -61.67 -57.11 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.608 0.763 . . . . 73.01 110.56 174.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.548 HG23 ' HG3' ' D' ' 125' ' ' GLN . 86.4 m -51.67 -44.68 63.15 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.721 1.208 . . . . 75.31 112.061 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.7 t -63.95 -42.59 97.26 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.196 -0.911 . . . . 63.42 109.999 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.9 mtm -69.81 -34.39 73.62 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.999 0.52 . . . . 61.42 111.469 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 114' ' ' ILE . 66.8 t -62.06 -44.89 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.612 0.765 . . . . 52.1 109.934 175.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.1 p -72.73 -30.48 64.21 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.981 0.512 . . . . 62.34 111.089 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -72.07 -29.76 64.45 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.466 0.706 . . . . 74.45 110.455 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.34 10.14 74.35 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.798 0.686 . . . . 51.41 112.556 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.522 HG23 ' HB3' ' C' ' 17' ' ' TYR . 73.0 p 56.85 20.78 5.49 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 126.68 1.992 . . . . 73.23 114.082 177.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.02 150.16 71.26 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 109.067 -0.716 . . . . 75.21 109.067 168.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.9 132.1 47.74 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.471 2.114 . . . . 75.41 111.202 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.548 ' HG3' HG23 ' D' ' 115' ' ' THR . 5.5 tt0 -51.78 127.19 20.1 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 124.464 1.102 . . . . 61.54 112.674 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.19 116.49 28.45 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.04 -1.096 . . . . 75.11 108.04 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -115.65 122.19 44.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.694 0.798 . . . . 72.41 109.524 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.64 HD22 ' HZ ' ' D' ' 107' ' ' PHE . 1.5 tt -74.9 129.71 38.13 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 108.967 -0.753 . . . . 73.43 108.967 173.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.18 157.75 79.91 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.395 1.078 . . . . 31.22 111.974 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.431 ' HB3' ' OH ' ' B' ' 101' ' ' TYR . 87.0 Cg_exo -50.01 107.82 0.18 Allowed 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 123.246 2.631 . . . . 73.32 113.284 172.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 84.0 t -109.59 116.24 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.542 0.737 . . . . 73.2 109.051 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -90.06 105.66 17.95 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.42 -0.585 . . . . 65.52 109.42 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -78.72 -20.18 50.64 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.571 0.748 . . . . 51.4 111.067 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 134' ' ' ASP . . . . . 0.436 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 6.5 t70 -65.17 -52.38 55.37 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.929 0.892 . . . . 74.12 110.66 -174.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.97 -34.89 76.06 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.288 -0.869 . . . . 71.22 111.034 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 47.3 tp -63.08 -35.26 79.65 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 114.986 -1.006 . . . . 63.4 111.407 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 89.2 t80 . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 123.573 0.749 . . . . 73.54 110.687 175.904 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.301 -0.629 . . . . 64.14 109.301 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.698 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 6.2 t80 -139.03 132.68 30.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.038 0.935 . . . . 73.01 108.62 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -149.98 103.56 3.22 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.528 -0.916 . . . . 72.12 108.528 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.555 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.3 mt -70.36 112.05 4.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.335 -0.987 . . . . 71.5 108.335 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -81.04 -31.14 34.65 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 124.237 0.961 . . . . 71.44 110.277 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -174.36 147.44 1.16 Allowed 'General case' 0 C--N 1.355 0.835 0 O-C-N 123.626 0.579 . . . . 73.52 110.228 -173.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.7 mt -137.02 133.6 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.878 -1.156 . . . . 74.34 107.878 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' HB3' HG23 ' B' ' 122' ' ' THR . 43.2 p90 -168.59 154.39 6.71 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 123.915 0.759 . . . . 72.04 111.412 -174.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -74.57 116.57 15.41 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.011 -0.737 . . . . 70.13 109.011 172.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -78.19 -42.86 30.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.368 -0.604 . . . . 74.11 109.368 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.594 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 7.0 m-20 -136.65 131.91 34.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.934 -1.03 . . . . 73.23 109.235 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.0 mt -128.18 141.06 47.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.09 -1.448 . . . . 73.23 107.09 172.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -152.51 120.78 6.29 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.199 -0.667 . . . . 75.32 109.199 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 87.3 t80 -123.78 130.6 52.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.274 -1.38 . . . . 75.45 107.274 174.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -126.48 153.01 45.68 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.023 -1.102 . . . . 74.54 108.023 172.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.51 79.16 10.6 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.486 -1.301 . . . . 72.43 107.486 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.21 -40.34 77.1 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.332 2.688 . . . . 54.23 112.843 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.563 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 17.1 m120 -109.22 39.68 2.01 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.28 -0.873 . . . . 72.43 109.767 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.54 -45.55 98.76 Favored Pre-proline 0 CA--C 1.565 1.536 0 C-N-CA 123.939 0.896 . . . . 65.3 113.079 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -71.79 -22.03 24.21 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 121.826 1.684 . . . . 75.13 112.29 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 42.0 m170 -86.91 -24.63 24.76 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.621 0.768 . . . . 64.01 112.333 -174.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.7 p -72.19 -25.21 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.759 0.424 . . . . 72.45 110.409 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.1 -31.78 70.74 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.528 0.731 . . . . 64.04 110.607 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -78.57 -47.75 16.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.101 0.96 . . . . 72.1 110.424 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -83.02 151.53 25.79 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.856 0.862 . . . . 73.23 110.757 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.36 146.04 53.61 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.616 -0.512 . . . . 64.11 109.616 170.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -70.7 85.15 0.65 Allowed 'General case' 0 C--N 1.351 0.662 0 CA-C-O 121.468 0.651 . . . . 73.12 109.752 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.98 78.78 75.77 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 106.451 -1.685 . . . . 74.35 106.451 173.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -89.89 -173.44 0.71 Allowed 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.453 2.102 . . . . 64.25 112.543 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -141.03 108.81 5.65 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.811 -1.551 . . . . 71.34 106.811 167.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 66' ' ' ALA . 22.1 m -96.5 135.81 29.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.317 0.58 . . . . 73.42 111.301 -172.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -120.71 145.47 47.45 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.284 -1.006 . . . . 73.24 108.284 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 tp -124.1 126.16 45.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.201 -0.666 . . . . 71.43 109.201 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.545 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.7 m-20 -113.95 144.1 43.62 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.106 -1.072 . . . . 54.02 108.106 170.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.18 146.65 37.22 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.353 -0.61 . . . . 71.05 109.353 169.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -152.06 147.96 27.11 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.195 0.598 . . . . 72.51 110.007 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 98' ' ' LEU . 80.0 m -118.49 128.95 55.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.276 1.03 . . . . 73.33 109.353 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.55 151.55 51.89 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.411 0.684 . . . . 74.03 109.156 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.0 m -118.09 157.52 26.72 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.326 0.651 . . . . 73.12 109.967 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -149.27 121.09 8.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.736 0.814 . . . . 72.05 109.342 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -84.49 103.2 13.43 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.612 -0.884 . . . . 61.14 108.612 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.15 -34.77 23.97 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.414 -0.812 . . . . 71.32 110.373 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.42 -176.56 5.97 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 124.268 0.98 . . . . 71.13 109.723 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.48 115.15 4.38 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.702 0.626 . . . . 71.13 110.073 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 62.67 26.53 15.7 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.44 1.496 . . . . 73.34 112.78 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -117.79 118.36 58.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-N 114.706 -1.134 . . . . 72.12 108.743 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.599 ' HD2' HD11 ' A' ' 86' ' ' ILE . 23.8 m-85 -125.11 124.97 43.0 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.478 0.711 . . . . 71.2 109.991 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.26 126.44 37.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.277 -1.008 . . . . 73.45 108.277 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.413 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 92.7 t -100.78 130.35 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.33 -1.359 . . . . 74.15 107.33 171.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.1 t -107.56 107.68 23.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 107.874 -1.158 . . . . 63.03 107.874 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.27 99.86 12.02 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.381 -1.34 . . . . 73.33 107.381 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 37.8 ttt180 -85.74 119.61 26.25 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.22 -0.9 . . . . 60.44 109.641 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.5 t -112.13 140.77 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.561 -0.903 . . . . 74.23 108.561 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 17.9 m -130.92 129.31 42.03 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.739 -0.837 . . . . 72.4 108.739 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.53 HG21 HG21 ' A' ' 114' ' ' ILE . 74.2 t -127.84 126.32 66.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.958 -1.497 . . . . 60.43 106.958 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 14.7 t -136.71 145.97 45.32 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.593 -0.891 . . . . 61.51 108.593 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.423 ' HB2' HG12 ' A' ' 40' ' ' VAL . . . -144.07 123.81 13.37 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.548 -0.908 . . . . 72.23 108.548 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 p -127.18 133.67 50.26 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.447 0.699 . . . . 74.44 110.607 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.581 HD13 ' HB2' ' A' ' 73' ' ' ALA . 7.6 mp -86.16 77.19 9.63 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.152 -1.795 . . . . 64.33 106.152 169.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.79 -115.69 4.81 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 114.515 -1.22 . . . . 65.31 111.082 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -87.98 -20.34 25.99 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.908 0.883 . . . . 71.3 110.319 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -80.06 100.98 8.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.754 0.822 . . . . 73.01 109.951 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.9 m -68.06 120.19 13.88 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 110.174 -0.306 . . . . 75.2 110.174 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.581 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -71.68 -55.42 7.74 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.84 -0.8 . . . . 63.41 108.84 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -160.64 165.79 30.03 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 115.524 -0.762 . . . . 73.13 111.708 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.7 tp -141.6 108.07 5.3 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.516 -1.22 . . . . 73.02 108.205 173.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.46 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 58.7 m -107.35 116.68 32.36 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.104 0.962 . . . . 74.2 109.898 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -134.0 126.04 29.41 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.151 -0.685 . . . . 72.41 109.151 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.4 t -133.38 110.28 14.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 124.292 1.037 . . . . 75.4 109.215 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.594 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 19.6 mt-30 -84.64 84.03 7.81 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.086 -1.079 . . . . 55.23 108.086 171.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -79.33 99.92 7.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.345 -1.298 . . . . 73.11 108.685 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.14 157.81 18.39 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 112.073 -0.411 . . . . 65.14 112.073 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.403 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -154.51 131.06 3.05 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 110.849 -0.9 . . . . 72.25 110.849 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -81.12 125.21 39.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.499 -0.926 . . . . 72.21 108.499 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.698 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 30.8 m-85 -131.06 119.95 22.73 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.845 -0.798 . . . . 63.13 108.845 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -91.8 108.63 20.05 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.286 -1.005 . . . . 64.0 108.286 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.599 HD11 ' HD2' ' A' ' 56' ' ' TYR . 2.6 pp -118.65 147.61 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.541 0.737 . . . . 75.34 110.533 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.34 176.92 6.36 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.137 0.975 . . . . 74.34 110.0 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.25 -24.58 21.61 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.854 -0.612 . . . . 53.02 113.583 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -136.39 148.83 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.501 0.72 . . . . 73.05 110.954 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.68 175.01 9.96 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.875 0.87 . . . . 70.21 109.365 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.37 -128.69 13.64 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 123.459 0.552 . . . . 63.13 112.386 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.4 p -68.84 -22.06 64.25 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.261 1.024 . . . . 63.01 111.958 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -68.45 -51.07 47.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.846 0.858 . . . . 74.33 110.68 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.498 ' SD ' HD13 ' A' ' 86' ' ' ILE . 41.5 ttp -78.08 -23.03 48.15 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 116.275 -0.42 . . . . 73.21 110.402 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -37.7 86.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.154 0.582 . . . . 61.34 110.199 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -67.72 -35.15 78.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.544 0.738 . . . . 62.4 110.85 174.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 76.8 m -62.1 -54.07 46.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.756 0.423 . . . . 71.5 110.582 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.402 ' O ' HG21 ' A' ' 46' ' ' THR . 3.7 pp -73.16 -34.5 66.08 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.771 0.428 . . . . 75.24 111.39 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.67 -2.0 56.39 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 114.905 0.722 . . . . 70.3 114.905 -168.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -148.75 -61.75 0.24 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.649 0.724 . . . . 74.3 112.727 -175.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -72.17 -61.91 1.62 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.106 0.963 . . . . 72.33 112.709 -165.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 72.7 m -67.65 -34.96 7.24 Favored Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 114.026 1.121 . . . . 75.43 114.026 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 27.9 Cg_endo -64.64 -31.09 59.97 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 121.769 1.646 . . . . 74.13 113.357 167.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 25.8 t-20 -67.89 -29.92 69.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.097 0.559 . . . . 61.13 110.206 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.15 -42.81 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.845 0.858 . . . . 61.32 110.573 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.403 HD21 ' HA3' ' A' ' 82' ' ' GLY . 42.9 mt -82.16 -20.79 37.2 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.474 1.11 . . . . 72.53 112.575 -173.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.77 -44.77 91.91 Favored Pre-proline 0 CA--C 1.572 1.805 0 C-N-CA 124.033 0.933 . . . . 73.5 113.437 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -64.73 -32.38 57.02 Favored 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 122.36 2.04 . . . . 75.44 113.434 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -70.8 -40.66 72.4 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.144 0.577 . . . . 71.23 110.933 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.37 -38.8 78.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.968 0.507 . . . . 74.41 110.49 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.424 ' HB2' HD11 ' A' ' 128' ' ' LEU . 36.0 ttm180 -51.09 -56.25 13.58 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.088 0.867 . . . . 73.5 109.517 172.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -59.11 -47.74 84.16 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.609 1.164 . . . . 74.21 112.163 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.06 -44.89 87.71 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.999 0.812 . . . . 53.55 110.975 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.53 HG21 HG21 ' A' ' 64' ' ' VAL . 96.6 mt -67.53 -49.05 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.039 0.936 . . . . 71.44 110.586 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.51 HG23 ' HG3' ' A' ' 125' ' ' GLN . 36.3 m -53.25 -40.72 64.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.146 0.978 . . . . 75.41 111.208 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.28 -47.82 66.64 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.989 -1.005 . . . . 73.53 110.018 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 42.5 mtp -60.92 -41.09 95.51 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 124.077 0.951 . . . . 72.01 111.686 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.8 t -65.62 -44.15 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.17 0.988 . . . . 64.04 110.339 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.9 t -68.53 -31.82 71.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.6 0.76 . . . . 64.52 111.313 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -72.69 -29.94 63.82 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.38 0.672 . . . . 70.02 110.075 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.52 2.64 84.99 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 123.69 0.619 . . . . 71.44 112.896 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.3 m 68.0 22.9 8.35 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.768 1.227 . . . . 74.52 111.151 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -91.93 150.88 41.4 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 123.355 0.662 . . . . 70.14 109.222 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.46 139.48 90.8 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.577 2.184 . . . . 71.33 112.575 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.51 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.0 tt0 -57.73 150.04 20.63 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.814 1.246 . . . . 71.43 112.682 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 pp -126.65 137.46 53.29 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.846 -1.168 . . . . 75.02 107.846 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -135.69 84.05 2.06 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.751 -1.203 . . . . 41.43 107.751 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 111' ' ' ARG . 2.7 pp -65.1 135.62 55.75 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.146 -0.479 . . . . 71.3 110.645 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.17 140.81 98.06 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 123.069 0.548 . . . . 42.23 110.068 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.75 126.92 22.63 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.196 1.931 . . . . 64.32 111.384 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 91.3 t -97.46 113.86 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 106.62 -1.622 . . . . 60.1 106.62 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -75.48 83.93 2.56 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.946 -1.131 . . . . 70.11 107.946 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -60.4 -33.41 72.45 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.108 -0.951 . . . . 74.04 110.589 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.05 -40.46 90.98 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.074 0.95 . . . . 63.12 110.98 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.06 -50.55 61.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.254 0.621 . . . . 75.51 110.259 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.0 mt -64.04 -42.15 97.17 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.22 -0.9 . . . . 63.53 111.573 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -66.49 -41.02 89.56 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.237 -0.892 . . . . 72.45 109.375 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.359 0.994 0 O-C-N 123.897 0.748 . . . . 71.33 109.774 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.638 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 70.6 m . . . . . 0 C--O 1.241 0.637 0 N-CA-C 107.122 -1.436 . . . . 64.52 107.122 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -139.39 141.49 37.55 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.759 0.423 . . . . 75.01 110.252 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -144.67 138.12 27.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.592 0.757 . . . . 71.13 109.906 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.94 126.78 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.048 -1.093 . . . . 73.43 108.048 171.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -95.35 -50.32 5.07 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.699 0.4 . . . . 72.24 110.079 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -161.72 131.07 4.56 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.531 -0.544 . . . . 74.33 109.531 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.2 mt -115.35 131.95 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 107.924 -1.139 . . . . 72.03 107.924 171.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -156.85 138.28 13.92 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.41 0.684 . . . . 71.4 110.144 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.5 m -72.23 121.84 20.04 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.478 -0.934 . . . . 55.42 108.478 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.426 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.8 mtpt -95.33 -23.5 17.17 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.433 0.693 . . . . 71.01 111.042 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -161.69 141.03 9.97 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.399 0.437 . . . . 74.12 110.732 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 33.7 mm -134.23 144.46 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.159 1.384 . . . . 73.3 108.765 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -138.55 139.95 38.87 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.591 -1.186 . . . . 73.21 107.974 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 85.2 t80 -152.58 130.61 11.84 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.637 -1.246 . . . . 74.53 107.637 166.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 49.0 mt-10 -140.45 116.7 10.61 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.645 0.778 . . . . 61.12 108.918 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.674 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -105.29 84.29 1.07 Allowed Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 106.922 -1.51 . . . . 54.0 106.922 165.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.39 -23.83 20.03 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.954 2.436 . . . . 70.32 111.97 -170.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 78.3 m-20 -116.93 6.71 13.07 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 114.433 -1.258 . . . . 75.03 110.368 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.674 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -29.13 -66.05 0.15 Allowed Pre-proline 0 C--N 1.38 1.899 0 C-N-CA 126.163 1.785 . . . . 55.01 114.787 -171.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.8 Cg_exo -64.78 -29.46 59.29 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 122.585 2.19 . . . . 64.43 112.509 -169.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -46.47 14.52 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.364 -0.835 . . . . 72.23 110.752 176.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.597 HG22 HD12 ' B' ' 68' ' ' LEU . 2.7 p -70.31 -17.85 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.147 0.579 . . . . 64.2 111.986 -166.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -69.37 -11.64 60.99 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 112.654 0.613 . . . . 73.35 112.654 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -77.28 -3.42 39.74 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.191 0.596 . . . . 73.0 110.877 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.7 105.35 15.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.907 1.283 . . . . 75.01 110.093 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.93 91.91 7.7 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.842 0.857 . . . . 65.21 109.729 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -161.92 155.57 21.3 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.918 0.887 . . . . 72.4 108.922 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -81.97 102.95 1.78 Allowed Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 107.201 -1.407 . . . . 74.14 107.201 170.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.67 133.35 31.54 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.555 2.17 . . . . 52.45 112.308 -171.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -69.23 129.54 40.11 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 123.855 0.722 . . . . 54.44 110.026 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' B' ' 66' ' ' ALA . 74.9 t -106.13 129.84 58.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.49 1.116 . . . . 74.31 109.968 -171.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -103.98 112.66 25.74 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 105.84 -1.911 . . . . 72.2 105.84 167.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.58 153.23 18.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.921 -1.036 . . . . 71.25 108.784 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.6 t70 -144.59 110.62 5.44 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.022 -0.732 . . . . 75.24 109.022 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -109.04 134.89 51.08 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.14 -1.059 . . . . 74.04 108.14 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -159.54 156.24 27.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.395 0.678 . . . . 75.35 109.377 170.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.6 p -124.82 128.33 48.54 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.352 0.661 . . . . 50.14 109.833 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.5 158.19 21.94 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.738 -1.208 . . . . 74.11 107.738 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.434 ' HB3' HD21 ' B' ' 98' ' ' LEU . 13.3 p -142.27 168.78 18.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.53 0.332 . . . . 60.13 111.107 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 2.1 m -148.53 136.06 20.52 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.424 -0.954 . . . . 53.12 108.424 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -90.36 100.53 13.35 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.416 -0.957 . . . . 63.52 108.416 170.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.21 -33.44 59.26 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.637 -0.71 . . . . 75.43 109.911 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.02 -175.35 3.33 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.147 -0.933 . . . . 72.52 110.696 -177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.28 122.22 16.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.371 -1.286 . . . . 71.02 109.154 173.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 66.62 14.65 9.85 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.926 0.891 . . . . 51.22 112.379 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -118.5 119.78 62.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 123.642 0.777 . . . . 74.11 109.032 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -112.64 152.78 28.56 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.641 0.776 . . . . 72.41 110.172 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 6.8 tm-20 -124.66 97.18 5.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.508 -1.664 . . . . 75.21 106.508 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.401 HG22 ' HG ' ' B' ' 98' ' ' LEU . 90.4 t -86.51 143.99 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.048 -0.978 . . . . 71.34 109.792 -175.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -131.95 112.43 20.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.432 -0.951 . . . . 74.35 108.432 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.439 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -93.64 118.72 31.75 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.465 -1.309 . . . . 70.02 107.465 177.006 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 69.3 ttt-85 -107.43 110.07 21.94 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.975 0.51 . . . . 74.53 109.719 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.407 ' HB ' HD11 ' B' ' 114' ' ' ILE . 22.8 t -108.11 104.31 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.982 -1.118 . . . . 64.04 107.982 173.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 11.1 m -100.54 137.37 39.04 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.116 -0.698 . . . . 63.51 109.116 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.661 HG21 HG21 ' B' ' 114' ' ' ILE . 50.3 t -123.82 126.49 72.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.982 1.313 . . . . 64.11 108.822 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 52.4 m -125.09 139.01 54.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.476 -1.305 . . . . 72.23 107.476 170.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' B' ' 40' ' ' VAL . . . -146.03 151.6 38.01 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.605 -0.517 . . . . 64.44 109.605 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 27.7 p -149.07 139.57 22.51 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 123.699 0.624 . . . . 60.3 112.132 -174.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.597 HD12 HG22 ' B' ' 31' ' ' VAL . 86.3 mt -106.08 102.22 11.66 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.639 1.176 . . . . 72.24 108.328 172.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.02 -131.5 12.46 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.786 -0.643 . . . . 44.44 112.541 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -86.97 3.81 44.3 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.384 1.073 . . . . 70.2 112.446 -175.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.493 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.9 pt-20 -132.16 155.61 47.89 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.957 0.503 . . . . 71.21 111.095 -175.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.6 m -67.1 137.3 56.26 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.891 0.744 . . . . 74.24 110.85 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.439 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -91.06 -67.29 0.86 Allowed 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.697 -1.223 . . . . 75.35 107.697 173.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -144.3 145.59 32.1 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 121.407 0.622 . . . . 73.1 110.626 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 94.1 mt -117.14 149.46 40.32 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.309 1.444 . . . . 72.53 107.281 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.531 ' SG ' HG23 ' B' ' 114' ' ' ILE . 42.5 t -158.15 158.53 34.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.659 -0.867 . . . . 63.02 108.659 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -165.73 133.54 2.96 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.994 -1.113 . . . . 63.45 107.994 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.468 HG23 HG12 ' B' ' 114' ' ' ILE . 94.2 t -124.88 141.32 45.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.615 -0.883 . . . . 62.44 108.615 174.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -119.63 84.19 2.16 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.3 -1.37 . . . . 63.22 107.3 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -79.77 99.33 7.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.357 -1.292 . . . . 64.43 109.079 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.426 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -96.0 171.41 28.52 Favored Glycine 0 C--O 1.245 0.788 0 CA-C-N 115.774 -0.648 . . . . 72.25 112.006 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.54 130.88 1.94 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 112.029 -0.429 . . . . 64.13 112.029 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 63.8 mt -83.73 127.29 39.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 108.293 -1.003 . . . . 75.41 108.293 170.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -136.08 143.28 44.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.646 0.778 . . . . 65.31 109.163 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -104.05 125.3 50.29 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.691 0.796 . . . . 72.1 109.014 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.622 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.8 pp -119.23 145.01 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.217 1.007 . . . . 55.42 110.103 -176.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.638 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.04 162.11 41.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.584 0.754 . . . . 75.33 110.119 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.72 -57.13 5.05 Favored Glycine 0 C--N 1.354 1.567 0 O-C-N 123.683 0.614 . . . . 60.24 112.854 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.622 HD11 ' HB ' ' B' ' 86' ' ' ILE . 11.8 pt -58.19 148.39 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.762 1.225 . . . . 74.43 112.178 174.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.514 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 31.2 tt0 -160.84 152.52 19.56 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.999 -1.0 . . . . 74.4 109.843 -175.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.8 -112.76 4.08 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 112.206 -0.358 . . . . 63.32 112.206 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.9 m -92.51 -16.98 25.08 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.895 0.478 . . . . 63.32 111.139 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.514 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 45.6 mt-30 -59.76 -39.22 84.09 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.268 0.627 . . . . 64.4 110.725 175.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.584 ' HA ' HD12 ' B' ' 89' ' ' ILE . 26.2 ptt? -74.71 -25.25 59.01 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.647 -0.706 . . . . 52.04 110.993 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.33 -33.5 71.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.412 0.685 . . . . 64.11 110.466 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -65.4 -39.19 91.89 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.548 0.739 . . . . 73.32 110.685 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.48 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 44.5 t -70.42 -58.06 4.13 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.758 -0.655 . . . . 65.43 110.547 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' B' ' 48' ' ' SER . 7.8 tt -65.13 -43.74 90.91 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.425 0.69 . . . . 65.21 111.38 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.19 -26.03 49.68 Favored Glycine 0 C--N 1.341 0.839 0 O-C-N 123.763 0.664 . . . . 61.1 114.238 -170.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.59 -53.17 1.25 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.215 0.508 . . . . 41.24 112.328 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.48 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 79.7 t80 -71.33 -45.72 62.29 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.565 0.746 . . . . 72.12 112.626 -169.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.533 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 81.0 m -67.82 -49.0 39.93 Favored Pre-proline 0 CA--C 1.565 1.551 0 C-N-CA 123.702 0.801 . . . . 73.13 110.424 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 66.8 Cg_exo -57.07 -30.04 85.36 Favored 'Trans proline' 0 C--N 1.399 3.229 0 C-N-CA 122.844 2.363 . . . . 74.52 113.898 169.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -62.55 -41.54 98.97 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.593 0.757 . . . . 73.3 109.803 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.79 -44.26 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.626 0.77 . . . . 73.21 110.063 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.3 mt -78.92 -15.76 57.9 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.029 0.932 . . . . 70.34 112.583 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -62.21 -51.82 71.34 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 118.102 -0.951 . . . . 72.03 113.348 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.27 -34.97 87.0 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 121.825 1.684 . . . . 74.12 112.515 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -62.73 -50.46 71.02 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.906 0.883 . . . . 75.32 110.911 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.41 97.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.789 0.836 . . . . 71.52 110.631 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -59.2 -54.34 48.03 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.636 1.574 . . . . 74.41 111.131 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.54 -30.66 70.36 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.193 0.597 . . . . 74.13 110.037 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.567 ' SG ' HD11 ' B' ' 21' ' ' ILE . 1.8 t -69.98 -28.42 65.52 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.745 0.418 . . . . 73.52 111.595 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.661 HG21 HG21 ' B' ' 64' ' ' VAL . 45.8 mt -76.03 -54.48 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 109.176 -0.676 . . . . 74.22 109.176 172.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.43 HG21 ' OG ' ' C' ' 119' ' ' SER . 23.5 m -54.2 -33.43 58.2 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.623 1.202 . . . . 71.01 111.568 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 24.8 t -60.42 -54.17 48.81 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 115.24 -0.891 . . . . 62.43 109.589 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.1 mmt -68.94 -35.33 76.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.7 0.8 . . . . 61.21 111.482 -173.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.422 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.3 t -60.63 -46.08 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.0 0.92 . . . . 74.33 109.811 174.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 34.8 t -72.59 -28.86 63.05 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.651 -1.159 . . . . 64.42 111.383 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.2 mtt-85 -68.75 -35.39 77.03 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.524 0.73 . . . . 65.51 109.533 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.71 11.13 57.73 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 124.119 0.887 . . . . 74.32 112.816 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.467 HG23 ' HB3' ' A' ' 17' ' ' TYR . 75.6 p 56.58 24.12 8.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.235 1.814 . . . . 74.13 113.631 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -84.52 154.81 62.55 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 123.326 0.65 . . . . 71.42 110.34 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.35 169.94 5.88 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.955 2.437 . . . . 72.4 113.778 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -63.62 131.18 47.18 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.01 -0.995 . . . . 74.04 112.211 -166.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.2 tp -135.11 111.54 9.81 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.859 0.863 . . . . 75.31 109.043 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -134.2 114.74 13.39 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.345 0.658 . . . . 73.34 109.272 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.27 141.75 55.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.794 0.837 . . . . 72.34 111.086 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.46 144.07 96.06 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.412 0.685 . . . . 75.44 110.365 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -69.32 100.54 0.77 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.405 2.07 . . . . 75.4 111.339 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.48 110.76 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.587 -0.894 . . . . 74.54 108.587 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -78.96 83.92 5.02 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.987 -1.116 . . . . 73.33 107.987 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -52.67 -39.11 61.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.578 1.151 . . . . 61.0 112.871 -172.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.41 -34.59 75.64 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.483 1.113 . . . . 72.03 112.396 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.79 -41.07 60.68 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.43 0.692 . . . . 64.41 110.863 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -70.13 -29.77 66.79 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.467 -0.788 . . . . 74.43 110.072 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 80.9 t80 . . . . . 0 N--CA 1.469 0.525 0 C-N-CA 123.976 0.91 . . . . 73.24 110.469 179.377 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 29.2 m . . . . . 0 C--O 1.236 0.362 0 N-CA-C 106.654 -1.61 . . . . 73.31 106.654 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -104.04 122.33 45.05 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.831 -1.077 . . . . 70.15 109.479 -172.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -137.05 108.12 6.74 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 107.289 -1.374 . . . . 75.02 107.289 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 42.8 mt -67.73 119.17 12.94 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 108.112 -1.07 . . . . 44.33 108.112 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.652 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.7 mm-40 -78.34 -48.88 14.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.791 0.682 . . . . 73.14 109.431 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -172.24 138.65 0.98 Allowed 'General case' 0 C--N 1.349 0.58 0 CA-C-N 115.526 -0.761 . . . . 75.01 110.271 -169.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.3 mt -120.78 139.42 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.56 -1.274 . . . . 65.41 107.56 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -172.99 166.68 5.06 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.257 0.551 . . . . 73.1 111.015 -172.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -94.12 124.8 38.36 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.634 -0.712 . . . . 65.25 109.287 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.605 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.0 OUTLIER -81.61 -49.06 10.96 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.985 -1.487 . . . . 44.43 106.985 173.561 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.2 t70 -135.7 132.65 37.17 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.198 -1.819 . . . . 70.41 109.068 -168.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.5 mt -135.17 141.41 42.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.828 -1.545 . . . . 73.24 106.828 173.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.4 t -159.51 150.36 19.51 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.443 0.639 . . . . 73.32 110.597 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -145.71 139.8 26.78 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.336 -1.357 . . . . 74.1 107.336 174.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.84 120.3 12.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.644 0.778 . . . . 73.24 109.476 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.82 87.15 36.49 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 107.047 -1.464 . . . . 74.31 107.047 168.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.61 -38.34 25.28 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.077 2.518 . . . . 71.53 111.828 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -102.24 29.35 5.19 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.19 -1.368 . . . . 62.12 110.069 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.41 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -51.85 -55.6 28.85 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.457 1.103 . . . . 71.2 113.926 -171.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 33.5 Cg_exo -57.67 -44.9 37.27 Favored 'Trans proline' 0 C--N 1.39 2.747 0 CA-C-N 121.714 1.648 . . . . 62.31 112.927 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -69.95 -35.29 74.38 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.718 0.807 . . . . 72.51 112.238 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.751 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.9 p -78.23 -23.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.823 0.449 . . . . 72.52 111.874 -172.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -69.15 -33.27 73.17 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.627 0.251 . . . . 74.14 110.494 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -94.4 38.9 1.09 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.598 0.759 . . . . 73.02 110.374 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.714 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -119.96 141.71 49.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.749 1.22 . . . . 75.41 109.533 174.166 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.59 99.99 1.38 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.063 -1.088 . . . . 60.41 108.063 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -80.6 115.15 19.96 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.675 0.75 . . . . 75.23 112.548 -171.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -122.2 79.05 43.82 Favored Pre-proline 0 CA--C 1.555 1.137 0 N-CA-C 106.843 -1.54 . . . . 74.0 106.843 162.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.1 128.19 7.21 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.363 2.709 . . . . 65.3 112.946 -172.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -84.82 89.24 7.5 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.435 -1.32 . . . . 70.15 107.435 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.37 99.8 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.017 -1.447 . . . . 55.41 109.168 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.517 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 57.2 tttm -92.75 112.54 24.53 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.723 -0.843 . . . . 73.44 108.723 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.65 125.05 34.15 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.064 -0.717 . . . . 61.23 109.064 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.428 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.9 t70 -121.49 131.06 53.93 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.919 -1.141 . . . . 74.13 107.919 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 45.5 mt -120.6 147.04 45.74 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.827 -1.175 . . . . 74.21 107.827 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 22.8 t70 -157.48 152.77 26.09 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.235 0.614 . . . . 62.5 109.725 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 11.2 m -137.41 128.02 26.84 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.631 0.729 . . . . 72.51 110.045 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.83 161.68 16.66 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.151 -1.386 . . . . 72.24 108.554 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 20.3 p -159.31 151.36 20.87 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.858 0.361 . . . . 43.34 111.165 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 86.4 p -145.14 142.68 29.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.131 0.972 . . . . 64.55 108.747 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -82.87 118.06 23.17 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.426 -0.583 . . . . 71.43 109.426 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.611 HD11 HD12 ' C' ' 83' ' ' ILE . 38.6 mt -92.59 -40.05 10.99 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.609 0.763 . . . . 73.13 109.248 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.5 -175.73 5.49 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.263 1.025 . . . . 74.43 109.348 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.31 108.85 1.71 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.544 -0.753 . . . . 64.11 109.925 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 32.6 m-20 71.8 5.87 5.49 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.55 1.54 . . . . 74.43 112.668 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -103.23 97.78 6.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.964 -1.125 . . . . 70.14 107.964 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -103.43 137.82 41.0 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.46 0.704 . . . . 72.51 110.097 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.525 ' HB2' HD11 ' C' ' 51' ' ' LEU . 22.1 tt0 -81.9 108.99 15.85 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.745 -1.576 . . . . 64.13 106.745 164.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 50.9 t -96.97 137.26 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 108.166 -1.05 . . . . 72.43 108.166 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.447 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 52.1 t -127.4 129.88 70.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.235 -1.024 . . . . 71.34 108.235 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.7 104.5 13.51 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.831 -1.544 . . . . 63.33 106.831 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.554 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 9.2 ttm180 -90.27 120.79 31.71 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.862 -1.063 . . . . 72.43 108.326 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.28 123.93 71.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.836 -1.172 . . . . 72.03 107.836 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 27.0 m -126.03 123.67 38.95 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.612 -0.885 . . . . 54.22 108.612 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.745 HG11 HD21 ' C' ' 126' ' ' LEU . 34.2 t -114.03 120.87 64.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 108.795 -0.817 . . . . 55.32 108.795 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 30.8 m -101.19 143.86 30.76 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.641 0.776 . . . . 75.11 108.967 172.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.67 107.86 6.08 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.12 -1.437 . . . . 74.51 107.12 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.2 m -128.02 131.72 49.16 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.519 -0.549 . . . . 72.43 109.519 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.714 HD13 ' HG2' ' C' ' 34' ' ' LYS . 25.0 mt -85.15 43.18 0.99 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.281 1.832 . . . . 75.13 110.045 -176.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.62 -88.68 0.68 Allowed Glycine 0 C--N 1.343 0.919 0 N-CA-C 110.303 -1.119 . . . . 71.41 110.303 -170.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -118.5 -20.09 8.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.816 0.846 . . . . 71.53 110.746 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -77.48 100.48 6.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.739 0.816 . . . . 74.23 109.143 172.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.7 m -66.85 120.26 13.26 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 118.922 0.783 . . . . 72.41 109.197 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.751 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.67 -52.36 18.3 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 124.095 0.872 . . . . 74.22 108.984 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -166.56 167.4 15.52 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.617 -1.174 . . . . 55.14 110.843 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -133.9 139.43 46.17 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 106.309 -1.737 . . . . 74.23 106.309 171.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.4 t -146.53 117.82 7.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.298 -0.631 . . . . 63.11 109.298 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -125.57 126.55 44.97 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 122.954 0.502 . . . . 73.43 109.909 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -120.46 132.46 70.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.338 -0.986 . . . . 63.34 108.338 167.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.554 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 69.0 mt-30 -106.08 94.66 5.29 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.587 -1.264 . . . . 72.1 107.587 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -84.2 105.73 15.28 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.532 -0.758 . . . . 64.03 109.701 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.605 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -95.64 163.73 23.86 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-O 121.609 0.56 . . . . 74.0 112.858 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.518 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -164.38 126.6 1.53 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.013 -1.235 . . . . 75.11 110.013 -177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 14.0 mm -85.23 128.77 38.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.125 -1.065 . . . . 74.43 108.125 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.11 119.41 20.91 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.392 -0.595 . . . . 75.14 109.392 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -83.95 107.58 16.41 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.162 -1.051 . . . . 72.1 108.162 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.447 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.4 pp -122.45 142.87 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.102 0.961 . . . . 73.24 110.144 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.92 169.53 21.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.628 0.771 . . . . 22.24 110.512 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.89 -44.21 1.52 Allowed Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.104 -0.498 . . . . 51.22 111.944 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.605 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -109.38 149.6 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.114 0.965 . . . . 63.03 109.234 178.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 11.7 pt-20 -143.01 172.59 12.5 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.652 0.263 . . . . 73.3 111.456 -171.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.81 -129.47 48.37 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.201 -0.909 . . . . 73.31 112.486 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -66.86 -19.32 65.71 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.671 0.788 . . . . 62.33 112.08 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -78.31 -35.26 48.0 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.404 0.681 . . . . 61.41 110.421 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.567 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 10.9 tmm? -72.63 -38.53 67.71 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.427 -0.953 . . . . 72.14 108.427 172.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.87 -32.8 71.05 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 115.248 -0.887 . . . . 62.13 110.558 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -77.37 -34.54 55.0 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.374 0.421 . . . . 73.12 110.918 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 15.2 t -63.29 -34.97 78.85 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.005 0.815 . . . . 63.54 109.913 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -99.15 -12.46 20.45 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.99 0.516 . . . . 65.44 111.969 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.29 -31.51 59.2 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 114.562 0.585 . . . . 51.12 114.562 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.9 -38.09 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.797 0.439 . . . . 73.43 111.042 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -56.93 -41.81 78.91 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 125.419 1.488 . . . . 74.54 112.209 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.2 m -82.26 -48.59 0.89 Allowed Pre-proline 0 CA--C 1.569 1.708 0 N-CA-C 112.897 0.703 . . . . 64.33 112.897 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.98 -29.85 28.83 Favored 'Trans proline' 0 C--N 1.392 2.855 0 C-N-CA 123.21 2.607 . . . . 73.04 115.131 172.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.24 -35.41 80.74 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.907 0.883 . . . . 63.35 110.836 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.422 HG23 ' NH1' ' A' ' 111' ' ' ARG . 40.9 mm -64.71 -40.3 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 115.511 -0.768 . . . . 75.13 109.585 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.518 HD21 ' HA3' ' C' ' 82' ' ' GLY . 53.5 mt -83.55 -18.14 39.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.652 1.181 . . . . 71.32 112.14 -175.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -56.75 -51.34 82.16 Favored Pre-proline 0 CA--C 1.56 1.352 0 N-CA-C 114.132 1.16 . . . . 75.41 114.132 -173.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.427 ' HA ' HH11 ' C' ' 111' ' ' ARG . 18.3 Cg_exo -66.15 -32.16 43.58 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 121.607 1.538 . . . . 61.3 112.778 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -65.63 -46.92 77.43 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.542 0.737 . . . . 74.45 110.503 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.04 -42.65 90.73 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.051 0.94 . . . . 73.32 110.679 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.427 HH11 ' HA ' ' C' ' 108' ' ' PRO . 27.6 mtp-105 -57.03 -55.93 28.33 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.333 1.02 . . . . 75.14 111.051 176.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.12 -29.91 70.8 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.139 0.576 . . . . 74.21 110.628 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 10.6 t -74.39 -33.13 62.96 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.265 0.626 . . . . 51.04 111.303 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.409 ' O ' HG23 ' C' ' 118' ' ' VAL . 71.5 mt -72.76 -51.29 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.037 0.535 . . . . 72.44 109.654 173.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 25.8 m -59.99 -32.96 71.33 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.094 0.957 . . . . 75.13 111.349 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.0 t -61.57 -51.51 68.26 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.189 -0.671 . . . . 65.33 109.189 172.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.583 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.69 -35.54 78.3 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.703 1.201 . . . . 65.12 112.914 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.409 HG23 ' O ' ' C' ' 114' ' ' ILE . 98.4 t -66.55 -47.13 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.52 0.728 . . . . 74.01 109.925 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.43 ' OG ' HG21 ' B' ' 115' ' ' THR . 48.4 t -66.18 -32.19 73.47 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.93 -1.032 . . . . 74.1 111.091 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.01 -35.53 74.44 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.73 0.812 . . . . 63.4 109.399 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 4.33 79.46 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.878 0.736 . . . . 74.33 112.873 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 60.0 p 59.38 25.55 14.28 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.509 1.924 . . . . 72.11 114.08 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -87.82 152.87 51.92 Favored Pre-proline 0 CA--C 1.557 1.237 0 N-CA-C 107.567 -1.272 . . . . 63.43 107.567 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.69 -179.81 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.729 2.286 . . . . 73.12 113.739 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -49.66 130.63 21.07 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.664 1.186 . . . . 64.41 112.89 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.745 HD21 HG11 ' C' ' 64' ' ' VAL . 14.3 tp -148.84 85.28 1.48 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.29 -1.004 . . . . 72.3 108.29 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -116.31 129.79 56.45 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.159 -1.052 . . . . 65.12 108.159 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 21.4 tp -76.18 132.69 40.11 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 109.78 -0.452 . . . . 71.43 109.78 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.1 154.91 75.78 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.243 1.017 . . . . 74.32 111.15 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -50.11 101.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.907 2.405 . . . . 72.4 112.867 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 80.8 t -96.55 110.69 25.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.217 -1.031 . . . . 55.1 108.217 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -87.12 86.14 7.27 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.898 -1.149 . . . . 54.13 107.898 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -60.55 -31.4 70.51 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.303 0.641 . . . . 52.11 110.227 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.7 -36.94 79.13 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.336 1.054 . . . . 63.23 112.263 -165.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.45 74.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.98 0.912 . . . . 72.02 111.188 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.29 -23.97 34.92 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.182 -0.917 . . . . 74.41 111.452 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 3.3 t80 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.011 0.434 . . . . 65.21 109.997 173.083 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.6 m . . . . . 0 C--O 1.241 0.618 0 N-CA-C 107.506 -1.294 . . . . 73.52 107.506 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -148.53 110.77 4.64 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.077 -1.453 . . . . 74.35 107.077 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -132.81 141.67 48.59 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.183 -1.043 . . . . 64.43 108.183 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.61 HD11 HD13 ' D' ' 105' ' ' ILE . 19.4 mt -98.45 133.3 41.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.164 -1.05 . . . . 74.44 108.164 171.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -96.96 -45.65 6.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.403 0.681 . . . . 63.22 111.574 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -172.16 120.5 0.43 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 118.008 0.367 . . . . 73.52 111.874 -163.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.505 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -104.96 135.6 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.417 -1.327 . . . . 73.33 107.417 171.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -159.7 167.06 29.24 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.156 0.91 . . . . 60.42 111.205 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 18' ' ' THR . . . . . 0.495 HG21 HD11 ' D' ' 21' ' ' ILE . 81.2 p -99.53 117.16 33.31 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.078 -1.419 . . . . 74.22 109.327 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -88.06 -20.05 26.28 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.343 -0.844 . . . . 74.22 109.04 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.3 t70 -159.0 132.69 7.44 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.515 -1.22 . . . . 72.41 109.185 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.583 HD13 ' HE3' ' C' ' 117' ' ' MET . 79.7 mt -134.66 144.26 35.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 124.931 1.292 . . . . 51.53 107.553 174.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -147.46 136.6 22.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.337 1.055 . . . . 63.34 108.579 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.493 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.5 t80 -148.98 126.92 11.9 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.281 -1.748 . . . . 72.44 106.281 170.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -134.51 128.63 33.75 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.854 0.862 . . . . 74.15 109.372 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.67 81.27 60.91 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 107.881 -1.155 . . . . 64.3 107.881 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.92 -23.48 10.71 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.989 2.46 . . . . 35.42 113.604 -172.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -108.4 11.34 27.11 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.346 0.658 . . . . 61.03 109.966 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -36.85 -67.84 0.23 Allowed Pre-proline 0 CA--C 1.564 1.516 0 C-N-CA 126.371 1.868 . . . . 65.11 115.794 -161.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.01 -19.18 16.03 Favored 'Trans proline' 0 C--N 1.38 2.196 0 CA-C-N 123.124 2.151 . . . . 75.53 113.839 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -73.04 -43.06 62.48 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.917 0.887 . . . . 74.23 109.68 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.6 p -82.92 -16.12 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 CA-C-N 115.708 -0.678 . . . . 54.22 111.045 -172.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -68.4 -22.9 64.6 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.23 0.456 . . . . 71.24 112.23 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -65.94 -12.64 56.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.646 0.779 . . . . 71.42 110.744 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -98.44 92.91 5.89 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.396 1.078 . . . . 51.14 108.702 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -82.56 74.93 9.49 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.485 0.659 . . . . 63.13 109.697 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -137.43 156.23 48.41 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.129 -1.063 . . . . 73.44 108.129 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 37' ' ' GLN . . . . . 0.434 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 1.8 mp0 -76.65 109.23 8.12 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.016 0.927 . . . . 63.14 108.921 174.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 21.6 Cg_exo -65.73 123.35 11.25 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 123.375 2.717 . . . . 41.11 113.432 -168.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -62.38 115.34 4.12 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.315 -0.624 . . . . 51.53 109.315 173.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.522 HG21 HG13 ' D' ' 64' ' ' VAL . 7.2 p -122.2 145.2 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.895 -1.048 . . . . 74.23 110.77 -170.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -117.26 147.9 42.13 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.978 0.911 . . . . 74.52 108.75 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.526 HD21 HG13 ' D' ' 62' ' ' VAL . 6.0 tt -121.34 125.61 47.43 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.339 -0.985 . . . . 74.54 108.339 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.612 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 29.3 t70 -108.11 137.49 46.01 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.941 0.896 . . . . 61.32 109.237 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 tp -113.14 140.45 47.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.651 0.78 . . . . 64.53 110.643 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.9 t70 -148.2 131.11 16.16 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.233 -1.395 . . . . 65.44 107.233 165.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.1 t -106.99 153.82 22.01 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.464 -0.939 . . . . 72.21 108.464 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.654 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.03 164.55 35.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.493 -0.929 . . . . 63.1 108.493 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 18.5 p -169.74 154.54 5.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.561 0.744 . . . . 75.1 109.806 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -154.22 142.61 20.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.784 0.834 . . . . 63.13 109.574 -166.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.11 118.66 28.99 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.644 -0.502 . . . . 75.3 109.644 175.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' D' ' 57' ' ' GLU . 49.6 mt -94.54 -42.02 9.04 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.351 0.66 . . . . 62.42 110.037 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.0 -174.75 4.89 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 124.013 0.925 . . . . 64.35 110.236 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -63.7 109.16 1.61 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.707 -1.133 . . . . 72.55 110.071 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 60.96 23.6 13.72 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.19 0.996 . . . . 55.24 111.906 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.52 121.79 67.9 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 124.758 1.223 . . . . 64.41 108.193 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -135.89 132.36 36.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.708 0.803 . . . . 65.05 109.311 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.537 ' HB2' HD11 ' D' ' 51' ' ' LEU . 30.4 tt0 -86.15 148.81 25.51 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 124.431 1.082 . . . . 53.04 108.98 169.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.2 t -125.96 124.77 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 107.653 -1.24 . . . . 75.33 107.653 168.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.4 t -99.64 128.29 51.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.26 -1.015 . . . . 70.35 108.26 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.54 115.58 30.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.502 -0.925 . . . . 74.44 108.502 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 45.9 ttm-85 -96.61 100.72 12.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.803 -1.184 . . . . 54.55 107.803 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.526 HG13 HD21 ' D' ' 42' ' ' LEU . 75.9 t -100.67 126.0 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.561 -0.903 . . . . 73.52 108.561 170.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 46.9 m -114.48 139.9 49.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.867 -0.79 . . . . 73.12 108.867 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.522 HG13 HG21 ' D' ' 40' ' ' VAL . 70.9 t -131.98 115.17 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.846 1.258 . . . . 75.04 108.213 -176.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 50.0 m -125.03 99.02 5.93 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.992 0.917 . . . . 75.23 109.227 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -101.59 158.84 15.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.669 0.787 . . . . 71.11 111.27 -175.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 50.8 p -149.92 133.31 16.51 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.669 -0.696 . . . . 65.34 111.548 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 34.9 mt -107.76 107.98 18.98 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.22 -1.4 . . . . 72.1 107.22 170.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.11 -133.3 12.35 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.934 -0.467 . . . . 72.4 111.934 -173.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -98.22 4.59 48.87 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.459 0.704 . . . . 72.31 111.401 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -120.23 165.23 15.09 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.922 0.489 . . . . 74.31 110.435 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -61.64 131.0 48.57 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.198 -0.91 . . . . 70.04 111.449 175.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.451 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.49 -74.88 0.43 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.732 -1.21 . . . . 72.53 107.732 166.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 74' ' ' PHE . . . . . 0.48 ' HZ ' HD12 ' D' ' 126' ' ' LEU . 48.9 p90 -139.7 138.98 36.45 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.118 0.485 . . . . 73.31 109.875 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 83.3 mt -110.43 144.0 39.88 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.601 1.16 . . . . 61.44 108.159 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.607 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.2 t -159.05 146.61 17.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.848 0.459 . . . . 44.51 110.409 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -155.62 134.72 12.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.577 0.751 . . . . 72.14 108.984 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 89.5 t -133.31 121.57 42.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.892 -0.781 . . . . 63.03 108.892 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.9 mt-30 -88.11 83.25 7.01 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.812 -1.181 . . . . 71.3 107.812 167.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -79.52 93.44 5.43 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.702 -1.59 . . . . 71.11 108.663 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -84.3 157.32 33.14 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.624 -0.716 . . . . 73.44 112.059 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.474 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -152.47 130.06 2.95 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.198 -0.761 . . . . 63.41 111.198 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.461 HG23 HD12 ' D' ' 51' ' ' LEU . 61.1 mt -89.84 128.74 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 123.883 0.873 . . . . 63.52 108.646 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -126.8 152.46 46.91 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.211 1.005 . . . . 75.23 109.388 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 52.3 m -115.39 107.81 15.7 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.167 0.987 . . . . 73.33 108.423 170.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 28.5 pt -125.24 116.88 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.533 0.733 . . . . 75.44 109.444 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.07 136.39 38.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.54 0.736 . . . . 74.23 110.459 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.09 -19.82 13.26 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 115.47 0.948 . . . . 72.31 115.47 172.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.532 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -125.51 150.5 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 117.659 0.729 . . . . 72.34 110.979 -171.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.427 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 0.0 OUTLIER -151.57 166.09 32.27 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.237 0.458 . . . . 75.14 112.237 -172.2 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.48 -116.81 8.25 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 114.693 -1.139 . . . . 52.43 114.677 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.4 p -64.4 -47.43 79.22 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.96 0.904 . . . . 75.35 111.981 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -74.22 -24.08 59.28 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 116.306 -0.406 . . . . 54.01 111.014 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.427 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 0.8 OUTLIER -65.63 -49.2 69.58 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.695 -0.483 . . . . 73.11 109.695 174.864 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.96 -37.16 86.4 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.689 0.796 . . . . 53.25 110.861 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -65.91 -30.3 70.87 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.838 0.855 . . . . 74.52 111.392 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -82.57 -51.9 7.34 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.342 -0.39 . . . . 74.31 110.544 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 tp -80.09 -31.13 39.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.798 0.439 . . . . 60.12 111.76 -168.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.04 13.96 55.81 Favored Glycine 0 N--CA 1.473 1.142 0 CA-C-N 115.982 -0.554 . . . . 61.13 113.362 -174.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -148.64 -63.67 0.24 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.812 0.445 . . . . 72.14 110.927 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -73.86 -43.0 59.97 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.242 0.617 . . . . 71.03 112.2 -172.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 97.3 m -63.55 -49.74 76.27 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 118.343 -0.836 . . . . 54.34 111.758 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.09 -20.74 43.68 Favored 'Trans proline' 0 C--N 1.399 3.213 0 C-N-CA 121.811 1.674 . . . . 44.32 113.131 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -71.18 -30.83 66.89 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.974 0.51 . . . . 61.02 110.769 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.61 HD13 HD11 ' D' ' 13' ' ' ILE . 63.7 mt -67.54 -39.27 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.943 0.897 . . . . 74.45 110.074 171.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.474 HD21 ' HA3' ' D' ' 82' ' ' GLY . 85.6 mt -77.19 -19.68 56.42 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.07 -0.968 . . . . 74.31 111.917 -175.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -70.38 -41.09 12.77 Favored Pre-proline 0 CA--C 1.563 1.449 0 N-CA-C 113.936 1.088 . . . . 61.24 113.936 -171.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.82 -40.96 82.54 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.192 1.928 . . . . 74.02 113.0 169.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -70.61 -35.49 73.01 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.742 0.817 . . . . 75.31 111.831 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -52.92 55.51 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.504 -0.554 . . . . 72.53 109.504 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 30.8 ttp-105 -52.27 -49.22 64.53 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.517 1.136 . . . . 64.01 111.098 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.79 -44.55 77.11 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.994 0.809 . . . . 63.33 111.252 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.95 -44.34 78.36 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.328 0.585 . . . . 62.05 110.636 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.607 HG12 ' SG ' ' D' ' 76' ' ' CYS . 78.3 mt -68.15 -51.37 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.582 -1.19 . . . . 72.33 110.959 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 52.7 m -51.56 -45.54 63.09 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.491 1.116 . . . . 70.42 111.174 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.7 t -62.26 -44.11 97.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.837 -1.074 . . . . 63.11 109.754 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.412 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 78.1 mtm -68.92 -31.38 70.25 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.222 0.609 . . . . 74.52 112.264 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' D' ' 114' ' ' ILE . 67.6 t -72.07 -38.83 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.85 0.86 . . . . 72.51 109.982 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.6 p -75.65 -29.49 59.14 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.112 0.565 . . . . 74.23 110.676 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -72.73 -34.91 67.38 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.697 0.799 . . . . 54.21 109.502 173.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 -1.71 88.0 Favored Glycine 0 C--N 1.356 1.688 0 CA-C-N 115.594 -0.73 . . . . 44.22 111.934 172.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p 64.84 19.3 11.8 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 127.219 2.207 . . . . 73.01 114.039 170.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -78.97 152.98 77.5 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.163 0.585 . . . . 75.25 109.429 170.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.52 126.1 17.08 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.117 2.545 . . . . 74.52 112.756 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -60.43 120.33 9.71 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 123.804 0.842 . . . . 53.13 110.981 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.48 HD12 ' HZ ' ' D' ' 74' ' ' PHE . 80.7 mt -117.58 108.56 15.61 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.482 -0.933 . . . . 73.02 108.482 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.6 95.43 6.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.859 -1.163 . . . . 72.54 107.859 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.497 ' HG ' HD12 ' D' ' 42' ' ' LEU . 3.2 mm? -63.82 125.92 25.93 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.182 -0.917 . . . . 72.55 110.044 -175.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.6 139.86 58.82 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 124.072 0.857 . . . . 53.13 111.11 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.33 137.34 55.45 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.225 1.95 . . . . 73.42 110.923 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 67.0 t -106.17 110.85 32.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.4 -0.963 . . . . 63.43 108.4 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -72.76 88.81 1.32 Allowed 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.569 -0.9 . . . . 64.11 108.569 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -61.95 -31.23 71.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.773 -1.103 . . . . 72.03 110.86 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 134' ' ' ASP . . . . . 0.4 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 3.9 t70 -55.83 -50.25 71.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.143 1.377 . . . . 73.42 112.169 -173.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.36 -45.48 83.94 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.477 -0.783 . . . . 62.11 111.956 -174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -22.98 56.33 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.921 -0.581 . . . . 73.01 110.485 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 N--CA 1.479 1.011 0 C-N-CA 123.841 0.856 . . . . 72.43 111.004 178.541 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.6 m . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 108.959 -0.756 . . . . 52.4 108.959 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -136.86 130.06 31.18 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.166 0.986 . . . . 63.34 108.544 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -146.62 135.21 22.09 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.667 -0.864 . . . . 72.44 108.667 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.466 ' CD1' HG21 ' A' ' 105' ' ' ILE . 13.0 mt -91.05 119.02 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.726 -0.842 . . . . 62.14 108.726 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -81.82 -40.65 22.22 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 123.525 0.516 . . . . 61.22 110.299 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -170.02 131.38 1.02 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.576 -0.283 . . . . 75.04 110.604 -169.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.455 HD12 ' HG3' ' C' ' 130' ' ' PRO . 87.8 mt -121.32 132.88 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.728 -0.841 . . . . 74.11 108.728 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.504 ' HB3' HG23 ' B' ' 122' ' ' THR . 34.5 p90 -166.14 151.87 8.78 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.922 0.764 . . . . 64.13 110.812 -175.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -80.25 106.88 12.6 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.732 -1.122 . . . . 60.24 109.027 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -73.06 -28.59 62.4 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.223 -0.444 . . . . 52.34 110.395 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -148.57 140.06 23.48 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.065 -0.97 . . . . 41.42 109.226 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.13 142.81 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 107.537 -1.283 . . . . 71.54 107.537 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -143.13 147.86 35.65 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.115 0.483 . . . . 74.0 109.73 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 83.4 t80 -150.07 114.51 5.21 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.032 -1.469 . . . . 64.23 107.032 174.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -124.34 110.36 14.48 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.838 -0.43 . . . . 52.12 109.838 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.44 84.81 19.12 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 124.052 0.941 . . . . 64.52 108.559 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.49 -32.38 12.34 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.513 2.142 . . . . 75.51 110.826 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 85.3 m-20 -102.62 28.87 5.68 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.604 1.162 . . . . 70.11 109.812 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.429 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.3 -46.34 99.09 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.529 0.731 . . . . 53.3 111.999 173.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -83.95 5.63 6.23 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.049 1.833 . . . . 31.03 112.756 172.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 54.7 m170 -104.47 -17.5 14.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.335 0.654 . . . . 72.44 111.903 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 28' ' ' ALA . 11.3 p -71.04 -31.07 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.47 0.544 . . . . 71.53 112.47 -170.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -80.15 -33.03 38.82 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.39 0.276 . . . . 73.12 110.813 -172.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -76.92 -24.36 52.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.939 -0.573 . . . . 74.32 110.167 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -83.53 151.61 25.32 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.758 0.823 . . . . 71.15 110.536 171.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.03 140.25 40.29 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.727 -0.842 . . . . 74.52 108.727 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -79.31 95.6 5.74 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.181 0.515 . . . . 71.53 111.083 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -126.92 83.81 64.86 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.41 1.084 . . . . 75.13 109.112 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.32 139.93 29.76 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.421 2.081 . . . . 74.21 112.726 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -106.82 100.52 10.02 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.252 -1.388 . . . . 71.43 107.252 172.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.8 m -76.26 101.25 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 CA-C-O 122.113 0.959 . . . . 72.13 111.432 -174.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -110.4 114.11 27.3 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.328 -1.36 . . . . 71.54 107.328 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 tp -120.43 136.84 54.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.085 0.554 . . . . 74.12 110.677 -172.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.583 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.1 m-20 -121.22 140.07 52.53 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.961 1.304 . . . . 52.14 108.22 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.555 HD21 ' HE1' ' A' ' 133' ' ' PHE . 7.7 tt -142.47 120.3 11.95 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.643 -0.873 . . . . 73.41 108.643 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -136.45 145.68 45.48 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.841 0.856 . . . . 74.11 110.243 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 m -113.19 135.07 54.22 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.291 1.036 . . . . 44.41 108.71 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.77 132.25 45.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.556 0.742 . . . . 54.32 109.433 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.4 m -90.99 152.49 20.67 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.597 0.759 . . . . 74.21 111.225 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 42.1 t -154.45 131.55 11.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.848 0.859 . . . . 71.02 109.329 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -112.18 111.92 23.15 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.748 -0.834 . . . . 74.53 108.748 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.5 mt -86.89 -39.68 15.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.257 0.623 . . . . 60.42 110.389 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.23 -174.99 4.33 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.008 0.923 . . . . 73.1 109.656 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.63 104.75 0.3 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.769 0.827 . . . . 72.21 109.744 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 66.54 9.75 6.82 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.125 1.37 . . . . 75.43 112.639 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.34 101.69 12.44 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 105.35 -2.093 . . . . 63.33 105.35 168.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -116.79 151.21 36.96 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.503 -1.226 . . . . 74.14 109.081 -164.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 43.7 tt0 -132.78 138.63 47.21 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.275 0.63 . . . . 63.33 110.031 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.6 t -119.85 130.98 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.106 -1.072 . . . . 70.03 108.106 171.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.4 t -115.69 109.6 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.134 0.973 . . . . 54.04 108.604 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.0 tp -89.2 101.42 14.08 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.055 -0.72 . . . . 63.03 109.055 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 ttp85 -85.4 107.51 17.41 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.051 -0.722 . . . . 75.43 109.051 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.426 HG13 HD11 ' A' ' 114' ' ' ILE . 3.1 p -113.52 121.87 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 108.93 -0.767 . . . . 72.13 108.93 176.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.6 m -116.49 135.45 53.82 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.586 0.754 . . . . 74.5 109.407 -177.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 126' ' ' LEU . 64.8 t -124.61 132.99 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 124.38 1.072 . . . . 70.24 108.634 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.3 m -131.21 120.55 23.43 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.049 -0.723 . . . . 75.02 109.049 173.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.41 122.52 44.02 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.677 -0.86 . . . . 75.33 108.677 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 t -130.18 146.72 51.83 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.916 0.886 . . . . 72.43 110.228 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.4 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -101.58 87.15 3.1 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 107.123 -1.436 . . . . 63.4 107.123 167.197 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.73 -105.09 3.23 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 114.835 -1.075 . . . . 41.14 110.518 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.54 -20.61 11.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.805 0.842 . . . . 74.55 110.616 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.05 104.89 9.99 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.831 0.853 . . . . 70.22 109.271 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.3 m -71.31 121.2 18.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.157 0.583 . . . . 72.34 110.732 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.01 -53.51 20.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.783 0.833 . . . . 53.53 109.38 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -150.22 158.08 43.77 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.502 -1.226 . . . . 75.12 111.618 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 64' ' ' VAL . 66.9 tp -125.57 140.89 52.36 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.371 1.468 . . . . 70.11 107.282 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.4 m -142.34 113.29 7.5 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.378 0.671 . . . . 73.01 109.585 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -127.05 120.52 29.18 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.272 -0.64 . . . . 65.14 109.272 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.4 t -127.63 110.64 22.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 123.665 0.786 . . . . 74.24 109.348 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -85.05 81.4 8.89 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.73 -1.211 . . . . 75.52 107.73 171.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -76.88 94.96 3.99 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.074 -0.967 . . . . 74.33 108.633 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.06 151.08 21.36 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 115.376 -0.829 . . . . 74.34 111.589 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.97 128.5 2.8 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.139 -0.784 . . . . 71.22 111.139 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -81.15 115.82 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.789 -0.819 . . . . 62.12 108.789 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -114.8 118.7 34.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.048 0.939 . . . . 74.32 109.586 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.9 m -85.36 103.7 14.51 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.63 -0.878 . . . . 72.22 108.63 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.9 pp -116.04 153.91 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.12 0.568 . . . . 61.14 110.812 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.55 149.98 5.89 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.615 1.166 . . . . 72.4 109.429 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.23 -26.75 23.45 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 122.856 0.265 . . . . 43.23 113.715 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.591 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.92 138.85 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.502 0.721 . . . . 72.24 110.321 -176.26 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 10.6 tt0 -152.59 174.4 14.0 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.89 0.476 . . . . 75.31 109.857 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.416 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 66.83 -127.7 28.33 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 116.344 -0.389 . . . . 63.25 112.248 -174.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -72.5 -21.07 61.25 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.464 0.706 . . . . 73.12 111.313 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -70.77 -45.26 65.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.503 0.721 . . . . 71.03 110.851 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.523 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 23.3 ttt -71.95 -37.34 69.99 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.347 -0.388 . . . . 71.32 110.013 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.88 72.19 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.346 0.404 . . . . 65.44 110.587 174.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 59.3 t-80 -71.74 -33.74 68.96 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.381 0.672 . . . . 73.32 110.706 173.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -66.55 -61.81 1.79 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 110.047 -0.353 . . . . 61.21 110.047 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.462 HD23 ' HG2' ' A' ' 94' ' ' MET . 4.2 pp -74.13 -24.62 59.45 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.449 0.7 . . . . 71.02 112.547 -174.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.44 1.08 37.14 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-O 119.538 -0.59 . . . . 65.2 114.28 -173.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -141.36 -65.34 0.43 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 117.533 0.667 . . . . 65.14 111.052 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 105' ' ' ILE . 48.3 t80 -66.63 -46.49 75.63 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 112.797 0.666 . . . . 62.24 112.797 -171.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -68.66 -47.37 34.07 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 124.064 0.945 . . . . 73.53 112.723 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.51 -26.8 69.97 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 121.823 1.682 . . . . 62.03 112.185 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -65.91 -37.83 87.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.158 0.583 . . . . 63.22 110.937 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.466 HG21 ' CD1' ' A' ' 13' ' ' ILE . 47.2 mm -66.34 -45.67 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.301 0.641 . . . . 72.14 110.046 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.6 mt -73.89 -23.37 59.56 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.381 -0.827 . . . . 73.34 111.918 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -60.69 -49.14 91.02 Favored Pre-proline 0 CA--C 1.563 1.451 0 N-CA-C 113.968 1.099 . . . . 50.05 113.968 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -63.11 -34.83 67.96 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.11 1.874 . . . . 62.25 112.841 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -67.52 -40.23 85.11 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.126 0.57 . . . . 75.54 110.872 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.42 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -69.77 -36.21 75.56 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.401 0.681 . . . . 65.33 110.79 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.606 ' HA ' HD21 ' A' ' 128' ' ' LEU . 38.1 ttm180 -57.15 -53.82 53.72 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 124.031 0.832 . . . . 71.4 109.715 176.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -57.76 -48.02 80.84 Favored 'General case' 0 C--N 1.348 0.531 0 O-C-N 124.563 1.164 . . . . 75.12 111.229 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 117' ' ' MET . 24.0 t -53.29 -47.84 68.87 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.334 1.021 . . . . 75.42 110.462 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.426 HD11 HG13 ' A' ' 62' ' ' VAL . 93.6 mt -68.55 -38.42 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.327 1.051 . . . . 63.32 111.176 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.2 m -64.34 -34.23 77.68 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.263 0.554 . . . . 75.43 110.115 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 t -74.24 -36.93 63.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.881 -0.599 . . . . 71.41 109.701 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 74.6 mmm -60.36 -46.98 88.03 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.98 0.512 . . . . 75.11 110.739 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.0 m -69.41 -39.68 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.571 -0.74 . . . . 74.22 110.826 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.8 m -67.23 -34.59 77.79 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.867 0.467 . . . . 73.31 111.639 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.542 HH12 ' HG3' ' B' ' 112' ' ' GLU . 86.8 mtt-85 -74.34 -28.92 61.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.225 0.61 . . . . 71.11 110.191 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.88 -4.74 88.49 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 123.758 0.661 . . . . 31.22 113.183 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.4 m 65.92 41.14 3.86 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 123.586 1.66 . . . . 73.32 111.132 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.89 151.61 43.62 Favored Pre-proline 0 C--O 1.244 0.772 0 CA-C-N 113.917 -1.492 . . . . 74.34 108.514 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -53.06 142.33 54.53 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.897 2.398 . . . . 55.13 112.697 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.06 145.88 24.39 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.987 0.804 . . . . 73.4 112.124 -177.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.476 ' CD2' HG11 ' A' ' 64' ' ' VAL . 18.4 tp -128.4 115.99 19.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.727 -1.124 . . . . 72.5 110.391 -175.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -120.8 89.29 3.1 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.248 -1.019 . . . . 63.44 108.248 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.703 ' H ' HD23 ' A' ' 128' ' ' LEU . 1.0 OUTLIER -64.38 129.58 40.47 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 116.057 -0.519 . . . . 73.23 109.779 176.616 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.82 144.65 85.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.494 1.118 . . . . 54.32 112.077 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -65.63 113.09 2.37 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.366 2.044 . . . . 71.43 110.844 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.05 127.56 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.595 -0.891 . . . . 72.23 108.595 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -80.44 89.87 5.62 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.582 -0.735 . . . . 71.31 109.387 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.555 ' HE1' HD21 ' A' ' 44' ' ' LEU . 97.3 m-85 -60.25 -37.43 80.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.147 0.979 . . . . 61.44 111.762 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -56.24 -51.14 69.18 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.975 0.797 . . . . 71.4 110.317 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.45 97.65 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 124.345 1.028 . . . . 71.43 111.28 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -57.53 -45.66 84.76 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.914 0.759 . . . . 72.31 111.215 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -67.69 -37.9 82.94 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.802 -0.635 . . . . 73.05 110.025 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.5 mmt . . . . . 0 N--CA 1.477 0.911 0 O-C-N 123.973 0.795 . . . . 73.31 111.763 -178.7 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 99.2 m . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 108.262 -1.014 . . . . 74.24 108.262 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -136.06 127.54 28.63 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.195 -1.039 . . . . 64.13 108.195 169.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -147.24 134.11 20.16 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.117 -0.697 . . . . 75.01 109.117 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.55 HD11 HD13 ' B' ' 105' ' ' ILE . 26.9 mt -86.84 122.03 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.439 -0.948 . . . . 54.05 108.439 172.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -95.23 -30.6 13.91 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.127 0.571 . . . . 73.14 110.177 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -172.72 138.05 0.82 Allowed 'General case' 0 C--N 1.353 0.725 0 O-C-N 123.642 0.589 . . . . 72.33 110.124 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.406 HD11 HD13 ' B' ' 13' ' ' ILE . 89.0 mt -118.74 137.66 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 106.922 -1.51 . . . . 70.14 106.922 171.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.449 ' HE1' HG13 ' B' ' 83' ' ' ILE . 10.8 p90 -167.17 143.61 4.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.249 0.547 . . . . 74.04 112.376 -173.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.4 m -73.56 125.64 28.44 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.134 -0.939 . . . . 53.13 108.73 169.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.404 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 47.9 mtpt -97.52 -31.74 12.17 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.698 0.799 . . . . 75.2 110.698 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 21.1 t70 -155.72 143.2 19.47 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.45 -0.341 . . . . 71.14 111.025 -174.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.479 HD11 ' SG ' ' B' ' 113' ' ' CYS . 42.6 mm -139.54 143.3 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.988 1.315 . . . . 72.22 109.007 177.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.1 t -142.45 120.8 12.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.83 -1.077 . . . . 73.45 108.452 167.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -121.24 124.26 44.22 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.479 -1.304 . . . . 73.4 107.479 168.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.638 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 34.3 mt-10 -128.61 117.33 21.04 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.532 1.133 . . . . 54.34 108.381 -174.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -108.18 86.57 3.35 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 108.002 -1.11 . . . . 75.45 108.002 171.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -65.11 -47.88 4.19 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.057 2.504 . . . . 72.23 113.17 -167.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -107.34 28.19 8.34 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.035 0.934 . . . . 73.22 109.764 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.506 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -39.44 -63.15 0.68 Allowed Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 114.985 1.476 . . . . 72.04 114.985 -163.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 12.1 Cg_exo -68.45 -24.24 36.74 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.137 1.891 . . . . 65.15 112.896 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -92.69 -28.04 16.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.756 0.822 . . . . 74.12 112.555 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' B' ' 73' ' ' ALA . 13.4 p -81.95 -18.96 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 120.69 0.281 . . . . 73.44 111.472 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -64.89 -17.27 64.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 113.164 0.802 . . . . 75.1 113.164 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -66.93 -21.17 65.99 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.206 0.602 . . . . 71.13 111.385 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.491 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 86.1 mttt -94.05 107.38 19.3 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.813 0.845 . . . . 74.32 109.177 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -87.21 86.06 7.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.954 0.501 . . . . 74.02 110.566 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -164.64 158.11 17.55 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.902 0.881 . . . . 72.02 109.161 173.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.22 109.23 5.89 Favored Pre-proline 0 C--N 1.354 0.792 0 N-CA-C 109.087 -0.709 . . . . 75.3 109.087 169.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.639 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 13.1 Cg_endo -56.34 146.61 72.05 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.017 2.478 . . . . 52.43 111.842 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -61.32 102.51 0.23 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 123.826 0.704 . . . . 71.53 109.181 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.418 HG23 ' O ' ' B' ' 38' ' ' PRO . 85.1 t -92.81 120.31 41.94 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 115.607 -0.724 . . . . 60.12 109.576 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -121.08 119.19 31.73 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.904 -1.517 . . . . 64.4 106.904 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 pp -93.96 160.56 14.67 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.251 0.548 . . . . 61.41 111.065 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.704 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 3.2 m-20 -123.67 129.57 51.32 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.773 -1.195 . . . . 64.43 107.773 173.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 tt -100.38 128.62 46.4 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.36 -1.348 . . . . 71.22 107.36 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -145.93 121.43 10.38 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.496 0.718 . . . . 34.12 109.689 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 43.3 p -120.65 122.79 41.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.62 0.368 . . . . 73.45 110.255 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.78 154.77 33.72 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.523 1.129 . . . . 72.13 108.327 172.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.3 p -144.77 168.06 21.11 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.909 0.385 . . . . 73.43 111.061 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.2 p -153.47 169.91 22.02 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.354 1.061 . . . . 61.3 109.337 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -114.26 136.35 53.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.706 0.802 . . . . 73.11 110.339 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 86.4 mt -99.41 -39.22 8.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.281 0.633 . . . . 63.33 110.727 174.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.54 -177.09 5.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.637 0.775 . . . . 75.14 110.287 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -68.95 123.64 21.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.409 -0.814 . . . . 71.31 109.126 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 69.8 9.62 7.22 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.569 1.147 . . . . 75.21 112.161 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.7 t -124.34 110.72 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 107.862 -1.162 . . . . 54.51 107.862 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.44 ' CD2' HD13 ' B' ' 98' ' ' LEU . 5.8 t80 -125.28 154.13 42.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.769 -0.826 . . . . 75.33 108.769 -177.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -130.62 110.02 11.08 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.439 -0.949 . . . . 74.21 108.439 -168.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.48 145.26 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.961 0.904 . . . . 72.4 109.948 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.8 t -128.4 114.73 35.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 121.37 0.605 . . . . 72.22 109.537 176.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -94.15 111.51 23.24 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.578 -1.268 . . . . 75.23 107.578 176.14 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -105.31 129.72 53.59 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.274 0.559 . . . . 75.23 109.868 171.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.426 ' HB ' HD11 ' B' ' 114' ' ' ILE . 21.2 t -124.32 119.78 57.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.831 -1.174 . . . . 74.22 107.831 174.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.704 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 95.5 m -98.18 148.87 23.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.274 -1.01 . . . . 40.31 108.274 175.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.704 HG21 HG21 ' B' ' 114' ' ' ILE . 42.7 t -134.67 125.6 46.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.55 1.14 . . . . 65.43 108.284 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 99.5 m -123.97 139.69 53.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.589 -0.893 . . . . 52.44 108.589 172.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -136.62 145.49 44.94 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 123.652 0.595 . . . . 44.23 110.275 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.1 p -136.13 126.98 27.51 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.638 0.586 . . . . 65.21 111.153 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.639 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 19.8 mt -100.86 112.13 24.49 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.292 -1.003 . . . . 73.23 108.292 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.09 -114.16 5.89 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 124.003 0.815 . . . . 64.23 112.168 -174.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -110.58 4.39 20.25 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.316 0.646 . . . . 73.15 111.304 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -122.41 160.45 25.45 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.999 0.52 . . . . 72.22 110.438 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -75.2 138.15 41.76 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 123.501 0.501 . . . . 53.43 110.079 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.809 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.59 -64.07 1.15 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.371 0.668 . . . . 64.42 109.536 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -144.31 155.33 43.77 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.737 0.78 . . . . 74.21 110.877 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.638 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 82.1 mt -128.02 135.55 50.03 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.74 1.616 . . . . 73.41 106.761 173.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.418 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 38.9 t -145.07 148.4 33.63 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.993 -0.743 . . . . 54.23 108.993 175.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -158.98 126.97 5.06 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.215 -0.661 . . . . 74.31 109.215 -172.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' B' ' 113' ' ' CYS . 65.5 t -124.37 147.37 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 115.401 -0.818 . . . . 63.42 109.419 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -124.8 86.63 2.59 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.249 -1.019 . . . . 73.04 108.249 170.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -80.05 103.03 9.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.717 -0.674 . . . . 73.3 109.486 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.15 164.5 28.51 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 112.042 -0.423 . . . . 51.42 112.042 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.32 134.86 3.79 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.94 -0.464 . . . . 62.24 111.94 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.449 HG13 ' HE1' ' B' ' 17' ' ' TYR . 59.0 mt -91.93 124.52 44.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.982 0.913 . . . . 53.55 109.056 174.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -131.69 135.97 47.29 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.253 0.621 . . . . 72.13 110.029 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.7 m -91.36 115.05 27.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.428 1.091 . . . . 73.24 109.198 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.735 HD13 HD11 ' B' ' 98' ' ' LEU . 35.7 pt -115.96 130.37 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.665 0.786 . . . . 74.01 110.83 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.549 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.78 167.4 30.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.599 0.76 . . . . 64.32 109.586 170.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.09 -56.77 5.08 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 111.5 -0.64 . . . . 71.44 111.5 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.455 HD11 ' HB ' ' B' ' 86' ' ' ILE . 2.8 pp -75.96 163.67 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.17 0.988 . . . . 73.23 111.246 175.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -168.59 157.32 8.58 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.628 0.58 . . . . 73.24 110.628 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.97 -116.03 7.37 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.533 0.521 . . . . 52.44 113.548 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 97.1 m -65.43 -36.1 82.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.88 0.872 . . . . 74.15 111.016 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -66.02 -41.79 90.53 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.689 0.796 . . . . 74.41 110.06 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 47.5 ttp -66.72 -36.65 82.97 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.608 -1.178 . . . . 73.4 110.931 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.19 -32.11 68.47 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.171 0.588 . . . . 61.34 110.572 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -69.96 -29.17 66.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.567 0.747 . . . . 35.23 110.676 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -77.57 -66.78 0.79 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.945 -0.57 . . . . 63.11 110.196 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.735 HD11 HD13 ' B' ' 86' ' ' ILE . 66.5 mt -78.43 -26.4 46.29 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.956 0.902 . . . . 71.32 112.92 -168.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.07 0.81 64.48 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-O 119.749 -0.473 . . . . 61.35 113.453 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 -66.21 0.25 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.28 0.54 . . . . 64.43 112.024 -174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -64.89 -42.39 94.82 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.769 0.827 . . . . 73.34 112.432 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.479 ' SG ' HD23 ' B' ' 98' ' ' LEU . 84.4 m -68.83 -47.44 32.0 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 124.288 1.035 . . . . 73.03 111.725 -177.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.448 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 86.8 Cg_exo -51.9 -39.75 68.02 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.321 2.014 . . . . 64.2 113.326 167.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -61.67 -31.96 72.11 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 112.709 0.633 . . . . 54.33 112.709 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.55 HD13 HD11 ' B' ' 13' ' ' ILE . 61.6 mt -67.85 -41.28 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.384 0.674 . . . . 63.33 110.156 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 66.8 mt -82.78 -19.47 37.7 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.871 -1.059 . . . . 70.02 111.867 -173.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.415 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 57.6 t80 -61.28 -45.22 95.14 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 114.166 1.173 . . . . 72.04 114.166 -170.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 18.2 Cg_endo -58.91 -38.01 90.54 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.089 1.859 . . . . 70.21 112.851 175.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -65.26 -46.26 81.24 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.374 0.67 . . . . 73.11 110.933 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.15 90.01 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.511 -0.768 . . . . 51.15 110.9 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -59.6 -60.52 3.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.495 1.118 . . . . 74.23 110.677 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.542 ' HG3' HH12 ' A' ' 120' ' ' ARG . 12.4 tp10 -58.45 -31.85 68.16 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.399 1.08 . . . . 62.04 111.075 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.546 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.4 t -71.67 -40.33 69.68 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 119.364 -0.351 . . . . 52.23 110.848 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.704 HG21 HG21 ' B' ' 64' ' ' VAL . 88.5 mt -65.1 -55.0 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 109.305 -0.628 . . . . 61.4 109.305 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 13.6 m -58.06 -34.61 70.29 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 124.367 1.042 . . . . 75.42 111.592 -173.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.7 t -61.52 -51.1 70.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 115.913 -0.585 . . . . 64.53 110.03 176.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.5 mmt -66.77 -38.64 86.98 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 123.645 0.59 . . . . 65.41 111.103 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 89.3 t -58.61 -44.56 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.998 0.919 . . . . 72.3 110.515 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 35.2 t -71.26 -30.54 66.42 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.011 -0.995 . . . . 60.11 111.56 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.7 mtt-85 -70.06 -28.91 65.83 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.515 0.726 . . . . 74.4 110.232 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -87.32 9.35 73.41 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 124.02 0.825 . . . . 64.4 112.737 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 17' ' ' TYR . 58.9 p 55.84 31.65 18.08 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.018 1.727 . . . . 54.21 112.941 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -92.09 155.2 43.16 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 123.734 0.814 . . . . 73.21 109.971 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.17 156.96 6.98 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.713 2.942 . . . . 63.1 114.843 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -60.39 130.43 46.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.095 0.958 . . . . 73.54 111.09 -174.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -141.61 95.36 2.81 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.601 -0.518 . . . . 73.32 109.601 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -94.5 136.55 34.67 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.684 -0.858 . . . . 71.33 108.684 169.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.47 140.33 39.8 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.502 0.721 . . . . 72.53 110.508 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.86 146.1 92.76 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.066 0.946 . . . . 33.43 111.737 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.91 97.67 0.49 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.282 2.654 . . . . 73.42 111.71 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 62.1 t -91.01 110.39 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.142 -1.058 . . . . 65.23 108.142 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -84.87 98.46 10.33 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.805 -1.183 . . . . 75.14 107.805 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -57.99 -48.57 79.6 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.983 0.802 . . . . 75.1 111.357 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.97 -37.23 76.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.195 0.998 . . . . 74.3 112.547 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.66 -47.34 78.85 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.756 0.822 . . . . 64.4 111.549 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -81.81 -24.77 35.72 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.847 -0.615 . . . . 74.01 110.369 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 79.4 t80 . . . . . 0 N--CA 1.47 0.552 0 C-N-CA 123.511 0.724 . . . . 74.43 109.727 175.732 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 70.3 m . . . . . 0 C--O 1.236 0.359 0 N-CA-C 108.354 -0.98 . . . . 62.21 108.354 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.555 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.8 t80 -124.52 128.06 48.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.539 0.736 . . . . 74.42 109.101 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -146.54 128.04 15.04 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.82 0.7 . . . . 63.24 109.605 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 95.4 mt -68.46 124.66 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.416 -0.957 . . . . 73.0 108.416 168.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.574 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 17.2 mm100 -93.28 -47.46 6.9 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.425 0.69 . . . . 74.05 110.192 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -175.24 124.44 0.24 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.59 -0.732 . . . . 64.14 110.013 -169.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.9 143.46 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 108.381 -0.97 . . . . 41.05 108.381 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.502 ' CE2' ' HD2' ' C' ' 19' ' ' LYS . 28.5 p90 -170.92 166.7 7.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.1 0.476 . . . . 72.33 110.77 -175.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.9 p -88.32 112.43 22.83 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.273 -0.876 . . . . 73.44 109.203 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.502 ' HD2' ' CE2' ' C' ' 17' ' ' TYR . 19.3 mmmt -64.97 -46.54 81.09 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.661 -1.237 . . . . 73.15 107.661 170.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.607 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.0 t70 -141.53 143.61 33.86 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 113.334 -1.757 . . . . 65.01 109.908 -170.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 59.0 mt -141.12 145.32 25.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 106.474 -1.676 . . . . 54.12 106.474 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.7 t -157.45 149.62 22.58 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.366 0.603 . . . . 75.04 109.984 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 84.1 t80 -149.55 116.72 6.03 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.017 -1.475 . . . . 72.21 107.017 172.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -120.78 111.1 17.15 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.162 0.585 . . . . 55.41 110.192 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.85 74.56 63.81 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.769 -1.567 . . . . 73.42 106.769 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.58 -15.87 30.53 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.652 2.234 . . . . 43.34 111.806 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -111.45 24.4 12.85 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.543 1.137 . . . . 74.15 109.623 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.487 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -51.27 -49.42 81.86 Favored Pre-proline 0 CA--C 1.562 1.404 0 N-CA-C 114.239 1.199 . . . . 71.42 114.239 -172.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.459 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 35.3 Cg_exo -60.13 -43.3 36.61 Favored 'Trans proline' 0 C--N 1.38 2.214 0 CA-C-N 122.021 1.757 . . . . 63.33 112.206 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -69.15 -30.0 68.14 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.826 -1.079 . . . . 71.51 112.053 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.83 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.4 p -79.78 -28.33 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 N-CA-C 111.858 0.318 . . . . 73.32 111.858 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -70.34 -31.68 69.06 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 120.791 0.329 . . . . 73.31 111.268 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -84.98 7.49 21.08 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.511 0.724 . . . . 74.21 111.228 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.75 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.07 164.43 13.95 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.343 1.057 . . . . 72.03 110.445 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 35' ' ' ASP . . . . . 0.402 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 9.8 t70 -85.31 104.17 14.91 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.929 -1.138 . . . . 55.44 107.929 167.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.6 t90 -70.09 87.83 0.58 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.923 1.289 . . . . 74.34 111.335 -171.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -123.03 79.12 51.26 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 124.479 1.111 . . . . 72.52 108.55 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.57 138.98 30.47 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.638 2.226 . . . . 54.35 114.495 -171.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.12 115.94 22.65 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.606 -1.628 . . . . 71.32 106.606 164.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.13 118.63 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.489 -0.778 . . . . 61.43 110.079 -163.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.506 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 87.3 tttt -127.22 134.1 50.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.824 0.85 . . . . 73.32 109.102 176.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 50.9 tp -126.0 129.37 49.07 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.016 -0.735 . . . . 72.54 109.016 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.3 t70 -118.84 133.5 55.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.618 -1.252 . . . . 75.11 107.618 175.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.432 HD13 ' HE2' ' C' ' 133' ' ' PHE . 87.4 mt -124.8 136.01 53.46 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.836 -1.172 . . . . 72.53 107.836 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 15.6 t70 -141.96 151.29 42.41 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.503 0.721 . . . . 71.31 109.371 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -134.92 151.9 51.28 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.896 -0.779 . . . . 73.53 108.896 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.19 170.4 20.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.672 0.789 . . . . 73.32 109.273 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.409 ' HB2' ' CE2' ' C' ' 56' ' ' TYR . 78.0 p -159.64 153.09 22.43 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.265 0.226 . . . . 70.24 111.346 -176.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 84.2 p -149.59 147.44 28.14 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.943 0.897 . . . . 62.4 109.991 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -89.76 121.16 31.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.175 0.59 . . . . 53.13 109.587 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.613 HD11 HD12 ' C' ' 83' ' ' ILE . 20.5 mt -95.32 -39.26 10.13 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.329 0.652 . . . . 74.04 109.759 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.73 -172.45 3.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.77 0.828 . . . . 72.04 110.261 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.27 111.51 1.57 Allowed 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.255 0.972 . . . . 75.43 109.953 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 70.06 -6.02 1.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.711 1.205 . . . . 74.43 112.733 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 68.1 t -94.22 95.79 5.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 106.833 -1.543 . . . . 70.24 106.833 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' C' ' 48' ' ' SER . 12.1 t80 -118.17 124.59 48.34 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.141 -0.936 . . . . 70.22 108.845 -172.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.548 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.3 tt0 -85.5 138.95 31.87 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 123.263 0.625 . . . . 72.03 110.587 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 42.6 t -116.81 142.16 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.925 -1.139 . . . . 64.42 107.925 165.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 85.8 t -127.83 130.73 70.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.99 -1.115 . . . . 51.32 107.99 172.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.23 107.67 18.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.451 -0.944 . . . . 71.11 108.451 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.446 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 49.5 ttm-85 -86.56 134.95 33.61 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.795 -1.093 . . . . 62.32 109.192 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.04 118.54 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.029 -1.1 . . . . 72.34 108.029 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.1 m -121.46 122.42 39.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.635 -0.876 . . . . 65.22 108.635 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.608 HG11 HD11 ' C' ' 126' ' ' LEU . 14.5 t -115.55 129.35 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.52 -0.918 . . . . 73.32 108.52 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 5.6 m -121.7 115.94 23.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.787 0.835 . . . . 72.43 108.871 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.59 120.82 43.64 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.79 -1.189 . . . . 75.04 107.79 172.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 45.3 m -122.2 169.07 11.26 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.578 0.751 . . . . 74.44 109.605 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.75 HD13 ' HG2' ' C' ' 34' ' ' LYS . 85.1 mt -132.24 15.68 4.59 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.577 1.151 . . . . 65.22 109.818 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.44 -91.08 0.59 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.253 -0.739 . . . . 42.24 111.253 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -89.91 -27.98 19.51 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.438 0.695 . . . . 74.13 109.878 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 4.3 tp10 -94.96 121.91 37.07 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.912 1.285 . . . . 72.35 110.357 -175.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.7 m -77.56 126.06 30.3 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.369 -0.975 . . . . 72.21 108.369 165.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.83 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -64.75 -60.91 2.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.284 1.04 . . . . 75.02 108.809 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -161.65 161.82 29.7 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-N 112.707 -2.042 . . . . 72.42 108.989 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.406 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -126.3 140.71 52.31 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 105.855 -1.906 . . . . 71.53 105.855 167.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.497 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.8 t -138.09 132.41 32.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.833 -1.173 . . . . 71.31 107.833 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.62 136.45 27.46 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.67 -0.863 . . . . 71.1 108.67 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -146.25 132.97 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 124.603 1.161 . . . . 74.34 108.507 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.607 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 39.9 mt-30 -118.58 94.9 4.63 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.966 -1.124 . . . . 74.14 107.966 173.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -81.69 104.28 11.97 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.888 -1.051 . . . . 60.41 109.819 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.8 157.29 35.6 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.991 -0.444 . . . . 73.52 111.991 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.502 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -159.63 117.81 0.79 Allowed Glycine 0 CA--C 1.501 -0.795 0 N-CA-C 110.83 -0.908 . . . . 62.4 110.83 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.613 HD12 HD11 ' C' ' 51' ' ' LEU . 10.5 mm -84.84 121.29 36.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.175 -1.046 . . . . 51.13 108.175 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.555 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 53.0 m-85 -128.67 118.33 22.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.774 -0.824 . . . . 62.52 108.774 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 54.8 m -77.79 108.21 10.85 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.515 -0.92 . . . . 65.11 108.515 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 45.4 pt -114.94 131.25 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.65 0.78 . . . . 74.11 109.217 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -146.98 152.3 38.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.148 0.979 . . . . 52.12 109.312 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.59 -23.1 17.55 Favored Glycine 0 N--CA 1.479 1.502 0 N-CA-C 113.941 0.336 . . . . 73.22 113.941 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 28.7 pt -103.05 152.11 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.803 0.841 . . . . 72.13 110.532 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 15.8 pt-20 -166.44 177.97 6.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.697 0.799 . . . . 70.23 109.49 173.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.31 -125.67 34.4 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.592 0.557 . . . . 51.23 113.661 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 82.4 p -72.26 -28.35 63.07 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.498 0.719 . . . . 54.45 111.075 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -65.15 -44.55 88.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.588 0.755 . . . . 54.15 110.032 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.516 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 22.0 ttt -62.57 -46.17 89.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.214 -0.903 . . . . 60.54 110.472 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.83 -50.27 61.19 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 124.245 0.966 . . . . 64.11 111.613 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -76.2 -32.38 58.94 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 123.377 0.423 . . . . 74.51 111.954 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.547 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.3 t -59.44 -36.13 75.34 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.312 0.383 . . . . 70.11 110.463 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 34.2 mt -96.13 -20.39 18.66 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.83 0.852 . . . . 74.22 110.882 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.93 -31.52 57.89 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.036 -0.529 . . . . 73.2 113.875 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.47 -39.48 0.06 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.628 0.251 . . . . 73.32 111.616 -169.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.547 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 42.6 t80 -65.39 -43.53 90.36 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.461 1.505 . . . . 75.34 113.158 -172.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 66.3 m -81.57 -44.89 1.11 Allowed Pre-proline 0 N--CA 1.486 1.336 0 CA-C-O 118.717 -0.659 . . . . 54.32 111.787 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.04 -27.0 34.39 Favored 'Trans proline' 0 C--N 1.394 2.954 0 C-N-CA 122.516 2.144 . . . . 73.31 113.738 169.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -59.76 -42.9 94.3 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.393 1.077 . . . . 63.52 111.027 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -66.1 -33.47 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 115.437 -0.801 . . . . 71.42 110.376 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.502 HD21 ' HA3' ' C' ' 82' ' ' GLY . 62.6 mt -91.25 -25.16 19.62 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.88 0.872 . . . . 72.15 112.389 -171.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -54.38 -50.53 84.5 Favored Pre-proline 0 CA--C 1.557 1.237 0 CA-C-O 117.966 -1.016 . . . . 42.51 113.682 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.35 -37.83 96.27 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.29 1.993 . . . . 31.24 113.184 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -68.24 -47.32 68.11 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.364 0.666 . . . . 73.23 110.974 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.51 79.56 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.258 -0.883 . . . . 72.3 110.612 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -60.72 -53.21 60.19 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.117 1.367 . . . . 63.32 111.026 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 112' ' ' GLU . . . . . 0.41 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.2 tm-20 -67.38 -34.02 76.42 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 123.656 0.598 . . . . 61.45 110.316 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.2 t -64.58 -36.76 85.28 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.481 0.488 . . . . 74.4 110.764 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.497 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 77.8 mt -67.67 -50.37 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.3 0.64 . . . . 73.45 110.31 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.6 m -62.47 -30.1 71.01 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.561 0.744 . . . . 71.34 111.374 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -69.68 -50.62 42.09 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 109.142 -0.688 . . . . 74.31 109.142 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.405 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.59 -44.62 66.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.21 1.004 . . . . 65.35 112.063 176.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.5 HG13 ' HB2' ' C' ' 123' ' ' PHE . 88.4 t -63.58 -46.58 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.915 0.886 . . . . 74.32 110.868 177.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 36.6 t -63.54 -33.49 75.71 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.873 0.869 . . . . 72.51 111.795 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -73.34 -39.35 65.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.838 0.855 . . . . 74.51 109.761 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.82 -2.15 69.61 Favored Glycine 0 C--N 1.352 1.468 0 O-C-N 123.832 0.707 . . . . 73.11 112.587 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 61.75 28.49 17.54 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 126.77 2.028 . . . . 74.04 113.302 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.5 ' HB2' HG13 ' C' ' 118' ' ' VAL . 78.4 m-85 -81.84 156.62 69.97 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.272 -1.01 . . . . 72.3 108.272 171.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.26 171.25 2.48 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.727 2.285 . . . . 73.0 113.622 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -51.26 136.45 24.62 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.731 1.212 . . . . 63.35 114.036 -173.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.608 HD11 HG11 ' C' ' 64' ' ' VAL . 7.0 tt -127.32 91.73 3.37 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 106.764 -1.569 . . . . 54.11 106.764 171.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -100.5 105.61 17.07 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.851 -0.796 . . . . 72.24 108.851 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.02 125.58 25.9 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.144 -1.058 . . . . 74.13 108.144 175.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.07 148.64 98.34 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 122.84 0.456 . . . . 75.41 111.29 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.455 ' HG3' HD12 ' A' ' 16' ' ' ILE . 34.8 Cg_exo -57.55 106.78 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.872 2.381 . . . . 45.24 112.172 174.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 23.3 m -112.21 119.66 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.402 0.681 . . . . 72.45 109.924 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -91.87 93.61 8.91 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.904 -0.776 . . . . 73.04 108.904 -176.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.432 ' HE2' HD13 ' C' ' 44' ' ' LEU . 91.7 m-85 -61.09 -40.04 92.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.484 0.714 . . . . 65.53 111.026 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.45 -43.9 96.39 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.342 -0.845 . . . . 61.2 112.226 -175.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.91 -33.72 72.24 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.89 0.744 . . . . 63.51 111.396 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 2.1 tt -79.86 -46.07 17.52 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.69 -0.485 . . . . 74.33 109.69 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 22.7 t80 . . . . . 0 N--CA 1.489 1.479 0 C-N-CA 122.88 0.472 . . . . 74.43 111.364 -176.721 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.239 0.549 0 CA-C-O 121.486 0.66 . . . . 40.24 110.497 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.464 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 55.0 t80 -163.21 88.48 0.59 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.031 -1.84 . . . . 71.31 106.031 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -119.27 115.35 23.98 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.202 -1.407 . . . . 73.4 107.202 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.407 HG21 HD11 ' D' ' 16' ' ' ILE . 16.4 mt -72.63 120.58 21.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.75 -0.833 . . . . 62.53 108.75 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -86.22 -34.0 20.58 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.402 0.681 . . . . 75.44 110.825 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -171.38 134.01 0.86 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.1 0.25 . . . . 73.35 111.663 -172.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.413 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.7 mp -113.24 134.68 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 107.493 -1.299 . . . . 72.11 107.493 171.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.413 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 36.6 p90 -166.56 174.5 8.79 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.901 0.858 . . . . 65.35 112.022 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -102.64 120.04 39.87 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.196 -1.366 . . . . 43.43 109.049 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.459 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.4 mtpt -81.16 -36.96 29.56 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.127 -0.694 . . . . 73.4 109.127 175.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 12.5 t70 -144.89 145.27 31.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.951 -1.022 . . . . 71.21 109.436 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.405 HG21 ' HE2' ' C' ' 117' ' ' MET . 73.9 mt -139.2 150.44 23.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.819 1.248 . . . . 61.03 107.811 175.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 13.0 t -155.29 145.78 22.07 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.678 0.791 . . . . 73.44 109.422 174.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.421 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.2 t80 -150.1 124.1 9.37 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.948 -1.501 . . . . 72.22 106.948 170.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 2.2 mp0 -122.0 152.51 39.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.079 0.552 . . . . 75.01 109.595 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.738 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -140.67 82.21 16.05 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.799 -1.186 . . . . 75.35 107.799 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.79 -34.25 11.44 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.035 2.49 . . . . 73.02 113.608 -171.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -107.82 8.63 28.81 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.319 0.648 . . . . 71.04 110.523 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.738 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -36.69 -64.88 0.35 Allowed Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 116.416 2.006 . . . . 42.34 116.416 -156.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -81.31 -13.41 11.13 Favored 'Trans proline' 0 C--N 1.371 1.756 0 CA-C-N 122.437 1.906 . . . . 74.11 113.65 -172.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -76.26 -42.88 44.26 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.182 0.993 . . . . 74.44 108.709 168.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.465 HG12 ' O ' ' D' ' 28' ' ' ALA . 6.5 p -81.86 -18.37 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 123.36 0.664 . . . . 64.45 111.547 -173.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -67.63 -15.1 63.48 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.965 0.728 . . . . 73.35 112.965 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -66.98 -13.15 61.59 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.674 0.79 . . . . 75.32 110.548 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -103.59 80.25 1.77 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.357 1.463 . . . . 73.04 109.005 173.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.6 82.92 5.64 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.972 -0.751 . . . . 63.3 108.972 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 t-105 -149.46 157.66 43.48 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.595 1.158 . . . . 75.2 108.231 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -71.76 104.99 1.11 Allowed Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 108.963 -0.754 . . . . 74.34 108.963 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.423 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 22.4 Cg_exo -66.23 140.91 60.7 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.928 2.418 . . . . 74.11 113.089 -169.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.41 112.83 1.36 Allowed 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.493 1.121 . . . . 73.51 109.24 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.617 HG23 HG13 ' D' ' 64' ' ' VAL . 2.5 p -98.18 115.0 37.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.626 -0.715 . . . . 73.01 110.752 -170.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -99.41 110.38 22.88 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.017 -1.475 . . . . 75.41 107.017 163.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.414 ' O ' HD12 ' D' ' 42' ' ' LEU . 1.1 pp -95.27 121.44 36.92 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.774 -1.195 . . . . 73.4 107.774 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.729 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 20.3 m-20 -106.05 145.61 31.19 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.064 -0.971 . . . . 75.53 108.38 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.5 130.07 39.97 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.424 -0.954 . . . . 75.31 108.424 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.7 t70 -132.05 143.42 50.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.109 -1.812 . . . . 72.31 106.109 170.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -135.72 155.93 49.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.649 -0.871 . . . . 71.41 108.649 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.07 173.29 14.04 Favored 'General case' 0 C--O 1.239 0.546 0 O-C-N 123.943 0.777 . . . . 52.53 109.854 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.588 ' HB2' ' HE1' ' D' ' 56' ' ' TYR . 19.9 p -155.61 151.23 27.27 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.655 0.782 . . . . 73.3 109.388 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 28.8 t -164.99 119.1 1.28 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.427 0.691 . . . . 64.35 109.545 -170.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -78.96 131.67 36.42 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.452 -0.573 . . . . 65.45 109.452 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.44 HD13 ' HB3' ' C' ' 29' ' ' PRO . 43.2 mt -102.24 -26.96 13.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.934 0.494 . . . . 70.24 111.101 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -168.09 -173.54 2.08 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.438 0.695 . . . . 55.24 110.629 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.05 111.98 10.82 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.984 -0.747 . . . . 64.24 108.984 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 76.09 4.01 3.73 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.777 1.631 . . . . 60.54 112.009 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 73.5 t -109.11 125.04 66.23 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 N-CA-C 108.032 -1.099 . . . . 70.34 108.032 169.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.588 ' HE1' ' HB2' ' D' ' 48' ' ' SER . 4.3 t80 -139.85 150.21 44.37 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.173 -1.047 . . . . 64.52 108.173 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -125.13 147.37 49.05 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.517 0.727 . . . . 74.43 109.973 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -124.3 141.83 43.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.959 -1.126 . . . . 73.42 107.959 171.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.476 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 53.4 t -118.37 139.17 46.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.185 -1.043 . . . . 74.41 108.185 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -123.69 113.68 18.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.652 -1.24 . . . . 63.4 107.652 179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -96.4 97.4 9.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.994 -1.113 . . . . 52.41 107.994 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 t -98.1 118.67 45.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.133 -1.062 . . . . 75.14 108.133 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.729 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.8 m -119.73 143.78 47.6 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.27 1.028 . . . . 64.34 108.47 -172.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.617 HG13 HG23 ' D' ' 40' ' ' VAL . 92.9 t -130.78 103.23 7.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.55 -0.907 . . . . 73.14 108.55 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 52.3 m -92.87 111.99 23.79 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.392 -0.966 . . . . 72.33 108.392 169.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -116.05 154.47 29.86 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.071 0.549 . . . . 73.13 110.518 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.449 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.9 m -148.41 135.48 20.17 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.606 0.566 . . . . 72.54 111.421 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.91 99.55 10.04 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.377 1.071 . . . . 74.22 108.451 173.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.71 -114.23 5.51 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.727 -0.67 . . . . 75.51 113.724 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.21 3.44 49.37 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.878 0.695 . . . . 73.43 112.878 -172.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -151.87 161.45 42.64 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 122.298 -0.251 . . . . 62.44 110.953 -168.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.2 m -63.74 137.1 57.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.053 0.941 . . . . 43.25 111.482 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.449 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -93.01 -73.59 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.184 -1.043 . . . . 70.42 108.184 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -140.49 143.4 35.45 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 121.429 0.633 . . . . 74.43 110.513 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 75.8 mt -109.28 141.99 40.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.202 -1.406 . . . . 61.31 107.202 173.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.58 ' SG ' HG23 ' D' ' 114' ' ' ILE . 51.6 t -151.73 143.55 23.73 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.271 -0.64 . . . . 74.41 109.271 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -155.72 136.5 13.48 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.203 -0.665 . . . . 72.33 109.203 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.75 114.04 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.847 -0.797 . . . . 65.01 108.847 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -88.56 81.68 7.07 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.267 -1.012 . . . . 71.3 108.267 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -78.12 99.46 6.17 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.102 -1.408 . . . . 74.14 109.32 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.01 148.97 18.65 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 111.549 -0.62 . . . . 44.34 111.549 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.9 132.01 4.7 Favored Glycine 0 C--N 1.335 0.513 0 N-CA-C 111.746 -0.542 . . . . 74.34 111.746 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.4 mt -90.28 128.79 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.044 0.938 . . . . 73.24 108.871 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.99 123.43 25.86 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.273 1.029 . . . . 74.01 109.672 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -76.56 105.67 7.76 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.176 -0.676 . . . . 74.42 109.176 168.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.574 HD13 HD21 ' D' ' 98' ' ' LEU . 48.3 pt -116.62 144.37 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 122.922 0.489 . . . . 63.4 110.163 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.2 158.8 19.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.852 0.861 . . . . 72.3 109.371 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.75 21.7 79.52 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 116.486 -0.325 . . . . 63.51 113.621 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' D' ' 86' ' ' ILE . 23.9 pt -128.52 127.43 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.383 0.673 . . . . 63.11 110.0 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.81 154.1 46.09 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.483 1.113 . . . . 74.41 109.777 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.24 -117.84 11.62 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.43 -0.805 . . . . 72.44 114.562 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 19.2 m -65.56 -36.6 84.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.404 0.682 . . . . 71.12 111.612 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -77.09 -40.57 45.53 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.24 -0.436 . . . . 70.24 111.911 -172.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.494 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -64.8 -35.74 82.08 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 120.785 0.326 . . . . 75.25 110.465 178.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 95' ' ' ALA . . . . . 0.494 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -65.04 -49.48 69.98 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 115.381 -0.827 . . . . 44.12 109.736 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -59.97 -35.53 75.18 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.717 0.636 . . . . 73.5 111.391 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -64.82 -50.6 66.07 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.076 0.551 . . . . 71.52 111.239 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.574 HD21 HD13 ' D' ' 86' ' ' ILE . 75.7 mt -92.33 -28.42 16.95 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.801 0.667 . . . . 75.13 112.801 -169.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.81 -4.24 57.96 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-O 119.761 -0.466 . . . . 55.52 113.953 -174.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -142.9 -59.41 0.43 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.104 0.452 . . . . 52.12 111.365 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 101' ' ' TYR . . . . . 0.41 ' O ' HG12 ' D' ' 105' ' ' ILE . 46.5 t80 -70.56 -39.89 73.68 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.487 0.551 . . . . 72.4 112.487 -171.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.464 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 97.5 m -69.86 -46.84 23.98 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.313 -0.851 . . . . 71.31 111.611 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.4 Cg_exo -55.24 -34.19 87.34 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.004 1.803 . . . . 71.44 112.736 169.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -64.05 -40.83 97.16 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.404 0.681 . . . . 71.43 110.41 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.41 HG12 ' O ' ' D' ' 101' ' ' TYR . 46.9 mm -63.2 -37.22 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.517 0.727 . . . . 72.43 110.659 174.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.23 -19.46 43.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.156 0.982 . . . . 72.23 112.237 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -65.91 -44.73 63.08 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 114.03 1.122 . . . . 74.14 114.03 -171.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.04 -44.62 38.02 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.282 1.988 . . . . 65.13 112.835 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -69.27 -34.72 75.2 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.384 -0.825 . . . . 65.32 111.263 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.55 -53.39 56.9 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.738 0.815 . . . . 72.24 110.341 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 30.0 ttp180 -53.39 -46.51 69.68 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 124.814 1.321 . . . . 74.11 111.292 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -63.38 -49.99 71.64 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.265 0.978 . . . . 52.35 111.29 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.7 t -57.22 -41.57 79.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.11 0.881 . . . . 74.22 111.018 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.58 HG23 ' SG ' ' D' ' 76' ' ' CYS . 70.2 mt -61.01 -56.41 18.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 123.788 0.835 . . . . 72.24 110.6 174.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.488 HG23 ' HG3' ' D' ' 125' ' ' GLN . 85.1 m -53.4 -43.57 68.02 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.437 1.095 . . . . 65.34 111.706 -175.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 40.1 t -65.07 -43.07 93.4 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.947 -1.024 . . . . 64.12 110.478 -177.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.4 mtm -68.92 -32.6 72.34 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.833 0.453 . . . . 75.14 111.573 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 114' ' ' ILE . 73.3 t -65.75 -42.41 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.675 0.79 . . . . 72.25 110.299 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -73.14 -27.73 61.84 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 122.686 0.394 . . . . 52.04 111.157 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' D' ' 116' ' ' SER . 80.3 mtt-85 -72.04 -33.95 68.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.595 0.758 . . . . 75.44 109.913 173.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.23 0.27 89.38 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.901 0.75 . . . . 60.41 112.0 174.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 19.2 p 64.4 19.82 11.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.599 1.959 . . . . 63.22 113.711 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -84.8 150.37 55.89 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 108.609 -0.886 . . . . 52.4 108.609 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.47 141.5 51.33 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 123.246 2.631 . . . . 52.34 113.546 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.488 ' HG3' HG23 ' D' ' 115' ' ' THR . 32.2 tt0 -51.0 140.44 15.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.905 1.282 . . . . 70.35 112.675 -172.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.457 HD11 HG21 ' D' ' 40' ' ' VAL . 0.3 OUTLIER -125.09 97.15 5.12 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.541 -0.911 . . . . 70.43 108.541 -175.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -99.0 110.37 22.99 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.868 -0.79 . . . . 71.24 108.868 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.479 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -69.39 113.41 6.69 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.656 -0.868 . . . . 73.01 108.656 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.73 140.6 97.84 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.042 0.537 . . . . 71.03 110.957 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.08 118.42 5.32 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.63 2.22 . . . . 54.0 111.778 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.73 123.17 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.522 0.729 . . . . 65.43 109.407 -176.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -85.17 79.32 9.61 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.572 -0.899 . . . . 65.52 108.572 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -83.56 -14.66 51.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.568 -0.742 . . . . 72.32 110.588 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 134' ' ' ASP . . . . . 0.405 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 2.3 m-20 -52.77 -53.55 46.58 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.969 0.908 . . . . 63.44 111.789 173.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.12 77.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.962 0.905 . . . . 52.22 111.691 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.1 -22.44 45.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.952 -1.022 . . . . 75.54 111.256 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 84.6 t80 . . . . . 0 N--CA 1.475 0.775 0 C-N-CA 123.403 0.681 . . . . 75.04 110.119 176.714 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 87.7 m . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 107.906 -1.146 . . . . 71.13 107.906 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -134.55 138.67 44.81 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.821 0.848 . . . . 62.01 108.758 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -152.8 127.61 9.54 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.429 0.692 . . . . 70.42 109.466 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.3 mt -83.39 115.74 26.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.302 -0.999 . . . . 75.41 108.302 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -81.51 -38.59 26.03 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.478 0.486 . . . . 61.22 109.864 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -170.11 124.07 0.73 Allowed 'General case' 0 C--N 1.356 0.875 0 CA-C-O 119.684 -0.198 . . . . 74.3 110.783 -167.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.481 HD12 ' HG3' ' C' ' 130' ' ' PRO . 46.8 mt -111.68 134.79 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.157 -1.053 . . . . 75.31 108.157 172.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HB3' HG23 ' B' ' 122' ' ' THR . 44.1 p90 -166.55 167.33 15.6 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.878 0.847 . . . . 70.24 111.272 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -91.3 110.69 21.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.732 -1.122 . . . . 72.24 108.138 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -70.95 -46.92 61.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.96 -0.756 . . . . 73.23 108.96 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.66 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 6.0 m-20 -133.5 132.97 41.63 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.598 -1.183 . . . . 75.2 109.256 -176.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -127.67 139.71 51.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 106.678 -1.601 . . . . 72.32 106.678 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -149.84 107.34 3.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 123.655 0.597 . . . . 70.21 109.718 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 60.0 t80 -111.2 113.7 26.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.707 -1.59 . . . . 53.53 106.707 171.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.0 114.37 22.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.319 -0.623 . . . . 65.32 109.319 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.72 80.56 70.26 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 107.613 -1.255 . . . . 72.12 107.613 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.76 -11.4 20.14 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.469 2.112 . . . . 71.25 111.214 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -107.72 20.84 18.29 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.874 1.269 . . . . 63.03 108.772 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.46 -45.02 99.71 Favored Pre-proline 0 CA--C 1.571 1.786 0 N-CA-C 114.43 1.271 . . . . 45.41 114.43 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -88.01 -8.44 5.78 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 121.678 1.585 . . . . 73.43 112.99 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -94.88 -15.53 23.6 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.215 1.006 . . . . 60.22 110.354 -175.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.533 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 8.8 p -77.01 -25.93 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.731 0.812 . . . . 74.12 110.205 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -66.68 -29.82 69.91 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.801 0.84 . . . . 63.53 110.113 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -78.94 -34.95 44.01 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.025 0.93 . . . . 64.12 111.612 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 31' ' ' VAL . 16.2 ptpt -82.87 169.2 16.33 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.115 0.413 . . . . 75.3 112.115 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -85.01 127.03 34.02 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.648 -0.871 . . . . 74.41 108.648 167.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -70.29 88.55 0.64 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.21 1.004 . . . . 75.31 111.594 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.457 ' HB2' HD13 ' A' ' 68' ' ' LEU . 98.5 mt-30 -132.88 76.78 70.01 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.141 0.976 . . . . 74.43 109.403 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -89.04 126.38 1.68 Allowed 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.339 2.026 . . . . 74.13 112.358 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.99 109.89 22.21 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.492 -1.299 . . . . 74.33 107.492 170.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.78 107.24 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 115.131 -0.94 . . . . 62.25 110.907 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -79.77 114.69 18.89 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.289 -1.004 . . . . 70.41 108.289 165.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.0 tp -98.24 111.55 23.84 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.302 -0.999 . . . . 64.33 108.302 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -116.11 129.49 56.36 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.055 -1.091 . . . . 62.12 108.055 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 tt -119.33 129.89 55.09 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.281 -1.007 . . . . 63.24 108.281 -171.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 18.7 t70 -130.34 155.28 46.62 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.13 0.972 . . . . 71.41 109.532 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.0 m -141.78 131.87 24.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.564 1.146 . . . . 75.32 109.207 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.1 148.64 45.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.973 0.909 . . . . 75.33 109.423 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.4 p -109.41 161.68 15.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.568 0.747 . . . . 51.31 109.313 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.1 p -152.95 138.08 17.35 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.134 0.574 . . . . 54.01 109.853 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.448 ' HA ' ' HD1' ' A' ' 56' ' ' TYR . 46.9 tt0 -91.25 114.83 27.47 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.944 0.498 . . . . 74.33 109.975 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 57' ' ' GLU . 18.9 mt -89.25 -43.42 10.98 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.832 -0.803 . . . . 51.11 108.832 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -150.67 -179.33 7.16 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 113.989 -1.459 . . . . 64.22 108.662 174.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.57 113.64 6.26 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.39 -0.596 . . . . 75.53 109.39 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 66.3 21.55 10.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.337 1.455 . . . . 74.45 112.101 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 60.3 t -121.33 102.08 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 106.759 -1.571 . . . . 70.32 106.759 167.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.448 ' HD1' ' HA ' ' A' ' 50' ' ' GLN . 18.7 m-85 -127.05 143.35 51.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.951 0.501 . . . . 73.41 110.014 -170.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' A' ' 51' ' ' LEU . 34.7 tt0 -114.89 137.91 51.41 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.782 0.833 . . . . 75.25 109.523 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.5 t -103.89 126.85 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.824 -1.176 . . . . 71.1 107.824 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.4 t -102.22 107.46 21.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.524 -0.917 . . . . 75.1 108.524 174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 tp -88.83 101.42 14.01 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.949 -0.759 . . . . 71.03 108.949 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.697 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 23.8 mtm105 -89.5 100.95 13.64 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.039 0.536 . . . . 74.54 109.619 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.518 HG21 ' HB1' ' A' ' 110' ' ' ALA . 2.5 m -113.25 108.48 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.154 0.581 . . . . 62.1 109.543 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -108.89 148.51 30.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.523 0.729 . . . . 53.42 110.741 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.423 ' O ' HD12 ' A' ' 75' ' ' LEU . 70.6 t -129.23 112.29 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 125.307 1.443 . . . . 72.22 108.067 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.7 m -102.6 104.2 14.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.562 -0.903 . . . . 53.21 108.562 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.84 109.57 21.35 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.562 -1.273 . . . . 74.1 107.562 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.7 p -147.39 140.93 25.49 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.18 0.514 . . . . 63.41 111.405 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' A' ' 37' ' ' GLN . 38.2 tp -90.39 68.64 6.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.828 1.251 . . . . 70.32 107.668 169.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.51 -89.71 0.63 Allowed Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.046 -0.979 . . . . 42.25 111.951 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.8 -26.01 14.17 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.2 1.0 . . . . 73.32 110.123 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -96.98 94.89 7.45 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.407 -0.815 . . . . 72.45 109.177 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.8 m -65.39 134.77 54.22 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.824 0.85 . . . . 63.51 111.99 -174.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.87 -64.54 1.16 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.874 -0.788 . . . . 70.51 108.874 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -157.06 174.14 15.96 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.166 -0.925 . . . . 75.14 110.937 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 64' ' ' VAL . 61.7 tp -140.2 130.36 25.02 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.973 1.309 . . . . 63.24 107.634 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.427 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 84.7 m -138.44 113.4 9.2 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.466 0.706 . . . . 41.2 110.204 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -132.74 126.76 33.21 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.897 -0.779 . . . . 73.1 108.897 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -129.17 119.15 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.513 -0.767 . . . . 75.04 109.362 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.66 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 44.9 mt-30 -91.05 89.77 7.56 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.877 -1.056 . . . . 63.35 108.286 172.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.422 ' HG3' HD22 ' A' ' 106' ' ' LEU . 63.3 tp60 -78.73 105.71 10.22 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.149 -0.932 . . . . 70.04 109.29 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.97 160.03 27.03 Favored Glycine 0 C--O 1.242 0.613 0 N-CA-C 111.317 -0.713 . . . . 74.54 111.317 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.47 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -162.43 121.91 1.06 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.003 -1.239 . . . . 52.01 110.003 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.418 HG23 HD12 ' A' ' 51' ' ' LEU . 59.3 mt -79.23 123.74 36.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.625 -0.88 . . . . 71.03 108.625 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -126.41 119.0 26.14 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.081 -0.711 . . . . 73.22 109.081 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 p -91.62 119.2 31.31 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.066 -1.087 . . . . 71.24 108.066 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.765 HD13 HD11 ' A' ' 89' ' ' ILE . 2.4 pp -126.54 161.59 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.589 0.755 . . . . 51.5 111.559 -171.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.605 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -167.72 155.28 8.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.376 1.071 . . . . 74.3 109.721 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.16 8.26 86.92 Favored Glycine 0 N--CA 1.475 1.249 0 N-CA-C 114.501 0.56 . . . . 64.4 114.501 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.765 HD11 HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -114.99 153.85 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.2 1.0 . . . . 71.11 109.153 178.029 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.414 ' H ' ' HB2' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -164.87 171.27 14.34 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.12 -1.067 . . . . 70.24 108.12 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.38 -114.54 1.47 Allowed Glycine 0 CA--C 1.542 1.721 0 N-CA-C 114.685 0.634 . . . . 71.41 114.685 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p -70.68 -29.72 66.12 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.267 1.027 . . . . 63.22 112.173 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.414 ' HB2' ' H ' ' A' ' 90' ' ' GLU . 69.7 mm-40 -65.86 -44.63 84.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.45 0.7 . . . . 75.03 110.865 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -71.43 -34.17 70.06 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.22 -0.445 . . . . 72.42 110.467 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -33.51 76.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.099 0.56 . . . . 74.21 110.618 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.526 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 63.9 t-80 -71.49 -21.69 61.9 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.739 0.816 . . . . 71.44 110.728 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 78.3 m -79.12 -60.27 2.44 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.401 -0.592 . . . . 72.54 109.401 172.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.14 -32.84 73.48 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.169 0.987 . . . . 75.32 112.423 -173.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.47 4.13 29.56 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 119.356 -0.691 . . . . 32.11 114.055 -172.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.1 -66.73 0.34 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.882 0.841 . . . . 61.44 111.782 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.413 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 76.1 t80 -70.65 -58.32 3.79 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.241 0.616 . . . . 73.12 112.478 -169.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.65 -46.28 98.59 Favored Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 113.517 0.932 . . . . 74.21 113.517 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.09 -26.49 65.5 Favored 'Trans proline' 0 C--N 1.399 3.185 0 C-N-CA 121.846 1.697 . . . . 71.23 112.636 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -68.22 -39.76 82.29 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.382 0.673 . . . . 54.33 110.601 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.8 mm -61.7 -43.43 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.893 0.877 . . . . 64.24 110.13 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.422 HD22 ' HG3' ' A' ' 80' ' ' GLN . 83.0 mt -77.94 -22.22 49.89 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.889 -1.05 . . . . 72.52 112.219 -174.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -61.46 -47.25 93.87 Favored Pre-proline 0 CA--C 1.567 1.62 0 N-CA-C 113.788 1.033 . . . . 65.03 113.788 -170.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.12 -37.0 66.66 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.143 1.895 . . . . 73.4 113.139 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -70.37 -39.98 74.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.639 0.776 . . . . 75.23 110.418 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.518 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -65.38 -43.11 91.77 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.388 -0.823 . . . . 41.51 110.549 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.474 ' NH1' HD12 ' C' ' 105' ' ' ILE . 31.8 ttm180 -55.14 -50.85 68.23 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 124.46 1.1 . . . . 62.53 110.33 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -59.86 -47.46 85.67 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.604 1.19 . . . . 75.35 111.343 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 117' ' ' MET . 36.1 t -61.7 -41.47 97.65 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 123.912 0.757 . . . . 64.14 110.643 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.487 HD11 HG23 ' A' ' 62' ' ' VAL . 96.1 mt -64.3 -50.23 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.895 0.878 . . . . 75.42 110.43 176.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 78.4 m -53.6 -45.03 69.91 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.839 0.855 . . . . 74.25 110.604 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -66.74 -38.77 87.3 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.165 -1.38 . . . . 73.54 110.228 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 30.9 mmt -58.61 -47.13 85.38 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.283 0.633 . . . . 74.15 111.235 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 114' ' ' ILE . 62.2 t -61.97 -43.64 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-N 114.897 -1.047 . . . . 72.22 110.408 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.1 m -73.29 -29.8 62.97 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.612 0.765 . . . . 40.0 111.917 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.492 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 93.9 mtt-85 -77.41 -25.31 50.67 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.207 0.603 . . . . 74.01 110.413 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.99 2.8 87.15 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.576 0.547 . . . . 40.43 112.758 171.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.9 m 68.01 16.79 9.56 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.908 1.283 . . . . 74.52 111.268 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -81.74 144.94 53.1 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 108.914 -0.773 . . . . 72.43 108.914 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.14 134.72 44.14 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.058 2.505 . . . . 64.41 112.226 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -52.75 141.95 19.94 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.369 1.068 . . . . 63.42 113.558 -171.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.0 tp -119.4 127.08 52.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.815 1.246 . . . . 75.32 109.766 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -135.9 102.39 5.04 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.492 -0.929 . . . . 71.33 108.492 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.0 pt? -68.45 151.59 46.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.535 0.734 . . . . 72.31 111.031 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.94 146.46 98.27 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.196 0.999 . . . . 70.24 111.23 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -67.1 123.63 11.17 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.558 2.172 . . . . 71.41 112.347 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 98.7 t -101.25 113.56 37.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 123.971 0.908 . . . . 71.44 108.619 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -87.84 97.39 10.89 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.631 -0.878 . . . . 73.43 108.631 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -66.48 -21.14 66.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.315 1.046 . . . . 75.13 111.685 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.86 -48.77 62.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.413 1.085 . . . . 73.52 110.88 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.14 -40.02 88.34 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.83 0.707 . . . . 73.34 110.348 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.49 -39.9 85.22 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.081 -0.963 . . . . 72.43 111.369 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -67.08 -36.74 82.65 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.38 -0.6 . . . . 74.22 109.38 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.0 mmt . . . . . 0 N--CA 1.471 0.612 0 O-C-N 124.023 0.827 . . . . 75.33 111.176 177.234 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.238 0.481 0 N-CA-C 109.2 -0.667 . . . . 62.22 109.2 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -126.91 114.7 18.21 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.181 -1.415 . . . . 71.13 107.181 164.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.418 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 7.1 tp60 -128.76 118.34 22.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.452 0.701 . . . . 75.52 109.268 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 59.2 mt -77.77 116.48 21.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.902 -1.147 . . . . 65.24 107.902 169.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -85.72 -47.27 9.93 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.115 -0.698 . . . . 74.42 109.115 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -161.62 136.4 7.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.319 -0.855 . . . . 63.44 109.447 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 86.2 mt -115.89 140.76 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 106.392 -1.707 . . . . 51.13 106.392 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -166.3 171.18 12.37 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.392 0.615 . . . . 64.25 111.553 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.47 HG21 HD11 ' B' ' 21' ' ' ILE . 58.4 m -98.53 128.24 44.78 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.112 -0.949 . . . . 75.43 108.719 170.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.44 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 19.4 mtpp -86.96 -37.28 17.72 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.996 0.919 . . . . 43.25 109.465 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -151.93 139.45 19.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.178 -0.465 . . . . 75.44 112.059 -173.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.47 HD11 HG21 ' B' ' 18' ' ' THR . 39.6 mm -124.24 141.1 45.57 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 124.965 1.306 . . . . 51.45 108.809 170.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.4 t -140.55 136.72 33.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.485 -1.234 . . . . 64.34 108.116 176.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.5 t80 -158.59 111.01 2.27 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 107.62 -1.252 . . . . 75.51 107.62 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -131.34 117.45 18.94 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.844 0.858 . . . . 65.54 109.269 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.593 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -109.94 85.83 4.42 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.166 0.987 . . . . 75.13 108.821 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.64 -32.38 24.23 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.759 2.306 . . . . 73.35 112.546 -170.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -108.9 8.41 26.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.535 0.734 . . . . 73.33 111.249 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.593 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -34.48 -65.25 0.26 Allowed Pre-proline 0 N--CA 1.503 2.204 0 C-N-CA 125.526 1.53 . . . . 74.52 114.852 -167.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.8 Cg_exo -69.88 -19.41 35.58 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.284 1.99 . . . . 64.25 112.836 -168.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -95.48 -34.11 12.19 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.32 -0.854 . . . . 72.32 110.07 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.482 HG22 HD12 ' B' ' 68' ' ' LEU . 2.0 p -71.85 -24.29 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.859 0.464 . . . . 72.02 110.703 -173.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -67.62 -3.51 9.18 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.928 0.891 . . . . 73.25 112.989 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.56 -19.55 65.28 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 120.796 0.331 . . . . 74.34 110.294 170.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.441 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 86.3 mttt -105.35 92.74 4.33 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.581 1.153 . . . . 72.43 108.576 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.55 87.55 7.41 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.353 0.597 . . . . 75.32 110.221 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -165.43 159.08 16.6 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.803 1.241 . . . . 75.04 108.181 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.438 ' HG3' ' HB2' ' B' ' 124' ' ' PRO . 17.0 mp0 -59.5 110.65 2.9 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 123.852 0.861 . . . . 75.53 109.934 172.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.655 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.0 Cg_endo -60.24 140.71 93.48 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.908 2.405 . . . . 74.21 112.603 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -51.58 107.84 0.22 Allowed 'General case' 0 C--N 1.357 0.928 0 O-C-N 124.471 1.107 . . . . 71.41 110.561 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 31.3 m -87.5 155.04 3.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.157 -0.929 . . . . 65.02 111.454 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.64 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 48.9 tttp -139.39 107.69 5.8 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.308 -1.367 . . . . 44.23 107.308 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.26 124.37 33.8 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.502 -0.555 . . . . 54.01 109.502 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.568 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 23.6 t70 -130.18 154.45 47.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.242 1.417 . . . . 72.34 107.838 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.71 147.29 35.4 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.701 -0.481 . . . . 53.1 109.701 -170.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.598 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 23.4 t70 -146.91 114.14 6.24 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.912 -0.773 . . . . 71.52 108.912 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.2 p -114.95 108.29 16.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.23 0.612 . . . . 73.13 110.697 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.16 162.65 17.14 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.827 1.251 . . . . 32.12 108.689 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.0 p -137.44 162.28 34.08 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.271 0.628 . . . . 70.21 109.468 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 97.8 p -150.41 136.48 18.55 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.855 0.462 . . . . 54.31 110.199 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -87.02 110.41 20.04 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.311 -0.626 . . . . 64.44 109.311 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 27.5 mt -82.42 -41.94 19.23 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.908 -0.587 . . . . 72.31 109.669 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.73 -172.31 4.01 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.51 -1.223 . . . . 74.33 110.303 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.03 105.52 0.41 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.782 -1.099 . . . . 55.44 110.723 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 66.76 16.43 10.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.952 1.301 . . . . 75.51 112.322 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -105.49 110.05 29.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.765 -1.198 . . . . 71.42 107.765 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.52 140.23 52.48 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.508 0.67 . . . . 75.34 109.675 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -116.04 104.11 11.24 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.356 -1.35 . . . . 74.11 107.356 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 90.8 t -85.4 139.68 17.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 CA-C-N 114.632 -1.167 . . . . 74.03 109.635 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.83 120.04 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 123.585 0.754 . . . . 61.33 109.116 -176.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -107.42 106.29 16.62 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.78 -1.193 . . . . 71.32 107.78 178.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.598 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 34.6 ttm180 -98.87 118.81 36.46 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.157 0.583 . . . . 72.54 109.616 170.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.617 ' HB ' HD11 ' B' ' 114' ' ' ILE . 29.3 t -107.84 108.64 25.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.621 -1.251 . . . . 73.0 107.621 169.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 41.7 m -97.11 122.57 40.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.519 -0.549 . . . . 64.3 109.519 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.712 HG21 HG21 ' B' ' 114' ' ' ILE . 79.5 t -115.83 103.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 124.046 0.939 . . . . 52.42 110.111 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 99.7 m -91.23 145.09 24.95 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.559 -0.904 . . . . 71.13 108.559 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -145.85 148.73 33.19 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.463 0.305 . . . . 62.35 111.027 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.1 p -153.41 130.62 11.18 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.808 -0.633 . . . . 61.24 110.801 -175.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.655 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 35.0 mt -98.68 112.73 24.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.924 0.89 . . . . 71.04 108.978 175.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.48 -114.54 6.96 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 115.211 -0.904 . . . . 65.45 112.342 -172.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -109.09 11.65 25.57 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.226 0.611 . . . . 71.45 112.282 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -128.29 150.14 50.19 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.199 0.6 . . . . 74.41 110.079 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 37.5 m -66.38 135.19 53.98 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.474 0.484 . . . . 62.25 110.594 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.466 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -91.16 -62.32 1.47 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.283 -1.006 . . . . 74.1 108.283 174.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -151.4 162.88 40.16 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.202 -0.908 . . . . 74.42 110.17 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -132.91 109.35 9.53 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.976 -1.491 . . . . 52.33 106.976 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' B' ' 114' ' ' ILE . 51.2 t -118.3 156.43 28.89 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.69 0.796 . . . . 61.4 109.267 -174.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.0 tt0 -165.81 139.87 4.53 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.7 -0.852 . . . . 64.14 108.7 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' B' ' 113' ' ' CYS . 72.3 t -131.67 141.66 45.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.656 -1.239 . . . . 73.42 107.656 172.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -122.31 87.62 2.78 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.753 -0.832 . . . . 74.42 108.753 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.34 99.48 7.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.551 -0.75 . . . . 73.4 109.014 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.44 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.97 144.29 16.55 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.635 -0.986 . . . . 60.23 110.635 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.42 130.43 4.1 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.491 -0.644 . . . . 75.25 111.491 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.0 mt -85.15 125.77 40.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 123.945 0.898 . . . . 74.43 109.208 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -136.54 135.45 38.49 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.29 1.036 . . . . 64.22 108.565 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 41.9 m -101.99 106.6 17.54 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.802 -0.814 . . . . 52.14 108.802 176.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.407 HG21 ' SG ' ' B' ' 97' ' ' CYS . 31.2 pt -110.66 125.15 67.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.776 0.83 . . . . 64.2 109.906 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.45 162.06 41.65 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.753 0.821 . . . . 60.34 109.331 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.18 -47.8 3.9 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.476 0.485 . . . . 75.31 112.636 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 31.1 pt -70.18 152.28 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.838 0.855 . . . . 71.13 110.644 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -162.85 163.86 26.29 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.363 0.665 . . . . 74.31 109.96 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.4 -113.65 3.71 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.438 0.461 . . . . 71.4 112.407 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 87.7 m -84.97 -26.74 26.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.182 0.515 . . . . 64.11 110.745 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -73.43 -28.89 62.22 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.831 -0.622 . . . . 75.22 110.663 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.404 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 0.0 OUTLIER -72.7 -33.75 66.68 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 109.589 -0.522 . . . . 71.3 109.589 173.234 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.55 -39.08 84.96 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.905 0.882 . . . . 71.01 110.891 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -62.65 -31.23 72.06 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.681 -1.145 . . . . 72.53 110.808 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.407 ' SG ' HG21 ' B' ' 86' ' ' ILE . 25.2 t -72.06 -66.35 0.66 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.924 -0.58 . . . . 60.4 110.367 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.441 HD12 ' N ' ' B' ' 99' ' ' GLY . 1.6 pp -68.93 -26.74 65.23 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.589 0.959 . . . . 75.22 113.589 -171.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' GLY . . . . . 0.441 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -104.56 3.05 42.55 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-O 119.52 -0.6 . . . . 74.22 114.242 -171.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.86 -61.16 0.18 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 117.429 0.615 . . . . 71.31 111.176 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -66.92 -52.38 43.82 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.338 1.055 . . . . 72.35 111.908 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.428 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 92.6 m -62.34 -50.38 79.68 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.371 1.068 . . . . 73.53 111.788 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.7 Cg_exo -56.36 -36.65 97.4 Favored 'Trans proline' 0 C--N 1.401 3.305 0 C-N-CA 122.045 1.83 . . . . 71.22 113.295 170.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -66.59 -29.56 69.64 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.008 0.523 . . . . 62.53 111.004 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.431 HG23 ' NH2' ' D' ' 111' ' ' ARG . 93.0 mt -68.49 -45.51 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.87 0.868 . . . . 73.01 110.244 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.405 ' HB2' HD12 ' B' ' 60' ' ' LEU . 56.2 mt -76.39 -20.93 56.66 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.975 -1.011 . . . . 73.02 111.833 -173.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -59.91 -48.79 93.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-O 117.661 -1.162 . . . . 73.0 113.419 -171.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -56.36 -38.69 94.73 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.124 1.882 . . . . 74.4 113.231 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -66.83 -47.64 71.38 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.158 0.583 . . . . 74.24 110.335 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.407 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -59.81 -40.27 87.81 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.593 0.757 . . . . 74.14 110.656 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.539 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 36.0 ttt180 -61.75 -52.3 64.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.334 1.454 . . . . 73.35 111.138 -176.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.74 -37.74 88.5 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.958 0.786 . . . . 62.22 109.916 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.492 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 5.1 t -67.38 -38.31 84.55 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.656 0.598 . . . . 75.42 111.796 -173.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.712 HG21 HG21 ' B' ' 64' ' ' VAL . 61.1 mt -66.74 -51.47 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 109.388 -0.597 . . . . 74.51 109.388 176.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.471 HG21 ' OG ' ' C' ' 119' ' ' SER . 88.9 m -54.91 -37.74 66.74 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.898 1.374 . . . . 75.52 110.848 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 46.7 t -63.43 -44.19 95.27 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 115.361 -0.836 . . . . 53.21 110.018 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.422 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 30.7 mmt -62.91 -43.07 99.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.337 0.398 . . . . 73.53 110.93 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.511 HG23 ' O ' ' B' ' 114' ' ' ILE . 48.4 t -58.96 -47.16 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.242 1.017 . . . . 55.43 109.605 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.532 ' HB3' HG21 ' C' ' 115' ' ' THR . 71.8 m -65.49 -34.54 78.51 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.261 -1.336 . . . . 70.15 112.062 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -68.87 -35.0 76.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.395 -0.821 . . . . 72.53 110.093 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -86.99 10.99 66.15 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 124.135 0.897 . . . . 52.51 112.957 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 17' ' ' TYR . 67.0 p 56.74 23.61 8.12 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.992 1.717 . . . . 52.32 113.628 176.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.47 149.99 62.44 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 122.797 0.439 . . . . 64.12 109.996 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.438 ' HB2' ' HG3' ' B' ' 37' ' ' GLN . 51.2 Cg_exo -55.29 164.76 3.57 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.736 2.958 . . . . 74.51 114.906 -177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -57.73 121.39 10.32 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.308 1.043 . . . . 71.23 112.895 -166.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 9.5 tt -128.54 123.85 34.52 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.075 -1.083 . . . . 70.41 108.075 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -134.98 127.1 29.89 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.611 0.764 . . . . 74.12 109.004 172.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.539 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -68.79 137.74 54.24 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.483 0.713 . . . . 50.41 109.919 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.03 138.4 61.07 Favored Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 123.625 0.578 . . . . 54.41 110.576 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.04 122.98 7.52 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.881 2.387 . . . . 55.41 112.847 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 t -116.2 112.08 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.42 -0.956 . . . . 43.41 108.42 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -76.68 88.71 3.35 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.461 -0.94 . . . . 74.53 108.461 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -59.51 -37.8 79.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.093 -0.958 . . . . 73.24 112.345 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.22 -43.59 87.79 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.978 0.911 . . . . 73.23 112.688 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.03 -53.64 29.28 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.537 0.735 . . . . 71.12 110.725 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.0 -14.72 61.07 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.282 -0.872 . . . . 71.44 111.433 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 84.2 t80 . . . . . 0 N--CA 1.476 0.837 0 O-C-N 123.396 0.435 . . . . 74.44 109.937 173.738 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 28.5 m . . . . . 0 CA--C 1.536 0.437 0 N-CA-C 107.632 -1.247 . . . . 52.02 107.632 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -97.44 128.45 44.24 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.491 -0.929 . . . . 73.41 108.491 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -153.88 125.74 7.74 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.18 0.592 . . . . 65.21 109.723 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.442 HD13 HD11 ' C' ' 16' ' ' ILE . 50.1 mt -75.75 132.57 32.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.857 -0.794 . . . . 61.42 108.857 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.499 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 15.0 mm100 -101.11 -39.52 7.64 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.593 0.757 . . . . 74.53 109.899 174.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -169.67 146.62 3.32 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.526 -0.546 . . . . 71.22 109.526 -172.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.442 HD11 HD13 ' C' ' 13' ' ' ILE . 89.8 mt -137.03 134.08 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.143 -1.058 . . . . 73.5 108.143 175.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.413 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 43.4 p90 -170.85 164.29 7.81 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.155 0.502 . . . . 71.4 110.904 -167.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -87.26 114.53 23.96 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.328 -0.851 . . . . 61.44 108.855 173.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.413 ' HD2' ' HE2' ' C' ' 17' ' ' TYR . 19.2 mmmt -64.02 -39.89 95.12 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.915 0.864 . . . . 75.13 109.139 172.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -160.4 144.98 14.38 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 113.696 -1.593 . . . . 75.22 108.349 -172.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 88.9 mt -133.78 146.99 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.585 -1.265 . . . . 73.41 107.585 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.8 t -151.92 149.76 29.29 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.471 0.653 . . . . 63.55 110.267 172.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 82.7 t80 -150.75 117.85 5.94 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 107.275 -1.38 . . . . 73.01 107.275 173.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.97 111.99 17.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.512 0.725 . . . . 75.53 109.882 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.88 82.34 60.94 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.25 -1.019 . . . . 60.22 108.25 169.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -65.17 -25.78 57.73 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.013 2.476 . . . . 75.32 112.712 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -102.31 13.02 35.73 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.154 0.982 . . . . 62.4 110.605 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.468 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -45.18 -58.42 5.74 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 114.703 1.371 . . . . 73.23 114.703 -165.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.549 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 23.5 Cg_endo -60.04 -43.22 37.78 Favored 'Trans proline' 0 C--N 1.383 2.382 0 CA-C-N 122.129 1.796 . . . . 70.13 111.817 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -71.67 -28.42 63.73 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.963 0.905 . . . . 75.35 112.674 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.761 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.7 p -80.25 -22.26 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.57 0.348 . . . . 65.14 111.567 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -72.91 -21.24 60.93 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.005 0.522 . . . . 74.24 111.783 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -102.1 6.5 40.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.734 0.814 . . . . 74.11 110.906 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.823 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -83.77 161.53 20.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.444 0.698 . . . . 63.24 110.546 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 35' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 7.2 m-20 -57.76 112.27 1.41 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.32 1.048 . . . . 74.33 109.646 168.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -73.57 88.45 1.67 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.028 0.531 . . . . 73.12 110.553 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -150.16 74.22 9.15 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.393 -0.966 . . . . 50.2 108.393 169.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -74.57 164.48 33.74 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.75 2.3 . . . . 74.22 112.87 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -115.8 94.38 4.66 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.374 -1.714 . . . . 74.14 106.374 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 90.9 t -73.38 98.4 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.548 -0.751 . . . . 73.12 109.256 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -101.5 107.39 18.68 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.912 -1.144 . . . . 72.21 107.912 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.07 138.48 31.41 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.273 0.559 . . . . 74.11 111.282 -174.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.577 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.2 t70 -130.74 132.86 45.58 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.11 1.364 . . . . 62.5 108.614 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.401 HD13 HG11 ' C' ' 131' ' ' VAL . 52.0 mt -123.05 131.9 53.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.845 -1.169 . . . . 74.45 107.845 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -144.4 144.58 31.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.322 0.649 . . . . 71.35 109.421 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -151.48 153.41 34.57 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 122.898 0.479 . . . . 55.33 110.101 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.95 168.86 24.97 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.432 -0.804 . . . . 54.14 109.564 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.4 p -129.9 151.22 50.7 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.882 0.873 . . . . 42.13 109.499 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 80.7 p -143.68 128.13 17.94 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.373 1.069 . . . . 73.1 108.197 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -76.94 116.43 17.6 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.36 -0.607 . . . . 64.43 109.36 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 HD12 ' C' ' 83' ' ' ILE . 75.3 mt -89.64 -39.7 13.05 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.0 -0.741 . . . . 63.04 109.0 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 -175.49 5.43 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.646 -1.161 . . . . 71.53 110.432 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.24 116.93 5.9 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.661 -1.154 . . . . 71.33 109.85 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 61.97 20.11 11.28 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.369 1.068 . . . . 63.53 112.136 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.8 t -119.72 116.43 50.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.535 -0.913 . . . . 74.13 108.535 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.38 125.9 44.15 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.077 0.951 . . . . 74.3 109.059 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.451 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.0 tt0 -83.6 132.55 34.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.911 -1.144 . . . . 75.44 107.911 164.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 56.1 t -112.43 139.71 35.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.088 -1.078 . . . . 74.42 108.088 166.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.402 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 47.1 t -121.44 124.88 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.792 -0.818 . . . . 64.31 108.792 171.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' C' ' 107' ' ' PHE . 1.1 tm? -104.42 106.09 16.45 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.712 -1.218 . . . . 61.33 107.712 172.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.517 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 0.8 OUTLIER -101.16 115.13 29.78 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.72 -1.127 . . . . 74.2 109.492 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.553 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.7 t -101.91 134.95 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.375 -0.972 . . . . 61.42 108.375 174.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -121.87 136.88 54.95 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.665 -0.865 . . . . 51.32 108.665 172.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.68 HG11 HD11 ' C' ' 126' ' ' LEU . 46.5 t -127.83 118.37 48.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 123.655 0.782 . . . . 65.42 109.329 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.453 HG23 HD23 ' C' ' 75' ' ' LEU . 3.2 m -102.53 144.63 30.71 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.011 -0.737 . . . . 64.43 109.011 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.17 114.22 9.0 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.391 -0.966 . . . . 71.15 108.391 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -131.2 142.33 50.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.413 0.685 . . . . 32.31 109.868 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.823 HD13 ' HG2' ' C' ' 34' ' ' LYS . 4.7 mt -94.34 16.81 14.14 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.949 1.3 . . . . 74.11 110.779 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.27 -87.71 0.35 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.78 -1.328 . . . . 62.41 109.78 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.53 -26.68 8.93 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.133 0.973 . . . . 72.44 110.567 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -82.77 119.0 23.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.707 0.803 . . . . 71.01 109.344 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -73.83 127.14 32.03 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.601 -0.518 . . . . 62.1 109.601 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.761 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.13 -54.76 7.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.162 -0.681 . . . . 63.44 109.162 173.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -169.28 173.39 6.69 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.335 -0.848 . . . . 74.23 110.924 176.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.453 HD23 HG23 ' C' ' 65' ' ' THR . 3.1 tm? -142.82 112.8 7.04 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.22 -1.4 . . . . 61.31 107.22 175.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -108.1 145.76 33.62 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.515 -0.92 . . . . 74.44 108.515 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -153.86 134.15 13.39 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.895 -0.78 . . . . 62.33 108.895 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 64.8 t -132.41 115.34 25.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.013 0.925 . . . . 75.41 108.898 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.517 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 57.8 mt-30 -93.53 89.9 6.46 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.32 -0.993 . . . . 64.34 108.32 174.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -86.7 102.16 13.96 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.152 0.581 . . . . 54.22 110.121 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.84 167.59 44.31 Favored Glycine 0 C--O 1.24 0.531 0 CA-C-O 121.175 0.319 . . . . 74.43 112.699 175.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -170.39 119.57 0.81 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.155 -0.778 . . . . 65.02 111.155 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.629 HD12 HD11 ' C' ' 51' ' ' LEU . 12.0 mm -82.9 132.35 31.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 109.129 -0.693 . . . . 74.21 109.129 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -134.28 119.89 19.28 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.322 0.649 . . . . 73.42 109.678 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 13.1 p -82.14 102.04 10.81 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.17 -1.048 . . . . 72.23 108.17 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.451 ' O ' HD12 ' C' ' 86' ' ' ILE . 2.5 pp -121.74 126.4 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 123.689 0.796 . . . . 74.32 110.982 -173.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.41 156.52 46.53 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.658 0.783 . . . . 65.34 109.899 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.42 -26.13 17.22 Favored Glycine 0 N--CA 1.476 1.314 0 N-CA-C 114.329 0.492 . . . . 71.12 114.329 172.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.626 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -87.28 145.81 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.056 0.543 . . . . 73.23 110.523 178.198 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.48 170.27 18.41 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.109 -0.95 . . . . 63.51 108.601 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.22 -119.27 6.86 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 124.118 0.887 . . . . 54.4 115.042 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 1.6 m -71.66 -32.35 67.79 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.641 1.176 . . . . 71.03 111.122 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.58 -43.16 90.64 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.466 0.707 . . . . 70.22 109.883 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 37.1 ttp -68.11 -40.73 82.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.17 -0.923 . . . . 74.41 110.593 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.8 -42.78 76.11 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 124.315 1.009 . . . . 61.42 110.697 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -83.14 -35.62 25.43 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.612 0.57 . . . . 63.11 111.956 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -58.0 -42.31 84.93 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.897 0.748 . . . . 64.1 110.62 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 21.9 mt -98.43 -24.91 14.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.266 -0.879 . . . . 63.22 110.686 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.61 -21.36 79.51 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.471 0.482 . . . . 55.45 114.174 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -158.26 -42.79 0.06 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.722 1.008 . . . . 75.45 113.722 -167.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.86 -46.63 74.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.915 0.486 . . . . 72.0 111.212 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.46 -49.06 54.3 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 124.254 1.022 . . . . 62.02 111.994 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -52.12 -34.44 58.15 Favored 'Trans proline' 0 C--N 1.399 3.186 0 C-N-CA 123.156 2.571 . . . . 62.0 114.654 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -60.23 -34.03 73.1 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.837 0.855 . . . . 71.11 111.722 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.474 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.9 mm -70.4 -37.33 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.183 0.593 . . . . 73.05 110.189 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.437 HD21 ' HA3' ' C' ' 82' ' ' GLY . 53.1 mt -87.73 -24.79 23.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.035 0.934 . . . . 72.53 112.587 -170.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.472 ' HA ' HD12 ' C' ' 60' ' ' LEU . 63.7 t80 -56.63 -48.74 96.64 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 117.812 -1.089 . . . . 74.04 113.853 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -55.33 -38.03 94.12 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 122.388 2.059 . . . . 72.21 113.234 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -67.25 -46.29 74.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.696 0.798 . . . . 74.02 110.467 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.43 ' O ' HG13 ' C' ' 114' ' ' ILE . . . -63.14 -38.99 93.35 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.669 -0.696 . . . . 74.35 110.878 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -57.25 -49.41 76.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.731 1.212 . . . . 65.21 111.079 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.63 -37.6 82.71 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 123.603 0.564 . . . . 60.33 110.084 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.3 t -68.18 -29.58 68.48 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.087 0.555 . . . . 73.05 111.443 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.553 HD11 ' HB ' ' C' ' 62' ' ' VAL . 74.1 mt -71.28 -50.45 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 108.949 -0.76 . . . . 53.34 108.949 172.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.532 HG21 ' HB3' ' B' ' 119' ' ' SER . 23.2 m -58.64 -35.12 72.01 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.679 0.792 . . . . 64.11 111.179 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.0 t -67.0 -54.14 24.63 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 123.813 0.845 . . . . 74.43 109.124 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.642 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.24 -38.71 80.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.487 1.115 . . . . 71.24 112.89 -177.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' C' ' 123' ' ' PHE . 67.1 t -65.98 -46.28 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.75 0.82 . . . . 72.41 110.165 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.471 ' OG ' HG21 ' B' ' 115' ' ' THR . 45.1 t -71.12 -24.12 62.22 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.617 -0.72 . . . . 73.14 111.582 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -69.44 -44.08 72.01 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.546 -0.909 . . . . 60.23 108.546 173.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.67 -1.59 72.34 Favored Glycine 0 C--N 1.357 1.744 0 O-C-N 123.712 0.632 . . . . 74.32 112.901 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 26.7 p 60.65 37.2 19.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.656 1.982 . . . . 64.11 113.359 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.458 ' HB2' HG13 ' C' ' 118' ' ' VAL . 91.4 m-85 -89.37 162.75 36.06 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-N 115.199 -0.909 . . . . 70.2 108.702 166.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.27 167.59 7.5 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.88 2.387 . . . . 75.44 113.301 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -51.66 131.69 30.19 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.706 1.202 . . . . 73.43 112.836 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.68 HD11 HG11 ' C' ' 64' ' ' VAL . 3.8 tt -136.3 85.08 2.12 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.306 -0.861 . . . . 63.35 108.918 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -95.48 124.22 39.41 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.818 -1.179 . . . . 54.52 107.818 171.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.05 134.9 47.44 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 108.487 -0.931 . . . . 71.42 108.487 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.5 152.39 34.32 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.311 1.044 . . . . 75.54 112.19 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.481 ' HG3' HD12 ' A' ' 16' ' ' ILE . 35.7 Cg_exo -56.33 92.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 122.566 2.177 . . . . 63.23 112.407 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.401 HG11 HD13 ' C' ' 44' ' ' LEU . 54.8 t -98.57 109.86 24.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 108.833 -0.803 . . . . 64.11 108.833 177.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -93.44 88.54 5.98 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.124 -1.436 . . . . 74.23 107.124 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -58.07 -32.79 68.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.495 0.718 . . . . 73.24 110.647 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.551 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 16.0 t70 -61.0 -39.03 88.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.878 0.871 . . . . 52.12 111.395 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.2 -39.22 71.91 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.244 0.617 . . . . 44.41 110.948 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 97.2 mt -67.79 -33.82 75.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.814 0.845 . . . . 72.43 112.232 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.0 t80 . . . . . 0 N--CA 1.48 1.066 0 C-N-CA 122.434 0.294 . . . . 73.3 110.994 -177.315 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 C--O 1.236 0.385 0 N-CA-C 108.845 -0.798 . . . . 72.41 108.845 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -165.81 92.08 0.51 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.479 -1.304 . . . . 73.35 107.479 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -123.32 117.16 24.61 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.277 -1.379 . . . . 74.03 107.277 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.503 HG21 HD11 ' D' ' 16' ' ' ILE . 27.8 mt -65.89 117.28 6.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.511 0 N-CA-C 108.798 -0.815 . . . . 74.45 108.798 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -83.79 -32.94 25.1 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 123.628 0.58 . . . . 72.21 111.111 -170.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -178.73 129.05 0.11 Allowed 'General case' 0 C--N 1.363 1.188 0 O-C-N 123.032 0.207 . . . . 73.44 110.705 -167.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.503 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -108.53 136.06 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.313 -1.365 . . . . 62.21 107.313 166.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.455 ' HE1' HG13 ' D' ' 83' ' ' ILE . 29.9 p90 -158.7 162.91 37.22 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.972 0.795 . . . . 74.34 111.055 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 56.9 p -97.8 114.39 26.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.033 -0.985 . . . . 62.24 109.442 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.549 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.5 mtpt -80.13 -22.85 41.62 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.592 -0.731 . . . . 75.43 109.786 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.2 t70 -163.04 139.49 7.27 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.755 -1.111 . . . . 52.12 109.236 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.642 HG21 ' HE2' ' C' ' 117' ' ' MET . 77.3 mt -134.9 146.67 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.565 1.146 . . . . 54.11 108.539 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -146.34 125.2 12.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.706 0.802 . . . . 74.54 109.801 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.498 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 80.7 t80 -123.85 132.65 53.8 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 106.889 -1.522 . . . . 64.01 106.889 163.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 41.6 mt-10 -131.82 134.9 46.29 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.033 -0.729 . . . . 72.11 109.033 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.73 82.29 68.98 Favored Pre-proline 0 C--O 1.242 0.703 0 N-CA-C 106.076 -1.824 . . . . 74.45 106.076 168.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.57 -36.02 35.49 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.515 2.143 . . . . 75.22 111.751 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -105.76 11.21 32.3 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.106 0.962 . . . . 72.13 110.684 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.477 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -18.53 -72.65 0.02 OUTLIER Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 116.287 1.958 . . . . 61.22 116.287 -166.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.479 ' HB3' HD11 ' C' ' 83' ' ' ILE . 49.1 Cg_endo -79.02 -16.42 12.52 Favored 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 123.771 2.383 . . . . 65.11 114.078 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -76.45 -37.45 56.94 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.431 1.093 . . . . 74.51 109.793 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.743 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.4 p -83.51 -23.94 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 116.108 -0.496 . . . . 71.35 111.642 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -67.46 -18.16 64.97 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 122.537 0.335 . . . . 71.01 111.811 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -57.76 -29.66 64.98 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.303 1.041 . . . . 74.33 110.778 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -95.41 91.8 6.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.981 0.913 . . . . 72.14 109.279 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.56 70.92 10.35 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 122.531 1.157 . . . . 72.12 109.296 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -130.92 161.43 31.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.287 -1.324 . . . . 75.24 108.269 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.99 107.9 2.04 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.121 0.968 . . . . 74.33 109.411 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.472 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 35.5 Cg_exo -61.72 122.33 10.86 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.206 2.604 . . . . 74.04 112.667 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 40.8 tt0 -57.0 114.94 2.33 Favored 'General case' 0 C--N 1.359 0.995 0 O-C-N 124.092 0.87 . . . . 74.05 110.025 -177.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.3 135.27 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.525 0.73 . . . . 72.2 111.556 -170.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -114.19 132.63 56.03 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 106.975 -1.491 . . . . 72.55 106.975 170.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.87 129.59 55.07 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.086 0.554 . . . . 72.0 110.161 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.578 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 17.5 t70 -112.92 128.83 56.58 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.634 1.174 . . . . 64.55 108.864 173.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 41.2 tp -98.92 133.45 43.19 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.542 -0.54 . . . . 71.11 109.542 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.3 t0 -153.52 155.8 36.89 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.734 -1.209 . . . . 55.24 107.734 174.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.7 t -145.96 169.27 18.96 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 122.909 0.484 . . . . 74.23 110.116 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.588 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.05 166.56 33.11 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.711 1.204 . . . . 74.42 108.521 173.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.412 ' HB2' ' CE2' ' D' ' 56' ' ' TYR . 64.9 p -173.25 153.24 2.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.885 0.474 . . . . 64.45 111.058 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 45.5 p -168.78 143.29 3.18 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.317 1.047 . . . . 73.43 109.654 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -83.8 125.25 31.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.137 0.575 . . . . 72.4 110.333 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.0 mt -96.13 -35.36 11.36 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.266 0.626 . . . . 72.12 111.298 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -155.12 -177.21 6.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.064 0.545 . . . . 61.03 110.71 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.37 120.25 8.41 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 123.91 0.756 . . . . 72.25 109.914 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.54 3.52 1.5 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.114 1.366 . . . . 75.41 112.521 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 92.6 t -109.78 119.45 58.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.141 -1.059 . . . . 72.33 108.141 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' D' ' 48' ' ' SER . 28.6 t80 -134.41 131.24 37.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.407 -0.815 . . . . 75.34 108.969 -173.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.451 ' HB2' HD11 ' D' ' 51' ' ' LEU . 17.3 tt0 -96.64 132.26 42.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.625 -0.716 . . . . 54.23 109.189 173.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.428 HG11 ' HD3' ' D' ' 103' ' ' PRO . 64.0 t -116.6 125.46 73.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.225 -1.398 . . . . 74.32 107.225 167.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 44.1 t -102.64 138.54 26.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.862 -0.792 . . . . 71.42 108.862 172.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.2 127.23 54.05 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.619 -1.252 . . . . 72.43 107.619 170.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.529 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 3.9 tmm_? -111.42 95.95 5.82 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.831 -1.174 . . . . 75.31 107.831 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 65.7 t -96.51 132.83 39.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.006 -0.997 . . . . 64.1 108.967 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 16.7 m -127.39 133.91 49.97 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.283 0.563 . . . . 74.14 109.502 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.02 102.41 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.534 1.533 . . . . 72.34 107.999 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 42.1 m -105.32 98.37 8.08 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.851 0.86 . . . . 60.43 109.448 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -104.72 149.86 25.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.856 0.462 . . . . 70.44 111.033 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.45 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 53.3 p -147.5 134.5 20.3 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.604 -0.725 . . . . 55.22 110.556 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.555 HD12 HG22 ' D' ' 31' ' ' VAL . 27.3 mt -98.76 110.94 23.46 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.308 -0.997 . . . . 72.22 108.308 174.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.76 -112.66 4.37 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 123.634 0.584 . . . . 73.25 112.812 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.94 16.8 16.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.407 1.083 . . . . 73.14 110.409 -172.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -141.22 155.33 46.05 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.466 0.706 . . . . 54.24 109.366 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -68.06 138.3 55.7 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 120.949 0.404 . . . . 64.33 110.527 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.743 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.96 -68.84 0.76 Allowed 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.535 -0.913 . . . . 62.11 108.535 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 74' ' ' PHE . . . . . 0.469 ' HZ ' HD13 ' D' ' 126' ' ' LEU . 50.2 p90 -152.96 149.24 28.0 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.61 -0.723 . . . . 73.22 110.252 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.6 mt -119.05 119.45 34.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.333 1.053 . . . . 73.52 108.234 175.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.449 ' SG ' ' HD1' ' D' ' 23' ' ' PHE . 1.3 m -121.9 104.92 9.89 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.167 0.987 . . . . 53.01 109.692 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -127.19 120.8 29.63 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.407 -0.96 . . . . 60.42 108.407 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -131.88 126.34 56.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 109.616 -0.512 . . . . 43.1 109.616 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.529 ' HG2' ' HG2' ' D' ' 61' ' ' ARG . 52.1 mt-30 -88.41 81.5 7.2 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.15 -1.056 . . . . 73.44 108.15 168.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.56 92.4 5.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.316 -1.311 . . . . 64.13 109.194 -178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.89 147.17 20.24 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.843 -0.617 . . . . 52.23 112.18 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.512 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.2 129.29 3.84 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 111.321 -0.712 . . . . 41.42 111.321 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.455 HG13 ' HE1' ' D' ' 17' ' ' TYR . 48.2 mt -93.78 140.47 16.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.066 0.946 . . . . 73.14 108.55 173.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -139.86 132.03 28.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.541 0.736 . . . . 72.21 109.018 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.6 m -87.5 94.91 9.84 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.633 -0.877 . . . . 72.23 108.633 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.411 HD12 ' SG ' ' D' ' 97' ' ' CYS . 2.3 tt -126.68 139.31 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 124.56 1.144 . . . . 75.3 110.103 -173.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.93 168.39 26.9 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.525 0.73 . . . . 70.34 111.752 -173.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.1 22.37 65.8 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 115.397 -0.819 . . . . 31.52 113.9 174.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.82 144.03 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.006 0.923 . . . . 55.31 110.665 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -142.64 161.88 36.93 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.856 0.862 . . . . 73.13 111.385 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.41 -122.39 29.67 Favored Glycine 0 C--N 1.355 1.597 0 O-C-N 124.606 1.191 . . . . 74.44 115.075 169.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.1 p -67.64 -26.18 66.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.807 0.843 . . . . 74.32 111.443 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -80.76 -38.68 28.18 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.193 0.597 . . . . 61.43 111.667 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 28.0 ptm -68.19 -34.61 76.6 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.471 -0.566 . . . . 74.42 109.471 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.74 -45.77 85.06 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.108 0.563 . . . . 64.22 110.245 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 11.4 t-80 -60.35 -44.51 95.49 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.655 1.182 . . . . 75.33 111.658 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 97' ' ' CYS . . . . . 0.411 ' SG ' HD12 ' D' ' 86' ' ' ILE . 16.2 t -76.14 -45.09 35.31 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.862 -173.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.61 -33.28 28.0 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.335 0.495 . . . . 72.15 112.335 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.21 -0.04 54.26 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 119.542 -0.588 . . . . 75.14 113.994 -173.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.447 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -141.99 -61.11 0.46 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.45 0.625 . . . . 74.24 111.429 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 101' ' ' TYR . . . . . 0.45 ' O ' HG12 ' D' ' 105' ' ' ILE . 72.6 t80 -66.21 -41.03 90.69 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.879 0.472 . . . . 71.1 112.202 -174.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.44 -45.87 19.24 Favored Pre-proline 0 CA--C 1.559 1.31 0 CA-C-O 118.277 -0.868 . . . . 53.3 111.091 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HD3' HG11 ' D' ' 58' ' ' VAL . 86.5 Cg_exo -53.27 -33.74 66.78 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 122.358 2.039 . . . . 52.11 113.438 166.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -35.29 79.18 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.441 0.697 . . . . 64.11 110.038 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.45 HG12 ' O ' ' D' ' 101' ' ' TYR . 40.7 mm -70.34 -36.15 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.092 0.957 . . . . 75.32 110.733 174.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.512 HD21 ' HA3' ' D' ' 82' ' ' GLY . 96.5 mt -78.73 -21.09 48.58 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.851 0.86 . . . . 75.52 112.276 -176.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -66.77 -42.4 43.98 Favored Pre-proline 0 CA--C 1.562 1.414 0 CA-C-O 117.939 -1.029 . . . . 73.45 113.515 -172.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.44 -39.41 87.79 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 122.163 1.909 . . . . 73.41 113.133 170.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -74.8 -36.74 62.46 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.721 0.808 . . . . 71.44 111.872 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.85 73.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.222 -0.658 . . . . 73.04 109.222 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.431 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.6 ttp180 -57.47 -45.14 85.14 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 114.17 -1.377 . . . . 74.43 110.668 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.93 -51.76 62.94 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.944 0.778 . . . . 75.33 111.652 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -55.62 -40.71 72.49 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 123.822 0.701 . . . . 71.33 110.591 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.448 ' O ' HG23 ' D' ' 118' ' ' VAL . 54.9 mt -64.36 -53.5 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.836 1.254 . . . . 65.31 111.407 174.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.9 m -59.08 -36.77 75.66 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.356 1.062 . . . . 71.11 111.037 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -65.78 -44.32 86.14 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.885 -1.052 . . . . 74.23 109.842 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 66.0 mtm -69.34 -29.84 67.75 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.825 0.45 . . . . 75.52 111.9 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' D' ' 123' ' ' PHE . 76.0 t -64.36 -47.85 87.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.585 0.754 . . . . 72.33 110.049 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.5 p -69.71 -34.24 73.62 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.081 -0.509 . . . . 75.21 110.71 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -68.72 -33.05 73.28 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.637 0.775 . . . . 53.02 110.293 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.98 11.04 73.34 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.67 0.606 . . . . 74.05 112.636 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 63.9 p 57.33 32.16 21.31 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 126.044 1.738 . . . . 73.53 114.53 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.468 ' HB2' HG13 ' D' ' 118' ' ' VAL . 98.5 m-85 -95.89 150.8 37.8 Favored Pre-proline 0 N--CA 1.478 0.941 0 N-CA-C 108.323 -0.991 . . . . 64.41 108.323 168.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -59.94 147.37 93.03 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.659 2.239 . . . . 54.22 111.375 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -60.25 142.12 55.04 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 124.05 0.844 . . . . 73.54 112.794 -166.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.469 HD13 ' HZ ' ' D' ' 74' ' ' PHE . 0.8 OUTLIER -122.81 104.73 9.47 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.4 1.08 . . . . 64.13 109.263 -175.44 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -124.3 95.06 4.4 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.698 0.799 . . . . 71.35 109.665 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.35 139.38 54.21 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.803 -0.443 . . . . 62.41 109.803 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.73 136.94 93.04 Favored Pre-proline 0 CA--C 1.549 0.936 0 O-C-N 123.815 0.697 . . . . 45.22 109.669 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -68.09 133.01 27.59 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.271 1.981 . . . . 72.43 110.244 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.88 131.94 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.251 -0.648 . . . . 75.01 109.251 -170.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -77.64 89.81 3.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.745 -0.835 . . . . 54.31 108.745 172.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -64.01 -28.71 69.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.653 0.781 . . . . 63.53 111.297 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 134' ' ' ASP . . . . . 0.447 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 2.0 m-20 -56.83 -55.88 28.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.295 1.438 . . . . 65.44 112.966 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.95 -47.23 87.39 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.279 0.632 . . . . 72.34 111.446 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 mp -66.31 -29.16 69.32 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.86 -1.064 . . . . 54.1 111.36 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 85.4 t80 . . . . . 0 N--CA 1.477 0.875 0 C-N-CA 124.038 0.935 . . . . 72.31 111.265 179.492 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 90.9 m . . . . . 0 C--O 1.24 0.563 0 N-CA-C 109.21 -0.663 . . . . 75.01 109.21 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.586 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.3 t80 -137.44 135.14 36.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.804 -0.813 . . . . 75.42 108.804 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -150.08 117.46 6.08 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.084 -1.08 . . . . 52.32 108.084 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.455 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.6 mt -80.87 118.24 28.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.813 -0.81 . . . . 71.51 108.813 175.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.9 -40.54 31.96 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.851 -0.796 . . . . 64.01 108.851 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -169.47 145.96 3.32 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.48 -0.327 . . . . 73.22 110.845 -176.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.536 HD12 ' HG3' ' C' ' 130' ' ' PRO . 84.4 mt -129.55 136.25 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 124.303 1.041 . . . . 73.15 108.726 172.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -169.53 177.81 4.45 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.017 0.927 . . . . 74.34 111.029 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -99.66 123.62 44.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.316 -0.624 . . . . 61.23 109.316 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -84.27 -28.86 26.89 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 110.011 -0.366 . . . . 74.21 110.011 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -152.75 146.27 24.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.502 -0.772 . . . . 74.5 109.692 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.06 142.44 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.391 1.476 . . . . 55.44 107.045 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -149.89 144.29 25.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.047 0.451 . . . . 75.11 110.181 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.58 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 92.7 t80 -150.21 129.42 12.79 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.888 -1.523 . . . . 62.54 106.888 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.62 127.83 39.76 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.608 0.763 . . . . 64.21 109.247 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.496 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -132.36 79.81 64.76 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 107.156 -1.424 . . . . 73.41 107.156 171.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.25 -16.6 24.89 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.485 2.123 . . . . 70.41 111.364 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -107.44 13.89 26.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.699 1.199 . . . . 75.41 109.533 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.496 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -57.18 -45.71 99.9 Favored Pre-proline 0 CA--C 1.569 1.685 0 N-CA-C 114.258 1.207 . . . . 72.24 114.258 -170.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.62 -24.12 18.95 Favored 'Trans proline' 0 C--N 1.388 2.624 0 C-N-CA 121.818 1.679 . . . . 70.42 113.243 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -91.21 -21.88 20.9 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.62 0.768 . . . . 75.11 112.031 -171.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.465 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 12.0 p -69.77 -28.57 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.646 0.779 . . . . 72.05 111.722 -175.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -68.12 -36.21 79.36 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.828 0.851 . . . . 72.15 110.761 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -77.26 -46.45 23.06 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.328 -0.851 . . . . 74.33 111.346 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.603 ' NZ ' ' HG3' ' A' ' 71' ' ' GLU . 64.9 pttt -76.26 164.64 25.86 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.563 0.345 . . . . 74.23 110.165 176.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.98 141.21 36.19 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.869 0.467 . . . . 70.43 110.223 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -79.13 99.31 6.91 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.485 0.714 . . . . 65.42 109.593 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 35.6 tt0 -149.97 67.05 8.32 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.1 -0.704 . . . . 65.23 109.1 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.62 158.98 9.24 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.711 2.274 . . . . 65.41 113.162 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -94.67 99.68 11.75 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.194 -1.41 . . . . 71.41 107.194 170.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.4 m -78.06 93.72 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 114.576 -1.193 . . . . 65.33 110.816 -173.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 56.2 mttm -91.17 113.41 25.67 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.477 -1.238 . . . . 52.32 108.41 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.7 tp -116.67 119.01 34.15 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.145 -0.687 . . . . 71.34 109.145 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -130.06 151.05 51.02 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.64 0.776 . . . . 72.34 109.302 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.62 HD23 HG22 ' A' ' 62' ' ' VAL . 3.0 tm? -132.26 141.1 48.88 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.707 0.803 . . . . 64.41 109.208 -173.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.416 ' H ' HD22 ' A' ' 44' ' ' LEU . 32.3 t70 -135.47 119.71 17.78 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.264 1.026 . . . . 62.53 109.145 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.2 m -111.72 130.17 55.87 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.126 0.97 . . . . 74.5 109.122 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.93 152.47 51.06 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.512 -0.921 . . . . 62.11 108.512 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.2 t -125.78 152.07 45.89 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.651 -0.5 . . . . 74.42 109.651 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 t -150.65 133.12 15.61 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.921 0.889 . . . . 61.33 109.084 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -77.85 131.45 37.54 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.501 -0.555 . . . . 73.34 109.501 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.437 HD12 HG23 ' A' ' 83' ' ' ILE . 70.8 mt -107.12 -41.98 5.0 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.865 0.866 . . . . 74.21 109.705 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.87 -175.01 4.64 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.678 -1.146 . . . . 74.21 109.272 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.69 114.11 3.11 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.427 0.691 . . . . 65.25 110.457 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.75 12.67 7.84 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.414 1.086 . . . . 74.24 112.105 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.1 t -101.68 112.56 35.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 124.909 1.284 . . . . 71.5 107.92 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -125.17 126.7 45.66 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.718 0.807 . . . . 71.02 109.292 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -101.94 126.91 48.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.74 -1.118 . . . . 75.11 108.477 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 m -100.89 133.33 44.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.99 -1.115 . . . . 73.05 107.99 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.62 110.68 26.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 107.972 -1.122 . . . . 63.14 107.972 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.0 tp -90.51 98.41 11.76 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.042 -0.725 . . . . 73.54 109.042 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.8 ttp85 -95.81 100.87 12.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.635 0.774 . . . . 64.22 109.712 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.62 HG22 HD23 ' A' ' 44' ' ' LEU . 12.3 t -97.15 117.29 41.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.219 -1.03 . . . . 75.04 108.219 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.0 t -107.55 141.89 38.29 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.734 0.778 . . . . 53.41 109.936 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 59.0 t -131.29 109.34 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.755 1.622 . . . . 41.32 107.641 -173.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 26.7 m -110.65 107.73 17.41 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.793 -0.818 . . . . 54.55 108.793 175.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.63 104.69 14.05 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 106.996 -1.483 . . . . 72.33 106.996 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.8 p -149.56 127.79 12.08 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.691 0.396 . . . . 74.3 110.569 -172.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -90.12 84.55 6.13 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.886 -0.783 . . . . 73.42 108.886 177.247 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.38 -104.8 1.81 Allowed Glycine 0 C--N 1.35 1.307 0 CA-C-N 115.065 -0.97 . . . . 61.54 112.283 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -97.28 -5.23 37.19 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.587 0.755 . . . . 74.45 110.314 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.603 ' HG3' ' NZ ' ' A' ' 34' ' ' LYS . 36.1 tp10 -112.22 94.65 5.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.606 1.162 . . . . 64.34 108.97 -169.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -71.45 138.41 49.0 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.424 0.289 . . . . 65.31 111.273 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.28 -59.45 2.25 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.944 0.898 . . . . 43.42 108.943 173.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -157.41 174.9 14.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.306 -0.861 . . . . 62.42 111.324 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -140.55 138.82 34.79 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.176 1.39 . . . . 75.25 107.896 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.493 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.9 m -141.28 139.51 33.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.96 0.904 . . . . 61.45 109.064 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -150.74 122.5 8.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.206 0.457 . . . . 44.54 109.826 174.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.3 t -122.35 132.85 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 123.875 0.87 . . . . 72.14 109.592 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -109.01 86.75 2.34 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.357 1.063 . . . . 74.03 108.293 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -79.09 103.18 8.85 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.96 -1.018 . . . . 71.14 108.462 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.39 142.84 16.38 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 111.368 -0.693 . . . . 65.33 111.368 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.546 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -140.61 123.51 2.38 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 111.142 -0.783 . . . . 30.21 111.142 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.437 HG23 HD12 ' A' ' 51' ' ' LEU . 44.1 mt -80.69 118.45 28.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.838 -0.801 . . . . 75.34 108.838 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.586 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 42.1 m-85 -125.22 119.35 28.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.887 0.475 . . . . 74.02 109.901 -176.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 m -86.82 105.0 16.71 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.845 -0.798 . . . . 63.4 108.845 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.554 ' HB ' HD11 ' A' ' 89' ' ' ILE . 43.5 pt -107.23 143.92 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.434 0.694 . . . . 73.4 110.75 -175.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.595 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -156.84 156.51 33.31 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.973 0.909 . . . . 74.32 109.778 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.0 7.04 87.63 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.897 0.719 . . . . 71.24 114.897 173.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.554 HD11 ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -122.31 156.21 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 108.686 -0.857 . . . . 54.22 108.686 172.543 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -157.61 173.95 16.09 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.242 0.617 . . . . 63.11 109.359 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.46 -136.64 47.38 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.514 0.509 . . . . 64.32 114.153 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -80.71 -16.14 54.69 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.537 0.735 . . . . 74.51 111.215 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' A' ' 96' ' ' HIS . 35.4 tt0 -67.64 -36.45 80.8 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.002 0.921 . . . . 52.25 109.598 171.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 34.2 ttp -76.83 -33.23 57.94 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.905 -1.043 . . . . 73.44 110.922 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -28.31 69.19 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.034 0.445 . . . . 71.54 110.583 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.409 ' HB3' ' O ' ' A' ' 93' ' ' GLN . 50.3 t-80 -64.57 -37.02 86.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.355 -0.839 . . . . 73.44 110.526 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 64.1 m -64.75 -35.74 82.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 122.871 0.469 . . . . 75.04 110.87 177.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 tt -72.96 -49.92 26.4 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.088 0.555 . . . . 71.23 109.983 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.15 4.8 52.28 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 115.059 0.784 . . . . 73.34 115.059 -165.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -145.57 -65.95 0.31 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.188 0.994 . . . . 62.3 112.201 -175.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.565 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 69.0 t80 -69.33 -66.6 0.56 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.927 -1.033 . . . . 62.41 113.402 -166.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.451 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 85.8 m -67.6 -35.06 7.46 Favored Pre-proline 0 CA--C 1.566 1.571 0 N-CA-C 114.079 1.14 . . . . 64.3 114.079 -174.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 27.9 Cg_endo -62.76 -30.15 77.76 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 122.015 1.81 . . . . 65.21 112.91 168.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -71.72 -27.86 63.3 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.091 0.556 . . . . 75.12 110.982 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.6 mm -59.31 -41.96 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-O 121.441 0.639 . . . . 74.13 109.872 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.546 HD21 ' HA3' ' A' ' 82' ' ' GLY . 84.1 mt -83.34 -16.24 46.89 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.035 -0.984 . . . . 73.13 112.581 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.79 -43.53 69.63 Favored Pre-proline 0 CA--C 1.561 1.366 0 N-CA-C 113.819 1.044 . . . . 74.12 113.819 -172.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -59.6 -37.55 87.65 Favored 'Trans proline' 0 C--N 1.387 2.574 0 CA-C-N 121.745 1.659 . . . . 64.24 112.7 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -69.89 -43.03 72.6 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.579 -0.737 . . . . 74.32 111.284 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.23 -39.24 82.37 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.13 0.572 . . . . 55.02 110.573 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.546 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.8 ttm180 -49.75 -55.1 15.23 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.645 1.215 . . . . 61.4 109.887 174.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -66.64 -44.09 82.9 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.055 -0.975 . . . . 71.5 111.569 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.1 t -60.43 -26.17 66.52 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.09 0.556 . . . . 63.12 111.844 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' A' ' 62' ' ' VAL . 95.6 mt -83.25 -52.23 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.75 0.82 . . . . 75.34 109.759 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.4 m -54.88 -50.88 67.62 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.818 0.847 . . . . 45.24 111.631 -173.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 47.1 t -59.6 -45.18 92.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.745 -1.116 . . . . 44.21 110.441 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 45.6 ttp -68.66 -35.05 76.72 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.073 0.949 . . . . 74.24 111.695 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.66 -41.26 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.096 0.958 . . . . 74.32 109.785 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.7 m -72.56 -24.41 61.11 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.334 -0.848 . . . . 70.12 111.467 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.45 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.8 mtt-85 -73.76 -30.95 63.07 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.521 0.729 . . . . 63.32 109.665 174.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.06 -1.64 80.28 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.658 -0.701 . . . . 41.01 112.637 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.8 m 69.16 21.0 7.4 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 125.161 1.384 . . . . 71.32 111.223 175.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.15 158.71 69.37 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 115.274 -0.875 . . . . 71.34 109.335 170.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.55 144.97 91.06 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.277 1.985 . . . . 72.02 111.54 173.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -59.35 134.53 57.09 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.621 0.768 . . . . 75.23 111.92 -173.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -117.32 102.46 9.27 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.211 -0.904 . . . . 70.42 109.803 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -102.03 108.04 19.35 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.12 -1.067 . . . . 73.14 108.12 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.16 117.34 10.68 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.066 -0.716 . . . . 64.41 109.066 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.33 139.14 96.39 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 122.841 0.456 . . . . 51.21 110.883 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -53.04 106.66 0.16 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.04 2.494 . . . . 74.13 111.877 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.46 133.06 42.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.578 0.704 . . . . 65.24 109.293 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -82.04 71.93 9.09 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.462 -1.245 . . . . 60.2 112.126 -170.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.509 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 35.2 m-85 -53.68 -41.05 66.47 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.612 0.765 . . . . 70.33 111.582 177.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 138' ' ' MET . 7.0 m-20 -68.85 -42.05 77.63 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.007 -0.997 . . . . 63.01 111.401 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.02 81.09 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.073 0.549 . . . . 62.53 110.981 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.53 -38.41 80.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.738 -1.119 . . . . 74.41 110.511 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -73.82 -37.64 64.81 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.539 -0.755 . . . . 65.44 110.347 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 20.1 mmt . . . . . 0 N--CA 1.491 1.622 0 C-N-CA 123.357 0.663 . . . . 74.55 111.551 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 72.3 m . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 108.041 -1.096 . . . . 74.42 108.041 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.34 157.63 44.59 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.73 0.3 . . . . 73.11 110.798 163.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -123.03 121.4 35.98 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 107.634 -1.247 . . . . 75.53 107.634 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 36.2 mt -71.71 119.87 18.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.572 -0.899 . . . . 74.13 108.572 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.542 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 13.3 mm100 -82.54 -39.33 22.49 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.185 -0.916 . . . . 72.53 109.913 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.5 ttt85 -174.06 134.89 0.45 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.101 -0.954 . . . . 74.31 109.583 -174.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -114.69 140.01 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 106.623 -1.621 . . . . 71.54 106.623 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -166.63 155.39 10.59 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.465 0.65 . . . . 64.04 111.639 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.402 HG21 HD11 ' B' ' 21' ' ' ILE . 96.2 m -83.19 127.01 33.24 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.684 -1.144 . . . . 71.03 109.059 171.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.467 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.0 mtpt -98.4 -22.22 16.17 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.68 0.792 . . . . 73.12 110.916 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -164.65 137.58 4.81 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 123.423 0.452 . . . . 42.04 110.86 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.452 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.2 mm -127.0 144.94 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.796 1.238 . . . . 70.42 109.276 173.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.474 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.1 t -145.04 138.88 27.03 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.464 -1.244 . . . . 74.52 107.66 174.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -153.98 123.03 6.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.277 -1.379 . . . . 72.12 107.277 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -124.21 138.22 54.43 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.144 -0.687 . . . . 75.34 109.144 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.31 83.87 64.05 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 106.723 -1.584 . . . . 73.35 106.723 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.15 -36.42 29.13 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.026 2.484 . . . . 74.12 112.998 -169.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -105.37 17.15 24.43 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.366 0.666 . . . . 60.33 110.588 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.629 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -36.28 -65.76 0.3 Allowed Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 115.002 1.482 . . . . 70.11 115.002 -164.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 23.1 Cg_exo -62.5 -24.99 75.61 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 122.527 2.151 . . . . 75.33 113.05 -174.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.457 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 63.4 m80 -95.25 -28.65 14.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.869 -1.06 . . . . 72.21 112.291 -173.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.745 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.2 p -78.85 -20.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 120.952 0.406 . . . . 73.25 111.34 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -67.75 -11.89 59.38 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.309 0.855 . . . . 62.31 113.309 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.9 pt20 -63.89 -34.48 78.05 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.016 0.527 . . . . 72.43 110.804 176.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -83.86 101.43 11.65 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.581 0.752 . . . . 73.14 109.582 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -85.51 90.08 7.87 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.092 -0.707 . . . . 74.33 109.092 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -157.85 158.46 35.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.706 1.202 . . . . 73.51 108.363 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -83.37 103.24 2.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.214 1.006 . . . . 73.35 108.476 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.89 135.37 66.38 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.373 2.715 . . . . 60.21 113.496 -168.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.3 125.8 25.05 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 123.908 0.755 . . . . 71.43 109.487 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.45 128.21 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.579 0.752 . . . . 60.35 112.078 -165.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -107.52 129.66 54.94 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.584 1.154 . . . . 53.53 108.458 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.5 146.67 23.61 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.314 -0.995 . . . . 65.44 108.314 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 21.9 t70 -140.21 112.31 7.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.342 -0.985 . . . . 73.21 108.342 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 74.0 mt -100.16 149.9 23.06 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.737 -0.468 . . . . 74.52 109.737 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' B' ' 61' ' ' ARG . 20.6 t70 -153.19 114.82 4.25 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.714 0.805 . . . . 74.04 109.275 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -110.38 114.41 27.84 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.209 0.604 . . . . 71.42 110.39 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.67 155.38 30.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.388 1.075 . . . . 21.41 108.729 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.3 p -144.19 164.45 30.68 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.439 0.296 . . . . 72.42 110.939 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -158.1 139.03 13.12 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.542 0.737 . . . . 72.44 109.939 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -80.83 113.89 19.34 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.46 0.704 . . . . 63.53 109.786 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.02 -42.68 37.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.835 0.454 . . . . 60.02 110.619 176.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.6 -175.32 5.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.273 -0.876 . . . . 73.43 110.25 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.03 117.22 3.78 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.376 -0.829 . . . . 73.33 109.862 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 71.3 1.0 3.65 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.708 1.203 . . . . 75.11 112.494 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.403 HG22 ' OG ' ' B' ' 85' ' ' SER . 48.0 t -104.72 114.55 44.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 124.725 1.21 . . . . 62.04 107.927 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -123.29 140.57 52.88 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.039 -1.097 . . . . 74.1 108.039 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -116.12 107.47 14.95 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.353 -1.351 . . . . 74.23 107.353 -174.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 99.3 t -89.22 143.37 11.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 C-N-CA 124.467 1.107 . . . . 73.01 109.461 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.408 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 36.5 t -125.95 128.64 72.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.543 -0.91 . . . . 60.22 108.543 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -114.1 108.02 16.43 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.8 -1.185 . . . . 73.02 107.8 -177.682 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.499 ' HD2' ' HB3' ' B' ' 45' ' ' ASP . 38.1 ttm180 -93.44 123.59 36.84 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.676 -0.49 . . . . 74.33 109.676 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.455 ' HB ' HD11 ' B' ' 114' ' ' ILE . 44.2 t -118.29 103.12 14.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.284 -1.376 . . . . 62.14 107.284 168.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 15.7 m -98.33 126.52 43.87 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.967 -0.753 . . . . 53.31 108.967 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.496 HG21 HG21 ' B' ' 114' ' ' ILE . 58.0 t -113.75 120.2 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 123.975 0.91 . . . . 71.24 109.774 -176.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 77.9 m -109.74 135.74 50.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.631 -0.877 . . . . 63.15 108.631 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.27 142.88 27.66 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.278 0.631 . . . . 74.24 109.599 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.456 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 37.1 p -148.05 137.09 22.02 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.223 -0.444 . . . . 71.41 111.999 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.672 HD12 HG22 ' B' ' 31' ' ' VAL . 39.1 mt -96.2 104.83 16.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.039 0.936 . . . . 74.23 110.053 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.2 -113.46 5.9 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.151 -0.932 . . . . 54.31 113.143 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -107.98 21.89 16.75 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.713 0.805 . . . . 74.51 110.945 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -140.77 157.77 44.92 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.755 -0.591 . . . . 62.35 109.854 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 38.1 m -73.54 135.42 43.97 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.805 -0.443 . . . . 64.45 109.805 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.745 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -90.99 -66.2 0.95 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.56 -1.274 . . . . 64.11 107.56 174.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -150.18 161.87 41.57 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.844 0.83 . . . . 61.24 110.689 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.0 149.85 50.24 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.946 1.698 . . . . 60.52 106.76 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.429 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 48.6 t -154.91 159.82 40.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.551 -0.537 . . . . 70.23 109.551 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.474 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 38.7 tt0 -164.44 129.58 2.76 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.486 -0.931 . . . . 42.12 108.486 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 78.7 t -124.2 142.24 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 107.993 -1.114 . . . . 74.35 107.993 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -123.03 84.47 2.27 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.15 -1.055 . . . . 72.52 108.15 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.536 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 47.9 tp60 -80.27 100.42 8.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.731 -1.122 . . . . 73.44 109.215 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.467 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -89.77 165.8 32.31 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.415 -0.674 . . . . 42.02 111.415 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.426 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -166.01 134.41 3.28 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.154 -0.779 . . . . 61.02 111.154 -175.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 24.5 mt -97.87 127.35 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.955 0.902 . . . . 71.04 108.727 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -131.78 133.66 44.98 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 107.793 -1.188 . . . . 74.03 107.793 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.403 ' OG ' HG22 ' B' ' 55' ' ' VAL . 40.4 m -110.76 94.27 4.91 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.593 -0.521 . . . . 74.43 109.593 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.49 ' HB ' HD11 ' B' ' 89' ' ' ILE . 32.5 pt -95.88 138.42 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.396 0.678 . . . . 72.51 111.65 -167.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.54 149.87 33.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.386 1.074 . . . . 64.14 109.299 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.29 -31.21 8.92 Favored Glycine 0 N--CA 1.473 1.131 0 C-N-CA 123.256 0.455 . . . . 71.11 112.821 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.49 HD11 ' HB ' ' B' ' 86' ' ' ILE . 9.7 pt -91.48 151.22 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.787 0.835 . . . . 61.34 111.7 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.96 148.83 17.44 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.655 -1.157 . . . . 73.22 108.749 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.17 -132.85 13.96 Favored Glycine 0 C--N 1.343 0.96 0 O-C-N 123.352 0.407 . . . . 62.23 112.608 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.4 m -74.54 -20.5 59.94 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.197 0.599 . . . . 71.11 112.183 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -59.87 -45.05 93.71 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.721 0.772 . . . . 61.42 109.804 170.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.49 ' HA ' HD12 ' B' ' 89' ' ' ILE . 9.8 tmm? -72.43 -38.07 68.44 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.37 -1.287 . . . . 64.53 110.57 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.0 -40.58 70.26 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.552 0.691 . . . . 70.24 110.593 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -71.38 -41.8 69.21 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.586 -1.188 . . . . 72.34 111.346 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.2 t -66.51 -60.1 3.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.955 0.502 . . . . 74.51 111.394 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.86 -41.18 78.78 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.824 0.849 . . . . 72.34 110.305 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.11 -34.39 41.87 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.318 0.387 . . . . 74.43 114.045 -171.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.43 -50.72 1.76 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 112.545 0.572 . . . . 62.13 112.545 -168.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -73.78 -35.78 64.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.692 0.797 . . . . 71.54 112.22 -171.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 97.1 m -70.83 -48.53 14.97 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 123.228 0.611 . . . . 71.04 111.053 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.485 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 75.3 Cg_exo -55.36 -34.82 90.17 Favored 'Trans proline' 0 C--N 1.399 3.232 0 C-N-CA 122.272 1.982 . . . . 65.41 113.542 168.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -58.72 -39.56 81.21 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.657 0.783 . . . . 75.12 110.758 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.61 -41.4 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.963 0.905 . . . . 72.1 110.791 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.426 HD21 ' HA3' ' B' ' 82' ' ' GLY . 59.8 mt -81.26 -16.15 53.47 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.683 0.793 . . . . 74.11 112.098 -173.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -61.8 -47.95 90.6 Favored Pre-proline 0 CA--C 1.558 1.285 0 N-CA-C 113.987 1.106 . . . . 74.32 113.987 -171.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.07 -34.46 89.9 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 121.744 1.63 . . . . 72.33 113.054 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.536 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 88.3 m-85 -65.05 -46.8 79.73 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.507 0.504 . . . . 73.24 110.32 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.6 96.92 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.532 0.733 . . . . 71.22 110.585 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -57.74 -55.93 28.54 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.203 1.001 . . . . 64.3 110.688 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.06 -34.56 77.85 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.866 0.728 . . . . 74.41 110.489 -175.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' B' ' 117' ' ' MET . 2.7 t -69.96 -38.07 76.01 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.029 -0.532 . . . . 51.43 111.18 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.496 HG21 HG21 ' B' ' 64' ' ' VAL . 72.5 mt -65.73 -54.84 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.29 0.636 . . . . 70.12 109.665 174.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.9 m -61.6 -26.46 67.99 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 124.215 0.947 . . . . 52.41 111.647 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.6 t -61.73 -55.57 28.86 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.476 0.711 . . . . 75.32 109.199 171.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -66.45 -33.73 76.36 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.693 0.797 . . . . 72.52 111.716 -174.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.8 t -59.49 -48.65 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.048 0.939 . . . . 73.41 110.272 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.727 ' HB2' HE21 ' C' ' 125' ' ' GLN . 13.0 t -76.37 -21.0 56.63 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.277 -0.874 . . . . 71.2 111.216 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.7 mtt-85 -67.65 -41.71 83.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.852 -0.796 . . . . 72.15 108.852 172.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.7 -0.47 80.53 Favored Glycine 0 C--N 1.36 1.879 0 O-C-N 123.767 0.667 . . . . 61.44 113.018 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 62.33 42.26 9.36 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.762 2.025 . . . . 72.34 113.061 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -97.65 159.66 30.51 Favored Pre-proline 0 CA--C 1.56 1.346 0 C-N-CA 124.04 0.936 . . . . 75.22 110.158 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -62.74 178.41 1.0 Allowed 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.516 2.81 . . . . 63.24 114.637 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.62 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 6.6 tp-100 -66.17 114.94 5.66 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.875 -1.057 . . . . 62.51 112.491 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 7.4 mp -116.76 91.31 3.55 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.145 -0.687 . . . . 73.34 109.145 167.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ASN . . . . . 0.448 HD21 ' HA ' ' C' ' 122' ' ' THR . 77.8 m-20 -92.5 107.1 18.96 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.155 -1.054 . . . . 73.32 108.155 170.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 18.4 tp -71.71 126.02 28.62 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 123.64 0.587 . . . . 74.42 110.677 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.06 144.55 98.83 Favored Pre-proline 0 CA--C 1.55 0.954 0 O-C-N 124.702 1.251 . . . . 65.02 110.96 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.442 ' HG3' HD11 ' D' ' 16' ' ' ILE . 28.2 Cg_endo -61.67 112.39 1.46 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.239 2.626 . . . . 72.35 111.396 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.29 107.26 17.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 106.136 -1.801 . . . . 44.2 106.136 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -82.46 82.2 7.99 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 107.236 -1.394 . . . . 74.43 107.236 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -63.69 -27.59 69.32 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.695 -1.139 . . . . 74.54 110.068 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.43 -44.05 92.4 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.225 1.41 . . . . 63.1 111.424 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.32 -39.63 78.1 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.547 0.739 . . . . 53.25 110.322 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 85.7 mt -72.83 -23.84 60.82 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.381 -0.827 . . . . 61.32 110.734 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 51.3 t80 . . . . . 0 N--CA 1.48 1.026 0 C-N-CA 124.002 0.921 . . . . 73.44 110.889 -179.803 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 98.4 m . . . . . 0 C--O 1.241 0.608 0 N-CA-C 107.642 -1.244 . . . . 74.14 107.642 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.435 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.2 t80 -124.99 119.29 28.3 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.916 -1.142 . . . . 74.04 107.916 171.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -141.02 125.21 17.37 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 107.25 -1.389 . . . . 73.15 107.25 170.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.469 HD13 HD11 ' C' ' 16' ' ' ILE . 61.2 mt -74.35 120.53 23.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.103 -0.703 . . . . 31.33 109.103 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.564 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 16.3 mm-40 -86.94 -35.24 19.0 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.808 -1.087 . . . . 71.4 109.454 -176.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -174.16 147.79 1.26 Allowed 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.659 0.599 . . . . 63.44 109.987 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.469 HD11 HD13 ' C' ' 13' ' ' ILE . 92.1 mt -138.39 134.66 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.871 -1.159 . . . . 74.1 107.871 174.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.462 ' HB3' HG23 ' D' ' 122' ' ' THR . 34.0 p90 -171.59 168.94 6.21 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.602 0.715 . . . . 71.33 111.728 -169.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -93.28 114.68 27.19 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.217 -0.901 . . . . 72.43 109.034 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.406 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 10.2 mmmm -68.82 -39.82 79.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.037 0.922 . . . . 73.24 108.875 168.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.0 t70 -145.33 140.18 27.55 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 113.991 -1.459 . . . . 71.54 109.819 -173.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 81.2 mt -135.25 145.92 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.504 -1.665 . . . . 65.44 106.504 170.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -156.59 149.12 23.51 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.008 0.432 . . . . 73.54 110.242 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -141.97 131.11 23.33 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.705 -1.22 . . . . 72.22 107.705 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -135.28 115.9 13.79 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.507 1.123 . . . . 73.01 108.046 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' C' ' 28' ' ' ALA . . . -108.32 91.8 8.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 105.195 -2.15 . . . . 64.32 105.195 167.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.02 -36.52 97.98 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.244 2.629 . . . . 73.42 112.942 -167.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -125.41 43.16 3.12 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.762 -1.108 . . . . 73.14 108.915 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.472 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -42.61 -60.68 2.06 Favored Pre-proline 0 CA--C 1.568 1.671 0 N-CA-C 115.213 1.56 . . . . 72.03 115.213 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 19.2 Cg_exo -62.35 -39.14 48.82 Favored 'Trans proline' 0 C--N 1.391 2.801 0 CA-C-N 122.02 1.757 . . . . 72.11 112.088 -178.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -68.76 -33.77 74.45 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.033 -1.44 . . . . 73.52 111.991 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.914 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.5 p -81.82 -27.54 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 122.947 0.499 . . . . 70.11 111.99 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -68.24 -34.19 75.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.738 0.415 . . . . 74.01 111.758 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -86.55 7.06 27.77 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 122.894 0.477 . . . . 72.44 111.299 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.91 170.2 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.88 0.872 . . . . 73.41 109.944 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.45 129.25 37.89 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.676 0.791 . . . . 74.32 110.377 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 31.3 t90 -79.97 88.37 5.34 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.861 0.865 . . . . 74.34 110.186 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.487 ' H ' HD22 ' C' ' 68' ' ' LEU . 0.6 OUTLIER -144.35 73.39 15.88 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 107.353 -1.351 . . . . 73.43 107.353 174.177 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -76.67 119.05 5.03 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.05 2.5 . . . . 75.51 113.698 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.63 88.12 7.32 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.95 -1.5 . . . . 64.35 106.95 166.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.1 136.73 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 114.36 -1.291 . . . . 72.31 110.17 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -128.82 110.27 12.0 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.2 1.0 . . . . 75.21 108.864 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.78 122.56 29.3 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.146 -1.057 . . . . 70.34 108.146 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -120.23 132.05 55.19 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.101 -1.074 . . . . 75.21 108.101 174.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.58 HD21 ' HE1' ' C' ' 133' ' ' PHE . 15.3 tp -125.5 152.61 44.75 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.666 -0.865 . . . . 70.04 108.666 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.4 t70 -151.66 147.95 27.35 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.871 0.869 . . . . 70.32 108.982 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -146.22 133.2 20.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.82 0.848 . . . . 72.11 109.691 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.45 161.75 36.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.636 1.174 . . . . 64.31 107.978 171.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 16.7 m -138.55 151.58 47.44 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.866 -0.79 . . . . 74.12 108.866 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 17.9 p -142.19 128.62 20.08 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.733 0.813 . . . . 73.34 109.263 -170.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -73.88 118.26 16.63 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.728 -0.669 . . . . 62.14 110.146 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' C' ' 57' ' ' GLU . 32.8 mt -92.5 -31.69 15.15 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.081 -0.711 . . . . 64.3 109.081 172.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.85 -179.38 7.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.394 1.078 . . . . 75.52 110.457 176.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -62.87 119.11 8.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.214 -0.903 . . . . 64.33 109.467 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 7.1 m-20 65.32 17.98 11.19 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.226 1.011 . . . . 71.1 112.234 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 74.1 t -124.41 115.65 45.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 108.218 -1.03 . . . . 61.42 108.218 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -128.82 131.48 47.74 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.935 0.894 . . . . 75.43 109.5 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.608 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.3 tt0 -83.75 114.94 21.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.775 -1.102 . . . . 71.41 108.135 166.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.47 HG11 ' HD3' ' C' ' 103' ' ' PRO . 76.2 t -96.03 137.87 22.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.671 -0.863 . . . . 41.25 108.671 173.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.95 131.8 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.171 -1.048 . . . . 72.42 108.171 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.458 HD21 HD11 ' C' ' 44' ' ' LEU . 1.0 OUTLIER -121.12 104.57 9.87 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.212 -1.403 . . . . 64.51 107.212 176.292 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.491 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 2.7 ttm180 -93.94 121.89 35.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.426 -1.261 . . . . 73.34 108.954 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.8 t -116.11 120.41 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.729 -1.212 . . . . 61.1 107.729 174.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 29.4 m -124.34 114.2 19.22 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.985 0.914 . . . . 63.2 108.714 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.642 HG11 HD11 ' C' ' 126' ' ' LEU . 43.8 t -107.56 120.1 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.857 -0.794 . . . . 73.43 108.857 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.4 m -104.54 150.6 24.48 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.669 -0.863 . . . . 75.34 108.669 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 66' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' C' ' 73' ' ' ALA . . . -141.86 137.16 31.23 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.361 -0.977 . . . . 73.42 108.361 172.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.2 m -145.1 133.47 21.8 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.23 0.612 . . . . 71.34 110.132 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.487 HD22 ' H ' ' C' ' 37' ' ' GLN . 18.2 mt -85.28 53.78 2.87 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.643 1.177 . . . . 54.11 108.999 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.82 -87.05 0.55 Allowed Glycine 0 C--N 1.342 0.867 0 N-CA-C 110.111 -1.195 . . . . 45.23 110.111 -167.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -125.55 -13.74 6.47 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.124 0.97 . . . . 51.51 111.664 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -76.24 116.59 17.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.253 0.621 . . . . 61.02 109.721 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.5 m -74.85 122.26 23.1 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.416 0.553 . . . . 71.15 110.083 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.914 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.89 -61.9 1.73 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.788 -1.096 . . . . 71.45 108.709 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -155.03 173.95 15.86 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 114.574 -1.193 . . . . 54.33 111.768 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.51 139.59 26.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 104.958 -2.238 . . . . 62.42 104.958 169.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.9 t -149.04 111.55 4.74 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.026 -0.731 . . . . 72.42 109.026 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -117.84 127.39 53.82 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.0 0.52 . . . . 73.41 109.82 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.97 114.03 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.137 0.975 . . . . 73.42 108.6 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.539 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 74.1 mt-30 -92.34 91.0 7.48 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.864 -0.791 . . . . 71.34 108.864 173.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.468 ' HG3' HD22 ' C' ' 106' ' ' LEU . 7.9 tp-100 -80.95 99.71 8.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.122 -0.945 . . . . 71.3 109.76 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.8 145.61 17.86 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.786 -0.526 . . . . 74.33 111.786 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.14 133.22 4.28 Favored Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 110.775 -0.93 . . . . 74.04 110.775 -175.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.595 HD12 HD11 ' C' ' 51' ' ' LEU . 8.7 mm -87.52 120.57 36.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 108.452 -0.944 . . . . 63.54 108.452 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.435 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 63.1 m-85 -127.79 126.22 41.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.455 0.702 . . . . 40.13 109.184 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 59.2 p -82.81 122.95 28.88 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.596 -0.89 . . . . 72.33 108.596 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.621 ' HB ' HD11 ' C' ' 89' ' ' ILE . 47.0 pt -117.24 142.36 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.892 0.877 . . . . 72.14 109.983 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.54 159.4 21.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.73 0.812 . . . . 62.34 109.194 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.04 -38.19 3.16 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 121.401 0.445 . . . . 72.11 113.27 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.621 HD11 ' HB ' ' C' ' 86' ' ' ILE . 1.8 pp -78.72 149.13 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.258 1.023 . . . . 73.33 109.079 175.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.587 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 11.4 tp10 -146.17 146.02 30.68 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.968 0.507 . . . . 72.43 110.384 -172.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.34 -111.57 2.14 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 124.039 0.837 . . . . 64.12 113.903 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 7.1 m -63.7 -34.61 78.25 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.283 1.033 . . . . 75.43 111.219 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.587 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 38.8 mt-30 -70.85 -32.6 69.66 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.857 0.863 . . . . 75.22 111.158 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.452 ' SD ' HD12 ' C' ' 98' ' ' LEU . 17.4 tmm? -73.86 -43.78 57.52 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.689 -0.485 . . . . 63.21 109.689 176.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.65 70.64 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.224 -0.898 . . . . 73.3 110.806 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -67.49 -46.29 73.37 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.347 1.059 . . . . 70.44 110.651 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.574 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 44.7 t -64.4 -40.41 95.75 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 123.905 0.753 . . . . 72.13 111.157 -176.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.483 HD21 HD13 ' C' ' 86' ' ' ILE . 77.0 mt -90.27 -34.65 15.67 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.648 0.61 . . . . 72.24 112.648 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.87 -7.19 64.69 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-O 119.619 -0.545 . . . . 44.42 114.363 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.22 -55.22 0.16 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.718 0.771 . . . . 54.45 111.697 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.574 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 55.7 t80 -67.79 -35.73 79.18 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.326 1.45 . . . . 73.42 112.526 -172.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 35.1 m -80.52 -43.74 1.33 Allowed Pre-proline 0 N--CA 1.485 1.294 0 CA-C-O 118.924 -0.56 . . . . 74.04 112.377 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.47 ' HD3' HG11 ' C' ' 58' ' ' VAL . 72.9 Cg_exo -50.33 -30.74 27.56 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.871 2.38 . . . . 72.31 114.257 166.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -60.95 -39.4 89.39 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.296 1.038 . . . . 75.44 110.334 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.546 HD12 ' NH1' ' A' ' 111' ' ' ARG . 40.8 mm -72.03 -40.3 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.719 0.807 . . . . 74.44 110.461 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.468 HD22 ' HG3' ' C' ' 80' ' ' GLN . 83.6 mt -78.93 -23.54 44.61 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.23 1.012 . . . . 74.52 112.644 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -59.67 -50.79 85.16 Favored Pre-proline 0 CA--C 1.556 1.173 0 N-CA-C 114.021 1.119 . . . . 61.15 114.021 -172.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.5 -35.44 96.74 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.088 1.859 . . . . 72.24 113.11 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -68.41 -50.04 55.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.587 0.755 . . . . 74.13 110.981 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.84 -37.44 84.48 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.532 -0.758 . . . . 73.11 111.042 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -58.15 -55.19 38.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.906 1.282 . . . . 72.24 110.817 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -66.97 -29.5 69.37 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.228 0.611 . . . . 75.12 110.58 -176.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.436 ' SG ' HG12 ' C' ' 21' ' ' ILE . 34.5 t -73.23 -32.19 64.6 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.23 0.612 . . . . 72.2 111.542 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' C' ' 62' ' ' VAL . 86.1 mt -71.23 -46.28 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.42 0.688 . . . . 74.22 109.483 172.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 23.1 m -61.34 -36.33 79.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.775 0.83 . . . . 70.13 111.33 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 37.7 t -60.19 -49.62 76.92 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.336 -0.847 . . . . 65.23 109.416 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.506 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.59 -32.62 74.3 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.586 1.155 . . . . 74.53 113.078 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' C' ' 123' ' ' PHE . 53.0 t -74.81 -35.39 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.437 0.695 . . . . 63.22 110.522 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 36.7 t -67.9 -35.86 79.2 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.576 0.75 . . . . 71.12 110.857 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' C' ' 116' ' ' SER . 71.7 mtt-85 -67.66 -43.76 79.48 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.435 -0.802 . . . . 73.33 109.613 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.87 1.21 84.88 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 123.737 0.648 . . . . 54.34 112.857 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.448 ' HA ' HD21 ' B' ' 127' ' ' ASN . 67.3 p 62.83 25.5 15.11 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.337 1.855 . . . . 52.31 114.823 167.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.468 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.8 m-85 -84.71 157.4 60.86 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 108.75 -0.833 . . . . 73.01 108.75 167.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.62 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 79.9 Cg_exo -51.61 142.28 40.51 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.93 2.42 . . . . 74.13 113.364 175.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.727 HE21 ' HB2' ' B' ' 119' ' ' SER . 14.7 mm100 -55.78 138.19 48.36 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.375 1.047 . . . . 71.41 113.015 -172.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.642 HD11 HG11 ' C' ' 64' ' ' VAL . 8.2 tt -104.58 114.79 29.24 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.5 -1.227 . . . . 71.14 108.778 -173.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -119.02 100.0 7.08 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.785 -0.821 . . . . 73.13 108.785 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.91 135.47 46.54 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.494 0.717 . . . . 75.34 109.946 -175.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.68 153.25 91.21 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.997 0.919 . . . . 63.22 111.411 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.536 ' HG3' HD12 ' A' ' 16' ' ' ILE . 31.6 Cg_exo -58.48 109.25 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.254 1.97 . . . . 54.33 112.06 172.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 91.0 t -96.28 110.73 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.031 -1.47 . . . . 70.51 107.031 173.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -83.01 94.1 7.7 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.916 -1.142 . . . . 74.44 107.916 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.58 ' HE1' HD21 ' C' ' 44' ' ' LEU . 84.8 m-85 -63.25 -38.79 92.54 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.151 0.98 . . . . 72.04 111.881 -175.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.21 -37.24 80.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.905 0.882 . . . . 74.34 111.35 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.93 -27.89 43.77 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.967 0.507 . . . . 70.01 110.373 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 54.0 tp -74.61 -26.25 59.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.257 0.623 . . . . 61.31 110.218 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 68.9 t80 . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 123.917 0.887 . . . . 74.53 111.775 -175.918 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 40.4 m . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 109.2 -0.667 . . . . 64.13 109.2 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.518 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 54.7 t80 -164.22 89.82 0.56 Allowed 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.013 -1.847 . . . . 72.44 106.013 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -128.41 130.67 47.99 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.725 -0.843 . . . . 74.42 108.725 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -90.83 110.98 22.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.123 -1.066 . . . . 52.25 108.123 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -73.86 -31.27 63.09 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.295 0.372 . . . . 74.24 110.711 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -168.68 131.68 1.4 Allowed 'General case' 0 C--N 1.349 0.547 0 O-C-N 123.268 0.355 . . . . 64.24 110.669 -169.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.477 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.0 mp -116.36 128.75 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 105.846 -1.909 . . . . 75.12 105.846 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.437 ' HE1' HG13 ' D' ' 83' ' ' ILE . 40.3 p90 -156.2 160.41 39.81 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.053 0.93 . . . . 71.21 112.477 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -91.33 118.43 30.51 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 113.738 -1.574 . . . . 73.42 108.887 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.0 mtpt -82.3 -37.37 25.89 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.632 -0.713 . . . . 63.25 109.404 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -150.24 139.06 20.85 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.106 -1.406 . . . . 61.1 109.125 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.506 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.9 mt -137.92 147.75 25.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.919 1.287 . . . . 74.15 108.118 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.6 t -148.15 126.23 12.11 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.622 0.769 . . . . 75.1 109.48 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.537 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 66.6 t80 -121.19 133.19 55.17 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.205 -1.406 . . . . 75.03 107.205 164.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.718 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.7 mt-10 -134.84 136.7 42.66 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.34 1.056 . . . . 72.24 108.343 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.21 83.74 63.12 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.46 -1.311 . . . . 51.13 107.46 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.92 -52.95 2.41 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.05 2.5 . . . . 63.4 112.967 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.577 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 5.1 m-20 -102.18 19.69 18.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.287 0.635 . . . . 62.32 109.64 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.499 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -23.85 -75.24 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 116.535 2.05 . . . . 64.41 116.535 -167.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.447 ' HB3' HD11 ' C' ' 83' ' ' ILE . 83.8 Cg_endo -77.28 -16.7 15.31 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 124.033 2.476 . . . . 64.32 113.539 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.435 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 0.2 OUTLIER -71.16 -44.45 65.49 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.209 1.004 . . . . 44.51 108.557 172.83 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' D' ' 27' ' ' ASN . 9.8 p -82.63 -20.74 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.466 0.706 . . . . 72.12 111.351 -168.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.84 -14.14 62.71 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.61 0.364 . . . . 63.14 111.599 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -67.27 -14.48 62.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.703 0.801 . . . . 71.22 110.925 174.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.423 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 97.4 mttt -97.79 101.63 13.18 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.855 1.262 . . . . 75.13 109.202 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -85.38 93.07 8.64 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.314 -0.625 . . . . 72.32 109.314 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -162.52 156.95 21.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.704 0.801 . . . . 72.45 109.192 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -76.52 105.45 2.33 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.386 -0.968 . . . . 72.5 108.386 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.05 124.97 17.16 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.002 2.468 . . . . 73.44 112.316 -170.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.52 114.83 4.62 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.864 0.727 . . . . 64.33 109.827 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.405 HG21 HD11 ' D' ' 126' ' ' LEU . 27.5 m -102.29 149.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.877 0.871 . . . . 73.4 112.018 -171.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' D' ' 64' ' ' VAL . 46.1 tptt -120.7 120.36 35.46 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.1 1.36 . . . . 71.51 107.866 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.5 HD21 HD12 ' D' ' 128' ' ' LEU . 7.2 mp -97.85 121.06 39.31 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.077 -0.712 . . . . 73.45 109.077 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.577 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 14.6 t70 -108.61 120.48 42.58 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.117 -1.068 . . . . 72.1 108.117 170.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 tt -106.43 127.79 53.56 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.506 -0.924 . . . . 70.52 108.506 -174.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.2 t70 -134.97 148.19 49.94 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.339 1.056 . . . . 73.12 108.434 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -120.19 152.21 38.01 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.999 0.52 . . . . 64.1 109.626 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.98 171.21 17.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.371 1.068 . . . . 71.14 108.252 174.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -174.62 161.66 3.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.065 0.546 . . . . 72.2 110.939 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.7 p -159.22 147.81 18.05 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.381 0.672 . . . . 45.32 109.93 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -87.0 127.06 35.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.474 -0.565 . . . . 74.1 109.474 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 67.6 mt -97.86 -38.62 9.37 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.289 0.635 . . . . 74.55 110.862 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.75 -173.74 4.66 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.567 0.747 . . . . 61.01 110.566 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.91 105.51 1.04 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.02 -0.991 . . . . 63.42 110.444 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 68.36 18.98 9.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.915 1.286 . . . . 71.2 111.554 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -110.77 123.08 66.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 N-CA-C 107.454 -1.313 . . . . 71.44 107.454 167.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -136.86 129.77 30.76 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.255 -0.646 . . . . 75.21 109.255 -176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -91.13 144.38 25.69 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.214 1.005 . . . . 74.52 109.624 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.0 t -123.12 145.64 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.079 1.352 . . . . 72.43 107.629 171.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 45.6 t -127.53 144.91 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.096 0.958 . . . . 51.22 108.914 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -127.7 122.09 32.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.863 -1.162 . . . . 72.1 107.863 178.405 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 37.0 ttm-85 -102.63 97.48 7.67 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.483 -0.932 . . . . 74.04 108.483 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.14 104.25 15.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.339 -0.985 . . . . 74.04 108.339 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.3 m -97.9 146.36 25.54 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.263 -0.88 . . . . 72.11 108.842 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 53.8 t -140.37 109.03 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.397 1.079 . . . . 75.35 108.841 -177.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -102.57 110.8 22.85 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.72 -0.845 . . . . 72.34 108.72 171.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.0 157.24 17.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.033 0.533 . . . . 73.33 110.48 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 21.6 p -154.64 130.97 10.43 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.449 0.642 . . . . 62.24 112.01 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.471 HD12 HG22 ' D' ' 31' ' ' VAL . 25.1 mt -97.91 101.62 13.16 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.384 -1.28 . . . . 62.43 107.876 170.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.97 -123.22 7.29 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.599 -0.728 . . . . 63.41 112.591 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.75 5.63 48.95 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.304 0.642 . . . . 62.14 112.341 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.423 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 13.0 pt-20 -129.09 160.14 33.75 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.207 0.603 . . . . 73.1 109.801 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -67.17 139.46 57.45 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.565 0.541 . . . . 61.11 110.412 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.563 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -92.89 -65.25 1.01 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.324 -0.853 . . . . 74.33 108.952 175.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -145.93 167.76 22.51 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.144 -0.935 . . . . 74.22 109.641 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.718 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.0 mt -132.14 140.38 48.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.404 -1.332 . . . . 72.53 107.404 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.504 ' SG ' HG23 ' D' ' 114' ' ' ILE . 1.2 m -144.91 139.51 27.67 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.022 0.929 . . . . 64.21 108.717 -177.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -158.2 130.19 6.88 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.007 -0.738 . . . . 72.42 109.007 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 62.8 t -134.87 117.5 22.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 109.258 -0.645 . . . . 60.33 109.258 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -89.58 85.48 6.5 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.612 0.72 . . . . 70.1 109.072 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -80.02 101.5 8.72 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.211 -1.359 . . . . 72.42 109.541 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.87 160.69 23.34 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.416 -0.673 . . . . 22.4 111.416 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.45 132.91 3.66 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.118 -0.793 . . . . 61.31 111.118 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.437 HG13 ' HE1' ' D' ' 17' ' ' TYR . 64.7 mt -87.69 124.56 41.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.152 0.981 . . . . 75.13 108.361 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -122.66 123.7 41.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.413 0.285 . . . . 62.12 110.368 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 48.5 m -83.49 110.19 17.99 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.745 -1.205 . . . . 52.51 107.745 164.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.406 HG22 ' HA ' ' D' ' 11' ' ' PHE . 15.6 pt -130.25 145.31 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.909 0.884 . . . . 52.05 110.617 -170.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.28 167.46 25.87 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.863 0.865 . . . . 42.25 109.913 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.73 -18.89 13.14 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 114.285 0.474 . . . . 62.1 114.285 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 pt -112.2 126.89 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.848 0.859 . . . . 62.24 109.113 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.53 164.33 30.44 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.068 0.547 . . . . 72.44 110.676 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 91' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' D' ' 94' ' ' MET . . . 66.47 -129.29 30.93 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.582 0.552 . . . . 71.23 113.94 175.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.4 m -70.52 -29.4 65.88 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.501 0.721 . . . . 72.5 111.452 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.68 -43.57 98.48 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.978 0.911 . . . . 74.24 111.444 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' D' ' 91' ' ' GLY . 0.0 OUTLIER -73.67 -31.83 63.66 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 116.244 -0.434 . . . . 52.24 110.746 179.103 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.64 88.06 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.998 0.519 . . . . 73.41 111.063 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 12.6 t-80 -64.71 -31.79 73.17 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.786 0.835 . . . . 63.24 111.054 176.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.9 t -79.71 -49.6 11.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.516 0.326 . . . . 61.15 110.783 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.468 HD23 ' SG ' ' D' ' 102' ' ' CYS . 84.3 mt -79.28 -29.37 42.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.692 0.797 . . . . 73.35 112.238 -169.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.37 6.65 63.5 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 119.792 -0.449 . . . . 73.1 113.183 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -148.26 -67.94 0.23 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.258 0.529 . . . . 53.41 111.955 -177.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 101' ' ' TYR . . . . . 0.418 ' O ' HG12 ' D' ' 105' ' ' ILE . 66.9 t80 -64.86 -37.77 88.74 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 112.467 0.544 . . . . 74.51 112.467 -172.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.518 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 85.9 m -70.65 -48.47 16.28 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-O 118.599 -0.715 . . . . 44.21 111.461 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.481 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 75.2 Cg_exo -55.96 -33.18 88.39 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.013 1.809 . . . . 71.02 113.185 167.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.56 -35.71 81.64 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.251 0.621 . . . . 73.43 111.169 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.418 HG12 ' O ' ' D' ' 101' ' ' TYR . 36.6 mm -67.84 -40.09 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.601 0.76 . . . . 73.14 110.523 174.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.7 mt -79.04 -16.93 56.14 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.642 -0.708 . . . . 73.22 111.514 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.31 -41.32 24.24 Favored Pre-proline 0 N--CA 1.485 1.317 0 N-CA-C 114.437 1.273 . . . . 71.51 114.437 -172.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.45 -39.21 92.85 Favored 'Trans proline' 0 C--N 1.385 2.476 0 CA-C-N 121.769 1.667 . . . . 63.33 112.74 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -71.16 -40.46 71.28 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.52 0.728 . . . . 75.43 110.95 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.79 -44.59 96.63 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.875 0.87 . . . . 55.45 110.639 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.517 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 19.8 ttp180 -59.92 -53.5 57.11 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.335 -1.302 . . . . 64.15 110.198 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.47 -42.77 99.72 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.28 0.988 . . . . 72.55 111.724 -172.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.8 t -58.52 -40.55 83.22 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.688 0.618 . . . . 64.23 110.875 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.504 HG23 ' SG ' ' D' ' 76' ' ' CYS . 84.3 mt -66.95 -50.3 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.626 0.77 . . . . 52.13 110.622 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -54.91 -43.86 73.67 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.213 1.005 . . . . 70.24 111.529 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.7 t -66.91 -42.02 86.11 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.48 -1.237 . . . . 74.51 110.519 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.537 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 71.9 mtm -66.12 -37.35 85.5 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.856 0.463 . . . . 73.32 111.638 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.423 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.0 t -63.21 -44.57 99.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.117 0.967 . . . . 71.33 110.479 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -73.57 -31.02 63.39 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 116.038 -0.528 . . . . 71.2 111.381 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -71.82 -30.3 65.34 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.205 0.602 . . . . 65.32 110.094 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.97 11.38 69.38 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.715 0.635 . . . . 62.13 112.663 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.462 HG23 ' HB3' ' C' ' 17' ' ' TYR . 66.2 p 58.15 21.93 8.54 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 126.446 1.899 . . . . 71.55 114.244 175.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -84.32 147.85 51.23 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 108.818 -0.808 . . . . 61.43 108.818 169.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.5 135.22 47.51 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 123.067 2.512 . . . . 74.33 112.488 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -50.63 140.91 13.52 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.957 1.303 . . . . 71.42 113.003 -170.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.405 HD11 HG21 ' D' ' 40' ' ' VAL . 55.2 tp -122.34 100.87 7.18 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.44 0.696 . . . . 72.33 110.713 -176.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -99.67 101.16 12.26 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.093 -1.077 . . . . 63.1 108.093 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.517 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.7 mm? -69.23 114.27 7.34 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.338 0.655 . . . . 71.3 109.517 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.09 132.72 83.96 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.177 0.591 . . . . 72.01 111.414 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.463 ' HB3' HH12 ' D' ' 111' ' ' ARG . 58.6 Cg_endo -72.85 126.1 11.04 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.252 1.968 . . . . 71.13 111.185 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.82 141.79 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.797 0.839 . . . . 71.43 110.065 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -77.68 103.15 7.44 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.403 -0.962 . . . . 72.02 108.403 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -72.0 -40.56 68.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.801 0.441 . . . . 74.45 110.492 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.29 -53.46 56.53 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.905 0.882 . . . . 71.53 112.668 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.33 99.08 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.28 0.632 . . . . 63.31 111.165 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.41 -27.65 67.25 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.204 -0.907 . . . . 60.41 111.6 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 84.1 t80 . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 123.465 0.706 . . . . 73.24 110.423 177.607 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.24 0.589 0 N-CA-C 109.341 -0.614 . . . . 64.44 109.341 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.661 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 10.1 t80 -135.99 129.37 31.97 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.954 0.902 . . . . 75.24 108.607 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -149.68 127.56 11.82 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.706 0.803 . . . . 64.35 109.155 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.573 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.1 mt -95.34 119.21 43.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.896 -0.779 . . . . 72.54 108.896 173.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -88.69 -34.29 17.26 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 123.46 0.475 . . . . 70.43 110.184 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -166.87 126.16 1.45 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 116.414 -0.357 . . . . 70.33 111.141 -166.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.496 HD12 ' HG3' ' C' ' 130' ' ' PRO . 73.4 mt -120.3 138.51 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 124.37 1.068 . . . . 75.04 108.969 173.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -158.37 176.08 12.9 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.288 0.992 . . . . 71.1 111.511 -171.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.0 p -106.13 119.4 39.11 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.657 -1.238 . . . . 72.24 107.657 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -80.02 -48.58 13.09 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.841 -0.8 . . . . 71.2 108.841 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 22.7 m-20 -134.55 125.23 26.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.611 -1.177 . . . . 61.34 109.014 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 79.3 mt -117.62 144.28 25.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 106.775 -1.565 . . . . 61.0 106.775 173.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 43.2 t -152.41 142.16 21.95 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.102 0.477 . . . . 60.22 109.777 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 35.4 t80 -144.33 124.09 13.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.802 -1.555 . . . . 62.23 106.802 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.97 111.55 10.51 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.312 -0.996 . . . . 72.53 108.312 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.22 81.71 17.24 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.903 0.881 . . . . 74.41 109.274 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 72' ' ' THR . 22.0 Cg_exo -66.99 -14.46 43.76 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.077 2.518 . . . . 75.32 112.328 174.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.5 ' HB2' ' HA ' ' A' ' 73' ' ' ALA . 21.9 m-80 -117.35 30.15 7.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.853 0.861 . . . . 63.13 110.395 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.52 98.23 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 123.717 0.807 . . . . 53.3 113.006 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -85.12 -24.8 1.95 Allowed 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 121.644 1.563 . . . . 63.31 113.188 169.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.479 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 58.9 m170 -70.97 -34.72 71.7 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.123 0.569 . . . . 73.55 110.922 -173.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -55.86 -31.77 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.495 1.118 . . . . 72.44 112.388 -175.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.67 -32.82 70.22 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.652 0.781 . . . . 64.33 111.347 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -88.84 -45.2 9.93 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.132 0.973 . . . . 74.43 111.647 -174.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 16.1 ptpt -83.32 173.59 11.44 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.821 0.848 . . . . 72.14 111.548 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -74.27 142.7 45.24 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.565 0.746 . . . . 53.11 111.514 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -93.2 78.65 4.52 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.522 0.677 . . . . 70.33 109.832 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -125.86 79.98 67.83 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.363 -0.977 . . . . 74.43 108.363 169.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -84.15 136.23 6.72 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.354 2.036 . . . . 73.52 112.315 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -96.44 102.05 13.77 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.154 -1.424 . . . . 60.34 107.154 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.7 p -76.87 100.1 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 115.451 -0.795 . . . . 74.12 109.98 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 63.3 mttp -78.98 111.02 14.76 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.74 -1.208 . . . . 70.1 107.74 164.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.495 HD13 HG22 ' A' ' 64' ' ' VAL . 33.4 tp -109.48 133.31 53.23 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.895 -1.15 . . . . 71.42 107.895 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.408 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 24.4 t70 -135.93 129.42 32.18 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.91 -0.774 . . . . 75.41 108.91 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.2 mt -112.12 132.05 55.09 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.903 0.881 . . . . 73.5 109.013 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.76 147.73 52.46 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.709 0.803 . . . . 73.45 108.85 172.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.0 m -131.49 131.78 43.73 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.553 0.741 . . . . 53.22 109.825 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.82 154.34 50.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.144 0.978 . . . . 72.21 110.115 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 26.5 t -131.87 155.77 47.26 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.731 0.413 . . . . 73.41 110.284 174.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.7 p -148.76 141.21 24.27 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.572 0.749 . . . . 74.41 109.911 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -81.68 106.68 13.81 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.734 0.414 . . . . 74.35 110.479 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' A' ' 57' ' ' GLU . 34.1 mt -83.3 -36.3 24.58 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.263 -0.643 . . . . 71.11 109.263 173.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.82 177.27 11.6 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.765 1.226 . . . . 71.33 108.647 173.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -68.5 116.31 8.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.012 -0.736 . . . . 63.23 109.012 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 70.6 12.24 7.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.811 1.244 . . . . 75.1 112.476 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 42.8 t -120.38 112.41 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 107.71 -1.218 . . . . 65.12 107.71 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.81 134.43 45.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.464 0.706 . . . . 74.45 110.469 -169.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.6 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.5 tt0 -88.17 137.5 32.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.503 -0.925 . . . . 74.44 108.503 173.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.9 136.67 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.517 -1.29 . . . . 72.41 107.517 168.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.6 111.64 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.18 0.992 . . . . 71.13 108.69 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -92.23 102.3 14.81 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.168 -1.049 . . . . 65.21 108.168 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -84.33 106.76 16.19 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.002 -0.74 . . . . 75.3 109.002 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.404 HG11 HD11 ' A' ' 128' ' ' LEU . 43.0 t -104.35 103.97 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.834 -0.802 . . . . 54.32 108.834 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.59 HG22 ' HG3' ' A' ' 77' ' ' GLU . 74.9 p -100.35 111.96 24.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.487 0.715 . . . . 44.51 109.977 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.495 HG22 HD13 ' A' ' 42' ' ' LEU . 92.3 t -102.9 113.83 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.059 0.944 . . . . 74.14 108.858 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 10.8 m -116.66 105.62 12.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.741 -0.837 . . . . 75.12 108.741 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.27 106.36 18.01 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 106.378 -1.712 . . . . 71.42 106.378 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 p -149.29 128.67 12.97 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.822 0.702 . . . . 71.45 110.171 -168.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.6 tp -91.3 87.22 6.39 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.678 -0.86 . . . . 52.3 108.678 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.45 -93.31 1.86 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 114.849 -1.069 . . . . 33.14 111.724 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -113.62 -27.24 7.92 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.031 0.532 . . . . 73.4 111.526 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -79.58 106.62 11.75 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 122.421 0.288 . . . . 73.24 110.226 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.418 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 26.8 m -76.1 116.53 16.89 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.682 -0.69 . . . . 73.1 109.327 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . . . -68.03 -50.87 52.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.911 0.884 . . . . 72.43 108.768 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.463 ' HB2' ' HE1' ' A' ' 23' ' ' PHE . 47.3 p90 -156.78 147.58 21.74 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.982 -1.463 . . . . 74.33 109.863 173.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 53.8 tp -123.02 107.85 12.26 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 107.622 -1.251 . . . . 75.33 107.622 175.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.434 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 79.8 m -106.85 99.31 8.88 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.296 0.639 . . . . 72.32 109.729 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.59 ' HG3' HG22 ' A' ' 63' ' ' THR . 32.4 tt0 -115.08 118.28 32.94 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.901 0.88 . . . . 72.52 109.309 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.4 t -130.2 109.27 17.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.617 0.722 . . . . 74.33 109.459 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -86.44 80.26 8.72 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.137 -1.392 . . . . 71.25 108.147 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -76.93 111.65 12.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.875 -1.057 . . . . 73.3 108.622 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.17 144.07 17.03 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.829 -0.508 . . . . 71.31 111.829 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.0 145.11 15.55 Favored Glycine 0 C--O 1.236 0.247 0 N-CA-C 111.283 -0.727 . . . . 63.5 111.283 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.4 mt -81.32 123.38 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 108.488 -0.93 . . . . 73.21 108.488 173.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.661 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.1 m-85 -130.18 116.35 18.31 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.804 -0.813 . . . . 71.04 108.804 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.7 p -85.7 102.98 14.08 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.203 -1.036 . . . . 75.53 108.203 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.0 pt -115.36 130.98 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.908 0.883 . . . . 74.41 109.096 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.22 147.0 30.99 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.908 0.883 . . . . 55.15 109.963 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.66 1.56 57.58 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 115.007 0.763 . . . . 62.44 115.007 171.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.53 154.72 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 118.105 0.952 . . . . 74.53 111.369 -176.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.6 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 10.8 tt0 -155.02 -174.68 5.08 Favored 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 123.931 0.892 . . . . 64.4 109.3 173.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.6 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 73.2 -139.02 26.24 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 123.331 0.491 . . . . 63.42 114.188 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.1 p -73.88 -20.88 60.28 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.441 0.696 . . . . 62.21 111.233 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -66.48 -48.14 70.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.854 0.862 . . . . 61.11 110.114 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 91' ' ' GLY . 24.7 ptt? -70.03 -30.95 68.37 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 116.136 -0.484 . . . . 63.43 110.342 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.24 -34.55 77.69 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.158 0.583 . . . . 64.45 110.56 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -71.85 -35.88 69.97 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.39 -0.823 . . . . 65.03 110.11 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.502 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 49.9 t -66.88 -43.29 83.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.962 0.505 . . . . 72.13 111.346 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.83 -38.19 23.37 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.258 -0.428 . . . . 74.43 110.785 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.91 3.03 57.06 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 114.365 0.506 . . . . 65.4 114.365 -169.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -146.87 -60.24 0.29 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.182 0.491 . . . . 51.2 111.577 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.502 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 77.2 t80 -68.89 -49.56 57.2 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.25 1.02 . . . . 71.33 113.126 -166.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.08 -34.46 0.95 Allowed Pre-proline 0 CA--C 1.565 1.55 0 N-CA-C 113.513 0.931 . . . . 74.11 113.513 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.24 -21.11 55.39 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 121.601 1.534 . . . . 42.14 113.184 165.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 51.5 m-20 -62.1 -38.69 89.85 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 118.197 0.453 . . . . 73.31 110.211 169.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.0 mm -63.04 -45.37 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 O-C-N 124.004 0.815 . . . . 74.13 110.138 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.56 -20.13 51.27 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.01 0.924 . . . . 74.43 112.781 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -62.8 -45.32 87.65 Favored Pre-proline 0 CA--C 1.569 1.705 0 N-CA-C 113.719 1.007 . . . . 75.32 113.719 -173.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -63.71 -36.15 53.65 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.1 1.867 . . . . 64.01 113.459 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -71.11 -40.45 71.46 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.018 0.527 . . . . 72.42 111.156 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.62 -43.97 83.33 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.307 0.643 . . . . 72.2 110.003 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HG3' ' H ' ' A' ' 128' ' ' LEU . 38.1 ttm180 -51.59 -51.43 55.64 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.612 1.195 . . . . 62.44 110.509 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.22 -41.9 96.81 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.439 1.087 . . . . 74.21 111.556 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.17 -29.42 69.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 116.095 -0.502 . . . . 72.44 111.412 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.6 mt -78.63 -40.14 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.359 1.063 . . . . 61.44 110.331 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.467 HG23 ' HG3' ' A' ' 125' ' ' GLN . 34.4 m -66.53 -43.55 84.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.46 0.648 . . . . 75.4 110.638 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.5 t -64.43 -44.44 91.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.033 -0.985 . . . . 74.52 109.519 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.434 ' SD ' ' HA ' ' A' ' 76' ' ' CYS . 43.2 ttm -60.27 -46.53 89.48 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.229 1.012 . . . . 52.52 112.242 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 123' ' ' PHE . 7.2 p -69.71 -31.05 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.133 0.573 . . . . 62.45 110.616 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.2 m -77.06 -29.73 55.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.425 0.69 . . . . 71.41 111.213 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -70.77 -31.92 68.87 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.626 0.77 . . . . 74.44 109.832 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.23 -2.26 90.4 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-N 115.779 -0.646 . . . . 62.02 113.209 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.9 m 65.34 36.53 6.86 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-O 122.824 1.297 . . . . 73.21 110.939 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.473 ' HB2' HG22 ' A' ' 118' ' ' VAL . 95.9 m-85 -104.91 164.39 15.26 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.308 1.043 . . . . 63.23 108.904 171.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -59.59 153.35 55.83 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 122.322 2.014 . . . . 63.23 112.504 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.467 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.7 tt0 -63.77 139.12 58.74 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.447 0.699 . . . . 61.02 111.16 -177.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.6 tp -131.3 116.42 17.58 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.307 -0.861 . . . . 73.42 109.093 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -121.03 117.83 28.25 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.252 -1.018 . . . . 74.43 108.252 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.438 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 85.9 mt -59.78 122.32 13.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.312 0.645 . . . . 65.3 110.082 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -61.57 128.65 90.4 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-O 119.17 -0.443 . . . . 63.12 109.881 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 26.3 Cg_exo -64.18 100.23 0.31 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.657 2.238 . . . . 61.2 111.584 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.3 m -100.06 138.0 25.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-N 115.623 -0.717 . . . . 43.24 109.441 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -83.1 87.46 6.91 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.079 -0.964 . . . . 74.42 109.046 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.497 ' HA ' HD12 ' A' ' 136' ' ' LEU . 58.4 m-85 -56.03 -27.49 53.38 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.642 0.777 . . . . 74.31 112.559 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.21 -51.29 61.88 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.017 0.527 . . . . 72.05 110.25 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.52 85.63 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.007 0.817 . . . . 60.34 110.896 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 133' ' ' PHE . 61.1 mt -67.52 -38.68 84.62 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.159 0.983 . . . . 74.02 111.06 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.7 -38.54 86.94 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.716 -0.675 . . . . 74.45 109.495 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 19.8 mmt . . . . . 0 C--N 1.348 0.517 0 O-C-N 124.221 0.951 . . . . 61.2 110.34 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 87.1 m . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.457 -0.572 . . . . 64.41 109.457 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -129.52 137.64 50.9 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.588 -0.893 . . . . 72.12 108.588 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -149.92 130.79 14.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.084 -0.71 . . . . 72.14 109.084 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.453 HD11 HD13 ' B' ' 105' ' ' ILE . 20.6 mt -76.52 118.09 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.738 -1.208 . . . . 74.34 107.738 166.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -86.22 -49.36 7.77 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.665 -0.865 . . . . 72.22 108.665 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.411 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 74.1 ttt180 -164.99 138.27 4.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.867 -1.061 . . . . 72.21 109.069 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.9 mt -115.6 141.92 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.321 -0.992 . . . . 74.13 108.321 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -164.12 147.2 9.45 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.767 0.427 . . . . 73.21 111.321 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.698 HG21 HD11 ' B' ' 21' ' ' ILE . 24.5 m -78.57 130.45 35.95 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.197 -1.038 . . . . 71.34 108.197 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -93.17 -47.48 6.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.58 0.752 . . . . 71.33 110.083 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.33 141.05 39.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.162 -0.927 . . . . 62.33 110.856 -171.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.698 HD11 HG21 ' B' ' 18' ' ' THR . 48.4 mm -131.44 144.91 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.914 1.286 . . . . 74.03 108.26 171.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.517 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.7 t -145.63 129.12 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.077 -1.453 . . . . 72.42 107.077 173.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.3 t80 -143.31 107.04 4.63 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 106.517 -1.66 . . . . 74.42 106.517 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -118.1 112.51 20.3 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.079 -1.082 . . . . 73.34 108.079 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.3 85.46 2.15 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.939 -1.504 . . . . 61.54 106.939 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.96 -26.21 26.88 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.92 2.413 . . . . 64.35 112.156 -166.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -114.4 15.47 17.94 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.979 -1.009 . . . . 62.45 110.34 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.88 -61.99 0.97 Allowed Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 115.19 1.552 . . . . 64.31 115.19 -163.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.62 -27.05 39.14 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 121.831 1.687 . . . . 74.22 113.023 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -89.01 -38.87 14.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.994 0.518 . . . . 71.22 111.733 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.787 HG21 ' HA ' ' B' ' 73' ' ' ALA . 13.3 p -69.71 -16.09 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.209 0.604 . . . . 72.42 111.128 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -68.33 -4.07 13.18 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.483 0.713 . . . . 74.54 112.791 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.503 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.4 pt20 -68.34 -23.41 64.7 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.919 0.487 . . . . 72.12 110.219 168.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.503 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 86.7 mttt -107.88 79.02 1.23 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.829 1.251 . . . . 74.13 108.648 177.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -80.12 86.51 5.55 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.717 0.77 . . . . 75.34 109.35 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.0 t-105 -150.87 155.9 40.12 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.891 1.276 . . . . 72.34 107.594 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -70.76 99.99 0.26 Allowed Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 125.916 1.686 . . . . 74.42 110.576 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.621 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 49.0 Cg_endo -67.65 137.43 42.32 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.557 2.171 . . . . 73.23 112.535 -173.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -54.89 123.33 13.11 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.04 0.838 . . . . 73.54 109.764 173.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -104.33 157.19 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.443 0.64 . . . . 73.11 111.682 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -142.14 127.7 19.04 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.565 -1.643 . . . . 54.15 106.565 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.586 ' H ' HD23 ' B' ' 42' ' ' LEU . 2.6 pt? -104.41 151.88 22.98 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.834 0.453 . . . . 73.42 110.607 -175.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -143.19 116.19 8.85 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.603 -0.888 . . . . 75.45 108.603 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 mt -99.26 156.9 16.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.716 0.406 . . . . 33.51 110.166 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.487 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 11.6 m-20 -141.57 111.39 6.63 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.121 -1.066 . . . . 75.51 108.121 167.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -109.82 104.06 12.95 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.74 -0.467 . . . . 71.51 109.74 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.84 152.78 34.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.237 1.015 . . . . 62.34 109.434 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -137.58 161.84 35.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.033 0.533 . . . . 73.03 109.916 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -163.32 160.85 24.22 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.059 0.543 . . . . 73.41 110.241 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -91.47 123.03 34.58 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.124 0.57 . . . . 75.34 110.273 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 81.1 mt -87.33 -43.77 11.9 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.718 0.807 . . . . 72.03 109.107 167.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.61 -170.54 3.11 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.58 -1.191 . . . . 74.51 110.033 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.98 111.95 2.38 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.598 -0.728 . . . . 73.2 110.429 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 43.7 m-20 70.23 0.38 3.14 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.256 1.423 . . . . 74.0 112.838 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.8 t -104.18 102.88 14.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.526 -0.916 . . . . 62.02 108.526 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -99.73 146.99 25.92 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.64 -1.164 . . . . 74.31 109.643 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -109.4 116.55 32.03 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.465 -1.309 . . . . 51.42 107.465 165.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.437 HG11 ' HD3' ' B' ' 103' ' ' PRO . 52.3 t -96.01 143.37 12.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.526 -0.916 . . . . 75.32 108.526 172.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.2 t -131.89 137.36 55.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.959 -0.756 . . . . 65.41 108.959 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.85 109.59 14.38 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.176 -1.416 . . . . 75.44 107.176 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 40.7 ttm180 -95.25 130.94 41.8 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.543 -0.54 . . . . 61.21 109.543 170.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 37.0 t -120.62 106.13 18.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.192 -1.41 . . . . 74.34 107.192 169.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -96.13 146.62 24.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.11 -1.07 . . . . 75.15 108.11 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 71.1 t -138.4 130.12 37.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.284 1.034 . . . . 73.31 108.466 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 98.3 m -117.39 136.95 52.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.385 -0.969 . . . . 70.51 108.385 172.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.12 143.79 50.25 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.473 0.483 . . . . 74.11 110.289 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 44.3 p -133.68 127.03 32.05 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 123.959 0.787 . . . . 74.22 110.771 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.621 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 34.1 mt -105.88 114.64 28.9 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.116 0.966 . . . . 74.4 108.697 171.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.37 -111.73 3.94 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.537 -1.025 . . . . 54.42 110.537 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.23 4.58 11.28 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.527 0.731 . . . . 72.13 111.027 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -114.47 160.64 18.97 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.424 0.69 . . . . 75.31 109.583 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.3 m -72.24 135.07 45.94 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.543 -0.54 . . . . 64.43 109.543 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.787 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -88.72 -59.62 2.18 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.411 -0.959 . . . . 52.22 108.411 175.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.638 ' HZ ' HD11 ' B' ' 126' ' ' LEU . 52.5 p90 -151.96 170.08 20.74 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 113.973 -1.467 . . . . 74.32 109.821 176.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.7 mt -133.05 138.86 46.9 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.878 -1.897 . . . . 72.33 105.878 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' B' ' 114' ' ' ILE . 38.0 t -141.1 150.95 43.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.882 -0.784 . . . . 63.53 108.882 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.8 tt0 -164.37 132.55 3.45 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.034 -0.728 . . . . 62.21 109.034 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 98.6 t -128.94 147.67 33.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.474 -0.936 . . . . 74.33 108.474 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -123.15 93.13 3.86 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.293 -1.002 . . . . 73.13 108.293 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.481 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.9 tp-100 -82.79 100.89 10.58 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.702 -1.135 . . . . 54.32 109.014 177.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.51 163.73 31.36 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 111.02 -0.832 . . . . 74.44 111.02 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.3 128.23 1.73 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.936 -0.866 . . . . 52.24 110.936 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 30.8 mt -84.6 133.65 28.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.619 0.768 . . . . 62.01 109.077 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' B' ' 102' ' ' CYS . 22.8 m-85 -138.04 135.52 35.96 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.033 -0.728 . . . . 75.0 109.033 174.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -97.44 107.97 20.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.57 0.748 . . . . 73.3 108.995 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 43.0 pt -111.79 145.06 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.758 0.823 . . . . 74.14 110.377 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -144.32 158.1 43.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.702 0.801 . . . . 74.24 109.741 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.08 -65.14 4.12 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.557 0.536 . . . . 63.45 112.574 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.42 HD11 ' HB ' ' B' ' 86' ' ' ILE . 25.7 pt -58.15 144.01 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.225 1.01 . . . . 52.45 112.491 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -150.66 149.88 30.4 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.246 -0.888 . . . . 72.33 109.458 -171.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.3 -115.6 8.13 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.905 0.753 . . . . 54.13 113.013 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 24.7 m -67.14 -31.43 71.87 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.824 0.85 . . . . 73.14 112.003 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.93 -47.82 73.43 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.191 0.596 . . . . 74.11 110.81 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.538 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 12.3 ptp -72.91 -29.47 63.16 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-O 119.077 -0.487 . . . . 73.4 110.113 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.89 -32.16 71.63 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.824 0.45 . . . . 52.04 111.053 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.42 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 28.0 t-80 -72.42 -30.44 64.62 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.961 0.504 . . . . 62.23 110.971 174.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.595 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 85.9 m -76.71 -71.69 0.38 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 110.385 -0.228 . . . . 74.2 110.385 176.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.4 pp -71.42 -14.41 62.15 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.384 0.883 . . . . 60.54 113.384 -171.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.89 0.33 36.04 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-O 119.488 -0.618 . . . . 71.12 113.93 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -152.42 -62.1 0.16 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.741 0.771 . . . . 61.52 112.4 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.595 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 90.0 t80 -70.18 -47.28 62.25 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.101 0.96 . . . . 74.52 112.205 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.465 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 71.5 m -62.7 -49.15 84.01 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.15 0.98 . . . . 65.23 111.428 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 86.3 Cg_exo -54.05 -35.33 81.0 Favored 'Trans proline' 0 C--N 1.397 3.099 0 C-N-CA 122.043 1.829 . . . . 64.35 114.128 167.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -62.9 -37.26 86.25 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 123.202 0.601 . . . . 75.13 110.468 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.453 HD13 HD11 ' B' ' 13' ' ' ILE . 68.1 mt -66.18 -41.83 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.958 0.903 . . . . 74.33 110.458 174.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 67.5 mt -78.73 -19.19 52.92 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.427 -0.806 . . . . 55.12 112.12 -175.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -58.79 -49.15 94.98 Favored Pre-proline 0 N--CA 1.483 1.214 0 CA-C-O 117.829 -1.081 . . . . 72.04 113.515 -171.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.41 -38.26 89.39 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.194 1.929 . . . . 74.55 113.723 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.481 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 83.4 m-85 -68.53 -48.66 63.75 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 123.516 0.51 . . . . 73.42 110.527 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.34 -42.25 91.04 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.557 0.743 . . . . 74.53 111.304 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 54.3 ttt-85 -61.58 -53.22 59.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.802 1.641 . . . . 73.25 110.946 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -68.27 -30.27 69.26 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.987 0.805 . . . . 64.12 110.198 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.489 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.4 t -69.0 -41.11 78.26 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.833 0.453 . . . . 73.43 111.131 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.462 HG23 ' SG ' ' B' ' 76' ' ' CYS . 73.0 mt -60.55 -52.4 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.609 -0.515 . . . . 74.54 109.609 172.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.4 HG21 ' OG ' ' C' ' 119' ' ' SER . 62.9 m -56.12 -34.45 66.09 Favored 'General case' 0 CA--C 1.554 1.124 0 O-C-N 124.477 1.111 . . . . 70.34 111.988 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.6 t -66.72 -49.06 67.26 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 123.229 0.612 . . . . 65.4 109.873 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.503 ' SD ' HG21 ' A' ' 21' ' ' ILE . 34.5 mmt -61.5 -41.41 97.25 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.095 0.558 . . . . 72.21 111.155 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 78.2 t -62.77 -43.7 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.427 1.091 . . . . 70.34 110.851 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.8 t -65.65 -36.84 84.83 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.821 -1.081 . . . . 72.0 111.607 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -67.69 -36.74 81.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.026 -0.988 . . . . 61.41 110.47 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.51 6.99 59.35 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.334 -0.703 . . . . 63.24 113.084 176.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 72.0 p 59.38 22.0 10.38 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.378 1.871 . . . . 61.14 113.332 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -85.13 151.79 57.56 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.61 0.764 . . . . 73.4 109.963 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.36 156.98 3.5 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 124.242 3.294 . . . . 73.44 116.328 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -65.86 117.8 8.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.229 -1.35 . . . . 73.11 111.844 -173.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.638 HD11 ' HZ ' ' B' ' 74' ' ' PHE . 22.5 mt -113.44 120.26 40.42 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.029 -0.73 . . . . 54.32 109.029 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -123.21 96.22 4.91 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 107.895 -1.15 . . . . 72.54 107.895 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.549 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.1 mm? -61.72 149.82 38.56 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.825 0.85 . . . . 73.43 112.334 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.63 151.25 87.02 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.987 0.915 . . . . 64.21 110.659 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.95 104.81 1.41 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.501 2.134 . . . . 72.13 111.634 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.0 t -90.57 108.66 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.277 -1.008 . . . . 62.44 108.277 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -90.07 98.36 11.73 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.1 -1.074 . . . . 71.01 108.1 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -61.92 -32.97 73.42 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.289 -0.869 . . . . 74.53 111.41 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.33 -39.3 78.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.716 1.207 . . . . 71.01 111.823 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.17 -41.17 90.67 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.312 0.645 . . . . 51.41 110.207 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.28 -37.27 85.05 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.685 -1.143 . . . . 72.55 110.965 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 60.3 t80 . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 123.64 0.776 . . . . 73.3 110.668 -178.268 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.735 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 64.4 m . . . . . 0 C--O 1.24 0.556 0 N-CA-C 108.04 -1.096 . . . . 64.12 108.04 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.566 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 44.9 t80 -102.02 128.93 48.24 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.556 -0.905 . . . . 72.04 108.556 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -137.56 126.35 23.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.949 -0.76 . . . . 72.11 108.949 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 83.8 mt -77.38 122.17 31.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.659 -0.867 . . . . 73.03 108.659 172.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -91.15 -39.22 12.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.228 -0.896 . . . . 63.43 109.712 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -172.59 144.75 1.48 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.101 -0.703 . . . . 70.04 109.101 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 92.3 mt -134.07 137.69 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.769 -1.197 . . . . 72.11 107.769 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.453 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 32.2 p90 -169.58 171.94 7.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.872 0.844 . . . . 73.43 111.458 -173.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.1 p -96.77 118.35 33.02 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.222 -0.899 . . . . 72.5 109.061 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.543 ' HE3' ' HA3' ' C' ' 81' ' ' GLY . 21.5 mmtp -67.37 -48.97 65.88 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.66 -1.237 . . . . 74.41 107.66 171.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -137.61 142.92 41.25 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 112.974 -1.921 . . . . 72.32 109.6 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.498 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 76.0 mt -136.5 144.07 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 106.283 -1.747 . . . . 71.12 106.283 172.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -160.51 146.92 15.39 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.372 0.606 . . . . 73.41 110.824 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -139.03 135.13 33.91 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.2 -1.407 . . . . 75.12 107.2 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.431 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 38.8 mt-10 -135.36 114.45 12.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.729 0.812 . . . . 64.21 109.988 -176.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.86 83.88 33.63 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 107.112 -1.44 . . . . 61.22 107.112 170.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -70.34 -19.85 32.83 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.048 2.499 . . . . 72.44 112.684 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -116.33 24.85 11.07 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.775 1.23 . . . . 72.34 110.06 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.87 -57.66 5.68 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 114.483 1.29 . . . . 73.31 114.483 -169.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.3 -36.56 55.74 Favored 'Trans proline' 0 C--N 1.388 2.655 0 CA-C-N 121.542 1.586 . . . . 71.24 112.172 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.534 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 68.3 t60 -69.9 -32.99 71.61 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.417 -0.81 . . . . 64.24 112.36 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.754 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.0 p -81.54 -22.12 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 N-CA-C 112.731 0.641 . . . . 44.44 112.731 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -64.33 -23.79 67.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.628 -0.67 . . . . 72.34 112.682 175.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.6 pt20 -88.48 8.32 28.56 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.952 0.501 . . . . 73.23 111.301 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' C' ' 31' ' ' VAL . 1.1 mptm? -92.52 177.87 5.99 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 122.255 1.026 . . . . 64.15 113.24 -172.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -87.47 114.04 23.72 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 112.905 -1.952 . . . . 73.23 108.074 168.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 51.5 t90 -84.48 71.32 10.73 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.742 0.782 . . . . 72.21 110.939 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -132.92 69.59 79.01 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 123.966 0.906 . . . . 63.15 109.034 170.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -87.95 158.05 7.3 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.046 2.497 . . . . 62.23 113.73 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.97 96.43 8.84 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 107.284 -1.376 . . . . 64.51 107.284 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 m -79.28 128.25 38.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-O 121.705 0.764 . . . . 63.35 110.373 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -132.65 113.54 13.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.503 1.121 . . . . 62.31 108.338 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.439 HD11 HD22 ' C' ' 128' ' ' LEU . 72.2 mt -86.0 158.79 19.78 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.825 -0.806 . . . . 75.23 108.825 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.7 t70 -137.4 105.14 5.58 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.602 -1.258 . . . . 73.32 107.602 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.27 129.49 43.58 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.044 -0.724 . . . . 75.33 109.044 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -144.24 125.01 14.16 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.57 -0.9 . . . . 74.32 108.57 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 5.2 t -116.46 139.78 50.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.447 -0.575 . . . . 61.3 109.447 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.45 135.61 37.03 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.106 0.962 . . . . 71.01 108.406 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 13.0 p -136.38 151.12 49.21 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 109.314 -0.625 . . . . 54.5 109.314 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 70.0 p -156.65 143.73 18.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.369 0.668 . . . . 74.03 109.765 -174.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -78.93 118.1 20.63 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.326 0.65 . . . . 64.13 109.991 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' C' ' 57' ' ' GLU . 68.8 mt -89.26 -29.73 19.0 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.05 0.54 . . . . 72.32 110.13 174.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.47 172.67 16.81 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.787 1.235 . . . . 45.53 109.034 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -57.37 128.58 37.75 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.842 -0.799 . . . . 72.11 108.842 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 69.48 -1.85 2.1 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.42 1.088 . . . . 73.05 113.015 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -111.95 117.56 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.338 0.655 . . . . 72.14 109.373 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -124.85 126.46 45.61 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.041 0.936 . . . . 51.4 109.983 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.574 ' HB2' HD11 ' C' ' 51' ' ' LEU . 21.5 tt0 -83.62 133.0 34.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.936 -1.135 . . . . 73.42 107.936 165.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.47 140.35 47.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 N-CA-C 108.842 -0.799 . . . . 65.35 108.842 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 81.6 t -124.56 133.18 70.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.838 1.255 . . . . 72.11 107.629 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.2 104.81 8.71 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.237 -1.394 . . . . 71.1 107.237 174.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.464 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 1.9 ttm180 -86.69 130.01 34.65 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 113.886 -1.506 . . . . 61.21 109.127 177.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.1 124.81 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.458 -1.312 . . . . 73.01 107.458 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 32.7 m -124.52 131.18 53.49 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.855 -0.794 . . . . 64.52 108.855 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.477 HG23 HD13 ' C' ' 114' ' ' ILE . 23.4 t -107.49 126.65 63.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.003 -0.74 . . . . 55.13 109.003 173.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.411 HG23 HD23 ' C' ' 75' ' ' LEU . 5.2 m -116.25 145.43 43.15 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.935 -1.135 . . . . 75.43 107.935 173.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.54 128.02 20.08 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.053 -0.721 . . . . 41.51 109.053 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.8 m -128.01 126.03 40.54 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 123.196 0.598 . . . . 73.0 110.141 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 39.5 mt -88.47 37.7 0.84 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.589 1.156 . . . . 65.31 110.198 172.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.6 -96.08 1.52 Allowed Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.374 -1.09 . . . . 70.35 110.374 -173.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -107.1 -5.46 18.01 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.313 1.045 . . . . 65.03 110.839 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.43 ' HG2' ' HZ3' ' C' ' 34' ' ' LYS . 4.0 tp10 -103.17 121.14 42.04 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.526 1.131 . . . . 63.11 109.062 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 35.6 m -69.32 126.95 31.36 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.779 0.718 . . . . 70.45 109.07 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.754 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.42 -54.64 6.44 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.093 -0.706 . . . . 55.21 109.093 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -169.08 168.87 9.79 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 114.836 -1.074 . . . . 74.22 111.097 175.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -140.08 143.83 36.51 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 106.883 -1.525 . . . . 64.5 106.883 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.404 ' N ' HD13 ' C' ' 75' ' ' LEU . 43.8 t -153.24 116.19 4.55 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.726 -0.472 . . . . 63.12 109.726 175.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -117.6 133.01 56.41 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.722 0.409 . . . . 74.31 110.086 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 84.6 t -126.57 138.07 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.225 1.01 . . . . 64.34 108.39 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.464 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 66.7 mt-30 -115.11 97.14 6.04 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.349 -0.982 . . . . 72.32 108.349 173.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -86.63 104.52 16.13 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.572 0.749 . . . . 62.22 110.683 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.543 ' HA3' ' HE3' ' C' ' 19' ' ' LYS . . . -110.42 143.78 16.96 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 121.532 -0.366 . . . . 73.02 112.729 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.03 142.06 10.22 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 111.361 -0.696 . . . . 53.3 111.361 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' D' ' 29' ' ' PRO . 14.4 mm -90.72 126.39 43.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.557 -0.905 . . . . 72.55 108.557 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -132.27 128.76 38.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.955 0.902 . . . . 55.13 109.19 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.8 p -96.78 126.1 41.7 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 109.225 -0.657 . . . . 55.33 109.225 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.402 ' O ' HD12 ' C' ' 86' ' ' ILE . 2.5 pp -115.48 143.9 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.89 1.276 . . . . 73.25 109.577 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -144.31 142.9 30.71 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.67 0.388 . . . . 65.34 110.953 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.71 -18.08 48.93 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 114.635 0.614 . . . . 62.41 114.635 175.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 38.5 pt -113.43 154.13 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 117.406 0.603 . . . . 75.42 112.227 -172.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -164.57 -178.68 5.5 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.163 0.985 . . . . 71.4 109.798 173.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.12 -123.5 33.24 Favored Glycine 0 C--N 1.352 1.458 0 O-C-N 123.427 0.454 . . . . 44.04 114.005 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 74.0 p -70.64 -32.25 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.048 0.939 . . . . 74.44 111.258 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -69.09 -36.15 77.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.342 0.657 . . . . 70.45 110.987 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 46.8 ttm -76.81 -32.89 57.94 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.496 -0.32 . . . . 74.24 110.267 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.89 -41.02 73.84 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.55 0.532 . . . . 72.23 110.275 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -81.24 -30.59 34.1 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.438 0.461 . . . . 74.51 111.705 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 23.0 t -62.09 -39.22 91.74 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.416 0.448 . . . . 74.42 110.666 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.32 -14.32 24.02 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.091 0.556 . . . . 62.1 110.718 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.05 -29.99 61.83 Favored Glycine 0 C--N 1.357 1.696 0 O-C-N 123.279 0.362 . . . . 55.43 113.886 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.09 -38.65 0.06 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.201 0.815 . . . . 64.53 113.201 -170.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -62.42 -52.45 63.5 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.906 0.482 . . . . 73.3 111.322 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.566 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 58.8 m -72.9 -46.19 8.7 Favored Pre-proline 0 CA--C 1.563 1.452 0 CA-C-O 118.732 -0.652 . . . . 74.02 112.289 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 64.6 Cg_exo -54.33 -28.5 53.48 Favored 'Trans proline' 0 C--N 1.398 3.14 0 C-N-CA 122.321 2.014 . . . . 73.45 114.306 171.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -69.65 -35.79 75.49 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.458 0.703 . . . . 75.22 109.774 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.438 HD12 ' NH1' ' A' ' 111' ' ' ARG . 27.8 mm -64.94 -41.8 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.509 -0.552 . . . . 61.15 109.509 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 39.8 mt -79.03 -27.95 43.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.063 0.945 . . . . 61.41 113.015 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -57.67 -49.82 91.59 Favored Pre-proline 0 CA--C 1.564 1.503 0 N-CA-C 114.337 1.236 . . . . 70.33 114.337 -171.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.93 -33.93 95.47 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 121.944 1.763 . . . . 74.11 112.905 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -69.19 -45.59 69.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.983 0.513 . . . . 53.32 110.502 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.25 -37.45 77.63 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.255 -0.884 . . . . 61.04 110.665 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -61.89 -58.94 6.0 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.863 -1.062 . . . . 60.45 110.621 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.03 78.66 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 110.137 -0.32 . . . . 51.2 110.137 -175.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.3 t -66.74 -28.65 68.58 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.974 0.509 . . . . 64.41 111.609 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.477 HD13 HG23 ' C' ' 64' ' ' VAL . 83.4 mt -77.13 -55.43 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 109.707 -0.479 . . . . 53.3 109.707 170.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.1 m -60.81 -28.62 68.92 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.211 1.005 . . . . 74.12 111.782 -170.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -68.84 -49.75 55.74 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.834 -0.802 . . . . 74.53 108.834 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.576 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.21 -34.84 75.75 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.561 1.144 . . . . 62.05 112.639 178.205 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.52 -48.16 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.743 0.817 . . . . 72.14 109.193 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.4 ' OG ' HG21 ' B' ' 115' ' ' THR . 41.9 t -67.85 -28.87 67.92 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.811 -1.086 . . . . 72.44 111.911 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -71.31 -43.95 66.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.578 -0.897 . . . . 62.12 108.578 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.86 3.27 61.34 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 123.901 0.751 . . . . 30.32 113.036 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 33.1 p 60.23 38.35 20.06 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.694 1.998 . . . . 71.34 113.898 170.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -94.4 149.8 37.21 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 108.655 -0.869 . . . . 62.21 108.655 166.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.31 176.71 0.35 Allowed 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.309 2.673 . . . . 72.1 115.376 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -59.85 122.16 13.54 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.325 1.05 . . . . 75.4 113.747 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.4 ' CD2' HG11 ' C' ' 64' ' ' VAL . 9.6 mp -112.66 86.26 2.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.218 1.007 . . . . 64.13 109.48 171.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -107.47 107.98 19.09 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.816 -0.809 . . . . 60.41 108.816 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.439 HD22 HD11 ' C' ' 42' ' ' LEU . 59.5 mt -73.38 142.83 46.98 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.643 -0.708 . . . . 74.35 110.519 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.67 148.32 94.95 Favored Pre-proline 0 CA--C 1.55 0.975 0 O-C-N 123.844 0.715 . . . . 75.12 110.111 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.496 ' HG3' HD12 ' A' ' 16' ' ' ILE . 37.4 Cg_exo -57.42 120.38 8.26 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.581 2.188 . . . . 75.34 112.221 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 98.7 t -97.52 119.51 45.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.296 -1.001 . . . . 75.43 108.296 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -77.93 73.12 4.5 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.761 0.663 . . . . 72.22 110.378 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -56.95 -41.05 77.6 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.558 0.743 . . . . 72.3 110.595 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -66.0 -49.49 67.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.069 -0.969 . . . . 71.23 111.762 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.02 96.22 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.959 0.787 . . . . 42.22 111.033 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.29 -29.32 66.04 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.376 -0.829 . . . . 63.34 111.665 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 15.3 t80 . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 110.062 -0.347 . . . . 74.32 110.062 177.873 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.238 0.463 0 N-CA-C 109.959 -0.386 . . . . 54.44 109.959 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.402 ' HZ ' HG13 ' D' ' 105' ' ' ILE . 74.9 t80 -152.68 94.31 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.654 -1.239 . . . . 61.5 107.654 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -123.18 116.84 24.08 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.516 0.727 . . . . 75.25 109.04 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.16 113.79 17.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.221 -1.029 . . . . 75.22 108.221 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -81.99 -22.93 36.31 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.604 0.761 . . . . 74.24 111.059 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -170.61 141.28 1.85 Allowed 'General case' 0 C--N 1.361 1.065 0 O-C-N 123.536 0.522 . . . . 71.11 111.234 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.404 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -119.7 133.93 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.683 -1.599 . . . . 54.14 106.683 169.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.448 ' HE1' HG13 ' D' ' 83' ' ' ILE . 20.7 p90 -163.13 163.08 25.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.407 0.622 . . . . 75.32 111.499 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -95.47 120.91 36.53 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.704 -0.85 . . . . 65.41 108.704 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 41.0 mtpt -83.92 -35.2 24.24 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.19 -0.67 . . . . 75.03 109.19 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.4 t70 -146.9 137.18 23.55 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.506 -1.225 . . . . 74.25 109.303 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.576 HG21 ' HE2' ' C' ' 117' ' ' MET . 78.5 mt -136.9 145.31 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.532 1.133 . . . . 71.12 107.976 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -146.77 135.98 22.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.11 0.964 . . . . 61.4 108.831 172.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.498 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.3 t80 -136.65 129.54 30.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 106.453 -1.684 . . . . 64.53 106.453 166.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 33.1 mt-10 -137.65 112.73 9.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.114 -1.069 . . . . 72.13 108.114 -172.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.88 88.34 2.89 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.568 -1.271 . . . . 71.12 107.568 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.08 -32.26 43.99 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.418 2.079 . . . . 55.12 112.695 -167.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.509 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 70.4 m-20 -113.94 14.42 18.48 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.969 0.908 . . . . 71.23 110.7 -177.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.471 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -18.6 -74.34 0.02 OUTLIER Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 116.566 2.061 . . . . 60.12 116.566 -166.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.497 ' HB3' HD11 ' C' ' 83' ' ' ILE . 84.3 Cg_endo -77.26 -20.08 12.94 Favored 'Trans proline' 0 C--N 1.382 2.324 0 CA-C-N 124.377 2.599 . . . . 74.14 114.246 -176.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -70.81 -39.16 73.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.192 0.997 . . . . 71.52 109.635 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.677 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.7 p -84.22 -24.34 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 115.675 -0.693 . . . . 63.11 112.172 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -66.68 -22.36 66.08 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 112.675 0.621 . . . . 71.3 112.675 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -61.71 -22.82 65.68 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.752 0.821 . . . . 63.31 110.849 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -88.69 96.23 10.57 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.5 1.12 . . . . 72.12 110.157 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.35 88.12 2.57 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.152 -0.476 . . . . 64.41 109.776 170.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -154.5 158.03 39.26 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.321 -0.992 . . . . 74.31 108.321 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.26 110.04 10.14 Favored Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 108.267 -1.012 . . . . 73.41 108.267 172.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -54.29 127.69 26.89 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.425 2.75 . . . . 72.11 113.584 -174.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 24.2 tt0 -56.61 111.84 1.12 Allowed 'General case' 0 C--N 1.368 1.387 0 O-C-N 124.208 0.942 . . . . 74.11 108.81 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.72 138.26 45.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.638 0.732 . . . . 70.11 110.437 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -129.87 124.15 32.53 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 106.389 -1.708 . . . . 70.42 106.389 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 51.4 tp -95.19 120.45 35.43 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.163 -0.68 . . . . 75.14 109.163 -172.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.602 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 10.8 m-20 -106.23 140.09 39.72 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.617 1.167 . . . . 43.01 107.942 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.47 168.21 19.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.27 0.557 . . . . 63.04 109.852 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 7.8 t70 -157.75 142.16 16.24 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.743 1.217 . . . . 50.44 107.726 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -114.8 144.42 43.53 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.405 0.621 . . . . 71.24 109.416 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.413 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.97 164.36 34.79 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.833 1.253 . . . . 74.31 107.815 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.5 p -168.85 158.47 8.9 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 123.599 0.562 . . . . 74.41 110.49 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 94.6 p -150.7 155.66 39.76 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.832 0.853 . . . . 71.13 109.704 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -91.34 119.0 31.0 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.55 -0.908 . . . . 64.43 108.55 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' D' ' 57' ' ' GLU . 58.7 mt -89.75 -40.52 12.45 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.195 0.598 . . . . 71.05 109.613 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.72 -171.24 3.48 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.964 0.906 . . . . 75.31 110.284 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.48 106.89 1.0 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.241 -0.891 . . . . 72.13 110.784 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 64.7 17.63 11.03 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.609 1.163 . . . . 63.53 112.168 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 91.0 t -109.52 105.13 18.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 107.122 -1.436 . . . . 73.3 107.122 170.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -121.98 126.73 49.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.261 -1.014 . . . . 75.34 108.261 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.464 ' HB2' HD11 ' D' ' 51' ' ' LEU . 19.3 tt0 -89.85 151.1 21.93 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.452 1.101 . . . . 61.44 108.707 174.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 91.4 t -131.81 128.52 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 C-N-CA 124.516 1.126 . . . . 55.33 108.11 172.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 57.7 t -104.87 130.51 55.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.331 1.052 . . . . 53.13 108.503 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.87 114.47 24.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.548 -0.908 . . . . 74.45 108.548 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.0 ttm-85 -96.36 101.3 12.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.194 -1.039 . . . . 72.42 108.194 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.5 t -100.84 103.67 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.57 -0.9 . . . . 54.14 108.57 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 6.0 m -100.64 137.3 39.22 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.063 0.945 . . . . 61.04 109.171 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.43 HG21 HG21 ' D' ' 114' ' ' ILE . 61.9 t -125.6 113.44 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.855 0.862 . . . . 71.14 109.516 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 12.6 m -103.11 119.53 39.02 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.765 -0.828 . . . . 53.41 108.765 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -135.81 152.06 50.7 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.917 0.487 . . . . 52.35 111.32 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 57.2 p -148.92 136.03 20.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.083 -0.508 . . . . 52.12 112.013 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.581 HD12 HG22 ' D' ' 31' ' ' VAL . 50.1 mt -102.49 96.36 6.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.46 1.104 . . . . 74.34 108.103 171.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.63 -139.1 20.49 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.129 -0.487 . . . . 63.24 113.11 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.05 0.76 46.98 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.91 0.484 . . . . 74.45 111.362 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -118.74 152.66 35.75 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.704 0.802 . . . . 73.31 109.286 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.7 m -73.63 139.68 45.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.75 0.42 . . . . 74.12 110.671 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.677 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.41 -69.83 0.66 Allowed 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.388 -0.824 . . . . 43.21 108.953 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -149.13 138.85 21.86 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.251 -0.886 . . . . 71.54 109.516 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.1 mt -111.78 132.43 54.67 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.359 1.463 . . . . 61.35 107.167 172.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.494 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.7 t -141.56 147.07 37.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.485 -0.561 . . . . 74.2 109.485 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -156.15 130.39 8.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.581 -0.526 . . . . 54.12 109.581 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.12 114.7 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.558 0.743 . . . . 52.35 109.127 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.534 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.27 86.56 6.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.567 -0.901 . . . . 72.01 108.567 170.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -78.7 100.76 7.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.237 -1.347 . . . . 64.34 108.901 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.07 146.57 20.46 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 116.1 -0.5 . . . . 73.55 112.16 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.443 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.9 130.45 4.34 Favored Glycine 0 CA--C 1.508 -0.358 0 N-CA-C 110.343 -1.103 . . . . 62.31 110.343 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.448 HG13 ' HE1' ' D' ' 17' ' ' TYR . 73.6 mt -89.41 122.85 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.722 -1.214 . . . . 61.24 107.722 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -118.2 145.28 45.09 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.906 0.882 . . . . 65.24 109.335 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 6.8 t -115.57 98.14 6.54 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.633 -1.247 . . . . 74.32 107.633 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 30.0 pt -129.92 137.12 57.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.18 -0.918 . . . . 72.15 110.099 -170.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.07 151.84 25.72 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.811 -0.631 . . . . 63.44 110.442 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.13 -13.17 60.41 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.131 -0.94 . . . . 14.32 113.444 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.572 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -95.71 136.86 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 121.463 0.649 . . . . 72.03 111.546 -170.56 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.5 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 44.8 mt-10 -143.02 -176.68 5.01 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.877 1.671 . . . . 75.14 109.685 -177.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.36 -128.06 27.22 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.347 -0.842 . . . . 21.0 113.425 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 46.0 m -85.45 -32.98 22.0 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.439 0.696 . . . . 61.4 111.031 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.33 -38.69 92.13 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.968 0.507 . . . . 74.14 111.977 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.5 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 26.1 ptt? -61.09 -45.09 96.13 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.348 0.405 . . . . 74.11 110.914 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.76 91.99 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.406 0.622 . . . . 75.41 110.137 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -68.33 -23.19 64.68 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.188 1.395 . . . . 65.45 111.757 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.0 t -79.02 -51.93 8.92 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.663 -0.495 . . . . 60.23 109.663 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.45 -29.54 62.61 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.306 0.642 . . . . 61.24 111.911 -176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.19 4.93 30.12 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.825 0.69 . . . . 74.24 114.825 -170.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.4 -55.91 0.24 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 117.929 0.864 . . . . 60.34 111.767 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -71.75 -51.85 20.67 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.058 0.392 . . . . 72.42 112.058 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 68.8 m -65.06 -42.48 61.62 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-O 118.401 -0.809 . . . . 73.4 112.256 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.56 -37.95 94.6 Favored 'Trans proline' 0 C--N 1.397 3.102 0 C-N-CA 122.227 1.951 . . . . 73.14 113.317 166.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -67.42 -30.04 69.69 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.199 0.6 . . . . 72.33 111.143 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.402 HG13 ' HZ ' ' D' ' 11' ' ' PHE . 40.0 mm -66.54 -42.91 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.416 0.686 . . . . 54.3 110.225 171.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.443 HD21 ' HA3' ' D' ' 82' ' ' GLY . 87.5 mt -74.07 -20.83 60.16 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.056 -0.975 . . . . 62.25 111.906 -174.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -65.1 -43.12 65.48 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 114.192 1.182 . . . . 61.45 114.192 -172.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.01 -46.0 23.4 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.342 2.028 . . . . 65.42 114.073 169.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -72.13 -38.62 69.21 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.463 0.705 . . . . 75.43 111.597 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.85 89.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.369 0.668 . . . . 64.45 110.777 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.413 ' NH2' HG23 ' B' ' 105' ' ' ILE . 29.2 ttp180 -58.0 -48.99 78.37 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.392 1.077 . . . . 73.53 110.6 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -58.04 -46.81 84.75 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.201 0.938 . . . . 74.41 111.359 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -59.81 -44.5 93.98 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.027 0.829 . . . . 62.12 111.413 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.494 HG12 ' SG ' ' D' ' 76' ' ' CYS . 75.7 mt -65.35 -50.6 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.78 0.832 . . . . 42.43 111.046 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 57.3 m -55.14 -41.85 72.29 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 124.095 0.958 . . . . 53.41 111.402 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.9 t -67.26 -41.47 85.52 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.568 -1.196 . . . . 71.23 110.4 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -71.46 -28.96 64.32 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.845 0.458 . . . . 61.22 112.187 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' D' ' 123' ' ' PHE . 59.0 t -64.61 -46.44 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.204 0.602 . . . . 71.01 109.581 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.01 -27.24 62.6 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 116.076 -0.511 . . . . 74.33 110.998 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.2 mtt-85 -71.2 -35.04 71.42 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.332 0.653 . . . . 72.43 109.841 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.65 7.97 77.29 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 115.901 -0.59 . . . . 73.11 112.329 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p 59.14 25.34 13.83 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 126.35 1.86 . . . . 71.42 114.725 173.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.554 ' HB2' HG13 ' D' ' 118' ' ' VAL . 99.0 m-85 -87.52 155.69 53.77 Favored Pre-proline 0 CA--C 1.556 1.206 0 N-CA-C 108.607 -0.886 . . . . 75.54 108.607 169.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.72 146.92 96.49 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.635 2.223 . . . . 72.34 112.436 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -58.36 139.54 55.14 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.732 1.213 . . . . 71.34 113.026 -172.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 9.1 mp -114.47 112.36 22.86 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.705 0.802 . . . . 74.24 109.569 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 127' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.2 m-20 -102.35 92.67 4.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.35 -0.981 . . . . 65.11 108.35 172.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.18 115.45 7.66 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.374 -0.602 . . . . 74.12 109.374 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.3 138.99 97.31 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.306 0.642 . . . . 73.31 110.585 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -69.66 119.93 6.81 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.162 1.908 . . . . 33.54 111.073 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.7 150.74 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.325 0.65 . . . . 73.21 111.053 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -80.49 107.16 13.07 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.284 -0.871 . . . . 73.15 109.601 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -80.5 -31.68 37.11 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.321 0.648 . . . . 54.51 110.869 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.75 -52.35 65.81 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.194 1.398 . . . . 71.21 111.861 -168.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.33 79.54 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.136 0.898 . . . . 65.52 111.718 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.65 -25.6 56.98 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.258 -0.883 . . . . 55.41 111.285 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 88.3 t80 . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 123.36 0.664 . . . . 75.22 110.647 175.08 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.7 m . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 120.684 0.278 . . . . 63.11 110.986 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.634 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 12.6 t80 -137.08 121.84 18.67 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.849 0.859 . . . . 75.53 108.923 172.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -136.45 108.38 7.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.398 0.679 . . . . 73.43 109.292 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.631 HG12 ' HD2' ' A' ' 84' ' ' PHE . 59.5 mt -80.66 109.46 15.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.508 -0.923 . . . . 73.14 108.508 172.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -74.41 -34.91 63.4 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.556 -0.747 . . . . 73.05 110.572 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -174.61 138.0 0.49 Allowed 'General case' 0 C--N 1.362 1.127 0 O-C-N 123.544 0.527 . . . . 74.32 110.624 -170.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.675 HD12 ' HG3' ' C' ' 130' ' ' PRO . 75.4 mt -123.3 133.79 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.75 0.82 . . . . 74.53 109.423 175.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -167.78 151.01 5.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.821 0.848 . . . . 65.14 110.557 -171.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.4 p -79.44 114.75 18.62 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.938 -0.764 . . . . 60.44 108.938 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -78.51 -33.34 48.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.162 -0.681 . . . . 73.25 109.162 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.8 t70 -147.72 132.72 18.18 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.973 -1.012 . . . . 45.42 109.584 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.42 141.49 45.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 107.237 -1.394 . . . . 70.42 107.237 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -145.91 132.55 19.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.627 0.727 . . . . 71.24 109.719 171.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 79.1 t80 -133.19 130.51 39.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.768 -1.567 . . . . 73.34 106.768 172.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.58 122.26 16.38 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.204 0.602 . . . . 41.55 109.456 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.12 78.47 68.96 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.539 -1.282 . . . . 73.21 107.539 174.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.3 -43.35 8.53 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.492 2.128 . . . . 71.32 110.734 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.406 ' O ' HG23 ' A' ' 31' ' ' VAL . 40.3 m-80 -88.62 20.55 3.37 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.386 -1.279 . . . . 71.43 111.423 -177.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.99 -45.93 88.03 Favored Pre-proline 0 CA--C 1.573 1.858 0 C-N-CA 123.71 0.804 . . . . 42.2 113.121 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 16.2 Cg_exo -68.82 -26.17 32.5 Favored 'Trans proline' 0 C--N 1.398 3.164 0 C-N-CA 121.666 1.577 . . . . 73.2 112.928 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -74.3 -37.42 63.66 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.292 0.637 . . . . 70.41 110.172 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.47 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 73.8 t -67.95 -32.94 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.229 1.012 . . . . 74.52 110.668 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -59.0 -27.95 65.92 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.198 0.999 . . . . 63.12 111.44 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -95.83 -48.62 5.67 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.677 0.791 . . . . 74.34 111.25 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 21.0 ptmt -81.66 164.68 21.65 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.909 0.483 . . . . 73.21 111.22 -175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.55 141.24 43.74 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.511 0.725 . . . . 74.14 111.876 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -92.34 83.78 5.07 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.092 -0.707 . . . . 74.33 109.092 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.97 62.07 44.35 Favored Pre-proline 0 N--CA 1.482 1.146 0 N-CA-C 108.235 -1.024 . . . . 72.42 108.235 172.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.54 157.29 28.65 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.441 2.094 . . . . 52.11 112.681 -167.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.21 109.77 22.46 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.53 -0.915 . . . . 73.42 108.53 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -83.5 115.24 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.394 -0.821 . . . . 74.3 109.781 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -104.12 144.41 31.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.87 0.868 . . . . 64.12 108.749 170.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 23.7 tp -136.79 128.84 29.48 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.809 -1.182 . . . . 74.43 107.809 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -135.15 113.01 10.95 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.85 -1.167 . . . . 74.53 107.85 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.2 mt -98.08 121.72 40.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.263 0.625 . . . . 61.22 110.207 -173.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -126.76 147.69 49.97 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.201 1.001 . . . . 73.04 109.054 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.1 m -135.64 126.05 26.71 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.82 0.848 . . . . 72.25 109.761 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.57 109.72 8.86 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 122.941 0.496 . . . . 73.11 110.583 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 29.4 m -89.68 167.99 12.47 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.692 0.797 . . . . 75.12 109.928 175.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.415 ' OG ' ' HB3' ' A' ' 57' ' ' GLU . 86.8 p -160.46 154.05 22.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.505 0.722 . . . . 72.53 109.616 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -89.58 117.46 28.49 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.654 0.382 . . . . 71.35 110.297 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.49 HD12 HG23 ' A' ' 83' ' ' ILE . 78.0 mt -87.27 -46.64 9.52 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.574 0.702 . . . . 75.22 109.42 172.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.43 -176.64 5.39 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 114.421 -1.263 . . . . 42.15 108.777 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -65.81 110.07 2.7 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 109.176 -0.676 . . . . 73.45 109.176 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 74.43 -0.98 3.2 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 125.505 1.522 . . . . 73.31 112.886 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -100.25 113.85 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.048 -1.093 . . . . 73.1 108.048 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -125.66 129.96 50.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.702 0.801 . . . . 51.22 110.642 -172.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.415 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 41.2 tp10 -89.94 114.72 26.58 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.506 -0.924 . . . . 73.54 108.506 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 61.9 t -100.89 129.49 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 107.985 -1.117 . . . . 62.22 107.985 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.5 105.66 19.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.126 -1.064 . . . . 71.02 108.126 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.7 97.78 11.0 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 106.918 -1.512 . . . . 61.03 106.918 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -92.32 105.64 17.8 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.994 1.318 . . . . 72.3 109.762 -174.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.479 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.7 t -98.84 105.46 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.869 -0.789 . . . . 64.53 108.869 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -98.94 107.51 19.97 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.091 0.556 . . . . 75.44 110.2 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' A' ' 126' ' ' LEU . 98.4 t -106.02 125.94 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.323 0.649 . . . . 61.32 109.443 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.4 m -127.75 107.92 10.3 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.038 -0.727 . . . . 71.54 109.038 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.4 117.86 35.63 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.358 -1.349 . . . . 63.34 107.358 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.8 p -144.82 145.38 31.61 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.089 0.556 . . . . 63.01 109.883 -173.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -129.09 90.22 2.99 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.112 0.965 . . . . 70.44 109.184 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.69 -114.89 3.95 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.383 -0.826 . . . . 72.33 111.269 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.92 -26.85 14.91 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.22 -0.659 . . . . 61.23 109.22 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -85.92 117.46 24.79 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.668 0.387 . . . . 70.24 110.374 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.6 m -73.71 131.04 41.2 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.076 -0.713 . . . . 65.32 109.076 168.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -73.55 -58.27 3.42 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.999 -0.741 . . . . 72.02 108.999 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -156.62 159.05 38.11 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.133 -1.394 . . . . 64.34 110.191 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 32.3 tp -127.48 119.14 25.41 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 107.337 -1.357 . . . . 71.33 107.337 173.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 68.3 m -125.68 99.45 5.99 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.975 -0.75 . . . . 50.52 108.975 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -121.95 116.55 24.55 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.494 -0.928 . . . . 75.13 108.494 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.3 111.49 26.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 123.673 0.789 . . . . 75.41 109.392 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 43.0 mt-30 -85.21 86.22 7.4 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.499 -0.926 . . . . 52.42 108.499 171.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.461 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.5 tp-100 -76.55 118.34 19.11 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 114.78 -1.1 . . . . 64.42 108.172 178.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.17 160.22 13.49 Favored Glycine 0 C--O 1.24 0.512 0 O-C-N 123.533 0.521 . . . . 70.03 112.121 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.47 132.63 2.91 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.799 -0.92 . . . . 64.11 110.799 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.49 HG23 HD12 ' A' ' 51' ' ' LEU . 42.7 mt -81.19 115.69 24.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 174.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.634 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.5 m-85 -122.82 118.59 28.33 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.24 -0.652 . . . . 75.33 109.24 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 m -99.68 100.73 11.74 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.963 -0.755 . . . . 52.42 108.963 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.9 pt -108.95 125.36 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.665 0.786 . . . . 74.42 111.122 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.71 161.73 38.48 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.983 0.913 . . . . 73.31 109.937 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.17 2.0 88.55 Favored Glycine 0 N--CA 1.477 1.381 0 N-CA-C 114.674 0.629 . . . . 71.14 114.674 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.542 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -114.82 146.09 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 123.784 0.834 . . . . 72.04 109.73 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 15.9 tt0 -150.93 179.44 8.24 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.413 0.285 . . . . 74.14 110.494 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.459 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 71.83 -136.71 24.63 Favored Glycine 0 C--N 1.351 1.405 0 C-N-CA 123.374 0.512 . . . . 52.24 113.747 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.2 p -80.43 -15.85 55.82 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.034 0.934 . . . . 71.23 110.744 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -71.96 -37.24 69.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.326 1.051 . . . . 71.31 110.742 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -73.32 -25.05 60.48 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.312 0.245 . . . . 64.33 111.016 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.6 -35.72 70.59 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.97 0.508 . . . . 71.03 109.908 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -66.52 -31.26 71.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.51 0.724 . . . . 74.2 111.27 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.542 ' SG ' HG13 ' A' ' 89' ' ' ILE . 72.1 m -57.21 -60.03 4.22 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.496 0.498 . . . . 62.42 111.179 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -83.62 -12.06 56.51 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 112.541 0.571 . . . . 73.43 112.541 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.14 -15.2 26.56 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 119.476 -0.625 . . . . 51.52 114.399 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.29 -61.59 0.35 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.95 0.875 . . . . 72.23 111.725 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.17 -65.99 0.61 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.974 1.31 . . . . 72.33 112.759 -169.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.42 -39.39 19.9 Favored Pre-proline 0 CA--C 1.569 1.703 0 N-CA-C 113.379 0.881 . . . . 71.42 113.379 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.87 -29.57 88.38 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 121.683 1.589 . . . . 61.14 113.341 169.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -70.57 -28.09 64.63 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 122.6 0.36 . . . . 71.41 110.453 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.448 HG21 HD13 ' A' ' 13' ' ' ILE . 36.3 mm -56.39 -40.35 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.462 0.705 . . . . 73.14 110.15 172.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.461 HD22 ' HG3' ' A' ' 80' ' ' GLN . 80.4 mt -80.39 -22.55 41.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.861 -1.063 . . . . 62.45 112.675 -173.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.46 -44.92 97.09 Favored Pre-proline 0 CA--C 1.572 1.825 0 N-CA-C 113.591 0.96 . . . . 74.12 113.591 -172.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -59.73 -43.64 36.85 Favored 'Trans proline' 0 C--N 1.394 2.954 0 C-N-CA 122.041 1.828 . . . . 73.24 112.954 173.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -65.48 -36.91 85.27 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.153 0.581 . . . . 72.33 111.037 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.69 -37.92 70.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.91 -0.586 . . . . 63.41 110.751 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.534 ' NH1' HD12 ' C' ' 105' ' ' ILE . 35.0 ttm180 -53.88 -52.87 59.11 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 123.943 0.777 . . . . 75.42 110.03 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -59.78 -49.14 78.87 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.572 1.17 . . . . 72.11 111.311 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.497 ' O ' ' HE3' ' A' ' 117' ' ' MET . 34.3 t -56.28 -40.85 74.92 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.317 1.011 . . . . 72.11 110.59 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.479 HD11 ' HB ' ' A' ' 62' ' ' VAL . 96.3 mt -70.37 -47.87 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.942 0.897 . . . . 42.14 111.076 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.497 HG23 ' HG3' ' A' ' 125' ' ' GLN . 33.5 m -54.66 -38.03 66.43 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.433 0.693 . . . . 64.13 110.349 177.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.6 t -69.42 -40.78 77.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.865 -1.061 . . . . 71.23 109.634 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.497 ' HE3' ' O ' ' A' ' 113' ' ' CYS . 33.2 mmt -59.8 -44.56 93.9 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 120.957 0.408 . . . . 74.34 110.624 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 114' ' ' ILE . 57.3 t -67.79 -44.61 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.299 1.04 . . . . 70.45 111.118 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -72.97 -33.05 65.6 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.359 0.664 . . . . 62.51 111.642 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -71.36 -32.66 68.76 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.964 0.506 . . . . 62.51 109.658 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.79 -2.96 72.12 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 115.571 -0.741 . . . . 74.4 113.578 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.1 m 70.06 11.48 7.64 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.994 1.318 . . . . 72.21 111.487 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -82.86 142.9 45.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 N-CA-C 108.819 -0.808 . . . . 73.35 108.819 173.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -46.86 132.91 17.55 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.403 2.735 . . . . 74.55 113.592 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.497 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.3 tt0 -52.07 144.36 12.29 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.367 1.467 . . . . 64.51 114.108 -169.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.409 ' CD2' HG11 ' A' ' 64' ' ' VAL . 16.4 tp -121.1 104.12 9.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.281 1.432 . . . . 64.05 109.255 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -116.05 96.02 5.37 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.751 -0.833 . . . . 73.44 108.751 170.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.39 151.78 46.36 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.513 -0.767 . . . . 41.14 110.665 176.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.59 152.28 91.63 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.672 0.789 . . . . 74.12 110.964 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.9 126.78 18.81 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.006 1.804 . . . . 64.11 111.918 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.2 t -99.05 115.69 40.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.534 -0.913 . . . . 74.14 108.534 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -81.7 81.61 7.69 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.958 -0.756 . . . . 74.34 108.958 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -59.74 -27.15 66.24 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.478 0.711 . . . . 71.32 111.601 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.92 -49.42 65.6 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.549 1.139 . . . . 74.22 111.032 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.56 -42.45 95.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.224 0.61 . . . . 73.13 110.474 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.9 mt -67.66 -25.2 65.6 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.688 -1.142 . . . . 74.32 111.711 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -78.45 -43.69 26.53 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.46 -0.57 . . . . 72.11 109.46 175.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.5 mmt . . . . . 0 N--CA 1.485 1.29 0 O-C-N 123.687 0.617 . . . . 71.52 111.543 -177.323 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 91.2 m . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 107.903 -1.147 . . . . 75.54 107.903 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -138.46 137.22 36.96 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.257 -1.016 . . . . 75.22 108.257 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -145.13 142.51 29.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.16 0.584 . . . . 74.31 110.328 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.2 mt -94.16 123.16 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.809 -1.182 . . . . 74.22 107.809 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -94.24 -31.45 14.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.075 0.55 . . . . 71.21 110.304 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -173.51 139.04 0.72 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 123.83 0.706 . . . . 74.2 109.458 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.2 mt -121.09 137.17 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 106.543 -1.651 . . . . 70.22 106.543 170.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -166.77 146.71 5.69 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.315 0.579 . . . . 63.03 111.397 -172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.9 m -74.0 126.97 31.68 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.223 -1.029 . . . . 72.33 108.223 168.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -95.16 -40.94 9.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.292 -0.633 . . . . 63.32 109.292 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 23.3 m-20 -144.55 133.49 22.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.776 -0.647 . . . . 73.45 110.375 -166.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.6 mm -127.85 142.96 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.248 1.019 . . . . 55.12 108.884 171.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.1 t -144.32 115.18 7.8 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.737 -1.209 . . . . 63.54 107.737 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -130.77 110.18 11.14 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 107.799 -1.185 . . . . 63.22 107.799 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.75 113.91 21.87 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.267 1.027 . . . . 72.54 108.921 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.99 82.67 7.09 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 106.958 -1.497 . . . . 55.14 106.958 169.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.13 -33.69 11.25 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.27 1.98 . . . . 74.25 112.176 -173.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.75 7.54 46.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.245 1.018 . . . . 74.44 110.544 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.6 -64.33 0.43 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 115.095 1.517 . . . . 70.14 115.095 -163.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.17 -22.85 29.64 Favored 'Trans proline' 0 C--N 1.39 2.746 0 C-N-CA 121.64 1.56 . . . . 41.13 112.817 -170.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -96.78 -20.88 17.9 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.493 0.717 . . . . 72.31 111.002 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' B' ' 68' ' ' LEU . 2.7 p -84.19 -20.73 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.52 0.328 . . . . 74.2 110.445 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -68.08 -24.21 65.03 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.543 0.737 . . . . 71.32 112.886 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -64.36 -15.11 59.8 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.542 0.337 . . . . 63.13 110.779 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -89.38 106.88 18.74 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.748 1.219 . . . . 75.04 109.711 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.04 89.35 7.97 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.277 0.631 . . . . 63.4 109.432 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -161.11 161.25 31.12 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.25 1.02 . . . . 73.11 108.829 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.44 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 68.5 mt-30 -85.83 104.32 5.07 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 108.723 -0.843 . . . . 71.51 108.723 173.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.494 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 16.6 Cg_endo -55.94 122.62 12.09 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 122.978 2.452 . . . . 73.42 111.801 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -62.71 109.17 1.33 Allowed 'General case' 0 C--O 1.243 0.741 0 O-C-N 123.759 0.662 . . . . 74.12 110.177 -175.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.561 HG13 HG13 ' B' ' 64' ' ' VAL . 65.9 t -87.01 128.68 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-N 115.045 -0.98 . . . . 70.13 111.231 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -106.42 118.03 35.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.77 1.628 . . . . 74.11 108.356 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.32 135.87 36.39 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.247 0.619 . . . . 35.34 110.244 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.852 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.5 m-20 -129.94 156.19 44.84 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.78 1.232 . . . . 62.53 109.084 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.546 HD13 ' HE2' ' B' ' 133' ' ' PHE . 45.5 mt -134.43 159.55 40.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.759 0.823 . . . . 71.25 109.31 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.3 t70 -159.74 112.91 2.19 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.375 -1.343 . . . . 44.21 107.375 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.1 p -116.88 119.98 37.06 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.83 0.452 . . . . 70.13 110.182 -175.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.42 161.83 25.17 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.397 1.079 . . . . 71.44 109.188 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m -142.26 165.92 26.12 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.447 -0.946 . . . . 74.4 108.447 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.7 p -150.08 136.21 18.74 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.828 0.451 . . . . 63.1 109.83 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -80.95 109.94 16.0 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.911 -0.403 . . . . 64.42 109.911 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.436 ' HB2' HG12 ' B' ' 55' ' ' VAL . 86.2 mt -76.48 -50.59 13.65 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.518 0.675 . . . . 72.34 109.226 172.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.91 -172.99 4.24 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.082 -0.963 . . . . 70.21 110.054 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -63.82 107.71 1.28 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.028 -0.987 . . . . 74.52 109.863 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 49.4 m-20 72.82 15.2 4.79 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.4 1.48 . . . . 74.21 111.642 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' B' ' 51' ' ' LEU . 75.6 t -115.51 122.15 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.348 1.059 . . . . 72.52 108.708 173.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -129.93 143.16 50.65 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.192 0.597 . . . . 74.23 111.21 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.482 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 4.6 tm-20 -103.65 100.19 10.01 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 106.809 -1.552 . . . . 63.32 106.809 171.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.0 t -90.98 139.52 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.601 0.76 . . . . 64.14 110.265 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.483 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 18.4 t -120.77 135.92 59.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.788 0.835 . . . . 71.05 109.867 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -118.17 107.47 13.99 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.604 -1.258 . . . . 73.54 107.604 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 23.1 ttm-85 -96.57 125.5 41.09 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.217 0.607 . . . . 75.12 109.69 172.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.549 ' HB ' HD11 ' B' ' 114' ' ' ILE . 14.6 t -117.0 119.81 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.565 -1.272 . . . . 65.13 107.565 169.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.852 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 62.3 m -100.49 148.07 25.18 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.639 0.776 . . . . 62.45 109.216 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.561 HG13 HG13 ' B' ' 40' ' ' VAL . 73.6 t -135.67 108.29 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.297 1.039 . . . . 63.22 108.359 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.0 m -95.82 137.84 34.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.92 -1.141 . . . . 64.32 107.92 167.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.72 150.43 32.08 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.729 -0.471 . . . . 63.43 109.729 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 50.8 p -150.89 136.72 18.14 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.493 0.496 . . . . 73.44 112.106 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.547 ' HB2' HG22 ' B' ' 31' ' ' VAL . 34.2 mt -104.95 121.41 43.68 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.336 1.054 . . . . 64.42 108.608 170.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.82 -116.98 5.01 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 115.672 -0.694 . . . . 33.43 112.341 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -122.34 23.4 9.76 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.359 1.064 . . . . 73.41 110.116 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -146.09 159.93 42.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.952 0.901 . . . . 71.14 109.961 -174.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 31.0 m -64.3 140.0 58.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.216 0.606 . . . . 70.34 111.292 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.423 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -100.97 -59.62 1.67 Allowed 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.665 -0.865 . . . . 61.45 108.665 171.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -154.35 152.29 30.05 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.788 -0.642 . . . . 63.22 110.684 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 33.3 mt -130.31 109.9 11.11 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 106.169 -1.789 . . . . 73.53 106.169 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.45 ' SG ' HG23 ' B' ' 114' ' ' ILE . 45.2 t -117.32 145.69 43.84 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.704 -0.85 . . . . 55.2 108.704 -175.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.3 tt0 -162.86 130.37 3.68 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.039 0.447 . . . . 62.45 110.046 -172.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 80.2 t -123.83 146.3 29.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.193 -0.912 . . . . 54.12 109.348 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 10.5 mt-30 -121.35 92.97 3.87 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 108.184 -1.043 . . . . 72.54 108.184 168.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.454 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 56.0 tp60 -83.65 100.27 10.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.169 -1.048 . . . . 74.54 108.169 174.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.63 170.13 36.43 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.204 -0.758 . . . . 74.32 111.204 175.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.62 127.33 1.45 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 112.311 -0.316 . . . . 72.11 112.311 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 62.5 mt -86.81 131.79 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.778 0.831 . . . . 64.1 109.125 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -136.56 164.54 27.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.104 0.962 . . . . 71.21 109.9 -175.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -129.19 108.97 10.76 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.125 -1.065 . . . . 74.42 108.125 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 40.2 pt -101.25 145.2 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.47 0.708 . . . . 61.44 110.839 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.34 160.55 38.61 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.876 0.871 . . . . 51.25 110.014 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.07 -69.93 3.01 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 123.573 0.545 . . . . 74.41 112.044 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' B' ' 97' ' ' CYS . 19.4 pt -54.39 127.86 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.744 1.218 . . . . 74.4 110.854 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.481 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 30.5 tt0 -149.59 156.02 41.25 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 110.204 -0.295 . . . . 74.41 110.204 -171.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.72 -109.71 2.94 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 112.139 -0.384 . . . . 75.04 112.139 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 42.4 m -79.6 -27.46 41.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.982 0.513 . . . . 75.42 110.649 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.481 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 40.7 mt-30 -66.3 -39.88 89.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 122.795 0.438 . . . . 74.5 110.525 -177.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -76.24 -29.54 57.57 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.988 -0.551 . . . . 74.41 110.505 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.51 -33.17 75.09 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.533 0.733 . . . . 70.34 110.501 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.446 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 17.6 t-80 -74.9 -20.35 59.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.826 1.25 . . . . 75.02 110.474 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.471 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 41.4 t -81.91 -68.51 0.69 Allowed 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.527 -0.546 . . . . 73.44 109.527 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 66.9 mt -66.95 -31.99 72.95 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.281 0.632 . . . . 70.53 112.567 -169.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.12 3.78 70.25 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-O 119.435 -0.647 . . . . 75.34 113.886 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -152.88 -65.95 0.16 Allowed 'General case' 0 C--N 1.357 0.895 0 CA-C-N 118.001 0.901 . . . . 64.41 112.553 -174.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.471 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 58.3 t80 -64.39 -47.42 79.3 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.725 0.81 . . . . 74.25 112.129 -174.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.446 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 87.7 m -60.17 -49.78 89.2 Favored Pre-proline 0 CA--C 1.566 1.562 0 C-N-CA 124.474 1.11 . . . . 63.33 111.908 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.503 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 50.8 Cg_exo -59.14 -34.77 98.63 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.068 1.846 . . . . 70.02 113.434 169.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -30.55 71.58 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.285 0.634 . . . . 71.32 110.874 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.93 -45.89 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.112 0.965 . . . . 73.31 110.565 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 49.8 mt -81.72 -12.71 58.5 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.908 -1.042 . . . . 72.4 112.065 -169.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.32 -49.08 94.51 Favored Pre-proline 0 CA--C 1.558 1.275 0 CA-C-O 117.645 -1.169 . . . . 74.13 113.502 -174.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.17 -35.84 98.37 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 121.951 1.768 . . . . 71.42 112.977 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.454 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 59.9 m-85 -68.96 -46.35 68.39 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.398 0.679 . . . . 74.11 109.851 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.03 88.59 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.611 0.764 . . . . 63.14 110.859 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.541 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 36.7 ttt180 -61.37 -54.81 38.9 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.174 1.389 . . . . 72.24 111.533 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.25 -36.05 82.84 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.541 0.736 . . . . 62.45 109.792 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.446 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.3 t -64.89 -39.31 93.33 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.526 -0.761 . . . . 45.43 111.171 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.549 HD11 ' HB ' ' B' ' 62' ' ' VAL . 70.3 mt -62.19 -54.57 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 109.633 -0.506 . . . . 75.52 109.633 174.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.478 HG21 ' OG ' ' C' ' 119' ' ' SER . 11.1 m -59.74 -30.67 68.99 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.33 1.019 . . . . 71.31 111.276 -173.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 41.7 t -60.63 -50.93 71.54 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 123.87 0.731 . . . . 71.03 109.541 173.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 7.9 mmt -68.19 -36.74 80.05 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.165 0.586 . . . . 65.0 111.453 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 114' ' ' ILE . 91.9 t -59.43 -43.42 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.056 0.942 . . . . 74.45 110.092 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.474 ' OG ' HG21 ' C' ' 115' ' ' THR . 45.9 t -71.46 -31.9 67.69 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.801 -1.09 . . . . 61.23 111.747 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.9 mtt-85 -65.8 -37.37 86.08 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 115.969 -0.56 . . . . 72.31 109.537 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.8 2.92 86.82 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.45 -0.639 . . . . 63.31 113.389 173.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 47.3 p 63.22 19.89 11.94 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 126.116 1.766 . . . . 62.51 114.182 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -81.75 153.51 70.33 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.249 0.62 . . . . 73.25 110.739 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.44 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 98.9 Cg_exo -48.77 162.62 0.36 Allowed 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 124.304 3.336 . . . . 63.12 115.67 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -61.62 128.9 38.49 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.701 1.2 . . . . 74.32 112.231 -169.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.422 HD23 HG21 ' B' ' 118' ' ' VAL . 35.5 tp -133.35 107.85 8.35 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.398 1.079 . . . . 62.22 109.202 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -124.37 134.72 53.06 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.457 0.703 . . . . 74.04 109.571 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.541 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.8 mm? -80.79 147.71 30.36 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.608 0.763 . . . . 52.14 111.075 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.87 146.63 46.5 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.738 0.815 . . . . 75.4 109.501 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.543 ' HG2' HD13 ' D' ' 16' ' ' ILE . 23.7 Cg_exo -64.12 102.75 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.414 2.076 . . . . 72.44 112.465 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 64.3 t -89.42 110.64 21.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.746 -1.205 . . . . 70.44 107.746 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -82.27 86.18 6.72 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.953 -1.128 . . . . 70.23 107.953 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.546 ' HE2' HD13 ' B' ' 44' ' ' LEU . 91.0 m-85 -54.8 -37.84 66.58 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.87 0.868 . . . . 75.03 110.728 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 134' ' ' ASP . . . . . 0.45 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 16.7 t70 -61.86 -43.77 98.17 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.104 -1.407 . . . . 62.22 111.109 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.19 -42.94 62.16 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.59 0.756 . . . . 65.51 111.116 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.42 -16.03 60.39 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.223 0.453 . . . . 71.52 112.223 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 63.4 t80 . . . . . 0 N--CA 1.483 1.205 0 C-N-CA 123.221 0.608 . . . . 71.55 109.817 171.641 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 24.9 m . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 108.707 -0.849 . . . . 71.12 108.707 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -122.41 123.21 40.81 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.264 0.626 . . . . 73.53 109.671 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -143.72 133.91 24.39 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.055 0.942 . . . . 53.1 108.492 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 36.5 mt -81.22 126.43 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.76 -0.829 . . . . 72.34 108.76 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.541 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 29.4 mm-40 -88.0 -47.02 8.85 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.646 -0.707 . . . . 72.52 110.148 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -174.81 138.88 0.49 Allowed 'General case' 0 C--N 1.352 0.706 0 CA-C-N 115.373 -0.83 . . . . 53.32 109.441 -168.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -128.31 141.0 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 107.824 -1.176 . . . . 73.15 107.824 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -170.41 171.14 6.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.469 0.652 . . . . 64.5 110.885 -170.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -96.26 110.91 23.13 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.758 -0.83 . . . . 64.23 108.758 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -71.81 -34.26 69.21 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.933 -0.766 . . . . 62.12 108.933 173.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.5 t70 -146.52 146.51 30.53 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.072 -0.967 . . . . 72.44 109.295 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.3 mt -141.86 144.26 25.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.815 1.646 . . . . 73.22 106.912 175.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t -155.05 151.05 27.94 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.641 0.734 . . . . 70.24 110.433 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -148.67 148.63 30.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.197 -1.365 . . . . 75.2 107.354 171.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.594 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.5 mt-10 -143.77 139.25 29.3 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.003 0.921 . . . . 74.42 109.29 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.45 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -155.06 73.42 5.67 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 106.263 -1.754 . . . . 43.44 106.263 169.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.29 -10.88 16.19 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.147 1.898 . . . . 74.32 111.766 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -114.98 20.7 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.984 1.314 . . . . 71.2 109.306 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.465 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -55.82 -53.49 62.35 Favored Pre-proline 0 CA--C 1.561 1.385 0 N-CA-C 113.348 0.869 . . . . 73.32 113.348 -168.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.38 -42.38 68.25 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 121.752 1.635 . . . . 73.21 113.015 177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -70.84 -35.36 72.4 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.657 0.783 . . . . 74.42 112.444 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -79.5 -24.17 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 112.262 0.467 . . . . 64.21 112.262 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -68.99 -22.86 64.06 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.983 -0.448 . . . . 75.21 111.79 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -95.61 6.42 48.99 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.238 0.615 . . . . 72.33 111.048 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.403 ' HG2' HD13 ' C' ' 68' ' ' LEU . 2.8 tppp? -92.89 142.5 27.24 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.756 0.822 . . . . 72.32 111.562 -172.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -71.2 134.14 46.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.748 1.219 . . . . 64.15 109.618 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -84.75 102.36 12.94 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.961 0.726 . . . . 73.41 112.961 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -121.16 67.84 17.32 Favored Pre-proline 0 N--CA 1.484 1.263 0 N-CA-C 107.507 -1.294 . . . . 73.52 107.507 160.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -84.15 118.75 2.35 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 122.969 2.446 . . . . 73.42 112.951 -171.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -86.35 99.16 11.41 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.953 -1.128 . . . . 74.13 107.953 167.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 p -76.83 98.82 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.688 0.756 . . . . 72.11 109.35 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.8 101.48 13.29 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.506 -2.035 . . . . 74.32 105.506 169.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 9.0 tt -86.38 142.3 28.55 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.305 -1.368 . . . . 75.01 107.305 174.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.567 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.1 t70 -119.58 133.63 55.58 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.685 -0.857 . . . . 73.21 108.685 -173.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.0 mt -112.71 123.36 50.14 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.467 -0.938 . . . . 71.41 108.467 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.3 t70 -135.78 126.6 27.47 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.397 -1.334 . . . . 44.23 107.397 172.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -137.58 128.17 26.76 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.583 0.706 . . . . 70.3 109.699 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.05 152.27 46.08 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 113.93 -1.486 . . . . 71.24 107.523 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -140.43 145.38 36.93 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.838 -0.43 . . . . 73.33 109.838 -174.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -143.84 135.71 26.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.492 0.717 . . . . 52.25 110.433 -168.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -72.75 122.67 21.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.471 0.708 . . . . 74.12 110.741 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.611 HD11 HD12 ' C' ' 83' ' ' ILE . 36.1 mt -91.71 -45.8 8.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.473 -0.936 . . . . 64.24 108.473 172.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.01 178.29 8.83 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.323 -1.308 . . . . 73.54 108.901 174.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -74.19 134.12 42.75 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.062 -0.718 . . . . 63.54 109.062 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 69.16 -0.21 2.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.478 1.511 . . . . 75.12 113.114 -171.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.1 t -123.35 94.82 3.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 123.961 0.904 . . . . 64.35 108.701 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -116.11 125.35 52.25 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.961 -1.125 . . . . 70.52 107.961 -176.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.491 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.1 tt0 -82.26 138.21 34.66 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.686 0.794 . . . . 65.44 109.519 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 63.6 t -115.45 130.05 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.916 -0.772 . . . . 73.31 108.916 170.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 97.0 t -111.76 133.73 56.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.542 -1.281 . . . . 73.43 107.542 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.06 104.31 8.8 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.455 -0.943 . . . . 72.12 108.455 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.54 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 33.1 ttm-85 -95.48 108.7 20.94 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.583 -0.895 . . . . 62.44 108.583 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.546 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.8 t -109.38 122.52 64.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.834 -1.173 . . . . 74.54 107.834 172.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.3 m -124.55 114.66 19.7 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.091 0.556 . . . . 71.31 109.837 -174.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.562 HG11 HD11 ' C' ' 126' ' ' LEU . 78.1 t -99.25 107.82 21.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.761 -0.829 . . . . 71.34 108.761 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.522 HG23 HD23 ' C' ' 75' ' ' LEU . 1.6 m -99.46 106.83 18.91 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.374 -1.343 . . . . 71.5 107.374 174.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.54 124.19 46.8 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.239 -1.023 . . . . 70.44 108.239 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 59.7 m -134.72 163.69 29.22 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.928 0.394 . . . . 65.34 110.651 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.403 HD13 ' HG2' ' C' ' 34' ' ' LYS . 30.7 mt -124.3 15.22 9.02 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.093 1.357 . . . . 62.44 109.785 -173.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.54 -93.04 0.42 Allowed Glycine 0 C--N 1.344 1.013 0 N-CA-C 110.381 -1.088 . . . . 51.03 110.381 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -100.04 -30.76 11.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.108 0.963 . . . . 71.12 109.599 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -75.34 122.68 24.12 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.592 1.157 . . . . 73.25 110.715 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 78.8 m -78.37 125.84 29.93 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.803 -1.184 . . . . 54.44 107.803 162.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.706 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.44 -64.74 0.86 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.549 -0.908 . . . . 51.33 108.549 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.69 168.72 24.14 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.28 -0.873 . . . . 65.11 109.675 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.1 tm? -128.36 142.28 51.17 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.515 -1.661 . . . . 74.23 106.515 169.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 47.4 t -144.23 145.47 32.08 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 107.817 -1.179 . . . . 75.1 107.817 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -157.61 128.14 6.41 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.891 -0.411 . . . . 74.12 109.891 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.58 125.29 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 123.855 0.862 . . . . 71.51 108.79 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.54 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.5 mt-30 -103.75 86.86 2.68 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.531 -0.914 . . . . 52.21 108.531 173.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -78.46 97.91 5.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.676 -1.147 . . . . 74.32 108.949 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.27 149.16 24.74 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.291 -0.868 . . . . 72.52 110.98 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.514 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -153.81 117.12 0.78 Allowed Glycine 0 CA--C 1.502 -0.723 0 N-CA-C 110.891 -0.884 . . . . 72.42 110.891 -176.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.611 HD12 HD11 ' C' ' 51' ' ' LEU . 9.6 mm -81.97 119.55 31.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.461 -0.941 . . . . 73.25 108.461 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -125.21 118.58 26.36 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.837 -0.801 . . . . 71.25 108.837 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.2 m -77.54 103.21 7.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.156 -0.683 . . . . 62.3 109.156 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.546 HG12 HD21 ' C' ' 98' ' ' LEU . 1.7 pp -122.63 123.52 68.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 123.762 0.825 . . . . 71.41 110.143 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.25 162.04 27.15 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.554 1.142 . . . . 62.23 109.225 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.68 -34.29 3.92 Favored Glycine 0 N--CA 1.473 1.133 0 N-CA-C 113.805 0.282 . . . . 73.11 113.805 173.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.472 HD11 ' HB ' ' C' ' 86' ' ' ILE . 28.0 pt -90.15 144.57 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.924 0.889 . . . . 62.42 111.07 -177.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -161.95 155.98 21.77 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.511 0.724 . . . . 63.52 110.079 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.72 -117.83 7.88 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.586 -0.734 . . . . 72.52 113.198 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 32.6 p -69.35 -25.07 64.01 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.001 0.92 . . . . 74.51 111.816 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -71.45 -52.34 19.0 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.591 0.757 . . . . 63.24 110.685 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -30.58 68.37 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.681 -0.69 . . . . 74.3 111.466 -174.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.13 -47.79 82.22 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 124.244 0.965 . . . . 74.3 110.692 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.439 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 10.5 t-160 -78.56 -35.56 45.82 Favored 'General case' 0 C--O 1.246 0.886 0 O-C-N 123.548 0.53 . . . . 62.31 111.994 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -58.65 -40.65 84.02 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.474 0.484 . . . . 74.54 110.665 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.546 HD21 HG12 ' C' ' 86' ' ' ILE . 31.0 mt -101.72 -10.68 19.75 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.994 0.518 . . . . 74.23 111.341 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.91 -30.55 63.31 Favored Glycine 0 C--N 1.355 1.584 0 N-CA-C 113.953 0.341 . . . . 53.32 113.953 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.63 -35.99 0.06 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.137 0.421 . . . . 71.22 112.137 -171.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -65.31 -43.49 90.91 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.318 1.447 . . . . 74.25 112.216 -176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -84.24 -42.59 0.74 Allowed Pre-proline 0 CA--C 1.567 1.601 0 CA-C-O 118.588 -0.72 . . . . 61.31 112.245 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -54.2 -25.55 38.5 Favored 'Trans proline' 0 C--N 1.397 3.113 0 C-N-CA 122.747 2.298 . . . . 72.12 114.095 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -61.37 -38.26 86.34 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.62 0.768 . . . . 60.01 110.822 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.534 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.5 mm -67.1 -39.88 84.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.196 -0.911 . . . . 73.24 110.306 177.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.514 HD21 ' HA3' ' C' ' 82' ' ' GLY . 60.5 mt -79.45 -22.75 43.73 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.943 0.897 . . . . 72.54 112.065 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -55.6 -52.8 69.02 Favored Pre-proline 0 CA--C 1.558 1.284 0 N-CA-C 114.08 1.141 . . . . 75.24 114.08 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.05 -29.01 65.85 Favored 'Trans proline' 0 C--N 1.386 2.531 0 CA-C-N 121.286 1.495 . . . . 72.03 112.637 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -70.29 -47.87 59.26 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.981 0.512 . . . . 75.34 109.674 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.82 -45.18 78.39 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.989 -1.005 . . . . 55.31 109.789 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.575 ' HG3' ' HB3' ' C' ' 128' ' ' LEU . 44.9 ttt-85 -56.21 -52.98 62.45 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.35 1.46 . . . . 71.12 111.708 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.28 -37.27 85.06 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.344 0.658 . . . . 75.31 110.483 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 21.1 t -71.36 -29.25 64.75 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 122.954 0.502 . . . . 73.32 111.628 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.546 HD11 ' HB ' ' C' ' 62' ' ' VAL . 98.0 mt -69.43 -52.34 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 109.342 -0.614 . . . . 52.24 109.342 173.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.474 HG21 ' OG ' ' B' ' 119' ' ' SER . 5.8 m -61.79 -31.16 71.36 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.58 0.752 . . . . 74.45 110.937 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.9 t -63.5 -52.68 60.2 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.433 0.693 . . . . 53.44 109.19 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.531 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.17 -38.01 84.97 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.263 1.025 . . . . 64.44 112.473 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' C' ' 114' ' ' ILE . 83.3 t -61.59 -48.35 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.656 0.783 . . . . 53.5 110.009 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.478 ' OG ' HG21 ' B' ' 115' ' ' THR . 41.7 t -67.23 -27.37 67.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.574 -1.194 . . . . 73.22 111.519 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -72.68 -40.75 66.02 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.181 0.592 . . . . 60.21 109.62 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -3.91 79.38 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.426 0.454 . . . . 51.42 112.747 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.1 p 62.95 33.78 14.66 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 126.853 2.061 . . . . 74.23 113.222 173.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.61 151.69 62.19 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.087 -1.079 . . . . 71.1 108.087 168.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -57.25 166.16 4.7 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.679 2.253 . . . . 72.35 113.6 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -46.44 138.24 5.89 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.344 1.457 . . . . 74.3 114.672 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.562 HD11 HG11 ' C' ' 64' ' ' VAL . 5.4 tt -119.84 85.29 2.35 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.91 -1.144 . . . . 61.54 107.91 169.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -92.17 94.59 9.28 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.225 -1.028 . . . . 74.23 108.225 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.575 ' HB3' ' HG3' ' C' ' 111' ' ' ARG . 16.7 tp -70.05 123.55 21.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.416 -0.811 . . . . 62.12 110.163 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.23 154.85 88.27 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 124.38 1.072 . . . . 60.44 111.402 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.675 ' HG3' HD12 ' A' ' 16' ' ' ILE . 45.9 Cg_exo -55.11 111.12 0.65 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.837 2.358 . . . . 54.24 113.291 172.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.55 115.74 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.443 -1.318 . . . . 61.11 107.443 167.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -82.13 86.62 6.58 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.775 -0.824 . . . . 70.44 108.775 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -62.63 -43.22 99.35 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.927 -1.033 . . . . 73.31 110.628 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.05 -42.99 93.73 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 114.049 -1.432 . . . . 70.43 111.27 -169.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.7 95.29 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 123.711 0.632 . . . . 74.44 111.676 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.04 -49.11 63.43 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.949 0.5 . . . . 74.24 110.021 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 137' ' ' PHE . . . . . 0.439 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 3.0 t80 . . . . . 0 CA--C 1.555 1.139 0 CA-C-N 116.087 -0.506 . . . . 61.34 110.107 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.585 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 27.9 m . . . . . 0 C--O 1.237 0.433 0 CA-C-O 120.993 0.425 . . . . 54.12 111.106 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -156.99 95.48 1.51 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.116 -1.439 . . . . 64.33 107.116 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -122.48 121.58 36.92 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.982 -0.747 . . . . 73.22 108.982 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.407 HD13 HG21 ' D' ' 105' ' ' ILE . 10.4 mt -84.75 121.61 37.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.046 -0.724 . . . . 55.31 109.046 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -87.04 -36.23 18.31 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 119.286 -0.387 . . . . 74.12 111.616 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -172.38 122.88 0.46 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 120.788 -0.365 . . . . 62.3 111.822 -164.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.543 HD13 ' HG2' ' B' ' 130' ' ' PRO . 1.7 mp -104.41 137.91 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.886 -1.153 . . . . 64.45 107.886 166.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.502 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 30.8 p90 -161.43 177.06 10.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.151 0.907 . . . . 73.34 111.223 178.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.3 p -108.71 126.05 52.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.798 -1.092 . . . . 74.24 108.959 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.502 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 24.9 mtpt -93.88 -12.72 28.29 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.575 -0.528 . . . . 74.13 109.575 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.4 t70 -169.8 136.02 1.52 Allowed 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.516 1.126 . . . . 74.04 108.66 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.531 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.4 mt -135.47 143.6 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.436 1.094 . . . . 75.04 108.403 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -142.69 134.98 27.56 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.249 1.02 . . . . 74.33 109.252 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.528 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.7 t80 -144.22 130.81 20.03 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.377 -1.712 . . . . 73.01 106.377 165.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.8 mt-10 -131.19 150.04 52.32 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.499 0.72 . . . . 73.42 109.377 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.12 76.86 10.21 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 106.939 -1.504 . . . . 74.11 106.939 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.78 -32.72 22.56 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.855 2.37 . . . . 63.14 112.326 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -96.62 0.09 49.38 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.078 -0.964 . . . . 72.22 110.864 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.14 -68.03 0.1 OUTLIER Pre-proline 0 CA--C 1.559 1.297 0 N-CA-C 115.64 1.718 . . . . 72.0 115.64 -160.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -78.04 -16.96 13.89 Favored 'Trans proline' 0 C--N 1.383 2.37 0 CA-C-N 122.655 1.984 . . . . 63.23 113.709 -172.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -74.7 -42.16 58.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.185 0.994 . . . . 74.33 109.394 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.567 HG22 HD12 ' D' ' 68' ' ' LEU . 9.2 p -83.82 -20.61 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 115.827 -0.624 . . . . 55.22 111.093 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -64.24 -16.92 63.0 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.208 0.603 . . . . 72.12 111.923 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -68.55 -2.93 9.96 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.83 0.852 . . . . 72.53 111.801 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 89.1 mttt -109.92 101.67 10.49 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 125.125 1.37 . . . . 75.11 109.809 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -84.35 83.34 8.02 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.444 0.64 . . . . 71.44 109.518 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -146.41 157.2 43.74 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.571 1.149 . . . . 73.4 108.735 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -77.09 105.37 2.4 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.67 -0.863 . . . . 65.54 108.67 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.26 119.07 5.93 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.13 2.553 . . . . 64.34 113.909 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.15 116.22 7.7 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.089 0.956 . . . . 74.04 109.101 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.525 HG12 ' HB2' ' D' ' 66' ' ' ALA . 27.6 m -101.96 119.57 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 121.665 0.745 . . . . 73.13 112.069 -169.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 107.98 18.83 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.123 -1.806 . . . . 72.45 106.123 167.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.556 ' H ' HD23 ' D' ' 42' ' ' LEU . 1.3 pt? -98.14 156.08 16.85 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.418 0.627 . . . . 72.54 110.795 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -141.08 146.56 37.28 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.575 1.15 . . . . 73.21 108.522 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 26.4 tp -127.28 131.98 50.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.709 0.804 . . . . 63.54 109.397 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.597 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.0 t70 -141.58 144.43 34.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.473 -0.936 . . . . 72.1 108.473 173.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.5 t -134.55 158.84 42.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.676 -0.49 . . . . 71.21 109.676 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.12 157.2 35.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.033 -0.985 . . . . 51.1 108.384 174.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.7 p -153.96 148.2 25.89 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.596 -0.52 . . . . 64.44 109.596 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 57.2 p -162.58 142.23 9.35 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.124 0.569 . . . . 71.42 110.236 -171.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -71.52 125.41 26.98 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.998 0.919 . . . . 74.5 111.353 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 mt -94.63 -35.47 12.19 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.102 0.561 . . . . 61.55 109.917 172.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.75 -171.45 3.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.792 0.837 . . . . 63.3 110.381 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -59.68 113.22 2.13 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.701 0.626 . . . . 64.14 110.508 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 65.24 13.29 8.66 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.927 1.291 . . . . 62.51 111.677 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 81.8 t -109.43 118.92 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.496 -0.927 . . . . 71.2 108.496 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -127.93 127.55 43.52 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.329 -0.989 . . . . 71.31 108.329 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -94.03 122.54 36.65 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.214 1.006 . . . . 72.22 108.648 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.11 124.57 53.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.714 -1.217 . . . . 73.22 107.714 172.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.549 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.3 t -100.56 127.59 53.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.654 -0.869 . . . . 55.02 108.654 171.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.03 117.38 33.85 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.309 -0.997 . . . . 54.34 108.309 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.597 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.3 ttm-85 -96.73 114.28 25.91 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.881 -1.525 . . . . 72.13 106.881 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.402 HG21 ' HB1' ' D' ' 110' ' ' ALA . 64.4 t -118.03 116.84 52.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.977 -1.12 . . . . 71.24 107.977 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 74.1 m -119.17 134.61 55.11 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.615 -0.721 . . . . 72.33 109.461 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 78.1 t -131.01 118.07 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.49 0.716 . . . . 73.34 109.905 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -112.39 97.29 6.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.462 1.105 . . . . 60.04 108.279 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.525 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -96.2 161.72 13.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.321 0.649 . . . . 63.02 111.318 -173.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 28.4 p -154.66 137.33 15.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.221 -0.899 . . . . 54.32 111.663 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.567 HD12 HG22 ' D' ' 31' ' ' VAL . 65.8 mt -101.28 96.56 7.27 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.675 -1.148 . . . . 74.23 108.104 168.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.24 -130.48 10.86 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.892 -0.594 . . . . 55.41 112.671 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.26 4.86 21.94 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.109 0.964 . . . . 71.33 112.156 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.45 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 6.4 tp10 -133.46 142.46 48.29 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.918 0.887 . . . . 73.55 110.742 -165.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.0 m -60.59 133.14 55.8 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.047 0.939 . . . . 75.55 111.309 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.431 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.06 -72.6 0.57 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.321 -0.992 . . . . 73.12 108.321 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -141.02 153.77 45.69 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 115.804 -0.635 . . . . 70.03 110.514 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 55.5 mt -114.68 151.09 34.2 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.397 1.079 . . . . 71.43 108.207 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.643 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.9 t -158.94 145.27 16.86 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.572 0.349 . . . . 71.42 110.721 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -155.75 122.7 5.35 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.448 0.699 . . . . 72.32 109.647 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.91 115.65 43.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 109.464 -0.569 . . . . 74.05 109.464 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.505 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -89.8 83.14 6.18 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.112 0.958 . . . . 65.11 108.775 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.42 91.87 5.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 113.619 -1.628 . . . . 63.51 108.997 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.23 141.95 17.15 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.635 -0.586 . . . . 73.41 111.635 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.54 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -140.07 130.14 4.54 Favored Glycine 0 C--O 1.228 -0.269 0 N-CA-C 111.49 -0.644 . . . . 54.42 111.49 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.7 mt -88.29 122.53 39.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.492 1.117 . . . . 62.52 108.977 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -123.74 156.98 35.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.303 0.641 . . . . 71.32 109.634 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.4 m -115.15 108.08 16.16 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.417 -0.957 . . . . 62.13 108.417 170.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.422 HD13 HD13 ' D' ' 98' ' ' LEU . 41.0 pt -105.75 139.84 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.486 0.714 . . . . 74.21 109.352 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -160.04 150.58 18.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.652 0.781 . . . . 60.03 109.74 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.43 -16.19 46.09 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.903 -0.387 . . . . 70.1 113.58 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' D' ' 94' ' ' MET . 43.2 pt -97.96 149.8 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.752 0.821 . . . . 72.32 109.822 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -168.3 177.68 5.29 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.165 0.586 . . . . 74.31 110.761 -168.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.07 -117.5 11.21 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.698 0.624 . . . . 74.32 112.817 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 19.3 m -92.27 -24.08 19.1 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.456 0.703 . . . . 71.45 110.861 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -61.16 -33.84 74.07 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.909 0.884 . . . . 74.35 111.164 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.505 ' HA ' HD12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -63.85 -33.98 76.9 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.099 -0.5 . . . . 72.42 111.332 177.379 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.32 -32.61 55.39 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.018 0.527 . . . . 74.34 110.758 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.4 t-80 -72.62 -26.38 61.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.755 0.822 . . . . 61.22 111.264 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -90.54 -50.37 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.931 0.493 . . . . 72.24 110.877 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.601 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 13.9 tp -82.42 -27.21 32.13 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.117 0.567 . . . . 75.4 111.68 -170.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.62 14.13 42.36 Favored Glycine 0 N--CA 1.477 1.379 0 CA-C-O 119.879 -0.401 . . . . 73.5 113.46 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -144.41 -64.41 0.36 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.929 0.492 . . . . 54.1 110.642 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -69.95 -40.11 75.66 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.677 0.391 . . . . 74.34 111.644 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.601 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 85.6 m -66.35 -47.27 59.92 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.405 -0.807 . . . . 73.33 112.152 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 78.1 Cg_exo -56.79 -32.62 92.14 Favored 'Trans proline' 0 C--N 1.4 3.237 0 C-N-CA 122.231 1.954 . . . . 73.24 113.386 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.46 -30.5 70.86 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.153 0.581 . . . . 63.02 111.678 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.407 HG21 HD13 ' D' ' 13' ' ' ILE . 95.2 mt -72.9 -37.25 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.72 0.808 . . . . 72.44 110.316 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.54 HD21 ' HA3' ' D' ' 82' ' ' GLY . 92.5 mt -75.66 -20.38 58.5 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.226 -0.897 . . . . 74.53 111.769 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -67.94 -43.47 37.09 Favored Pre-proline 0 CA--C 1.563 1.451 0 N-CA-C 113.763 1.023 . . . . 75.42 113.763 -171.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.69 -38.73 87.7 Favored 'Trans proline' 0 C--N 1.395 2.99 0 C-N-CA 121.931 1.754 . . . . 75.33 112.383 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -74.75 -32.74 62.17 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.902 0.751 . . . . 75.33 111.348 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.402 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -64.71 -53.93 39.46 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.224 -0.658 . . . . 62.03 109.224 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.431 HH12 ' HB3' ' D' ' 130' ' ' PRO . 40.5 ttp180 -58.14 -44.3 87.77 Favored 'General case' 0 C--O 1.212 -0.907 0 O-C-N 124.603 1.189 . . . . 64.32 110.509 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.17 -46.22 89.95 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.863 0.727 . . . . 74.3 111.137 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.82 -44.67 90.91 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.012 0.82 . . . . 65.14 110.339 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.643 HG12 ' SG ' ' D' ' 76' ' ' CYS . 69.0 mt -64.28 -52.29 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 124.033 0.833 . . . . 71.33 110.617 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 88.2 m -56.06 -43.68 78.14 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.679 1.192 . . . . 71.14 111.338 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.6 t -64.83 -41.63 95.58 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.995 -1.002 . . . . 43.33 109.978 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.8 mtm -69.85 -28.76 65.94 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.937 0.495 . . . . 61.34 111.917 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' D' ' 123' ' ' PHE . 54.7 t -70.72 -39.75 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.69 0.796 . . . . 71.1 110.419 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.2 p -76.66 -26.9 55.34 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.73 0.412 . . . . 52.32 110.729 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -73.78 -35.38 64.95 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.133 0.573 . . . . 74.15 109.475 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.95 -0.51 89.59 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 115.743 -0.662 . . . . 74.02 112.338 173.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.2 p 64.9 18.93 11.7 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.899 2.08 . . . . 71.44 114.327 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.417 ' HB2' HG13 ' D' ' 118' ' ' VAL . 96.3 m-85 -79.45 150.79 74.06 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 109.131 -0.692 . . . . 74.11 109.131 169.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.35 137.85 47.04 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.924 2.416 . . . . 52.22 112.771 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -55.74 143.36 31.11 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.915 1.286 . . . . 74.02 113.42 -168.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 50.0 tp -115.17 97.42 6.19 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.336 1.054 . . . . 70.41 109.716 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -104.16 89.65 3.33 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.731 -0.47 . . . . 72.53 109.731 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 36.4 tp -67.05 137.55 56.52 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.434 -0.803 . . . . 73.0 109.714 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.31 130.39 91.65 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.594 0.757 . . . . 62.25 111.113 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.431 ' HB3' HH12 ' D' ' 111' ' ' ARG . 56.6 Cg_endo -70.88 116.84 4.85 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.189 1.926 . . . . 72.03 110.756 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.03 124.39 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.554 0.742 . . . . 55.42 109.773 -171.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -73.9 96.28 2.59 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.659 -0.867 . . . . 73.24 108.659 171.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -68.38 -23.73 64.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.824 -0.625 . . . . 70.04 111.3 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.03 -54.85 41.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.277 1.031 . . . . 65.01 110.642 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.06 91.33 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.306 1.004 . . . . 74.03 111.144 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 16.6 tp -72.93 -22.18 60.77 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 115.85 -0.614 . . . . 73.33 111.634 -176.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 78.4 t80 . . . . . 0 N--CA 1.483 1.199 0 C-N-CA 123.852 0.861 . . . . 74.23 110.044 176.059 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 60.5 m . . . . . 0 C--O 1.244 0.787 0 N-CA-C 108.048 -1.093 . . . . 62.33 108.048 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.611 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.0 t80 -135.88 129.53 32.44 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.298 -0.63 . . . . 64.05 109.298 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -143.43 117.01 9.17 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.639 -1.245 . . . . 71.34 107.639 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.485 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.1 mt -87.07 125.28 40.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.934 -0.765 . . . . 74.43 108.934 176.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.43 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -79.62 -43.86 22.08 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 124.05 0.844 . . . . 74.11 108.901 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -173.38 128.79 0.44 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 119.495 -0.288 . . . . 72.14 111.096 -168.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.7 mt -113.04 124.05 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 123.665 0.786 . . . . 75.12 109.427 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HE1' HG13 ' A' ' 83' ' ' ILE . 25.3 p90 -152.96 141.33 20.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.31 1.044 . . . . 73.2 110.423 -169.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.8 p -75.53 110.98 10.36 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.552 -0.536 . . . . 74.22 109.552 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.531 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 36.0 mtpt -75.96 -27.57 57.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.978 -0.378 . . . . 41.34 109.978 176.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.669 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.3 t70 -148.53 138.57 22.36 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.166 -0.924 . . . . 62.24 110.061 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 86.9 mt -134.77 142.32 40.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 125.629 1.572 . . . . 65.01 106.895 173.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -148.73 140.72 23.85 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 123.63 0.581 . . . . 64.32 109.972 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.523 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 77.0 t80 -143.05 127.07 17.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.255 -1.757 . . . . 75.21 106.255 173.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -137.64 121.37 17.47 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.91 -0.404 . . . . 61.12 109.91 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -129.83 77.24 77.15 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 107.997 -1.112 . . . . 71.23 107.997 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.43 -19.38 37.78 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.059 2.506 . . . . 72.33 112.188 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -120.17 28.91 7.78 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.88 0.872 . . . . 71.33 109.743 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -55.69 -46.84 99.67 Favored Pre-proline 0 CA--C 1.566 1.58 0 N-CA-C 113.45 0.907 . . . . 52.04 113.45 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.29 -13.23 18.88 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 122.2 1.933 . . . . 63.41 112.576 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -90.81 -34.27 15.37 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.745 0.818 . . . . 74.41 110.717 -173.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.554 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 35.9 m -77.78 -17.42 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.494 0.718 . . . . 75.34 111.416 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.584 ' HD1' HH11 ' B' ' 15' ' ' ARG . 75.2 t80 -60.26 -35.07 74.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.318 1.047 . . . . 74.13 110.145 165.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -86.73 -52.58 5.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.097 0.959 . . . . 55.33 111.65 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 17.7 ptpt -73.89 170.77 14.68 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.735 0.414 . . . . 64.13 111.419 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.93 128.21 35.13 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.105 -0.498 . . . . 71.24 109.663 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.3 t-105 -72.34 94.2 1.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 O-C-N 123.793 0.683 . . . . 72.22 109.861 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -128.45 84.85 61.97 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.58 1.152 . . . . 70.43 108.706 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 49.2 Cg_endo -87.49 165.25 7.94 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.351 2.034 . . . . 73.4 112.451 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -121.99 106.71 11.46 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.83 -1.174 . . . . 62.02 107.83 168.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.8 m -73.7 92.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-O 122.764 1.268 . . . . 42.24 110.761 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -95.05 124.55 39.16 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.516 -1.22 . . . . 72.34 109.315 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.416 HD22 HD11 ' A' ' 128' ' ' LEU . 50.7 tp -120.52 115.56 23.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.412 0.685 . . . . 72.42 110.072 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 15.1 t70 -106.52 108.43 19.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.945 -1.132 . . . . 74.43 107.945 168.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 60' ' ' LEU . 1.2 tm? -97.59 119.2 35.72 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.584 -1.265 . . . . 53.13 107.584 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -127.08 151.11 49.06 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.508 1.123 . . . . 73.04 109.561 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.8 m -134.9 139.78 45.26 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.05 0.94 . . . . 72.02 109.541 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.28 153.6 51.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.913 1.285 . . . . 73.41 108.387 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 m -133.0 151.63 52.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.235 0.614 . . . . 74.1 109.669 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -150.36 121.47 7.74 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.651 -0.87 . . . . 73.21 108.651 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -79.67 125.55 29.78 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.902 0.382 . . . . 64.21 110.762 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.423 ' HB2' HG12 ' A' ' 55' ' ' VAL . 66.3 mt -93.37 -34.7 13.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.964 0.906 . . . . 74.11 111.448 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.498 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -164.19 -172.49 2.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.534 0.734 . . . . 60.32 110.866 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.05 116.98 5.83 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.431 0.693 . . . . 70.22 109.558 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 71.47 -7.19 1.24 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 125.412 1.485 . . . . 75.42 112.419 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 60.6 t -104.69 125.06 59.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 124.45 1.1 . . . . 73.44 109.1 -174.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -143.0 171.3 14.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.018 -0.734 . . . . 72.0 109.018 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -125.12 152.0 45.0 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.776 -0.824 . . . . 73.44 108.776 167.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.7 t -115.62 126.73 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 107.876 -1.157 . . . . 75.15 107.876 168.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.3 t -97.96 105.48 17.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.046 -1.094 . . . . 74.53 108.046 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 44' ' ' LEU . 42.7 tp -91.96 100.19 12.89 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.074 -0.714 . . . . 71.12 109.074 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -83.59 101.37 11.43 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.872 -0.788 . . . . 72.21 108.872 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.4 t -100.14 101.84 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.781 -1.192 . . . . 72.11 107.781 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.8 m -96.36 109.62 22.11 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.174 -0.676 . . . . 70.21 109.174 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.5 t -112.31 131.43 63.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.913 -1.143 . . . . 70.52 107.913 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -135.64 150.55 49.65 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.264 -1.013 . . . . 70.12 108.264 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -139.44 116.43 10.98 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.668 -1.234 . . . . 65.04 107.668 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.7 m -141.38 145.08 34.93 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.677 0.391 . . . . 53.11 111.793 -170.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.535 HD12 ' HZ3' ' A' ' 34' ' ' LYS . 3.2 tm? -94.79 87.53 5.04 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.708 -1.219 . . . . 73.03 107.708 170.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.5 -104.82 1.82 Allowed Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.791 -0.641 . . . . 53.44 112.583 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -95.36 -25.84 16.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.5 0.72 . . . . 71.32 110.771 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.55 123.08 29.39 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.789 0.435 . . . . 54.23 110.504 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 m -77.97 127.07 31.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.022 0.529 . . . . 72.34 110.121 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -80.43 -51.13 9.19 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.647 -0.871 . . . . 72.42 108.647 173.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -160.94 159.98 30.25 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.431 -1.259 . . . . 75.22 110.827 172.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 55.2 tp -129.84 143.03 50.6 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.289 1.435 . . . . 63.02 107.776 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.609 ' SG ' HG22 ' A' ' 118' ' ' VAL . 56.9 m -147.17 103.85 3.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.157 0.983 . . . . 51.22 109.099 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -128.54 127.46 42.42 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.654 -0.869 . . . . 73.14 108.654 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.5 t -128.75 110.96 22.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.732 -0.84 . . . . 74.23 108.732 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.669 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.3 mt-30 -85.26 85.67 7.44 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 108.449 -0.945 . . . . 74.2 108.449 171.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.516 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.1 tp-100 -76.51 102.17 5.93 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.096 -1.411 . . . . 75.34 109.035 -178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.89 164.96 37.74 Favored Glycine 0 C--N 1.337 0.639 0 N-CA-C 111.334 -0.706 . . . . 61.51 111.334 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.05 124.94 1.1 Allowed Glycine 0 CA--C 1.51 -0.272 0 N-CA-C 111.765 -0.534 . . . . 73.2 111.765 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.469 HG13 ' HE1' ' A' ' 17' ' ' TYR . 46.5 mt -81.13 126.06 39.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.275 -0.639 . . . . 64.21 109.275 176.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.611 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 37.3 m-85 -128.56 137.72 51.87 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.388 1.075 . . . . 74.14 108.135 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.5 m -107.77 115.9 30.98 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.726 -0.842 . . . . 63.41 108.726 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.4 tt -105.52 143.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.628 0.771 . . . . 75.32 110.484 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.49 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -161.68 146.41 13.12 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.754 0.821 . . . . 73.42 109.701 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.36 -32.45 6.81 Favored Glycine 0 C--N 1.341 0.84 0 O-C-N 123.541 0.526 . . . . 52.45 113.713 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.29 146.11 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.947 0.499 . . . . 65.24 112.179 -165.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -135.71 173.07 12.12 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.279 1.031 . . . . 72.14 110.46 -174.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.479 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 56.95 -115.66 6.78 Favored Glycine 0 C--N 1.356 1.666 0 N-CA-C 115.61 1.004 . . . . 63.52 115.61 170.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.5 p -66.17 -33.98 77.0 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.671 0.789 . . . . 75.42 111.159 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -70.17 -43.43 70.82 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.199 -0.91 . . . . 71.31 110.874 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.513 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 13.2 ptt? -66.04 -37.23 85.34 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.132 -0.692 . . . . 62.41 109.132 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.78 81.58 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 123.542 0.737 . . . . 72.3 110.628 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -64.87 -35.8 82.31 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.646 -0.706 . . . . 45.2 110.639 174.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 61.0 m -69.0 -41.66 77.5 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.013 0.525 . . . . 71.24 111.331 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 94' ' ' MET . 65.3 mt -78.9 -43.69 24.32 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.513 0.725 . . . . 73.53 111.885 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.72 4.01 53.3 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-O 119.268 -0.74 . . . . 73.41 114.472 -169.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.48 -57.91 0.23 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 118.075 0.938 . . . . 61.41 112.611 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.622 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 81.3 t80 -66.51 -53.92 29.66 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.996 0.918 . . . . 72.04 112.005 -168.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.3 m -72.98 -36.42 3.36 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.611 -0.709 . . . . 72.52 112.842 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -49.97 -41.35 48.31 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.405 2.07 . . . . 72.42 113.265 161.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -67.36 -32.96 74.25 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.652 0.781 . . . . 75.35 111.227 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.37 -45.25 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.225 0.61 . . . . 60.34 110.305 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.516 HD22 ' HG3' ' A' ' 80' ' ' GLN . 74.3 mt -74.85 -20.74 59.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.116 -0.947 . . . . 73.31 112.144 -175.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.566 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 61.9 t80 -62.3 -44.79 89.37 Favored Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 114.134 1.161 . . . . 74.03 114.134 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -59.54 -37.93 85.75 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 121.878 1.719 . . . . 75.21 112.988 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -70.15 -42.0 73.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.421 0.688 . . . . 75.24 111.029 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.07 -36.6 72.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.856 -0.611 . . . . 74.11 110.844 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.554 ' NH1' HD12 ' C' ' 105' ' ' ILE . 32.0 ttm180 -50.43 -56.41 11.57 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.353 1.033 . . . . 73.23 109.669 174.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -65.39 -43.39 90.81 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.345 1.028 . . . . 64.33 111.8 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.599 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.4 t -61.39 -24.82 66.77 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.048 0.539 . . . . 73.15 112.151 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.466 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.8 mt -84.93 -53.71 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.163 0.985 . . . . 72.2 109.821 172.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.501 HG23 ' HG3' ' A' ' 125' ' ' GLN . 85.5 m -53.33 -52.53 58.87 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.931 1.292 . . . . 55.1 112.521 -174.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.3 t -58.41 -44.55 89.09 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.398 -0.819 . . . . 75.51 110.646 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.523 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.3 ttp -66.15 -32.34 73.72 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.422 1.089 . . . . 45.33 111.644 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.609 HG22 ' SG ' ' A' ' 76' ' ' CYS . 87.1 t -70.39 -45.14 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.117 0.967 . . . . 75.11 110.423 174.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.8 m -68.08 -25.59 65.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.557 0.743 . . . . 71.42 111.596 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -72.55 -32.38 66.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.668 0.787 . . . . 74.13 109.541 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.93 0.34 83.08 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 124.005 0.816 . . . . 64.51 113.288 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.8 m 65.72 16.5 10.52 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.754 1.222 . . . . 74.5 111.199 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -86.8 153.83 55.3 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.79 0.836 . . . . 61.03 109.058 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -53.63 119.19 5.82 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 123.162 2.575 . . . . 75.51 112.343 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.501 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.9 tt0 -53.0 128.93 29.01 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.304 1.042 . . . . 74.15 111.627 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 pp -109.36 137.18 47.61 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.462 -0.94 . . . . 72.21 108.462 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -123.19 91.67 3.53 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.029 -1.471 . . . . 74.53 107.029 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.566 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -63.46 122.24 15.78 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.198 -0.91 . . . . 75.43 109.45 -173.599 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.64 140.17 96.96 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.223 0.609 . . . . 72.34 110.806 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.12 128.74 29.91 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.41 2.073 . . . . 73.02 111.754 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.3 t -97.82 137.01 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.972 -0.751 . . . . 73.34 108.972 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -77.1 69.04 3.33 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.569 1.148 . . . . 50.14 111.249 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -53.21 -43.6 67.36 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.139 0.976 . . . . 73.12 111.621 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -58.86 -51.64 69.13 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.226 0.953 . . . . 74.14 111.201 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.15 99.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.872 0.733 . . . . 51.34 111.582 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.29 -44.53 95.29 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.217 0.948 . . . . 73.0 110.269 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -72.99 -30.96 64.19 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 115.388 -0.824 . . . . 74.02 110.672 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 15.9 mmt . . . . . 0 N--CA 1.484 1.258 0 C-N-CA 123.26 0.624 . . . . 64.03 111.44 179.828 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 C--O 1.238 0.491 0 N-CA-C 107.946 -1.131 . . . . 74.11 107.946 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -137.46 142.94 41.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.014 0.525 . . . . 62.52 109.633 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -144.59 141.0 29.12 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.465 0.706 . . . . 73.53 109.755 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.465 HD11 HD13 ' B' ' 105' ' ' ILE . 31.6 mt -94.59 125.77 47.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 107.705 -1.22 . . . . 74.43 107.705 170.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -92.8 -41.25 10.2 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.618 -0.512 . . . . 75.24 109.618 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.584 HH11 ' HD1' ' A' ' 32' ' ' PHE . 58.9 ttt180 -168.92 132.86 1.43 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.613 -0.721 . . . . 72.12 109.562 -173.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.412 HD11 HD13 ' B' ' 13' ' ' ILE . 81.7 mt -114.84 135.32 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 106.595 -1.632 . . . . 61.15 106.595 170.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.454 ' HE1' HG13 ' B' ' 83' ' ' ILE . 19.2 p90 -165.52 139.97 4.79 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.229 0.538 . . . . 71.44 110.921 -172.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.4 m -73.4 125.57 28.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.052 -0.976 . . . . 73.32 108.929 174.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.418 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.4 mtpt -98.35 -27.81 13.94 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.478 0.711 . . . . 61.3 110.855 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.7 t70 -157.16 137.7 13.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.62 0.368 . . . . 64.02 110.837 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.6 mm -133.37 145.03 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.644 1.178 . . . . 70.24 108.963 174.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -141.31 141.57 33.89 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.723 1.209 . . . . 54.23 108.427 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.422 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 71.8 t80 -156.07 113.98 3.32 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.143 -1.058 . . . . 73.43 108.143 170.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.18 115.91 20.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.825 0.85 . . . . 71.5 109.213 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.453 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.92 86.31 3.02 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.141 -1.059 . . . . 75.44 108.141 172.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.65 -27.64 26.75 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 122.869 2.38 . . . . 64.44 112.73 -172.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -108.75 15.85 23.28 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.564 -0.731 . . . . 65.1 110.574 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.531 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -40.06 -61.7 1.06 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 115.122 1.527 . . . . 62.41 115.122 -164.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.95 -31.06 56.88 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 121.837 1.692 . . . . 64.34 112.735 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -74.81 -49.23 21.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.681 0.792 . . . . 71.43 110.923 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.698 HG22 HD12 ' B' ' 68' ' ' LEU . 8.6 p -67.97 -21.98 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.771 0.828 . . . . 73.3 112.281 -164.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -66.38 -8.12 23.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.444 0.697 . . . . 70.35 112.822 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.593 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 27.7 pt20 -58.25 -26.03 62.42 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.439 0.696 . . . . 71.24 111.575 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.593 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 90.6 mttt -104.16 105.07 15.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.898 0.879 . . . . 75.15 109.077 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.29 81.31 8.76 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.426 0.631 . . . . 72.55 109.298 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -152.69 156.99 40.25 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.839 -1.171 . . . . 64.44 107.839 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -79.7 110.59 16.23 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 107.318 -1.364 . . . . 43.41 107.318 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.477 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 18.1 Cg_endo -58.03 139.67 91.25 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 123.079 2.519 . . . . 74.52 114.484 -170.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -65.89 124.15 21.71 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 124.236 0.96 . . . . 71.32 109.471 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' B' ' 66' ' ' ALA . 31.0 m -103.68 165.28 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.782 0.833 . . . . 72.51 112.459 -171.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -134.24 114.54 13.15 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 106.386 -1.709 . . . . 74.21 106.386 172.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 5.8 mp -86.27 133.97 33.79 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.405 1.082 . . . . 74.35 108.324 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -149.03 111.72 4.79 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.622 -1.251 . . . . 75.31 107.622 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.97 167.81 10.5 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.069 0.462 . . . . 73.52 109.893 -173.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 26.0 t70 -160.99 141.12 11.02 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.483 1.113 . . . . 64.03 109.139 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 22.8 p -136.28 125.13 24.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.414 0.686 . . . . 71.21 109.62 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.16 154.34 46.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.445 1.098 . . . . 63.43 108.318 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.2 p -142.36 170.51 15.56 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.963 0.411 . . . . 74.43 111.22 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.21 137.52 17.53 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.18 -0.918 . . . . 72.44 109.154 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -82.02 126.29 31.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.935 0.494 . . . . 54.23 109.947 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 91.1 mt -93.28 -34.2 13.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.203 0.601 . . . . 74.23 110.396 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.99 -173.53 2.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.641 0.776 . . . . 71.01 110.707 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.98 127.84 34.08 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.749 -1.114 . . . . 75.32 109.192 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 67.72 0.03 2.13 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.537 1.135 . . . . 74.21 112.612 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 109.9 30.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 123.66 0.784 . . . . 73.25 109.005 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -123.52 137.93 54.67 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.441 -0.948 . . . . 72.14 108.441 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -108.68 106.33 16.33 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.284 -1.376 . . . . 64.34 107.284 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.561 HG22 ' HG ' ' B' ' 98' ' ' LEU . 86.7 t -92.27 142.42 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 O-C-N 124.101 0.876 . . . . 35.03 109.925 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.73 141.54 42.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.731 -0.84 . . . . 62.35 108.731 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -124.29 105.51 9.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.284 -1.376 . . . . 73.22 107.284 178.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 36.4 ttm180 -92.68 123.87 36.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.794 0.438 . . . . 74.42 109.889 171.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.456 ' HB ' HD11 ' B' ' 114' ' ' ILE . 44.3 t -114.57 108.55 25.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.552 -1.277 . . . . 72.15 107.552 170.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 27.5 m -95.07 135.98 35.96 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.719 -0.845 . . . . 72.24 108.719 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.48 129.76 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.915 0.886 . . . . 72.11 109.146 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 28.8 m -118.01 142.43 47.38 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 107.961 -1.126 . . . . 71.43 107.961 169.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -144.79 155.51 43.56 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 117.803 0.274 . . . . 60.13 110.595 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 39.7 p -155.14 138.87 16.14 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 124.154 0.909 . . . . 74.32 111.007 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.698 HD12 HG22 ' B' ' 31' ' ' VAL . 67.7 mt -96.65 107.03 19.41 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.301 -0.863 . . . . 55.24 108.749 170.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.29 -111.56 4.18 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 114.885 -1.052 . . . . 64.51 112.847 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -108.58 0.03 20.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.64 0.776 . . . . 74.41 110.978 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.474 ' HG3' HG23 ' B' ' 31' ' ' VAL . 12.1 pt-20 -118.49 142.67 47.36 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.73 -0.606 . . . . 72.13 110.182 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.7 m -63.94 134.84 55.85 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 123.16 0.584 . . . . 72.14 111.238 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.557 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -91.11 -65.97 0.97 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.253 -0.885 . . . . 74.22 108.644 174.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -150.45 158.19 43.88 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.518 -0.765 . . . . 65.0 111.046 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 58.2 mt -128.3 108.98 11.04 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.105 -1.813 . . . . 74.14 106.105 172.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.41 ' SG ' HG23 ' B' ' 114' ' ' ILE . 49.8 t -119.26 148.34 43.25 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.344 -0.613 . . . . 75.33 109.344 -176.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -160.4 134.71 7.35 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.152 -0.684 . . . . 65.11 109.152 -178.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.9 t -125.79 144.0 37.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.163 -0.926 . . . . 61.51 108.636 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.4 mt-30 -122.9 85.94 2.5 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.891 -1.151 . . . . 74.31 107.891 172.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.436 ' O ' HD13 ' B' ' 106' ' ' LEU . 7.0 tp-100 -80.01 101.08 8.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.199 -1.364 . . . . 74.3 108.623 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.418 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.74 167.92 27.35 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 111.558 -0.617 . . . . 71.11 111.558 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.41 130.76 2.2 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 112.099 -0.4 . . . . 65.22 112.099 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.454 HG13 ' HE1' ' B' ' 17' ' ' TYR . 61.1 mt -85.14 120.36 35.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.028 -1.101 . . . . 73.24 108.028 171.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -127.46 135.58 50.61 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.208 0.603 . . . . 64.41 109.54 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 68.2 m -97.93 109.33 22.11 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.019 0.527 . . . . 72.33 109.755 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.58 ' HB ' HG12 ' B' ' 89' ' ' ILE . 38.9 pt -102.47 122.66 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.316 1.046 . . . . 74.13 109.045 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.84 141.6 44.7 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.616 0.766 . . . . 63.13 109.612 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.53 -29.33 4.06 Favored Glycine 0 N--CA 1.473 1.157 0 CA-C-O 119.925 -0.375 . . . . 63.43 113.343 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.58 HG12 ' HB ' ' B' ' 86' ' ' ILE . 2.8 pp -56.23 132.53 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.874 0.87 . . . . 63.23 111.94 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 5.8 tp10 -160.43 161.4 32.96 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 120.922 0.391 . . . . 65.03 111.688 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.22 -95.65 1.56 Allowed Glycine 0 C--N 1.352 1.455 0 CA-C-N 115.484 -0.78 . . . . 53.45 111.286 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.2 m -105.22 -20.45 13.5 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.392 0.677 . . . . 62.43 110.247 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.427 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 95.3 mt-30 -61.66 -31.02 71.11 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.468 0.707 . . . . 62.4 111.319 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.495 ' HA ' HD13 ' B' ' 89' ' ' ILE . 21.5 ptt? -58.06 -44.88 87.72 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 123.985 0.803 . . . . 74.05 110.928 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ALA . . . . . 0.403 ' HB1' ' HZ ' ' B' ' 137' ' ' PHE . . . -76.16 -50.28 15.0 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 123.988 0.915 . . . . 53.51 109.679 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -60.13 -31.6 70.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.674 0.79 . . . . 61.24 111.88 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 11.7 t -73.38 -63.15 1.25 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.353 0.408 . . . . 72.24 110.262 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.561 ' HG ' HG22 ' B' ' 58' ' ' VAL . 10.3 tt -67.6 -39.2 84.77 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.323 0.49 . . . . 53.13 112.323 -172.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.42 3.34 57.88 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 114.965 0.746 . . . . 41.55 114.965 -168.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.48 -56.1 0.27 Allowed 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 117.675 0.737 . . . . 42.33 111.381 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -71.39 -46.64 59.79 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.584 0.754 . . . . 65.41 111.85 -171.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.478 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 75.1 m -65.86 -47.85 63.65 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 123.728 0.811 . . . . 71.24 111.363 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.4 Cg_exo -58.42 -32.88 97.23 Favored 'Trans proline' 0 C--N 1.398 3.143 0 C-N-CA 122.337 2.025 . . . . 72.15 113.629 168.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -62.03 -39.27 91.73 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.209 0.603 . . . . 62.2 110.316 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.465 HD13 HD11 ' B' ' 13' ' ' ILE . 69.4 mt -63.68 -45.03 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.576 0.75 . . . . 74.32 110.457 174.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.436 HD13 ' O ' ' B' ' 80' ' ' GLN . 87.1 mt -75.27 -18.36 60.09 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.891 -1.05 . . . . 61.15 112.192 -176.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.402 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 64.0 t80 -60.91 -51.09 81.88 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 117.784 -1.103 . . . . 61.12 113.563 -171.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 48.6 Cg_exo -59.16 -33.44 98.25 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 121.939 1.76 . . . . 60.41 112.949 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.411 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 78.7 m-85 -69.54 -47.36 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.334 0.654 . . . . 75.34 110.556 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.97 88.73 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.549 0.74 . . . . 71.12 110.531 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.701 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 53.3 ttt180 -60.46 -55.99 26.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.627 1.571 . . . . 73.25 111.028 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.72 -34.79 79.01 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 124.053 0.846 . . . . 65.11 110.128 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.9 t -67.04 -35.3 79.59 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 122.768 0.427 . . . . 64.42 111.825 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.456 HD11 ' HB ' ' B' ' 62' ' ' VAL . 64.5 mt -64.26 -52.96 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.986 -0.746 . . . . 73.41 108.986 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -59.44 -30.68 68.67 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 124.498 1.124 . . . . 74.43 111.769 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.9 t -66.65 -46.54 75.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.615 0.766 . . . . 60.42 110.277 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.2 mmt -68.25 -35.16 77.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.993 0.517 . . . . 71.32 110.663 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.482 HG13 ' HB2' ' B' ' 123' ' ' PHE . 68.9 t -58.13 -48.18 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.278 1.031 . . . . 74.52 110.437 172.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.472 ' HB3' HG21 ' C' ' 115' ' ' THR . 65.5 m -61.23 -35.89 78.44 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.444 -1.253 . . . . 74.52 112.042 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.599 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 74.4 mtt-85 -69.15 -37.11 78.07 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.421 -0.809 . . . . 71.01 110.1 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.51 11.23 59.43 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.749 0.656 . . . . 54.5 113.297 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 57.5 p 64.2 18.79 11.47 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.317 1.847 . . . . 75.32 114.687 172.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.482 ' HB2' HG13 ' B' ' 118' ' ' VAL . 98.8 m-85 -80.95 151.29 70.32 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 109.148 -0.686 . . . . 53.24 109.148 175.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.95 -160.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.68 2.92 . . . . 74.21 114.102 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -65.9 111.33 3.24 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 121.017 0.436 . . . . 75.11 110.76 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.412 HD21 ' HD2' ' B' ' 38' ' ' PRO . 4.0 mm? -122.63 84.7 2.3 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.392 -0.966 . . . . 74.4 108.392 171.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -92.7 128.04 38.41 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.328 -0.619 . . . . 62.14 109.328 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.701 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 32.9 tp -71.98 136.78 46.89 Favored 'General case' 0 CA--C 1.552 1.034 0 O-C-N 123.952 0.783 . . . . 61.44 109.785 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.06 151.98 92.69 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.127 0.571 . . . . 72.41 111.304 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.504 ' HG3' HD13 ' D' ' 16' ' ' ILE . 25.3 Cg_exo -61.3 102.9 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 122.311 2.007 . . . . 74.23 111.836 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.89 111.37 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.168 -1.049 . . . . 72.43 108.168 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -78.91 99.43 6.79 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.237 -1.023 . . . . 73.53 108.237 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -62.95 -48.03 80.62 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 123.371 0.42 . . . . 75.25 110.795 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.07 -41.74 90.35 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.369 1.068 . . . . 73.12 112.966 -166.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.29 -34.41 63.52 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.368 0.667 . . . . 73.32 111.347 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.8 mp -77.65 -32.15 53.12 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.232 0.613 . . . . 74.44 109.928 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 137' ' ' PHE . . . . . 0.403 ' HZ ' ' HB1' ' B' ' 95' ' ' ALA . 92.7 t80 . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 124.753 1.221 . . . . 73.12 110.452 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 58.5 m . . . . . 0 C--O 1.239 0.522 0 N-CA-C 108.194 -1.039 . . . . 64.4 108.194 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.567 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 4.5 t80 -123.6 125.48 44.92 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.968 -0.753 . . . . 74.42 108.968 176.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -147.02 119.99 8.75 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.065 -1.087 . . . . 71.45 108.065 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.5 mt -74.08 122.25 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.901 -0.777 . . . . 54.42 108.901 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.678 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 14.9 mm100 -85.0 -45.74 11.86 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.173 -0.922 . . . . 72.23 110.508 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -174.16 126.02 0.34 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.032 -0.531 . . . . 73.34 110.31 -168.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.78 141.64 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 107.868 -1.16 . . . . 54.34 107.868 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.477 ' HB3' HG23 ' D' ' 122' ' ' THR . 27.0 p90 -173.15 168.43 4.75 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.306 0.574 . . . . 74.21 111.941 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -89.38 117.57 28.42 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.013 -0.736 . . . . 51.0 109.013 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -78.73 -35.47 44.73 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.506 -0.553 . . . . 75.5 109.506 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.426 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 13.9 t70 -146.62 147.83 31.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.127 -0.942 . . . . 71.0 109.323 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.0 mt -141.83 146.09 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.169 1.388 . . . . 62.21 107.394 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.7 t -158.11 149.35 21.13 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.355 0.597 . . . . 62.15 110.748 174.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -143.49 145.11 32.32 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.446 -1.316 . . . . 63.14 107.446 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.472 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.1 mt-10 -135.05 127.9 31.26 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.987 0.915 . . . . 75.24 109.926 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.72 72.7 7.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.591 1.557 . . . . 72.21 106.933 170.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.1 -39.94 21.96 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.763 2.309 . . . . 73.52 111.062 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -93.46 22.29 5.45 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 113.846 -1.525 . . . . 65.03 111.279 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.21 -56.08 5.79 Favored Pre-proline 0 CA--C 1.564 1.509 0 N-CA-C 114.135 1.161 . . . . 64.44 114.135 -173.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.42 -38.15 44.58 Favored 'Trans proline' 0 C--N 1.389 2.691 0 CA-C-N 121.77 1.668 . . . . 62.24 112.716 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -69.4 -38.42 77.94 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.596 0.759 . . . . 73.22 112.103 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.716 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.4 p -77.08 -22.26 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 N-CA-C 112.286 0.476 . . . . 61.23 112.286 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -68.1 -30.0 69.06 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.925 0.393 . . . . 74.33 110.87 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -99.82 31.67 3.17 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.255 0.622 . . . . 62.41 110.574 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -108.86 157.79 18.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.83 0.852 . . . . 63.11 109.746 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -61.61 121.36 12.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.062 -0.718 . . . . 74.12 109.062 168.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 58.7 t-105 -86.55 96.6 10.13 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.146 0.578 . . . . 72.03 110.478 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.479 ' H ' HD22 ' C' ' 68' ' ' LEU . 63.7 tt0 -144.72 78.48 12.88 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 108.585 -0.894 . . . . 62.13 108.585 170.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -85.67 139.96 6.89 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.74 2.293 . . . . 52.35 112.641 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' GLU . . . . . 0.437 ' HB3' ' HE3' ' C' ' 41' ' ' LYS . 36.6 mt-10 -87.28 85.43 7.17 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.15 -1.796 . . . . 73.51 106.15 169.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 48.1 t -63.13 107.99 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.504 0 CA-C-N 114.698 -1.137 . . . . 75.14 108.655 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' C' ' 39' ' ' GLU . 99.2 mttt -125.12 104.8 8.73 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.008 0.923 . . . . 62.4 109.763 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.537 HD11 HD21 ' C' ' 126' ' ' LEU . 4.0 mm? -86.09 125.6 33.58 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.159 -0.928 . . . . 74.54 109.194 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -118.25 105.31 11.63 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.812 -1.181 . . . . 71.01 107.812 173.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 tt -107.57 122.31 46.42 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.464 -0.569 . . . . 60.21 109.464 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -124.27 142.54 51.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.969 1.308 . . . . 74.21 108.654 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' THR . . . . . 0.41 HG21 ' HG3' ' C' ' 103' ' ' PRO . 1.5 m -123.48 126.6 47.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.465 0.65 . . . . 73.21 109.597 173.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.55 170.33 8.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.275 -1.329 . . . . 70.32 107.872 171.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -165.0 156.84 15.34 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.048 -0.723 . . . . 64.44 109.048 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 49.9 p -156.64 136.75 12.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.845 0.458 . . . . 73.22 110.713 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -70.2 126.35 29.41 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.415 -0.587 . . . . 74.13 109.415 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' C' ' 57' ' ' GLU . 57.6 mt -97.47 -35.93 10.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.421 0.688 . . . . 73.31 110.336 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.0 -174.08 4.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.031 0.933 . . . . 74.23 110.455 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -62.29 106.73 0.78 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.237 -0.892 . . . . 75.42 109.874 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 68.68 11.03 8.21 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.498 1.119 . . . . 71.11 112.876 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 99.4 t -105.94 105.76 19.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.62 -1.252 . . . . 72.42 107.62 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -117.73 123.88 47.12 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.722 -0.844 . . . . 75.13 108.722 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.568 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.6 tt0 -85.54 143.87 28.25 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.748 0.819 . . . . 75.05 109.218 171.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 43.7 t -119.26 139.08 47.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 108.102 -1.073 . . . . 74.51 108.102 166.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.76 123.36 65.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 107.43 -1.322 . . . . 71.43 107.43 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.4 107.7 18.82 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.629 -0.878 . . . . 62.22 108.629 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.15 102.96 14.81 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.706 -0.85 . . . . 71.23 108.706 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.402 ' HB ' HD11 ' C' ' 114' ' ' ILE . 58.7 t -103.59 108.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.344 -0.984 . . . . 74.31 108.344 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.7 m -98.1 137.1 37.39 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.853 -1.166 . . . . 71.13 107.853 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.56 HG21 HG21 ' C' ' 114' ' ' ILE . 61.3 t -132.24 108.82 14.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.591 -0.522 . . . . 64.41 109.591 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -103.9 142.93 33.55 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.117 -0.947 . . . . 64.31 109.737 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.26 123.23 15.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.874 -1.528 . . . . 45.23 106.874 173.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 7.9 m -130.45 128.42 41.23 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.492 0.495 . . . . 61.32 109.968 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.479 HD22 ' H ' ' C' ' 37' ' ' GLN . 18.3 mt -86.93 47.57 1.52 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.4 1.08 . . . . 75.43 108.752 175.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.22 -109.47 3.71 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 110.091 -1.204 . . . . 61.5 110.091 -172.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.29 -26.46 17.31 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.292 1.037 . . . . 72.43 110.418 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -71.78 121.3 18.69 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.297 0.639 . . . . 71.34 110.028 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -68.63 126.37 29.47 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.65 -0.87 . . . . 75.03 108.65 168.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.716 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.6 -58.49 3.25 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.164 -1.05 . . . . 62.13 108.164 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.07 165.45 27.19 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.795 -1.093 . . . . 74.52 110.169 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.472 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.6 tm? -128.62 140.42 51.78 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.387 -1.708 . . . . 70.24 106.387 168.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.5 t -144.35 140.09 28.88 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.124 -1.065 . . . . 73.34 108.124 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -156.29 137.0 13.31 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 110.152 -0.314 . . . . 62.51 110.152 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -136.21 135.29 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.066 0.946 . . . . 61.14 108.833 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 41.9 mt-30 -107.07 94.62 5.2 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.259 1.023 . . . . 75.32 109.388 173.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.41 ' HG3' HD22 ' C' ' 106' ' ' LEU . 9.3 tp-100 -85.59 98.1 10.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.989 -1.005 . . . . 71.34 110.226 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.69 145.98 17.9 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 112.117 -0.393 . . . . 41.41 112.117 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.571 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.51 124.72 1.84 Allowed Glycine 0 CA--C 1.507 -0.441 0 N-CA-C 110.568 -1.013 . . . . 75.02 110.568 -174.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 4.8 mm -82.82 123.55 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.513 -0.921 . . . . 75.22 108.513 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.567 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 64.2 m-85 -129.32 120.7 26.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.222 0.609 . . . . 71.4 109.512 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -70.81 118.82 14.08 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.137 -0.69 . . . . 63.52 109.137 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' C' ' 94' ' ' MET . 4.7 tt -122.05 122.88 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.312 0.645 . . . . 61.52 110.313 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.605 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -156.57 168.89 26.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.493 0.717 . . . . 50.42 109.656 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.96 -54.45 4.3 Favored Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.045 0.355 . . . . 71.32 112.495 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 pt -83.01 156.1 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.408 1.083 . . . . 71.45 110.964 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.98 175.81 10.39 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.543 0.737 . . . . 54.15 110.635 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.11 -127.71 43.16 Favored Glycine 0 C--N 1.349 1.27 0 O-C-N 123.981 0.801 . . . . 73.14 114.128 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p -70.07 -26.95 64.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.017 0.927 . . . . 61.05 111.97 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -68.49 -44.65 74.29 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.869 0.868 . . . . 74.32 110.705 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.792 ' HB2' HD11 ' C' ' 86' ' ' ILE . 3.6 ppp? -74.13 -33.75 63.66 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.729 -0.471 . . . . 61.33 109.729 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.31 93.6 Favored 'General case' 0 C--N 1.36 1.046 0 O-C-N 124.242 0.964 . . . . 73.23 110.391 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -80.97 -33.9 33.49 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.046 0.841 . . . . 72.51 112.301 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.9 t -55.4 -38.44 68.92 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.444 0.465 . . . . 42.13 110.053 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 30.6 mt -101.46 -13.29 18.0 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.74 0.816 . . . . 73.35 111.609 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.55 -30.54 56.32 Favored Glycine 0 C--N 1.354 1.58 0 N-CA-C 114.982 0.753 . . . . 74.33 114.982 -174.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.61 -35.38 0.07 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.814 0.445 . . . . 72.51 110.774 -171.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -68.45 -50.15 54.69 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.958 1.303 . . . . 75.45 112.467 -177.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 66.7 m -71.89 -41.39 9.02 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.877 -0.582 . . . . 63.02 112.354 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.41 ' HG3' HG21 ' C' ' 46' ' ' THR . 73.3 Cg_exo -53.84 -32.0 64.8 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 122.561 2.174 . . . . 65.31 113.927 166.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -69.24 -34.81 75.38 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.363 0.665 . . . . 63.15 109.904 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.554 HD12 ' NH1' ' A' ' 111' ' ' ARG . 34.2 mm -62.86 -40.45 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 109.37 -0.604 . . . . 73.23 109.37 174.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.571 HD21 ' HA3' ' C' ' 82' ' ' GLY . 69.1 mt -82.26 -17.98 44.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.296 1.038 . . . . 72.21 112.449 -177.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -60.07 -50.36 86.65 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-O 117.911 -1.043 . . . . 75.11 113.662 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.31 -31.51 62.88 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 121.955 1.77 . . . . 71.52 112.818 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -70.24 -47.76 59.91 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.178 0.591 . . . . 64.23 110.556 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.95 84.3 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.346 -0.843 . . . . 31.41 109.948 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -59.93 -49.35 78.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.021 1.329 . . . . 75.51 110.855 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.41 -39.1 91.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.375 0.67 . . . . 74.1 110.517 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 19.6 t -66.79 -27.53 67.65 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.826 0.45 . . . . 65.44 111.659 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.61 HG23 ' SG ' ' C' ' 76' ' ' CYS . 63.5 mt -80.78 -43.46 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.218 0.607 . . . . 63.32 110.067 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.472 HG21 ' HB3' ' B' ' 119' ' ' SER . 5.7 m -61.16 -29.33 69.73 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.321 0.582 . . . . 61.34 110.373 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -72.92 -53.5 11.14 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.754 -1.112 . . . . 72.14 109.818 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.546 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.37 -39.09 92.04 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.954 0.902 . . . . 62.14 113.167 -175.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' C' ' 123' ' ' PHE . 78.3 t -64.99 -42.17 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.689 0.795 . . . . 73.12 110.184 175.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -69.46 -29.95 67.75 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.26 -0.882 . . . . 73.42 111.244 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.45 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 86.4 mtt-85 -68.5 -39.24 81.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.636 0.775 . . . . 72.3 108.921 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.32 1.47 81.09 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 123.908 0.755 . . . . 53.13 113.17 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 38.4 p 64.03 27.31 14.22 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.543 1.937 . . . . 70.33 113.941 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.413 ' HB2' HG13 ' C' ' 118' ' ' VAL . 93.4 m-85 -92.19 149.39 38.5 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 109.012 -0.736 . . . . 74.15 109.012 171.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -45.03 119.68 2.57 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.583 2.855 . . . . 74.12 113.128 170.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -59.9 155.9 15.51 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.81 1.244 . . . . 71.23 113.566 -170.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.537 HD21 HD11 ' C' ' 42' ' ' LEU . 34.3 tp -104.2 102.33 12.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.779 0.832 . . . . 75.51 109.89 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.76 89.77 4.46 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.951 -1.129 . . . . 73.31 107.951 168.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.03 134.39 43.01 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.628 -0.714 . . . . 74.34 110.282 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.96 151.6 96.14 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 124.111 0.964 . . . . 33.42 111.746 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.52 121.22 9.53 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.983 2.456 . . . . 73.22 112.683 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 t -102.95 137.6 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.966 -0.753 . . . . 71.02 108.966 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 132' ' ' ASN . . . . . 0.443 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 89.9 m-20 -82.27 73.4 9.31 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.541 -0.54 . . . . 73.44 109.541 173.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -61.53 -43.64 98.5 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.386 -0.824 . . . . 71.54 109.481 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -64.07 -53.51 48.72 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 113.954 -1.475 . . . . 55.5 111.837 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 135' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -56.03 -38.4 70.51 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.487 1.117 . . . . 74.11 111.171 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.78 -45.0 79.84 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.213 -0.903 . . . . 75.32 110.693 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.488 1.458 0 C-N-CA 123.052 0.541 . . . . 70.21 110.422 179.466 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 90.0 m . . . . . 0 C--O 1.239 0.508 0 N-CA-C 108.79 -0.818 . . . . 72.21 108.79 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -159.95 90.13 0.9 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.56 -1.274 . . . . 72.33 107.56 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -118.78 116.91 27.53 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.24 -1.022 . . . . 72.33 108.24 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.444 HG21 HD11 ' D' ' 16' ' ' ILE . 13.7 mt -73.2 109.97 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.091 -0.707 . . . . 75.41 109.091 177.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -80.65 -37.85 30.18 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.449 0.7 . . . . 74.23 111.846 -173.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -168.9 139.01 2.3 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 117.414 0.097 . . . . 64.53 111.126 -168.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.504 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.4 mp -117.82 135.04 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.144 -1.428 . . . . 75.03 107.144 169.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -160.53 150.29 17.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.434 0.635 . . . . 71.24 111.798 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 64.3 p -86.5 113.56 22.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.949 -1.023 . . . . 74.2 109.18 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -81.31 -22.04 38.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.298 0.639 . . . . 73.14 110.554 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.476 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.6 t70 -160.39 142.39 12.74 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.151 -0.931 . . . . 74.05 109.042 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.546 HG21 ' HE2' ' C' ' 117' ' ' MET . 85.5 mt -138.65 143.54 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.116 -1.068 . . . . 71.21 108.116 175.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -143.54 133.12 23.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.754 0.822 . . . . 72.13 108.916 171.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.4 t80 -134.77 131.85 38.03 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.328 -1.73 . . . . 71.3 106.328 166.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 25.4 mt-10 -133.09 130.41 39.28 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.91 0.884 . . . . 75.44 108.83 -173.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -138.65 78.34 31.59 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.048 -1.093 . . . . 54.52 108.048 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.52 -31.29 21.87 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.896 2.397 . . . . 72.14 112.388 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -99.84 -1.29 37.86 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.457 -1.247 . . . . 72.31 110.971 -173.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.513 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -29.93 -67.2 0.14 Allowed Pre-proline 0 C--N 1.36 1.058 0 C-N-CA 126.517 1.927 . . . . 75.15 116.134 -160.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.405 ' HB3' HD11 ' C' ' 83' ' ' ILE . 80.9 Cg_endo -71.62 -29.64 15.83 Favored 'Trans proline' 0 C--N 1.375 1.959 0 CA-C-N 122.63 1.975 . . . . 72.13 113.318 -170.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -84.91 -23.44 28.87 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 117.678 0.217 . . . . 64.44 111.137 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.513 HG12 ' O ' ' D' ' 28' ' ' ALA . 8.9 p -80.6 -26.73 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 122.65 0.38 . . . . 74.34 110.444 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -61.71 -25.4 67.4 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.328 0.651 . . . . 74.13 112.436 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -53.21 -28.78 28.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.275 1.03 . . . . 75.23 111.509 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -84.1 101.52 11.87 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.139 0.975 . . . . 74.01 110.116 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.34 80.43 7.75 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.991 -1.004 . . . . 75.33 108.987 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.422 ' HD1' HD23 ' D' ' 68' ' ' LEU . 50.6 t-105 -142.98 156.47 44.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.85 1.26 . . . . 73.14 108.253 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -80.3 101.98 1.08 Allowed Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 108.066 -1.087 . . . . 61.12 108.066 174.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.92 119.72 6.5 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.084 2.523 . . . . 74.22 112.901 -167.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.84 112.86 2.73 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 123.957 0.785 . . . . 71.43 109.912 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' D' ' 66' ' ' ALA . 27.5 m -100.02 151.07 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.881 -1.054 . . . . 53.25 111.131 -172.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -118.08 117.96 30.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.118 -1.067 . . . . 73.13 108.118 173.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.0 tp -94.62 120.21 34.49 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.919 -0.771 . . . . 72.04 108.919 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.538 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.4 t70 -127.67 112.88 15.33 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.76 -1.2 . . . . 74.22 107.76 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 67.0 mt -96.16 129.08 43.56 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.003 0.521 . . . . 72.11 109.688 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -136.05 121.55 19.43 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.069 -0.715 . . . . 71.44 109.069 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -105.84 168.28 9.22 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.519 0.675 . . . . 55.11 110.512 -177.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -161.05 162.73 31.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.286 -1.325 . . . . 53.44 108.539 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 24.4 p -156.88 153.32 28.0 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.868 -0.79 . . . . 71.41 108.868 172.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 37.3 p -155.69 131.36 9.76 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.543 0.737 . . . . 73.42 109.544 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -73.6 127.96 34.2 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.928 0.491 . . . . 54.15 110.073 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' D' ' 57' ' ' GLU . 61.4 mt -92.64 -35.08 13.72 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.625 -0.509 . . . . 70.41 109.625 175.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.28 -178.48 3.63 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.359 1.063 . . . . 63.13 109.512 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -65.67 127.64 32.75 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.983 -0.747 . . . . 71.43 108.983 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.81 19.3 11.32 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.39 1.076 . . . . 73.44 112.105 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.97 124.28 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.846 0.858 . . . . 74.05 109.173 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.407 ' HD1' HD11 ' D' ' 86' ' ' ILE . 15.0 m-85 -133.57 131.7 40.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.485 0.714 . . . . 71.02 109.751 176.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.527 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.0 tt0 -92.43 120.12 32.62 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.19 -1.041 . . . . 64.2 108.19 167.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -100.9 140.3 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.929 -1.137 . . . . 70.4 107.929 170.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.525 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.8 t -122.76 129.18 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.468 -0.938 . . . . 62.42 108.468 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.45 116.68 32.27 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.163 -1.421 . . . . 63.45 107.163 170.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -104.94 101.86 11.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.942 -1.133 . . . . 73.34 107.942 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.28 137.66 21.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.663 -0.699 . . . . 61.15 109.156 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 32.6 m -117.93 142.16 47.65 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.516 0.727 . . . . 63.04 109.805 177.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.414 HG21 HG21 ' D' ' 114' ' ' ILE . 59.3 t -136.5 113.08 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.058 0.943 . . . . 71.32 109.457 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 89.9 m -106.56 108.92 20.67 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.507 -0.553 . . . . 64.14 109.507 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -106.54 158.45 16.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.185 0.594 . . . . 74.53 110.368 -176.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 4.8 p -153.73 140.73 19.3 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-O 121.438 0.637 . . . . 63.13 112.404 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.481 HD12 HG22 ' D' ' 31' ' ' VAL . 70.5 mt -111.57 116.25 30.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.799 1.24 . . . . 72.41 107.764 169.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.76 -120.78 8.29 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 123.563 0.539 . . . . 74.0 113.112 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -102.84 6.66 39.33 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.82 0.848 . . . . 65.34 111.408 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -135.21 162.13 33.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.83 0.452 . . . . 54.41 110.725 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 30.4 m -57.61 142.9 43.2 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.175 0.99 . . . . 71.03 111.45 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.37 -68.58 0.79 Allowed 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.049 -1.093 . . . . 45.01 108.049 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -141.15 149.17 41.15 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.963 -1.017 . . . . 71.14 109.472 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.6 mt -112.55 146.27 38.83 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.681 -1.229 . . . . 72.13 107.681 169.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.51 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.8 t -153.97 133.45 12.79 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.765 -0.458 . . . . 70.14 109.765 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -154.26 126.61 7.94 Favored 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.97 -0.381 . . . . 73.43 109.97 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 97.9 t -131.09 125.02 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.783 0.833 . . . . 71.55 110.16 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 37.7 mt-30 -87.71 86.33 7.17 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.795 -0.817 . . . . 73.24 108.795 168.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -81.43 92.15 6.4 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.234 -0.893 . . . . 75.44 109.503 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.96 162.59 27.58 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 111.951 -0.46 . . . . 72.31 111.951 178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.31 136.46 4.43 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.997 -0.441 . . . . 54.11 111.997 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.78 127.77 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.73 -0.841 . . . . 74.14 108.73 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.43 125.65 47.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.236 1.014 . . . . 60.34 108.915 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 6.4 t -87.98 97.16 10.8 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.086 -1.079 . . . . 52.13 108.086 176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.455 ' HB ' HD11 ' D' ' 89' ' ' ILE . 2.7 pp -111.32 139.03 37.3 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 C-N-CA 123.546 0.738 . . . . 73.12 110.154 -171.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -157.82 157.18 32.82 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.06 0.544 . . . . 72.53 109.643 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.03 17.99 77.49 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.329 0.393 . . . . 73.11 113.512 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.455 HD11 ' HB ' ' D' ' 86' ' ' ILE . 0.2 OUTLIER -126.68 134.41 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.817 0.847 . . . . 71.52 108.944 178.349 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.57 177.02 8.77 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.269 0.628 . . . . 64.4 111.136 -174.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.53 -111.36 2.06 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 124.284 0.99 . . . . 65.5 114.573 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.3 m -89.55 -27.05 20.52 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.712 0.805 . . . . 74.42 110.804 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -64.65 -41.03 96.4 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.314 0.645 . . . . 72.43 110.642 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -69.21 -34.04 74.26 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 116.036 -0.529 . . . . 71.33 111.08 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.32 -32.29 64.49 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.286 0.634 . . . . 50.21 110.968 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -77.65 -34.93 52.96 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.427 1.091 . . . . 73.13 110.262 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.2 -51.68 11.6 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.859 -0.61 . . . . 51.42 111.091 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.489 HD23 ' SG ' ' D' ' 102' ' ' CYS . 83.8 mt -85.86 -24.29 26.76 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.948 0.499 . . . . 62.31 112.03 -172.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.84 -14.06 55.63 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.751 -0.472 . . . . 61.23 113.668 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.628 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -135.81 -59.2 0.76 Allowed 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 117.354 0.577 . . . . 21.14 111.89 -173.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -67.8 -41.19 83.55 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.098 0.559 . . . . 71.31 112.295 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.489 ' SG ' HD23 ' D' ' 98' ' ' LEU . 70.4 m -67.86 -45.77 43.41 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 118.483 -0.77 . . . . 75.24 112.321 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -56.5 -36.2 97.44 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.184 1.923 . . . . 51.21 112.909 168.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -65.36 -30.66 71.51 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.606 0.763 . . . . 72.22 111.558 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.422 HD13 HD11 ' D' ' 13' ' ' ILE . 80.0 mt -71.3 -39.27 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.192 0.997 . . . . 52.32 110.463 174.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -76.0 -19.51 58.62 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.441 -0.799 . . . . 52.12 111.527 -176.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -64.88 -43.56 69.05 Favored Pre-proline 0 CA--C 1.562 1.409 0 CA-C-O 117.987 -1.006 . . . . 74.01 113.603 -174.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -51.48 -43.8 47.72 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.241 1.961 . . . . 61.34 113.923 170.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -72.83 -37.52 67.42 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.33 0.652 . . . . 74.15 111.2 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.33 -48.26 80.6 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.44 0.696 . . . . 73.24 109.674 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -54.38 -49.57 69.54 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.875 1.359 . . . . 73.34 110.942 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.16 -45.62 92.61 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.24 0.963 . . . . 53.23 111.372 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.7 t -58.51 -44.87 89.63 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.873 0.733 . . . . 71.42 110.697 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.51 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.0 mt -60.04 -56.56 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.184 0.994 . . . . 73.12 110.743 175.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.7 m -55.21 -42.78 73.77 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.932 1.293 . . . . 74.35 111.561 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 36.8 t -66.18 -40.63 90.6 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 114.561 -1.2 . . . . 74.25 110.047 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.5 mtm -70.57 -30.79 67.59 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.961 0.505 . . . . 62.14 111.869 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.448 HG23 ' O ' ' D' ' 114' ' ' ILE . 73.8 t -64.05 -45.89 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.484 0.714 . . . . 53.55 109.947 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -74.97 -28.13 60.44 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.648 -0.706 . . . . 54.51 111.28 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -70.85 -34.01 71.21 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.236 -0.653 . . . . 60.23 109.236 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.66 11.09 62.63 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.924 0.765 . . . . 71.33 112.919 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.477 HG23 ' HB3' ' C' ' 17' ' ' TYR . 78.9 p 58.51 16.84 4.48 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 126.499 1.92 . . . . 73.4 114.606 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -80.16 146.88 63.8 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.096 -0.705 . . . . 73.04 109.096 171.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.53 133.2 25.92 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.291 2.661 . . . . 64.13 112.428 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -53.34 136.93 36.33 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.346 1.029 . . . . 72.33 112.589 -168.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 51.6 tp -108.37 107.33 17.86 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.488 -0.778 . . . . 72.44 109.74 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -101.23 96.22 7.05 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.4 -0.963 . . . . 72.01 108.4 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.37 122.22 15.68 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.851 0.46 . . . . 71.25 110.05 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.71 123.06 80.18 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 122.993 0.517 . . . . 53.34 109.844 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.89 122.84 11.83 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.626 2.217 . . . . 65.05 112.031 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 75.0 t -106.78 123.27 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.854 -0.795 . . . . 73.22 108.854 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -80.29 93.32 5.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.019 -0.734 . . . . 75.1 109.019 174.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -60.81 -28.07 68.51 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.545 0.738 . . . . 73.45 111.292 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 134' ' ' ASP . . . . . 0.628 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 6.0 t70 -62.8 -50.08 72.42 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.423 1.089 . . . . 73.13 111.265 -173.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.66 -45.26 87.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.556 0.743 . . . . 65.2 111.408 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.66 -26.05 66.01 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.603 0.761 . . . . 71.11 111.603 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 90.5 t80 . . . . . 0 N--CA 1.478 0.973 0 C-N-CA 123.608 0.763 . . . . 71.14 110.447 175.591 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 92.3 m . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 108.845 -0.798 . . . . 55.32 108.845 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.58 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 13.7 t80 -137.93 126.83 24.01 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.958 0.503 . . . . 65.21 109.713 177.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -138.16 132.5 32.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.418 -1.327 . . . . 62.55 107.418 172.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.527 HG12 ' HD2' ' A' ' 84' ' ' PHE . 46.9 mt -92.76 116.82 34.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.188 -0.671 . . . . 71.41 109.188 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.6 -43.4 59.79 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 124.256 0.973 . . . . 70.11 108.909 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -173.71 129.73 0.42 Allowed 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.243 0.34 . . . . 73.43 111.007 -172.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.492 HD11 HD13 ' A' ' 13' ' ' ILE . 77.1 mt -113.87 139.74 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.954 0.902 . . . . 55.12 109.097 172.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -168.97 -179.78 3.79 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 124.537 1.148 . . . . 72.42 110.495 -170.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -110.15 126.38 54.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.42 -0.809 . . . . 65.23 109.466 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -80.54 -48.8 12.22 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.338 -0.615 . . . . 74.11 109.338 171.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 19.3 t70 -135.58 132.27 36.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.652 -0.704 . . . . 72.44 109.481 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.3 mt -123.21 141.66 42.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.239 -1.393 . . . . 54.03 107.239 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.0 t -144.64 139.07 27.8 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 123.576 0.547 . . . . 74.01 109.586 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.452 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.6 t80 -146.36 126.3 13.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.632 -1.618 . . . . 74.42 106.632 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 22.5 mt-10 -129.6 127.75 41.27 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.438 0.695 . . . . 61.32 109.511 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -137.95 73.93 44.97 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.976 -1.12 . . . . 74.12 107.976 170.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.3 -16.19 13.85 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.664 2.243 . . . . 73.25 110.795 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -105.35 13.54 30.2 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.973 1.309 . . . . 62.02 108.96 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -53.12 -47.93 93.98 Favored Pre-proline 0 CA--C 1.566 1.589 0 C-N-CA 124.935 1.294 . . . . 53.13 113.568 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 37.5 Cg_exo -64.17 -24.39 65.94 Favored 'Trans proline' 0 C--N 1.397 3.107 0 C-N-CA 122.131 1.887 . . . . 71.4 113.608 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -74.07 -42.44 60.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.172 0.589 . . . . 71.1 110.597 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.428 HG21 ' HE1' ' A' ' 123' ' ' PHE . 90.3 t -50.37 -33.54 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.735 1.214 . . . . 74.42 112.356 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -58.02 -39.9 79.51 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.427 1.091 . . . . 74.0 111.694 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -91.67 -23.21 19.88 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.244 1.018 . . . . 74.21 111.628 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 32.0 mmmt -80.4 147.59 30.94 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.402 0.681 . . . . 52.34 111.654 -175.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.34 129.0 35.97 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.404 -0.961 . . . . 65.24 108.404 170.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -76.21 96.38 3.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.0 0.52 . . . . 74.44 110.85 -172.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -148.07 67.17 9.89 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 109.339 -0.615 . . . . 65.21 109.339 170.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.26 152.87 12.35 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.762 2.308 . . . . 74.1 111.589 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -97.0 106.44 18.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.452 -1.314 . . . . 73.52 107.452 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.07 98.19 4.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 116.016 -0.538 . . . . 63.44 109.984 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -78.73 113.45 16.8 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.09 -0.959 . . . . 73.52 108.478 170.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.429 HD22 ' HB2' ' A' ' 128' ' ' LEU . 46.1 tp -100.22 142.87 31.11 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.794 -1.188 . . . . 74.55 107.794 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.54 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 38.8 t70 -145.44 150.26 36.18 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.061 0.545 . . . . 74.23 109.834 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.2 mt -130.53 126.54 37.05 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.479 0.711 . . . . 71.25 110.49 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.673 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 10.5 m-20 -124.72 141.22 52.26 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.328 1.051 . . . . 64.34 109.499 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.5 m -134.8 131.12 37.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.008 0.523 . . . . 63.54 110.366 175.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.01 152.48 50.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.082 0.953 . . . . 55.04 109.383 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.425 ' HB2' HD11 ' A' ' 98' ' ' LEU . 22.4 t -123.45 153.92 39.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.452 0.701 . . . . 43.54 110.424 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.7 t -149.33 119.62 7.32 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.34 1.056 . . . . 72.33 108.695 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -78.42 106.59 10.46 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.482 -0.562 . . . . 44.34 109.482 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 57' ' ' GLU . 42.3 mt -82.0 -35.81 28.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.595 0.758 . . . . 55.41 110.224 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -164.48 -174.36 3.43 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.06 -0.973 . . . . 74.04 109.86 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.84 126.12 28.71 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.264 -1.013 . . . . 65.23 108.264 172.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 85' ' ' SER . 4.8 m-20 65.04 14.63 9.49 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.171 0.989 . . . . 74.23 111.4 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.9 t -128.64 104.88 12.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 N-CA-C 107.8 -1.185 . . . . 63.35 107.8 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.95 126.52 36.27 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.644 -0.707 . . . . 74.22 109.711 -170.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.461 ' HB2' HD11 ' A' ' 51' ' ' LEU . 21.0 tp10 -86.98 128.72 35.07 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 124.438 1.095 . . . . 70.24 109.225 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -128.02 120.32 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.379 -1.341 . . . . 65.44 107.379 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.5 t -110.97 118.51 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.778 0.831 . . . . 73.31 109.146 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.6 tp -100.06 108.11 20.2 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.88 -0.785 . . . . 74.12 108.88 172.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.673 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 27.5 ttp180 -87.18 104.98 16.88 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.543 -0.54 . . . . 75.31 109.543 173.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.1 t -94.39 104.75 16.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.119 -1.067 . . . . 74.31 108.119 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 30.7 m -96.27 135.87 37.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.728 0.811 . . . . 62.3 110.298 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.535 HG21 HG21 ' A' ' 114' ' ' ILE . 74.6 t -128.51 116.79 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.227 1.411 . . . . 62.25 108.544 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -120.95 123.36 42.27 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.209 -1.034 . . . . 55.53 108.209 172.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.84 113.78 21.1 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.839 -1.171 . . . . 52.33 107.839 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.6 t -144.76 143.85 30.88 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.902 0.481 . . . . 73.5 110.173 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -119.33 84.68 2.24 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.013 1.325 . . . . 74.21 108.961 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.14 -119.57 5.22 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.238 -0.892 . . . . 72.12 112.645 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -87.83 -18.98 28.09 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.435 0.694 . . . . 74.45 110.967 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.41 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 1.5 tp10 -94.07 120.27 34.09 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.468 -0.938 . . . . 70.32 108.468 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.3 m -87.35 143.5 27.22 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.114 0.415 . . . . 70.54 110.211 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.71 -66.41 0.89 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.356 -0.609 . . . . 72.12 109.356 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -161.49 174.23 13.71 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.199 -0.91 . . . . 75.42 110.985 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 64' ' ' VAL . 58.2 tp -137.81 137.41 38.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.852 1.261 . . . . 70.34 108.113 175.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.447 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 56.7 m -141.32 130.62 23.61 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.857 -1.164 . . . . 74.3 107.857 175.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -146.7 120.5 9.26 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.603 0.638 . . . . 73.53 109.739 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.84 113.39 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.36 0.664 . . . . 63.4 110.623 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -82.99 87.1 6.89 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.413 -0.958 . . . . 63.32 108.413 166.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.46 ' HG3' HD22 ' A' ' 106' ' ' LEU . 60.3 tp60 -77.19 102.71 6.75 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.304 -0.999 . . . . 62.54 108.304 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.07 143.58 17.1 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.603 -0.599 . . . . 71.34 111.603 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.93 121.89 1.56 Allowed Glycine 0 N--CA 1.451 -0.336 0 N-CA-C 111.041 -0.824 . . . . 72.1 111.041 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.5 mt -82.02 122.26 36.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.107 -1.071 . . . . 43.3 108.107 171.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.58 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.6 m-85 -127.64 119.59 26.24 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.993 0.917 . . . . 73.4 108.962 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 74.4 m -81.07 91.63 6.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.584 0.754 . . . . 71.41 109.692 169.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.5 tt -96.61 135.64 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 114.555 -1.202 . . . . 74.54 109.232 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -161.05 163.56 31.47 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.091 0.956 . . . . 75.1 110.109 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.42 -33.61 5.71 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 116.259 -0.428 . . . . 64.31 113.879 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.553 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.58 155.16 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.928 0.491 . . . . 74.45 111.043 -174.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.96 175.36 13.04 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.73 -1.123 . . . . 74.43 110.169 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.36 -142.49 34.15 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 116.022 -0.535 . . . . 71.54 111.892 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.1 p -70.17 -15.86 63.01 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.338 0.655 . . . . 73.33 111.581 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -75.18 -37.39 61.27 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.738 0.815 . . . . 64.22 111.137 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -28.64 58.79 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 110.132 -0.321 . . . . 74.21 110.132 173.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.92 -24.97 62.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.09 0.556 . . . . 72.41 110.458 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -68.17 -38.68 82.34 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 122.908 0.483 . . . . 71.22 109.847 171.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 68.8 m -65.86 -39.56 90.84 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.462 -0.335 . . . . 75.21 110.279 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.425 HD11 ' HB2' ' A' ' 48' ' ' SER . 36.0 tp -66.69 -51.44 55.99 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.914 0.886 . . . . 73.15 111.91 -175.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.11 -26.84 10.76 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.558 -0.746 . . . . 70.22 114.075 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -111.41 -66.22 1.1 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.204 0.502 . . . . 53.03 112.034 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.622 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 72.2 t80 -68.77 -61.11 1.95 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.264 1.026 . . . . 74.04 112.766 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 94.2 m -67.6 -36.68 10.51 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 113.916 1.08 . . . . 70.41 113.916 -174.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.54 -31.34 50.92 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 121.548 1.499 . . . . 73.42 112.506 167.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.21 -28.47 68.77 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.521 0.328 . . . . 62.33 110.633 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.481 HG21 ' CD1' ' A' ' 13' ' ' ILE . 50.1 mm -62.53 -45.28 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.765 0.826 . . . . 73.11 109.86 171.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.46 HD22 ' HG3' ' A' ' 80' ' ' GLN . 80.0 mt -72.29 -27.0 62.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.977 0.911 . . . . 71.43 112.256 -175.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -57.7 -45.68 99.81 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 114.142 1.164 . . . . 73.03 114.142 -168.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -62.11 -38.81 53.67 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 121.978 1.785 . . . . 71.44 112.915 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -67.13 -39.38 86.59 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.302 0.641 . . . . 53.01 111.075 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.93 -43.49 71.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.31 0.644 . . . . 74.23 110.448 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -52.05 -48.07 64.8 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 124.421 1.075 . . . . 72.33 110.2 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.08 -47.94 75.5 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 124.089 0.868 . . . . 75.04 111.342 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.45 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.5 t -58.25 -27.68 64.21 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.833 0.708 . . . . 60.34 111.22 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.535 HG21 HG21 ' A' ' 64' ' ' VAL . 86.6 mt -77.46 -58.58 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.592 1.157 . . . . 63.51 110.287 174.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.7 m -57.36 -33.72 68.06 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 124.667 1.187 . . . . 74.54 111.344 -173.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -63.67 -49.02 74.81 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.848 0.859 . . . . 61.34 109.977 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.452 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 69.3 mtm -63.56 -34.12 77.1 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.389 0.676 . . . . 73.14 111.459 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -66.46 -46.0 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.196 0.998 . . . . 75.12 110.461 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.2 m -70.22 -28.67 65.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.442 0.697 . . . . 74.43 111.388 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -73.35 -31.69 64.1 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.428 0.691 . . . . 72.22 109.782 174.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.06 2.78 86.31 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.88 0.738 . . . . 75.0 112.735 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.5 m 68.5 16.73 9.13 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.918 1.287 . . . . 42.24 111.552 173.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.428 ' HE1' HG21 ' A' ' 31' ' ' VAL . 96.9 m-85 -78.85 156.29 77.44 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 109.011 -0.737 . . . . 74.03 109.011 171.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.73 163.8 17.75 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.486 2.124 . . . . 75.45 112.531 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -60.36 121.61 12.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.062 0.945 . . . . 75.52 110.998 -172.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.524 HD21 HG11 ' A' ' 64' ' ' VAL . 53.0 tp -106.16 93.92 4.88 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.743 -0.836 . . . . 61.04 108.743 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -107.1 85.27 2.11 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.889 -1.152 . . . . 73.15 107.889 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.429 ' HB2' HD22 ' A' ' 42' ' ' LEU . 4.0 pp -60.11 137.52 58.08 Favored 'General case' 0 C--O 1.251 1.178 0 CA-C-N 114.447 -1.251 . . . . 61.51 109.246 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.63 143.91 85.79 Favored Pre-proline 0 C--O 1.243 0.758 0 C-N-CA 123.162 0.585 . . . . 72.1 110.948 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.05 161.61 45.46 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 121.702 1.601 . . . . 75.33 110.214 170.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.86 130.22 18.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.675 -0.861 . . . . 73.04 108.675 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -75.07 92.03 2.6 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.888 -0.596 . . . . 62.13 110.071 -174.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.558 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 83.9 m-85 -58.09 -35.51 71.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.86 0.864 . . . . 73.11 111.91 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.46 -50.73 72.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.531 0.733 . . . . 54.24 110.302 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.47 94.43 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.135 0.897 . . . . 71.33 111.434 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.72 -41.91 91.7 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.859 -0.61 . . . . 54.43 111.15 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -68.37 -32.26 72.22 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.029 -0.532 . . . . 54.43 109.578 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 15.9 mmt . . . . . 0 N--CA 1.475 0.811 0 O-C-N 123.667 0.605 . . . . 52.31 110.835 177.676 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.5 m . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 108.63 -0.878 . . . . 63.55 108.63 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.93 156.71 48.35 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.533 -0.543 . . . . 71.41 109.533 157.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -124.24 137.52 54.5 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 107.442 -1.318 . . . . 65.01 107.442 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.489 HD11 HD13 ' B' ' 105' ' ' ILE . 27.4 mt -78.92 117.45 24.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 107.708 -1.219 . . . . 73.01 107.708 176.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -78.23 -42.47 31.13 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.874 -0.787 . . . . 75.45 108.874 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -164.9 135.71 4.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.022 -0.99 . . . . 74.1 110.155 -170.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 85.5 mt -114.46 139.15 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 106.619 -1.623 . . . . 62.2 106.619 167.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -166.98 150.65 6.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.241 0.543 . . . . 75.03 111.524 -176.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 75.9 m -78.24 128.98 34.53 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.935 -1.029 . . . . 63.14 109.084 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 20.9 mttp -91.4 -46.24 8.12 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.661 0.784 . . . . 71.12 110.616 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 22.5 t70 -144.41 133.25 22.49 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.217 -0.447 . . . . 63.2 110.687 -165.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.8 mm -130.82 142.15 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.157 0.983 . . . . 74.12 109.114 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 81.5 p -139.2 144.45 38.52 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.376 -0.972 . . . . 72.33 108.376 170.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.1 t80 -145.81 134.13 21.81 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.971 -1.492 . . . . 73.44 106.971 163.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.645 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 36.7 mt-10 -136.89 127.24 26.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.518 -0.919 . . . . 63.02 108.518 -175.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.561 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -124.55 84.94 56.75 Favored Pre-proline 0 C--O 1.24 0.571 0 N-CA-C 107.69 -1.226 . . . . 72.22 107.69 171.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.71 -32.93 46.13 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.701 2.268 . . . . 52.34 111.394 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -104.45 10.71 35.12 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 117.873 -1.06 . . . . 71.43 110.793 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.617 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -29.64 -68.7 0.11 Allowed Pre-proline 0 N--CA 1.5 2.06 0 C-N-CA 125.355 1.462 . . . . 73.21 114.869 -170.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 11.6 Cg_exo -67.49 -21.21 46.83 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 122.199 1.933 . . . . 73.23 113.042 -171.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -96.81 -32.68 11.99 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.296 1.039 . . . . 71.15 112.434 -172.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.565 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.8 p -82.69 -19.7 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 122.683 0.393 . . . . 72.31 111.327 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -62.43 -25.41 67.95 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 113.976 1.102 . . . . 72.21 113.976 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -56.56 -25.62 52.83 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.081 0.552 . . . . 75.31 111.198 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.528 ' HB2' HD13 ' B' ' 68' ' ' LEU . 87.5 mttt -88.45 92.94 9.37 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.268 1.027 . . . . 74.14 109.435 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.24 91.25 6.17 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.099 -0.704 . . . . 63.02 109.099 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -163.32 156.82 19.4 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.837 0.855 . . . . 74.13 109.497 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -76.45 104.65 1.7 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.026 0.93 . . . . 70.41 108.649 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.607 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.2 Cg_endo -63.44 153.07 76.96 Favored 'Trans proline' 0 C--N 1.366 1.46 0 C-N-CA 123.137 2.558 . . . . 73.25 113.238 -176.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.8 118.6 7.38 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 123.778 0.674 . . . . 74.3 109.37 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.46 161.06 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 114.977 -1.011 . . . . 65.02 111.569 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -149.26 107.77 3.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.521 -1.659 . . . . 75.14 106.521 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 mp -100.27 148.69 24.37 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.164 0.585 . . . . 74.43 110.313 -171.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -131.74 113.44 13.54 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.708 -1.219 . . . . 65.31 107.708 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.2 127.25 45.14 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 106.02 -1.844 . . . . 74.02 106.02 176.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -144.99 148.64 33.99 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.797 0.839 . . . . 72.02 109.364 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 37.0 p -134.91 118.55 17.04 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.23 0.612 . . . . 65.4 109.995 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.48 153.31 31.36 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.766 1.226 . . . . 73.32 108.325 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 77.6 p -143.75 166.14 25.71 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.183 0.447 . . . . 50.5 111.34 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.0 p -152.33 149.97 29.22 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.25 1.02 . . . . 73.34 109.22 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -93.8 124.6 37.91 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.546 -0.539 . . . . 64.43 109.546 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.29 -52.42 5.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.128 -0.693 . . . . 73.31 109.128 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.41 -175.59 4.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.206 1.003 . . . . 62.2 109.646 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.46 116.33 8.09 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.577 -0.738 . . . . 75.42 109.218 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 83.0 m-20 74.08 -3.37 2.54 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.27 1.428 . . . . 74.4 112.887 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 48.4 t -106.04 110.41 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.521 -0.918 . . . . 72.05 108.521 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.488 ' HE2' ' HB ' ' B' ' 86' ' ' ILE . 1.3 p90 -119.97 173.34 7.13 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.88 0.872 . . . . 73.34 109.65 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -143.08 110.97 5.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.047 -1.094 . . . . 72.14 108.047 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 55.8 t -91.52 145.28 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.184 0.994 . . . . 62.13 109.817 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.5 t -129.33 115.13 34.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.263 -1.014 . . . . 73.42 108.263 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.4 OUTLIER -97.09 110.71 23.2 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.623 -0.88 . . . . 70.44 108.623 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -95.18 118.67 32.37 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.661 0.785 . . . . 63.05 110.746 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.484 ' HB ' HD11 ' B' ' 114' ' ' ILE . 26.3 t -116.54 103.19 14.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.53 -1.285 . . . . 74.02 107.53 168.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.567 HG23 ' HB2' ' B' ' 77' ' ' GLU . 2.8 m -99.6 131.3 45.69 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.222 -0.659 . . . . 64.13 109.222 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -125.21 116.99 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.342 0.657 . . . . 64.52 109.944 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.6 m -99.53 142.98 30.3 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.762 0.825 . . . . 60.21 108.957 167.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.404 ' HB1' ' HG2' ' B' ' 38' ' ' PRO . . . -149.22 147.04 27.93 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.033 0.533 . . . . 70.32 110.36 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.445 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 23.8 p -146.93 130.6 16.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.702 0.401 . . . . 72.41 111.93 -174.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.607 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 25.2 mt -95.84 118.85 33.27 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.679 1.191 . . . . 74.34 109.772 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.73 -108.8 2.6 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 123.742 0.651 . . . . 72.5 112.307 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -118.63 1.59 11.66 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.211 1.004 . . . . 74.24 110.384 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -122.51 155.2 36.69 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.993 0.517 . . . . 74.55 109.936 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.1 m -63.37 134.98 56.66 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.82 0.7 . . . . 72.33 110.842 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.565 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.4 -64.84 1.06 Allowed 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.492 -1.299 . . . . 65.22 107.492 174.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -148.75 157.92 43.79 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.203 -0.908 . . . . 73.14 111.012 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.645 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 69.3 mt -130.18 143.57 50.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.589 -1.634 . . . . 62.52 106.589 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 41.9 t -155.28 156.67 35.96 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.644 -0.502 . . . . 71.02 109.644 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.567 ' HB2' HG23 ' B' ' 63' ' ' THR . 34.7 tt0 -160.27 136.17 8.46 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.123 -1.065 . . . . 71.12 108.123 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 93.4 t -124.06 141.53 43.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.622 -0.881 . . . . 73.44 108.622 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -120.57 89.6 3.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.581 -0.896 . . . . 73.52 108.581 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.563 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.6 tp-100 -83.3 99.09 9.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.678 -1.146 . . . . 72.2 108.821 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.84 169.95 35.9 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 116.19 -0.459 . . . . 53.51 111.968 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.36 129.86 1.97 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.68 -0.568 . . . . 61.12 111.68 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.3 mt -85.21 129.35 37.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.597 0.759 . . . . 71.52 109.227 172.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -131.92 139.76 48.82 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.947 -1.131 . . . . 74.23 107.947 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.3 m -112.71 97.87 6.85 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.867 -0.79 . . . . 73.45 108.867 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.488 ' HB ' ' HE2' ' B' ' 56' ' ' TYR . 17.4 tt -96.54 147.02 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.697 0.799 . . . . 72.21 111.097 -166.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.97 141.34 24.17 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.326 0.65 . . . . 65.33 110.396 -174.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.57 -63.2 0.69 Allowed Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.617 -0.719 . . . . 24.41 114.488 169.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' B' ' 93' ' ' GLN . 17.2 tt -66.49 163.68 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.369 0 C-N-CA 124.042 0.937 . . . . 74.25 111.126 -173.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -158.91 175.47 13.53 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.085 0.402 . . . . 74.34 110.689 -172.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' B' ' 94' ' ' MET . . . 66.91 -132.2 31.26 Favored Glycine 0 C--N 1.355 1.59 0 C-N-CA 123.656 0.646 . . . . 34.33 114.446 169.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 46.3 m -75.9 -27.41 57.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.666 0.787 . . . . 72.42 110.947 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.486 ' HB3' HD11 ' B' ' 89' ' ' ILE . 52.1 mt-30 -68.63 -33.66 74.4 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.853 -0.612 . . . . 73.23 111.437 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' B' ' 91' ' ' GLY . 0.0 OUTLIER -71.26 -24.66 62.21 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.378 0.271 . . . . 54.32 110.734 176.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.52 78.28 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.114 0.566 . . . . 64.44 110.834 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -63.1 -29.95 71.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.3 -0.863 . . . . 75.44 110.976 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.481 ' SG ' HD12 ' B' ' 86' ' ' ILE . 49.2 t -74.67 -62.11 1.65 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.411 -0.359 . . . . 60.55 110.771 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.523 HD12 ' N ' ' B' ' 99' ' ' GLY . 3.0 pp -63.49 -32.79 74.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.126 0.788 . . . . 75.35 113.126 -173.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' GLY . . . . . 0.523 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -92.25 -36.36 6.3 Favored Glycine 0 C--N 1.345 1.056 0 O-C-N 123.482 0.488 . . . . 50.3 113.273 -172.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.0 -53.76 2.15 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.615 0.598 . . . . 64.31 112.615 -167.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 51.7 t80 -72.03 -45.05 62.31 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.862 0.865 . . . . 75.1 111.617 -168.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.492 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 70.8 m -66.11 -49.68 54.86 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 123.6 0.76 . . . . 61.34 111.253 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 80.4 Cg_exo -53.63 -36.42 81.04 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 122.479 2.12 . . . . 71.32 114.203 168.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -57.44 -38.85 75.1 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 123.399 0.679 . . . . 72.2 110.709 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.489 HD13 HD11 ' B' ' 13' ' ' ILE . 80.5 mt -64.99 -43.4 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.117 0.967 . . . . 44.12 110.633 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 52.5 mt -83.23 -15.17 51.42 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.978 0.911 . . . . 75.22 112.043 -172.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -61.28 -49.32 88.46 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.023 -0.989 . . . . 70.42 113.558 -170.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.01 -31.01 83.85 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 121.729 1.619 . . . . 74.24 112.97 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.563 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 86.7 m-85 -67.92 -50.02 58.5 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.889 0.476 . . . . 71.11 110.207 176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.41 -40.51 78.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.831 0.852 . . . . 74.3 110.582 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.749 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 30.8 ttt180 -58.08 -56.67 19.05 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.39 1.476 . . . . 72.52 111.065 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.54 -34.81 78.61 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.937 0.773 . . . . 73.45 110.51 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.7 t -69.88 -40.32 75.75 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.209 0.603 . . . . 72.44 111.417 -176.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.484 HD11 ' HB ' ' B' ' 62' ' ' VAL . 70.5 mt -62.22 -53.54 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 109.563 -0.532 . . . . 54.43 109.563 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.414 HG21 ' OG ' ' C' ' 119' ' ' SER . 12.0 m -60.07 -30.08 68.99 Favored 'General case' 0 CA--C 1.554 1.124 0 O-C-N 124.539 1.149 . . . . 41.21 111.403 -175.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.7 t -64.66 -54.09 37.18 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.555 0.742 . . . . 61.31 110.022 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.4 mmt -67.26 -34.59 77.75 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.411 0.684 . . . . 75.32 111.991 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.96 -38.31 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.134 0.974 . . . . 61.15 110.463 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.421 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 11.8 t -78.07 -20.64 51.92 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.886 -0.597 . . . . 42.55 111.139 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.45 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 92.7 mtt-85 -69.24 -33.79 73.81 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.422 -0.584 . . . . 74.54 109.422 171.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.29 11.3 58.63 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.595 0.559 . . . . 71.52 112.698 168.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.7 p 58.98 31.44 21.36 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.637 1.975 . . . . 62.3 114.18 170.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -84.81 157.93 59.89 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.133 0.573 . . . . 74.44 110.133 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.38 -175.29 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.994 2.463 . . . . 75.42 113.349 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -61.7 114.41 3.28 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.3 -0.864 . . . . 73.3 112.149 -170.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 35.9 tp -110.23 84.76 1.98 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.331 -0.989 . . . . 71.44 108.331 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.23 93.79 8.43 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.284 -0.636 . . . . 71.31 109.284 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.749 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 22.7 tp -57.68 127.77 33.69 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.737 0.815 . . . . 70.13 111.421 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.57 153.77 94.79 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 124.509 1.124 . . . . 74.32 111.813 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.19 100.56 0.46 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.836 2.357 . . . . 61.32 112.162 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.92 108.93 20.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.073 -1.084 . . . . 61.24 108.073 172.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 60.9 t30 -94.08 95.21 8.86 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 107.686 -1.227 . . . . 53.2 107.686 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.78 -42.74 89.69 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 124.081 0.863 . . . . 65.41 109.501 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.36 -39.09 69.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.191 1.397 . . . . 73.54 112.843 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.423 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -63.92 -50.33 69.13 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.717 0.807 . . . . 54.54 111.304 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 82.6 mt -79.11 -28.91 43.01 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.254 -0.885 . . . . 61.43 111.305 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 78.5 t80 . . . . . 0 N--CA 1.479 0.982 0 C-N-CA 123.756 0.822 . . . . 74.42 109.947 179.629 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m . . . . . 0 C--O 1.237 0.41 0 N-CA-C 106.336 -1.727 . . . . 71.13 106.336 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.45 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 9.0 t80 -124.64 117.48 24.37 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.013 0.525 . . . . 74.43 110.893 -175.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -137.27 133.2 34.76 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.21 -1.404 . . . . 71.43 107.21 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.413 HD13 HG21 ' C' ' 105' ' ' ILE . 45.5 mt -74.36 118.57 20.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.567 -0.901 . . . . 72.31 108.567 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.511 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 1.4 mt-30 -77.09 -40.92 44.26 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.131 0.894 . . . . 73.3 109.892 -176.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -170.56 147.65 2.94 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 116.045 -0.525 . . . . 74.21 110.077 -173.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.46 137.4 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.791 -1.188 . . . . 63.11 107.791 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.474 ' HB3' HG23 ' D' ' 122' ' ' THR . 29.8 p90 -176.01 173.78 2.2 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.903 0.752 . . . . 75.35 111.228 -171.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -100.03 123.82 44.71 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.615 0.766 . . . . 62.51 109.594 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.425 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.0 mmtp -70.67 -48.94 52.28 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.821 -1.177 . . . . 75.44 107.821 168.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -135.37 143.12 45.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 113.863 -1.517 . . . . 53.41 110.283 -172.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.0 mt -137.89 146.97 26.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 126.077 1.751 . . . . 73.31 106.359 174.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -162.21 149.95 14.31 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.423 0.63 . . . . 54.25 110.405 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.449 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 93.7 t80 -140.35 139.19 35.32 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.661 -1.237 . . . . 64.43 107.661 171.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -136.23 128.83 30.61 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.509 0.724 . . . . 71.13 110.061 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.92 82.65 11.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 106.838 -1.541 . . . . 61.22 106.838 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.85 -26.1 38.53 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.974 2.449 . . . . 63.43 112.268 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -112.28 27.23 9.83 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 114.822 -1.081 . . . . 75.21 109.641 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.415 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -50.19 -58.62 9.08 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 114.449 1.277 . . . . 71.43 114.449 -170.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.57 -31.49 79.82 Favored 'Trans proline' 0 C--N 1.388 2.624 0 CA-C-N 121.891 1.711 . . . . 65.42 112.092 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -69.75 -43.06 73.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.354 1.062 . . . . 73.12 112.031 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.67 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.7 p -77.81 -24.87 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 123.04 0.536 . . . . 55.32 111.644 -173.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.0 -29.11 70.29 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.354 0.262 . . . . 54.32 111.664 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -104.78 36.18 2.52 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.202 0.601 . . . . 74.33 110.615 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -111.07 169.46 8.76 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.235 1.014 . . . . 71.23 109.969 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -68.42 130.57 43.28 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.03 0.532 . . . . 63.23 110.147 173.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -73.99 93.37 2.22 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.324 1.049 . . . . 70.34 109.224 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -150.24 59.25 3.54 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.302 0.641 . . . . 70.14 109.712 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.4 110.28 3.03 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.643 2.229 . . . . 74.12 111.768 -175.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -86.52 108.51 18.58 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.522 -0.918 . . . . 45.12 108.522 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.53 142.33 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.308 1.043 . . . . 71.03 111.257 -171.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -130.57 119.45 22.55 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.875 -1.528 . . . . 74.21 106.875 174.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 30.1 tp -101.38 124.79 47.63 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 109.635 -0.506 . . . . 54.03 109.635 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.475 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.7 t70 -117.24 112.2 20.47 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.258 -1.016 . . . . 74.42 108.258 -176.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.438 HD13 ' HE1' ' C' ' 133' ' ' PHE . 79.9 mt -110.86 111.1 22.01 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.963 -0.754 . . . . 64.53 108.963 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -122.63 139.78 53.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.34 1.056 . . . . 75.12 108.674 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 m -126.8 126.37 43.28 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.511 0.672 . . . . 34.24 110.258 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.76 154.91 25.46 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.108 -1.406 . . . . 53.53 107.975 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.524 ' HB2' ' HE1' ' C' ' 56' ' ' TYR . 13.4 p -149.5 142.71 25.07 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.87 0.468 . . . . 72.32 109.871 -177.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.7 t -149.74 146.65 27.32 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.896 0.878 . . . . 75.31 110.162 -171.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -82.95 133.82 35.09 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.486 -0.561 . . . . 74.31 109.486 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.556 HD11 HD12 ' C' ' 83' ' ' ILE . 43.7 mt -106.53 -41.29 5.31 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.052 -0.722 . . . . 71.4 109.052 173.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.01 -175.65 5.54 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.731 -1.122 . . . . 34.41 109.963 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -67.22 119.08 11.52 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 114.973 -1.012 . . . . 64.44 109.679 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 65.34 8.21 4.79 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.017 1.327 . . . . 75.23 112.584 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -113.18 96.96 5.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 107.657 -1.238 . . . . 72.02 107.657 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.524 ' HE1' ' HB2' ' C' ' 48' ' ' SER . 1.6 t80 -114.87 129.51 56.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.652 -0.704 . . . . 71.05 109.597 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.504 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.7 tt0 -88.77 135.02 33.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.983 -1.008 . . . . 62.53 110.218 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.85 141.59 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.704 -1.221 . . . . 70.11 107.704 166.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -128.66 123.43 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.614 -1.254 . . . . 72.55 107.614 173.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.97 102.83 12.23 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.424 -1.325 . . . . 64.44 107.424 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 -85.86 122.85 30.51 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.947 -1.478 . . . . 75.12 108.443 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.6 t -117.73 126.04 74.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 107.735 -1.209 . . . . 73.43 107.735 169.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 13.0 m -126.75 115.88 20.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.61 -0.885 . . . . 72.5 108.61 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.534 HG11 HD11 ' C' ' 126' ' ' LEU . 65.2 t -102.67 120.57 52.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 109.012 -0.736 . . . . 61.13 109.012 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 16.3 m -103.52 142.83 33.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.382 -0.97 . . . . 52.33 108.382 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.44 118.25 13.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.545 -1.28 . . . . 64.43 107.545 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -132.29 134.01 44.75 Favored 'General case' 0 C--O 1.224 -0.262 0 O-C-N 123.855 0.722 . . . . 65.2 109.575 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 12.1 mt -86.2 28.01 0.87 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.809 1.243 . . . . 75.14 111.081 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.7 -104.84 1.53 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 110.453 -1.059 . . . . 32.34 110.453 -169.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -90.57 -30.89 16.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.908 0.883 . . . . 70.32 110.587 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -75.45 124.3 26.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.284 1.034 . . . . 72.33 110.206 172.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 18.0 m -80.68 125.61 30.25 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.789 -0.819 . . . . 44.21 108.789 167.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.67 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.82 -61.22 2.07 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.374 -0.602 . . . . 45.25 109.374 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -151.34 156.83 41.57 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.475 0.655 . . . . 73.42 111.237 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.447 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -127.79 142.2 51.37 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 106.75 -1.574 . . . . 61.45 106.75 172.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.447 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.4 t -148.07 141.07 24.87 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.597 -0.89 . . . . 74.31 108.597 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -147.35 133.72 19.62 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.123 -0.695 . . . . 74.41 109.123 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' C' ' 110' ' ' ALA . 59.8 t -135.97 113.75 14.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.569 1.147 . . . . 74.34 108.145 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -95.5 89.11 5.28 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.769 -0.826 . . . . 72.12 108.769 174.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -79.78 98.77 7.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.268 -0.878 . . . . 64.11 110.144 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.65 144.82 17.99 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-O 121.177 0.321 . . . . 52.53 112.45 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.58 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -146.2 128.17 2.98 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.346 -1.102 . . . . 73.52 110.346 -176.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.556 HD12 HD11 ' C' ' 51' ' ' LEU . 11.0 mm -88.32 122.68 40.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.36 -0.978 . . . . 71.45 108.36 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.45 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 62.0 m-85 -127.24 119.51 26.54 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.108 -0.701 . . . . 64.31 109.108 -175.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 85' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 31.2 p -82.96 109.64 17.25 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.797 -0.816 . . . . 61.51 108.797 176.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.578 HD13 HD21 ' C' ' 98' ' ' LEU . 32.9 pt -116.12 102.53 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-O 122.151 0.976 . . . . 61.54 110.276 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.16 158.65 30.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.106 0.962 . . . . 31.14 108.9 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.11 -18.67 34.96 Favored Glycine 0 C--N 1.344 0.986 0 N-CA-C 114.06 0.384 . . . . 62.52 114.06 173.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.19 158.74 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.381 1.072 . . . . 70.13 110.608 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -161.25 -177.26 5.91 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.119 0.567 . . . . 63.11 110.94 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.45 -116.19 8.83 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-N 115.308 -0.86 . . . . 73.02 113.78 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.6 p -70.23 -34.49 72.94 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.096 0.959 . . . . 74.44 111.24 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -70.25 -38.72 75.22 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.68 -0.691 . . . . 72.2 111.207 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 22.0 ptm -78.97 -25.55 43.44 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 119.588 -0.244 . . . . 72.54 110.697 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.47 85.53 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.646 -0.502 . . . . 63.23 109.646 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -75.73 -34.66 60.34 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.394 0.434 . . . . 64.45 111.673 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 40.3 t -59.0 -35.89 74.0 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.654 0.596 . . . . 71.04 110.661 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.578 HD21 HD13 ' C' ' 86' ' ' ILE . 51.3 mt -100.49 -16.3 17.59 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.273 0.629 . . . . 74.52 111.308 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.79 -30.5 57.72 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 114.491 0.556 . . . . 74.22 114.491 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.18 -39.09 0.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.861 0.464 . . . . 31.43 110.866 -168.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -66.07 -48.95 69.3 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.143 1.777 . . . . 64.54 112.718 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 51.0 m -73.12 -45.65 8.17 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 118.57 -0.728 . . . . 32.03 112.133 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -53.37 -30.78 54.24 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 122.602 2.201 . . . . 65.35 113.528 170.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -64.82 -40.69 95.61 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.862 0.865 . . . . 70.51 110.364 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.413 HG21 HD13 ' C' ' 13' ' ' ILE . 47.9 mm -60.71 -44.15 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.056 0.542 . . . . 74.53 109.795 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.58 HD21 ' HA3' ' C' ' 82' ' ' GLY . 88.0 mt -80.08 -26.81 39.46 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.907 -1.042 . . . . 75.43 112.764 -170.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -57.36 -48.55 97.12 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 117.575 -1.203 . . . . 72.13 113.534 -172.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.74 -37.96 94.92 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.356 2.037 . . . . 74.42 113.732 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -68.27 -44.68 75.03 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.844 0.458 . . . . 70.44 110.587 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.411 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -64.64 -38.3 90.53 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.803 -0.635 . . . . 62.54 110.78 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -57.16 -48.58 78.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.477 1.511 . . . . 72.13 110.834 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.35 -34.59 68.13 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.398 0.679 . . . . 62.12 110.69 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.5 t -69.11 -30.71 69.05 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.031 0.532 . . . . 45.42 111.287 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.517 HD11 ' HB ' ' C' ' 62' ' ' VAL . 97.7 mt -68.47 -51.36 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.439 0.696 . . . . 71.21 109.541 173.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.415 HG21 ' OG ' ' B' ' 119' ' ' SER . 10.5 m -60.25 -31.95 70.69 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.166 0.916 . . . . 71.43 111.104 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.9 t -64.51 -54.78 27.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.722 0.809 . . . . 55.03 109.465 174.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.449 ' HB3' ' HB2' ' C' ' 23' ' ' PHE . 0.0 OUTLIER -57.56 -42.52 83.19 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.741 1.216 . . . . 71.21 112.84 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' C' ' 123' ' ' PHE . 58.3 t -66.27 -41.74 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.105 0.962 . . . . 74.12 110.422 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.414 ' OG ' HG21 ' B' ' 115' ' ' THR . 32.7 t -70.64 -26.51 63.5 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.954 -0.567 . . . . 74.15 111.011 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.5 mtt-85 -70.93 -40.45 72.07 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.211 0.605 . . . . 73.54 109.439 175.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 121' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' C' ' 23' ' ' PHE . . . -82.57 1.26 88.22 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.87 0.731 . . . . 33.35 112.934 173.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 16.5 p 66.1 24.83 10.89 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.479 1.912 . . . . 50.34 113.931 170.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.477 ' HB2' HG13 ' C' ' 118' ' ' VAL . 79.7 m-85 -85.27 163.76 43.83 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.018 0.927 . . . . 62.41 110.056 172.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -54.67 124.18 15.54 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.979 2.453 . . . . 55.42 112.721 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.421 ' NE2' ' HB2' ' B' ' 119' ' ' SER . 47.1 mt-30 -60.49 137.89 58.09 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.074 0.549 . . . . 74.52 110.855 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.534 HD11 HG11 ' C' ' 64' ' ' VAL . 2.5 pt? -130.22 127.52 39.8 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.895 -0.593 . . . . 71.33 110.049 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -110.1 110.24 21.05 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.267 -1.012 . . . . 75.54 108.267 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.31 134.53 56.62 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 124.134 0.896 . . . . 71.44 110.99 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 129' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -70.81 147.07 94.05 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 123.857 0.723 . . . . 73.42 111.499 -175.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.456 ' HG3' HD12 ' A' ' 16' ' ' ILE . 9.7 Cg_exo -69.4 109.7 2.3 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.601 2.201 . . . . 72.41 111.905 176.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 m -106.07 138.95 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.756 -0.831 . . . . 74.02 108.756 170.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -75.85 88.34 2.86 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.91 0.484 . . . . 75.12 110.204 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.438 ' HE1' HD13 ' C' ' 44' ' ' LEU . 98.5 m-85 -62.05 -48.32 80.76 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.664 -0.698 . . . . 75.31 110.429 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.12 -44.64 68.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.667 -1.151 . . . . 70.13 112.455 -170.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.65 87.85 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.242 0.964 . . . . 75.01 111.307 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 -50.4 70.92 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 124.439 1.087 . . . . 73.35 109.852 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 4.5 t80 . . . . . 0 CA--C 1.554 1.132 0 CA-C-N 115.834 -0.621 . . . . 74.2 110.282 -178.488 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.544 0.724 0 N-CA-C 109.8 -0.444 . . . . 71.42 109.8 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -152.5 113.29 4.15 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.115 -1.069 . . . . 73.04 108.115 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -131.57 121.48 24.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.871 0.868 . . . . 63.34 108.751 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 23.7 mt -75.35 121.29 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.544 -0.91 . . . . 55.03 108.544 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -88.57 -31.49 18.61 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.188 0.595 . . . . 52.24 111.584 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -169.08 142.63 2.86 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.587 0.232 . . . . 73.23 111.526 -174.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.4 132.85 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 107.188 -1.412 . . . . 74.32 107.188 169.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.463 ' HE1' HG13 ' D' ' 83' ' ' ILE . 36.9 p90 -161.15 152.28 18.69 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.925 0.869 . . . . 75.22 111.438 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -88.47 116.13 26.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.428 -1.26 . . . . 74.42 108.975 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -83.56 -26.42 30.1 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.407 -0.59 . . . . 63.32 109.407 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -154.31 139.97 17.97 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.967 -1.015 . . . . 61.33 109.352 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.448 HG21 ' HE2' ' C' ' 117' ' ' MET . 38.5 mt -137.33 147.31 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.865 1.266 . . . . 71.24 107.851 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -156.27 143.29 18.91 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.348 0.595 . . . . 73.3 110.068 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.9 t80 -138.05 133.58 33.71 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.401 -1.703 . . . . 73.02 106.401 170.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.2 mt-10 -129.2 141.13 51.24 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.887 0.875 . . . . 73.13 109.061 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.98 81.27 39.86 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.166 -1.42 . . . . 70.41 107.166 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.79 -36.15 8.51 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.006 2.471 . . . . 73.25 113.012 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -104.84 17.66 23.74 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.709 0.804 . . . . 75.22 110.793 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -32.49 -64.79 0.23 Allowed Pre-proline 0 CA--C 1.564 1.488 0 N-CA-C 116.11 1.892 . . . . 65.05 116.11 -164.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.415 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 68.8 Cg_endo -77.91 -20.88 11.41 Favored 'Trans proline' 0 C--N 1.382 2.295 0 CA-C-N 122.896 2.07 . . . . 61.34 113.732 -176.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -72.9 -40.09 65.84 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.759 1.223 . . . . 72.2 109.884 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.769 HG21 ' HA ' ' D' ' 73' ' ' ALA . 14.6 p -83.59 -14.54 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.485 -0.78 . . . . 71.04 111.807 -175.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 20.0 m-85 -68.15 -15.99 63.81 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.666 -0.646 . . . . 73.12 111.862 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -67.29 -19.16 65.44 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.74 0.816 . . . . 64.55 110.971 173.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.497 ' HB2' HD13 ' D' ' 68' ' ' LEU . 28.3 mmtp -84.96 87.61 7.37 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.034 0.934 . . . . 64.0 108.847 174.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.54 68.06 10.3 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.737 0.78 . . . . 71.44 108.919 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 48.3 t-105 -142.19 158.46 43.71 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.984 0.913 . . . . 62.31 109.251 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -72.95 111.1 10.07 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.676 1.19 . . . . 54.3 110.031 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.83 141.73 55.07 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.927 2.418 . . . . 54.02 112.33 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.67 124.72 27.71 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.153 -0.684 . . . . 75.45 109.153 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.663 HG13 HG13 ' D' ' 64' ' ' VAL . 59.2 t -97.93 107.67 20.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.831 -0.803 . . . . 41.13 108.831 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -95.28 118.5 32.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.433 -1.321 . . . . 72.31 107.433 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.57 143.2 28.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.238 0.615 . . . . 64.21 110.326 -175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.726 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.7 m-20 -127.45 112.36 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.576 -1.268 . . . . 70.23 107.576 169.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 88.2 mt -99.72 130.2 45.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.433 0.693 . . . . 70.54 110.114 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.447 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.2 t0 -144.87 149.76 35.9 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.51 1.124 . . . . 63.31 108.373 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -125.12 159.65 30.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.519 0.676 . . . . 55.41 110.257 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.496 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.96 154.28 37.99 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.818 -1.549 . . . . 72.23 106.818 172.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.7 p -167.64 152.97 7.13 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.853 0.297 . . . . 62.14 111.223 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.7 p -163.74 142.47 7.82 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.91 0.884 . . . . 65.51 109.707 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -75.92 121.05 22.11 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.231 -0.655 . . . . 55.14 109.231 176.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 49.4 mt -89.93 -38.61 13.55 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.855 0.36 . . . . 75.44 110.436 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.42 -176.07 5.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.053 -0.522 . . . . 73.22 110.438 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -69.49 118.51 12.45 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.229 0.611 . . . . 64.12 109.594 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 67.99 9.2 7.0 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.907 1.283 . . . . 63.01 111.856 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 66.2 t -113.44 119.1 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.327 0.651 . . . . 63.42 109.693 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -128.41 129.56 46.36 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.009 0.924 . . . . 75.24 108.79 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -96.53 138.96 33.33 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.953 0.901 . . . . 73.42 109.072 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -126.42 122.76 61.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 N-CA-C 108.113 -1.069 . . . . 64.15 108.113 173.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.559 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 23.6 t -99.11 137.62 26.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 123.693 0.797 . . . . 75.01 108.903 171.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.41 123.32 44.95 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.67 -0.863 . . . . 71.5 108.67 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.447 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.4 ttm-85 -98.6 113.67 25.82 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.086 -0.709 . . . . 74.42 109.086 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.8 t -112.74 113.35 43.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.778 -1.193 . . . . 65.15 107.778 170.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.726 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 48.5 m -111.74 136.8 50.51 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.817 0.847 . . . . 70.55 109.141 -177.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.663 HG13 HG13 ' D' ' 40' ' ' VAL . 78.0 t -130.13 108.34 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.419 1.088 . . . . 64.41 109.635 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 38.1 m -107.58 114.67 28.81 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.371 -0.974 . . . . 64.03 108.371 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.4 145.13 48.22 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.328 0.651 . . . . 72.32 110.533 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 50.6 p -129.67 147.76 51.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.972 0.909 . . . . 75.34 109.246 173.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' D' ' 34' ' ' LYS . 25.6 mt -118.5 108.75 15.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.389 1.076 . . . . 72.53 108.243 171.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.42 -126.11 15.18 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 123.686 0.617 . . . . 61.5 112.447 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -90.61 2.36 55.92 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.31 0.644 . . . . 73.41 112.602 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -134.06 158.98 42.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.551 0.34 . . . . 70.33 111.354 -166.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.7 m -65.17 124.35 21.92 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.17 -0.923 . . . . 61.01 109.651 174.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.769 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -80.81 -72.8 0.4 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.158 -1.052 . . . . 52.33 108.158 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -155.45 139.48 16.41 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.477 -0.783 . . . . 52.01 110.036 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 37.0 mt -105.47 150.76 25.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.326 -1.306 . . . . 54.42 107.795 176.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.1 t -158.38 147.63 19.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.909 -0.404 . . . . 63.01 109.909 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.01 134.13 10.39 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.917 -0.771 . . . . 73.3 108.917 172.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.2 t -128.46 137.23 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.406 -0.961 . . . . 64.24 108.406 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -117.86 81.55 1.68 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.73 -1.211 . . . . 64.42 107.73 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 35.8 tp60 -80.06 96.48 6.49 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 112.961 -1.927 . . . . 64.34 109.802 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.63 143.17 17.58 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.676 -0.569 . . . . 62.33 111.676 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.66 130.81 5.38 Favored Glycine 0 C--O 1.228 -0.243 0 N-CA-C 111.214 -0.755 . . . . 74.1 111.214 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.463 HG13 ' HE1' ' D' ' 17' ' ' TYR . 70.8 mt -90.3 122.74 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.95 -1.13 . . . . 73.23 107.95 172.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -124.15 149.54 46.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.035 0.934 . . . . 70.32 109.049 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t -115.01 102.7 10.2 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.981 -1.118 . . . . 64.5 107.981 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.569 HG23 HD12 ' D' ' 89' ' ' ILE . 46.1 mt -108.81 128.03 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.988 0.915 . . . . 71.31 110.443 -171.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.18 157.31 42.51 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.961 0.905 . . . . 72.22 110.272 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.87 11.96 81.03 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.331 -0.395 . . . . 62.1 113.933 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.569 HD12 HG23 ' D' ' 86' ' ' ILE . 15.8 mt -111.42 127.65 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.062 0.945 . . . . 72.51 110.443 -173.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.04 164.1 34.12 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.228 1.011 . . . . 73.54 111.039 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.18 -131.57 11.34 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.54 -0.754 . . . . 31.24 113.569 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -75.79 -24.43 55.97 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.813 0.845 . . . . 75.12 111.487 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -65.15 -26.37 68.15 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.44 0.696 . . . . 73.43 110.724 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 54.3 mtp -54.31 -55.15 31.24 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.489 1.116 . . . . 73.12 110.831 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.71 -41.43 83.57 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.952 -1.022 . . . . 65.21 110.648 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.402 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 28.4 t-80 -65.9 -24.89 66.93 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.88 0.872 . . . . 60.12 111.742 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -80.38 -48.85 12.3 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.832 -0.432 . . . . 52.12 109.832 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 28.5 tp -67.72 -56.01 10.95 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.729 0.812 . . . . 75.14 112.452 -171.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.88 -0.1 51.98 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 114.654 0.621 . . . . 41.23 114.654 -168.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -124.84 -66.07 0.99 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.673 0.737 . . . . 43.43 110.88 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -65.88 -54.21 29.59 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.536 0.734 . . . . 75.43 111.763 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.2 m -62.69 -46.35 88.52 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.305 -0.855 . . . . 64.13 112.387 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.32 -36.6 97.21 Favored 'Trans proline' 0 C--N 1.393 2.909 0 C-N-CA 122.523 2.149 . . . . 70.32 113.378 168.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 104' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' D' ' 133' ' ' PHE . 64.3 t30 -71.09 -23.86 62.19 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.213 0.605 . . . . 73.54 110.77 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 29.7 mm -76.68 -36.51 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.961 0.904 . . . . 75.2 110.252 171.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.88 -18.62 53.63 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.31 0.644 . . . . 70.32 111.862 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -71.34 -37.94 6.2 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 113.901 1.074 . . . . 63.44 113.901 -173.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.99 -45.63 37.52 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 121.883 1.722 . . . . 71.21 112.281 168.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -70.61 -33.49 71.1 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.32 -0.855 . . . . 60.34 111.764 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.85 -51.48 54.99 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.301 0.64 . . . . 62.3 110.084 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -51.2 -52.32 45.52 Favored 'General case' 0 C--N 1.358 0.942 0 O-C-N 124.797 1.311 . . . . 73.43 110.309 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.38 -46.23 91.06 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.383 1.052 . . . . 73.45 111.839 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.6 t -58.97 -41.9 88.62 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.863 0.727 . . . . 64.44 110.659 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.477 HG23 ' SG ' ' D' ' 76' ' ' CYS . 80.4 mt -64.33 -56.08 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 123.996 0.81 . . . . 73.2 110.411 174.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 61.4 m -51.89 -44.55 63.79 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.816 1.247 . . . . 43.34 111.574 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.5 t -65.29 -42.0 93.58 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.912 -1.04 . . . . 71.3 110.201 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.4 mtm -68.58 -34.25 75.48 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.028 0.531 . . . . 65.4 111.772 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -66.99 -40.85 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.002 0.921 . . . . 55.41 110.099 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 77.7 p -76.66 -28.47 55.99 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.979 0.512 . . . . 74.35 111.012 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -73.68 -28.53 61.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.222 0.609 . . . . 72.41 109.633 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.18 3.64 86.66 Favored Glycine 0 C--N 1.351 1.381 0 O-C-N 123.837 0.71 . . . . 71.3 112.378 172.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.474 HG23 ' HB3' ' C' ' 17' ' ' TYR . 45.2 p 60.09 20.0 9.23 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 126.845 2.058 . . . . 64.31 114.181 175.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -79.61 157.23 74.9 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 123.13 0.572 . . . . 74.23 109.853 171.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.53 126.34 17.69 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.946 2.431 . . . . 73.54 112.367 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -56.05 138.99 48.3 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.425 1.09 . . . . 73.43 112.041 -174.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 32.5 mt -107.92 101.41 10.68 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.557 -0.535 . . . . 74.23 109.557 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -100.65 84.83 2.8 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.615 -1.254 . . . . 74.14 107.615 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -59.18 115.68 3.36 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 114.775 -1.102 . . . . 71.42 109.991 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.79 136.06 86.87 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 124.189 0.931 . . . . 45.11 110.191 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 24.3 Cg_exo -61.7 114.31 2.21 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.802 2.335 . . . . 62.01 112.55 -172.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.1 m -108.02 128.38 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.483 0.713 . . . . 75.01 109.243 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -85.84 103.98 15.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.632 0.773 . . . . 41.34 110.544 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 133' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' D' ' 104' ' ' ASN . 63.9 m-85 -66.5 -25.63 66.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.205 0.602 . . . . 70.44 112.041 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 134' ' ' ASP . . . . . 0.468 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 2.5 m-20 -57.42 -58.67 7.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.892 0.877 . . . . 71.31 111.258 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.17 90.19 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.815 0.846 . . . . 62.0 111.713 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.88 -29.76 68.95 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.181 -0.918 . . . . 74.12 112.067 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.7 t80 . . . . . 0 N--CA 1.485 1.283 0 C-N-CA 123.537 0.735 . . . . 73.3 110.66 178.434 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.9 m . . . . . 0 C--O 1.24 0.565 0 N-CA-C 108.704 -0.85 . . . . 53.31 108.704 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.691 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 11.5 t80 -123.09 124.71 43.7 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.329 -0.989 . . . . 74.24 108.329 170.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -141.7 112.07 6.99 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.73 -0.668 . . . . 41.45 109.851 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.594 HG12 ' HD2' ' A' ' 84' ' ' PHE . 52.7 mt -83.05 113.87 22.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.804 -0.813 . . . . 72.3 108.804 173.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -81.34 -31.97 33.21 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.792 -0.64 . . . . 63.03 109.843 -177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -171.53 143.54 1.78 Allowed 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.008 0.193 . . . . 64.43 111.108 -173.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.86 126.92 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 124.251 1.02 . . . . 65.31 108.384 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -160.54 168.71 24.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.028 0.931 . . . . 75.12 110.698 -170.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.6 p -93.39 121.06 34.39 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.083 -0.71 . . . . 72.55 109.083 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -85.76 -26.07 26.03 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.037 -0.529 . . . . 72.11 109.675 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.2 t70 -152.77 142.59 22.06 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.934 -1.03 . . . . 72.13 110.197 -175.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.599 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 88.2 mt -146.19 141.72 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.728 1.611 . . . . 72.55 107.057 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -151.82 132.14 13.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.579 -0.526 . . . . 74.45 109.579 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 82.9 t80 -130.99 122.6 27.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.74 -1.578 . . . . 63.41 106.74 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -129.99 118.42 21.59 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.36 -0.607 . . . . 73.15 109.36 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.12 79.03 70.11 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.826 -1.175 . . . . 75.11 107.826 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.26 -33.05 40.61 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.052 2.501 . . . . 55.3 111.686 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.429 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 24.4 m120 -107.03 36.73 2.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.779 -1.1 . . . . 60.14 109.631 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.536 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -60.39 -44.58 96.28 Favored Pre-proline 0 CA--C 1.57 1.743 0 C-N-CA 124.537 1.135 . . . . 61.22 113.967 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.88 -20.85 11.46 Favored 'Trans proline' 0 C--N 1.385 2.468 0 CA-C-N 121.522 1.579 . . . . 74.13 112.876 172.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 61.7 m170 -77.67 -38.97 46.47 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.143 0.577 . . . . 72.14 110.876 -176.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.649 HG23 HD12 ' A' ' 68' ' ' LEU . 10.6 p -63.48 -27.7 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.989 0.916 . . . . 51.4 110.998 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.602 ' HD1' HH11 ' B' ' 15' ' ' ARG . 91.7 t80 -62.44 -35.57 79.7 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.315 1.046 . . . . 42.21 110.907 174.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -93.03 -25.43 17.95 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.641 0.776 . . . . 63.44 111.264 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HE2' HD22 ' A' ' 68' ' ' LEU . 53.9 mtpt -82.87 165.31 19.89 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.463 0.705 . . . . 72.45 111.489 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.472 ' O ' HD21 ' A' ' 68' ' ' LEU . 10.3 m-20 -80.77 128.66 33.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.178 0.991 . . . . 72.14 108.919 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -69.28 85.92 0.4 Allowed 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.37 0.605 . . . . 75.24 111.245 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -127.25 82.28 68.47 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.543 1.137 . . . . 74.32 108.647 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -85.11 152.52 10.95 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.418 2.079 . . . . 64.0 113.117 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.435 ' HB3' ' NZ ' ' A' ' 41' ' ' LYS . 63.1 mm-40 -105.6 85.49 2.25 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.865 -1.161 . . . . 70.25 107.865 176.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -82.5 93.83 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 122.323 1.059 . . . . 62.42 111.357 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 39' ' ' GLU . 13.7 mptt -98.17 136.05 38.94 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.912 -1.04 . . . . 72.0 108.61 169.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.419 HD13 HG22 ' A' ' 64' ' ' VAL . 37.2 tp -119.57 114.8 22.79 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.009 -0.737 . . . . 70.4 109.009 172.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -102.67 128.55 49.32 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.028 -1.101 . . . . 70.25 108.028 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.1 mt -107.35 143.03 36.22 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.625 -0.88 . . . . 62.53 108.625 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 26.2 t70 -143.29 130.46 20.79 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.987 -0.746 . . . . 64.34 108.987 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -105.77 131.09 53.54 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.065 -0.717 . . . . 74.33 109.065 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.6 127.37 38.86 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.658 0.783 . . . . 72.22 109.664 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.1 p -94.83 153.22 17.83 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.143 0.977 . . . . 55.44 110.214 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.9 t -150.39 127.39 11.15 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.872 -0.788 . . . . 62.34 108.872 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -103.01 106.7 17.27 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.282 -0.636 . . . . 75.3 109.282 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.584 HD11 ' HB2' ' A' ' 57' ' ' GLU . 65.6 mt -83.37 -30.47 27.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.047 0.539 . . . . 70.34 110.505 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -163.73 -177.98 5.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.12 -0.946 . . . . 53.44 109.748 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.43 126.27 28.76 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.518 -1.29 . . . . 62.54 107.518 164.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 74.19 -3.85 2.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.272 1.029 . . . . 74.55 112.85 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 50.5 t -115.64 111.4 35.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 107.403 -1.332 . . . . 63.53 107.403 177.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -130.99 123.73 29.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.39 -0.596 . . . . 52.41 109.39 -172.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.584 ' HB2' HD11 ' A' ' 51' ' ' LEU . 45.3 tt0 -93.95 140.34 29.82 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.762 0.825 . . . . 73.15 109.404 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -119.29 143.43 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.483 -1.302 . . . . 54.24 107.483 170.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.03 117.74 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.967 -1.123 . . . . 72.54 107.967 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -99.54 106.8 18.84 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.215 -1.031 . . . . 73.22 108.215 178.221 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.569 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 62.9 ttt180 -84.34 105.89 15.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.063 0.945 . . . . 72.4 109.29 176.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.536 HG22 HD12 ' A' ' 60' ' ' LEU . 15.9 t -104.71 115.84 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.869 0.868 . . . . 61.53 109.003 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.3 m -110.71 112.71 24.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.091 0.957 . . . . 74.43 110.511 -175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 114' ' ' ILE . 53.0 t -102.89 107.35 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.888 0.875 . . . . 74.43 109.176 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.1 m -105.13 109.91 22.08 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.531 -0.915 . . . . 74.45 108.531 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.71 104.1 9.96 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.611 -0.885 . . . . 24.2 108.611 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.8 m -107.76 127.15 53.44 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.563 0.745 . . . . 71.1 109.13 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.649 HD12 HG23 ' A' ' 31' ' ' VAL . 2.2 tt -86.62 87.14 7.38 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 106.781 -1.563 . . . . 43.13 106.781 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.86 -98.7 1.32 Allowed Glycine 0 C--N 1.343 0.926 0 CA-C-N 114.51 -1.223 . . . . 70.44 110.632 -172.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -115.5 -12.54 11.65 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.124 0.97 . . . . 73.15 110.443 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.408 ' HB2' ' HZ3' ' A' ' 34' ' ' LYS . 11.1 mp0 -99.48 119.5 38.12 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.227 1.011 . . . . 70.43 109.671 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.3 m -61.82 122.44 15.39 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 123.459 0.474 . . . . 75.42 111.409 -178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.93 -55.67 5.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.045 -1.095 . . . . 75.13 108.045 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.511 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 51.7 p90 -158.95 150.43 20.56 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.854 -1.066 . . . . 71.32 110.601 175.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 64' ' ' VAL . 47.0 tp -131.1 107.57 9.14 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 107.741 -1.207 . . . . 54.14 107.741 176.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.511 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 60.4 m -109.74 99.78 8.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.659 0.784 . . . . 62.32 109.715 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -119.71 116.04 25.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.636 -0.876 . . . . 54.34 108.636 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.24 132.3 68.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 123.992 0.917 . . . . 64.55 109.29 -173.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 44.9 mt-30 -104.55 101.13 10.79 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 109.232 -0.655 . . . . 62.51 109.232 168.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -86.82 105.4 16.99 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.107 -1.072 . . . . 74.4 108.107 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.44 144.6 17.15 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 111.756 -0.538 . . . . 73.35 111.756 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.485 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.23 137.09 7.89 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.078 -0.809 . . . . 63.33 111.078 177.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.4 mt -89.08 123.58 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.844 -0.799 . . . . 62.41 108.844 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.691 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 34.8 m-85 -128.18 133.59 48.93 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.264 0.626 . . . . 74.32 109.654 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.3 t -100.89 114.31 28.05 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.67 -0.863 . . . . 74.24 108.67 176.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.31 142.31 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.831 0.852 . . . . 72.32 109.25 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.49 152.35 19.97 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.088 0.955 . . . . 54.52 109.792 173.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.2 -17.19 57.82 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.558 0.536 . . . . 54.01 114.398 173.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.544 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -132.18 152.95 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.483 0.713 . . . . 73.31 109.874 178.586 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.492 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 17.9 tt0 -150.27 -179.05 6.88 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.845 0.858 . . . . 54.55 108.866 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 71.9 -135.58 23.2 Favored Glycine 0 C--N 1.35 1.359 0 C-N-CA 123.003 0.335 . . . . 71.1 113.888 176.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.2 p -79.32 -15.13 58.43 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.075 0.55 . . . . 73.12 110.918 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -74.96 -36.84 62.07 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.151 0.98 . . . . 74.42 110.532 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.492 ' SD ' ' HA ' ' A' ' 90' ' ' GLU . 12.9 ptt? -74.94 -25.13 58.67 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 110.259 -0.274 . . . . 64.32 110.259 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.45 -26.53 62.76 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.294 0.637 . . . . 73.2 110.26 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.484 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 27.5 t-80 -71.88 -34.56 69.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.069 0.548 . . . . 73.45 110.494 171.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.544 ' SG ' HG13 ' A' ' 89' ' ' ILE . 79.3 m -69.58 -61.27 1.85 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.454 0.302 . . . . 73.22 110.769 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -76.21 -24.23 54.65 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.676 0.39 . . . . 70.33 111.194 -173.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.0 3.75 38.53 Favored Glycine 0 N--CA 1.476 1.325 0 CA-C-O 119.762 -0.466 . . . . 73.35 114.251 -171.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -147.49 -59.0 0.26 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 117.375 0.588 . . . . 24.34 111.755 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.424 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 84.6 t80 -70.74 -51.05 29.74 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.776 0.831 . . . . 75.35 112.511 -173.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.437 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 74.5 m -76.18 -34.2 1.38 Allowed Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 113.876 1.065 . . . . 75.14 113.876 -173.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.455 ' HB2' HD23 ' A' ' 60' ' ' LEU . 42.8 Cg_endo -69.12 -22.38 35.08 Favored 'Trans proline' 0 C--N 1.379 2.143 0 CA-C-N 121.596 1.606 . . . . 61.52 112.92 167.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -70.35 -31.36 68.6 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.389 0.676 . . . . 73.22 109.721 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 35.9 mm -57.08 -39.09 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.185 0.994 . . . . 74.12 110.962 171.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.485 HD21 ' HA3' ' A' ' 82' ' ' GLY . 54.0 mt -86.23 -16.99 35.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.788 0.835 . . . . 73.32 112.748 -172.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -64.79 -43.14 68.17 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 113.453 0.909 . . . . 73.15 113.453 -175.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.46 -36.25 78.44 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.058 1.839 . . . . 44.15 113.243 173.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -70.5 -40.06 73.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.347 0.659 . . . . 74.42 111.223 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.11 -40.55 86.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.299 0.64 . . . . 71.2 110.149 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.523 ' NH1' HD12 ' C' ' 105' ' ' ILE . 36.9 ttm180 -51.56 -55.52 18.68 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 124.334 1.021 . . . . 65.41 110.143 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.37 -47.31 86.41 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.367 1.042 . . . . 52.43 111.537 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.4 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 37.3 t -55.14 -45.01 75.6 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.93 0.769 . . . . 65.33 110.987 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.475 HG21 HG21 ' A' ' 64' ' ' VAL . 83.9 mt -64.69 -55.68 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.773 -1.103 . . . . 73.04 110.758 176.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -55.58 -37.35 67.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.985 0.914 . . . . 52.24 111.799 -175.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -66.79 -49.89 64.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.88 -1.055 . . . . 44.41 109.912 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 38.8 mtp -58.44 -37.18 74.89 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.773 0.829 . . . . 62.12 111.847 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 114' ' ' ILE . 98.2 t -65.69 -47.86 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.851 0.86 . . . . 73.14 110.263 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 p -74.98 -21.61 59.05 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.18 0.592 . . . . 72.04 111.876 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -73.0 -34.27 66.29 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.519 0.728 . . . . 72.51 109.362 172.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.82 0.66 76.95 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.894 0.746 . . . . 42.35 113.1 172.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.4 m 69.25 19.63 7.76 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 124.648 1.179 . . . . 75.31 111.141 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -86.97 150.46 50.08 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.627 0.771 . . . . 72.1 109.987 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.48 152.6 15.61 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.722 2.948 . . . . 71.32 114.374 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -57.67 140.92 50.05 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.238 1.015 . . . . 73.14 112.413 -172.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.8 tp -127.14 113.36 16.28 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.853 0.461 . . . . 45.24 110.558 -176.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -122.41 86.7 2.62 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.387 0.675 . . . . 71.25 109.206 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.69 ' H ' HD23 ' A' ' 128' ' ' LEU . 0.5 OUTLIER -65.61 131.06 45.44 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.278 0.631 . . . . 52.03 110.028 175.22 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.38 146.39 81.09 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 123.756 0.822 . . . . 71.21 111.847 -170.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.51 121.99 7.9 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 122.942 2.428 . . . . 75.21 112.548 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -108.39 134.73 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 109.217 -0.661 . . . . 71.25 109.217 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.403 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 52.5 t-20 -80.76 101.94 9.64 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.701 0.8 . . . . 72.12 109.355 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -66.9 -27.15 67.27 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.275 0.63 . . . . 62.4 111.596 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.538 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 5.1 m-20 -67.87 -37.49 81.88 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.836 0.855 . . . . 65.52 110.816 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.48 -37.24 84.66 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.893 0.746 . . . . 44.0 110.589 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 132' ' ' ASN . 84.3 mt -67.07 -45.14 78.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.655 0.782 . . . . 71.44 111.396 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -64.0 -39.49 94.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.507 -0.769 . . . . 73.2 109.322 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 CA--C 1.543 0.69 0 O-C-N 124.211 0.944 . . . . 63.41 110.668 -178.355 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 95.5 m . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 106.608 -1.627 . . . . 74.33 106.608 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -133.49 132.83 41.48 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.686 0.395 . . . . 74.41 110.317 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -140.09 142.08 36.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.34 0.656 . . . . 75.12 109.732 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.449 HD11 HD13 ' B' ' 105' ' ' ILE . 32.1 mt -95.64 120.68 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 107.989 -1.115 . . . . 73.35 107.989 170.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -85.2 -50.86 7.04 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.334 -0.617 . . . . 63.44 109.334 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.602 HH11 ' HD1' ' A' ' 32' ' ' PHE . 46.0 ttt180 -162.03 137.99 7.68 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.364 -0.834 . . . . 75.42 109.508 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 91.4 mt -114.99 145.46 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 106.77 -1.567 . . . . 74.33 106.77 171.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -165.61 141.24 5.1 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.931 0.396 . . . . 74.2 111.416 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 59.0 m -72.92 120.92 19.21 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.108 -1.071 . . . . 74.45 108.108 171.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.536 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 46.8 mtpt -92.67 -32.42 14.76 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.221 0.608 . . . . 73.53 111.267 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.9 t70 -153.93 137.8 16.25 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.064 0.228 . . . . 73.55 110.689 -171.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.8 mm -134.87 141.3 43.47 Favored 'Isoleucine or valine' 0 C--N 1.348 0.533 0 C-N-CA 124.834 1.254 . . . . 64.32 108.223 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.3 t -139.16 127.07 22.2 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.526 -1.286 . . . . 74.23 107.526 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.599 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.0 t80 -143.39 114.35 7.74 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.478 -0.934 . . . . 64.1 108.478 173.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -119.48 137.94 53.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.031 0.933 . . . . 65.35 108.817 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.01 81.04 71.17 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.461 -1.311 . . . . 74.54 107.461 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.87 -44.39 16.61 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.25 2.633 . . . . 71.33 113.356 -166.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.53 ' HB2' ' HB ' ' B' ' 31' ' ' VAL . 33.5 m-80 -100.25 15.49 27.41 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 117.905 -1.045 . . . . 72.4 110.792 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.424 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -30.17 -72.26 0.06 OUTLIER Pre-proline 0 N--CA 1.511 2.59 0 C-N-CA 125.927 1.691 . . . . 64.12 115.048 -165.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 33.9 Cg_endo -66.3 -21.61 54.25 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.462 2.108 . . . . 64.01 113.166 -172.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -83.11 -49.53 9.42 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.383 -0.826 . . . . 71.11 111.308 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.658 HG22 HD12 ' B' ' 68' ' ' LEU . 8.1 p -64.37 -19.61 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.133 0.973 . . . . 31.14 112.056 -166.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -61.37 -11.77 11.49 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 123.821 0.848 . . . . 75.35 112.319 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.607 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 24.7 pt20 -55.34 -40.27 71.03 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.08 1.352 . . . . 51.41 111.574 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.607 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 90.0 mttt -94.54 89.65 5.89 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.622 0.769 . . . . 65.43 108.925 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.32 86.91 2.51 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.388 -0.824 . . . . 64.25 109.641 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -154.16 155.15 34.81 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.087 1.355 . . . . 73.34 107.377 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -76.2 102.91 0.87 Allowed Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.559 -0.904 . . . . 63.53 108.559 170.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.524 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 34.6 Cg_endo -60.06 142.06 97.59 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 123.136 2.558 . . . . 62.53 113.098 -170.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.41 121.58 13.57 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 123.701 0.625 . . . . 74.41 109.441 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' B' ' 65' ' ' THR . 18.3 m -104.05 135.5 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.587 -0.733 . . . . 65.25 112.314 -171.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.592 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 54.1 tttp -106.1 103.48 12.97 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.597 -1.26 . . . . 63.54 107.597 170.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.644 ' H ' HD23 ' B' ' 42' ' ' LEU . 2.2 pt? -95.81 132.31 41.19 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.81 -0.811 . . . . 73.03 108.81 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 19.5 t70 -131.77 146.96 52.44 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.14 1.376 . . . . 73.32 109.123 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 tp -125.04 131.4 53.38 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.106 0.962 . . . . 75.45 109.724 -172.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -148.87 155.89 41.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.643 1.177 . . . . 71.13 108.822 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.5 p -134.93 130.41 35.81 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.452 0.701 . . . . 62.11 109.753 173.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.79 122.71 46.26 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.97 -1.122 . . . . 74.52 107.97 174.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.3 m -124.8 160.79 27.89 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 122.915 0.486 . . . . 74.11 109.865 -175.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 94.6 p -152.35 139.82 19.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.493 0.717 . . . . 73.13 110.064 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -82.19 105.26 13.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.27 0.628 . . . . 63.04 110.067 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 78.4 mt -72.23 -42.77 65.32 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.62 0.724 . . . . 74.11 109.603 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.37 -179.16 7.92 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.269 -1.332 . . . . 63.13 108.782 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.25 123.12 22.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.291 -1.003 . . . . 65.31 108.291 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 72.82 -5.4 1.89 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.517 1.527 . . . . 62.45 113.288 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -111.49 109.83 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 107.59 -1.263 . . . . 75.32 107.59 173.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.72 140.5 52.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.183 -0.673 . . . . 74.34 109.183 -173.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -99.7 133.65 43.74 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.149 -1.056 . . . . 74.31 108.149 172.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -115.69 139.58 41.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.2 -1.037 . . . . 75.41 108.2 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 33.0 t -126.54 120.83 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.62 -0.881 . . . . 64.04 108.62 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.66 113.13 25.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.125 -1.065 . . . . 63.04 108.125 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -100.65 122.43 43.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.806 0.442 . . . . 73.14 110.315 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -116.09 114.61 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 107.783 -1.192 . . . . 63.34 107.783 171.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 48.7 m -96.4 137.72 35.06 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.474 -0.935 . . . . 51.51 108.474 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 85.5 t -131.99 133.08 61.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.998 -0.742 . . . . 72.11 108.998 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 91.4 m -120.09 148.88 43.05 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.767 1.227 . . . . 72.23 107.721 175.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.45 134.65 21.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 122.858 0.463 . . . . 64.13 110.077 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.6 p -132.62 126.69 33.28 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.308 0.643 . . . . 61.33 110.751 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.658 HD12 HG22 ' B' ' 31' ' ' VAL . 41.2 mt -95.13 103.15 15.0 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 108.149 -1.056 . . . . 74.2 108.149 170.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.48 -109.78 3.1 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.008 -0.996 . . . . 73.34 111.206 -170.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -117.37 5.15 12.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.928 0.891 . . . . 64.23 111.583 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -116.17 149.21 39.44 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.185 -0.672 . . . . 75.4 109.185 175.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 65.7 m -72.89 134.0 44.63 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.192 0.308 . . . . 65.53 111.097 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.495 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -82.97 -68.21 0.72 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.249 -1.019 . . . . 64.4 108.249 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -144.25 158.94 43.46 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.811 -1.086 . . . . 63.21 110.395 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 94.8 mt -131.2 120.82 23.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.08 -1.822 . . . . 64.12 106.08 174.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 36.9 t -132.35 145.24 51.11 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.194 -0.669 . . . . 74.41 109.194 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -160.19 133.96 7.11 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.865 -0.791 . . . . 71.53 108.865 -175.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -128.01 146.39 33.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.87 0.868 . . . . 74.02 108.918 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 17.6 mt-30 -124.96 93.32 3.85 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.233 -1.025 . . . . 72.33 108.233 170.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.531 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -85.57 101.0 12.32 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.845 -1.071 . . . . 71.53 109.155 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.07 160.26 29.52 Favored Glycine 0 C--N 1.339 0.748 0 O-C-N 123.435 0.459 . . . . 65.11 112.047 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.18 130.42 2.34 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 119.952 -0.36 . . . . 73.11 112.22 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -84.54 126.09 40.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 108.806 -0.813 . . . . 74.24 108.806 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -132.37 134.18 44.86 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.282 1.033 . . . . 73.55 108.972 -176.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.6 m -102.06 103.08 13.65 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.822 0.849 . . . . 74.13 109.51 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.672 ' HB ' HD11 ' B' ' 89' ' ' ILE . 46.2 pt -103.92 135.33 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.496 0.719 . . . . 74.21 109.794 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -146.69 151.81 37.81 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.863 -0.792 . . . . 41.12 108.863 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.93 -62.16 3.66 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 112.109 -0.396 . . . . 61.11 112.109 -176.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.672 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -62.12 142.07 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.679 0.392 . . . . 72.44 111.781 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.84 167.73 26.61 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.969 0.907 . . . . 71.1 109.526 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.07 -113.62 5.28 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.794 0.684 . . . . 74.15 113.042 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 2.2 m -87.17 -17.49 32.57 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.609 -0.348 . . . . 44.32 111.26 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -65.61 -46.75 78.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.982 0.513 . . . . 65.23 110.262 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -24.42 57.03 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 116.058 -0.519 . . . . 74.44 110.529 177.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.77 98.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.33 0.586 . . . . 44.32 109.918 169.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -70.25 -30.91 68.08 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.31 1.044 . . . . 73.21 111.203 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.484 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 69.2 m -70.76 -67.68 0.49 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 110.247 -0.279 . . . . 63.32 110.247 174.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 59.3 mt -74.34 -21.93 59.46 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.585 0.587 . . . . 74.21 112.585 -168.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.95 3.09 41.2 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-O 119.522 -0.599 . . . . 60.54 114.302 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.48 -62.85 0.2 Allowed 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.789 0.795 . . . . 70.41 111.909 -177.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 89.4 t80 -68.18 -39.18 82.61 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.915 0.886 . . . . 72.14 112.372 -172.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.411 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 91.3 m -73.08 -46.36 8.22 Favored Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 123.693 0.797 . . . . 64.24 111.103 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.411 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 78.5 Cg_exo -55.87 -34.05 90.39 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.025 1.817 . . . . 53.31 113.727 167.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -59.6 -38.77 82.13 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.231 0.613 . . . . 72.24 110.799 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.449 HD13 HD11 ' B' ' 13' ' ' ILE . 70.4 mt -64.12 -42.99 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.06 0.944 . . . . 74.14 110.836 175.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 80' ' ' GLN . 74.1 mt -79.03 -19.73 50.73 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.657 -1.156 . . . . 71.33 112.399 -173.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -59.7 -47.41 97.59 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.179 1.177 . . . . 71.42 114.179 -171.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.96 -42.78 61.84 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.373 2.048 . . . . 73.13 113.788 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.531 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 82.5 m-85 -66.27 -48.63 69.81 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.839 -0.619 . . . . 64.43 110.421 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.96 -42.12 84.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.742 0.817 . . . . 63.54 110.908 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 49.5 ttt180 -61.86 -54.71 38.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.245 1.418 . . . . 64.41 110.995 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -67.17 -34.16 76.95 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 123.998 0.811 . . . . 73.24 110.147 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.6 t -68.18 -33.93 75.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.71 0.404 . . . . 74.24 111.088 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 70.9 mt -65.28 -52.01 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.415 -0.587 . . . . 65.34 109.415 171.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.0 m -60.01 -30.62 69.27 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 123.979 0.8 . . . . 75.53 111.543 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.2 t -63.63 -51.86 63.36 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 123.454 0.702 . . . . 52.23 109.858 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -68.59 -34.91 76.6 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.148 0.579 . . . . 64.11 110.985 -174.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.05 -43.04 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.736 0.815 . . . . 64.03 110.312 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.3 t -68.75 -30.19 68.75 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.393 -0.821 . . . . 52.24 111.598 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.8 mtt-85 -69.59 -43.4 72.88 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.547 -0.751 . . . . 75.54 109.612 176.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.21 -3.09 64.24 Favored Glycine 0 C--N 1.357 1.708 0 O-C-N 124.072 0.857 . . . . 55.45 112.924 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 28.2 p 62.18 25.87 15.5 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 126.506 1.922 . . . . 71.23 112.86 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -80.34 161.51 64.64 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 123.837 0.855 . . . . 54.43 110.729 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -49.41 157.86 1.95 Allowed 'Trans proline' 0 C--N 1.387 2.581 0 C-N-CA 123.742 2.961 . . . . 71.41 115.178 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -59.61 114.17 2.6 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.226 1.01 . . . . 52.31 111.306 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -119.1 108.97 15.35 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.657 -0.868 . . . . 65.35 108.657 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -124.02 134.44 53.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.511 -0.922 . . . . 75.22 108.511 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.429 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.3 mm? -77.02 147.42 36.78 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.299 0.639 . . . . 74.02 109.848 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.23 147.23 53.04 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 123.092 0.557 . . . . 62.52 109.667 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.33 110.78 0.85 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.151 2.568 . . . . 73.23 112.322 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.0 t -90.11 112.63 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.435 -0.95 . . . . 72.22 108.435 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -82.08 83.83 7.2 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.968 -1.123 . . . . 74.22 107.968 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -54.41 -42.26 70.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.288 1.035 . . . . 64.42 111.302 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.73 -43.09 80.79 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.408 1.083 . . . . 71.32 111.888 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.52 -54.25 45.64 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.316 0.646 . . . . 74.2 110.271 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.4 -29.37 70.43 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.613 -1.176 . . . . 54.2 111.47 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 75.2 t80 . . . . . 0 C--N 1.349 0.559 0 C-N-CA 123.151 0.58 . . . . 54.14 110.433 177.774 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 31.4 m . . . . . 0 C--O 1.237 0.395 0 N-CA-C 108.368 -0.975 . . . . 74.01 108.368 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.56 122.93 33.8 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.79 -1.095 . . . . 61.32 109.155 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -137.21 108.41 6.81 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.593 -1.262 . . . . 74.22 107.593 168.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.9 118.62 6.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.071 -1.085 . . . . 74.45 108.071 172.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.478 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.1 mm-40 -82.74 -48.84 10.4 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.705 0.628 . . . . 41.24 109.415 -178.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -170.19 124.46 0.74 Allowed 'General case' 0 C--N 1.354 0.78 0 CA-C-N 115.947 -0.569 . . . . 62.34 110.677 -172.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.1 mt -112.35 139.27 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 107.736 -1.209 . . . . 63.11 107.736 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -173.5 153.12 2.26 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.094 0.474 . . . . 74.45 110.435 -168.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.9 p -82.32 116.64 21.91 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.96 -0.755 . . . . 71.42 108.96 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.43 ' HG3' ' HA3' ' C' ' 81' ' ' GLY . 15.2 mtmt -83.58 -29.79 27.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.09 0.472 . . . . 75.53 109.947 176.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 27.4 t70 -144.37 138.68 27.97 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.132 -0.94 . . . . 75.42 109.354 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 87.0 mt -136.51 140.24 43.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.924 -1.509 . . . . 74.44 106.924 171.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -157.05 141.23 16.39 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.842 0.353 . . . . 72.31 110.155 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 86.8 t80 -136.44 148.2 47.62 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.489 -1.3 . . . . 75.42 107.489 171.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -145.08 118.12 8.84 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.0 0.92 . . . . 74.33 110.062 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.83 83.78 51.7 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 107.222 -1.399 . . . . 15.4 107.222 163.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.01 -27.89 19.94 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.331 2.021 . . . . 72.33 111.394 175.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -92.25 12.2 23.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.579 1.151 . . . . 74.22 110.747 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.81 -58.76 7.63 Favored Pre-proline 0 C--N 1.37 1.463 0 N-CA-C 114.698 1.37 . . . . 63.12 114.698 -165.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -62.98 -39.77 38.44 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 121.503 1.468 . . . . 51.14 112.171 -174.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -70.3 -34.96 73.36 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.787 -1.097 . . . . 71.33 112.233 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.692 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.3 p -80.6 -26.06 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 112.906 0.706 . . . . 72.32 112.906 -170.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -64.77 -20.48 66.39 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 113.29 0.848 . . . . 73.02 113.29 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -99.11 12.07 37.18 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.302 0.641 . . . . 73.11 111.286 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.726 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -88.06 146.32 25.52 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.276 -0.638 . . . . 61.35 109.276 172.799 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -57.98 119.18 6.3 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.116 -0.698 . . . . 73.44 109.116 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -67.8 93.17 0.38 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.803 0.841 . . . . 71.2 111.283 -173.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -148.99 69.1 9.81 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 124.839 1.255 . . . . 73.41 108.251 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -80.16 133.27 9.78 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.573 2.182 . . . . 73.44 111.152 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.09 105.11 15.59 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.107 -1.072 . . . . 74.42 108.107 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.55 113.56 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.36 -0.836 . . . . 70.21 110.329 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -111.17 110.7 21.34 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.183 -1.414 . . . . 72.41 107.183 170.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 40.4 tp -91.28 142.26 27.9 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.124 0.569 . . . . 71.31 109.7 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.42 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 20.1 t70 -131.95 117.75 18.86 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.823 -1.177 . . . . 73.31 107.823 175.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.6 mt -108.72 151.67 25.87 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.607 0.763 . . . . 63.33 109.953 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 30.0 t70 -157.6 150.19 22.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.198 0.599 . . . . 55.44 109.949 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -144.45 123.36 12.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.629 0.772 . . . . 54.22 110.117 176.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.78 135.11 54.44 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.619 -0.882 . . . . 73.14 108.619 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.4 p -131.2 142.31 50.17 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.239 0.616 . . . . 74.42 109.623 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 29.6 t -145.79 150.8 36.88 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.137 0.975 . . . . 73.13 109.532 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.75 138.77 41.46 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.957 -0.565 . . . . 74.44 109.829 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.632 HD11 HD12 ' C' ' 83' ' ' ILE . 62.6 mt -106.22 -43.26 4.85 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.681 -0.859 . . . . 74.34 108.681 169.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.66 -176.34 5.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.63 -1.168 . . . . 60.02 109.525 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -66.18 126.1 27.63 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.511 -0.768 . . . . 62.23 109.684 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 72.2 -1.82 2.78 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.31 1.444 . . . . 73.35 112.032 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -114.89 114.12 45.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 123.264 0.625 . . . . 55.11 109.418 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -124.84 135.3 52.78 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.063 0.945 . . . . 74.34 109.192 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.562 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.8 tt0 -92.6 123.97 36.29 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 124.154 0.909 . . . . 70.23 108.877 168.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 85.3 t -103.79 136.95 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.293 -1.003 . . . . 62.5 108.293 168.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -121.17 130.58 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.303 -1.369 . . . . 75.5 107.303 174.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.26 104.26 11.64 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.818 -1.178 . . . . 52.1 107.818 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.575 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 30.4 ttm-85 -88.39 126.19 35.09 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.241 -1.345 . . . . 74.22 108.297 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.597 ' HB ' HD11 ' C' ' 114' ' ' ILE . 21.5 t -123.58 128.22 74.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.583 -1.266 . . . . 64.41 107.583 173.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 9.8 m -128.37 112.0 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.746 -0.835 . . . . 71.44 108.746 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.455 HG21 HG21 ' C' ' 114' ' ' ILE . 51.7 t -104.84 116.02 47.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.92 -1.036 . . . . 71.25 108.788 -173.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.9 m -105.8 141.37 37.34 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.07 -0.715 . . . . 72.41 109.07 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.15 115.15 8.74 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.85 -1.167 . . . . 73.13 107.85 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.9 m -137.17 134.25 36.11 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.483 0.49 . . . . 54.53 109.833 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.726 HD13 ' HG2' ' C' ' 34' ' ' LYS . 0.5 OUTLIER -87.88 42.03 1.03 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.936 1.294 . . . . 61.22 108.596 177.135 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.27 -112.62 4.17 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.209 -0.756 . . . . 70.54 111.209 -171.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.56 -30.71 19.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.326 0.65 . . . . 71.25 109.485 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.15 110.53 3.02 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 115.222 -0.899 . . . . 64.44 109.032 173.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -77.95 125.49 29.42 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.001 -0.74 . . . . 74.05 109.001 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.692 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.85 -57.87 3.75 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.421 -1.325 . . . . 62.23 107.421 171.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -167.4 169.23 12.45 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 121.885 0.85 . . . . 71.13 111.939 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -133.77 141.63 47.57 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 105.947 -1.872 . . . . 72.11 105.947 170.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 47.4 t -151.34 113.44 4.53 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.963 -0.384 . . . . 44.32 109.963 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -117.02 127.62 54.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.478 0.311 . . . . 73.21 110.309 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.5 t -118.24 138.33 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.953 -1.129 . . . . 74.33 107.953 167.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.6 mt-30 -116.05 94.96 4.88 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 108.68 -0.859 . . . . 72.12 108.68 173.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.478 ' HG3' HD22 ' C' ' 106' ' ' LEU . 71.4 tp60 -79.79 102.64 9.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.954 -1.021 . . . . 62.33 109.903 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.43 ' HA3' ' HG3' ' C' ' 19' ' ' LYS . . . -85.58 151.85 25.75 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 111.759 -0.536 . . . . 72.51 111.759 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.59 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.37 118.47 0.86 Allowed Glycine 0 CA--C 1.506 -0.475 0 N-CA-C 111.697 -0.561 . . . . 71.34 111.697 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.632 HD12 HD11 ' C' ' 51' ' ' LEU . 8.8 mm -84.71 125.91 40.29 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 N-CA-C 108.764 -0.828 . . . . 70.51 108.764 173.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -134.24 120.08 19.55 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.673 -0.862 . . . . 73.22 108.673 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 61.1 p -91.07 118.82 30.71 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.189 -0.671 . . . . 71.44 109.189 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.749 HG21 ' SG ' ' C' ' 97' ' ' CYS . 1.8 pp -125.61 141.13 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.594 1.158 . . . . 72.43 111.356 -174.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.508 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -149.53 167.46 26.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.333 0.653 . . . . 75.43 110.326 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.64 -54.41 3.78 Favored Glycine 0 N--CA 1.475 1.269 0 N-CA-C 112.43 -0.268 . . . . 55.0 112.43 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.4 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -81.42 157.54 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.254 0.622 . . . . 75.12 110.564 177.555 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.79 178.63 8.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.851 0.46 . . . . 73.34 110.418 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.54 -114.1 5.58 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.718 0.637 . . . . 64.25 113.533 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -82.55 -20.08 37.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.672 0.789 . . . . 64.5 112.087 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.56 -42.92 61.01 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.513 -0.551 . . . . 73.15 109.513 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 23.9 ptm -74.23 -30.11 62.02 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 110.248 -0.278 . . . . 73.22 110.248 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.69 93.59 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 123.489 0.493 . . . . 75.15 110.118 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -74.72 -35.83 62.67 Favored 'General case' 0 C--O 1.245 0.832 0 O-C-N 123.477 0.485 . . . . 72.43 111.78 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.749 ' SG ' HG21 ' C' ' 86' ' ' ILE . 53.3 t -56.6 -36.37 69.32 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.644 0.59 . . . . 70.41 110.558 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 24.4 mt -98.31 -18.06 18.56 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.856 0.862 . . . . 75.33 111.18 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.43 -29.62 55.44 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 115.015 0.766 . . . . 51.1 115.015 -172.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.94 -36.0 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.654 0.382 . . . . 63.14 111.081 -170.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -67.61 -45.8 74.39 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.216 1.406 . . . . 74.42 112.677 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.0 m -79.79 -40.41 1.37 Allowed Pre-proline 0 CA--C 1.557 1.247 0 CA-C-O 118.475 -0.774 . . . . 61.12 112.481 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -54.0 -27.58 45.92 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 122.249 1.966 . . . . 70.05 114.078 166.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -68.28 -37.9 81.14 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.679 0.792 . . . . 74.15 109.768 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.523 HD12 ' NH1' ' A' ' 111' ' ' ARG . 43.8 mm -68.94 -34.01 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.008 0.523 . . . . 73.11 109.983 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.59 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.4 mt -81.34 -27.3 35.01 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.917 0.887 . . . . 75.35 112.756 -177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -57.8 -48.52 97.03 Favored Pre-proline 0 CA--C 1.559 1.31 0 N-CA-C 113.959 1.096 . . . . 73.4 113.959 -174.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.94 -37.15 79.29 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 121.992 1.795 . . . . 74.42 113.056 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -66.69 -42.46 86.43 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.103 0.561 . . . . 61.11 110.895 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.56 99.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.539 0.736 . . . . 61.0 110.461 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.598 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 35.9 ttt180 -54.12 -56.47 17.85 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.464 1.506 . . . . 63.5 111.412 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.23 -35.43 77.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.733 0.413 . . . . 73.21 110.543 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 20.0 t -64.75 -33.58 76.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.957 0.503 . . . . 73.11 111.973 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.597 HD11 ' HB ' ' C' ' 62' ' ' VAL . 75.4 mt -76.75 -52.7 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.585 0.754 . . . . 74.4 110.231 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -60.94 -28.67 69.12 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.356 0.662 . . . . 71.03 111.38 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.2 t -67.31 -52.07 44.86 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.779 0.832 . . . . 51.4 109.156 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.547 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.37 -36.84 78.97 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.226 1.011 . . . . 71.25 112.338 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.498 HG11 HD13 ' C' ' 126' ' ' LEU . 78.3 t -66.53 -44.84 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.633 0.773 . . . . 72.33 109.904 175.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 40.4 t -69.2 -22.92 63.86 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.262 -0.881 . . . . 71.11 111.645 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.3 mtt-85 -75.65 -41.05 55.13 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.49 0.716 . . . . 75.15 109.082 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.01 -2.87 62.89 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 123.83 0.706 . . . . 63.44 112.498 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p 67.03 27.76 8.62 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.88 2.072 . . . . 74.12 113.611 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -83.8 153.45 64.13 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 108.813 -0.81 . . . . 73.53 108.813 168.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -60.67 178.49 0.47 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.149 2.566 . . . . 74.24 114.75 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -60.8 114.33 2.98 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 114.171 1.174 . . . . 54.21 114.171 -174.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.498 HD13 HG11 ' C' ' 118' ' ' VAL . 7.2 mp -112.2 89.49 3.08 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.81 -0.811 . . . . 73.41 108.81 163.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -91.32 112.68 24.69 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.513 -0.921 . . . . 53.54 108.513 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.598 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -65.0 126.29 27.55 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.618 0.767 . . . . 61.32 110.587 -177.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.21 149.18 81.82 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 124.423 1.089 . . . . 72.4 111.887 -173.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.07 105.3 0.32 Allowed 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.11 2.54 . . . . 73.32 113.212 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.6 111.33 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.707 -0.849 . . . . 73.54 108.707 171.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -87.22 90.31 8.31 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 108.622 -0.881 . . . . 65.11 108.622 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -60.36 -29.95 69.24 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.251 1.021 . . . . 63.22 111.261 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.56 -43.93 68.88 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.415 1.486 . . . . 75.01 112.915 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.61 82.97 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.348 1.03 . . . . 74.24 110.604 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 20.6 tp -71.72 -29.31 64.41 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.142 -0.935 . . . . 74.13 111.152 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 12.2 t80 . . . . . 0 N--CA 1.487 1.396 0 C-N-CA 122.639 0.375 . . . . 72.04 110.344 177.008 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 21.0 m . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.403 0.621 . . . . 75.04 110.905 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.545 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 71.1 t80 -162.58 97.7 0.98 Allowed 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.063 -1.458 . . . . 73.33 107.063 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -112.22 115.01 28.11 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.394 -1.336 . . . . 75.24 107.394 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.474 HD11 HD12 ' D' ' 105' ' ' ILE . 59.7 mt -73.59 119.31 20.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.384 -0.969 . . . . 75.43 108.384 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 14' ' ' GLN . . . . . 0.46 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 5.3 mm-40 -85.34 -41.77 15.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.693 -0.685 . . . . 75.24 109.219 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -174.67 144.27 0.83 Allowed 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.251 0.345 . . . . 64.42 111.164 -167.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.469 HD11 HG21 ' D' ' 13' ' ' ILE . 4.1 mp -120.66 142.39 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.112 -1.44 . . . . 72.11 107.112 170.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -164.87 160.44 19.4 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.405 0.682 . . . . 75.54 111.121 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.8 p -93.15 116.48 29.07 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.325 -0.621 . . . . 72.13 109.325 173.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -85.38 -19.88 30.73 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.965 0.506 . . . . 75.42 110.105 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.1 t70 -160.31 140.03 11.15 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.782 0.833 . . . . 75.15 109.261 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.547 HG21 ' HE2' ' C' ' 117' ' ' MET . 98.6 mt -137.95 142.86 34.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.859 1.263 . . . . 74.21 107.701 175.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -141.6 136.23 30.81 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.957 0.903 . . . . 75.43 108.807 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.505 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 82.4 t80 -143.53 124.87 14.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.587 -1.634 . . . . 64.12 106.587 168.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 27.0 mt-10 -135.13 118.02 16.25 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.612 -0.884 . . . . 63.45 108.612 -173.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.59 82.39 9.97 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.729 -1.212 . . . . 65.23 107.729 174.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.47 -33.74 10.45 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.681 2.254 . . . . 64.13 113.183 -170.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -103.52 11.06 36.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.542 0.737 . . . . 65.53 110.666 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.441 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -30.66 -70.57 0.09 OUTLIER Pre-proline 0 CA--C 1.565 1.521 0 N-CA-C 116.276 1.954 . . . . 55.11 116.276 -160.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.46 -15.42 19.77 Favored 'Trans proline' 0 C--N 1.375 1.946 0 CA-C-N 123.55 2.304 . . . . 72.12 113.829 -173.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.79 -41.1 27.21 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.485 1.114 . . . . 52.34 110.044 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.5 p -79.96 -23.46 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 116.235 -0.439 . . . . 72.25 111.34 -173.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -63.19 -19.81 64.85 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.127 0.417 . . . . 72.33 112.127 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -61.47 -17.1 52.94 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.877 0.871 . . . . 75.32 111.947 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.419 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 37.6 mtmt -99.83 110.75 23.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.772 0.829 . . . . 61.5 111.09 174.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.49 93.85 9.47 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.576 -0.738 . . . . 62.13 109.722 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -157.39 157.07 33.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.432 1.093 . . . . 64.35 108.235 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.44 106.38 3.24 Favored Pre-proline 0 N--CA 1.477 0.908 0 N-CA-C 107.374 -1.343 . . . . 71.32 107.374 171.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.58 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 24.5 Cg_exo -63.21 137.31 60.5 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.796 2.331 . . . . 74.22 112.452 -167.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 7.4 mm-40 -56.93 109.72 0.69 Allowed 'General case' 0 C--N 1.361 1.075 0 O-C-N 124.082 0.864 . . . . 73.41 109.692 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.609 HG23 HG13 ' D' ' 64' ' ' VAL . 2.1 p -99.63 111.71 29.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 115.198 -0.91 . . . . 53.15 110.586 -171.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -86.49 111.86 20.97 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.366 -1.346 . . . . 72.21 107.366 169.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -95.79 151.86 19.0 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 108.961 -0.755 . . . . 73.44 108.961 173.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -151.44 154.12 35.99 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.438 -0.949 . . . . 70.0 108.438 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 89.6 mt -131.14 144.04 51.09 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.725 0.81 . . . . 72.4 109.711 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.672 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.8 t70 -141.41 125.48 17.29 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.61 1.164 . . . . 64.43 108.234 175.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -104.66 145.38 30.42 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 109.215 -0.661 . . . . 71.15 109.215 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.99 142.69 24.61 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.158 -1.053 . . . . 74.44 108.158 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 47.6 p -141.94 159.92 41.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.602 0.637 . . . . 65.32 111.35 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -163.39 125.91 2.59 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.893 0.877 . . . . 64.53 109.668 -173.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -74.99 121.87 22.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.576 -0.528 . . . . 72.55 109.576 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' D' ' 57' ' ' GLU . 55.9 mt -96.36 -29.65 13.84 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.139 0.576 . . . . 74.14 111.283 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.21 -173.01 3.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.391 0.677 . . . . 41.0 110.45 -177.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.89 120.84 18.06 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.968 -1.014 . . . . 75.44 110.762 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 65.05 3.74 2.26 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.487 1.115 . . . . 74.21 112.005 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 51.5 t -117.0 124.2 72.73 Favored 'Isoleucine or valine' 0 C--N 1.349 0.575 0 C-N-CA 123.369 0.668 . . . . 64.51 109.572 -173.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -120.81 173.13 7.41 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.957 1.303 . . . . 74.2 109.99 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.538 ' HB2' HD11 ' D' ' 51' ' ' LEU . 33.4 tt0 -131.3 133.84 45.77 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.733 -1.576 . . . . 61.41 107.008 168.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.6 t -120.63 141.77 39.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.004 -1.11 . . . . 64.13 108.004 168.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 39.8 t -120.77 131.32 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.718 -1.216 . . . . 65.05 107.718 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.419 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -115.16 119.75 37.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.464 -0.939 . . . . 72.2 108.464 178.448 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.672 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.2 ttm180 -104.77 102.37 11.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.129 -1.063 . . . . 72.32 108.129 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.2 t -94.48 102.51 13.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.693 -1.225 . . . . 72.45 107.693 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 28.4 m -100.32 140.0 35.2 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.544 -0.753 . . . . 74.54 109.588 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.76 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 52.0 t -132.35 133.68 59.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.628 1.571 . . . . 54.43 108.6 -172.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.0 m -134.66 100.77 4.72 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.117 -1.068 . . . . 51.41 108.117 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -104.2 153.14 21.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.644 0.778 . . . . 62.24 110.868 -176.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 65.1 p -146.08 137.96 25.06 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.29 0.567 . . . . 70.13 111.909 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.509 HD12 HG22 ' D' ' 31' ' ' VAL . 53.3 mt -105.69 125.7 51.29 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.586 1.154 . . . . 72.21 108.131 170.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.03 -113.29 5.5 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.454 0.471 . . . . 75.23 112.728 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.96 5.32 13.94 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.346 0.659 . . . . 75.24 110.706 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.419 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 12.4 pt-20 -127.11 159.9 32.81 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.151 0.58 . . . . 73.22 110.276 -174.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -68.92 130.72 43.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.598 0.759 . . . . 61.15 111.95 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.525 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.99 -77.46 0.3 Allowed 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.82 -0.807 . . . . 74.32 108.82 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -141.33 147.57 38.32 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 121.227 0.537 . . . . 72.45 110.859 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 55.8 mt -117.85 140.03 50.27 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.805 -1.183 . . . . 61.15 107.805 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.76 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 33.0 m -141.21 144.7 34.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.118 0.967 . . . . 70.43 109.035 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -156.94 118.07 3.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.16 -1.052 . . . . 74.01 108.16 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.83 113.05 25.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 109.361 -0.607 . . . . 73.11 109.361 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -89.73 85.88 6.54 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.649 -0.871 . . . . 74.23 108.649 172.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -79.09 94.66 5.38 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.618 -1.174 . . . . 73.42 108.509 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.83 145.95 21.12 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.781 -0.528 . . . . 55.03 111.781 177.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.474 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -145.67 131.41 4.15 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.445 -0.662 . . . . 52.54 111.445 -176.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 43.6 mt -89.0 128.73 40.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 N-CA-C 108.248 -1.019 . . . . 73.42 108.248 176.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -135.08 123.9 23.91 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.175 0.59 . . . . 73.4 110.1 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 57.8 m -74.19 108.46 7.0 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.081 -0.711 . . . . 53.25 109.081 166.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.54 HD13 HD23 ' D' ' 98' ' ' LEU . 45.1 pt -105.22 138.29 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.355 0.662 . . . . 71.11 109.271 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -167.76 170.43 10.86 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.377 1.071 . . . . 73.23 108.934 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.19 -15.1 29.93 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-O 119.899 -0.39 . . . . 63.32 112.718 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.401 HD11 ' HB ' ' D' ' 86' ' ' ILE . 1.5 pp -128.49 134.97 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.401 1.08 . . . . 72.42 109.631 -174.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -132.42 158.36 42.21 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.851 0.861 . . . . 73.43 109.726 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.08 -127.05 39.87 Favored Glycine 0 C--N 1.355 1.587 0 O-C-N 124.366 1.041 . . . . 41.12 114.426 172.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 75.1 p -63.17 -39.86 95.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.699 0.8 . . . . 73.31 111.257 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -73.76 -27.11 60.99 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.578 -0.737 . . . . 71.12 111.623 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 18.3 tmm? -70.93 -44.72 65.54 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 109.516 -0.549 . . . . 70.5 109.516 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.04 -25.04 66.63 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.519 0.728 . . . . 44.24 111.462 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.2 t-160 -78.67 -38.51 39.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.785 0.834 . . . . 71.1 110.713 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -73.69 -27.29 61.14 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.258 0.623 . . . . 63.43 111.506 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.54 HD23 HD13 ' D' ' 86' ' ' ILE . 2.3 tm? -100.1 -54.01 2.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.311 1.044 . . . . 72.31 109.819 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.9 14.42 58.72 Favored Glycine 0 N--CA 1.472 1.065 0 CA-C-O 119.557 -0.579 . . . . 52.2 114.433 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.508 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -149.74 -55.44 0.17 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.574 0.687 . . . . 75.41 112.016 -178.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -72.6 -37.85 68.0 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 112.233 0.457 . . . . 74.13 112.233 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.545 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 96.6 m -61.94 -46.93 92.28 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 118.687 -0.673 . . . . 64.54 112.392 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.419 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 82.4 Cg_exo -52.06 -35.29 61.13 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.285 1.99 . . . . 74.41 114.325 167.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -68.67 -25.34 64.76 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 122.909 0.484 . . . . 60.43 112.079 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.474 HD12 HD11 ' D' ' 13' ' ' ILE . 23.8 mm -73.01 -40.05 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.706 0.765 . . . . 70.41 109.813 171.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.474 HD21 ' HA3' ' D' ' 82' ' ' GLY . 91.8 mt -77.27 -26.8 52.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.776 -1.102 . . . . 64.53 112.839 -173.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -62.83 -43.5 83.08 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 113.725 1.009 . . . . 72.33 113.725 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.42 -45.87 34.86 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.051 1.834 . . . . 74.31 113.949 171.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -72.26 -37.15 69.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.584 0.754 . . . . 73.0 111.342 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.41 90.2 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.906 0.882 . . . . 72.42 110.43 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.476 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 29.4 ttp180 -55.22 -52.71 62.48 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 114.523 -1.217 . . . . 75.22 110.181 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -60.16 -43.41 95.79 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.295 0.997 . . . . 73.34 111.629 -174.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.2 t -59.41 -43.97 92.93 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.512 0.508 . . . . 73.31 110.771 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.473 HG23 ' SG ' ' D' ' 76' ' ' CYS . 80.6 mt -64.8 -49.68 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.918 0.887 . . . . 74.22 110.987 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 23.2 m -56.31 -40.82 74.99 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.414 1.086 . . . . 61.15 111.192 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 14.4 t -66.59 -44.24 82.71 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 114.447 -1.251 . . . . 64.32 110.045 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.505 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.1 mtm -67.87 -32.01 72.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.904 0.482 . . . . 73.43 111.82 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' D' ' 114' ' ' ILE . 61.9 t -67.65 -42.7 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.681 0.793 . . . . 72.44 110.216 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.2 p -74.87 -29.95 61.17 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.829 0.451 . . . . 75.13 111.181 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -72.3 -36.73 69.02 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.622 0.769 . . . . 52.25 109.893 174.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.96 2.7 79.65 Favored Glycine 0 C--N 1.356 1.657 0 O-C-N 123.696 0.622 . . . . 74.24 112.427 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.3 p 62.28 23.26 13.75 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.819 2.048 . . . . 73.22 113.964 171.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.54 155.85 65.62 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 109.029 -0.73 . . . . 70.35 109.029 167.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.413 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 27.8 Cg_endo -60.79 142.24 97.15 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 122.39 2.06 . . . . 64.1 111.405 176.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -51.6 147.67 6.14 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.256 1.422 . . . . 72.2 113.669 -167.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.431 HD11 HG21 ' D' ' 40' ' ' VAL . 23.2 tp -122.61 98.82 6.09 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.003 0.521 . . . . 74.11 110.477 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -101.73 92.18 4.73 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.696 0.798 . . . . 71.24 109.849 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.476 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -64.38 118.52 8.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.453 0.701 . . . . 61.42 110.397 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -60.57 132.9 91.26 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 123.466 0.707 . . . . 70.11 111.021 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 4.7 Cg_exo -73.09 117.59 5.18 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.795 2.33 . . . . 71.43 111.287 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.61 145.36 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.016 0.526 . . . . 71.22 110.926 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -89.27 97.9 11.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.019 0.928 . . . . 51.05 109.946 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 133' ' ' PHE . . . . . 0.504 ' HA ' HD12 ' D' ' 136' ' ' LEU . 7.5 t80 -76.19 -16.97 59.74 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.263 0.625 . . . . 65.32 111.183 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 134' ' ' ASP . . . . . 0.508 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 13.1 m-20 -62.65 -49.23 75.96 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.325 0.65 . . . . 74.11 110.924 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.92 -45.87 89.29 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.643 0.59 . . . . 72.02 110.597 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 136' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' D' ' 133' ' ' PHE . 82.4 mt -58.56 -42.18 87.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.629 -1.169 . . . . 74.54 111.925 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 85.1 t80 . . . . . 0 N--CA 1.475 0.819 0 C-N-CA 123.649 0.78 . . . . 71.13 110.973 -178.227 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.466 0.373 0 N-CA-C 108.13 -1.063 . . . . 62.43 108.13 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.633 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.6 t80 -138.48 129.88 27.45 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.826 0.346 . . . . 71.4 110.472 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -153.23 108.64 3.24 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 107.811 -1.181 . . . . 75.24 107.811 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.427 HG12 ' HD2' ' A' ' 84' ' ' PHE . 52.8 mt -74.51 116.32 16.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.815 -0.439 . . . . 74.43 109.815 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -74.13 -42.11 60.52 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.072 0.858 . . . . 74.23 110.781 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -178.31 121.39 0.1 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.162 0.289 . . . . 70.34 110.734 -169.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 82.4 mt -106.96 129.56 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.717 0.807 . . . . 75.32 108.878 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.423 ' HB3' HG23 ' B' ' 122' ' ' THR . 34.0 p90 -163.06 148.39 11.7 Favored 'General case' 0 C--N 1.346 0.418 0 O-C-N 123.646 0.591 . . . . 74.21 111.653 -174.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.1 p -75.02 112.39 11.2 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.863 -0.608 . . . . 60.35 109.406 175.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 35.7 mtpt -80.79 -23.78 39.03 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.421 -0.354 . . . . 71.52 110.192 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.2 t70 -153.24 142.08 21.11 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.964 0.906 . . . . 75.51 110.393 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.6 mt -135.03 141.73 42.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 125.64 1.576 . . . . 72.12 107.574 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.7 t -145.72 112.42 5.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.141 0.576 . . . . 65.01 110.026 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 87.5 t80 -125.83 119.92 29.15 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.3 -1.0 . . . . 72.54 108.3 174.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -118.42 136.2 53.91 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.927 -0.768 . . . . 61.31 108.927 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.726 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -148.67 78.78 8.97 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 107.813 -1.18 . . . . 74.31 107.813 170.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.35 -29.93 5.76 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.698 2.265 . . . . 75.43 111.253 175.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -102.7 23.55 11.88 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.943 1.297 . . . . 73.55 109.909 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.726 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -58.82 -45.06 99.64 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 125.26 1.424 . . . . 75.01 112.327 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -64.81 -34.11 50.82 Favored 'Trans proline' 0 C--N 1.399 3.217 0 CA-C-N 120.995 1.391 . . . . 70.42 112.713 172.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.422 ' HA ' ' OE1' ' A' ' 33' ' ' GLN . 30.4 m170 -68.76 -16.23 63.74 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.527 0.731 . . . . 75.2 112.616 -171.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 28' ' ' ALA . 9.3 p -72.73 -19.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 122.438 0.295 . . . . 73.22 110.665 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -78.5 -29.03 46.41 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 108.412 -0.959 . . . . 53.12 108.412 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.422 ' OE1' ' HA ' ' A' ' 30' ' ' HIS . 1.0 OUTLIER -80.95 -54.78 5.27 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.931 -1.031 . . . . 63.31 110.737 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 30' ' ' HIS . 54.5 mtmt -84.78 171.43 12.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.093 0.957 . . . . 62.24 112.577 -173.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.29 153.2 21.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.848 0.859 . . . . 64.44 109.819 172.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -85.2 94.05 8.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.42 0.688 . . . . 62.24 110.756 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -127.37 83.56 65.71 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.175 0.99 . . . . 74.21 108.868 172.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -86.54 149.75 8.84 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.61 2.207 . . . . 73.23 112.72 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -99.09 91.66 5.11 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.613 -1.254 . . . . 54.4 107.613 168.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -66.34 99.06 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 CA-C-O 121.701 0.762 . . . . 65.1 110.388 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -108.16 113.35 26.42 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.531 -0.914 . . . . 54.25 108.531 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -107.06 145.23 32.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.54 0.736 . . . . 63.44 109.059 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -139.42 133.21 30.69 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.498 1.119 . . . . 54.53 108.484 174.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -119.48 123.15 43.32 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 109.059 -0.719 . . . . 73.13 109.059 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 24.3 m-20 -119.81 121.7 39.71 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.764 -0.828 . . . . 60.44 108.764 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.4 m -106.95 122.87 47.28 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.767 -0.827 . . . . 74.43 108.767 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.68 151.33 49.15 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.945 0.898 . . . . 41.24 108.66 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.5 m -132.8 155.87 48.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.178 -0.675 . . . . 75.23 109.178 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -148.03 128.96 14.41 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.78 0.432 . . . . 74.3 110.378 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -73.7 107.7 6.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.91 0.884 . . . . 72.42 109.839 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.1 mt -78.37 -41.26 33.88 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.751 -0.659 . . . . 70.12 109.512 175.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.65 -179.18 7.86 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.647 1.179 . . . . 53.23 108.752 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -61.98 113.26 2.71 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.672 0.389 . . . . 70.3 110.243 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 68.39 12.23 8.65 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.89 1.276 . . . . 64.12 112.28 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.48 110.7 33.16 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 N-CA-C 107.485 -1.302 . . . . 72.22 107.485 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -126.24 152.88 45.51 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.812 -0.81 . . . . 75.01 108.812 -174.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -117.84 153.58 33.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.658 -0.867 . . . . 73.42 108.658 167.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.5 t -117.98 125.24 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.24 -1.392 . . . . 75.05 107.24 167.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.86 107.61 22.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 124.099 0.96 . . . . 61.23 108.681 174.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.7 tp -99.78 101.85 13.13 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.871 -0.788 . . . . 74.03 108.871 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 14.4 ttm180 -84.42 102.75 13.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.187 -0.672 . . . . 64.32 109.187 175.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.8 t -95.32 102.33 13.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.279 -1.008 . . . . 74.15 108.279 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.4 m -98.25 119.46 36.95 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.047 0.939 . . . . 72.03 110.322 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.535 ' O ' HD12 ' A' ' 75' ' ' LEU . 97.9 t -115.51 123.84 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.926 0.89 . . . . 62.12 108.874 175.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 t -132.2 126.63 34.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.516 -0.92 . . . . 52.12 108.516 169.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -124.13 107.13 10.93 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.633 -0.877 . . . . 71.05 108.633 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.6 p -113.85 143.02 45.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.653 0.781 . . . . 40.12 111.021 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 68' ' ' LEU . 1.3 pt? -110.61 85.87 2.2 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.103 -1.073 . . . . 62.32 108.103 171.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.89 -125.57 8.03 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 114.66 -1.155 . . . . 71.54 110.932 -173.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -87.72 -26.87 22.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.593 0.697 . . . . 63.02 109.621 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -76.23 118.97 19.5 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 123.006 0.522 . . . . 53.23 110.779 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.7 m -77.19 132.42 38.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.192 -0.67 . . . . 63.24 109.192 171.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.03 -57.08 3.99 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.616 -0.883 . . . . 61.03 108.616 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.406 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 47.8 p90 -149.39 152.59 36.02 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.88 -1.055 . . . . 73.41 111.223 175.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.535 HD12 ' O ' ' A' ' 64' ' ' VAL . 40.9 tp -114.3 135.19 54.35 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.147 -1.427 . . . . 63.51 107.147 166.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.406 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 76.1 m -135.96 98.1 3.8 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.481 -0.933 . . . . 72.23 108.481 170.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -125.11 116.04 21.43 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.717 1.207 . . . . 75.43 108.379 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.4 t -128.73 115.69 38.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.765 0.826 . . . . 61.02 109.466 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 72.0 mt-30 -85.51 84.98 7.46 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 107.973 -1.121 . . . . 75.13 107.973 170.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.456 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.4 tp-100 -76.47 99.58 4.96 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.715 -1.13 . . . . 71.32 108.186 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.86 155.79 29.37 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 110.683 -0.967 . . . . 73.22 110.683 176.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.34 120.63 0.98 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.351 -1.1 . . . . 35.41 110.351 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.9 mt -81.5 122.22 36.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.109 -1.071 . . . . 71.04 108.109 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.633 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 43.8 m-85 -123.46 118.15 26.78 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.834 -1.173 . . . . 74.22 107.834 -176.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.0 t -84.69 104.0 14.28 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.52 -1.289 . . . . 64.23 107.52 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.85 139.97 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 116.118 -0.492 . . . . 63.41 110.874 -170.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.82 176.05 13.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.357 1.063 . . . . 52.13 110.239 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.02 -7.11 62.41 Favored Glycine 0 N--CA 1.475 1.235 0 N-CA-C 114.961 0.744 . . . . 71.23 114.961 172.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.574 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -138.75 158.21 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 117.885 0.843 . . . . 73.42 110.859 -177.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.37 174.48 14.8 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.965 0.506 . . . . 75.25 109.989 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.34 -127.52 26.72 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 114.528 0.571 . . . . 72.04 114.528 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.5 p -68.78 -20.89 64.36 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.196 0.598 . . . . 72.03 111.234 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -75.9 -42.99 47.41 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.659 0.784 . . . . 71.35 109.893 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -72.97 -27.94 62.11 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 110.038 -0.356 . . . . 72.53 110.038 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.12 -27.71 65.81 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 115.803 -0.635 . . . . 72.02 110.269 173.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -78.31 -30.14 48.12 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.218 0.607 . . . . 74.03 111.125 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.574 ' SG ' HG13 ' A' ' 89' ' ' ILE . 70.9 m -61.86 -46.59 88.8 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.875 -0.602 . . . . 62.52 111.09 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -81.26 -24.57 37.23 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.096 -0.502 . . . . 73.0 110.605 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.24 -33.21 49.84 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 114.772 0.669 . . . . 75.35 114.772 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.53 -45.75 0.17 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.379 0.589 . . . . 71.03 112.091 -169.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 55.1 t80 -62.54 -64.47 0.91 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.512 1.125 . . . . 72.45 112.035 -168.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 92.7 m -78.6 -33.61 0.93 Allowed Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.428 1.27 . . . . 73.53 114.428 -174.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 35.4 Cg_endo -64.18 -30.77 64.91 Favored 'Trans proline' 0 C--N 1.394 2.959 0 CA-C-N 122.23 1.832 . . . . 73.11 112.841 171.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -69.29 -26.57 64.81 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.677 0.391 . . . . 71.42 110.882 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.61 -40.9 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 64.12 110.125 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.456 HD22 ' HG3' ' A' ' 80' ' ' GLN . 79.7 mt -80.6 -21.82 41.22 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.067 0.947 . . . . 71.15 112.613 -174.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -63.57 -44.27 80.58 Favored Pre-proline 0 CA--C 1.567 1.605 0 CA-C-O 117.64 -1.171 . . . . 74.54 113.229 -172.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.4 -34.48 76.55 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.112 1.874 . . . . 62.22 113.474 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -72.97 -41.25 64.58 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.211 0.605 . . . . 74.44 111.329 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.45 -38.2 74.47 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.994 0.518 . . . . 71.35 110.182 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.559 ' HA ' HD23 ' A' ' 128' ' ' LEU . 29.7 ttm180 -54.44 -51.15 65.86 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.203 1.001 . . . . 72.43 109.888 174.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.63 -48.39 77.49 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.485 1.116 . . . . 75.25 111.361 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.413 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.1 t -55.91 -44.58 78.41 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.047 0.842 . . . . 34.45 110.538 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 118' ' ' VAL . 74.5 mt -65.22 -50.5 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.526 1.13 . . . . 71.24 110.747 176.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.492 HG23 ' HG3' ' A' ' 125' ' ' GLN . 95.0 m -53.17 -46.07 68.77 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.835 0.854 . . . . 75.22 110.322 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -65.13 -46.23 81.84 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.922 -1.49 . . . . 65.1 109.527 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 37.5 mtp -59.43 -41.18 88.96 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.696 0.798 . . . . 64.54 111.865 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 114' ' ' ILE . 93.4 t -62.94 -45.61 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.912 0.885 . . . . 50.45 110.236 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.3 m -72.58 -27.45 62.19 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.447 -0.797 . . . . 32.31 111.831 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.605 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.9 mtt-85 -75.12 -31.72 61.18 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.492 0.717 . . . . 73.12 109.723 175.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.13 -0.7 86.62 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.58 -0.736 . . . . 64.11 112.878 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m 69.53 20.12 7.24 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.763 1.225 . . . . 54.34 111.047 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -89.67 146.87 36.44 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 123.45 0.7 . . . . 75.11 109.657 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.64 133.09 31.98 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.52 2.813 . . . . 71.24 113.517 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.492 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.6 tt0 -54.93 137.44 45.71 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.238 1.015 . . . . 63.22 113.24 -170.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.439 ' CD2' HG11 ' A' ' 64' ' ' VAL . 27.7 tp -119.82 102.4 8.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.859 1.264 . . . . 64.13 109.349 177.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -99.34 114.65 27.64 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.213 -1.403 . . . . 64.04 107.213 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 111' ' ' ARG . 3.7 mm? -62.53 132.9 54.0 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.099 0.559 . . . . 64.11 110.476 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.8 146.01 91.47 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.213 0.605 . . . . 62.54 110.776 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.562 ' HG3' ' HD2' ' C' ' 11' ' ' PHE . 34.2 Cg_endo -60.74 112.16 1.26 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.382 2.054 . . . . 64.13 111.323 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 80.6 t -99.92 113.91 36.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 108.473 -0.936 . . . . 50.31 108.473 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -78.79 85.95 4.75 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 108.767 -0.827 . . . . 74.42 108.767 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -64.02 -27.82 69.38 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.649 -0.705 . . . . 74.01 111.144 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.07 -48.45 76.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.801 0.84 . . . . 62.43 110.224 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.43 -57.01 12.8 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.003 -0.999 . . . . 65.33 110.463 175.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.2 mt -58.05 -36.73 73.19 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.562 1.145 . . . . 74.13 112.812 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -61.62 -50.81 71.08 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.772 0.67 . . . . 61.3 110.381 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 95.2 mmm . . . . . 0 CA--C 1.551 0.987 0 CA-C-N 115.909 -0.587 . . . . 62.2 110.612 -174.348 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 66.2 m . . . . . 0 C--O 1.239 0.537 0 N-CA-C 108.932 -0.766 . . . . 74.24 108.932 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -136.11 137.35 40.94 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.712 -0.847 . . . . 64.34 108.712 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -148.5 140.8 24.16 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.562 0.745 . . . . 72.44 109.258 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.5 mt -90.32 113.55 26.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.434 -1.321 . . . . 73.24 107.434 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -76.22 -43.57 41.63 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.446 -0.576 . . . . 64.23 109.446 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -164.78 139.63 5.36 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.719 -0.673 . . . . 73.42 110.071 -175.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 88.2 mt -115.7 144.12 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 106.212 -1.773 . . . . 70.34 106.212 168.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.522 ' HE1' HG13 ' B' ' 83' ' ' ILE . 32.5 p90 -170.08 149.36 3.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.449 0.642 . . . . 75.11 111.648 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -77.81 125.71 29.76 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.872 -1.058 . . . . 64.52 109.347 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.451 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.3 mtpt -99.4 -21.51 15.96 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.872 0.869 . . . . 72.52 111.57 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -160.78 133.41 6.25 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.495 0.318 . . . . 64.0 110.441 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 40.8 mm -126.33 137.91 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.273 -1.01 . . . . 73.3 108.273 168.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 37.2 t -139.48 134.21 31.98 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.746 -1.205 . . . . 72.11 107.746 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -150.32 109.48 3.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.895 -1.15 . . . . 63.14 107.895 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -119.71 115.0 23.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.278 1.031 . . . . 74.02 108.895 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.45 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -109.39 86.64 4.44 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 108.486 -0.931 . . . . 60.15 108.486 172.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.41 -32.45 8.02 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.742 2.295 . . . . 73.15 113.011 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -104.2 14.68 29.93 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.713 0.805 . . . . 50.34 110.403 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.49 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -38.39 -60.79 0.97 Allowed Pre-proline 0 CA--C 1.562 1.437 0 N-CA-C 114.758 1.392 . . . . 62.23 114.758 -165.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 20.4 Cg_exo -63.24 -35.28 64.2 Favored 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 122.101 1.867 . . . . 74.15 112.504 -175.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -78.84 -47.01 17.43 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.168 -0.923 . . . . 71.21 111.593 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.673 HG22 HD12 ' B' ' 68' ' ' LEU . 9.1 p -62.4 -22.4 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.583 0.753 . . . . 72.44 112.332 -167.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -63.34 -13.95 44.64 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.988 0.915 . . . . 73.12 112.993 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.542 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 25.6 pt20 -60.36 -33.14 72.01 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.422 1.089 . . . . 72.42 111.585 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.542 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.3 mttt -96.18 86.18 4.18 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.585 0.754 . . . . 74.0 108.993 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -74.22 97.36 2.95 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 115.806 -0.634 . . . . 71.12 110.902 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -163.43 157.3 19.69 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.32 1.448 . . . . 74.25 108.179 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.462 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 14.4 mt-30 -72.85 108.74 4.85 Favored Pre-proline 0 C--N 1.356 0.861 0 N-CA-C 107.827 -1.175 . . . . 74.04 107.827 169.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.412 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.0 Cg_endo -60.18 147.06 94.85 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.796 2.331 . . . . 64.44 113.702 -167.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 11.3 tp10 -53.31 109.33 0.42 Allowed 'General case' 0 N--CA 1.484 1.246 0 O-C-N 124.349 1.031 . . . . 75.14 110.42 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.87 131.03 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 O-C-N 123.7 0.625 . . . . 73.12 110.625 -172.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -121.23 121.75 38.45 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.597 -1.26 . . . . 63.41 107.597 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -106.05 124.88 50.28 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.763 -0.828 . . . . 73.52 108.763 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.515 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.5 m-20 -122.16 111.33 16.84 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.398 -1.705 . . . . 64.02 106.398 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 87.3 mt -101.38 127.21 48.13 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.157 -1.053 . . . . 75.34 108.157 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -140.02 136.5 33.77 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.384 -1.339 . . . . 53.24 107.384 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.5 p -128.96 115.85 18.46 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.827 -0.434 . . . . 54.25 109.827 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.7 134.82 54.65 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.443 -1.317 . . . . 72.22 107.443 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.0 m -138.89 162.88 33.74 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.316 0.507 . . . . 62.3 111.312 -172.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.0 p -157.8 143.3 17.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.744 0.818 . . . . 75.1 110.888 -172.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -83.4 135.21 34.78 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.711 0.804 . . . . 75.03 109.77 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 mt -99.26 -40.88 7.72 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.205 0.526 . . . . 75.34 109.891 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.85 -178.45 7.32 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.906 -1.043 . . . . 73.35 109.997 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -71.63 122.28 20.28 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.468 -0.787 . . . . 74.32 109.289 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 74.0 -4.76 2.19 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 125.765 1.626 . . . . 75.3 112.04 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.3 110.16 30.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.51 -0.922 . . . . 51.04 108.51 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -125.25 140.22 53.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.617 -0.883 . . . . 72.5 108.617 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -122.78 115.05 21.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.243 -1.021 . . . . 71.33 108.243 -171.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 83.5 t -99.37 141.98 15.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 123.815 0.846 . . . . 70.33 109.617 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.15 119.34 58.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 109.046 -0.724 . . . . 64.51 109.046 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.94 129.42 40.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.013 -1.476 . . . . 74.11 107.013 175.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -121.75 109.9 15.27 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.818 0.847 . . . . 64.14 109.04 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 56.0 t -104.76 102.81 14.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.257 -1.386 . . . . 74.34 107.257 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 24.4 m -97.86 126.06 43.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.886 -0.783 . . . . 74.31 108.886 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.604 HG21 HG21 ' B' ' 114' ' ' ILE . 70.2 t -116.31 121.9 68.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 124.792 1.237 . . . . 63.44 108.27 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 62.9 m -113.29 137.1 52.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.815 -0.809 . . . . 72.45 108.815 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -144.03 146.15 32.68 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 122.628 0.371 . . . . 71.21 110.602 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.52 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 76.0 p -150.32 140.63 22.28 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.656 0.598 . . . . 64.34 111.306 -174.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.673 HD12 HG22 ' B' ' 31' ' ' VAL . 76.5 mt -102.51 109.66 21.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.198 -1.038 . . . . 64.01 108.198 170.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.75 -131.61 37.22 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 116.001 -0.545 . . . . 74.15 112.389 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -95.92 14.7 22.65 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.477 0.547 . . . . 72.02 112.477 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.508 ' HG3' HG23 ' B' ' 31' ' ' VAL . 12.6 pt-20 -126.7 141.0 51.98 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.961 0.505 . . . . 73.45 109.915 178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 48.2 m -70.51 127.51 32.95 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 123.289 0.635 . . . . 71.3 111.233 -175.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.562 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -80.28 -67.36 0.77 Allowed 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.454 -0.943 . . . . 61.42 108.454 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.496 ' HZ ' HD13 ' B' ' 126' ' ' LEU . 51.5 p90 -150.25 155.37 39.58 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-O 121.619 0.723 . . . . 72.51 111.869 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 33.7 mt -122.86 109.52 14.27 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.124 -1.806 . . . . 64.44 106.124 172.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' B' ' 114' ' ' ILE . 37.6 t -120.75 115.39 23.22 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.449 -0.574 . . . . 72.23 109.449 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -121.36 123.84 43.09 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.645 -1.242 . . . . 64.11 107.645 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.51 143.42 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.667 -0.864 . . . . 54.02 108.667 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -124.66 100.65 6.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.312 -0.858 . . . . 53.0 108.813 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.454 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 60.1 tp60 -90.25 105.81 18.06 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.224 -0.658 . . . . 72.43 109.224 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.451 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.13 164.74 26.17 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.799 -0.521 . . . . 63.43 111.799 175.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.67 128.3 1.92 Allowed Glycine 0 CA--C 1.52 0.365 0 CA-C-O 120.024 -0.32 . . . . 72.44 112.497 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.522 HG13 ' HE1' ' B' ' 17' ' ' TYR . 48.5 mt -84.37 123.83 39.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.966 -0.753 . . . . 71.05 108.966 172.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -133.12 136.55 45.88 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.015 . . . . 65.24 108.795 -175.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.9 m -103.51 108.57 19.89 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.346 0.659 . . . . 72.42 110.047 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.623 HD13 HD21 ' B' ' 98' ' ' LEU . 41.0 pt -100.11 132.03 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.251 1.02 . . . . 74.13 109.912 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.47 144.12 20.45 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 122.721 0.409 . . . . 55.31 110.057 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.75 -55.06 1.66 Allowed Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.808 -0.633 . . . . 74.31 112.164 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.457 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -72.57 155.06 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 75.45 111.255 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.27 167.37 28.85 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.127 -0.942 . . . . 73.11 109.502 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.07 -121.74 27.13 Favored Glycine 0 C--N 1.346 1.09 0 O-C-N 124.103 0.877 . . . . 70.33 114.589 172.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 89.8 m -71.89 -35.05 69.63 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.399 1.079 . . . . 70.35 111.784 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -70.51 -31.88 69.14 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 120.986 0.422 . . . . 54.34 110.373 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 49.3 ttp -74.08 -34.22 63.91 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.637 -0.71 . . . . 63.4 110.382 173.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.93 93.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.198 0.599 . . . . 52.32 110.25 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -64.17 -25.36 68.05 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.578 1.151 . . . . 71.34 111.39 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -78.83 -59.2 2.88 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.993 0.517 . . . . 44.35 110.282 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.623 HD21 HD13 ' B' ' 86' ' ' ILE . 66.3 mt -72.63 -40.53 66.35 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.856 0.688 . . . . 72.52 112.856 -167.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.32 3.97 61.98 Favored Glycine 0 N--CA 1.469 0.859 0 CA-C-O 119.728 -0.484 . . . . 64.4 114.073 -173.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.608 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -143.37 -69.65 0.33 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.33 0.565 . . . . 62.21 111.386 -175.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.34 -43.49 96.42 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.702 1.201 . . . . 62.33 112.049 -172.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.423 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 94.4 m -66.39 -50.43 48.28 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 124.206 1.003 . . . . 74.31 111.562 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 78.1 Cg_exo -55.18 -35.17 90.27 Favored 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.187 1.925 . . . . 71.43 113.995 169.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.403 HD21 ' N ' ' B' ' 134' ' ' ASP . 63.4 m-80 -63.27 -33.59 75.84 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 118.159 0.436 . . . . 74.44 111.825 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 77.4 mt -66.06 -40.94 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.362 0.665 . . . . 74.05 110.408 175.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.7 mt -82.61 -20.82 35.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.192 0.997 . . . . 72.02 112.851 -172.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.2 -47.98 97.24 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-O 117.864 -1.065 . . . . 75.04 113.822 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.36 -32.78 89.7 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 121.993 1.796 . . . . 73.4 113.166 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.454 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 91.7 m-85 -70.37 -48.96 53.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.842 0.457 . . . . 72.21 110.133 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.62 -43.35 72.15 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.95 0.9 . . . . 71.11 110.251 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.545 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 35.9 ttt-85 -59.97 -55.03 39.1 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.322 1.449 . . . . 73.32 111.824 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.56 -33.81 76.78 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.766 0.827 . . . . 72.31 110.065 -175.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.605 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.1 t -72.16 -43.3 64.83 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.8 -0.636 . . . . 75.12 111.355 -176.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.604 HG21 HG21 ' B' ' 64' ' ' VAL . 99.1 mt -60.0 -53.59 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 109.819 -0.437 . . . . 72.1 109.819 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 86.8 m -59.32 -32.82 70.42 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 124.084 0.865 . . . . 74.12 111.41 -176.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.3 t -61.98 -47.42 84.89 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.297 0.639 . . . . 50.11 109.674 174.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.8 mmt -69.24 -34.42 74.77 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.17 0.588 . . . . 74.23 111.368 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 114' ' ' ILE . 92.4 t -60.83 -43.15 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.148 0.979 . . . . 71.03 109.924 174.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.0 t -68.22 -33.77 75.02 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.634 -1.166 . . . . 72.42 111.471 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.1 mtt-85 -66.95 -35.93 81.09 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.518 0.727 . . . . 71.41 110.152 177.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.09 9.51 60.44 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-O 119.483 -0.62 . . . . 61.24 113.361 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 17' ' ' TYR . 70.4 p 57.06 22.14 7.07 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 126.158 1.783 . . . . 74.01 113.72 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -78.79 149.26 73.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.796 -0.446 . . . . 61.14 109.796 175.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.462 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 28.7 Cg_endo -59.57 171.57 2.56 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.306 2.67 . . . . 63.12 113.672 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.428 HE21 HD22 ' B' ' 127' ' ' ASN . 51.9 tp60 -62.91 114.77 3.85 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.038 -0.983 . . . . 63.43 111.88 -167.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.496 HD13 ' HZ ' ' B' ' 74' ' ' PHE . 8.6 tt -135.78 106.64 6.62 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.961 -0.755 . . . . 61.02 108.961 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 127' ' ' ASN . . . . . 0.428 HD22 HE21 ' B' ' 125' ' ' GLN . 78.9 m-20 -114.26 135.14 54.39 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.847 0.859 . . . . 75.12 109.843 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.545 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.5 mm? -72.24 124.73 25.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.198 -0.667 . . . . 74.35 109.198 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.72 152.25 89.21 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.296 0.639 . . . . 73.42 110.962 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.17 110.1 1.28 Allowed 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 122.402 2.068 . . . . 61.33 112.947 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 31.2 t -100.71 111.0 29.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.106 -1.072 . . . . 72.24 108.106 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 132' ' ' ASN . . . . . 0.409 ' O ' HD13 ' B' ' 136' ' ' LEU . 43.6 t-20 -85.05 90.29 7.81 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.459 -0.941 . . . . 63.12 108.459 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -57.04 -31.53 65.27 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.45 0.7 . . . . 74.31 111.321 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 134' ' ' ASP . . . . . 0.608 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 11.7 t70 -73.11 -44.92 59.68 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.259 1.024 . . . . 72.31 111.054 -173.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.53 -39.0 93.27 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.075 0.95 . . . . 44.13 111.48 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 136' ' ' LEU . . . . . 0.409 HD13 ' O ' ' B' ' 132' ' ' ASN . 8.5 mp -75.1 -33.54 61.63 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.105 -0.952 . . . . 62.23 110.866 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 69.3 t80 . . . . . 0 N--CA 1.48 1.031 0 C-N-CA 124.05 0.94 . . . . 53.25 111.645 -177.248 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 51.6 m . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 108.062 -1.088 . . . . 62.23 108.062 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.562 ' HD2' ' HG3' ' A' ' 130' ' ' PRO . 64.4 t80 -107.81 122.95 47.81 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.354 -0.98 . . . . 72.21 108.354 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -139.1 117.85 12.3 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.382 0.673 . . . . 74.33 109.644 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.2 mt -73.22 127.11 34.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 108.856 -0.794 . . . . 53.1 108.856 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.599 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 14.8 mm100 -94.0 -46.22 7.24 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.466 -0.568 . . . . 72.03 109.466 173.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -170.97 141.32 1.69 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.602 -0.726 . . . . 75.34 109.418 -167.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.0 mt -136.13 130.25 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.295 -1.372 . . . . 72.14 107.295 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -166.34 157.81 13.34 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.154 0.502 . . . . 73.12 110.611 -164.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.8 p -88.56 117.29 27.41 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.45 -0.796 . . . . 74.3 109.047 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -86.88 -37.6 17.54 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.144 0.497 . . . . 71.24 109.893 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -138.35 127.72 24.59 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.13 -0.941 . . . . 75.44 109.137 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.5 mt -129.8 139.5 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.398 -1.334 . . . . 72.13 107.398 175.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -147.71 145.38 28.85 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.529 0.731 . . . . 74.01 109.678 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -143.12 134.44 26.05 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.469 -1.308 . . . . 74.02 107.469 168.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.4 mt-10 -129.11 126.98 40.53 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 124.326 1.05 . . . . 73.15 108.421 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.76 81.04 23.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 106.664 -1.606 . . . . 70.44 106.664 169.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -64.29 -31.58 62.96 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.966 2.444 . . . . 75.25 112.233 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -105.7 19.28 20.81 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.232 -0.895 . . . . 63.4 111.215 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.419 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -41.28 -62.15 1.14 Allowed Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 117.598 -1.191 . . . . 74.32 114.199 -167.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.0 -44.1 26.52 Favored 'Trans proline' 0 C--N 1.391 2.788 0 CA-C-N 121.977 1.742 . . . . 71.34 111.628 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -68.81 -31.71 70.91 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.016 0.926 . . . . 61.14 112.514 -174.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.709 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.5 p -80.5 -16.59 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 C-N-CA 122.731 0.413 . . . . 73.11 111.322 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -75.39 -22.55 57.39 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.563 0.345 . . . . 75.43 111.683 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -95.74 4.49 52.9 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.452 0.301 . . . . 62.31 111.113 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -91.5 151.64 20.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.444 0.697 . . . . 74.44 110.337 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -56.87 124.33 18.19 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 124.092 0.87 . . . . 51.02 110.303 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.9 t90 -84.58 93.39 8.35 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.784 -0.644 . . . . 62.43 110.273 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -145.24 76.98 13.12 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.182 -1.044 . . . . 50.24 108.182 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.8 128.88 6.09 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.687 2.258 . . . . 75.14 112.867 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -85.28 109.43 18.35 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.072 -1.455 . . . . 71.34 107.072 161.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 m -96.48 113.27 30.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.045 0.938 . . . . 75.13 110.571 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -119.65 112.41 19.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.892 1.277 . . . . 73.53 108.186 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.06 168.62 12.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.424 0.69 . . . . 63.13 111.632 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 29.5 t70 -145.5 105.52 4.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.19 0.596 . . . . 72.14 109.976 173.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.42 130.36 55.5 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.576 1.15 . . . . 73.13 109.38 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -156.49 153.88 29.48 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.461 0.705 . . . . 74.33 109.946 171.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -129.81 152.46 49.27 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.947 0.899 . . . . 70.41 110.239 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.7 167.43 22.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.257 1.023 . . . . 71.22 108.84 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.468 ' HB3' HG22 ' C' ' 58' ' ' VAL . 93.1 p -148.15 152.75 37.81 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.046 0.538 . . . . 65.51 109.912 174.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 27.4 p -143.87 135.05 25.67 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.493 0.717 . . . . 62.53 109.545 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -64.91 116.25 6.18 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.941 0.775 . . . . 71.22 109.59 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.634 HD11 HD12 ' C' ' 83' ' ' ILE . 94.5 mt -84.38 -39.72 18.71 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.349 0.595 . . . . 74.42 109.44 174.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.18 -174.84 5.02 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.291 -1.322 . . . . 72.15 109.663 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.84 113.75 2.67 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.986 -1.006 . . . . 71.45 109.954 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 69.97 4.43 4.79 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.94 1.296 . . . . 75.24 112.975 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -105.86 123.0 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.04 0.936 . . . . 65.11 109.444 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -111.91 161.43 16.41 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.694 0.759 . . . . 70.45 110.37 172.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.547 ' HB2' HD11 ' C' ' 51' ' ' LEU . 32.9 tt0 -123.67 111.82 16.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.949 -1.5 . . . . 65.13 106.949 166.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' C' ' 48' ' ' SER . 74.0 t -94.07 121.29 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.026 -1.102 . . . . 72.13 108.026 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.33 133.51 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.502 -0.925 . . . . 72.54 108.502 173.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -119.45 109.06 15.3 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.247 -1.02 . . . . 75.33 108.247 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -99.77 112.97 25.17 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.685 0.794 . . . . 73.3 109.784 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.3 t -106.4 130.93 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.259 1.024 . . . . 70.32 108.357 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 4.9 m -125.31 146.42 49.57 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.725 -0.843 . . . . 71.11 108.725 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -136.35 109.46 8.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.506 1.122 . . . . 75.31 108.644 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 22.1 m -99.25 140.83 32.83 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.512 -0.921 . . . . 74.2 108.512 171.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.11 105.71 5.83 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.825 -1.176 . . . . 71.45 107.825 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 52.3 m -119.67 133.17 55.75 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.698 -0.852 . . . . 53.55 108.698 177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 mt -82.68 51.34 1.86 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.263 1.425 . . . . 74.31 110.303 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.81 -76.68 0.31 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.504 -1.038 . . . . 64.14 110.504 -175.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.99 -31.7 2.12 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.701 1.2 . . . . 61.52 109.809 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -70.88 100.32 1.92 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.344 1.057 . . . . 75.14 110.257 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 72' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 49.8 m -66.64 125.13 24.82 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 118.007 0.367 . . . . 72.15 110.273 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.709 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -82.0 -55.02 4.84 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 114.982 -1.008 . . . . 31.42 109.161 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -161.14 176.08 11.69 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.259 1.028 . . . . 72.41 112.448 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.2 tm? -137.88 146.53 43.48 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 113.001 -1.909 . . . . 74.1 106.212 172.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.458 ' N ' HD13 ' C' ' 75' ' ' LEU . 44.1 t -148.3 143.39 26.89 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.614 -0.884 . . . . 74.41 108.614 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -155.89 137.12 13.84 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.718 0.294 . . . . 74.0 110.345 -177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.9 t -135.62 137.84 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.466 1.106 . . . . 72.34 108.751 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -115.31 94.55 4.77 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.329 -0.989 . . . . 51.53 108.329 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -79.44 98.55 6.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.489 -0.778 . . . . 74.5 109.452 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.24 143.4 22.87 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.208 -1.157 . . . . 70.22 110.208 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.488 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.84 117.23 0.88 Allowed Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 111.53 -0.628 . . . . 32.23 111.53 -174.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.634 HD12 HD11 ' C' ' 51' ' ' LEU . 6.4 mm -82.61 128.79 38.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 108.638 -0.875 . . . . 62.42 108.638 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -135.85 122.03 20.3 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.43 0.457 . . . . 72.03 110.109 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 22.1 m -79.48 107.55 12.33 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.059 -1.089 . . . . 70.35 108.059 169.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.68 143.83 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.069 0.547 . . . . 72.11 110.637 -175.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -158.5 166.28 32.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.314 1.046 . . . . 73.12 109.652 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.46 -34.58 4.4 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.984 -0.553 . . . . 75.4 112.896 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.17 140.42 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.731 0.813 . . . . 71.42 110.531 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -148.3 156.65 42.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.585 0.754 . . . . 75.4 109.712 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.81 -117.54 8.21 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 116.209 -0.45 . . . . 34.14 113.248 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 5.2 m -70.6 -33.53 71.16 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.036 0.934 . . . . 72.42 110.501 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -67.14 -39.9 86.66 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.732 -1.122 . . . . 73.4 110.085 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 39.6 ttp -78.11 -24.64 47.41 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.272 -0.876 . . . . 63.13 110.741 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.39 95.65 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 122.752 0.421 . . . . 71.1 110.435 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -75.94 -41.19 52.42 Favored 'General case' 0 C--O 1.248 0.979 0 N-CA-C 111.927 0.343 . . . . 75.32 111.927 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -55.61 -48.89 74.16 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.069 0.856 . . . . 73.41 110.543 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.449 HD23 ' SG ' ' C' ' 102' ' ' CYS . 34.9 mt -92.88 -14.26 27.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.277 0.631 . . . . 43.02 111.076 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.93 -29.39 65.07 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 123.329 0.49 . . . . 73.42 113.835 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -156.5 -39.83 0.08 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 113.13 0.789 . . . . 72.43 113.13 -166.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -66.04 -55.82 14.68 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.453 0.471 . . . . 72.54 111.184 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.545 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 37.8 m -64.52 -46.28 77.35 Favored Pre-proline 0 CA--C 1.563 1.478 0 C-N-CA 123.643 0.777 . . . . 42.32 112.943 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.56 -19.81 54.15 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 121.967 1.778 . . . . 74.54 113.967 174.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 104' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' C' ' 100' ' ' ALA . 0.2 OUTLIER -71.98 -28.41 63.4 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.714 -0.476 . . . . 71.31 109.714 176.189 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.71 -43.21 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.673 0.789 . . . . 73.31 109.67 171.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.488 HD21 ' HA3' ' C' ' 82' ' ' GLY . 66.0 mt -74.95 -28.2 60.49 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 114.886 -1.052 . . . . 52.22 112.133 -172.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -56.7 -50.2 89.31 Favored Pre-proline 0 CA--C 1.566 1.578 0 CA-C-O 117.34 -1.314 . . . . 74.43 114.243 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.54 -39.14 55.58 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 122.4 2.067 . . . . 72.11 113.367 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.472 ' HE2' HG21 ' A' ' 115' ' ' THR . 20.1 m-85 -67.94 -48.34 66.19 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.781 0.832 . . . . 72.51 110.405 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.15 -34.84 75.66 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.011 -0.995 . . . . 54.25 110.843 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -61.33 -56.53 19.42 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 124.12 0.968 . . . . 73.53 109.988 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.01 -30.33 71.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 123.724 0.64 . . . . 71.1 110.717 -175.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.5 t -73.91 -31.24 63.0 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.142 0.577 . . . . 73.32 110.884 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 58.7 mt -74.0 -50.33 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.945 0.498 . . . . 63.31 109.724 173.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 5.2 m -62.62 -30.27 71.23 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.013 0.925 . . . . 45.45 110.887 -175.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.3 t -65.5 -51.75 57.75 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.999 -0.741 . . . . 61.21 108.999 172.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.627 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.59 -36.65 76.67 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.541 1.136 . . . . 71.44 112.926 -179.619 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.708 HG11 HD23 ' C' ' 126' ' ' LEU . 95.0 t -71.72 -39.36 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.473 0.709 . . . . 74.23 109.775 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.5 t -70.77 -26.45 63.36 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.655 0.782 . . . . 51.24 111.234 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 78.2 mtt-85 -72.93 -42.49 63.41 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.744 -0.836 . . . . 75.43 108.744 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.1 -4.17 82.93 Favored Glycine 0 C--N 1.356 1.649 0 O-C-N 123.706 0.629 . . . . 70.33 112.942 173.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 23.4 p 66.83 25.84 9.48 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.633 1.973 . . . . 72.3 113.62 171.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.506 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 98.6 m-85 -86.49 166.08 29.7 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 123.841 0.857 . . . . 74.14 109.115 169.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 51.3 Cg_endo -62.67 178.31 1.01 Allowed 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 123.139 2.559 . . . . 51.31 114.708 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -59.67 112.22 1.73 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.877 1.271 . . . . 72.42 111.742 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.708 HD23 HG11 ' C' ' 118' ' ' VAL . 4.1 mm? -106.62 96.78 6.69 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.211 -0.663 . . . . 72.3 109.211 172.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -124.79 122.48 37.54 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.708 1.203 . . . . 74.01 108.539 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 14.8 tp -79.96 135.4 36.39 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.932 -0.395 . . . . 75.43 109.932 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.13 140.44 78.14 Favored Pre-proline 0 CA--C 1.547 0.849 0 O-C-N 124.45 1.094 . . . . 64.02 110.304 173.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.84 102.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.582 2.188 . . . . 51.23 112.676 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 50.0 t -95.74 111.17 25.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 106.675 -1.602 . . . . 53.25 106.675 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -76.24 83.22 3.03 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.633 -1.247 . . . . 74.53 107.633 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -56.43 -36.64 69.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.731 0.812 . . . . 62.12 110.825 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.7 -43.13 99.45 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 114.857 -1.065 . . . . 64.44 111.213 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.02 91.53 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.637 0.586 . . . . 62.52 110.952 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.1 mp -57.48 -50.66 72.33 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 123.97 0.794 . . . . 75.35 111.409 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 123.347 0.659 . . . . 73.04 110.396 -177.834 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 C--O 1.236 0.39 0 N-CA-C 109.737 -0.468 . . . . 73.44 109.737 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -175.13 102.01 0.08 Allowed 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.458 -2.053 . . . . 74.21 105.458 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -144.2 134.47 24.39 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.243 -0.89 . . . . 64.44 108.799 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.3 mt -84.25 122.6 38.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 115.203 -0.908 . . . . 72.13 109.182 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -90.07 -39.8 12.69 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 122.617 0.367 . . . . 74.13 111.315 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -166.56 127.79 1.71 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 111.755 0.28 . . . . 65.35 111.755 -167.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.75 136.13 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.343 -1.354 . . . . 72.11 107.343 167.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.41 ' HE1' HG13 ' D' ' 83' ' ' ILE . 25.1 p90 -156.51 164.38 38.29 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.771 0.796 . . . . 73.22 111.334 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 65.3 p -100.15 123.27 44.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.043 -0.981 . . . . 75.14 108.839 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -87.24 -36.01 18.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.67 0.748 . . . . 60.52 109.132 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 2.6 t70 -142.07 138.88 32.05 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.233 -1.349 . . . . 61.22 108.942 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.627 HG21 ' HE2' ' C' ' 117' ' ' MET . 82.3 mt -134.25 145.89 32.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.63 -1.248 . . . . 63.53 107.63 169.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -148.11 137.87 22.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.886 -0.783 . . . . 65.1 108.886 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.422 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.5 t80 -146.12 124.06 12.03 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.239 -1.393 . . . . 74.31 107.239 170.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -121.75 148.49 44.57 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.079 -0.711 . . . . 75.4 109.079 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.78 84.19 27.27 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 106.738 -1.578 . . . . 64.51 106.738 171.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.4 -46.08 6.16 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.198 2.598 . . . . 74.23 113.586 -167.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -104.95 28.0 7.6 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.703 0.801 . . . . 50.12 109.591 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.27 -66.72 0.34 Allowed Pre-proline 0 CA--C 1.565 1.528 0 N-CA-C 114.908 1.447 . . . . 75.31 114.908 -161.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.451 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.7 Cg_endo -73.8 -20.13 20.24 Favored 'Trans proline' 0 C--N 1.382 2.324 0 CA-C-N 122.533 1.94 . . . . 75.15 113.3 -174.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -73.88 -40.44 63.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.595 1.158 . . . . 62.14 110.328 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.463 HG21 ' HA ' ' D' ' 73' ' ' ALA . 4.0 p -85.54 -23.95 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 123.341 0.657 . . . . 64.11 111.803 -171.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -60.64 -22.09 63.46 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 123.286 0.634 . . . . 74.01 112.428 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -68.17 -10.3 53.19 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.579 0.752 . . . . 73.34 111.052 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -100.95 107.73 19.29 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.737 1.215 . . . . 73.24 110.246 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -93.27 91.87 7.44 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.293 0.637 . . . . 72.31 110.423 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.548 ' HZ3' ' H ' ' D' ' 69' ' ' GLY . 22.0 t90 -161.62 158.41 26.13 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.937 1.295 . . . . 63.41 108.127 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -69.31 108.03 2.74 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 107.999 -1.111 . . . . 74.03 107.999 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.74 124.23 15.75 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.967 2.444 . . . . 63.31 112.495 -173.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -57.28 110.98 0.94 Allowed 'General case' 0 C--N 1.359 0.996 0 O-C-N 124.442 1.088 . . . . 70.32 110.244 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.458 HG23 HG13 ' D' ' 64' ' ' VAL . 2.8 p -101.68 112.39 34.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 115.283 -0.871 . . . . 75.32 110.269 -172.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.55 109.82 18.79 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 104.908 -2.256 . . . . 74.34 104.908 165.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.454 HD21 HD11 ' D' ' 128' ' ' LEU . 5.4 tt -95.49 127.9 41.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.36 -1.348 . . . . 70.25 107.36 -170.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.523 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 10.0 t70 -130.17 147.0 51.85 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 123.542 0.527 . . . . 72.31 109.915 -176.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -127.99 153.02 47.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.584 0.753 . . . . 73.21 109.682 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -157.69 147.78 20.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.055 0.942 . . . . 73.2 108.828 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -127.73 160.85 30.42 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.409 -0.589 . . . . 72.33 109.409 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.477 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.05 166.77 31.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.755 -1.112 . . . . 63.52 108.661 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 21.8 p -165.72 161.31 18.01 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.609 0.764 . . . . 55.42 109.557 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.2 p -151.98 160.47 43.47 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.282 1.033 . . . . 72.45 109.238 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -98.81 120.65 39.6 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.995 -0.742 . . . . 72.35 108.995 171.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' D' ' 57' ' ' GLU . 59.2 mt -91.0 -41.3 11.18 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.124 0.488 . . . . 73.02 110.198 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -153.51 -172.44 4.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.754 0.822 . . . . 43.44 110.896 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.37 105.96 1.59 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 114.968 -1.015 . . . . 70.33 109.53 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 64.11 18.59 11.33 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.517 1.127 . . . . 74.23 112.404 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 98.1 t -117.83 120.44 64.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.587 0 N-CA-C 107.843 -1.169 . . . . 74.41 107.843 169.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -125.46 163.8 21.86 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.671 0.788 . . . . 73.35 109.411 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.523 ' HB2' HD11 ' D' ' 51' ' ' LEU . 22.2 tt0 -121.52 148.38 44.55 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 124.746 1.218 . . . . 72.51 107.714 169.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.1 t -129.75 119.28 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 106.896 -1.52 . . . . 75.31 106.896 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.522 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 41.4 t -99.38 125.29 52.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.987 -0.746 . . . . 73.4 108.987 176.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.64 124.86 49.61 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.702 -1.221 . . . . 64.3 107.702 175.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -118.98 95.66 4.91 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.987 -0.746 . . . . 74.42 108.987 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -91.24 123.1 43.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.078 -1.082 . . . . 75.4 108.078 174.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 24.0 m -111.15 144.06 40.9 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.25 0.548 . . . . 72.14 110.041 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.458 HG13 HG23 ' D' ' 40' ' ' VAL . 93.9 t -137.44 120.28 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.111 0.964 . . . . 74.22 109.503 -175.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 100.0 m -113.39 121.03 43.12 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 107.912 -1.144 . . . . 74.54 107.912 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.88 145.49 48.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.333 0.653 . . . . 51.3 110.319 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.456 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.8 m -146.83 129.96 16.48 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 123.526 0.516 . . . . 72.2 111.129 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 mt -92.86 92.6 7.98 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.945 -1.132 . . . . 74.31 107.945 173.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 69' ' ' GLY . . . . . 0.548 ' H ' ' HZ3' ' D' ' 36' ' ' TRP . . . 70.22 -114.77 5.67 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 114.571 -1.195 . . . . 54.31 113.382 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.15 6.37 40.36 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.299 0.852 . . . . 74.15 113.299 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.91 156.94 43.02 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.11 0.414 . . . . 54.33 110.222 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.5 m -67.29 136.89 55.59 Favored 'General case' 0 C--O 1.242 0.697 0 O-C-N 123.633 0.583 . . . . 65.44 110.694 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.463 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.34 -69.57 0.71 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.252 -1.34 . . . . 75.44 108.522 175.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -145.58 157.46 43.98 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 121.319 0.58 . . . . 72.22 109.958 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -131.96 144.58 50.91 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.255 -1.387 . . . . 72.33 107.255 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.563 ' SG ' HG12 ' D' ' 114' ' ' ILE . 43.6 t -158.22 136.68 11.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.336 0.254 . . . . 65.3 110.589 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -154.07 128.35 9.1 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.387 0.675 . . . . 73.21 109.32 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.2 118.39 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.382 0.673 . . . . 54.13 109.905 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.626 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.6 mt-30 -89.77 82.97 6.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.34 0.656 . . . . 61.33 109.307 169.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -80.37 91.86 5.73 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.963 1.305 . . . . 63.31 109.359 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.25 142.18 17.98 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.713 -0.555 . . . . 65.13 111.713 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.93 132.31 5.5 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 119.716 -0.491 . . . . 70.43 112.064 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.41 HG13 ' HE1' ' D' ' 17' ' ' TYR . 61.9 mt -89.17 131.23 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.379 0.672 . . . . 70.55 109.99 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -131.22 124.55 30.81 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.886 0.875 . . . . 70.31 109.341 175.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 71.5 m -83.75 111.7 19.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.088 -1.078 . . . . 73.12 108.088 168.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.461 HD12 ' SG ' ' D' ' 97' ' ' CYS . 5.5 tt -138.06 127.99 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 122.902 0.481 . . . . 63.01 111.117 -172.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.68 167.66 27.86 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.398 1.479 . . . . 54.25 109.099 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.05 11.51 63.11 Favored Glycine 0 N--CA 1.473 1.128 0 CA-C-O 119.463 -0.632 . . . . 75.42 113.66 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.8 169.22 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 125.079 1.352 . . . . 74.25 109.661 171.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -153.91 175.82 12.91 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.723 0.409 . . . . 63.24 111.912 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.89 -107.42 0.71 Allowed Glycine 0 C--N 1.36 1.868 0 O-C-N 124.757 1.285 . . . . 64.31 115.263 164.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.0 p -66.04 -41.54 90.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.816 0.847 . . . . 72.13 110.974 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -74.72 -38.03 62.41 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.344 0.657 . . . . 65.21 111.685 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -66.63 -34.46 77.92 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.867 0.365 . . . . 75.24 110.671 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.98 -42.65 69.4 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.907 -0.588 . . . . 73.22 109.646 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.408 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 49.8 t-80 -66.25 -26.41 67.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.421 1.088 . . . . 70.53 111.817 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 97' ' ' CYS . . . . . 0.461 ' SG ' HD12 ' D' ' 86' ' ' ILE . 25.3 t -91.12 -54.14 4.07 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.844 -0.122 . . . . 73.33 110.864 -176.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -72.31 -29.77 64.16 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.391 0.276 . . . . 72.42 111.494 -176.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.5 12.91 27.98 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.122 -0.821 . . . . 73.01 114.532 -172.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -154.46 -59.65 0.12 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.983 0.891 . . . . 62.41 112.207 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -68.59 -50.41 51.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.006 0.523 . . . . 73.43 111.499 -173.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 83.7 m -62.6 -45.71 88.78 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.11 0.964 . . . . 72.41 112.243 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -52.56 -40.79 71.58 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.203 1.935 . . . . 71.5 112.967 167.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -66.07 -29.87 70.28 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.256 0.622 . . . . 75.54 111.328 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.7 mm -69.59 -42.4 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.894 0.878 . . . . 61.52 110.436 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 62.8 mt -74.83 -16.28 60.7 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.224 -0.898 . . . . 61.23 111.67 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.423 ' HE2' ' HA ' ' D' ' 130' ' ' PRO . 27.6 t80 -68.07 -40.37 21.73 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.916 -1.04 . . . . 75.24 113.74 -169.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.39 -44.84 45.6 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.011 1.807 . . . . 45.23 112.895 167.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -69.24 -36.64 77.37 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.692 0.797 . . . . 73.12 111.783 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.07 -49.46 69.95 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.241 0.616 . . . . 64.42 109.717 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.492 HH12 ' HB3' ' D' ' 130' ' ' PRO . 26.5 ttp180 -55.99 -47.62 77.37 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 124.357 1.036 . . . . 73.03 110.946 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -62.13 -49.03 77.49 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.073 0.858 . . . . 65.22 111.534 -174.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.0 -41.86 83.98 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.053 0.846 . . . . 72.44 110.636 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.563 HG12 ' SG ' ' D' ' 76' ' ' CYS . 81.1 mt -60.4 -56.51 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 O-C-N 124.293 0.996 . . . . 70.55 110.79 173.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -58.21 -37.55 75.04 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.588 1.155 . . . . 75.52 111.372 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -66.78 -42.15 86.5 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.155 -0.93 . . . . 75.45 110.079 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.4 mtm -72.52 -27.11 62.04 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.809 0.444 . . . . 65.53 111.766 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.408 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.0 t -67.97 -42.14 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.458 0.703 . . . . 64.11 110.078 173.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.6 p -75.62 -29.44 59.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.813 0.445 . . . . 71.3 111.108 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -74.26 -33.84 63.41 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.245 0.618 . . . . 73.42 109.599 174.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.68 -2.25 90.62 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-N 115.746 -0.661 . . . . 53.02 112.237 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p 66.57 21.3 10.73 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.876 2.07 . . . . 44.43 113.904 170.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -82.62 156.77 67.95 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.452 0.701 . . . . 75.12 110.348 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.97 137.23 44.23 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.298 2.666 . . . . 63.14 112.138 173.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -54.66 136.77 45.18 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.359 1.037 . . . . 74.33 111.929 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -113.44 102.32 10.2 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.568 -0.901 . . . . 74.02 108.568 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -98.29 95.08 7.13 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.221 -1.4 . . . . 42.31 107.221 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.454 HD11 HD21 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -57.11 113.89 1.9 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.566 -1.197 . . . . 65.24 108.273 -176.316 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.88 122.65 70.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 123.963 0.789 . . . . 75.53 110.632 -171.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.492 ' HB3' HH12 ' D' ' 111' ' ' ARG . 59.1 Cg_endo -72.64 112.52 3.5 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.944 1.763 . . . . 63.51 111.427 -176.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.0 m -105.81 138.52 30.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 108.317 -0.994 . . . . 70.11 108.317 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -79.25 77.11 5.78 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.872 0.844 . . . . 62.01 109.726 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -56.71 -29.39 62.39 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.623 1.569 . . . . 70.3 111.64 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 134' ' ' ASP . . . . . 0.658 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 21.7 t70 -60.51 -45.1 95.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.13 1.372 . . . . 75.54 110.747 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.07 -37.84 57.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.807 0.843 . . . . 63.31 111.329 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 9.8 mp -58.93 -31.23 68.48 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.33 0.652 . . . . 65.54 111.043 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.6 t80 . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 123.986 0.914 . . . . 71.51 110.8 177.715 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.1 m . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.865 -0.42 . . . . 61.12 109.865 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.651 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.4 t80 -133.25 132.87 41.96 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.647 -0.872 . . . . 65.52 108.647 173.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -147.39 116.64 6.94 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.682 -0.858 . . . . 74.52 108.682 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.463 HG12 ' HD2' ' A' ' 84' ' ' PHE . 50.7 mt -81.19 117.4 27.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.87 -0.789 . . . . 71.12 108.87 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -86.34 -40.37 15.52 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 123.742 0.651 . . . . 74.42 110.757 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -168.12 137.46 2.48 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 122.969 0.168 . . . . 74.55 110.744 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.593 HD12 ' HG3' ' C' ' 130' ' ' PRO . 88.6 mt -125.44 133.48 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.378 1.071 . . . . 72.52 108.584 177.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' HB3' HG23 ' B' ' 122' ' ' THR . 41.4 p90 -168.97 177.32 4.99 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 123.97 0.794 . . . . 75.44 111.355 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -102.2 122.96 45.19 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.05 -0.977 . . . . 74.3 108.749 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 31.3 mtpt -88.07 -45.21 10.36 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.316 -0.624 . . . . 65.43 109.316 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.3 t70 -134.34 125.67 28.08 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.507 -1.224 . . . . 72.02 108.288 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 58.9 mt -124.91 140.39 48.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.696 -1.594 . . . . 64.21 106.696 173.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -156.09 121.12 4.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.17 0.509 . . . . 74.53 109.727 171.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.474 ' H ' ' HB ' ' B' ' 21' ' ' ILE . 86.8 t80 -116.3 118.54 33.05 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 106.36 -1.718 . . . . 72.42 106.36 173.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -119.56 126.48 51.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.058 0.39 . . . . 51.43 110.145 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.17 75.64 23.15 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.685 -1.228 . . . . 54.33 107.685 169.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.56 -28.68 25.91 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.26 1.974 . . . . 62.42 110.405 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.454 ' O ' HG23 ' A' ' 31' ' ' VAL . 43.1 m-20 -93.33 12.41 24.81 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.196 -1.365 . . . . 71.13 110.898 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.73 -46.88 80.19 Favored Pre-proline 0 CA--C 1.571 1.752 0 C-N-CA 124.185 0.994 . . . . 70.4 113.607 -176.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.13 -21.77 20.05 Favored 'Trans proline' 0 C--N 1.396 3.073 0 C-N-CA 122.082 1.855 . . . . 75.31 113.651 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -71.65 -47.57 53.53 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.623 -0.51 . . . . 70.02 109.623 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.614 HG22 HD21 ' A' ' 68' ' ' LEU . 88.1 t -60.91 -33.88 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.738 1.215 . . . . 72.3 110.936 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.446 ' HD1' HH11 ' B' ' 15' ' ' ARG . 90.9 t80 -56.46 -39.52 73.3 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.643 1.177 . . . . 74.41 111.918 176.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -96.43 -35.15 11.26 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.652 0.781 . . . . 60.21 111.87 -172.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -83.15 170.63 14.54 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.596 0.758 . . . . 74.55 112.88 -172.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.63 115.86 9.36 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.825 0.85 . . . . 43.52 111.101 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -79.63 92.65 5.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.022 0.929 . . . . 71.42 109.966 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -140.51 75.83 26.09 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 107.38 -1.341 . . . . 72.2 107.38 172.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 67' ' ' SER . 24.6 Cg_endo -90.52 163.85 4.35 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.095 2.53 . . . . 72.4 113.98 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -126.32 118.39 24.97 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.04 -0.982 . . . . 64.33 108.534 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.69 110.05 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.602 0.761 . . . . 74.32 110.831 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -103.24 140.07 37.86 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.679 -0.86 . . . . 74.25 108.679 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 63' ' ' THR . 64.7 tp -132.09 124.76 29.83 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.491 0.716 . . . . 73.1 109.701 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.452 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 64.4 m-20 -102.95 124.33 48.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.152 -1.055 . . . . 71.31 108.152 175.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.35 115.21 29.82 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.788 -1.56 . . . . 72.3 106.788 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 12.0 m-20 -132.07 124.6 29.53 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.096 -1.075 . . . . 62.32 108.096 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.9 m -115.35 121.94 44.36 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.404 -0.591 . . . . 71.23 109.404 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.76 140.86 48.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.182 0.993 . . . . 71.22 108.614 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.559 ' HB2' HD21 ' A' ' 98' ' ' LEU . 37.0 t -130.59 163.92 26.06 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.358 0.599 . . . . 65.31 111.628 -173.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.2 t -148.91 121.62 8.64 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.198 -1.365 . . . . 74.44 108.256 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -71.67 107.89 4.74 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.822 0.849 . . . . 70.45 109.279 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.9 mt -78.52 -34.51 47.24 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.221 0.608 . . . . 71.34 110.281 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.54 -177.71 6.59 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.939 0.895 . . . . 72.25 109.878 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.72 119.44 14.86 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.412 -0.588 . . . . 75.33 109.412 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 67.34 20.15 10.04 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.084 1.354 . . . . 73.41 112.151 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.12 124.05 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.414 1.086 . . . . 75.31 108.35 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.499 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -142.43 169.22 17.99 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.337 -0.616 . . . . 73.54 109.337 174.337 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -128.75 130.51 47.17 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.498 -0.927 . . . . 74.3 108.498 174.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.8 m -102.42 132.06 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.586 -0.894 . . . . 62.12 108.586 169.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.51 106.92 21.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 125.194 1.397 . . . . 73.41 107.68 177.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.7 tp -87.57 99.14 11.82 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.693 -0.685 . . . . 71.12 109.155 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.709 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 52.6 ttt-85 -84.38 105.24 15.06 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.805 -0.813 . . . . 75.14 108.805 174.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.507 HG21 ' HB1' ' A' ' 110' ' ' ALA . 1.7 m -112.95 106.58 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 108.37 -0.974 . . . . 62.23 108.37 175.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 25.6 m -109.83 112.01 23.79 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.451 1.1 . . . . 74.32 110.716 -167.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 78.2 t -101.74 110.97 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.52 0.728 . . . . 74.42 109.656 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -115.44 108.29 16.29 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.735 -0.839 . . . . 70.25 108.735 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.79 133.49 53.08 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.312 -0.995 . . . . 61.11 108.312 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 39.4 t -140.27 134.38 30.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.905 0.482 . . . . 71.11 110.595 -176.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.657 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -94.78 80.17 3.74 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.432 1.093 . . . . 74.43 108.436 172.807 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.06 -118.86 5.48 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.311 -0.858 . . . . 74.44 112.593 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -89.41 5.97 42.82 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.61 0.764 . . . . 73.3 111.368 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.439 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . 6.3 tp10 -116.84 112.92 21.77 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.636 -0.876 . . . . 73.23 108.636 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.0 m -73.75 130.08 39.24 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.541 0.609 . . . . 72.25 109.864 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.533 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.81 -59.96 2.53 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.433 0.693 . . . . 74.21 109.789 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -159.28 163.35 35.85 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 115.157 -0.928 . . . . 71.33 110.782 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 34.6 tp -135.68 106.38 6.55 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.751 -1.113 . . . . 74.23 108.172 175.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 118' ' ' VAL . 57.2 m -107.69 97.36 7.1 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.241 -0.651 . . . . 73.43 109.241 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -113.06 117.16 31.23 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.671 -1.233 . . . . 74.53 107.671 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.4 t -126.3 109.55 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.492 -0.776 . . . . 73.0 109.119 -175.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.579 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.3 mt-30 -90.34 86.23 6.42 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.866 -1.061 . . . . 63.35 108.608 171.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.49 ' HG3' HD22 ' A' ' 106' ' ' LEU . 53.4 tp60 -76.42 109.05 9.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.156 -1.384 . . . . 65.03 108.104 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.37 144.83 17.53 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.429 -0.668 . . . . 61.41 111.429 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.418 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -148.59 122.46 1.49 Allowed Glycine 0 CA--C 1.502 -0.746 0 N-CA-C 110.869 -0.892 . . . . 72.43 110.869 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.9 mt -80.93 121.77 35.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 108.406 -0.961 . . . . 75.25 108.406 175.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.651 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.2 m-85 -130.37 135.53 48.13 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.511 -0.922 . . . . 74.02 108.511 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.4 p -112.62 98.02 6.96 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.325 -0.62 . . . . 61.33 109.325 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.44 HD12 HD11 ' A' ' 89' ' ' ILE . 39.3 pt -99.52 149.8 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 115.733 -0.667 . . . . 73.33 109.469 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.58 147.73 14.02 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.413 0.685 . . . . 74.13 110.121 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.24 9.75 64.93 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 114.873 0.709 . . . . 62.41 114.873 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -123.39 153.36 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.748 0.819 . . . . 72.24 110.085 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 14.2 tt0 -160.78 179.4 8.55 Favored 'General case' 0 CA--C 1.557 1.228 0 O-C-N 123.251 0.345 . . . . 74.43 111.085 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.457 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 73.61 -133.62 17.85 Favored Glycine 0 C--N 1.351 1.38 0 C-N-CA 123.907 0.765 . . . . 71.32 113.838 177.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.0 p -64.86 -35.25 80.51 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.934 0.894 . . . . 72.44 110.961 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -64.96 -35.58 81.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.994 0.918 . . . . 75.04 110.846 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.571 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 28.1 ttt -62.37 -47.06 85.82 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.635 0.774 . . . . 75.1 110.904 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.71 -39.24 91.02 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.777 -0.647 . . . . 71.0 110.865 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -67.24 -31.86 72.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.287 1.035 . . . . 71.14 111.633 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 24.6 t -69.95 -29.27 66.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.991 0.424 . . . . 74.42 110.899 -175.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 48' ' ' SER . 1.8 tt -95.09 -32.68 12.99 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.75 -0.659 . . . . 63.42 110.235 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.2 -1.93 66.51 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-O 119.578 -0.568 . . . . 74.2 113.942 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -147.82 -64.54 0.26 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 117.827 0.813 . . . . 75.31 111.967 -176.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.435 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 51.1 t80 -56.22 -70.83 0.1 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.252 1.421 . . . . 73.33 113.607 -169.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.424 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 86.6 m -72.35 -35.64 3.4 Favored Pre-proline 0 CA--C 1.565 1.541 0 N-CA-C 114.894 1.442 . . . . 73.31 114.894 -173.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 37.8 Cg_endo -64.65 -26.12 61.38 Favored 'Trans proline' 0 C--N 1.392 2.866 0 CA-C-N 121.99 1.746 . . . . 72.15 113.103 173.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -72.53 -23.1 60.95 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.847 0.459 . . . . 74.21 111.217 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.3 mm -61.91 -40.58 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.092 0.472 . . . . 74.2 109.759 171.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.49 HD22 ' HG3' ' A' ' 80' ' ' GLN . 83.7 mt -82.82 -13.45 56.18 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.298 -0.864 . . . . 73.54 112.507 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.415 ' HE2' ' HA ' ' A' ' 130' ' ' PRO . 49.2 t80 -63.94 -43.23 74.73 Favored Pre-proline 0 CA--C 1.567 1.613 0 C-N-CA 123.709 0.804 . . . . 75.23 113.101 -174.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.56 -35.77 57.59 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 122.215 1.943 . . . . 60.55 113.904 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.2 -40.54 64.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.918 0.487 . . . . 74.11 110.79 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.507 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -69.81 -36.12 75.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.528 -0.76 . . . . 65.44 110.514 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.467 ' NH1' HD12 ' C' ' 105' ' ' ILE . 36.5 ttm180 -52.95 -53.07 55.09 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.292 0.995 . . . . 74.42 109.66 171.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.75 -44.61 95.74 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 124.385 1.053 . . . . 72.42 111.701 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 17.1 t -62.2 -45.3 93.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.474 0.71 . . . . 61.42 110.555 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.3 mt -60.97 -54.66 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.799 0.84 . . . . 74.22 110.016 175.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.586 HG23 ' HG3' ' A' ' 125' ' ' GLN . 85.0 m -48.55 -48.0 38.92 Favored 'General case' 0 C--O 1.248 1.024 0 C-N-CA 124.515 1.126 . . . . 64.43 111.585 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -64.31 -47.69 78.48 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.272 -1.331 . . . . 62.43 110.034 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 39.0 mtp -61.07 -41.04 95.9 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.183 0.993 . . . . 73.2 112.32 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 114' ' ' ILE . 98.3 t -62.2 -45.94 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.691 0.796 . . . . 73.25 109.954 177.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.0 m -70.68 -27.77 64.27 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.386 -0.825 . . . . 50.32 111.978 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -72.55 -30.14 64.17 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.505 0.722 . . . . 72.05 110.186 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.82 7.07 75.9 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.541 0.525 . . . . 40.12 112.981 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.1 m 69.41 12.23 8.24 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.772 1.229 . . . . 74.11 111.791 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.533 ' HE1' HG11 ' A' ' 31' ' ' VAL . 89.3 m-85 -81.1 152.35 71.14 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.177 0.591 . . . . 72.32 109.792 173.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.4 138.16 79.31 Favored 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 123.162 2.575 . . . . 71.44 112.224 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.586 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.5 tt0 -55.39 129.48 38.78 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 123.875 0.734 . . . . 75.23 111.654 -176.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.4 tp -110.4 116.76 32.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.945 -1.025 . . . . 71.02 109.566 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -118.84 101.87 8.38 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.723 -1.214 . . . . 63.42 107.723 172.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 pp -64.4 134.24 54.16 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 109.8 -0.445 . . . . 63.21 109.8 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.28 146.9 94.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.058 0.543 . . . . 62.04 110.46 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.415 ' HA ' ' HE2' ' A' ' 107' ' ' PHE . 36.3 Cg_exo -61.83 115.18 2.64 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.54 2.16 . . . . 54.23 111.38 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.35 121.08 48.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.986 -1.116 . . . . 75.01 107.986 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -71.98 95.81 1.63 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.801 -0.815 . . . . 73.34 108.801 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 94.3 m-85 -60.51 -31.61 70.66 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.67 0.788 . . . . 71.43 111.996 -177.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.66 -50.74 70.02 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.911 0.757 . . . . 61.03 109.921 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.11 90.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.574 0.75 . . . . 62.44 111.064 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.41 -34.18 77.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.738 0.815 . . . . 73.33 111.42 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -73.19 -34.6 66.07 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.187 0.595 . . . . 74.01 110.036 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 123.041 0.536 . . . . 72.22 111.306 -179.539 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 87.7 m . . . . . 0 C--O 1.235 0.321 0 N-CA-C 107.663 -1.236 . . . . 75.13 107.663 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.455 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 30.8 t80 -139.32 138.96 37.13 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.546 -0.909 . . . . 55.22 108.546 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -158.93 141.12 13.88 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.215 0.606 . . . . 73.31 109.674 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.418 HD13 HD11 ' B' ' 16' ' ' ILE . 54.1 mt -83.69 121.98 37.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.989 -1.115 . . . . 64.04 107.989 172.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -94.11 -43.8 8.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.204 0.602 . . . . 61.31 109.401 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.446 HH11 ' HD1' ' A' ' 32' ' ' PHE . 50.0 ttt180 -163.89 132.69 3.77 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.515 -0.766 . . . . 73.31 109.314 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.418 HD11 HD13 ' B' ' 13' ' ' ILE . 96.0 mt -115.02 141.29 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.237 -1.394 . . . . 63.35 107.237 169.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.428 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 33.1 p90 -164.73 157.27 16.44 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.837 0.711 . . . . 74.21 110.735 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.502 HG21 HD11 ' B' ' 21' ' ' ILE . 22.6 m -83.72 122.92 29.29 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.635 -1.246 . . . . 72.15 107.635 168.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.414 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 19.4 mtpp -84.15 -52.82 5.96 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.917 -0.772 . . . . 75.34 108.917 176.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 28.9 t70 -134.96 149.43 50.22 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.687 -0.688 . . . . 63.25 111.256 -170.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.502 HD11 HG21 ' B' ' 18' ' ' THR . 25.7 mm -139.81 144.74 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.528 1.531 . . . . 74.53 108.575 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -147.73 110.99 4.88 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.098 0.873 . . . . 75.44 108.667 166.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.477 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 85.7 t80 -119.81 113.06 20.03 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.204 -1.406 . . . . 72.3 107.204 170.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -122.95 124.23 42.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.611 0.764 . . . . 72.41 109.203 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.49 85.0 12.78 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.162 -1.421 . . . . 71.02 107.162 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.44 -36.83 19.02 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.886 2.39 . . . . 71.01 112.811 -169.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -105.5 17.26 24.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.887 0.875 . . . . 61.44 110.378 -176.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.435 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -41.59 -61.97 1.25 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 115.349 1.611 . . . . 63.52 115.349 -164.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.3 Cg_exo -66.97 -16.06 48.61 Favored 'Trans proline' 0 C--N 1.4 3.287 0 C-N-CA 122.314 2.01 . . . . 55.14 112.372 -170.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -97.73 -49.04 4.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.19 0.996 . . . . 74.11 111.408 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.516 HG22 HD12 ' B' ' 68' ' ' LEU . 9.8 p -64.38 -20.49 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.563 0.745 . . . . 51.23 112.333 -166.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -65.04 -17.76 64.73 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.45 0.908 . . . . 72.23 113.45 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -59.3 -25.52 64.21 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.114 0.566 . . . . 71.34 110.901 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -94.46 80.11 3.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.512 1.125 . . . . 65.35 108.674 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.3 93.25 3.4 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.294 0.569 . . . . 72.02 109.59 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -161.74 158.26 25.56 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.752 1.221 . . . . 70.35 107.988 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -60.43 106.15 0.71 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.903 0.881 . . . . 72.05 110.032 169.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.546 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 35.5 Cg_endo -64.35 124.71 13.79 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.872 1.714 . . . . 73.03 110.497 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -58.15 107.23 0.45 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 123.724 0.64 . . . . 61.42 110.126 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' B' ' 66' ' ' ALA . 28.5 m -96.68 150.52 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.744 0.783 . . . . 74.33 112.535 -173.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -119.42 115.12 23.44 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.253 -1.34 . . . . 64.23 107.657 170.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 mp -85.15 132.22 34.33 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.421 -1.326 . . . . 71.22 107.421 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 14.4 t70 -147.38 110.96 4.95 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 110.135 -0.32 . . . . 75.3 110.135 -177.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 mp -100.57 163.79 12.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.995 0.426 . . . . 72.31 110.211 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 17.7 t70 -158.43 139.25 12.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.712 1.205 . . . . 52.4 108.397 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 47.8 p -133.6 117.73 17.4 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.938 0.495 . . . . 71.53 110.452 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.64 162.8 17.44 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.632 1.173 . . . . 50.24 108.662 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.434 ' HB2' ' HD2' ' B' ' 56' ' ' TYR . 64.1 p -143.22 160.93 39.54 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.184 -0.672 . . . . 71.31 109.184 170.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.0 p -152.16 135.6 16.02 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.509 0.724 . . . . 64.33 109.426 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.33 124.95 29.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.08 0.552 . . . . 43.42 110.215 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 64.6 mt -86.96 -44.68 11.44 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.672 -0.492 . . . . 74.43 109.672 172.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.96 -175.63 5.47 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.675 -0.693 . . . . 62.24 111.098 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.48 124.32 21.02 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.524 -1.216 . . . . 73.04 109.443 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 67.29 19.59 10.2 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.563 1.145 . . . . 72.13 111.663 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -131.27 125.82 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.166 0.986 . . . . 72.22 109.464 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.434 ' HD2' ' HB2' ' B' ' 48' ' ' SER . 0.2 OUTLIER -131.81 140.51 49.18 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.977 -0.749 . . . . 74.34 108.977 174.501 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -112.41 106.67 15.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.982 -1.488 . . . . 73.43 106.982 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.4 t -93.74 140.66 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.921 0.488 . . . . 62.21 109.924 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.3 t -116.77 135.34 57.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 124.41 1.084 . . . . 72.3 109.062 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.07 109.87 16.41 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.82 -1.178 . . . . 74.23 107.82 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.501 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.2 ttt180 -95.38 123.64 39.01 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.813 0.845 . . . . 75.12 109.727 173.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.514 ' HB ' HD11 ' B' ' 114' ' ' ILE . 15.2 t -118.34 123.85 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.347 -0.982 . . . . 64.54 108.347 171.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 39.6 m -107.85 140.78 40.43 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.676 1.19 . . . . 72.42 109.455 -178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.463 HG21 HG21 ' B' ' 114' ' ' ILE . 97.8 t -133.13 100.59 3.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 124.155 0.982 . . . . 64.11 108.715 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 70.8 m -84.0 138.88 32.88 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.023 -1.102 . . . . 52.31 108.023 167.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.554 ' HB2' HG12 ' B' ' 40' ' ' VAL . . . -147.69 149.39 32.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.985 0.357 . . . . 61.14 110.459 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 62.5 p -152.11 135.91 16.3 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.834 0.709 . . . . 70.51 111.541 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.546 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 43.6 mt -103.21 117.35 34.34 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.182 0.993 . . . . 75.12 108.942 173.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.04 -112.69 5.13 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.244 -0.889 . . . . 65.03 112.189 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -115.88 4.21 13.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.691 0.796 . . . . 75.31 111.703 -175.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -118.96 158.72 25.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.591 0.756 . . . . 73.25 110.012 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.5 m -64.56 138.25 58.3 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.615 0.572 . . . . 74.34 110.792 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.448 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -96.71 -65.11 0.99 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.337 -0.847 . . . . 72.21 108.811 171.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -149.82 155.29 39.83 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.368 -0.833 . . . . 74.05 109.721 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 41.4 mt -131.98 108.56 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.232 -1.766 . . . . 64.35 106.232 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.444 ' SG ' HG23 ' B' ' 114' ' ' ILE . 49.4 t -118.82 139.46 51.57 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.693 -0.854 . . . . 44.04 108.693 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -159.69 133.78 7.47 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.29 -0.633 . . . . 65.11 109.29 -173.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.7 t -124.62 146.48 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.126 -0.943 . . . . 73.33 109.019 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 29.1 mt-30 -122.3 84.12 2.21 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.076 -1.083 . . . . 71.15 108.076 171.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -81.75 101.06 9.88 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.721 -1.127 . . . . 73.31 109.473 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -92.2 167.78 30.58 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 111.9 -0.48 . . . . 44.35 111.9 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.87 126.81 1.66 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.109 -0.796 . . . . 54.12 111.109 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 65.6 mt -84.83 127.78 39.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.605 -0.887 . . . . 72.24 108.605 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -134.87 146.36 49.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.153 0.981 . . . . 72.04 108.618 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -99.94 106.9 18.76 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.883 -0.784 . . . . 63.3 108.883 170.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.661 ' HB ' HD11 ' B' ' 89' ' ' ILE . 48.4 pt -116.06 130.41 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.171 0.588 . . . . 62.51 110.239 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -149.52 159.9 43.92 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.559 0.744 . . . . 34.05 110.304 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.99 -54.32 4.73 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.741 -0.663 . . . . 55.41 112.692 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.661 HD11 ' HB ' ' B' ' 86' ' ' ILE . 17.6 pt -54.23 138.56 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.736 1.214 . . . . 65.52 112.798 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -162.8 172.5 15.11 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.793 -1.094 . . . . 71.43 109.749 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.42 -109.93 2.94 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.994 -0.548 . . . . 44.24 112.282 -173.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.2 m -89.61 -26.62 20.68 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.481 0.712 . . . . 63.44 110.946 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.511 ' HB3' HG22 ' B' ' 89' ' ' ILE . 48.5 mt-30 -58.52 -46.08 87.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.394 0.616 . . . . 71.02 110.049 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.416 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 0.0 OUTLIER -70.32 -35.29 73.55 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.584 -1.189 . . . . 65.05 110.507 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.72 -47.85 84.03 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 124.119 0.887 . . . . 62.42 109.954 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -62.24 -27.8 69.25 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.263 -1.335 . . . . 74.21 111.306 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 t -76.06 -66.93 0.73 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.008 0.523 . . . . 72.13 110.888 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 94' ' ' MET . 1.5 pp -71.83 -22.54 61.53 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 112.92 0.711 . . . . 64.41 112.92 -173.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.6 -1.21 53.04 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.553 -0.582 . . . . 33.43 114.058 -175.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.98 -64.43 0.19 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.608 0.704 . . . . 73.01 111.755 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -59.91 -55.03 39.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.314 1.045 . . . . 75.33 112.021 -168.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.482 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 92.1 m -59.52 -52.09 76.6 Favored Pre-proline 0 CA--C 1.568 1.665 0 C-N-CA 124.397 1.079 . . . . 72.05 112.097 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 71.1 Cg_exo -54.92 -40.5 85.23 Favored 'Trans proline' 0 C--N 1.404 3.485 0 C-N-CA 122.433 2.089 . . . . 72.45 114.393 172.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -63.89 -24.18 67.64 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.888 0.699 . . . . 73.43 112.888 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.53 -43.98 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.603 -0.517 . . . . 52.23 109.603 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 60.8 mt -76.71 -21.99 54.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.55 -1.205 . . . . 71.31 112.015 -173.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -60.57 -48.38 93.58 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 118.073 -0.965 . . . . 72.01 113.283 -171.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.28 -39.5 86.54 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.987 1.791 . . . . 63.24 113.277 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -66.57 -45.83 78.03 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.193 0.597 . . . . 75.32 110.684 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.88 -34.75 78.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.278 0.631 . . . . 64.2 111.045 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.721 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 39.1 ttt180 -63.62 -54.33 37.55 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.143 1.377 . . . . 64.11 111.178 -177.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.39 -33.9 76.74 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.716 0.635 . . . . 73.53 109.821 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.499 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.4 t -66.73 -31.52 72.23 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.146 0.578 . . . . 72.3 111.907 -177.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.582 HD12 HD22 ' B' ' 128' ' ' LEU . 80.5 mt -70.45 -58.66 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 109.033 -0.729 . . . . 75.51 109.033 172.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.6 m -59.02 -26.63 64.72 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 124.29 0.994 . . . . 51.42 111.825 -173.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 36.3 t -60.52 -56.6 19.36 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.205 1.002 . . . . 64.54 109.268 173.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.3 mmt -67.48 -34.21 76.69 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.655 0.782 . . . . 75.31 111.375 -173.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 114' ' ' ILE . 94.0 t -59.71 -49.69 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.958 0.903 . . . . 62.45 110.121 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.7 t -66.31 -34.75 78.7 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.651 -1.158 . . . . 60.45 111.363 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.403 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.6 mtt-85 -65.46 -35.84 82.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.388 0.675 . . . . 62.23 110.337 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.52 15.07 53.13 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 123.923 0.764 . . . . 51.12 112.96 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.503 HG23 ' HB3' ' A' ' 17' ' ' TYR . 69.3 p 54.37 26.78 7.33 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.959 1.704 . . . . 73.44 113.608 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -85.3 151.16 56.11 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.357 0.663 . . . . 63.22 110.906 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.61 167.71 1.34 Allowed 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 124.049 3.166 . . . . 64.12 115.315 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -63.85 114.83 4.31 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.036 -0.984 . . . . 65.2 112.548 -167.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 17.0 tp -116.28 98.49 6.62 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 115.432 -0.804 . . . . 64.12 109.501 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -97.37 95.96 8.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.25 -1.018 . . . . 75.43 108.25 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.721 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 31.8 tp -55.18 116.87 3.04 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.352 0.661 . . . . 73.53 110.69 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.62 146.18 88.17 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.886 0.874 . . . . 55.22 111.582 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -76.61 110.71 3.1 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.328 2.685 . . . . 75.5 111.923 -173.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.2 t -90.82 111.0 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 108.576 -0.898 . . . . 74.24 108.576 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -78.75 110.81 14.25 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.68 -0.859 . . . . 60.34 108.68 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -69.5 -48.66 59.86 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.581 0.55 . . . . 71.21 110.619 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -56.95 -40.78 77.08 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.187 0.995 . . . . 73.54 112.442 -171.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.43 -53.84 53.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.211 1.004 . . . . 70.12 111.384 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.5 mp -84.64 -11.98 54.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.493 -0.776 . . . . 74.1 111.664 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 66.7 t80 . . . . . 0 N--CA 1.48 1.026 0 C-N-CA 123.16 0.584 . . . . 53.44 110.272 -179.921 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 32.4 m . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 109.029 -0.73 . . . . 73.31 109.029 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.546 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 3.5 t80 -121.14 124.2 44.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.487 0.715 . . . . 74.1 109.896 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -140.61 140.16 35.03 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.165 -1.05 . . . . 55.33 108.165 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 68.0 mt -85.96 129.74 37.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.159 -0.682 . . . . 74.05 109.159 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.486 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.4 mm100 -87.94 -45.43 10.24 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.64 0.776 . . . . 75.35 109.727 178.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -169.7 148.21 3.59 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.024 -0.534 . . . . 72.44 109.667 -172.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.4 mt -137.58 136.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.747 -1.205 . . . . 73.03 107.747 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.464 ' HB3' HG23 ' D' ' 122' ' ' THR . 28.9 p90 -169.74 161.03 9.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.007 0.432 . . . . 73.13 111.838 -172.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.9 p -80.39 108.06 13.7 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.095 -0.705 . . . . 54.3 109.095 170.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -68.34 -37.3 80.39 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.445 -0.576 . . . . 73.14 109.445 172.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 12.8 t70 -149.78 150.27 31.78 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.49 -0.777 . . . . 65.14 109.83 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.5 mt -141.63 146.94 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.34 1.456 . . . . 61.32 107.62 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -152.19 142.37 22.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.484 0.714 . . . . 73.12 109.563 173.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -142.9 137.86 29.8 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.618 -1.253 . . . . 75.45 107.618 170.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.08 121.68 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.365 1.066 . . . . 74.33 109.293 -172.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.34 69.11 13.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 106.12 -1.807 . . . . 74.41 106.12 165.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.22 -10.35 27.09 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.555 2.17 . . . . 34.4 112.178 -174.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -123.23 26.38 8.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.664 1.585 . . . . 70.35 109.774 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.61 -58.12 4.06 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 114.64 1.348 . . . . 72.31 114.64 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.57 -33.32 46.18 Favored 'Trans proline' 0 C--N 1.388 2.609 0 CA-C-N 121.844 1.694 . . . . 73.03 112.362 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -69.41 -37.53 77.51 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.846 0.859 . . . . 75.11 111.575 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.876 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -79.31 -26.33 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 112.513 0.56 . . . . 74.5 112.513 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.25 -31.87 73.24 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 112.212 0.449 . . . . 64.04 112.212 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -85.79 9.55 16.23 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.542 0.337 . . . . 72.04 111.881 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.62 166.1 11.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.484 0.714 . . . . 54.55 111.037 -175.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -58.2 127.53 32.58 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.003 0.921 . . . . 55.33 110.018 170.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.46 ' NE1' ' HG2' ' C' ' 124' ' ' PRO . 32.9 t90 -84.95 93.24 8.51 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.613 0.765 . . . . 73.21 109.831 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -150.47 78.73 7.59 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 108.51 -0.922 . . . . 74.23 108.51 164.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.501 ' HB3' ' HB1' ' C' ' 66' ' ' ALA . 16.6 Cg_exo -68.56 136.95 37.85 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.681 2.254 . . . . 41.43 112.183 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -86.21 93.43 9.04 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 105.359 -2.089 . . . . 61.21 105.359 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 17.0 m -68.6 131.41 33.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 115.368 -0.833 . . . . 60.1 109.755 -176.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 tptt -134.9 129.62 34.64 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.526 -1.657 . . . . 74.13 106.526 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.55 HD21 HD11 ' C' ' 128' ' ' LEU . 2.8 tm? -116.32 139.68 50.13 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.508 -0.923 . . . . 70.23 108.508 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.549 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.2 t70 -134.4 141.2 46.76 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.453 1.101 . . . . 55.32 108.971 -177.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 79.6 mt -132.11 137.15 47.61 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.309 1.044 . . . . 64.42 108.917 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.509 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 27.3 t70 -144.81 155.23 43.39 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.11 0.964 . . . . 71.13 109.201 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 5.1 m -151.1 138.55 19.51 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.29 1.036 . . . . 62.43 109.577 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.67 173.92 10.17 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.742 1.217 . . . . 62.12 108.926 175.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -159.95 153.95 23.18 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.65 0.78 . . . . 71.14 110.039 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.8 p -155.3 137.54 14.8 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.258 0.623 . . . . 65.54 109.434 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -77.32 118.8 20.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.053 -0.721 . . . . 71.42 109.053 174.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.575 HD11 HD12 ' C' ' 83' ' ' ILE . 54.1 mt -93.35 -43.16 8.92 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.348 -0.612 . . . . 72.33 109.348 176.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -148.79 -177.89 6.05 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.227 -0.897 . . . . 75.12 110.919 -177.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.91 123.8 21.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.722 -1.126 . . . . 73.54 109.101 175.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 61.27 18.81 9.55 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.444 1.098 . . . . 65.01 112.056 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 77.4 t -127.88 103.67 10.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 124.351 1.06 . . . . 64.12 109.238 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.503 ' HD1' HD11 ' C' ' 86' ' ' ILE . 24.7 m-85 -102.3 146.49 27.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.489 -0.778 . . . . 72.25 108.986 169.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.55 ' HB2' HD11 ' C' ' 51' ' ' LEU . 35.0 tt0 -94.35 129.07 41.18 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.408 -1.33 . . . . 70.42 107.408 160.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.408 HG11 ' HD3' ' C' ' 103' ' ' PRO . 42.4 t -106.27 143.4 17.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.993 -1.114 . . . . 74.3 107.993 165.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.0 t -121.28 140.66 44.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 107.931 -1.137 . . . . 75.25 107.931 172.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -129.71 106.97 9.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.553 -1.277 . . . . 72.15 107.553 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.509 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 58.7 ttt-85 -95.41 122.64 38.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.993 -1.458 . . . . 74.23 108.83 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.9 t -117.27 132.35 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.013 -1.106 . . . . 64.5 108.013 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.8 m -134.12 128.95 35.18 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.3 0.64 . . . . 74.22 109.715 -174.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.624 HG23 HD13 ' C' ' 114' ' ' ILE . 61.6 t -115.64 121.03 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.839 0.856 . . . . 74.54 109.712 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.7 m -100.81 145.36 28.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.476 0.71 . . . . 74.53 109.179 170.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 66' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' C' ' 38' ' ' PRO . . . -136.98 131.37 32.85 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.792 -1.188 . . . . 62.01 107.792 169.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.7 m -139.95 129.17 23.83 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 123.598 0.561 . . . . 72.11 110.266 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 37.1 mt -85.22 41.5 0.89 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.319 1.048 . . . . 64.01 109.704 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.73 -104.17 2.54 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 110.053 -1.219 . . . . 54.04 110.053 -170.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -93.8 -29.72 15.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.263 1.025 . . . . 65.52 110.003 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -73.14 120.17 18.4 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.823 0.849 . . . . 71.14 110.268 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 35.7 m -75.88 129.64 37.29 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.568 -0.53 . . . . 51.11 109.568 173.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.876 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.27 -60.95 2.07 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.398 -0.964 . . . . 73.22 108.398 170.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -158.09 173.77 16.23 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 114.417 -1.265 . . . . 63.34 111.436 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -138.89 130.04 26.79 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.572 -1.64 . . . . 70.23 106.572 162.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 46.0 t -128.35 138.73 52.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.946 -1.131 . . . . 74.43 107.946 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 77' ' ' GLU . . . . . 0.415 ' HG2' ' OE1' ' C' ' 79' ' ' GLN . 28.7 tt0 -154.54 129.07 9.19 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.522 -0.548 . . . . 75.52 109.522 -170.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' C' ' 61' ' ' ARG . 97.2 t -135.03 114.3 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.689 0.796 . . . . 54.41 109.921 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.415 ' OE1' ' HG2' ' C' ' 77' ' ' GLU . 1.7 mp0 -90.08 87.84 7.04 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.531 -0.915 . . . . 71.31 108.531 174.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -83.21 98.77 9.55 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.308 -0.86 . . . . 35.34 109.662 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.42 159.49 38.86 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.441 -0.664 . . . . 52.44 111.441 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.582 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -161.25 118.83 0.85 Allowed Glycine 0 CA--C 1.504 -0.614 0 N-CA-C 111.047 -0.821 . . . . 74.31 111.047 -177.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.575 HD12 HD11 ' C' ' 51' ' ' LEU . 6.9 mm -84.1 121.13 36.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.334 -0.987 . . . . 74.2 108.334 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.546 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 57.6 m-85 -126.58 118.46 24.89 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.421 -0.955 . . . . 75.32 108.421 -177.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 54.5 p -87.95 105.87 17.74 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.688 -0.856 . . . . 64.0 108.688 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.608 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -116.97 125.9 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.038 0.935 . . . . 73.22 109.341 -176.674 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.96 163.93 32.05 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.473 0.709 . . . . 43.51 110.697 -172.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.04 -41.99 2.88 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 115.519 -0.764 . . . . 71.14 113.111 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 46.9 mm -122.73 150.4 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.901 0.88 . . . . 70.41 110.421 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.52 -174.22 4.34 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.179 0.992 . . . . 73.41 111.544 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.64 -138.17 25.62 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 115.414 -0.812 . . . . 74.13 113.778 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 53.5 p -61.87 -29.12 69.98 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.152 0.981 . . . . 71.54 111.113 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -70.04 -44.71 68.66 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.471 -1.24 . . . . 75.35 111.326 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -73.7 -30.45 62.88 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 110.17 -0.307 . . . . 64.23 110.17 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.4 81.11 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.134 0.574 . . . . 63.11 109.615 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -72.17 -41.05 67.49 Favored 'General case' 0 C--O 1.241 0.636 0 O-C-N 123.464 0.478 . . . . 71.14 110.935 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -59.5 -38.18 80.23 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.272 0.983 . . . . 70.13 111.119 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 37.4 mt -101.13 -23.48 14.46 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.356 0.662 . . . . 54.55 112.417 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.78 -23.74 57.2 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 116.138 -0.483 . . . . 61.52 114.107 -170.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.64 -43.47 0.1 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.148 0.499 . . . . 62.44 111.034 -171.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -66.34 -42.79 87.61 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.425 1.49 . . . . 75.11 112.729 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 33.8 m -73.76 -43.48 6.61 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-O 118.832 -0.604 . . . . 51.13 112.277 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.408 ' HD3' HG11 ' C' ' 58' ' ' VAL . 84.8 Cg_exo -51.22 -31.83 38.2 Favored 'Trans proline' 0 C--N 1.393 2.873 0 C-N-CA 122.361 2.041 . . . . 73.13 114.201 167.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 104' ' ' ASN . . . . . 0.446 ' ND2' ' HD1' ' C' ' 133' ' ' PHE . 10.1 m120 -64.17 -35.18 79.95 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.854 0.862 . . . . 74.42 111.712 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.467 HD12 ' NH1' ' A' ' 111' ' ' ARG . 50.8 mm -68.43 -38.69 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.281 0.563 . . . . 53.24 109.723 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.582 HD21 ' HA3' ' C' ' 82' ' ' GLY . 90.9 mt -80.56 -22.71 40.53 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.725 -1.125 . . . . 73.55 112.736 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.49 ' HZ ' HD22 ' C' ' 128' ' ' LEU . 45.7 t80 -59.48 -49.73 90.84 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-O 117.75 -1.119 . . . . 75.14 113.631 -173.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -53.02 -36.68 76.91 Favored 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 122.44 2.094 . . . . 72.42 114.006 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -69.3 -52.88 23.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.763 0.825 . . . . 71.32 110.763 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.3 81.66 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.148 -0.933 . . . . 62.21 111.142 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -59.11 -54.96 41.05 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.657 1.583 . . . . 72.51 110.814 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -67.75 -33.72 75.4 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.554 0.742 . . . . 75.41 110.251 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 28.1 t -68.58 -31.84 71.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.03 0.532 . . . . 74.11 111.496 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.624 HD13 HG23 ' C' ' 64' ' ' VAL . 64.2 mt -68.92 -52.44 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.129 -0.487 . . . . 65.14 109.993 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 3.6 m -65.49 -28.83 69.48 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 123.741 0.651 . . . . 72.42 111.24 -174.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 46.3 t -66.53 -49.31 66.92 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 123.771 0.828 . . . . 51.4 109.413 171.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.619 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.09 -40.72 86.16 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.804 1.242 . . . . 65.41 112.917 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.542 HG13 ' HB2' ' C' ' 123' ' ' PHE . 39.2 t -67.75 -42.48 86.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.323 1.049 . . . . 64.45 110.351 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.0 t -70.0 -27.22 64.51 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.716 -0.675 . . . . 51.2 111.154 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.481 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.1 mtt-85 -68.38 -36.85 79.78 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.807 0.843 . . . . 74.33 108.93 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.39 9.26 67.98 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 124.052 0.845 . . . . 51.23 112.834 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 57.0 p 55.52 36.61 27.5 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.614 1.565 . . . . 54.21 113.759 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.542 ' HB2' HG13 ' C' ' 118' ' ' VAL . 97.0 m-85 -96.64 158.03 34.32 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.916 0.887 . . . . 63.42 109.243 172.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.46 ' HG2' ' NE1' ' C' ' 36' ' ' TRP . 34.6 Cg_exo -61.52 157.7 40.21 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 122.993 2.462 . . . . 70.34 113.882 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -60.18 141.24 56.25 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.448 1.099 . . . . 73.23 113.184 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.54 HD22 HG11 ' C' ' 64' ' ' VAL . 0.5 OUTLIER -134.72 96.7 3.6 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.961 -1.018 . . . . 75.3 109.816 170.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -90.65 95.62 10.24 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.288 -1.005 . . . . 75.53 108.288 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.55 HD11 HD21 ' C' ' 42' ' ' LEU . 1.3 tt -60.49 129.36 41.21 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.498 1.119 . . . . 73.03 110.628 -172.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.86 148.72 98.44 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.373 0.669 . . . . 72.54 111.284 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.593 ' HG3' HD12 ' A' ' 16' ' ' ILE . 50.1 Cg_exo -54.29 117.56 4.06 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.783 2.322 . . . . 53.14 112.693 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.35 118.21 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.822 -0.807 . . . . 73.01 108.822 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.91 88.56 4.71 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.089 0.556 . . . . 73.44 109.935 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.446 ' HD1' ' ND2' ' C' ' 104' ' ' ASN . 96.8 m-85 -73.82 -45.25 52.49 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.072 -0.714 . . . . 73.14 109.072 174.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -66.98 -41.64 86.44 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.277 -1.328 . . . . 72.45 111.707 -168.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.86 94.19 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.755 -1.111 . . . . 63.12 112.075 -177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.31 -26.44 46.93 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 116.035 -0.53 . . . . 62.55 112.378 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 11.2 t80 . . . . . 0 N--CA 1.484 1.263 0 C-N-CA 122.717 0.407 . . . . 71.04 110.742 179.404 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 57.5 m . . . . . 0 C--O 1.238 0.461 0 N-CA-C 109.371 -0.603 . . . . 72.13 109.371 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -157.46 96.21 1.52 Allowed 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.879 -1.156 . . . . 70.25 107.879 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -113.67 130.15 56.45 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.292 -1.373 . . . . 63.22 107.292 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.511 HG21 HD11 ' D' ' 16' ' ' ILE . 39.9 mt -73.21 119.28 19.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.503 -0.925 . . . . 71.55 108.503 176.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -87.06 -30.97 20.76 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.462 0.476 . . . . 63.44 110.651 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -176.55 139.59 0.33 Allowed 'General case' 0 C--N 1.369 1.443 0 C-N-CA 122.483 0.313 . . . . 75.53 110.53 -170.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.511 HD11 HG21 ' D' ' 13' ' ' ILE . 3.1 mp -120.89 134.58 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.76 -1.2 . . . . 71.22 107.76 172.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -161.3 172.42 16.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.948 0.88 . . . . 71.0 111.919 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 45.7 p -104.34 124.3 48.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.758 -1.11 . . . . 72.21 109.221 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -94.55 -20.04 19.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.334 0.654 . . . . 73.43 110.186 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.721 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 3.7 t70 -158.66 135.18 9.39 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.139 -1.06 . . . . 34.42 108.139 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.619 HG21 ' HE2' ' C' ' 117' ' ' MET . 72.6 mt -135.9 145.33 31.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.068 -1.086 . . . . 73.33 108.068 175.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -151.21 144.1 24.51 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.897 0.748 . . . . 73.33 109.325 172.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.0 t80 -145.13 115.61 7.62 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 105.939 -1.875 . . . . 73.55 105.939 168.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 22.9 mt-10 -119.86 110.65 16.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.934 -0.765 . . . . 50.21 108.934 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.52 88.36 4.1 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.842 -1.17 . . . . 42.42 107.842 172.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.88 -28.78 7.48 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.744 2.296 . . . . 52.42 112.754 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -114.67 17.97 16.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.517 1.127 . . . . 73.13 109.96 -171.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.63 -67.53 0.33 Allowed Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 114.85 1.426 . . . . 50.31 114.85 -160.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.82 -15.62 23.81 Favored 'Trans proline' 0 C--N 1.39 2.722 0 CA-C-N 122.426 1.902 . . . . 54.1 113.54 -173.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -78.45 -45.2 22.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.45 1.1 . . . . 60.04 110.736 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.04 -24.59 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 CA-C-N 115.986 -0.552 . . . . 71.55 111.617 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -52.87 -31.27 38.61 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 123.797 0.839 . . . . 73.41 113.004 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -53.01 -24.28 9.21 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.627 1.171 . . . . 72.42 111.916 -176.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -83.41 96.38 8.53 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.441 1.096 . . . . 53.33 110.066 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -74.88 83.54 2.19 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.52 0.676 . . . . 63.41 110.078 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 -155.89 156.94 35.5 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.017 1.327 . . . . 73.05 107.915 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -82.21 112.2 34.02 Favored Pre-proline 0 N--CA 1.483 1.198 0 N-CA-C 109.147 -0.686 . . . . 71.32 109.147 173.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.1 124.85 16.87 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.416 2.744 . . . . 73.54 113.917 -173.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -62.1 120.36 10.73 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.021 1.329 . . . . 74.35 110.894 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.543 HG23 HG13 ' D' ' 64' ' ' VAL . 7.2 p -95.43 127.44 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.466 0.65 . . . . 70.14 110.882 -170.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -119.61 106.78 12.51 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 105.988 -1.856 . . . . 72.54 105.988 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.539 ' H ' HD23 ' D' ' 42' ' ' LEU . 1.3 pt? -110.72 134.44 52.47 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.945 0.498 . . . . 71.13 110.612 -170.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.72 126.4 52.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.455 0.702 . . . . 74.3 109.198 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -100.81 137.09 39.67 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.162 0.985 . . . . 74.51 109.75 -175.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.542 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.9 t70 -153.9 139.13 17.49 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.437 -0.949 . . . . 70.24 108.437 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.7 t -117.24 155.65 29.09 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.094 0.473 . . . . 71.12 110.095 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.54 176.22 11.54 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.42 1.088 . . . . 75.43 108.866 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.5 p -174.21 161.36 3.51 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.82 0.448 . . . . 43.14 111.989 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 28.4 t -157.04 124.04 5.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.605 1.162 . . . . 63.03 109.806 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -78.73 123.72 27.46 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.454 -0.573 . . . . 74.14 109.454 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 38.5 mt -94.08 -32.8 13.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.16 0.584 . . . . 71.11 109.954 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.62 -176.73 4.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.775 1.23 . . . . 52.03 108.922 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.71 135.05 36.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.093 -1.077 . . . . 54.42 108.093 171.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 74.28 -0.19 3.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.412 1.485 . . . . 63.44 111.605 -174.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.0 t -129.79 118.54 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.125 0.97 . . . . 72.51 108.782 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -141.86 128.55 20.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.702 -0.481 . . . . 73.12 109.702 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -94.23 140.26 30.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.893 0.877 . . . . 75.25 109.316 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -122.75 138.56 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.971 -1.122 . . . . 73.45 107.971 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.6 t -111.55 143.19 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.541 1.136 . . . . 65.03 108.388 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.51 123.58 41.58 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.506 -0.924 . . . . 71.02 108.506 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.542 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.4 ttm-85 -102.57 96.0 6.61 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.108 -1.071 . . . . 54.32 108.108 176.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 78.2 t -99.47 128.94 50.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.327 -0.99 . . . . 71.24 108.327 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 3.6 m -120.93 144.06 48.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.226 -1.027 . . . . 73.42 108.226 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.543 HG13 HG23 ' D' ' 40' ' ' VAL . 53.3 t -136.66 101.83 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.443 -1.317 . . . . 73.45 107.443 -174.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 88.5 m -107.33 97.69 7.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.17 0.988 . . . . 72.23 108.571 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.08 152.83 18.38 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.817 -0.628 . . . . 75.12 110.958 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.7 m -144.05 130.68 20.11 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.715 -0.675 . . . . 73.41 110.518 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 32.5 mt -91.82 101.09 13.68 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.833 -1.543 . . . . 73.13 106.833 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.71 -128.64 12.74 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.625 0.578 . . . . 61.44 112.383 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.3 5.73 43.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.826 0.85 . . . . 61.44 111.804 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -123.88 140.94 52.49 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.592 0.757 . . . . 73.34 110.604 -171.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.2 m -58.16 125.73 24.44 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.106 0.962 . . . . 71.12 110.721 175.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.476 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.14 -74.72 0.43 Allowed 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.908 -1.145 . . . . 75.35 107.908 175.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 74' ' ' PHE . . . . . 0.499 ' HZ ' HD22 ' D' ' 126' ' ' LEU . 54.4 p90 -140.86 154.3 46.12 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-O 121.543 0.687 . . . . 72.04 110.221 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 39.7 mt -115.86 147.25 41.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.352 -1.722 . . . . 71.4 106.352 172.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.525 ' SG ' HG12 ' D' ' 114' ' ' ILE . 23.5 t -160.25 127.79 4.53 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 109.681 -0.488 . . . . 71.41 109.681 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -142.27 124.14 15.21 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.623 -0.51 . . . . 73.45 109.623 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.19 122.7 62.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 C-N-CA 123.464 0.706 . . . . 72.43 109.641 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.721 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 21.1 mt-30 -88.12 88.92 7.79 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.159 -1.052 . . . . 71.54 108.159 164.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.13 101.0 8.52 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.406 -1.27 . . . . 72.33 108.903 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.74 148.25 20.3 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.853 -0.499 . . . . 53.42 111.853 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.481 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -147.54 128.99 3.07 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 111.371 -0.692 . . . . 62.11 111.371 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.9 mt -91.76 141.75 14.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.547 -0.909 . . . . 71.43 108.547 174.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -139.43 129.47 25.07 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.459 0.703 . . . . 44.11 110.09 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -74.24 99.12 3.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.145 0.578 . . . . 65.45 109.687 168.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 9.4 tt -122.02 118.63 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-O 121.364 0.602 . . . . 44.52 110.9 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.0 167.92 21.03 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.454 1.102 . . . . 54.44 109.31 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.4 24.94 66.88 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-O 119.906 -0.386 . . . . 74.1 113.439 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.28 156.41 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.981 0.912 . . . . 74.25 111.682 -175.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.28 171.73 4.71 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.412 1.085 . . . . 72.32 110.717 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.21 -118.65 12.9 Favored Glycine 0 C--N 1.355 1.629 0 N-CA-C 114.894 0.718 . . . . 74.03 114.894 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.2 m -82.64 -28.96 30.37 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.234 0.614 . . . . 74.02 110.599 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -66.76 -42.36 86.29 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.269 0.628 . . . . 64.42 111.335 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.412 ' O ' ' HB2' ' D' ' 98' ' ' LEU . 25.9 ptt? -62.5 -39.45 93.52 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.878 -0.601 . . . . 53.11 110.244 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.77 74.53 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.543 0.737 . . . . 51.32 110.954 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -67.08 -30.36 70.38 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.76 0.824 . . . . 74.21 110.9 -176.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -79.92 -47.09 15.6 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.717 -0.674 . . . . 62.12 110.304 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' D' ' 94' ' ' MET . 4.7 tt -69.58 -55.25 10.63 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.29 1.036 . . . . 72.25 111.575 -168.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.97 10.82 73.65 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.964 -0.562 . . . . 64.32 114.09 -171.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.689 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -140.14 -65.85 0.45 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 117.346 0.573 . . . . 71.45 111.306 -175.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -70.8 -43.86 67.77 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.376 -0.829 . . . . 72.42 111.776 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -63.51 -50.02 75.11 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 124.012 0.925 . . . . 71.05 112.614 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.21 -21.9 30.78 Favored 'Trans proline' 0 C--N 1.397 3.114 0 C-N-CA 121.865 1.71 . . . . 75.13 112.907 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 104' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' D' ' 100' ' ' ALA . 0.2 OUTLIER -68.53 -32.8 73.0 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.989 0.516 . . . . 72.51 110.21 178.279 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 57.6 mt -67.6 -36.76 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 124.324 1.05 . . . . 62.12 110.643 173.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.481 HD21 ' HA3' ' D' ' 82' ' ' GLY . 89.2 mt -76.11 -18.17 59.28 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.126 -0.943 . . . . 75.33 112.392 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -68.21 -45.36 39.35 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 113.662 0.986 . . . . 74.43 113.662 -173.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -53.24 -38.87 82.1 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.324 2.016 . . . . 71.53 113.702 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -77.99 -33.35 51.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.703 0.801 . . . . 71.22 111.935 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.08 64.58 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.067 -0.716 . . . . 73.42 109.067 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -53.7 -48.08 69.9 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 124.813 1.321 . . . . 72.12 110.602 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.49 -52.13 66.52 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.329 0.652 . . . . 72.52 111.305 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.76 -44.33 77.55 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 124.081 0.863 . . . . 75.24 110.99 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.525 HG12 ' SG ' ' D' ' 76' ' ' CYS . 32.7 mt -62.26 -60.12 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.929 0.892 . . . . 70.01 110.855 174.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 93.7 m -51.67 -39.55 58.44 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.113 1.365 . . . . 75.11 112.214 -173.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 48.4 t -67.08 -44.49 79.92 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.018 -0.992 . . . . 51.0 110.022 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.41 ' HB2' ' HE3' ' D' ' 117' ' ' MET . 72.9 mtm -68.02 -26.41 65.88 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.174 0.59 . . . . 74.3 112.184 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' D' ' 114' ' ' ILE . 80.0 t -67.81 -45.59 83.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.75 0.82 . . . . 73.21 109.784 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.9 p -73.84 -26.85 60.79 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.843 -0.617 . . . . 74.12 111.054 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -70.16 -37.16 75.14 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.613 0.765 . . . . 74.1 109.481 173.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.48 11.2 61.92 Favored Glycine 0 C--N 1.357 1.704 0 O-C-N 123.986 0.804 . . . . 74.24 112.732 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.464 HG23 ' HB3' ' C' ' 17' ' ' TYR . 67.5 p 58.17 16.93 4.21 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 126.815 2.046 . . . . 72.54 115.093 174.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -79.49 146.98 66.97 Favored Pre-proline 0 C--O 1.243 0.719 0 N-CA-C 107.961 -1.125 . . . . 73.42 107.961 166.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.67 138.43 14.67 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 123.534 2.823 . . . . 74.35 112.757 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -64.68 120.04 11.68 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 123.767 0.667 . . . . 65.31 110.49 -174.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.499 HD22 ' HZ ' ' D' ' 74' ' ' PHE . 4.8 mp -104.63 101.96 11.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.959 -0.756 . . . . 72.33 108.959 -176.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -100.64 93.51 5.62 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.437 -0.949 . . . . 74.15 108.437 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.29 133.48 47.03 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.914 0.886 . . . . 71.31 110.23 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.3 137.65 95.6 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.885 0.474 . . . . 43.32 110.657 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.79 130.04 17.45 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.841 2.361 . . . . 64.21 112.339 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.71 140.74 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.423 0.689 . . . . 73.21 110.268 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -97.01 108.37 21.09 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.095 0.958 . . . . 75.33 109.73 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -76.51 -21.11 56.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.371 0.668 . . . . 64.35 111.401 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 134' ' ' ASP . . . . . 0.689 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 9.9 t70 -65.81 -49.91 66.53 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.527 0.731 . . . . 75.12 111.744 -171.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.1 89.87 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.842 0.714 . . . . 74.41 111.372 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.7 mp -81.01 -17.19 51.15 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.535 -1.212 . . . . 75.41 111.732 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 81.8 t80 . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 109.439 -0.578 . . . . 74.42 109.439 173.136 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.7 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 31.3 m . . . . . 0 C--O 1.239 0.538 0 N-CA-C 108.711 -0.848 . . . . 74.13 108.711 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.436 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 16.8 t80 -133.68 121.23 21.66 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.898 -1.149 . . . . 73.05 107.898 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -136.97 112.59 9.4 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.037 -0.727 . . . . 72.35 109.037 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.538 HG12 ' HD2' ' A' ' 84' ' ' PHE . 46.3 mt -81.98 114.96 23.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.42 -0.955 . . . . 72.4 108.42 171.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -80.34 -39.26 28.97 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.475 -0.784 . . . . 72.44 109.686 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -168.16 133.16 1.77 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 116.236 -0.438 . . . . 72.12 111.035 -167.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.449 HD11 HD13 ' A' ' 13' ' ' ILE . 91.5 mt -119.47 132.13 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.289 1.036 . . . . 54.14 108.304 173.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.402 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 24.7 p90 -164.22 176.72 8.94 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.709 0.766 . . . . 73.15 111.427 -171.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.6 p -109.3 118.07 35.72 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.978 -1.01 . . . . 51.14 109.112 177.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 36.9 mtpt -84.87 -26.69 27.18 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.441 -0.345 . . . . 75.41 110.328 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -152.28 132.33 13.45 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.507 -0.769 . . . . 65.25 109.083 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 62.7 mt -128.93 141.81 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.505 -1.294 . . . . 74.13 107.505 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.4 t -151.79 144.21 24.12 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 123.494 0.496 . . . . 72.33 110.831 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.477 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 59.1 t80 -144.6 128.83 17.75 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 106.712 -1.588 . . . . 74.11 106.712 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -135.83 110.72 8.78 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.638 -0.875 . . . . 63.33 108.638 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.84 85.97 8.33 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.99 -1.115 . . . . 63.42 107.99 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.67 -25.76 20.31 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.562 2.175 . . . . 64.33 111.939 -174.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -107.91 31.09 5.77 Favored 'General case' 0 C--O 1.206 -1.2 0 C-N-CA 123.784 0.834 . . . . 71.34 109.846 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -50.95 -53.98 42.12 Favored Pre-proline 0 CA--C 1.577 2.015 0 N-CA-C 113.64 0.978 . . . . 65.23 113.64 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 2.6 Cg_exo -79.58 -20.54 9.31 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.004 1.803 . . . . 75.41 113.106 173.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -88.0 -29.96 20.35 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.786 0.834 . . . . 72.14 112.131 -167.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.43 HG11 ' HE1' ' A' ' 123' ' ' PHE . 9.2 p -76.52 -13.83 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.101 0.96 . . . . 72.44 110.404 -175.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.49 -37.52 75.7 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.104 0.962 . . . . 74.25 110.857 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -73.54 -27.8 61.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.484 -0.78 . . . . 75.42 111.715 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -81.98 151.89 26.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.418 0.687 . . . . 64.12 112.219 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -64.04 140.48 58.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.617 0.767 . . . . 74.23 109.157 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -80.28 80.66 6.68 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.74 0.781 . . . . 64.32 109.474 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -132.84 72.9 76.64 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.862 -1.063 . . . . 73.23 108.716 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -89.67 149.0 5.07 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.535 2.157 . . . . 70.23 112.002 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -96.41 117.73 31.47 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.259 -1.386 . . . . 73.53 107.259 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.79 112.33 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 123.423 0.689 . . . . 75.43 110.376 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 43' ' ' ASP . 25.7 ttpt -114.23 130.78 56.63 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.662 -0.866 . . . . 71.45 108.662 172.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.434 HD22 HD22 ' A' ' 128' ' ' LEU . 69.2 tp -96.46 109.98 22.43 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.663 -1.236 . . . . 73.52 107.663 173.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.446 ' HB2' ' HE3' ' A' ' 41' ' ' LYS . 21.9 t70 -102.99 107.71 18.61 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.086 -1.079 . . . . 62.13 108.086 -177.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -96.64 161.36 13.92 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.675 -0.491 . . . . 75.33 109.675 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.611 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 8.9 t0 -153.34 127.11 8.84 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.141 -0.689 . . . . 63.12 109.141 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -105.74 120.45 41.73 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.868 -0.79 . . . . 73.11 108.868 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.17 153.31 51.91 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.052 0.941 . . . . 43.12 108.759 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.0 m -127.2 156.9 41.11 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.856 0.462 . . . . 72.02 110.874 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 38.1 t -149.23 133.17 17.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.317 0.647 . . . . 72.4 110.139 -171.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -88.05 117.45 26.94 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.83 -0.433 . . . . 63.21 109.83 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 57' ' ' GLU . 48.8 mt -95.57 -36.19 11.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.373 0.669 . . . . 73.24 110.89 -176.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.76 -168.0 0.73 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.984 0.913 . . . . 51.42 111.016 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.26 112.83 3.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.504 1.122 . . . . 74.51 110.856 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 65.39 3.77 2.44 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 124.817 1.247 . . . . 74.1 112.792 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.7 t -104.44 115.28 46.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.051 -1.092 . . . . 53.42 108.051 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.07 168.15 12.73 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.445 -0.946 . . . . 73.11 108.445 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.524 ' HB2' HD11 ' A' ' 51' ' ' LEU . 44.7 tt0 -132.04 147.38 52.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.059 -0.973 . . . . 70.24 108.885 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.433 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 65.4 t -120.87 125.52 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.006 -1.479 . . . . 73.33 107.006 164.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.86 114.62 47.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.123 -1.066 . . . . 75.34 108.123 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.606 HD22 HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -96.69 109.5 22.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.377 -0.972 . . . . 74.33 108.377 178.456 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 66.1 ttp85 -83.17 103.86 12.9 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.592 -0.892 . . . . 62.04 108.592 172.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.707 HG21 ' HB1' ' A' ' 110' ' ' ALA . 2.5 m -103.5 103.81 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.631 0.729 . . . . 55.11 109.228 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 m -103.12 117.05 33.68 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.449 1.1 . . . . 63.23 110.096 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 56.1 t -101.09 109.44 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.834 0.854 . . . . 54.22 109.629 176.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.1 m -103.28 108.49 19.73 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.321 -0.622 . . . . 65.45 109.321 175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.47 106.91 14.51 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.017 0.927 . . . . 64.35 108.763 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 m -140.92 148.33 40.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.939 0.496 . . . . 72.31 110.519 -175.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.15 85.68 2.45 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.982 0.896 . . . . 63.3 109.083 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.14 -106.58 2.4 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 114.421 -1.263 . . . . 62.2 112.424 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -96.4 -26.08 15.47 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.331 1.052 . . . . 72.41 110.6 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -92.73 109.17 20.59 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.821 0.849 . . . . 75.13 109.682 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.8 m -72.7 123.88 24.19 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.323 -0.621 . . . . 70.33 109.323 171.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -58.33 5.7 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.065 0.853 . . . . 74.23 108.8 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -158.85 155.77 28.41 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.233 -1.349 . . . . 75.33 109.721 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 64' ' ' VAL . 64.0 tp -126.92 138.21 53.26 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.789 -1.189 . . . . 52.41 107.789 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.565 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 73.7 m -134.43 139.99 45.94 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.095 -1.076 . . . . 73.34 108.095 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -149.35 125.59 10.78 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 117.818 0.281 . . . . 63.55 110.251 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.88 112.0 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.771 0.829 . . . . 72.21 109.819 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.409 ' OE1' ' HG3' ' A' ' 61' ' ' ARG . 2.4 mp0 -87.29 84.32 7.24 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.473 -0.936 . . . . 73.33 108.473 173.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.414 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.2 tp-100 -76.65 95.31 3.94 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 114.629 -1.169 . . . . 73.11 108.678 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.28 143.92 17.21 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.073 -0.811 . . . . 60.51 111.073 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.54 130.87 4.25 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.115 -0.794 . . . . 62.23 111.115 -177.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.0 mt -81.93 123.36 38.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.73 -0.841 . . . . 74.12 108.73 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.538 ' HD2' HG12 ' A' ' 13' ' ' ILE . 32.1 m-85 -130.81 137.38 49.4 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.852 -0.796 . . . . 74.15 108.852 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 m -97.19 116.46 29.44 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.037 -0.727 . . . . 75.33 109.037 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.78 135.15 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.062 -1.088 . . . . 74.42 108.062 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.7 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -164.0 136.72 5.1 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.001 0.921 . . . . 61.5 109.182 169.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.65 -16.38 60.89 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 114.664 0.626 . . . . 33.03 114.664 173.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.512 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -114.03 135.4 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 117.645 0.722 . . . . 72.3 109.734 178.032 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -140.53 172.47 12.68 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.104 0.962 . . . . 73.01 109.998 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.69 -123.78 33.1 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.036 0.835 . . . . 64.2 114.57 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.1 p -78.35 -27.59 47.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.216 1.007 . . . . 63.35 111.583 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -68.34 -36.57 79.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.813 0.845 . . . . 75.3 109.97 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 48.3 ttm -69.44 -41.98 75.55 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 116.056 -0.52 . . . . 71.02 110.203 171.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.54 -30.12 69.56 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.988 0.515 . . . . 73.02 111.421 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -71.63 -36.43 70.75 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.244 0.618 . . . . 75.3 110.97 173.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.562 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 99.6 m -67.12 -63.09 1.13 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.815 0.446 . . . . 70.11 111.59 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.15 -17.92 61.33 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.273 0.471 . . . . 73.1 112.273 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.01 -11.96 38.23 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.262 -0.743 . . . . 63.11 114.415 -175.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.04 -52.56 0.19 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.153 0.976 . . . . 74.43 112.965 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.562 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 28.2 t80 -63.37 -56.37 16.9 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.752 1.221 . . . . 74.24 111.491 -172.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.8 m -77.67 -35.41 1.27 Allowed Pre-proline 0 CA--C 1.565 1.555 0 N-CA-C 113.245 0.832 . . . . 62.33 113.245 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.83 -39.73 57.85 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.364 2.043 . . . . 74.11 113.19 163.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -64.06 -35.16 79.82 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.073 0.549 . . . . 74.22 111.376 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.53 HG21 ' CD1' ' A' ' 13' ' ' ILE . 51.0 mm -63.25 -42.24 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.787 0.835 . . . . 72.04 110.645 176.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.414 HD22 ' HG3' ' A' ' 80' ' ' GLN . 85.5 mt -72.57 -30.06 64.09 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.08 -0.964 . . . . 72.21 112.068 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -58.36 -44.21 98.94 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 114.6 1.334 . . . . 63.14 114.6 -170.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.68 -39.84 84.5 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.191 1.927 . . . . 62.3 114.115 173.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -72.88 -40.0 65.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.231 0.613 . . . . 74.42 111.228 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.707 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.68 -40.1 88.4 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.525 -0.761 . . . . 74.43 110.489 176.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.435 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.3 ttm180 -54.15 -50.66 66.44 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.554 1.159 . . . . 75.21 110.292 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -66.86 -42.69 85.26 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.14 0.9 . . . . 72.41 111.559 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.579 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.2 t -61.46 -24.66 66.71 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.228 0.611 . . . . 74.01 111.622 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.434 HG21 HG21 ' A' ' 64' ' ' VAL . 96.7 mt -87.29 -44.19 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.4 1.08 . . . . 71.03 110.897 174.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 125' ' ' GLN . 87.7 m -62.64 -40.58 97.45 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.451 0.643 . . . . 74.23 111.244 -174.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.0 t -70.72 -41.01 72.46 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.191 -0.913 . . . . 73.53 109.595 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.477 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.2 ttm -58.4 -48.94 79.05 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.598 1.159 . . . . 73.35 112.079 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.73 -33.78 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.523 0.729 . . . . 64.31 110.734 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.4 t -72.71 -28.44 62.67 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.755 0.822 . . . . 71.5 111.191 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.1 mtt-85 -75.17 -30.24 60.66 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.545 0.738 . . . . 72.1 110.138 175.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.54 -2.17 79.27 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.794 0.684 . . . . 43.14 112.703 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.9 m 69.4 14.67 8.44 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.057 1.343 . . . . 54.43 111.596 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.43 ' HE1' HG11 ' A' ' 31' ' ' VAL . 94.0 m-85 -82.35 152.59 67.75 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 108.572 -0.899 . . . . 61.35 108.572 169.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.12 150.1 10.96 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.266 2.644 . . . . 74.25 114.064 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.7 tt0 -61.37 136.46 58.05 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.763 -0.653 . . . . 51.53 111.438 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.8 tp -117.01 102.02 8.99 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.824 -1.08 . . . . 73.24 108.857 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -97.96 104.33 16.35 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.948 -1.131 . . . . 74.1 107.948 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.434 HD22 HD22 ' A' ' 42' ' ' LEU . 89.8 mt -64.08 130.29 43.39 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.575 0.547 . . . . 62.32 109.797 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.28 138.53 97.18 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 119.086 -0.483 . . . . 74.05 110.268 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.07 115.52 2.55 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.472 2.115 . . . . 54.44 112.403 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.65 113.21 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.671 -1.233 . . . . 71.41 107.671 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -88.97 85.25 6.68 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.677 -0.86 . . . . 73.42 108.677 -175.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.509 ' HA ' HD12 ' A' ' 136' ' ' LEU . 93.1 m-85 -58.57 -32.64 69.11 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.52 1.128 . . . . 74.42 112.607 -174.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.41 -47.75 80.68 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.455 -0.793 . . . . 51.22 111.319 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.46 77.78 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.636 0.585 . . . . 50.35 109.997 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 133' ' ' PHE . 76.2 mt -54.95 -41.14 70.74 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 124.731 1.269 . . . . 75.35 112.238 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -74.78 -34.64 62.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.99 -0.55 . . . . 64.15 110.437 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 8.5 mmt . . . . . 0 N--CA 1.48 1.062 0 C-N-CA 122.567 0.347 . . . . 52.53 110.49 177.837 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 87.7 m . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 108.054 -1.091 . . . . 74.42 108.054 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -144.76 135.36 24.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.012 0.525 . . . . 73.13 109.939 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -154.45 125.46 7.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.819 0.848 . . . . 75.24 109.053 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.511 HD11 HD13 ' B' ' 105' ' ' ILE . 17.9 mt -77.97 118.4 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.606 -0.887 . . . . 43.52 108.606 171.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -91.49 -39.52 11.9 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.868 -0.419 . . . . 50.2 109.868 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -166.88 138.29 3.32 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.756 0.66 . . . . 72.33 109.731 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.416 HD11 HD13 ' B' ' 13' ' ' ILE . 96.7 mt -115.73 145.24 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 106.878 -1.527 . . . . 64.22 106.878 169.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -169.52 168.24 9.41 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.578 0.704 . . . . 64.3 111.578 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 86.4 m -96.51 131.92 42.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.251 -0.886 . . . . 62.41 108.668 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.424 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.8 mtpt -96.58 -36.31 10.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.497 0.719 . . . . 74.22 109.979 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -152.48 145.25 24.33 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.024 -0.534 . . . . 71.2 110.91 -172.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 41.3 mm -134.46 145.18 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.755 1.222 . . . . 73.0 109.104 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 23.0 t -145.94 134.63 22.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.128 -0.942 . . . . 73.43 108.896 172.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.457 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.4 t80 -149.3 109.77 4.21 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.885 -1.154 . . . . 74.1 107.885 170.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -117.3 114.77 24.07 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.542 -0.91 . . . . 71.02 108.542 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.7 87.61 2.92 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 107.848 -1.167 . . . . 74.54 107.848 169.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.65 -51.76 4.63 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.905 2.403 . . . . 65.04 112.462 -171.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -98.2 23.17 8.57 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.578 0.751 . . . . 53.1 110.957 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -33.17 -67.06 0.2 Allowed Pre-proline 0 N--CA 1.498 1.925 0 C-N-CA 125.327 1.451 . . . . 73.45 114.64 -168.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.93 -20.78 57.75 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.348 2.032 . . . . 50.42 113.013 -172.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -96.57 -28.47 14.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.889 0.876 . . . . 73.2 112.16 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' B' ' 73' ' ' ALA . 10.7 p -83.22 -18.35 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 122.633 0.373 . . . . 71.44 111.117 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -66.39 -15.34 63.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.102 0.779 . . . . 72.31 113.102 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.483 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -62.64 -24.52 67.65 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 120.935 0.398 . . . . 70.13 110.753 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.59 ' HB2' HD13 ' B' ' 68' ' ' LEU . 89.8 mttt -96.17 101.39 13.03 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.477 1.111 . . . . 75.33 109.498 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.61 80.9 5.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.498 0.719 . . . . 71.41 109.692 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -154.17 158.91 41.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.113 -0.949 . . . . 75.54 108.682 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -75.79 108.5 6.03 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 124.081 0.952 . . . . 64.13 109.929 174.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.598 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 43.3 Cg_endo -66.72 150.02 83.61 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.918 2.412 . . . . 74.33 112.778 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -58.66 108.11 0.6 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.686 0.616 . . . . 73.23 110.771 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.463 HG13 HG13 ' B' ' 64' ' ' VAL . 81.4 t -89.86 120.99 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.975 -1.011 . . . . 51.24 110.28 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -108.07 128.95 55.13 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.703 -1.221 . . . . 70.21 107.703 168.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.575 HD22 HD11 ' B' ' 128' ' ' LEU . 40.5 tp -90.7 148.44 22.6 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.831 -0.433 . . . . 73.12 109.831 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -148.11 141.11 24.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.393 1.077 . . . . 74.35 108.167 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 96.0 mt -135.42 142.74 45.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.484 0.714 . . . . 74.25 109.783 -175.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 6.2 m-20 -132.08 110.29 10.6 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.898 -1.149 . . . . 73.31 107.898 165.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 23.6 p -109.84 100.07 9.11 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.767 -0.827 . . . . 74.51 108.767 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.63 116.36 23.7 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.473 0.709 . . . . 51.13 109.28 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.408 ' HB3' HG22 ' B' ' 58' ' ' VAL . 20.2 p -100.84 162.78 12.67 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.949 0.9 . . . . 75.01 109.282 176.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.5 p -150.11 170.63 18.46 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.504 0.721 . . . . 61.31 109.641 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -113.45 107.67 16.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.499 0.72 . . . . 61.12 109.719 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.97 -38.15 64.28 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.955 0.502 . . . . 71.35 110.06 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -161.69 177.78 9.63 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.66 -1.154 . . . . 32.31 109.991 -174.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -63.48 119.21 9.32 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.704 -0.48 . . . . 63.13 109.704 174.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 71.99 -3.01 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.854 1.262 . . . . 73.34 112.779 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 97.8 t -105.09 112.5 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.812 -0.81 . . . . 71.33 108.812 175.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -126.94 139.64 52.91 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.151 0.58 . . . . 74.43 109.748 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -120.53 106.94 12.27 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.867 -0.79 . . . . 71.01 108.867 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' B' ' 48' ' ' SER . 96.7 t -92.91 122.44 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.656 1.182 . . . . 74.13 111.028 -177.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.83 115.03 45.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.726 -0.472 . . . . 74.03 109.726 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.22 120.27 37.27 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.579 -1.267 . . . . 72.55 107.579 174.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.447 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 13.4 ttm180 -109.0 127.74 54.34 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.23 -0.655 . . . . 71.44 109.23 172.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.49 103.73 14.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.038 -1.097 . . . . 71.45 108.038 174.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -102.61 130.81 49.6 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.393 -0.595 . . . . 63.04 109.393 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.613 HG11 HD21 ' B' ' 126' ' ' LEU . 92.1 t -122.37 112.48 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.359 1.063 . . . . 72.34 109.241 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.2 m -92.8 138.15 31.74 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.568 0.747 . . . . 32.43 109.361 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.76 142.88 24.09 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.813 0.445 . . . . 71.0 111.249 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.489 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 21.5 p -153.36 133.69 13.5 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.571 0.582 . . . . 73.13 112.571 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.598 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 52.8 mt -100.12 122.4 42.92 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.531 1.132 . . . . 64.23 111.183 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.25 -110.84 3.72 Favored Glycine 0 C--N 1.342 0.892 0 O-C-N 123.906 0.754 . . . . 62.24 113.042 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.09 5.27 20.04 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.616 0.766 . . . . 73.05 111.551 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -129.13 159.25 36.59 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.851 0.46 . . . . 64.31 110.74 -175.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 61.9 m -75.38 138.26 41.6 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.131 0.491 . . . . 72.13 110.706 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.589 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.57 -71.46 0.65 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.114 -1.069 . . . . 72.12 108.114 176.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -146.4 144.39 29.69 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.761 -0.654 . . . . 74.14 110.203 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.9 mt -123.41 112.46 17.57 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 106.656 -1.609 . . . . 73.31 106.656 174.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.497 ' SG ' HG23 ' B' ' 114' ' ' ILE . 35.6 t -116.93 154.95 29.94 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.071 -0.715 . . . . 74.34 109.071 -178.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.7 tt0 -163.97 137.22 5.31 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.012 -0.736 . . . . 63.3 109.012 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 75.4 t -133.71 146.01 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.267 1.027 . . . . 73.25 108.744 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -122.2 95.8 4.79 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.905 -0.776 . . . . 75.14 108.905 170.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -85.56 98.98 10.95 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.92 -0.771 . . . . 74.14 108.92 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.424 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -93.08 143.1 16.28 Favored Glycine 0 C--N 1.343 0.952 0 N-CA-C 111.187 -0.765 . . . . 72.32 111.187 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.417 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -143.52 127.0 2.93 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 112.165 -0.374 . . . . 61.24 112.165 -173.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 51.3 mt -85.93 127.91 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 109.11 -0.7 . . . . 74.44 109.11 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.33 157.21 47.49 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.818 1.247 . . . . 64.25 108.465 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 68.5 m -117.75 100.36 7.55 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.392 0.677 . . . . 71.34 109.41 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.536 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.5 pp -111.11 137.36 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.862 0.465 . . . . 53.21 110.001 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.55 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -154.53 166.91 31.82 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.015 0.926 . . . . 54.55 110.12 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.27 -59.27 4.81 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 111.46 -0.656 . . . . 75.33 111.46 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.536 HD11 ' HB ' ' B' ' 86' ' ' ILE . 15.4 pt -63.2 139.45 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 124.428 1.091 . . . . 42.12 110.892 171.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -152.14 151.41 31.01 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.315 0.646 . . . . 73.3 110.2 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.65 -111.86 4.11 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.959 -0.456 . . . . 25.54 111.959 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -80.53 -25.01 38.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.379 0.672 . . . . 70.24 110.812 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -68.79 -35.64 77.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.765 -0.652 . . . . 74.13 110.133 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -85.92 -23.57 26.94 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.598 -0.728 . . . . 65.35 110.598 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.02 77.19 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.967 0.413 . . . . 72.01 110.769 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 30.4 t-80 -68.3 -27.05 65.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.33 0.652 . . . . 74.35 110.823 176.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.437 ' SG ' HG21 ' B' ' 86' ' ' ILE . 18.9 t -81.19 -68.5 0.68 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.479 -0.563 . . . . 71.11 109.479 176.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.534 HD21 HG12 ' B' ' 86' ' ' ILE . 23.9 mt -69.57 -22.44 63.54 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.888 0.699 . . . . 73.01 112.888 -171.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.89 -11.17 47.41 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-O 119.53 -0.594 . . . . 44.44 113.772 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -138.37 -58.86 0.64 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.659 0.73 . . . . 43.44 112.317 -173.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -72.51 -41.69 65.63 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.941 0.496 . . . . 74.14 111.935 -172.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 86.3 m -68.66 -47.65 33.43 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.066 0.947 . . . . 72.14 111.489 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -56.78 -31.33 87.94 Favored 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 122.143 1.895 . . . . 70.42 113.582 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -62.34 -38.74 90.65 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 123.373 0.669 . . . . 73.22 110.673 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.511 HD13 HD11 ' B' ' 13' ' ' ILE . 68.0 mt -69.34 -44.11 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.789 0.836 . . . . 73.23 110.617 175.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.417 HD21 ' HA3' ' B' ' 82' ' ' GLY . 59.5 mt -73.64 -20.17 60.65 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.327 -0.851 . . . . 74.34 111.776 -176.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -62.33 -49.44 84.04 Favored Pre-proline 0 N--CA 1.481 1.105 0 N-CA-C 114.748 1.388 . . . . 71.51 114.748 -169.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.27 -32.19 82.07 Favored 'Trans proline' 0 C--N 1.377 2.077 0 CA-C-N 121.384 1.53 . . . . 73.3 112.474 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -66.58 -48.49 69.43 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.069 0.548 . . . . 72.13 110.363 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.05 -41.15 87.19 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.203 -0.908 . . . . 74.54 110.747 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -60.35 -56.29 23.22 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.487 1.115 . . . . 75.35 111.102 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.88 -35.29 80.67 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.032 0.533 . . . . 74.43 110.266 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.6 t -66.87 -37.44 84.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.879 0.472 . . . . 63.54 111.209 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.497 HG23 ' SG ' ' B' ' 76' ' ' CYS . 50.3 mt -63.22 -52.32 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.879 0.472 . . . . 74.13 110.05 172.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.451 HG21 ' OG ' ' C' ' 119' ' ' SER . 21.0 m -59.83 -31.94 70.2 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.885 0.874 . . . . 74.32 111.591 -177.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.8 t -64.8 -49.13 71.86 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.406 -0.816 . . . . 72.45 109.766 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -68.88 -31.77 70.94 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.078 0.551 . . . . 74.41 111.342 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.52 -43.71 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.776 0.83 . . . . 65.25 110.065 172.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.434 ' HA ' ' NE2' ' C' ' 125' ' ' GLN . 47.1 t -68.45 -31.91 71.56 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.642 -0.708 . . . . 71.24 111.499 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.579 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 76.1 mtt-85 -68.03 -41.85 81.47 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.894 -0.593 . . . . 71.23 109.728 176.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.62 1.24 86.55 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.704 0.627 . . . . 73.15 113.12 173.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 26.4 p 60.87 26.64 16.5 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.404 1.882 . . . . 71.42 113.822 171.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -80.09 162.3 62.41 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 123.819 0.848 . . . . 73.55 111.443 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -55.22 158.51 11.86 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 123.263 2.642 . . . . 72.34 113.242 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -58.81 134.51 56.94 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.148 -0.933 . . . . 64.43 112.528 -171.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.613 HD21 HG11 ' B' ' 64' ' ' VAL . 30.9 tp -130.2 109.99 11.23 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.314 -0.857 . . . . 65.12 108.976 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -122.11 120.05 33.13 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.303 -0.999 . . . . 74.54 108.303 171.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.575 HD11 HD22 ' B' ' 42' ' ' LEU . 39.6 tp -84.72 136.22 33.81 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.71 0.404 . . . . 74.42 109.975 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.35 145.08 84.95 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.885 0.874 . . . . 60.42 111.462 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.77 130.16 35.6 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.159 2.573 . . . . 74.54 113.064 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.15 113.16 28.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 114.807 -1.088 . . . . 55.33 108.381 172.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -74.47 79.83 1.93 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.163 -1.421 . . . . 72.32 107.163 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -54.7 -38.59 67.22 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.481 0.713 . . . . 74.04 111.24 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.94 -43.13 77.12 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.354 1.062 . . . . 75.52 111.742 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.97 38.83 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.935 0.894 . . . . 75.5 111.437 -176.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -79.54 -22.28 44.08 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 116.4 -0.364 . . . . 73.52 111.203 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 73.1 t80 . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 109.943 -0.392 . . . . 70.12 109.943 178.914 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.615 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 89.5 m . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 108.125 -1.065 . . . . 60.53 108.125 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.497 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.5 t80 -108.6 122.87 47.99 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.735 -0.839 . . . . 75.04 108.735 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -136.67 128.28 28.74 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.493 -0.929 . . . . 75.04 108.493 172.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.454 HD13 HD11 ' C' ' 16' ' ' ILE . 61.1 mt -71.64 124.45 28.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.645 -0.872 . . . . 74.02 108.645 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -88.84 -46.42 8.96 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.098 0.559 . . . . 73.53 109.558 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -172.31 125.57 0.52 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.95 -0.568 . . . . 72.2 110.329 -171.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.454 HD11 HD13 ' C' ' 13' ' ' ILE . 91.3 mt -109.93 141.37 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 107.946 -1.131 . . . . 72.24 107.946 176.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.506 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 25.8 p90 -175.71 174.99 2.12 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.421 0.629 . . . . 71.31 110.775 -171.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -104.09 124.97 50.02 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.569 -0.741 . . . . 72.25 109.065 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.506 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 27.4 mmtp -69.88 -49.72 49.52 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.755 -1.202 . . . . 73.13 107.755 168.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -139.2 142.46 37.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 113.253 -1.794 . . . . 72.14 109.172 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.579 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.6 mt -138.79 142.67 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.292 -1.373 . . . . 41.03 107.292 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.1 t -156.81 150.44 24.54 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.459 0.647 . . . . 63.24 110.624 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.434 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 89.4 t80 -141.75 124.94 16.37 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.433 -1.321 . . . . 74.51 107.433 172.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 39.3 mt-10 -122.21 111.74 17.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.664 0.786 . . . . 65.12 109.516 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.92 82.04 69.18 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 107.641 -1.244 . . . . 71.45 107.641 170.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.1 -29.55 11.64 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.388 2.059 . . . . 73.41 111.824 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -99.38 19.41 15.59 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.842 0.857 . . . . 73.3 110.04 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.443 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -47.84 -55.16 18.62 Favored Pre-proline 0 CA--C 1.561 1.366 0 N-CA-C 113.793 1.034 . . . . 63.43 113.793 -171.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.513 ' HB3' HD13 ' D' ' 51' ' ' LEU . 36.3 Cg_exo -60.62 -43.39 32.94 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 121.644 1.562 . . . . 64.2 112.284 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -69.84 -30.09 67.5 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 113.861 -1.518 . . . . 73.34 112.663 -174.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.732 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.6 p -82.0 -22.06 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 112.282 0.475 . . . . 61.23 112.282 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -71.44 -23.94 61.93 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 122.246 -0.284 . . . . 73.35 111.706 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -87.19 10.58 16.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.33 0.652 . . . . 72.11 110.946 174.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.702 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -106.56 159.93 15.81 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.929 0.892 . . . . 51.21 109.818 176.081 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -73.11 121.24 19.9 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.503 0.721 . . . . 74.53 109.479 167.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -84.87 95.84 9.14 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.019 0.528 . . . . 73.11 110.171 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -142.74 75.98 17.85 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 108.162 -1.051 . . . . 71.44 108.162 166.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -87.24 156.18 8.19 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.898 2.398 . . . . 70.13 113.569 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.37 118.89 27.11 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 113.731 -1.577 . . . . 73.41 108.386 173.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.41 101.59 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 122.934 0.494 . . . . 62.54 110.003 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.476 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 2.3 mptp? -91.39 102.69 15.38 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 106.427 -1.694 . . . . 74.45 106.427 169.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 50.1 tp -97.26 126.22 42.33 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.112 0.565 . . . . 73.32 110.086 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -120.38 136.13 54.81 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.366 1.066 . . . . 62.41 108.963 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.78 132.28 54.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.048 0.939 . . . . 72.45 108.657 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -130.76 151.65 50.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.176 0.991 . . . . 75.33 108.852 169.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -149.89 144.14 25.73 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.073 -0.714 . . . . 72.13 109.073 169.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.55 149.05 43.42 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.617 0.767 . . . . 73.04 108.939 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 28.5 p -127.21 142.78 51.4 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.346 0.658 . . . . 73.21 110.397 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.7 t -145.2 128.06 16.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.955 0.902 . . . . 72.31 109.369 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -70.34 119.68 14.89 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.522 0.729 . . . . 53.22 109.728 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.576 HD11 HD12 ' C' ' 83' ' ' ILE . 51.1 mt -92.3 -29.9 16.13 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.999 0.519 . . . . 61.14 109.753 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.35 179.22 7.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.429 1.092 . . . . 64.25 110.097 176.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.68 123.32 17.62 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.597 -0.729 . . . . 64.45 109.292 175.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.99 19.42 11.85 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.177 0.923 . . . . 74.04 111.706 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.69 115.31 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.695 -0.854 . . . . 74.35 108.695 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.504 ' HD2' HD11 ' C' ' 86' ' ' ILE . 1.0 OUTLIER -115.38 157.94 23.17 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.578 0.751 . . . . 72.21 109.057 175.182 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' C' ' 48' ' ' SER . 22.5 tt0 -116.34 120.45 38.91 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.334 -1.303 . . . . 54.31 107.506 170.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.4 t -107.75 135.22 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.606 -0.887 . . . . 62.03 108.606 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.57 108.45 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.918 -0.771 . . . . 73.01 108.918 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.57 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -86.45 108.7 18.63 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.519 -1.289 . . . . 75.4 107.519 175.792 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.5 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 24.0 ttm180 -95.94 119.64 34.8 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.435 -0.95 . . . . 74.24 108.435 173.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.497 ' HB ' HD11 ' C' ' 114' ' ' ILE . 29.1 t -111.94 130.95 64.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.01 -1.107 . . . . 72.43 108.01 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 13.3 m -126.92 121.73 32.58 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.654 -0.869 . . . . 71.43 108.654 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.688 HG11 HD21 ' C' ' 126' ' ' LEU . 22.1 t -112.19 116.7 53.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.244 -0.65 . . . . 64.42 109.244 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 3.5 m -102.1 137.32 40.52 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.543 -0.91 . . . . 74.24 108.543 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.1 118.62 21.78 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.307 -0.997 . . . . 64.32 108.307 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 13.3 m -133.58 130.64 38.67 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.521 0.513 . . . . 74.34 110.664 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.702 HD13 ' HG2' ' C' ' 34' ' ' LYS . 25.6 mt -86.81 45.63 1.28 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.238 1.415 . . . . 61.23 109.796 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.09 -85.21 0.49 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 110.476 -1.05 . . . . 65.25 110.476 -171.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.42 -29.13 5.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.486 0.715 . . . . 51.05 110.496 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 8.2 tp10 -63.17 118.72 8.33 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.072 0.949 . . . . 73.11 109.918 175.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -74.31 117.72 16.44 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.532 -0.914 . . . . 71.44 108.532 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.732 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.68 -55.05 7.4 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.333 -0.988 . . . . 74.23 108.333 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -164.99 163.46 20.76 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.91 -1.041 . . . . 74.34 110.288 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -130.31 142.43 50.54 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 105.803 -1.925 . . . . 74.21 105.803 172.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.481 ' SG ' HG23 ' C' ' 114' ' ' ILE . 50.1 t -144.63 142.91 30.47 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.316 -0.994 . . . . 73.12 108.316 174.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -150.29 127.82 11.53 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.433 -0.58 . . . . 74.23 109.433 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 74.8 t -127.73 136.23 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.559 1.144 . . . . 60.01 108.267 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.5 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 69.7 mt-30 -109.59 87.35 2.48 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.121 -1.066 . . . . 74.33 108.121 174.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -78.21 96.9 5.33 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.341 -0.845 . . . . 52.51 109.251 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.2 146.45 21.09 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.327 -0.851 . . . . 73.2 112.399 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.493 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.27 118.11 0.9 Allowed Glycine 0 C--O 1.238 0.373 0 N-CA-C 110.958 -0.857 . . . . 63.3 110.958 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.576 HD12 HD11 ' C' ' 51' ' ' LEU . 15.5 mm -82.22 131.29 34.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.725 -0.843 . . . . 62.04 108.725 176.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -134.75 120.06 18.98 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 123.615 0.572 . . . . 72.14 110.083 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.0 p -79.72 106.16 11.54 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.153 -1.055 . . . . 62.52 108.153 170.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.504 HD11 ' HD2' ' C' ' 56' ' ' TYR . 2.3 pp -116.11 142.82 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.178 0.991 . . . . 71.3 109.98 -172.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -149.88 158.21 43.94 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.884 0.474 . . . . 53.42 110.607 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.55 -29.01 6.46 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.218 -0.447 . . . . 63.12 113.963 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.639 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -84.67 164.68 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.123 0.569 . . . . 73.41 111.401 -176.306 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -164.55 148.48 9.28 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.879 0.872 . . . . 72.42 109.205 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.88 -115.07 7.43 Favored Glycine 0 C--N 1.351 1.389 0 O-C-N 123.79 0.681 . . . . 73.13 114.516 170.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 70.4 p -79.88 -26.99 40.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.783 0.833 . . . . 54.11 110.906 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.34 -38.8 85.45 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.455 0.702 . . . . 73.22 109.746 173.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 40.4 ttp -73.11 -38.99 66.14 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.811 -0.632 . . . . 65.3 110.464 174.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 -40.69 85.51 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 123.776 0.672 . . . . 52.41 110.588 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.407 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 12.7 t-80 -79.1 -34.1 43.83 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 123.576 0.548 . . . . 72.13 112.029 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -53.96 -41.76 68.16 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.634 0.584 . . . . 74.21 110.533 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.99 -14.65 17.76 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.309 -0.859 . . . . 51.33 110.954 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.16 -21.9 64.25 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 114.086 0.395 . . . . 62.12 114.086 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.27 -45.03 0.09 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.489 0.552 . . . . 63.24 112.489 -171.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -67.54 -48.99 65.4 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.315 0.385 . . . . 72.33 111.439 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.497 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 94.5 m -64.58 -49.56 69.95 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 118.714 -0.66 . . . . 53.04 111.895 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.57 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 75.1 Cg_exo -56.55 -30.22 81.93 Favored 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 122.259 1.973 . . . . 63.24 114.309 170.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -64.64 -41.03 96.42 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.594 0.758 . . . . 62.53 110.589 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.435 HD12 ' NH1' ' A' ' 111' ' ' ARG . 39.3 mm -61.08 -45.23 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.557 -0.747 . . . . 71.04 110.173 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.493 HD21 ' HA3' ' C' ' 82' ' ' GLY . 71.8 mt -79.23 -16.6 56.26 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.193 -0.912 . . . . 74.22 112.418 -172.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -62.68 -48.32 86.12 Favored Pre-proline 0 CA--C 1.561 1.372 0 N-CA-C 114.194 1.183 . . . . 73.0 114.194 -172.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -59.06 -34.72 99.0 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 121.833 1.689 . . . . 52.33 112.94 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -71.2 -44.95 64.42 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.504 0.721 . . . . 75.25 110.831 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.14 -44.7 87.98 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.333 -0.848 . . . . 61.11 109.925 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -54.1 -54.62 36.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.705 1.202 . . . . 74.52 111.305 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.62 -29.39 68.7 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.269 0.628 . . . . 71.22 110.872 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.1 t -73.9 -37.0 64.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.998 0.519 . . . . 72.44 110.973 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.497 HD11 ' HB ' ' C' ' 62' ' ' VAL . 89.4 mt -67.81 -51.72 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.342 -0.614 . . . . 71.01 109.342 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 14.5 m -58.36 -31.84 67.99 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.613 0.765 . . . . 70.32 111.404 -177.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -62.42 -57.73 10.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.328 0.651 . . . . 75.1 109.599 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.569 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.77 -41.89 61.98 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.715 1.206 . . . . 52.54 112.843 177.831 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' C' ' 114' ' ' ILE . 95.7 t -67.48 -46.26 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.067 0.947 . . . . 62.44 110.758 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.451 ' OG ' HG21 ' B' ' 115' ' ' THR . 39.5 t -69.72 -26.42 64.32 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.556 -0.747 . . . . 72.35 111.281 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' D' ' 17' ' ' TYR . 78.1 mtt-85 -71.63 -42.11 68.02 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.467 0.707 . . . . 74.13 109.339 174.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.03 -3.11 67.6 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 123.759 0.662 . . . . 62.23 112.852 170.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p 65.5 30.82 10.56 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.828 2.051 . . . . 71.31 113.506 171.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -88.79 142.18 30.43 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 108.078 -1.082 . . . . 55.05 108.078 167.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.49 172.39 0.48 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 123.213 2.609 . . . . 73.53 115.732 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.434 ' NE2' ' HA ' ' B' ' 119' ' ' SER . 13.1 mm100 -46.19 135.0 8.16 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.746 1.619 . . . . 75.43 114.83 -169.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.688 HD21 HG11 ' C' ' 64' ' ' VAL . 43.7 tp -137.15 86.86 2.23 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.183 -1.371 . . . . 61.15 108.631 176.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -116.21 114.94 25.12 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.004 0.922 . . . . 71.42 109.105 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.09 137.3 38.15 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 122.588 0.355 . . . . 42.44 110.562 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.66 157.98 88.72 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 124.744 1.217 . . . . 74.33 111.272 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.73 111.67 0.65 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.233 2.622 . . . . 72.23 112.835 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.5 t -97.52 112.07 28.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.193 -0.669 . . . . 73.44 109.193 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.64 77.94 7.42 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.392 0.677 . . . . 55.04 109.744 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -60.14 -38.96 84.68 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.689 -0.687 . . . . 64.24 109.414 171.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -57.46 -35.28 69.95 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 114.095 -1.411 . . . . 64.12 112.745 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.64 -51.98 67.08 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 124.122 0.889 . . . . 74.35 111.134 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.8 mp -74.83 -35.01 62.43 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.836 -0.62 . . . . 63.45 111.435 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 137' ' ' PHE . . . . . 0.407 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 2.2 t80 . . . . . 0 CA--C 1.551 1.011 0 C-N-CA 122.678 0.391 . . . . 73.31 110.566 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 C--O 1.239 0.542 0 N-CA-C 109.652 -0.499 . . . . 43.35 109.652 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -148.53 96.46 2.6 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.306 -1.368 . . . . 72.23 107.306 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -119.25 122.42 41.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.378 -0.971 . . . . 64.14 108.378 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.446 HD11 HD13 ' D' ' 105' ' ' ILE . 41.2 mt -78.49 114.66 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.841 -1.17 . . . . 74.44 107.841 169.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -84.86 -38.73 19.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.356 0.262 . . . . 74.43 111.504 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -169.3 127.22 0.96 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 119.757 -0.163 . . . . 75.24 111.248 -166.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.41 HD11 HG21 ' D' ' 13' ' ' ILE . 2.4 mp -105.33 134.59 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.144 -1.428 . . . . 73.45 107.144 164.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 36.2 p90 -154.87 165.45 36.63 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.975 0.893 . . . . 64.32 111.033 174.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -98.54 117.97 34.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.337 -1.301 . . . . 65.22 109.46 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.44 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 33.2 mtpt -82.25 -33.68 29.12 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.729 -0.841 . . . . 74.21 108.729 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -143.95 144.53 31.74 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.535 -1.211 . . . . 51.15 109.398 173.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.569 HD13 ' HE3' ' C' ' 117' ' ' MET . 47.2 mt -133.73 141.25 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.41 -1.33 . . . . 62.31 107.41 172.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -144.1 137.1 27.3 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.955 0.902 . . . . 70.04 108.917 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.579 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.0 t80 -152.33 128.66 10.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.237 -1.764 . . . . 74.23 106.237 172.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -138.41 125.66 21.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.67 0.788 . . . . 74.33 109.354 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.29 83.8 60.59 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.257 -1.016 . . . . 73.03 108.257 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.42 -23.55 20.25 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.692 2.262 . . . . 53.14 112.62 -173.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 -106.84 1.69 24.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.569 0.748 . . . . 65.55 111.075 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.404 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -27.27 -66.64 0.11 Allowed Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 116.702 2.112 . . . . 53.21 116.702 -161.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.75 -22.29 9.12 Favored 'Trans proline' 0 C--N 1.38 2.229 0 CA-C-N 123.544 2.301 . . . . 72.14 113.718 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -70.73 -38.09 73.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.213 1.005 . . . . 73.22 109.291 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.515 HG22 HD12 ' D' ' 68' ' ' LEU . 9.9 p -84.92 -21.86 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 115.801 -0.636 . . . . 64.23 111.738 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -65.95 -20.36 66.18 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 112.418 0.525 . . . . 72.42 112.418 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.54 -22.15 64.89 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.296 0.638 . . . . 74.1 110.439 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -88.6 83.52 6.77 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.43 1.092 . . . . 70.12 108.396 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.23 93.2 5.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.552 -0.749 . . . . 44.42 110.099 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -160.36 158.28 29.36 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.3 1.04 . . . . 75.53 109.102 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -65.92 107.42 1.53 Allowed Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 124.007 0.923 . . . . 62.43 109.548 171.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.92 117.29 4.3 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 122.964 2.443 . . . . 73.44 112.867 -167.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.84 121.61 21.16 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.103 -0.703 . . . . 64.24 109.103 -175.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' D' ' 66' ' ' ALA . 14.5 m -107.86 151.05 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.492 0.717 . . . . 70.5 112.309 -168.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -109.37 125.3 52.23 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.709 -1.219 . . . . 75.24 107.709 164.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 65.4 mt -97.03 133.89 41.11 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.796 -0.446 . . . . 74.31 109.796 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -145.65 128.45 16.31 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.452 -1.314 . . . . 51.23 107.452 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.85 159.18 42.21 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.418 0.627 . . . . 72.31 111.071 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.0 t70 -136.48 128.96 30.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.479 1.512 . . . . 61.22 108.304 -170.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.6 t -106.06 146.77 29.71 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.28 -0.637 . . . . 72.22 109.28 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.99 170.48 19.77 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.709 0.804 . . . . 72.55 109.032 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 88.9 p -162.9 155.2 18.59 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 123.163 0.289 . . . . 65.24 110.83 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 22.2 t -153.44 153.88 33.34 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.489 1.116 . . . . 72.23 109.726 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.96 136.99 32.72 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 109.542 -0.54 . . . . 64.41 109.542 172.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' C' ' 29' ' ' PRO . 26.7 mt -109.5 -34.64 6.45 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.156 0.583 . . . . 75.54 110.138 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -157.01 -178.62 7.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.937 0.895 . . . . 71.43 110.243 176.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.72 118.62 10.52 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.474 -0.785 . . . . 74.33 110.082 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 56.79 17.22 3.09 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 124.998 1.319 . . . . 73.31 113.036 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 77.9 t -118.51 110.29 29.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 106.696 -1.594 . . . . 73.4 106.696 171.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.477 ' HB2' HD11 ' D' ' 86' ' ' ILE . 6.0 t80 -120.7 161.26 21.72 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.431 -0.952 . . . . 64.5 108.431 -170.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -129.74 145.42 51.54 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.306 -0.861 . . . . 63.3 109.516 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.71 125.05 66.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.064 -1.458 . . . . 61.23 107.064 172.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 43.6 t -103.26 133.2 47.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.935 -0.765 . . . . 64.42 108.935 176.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.57 118.42 31.62 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.665 -0.865 . . . . 73.24 108.665 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.469 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.2 ttm-85 -104.27 96.05 6.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.253 -1.018 . . . . 74.41 108.253 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.35 125.21 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.874 -0.787 . . . . 51.43 108.874 174.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 5.9 m -118.07 134.01 55.38 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 123.633 0.583 . . . . 73.04 109.669 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.407 HG21 HG21 ' D' ' 114' ' ' ILE . 64.4 t -119.58 117.66 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.305 1.042 . . . . 72.24 108.914 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 31.9 m -105.91 94.1 5.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.885 0.874 . . . . 72.2 108.652 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -96.2 151.31 19.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.013 0.525 . . . . 61.4 111.337 -172.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.424 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 56.7 p -147.0 135.62 22.02 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.35 -0.841 . . . . 74.34 111.449 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.515 HD12 HG22 ' D' ' 31' ' ' VAL . 22.6 mt -96.56 94.42 7.35 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.518 -1.29 . . . . 74.32 107.518 167.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.77 -117.01 8.76 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.313 -0.858 . . . . 74.2 112.577 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -93.69 4.77 53.42 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.851 0.86 . . . . 74.15 111.914 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -118.9 140.29 50.22 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.013 0.525 . . . . 74.45 110.183 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.6 m -63.57 116.15 5.36 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 123.456 0.472 . . . . 52.31 110.255 174.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.488 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -77.24 -72.12 0.37 Allowed 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.949 -0.759 . . . . 51.21 108.949 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -142.03 153.42 44.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.573 -0.739 . . . . 74.52 109.935 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 79.2 mt -115.48 148.52 39.35 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.935 -1.506 . . . . 72.23 106.935 169.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.528 ' SG ' HG12 ' D' ' 114' ' ' ILE . 47.4 t -155.1 143.12 20.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.27 -0.641 . . . . 74.21 109.27 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -155.8 127.28 7.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.61 -0.515 . . . . 74.14 109.61 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.31 120.52 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 122.863 0.465 . . . . 74.24 110.125 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -89.48 83.57 6.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.977 -0.749 . . . . 72.3 108.977 171.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -79.7 91.55 5.28 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.789 -1.096 . . . . 71.43 108.78 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.84 143.23 18.92 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 110.96 -0.856 . . . . 75.12 110.96 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.517 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -135.31 130.77 5.54 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 112.059 -0.416 . . . . 74.25 112.059 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.44 HG13 ' HE1' ' D' ' 17' ' ' TYR . 43.5 mt -89.44 126.15 42.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 124.028 0.931 . . . . 71.21 109.026 174.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -127.76 125.57 40.15 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.532 -0.914 . . . . 64.11 108.532 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.5 t -86.45 111.17 20.29 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.652 -1.24 . . . . 65.13 107.652 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' D' ' 56' ' ' TYR . 0.9 OUTLIER -130.24 136.7 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.288 0.566 . . . . 74.02 110.538 -173.411 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.4 156.3 40.4 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.8 1.24 . . . . 74.4 107.882 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.28 20.92 79.46 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 121.117 -0.564 . . . . 62.4 112.322 -175.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 45.5 pt -109.8 152.35 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.057 0.943 . . . . 60.23 109.24 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -163.16 146.04 10.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.903 0.481 . . . . 72.33 110.912 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.91 -120.81 11.41 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.17 0.828 . . . . 51.02 115.17 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 24.2 p -70.08 -24.06 63.16 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.482 1.113 . . . . 73.51 112.272 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -64.19 -36.11 82.99 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.443 0.697 . . . . 62.33 110.211 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.441 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 19.4 mtm -68.25 -51.88 40.19 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.52 0.513 . . . . 72.3 110.318 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.33 70.92 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.067 0.547 . . . . 71.11 111.915 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 28.9 t-80 -72.68 -32.17 65.6 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.887 0.875 . . . . 75.23 111.161 176.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.4 t -78.31 -53.52 7.21 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.491 0.316 . . . . 63.41 111.258 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' D' ' 94' ' ' MET . 4.6 pp -95.3 -18.98 20.36 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.308 0.643 . . . . 74.31 112.163 -169.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.4 13.23 56.95 Favored Glycine 0 N--CA 1.473 1.152 0 CA-C-O 120.051 -0.305 . . . . 52.23 112.693 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.685 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -152.63 -71.03 0.15 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 111.969 0.359 . . . . 73.25 111.969 -176.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -73.11 -32.74 65.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 112.378 0.51 . . . . 73.33 112.378 -171.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -71.71 -43.89 11.73 Favored Pre-proline 0 CA--C 1.561 1.365 0 CA-C-O 118.48 -0.771 . . . . 74.34 111.791 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -52.95 -36.1 73.92 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.194 1.929 . . . . 75.14 113.287 164.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -67.84 -22.31 65.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.517 0.727 . . . . 74.31 111.586 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.446 HD13 HD11 ' D' ' 13' ' ' ILE . 87.1 mt -81.1 -40.24 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.415 1.086 . . . . 71.41 110.463 172.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.517 HD21 ' HA3' ' D' ' 82' ' ' GLY . 93.9 mt -73.03 -22.75 60.58 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.246 -0.888 . . . . 71.33 111.82 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -71.68 -40.34 8.31 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 124.263 1.025 . . . . 75.31 113.308 -171.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -52.58 -42.66 60.57 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.292 1.994 . . . . 74.51 114.243 166.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -74.82 -35.72 62.43 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.167 0.587 . . . . 71.13 111.482 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.65 -42.42 86.71 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.562 -0.533 . . . . 54.04 109.562 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.637 HH12 ' HB3' ' D' ' 130' ' ' PRO . 21.2 ttp180 -51.49 -56.71 11.85 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 124.805 1.316 . . . . 72.25 110.708 173.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -67.17 -37.76 84.27 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.346 1.028 . . . . 73.34 111.584 -171.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.39 -45.25 94.22 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.467 0.479 . . . . 74.01 110.445 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.528 HG12 ' SG ' ' D' ' 76' ' ' CYS . 96.6 mt -61.8 -53.64 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.036 -0.984 . . . . 71.2 110.706 174.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -56.39 -40.35 74.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.305 1.042 . . . . 53.24 111.525 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.4 t -66.48 -43.4 85.51 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 114.783 -1.099 . . . . 61.42 110.6 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.3 mtm -70.17 -26.24 63.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.705 0.402 . . . . 61.22 111.66 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' D' ' 114' ' ' ILE . 69.2 t -68.06 -45.23 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.566 0.746 . . . . 73.44 110.019 173.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.9 p -74.84 -26.21 59.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.816 0.446 . . . . 64.24 111.473 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -75.65 -34.71 60.52 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.204 0.601 . . . . 74.11 109.646 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.36 1.65 84.68 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.651 0.595 . . . . 73.02 112.303 171.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 44.6 p 61.04 21.23 11.62 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.073 2.149 . . . . 60.43 114.458 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -78.44 142.7 62.83 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 107.86 -1.163 . . . . 73.3 107.86 168.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -50.18 137.74 37.52 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.245 2.63 . . . . 71.21 113.192 176.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -50.22 135.49 21.19 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.842 1.257 . . . . 71.01 114.04 -164.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 18.7 tp -108.84 102.0 11.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.196 0.599 . . . . 50.3 110.675 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -100.35 96.91 7.75 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.368 0.604 . . . . 74.34 109.931 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.94 123.2 19.18 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.122 1.369 . . . . 50.21 111.357 -175.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.07 122.84 88.14 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.396 0.679 . . . . 73.13 110.385 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.637 ' HB3' HH12 ' D' ' 111' ' ' ARG . 74.2 Cg_endo -80.87 128.85 6.81 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.304 2.003 . . . . 62.11 112.674 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.39 146.1 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.497 0.719 . . . . 72.33 109.807 176.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -85.6 89.83 7.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.029 0.532 . . . . 75.13 109.566 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -59.21 -24.08 62.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.61 0.764 . . . . 71.12 112.344 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 134' ' ' ASP . . . . . 0.685 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 9.8 t70 -60.23 -52.47 65.16 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.075 0.95 . . . . 71.34 110.7 -176.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.77 -40.04 69.55 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.127 -0.942 . . . . 71.12 111.359 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 91.4 mt -58.17 -34.5 70.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.627 0.771 . . . . 63.33 112.111 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.4 t80 . . . . . 0 N--CA 1.474 0.767 0 C-N-CA 123.377 0.671 . . . . 74.1 110.57 178.5 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.236 0.371 0 N-CA-C 109.137 -0.69 . . . . 72.23 109.137 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.488 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 21.6 t80 -134.28 125.0 26.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.7 0.8 . . . . 74.05 109.32 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -137.93 135.71 36.33 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.145 -1.057 . . . . 75.11 108.145 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.594 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.5 mt -92.83 118.31 38.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.22 -1.03 . . . . 75.52 108.22 174.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -88.83 -30.21 19.12 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 124.003 0.814 . . . . 64.44 110.272 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -171.28 147.61 2.51 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 123.275 0.359 . . . . 74.15 110.721 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 84.6 mt -137.05 134.16 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.503 1.121 . . . . 75.34 108.058 173.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.542 ' HB3' HG23 ' B' ' 122' ' ' THR . 25.1 p90 -166.54 169.2 13.97 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.773 0.797 . . . . 74.12 112.193 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -89.36 122.75 32.89 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.303 -0.862 . . . . 72.12 108.778 170.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.461 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.6 mtpt -87.7 -18.65 29.03 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.926 -0.398 . . . . 74.22 109.926 173.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.1 t70 -161.73 144.73 12.09 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.102 0.961 . . . . 75.21 109.297 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.613 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 82.0 mt -140.49 142.52 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.813 1.645 . . . . 62.41 107.172 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -146.32 139.99 26.1 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.176 0.513 . . . . 61.02 110.147 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 89.1 t80 -141.44 127.15 19.1 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.204 -1.406 . . . . 71.22 107.204 173.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -133.87 122.43 23.18 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.734 -0.469 . . . . 74.41 109.734 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.02 74.53 79.72 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.278 -1.378 . . . . 74.34 107.278 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.57 -22.09 51.66 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.662 2.241 . . . . 70.25 112.543 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 21.1 m120 -120.01 34.81 5.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.124 0.97 . . . . 73.33 109.314 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.45 -54.21 37.39 Favored Pre-proline 0 CA--C 1.565 1.522 0 CA-C-O 118.128 -0.939 . . . . 44.32 113.4 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.97 -22.02 31.68 Favored 'Trans proline' 0 C--N 1.387 2.599 0 CA-C-N 121.607 1.609 . . . . 70.51 113.147 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 6.0 t-160 -82.03 -38.83 24.41 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.99 0.916 . . . . 63.13 110.885 -171.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 73' ' ' ALA . 34.2 m -69.43 -25.92 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.311 0.644 . . . . 74.24 111.957 -175.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -72.43 -24.51 61.23 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.192 0.597 . . . . 71.5 111.004 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -77.09 -49.07 16.12 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.687 0.795 . . . . 71.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -75.36 172.77 11.89 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.372 0.669 . . . . 75.12 111.779 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.56 116.96 4.74 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 123.444 0.698 . . . . 75.25 110.525 176.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -73.65 90.41 1.8 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.455 -0.793 . . . . 70.24 109.549 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -131.4 72.0 81.13 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.092 -1.077 . . . . 74.54 108.092 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.57 116.77 2.96 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.396 2.064 . . . . 62.32 111.245 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -94.78 111.46 23.24 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.658 -1.238 . . . . 63.13 107.658 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 m -85.71 127.82 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 114.458 -1.246 . . . . 50.32 112.013 -170.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -122.01 114.54 21.1 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.334 1.453 . . . . 75.02 107.805 177.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.6 tp -110.44 113.73 26.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.032 0.533 . . . . 52.01 109.823 -175.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -113.11 110.05 19.8 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.744 0.818 . . . . 64.11 108.902 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mp -97.88 155.35 17.1 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.179 -0.674 . . . . 75.03 109.179 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.9 t70 -148.83 146.76 28.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.432 1.093 . . . . 73.23 108.437 -174.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.2 m -141.89 134.44 28.25 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.614 0.765 . . . . 74.14 110.175 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.2 140.51 46.55 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.807 0.843 . . . . 74.32 110.61 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.464 ' HB3' HD21 ' A' ' 98' ' ' LEU . 39.5 p -92.16 152.97 19.62 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.029 0.932 . . . . 63.12 109.834 176.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -151.85 145.25 24.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.946 0.898 . . . . 61.12 109.178 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -113.44 137.76 51.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.976 -0.75 . . . . 63.23 108.976 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.3 mt -110.96 -36.42 5.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.496 0.718 . . . . 74.25 110.469 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -160.45 -176.85 5.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.388 0.675 . . . . 74.11 110.828 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.28 120.54 12.95 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.166 -1.05 . . . . 74.32 108.166 170.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 72.46 -5.91 1.71 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.778 1.231 . . . . 63.42 112.702 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 52.3 t -109.25 116.38 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.081 0.952 . . . . 65.22 108.832 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.78 162.56 28.17 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.26 0.624 . . . . 72.41 109.549 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -134.88 145.74 48.55 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.063 0.945 . . . . 72.54 109.732 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -131.6 147.57 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.5 -0.926 . . . . 75.1 108.5 166.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.13 117.3 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.728 0.811 . . . . 72.4 109.382 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.7 tp -97.91 103.28 15.2 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.874 -0.787 . . . . 51.32 108.874 173.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.612 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 27.3 ttp180 -88.26 112.99 23.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.3 0.64 . . . . 70.11 109.673 172.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.85 123.2 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.598 -0.89 . . . . 55.21 108.598 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -115.77 120.65 39.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.748 0.819 . . . . 70.4 110.061 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.446 ' O ' HD12 ' A' ' 75' ' ' LEU . 86.0 t -111.39 113.46 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.992 0.917 . . . . 51.04 110.007 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.2 m -112.06 105.6 14.03 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.82 -0.807 . . . . 64.13 108.82 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -111.38 105.36 13.97 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.198 -1.038 . . . . 70.55 108.198 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.3 p -128.85 131.29 47.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.49 0.716 . . . . 60.35 110.753 -174.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.715 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -91.83 87.15 6.14 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.564 -0.902 . . . . 71.4 108.564 175.371 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.15 -102.88 2.32 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 114.981 -1.009 . . . . 72.23 111.902 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.43 -26.12 12.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.994 0.517 . . . . 72.2 110.327 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -91.68 127.4 37.12 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.894 0.878 . . . . 52.42 109.159 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.7 m -87.4 134.56 33.56 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 122.643 0.377 . . . . 75.34 110.751 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.648 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -76.48 -61.09 2.07 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 124.283 0.989 . . . . 74.5 108.668 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -152.88 153.79 33.76 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.554 -1.203 . . . . 62.22 110.725 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 58.6 tp -122.18 136.73 54.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.849 -1.537 . . . . 71.31 106.849 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 85.8 m -140.05 103.39 4.61 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.187 0.595 . . . . 72.55 109.445 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.22 117.68 24.37 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.216 -0.661 . . . . 74.13 109.216 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -126.11 113.79 35.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 123.862 0.865 . . . . 74.34 109.683 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.612 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 50.0 mt-30 -85.38 84.86 7.51 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.65 -0.871 . . . . 73.12 108.65 170.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.403 ' O ' HD13 ' A' ' 106' ' ' LEU . 62.0 tp60 -79.84 100.87 8.21 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.367 -0.975 . . . . 72.33 108.367 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.12 144.79 17.36 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 111.335 -0.706 . . . . 71.42 111.335 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.535 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.02 128.43 4.22 Favored Glycine 0 CA--C 1.504 -0.639 0 N-CA-C 111.369 -0.692 . . . . 70.11 111.369 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.0 mt -82.22 119.63 32.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.406 -0.961 . . . . 74.23 108.406 172.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.594 ' HD2' HG12 ' A' ' 13' ' ' ILE . 26.9 m-85 -130.31 117.73 20.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.954 -1.128 . . . . 70.03 107.954 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 p -78.75 108.42 12.16 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.973 -1.121 . . . . 73.25 107.973 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.538 ' HB ' HD11 ' A' ' 89' ' ' ILE . 42.9 pt -119.19 139.45 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.361 0.664 . . . . 63.5 109.943 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.32 159.68 28.75 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.478 1.111 . . . . 73.11 109.522 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.54 4.0 89.05 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.926 -0.375 . . . . 40.34 113.879 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -120.46 136.58 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.284 -1.006 . . . . 72.22 108.284 172.268 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -141.22 173.6 11.33 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.34 1.056 . . . . 74.13 109.659 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.83 -133.14 51.33 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 123.948 0.78 . . . . 72.12 114.198 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.5 p -71.55 -24.82 62.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.01 0.924 . . . . 73.11 111.854 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -68.82 -44.11 74.18 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.582 0.753 . . . . 71.33 110.17 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 52.3 ttp -63.33 -48.4 78.18 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.956 -0.387 . . . . 62.42 109.956 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.9 -31.6 68.76 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.171 0.919 . . . . 55.23 112.034 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -73.98 -45.08 52.26 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.95 0.5 . . . . 70.41 110.62 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 78.7 m -66.55 -25.04 66.46 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.177 0.591 . . . . 40.14 111.575 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 48' ' ' SER . 6.0 tt -95.72 -42.5 8.34 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.459 1.103 . . . . 74.44 110.159 -173.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.77 4.31 53.3 Favored Glycine 0 N--CA 1.472 1.045 0 CA-C-N 115.945 -0.57 . . . . 74.24 113.681 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.6 -57.79 0.32 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.224 0.512 . . . . 74.42 111.772 -176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.496 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.2 t80 -70.68 -62.43 1.4 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.118 0.567 . . . . 75.11 112.395 -170.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.3 m -68.71 -33.09 4.06 Favored Pre-proline 0 CA--C 1.567 1.618 0 N-CA-C 114.369 1.248 . . . . 73.34 114.369 -173.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.02 -24.77 44.93 Favored 'Trans proline' 0 C--N 1.39 2.742 0 CA-C-N 121.725 1.652 . . . . 63.43 112.776 167.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -73.41 -26.56 61.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.776 -0.453 . . . . 73.34 109.776 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.5 mm -63.63 -36.52 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.466 0.707 . . . . 73.03 109.818 169.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.535 HD21 ' HA3' ' A' ' 82' ' ' GLY . 76.5 mt -79.97 -17.61 52.5 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.899 0.88 . . . . 63.32 111.932 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -64.69 -46.17 76.17 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 117.755 -1.117 . . . . 65.14 113.684 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.47 -33.88 67.24 Favored 'Trans proline' 0 C--N 1.389 2.675 0 CA-C-N 122.071 1.776 . . . . 74.14 112.838 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -70.53 -41.16 72.91 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.37 0.668 . . . . 70.21 111.239 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.98 -39.68 79.28 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.925 0.49 . . . . 75.21 110.405 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.474 ' NH1' HG23 ' C' ' 105' ' ' ILE . 36.5 ttm180 -53.2 -51.54 61.76 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 124.402 1.064 . . . . 54.22 109.611 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -66.59 -44.21 82.81 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.023 -0.989 . . . . 75.31 111.653 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.418 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.9 t -62.2 -33.99 75.6 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.174 0.59 . . . . 75.14 111.306 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 118' ' ' VAL . 83.3 mt -70.63 -55.97 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.112 0.965 . . . . 64.35 110.092 173.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.8 m -51.67 -43.43 62.69 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.697 1.199 . . . . 62.35 111.466 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -63.37 -47.07 83.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.906 -1.497 . . . . 54.41 110.268 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.429 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 69.0 mtm -63.13 -36.96 85.34 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.053 0.541 . . . . 62.31 111.722 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 114' ' ' ILE . 86.1 t -62.83 -47.2 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 123.507 0.723 . . . . 72.35 110.298 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.4 p -76.75 -20.25 56.71 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.153 0.581 . . . . 52.33 112.089 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -75.59 -34.89 60.66 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.005 -0.739 . . . . 72.31 109.005 172.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.43 -0.88 80.35 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.457 -0.792 . . . . 73.43 112.291 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.8 m 70.92 14.22 6.94 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 125.246 1.418 . . . . 25.24 111.578 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -77.91 157.43 79.02 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 123.619 0.767 . . . . 74.52 110.027 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.63 131.19 44.35 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.214 2.609 . . . . 71.05 111.897 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -55.24 126.41 24.78 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 124.414 1.071 . . . . 70.33 112.148 -170.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.8 tp -106.16 97.63 7.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.553 -0.748 . . . . 74.01 109.295 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 80.4 m-20 -95.78 107.63 19.88 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.389 -1.337 . . . . 71.43 107.389 174.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.441 ' HB3' ' HG3' ' A' ' 111' ' ' ARG . 30.5 tp -72.03 126.81 30.71 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.441 -0.799 . . . . 64.22 110.213 -176.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.1 139.02 92.5 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.401 0.68 . . . . 41.01 110.441 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.58 128.46 28.36 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.906 2.404 . . . . 74.14 113.192 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 96.8 t -100.22 120.88 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.858 -0.793 . . . . 72.5 108.858 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -76.7 74.01 3.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.515 1.126 . . . . 65.03 110.932 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -56.36 -39.54 73.05 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.406 0.682 . . . . 74.34 111.862 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.8 -33.35 72.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.509 1.124 . . . . 73.22 111.864 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.46 -43.01 51.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.158 0.583 . . . . 65.42 110.168 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.5 -38.19 90.15 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.333 -0.849 . . . . 74.44 110.131 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -69.22 -38.62 78.64 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.294 -0.866 . . . . 72.02 109.949 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 C-N-CA 124.213 1.005 . . . . 61.34 110.599 176.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 C--O 1.243 0.748 0 N-CA-C 108.367 -0.975 . . . . 74.23 108.367 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -148.27 157.05 43.26 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.444 0.64 . . . . 72.23 111.389 161.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -124.1 133.33 53.63 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.116 -1.439 . . . . 70.14 107.116 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.465 HD11 HD13 ' B' ' 105' ' ' ILE . 27.7 mt -77.0 123.96 34.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.902 -0.777 . . . . 52.24 108.902 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -83.01 -45.48 14.01 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.818 0.698 . . . . 70.45 109.911 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -170.32 130.98 0.94 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.931 -0.577 . . . . 63.53 110.279 -171.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.432 HD11 HD13 ' B' ' 13' ' ' ILE . 77.6 mt -113.91 139.47 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 107.408 -1.33 . . . . 75.35 107.408 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -161.93 152.73 17.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.576 0.703 . . . . 65.24 111.762 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 81.7 m -77.47 121.36 23.74 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.165 -1.379 . . . . 73.13 108.195 171.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.587 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.1 mtpt -93.62 -29.53 15.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.528 0.731 . . . . 71.22 110.453 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -160.69 139.25 10.1 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.363 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.515 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.6 mm -133.21 142.01 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.867 1.267 . . . . 52.22 108.802 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -138.56 129.99 27.41 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.493 -1.299 . . . . 75.41 107.493 171.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.613 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.7 t80 -142.78 132.4 23.84 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.294 -1.373 . . . . 64.4 107.294 170.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.29 148.43 51.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.686 -0.857 . . . . 73.45 108.686 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.789 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -142.85 77.67 16.25 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 107.538 -1.282 . . . . 74.23 107.538 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.83 -36.83 17.27 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.928 2.419 . . . . 72.33 112.265 -171.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -100.37 -0.94 37.27 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.598 0.759 . . . . 72.32 111.346 -174.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.789 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -36.67 -66.08 0.29 Allowed Pre-proline 0 N--CA 1.494 1.728 0 C-N-CA 125.834 1.653 . . . . 61.34 115.013 -165.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.09 -24.42 73.32 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.332 2.021 . . . . 73.42 113.305 -170.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -93.12 -32.21 14.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.367 0.667 . . . . 71.24 111.262 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.612 HG22 HD12 ' B' ' 68' ' ' LEU . 1.5 p -75.56 -20.81 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 122.895 0.478 . . . . 74.34 110.922 -172.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -66.4 -10.11 40.45 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.633 0.773 . . . . 74.23 112.952 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -61.73 -28.72 69.63 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.231 0.612 . . . . 72.34 110.266 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -90.44 96.84 10.85 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 124.34 1.056 . . . . 72.42 109.536 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.08 94.99 1.97 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.507 -0.923 . . . . 64.31 108.507 171.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.439 ' HZ3' ' H ' ' B' ' 69' ' ' GLY . 26.9 t90 -169.35 154.96 6.05 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.372 1.069 . . . . 74.45 108.844 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.416 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 0.1 OUTLIER -87.07 110.59 34.35 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.046 -1.094 . . . . 64.35 108.046 170.175 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.422 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 53.8 Cg_endo -68.69 143.24 55.52 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.817 2.345 . . . . 63.43 113.407 -170.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.5 107.96 0.75 Allowed 'General case' 0 C--O 1.242 0.663 0 O-C-N 124.281 0.988 . . . . 73.03 110.066 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.5 m -86.34 161.2 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.207 -0.906 . . . . 75.35 110.972 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.482 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 60.3 tttp -134.16 104.29 6.14 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.612 -1.255 . . . . 72.04 107.612 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.17 124.22 31.58 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.523 -0.917 . . . . 73.1 108.523 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -140.81 109.82 6.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.214 -1.402 . . . . 64.42 107.214 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.61 155.09 17.78 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.876 -0.787 . . . . 75.31 108.876 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -155.71 149.89 25.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.452 -1.249 . . . . 72.44 108.374 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -140.65 143.12 34.98 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.352 0.596 . . . . 72.34 111.099 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.43 148.48 37.85 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.942 1.297 . . . . 63.14 107.915 172.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 72.4 p -145.03 162.92 35.76 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.114 0.416 . . . . 74.1 111.456 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -151.84 147.82 27.08 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.906 0.882 . . . . 44.53 109.833 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -84.04 131.36 34.82 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.331 0.652 . . . . 74.22 109.566 172.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 43.3 mt -93.66 -44.31 8.24 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.333 0.653 . . . . 73.22 109.509 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.62 -176.35 5.89 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.369 1.068 . . . . 74.05 110.177 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -69.47 120.35 15.13 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.713 -1.131 . . . . 64.3 109.346 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.77 16.75 10.62 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.3 1.04 . . . . 73.2 112.072 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 67.1 t -130.15 104.06 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.221 -1.029 . . . . 74.41 108.221 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -112.55 167.25 10.61 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.922 -1.14 . . . . 74.31 107.922 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -143.38 121.37 12.07 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.202 -1.036 . . . . 63.34 108.202 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -106.5 143.29 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.173 0.989 . . . . 61.32 109.39 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.508 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 35.6 t -116.78 144.53 24.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.977 -0.749 . . . . 64.35 108.977 176.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -127.71 110.06 12.28 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.143 -1.058 . . . . 72.32 108.143 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 36.1 ttm180 -94.36 122.3 36.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.841 0.856 . . . . 72.03 110.162 171.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 47.7 t -116.44 103.43 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.387 -1.338 . . . . 65.23 107.387 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.2 m -98.9 131.7 44.78 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.302 0.641 . . . . 73.11 109.542 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 91.5 t -123.49 130.02 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.023 0.929 . . . . 61.01 109.631 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.5 m -119.25 136.88 54.01 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 108.85 -0.796 . . . . 73.32 108.85 172.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.49 151.95 43.76 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.057 0.389 . . . . 65.42 110.917 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.5 p -152.22 132.77 13.87 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.175 0.922 . . . . 75.1 111.515 -173.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.612 HD12 HG22 ' B' ' 31' ' ' VAL . 77.4 mt -93.51 104.17 16.32 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.682 -1.229 . . . . 62.21 107.682 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.439 ' H ' ' HZ3' ' B' ' 36' ' ' TRP . . . 85.57 -110.7 3.47 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.462 -0.655 . . . . 54.03 111.462 -174.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.77 1.17 9.93 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.888 0.875 . . . . 73.52 110.419 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -113.55 150.87 32.36 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.034 -0.728 . . . . 70.13 109.034 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -62.16 139.11 58.48 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.822 0.702 . . . . 73.13 110.908 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.465 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -97.4 -67.78 0.83 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.545 -1.279 . . . . 65.24 107.545 170.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -145.18 160.61 41.18 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.005 -0.998 . . . . 74.54 109.993 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -135.0 138.64 44.16 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.471 -1.677 . . . . 63.03 106.471 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -150.04 157.87 43.58 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.876 0.369 . . . . 74.14 110.084 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -164.62 135.55 4.18 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.03 -1.1 . . . . 33.44 108.03 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.44 HG22 HD12 ' B' ' 21' ' ' ILE . 95.8 t -126.2 145.88 32.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.572 -0.899 . . . . 75.12 108.572 172.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.424 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 45.3 mt-30 -123.29 86.69 2.62 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.739 -0.837 . . . . 75.45 108.739 171.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.6 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 46.4 tp60 -83.26 101.43 11.25 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.955 -1.021 . . . . 73.43 109.424 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.587 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.55 169.9 34.74 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.894 -0.482 . . . . 55.42 111.894 175.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.26 137.12 4.57 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 111.304 -0.718 . . . . 43.45 111.304 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.3 mt -96.87 125.91 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.044 0.938 . . . . 70.11 108.529 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -128.3 131.26 48.67 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.662 -1.236 . . . . 72.11 107.662 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 45.0 m -97.96 89.82 4.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.463 -0.569 . . . . 72.21 109.463 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.467 ' HB ' HD12 ' B' ' 89' ' ' ILE . 1.6 pp -94.42 139.67 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.424 0.69 . . . . 74.42 111.527 -166.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.29 138.49 21.43 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.37 1.068 . . . . 75.42 109.294 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.4 -35.87 4.02 Favored Glycine 0 C--N 1.345 1.033 0 O-C-N 123.642 0.589 . . . . 62.41 113.307 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.467 HD12 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -54.64 137.48 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 C-N-CA 124.805 1.242 . . . . 71.41 112.752 -175.315 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -158.9 142.34 14.89 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.563 0.345 . . . . 75.44 111.282 175.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' B' ' 94' ' ' MET . . . 67.04 -121.92 17.57 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 114.573 0.589 . . . . 72.04 114.573 173.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 84.8 m -65.66 -33.21 75.36 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.645 0.778 . . . . 75.03 110.193 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -68.29 -39.26 82.14 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.34 -0.845 . . . . 74.41 110.202 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' B' ' 91' ' ' GLY . 17.5 ptm -78.79 -28.9 44.68 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 116.314 -0.403 . . . . 64.02 110.72 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.91 -30.55 62.65 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.2 0.6 . . . . 70.33 110.916 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -79.61 -33.48 41.48 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.092 0.957 . . . . 72.53 109.994 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.6 t -71.37 -65.15 0.79 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.587 0.755 . . . . 61.42 110.298 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.436 HD21 HG21 ' B' ' 86' ' ' ILE . 50.6 mt -80.45 -20.24 44.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.823 0.849 . . . . 71.23 112.395 -171.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.65 -13.16 41.75 Favored Glycine 0 N--CA 1.477 1.383 0 CA-C-O 119.646 -0.53 . . . . 71.12 114.363 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.93 -52.86 0.52 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 117.612 0.706 . . . . 74.32 111.688 -172.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -73.58 -38.47 65.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.047 0.539 . . . . 73.14 111.601 -173.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.41 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.4 m -70.43 -48.23 18.1 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-O 118.655 -0.688 . . . . 74.13 111.246 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.43 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 53.5 Cg_exo -55.86 -33.26 87.97 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.107 1.872 . . . . 70.4 113.701 168.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -59.52 -39.21 83.16 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.332 0.653 . . . . 72.12 111.644 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.465 HD13 HD11 ' B' ' 13' ' ' ILE . 79.8 mt -66.11 -41.06 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.09 0.956 . . . . 62.14 110.844 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 52.6 mt -80.13 -16.04 55.78 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.404 -0.817 . . . . 70.32 111.887 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -60.21 -48.8 93.26 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.198 0.999 . . . . 73.02 113.589 -172.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.553 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 33.3 Cg_endo -61.34 -34.08 88.0 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.141 1.894 . . . . 72.32 113.498 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.6 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 94.3 m-85 -67.39 -46.86 72.01 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.692 0.397 . . . . 75.3 110.234 177.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.45 86.08 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.47 -0.786 . . . . 41.21 111.112 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.568 ' HA ' HD23 ' B' ' 128' ' ' LEU . 29.0 mtp-105 -55.16 -61.39 2.35 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.376 1.07 . . . . 71.22 111.36 175.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.37 -27.85 69.29 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.07 0.856 . . . . 74.44 110.781 -173.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.515 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.5 t -73.32 -37.94 65.97 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.108 0.563 . . . . 73.02 111.048 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 71.2 mt -64.89 -51.86 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.449 -0.574 . . . . 73.44 109.449 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.537 HG21 ' OG ' ' C' ' 119' ' ' SER . 14.4 m -58.19 -34.63 70.56 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 124.406 1.067 . . . . 71.42 111.902 -176.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 25.7 t -58.86 -52.25 66.55 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 124.028 0.83 . . . . 74.53 109.46 175.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.2 mmt -69.28 -33.46 73.24 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.496 0.719 . . . . 75.32 111.417 -174.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.04 -44.33 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.974 0.91 . . . . 53.32 110.496 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -69.48 -32.17 70.9 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.178 -0.919 . . . . 61.45 111.209 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.1 mtt-85 -67.7 -37.97 83.02 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.393 -0.821 . . . . 72.32 109.357 175.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.43 4.14 64.86 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 124.161 0.913 . . . . 52.22 113.237 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.542 HG23 ' HB3' ' A' ' 17' ' ' TYR . 82.1 p 58.8 32.07 21.85 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.169 1.787 . . . . 70.54 113.12 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -95.47 154.25 39.36 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 124.203 1.001 . . . . 71.44 110.972 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.416 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 81.2 Cg_exo -49.92 158.77 1.97 Allowed 'Trans proline' 0 C--N 1.39 2.731 0 C-N-CA 124.299 3.333 . . . . 64.42 115.652 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -63.94 130.75 45.34 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 114.636 -1.166 . . . . 72.45 112.251 -172.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 68.6 tp -141.53 123.77 15.63 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.938 0.895 . . . . 52.44 109.709 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -130.49 136.36 48.9 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.209 -1.034 . . . . 74.43 108.209 168.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.568 HD23 ' HA ' ' B' ' 111' ' ' ARG . 1.9 mm? -82.93 119.66 24.7 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.457 -0.942 . . . . 64.21 108.457 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.02 150.37 71.64 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.183 0.593 . . . . 61.12 111.054 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.09 140.58 41.78 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.061 2.508 . . . . 75.14 112.817 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.38 145.6 34.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.446 -1.316 . . . . 71.44 107.446 167.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -66.61 101.51 0.79 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.605 0.762 . . . . 61.45 110.902 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -61.11 -32.58 72.26 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.004 0.521 . . . . 75.11 110.126 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -69.78 -52.61 23.75 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.407 1.083 . . . . 60.13 111.193 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.19 -44.4 95.12 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 123.707 0.63 . . . . 52.2 111.184 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 66.7 mt -61.2 -37.48 83.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.959 0.504 . . . . 64.51 111.44 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 72.4 t80 . . . . . 0 N--CA 1.472 0.627 0 O-C-N 123.53 0.519 . . . . 73.43 110.733 -176.913 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.596 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 43.6 m . . . . . 0 C--O 1.242 0.674 0 N-CA-C 108.84 -0.8 . . . . 73.04 108.84 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.562 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 6.0 t80 -110.03 124.81 52.11 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.827 -0.805 . . . . 74.22 108.827 174.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -145.83 134.19 21.87 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.601 0.76 . . . . 72.15 109.162 171.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 67.2 mt -78.17 122.44 33.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.323 -0.991 . . . . 73.31 108.323 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.622 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 17.2 mm100 -89.77 -42.19 11.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.217 -0.901 . . . . 73.41 110.639 -175.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.401 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 17.6 ttt180 -175.6 129.82 0.26 Allowed 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.384 0.427 . . . . 74.01 110.214 -168.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 66.5 mt -121.77 131.8 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.636 -0.876 . . . . 62.54 108.636 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.502 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 32.6 p90 -171.36 173.09 4.96 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.706 0.765 . . . . 73.44 111.311 -169.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.3 p -95.88 119.58 34.64 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.32 -0.855 . . . . 63.34 109.572 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.502 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 21.8 mmtp -65.32 -47.74 75.49 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 107.581 -1.266 . . . . 70.55 107.581 169.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 21.9 t70 -144.04 143.84 31.36 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 113.352 -1.749 . . . . 70.32 109.936 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.3 mt -129.96 144.36 38.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.475 -1.676 . . . . 73.4 106.475 172.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -152.53 147.25 25.98 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.35 0.595 . . . . 63.53 109.712 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -144.55 137.06 26.53 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.451 -1.314 . . . . 75.23 107.451 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -135.22 131.43 36.67 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.858 0.863 . . . . 74.51 109.352 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -154.28 76.63 5.65 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 106.799 -1.556 . . . . 61.3 106.799 172.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.66 -42.0 5.38 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.229 1.953 . . . . 75.31 111.429 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -96.96 29.04 3.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.525 1.13 . . . . 74.12 110.595 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.569 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -51.63 -55.87 25.97 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.201 -0.904 . . . . 42.52 113.408 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.5 -32.9 70.18 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 121.723 1.615 . . . . 73.34 112.684 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -67.99 -44.48 76.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.081 0.553 . . . . 54.14 110.859 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.753 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.8 p -77.17 -22.65 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 112.708 0.632 . . . . 72.22 112.708 -173.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -63.72 -33.6 76.02 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.22 0.452 . . . . 74.42 112.22 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -85.79 11.18 11.68 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.471 0.308 . . . . 60.12 111.572 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.799 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -89.95 158.51 17.36 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.505 0.722 . . . . 74.43 109.978 175.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -65.17 129.0 38.11 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.942 0.897 . . . . 73.53 109.791 165.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 58.9 t90 -82.03 94.16 7.12 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.386 0.674 . . . . 65.11 111.312 -172.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -141.39 76.15 21.65 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.644 0.778 . . . . 74.12 108.934 172.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -83.54 126.98 4.25 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.118 2.545 . . . . 51.43 113.252 -175.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.37 103.38 13.49 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.271 -1.381 . . . . 62.15 107.271 168.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 19.6 m -88.33 103.56 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.155 0.979 . . . . 61.42 110.855 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.541 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 82.7 tttt -93.87 104.11 16.19 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.802 -1.09 . . . . 74.33 108.644 177.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.13 136.72 32.82 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.351 -0.981 . . . . 74.21 108.351 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -130.88 105.34 7.7 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.927 -0.768 . . . . 54.12 108.927 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mp -103.19 135.02 45.63 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.239 -1.023 . . . . 52.2 108.239 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -151.44 155.48 38.67 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.515 0.726 . . . . 60.15 110.061 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -139.04 146.72 41.16 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.128 0.571 . . . . 75.34 109.719 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.84 146.66 43.71 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.153 0.981 . . . . 71.22 108.949 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.1 p -137.0 151.78 49.38 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.111 0.564 . . . . 53.45 110.297 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 86.4 p -149.41 157.94 43.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.854 0.862 . . . . 72.33 109.76 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -89.36 118.77 29.27 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.982 -0.747 . . . . 74.5 108.982 174.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.567 HD11 HD12 ' C' ' 83' ' ' ILE . 57.5 mt -90.8 -40.3 11.87 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.299 0.571 . . . . 55.54 109.779 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.71 177.82 10.28 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 114.395 -1.275 . . . . 62.12 108.95 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.64 119.56 14.06 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 109.264 -0.643 . . . . 63.15 109.264 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 66.92 21.81 10.27 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.545 1.138 . . . . 74.4 111.15 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 65.9 t -126.69 101.61 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.855 1.262 . . . . 73.14 108.158 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.58 ' HB2' HD11 ' C' ' 86' ' ' ILE . 0.2 OUTLIER -104.23 138.04 41.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.173 -0.677 . . . . 72.32 109.173 177.516 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.432 ' HB2' HD11 ' C' ' 51' ' ' LEU . 29.1 tt0 -85.57 137.75 32.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.577 -1.192 . . . . 70.35 108.667 166.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 t -122.18 139.54 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.682 -1.229 . . . . 64.41 107.682 167.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 49.6 t -131.79 131.94 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 108.545 -0.909 . . . . 73.54 108.545 175.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.21 109.35 21.01 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.802 -1.555 . . . . 65.2 106.802 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.443 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 5.8 tmm_? -99.5 105.73 17.67 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.748 -1.204 . . . . 64.42 107.748 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.466 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.3 t -107.77 138.37 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.478 -0.934 . . . . 64.21 108.478 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 35.7 m -134.04 121.22 21.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.35 -0.611 . . . . 74.03 109.35 171.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.594 HG11 HD13 ' C' ' 126' ' ' LEU . 59.7 t -106.35 111.72 36.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 114.885 -1.052 . . . . 73.45 109.014 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 7.0 m -103.36 142.72 33.74 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.213 -0.903 . . . . 72.11 109.42 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.88 120.71 19.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.716 -1.216 . . . . 74.32 107.716 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.6 m -140.44 128.0 21.5 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.565 0.541 . . . . 71.34 110.816 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.799 HD13 ' HG2' ' C' ' 34' ' ' LYS . 8.5 mt -89.27 31.63 0.89 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.174 1.39 . . . . 62.33 110.813 -176.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.67 -105.42 0.95 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 109.808 -1.317 . . . . 44.4 109.808 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.13 -18.08 17.87 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.981 0.913 . . . . 55.01 110.053 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.515 ' HG2' ' NZ ' ' C' ' 34' ' ' LYS . 5.7 tp10 -76.37 119.17 19.88 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.898 0.879 . . . . 73.22 109.515 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 44.8 m -76.98 128.42 34.48 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.261 -0.644 . . . . 74.24 109.261 172.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.753 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -78.39 -56.39 4.49 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.287 -1.005 . . . . 71.44 108.287 170.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 74' ' ' PHE . . . . . 0.549 ' HZ ' HD11 ' C' ' 126' ' ' LEU . 41.5 p90 -163.83 174.31 11.71 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.359 0.663 . . . . 71.24 110.716 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.12 107.68 5.07 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.37 -1.344 . . . . 72.23 107.37 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -110.58 143.43 41.0 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.827 -0.805 . . . . 62.3 108.827 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.81 134.39 15.44 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.348 0.659 . . . . 63.24 109.646 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.1 t -135.89 119.54 24.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 124.281 1.032 . . . . 64.01 109.19 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.443 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 54.3 mt-30 -92.17 88.27 6.43 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.58 -0.896 . . . . 72.3 108.58 170.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -79.64 99.49 7.39 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.736 -0.665 . . . . 44.52 109.785 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.22 144.2 16.97 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 116.416 -0.356 . . . . 71.52 112.518 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.569 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.23 135.4 5.35 Favored Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 110.536 -1.026 . . . . 41.34 110.536 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 8.8 mm -94.8 127.01 47.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.429 -0.952 . . . . 72.22 108.429 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.562 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 47.0 m-85 -134.22 118.38 17.55 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.251 -0.648 . . . . 71.41 109.251 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 85' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 53.8 m -75.7 132.92 40.84 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.219 -0.66 . . . . 73.04 109.219 175.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' C' ' 56' ' ' TYR . 1.1 pp -134.38 107.23 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.189 0.996 . . . . 74.35 109.219 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.596 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -130.25 157.71 41.75 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.898 -0.779 . . . . 72.42 108.898 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.22 -42.8 3.02 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 123.15 0.281 . . . . 53.44 113.22 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 46.4 pt -93.26 169.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.544 0.738 . . . . 71.54 110.445 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -170.47 171.88 6.29 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 124.012 0.82 . . . . 73.33 109.622 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.87 -123.64 7.53 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.777 -0.457 . . . . 64.21 112.755 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 69.1 p -68.44 -29.24 67.84 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.418 0.687 . . . . 52.1 111.234 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -64.16 -51.23 64.85 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.244 1.017 . . . . 62.52 110.645 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 21.2 ptm -74.01 -28.18 61.32 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.284 0.365 . . . . 72.4 110.564 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.11 -43.98 87.45 Favored 'General case' 0 C--N 1.362 1.135 0 O-C-N 123.682 0.614 . . . . 41.4 109.594 173.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -77.61 -42.05 36.38 Favored 'General case' 0 C--O 1.245 0.863 0 O-C-N 123.562 0.539 . . . . 64.34 111.809 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -61.79 -39.03 90.25 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.058 0.849 . . . . 61.4 110.693 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.488 HD11 HG12 ' C' ' 86' ' ' ILE . 33.5 mt -101.3 -17.01 16.75 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 122.888 0.475 . . . . 65.14 111.74 -177.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 99' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' C' ' 137' ' ' PHE . . . -77.2 -29.2 56.9 Favored Glycine 0 C--N 1.354 1.583 0 N-CA-C 114.558 0.583 . . . . 55.21 114.558 -175.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.12 -36.09 0.09 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 120.805 0.336 . . . . 63.14 111.736 -169.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.53 -45.88 74.43 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.267 1.427 . . . . 75.31 112.125 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 55.5 m -76.68 -42.56 2.98 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 118.625 -0.702 . . . . 71.01 112.734 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.31 -27.35 57.03 Favored 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 122.194 1.929 . . . . 65.12 113.832 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -66.74 -36.92 83.6 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.519 0.727 . . . . 64.01 110.845 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.474 HG23 ' NH1' ' A' ' 111' ' ' ARG . 44.2 mm -63.18 -38.28 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.352 0.661 . . . . 62.01 109.617 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.569 HD21 ' HA3' ' C' ' 82' ' ' GLY . 90.9 mt -81.83 -18.12 45.04 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.808 -1.087 . . . . 71.02 112.765 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -60.49 -48.67 92.99 Favored Pre-proline 0 CA--C 1.561 1.371 0 N-CA-C 114.133 1.16 . . . . 74.24 114.133 -172.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -62.85 -34.11 73.26 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.845 1.697 . . . . 63.23 112.7 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -70.05 -45.64 66.67 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.47 0.708 . . . . 72.4 111.013 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.38 95.79 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 115.834 -0.621 . . . . 71.11 109.613 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.533 ' HG3' HD23 ' C' ' 128' ' ' LEU . 65.3 ttt180 -57.45 -52.85 63.73 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 124.599 1.187 . . . . 62.21 111.341 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.43 -31.33 71.44 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.921 0.488 . . . . 65.43 110.584 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.8 t -73.06 -34.5 66.3 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.965 0.506 . . . . 71.44 111.132 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.466 HD11 ' HB ' ' C' ' 62' ' ' VAL . 83.8 mt -68.59 -53.71 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.261 0.624 . . . . 52.12 109.591 174.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.3 m -63.19 -28.27 69.93 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.205 1.002 . . . . 71.21 111.389 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.8 t -64.05 -51.93 61.79 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.359 0.663 . . . . 72.15 109.417 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.575 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.55 -32.13 73.04 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.3 1.04 . . . . 70.21 112.766 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.574 HG21 HD12 ' C' ' 126' ' ' LEU . 71.7 t -67.02 -46.59 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.664 0.786 . . . . 54.44 110.095 174.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.537 ' OG ' HG21 ' B' ' 115' ' ' THR . 36.9 t -63.51 -34.86 78.71 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.045 -0.979 . . . . 74.54 111.445 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -69.29 -43.57 73.57 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.305 -0.861 . . . . 71.11 109.355 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.75 -4.87 72.41 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.783 0.677 . . . . 60.53 112.802 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.5 p 61.9 34.83 16.7 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.776 2.03 . . . . 55.34 113.138 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.426 ' HB2' HG13 ' C' ' 118' ' ' VAL . 83.5 m-85 -88.09 159.74 47.56 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.397 1.079 . . . . 73.22 109.704 171.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.1 164.34 8.53 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 123.373 2.715 . . . . 71.41 114.639 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -55.32 133.22 49.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.871 1.268 . . . . 61.23 113.001 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.594 HD13 HG11 ' C' ' 64' ' ' VAL . 36.2 mt -117.38 108.77 15.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.794 0.837 . . . . 65.34 109.607 170.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.7 110.97 22.52 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.491 -0.929 . . . . 70.14 108.491 174.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.533 HD23 ' HG3' ' C' ' 111' ' ' ARG . 3.7 mm? -76.6 133.14 39.74 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.627 -0.509 . . . . 75.41 109.627 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.08 139.6 82.45 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 124.054 0.846 . . . . 74.12 111.133 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.58 96.43 0.42 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.647 2.231 . . . . 73.31 111.99 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.23 116.05 39.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.482 -1.303 . . . . 70.2 107.482 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -78.19 79.28 4.65 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.584 -0.895 . . . . 61.22 108.584 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -55.8 -34.22 65.12 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.867 0.867 . . . . 73.53 110.814 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -60.48 -51.29 70.09 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.854 1.262 . . . . 62.24 111.451 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.1 -38.8 92.39 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.046 0.539 . . . . 31.15 111.088 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.35 -27.8 67.43 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.374 -0.83 . . . . 55.04 111.338 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 137' ' ' PHE . . . . . 0.411 ' CE2' ' HA3' ' C' ' 99' ' ' GLY . 3.4 t80 . . . . . 0 N--CA 1.486 1.362 0 C-N-CA 123.283 0.633 . . . . 71.2 110.179 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 86.5 m . . . . . 0 CA--C 1.538 0.481 0 CA-C-O 121.237 0.541 . . . . 65.54 110.207 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -156.25 103.83 2.2 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.355 -1.35 . . . . 64.35 107.355 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -125.86 147.28 49.5 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.417 -0.957 . . . . 74.52 108.417 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.503 HG21 HD11 ' D' ' 16' ' ' ILE . 8.7 mt -95.85 129.51 45.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.71 -0.848 . . . . 74.21 108.71 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -87.08 -37.35 17.5 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.457 0.703 . . . . 73.12 111.711 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -167.82 124.71 1.12 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.004 0.372 . . . . 72.0 112.004 -170.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.503 HD11 HG21 ' D' ' 13' ' ' ILE . 2.0 mp -104.15 132.49 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.133 -1.432 . . . . 63.51 107.133 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.439 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 21.6 p90 -162.91 153.21 16.32 Favored 'General case' 0 C--N 1.337 0.061 0 O-C-N 123.652 0.595 . . . . 75.43 110.908 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -84.32 123.33 30.06 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.874 -0.787 . . . . 62.12 108.874 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.439 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.8 mtpt -92.25 -22.91 19.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.46 -0.57 . . . . 73.31 109.46 175.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.3 t70 -152.52 140.24 19.9 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.612 0.765 . . . . 74.45 109.496 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.575 HG21 ' HE2' ' C' ' 117' ' ' MET . 78.0 mt -139.83 145.6 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.805 -1.183 . . . . 74.24 107.805 174.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 58.6 m -148.5 121.45 8.78 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.431 1.093 . . . . 72.51 109.718 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.542 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 92.6 t80 -124.13 117.68 25.18 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.296 -1.742 . . . . 72.43 106.296 166.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.578 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 31.6 mt-10 -127.92 109.29 11.45 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.62 -0.511 . . . . 64.14 109.62 -174.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.41 85.91 17.04 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 108.099 -1.075 . . . . 62.05 108.099 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.83 -26.93 15.19 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.502 2.134 . . . . 75.34 112.092 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -104.24 8.37 36.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.884 0.874 . . . . 74.31 110.259 -174.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.428 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -32.99 -68.68 0.15 Allowed Pre-proline 0 CA--C 1.567 1.617 0 N-CA-C 116.32 1.97 . . . . 72.45 116.32 -165.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.459 ' HB3' HD11 ' C' ' 83' ' ' ILE . 75.7 Cg_endo -73.06 -21.49 20.55 Favored 'Trans proline' 0 C--N 1.384 2.423 0 CA-C-N 123.598 2.321 . . . . 65.44 113.699 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -74.47 -39.84 62.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.823 1.249 . . . . 72.12 110.004 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.4 p -83.67 -24.74 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.076 0.55 . . . . 64.11 112.274 -170.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.92 -19.03 63.84 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 122.867 0.467 . . . . 73.5 112.157 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -69.03 0.06 5.07 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.348 1.059 . . . . 73.14 111.933 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -110.72 100.85 9.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.881 1.272 . . . . 74.21 109.949 168.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.31 90.01 4.96 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.341 0.591 . . . . 74.44 109.598 171.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' D' ' 39' ' ' GLU . 19.7 t90 -154.32 156.11 36.34 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.1 -1.444 . . . . 64.14 107.1 174.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -70.58 107.88 2.98 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.398 -1.334 . . . . 75.41 107.398 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.458 ' O ' HG13 ' D' ' 40' ' ' VAL . 50.6 Cg_exo -55.21 125.55 19.53 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.89 2.394 . . . . 62.11 111.473 -171.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.464 ' HB2' ' CH2' ' D' ' 36' ' ' TRP . 34.1 tt0 -58.48 110.66 1.02 Allowed 'General case' 0 C--N 1.353 0.756 0 O-C-N 124.172 0.92 . . . . 74.43 109.667 -177.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.458 HG13 ' O ' ' D' ' 38' ' ' PRO . 16.2 m -98.25 122.36 49.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 121.607 0.717 . . . . 74.23 110.455 -171.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.421 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 53.3 tttm -86.27 132.28 34.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 106.392 -1.707 . . . . 63.22 106.392 165.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.21 109.15 12.0 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.326 -0.99 . . . . 54.03 108.326 -169.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -127.41 149.75 49.94 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.387 1.075 . . . . 64.04 108.387 -176.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.51 HD21 HD21 ' D' ' 60' ' ' LEU . 8.4 tt -139.43 139.25 37.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.076 -0.713 . . . . 73.21 109.076 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -133.54 139.7 46.75 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.384 1.474 . . . . 61.11 107.31 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -105.82 164.73 11.71 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.074 -0.713 . . . . 74.1 109.074 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.54 160.55 40.61 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.879 0.872 . . . . 73.11 108.899 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -159.15 151.22 20.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.053 0.541 . . . . 70.1 110.046 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.2 p -160.64 129.84 4.88 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.053 0.941 . . . . 74.33 109.167 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -73.93 133.64 43.09 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.19 0.596 . . . . 62.32 110.251 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 54.2 mt -100.76 -34.5 9.81 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.248 0.619 . . . . 42.22 110.717 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.96 -176.24 5.38 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.807 0.843 . . . . 54.54 109.974 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.85 121.62 14.48 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.108 -0.951 . . . . 74.31 109.933 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 65.61 2.93 2.23 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.886 1.275 . . . . 75.22 113.101 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.0 t -112.67 116.41 52.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.327 -0.99 . . . . 72.34 108.327 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -133.53 130.48 38.53 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.091 -1.077 . . . . 74.42 108.091 -171.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -98.65 143.81 28.62 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.923 0.889 . . . . 74.52 109.48 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 54.8 t -120.04 137.66 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.78 -1.193 . . . . 63.22 107.78 166.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.476 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.3 t -116.0 126.58 73.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.788 -1.19 . . . . 71.25 107.788 175.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.51 HD21 HD21 ' D' ' 44' ' ' LEU . 0.0 OUTLIER -104.17 117.41 34.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.619 -0.882 . . . . 60.11 108.619 -177.268 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -102.84 96.35 6.78 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.66 -0.867 . . . . 72.43 108.66 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 50.7 t -96.31 130.22 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.21 -1.033 . . . . 55.03 108.21 170.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 19.2 m -128.9 132.99 47.73 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.273 0.629 . . . . 43.11 110.446 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 69.1 t -126.29 112.39 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.736 1.214 . . . . 74.43 109.555 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 30.7 m -103.1 96.04 6.52 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.493 0.717 . . . . 44.32 109.301 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.13 153.83 17.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.95 0.5 . . . . 71.22 111.2 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.444 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.6 p -152.37 127.63 9.86 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.925 -0.579 . . . . 71.03 111.276 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.412 HD12 HG22 ' D' ' 31' ' ' VAL . 25.2 mt -95.76 101.71 13.43 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.967 -1.123 . . . . 73.41 107.967 170.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 69' ' ' GLY . . . . . 0.442 ' H ' ' HZ3' ' D' ' 36' ' ' TRP . . . 68.14 -118.6 9.63 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 123.63 0.581 . . . . 42.14 113.797 177.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.76 5.3 46.63 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.629 0.771 . . . . 71.34 113.053 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.21 164.49 32.11 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 120.89 0.376 . . . . 75.14 110.791 -174.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.1 m -68.15 132.03 46.47 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.045 -0.98 . . . . 73.13 110.697 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -86.74 -71.98 0.53 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.711 -1.218 . . . . 75.33 107.711 174.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -141.43 151.37 43.35 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 121.318 0.58 . . . . 73.35 110.436 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 72.2 mt -111.41 146.37 37.29 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.565 -1.272 . . . . 71.03 107.565 171.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.511 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.2 m -146.69 132.46 18.97 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.876 0.87 . . . . 74.31 108.686 -174.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -155.7 126.24 6.81 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.138 -1.06 . . . . 73.03 108.138 170.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.1 t -131.15 115.28 29.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 108.911 -0.774 . . . . 75.34 108.911 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 70.7 mt-30 -93.1 85.59 5.12 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.966 -0.753 . . . . 71.11 108.966 173.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.09 97.11 6.71 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.516 -1.22 . . . . 64.33 109.022 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.7 144.03 20.22 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.862 -0.495 . . . . 71.23 111.862 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.416 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -140.06 130.04 4.5 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 111.037 -0.825 . . . . 41.43 111.037 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.409 HG13 ' HE1' ' D' ' 17' ' ' TYR . 54.5 mt -90.54 123.95 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.989 -1.115 . . . . 71.04 107.989 177.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -123.95 136.06 54.07 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.638 0.775 . . . . 75.35 110.13 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 20.8 m -93.3 112.08 23.91 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.442 -0.947 . . . . 73.42 108.442 171.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 31.4 pt -108.19 122.27 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-O 121.19 0.519 . . . . 73.24 110.211 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -147.47 154.41 40.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.529 1.132 . . . . 51.32 109.072 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.23 -19.63 7.98 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 114.054 0.382 . . . . 61.4 114.054 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -127.3 154.49 37.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 124.448 1.099 . . . . 72.13 109.332 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.49 159.39 22.03 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 123.632 0.582 . . . . 75.34 110.695 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.61 -99.16 0.08 OUTLIER Glycine 0 C--N 1.355 1.597 0 O-C-N 124.218 0.949 . . . . 71.35 114.763 170.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 25.6 m -68.42 -44.38 75.12 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.246 1.018 . . . . 54.03 111.453 -174.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -72.61 -29.54 63.58 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.056 -0.52 . . . . 73.34 110.563 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 35.1 ttp -60.25 -34.97 74.45 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 123.662 0.601 . . . . 75.03 110.35 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.16 82.07 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 122.306 -0.247 . . . . 31.14 111.438 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -80.08 -43.94 20.9 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.284 0.634 . . . . 61.42 111.945 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 43.8 t -74.29 -42.57 59.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.361 0.664 . . . . 74.44 110.703 -172.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.542 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 15.0 tp -87.93 -33.84 18.32 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.362 1.065 . . . . 70.15 110.45 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.22 -26.09 29.37 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-N 116.356 -0.383 . . . . 72.23 113.948 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.18 -57.88 2.04 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 117.186 0.493 . . . . 70.55 111.389 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -70.13 -33.83 72.3 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.553 0.575 . . . . 64.45 112.553 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 69.4 m -67.36 -49.55 42.49 Favored Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 118.477 -0.773 . . . . 52.32 111.825 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.38 -30.06 90.13 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 121.864 1.71 . . . . 62.41 113.727 168.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -64.78 -37.98 89.44 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.516 0.726 . . . . 73.0 110.118 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.4 HG21 HD13 ' D' ' 13' ' ' ILE . 30.5 mm -62.94 -45.48 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.722 0.809 . . . . 64.12 110.873 173.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.416 HD21 ' HA3' ' D' ' 82' ' ' GLY . 83.2 mt -77.25 -18.18 57.82 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.926 -1.034 . . . . 71.22 112.399 -170.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -69.69 -42.12 18.15 Favored Pre-proline 0 N--CA 1.486 1.329 0 N-CA-C 113.914 1.079 . . . . 70.01 113.914 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.69 -41.75 60.12 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.033 1.822 . . . . 52.23 113.107 169.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -75.36 -35.15 61.17 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.975 0.91 . . . . 73.41 111.6 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.24 -46.55 67.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.01 0.524 . . . . 64.34 110.192 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -53.67 -49.12 68.67 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.751 1.282 . . . . 65.41 110.73 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.72 -45.77 92.54 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.308 1.005 . . . . 75.33 111.977 -175.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.4 t -63.15 -39.57 95.06 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.63 0.581 . . . . 54.22 111.231 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.457 ' O ' HG23 ' D' ' 118' ' ' VAL . 86.2 mt -59.76 -55.49 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.554 0.741 . . . . 62.05 110.093 172.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 38.3 m -56.68 -40.16 75.08 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.804 1.242 . . . . 74.41 112.005 -174.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -68.35 -40.62 81.48 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.06 -0.973 . . . . 74.33 110.561 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 68.5 mtm -68.33 -33.2 73.88 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.611 0.365 . . . . 71.21 111.524 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.8 t -63.65 -43.46 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.601 0.761 . . . . 64.34 110.36 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.89 -30.93 61.45 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 116.178 -0.464 . . . . 65.31 111.206 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -74.18 -26.15 60.12 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.205 0.602 . . . . 73.11 110.32 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.44 7.96 74.94 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.646 0.591 . . . . 63.2 112.404 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.447 HG23 ' HB3' ' C' ' 17' ' ' TYR . 44.3 p 61.11 17.21 7.84 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.514 1.926 . . . . 62.32 114.81 174.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.09 150.97 72.44 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 109.558 -0.534 . . . . 72.44 109.558 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.6 127.87 22.04 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.116 2.544 . . . . 53.01 111.448 171.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -51.65 145.31 9.39 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.676 1.235 . . . . 74.41 113.007 -171.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.427 HD13 HG11 ' D' ' 40' ' ' VAL . 56.8 tp -117.05 106.19 13.11 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.692 -0.686 . . . . 73.44 109.538 -175.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -101.95 104.19 14.87 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.037 -0.727 . . . . 74.41 109.037 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.82 118.35 13.5 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.156 -0.683 . . . . 65.45 109.156 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 135.76 89.24 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.214 0.605 . . . . 75.31 110.137 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.84 119.34 6.35 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.63 2.22 . . . . 72.32 112.314 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 82.8 t -108.85 115.55 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.083 0.953 . . . . 74.32 108.916 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -77.79 113.2 15.42 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.943 0.497 . . . . 54.24 110.037 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -72.22 -35.88 68.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.684 0.793 . . . . 72.24 111.509 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.47 -50.35 74.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.412 1.085 . . . . 71.11 111.739 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.31 71.51 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.156 0.582 . . . . 54.23 110.636 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 34.4 mt -63.3 -23.76 67.56 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.41 0.684 . . . . 43.3 112.571 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 88.4 t80 . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 123.654 0.782 . . . . 71.13 110.238 178.946 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 109.82 -0.437 . . . . 72.04 109.82 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.695 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 17.3 t80 -127.14 131.07 50.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.303 1.041 . . . . 64.01 109.191 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 26.5 tp60 -147.79 107.34 3.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.276 0.631 . . . . 71.45 110.052 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.598 HG12 ' HD2' ' A' ' 84' ' ' PHE . 60.7 mt -75.02 120.58 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.586 -0.524 . . . . 71.02 109.586 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -89.63 -36.99 14.96 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 124.079 0.862 . . . . 73.04 110.027 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -169.15 146.0 3.52 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 110.454 -0.202 . . . . 73.01 110.454 -171.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 97.6 mt -137.9 128.37 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 124.544 1.138 . . . . 73.35 108.058 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.465 ' HB3' HG23 ' B' ' 122' ' ' THR . 44.3 p90 -167.83 154.63 8.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.716 0.806 . . . . 73.12 111.205 -172.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.7 p -75.14 112.82 11.79 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.238 -0.652 . . . . 73.22 109.238 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HG3' ' HA3' ' A' ' 81' ' ' GLY . 32.6 mtpt -71.61 -34.35 69.78 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.251 -0.431 . . . . 63.42 110.481 174.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -153.79 148.65 26.57 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.056 -0.974 . . . . 73.4 109.111 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 80.9 mt -138.19 148.77 24.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 C-N-CA 124.947 1.299 . . . . 63.31 108.043 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 17.9 t -147.14 142.3 27.19 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.892 0.877 . . . . 74.42 109.93 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.544 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.3 t80 -153.06 132.88 13.2 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.625 1.17 . . . . 71.41 107.859 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -139.85 135.1 32.59 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.499 1.119 . . . . 72.0 108.34 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.06 87.46 48.39 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 108.32 -0.993 . . . . 74.13 108.32 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.458 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 37.3 Cg_exo -64.09 -48.65 4.7 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.608 2.872 . . . . 74.1 113.107 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -91.96 24.43 3.24 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.784 0.834 . . . . 74.13 111.169 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.571 ' HB1' ' HE2' ' B' ' 17' ' ' TYR . . . -53.07 -48.91 90.23 Favored Pre-proline 0 CA--C 1.568 1.638 0 N-CA-C 114.837 1.421 . . . . 65.14 114.837 -173.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.47 -19.73 16.62 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 121.742 1.628 . . . . 75.3 111.94 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -100.64 -13.42 18.56 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.074 -0.966 . . . . 75.1 112.29 -170.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.56 -26.04 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.798 0.839 . . . . 51.15 112.055 -169.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -78.9 -33.77 45.28 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.988 -1.006 . . . . 52.41 110.413 176.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -82.43 -32.19 29.14 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.917 0.887 . . . . 74.34 111.568 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.97 161.1 26.89 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.299 -0.63 . . . . 73.23 109.299 175.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.36 134.67 56.16 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.145 0.578 . . . . 74.53 110.059 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -95.69 85.88 4.26 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.343 0.657 . . . . 63.3 110.715 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.55 ' H ' HD12 ' A' ' 68' ' ' LEU . 79.7 mt-30 -135.58 68.53 66.74 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 123.648 0.779 . . . . 75.24 109.005 169.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -78.72 159.21 28.18 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.169 1.913 . . . . 74.24 111.867 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -106.73 105.69 15.85 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.042 -1.095 . . . . 61.3 108.042 173.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 p -74.62 93.35 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 122.363 1.078 . . . . 73.13 110.274 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 49.4 mtpt -85.82 115.56 23.54 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.347 -1.297 . . . . 53.51 108.279 172.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.3 tp -116.05 134.8 54.56 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.146 -0.687 . . . . 75.22 109.146 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.662 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 32.4 t70 -128.62 146.68 50.79 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.301 1.04 . . . . 72.32 109.168 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.2 mt -128.45 125.09 37.79 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.184 0.994 . . . . 74.55 108.496 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 21.8 t0 -129.2 148.97 51.18 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.101 0.96 . . . . 55.22 109.413 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.0 m -144.14 138.42 28.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.252 1.021 . . . . 72.53 109.923 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.9 138.59 18.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.02 0.928 . . . . 64.34 109.324 169.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.6 m -90.36 162.42 15.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.138 0.575 . . . . 73.45 110.199 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.8 t -148.8 119.61 7.58 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.384 1.073 . . . . 63.42 108.231 -174.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -78.65 120.31 23.15 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.808 -0.442 . . . . 70.0 109.808 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.0 mt -92.17 -44.99 8.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.738 -0.838 . . . . 54.12 108.738 171.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.12 -178.88 6.75 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.157 -1.383 . . . . 71.44 108.88 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -74.57 133.34 42.24 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.897 -1.149 . . . . 73.31 107.897 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 70.27 -8.66 0.83 Allowed 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 125.489 1.516 . . . . 72.21 112.871 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.7 t -110.76 106.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 N-CA-C 108.863 -0.791 . . . . 74.23 108.863 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -130.36 121.65 26.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.732 0.777 . . . . 74.51 109.202 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -93.37 121.83 35.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 124.903 1.281 . . . . 64.12 109.396 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.07 132.97 45.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.898 -1.149 . . . . 52.14 107.898 176.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.6 t -120.1 115.59 47.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.585 -0.895 . . . . 42.52 108.585 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 tt -94.33 116.64 29.05 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.277 -1.008 . . . . 62.1 108.277 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.744 ' HG3' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -93.01 102.13 14.48 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.816 -0.809 . . . . 74.13 108.816 172.487 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.514 HG11 ' HB1' ' A' ' 110' ' ' ALA . 2.4 p -99.61 110.17 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 108.998 -0.742 . . . . 74.14 108.998 176.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.662 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 33.8 m -95.99 133.58 40.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.282 1.033 . . . . 71.2 109.055 -176.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.4 t -130.99 115.72 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 107.981 -1.118 . . . . 74.32 107.981 -174.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 16.8 m -127.39 108.24 10.67 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.732 -0.84 . . . . 74.32 108.732 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.61 103.44 14.26 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 106.828 -1.545 . . . . 75.24 106.828 171.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.4 p -136.71 127.4 27.14 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.181 0.592 . . . . 75.41 110.39 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.55 HD12 ' H ' ' A' ' 37' ' ' GLN . 6.4 tt -89.71 88.22 7.3 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 106.844 -1.539 . . . . 73.34 106.844 173.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.29 -83.86 0.97 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.257 -0.737 . . . . 62.41 111.257 178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -119.84 -26.25 5.68 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.87 0.868 . . . . 52.33 110.866 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -82.26 101.65 10.65 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.372 0.269 . . . . 72.44 111.016 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 26' ' ' PRO . 61.6 m -70.35 112.8 6.93 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.334 0.654 . . . . 64.23 109.842 173.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.61 -59.4 4.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.174 0.989 . . . . 71.13 109.476 171.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -149.16 160.92 42.93 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.997 -1.002 . . . . 73.24 111.029 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 64' ' ' VAL . 49.1 tp -141.33 133.66 28.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.548 1.539 . . . . 63.11 107.3 -175.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.55 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 35.0 m -147.28 120.29 8.79 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 118.807 0.73 . . . . 55.14 110.381 -171.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 9.5 mp0 -128.09 128.8 45.56 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.012 -1.107 . . . . 72.44 108.012 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.7 t -131.24 110.67 18.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.34 -0.615 . . . . 73.31 109.34 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.744 ' HG3' ' HG3' ' A' ' 61' ' ' ARG . 15.5 mp0 -85.04 79.43 9.63 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.474 -1.306 . . . . 75.22 107.474 174.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.44 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.4 tp-100 -78.21 97.27 5.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.801 -1.185 . . . . 63.41 107.801 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 19' ' ' LYS . . . -93.91 147.2 18.49 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.041 -0.823 . . . . 34.14 111.041 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.41 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -148.78 126.87 2.37 Favored Glycine 0 CA--C 1.499 -0.929 0 N-CA-C 110.264 -1.134 . . . . 64.32 110.264 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 60.6 mt -82.38 114.28 23.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.653 -0.869 . . . . 72.23 108.653 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.695 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.6 m-85 -122.46 119.14 30.08 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.66 -0.867 . . . . 75.32 108.66 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 23.1 t -84.63 91.13 7.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.064 -0.717 . . . . 73.13 109.064 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -100.39 128.48 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.502 0.668 . . . . 55.32 109.23 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.89 154.75 44.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.939 1.296 . . . . 55.14 108.496 -175.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.19 9.54 81.93 Favored Glycine 0 N--CA 1.48 1.618 0 C-N-CA 121.673 -0.299 . . . . 41.31 113.715 172.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.533 HG22 ' HB3' ' A' ' 93' ' ' GLN . 0.9 OUTLIER -127.17 138.2 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.269 1.028 . . . . 61.51 110.772 -174.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -142.43 173.26 11.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.226 1.011 . . . . 73.01 109.707 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.92 -117.16 10.67 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.703 -0.681 . . . . 55.01 113.524 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.3 p -86.64 -26.63 24.27 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.702 0.801 . . . . 71.35 112.365 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.533 ' HB3' HG22 ' A' ' 89' ' ' ILE . 16.5 mm100 -60.09 -43.97 95.15 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.44 0.696 . . . . 73.31 110.512 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -62.85 -40.37 97.24 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.249 -0.887 . . . . 74.13 110.888 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.7 -26.04 62.34 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.616 0.766 . . . . 65.41 110.568 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -78.09 -30.47 49.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.243 0.617 . . . . 73.31 110.514 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.478 ' SG ' HG21 ' A' ' 89' ' ' ILE . 72.0 m -70.74 -64.84 0.82 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.48 -0.327 . . . . 61.42 110.531 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.51 -9.19 53.26 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.206 0.817 . . . . 71.32 113.206 -171.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.6 3.53 32.49 Favored Glycine 0 N--CA 1.48 1.631 0 CA-C-O 119.791 -0.449 . . . . 74.11 113.635 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.65 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.25 -64.05 0.31 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.287 0.543 . . . . 75.14 111.414 -176.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.471 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 84.2 t80 -70.5 -51.65 27.44 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.244 -0.889 . . . . 62.44 111.588 -172.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -72.9 -36.11 3.26 Favored Pre-proline 0 CA--C 1.566 1.564 0 N-CA-C 113.859 1.059 . . . . 63.04 113.859 -172.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.495 ' HA ' HD12 ' A' ' 106' ' ' LEU . 30.4 Cg_endo -65.39 -26.9 55.24 Favored 'Trans proline' 0 C--N 1.39 2.727 0 CA-C-N 121.732 1.654 . . . . 73.05 112.507 167.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.84 -25.86 62.14 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.505 0.322 . . . . 64.52 110.252 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -62.84 -36.49 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.467 0.707 . . . . 71.22 109.926 170.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 103' ' ' PRO . 65.5 mt -78.11 -23.23 47.96 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.298 1.039 . . . . 70.1 112.36 -178.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -61.81 -43.48 87.59 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 117.797 -1.097 . . . . 73.33 113.672 -172.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.56 -38.75 60.08 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.124 1.883 . . . . 74.35 113.076 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -69.44 -41.45 76.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.374 0.669 . . . . 75.14 111.057 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.514 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -67.61 -42.41 82.42 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.499 0.719 . . . . 73.14 110.128 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.589 ' HA ' HD23 ' A' ' 128' ' ' LEU . 29.8 ttm180 -51.17 -53.33 35.77 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.833 1.333 . . . . 55.0 110.256 175.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -66.16 -42.33 89.13 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.436 1.085 . . . . 73.12 111.214 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.4 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.9 t -60.88 -34.77 75.15 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.249 0.619 . . . . 74.42 111.398 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 81.0 mt -73.75 -51.66 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.815 0.846 . . . . 51.23 109.837 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.564 HG23 ' HG3' ' A' ' 125' ' ' GLN . 95.4 m -52.35 -51.28 59.71 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.334 1.054 . . . . 52.12 111.359 -174.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -65.42 -44.0 88.75 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.117 -1.401 . . . . 73.01 110.461 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.544 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 43.0 ttp -67.2 -35.45 79.64 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.03 0.932 . . . . 64.1 111.9 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.91 -40.39 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.246 1.018 . . . . 71.34 110.037 174.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -71.71 -25.42 62.07 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.952 0.901 . . . . 73.53 111.304 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -76.29 -25.92 55.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.756 0.822 . . . . 74.0 109.605 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.04 0.12 88.95 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.826 0.704 . . . . 75.23 112.712 171.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.3 m 67.88 15.98 9.61 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.848 1.259 . . . . 74.15 111.679 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.96 156.71 69.62 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.373 0.669 . . . . 73.13 109.365 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.85 141.96 92.76 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.476 2.117 . . . . 71.12 111.554 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.564 ' HG3' HG23 ' A' ' 115' ' ' THR . 29.7 tt0 -55.03 134.77 49.25 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.192 0.933 . . . . 72.43 111.78 -175.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.7 tp -118.69 98.97 6.49 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.492 -0.776 . . . . 74.34 110.287 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -100.18 113.21 25.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.379 -1.341 . . . . 64.12 107.379 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.589 HD23 ' HA ' ' A' ' 111' ' ' ARG . 2.6 mm? -72.85 128.41 35.43 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.149 0.58 . . . . 71.2 109.522 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -56.03 135.48 73.92 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.632 0.773 . . . . 50.4 111.235 -178.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.534 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 42.8 Cg_exo -58.08 98.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.727 2.285 . . . . 74.15 112.762 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 129' ' ' ALA . 95.3 t -100.18 113.99 37.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.371 -0.974 . . . . 73.24 108.371 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -84.74 102.4 12.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.671 0.388 . . . . 73.43 110.045 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -63.67 -25.28 68.14 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.927 0.891 . . . . 70.21 111.468 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.65 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 7.2 t70 -65.96 -48.71 70.42 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.111 0.882 . . . . 74.52 110.432 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.37 -39.57 94.89 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.61 0.764 . . . . 70.52 111.334 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.94 -40.73 83.22 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.15 -0.932 . . . . 74.04 111.081 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -68.0 -38.45 82.65 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.191 -0.913 . . . . 72.32 109.5 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.354 0.765 0 O-C-N 124.228 0.955 . . . . 73.32 110.624 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 108.579 -0.897 . . . . 72.52 108.579 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.97 157.42 43.41 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.485 0.66 . . . . 74.44 110.21 160.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -125.45 139.11 53.92 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 107.757 -1.201 . . . . 72.11 107.757 172.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.496 HD11 HD13 ' B' ' 105' ' ' ILE . 50.4 mt -76.66 120.41 26.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.482 -0.932 . . . . 62.11 108.482 173.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -83.5 -39.61 20.25 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.075 -0.713 . . . . 75.01 109.075 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -165.73 135.78 3.51 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.597 -0.729 . . . . 74.34 110.277 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.479 HD11 HD13 ' B' ' 13' ' ' ILE . 79.9 mt -114.96 140.73 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 106.411 -1.7 . . . . 73.52 106.411 168.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.571 ' HE2' ' HB1' ' A' ' 28' ' ' ALA . 36.4 p90 -171.49 170.62 5.74 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.597 0.713 . . . . 73.15 112.041 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.684 HG21 HD11 ' B' ' 21' ' ' ILE . 24.8 m -98.11 130.72 44.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.546 -1.206 . . . . 71.3 108.792 174.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -96.26 -34.47 11.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.875 0.87 . . . . 73.11 110.407 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -148.98 136.34 20.19 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.792 -0.64 . . . . 71.02 110.555 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.684 HD11 HG21 ' B' ' 18' ' ' THR . 47.0 mm -127.98 138.62 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.222 1.009 . . . . 65.43 108.915 171.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 39.8 t -135.66 129.55 32.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.228 1.411 . . . . 71.12 107.217 174.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.4 t80 -139.7 119.79 13.65 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 107.155 -1.424 . . . . 54.04 107.155 168.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.52 113.83 19.26 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.249 -0.648 . . . . 72.2 109.249 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.644 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.59 84.55 1.95 Allowed Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 107.556 -1.276 . . . . 74.11 107.556 166.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.19 -22.83 18.66 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.748 2.299 . . . . 60.22 111.385 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.413 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 89.2 m-20 -116.55 7.81 13.78 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.664 1.186 . . . . 62.23 110.898 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.644 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -29.02 -62.62 0.21 Allowed Pre-proline 0 N--CA 1.491 1.576 0 C-N-CA 126.244 1.817 . . . . 71.25 115.186 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 21.2 Cg_exo -61.9 -49.47 6.69 Favored 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 122.183 1.922 . . . . 75.2 112.122 -170.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 77.4 m80 -88.92 -11.9 43.19 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.052 -0.977 . . . . 73.31 112.251 -171.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.718 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.4 p -81.08 -23.36 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 CA-C-N 118.303 0.501 . . . . 72.05 110.525 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -64.77 -18.96 65.53 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.929 0.892 . . . . 64.24 113.331 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.9 pt20 -66.21 -23.3 66.41 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.882 0.473 . . . . 63.42 111.043 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -83.98 95.67 8.61 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.295 0.638 . . . . 55.44 109.589 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.38 83.32 1.93 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.922 0.889 . . . . 75.12 109.352 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.414 ' HZ3' ' H ' ' B' ' 69' ' ' GLY . 28.3 t90 -159.08 155.93 28.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.947 -1.024 . . . . 71.33 109.156 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -83.03 108.31 12.22 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.057 0.943 . . . . 73.0 108.502 169.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.556 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 55.6 Cg_endo -68.66 129.53 18.97 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.418 2.079 . . . . 72.32 112.294 -173.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.89 123.48 18.14 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 123.897 0.748 . . . . 73.4 110.164 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.517 HG11 HD21 ' B' ' 126' ' ' LEU . 33.0 m -104.0 150.68 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.463 0.705 . . . . 75.3 111.785 -169.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -133.57 119.85 20.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.542 -0.91 . . . . 74.42 108.542 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.22 144.26 25.47 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.782 0.833 . . . . 73.4 109.625 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.665 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 10.2 m-20 -136.08 115.32 12.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.716 1.207 . . . . 55.15 108.368 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.9 149.47 23.37 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.415 -0.587 . . . . 74.11 109.415 177.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.9 t70 -155.62 114.23 3.48 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.353 -0.98 . . . . 74.12 108.353 177.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -113.7 103.85 11.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.23 0.612 . . . . 71.22 109.656 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.24 118.46 32.35 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.638 0.775 . . . . 62.34 109.281 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 14.0 p -102.82 162.28 13.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.983 0.513 . . . . 63.54 110.755 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -151.82 136.84 17.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.057 0.943 . . . . 73.52 109.33 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -80.87 112.25 18.08 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.358 0.663 . . . . 75.12 109.721 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' B' ' 57' ' ' GLU . 75.3 mt -81.39 -54.06 5.78 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.31 0.576 . . . . 44.44 111.023 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.409 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -144.34 -163.74 1.75 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.372 1.069 . . . . 74.3 109.362 -176.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.42 100.95 0.53 Allowed 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.966 0.791 . . . . 74.04 109.432 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 22.1 m-20 62.13 15.7 7.65 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.582 1.153 . . . . 55.44 112.839 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 95.5 t -104.39 123.89 58.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 106.085 -1.82 . . . . 73.03 106.085 169.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.91 167.22 21.61 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.944 -0.761 . . . . 74.12 108.944 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.528 ' HB2' HD11 ' B' ' 51' ' ' LEU . 12.1 tt0 -124.38 120.7 32.87 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.608 -0.886 . . . . 71.51 108.608 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.1 t -88.19 137.72 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.714 -0.847 . . . . 62.23 108.714 170.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 56.3 t -120.88 110.39 28.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.484 -0.932 . . . . 71.32 108.484 175.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.05 99.08 11.45 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.712 -1.218 . . . . 74.24 107.712 177.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.485 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 13.2 ttm180 -87.27 113.11 22.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.595 -0.729 . . . . 64.1 109.429 170.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.54 123.84 63.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.764 -1.198 . . . . 73.13 107.764 170.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.665 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 6.9 m -118.55 134.75 54.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.926 -0.768 . . . . 54.44 108.926 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.464 HG23 HD13 ' B' ' 114' ' ' ILE . 88.1 t -122.45 127.92 75.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 123.964 0.906 . . . . 72.33 108.636 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.5 m -112.22 147.57 35.92 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 124.265 1.026 . . . . 60.21 108.739 172.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.23 147.21 33.29 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.439 0.696 . . . . 74.45 109.831 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.1 p -137.48 125.99 23.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.408 0.683 . . . . 72.11 110.381 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.653 HD12 HG22 ' B' ' 31' ' ' VAL . 42.2 mt -93.18 99.88 12.37 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 106.979 -1.489 . . . . 75.53 106.979 171.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.414 ' H ' ' HZ3' ' B' ' 36' ' ' TRP . . . 77.58 -118.55 5.06 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.492 -0.776 . . . . 72.45 112.651 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -103.33 14.77 30.77 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.128 0.971 . . . . 74.14 111.076 -171.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.413 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.9 pt-20 -147.84 156.49 42.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.721 0.808 . . . . 74.43 110.209 -173.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 86.7 m -66.26 135.83 55.0 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.698 0.624 . . . . 50.11 110.755 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.718 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -89.68 -62.57 1.44 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.584 -0.895 . . . . 73.43 108.584 174.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -150.92 157.88 43.46 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.095 -1.411 . . . . 54.4 109.96 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -132.34 138.63 47.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.766 -1.568 . . . . 61.31 106.766 175.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.424 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 49.8 t -142.65 151.01 40.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.467 -0.938 . . . . 42.04 108.467 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 44.8 tt0 -161.96 126.91 3.4 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.717 -0.845 . . . . 72.54 108.717 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.68 144.07 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 123.84 0.856 . . . . 61.24 108.934 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -115.16 91.2 3.54 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.36 -0.978 . . . . 73.53 108.36 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -81.19 97.63 7.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.545 -0.909 . . . . 73.03 108.545 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.96 142.7 16.14 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.129 -0.788 . . . . 74.25 111.129 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.85 128.86 3.58 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.123 -0.791 . . . . 74.33 111.123 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.7 mt -87.98 126.86 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.843 0.857 . . . . 63.24 109.837 175.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -134.47 134.6 41.72 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.501 -1.296 . . . . 72.33 107.501 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -109.38 93.02 4.29 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.036 0.535 . . . . 74.13 110.205 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 30.0 pt -94.38 144.85 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.327 0.584 . . . . 73.01 112.445 -167.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.79 146.86 19.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.915 1.286 . . . . 75.45 107.926 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.4 -25.85 26.21 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-O 119.884 -0.398 . . . . 64.41 113.761 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' B' ' 94' ' ' MET . 5.4 pt -84.31 165.56 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 117.48 0.64 . . . . 71.44 111.664 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -171.8 175.32 3.96 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.047 1.339 . . . . 74.41 108.726 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.21 -125.6 8.25 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.931 -0.468 . . . . 54.24 111.931 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.2 m -103.32 -13.14 16.81 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.511 0.724 . . . . 71.24 109.434 170.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -62.34 -27.78 69.29 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.148 0.979 . . . . 74.01 109.971 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.599 ' HA ' HD12 ' B' ' 89' ' ' ILE . 25.4 ptt? -71.06 -37.39 72.49 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.54 -0.754 . . . . 75.23 110.789 171.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.04 -21.24 59.17 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 115.451 -0.795 . . . . 74.02 110.766 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -76.99 -28.43 55.08 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.12 0.568 . . . . 71.22 111.425 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.24 -37.69 75.39 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.834 0.709 . . . . 72.15 110.052 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -102.8 -9.12 20.23 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.736 0.814 . . . . 74.52 111.819 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.32 -25.39 57.26 Favored Glycine 0 N--CA 1.475 1.265 0 C-N-CA 123.677 0.656 . . . . 75.12 112.728 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.47 -56.52 0.11 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.096 -0.552 . . . . 71.14 110.975 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -55.24 -54.81 38.7 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.604 1.162 . . . . 73.21 112.187 -168.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 78.9 m -69.62 -48.74 23.23 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 118.191 -0.909 . . . . 62.25 112.032 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -50.81 -35.79 49.83 Favored 'Trans proline' 0 C--N 1.399 3.195 0 C-N-CA 122.61 2.207 . . . . 73.22 113.929 170.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -75.15 -23.87 57.87 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.531 0.732 . . . . 72.1 111.701 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.496 HD13 HD11 ' B' ' 13' ' ' ILE . 83.2 mt -70.01 -44.14 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.089 -0.708 . . . . 63.32 109.089 168.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -80.6 -21.46 41.57 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.831 -1.077 . . . . 74.11 112.448 -173.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -62.48 -46.11 89.49 Favored Pre-proline 0 N--CA 1.487 1.394 0 N-CA-C 113.754 1.02 . . . . 62.22 113.754 -169.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.83 -35.71 98.17 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.859 1.706 . . . . 74.52 112.817 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -68.66 -45.31 72.11 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.991 0.517 . . . . 74.43 110.066 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.52 -37.53 78.56 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.689 0.796 . . . . 54.13 110.487 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -62.33 -57.88 9.71 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.29 1.036 . . . . 71.52 110.694 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -65.34 -28.88 69.61 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.988 0.805 . . . . 70.11 110.655 -173.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.488 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.3 t -75.09 -36.05 61.74 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.903 0.481 . . . . 74.42 111.377 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.464 HD13 HG23 ' B' ' 64' ' ' VAL . 81.7 mt -66.96 -52.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.671 -0.492 . . . . 61.11 109.671 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.458 HG21 ' OG ' ' C' ' 119' ' ' SER . 28.6 m -58.24 -33.56 69.49 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 124.339 1.024 . . . . 75.41 111.568 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 22.7 t -58.49 -53.94 52.62 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 123.813 0.696 . . . . 63.33 109.85 175.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.6 mmt -69.64 -35.22 75.03 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.493 0.717 . . . . 73.53 111.723 -171.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.98 -45.58 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.635 0.774 . . . . 71.22 110.428 174.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.41 ' OG ' HG21 ' C' ' 115' ' ' THR . 47.0 t -68.6 -32.58 72.56 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.969 -1.014 . . . . 65.42 111.357 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.7 mtt-85 -65.62 -37.2 85.93 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.552 -0.749 . . . . 74.0 109.389 175.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.37 5.0 65.2 Favored Glycine 0 C--N 1.357 1.72 0 O-C-N 124.213 0.946 . . . . 63.15 113.511 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.465 HG23 ' HB3' ' A' ' 17' ' ' TYR . 82.3 p 57.28 35.63 26.34 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.827 1.651 . . . . 72.34 112.96 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -95.26 162.53 24.43 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.83 0.852 . . . . 73.3 110.214 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.24 159.84 7.37 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 123.717 2.944 . . . . 72.32 114.19 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -66.4 117.39 8.57 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.058 -0.973 . . . . 72.54 111.757 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.517 HD21 HG11 ' B' ' 40' ' ' VAL . 10.2 mp -120.13 127.42 52.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.146 0.978 . . . . 73.15 109.455 173.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -123.75 134.8 53.61 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.539 -0.911 . . . . 44.33 108.539 168.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.08 125.72 27.57 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.004 0.922 . . . . 75.31 109.892 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.28 151.14 87.75 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 124.011 0.924 . . . . 70.41 111.5 -176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.23 120.33 7.47 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.008 2.472 . . . . 71.44 112.431 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.9 t -118.33 112.7 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.941 -1.133 . . . . 54.11 107.941 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -79.13 84.86 5.07 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.838 -0.801 . . . . 63.55 108.838 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.72 -23.55 67.22 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.571 0.748 . . . . 75.02 111.83 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.07 -48.66 62.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.771 0.828 . . . . 71.11 110.696 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.43 95.39 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.683 -1.144 . . . . 75.3 110.306 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -71.53 -31.21 66.79 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.254 -1.339 . . . . 74.54 111.868 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 51.4 t80 . . . . . 0 N--CA 1.48 1.036 0 C-N-CA 122.717 0.407 . . . . 74.21 110.723 -176.622 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 10.6 m . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 107.943 -1.132 . . . . 62.34 107.943 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.933 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 62.5 t80 -123.41 121.33 35.48 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.655 -1.239 . . . . 64.41 107.655 174.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -137.21 122.76 19.69 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.168 -0.679 . . . . 63.42 109.168 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.04 125.35 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.807 -0.812 . . . . 73.05 108.807 172.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.564 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 29.3 mm-40 -91.97 -42.85 9.78 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.695 0.798 . . . . 71.31 109.306 175.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -175.61 138.58 0.39 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.63 -0.878 . . . . 64.22 108.63 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -127.91 141.67 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.862 -1.162 . . . . 60.14 107.862 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -170.57 161.18 7.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.714 0.768 . . . . 74.1 111.582 -171.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 18' ' ' THR . . . . . 0.457 HG21 ' SG ' ' C' ' 113' ' ' CYS . 68.3 p -83.95 107.47 16.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.753 -1.112 . . . . 71.3 108.338 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -68.81 -41.67 78.31 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.309 -0.996 . . . . 72.51 108.309 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 26.8 t70 -139.27 142.32 37.76 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 114.381 -1.282 . . . . 74.01 109.555 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.617 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.4 mt -135.99 145.35 31.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.548 1.539 . . . . 72.02 106.911 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -154.28 149.36 26.87 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.463 0.705 . . . . 73.42 109.504 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -155.82 109.01 2.71 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.2 -1.037 . . . . 74.21 108.2 174.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -119.3 111.9 18.78 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.266 0.626 . . . . 72.51 110.352 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -110.64 87.64 6.85 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 106.732 -1.581 . . . . 65.34 106.732 169.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.15 -23.65 24.39 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.698 2.266 . . . . 71.3 112.299 -170.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -121.39 29.71 7.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.367 1.067 . . . . 51.44 109.546 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.479 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -49.68 -53.54 40.54 Favored Pre-proline 0 CA--C 1.562 1.426 0 N-CA-C 114.031 1.123 . . . . 53.12 114.031 -171.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.468 ' HB3' HD13 ' D' ' 51' ' ' LEU . 26.3 Cg_exo -60.52 -48.72 10.55 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 121.671 1.581 . . . . 74.33 112.091 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -69.99 -27.08 64.42 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.244 -1.344 . . . . 63.3 112.27 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.767 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -79.54 -26.95 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 112.557 0.577 . . . . 72.53 112.557 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -68.19 -27.39 66.35 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.01 0.374 . . . . 73.21 112.01 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -89.9 9.62 26.95 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.441 0.696 . . . . 62.24 111.797 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.6 176.57 5.97 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.585 0.754 . . . . 65.31 110.065 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -76.93 124.37 27.65 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.47 0.708 . . . . 74.51 109.367 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 50.7 t90 -85.15 84.84 7.56 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.711 0.804 . . . . 75.14 111.157 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -142.56 79.92 14.88 Favored Pre-proline 0 N--CA 1.478 0.943 0 N-CA-C 107.334 -1.358 . . . . 74.54 107.334 164.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.42 139.95 14.9 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.678 2.252 . . . . 75.51 112.922 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.73 104.92 14.23 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 106.19 -1.781 . . . . 63.24 106.19 165.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.46 102.74 13.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.197 -1.365 . . . . 73.24 110.791 -169.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.546 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 54.4 mttp -91.84 111.13 22.54 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.489 -0.778 . . . . 75.23 109.005 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 pp -86.41 157.22 19.89 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.515 -0.55 . . . . 75.55 109.515 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.641 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.6 t70 -151.75 137.32 17.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.044 -1.095 . . . . 55.13 108.044 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 tt -137.97 137.2 37.7 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.556 -0.905 . . . . 73.32 108.556 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -148.21 125.58 11.6 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.973 1.309 . . . . 71.22 108.596 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m -114.22 126.35 54.95 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.431 0.634 . . . . 74.44 110.342 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.23 141.05 52.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.862 1.265 . . . . 73.25 107.805 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -152.24 143.68 23.39 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.851 0.46 . . . . 73.15 110.46 -170.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 80.5 p -148.43 151.93 36.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.211 0.605 . . . . 60.51 111.23 -171.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -79.22 136.89 37.2 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.466 0.706 . . . . 73.15 110.269 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.607 HD11 ' HB2' ' C' ' 57' ' ' GLU . 29.8 mt -110.12 -34.42 6.39 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.53 0.732 . . . . 71.04 110.245 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -154.47 179.82 8.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.36 0.664 . . . . 54.45 110.242 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -58.46 112.93 1.75 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.719 0.808 . . . . 64.51 109.907 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 64.12 9.82 5.0 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.672 1.189 . . . . 63.15 113.473 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 94.2 t -105.59 116.25 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.558 -1.275 . . . . 50.13 107.558 172.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.423 ' HB2' HD11 ' C' ' 86' ' ' ILE . 39.8 t80 -134.09 124.21 25.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.013 -0.736 . . . . 73.53 109.013 -175.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.607 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.3 tt0 -83.42 139.01 33.23 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.92 0.888 . . . . 74.41 109.635 175.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.403 HG11 ' HD3' ' C' ' 103' ' ' PRO . 42.0 t -120.05 135.33 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 124.185 0.994 . . . . 64.55 108.496 166.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.578 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 59.1 t -115.84 144.55 23.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.543 -0.91 . . . . 64.25 108.543 175.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.4 104.64 8.56 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.197 -1.038 . . . . 75.02 108.197 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -88.16 117.46 27.07 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.79 -1.189 . . . . 63.4 107.79 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.483 HG11 HD21 ' C' ' 128' ' ' LEU . 21.4 t -118.88 118.85 59.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.741 -1.207 . . . . 71.23 107.741 175.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.641 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.9 m -122.3 122.32 38.81 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.579 0.752 . . . . 71.35 109.54 -173.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.564 HG21 HG21 ' C' ' 114' ' ' ILE . 99.5 t -110.36 122.16 64.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.083 1.353 . . . . 71.23 109.258 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.6 m -117.55 144.17 45.38 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.446 -0.946 . . . . 71.24 108.446 175.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.28 128.47 19.81 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.482 -0.933 . . . . 65.15 108.482 176.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 21.4 m -142.91 129.3 20.03 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.092 0.557 . . . . 54.32 110.586 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 49.0 mt -87.67 32.95 0.71 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.174 1.39 . . . . 74.54 111.334 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 -100.72 1.41 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.41 -1.076 . . . . 74.55 110.41 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.64 -31.09 17.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.808 0.843 . . . . 71.04 109.953 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -76.62 120.23 21.53 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.276 1.03 . . . . 74.14 110.092 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.2 m -78.14 126.18 30.44 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.561 -0.903 . . . . 71.51 108.561 168.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.767 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -60.98 2.06 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.589 -0.893 . . . . 74.21 108.589 173.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -163.61 172.49 14.25 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.068 0.937 . . . . 74.24 111.83 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.407 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.6 tm? -135.8 145.57 46.65 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 105.863 -1.902 . . . . 74.44 105.863 172.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.415 ' SG ' HG23 ' C' ' 114' ' ' ILE . 41.8 t -147.98 150.42 33.96 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.059 -1.089 . . . . 74.32 108.059 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.99 132.83 8.5 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.759 -0.46 . . . . 74.25 109.759 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.52 114.1 22.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.263 -1.014 . . . . 62.53 108.263 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 68.4 mt-30 -94.15 85.12 4.59 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.401 -0.963 . . . . 62.32 108.401 173.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -78.33 97.4 5.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.053 -1.431 . . . . 72.14 110.324 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -89.37 161.13 29.81 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 116.465 -0.334 . . . . 71.01 112.382 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.513 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -163.16 123.06 1.15 Allowed Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 111.058 -0.817 . . . . 73.24 111.058 -175.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.58 HD12 HD11 ' C' ' 51' ' ' LEU . 6.2 mm -82.26 125.92 39.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.532 -0.914 . . . . 74.42 108.532 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -131.6 119.74 21.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.166 0.587 . . . . 70.45 110.257 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 71.9 m -80.66 111.89 17.52 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.934 -0.765 . . . . 52.25 108.934 170.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.74 HG12 HD21 ' C' ' 98' ' ' LEU . 1.2 pp -117.06 139.31 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.225 1.01 . . . . 63.5 110.317 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.07 172.68 13.46 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.409 1.084 . . . . 73.23 110.514 -172.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.93 -59.67 3.55 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 116.179 -0.464 . . . . 71.24 112.086 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.81 157.57 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.756 0.823 . . . . 75.11 109.475 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.595 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 13.3 pt-20 -145.53 -170.8 3.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.0 0.52 . . . . 74.42 109.925 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.82 -121.73 24.26 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 114.621 0.608 . . . . 72.15 114.621 174.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 62.6 p -73.33 -34.27 65.58 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.792 0.837 . . . . 73.51 110.555 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -70.14 -32.7 70.81 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.243 1.017 . . . . 64.25 109.981 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.595 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 39.4 ttp -79.61 -33.13 41.8 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.836 -1.074 . . . . 61.42 110.838 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.45 84.17 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.369 0.604 . . . . 40.43 109.913 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 49.2 t-80 -65.42 -29.21 69.88 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.562 -1.199 . . . . 72.23 111.478 175.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.3 -60.81 2.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.057 0.543 . . . . 72.22 110.448 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.74 HD21 HG12 ' C' ' 86' ' ' ILE . 92.9 mt -74.16 -33.81 63.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.074 0.95 . . . . 54.22 112.696 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.35 8.79 77.08 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-O 119.475 -0.625 . . . . 72.04 113.551 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -156.87 -66.23 0.1 Allowed 'General case' 0 C--N 1.357 0.916 0 CA-C-N 117.724 0.762 . . . . 52.44 112.874 -172.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' C' ' 104' ' ' ASN . 87.9 t80 -63.89 -34.8 78.76 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.286 0.634 . . . . 75.42 112.328 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.933 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 56.2 m -72.75 -46.28 9.18 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.69 -0.671 . . . . 74.04 111.148 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 83.2 Cg_exo -52.99 -32.95 60.25 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.312 2.008 . . . . 75.54 113.791 164.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 104' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' C' ' 101' ' ' TYR . 5.1 m-20 -60.09 -39.83 87.49 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 123.158 0.583 . . . . 62.32 110.911 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.447 HD12 ' NH1' ' A' ' 111' ' ' ARG . 40.2 mm -66.5 -45.22 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 115.954 -0.567 . . . . 64.51 110.198 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.513 HD21 ' HA3' ' C' ' 82' ' ' GLY . 42.3 mt -75.88 -16.39 60.06 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.433 -0.803 . . . . 74.53 111.986 -174.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -59.92 -52.7 71.76 Favored Pre-proline 0 CA--C 1.566 1.583 0 C-N-CA 125.035 1.334 . . . . 60.12 113.811 -172.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.18 -31.38 64.34 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 121.948 1.765 . . . . 62.51 112.784 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.514 ' HE2' HG21 ' A' ' 115' ' ' THR . 90.3 m-85 -69.09 -47.6 64.78 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.188 0.595 . . . . 74.33 110.546 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.37 -41.85 85.66 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.179 -0.918 . . . . 71.13 109.925 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.412 HH21 ' ND2' ' C' ' 127' ' ' ASN . 51.7 ttt180 -56.08 -57.72 10.97 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 124.437 1.086 . . . . 71.34 111.126 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -66.93 -30.93 71.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.181 0.593 . . . . 54.44 111.036 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.457 ' SG ' HG21 ' C' ' 18' ' ' THR . 9.6 t -70.5 -34.1 71.95 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.779 0.432 . . . . 72.34 110.971 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.564 HG21 HG21 ' C' ' 64' ' ' VAL . 88.4 mt -69.34 -51.24 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.277 -0.638 . . . . 52.31 109.277 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.41 HG21 ' OG ' ' B' ' 119' ' ' SER . 13.7 m -58.43 -33.53 69.79 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.05 0.94 . . . . 72.12 111.286 -174.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 28.3 t -62.9 -54.85 32.32 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.834 -1.075 . . . . 52.24 109.13 173.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.523 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.96 -40.05 72.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.91 1.284 . . . . 74.32 112.639 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.3 t -63.34 -47.72 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.956 0.902 . . . . 73.45 109.691 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.458 ' OG ' HG21 ' B' ' 115' ' ' THR . 48.4 t -69.95 -27.98 65.19 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.238 -0.892 . . . . 63.02 111.93 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' C' ' 116' ' ' SER . 84.3 mtt-85 -70.65 -43.68 68.67 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.688 0.795 . . . . 75.42 109.29 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.15 5.86 65.39 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.955 -1.02 . . . . 65.3 112.522 172.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 64.8 p 61.66 29.76 18.28 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.175 1.79 . . . . 65.51 113.757 168.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.408 ' HB2' HG13 ' C' ' 118' ' ' VAL . 95.6 m-85 -86.62 152.53 54.56 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 108.981 -0.748 . . . . 75.31 108.981 169.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.43 173.26 3.58 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.258 2.639 . . . . 71.32 114.649 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -50.79 130.92 25.75 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.308 1.443 . . . . 75.31 114.043 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -133.88 112.6 11.43 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.388 -1.338 . . . . 71.0 107.388 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 127' ' ' ASN . . . . . 0.412 ' ND2' HH21 ' C' ' 111' ' ' ARG . 28.7 m120 -133.16 132.15 41.26 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.497 0.719 . . . . 73.21 109.99 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.483 HD21 HG11 ' C' ' 62' ' ' VAL . 6.8 mp -86.07 125.93 33.81 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.765 0.826 . . . . 74.41 110.11 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.86 155.67 75.32 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 124.75 1.22 . . . . 61.34 111.18 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.03 113.93 1.79 Allowed 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 123.361 2.708 . . . . 74.32 113.522 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.39 113.38 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.786 0.834 . . . . 74.22 109.279 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -76.38 91.05 3.25 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.689 0.795 . . . . 74.32 110.473 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -68.55 -33.06 73.43 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 110.062 -0.348 . . . . 72.55 110.062 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.511 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 12.7 p-10 -65.02 -45.83 83.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.527 1.131 . . . . 74.52 111.447 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.53 -37.09 71.18 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.372 0.669 . . . . 73.53 110.897 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.26 -18.45 55.32 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.23 -0.895 . . . . 70.35 112.347 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 57.1 t80 . . . . . 0 N--CA 1.493 1.721 0 C-N-CA 123.096 0.558 . . . . 71.33 111.626 -178.887 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.237 0.433 0 N-CA-C 108.072 -1.085 . . . . 75.11 108.072 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -157.19 91.28 1.17 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.951 -1.5 . . . . 72.4 106.951 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -113.43 114.71 26.96 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.341 -0.985 . . . . 65.21 108.341 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.475 HG21 HD11 ' D' ' 16' ' ' ILE . 12.6 mt -75.27 114.76 15.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.014 -1.106 . . . . 63.0 108.014 174.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -89.96 -32.27 16.88 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.423 0.452 . . . . 71.0 111.096 -178.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -172.76 146.42 1.61 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.062 0.226 . . . . 74.22 111.555 -170.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.475 HD11 HG21 ' D' ' 13' ' ' ILE . 2.9 mp -126.56 132.27 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 105.79 -1.929 . . . . 71.1 105.79 170.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.409 ' HE1' HG13 ' D' ' 83' ' ' ILE . 28.8 p90 -158.53 150.92 21.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.203 1.001 . . . . 74.44 111.03 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -84.23 119.22 24.78 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.222 -1.808 . . . . 55.31 108.487 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -95.08 -28.53 15.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.34 -0.615 . . . . 63.44 109.34 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.1 t70 -145.16 128.74 17.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.583 -1.189 . . . . 73.03 108.232 175.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.523 HG21 ' HE2' ' C' ' 117' ' ' MET . 73.4 mt -129.92 137.72 55.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.401 -1.333 . . . . 74.24 107.401 172.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -138.24 139.42 39.22 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.438 1.095 . . . . 75.24 108.312 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.617 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -150.61 129.45 12.46 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.093 -1.447 . . . . 74.21 107.093 170.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.7 mt-10 -131.26 150.98 51.92 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.895 0.878 . . . . 75.31 109.178 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.23 78.21 19.2 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 106.946 -1.501 . . . . 44.12 106.946 173.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.8 -22.88 17.18 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.78 2.32 . . . . 74.13 113.596 -170.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -108.15 16.34 23.39 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.102 0.561 . . . . 73.13 110.256 176.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.1 -66.92 0.29 Allowed Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 115.581 1.697 . . . . 53.54 115.581 -160.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.437 ' HB3' HD11 ' C' ' 83' ' ' ILE . 96.2 Cg_endo -74.15 -20.51 18.93 Favored 'Trans proline' 0 C--N 1.387 2.568 0 CA-C-N 122.435 1.905 . . . . 73.14 112.717 -173.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -74.26 -41.05 61.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.148 1.379 . . . . 72.11 110.445 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' D' ' 73' ' ' ALA . 3.6 p -84.04 -20.92 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 115.883 -0.599 . . . . 63.54 111.066 -170.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -62.74 -22.08 66.29 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.076 0.551 . . . . 74.42 112.433 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -65.75 -18.0 65.02 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.489 0.715 . . . . 64.52 111.06 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -84.09 102.55 12.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.489 1.115 . . . . 65.13 108.972 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -84.56 89.42 7.44 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.373 -0.603 . . . . 52.32 109.373 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.1 t-105 -168.5 158.85 9.84 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.618 1.167 . . . . 71.43 109.368 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -72.13 109.8 6.56 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 108.315 -0.994 . . . . 71.41 108.315 169.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.52 125.91 20.07 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.307 2.671 . . . . 64.34 113.329 -173.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.02 115.66 2.75 Favored 'General case' 0 C--N 1.361 1.101 0 O-C-N 124.484 1.115 . . . . 70.04 109.61 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.597 HG23 HG13 ' D' ' 64' ' ' VAL . 3.0 p -96.66 112.76 29.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-O 121.86 0.838 . . . . 64.31 110.562 -170.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -101.91 151.24 22.34 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.846 -1.07 . . . . 65.44 108.258 167.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.45 HD21 HD12 ' D' ' 128' ' ' LEU . 5.3 mp -131.49 136.12 47.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.771 0.428 . . . . 73.42 110.637 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.652 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 30.4 m-20 -107.79 150.28 27.19 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 107.376 -1.342 . . . . 74.55 107.376 165.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.456 HD11 HD21 ' D' ' 60' ' ' LEU . 18.8 tp -137.36 131.27 31.87 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.584 0.23 . . . . 70.33 110.993 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 34.3 m-20 -138.87 158.42 44.24 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.61 1.164 . . . . 73.21 108.711 170.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.0 t -124.48 175.35 7.2 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.601 0.761 . . . . 72.34 109.189 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -161.34 163.99 30.38 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.9 0.88 . . . . 74.44 109.448 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 71.9 p -150.26 153.0 35.42 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.617 0.767 . . . . 73.4 109.264 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.7 p -156.62 140.41 16.11 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.485 0.714 . . . . 72.11 110.262 -174.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -91.56 116.43 28.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.511 0.724 . . . . 64.52 109.064 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' C' ' 29' ' ' PRO . 26.8 mt -98.5 -42.17 7.43 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.093 0.473 . . . . 71.23 110.297 -173.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.16 176.02 10.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.431 1.093 . . . . 55.33 108.097 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.08 130.61 41.33 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.581 -0.526 . . . . 71.14 109.581 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 61.42 11.0 3.45 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 124.425 1.09 . . . . 64.24 112.813 -171.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.67 114.37 43.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 108.211 -1.033 . . . . 75.22 108.211 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.12 164.66 12.61 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.175 -1.046 . . . . 73.04 108.175 -175.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.437 ' HB2' HD11 ' D' ' 51' ' ' LEU . 62.3 tt0 -131.04 150.89 51.94 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.838 -0.801 . . . . 73.24 108.838 169.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.61 141.87 42.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.795 1.238 . . . . 61.21 107.874 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 47.2 t -128.1 126.41 66.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.778 -1.194 . . . . 64.24 107.778 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.08 120.9 43.35 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.074 -1.084 . . . . 63.31 108.074 -175.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.417 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 22.3 ttm-85 -100.99 97.63 8.18 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.583 -0.895 . . . . 64.4 108.583 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.19 123.93 47.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.619 -1.252 . . . . 74.4 107.619 167.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.652 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 12.9 m -118.74 130.37 55.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.959 -0.756 . . . . 72.43 108.959 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.597 HG13 HG23 ' D' ' 40' ' ' VAL . 94.2 t -117.48 121.1 66.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.106 0.962 . . . . 61.11 109.157 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.1 m -116.01 104.0 11.15 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.083 -1.08 . . . . 62.22 108.083 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.27 150.57 24.32 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.641 -0.709 . . . . 64.24 110.493 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 55.1 p -143.96 142.19 30.6 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.705 0.628 . . . . 73.03 111.053 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 21.4 mt -110.32 104.37 13.15 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 124.633 1.173 . . . . 62.55 109.191 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.03 -112.9 3.55 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.443 -0.663 . . . . 71.31 111.443 -177.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -117.52 14.32 14.53 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.249 0.619 . . . . 72.41 111.488 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.58 156.04 45.52 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.071 0.548 . . . . 74.4 110.59 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.5 m -63.4 127.28 30.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.09 0.956 . . . . 63.24 111.502 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.504 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -86.03 -75.78 0.36 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.842 -0.799 . . . . 73.2 108.842 174.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.29 139.46 35.5 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-O 121.349 0.595 . . . . 75.55 110.03 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 80.6 mt -103.54 147.37 27.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.912 -1.144 . . . . 74.03 107.912 171.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.548 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.6 t -158.02 146.66 19.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 122.914 0.486 . . . . 71.22 109.859 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -156.2 134.28 11.29 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 108.858 -0.793 . . . . 51.41 108.858 171.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.32 114.75 24.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 109.104 -0.702 . . . . 75.12 109.104 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.452 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 72.3 mt-30 -89.08 83.23 6.54 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.295 -1.002 . . . . 53.14 108.295 171.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -80.96 99.22 8.29 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.457 -1.702 . . . . 75.25 109.946 -175.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.08 163.62 29.3 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.441 -0.345 . . . . 73.44 112.483 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.467 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -161.96 132.87 2.94 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 111.883 -0.487 . . . . 73.13 111.883 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.409 HG13 ' HE1' ' D' ' 17' ' ' TYR . 43.7 mt -88.93 130.41 38.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 123.822 0.849 . . . . 71.12 109.311 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -133.85 124.23 26.13 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.356 0.662 . . . . 73.52 110.04 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -83.41 105.5 14.41 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.594 -0.891 . . . . 64.52 108.594 170.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.434 HD13 HD13 ' D' ' 98' ' ' LEU . 47.8 pt -109.78 141.93 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 122.985 0.514 . . . . 75.35 110.855 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.35 159.88 41.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.309 1.044 . . . . 52.24 109.354 176.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.04 10.59 81.16 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 115.009 0.764 . . . . 54.43 115.009 173.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 24.0 pt -124.06 135.07 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.596 0.758 . . . . 71.22 109.549 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.73 164.9 28.95 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.517 0.727 . . . . 73.14 110.682 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.14 -121.9 25.57 Favored Glycine 0 C--N 1.353 1.481 0 O-C-N 124.091 0.87 . . . . 75.24 114.393 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 12.5 t -72.04 -32.4 67.07 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.691 0.796 . . . . 53.4 111.44 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -71.62 -35.28 70.39 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.167 0.587 . . . . 73.01 110.706 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -66.56 -47.48 72.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.295 -0.866 . . . . 73.35 110.154 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.54 -28.37 69.89 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.21 -0.905 . . . . 63.43 111.479 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -76.47 -46.51 26.5 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.939 0.896 . . . . 71.31 110.869 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.71 -42.48 73.97 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.013 -0.54 . . . . 75.23 111.296 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.434 HD13 HD13 ' D' ' 86' ' ' ILE . 12.4 tp -84.51 -36.21 22.38 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 122.68 0.392 . . . . 73.23 111.195 -173.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.0 -23.09 42.65 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.036 -0.529 . . . . 55.25 113.705 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.572 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -122.17 -56.34 1.83 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.23 0.515 . . . . 70.53 111.949 -175.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 101' ' ' TYR . . . . . 0.413 ' O ' HG12 ' D' ' 105' ' ' ILE . 63.7 t80 -66.76 -43.36 84.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 111.841 0.312 . . . . 74.32 111.841 -173.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 98.8 m -65.85 -47.83 63.88 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.053 -0.975 . . . . 72.14 112.912 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.463 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.3 Cg_exo -57.0 -36.22 99.25 Favored 'Trans proline' 0 C--N 1.4 3.263 0 C-N-CA 121.847 1.698 . . . . 72.31 112.7 170.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -65.1 -31.22 72.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.851 0.86 . . . . 71.34 111.119 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.413 HG12 ' O ' ' D' ' 101' ' ' TYR . 46.3 mm -68.25 -40.89 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.502 0.721 . . . . 75.32 110.164 173.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.467 HD21 ' HA3' ' D' ' 82' ' ' GLY . 63.3 mt -77.96 -21.82 50.4 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.252 -0.886 . . . . 75.2 111.856 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -64.27 -41.29 59.44 Favored Pre-proline 0 CA--C 1.566 1.562 0 N-CA-C 114.098 1.147 . . . . 71.31 114.098 -172.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -51.19 -43.38 49.05 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.263 1.975 . . . . 71.02 113.56 170.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -72.51 -37.89 68.26 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.57 -0.741 . . . . 72.13 111.03 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.22 -45.11 93.16 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.498 0.719 . . . . 71.23 110.528 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -57.28 -51.85 67.71 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.416 1.072 . . . . 74.01 110.395 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.02 -44.65 96.25 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.175 0.922 . . . . 72.13 112.009 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -54.59 -48.14 72.5 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.91 0.756 . . . . 70.44 110.359 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.548 HG12 ' SG ' ' D' ' 76' ' ' CYS . 82.2 mt -60.4 -54.85 29.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 CA-C-N 114.502 -1.226 . . . . 60.41 110.38 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.0 m -55.39 -39.92 70.75 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.301 1.04 . . . . 73.3 111.806 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -68.05 -41.93 81.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.005 -0.998 . . . . 73.21 110.566 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -70.01 -29.19 66.19 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.8 0.44 . . . . 72.42 111.828 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' D' ' 114' ' ' ILE . 65.9 t -66.12 -45.1 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 123.961 0.904 . . . . 72.44 109.834 175.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.0 p -74.49 -28.93 61.22 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.992 -0.549 . . . . 72.35 111.251 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 -72.86 -33.5 66.14 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.429 0.692 . . . . 73.21 109.809 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.47 2.01 86.28 Favored Glycine 0 C--N 1.355 1.603 0 CA-C-N 115.769 -0.65 . . . . 53.31 112.165 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.8 p 64.37 18.98 11.62 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 127.142 2.177 . . . . 63.23 113.984 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -80.02 147.38 65.57 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 108.587 -0.894 . . . . 70.41 108.587 168.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.87 148.8 91.19 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.083 1.855 . . . . 63.41 111.463 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -57.8 139.84 53.09 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.723 1.209 . . . . 32.41 113.883 -165.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.487 HD11 HG21 ' D' ' 40' ' ' VAL . 42.2 tp -109.09 102.59 11.55 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.055 -0.975 . . . . 74.02 109.678 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -100.91 104.39 15.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.266 0.626 . . . . 74.11 109.385 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.45 HD12 HD21 ' D' ' 42' ' ' LEU . 3.0 mm? -74.56 118.62 17.72 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.16 0.584 . . . . 65.42 109.441 175.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.9 136.35 72.89 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.691 0.796 . . . . 72.4 111.368 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.83 118.97 5.81 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.217 1.945 . . . . 75.14 110.76 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.5 p -107.38 136.75 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.521 0.728 . . . . 53.43 110.028 -173.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -76.73 76.27 3.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.688 -1.227 . . . . 73.44 107.688 169.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 133' ' ' PHE . . . . . 0.442 ' HE2' HD21 ' D' ' 44' ' ' LEU . 87.4 t80 -59.98 -33.15 71.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.075 -1.421 . . . . 74.41 112.006 -172.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 134' ' ' ASP . . . . . 0.572 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 17.4 t70 -60.27 -34.8 74.24 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.656 1.182 . . . . 63.45 111.392 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.18 -37.92 84.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.16 -0.927 . . . . 44.21 111.716 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.6 mp -64.21 -33.34 75.58 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.707 0.803 . . . . 42.25 110.956 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 N--CA 1.482 1.162 0 C-N-CA 124.121 0.969 . . . . 75.34 111.808 -178.109 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m . . . . . 0 N--CA 1.462 0.173 0 N-CA-C 107.985 -1.117 . . . . 52.11 107.985 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -137.81 134.92 35.76 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.529 -0.915 . . . . 73.34 108.529 172.583 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -149.96 110.96 4.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.215 -1.032 . . . . 65.42 108.215 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.443 HG21 ' HG2' ' C' ' 130' ' ' PRO . 32.7 mt -78.14 110.38 13.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.59 -0.892 . . . . 73.55 108.59 176.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -80.08 -32.62 39.26 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.957 -1.02 . . . . 74.0 110.175 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -177.44 126.25 0.14 Allowed 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.375 0.422 . . . . 74.14 110.415 -172.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.435 HD12 ' HG3' ' C' ' 130' ' ' PRO . 93.8 mt -113.52 130.99 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.424 -0.954 . . . . 72.15 108.424 169.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -160.18 154.31 23.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.334 1.054 . . . . 54.1 109.561 -172.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.5 p -79.84 120.27 23.86 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.937 -0.764 . . . . 74.01 108.937 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -81.0 -31.23 34.74 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.04 0.448 . . . . 65.21 109.855 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -153.26 143.57 22.41 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.774 -1.103 . . . . 64.11 109.537 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -133.86 145.1 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.852 1.261 . . . . 72.32 108.122 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -144.82 134.38 23.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.346 0.593 . . . . 73.21 109.471 171.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -134.56 131.13 37.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.184 -1.784 . . . . 75.1 106.184 162.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -134.33 142.07 47.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.974 -0.75 . . . . 63.45 108.974 171.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.45 79.08 55.39 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 106.459 -1.682 . . . . 62.53 106.459 169.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.2 -15.23 35.39 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.486 2.124 . . . . 52.13 110.329 174.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -112.44 28.01 9.15 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.848 1.259 . . . . 74.15 111.139 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.663 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -60.12 -54.54 54.27 Favored Pre-proline 0 CA--C 1.575 1.907 0 CA-C-O 118.933 -0.556 . . . . 72.43 111.344 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.663 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 11.6 Cg_exo -76.48 -14.93 17.85 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 122.192 1.928 . . . . 74.34 113.373 173.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -69.88 -53.28 18.75 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 109.633 -0.506 . . . . 73.53 109.633 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.567 HG11 ' HE1' ' A' ' 123' ' ' PHE . 12.1 p -64.44 -23.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.783 0.833 . . . . 62.01 111.424 -175.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -58.09 -40.4 81.03 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.607 0.763 . . . . 64.43 110.4 171.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -90.64 -30.3 17.24 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.327 1.051 . . . . 72.02 111.021 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 14.1 mmmm -84.0 172.16 12.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.275 1.03 . . . . 71.11 111.38 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.23 148.59 23.52 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.675 0.79 . . . . 71.54 109.818 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.404 ' CZ2' ' HG3' ' A' ' 38' ' ' PRO . 68.8 t-105 -79.59 90.94 5.15 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.234 0.614 . . . . 74.42 109.761 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -132.37 42.03 0.81 Allowed Pre-proline 0 CA--C 1.574 1.869 0 C-N-CA 123.313 0.645 . . . . 74.54 112.69 -176.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 45.0 Cg_endo -81.47 140.03 11.76 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.308 2.006 . . . . 72.4 113.564 -171.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -98.69 99.96 11.13 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.764 -1.199 . . . . 65.23 107.764 168.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.13 93.33 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 115.619 -0.719 . . . . 64.53 109.999 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -78.4 153.03 31.91 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.869 0.366 . . . . 74.25 110.375 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.1 tp -122.2 130.2 52.98 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.387 -0.824 . . . . 60.1 109.969 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -130.98 146.84 52.51 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.562 1.145 . . . . 64.34 107.916 172.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.552 HD22 HD21 ' A' ' 60' ' ' LEU . 85.2 mt -129.53 148.53 51.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.468 0.707 . . . . 62.32 109.845 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.713 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 14.9 m-20 -132.48 140.14 48.25 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.183 0.993 . . . . 71.44 109.1 172.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.0 m -108.22 126.2 52.53 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.062 1.345 . . . . 54.43 108.488 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.16 146.16 51.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.593 0.757 . . . . 54.45 109.163 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.5 m -134.45 158.51 43.72 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.847 0.459 . . . . 70.11 111.045 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 40.2 t -154.44 129.49 9.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.451 1.1 . . . . 71.31 108.605 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -84.48 107.75 16.9 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.15 -0.685 . . . . 51.13 109.15 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.0 mt -79.57 -38.43 34.1 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.986 0.515 . . . . 55.44 110.372 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.19 -177.03 6.25 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.495 -0.775 . . . . 74.22 110.315 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.13 111.82 2.37 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.875 0.87 . . . . 64.45 109.95 174.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 65.28 17.23 10.92 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.053 1.341 . . . . 75.11 112.873 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.79 116.7 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.223 -1.029 . . . . 71.02 108.223 169.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -110.7 167.57 10.13 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.603 1.192 . . . . 71.45 111.501 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 9.6 tp10 -128.78 126.43 39.92 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 112.393 -2.185 . . . . 50.11 105.661 169.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.24 131.27 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 107.482 -1.303 . . . . 62.32 107.482 173.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 21.9 t -119.49 115.52 47.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 124.128 0.971 . . . . 54.23 108.656 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.552 HD21 HD22 ' A' ' 44' ' ' LEU . 3.7 tt -88.19 98.01 11.32 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.322 -1.733 . . . . 64.31 106.322 167.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.713 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 46.8 ttt-85 -85.61 101.97 13.16 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.952 -1.129 . . . . 65.41 107.952 174.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.486 HG11 ' HB1' ' A' ' 110' ' ' ALA . 2.3 p -105.02 124.26 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.294 0.637 . . . . 41.22 110.291 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.0 m -108.13 130.84 55.09 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 123.846 0.858 . . . . 74.32 109.593 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.41 ' O ' HD12 ' A' ' 75' ' ' LEU . 45.9 t -126.32 122.65 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.02 1.328 . . . . 74.13 107.973 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 t -128.88 120.59 26.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.018 0.527 . . . . 71.54 109.68 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -105.15 110.18 22.45 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.589 -0.893 . . . . 41.54 108.589 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.3 p -124.88 126.89 46.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.862 0.465 . . . . 74.14 111.403 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.521 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -104.62 84.78 2.22 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.806 -1.183 . . . . 52.23 107.806 166.843 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.94 -117.32 5.08 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.386 -0.824 . . . . 23.02 111.846 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -87.94 -23.22 23.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.056 0.542 . . . . 71.23 109.889 175.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.53 134.87 35.57 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.026 0.93 . . . . 74.22 110.725 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.3 m -83.15 154.37 24.33 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.072 0.949 . . . . 73.5 109.148 168.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.9 -61.18 1.4 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.197 -1.038 . . . . 51.31 108.197 164.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -151.07 170.36 19.58 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.53 -1.214 . . . . 73.51 110.722 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 64' ' ' VAL . 51.2 tp -138.83 129.22 25.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.043 1.337 . . . . 64.45 107.729 177.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.3 m -136.07 117.6 14.83 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.809 0.844 . . . . 74.15 108.761 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -138.79 115.38 10.59 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.274 -0.639 . . . . 61.33 109.274 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.7 t -123.99 115.72 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.202 1.001 . . . . 62.41 109.498 -171.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.631 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 17.3 mt-30 -87.85 82.43 7.3 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.156 -1.053 . . . . 73.44 108.156 169.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -76.4 115.5 16.2 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.022 -1.103 . . . . 73.2 108.022 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.14 170.85 13.59 Favored Glycine 0 C--O 1.242 0.618 0 CA-C-O 121.227 0.348 . . . . 64.1 112.255 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.51 136.05 3.97 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.144 -0.528 . . . . 74.33 112.0 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.5 mt -81.1 122.84 36.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 108.131 -1.063 . . . . 72.43 108.131 169.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.496 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.3 m-85 -130.95 118.49 20.74 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.717 -0.846 . . . . 71.12 108.717 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.5 p -94.98 118.11 31.27 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.896 -0.779 . . . . 74.24 108.896 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.416 ' HB ' HD11 ' A' ' 89' ' ' ILE . 2.8 pp -128.55 157.11 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.137 0.975 . . . . 31.2 110.624 -174.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.48 154.01 13.71 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.975 0.91 . . . . 74.32 109.947 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.4 9.63 61.51 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 113.752 0.261 . . . . 73.32 113.752 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.629 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -133.19 145.09 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.937 0.895 . . . . 65.21 109.934 178.707 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.534 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.6 tt0 -156.13 174.13 15.82 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.15 0.58 . . . . 65.41 109.819 177.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.534 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 60.07 -116.94 9.81 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.678 0.656 . . . . 65.34 113.444 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.4 p -71.55 -27.01 62.87 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.745 0.818 . . . . 75.41 110.934 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -71.02 -36.2 72.3 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.762 0.825 . . . . 61.5 110.432 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.414 ' HA ' ' SG ' ' A' ' 97' ' ' CYS . 49.3 ttm -73.11 -37.17 66.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.068 0.547 . . . . 72.43 110.09 175.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 -24.69 66.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.792 -0.64 . . . . 71.43 110.231 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.528 ' NE2' ' HB3' ' A' ' 100' ' ' ALA . 9.8 t-160 -83.38 -25.95 30.91 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.562 0.745 . . . . 44.21 111.204 176.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.629 ' SG ' HG13 ' A' ' 89' ' ' ILE . 74.0 m -56.86 -43.21 80.98 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.004 0.431 . . . . 73.44 110.492 175.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -90.73 -20.74 22.09 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.567 -0.742 . . . . 70.24 111.268 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -38.56 41.8 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 114.071 0.388 . . . . 74.11 114.071 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.528 ' HB3' ' NE2' ' A' ' 96' ' ' HIS . . . -150.88 -47.12 0.12 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 117.508 0.654 . . . . 52.23 112.004 -175.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.413 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 31.2 t80 -45.08 -70.24 0.11 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 126.053 1.741 . . . . 74.42 112.865 -175.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.1 m -81.29 -34.53 0.73 Allowed Pre-proline 0 CA--C 1.572 1.79 0 N-CA-C 115.462 1.653 . . . . 64.24 115.462 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.447 ' O ' HD12 ' A' ' 60' ' ' LEU . 37.4 Cg_endo -63.88 -34.74 59.27 Favored 'Trans proline' 0 C--N 1.399 3.231 0 CA-C-N 122.701 2.0 . . . . 61.32 112.619 175.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -66.56 -26.62 67.21 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 120.716 0.293 . . . . 60.22 111.299 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.06 -43.44 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.67 0.788 . . . . 75.53 110.18 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.03 -14.66 59.42 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.061 0.944 . . . . 74.34 112.479 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.16 -49.38 84.93 Favored Pre-proline 0 CA--C 1.565 1.555 0 N-CA-C 113.486 0.921 . . . . 74.44 113.486 -171.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.1 -32.3 75.09 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 121.929 1.753 . . . . 71.34 112.572 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -74.48 -37.63 63.13 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.694 0.798 . . . . 71.02 111.58 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.486 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -70.26 -45.15 67.02 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.843 0.457 . . . . 54.34 110.099 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.41 ' NH1' HD12 ' C' ' 105' ' ' ILE . 31.9 ttm180 -54.2 -47.73 71.79 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.365 1.041 . . . . 64.12 110.342 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.27 -46.38 89.06 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.139 0.9 . . . . 74.02 111.725 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 117' ' ' MET . 37.1 t -59.81 -38.39 81.82 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.408 0.683 . . . . 72.44 110.537 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.2 mt -70.82 -47.84 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.034 0.934 . . . . 73.35 110.896 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -54.41 -38.16 65.91 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.791 0.836 . . . . 74.1 110.343 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.6 t -65.86 -47.01 76.34 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.325 -1.307 . . . . 75.53 110.253 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 34.0 mmt -57.18 -48.21 79.32 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.159 0.583 . . . . 71.32 111.246 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 114' ' ' ILE . 58.6 t -64.27 -48.63 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.443 1.097 . . . . 72.03 111.046 -175.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -69.97 -29.57 66.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.33 0.652 . . . . 74.23 112.209 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -71.11 -28.33 64.23 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.832 0.453 . . . . 75.4 110.255 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.48 7.97 66.65 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-O 119.755 -0.469 . . . . 55.34 113.126 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.492 ' HB ' HH21 ' B' ' 15' ' ' ARG . 15.7 m 68.28 15.01 9.3 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.776 1.231 . . . . 72.14 111.245 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.567 ' HE1' HG11 ' A' ' 31' ' ' VAL . 63.6 m-85 -89.54 144.5 32.12 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.451 -0.944 . . . . 72.12 108.451 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.37 142.89 88.12 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.822 2.348 . . . . 65.34 111.898 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.25 138.45 16.47 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.391 1.076 . . . . 70.31 112.486 -175.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.1 tp -115.6 103.03 10.31 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.732 -1.122 . . . . 60.33 110.062 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -111.47 96.85 6.35 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.044 -1.095 . . . . 73.3 108.044 168.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.9 151.28 47.86 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.422 -0.808 . . . . 73.5 110.056 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.69 145.72 95.21 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.745 0.818 . . . . 74.3 111.73 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -57.68 127.62 26.0 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.832 2.355 . . . . 73.44 112.657 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 93.8 t -102.04 115.97 44.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 124.457 1.103 . . . . 71.14 109.243 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -84.86 93.62 8.55 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.521 -0.918 . . . . 72.53 108.521 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -65.06 -27.36 68.73 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.657 0.783 . . . . 73.02 111.801 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -66.72 -47.15 73.21 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.935 0.494 . . . . 72.43 110.175 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.04 -50.88 71.92 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.114 0.884 . . . . 73.24 109.912 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.2 mt -62.29 -38.42 89.3 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.647 -1.16 . . . . 72.41 112.343 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -65.82 -46.78 77.33 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.361 0.665 . . . . 74.41 110.472 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 CA--C 1.543 0.699 0 CA-C-N 115.913 -0.585 . . . . 71.03 110.624 -175.626 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 56.0 m . . . . . 0 N--CA 1.468 0.442 0 N-CA-C 107.875 -1.157 . . . . 72.34 107.875 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -147.37 140.97 25.54 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.801 -0.814 . . . . 72.3 108.801 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -153.0 141.21 20.5 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.17 -0.678 . . . . 62.11 109.17 175.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 mt -85.86 121.26 37.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.179 -1.045 . . . . 71.34 108.179 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -88.08 -42.45 12.38 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.527 0.517 . . . . 63.52 109.931 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.492 HH21 ' HB ' ' A' ' 122' ' ' THR . 65.5 ttt180 -167.8 133.76 2.01 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.765 -0.652 . . . . 74.21 109.695 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.0 mt -115.15 140.48 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.025 -1.472 . . . . 60.2 107.025 168.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.497 ' CE2' ' HB1' ' A' ' 28' ' ' ALA . 34.8 p90 -164.25 158.34 18.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.881 0.848 . . . . 74.24 111.544 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 96.9 m -83.6 120.84 26.45 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.43 -1.259 . . . . 74.24 108.545 171.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.412 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 35.8 mtpt -88.43 -33.38 17.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.44 0.696 . . . . 74.32 110.423 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.5 t70 -150.82 135.94 17.62 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.739 -0.664 . . . . 72.3 110.826 -171.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.42 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.2 mm -127.98 139.79 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.617 1.167 . . . . 74.12 108.678 166.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 43.5 t -140.93 131.34 25.21 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.077 -1.083 . . . . 72.54 108.077 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -141.89 115.4 9.01 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.861 -1.163 . . . . 54.13 107.861 170.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 36.5 mt-10 -118.26 112.54 20.22 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.902 -1.148 . . . . 60.24 107.902 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.487 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.83 83.23 1.22 Allowed Pre-proline 0 C--O 1.24 0.575 0 N-CA-C 106.311 -1.737 . . . . 72.1 106.311 164.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.91 -13.74 29.25 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 122.459 2.106 . . . . 74.23 112.139 -171.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -123.59 12.48 9.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.075 0.95 . . . . 61.42 110.774 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.512 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -34.86 -62.7 0.4 Allowed Pre-proline 0 N--CA 1.501 2.096 0 N-CA-C 114.456 1.28 . . . . 74.1 114.456 -170.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 25.9 Cg_exo -61.18 -36.3 81.35 Favored 'Trans proline' 0 C--N 1.396 3.067 0 C-N-CA 122.154 1.903 . . . . 61.32 113.429 -174.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -92.1 -18.8 23.06 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.891 0.7 . . . . 74.4 112.891 -173.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.717 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.6 p -83.12 -19.91 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 118.69 0.677 . . . . 72.14 111.422 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -67.91 -14.38 62.92 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 112.94 0.719 . . . . 72.33 112.94 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.489 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.8 pt20 -60.49 -26.32 66.73 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.125 0.488 . . . . 41.41 110.371 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.489 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 88.2 mttt -101.66 87.65 3.21 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.535 1.134 . . . . 73.51 108.728 175.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -79.54 101.98 8.57 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.315 -0.624 . . . . 71.33 109.315 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -172.66 158.01 3.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.48 1.112 . . . . 74.11 108.877 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.533 ' HG2' ' HB2' ' B' ' 124' ' ' PRO . 47.6 mt-30 -64.65 107.59 1.47 Allowed Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.948 0.899 . . . . 74.14 109.123 168.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.61 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.7 Cg_endo -59.14 160.86 17.67 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 123.351 2.7 . . . . 71.55 113.653 -176.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -59.81 103.02 0.18 Allowed 'General case' 0 C--N 1.35 0.614 0 N-CA-C 107.722 -1.214 . . . . 71.32 107.722 169.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.0 m -91.55 161.22 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.3 -0.864 . . . . 65.04 110.509 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -135.71 113.75 11.27 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.398 -1.334 . . . . 75.12 107.398 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 tt -85.2 126.2 33.46 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.692 -1.595 . . . . 73.33 106.692 173.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.72 144.79 26.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.942 -1.132 . . . . 52.35 107.942 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -146.63 160.02 42.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.061 0.544 . . . . 52.35 110.145 174.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -143.65 150.17 38.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.037 0.935 . . . . 63.3 109.335 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -125.52 115.26 19.93 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.007 0.923 . . . . 73.51 109.85 -174.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.02 161.66 19.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.479 1.112 . . . . 60.11 108.501 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 77.4 p -145.37 162.84 36.3 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.538 0.335 . . . . 64.11 110.351 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -154.49 136.19 14.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.684 0.794 . . . . 75.24 109.543 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -89.89 116.06 27.68 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.924 -0.398 . . . . 73.13 109.924 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 24.5 mt -80.25 -52.15 8.07 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.146 0.978 . . . . 72.54 110.741 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.32 -168.53 2.56 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.42 1.088 . . . . 73.42 109.013 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -63.05 100.8 0.23 Allowed 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.492 0.495 . . . . 73.12 110.205 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 63.62 16.16 9.47 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.064 1.345 . . . . 75.25 113.227 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 69.1 t -103.44 101.12 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 105.065 -2.198 . . . . 62.05 105.065 167.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -118.97 168.93 10.34 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.388 -0.967 . . . . 73.3 108.388 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -144.9 111.86 5.91 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.433 -0.951 . . . . 62.31 108.433 -171.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -96.27 137.78 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 O-C-N 124.029 0.831 . . . . 61.32 109.471 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 37.3 t -113.48 117.64 56.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.808 0.843 . . . . 64.35 109.274 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.39 110.73 23.23 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.317 -1.364 . . . . 75.31 107.317 173.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -100.31 128.85 46.28 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.794 -0.817 . . . . 74.13 108.794 173.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.52 ' HB ' HD11 ' B' ' 114' ' ' ILE . 11.4 t -126.91 123.7 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.024 -1.102 . . . . 65.12 108.024 172.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -118.81 134.52 55.1 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.704 0.802 . . . . 72.1 110.807 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.432 HG21 HG21 ' B' ' 114' ' ' ILE . 66.8 t -120.26 101.77 11.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.488 1.515 . . . . 74.22 108.452 177.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 90.5 m -84.65 135.28 34.24 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.883 -1.155 . . . . 70.21 107.883 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.22 141.48 26.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.935 0.334 . . . . 63.1 111.325 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.469 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 58.2 p -148.84 135.3 19.49 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.226 0.61 . . . . 65.31 111.341 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.61 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 24.1 mt -96.67 115.3 27.21 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 124.395 1.078 . . . . 73.23 109.995 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.32 -108.44 2.36 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 115.477 -0.783 . . . . 61.51 112.492 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -116.19 2.1 13.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.404 0.681 . . . . 52.21 110.982 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -116.2 145.28 43.23 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.438 -0.578 . . . . 71.32 109.438 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 51.2 m -64.74 135.91 56.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.972 0.509 . . . . 63.35 110.778 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.717 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.29 -64.26 1.13 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.339 -0.986 . . . . 55.22 108.339 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -154.11 154.7 34.07 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.79 -1.096 . . . . 62.42 109.827 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.41 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 41.6 mt -131.95 108.7 9.55 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.917 -1.883 . . . . 73.54 105.917 176.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.4 t -118.26 143.38 46.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.48 -0.933 . . . . 74.2 108.48 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -157.14 129.31 7.29 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.627 -0.879 . . . . 72.43 108.627 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' B' ' 113' ' ' CYS . 81.1 t -123.42 146.35 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.638 0.775 . . . . 65.11 109.148 176.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.2 mt-30 -123.58 96.17 4.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.405 -0.961 . . . . 64.21 108.405 169.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.0 tp-100 -86.47 99.52 11.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.503 -0.925 . . . . 74.15 108.503 174.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.23 167.96 33.34 Favored Glycine 0 C--O 1.244 0.734 0 N-CA-C 110.906 -0.877 . . . . 42.44 110.906 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.19 125.46 1.42 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 112.299 -0.32 . . . . 74.11 112.299 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 53.0 mt -85.85 128.91 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.02 0.928 . . . . 70.52 108.982 172.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -134.62 158.87 42.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.617 1.167 . . . . 74.42 108.366 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.6 m -131.83 129.26 40.23 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.854 -0.795 . . . . 63.41 108.854 171.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 13.9 tt -139.9 145.54 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.093 0.557 . . . . 55.11 110.686 -175.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.17 164.24 34.54 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.45 1.1 . . . . 70.21 109.162 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.21 -25.23 15.3 Favored Glycine 0 N--CA 1.475 1.264 0 CA-C-O 121.039 0.244 . . . . 15.11 112.502 -175.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 17.3 tt -88.91 133.03 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.722 1.209 . . . . 72.34 111.849 -167.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -149.6 -176.47 5.42 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.193 1.397 . . . . 65.01 109.219 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.05 -134.11 27.01 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 114.897 -1.047 . . . . 61.32 113.162 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 61.0 m -73.39 -29.19 62.44 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.175 0.99 . . . . 74.25 111.417 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -57.96 -33.34 68.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.562 0.745 . . . . 64.11 111.863 -171.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 22.9 ptm -60.4 -39.84 88.78 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.705 0.802 . . . . 73.21 111.194 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.81 -32.45 59.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.834 0.854 . . . . 54.23 110.319 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -68.57 -28.3 66.84 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.014 -0.994 . . . . 72.55 111.303 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.498 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 48.9 t -75.4 -66.61 0.75 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.089 0.555 . . . . 74.2 110.162 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.95 -26.42 65.05 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.123 0.569 . . . . 73.3 111.967 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.87 -9.8 62.1 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-O 119.489 -0.617 . . . . 60.03 114.462 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.59 -56.21 0.13 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.818 0.809 . . . . 60.21 113.177 -167.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 92.7 t80 -67.6 -49.48 62.91 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.366 0.667 . . . . 72.32 111.899 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.486 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.1 m -61.96 -51.51 74.66 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.646 0.779 . . . . 74.2 111.604 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 89.0 Cg_exo -53.5 -35.34 75.97 Favored 'Trans proline' 0 C--N 1.4 3.262 0 C-N-CA 122.547 2.165 . . . . 64.4 114.332 172.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -58.63 -43.87 89.83 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 123.359 0.664 . . . . 63.23 110.612 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mt -59.71 -41.0 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.167 0.987 . . . . 73.31 110.912 177.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 46.9 mt -84.5 -17.05 40.29 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.236 1.014 . . . . 73.45 112.207 -172.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -58.83 -50.07 89.97 Favored Pre-proline 0 CA--C 1.556 1.182 0 N-CA-C 114.02 1.119 . . . . 73.35 114.02 -170.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.49 -34.33 92.95 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.03 1.82 . . . . 62.44 113.12 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.504 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 74.4 m-85 -65.69 -50.45 64.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.001 0.52 . . . . 74.4 110.091 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.16 81.47 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.818 0.847 . . . . 70.13 111.197 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.414 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 36.0 ttt180 -63.89 -53.5 49.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.409 1.483 . . . . 73.03 111.18 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.92 -38.43 90.96 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.874 0.734 . . . . 75.12 109.71 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.454 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.2 t -66.63 -36.66 83.11 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.511 -0.768 . . . . 71.32 111.958 -174.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.52 HD11 ' HB ' ' B' ' 62' ' ' VAL . 66.3 mt -62.11 -56.59 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 109.104 -0.702 . . . . 71.41 109.104 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.8 m -60.85 -25.61 66.78 Favored 'General case' 0 CA--C 1.556 1.21 0 O-C-N 124.334 1.021 . . . . 70.04 111.648 -173.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.9 t -68.3 -46.19 70.98 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.7 0.8 . . . . 75.11 110.261 175.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 7.9 mmt -72.54 -34.65 67.69 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.89 0.476 . . . . 74.12 111.063 -177.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 114' ' ' ILE . 93.8 t -57.53 -44.22 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.231 1.013 . . . . 73.42 109.567 171.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.5 t -70.74 -30.88 67.53 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.427 -1.26 . . . . 72.51 112.07 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' B' ' 116' ' ' SER . 89.1 mtt-85 -69.8 -36.03 75.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.983 0.513 . . . . 63.1 110.036 177.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.64 1.95 84.34 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.592 0.558 . . . . 54.52 112.559 171.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 26.7 p 62.18 30.77 17.75 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.687 1.995 . . . . 73.24 113.0 172.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -85.16 155.05 60.63 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.667 0.787 . . . . 74.2 110.095 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.533 ' HB2' ' HG2' ' B' ' 37' ' ' GLN . 48.0 Cg_exo -57.15 168.82 2.38 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.231 2.621 . . . . 74.1 114.537 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.417 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 63.9 tp60 -56.85 133.42 54.44 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.573 1.149 . . . . 75.14 112.065 -172.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.47 102.48 6.65 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.269 -1.012 . . . . 53.13 108.269 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.53 101.31 12.21 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.611 0.764 . . . . 74.5 109.553 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.414 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 0.2 OUTLIER -61.28 129.35 40.83 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 109.259 -0.645 . . . . 71.23 109.259 179.451 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.64 152.13 80.47 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 123.625 0.77 . . . . 64.55 111.941 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.426 ' HG2' ' HB ' ' D' ' 13' ' ' ILE . 6.2 Cg_endo -81.26 109.69 2.16 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.25 2.633 . . . . 50.23 112.137 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 t -115.06 112.4 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.19 -0.67 . . . . 61.01 109.19 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 132' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' B' ' 136' ' ' LEU . 56.2 t-20 -85.24 112.85 21.12 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.905 -0.776 . . . . 74.4 108.905 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -89.86 -27.47 19.9 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.01 0.744 . . . . 72.21 113.01 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -73.77 -42.71 60.68 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 118.602 0.637 . . . . 73.42 111.416 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.2 89.25 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.542 0.737 . . . . 60.15 110.307 172.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 136' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' B' ' 132' ' ' ASN . 0.9 OUTLIER -68.78 -33.5 73.98 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.079 0.951 . . . . 75.32 110.25 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 80.3 t80 . . . . . 0 N--CA 1.475 0.79 0 C-N-CA 123.429 0.692 . . . . 74.34 110.767 -175.643 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 90.9 m . . . . . 0 C--O 1.239 0.51 0 N-CA-C 108.93 -0.766 . . . . 72.12 108.93 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -94.31 140.83 29.29 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.535 -0.757 . . . . 74.35 109.387 175.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -152.63 136.05 15.92 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.536 -0.542 . . . . 65.11 109.536 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.14 127.84 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.517 -0.92 . . . . 74.51 108.517 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.497 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 14.4 mm100 -89.8 -47.47 7.88 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.207 -0.664 . . . . 73.24 109.207 174.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -175.0 134.41 0.34 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.798 -0.637 . . . . 62.23 109.836 -170.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.8 mt -117.34 144.98 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.791 -1.189 . . . . 73.34 107.791 176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.431 ' CE2' ' HG2' ' C' ' 19' ' ' LYS . 36.7 p90 -171.53 161.72 6.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.506 0.669 . . . . 73.24 111.301 -174.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.9 p -88.63 112.51 23.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.876 -1.157 . . . . 73.32 107.876 169.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' C' ' 17' ' ' TYR . 18.1 mttt -67.44 -48.97 65.67 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 122.24 1.019 . . . . 73.21 108.345 171.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.34 133.37 36.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 113.599 -1.637 . . . . 74.13 109.045 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 79.6 mt -124.49 141.31 45.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.692 -1.596 . . . . 60.53 106.692 172.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -153.92 147.61 25.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.398 0.618 . . . . 53.34 110.997 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 81.7 t80 -146.37 132.12 18.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 106.899 -1.519 . . . . 71.42 106.899 169.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -132.54 124.93 29.4 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.729 0.811 . . . . 73.14 109.35 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.41 79.87 29.03 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.06 -1.459 . . . . 54.31 107.06 172.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.72 -26.74 19.05 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.748 2.299 . . . . 71.14 111.569 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -102.43 17.6 23.16 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.283 1.033 . . . . 73.41 110.218 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.419 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -47.96 -59.63 5.53 Favored Pre-proline 0 C--N 1.371 1.512 0 N-CA-C 114.774 1.398 . . . . 62.4 114.774 -166.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 23.7 Cg_exo -61.14 -42.36 36.53 Favored 'Trans proline' 0 C--N 1.393 2.917 0 CA-C-N 121.834 1.691 . . . . 55.04 111.919 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -69.73 -33.16 72.1 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.402 -1.272 . . . . 71.13 112.232 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.699 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.0 p -79.43 -21.6 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 O-C-N 122.094 -0.379 . . . . 63.13 111.867 -176.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -69.83 -22.18 63.31 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.762 0.425 . . . . 61.14 111.742 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -97.29 19.46 13.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.671 0.388 . . . . 74.14 111.295 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.761 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.76 149.83 21.41 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.902 -0.777 . . . . 75.33 108.902 170.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -69.41 129.7 40.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.88 -0.785 . . . . 70.45 108.88 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -68.51 109.72 3.85 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.165 0.586 . . . . 73.34 111.418 -172.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -163.08 70.19 1.93 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.948 0.899 . . . . 54.41 108.879 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -88.52 128.5 2.12 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.94 2.427 . . . . 62.3 112.818 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 39' ' ' GLU . . . . . 0.442 ' HB3' ' HE2' ' C' ' 41' ' ' LYS . 26.4 mt-10 -84.68 94.96 8.76 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.381 -0.97 . . . . 74.11 108.381 168.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 m -74.7 99.17 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-N 114.419 -1.264 . . . . 64.53 110.314 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' C' ' 39' ' ' GLU . 73.4 mmtt -92.76 103.35 15.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.76 -1.109 . . . . 72.14 108.497 177.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.498 HD21 HG13 ' C' ' 62' ' ' VAL . 7.3 tt -95.04 136.71 35.03 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.913 -0.773 . . . . 74.22 108.913 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -118.4 112.73 20.37 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.253 1.421 . . . . 73.2 107.739 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp -104.14 133.96 48.2 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.926 -0.768 . . . . 75.11 108.926 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.4 t70 -140.47 149.33 42.4 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.045 0.938 . . . . 70.24 109.153 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 7.9 m -132.57 130.36 40.21 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 123.505 0.722 . . . . 64.22 109.301 169.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.37 153.23 26.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.933 1.293 . . . . 71.22 108.241 175.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 17.8 p -149.85 140.92 22.97 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.711 -0.477 . . . . 74.4 109.711 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -161.16 150.81 16.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.878 0.871 . . . . 73.31 109.453 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -86.08 132.7 33.98 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.936 -0.394 . . . . 73.1 109.936 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.559 HD11 HD12 ' C' ' 83' ' ' ILE . 50.0 mt -98.88 -38.41 9.04 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.426 0.69 . . . . 74.32 109.269 173.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.63 178.0 10.77 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.229 1.012 . . . . 70.52 109.635 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.89 123.17 17.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.94 0.496 . . . . 73.34 109.891 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 71.38 -8.77 0.98 Allowed 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 126.316 1.846 . . . . 72.05 113.311 -173.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -95.27 97.5 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.77 -0.826 . . . . 61.53 108.77 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.66 124.54 49.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.132 -0.692 . . . . 72.41 109.132 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.43 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.4 tt0 -90.16 135.4 33.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.163 0.585 . . . . 74.1 109.715 173.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.34 141.34 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.502 1.121 . . . . 73.35 107.979 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.7 t -127.49 129.27 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 107.662 -1.236 . . . . 74.21 107.662 172.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.17 102.81 11.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.575 -1.269 . . . . 73.01 107.575 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -84.22 127.83 34.19 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.037 -0.983 . . . . 74.41 108.388 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.498 HG13 HD21 ' C' ' 42' ' ' LEU . 40.9 t -124.45 121.06 60.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 107.123 -1.436 . . . . 75.23 107.123 168.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 9.5 m -124.98 115.36 20.44 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.479 -0.563 . . . . 71.14 109.479 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.413 HG23 HD13 ' C' ' 114' ' ' ILE . 81.2 t -99.92 107.96 21.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.298 -1.001 . . . . 62.33 108.298 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 55.6 m -96.18 139.82 31.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.276 -1.75 . . . . 73.54 106.276 169.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.75 116.19 11.99 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.527 -1.286 . . . . 63.12 107.527 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.6 m -127.08 168.39 14.67 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.031 -0.729 . . . . 70.53 109.031 175.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.761 HD13 ' HG2' ' C' ' 34' ' ' LYS . 5.6 mt -123.47 21.41 9.43 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.535 1.134 . . . . 53.3 109.004 -174.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.72 -99.76 1.0 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.66 -1.376 . . . . 64.42 109.66 -166.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -90.89 -31.62 16.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.418 0.687 . . . . 74.15 110.64 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -85.36 120.17 26.54 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.059 0.943 . . . . 63.53 110.875 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 40.5 m -73.55 125.78 28.76 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.744 -0.465 . . . . 63.54 109.744 170.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.699 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.0 -61.86 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.091 0.869 . . . . 41.23 109.003 171.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 74' ' ' PHE . . . . . 0.476 ' HZ ' HD21 ' C' ' 126' ' ' LEU . 54.6 p90 -164.86 176.08 9.03 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.708 0.766 . . . . 71.23 111.739 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -130.41 144.77 51.6 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 106.508 -1.664 . . . . 74.24 106.508 168.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.456 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.8 t -152.47 111.65 3.86 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.085 -0.709 . . . . 64.42 109.085 174.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.69 133.86 55.5 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.822 -0.436 . . . . 62.35 109.822 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 56.1 t -124.95 135.05 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.735 0.814 . . . . 63.2 108.846 168.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -111.99 90.4 3.33 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.835 -1.172 . . . . 64.15 107.835 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.05 96.59 6.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.427 -0.806 . . . . 65.41 109.403 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.63 146.8 20.92 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.218 -0.753 . . . . 73.05 111.218 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.527 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.36 117.5 0.85 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.312 -1.115 . . . . 72.22 110.312 -175.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.559 HD12 HD11 ' C' ' 51' ' ' LEU . 10.7 mm -82.88 126.54 40.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 107.714 -1.217 . . . . 72.42 107.714 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -133.13 121.28 22.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.481 0.713 . . . . 74.44 109.378 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.6 p -85.24 111.07 19.51 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.204 -0.665 . . . . 63.15 109.204 174.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 49.4 pt -114.68 141.17 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.088 0.955 . . . . 71.4 108.975 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.95 164.42 31.19 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.399 0.68 . . . . 24.23 110.004 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.75 -55.8 0.72 Allowed Glycine 0 C--N 1.341 0.82 0 O-C-N 123.512 0.508 . . . . 60.11 113.137 172.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.48 170.52 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 112.577 0.584 . . . . 72.43 112.577 -173.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.484 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 17.1 pt-20 -151.97 -172.64 4.28 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.941 0.897 . . . . 70.55 109.819 172.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.49 -137.92 16.96 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-O 119.338 -0.701 . . . . 42.13 113.231 172.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 25.3 p -63.49 -33.58 75.89 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.895 0.878 . . . . 53.22 111.402 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.65 -48.53 81.32 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.242 1.017 . . . . 71.04 110.064 176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.484 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 35.8 ttp -72.97 -30.09 63.57 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.613 -1.176 . . . . 74.31 110.845 176.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.58 -35.13 73.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.912 0.485 . . . . 74.12 110.23 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -78.67 -33.16 47.26 Favored 'General case' 0 C--O 1.242 0.702 0 O-C-N 123.693 0.621 . . . . 63.33 111.827 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 39.8 t -57.23 -39.28 75.18 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.412 0.445 . . . . 31.2 110.442 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.8 mt -95.21 -19.54 19.96 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.794 0.837 . . . . 71.13 110.348 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.99 -29.4 54.32 Favored Glycine 0 C--N 1.349 1.252 0 C-N-CA 123.559 0.6 . . . . 73.42 114.036 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.03 -41.94 0.08 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.601 0.593 . . . . 55.34 112.601 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -61.85 -57.54 11.4 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.222 0.609 . . . . 72.11 111.961 -173.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 97.0 m -66.64 -46.6 57.35 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.927 0.891 . . . . 54.12 112.45 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.58 -35.92 69.14 Favored 'Trans proline' 0 C--N 1.401 3.328 0 C-N-CA 122.428 2.085 . . . . 75.53 113.388 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -67.75 -35.65 79.09 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.763 0.825 . . . . 64.42 110.463 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.41 HD12 ' NH1' ' A' ' 111' ' ' ARG . 46.8 mm -63.73 -39.5 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 122.863 0.465 . . . . 70.4 109.995 174.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.527 HD21 ' HA3' ' C' ' 82' ' ' GLY . 83.2 mt -85.78 -22.82 27.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.098 0.959 . . . . 74.43 112.847 -173.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -60.29 -46.59 97.69 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 124.984 1.314 . . . . 74.52 113.787 -172.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.614 ' HA ' ' HD3' ' C' ' 111' ' ' ARG . 35.2 Cg_exo -63.55 -34.53 63.95 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 122.307 2.005 . . . . 73.31 113.463 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -67.49 -44.59 78.15 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.752 0.421 . . . . 75.43 110.142 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.37 78.49 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 115.285 -0.871 . . . . 61.24 110.891 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.744 ' HG2' ' HG ' ' C' ' 128' ' ' LEU . 21.3 mtp-105 -56.88 -62.32 1.82 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.784 0.833 . . . . 65.42 110.707 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.51 -30.13 71.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.243 0.617 . . . . 71.43 111.286 -172.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.5 t -74.07 -32.85 63.46 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.073 0.549 . . . . 64.31 111.502 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.44 HG23 ' SG ' ' C' ' 76' ' ' CYS . 66.4 mt -73.71 -49.81 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.274 0.63 . . . . 74.22 109.846 172.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 90.6 m -57.26 -37.79 72.88 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.343 1.057 . . . . 75.34 111.407 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -63.72 -48.07 78.54 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.34 -0.846 . . . . 75.21 109.622 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.674 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.59 -37.89 88.0 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.617 1.167 . . . . 65.13 112.991 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.445 HG21 HD11 ' C' ' 126' ' ' LEU . 78.5 t -68.36 -43.28 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.657 0.783 . . . . 72.44 110.611 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -66.19 -30.42 70.89 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 115.018 -0.992 . . . . 72.34 110.604 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -71.86 -34.29 69.1 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 123.69 0.796 . . . . 63.31 109.455 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.69 5.58 77.8 Favored Glycine 0 C--N 1.353 1.484 0 O-C-N 123.73 0.644 . . . . 74.12 113.04 174.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.451 HG23 ' HB3' ' D' ' 17' ' ' TYR . 75.5 p 60.62 23.36 13.13 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.524 1.93 . . . . 72.21 113.974 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.444 ' HB2' HG13 ' C' ' 118' ' ' VAL . 90.1 m-85 -85.06 156.56 60.41 Favored Pre-proline 0 CA--C 1.555 1.145 0 N-CA-C 108.739 -0.837 . . . . 64.02 108.739 170.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.11 155.35 40.05 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.195 2.597 . . . . 53.2 113.129 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.417 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 52.3 mm-40 -60.13 131.39 50.68 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.978 0.911 . . . . 75.12 112.017 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.476 HD21 ' HZ ' ' C' ' 74' ' ' PHE . 2.9 pp -144.67 126.82 15.63 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.819 0.848 . . . . 71.34 108.809 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -127.7 124.88 38.95 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.537 -1.653 . . . . 63.32 106.537 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.744 ' HG ' ' HG2' ' C' ' 111' ' ' ARG . 0.0 OUTLIER -75.82 130.12 38.08 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.475 -0.565 . . . . 71.5 109.475 -171.945 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.57 154.39 93.31 Favored Pre-proline 0 CA--C 1.551 1.001 0 O-C-N 124.726 1.266 . . . . 72.31 112.589 -170.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.443 ' HG2' HG21 ' A' ' 13' ' ' ILE . 7.6 Cg_exo -68.79 115.2 3.83 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.372 2.048 . . . . 73.01 111.749 175.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 51.0 t -99.12 134.28 38.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.084 -1.45 . . . . 62.21 107.084 168.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -73.65 73.34 1.49 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.219 0.608 . . . . 65.23 110.358 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -60.75 -39.63 89.45 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.448 0.699 . . . . 74.21 110.656 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -61.61 -49.36 76.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.299 -0.864 . . . . 71.14 111.606 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.49 87.67 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.88 0.737 . . . . 54.2 111.183 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 93.8 mt -67.71 -34.8 77.6 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.543 -0.753 . . . . 74.41 111.894 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 10.6 t80 . . . . . 0 N--CA 1.486 1.327 0 C-N-CA 122.663 0.385 . . . . 61.04 110.677 -178.663 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 61.6 m . . . . . 0 C--O 1.236 0.354 0 CA-C-O 121.463 0.649 . . . . 62.52 111.066 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -154.47 93.01 1.55 Allowed 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.579 -1.637 . . . . 74.51 106.579 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -113.23 126.87 55.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.177 -0.675 . . . . 71.42 109.177 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.426 ' HB ' ' HG2' ' B' ' 130' ' ' PRO . 10.2 mt -87.56 119.87 35.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.062 -1.088 . . . . 74.3 108.062 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -85.62 -28.52 24.72 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 123.643 0.589 . . . . 60.43 111.125 -175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -172.4 121.03 0.42 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 110.399 -0.223 . . . . 52.23 110.399 -166.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.4 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.2 mp -106.02 133.49 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 107.328 -1.36 . . . . 74.05 107.328 169.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.451 ' HB3' HG23 ' C' ' 122' ' ' THR . 42.6 p90 -162.63 174.18 12.93 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 122.007 0.908 . . . . 75.44 112.045 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 18' ' ' THR . . . . . 0.511 HG21 HD11 ' D' ' 21' ' ' ILE . 74.9 p -104.57 124.18 48.86 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.188 -1.369 . . . . 65.43 109.188 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 36.4 mtpt -93.86 -18.49 21.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.418 0.687 . . . . 53.24 109.559 177.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.7 t70 -162.12 135.17 6.06 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 124.377 1.071 . . . . 73.52 108.989 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.674 HD13 ' HE3' ' C' ' 117' ' ' MET . 86.8 mt -136.16 133.86 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.602 1.161 . . . . 64.22 108.076 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 57.8 m -137.59 113.46 9.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.413 1.085 . . . . 64.4 109.655 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.521 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 83.8 t80 -116.82 117.12 28.86 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.353 -1.721 . . . . 72.35 106.353 163.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.4 mt-10 -126.3 111.33 14.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.422 0.689 . . . . 72.01 109.357 -175.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.17 87.31 7.17 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.272 -1.01 . . . . 71.25 108.272 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -75.54 -32.61 4.67 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.7 2.267 . . . . 72.31 113.01 -171.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 44.6 m-20 -100.42 9.09 43.11 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.557 0.743 . . . . 71.43 110.161 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.434 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -28.06 -69.79 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 116.18 1.919 . . . . 72.12 116.18 -161.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.405 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 68.4 Cg_endo -77.41 -19.6 13.08 Favored 'Trans proline' 0 C--N 1.383 2.353 0 CA-C-N 123.558 2.306 . . . . 70.22 113.765 -174.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 5.9 t-160 -70.18 -43.07 71.54 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.366 1.066 . . . . 52.34 109.13 173.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.567 HG21 ' HA ' ' D' ' 73' ' ' ALA . 6.3 p -84.28 -15.65 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.81 0.844 . . . . 71.32 111.398 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.405 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.8 m-85 -70.4 -19.69 62.99 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 120.784 0.325 . . . . 54.34 111.38 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -72.66 -12.44 61.04 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.413 -0.812 . . . . 71.31 111.069 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -83.26 84.51 7.47 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.208 1.003 . . . . 64.01 108.885 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -77.46 80.43 3.95 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.457 0.646 . . . . 71.21 109.282 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -156.23 163.8 39.12 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.501 -1.227 . . . . 73.24 108.842 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -89.99 108.18 24.23 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.204 1.002 . . . . 74.12 109.65 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.85 158.09 30.51 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 123.329 2.686 . . . . 73.34 114.302 -174.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -79.82 157.31 27.06 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.356 1.062 . . . . 74.45 110.736 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.83 118.47 57.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.178 -0.675 . . . . 73.22 109.178 172.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -117.65 114.04 22.79 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.819 0.847 . . . . 51.03 108.832 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.35 126.33 43.82 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.113 0.565 . . . . 72.41 111.034 -172.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -124.97 120.09 30.6 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.959 1.304 . . . . 65.52 107.654 170.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt -110.95 146.03 37.33 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.728 0.411 . . . . 73.33 110.093 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 34.5 t70 -147.82 151.5 36.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.651 1.18 . . . . 75.51 108.342 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -132.16 163.73 27.88 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.735 0.414 . . . . 75.3 110.432 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.673 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.93 175.21 13.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.371 1.068 . . . . 60.1 109.512 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.578 ' HB3' HD21 ' D' ' 98' ' ' LEU . 50.5 p -168.5 157.25 8.69 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.81 0.844 . . . . 61.33 110.573 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 88.5 p -153.2 154.56 34.95 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.962 0.905 . . . . 72.11 109.038 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -94.59 116.97 29.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.728 -0.842 . . . . 75.22 108.728 170.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 42.7 mt -93.38 -30.01 15.32 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 110.02 -0.363 . . . . 73.44 110.02 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.83 -174.84 4.1 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.444 0.698 . . . . 72.42 111.2 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -67.09 116.47 7.94 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.661 -1.154 . . . . 71.44 109.455 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 66.02 5.5 3.56 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.867 1.267 . . . . 73.12 112.567 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 78.8 t -110.18 120.05 60.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 108.545 -0.909 . . . . 75.35 108.545 176.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -135.26 131.27 36.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.752 -0.833 . . . . 73.52 108.752 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -89.81 148.01 23.46 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.698 0.799 . . . . 63.35 109.355 173.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.8 t -125.49 139.87 50.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 124.737 1.215 . . . . 74.23 107.867 170.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.673 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 77.8 t -118.69 135.37 59.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.282 -1.007 . . . . 73.32 108.282 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 121.01 39.39 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.785 -0.82 . . . . 74.54 108.785 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 24.8 ttm-85 -103.38 96.0 6.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.048 -1.093 . . . . 64.22 108.048 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 74.5 t -97.81 119.0 45.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.295 -1.002 . . . . 52.11 108.295 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 14.2 m -119.77 129.87 54.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.846 -1.07 . . . . 55.33 108.541 -172.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 67.2 t -122.47 128.97 75.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 124.837 1.255 . . . . 73.24 108.261 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 95.9 m -122.34 120.63 34.58 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.199 -1.037 . . . . 63.21 108.199 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.71 151.94 39.95 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.472 -0.785 . . . . 75.31 110.08 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.463 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 19.7 p -149.6 125.37 10.47 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.293 -0.867 . . . . 65.41 109.368 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 12.0 mt -92.83 114.21 26.7 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.221 1.008 . . . . 74.31 108.931 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.92 -110.1 2.94 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.966 -0.854 . . . . 75.01 110.966 -174.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 5.94 8.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.013 0.925 . . . . 74.42 110.844 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -123.02 155.41 36.91 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.539 0.736 . . . . 74.32 109.788 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -60.51 129.98 44.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.851 0.86 . . . . 75.41 111.979 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.567 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.96 -72.74 0.55 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.756 -1.201 . . . . 72.04 107.756 176.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -145.57 146.36 31.36 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.216 -0.902 . . . . 73.4 110.217 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.7 mt -114.34 143.58 44.65 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.534 1.134 . . . . 73.45 108.134 175.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.551 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 23.7 m -142.09 137.49 31.03 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.832 0.853 . . . . 72.23 109.232 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -154.41 121.0 5.45 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.799 -1.186 . . . . 72.44 107.799 170.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.7 t -130.8 115.23 29.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.684 -0.858 . . . . 63.02 108.684 -175.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -88.49 85.37 6.84 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.431 -0.952 . . . . 72.21 108.431 172.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -78.61 96.77 5.58 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.248 -1.342 . . . . 62.24 108.771 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.85 143.12 17.4 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 115.827 -0.624 . . . . 74.43 111.867 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -140.75 129.64 4.22 Favored Glycine 0 C--N 1.329 0.187 0 N-CA-C 110.685 -0.966 . . . . 72.53 110.685 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.0 mt -90.15 129.43 41.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.321 -0.992 . . . . 73.14 108.321 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -128.92 153.46 47.49 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.71 0.404 . . . . 74.15 111.06 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -114.88 105.65 13.25 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.806 1.242 . . . . 65.23 108.097 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.35 122.76 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.125 0.57 . . . . 52.31 110.305 -175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.08 141.94 24.67 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.316 1.046 . . . . 34.42 108.48 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.94 -20.13 29.35 Favored Glycine 0 N--CA 1.468 0.825 0 O-C-N 123.116 0.26 . . . . 60.02 112.59 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 32.9 pt -131.95 147.0 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.414 0.686 . . . . 74.44 109.17 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.07 163.48 33.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.807 0.843 . . . . 73.51 111.317 -176.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.64 -127.52 31.37 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.173 -0.921 . . . . 65.14 114.264 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.1 m -74.32 -30.63 62.14 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.192 0.997 . . . . 74.12 111.135 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -65.46 -34.83 79.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.32 0.648 . . . . 75.34 109.977 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -83.62 -26.17 30.18 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.534 -0.757 . . . . 71.12 110.817 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.08 -23.16 67.09 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.86 0.362 . . . . 52.02 110.612 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -70.48 -43.6 69.42 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.672 0.789 . . . . 72.34 110.557 168.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -63.59 -46.83 84.03 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.933 0.493 . . . . 63.14 110.966 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' D' ' 48' ' ' SER . 7.3 tt -77.2 -46.26 23.88 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.838 0.855 . . . . 72.21 109.785 -175.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.37 -12.69 83.58 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.83 -0.623 . . . . 71.34 114.149 -172.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.49 -61.03 0.65 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.424 0.612 . . . . 74.4 112.546 -172.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -67.06 -39.7 86.95 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 112.639 0.607 . . . . 75.14 112.639 -172.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.445 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 97.7 m -68.91 -48.94 28.15 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 118.547 -0.739 . . . . 71.25 111.086 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 71.0 Cg_exo -55.74 -35.11 92.81 Favored 'Trans proline' 0 C--N 1.399 3.209 0 C-N-CA 122.413 2.075 . . . . 65.5 113.169 168.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -63.36 -37.37 87.02 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.338 0.655 . . . . 74.25 110.276 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.5 mm -67.58 -43.42 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.664 0.786 . . . . 64.35 110.703 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' D' ' 82' ' ' GLY . 95.1 mt -75.08 -16.71 60.55 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.382 -0.826 . . . . 72.24 111.809 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -69.64 -43.08 21.07 Favored Pre-proline 0 CA--C 1.56 1.334 0 CA-C-O 118.209 -0.9 . . . . 73.43 113.274 -170.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -53.15 -44.74 46.37 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.2 1.934 . . . . 74.52 112.964 168.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.49 -36.09 76.19 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.665 0.786 . . . . 71.05 111.817 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.94 -54.66 31.11 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.49 0.716 . . . . 55.14 109.678 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -49.56 -49.46 46.28 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 125.068 1.48 . . . . 65.44 111.038 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -64.79 -44.0 91.39 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 124.132 0.895 . . . . 55.21 111.608 -173.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.0 t -60.33 -43.7 96.18 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.511 0.507 . . . . 75.44 110.717 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.493 HG21 HG21 ' D' ' 64' ' ' VAL . 77.3 mt -59.42 -56.97 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.399 1.08 . . . . 74.02 110.057 173.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.3 m -59.07 -35.35 73.22 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.205 1.402 . . . . 61.12 112.053 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -69.27 -43.85 73.06 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.643 -0.708 . . . . 72.44 109.753 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 72.3 mtm -67.38 -31.82 72.3 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.974 0.51 . . . . 64.05 111.875 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.477 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.6 t -62.69 -45.37 98.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.976 0.91 . . . . 72.53 110.334 175.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.8 p -73.59 -32.08 63.93 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 116.126 -0.488 . . . . 44.05 111.136 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -70.67 -31.78 68.82 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.633 0.773 . . . . 72.55 110.509 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.06 8.84 76.96 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-N 115.491 -0.777 . . . . 73.42 112.419 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 28.3 p 63.94 18.45 11.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.494 1.918 . . . . 74.54 114.231 171.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.82 147.69 49.28 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.198 0.599 . . . . 74.01 109.446 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.42 124.07 13.43 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.358 2.705 . . . . 72.42 112.932 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -61.86 130.09 44.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.955 1.302 . . . . 61.23 112.092 -173.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 71.2 mt -119.09 112.5 19.62 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.015 0.926 . . . . 60.04 109.12 -176.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -100.79 103.06 14.27 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.749 -0.834 . . . . 70.12 108.749 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 29.2 tp -68.91 135.85 51.67 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.679 -1.146 . . . . 70.33 112.053 -169.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.31 135.9 93.46 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 122.989 0.516 . . . . 61.24 110.428 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -64.04 136.41 52.23 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.719 2.279 . . . . 75.44 111.925 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.85 123.19 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.563 0.745 . . . . 64.34 109.211 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -82.66 92.59 7.19 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.954 -0.758 . . . . 43.12 108.954 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -67.23 -35.76 80.26 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.982 -0.554 . . . . 70.23 110.555 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.62 -53.51 57.25 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.575 1.15 . . . . 71.41 112.789 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.82 93.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.116 0.566 . . . . 35.42 110.973 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 33.4 tp -76.2 -17.77 59.37 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.592 -0.731 . . . . 64.54 111.951 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 89.8 t80 . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 109.398 -0.593 . . . . 74.14 109.398 171.569 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 68.9 m . . . . . 0 C--O 1.241 0.611 0 N-CA-C 109.388 -0.597 . . . . 74.55 109.388 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.68 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.6 t80 -136.44 131.63 34.33 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.745 1.218 . . . . 62.44 108.951 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -138.93 117.93 12.5 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.013 0.925 . . . . 73.34 108.652 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.532 HG12 ' HD2' ' A' ' 84' ' ' PHE . 39.1 mt -84.19 110.91 19.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.549 -0.908 . . . . 74.15 108.549 172.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -78.07 -40.03 39.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.991 0.807 . . . . 73.11 110.132 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -169.84 143.77 2.68 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 121.137 -0.225 . . . . 65.44 111.125 -171.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.533 HD12 ' HG3' ' C' ' 130' ' ' PRO . 94.2 mt -135.71 128.31 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.121 -1.066 . . . . 63.03 108.121 175.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' HB3' HG23 ' B' ' 122' ' ' THR . 28.7 p90 -165.62 150.21 8.57 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.177 0.991 . . . . 70.31 110.37 -169.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -75.32 114.91 14.4 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.978 -0.749 . . . . 52.01 108.978 173.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 37.5 mtpt -81.74 -28.36 33.39 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.297 -0.631 . . . . 71.12 109.297 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.1 t70 -149.08 138.52 21.67 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.235 -0.893 . . . . 74.23 109.723 174.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.11 150.43 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 107.257 -1.386 . . . . 74.15 107.257 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.0 t -158.23 146.4 18.62 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.387 0.429 . . . . 63.45 109.972 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 82.4 t80 -137.72 141.07 41.02 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.262 -1.384 . . . . 75.51 107.262 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 50.7 mt-10 -139.13 133.55 31.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.374 0.67 . . . . 74.02 109.39 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -147.32 73.39 11.88 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 107.235 -1.394 . . . . 63.33 107.235 171.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.51 -22.25 18.57 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.63 2.22 . . . . 74.44 111.779 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -112.27 32.8 5.29 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.019 1.328 . . . . 42.35 109.367 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -60.47 -46.75 97.44 Favored Pre-proline 0 CA--C 1.571 1.763 0 N-CA-C 113.054 0.761 . . . . 70.4 113.054 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 25.4 Cg_exo -66.61 -19.28 54.26 Favored 'Trans proline' 0 C--N 1.393 2.909 0 C-N-CA 122.002 1.801 . . . . 72.31 113.216 172.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -79.93 -48.86 12.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.398 0.679 . . . . 71.25 110.892 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 7.8 p -68.43 -18.93 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.963 0.505 . . . . 54.34 110.71 -178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -62.2 -39.63 93.39 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.108 0.963 . . . . 73.15 111.29 175.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -95.06 -13.14 25.44 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.591 0.756 . . . . 71.54 111.552 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 31.9 mmtp -83.19 167.93 17.26 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.24 0.616 . . . . 72.54 111.928 177.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -83.85 137.27 33.77 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.92 0.888 . . . . 71.04 109.819 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -77.68 86.77 3.96 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.469 0.652 . . . . 72.53 109.86 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -138.34 73.77 42.63 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 107.652 -1.24 . . . . 75.04 107.652 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 37.2 Cg_endo -91.05 166.06 3.75 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.48 2.12 . . . . 72.22 113.506 -174.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -99.58 105.51 17.39 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.06 -1.459 . . . . 74.54 107.06 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.13 90.87 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-O 122.728 1.251 . . . . 70.02 110.78 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 65' ' ' THR . 29.8 mmmt -94.91 118.09 31.21 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.899 -1.046 . . . . 71.43 108.887 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.9 tp -116.77 127.2 54.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.25 -1.389 . . . . 72.04 107.25 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HB2' HG22 ' A' ' 63' ' ' THR . 6.7 m-20 -123.54 122.91 39.41 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.334 -1.358 . . . . 71.3 107.334 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.412 ' HG ' HG22 ' A' ' 62' ' ' VAL . 6.3 tt -128.75 136.46 50.59 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.75 -0.833 . . . . 75.42 108.75 -169.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 28.8 t70 -143.75 145.35 32.33 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.993 1.317 . . . . 73.03 108.431 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.0 m -114.35 133.77 55.45 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.262 -1.014 . . . . 73.2 108.262 171.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.96 143.15 50.65 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.881 -0.785 . . . . 71.15 108.881 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.8 m -127.8 152.54 47.66 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.077 0.551 . . . . 72.14 111.017 -170.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.6 p -159.44 140.36 12.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.724 0.64 . . . . 72.11 110.123 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -87.18 109.22 19.32 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.304 -0.628 . . . . 74.31 109.304 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 57' ' ' GLU . 82.7 mt -78.95 -41.63 28.87 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.229 0.538 . . . . 52.54 109.984 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.454 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -150.99 176.86 10.72 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.228 -1.027 . . . . 73.31 108.228 177.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -60.58 117.54 5.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.13 -0.693 . . . . 63.52 109.13 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 72.58 13.1 5.39 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.731 1.212 . . . . 72.45 112.317 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.454 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 49.1 t -118.93 125.17 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.395 -0.965 . . . . 60.44 108.395 176.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -123.55 153.34 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.549 0.69 . . . . 73.54 111.582 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' A' ' 51' ' ' LEU . 8.4 tp10 -118.05 114.15 22.69 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.186 -1.783 . . . . 73.22 106.186 166.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.74 122.37 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 107.782 -1.192 . . . . 75.43 107.782 169.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -99.31 123.21 51.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.175 -1.046 . . . . 61.04 108.175 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 tp -86.74 96.83 10.3 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 106.754 -1.572 . . . . 60.42 106.754 173.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.597 ' HG2' ' HG3' ' A' ' 79' ' ' GLN . 0.8 OUTLIER -85.77 101.95 13.23 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.526 -1.216 . . . . 65.34 107.908 -175.161 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.412 HG22 ' HG ' ' A' ' 44' ' ' LEU . 62.1 t -125.08 137.97 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.067 0.547 . . . . 73.04 109.689 -174.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.428 HG22 ' HB2' ' A' ' 43' ' ' ASP . 7.5 t -138.53 145.63 40.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.348 0.659 . . . . 73.12 110.003 172.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 93.2 t -120.11 111.57 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.915 0.886 . . . . 70.41 108.614 177.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 20.7 m -105.52 107.91 19.15 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.199 -0.667 . . . . 74.41 109.199 173.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.64 104.64 15.02 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.736 -1.209 . . . . 53.33 107.736 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 25.0 m -117.27 123.53 46.81 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.954 -0.387 . . . . 73.13 109.954 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.72 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -90.26 86.33 6.48 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.049 0.928 . . . . 74.14 108.895 -178.372 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.29 -95.94 1.8 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 114.434 -1.257 . . . . 62.51 110.853 -174.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -114.73 -25.78 8.12 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.277 0.631 . . . . 73.31 111.455 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -87.72 134.07 33.73 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.772 0.829 . . . . 65.24 110.693 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 49.4 m -84.96 135.07 34.2 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 120.923 0.392 . . . . 71.05 110.74 174.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.21 -61.61 1.85 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.83 1.252 . . . . 71.44 109.425 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -147.07 165.16 30.75 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.888 -1.051 . . . . 73.24 111.456 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 61.6 tp -135.65 108.79 7.71 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.028 -1.442 . . . . 72.31 107.561 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.429 ' SG ' HG22 ' A' ' 118' ' ' VAL . 90.0 m -108.35 104.38 13.74 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.269 0.628 . . . . 62.15 109.596 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 37.9 tt0 -124.13 117.28 24.29 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.171 0.988 . . . . 73.44 110.269 -169.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.1 t -133.69 112.83 17.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 123.7 0.8 . . . . 72.1 109.808 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.597 ' HG3' ' HG2' ' A' ' 61' ' ' ARG . 2.2 mp0 -89.68 84.22 6.3 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.657 1.183 . . . . 72.33 107.953 173.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -82.68 100.85 10.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.754 -1.112 . . . . 63.11 109.387 -175.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.13 151.91 20.99 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.45 0.469 . . . . 73.34 112.33 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.531 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -146.3 125.49 2.26 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.657 -0.577 . . . . 44.44 111.657 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.8 mt -81.45 118.13 28.68 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.252 -1.018 . . . . 72.34 108.252 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.68 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 41.1 m-85 -131.27 126.97 36.79 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.793 0.837 . . . . 74.3 108.971 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.3 m -83.75 115.64 22.31 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.379 1.072 . . . . 60.41 109.878 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 94' ' ' MET . 6.0 tt -97.14 136.68 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.246 1.019 . . . . 74.32 109.063 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -160.72 137.56 8.91 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.359 0.264 . . . . 62.14 111.368 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.97 -32.2 6.51 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.86 -0.609 . . . . 64.33 114.515 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -133.15 148.03 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 116.931 0.366 . . . . 70.41 111.693 -165.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.501 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 9.5 tt0 -134.99 -176.8 4.37 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.042 0.937 . . . . 72.25 109.18 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.501 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.94 -130.67 36.22 Favored Glycine 0 C--N 1.353 1.501 0 C-N-CA 123.178 0.418 . . . . 73.05 113.951 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.0 p -74.08 -21.71 59.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.537 0.735 . . . . 54.42 111.472 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.24 -49.68 47.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.446 0.698 . . . . 73.43 109.841 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.474 ' HB2' HD11 ' A' ' 86' ' ' ILE . 25.7 ptm -65.71 -32.13 73.52 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 116.189 -0.46 . . . . 41.13 110.269 177.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.79 88.66 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 124.044 0.84 . . . . 62.33 111.388 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 51.9 t-80 -69.43 -36.53 76.74 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.562 0.745 . . . . 75.24 111.301 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.8 m -73.27 -43.49 60.98 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.213 0.53 . . . . 70.25 111.008 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 tt -83.05 -38.38 22.63 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.337 1.055 . . . . 62.31 110.495 -169.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.97 3.78 52.31 Favored Glycine 0 N--CA 1.473 1.12 0 CA-C-N 116.111 -0.495 . . . . 74.43 114.259 -171.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.543 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -139.76 -62.77 0.51 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 117.452 0.626 . . . . 32.43 111.573 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.479 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 83.5 t80 -68.38 -55.28 12.51 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.977 0.911 . . . . 75.44 112.508 -170.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 76.0 m -72.05 -36.35 4.1 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 114.605 1.335 . . . . 52.41 114.605 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.56 -21.34 46.23 Favored 'Trans proline' 0 C--N 1.386 2.536 0 CA-C-N 121.787 1.674 . . . . 74.44 112.921 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -75.1 -28.64 60.33 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.069 0.548 . . . . 72.0 110.658 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.7 mm -59.9 -37.53 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.566 0.747 . . . . 74.15 109.9 172.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.531 HD21 ' HA3' ' A' ' 82' ' ' GLY . 83.5 mt -78.35 -21.19 49.88 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.308 1.043 . . . . 74.04 112.527 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -61.22 -45.62 95.5 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.936 -1.03 . . . . 75.3 113.636 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.99 -34.57 80.48 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 121.929 1.753 . . . . 73.32 113.27 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.42 -43.4 66.82 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.573 0.749 . . . . 71.24 111.193 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.9 -41.08 75.18 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.095 0.558 . . . . 73.51 110.333 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.473 ' NH1' HG23 ' C' ' 105' ' ' ILE . 30.8 ttm180 -52.38 -52.81 51.55 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.158 0.983 . . . . 64.44 109.494 174.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.15 -52.52 65.37 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 124.637 1.211 . . . . 75.1 111.471 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 117' ' ' MET . 40.4 t -55.82 -50.09 71.48 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 124.38 1.05 . . . . 71.03 110.621 -176.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.4 mt -58.77 -50.64 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 124.07 0.948 . . . . 72.24 110.985 177.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.41 HG23 ' HG3' ' A' ' 125' ' ' GLN . 86.5 m -51.92 -46.06 64.52 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.814 0.846 . . . . 54.4 110.65 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -64.09 -41.51 97.28 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 113.967 -1.469 . . . . 74.15 109.579 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 64.4 mmm -61.4 -42.5 98.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.182 0.593 . . . . 64.45 111.1 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 114' ' ' ILE . 57.8 t -62.05 -48.69 87.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.807 0.843 . . . . 64.52 110.091 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.0 p -71.75 -26.51 62.48 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.342 0.657 . . . . 45.5 111.956 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -70.76 -32.36 69.48 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.158 0.583 . . . . 72.12 109.996 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.75 -0.44 87.97 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.543 0.527 . . . . 34.53 112.987 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m 69.36 19.42 7.7 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 125.207 1.403 . . . . 71.42 111.217 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -86.06 150.8 53.33 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.542 -0.91 . . . . 73.1 108.542 171.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.91 143.12 92.78 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.721 2.281 . . . . 63.42 111.482 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.41 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.1 tt0 -57.63 136.67 56.83 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.469 0.708 . . . . 72.34 112.398 -171.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.459 ' HB3' HG21 ' A' ' 118' ' ' VAL . 29.1 tp -120.42 99.93 6.85 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.656 1.182 . . . . 73.23 109.335 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -99.8 101.47 12.63 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.606 -0.887 . . . . 73.04 108.606 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.17 117.72 5.91 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.057 -0.72 . . . . 72.04 109.057 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.23 142.58 86.01 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.373 0.669 . . . . 73.4 110.744 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.68 119.22 6.34 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.85 2.366 . . . . 74.15 112.826 -174.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.2 t -99.21 112.76 32.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 107.626 -1.25 . . . . 64.13 107.626 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -83.39 91.34 7.32 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 108.339 -0.985 . . . . 74.15 108.339 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -64.93 -24.58 67.57 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.659 -0.7 . . . . 74.34 111.489 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.543 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 8.6 t70 -69.7 -50.29 45.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.73 0.812 . . . . 72.41 110.066 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.16 -45.68 93.65 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.541 1.136 . . . . 64.01 110.87 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.24 -30.89 70.04 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.925 -1.034 . . . . 64.02 111.919 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -70.66 -35.43 72.86 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 123.366 0.416 . . . . 73.53 109.914 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 32.4 tpp . . . . . 0 N--CA 1.483 1.22 0 O-C-N 123.719 0.637 . . . . 70.55 110.492 176.315 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 89.6 m . . . . . 0 N--CA 1.472 0.657 0 CA-C-O 119.169 -0.443 . . . . 71.05 110.011 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . 0.266 0.3 OUTLIER -154.96 155.29 33.96 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.265 0.353 . . . . 61.43 110.951 147.246 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -126.88 140.86 52.03 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 107.702 -1.222 . . . . 70.1 107.702 170.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.533 HD11 HD13 ' B' ' 105' ' ' ILE . 30.4 mt -78.47 122.85 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.618 -0.719 . . . . 65.32 109.32 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -86.42 -49.92 7.26 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.883 0.74 . . . . 71.34 109.69 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -158.53 129.88 6.47 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.605 -0.725 . . . . 75.21 110.074 -171.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.468 HD11 HD13 ' B' ' 13' ' ' ILE . 94.8 mt -116.45 119.15 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 106.807 -1.553 . . . . 72.32 106.807 172.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -151.89 143.54 23.59 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.246 0.546 . . . . 74.2 110.942 -168.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -72.46 124.62 25.55 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.937 -1.029 . . . . 60.22 108.714 172.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.502 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.7 mtpt -95.01 -36.76 11.43 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.533 0.733 . . . . 70.32 110.319 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.0 t70 -157.07 141.08 16.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.602 -0.272 . . . . 72.52 110.984 -167.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' B' ' 78' ' ' VAL . 40.7 mm -141.13 148.08 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.118 1.367 . . . . 75.42 108.866 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 41.6 t -144.42 139.15 28.2 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.555 1.142 . . . . 64.34 108.13 170.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -145.01 114.21 7.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.665 -1.606 . . . . 70.11 106.665 170.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -124.85 112.51 16.74 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.825 0.45 . . . . 75.23 109.893 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.35 86.65 8.31 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 108.225 -1.028 . . . . 70.0 108.225 172.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.1 -35.29 11.92 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.916 2.41 . . . . 74.24 113.033 -173.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -102.87 19.33 19.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.587 0.755 . . . . 72.34 110.611 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.592 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -40.31 -65.48 0.44 Allowed Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 125.183 1.393 . . . . 75.25 113.836 -166.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 52.6 Cg_exo -53.54 -38.56 83.73 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.838 2.359 . . . . 75.24 114.018 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.412 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 52.8 m80 -87.48 -35.77 18.04 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.317 -0.856 . . . . 74.34 112.406 -170.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.576 HG22 HD12 ' B' ' 68' ' ' LEU . 11.1 p -69.99 -17.44 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.699 0.4 . . . . 64.42 111.425 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -68.7 -10.73 58.07 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 113.512 0.93 . . . . 62.12 113.512 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.7 pt20 -66.52 -25.13 66.53 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 122.811 0.444 . . . . 71.42 110.843 174.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -91.81 88.97 6.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.161 0.984 . . . . 70.1 108.747 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.51 76.79 6.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.823 0.849 . . . . 73.51 109.712 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -154.39 160.9 41.92 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.556 1.142 . . . . 70.13 108.37 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -75.15 107.41 3.93 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 124.833 1.253 . . . . 65.34 109.634 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.598 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 12.5 Cg_endo -59.95 133.71 52.19 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.103 2.536 . . . . 72.14 112.834 -175.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -57.7 114.59 2.34 Favored 'General case' 0 C--N 1.361 1.091 0 O-C-N 124.138 0.899 . . . . 74.22 111.051 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.23 156.75 3.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 114.775 -1.102 . . . . 63.1 111.485 -173.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -145.87 121.49 10.45 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.943 -1.503 . . . . 73.12 106.943 169.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.2 mp -86.22 155.39 20.73 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.11 -0.7 . . . . 61.32 109.11 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 27.2 t70 -144.6 145.2 31.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.981 -1.489 . . . . 75.44 106.981 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.89 135.85 29.89 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.146 -0.687 . . . . 75.3 109.146 -169.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.0 t70 -145.69 140.0 26.95 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.2 1.4 . . . . 70.15 108.254 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 74.8 p -134.26 141.31 46.94 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.987 -0.746 . . . . 63.52 108.987 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.44 120.68 4.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.41 0.684 . . . . 71.04 109.881 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 57.3 p -99.4 168.75 9.8 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.981 0.513 . . . . 74.54 109.911 176.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 86.5 p -151.15 135.87 17.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.06 0.544 . . . . 73.33 109.927 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -82.5 103.44 12.04 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.297 -0.631 . . . . 71.03 109.297 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' B' ' 57' ' ' GLU . 58.8 mt -75.02 -53.79 8.3 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.418 0.628 . . . . 62.33 110.629 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.88 -170.61 3.57 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.754 -1.112 . . . . 72.3 109.375 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -64.73 109.84 2.18 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.815 0.697 . . . . 51.32 109.72 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 13.3 m-20 71.97 1.55 3.96 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.123 1.369 . . . . 72.04 112.667 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -104.69 122.63 57.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.08 -1.081 . . . . 54.51 108.08 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.492 ' HE2' ' HB3' ' B' ' 98' ' ' LEU . 0.1 OUTLIER -135.98 154.64 51.02 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.034 -0.728 . . . . 71.45 109.034 178.468 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.672 ' HB2' HD11 ' B' ' 51' ' ' LEU . 12.5 tm-20 -123.29 110.53 15.31 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.672 -1.233 . . . . 75.43 107.672 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 95.0 t -89.81 141.35 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 O-C-N 123.777 0.673 . . . . 73.15 109.446 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.5 t -117.22 145.45 22.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 108.675 -0.861 . . . . 74.02 108.675 176.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.458 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -128.66 104.72 7.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.619 -1.252 . . . . 73.01 107.619 178.291 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.456 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 33.1 ttt180 -94.03 113.47 25.45 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.582 0.753 . . . . 64.34 110.596 173.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.19 104.36 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.258 -1.016 . . . . 65.31 108.258 171.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 41.3 m -96.34 142.0 28.99 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.534 -0.913 . . . . 63.44 108.534 175.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.455 HG11 HD21 ' B' ' 126' ' ' LEU . 90.4 t -136.5 136.01 48.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.507 -0.923 . . . . 75.4 108.507 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 74.6 m -122.48 137.7 54.79 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.599 -0.889 . . . . 73.41 108.599 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -141.64 141.83 33.4 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.617 0.767 . . . . 64.3 109.684 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.508 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 57.5 p -145.03 133.5 21.91 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.959 -0.564 . . . . 62.55 111.908 -173.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.598 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.1 mt -94.06 106.89 18.85 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.17 0.988 . . . . 74.14 109.033 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.49 -111.8 4.34 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 114.887 -1.051 . . . . 65.52 111.909 -173.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -107.64 5.36 26.8 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.81 0.844 . . . . 73.52 111.813 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -124.72 144.8 50.03 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.039 0.382 . . . . 61.14 111.237 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 99.8 m -64.72 119.92 11.48 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 123.817 0.698 . . . . 74.43 110.524 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.543 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -81.55 -65.63 0.99 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.712 -1.131 . . . . 72.43 108.02 176.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -144.2 150.75 38.49 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-O 121.723 0.773 . . . . 74.13 111.457 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 74.7 mt -115.03 142.19 46.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.086 -1.82 . . . . 73.1 106.086 166.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.541 ' SG ' HG23 ' B' ' 114' ' ' ILE . 49.7 t -147.55 146.8 29.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.804 -0.813 . . . . 73.01 108.804 176.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -160.7 136.39 8.14 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.512 -0.551 . . . . 74.01 109.512 -173.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.435 ' HA ' HD13 ' B' ' 21' ' ' ILE . 98.1 t -131.23 145.15 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 123.863 0.865 . . . . 73.43 109.203 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 42.2 mt-30 -122.71 88.49 2.94 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.076 -1.083 . . . . 74.54 108.076 171.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.4 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 11.2 tp-100 -81.24 101.62 9.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.783 -1.099 . . . . 61.13 109.157 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.502 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -95.75 163.06 23.44 Favored Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.677 -0.569 . . . . 73.44 111.677 176.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.74 127.41 1.9 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.114 -0.795 . . . . 74.14 111.114 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.89 127.2 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 109.045 -0.724 . . . . 73.23 109.045 172.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.421 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 24.0 m-85 -132.02 153.93 49.88 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 107.227 -1.397 . . . . 61.15 107.227 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 59.0 m -122.48 91.21 3.45 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.825 0.45 . . . . 72.14 110.41 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.429 HD11 HD11 ' B' ' 89' ' ' ILE . 15.4 tt -94.82 145.81 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.844 0.858 . . . . 73.43 112.474 -166.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.47 161.14 40.07 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 124.709 1.204 . . . . 65.21 108.999 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.06 -68.17 0.39 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.095 -0.502 . . . . 52.42 113.207 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.65 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -90.38 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 121.418 0.628 . . . . 71.33 112.03 -173.708 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.453 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 33.2 tt0 -156.94 179.38 9.35 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.826 1.25 . . . . 54.15 108.26 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.453 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 72.4 -123.55 9.27 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 117.676 0.217 . . . . 61.42 112.621 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 32.2 m -93.41 -18.16 22.67 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.323 0.649 . . . . 70.11 111.436 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -68.08 -33.87 75.35 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 122.081 -0.387 . . . . 74.34 110.289 173.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -29.31 52.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.26 0.224 . . . . 75.33 110.477 173.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 95' ' ' ALA . . . . . 0.471 ' HB1' ' HZ ' ' B' ' 137' ' ' PHE . . . -60.14 -40.78 91.01 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-O 121.403 0.621 . . . . 62.41 109.922 176.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 40.6 t-80 -64.12 -29.51 70.63 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.713 -1.13 . . . . 74.31 111.395 175.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.408 ' SG ' HD12 ' B' ' 86' ' ' ILE . 37.9 t -70.83 -66.11 0.65 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 110.312 -0.255 . . . . 75.41 110.312 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.492 ' HB3' ' HE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -72.23 -23.83 61.29 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.56 0.948 . . . . 62.31 113.56 -174.356 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.92 1.07 56.45 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 119.651 -0.527 . . . . 61.11 113.346 -174.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.595 ' HA ' ' HB3' ' B' ' 133' ' ' PHE . . . -152.06 -62.43 0.17 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.413 0.523 . . . . 61.4 112.413 -175.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -66.65 -42.52 86.52 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.187 0.995 . . . . 75.13 111.89 -170.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.492 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 73.2 m -71.25 -50.58 11.07 Favored Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 124.332 1.053 . . . . 70.43 111.069 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 65.3 Cg_exo -57.16 -30.86 88.7 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.115 1.876 . . . . 73.01 114.014 170.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -59.13 -43.01 91.98 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 123.65 0.78 . . . . 75.33 110.298 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.533 HD13 HD11 ' B' ' 13' ' ' ILE . 73.8 mt -62.9 -41.37 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 115.09 -0.959 . . . . 53.55 110.889 176.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.15 -22.93 38.62 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.953 -1.022 . . . . 70.1 112.314 -172.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -58.72 -49.03 95.66 Favored Pre-proline 0 N--CA 1.486 1.333 0 N-CA-C 114.205 1.187 . . . . 71.32 114.205 -170.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -55.95 -36.82 96.36 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.029 1.819 . . . . 60.31 113.937 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.4 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 78.7 m-85 -67.43 -46.59 72.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.158 0.583 . . . . 73.51 110.601 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.54 88.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.686 0.794 . . . . 71.23 110.856 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.659 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 34.6 ttt180 -61.21 -54.69 41.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.632 1.573 . . . . 75.23 111.014 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -38.12 89.9 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.36 0.664 . . . . 61.31 110.021 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.475 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.8 t -66.63 -33.89 76.66 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 116.18 -0.464 . . . . 73.3 111.535 -176.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.541 HG23 ' SG ' ' B' ' 76' ' ' CYS . 62.6 mt -66.46 -52.05 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 109.896 -0.409 . . . . 75.31 109.896 175.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.45 HG21 ' OG ' ' C' ' 119' ' ' SER . 5.1 m -62.5 -30.57 71.37 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.732 0.645 . . . . 50.12 111.487 -176.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.5 t -61.3 -49.92 75.09 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.449 0.7 . . . . 74.23 109.376 174.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.0 mmt -58.44 -44.87 89.33 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.637 0.775 . . . . 63.42 111.03 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.11 -45.49 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.291 1.036 . . . . 64.54 111.269 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.0 t -63.45 -37.48 87.44 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.307 -0.86 . . . . 42.22 111.476 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.5 mtt-85 -66.16 -36.19 82.46 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.751 -1.113 . . . . 72.21 109.949 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.43 9.74 66.52 Favored Glycine 0 C--N 1.356 1.678 0 O-C-N 123.93 0.769 . . . . 65.31 113.898 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.445 HG23 ' HB3' ' A' ' 17' ' ' TYR . 72.4 p 54.76 35.38 23.89 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.781 1.632 . . . . 75.41 113.222 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -99.31 153.58 37.71 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.171 0.588 . . . . 70.22 110.342 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -50.82 158.6 2.89 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 123.868 3.046 . . . . 72.42 115.187 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -63.33 119.66 10.09 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.655 1.182 . . . . 71.51 112.699 -170.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.455 HD21 HG11 ' B' ' 64' ' ' VAL . 55.9 tp -108.54 102.75 11.8 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.064 -0.717 . . . . 74.53 109.064 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -100.21 105.29 16.86 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.22 -0.659 . . . . 70.41 109.22 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.659 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -73.33 113.0 9.92 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.037 -0.727 . . . . 71.53 109.037 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.09 149.94 96.18 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.922 0.889 . . . . 74.31 110.752 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.488 ' HG3' HD11 ' D' ' 16' ' ' ILE . 55.6 Cg_endo -66.37 123.35 11.04 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.441 2.094 . . . . 31.42 112.383 -175.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.8 111.61 24.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.306 -1.368 . . . . 73.43 107.306 172.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -76.97 86.56 3.5 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.63 -1.248 . . . . 73.51 107.63 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.595 ' HB3' ' HA ' ' B' ' 100' ' ' ALA . 97.7 m-85 -55.37 -42.65 74.22 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.895 0.878 . . . . 74.23 111.529 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.72 -42.43 97.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.361 1.064 . . . . 74.44 111.696 -174.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.04 -52.81 31.14 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.586 0.754 . . . . 74.33 110.283 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.25 -18.62 61.8 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.112 -0.949 . . . . 63.24 112.282 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 137' ' ' PHE . . . . . 0.471 ' HZ ' ' HB1' ' B' ' 95' ' ' ALA . 72.1 t80 . . . . . 0 N--CA 1.471 0.582 0 C-N-CA 123.329 0.651 . . . . 62.55 109.757 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 40.2 m . . . . . 0 C--O 1.24 0.576 0 N-CA-C 107.711 -1.218 . . . . 73.1 107.711 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.522 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 3.2 t80 -116.14 119.85 37.12 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.127 -0.942 . . . . 74.21 108.578 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -136.47 131.9 34.64 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 107.981 -1.118 . . . . 61.22 107.981 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 63.8 mt -76.59 120.33 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.556 -0.905 . . . . 71.03 108.556 173.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.654 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 10.8 mm100 -82.71 -42.31 18.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.075 -0.966 . . . . 63.02 109.106 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -170.94 149.31 2.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.639 -0.71 . . . . 73.33 109.703 -170.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.5 mt -138.3 133.77 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.645 -1.243 . . . . 65.11 107.645 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.423 ' HB3' HG23 ' D' ' 122' ' ' THR . 31.5 p90 -169.77 172.04 6.98 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.847 0.832 . . . . 74.01 111.77 -172.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -97.27 123.14 40.98 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.094 -0.957 . . . . 71.02 109.101 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.416 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.9 mmtp -71.21 -50.46 32.85 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 122.755 1.264 . . . . 73.5 107.631 168.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -134.92 141.88 46.41 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 112.517 -2.129 . . . . 71.23 108.889 -168.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 74.2 mt -137.95 142.03 36.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 106.024 -1.843 . . . . 55.34 106.024 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -155.99 150.15 25.49 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.316 0.579 . . . . 74.54 110.439 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -150.87 134.95 16.77 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.526 -1.287 . . . . 64.32 107.526 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.69 124.27 19.58 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.737 0.815 . . . . 75.34 109.499 -171.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.62 79.02 7.37 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 107.517 -1.29 . . . . 71.45 107.517 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.93 -42.71 61.5 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.026 2.484 . . . . 64.14 111.494 174.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -91.53 29.76 1.44 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.11 -1.404 . . . . 71.54 110.362 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.94 -58.91 8.71 Favored Pre-proline 0 N--CA 1.487 1.405 0 CA-C-O 118.084 -0.96 . . . . 74.41 113.046 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.33 -33.41 58.97 Favored 'Trans proline' 0 C--N 1.388 2.62 0 CA-C-N 121.735 1.655 . . . . 71.21 111.898 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -68.48 -37.63 80.3 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.202 1.401 . . . . 64.41 112.496 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.813 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.9 p -82.02 -23.51 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.372 0.269 . . . . 65.33 111.68 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -68.07 -35.83 78.85 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.877 0.37 . . . . 73.43 110.561 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -89.37 12.38 16.42 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.815 0.846 . . . . 71.43 111.062 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -101.27 160.51 14.35 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.154 0.982 . . . . 72.32 109.621 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.48 114.19 9.29 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.461 0.704 . . . . 60.42 109.91 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -78.84 100.95 7.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.879 0.872 . . . . 73.33 111.155 -174.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.545 ' H ' HD22 ' C' ' 68' ' ' LEU . 10.8 pt20 -149.9 78.42 8.14 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 124.107 0.963 . . . . 75.0 109.535 171.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -87.3 128.31 2.6 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.351 2.034 . . . . 73.31 112.571 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -86.27 91.5 8.49 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 106.075 -1.824 . . . . 65.25 106.075 165.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 18.0 m -72.49 131.81 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.737 -1.119 . . . . 64.22 111.831 -171.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -113.77 102.89 10.66 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.548 -1.279 . . . . 50.33 107.548 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -87.98 152.49 22.01 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.167 -0.679 . . . . 64.43 109.167 170.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.568 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.5 t70 -137.45 104.65 5.42 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.584 -0.895 . . . . 75.44 108.584 177.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 85.6 mt -92.65 113.09 25.28 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.839 -1.171 . . . . 63.12 107.839 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.3 t70 -122.27 153.7 38.55 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.856 1.262 . . . . 71.5 109.399 178.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 5.3 t -143.87 154.2 43.12 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.119 -0.697 . . . . 73.22 109.119 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.12 135.93 15.37 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.16 0.984 . . . . 51.24 109.097 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.459 ' HB3' HG22 ' C' ' 58' ' ' VAL . 29.6 p -125.71 142.18 51.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.363 0.665 . . . . 72.4 109.665 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.7 p -153.43 140.33 19.16 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.393 0.677 . . . . 73.14 110.766 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -72.18 127.14 31.62 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.955 0.902 . . . . 64.43 111.104 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' C' ' 57' ' ' GLU . 55.7 mt -96.06 -44.3 7.39 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.018 0.927 . . . . 72.22 109.708 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.25 -176.57 5.28 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.771 -1.104 . . . . 60.34 109.807 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.73 108.07 0.93 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.689 0.796 . . . . 72.2 110.369 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 70.63 1.6 3.76 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.745 1.618 . . . . 73.43 112.974 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 68.5 t -98.16 118.43 44.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.86 -0.793 . . . . 73.24 108.86 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -108.83 158.74 17.38 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.182 0.992 . . . . 73.04 110.28 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.586 ' HB2' HD11 ' C' ' 51' ' ' LEU . 24.6 tt0 -119.41 130.81 55.48 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 112.884 -1.962 . . . . 73.34 107.285 169.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.459 HG22 ' HB3' ' C' ' 48' ' ' SER . 76.0 t -115.28 126.4 72.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.877 -0.786 . . . . 60.24 108.877 170.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.486 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 88.0 t -105.79 130.36 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 107.788 -1.19 . . . . 73.01 107.788 171.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.41 103.75 10.43 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.837 -1.542 . . . . 54.22 106.837 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.423 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.9 ttm-85 -84.27 123.18 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.15 -1.386 . . . . 71.44 108.47 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -116.46 118.58 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.973 -1.121 . . . . 73.21 107.973 169.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 42.3 m -110.72 141.81 43.5 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.087 0.955 . . . . 63.24 108.628 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.706 HG11 HD11 ' C' ' 126' ' ' LEU . 55.8 t -126.1 127.65 71.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 108.663 -0.866 . . . . 24.44 108.663 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -115.81 137.37 52.15 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.22 -1.4 . . . . 74.44 107.22 167.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.51 114.39 14.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.187 -1.412 . . . . 62.42 107.187 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.6 m -134.75 134.08 40.6 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.562 0.539 . . . . 55.51 110.027 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.545 HD22 ' H ' ' C' ' 37' ' ' GLN . 12.5 mt -90.91 23.04 3.33 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 126.005 1.722 . . . . 73.14 110.133 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.39 -87.8 0.51 Allowed Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.024 -0.83 . . . . 65.53 111.024 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.2 -30.51 18.49 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.572 0.749 . . . . 71.31 110.326 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -92.97 118.36 31.07 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.455 0.702 . . . . 55.33 110.429 -173.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -77.44 122.4 25.14 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.614 -0.884 . . . . 71.13 108.614 169.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.813 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.5 -54.24 7.91 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.298 -0.865 . . . . 73.21 109.461 176.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -167.24 157.05 10.8 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.283 -0.871 . . . . 75.04 110.909 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.419 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -118.0 144.99 45.08 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 106.365 -1.717 . . . . 64.4 106.365 168.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.43 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.8 t -148.78 149.45 31.4 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.504 -0.924 . . . . 63.14 108.504 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -159.22 130.25 6.08 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.374 0.421 . . . . 54.32 110.073 175.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.5 t -125.54 131.6 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.891 0.876 . . . . 72.52 108.646 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -109.32 87.53 2.52 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.605 -1.257 . . . . 70.14 107.605 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.407 ' HG3' HD22 ' C' ' 106' ' ' LEU . 8.8 tp-100 -79.42 96.77 6.14 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.483 -0.78 . . . . 64.3 110.357 -175.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -97.7 143.23 16.58 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 112.306 -0.317 . . . . 61.22 112.306 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.99 140.62 8.53 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 110.357 -1.097 . . . . 71.1 110.357 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.654 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.7 mm -91.39 122.7 43.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.553 -0.906 . . . . 62.42 108.553 -178.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.522 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 63.8 m-85 -127.46 119.33 25.85 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.201 -1.037 . . . . 64.12 108.201 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 39.9 p -84.46 125.49 32.41 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.066 0.546 . . . . 75.33 109.563 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.624 HD13 HD11 ' C' ' 98' ' ' LEU . 39.0 pt -116.51 135.33 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.214 0.606 . . . . 70.11 109.776 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -153.45 151.29 29.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.947 0.899 . . . . 74.14 109.321 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.15 -57.74 4.26 Favored Glycine 0 N--CA 1.474 1.188 0 N-CA-C 112.243 -0.343 . . . . 72.43 112.243 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -85.48 156.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.869 0.868 . . . . 73.41 111.834 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.549 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 11.9 pt-20 -161.42 -175.74 4.97 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.416 -0.811 . . . . 74.34 110.421 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.1 -119.75 18.43 Favored Glycine 0 C--N 1.352 1.47 0 O-C-N 123.902 0.751 . . . . 61.44 113.845 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.3 p -72.94 -33.32 65.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.246 1.019 . . . . 72.51 111.171 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -67.9 -34.9 77.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.736 0.815 . . . . 72.04 110.903 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.549 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 55.3 ttp -75.35 -41.77 55.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.837 0.855 . . . . 72.34 110.396 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.37 -41.04 75.54 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.076 0.86 . . . . 50.04 110.086 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 18.7 t-160 -76.39 -43.2 41.68 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 124.05 0.844 . . . . 74.24 111.811 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -55.68 -40.25 72.06 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 123.956 0.785 . . . . 72.55 110.648 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.624 HD11 HD13 ' C' ' 86' ' ' ILE . 22.0 mt -101.71 -14.9 17.17 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.748 0.819 . . . . 71.51 111.632 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.87 -30.89 55.24 Favored Glycine 0 C--N 1.355 1.615 0 N-CA-C 114.77 0.668 . . . . 55.33 114.77 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.2 -36.32 0.06 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.07 0.396 . . . . 62.41 112.07 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -59.2 -49.59 77.29 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 125.231 1.412 . . . . 71.14 112.535 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 88.1 m -77.94 -41.99 2.17 Favored Pre-proline 0 CA--C 1.563 1.464 0 CA-C-O 118.727 -0.654 . . . . 63.21 112.575 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.08 -33.44 34.98 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.449 2.099 . . . . 74.44 114.558 168.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.33 -26.68 63.87 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.581 0.752 . . . . 71.23 110.458 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.473 HG23 ' NH1' ' A' ' 111' ' ' ARG . 48.0 mm -68.71 -39.36 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.829 0.852 . . . . 62.35 109.725 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.407 HD22 ' HG3' ' C' ' 80' ' ' GLN . 35.8 mt -80.64 -23.82 39.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.668 1.187 . . . . 74.4 112.597 -174.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -57.3 -49.25 94.95 Favored Pre-proline 0 CA--C 1.563 1.45 0 N-CA-C 114.212 1.19 . . . . 75.12 114.212 -173.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.41 -37.64 96.82 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 121.945 1.764 . . . . 62.11 113.223 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -66.36 -49.01 68.34 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.837 0.855 . . . . 73.43 111.178 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.09 -38.97 84.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.289 -0.868 . . . . 65.43 110.628 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -58.54 -55.71 31.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.564 1.146 . . . . 74.42 110.8 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.29 -33.08 75.13 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.852 0.461 . . . . 75.13 110.39 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 33.4 t -71.16 -31.4 67.64 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.009 0.524 . . . . 64.55 111.48 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.43 HG23 ' SG ' ' C' ' 76' ' ' CYS . 76.9 mt -73.2 -54.04 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.523 -0.547 . . . . 75.21 109.523 172.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 4.7 m -62.46 -27.82 69.39 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.166 0.587 . . . . 73.34 111.271 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.6 t -61.33 -53.66 53.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.626 0.771 . . . . 54.12 109.094 169.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.57 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.28 -35.23 75.06 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.791 1.236 . . . . 73.44 112.46 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' C' ' 123' ' ' PHE . 75.0 t -65.67 -45.27 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.683 0.793 . . . . 73.5 109.622 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.45 ' OG ' HG21 ' B' ' 115' ' ' THR . 42.3 t -68.69 -28.55 66.95 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.001 0.813 . . . . 32.45 111.449 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.469 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 82.7 mtt-85 -70.74 -43.11 69.52 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.503 0.721 . . . . 72.21 109.211 176.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.09 -3.79 82.13 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 124.287 0.992 . . . . 51.52 112.24 172.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 65.82 26.55 11.18 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 127.026 2.13 . . . . 74.44 113.588 170.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.411 ' HB2' HG13 ' C' ' 118' ' ' VAL . 92.1 m-85 -82.8 156.62 67.56 Favored Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 109.021 -0.733 . . . . 73.25 109.021 171.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.14 175.1 2.72 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.909 2.406 . . . . 73.25 114.285 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -56.84 137.56 54.78 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.784 1.031 . . . . 74.22 113.784 -171.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.706 HD11 HG11 ' C' ' 64' ' ' VAL . 3.0 tt -126.9 87.03 2.59 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.662 -1.154 . . . . 70.55 108.278 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -107.89 109.66 21.23 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.21 0.604 . . . . 73.4 109.846 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -74.73 135.63 41.79 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 122.918 0.487 . . . . 73.1 110.762 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.26 151.38 87.86 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.894 0.877 . . . . 74.1 110.241 174.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.533 ' HG3' HD12 ' A' ' 16' ' ' ILE . 24.6 Cg_exo -60.93 103.34 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.816 2.344 . . . . 53.23 112.794 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 17.9 m -98.46 111.13 27.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.244 -1.021 . . . . 61.44 108.244 168.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -75.72 84.57 2.72 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.32 -0.854 . . . . 74.41 109.196 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -54.39 -44.82 72.61 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.752 0.658 . . . . 75.55 110.121 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.74 -47.53 85.29 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.574 -1.194 . . . . 61.52 111.682 -174.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.27 87.01 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.345 0.658 . . . . 55.4 111.209 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.96 -42.49 99.84 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.776 -0.647 . . . . 64.53 111.422 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 137' ' ' PHE . . . . . 0.414 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 10.1 t80 . . . . . 0 N--CA 1.487 1.405 0 C-N-CA 122.935 0.494 . . . . 74.14 110.807 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 37.1 m . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.067 0.46 . . . . 75.42 110.024 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -158.14 97.01 1.49 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.87 -1.529 . . . . 74.12 106.87 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -134.46 149.82 50.77 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.828 -0.805 . . . . 70.23 108.828 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.464 HD11 HG21 ' D' ' 105' ' ' ILE . 4.5 mt -92.87 130.48 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.404 -0.591 . . . . 70.32 109.404 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -86.73 -35.22 19.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.055 0.542 . . . . 52.23 110.5 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -174.54 130.56 0.35 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.488 0.315 . . . . 65.2 111.091 -172.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.488 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.5 mp -107.47 140.78 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.747 -1.205 . . . . 74.13 107.747 172.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -162.65 158.62 23.44 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.733 0.646 . . . . 71.15 111.679 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.8 p -93.59 118.85 31.89 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.169 -0.923 . . . . 72.55 109.56 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -90.28 -20.59 22.76 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 116.045 -0.525 . . . . 75.41 109.923 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.1 t70 -157.02 132.36 9.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.517 -0.765 . . . . 75.3 109.821 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.57 HG21 ' HE2' ' C' ' 117' ' ' MET . 60.4 mt -135.9 147.06 28.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 124.548 1.139 . . . . 41.31 107.982 171.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -153.52 115.68 4.35 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.82 0.7 . . . . 53.1 110.142 171.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -110.21 134.22 52.44 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.487 -1.671 . . . . 72.33 106.487 166.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.718 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 31.4 mt-10 -140.0 120.21 13.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.777 0.831 . . . . 72.02 108.959 -173.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.05 89.43 50.75 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.845 -1.169 . . . . 75.34 107.845 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.3 -46.8 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.103 2.536 . . . . 73.13 111.795 -174.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 26.3 m-20 -98.2 34.93 1.85 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.256 1.023 . . . . 71.14 109.01 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.8 -66.86 0.53 Allowed Pre-proline 0 CA--C 1.567 1.614 0 N-CA-C 114.101 1.149 . . . . 70.14 114.101 -162.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.428 ' HB3' HD11 ' C' ' 83' ' ' ILE . 95.1 Cg_endo -76.03 -20.28 15.04 Favored 'Trans proline' 0 C--N 1.384 2.447 0 CA-C-N 122.705 2.002 . . . . 75.34 113.02 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.413 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 6.6 t-160 -64.49 -47.65 78.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.575 1.55 . . . . 73.51 109.746 176.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.707 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.1 p -85.26 -23.94 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 CA-C-N 114.821 -1.081 . . . . 73.01 112.194 -168.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -60.79 -30.45 70.05 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 123.355 0.662 . . . . 73.31 112.765 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -60.08 -24.06 64.3 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.931 -1.031 . . . . 62.03 111.166 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -86.84 85.14 7.25 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.365 1.066 . . . . 75.44 108.775 173.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.15 82.08 3.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.419 0.628 . . . . 72.22 110.414 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -142.17 157.88 44.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.012 1.325 . . . . 53.45 107.759 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -68.22 107.69 2.15 Favored Pre-proline 0 CA--C 1.555 1.139 0 N-CA-C 108.635 -0.876 . . . . 71.32 108.635 172.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.412 ' O ' HG13 ' D' ' 40' ' ' VAL . 35.8 Cg_exo -59.93 120.96 9.06 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.122 2.548 . . . . 73.41 112.157 -168.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.15 111.78 4.1 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 123.943 0.777 . . . . 51.34 109.983 -175.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.608 HG12 ' HB2' ' D' ' 66' ' ' ALA . 35.9 m -104.5 142.49 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.109 -0.951 . . . . 75.23 110.745 -173.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.49 136.93 40.51 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.912 -1.144 . . . . 72.05 107.912 162.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.4 112.42 24.35 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.168 -1.049 . . . . 71.12 108.168 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -127.54 123.13 35.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.331 -0.989 . . . . 73.1 108.331 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.05 160.81 19.79 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.446 0.641 . . . . 71.34 110.047 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -149.73 151.6 33.92 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.202 -1.407 . . . . 64.23 107.202 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -128.37 154.18 46.26 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.464 -0.569 . . . . 71.3 109.464 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.69 157.75 43.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.983 0.913 . . . . 72.51 109.402 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.4 m -149.01 153.44 37.91 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.332 0.653 . . . . 50.52 109.968 175.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.8 t -152.67 126.01 8.69 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.669 0.788 . . . . 73.13 109.757 -169.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -78.01 118.33 20.19 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.78 0.432 . . . . 75.32 109.842 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.472 HD11 ' HB2' ' D' ' 57' ' ' GLU . 67.0 mt -91.72 -42.09 10.34 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.579 -0.526 . . . . 54.2 109.579 176.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.62 -174.95 5.09 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.872 -1.058 . . . . 73.32 110.05 -176.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.11 117.86 9.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.924 -1.035 . . . . 64.24 110.031 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 64.39 18.01 11.09 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.501 1.126 . . . . 71.01 111.68 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.98 119.25 59.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 124.228 1.011 . . . . 64.25 108.356 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.403 ' CD1' HD11 ' D' ' 86' ' ' ILE . 14.6 m-85 -132.44 127.33 35.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.501 -0.926 . . . . 74.11 108.501 175.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.472 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.1 tt0 -90.21 121.65 32.43 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.656 1.183 . . . . 72.4 108.897 169.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 74.3 t -102.27 142.37 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.542 -0.91 . . . . 64.41 108.542 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.455 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.6 t -121.91 130.76 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.463 -0.94 . . . . 65.41 108.463 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -110.59 119.85 40.52 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.442 -1.318 . . . . 71.1 107.442 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -98.02 96.6 8.26 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.034 -1.099 . . . . 74.42 108.034 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.9 t -93.44 120.01 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.012 -1.107 . . . . 74.55 108.012 171.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -119.18 140.87 49.46 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.432 0.693 . . . . 75.51 109.601 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.49 HG11 HD11 ' D' ' 126' ' ' LEU . 91.5 t -136.51 122.26 28.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 125.031 1.333 . . . . 55.44 108.276 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 93.3 m -119.51 112.63 19.6 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.743 -0.836 . . . . 55.21 108.743 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -111.02 154.82 23.64 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.855 0.862 . . . . 52.3 110.293 -172.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 34.0 p -149.8 134.14 17.35 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.783 0.677 . . . . 63.43 111.415 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.455 ' HB2' HG22 ' D' ' 31' ' ' VAL . 48.1 mt -113.19 122.62 48.04 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.933 1.293 . . . . 71.14 107.855 171.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.4 -112.46 3.48 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.999 -0.44 . . . . 63.32 111.999 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 4.08 9.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.118 0.967 . . . . 73.52 110.036 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -126.15 163.0 24.08 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.64 0.776 . . . . 70.24 110.392 -170.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.0 m -61.91 125.41 23.76 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 124.22 0.95 . . . . 74.03 111.801 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.707 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -81.13 -72.87 0.4 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.339 -0.985 . . . . 44.12 108.339 171.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 74' ' ' PHE . . . . . 0.525 ' HZ ' HD12 ' D' ' 126' ' ' LEU . 48.1 p90 -144.7 160.45 41.18 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.559 0.695 . . . . 65.41 110.311 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.718 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 64.8 mt -122.58 141.4 51.74 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.451 -1.685 . . . . 74.15 106.451 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.579 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.8 t -153.49 136.66 15.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.782 -0.451 . . . . 64.21 109.782 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.8 130.82 11.02 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.619 0.768 . . . . 74.23 108.936 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.8 t -129.44 114.19 30.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.532 -0.914 . . . . 74.13 108.532 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.0 mt-30 -89.9 84.75 6.24 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 122.045 0.926 . . . . 73.53 109.07 171.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.86 101.41 8.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 113.474 -1.694 . . . . 75.0 110.146 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.87 161.37 29.36 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.957 -0.457 . . . . 71.01 111.957 175.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.22 134.92 3.58 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.942 -0.863 . . . . 43.03 110.942 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.1 mt -87.33 128.51 39.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 124.101 0.96 . . . . 51.34 108.93 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -128.12 126.59 41.42 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.237 0.615 . . . . 63.3 110.175 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.4 m -81.13 102.45 10.28 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.984 -0.747 . . . . 73.4 108.984 169.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.538 HD13 HD11 ' D' ' 98' ' ' LEU . 44.7 pt -109.7 140.99 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.195 0.998 . . . . 70.23 110.689 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.9 159.16 34.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.836 0.854 . . . . 65.34 109.448 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.98 -0.36 89.08 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 114.349 0.499 . . . . 32.21 114.349 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.521 HD11 HD12 ' D' ' 86' ' ' ILE . 29.0 pt -105.37 147.86 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.473 0.709 . . . . 74.04 110.389 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.1 146.65 28.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.117 0.567 . . . . 73.21 111.588 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.65 -113.5 2.78 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 124.254 0.931 . . . . 74.35 115.143 175.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.9 p -64.43 -33.22 75.36 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.693 1.197 . . . . 64.04 111.6 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -65.64 -31.11 71.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.486 0.715 . . . . 75.05 111.032 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 55.9 mtm -67.97 -45.79 73.19 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.614 0.365 . . . . 70.31 110.128 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.12 -37.36 82.53 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.074 0.55 . . . . 74.42 111.317 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -71.15 -38.8 72.2 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.86 0.864 . . . . 44.43 111.078 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -72.75 -51.11 20.47 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.377 -0.374 . . . . 45.33 111.632 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.596 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.2 mm? -86.06 -28.52 24.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.422 0.689 . . . . 74.11 111.041 -174.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.95 -22.97 47.35 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 114.242 0.457 . . . . 71.51 114.242 -176.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -129.04 -56.6 1.18 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.983 0.513 . . . . 75.23 111.479 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 101' ' ' TYR . . . . . 0.548 ' HA ' HD22 ' D' ' 104' ' ' ASN . 63.2 t80 -70.63 -34.88 72.57 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 112.839 0.681 . . . . 73.13 112.839 -172.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.596 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 75.7 m -69.57 -49.45 21.77 Favored Pre-proline 0 CA--C 1.569 1.679 0 CA-C-O 118.562 -0.732 . . . . 63.12 111.625 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 84.1 Cg_exo -55.25 -30.3 71.14 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 122.565 2.176 . . . . 52.34 114.48 170.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 104' ' ' ASN . . . . . 0.548 HD22 ' HA ' ' D' ' 101' ' ' TYR . 72.9 m-20 -53.96 -40.26 66.69 Favored 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 123.584 0.754 . . . . 75.24 111.857 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.464 HG21 HD11 ' D' ' 13' ' ' ILE . 36.2 mt -78.69 -40.65 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.899 0.88 . . . . 63.41 110.761 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.2 mt -72.36 -20.82 61.39 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.506 -0.77 . . . . 73.11 111.973 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -68.22 -45.3 39.23 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.035 0.934 . . . . 73.24 113.119 -173.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -50.05 -45.77 31.4 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.591 2.194 . . . . 72.12 114.415 169.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.16 -41.57 77.07 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.446 0.698 . . . . 64.44 111.32 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.34 95.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.723 0.809 . . . . 73.23 110.51 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.461 ' HA ' HD23 ' D' ' 128' ' ' LEU . 29.5 ttp180 -59.72 -51.23 70.68 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.41 -1.268 . . . . 74.54 110.385 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.64 -45.81 92.45 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 124.528 1.143 . . . . 75.53 111.154 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.55 -41.34 80.77 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.01 0.819 . . . . 73.45 110.856 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.579 HG12 ' SG ' ' D' ' 76' ' ' CYS . 76.3 mt -63.05 -56.34 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 123.74 0.65 . . . . 64.5 110.262 173.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.3 m -53.7 -39.38 65.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.409 1.083 . . . . 33.42 111.682 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -66.15 -46.28 78.01 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.83 -1.077 . . . . 64.33 109.867 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.3 mtm -69.34 -30.21 68.19 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.002 0.521 . . . . 73.23 112.317 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.49 HG13 ' HB2' ' D' ' 123' ' ' PHE . 72.7 t -66.02 -45.32 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.461 0.704 . . . . 71.52 109.209 175.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -71.51 -33.03 68.87 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 123.391 0.432 . . . . 72.13 110.822 -178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -69.97 -33.03 71.54 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.927 0.891 . . . . 74.22 110.089 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.8 3.28 86.08 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 123.884 0.74 . . . . 73.53 112.463 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.423 HG23 ' HB3' ' C' ' 17' ' ' TYR . 36.4 p 63.1 23.77 14.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.721 2.008 . . . . 33.24 114.446 171.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.49 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.6 m-85 -86.74 151.5 52.68 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 108.924 -0.769 . . . . 73.01 108.924 170.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.07 145.92 31.97 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.352 2.701 . . . . 71.01 113.792 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -54.76 140.19 36.95 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.352 1.061 . . . . 72.22 113.668 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.525 HD12 ' HZ ' ' D' ' 74' ' ' PHE . 4.8 tt -119.75 106.69 12.36 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.482 -0.932 . . . . 71.32 108.482 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -108.95 111.57 23.31 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.843 -0.799 . . . . 55.21 108.843 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' D' ' 111' ' ' ARG . 3.1 mm? -73.69 120.28 19.06 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.97 -0.752 . . . . 75.13 108.97 171.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.28 137.93 94.14 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 109.812 -0.44 . . . . 64.12 109.812 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.85 115.03 3.26 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.385 2.056 . . . . 43.42 111.548 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.7 m -108.04 152.8 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.436 0.694 . . . . 75.32 110.09 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -81.51 96.18 7.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.399 -0.819 . . . . 73.02 109.121 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -63.49 -31.64 72.86 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.653 0.381 . . . . 74.23 111.22 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 134' ' ' ASP . . . . . 0.429 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 54.9 m-20 -62.09 -57.82 10.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.531 0.732 . . . . 74.11 111.564 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.61 96.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.642 0.777 . . . . 64.44 111.17 -176.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 5.0 mp -67.23 -28.18 67.85 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.16 -0.927 . . . . 73.24 111.797 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.7 t80 . . . . . 0 N--CA 1.486 1.352 0 C-N-CA 124.004 0.922 . . . . 74.05 111.333 175.691 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 109.071 -0.714 . . . . 72.22 109.071 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.623 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.6 t80 -136.21 129.71 32.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.062 -0.718 . . . . 71.42 109.062 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 48.1 tp60 -149.87 109.6 4.05 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.947 0.899 . . . . 73.53 109.04 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.539 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.4 mt -78.59 112.53 16.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.408 -0.96 . . . . 61.13 108.408 174.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.9 -41.83 25.35 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.825 -0.625 . . . . 61.23 109.317 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -171.19 123.57 0.59 Allowed 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.157 0.286 . . . . 75.31 111.185 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.615 HD12 ' HG3' ' C' ' 130' ' ' PRO . 72.2 mt -111.95 136.26 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.74 0.816 . . . . 64.32 109.166 174.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 24.9 p90 -166.52 177.8 6.45 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.204 0.94 . . . . 70.01 110.928 -171.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -103.08 120.23 40.3 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.459 -0.791 . . . . 61.22 109.01 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 27.2 mtpt -84.77 -38.42 19.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.404 -0.591 . . . . 73.2 109.404 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.719 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.7 t70 -138.97 136.28 35.22 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.063 -0.971 . . . . 74.31 109.534 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 49.7 mt -133.55 146.68 31.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.116 -1.438 . . . . 74.11 107.116 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.1 t -155.16 145.71 22.17 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.636 0.585 . . . . 54.23 109.811 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.449 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.6 t80 -145.89 131.72 19.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.926 -1.509 . . . . 73.22 106.926 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -138.72 129.96 27.05 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.721 -0.844 . . . . 72.41 108.721 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -129.43 81.41 70.1 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.316 -0.994 . . . . 74.51 108.316 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.26 -25.91 25.8 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.024 2.482 . . . . 70.22 112.986 -172.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 31' ' ' VAL . 51.4 m-80 -114.67 24.11 12.1 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.411 0.685 . . . . 64.15 110.445 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -52.1 -49.31 85.13 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 113.705 1.002 . . . . 73.24 113.705 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.54 -21.83 18.99 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 121.982 1.788 . . . . 74.22 111.964 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -80.1 -23.04 41.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.98 -1.009 . . . . 74.21 111.006 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 86.2 t -59.96 -24.65 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.637 0.775 . . . . 74.15 111.3 177.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -56.96 -38.85 73.54 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.852 0.861 . . . . 63.21 111.188 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -93.11 -20.92 20.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.497 0.719 . . . . 72.44 110.921 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.533 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 30.7 mmmt -79.86 143.41 34.34 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.62 0.768 . . . . 73.24 111.468 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.27 121.12 20.8 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.34 -0.985 . . . . 72.03 108.34 168.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -68.88 89.91 0.42 Allowed 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.472 0.482 . . . . 71.52 110.689 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -144.13 81.55 11.48 Favored Pre-proline 0 C--O 1.245 0.834 0 N-CA-C 107.519 -1.289 . . . . 74.5 107.519 167.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 95.5 Cg_endo -81.94 157.66 18.13 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.693 2.262 . . . . 73.43 112.798 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.413 ' HB3' ' HE3' ' A' ' 41' ' ' LYS . 16.6 mm-40 -95.74 99.97 11.74 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.084 -1.08 . . . . 75.55 108.084 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.2 m -71.21 94.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-O 122.292 1.044 . . . . 72.21 110.776 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 39' ' ' GLU . 97.6 mttt -110.03 135.63 50.56 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.753 -1.112 . . . . 74.12 109.443 -177.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.5 tp -136.15 126.6 26.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.076 0.55 . . . . 65.42 110.737 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -126.42 131.29 51.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.83 0.852 . . . . 62.33 109.397 173.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.64 HD22 HG12 ' A' ' 62' ' ' VAL . 54.5 mt -119.69 134.33 55.27 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.413 0.685 . . . . 61.03 110.518 -175.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 8.2 m-20 -125.8 141.15 52.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.799 1.24 . . . . 74.43 108.188 173.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.5 m -126.32 129.85 49.66 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.006 -0.739 . . . . 73.31 109.006 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.58 153.95 50.5 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.438 1.095 . . . . 63.45 108.491 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.7 t -126.72 152.95 46.14 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 120.911 0.386 . . . . 53.24 110.17 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.5 t -149.45 121.41 8.22 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.386 1.074 . . . . 63.5 108.766 -176.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -74.28 125.85 29.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.092 0.557 . . . . 73.31 109.69 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.5 mt -95.49 -34.42 12.08 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.316 0.646 . . . . 75.12 110.421 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.0 177.36 10.83 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.08 0.952 . . . . 74.33 109.268 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -66.22 125.75 26.53 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.287 -0.634 . . . . 73.35 109.287 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 70.82 3.59 4.67 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.056 1.343 . . . . 73.42 112.142 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.75 115.0 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.251 1.021 . . . . 63.4 108.621 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -126.77 156.29 41.46 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.59 0.756 . . . . 74.1 109.604 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -130.19 142.85 50.54 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.266 -1.013 . . . . 62.4 108.266 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.51 139.91 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 108.241 -1.022 . . . . 75.31 108.241 165.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -112.41 107.34 22.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 107.824 -1.176 . . . . 65.24 107.824 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.8 tp -88.94 100.76 13.45 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.332 -0.849 . . . . 61.12 109.11 178.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 14.0 ttm-85 -84.46 107.89 16.96 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.65 -0.704 . . . . 62.22 109.155 175.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.64 HG12 HD22 ' A' ' 44' ' ' LEU . 19.8 m -103.96 130.22 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 123.857 0.863 . . . . 70.13 109.559 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.1 m -121.26 116.36 24.74 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.641 0.777 . . . . 72.24 110.075 -176.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.3 t -116.14 121.45 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.486 1.114 . . . . 64.41 108.83 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.6 m -126.71 124.9 40.85 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.347 -0.983 . . . . 63.44 108.347 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -125.56 105.24 8.89 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.163 -0.68 . . . . 72.32 109.163 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 42.4 t -116.73 128.86 55.73 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.377 0.671 . . . . 73.41 111.207 -173.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' A' ' 73' ' ' ALA . 5.1 mp -89.92 86.37 6.6 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.223 -1.399 . . . . 75.3 107.223 175.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.08 -104.88 2.07 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.512 -1.035 . . . . 73.41 110.512 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -109.23 -14.02 14.55 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.179 0.592 . . . . 75.34 110.534 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -85.48 95.97 9.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.934 0.894 . . . . 75.43 110.118 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 26.5 m -67.44 125.46 26.21 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 123.441 0.463 . . . . 43.24 110.535 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.491 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -78.01 -54.06 6.72 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.318 -0.856 . . . . 61.01 109.003 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -146.59 155.47 42.5 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.429 -1.26 . . . . 63.44 110.878 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.7 tp -133.48 132.07 40.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.527 -1.657 . . . . 54.33 106.527 176.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 85.1 m -133.92 110.44 9.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.342 -0.614 . . . . 74.22 109.342 -174.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -124.38 117.07 23.63 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.044 0.938 . . . . 71.35 109.118 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.4 ' O ' HG22 ' A' ' 62' ' ' VAL . 75.3 t -132.91 111.33 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.221 0.608 . . . . 74.21 109.817 -173.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.719 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 26.3 mt-30 -87.81 87.12 7.27 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 108.609 -0.886 . . . . 75.4 108.609 167.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.408 ' HG3' HD22 ' A' ' 106' ' ' LEU . 62.8 tp60 -76.91 116.63 17.75 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.919 -1.037 . . . . 63.43 108.448 176.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.84 144.25 18.35 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.56 -0.616 . . . . 71.2 111.56 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.477 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.99 134.22 6.06 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 111.167 -0.773 . . . . 74.51 111.167 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.3 mt -82.89 115.43 25.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.645 -0.872 . . . . 52.31 108.645 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.623 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.4 m-85 -122.29 117.7 26.74 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.857 0.863 . . . . 74.23 108.937 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 12.6 m -90.81 89.94 7.7 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.321 -0.992 . . . . 52.24 108.321 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.7 pt -109.74 139.72 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.347 -0.842 . . . . 62.51 110.766 -172.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.8 168.95 25.56 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.846 -1.07 . . . . 64.11 109.695 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.11 9.61 85.93 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.606 0.566 . . . . 74.05 114.039 174.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.15 153.69 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.126 0.57 . . . . 64.24 110.603 -176.616 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -160.43 -172.48 3.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.669 0.788 . . . . 73.23 110.506 -171.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.1 -143.34 48.47 Favored Glycine 0 C--N 1.359 1.824 0 O-C-N 123.537 0.523 . . . . 43.41 112.636 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.9 t -86.44 -11.24 52.39 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 122.866 0.466 . . . . 74.45 111.038 166.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -33.99 74.83 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.925 0.89 . . . . 73.24 109.827 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -31.71 70.8 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.375 0.27 . . . . 63.45 110.966 173.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.68 -28.18 55.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.65 0.78 . . . . 61.21 110.826 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 43.8 t-80 -69.73 -29.36 66.71 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.136 0.574 . . . . 64.5 110.313 170.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 78.0 m -69.69 -49.34 54.39 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.489 0.316 . . . . 71.32 110.928 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 pp -85.16 -18.93 32.65 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.017 0.527 . . . . 52.14 112.339 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.69 3.87 27.63 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-O 119.782 -0.455 . . . . 63.11 114.117 -173.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -148.09 -63.57 0.26 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.33 0.565 . . . . 74.45 111.378 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -61.66 -66.0 0.6 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.367 1.467 . . . . 72.11 112.826 -168.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.401 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 95.9 m -73.9 -37.98 3.6 Favored Pre-proline 0 CA--C 1.569 1.675 0 N-CA-C 114.701 1.371 . . . . 44.13 114.701 -175.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 35.8 Cg_endo -64.55 -24.53 63.18 Favored 'Trans proline' 0 C--N 1.388 2.626 0 CA-C-N 121.837 1.692 . . . . 71.34 113.369 173.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -69.43 -29.78 67.57 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.017 0.527 . . . . 72.55 110.13 177.656 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.4 mm -62.66 -40.66 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.443 0.697 . . . . 53.15 110.184 176.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.477 HD21 ' HA3' ' A' ' 82' ' ' GLY . 96.3 mt -79.53 -19.24 50.06 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.166 0.986 . . . . 74.13 112.967 -175.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -59.4 -47.74 97.38 Favored Pre-proline 0 CA--C 1.569 1.693 0 N-CA-C 113.584 0.957 . . . . 74.44 113.584 -172.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.9 -37.05 57.08 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.061 1.841 . . . . 74.33 113.096 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -67.31 -40.22 85.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.319 0.648 . . . . 74.12 111.153 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.474 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.59 -42.65 86.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.151 0.58 . . . . 64.44 110.137 177.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -50.31 -53.68 26.92 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.475 1.11 . . . . 75.42 110.506 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -68.65 -38.05 80.14 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.394 -0.821 . . . . 63.2 111.433 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.37 -34.18 74.89 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.107 0.48 . . . . 74.14 111.095 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 118' ' ' VAL . 60.7 mt -69.49 -57.25 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.132 -0.94 . . . . 71.22 109.624 172.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -55.35 -37.07 67.01 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.869 1.268 . . . . 74.21 111.923 -172.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.4 t -65.38 -50.3 66.05 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.117 -0.947 . . . . 73.51 109.903 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.449 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 67.6 mtm -62.27 -37.84 87.04 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.173 0.589 . . . . 74.34 111.454 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 114' ' ' ILE . 99.3 t -59.57 -49.12 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.676 0.79 . . . . 75.41 110.062 176.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.3 m -69.74 -29.78 67.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.537 -0.756 . . . . 72.54 111.615 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -72.8 -26.96 61.7 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.638 0.775 . . . . 72.21 110.126 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.87 6.64 77.84 Favored Glycine 0 C--N 1.354 1.563 0 O-C-N 123.685 0.616 . . . . 34.24 112.913 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.478 ' HB ' HH21 ' B' ' 15' ' ' ARG . 22.9 m 67.66 15.48 9.72 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.534 1.134 . . . . 71.01 111.175 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.463 ' HE1' HG21 ' A' ' 31' ' ' VAL . 63.6 m-85 -87.82 140.93 31.36 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 108.546 -0.909 . . . . 62.12 108.546 174.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -49.45 148.23 11.4 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.267 2.645 . . . . 75.32 113.25 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -59.63 129.46 42.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.5 0.72 . . . . 73.11 112.236 -173.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -110.18 101.55 10.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.121 0.968 . . . . 65.21 109.844 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -102.25 103.79 14.3 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.142 -1.059 . . . . 71.31 108.142 171.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.61 154.58 41.31 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.661 0.384 . . . . 73.32 110.575 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.56 142.84 92.17 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.363 0.665 . . . . 54.44 111.079 -175.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.33 127.91 13.14 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.343 2.029 . . . . 72.44 112.771 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 76.8 t -102.28 115.06 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.856 0.862 . . . . 75.03 108.878 175.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -92.14 85.91 5.62 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.671 -1.233 . . . . 70.23 107.671 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 91.8 m-85 -59.05 -31.6 69.01 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.745 -1.116 . . . . 52.43 113.203 -169.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.12 -36.67 83.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.351 0.26 . . . . 74.34 111.419 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.62 -38.17 89.19 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.109 0.563 . . . . 73.34 110.895 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.5 -39.38 88.69 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.211 -0.904 . . . . 64.1 111.311 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -68.61 -25.91 65.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.998 -0.546 . . . . 73.35 110.833 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 17.0 mmt . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 123.04 0.536 . . . . 50.31 111.665 177.945 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 81.0 m . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 107.415 -1.328 . . . . 73.42 107.415 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -150.79 142.14 23.33 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.991 -0.374 . . . . 71.2 109.991 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -159.11 141.94 14.28 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 123.919 0.762 . . . . 63.43 109.644 169.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.545 HD13 HD11 ' B' ' 16' ' ' ILE . 45.8 mt -80.26 125.39 39.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.877 -0.786 . . . . 65.45 108.877 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -96.3 -35.52 11.2 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.343 0.657 . . . . 74.45 109.609 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.478 HH21 ' HB ' ' A' ' 122' ' ' THR . 56.6 ttt180 -170.66 131.92 0.91 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.529 -0.76 . . . . 72.33 109.557 -176.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.545 HD11 HD13 ' B' ' 13' ' ' ILE . 87.2 mt -114.89 136.33 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 106.641 -1.614 . . . . 64.31 106.641 168.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -166.48 162.97 17.17 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.695 0.622 . . . . 61.14 111.306 -174.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.646 HG21 HD11 ' B' ' 21' ' ' ILE . 27.5 m -98.32 127.4 44.24 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.444 -0.947 . . . . 71.13 108.444 176.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -98.05 -23.72 15.64 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.745 0.818 . . . . 73.45 111.018 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 9.3 t70 -158.78 139.33 12.55 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.142 0.276 . . . . 70.3 111.188 -170.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.646 HD11 HG21 ' B' ' 18' ' ' THR . 40.8 mm -135.79 149.15 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.598 1.159 . . . . 74.04 108.754 175.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 17.7 m -146.89 143.62 28.67 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.524 1.13 . . . . 73.23 109.082 165.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -152.2 108.77 3.45 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.662 -1.236 . . . . 72.33 107.662 169.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -122.08 118.18 28.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.262 1.025 . . . . 72.12 108.399 -174.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -116.45 84.22 14.41 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.264 1.026 . . . . 72.11 108.549 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.23 -40.49 19.34 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.872 2.381 . . . . 62.43 112.585 -174.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -96.67 13.8 27.09 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.987 -1.006 . . . . 70.11 111.078 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.44 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -40.29 -62.75 0.85 Allowed Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 115.086 1.513 . . . . 71.42 115.086 -164.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 6.7 Cg_exo -69.4 -25.58 30.13 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 121.721 1.614 . . . . 61.13 112.204 -171.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 69.7 m80 -95.44 -25.43 16.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.865 -1.061 . . . . 73.32 111.731 -170.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.672 HG22 HD12 ' B' ' 68' ' ' LEU . 8.7 p -83.9 -18.25 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.995 0.518 . . . . 64.03 110.981 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -61.11 -30.91 70.64 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.309 0.855 . . . . 73.34 113.309 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 28.7 pt20 -61.27 -18.12 56.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.831 0.452 . . . . 72.12 111.608 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -92.29 82.87 4.97 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.146 0.978 . . . . 71.15 108.865 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -86.52 90.83 8.36 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.281 -0.637 . . . . 72.53 109.281 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.7 t-105 -158.15 156.12 30.32 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.898 1.279 . . . . 71.11 107.988 174.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -59.79 104.76 0.47 Allowed Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.991 1.316 . . . . 71.11 111.295 173.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.616 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 60.9 Cg_endo -74.45 128.17 11.71 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.689 2.26 . . . . 64.01 112.415 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.88 125.74 24.81 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 123.565 0.541 . . . . 74.12 109.911 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.592 HG12 ' HB2' ' B' ' 66' ' ' ALA . 25.2 m -104.67 153.32 6.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.848 -0.615 . . . . 70.5 111.014 -176.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.462 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 79.4 tttt -108.71 117.98 35.59 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.789 -1.189 . . . . 75.33 107.789 169.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.38 140.67 30.7 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.877 0.471 . . . . 74.21 110.23 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.558 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 6.1 t70 -145.42 155.85 43.4 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.616 -0.883 . . . . 74.23 108.616 -177.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.484 ' H ' HD23 ' B' ' 44' ' ' LEU . 1.5 pt? -115.51 163.12 16.22 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.596 0.712 . . . . 75.34 110.771 -175.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.581 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.0 t70 -163.64 111.3 1.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.19 -1.411 . . . . 74.31 107.19 167.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.6 p -128.73 125.34 37.74 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.167 0.587 . . . . 71.54 110.239 -172.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.66 159.47 41.89 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.034 0.934 . . . . 41.23 109.932 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.9 p -133.29 159.24 40.84 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.138 0.575 . . . . 73.41 109.678 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 98.1 p -153.1 140.75 19.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.173 0.589 . . . . 71.34 109.582 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -89.01 115.84 26.86 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.882 0.473 . . . . 70.01 109.996 176.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.96 -39.91 17.56 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.682 0.793 . . . . 64.23 109.207 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.43 -176.51 5.83 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.594 1.158 . . . . 74.12 109.717 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -67.43 126.15 28.37 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.851 -0.613 . . . . 62.32 110.033 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' B' ' 85' ' ' SER . 7.2 m-20 69.02 -9.95 0.55 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.093 1.757 . . . . 74.34 112.487 -173.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.9 t -105.63 104.13 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.789 -0.819 . . . . 62.4 108.789 -172.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -115.18 168.08 10.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.413 -1.267 . . . . 74.4 108.979 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -143.64 117.43 9.3 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.848 -1.168 . . . . 74.14 107.848 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.88 144.71 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.591 1.156 . . . . 75.54 109.247 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.5 t -127.82 119.82 52.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.088 -0.708 . . . . 62.13 109.088 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -98.28 114.7 27.08 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.642 -1.614 . . . . 71.54 106.642 172.109 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.581 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 3.7 ttt180 -111.56 125.89 54.4 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.409 -0.589 . . . . 73.34 109.409 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 49.5 t -114.3 116.21 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.681 1.192 . . . . 74.22 108.429 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.8 m -97.61 137.03 37.14 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.18 -0.674 . . . . 75.44 109.18 173.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 76.9 t -133.02 126.22 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.859 0.864 . . . . 60.24 109.529 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 91.9 m -124.66 107.16 10.7 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.373 0.669 . . . . 75.11 110.236 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.592 ' HB2' HG12 ' B' ' 40' ' ' VAL . . . -106.5 151.83 24.47 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.217 0.607 . . . . 75.23 110.992 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 57.0 p -153.24 139.86 18.85 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.051 -0.977 . . . . 73.24 110.497 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.672 HD12 HG22 ' B' ' 31' ' ' VAL . 48.5 mt -107.87 102.33 11.54 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.28 1.032 . . . . 74.23 109.201 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.08 -110.18 3.2 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.609 -0.723 . . . . 72.12 112.733 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.94 2.81 46.81 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.637 0.775 . . . . 71.31 111.138 -169.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.07 158.13 43.9 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.967 0.507 . . . . 75.11 110.875 -170.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -65.82 143.71 57.31 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.955 0.785 . . . . 75.12 111.171 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.471 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -96.18 -70.22 0.72 Allowed 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.508 -0.923 . . . . 71.02 108.508 169.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -148.6 153.03 37.77 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.167 -0.924 . . . . 70.45 109.466 -173.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 23.4 mt -131.12 109.44 10.46 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.538 -1.282 . . . . 52.14 107.538 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.0 t -119.96 147.32 44.9 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.816 -0.439 . . . . 63.44 109.816 -175.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -157.6 133.69 9.47 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 109.486 -0.561 . . . . 63.44 109.486 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 89.6 t -129.62 148.52 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.4 0.68 . . . . 73.11 109.474 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.0 mt-30 -118.33 98.9 6.51 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.75 -1.204 . . . . 73.53 107.75 166.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -85.89 99.55 11.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.1 -1.074 . . . . 74.1 108.1 171.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.68 169.81 35.98 Favored Glycine 0 C--O 1.242 0.626 0 N-CA-C 111.228 -0.749 . . . . 62.15 111.228 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.42 127.74 1.59 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 112.111 -0.396 . . . . 73.22 112.111 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 46.8 mt -84.53 120.78 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 107.727 -1.212 . . . . 71.15 107.727 171.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -128.41 135.11 49.06 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.84 0.856 . . . . 75.35 109.211 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 67.5 m -93.91 117.25 29.84 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 110.045 -0.354 . . . . 54.32 110.045 172.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.597 HD13 HD21 ' B' ' 98' ' ' LEU . 45.3 pt -117.11 146.81 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.821 1.248 . . . . 70.21 110.025 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.637 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -152.69 161.37 42.65 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.391 1.077 . . . . 75.55 108.62 170.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.86 -28.76 4.38 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 113.794 0.278 . . . . 62.13 113.794 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.89 140.06 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 124.608 1.163 . . . . 71.0 112.209 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.539 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 36.0 tt0 -162.71 144.81 10.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.25 0.62 . . . . 65.22 110.175 -177.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.39 -113.3 5.58 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.578 0.548 . . . . 61.24 113.768 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 88.4 m -82.14 -24.32 35.13 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.609 0.764 . . . . 73.35 111.17 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.539 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 44.2 mt-30 -60.52 -43.87 96.66 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.044 0.537 . . . . 61.24 111.271 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -65.02 -36.49 84.55 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.41 0.444 . . . . 54.44 110.269 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.67 -37.35 86.26 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.229 1.012 . . . . 75.13 111.157 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -82.68 -29.36 29.99 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.234 0.614 . . . . 73.03 110.858 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -67.09 -64.39 0.86 Allowed 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.661 0.601 . . . . 74.51 110.177 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.597 HD21 HD13 ' B' ' 86' ' ' ILE . 60.2 mt -81.76 -18.57 43.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.837 0.455 . . . . 71.03 111.173 -176.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.46 -35.53 11.85 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.427 0.454 . . . . 55.24 113.955 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.451 ' HB1' ' HD1' ' B' ' 133' ' ' PHE . . . -134.99 -41.16 0.75 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.033 0.753 . . . . 65.4 113.033 -167.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -77.44 -48.61 16.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.659 0.784 . . . . 74.43 111.277 -170.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.48 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 86.5 m -64.88 -48.0 73.17 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.684 0.794 . . . . 71.53 110.859 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 53.4 Cg_exo -58.05 -30.29 89.69 Favored 'Trans proline' 0 C--N 1.397 3.105 0 C-N-CA 122.085 1.856 . . . . 74.51 114.339 170.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -61.06 -42.17 97.98 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 123.084 0.554 . . . . 64.24 110.856 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.88 -40.94 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 115.357 -0.838 . . . . 24.33 110.105 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.3 mt -77.65 -20.99 52.89 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.729 -1.123 . . . . 73.2 112.125 -174.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -59.71 -50.65 85.8 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 114.269 1.211 . . . . 73.34 114.269 -171.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.87 -31.74 95.96 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 121.755 1.637 . . . . 72.54 113.087 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -73.32 -47.21 44.4 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.462 0.705 . . . . 73.33 110.965 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.99 -43.07 81.34 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.287 0.635 . . . . 60.42 110.291 175.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -60.08 -51.2 70.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.371 1.468 . . . . 75.14 111.204 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.82 -34.91 79.24 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.12 0.568 . . . . 62.42 109.794 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.8 t -70.71 -34.85 72.37 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.962 0.505 . . . . 73.33 111.665 -177.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.476 ' O ' HG23 ' B' ' 118' ' ' VAL . 58.8 mt -65.34 -55.87 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 109.178 -0.675 . . . . 71.51 109.178 173.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 15.5 m -59.76 -27.5 66.58 Favored 'General case' 0 CA--C 1.552 1.043 0 O-C-N 124.001 0.813 . . . . 71.0 111.557 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -64.07 -51.02 66.05 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.341 0.657 . . . . 64.21 109.77 174.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -69.24 -35.04 75.72 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.082 0.553 . . . . 63.11 111.125 -175.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.9 t -59.16 -46.75 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.554 0.741 . . . . 61.3 109.697 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.4 t -67.12 -30.83 70.94 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.749 -1.114 . . . . 62.42 111.811 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.449 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -70.21 -38.65 75.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.834 -0.621 . . . . 55.31 110.12 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.06 1.88 83.17 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.85 0.719 . . . . 70.51 112.695 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 27.1 p 61.84 25.47 15.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.69 1.996 . . . . 51.35 113.302 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -80.51 155.01 74.09 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 123.568 0.747 . . . . 65.13 110.953 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -50.48 158.6 2.57 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.809 3.006 . . . . 65.11 115.042 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -61.16 119.58 8.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.536 1.134 . . . . 75.21 112.531 -168.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.4 tp -110.18 127.15 54.77 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.269 0.628 . . . . 62.54 109.854 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.06 126.13 38.76 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.587 0.755 . . . . 61.01 109.093 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.9 131.1 34.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.419 -0.585 . . . . 70.45 109.419 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.62 152.02 96.37 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.748 0.819 . . . . 75.3 111.365 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.09 109.12 0.87 Allowed 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.621 2.214 . . . . 44.4 111.464 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 24.1 t -91.21 115.53 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.39 -0.596 . . . . 53.52 109.39 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 132' ' ' ASN . . . . . 0.451 ' O ' HD13 ' B' ' 136' ' ' LEU . 57.4 t-20 -72.7 90.72 1.41 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.198 0.599 . . . . 74.02 109.561 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.451 ' HD1' ' HB1' ' B' ' 100' ' ' ALA . 33.1 p90 -57.22 -32.93 67.01 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.97 0.908 . . . . 73.02 112.708 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -82.87 -41.31 19.13 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.389 0.676 . . . . 72.42 112.387 -168.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.33 61.99 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.125 0.57 . . . . 73.33 110.944 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 136' ' ' LEU . . . . . 0.451 HD13 ' O ' ' B' ' 132' ' ' ASN . 6.7 mp -74.92 -30.67 61.32 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.672 -0.695 . . . . 73.12 109.868 172.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 59.6 t80 . . . . . 0 CA--C 1.552 1.027 0 CA-C-N 115.46 -0.791 . . . . 72.44 110.159 173.293 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 107.9 -1.148 . . . . 60.4 107.9 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -93.55 118.64 31.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.16 -0.927 . . . . 74.25 108.637 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -138.12 135.37 35.68 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.48 -1.304 . . . . 72.4 107.48 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.2 mt -74.81 121.17 25.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.401 -0.963 . . . . 64.02 108.401 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.514 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 19.6 mm-40 -83.68 -44.05 14.9 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 123.888 0.743 . . . . 71.2 109.051 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -177.42 137.52 0.21 Allowed 'General case' 0 C--N 1.359 1.001 0 CA-C-N 115.491 -0.777 . . . . 73.1 109.72 -173.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.3 mt -124.46 143.8 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.008 -1.108 . . . . 75.04 108.008 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.476 ' OH ' HD11 ' C' ' 83' ' ' ILE . 30.7 p90 -171.43 165.13 7.02 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.36 0.6 . . . . 64.43 111.923 -172.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -92.64 107.67 19.39 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.967 -1.015 . . . . 73.04 109.191 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -68.38 -39.97 81.56 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.672 0.749 . . . . 54.14 109.548 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.471 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 19.3 t70 -143.28 139.36 30.12 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 113.918 -1.492 . . . . 75.5 109.192 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 96.4 mt -137.05 143.13 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 106.704 -1.591 . . . . 65.11 106.704 172.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -149.44 147.84 28.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.096 0.474 . . . . 54.23 110.001 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -147.46 135.32 21.18 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.45 -1.315 . . . . 72.2 107.45 169.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.596 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 33.7 mt-10 -138.13 111.3 7.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.561 0.745 . . . . 73.04 109.742 -170.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.11 74.02 11.0 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.445 -1.316 . . . . 73.32 107.445 166.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.46 -28.72 21.51 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.58 2.187 . . . . 73.42 111.163 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -88.22 14.49 9.25 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.957 -1.474 . . . . 72.43 111.787 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -44.83 -54.49 12.95 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 114.184 1.179 . . . . 63.42 114.184 -174.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.23 -37.08 85.55 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 121.916 1.744 . . . . 54.23 113.175 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -69.05 -45.1 71.26 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.836 0.854 . . . . 71.43 111.818 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.756 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -76.53 -22.28 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 113.156 0.798 . . . . 74.25 113.156 -174.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -65.49 -31.53 72.65 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.58 0.585 . . . . 72.24 112.58 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -94.84 11.55 31.19 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.355 0.662 . . . . 73.34 111.667 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -85.14 160.55 19.91 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.981 0.912 . . . . 73.42 110.688 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.92 115.38 3.37 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.339 0.656 . . . . 71.23 109.372 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -84.72 91.75 8.03 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.355 0.597 . . . . 54.25 110.01 -177.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -143.46 79.95 13.49 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 106.756 -1.572 . . . . 72.22 106.756 173.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' C' ' 67' ' ' SER . 6.4 Cg_exo -80.35 149.92 19.48 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 123.029 2.486 . . . . 62.54 113.619 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -108.03 110.79 22.58 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 107.064 -1.458 . . . . 64.11 107.064 169.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 m -80.43 124.11 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.334 0.588 . . . . 73.22 110.292 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 1.8 tmtp? -125.03 102.52 7.55 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.376 -1.713 . . . . 74.21 106.376 171.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.68 HD11 HD12 ' C' ' 128' ' ' LEU . 4.2 tt -108.44 121.71 45.52 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.968 -1.864 . . . . 71.11 105.968 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -122.72 117.06 24.83 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.88 -0.415 . . . . 74.41 109.88 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.464 HD11 HG21 ' C' ' 131' ' ' VAL . 89.4 mt -92.23 150.93 20.61 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.677 0.791 . . . . 72.3 109.322 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 12.7 t70 -151.32 142.77 23.48 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.235 -1.024 . . . . 61.34 108.235 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -126.75 139.51 53.07 Favored 'General case' 0 C--O 1.249 1.072 0 N-CA-C 108.607 -0.886 . . . . 75.15 108.607 172.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.91 141.92 21.27 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.896 -1.149 . . . . 54.32 107.896 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 16.5 p -148.1 156.8 43.03 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 120.853 0.359 . . . . 64.33 110.844 -171.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 95.5 p -144.12 158.64 43.6 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.723 0.809 . . . . 63.22 110.014 -172.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -94.46 130.91 40.65 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.797 -0.816 . . . . 75.5 108.797 172.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.649 HD11 HD12 ' C' ' 83' ' ' ILE . 39.1 mt -99.79 -42.6 6.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.335 0.654 . . . . 43.1 110.489 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -152.67 -172.25 4.18 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.322 -0.853 . . . . 74.51 110.245 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.67 105.87 1.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.013 -0.994 . . . . 70.1 109.826 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 70.06 3.69 4.48 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.01 1.324 . . . . 71.23 113.13 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 56.1 t -100.76 122.78 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.109 -1.071 . . . . 55.53 108.109 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -138.25 124.39 20.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.01 -0.541 . . . . 61.35 109.736 -166.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' C' ' 51' ' ' LEU . 41.1 tt0 -84.83 137.8 32.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.561 0.745 . . . . 73.53 109.496 174.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.51 129.57 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.791 -1.189 . . . . 73.4 107.791 170.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.4 148.24 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.693 0.797 . . . . 73.14 109.109 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.09 111.92 14.02 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.481 -1.303 . . . . 60.24 107.481 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.6 tmm_? -98.42 107.13 19.52 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 107.731 -1.211 . . . . 75.43 107.731 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 t -103.62 123.11 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.186 -1.042 . . . . 74.11 108.186 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -111.83 141.55 45.32 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.021 -0.733 . . . . 65.11 109.021 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.625 HG21 HG21 ' C' ' 114' ' ' ILE . 91.1 t -131.84 123.21 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.515 1.126 . . . . 75.1 108.146 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 12.8 m -124.69 141.84 51.82 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.795 0.838 . . . . 65.13 108.764 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.69 123.98 16.72 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.235 -1.394 . . . . 61.12 107.235 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 60.4 m -133.3 158.22 43.49 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.6 0.714 . . . . 71.34 111.312 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 mt -121.35 39.85 3.73 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.356 1.463 . . . . 64.01 107.338 -171.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.29 -111.6 3.88 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 109.507 -1.437 . . . . 75.35 109.507 -166.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -90.48 -31.08 16.93 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.105 0.562 . . . . 72.21 110.389 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -70.67 106.91 3.69 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.026 0.93 . . . . 71.32 109.911 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.7 m -72.83 126.73 30.61 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.94 -0.763 . . . . 61.43 108.94 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.756 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.92 -58.23 4.1 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.029 -0.73 . . . . 63.04 109.029 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -159.43 163.8 35.1 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.536 -0.756 . . . . 74.41 110.897 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -128.27 144.84 51.16 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 106.517 -1.66 . . . . 72.13 106.517 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.46 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.3 t -149.42 147.11 27.87 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.334 -0.987 . . . . 75.02 108.334 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.43 135.28 10.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.72 0.295 . . . . 74.14 110.48 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' C' ' 110' ' ' ALA . 50.4 t -135.33 114.77 17.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 124.332 1.053 . . . . 74.33 108.704 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 65.4 mt-30 -97.35 89.9 4.89 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.143 -0.688 . . . . 54.53 109.143 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.1 tp-100 -79.39 102.47 8.72 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.053 -0.976 . . . . 52.33 110.498 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.96 157.14 31.89 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 116.202 -0.454 . . . . 51.31 112.035 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.589 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -160.81 116.64 0.73 Allowed Glycine 0 CA--C 1.508 -0.369 0 N-CA-C 111.72 -0.552 . . . . 74.24 111.72 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.649 HD12 HD11 ' C' ' 51' ' ' LEU . 7.4 mm -82.7 127.28 39.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.727 -0.842 . . . . 62.3 108.727 177.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -132.12 141.05 49.01 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.758 0.823 . . . . 64.24 109.082 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 13.5 p -83.73 122.92 29.29 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.142 -0.688 . . . . 65.3 109.142 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 46.6 pt -120.86 133.14 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.602 0.761 . . . . 63.11 109.804 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.63 159.68 21.99 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.302 1.041 . . . . 35.43 108.704 176.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.33 -57.6 4.22 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 112.713 -0.155 . . . . 70.54 112.713 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.407 ' H ' HG13 ' C' ' 89' ' ' ILE . 2.7 pp -88.57 163.76 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.184 0.594 . . . . 71.0 111.687 -177.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -165.85 163.21 18.71 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.673 0.789 . . . . 51.42 110.392 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.92 -114.96 7.03 Favored Glycine 0 C--N 1.355 1.594 0 C-N-CA 123.44 0.543 . . . . 43.12 113.703 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -63.34 -40.47 97.37 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.731 0.812 . . . . 63.31 111.574 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -76.59 -32.1 57.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.675 0.39 . . . . 74.15 110.861 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 41.5 ttm -76.99 -28.71 55.19 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.274 0.358 . . . . 65.53 110.817 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.63 91.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.441 -0.577 . . . . 51.14 109.441 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -77.33 -25.22 50.92 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.308 0.38 . . . . 62.14 111.718 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.05 -52.18 66.47 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.542 0.526 . . . . 74.31 109.733 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 pp -81.99 -20.53 38.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.931 0.492 . . . . 74.34 110.882 176.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.27 -29.19 56.74 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 114.482 0.553 . . . . 75.24 114.482 -173.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.14 -43.52 0.06 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.918 0.71 . . . . 73.32 112.918 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -59.42 -46.08 89.73 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.477 0.711 . . . . 74.24 112.309 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.411 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 81.1 m -78.92 -46.87 1.74 Allowed Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.699 0.8 . . . . 71.31 111.396 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.411 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 53.0 Cg_exo -55.86 -26.3 56.92 Favored 'Trans proline' 0 C--N 1.399 3.185 0 C-N-CA 122.402 2.068 . . . . 74.3 113.831 169.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.33 -43.37 97.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.561 1.145 . . . . 73.32 109.936 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.0 mm -64.05 -45.21 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 114.84 -1.073 . . . . 71.22 109.789 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.589 HD21 ' HA3' ' C' ' 82' ' ' GLY . 86.4 mt -75.72 -25.18 56.39 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.149 -0.932 . . . . 72.0 112.812 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -56.22 -53.42 63.87 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 113.78 1.029 . . . . 71.21 113.78 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.69 -29.63 88.77 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 121.725 1.617 . . . . 75.52 113.387 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -68.94 -48.71 62.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.781 0.433 . . . . 63.13 110.478 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.23 -31.11 72.17 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.461 -0.791 . . . . 71.31 110.773 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.674 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 46.6 ttt180 -63.42 -58.86 5.71 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.472 1.509 . . . . 54.21 111.146 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -31.91 73.36 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.686 0.394 . . . . 74.21 110.262 -177.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -65.29 -31.34 72.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.141 0.576 . . . . 62.11 111.579 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.625 HG21 HG21 ' C' ' 64' ' ' VAL . 84.8 mt -74.89 -56.61 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 116.154 -0.475 . . . . 71.54 109.933 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 3.3 m -62.7 -27.72 69.45 Favored 'General case' 0 CA--C 1.553 1.066 0 O-C-N 123.688 0.617 . . . . 61.4 111.412 -172.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -62.39 -51.34 67.98 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.349 0.66 . . . . 74.32 109.304 170.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.668 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.79 -39.61 89.53 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.333 1.053 . . . . 61.33 112.435 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' C' ' 114' ' ' ILE . 60.4 t -59.91 -47.88 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.436 0.694 . . . . 73.52 109.422 176.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -66.31 -32.42 73.81 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.494 -1.23 . . . . 65.43 111.755 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -67.8 -35.02 77.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.31 0.644 . . . . 74.21 109.879 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.39 10.84 69.91 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.928 0.767 . . . . 41.21 112.888 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.45 HG23 ' HB3' ' D' ' 17' ' ' TYR . 46.6 p 54.84 37.26 28.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.058 1.743 . . . . 73.34 113.752 177.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -95.65 153.48 39.41 Favored Pre-proline 0 N--CA 1.477 0.911 0 N-CA-C 108.196 -1.038 . . . . 71.4 108.196 168.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -64.76 168.9 12.47 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.5 2.134 . . . . 75.12 112.688 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -54.44 113.33 1.24 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.353 1.061 . . . . 73.35 113.412 -174.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 5.5 tt -113.87 87.03 2.53 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.307 -1.368 . . . . 64.22 107.307 167.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -95.47 127.47 41.54 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.23 -1.026 . . . . 73.34 108.23 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.68 HD12 HD11 ' C' ' 42' ' ' LEU . 2.3 mm? -73.62 132.15 42.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.552 0.741 . . . . 75.2 109.546 -174.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.62 153.47 75.91 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.518 0.727 . . . . 42.3 110.606 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.615 ' HG3' HD12 ' A' ' 16' ' ' ILE . 50.2 Cg_exo -51.58 115.68 2.25 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.771 2.314 . . . . 52.13 112.73 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.464 HG21 HD11 ' C' ' 44' ' ' LEU . 85.0 t -97.95 122.58 49.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.199 -0.667 . . . . 63.41 109.199 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -83.88 76.11 10.05 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.17 0.588 . . . . 75.11 109.497 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -60.51 -44.67 95.77 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 122.116 0.96 . . . . 72.32 109.038 170.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -65.09 -50.0 67.81 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 113.184 -1.825 . . . . 75.23 112.366 -172.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.67 88.32 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.814 0.696 . . . . 43.24 111.825 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -42.93 74.38 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.762 -1.108 . . . . 70.34 109.82 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 4.8 t80 . . . . . 0 N--CA 1.483 1.199 0 C-N-CA 122.739 0.416 . . . . 75.03 111.285 -175.719 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.6 m . . . . . 0 C--O 1.241 0.62 0 N-CA-C 108.733 -0.84 . . . . 75.55 108.733 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -148.23 102.21 3.34 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.506 -1.294 . . . . 71.35 107.506 172.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -126.1 115.91 20.56 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.763 -1.199 . . . . 73.02 107.763 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.436 HD13 HG21 ' D' ' 105' ' ' ILE . 13.7 mt -72.33 115.76 13.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 N-CA-C 108.247 -1.02 . . . . 75.41 108.247 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -88.01 -29.53 20.65 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.722 -0.672 . . . . 75.0 110.783 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -179.54 141.13 0.15 Allowed 'General case' 0 C--N 1.366 1.315 0 C-N-CA 122.34 0.256 . . . . 74.22 110.411 -170.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.409 HD11 HG21 ' D' ' 13' ' ' ILE . 3.7 mp -122.46 135.79 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.256 -1.387 . . . . 53.41 107.256 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.45 ' HB3' HG23 ' C' ' 122' ' ' THR . 34.7 p90 -165.86 174.02 10.0 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-O 121.654 0.74 . . . . 75.13 112.258 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -105.06 120.17 40.84 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.735 -1.12 . . . . 62.41 108.912 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -89.91 -21.47 22.47 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.307 0.643 . . . . 73.4 109.805 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.673 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.0 t70 -155.37 139.36 16.37 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.081 -0.963 . . . . 71.03 108.856 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.668 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.3 mt -137.53 142.77 35.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.56 -1.274 . . . . 74.43 107.56 172.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -149.07 130.09 14.39 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.543 -0.91 . . . . 73.11 108.543 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.411 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 85.5 t80 -136.78 126.23 25.09 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.992 -1.484 . . . . 75.11 106.992 170.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.5 mt-10 -130.82 138.3 49.82 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.74 -0.837 . . . . 74.34 108.74 -175.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.77 82.86 67.81 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 106.97 -1.492 . . . . 74.51 106.97 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.08 -32.4 27.92 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.196 2.597 . . . . 61.43 113.034 -169.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -111.77 26.53 10.53 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.308 0.643 . . . . 75.52 109.385 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.04 -70.09 0.16 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 114.746 1.387 . . . . 50.41 114.746 -161.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.536 ' HB3' HD11 ' C' ' 83' ' ' ILE . 65.2 Cg_endo -77.04 -16.35 15.91 Favored 'Trans proline' 0 C--N 1.38 2.198 0 CA-C-N 122.401 1.893 . . . . 71.13 113.612 -172.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -76.13 -41.71 49.2 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.597 1.159 . . . . 74.45 110.327 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.48 HG22 HD12 ' D' ' 68' ' ' LEU . 6.6 p -82.66 -25.29 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 115.649 -0.705 . . . . 73.22 111.138 -170.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -61.5 -20.78 63.59 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.761 0.824 . . . . 75.34 113.004 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -60.86 -26.29 67.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.425 0.69 . . . . 75.01 110.945 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -91.72 86.4 5.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.941 0.897 . . . . 70.15 109.113 168.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -76.91 88.73 3.48 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.664 -0.698 . . . . 74.33 109.631 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -155.78 158.34 37.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.515 1.126 . . . . 75.44 108.489 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -69.09 106.1 1.32 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.891 0.876 . . . . 65.32 108.966 174.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.571 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 35.4 Cg_exo -63.17 141.15 81.6 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.664 2.243 . . . . 60.0 113.287 -171.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 8.5 mm-40 -58.73 111.35 1.24 Allowed 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.051 0.844 . . . . 70.51 110.2 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.498 HG13 ' O ' ' D' ' 38' ' ' PRO . 16.1 m -101.4 128.02 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.656 0.741 . . . . 75.33 111.83 -170.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -106.55 112.76 25.9 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.821 1.248 . . . . 72.01 107.913 171.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.64 ' H ' HD23 ' D' ' 42' ' ' LEU . 1.8 pt? -95.98 112.92 24.52 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.039 -1.097 . . . . 73.35 108.039 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -114.84 113.21 23.91 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.667 -1.235 . . . . 71.23 107.667 174.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.646 HD13 ' H ' ' D' ' 44' ' ' LEU . 0.0 OUTLIER -110.34 155.48 22.06 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.904 0.882 . . . . 74.02 109.247 -176.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.589 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -158.64 152.65 23.7 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.528 0.731 . . . . 64.11 109.983 -177.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -109.87 167.59 10.05 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.617 -0.512 . . . . 64.41 109.617 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.47 160.52 36.85 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.795 0.838 . . . . 71.55 108.866 173.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -146.4 151.52 37.59 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.656 0.382 . . . . 72.12 110.736 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.7 t -165.55 122.13 1.42 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.582 0.753 . . . . 53.03 109.873 -171.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -82.42 117.71 22.67 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.809 -0.441 . . . . 61.55 109.809 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.2 mt -97.63 -24.98 15.28 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.162 0.585 . . . . 72.24 110.71 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.62 -178.54 6.27 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.482 0.713 . . . . 54.13 111.037 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.51 114.3 4.78 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.475 -1.239 . . . . 33.14 109.791 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.14 21.18 11.62 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.302 1.041 . . . . 63.3 111.795 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 66.3 t -118.82 128.72 75.65 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 N-CA-C 108.159 -1.052 . . . . 72.11 108.159 170.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.443 ' HB2' HD11 ' D' ' 86' ' ' ILE . 0.4 OUTLIER -122.27 172.7 8.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.054 0.93 . . . . 65.11 110.287 174.386 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.9 tt0 -132.31 138.54 47.86 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.255 -1.793 . . . . 74.11 107.577 169.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.27 138.63 47.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.513 -1.292 . . . . 72.12 107.513 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 47.6 t -119.57 128.67 75.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.077 -1.083 . . . . 53.03 108.077 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.416 HD23 ' O ' ' D' ' 45' ' ' ASP . 0.1 OUTLIER -99.1 116.45 31.35 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.25 -1.019 . . . . 63.21 108.25 175.771 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.618 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 2.4 tmm_? -99.71 96.29 7.51 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.652 -1.61 . . . . 75.44 106.652 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.579 HG21 ' HB1' ' D' ' 110' ' ' ALA . 37.0 t -107.96 125.63 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.599 -0.889 . . . . 74.44 108.599 -177.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 20.8 m -130.26 135.29 47.96 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.366 0.667 . . . . 52.04 109.398 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 63.9 t -122.3 109.33 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.858 0.863 . . . . 65.33 109.257 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.1 m -95.39 111.54 23.4 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.832 -0.803 . . . . 44.14 108.832 170.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -115.28 149.84 37.18 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.48 0.712 . . . . 71.43 110.771 -173.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.404 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.1 m -149.32 132.28 16.17 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 123.778 0.674 . . . . 55.31 111.603 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.48 HD12 HG22 ' D' ' 31' ' ' VAL . 30.5 mt -96.24 109.35 21.84 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.554 -0.906 . . . . 61.45 108.554 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.38 -114.57 4.99 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 123.678 0.612 . . . . 54.05 113.02 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.57 16.53 20.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.57 0.748 . . . . 52.45 111.386 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -137.23 161.22 36.78 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.219 0.607 . . . . 74.31 109.785 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 19.5 m -69.62 138.9 53.47 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.561 0.538 . . . . 74.22 111.239 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.469 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -95.72 -70.64 0.7 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.955 0.902 . . . . 73.24 109.375 173.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -144.72 138.45 27.23 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 121.136 0.493 . . . . 73.2 110.286 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.7 mt -111.37 109.83 20.0 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.027 -1.101 . . . . 74.23 108.027 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.542 ' SG ' HG23 ' D' ' 114' ' ' ILE . 53.3 t -118.78 140.64 49.62 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.473 0.709 . . . . 65.34 109.406 -177.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -155.57 134.5 12.06 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.28 0.632 . . . . 72.42 109.629 175.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.18 119.06 18.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.929 0.892 . . . . 51.24 108.873 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.673 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.7 83.71 6.26 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.2 -1.037 . . . . 73.44 108.2 168.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.31 94.35 5.46 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.29 -1.323 . . . . 74.52 109.0 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.9 142.67 16.67 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.985 -0.446 . . . . 64.14 111.985 -178.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.523 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.15 130.02 4.14 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.542 -1.023 . . . . 62.21 110.542 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 39.0 mt -90.82 136.75 23.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.422 -0.955 . . . . 74.23 108.422 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -138.86 131.83 29.51 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.26 0.624 . . . . 64.13 109.84 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -80.17 109.31 14.51 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.772 -0.825 . . . . 54.21 108.772 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.443 HD11 ' HB2' ' D' ' 56' ' ' TYR . 1.6 pp -119.83 133.88 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.648 0.779 . . . . 74.34 111.81 -171.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.24 169.0 9.49 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.434 1.094 . . . . 72.42 109.207 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.18 11.46 84.89 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 115.368 0.907 . . . . 74.5 115.368 169.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.42 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -119.81 143.35 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 117.837 0.819 . . . . 73.52 110.059 177.117 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.2 -174.42 4.37 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.717 0.807 . . . . 73.41 111.072 -176.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.93 -120.85 14.86 Favored Glycine 0 C--N 1.357 1.728 0 O-C-N 123.455 0.472 . . . . 40.31 113.0 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 29.7 m -88.82 -28.65 20.28 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.213 0.605 . . . . 74.13 110.333 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -62.85 -30.23 71.35 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.273 1.029 . . . . 73.03 111.857 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 12.1 ptm -68.65 -29.39 67.87 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.079 0.552 . . . . 74.51 111.574 177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.54 -36.26 24.15 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.586 0.754 . . . . 73.35 110.651 174.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -70.02 -41.32 74.46 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.214 1.005 . . . . 74.22 111.61 -174.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.6 t -65.94 -50.33 64.76 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.099 0.56 . . . . 74.52 110.66 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 18.2 tp -76.95 -31.36 56.53 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 115.715 -0.675 . . . . 73.04 111.104 -173.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.28 -26.94 10.47 Favored Glycine 0 C--N 1.354 1.541 0 N-CA-C 114.931 0.732 . . . . 51.5 114.931 -170.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.37 -49.63 1.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 117.609 0.704 . . . . 53.2 112.118 -171.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -69.95 -48.29 58.96 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.26 0.624 . . . . 72.2 111.932 -173.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 92.6 m -61.44 -48.18 91.5 Favored Pre-proline 0 CA--C 1.564 1.502 0 CA-C-O 118.509 -0.758 . . . . 72.52 112.15 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.3 -35.68 91.96 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.113 1.875 . . . . 70.11 113.765 170.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -63.85 -39.74 94.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.993 0.517 . . . . 73.55 110.424 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.436 HG21 HD13 ' D' ' 13' ' ' ILE . 49.0 mm -60.51 -40.64 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.568 0.699 . . . . 61.42 110.544 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.523 HD21 ' HA3' ' D' ' 82' ' ' GLY . 96.1 mt -76.34 -19.17 58.47 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.84 -1.073 . . . . 74.51 112.061 -175.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -65.33 -43.8 65.68 Favored Pre-proline 0 CA--C 1.564 1.498 0 N-CA-C 114.189 1.181 . . . . 72.22 114.189 -170.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.63 -42.06 71.77 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 122.1 1.867 . . . . 52.34 113.432 172.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -73.68 -35.2 65.17 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.742 0.817 . . . . 65.55 111.808 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.579 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -61.51 -51.03 70.33 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.519 0.728 . . . . 44.42 109.592 176.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 31.4 ttp180 -54.92 -52.22 63.63 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 113.891 -1.504 . . . . 75.42 110.586 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.84 -48.0 81.05 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 124.023 0.827 . . . . 74.34 111.703 -174.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.9 t -59.9 -42.56 94.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.898 0.479 . . . . 54.25 111.169 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.542 HG23 ' SG ' ' D' ' 76' ' ' CYS . 70.3 mt -60.5 -52.53 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.927 0.891 . . . . 54.11 110.528 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 39.5 m -56.55 -44.88 81.33 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 125.063 1.345 . . . . 73.01 111.573 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 25.7 t -64.54 -41.36 96.4 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.696 -1.138 . . . . 51.41 110.457 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.427 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 71.8 mtm -70.56 -34.02 71.76 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.698 0.399 . . . . 64.22 111.749 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.425 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.7 t -63.12 -43.62 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.304 0.642 . . . . 64.43 110.044 176.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.4 p -72.45 -31.17 65.22 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 116.054 -0.521 . . . . 74.41 111.196 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.3 mtt-85 -71.46 -32.56 68.46 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.494 0.718 . . . . 73.33 110.411 175.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.29 7.22 79.42 Favored Glycine 0 C--N 1.351 1.405 0 O-C-N 123.67 0.606 . . . . 55.35 112.072 175.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 66.2 p 63.08 13.59 6.91 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.88 2.072 . . . . 73.12 114.309 173.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -79.26 149.82 73.21 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 108.543 -0.91 . . . . 75.24 108.543 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -48.25 122.08 7.05 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.075 2.517 . . . . 73.44 112.755 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -49.49 135.87 17.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.395 1.478 . . . . 62.41 112.345 -171.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 29.5 tp -108.16 95.9 5.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.941 0.496 . . . . 64.41 110.736 -169.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 127' ' ' ASN . . . . . 0.434 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 85.6 m-20 -103.4 87.74 2.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.674 0.79 . . . . 71.52 109.062 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.421 HD11 HD13 ' D' ' 42' ' ' LEU . 39.1 tp -71.68 133.63 45.77 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.014 -0.993 . . . . 63.15 110.549 -176.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.05 141.07 98.01 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 123.131 0.573 . . . . 73.33 110.892 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -61.4 130.98 33.98 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.666 2.244 . . . . 64.44 111.868 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 80.0 t -108.58 120.84 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.424 0.689 . . . . 41.53 109.77 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -82.99 91.37 7.15 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.591 -0.892 . . . . 73.41 108.591 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -66.72 -35.1 79.33 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.798 -0.637 . . . . 70.12 110.632 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.39 -52.14 55.24 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.201 1.4 . . . . 52.51 112.743 -173.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.68 75.26 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.19 0.596 . . . . 44.54 111.518 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -68.46 -28.5 67.1 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.569 -0.741 . . . . 64.43 111.19 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 90.4 t80 . . . . . 0 N--CA 1.475 0.816 0 C-N-CA 123.968 0.907 . . . . 73.33 110.555 176.634 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 C--O 1.237 0.438 0 N-CA-C 106.125 -1.806 . . . . 75.43 106.125 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.611 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.6 t80 -114.49 129.96 56.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.001 -1.0 . . . . 75.42 109.213 -171.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -140.99 108.84 5.67 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.36 -0.978 . . . . 75.11 108.36 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.551 HG12 ' HD2' ' A' ' 84' ' ' PHE . 55.0 mt -81.16 116.94 26.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.971 -0.751 . . . . 71.43 108.971 173.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.486 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -73.82 -40.77 63.11 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.634 -0.712 . . . . 75.24 109.301 -178.683 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -173.64 122.96 0.35 Allowed 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.299 0.374 . . . . 62.52 111.384 -171.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.561 HD12 ' HG3' ' C' ' 130' ' ' PRO . 71.3 mt -106.43 133.83 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.067 -0.716 . . . . 74.42 109.067 173.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB3' HG23 ' B' ' 122' ' ' THR . 33.2 p90 -163.76 178.86 7.53 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.882 0.873 . . . . 41.44 110.901 -173.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.9 p -106.2 116.26 31.63 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.951 -0.759 . . . . 74.11 108.951 176.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 22.7 mtpt -81.26 -29.71 34.31 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.422 -0.585 . . . . 73.13 109.422 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.3 t70 -146.84 141.75 26.95 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.719 -1.128 . . . . 45.25 109.697 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 88.0 mt -139.05 141.26 36.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 125.616 1.566 . . . . 74.32 106.807 171.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -147.96 136.85 21.94 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.184 0.516 . . . . 62.43 109.986 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.592 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.4 t80 -135.26 126.23 27.69 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.682 -1.229 . . . . 75.45 107.682 171.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.81 119.88 24.1 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.885 0.474 . . . . 74.14 110.159 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -132.93 80.4 60.71 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 107.367 -1.345 . . . . 62.24 107.367 170.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.66 -19.38 12.87 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.68 2.253 . . . . 74.34 111.192 175.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.496 ' O ' HG23 ' A' ' 31' ' ' VAL . 91.0 m-20 -103.94 16.98 25.08 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.294 1.038 . . . . 62.34 110.56 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.583 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -55.25 -46.6 99.66 Favored Pre-proline 0 CA--C 1.57 1.725 0 C-N-CA 123.54 0.736 . . . . 52.12 112.277 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.52 6.1 4.69 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 122.318 2.012 . . . . 72.43 113.383 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -100.78 -40.25 7.42 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.125 0.57 . . . . 75.2 109.8 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 27' ' ' ASN . 98.6 t -66.78 -34.39 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.716 0.806 . . . . 62.23 111.34 -175.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.457 ' CE1' ' HG3' ' A' ' 33' ' ' GLN . 1.1 p90 -65.82 -26.14 67.54 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 120.898 0.38 . . . . 75.12 111.029 -177.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.457 ' HG3' ' CE1' ' A' ' 32' ' ' PHE . 49.2 mt-30 -87.08 -44.11 11.79 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.372 0.669 . . . . 62.13 111.068 177.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HE3' HD11 ' A' ' 68' ' ' LEU . 53.4 mtmt -82.86 168.55 17.0 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.086 0.47 . . . . 73.54 112.251 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.24 131.96 41.69 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.009 -0.996 . . . . 61.15 110.535 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -77.44 98.62 5.35 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.589 1.156 . . . . 73.1 110.256 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -139.01 75.66 34.78 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 108.879 -0.786 . . . . 75.45 108.879 172.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -84.96 152.81 11.19 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.554 2.169 . . . . 72.54 112.863 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -118.33 108.76 15.48 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.603 -1.258 . . . . 73.05 107.603 172.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.6 m -82.54 135.41 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.609 0.764 . . . . 74.24 111.649 -171.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -123.28 113.28 18.67 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.895 -1.15 . . . . 73.14 107.895 174.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.7 tp -110.46 116.72 31.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.045 0.538 . . . . 75.51 110.078 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.497 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 31.5 t70 -103.15 132.93 49.04 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 109.029 -0.73 . . . . 75.14 109.029 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.5 mt -110.47 132.4 54.21 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.459 -0.941 . . . . 73.33 108.459 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.749 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 16.9 t70 -145.39 153.17 40.92 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.907 0.483 . . . . 62.2 110.068 177.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.6 m -127.71 139.39 52.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.667 1.187 . . . . 71.21 108.659 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.57 123.69 25.58 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.491 -0.559 . . . . 45.2 109.491 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.6 m -88.11 152.21 22.17 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.333 -0.617 . . . . 24.25 109.333 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -160.42 122.52 3.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.368 0.667 . . . . 73.21 109.819 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -81.04 139.12 35.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.026 0.53 . . . . 73.43 110.239 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.448 HD12 HG23 ' A' ' 83' ' ' ILE . 83.7 mt -117.49 -28.76 5.99 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.522 0.729 . . . . 61.22 110.138 176.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.2 -177.35 4.92 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.08 0.952 . . . . 62.24 109.374 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.18 128.22 35.57 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.269 -0.641 . . . . 54.22 109.269 173.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 69.38 2.42 3.7 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.204 1.402 . . . . 74.33 112.309 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.87 116.43 52.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 123.923 0.889 . . . . 71.23 109.389 -177.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.16 125.59 23.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.987 0.915 . . . . 74.24 108.678 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -93.83 145.39 24.64 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.632 -0.877 . . . . 63.22 108.632 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -111.58 138.26 40.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.995 -1.113 . . . . 54.4 107.995 172.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -114.73 106.78 21.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.021 -1.103 . . . . 72.4 108.021 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.7 tp -88.09 105.91 17.81 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.656 -0.868 . . . . 74.35 108.656 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.749 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 59.1 mtt85 -83.75 121.94 27.98 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.838 -0.801 . . . . 64.42 108.838 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.627 HG21 ' HB1' ' A' ' 110' ' ' ALA . 2.1 m -127.61 101.52 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.644 -0.873 . . . . 75.03 108.644 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 86.6 m -98.13 108.54 21.27 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.344 1.057 . . . . 72.13 109.87 -175.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.424 HG21 HG21 ' A' ' 114' ' ' ILE . 85.0 t -103.03 113.65 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.42 -0.585 . . . . 34.15 109.42 176.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.9 m -123.6 107.05 11.09 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.071 -0.714 . . . . 72.1 109.071 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.25 125.1 53.79 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.977 -0.749 . . . . 64.43 108.977 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.4 p -120.95 130.38 53.83 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.535 0.734 . . . . 70.44 110.161 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 68' ' ' LEU . 2.7 pt? -90.4 48.31 1.54 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 122.278 1.037 . . . . 64.41 109.661 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.78 -125.34 6.36 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 114.915 -1.039 . . . . 22.11 111.071 -170.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.27 -28.34 23.83 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 117.48 0.64 . . . . 75.31 109.73 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -86.12 134.5 33.81 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.85 0.86 . . . . 74.12 110.571 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 m -74.72 133.4 42.04 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.649 0.593 . . . . 62.33 109.869 172.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.83 -51.88 9.1 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.891 0.877 . . . . 71.3 108.963 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -155.92 157.08 35.7 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.447 -1.252 . . . . 52.22 111.551 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 62.8 tp -121.97 109.76 14.99 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.403 -1.332 . . . . 70.32 107.403 166.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 80.1 m -107.28 97.36 7.13 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.939 -1.134 . . . . 72.33 107.939 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -122.13 115.8 23.08 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.36 -0.978 . . . . 52.41 108.36 -173.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.7 t -126.22 136.11 61.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.49 -0.777 . . . . 73.13 109.184 -172.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 24.5 mt-30 -110.28 91.17 3.55 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.826 -0.805 . . . . 64.24 108.826 167.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -77.18 113.17 14.63 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.867 -1.16 . . . . 63.15 107.867 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.72 142.19 16.12 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 112.198 -0.361 . . . . 22.32 112.198 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.41 141.54 10.86 Favored Glycine 0 CA--C 1.505 -0.557 0 N-CA-C 110.743 -0.943 . . . . 75.02 110.743 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 14' ' ' GLN . 36.2 mt -88.63 124.45 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.868 -0.79 . . . . 74.44 108.868 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.611 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 39.0 m-85 -129.3 128.97 44.27 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.706 0.802 . . . . 74.04 109.522 -171.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.2 t -89.05 120.84 30.82 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.912 -0.774 . . . . 61.25 108.912 174.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.1 pt -95.84 129.24 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.437 0.695 . . . . 74.23 109.898 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.03 158.9 7.34 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.934 0.894 . . . . 71.41 111.164 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.18 -33.38 6.63 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 115.771 -0.649 . . . . 61.15 113.494 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -137.62 170.7 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.837 0.855 . . . . 71.13 109.905 -177.25 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.95 173.33 11.61 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.524 0.73 . . . . 70.14 109.449 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.28 -145.09 43.81 Favored Glycine 0 C--N 1.351 1.387 0 C-N-CA 122.648 0.166 . . . . 53.41 113.498 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.549 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 23.3 p -72.64 -14.85 61.69 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.802 0.841 . . . . 73.15 111.921 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -68.07 -38.36 82.3 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.968 -0.753 . . . . 61.42 108.968 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 38.1 ttp -82.93 -35.49 26.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.485 0.714 . . . . 70.15 111.054 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.549 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -63.21 -26.5 68.83 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.942 0.497 . . . . 73.51 110.631 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.401 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 18.4 t-80 -66.38 -50.35 63.78 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.502 1.121 . . . . 74.31 110.506 169.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 71.0 m -67.2 -27.31 67.15 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.852 0.461 . . . . 73.03 112.1 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.88 -41.82 12.95 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.14 0.976 . . . . 74.02 109.589 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.84 2.18 56.9 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-O 119.469 -0.628 . . . . 75.43 114.585 -171.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.447 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -138.37 -62.06 0.58 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.608 0.704 . . . . 70.1 111.262 -177.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.44 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 80.6 t80 -62.75 -49.72 73.91 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.729 0.812 . . . . 71.41 111.736 -175.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 89.6 m -71.1 -39.64 8.49 Favored Pre-proline 0 CA--C 1.571 1.76 0 N-CA-C 114.101 1.148 . . . . 45.23 114.101 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.38 -24.4 50.09 Favored 'Trans proline' 0 C--N 1.387 2.571 0 CA-C-N 121.742 1.658 . . . . 63.41 112.826 167.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -27.57 61.76 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.907 -0.405 . . . . 75.05 109.907 177.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.8 mm -60.25 -40.7 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.911 0.884 . . . . 73.44 109.818 170.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.5 mt -80.07 -17.22 53.25 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.066 0.947 . . . . 62.32 112.338 -175.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -63.75 -45.22 81.78 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 113.916 1.08 . . . . 71.44 113.916 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.46 -39.51 65.36 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 121.596 1.53 . . . . 73.34 112.701 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -69.47 -38.48 77.73 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.379 0.672 . . . . 75.14 111.085 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.627 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.85 -41.73 86.87 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.816 -0.629 . . . . 63.24 110.39 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.581 ' HA ' HD21 ' A' ' 128' ' ' LEU . 40.9 ttm180 -54.78 -50.47 68.41 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 124.7 1.25 . . . . 74.13 110.29 177.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -63.65 -42.69 98.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.485 1.116 . . . . 72.23 111.397 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 117' ' ' MET . 27.6 t -60.93 -37.4 82.18 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 123.695 0.622 . . . . 45.34 110.61 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.424 HG21 HG21 ' A' ' 64' ' ' VAL . 78.5 mt -71.61 -43.05 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.483 1.113 . . . . 73.34 110.561 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.406 HG23 ' HG3' ' A' ' 125' ' ' GLN . 24.0 m -61.6 -33.99 74.86 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.731 0.776 . . . . 64.44 109.94 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.7 t -70.93 -40.09 72.27 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.712 -1.131 . . . . 74.33 109.864 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.592 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 18.4 mmt -59.08 -48.38 81.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.308 0.643 . . . . 65.35 111.626 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.1 m -68.13 -42.14 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 O-C-N 123.448 0.467 . . . . 74.24 111.43 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.9 m -69.01 -35.71 76.97 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.054 0.541 . . . . 72.22 111.692 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.515 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 95.2 mtt-85 -70.55 -35.19 72.98 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.896 0.479 . . . . 72.13 110.029 175.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.14 19.72 20.65 Favored Glycine 0 C--N 1.354 1.57 0 CA-C-O 119.14 -0.811 . . . . 75.05 114.32 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' B' ' 17' ' ' TYR . 2.4 t 61.4 10.73 3.3 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 127.16 2.184 . . . . 63.44 114.311 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -86.52 150.54 51.5 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 108.542 -0.91 . . . . 72.21 108.542 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.55 159.03 21.29 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.395 2.063 . . . . 62.52 112.2 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.406 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.1 tt0 -60.83 142.97 55.65 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.071 0.549 . . . . 72.03 112.308 -177.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.3 tp -128.15 121.8 30.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.117 0.967 . . . . 73.41 109.938 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -124.7 109.66 13.4 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.681 -0.859 . . . . 71.12 108.681 173.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.757 ' H ' HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -73.23 126.34 29.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 109.101 -0.703 . . . . 70.23 109.101 173.662 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.13 151.22 27.1 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 124.895 1.278 . . . . 61.21 112.715 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 110.23 0.65 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.805 2.337 . . . . 73.14 112.54 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 81.7 t -99.37 113.09 33.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.072 -1.084 . . . . 70.42 108.072 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -85.27 81.65 8.7 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.433 -0.951 . . . . 73.5 108.433 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -56.27 -31.9 64.02 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.456 0.702 . . . . 72.3 111.407 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.447 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 9.8 t70 -63.31 -48.3 78.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.546 1.138 . . . . 73.3 110.706 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.69 92.61 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.994 0.918 . . . . 44.31 111.445 176.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.7 mt -69.53 -34.6 74.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.731 0.812 . . . . 70.02 111.878 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.96 -38.48 79.44 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.652 -0.87 . . . . 63.31 108.652 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 10.4 mmt . . . . . 0 CA--C 1.545 0.764 0 O-C-N 124.109 0.881 . . . . 62.34 111.195 177.129 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 85.0 m . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 108.544 -0.91 . . . . 64.21 108.544 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -114.42 143.25 45.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.215 0.606 . . . . 63.44 109.848 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -149.72 140.81 22.99 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.289 0.636 . . . . 72.4 109.749 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.64 123.49 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.75 -1.204 . . . . 65.22 107.75 172.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.414 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 14.0 mm100 -86.23 -50.65 6.81 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.233 -0.654 . . . . 75.31 109.233 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -170.12 133.24 1.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.508 -0.769 . . . . 74.51 109.704 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.04 138.76 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 107.87 -1.159 . . . . 74.32 107.87 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.446 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 33.7 p90 -165.11 164.65 20.27 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 122.304 1.049 . . . . 73.03 112.379 -177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 74.3 m -87.73 130.08 34.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.938 -1.483 . . . . 73.41 108.063 169.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.405 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 40.5 mtpt -98.02 -36.62 10.06 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.381 0.672 . . . . 64.2 110.302 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -149.99 132.21 15.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.814 -0.63 . . . . 55.44 110.545 -170.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.454 HD12 HG22 ' B' ' 78' ' ' VAL . 48.8 mm -128.3 141.97 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.116 0.966 . . . . 75.43 108.553 171.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -142.34 130.67 22.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.227 -1.397 . . . . 73.12 107.227 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.417 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.0 t80 -144.99 109.85 5.06 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.585 -1.265 . . . . 71.12 107.585 170.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -120.89 123.42 42.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.54 -0.911 . . . . 72.03 108.54 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.96 87.16 2.25 Favored Pre-proline 0 C--O 1.242 0.68 0 N-CA-C 106.722 -1.584 . . . . 51.5 106.722 171.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.85 -36.1 19.26 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.639 2.226 . . . . 74.02 112.735 -165.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -110.83 22.25 15.57 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.86 0.864 . . . . 61.25 110.423 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -36.29 -64.93 0.34 Allowed Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 115.195 1.554 . . . . 42.33 115.195 -162.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.7 Cg_exo -66.21 -30.28 46.28 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 121.828 1.685 . . . . 53.12 112.682 -173.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.419 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 65.8 m80 -93.32 -15.87 25.29 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.373 -0.831 . . . . 74.42 112.284 -174.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.732 HG21 ' HA ' ' B' ' 73' ' ' ALA . 7.5 p -85.93 -30.12 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 117.93 0.332 . . . . 73.55 110.529 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -61.2 -19.54 61.73 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.742 0.817 . . . . 75.12 113.081 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.1 pt20 -64.85 -15.7 62.22 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.99 0.516 . . . . 75.23 111.594 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -99.57 97.58 8.55 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.109 0.964 . . . . 50.41 109.024 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -79.65 91.72 5.28 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.281 0.563 . . . . 74.05 109.796 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -164.36 159.81 20.13 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.322 1.049 . . . . 72.43 108.993 -174.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.8 pm0 -82.52 109.74 17.93 Favored Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 109.217 -0.661 . . . . 72.21 109.217 173.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.483 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 35.3 Cg_endo -62.41 127.38 20.75 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.815 2.343 . . . . 53.42 113.074 -171.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -56.73 120.16 7.37 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.294 0.996 . . . . 73.31 110.969 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.481 HG11 HD11 ' B' ' 126' ' ' LEU . 29.6 m -96.18 163.03 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.159 -0.928 . . . . 43.43 113.19 -168.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.549 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 81.8 tttt -148.88 137.46 21.19 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.982 1.713 . . . . 72.2 107.512 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.412 ' HB3' HD11 ' B' ' 44' ' ' LEU . 2.6 mm? -105.25 131.41 52.74 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.119 -0.697 . . . . 71.32 109.119 176.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.8 t70 -124.29 110.71 14.95 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 106.697 -1.594 . . . . 73.43 106.697 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' B' ' 42' ' ' LEU . 0.5 OUTLIER -114.98 129.26 56.68 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.832 -0.803 . . . . 74.04 108.832 -165.422 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 20.7 m-20 -130.65 112.79 13.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.035 0.534 . . . . 73.12 109.841 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 28.6 p -107.15 102.27 11.61 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.217 -1.031 . . . . 51.41 108.217 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.19 119.15 26.74 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.241 1.016 . . . . 73.23 109.321 -174.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.524 ' HB3' HG22 ' B' ' 58' ' ' VAL . 16.6 p -100.3 161.62 13.49 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.615 0.766 . . . . 73.01 109.931 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 81.2 p -151.07 137.21 18.35 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.5 0.72 . . . . 64.11 109.355 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -81.9 118.35 22.87 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.206 0.602 . . . . 74.42 109.788 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.17 -43.72 15.86 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.959 -0.756 . . . . 73.15 108.959 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.64 177.37 11.3 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.186 -1.37 . . . . 60.54 108.923 174.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.92 130.78 43.76 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.895 -0.78 . . . . 65.22 108.895 178.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 75.28 -4.45 2.37 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 125.056 1.343 . . . . 71.54 112.424 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -117.56 109.18 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.759 0.824 . . . . 65.05 109.332 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -125.56 138.61 53.96 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.401 -0.592 . . . . 71.32 109.401 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -119.07 107.09 13.07 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.092 -1.077 . . . . 72.32 108.092 -172.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' B' ' 48' ' ' SER . 85.8 t -94.3 135.13 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.991 0.916 . . . . 74.21 110.617 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.15 130.08 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.385 -0.969 . . . . 72.33 108.385 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.84 112.81 23.34 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.112 -1.07 . . . . 70.53 108.112 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.406 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 36.8 ttm180 -99.83 127.49 45.99 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.412 0.685 . . . . 73.12 109.829 173.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' B' ' 114' ' ' ILE . 46.0 t -123.12 102.64 11.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 106.67 -1.604 . . . . 74.34 106.67 167.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.5 m -99.44 126.25 45.32 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.346 -0.613 . . . . 75.32 109.346 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.522 HG11 HD21 ' B' ' 126' ' ' LEU . 60.3 t -108.94 105.43 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 123.298 0.639 . . . . 70.31 109.721 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 42.0 m -84.02 137.42 33.61 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.966 -1.124 . . . . 62.22 107.966 167.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.442 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -149.02 143.43 26.09 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.51 0.324 . . . . 44.23 110.182 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 49.4 p -146.0 134.23 21.7 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.579 0.549 . . . . 52.2 111.373 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.659 HD12 HG22 ' B' ' 31' ' ' VAL . 39.2 mt -93.35 109.94 21.49 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.511 -0.922 . . . . 62.21 108.511 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.67 -108.8 2.6 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.866 -1.061 . . . . 71.03 111.713 -170.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.95 3.97 10.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.045 0.938 . . . . 75.53 111.905 -175.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -115.03 149.78 36.92 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.436 -0.579 . . . . 72.41 109.436 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.2 m -67.31 133.26 49.33 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.936 0.398 . . . . 54.35 111.161 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.732 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -90.46 -64.07 1.19 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.962 -1.017 . . . . 74.53 109.234 176.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -150.02 154.68 38.6 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.316 -0.856 . . . . 73.34 110.393 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.0 mt -128.79 110.77 12.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.669 -1.604 . . . . 74.45 106.669 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.9 t -117.57 155.69 29.38 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.856 -0.794 . . . . 75.22 108.856 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -163.55 130.67 3.39 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.836 -0.801 . . . . 74.54 108.836 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.454 HG22 HD12 ' B' ' 21' ' ' ILE . 88.3 t -124.07 141.32 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.593 -0.891 . . . . 73.32 108.593 172.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -123.04 88.42 2.92 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.89 -0.782 . . . . 44.22 108.89 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.405 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 57.6 tp60 -79.76 100.82 8.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.141 -0.936 . . . . 72.13 109.102 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.31 143.69 16.88 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.744 -0.542 . . . . 74.42 111.744 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.534 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -145.81 127.13 2.72 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.135 -0.786 . . . . 70.51 111.135 -172.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 14.3 mt -91.2 129.68 41.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 123.918 0.887 . . . . 62.43 108.617 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -137.71 133.68 34.47 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.889 -0.782 . . . . 53.21 108.889 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.8 m -93.42 109.19 20.77 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.953 -0.758 . . . . 70.32 108.953 172.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 pt -112.92 117.83 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.228 1.011 . . . . 71.22 109.118 -174.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -129.84 152.72 49.02 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.18 0.592 . . . . 61.21 110.791 -175.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.43 -60.22 4.32 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.824 0.702 . . . . 63.0 112.522 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -67.12 145.29 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.351 0.661 . . . . 60.25 112.391 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -166.32 174.51 9.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.186 0.595 . . . . 74.54 109.561 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.6 -112.29 3.91 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 112.217 -0.353 . . . . 75.55 112.217 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 92' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' B' ' 95' ' ' ALA . 31.6 m -78.13 -29.53 48.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.142 0.496 . . . . 74.4 110.742 176.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -69.99 -33.81 72.53 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.34 -0.391 . . . . 74.02 110.575 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -30.81 61.46 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.957 -0.565 . . . . 62.45 110.212 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 95' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' B' ' 92' ' ' THR . . . -59.83 -38.45 82.05 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.45 0.7 . . . . 64.22 110.032 171.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -76.08 -36.31 59.01 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.284 1.034 . . . . 71.05 111.608 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.64 -57.36 6.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 123.593 0.558 . . . . 65.13 109.846 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.3 mp -79.62 -15.83 56.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.94 0.496 . . . . 65.45 111.521 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.39 -15.02 48.98 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.41 0.524 . . . . 65.24 114.41 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.35 -56.74 0.32 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 117.341 0.57 . . . . 52.34 111.879 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -68.5 -52.56 30.97 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.835 0.854 . . . . 62.13 112.001 -167.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.452 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 92.2 m -63.04 -49.07 83.05 Favored Pre-proline 0 CA--C 1.565 1.542 0 C-N-CA 124.319 1.047 . . . . 74.31 112.13 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.0 Cg_exo -58.49 -34.07 98.48 Favored 'Trans proline' 0 C--N 1.398 3.15 0 C-N-CA 122.095 1.864 . . . . 74.33 113.559 171.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.24 -37.62 83.72 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.374 0.67 . . . . 75.25 111.747 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 45.4 mt -63.9 -41.72 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.843 0.857 . . . . 72.34 110.759 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.534 HD21 ' HA3' ' B' ' 82' ' ' GLY . 51.2 mt -80.19 -19.91 45.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.348 1.059 . . . . 54.32 112.311 -173.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -59.7 -49.38 92.1 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.278 1.214 . . . . 75.51 114.278 -171.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -61.67 -33.7 85.58 Favored 'Trans proline' 0 C--N 1.381 2.258 0 CA-C-N 121.452 1.554 . . . . 73.34 112.618 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.405 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 84.5 m-85 -68.06 -46.0 72.3 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 123.662 0.601 . . . . 63.51 110.087 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.25 -47.1 84.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.521 0.729 . . . . 73.24 110.22 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -54.26 -55.36 28.97 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.129 1.372 . . . . 75.32 111.581 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.02 -35.04 79.48 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.854 0.721 . . . . 75.01 110.389 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.515 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 6.8 t -69.03 -37.63 78.73 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.95 -0.568 . . . . 74.32 111.227 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.522 HD11 ' HB ' ' B' ' 62' ' ' VAL . 58.5 mt -63.2 -55.33 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.715 -0.476 . . . . 74.14 109.715 174.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.533 HG21 ' OG ' ' C' ' 119' ' ' SER . 18.9 m -59.0 -34.01 71.36 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 124.468 1.105 . . . . 74.42 111.404 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.5 t -57.98 -52.21 66.46 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.423 -0.808 . . . . 64.43 109.503 174.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 9.9 mmt -66.83 -38.19 85.95 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.333 0.653 . . . . 74.44 111.748 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.421 HG23 ' O ' ' B' ' 114' ' ' ILE . 91.2 t -58.9 -46.12 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.087 0.955 . . . . 73.32 110.303 176.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 45.3 t -70.99 -33.06 70.05 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.605 -1.18 . . . . 74.23 111.433 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' B' ' 116' ' ' SER . 90.8 mtt-85 -63.84 -36.84 85.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.106 0.563 . . . . 74.44 110.089 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.1 14.32 53.94 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-O 119.43 -0.65 . . . . 53.44 113.322 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.45 HG23 ' HB3' ' A' ' 17' ' ' TYR . 82.5 p 55.93 26.9 10.35 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.917 1.687 . . . . 71.45 113.636 176.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -87.06 153.01 54.07 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 123.609 0.764 . . . . 74.22 110.55 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 161.06 2.16 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 124.17 3.247 . . . . 72.44 115.271 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.51 HE21 ' ND2' ' B' ' 127' ' ' ASN . 63.7 tp60 -63.05 140.56 58.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.925 0.89 . . . . 74.53 111.982 -171.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.522 HD21 HG11 ' B' ' 64' ' ' VAL . 13.7 tp -146.05 117.67 8.07 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.906 -0.588 . . . . 72.3 109.433 -173.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 127' ' ' ASN . . . . . 0.51 ' ND2' HE21 ' B' ' 125' ' ' GLN . 26.4 m-80 -130.98 135.12 47.34 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.422 0.689 . . . . 74.35 110.06 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.73 130.87 34.31 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.825 0.85 . . . . 72.13 110.012 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.75 152.53 59.89 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.247 1.019 . . . . 63.54 111.285 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.804 ' HG2' HD13 ' D' ' 16' ' ' ILE . 20.5 Cg_exo -65.94 133.58 34.09 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.701 2.267 . . . . 74.01 112.81 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.1 t -121.22 115.12 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.126 -1.064 . . . . 73.34 108.126 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -80.45 82.23 6.53 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 109.684 -0.487 . . . . 75.12 109.684 -178.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -60.15 -27.24 66.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.882 0.873 . . . . 74.31 111.325 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -54.6 -47.74 73.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.986 1.314 . . . . 72.44 111.365 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.87 -37.95 85.41 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.706 -0.679 . . . . 64.21 111.274 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.19 -19.06 60.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.551 0.74 . . . . 74.35 111.317 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 66.3 t80 . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 122.932 0.493 . . . . 73.33 111.51 -176.517 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 108.268 -1.012 . . . . 52.13 108.268 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.487 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.7 t80 -118.77 126.69 52.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.413 0.685 . . . . 64.43 109.743 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -146.59 133.58 20.28 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 109.111 -0.7 . . . . 73.4 109.111 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -71.95 118.73 17.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.351 -0.981 . . . . 44.44 108.351 170.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.615 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.4 mm100 -83.49 -49.22 9.49 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.415 0.447 . . . . 55.21 109.969 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -169.51 127.15 0.93 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 116.382 -0.372 . . . . 75.52 110.524 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -107.85 148.76 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 107.867 -1.161 . . . . 65.12 107.867 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' C' ' 19' ' ' LYS . 32.1 p90 -174.53 167.8 3.85 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.401 0.619 . . . . 74.44 111.223 -174.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.1 p -96.55 111.62 23.68 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.135 -1.061 . . . . 64.14 108.135 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' C' ' 17' ' ' TYR . 19.0 mttt -68.77 -47.6 65.79 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.812 -1.181 . . . . 61.13 107.812 170.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.2 t70 -133.55 139.68 46.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 113.558 -1.655 . . . . 65.23 109.69 -169.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.6 mt -140.97 143.78 27.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.898 -1.89 . . . . 64.11 105.898 174.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.0 t -158.09 148.46 20.42 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.278 -0.638 . . . . 54.22 109.278 173.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -147.64 130.95 16.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.122 -1.436 . . . . 62.31 107.122 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -133.47 126.47 31.2 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.001 0.52 . . . . 64.34 109.731 -176.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.39 80.86 18.56 Favored Pre-proline 0 C--O 1.242 0.705 0 N-CA-C 106.683 -1.599 . . . . 74.42 106.683 168.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.48 -12.49 29.5 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.73 2.286 . . . . 51.22 112.083 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -121.11 25.0 9.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.474 1.51 . . . . 71.21 109.628 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -46.38 -55.78 12.94 Favored Pre-proline 0 CA--C 1.563 1.46 0 N-CA-C 114.093 1.146 . . . . 71.44 114.093 -168.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 51.4 Cg_exo -56.67 -41.24 77.87 Favored 'Trans proline' 0 C--N 1.385 2.485 0 CA-C-N 121.829 1.689 . . . . 74.1 112.888 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -69.3 -33.76 73.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.082 -0.508 . . . . 71.41 112.091 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.87 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.4 p -79.03 -24.52 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 112.716 0.636 . . . . 71.1 112.716 176.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -67.34 -30.64 70.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.877 -0.514 . . . . 74.55 112.278 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -87.5 34.11 0.7 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.245 0.618 . . . . 61.53 111.071 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.54 153.8 41.56 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.568 0.747 . . . . 65.22 111.534 -172.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.5 118.06 13.84 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.709 -0.849 . . . . 73.55 108.709 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -77.8 99.15 5.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.438 0.695 . . . . 72.22 110.681 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -156.21 74.6 4.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.851 -0.796 . . . . 62.44 108.851 171.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -92.36 161.76 3.04 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.882 2.388 . . . . 63.44 114.029 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.37 95.38 10.18 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.766 -1.198 . . . . 61.32 107.766 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.4 t -80.26 98.48 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 115.358 -0.837 . . . . 74.15 109.841 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -106.77 110.11 22.19 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.405 -0.961 . . . . 74.22 108.405 174.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 mp -85.77 144.65 27.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.249 -1.76 . . . . 74.12 106.249 167.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -123.88 111.94 16.66 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.708 -0.849 . . . . 73.22 108.708 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 90.8 mt -93.88 142.01 27.86 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.082 0.553 . . . . 72.0 110.032 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.2 t70 -157.79 161.14 38.4 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.65 1.18 . . . . 71.21 108.343 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.1 t -146.57 135.0 21.95 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.028 0.442 . . . . 72.42 110.491 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.83 156.25 32.33 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.221 1.008 . . . . 64.33 108.738 172.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.452 ' HB2' ' CE2' ' C' ' 56' ' ' TYR . 63.8 p -160.74 151.99 19.1 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.334 0.253 . . . . 74.44 111.563 -173.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -161.21 142.66 11.7 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.847 0.859 . . . . 73.34 110.307 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.24 136.34 39.68 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.776 -0.453 . . . . 72.54 109.776 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.492 HD11 HD12 ' C' ' 83' ' ' ILE . 39.8 mt -108.95 -44.97 3.87 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.346 0.658 . . . . 74.32 109.701 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.41 -173.07 3.84 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.669 -0.696 . . . . 71.11 111.045 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -67.86 108.59 3.05 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.136 -0.938 . . . . 70.21 110.392 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 63.42 24.65 14.24 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.792 1.237 . . . . 61.25 111.512 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.29 114.47 45.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.361 -0.977 . . . . 74.23 108.361 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.452 ' CE2' ' HB2' ' C' ' 48' ' ' SER . 35.5 t80 -126.22 124.99 41.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.564 -0.902 . . . . 74.12 108.564 -176.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.466 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.9 tt0 -82.09 141.64 32.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.027 -0.988 . . . . 71.15 109.929 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.28 142.22 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.487 1.115 . . . . 65.41 108.196 169.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.08 133.33 60.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.836 -0.801 . . . . 53.54 108.836 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.43 114.88 29.33 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.911 -1.144 . . . . 75.34 107.911 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.557 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 41.5 ttm-85 -99.29 117.53 33.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.033 -0.729 . . . . 74.42 109.033 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.582 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.4 t -118.57 133.57 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.299 -1.001 . . . . 74.11 108.299 172.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 14.8 m -131.55 114.85 15.36 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.258 -0.645 . . . . 72.43 109.258 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.597 HG11 HD21 ' C' ' 126' ' ' LEU . 21.8 t -99.51 128.84 50.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.847 -0.798 . . . . 73.45 108.847 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.1 m -122.87 140.4 53.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.803 -1.184 . . . . 74.53 107.803 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 66' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' C' ' 73' ' ' ALA . . . -132.03 113.13 13.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.763 -1.199 . . . . 64.43 107.763 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.2 m -113.69 122.58 47.57 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.356 0.598 . . . . 63.44 110.173 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 mt -92.1 24.63 3.2 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.042 1.337 . . . . 73.24 109.52 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.1 -108.52 2.6 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 110.569 -1.012 . . . . 71.43 110.569 -170.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.63 -27.37 20.22 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.587 0.755 . . . . 73.33 110.276 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -79.42 119.26 22.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.685 0.794 . . . . 74.13 109.331 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 39.4 m -87.53 130.81 34.59 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.159 -0.682 . . . . 64.35 109.159 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.87 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.79 -61.61 1.75 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.249 0.619 . . . . 70.32 110.613 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -156.92 170.52 22.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.54 -0.755 . . . . 74.35 110.858 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -142.47 116.82 9.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.216 -1.401 . . . . 64.21 107.216 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.423 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -124.78 119.35 28.64 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.079 0.552 . . . . 64.12 109.751 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -121.94 125.67 46.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.684 0.394 . . . . 71.04 110.019 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.87 137.19 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.01 0.924 . . . . 63.5 108.817 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.9 mt-30 -115.56 95.41 5.14 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.635 -0.876 . . . . 65.0 108.635 172.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -79.71 100.25 7.8 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.626 -1.17 . . . . 74.21 110.081 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.45 149.34 27.32 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 116.194 -0.457 . . . . 75.55 112.071 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.553 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -157.03 122.2 1.15 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 111.713 -0.555 . . . . 34.43 111.713 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.615 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.9 mm -88.99 124.52 41.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.788 -0.819 . . . . 72.13 108.788 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.487 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 53.0 m-85 -131.44 118.82 20.75 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.074 0.549 . . . . 71.2 109.945 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 85' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 66.8 m -80.9 118.72 22.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.777 -0.823 . . . . 71.33 108.777 171.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 pp -135.05 141.32 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.849 0.86 . . . . 53.12 110.119 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.0 142.87 17.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.176 0.59 . . . . 51.13 110.522 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.94 -23.43 35.65 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.506 0.504 . . . . 75.23 114.264 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.568 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -89.82 153.55 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.451 0.7 . . . . 63.32 110.813 178.803 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -160.06 -179.07 7.46 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.344 -0.844 . . . . 71.42 110.221 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.85 -112.44 3.81 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.864 0.728 . . . . 41.12 114.249 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 21.2 p -68.89 -43.02 76.14 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.178 0.991 . . . . 72.3 111.292 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -66.47 -37.44 85.13 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.856 -0.611 . . . . 64.33 111.418 -174.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -72.86 -39.96 66.07 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 110.364 -0.235 . . . . 73.21 110.364 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.13 -44.27 92.04 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 123.533 0.52 . . . . 74.44 110.81 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -80.39 -34.05 36.61 Favored 'General case' 0 C--O 1.245 0.864 0 O-C-N 123.411 0.444 . . . . 73.54 112.128 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.442 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 42.4 t -59.3 -37.16 77.03 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 123.425 0.453 . . . . 72.53 110.101 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 32.1 mt -93.94 -22.83 18.34 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.866 0.866 . . . . 75.11 111.033 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -31.65 57.98 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 115.077 0.791 . . . . 54.51 115.077 -172.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.65 -35.43 0.05 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.217 0.451 . . . . 32.01 112.217 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.442 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 45.5 t80 -60.18 -50.96 71.61 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.442 1.497 . . . . 62.3 112.567 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 61.4 m -75.41 -44.24 4.37 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-O 118.319 -0.848 . . . . 52.2 112.258 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -53.91 -26.71 41.13 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 122.001 1.801 . . . . 62.14 113.66 170.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -68.33 -34.91 76.97 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.514 0.725 . . . . 74.23 111.166 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -64.01 -36.51 77.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.356 0.662 . . . . 64.21 109.983 175.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.553 HD21 ' HA3' ' C' ' 82' ' ' GLY . 63.4 mt -84.94 -15.3 44.85 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.058 . . . . 71.52 112.265 -176.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.33 -48.57 90.88 Favored Pre-proline 0 CA--C 1.56 1.36 0 N-CA-C 114.115 1.154 . . . . 52.41 114.115 -173.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.82 -33.13 76.89 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 121.877 1.718 . . . . 61.34 112.767 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -71.5 -46.69 59.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.612 -0.722 . . . . 71.21 110.327 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.23 -41.9 76.43 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 115.321 -0.854 . . . . 63.31 109.847 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -56.21 -60.34 3.64 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.47 1.106 . . . . 71.33 111.718 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.02 -29.08 68.79 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.941 0.496 . . . . 70.04 111.237 -173.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 24.3 t -69.95 -35.87 74.84 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.009 0.524 . . . . 75.31 111.219 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.582 HD11 ' HB ' ' C' ' 62' ' ' VAL . 94.9 mt -72.92 -47.24 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.631 0.772 . . . . 70.13 110.036 174.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.0 m -61.0 -34.58 75.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.022 0.929 . . . . 75.54 111.125 -177.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -62.49 -51.72 66.32 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 115.351 -0.84 . . . . 52.25 109.59 174.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.549 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.46 -35.56 76.16 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.626 1.17 . . . . 72.32 112.867 -179.074 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.525 HG13 ' HB2' ' C' ' 123' ' ' PHE . 68.3 t -67.1 -44.99 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.548 0.739 . . . . 53.22 110.465 176.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.533 ' OG ' HG21 ' B' ' 115' ' ' THR . 47.3 t -66.8 -31.35 71.92 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.733 -0.667 . . . . 63.01 111.186 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' D' ' 17' ' ' TYR . 83.3 mtt-85 -67.29 -46.06 74.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.414 0.686 . . . . 74.31 109.391 176.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.21 -0.8 67.13 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.683 0.614 . . . . 62.11 113.24 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 34.2 p 64.6 27.96 13.27 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.742 2.017 . . . . 74.32 114.19 170.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.525 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.7 m-85 -83.73 155.67 65.04 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.529 0.731 . . . . 75.53 109.737 172.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -53.16 173.58 0.15 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 124.072 3.181 . . . . 75.5 115.573 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -55.6 132.97 50.13 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.728 1.211 . . . . 61.34 112.851 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.597 HD21 HG11 ' C' ' 64' ' ' VAL . 17.4 tp -135.14 102.48 5.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.929 -1.137 . . . . 73.04 107.929 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -123.42 126.81 47.46 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.105 0.562 . . . . 45.21 110.221 -175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mp -77.01 117.11 18.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.312 0.645 . . . . 71.52 109.379 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.79 162.36 58.82 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.507 1.123 . . . . 75.12 111.506 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.561 ' HG3' HD12 ' A' ' 16' ' ' ILE . 51.2 Cg_exo -55.19 103.61 0.11 Allowed 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.407 2.071 . . . . 45.13 112.152 169.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 89.0 t -97.99 113.24 32.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.57 0.748 . . . . 75.35 109.533 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -90.68 59.81 4.32 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.669 0.747 . . . . 63.03 110.025 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.484 ' HD1' ' H ' ' C' ' 133' ' ' PHE . 1.2 p90 -78.44 -14.21 59.48 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.214 -0.903 . . . . 64.41 110.066 175.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -75.47 -49.04 20.03 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.642 0.777 . . . . 71.45 109.818 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.66 74.17 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.524 -0.762 . . . . 73.32 110.622 174.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.17 -42.8 83.65 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.311 -0.859 . . . . 62.41 110.415 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 16.9 t80 . . . . . 0 N--CA 1.487 1.423 0 C-N-CA 122.488 0.315 . . . . 65.25 110.81 179.762 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 94.3 m . . . . . 0 C--O 1.24 0.559 0 N-CA-C 109.749 -0.463 . . . . 71.3 109.749 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.415 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 47.7 t80 -151.81 88.21 1.39 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.297 -1.372 . . . . 73.23 107.297 174.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -114.05 121.84 45.08 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.103 -1.073 . . . . 72.32 108.103 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.518 HD13 HG21 ' D' ' 105' ' ' ILE . 9.4 mt -86.98 128.47 39.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 116.213 -0.449 . . . . 65.12 110.117 -171.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -90.79 -39.74 12.2 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.437 0.695 . . . . 62.42 112.096 -173.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -175.08 122.19 0.22 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 112.219 0.452 . . . . 71.21 112.219 -167.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.804 HD13 ' HG2' ' B' ' 130' ' ' PRO . 1.5 mp -108.9 134.23 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.708 -0.849 . . . . 71.14 108.708 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.51 ' HE1' HG13 ' D' ' 83' ' ' ILE . 27.8 p90 -159.65 159.43 33.05 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 124.16 0.912 . . . . 74.35 110.487 -172.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -94.78 114.24 26.11 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.638 -0.71 . . . . 71.11 109.552 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.462 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 3.8 mtpp -77.84 -26.71 49.63 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.23 -0.656 . . . . 64.44 109.23 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -160.74 144.74 13.71 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.847 -1.069 . . . . 74.15 109.864 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.549 HG21 ' HE2' ' C' ' 117' ' ' MET . 68.0 mt -140.16 148.62 22.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 125.549 1.54 . . . . 55.43 107.388 174.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 26.9 t -156.08 119.44 4.3 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.226 0.61 . . . . 71.4 109.612 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.417 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.6 t80 -125.63 118.38 25.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.849 1.26 . . . . 74.31 107.879 173.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -124.16 135.96 53.86 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.124 -0.695 . . . . 74.12 109.124 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.48 86.36 39.21 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.442 -1.318 . . . . 63.54 107.442 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -66.61 -39.04 16.84 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.803 2.336 . . . . 62.42 113.115 -170.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 82.1 m-20 -101.3 17.33 22.86 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.869 0.868 . . . . 72.23 110.732 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.24 -70.81 0.12 Allowed Pre-proline 0 CA--C 1.562 1.424 0 N-CA-C 115.69 1.737 . . . . 61.43 115.69 -162.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.69 -18.79 14.96 Favored 'Trans proline' 0 C--N 1.382 2.328 0 CA-C-N 123.531 2.297 . . . . 60.44 113.198 -172.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.447 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 11.2 t-160 -68.1 -47.64 67.65 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.794 1.238 . . . . 73.21 109.347 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.6 p -83.17 -20.21 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.241 1.016 . . . . 63.2 111.838 -172.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -63.52 -32.19 73.57 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.175 0.512 . . . . 62.21 111.431 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -67.42 -10.48 51.75 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.969 -1.014 . . . . 71.32 111.544 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -96.17 84.74 3.84 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.119 0.967 . . . . 73.44 109.17 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.89 82.79 5.91 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.679 0.792 . . . . 64.32 109.866 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.4 t-105 -147.46 163.1 37.59 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.821 0.848 . . . . 74.43 109.665 -175.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.95 109.26 4.86 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.474 1.11 . . . . 75.05 110.438 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.39 144.04 25.44 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.795 2.33 . . . . 74.01 112.242 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -90.03 135.62 33.54 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.874 -0.787 . . . . 65.21 108.874 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.52 ' HB ' HG13 ' D' ' 64' ' ' VAL . 32.9 m -105.78 127.67 60.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 123.045 0.538 . . . . 75.34 109.555 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -87.42 114.03 23.66 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.923 -1.51 . . . . 61.41 106.923 172.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.472 ' O ' HD12 ' D' ' 42' ' ' LEU . 2.9 pp -94.75 117.81 30.73 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.011 0.91 . . . . 72.02 109.28 -174.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -122.96 112.54 17.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.726 -1.583 . . . . 73.41 106.726 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.93 152.34 22.09 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.159 0.584 . . . . 51.32 109.712 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.0 t70 -151.02 156.28 40.81 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.756 1.222 . . . . 74.24 108.367 174.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -138.95 156.71 47.03 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.372 0.669 . . . . 73.2 109.464 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.409 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.47 177.86 10.78 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.283 0.633 . . . . 72.21 110.282 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.6 p -163.19 164.82 25.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.485 0.714 . . . . 53.22 111.2 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 91.1 p -156.36 132.71 10.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.402 1.081 . . . . 54.32 108.744 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -86.37 117.99 25.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.404 -0.591 . . . . 62.4 109.404 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.08 -25.42 16.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.084 0.554 . . . . 72.32 110.629 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.49 -178.68 5.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.392 1.077 . . . . 50.41 109.496 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.49 137.05 49.92 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.88 -0.785 . . . . 73.42 108.88 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 61.2 10.8 3.16 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.095 0.958 . . . . 72.23 112.772 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -123.78 124.79 70.03 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 C-N-CA 124.63 1.172 . . . . 61.23 108.47 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.576 ' HD2' HD11 ' D' ' 86' ' ' ILE . 8.1 m-85 -128.29 158.59 37.76 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.399 -0.963 . . . . 75.43 108.399 171.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -125.9 128.04 46.95 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 105.729 -1.952 . . . . 72.55 105.729 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.45 141.23 31.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.598 -0.89 . . . . 65.11 108.598 -174.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 48.2 t -121.3 134.04 65.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 O-C-N 123.852 0.72 . . . . 64.23 109.136 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -117.49 121.89 42.23 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.18 -1.415 . . . . 74.35 107.18 174.139 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 15.7 ttm-85 -105.6 102.65 12.1 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.765 -0.828 . . . . 73.04 108.765 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 71.9 t -99.76 113.39 34.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.549 -0.908 . . . . 63.14 108.549 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 11.8 m -114.61 134.36 55.11 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.263 0.625 . . . . 73.03 109.377 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 78.8 t -131.67 102.44 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.344 1.457 . . . . 72.51 108.623 -171.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 96.5 m -103.36 95.8 6.33 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.323 -0.991 . . . . 74.23 108.323 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.56 159.94 14.62 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.059 0.456 . . . . 63.13 111.843 -172.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 53.3 p -145.47 142.93 29.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.135 -0.939 . . . . 72.12 110.912 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 mt -113.09 114.59 27.06 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.597 1.159 . . . . 64.41 108.711 169.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.96 -112.39 4.55 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.672 0.608 . . . . 61.24 112.857 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -106.94 3.75 26.49 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.289 0.636 . . . . 74.34 112.092 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -135.81 167.6 20.86 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.654 0.381 . . . . 74.43 110.677 -172.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.0 m -70.06 132.18 45.47 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.608 -0.724 . . . . 74.2 110.942 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.579 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -90.32 -76.46 0.43 Allowed 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.913 -1.143 . . . . 63.34 107.913 174.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -142.22 136.84 30.28 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 121.242 0.544 . . . . 62.41 111.641 -176.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 63.3 mt -104.34 140.29 38.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.124 1.369 . . . . 71.52 107.63 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.679 ' SG ' HG12 ' D' ' 114' ' ' ILE . 50.5 t -154.15 143.09 21.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.038 0.535 . . . . 43.43 109.615 -175.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -155.89 131.84 9.91 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.262 -1.014 . . . . 74.34 108.262 172.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.0 t -131.94 114.78 25.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.248 -0.649 . . . . 73.15 109.248 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -88.17 82.48 7.12 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.094 -1.076 . . . . 64.35 108.094 169.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -79.86 96.43 6.34 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.694 -1.594 . . . . 71.14 108.744 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.11 164.24 25.92 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.132 -0.486 . . . . 55.35 112.075 177.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.2 135.06 3.71 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 112.562 -0.215 . . . . 64.12 112.562 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.51 HG13 ' HE1' ' D' ' 17' ' ' TYR . 45.3 mt -89.79 129.66 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.343 1.057 . . . . 72.43 108.875 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -129.84 147.21 51.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.395 1.078 . . . . 75.4 110.321 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.1 m -108.01 109.78 21.33 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.555 -0.906 . . . . 74.22 108.555 171.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.576 HD11 ' HD2' ' D' ' 56' ' ' TYR . 19.2 pt -115.94 136.64 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.529 0.732 . . . . 71.52 110.942 -173.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -154.54 159.54 40.99 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.195 0.998 . . . . 75.34 109.115 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.01 -12.37 30.78 Favored Glycine 0 N--CA 1.478 1.457 0 N-CA-C 114.257 0.463 . . . . 75.14 114.257 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.6 pt -123.09 142.1 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.424 1.089 . . . . 74.41 109.165 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 6.3 pt-20 -165.83 164.55 18.66 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.506 0.722 . . . . 74.51 110.781 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.89 -114.72 7.11 Favored Glycine 0 C--N 1.354 1.56 0 O-C-N 123.851 0.719 . . . . 75.4 112.254 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.9 m -67.85 -37.79 82.3 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.492 0.717 . . . . 73.34 110.421 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -70.22 -28.78 65.54 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.602 0.761 . . . . 64.51 112.572 -177.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.51 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 18.5 tmm? -83.54 -32.03 26.08 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.25 -0.278 . . . . 73.04 110.25 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 -33.92 76.92 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.276 0.56 . . . . 71.42 110.379 169.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.429 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.1 t-80 -73.58 -20.28 60.66 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.994 1.317 . . . . 74.12 111.14 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -88.01 -53.83 4.54 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.435 0.294 . . . . 64.33 110.712 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.444 HD22 ' SD ' ' D' ' 94' ' ' MET . 9.8 mp -74.57 -32.92 62.55 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.659 0.783 . . . . 73.22 111.77 -173.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.19 14.54 61.13 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 119.072 -0.849 . . . . 74.44 113.311 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -157.58 -69.66 0.1 Allowed 'General case' 0 C--N 1.356 0.871 0 CA-C-N 118.212 1.006 . . . . 65.11 112.846 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -68.14 -39.61 82.62 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.818 0.447 . . . . 65.53 112.057 -171.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.415 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 74.8 m -69.5 -46.3 26.73 Favored Pre-proline 0 CA--C 1.557 1.242 0 CA-C-O 118.372 -0.823 . . . . 73.52 111.516 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.463 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 97.9 Cg_exo -51.29 -36.97 58.94 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 122.314 2.01 . . . . 75.22 113.373 165.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -65.83 -29.81 70.33 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.025 0.53 . . . . 64.54 111.792 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.518 HG21 HD13 ' D' ' 13' ' ' ILE . 46.2 mm -68.96 -44.81 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.521 -0.548 . . . . 73.33 109.521 171.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -77.05 -14.98 59.75 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.99 -1.005 . . . . 72.05 112.021 -173.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -73.73 -40.1 4.94 Favored Pre-proline 0 CA--C 1.561 1.395 0 N-CA-C 113.924 1.083 . . . . 61.45 113.924 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.7 -39.35 88.38 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 121.742 1.628 . . . . 73.24 112.782 169.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -72.67 -35.33 67.68 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.612 0.765 . . . . 73.31 110.985 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.1 -51.46 67.81 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.657 -0.701 . . . . 73.42 109.359 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 29.7 ttp-105 -54.34 -50.24 67.87 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.794 1.309 . . . . 53.51 110.874 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -64.11 -46.04 85.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.861 0.865 . . . . 71.45 111.898 -173.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.7 t -59.47 -40.42 86.86 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.994 0.809 . . . . 54.32 110.507 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.679 HG12 ' SG ' ' D' ' 76' ' ' CYS . 95.4 mt -63.01 -56.06 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.111 0.964 . . . . 61.21 110.35 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -55.36 -37.01 66.95 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.574 1.15 . . . . 64.11 111.376 -174.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.4 t -68.73 -46.23 69.43 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.009 -0.996 . . . . 61.24 110.144 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.8 mtm -68.21 -29.24 68.03 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.783 0.433 . . . . 62.41 111.897 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' D' ' 123' ' ' PHE . 54.7 t -68.7 -41.75 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.788 0.835 . . . . 63.54 110.266 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.6 p -74.88 -32.11 61.77 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.615 0.366 . . . . 63.12 110.909 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -70.43 -34.8 72.88 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.469 0.708 . . . . 63.42 109.82 174.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.51 5.61 82.89 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 115.345 -0.843 . . . . 54.32 112.537 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 26.6 p 63.04 16.32 9.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.407 1.883 . . . . 63.0 114.84 171.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.426 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.8 m-85 -80.71 153.82 73.22 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.462 0.705 . . . . 51.35 109.292 170.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.02 141.83 94.08 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.73 2.287 . . . . 62.04 113.083 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.76 134.92 47.85 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.865 1.266 . . . . 74.24 112.555 -174.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -110.01 107.13 16.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.109 -1.071 . . . . 42.03 108.109 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -99.22 89.06 4.1 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.911 -0.774 . . . . 72.44 108.911 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.49 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 44.0 tp -70.53 115.83 10.15 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.936 -1.029 . . . . 75.11 109.787 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.96 133.44 87.14 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 123.459 0.704 . . . . 70.4 111.396 -176.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 16.7 Cg_exo -66.71 113.35 2.71 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.626 2.217 . . . . 63.43 111.161 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 61.1 t -106.43 128.11 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.532 0.733 . . . . 71.23 109.045 -175.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -78.29 98.23 5.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.529 0.732 . . . . 73.42 109.713 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -63.46 -22.42 66.88 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.169 0.588 . . . . 72.4 111.855 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -61.87 -48.56 79.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.321 0.648 . . . . 63.11 111.689 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.41 -45.77 89.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.551 0.74 . . . . 72.4 111.702 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.49 -31.8 72.19 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.934 -0.575 . . . . 74.25 111.128 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 89.4 t80 . . . . . 0 N--CA 1.485 1.3 0 C-N-CA 123.248 0.619 . . . . 75.21 110.179 176.311 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 110.104 -0.332 . . . . 74.12 110.104 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m -70.31 86.47 0.6 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.515 0.726 . . . . 73.44 110.45 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.74 115.72 28.97 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.495 -1.298 . . . . 74.53 107.495 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -124.76 13.75 8.61 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.141 0.576 . . . . 74.31 112.199 -167.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -151.45 -84.82 0.08 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.976 -0.379 . . . . 61.31 109.976 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 171.63 108.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.376 1.47 . . . . 54.23 107.056 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -66.14 128.68 37.04 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 108.996 -0.742 . . . . 65.51 108.996 170.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -88.52 158.44 18.31 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.178 0.591 . . . . 65.15 110.433 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 15.5 ptp -49.59 133.94 20.3 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 124.416 1.086 . . . . 53.13 113.061 -176.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.8 m -152.67 138.64 18.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.142 1.377 . . . . 72.31 108.252 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.612 ' HA ' HG22 ' A' ' 86' ' ' ILE . 72.8 t80 -130.41 114.13 15.19 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.695 -1.224 . . . . 74.22 107.695 170.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -134.18 134.58 42.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.418 -0.956 . . . . 71.52 108.418 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.429 ' CD1' HG21 ' A' ' 105' ' ' ILE . 14.6 mt -84.99 112.32 21.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 108.485 -0.932 . . . . 73.54 108.485 174.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.27 -39.77 65.13 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.515 -0.92 . . . . 63.54 108.515 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -172.17 148.28 2.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 116.591 -0.277 . . . . 55.43 110.622 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.7 mt -132.16 129.06 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.101 -1.074 . . . . 73.41 108.101 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.437 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 33.1 p90 -168.37 147.99 4.57 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 124.209 0.943 . . . . 73.21 110.562 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -75.68 112.53 12.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.865 -1.061 . . . . 33.05 109.121 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 37.7 mtpt -82.08 -27.51 32.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.955 0.407 . . . . 71.13 109.951 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.642 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 19.5 t70 -143.7 140.02 29.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.008 -0.997 . . . . 70.04 109.885 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.4 mt -137.15 140.91 41.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 107.204 -1.406 . . . . 70.34 107.204 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -147.77 134.5 19.99 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.78 -0.822 . . . . 70.14 108.78 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.575 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 55.2 t80 -140.09 121.6 15.15 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.834 -1.173 . . . . 73.42 107.834 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.98 110.2 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.809 -0.811 . . . . 53.44 108.809 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.726 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -126.05 76.14 71.85 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 107.246 -1.391 . . . . 72.33 107.246 170.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.42 -30.87 7.79 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.33 2.02 . . . . 70.15 110.697 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 72' ' ' THR . 16.4 m120 -101.16 19.57 17.32 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.216 1.006 . . . . 71.3 110.112 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.726 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -52.98 -48.26 92.44 Favored Pre-proline 0 CA--C 1.571 1.762 0 C-N-CA 123.694 0.798 . . . . 54.22 111.87 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.36 -17.38 16.71 Favored 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 121.88 1.72 . . . . 72.32 113.609 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -69.99 -49.21 53.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.974 0.509 . . . . 72.25 109.771 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.66 HG21 ' HA ' ' A' ' 73' ' ' ALA . 42.7 t -72.55 -20.18 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.861 0.864 . . . . 73.21 111.21 -175.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.406 ' HB2' ' NH1' ' B' ' 15' ' ' ARG . 81.3 t80 -60.21 -34.4 73.59 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.367 0.667 . . . . 73.03 110.447 168.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -94.18 -24.39 17.53 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.362 1.065 . . . . 72.34 110.977 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 32.9 mmtp -75.89 170.89 15.37 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.486 0.714 . . . . 71.31 110.304 172.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -81.31 138.43 35.7 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.973 -1.121 . . . . 54.32 107.973 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 41.5 t-105 -76.43 83.76 3.16 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.709 0.766 . . . . 75.3 110.443 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -129.82 77.63 76.5 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.863 1.265 . . . . 70.01 108.751 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 39.1 Cg_endo -93.03 146.38 2.42 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.55 2.167 . . . . 62.44 113.074 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 28.1 tt0 -97.87 95.73 7.72 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.766 -0.827 . . . . 72.42 108.766 172.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.36 91.21 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.499 0.666 . . . . 62.12 109.747 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -101.18 128.92 47.06 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.088 -0.708 . . . . 71.33 109.088 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.476 HD11 HG13 ' A' ' 62' ' ' VAL . 45.6 tp -98.2 146.6 25.45 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.707 -0.849 . . . . 45.14 108.707 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.653 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.4 m-20 -134.46 109.35 8.68 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.269 -1.382 . . . . 73.32 107.269 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -96.99 120.37 37.21 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.847 -0.427 . . . . 75.35 109.847 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -128.37 143.97 51.07 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.991 -1.115 . . . . 53.14 107.991 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.1 m -133.44 142.22 48.21 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.104 0.562 . . . . 64.33 110.085 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -130.36 152.93 49.23 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.809 1.244 . . . . 53.03 109.217 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.3 t -127.49 151.61 48.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.622 0.769 . . . . 54.55 109.744 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.7 t -153.31 128.3 9.63 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.576 0.75 . . . . 64.24 110.176 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -101.38 108.01 19.5 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.139 -0.689 . . . . 75.43 109.139 174.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.464 HD12 HG23 ' A' ' 83' ' ' ILE . 79.2 mt -88.43 -35.25 17.18 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.931 0.492 . . . . 64.04 110.696 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -159.62 -179.64 8.07 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 124.029 0.831 . . . . 41.44 110.461 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -67.41 116.65 8.4 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.721 -1.127 . . . . 73.35 109.136 171.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.722 ' HA ' HG12 ' E' ' 451' ' ' VAL . 3.5 m-20 67.54 11.21 8.26 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.728 1.211 . . . . 71.11 113.157 -177.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 62.1 t -115.54 111.6 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.376 -1.342 . . . . 61.01 107.376 171.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.43 ' CD2' HG12 ' E' ' 452' ' ' VAL . 1.6 t80 -130.78 141.93 50.38 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.894 -0.78 . . . . 72.1 108.894 -171.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -123.13 134.32 54.21 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.135 0.974 . . . . 73.03 109.213 -173.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.74 131.04 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 108.015 -1.106 . . . . 62.2 108.015 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 46.8 t -116.06 110.15 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.867 -0.79 . . . . 62.24 108.867 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.1 tp -90.26 105.71 17.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.487 -0.56 . . . . 75.24 109.487 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.451 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 51.8 ttt180 -85.07 101.69 12.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.504 0.722 . . . . 63.1 109.298 173.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.476 HG13 HD11 ' A' ' 42' ' ' LEU . 48.4 t -95.37 102.09 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.097 -1.075 . . . . 51.43 108.097 175.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.653 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 56.4 m -96.98 110.31 22.88 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.513 0.725 . . . . 63.43 109.051 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.615 HG21 HG21 ' A' ' 114' ' ' ILE . 41.9 t -102.92 137.28 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.392 -0.966 . . . . 72.05 108.392 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 t -143.09 150.5 39.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.863 -0.421 . . . . 73.33 109.863 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -138.67 109.61 6.75 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.823 -1.177 . . . . 71.1 107.823 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.8 p -135.04 127.04 29.65 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.416 0.687 . . . . 74.31 110.188 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.23 78.67 6.51 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.24 -1.393 . . . . 64.23 107.24 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.55 -91.42 0.66 Allowed Glycine 0 C--N 1.349 1.25 0 CA-C-N 115.142 -0.935 . . . . 73.11 112.783 173.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -91.91 -26.53 18.4 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.914 0.886 . . . . 71.02 111.823 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -113.55 129.92 56.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.721 0.408 . . . . 72.34 110.955 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 59.0 m -88.65 124.81 34.45 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.487 0.715 . . . . 64.3 110.289 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.66 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -70.59 -56.58 6.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.883 0.873 . . . . 75.45 110.071 175.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -155.83 158.77 38.64 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.617 -1.174 . . . . 73.35 111.128 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 tp -134.29 124.51 25.99 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.369 1.468 . . . . 75.44 107.217 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.441 ' SG ' HG12 ' A' ' 118' ' ' VAL . 61.6 m -132.22 99.96 4.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.111 0.964 . . . . 55.41 109.005 -174.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -123.68 127.39 48.13 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.527 0.731 . . . . 53.22 109.704 -171.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.2 t -135.63 113.85 15.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 123.445 0.698 . . . . 72.23 109.764 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.642 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.7 mt-30 -84.18 83.91 7.8 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.304 -0.998 . . . . 70.44 108.304 169.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -76.84 97.59 4.59 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.524 -1.216 . . . . 71.43 108.844 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.49 150.24 23.3 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.664 -0.574 . . . . 33.33 111.664 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.542 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -143.89 122.49 1.84 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.905 -0.878 . . . . 64.22 110.905 173.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.464 HG23 HD12 ' A' ' 51' ' ' LEU . 35.7 mt -82.02 130.52 35.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.801 -1.185 . . . . 74.14 107.801 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -127.67 122.64 33.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.85 -0.796 . . . . 64.41 108.85 -176.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -89.44 91.62 8.79 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.453 -0.943 . . . . 74.32 108.453 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.612 HG22 ' HA ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -126.74 155.62 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.175 0.59 . . . . 73.41 110.186 -175.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' MET . . . -169.56 170.72 8.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.156 0.982 . . . . 70.41 109.509 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.5 -32.34 6.08 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 123.675 0.61 . . . . 70.14 113.336 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.58 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.44 156.62 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.86 0.864 . . . . 74.05 109.748 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -163.35 177.39 8.98 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.456 0.702 . . . . 71.12 109.403 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.66 -130.51 23.07 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 114.097 0.399 . . . . 62.13 114.097 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.0 p -76.44 -35.57 58.43 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.56 1.144 . . . . 71.2 111.577 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -59.87 -43.92 94.46 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.963 0.905 . . . . 73.21 110.111 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.519 ' SD ' HG22 ' E' ' 451' ' ' VAL . 65.6 ttp -72.48 -36.01 68.32 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.005 -0.998 . . . . 63.52 110.848 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.23 -29.67 68.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.037 0.535 . . . . 55.21 110.883 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -69.15 -46.46 67.55 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.016 0.527 . . . . 64.25 110.94 168.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.5 m -59.98 -65.15 0.73 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 122.321 0.248 . . . . 60.24 110.824 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 94' ' ' MET . 2.0 pp -73.5 -21.64 60.35 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.028 0.751 . . . . 74.14 113.028 -176.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.419 ' N ' HD12 ' A' ' 98' ' ' LEU . . . -101.56 -4.53 52.47 Favored Glycine 0 N--CA 1.475 1.268 0 CA-C-O 119.599 -0.556 . . . . 63.41 113.577 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.32 -60.75 0.42 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.239 0.519 . . . . 41.25 111.612 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.58 -45.57 65.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.018 0.527 . . . . 74.45 111.991 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.3 m -67.76 -45.74 44.55 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.122 0.969 . . . . 73.22 111.943 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.95 -26.55 58.8 Favored 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 121.549 1.499 . . . . 74.24 112.576 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -70.09 -30.42 67.64 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.771 0.428 . . . . 73.34 110.307 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.429 HG21 ' CD1' ' A' ' 13' ' ' ILE . 41.7 mm -67.53 -41.43 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.79 0.836 . . . . 74.02 109.988 171.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.542 HD21 ' HA3' ' A' ' 82' ' ' GLY . 69.9 mt -74.99 -22.13 58.72 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.302 -0.863 . . . . 71.51 111.453 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -63.34 -43.49 79.85 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 117.464 -1.255 . . . . 72.13 114.233 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.1 -40.41 77.25 Favored 'Trans proline' 0 C--N 1.387 2.56 0 CA-C-N 122.093 1.783 . . . . 64.54 112.765 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -66.02 -44.64 84.13 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.453 0.701 . . . . 74.31 111.463 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.83 84.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.178 0.591 . . . . 73.41 110.711 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.414 ' NH1' HD12 ' C' ' 105' ' ' ILE . 26.8 ttm180 -50.79 -54.62 22.07 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.552 1.158 . . . . 72.21 109.76 174.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -67.01 -38.99 86.95 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.402 1.064 . . . . 53.05 111.833 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.561 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.2 t -62.06 -27.8 69.15 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.015 0.526 . . . . 72.4 111.019 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.615 HG21 HG21 ' A' ' 64' ' ' VAL . 97.5 mt -87.52 -41.09 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.227 1.411 . . . . 64.11 111.027 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 49.3 m -64.46 -44.48 90.95 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.482 0.713 . . . . 72.43 110.508 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.8 t -65.77 -40.89 92.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.794 -1.093 . . . . 51.24 109.93 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.575 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.7 ttm -59.58 -47.17 86.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.366 1.066 . . . . 63.02 111.903 -177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.441 HG12 ' SG ' ' A' ' 76' ' ' CYS . 20.5 m -66.02 -39.45 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.251 0.345 . . . . 61.43 110.317 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.0 m -67.45 -32.57 73.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.42 0.688 . . . . 73.01 111.362 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.622 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 86.5 mtt-85 -71.47 -31.5 67.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.518 0.727 . . . . 74.12 110.018 174.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.54 3.56 86.26 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.614 -0.721 . . . . 63.44 113.519 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.0 m 62.28 47.27 5.5 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 123.545 1.64 . . . . 73.34 110.797 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -116.75 137.64 23.89 Favored Pre-proline 0 C--O 1.246 0.92 0 CA-C-N 114.055 -1.429 . . . . 74.35 107.18 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.55 144.28 10.67 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.283 2.656 . . . . 73.33 113.705 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -55.98 132.38 49.76 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 124.357 1.036 . . . . 54.05 112.403 -173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 tp -118.97 100.69 7.52 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.143 -0.935 . . . . 72.12 109.68 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -98.03 107.3 19.74 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.839 -1.171 . . . . 74.44 107.839 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.46 139.31 58.76 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.169 0.587 . . . . 63.41 109.73 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.18 145.57 98.03 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 122.886 0.474 . . . . 52.35 110.673 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.406 ' HG3' ' HD2' ' C' ' 11' ' ' PHE . 37.0 Cg_endo -62.84 107.84 0.67 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.083 1.855 . . . . 64.2 111.269 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 89.9 t -98.99 113.76 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.488 -0.93 . . . . 54.24 108.488 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -84.21 89.02 7.25 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.236 -1.024 . . . . 73.21 108.236 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -59.9 -29.67 68.5 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.645 0.778 . . . . 75.51 111.52 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' C' ' 147' ' ' GLU . 5.2 m-20 -69.17 -44.39 72.31 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.699 1.2 . . . . 73.23 110.681 -177.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.12 -45.36 92.38 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.992 0.808 . . . . 70.55 110.181 175.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.86 -37.04 80.74 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.164 -0.926 . . . . 73.11 111.212 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -68.86 -34.52 75.59 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.326 -0.852 . . . . 75.44 109.941 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.6 mmt -61.89 -35.46 78.42 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.679 0.612 . . . . 71.53 111.124 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.542 ' HA ' ' H ' ' A' ' 144' ' ' GLN . 29.5 m120 -66.29 -40.25 89.93 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.943 -0.571 . . . . 74.31 110.888 176.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -73.54 -31.63 63.76 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.181 0.592 . . . . 72.11 111.113 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.45 HD21 ' O ' ' C' ' 150' ' ' GLU . 24.8 tp -66.89 -49.45 65.58 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.892 1.277 . . . . 74.52 111.006 -171.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -172.14 30.75 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 108.91 -0.774 . . . . 74.44 108.91 -174.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 59.81 78.75 0.26 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.441 0.697 . . . . 72.13 110.184 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.542 ' H ' ' HA ' ' A' ' 139' ' ' ASN . 91.2 mt-30 76.1 -43.77 0.48 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.573 1.549 . . . . 72.32 111.689 -176.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 67.56 -77.48 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.382 1.473 . . . . 53.15 111.344 172.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.72 -93.97 0.66 Allowed Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.34 -1.104 . . . . 73.43 110.34 173.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.429 ' H ' ' HA3' ' C' ' 148' ' ' GLY . 6.8 tp10 66.55 157.79 0.12 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.727 1.611 . . . . 74.22 112.059 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.34 32.53 62.37 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.247 -0.433 . . . . 32.54 112.487 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.1 t -84.0 10.33 10.18 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.92 0.888 . . . . 65.1 111.22 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.555 ' HA ' ' HB3' ' C' ' 145' ' ' ALA . 0.2 OUTLIER -63.13 92.24 0.05 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.038 0.935 . . . . 73.33 109.449 -177.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -56.94 -39.33 74.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.113 1.365 . . . . 73.23 111.272 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 62.55 82.51 0.18 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.603 1.189 . . . . 73.23 111.506 173.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -127.77 123.5 35.45 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.278 -1.008 . . . . 73.24 108.278 170.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.678 ' HA ' ' HA ' ' C' ' 142' ' ' GLN . 7.8 p-10 -75.64 165.6 24.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.11 0.564 . . . . 74.22 110.488 176.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 N-CA-C 108.427 -0.953 . . . . 72.34 108.427 173.914 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.418 -0.216 . . . . 74.24 110.418 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 24.7 m -74.66 83.03 2.07 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.534 0.733 . . . . 54.54 110.48 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -96.08 60.58 2.04 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.572 0.701 . . . . 62.2 109.685 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -130.24 135.49 48.18 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.942 -1.026 . . . . 72.14 108.306 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -130.77 -171.82 2.66 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.584 0.754 . . . . 63.01 110.248 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 37.3 t30 65.08 106.38 0.03 OUTLIER 'General case' 0 C--N 1.362 1.122 0 C-N-CA 124.61 1.164 . . . . 75.43 110.628 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 37.8 p -77.68 76.84 4.21 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.681 0.753 . . . . 62.54 110.631 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -99.76 -71.56 0.69 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.909 -1.515 . . . . 72.44 106.909 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 7.9 ptm 47.45 167.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 127.804 2.441 . . . . 72.02 114.398 -172.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 60.5 m -165.09 134.37 3.51 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.382 -0.599 . . . . 73.43 109.382 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.37 156.75 42.54 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.479 0.657 . . . . 72.51 110.039 155.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -126.31 135.15 51.15 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.639 -1.245 . . . . 52.13 107.639 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.459 HD13 HD11 ' B' ' 16' ' ' ILE . 51.0 mt -68.63 116.08 8.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.319 -0.993 . . . . 75.11 108.319 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -86.87 -36.41 18.44 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.235 -0.893 . . . . 71.42 109.45 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.406 ' NH1' ' HB2' ' A' ' 32' ' ' PHE . 75.2 ttt180 -167.33 133.71 2.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.894 -1.048 . . . . 62.33 109.715 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.489 ' H ' ' ND2' ' D' ' 127' ' ' ASN . 88.8 mt -115.61 135.08 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 105.809 -1.923 . . . . 73.22 105.809 166.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.402 ' HE1' HG13 ' B' ' 83' ' ' ILE . 10.0 p90 -168.4 151.04 5.32 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.213 0.53 . . . . 75.11 111.059 -174.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.669 HG21 HD11 ' B' ' 21' ' ' ILE . 17.8 m -82.62 129.84 35.01 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.942 -0.762 . . . . 75.33 108.942 175.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -97.89 -30.56 12.67 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.354 0.662 . . . . 72.51 110.721 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 11.8 t70 -145.09 139.11 27.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.428 -0.351 . . . . 72.24 110.232 -175.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.669 HD11 HG21 ' B' ' 18' ' ' THR . 33.3 mm -131.17 139.53 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 106.768 -1.568 . . . . 74.33 106.768 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.8 t -147.6 138.25 23.29 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.32 -0.993 . . . . 52.11 108.32 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.0 t80 -154.71 110.38 3.15 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.662 -1.236 . . . . 72.44 107.662 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -117.95 114.42 23.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.627 1.171 . . . . 72.21 108.09 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.727 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -111.82 83.78 4.93 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.348 -0.982 . . . . 72.43 108.348 175.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.97 -34.26 6.69 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.775 2.316 . . . . 64.01 112.94 -170.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -98.14 -2.61 39.59 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.921 0.888 . . . . 54.15 111.426 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.727 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -35.83 -63.02 0.43 Allowed Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 125.867 1.667 . . . . 61.54 114.803 -165.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 37.9 Cg_exo -54.97 -31.02 72.24 Favored 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 122.775 2.316 . . . . 75.0 113.794 -173.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -96.78 -34.49 11.3 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.692 -1.14 . . . . 74.51 111.404 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.592 HG22 HD12 ' B' ' 68' ' ' LEU . 5.6 p -74.45 -18.63 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 122.336 0.254 . . . . 75.32 111.672 -171.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.95 -15.49 62.24 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.619 0.768 . . . . 72.2 112.855 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -57.25 -29.98 64.26 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.425 0.69 . . . . 73.03 110.473 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -95.38 98.66 10.73 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 124.623 1.169 . . . . 74.23 109.025 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -83.36 92.92 7.64 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.41 0.684 . . . . 74.15 109.725 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -162.94 156.26 19.71 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.762 0.825 . . . . 75.03 109.347 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.449 ' HB3' HD22 ' F' ' 470' ' ' LEU . 17.7 mm-40 -67.05 105.44 0.85 Allowed Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 124.524 1.13 . . . . 74.45 110.676 170.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.523 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 40.3 Cg_endo -67.37 137.58 43.71 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.597 2.198 . . . . 62.53 112.115 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 11.9 tp10 -59.23 121.46 11.43 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 124.187 0.929 . . . . 72.22 112.099 -169.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.661 HG23 HD11 ' F' ' 470' ' ' LEU . 73.2 t -85.94 132.47 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.968 0.907 . . . . 73.1 110.23 -172.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.563 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 12.9 tmtt? -131.9 117.29 18.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.275 -1.75 . . . . 74.13 106.275 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.463 HD22 HD11 ' B' ' 128' ' ' LEU . 40.4 tp -93.98 150.56 20.25 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.154 0.502 . . . . 73.24 111.188 -172.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.722 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.8 m-20 -140.59 143.64 35.39 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.694 -1.225 . . . . 63.55 107.694 171.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.503 HD12 ' HG ' ' F' ' 460' ' ' LEU . 0.4 OUTLIER -143.0 125.94 16.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.926 -1.139 . . . . 73.13 107.926 -177.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 12.2 m-20 -127.04 150.42 49.45 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.026 -1.102 . . . . 63.0 108.026 171.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.0 p -135.72 124.46 23.87 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.943 0.401 . . . . 72.3 110.817 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.19 164.08 16.77 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.542 1.537 . . . . 74.5 109.493 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 22.2 p -145.07 168.67 19.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.482 1.113 . . . . 70.53 109.104 170.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 97.4 p -151.23 168.47 24.63 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.156 0.582 . . . . 75.42 109.815 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -116.53 110.2 18.26 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.731 -1.211 . . . . 64.14 107.731 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 24.6 mt -88.02 -55.51 3.72 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.1 0.953 . . . . 73.2 108.777 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.67 -179.32 5.85 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 113.431 -1.713 . . . . 42.31 108.053 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.32 130.36 40.58 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 116.158 -0.474 . . . . 73.02 110.627 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 67.03 -1.19 1.48 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.969 1.708 . . . . 64.23 112.724 -172.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.2 t -103.61 104.11 16.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 108.074 -1.084 . . . . 74.31 108.074 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.657 ' HH ' ' N ' ' F' ' 450' ' ' ASN . 16.7 m-85 -114.19 140.45 48.53 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.026 -1.101 . . . . 71.42 108.026 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -119.87 104.67 10.39 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.212 -1.033 . . . . 71.42 108.212 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 72.3 t -89.08 140.09 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.358 0.663 . . . . 62.42 110.589 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.464 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 38.0 t -118.28 118.9 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.797 0.839 . . . . 75.15 109.403 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.5 OUTLIER -93.82 122.98 36.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.203 -1.406 . . . . 73.44 107.203 174.264 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 46.8 ttt180 -110.27 122.14 46.96 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.403 0.681 . . . . 72.11 109.486 175.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 13.6 t -117.62 131.36 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 107.67 -1.233 . . . . 72.54 107.67 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.722 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.1 m -127.07 130.28 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.758 -0.83 . . . . 74.52 108.758 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.33 116.39 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.844 -0.799 . . . . 73.24 108.844 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 89.2 m -99.05 138.46 36.13 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.917 -1.142 . . . . 70.12 107.917 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.17 147.36 30.42 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 122.437 0.295 . . . . 71.31 110.593 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 54.9 p -151.66 135.74 16.6 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 124.125 0.891 . . . . 72.45 111.383 -174.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.592 HD12 HG22 ' B' ' 31' ' ' VAL . 56.1 mt -95.45 110.44 22.49 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.947 0.899 . . . . 62.33 109.477 174.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.43 -111.12 3.43 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.581 -1.19 . . . . 73.13 111.764 -169.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -119.06 2.57 11.47 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.802 0.841 . . . . 73.22 110.905 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -112.66 148.96 33.56 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.888 -0.782 . . . . 75.23 108.888 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.6 m -61.6 140.42 58.14 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.55 0.531 . . . . 53.11 110.874 -176.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.76 -67.14 0.86 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.676 -1.231 . . . . 63.12 107.676 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -148.1 158.07 43.86 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.969 -1.014 . . . . 64.5 109.862 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 41.7 mt -132.6 109.42 9.73 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 106.365 -1.717 . . . . 61.31 106.365 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 39.3 t -120.77 117.04 26.41 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.27 0.487 . . . . 50.14 110.05 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.4 tt0 -122.28 132.67 54.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.22 1.008 . . . . 65.11 108.736 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 75.5 t -128.48 147.64 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.111 -0.7 . . . . 74.01 109.111 173.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.534 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 80.2 mt-30 -125.36 102.99 7.68 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.094 -0.706 . . . . 62.53 109.094 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -90.44 104.78 17.32 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.658 -0.868 . . . . 64.25 108.658 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.59 171.11 37.62 Favored Glycine 0 C--O 1.243 0.68 0 N-CA-C 111.364 -0.694 . . . . 71.34 111.364 174.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.67 130.65 2.15 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 112.121 -0.392 . . . . 71.45 112.121 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.402 HG13 ' HE1' ' B' ' 17' ' ' TYR . 39.3 mt -89.89 127.47 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.334 0.653 . . . . 74.43 109.32 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -135.15 132.92 38.61 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.393 -1.336 . . . . 71.44 107.393 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m -101.62 90.97 4.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.705 0.402 . . . . 72.55 110.787 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.532 ' HB ' HD11 ' B' ' 89' ' ' ILE . 16.1 pt -96.25 145.25 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.494 0.718 . . . . 64.44 111.614 -167.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.77 157.16 32.85 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.279 1.031 . . . . 72.31 109.96 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.02 -39.31 2.94 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 123.378 0.513 . . . . 71.01 113.657 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.64 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -79.12 146.65 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.062 0.545 . . . . 65.4 111.237 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -162.95 162.62 26.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.046 0.841 . . . . 74.42 109.506 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.99 -118.13 9.28 Favored Glycine 0 N--CA 1.474 1.171 0 CA-C-N 115.976 -0.556 . . . . 44.12 113.553 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 99.5 m -69.63 -33.48 72.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.663 0.785 . . . . 72.11 110.708 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -66.74 -38.98 87.74 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.264 0.625 . . . . 62.31 111.466 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -32.92 60.49 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.357 0.263 . . . . 75.22 111.29 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.27 75.13 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.495 -0.775 . . . . 44.12 110.103 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -72.36 -34.85 68.29 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.034 0.933 . . . . 63.24 110.677 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -68.11 -67.5 0.46 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.498 0.499 . . . . 64.12 110.812 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.426 HD12 HD13 ' F' ' 454' ' ' LEU . 68.2 mt -81.84 -16.51 50.57 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 111.873 0.323 . . . . 61.34 111.873 -173.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.512 ' HA2' ' NE2' ' F' ' 457' ' ' GLN . . . -97.13 -9.69 55.49 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 114.57 0.588 . . . . 70.41 114.57 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.99 -56.3 0.25 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.382 0.591 . . . . 73.22 111.722 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -71.7 -48.53 46.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.709 0.804 . . . . 71.43 112.06 -169.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 98.6 m -61.27 -47.23 94.81 Favored Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 124.158 0.983 . . . . 63.23 111.777 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.421 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 76.1 Cg_exo -56.03 -41.17 79.75 Favored 'Trans proline' 0 C--N 1.395 3.0 0 C-N-CA 122.406 2.071 . . . . 70.32 113.587 167.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -62.73 -29.37 70.62 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.482 0.713 . . . . 74.22 111.914 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.52 HG23 ' NH2' ' D' ' 111' ' ' ARG . 77.7 mt -69.63 -41.65 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.85 0.86 . . . . 74.35 110.748 173.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.76 -19.52 57.52 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.981 -1.009 . . . . 62.12 112.255 -173.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -56.71 -48.58 96.99 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 114.872 1.434 . . . . 74.51 114.872 -170.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.77 -37.53 95.49 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.457 2.104 . . . . 72.11 113.828 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -71.25 -43.03 68.06 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.661 -0.699 . . . . 54.21 110.369 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -40.57 87.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.597 0.759 . . . . 74.33 110.776 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -60.53 -53.11 61.42 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.192 0.997 . . . . 45.33 111.212 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.23 -33.25 75.56 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.459 0.704 . . . . 61.31 110.397 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.622 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -67.89 -42.91 80.49 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.804 0.842 . . . . 74.14 111.658 177.389 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.63 -51.51 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.77 -0.456 . . . . 45.02 109.77 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.48 HG21 ' OG ' ' C' ' 119' ' ' SER . 19.8 m -60.13 -34.35 73.41 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.873 0.869 . . . . 32.23 111.646 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.4 t -60.34 -48.01 83.59 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.732 0.645 . . . . 54.21 110.075 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -74.77 -31.29 61.73 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.446 0.698 . . . . 63.52 111.524 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.08 -39.4 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.894 0.878 . . . . 64.04 110.559 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.407 ' OG ' HG21 ' C' ' 115' ' ' THR . 30.4 t -65.28 -40.64 94.13 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.84 0.856 . . . . 75.14 111.065 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.561 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 78.0 mtt-85 -66.24 -33.49 75.87 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 114.843 -1.071 . . . . 52.14 110.128 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.12 7.42 75.34 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-O 119.361 -0.688 . . . . 54.53 113.677 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.437 HG23 ' HB3' ' A' ' 17' ' ' TYR . 80.6 p 56.12 29.68 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.905 1.682 . . . . 73.23 113.537 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -93.24 154.76 41.47 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.025 0.93 . . . . 75.24 110.787 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.23 165.94 1.91 Allowed 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 123.909 3.073 . . . . 71.23 115.556 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -63.58 137.62 58.19 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.461 1.104 . . . . 73.31 113.191 -168.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.99 112.31 15.09 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 107.753 -1.202 . . . . 75.51 107.753 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -130.53 109.54 10.76 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.589 -0.893 . . . . 53.54 108.589 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.463 HD11 HD22 ' B' ' 42' ' ' LEU . 33.6 tp -82.87 137.41 34.28 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.637 0.375 . . . . 65.24 110.397 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.32 144.75 92.47 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.148 0.979 . . . . 63.43 111.415 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.449 ' HG3' HD13 ' D' ' 16' ' ' ILE . 33.3 Cg_endo -61.64 109.2 0.72 Allowed 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.897 2.398 . . . . 75.22 112.298 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -89.83 111.9 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.615 -0.884 . . . . 74.43 108.615 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -78.5 87.93 4.47 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.22 -1.03 . . . . 45.42 108.22 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -59.06 -36.72 75.53 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.519 0.727 . . . . 73.43 111.339 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.12 -40.85 95.07 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.581 1.152 . . . . 73.25 111.998 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.85 -47.27 66.37 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.738 0.815 . . . . 62.13 110.855 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.89 -20.75 59.59 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.535 -0.757 . . . . 73.02 110.873 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.441 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 94.4 t80 -66.9 -44.26 81.27 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.588 0.755 . . . . 74.52 110.112 173.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.75 -36.71 74.79 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.83 0.852 . . . . 73.33 110.633 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -76.61 -28.21 56.03 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.282 -0.872 . . . . 65.41 111.45 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -65.36 -33.9 77.05 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.999 0.92 . . . . 75.0 111.336 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 31.4 mt -76.21 -3.47 36.58 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.596 0.759 . . . . 72.12 111.48 -174.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -122.33 -37.2 2.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.388 1.075 . . . . 74.15 109.587 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 50.99 64.99 1.61 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.806 1.242 . . . . 74.04 110.425 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -166.58 161.73 16.14 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.757 -1.11 . . . . 51.55 110.212 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.26 151.36 36.81 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.452 0.701 . . . . 74.54 111.017 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.97 139.44 32.73 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 123.582 0.551 . . . . 54.12 113.202 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -97.76 107.57 20.09 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.785 -0.82 . . . . 74.41 108.785 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -144.78 37.79 1.33 Allowed Glycine 0 C--N 1.342 0.899 0 N-CA-C 111.471 -0.651 . . . . 75.2 111.471 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 28.0 m -58.17 106.21 0.35 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.428 1.091 . . . . 74.25 110.936 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.7 173.71 11.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.928 0.491 . . . . 72.34 110.424 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -132.14 85.12 2.21 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.732 0.777 . . . . 43.35 109.158 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -68.45 -46.43 69.86 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.434 -0.803 . . . . 71.13 109.754 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 50.5 80.33 0.08 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.024 1.33 . . . . 61.23 111.809 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -108.31 109.44 20.77 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.46 -1.246 . . . . 44.32 108.769 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.735 0 C-N-CA 123.537 0.735 . . . . 63.14 109.141 -177.968 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.921 0.391 . . . . 73.21 110.676 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 39.8 m -146.33 150.24 35.35 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.881 0.873 . . . . 74.14 109.365 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -78.6 88.47 4.52 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.684 0.793 . . . . 72.42 109.102 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -96.28 108.11 20.56 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.735 0.814 . . . . 72.25 111.272 -171.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 9.6 t30 57.33 92.52 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.42 1.488 . . . . 75.33 112.348 174.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -64.41 -36.13 83.16 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.068 0.947 . . . . 43.44 111.991 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 25.1 m -84.69 79.9 9.44 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.602 0.715 . . . . 75.32 110.795 -170.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -118.93 -31.79 4.66 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.289 1.035 . . . . 63.21 109.537 171.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.465 ' HG3' HD12 ' C' ' 89' ' ' ILE . 24.8 ttt 64.05 112.61 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.269 1.428 . . . . 74.4 111.948 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 36.4 m -88.07 91.15 8.66 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 108.613 -0.884 . . . . 72.42 108.613 174.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.406 ' HD2' ' HG3' ' A' ' 130' ' ' PRO . 60.2 t80 -115.57 126.48 54.28 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.801 -0.814 . . . . 75.53 108.801 176.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -140.68 125.45 18.11 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.875 -0.787 . . . . 71.14 108.875 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.418 ' HA ' ' HD2' ' C' ' 84' ' ' PHE . 56.1 mt -66.44 123.94 20.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.81 -0.811 . . . . 73.45 108.81 171.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -89.63 -48.74 7.09 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.157 -0.683 . . . . 71.32 109.157 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -174.33 125.89 0.33 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 115.565 -0.743 . . . . 74.13 110.404 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -109.46 143.22 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 107.919 -1.141 . . . . 63.12 107.919 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.432 ' HE1' HG12 ' C' ' 83' ' ' ILE . 25.1 p90 -176.25 169.58 2.73 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.406 0.622 . . . . 70.03 111.007 -173.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -93.02 114.59 27.18 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.318 -0.856 . . . . 61.14 109.533 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.633 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -68.34 -34.09 75.46 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.814 -0.81 . . . . 72.33 108.814 175.089 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -154.19 146.45 23.83 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.945 -1.479 . . . . 75.12 109.618 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.7 mt -140.61 144.37 27.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 125.607 1.563 . . . . 73.14 106.846 175.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -154.04 149.32 27.05 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.51 0.672 . . . . 65.23 110.116 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -153.68 125.16 7.57 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.159 -1.423 . . . . 41.52 107.159 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -132.23 109.96 10.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.062 0.545 . . . . 62.04 109.724 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.59 79.58 73.43 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 106.716 -1.587 . . . . 53.13 106.716 168.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.74 -25.34 28.8 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.767 2.311 . . . . 71.51 112.001 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -106.1 17.57 23.34 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.214 1.406 . . . . 72.42 110.932 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.404 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -42.89 -57.57 4.83 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 114.864 1.431 . . . . 15.15 114.864 -167.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.17 -36.63 68.22 Favored 'Trans proline' 0 C--N 1.391 2.774 0 CA-C-N 122.24 1.836 . . . . 74.34 112.529 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -69.09 -39.09 79.22 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.446 0.698 . . . . 74.12 111.637 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.813 HG21 ' HA ' ' C' ' 73' ' ' ALA . 2.9 p -79.39 -20.79 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 N-CA-C 112.412 0.523 . . . . 63.42 112.412 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -67.91 -31.71 71.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.545 0.572 . . . . 74.33 112.545 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -88.35 15.25 8.01 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.874 0.47 . . . . 73.54 111.057 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.43 161.34 13.83 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.954 0.902 . . . . 71.33 110.544 -176.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.92 126.85 30.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.624 0.77 . . . . 63.1 109.798 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.4 ' HZ2' HD22 ' G' ' 470' ' ' LEU . 59.9 t90 -76.0 107.14 8.0 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.654 0.782 . . . . 74.32 109.847 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.56 73.16 2.87 Favored Pre-proline 0 CA--C 1.555 1.138 0 N-CA-C 107.328 -1.36 . . . . 54.04 107.328 173.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.552 ' HG2' HD13 ' G' ' 470' ' ' LEU . 2.7 Cg_endo -81.59 134.18 8.59 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.092 2.528 . . . . 64.24 113.949 -174.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -87.38 95.13 9.9 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 106.345 -1.724 . . . . 74.24 106.345 168.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 m -75.88 96.23 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 122.275 1.036 . . . . 73.21 109.815 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.428 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 40.2 ttmt -100.8 103.09 14.3 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.582 -1.19 . . . . 64.01 108.082 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.65 HD21 HD21 ' G' ' 468' ' ' LEU . 5.8 mp -88.32 132.54 34.37 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 107.783 -1.191 . . . . 63.42 107.783 174.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.4 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.1 t70 -117.63 104.72 11.3 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.469 -1.308 . . . . 73.31 107.469 173.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 84.3 mt -95.58 143.23 27.05 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.305 -0.861 . . . . 60.42 109.236 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.2 t70 -148.33 144.27 27.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.993 0.917 . . . . 65.24 108.954 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 t -138.42 124.75 20.46 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.648 -0.871 . . . . 64.42 108.648 172.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.07 145.3 45.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.782 -0.821 . . . . 70.42 108.782 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -130.49 156.0 45.52 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.989 0.516 . . . . 63.31 111.115 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 29.5 t -144.8 139.84 28.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.369 1.067 . . . . 75.03 109.587 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.405 ' HB2' ' HB2' ' G' ' 454' ' ' LEU . 37.5 tp60 -88.86 118.32 28.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.963 -1.125 . . . . 71.34 107.963 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.625 HD11 HD12 ' C' ' 83' ' ' ILE . 62.2 mt -90.0 -48.84 6.95 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.802 0.811 . . . . 72.03 109.362 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.18 -177.85 5.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 113.996 -1.456 . . . . 50.01 108.501 170.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.41 110.73 1.16 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.442 1.089 . . . . 72.14 110.703 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 22.6 m-20 68.3 9.28 7.14 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 125.386 1.474 . . . . 71.04 113.367 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.7 t -93.1 107.53 19.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 107.198 -1.408 . . . . 72.0 107.198 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.45 ' CD1' HG11 ' G' ' 452' ' ' VAL . 2.5 t80 -102.08 122.37 43.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.149 -1.387 . . . . 74.15 108.088 -164.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -105.01 122.57 46.13 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.944 -1.132 . . . . 75.44 107.944 173.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -114.99 141.06 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 108.515 -0.92 . . . . 73.13 108.515 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.417 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 87.2 t -128.99 139.75 51.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.811 -0.811 . . . . 63.53 108.811 174.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.81 105.95 11.21 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.524 -1.287 . . . . 73.42 107.524 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.615 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 23.3 ttm-85 -93.58 107.7 19.52 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.603 -0.888 . . . . 72.31 108.603 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.448 ' HB ' HD11 ' C' ' 114' ' ' ILE . 24.1 t -107.11 120.42 58.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.438 -0.949 . . . . 74.34 108.438 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 43.6 m -117.68 131.53 56.62 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.23 -0.656 . . . . 45.4 109.23 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.405 HG23 HD13 ' C' ' 114' ' ' ILE . 60.2 t -108.41 125.28 65.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.972 -0.751 . . . . 54.03 108.972 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 6.6 m -118.38 123.93 46.47 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.515 -0.92 . . . . 72.12 108.515 173.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.92 99.65 7.23 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.493 -1.299 . . . . 62.13 107.493 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.9 m -108.18 120.6 42.83 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 109.7 -0.482 . . . . 72.5 109.7 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 8.7 mt -84.92 49.29 1.7 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.182 1.393 . . . . 75.43 109.589 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.79 -98.85 1.81 Allowed Glycine 0 C--N 1.35 1.317 0 N-CA-C 110.557 -1.017 . . . . 50.22 110.557 -174.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.39 -30.28 12.29 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.319 1.048 . . . . 61.23 109.97 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -79.78 120.07 23.55 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 124.348 1.059 . . . . 73.5 110.581 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 86.8 m -85.29 127.12 34.21 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 119.057 0.844 . . . . 72.33 109.764 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.813 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.85 -56.81 5.06 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.653 1.181 . . . . 70.53 110.101 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 74' ' ' PHE . . . . . 0.437 ' HZ ' HD22 ' C' ' 126' ' ' LEU . 33.0 p90 -157.4 164.52 37.43 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.287 -0.869 . . . . 75.04 112.284 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -128.25 105.29 8.25 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.636 -1.616 . . . . 73.33 106.636 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.9 t -109.41 148.69 30.7 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.974 -0.75 . . . . 74.24 108.974 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -156.42 136.81 13.04 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.414 -0.587 . . . . 71.22 109.414 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.0 t -133.93 135.02 55.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.89 -1.152 . . . . 70.24 107.89 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -111.5 89.42 3.05 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.952 -1.129 . . . . 65.02 107.952 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -78.99 100.27 7.23 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.061 -0.972 . . . . 74.5 110.04 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.633 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -89.24 169.07 35.79 Favored Glycine 0 C--O 1.242 0.636 0 CA-C-N 115.728 -0.669 . . . . 71.11 112.799 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.448 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -168.06 118.51 0.79 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.384 -0.686 . . . . 41.22 111.384 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.625 HD12 HD11 ' C' ' 51' ' ' LEU . 12.9 mm -84.01 133.44 29.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 108.821 -0.807 . . . . 61.43 108.821 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.418 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 45.3 m-85 -141.09 122.68 15.13 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.639 0.775 . . . . 72.23 109.337 -177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 53.0 p -79.84 127.31 32.07 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.09 -1.078 . . . . 62.12 108.09 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.54 HD11 HD11 ' C' ' 89' ' ' ILE . 9.6 tt -141.91 143.09 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-O 121.036 0.446 . . . . 54.02 111.714 -170.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.78 169.18 24.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.344 1.058 . . . . 64.44 109.649 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.07 -46.34 1.19 Allowed Glycine 0 N--CA 1.471 1.012 0 CA-C-N 116.458 -0.337 . . . . 74.24 113.878 171.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.54 HD11 HD11 ' C' ' 86' ' ' ILE . 0.2 OUTLIER -113.39 146.77 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 122.935 0.494 . . . . 75.25 110.236 -176.253 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -146.83 -177.89 5.9 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.786 0.434 . . . . 73.11 111.008 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.25 -122.6 11.29 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 115.753 -0.658 . . . . 61.42 113.078 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 79.9 p -70.53 -23.79 62.7 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.589 0.756 . . . . 62.34 110.929 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -73.68 -32.16 63.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.661 0.785 . . . . 72.01 110.746 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 55.5 ttp -66.78 -40.64 88.24 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.086 -0.709 . . . . 71.12 109.086 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.27 -36.3 83.68 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.563 -0.744 . . . . 73.05 111.383 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -76.86 -21.02 55.61 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.576 0.35 . . . . 74.14 111.607 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.9 t -61.28 -54.5 43.25 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.63 0.372 . . . . 35.15 110.097 173.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.511 HD13 ' HG3' ' G' ' 457' ' ' GLN . 4.5 pp -75.66 -22.14 57.01 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.102 0.561 . . . . 75.12 111.147 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.55 -26.41 65.5 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 114.889 0.716 . . . . 34.43 114.889 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.56 -60.21 0.08 Allowed 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 112.494 0.553 . . . . 72.01 112.494 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -52.71 -47.76 67.08 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 124.154 0.909 . . . . 73.12 112.604 -167.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.9 m -78.4 -48.44 1.89 Allowed Pre-proline 0 CA--C 1.561 1.379 0 CA-C-O 117.78 -1.105 . . . . 63.51 112.422 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.57 -32.51 44.4 Favored 'Trans proline' 0 C--N 1.403 3.402 0 C-N-CA 122.197 1.931 . . . . 62.03 113.636 170.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -66.71 -38.04 85.91 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.278 1.031 . . . . 64.43 111.417 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.414 HD12 ' NH1' ' A' ' 111' ' ' ARG . 36.7 mm -64.5 -45.65 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 109.488 -0.56 . . . . 65.02 109.488 173.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.448 HD21 ' HA3' ' C' ' 82' ' ' GLY . 74.5 mt -78.48 -18.6 54.59 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.03 -0.987 . . . . 64.41 112.493 -172.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.404 ' HE1' HD13 ' C' ' 128' ' ' LEU . 79.0 t80 -59.0 -50.99 85.04 Favored Pre-proline 0 CA--C 1.56 1.358 0 N-CA-C 114.233 1.197 . . . . 71.54 114.233 -171.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.36 -32.48 72.13 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.789 1.659 . . . . 74.14 112.518 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -67.65 -45.15 76.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.15 0.58 . . . . 70.53 110.195 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.54 -45.2 89.39 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.918 0.887 . . . . 45.34 110.519 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -57.7 -54.74 43.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.634 1.174 . . . . 72.14 111.117 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -67.18 -33.05 74.57 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.299 0.64 . . . . 71.44 110.877 -173.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.2 t -69.5 -32.21 70.93 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.888 0.475 . . . . 53.14 110.932 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.448 HD11 ' HB ' ' C' ' 62' ' ' VAL . 74.7 mt -71.31 -53.32 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.59 -0.522 . . . . 51.42 109.59 173.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.407 HG21 ' OG ' ' B' ' 119' ' ' SER . 14.5 m -60.73 -29.68 69.52 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.74 0.816 . . . . 70.25 111.326 -173.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 31.7 t -61.78 -54.54 40.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.235 -0.893 . . . . 72.31 109.155 171.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.492 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.73 -37.66 79.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.794 1.238 . . . . 72.01 112.867 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.485 HG11 HD13 ' C' ' 126' ' ' LEU . 85.6 t -64.49 -46.7 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.59 0.756 . . . . 73.32 109.8 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.48 ' OG ' HG21 ' B' ' 115' ' ' THR . 34.7 t -66.28 -32.71 74.29 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.985 -1.007 . . . . 50.1 111.473 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.421 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 74.6 mtt-85 -66.49 -41.16 89.33 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.408 0.683 . . . . 71.33 109.481 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.23 7.81 62.85 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.706 -0.679 . . . . 75.22 112.989 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 77.4 p 57.96 33.32 23.06 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.906 1.682 . . . . 74.05 113.661 171.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -91.08 163.13 30.52 Favored Pre-proline 0 CA--C 1.565 1.526 0 C-N-CA 124.231 1.012 . . . . 61.22 108.86 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.11 172.75 3.75 Favored 'Trans proline' 0 C--N 1.39 2.729 0 C-N-CA 122.997 2.465 . . . . 60.1 113.82 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -62.48 112.74 2.59 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.945 0.898 . . . . 75.25 112.669 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.503 HD11 HD11 ' G' ' 470' ' ' LEU . 8.9 mp -110.98 112.0 23.51 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.431 -0.952 . . . . 64.2 108.431 169.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -124.59 131.29 53.48 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.498 0.719 . . . . 53.04 109.223 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.404 HD13 ' HE1' ' C' ' 107' ' ' PHE . 1.4 tt -79.33 131.2 36.06 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.333 -0.617 . . . . 65.31 109.333 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.17 150.75 91.82 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.235 1.014 . . . . 51.15 111.433 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.07 103.29 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.382 2.055 . . . . 73.11 112.533 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 90.6 t -97.22 111.23 26.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.663 -0.866 . . . . 75.42 108.663 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -82.96 83.81 7.67 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 108.042 -1.096 . . . . 74.44 108.042 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -59.36 -22.47 61.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.11 0.564 . . . . 73.41 111.87 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.444 ' O ' ' HG3' ' C' ' 138' ' ' MET . 33.7 m-20 -63.19 -56.2 18.72 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.692 0.797 . . . . 64.44 110.848 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.11 -38.58 79.93 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.725 1.266 . . . . 71.43 110.641 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 74.8 mt -74.19 -29.5 61.78 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.493 -1.23 . . . . 63.43 111.675 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -75.45 -28.69 59.41 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 110.142 -0.318 . . . . 75.22 110.142 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 60.7 mtt -63.95 -34.86 78.92 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.252 0.621 . . . . 50.5 111.876 -176.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -71.7 -37.11 70.71 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.204 0.315 . . . . 72.43 110.383 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -67.2 -81.7 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.552 1.141 . . . . 71.43 110.064 176.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 52.4 tp -127.06 135.42 50.76 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.575 0.75 . . . . 62.14 110.26 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.678 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 45.0 tt0 65.26 93.94 0.06 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.181 1.393 . . . . 73.25 112.407 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -69.34 88.14 0.45 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.281 -1.007 . . . . 74.34 108.281 166.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -77.37 136.76 38.46 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.455 -1.248 . . . . 74.52 110.443 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.555 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . . . -84.23 159.8 20.91 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.085 0.554 . . . . 71.35 110.447 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.67 -151.73 5.86 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 114.27 0.468 . . . . 74.02 114.27 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 147' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 3.5 mp0 -81.81 152.23 27.03 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.213 0.605 . . . . 61.22 109.544 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 148' ' ' GLY . . . . . 0.429 ' HA3' ' H ' ' A' ' 147' ' ' GLU . . . -84.54 62.86 4.5 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.744 -0.542 . . . . 70.0 111.744 177.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 58.3 p -78.4 112.92 15.92 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.236 1.015 . . . . 73.34 111.176 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 150' ' ' GLU . . . . . 0.45 ' O ' HD21 ' A' ' 141' ' ' LEU . 41.1 tt0 -89.57 159.03 17.39 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.291 0.636 . . . . 62.0 109.709 176.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -92.32 107.13 18.98 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.513 -1.291 . . . . 72.44 107.513 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -171.16 133.37 0.86 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.297 0.639 . . . . 53.03 110.867 171.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -157.09 131.89 8.8 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.109 -0.701 . . . . 74.12 109.109 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -138.59 133.35 32.39 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.699 0.8 . . . . 73.32 109.042 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 N-CA-C 108.894 -0.78 . . . . 72.03 108.894 -176.719 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.748 -0.464 . . . . 71.23 109.748 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 40.4 m -84.39 69.02 10.45 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.878 0.847 . . . . 71.42 109.661 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -99.6 142.89 30.49 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.37 -1.286 . . . . 71.45 110.874 -172.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 53.04 71.19 0.51 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.233 1.413 . . . . 75.34 111.819 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -69.93 109.01 4.26 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.226 -0.897 . . . . 75.52 109.47 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -111.93 79.12 1.18 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.48 0.712 . . . . 63.42 109.637 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.8 t -155.89 66.4 0.6 Allowed 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.425 -1.324 . . . . 74.44 107.425 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 67.03 147.42 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.56 1.544 . . . . 73.04 110.842 -168.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.3 ttp -34.43 125.45 0.5 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.864 1.266 . . . . 65.23 112.654 171.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 89.3 m -114.81 139.73 49.5 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.034 0.534 . . . . 62.13 110.022 176.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -164.01 91.34 0.63 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.785 -1.561 . . . . 74.05 106.785 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -112.84 114.06 26.42 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.868 -1.16 . . . . 71.01 107.868 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.58 105.57 4.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.678 -0.86 . . . . 64.44 108.678 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -77.38 -37.85 51.23 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.172 -0.467 . . . . 63.11 111.892 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -166.2 144.1 5.48 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 111.786 0.291 . . . . 71.44 111.786 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.449 HD13 ' HG3' ' B' ' 130' ' ' PRO . 1.7 mp -121.86 134.12 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 106.016 -1.846 . . . . 62.14 106.016 167.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -161.44 163.18 30.64 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.9 0.857 . . . . 74.13 111.489 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -95.01 119.72 34.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.267 -1.333 . . . . 55.45 108.924 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -88.96 -22.34 23.1 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.568 -0.53 . . . . 70.11 109.568 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.609 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.2 t70 -155.67 139.4 16.11 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 114.933 -1.031 . . . . 64.22 109.8 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.492 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.0 mt -143.62 136.78 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.938 1.295 . . . . 74.42 107.553 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.6 t -146.76 109.25 4.53 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.807 -0.812 . . . . 63.2 108.807 174.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.601 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.8 t80 -114.22 128.28 56.29 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.991 -1.114 . . . . 73.41 107.991 168.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.14 127.14 40.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.516 0.727 . . . . 75.11 109.324 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.31 87.42 2.05 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 106.559 -1.645 . . . . 62.22 106.559 165.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.55 -41.72 18.82 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.276 1.984 . . . . 72.42 112.505 -166.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -111.09 15.2 21.75 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.125 0.97 . . . . 75.24 109.979 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.488 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -18.61 -70.26 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 117.227 2.306 . . . . 74.35 117.227 -168.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 64.6 Cg_endo -77.14 -23.75 10.15 Favored 'Trans proline' 0 C--N 1.382 2.329 0 CA-C-N 123.953 2.447 . . . . 74.13 113.772 -173.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -72.88 -36.54 67.37 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.631 0.772 . . . . 74.44 109.218 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' D' ' 73' ' ' ALA . 6.8 p -83.26 -19.13 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.229 0 CA-C-N 115.731 -0.668 . . . . 62.13 110.694 -176.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.6 m-85 -70.01 -19.02 63.34 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.835 0.454 . . . . 75.42 111.928 175.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -55.3 -34.09 63.84 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.817 0.698 . . . . 64.14 110.073 172.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.425 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 42.1 mtmt -91.88 78.02 5.42 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.583 -1.19 . . . . 75.33 109.095 168.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.01 82.0 3.53 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.836 0.827 . . . . 73.14 109.493 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -147.84 157.96 43.79 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.532 -1.213 . . . . 74.4 108.79 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -63.8 106.89 1.04 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.133 0.973 . . . . 74.31 108.979 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.506 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 23.1 Cg_exo -65.82 146.0 82.16 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.754 2.302 . . . . 62.45 112.196 -172.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -63.27 110.97 2.06 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.164 -1.05 . . . . 74.02 108.164 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.14 146.07 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-O 121.427 0.632 . . . . 74.15 111.225 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' H' ' 465' ' ' LYS . 8.0 tmtt? -129.59 118.94 22.8 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.401 -2.074 . . . . 70.42 105.401 172.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -97.01 145.37 26.01 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.633 -0.877 . . . . 75.43 108.633 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.558 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.8 m-20 -129.29 143.34 50.81 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.024 -0.732 . . . . 74.25 109.024 172.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -119.38 136.42 54.29 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.232 -1.025 . . . . 71.12 108.232 173.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 37.9 t70 -138.37 131.5 30.05 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.274 -1.38 . . . . 70.14 107.274 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -104.09 148.12 26.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.221 0.534 . . . . 62.44 109.57 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.58 165.41 33.4 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.897 -1.047 . . . . 53.31 108.536 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 31.1 p -164.77 155.97 15.01 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.179 0.592 . . . . 62.41 110.151 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 32.0 t -151.62 123.95 8.29 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.317 0.647 . . . . 71.35 110.626 -171.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -73.4 116.65 14.21 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.179 -1.045 . . . . 72.02 108.179 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' D' ' 57' ' ' GLU . 60.1 mt -91.79 -41.11 10.84 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.302 0.572 . . . . 75.51 110.11 -177.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.17 -175.09 5.25 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.449 -1.251 . . . . 41.32 109.261 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -66.27 124.91 23.97 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 123.731 0.644 . . . . 74.5 109.434 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 63.77 0.59 0.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.84 1.256 . . . . 50.11 113.887 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.9 t -108.29 114.11 45.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 107.728 -1.212 . . . . 61.44 107.728 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 129.33 37.12 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.195 -1.039 . . . . 75.14 108.195 -170.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.48 ' HB2' HD11 ' D' ' 51' ' ' LEU . 30.2 tt0 -99.82 147.47 25.46 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.325 1.05 . . . . 53.24 109.4 177.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.16 127.47 73.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.378 -1.342 . . . . 72.41 107.378 170.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.433 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 61.8 t -109.58 109.95 30.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.994 -0.743 . . . . 73.22 108.994 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.85 119.35 30.98 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.789 -0.819 . . . . 74.21 108.789 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.539 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 47.7 ttm-85 -98.74 109.98 22.66 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.88 -1.156 . . . . 73.55 107.88 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.51 HG21 ' HB1' ' D' ' 110' ' ' ALA . 38.8 t -115.06 118.77 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.787 -0.819 . . . . 72.51 108.787 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 12.0 m -115.46 144.31 44.02 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.487 1.115 . . . . 74.53 109.381 -171.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.483 HG21 HD21 ' D' ' 126' ' ' LEU . 58.5 t -139.01 103.82 2.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.18 0.992 . . . . 72.04 108.919 172.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 99.9 m -97.47 120.19 37.38 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.25 -1.019 . . . . 71.51 108.25 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -122.37 154.93 37.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.659 0.784 . . . . 72.4 110.925 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 54.7 m -150.6 139.69 21.1 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.562 0.539 . . . . 70.12 112.127 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.433 HD12 HG22 ' D' ' 31' ' ' VAL . 11.7 mt -110.7 121.05 44.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.054 1.342 . . . . 64.12 108.977 171.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.0 -113.28 4.27 Favored Glycine 0 C--N 1.341 0.829 0 O-C-N 123.338 0.399 . . . . 72.11 112.72 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.12 5.86 18.81 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.103 0.961 . . . . 74.11 110.898 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.425 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 15.8 pt-20 -132.13 158.75 40.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.86 0.464 . . . . 63.23 110.613 -174.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 65.4 m -71.39 138.48 49.19 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 116.061 -0.518 . . . . 41.32 110.603 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.624 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.19 -68.67 0.78 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.891 0.876 . . . . 43.24 109.624 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -146.36 145.96 30.49 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 121.551 0.691 . . . . 74.21 110.25 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -120.24 141.03 50.31 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.658 1.583 . . . . 74.22 106.956 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.564 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.4 t -153.79 139.0 17.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.56 -0.534 . . . . 72.43 109.56 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -156.9 132.16 9.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.41 -0.589 . . . . 75.33 109.41 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.06 120.15 46.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.756 0.823 . . . . 75.21 109.277 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.609 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.3 mt-30 -89.43 86.82 6.87 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.647 -0.872 . . . . 72.31 108.647 169.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -80.03 94.4 5.93 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.695 -1.139 . . . . 63.12 108.917 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.09 143.34 18.07 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.926 -0.47 . . . . 34.4 111.926 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.558 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -140.64 131.5 5.01 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.714 -0.554 . . . . 64.13 111.714 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -94.67 125.13 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.719 0.808 . . . . 73.23 109.447 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -132.18 125.11 30.4 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.052 0.941 . . . . 71.34 109.743 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.6 m -87.76 104.15 16.29 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.524 -0.547 . . . . 72.54 109.524 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.438 HD12 ' SD ' ' D' ' 94' ' ' MET . 39.9 pt -107.08 141.19 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.902 0.881 . . . . 63.43 110.807 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -169.14 165.96 10.95 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.976 0.91 . . . . 75.33 110.889 173.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.72 -19.62 19.39 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.197 -0.456 . . . . 71.13 112.925 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.489 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -118.97 149.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.084 0.953 . . . . 71.24 108.691 177.246 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -154.32 160.06 41.54 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.336 0.495 . . . . 73.42 112.336 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.36 -121.31 24.98 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 114.791 -1.095 . . . . 74.12 113.51 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.7 p -71.12 -31.98 68.44 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.892 0.877 . . . . 72.33 111.484 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -69.59 -40.34 76.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.761 0.425 . . . . 70.33 110.109 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.438 ' SD ' HD12 ' D' ' 86' ' ' ILE . 7.1 tmm? -72.45 -37.65 68.48 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.382 -0.826 . . . . 64.11 109.777 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.74 71.27 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.031 0.532 . . . . 70.34 111.507 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.408 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.7 t-160 -69.49 -39.39 77.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.129 0.972 . . . . 63.23 110.16 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -68.85 -50.31 50.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.808 -0.633 . . . . 74.22 110.435 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.68 -25.21 44.78 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.554 0.742 . . . . 73.12 111.645 -168.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.12 11.23 37.22 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-O 119.607 -0.552 . . . . 42.43 113.543 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -149.36 -58.25 0.2 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.184 0.492 . . . . 74.21 111.227 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -70.7 -46.95 62.17 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.272 0.629 . . . . 64.53 111.689 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.401 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 55.1 m -67.37 -44.21 45.75 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.503 -0.76 . . . . 71.1 111.693 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 76.9 Cg_exo -56.52 -32.82 90.96 Favored 'Trans proline' 0 C--N 1.394 2.922 0 C-N-CA 122.479 2.119 . . . . 63.13 113.423 165.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -71.34 -25.32 62.34 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.002 0.521 . . . . 72.32 111.216 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 64.0 mt -77.12 -34.47 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.894 0.877 . . . . 75.23 110.138 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.558 HD21 ' HA3' ' D' ' 82' ' ' GLY . 95.9 mt -76.77 -22.71 53.37 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.561 -0.745 . . . . 73.51 111.724 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -67.41 -42.05 35.74 Favored Pre-proline 0 CA--C 1.565 1.557 0 N-CA-C 113.941 1.089 . . . . 74.11 113.941 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -60.41 -40.49 57.32 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.097 1.865 . . . . 60.21 112.71 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -73.06 -33.71 65.83 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.586 0.754 . . . . 72.33 111.511 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.51 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -63.79 -53.12 55.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.641 0.776 . . . . 75.2 109.523 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.52 ' NH2' HG23 ' B' ' 105' ' ' ILE . 28.5 ttp180 -54.65 -48.57 72.15 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 124.895 1.372 . . . . 75.01 110.588 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -60.33 -46.3 90.4 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.155 0.909 . . . . 72.31 111.651 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.02 -42.08 93.59 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.788 0.68 . . . . 73.1 110.719 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.564 HG23 ' SG ' ' D' ' 76' ' ' CYS . 72.2 mt -64.17 -50.66 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 124.174 0.921 . . . . 72.23 110.988 174.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 41.5 m -57.32 -42.42 81.81 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.808 1.243 . . . . 74.34 110.831 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -65.31 -41.61 93.87 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.264 -1.334 . . . . 74.25 110.446 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.41 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 73.3 mtm -71.6 -31.06 66.51 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.198 0.444 . . . . 52.33 112.198 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.73 -42.06 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.328 0.651 . . . . 74.42 109.842 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 84.6 p -76.22 -27.08 56.67 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.876 0.47 . . . . 54.02 111.531 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -75.83 -34.2 60.1 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.002 0.521 . . . . 72.15 110.057 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.72 89.41 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.981 -0.554 . . . . 53.02 111.962 171.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 38.5 p 64.01 19.57 11.81 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.153 2.181 . . . . 62.14 114.077 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -78.4 149.39 75.4 Favored Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 108.549 -0.908 . . . . 71.13 108.549 170.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.34 137.35 71.4 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.817 2.345 . . . . 71.55 112.113 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -55.55 146.21 21.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.793 1.237 . . . . 71.2 113.247 -164.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.483 HD21 HG21 ' D' ' 64' ' ' VAL . 38.3 tp -116.48 94.21 4.53 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.256 -0.884 . . . . 71.13 109.328 -176.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 88.0 m-20 -104.82 91.48 3.85 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.563 -0.903 . . . . 74.52 108.563 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 23.6 tp -73.66 133.54 43.44 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.409 -0.814 . . . . 75.11 110.314 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.19 146.02 99.0 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.582 0.753 . . . . 55.34 111.167 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.4 124.33 3.63 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.329 2.019 . . . . 74.44 111.048 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 99.3 t -107.27 133.48 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.032 -0.531 . . . . 73.41 109.594 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -79.35 88.61 4.97 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.007 -0.738 . . . . 72.23 109.007 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -65.21 -24.87 67.48 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.759 -1.109 . . . . 72.24 111.469 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.95 -52.67 63.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.884 0.873 . . . . 71.53 110.593 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.02 -37.59 66.87 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.348 -0.842 . . . . 60.23 111.721 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.25 -31.33 72.07 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 115.616 -0.72 . . . . 75.42 110.162 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.404 ' O ' HD13 ' D' ' 141' ' ' LEU . 84.4 t80 -63.68 -39.88 95.41 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.811 0.845 . . . . 63.44 110.653 176.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 30.8 mtt -63.44 -46.16 87.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.222 0.609 . . . . 72.23 109.708 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.427 ' HA ' HE21 ' D' ' 142' ' ' GLN . 79.5 m-20 -74.15 -20.82 60.1 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.167 -0.924 . . . . 60.1 111.674 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -73.27 -39.98 64.96 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.915 0.886 . . . . 74.42 110.247 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.404 HD13 ' O ' ' D' ' 137' ' ' PHE . 6.6 mp -65.41 -38.01 88.66 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.323 0.649 . . . . 74.42 111.794 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.427 HE21 ' HA ' ' D' ' 139' ' ' ASN . 23.2 pt20 -86.73 32.96 0.65 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.579 0.585 . . . . 75.31 112.579 -174.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -119.15 91.39 3.54 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.319 0.648 . . . . 75.52 110.33 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -147.87 85.62 1.56 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.095 0.958 . . . . 71.32 108.513 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.57 141.57 18.24 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.565 -0.743 . . . . 54.45 110.195 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -116.14 8.03 18.64 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.735 -0.48 . . . . 72.3 113.669 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -84.5 149.92 25.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.552 0.741 . . . . 64.03 110.848 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.82 90.04 2.15 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 116.559 -0.291 . . . . 61.05 112.384 176.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 26.4 m -68.35 99.04 0.89 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.618 0.767 . . . . 74.21 110.642 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -80.96 97.53 7.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.411 0.684 . . . . 71.33 109.515 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -88.16 -68.02 0.79 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.021 0.928 . . . . 62.24 110.931 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 60.6 99.84 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.311 1.044 . . . . 72.52 110.585 -173.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -129.22 101.35 5.97 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.913 0.885 . . . . 74.42 109.014 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -79.36 155.41 28.44 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.815 -0.439 . . . . 74.14 109.815 172.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 N-CA-C 108.37 -0.974 . . . . 72.2 108.37 -178.846 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 110.15 -0.315 . . . . 54.35 110.15 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 451' ' ' VAL . . . . . 0.722 HG12 ' HA ' ' A' ' 54' ' ' ASP . 8.9 p -168.0 29.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.391 0 CA-C-O 122.785 1.279 . . . . 54.51 108.52 -174.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 452' ' ' VAL . . . . . 0.43 HG12 ' CD2' ' A' ' 56' ' ' TYR . 28.9 m -132.53 -171.73 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 115.056 -0.974 . . . . 64.31 111.736 -162.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 99.7 21.59 14.06 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 114.346 0.498 . . . . 43.35 114.346 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 6.2 mp -99.39 -175.87 3.13 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 117.477 0.639 . . . . 74.43 111.074 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 12.9 t -141.4 178.79 7.18 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.967 0.907 . . . . 71.14 109.367 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -81.81 165.53 20.8 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.937 0.895 . . . . 62.11 109.817 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -154.04 131.87 11.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.068 0.547 . . . . 70.45 110.008 174.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 53.0 p -69.66 94.83 0.82 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.784 0.834 . . . . 62.01 109.454 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 7.5 t70 73.47 146.69 0.08 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.381 1.472 . . . . 64.21 111.587 -172.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.69 -71.87 0.32 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.599 -0.728 . . . . 71.34 109.363 170.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -175.37 18.86 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.884 0.874 . . . . 71.35 111.504 -171.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -162.12 130.99 4.28 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 111.667 0.247 . . . . 64.33 111.667 -168.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 4.7 p -95.46 -60.19 1.72 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.894 0.878 . . . . 53.44 110.782 175.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 464' ' ' MET . . . . . 0.413 ' HB3' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER 82.11 125.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 126.509 1.924 . . . . 75.41 109.874 -170.048 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.44 98.67 7.42 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.579 -0.897 . . . . 73.22 108.579 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -81.46 152.5 27.34 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.043 0.537 . . . . 43.23 110.852 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -158.82 93.96 1.2 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.43 -0.582 . . . . 54.14 109.43 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 468' ' ' LEU . . . . . 0.571 ' HB2' ' HG ' ' E' ' 470' ' ' LEU . 77.1 mt -82.95 -179.98 7.6 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.543 -0.753 . . . . 72.14 109.65 175.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -82.27 55.75 4.96 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.752 -0.539 . . . . 63.34 111.752 173.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 470' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' E' ' 468' ' ' LEU . 62.7 mt -85.11 86.86 7.35 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 123.443 0.697 . . . . 72.01 109.575 -175.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt . . . . . 0 C--O 1.247 0.939 0 CA-C-N 114.721 -1.127 . . . . 74.23 108.52 -178.294 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 450' ' ' ASN . . . . . 0.657 ' N ' ' HH ' ' B' ' 56' ' ' TYR . 52.4 m-20 . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 109.593 -0.521 . . . . 71.52 109.593 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 451' ' ' VAL . . . . . 0.409 HG23 HG13 ' F' ' 452' ' ' VAL . 30.5 m -68.29 -30.27 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 120.656 0.265 . . . . 55.3 110.654 171.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 452' ' ' VAL . . . . . 0.409 HG13 HG23 ' F' ' 451' ' ' VAL . 23.1 m -139.18 170.42 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.647 1.179 . . . . 75.4 109.563 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -174.54 118.16 0.66 Allowed Glycine 0 C--N 1.344 1.003 0 N-CA-C 111.358 -0.697 . . . . 45.42 111.358 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 454' ' ' LEU . . . . . 0.426 HD13 HD12 ' B' ' 98' ' ' LEU . 7.6 mp -86.67 167.38 14.55 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.532 0.733 . . . . 65.14 110.999 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 6.2 m -70.86 -15.99 62.67 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.856 0.863 . . . . 73.32 110.512 173.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 5.9 t70 74.11 68.82 0.1 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 125.707 1.603 . . . . 75.13 108.831 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 457' ' ' GLN . . . . . 0.512 ' NE2' ' HA2' ' B' ' 99' ' ' GLY . 4.5 pm0 -58.8 93.76 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.013 -1.449 . . . . 64.53 112.001 -171.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 29.6 m -67.1 -44.09 80.85 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.593 -1.185 . . . . 73.24 109.075 171.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -87.67 115.31 25.02 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.754 -1.112 . . . . 73.04 109.637 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 460' ' ' LEU . . . . . 0.503 ' HG ' HD12 ' B' ' 44' ' ' LEU . 4.6 mm? -92.88 -169.73 2.25 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.672 0.789 . . . . 72.3 111.622 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -134.0 14.08 3.93 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.684 1.194 . . . . 75.32 111.579 -168.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -73.05 112.61 9.24 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 121.412 0.625 . . . . 70.43 110.731 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 20.7 p -126.21 137.92 53.59 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.268 1.027 . . . . 53.22 109.548 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 49.5 ttm -151.44 122.31 7.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.599 0.76 . . . . 75.01 109.656 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -85.22 72.53 10.73 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.455 -0.943 . . . . 64.15 108.455 171.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . 179.79 -178.4 0.4 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.828 1.251 . . . . 74.5 109.783 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -133.87 -169.44 2.31 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.227 1.011 . . . . 62.12 109.3 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 468' ' ' LEU . . . . . 0.47 HD13 HG21 ' B' ' 40' ' ' VAL . 8.5 tt -65.33 -35.81 82.11 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.875 0.47 . . . . 62.14 110.243 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.12 54.47 1.87 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 110.792 -0.923 . . . . 72.1 110.792 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 470' ' ' LEU . . . . . 0.661 HD11 HG23 ' B' ' 40' ' ' VAL . 77.5 mt -67.36 95.75 0.46 Allowed 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.893 0.877 . . . . 74.5 110.848 -178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--O 1.25 1.085 0 N-CA-C 108.242 -1.021 . . . . 74.45 108.242 175.621 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 450' ' ' ASN . . . . . 0.593 HD21 ' N ' ' G' ' 450' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 110.207 -0.294 . . . . 75.14 110.207 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.29 -63.75 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 123.949 0.9 . . . . 62.32 111.142 -174.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 452' ' ' VAL . . . . . 0.45 HG11 ' CD1' ' C' ' 56' ' ' TYR . 52.4 t -94.59 131.69 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.509 0.723 . . . . 73.42 112.232 -167.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . -135.42 79.62 0.32 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 110.879 -0.888 . . . . 63.03 110.879 172.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 454' ' ' LEU . . . . . 0.405 ' HB2' ' HB2' ' C' ' 50' ' ' GLN . 92.5 mt -66.76 131.04 45.09 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.605 0.762 . . . . 71.11 112.207 -178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 34.0 p -100.53 -73.16 0.65 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.779 0.832 . . . . 53.02 109.182 171.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -167.19 173.44 9.04 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.557 0.743 . . . . 72.23 109.843 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 457' ' ' GLN . . . . . 0.511 ' HG3' HD13 ' C' ' 98' ' ' LEU . 0.0 OUTLIER -146.08 128.07 15.52 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 107.421 -1.326 . . . . 54.4 107.421 -178.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 22.7 p -135.02 11.79 3.6 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.297 0.851 . . . . 75.3 113.297 -173.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -121.1 122.62 40.45 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 118.431 0.559 . . . . 61.42 111.365 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.54 85.69 2.38 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.866 -0.79 . . . . 62.05 108.866 167.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -51.54 -33.56 32.62 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.068 1.347 . . . . 60.24 112.667 171.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -78.27 102.02 7.44 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.39 -0.596 . . . . 52.24 109.39 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 81.3 p -86.04 -6.16 59.08 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.197 0.999 . . . . 74.32 111.904 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 74.43 123.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.56 1.544 . . . . 74.14 111.07 174.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -131.77 25.06 4.69 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.361 0.664 . . . . 71.4 110.571 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -138.46 154.47 48.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.96 0.504 . . . . 63.23 110.984 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -102.31 175.36 5.54 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.214 -0.903 . . . . 72.52 110.615 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 468' ' ' LEU . . . . . 0.65 HD21 HD21 ' C' ' 42' ' ' LEU . 96.1 mt -97.34 24.49 6.45 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.03 0.932 . . . . 73.34 111.835 -176.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 85.67 -8.14 73.6 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.185 -0.461 . . . . 32.12 112.922 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 470' ' ' LEU . . . . . 0.552 HD13 ' HG2' ' C' ' 38' ' ' PRO . 42.9 mt -82.78 156.19 23.82 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 122.792 0.437 . . . . 72.22 110.537 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt . . . . . 0 C--O 1.246 0.9 0 C-N-CA 124.474 1.11 . . . . 74.35 108.976 172.802 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 450' ' ' ASN . . . . . 0.643 ' N ' HD21 ' H' ' 450' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.326 -0.62 . . . . 62.13 109.326 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.95 -65.56 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.494 0.718 . . . . 61.42 109.14 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 452' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.39 -176.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.205 0.602 . . . . 70.22 111.553 -175.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 453' ' ' GLY . . . . . 0.457 ' H ' HD22 ' H' ' 454' ' ' LEU . . . 152.43 57.01 0.01 OUTLIER Glycine 0 C--N 1.35 1.324 0 N-CA-C 111.576 -0.61 . . . . 63.52 111.576 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 454' ' ' LEU . . . . . 0.457 HD22 ' H ' ' H' ' 453' ' ' GLY . 3.2 mm? -90.44 160.52 15.99 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.632 0.773 . . . . 72.23 111.828 -174.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 4.7 t -159.32 74.75 0.64 Allowed 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 114.304 -1.317 . . . . 71.3 108.327 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -86.26 150.88 24.06 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.014 -0.994 . . . . 61.34 111.726 -172.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -134.76 156.78 48.24 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.508 1.123 . . . . 65.55 108.948 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 77.0 p -72.83 -28.0 62.28 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.893 0.477 . . . . 73.23 110.859 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -89.73 132.49 35.16 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.331 -0.988 . . . . 61.15 108.331 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -157.76 135.15 10.34 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 122.943 0.497 . . . . 64.5 109.863 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 64.51 -80.75 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.159 1.383 . . . . 75.35 113.715 168.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -152.9 176.93 11.3 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.74 0.816 . . . . 72.24 111.094 -173.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 44.6 p -119.16 -57.62 2.0 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.892 0.877 . . . . 34.12 110.995 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 64.4 mtt 59.2 104.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.405 1.482 . . . . 64.11 113.255 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 465' ' ' LYS . . . . . 0.453 ' HA ' ' HG2' ' D' ' 41' ' ' LYS . 40.1 ttmt -113.95 59.38 0.67 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.543 -0.91 . . . . 74.21 108.543 174.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -176.27 -75.47 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.698 -1.137 . . . . 52.55 108.676 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . 56.14 -174.1 0.06 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.297 1.039 . . . . 72.3 112.284 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 468' ' ' LEU . . . . . 0.435 HD21 HD12 ' D' ' 126' ' ' LEU . 84.3 mt 56.32 -81.59 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.277 1.431 . . . . 65.53 113.547 172.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 134.57 72.31 0.08 OUTLIER Glycine 0 C--N 1.345 1.052 0 N-CA-C 108.696 -1.762 . . . . 62.34 108.696 -167.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.43 115.75 5.43 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.603 0.761 . . . . 61.01 109.204 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 13.3 mptt . . . . . 0 N--CA 1.483 1.198 0 C-N-CA 123.899 0.88 . . . . 65.11 110.495 -178.155 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.487 1.375 0 N-CA-C 108.914 -0.773 . . . . 72.53 108.914 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.4 p 56.59 97.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.708 1.603 . . . . 63.21 112.471 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -84.81 149.77 25.49 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 116.169 -0.469 . . . . 73.52 110.382 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -100.26 56.07 0.92 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.749 -0.834 . . . . 53.43 108.749 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 9' ' ' MET . 28.6 t-20 -67.0 105.74 1.73 Allowed 'General case' 0 C--N 1.347 0.476 0 CA-C-N 115.323 -0.853 . . . . 54.32 109.224 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -69.16 -79.41 0.06 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.781 -0.822 . . . . 65.24 108.781 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.0 p -146.04 0.36 0.83 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.105 0.562 . . . . 72.5 110.931 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.14 -45.39 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.119 0.568 . . . . 74.33 110.379 -174.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.501 ' O ' ' HA ' ' A' ' 5' ' ' ASN . 20.3 ptp -85.32 144.03 28.32 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.123 0.569 . . . . 70.13 109.868 -174.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.6 m -140.94 134.28 29.72 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.732 -0.84 . . . . 61.52 108.732 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.488 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 35.9 t80 -136.31 111.91 9.34 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.32 -0.992 . . . . 71.24 108.32 170.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.751 ' HG2' ' HB3' ' C' ' 150' ' ' GLU . 41.1 tp60 -136.47 124.56 22.96 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.549 -0.908 . . . . 41.32 108.549 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.568 HD11 HG21 ' A' ' 105' ' ' ILE . 50.3 mt -89.45 112.04 23.82 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.781 -0.822 . . . . 73.14 108.781 172.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -74.29 -38.59 63.32 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 124.412 1.07 . . . . 65.41 109.523 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -167.07 140.87 3.72 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.829 -0.623 . . . . 73.01 110.568 -169.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.484 HD11 HD13 ' A' ' 13' ' ' ILE . 79.6 mt -128.72 135.1 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.054 -1.091 . . . . 73.41 108.054 172.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.413 ' HB3' HG23 ' B' ' 122' ' ' THR . 33.0 p90 -162.98 151.24 13.99 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 124.18 0.925 . . . . 74.34 110.249 -176.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -74.64 121.93 22.39 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.842 -0.799 . . . . 74.15 108.842 172.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 27.7 mtpt -82.07 -32.61 30.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.716 -0.475 . . . . 72.54 109.716 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.6 t70 -147.72 141.53 25.73 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.057 -0.974 . . . . 73.31 109.462 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.52 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 70.1 mt -136.67 147.67 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.138 1.375 . . . . 53.13 107.494 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.554 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 40.4 t -157.23 149.45 22.81 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.305 0.642 . . . . 44.22 109.699 172.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.482 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 88.8 t80 -151.53 124.53 8.65 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.368 -1.716 . . . . 71.43 106.368 177.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -129.41 114.27 15.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.73 0.412 . . . . 71.33 109.954 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.28 77.0 67.54 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 108.018 -1.105 . . . . 53.43 108.018 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.68 -29.01 20.13 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.203 1.935 . . . . 73.04 110.354 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.403 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 72.3 m-20 -100.94 24.64 9.0 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.139 1.376 . . . . 74.3 110.072 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -56.98 -42.59 97.17 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 124.536 1.134 . . . . 72.32 112.742 170.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.3 -24.61 14.24 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 121.87 1.713 . . . . 71.02 112.52 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -72.86 -33.7 66.27 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.223 0.609 . . . . 73.13 111.184 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.621 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 9.8 p -68.33 -25.36 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 123.52 0.513 . . . . 54.01 111.049 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -69.8 -33.66 72.66 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.241 1.016 . . . . 43.43 110.118 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -92.27 -33.73 14.53 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.76 0.824 . . . . 73.34 111.562 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.621 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -82.67 171.77 13.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.189 0.595 . . . . 73.42 110.364 176.334 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -86.2 138.96 31.48 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.009 0.524 . . . . 70.44 110.687 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.452 ' HZ2' HD13 ' E' ' 470' ' ' LEU . 77.6 t-105 -76.26 87.0 3.08 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 121.506 0.669 . . . . 63.13 110.205 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -125.52 79.68 66.94 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 108.341 -0.985 . . . . 63.42 108.341 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -86.39 138.65 5.61 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.104 2.536 . . . . 54.32 114.248 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -112.04 110.71 21.16 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 106.334 -1.728 . . . . 73.41 106.334 166.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.502 HG11 HD11 ' E' ' 470' ' ' LEU . 16.7 m -112.97 134.87 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.917 0.887 . . . . 72.51 111.619 -165.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -121.69 149.18 43.61 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.719 0.808 . . . . 64.23 110.171 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.486 ' HB2' ' HG ' ' E' ' 468' ' ' LEU . 46.9 tp -127.32 109.29 11.65 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.035 0.934 . . . . 65.33 108.505 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -106.58 118.5 36.82 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.673 -0.862 . . . . 73.43 108.673 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.409 HD11 HD11 ' A' ' 60' ' ' LEU . 9.8 tt -116.04 141.62 47.88 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 122.788 0.435 . . . . 61.5 110.216 -177.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -143.23 132.56 23.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.934 1.293 . . . . 72.12 108.91 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.47 ' H ' HD21 ' E' ' 460' ' ' LEU . 90.0 m -109.94 135.9 50.07 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.116 0.967 . . . . 75.01 108.631 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.01 129.67 40.41 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.716 0.806 . . . . 60.14 109.917 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.5 p -93.73 152.07 19.2 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.001 0.52 . . . . 73.44 110.545 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 43.3 t -150.03 151.96 34.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.19 0.996 . . . . 64.21 108.379 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -112.46 116.14 29.81 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.121 -0.696 . . . . 73.52 109.121 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.0 mt -92.04 -33.45 14.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.532 0.733 . . . . 71.24 110.421 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.67 178.67 10.07 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.32 -0.855 . . . . 70.43 109.968 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.59 121.77 14.7 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.198 -0.668 . . . . 73.04 109.198 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 69.25 9.53 7.38 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.602 1.161 . . . . 75.1 112.199 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.21 115.93 51.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 108.74 -0.837 . . . . 73.31 108.74 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -112.74 127.33 56.11 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.426 0.69 . . . . 72.43 110.022 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 44.9 tt0 -91.78 127.74 37.35 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.876 -1.056 . . . . 73.44 108.795 169.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.412 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 64.7 t -108.77 122.5 63.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.714 -1.217 . . . . 71.14 107.714 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.9 t -104.37 107.04 21.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.896 -1.15 . . . . 63.24 107.896 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.409 HD11 HD11 ' A' ' 44' ' ' LEU . 43.6 tp -87.85 98.96 11.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.53 -0.915 . . . . 64.34 108.53 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -84.99 110.59 19.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.438 -0.801 . . . . 71.02 109.447 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.4 t -112.84 107.72 23.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.64 -0.874 . . . . 72.22 108.64 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.7 m -95.29 125.71 40.1 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.117 0.967 . . . . 75.44 108.984 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.727 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 26.5 t -118.43 135.52 58.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 124.721 1.209 . . . . 60.01 108.901 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 t -141.31 138.16 32.94 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.23 0.612 . . . . 74.32 109.542 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.58 103.3 6.79 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.947 0.899 . . . . 62.42 108.933 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.2 p -111.24 124.77 52.89 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.009 0.523 . . . . 65.23 109.92 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 73' ' ' ALA . 8.6 mp -96.82 85.34 3.78 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.063 -1.088 . . . . 64.01 108.063 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.18 -105.62 2.91 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 114.413 -1.267 . . . . 54.55 110.472 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -105.85 -24.73 12.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.821 0.848 . . . . 75.24 110.402 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.403 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 22.4 tt0 -96.55 120.33 36.66 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.416 0.687 . . . . 65.54 111.088 -176.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.624 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 57.1 m -75.93 126.86 31.8 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.265 1.026 . . . . 73.2 110.959 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -69.61 -57.99 4.5 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.147 0.579 . . . . 31.15 109.806 174.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -145.77 157.67 43.91 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 114.719 -1.128 . . . . 75.15 111.419 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 64' ' ' VAL . 66.0 tp -129.74 146.29 51.5 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.677 -1.601 . . . . 70.21 107.439 177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.727 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.0 m -141.8 141.12 33.16 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.526 -0.916 . . . . 71.32 108.526 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 8.2 tp10 -147.22 120.96 9.22 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.792 -0.818 . . . . 61.52 108.792 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -135.23 110.22 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.706 -0.479 . . . . 75.55 109.706 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 68.5 mt-30 -91.48 82.87 5.35 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.183 -1.043 . . . . 72.21 108.183 172.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -75.74 106.88 7.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.834 -1.075 . . . . 73.14 109.386 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.98 151.83 20.08 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 112.02 -0.432 . . . . 51.45 112.02 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.02 141.58 10.05 Favored Glycine 0 C--O 1.239 0.442 0 N-CA-C 111.246 -0.742 . . . . 54.13 111.246 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mt -90.65 118.78 36.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.613 -0.884 . . . . 75.02 108.613 173.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.491 ' HD2' HG12 ' A' ' 13' ' ' ILE . 17.7 m-85 -124.08 118.91 28.01 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.559 -0.904 . . . . 63.25 108.559 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.4 p -90.56 110.23 21.36 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 108.473 -0.936 . . . . 51.34 108.473 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.468 ' HB ' HD11 ' A' ' 89' ' ' ILE . 2.8 pp -112.57 150.5 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.361 0.665 . . . . 74.13 111.422 -171.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.446 ' HA ' HG21 ' E' ' 451' ' ' VAL . . . -156.54 159.91 38.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.913 0.885 . . . . 72.54 109.534 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 77.27 4.94 84.89 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 123.533 0.52 . . . . 72.01 114.137 170.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.468 HD11 ' HB ' ' A' ' 86' ' ' ILE . 2.6 pp -134.42 148.65 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.97 0.908 . . . . 64.01 109.537 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.47 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 19.3 tt0 -166.89 175.5 7.67 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.962 0.505 . . . . 74.14 110.363 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.47 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 62.04 -134.89 46.14 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.44 0.543 . . . . 73.22 113.741 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.9 p -71.3 -24.6 62.17 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.618 0.767 . . . . 65.31 111.682 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -72.28 -37.94 68.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.156 0.583 . . . . 74.42 110.07 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.428 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 48.2 ttm -62.6 -42.35 99.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.944 0.498 . . . . 71.22 110.374 172.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.11 -33.58 65.25 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.937 0.773 . . . . 70.22 111.143 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -76.03 -36.47 59.1 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 116.046 -0.524 . . . . 73.23 111.262 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 64.5 m -62.05 -57.58 11.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.798 0.439 . . . . 61.43 111.064 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.529 HD21 HD11 ' E' ' 454' ' ' LEU . 1.7 pp -91.11 -9.13 46.75 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.433 0.693 . . . . 70.24 112.583 -176.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.86 3.67 30.42 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 119.893 -0.393 . . . . 64.42 113.788 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.17 -63.13 0.35 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.318 0.559 . . . . 62.35 111.31 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.488 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 75.2 t80 -61.94 -58.78 6.58 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.25 -0.887 . . . . 73.43 111.886 -173.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.9 m -70.24 -34.92 4.43 Favored Pre-proline 0 CA--C 1.569 1.697 0 N-CA-C 114.128 1.159 . . . . 62.44 114.128 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -52.63 -42.9 59.28 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.24 1.96 . . . . 53.12 112.492 163.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -67.44 -28.32 67.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.247 0.619 . . . . 75.21 111.197 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.568 HG21 HD11 ' A' ' 13' ' ' ILE . 47.4 mm -67.96 -45.44 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.814 0.845 . . . . 73.5 110.468 173.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.19 -18.07 60.81 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.838 -0.619 . . . . 75.02 111.63 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -62.35 -44.44 88.1 Favored Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 124.273 1.029 . . . . 74.34 113.715 -170.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.32 -36.43 79.14 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.1 1.867 . . . . 65.45 113.268 172.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -68.22 -43.02 78.93 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.474 0.71 . . . . 63.13 111.516 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.24 83.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.092 0.557 . . . . 71.43 109.95 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -52.03 -51.43 57.47 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 124.164 0.915 . . . . 75.01 110.151 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.66 -45.85 84.97 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.036 0.935 . . . . 64.12 111.307 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.0 t -59.84 -34.13 72.69 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.047 0.539 . . . . 51.41 111.37 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.462 HG21 HG21 ' A' ' 64' ' ' VAL . 81.6 mt -74.41 -54.54 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.749 0.82 . . . . 65.43 109.848 175.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.496 HG23 ' HG3' ' A' ' 125' ' ' GLN . 89.3 m -48.81 -45.39 40.25 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.909 1.284 . . . . 65.5 111.66 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -63.48 -46.37 86.46 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.811 -1.086 . . . . 45.53 109.95 -175.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 64.1 mtm -64.38 -38.46 91.09 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.144 0.578 . . . . 71.23 111.201 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.8 t -64.69 -43.09 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.569 0.748 . . . . 72.3 110.391 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.8 m -73.61 -32.4 64.06 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.532 0.733 . . . . 74.12 111.159 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -72.33 -30.17 64.5 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.653 0.781 . . . . 70.5 109.672 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.67 -2.89 90.2 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 124.028 0.83 . . . . 74.22 112.788 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m 66.98 25.39 9.33 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 122.479 1.133 . . . . 74.13 110.838 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.425 ' CE1' HG11 ' A' ' 31' ' ' VAL . 96.6 m-85 -91.26 155.68 44.28 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 115.451 -0.795 . . . . 70.45 109.524 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.02 124.61 15.12 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.77 2.313 . . . . 62.1 112.024 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.496 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.3 tt0 -54.76 134.81 47.78 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 124.214 0.947 . . . . 73.35 112.184 -173.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.538 HD13 HD23 ' E' ' 470' ' ' LEU . 19.0 tp -112.03 116.52 30.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.85 -1.068 . . . . 73.44 109.502 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -130.98 100.12 5.13 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.285 -1.005 . . . . 74.52 108.285 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.74 151.14 43.81 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.86 0.464 . . . . 64.24 110.255 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.55 150.61 89.11 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 123.139 0.576 . . . . 62.33 110.601 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.11 120.0 7.05 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.652 2.235 . . . . 71.01 110.472 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.56 124.43 54.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.657 -0.868 . . . . 70.32 108.657 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 135' ' ' ALA . 58.4 t30 -77.02 88.53 3.55 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.982 0.801 . . . . 73.34 109.683 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -64.31 -24.12 67.54 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.146 -0.934 . . . . 72.32 111.05 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.2 -52.71 64.42 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 123.896 0.747 . . . . 71.44 110.107 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.422 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -60.8 -50.79 72.02 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 124.018 0.824 . . . . 70.55 110.285 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -54.36 -43.88 71.71 Favored 'General case' 0 C--O 1.243 0.726 0 O-C-N 124.503 1.127 . . . . 70.43 111.857 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -72.52 -41.45 65.87 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 116.113 -0.494 . . . . 65.34 109.868 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.641 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 22.3 mtp -69.08 -25.91 64.67 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-O 119.28 -0.391 . . . . 71.31 111.483 -175.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -59.57 -31.69 69.67 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.596 0.758 . . . . 45.21 110.3 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -85.85 -41.52 14.92 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.204 1.001 . . . . 64.21 110.758 174.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.641 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 63.3 tp -67.88 -50.65 55.17 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.359 1.063 . . . . 74.55 112.431 -169.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.43 ' HG3' ' HB3' ' A' ' 145' ' ' ALA . 6.4 tp-100 -163.83 25.33 0.08 Allowed 'General case' 0 CA--C 1.556 1.19 0 CA-C-O 121.597 0.713 . . . . 65.31 109.85 -173.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 64.67 -74.88 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.519 1.528 . . . . 74.32 112.451 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.4 tm0? -134.39 -38.26 0.84 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.237 0.615 . . . . 72.02 109.366 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.43 ' HB3' ' HG3' ' A' ' 142' ' ' GLN . . . -60.05 138.28 57.9 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.287 0.635 . . . . 63.23 111.375 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.23 70.46 0.06 OUTLIER Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.137 -0.785 . . . . 72.25 111.137 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -148.18 154.13 39.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.697 0.799 . . . . 62.54 109.018 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 174.01 75.2 0.05 OUTLIER Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.042 -0.823 . . . . 74.14 111.042 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 35.7 p -60.66 94.49 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.825 0.85 . . . . 65.22 111.227 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -103.01 100.21 10.13 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.245 1.018 . . . . 73.0 108.526 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.27 158.36 36.01 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.424 0.689 . . . . 70.54 110.906 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -115.21 94.29 4.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.733 -0.667 . . . . 73.43 109.546 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -79.21 124.61 28.52 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.405 -0.816 . . . . 74.41 109.567 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -66.86 -24.94 66.19 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.304 0.642 . . . . 74.41 111.344 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 C-N-CA 124.543 1.137 . . . . 73.01 111.055 175.578 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.952 0.405 . . . . 74.23 110.8 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.8 p -142.68 139.43 31.17 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.858 -0.526 . . . . 72.44 110.536 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.98 134.14 34.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.881 0.472 . . . . 73.33 110.126 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.88 118.79 3.13 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.38 -0.97 . . . . 62.33 108.38 176.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -134.29 -7.19 2.61 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.031 0.933 . . . . 75.42 110.918 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -69.18 122.98 19.9 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.719 0.807 . . . . 72.24 109.89 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 35.1 p -69.8 95.3 0.89 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.382 0.673 . . . . 44.13 111.47 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -131.64 172.35 12.36 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.877 0.871 . . . . 72.12 110.802 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.2 ptm 52.9 167.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 127.698 2.399 . . . . 71.53 114.04 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.4 m -167.4 140.26 3.4 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.767 1.227 . . . . 72.34 107.936 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.11 156.76 43.67 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.083 0.468 . . . . 63.14 109.971 160.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -125.96 141.19 52.08 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.072 -0.967 . . . . 70.01 108.645 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.604 HD11 HD13 ' B' ' 105' ' ' ILE . 48.7 mt -84.69 121.5 36.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.525 -0.917 . . . . 75.11 108.525 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -88.06 -38.26 15.59 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.601 0.563 . . . . 75.34 110.196 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -170.52 131.14 0.9 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.986 -0.552 . . . . 75.31 109.92 -170.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.7 mt -114.94 140.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 107.153 -1.425 . . . . 53.43 107.153 170.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -167.34 145.54 4.81 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.353 0.597 . . . . 64.3 112.376 -174.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.1 m -75.02 124.88 27.77 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.475 -1.238 . . . . 75.21 109.158 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -98.08 -36.28 10.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.953 0.501 . . . . 74.04 110.391 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 17.8 t70 -147.76 133.66 19.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.51 -0.314 . . . . 70.21 110.643 -168.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.1 mm -133.55 145.95 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.756 1.222 . . . . 72.1 108.842 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.0 t -147.1 136.25 22.5 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.655 1.182 . . . . 50.21 108.147 173.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.52 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -147.84 113.91 5.83 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.925 -1.139 . . . . 71.42 107.925 172.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -119.07 119.25 33.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.071 0.948 . . . . 73.2 108.562 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.629 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.3 85.1 2.57 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 108.189 -1.041 . . . . 72.53 108.189 168.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -65.94 -35.94 32.8 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 122.997 2.465 . . . . 53.12 112.028 -173.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -106.28 9.86 31.89 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.856 -1.065 . . . . 61.15 110.68 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.629 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -25.2 -66.16 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.061 0 C-N-CA 126.287 1.835 . . . . 70.32 115.162 -174.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 10.5 Cg_exo -67.2 -30.79 37.24 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 122.362 2.042 . . . . 74.44 112.168 -169.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -96.57 -30.16 13.45 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.019 -0.991 . . . . 64.14 112.053 -170.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.684 HG21 ' HA ' ' B' ' 73' ' ' ALA . 10.7 p -72.4 -19.74 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 122.471 0.308 . . . . 45.31 111.132 -174.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -63.73 -14.11 49.51 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.574 0.75 . . . . 71.41 112.295 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -64.01 -22.93 67.14 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.57 0.748 . . . . 60.0 111.794 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.92 100.97 12.34 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.022 0.929 . . . . 74.03 109.353 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.47 95.98 4.6 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.636 -0.505 . . . . 72.33 109.636 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -166.61 155.86 11.05 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.67 0.788 . . . . 74.43 109.237 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.409 ' HB3' HD13 ' F' ' 470' ' ' LEU . 46.4 mt-30 -75.37 105.1 1.73 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.006 -0.738 . . . . 72.02 109.006 170.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.492 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 21.1 Cg_endo -58.89 127.48 24.52 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.692 2.261 . . . . 73.33 112.202 -171.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -51.56 126.16 16.67 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.376 1.047 . . . . 71.21 110.225 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.635 HG13 HG13 ' B' ' 64' ' ' VAL . 89.6 t -106.22 139.58 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.363 0.665 . . . . 75.43 110.911 -171.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -108.02 125.72 51.88 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.821 -1.178 . . . . 63.23 107.821 162.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -85.04 137.86 32.8 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.451 -0.944 . . . . 71.32 108.451 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.1 t70 -133.2 135.65 45.19 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.51 -1.293 . . . . 72.31 107.51 175.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.594 HD12 HD12 ' F' ' 460' ' ' LEU . 0.2 OUTLIER -136.59 127.45 27.46 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.226 -1.028 . . . . 34.31 108.226 -177.404 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.49 145.75 34.02 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.069 -1.456 . . . . 73.14 107.069 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 34.6 p -127.86 120.1 27.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.012 -0.736 . . . . 75.21 109.012 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.43 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -119.95 116.14 25.19 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.747 0.819 . . . . 73.21 108.886 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -113.87 170.58 8.16 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.751 0.421 . . . . 64.24 111.616 -172.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 87.2 p -152.8 143.89 23.08 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.786 0.834 . . . . 74.34 110.251 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -83.13 136.14 34.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.198 0.599 . . . . 70.25 109.785 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 58.7 mt -101.67 -46.71 4.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.557 0.743 . . . . 60.01 110.645 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.07 -169.47 2.96 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.305 -0.862 . . . . 51.41 111.156 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -62.98 105.67 0.71 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.01 -0.996 . . . . 64.34 110.343 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 64.11 11.69 6.41 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.277 1.031 . . . . 73.31 112.026 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.4 112.2 37.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 106.567 -1.642 . . . . 74.22 106.567 173.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -133.85 137.94 45.32 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.491 -0.929 . . . . 75.11 108.491 -173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -107.89 137.09 46.51 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.483 0.713 . . . . 74.31 109.641 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.84 143.01 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.53 -0.915 . . . . 55.33 108.53 171.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 40.4 t -125.67 125.17 68.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 109.088 -0.708 . . . . 74.31 109.088 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.4 HD22 HG23 ' B' ' 62' ' ' VAL . 0.2 OUTLIER -102.54 112.33 25.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.71 -1.132 . . . . 72.14 108.572 -174.377 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -97.62 110.98 23.44 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.587 0.755 . . . . 71.23 110.627 174.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.4 HG23 HD22 ' B' ' 60' ' ' LEU . 39.2 t -107.06 104.46 17.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.968 -1.123 . . . . 73.33 107.968 170.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 9.5 m -99.21 130.77 45.53 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.761 -0.829 . . . . 72.13 108.761 174.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.635 HG13 HG13 ' B' ' 40' ' ' VAL . 43.4 t -118.13 127.33 75.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 123.907 0.883 . . . . 73.51 108.93 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 87.9 m -109.75 137.85 46.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.403 -0.962 . . . . 75.11 108.403 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -146.61 145.86 30.22 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 122.844 0.457 . . . . 60.23 109.812 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.5 p -151.61 138.05 18.59 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.309 -0.86 . . . . 52.14 110.663 -172.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.667 HD12 HG22 ' B' ' 31' ' ' VAL . 60.4 mt -103.78 124.3 48.65 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.916 0.886 . . . . 71.14 109.923 174.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.51 -108.55 2.46 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 123.636 0.585 . . . . 61.51 112.733 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.61 5.0 12.36 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.854 0.862 . . . . 71.45 111.399 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -119.71 156.61 30.18 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.97 0.508 . . . . 71.54 110.019 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.2 m -68.3 137.84 55.0 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.595 0.56 . . . . 73.2 110.459 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.684 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -91.64 -65.01 1.04 Allowed 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.478 -1.304 . . . . 62.42 107.478 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -150.88 161.56 42.45 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.088 -0.96 . . . . 74.0 110.244 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.8 mt -132.85 111.56 11.19 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.047 -1.464 . . . . 64.44 107.047 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.2 t -118.86 153.45 34.52 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.005 -0.739 . . . . 51.44 109.005 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -160.64 131.39 5.44 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.875 -0.787 . . . . 75.42 108.875 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.2 t -128.09 145.29 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.679 -0.86 . . . . 51.54 108.679 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.54 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.0 mt-30 -126.37 95.96 4.54 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.999 -0.741 . . . . 73.42 108.999 172.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -86.2 104.01 15.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.167 -0.924 . . . . 73.14 109.895 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -87.44 153.85 25.55 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 111.673 -0.571 . . . . 52.33 111.673 176.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -154.02 127.11 2.06 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 111.417 -0.673 . . . . 75.12 111.417 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 62.7 mt -86.87 126.04 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.6 0.76 . . . . 73.14 109.68 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -131.74 132.07 43.54 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 107.713 -1.217 . . . . 54.33 107.713 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 31.6 m -102.95 91.66 4.23 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.194 -0.669 . . . . 73.2 109.194 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.572 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -94.79 142.58 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 115.859 -0.61 . . . . 72.35 110.939 -167.64 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.07 158.31 42.83 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.328 1.051 . . . . 73.44 109.399 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.47 -56.71 3.87 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.705 -0.68 . . . . 54.3 111.801 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.494 HD11 ' HB ' ' B' ' 86' ' ' ILE . 11.4 pt -69.13 149.7 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.81 0.844 . . . . 74.43 112.168 177.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -159.16 176.15 12.58 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 125.481 1.512 . . . . 72.22 107.588 171.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.09 -129.78 50.06 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.392 0.433 . . . . 62.53 112.716 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -83.38 -19.26 36.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.609 0.364 . . . . 52.21 111.719 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -72.89 -25.98 61.27 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.785 -0.45 . . . . 71.41 109.785 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 24.1 ttt -78.85 -33.57 45.78 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.127 -0.488 . . . . 71.52 110.12 170.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.17 -29.83 70.03 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.219 0.608 . . . . 54.03 111.001 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -69.2 -39.4 78.65 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.463 0.705 . . . . 63.21 111.414 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.8 t -66.87 -66.19 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.267 -0.879 . . . . 42.53 109.81 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 38.8 mt -70.18 -27.31 64.42 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.555 0.742 . . . . 71.3 112.098 -172.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.25 -12.61 58.48 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.574 0.546 . . . . 64.3 114.298 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.51 -55.36 0.39 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.58 0.69 . . . . 72.04 112.282 -173.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.431 ' OH ' ' HB3' ' D' ' 130' ' ' PRO . 66.2 t80 -75.86 -48.17 22.57 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.392 0.516 . . . . 75.44 112.392 -169.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.434 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 88.1 m -59.3 -50.09 89.31 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 123.676 0.791 . . . . 73.44 111.567 176.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 69.9 Cg_exo -55.22 -36.3 93.02 Favored 'Trans proline' 0 C--N 1.389 2.683 0 C-N-CA 121.968 1.779 . . . . 62.14 113.561 169.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.16 -40.63 90.58 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 123.185 0.594 . . . . 73.43 110.643 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.604 HD13 HD11 ' B' ' 13' ' ' ILE . 67.6 mt -63.79 -43.61 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.599 0.76 . . . . 63.33 110.404 175.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.449 HD21 ' HA3' ' B' ' 82' ' ' GLY . 65.9 mt -78.66 -18.89 53.72 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.064 -0.971 . . . . 74.34 112.034 -174.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -58.49 -51.83 79.01 Favored Pre-proline 0 N--CA 1.482 1.162 0 N-CA-C 113.963 1.097 . . . . 75.25 113.963 -170.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.95 -32.23 92.25 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 121.671 1.58 . . . . 62.22 113.312 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -66.05 -50.63 63.47 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.286 0.634 . . . . 74.33 110.472 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.16 -40.09 84.5 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.2 -0.909 . . . . 74.53 110.812 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -65.56 -49.02 70.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.506 1.523 . . . . 53.53 110.939 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -68.27 -34.53 76.34 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.81 -0.632 . . . . 53.54 109.842 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.7 t -67.99 -34.32 76.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.777 0.431 . . . . 74.01 111.223 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.465 ' O ' HG23 ' B' ' 118' ' ' VAL . 66.6 mt -63.83 -56.48 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.662 -0.495 . . . . 53.03 109.662 172.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.1 m -60.42 -26.02 66.39 Favored 'General case' 0 CA--C 1.554 1.131 0 O-C-N 123.973 0.796 . . . . 55.0 111.473 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.0 t -62.99 -50.45 70.69 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.225 0.61 . . . . 62.43 109.836 173.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -71.57 -32.1 67.7 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.414 0.686 . . . . 62.05 111.079 -176.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 114' ' ' ILE . 87.6 t -61.98 -44.62 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.65 0.78 . . . . 64.32 109.55 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.6 t -65.37 -35.76 81.93 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.039 -0.982 . . . . 60.14 111.368 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.0 mtt-85 -68.06 -32.17 72.32 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.475 -0.784 . . . . 62.42 110.323 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.87 8.12 77.29 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.952 0.783 . . . . 75.53 112.965 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 17' ' ' TYR . 61.5 p 54.77 27.42 8.82 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.15 1.78 . . . . 74.14 113.626 176.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -83.43 154.74 66.16 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.397 0.679 . . . . 73.55 110.09 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -55.99 157.42 16.89 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.083 2.522 . . . . 55.33 113.223 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -64.56 113.77 3.92 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.369 -0.832 . . . . 73.23 111.38 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.461 HD22 HD22 ' F' ' 470' ' ' LEU . 49.1 mt -121.09 119.51 32.64 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.899 -0.778 . . . . 53.21 108.899 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.421 ' O ' HD21 ' F' ' 468' ' ' LEU . 29.1 m-80 -115.0 112.98 23.5 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.806 -0.813 . . . . 64.32 108.806 -177.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.35 143.26 56.06 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.33 0.652 . . . . 55.34 111.353 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.56 150.9 64.16 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.843 0.857 . . . . 63.41 110.687 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.23 145.3 17.02 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.879 2.386 . . . . 71.43 111.775 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.31 118.59 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.246 -1.02 . . . . 63.52 108.246 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -79.8 83.37 5.75 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.618 -0.512 . . . . 61.14 109.618 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -64.45 -24.28 67.57 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.528 0.731 . . . . 74.1 111.962 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.56 -52.05 55.28 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.523 0.729 . . . . 74.51 110.268 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.16 95.26 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.937 0.895 . . . . 71.23 110.938 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 89.9 mt -74.07 -20.89 60.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.075 -0.966 . . . . 61.53 112.028 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.599 ' CE1' HD11 ' B' ' 141' ' ' LEU . 61.0 t80 -65.96 -29.91 70.39 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.625 0.37 . . . . 64.02 110.732 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 53.8 mtt -72.03 -30.63 65.39 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 109.732 -0.47 . . . . 71.43 109.732 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -80.88 -23.17 39.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.788 0.835 . . . . 64.33 110.694 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' B' ' 137' ' ' PHE . 39.5 t80 -62.08 -21.06 64.65 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.749 1.219 . . . . 71.52 111.236 171.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.599 HD11 ' CE1' ' B' ' 137' ' ' PHE . 30.2 mt -118.28 12.4 13.42 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.35 1.06 . . . . 75.21 110.806 -172.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -140.7 173.95 11.0 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.107 0.963 . . . . 75.14 110.095 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -144.71 8.19 1.29 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.813 0.845 . . . . 72.12 109.843 168.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -82.22 119.72 24.44 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 123.618 0.767 . . . . 74.1 109.86 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.18 124.4 31.13 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.407 -0.59 . . . . 33.04 109.407 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.7 72.85 2.71 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.322 0.389 . . . . 72.43 112.926 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -76.5 108.93 9.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.299 0.639 . . . . 73.13 109.712 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -111.03 -131.62 5.93 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.178 -0.769 . . . . 51.24 111.178 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.628 ' H ' ' HB ' ' D' ' 7' ' ' THR . 86.3 m -156.81 92.18 1.27 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.833 0.853 . . . . 71.54 108.903 173.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' GLU . . . . . 0.571 ' HB3' ' HB2' ' D' ' 8' ' ' GLU . 0.0 OUTLIER -77.7 163.27 26.33 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.723 -0.473 . . . . 63.12 109.723 173.103 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -163.96 130.67 3.2 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.121 -0.696 . . . . 55.34 109.121 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -90.92 132.65 35.81 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.836 0.454 . . . . 75.23 110.377 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -110.93 158.01 19.23 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.913 -1.143 . . . . 71.13 107.913 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -138.6 129.18 26.22 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.501 -0.555 . . . . 74.35 109.501 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 C-N-CA 123.625 0.77 . . . . 75.42 110.212 179.838 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.732 0.301 . . . . 72.24 110.818 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -145.03 95.45 2.69 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 106.874 -1.528 . . . . 74.33 106.874 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -62.86 -55.77 23.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.977 0.911 . . . . 53.03 110.213 -174.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -165.45 86.93 0.39 Allowed 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.694 -1.139 . . . . 73.23 108.57 172.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -74.17 90.85 2.08 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.842 -0.799 . . . . 72.52 108.842 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -62.37 91.6 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.015 0.926 . . . . 71.13 110.146 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 31.2 m -98.72 97.84 9.03 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.415 -0.958 . . . . 61.41 108.415 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.92 120.21 13.84 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 106.82 -1.548 . . . . 72.3 106.82 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 26.7 ttt 63.98 113.41 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.591 1.182 . . . . 71.14 110.12 -162.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 59.5 m -127.93 117.56 21.98 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.206 -1.035 . . . . 74.35 108.206 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.611 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.1 t80 -120.23 126.32 50.34 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.808 -0.812 . . . . 74.02 108.808 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -142.51 109.05 5.34 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.385 -0.968 . . . . 74.02 108.385 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -73.82 122.11 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.158 -0.682 . . . . 64.45 109.158 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.569 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.8 mm-40 -86.47 -42.26 13.73 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.179 -0.919 . . . . 74.54 110.35 -175.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -175.56 139.93 0.45 Allowed 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.614 0.571 . . . . 74.55 109.523 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.0 mt -131.56 133.87 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.463 -0.94 . . . . 71.21 108.463 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.522 ' HB3' HG23 ' D' ' 122' ' ' THR . 27.3 p90 -170.64 172.61 5.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.691 0.758 . . . . 73.13 111.565 -169.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -96.07 118.5 32.79 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.382 -0.827 . . . . 72.32 109.16 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.454 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.8 mmtp -65.78 -48.16 72.73 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 122.33 1.062 . . . . 61.02 108.156 169.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.438 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.5 t70 -139.82 146.25 39.16 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 113.814 -1.539 . . . . 74.04 109.884 -172.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.59 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 80.5 mt -140.39 140.93 33.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 106.701 -1.592 . . . . 74.01 106.701 174.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -159.25 149.84 19.51 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.173 0.511 . . . . 75.31 110.663 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.2 t80 -148.49 136.96 21.34 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.918 -1.141 . . . . 70.32 107.918 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.67 118.65 18.4 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.695 0.798 . . . . 63.41 109.754 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.92 76.87 45.2 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 106.356 -1.72 . . . . 62.51 106.356 165.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.07 -40.61 11.29 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.738 2.292 . . . . 74.33 111.199 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.03 21.12 3.27 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.628 -1.169 . . . . 73.22 111.417 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.412 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -44.65 -57.83 6.18 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 114.39 1.256 . . . . 65.33 114.39 -171.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.4 -36.43 66.67 Favored 'Trans proline' 0 C--N 1.385 2.459 0 CA-C-N 121.744 1.658 . . . . 60.31 112.397 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -70.07 -35.42 74.2 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.372 0.669 . . . . 74.31 112.135 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.5 p -79.6 -24.49 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 N-CA-C 111.886 0.328 . . . . 72.41 111.886 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.59 -30.2 69.75 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.617 0.367 . . . . 72.35 111.867 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -86.67 11.45 12.92 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.905 0.482 . . . . 74.45 111.12 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.799 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.99 160.05 14.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.231 1.012 . . . . 65.41 109.563 170.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -71.48 131.44 43.31 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.514 0.725 . . . . 63.14 110.561 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.532 ' NE1' ' HG3' ' C' ' 124' ' ' PRO . 31.5 t90 -73.86 91.91 2.02 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.424 -0.807 . . . . 72.22 111.297 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.539 ' HG2' ' HD2' ' G' ' 471' ' ' LYS . 9.1 tm0? -147.04 74.43 11.98 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 107.444 -1.317 . . . . 75.33 107.444 169.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -85.15 137.14 6.04 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.732 2.288 . . . . 54.45 112.717 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -86.06 110.07 19.27 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.268 -1.012 . . . . 72.51 108.268 171.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' G' ' 468' ' ' LEU . 15.9 m -84.6 100.47 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-O 122.532 1.158 . . . . 74.14 110.978 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -95.74 103.29 15.16 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.784 -1.098 . . . . 74.52 108.279 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.52 134.75 36.73 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.25 -0.648 . . . . 72.32 109.25 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -127.67 136.08 51.1 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.352 -0.981 . . . . 55.42 108.352 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 tp -129.22 135.12 48.4 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.438 0.695 . . . . 72.04 109.683 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.412 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 27.5 t70 -149.04 153.06 37.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.883 0.873 . . . . 72.25 109.664 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -146.19 153.39 40.58 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.155 0.582 . . . . 72.21 109.441 170.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.55 160.54 39.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.248 1.019 . . . . 63.01 109.011 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -144.43 155.67 43.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.461 0.704 . . . . 54.24 109.223 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.5 p -157.4 153.78 27.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.601 0.76 . . . . 60.53 109.353 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -95.8 118.05 31.72 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.993 -0.743 . . . . 60.24 108.993 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' C' ' 57' ' ' GLU . 60.5 mt -89.37 -34.92 16.34 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.179 0.592 . . . . 75.43 110.337 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.3 -170.06 2.16 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.645 0.778 . . . . 50.2 111.004 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.91 111.44 1.66 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.85 0.86 . . . . 42.14 110.417 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 70.79 -5.75 1.4 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.344 1.458 . . . . 71.52 112.564 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.0 t -93.77 105.7 17.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.456 -0.942 . . . . 73.54 108.456 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -118.79 122.96 43.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.542 -0.754 . . . . 73.31 109.357 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.486 ' HB2' HD11 ' C' ' 51' ' ' LEU . 35.4 tt0 -84.36 144.7 28.65 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.532 0.733 . . . . 72.31 110.294 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -131.14 140.55 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.259 -1.015 . . . . 70.12 108.259 167.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.427 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 90.9 t -130.95 130.83 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.067 -1.086 . . . . 75.13 108.067 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.96 109.42 21.41 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.456 -1.313 . . . . 63.51 107.456 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.412 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.2 tmm_? -101.65 106.77 17.86 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.127 -1.064 . . . . 65.14 108.127 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.621 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.7 t -107.96 137.55 38.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.88 -1.156 . . . . 75.01 107.88 175.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -132.48 121.93 24.11 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.171 -0.678 . . . . 71.01 109.171 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 64.8 t -111.51 110.33 31.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 124.18 0.992 . . . . 73.11 108.9 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.487 HG23 HD23 ' C' ' 75' ' ' LEU . 4.0 m -108.85 108.28 19.0 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.226 0.61 . . . . 72.03 109.38 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.04 123.47 45.98 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.828 -0.804 . . . . 74.44 108.828 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.6 m -137.83 130.47 29.67 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.949 0.5 . . . . 65.23 111.046 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.799 HD13 ' HG2' ' C' ' 34' ' ' LYS . 6.6 mt -84.81 33.99 0.53 Allowed 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 125.255 1.422 . . . . 74.55 110.723 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.62 -100.13 1.84 Allowed Glycine 0 C--N 1.352 1.427 0 N-CA-C 111.052 -0.819 . . . . 74.22 111.052 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.61 -31.89 18.36 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.474 -0.565 . . . . 75.45 109.474 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.02 120.87 24.78 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.725 0.81 . . . . 63.31 109.13 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.5 m -76.73 128.7 35.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.981 -0.748 . . . . 61.13 108.981 169.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.747 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.08 -57.78 4.2 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.424 -0.954 . . . . 75.12 108.424 173.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -165.65 173.72 10.52 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.309 -0.86 . . . . 73.55 110.768 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.487 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -133.24 144.23 49.63 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.089 -1.448 . . . . 60.03 107.089 172.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.454 ' SG ' HG23 ' C' ' 114' ' ' ILE . 46.6 t -146.31 139.65 25.87 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.158 -1.053 . . . . 70.05 108.158 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -151.6 133.65 15.1 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.517 -0.549 . . . . 73.43 109.517 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.4 t -134.99 138.89 48.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.26 1.024 . . . . 75.12 108.474 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -114.17 88.17 2.79 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.258 -1.015 . . . . 72.42 108.258 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.401 ' HG3' HD22 ' C' ' 106' ' ' LEU . 71.9 tp60 -79.1 97.77 6.27 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.175 -0.92 . . . . 74.43 110.197 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -98.74 144.13 17.03 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-O 121.199 0.333 . . . . 51.13 113.035 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.432 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -145.09 132.81 4.84 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.514 -1.034 . . . . 52.44 110.514 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 15.3 mm -88.97 123.7 41.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 108.394 -0.965 . . . . 71.35 108.394 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.611 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 51.2 m-85 -130.4 116.14 17.86 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.159 0.583 . . . . 71.51 109.787 -173.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 74.0 m -84.0 108.51 17.0 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.684 -0.487 . . . . 31.33 109.684 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.523 ' HB ' HD11 ' C' ' 89' ' ' ILE . 2.7 pp -117.06 138.61 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.949 0.899 . . . . 74.32 110.25 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.34 158.14 43.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.162 0.985 . . . . 64.33 109.554 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.39 -30.41 5.26 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 113.892 0.317 . . . . 73.22 113.892 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.567 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -105.72 150.2 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 121.23 0.538 . . . . 75.1 111.792 -176.697 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.91 -170.79 3.73 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.784 -1.098 . . . . 75.55 108.505 166.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.401 ' HA2' HG23 ' G' ' 455' ' ' THR . . . 64.05 -124.45 30.33 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 114.112 0.405 . . . . 74.22 114.112 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.518 ' HB ' HD21 ' C' ' 141' ' ' LEU . 74.1 p -76.35 -29.53 57.26 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.834 0.853 . . . . 63.03 111.806 -175.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.87 -42.46 85.56 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.592 -0.521 . . . . 74.42 109.592 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.557 ' SD ' ' HA ' ' G' ' 452' ' ' VAL . 28.1 ttt -74.66 -33.12 62.45 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.857 -0.61 . . . . 72.12 110.807 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.62 -48.69 69.09 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.75 0.657 . . . . 52.23 109.706 174.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.434 ' NE2' ' HA ' ' C' ' 134' ' ' ASP . 11.6 t-80 -77.62 -35.16 52.99 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.857 0.723 . . . . 75.42 111.492 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.412 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 51.8 t -56.86 -36.79 70.46 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.849 0.718 . . . . 74.52 110.407 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.451 HD12 HD13 ' G' ' 454' ' ' LEU . 23.9 mt -101.07 -15.22 17.5 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.877 0.871 . . . . 71.52 110.917 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.76 -30.41 48.27 Favored Glycine 0 C--N 1.352 1.42 0 N-CA-C 114.842 0.697 . . . . 74.34 114.842 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.83 -36.88 0.06 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.938 0.495 . . . . 54.01 110.859 -172.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.412 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 70.4 t80 -66.88 -44.29 81.29 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.38 1.472 . . . . 74.42 112.282 -175.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 23.3 m -77.12 -47.91 2.6 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 123.394 0.678 . . . . 72.24 111.836 174.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -53.96 -28.85 51.37 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.138 1.892 . . . . 74.1 114.273 171.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -68.35 -39.56 81.81 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 123.109 0.564 . . . . 62.43 109.939 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 42.3 mm -59.92 -39.44 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.439 -0.578 . . . . 63.22 109.439 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.432 HD21 ' HA3' ' C' ' 82' ' ' GLY . 76.7 mt -85.52 -12.77 50.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.599 1.16 . . . . 75.33 112.501 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -63.37 -51.4 68.32 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 113.784 1.031 . . . . 73.42 113.784 -171.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -66.79 -30.99 40.26 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 121.731 1.621 . . . . 51.22 112.263 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -67.82 -46.25 72.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.457 0.703 . . . . 74.42 110.935 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.31 93.02 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.482 0.713 . . . . 60.13 109.806 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -53.15 -60.26 3.51 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.293 0.995 . . . . 62.33 110.938 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -62.56 -29.4 70.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.614 0.766 . . . . 74.15 110.945 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.432 ' SG ' HG12 ' C' ' 21' ' ' ILE . 8.3 t -72.55 -44.48 62.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.774 0.43 . . . . 74.11 110.832 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.621 HD11 ' HB ' ' C' ' 62' ' ' VAL . 85.5 mt -64.88 -50.09 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.31 0.644 . . . . 73.54 110.333 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.4 m -64.21 -29.34 70.45 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.413 -0.812 . . . . 75.1 110.741 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 28.1 t -65.54 -52.62 51.15 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.987 0.515 . . . . 74.03 109.71 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.436 ' HB3' ' HB2' ' C' ' 23' ' ' PHE . 0.0 OUTLIER -54.15 -46.86 72.37 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.472 1.109 . . . . 54.5 112.026 178.58 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.576 HG11 HD13 ' C' ' 126' ' ' LEU . 71.2 t -65.97 -43.41 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.45 -0.796 . . . . 72.21 111.157 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.9 t -61.08 -36.94 81.0 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.445 0.698 . . . . 63.43 111.167 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -69.71 -32.02 70.36 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.134 -0.939 . . . . 65.12 110.329 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.08 7.05 76.98 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.894 0.746 . . . . 61.53 112.958 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.412 HG23 ' HB3' ' D' ' 17' ' ' TYR . 53.2 p 57.7 28.63 16.1 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 126.37 1.868 . . . . 71.14 113.751 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.5 ' HB2' HG13 ' C' ' 118' ' ' VAL . 93.2 m-85 -91.98 163.44 27.48 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 108.914 -0.772 . . . . 65.43 108.914 170.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.532 ' HG3' ' NE1' ' C' ' 36' ' ' TRP . 56.5 Cg_endo -64.06 -178.93 0.67 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.934 2.423 . . . . 73.33 114.641 -174.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -61.2 128.89 38.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.945 -1.025 . . . . 74.41 111.683 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.576 HD13 HG11 ' C' ' 118' ' ' VAL . 6.7 mp -134.81 86.49 2.26 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.445 -0.946 . . . . 72.14 108.445 170.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -99.77 123.68 44.27 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.089 -0.708 . . . . 64.14 109.089 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -64.93 118.87 9.69 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.782 -0.821 . . . . 63.43 108.782 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.02 141.25 93.75 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.727 0.811 . . . . 75.04 111.318 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.442 ' HB3' HD12 ' A' ' 16' ' ' ILE . 14.8 Cg_endo -58.05 103.74 0.16 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.436 2.091 . . . . 73.43 112.094 174.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.448 HG22 ' SD ' ' G' ' 464' ' ' MET . 29.2 t -95.46 140.82 16.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.642 -1.614 . . . . 75.32 106.642 174.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -77.36 66.77 3.18 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.345 -0.613 . . . . 34.33 109.345 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -54.33 -43.12 70.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.912 0.885 . . . . 72.22 111.183 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.434 ' HA ' ' NE2' ' C' ' 96' ' ' HIS . 7.8 m-20 -66.49 -41.93 88.17 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.89 -1.05 . . . . 61.42 112.484 -175.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.91 -43.08 72.43 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.799 0.687 . . . . 64.42 110.398 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.05 -21.15 60.84 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.027 -0.988 . . . . 63.31 111.9 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -82.48 -34.6 27.98 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.902 -0.407 . . . . 72.01 109.902 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 37.1 tpp -64.86 -46.64 80.97 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.206 -0.452 . . . . 44.44 110.938 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -72.15 -35.18 68.98 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.47 -0.786 . . . . 74.14 110.933 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -56.5 -86.93 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.149 0.979 . . . . 74.45 109.81 171.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.518 HD21 ' HB ' ' C' ' 92' ' ' THR . 1.1 tm? 62.74 -75.44 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.977 1.311 . . . . 42.44 109.838 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -151.4 42.06 0.73 Allowed 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 107.78 -1.193 . . . . 73.13 107.78 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -152.25 168.08 26.51 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.048 1.339 . . . . 75.22 108.091 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -78.73 146.57 33.84 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 122.797 0.439 . . . . 75.54 110.567 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.592 ' HB3' HG21 ' G' ' 463' ' ' THR . . . -82.07 171.1 14.75 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.556 0.742 . . . . 72.14 110.656 175.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.97 -106.55 2.34 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 111.301 -0.72 . . . . 62.22 111.301 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 59.72 -171.3 0.13 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.831 1.252 . . . . 74.45 112.838 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.02 -111.02 0.44 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.623 -1.391 . . . . 73.31 109.623 170.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.3 t 177.65 169.54 0.66 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.73 1.212 . . . . 72.44 109.905 170.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 150' ' ' GLU . . . . . 0.751 ' HB3' ' HG2' ' A' ' 12' ' ' GLN . 31.7 tt0 -155.5 100.78 2.14 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.92 0.888 . . . . 64.22 108.939 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 62.24 178.88 0.13 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.585 1.154 . . . . 74.54 112.796 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -168.04 178.65 4.99 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.581 1.153 . . . . 74.12 109.684 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.9 pm0 -67.88 178.13 1.88 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.812 0.845 . . . . 71.31 110.824 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -64.15 -64.8 0.79 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 120.925 0.393 . . . . 63.14 110.422 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.824 0 CA-C-N 115.427 -0.806 . . . . 74.31 109.208 -174.349 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.784 0.326 . . . . 62.15 110.946 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 56.0 m -126.93 95.88 4.45 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.389 0.675 . . . . 72.53 109.6 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.13 151.13 28.43 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.546 -0.538 . . . . 74.33 109.546 176.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -167.07 157.43 11.4 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.983 0.913 . . . . 63.25 109.812 -173.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -157.65 144.38 18.0 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.994 -0.743 . . . . 55.1 108.994 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' ASN . . . . . 0.434 HD22 ' N ' ' D' ' 6' ' ' ASN . 0.9 OUTLIER -98.86 99.2 10.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.351 -0.981 . . . . 72.41 108.351 178.053 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.628 ' HB ' ' H ' ' B' ' 149' ' ' THR . 18.1 p -66.01 -60.97 2.32 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.112 0.565 . . . . 61.04 109.908 174.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' B' ' 150' ' ' GLU . 50.7 mt-10 -128.64 74.04 1.54 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.88 0.872 . . . . 64.43 108.821 171.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.429 ' HG2' HD11 ' D' ' 89' ' ' ILE . 7.0 ttp -33.21 126.39 0.35 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.026 1.33 . . . . 55.21 112.759 170.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 87.9 m -124.95 135.6 52.97 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.18 0.515 . . . . 73.14 110.991 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -158.7 89.86 0.98 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.727 -1.582 . . . . 74.4 106.727 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -116.69 116.36 27.39 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.584 -0.895 . . . . 74.44 108.584 -176.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.42 HG21 HD11 ' D' ' 16' ' ' ILE . 14.7 mt -82.48 117.55 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.569 -0.9 . . . . 74.21 108.569 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -78.56 -34.8 46.76 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.992 0.517 . . . . 73.13 111.37 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -169.2 130.92 1.17 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 111.631 0.234 . . . . 73.22 111.631 -168.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.446 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.6 mp -115.02 134.4 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.075 -1.454 . . . . 62.02 107.075 173.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.412 ' HB3' HG23 ' C' ' 122' ' ' THR . 36.4 p90 -165.52 170.3 14.52 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.811 0.815 . . . . 75.13 111.868 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -102.52 123.15 45.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.265 -1.334 . . . . 73.34 108.817 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -93.25 -18.45 22.48 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.114 -0.494 . . . . 75.35 110.011 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -156.39 136.12 12.52 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.329 -0.989 . . . . 73.15 108.329 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.426 ' CD1' ' HE3' ' C' ' 117' ' ' MET . 17.5 mt -134.59 138.77 49.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.627 -1.249 . . . . 70.54 107.627 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -144.67 133.87 22.9 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.353 0.661 . . . . 54.33 109.773 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.59 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 70.5 t80 -144.67 127.48 16.3 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.56 -1.644 . . . . 72.44 106.56 167.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.5 mt-10 -134.89 126.64 29.13 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.638 0.775 . . . . 71.01 109.357 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.54 85.14 25.82 Favored Pre-proline 0 C--O 1.242 0.673 0 N-CA-C 107.953 -1.129 . . . . 73.44 107.953 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.22 -40.47 11.18 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.909 2.406 . . . . 70.22 112.482 -171.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -107.73 27.59 9.04 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 123.871 0.868 . . . . 74.32 109.789 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.74 -68.57 0.22 Allowed Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 115.284 1.586 . . . . 73.14 115.284 -161.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.57 -19.97 16.2 Favored 'Trans proline' 0 C--N 1.382 2.299 0 CA-C-N 122.394 1.891 . . . . 72.35 113.385 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -74.81 -38.79 61.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.534 1.133 . . . . 71.42 110.698 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' D' ' 73' ' ' ALA . 10.7 p -84.38 -25.24 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 122.789 0.435 . . . . 70.22 111.694 -172.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -58.43 -27.99 64.84 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.371 0.669 . . . . 75.13 112.359 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -53.73 -31.33 47.86 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.786 1.234 . . . . 74.11 111.541 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -87.51 96.95 10.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.984 0.913 . . . . 74.45 109.135 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -81.33 88.58 6.08 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.992 -0.549 . . . . 53.54 110.946 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -163.15 162.64 25.68 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.664 0.786 . . . . 71.33 109.153 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 1.5 mp0 -73.47 116.35 50.5 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 109.238 -0.652 . . . . 63.34 109.238 171.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.716 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 77.5 Cg_exo -56.55 138.97 86.61 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.94 3.094 . . . . 74.12 113.971 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.11 111.73 1.44 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.025 0.828 . . . . 71.12 109.372 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.496 HG23 HG13 ' D' ' 64' ' ' VAL . 7.3 p -103.79 135.35 41.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.357 -0.838 . . . . 73.45 110.917 -168.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -115.52 132.39 56.64 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.326 1.05 . . . . 72.44 108.346 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.657 ' HB2' HD23 ' H' ' 468' ' ' LEU . 8.5 tt -98.17 126.23 43.54 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.955 0.502 . . . . 73.44 109.746 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.521 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.8 m-20 -133.49 116.08 15.54 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.898 -1.149 . . . . 74.01 107.898 171.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.408 ' HG ' HD21 ' D' ' 42' ' ' LEU . 91.6 mt -113.88 142.34 46.23 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.153 0.581 . . . . 73.2 109.988 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.459 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.2 t70 -141.8 154.89 45.52 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.947 -1.131 . . . . 75.42 107.947 173.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.466 ' HB ' HD23 ' H' ' 460' ' ' LEU . 13.4 t -127.68 164.4 22.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.104 0.561 . . . . 55.14 109.712 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.542 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.24 161.79 42.1 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.784 0.834 . . . . 52.3 109.627 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 37.3 p -159.1 151.84 21.83 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.099 0.559 . . . . 72.53 109.726 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.4 p -157.93 139.23 13.51 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.36 0.664 . . . . 71.44 109.707 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -79.13 119.37 22.15 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.553 -0.536 . . . . 72.24 109.553 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.7 mt -90.15 -34.63 15.78 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.86 -0.793 . . . . 72.4 108.86 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.16 -178.95 5.36 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.224 1.01 . . . . 63.22 109.672 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.64 122.17 17.48 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.221 -0.899 . . . . 65.21 109.197 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 72.16 12.46 5.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.394 1.478 . . . . 74.41 112.402 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.6 t -128.98 117.6 44.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 123.972 0.909 . . . . 41.32 108.879 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' H' ' 454' ' ' LEU . 5.5 m-85 -132.88 130.08 39.25 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.398 1.079 . . . . 74.1 108.703 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.5 ' HB2' HD11 ' D' ' 51' ' ' LEU . 18.5 tt0 -91.83 142.29 27.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.972 -0.751 . . . . 61.42 108.972 170.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -123.08 142.31 40.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.421 -1.326 . . . . 74.14 107.421 172.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 45.9 t -126.37 132.09 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.807 -0.812 . . . . 72.53 108.807 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.32 120.39 42.25 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.705 -0.85 . . . . 75.35 108.705 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.459 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 33.3 ttm-85 -102.94 98.45 8.41 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.312 -0.996 . . . . 64.4 108.312 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -100.2 123.37 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.859 -0.793 . . . . 51.44 108.859 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 15.4 m -119.13 141.82 48.47 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.496 0.718 . . . . 75.22 109.85 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.496 HG13 HG23 ' D' ' 40' ' ' VAL . 75.6 t -136.64 103.29 3.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.0 1.32 . . . . 55.25 108.561 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 83.4 m -100.9 113.72 26.93 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.349 -0.982 . . . . 61.33 108.349 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -122.55 142.82 50.21 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.726 0.811 . . . . 72.1 109.857 -174.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 23.5 m -144.13 134.39 24.41 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.652 0.595 . . . . 72.1 111.795 -176.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.621 HD12 HG22 ' D' ' 31' ' ' VAL . 48.9 mt -106.23 123.34 47.88 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.325 1.05 . . . . 63.15 109.198 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.56 -124.56 36.41 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 115.155 -0.93 . . . . 61.2 113.609 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.89 6.47 47.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 71.02 112.326 -175.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.0 165.1 26.79 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.668 0.387 . . . . 75.13 110.875 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 34.7 m -68.23 138.07 55.28 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.762 0.663 . . . . 70.33 110.473 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.775 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -90.33 -70.69 0.66 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.342 -0.984 . . . . 60.14 108.342 173.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -147.63 140.6 24.96 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.576 -0.738 . . . . 72.33 109.605 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 88.1 mt -109.62 143.18 39.7 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.49 -1.3 . . . . 63.52 107.49 172.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.545 ' SG ' HG23 ' D' ' 114' ' ' ILE . 38.7 t -158.05 137.19 11.63 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.231 -0.285 . . . . 53.22 110.231 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.59 133.27 13.01 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.945 -0.761 . . . . 74.31 108.945 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.7 t -128.77 138.02 55.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.572 -0.899 . . . . 72.35 108.572 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -116.32 87.35 2.67 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.096 -1.075 . . . . 65.22 108.096 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.14 103.95 10.37 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.347 -1.297 . . . . 72.24 108.944 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.09 141.39 15.96 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.314 -0.714 . . . . 73.43 111.314 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.475 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -139.86 130.02 4.53 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.681 -0.968 . . . . 73.05 110.681 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 58.7 mt -92.57 115.95 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.717 -0.846 . . . . 54.1 108.717 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -116.33 125.55 52.28 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.931 0.892 . . . . 53.12 109.692 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -104.39 109.29 21.09 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.481 0.712 . . . . 73.34 109.353 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.461 HD11 HG12 ' H' ' 452' ' ' VAL . 2.4 pp -110.78 144.14 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.244 0.617 . . . . 54.34 109.866 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.45 127.07 8.73 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.789 -0.819 . . . . 74.42 108.789 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.36 -20.51 42.25 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.398 -0.681 . . . . 64.35 111.398 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.429 HD11 ' HG2' ' D' ' 9' ' ' MET . 3.5 mp -98.41 130.75 46.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.231 1.013 . . . . 74.22 108.341 -176.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.692 ' HB3' HG22 ' H' ' 451' ' ' VAL . 8.4 pt-20 -160.47 173.8 15.03 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.442 0.697 . . . . 74.13 110.7 -174.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.01 -133.82 49.17 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 124.023 0.827 . . . . 72.32 113.879 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.1 m -63.35 -31.73 72.97 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.706 0.803 . . . . 52.22 110.73 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -69.34 -33.66 73.44 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.74 0.816 . . . . 73.03 110.945 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.488 ' SD ' HD12 ' D' ' 98' ' ' LEU . 17.5 tmm? -72.74 -37.61 67.66 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.263 0.625 . . . . 63.3 110.389 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.31 95.94 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.61 0.719 . . . . 40.15 110.55 171.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -71.53 -29.53 64.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.899 1.28 . . . . 61.22 111.405 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -81.12 -52.26 7.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.811 0.445 . . . . 62.14 110.874 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.488 HD12 ' SD ' ' D' ' 94' ' ' MET . 92.6 mt -84.35 -27.9 27.39 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.995 0.518 . . . . 70.42 111.697 -171.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.02 7.41 58.8 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.677 -0.513 . . . . 63.23 114.138 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -150.29 -61.3 0.2 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.393 0.597 . . . . 72.42 111.232 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -69.7 -41.65 75.1 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.034 0.534 . . . . 73.34 112.145 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.444 ' SG ' HD23 ' D' ' 98' ' ' LEU . 88.5 m -65.35 -45.97 70.48 Favored Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 123.62 0.768 . . . . 64.42 112.38 -178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -53.1 -36.89 78.51 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.155 1.903 . . . . 70.03 113.177 167.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -67.77 -30.89 70.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.099 0.56 . . . . 64.24 111.438 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.0 -37.33 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.276 0.631 . . . . 63.12 110.584 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.475 HD21 ' HA3' ' D' ' 82' ' ' GLY . 92.7 mt -77.49 -19.77 55.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.057 0.943 . . . . 72.33 111.997 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.64 ' HZ ' HD22 ' D' ' 128' ' ' LEU . 40.5 t80 -64.65 -43.64 71.01 Favored Pre-proline 0 CA--C 1.56 1.327 0 N-CA-C 114.347 1.24 . . . . 73.11 114.347 -170.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -54.35 -45.51 40.42 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 121.952 1.768 . . . . 74.33 112.491 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -70.0 -35.59 74.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.041 0.936 . . . . 75.32 111.759 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.71 67.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.269 0.628 . . . . 60.32 110.502 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.445 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.2 ttp180 -58.48 -49.09 78.61 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.253 -0.885 . . . . 54.42 110.534 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.52 -46.63 87.53 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.136 0.897 . . . . 72.45 111.477 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.8 t -57.73 -42.15 83.28 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.739 0.65 . . . . 63.15 110.639 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.545 HG23 ' SG ' ' D' ' 76' ' ' CYS . 67.8 mt -61.67 -57.11 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.608 0.763 . . . . 73.01 110.56 174.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.548 HG23 ' HG3' ' D' ' 125' ' ' GLN . 86.4 m -51.67 -44.68 63.15 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.721 1.208 . . . . 75.31 112.061 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.7 t -63.95 -42.59 97.26 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.196 -0.911 . . . . 63.42 109.999 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.9 mtm -69.81 -34.39 73.62 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.999 0.52 . . . . 61.42 111.469 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 114' ' ' ILE . 66.8 t -62.06 -44.89 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.612 0.765 . . . . 52.1 109.934 175.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.1 p -72.73 -30.48 64.21 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.981 0.512 . . . . 62.34 111.089 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -72.07 -29.76 64.45 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.466 0.706 . . . . 74.45 110.455 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.34 10.14 74.35 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.798 0.686 . . . . 51.41 112.556 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.522 HG23 ' HB3' ' C' ' 17' ' ' TYR . 73.0 p 56.85 20.78 5.49 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 126.68 1.992 . . . . 73.23 114.082 177.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.02 150.16 71.26 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 109.067 -0.716 . . . . 75.21 109.067 168.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.9 132.1 47.74 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.471 2.114 . . . . 75.41 111.202 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.548 ' HG3' HG23 ' D' ' 115' ' ' THR . 5.5 tt0 -51.78 127.19 20.1 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 124.464 1.102 . . . . 61.54 112.674 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.19 116.49 28.45 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.04 -1.096 . . . . 75.11 108.04 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -115.65 122.19 44.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.694 0.798 . . . . 72.41 109.524 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.64 HD22 ' HZ ' ' D' ' 107' ' ' PHE . 1.5 tt -74.9 129.71 38.13 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 108.967 -0.753 . . . . 73.43 108.967 173.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.18 157.75 79.91 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.395 1.078 . . . . 31.22 111.974 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.431 ' HB3' ' OH ' ' B' ' 101' ' ' TYR . 87.0 Cg_exo -50.01 107.82 0.18 Allowed 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 123.246 2.631 . . . . 73.32 113.284 172.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 84.0 t -109.59 116.24 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.542 0.737 . . . . 73.2 109.051 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -90.06 105.66 17.95 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.42 -0.585 . . . . 65.52 109.42 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -78.72 -20.18 50.64 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.571 0.748 . . . . 51.4 111.067 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.436 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 6.5 t70 -65.17 -52.38 55.37 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.929 0.892 . . . . 74.12 110.66 -174.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.492 ' HA ' ' SD ' ' D' ' 138' ' ' MET . . . -68.97 -34.89 76.06 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.288 -0.869 . . . . 71.22 111.034 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' H' ' 462' ' ' TYR . 47.3 tp -63.08 -35.26 79.65 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 114.986 -1.006 . . . . 63.4 111.407 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -64.26 -37.33 87.11 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.573 0.749 . . . . 73.54 110.687 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.492 ' SD ' ' HA ' ' D' ' 135' ' ' ALA . 35.5 mtt -63.49 -39.57 94.79 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.671 -0.695 . . . . 73.12 109.596 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -61.68 -39.75 92.54 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.993 0.917 . . . . 74.4 111.389 176.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -64.41 -34.95 79.37 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.86 0.864 . . . . 73.24 111.021 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.5 mp -76.62 -30.93 57.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.336 0.654 . . . . 70.23 111.877 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -91.3 44.16 1.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.51 0.671 . . . . 75.04 111.081 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -119.56 49.17 1.4 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.857 0.863 . . . . 74.31 108.767 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -170.86 -52.0 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.302 -1.317 . . . . 63.54 109.723 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -174.85 96.6 0.08 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.549 1.14 . . . . 73.45 108.793 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -153.78 41.04 0.66 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 112.094 -0.403 . . . . 63.43 112.094 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.41 179.92 6.07 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.172 0.989 . . . . 74.24 109.388 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.73 22.67 71.97 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 112.323 -0.311 . . . . 53.43 112.323 -174.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 47.6 p -81.8 88.09 6.32 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.436 1.094 . . . . 54.14 110.63 -173.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -144.7 103.1 3.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.457 1.103 . . . . 74.44 108.596 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -85.1 -22.47 28.89 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.232 0.613 . . . . 72.11 110.051 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 23.7 m170 71.71 162.89 0.26 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.333 1.453 . . . . 75.33 111.306 -176.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.6 106.87 5.55 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.654 -0.703 . . . . 64.11 110.157 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -77.61 -32.68 53.67 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.783 -0.644 . . . . 64.21 110.444 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 C-N-CA 124.077 0.951 . . . . 54.52 108.759 -174.297 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 121.037 0.446 . . . . 74.34 110.115 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 451' ' ' VAL . . . . . 0.446 HG21 ' HA ' ' A' ' 87' ' ' ALA . 15.5 m -118.72 87.99 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.346 -1.724 . . . . 75.34 106.346 161.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.95 169.76 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.016 1.326 . . . . 63.3 108.626 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 158.44 -82.82 0.14 Allowed Glycine 0 C--N 1.344 0.983 0 C-N-CA 121.437 -0.411 . . . . 15.41 113.313 172.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 454' ' ' LEU . . . . . 0.529 HD11 HD21 ' A' ' 98' ' ' LEU . 6.8 mp 58.62 -98.53 0.09 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.306 1.042 . . . . 75.21 110.335 -170.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 3.6 m 63.78 -3.42 0.43 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 124.818 1.247 . . . . 64.15 113.491 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -85.91 -25.1 26.33 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.135 0.974 . . . . 52.43 110.877 -172.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 72.86 141.55 0.06 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.725 1.61 . . . . 74.31 111.12 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 8.6 t -132.18 137.11 47.49 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.715 0.806 . . . . 74.02 108.836 175.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -118.23 5.48 11.93 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.693 0.797 . . . . 54.11 110.121 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 460' ' ' LEU . . . . . 0.47 HD21 ' H ' ' A' ' 46' ' ' THR . 3.9 mm? 68.83 160.88 0.19 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.044 1.338 . . . . 72.42 112.534 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -147.31 26.45 1.06 Allowed 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.411 -1.268 . . . . 75.51 109.38 -169.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -72.85 91.88 1.55 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.762 -0.829 . . . . 73.4 108.762 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 32.4 p -71.32 -81.56 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.462 -0.79 . . . . 71.12 111.051 -174.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 82.9 mmm 51.19 87.18 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.403 1.081 . . . . 63.3 111.663 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -63.29 -38.01 89.49 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.774 0.429 . . . . 74.25 110.407 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -94.21 101.23 13.2 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.492 -1.299 . . . . 70.41 107.492 163.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -68.41 -58.71 3.94 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.478 0.711 . . . . 63.53 111.31 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 468' ' ' LEU . . . . . 0.494 HD22 HD11 ' A' ' 126' ' ' LEU . 81.7 mt -130.03 156.84 43.83 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.967 0.907 . . . . 74.11 109.066 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -131.85 105.34 0.61 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.981 -0.847 . . . . 73.12 110.981 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 470' ' ' LEU . . . . . 0.538 HD23 HD13 ' A' ' 126' ' ' LEU . 2.1 pp -151.79 153.31 34.01 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.549 0.739 . . . . 62.15 109.985 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 26.6 tptp . . . . . 0 C--O 1.253 1.269 0 N-CA-C 108.434 -0.95 . . . . 73.22 108.434 174.683 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 450' ' ' ASN . . . . . 0.542 ' N ' HD21 ' F' ' 450' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 121.151 0.501 . . . . 71.42 110.147 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 451' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' B' ' 89' ' ' ILE . 18.7 m -81.03 -15.38 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.971 0.908 . . . . 75.01 112.609 -171.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 13.7 m -70.05 140.92 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 122.688 0.395 . . . . 72.43 111.938 -171.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 163.96 76.19 0.03 OUTLIER Glycine 0 C--N 1.345 1.076 0 N-CA-C 111.737 -0.545 . . . . 65.11 111.737 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 65.9 tp -147.17 143.25 28.09 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.74 0.816 . . . . 74.44 110.023 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 41.2 m -96.32 133.2 40.99 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.799 -0.815 . . . . 60.13 108.799 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -138.15 -171.85 3.13 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.81 -0.811 . . . . 70.51 108.81 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 72.1 66.08 0.13 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.043 1.337 . . . . 72.54 109.215 -175.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 32.7 m -146.52 141.71 27.3 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.247 -1.342 . . . . 53.13 108.397 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.72 120.36 7.7 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.29 0.636 . . . . 74.31 110.175 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 460' ' ' LEU . . . . . 0.594 HD12 HD12 ' B' ' 44' ' ' LEU . 40.7 mt -83.66 162.89 20.6 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.706 0.765 . . . . 70.31 112.111 -174.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -80.33 153.72 28.22 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.063 -1.426 . . . . 64.14 112.025 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -129.89 -177.44 4.29 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.745 1.218 . . . . 71.33 110.057 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 15.3 t -151.13 -1.13 0.36 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.932 -1.031 . . . . 74.11 109.949 171.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 464' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' F' ' 466' ' ' ALA . 15.0 tmm? -80.49 84.71 6.04 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.562 -0.903 . . . . 60.12 108.562 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -75.87 79.09 2.78 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.676 -0.693 . . . . 72.21 109.527 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 466' ' ' ALA . . . . . 0.513 ' HB3' ' SD ' ' F' ' 464' ' ' MET . . . -175.26 178.23 1.73 Allowed 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.563 1.145 . . . . 74.03 110.094 -177.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -75.35 -57.26 4.0 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.035 -0.728 . . . . 71.22 109.035 172.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 468' ' ' LEU . . . . . 0.599 HD13 HD21 ' F' ' 470' ' ' LEU . 6.1 tt -162.73 -48.58 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.421 -0.955 . . . . 72.41 108.421 175.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 106.71 50.99 0.82 Allowed Glycine 0 N--CA 1.469 0.856 0 N-CA-C 110.413 -1.075 . . . . 55.42 110.413 -172.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 470' ' ' LEU . . . . . 0.599 HD21 HD13 ' F' ' 468' ' ' LEU . 90.2 mt -75.82 -67.64 0.65 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.734 0.814 . . . . 62.2 110.488 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? . . . . . 0 CA--C 1.56 1.336 0 C-N-CA 125.079 1.352 . . . . 71.4 110.086 179.276 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 109.253 -0.647 . . . . 74.44 109.253 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' G' G ' 451' ' ' VAL . . . . . 0.648 HG22 HG23 ' G' ' 452' ' ' VAL . 7.1 p -164.07 136.48 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 124.503 1.121 . . . . 64.43 109.29 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 452' ' ' VAL . . . . . 0.648 HG23 HG22 ' G' ' 451' ' ' VAL . 95.9 t 56.66 92.15 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 125.064 1.345 . . . . 61.1 111.818 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 453' ' ' GLY . . . . . 0.446 ' N ' ' SD ' ' C' ' 94' ' ' MET . . . -157.6 70.23 0.26 Allowed Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.769 -0.932 . . . . 44.22 110.769 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 454' ' ' LEU . . . . . 0.451 HD13 HD12 ' C' ' 98' ' ' LEU . 62.3 tp -63.39 109.37 1.58 Allowed 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.229 0.612 . . . . 62.44 110.067 178.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 455' ' ' THR . . . . . 0.401 HG23 ' HA2' ' C' ' 91' ' ' GLY . 23.6 p -69.2 167.52 16.06 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.815 -0.63 . . . . 54.13 111.217 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.63 107.77 17.68 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.871 -0.604 . . . . 72.52 109.861 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -109.18 134.95 51.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.728 -0.842 . . . . 70.11 108.728 171.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 30.5 p -78.06 78.93 4.54 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 123.861 0.865 . . . . 75.33 110.242 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 62.19 -174.23 0.14 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.703 1.201 . . . . 62.31 111.968 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 77.8 mt -79.1 138.21 37.83 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.305 -0.628 . . . . 74.41 109.305 171.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -47.01 -53.48 12.37 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.714 1.206 . . . . 73.12 111.077 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 33.7 t80 38.55 51.48 1.69 Allowed 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 125.634 1.574 . . . . 75.44 111.567 -173.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 463' ' ' THR . . . . . 0.592 HG21 ' HB3' ' C' ' 145' ' ' ALA . 10.4 p -80.81 15.22 1.84 Allowed 'General case' 0 CA--C 1.555 1.173 0 CA-C-N 114.773 -1.103 . . . . 70.15 112.302 -173.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 464' ' ' MET . . . . . 0.448 ' SD ' HG22 ' C' ' 131' ' ' VAL . 55.4 ttp -82.28 -14.75 54.93 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.023 0.929 . . . . 75.3 111.237 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 10.6 mptt 70.35 -73.79 0.09 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.3 1.44 . . . . 74.41 109.645 -174.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -149.6 174.37 12.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.629 1.172 . . . . 43.43 109.552 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -144.13 -171.39 3.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.658 0.783 . . . . 32.23 110.28 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 468' ' ' LEU . . . . . 0.517 ' HB2' HG21 ' C' ' 40' ' ' VAL . 91.3 mt 68.78 -171.11 0.18 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.751 1.22 . . . . 71.32 112.007 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.61 82.48 0.05 OUTLIER Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.148 -1.181 . . . . 74.53 110.148 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 71.5 mt -86.67 54.87 3.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.399 0.679 . . . . 53.24 111.571 -175.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 471' ' ' LYS . . . . . 0.539 ' HD2' ' HG2' ' C' ' 37' ' ' GLN . 62.7 tttp . . . . . 0 CA--C 1.551 0.99 0 C-N-CA 125.25 1.42 . . . . 71.12 108.064 173.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 119.558 -0.258 . . . . 60.22 110.634 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' H' H ' 451' ' ' VAL . . . . . 0.692 HG22 ' HB3' ' D' ' 90' ' ' GLU . 4.1 p -65.73 -16.43 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 123.625 0.77 . . . . 75.21 112.898 -166.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 452' ' ' VAL . . . . . 0.461 HG12 HD11 ' D' ' 86' ' ' ILE . 15.5 m -79.27 175.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.932 0.893 . . . . 75.12 113.253 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 158.11 60.78 0.01 OUTLIER Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.177 -0.92 . . . . 74.35 111.732 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 454' ' ' LEU . . . . . 0.484 ' HB3' ' CE1' ' D' ' 56' ' ' TYR . 62.3 tp -94.14 139.94 30.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.153 0.581 . . . . 74.13 110.978 -176.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 11.8 t -153.31 153.2 32.16 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.659 1.184 . . . . 74.44 109.27 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 60.8 85.98 0.11 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.745 1.218 . . . . 64.42 111.981 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -96.89 103.04 14.93 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.183 -1.043 . . . . 73.03 108.183 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 30.5 m -64.76 150.3 47.65 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.63 0.772 . . . . 75.4 110.514 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.36 146.28 7.26 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.618 0.767 . . . . 65.11 110.762 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 460' ' ' LEU . . . . . 0.466 HD23 ' HB ' ' D' ' 46' ' ' THR . 0.7 OUTLIER -64.96 107.2 1.42 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 108.189 -1.041 . . . . 64.43 108.189 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -80.26 66.24 5.68 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.752 -1.567 . . . . 72.34 111.307 -173.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 462' ' ' TYR . . . . . 0.487 ' HB2' HD21 ' D' ' 136' ' ' LEU . 57.8 t80 -157.53 111.85 2.64 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.918 -0.771 . . . . 74.31 108.918 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 68.3 p -109.45 16.69 22.1 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.759 0.824 . . . . 73.4 110.783 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 464' ' ' MET . . . . . 0.555 ' HB2' HD13 ' D' ' 42' ' ' LEU . 34.9 tpp 70.4 144.3 0.06 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.248 1.419 . . . . 61.43 111.871 -176.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.19 -53.15 27.01 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.343 -0.844 . . . . 64.14 110.582 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -150.85 -74.23 0.15 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.798 0.439 . . . . 50.21 110.815 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -129.11 136.34 50.08 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.503 0.721 . . . . 75.22 109.908 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 468' ' ' LEU . . . . . 0.657 HD23 ' HB2' ' D' ' 42' ' ' LEU . 2.8 pp -91.11 -17.34 26.33 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.259 0.466 . . . . 75.24 112.259 -177.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.38 54.46 0.04 OUTLIER Glycine 0 N--CA 1.464 0.539 0 N-CA-C 111.546 -0.622 . . . . 52.44 111.546 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 6.5 tt -159.3 118.45 2.94 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.38 -1.341 . . . . 64.11 107.38 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt . . . . . 0 C--O 1.25 1.112 0 N-CA-C 108.789 -0.819 . . . . 74.31 108.789 175.034 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.674 0.273 . . . . 71.25 110.486 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t -119.58 70.53 0.85 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.944 0.897 . . . . 44.14 108.676 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -74.17 108.09 6.75 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.786 -1.097 . . . . 70.34 109.769 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -100.32 109.93 22.14 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.272 1.029 . . . . 72.24 108.977 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -78.56 133.12 37.37 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.062 -0.718 . . . . 73.14 109.062 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' C' ' 147' ' ' GLU . 4.1 p30 -154.1 108.07 2.99 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.534 0.734 . . . . 72.51 110.55 -175.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 p -142.11 92.52 2.44 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.831 0.852 . . . . 75.33 108.961 171.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.37 -41.71 10.74 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.426 -0.583 . . . . 72.32 109.426 174.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -95.78 165.73 12.15 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.279 0.632 . . . . 74.5 110.036 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.5 m -147.35 128.3 14.5 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.972 0.909 . . . . 64.14 109.301 169.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.698 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 6.2 t80 -139.03 132.68 30.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.038 0.935 . . . . 73.01 108.62 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -149.98 103.56 3.22 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.528 -0.916 . . . . 72.12 108.528 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.555 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.3 mt -70.36 112.05 4.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.335 -0.987 . . . . 71.5 108.335 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -81.04 -31.14 34.65 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 124.237 0.961 . . . . 71.44 110.277 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -174.36 147.44 1.16 Allowed 'General case' 0 C--N 1.355 0.835 0 O-C-N 123.626 0.579 . . . . 73.52 110.228 -173.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.7 mt -137.02 133.6 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.878 -1.156 . . . . 74.34 107.878 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' HB3' HG23 ' B' ' 122' ' ' THR . 43.2 p90 -168.59 154.39 6.71 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 123.915 0.759 . . . . 72.04 111.412 -174.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -74.57 116.57 15.41 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.011 -0.737 . . . . 70.13 109.011 172.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -78.19 -42.86 30.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.368 -0.604 . . . . 74.11 109.368 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.594 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 7.0 m-20 -136.65 131.91 34.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.934 -1.03 . . . . 73.23 109.235 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.0 mt -128.18 141.06 47.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.09 -1.448 . . . . 73.23 107.09 172.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -152.51 120.78 6.29 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.199 -0.667 . . . . 75.32 109.199 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 87.3 t80 -123.78 130.6 52.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.274 -1.38 . . . . 75.45 107.274 174.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -126.48 153.01 45.68 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.023 -1.102 . . . . 74.54 108.023 172.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.51 79.16 10.6 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.486 -1.301 . . . . 72.43 107.486 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.21 -40.34 77.1 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.332 2.688 . . . . 54.23 112.843 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.563 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 17.1 m120 -109.22 39.68 2.01 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.28 -0.873 . . . . 72.43 109.767 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.54 -45.55 98.76 Favored Pre-proline 0 CA--C 1.565 1.536 0 C-N-CA 123.939 0.896 . . . . 65.3 113.079 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -71.79 -22.03 24.21 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 121.826 1.684 . . . . 75.13 112.29 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 42.0 m170 -86.91 -24.63 24.76 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.621 0.768 . . . . 64.01 112.333 -174.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.7 p -72.19 -25.21 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.759 0.424 . . . . 72.45 110.409 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.1 -31.78 70.74 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.528 0.731 . . . . 64.04 110.607 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -78.57 -47.75 16.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.101 0.96 . . . . 72.1 110.424 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -83.02 151.53 25.79 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.856 0.862 . . . . 73.23 110.757 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.36 146.04 53.61 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.616 -0.512 . . . . 64.11 109.616 170.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.441 ' HE1' HD22 ' E' ' 470' ' ' LEU . 65.0 t-105 -70.7 85.15 0.65 Allowed 'General case' 0 C--N 1.351 0.662 0 CA-C-O 121.468 0.651 . . . . 73.12 109.752 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.98 78.78 75.77 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 106.451 -1.685 . . . . 74.35 106.451 173.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -89.89 -173.44 0.71 Allowed 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.453 2.102 . . . . 64.25 112.543 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -141.03 108.81 5.65 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.811 -1.551 . . . . 71.34 106.811 167.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.478 HG11 ' HB2' ' E' ' 470' ' ' LEU . 22.1 m -96.5 135.81 29.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.317 0.58 . . . . 73.42 111.301 -172.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -120.71 145.47 47.45 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.284 -1.006 . . . . 73.24 108.284 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 tp -124.1 126.16 45.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.201 -0.666 . . . . 71.43 109.201 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.545 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.7 m-20 -113.95 144.1 43.62 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.106 -1.072 . . . . 54.02 108.106 170.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.18 146.65 37.22 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.353 -0.61 . . . . 71.05 109.353 169.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -152.06 147.96 27.11 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.195 0.598 . . . . 72.51 110.007 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.421 ' HB ' HD11 ' E' ' 460' ' ' LEU . 80.0 m -118.49 128.95 55.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.276 1.03 . . . . 73.33 109.353 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.55 151.55 51.89 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.411 0.684 . . . . 74.03 109.156 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.0 m -118.09 157.52 26.72 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.326 0.651 . . . . 73.12 109.967 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -149.27 121.09 8.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.736 0.814 . . . . 72.05 109.342 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -84.49 103.2 13.43 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.612 -0.884 . . . . 61.14 108.612 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.15 -34.77 23.97 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.414 -0.812 . . . . 71.32 110.373 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.42 -176.56 5.97 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 124.268 0.98 . . . . 71.13 109.723 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.48 115.15 4.38 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.702 0.626 . . . . 71.13 110.073 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 62.67 26.53 15.7 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.44 1.496 . . . . 73.34 112.78 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -117.79 118.36 58.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-N 114.706 -1.134 . . . . 72.12 108.743 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.599 ' HD2' HD11 ' A' ' 86' ' ' ILE . 23.8 m-85 -125.11 124.97 43.0 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.478 0.711 . . . . 71.2 109.991 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.26 126.44 37.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.277 -1.008 . . . . 73.45 108.277 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.413 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 92.7 t -100.78 130.35 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.33 -1.359 . . . . 74.15 107.33 171.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.1 t -107.56 107.68 23.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 107.874 -1.158 . . . . 63.03 107.874 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.27 99.86 12.02 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.381 -1.34 . . . . 73.33 107.381 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 37.8 ttt180 -85.74 119.61 26.25 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.22 -0.9 . . . . 60.44 109.641 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.5 t -112.13 140.77 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.561 -0.903 . . . . 74.23 108.561 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 17.9 m -130.92 129.31 42.03 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.739 -0.837 . . . . 72.4 108.739 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.53 HG21 HG21 ' A' ' 114' ' ' ILE . 74.2 t -127.84 126.32 66.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.958 -1.497 . . . . 60.43 106.958 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 14.7 t -136.71 145.97 45.32 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.593 -0.891 . . . . 61.51 108.593 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.423 ' HB2' HG12 ' A' ' 40' ' ' VAL . . . -144.07 123.81 13.37 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.548 -0.908 . . . . 72.23 108.548 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 p -127.18 133.67 50.26 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.447 0.699 . . . . 74.44 110.607 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.581 HD13 ' HB2' ' A' ' 73' ' ' ALA . 7.6 mp -86.16 77.19 9.63 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.152 -1.795 . . . . 64.33 106.152 169.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.79 -115.69 4.81 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 114.515 -1.22 . . . . 65.31 111.082 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -87.98 -20.34 25.99 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.908 0.883 . . . . 71.3 110.319 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -80.06 100.98 8.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.754 0.822 . . . . 73.01 109.951 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.9 m -68.06 120.19 13.88 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 110.174 -0.306 . . . . 75.2 110.174 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.581 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -71.68 -55.42 7.74 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.84 -0.8 . . . . 63.41 108.84 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -160.64 165.79 30.03 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 115.524 -0.762 . . . . 73.13 111.708 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.7 tp -141.6 108.07 5.3 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.516 -1.22 . . . . 73.02 108.205 173.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.46 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 58.7 m -107.35 116.68 32.36 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.104 0.962 . . . . 74.2 109.898 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -134.0 126.04 29.41 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.151 -0.685 . . . . 72.41 109.151 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.4 t -133.38 110.28 14.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 124.292 1.037 . . . . 75.4 109.215 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.594 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 19.6 mt-30 -84.64 84.03 7.81 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.086 -1.079 . . . . 55.23 108.086 171.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -79.33 99.92 7.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.345 -1.298 . . . . 73.11 108.685 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.14 157.81 18.39 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 112.073 -0.411 . . . . 65.14 112.073 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.403 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -154.51 131.06 3.05 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 110.849 -0.9 . . . . 72.25 110.849 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -81.12 125.21 39.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.499 -0.926 . . . . 72.21 108.499 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.698 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 30.8 m-85 -131.06 119.95 22.73 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.845 -0.798 . . . . 63.13 108.845 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -91.8 108.63 20.05 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.286 -1.005 . . . . 64.0 108.286 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.599 HD11 ' HD2' ' A' ' 56' ' ' TYR . 2.6 pp -118.65 147.61 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.541 0.737 . . . . 75.34 110.533 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.34 176.92 6.36 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.137 0.975 . . . . 74.34 110.0 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.25 -24.58 21.61 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.854 -0.612 . . . . 53.02 113.583 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -136.39 148.83 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.501 0.72 . . . . 73.05 110.954 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.68 175.01 9.96 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.875 0.87 . . . . 70.21 109.365 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.37 -128.69 13.64 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 123.459 0.552 . . . . 63.13 112.386 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.607 ' HB ' HD11 ' A' ' 141' ' ' LEU . 61.4 p -68.84 -22.06 64.25 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.261 1.024 . . . . 63.01 111.958 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -68.45 -51.07 47.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.846 0.858 . . . . 74.33 110.68 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.498 ' SD ' HD13 ' A' ' 86' ' ' ILE . 41.5 ttp -78.08 -23.03 48.15 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 116.275 -0.42 . . . . 73.21 110.402 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -37.7 86.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.154 0.582 . . . . 61.34 110.199 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -67.72 -35.15 78.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.544 0.738 . . . . 62.4 110.85 174.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 76.8 m -62.1 -54.07 46.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.756 0.423 . . . . 71.5 110.582 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.442 HD22 HD13 ' E' ' 454' ' ' LEU . 3.7 pp -73.16 -34.5 66.08 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.771 0.428 . . . . 75.24 111.39 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.67 -2.0 56.39 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 114.905 0.722 . . . . 70.3 114.905 -168.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -148.75 -61.75 0.24 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.649 0.724 . . . . 74.3 112.727 -175.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -72.17 -61.91 1.62 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.106 0.963 . . . . 72.33 112.709 -165.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 72.7 m -67.65 -34.96 7.24 Favored Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 114.026 1.121 . . . . 75.43 114.026 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 27.9 Cg_endo -64.64 -31.09 59.97 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 121.769 1.646 . . . . 74.13 113.357 167.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 25.8 t-20 -67.89 -29.92 69.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.097 0.559 . . . . 61.13 110.206 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.15 -42.81 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.845 0.858 . . . . 61.32 110.573 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.403 HD21 ' HA3' ' A' ' 82' ' ' GLY . 42.9 mt -82.16 -20.79 37.2 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.474 1.11 . . . . 72.53 112.575 -173.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.77 -44.77 91.91 Favored Pre-proline 0 CA--C 1.572 1.805 0 C-N-CA 124.033 0.933 . . . . 73.5 113.437 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -64.73 -32.38 57.02 Favored 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 122.36 2.04 . . . . 75.44 113.434 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -70.8 -40.66 72.4 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.144 0.577 . . . . 71.23 110.933 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.37 -38.8 78.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.968 0.507 . . . . 74.41 110.49 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.424 ' HB2' HD11 ' A' ' 128' ' ' LEU . 36.0 ttm180 -51.09 -56.25 13.58 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.088 0.867 . . . . 73.5 109.517 172.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -59.11 -47.74 84.16 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.609 1.164 . . . . 74.21 112.163 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.06 -44.89 87.71 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.999 0.812 . . . . 53.55 110.975 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.53 HG21 HG21 ' A' ' 64' ' ' VAL . 96.6 mt -67.53 -49.05 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.039 0.936 . . . . 71.44 110.586 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.51 HG23 ' HG3' ' A' ' 125' ' ' GLN . 36.3 m -53.25 -40.72 64.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.146 0.978 . . . . 75.41 111.208 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.28 -47.82 66.64 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.989 -1.005 . . . . 73.53 110.018 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 42.5 mtp -60.92 -41.09 95.51 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 124.077 0.951 . . . . 72.01 111.686 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.8 t -65.62 -44.15 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.17 0.988 . . . . 64.04 110.339 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.9 t -68.53 -31.82 71.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.6 0.76 . . . . 64.52 111.313 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -72.69 -29.94 63.82 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.38 0.672 . . . . 70.02 110.075 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.52 2.64 84.99 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 123.69 0.619 . . . . 71.44 112.896 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.3 m 68.0 22.9 8.35 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.768 1.227 . . . . 74.52 111.151 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -91.93 150.88 41.4 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 123.355 0.662 . . . . 70.14 109.222 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.46 139.48 90.8 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.577 2.184 . . . . 71.33 112.575 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.51 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.0 tt0 -57.73 150.04 20.63 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.814 1.246 . . . . 71.43 112.682 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.541 ' HA ' ' HA3' ' E' ' 469' ' ' GLY . 2.9 pp -126.65 137.46 53.29 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.846 -1.168 . . . . 75.02 107.846 173.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -135.69 84.05 2.06 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.751 -1.203 . . . . 41.43 107.751 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 111' ' ' ARG . 2.7 pp -65.1 135.62 55.75 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.146 -0.479 . . . . 71.3 110.645 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.17 140.81 98.06 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 123.069 0.548 . . . . 42.23 110.068 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.75 126.92 22.63 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.196 1.931 . . . . 64.32 111.384 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 91.3 t -97.46 113.86 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 106.62 -1.622 . . . . 60.1 106.62 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -75.48 83.93 2.56 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.946 -1.131 . . . . 70.11 107.946 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -60.4 -33.41 72.45 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.108 -0.951 . . . . 74.04 110.589 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.05 -40.46 90.98 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.074 0.95 . . . . 63.12 110.98 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.06 -50.55 61.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.254 0.621 . . . . 75.51 110.259 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.0 mt -64.04 -42.15 97.17 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.22 -0.9 . . . . 63.53 111.573 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -66.49 -41.02 89.56 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.237 -0.892 . . . . 72.45 109.375 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.413 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -66.05 -36.64 83.77 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 123.897 0.748 . . . . 71.33 109.774 -177.257 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -57.55 -39.57 76.97 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.019 0.528 . . . . 73.01 111.214 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -73.64 -39.67 64.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.137 0.575 . . . . 75.44 110.738 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.607 HD11 ' HB ' ' A' ' 92' ' ' THR . 64.5 tp -61.69 -46.48 89.53 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.744 1.218 . . . . 74.43 111.814 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -175.45 -18.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.285 0.634 . . . . 73.12 110.941 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 54.67 75.23 0.31 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.047 1.739 . . . . 64.54 110.909 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -144.01 88.92 1.99 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.358 -0.837 . . . . 71.1 109.193 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.0 160.16 20.09 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 124.479 1.112 . . . . 71.11 110.349 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -144.99 147.53 18.76 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 111.7 -0.56 . . . . 74.45 111.7 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.2 133.36 29.6 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 107.899 -1.148 . . . . 72.41 107.899 -177.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.41 41.15 0.28 Allowed Glycine 0 C--N 1.345 1.028 0 CA-C-O 119.711 -0.494 . . . . 62.42 113.426 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.3 p -69.49 98.75 1.16 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.975 0.387 . . . . 65.33 111.081 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -81.02 163.89 22.91 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.079 0.951 . . . . 75.24 109.318 171.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.59 139.62 39.55 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 109.31 -0.626 . . . . 74.13 109.31 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -89.1 3.61 51.23 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.797 0.839 . . . . 73.11 112.293 -173.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 67.23 -168.38 0.2 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.58 1.152 . . . . 74.34 110.619 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -76.52 128.42 34.73 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.972 -0.751 . . . . 53.04 108.972 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 N-CA-C 108.921 -0.77 . . . . 71.13 108.921 -177.325 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 109.196 -0.668 . . . . 53.23 109.196 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 37.5 p -135.21 62.89 1.63 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.76 0.824 . . . . 73.11 110.457 -176.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -78.28 104.07 8.63 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 107.857 -1.164 . . . . 65.41 107.857 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -122.62 79.05 1.59 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.334 0.654 . . . . 75.51 109.549 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -73.99 138.98 44.49 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.466 -0.568 . . . . 70.34 109.466 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -81.24 136.44 35.82 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.175 0.59 . . . . 74.15 109.583 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.4 t -78.23 149.51 33.63 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 123.549 0.531 . . . . 71.32 109.855 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.18 -143.84 0.32 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 107.779 -1.193 . . . . 55.52 107.779 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.561 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 12.2 ptm 59.41 171.26 0.07 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.548 1.939 . . . . 71.24 114.435 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.638 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 70.6 m -150.85 136.86 18.3 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 125.346 1.458 . . . . 64.52 107.122 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -139.39 141.49 37.55 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.759 0.423 . . . . 75.01 110.252 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -144.67 138.12 27.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.592 0.757 . . . . 71.13 109.906 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.94 126.78 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.048 -1.093 . . . . 73.43 108.048 171.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -95.35 -50.32 5.07 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.699 0.4 . . . . 72.24 110.079 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -161.72 131.07 4.56 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.531 -0.544 . . . . 74.33 109.531 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.2 mt -115.35 131.95 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 107.924 -1.139 . . . . 72.03 107.924 171.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -156.85 138.28 13.92 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.41 0.684 . . . . 71.4 110.144 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.5 m -72.23 121.84 20.04 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.478 -0.934 . . . . 55.42 108.478 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.426 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.8 mtpt -95.33 -23.5 17.17 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.433 0.693 . . . . 71.01 111.042 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -161.69 141.03 9.97 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.399 0.437 . . . . 74.12 110.732 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 33.7 mm -134.23 144.46 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.159 1.384 . . . . 73.3 108.765 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -138.55 139.95 38.87 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.591 -1.186 . . . . 73.21 107.974 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 85.2 t80 -152.58 130.61 11.84 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.637 -1.246 . . . . 74.53 107.637 166.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 49.0 mt-10 -140.45 116.7 10.61 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.645 0.778 . . . . 61.12 108.918 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.674 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -105.29 84.29 1.07 Allowed Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 106.922 -1.51 . . . . 54.0 106.922 165.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.39 -23.83 20.03 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.954 2.436 . . . . 70.32 111.97 -170.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 78.3 m-20 -116.93 6.71 13.07 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 114.433 -1.258 . . . . 75.03 110.368 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.674 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -29.13 -66.05 0.15 Allowed Pre-proline 0 C--N 1.38 1.899 0 C-N-CA 126.163 1.785 . . . . 55.01 114.787 -171.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.8 Cg_exo -64.78 -29.46 59.29 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 122.585 2.19 . . . . 64.43 112.509 -169.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -46.47 14.52 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.364 -0.835 . . . . 72.23 110.752 176.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.597 HG22 HD12 ' B' ' 68' ' ' LEU . 2.7 p -70.31 -17.85 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.147 0.579 . . . . 64.2 111.986 -166.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -69.37 -11.64 60.99 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 112.654 0.613 . . . . 73.35 112.654 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -77.28 -3.42 39.74 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.191 0.596 . . . . 73.0 110.877 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.7 105.35 15.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.907 1.283 . . . . 75.01 110.093 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.93 91.91 7.7 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.842 0.857 . . . . 65.21 109.729 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -161.92 155.57 21.3 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.918 0.887 . . . . 72.4 108.922 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.502 ' HG3' HD13 ' F' ' 470' ' ' LEU . 7.9 tp60 -81.97 102.95 1.78 Allowed Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 107.201 -1.407 . . . . 74.14 107.201 170.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.67 133.35 31.54 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.555 2.17 . . . . 52.45 112.308 -171.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.405 ' HA ' HD21 ' F' ' 470' ' ' LEU . 35.5 tt0 -69.23 129.54 40.11 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 123.855 0.722 . . . . 54.44 110.026 -175.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.668 ' H ' HD21 ' F' ' 470' ' ' LEU . 74.9 t -106.13 129.84 58.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.49 1.116 . . . . 74.31 109.968 -171.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -103.98 112.66 25.74 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 105.84 -1.911 . . . . 72.2 105.84 167.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.58 153.23 18.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.921 -1.036 . . . . 71.25 108.784 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.6 t70 -144.59 110.62 5.44 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.022 -0.732 . . . . 75.24 109.022 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -109.04 134.89 51.08 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.14 -1.059 . . . . 74.04 108.14 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -159.54 156.24 27.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.395 0.678 . . . . 75.35 109.377 170.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.6 p -124.82 128.33 48.54 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.352 0.661 . . . . 50.14 109.833 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.5 158.19 21.94 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.738 -1.208 . . . . 74.11 107.738 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.434 ' HB3' HD21 ' B' ' 98' ' ' LEU . 13.3 p -142.27 168.78 18.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.53 0.332 . . . . 60.13 111.107 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 2.1 m -148.53 136.06 20.52 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.424 -0.954 . . . . 53.12 108.424 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -90.36 100.53 13.35 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.416 -0.957 . . . . 63.52 108.416 170.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.21 -33.44 59.26 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.637 -0.71 . . . . 75.43 109.911 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.02 -175.35 3.33 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.147 -0.933 . . . . 72.52 110.696 -177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.28 122.22 16.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.371 -1.286 . . . . 71.02 109.154 173.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 66.62 14.65 9.85 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.926 0.891 . . . . 51.22 112.379 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -118.5 119.78 62.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 123.642 0.777 . . . . 74.11 109.032 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -112.64 152.78 28.56 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.641 0.776 . . . . 72.41 110.172 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 6.8 tm-20 -124.66 97.18 5.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.508 -1.664 . . . . 75.21 106.508 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.401 HG22 ' HG ' ' B' ' 98' ' ' LEU . 90.4 t -86.51 143.99 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.048 -0.978 . . . . 71.34 109.792 -175.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -131.95 112.43 20.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.432 -0.951 . . . . 74.35 108.432 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.439 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -93.64 118.72 31.75 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.465 -1.309 . . . . 70.02 107.465 177.006 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 69.3 ttt-85 -107.43 110.07 21.94 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.975 0.51 . . . . 74.53 109.719 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.407 ' HB ' HD11 ' B' ' 114' ' ' ILE . 22.8 t -108.11 104.31 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.982 -1.118 . . . . 64.04 107.982 173.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 11.1 m -100.54 137.37 39.04 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.116 -0.698 . . . . 63.51 109.116 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.661 HG21 HG21 ' B' ' 114' ' ' ILE . 50.3 t -123.82 126.49 72.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.982 1.313 . . . . 64.11 108.822 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 52.4 m -125.09 139.01 54.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.476 -1.305 . . . . 72.23 107.476 170.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' B' ' 40' ' ' VAL . . . -146.03 151.6 38.01 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.605 -0.517 . . . . 64.44 109.605 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 27.7 p -149.07 139.57 22.51 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 123.699 0.624 . . . . 60.3 112.132 -174.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.597 HD12 HG22 ' B' ' 31' ' ' VAL . 86.3 mt -106.08 102.22 11.66 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.639 1.176 . . . . 72.24 108.328 172.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.02 -131.5 12.46 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.786 -0.643 . . . . 44.44 112.541 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -86.97 3.81 44.3 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.384 1.073 . . . . 70.2 112.446 -175.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.493 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.9 pt-20 -132.16 155.61 47.89 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.957 0.503 . . . . 71.21 111.095 -175.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.6 m -67.1 137.3 56.26 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.891 0.744 . . . . 74.24 110.85 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.439 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -91.06 -67.29 0.86 Allowed 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.697 -1.223 . . . . 75.35 107.697 173.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -144.3 145.59 32.1 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 121.407 0.622 . . . . 73.1 110.626 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 94.1 mt -117.14 149.46 40.32 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.309 1.444 . . . . 72.53 107.281 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.531 ' SG ' HG23 ' B' ' 114' ' ' ILE . 42.5 t -158.15 158.53 34.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.659 -0.867 . . . . 63.02 108.659 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -165.73 133.54 2.96 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.994 -1.113 . . . . 63.45 107.994 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.468 HG23 HG12 ' B' ' 114' ' ' ILE . 94.2 t -124.88 141.32 45.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.615 -0.883 . . . . 62.44 108.615 174.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -119.63 84.19 2.16 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.3 -1.37 . . . . 63.22 107.3 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -79.77 99.33 7.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.357 -1.292 . . . . 64.43 109.079 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.426 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -96.0 171.41 28.52 Favored Glycine 0 C--O 1.245 0.788 0 CA-C-N 115.774 -0.648 . . . . 72.25 112.006 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.54 130.88 1.94 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 112.029 -0.429 . . . . 64.13 112.029 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 63.8 mt -83.73 127.29 39.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 108.293 -1.003 . . . . 75.41 108.293 170.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -136.08 143.28 44.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.646 0.778 . . . . 65.31 109.163 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -104.05 125.3 50.29 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.691 0.796 . . . . 72.1 109.014 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.622 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.8 pp -119.23 145.01 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.217 1.007 . . . . 55.42 110.103 -176.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.638 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.04 162.11 41.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.584 0.754 . . . . 75.33 110.119 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.72 -57.13 5.05 Favored Glycine 0 C--N 1.354 1.567 0 O-C-N 123.683 0.614 . . . . 60.24 112.854 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.622 HD11 ' HB ' ' B' ' 86' ' ' ILE . 11.8 pt -58.19 148.39 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.762 1.225 . . . . 74.43 112.178 174.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.514 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 31.2 tt0 -160.84 152.52 19.56 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.999 -1.0 . . . . 74.4 109.843 -175.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.8 -112.76 4.08 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 112.206 -0.358 . . . . 63.32 112.206 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.9 m -92.51 -16.98 25.08 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.895 0.478 . . . . 63.32 111.139 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.514 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 45.6 mt-30 -59.76 -39.22 84.09 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.268 0.627 . . . . 64.4 110.725 175.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.584 ' HA ' HD12 ' B' ' 89' ' ' ILE . 26.2 ptt? -74.71 -25.25 59.01 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.647 -0.706 . . . . 52.04 110.993 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.33 -33.5 71.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.412 0.685 . . . . 64.11 110.466 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -65.4 -39.19 91.89 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.548 0.739 . . . . 73.32 110.685 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.48 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 44.5 t -70.42 -58.06 4.13 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.758 -0.655 . . . . 65.43 110.547 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' B' ' 48' ' ' SER . 7.8 tt -65.13 -43.74 90.91 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.425 0.69 . . . . 65.21 111.38 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.19 -26.03 49.68 Favored Glycine 0 C--N 1.341 0.839 0 O-C-N 123.763 0.664 . . . . 61.1 114.238 -170.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.59 -53.17 1.25 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.215 0.508 . . . . 41.24 112.328 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.48 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 79.7 t80 -71.33 -45.72 62.29 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.565 0.746 . . . . 72.12 112.626 -169.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.533 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 81.0 m -67.82 -49.0 39.93 Favored Pre-proline 0 CA--C 1.565 1.551 0 C-N-CA 123.702 0.801 . . . . 73.13 110.424 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 66.8 Cg_exo -57.07 -30.04 85.36 Favored 'Trans proline' 0 C--N 1.399 3.229 0 C-N-CA 122.844 2.363 . . . . 74.52 113.898 169.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -62.55 -41.54 98.97 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.593 0.757 . . . . 73.3 109.803 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.79 -44.26 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.626 0.77 . . . . 73.21 110.063 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.3 mt -78.92 -15.76 57.9 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.029 0.932 . . . . 70.34 112.583 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -62.21 -51.82 71.34 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 118.102 -0.951 . . . . 72.03 113.348 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.27 -34.97 87.0 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 121.825 1.684 . . . . 74.12 112.515 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -62.73 -50.46 71.02 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.906 0.883 . . . . 75.32 110.911 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.41 97.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.789 0.836 . . . . 71.52 110.631 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -59.2 -54.34 48.03 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.636 1.574 . . . . 74.41 111.131 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.54 -30.66 70.36 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.193 0.597 . . . . 74.13 110.037 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.567 ' SG ' HD11 ' B' ' 21' ' ' ILE . 1.8 t -69.98 -28.42 65.52 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.745 0.418 . . . . 73.52 111.595 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.661 HG21 HG21 ' B' ' 64' ' ' VAL . 45.8 mt -76.03 -54.48 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 109.176 -0.676 . . . . 74.22 109.176 172.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.43 HG21 ' OG ' ' C' ' 119' ' ' SER . 23.5 m -54.2 -33.43 58.2 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.623 1.202 . . . . 71.01 111.568 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 24.8 t -60.42 -54.17 48.81 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 115.24 -0.891 . . . . 62.43 109.589 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.1 mmt -68.94 -35.33 76.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.7 0.8 . . . . 61.21 111.482 -173.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.422 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.3 t -60.63 -46.08 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.0 0.92 . . . . 74.33 109.811 174.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 34.8 t -72.59 -28.86 63.05 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.651 -1.159 . . . . 64.42 111.383 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.2 mtt-85 -68.75 -35.39 77.03 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.524 0.73 . . . . 65.51 109.533 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.71 11.13 57.73 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 124.119 0.887 . . . . 74.32 112.816 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.467 HG23 ' HB3' ' A' ' 17' ' ' TYR . 75.6 p 56.58 24.12 8.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.235 1.814 . . . . 74.13 113.631 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -84.52 154.81 62.55 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 123.326 0.65 . . . . 71.42 110.34 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.35 169.94 5.88 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.955 2.437 . . . . 72.4 113.778 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -63.62 131.18 47.18 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.01 -0.995 . . . . 74.04 112.211 -166.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.2 tp -135.11 111.54 9.81 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.859 0.863 . . . . 75.31 109.043 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -134.2 114.74 13.39 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.345 0.658 . . . . 73.34 109.272 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.419 HD13 HD23 ' F' ' 468' ' ' LEU . 4.2 mm? -60.27 141.75 55.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.794 0.837 . . . . 72.34 111.086 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.46 144.07 96.06 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.412 0.685 . . . . 75.44 110.365 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -69.32 100.54 0.77 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.405 2.07 . . . . 75.4 111.339 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.48 110.76 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.587 -0.894 . . . . 74.54 108.587 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -78.96 83.92 5.02 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.987 -1.116 . . . . 73.33 107.987 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -52.67 -39.11 61.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.578 1.151 . . . . 61.0 112.871 -172.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.41 -34.59 75.64 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.483 1.113 . . . . 72.03 112.396 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.79 -41.07 60.68 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.43 0.692 . . . . 64.41 110.863 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -70.13 -29.77 66.79 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.467 -0.788 . . . . 74.43 110.072 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.47 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 80.9 t80 -68.76 -33.35 73.75 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.976 0.91 . . . . 73.24 110.469 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -39.34 83.78 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.437 0.637 . . . . 75.01 109.837 177.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -88.57 -12.09 43.73 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.922 -1.035 . . . . 65.54 110.704 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -71.07 -33.99 70.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.397 0.679 . . . . 75.3 110.193 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 40.7 mt -82.71 -6.23 59.28 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 114.914 -1.039 . . . . 73.35 111.901 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.51 ' HG3' ' HG2' ' B' ' 144' ' ' GLN . 7.1 tp60 -151.2 115.73 5.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.81 -0.811 . . . . 64.52 108.81 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -84.46 49.84 1.76 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.46 1.104 . . . . 45.31 111.602 -168.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.51 ' HG2' ' HG3' ' B' ' 142' ' ' GLN . 20.2 pt20 -158.49 170.81 21.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.449 1.1 . . . . 65.02 109.519 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.92 138.33 50.84 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.865 0.866 . . . . 61.1 109.145 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.52 137.74 23.06 Favored Glycine 0 C--N 1.348 1.227 0 O-C-N 123.531 0.519 . . . . 73.11 111.848 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.53 106.21 1.38 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.643 0.777 . . . . 73.22 110.346 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.4 148.71 46.58 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.782 0.676 . . . . 74.4 112.355 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.2 t -84.38 49.71 1.73 Allowed 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 122.304 1.049 . . . . 63.12 109.959 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -67.41 95.48 0.45 Allowed 'General case' 0 C--O 1.244 0.764 0 CA-C-N 114.276 -1.329 . . . . 73.01 110.865 -168.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.7 118.79 14.97 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 123.56 0.538 . . . . 74.14 109.661 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -88.27 -13.98 39.55 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.314 -0.857 . . . . 70.44 110.731 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -81.71 109.22 15.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.69 0.796 . . . . 73.21 109.768 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.36 158.84 33.24 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.946 0.898 . . . . 74.44 110.834 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.165 0 C-N-CA 124.479 1.112 . . . . 64.24 111.311 -177.053 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.405 -0.591 . . . . 74.53 109.405 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 35.2 m -72.64 125.89 28.56 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.565 0.746 . . . . 61.54 111.277 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.24 90.28 3.3 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.994 0.917 . . . . 72.42 110.535 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -95.32 126.81 40.89 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.087 0.555 . . . . 74.55 110.242 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -124.25 114.23 19.33 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.106 0.962 . . . . 75.32 108.652 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -131.1 -81.41 0.53 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.376 0.67 . . . . 64.12 111.106 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 27.1 p -106.17 -4.31 20.4 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.347 0.659 . . . . 70.43 112.766 -170.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -86.49 53.2 2.72 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.312 0.645 . . . . 62.42 111.432 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.475 ' HG3' HD12 ' C' ' 89' ' ' ILE . 1.4 mpt? 61.31 126.13 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.286 1.434 . . . . 75.53 112.352 -175.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 29.2 m -85.78 78.72 9.49 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.654 -1.61 . . . . 73.31 106.654 167.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -104.04 122.33 45.05 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.831 -1.077 . . . . 70.15 109.479 -172.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -137.05 108.12 6.74 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 107.289 -1.374 . . . . 75.02 107.289 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 42.8 mt -67.73 119.17 12.94 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 108.112 -1.07 . . . . 44.33 108.112 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.652 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.7 mm-40 -78.34 -48.88 14.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.791 0.682 . . . . 73.14 109.431 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -172.24 138.65 0.98 Allowed 'General case' 0 C--N 1.349 0.58 0 CA-C-N 115.526 -0.761 . . . . 75.01 110.271 -169.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.3 mt -120.78 139.42 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.56 -1.274 . . . . 65.41 107.56 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -172.99 166.68 5.06 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.257 0.551 . . . . 73.1 111.015 -172.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -94.12 124.8 38.36 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.634 -0.712 . . . . 65.25 109.287 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.605 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.0 OUTLIER -81.61 -49.06 10.96 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.985 -1.487 . . . . 44.43 106.985 173.561 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.2 t70 -135.7 132.65 37.17 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.198 -1.819 . . . . 70.41 109.068 -168.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.5 mt -135.17 141.41 42.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.828 -1.545 . . . . 73.24 106.828 173.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.4 t -159.51 150.36 19.51 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.443 0.639 . . . . 73.32 110.597 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -145.71 139.8 26.78 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.336 -1.357 . . . . 74.1 107.336 174.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.84 120.3 12.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.644 0.778 . . . . 73.24 109.476 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.82 87.15 36.49 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 107.047 -1.464 . . . . 74.31 107.047 168.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.61 -38.34 25.28 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.077 2.518 . . . . 71.53 111.828 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -102.24 29.35 5.19 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.19 -1.368 . . . . 62.12 110.069 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.41 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -51.85 -55.6 28.85 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.457 1.103 . . . . 71.2 113.926 -171.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 33.5 Cg_exo -57.67 -44.9 37.27 Favored 'Trans proline' 0 C--N 1.39 2.747 0 CA-C-N 121.714 1.648 . . . . 62.31 112.927 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -69.95 -35.29 74.38 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.718 0.807 . . . . 72.51 112.238 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.751 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.9 p -78.23 -23.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.823 0.449 . . . . 72.52 111.874 -172.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -69.15 -33.27 73.17 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.627 0.251 . . . . 74.14 110.494 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -94.4 38.9 1.09 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.598 0.759 . . . . 73.02 110.374 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.714 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -119.96 141.71 49.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.749 1.22 . . . . 75.41 109.533 174.166 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.59 99.99 1.38 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.063 -1.088 . . . . 60.41 108.063 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -80.6 115.15 19.96 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.675 0.75 . . . . 75.23 112.548 -171.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -122.2 79.05 43.82 Favored Pre-proline 0 CA--C 1.555 1.137 0 N-CA-C 106.843 -1.54 . . . . 74.0 106.843 162.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.1 128.19 7.21 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.363 2.709 . . . . 65.3 112.946 -172.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -84.82 89.24 7.5 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.435 -1.32 . . . . 70.15 107.435 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.37 99.8 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.017 -1.447 . . . . 55.41 109.168 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.517 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 57.2 tttm -92.75 112.54 24.53 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.723 -0.843 . . . . 73.44 108.723 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.741 HD11 HD11 ' G' ' 468' ' ' LEU . 3.0 mm? -87.65 125.05 34.15 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.064 -0.717 . . . . 61.23 109.064 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.428 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.9 t70 -121.49 131.06 53.93 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.919 -1.141 . . . . 74.13 107.919 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.561 ' HB2' HD11 ' G' ' 460' ' ' LEU . 45.5 mt -120.6 147.04 45.74 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.827 -1.175 . . . . 74.21 107.827 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 22.8 t70 -157.48 152.77 26.09 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.235 0.614 . . . . 62.5 109.725 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 11.2 m -137.41 128.02 26.84 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.631 0.729 . . . . 72.51 110.045 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.83 161.68 16.66 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.151 -1.386 . . . . 72.24 108.554 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 20.3 p -159.31 151.36 20.87 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.858 0.361 . . . . 43.34 111.165 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 86.4 p -145.14 142.68 29.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.131 0.972 . . . . 64.55 108.747 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -82.87 118.06 23.17 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.426 -0.583 . . . . 71.43 109.426 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.611 HD11 HD12 ' C' ' 83' ' ' ILE . 38.6 mt -92.59 -40.05 10.99 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.609 0.763 . . . . 73.13 109.248 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.5 -175.73 5.49 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.263 1.025 . . . . 74.43 109.348 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.31 108.85 1.71 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.544 -0.753 . . . . 64.11 109.925 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 32.6 m-20 71.8 5.87 5.49 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.55 1.54 . . . . 74.43 112.668 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -103.23 97.78 6.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.964 -1.125 . . . . 70.14 107.964 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.437 ' HE2' HG12 ' G' ' 452' ' ' VAL . 51.0 m-85 -103.43 137.82 41.0 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.46 0.704 . . . . 72.51 110.097 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.525 ' HB2' HD11 ' C' ' 51' ' ' LEU . 22.1 tt0 -81.9 108.99 15.85 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.745 -1.576 . . . . 64.13 106.745 164.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 50.9 t -96.97 137.26 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 108.166 -1.05 . . . . 72.43 108.166 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.447 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 52.1 t -127.4 129.88 70.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.235 -1.024 . . . . 71.34 108.235 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.7 104.5 13.51 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.831 -1.544 . . . . 63.33 106.831 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.554 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 9.2 ttm180 -90.27 120.79 31.71 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.862 -1.063 . . . . 72.43 108.326 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.28 123.93 71.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.836 -1.172 . . . . 72.03 107.836 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 27.0 m -126.03 123.67 38.95 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.612 -0.885 . . . . 54.22 108.612 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.745 HG11 HD21 ' C' ' 126' ' ' LEU . 34.2 t -114.03 120.87 64.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 108.795 -0.817 . . . . 55.32 108.795 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 30.8 m -101.19 143.86 30.76 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.641 0.776 . . . . 75.11 108.967 172.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.67 107.86 6.08 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.12 -1.437 . . . . 74.51 107.12 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.2 m -128.02 131.72 49.16 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.519 -0.549 . . . . 72.43 109.519 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.714 HD13 ' HG2' ' C' ' 34' ' ' LYS . 25.0 mt -85.15 43.18 0.99 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.281 1.832 . . . . 75.13 110.045 -176.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.62 -88.68 0.68 Allowed Glycine 0 C--N 1.343 0.919 0 N-CA-C 110.303 -1.119 . . . . 71.41 110.303 -170.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -118.5 -20.09 8.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.816 0.846 . . . . 71.53 110.746 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -77.48 100.48 6.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.739 0.816 . . . . 74.23 109.143 172.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.7 m -66.85 120.26 13.26 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 118.922 0.783 . . . . 72.41 109.197 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.751 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.67 -52.36 18.3 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 124.095 0.872 . . . . 74.22 108.984 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -166.56 167.4 15.52 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.617 -1.174 . . . . 55.14 110.843 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -133.9 139.43 46.17 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 106.309 -1.737 . . . . 74.23 106.309 171.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.4 t -146.53 117.82 7.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.298 -0.631 . . . . 63.11 109.298 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -125.57 126.55 44.97 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 122.954 0.502 . . . . 73.43 109.909 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -120.46 132.46 70.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.338 -0.986 . . . . 63.34 108.338 167.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.554 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 69.0 mt-30 -106.08 94.66 5.29 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.587 -1.264 . . . . 72.1 107.587 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -84.2 105.73 15.28 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.532 -0.758 . . . . 64.03 109.701 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.605 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -95.64 163.73 23.86 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-O 121.609 0.56 . . . . 74.0 112.858 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.518 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -164.38 126.6 1.53 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.013 -1.235 . . . . 75.11 110.013 -177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 14.0 mm -85.23 128.77 38.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.125 -1.065 . . . . 74.43 108.125 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.11 119.41 20.91 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.392 -0.595 . . . . 75.14 109.392 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -83.95 107.58 16.41 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.162 -1.051 . . . . 72.1 108.162 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.447 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.4 pp -122.45 142.87 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.102 0.961 . . . . 73.24 110.144 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.479 ' HA ' HG21 ' G' ' 451' ' ' VAL . . . -161.92 169.53 21.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.628 0.771 . . . . 22.24 110.512 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.89 -44.21 1.52 Allowed Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.104 -0.498 . . . . 51.22 111.944 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.605 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -109.38 149.6 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.114 0.965 . . . . 63.03 109.234 178.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 11.7 pt-20 -143.01 172.59 12.5 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.652 0.263 . . . . 73.3 111.456 -171.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.81 -129.47 48.37 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.201 -0.909 . . . . 73.31 112.486 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -66.86 -19.32 65.71 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.671 0.788 . . . . 62.33 112.08 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -78.31 -35.26 48.0 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.404 0.681 . . . . 61.41 110.421 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.567 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 10.9 tmm? -72.63 -38.53 67.71 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.427 -0.953 . . . . 72.14 108.427 172.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.87 -32.8 71.05 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 115.248 -0.887 . . . . 62.13 110.558 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -77.37 -34.54 55.0 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.374 0.421 . . . . 73.12 110.918 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 15.2 t -63.29 -34.97 78.85 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.005 0.815 . . . . 63.54 109.913 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -99.15 -12.46 20.45 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.99 0.516 . . . . 65.44 111.969 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.29 -31.51 59.2 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 114.562 0.585 . . . . 51.12 114.562 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.9 -38.09 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.797 0.439 . . . . 73.43 111.042 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -56.93 -41.81 78.91 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 125.419 1.488 . . . . 74.54 112.209 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.2 m -82.26 -48.59 0.89 Allowed Pre-proline 0 CA--C 1.569 1.708 0 N-CA-C 112.897 0.703 . . . . 64.33 112.897 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.98 -29.85 28.83 Favored 'Trans proline' 0 C--N 1.392 2.855 0 C-N-CA 123.21 2.607 . . . . 73.04 115.131 172.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.24 -35.41 80.74 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.907 0.883 . . . . 63.35 110.836 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.422 HG23 ' NH1' ' A' ' 111' ' ' ARG . 40.9 mm -64.71 -40.3 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 115.511 -0.768 . . . . 75.13 109.585 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.518 HD21 ' HA3' ' C' ' 82' ' ' GLY . 53.5 mt -83.55 -18.14 39.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.652 1.181 . . . . 71.32 112.14 -175.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -56.75 -51.34 82.16 Favored Pre-proline 0 CA--C 1.56 1.352 0 N-CA-C 114.132 1.16 . . . . 75.41 114.132 -173.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.427 ' HA ' HH11 ' C' ' 111' ' ' ARG . 18.3 Cg_exo -66.15 -32.16 43.58 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 121.607 1.538 . . . . 61.3 112.778 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -65.63 -46.92 77.43 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.542 0.737 . . . . 74.45 110.503 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.04 -42.65 90.73 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.051 0.94 . . . . 73.32 110.679 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.427 HH11 ' HA ' ' C' ' 108' ' ' PRO . 27.6 mtp-105 -57.03 -55.93 28.33 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.333 1.02 . . . . 75.14 111.051 176.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.12 -29.91 70.8 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.139 0.576 . . . . 74.21 110.628 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 10.6 t -74.39 -33.13 62.96 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.265 0.626 . . . . 51.04 111.303 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.409 ' O ' HG23 ' C' ' 118' ' ' VAL . 71.5 mt -72.76 -51.29 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.037 0.535 . . . . 72.44 109.654 173.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 25.8 m -59.99 -32.96 71.33 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.094 0.957 . . . . 75.13 111.349 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.0 t -61.57 -51.51 68.26 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.189 -0.671 . . . . 65.33 109.189 172.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.583 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.69 -35.54 78.3 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.703 1.201 . . . . 65.12 112.914 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.409 HG23 ' O ' ' C' ' 114' ' ' ILE . 98.4 t -66.55 -47.13 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.52 0.728 . . . . 74.01 109.925 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.43 ' OG ' HG21 ' B' ' 115' ' ' THR . 48.4 t -66.18 -32.19 73.47 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.93 -1.032 . . . . 74.1 111.091 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.01 -35.53 74.44 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.73 0.812 . . . . 63.4 109.399 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 4.33 79.46 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.878 0.736 . . . . 74.33 112.873 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 60.0 p 59.38 25.55 14.28 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.509 1.924 . . . . 72.11 114.08 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -87.82 152.87 51.92 Favored Pre-proline 0 CA--C 1.557 1.237 0 N-CA-C 107.567 -1.272 . . . . 63.43 107.567 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.69 -179.81 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.729 2.286 . . . . 73.12 113.739 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -49.66 130.63 21.07 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.664 1.186 . . . . 64.41 112.89 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.745 HD21 HG11 ' C' ' 64' ' ' VAL . 14.3 tp -148.84 85.28 1.48 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.29 -1.004 . . . . 72.3 108.29 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -116.31 129.79 56.45 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.159 -1.052 . . . . 65.12 108.159 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 21.4 tp -76.18 132.69 40.11 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 109.78 -0.452 . . . . 71.43 109.78 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.1 154.91 75.78 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.243 1.017 . . . . 74.32 111.15 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -50.11 101.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.907 2.405 . . . . 72.4 112.867 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 80.8 t -96.55 110.69 25.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.217 -1.031 . . . . 55.1 108.217 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -87.12 86.14 7.27 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.898 -1.149 . . . . 54.13 107.898 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -60.55 -31.4 70.51 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.303 0.641 . . . . 52.11 110.227 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' C' ' 138' ' ' MET . 6.8 t70 -68.7 -36.94 79.13 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.336 1.054 . . . . 63.23 112.263 -165.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.45 74.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.98 0.912 . . . . 72.02 111.188 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.29 -23.97 34.92 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.182 -0.917 . . . . 74.41 111.452 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -81.73 -15.17 55.21 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.011 0.434 . . . . 65.21 109.997 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 67.2 mtt -71.66 -32.1 67.53 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.577 -0.527 . . . . 74.2 109.577 168.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -65.33 -34.92 79.45 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.183 0.593 . . . . 71.34 110.347 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -56.35 -82.74 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 109.005 -0.739 . . . . 72.12 109.005 168.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 8.0 tt -134.25 107.16 7.51 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.127 0.489 . . . . 55.33 109.978 172.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -110.67 -56.04 2.4 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 106.861 -1.533 . . . . 65.41 106.861 160.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -174.72 -49.83 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.071 -1.422 . . . . 72.22 109.217 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -169.13 -60.77 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.888 -1.523 . . . . 71.54 106.888 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.88 164.78 0.18 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.052 1.341 . . . . 74.3 113.222 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.77 -36.03 0.18 Allowed Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.763 -0.653 . . . . 40.51 111.604 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 147' ' ' GLU . . . . . 0.457 ' HA ' ' OD1' ' A' ' 6' ' ' ASN . 1.9 tm-20 -72.19 139.16 48.07 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 109.181 -0.674 . . . . 62.33 109.181 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.59 -10.68 8.03 Favored Glycine 0 C--N 1.345 1.051 0 O-C-N 123.663 0.602 . . . . 62.44 112.584 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 45.3 p 54.16 -170.88 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.836 1.655 . . . . 72.33 113.858 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -147.88 -172.37 4.03 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.026 0.93 . . . . 74.32 110.388 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -153.5 83.48 1.18 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.283 0.633 . . . . 63.01 110.015 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -175.75 139.95 0.43 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.321 1.448 . . . . 74.15 108.473 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -100.76 32.54 3.1 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.531 0.732 . . . . 54.42 111.857 -171.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -76.21 78.97 3.0 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.96 -0.756 . . . . 70.31 108.96 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 N-CA-C 108.618 -0.882 . . . . 53.3 108.618 177.968 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.434 ' HG3' ' HA ' ' D' ' 151' ' ' GLU . 1.5 mpt? . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 108.344 -0.984 . . . . 74.41 108.344 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 2' ' ' SER . . . . . 0.412 ' H ' ' H ' ' D' ' 3' ' ' GLU . 12.8 p -176.55 7.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.078 0.951 . . . . 73.15 111.955 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 3' ' ' GLU . . . . . 0.412 ' H ' ' H ' ' D' ' 2' ' ' SER . 1.4 tm-20 -79.11 131.43 36.24 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.514 0.725 . . . . 60.45 109.394 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.434 ' HA ' ' ND2' ' H' ' 450' ' ' ASN . 25.7 pt20 -138.83 27.79 2.41 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.806 0.669 . . . . 65.31 112.806 -161.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.76 128.47 35.63 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.472 -0.566 . . . . 65.41 109.472 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -158.2 151.51 23.13 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.196 0.522 . . . . 63.44 110.848 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.522 HG22 ' H ' ' D' ' 8' ' ' GLU . 2.6 m -134.96 -161.05 1.11 Allowed 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 125.481 1.512 . . . . 60.32 106.955 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.522 ' H ' HG22 ' D' ' 7' ' ' THR . 42.7 tt0 -65.44 136.32 56.32 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.135 0.88 . . . . 74.14 109.452 167.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 11.3 ttp -33.71 127.0 0.39 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.977 1.311 . . . . 73.22 113.247 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.6 m -130.05 140.92 50.78 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.506 -1.294 . . . . 73.52 107.506 172.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -148.53 110.77 4.64 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.077 -1.453 . . . . 74.35 107.077 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -132.81 141.67 48.59 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.183 -1.043 . . . . 64.43 108.183 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.61 HD11 HD13 ' D' ' 105' ' ' ILE . 19.4 mt -98.45 133.3 41.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.164 -1.05 . . . . 74.44 108.164 171.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -96.96 -45.65 6.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.403 0.681 . . . . 63.22 111.574 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -172.16 120.5 0.43 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 118.008 0.367 . . . . 73.52 111.874 -163.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.505 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -104.96 135.6 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.417 -1.327 . . . . 73.33 107.417 171.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -159.7 167.06 29.24 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.156 0.91 . . . . 60.42 111.205 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 18' ' ' THR . . . . . 0.495 HG21 HD11 ' D' ' 21' ' ' ILE . 81.2 p -99.53 117.16 33.31 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.078 -1.419 . . . . 74.22 109.327 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -88.06 -20.05 26.28 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.343 -0.844 . . . . 74.22 109.04 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.3 t70 -159.0 132.69 7.44 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.515 -1.22 . . . . 72.41 109.185 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.583 HD13 ' HE3' ' C' ' 117' ' ' MET . 79.7 mt -134.66 144.26 35.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 124.931 1.292 . . . . 51.53 107.553 174.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -147.46 136.6 22.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.337 1.055 . . . . 63.34 108.579 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.493 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.5 t80 -148.98 126.92 11.9 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.281 -1.748 . . . . 72.44 106.281 170.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -134.51 128.63 33.75 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.854 0.862 . . . . 74.15 109.372 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.67 81.27 60.91 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 107.881 -1.155 . . . . 64.3 107.881 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.92 -23.48 10.71 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.989 2.46 . . . . 35.42 113.604 -172.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -108.4 11.34 27.11 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.346 0.658 . . . . 61.03 109.966 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -36.85 -67.84 0.23 Allowed Pre-proline 0 CA--C 1.564 1.516 0 C-N-CA 126.371 1.868 . . . . 65.11 115.794 -161.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.01 -19.18 16.03 Favored 'Trans proline' 0 C--N 1.38 2.196 0 CA-C-N 123.124 2.151 . . . . 75.53 113.839 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -73.04 -43.06 62.48 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.917 0.887 . . . . 74.23 109.68 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.6 p -82.92 -16.12 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 CA-C-N 115.708 -0.678 . . . . 54.22 111.045 -172.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -68.4 -22.9 64.6 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.23 0.456 . . . . 71.24 112.23 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -65.94 -12.64 56.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.646 0.779 . . . . 71.42 110.744 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -98.44 92.91 5.89 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.396 1.078 . . . . 51.14 108.702 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -82.56 74.93 9.49 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.485 0.659 . . . . 63.13 109.697 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -137.43 156.23 48.41 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.129 -1.063 . . . . 73.44 108.129 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.696 ' HB3' HD13 ' H' ' 470' ' ' LEU . 1.8 mp0 -76.65 109.23 8.12 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.016 0.927 . . . . 63.14 108.921 174.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 21.6 Cg_exo -65.73 123.35 11.25 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 123.375 2.717 . . . . 41.11 113.432 -168.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -62.38 115.34 4.12 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.315 -0.624 . . . . 51.53 109.315 173.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.522 HG21 HG13 ' D' ' 64' ' ' VAL . 7.2 p -122.2 145.2 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.895 -1.048 . . . . 74.23 110.77 -170.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -117.26 147.9 42.13 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.978 0.911 . . . . 74.52 108.75 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.526 HD21 HG13 ' D' ' 62' ' ' VAL . 6.0 tt -121.34 125.61 47.43 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.339 -0.985 . . . . 74.54 108.339 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.612 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 29.3 t70 -108.11 137.49 46.01 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.941 0.896 . . . . 61.32 109.237 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 tp -113.14 140.45 47.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.651 0.78 . . . . 64.53 110.643 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.9 t70 -148.2 131.11 16.16 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.233 -1.395 . . . . 65.44 107.233 165.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.1 t -106.99 153.82 22.01 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.464 -0.939 . . . . 72.21 108.464 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.654 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.03 164.55 35.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.493 -0.929 . . . . 63.1 108.493 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 18.5 p -169.74 154.54 5.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.561 0.744 . . . . 75.1 109.806 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -154.22 142.61 20.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.784 0.834 . . . . 63.13 109.574 -166.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.11 118.66 28.99 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.644 -0.502 . . . . 75.3 109.644 175.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' D' ' 57' ' ' GLU . 49.6 mt -94.54 -42.02 9.04 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.351 0.66 . . . . 62.42 110.037 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.0 -174.75 4.89 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 124.013 0.925 . . . . 64.35 110.236 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -63.7 109.16 1.61 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.707 -1.133 . . . . 72.55 110.071 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 60.96 23.6 13.72 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.19 0.996 . . . . 55.24 111.906 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.52 121.79 67.9 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 124.758 1.223 . . . . 64.41 108.193 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -135.89 132.36 36.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.708 0.803 . . . . 65.05 109.311 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.537 ' HB2' HD11 ' D' ' 51' ' ' LEU . 30.4 tt0 -86.15 148.81 25.51 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 124.431 1.082 . . . . 53.04 108.98 169.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.2 t -125.96 124.77 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 107.653 -1.24 . . . . 75.33 107.653 168.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.4 t -99.64 128.29 51.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.26 -1.015 . . . . 70.35 108.26 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.54 115.58 30.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.502 -0.925 . . . . 74.44 108.502 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 45.9 ttm-85 -96.61 100.72 12.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.803 -1.184 . . . . 54.55 107.803 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.526 HG13 HD21 ' D' ' 42' ' ' LEU . 75.9 t -100.67 126.0 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.561 -0.903 . . . . 73.52 108.561 170.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 46.9 m -114.48 139.9 49.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.867 -0.79 . . . . 73.12 108.867 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.522 HG13 HG21 ' D' ' 40' ' ' VAL . 70.9 t -131.98 115.17 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.846 1.258 . . . . 75.04 108.213 -176.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 50.0 m -125.03 99.02 5.93 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.992 0.917 . . . . 75.23 109.227 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -101.59 158.84 15.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.669 0.787 . . . . 71.11 111.27 -175.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 50.8 p -149.92 133.31 16.51 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.669 -0.696 . . . . 65.34 111.548 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 34.9 mt -107.76 107.98 18.98 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.22 -1.4 . . . . 72.1 107.22 170.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.11 -133.3 12.35 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.934 -0.467 . . . . 72.4 111.934 -173.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -98.22 4.59 48.87 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.459 0.704 . . . . 72.31 111.401 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -120.23 165.23 15.09 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.922 0.489 . . . . 74.31 110.435 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -61.64 131.0 48.57 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.198 -0.91 . . . . 70.04 111.449 175.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.451 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.49 -74.88 0.43 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.732 -1.21 . . . . 72.53 107.732 166.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 74' ' ' PHE . . . . . 0.48 ' HZ ' HD12 ' D' ' 126' ' ' LEU . 48.9 p90 -139.7 138.98 36.45 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.118 0.485 . . . . 73.31 109.875 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 83.3 mt -110.43 144.0 39.88 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.601 1.16 . . . . 61.44 108.159 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.607 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.2 t -159.05 146.61 17.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.848 0.459 . . . . 44.51 110.409 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -155.62 134.72 12.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.577 0.751 . . . . 72.14 108.984 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 89.5 t -133.31 121.57 42.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.892 -0.781 . . . . 63.03 108.892 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.9 mt-30 -88.11 83.25 7.01 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.812 -1.181 . . . . 71.3 107.812 167.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -79.52 93.44 5.43 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.702 -1.59 . . . . 71.11 108.663 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -84.3 157.32 33.14 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.624 -0.716 . . . . 73.44 112.059 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.474 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -152.47 130.06 2.95 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.198 -0.761 . . . . 63.41 111.198 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.461 HG23 HD12 ' D' ' 51' ' ' LEU . 61.1 mt -89.84 128.74 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 123.883 0.873 . . . . 63.52 108.646 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -126.8 152.46 46.91 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.211 1.005 . . . . 75.23 109.388 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 52.3 m -115.39 107.81 15.7 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.167 0.987 . . . . 73.33 108.423 170.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 28.5 pt -125.24 116.88 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.533 0.733 . . . . 75.44 109.444 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' H' ' 451' ' ' VAL . . . -137.07 136.39 38.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.54 0.736 . . . . 74.23 110.459 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.435 ' HA2' ' H ' ' D' ' 7' ' ' THR . . . 116.09 -19.82 13.26 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 115.47 0.948 . . . . 72.31 115.47 172.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.532 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -125.51 150.5 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 117.659 0.729 . . . . 72.34 110.979 -171.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.427 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 0.0 OUTLIER -151.57 166.09 32.27 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.237 0.458 . . . . 75.14 112.237 -172.2 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.48 -116.81 8.25 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 114.693 -1.139 . . . . 52.43 114.677 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.4 p -64.4 -47.43 79.22 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.96 0.904 . . . . 75.35 111.981 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -74.22 -24.08 59.28 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 116.306 -0.406 . . . . 54.01 111.014 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.427 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 0.8 OUTLIER -65.63 -49.2 69.58 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.695 -0.483 . . . . 73.11 109.695 174.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.96 -37.16 86.4 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.689 0.796 . . . . 53.25 110.861 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -65.91 -30.3 70.87 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.838 0.855 . . . . 74.52 111.392 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -82.57 -51.9 7.34 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.342 -0.39 . . . . 74.31 110.544 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 tp -80.09 -31.13 39.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.798 0.439 . . . . 60.12 111.76 -168.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.04 13.96 55.81 Favored Glycine 0 N--CA 1.473 1.142 0 CA-C-N 115.982 -0.554 . . . . 61.13 113.362 -174.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -148.64 -63.67 0.24 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.812 0.445 . . . . 72.14 110.927 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -73.86 -43.0 59.97 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.242 0.617 . . . . 71.03 112.2 -172.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 97.3 m -63.55 -49.74 76.27 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 118.343 -0.836 . . . . 54.34 111.758 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.09 -20.74 43.68 Favored 'Trans proline' 0 C--N 1.399 3.213 0 C-N-CA 121.811 1.674 . . . . 44.32 113.131 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -71.18 -30.83 66.89 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.974 0.51 . . . . 61.02 110.769 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.61 HD13 HD11 ' D' ' 13' ' ' ILE . 63.7 mt -67.54 -39.27 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.943 0.897 . . . . 74.45 110.074 171.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.474 HD21 ' HA3' ' D' ' 82' ' ' GLY . 85.6 mt -77.19 -19.68 56.42 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.07 -0.968 . . . . 74.31 111.917 -175.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -70.38 -41.09 12.77 Favored Pre-proline 0 CA--C 1.563 1.449 0 N-CA-C 113.936 1.088 . . . . 61.24 113.936 -171.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.82 -40.96 82.54 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.192 1.928 . . . . 74.02 113.0 169.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -70.61 -35.49 73.01 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.742 0.817 . . . . 75.31 111.831 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -52.92 55.51 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.504 -0.554 . . . . 72.53 109.504 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 30.8 ttp-105 -52.27 -49.22 64.53 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.517 1.136 . . . . 64.01 111.098 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.79 -44.55 77.11 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.994 0.809 . . . . 63.33 111.252 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.95 -44.34 78.36 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.328 0.585 . . . . 62.05 110.636 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.607 HG12 ' SG ' ' D' ' 76' ' ' CYS . 78.3 mt -68.15 -51.37 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.582 -1.19 . . . . 72.33 110.959 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 52.7 m -51.56 -45.54 63.09 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.491 1.116 . . . . 70.42 111.174 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.7 t -62.26 -44.11 97.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.837 -1.074 . . . . 63.11 109.754 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.412 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 78.1 mtm -68.92 -31.38 70.25 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.222 0.609 . . . . 74.52 112.264 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' D' ' 114' ' ' ILE . 67.6 t -72.07 -38.83 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.85 0.86 . . . . 72.51 109.982 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.6 p -75.65 -29.49 59.14 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.112 0.565 . . . . 74.23 110.676 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -72.73 -34.91 67.38 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.697 0.799 . . . . 54.21 109.502 173.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 -1.71 88.0 Favored Glycine 0 C--N 1.356 1.688 0 CA-C-N 115.594 -0.73 . . . . 44.22 111.934 172.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p 64.84 19.3 11.8 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 127.219 2.207 . . . . 73.01 114.039 170.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -78.97 152.98 77.5 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.163 0.585 . . . . 75.25 109.429 170.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.52 126.1 17.08 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.117 2.545 . . . . 74.52 112.756 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -60.43 120.33 9.71 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 123.804 0.842 . . . . 53.13 110.981 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.48 HD12 ' HZ ' ' D' ' 74' ' ' PHE . 80.7 mt -117.58 108.56 15.61 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.482 -0.933 . . . . 73.02 108.482 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.6 95.43 6.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.859 -1.163 . . . . 72.54 107.859 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.497 ' HG ' HD12 ' D' ' 42' ' ' LEU . 3.2 mm? -63.82 125.92 25.93 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.182 -0.917 . . . . 72.55 110.044 -175.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.6 139.86 58.82 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 124.072 0.857 . . . . 53.13 111.11 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.33 137.34 55.45 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.225 1.95 . . . . 73.42 110.923 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 67.0 t -106.17 110.85 32.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.4 -0.963 . . . . 63.43 108.4 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -72.76 88.81 1.32 Allowed 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.569 -0.9 . . . . 64.11 108.569 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -61.95 -31.23 71.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.773 -1.103 . . . . 72.03 110.86 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.4 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 3.9 t70 -55.83 -50.25 71.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.143 1.377 . . . . 73.42 112.169 -173.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.36 -45.48 83.94 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.477 -0.783 . . . . 62.11 111.956 -174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -22.98 56.33 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.921 -0.581 . . . . 73.01 110.485 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -68.89 -31.88 71.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.841 0.856 . . . . 72.43 111.004 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.412 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 33.5 mtt -59.06 -47.31 85.7 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.48 -0.782 . . . . 74.12 109.593 174.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -63.22 -40.57 97.85 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.982 0.913 . . . . 52.41 111.608 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -58.55 -39.88 81.48 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.091 0.956 . . . . 70.2 111.266 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.56 -28.34 62.76 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.476 0.711 . . . . 63.12 111.796 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' D' ' 138' ' ' MET . 91.6 mt-30 -81.8 -1.01 45.86 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.91 0.484 . . . . 63.22 111.988 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -140.49 45.23 1.84 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.888 0.475 . . . . 72.42 110.284 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -173.54 120.8 0.33 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.392 0.677 . . . . 72.21 109.879 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.88 168.93 10.0 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.87 0.868 . . . . 74.43 110.224 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.91 134.89 3.38 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.802 -0.519 . . . . 42.54 111.802 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -111.17 132.04 54.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.426 0.691 . . . . 74.24 111.2 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -113.81 -148.38 9.95 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.141 -1.184 . . . . 52.51 110.141 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 10.6 t -170.7 176.67 4.16 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 124.075 0.95 . . . . 75.32 109.503 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.5 177.4 4.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.573 0.349 . . . . 64.43 110.523 169.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 151' ' ' GLU . . . . . 0.434 ' HA ' ' HG3' ' D' ' 1' ' ' MET . 0.5 OUTLIER -140.22 79.16 1.69 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.918 -0.401 . . . . 74.53 109.918 -177.309 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -160.45 159.53 31.01 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.783 1.233 . . . . 72.11 109.619 164.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -141.86 0.7 1.43 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.161 0.985 . . . . 61.14 108.401 164.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.77 115.71 8.43 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.544 1.138 . . . . 52.03 110.373 -174.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 C-N-CA 124.173 0.989 . . . . 52.23 108.446 177.437 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.996 0.427 . . . . 73.51 110.944 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.92 -30.69 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 124.233 1.013 . . . . 53.41 112.059 -173.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 452' ' ' VAL . . . . . 0.461 HG12 ' CE2' ' A' ' 56' ' ' TYR . 31.2 m -55.49 162.14 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 115.416 1.636 . . . . 73.33 115.416 -172.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 158.15 -71.36 0.24 Allowed Glycine 0 C--N 1.342 0.888 0 CA-C-N 114.029 -1.441 . . . . 60.24 110.314 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 454' ' ' LEU . . . . . 0.442 HD13 HD22 ' A' ' 98' ' ' LEU . 20.6 mt 64.18 175.0 0.18 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.992 1.717 . . . . 63.13 112.823 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 21.3 p -108.4 138.55 44.51 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.427 1.091 . . . . 74.41 109.058 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -63.27 -44.58 94.7 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.929 0.768 . . . . 74.4 109.755 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -70.25 122.04 18.76 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.76 -1.109 . . . . 74.23 109.477 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 72.4 m -124.59 -56.53 1.59 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.144 0.578 . . . . 72.3 109.643 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 34.8 t70 60.95 98.96 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.836 1.254 . . . . 74.35 111.219 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 460' ' ' LEU . . . . . 0.421 HD11 ' HB ' ' A' ' 46' ' ' THR . 4.2 mm? -81.6 169.89 16.5 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.641 0.734 . . . . 74.13 111.178 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -133.38 144.6 49.69 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 114.284 -1.325 . . . . 64.32 109.31 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -150.67 109.3 3.83 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.684 0.794 . . . . 72.32 109.525 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 18.4 p -143.91 100.56 3.6 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.855 0.862 . . . . 65.04 109.473 171.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 27.2 ptm -156.77 166.59 32.96 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.501 -0.925 . . . . 74.12 108.501 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 465' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' E' ' 465' ' ' LYS . 0.3 OUTLIER -81.44 106.06 13.1 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.721 -1.214 . . . . 74.2 107.721 177.178 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -70.98 78.04 0.65 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.373 1.069 . . . . 63.21 110.126 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -103.92 -51.21 3.21 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.039 -1.097 . . . . 63.32 108.039 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 45.3 mt 69.79 -75.11 0.07 Allowed 'General case' 0 C--N 1.367 1.33 0 C-N-CA 125.46 1.504 . . . . 74.33 110.002 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 469' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 126' ' ' LEU . . . -162.16 16.05 0.15 Allowed Glycine 0 N--CA 1.48 1.581 0 N-CA-C 110.013 -1.235 . . . . 63.21 110.013 170.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 470' ' ' LEU . . . . . 0.478 ' HB2' HG11 ' A' ' 40' ' ' VAL . 51.1 mt -138.69 -163.26 1.44 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.51 1.924 . . . . 64.11 107.447 -170.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 117.736 -1.125 . . . . 71.12 108.442 172.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 10.4 t30 . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 122.072 0.939 . . . . 73.52 109.296 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.6 146.54 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.15 0.98 . . . . 73.45 108.632 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 75.6 t 71.13 118.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.681 1.192 . . . . 64.41 111.64 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 154.45 60.71 0.01 OUTLIER Glycine 0 C--N 1.346 1.102 0 CA-C-N 116.018 -0.537 . . . . 55.4 112.365 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 2.6 pp -137.99 130.99 30.09 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 109.567 -0.531 . . . . 61.32 109.567 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 32.8 m -155.95 85.34 1.02 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.662 1.185 . . . . 64.45 108.03 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -126.27 98.51 5.49 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.644 0.778 . . . . 75.01 109.954 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -74.09 100.39 3.61 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.202 -1.407 . . . . 64.54 107.202 170.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 20.1 m -143.92 167.16 22.98 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.272 1.029 . . . . 72.23 108.653 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -49.59 109.61 0.29 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.571 1.148 . . . . 71.41 111.163 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.11 119.67 12.43 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.98 -0.748 . . . . 73.11 108.98 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -52.83 111.65 0.7 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.839 1.256 . . . . 51.42 111.414 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -149.34 49.63 0.96 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.047 -0.524 . . . . 75.14 109.924 -174.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 67.0 m -65.71 91.12 0.13 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.51 -0.552 . . . . 73.02 109.51 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 16.8 tmm? -164.92 -55.59 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.338 -1.356 . . . . 62.43 107.338 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp 73.01 -26.22 0.19 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 125.301 1.44 . . . . 74.54 114.239 168.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -75.9 179.03 5.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.336 0.655 . . . . 43.15 110.505 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -98.82 -95.73 0.23 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 119.392 -0.337 . . . . 65.01 110.403 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 468' ' ' LEU . . . . . 0.419 HD23 HD13 ' B' ' 128' ' ' LEU . 1.2 pp -172.29 43.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.497 0.719 . . . . 41.43 110.856 -169.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 95.8 -34.21 5.04 Favored Glycine 0 N--CA 1.483 1.788 0 CA-C-N 115.745 -0.662 . . . . 53.45 111.689 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 470' ' ' LEU . . . . . 0.668 HD21 ' H ' ' B' ' 40' ' ' VAL . 16.1 tp -49.1 -51.09 33.8 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.172 1.789 . . . . 53.2 112.244 169.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.248 1.013 0 N-CA-C 108.944 -0.761 . . . . 64.33 108.944 -173.287 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 . . . . . 0 CA--C 1.54 0.572 0 CA-C-O 119.43 -0.319 . . . . 53.51 111.311 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' G' G ' 451' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' C' ' 87' ' ' ALA . 19.1 m -89.66 4.83 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 122.847 0.459 . . . . 62.51 111.883 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 452' ' ' VAL . . . . . 0.437 HG12 ' HE2' ' C' ' 56' ' ' TYR . 27.2 m -52.0 139.41 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 C-N-CA 123.522 0.729 . . . . 74.51 111.351 174.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 163.83 108.98 0.22 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.928 -0.869 . . . . 73.53 110.928 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 22.8 tp -136.77 100.17 4.25 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.318 0.647 . . . . 71.35 109.468 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 7.8 p -78.79 118.64 21.04 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.205 -1.035 . . . . 64.52 108.205 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -76.81 160.44 29.26 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.402 0.681 . . . . 74.31 111.657 -173.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 457' ' ' GLN . . . . . 0.437 ' HG2' ' HB3' ' G' ' 459' ' ' ASP . 53.6 tt0 -158.18 100.73 1.71 Allowed 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.453 -1.314 . . . . 73.5 107.453 166.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 27.3 p -73.89 77.98 1.63 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.701 0.763 . . . . 70.11 109.413 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 459' ' ' ASP . . . . . 0.437 ' HB3' ' HG2' ' G' ' 457' ' ' GLN . 25.7 t70 -162.75 119.68 1.95 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.482 -1.235 . . . . 62.03 108.119 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 460' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' C' ' 44' ' ' LEU . 0.5 OUTLIER -97.46 126.77 42.92 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.054 -0.721 . . . . 74.44 109.054 -176.438 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -94.71 -172.09 2.64 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.06 1.344 . . . . 70.33 111.476 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 86.1 t80 68.92 103.58 0.06 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.829 1.252 . . . . 74.2 111.362 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 28.9 p -82.46 98.04 8.7 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.153 0.581 . . . . 72.31 109.676 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 15.2 tpt -77.19 146.21 37.17 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.987 0.515 . . . . 72.52 110.193 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -143.64 162.7 35.25 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.373 1.069 . . . . 71.35 109.591 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . 71.01 147.5 0.08 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.26 1.424 . . . . 60.34 112.768 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -76.22 143.21 41.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.573 0.749 . . . . 64.12 109.977 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 468' ' ' LEU . . . . . 0.741 HD11 HD11 ' C' ' 42' ' ' LEU . 65.4 mt -68.17 -56.09 10.01 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.649 0.78 . . . . 74.43 111.901 -174.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -162.17 28.16 0.26 Allowed Glycine 0 N--CA 1.469 0.866 0 CA-C-N 115.755 -0.657 . . . . 75.04 111.647 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -110.05 125.69 53.21 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.646 0.778 . . . . 75.51 109.502 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 59.2 tttm . . . . . 0 C--O 1.249 1.032 0 N-CA-C 107.211 -1.403 . . . . 75.54 107.211 -179.178 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' H' H ' 450' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' D' ' 4' ' ' GLN . 21.6 t-20 . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 112.193 0.442 . . . . 63.33 112.193 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 451' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' D' ' 87' ' ' ALA . 47.2 t -76.39 70.81 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-O 121.946 0.879 . . . . 53.32 111.088 -175.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 452' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -155.49 145.0 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.882 1.273 . . . . 62.21 108.041 174.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 178.85 43.82 0.07 OUTLIER Glycine 0 N--CA 1.461 0.361 0 N-CA-C 110.356 -1.098 . . . . 53.33 110.356 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 66.5 mt -82.23 148.08 28.6 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.2 0.6 . . . . 74.3 110.229 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 27.3 p -92.02 -54.73 3.72 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.985 0.914 . . . . 72.21 109.198 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -164.41 161.12 21.36 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.903 0.881 . . . . 74.02 109.637 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -129.77 98.49 4.82 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.17 0.988 . . . . 71.24 110.308 -177.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 2.4 p -145.83 -152.22 0.42 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.045 1.338 . . . . 74.44 108.025 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.15 135.87 57.85 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.122 -0.696 . . . . 72.53 109.122 167.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 95.0 mt -85.22 -56.67 3.42 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.586 -0.734 . . . . 72.13 110.866 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -175.56 18.75 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 123.391 0.676 . . . . 61.25 111.836 -168.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -76.44 89.64 3.23 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.849 -0.426 . . . . 73.51 109.849 -169.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 29.4 m -96.67 -73.85 0.59 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.904 0.881 . . . . 52.33 110.667 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 59.4 mtt 63.9 146.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.897 1.279 . . . . 70.52 111.442 -166.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -89.39 -9.78 49.02 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 111.98 0.363 . . . . 74.44 111.98 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -152.68 -178.26 6.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.831 0.852 . . . . 54.44 110.072 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -63.64 -64.51 0.88 Allowed 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.215 -0.661 . . . . 75.35 109.215 173.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -172.2 -31.24 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.244 0.965 . . . . 75.34 110.347 170.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 72.91 70.47 1.22 Allowed Glycine 0 C--N 1.359 1.858 0 O-C-N 123.19 0.306 . . . . 45.3 112.388 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 470' ' ' LEU . . . . . 0.696 HD13 ' HB3' ' D' ' 37' ' ' GLN . 23.7 mt -70.62 98.2 1.46 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.932 0.893 . . . . 74.23 111.71 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt . . . . . 0 C--O 1.254 1.301 0 C-N-CA 124.94 1.296 . . . . 64.11 110.774 176.288 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.035 -0.358 . . . . 74.52 110.035 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.7 p -81.72 143.11 32.08 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.094 0.957 . . . . 73.2 110.221 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -124.32 148.35 47.52 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.855 0.462 . . . . 71.42 109.941 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.18 85.79 3.02 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.456 -0.942 . . . . 62.23 108.456 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -132.01 86.34 2.33 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.296 -1.372 . . . . 72.13 107.296 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -67.93 -17.15 64.37 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.751 -1.113 . . . . 72.11 111.342 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 m -67.41 123.64 20.95 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.289 0.635 . . . . 74.05 109.911 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.76 -55.97 26.8 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.852 0.72 . . . . 75.43 110.968 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.5 mtp -72.07 134.67 45.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.233 -0.44 . . . . 74.25 109.883 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.6 m -141.81 121.86 13.74 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.959 -0.756 . . . . 52.4 108.959 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -136.86 130.06 31.18 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.166 0.986 . . . . 63.34 108.544 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -146.62 135.21 22.09 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.667 -0.864 . . . . 72.44 108.667 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.466 ' CD1' HG21 ' A' ' 105' ' ' ILE . 13.0 mt -91.05 119.02 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.726 -0.842 . . . . 62.14 108.726 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -81.82 -40.65 22.22 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 123.525 0.516 . . . . 61.22 110.299 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -170.02 131.38 1.02 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.576 -0.283 . . . . 75.04 110.604 -169.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.455 HD12 ' HG3' ' C' ' 130' ' ' PRO . 87.8 mt -121.32 132.88 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.728 -0.841 . . . . 74.11 108.728 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' HB3' HG23 ' B' ' 122' ' ' THR . 34.5 p90 -166.14 151.87 8.78 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.922 0.764 . . . . 64.13 110.812 -175.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -80.25 106.88 12.6 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.732 -1.122 . . . . 60.24 109.027 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -73.06 -28.59 62.4 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.223 -0.444 . . . . 52.34 110.395 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -148.57 140.06 23.48 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.065 -0.97 . . . . 41.42 109.226 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.13 142.81 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 107.537 -1.283 . . . . 71.54 107.537 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -143.13 147.86 35.65 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.115 0.483 . . . . 74.0 109.73 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 83.4 t80 -150.07 114.51 5.21 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.032 -1.469 . . . . 64.23 107.032 174.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -124.34 110.36 14.48 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.838 -0.43 . . . . 52.12 109.838 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.44 84.81 19.12 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 124.052 0.941 . . . . 64.52 108.559 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.49 -32.38 12.34 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.513 2.142 . . . . 75.51 110.826 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 85.3 m-20 -102.62 28.87 5.68 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.604 1.162 . . . . 70.11 109.812 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.429 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.3 -46.34 99.09 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.529 0.731 . . . . 53.3 111.999 173.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -83.95 5.63 6.23 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.049 1.833 . . . . 31.03 112.756 172.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 54.7 m170 -104.47 -17.5 14.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.335 0.654 . . . . 72.44 111.903 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 28' ' ' ALA . 11.3 p -71.04 -31.07 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.47 0.544 . . . . 71.53 112.47 -170.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -80.15 -33.03 38.82 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.39 0.276 . . . . 73.12 110.813 -172.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -76.92 -24.36 52.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.939 -0.573 . . . . 74.32 110.167 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -83.53 151.61 25.32 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.758 0.823 . . . . 71.15 110.536 171.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.03 140.25 40.29 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.727 -0.842 . . . . 74.52 108.727 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -79.31 95.6 5.74 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.181 0.515 . . . . 71.53 111.083 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -126.92 83.81 64.86 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.41 1.084 . . . . 75.13 109.112 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.32 139.93 29.76 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.421 2.081 . . . . 74.21 112.726 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -106.82 100.52 10.02 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.252 -1.388 . . . . 71.43 107.252 172.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.8 m -76.26 101.25 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 CA-C-O 122.113 0.959 . . . . 72.13 111.432 -174.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -110.4 114.11 27.3 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.328 -1.36 . . . . 71.54 107.328 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.491 HD22 HD21 ' E' ' 468' ' ' LEU . 52.6 tp -120.43 136.84 54.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.085 0.554 . . . . 74.12 110.677 -172.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.583 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.1 m-20 -121.22 140.07 52.53 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.961 1.304 . . . . 52.14 108.22 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.555 HD21 ' HE1' ' A' ' 133' ' ' PHE . 7.7 tt -142.47 120.3 11.95 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.643 -0.873 . . . . 73.41 108.643 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -136.45 145.68 45.48 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.841 0.856 . . . . 74.11 110.243 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 m -113.19 135.07 54.22 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.291 1.036 . . . . 44.41 108.71 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.77 132.25 45.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.556 0.742 . . . . 54.32 109.433 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.4 m -90.99 152.49 20.67 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.597 0.759 . . . . 74.21 111.225 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 42.1 t -154.45 131.55 11.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.848 0.859 . . . . 71.02 109.329 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -112.18 111.92 23.15 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.748 -0.834 . . . . 74.53 108.748 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.5 mt -86.89 -39.68 15.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.257 0.623 . . . . 60.42 110.389 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.23 -174.99 4.33 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.008 0.923 . . . . 73.1 109.656 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.63 104.75 0.3 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.769 0.827 . . . . 72.21 109.744 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 66.54 9.75 6.82 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.125 1.37 . . . . 75.43 112.639 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.34 101.69 12.44 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 105.35 -2.093 . . . . 63.33 105.35 168.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -116.79 151.21 36.96 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.503 -1.226 . . . . 74.14 109.081 -164.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 43.7 tt0 -132.78 138.63 47.21 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.275 0.63 . . . . 63.33 110.031 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.6 t -119.85 130.98 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.106 -1.072 . . . . 70.03 108.106 171.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.4 t -115.69 109.6 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.134 0.973 . . . . 54.04 108.604 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.0 tp -89.2 101.42 14.08 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.055 -0.72 . . . . 63.03 109.055 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 ttp85 -85.4 107.51 17.41 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.051 -0.722 . . . . 75.43 109.051 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG13 HD11 ' A' ' 114' ' ' ILE . 3.1 p -113.52 121.87 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 108.93 -0.767 . . . . 72.13 108.93 176.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.6 m -116.49 135.45 53.82 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.586 0.754 . . . . 74.5 109.407 -177.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 126' ' ' LEU . 64.8 t -124.61 132.99 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 124.38 1.072 . . . . 70.24 108.634 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.3 m -131.21 120.55 23.43 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.049 -0.723 . . . . 75.02 109.049 173.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.41 122.52 44.02 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.677 -0.86 . . . . 75.33 108.677 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 t -130.18 146.72 51.83 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.916 0.886 . . . . 72.43 110.228 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.4 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -101.58 87.15 3.1 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 107.123 -1.436 . . . . 63.4 107.123 167.197 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.73 -105.09 3.23 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 114.835 -1.075 . . . . 41.14 110.518 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.54 -20.61 11.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.805 0.842 . . . . 74.55 110.616 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.05 104.89 9.99 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.831 0.853 . . . . 70.22 109.271 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.3 m -71.31 121.2 18.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.157 0.583 . . . . 72.34 110.732 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.01 -53.51 20.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.783 0.833 . . . . 53.53 109.38 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -150.22 158.08 43.77 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.502 -1.226 . . . . 75.12 111.618 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 64' ' ' VAL . 66.9 tp -125.57 140.89 52.36 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.371 1.468 . . . . 70.11 107.282 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.4 m -142.34 113.29 7.5 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.378 0.671 . . . . 73.01 109.585 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -127.05 120.52 29.18 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.272 -0.64 . . . . 65.14 109.272 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.4 t -127.63 110.64 22.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 123.665 0.786 . . . . 74.24 109.348 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -85.05 81.4 8.89 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.73 -1.211 . . . . 75.52 107.73 171.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -76.88 94.96 3.99 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.074 -0.967 . . . . 74.33 108.633 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.06 151.08 21.36 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 115.376 -0.829 . . . . 74.34 111.589 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.97 128.5 2.8 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.139 -0.784 . . . . 71.22 111.139 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -81.15 115.82 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.789 -0.819 . . . . 62.12 108.789 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -114.8 118.7 34.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.048 0.939 . . . . 74.32 109.586 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.9 m -85.36 103.7 14.51 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.63 -0.878 . . . . 72.22 108.63 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.9 pp -116.04 153.91 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.12 0.568 . . . . 61.14 110.812 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.55 149.98 5.89 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.615 1.166 . . . . 72.4 109.429 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.23 -26.75 23.45 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 122.856 0.265 . . . . 43.23 113.715 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.591 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.92 138.85 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.502 0.721 . . . . 72.24 110.321 -176.26 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 10.6 tt0 -152.59 174.4 14.0 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.89 0.476 . . . . 75.31 109.857 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.416 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 66.83 -127.7 28.33 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 116.344 -0.389 . . . . 63.25 112.248 -174.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -72.5 -21.07 61.25 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.464 0.706 . . . . 73.12 111.313 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -70.77 -45.26 65.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.503 0.721 . . . . 71.03 110.851 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.523 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 23.3 ttt -71.95 -37.34 69.99 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.347 -0.388 . . . . 71.32 110.013 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.88 72.19 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.346 0.404 . . . . 65.44 110.587 174.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 59.3 t-80 -71.74 -33.74 68.96 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.381 0.672 . . . . 73.32 110.706 173.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -66.55 -61.81 1.79 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 110.047 -0.353 . . . . 61.21 110.047 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.462 HD23 ' HG2' ' A' ' 94' ' ' MET . 4.2 pp -74.13 -24.62 59.45 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.449 0.7 . . . . 71.02 112.547 -174.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.44 1.08 37.14 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-O 119.538 -0.59 . . . . 65.2 114.28 -173.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -141.36 -65.34 0.43 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 117.533 0.667 . . . . 65.14 111.052 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 105' ' ' ILE . 48.3 t80 -66.63 -46.49 75.63 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 112.797 0.666 . . . . 62.24 112.797 -171.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -68.66 -47.37 34.07 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 124.064 0.945 . . . . 73.53 112.723 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.51 -26.8 69.97 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 121.823 1.682 . . . . 62.03 112.185 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -65.91 -37.83 87.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.158 0.583 . . . . 63.22 110.937 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.466 HG21 ' CD1' ' A' ' 13' ' ' ILE . 47.2 mm -66.34 -45.67 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.301 0.641 . . . . 72.14 110.046 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.6 mt -73.89 -23.37 59.56 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.381 -0.827 . . . . 73.34 111.918 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -60.69 -49.14 91.02 Favored Pre-proline 0 CA--C 1.563 1.451 0 N-CA-C 113.968 1.099 . . . . 50.05 113.968 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -63.11 -34.83 67.96 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.11 1.874 . . . . 62.25 112.841 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -67.52 -40.23 85.11 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.126 0.57 . . . . 75.54 110.872 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.42 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -69.77 -36.21 75.56 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.401 0.681 . . . . 65.33 110.79 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.606 ' HA ' HD21 ' A' ' 128' ' ' LEU . 38.1 ttm180 -57.15 -53.82 53.72 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 124.031 0.832 . . . . 71.4 109.715 176.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -57.76 -48.02 80.84 Favored 'General case' 0 C--N 1.348 0.531 0 O-C-N 124.563 1.164 . . . . 75.12 111.229 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 117' ' ' MET . 24.0 t -53.29 -47.84 68.87 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.334 1.021 . . . . 75.42 110.462 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.426 HD11 HG13 ' A' ' 62' ' ' VAL . 93.6 mt -68.55 -38.42 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.327 1.051 . . . . 63.32 111.176 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.2 m -64.34 -34.23 77.68 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.263 0.554 . . . . 75.43 110.115 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 t -74.24 -36.93 63.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.881 -0.599 . . . . 71.41 109.701 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 74.6 mmm -60.36 -46.98 88.03 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.98 0.512 . . . . 75.11 110.739 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.0 m -69.41 -39.68 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.571 -0.74 . . . . 74.22 110.826 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.8 m -67.23 -34.59 77.79 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.867 0.467 . . . . 73.31 111.639 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.542 HH12 ' HG3' ' B' ' 112' ' ' GLU . 86.8 mtt-85 -74.34 -28.92 61.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.225 0.61 . . . . 71.11 110.191 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.88 -4.74 88.49 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 123.758 0.661 . . . . 31.22 113.183 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.4 m 65.92 41.14 3.86 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 123.586 1.66 . . . . 73.32 111.132 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.89 151.61 43.62 Favored Pre-proline 0 C--O 1.244 0.772 0 CA-C-N 113.917 -1.492 . . . . 74.34 108.514 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -53.06 142.33 54.53 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.897 2.398 . . . . 55.13 112.697 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.06 145.88 24.39 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.987 0.804 . . . . 73.4 112.124 -177.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.476 ' CD2' HG11 ' A' ' 64' ' ' VAL . 18.4 tp -128.4 115.99 19.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.727 -1.124 . . . . 72.5 110.391 -175.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -120.8 89.29 3.1 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.248 -1.019 . . . . 63.44 108.248 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.703 ' H ' HD23 ' A' ' 128' ' ' LEU . 1.0 OUTLIER -64.38 129.58 40.47 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 116.057 -0.519 . . . . 73.23 109.779 176.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.82 144.65 85.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.494 1.118 . . . . 54.32 112.077 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -65.63 113.09 2.37 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.366 2.044 . . . . 71.43 110.844 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.05 127.56 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.595 -0.891 . . . . 72.23 108.595 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -80.44 89.87 5.62 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.582 -0.735 . . . . 71.31 109.387 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.555 ' HE1' HD21 ' A' ' 44' ' ' LEU . 97.3 m-85 -60.25 -37.43 80.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.147 0.979 . . . . 61.44 111.762 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -56.24 -51.14 69.18 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.975 0.797 . . . . 71.4 110.317 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.45 97.65 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 124.345 1.028 . . . . 71.43 111.28 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -57.53 -45.66 84.76 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.914 0.759 . . . . 72.31 111.215 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -67.69 -37.9 82.94 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.802 -0.635 . . . . 73.05 110.025 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.5 mmt -58.16 -35.43 71.53 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.973 0.795 . . . . 73.31 111.763 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -60.77 -47.42 86.41 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 123.713 0.633 . . . . 74.51 110.999 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -73.93 -32.93 63.75 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.623 -0.717 . . . . 74.54 111.247 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.06 -46.52 77.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.232 1.013 . . . . 71.32 110.738 -173.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.437 ' H ' ' H ' ' A' ' 143' ' ' GLN . 0.3 OUTLIER -167.32 -14.22 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.895 -0.593 . . . . 72.23 110.129 -174.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.586 ' HG2' ' HG2' ' C' ' 151' ' ' GLU . 57.7 tt0 59.07 92.45 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.482 1.513 . . . . 61.43 110.154 -164.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.556 ' HA ' ' HB3' ' C' ' 151' ' ' GLU . 14.1 pt20 -171.84 172.81 4.71 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.277 0.56 . . . . 72.53 111.633 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.462 ' HB3' ' H ' ' C' ' 150' ' ' GLU . . . -81.26 143.67 32.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.521 -1.218 . . . . 72.31 108.343 165.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.51 45.43 0.92 Allowed Glycine 0 N--CA 1.467 0.716 0 N-CA-C 112.255 -0.338 . . . . 61.42 112.255 -175.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -159.93 134.93 7.94 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.083 0.553 . . . . 74.1 110.629 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -115.89 -147.26 8.94 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 110.702 -0.959 . . . . 61.12 110.702 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.1 m -124.97 146.79 49.22 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.455 -0.943 . . . . 70.32 108.455 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.76 133.74 49.78 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.244 -0.65 . . . . 72.45 109.244 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -58.97 -28.31 66.2 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.199 0.999 . . . . 73.22 111.624 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -65.08 97.58 0.25 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.676 0.751 . . . . 63.31 110.089 168.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -79.06 -175.72 4.72 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.847 -1.07 . . . . 52.54 109.441 168.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -136.51 143.16 43.6 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.079 -0.712 . . . . 72.43 109.079 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 C-N-CA 123.309 0.643 . . . . 72.25 109.498 178.917 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 86.8 mtp . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 109.291 -0.633 . . . . 74.22 109.291 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 44.6 p -80.27 92.13 5.71 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.598 0.759 . . . . 74.41 110.224 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -77.62 86.73 3.93 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.457 -1.312 . . . . 62.11 107.457 174.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.44 136.32 56.97 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.815 -0.629 . . . . 70.31 110.802 -171.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -125.23 99.93 6.3 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.015 -1.106 . . . . 73.43 108.015 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -89.44 -33.8 16.69 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.3 -0.864 . . . . 65.11 110.986 -172.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.2 t -64.2 -24.07 67.54 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.302 0.641 . . . . 71.32 111.297 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -92.64 -37.93 12.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.415 0.686 . . . . 71.23 110.148 175.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.406 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 24.5 ptm 43.52 -156.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.628 1.571 . . . . 64.25 112.491 -176.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 99.2 m -152.27 120.11 6.15 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.262 -1.014 . . . . 74.24 108.262 168.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -136.06 127.54 28.63 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.195 -1.039 . . . . 64.13 108.195 169.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -147.24 134.11 20.16 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.117 -0.697 . . . . 75.01 109.117 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.55 HD11 HD13 ' B' ' 105' ' ' ILE . 26.9 mt -86.84 122.03 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.439 -0.948 . . . . 54.05 108.439 172.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -95.23 -30.6 13.91 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.127 0.571 . . . . 73.14 110.177 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -172.72 138.05 0.82 Allowed 'General case' 0 C--N 1.353 0.725 0 O-C-N 123.642 0.589 . . . . 72.33 110.124 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.406 HD11 HD13 ' B' ' 13' ' ' ILE . 89.0 mt -118.74 137.66 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 106.922 -1.51 . . . . 70.14 106.922 171.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.449 ' HE1' HG13 ' B' ' 83' ' ' ILE . 10.8 p90 -167.17 143.61 4.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.249 0.547 . . . . 74.04 112.376 -173.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.4 m -73.56 125.64 28.44 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.134 -0.939 . . . . 53.13 108.73 169.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.404 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 47.9 mtpt -97.52 -31.74 12.17 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.698 0.799 . . . . 75.2 110.698 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 21.1 t70 -155.72 143.2 19.47 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.45 -0.341 . . . . 71.14 111.025 -174.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.479 HD11 ' SG ' ' B' ' 113' ' ' CYS . 42.6 mm -139.54 143.3 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.988 1.315 . . . . 72.22 109.007 177.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.1 t -142.45 120.8 12.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.83 -1.077 . . . . 73.45 108.452 167.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -121.24 124.26 44.22 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.479 -1.304 . . . . 73.4 107.479 168.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.638 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 34.3 mt-10 -128.61 117.33 21.04 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.532 1.133 . . . . 54.34 108.381 -174.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -108.18 86.57 3.35 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 108.002 -1.11 . . . . 75.45 108.002 171.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -65.11 -47.88 4.19 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.057 2.504 . . . . 72.23 113.17 -167.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -107.34 28.19 8.34 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.035 0.934 . . . . 73.22 109.764 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.506 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -39.44 -63.15 0.68 Allowed Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 114.985 1.476 . . . . 72.04 114.985 -163.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 12.1 Cg_exo -68.45 -24.24 36.74 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.137 1.891 . . . . 65.15 112.896 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -92.69 -28.04 16.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.756 0.822 . . . . 74.12 112.555 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' B' ' 73' ' ' ALA . 13.4 p -81.95 -18.96 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 120.69 0.281 . . . . 73.44 111.472 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -64.89 -17.27 64.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 113.164 0.802 . . . . 75.1 113.164 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -66.93 -21.17 65.99 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.206 0.602 . . . . 71.13 111.385 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.491 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 86.1 mttt -94.05 107.38 19.3 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.813 0.845 . . . . 74.32 109.177 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -87.21 86.06 7.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.954 0.501 . . . . 74.02 110.566 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -164.64 158.11 17.55 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.902 0.881 . . . . 72.02 109.161 173.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.514 ' HB3' HD22 ' F' ' 470' ' ' LEU . 42.0 mt-30 -73.22 109.23 5.89 Favored Pre-proline 0 C--N 1.354 0.792 0 N-CA-C 109.087 -0.709 . . . . 75.3 109.087 169.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.639 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 13.1 Cg_endo -56.34 146.61 72.05 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.017 2.478 . . . . 52.43 111.842 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -61.32 102.51 0.23 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 123.826 0.704 . . . . 71.53 109.181 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.418 HG23 ' O ' ' B' ' 38' ' ' PRO . 85.1 t -92.81 120.31 41.94 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 115.607 -0.724 . . . . 60.12 109.576 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -121.08 119.19 31.73 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.904 -1.517 . . . . 64.4 106.904 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 pp -93.96 160.56 14.67 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.251 0.548 . . . . 61.41 111.065 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.704 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 3.2 m-20 -123.67 129.57 51.32 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.773 -1.195 . . . . 64.43 107.773 173.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 tt -100.38 128.62 46.4 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.36 -1.348 . . . . 71.22 107.36 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.422 ' HA ' HD23 ' F' ' 460' ' ' LEU . 24.1 t70 -145.93 121.43 10.38 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.496 0.718 . . . . 34.12 109.689 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 43.3 p -120.65 122.79 41.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.62 0.368 . . . . 73.45 110.255 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.78 154.77 33.72 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.523 1.129 . . . . 72.13 108.327 172.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.3 p -144.77 168.06 21.11 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.909 0.385 . . . . 73.43 111.061 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.2 p -153.47 169.91 22.02 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.354 1.061 . . . . 61.3 109.337 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -114.26 136.35 53.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.706 0.802 . . . . 73.11 110.339 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 86.4 mt -99.41 -39.22 8.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.281 0.633 . . . . 63.33 110.727 174.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.54 -177.09 5.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.637 0.775 . . . . 75.14 110.287 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -68.95 123.64 21.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.409 -0.814 . . . . 71.31 109.126 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 69.8 9.62 7.22 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.569 1.147 . . . . 75.21 112.161 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.7 t -124.34 110.72 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 107.862 -1.162 . . . . 54.51 107.862 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.44 ' CD2' HD13 ' B' ' 98' ' ' LEU . 5.8 t80 -125.28 154.13 42.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.769 -0.826 . . . . 75.33 108.769 -177.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -130.62 110.02 11.08 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.439 -0.949 . . . . 74.21 108.439 -168.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.48 145.26 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.961 0.904 . . . . 72.4 109.948 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.8 t -128.4 114.73 35.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 121.37 0.605 . . . . 72.22 109.537 176.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -94.15 111.51 23.24 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.578 -1.268 . . . . 75.23 107.578 176.14 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -105.31 129.72 53.59 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.274 0.559 . . . . 75.23 109.868 171.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.426 ' HB ' HD11 ' B' ' 114' ' ' ILE . 21.2 t -124.32 119.78 57.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.831 -1.174 . . . . 74.22 107.831 174.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.704 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 95.5 m -98.18 148.87 23.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.274 -1.01 . . . . 40.31 108.274 175.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.704 HG21 HG21 ' B' ' 114' ' ' ILE . 42.7 t -134.67 125.6 46.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.55 1.14 . . . . 65.43 108.284 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 99.5 m -123.97 139.69 53.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.589 -0.893 . . . . 52.44 108.589 172.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -136.62 145.49 44.94 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 123.652 0.595 . . . . 44.23 110.275 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.1 p -136.13 126.98 27.51 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.638 0.586 . . . . 65.21 111.153 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.639 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 19.8 mt -100.86 112.13 24.49 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.292 -1.003 . . . . 73.23 108.292 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.09 -114.16 5.89 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 124.003 0.815 . . . . 64.23 112.168 -174.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -110.58 4.39 20.25 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.316 0.646 . . . . 73.15 111.304 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -122.41 160.45 25.45 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.999 0.52 . . . . 72.22 110.438 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -75.2 138.15 41.76 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 123.501 0.501 . . . . 53.43 110.079 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.809 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.59 -64.07 1.15 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.371 0.668 . . . . 64.42 109.536 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -144.31 155.33 43.77 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.737 0.78 . . . . 74.21 110.877 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.638 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 82.1 mt -128.02 135.55 50.03 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.74 1.616 . . . . 73.41 106.761 173.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.418 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 38.9 t -145.07 148.4 33.63 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.993 -0.743 . . . . 54.23 108.993 175.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -158.98 126.97 5.06 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.215 -0.661 . . . . 74.31 109.215 -172.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' B' ' 113' ' ' CYS . 65.5 t -124.37 147.37 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 115.401 -0.818 . . . . 63.42 109.419 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -124.8 86.63 2.59 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.249 -1.019 . . . . 73.04 108.249 170.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -80.05 103.03 9.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.717 -0.674 . . . . 73.3 109.486 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.15 164.5 28.51 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 112.042 -0.423 . . . . 51.42 112.042 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.32 134.86 3.79 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.94 -0.464 . . . . 62.24 111.94 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.449 HG13 ' HE1' ' B' ' 17' ' ' TYR . 59.0 mt -91.93 124.52 44.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.982 0.913 . . . . 53.55 109.056 174.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -131.69 135.97 47.29 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.253 0.621 . . . . 72.13 110.029 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.7 m -91.36 115.05 27.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.428 1.091 . . . . 73.24 109.198 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.735 HD13 HD11 ' B' ' 98' ' ' LEU . 35.7 pt -115.96 130.37 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.665 0.786 . . . . 74.01 110.83 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.549 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.78 167.4 30.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.599 0.76 . . . . 64.32 109.586 170.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.09 -56.77 5.08 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 111.5 -0.64 . . . . 71.44 111.5 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.455 HD11 ' HB ' ' B' ' 86' ' ' ILE . 2.8 pp -75.96 163.67 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.17 0.988 . . . . 73.23 111.246 175.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -168.59 157.32 8.58 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.628 0.58 . . . . 73.24 110.628 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.97 -116.03 7.37 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.533 0.521 . . . . 52.44 113.548 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 97.1 m -65.43 -36.1 82.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.88 0.872 . . . . 74.15 111.016 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -66.02 -41.79 90.53 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.689 0.796 . . . . 74.41 110.06 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 47.5 ttp -66.72 -36.65 82.97 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.608 -1.178 . . . . 73.4 110.931 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.19 -32.11 68.47 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.171 0.588 . . . . 61.34 110.572 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -69.96 -29.17 66.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.567 0.747 . . . . 35.23 110.676 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -77.57 -66.78 0.79 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.945 -0.57 . . . . 63.11 110.196 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.735 HD11 HD13 ' B' ' 86' ' ' ILE . 66.5 mt -78.43 -26.4 46.29 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.956 0.902 . . . . 71.32 112.92 -168.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.07 0.81 64.48 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-O 119.749 -0.473 . . . . 61.35 113.453 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 -66.21 0.25 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.28 0.54 . . . . 64.43 112.024 -174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -64.89 -42.39 94.82 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.769 0.827 . . . . 73.34 112.432 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.479 ' SG ' HD23 ' B' ' 98' ' ' LEU . 84.4 m -68.83 -47.44 32.0 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 124.288 1.035 . . . . 73.03 111.725 -177.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.448 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 86.8 Cg_exo -51.9 -39.75 68.02 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.321 2.014 . . . . 64.2 113.326 167.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -61.67 -31.96 72.11 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 112.709 0.633 . . . . 54.33 112.709 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.55 HD13 HD11 ' B' ' 13' ' ' ILE . 61.6 mt -67.85 -41.28 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.384 0.674 . . . . 63.33 110.156 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 66.8 mt -82.78 -19.47 37.7 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.871 -1.059 . . . . 70.02 111.867 -173.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.415 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 57.6 t80 -61.28 -45.22 95.14 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 114.166 1.173 . . . . 72.04 114.166 -170.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 18.2 Cg_endo -58.91 -38.01 90.54 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.089 1.859 . . . . 70.21 112.851 175.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -65.26 -46.26 81.24 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.374 0.67 . . . . 73.11 110.933 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.15 90.01 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.511 -0.768 . . . . 51.15 110.9 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -59.6 -60.52 3.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.495 1.118 . . . . 74.23 110.677 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.542 ' HG3' HH12 ' A' ' 120' ' ' ARG . 12.4 tp10 -58.45 -31.85 68.16 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.399 1.08 . . . . 62.04 111.075 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.546 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.4 t -71.67 -40.33 69.68 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 119.364 -0.351 . . . . 52.23 110.848 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.704 HG21 HG21 ' B' ' 64' ' ' VAL . 88.5 mt -65.1 -55.0 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 109.305 -0.628 . . . . 61.4 109.305 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 13.6 m -58.06 -34.61 70.29 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 124.367 1.042 . . . . 75.42 111.592 -173.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.7 t -61.52 -51.1 70.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 115.913 -0.585 . . . . 64.53 110.03 176.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.5 mmt -66.77 -38.64 86.98 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 123.645 0.59 . . . . 65.41 111.103 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 89.3 t -58.61 -44.56 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.998 0.919 . . . . 72.3 110.515 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 35.2 t -71.26 -30.54 66.42 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.011 -0.995 . . . . 60.11 111.56 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.7 mtt-85 -70.06 -28.91 65.83 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.515 0.726 . . . . 74.4 110.232 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -87.32 9.35 73.41 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 124.02 0.825 . . . . 64.4 112.737 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 17' ' ' TYR . 58.9 p 55.84 31.65 18.08 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.018 1.727 . . . . 54.21 112.941 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -92.09 155.2 43.16 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 123.734 0.814 . . . . 73.21 109.971 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.17 156.96 6.98 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.713 2.942 . . . . 63.1 114.843 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -60.39 130.43 46.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.095 0.958 . . . . 73.54 111.09 -174.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.515 HD21 HD13 ' F' ' 468' ' ' LEU . 2.9 tm? -141.61 95.36 2.81 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.601 -0.518 . . . . 73.32 109.601 -174.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -94.5 136.55 34.67 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.684 -0.858 . . . . 71.33 108.684 169.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.47 140.33 39.8 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.502 0.721 . . . . 72.53 110.508 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.86 146.1 92.76 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.066 0.946 . . . . 33.43 111.737 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.91 97.67 0.49 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.282 2.654 . . . . 73.42 111.71 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 62.1 t -91.01 110.39 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.142 -1.058 . . . . 65.23 108.142 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -84.87 98.46 10.33 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.805 -1.183 . . . . 75.14 107.805 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -57.99 -48.57 79.6 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.983 0.802 . . . . 75.1 111.357 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.97 -37.23 76.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.195 0.998 . . . . 74.3 112.547 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.66 -47.34 78.85 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.756 0.822 . . . . 64.4 111.549 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -81.81 -24.77 35.72 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.847 -0.615 . . . . 74.01 110.369 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.497 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 79.4 t80 -69.61 -30.06 67.72 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.511 0.724 . . . . 74.43 109.727 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -63.41 -37.55 87.72 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.194 0.521 . . . . 53.11 109.692 175.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -79.66 -11.23 59.87 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.309 -0.859 . . . . 62.12 111.543 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -72.26 -36.46 69.05 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.199 -0.667 . . . . 75.13 109.199 169.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 12.5 mt -86.99 -10.93 51.95 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.396 -0.82 . . . . 71.14 110.928 -175.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 176.26 94.31 0.01 OUTLIER 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.266 1.426 . . . . 71.35 107.836 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -70.89 97.52 1.43 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.473 -0.566 . . . . 64.12 109.473 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -159.98 110.23 1.87 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.415 -0.812 . . . . 74.41 109.059 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.59 105.43 11.83 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 109.712 -0.477 . . . . 73.35 109.712 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.28 178.34 52.82 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 116.503 -0.317 . . . . 75.34 112.986 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.429 ' HG2' HG23 ' B' ' 149' ' ' THR . 37.0 tt0 -151.09 97.94 2.51 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.377 -0.601 . . . . 73.21 109.377 -177.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.5 77.99 2.05 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.744 -0.662 . . . . 61.44 113.054 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.429 HG23 ' HG2' ' B' ' 147' ' ' GLU . 46.1 p -96.2 127.49 42.26 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.175 0.59 . . . . 72.11 109.914 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.36 -178.52 5.26 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.849 0.859 . . . . 74.14 109.971 175.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -150.35 108.31 3.72 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.982 0.513 . . . . 54.32 110.258 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -104.41 92.48 4.34 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 109.175 -0.676 . . . . 75.03 109.175 176.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -61.88 134.19 56.37 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.828 0.851 . . . . 63.41 110.804 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -64.33 126.31 27.38 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 123.172 0.589 . . . . 73.24 110.696 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 C-N-CA 125.165 1.386 . . . . 73.1 108.354 176.02 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.837 0.351 . . . . 75.22 110.677 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 33.4 t -174.83 129.17 0.31 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.738 0.815 . . . . 74.11 109.216 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -133.46 86.26 2.28 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.723 0.809 . . . . 62.34 109.266 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -78.81 104.14 9.23 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.153 0.502 . . . . 71.22 110.266 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -148.05 51.72 1.03 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.281 1.032 . . . . 75.45 108.366 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -90.07 55.25 3.05 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.105 -0.702 . . . . 35.44 109.105 176.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.3 p -63.8 -30.07 71.2 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.524 1.129 . . . . 73.42 112.245 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -83.8 80.37 9.16 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.081 -0.711 . . . . 73.41 109.081 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.404 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 27.5 ttt 64.8 115.21 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.445 1.498 . . . . 75.03 112.922 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 70.3 m -103.1 109.14 20.6 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.354 -0.98 . . . . 62.21 108.354 170.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.555 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.8 t80 -124.52 128.06 48.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.539 0.736 . . . . 74.42 109.101 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -146.54 128.04 15.04 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.82 0.7 . . . . 63.24 109.605 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 95.4 mt -68.46 124.66 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.416 -0.957 . . . . 73.0 108.416 168.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.574 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 17.2 mm100 -93.28 -47.46 6.9 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.425 0.69 . . . . 74.05 110.192 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -175.24 124.44 0.24 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.59 -0.732 . . . . 64.14 110.013 -169.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.9 143.46 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 108.381 -0.97 . . . . 41.05 108.381 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.502 ' CE2' ' HD2' ' C' ' 19' ' ' LYS . 28.5 p90 -170.92 166.7 7.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.1 0.476 . . . . 72.33 110.77 -175.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.9 p -88.32 112.43 22.83 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.273 -0.876 . . . . 73.44 109.203 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.502 ' HD2' ' CE2' ' C' ' 17' ' ' TYR . 19.3 mmmt -64.97 -46.54 81.09 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.661 -1.237 . . . . 73.15 107.661 170.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.607 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.0 t70 -141.53 143.61 33.86 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 113.334 -1.757 . . . . 65.01 109.908 -170.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 59.0 mt -141.12 145.32 25.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 106.474 -1.676 . . . . 54.12 106.474 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.7 t -157.45 149.62 22.58 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.366 0.603 . . . . 75.04 109.984 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 84.1 t80 -149.55 116.72 6.03 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.017 -1.475 . . . . 72.21 107.017 172.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -120.78 111.1 17.15 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.162 0.585 . . . . 55.41 110.192 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.85 74.56 63.81 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.769 -1.567 . . . . 73.42 106.769 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.58 -15.87 30.53 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.652 2.234 . . . . 43.34 111.806 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -111.45 24.4 12.85 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.543 1.137 . . . . 74.15 109.623 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.487 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -51.27 -49.42 81.86 Favored Pre-proline 0 CA--C 1.562 1.404 0 N-CA-C 114.239 1.199 . . . . 71.42 114.239 -172.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.459 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 35.3 Cg_exo -60.13 -43.3 36.61 Favored 'Trans proline' 0 C--N 1.38 2.214 0 CA-C-N 122.021 1.757 . . . . 63.33 112.206 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -69.15 -30.0 68.14 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.826 -1.079 . . . . 71.51 112.053 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.83 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.4 p -79.78 -28.33 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 N-CA-C 111.858 0.318 . . . . 73.32 111.858 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -70.34 -31.68 69.06 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 120.791 0.329 . . . . 73.31 111.268 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -84.98 7.49 21.08 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.511 0.724 . . . . 74.21 111.228 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.75 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.07 164.43 13.95 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.343 1.057 . . . . 72.03 110.445 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ASP . . . . . 0.402 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 9.8 t70 -85.31 104.17 14.91 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.929 -1.138 . . . . 55.44 107.929 167.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.6 t90 -70.09 87.83 0.58 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.923 1.289 . . . . 74.34 111.335 -171.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -123.03 79.12 51.26 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 124.479 1.111 . . . . 72.52 108.55 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.57 138.98 30.47 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.638 2.226 . . . . 54.35 114.495 -171.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.12 115.94 22.65 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.606 -1.628 . . . . 71.32 106.606 164.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.474 HG12 ' HB1' ' G' ' 466' ' ' ALA . 2.6 t -95.13 118.63 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.489 -0.778 . . . . 61.43 110.079 -163.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.506 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 87.3 tttt -127.22 134.1 50.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.824 0.85 . . . . 73.32 109.102 176.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.42 HD23 ' HB3' ' G' ' 464' ' ' MET . 50.9 tp -126.0 129.37 49.07 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.016 -0.735 . . . . 72.54 109.016 175.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.3 t70 -118.84 133.5 55.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.618 -1.252 . . . . 75.11 107.618 175.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.567 ' HB3' HD13 ' G' ' 460' ' ' LEU . 87.4 mt -124.8 136.01 53.46 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.836 -1.172 . . . . 72.53 107.836 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 15.6 t70 -141.96 151.29 42.41 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.503 0.721 . . . . 71.31 109.371 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -134.92 151.9 51.28 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.896 -0.779 . . . . 73.53 108.896 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.19 170.4 20.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.672 0.789 . . . . 73.32 109.273 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.409 ' HB2' ' CE2' ' C' ' 56' ' ' TYR . 78.0 p -159.64 153.09 22.43 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.265 0.226 . . . . 70.24 111.346 -176.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 84.2 p -149.59 147.44 28.14 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.943 0.897 . . . . 62.4 109.991 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -89.76 121.16 31.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.175 0.59 . . . . 53.13 109.587 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.613 HD11 HD12 ' C' ' 83' ' ' ILE . 20.5 mt -95.32 -39.26 10.13 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.329 0.652 . . . . 74.04 109.759 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.73 -172.45 3.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.77 0.828 . . . . 72.04 110.261 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.27 111.51 1.57 Allowed 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.255 0.972 . . . . 75.43 109.953 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 70.06 -6.02 1.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.711 1.205 . . . . 74.43 112.733 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 68.1 t -94.22 95.79 5.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 106.833 -1.543 . . . . 70.24 106.833 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' C' ' 48' ' ' SER . 12.1 t80 -118.17 124.59 48.34 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.141 -0.936 . . . . 70.22 108.845 -172.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.548 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.3 tt0 -85.5 138.95 31.87 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 123.263 0.625 . . . . 72.03 110.587 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 42.6 t -116.81 142.16 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.925 -1.139 . . . . 64.42 107.925 165.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 85.8 t -127.83 130.73 70.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.99 -1.115 . . . . 51.32 107.99 172.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.23 107.67 18.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.451 -0.944 . . . . 71.11 108.451 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.446 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 49.5 ttm-85 -86.56 134.95 33.61 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.795 -1.093 . . . . 62.32 109.192 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.04 118.54 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.029 -1.1 . . . . 72.34 108.029 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.1 m -121.46 122.42 39.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.635 -0.876 . . . . 65.22 108.635 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.608 HG11 HD11 ' C' ' 126' ' ' LEU . 14.5 t -115.55 129.35 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.52 -0.918 . . . . 73.32 108.52 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 5.6 m -121.7 115.94 23.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.787 0.835 . . . . 72.43 108.871 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.59 120.82 43.64 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.79 -1.189 . . . . 75.04 107.79 172.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 45.3 m -122.2 169.07 11.26 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.578 0.751 . . . . 74.44 109.605 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.75 HD13 ' HG2' ' C' ' 34' ' ' LYS . 85.1 mt -132.24 15.68 4.59 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.577 1.151 . . . . 65.22 109.818 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.44 -91.08 0.59 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.253 -0.739 . . . . 42.24 111.253 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -89.91 -27.98 19.51 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.438 0.695 . . . . 74.13 109.878 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 4.3 tp10 -94.96 121.91 37.07 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.912 1.285 . . . . 72.35 110.357 -175.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.7 m -77.56 126.06 30.3 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.369 -0.975 . . . . 72.21 108.369 165.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.83 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -64.75 -60.91 2.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.284 1.04 . . . . 75.02 108.809 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -161.65 161.82 29.7 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-N 112.707 -2.042 . . . . 72.42 108.989 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.406 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -126.3 140.71 52.31 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 105.855 -1.906 . . . . 71.53 105.855 167.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.497 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.8 t -138.09 132.41 32.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.833 -1.173 . . . . 71.31 107.833 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.62 136.45 27.46 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.67 -0.863 . . . . 71.1 108.67 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -146.25 132.97 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 124.603 1.161 . . . . 74.34 108.507 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.607 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 39.9 mt-30 -118.58 94.9 4.63 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.966 -1.124 . . . . 74.14 107.966 173.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -81.69 104.28 11.97 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.888 -1.051 . . . . 60.41 109.819 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.8 157.29 35.6 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.991 -0.444 . . . . 73.52 111.991 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.502 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -159.63 117.81 0.79 Allowed Glycine 0 CA--C 1.501 -0.795 0 N-CA-C 110.83 -0.908 . . . . 62.4 110.83 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.613 HD12 HD11 ' C' ' 51' ' ' LEU . 10.5 mm -84.84 121.29 36.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.175 -1.046 . . . . 51.13 108.175 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.555 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 53.0 m-85 -128.67 118.33 22.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.774 -0.824 . . . . 62.52 108.774 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 54.8 m -77.79 108.21 10.85 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.515 -0.92 . . . . 65.11 108.515 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 45.4 pt -114.94 131.25 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.65 0.78 . . . . 74.11 109.217 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -146.98 152.3 38.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.148 0.979 . . . . 52.12 109.312 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.59 -23.1 17.55 Favored Glycine 0 N--CA 1.479 1.502 0 N-CA-C 113.941 0.336 . . . . 73.22 113.941 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 28.7 pt -103.05 152.11 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.803 0.841 . . . . 72.13 110.532 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 15.8 pt-20 -166.44 177.97 6.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.697 0.799 . . . . 70.23 109.49 173.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.31 -125.67 34.4 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.592 0.557 . . . . 51.23 113.661 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.424 HG22 ' HG2' ' C' ' 142' ' ' GLN . 82.4 p -72.26 -28.35 63.07 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.498 0.719 . . . . 54.45 111.075 -177.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -65.15 -44.55 88.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.588 0.755 . . . . 54.15 110.032 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.516 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 22.0 ttt -62.57 -46.17 89.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.214 -0.903 . . . . 60.54 110.472 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.83 -50.27 61.19 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 124.245 0.966 . . . . 64.11 111.613 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -76.2 -32.38 58.94 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 123.377 0.423 . . . . 74.51 111.954 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.547 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.3 t -59.44 -36.13 75.34 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.312 0.383 . . . . 70.11 110.463 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 34.2 mt -96.13 -20.39 18.66 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.83 0.852 . . . . 74.22 110.882 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.93 -31.52 57.89 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.036 -0.529 . . . . 73.2 113.875 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.47 -39.48 0.06 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.628 0.251 . . . . 73.32 111.616 -169.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.547 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 42.6 t80 -65.39 -43.53 90.36 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.461 1.505 . . . . 75.34 113.158 -172.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 66.3 m -81.57 -44.89 1.11 Allowed Pre-proline 0 N--CA 1.486 1.336 0 CA-C-O 118.717 -0.659 . . . . 54.32 111.787 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.04 -27.0 34.39 Favored 'Trans proline' 0 C--N 1.394 2.954 0 C-N-CA 122.516 2.144 . . . . 73.31 113.738 169.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -59.76 -42.9 94.3 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.393 1.077 . . . . 63.52 111.027 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -66.1 -33.47 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 115.437 -0.801 . . . . 71.42 110.376 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.502 HD21 ' HA3' ' C' ' 82' ' ' GLY . 62.6 mt -91.25 -25.16 19.62 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.88 0.872 . . . . 72.15 112.389 -171.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -54.38 -50.53 84.5 Favored Pre-proline 0 CA--C 1.557 1.237 0 CA-C-O 117.966 -1.016 . . . . 42.51 113.682 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.35 -37.83 96.27 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.29 1.993 . . . . 31.24 113.184 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -68.24 -47.32 68.11 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.364 0.666 . . . . 73.23 110.974 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.51 79.56 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.258 -0.883 . . . . 72.3 110.612 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -60.72 -53.21 60.19 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.117 1.367 . . . . 63.32 111.026 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' GLU . . . . . 0.41 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.2 tm-20 -67.38 -34.02 76.42 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 123.656 0.598 . . . . 61.45 110.316 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.2 t -64.58 -36.76 85.28 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.481 0.488 . . . . 74.4 110.764 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.497 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 77.8 mt -67.67 -50.37 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.3 0.64 . . . . 73.45 110.31 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.6 m -62.47 -30.1 71.01 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.561 0.744 . . . . 71.34 111.374 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -69.68 -50.62 42.09 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 109.142 -0.688 . . . . 74.31 109.142 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.405 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.59 -44.62 66.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.21 1.004 . . . . 65.35 112.063 176.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.5 HG13 ' HB2' ' C' ' 123' ' ' PHE . 88.4 t -63.58 -46.58 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.915 0.886 . . . . 74.32 110.868 177.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 36.6 t -63.54 -33.49 75.71 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.873 0.869 . . . . 72.51 111.795 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -73.34 -39.35 65.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.838 0.855 . . . . 74.51 109.761 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.82 -2.15 69.61 Favored Glycine 0 C--N 1.352 1.468 0 O-C-N 123.832 0.707 . . . . 73.11 112.587 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 61.75 28.49 17.54 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 126.77 2.028 . . . . 74.04 113.302 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.5 ' HB2' HG13 ' C' ' 118' ' ' VAL . 78.4 m-85 -81.84 156.62 69.97 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.272 -1.01 . . . . 72.3 108.272 171.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.26 171.25 2.48 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.727 2.285 . . . . 73.0 113.622 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -51.26 136.45 24.62 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.731 1.212 . . . . 63.35 114.036 -173.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.608 HD11 HG11 ' C' ' 64' ' ' VAL . 7.0 tt -127.32 91.73 3.37 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 106.764 -1.569 . . . . 54.11 106.764 171.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -100.5 105.61 17.07 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.851 -0.796 . . . . 72.24 108.851 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.02 125.58 25.9 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.144 -1.058 . . . . 74.13 108.144 175.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.07 148.64 98.34 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 122.84 0.456 . . . . 75.41 111.29 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.455 ' HG3' HD12 ' A' ' 16' ' ' ILE . 34.8 Cg_exo -57.55 106.78 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.872 2.381 . . . . 45.24 112.172 174.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 23.3 m -112.21 119.66 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.402 0.681 . . . . 72.45 109.924 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -91.87 93.61 8.91 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.904 -0.776 . . . . 73.04 108.904 -176.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.432 ' HE2' HD13 ' C' ' 44' ' ' LEU . 91.7 m-85 -61.09 -40.04 92.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.484 0.714 . . . . 65.53 111.026 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' C' ' 138' ' ' MET . 9.7 m-20 -60.45 -43.9 96.39 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.342 -0.845 . . . . 61.2 112.226 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.91 -33.72 72.24 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.89 0.744 . . . . 63.51 111.396 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 2.1 tt -79.86 -46.07 17.52 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.69 -0.485 . . . . 74.33 109.69 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.432 ' HD2' ' CE2' ' G' ' 461' ' ' PHE . 22.7 t80 -59.71 -31.38 69.54 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.88 0.472 . . . . 74.43 111.364 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 66.7 mtt -63.04 -60.42 3.46 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.736 -0.665 . . . . 74.14 111.512 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -63.05 -33.72 76.03 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.571 0.348 . . . . 73.43 111.243 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -51.63 -84.57 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.468 1.507 . . . . 74.21 110.406 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 pp -175.93 160.76 2.37 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.716 0.806 . . . . 75.12 111.755 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.424 ' HG2' HG22 ' C' ' 92' ' ' THR . 79.2 mt-30 62.47 98.46 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.145 1.378 . . . . 63.44 113.173 171.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -121.48 175.71 6.05 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.651 0.78 . . . . 73.14 111.516 -174.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -73.01 140.08 47.08 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 114.703 -1.135 . . . . 63.55 109.53 169.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.23 97.9 11.27 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.954 0.502 . . . . 65.21 110.088 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.72 132.47 13.12 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.262 -0.735 . . . . 60.32 111.262 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -76.62 -19.78 57.44 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.702 0.801 . . . . 74.24 112.651 -172.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.04 -111.51 1.92 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.372 -0.291 . . . . 72.44 112.372 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 3.6 t -148.69 83.65 1.47 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.949 0.881 . . . . 64.41 110.2 -175.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 150' ' ' GLU . . . . . 0.462 ' H ' ' HB3' ' A' ' 145' ' ' ALA . 1.6 mp0 -92.56 174.49 7.25 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.862 0.865 . . . . 53.3 110.501 174.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 151' ' ' GLU . . . . . 0.586 ' HG2' ' HG2' ' A' ' 143' ' ' GLN . 10.1 tp10 69.14 109.76 0.05 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.356 1.462 . . . . 50.24 109.502 -172.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -73.64 -95.79 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.763 0.825 . . . . 70.14 112.126 -170.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 174.47 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.132 -1.432 . . . . 73.25 107.132 -166.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -79.22 105.08 10.29 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.102 -0.703 . . . . 74.11 109.102 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.305 0 C-N-CA 123.918 0.887 . . . . 72.51 110.637 -178.894 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 43.3 tpp . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.762 -0.458 . . . . 72.25 109.762 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 58.6 m -137.06 129.26 29.58 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.065 0.946 . . . . 62.0 110.038 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.17 152.75 40.51 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.551 0.741 . . . . 44.24 109.728 174.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -128.71 143.27 50.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.044 0.538 . . . . 63.53 110.642 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -133.63 150.61 51.59 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.504 0.722 . . . . 71.33 109.84 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -141.23 103.89 4.52 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.807 -0.812 . . . . 72.22 108.807 174.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 78.1 p -105.04 -172.1 2.04 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.148 0.979 . . . . 74.33 108.718 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.49 158.23 12.57 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 118.56 -0.733 . . . . 72.35 110.046 169.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 3.5 ttp 19.61 118.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 126.395 1.878 . . . . 74.34 114.483 -168.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 23.7 m -107.08 139.34 41.64 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.252 -0.905 . . . . 40.24 110.497 -174.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.464 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 55.0 t80 -163.21 88.48 0.59 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.031 -1.84 . . . . 71.31 106.031 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -119.27 115.35 23.98 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.202 -1.407 . . . . 73.4 107.202 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.407 HG21 HD11 ' D' ' 16' ' ' ILE . 16.4 mt -72.63 120.58 21.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.75 -0.833 . . . . 62.53 108.75 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -86.22 -34.0 20.58 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.402 0.681 . . . . 75.44 110.825 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -171.38 134.01 0.86 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.1 0.25 . . . . 73.35 111.663 -172.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.413 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.7 mp -113.24 134.68 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 107.493 -1.299 . . . . 72.11 107.493 171.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.413 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 36.6 p90 -166.56 174.5 8.79 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.901 0.858 . . . . 65.35 112.022 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -102.64 120.04 39.87 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.196 -1.366 . . . . 43.43 109.049 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.459 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.4 mtpt -81.16 -36.96 29.56 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.127 -0.694 . . . . 73.4 109.127 175.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 12.5 t70 -144.89 145.27 31.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.951 -1.022 . . . . 71.21 109.436 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.405 HG21 ' HE2' ' C' ' 117' ' ' MET . 73.9 mt -139.2 150.44 23.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.819 1.248 . . . . 61.03 107.811 175.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 13.0 t -155.29 145.78 22.07 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.678 0.791 . . . . 73.44 109.422 174.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.421 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.2 t80 -150.1 124.1 9.37 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.948 -1.501 . . . . 72.22 106.948 170.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 2.2 mp0 -122.0 152.51 39.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.079 0.552 . . . . 75.01 109.595 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.738 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -140.67 82.21 16.05 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.799 -1.186 . . . . 75.35 107.799 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.79 -34.25 11.44 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.035 2.49 . . . . 73.02 113.608 -171.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -107.82 8.63 28.81 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.319 0.648 . . . . 71.04 110.523 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.738 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -36.69 -64.88 0.35 Allowed Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 116.416 2.006 . . . . 42.34 116.416 -156.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -81.31 -13.41 11.13 Favored 'Trans proline' 0 C--N 1.371 1.756 0 CA-C-N 122.437 1.906 . . . . 74.11 113.65 -172.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -76.26 -42.88 44.26 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.182 0.993 . . . . 74.44 108.709 168.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.465 HG12 ' O ' ' D' ' 28' ' ' ALA . 6.5 p -81.86 -18.37 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 123.36 0.664 . . . . 64.45 111.547 -173.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -67.63 -15.1 63.48 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.965 0.728 . . . . 73.35 112.965 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -66.98 -13.15 61.59 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.674 0.79 . . . . 75.32 110.548 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -103.59 80.25 1.77 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.357 1.463 . . . . 73.04 109.005 173.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.6 82.92 5.64 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.972 -0.751 . . . . 63.3 108.972 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 t-105 -149.46 157.66 43.48 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.595 1.158 . . . . 75.2 108.231 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.634 ' HG3' HD11 ' H' ' 470' ' ' LEU . 7.9 tp-100 -71.76 104.99 1.11 Allowed Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 108.963 -0.754 . . . . 74.34 108.963 176.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.423 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 22.4 Cg_exo -66.23 140.91 60.7 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.928 2.418 . . . . 74.11 113.089 -169.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.41 112.83 1.36 Allowed 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.493 1.121 . . . . 73.51 109.24 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.617 HG23 HG13 ' D' ' 64' ' ' VAL . 2.5 p -98.18 115.0 37.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.626 -0.715 . . . . 73.01 110.752 -170.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -99.41 110.38 22.88 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.017 -1.475 . . . . 75.41 107.017 163.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.414 ' O ' HD12 ' D' ' 42' ' ' LEU . 1.1 pp -95.27 121.44 36.92 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.774 -1.195 . . . . 73.4 107.774 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.729 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 20.3 m-20 -106.05 145.61 31.19 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.064 -0.971 . . . . 75.53 108.38 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.5 130.07 39.97 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.424 -0.954 . . . . 75.31 108.424 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.7 t70 -132.05 143.42 50.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.109 -1.812 . . . . 72.31 106.109 170.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -135.72 155.93 49.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.649 -0.871 . . . . 71.41 108.649 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.07 173.29 14.04 Favored 'General case' 0 C--O 1.239 0.546 0 O-C-N 123.943 0.777 . . . . 52.53 109.854 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.588 ' HB2' ' HE1' ' D' ' 56' ' ' TYR . 19.9 p -155.61 151.23 27.27 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.655 0.782 . . . . 73.3 109.388 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 28.8 t -164.99 119.1 1.28 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.427 0.691 . . . . 64.35 109.545 -170.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -78.96 131.67 36.42 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.452 -0.573 . . . . 65.45 109.452 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.44 HD13 ' HB3' ' C' ' 29' ' ' PRO . 43.2 mt -102.24 -26.96 13.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.934 0.494 . . . . 70.24 111.101 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -168.09 -173.54 2.08 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.438 0.695 . . . . 55.24 110.629 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.05 111.98 10.82 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.984 -0.747 . . . . 64.24 108.984 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 76.09 4.01 3.73 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.777 1.631 . . . . 60.54 112.009 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 73.5 t -109.11 125.04 66.23 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 N-CA-C 108.032 -1.099 . . . . 70.34 108.032 169.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.588 ' HE1' ' HB2' ' D' ' 48' ' ' SER . 4.3 t80 -139.85 150.21 44.37 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.173 -1.047 . . . . 64.52 108.173 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -125.13 147.37 49.05 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.517 0.727 . . . . 74.43 109.973 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -124.3 141.83 43.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.959 -1.126 . . . . 73.42 107.959 171.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.476 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 53.4 t -118.37 139.17 46.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.185 -1.043 . . . . 74.41 108.185 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -123.69 113.68 18.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.652 -1.24 . . . . 63.4 107.652 179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -96.4 97.4 9.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.994 -1.113 . . . . 52.41 107.994 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 t -98.1 118.67 45.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.133 -1.062 . . . . 75.14 108.133 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.729 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.8 m -119.73 143.78 47.6 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.27 1.028 . . . . 64.34 108.47 -172.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.617 HG13 HG23 ' D' ' 40' ' ' VAL . 92.9 t -130.78 103.23 7.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.55 -0.907 . . . . 73.14 108.55 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 52.3 m -92.87 111.99 23.79 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.392 -0.966 . . . . 72.33 108.392 169.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -116.05 154.47 29.86 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.071 0.549 . . . . 73.13 110.518 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.449 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.9 m -148.41 135.48 20.17 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.606 0.566 . . . . 72.54 111.421 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.91 99.55 10.04 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.377 1.071 . . . . 74.22 108.451 173.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.71 -114.23 5.51 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.727 -0.67 . . . . 75.51 113.724 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.21 3.44 49.37 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.878 0.695 . . . . 73.43 112.878 -172.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -151.87 161.45 42.64 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 122.298 -0.251 . . . . 62.44 110.953 -168.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.2 m -63.74 137.1 57.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.053 0.941 . . . . 43.25 111.482 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.449 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -93.01 -73.59 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.184 -1.043 . . . . 70.42 108.184 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -140.49 143.4 35.45 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 121.429 0.633 . . . . 74.43 110.513 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 75.8 mt -109.28 141.99 40.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.202 -1.406 . . . . 61.31 107.202 173.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.58 ' SG ' HG23 ' D' ' 114' ' ' ILE . 51.6 t -151.73 143.55 23.73 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.271 -0.64 . . . . 74.41 109.271 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -155.72 136.5 13.48 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.203 -0.665 . . . . 72.33 109.203 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.75 114.04 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.847 -0.797 . . . . 65.01 108.847 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -88.56 81.68 7.07 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.267 -1.012 . . . . 71.3 108.267 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -78.12 99.46 6.17 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.102 -1.408 . . . . 74.14 109.32 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.01 148.97 18.65 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 111.549 -0.62 . . . . 44.34 111.549 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.9 132.01 4.7 Favored Glycine 0 C--N 1.335 0.513 0 N-CA-C 111.746 -0.542 . . . . 74.34 111.746 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.4 mt -90.28 128.79 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.044 0.938 . . . . 73.24 108.871 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.99 123.43 25.86 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.273 1.029 . . . . 74.01 109.672 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -76.56 105.67 7.76 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.176 -0.676 . . . . 74.42 109.176 168.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.574 HD13 HD21 ' D' ' 98' ' ' LEU . 48.3 pt -116.62 144.37 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 122.922 0.489 . . . . 63.4 110.163 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.2 158.8 19.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.852 0.861 . . . . 72.3 109.371 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.75 21.7 79.52 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 116.486 -0.325 . . . . 63.51 113.621 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' D' ' 86' ' ' ILE . 23.9 pt -128.52 127.43 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.383 0.673 . . . . 63.11 110.0 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.81 154.1 46.09 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.483 1.113 . . . . 74.41 109.777 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.24 -117.84 11.62 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.43 -0.805 . . . . 72.44 114.562 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 19.2 m -65.56 -36.6 84.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.404 0.682 . . . . 71.12 111.612 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -77.09 -40.57 45.53 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.24 -0.436 . . . . 70.24 111.911 -172.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.713 ' SD ' HG21 ' H' ' 452' ' ' VAL . 0.0 OUTLIER -64.8 -35.74 82.08 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 120.785 0.326 . . . . 75.25 110.465 178.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.494 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -65.04 -49.48 69.98 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 115.381 -0.827 . . . . 44.12 109.736 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -59.97 -35.53 75.18 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.717 0.636 . . . . 73.5 111.391 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -64.82 -50.6 66.07 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.076 0.551 . . . . 71.52 111.239 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.574 HD21 HD13 ' D' ' 86' ' ' ILE . 75.7 mt -92.33 -28.42 16.95 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.801 0.667 . . . . 75.13 112.801 -169.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.81 -4.24 57.96 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-O 119.761 -0.466 . . . . 55.52 113.953 -174.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -142.9 -59.41 0.43 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.104 0.452 . . . . 52.12 111.365 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 101' ' ' TYR . . . . . 0.41 ' O ' HG12 ' D' ' 105' ' ' ILE . 46.5 t80 -70.56 -39.89 73.68 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.487 0.551 . . . . 72.4 112.487 -171.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.464 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 97.5 m -69.86 -46.84 23.98 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.313 -0.851 . . . . 71.31 111.611 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.4 Cg_exo -55.24 -34.19 87.34 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.004 1.803 . . . . 71.44 112.736 169.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -64.05 -40.83 97.16 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.404 0.681 . . . . 71.43 110.41 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.41 HG12 ' O ' ' D' ' 101' ' ' TYR . 46.9 mm -63.2 -37.22 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.517 0.727 . . . . 72.43 110.659 174.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.23 -19.46 43.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.156 0.982 . . . . 72.23 112.237 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -65.91 -44.73 63.08 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 114.03 1.122 . . . . 74.14 114.03 -171.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.04 -44.62 38.02 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.282 1.988 . . . . 65.13 112.835 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -69.27 -34.72 75.2 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.384 -0.825 . . . . 65.32 111.263 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.55 -53.39 56.9 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.738 0.815 . . . . 72.24 110.341 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 30.0 ttp180 -53.39 -46.51 69.68 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 124.814 1.321 . . . . 74.11 111.292 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -63.38 -49.99 71.64 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.265 0.978 . . . . 52.35 111.29 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.7 t -57.22 -41.57 79.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.11 0.881 . . . . 74.22 111.018 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.58 HG23 ' SG ' ' D' ' 76' ' ' CYS . 70.2 mt -61.01 -56.41 18.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 123.788 0.835 . . . . 72.24 110.6 174.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.488 HG23 ' HG3' ' D' ' 125' ' ' GLN . 85.1 m -53.4 -43.57 68.02 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.437 1.095 . . . . 65.34 111.706 -175.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 40.1 t -65.07 -43.07 93.4 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.947 -1.024 . . . . 64.12 110.478 -177.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.4 mtm -68.92 -32.6 72.34 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.833 0.453 . . . . 75.14 111.573 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 114' ' ' ILE . 73.3 t -65.75 -42.41 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.675 0.79 . . . . 72.25 110.299 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -73.14 -27.73 61.84 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 122.686 0.394 . . . . 52.04 111.157 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' D' ' 116' ' ' SER . 80.3 mtt-85 -72.04 -33.95 68.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.595 0.758 . . . . 75.44 109.913 173.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.23 0.27 89.38 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.901 0.75 . . . . 60.41 112.0 174.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 19.2 p 64.4 19.82 11.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.599 1.959 . . . . 63.22 113.711 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -84.8 150.37 55.89 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 108.609 -0.886 . . . . 52.4 108.609 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.47 141.5 51.33 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 123.246 2.631 . . . . 52.34 113.546 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.488 ' HG3' HG23 ' D' ' 115' ' ' THR . 32.2 tt0 -51.0 140.44 15.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.905 1.282 . . . . 70.35 112.675 -172.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.457 HD11 HG21 ' D' ' 40' ' ' VAL . 0.3 OUTLIER -125.09 97.15 5.12 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.541 -0.911 . . . . 70.43 108.541 -175.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -99.0 110.37 22.99 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.868 -0.79 . . . . 71.24 108.868 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.479 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -69.39 113.41 6.69 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.656 -0.868 . . . . 73.01 108.656 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.73 140.6 97.84 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.042 0.537 . . . . 71.03 110.957 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.08 118.42 5.32 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.63 2.22 . . . . 54.0 111.778 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.73 123.17 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.522 0.729 . . . . 65.43 109.407 -176.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -85.17 79.32 9.61 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.572 -0.899 . . . . 65.52 108.572 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -83.56 -14.66 51.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.568 -0.742 . . . . 72.32 110.588 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' D' ' 138' ' ' MET . 2.3 m-20 -52.77 -53.55 46.58 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.969 0.908 . . . . 63.44 111.789 173.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.12 77.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.962 0.905 . . . . 52.22 111.691 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.1 -22.44 45.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.952 -1.022 . . . . 75.54 111.256 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.506 ' O ' HD13 ' D' ' 141' ' ' LEU . 84.6 t80 -70.51 -40.21 73.67 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.403 0.681 . . . . 75.04 110.119 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.453 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 35.0 mtt -62.55 -35.76 80.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.467 0.707 . . . . 64.11 110.137 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -76.12 -40.18 53.45 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.131 -0.94 . . . . 74.03 110.434 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -58.59 -35.14 71.95 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.009 1.323 . . . . 73.51 110.874 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.506 HD13 ' O ' ' D' ' 137' ' ' PHE . 2.8 mp -62.93 -37.14 85.84 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.232 1.013 . . . . 74.1 111.342 176.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -85.1 3.22 39.88 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.099 0.559 . . . . 74.5 111.751 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -119.37 49.11 1.39 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.828 0.823 . . . . 62.44 109.714 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -157.85 -171.22 3.45 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.361 -1.29 . . . . 53.24 108.789 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.17 58.52 3.55 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.312 0.645 . . . . 34.2 110.787 178.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.46 39.39 3.0 Favored Glycine 0 C--N 1.354 1.537 0 C-N-CA 123.341 0.496 . . . . 41.2 113.049 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -152.36 134.45 14.96 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.382 -1.34 . . . . 72.4 107.382 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.11 62.79 0.2 Allowed Glycine 0 C--N 1.342 0.893 0 O-C-N 123.24 0.337 . . . . 54.53 112.313 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 6.3 t -79.02 167.48 21.03 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 109.605 -0.517 . . . . 52.32 109.605 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -102.74 146.06 28.8 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.577 0.751 . . . . 75.25 109.926 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -71.03 125.25 26.35 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.43 -0.952 . . . . 64.4 108.43 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.52 154.97 37.09 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.567 0.542 . . . . 72.24 110.742 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -63.1 91.57 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.836 0.826 . . . . 73.3 110.848 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -143.12 73.88 1.42 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.121 1.368 . . . . 62.44 107.999 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-N 114.965 -1.016 . . . . 63.51 109.035 -175.826 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 121.275 0.559 . . . . 74.23 110.106 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 79.7 t -135.89 -45.48 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.992 1.717 . . . . 74.21 107.847 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.78 147.47 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 114.751 -1.113 . . . . 73.52 111.857 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 167.79 -43.94 0.24 Allowed Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.44 -0.345 . . . . 64.4 112.443 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 7.3 mp 66.29 -177.99 0.2 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.01 1.324 . . . . 72.54 112.11 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 5.2 t -155.69 87.35 1.08 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.818 0.847 . . . . 73.4 109.242 175.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 66.17 103.76 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.587 1.155 . . . . 51.01 111.814 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -63.43 -43.4 97.56 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.244 -0.65 . . . . 71.25 109.244 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 27.0 m 65.78 -77.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.816 1.646 . . . . 73.21 113.301 169.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -142.47 140.73 32.0 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.156 0.982 . . . . 64.22 109.838 -171.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -99.75 111.85 24.15 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 106.702 -1.592 . . . . 71.24 106.702 169.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -77.25 66.22 2.99 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.62 1.168 . . . . 74.22 111.59 -173.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -86.81 124.6 33.22 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.432 -0.803 . . . . 73.13 109.101 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 12.6 t -153.12 128.57 9.95 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.736 -0.838 . . . . 72.4 108.736 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 55.8 ttp -172.32 149.8 2.28 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.216 1.006 . . . . 73.14 108.397 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -64.84 132.66 50.08 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.047 0.539 . . . . 61.34 110.555 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -68.68 88.66 0.36 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.352 0.596 . . . . 73.05 109.97 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -152.66 103.67 2.81 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.139 -0.937 . . . . 72.34 108.89 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 468' ' ' LEU . . . . . 0.491 HD21 HD22 ' A' ' 42' ' ' LEU . 59.1 mt -114.15 150.32 34.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.437 0.695 . . . . 73.42 109.947 -177.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -76.6 78.65 1.31 Allowed Glycine 0 C--N 1.349 1.285 0 O-C-N 123.401 0.438 . . . . 72.33 112.18 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 6.8 tt -145.1 132.0 20.19 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.528 -1.286 . . . . 63.42 107.528 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.559 1.32 0 C-N-CA 123.797 0.839 . . . . 73.23 109.995 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 450' ' ' ASN . . . . . 0.523 ' N ' HD21 ' F' ' 450' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 110.348 -0.242 . . . . 42.14 110.348 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 33.3 t -81.79 72.63 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.891 0.876 . . . . 71.41 110.041 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 15.8 m -155.42 -179.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 125.205 1.402 . . . . 51.53 110.004 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 105.61 40.46 2.03 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-N 116.576 -0.284 . . . . 63.33 112.662 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.57 109.84 16.39 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.383 0.673 . . . . 74.3 109.33 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 70.1 p -76.35 149.29 37.01 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.766 0.827 . . . . 75.24 110.449 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.74 167.56 20.6 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.12 0.568 . . . . 60.15 109.711 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -133.49 121.56 22.36 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.636 -0.505 . . . . 73.02 109.636 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 5.2 t -64.15 -39.09 93.27 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.85 0.86 . . . . 72.1 111.324 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.47 102.59 5.58 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.013 0.925 . . . . 74.33 108.989 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 460' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' B' ' 45' ' ' ASP . 4.3 mm? -71.76 144.27 49.27 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.23 0.538 . . . . 72.22 109.934 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -74.48 112.37 10.59 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.674 -1.148 . . . . 73.34 110.695 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -162.76 151.64 14.85 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.821 0.849 . . . . 73.33 108.96 169.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 8.5 t -140.77 130.59 24.38 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.748 -0.834 . . . . 73.15 108.748 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 464' ' ' MET . . . . . 0.577 ' SD ' ' HA ' ' F' ' 468' ' ' LEU . 31.5 ttp -162.61 90.91 0.73 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.795 -0.817 . . . . 74.41 108.795 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -90.19 26.96 1.75 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.473 1.109 . . . . 72.42 111.797 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -131.89 25.28 4.65 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.359 1.063 . . . . 53.35 109.86 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . 69.47 -68.53 0.19 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.711 1.604 . . . . 74.43 110.507 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 468' ' ' LEU . . . . . 0.577 ' HA ' ' SD ' ' F' ' 464' ' ' MET . 6.0 tt -151.95 -61.08 0.16 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.577 -1.268 . . . . 73.13 107.577 173.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 175.34 41.03 0.05 OUTLIER Glycine 0 C--N 1.349 1.294 0 CA-C-N 116.126 -0.488 . . . . 61.34 112.077 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 470' ' ' LEU . . . . . 0.514 HD22 ' HB3' ' B' ' 37' ' ' GLN . 2.7 pp -153.2 21.84 0.56 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.009 0.924 . . . . 73.24 110.222 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? . . . . . 0 C--O 1.25 1.11 0 N-CA-C 107.375 -1.342 . . . . 71.3 107.375 -174.822 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.59 -0.152 . . . . 51.3 110.59 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' G' G ' 451' ' ' VAL . . . . . 0.428 HG13 HG13 ' G' ' 452' ' ' VAL . 7.5 p -72.12 -32.24 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.662 0.785 . . . . 63.32 110.944 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 452' ' ' VAL . . . . . 0.428 HG13 HG13 ' G' ' 451' ' ' VAL . 27.3 m -126.81 150.87 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.454 1.102 . . . . 54.45 110.237 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 119.28 43.53 0.51 Allowed Glycine 0 C--N 1.348 1.215 0 N-CA-C 114.003 0.361 . . . . 62.33 114.003 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 44.4 tp -77.1 88.68 3.6 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.822 -0.807 . . . . 64.45 108.822 172.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 31.2 p -85.61 -8.08 58.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.721 0.808 . . . . 73.2 110.986 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -68.52 97.02 0.74 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.935 0.894 . . . . 73.54 110.176 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -73.43 83.62 1.47 Allowed 'General case' 0 C--N 1.349 0.557 0 N-CA-C 109.099 -0.704 . . . . 73.31 109.099 173.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 40.0 p -99.83 128.42 45.93 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.179 -0.919 . . . . 72.02 109.374 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.65 144.38 52.04 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.658 -0.868 . . . . 73.02 108.658 170.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 460' ' ' LEU . . . . . 0.567 HD13 ' HB3' ' C' ' 44' ' ' LEU . 2.4 tt -68.79 103.49 1.78 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 107.902 -1.147 . . . . 73.12 107.902 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 461' ' ' PHE . . . . . 0.432 ' CE2' ' HD2' ' C' ' 137' ' ' PHE . 31.0 p90 -33.76 -36.25 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 128.112 2.565 . . . . 74.51 114.646 175.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -76.28 105.37 7.29 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.942 -0.762 . . . . 72.5 108.942 -178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 26.3 m -76.24 -52.93 9.01 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.316 0.646 . . . . 74.1 110.069 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 464' ' ' MET . . . . . 0.42 ' HB3' HD23 ' C' ' 42' ' ' LEU . 0.0 OUTLIER 70.71 133.6 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.579 1.552 . . . . 73.42 110.315 -175.606 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -75.15 4.18 7.33 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.926 0.713 . . . . 75.13 112.926 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 466' ' ' ALA . . . . . 0.474 ' HB1' HG12 ' C' ' 40' ' ' VAL . . . 57.53 57.89 4.09 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.705 1.202 . . . . 71.24 111.469 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -109.28 105.24 14.57 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.632 -0.713 . . . . 71.04 109.348 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 468' ' ' LEU . . . . . 0.716 ' HB2' HD22 ' G' ' 470' ' ' LEU . 42.9 mt -116.32 -11.44 11.24 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.81 0.844 . . . . 64.31 111.549 -173.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 71.11 60.62 4.38 Favored Glycine 0 C--N 1.356 1.654 0 O-C-N 123.523 0.514 . . . . 62.45 111.932 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 470' ' ' LEU . . . . . 0.716 HD22 ' HB2' ' G' ' 468' ' ' LEU . 2.4 pt? -126.8 18.5 7.29 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.628 0.771 . . . . 60.5 110.654 -172.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp . . . . . 0 CA--C 1.564 1.5 0 CA-C-O 117.555 -1.212 . . . . 73.22 110.9 175.965 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' H' H ' 450' ' ' ASN . . . . . 0.506 ' N ' HD21 ' H' ' 450' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.008 -0.368 . . . . 61.44 110.008 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.78 -47.35 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 124.111 0.964 . . . . 61.1 110.041 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 452' ' ' VAL . . . . . 0.713 HG21 ' SD ' ' D' ' 94' ' ' MET . 7.4 p -168.72 151.03 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 114.191 -1.368 . . . . 51.24 110.39 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -143.64 58.34 0.54 Allowed Glycine 0 C--N 1.335 0.514 0 N-CA-C 109.077 -1.609 . . . . 73.32 109.077 167.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 454' ' ' LEU . . . . . 0.508 ' H ' HG22 ' H' ' 452' ' ' VAL . 2.3 pt? -58.94 159.7 6.76 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.34 1.056 . . . . 73.44 111.496 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 90.6 m -57.69 121.56 10.69 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 109.574 -0.528 . . . . 75.55 109.574 173.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -56.64 104.95 0.17 Allowed 'General case' 0 CA--C 1.541 0.617 0 O-C-N 124.161 0.913 . . . . 75.13 109.87 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -68.98 106.81 2.88 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.616 0.766 . . . . 61.12 109.018 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 60.7 p -81.4 -45.43 16.1 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.705 0.802 . . . . 55.41 110.646 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.48 148.93 21.94 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.03 0.932 . . . . 74.02 110.35 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.67 54.96 1.89 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.763 -0.828 . . . . 63.22 108.763 173.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 23.1 p90 29.24 -60.44 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 129.189 2.996 . . . . 71.01 118.059 168.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 77.13 170.42 0.23 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.649 1.58 . . . . 75.04 111.604 -170.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 9.7 t -162.15 -9.71 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.755 0.65 . . . . 64.0 112.755 -169.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -103.33 -167.69 1.41 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.77 0.428 . . . . 73.51 111.104 -171.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 465' ' ' LYS . . . . . 0.42 ' HG2' ' H ' ' H' ' 466' ' ' ALA . 30.7 ttmt -123.91 -156.36 0.71 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 107.846 -1.168 . . . . 71.34 107.846 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 466' ' ' ALA . . . . . 0.42 ' H ' ' HG2' ' H' ' 465' ' ' LYS . . . -62.4 97.41 0.09 Allowed 'General case' 0 C--N 1.363 1.159 0 CA-C-N 118.89 0.768 . . . . 63.11 110.539 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -60.36 -42.74 96.41 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.231 1.013 . . . . 72.1 112.943 -170.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 468' ' ' LEU . . . . . 0.406 HD22 ' HG ' ' H' ' 470' ' ' LEU . 4.9 tt -77.15 -35.33 56.15 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 109.164 -0.68 . . . . 74.14 109.164 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 103.72 15.45 22.52 Favored Glycine 0 N--CA 1.472 1.096 0 CA-C-O 119.84 -0.422 . . . . 73.35 113.256 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 470' ' ' LEU . . . . . 0.634 HD11 ' HG3' ' D' ' 37' ' ' GLN . 84.2 mt -79.7 84.6 5.5 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.738 -0.838 . . . . 72.54 108.738 173.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 92.1 mttt . . . . . 0 C--O 1.248 1.018 0 C-N-CA 123.802 0.841 . . . . 70.52 109.006 -176.691 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 109.699 -0.482 . . . . 53.32 109.699 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.3 m -82.24 124.15 29.67 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.412 0.685 . . . . 70.24 110.742 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -145.08 34.23 1.1 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.799 0.84 . . . . 64.35 109.576 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.71 136.14 47.09 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.42 0.688 . . . . 73.33 109.406 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -74.32 85.38 1.95 Allowed 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.746 0.784 . . . . 74.22 110.637 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -84.44 87.47 7.23 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.169 -0.923 . . . . 72.11 108.961 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 m -75.61 -46.72 30.08 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.714 0.805 . . . . 64.35 111.804 -167.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -122.7 -52.81 1.9 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.612 0.765 . . . . 73.14 109.084 171.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.2 mtt -90.44 176.5 6.68 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.412 -1.267 . . . . 53.1 110.632 -172.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 87.7 m -148.84 124.19 10.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.666 1.186 . . . . 71.13 107.906 173.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -134.55 138.67 44.81 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.821 0.848 . . . . 62.01 108.758 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -152.8 127.61 9.54 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.429 0.692 . . . . 70.42 109.466 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.3 mt -83.39 115.74 26.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.302 -0.999 . . . . 75.41 108.302 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -81.51 -38.59 26.03 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.478 0.486 . . . . 61.22 109.864 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -170.11 124.07 0.73 Allowed 'General case' 0 C--N 1.356 0.875 0 CA-C-O 119.684 -0.198 . . . . 74.3 110.783 -167.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.481 HD12 ' HG3' ' C' ' 130' ' ' PRO . 46.8 mt -111.68 134.79 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.157 -1.053 . . . . 75.31 108.157 172.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HB3' HG23 ' B' ' 122' ' ' THR . 44.1 p90 -166.55 167.33 15.6 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.878 0.847 . . . . 70.24 111.272 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -91.3 110.69 21.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.732 -1.122 . . . . 72.24 108.138 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -70.95 -46.92 61.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.96 -0.756 . . . . 73.23 108.96 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.66 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 6.0 m-20 -133.5 132.97 41.63 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.598 -1.183 . . . . 75.2 109.256 -176.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -127.67 139.71 51.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 106.678 -1.601 . . . . 72.32 106.678 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -149.84 107.34 3.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 123.655 0.597 . . . . 70.21 109.718 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 60.0 t80 -111.2 113.7 26.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.707 -1.59 . . . . 53.53 106.707 171.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.0 114.37 22.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.319 -0.623 . . . . 65.32 109.319 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.72 80.56 70.26 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 107.613 -1.255 . . . . 72.12 107.613 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.76 -11.4 20.14 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.469 2.112 . . . . 71.25 111.214 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -107.72 20.84 18.29 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.874 1.269 . . . . 63.03 108.772 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.46 -45.02 99.71 Favored Pre-proline 0 CA--C 1.571 1.786 0 N-CA-C 114.43 1.271 . . . . 45.41 114.43 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -88.01 -8.44 5.78 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 121.678 1.585 . . . . 73.43 112.99 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -94.88 -15.53 23.6 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.215 1.006 . . . . 60.22 110.354 -175.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.533 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 8.8 p -77.01 -25.93 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.731 0.812 . . . . 74.12 110.205 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -66.68 -29.82 69.91 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.801 0.84 . . . . 63.53 110.113 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -78.94 -34.95 44.01 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.025 0.93 . . . . 64.12 111.612 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 31' ' ' VAL . 16.2 ptpt -82.87 169.2 16.33 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.115 0.413 . . . . 75.3 112.115 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -85.01 127.03 34.02 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.648 -0.871 . . . . 74.41 108.648 167.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -70.29 88.55 0.64 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.21 1.004 . . . . 75.31 111.594 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.457 ' HB2' HD13 ' A' ' 68' ' ' LEU . 98.5 mt-30 -132.88 76.78 70.01 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.141 0.976 . . . . 74.43 109.403 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -89.04 126.38 1.68 Allowed 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.339 2.026 . . . . 74.13 112.358 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.99 109.89 22.21 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.492 -1.299 . . . . 74.33 107.492 170.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.78 107.24 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 115.131 -0.94 . . . . 62.25 110.907 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -79.77 114.69 18.89 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.289 -1.004 . . . . 70.41 108.289 165.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.0 tp -98.24 111.55 23.84 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.302 -0.999 . . . . 64.33 108.302 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -116.11 129.49 56.36 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.055 -1.091 . . . . 62.12 108.055 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 tt -119.33 129.89 55.09 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.281 -1.007 . . . . 63.24 108.281 -171.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 18.7 t70 -130.34 155.28 46.62 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.13 0.972 . . . . 71.41 109.532 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.627 ' H ' HD21 ' E' ' 460' ' ' LEU . 90.0 m -141.78 131.87 24.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.564 1.146 . . . . 75.32 109.207 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.1 148.64 45.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.973 0.909 . . . . 75.33 109.423 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.4 p -109.41 161.68 15.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.568 0.747 . . . . 51.31 109.313 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.1 p -152.95 138.08 17.35 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.134 0.574 . . . . 54.01 109.853 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.448 ' HA ' ' HD1' ' A' ' 56' ' ' TYR . 46.9 tt0 -91.25 114.83 27.47 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.944 0.498 . . . . 74.33 109.975 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 57' ' ' GLU . 18.9 mt -89.25 -43.42 10.98 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.832 -0.803 . . . . 51.11 108.832 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -150.67 -179.33 7.16 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 113.989 -1.459 . . . . 64.22 108.662 174.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' E' ' 450' ' ' ASN . 2.4 m-20 -68.57 113.64 6.26 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.39 -0.596 . . . . 75.53 109.39 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 66.3 21.55 10.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.337 1.455 . . . . 74.45 112.101 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 60.3 t -121.33 102.08 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 106.759 -1.571 . . . . 70.32 106.759 167.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.448 ' HD1' ' HA ' ' A' ' 50' ' ' GLN . 18.7 m-85 -127.05 143.35 51.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.951 0.501 . . . . 73.41 110.014 -170.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' A' ' 51' ' ' LEU . 34.7 tt0 -114.89 137.91 51.41 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.782 0.833 . . . . 75.25 109.523 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.5 t -103.89 126.85 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.824 -1.176 . . . . 71.1 107.824 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.4 t -102.22 107.46 21.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.524 -0.917 . . . . 75.1 108.524 174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 tp -88.83 101.42 14.01 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.949 -0.759 . . . . 71.03 108.949 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.697 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 23.8 mtm105 -89.5 100.95 13.64 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.039 0.536 . . . . 74.54 109.619 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.518 HG21 ' HB1' ' A' ' 110' ' ' ALA . 2.5 m -113.25 108.48 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.154 0.581 . . . . 62.1 109.543 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -108.89 148.51 30.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.523 0.729 . . . . 53.42 110.741 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.423 ' O ' HD12 ' A' ' 75' ' ' LEU . 70.6 t -129.23 112.29 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 125.307 1.443 . . . . 72.22 108.067 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.7 m -102.6 104.2 14.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.562 -0.903 . . . . 53.21 108.562 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.84 109.57 21.35 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.562 -1.273 . . . . 74.1 107.562 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.7 p -147.39 140.93 25.49 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.18 0.514 . . . . 63.41 111.405 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' A' ' 37' ' ' GLN . 38.2 tp -90.39 68.64 6.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.828 1.251 . . . . 70.32 107.668 169.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.51 -89.71 0.63 Allowed Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.046 -0.979 . . . . 42.25 111.951 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.8 -26.01 14.17 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.2 1.0 . . . . 73.32 110.123 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -96.98 94.89 7.45 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.407 -0.815 . . . . 72.45 109.177 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.8 m -65.39 134.77 54.22 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.824 0.85 . . . . 63.51 111.99 -174.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.87 -64.54 1.16 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.874 -0.788 . . . . 70.51 108.874 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -157.06 174.14 15.96 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.166 -0.925 . . . . 75.14 110.937 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 64' ' ' VAL . 61.7 tp -140.2 130.36 25.02 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.973 1.309 . . . . 63.24 107.634 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.427 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 84.7 m -138.44 113.4 9.2 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.466 0.706 . . . . 41.2 110.204 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -132.74 126.76 33.21 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.897 -0.779 . . . . 73.1 108.897 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -129.17 119.15 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.513 -0.767 . . . . 75.04 109.362 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.66 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 44.9 mt-30 -91.05 89.77 7.56 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.877 -1.056 . . . . 63.35 108.286 172.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.422 ' HG3' HD22 ' A' ' 106' ' ' LEU . 63.3 tp60 -78.73 105.71 10.22 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.149 -0.932 . . . . 70.04 109.29 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.97 160.03 27.03 Favored Glycine 0 C--O 1.242 0.613 0 N-CA-C 111.317 -0.713 . . . . 74.54 111.317 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.47 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -162.43 121.91 1.06 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.003 -1.239 . . . . 52.01 110.003 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.418 HG23 HD12 ' A' ' 51' ' ' LEU . 59.3 mt -79.23 123.74 36.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.625 -0.88 . . . . 71.03 108.625 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -126.41 119.0 26.14 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.081 -0.711 . . . . 73.22 109.081 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 p -91.62 119.2 31.31 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.066 -1.087 . . . . 71.24 108.066 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.765 HD13 HD11 ' A' ' 89' ' ' ILE . 2.4 pp -126.54 161.59 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.589 0.755 . . . . 51.5 111.559 -171.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.605 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -167.72 155.28 8.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.376 1.071 . . . . 74.3 109.721 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.16 8.26 86.92 Favored Glycine 0 N--CA 1.475 1.249 0 N-CA-C 114.501 0.56 . . . . 64.4 114.501 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.765 HD11 HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -114.99 153.85 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.2 1.0 . . . . 71.11 109.153 178.029 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.414 ' H ' ' HB2' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -164.87 171.27 14.34 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.12 -1.067 . . . . 70.24 108.12 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.38 -114.54 1.47 Allowed Glycine 0 CA--C 1.542 1.721 0 N-CA-C 114.685 0.634 . . . . 71.41 114.685 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p -70.68 -29.72 66.12 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.267 1.027 . . . . 63.22 112.173 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.414 ' HB2' ' H ' ' A' ' 90' ' ' GLU . 69.7 mm-40 -65.86 -44.63 84.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.45 0.7 . . . . 75.03 110.865 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -71.43 -34.17 70.06 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.22 -0.445 . . . . 72.42 110.467 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -33.51 76.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.099 0.56 . . . . 74.21 110.618 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.526 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 63.9 t-80 -71.49 -21.69 61.9 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.739 0.816 . . . . 71.44 110.728 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 78.3 m -79.12 -60.27 2.44 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.401 -0.592 . . . . 72.54 109.401 172.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.14 -32.84 73.48 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.169 0.987 . . . . 75.32 112.423 -173.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.47 4.13 29.56 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 119.356 -0.691 . . . . 32.11 114.055 -172.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.1 -66.73 0.34 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.882 0.841 . . . . 61.44 111.782 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.413 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 76.1 t80 -70.65 -58.32 3.79 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.241 0.616 . . . . 73.12 112.478 -169.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.65 -46.28 98.59 Favored Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 113.517 0.932 . . . . 74.21 113.517 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.09 -26.49 65.5 Favored 'Trans proline' 0 C--N 1.399 3.185 0 C-N-CA 121.846 1.697 . . . . 71.23 112.636 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -68.22 -39.76 82.29 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.382 0.673 . . . . 54.33 110.601 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.8 mm -61.7 -43.43 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.893 0.877 . . . . 64.24 110.13 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.422 HD22 ' HG3' ' A' ' 80' ' ' GLN . 83.0 mt -77.94 -22.22 49.89 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.889 -1.05 . . . . 72.52 112.219 -174.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -61.46 -47.25 93.87 Favored Pre-proline 0 CA--C 1.567 1.62 0 N-CA-C 113.788 1.033 . . . . 65.03 113.788 -170.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.12 -37.0 66.66 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.143 1.895 . . . . 73.4 113.139 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -70.37 -39.98 74.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.639 0.776 . . . . 75.23 110.418 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.518 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -65.38 -43.11 91.77 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.388 -0.823 . . . . 41.51 110.549 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.474 ' NH1' HD12 ' C' ' 105' ' ' ILE . 31.8 ttm180 -55.14 -50.85 68.23 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 124.46 1.1 . . . . 62.53 110.33 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -59.86 -47.46 85.67 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.604 1.19 . . . . 75.35 111.343 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 117' ' ' MET . 36.1 t -61.7 -41.47 97.65 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 123.912 0.757 . . . . 64.14 110.643 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.487 HD11 HG23 ' A' ' 62' ' ' VAL . 96.1 mt -64.3 -50.23 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.895 0.878 . . . . 75.42 110.43 176.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 78.4 m -53.6 -45.03 69.91 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.839 0.855 . . . . 74.25 110.604 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -66.74 -38.77 87.3 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.165 -1.38 . . . . 73.54 110.228 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 30.9 mmt -58.61 -47.13 85.38 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.283 0.633 . . . . 74.15 111.235 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 114' ' ' ILE . 62.2 t -61.97 -43.64 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-N 114.897 -1.047 . . . . 72.22 110.408 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.1 m -73.29 -29.8 62.97 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.612 0.765 . . . . 40.0 111.917 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.492 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 93.9 mtt-85 -77.41 -25.31 50.67 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.207 0.603 . . . . 74.01 110.413 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.99 2.8 87.15 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.576 0.547 . . . . 40.43 112.758 171.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.9 m 68.01 16.79 9.56 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.908 1.283 . . . . 74.52 111.268 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -81.74 144.94 53.1 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 108.914 -0.773 . . . . 72.43 108.914 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.14 134.72 44.14 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.058 2.505 . . . . 64.41 112.226 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -52.75 141.95 19.94 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.369 1.068 . . . . 63.42 113.558 -171.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.0 tp -119.4 127.08 52.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.815 1.246 . . . . 75.32 109.766 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -135.9 102.39 5.04 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.492 -0.929 . . . . 71.33 108.492 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.0 pt? -68.45 151.59 46.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.535 0.734 . . . . 72.31 111.031 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.94 146.46 98.27 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.196 0.999 . . . . 70.24 111.23 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -67.1 123.63 11.17 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.558 2.172 . . . . 71.41 112.347 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 98.7 t -101.25 113.56 37.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 123.971 0.908 . . . . 71.44 108.619 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -87.84 97.39 10.89 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.631 -0.878 . . . . 73.43 108.631 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -66.48 -21.14 66.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.315 1.046 . . . . 75.13 111.685 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.86 -48.77 62.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.413 1.085 . . . . 73.52 110.88 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.14 -40.02 88.34 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.83 0.707 . . . . 73.34 110.348 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.49 -39.9 85.22 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.081 -0.963 . . . . 72.43 111.369 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -67.08 -36.74 82.65 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.38 -0.6 . . . . 74.22 109.38 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.0 mmt -64.46 -35.11 79.87 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.023 0.827 . . . . 75.33 111.176 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 42.2 m-80 -60.0 -45.1 93.84 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.993 0.517 . . . . 64.12 110.787 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -68.26 -42.82 79.05 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.066 0.546 . . . . 71.05 110.759 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.51 -47.26 70.48 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.323 1.049 . . . . 72.32 111.568 -167.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -163.71 17.77 0.07 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.888 -0.596 . . . . 73.0 111.53 -172.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.662 ' HG2' ' HG3' ' A' ' 144' ' ' GLN . 50.6 tt0 64.97 -77.27 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.429 1.092 . . . . 51.15 110.189 -170.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.662 ' HG3' ' HG2' ' A' ' 143' ' ' GLN . 0.9 OUTLIER -163.28 155.5 18.03 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.827 0.851 . . . . 71.03 110.795 177.208 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -168.84 -77.25 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.12 0.968 . . . . 65.21 108.853 172.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 52.95 -121.12 14.32 Favored Glycine 0 C--N 1.36 1.864 0 O-C-N 124.115 0.885 . . . . 63.43 113.148 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -118.76 -178.54 3.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.307 1.043 . . . . 62.4 109.247 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 151.81 51.08 0.01 OUTLIER Glycine 0 C--N 1.345 1.053 0 C-N-CA 121.674 -0.298 . . . . 42.33 113.211 177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.3 t -161.96 156.97 23.04 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 122.946 0.499 . . . . 71.23 110.338 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -161.82 102.89 1.17 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.11 -1.07 . . . . 73.32 108.11 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -67.43 114.77 6.37 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.638 0.775 . . . . 70.12 111.672 -170.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -114.87 127.32 55.64 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.492 -1.299 . . . . 63.15 107.492 168.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -66.97 85.66 0.13 Allowed 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.961 0.886 . . . . 44.24 111.118 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -92.54 125.77 37.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.862 -1.063 . . . . 73.14 109.474 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 C-N-CA 123.653 0.781 . . . . 63.41 109.822 -176.358 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 108.44 -0.948 . . . . 74.54 108.44 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 28.8 p -141.68 81.21 1.76 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.13 0.572 . . . . 63.23 110.467 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -156.68 162.2 39.83 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.846 0.858 . . . . 75.01 109.325 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -157.05 162.82 39.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.394 0.678 . . . . 74.42 110.298 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -77.05 88.87 3.57 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.825 -0.805 . . . . 70.13 108.825 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -154.99 157.67 38.01 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.9 0.381 . . . . 71.12 110.92 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 38.9 p -63.97 -11.18 26.32 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.931 1.293 . . . . 74.22 112.214 174.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -55.55 -47.46 76.31 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.703 0.801 . . . . 73.23 110.935 169.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.546 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 19.7 ptm 53.8 177.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.174 1.79 . . . . 62.22 114.765 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 63.7 m -149.05 130.68 14.95 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.641 -1.163 . . . . 62.22 109.2 170.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -126.91 114.7 18.21 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.181 -1.415 . . . . 71.13 107.181 164.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.418 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 7.1 tp60 -128.76 118.34 22.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.452 0.701 . . . . 75.52 109.268 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 59.2 mt -77.77 116.48 21.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.902 -1.147 . . . . 65.24 107.902 169.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -85.72 -47.27 9.93 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.115 -0.698 . . . . 74.42 109.115 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -161.62 136.4 7.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.319 -0.855 . . . . 63.44 109.447 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 86.2 mt -115.89 140.76 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 106.392 -1.707 . . . . 51.13 106.392 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -166.3 171.18 12.37 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.392 0.615 . . . . 64.25 111.553 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.47 HG21 HD11 ' B' ' 21' ' ' ILE . 58.4 m -98.53 128.24 44.78 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.112 -0.949 . . . . 75.43 108.719 170.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.44 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 19.4 mtpp -86.96 -37.28 17.72 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.996 0.919 . . . . 43.25 109.465 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -151.93 139.45 19.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.178 -0.465 . . . . 75.44 112.059 -173.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.47 HD11 HG21 ' B' ' 18' ' ' THR . 39.6 mm -124.24 141.1 45.57 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 124.965 1.306 . . . . 51.45 108.809 170.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.4 t -140.55 136.72 33.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.485 -1.234 . . . . 64.34 108.116 176.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.5 t80 -158.59 111.01 2.27 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 107.62 -1.252 . . . . 75.51 107.62 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -131.34 117.45 18.94 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.844 0.858 . . . . 65.54 109.269 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.593 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -109.94 85.83 4.42 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.166 0.987 . . . . 75.13 108.821 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.64 -32.38 24.23 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.759 2.306 . . . . 73.35 112.546 -170.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -108.9 8.41 26.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.535 0.734 . . . . 73.33 111.249 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.593 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -34.48 -65.25 0.26 Allowed Pre-proline 0 N--CA 1.503 2.204 0 C-N-CA 125.526 1.53 . . . . 74.52 114.852 -167.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.8 Cg_exo -69.88 -19.41 35.58 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.284 1.99 . . . . 64.25 112.836 -168.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -95.48 -34.11 12.19 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.32 -0.854 . . . . 72.32 110.07 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.482 HG22 HD12 ' B' ' 68' ' ' LEU . 2.0 p -71.85 -24.29 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.859 0.464 . . . . 72.02 110.703 -173.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -67.62 -3.51 9.18 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.928 0.891 . . . . 73.25 112.989 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.56 -19.55 65.28 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 120.796 0.331 . . . . 74.34 110.294 170.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.441 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 86.3 mttt -105.35 92.74 4.33 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.581 1.153 . . . . 72.43 108.576 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.55 87.55 7.41 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.353 0.597 . . . . 75.32 110.221 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -165.43 159.08 16.6 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.803 1.241 . . . . 75.04 108.181 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.438 ' HG3' ' HB2' ' B' ' 124' ' ' PRO . 17.0 mp0 -59.5 110.65 2.9 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 123.852 0.861 . . . . 75.53 109.934 172.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.655 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.0 Cg_endo -60.24 140.71 93.48 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.908 2.405 . . . . 74.21 112.603 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -51.58 107.84 0.22 Allowed 'General case' 0 C--N 1.357 0.928 0 O-C-N 124.471 1.107 . . . . 71.41 110.561 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 31.3 m -87.5 155.04 3.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.157 -0.929 . . . . 65.02 111.454 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.64 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 48.9 tttp -139.39 107.69 5.8 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.308 -1.367 . . . . 44.23 107.308 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.26 124.37 33.8 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.502 -0.555 . . . . 54.01 109.502 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.568 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 23.6 t70 -130.18 154.45 47.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.242 1.417 . . . . 72.34 107.838 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.433 ' HB2' ' CD2' ' F' ' 462' ' ' TYR . 0.2 OUTLIER -142.71 147.29 35.4 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.701 -0.481 . . . . 53.1 109.701 -170.278 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.598 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 23.4 t70 -146.91 114.14 6.24 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.912 -0.773 . . . . 71.52 108.912 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.2 p -114.95 108.29 16.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.23 0.612 . . . . 73.13 110.697 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.16 162.65 17.14 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.827 1.251 . . . . 32.12 108.689 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.0 p -137.44 162.28 34.08 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.271 0.628 . . . . 70.21 109.468 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 97.8 p -150.41 136.48 18.55 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.855 0.462 . . . . 54.31 110.199 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -87.02 110.41 20.04 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.311 -0.626 . . . . 64.44 109.311 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 27.5 mt -82.42 -41.94 19.23 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.908 -0.587 . . . . 72.31 109.669 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.73 -172.31 4.01 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.51 -1.223 . . . . 74.33 110.303 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.03 105.52 0.41 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.782 -1.099 . . . . 55.44 110.723 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 66.76 16.43 10.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.952 1.301 . . . . 75.51 112.322 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -105.49 110.05 29.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.765 -1.198 . . . . 71.42 107.765 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.52 140.23 52.48 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.508 0.67 . . . . 75.34 109.675 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -116.04 104.11 11.24 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.356 -1.35 . . . . 74.11 107.356 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 90.8 t -85.4 139.68 17.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 CA-C-N 114.632 -1.167 . . . . 74.03 109.635 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.83 120.04 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 123.585 0.754 . . . . 61.33 109.116 -176.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -107.42 106.29 16.62 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.78 -1.193 . . . . 71.32 107.78 178.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.598 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 34.6 ttm180 -98.87 118.81 36.46 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.157 0.583 . . . . 72.54 109.616 170.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.617 ' HB ' HD11 ' B' ' 114' ' ' ILE . 29.3 t -107.84 108.64 25.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.621 -1.251 . . . . 73.0 107.621 169.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 41.7 m -97.11 122.57 40.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.519 -0.549 . . . . 64.3 109.519 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.712 HG21 HG21 ' B' ' 114' ' ' ILE . 79.5 t -115.83 103.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 124.046 0.939 . . . . 52.42 110.111 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 99.7 m -91.23 145.09 24.95 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.559 -0.904 . . . . 71.13 108.559 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -145.85 148.73 33.19 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.463 0.305 . . . . 62.35 111.027 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.1 p -153.41 130.62 11.18 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.808 -0.633 . . . . 61.24 110.801 -175.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.655 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 35.0 mt -98.68 112.73 24.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.924 0.89 . . . . 71.04 108.978 175.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.48 -114.54 6.96 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 115.211 -0.904 . . . . 65.45 112.342 -172.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -109.09 11.65 25.57 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.226 0.611 . . . . 71.45 112.282 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -128.29 150.14 50.19 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.199 0.6 . . . . 74.41 110.079 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 37.5 m -66.38 135.19 53.98 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.474 0.484 . . . . 62.25 110.594 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.466 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -91.16 -62.32 1.47 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.283 -1.006 . . . . 74.1 108.283 174.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -151.4 162.88 40.16 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.202 -0.908 . . . . 74.42 110.17 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -132.91 109.35 9.53 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.976 -1.491 . . . . 52.33 106.976 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' B' ' 114' ' ' ILE . 51.2 t -118.3 156.43 28.89 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.69 0.796 . . . . 61.4 109.267 -174.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.0 tt0 -165.81 139.87 4.53 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.7 -0.852 . . . . 64.14 108.7 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' B' ' 113' ' ' CYS . 72.3 t -131.67 141.66 45.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.656 -1.239 . . . . 73.42 107.656 172.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -122.31 87.62 2.78 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.753 -0.832 . . . . 74.42 108.753 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.34 99.48 7.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.551 -0.75 . . . . 73.4 109.014 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.44 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.97 144.29 16.55 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.635 -0.986 . . . . 60.23 110.635 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.42 130.43 4.1 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.491 -0.644 . . . . 75.25 111.491 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.0 mt -85.15 125.77 40.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 123.945 0.898 . . . . 74.43 109.208 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -136.54 135.45 38.49 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.29 1.036 . . . . 64.22 108.565 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 41.9 m -101.99 106.6 17.54 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.802 -0.814 . . . . 52.14 108.802 176.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.407 HG21 ' SG ' ' B' ' 97' ' ' CYS . 31.2 pt -110.66 125.15 67.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.776 0.83 . . . . 64.2 109.906 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.45 162.06 41.65 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.753 0.821 . . . . 60.34 109.331 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.18 -47.8 3.9 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.476 0.485 . . . . 75.31 112.636 -177.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 31.1 pt -70.18 152.28 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.838 0.855 . . . . 71.13 110.644 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -162.85 163.86 26.29 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.363 0.665 . . . . 74.31 109.96 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.4 -113.65 3.71 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.438 0.461 . . . . 71.4 112.407 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 87.7 m -84.97 -26.74 26.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.182 0.515 . . . . 64.11 110.745 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -73.43 -28.89 62.22 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.831 -0.622 . . . . 75.22 110.663 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.518 ' SD ' HG22 ' F' ' 452' ' ' VAL . 0.0 OUTLIER -72.7 -33.75 66.68 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 109.589 -0.522 . . . . 71.3 109.589 173.234 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.55 -39.08 84.96 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.905 0.882 . . . . 71.01 110.891 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -62.65 -31.23 72.06 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.681 -1.145 . . . . 72.53 110.808 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.407 ' SG ' HG21 ' B' ' 86' ' ' ILE . 25.2 t -72.06 -66.35 0.66 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.924 -0.58 . . . . 60.4 110.367 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.441 HD12 ' N ' ' B' ' 99' ' ' GLY . 1.6 pp -68.93 -26.74 65.23 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.589 0.959 . . . . 75.22 113.589 -171.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.441 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -104.56 3.05 42.55 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-O 119.52 -0.6 . . . . 74.22 114.242 -171.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.86 -61.16 0.18 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 117.429 0.615 . . . . 71.31 111.176 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -66.92 -52.38 43.82 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.338 1.055 . . . . 72.35 111.908 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.428 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 92.6 m -62.34 -50.38 79.68 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.371 1.068 . . . . 73.53 111.788 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.7 Cg_exo -56.36 -36.65 97.4 Favored 'Trans proline' 0 C--N 1.401 3.305 0 C-N-CA 122.045 1.83 . . . . 71.22 113.295 170.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -66.59 -29.56 69.64 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.008 0.523 . . . . 62.53 111.004 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.431 HG23 ' NH2' ' D' ' 111' ' ' ARG . 93.0 mt -68.49 -45.51 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.87 0.868 . . . . 73.01 110.244 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.405 ' HB2' HD12 ' B' ' 60' ' ' LEU . 56.2 mt -76.39 -20.93 56.66 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.975 -1.011 . . . . 73.02 111.833 -173.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -59.91 -48.79 93.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-O 117.661 -1.162 . . . . 73.0 113.419 -171.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -56.36 -38.69 94.73 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.124 1.882 . . . . 74.4 113.231 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -66.83 -47.64 71.38 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.158 0.583 . . . . 74.24 110.335 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.407 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -59.81 -40.27 87.81 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.593 0.757 . . . . 74.14 110.656 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.539 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 36.0 ttt180 -61.75 -52.3 64.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.334 1.454 . . . . 73.35 111.138 -176.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.74 -37.74 88.5 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.958 0.786 . . . . 62.22 109.916 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.492 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 5.1 t -67.38 -38.31 84.55 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.656 0.598 . . . . 75.42 111.796 -173.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.712 HG21 HG21 ' B' ' 64' ' ' VAL . 61.1 mt -66.74 -51.47 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 109.388 -0.597 . . . . 74.51 109.388 176.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.471 HG21 ' OG ' ' C' ' 119' ' ' SER . 88.9 m -54.91 -37.74 66.74 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.898 1.374 . . . . 75.52 110.848 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 46.7 t -63.43 -44.19 95.27 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 115.361 -0.836 . . . . 53.21 110.018 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.422 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 30.7 mmt -62.91 -43.07 99.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.337 0.398 . . . . 73.53 110.93 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.511 HG23 ' O ' ' B' ' 114' ' ' ILE . 48.4 t -58.96 -47.16 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.242 1.017 . . . . 55.43 109.605 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.532 ' HB3' HG21 ' C' ' 115' ' ' THR . 71.8 m -65.49 -34.54 78.51 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.261 -1.336 . . . . 70.15 112.062 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -68.87 -35.0 76.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.395 -0.821 . . . . 72.53 110.093 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -86.99 10.99 66.15 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 124.135 0.897 . . . . 52.51 112.957 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 17' ' ' TYR . 67.0 p 56.74 23.61 8.12 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.992 1.717 . . . . 52.32 113.628 176.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.47 149.99 62.44 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 122.797 0.439 . . . . 64.12 109.996 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.438 ' HB2' ' HG3' ' B' ' 37' ' ' GLN . 51.2 Cg_exo -55.29 164.76 3.57 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.736 2.958 . . . . 74.51 114.906 -177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -57.73 121.39 10.32 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.308 1.043 . . . . 71.23 112.895 -166.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.624 ' HG ' HD11 ' F' ' 468' ' ' LEU . 9.5 tt -128.54 123.85 34.52 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.075 -1.083 . . . . 70.41 108.075 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -134.98 127.1 29.89 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.611 0.764 . . . . 74.12 109.004 172.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.539 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -68.79 137.74 54.24 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.483 0.713 . . . . 50.41 109.919 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.03 138.4 61.07 Favored Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 123.625 0.578 . . . . 54.41 110.576 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.04 122.98 7.52 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.881 2.387 . . . . 55.41 112.847 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 t -116.2 112.08 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.42 -0.956 . . . . 43.41 108.42 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -76.68 88.71 3.35 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.461 -0.94 . . . . 74.53 108.461 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -59.51 -37.8 79.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.093 -0.958 . . . . 73.24 112.345 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.22 -43.59 87.79 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.978 0.911 . . . . 73.23 112.688 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.03 -53.64 29.28 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.537 0.735 . . . . 71.12 110.725 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.0 -14.72 61.07 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.282 -0.872 . . . . 71.44 111.433 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.495 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 84.2 t80 -71.67 -42.95 66.86 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.396 0.435 . . . . 74.44 109.937 173.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 61.9 mtt -62.16 -33.78 75.15 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.024 0.53 . . . . 73.4 110.601 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -79.38 -25.7 42.11 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.582 -0.735 . . . . 62.5 111.272 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.407 ' OH ' ' HB2' ' F' ' 459' ' ' ASP . 62.8 t80 -64.03 -28.5 69.84 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.289 0.636 . . . . 75.02 111.334 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 17.5 mt -83.56 5.83 22.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.478 0.711 . . . . 74.33 111.453 -174.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -143.78 153.34 42.31 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.386 1.074 . . . . 74.11 108.819 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -89.46 11.75 18.44 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.735 0.414 . . . . 72.53 111.598 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -113.37 151.85 30.74 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.505 0.722 . . . . 74.23 109.89 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.98 160.22 43.0 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.645 0.778 . . . . 64.34 110.226 -177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.95 171.78 28.95 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.745 -0.661 . . . . 74.4 112.589 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -152.66 102.22 2.69 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.569 -0.9 . . . . 73.31 108.569 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -134.46 52.23 0.81 Allowed Glycine 0 CA--C 1.504 -0.628 0 N-CA-C 109.661 -1.376 . . . . 73.35 109.661 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 1.8 m -118.76 30.54 7.13 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.638 -0.781 . . . . 75.31 109.839 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.82 174.65 11.12 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.879 -0.6 . . . . 62.04 109.783 175.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.32 133.43 35.23 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.288 0.565 . . . . 70.54 110.475 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -163.51 137.64 5.92 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.7 1.2 . . . . 65.2 108.428 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -129.18 117.92 21.56 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.25 0.62 . . . . 64.22 110.087 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -143.7 99.17 3.36 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.802 0.841 . . . . 74.44 109.217 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.415 0 C-N-CA 123.675 0.79 . . . . 72.33 109.745 177.488 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.77 -0.456 . . . . 74.45 109.77 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m 72.63 20.42 3.8 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.369 1.467 . . . . 74.24 111.808 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.35 102.32 6.72 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.895 0.878 . . . . 73.33 110.546 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -140.45 116.68 10.59 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.652 0.781 . . . . 74.32 109.397 168.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -103.58 120.87 41.74 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.131 0.972 . . . . 73.14 108.873 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -76.74 86.78 3.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.851 -0.796 . . . . 45.45 108.851 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 37.7 p -65.07 -29.28 70.16 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.99 0.916 . . . . 50.13 112.049 -174.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.69 77.95 4.2 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.63 0.772 . . . . 74.31 109.634 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.6 ttt 65.42 111.73 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 126.13 1.772 . . . . 71.32 112.299 -173.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 28.5 m -103.69 96.58 6.81 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.632 -1.247 . . . . 52.02 107.632 170.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -97.44 128.45 44.24 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.491 -0.929 . . . . 73.41 108.491 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -153.88 125.74 7.74 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.18 0.592 . . . . 65.21 109.723 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.442 HD13 HD11 ' C' ' 16' ' ' ILE . 50.1 mt -75.75 132.57 32.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.857 -0.794 . . . . 61.42 108.857 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.499 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 15.0 mm100 -101.11 -39.52 7.64 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.593 0.757 . . . . 74.53 109.899 174.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.407 HH12 ' HG3' ' E' ' 471' ' ' LYS . 24.6 ttt85 -169.67 146.62 3.32 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.526 -0.546 . . . . 71.22 109.526 -172.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.442 HD11 HD13 ' C' ' 13' ' ' ILE . 89.8 mt -137.03 134.08 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.143 -1.058 . . . . 73.5 108.143 175.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.413 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 43.4 p90 -170.85 164.29 7.81 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.155 0.502 . . . . 71.4 110.904 -167.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -87.26 114.53 23.96 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.328 -0.851 . . . . 61.44 108.855 173.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.413 ' HD2' ' HE2' ' C' ' 17' ' ' TYR . 19.2 mmmt -64.02 -39.89 95.12 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.915 0.864 . . . . 75.13 109.139 172.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -160.4 144.98 14.38 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 113.696 -1.593 . . . . 75.22 108.349 -172.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 88.9 mt -133.78 146.99 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.585 -1.265 . . . . 73.41 107.585 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.8 t -151.92 149.76 29.29 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.471 0.653 . . . . 63.55 110.267 172.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 82.7 t80 -150.75 117.85 5.94 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 107.275 -1.38 . . . . 73.01 107.275 173.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.97 111.99 17.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.512 0.725 . . . . 75.53 109.882 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.88 82.34 60.94 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.25 -1.019 . . . . 60.22 108.25 169.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -65.17 -25.78 57.73 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.013 2.476 . . . . 75.32 112.712 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -102.31 13.02 35.73 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.154 0.982 . . . . 62.4 110.605 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.468 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -45.18 -58.42 5.74 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 114.703 1.371 . . . . 73.23 114.703 -165.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.549 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 23.5 Cg_endo -60.04 -43.22 37.78 Favored 'Trans proline' 0 C--N 1.383 2.382 0 CA-C-N 122.129 1.796 . . . . 70.13 111.817 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -71.67 -28.42 63.73 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.963 0.905 . . . . 75.35 112.674 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.761 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.7 p -80.25 -22.26 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.57 0.348 . . . . 65.14 111.567 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -72.91 -21.24 60.93 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.005 0.522 . . . . 74.24 111.783 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -102.1 6.5 40.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.734 0.814 . . . . 74.11 110.906 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.823 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -83.77 161.53 20.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.444 0.698 . . . . 63.24 110.546 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 7.2 m-20 -57.76 112.27 1.41 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.32 1.048 . . . . 74.33 109.646 168.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -73.57 88.45 1.67 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.028 0.531 . . . . 73.12 110.553 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -150.16 74.22 9.15 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.393 -0.966 . . . . 50.2 108.393 169.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.58 ' HD2' HD21 ' G' ' 470' ' ' LEU . 9.5 Cg_exo -74.57 164.48 33.74 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.75 2.3 . . . . 74.22 112.87 173.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -115.8 94.38 4.66 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.374 -1.714 . . . . 74.14 106.374 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.431 HG23 HD22 ' G' ' 470' ' ' LEU . 90.9 t -73.38 98.4 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.548 -0.751 . . . . 73.12 109.256 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -101.5 107.39 18.68 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.912 -1.144 . . . . 72.21 107.912 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.07 138.48 31.41 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.273 0.559 . . . . 74.11 111.282 -174.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.577 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.2 t70 -130.74 132.86 45.58 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.11 1.364 . . . . 62.5 108.614 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.401 HD13 HG11 ' C' ' 131' ' ' VAL . 52.0 mt -123.05 131.9 53.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.845 -1.169 . . . . 74.45 107.845 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.521 ' HA ' ' HG ' ' G' ' 460' ' ' LEU . 19.2 t70 -144.4 144.58 31.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.322 0.649 . . . . 71.35 109.421 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.433 HG22 HD21 ' G' ' 460' ' ' LEU . 15.3 t -151.48 153.41 34.57 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 122.898 0.479 . . . . 55.33 110.101 175.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.95 168.86 24.97 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.432 -0.804 . . . . 54.14 109.564 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.4 p -129.9 151.22 50.7 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.882 0.873 . . . . 42.13 109.499 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 80.7 p -143.68 128.13 17.94 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.373 1.069 . . . . 73.1 108.197 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -76.94 116.43 17.6 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.36 -0.607 . . . . 64.43 109.36 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 HD12 ' C' ' 83' ' ' ILE . 75.3 mt -89.64 -39.7 13.05 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.0 -0.741 . . . . 63.04 109.0 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 -175.49 5.43 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.646 -1.161 . . . . 71.53 110.432 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.24 116.93 5.9 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.661 -1.154 . . . . 71.33 109.85 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 61.97 20.11 11.28 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.369 1.068 . . . . 63.53 112.136 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.8 t -119.72 116.43 50.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.535 -0.913 . . . . 74.13 108.535 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.621 ' HE2' ' HB ' ' G' ' 452' ' ' VAL . 0.6 OUTLIER -125.38 125.9 44.15 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.077 0.951 . . . . 74.3 109.059 -179.263 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.451 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.0 tt0 -83.6 132.55 34.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.911 -1.144 . . . . 75.44 107.911 164.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 56.1 t -112.43 139.71 35.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.088 -1.078 . . . . 74.42 108.088 166.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.402 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 47.1 t -121.44 124.88 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.792 -0.818 . . . . 64.31 108.792 171.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' C' ' 107' ' ' PHE . 1.1 tm? -104.42 106.09 16.45 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.712 -1.218 . . . . 61.33 107.712 172.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.517 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 0.8 OUTLIER -101.16 115.13 29.78 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.72 -1.127 . . . . 74.2 109.492 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.553 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.7 t -101.91 134.95 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.375 -0.972 . . . . 61.42 108.375 174.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -121.87 136.88 54.95 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.665 -0.865 . . . . 51.32 108.665 172.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.68 HG11 HD11 ' C' ' 126' ' ' LEU . 46.5 t -127.83 118.37 48.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 123.655 0.782 . . . . 65.42 109.329 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.453 HG23 HD23 ' C' ' 75' ' ' LEU . 3.2 m -102.53 144.63 30.71 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.011 -0.737 . . . . 64.43 109.011 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.17 114.22 9.0 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.391 -0.966 . . . . 71.15 108.391 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -131.2 142.33 50.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.413 0.685 . . . . 32.31 109.868 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.823 HD13 ' HG2' ' C' ' 34' ' ' LYS . 4.7 mt -94.34 16.81 14.14 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.949 1.3 . . . . 74.11 110.779 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.27 -87.71 0.35 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.78 -1.328 . . . . 62.41 109.78 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.53 -26.68 8.93 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.133 0.973 . . . . 72.44 110.567 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -82.77 119.0 23.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.707 0.803 . . . . 71.01 109.344 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -73.83 127.14 32.03 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.601 -0.518 . . . . 62.1 109.601 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.761 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.13 -54.76 7.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.162 -0.681 . . . . 63.44 109.162 173.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -169.28 173.39 6.69 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.335 -0.848 . . . . 74.23 110.924 176.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.453 HD23 HG23 ' C' ' 65' ' ' THR . 3.1 tm? -142.82 112.8 7.04 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.22 -1.4 . . . . 61.31 107.22 175.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -108.1 145.76 33.62 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.515 -0.92 . . . . 74.44 108.515 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -153.86 134.15 13.39 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.895 -0.78 . . . . 62.33 108.895 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 64.8 t -132.41 115.34 25.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.013 0.925 . . . . 75.41 108.898 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.517 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 57.8 mt-30 -93.53 89.9 6.46 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.32 -0.993 . . . . 64.34 108.32 174.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -86.7 102.16 13.96 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.152 0.581 . . . . 54.22 110.121 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.84 167.59 44.31 Favored Glycine 0 C--O 1.24 0.531 0 CA-C-O 121.175 0.319 . . . . 74.43 112.699 175.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -170.39 119.57 0.81 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.155 -0.778 . . . . 65.02 111.155 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.629 HD12 HD11 ' C' ' 51' ' ' LEU . 12.0 mm -82.9 132.35 31.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 109.129 -0.693 . . . . 74.21 109.129 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -134.28 119.89 19.28 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.322 0.649 . . . . 73.42 109.678 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 13.1 p -82.14 102.04 10.81 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.17 -1.048 . . . . 72.23 108.17 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.451 ' O ' HD12 ' C' ' 86' ' ' ILE . 2.5 pp -121.74 126.4 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 123.689 0.796 . . . . 74.32 110.982 -173.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.41 156.52 46.53 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.658 0.783 . . . . 65.34 109.899 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.42 -26.13 17.22 Favored Glycine 0 N--CA 1.476 1.314 0 N-CA-C 114.329 0.492 . . . . 71.12 114.329 172.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.626 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -87.28 145.81 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.056 0.543 . . . . 73.23 110.523 178.198 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.48 170.27 18.41 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.109 -0.95 . . . . 63.51 108.601 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.22 -119.27 6.86 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 124.118 0.887 . . . . 54.4 115.042 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 1.6 m -71.66 -32.35 67.79 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.641 1.176 . . . . 71.03 111.122 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.58 -43.16 90.64 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.466 0.707 . . . . 70.22 109.883 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.685 ' SD ' ' HA ' ' G' ' 452' ' ' VAL . 37.1 ttp -68.11 -40.73 82.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.17 -0.923 . . . . 74.41 110.593 175.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.8 -42.78 76.11 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 124.315 1.009 . . . . 61.42 110.697 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -83.14 -35.62 25.43 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.612 0.57 . . . . 63.11 111.956 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -58.0 -42.31 84.93 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.897 0.748 . . . . 64.1 110.62 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 21.9 mt -98.43 -24.91 14.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.266 -0.879 . . . . 63.22 110.686 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.61 -21.36 79.51 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.471 0.482 . . . . 55.45 114.174 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -158.26 -42.79 0.06 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.722 1.008 . . . . 75.45 113.722 -167.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.86 -46.63 74.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.915 0.486 . . . . 72.0 111.212 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.46 -49.06 54.3 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 124.254 1.022 . . . . 62.02 111.994 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -52.12 -34.44 58.15 Favored 'Trans proline' 0 C--N 1.399 3.186 0 C-N-CA 123.156 2.571 . . . . 62.0 114.654 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -60.23 -34.03 73.1 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.837 0.855 . . . . 71.11 111.722 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.474 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.9 mm -70.4 -37.33 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.183 0.593 . . . . 73.05 110.189 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.437 HD21 ' HA3' ' C' ' 82' ' ' GLY . 53.1 mt -87.73 -24.79 23.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.035 0.934 . . . . 72.53 112.587 -170.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.472 ' HA ' HD12 ' C' ' 60' ' ' LEU . 63.7 t80 -56.63 -48.74 96.64 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 117.812 -1.089 . . . . 74.04 113.853 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -55.33 -38.03 94.12 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 122.388 2.059 . . . . 72.21 113.234 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -67.25 -46.29 74.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.696 0.798 . . . . 74.02 110.467 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.43 ' O ' HG13 ' C' ' 114' ' ' ILE . . . -63.14 -38.99 93.35 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.669 -0.696 . . . . 74.35 110.878 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -57.25 -49.41 76.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.731 1.212 . . . . 65.21 111.079 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.63 -37.6 82.71 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 123.603 0.564 . . . . 60.33 110.084 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.3 t -68.18 -29.58 68.48 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.087 0.555 . . . . 73.05 111.443 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.553 HD11 ' HB ' ' C' ' 62' ' ' VAL . 74.1 mt -71.28 -50.45 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 108.949 -0.76 . . . . 53.34 108.949 172.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.532 HG21 ' HB3' ' B' ' 119' ' ' SER . 23.2 m -58.64 -35.12 72.01 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.679 0.792 . . . . 64.11 111.179 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.0 t -67.0 -54.14 24.63 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 123.813 0.845 . . . . 74.43 109.124 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.642 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.24 -38.71 80.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.487 1.115 . . . . 71.24 112.89 -177.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' C' ' 123' ' ' PHE . 67.1 t -65.98 -46.28 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.75 0.82 . . . . 72.41 110.165 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.471 ' OG ' HG21 ' B' ' 115' ' ' THR . 45.1 t -71.12 -24.12 62.22 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.617 -0.72 . . . . 73.14 111.582 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -69.44 -44.08 72.01 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.546 -0.909 . . . . 60.23 108.546 173.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.67 -1.59 72.34 Favored Glycine 0 C--N 1.357 1.744 0 O-C-N 123.712 0.632 . . . . 74.32 112.901 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 26.7 p 60.65 37.2 19.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.656 1.982 . . . . 64.11 113.359 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.458 ' HB2' HG13 ' C' ' 118' ' ' VAL . 91.4 m-85 -89.37 162.75 36.06 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-N 115.199 -0.909 . . . . 70.2 108.702 166.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.27 167.59 7.5 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.88 2.387 . . . . 75.44 113.301 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -51.66 131.69 30.19 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.706 1.202 . . . . 73.43 112.836 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.68 HD11 HG11 ' C' ' 64' ' ' VAL . 3.8 tt -136.3 85.08 2.12 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.306 -0.861 . . . . 63.35 108.918 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 127' ' ' ASN . . . . . 0.518 ' H ' HD21 ' G' ' 468' ' ' LEU . 14.2 m120 -95.48 124.22 39.41 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.818 -1.179 . . . . 54.52 107.818 171.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.05 134.9 47.44 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 108.487 -0.931 . . . . 71.42 108.487 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' G' ' 467' ' ' ALA . . . -57.5 152.39 34.32 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.311 1.044 . . . . 75.54 112.19 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.481 ' HG3' HD12 ' A' ' 16' ' ' ILE . 35.7 Cg_exo -56.33 92.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 122.566 2.177 . . . . 63.23 112.407 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.401 HG11 HD13 ' C' ' 44' ' ' LEU . 54.8 t -98.57 109.86 24.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 108.833 -0.803 . . . . 64.11 108.833 177.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -93.44 88.54 5.98 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.124 -1.436 . . . . 74.23 107.124 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -58.07 -32.79 68.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.495 0.718 . . . . 73.24 110.647 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.551 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 16.0 t70 -61.0 -39.03 88.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.878 0.871 . . . . 52.12 111.395 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.2 -39.22 71.91 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.244 0.617 . . . . 44.41 110.948 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 97.2 mt -67.79 -33.82 75.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.814 0.845 . . . . 72.43 112.232 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -74.3 -16.29 60.93 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.434 0.294 . . . . 73.3 110.994 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 91.4 mtp -73.27 -30.22 63.29 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.525 0.33 . . . . 71.14 111.003 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -71.35 -35.76 71.27 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 110.012 -0.366 . . . . 72.53 110.012 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.447 ' OH ' ' HA ' ' G' ' 458' ' ' THR . 75.5 t80 -71.51 -84.93 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 123.676 0.79 . . . . 74.3 110.129 169.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 23.0 tp 70.45 -77.1 0.06 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.819 1.648 . . . . 75.13 111.146 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -153.48 -67.49 0.15 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.554 0.742 . . . . 63.0 109.342 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -108.94 22.02 16.46 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.816 0.847 . . . . 75.22 109.848 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . 0.281 0.7 OUTLIER 58.21 163.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 127.114 2.166 . . . . 65.31 115.461 179.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -163.2 162.94 25.67 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.076 1.35 . . . . 52.51 109.352 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.17 65.5 0.01 OUTLIER Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.512 -0.635 . . . . 73.44 111.512 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.89 173.41 11.54 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.948 0.899 . . . . 75.22 110.715 -176.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 123.51 -168.87 15.67 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.607 -0.724 . . . . 73.12 111.773 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 14.0 t -137.59 173.56 11.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.758 0.823 . . . . 74.02 109.303 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -146.13 156.56 43.52 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.101 0.561 . . . . 72.52 111.131 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -162.22 150.09 14.4 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.351 1.06 . . . . 73.21 108.715 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 152' ' ' HIS . . . . . 0.458 ' CD2' ' HB2' ' C' ' 154' ' ' ASP . 18.5 t60 -167.15 96.5 0.5 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.633 -0.506 . . . . 63.21 109.633 -176.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -98.97 86.25 3.43 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 122.07 0.938 . . . . 74.03 108.49 170.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 154' ' ' ASP . . . . . 0.458 ' HB2' ' CD2' ' C' ' 152' ' ' HIS . 12.4 t70 -78.01 155.93 30.43 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.369 -0.832 . . . . 71.25 110.916 -172.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 155' ' ' ALA . . . . . 0.504 ' HB3' HG12 ' E' ' 451' ' ' VAL . . . . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.262 -0.875 . . . . 74.32 109.869 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.805 -0.443 . . . . 74.21 109.805 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 41.5 m -136.57 161.36 36.11 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.323 1.049 . . . . 53.42 109.035 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.01 167.54 23.76 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.94 0.896 . . . . 73.52 109.963 -175.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -68.85 139.92 55.2 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.441 0.697 . . . . 64.52 110.869 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -89.22 79.94 7.0 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.873 0.844 . . . . 72.24 109.726 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -59.84 112.01 1.68 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.089 -0.96 . . . . 64.21 108.886 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.8 m -143.28 114.79 8.04 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 122.412 0.285 . . . . 65.32 110.701 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -84.55 133.09 34.45 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 105.387 -2.079 . . . . 61.21 105.387 151.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 4.9 ttp -29.54 122.78 0.15 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 125.101 1.501 . . . . 62.0 113.503 -173.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.1 m -111.55 146.49 37.24 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.845 -0.798 . . . . 72.41 108.845 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -165.81 92.08 0.51 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.479 -1.304 . . . . 73.35 107.479 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -123.32 117.16 24.61 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.277 -1.379 . . . . 74.03 107.277 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.503 HG21 HD11 ' D' ' 16' ' ' ILE . 27.8 mt -65.89 117.28 6.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.511 0 N-CA-C 108.798 -0.815 . . . . 74.45 108.798 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -83.79 -32.94 25.1 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 123.628 0.58 . . . . 72.21 111.111 -170.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -178.73 129.05 0.11 Allowed 'General case' 0 C--N 1.363 1.188 0 O-C-N 123.032 0.207 . . . . 73.44 110.705 -167.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.503 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -108.53 136.06 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.313 -1.365 . . . . 62.21 107.313 166.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.455 ' HE1' HG13 ' D' ' 83' ' ' ILE . 29.9 p90 -158.7 162.91 37.22 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.972 0.795 . . . . 74.34 111.055 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 56.9 p -97.8 114.39 26.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.033 -0.985 . . . . 62.24 109.442 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.549 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.5 mtpt -80.13 -22.85 41.62 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.592 -0.731 . . . . 75.43 109.786 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.2 t70 -163.04 139.49 7.27 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.755 -1.111 . . . . 52.12 109.236 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.642 HG21 ' HE2' ' C' ' 117' ' ' MET . 77.3 mt -134.9 146.67 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.565 1.146 . . . . 54.11 108.539 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -146.34 125.2 12.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.706 0.802 . . . . 74.54 109.801 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.498 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 80.7 t80 -123.85 132.65 53.8 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 106.889 -1.522 . . . . 64.01 106.889 163.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 41.6 mt-10 -131.82 134.9 46.29 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.033 -0.729 . . . . 72.11 109.033 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.73 82.29 68.98 Favored Pre-proline 0 C--O 1.242 0.703 0 N-CA-C 106.076 -1.824 . . . . 74.45 106.076 168.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.57 -36.02 35.49 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.515 2.143 . . . . 75.22 111.751 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -105.76 11.21 32.3 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.106 0.962 . . . . 72.13 110.684 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.477 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -18.53 -72.65 0.02 OUTLIER Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 116.287 1.958 . . . . 61.22 116.287 -166.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.479 ' HB3' HD11 ' C' ' 83' ' ' ILE . 49.1 Cg_endo -79.02 -16.42 12.52 Favored 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 123.771 2.383 . . . . 65.11 114.078 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -76.45 -37.45 56.94 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.431 1.093 . . . . 74.51 109.793 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.743 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.4 p -83.51 -23.94 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 116.108 -0.496 . . . . 71.35 111.642 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -67.46 -18.16 64.97 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 122.537 0.335 . . . . 71.01 111.811 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -57.76 -29.66 64.98 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.303 1.041 . . . . 74.33 110.778 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -95.41 91.8 6.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.981 0.913 . . . . 72.14 109.279 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.56 70.92 10.35 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 122.531 1.157 . . . . 72.12 109.296 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -130.92 161.43 31.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.287 -1.324 . . . . 75.24 108.269 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.524 ' HB3' HD22 ' H' ' 470' ' ' LEU . 2.0 mp0 -66.99 107.9 2.04 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.121 0.968 . . . . 74.33 109.411 174.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.472 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 35.5 Cg_exo -61.72 122.33 10.86 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.206 2.604 . . . . 74.04 112.667 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 40.8 tt0 -57.0 114.94 2.33 Favored 'General case' 0 C--N 1.359 0.995 0 O-C-N 124.092 0.87 . . . . 74.05 110.025 -177.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.478 HG11 HD12 ' H' ' 468' ' ' LEU . 7.6 p -98.3 135.27 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.525 0.73 . . . . 72.2 111.556 -170.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -114.19 132.63 56.03 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 106.975 -1.491 . . . . 72.55 106.975 170.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.87 129.59 55.07 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.086 0.554 . . . . 72.0 110.161 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.578 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 17.5 t70 -112.92 128.83 56.58 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.634 1.174 . . . . 64.55 108.864 173.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 41.2 tp -98.92 133.45 43.19 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.542 -0.54 . . . . 71.11 109.542 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.3 t0 -153.52 155.8 36.89 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.734 -1.209 . . . . 55.24 107.734 174.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.652 HG23 ' HB2' ' H' ' 456' ' ' ASP . 13.7 t -145.96 169.27 18.96 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 122.909 0.484 . . . . 74.23 110.116 -177.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.588 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.05 166.56 33.11 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.711 1.204 . . . . 74.42 108.521 173.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.412 ' HB2' ' CE2' ' D' ' 56' ' ' TYR . 64.9 p -173.25 153.24 2.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.885 0.474 . . . . 64.45 111.058 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 45.5 p -168.78 143.29 3.18 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.317 1.047 . . . . 73.43 109.654 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -83.8 125.25 31.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.137 0.575 . . . . 72.4 110.333 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.0 mt -96.13 -35.36 11.36 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.266 0.626 . . . . 72.12 111.298 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -155.12 -177.21 6.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.064 0.545 . . . . 61.03 110.71 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.37 120.25 8.41 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 123.91 0.756 . . . . 72.25 109.914 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.54 3.52 1.5 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.114 1.366 . . . . 75.41 112.521 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 92.6 t -109.78 119.45 58.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.141 -1.059 . . . . 72.33 108.141 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' D' ' 48' ' ' SER . 28.6 t80 -134.41 131.24 37.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.407 -0.815 . . . . 75.34 108.969 -173.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.451 ' HB2' HD11 ' D' ' 51' ' ' LEU . 17.3 tt0 -96.64 132.26 42.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.625 -0.716 . . . . 54.23 109.189 173.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.428 HG11 ' HD3' ' D' ' 103' ' ' PRO . 64.0 t -116.6 125.46 73.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.225 -1.398 . . . . 74.32 107.225 167.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 44.1 t -102.64 138.54 26.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.862 -0.792 . . . . 71.42 108.862 172.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.2 127.23 54.05 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.619 -1.252 . . . . 72.43 107.619 170.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.529 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 3.9 tmm_? -111.42 95.95 5.82 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.831 -1.174 . . . . 75.31 107.831 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 65.7 t -96.51 132.83 39.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.006 -0.997 . . . . 64.1 108.967 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 16.7 m -127.39 133.91 49.97 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.283 0.563 . . . . 74.14 109.502 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.02 102.41 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.534 1.533 . . . . 72.34 107.999 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 42.1 m -105.32 98.37 8.08 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.851 0.86 . . . . 60.43 109.448 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -104.72 149.86 25.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.856 0.462 . . . . 70.44 111.033 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.45 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 53.3 p -147.5 134.5 20.3 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.604 -0.725 . . . . 55.22 110.556 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.555 HD12 HG22 ' D' ' 31' ' ' VAL . 27.3 mt -98.76 110.94 23.46 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.308 -0.997 . . . . 72.22 108.308 174.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.76 -112.66 4.37 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 123.634 0.584 . . . . 73.25 112.812 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.94 16.8 16.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.407 1.083 . . . . 73.14 110.409 -172.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -141.22 155.33 46.05 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.466 0.706 . . . . 54.24 109.366 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -68.06 138.3 55.7 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 120.949 0.404 . . . . 64.33 110.527 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.743 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.96 -68.84 0.76 Allowed 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.535 -0.913 . . . . 62.11 108.535 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 74' ' ' PHE . . . . . 0.469 ' HZ ' HD13 ' D' ' 126' ' ' LEU . 50.2 p90 -152.96 149.24 28.0 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.61 -0.723 . . . . 73.22 110.252 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.6 mt -119.05 119.45 34.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.333 1.053 . . . . 73.52 108.234 175.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.449 ' SG ' ' HD1' ' D' ' 23' ' ' PHE . 1.3 m -121.9 104.92 9.89 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.167 0.987 . . . . 53.01 109.692 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -127.19 120.8 29.63 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.407 -0.96 . . . . 60.42 108.407 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -131.88 126.34 56.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 109.616 -0.512 . . . . 43.1 109.616 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.529 ' HG2' ' HG2' ' D' ' 61' ' ' ARG . 52.1 mt-30 -88.41 81.5 7.2 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.15 -1.056 . . . . 73.44 108.15 168.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.56 92.4 5.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.316 -1.311 . . . . 64.13 109.194 -178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.89 147.17 20.24 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.843 -0.617 . . . . 52.23 112.18 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.512 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.2 129.29 3.84 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 111.321 -0.712 . . . . 41.42 111.321 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.455 HG13 ' HE1' ' D' ' 17' ' ' TYR . 48.2 mt -93.78 140.47 16.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.066 0.946 . . . . 73.14 108.55 173.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -139.86 132.03 28.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.541 0.736 . . . . 72.21 109.018 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.6 m -87.5 94.91 9.84 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.633 -0.877 . . . . 72.23 108.633 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.604 HG23 HG11 ' H' ' 452' ' ' VAL . 2.3 tt -126.68 139.31 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 124.56 1.144 . . . . 75.3 110.103 -173.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.93 168.39 26.9 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.525 0.73 . . . . 70.34 111.752 -173.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.1 22.37 65.8 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 115.397 -0.819 . . . . 31.52 113.9 174.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.82 144.03 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.006 0.923 . . . . 55.31 110.665 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -142.64 161.88 36.93 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.856 0.862 . . . . 73.13 111.385 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.41 -122.39 29.67 Favored Glycine 0 C--N 1.355 1.597 0 O-C-N 124.606 1.191 . . . . 74.44 115.075 169.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.1 p -67.64 -26.18 66.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.807 0.843 . . . . 74.32 111.443 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -80.76 -38.68 28.18 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.193 0.597 . . . . 61.43 111.667 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 28.0 ptm -68.19 -34.61 76.6 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.471 -0.566 . . . . 74.42 109.471 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.74 -45.77 85.06 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.108 0.563 . . . . 64.22 110.245 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 11.4 t-80 -60.35 -44.51 95.49 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.655 1.182 . . . . 75.33 111.658 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 97' ' ' CYS . . . . . 0.411 ' SG ' HD12 ' D' ' 86' ' ' ILE . 16.2 t -76.14 -45.09 35.31 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.862 -173.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.61 -33.28 28.0 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.335 0.495 . . . . 72.15 112.335 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.21 -0.04 54.26 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 119.542 -0.588 . . . . 75.14 113.994 -173.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.447 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -141.99 -61.11 0.46 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.45 0.625 . . . . 74.24 111.429 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 101' ' ' TYR . . . . . 0.45 ' O ' HG12 ' D' ' 105' ' ' ILE . 72.6 t80 -66.21 -41.03 90.69 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.879 0.472 . . . . 71.1 112.202 -174.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.44 -45.87 19.24 Favored Pre-proline 0 CA--C 1.559 1.31 0 CA-C-O 118.277 -0.868 . . . . 53.3 111.091 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HD3' HG11 ' D' ' 58' ' ' VAL . 86.5 Cg_exo -53.27 -33.74 66.78 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 122.358 2.039 . . . . 52.11 113.438 166.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -35.29 79.18 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.441 0.697 . . . . 64.11 110.038 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.45 HG12 ' O ' ' D' ' 101' ' ' TYR . 40.7 mm -70.34 -36.15 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.092 0.957 . . . . 75.32 110.733 174.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.512 HD21 ' HA3' ' D' ' 82' ' ' GLY . 96.5 mt -78.73 -21.09 48.58 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.851 0.86 . . . . 75.52 112.276 -176.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -66.77 -42.4 43.98 Favored Pre-proline 0 CA--C 1.562 1.414 0 CA-C-O 117.939 -1.029 . . . . 73.45 113.515 -172.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.44 -39.41 87.79 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 122.163 1.909 . . . . 73.41 113.133 170.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -74.8 -36.74 62.46 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.721 0.808 . . . . 71.44 111.872 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.85 73.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.222 -0.658 . . . . 73.04 109.222 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.431 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.6 ttp180 -57.47 -45.14 85.14 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 114.17 -1.377 . . . . 74.43 110.668 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.93 -51.76 62.94 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.944 0.778 . . . . 75.33 111.652 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -55.62 -40.71 72.49 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 123.822 0.701 . . . . 71.33 110.591 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.448 ' O ' HG23 ' D' ' 118' ' ' VAL . 54.9 mt -64.36 -53.5 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.836 1.254 . . . . 65.31 111.407 174.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.9 m -59.08 -36.77 75.66 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.356 1.062 . . . . 71.11 111.037 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -65.78 -44.32 86.14 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.885 -1.052 . . . . 74.23 109.842 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 66.0 mtm -69.34 -29.84 67.75 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.825 0.45 . . . . 75.52 111.9 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' D' ' 123' ' ' PHE . 76.0 t -64.36 -47.85 87.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.585 0.754 . . . . 72.33 110.049 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.5 p -69.71 -34.24 73.62 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.081 -0.509 . . . . 75.21 110.71 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -68.72 -33.05 73.28 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.637 0.775 . . . . 53.02 110.293 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.98 11.04 73.34 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.67 0.606 . . . . 74.05 112.636 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 63.9 p 57.33 32.16 21.31 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 126.044 1.738 . . . . 73.53 114.53 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.468 ' HB2' HG13 ' D' ' 118' ' ' VAL . 98.5 m-85 -95.89 150.8 37.8 Favored Pre-proline 0 N--CA 1.478 0.941 0 N-CA-C 108.323 -0.991 . . . . 64.41 108.323 168.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -59.94 147.37 93.03 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.659 2.239 . . . . 54.22 111.375 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -60.25 142.12 55.04 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 124.05 0.844 . . . . 73.54 112.794 -166.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.469 HD13 ' HZ ' ' D' ' 74' ' ' PHE . 0.8 OUTLIER -122.81 104.73 9.47 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.4 1.08 . . . . 64.13 109.263 -175.44 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -124.3 95.06 4.4 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.698 0.799 . . . . 71.35 109.665 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.35 139.38 54.21 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.803 -0.443 . . . . 62.41 109.803 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.73 136.94 93.04 Favored Pre-proline 0 CA--C 1.549 0.936 0 O-C-N 123.815 0.697 . . . . 45.22 109.669 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -68.09 133.01 27.59 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.271 1.981 . . . . 72.43 110.244 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.88 131.94 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.251 -0.648 . . . . 75.01 109.251 -170.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -77.64 89.81 3.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.745 -0.835 . . . . 54.31 108.745 172.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -64.01 -28.71 69.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.653 0.781 . . . . 63.53 111.297 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.447 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 2.0 m-20 -56.83 -55.88 28.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.295 1.438 . . . . 65.44 112.966 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.95 -47.23 87.39 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.279 0.632 . . . . 72.34 111.446 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 mp -66.31 -29.16 69.32 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.86 -1.064 . . . . 54.1 111.36 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.419 ' HD1' ' HE1' ' H' ' 461' ' ' PHE . 85.4 t80 -67.48 -38.99 85.21 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.038 0.935 . . . . 72.31 111.265 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 38.1 mtt -63.24 -37.41 87.13 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.621 -0.718 . . . . 72.35 110.112 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -65.31 -44.22 88.55 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.959 -1.019 . . . . 74.15 110.429 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -62.87 -36.33 82.92 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.136 0.975 . . . . 71.42 111.937 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.4 mp -67.41 -27.4 67.05 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.423 0.689 . . . . 72.13 111.644 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -84.0 9.63 11.91 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.357 0.663 . . . . 62.4 111.388 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -129.99 46.11 2.7 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.07 0.948 . . . . 74.24 109.943 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -162.42 121.53 2.27 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.565 0.746 . . . . 74.23 109.913 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.32 173.06 6.96 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.262 1.025 . . . . 51.4 110.233 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.67 122.57 0.92 Allowed Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.249 -0.741 . . . . 74.13 111.249 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -81.81 166.66 19.8 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.642 0.777 . . . . 75.51 110.659 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.8 159.24 52.6 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 115.939 -0.573 . . . . 53.11 113.431 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 41.3 m -112.04 98.72 7.54 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.963 0.905 . . . . 62.22 109.501 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.12 177.58 4.81 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.5 0.72 . . . . 53.01 110.318 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -135.05 170.6 15.66 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.264 1.026 . . . . 73.34 109.548 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -157.47 116.08 3.21 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.308 0.643 . . . . 74.33 109.781 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -75.38 105.68 6.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.19 0.596 . . . . 72.34 109.424 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.7 133.0 38.84 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.778 -0.823 . . . . 74.21 108.778 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.398 0 N-CA-C 109.033 -0.728 . . . . 50.12 109.033 177.783 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 450' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 53' ' ' ASP . 47.6 t30 . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.996 -0.372 . . . . 73.11 109.996 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 451' ' ' VAL . . . . . 0.504 HG12 ' HB3' ' C' ' 155' ' ' ALA . 10.2 m -77.36 -26.44 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.37 0.605 . . . . 71.13 109.492 172.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 10.9 p -143.03 164.52 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 124.572 1.149 . . . . 74.12 108.722 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -144.41 151.42 23.47 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 111.261 -0.736 . . . . 62.41 111.261 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 67.6 mt -85.52 13.37 6.95 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.803 0.841 . . . . 63.54 113.159 -172.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 41.5 p -77.86 72.22 4.38 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 121.351 0.596 . . . . 72.44 110.701 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -170.12 157.27 6.34 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.893 1.277 . . . . 43.33 108.278 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 16.1 mp0 -97.96 149.71 22.13 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.241 0.616 . . . . 74.44 109.96 -173.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 59.1 m -123.06 -64.19 1.19 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.466 0.706 . . . . 64.35 110.209 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 30.1 t70 63.17 163.15 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.824 1.25 . . . . 75.22 112.422 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 460' ' ' LEU . . . . . 0.627 HD21 ' H ' ' A' ' 46' ' ' THR . 3.8 mm? -88.72 128.45 35.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.482 0.713 . . . . 73.41 110.099 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -123.85 16.17 9.38 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.704 1.202 . . . . 70.54 110.349 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -76.2 143.47 41.05 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.252 0.621 . . . . 75.41 110.001 -176.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 24.6 m -84.5 -75.31 0.35 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.806 -0.813 . . . . 63.13 108.806 174.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.19 113.27 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.528 1.531 . . . . 73.32 112.353 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -152.43 85.47 1.26 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.439 -0.949 . . . . 72.02 108.439 173.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -151.23 106.7 3.35 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.486 -0.779 . . . . 63.01 109.527 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -75.93 172.78 12.13 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.401 0.681 . . . . 74.52 110.496 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 3.1 pp -151.98 166.04 32.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.143 0.577 . . . . 71.51 110.656 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -120.55 154.65 16.39 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.757 -0.656 . . . . 34.23 111.762 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -96.44 142.29 28.72 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.516 1.126 . . . . 75.12 109.101 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 471' ' ' LYS . . . . . 0.407 ' HG3' HH12 ' C' ' 15' ' ' ARG . 54.5 tptt . . . . . 0 CA--C 1.558 1.264 0 N-CA-C 108.223 -1.028 . . . . 75.51 108.223 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 450' ' ' ASN . . . . . 0.509 ' N ' HD21 ' F' ' 450' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.608 0.242 . . . . 74.53 111.484 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 451' ' ' VAL . . . . . 0.527 HG12 HG23 ' F' ' 452' ' ' VAL . 46.9 t -73.61 144.8 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.609 0.764 . . . . 75.31 109.371 176.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 452' ' ' VAL . . . . . 0.527 HG23 HG12 ' F' ' 451' ' ' VAL . 92.4 t 72.68 142.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 125.068 1.347 . . . . 70.5 111.986 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -146.65 36.43 1.25 Allowed Glycine 0 C--N 1.342 0.902 0 N-CA-C 110.764 -0.934 . . . . 32.43 110.764 172.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 36.3 tp -92.11 140.98 29.1 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.335 0.654 . . . . 71.51 111.277 -173.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 25.6 p -100.41 -65.83 0.94 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.123 0.969 . . . . 63.15 110.144 172.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -163.06 5.13 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.326 0.65 . . . . 74.22 111.699 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -63.62 -28.74 70.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.119 0.968 . . . . 74.04 113.212 -167.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 10.9 p -61.17 120.21 9.89 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.665 0.786 . . . . 71.42 111.823 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 459' ' ' ASP . . . . . 0.407 ' HB2' ' OH ' ' B' ' 140' ' ' TYR . 17.5 m-20 -85.74 136.62 33.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.38 0.672 . . . . 74.2 109.202 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 37.9 tp -99.99 123.12 43.88 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.694 -0.484 . . . . 55.15 109.694 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -51.89 -58.22 7.11 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.754 1.622 . . . . 65.41 111.888 176.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 462' ' ' TYR . . . . . 0.433 ' CD2' ' HB2' ' B' ' 44' ' ' LEU . 1.0 OUTLIER 42.04 -141.52 0.11 Allowed 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 125.723 1.609 . . . . 70.21 111.596 -178.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 3.4 m 58.18 43.06 21.09 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.36 1.064 . . . . 71.24 111.768 166.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.8 151.74 40.49 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.781 0.832 . . . . 72.15 111.14 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.54 -37.67 81.98 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.045 0.938 . . . . 64.53 112.015 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -81.49 85.41 6.5 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.459 -0.941 . . . . 61.32 108.459 172.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -70.08 -42.5 72.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.193 0.597 . . . . 54.34 110.784 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 468' ' ' LEU . . . . . 0.624 HD11 ' HG ' ' B' ' 126' ' ' LEU . 5.0 tt -167.73 -59.1 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.095 -1.076 . . . . 64.35 108.095 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 87.82 57.66 1.91 Allowed Glycine 0 C--N 1.348 1.206 0 N-CA-C 110.555 -1.018 . . . . 61.12 110.555 -169.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 470' ' ' LEU . . . . . 0.595 ' H ' HD23 ' F' ' 470' ' ' LEU . 1.5 pt? -97.68 -8.08 29.51 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.02 0.928 . . . . 63.31 111.268 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? . . . . . 0 C--O 1.249 1.076 0 C-N-CA 124.043 0.937 . . . . 74.21 109.511 175.408 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.112 -0.699 . . . . 71.23 109.112 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 85.9 t 70.49 -71.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 124.948 1.299 . . . . 71.1 111.227 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 452' ' ' VAL . . . . . 0.685 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 27.5 m -83.59 158.25 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.181 0.992 . . . . 72.23 111.733 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 140.95 68.33 0.03 OUTLIER Glycine 0 C--N 1.347 1.15 0 N-CA-C 111.702 -0.559 . . . . 74.54 111.702 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 6.8 tt -78.53 -48.45 15.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.403 0.681 . . . . 75.44 110.738 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 11.4 m -56.9 93.05 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 O-C-N 124.293 0.996 . . . . 63.22 112.448 -167.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 29.1 t70 177.51 131.23 0.06 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.572 1.949 . . . . 73.14 106.903 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 59.96 -156.29 0.34 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.807 0.843 . . . . 74.5 110.187 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 458' ' ' THR . . . . . 0.447 ' HA ' ' OH ' ' C' ' 140' ' ' TYR . 34.6 m 76.43 126.82 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.952 1.301 . . . . 75.43 112.205 170.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.82 147.12 42.4 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.865 0.866 . . . . 53.43 109.335 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 460' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' C' ' 45' ' ' ASP . 0.1 OUTLIER -82.59 140.24 33.34 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.043 -1.095 . . . . 63.13 108.043 173.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 461' ' ' PHE . . . . . 0.416 ' H ' HD13 ' G' ' 460' ' ' LEU . 32.2 p90 -133.03 175.65 9.19 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.305 1.042 . . . . 75.12 110.231 -173.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 7.4 t80 73.2 107.74 0.07 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.305 1.442 . . . . 74.53 111.515 171.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 86.2 m -89.59 -71.22 0.62 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.433 0.693 . . . . 63.3 110.133 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 39.0 ttp 69.0 153.76 0.11 Allowed 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.059 1.344 . . . . 64.54 112.171 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -159.86 5.44 0.09 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.8 0.84 . . . . 75.32 111.003 168.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -75.95 80.04 2.83 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.186 0.594 . . . . 63.55 109.649 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 467' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' C' ' 129' ' ' ALA . . . -161.46 157.15 24.62 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.272 -0.877 . . . . 74.14 110.425 -176.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 468' ' ' LEU . . . . . 0.518 HD21 ' H ' ' C' ' 127' ' ' ASN . 79.1 mt 70.26 161.22 0.22 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.269 1.428 . . . . 54.43 113.108 170.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -90.19 46.9 3.08 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-N 115.139 -0.937 . . . . 54.23 111.312 171.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 470' ' ' LEU . . . . . 0.58 HD21 ' HD2' ' C' ' 38' ' ' PRO . 6.2 tt -138.95 -69.15 0.43 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.406 -1.331 . . . . 61.14 107.406 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 58.2 mttp . . . . . 0 CA--C 1.562 1.405 0 O-C-N 124.671 1.232 . . . . 74.32 110.92 -177.351 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 108.801 -0.814 . . . . 71.21 108.801 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 13.6 p -70.42 -28.46 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.72 0.771 . . . . 71.31 109.711 172.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 452' ' ' VAL . . . . . 0.604 HG11 HG23 ' D' ' 86' ' ' ILE . 11.9 m -134.91 124.95 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.718 1.207 . . . . 74.43 109.374 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 159.74 116.78 0.45 Allowed Glycine 0 C--N 1.349 1.254 0 CA-C-O 119.662 -0.521 . . . . 74.25 112.409 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.86 158.43 36.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.474 0.71 . . . . 63.1 109.935 173.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 22.8 m -85.24 137.9 32.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.226 0.611 . . . . 51.2 109.592 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 456' ' ' ASP . . . . . 0.652 ' HB2' HG23 ' D' ' 46' ' ' THR . 5.0 p-10 -98.67 149.86 22.37 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.362 1.065 . . . . 52.14 110.391 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -131.8 155.29 48.01 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.741 0.816 . . . . 71.14 109.565 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 68.6 p -73.22 -59.38 2.73 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.285 0.634 . . . . 72.32 110.887 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -85.83 88.07 7.5 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.705 0.802 . . . . 72.32 110.142 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 94.5 mt -90.48 -66.32 0.94 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.709 -0.678 . . . . 73.25 110.129 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 461' ' ' PHE . . . . . 0.419 ' HE1' ' HD1' ' D' ' 137' ' ' PHE . 13.3 p90 -171.11 146.25 2.38 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.195 0.998 . . . . 74.33 109.624 -171.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -167.6 87.98 0.27 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.906 0.384 . . . . 73.23 110.512 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 9.0 t -113.04 105.33 13.34 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 107.711 -1.218 . . . . 72.41 107.711 166.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 464' ' ' MET . . . . . 0.526 ' HG3' ' HB2' ' H' ' 467' ' ' ALA . 14.4 tpt -110.47 124.69 52.25 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.45 -0.796 . . . . 63.02 109.707 -169.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -133.12 145.83 51.05 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.07 -1.085 . . . . 52.53 108.07 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . 63.4 40.26 8.58 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.262 1.025 . . . . 45.24 110.131 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 467' ' ' ALA . . . . . 0.526 ' HB2' ' HG3' ' H' ' 464' ' ' MET . . . -77.84 -164.6 0.53 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.723 -1.126 . . . . 53.44 110.365 175.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 468' ' ' LEU . . . . . 0.478 HD12 HG11 ' D' ' 40' ' ' VAL . 94.7 mt -68.23 -56.83 7.28 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.585 -0.524 . . . . 54.32 109.585 171.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 54.91 32.07 55.55 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 124.119 0.887 . . . . 64.21 113.22 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 470' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' D' ' 37' ' ' GLN . 2.3 pp -76.04 -30.92 58.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.558 0.743 . . . . 64.4 111.802 -168.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 471' ' ' LYS . . . . . 0.456 ' NZ ' ' HB3' ' H' ' 471' ' ' LYS . 2.6 ttpm? . . . . . 0 CA--C 1.569 1.679 0 C-N-CA 124.681 1.192 . . . . 64.33 112.07 171.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptp . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 109.861 -0.422 . . . . 63.53 109.861 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 p -164.17 92.78 0.67 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.411 1.085 . . . . 43.31 108.498 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -82.22 163.45 21.87 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.785 0.834 . . . . 65.34 111.17 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 64.04 -179.39 0.16 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.885 1.274 . . . . 73.3 112.336 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -70.05 170.36 11.55 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.593 -0.521 . . . . 72.24 109.593 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 73.08 82.72 0.13 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.349 1.06 . . . . 74.54 108.67 -171.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -99.2 158.57 15.6 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.087 0.955 . . . . 62.24 110.335 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 54.53 -84.93 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.707 1.203 . . . . 74.25 111.464 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -69.66 150.25 47.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.734 0.813 . . . . 74.3 110.208 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 90.9 m -145.65 131.29 18.89 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.893 0.877 . . . . 75.01 109.21 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.586 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.3 t80 -137.44 135.14 36.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.804 -0.813 . . . . 75.42 108.804 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -150.08 117.46 6.08 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.084 -1.08 . . . . 52.32 108.084 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.455 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.6 mt -80.87 118.24 28.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.813 -0.81 . . . . 71.51 108.813 175.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.9 -40.54 31.96 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.851 -0.796 . . . . 64.01 108.851 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -169.47 145.96 3.32 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.48 -0.327 . . . . 73.22 110.845 -176.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.536 HD12 ' HG3' ' C' ' 130' ' ' PRO . 84.4 mt -129.55 136.25 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 124.303 1.041 . . . . 73.15 108.726 172.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -169.53 177.81 4.45 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.017 0.927 . . . . 74.34 111.029 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -99.66 123.62 44.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.316 -0.624 . . . . 61.23 109.316 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -84.27 -28.86 26.89 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 110.011 -0.366 . . . . 74.21 110.011 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -152.75 146.27 24.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.502 -0.772 . . . . 74.5 109.692 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.06 142.44 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.391 1.476 . . . . 55.44 107.045 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -149.89 144.29 25.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.047 0.451 . . . . 75.11 110.181 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.58 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 92.7 t80 -150.21 129.42 12.79 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.888 -1.523 . . . . 62.54 106.888 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.62 127.83 39.76 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.608 0.763 . . . . 64.21 109.247 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.496 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -132.36 79.81 64.76 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 107.156 -1.424 . . . . 73.41 107.156 171.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.25 -16.6 24.89 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.485 2.123 . . . . 70.41 111.364 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -107.44 13.89 26.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.699 1.199 . . . . 75.41 109.533 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.496 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -57.18 -45.71 99.9 Favored Pre-proline 0 CA--C 1.569 1.685 0 N-CA-C 114.258 1.207 . . . . 72.24 114.258 -170.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.62 -24.12 18.95 Favored 'Trans proline' 0 C--N 1.388 2.624 0 C-N-CA 121.818 1.679 . . . . 70.42 113.243 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -91.21 -21.88 20.9 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.62 0.768 . . . . 75.11 112.031 -171.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.465 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 12.0 p -69.77 -28.57 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.646 0.779 . . . . 72.05 111.722 -175.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -68.12 -36.21 79.36 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.828 0.851 . . . . 72.15 110.761 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -77.26 -46.45 23.06 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.328 -0.851 . . . . 74.33 111.346 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.603 ' NZ ' ' HG3' ' A' ' 71' ' ' GLU . 64.9 pttt -76.26 164.64 25.86 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.563 0.345 . . . . 74.23 110.165 176.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.98 141.21 36.19 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.869 0.467 . . . . 70.43 110.223 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -79.13 99.31 6.91 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.485 0.714 . . . . 65.42 109.593 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 35.6 tt0 -149.97 67.05 8.32 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.1 -0.704 . . . . 65.23 109.1 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.62 158.98 9.24 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.711 2.274 . . . . 65.41 113.162 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -94.67 99.68 11.75 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.194 -1.41 . . . . 71.41 107.194 170.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.428 HG11 HD12 ' E' ' 468' ' ' LEU . 18.4 m -78.06 93.72 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 114.576 -1.193 . . . . 65.33 110.816 -173.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 56.2 mttm -91.17 113.41 25.67 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.477 -1.238 . . . . 52.32 108.41 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.623 HD23 ' SD ' ' E' ' 464' ' ' MET . 58.7 tp -116.67 119.01 34.15 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.145 -0.687 . . . . 71.34 109.145 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -130.06 151.05 51.02 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.64 0.776 . . . . 72.34 109.302 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.62 HD23 HG22 ' A' ' 62' ' ' VAL . 3.0 tm? -132.26 141.1 48.88 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.707 0.803 . . . . 64.41 109.208 -173.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.416 ' H ' HD22 ' A' ' 44' ' ' LEU . 32.3 t70 -135.47 119.71 17.78 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.264 1.026 . . . . 62.53 109.145 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.501 ' H ' HD21 ' E' ' 460' ' ' LEU . 67.2 m -111.72 130.17 55.87 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.126 0.97 . . . . 74.5 109.122 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.93 152.47 51.06 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.512 -0.921 . . . . 62.11 108.512 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.2 t -125.78 152.07 45.89 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.651 -0.5 . . . . 74.42 109.651 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 t -150.65 133.12 15.61 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.921 0.889 . . . . 61.33 109.084 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -77.85 131.45 37.54 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.501 -0.555 . . . . 73.34 109.501 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.437 HD12 HG23 ' A' ' 83' ' ' ILE . 70.8 mt -107.12 -41.98 5.0 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.865 0.866 . . . . 74.21 109.705 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.87 -175.01 4.64 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.678 -1.146 . . . . 74.21 109.272 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.69 114.11 3.11 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.427 0.691 . . . . 65.25 110.457 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.75 12.67 7.84 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.414 1.086 . . . . 74.24 112.105 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.1 t -101.68 112.56 35.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 124.909 1.284 . . . . 71.5 107.92 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -125.17 126.7 45.66 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.718 0.807 . . . . 71.02 109.292 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -101.94 126.91 48.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.74 -1.118 . . . . 75.11 108.477 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 m -100.89 133.33 44.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.99 -1.115 . . . . 73.05 107.99 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.62 110.68 26.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 107.972 -1.122 . . . . 63.14 107.972 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.0 tp -90.51 98.41 11.76 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.042 -0.725 . . . . 73.54 109.042 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.8 ttp85 -95.81 100.87 12.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.635 0.774 . . . . 64.22 109.712 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.62 HG22 HD23 ' A' ' 44' ' ' LEU . 12.3 t -97.15 117.29 41.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.219 -1.03 . . . . 75.04 108.219 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.0 t -107.55 141.89 38.29 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.734 0.778 . . . . 53.41 109.936 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 59.0 t -131.29 109.34 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.755 1.622 . . . . 41.32 107.641 -173.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 26.7 m -110.65 107.73 17.41 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.793 -0.818 . . . . 54.55 108.793 175.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.63 104.69 14.05 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 106.996 -1.483 . . . . 72.33 106.996 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.8 p -149.56 127.79 12.08 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.691 0.396 . . . . 74.3 110.569 -172.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -90.12 84.55 6.13 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.886 -0.783 . . . . 73.42 108.886 177.247 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.38 -104.8 1.81 Allowed Glycine 0 C--N 1.35 1.307 0 CA-C-N 115.065 -0.97 . . . . 61.54 112.283 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -97.28 -5.23 37.19 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.587 0.755 . . . . 74.45 110.314 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.603 ' HG3' ' NZ ' ' A' ' 34' ' ' LYS . 36.1 tp10 -112.22 94.65 5.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.606 1.162 . . . . 64.34 108.97 -169.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -71.45 138.41 49.0 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.424 0.289 . . . . 65.31 111.273 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.28 -59.45 2.25 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.944 0.898 . . . . 43.42 108.943 173.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -157.41 174.9 14.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.306 -0.861 . . . . 62.42 111.324 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -140.55 138.82 34.79 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.176 1.39 . . . . 75.25 107.896 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.493 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.9 m -141.28 139.51 33.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.96 0.904 . . . . 61.45 109.064 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -150.74 122.5 8.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.206 0.457 . . . . 44.54 109.826 174.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.3 t -122.35 132.85 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 123.875 0.87 . . . . 72.14 109.592 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -109.01 86.75 2.34 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.357 1.063 . . . . 74.03 108.293 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -79.09 103.18 8.85 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.96 -1.018 . . . . 71.14 108.462 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.39 142.84 16.38 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 111.368 -0.693 . . . . 65.33 111.368 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.546 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -140.61 123.51 2.38 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 111.142 -0.783 . . . . 30.21 111.142 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.437 HG23 HD12 ' A' ' 51' ' ' LEU . 44.1 mt -80.69 118.45 28.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.838 -0.801 . . . . 75.34 108.838 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.586 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 42.1 m-85 -125.22 119.35 28.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.887 0.475 . . . . 74.02 109.901 -176.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 m -86.82 105.0 16.71 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.845 -0.798 . . . . 63.4 108.845 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.554 ' HB ' HD11 ' A' ' 89' ' ' ILE . 43.5 pt -107.23 143.92 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.434 0.694 . . . . 73.4 110.75 -175.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.595 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -156.84 156.51 33.31 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.973 0.909 . . . . 74.32 109.778 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.419 ' H ' HG11 ' E' ' 451' ' ' VAL . . . 78.0 7.04 87.63 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.897 0.719 . . . . 71.24 114.897 173.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.554 HD11 ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -122.31 156.21 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 108.686 -0.857 . . . . 54.22 108.686 172.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -157.61 173.95 16.09 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.242 0.617 . . . . 63.11 109.359 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.46 -136.64 47.38 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.514 0.509 . . . . 64.32 114.153 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -80.71 -16.14 54.69 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.537 0.735 . . . . 74.51 111.215 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' A' ' 96' ' ' HIS . 35.4 tt0 -67.64 -36.45 80.8 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.002 0.921 . . . . 52.25 109.598 171.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 34.2 ttp -76.83 -33.23 57.94 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.905 -1.043 . . . . 73.44 110.922 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -28.31 69.19 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.034 0.445 . . . . 71.54 110.583 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.409 ' HB3' ' O ' ' A' ' 93' ' ' GLN . 50.3 t-80 -64.57 -37.02 86.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.355 -0.839 . . . . 73.44 110.526 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 64.1 m -64.75 -35.74 82.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 122.871 0.469 . . . . 75.04 110.87 177.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.42 HD12 HD11 ' E' ' 454' ' ' LEU . 6.8 tt -72.96 -49.92 26.4 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.088 0.555 . . . . 71.23 109.983 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.15 4.8 52.28 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 115.059 0.784 . . . . 73.34 115.059 -165.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -145.57 -65.95 0.31 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.188 0.994 . . . . 62.3 112.201 -175.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.565 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 69.0 t80 -69.33 -66.6 0.56 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.927 -1.033 . . . . 62.41 113.402 -166.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.451 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 85.8 m -67.6 -35.06 7.46 Favored Pre-proline 0 CA--C 1.566 1.571 0 N-CA-C 114.079 1.14 . . . . 64.3 114.079 -174.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 27.9 Cg_endo -62.76 -30.15 77.76 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 122.015 1.81 . . . . 65.21 112.91 168.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -71.72 -27.86 63.3 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.091 0.556 . . . . 75.12 110.982 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.6 mm -59.31 -41.96 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-O 121.441 0.639 . . . . 74.13 109.872 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.546 HD21 ' HA3' ' A' ' 82' ' ' GLY . 84.1 mt -83.34 -16.24 46.89 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.035 -0.984 . . . . 73.13 112.581 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.79 -43.53 69.63 Favored Pre-proline 0 CA--C 1.561 1.366 0 N-CA-C 113.819 1.044 . . . . 74.12 113.819 -172.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -59.6 -37.55 87.65 Favored 'Trans proline' 0 C--N 1.387 2.574 0 CA-C-N 121.745 1.659 . . . . 64.24 112.7 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -69.89 -43.03 72.6 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.579 -0.737 . . . . 74.32 111.284 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.23 -39.24 82.37 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.13 0.572 . . . . 55.02 110.573 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.546 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.8 ttm180 -49.75 -55.1 15.23 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.645 1.215 . . . . 61.4 109.887 174.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -66.64 -44.09 82.9 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.055 -0.975 . . . . 71.5 111.569 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.1 t -60.43 -26.17 66.52 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.09 0.556 . . . . 63.12 111.844 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' A' ' 62' ' ' VAL . 95.6 mt -83.25 -52.23 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.75 0.82 . . . . 75.34 109.759 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.4 m -54.88 -50.88 67.62 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.818 0.847 . . . . 45.24 111.631 -173.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 47.1 t -59.6 -45.18 92.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.745 -1.116 . . . . 44.21 110.441 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 45.6 ttp -68.66 -35.05 76.72 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.073 0.949 . . . . 74.24 111.695 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.66 -41.26 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.096 0.958 . . . . 74.32 109.785 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.7 m -72.56 -24.41 61.11 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.334 -0.848 . . . . 70.12 111.467 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.45 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.8 mtt-85 -73.76 -30.95 63.07 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.521 0.729 . . . . 63.32 109.665 174.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.06 -1.64 80.28 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.658 -0.701 . . . . 41.01 112.637 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.8 m 69.16 21.0 7.4 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 125.161 1.384 . . . . 71.32 111.223 175.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.15 158.71 69.37 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 115.274 -0.875 . . . . 71.34 109.335 170.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.55 144.97 91.06 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.277 1.985 . . . . 72.02 111.54 173.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -59.35 134.53 57.09 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.621 0.768 . . . . 75.23 111.92 -173.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -117.32 102.46 9.27 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.211 -0.904 . . . . 70.42 109.803 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -102.03 108.04 19.35 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.12 -1.067 . . . . 73.14 108.12 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.16 117.34 10.68 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.066 -0.716 . . . . 64.41 109.066 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.33 139.14 96.39 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 122.841 0.456 . . . . 51.21 110.883 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -53.04 106.66 0.16 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.04 2.494 . . . . 74.13 111.877 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.46 133.06 42.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.578 0.704 . . . . 65.24 109.293 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -82.04 71.93 9.09 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.462 -1.245 . . . . 60.2 112.126 -170.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.509 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 35.2 m-85 -53.68 -41.05 66.47 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.612 0.765 . . . . 70.33 111.582 177.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 138' ' ' MET . 7.0 m-20 -68.85 -42.05 77.63 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.007 -0.997 . . . . 63.01 111.401 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.02 81.09 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.073 0.549 . . . . 62.53 110.981 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.53 -38.41 80.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.738 -1.119 . . . . 74.41 110.511 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.453 ' HE2' HD13 ' A' ' 141' ' ' LEU . 56.3 t80 -73.82 -37.64 64.81 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.539 -0.755 . . . . 65.44 110.347 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.48 ' SD ' HD23 ' A' ' 141' ' ' LEU . 20.1 mmt -61.26 -33.52 73.67 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.357 0.663 . . . . 74.55 111.551 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -54.35 -45.9 72.83 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.09 0.956 . . . . 63.4 110.575 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -77.36 -37.45 52.19 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.108 -0.951 . . . . 74.03 110.983 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.48 HD23 ' SD ' ' A' ' 138' ' ' MET . 32.7 tp -65.87 -49.68 67.24 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.871 0.868 . . . . 64.4 111.564 -168.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' C' ' 153' ' ' GLN . 35.5 tt0 -168.89 25.38 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 O-C-N 123.92 0.762 . . . . 71.42 109.646 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 71.53 -64.89 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.426 1.49 . . . . 54.15 111.861 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -139.43 132.79 30.05 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.497 1.119 . . . . 74.14 109.323 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' C' ' 152' ' ' HIS . . . -165.23 107.14 0.8 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.665 0.786 . . . . 74.21 110.046 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -174.37 -172.32 39.42 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.114 -0.394 . . . . 74.23 112.114 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.729 ' HG2' ' HA ' ' C' ' 149' ' ' THR . 10.5 tp10 -161.3 156.17 23.6 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.151 0.98 . . . . 71.22 109.857 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.89 151.46 39.15 Favored Glycine 0 C--N 1.353 1.483 0 N-CA-C 112.262 -0.335 . . . . 62.51 112.262 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.7 p -85.64 148.84 25.71 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.707 0.803 . . . . 74.01 110.676 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -68.05 130.25 42.37 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.386 0.674 . . . . 74.54 110.175 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -117.97 119.88 36.15 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.859 0.864 . . . . 75.42 111.229 -174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -151.09 90.6 1.62 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.03 1.332 . . . . 63.01 107.872 168.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -81.15 69.47 7.76 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 108.675 -0.861 . . . . 72.14 108.675 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.465 ' H ' HD11 ' C' ' 141' ' ' LEU . 25.2 t70 -83.06 -22.99 33.35 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.918 -1.037 . . . . 75.43 110.535 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.96 0 C-N-CA 124.439 1.096 . . . . 73.33 108.723 177.903 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 110.281 -0.266 . . . . 72.24 110.281 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 23.9 m -77.46 99.96 5.84 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.705 0.802 . . . . 74.42 110.058 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -92.77 126.18 37.73 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.292 1.037 . . . . 73.21 111.102 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -89.58 91.22 8.59 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.193 0.597 . . . . 75.35 109.793 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -85.02 97.15 9.67 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.772 -0.455 . . . . 70.2 109.772 174.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -81.31 147.14 30.03 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.605 -0.887 . . . . 72.51 108.605 175.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.7 t -65.69 134.73 53.83 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 109.956 -0.387 . . . . 63.12 109.956 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -105.49 156.26 18.38 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.718 0.807 . . . . 63.51 110.295 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.42 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 5.1 ptm 65.1 168.2 0.19 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 127.727 2.411 . . . . 72.32 114.382 175.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 72.3 m -169.36 143.23 2.83 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.685 1.594 . . . . 74.42 108.041 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.34 157.63 44.59 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.73 0.3 . . . . 73.11 110.798 163.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -123.03 121.4 35.98 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 107.634 -1.247 . . . . 75.53 107.634 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 36.2 mt -71.71 119.87 18.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.572 -0.899 . . . . 74.13 108.572 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.542 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 13.3 mm100 -82.54 -39.33 22.49 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.185 -0.916 . . . . 72.53 109.913 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.5 ttt85 -174.06 134.89 0.45 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.101 -0.954 . . . . 74.31 109.583 -174.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -114.69 140.01 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 106.623 -1.621 . . . . 71.54 106.623 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -166.63 155.39 10.59 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.465 0.65 . . . . 64.04 111.639 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.402 HG21 HD11 ' B' ' 21' ' ' ILE . 96.2 m -83.19 127.01 33.24 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.684 -1.144 . . . . 71.03 109.059 171.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.467 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.0 mtpt -98.4 -22.22 16.17 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.68 0.792 . . . . 73.12 110.916 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -164.65 137.58 4.81 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 123.423 0.452 . . . . 42.04 110.86 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.452 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.2 mm -127.0 144.94 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.796 1.238 . . . . 70.42 109.276 173.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.474 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.1 t -145.04 138.88 27.03 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.464 -1.244 . . . . 74.52 107.66 174.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -153.98 123.03 6.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.277 -1.379 . . . . 72.12 107.277 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -124.21 138.22 54.43 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.144 -0.687 . . . . 75.34 109.144 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.31 83.87 64.05 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 106.723 -1.584 . . . . 73.35 106.723 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.15 -36.42 29.13 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.026 2.484 . . . . 74.12 112.998 -169.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -105.37 17.15 24.43 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.366 0.666 . . . . 60.33 110.588 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.629 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -36.28 -65.76 0.3 Allowed Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 115.002 1.482 . . . . 70.11 115.002 -164.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 23.1 Cg_exo -62.5 -24.99 75.61 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 122.527 2.151 . . . . 75.33 113.05 -174.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.457 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 63.4 m80 -95.25 -28.65 14.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.869 -1.06 . . . . 72.21 112.291 -173.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.745 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.2 p -78.85 -20.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 120.952 0.406 . . . . 73.25 111.34 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -67.75 -11.89 59.38 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.309 0.855 . . . . 62.31 113.309 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.9 pt20 -63.89 -34.48 78.05 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.016 0.527 . . . . 72.43 110.804 176.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -83.86 101.43 11.65 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.581 0.752 . . . . 73.14 109.582 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -85.51 90.08 7.87 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.092 -0.707 . . . . 74.33 109.092 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -157.85 158.46 35.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.706 1.202 . . . . 73.51 108.363 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -83.37 103.24 2.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.214 1.006 . . . . 73.35 108.476 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.89 135.37 66.38 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.373 2.715 . . . . 60.21 113.496 -168.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.3 125.8 25.05 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 123.908 0.755 . . . . 71.43 109.487 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.599 HG11 ' HG ' ' F' ' 468' ' ' LEU . 2.4 p -123.45 128.21 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.579 0.752 . . . . 60.35 112.078 -165.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -107.52 129.66 54.94 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.584 1.154 . . . . 53.53 108.458 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.5 146.67 23.61 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.314 -0.995 . . . . 65.44 108.314 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 21.9 t70 -140.21 112.31 7.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.342 -0.985 . . . . 73.21 108.342 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 74.0 mt -100.16 149.9 23.06 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.737 -0.468 . . . . 74.52 109.737 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' B' ' 61' ' ' ARG . 20.6 t70 -153.19 114.82 4.25 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.714 0.805 . . . . 74.04 109.275 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -110.38 114.41 27.84 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.209 0.604 . . . . 71.42 110.39 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.67 155.38 30.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.388 1.075 . . . . 21.41 108.729 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.3 p -144.19 164.45 30.68 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.439 0.296 . . . . 72.42 110.939 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -158.1 139.03 13.12 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.542 0.737 . . . . 72.44 109.939 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -80.83 113.89 19.34 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.46 0.704 . . . . 63.53 109.786 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.02 -42.68 37.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.835 0.454 . . . . 60.02 110.619 176.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.6 -175.32 5.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.273 -0.876 . . . . 73.43 110.25 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.03 117.22 3.78 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.376 -0.829 . . . . 73.33 109.862 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 71.3 1.0 3.65 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.708 1.203 . . . . 75.11 112.494 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.403 HG22 ' OG ' ' B' ' 85' ' ' SER . 48.0 t -104.72 114.55 44.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 124.725 1.21 . . . . 62.04 107.927 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -123.29 140.57 52.88 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.039 -1.097 . . . . 74.1 108.039 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -116.12 107.47 14.95 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.353 -1.351 . . . . 74.23 107.353 -174.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 99.3 t -89.22 143.37 11.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 C-N-CA 124.467 1.107 . . . . 73.01 109.461 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.408 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 36.5 t -125.95 128.64 72.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.543 -0.91 . . . . 60.22 108.543 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -114.1 108.02 16.43 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.8 -1.185 . . . . 73.02 107.8 -177.682 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.499 ' HD2' ' HB3' ' B' ' 45' ' ' ASP . 38.1 ttm180 -93.44 123.59 36.84 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.676 -0.49 . . . . 74.33 109.676 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.455 ' HB ' HD11 ' B' ' 114' ' ' ILE . 44.2 t -118.29 103.12 14.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.284 -1.376 . . . . 62.14 107.284 168.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 15.7 m -98.33 126.52 43.87 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.967 -0.753 . . . . 53.31 108.967 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.496 HG21 HG21 ' B' ' 114' ' ' ILE . 58.0 t -113.75 120.2 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 123.975 0.91 . . . . 71.24 109.774 -176.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 77.9 m -109.74 135.74 50.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.631 -0.877 . . . . 63.15 108.631 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.27 142.88 27.66 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.278 0.631 . . . . 74.24 109.599 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.456 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 37.1 p -148.05 137.09 22.02 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.223 -0.444 . . . . 71.41 111.999 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.672 HD12 HG22 ' B' ' 31' ' ' VAL . 39.1 mt -96.2 104.83 16.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.039 0.936 . . . . 74.23 110.053 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.2 -113.46 5.9 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.151 -0.932 . . . . 54.31 113.143 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -107.98 21.89 16.75 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.713 0.805 . . . . 74.51 110.945 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -140.77 157.77 44.92 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.755 -0.591 . . . . 62.35 109.854 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 38.1 m -73.54 135.42 43.97 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.805 -0.443 . . . . 64.45 109.805 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.745 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -90.99 -66.2 0.95 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.56 -1.274 . . . . 64.11 107.56 174.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -150.18 161.87 41.57 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.844 0.83 . . . . 61.24 110.689 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.0 149.85 50.24 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.946 1.698 . . . . 60.52 106.76 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.429 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 48.6 t -154.91 159.82 40.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.551 -0.537 . . . . 70.23 109.551 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.474 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 38.7 tt0 -164.44 129.58 2.76 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.486 -0.931 . . . . 42.12 108.486 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 78.7 t -124.2 142.24 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 107.993 -1.114 . . . . 74.35 107.993 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -123.03 84.47 2.27 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.15 -1.055 . . . . 72.52 108.15 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.536 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 47.9 tp60 -80.27 100.42 8.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.731 -1.122 . . . . 73.44 109.215 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.467 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -89.77 165.8 32.31 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.415 -0.674 . . . . 42.02 111.415 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.426 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -166.01 134.41 3.28 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.154 -0.779 . . . . 61.02 111.154 -175.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 24.5 mt -97.87 127.35 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.955 0.902 . . . . 71.04 108.727 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -131.78 133.66 44.98 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 107.793 -1.188 . . . . 74.03 107.793 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.403 ' OG ' HG22 ' B' ' 55' ' ' VAL . 40.4 m -110.76 94.27 4.91 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.593 -0.521 . . . . 74.43 109.593 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.49 ' HB ' HD11 ' B' ' 89' ' ' ILE . 32.5 pt -95.88 138.42 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.396 0.678 . . . . 72.51 111.65 -167.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.54 149.87 33.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.386 1.074 . . . . 64.14 109.299 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 101.29 -31.21 8.92 Favored Glycine 0 N--CA 1.473 1.131 0 C-N-CA 123.256 0.455 . . . . 71.11 112.821 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.49 HD11 ' HB ' ' B' ' 86' ' ' ILE . 9.7 pt -91.48 151.22 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.787 0.835 . . . . 61.34 111.7 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.96 148.83 17.44 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.655 -1.157 . . . . 73.22 108.749 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.17 -132.85 13.96 Favored Glycine 0 C--N 1.343 0.96 0 O-C-N 123.352 0.407 . . . . 62.23 112.608 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.4 m -74.54 -20.5 59.94 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.197 0.599 . . . . 71.11 112.183 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -59.87 -45.05 93.71 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.721 0.772 . . . . 61.42 109.804 170.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.49 ' HA ' HD12 ' B' ' 89' ' ' ILE . 9.8 tmm? -72.43 -38.07 68.44 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.37 -1.287 . . . . 64.53 110.57 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.0 -40.58 70.26 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.552 0.691 . . . . 70.24 110.593 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -71.38 -41.8 69.21 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.586 -1.188 . . . . 72.34 111.346 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.2 t -66.51 -60.1 3.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.955 0.502 . . . . 74.51 111.394 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.541 HD22 HD23 ' F' ' 454' ' ' LEU . 6.9 tt -68.86 -41.18 78.78 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.824 0.849 . . . . 72.34 110.305 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.11 -34.39 41.87 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.318 0.387 . . . . 74.43 114.045 -171.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.43 -50.72 1.76 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 112.545 0.572 . . . . 62.13 112.545 -168.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -73.78 -35.78 64.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.692 0.797 . . . . 71.54 112.22 -171.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 97.1 m -70.83 -48.53 14.97 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 123.228 0.611 . . . . 71.04 111.053 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.485 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 75.3 Cg_exo -55.36 -34.82 90.17 Favored 'Trans proline' 0 C--N 1.399 3.232 0 C-N-CA 122.272 1.982 . . . . 65.41 113.542 168.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -58.72 -39.56 81.21 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.657 0.783 . . . . 75.12 110.758 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.61 -41.4 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.963 0.905 . . . . 72.1 110.791 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.426 HD21 ' HA3' ' B' ' 82' ' ' GLY . 59.8 mt -81.26 -16.15 53.47 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.683 0.793 . . . . 74.11 112.098 -173.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -61.8 -47.95 90.6 Favored Pre-proline 0 CA--C 1.558 1.285 0 N-CA-C 113.987 1.106 . . . . 74.32 113.987 -171.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.07 -34.46 89.9 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 121.744 1.63 . . . . 72.33 113.054 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.536 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 88.3 m-85 -65.05 -46.8 79.73 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.507 0.504 . . . . 73.24 110.32 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.6 96.92 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.532 0.733 . . . . 71.22 110.585 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -57.74 -55.93 28.54 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.203 1.001 . . . . 64.3 110.688 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.06 -34.56 77.85 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.866 0.728 . . . . 74.41 110.489 -175.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' B' ' 117' ' ' MET . 2.7 t -69.96 -38.07 76.01 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.029 -0.532 . . . . 51.43 111.18 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.496 HG21 HG21 ' B' ' 64' ' ' VAL . 72.5 mt -65.73 -54.84 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.29 0.636 . . . . 70.12 109.665 174.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.9 m -61.6 -26.46 67.99 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 124.215 0.947 . . . . 52.41 111.647 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.6 t -61.73 -55.57 28.86 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.476 0.711 . . . . 75.32 109.199 171.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -66.45 -33.73 76.36 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.693 0.797 . . . . 72.52 111.716 -174.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.8 t -59.49 -48.65 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.048 0.939 . . . . 73.41 110.272 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.727 ' HB2' HE21 ' C' ' 125' ' ' GLN . 13.0 t -76.37 -21.0 56.63 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.277 -0.874 . . . . 71.2 111.216 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.7 mtt-85 -67.65 -41.71 83.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.852 -0.796 . . . . 72.15 108.852 172.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.7 -0.47 80.53 Favored Glycine 0 C--N 1.36 1.879 0 O-C-N 123.767 0.667 . . . . 61.44 113.018 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 62.33 42.26 9.36 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.762 2.025 . . . . 72.34 113.061 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -97.65 159.66 30.51 Favored Pre-proline 0 CA--C 1.56 1.346 0 C-N-CA 124.04 0.936 . . . . 75.22 110.158 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -62.74 178.41 1.0 Allowed 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.516 2.81 . . . . 63.24 114.637 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.62 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 6.6 tp-100 -66.17 114.94 5.66 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.875 -1.057 . . . . 62.51 112.491 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.512 ' HA ' HD11 ' F' ' 468' ' ' LEU . 7.4 mp -116.76 91.31 3.55 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.145 -0.687 . . . . 73.34 109.145 167.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.448 HD21 ' HA ' ' C' ' 122' ' ' THR . 77.8 m-20 -92.5 107.1 18.96 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.155 -1.054 . . . . 73.32 108.155 170.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 18.4 tp -71.71 126.02 28.62 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 123.64 0.587 . . . . 74.42 110.677 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.06 144.55 98.83 Favored Pre-proline 0 CA--C 1.55 0.954 0 O-C-N 124.702 1.251 . . . . 65.02 110.96 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.442 ' HG3' HD11 ' D' ' 16' ' ' ILE . 28.2 Cg_endo -61.67 112.39 1.46 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.239 2.626 . . . . 72.35 111.396 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.29 107.26 17.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 106.136 -1.801 . . . . 44.2 106.136 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -82.46 82.2 7.99 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 107.236 -1.394 . . . . 74.43 107.236 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -63.69 -27.59 69.32 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.695 -1.139 . . . . 74.54 110.068 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.43 -44.05 92.4 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.225 1.41 . . . . 63.1 111.424 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.32 -39.63 78.1 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.547 0.739 . . . . 53.25 110.322 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 85.7 mt -72.83 -23.84 60.82 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.381 -0.827 . . . . 61.32 110.734 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.497 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 51.3 t80 -69.82 -24.56 63.49 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.002 0.921 . . . . 73.44 110.889 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 68.0 mtm -61.79 -31.59 71.82 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.395 0.678 . . . . 73.31 110.869 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -76.88 -18.5 58.28 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.386 1.074 . . . . 75.03 111.296 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -76.41 -30.3 57.4 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.477 0.711 . . . . 73.45 110.25 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 21.2 mt -95.82 18.61 12.8 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.115 -0.948 . . . . 72.33 111.977 -169.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -68.97 84.66 0.33 Allowed 'General case' 0 C--N 1.353 0.743 0 CA-C-O 121.341 0.591 . . . . 74.14 110.05 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -172.9 -50.65 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.909 1.284 . . . . 75.31 108.306 -176.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.18 75.2 1.06 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.337 -0.986 . . . . 72.24 108.337 175.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.44 38.67 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.731 1.212 . . . . 73.32 109.21 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.27 77.14 1.21 Allowed Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.502 -0.772 . . . . 74.51 111.971 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.71 96.17 1.57 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.136 0.974 . . . . 64.44 110.39 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.83 132.42 9.87 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.844 -0.616 . . . . 73.32 111.717 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.9 t -166.37 136.01 3.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.072 0.949 . . . . 65.02 109.556 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.24 131.35 53.58 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.304 -0.628 . . . . 70.21 109.304 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -157.37 132.91 9.16 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.536 -1.283 . . . . 72.33 107.536 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -172.22 77.09 0.05 OUTLIER 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.581 -1.266 . . . . 74.55 107.581 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.9 84.43 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 122.178 0.99 . . . . 73.23 111.633 173.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -101.69 130.22 48.02 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.197 0.999 . . . . 72.12 109.001 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 C-N-CA 124.203 1.001 . . . . 74.22 108.87 -178.947 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 108.228 -1.026 . . . . 74.22 108.228 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 69.3 m 60.78 -175.87 0.11 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.775 1.23 . . . . 64.13 111.399 -168.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -149.91 77.62 1.33 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.923 -0.769 . . . . 73.14 108.923 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -95.47 90.2 5.69 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.981 -1.859 . . . . 73.01 105.981 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -56.07 124.88 19.28 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.623 0.769 . . . . 65.32 110.541 -174.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -66.62 98.37 0.51 Allowed 'General case' 0 CA--C 1.547 0.859 0 O-C-N 123.896 0.748 . . . . 74.21 109.769 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 12.7 t -86.9 0.22 55.38 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.234 1.014 . . . . 71.14 110.839 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -102.28 55.06 0.79 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.302 1.041 . . . . 74.52 108.879 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 89.8 mtp 64.82 114.67 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.344 1.858 . . . . 54.42 113.52 -176.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 98.4 m -123.28 113.67 19.19 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.015 -1.448 . . . . 74.14 107.642 170.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.435 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.2 t80 -124.99 119.29 28.3 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.916 -1.142 . . . . 74.04 107.916 171.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -141.02 125.21 17.37 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 107.25 -1.389 . . . . 73.15 107.25 170.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.469 HD13 HD11 ' C' ' 16' ' ' ILE . 61.2 mt -74.35 120.53 23.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.103 -0.703 . . . . 31.33 109.103 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.564 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 16.3 mm-40 -86.94 -35.24 19.0 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.808 -1.087 . . . . 71.4 109.454 -176.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -174.16 147.79 1.26 Allowed 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.659 0.599 . . . . 63.44 109.987 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.469 HD11 HD13 ' C' ' 13' ' ' ILE . 92.1 mt -138.39 134.66 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.871 -1.159 . . . . 74.1 107.871 174.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.462 ' HB3' HG23 ' D' ' 122' ' ' THR . 34.0 p90 -171.59 168.94 6.21 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.602 0.715 . . . . 71.33 111.728 -169.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -93.28 114.68 27.19 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.217 -0.901 . . . . 72.43 109.034 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.406 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 10.2 mmmm -68.82 -39.82 79.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.037 0.922 . . . . 73.24 108.875 168.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.0 t70 -145.33 140.18 27.55 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 113.991 -1.459 . . . . 71.54 109.819 -173.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 81.2 mt -135.25 145.92 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.504 -1.665 . . . . 65.44 106.504 170.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -156.59 149.12 23.51 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.008 0.432 . . . . 73.54 110.242 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -141.97 131.11 23.33 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.705 -1.22 . . . . 72.22 107.705 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -135.28 115.9 13.79 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.507 1.123 . . . . 73.01 108.046 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' C' ' 28' ' ' ALA . . . -108.32 91.8 8.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 105.195 -2.15 . . . . 64.32 105.195 167.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.02 -36.52 97.98 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.244 2.629 . . . . 73.42 112.942 -167.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -125.41 43.16 3.12 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.762 -1.108 . . . . 73.14 108.915 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.472 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -42.61 -60.68 2.06 Favored Pre-proline 0 CA--C 1.568 1.671 0 N-CA-C 115.213 1.56 . . . . 72.03 115.213 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 19.2 Cg_exo -62.35 -39.14 48.82 Favored 'Trans proline' 0 C--N 1.391 2.801 0 CA-C-N 122.02 1.757 . . . . 72.11 112.088 -178.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -68.76 -33.77 74.45 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.033 -1.44 . . . . 73.52 111.991 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.914 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.5 p -81.82 -27.54 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 122.947 0.499 . . . . 70.11 111.99 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -68.24 -34.19 75.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.738 0.415 . . . . 74.01 111.758 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -86.55 7.06 27.77 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 122.894 0.477 . . . . 72.44 111.299 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.91 170.2 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.88 0.872 . . . . 73.41 109.944 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.45 129.25 37.89 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.676 0.791 . . . . 74.32 110.377 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 31.3 t90 -79.97 88.37 5.34 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.861 0.865 . . . . 74.34 110.186 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.487 ' H ' HD22 ' C' ' 68' ' ' LEU . 0.6 OUTLIER -144.35 73.39 15.88 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 107.353 -1.351 . . . . 73.43 107.353 174.177 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.417 ' HG2' HD12 ' G' ' 470' ' ' LEU . 8.7 Cg_exo -76.67 119.05 5.03 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.05 2.5 . . . . 75.51 113.698 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.63 88.12 7.32 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.95 -1.5 . . . . 64.35 106.95 166.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.693 HG21 HD12 ' G' ' 468' ' ' LEU . 14.4 p -79.1 136.73 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 114.36 -1.291 . . . . 72.31 110.17 -175.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -128.82 110.27 12.0 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.2 1.0 . . . . 75.21 108.864 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.48 ' H ' ' HA ' ' G' ' 465' ' ' LYS . 6.4 mp -84.78 122.56 29.3 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.146 -1.057 . . . . 70.34 108.146 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -120.23 132.05 55.19 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.101 -1.074 . . . . 75.21 108.101 174.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.58 HD21 ' HE1' ' C' ' 133' ' ' PHE . 15.3 tp -125.5 152.61 44.75 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.666 -0.865 . . . . 70.04 108.666 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.4 t70 -151.66 147.95 27.35 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.871 0.869 . . . . 70.32 108.982 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -146.22 133.2 20.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.82 0.848 . . . . 72.11 109.691 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.45 161.75 36.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.636 1.174 . . . . 64.31 107.978 171.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.426 ' HB2' ' HG ' ' G' ' 454' ' ' LEU . 16.7 m -138.55 151.58 47.44 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.866 -0.79 . . . . 74.12 108.866 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 17.9 p -142.19 128.62 20.08 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.733 0.813 . . . . 73.34 109.263 -170.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -73.88 118.26 16.63 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.728 -0.669 . . . . 62.14 110.146 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' C' ' 57' ' ' GLU . 32.8 mt -92.5 -31.69 15.15 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.081 -0.711 . . . . 64.3 109.081 172.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.85 -179.38 7.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.394 1.078 . . . . 75.52 110.457 176.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -62.87 119.11 8.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.214 -0.903 . . . . 64.33 109.467 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 7.1 m-20 65.32 17.98 11.19 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.226 1.011 . . . . 71.1 112.234 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 74.1 t -124.41 115.65 45.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 108.218 -1.03 . . . . 61.42 108.218 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -128.82 131.48 47.74 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.935 0.894 . . . . 75.43 109.5 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.608 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.3 tt0 -83.75 114.94 21.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.775 -1.102 . . . . 71.41 108.135 166.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.47 HG11 ' HD3' ' C' ' 103' ' ' PRO . 76.2 t -96.03 137.87 22.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.671 -0.863 . . . . 41.25 108.671 173.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.95 131.8 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.171 -1.048 . . . . 72.42 108.171 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.458 HD21 HD11 ' C' ' 44' ' ' LEU . 1.0 OUTLIER -121.12 104.57 9.87 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.212 -1.403 . . . . 64.51 107.212 176.292 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.491 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 2.7 ttm180 -93.94 121.89 35.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.426 -1.261 . . . . 73.34 108.954 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.8 t -116.11 120.41 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.729 -1.212 . . . . 61.1 107.729 174.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 29.4 m -124.34 114.2 19.22 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.985 0.914 . . . . 63.2 108.714 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.642 HG11 HD11 ' C' ' 126' ' ' LEU . 43.8 t -107.56 120.1 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.857 -0.794 . . . . 73.43 108.857 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.4 m -104.54 150.6 24.48 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.669 -0.863 . . . . 75.34 108.669 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' C' ' 73' ' ' ALA . . . -141.86 137.16 31.23 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.361 -0.977 . . . . 73.42 108.361 172.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.2 m -145.1 133.47 21.8 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.23 0.612 . . . . 71.34 110.132 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.487 HD22 ' H ' ' C' ' 37' ' ' GLN . 18.2 mt -85.28 53.78 2.87 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.643 1.177 . . . . 54.11 108.999 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.82 -87.05 0.55 Allowed Glycine 0 C--N 1.342 0.867 0 N-CA-C 110.111 -1.195 . . . . 45.23 110.111 -167.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -125.55 -13.74 6.47 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.124 0.97 . . . . 51.51 111.664 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -76.24 116.59 17.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.253 0.621 . . . . 61.02 109.721 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.5 m -74.85 122.26 23.1 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.416 0.553 . . . . 71.15 110.083 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.914 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.89 -61.9 1.73 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.788 -1.096 . . . . 71.45 108.709 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -155.03 173.95 15.86 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 114.574 -1.193 . . . . 54.33 111.768 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.51 139.59 26.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 104.958 -2.238 . . . . 62.42 104.958 169.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.9 t -149.04 111.55 4.74 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.026 -0.731 . . . . 72.42 109.026 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -117.84 127.39 53.82 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.0 0.52 . . . . 73.41 109.82 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.97 114.03 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.137 0.975 . . . . 73.42 108.6 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.539 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 74.1 mt-30 -92.34 91.0 7.48 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.864 -0.791 . . . . 71.34 108.864 173.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.468 ' HG3' HD22 ' C' ' 106' ' ' LEU . 7.9 tp-100 -80.95 99.71 8.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.122 -0.945 . . . . 71.3 109.76 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.8 145.61 17.86 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.786 -0.526 . . . . 74.33 111.786 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.14 133.22 4.28 Favored Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 110.775 -0.93 . . . . 74.04 110.775 -175.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.595 HD12 HD11 ' C' ' 51' ' ' LEU . 8.7 mm -87.52 120.57 36.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 108.452 -0.944 . . . . 63.54 108.452 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.435 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 63.1 m-85 -127.79 126.22 41.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.455 0.702 . . . . 40.13 109.184 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 59.2 p -82.81 122.95 28.88 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.596 -0.89 . . . . 72.33 108.596 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.621 ' HB ' HD11 ' C' ' 89' ' ' ILE . 47.0 pt -117.24 142.36 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.892 0.877 . . . . 72.14 109.983 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -163.54 159.4 21.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.73 0.812 . . . . 62.34 109.194 175.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.04 -38.19 3.16 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 121.401 0.445 . . . . 72.11 113.27 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.621 HD11 ' HB ' ' C' ' 86' ' ' ILE . 1.8 pp -78.72 149.13 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.258 1.023 . . . . 73.33 109.079 175.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.587 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 11.4 tp10 -146.17 146.02 30.68 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.968 0.507 . . . . 72.43 110.384 -172.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.34 -111.57 2.14 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 124.039 0.837 . . . . 64.12 113.903 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 7.1 m -63.7 -34.61 78.25 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.283 1.033 . . . . 75.43 111.219 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.587 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 38.8 mt-30 -70.85 -32.6 69.66 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.857 0.863 . . . . 75.22 111.158 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.544 ' HG3' HG22 ' G' ' 451' ' ' VAL . 17.4 tmm? -73.86 -43.78 57.52 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.689 -0.485 . . . . 63.21 109.689 176.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.65 70.64 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.224 -0.898 . . . . 73.3 110.806 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -67.49 -46.29 73.37 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.347 1.059 . . . . 70.44 110.651 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.574 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 44.7 t -64.4 -40.41 95.75 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 123.905 0.753 . . . . 72.13 111.157 -176.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.483 HD21 HD13 ' C' ' 86' ' ' ILE . 77.0 mt -90.27 -34.65 15.67 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.648 0.61 . . . . 72.24 112.648 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.87 -7.19 64.69 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-O 119.619 -0.545 . . . . 44.42 114.363 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.22 -55.22 0.16 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.718 0.771 . . . . 54.45 111.697 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.574 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 55.7 t80 -67.79 -35.73 79.18 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.326 1.45 . . . . 73.42 112.526 -172.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 35.1 m -80.52 -43.74 1.33 Allowed Pre-proline 0 N--CA 1.485 1.294 0 CA-C-O 118.924 -0.56 . . . . 74.04 112.377 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.47 ' HD3' HG11 ' C' ' 58' ' ' VAL . 72.9 Cg_exo -50.33 -30.74 27.56 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.871 2.38 . . . . 72.31 114.257 166.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -60.95 -39.4 89.39 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.296 1.038 . . . . 75.44 110.334 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.546 HD12 ' NH1' ' A' ' 111' ' ' ARG . 40.8 mm -72.03 -40.3 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.719 0.807 . . . . 74.44 110.461 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.468 HD22 ' HG3' ' C' ' 80' ' ' GLN . 83.6 mt -78.93 -23.54 44.61 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.23 1.012 . . . . 74.52 112.644 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -59.67 -50.79 85.16 Favored Pre-proline 0 CA--C 1.556 1.173 0 N-CA-C 114.021 1.119 . . . . 61.15 114.021 -172.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.5 -35.44 96.74 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.088 1.859 . . . . 72.24 113.11 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -68.41 -50.04 55.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.587 0.755 . . . . 74.13 110.981 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.84 -37.44 84.48 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.532 -0.758 . . . . 73.11 111.042 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -58.15 -55.19 38.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.906 1.282 . . . . 72.24 110.817 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -66.97 -29.5 69.37 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.228 0.611 . . . . 75.12 110.58 -176.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.436 ' SG ' HG12 ' C' ' 21' ' ' ILE . 34.5 t -73.23 -32.19 64.6 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.23 0.612 . . . . 72.2 111.542 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' C' ' 62' ' ' VAL . 86.1 mt -71.23 -46.28 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.42 0.688 . . . . 74.22 109.483 172.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 23.1 m -61.34 -36.33 79.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.775 0.83 . . . . 70.13 111.33 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 37.7 t -60.19 -49.62 76.92 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.336 -0.847 . . . . 65.23 109.416 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.506 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.59 -32.62 74.3 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.586 1.155 . . . . 74.53 113.078 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' C' ' 123' ' ' PHE . 53.0 t -74.81 -35.39 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.437 0.695 . . . . 63.22 110.522 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 36.7 t -67.9 -35.86 79.2 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.576 0.75 . . . . 71.12 110.857 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' C' ' 116' ' ' SER . 71.7 mtt-85 -67.66 -43.76 79.48 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.435 -0.802 . . . . 73.33 109.613 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.87 1.21 84.88 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 123.737 0.648 . . . . 54.34 112.857 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.448 ' HA ' HD21 ' B' ' 127' ' ' ASN . 67.3 p 62.83 25.5 15.11 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.337 1.855 . . . . 52.31 114.823 167.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.468 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.8 m-85 -84.71 157.4 60.86 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 108.75 -0.833 . . . . 73.01 108.75 167.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.62 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 79.9 Cg_exo -51.61 142.28 40.51 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.93 2.42 . . . . 74.13 113.364 175.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.727 HE21 ' HB2' ' B' ' 119' ' ' SER . 14.7 mm100 -55.78 138.19 48.36 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.375 1.047 . . . . 71.41 113.015 -172.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.642 HD11 HG11 ' C' ' 64' ' ' VAL . 8.2 tt -104.58 114.79 29.24 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.5 -1.227 . . . . 71.14 108.778 -173.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -119.02 100.0 7.08 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.785 -0.821 . . . . 73.13 108.785 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.452 HD22 HD21 ' G' ' 468' ' ' LEU . 0.1 OUTLIER -71.91 135.47 46.54 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.494 0.717 . . . . 75.34 109.946 -175.436 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.68 153.25 91.21 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.997 0.919 . . . . 63.22 111.411 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.536 ' HG3' HD12 ' A' ' 16' ' ' ILE . 31.6 Cg_exo -58.48 109.25 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.254 1.97 . . . . 54.33 112.06 172.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 91.0 t -96.28 110.73 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.031 -1.47 . . . . 70.51 107.031 173.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -83.01 94.1 7.7 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.916 -1.142 . . . . 74.44 107.916 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.58 ' HE1' HD21 ' C' ' 44' ' ' LEU . 84.8 m-85 -63.25 -38.79 92.54 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.151 0.98 . . . . 72.04 111.881 -175.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.21 -37.24 80.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.905 0.882 . . . . 74.34 111.35 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.93 -27.89 43.77 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.967 0.507 . . . . 70.01 110.373 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 54.0 tp -74.61 -26.25 59.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.257 0.623 . . . . 61.31 110.218 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.42 ' HA ' ' HE1' ' G' ' 461' ' ' PHE . 68.9 t80 -61.05 -51.07 70.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.917 0.887 . . . . 74.53 111.775 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 26.5 ptm -57.12 -27.28 61.68 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.349 0.66 . . . . 73.44 112.705 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -56.96 -30.72 64.32 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.968 1.307 . . . . 71.35 113.286 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -155.23 0.02 OUTLIER 'General case' 0 CA--C 1.573 1.857 0 C-N-CA 123.205 0.602 . . . . 74.5 111.463 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' C' ' 144' ' ' GLN . 16.3 tp 71.82 131.56 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.689 1.195 . . . . 53.25 112.25 167.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -69.88 -61.26 1.85 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.206 -0.664 . . . . 71.11 109.206 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -98.05 87.79 4.05 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.871 -0.604 . . . . 71.11 110.069 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.474 ' HA ' HD23 ' C' ' 141' ' ' LEU . 73.0 mt-30 -73.79 158.45 34.56 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.706 0.402 . . . . 61.53 110.509 172.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.25 151.64 45.3 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.591 0.756 . . . . 73.55 109.645 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.94 167.52 51.17 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.736 0.648 . . . . 70.1 112.554 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -134.99 99.15 4.2 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.289 0.545 . . . . 72.33 110.321 -171.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.65 91.83 1.09 Allowed Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.823 -0.626 . . . . 55.24 112.018 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.729 ' HA ' ' HG2' ' A' ' 147' ' ' GLU . 40.0 p -90.01 105.6 17.92 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.263 0.625 . . . . 75.41 110.176 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -76.56 124.55 27.77 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.515 -0.55 . . . . 73.3 109.515 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.8 108.48 2.99 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.585 -0.895 . . . . 65.44 108.585 171.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 152' ' ' HIS . . . . . 0.491 ' HB3' ' HA ' ' A' ' 145' ' ' ALA . 54.1 t-80 -74.93 82.31 2.19 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.516 -0.92 . . . . 73.21 108.516 174.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 153' ' ' GLN . . . . . 0.487 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 59.7 tt0 -99.38 103.34 15.14 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.015 0.526 . . . . 50.44 109.725 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -84.04 86.31 7.22 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.637 -0.875 . . . . 54.55 108.637 172.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.213 0 CA-C-N 115.081 -0.963 . . . . 63.12 110.162 179.313 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 109.854 -0.424 . . . . 64.1 109.854 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -82.46 85.59 6.9 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.21 -0.663 . . . . 55.12 109.21 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.56 131.49 34.37 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.243 -0.651 . . . . 74.22 109.243 -175.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -139.07 161.59 37.0 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.016 0.526 . . . . 75.4 112.076 -170.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -170.68 112.33 0.4 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 106.632 -1.618 . . . . 65.23 106.632 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -78.58 147.56 33.67 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.195 0.452 . . . . 62.33 111.097 -172.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.509 HG22 ' H ' ' D' ' 8' ' ' GLU . 0.8 OUTLIER -99.46 -166.02 1.3 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 124.256 1.022 . . . . 72.41 108.773 178.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.509 ' H ' HG22 ' D' ' 7' ' ' THR . 42.9 mm-40 -62.67 -86.88 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 109.246 -0.65 . . . . 51.41 109.246 171.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -37.15 136.47 0.42 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.275 0.63 . . . . 60.11 112.067 157.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 40.4 m -143.29 140.89 30.82 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.2 -0.667 . . . . 64.13 109.2 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.518 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 54.7 t80 -164.22 89.82 0.56 Allowed 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.013 -1.847 . . . . 72.44 106.013 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -128.41 130.67 47.99 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.725 -0.843 . . . . 74.42 108.725 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -90.83 110.98 22.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.123 -1.066 . . . . 52.25 108.123 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -73.86 -31.27 63.09 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.295 0.372 . . . . 74.24 110.711 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -168.68 131.68 1.4 Allowed 'General case' 0 C--N 1.349 0.547 0 O-C-N 123.268 0.355 . . . . 64.24 110.669 -169.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.477 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.0 mp -116.36 128.75 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 105.846 -1.909 . . . . 75.12 105.846 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.437 ' HE1' HG13 ' D' ' 83' ' ' ILE . 40.3 p90 -156.2 160.41 39.81 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.053 0.93 . . . . 71.21 112.477 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -91.33 118.43 30.51 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 113.738 -1.574 . . . . 73.42 108.887 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.0 mtpt -82.3 -37.37 25.89 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.632 -0.713 . . . . 63.25 109.404 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -150.24 139.06 20.85 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.106 -1.406 . . . . 61.1 109.125 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.506 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.9 mt -137.92 147.75 25.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.919 1.287 . . . . 74.15 108.118 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.6 t -148.15 126.23 12.11 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.622 0.769 . . . . 75.1 109.48 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.537 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 66.6 t80 -121.19 133.19 55.17 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.205 -1.406 . . . . 75.03 107.205 164.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.718 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.7 mt-10 -134.84 136.7 42.66 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.34 1.056 . . . . 72.24 108.343 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.21 83.74 63.12 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.46 -1.311 . . . . 51.13 107.46 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.92 -52.95 2.41 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.05 2.5 . . . . 63.4 112.967 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.577 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 5.1 m-20 -102.18 19.69 18.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.287 0.635 . . . . 62.32 109.64 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.499 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -23.85 -75.24 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 116.535 2.05 . . . . 64.41 116.535 -167.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.447 ' HB3' HD11 ' C' ' 83' ' ' ILE . 83.8 Cg_endo -77.28 -16.7 15.31 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 124.033 2.476 . . . . 64.32 113.539 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.435 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 0.2 OUTLIER -71.16 -44.45 65.49 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.209 1.004 . . . . 44.51 108.557 172.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' D' ' 27' ' ' ASN . 9.8 p -82.63 -20.74 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.466 0.706 . . . . 72.12 111.351 -168.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.84 -14.14 62.71 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.61 0.364 . . . . 63.14 111.599 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -67.27 -14.48 62.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.703 0.801 . . . . 71.22 110.925 174.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.423 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 97.4 mttt -97.79 101.63 13.18 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.855 1.262 . . . . 75.13 109.202 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -85.38 93.07 8.64 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.314 -0.625 . . . . 72.32 109.314 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -162.52 156.95 21.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.704 0.801 . . . . 72.45 109.192 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -76.52 105.45 2.33 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.386 -0.968 . . . . 72.5 108.386 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.05 124.97 17.16 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.002 2.468 . . . . 73.44 112.316 -170.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.52 114.83 4.62 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.864 0.727 . . . . 64.33 109.827 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.405 HG21 HD11 ' D' ' 126' ' ' LEU . 27.5 m -102.29 149.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.877 0.871 . . . . 73.4 112.018 -171.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' D' ' 64' ' ' VAL . 46.1 tptt -120.7 120.36 35.46 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.1 1.36 . . . . 71.51 107.866 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.5 HD21 HD12 ' D' ' 128' ' ' LEU . 7.2 mp -97.85 121.06 39.31 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.077 -0.712 . . . . 73.45 109.077 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.577 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 14.6 t70 -108.61 120.48 42.58 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.117 -1.068 . . . . 72.1 108.117 170.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 tt -106.43 127.79 53.56 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.506 -0.924 . . . . 70.52 108.506 -174.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.2 t70 -134.97 148.19 49.94 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.339 1.056 . . . . 73.12 108.434 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -120.19 152.21 38.01 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.999 0.52 . . . . 64.1 109.626 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.98 171.21 17.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.371 1.068 . . . . 71.14 108.252 174.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -174.62 161.66 3.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.065 0.546 . . . . 72.2 110.939 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.7 p -159.22 147.81 18.05 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.381 0.672 . . . . 45.32 109.93 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -87.0 127.06 35.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.474 -0.565 . . . . 74.1 109.474 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 67.6 mt -97.86 -38.62 9.37 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.289 0.635 . . . . 74.55 110.862 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.75 -173.74 4.66 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.567 0.747 . . . . 61.01 110.566 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.91 105.51 1.04 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.02 -0.991 . . . . 63.42 110.444 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 68.36 18.98 9.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.915 1.286 . . . . 71.2 111.554 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -110.77 123.08 66.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 N-CA-C 107.454 -1.313 . . . . 71.44 107.454 167.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.402 ' CG ' HG11 ' H' ' 452' ' ' VAL . 28.0 t80 -136.86 129.77 30.76 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.255 -0.646 . . . . 75.21 109.255 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -91.13 144.38 25.69 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.214 1.005 . . . . 74.52 109.624 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.0 t -123.12 145.64 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.079 1.352 . . . . 72.43 107.629 171.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 45.6 t -127.53 144.91 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.096 0.958 . . . . 51.22 108.914 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -127.7 122.09 32.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.863 -1.162 . . . . 72.1 107.863 178.405 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 37.0 ttm-85 -102.63 97.48 7.67 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.483 -0.932 . . . . 74.04 108.483 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.14 104.25 15.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.339 -0.985 . . . . 74.04 108.339 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.3 m -97.9 146.36 25.54 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.263 -0.88 . . . . 72.11 108.842 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 53.8 t -140.37 109.03 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.397 1.079 . . . . 75.35 108.841 -177.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -102.57 110.8 22.85 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.72 -0.845 . . . . 72.34 108.72 171.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.0 157.24 17.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.033 0.533 . . . . 73.33 110.48 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 21.6 p -154.64 130.97 10.43 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.449 0.642 . . . . 62.24 112.01 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.471 HD12 HG22 ' D' ' 31' ' ' VAL . 25.1 mt -97.91 101.62 13.16 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.384 -1.28 . . . . 62.43 107.876 170.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.97 -123.22 7.29 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.599 -0.728 . . . . 63.41 112.591 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.75 5.63 48.95 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.304 0.642 . . . . 62.14 112.341 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.423 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 13.0 pt-20 -129.09 160.14 33.75 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.207 0.603 . . . . 73.1 109.801 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -67.17 139.46 57.45 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.565 0.541 . . . . 61.11 110.412 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.563 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -92.89 -65.25 1.01 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.324 -0.853 . . . . 74.33 108.952 175.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -145.93 167.76 22.51 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.144 -0.935 . . . . 74.22 109.641 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.718 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.0 mt -132.14 140.38 48.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.404 -1.332 . . . . 72.53 107.404 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.504 ' SG ' HG23 ' D' ' 114' ' ' ILE . 1.2 m -144.91 139.51 27.67 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.022 0.929 . . . . 64.21 108.717 -177.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -158.2 130.19 6.88 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.007 -0.738 . . . . 72.42 109.007 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 62.8 t -134.87 117.5 22.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 109.258 -0.645 . . . . 60.33 109.258 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -89.58 85.48 6.5 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.612 0.72 . . . . 70.1 109.072 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -80.02 101.5 8.72 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.211 -1.359 . . . . 72.42 109.541 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.87 160.69 23.34 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.416 -0.673 . . . . 22.4 111.416 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.45 132.91 3.66 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.118 -0.793 . . . . 61.31 111.118 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.437 HG13 ' HE1' ' D' ' 17' ' ' TYR . 64.7 mt -87.69 124.56 41.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.152 0.981 . . . . 75.13 108.361 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -122.66 123.7 41.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.413 0.285 . . . . 62.12 110.368 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 48.5 m -83.49 110.19 17.99 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.745 -1.205 . . . . 52.51 107.745 164.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.496 HG13 HG11 ' H' ' 451' ' ' VAL . 15.6 pt -130.25 145.31 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.909 0.884 . . . . 52.05 110.617 -170.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.28 167.46 25.87 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.863 0.865 . . . . 42.25 109.913 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.73 -18.89 13.14 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 114.285 0.474 . . . . 62.1 114.285 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 pt -112.2 126.89 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.848 0.859 . . . . 62.24 109.113 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.53 164.33 30.44 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.068 0.547 . . . . 72.44 110.676 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' D' ' 94' ' ' MET . . . 66.47 -129.29 30.93 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.582 0.552 . . . . 71.23 113.94 175.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.4 m -70.52 -29.4 65.88 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.501 0.721 . . . . 72.5 111.452 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.68 -43.57 98.48 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.978 0.911 . . . . 74.24 111.444 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' D' ' 91' ' ' GLY . 0.0 OUTLIER -73.67 -31.83 63.66 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 116.244 -0.434 . . . . 52.24 110.746 179.103 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.64 88.06 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.998 0.519 . . . . 73.41 111.063 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 12.6 t-80 -64.71 -31.79 73.17 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.786 0.835 . . . . 63.24 111.054 176.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.9 t -79.71 -49.6 11.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.516 0.326 . . . . 61.15 110.783 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.468 HD23 ' SG ' ' D' ' 102' ' ' CYS . 84.3 mt -79.28 -29.37 42.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.692 0.797 . . . . 73.35 112.238 -169.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.37 6.65 63.5 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 119.792 -0.449 . . . . 73.1 113.183 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -148.26 -67.94 0.23 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.258 0.529 . . . . 53.41 111.955 -177.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 101' ' ' TYR . . . . . 0.418 ' O ' HG12 ' D' ' 105' ' ' ILE . 66.9 t80 -64.86 -37.77 88.74 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 112.467 0.544 . . . . 74.51 112.467 -172.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.518 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 85.9 m -70.65 -48.47 16.28 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-O 118.599 -0.715 . . . . 44.21 111.461 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.481 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 75.2 Cg_exo -55.96 -33.18 88.39 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.013 1.809 . . . . 71.02 113.185 167.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.56 -35.71 81.64 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.251 0.621 . . . . 73.43 111.169 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.418 HG12 ' O ' ' D' ' 101' ' ' TYR . 36.6 mm -67.84 -40.09 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.601 0.76 . . . . 73.14 110.523 174.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.7 mt -79.04 -16.93 56.14 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.642 -0.708 . . . . 73.22 111.514 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.31 -41.32 24.24 Favored Pre-proline 0 N--CA 1.485 1.317 0 N-CA-C 114.437 1.273 . . . . 71.51 114.437 -172.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.45 -39.21 92.85 Favored 'Trans proline' 0 C--N 1.385 2.476 0 CA-C-N 121.769 1.667 . . . . 63.33 112.74 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -71.16 -40.46 71.28 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.52 0.728 . . . . 75.43 110.95 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.79 -44.59 96.63 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.875 0.87 . . . . 55.45 110.639 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.517 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 19.8 ttp180 -59.92 -53.5 57.11 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.335 -1.302 . . . . 64.15 110.198 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.47 -42.77 99.72 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.28 0.988 . . . . 72.55 111.724 -172.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.8 t -58.52 -40.55 83.22 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.688 0.618 . . . . 64.23 110.875 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.504 HG23 ' SG ' ' D' ' 76' ' ' CYS . 84.3 mt -66.95 -50.3 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.626 0.77 . . . . 52.13 110.622 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -54.91 -43.86 73.67 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.213 1.005 . . . . 70.24 111.529 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.7 t -66.91 -42.02 86.11 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.48 -1.237 . . . . 74.51 110.519 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.537 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 71.9 mtm -66.12 -37.35 85.5 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.856 0.463 . . . . 73.32 111.638 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.423 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.0 t -63.21 -44.57 99.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.117 0.967 . . . . 71.33 110.479 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -73.57 -31.02 63.39 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 116.038 -0.528 . . . . 71.2 111.381 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -71.82 -30.3 65.34 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.205 0.602 . . . . 65.32 110.094 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.97 11.38 69.38 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.715 0.635 . . . . 62.13 112.663 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.462 HG23 ' HB3' ' C' ' 17' ' ' TYR . 66.2 p 58.15 21.93 8.54 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 126.446 1.899 . . . . 71.55 114.244 175.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -84.32 147.85 51.23 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 108.818 -0.808 . . . . 61.43 108.818 169.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.5 135.22 47.51 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 123.067 2.512 . . . . 74.33 112.488 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -50.63 140.91 13.52 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.957 1.303 . . . . 71.42 113.003 -170.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.45 ' HA ' HD11 ' H' ' 468' ' ' LEU . 55.2 tp -122.34 100.87 7.18 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.44 0.696 . . . . 72.33 110.713 -176.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.531 ' H ' HD11 ' H' ' 468' ' ' LEU . 74.0 m-20 -99.67 101.16 12.26 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.093 -1.077 . . . . 63.1 108.093 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.517 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.7 mm? -69.23 114.27 7.34 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.338 0.655 . . . . 71.3 109.517 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.401 ' HB3' ' SD ' ' H' ' 464' ' ' MET . . . -58.09 132.72 83.96 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.177 0.591 . . . . 72.01 111.414 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.463 ' HB3' HH12 ' D' ' 111' ' ' ARG . 58.6 Cg_endo -72.85 126.1 11.04 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.252 1.968 . . . . 71.13 111.185 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.82 141.79 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.797 0.839 . . . . 71.43 110.065 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -77.68 103.15 7.44 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.403 -0.962 . . . . 72.02 108.403 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -72.0 -40.56 68.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.801 0.441 . . . . 74.45 110.492 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' D' ' 138' ' ' MET . 5.8 m-20 -61.29 -53.46 56.53 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.905 0.882 . . . . 71.53 112.668 -172.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.33 99.08 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.28 0.632 . . . . 63.31 111.165 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.41 -27.65 67.25 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.204 -0.907 . . . . 60.41 111.6 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.457 ' O ' HD13 ' D' ' 141' ' ' LEU . 84.1 t80 -72.02 -40.06 68.72 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.465 0.706 . . . . 73.24 110.423 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 36.6 mtt -64.16 -36.76 85.11 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.272 0.629 . . . . 73.03 110.11 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -70.56 -41.6 72.24 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.2 -0.909 . . . . 74.11 110.402 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -61.42 -34.63 75.71 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.215 1.006 . . . . 75.31 111.427 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.457 HD13 ' O ' ' D' ' 137' ' ' PHE . 1.2 mp -59.45 -34.33 72.39 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.722 0.809 . . . . 71.55 111.339 175.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -87.98 0.71 55.57 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.855 0.862 . . . . 72.5 111.567 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -121.71 90.66 3.35 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.001 0.92 . . . . 64.14 109.647 -175.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -146.04 160.07 42.39 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.789 0.836 . . . . 63.42 109.521 176.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.57 91.43 1.42 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.311 0.644 . . . . 72.0 110.248 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.08 -156.32 31.48 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.828 -0.624 . . . . 45.03 112.001 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -129.3 123.35 31.63 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.843 0.857 . . . . 71.14 109.874 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.1 61.58 4.28 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 111.283 -0.727 . . . . 73.12 111.283 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.3 t -62.04 142.84 57.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.072 0.949 . . . . 53.11 111.089 -175.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.74 141.29 19.84 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.004 0.522 . . . . 71.05 109.872 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -105.73 134.35 48.99 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.328 -1.36 . . . . 60.44 107.328 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -137.13 94.86 3.0 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.637 0.775 . . . . 71.21 108.958 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -64.49 129.45 39.91 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 122.877 0.471 . . . . 74.22 110.653 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -108.6 6.47 25.96 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.554 0.741 . . . . 73.15 110.753 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.217 0 C-N-CA 123.622 0.769 . . . . 74.14 109.992 179.759 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 450' ' ' ASN . . . . . 0.46 ' N ' HD21 ' E' ' 450' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.444 0.164 . . . . 74.11 110.624 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 451' ' ' VAL . . . . . 0.595 HG13 HG13 ' E' ' 452' ' ' VAL . 7.4 p -76.23 -42.79 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 122.835 0.454 . . . . 65.24 111.226 -177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 452' ' ' VAL . . . . . 0.595 HG13 HG13 ' E' ' 451' ' ' VAL . 15.6 m -99.89 111.11 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.051 0.54 . . . . 75.51 111.511 -171.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -73.88 -62.11 3.09 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-N 115.739 -0.664 . . . . 51.42 111.728 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 454' ' ' LEU . . . . . 0.42 HD11 HD12 ' A' ' 98' ' ' LEU . 2.2 tm? 56.21 92.69 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.489 1.516 . . . . 63.33 112.084 170.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 15.2 t -77.57 171.36 15.03 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.989 0.515 . . . . 71.44 110.414 174.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -73.06 81.12 1.23 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.187 0.595 . . . . 73.41 110.026 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -81.68 130.63 35.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.029 -0.73 . . . . 54.51 109.029 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 15.0 t -137.34 -174.82 3.86 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.923 0.889 . . . . 60.53 109.189 -174.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 31.0 t70 70.25 112.54 0.05 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.52 1.128 . . . . 72.43 110.429 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 460' ' ' LEU . . . . . 0.501 HD21 ' H ' ' A' ' 46' ' ' THR . 4.3 mm? -98.42 132.64 43.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.357 0.663 . . . . 52.55 109.677 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -86.17 27.36 0.92 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.02 1.328 . . . . 72.14 110.503 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -74.87 130.94 40.3 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.46 0.704 . . . . 74.15 110.552 -174.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 8.9 t -167.73 143.78 4.04 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.519 1.127 . . . . 63.3 108.602 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 464' ' ' MET . . . . . 0.623 ' SD ' HD23 ' A' ' 42' ' ' LEU . 22.7 ptm -144.51 113.23 6.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.513 0.725 . . . . 61.01 109.173 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -107.32 99.36 8.89 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.359 -0.978 . . . . 61.03 108.359 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -167.52 -33.94 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.788 0.835 . . . . 74.3 110.554 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . 69.68 173.22 0.3 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.036 1.334 . . . . 51.04 112.205 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 468' ' ' LEU . . . . . 0.428 HD12 HG11 ' A' ' 40' ' ' VAL . 88.8 mt -90.12 -62.1 1.54 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.134 0.574 . . . . 71.51 110.894 -174.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 93.91 40.96 4.49 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 115.528 -0.76 . . . . 33.01 112.63 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 91.3 mt -68.71 -53.82 19.81 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.718 -1.216 . . . . 64.23 107.718 167.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt . . . . . 0 CA--C 1.549 0.928 0 C-N-CA 125.757 1.623 . . . . 75.11 107.46 169.827 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 57.9 t30 . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 108.364 -0.976 . . . . 72.41 108.364 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 451' ' ' VAL . . . . . 0.563 HG23 HG22 ' F' ' 452' ' ' VAL . 21.6 m -61.6 -44.61 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 123.404 0.44 . . . . 71.15 111.78 -177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 452' ' ' VAL . . . . . 0.563 HG22 HG23 ' F' ' 451' ' ' VAL . 23.5 m -138.95 -59.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 112.706 0.632 . . . . 74.1 112.706 -172.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 453' ' ' GLY . . . . . 0.428 ' N ' HG23 ' F' ' 452' ' ' VAL . . . 72.48 63.19 2.99 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.236 -1.146 . . . . 44.2 110.236 -163.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 454' ' ' LEU . . . . . 0.541 HD23 HD22 ' B' ' 98' ' ' LEU . 58.4 tp -66.8 131.09 45.21 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 122.761 0.425 . . . . 64.23 110.431 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 7.3 t -145.22 126.29 14.62 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.957 0.903 . . . . 72.4 108.934 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -169.05 136.75 1.9 Allowed 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.125 -1.435 . . . . 73.11 107.125 173.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -147.64 72.78 1.25 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.829 0.823 . . . . 75.41 109.606 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 7.6 p -106.45 -75.75 0.62 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.703 -1.135 . . . . 73.12 108.44 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -178.54 -174.9 0.41 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 125.502 1.521 . . . . 72.44 108.161 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 460' ' ' LEU . . . . . 0.453 HD21 ' HA ' ' B' ' 45' ' ' ASP . 2.0 pt? -137.65 148.79 46.05 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.237 0.615 . . . . 75.44 109.451 177.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -72.89 146.16 46.36 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.588 1.155 . . . . 74.23 111.697 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -132.13 67.4 1.53 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.288 -1.375 . . . . 72.33 107.288 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 28.8 m -80.26 84.34 5.95 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.014 -0.994 . . . . 75.44 108.37 174.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 464' ' ' MET . . . . . 0.45 ' SD ' ' HA ' ' F' ' 467' ' ' ALA . 39.0 tpp -91.01 146.85 23.5 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.101 -0.954 . . . . 75.2 110.796 -172.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.5 -63.11 0.9 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.169 0.988 . . . . 64.33 109.435 -175.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -82.94 -30.6 28.22 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.271 0.628 . . . . 34.3 111.565 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 467' ' ' ALA . . . . . 0.45 ' HA ' ' SD ' ' F' ' 464' ' ' MET . . . 68.84 -77.49 0.05 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.321 1.448 . . . . 54.32 111.569 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 468' ' ' LEU . . . . . 0.599 ' HG ' HG11 ' B' ' 40' ' ' VAL . 2.6 tm? -147.43 -25.49 0.38 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.093 0.957 . . . . 73.24 108.948 -174.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 469' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' F' ' 468' ' ' LEU . . . 94.11 -58.55 2.05 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 110.009 -1.236 . . . . 72.1 110.009 -168.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 10.4 tp 55.9 74.97 0.36 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.034 1.334 . . . . 73.31 109.578 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--O 1.253 1.239 0 CA-C-O 118.562 -0.732 . . . . 63.34 109.959 -174.546 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' G' G ' 450' ' ' ASN . . . . . 0.587 HD21 ' N ' ' G' ' 450' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 110.284 -0.265 . . . . 73.24 110.284 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 451' ' ' VAL . . . . . 0.544 HG22 ' HG3' ' C' ' 94' ' ' MET . 15.0 p -87.21 114.97 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 122.01 0.91 . . . . 72.32 111.312 -170.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 19.7 m -141.03 -168.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.806 1.242 . . . . 61.3 109.305 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 86.81 58.53 1.9 Allowed Glycine 0 C--N 1.342 0.909 0 CA-C-O 121.125 0.292 . . . . 63.21 112.733 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 454' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' C' ' 48' ' ' SER . 3.4 tm? -88.38 121.26 30.58 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.616 -1.253 . . . . 71.23 107.616 173.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 9.9 t -89.11 136.23 33.13 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 109.938 -0.393 . . . . 63.24 109.938 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -77.44 98.76 5.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.235 -0.439 . . . . 62.51 110.375 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -88.77 88.19 7.51 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.763 -1.199 . . . . 73.44 107.763 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 31.5 p -63.49 -37.65 88.13 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.423 1.089 . . . . 64.21 112.069 -173.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -78.73 84.59 4.8 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 109.109 -0.7 . . . . 74.32 109.109 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.28 110.39 5.22 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.615 -0.883 . . . . 73.45 108.615 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 461' ' ' PHE . . . . . 0.42 ' HE1' ' HA ' ' C' ' 137' ' ' PHE . 16.6 p90 -52.74 83.76 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 126.117 1.767 . . . . 63.43 111.941 173.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -137.89 90.95 2.53 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.682 -0.859 . . . . 75.1 108.682 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 41.6 p -92.48 82.63 4.87 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.995 -0.742 . . . . 73.24 108.995 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 52.3 ttm -163.74 117.16 1.49 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.172 -1.048 . . . . 64.24 108.172 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 465' ' ' LYS . . . . . 0.48 ' HA ' ' H ' ' C' ' 42' ' ' LEU . 65.1 mttm -129.56 -60.03 1.06 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.208 0.603 . . . . 61.42 109.847 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -90.07 85.33 6.28 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.955 -0.757 . . . . 71.5 108.955 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -129.41 6.4 5.27 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.633 0.773 . . . . 53.03 111.209 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 468' ' ' LEU . . . . . 0.693 HD12 HG21 ' C' ' 40' ' ' VAL . 82.3 mt -117.78 124.04 47.44 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.632 0.773 . . . . 71.24 109.059 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -80.86 61.92 4.47 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 110.919 -0.872 . . . . 61.53 110.919 172.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 470' ' ' LEU . . . . . 0.417 HD12 ' HG2' ' C' ' 38' ' ' PRO . 0.2 OUTLIER -95.14 31.13 1.97 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.541 1.136 . . . . 74.15 108.215 -176.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt . . . . . 0 C--O 1.255 1.36 0 C-N-CA 125.024 1.33 . . . . 64.21 108.904 -172.205 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 20.2 m120 . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.628 -0.508 . . . . 72.25 109.628 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' H' H ' 451' ' ' VAL . . . . . 0.719 HG13 HG13 ' H' ' 452' ' ' VAL . 9.7 p -54.55 -32.77 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 124.182 0.993 . . . . 74.01 112.789 -174.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 452' ' ' VAL . . . . . 0.719 HG13 HG13 ' H' ' 451' ' ' VAL . 20.1 m -114.37 151.7 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.629 0.728 . . . . 73.12 112.449 -172.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -158.82 28.71 0.42 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-N 114.115 -1.402 . . . . 61.52 111.065 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.55 127.52 42.62 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.253 0.621 . . . . 74.31 109.847 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 38.2 p -78.02 -4.79 48.93 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.917 0.887 . . . . 74.44 111.658 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 31.8 t70 73.46 148.94 0.09 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.71 1.604 . . . . 74.03 111.059 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 457' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' H' ' 458' ' ' THR . 17.6 tt0 -152.53 141.11 20.8 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.333 0.653 . . . . 72.24 109.381 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 458' ' ' THR . . . . . 0.414 ' O ' ' HG2' ' H' ' 457' ' ' GLN . 13.4 t -86.77 151.36 23.45 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.392 -0.966 . . . . 74.13 108.392 166.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 71.66 155.7 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.035 1.334 . . . . 72.41 111.456 -174.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 460' ' ' LEU . . . . . 0.49 ' HG ' ' H ' ' H' ' 461' ' ' PHE . 1.8 pt? -162.17 -73.57 0.05 Allowed 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.62 -0.718 . . . . 72.43 109.833 175.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 461' ' ' PHE . . . . . 0.49 ' H ' ' HG ' ' H' ' 460' ' ' LEU . 30.3 p90 -176.8 157.42 1.51 Allowed 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.561 1.144 . . . . 72.12 109.362 -171.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -162.56 120.02 2.04 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.726 0.81 . . . . 73.2 109.476 167.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 34.5 m -152.16 106.52 3.17 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.72 0.808 . . . . 72.15 109.017 170.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 464' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' D' ' 129' ' ' ALA . 16.4 tmm? -149.48 113.86 5.24 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.21 -1.033 . . . . 74.01 108.21 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -90.25 118.85 30.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.363 0.665 . . . . 74.24 110.48 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . 72.32 97.39 0.07 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.005 1.322 . . . . 75.32 112.424 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -72.85 -53.83 10.4 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.847 -0.615 . . . . 61.13 109.85 174.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 468' ' ' LEU . . . . . 0.531 HD11 ' H ' ' D' ' 127' ' ' ASN . 87.6 mt -132.28 28.18 4.41 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.154 1.382 . . . . 74.1 108.676 173.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 79.08 -73.57 2.31 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.763 -0.535 . . . . 61.43 111.763 -170.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 64.19 95.77 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.091 1.356 . . . . 73.52 110.986 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 23.1 tptm . . . . . 0 CA--C 1.559 1.325 0 C-N-CA 124.534 1.134 . . . . 74.43 111.246 173.557 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptm . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.183 -0.303 . . . . 73.21 110.183 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.9 m -94.6 78.95 3.78 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.604 0.762 . . . . 53.43 109.38 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -99.21 81.89 2.63 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.296 -0.866 . . . . 74.23 108.805 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.83 88.58 6.78 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.721 -1.127 . . . . 73.42 109.242 174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -66.27 116.22 7.08 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.035 -0.529 . . . . 71.55 110.824 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.9 t30 60.91 -90.47 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.407 1.483 . . . . 51.42 112.587 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 m -78.99 80.8 5.31 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.761 0.791 . . . . 63.54 110.352 -168.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -80.98 104.05 11.22 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.686 -1.143 . . . . 75.14 109.023 176.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.27 174.06 12.39 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.633 -1.167 . . . . 65.43 109.717 -175.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m -141.56 137.25 31.83 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.432 0.693 . . . . 64.44 109.341 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.661 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 10.1 t80 -135.99 129.37 31.97 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.954 0.902 . . . . 75.24 108.607 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -149.68 127.56 11.82 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.706 0.803 . . . . 64.35 109.155 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.573 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.1 mt -95.34 119.21 43.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.896 -0.779 . . . . 72.54 108.896 173.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -88.69 -34.29 17.26 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 123.46 0.475 . . . . 70.43 110.184 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -166.87 126.16 1.45 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 116.414 -0.357 . . . . 70.33 111.141 -166.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.496 HD12 ' HG3' ' C' ' 130' ' ' PRO . 73.4 mt -120.3 138.51 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 124.37 1.068 . . . . 75.04 108.969 173.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -158.37 176.08 12.9 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.288 0.992 . . . . 71.1 111.511 -171.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.0 p -106.13 119.4 39.11 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.657 -1.238 . . . . 72.24 107.657 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -80.02 -48.58 13.09 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.841 -0.8 . . . . 71.2 108.841 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 22.7 m-20 -134.55 125.23 26.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.611 -1.177 . . . . 61.34 109.014 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 79.3 mt -117.62 144.28 25.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 106.775 -1.565 . . . . 61.0 106.775 173.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 43.2 t -152.41 142.16 21.95 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.102 0.477 . . . . 60.22 109.777 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 35.4 t80 -144.33 124.09 13.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.802 -1.555 . . . . 62.23 106.802 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.97 111.55 10.51 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.312 -0.996 . . . . 72.53 108.312 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.22 81.71 17.24 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.903 0.881 . . . . 74.41 109.274 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 72' ' ' THR . 22.0 Cg_exo -66.99 -14.46 43.76 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.077 2.518 . . . . 75.32 112.328 174.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.5 ' HB2' ' HA ' ' A' ' 73' ' ' ALA . 21.9 m-80 -117.35 30.15 7.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.853 0.861 . . . . 63.13 110.395 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.52 98.23 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 123.717 0.807 . . . . 53.3 113.006 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -85.12 -24.8 1.95 Allowed 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 121.644 1.563 . . . . 63.31 113.188 169.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.479 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 58.9 m170 -70.97 -34.72 71.7 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.123 0.569 . . . . 73.55 110.922 -173.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -55.86 -31.77 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.495 1.118 . . . . 72.44 112.388 -175.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.67 -32.82 70.22 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.652 0.781 . . . . 64.33 111.347 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -88.84 -45.2 9.93 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.132 0.973 . . . . 74.43 111.647 -174.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 16.1 ptpt -83.32 173.59 11.44 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.821 0.848 . . . . 72.14 111.548 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -74.27 142.7 45.24 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.565 0.746 . . . . 53.11 111.514 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -93.2 78.65 4.52 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.522 0.677 . . . . 70.33 109.832 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -125.86 79.98 67.83 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.363 -0.977 . . . . 74.43 108.363 169.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -84.15 136.23 6.72 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.354 2.036 . . . . 73.52 112.315 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -96.44 102.05 13.77 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.154 -1.424 . . . . 60.34 107.154 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.421 ' O ' ' HB1' ' E' ' 466' ' ' ALA . 5.7 p -76.87 100.1 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 115.451 -0.795 . . . . 74.12 109.98 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 63.3 mttp -78.98 111.02 14.76 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.74 -1.208 . . . . 70.1 107.74 164.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.495 HD13 HG22 ' A' ' 64' ' ' VAL . 33.4 tp -109.48 133.31 53.23 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.895 -1.15 . . . . 71.42 107.895 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.408 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 24.4 t70 -135.93 129.42 32.18 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.91 -0.774 . . . . 75.41 108.91 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.2 mt -112.12 132.05 55.09 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.903 0.881 . . . . 73.5 109.013 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.76 147.73 52.46 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.709 0.803 . . . . 73.45 108.85 172.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.0 m -131.49 131.78 43.73 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.553 0.741 . . . . 53.22 109.825 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.82 154.34 50.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.144 0.978 . . . . 72.21 110.115 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.675 ' HB3' HD13 ' E' ' 454' ' ' LEU . 26.5 t -131.87 155.77 47.26 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.731 0.413 . . . . 73.41 110.284 174.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.7 p -148.76 141.21 24.27 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.572 0.749 . . . . 74.41 109.911 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -81.68 106.68 13.81 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.734 0.414 . . . . 74.35 110.479 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' A' ' 57' ' ' GLU . 34.1 mt -83.3 -36.3 24.58 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.263 -0.643 . . . . 71.11 109.263 173.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.82 177.27 11.6 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.765 1.226 . . . . 71.33 108.647 173.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -68.5 116.31 8.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.012 -0.736 . . . . 63.23 109.012 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 70.6 12.24 7.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.811 1.244 . . . . 75.1 112.476 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 42.8 t -120.38 112.41 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 107.71 -1.218 . . . . 65.12 107.71 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.81 134.43 45.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.464 0.706 . . . . 74.45 110.469 -169.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.6 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.5 tt0 -88.17 137.5 32.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.503 -0.925 . . . . 74.44 108.503 173.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.9 136.67 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.517 -1.29 . . . . 72.41 107.517 168.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.6 111.64 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.18 0.992 . . . . 71.13 108.69 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -92.23 102.3 14.81 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.168 -1.049 . . . . 65.21 108.168 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -84.33 106.76 16.19 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.002 -0.74 . . . . 75.3 109.002 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.404 HG11 HD11 ' A' ' 128' ' ' LEU . 43.0 t -104.35 103.97 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.834 -0.802 . . . . 54.32 108.834 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.59 HG22 ' HG3' ' A' ' 77' ' ' GLU . 74.9 p -100.35 111.96 24.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.487 0.715 . . . . 44.51 109.977 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.495 HG22 HD13 ' A' ' 42' ' ' LEU . 92.3 t -102.9 113.83 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.059 0.944 . . . . 74.14 108.858 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 10.8 m -116.66 105.62 12.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.741 -0.837 . . . . 75.12 108.741 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.27 106.36 18.01 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 106.378 -1.712 . . . . 71.42 106.378 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 p -149.29 128.67 12.97 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.822 0.702 . . . . 71.45 110.171 -168.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.6 tp -91.3 87.22 6.39 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.678 -0.86 . . . . 52.3 108.678 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.45 -93.31 1.86 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 114.849 -1.069 . . . . 33.14 111.724 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -113.62 -27.24 7.92 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.031 0.532 . . . . 73.4 111.526 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -79.58 106.62 11.75 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 122.421 0.288 . . . . 73.24 110.226 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.418 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 26.8 m -76.1 116.53 16.89 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.682 -0.69 . . . . 73.1 109.327 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . . . -68.03 -50.87 52.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.911 0.884 . . . . 72.43 108.768 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.463 ' HB2' ' HE1' ' A' ' 23' ' ' PHE . 47.3 p90 -156.78 147.58 21.74 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.982 -1.463 . . . . 74.33 109.863 173.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 53.8 tp -123.02 107.85 12.26 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 107.622 -1.251 . . . . 75.33 107.622 175.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.434 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 79.8 m -106.85 99.31 8.88 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.296 0.639 . . . . 72.32 109.729 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.59 ' HG3' HG22 ' A' ' 63' ' ' THR . 32.4 tt0 -115.08 118.28 32.94 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.901 0.88 . . . . 72.52 109.309 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.4 t -130.2 109.27 17.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.617 0.722 . . . . 74.33 109.459 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -86.44 80.26 8.72 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.137 -1.392 . . . . 71.25 108.147 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -76.93 111.65 12.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.875 -1.057 . . . . 73.3 108.622 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.17 144.07 17.03 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.829 -0.508 . . . . 71.31 111.829 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.0 145.11 15.55 Favored Glycine 0 C--O 1.236 0.247 0 N-CA-C 111.283 -0.727 . . . . 63.5 111.283 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.4 mt -81.32 123.38 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 108.488 -0.93 . . . . 73.21 108.488 173.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.661 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.1 m-85 -130.18 116.35 18.31 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.804 -0.813 . . . . 71.04 108.804 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.7 p -85.7 102.98 14.08 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.203 -1.036 . . . . 75.53 108.203 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.0 pt -115.36 130.98 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.908 0.883 . . . . 74.41 109.096 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.22 147.0 30.99 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.908 0.883 . . . . 55.15 109.963 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.66 1.56 57.58 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 115.007 0.763 . . . . 62.44 115.007 171.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.53 154.72 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 118.105 0.952 . . . . 74.53 111.369 -176.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.6 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 10.8 tt0 -155.02 -174.68 5.08 Favored 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 123.931 0.892 . . . . 64.4 109.3 173.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.6 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 73.2 -139.02 26.24 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 123.331 0.491 . . . . 63.42 114.188 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.1 p -73.88 -20.88 60.28 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.441 0.696 . . . . 62.21 111.233 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -66.48 -48.14 70.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.854 0.862 . . . . 61.11 110.114 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 91' ' ' GLY . 24.7 ptt? -70.03 -30.95 68.37 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 116.136 -0.484 . . . . 63.43 110.342 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.24 -34.55 77.69 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.158 0.583 . . . . 64.45 110.56 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -71.85 -35.88 69.97 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.39 -0.823 . . . . 65.03 110.11 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.502 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 49.9 t -66.88 -43.29 83.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.962 0.505 . . . . 72.13 111.346 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.424 HD22 HD11 ' E' ' 454' ' ' LEU . 3.6 pp -82.83 -38.19 23.37 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.258 -0.428 . . . . 74.43 110.785 -175.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.91 3.03 57.06 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 114.365 0.506 . . . . 65.4 114.365 -169.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -146.87 -60.24 0.29 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.182 0.491 . . . . 51.2 111.577 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.502 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 77.2 t80 -68.89 -49.56 57.2 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.25 1.02 . . . . 71.33 113.126 -166.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.08 -34.46 0.95 Allowed Pre-proline 0 CA--C 1.565 1.55 0 N-CA-C 113.513 0.931 . . . . 74.11 113.513 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.24 -21.11 55.39 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 121.601 1.534 . . . . 42.14 113.184 165.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 51.5 m-20 -62.1 -38.69 89.85 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 118.197 0.453 . . . . 73.31 110.211 169.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.0 mm -63.04 -45.37 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 O-C-N 124.004 0.815 . . . . 74.13 110.138 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.56 -20.13 51.27 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.01 0.924 . . . . 74.43 112.781 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -62.8 -45.32 87.65 Favored Pre-proline 0 CA--C 1.569 1.705 0 N-CA-C 113.719 1.007 . . . . 75.32 113.719 -173.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -63.71 -36.15 53.65 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.1 1.867 . . . . 64.01 113.459 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -71.11 -40.45 71.46 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.018 0.527 . . . . 72.42 111.156 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.62 -43.97 83.33 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.307 0.643 . . . . 72.2 110.003 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HG3' ' H ' ' A' ' 128' ' ' LEU . 38.1 ttm180 -51.59 -51.43 55.64 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.612 1.195 . . . . 62.44 110.509 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.22 -41.9 96.81 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.439 1.087 . . . . 74.21 111.556 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.17 -29.42 69.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 116.095 -0.502 . . . . 72.44 111.412 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.6 mt -78.63 -40.14 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.359 1.063 . . . . 61.44 110.331 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.467 HG23 ' HG3' ' A' ' 125' ' ' GLN . 34.4 m -66.53 -43.55 84.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.46 0.648 . . . . 75.4 110.638 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.5 t -64.43 -44.44 91.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.033 -0.985 . . . . 74.52 109.519 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.434 ' SD ' ' HA ' ' A' ' 76' ' ' CYS . 43.2 ttm -60.27 -46.53 89.48 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.229 1.012 . . . . 52.52 112.242 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 123' ' ' PHE . 7.2 p -69.71 -31.05 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.133 0.573 . . . . 62.45 110.616 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.2 m -77.06 -29.73 55.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.425 0.69 . . . . 71.41 111.213 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -70.77 -31.92 68.87 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.626 0.77 . . . . 74.44 109.832 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.23 -2.26 90.4 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-N 115.779 -0.646 . . . . 62.02 113.209 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.9 m 65.34 36.53 6.86 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-O 122.824 1.297 . . . . 73.21 110.939 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.473 ' HB2' HG22 ' A' ' 118' ' ' VAL . 95.9 m-85 -104.91 164.39 15.26 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.308 1.043 . . . . 63.23 108.904 171.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -59.59 153.35 55.83 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 122.322 2.014 . . . . 63.23 112.504 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.467 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.7 tt0 -63.77 139.12 58.74 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.447 0.699 . . . . 61.02 111.16 -177.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.6 tp -131.3 116.42 17.58 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.307 -0.861 . . . . 73.42 109.093 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -121.03 117.83 28.25 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.252 -1.018 . . . . 74.43 108.252 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.438 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 85.9 mt -59.78 122.32 13.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.312 0.645 . . . . 65.3 110.082 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -61.57 128.65 90.4 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-O 119.17 -0.443 . . . . 63.12 109.881 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 26.3 Cg_exo -64.18 100.23 0.31 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.657 2.238 . . . . 61.2 111.584 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.3 m -100.06 138.0 25.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-N 115.623 -0.717 . . . . 43.24 109.441 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -83.1 87.46 6.91 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.079 -0.964 . . . . 74.42 109.046 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.497 ' HA ' HD12 ' A' ' 136' ' ' LEU . 58.4 m-85 -56.03 -27.49 53.38 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.642 0.777 . . . . 74.31 112.559 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.21 -51.29 61.88 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.017 0.527 . . . . 72.05 110.25 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.52 85.63 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.007 0.817 . . . . 60.34 110.896 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 133' ' ' PHE . 61.1 mt -67.52 -38.68 84.62 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.159 0.983 . . . . 74.02 111.06 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.7 -38.54 86.94 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.716 -0.675 . . . . 74.45 109.495 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 19.8 mmt -63.18 -41.6 99.24 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 124.221 0.951 . . . . 61.2 110.34 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.63 ' HA ' ' HB3' ' A' ' 143' ' ' GLN . 18.8 m120 -54.22 -47.25 72.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 123.743 0.652 . . . . 70.32 110.403 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -67.36 -37.11 82.68 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.177 -0.92 . . . . 52.01 111.303 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.02 -56.03 8.01 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.992 0.917 . . . . 63.22 112.304 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -166.06 -11.62 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 123.955 0.902 . . . . 75.44 112.479 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.63 ' HB3' ' HA ' ' A' ' 139' ' ' ASN . 17.9 tm0? -65.59 107.36 1.7 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.519 0.728 . . . . 73.21 109.609 -174.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -134.98 -163.87 1.44 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.938 1.295 . . . . 63.12 109.025 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.3 94.16 0.08 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.041 0.448 . . . . 72.43 110.4 175.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.72 119.29 0.69 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 110.923 -0.871 . . . . 44.54 110.923 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -110.12 133.19 53.47 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.233 0.613 . . . . 71.34 111.627 -171.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -92.53 93.64 1.8 Allowed Glycine 0 C--N 1.351 1.393 0 N-CA-C 112.161 -0.376 . . . . 71.44 112.161 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.3 m -134.09 161.0 36.07 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.959 0.903 . . . . 63.11 110.099 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.18 175.87 5.67 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.336 0.654 . . . . 74.24 111.236 175.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -124.2 -15.41 6.77 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.592 0.757 . . . . 74.54 111.787 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -166.12 141.37 4.68 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.833 -0.803 . . . . 63.12 108.833 -174.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -166.24 94.11 0.53 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.299 -1.0 . . . . 75.35 108.299 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -122.94 -71.47 0.72 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.658 0.783 . . . . 71.04 109.06 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.883 0 N-CA-C 107.751 -1.203 . . . . 55.12 107.751 175.272 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.438 -0.579 . . . . 61.22 109.438 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 65.5 p -136.14 160.28 39.13 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.203 0.601 . . . . 75.14 111.071 -176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.11 117.82 35.07 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.026 -0.731 . . . . 60.13 109.026 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -80.27 -25.64 39.36 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.486 0.715 . . . . 73.23 111.368 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -80.43 88.78 5.59 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.401 0.62 . . . . 62.41 109.559 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -102.27 82.65 2.22 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.461 -0.94 . . . . 63.15 108.461 173.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -84.29 -42.73 15.53 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.288 -0.869 . . . . 73.41 109.76 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -119.19 -42.8 2.66 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.798 -0.637 . . . . 64.34 112.393 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.413 ' SD ' HG23 ' B' ' 89' ' ' ILE . 0.8 OUTLIER 66.48 164.62 0.19 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.437 1.095 . . . . 70.15 111.287 -167.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 87.1 m -155.28 133.9 11.92 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.199 0.999 . . . . 64.41 109.457 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -129.52 137.64 50.9 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.588 -0.893 . . . . 72.12 108.588 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -149.92 130.79 14.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.084 -0.71 . . . . 72.14 109.084 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.453 HD11 HD13 ' B' ' 105' ' ' ILE . 20.6 mt -76.52 118.09 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.738 -1.208 . . . . 74.34 107.738 166.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -86.22 -49.36 7.77 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.665 -0.865 . . . . 72.22 108.665 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.411 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 74.1 ttt180 -164.99 138.27 4.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.867 -1.061 . . . . 72.21 109.069 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.9 mt -115.6 141.92 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.321 -0.992 . . . . 74.13 108.321 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -164.12 147.2 9.45 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.767 0.427 . . . . 73.21 111.321 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.698 HG21 HD11 ' B' ' 21' ' ' ILE . 24.5 m -78.57 130.45 35.95 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.197 -1.038 . . . . 71.34 108.197 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -93.17 -47.48 6.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.58 0.752 . . . . 71.33 110.083 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.33 141.05 39.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.162 -0.927 . . . . 62.33 110.856 -171.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.698 HD11 HG21 ' B' ' 18' ' ' THR . 48.4 mm -131.44 144.91 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.914 1.286 . . . . 74.03 108.26 171.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.517 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.7 t -145.63 129.12 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.077 -1.453 . . . . 72.42 107.077 173.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.3 t80 -143.31 107.04 4.63 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 106.517 -1.66 . . . . 74.42 106.517 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -118.1 112.51 20.3 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.079 -1.082 . . . . 73.34 108.079 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.3 85.46 2.15 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.939 -1.504 . . . . 61.54 106.939 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.96 -26.21 26.88 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.92 2.413 . . . . 64.35 112.156 -166.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -114.4 15.47 17.94 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.979 -1.009 . . . . 62.45 110.34 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.88 -61.99 0.97 Allowed Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 115.19 1.552 . . . . 64.31 115.19 -163.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.62 -27.05 39.14 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 121.831 1.687 . . . . 74.22 113.023 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -89.01 -38.87 14.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.994 0.518 . . . . 71.22 111.733 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.787 HG21 ' HA ' ' B' ' 73' ' ' ALA . 13.3 p -69.71 -16.09 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.209 0.604 . . . . 72.42 111.128 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -68.33 -4.07 13.18 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.483 0.713 . . . . 74.54 112.791 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.503 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.4 pt20 -68.34 -23.41 64.7 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.919 0.487 . . . . 72.12 110.219 168.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.503 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 86.7 mttt -107.88 79.02 1.23 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.829 1.251 . . . . 74.13 108.648 177.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -80.12 86.51 5.55 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.717 0.77 . . . . 75.34 109.35 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.0 t-105 -150.87 155.9 40.12 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.891 1.276 . . . . 72.34 107.594 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -70.76 99.99 0.26 Allowed Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 125.916 1.686 . . . . 74.42 110.576 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.621 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 49.0 Cg_endo -67.65 137.43 42.32 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.557 2.171 . . . . 73.23 112.535 -173.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -54.89 123.33 13.11 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.04 0.838 . . . . 73.54 109.764 173.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -104.33 157.19 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.443 0.64 . . . . 73.11 111.682 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -142.14 127.7 19.04 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.565 -1.643 . . . . 54.15 106.565 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.586 ' H ' HD23 ' B' ' 42' ' ' LEU . 2.6 pt? -104.41 151.88 22.98 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.834 0.453 . . . . 73.42 110.607 -175.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.426 ' HA ' ' OH ' ' F' ' 462' ' ' TYR . 13.0 t70 -143.19 116.19 8.85 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.603 -0.888 . . . . 75.45 108.603 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.43 ' O ' ' HG ' ' F' ' 460' ' ' LEU . 63.7 mt -99.26 156.9 16.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.716 0.406 . . . . 33.51 110.166 -174.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.487 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 11.6 m-20 -141.57 111.39 6.63 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.121 -1.066 . . . . 75.51 108.121 167.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -109.82 104.06 12.95 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.74 -0.467 . . . . 71.51 109.74 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.84 152.78 34.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.237 1.015 . . . . 62.34 109.434 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -137.58 161.84 35.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.033 0.533 . . . . 73.03 109.916 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -163.32 160.85 24.22 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.059 0.543 . . . . 73.41 110.241 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -91.47 123.03 34.58 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.124 0.57 . . . . 75.34 110.273 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 81.1 mt -87.33 -43.77 11.9 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.718 0.807 . . . . 72.03 109.107 167.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.61 -170.54 3.11 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.58 -1.191 . . . . 74.51 110.033 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.98 111.95 2.38 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.598 -0.728 . . . . 73.2 110.429 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 43.7 m-20 70.23 0.38 3.14 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.256 1.423 . . . . 74.0 112.838 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.8 t -104.18 102.88 14.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.526 -0.916 . . . . 62.02 108.526 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -99.73 146.99 25.92 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.64 -1.164 . . . . 74.31 109.643 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -109.4 116.55 32.03 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.465 -1.309 . . . . 51.42 107.465 165.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.437 HG11 ' HD3' ' B' ' 103' ' ' PRO . 52.3 t -96.01 143.37 12.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.526 -0.916 . . . . 75.32 108.526 172.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.2 t -131.89 137.36 55.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.959 -0.756 . . . . 65.41 108.959 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.85 109.59 14.38 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.176 -1.416 . . . . 75.44 107.176 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 40.7 ttm180 -95.25 130.94 41.8 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.543 -0.54 . . . . 61.21 109.543 170.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 37.0 t -120.62 106.13 18.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.192 -1.41 . . . . 74.34 107.192 169.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -96.13 146.62 24.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.11 -1.07 . . . . 75.15 108.11 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 71.1 t -138.4 130.12 37.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.284 1.034 . . . . 73.31 108.466 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 98.3 m -117.39 136.95 52.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.385 -0.969 . . . . 70.51 108.385 172.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.12 143.79 50.25 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.473 0.483 . . . . 74.11 110.289 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 44.3 p -133.68 127.03 32.05 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 123.959 0.787 . . . . 74.22 110.771 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.621 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 34.1 mt -105.88 114.64 28.9 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.116 0.966 . . . . 74.4 108.697 171.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.37 -111.73 3.94 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.537 -1.025 . . . . 54.42 110.537 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.23 4.58 11.28 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.527 0.731 . . . . 72.13 111.027 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -114.47 160.64 18.97 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.424 0.69 . . . . 75.31 109.583 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.3 m -72.24 135.07 45.94 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.543 -0.54 . . . . 64.43 109.543 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.787 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -88.72 -59.62 2.18 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.411 -0.959 . . . . 52.22 108.411 175.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.638 ' HZ ' HD11 ' B' ' 126' ' ' LEU . 52.5 p90 -151.96 170.08 20.74 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 113.973 -1.467 . . . . 74.32 109.821 176.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.7 mt -133.05 138.86 46.9 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.878 -1.897 . . . . 72.33 105.878 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' B' ' 114' ' ' ILE . 38.0 t -141.1 150.95 43.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.882 -0.784 . . . . 63.53 108.882 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.8 tt0 -164.37 132.55 3.45 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.034 -0.728 . . . . 62.21 109.034 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 98.6 t -128.94 147.67 33.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.474 -0.936 . . . . 74.33 108.474 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -123.15 93.13 3.86 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.293 -1.002 . . . . 73.13 108.293 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.481 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.9 tp-100 -82.79 100.89 10.58 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.702 -1.135 . . . . 54.32 109.014 177.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.51 163.73 31.36 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 111.02 -0.832 . . . . 74.44 111.02 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.3 128.23 1.73 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.936 -0.866 . . . . 52.24 110.936 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 30.8 mt -84.6 133.65 28.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.619 0.768 . . . . 62.01 109.077 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' B' ' 102' ' ' CYS . 22.8 m-85 -138.04 135.52 35.96 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.033 -0.728 . . . . 75.0 109.033 174.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -97.44 107.97 20.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.57 0.748 . . . . 73.3 108.995 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 43.0 pt -111.79 145.06 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.758 0.823 . . . . 74.14 110.377 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.511 ' HA ' HG11 ' F' ' 451' ' ' VAL . . . -144.32 158.1 43.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.702 0.801 . . . . 74.24 109.741 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.08 -65.14 4.12 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.557 0.536 . . . . 63.45 112.574 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.42 HD11 ' HB ' ' B' ' 86' ' ' ILE . 25.7 pt -58.15 144.01 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.225 1.01 . . . . 52.45 112.491 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -150.66 149.88 30.4 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.246 -0.888 . . . . 72.33 109.458 -171.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.3 -115.6 8.13 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.905 0.753 . . . . 54.13 113.013 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 24.7 m -67.14 -31.43 71.87 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.824 0.85 . . . . 73.14 112.003 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.93 -47.82 73.43 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.191 0.596 . . . . 74.11 110.81 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.538 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 12.3 ptp -72.91 -29.47 63.16 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-O 119.077 -0.487 . . . . 73.4 110.113 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.89 -32.16 71.63 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.824 0.45 . . . . 52.04 111.053 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.42 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 28.0 t-80 -72.42 -30.44 64.62 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.961 0.504 . . . . 62.23 110.971 174.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.595 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 85.9 m -76.71 -71.69 0.38 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 110.385 -0.228 . . . . 74.2 110.385 176.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.4 pp -71.42 -14.41 62.15 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.384 0.883 . . . . 60.54 113.384 -171.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.89 0.33 36.04 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-O 119.488 -0.618 . . . . 71.12 113.93 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -152.42 -62.1 0.16 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.741 0.771 . . . . 61.52 112.4 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.595 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 90.0 t80 -70.18 -47.28 62.25 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.101 0.96 . . . . 74.52 112.205 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.465 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 71.5 m -62.7 -49.15 84.01 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.15 0.98 . . . . 65.23 111.428 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 86.3 Cg_exo -54.05 -35.33 81.0 Favored 'Trans proline' 0 C--N 1.397 3.099 0 C-N-CA 122.043 1.829 . . . . 64.35 114.128 167.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -62.9 -37.26 86.25 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 123.202 0.601 . . . . 75.13 110.468 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.453 HD13 HD11 ' B' ' 13' ' ' ILE . 68.1 mt -66.18 -41.83 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.958 0.903 . . . . 74.33 110.458 174.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 67.5 mt -78.73 -19.19 52.92 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.427 -0.806 . . . . 55.12 112.12 -175.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -58.79 -49.15 94.98 Favored Pre-proline 0 N--CA 1.483 1.214 0 CA-C-O 117.829 -1.081 . . . . 72.04 113.515 -171.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.41 -38.26 89.39 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.194 1.929 . . . . 74.55 113.723 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.481 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 83.4 m-85 -68.53 -48.66 63.75 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 123.516 0.51 . . . . 73.42 110.527 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.34 -42.25 91.04 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.557 0.743 . . . . 74.53 111.304 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 54.3 ttt-85 -61.58 -53.22 59.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.802 1.641 . . . . 73.25 110.946 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -68.27 -30.27 69.26 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.987 0.805 . . . . 64.12 110.198 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.489 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.4 t -69.0 -41.11 78.26 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.833 0.453 . . . . 73.43 111.131 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.462 HG23 ' SG ' ' B' ' 76' ' ' CYS . 73.0 mt -60.55 -52.4 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.609 -0.515 . . . . 74.54 109.609 172.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.4 HG21 ' OG ' ' C' ' 119' ' ' SER . 62.9 m -56.12 -34.45 66.09 Favored 'General case' 0 CA--C 1.554 1.124 0 O-C-N 124.477 1.111 . . . . 70.34 111.988 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.6 t -66.72 -49.06 67.26 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 123.229 0.612 . . . . 65.4 109.873 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.503 ' SD ' HG21 ' A' ' 21' ' ' ILE . 34.5 mmt -61.5 -41.41 97.25 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.095 0.558 . . . . 72.21 111.155 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 78.2 t -62.77 -43.7 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.427 1.091 . . . . 70.34 110.851 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.8 t -65.65 -36.84 84.83 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.821 -1.081 . . . . 72.0 111.607 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -67.69 -36.74 81.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.026 -0.988 . . . . 61.41 110.47 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.51 6.99 59.35 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.334 -0.703 . . . . 63.24 113.084 176.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 72.0 p 59.38 22.0 10.38 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.378 1.871 . . . . 61.14 113.332 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -85.13 151.79 57.56 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.61 0.764 . . . . 73.4 109.963 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.36 156.98 3.5 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 124.242 3.294 . . . . 73.44 116.328 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -65.86 117.8 8.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.229 -1.35 . . . . 73.11 111.844 -173.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.638 HD11 ' HZ ' ' B' ' 74' ' ' PHE . 22.5 mt -113.44 120.26 40.42 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.029 -0.73 . . . . 54.32 109.029 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -123.21 96.22 4.91 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 107.895 -1.15 . . . . 72.54 107.895 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.549 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.1 mm? -61.72 149.82 38.56 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.825 0.85 . . . . 73.43 112.334 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.63 151.25 87.02 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.987 0.915 . . . . 64.21 110.659 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.95 104.81 1.41 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.501 2.134 . . . . 72.13 111.634 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.0 t -90.57 108.66 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.277 -1.008 . . . . 62.44 108.277 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -90.07 98.36 11.73 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.1 -1.074 . . . . 71.01 108.1 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -61.92 -32.97 73.42 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.289 -0.869 . . . . 74.53 111.41 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.33 -39.3 78.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.716 1.207 . . . . 71.01 111.823 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.17 -41.17 90.67 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.312 0.645 . . . . 51.41 110.207 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.28 -37.27 85.05 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.685 -1.143 . . . . 72.55 110.965 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.466 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 60.3 t80 -69.32 -36.49 77.02 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.64 0.776 . . . . 73.3 110.668 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -62.37 -38.27 88.9 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.116 0.567 . . . . 44.33 110.291 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -75.44 -28.24 59.24 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.475 -0.784 . . . . 74.43 110.854 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -61.36 -44.75 96.64 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.074 0.549 . . . . 62.44 110.501 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 15.5 mt -83.63 -9.63 58.76 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.549 -0.75 . . . . 71.23 111.756 -171.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -139.76 111.29 7.18 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.299 0.639 . . . . 71.4 109.947 -172.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -70.4 -28.47 65.1 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.42 -0.585 . . . . 73.22 109.42 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -57.01 97.79 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.088 0.955 . . . . 74.42 110.155 173.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.69 130.18 36.48 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.748 -0.834 . . . . 65.01 108.748 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.71 146.37 4.4 Favored Glycine 0 C--O 1.241 0.542 0 N-CA-C 111.072 -0.811 . . . . 70.52 111.072 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -164.78 175.83 9.31 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.116 0.566 . . . . 73.35 110.158 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 141.99 176.94 16.62 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 116.065 -0.516 . . . . 74.05 112.179 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.596 HG23 ' HB3' ' D' ' 6' ' ' ASN . 3.0 t -141.97 144.54 33.76 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.428 0.691 . . . . 73.41 110.727 -173.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.46 130.22 34.96 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.803 -0.814 . . . . 74.3 108.803 172.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.524 ' HG2' ' H ' ' B' ' 152' ' ' HIS . 29.6 tt0 -155.01 -176.41 5.92 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.534 -0.914 . . . . 52.14 108.534 -172.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' HIS . . . . . 0.524 ' H ' ' HG2' ' B' ' 151' ' ' GLU . 68.9 m80 -132.24 135.09 46.04 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.636 -0.665 . . . . 73.12 109.679 175.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -75.75 113.86 13.69 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.977 0.911 . . . . 72.42 109.353 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -65.03 -70.27 0.24 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 109.172 -0.677 . . . . 74.32 109.172 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 N-CA-C 108.326 -0.99 . . . . 74.52 108.326 -178.06 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 109.931 -0.396 . . . . 73.24 109.931 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 10.4 m -68.15 97.17 0.68 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.847 0.859 . . . . 54.13 110.295 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -119.35 156.69 29.6 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.837 0.855 . . . . 54.12 109.972 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -154.72 -70.12 0.13 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.042 -0.526 . . . . 62.55 110.03 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -91.53 58.64 3.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.549 0.739 . . . . 61.1 110.411 -173.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -79.95 -47.21 15.37 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.922 0.889 . . . . 74.25 108.978 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -157.93 150.76 22.79 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 114.262 -1.336 . . . . 73.45 108.545 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.04 140.27 48.92 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.931 -0.766 . . . . 74.23 108.931 172.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.408 ' SD ' HD13 ' C' ' 89' ' ' ILE . 45.7 ttp 63.26 112.53 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.977 1.311 . . . . 74.52 110.875 -167.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.735 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 64.4 m -101.0 97.26 7.85 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.04 -1.096 . . . . 64.12 108.04 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.566 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 44.9 t80 -102.02 128.93 48.24 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.556 -0.905 . . . . 72.04 108.556 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -137.56 126.35 23.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.949 -0.76 . . . . 72.11 108.949 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 83.8 mt -77.38 122.17 31.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.659 -0.867 . . . . 73.03 108.659 172.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -91.15 -39.22 12.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.228 -0.896 . . . . 63.43 109.712 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -172.59 144.75 1.48 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.101 -0.703 . . . . 70.04 109.101 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 92.3 mt -134.07 137.69 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.769 -1.197 . . . . 72.11 107.769 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.453 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 32.2 p90 -169.58 171.94 7.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.872 0.844 . . . . 73.43 111.458 -173.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.1 p -96.77 118.35 33.02 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.222 -0.899 . . . . 72.5 109.061 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.543 ' HE3' ' HA3' ' C' ' 81' ' ' GLY . 21.5 mmtp -67.37 -48.97 65.88 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.66 -1.237 . . . . 74.41 107.66 171.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -137.61 142.92 41.25 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 112.974 -1.921 . . . . 72.32 109.6 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.498 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 76.0 mt -136.5 144.07 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 106.283 -1.747 . . . . 71.12 106.283 172.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -160.51 146.92 15.39 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.372 0.606 . . . . 73.41 110.824 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -139.03 135.13 33.91 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.2 -1.407 . . . . 75.12 107.2 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.431 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 38.8 mt-10 -135.36 114.45 12.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.729 0.812 . . . . 64.21 109.988 -176.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.86 83.88 33.63 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 107.112 -1.44 . . . . 61.22 107.112 170.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -70.34 -19.85 32.83 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.048 2.499 . . . . 72.44 112.684 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -116.33 24.85 11.07 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.775 1.23 . . . . 72.34 110.06 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.87 -57.66 5.68 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 114.483 1.29 . . . . 73.31 114.483 -169.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.3 -36.56 55.74 Favored 'Trans proline' 0 C--N 1.388 2.655 0 CA-C-N 121.542 1.586 . . . . 71.24 112.172 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.534 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 68.3 t60 -69.9 -32.99 71.61 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.417 -0.81 . . . . 64.24 112.36 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.754 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.0 p -81.54 -22.12 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 N-CA-C 112.731 0.641 . . . . 44.44 112.731 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -64.33 -23.79 67.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.628 -0.67 . . . . 72.34 112.682 175.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.6 pt20 -88.48 8.32 28.56 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.952 0.501 . . . . 73.23 111.301 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' C' ' 31' ' ' VAL . 1.1 mptm? -92.52 177.87 5.99 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 122.255 1.026 . . . . 64.15 113.24 -172.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -87.47 114.04 23.72 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 112.905 -1.952 . . . . 73.23 108.074 168.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.473 ' CZ2' HD11 ' G' ' 470' ' ' LEU . 51.5 t90 -84.48 71.32 10.73 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.742 0.782 . . . . 72.21 110.939 -174.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -132.92 69.59 79.01 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 123.966 0.906 . . . . 63.15 109.034 170.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.529 ' HD2' HD13 ' G' ' 470' ' ' LEU . 9.8 Cg_endo -87.95 158.05 7.3 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.046 2.497 . . . . 62.23 113.73 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.97 96.43 8.84 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 107.284 -1.376 . . . . 64.51 107.284 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 m -79.28 128.25 38.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-O 121.705 0.764 . . . . 63.35 110.373 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -132.65 113.54 13.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.503 1.121 . . . . 62.31 108.338 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.64 HD12 ' SD ' ' G' ' 464' ' ' MET . 72.2 mt -86.0 158.79 19.78 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.825 -0.806 . . . . 75.23 108.825 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.7 t70 -137.4 105.14 5.58 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.602 -1.258 . . . . 73.32 107.602 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.27 129.49 43.58 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.044 -0.724 . . . . 75.33 109.044 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -144.24 125.01 14.16 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.57 -0.9 . . . . 74.32 108.57 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.427 ' H ' HD23 ' G' ' 460' ' ' LEU . 5.2 t -116.46 139.78 50.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.447 -0.575 . . . . 61.3 109.447 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.45 135.61 37.03 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.106 0.962 . . . . 71.01 108.406 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 13.0 p -136.38 151.12 49.21 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 109.314 -0.625 . . . . 54.5 109.314 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 70.0 p -156.65 143.73 18.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.369 0.668 . . . . 74.03 109.765 -174.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -78.93 118.1 20.63 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.326 0.65 . . . . 64.13 109.991 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' C' ' 57' ' ' GLU . 68.8 mt -89.26 -29.73 19.0 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.05 0.54 . . . . 72.32 110.13 174.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.47 172.67 16.81 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.787 1.235 . . . . 45.53 109.034 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -57.37 128.58 37.75 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.842 -0.799 . . . . 72.11 108.842 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 69.48 -1.85 2.1 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.42 1.088 . . . . 73.05 113.015 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -111.95 117.56 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.338 0.655 . . . . 72.14 109.373 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -124.85 126.46 45.61 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.041 0.936 . . . . 51.4 109.983 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.574 ' HB2' HD11 ' C' ' 51' ' ' LEU . 21.5 tt0 -83.62 133.0 34.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.936 -1.135 . . . . 73.42 107.936 165.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.47 140.35 47.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 N-CA-C 108.842 -0.799 . . . . 65.35 108.842 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 81.6 t -124.56 133.18 70.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.838 1.255 . . . . 72.11 107.629 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.2 104.81 8.71 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.237 -1.394 . . . . 71.1 107.237 174.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.464 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 1.9 ttm180 -86.69 130.01 34.65 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 113.886 -1.506 . . . . 61.21 109.127 177.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.1 124.81 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.458 -1.312 . . . . 73.01 107.458 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 32.7 m -124.52 131.18 53.49 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.855 -0.794 . . . . 64.52 108.855 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.477 HG23 HD13 ' C' ' 114' ' ' ILE . 23.4 t -107.49 126.65 63.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.003 -0.74 . . . . 55.13 109.003 173.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.411 HG23 HD23 ' C' ' 75' ' ' LEU . 5.2 m -116.25 145.43 43.15 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.935 -1.135 . . . . 75.43 107.935 173.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.54 128.02 20.08 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.053 -0.721 . . . . 41.51 109.053 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.8 m -128.01 126.03 40.54 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 123.196 0.598 . . . . 73.0 110.141 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 39.5 mt -88.47 37.7 0.84 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.589 1.156 . . . . 65.31 110.198 172.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.6 -96.08 1.52 Allowed Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.374 -1.09 . . . . 70.35 110.374 -173.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -107.1 -5.46 18.01 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.313 1.045 . . . . 65.03 110.839 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.43 ' HG2' ' HZ3' ' C' ' 34' ' ' LYS . 4.0 tp10 -103.17 121.14 42.04 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.526 1.131 . . . . 63.11 109.062 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 35.6 m -69.32 126.95 31.36 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.779 0.718 . . . . 70.45 109.07 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.754 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.42 -54.64 6.44 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.093 -0.706 . . . . 55.21 109.093 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -169.08 168.87 9.79 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 114.836 -1.074 . . . . 74.22 111.097 175.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -140.08 143.83 36.51 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 106.883 -1.525 . . . . 64.5 106.883 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.404 ' N ' HD13 ' C' ' 75' ' ' LEU . 43.8 t -153.24 116.19 4.55 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.726 -0.472 . . . . 63.12 109.726 175.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -117.6 133.01 56.41 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.722 0.409 . . . . 74.31 110.086 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 84.6 t -126.57 138.07 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.225 1.01 . . . . 64.34 108.39 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.464 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 66.7 mt-30 -115.11 97.14 6.04 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.349 -0.982 . . . . 72.32 108.349 173.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -86.63 104.52 16.13 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.572 0.749 . . . . 62.22 110.683 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.543 ' HA3' ' HE3' ' C' ' 19' ' ' LYS . . . -110.42 143.78 16.96 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 121.532 -0.366 . . . . 73.02 112.729 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.03 142.06 10.22 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 111.361 -0.696 . . . . 53.3 111.361 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' D' ' 29' ' ' PRO . 14.4 mm -90.72 126.39 43.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.557 -0.905 . . . . 72.55 108.557 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -132.27 128.76 38.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.955 0.902 . . . . 55.13 109.19 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.8 p -96.78 126.1 41.7 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 109.225 -0.657 . . . . 55.33 109.225 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.402 ' O ' HD12 ' C' ' 86' ' ' ILE . 2.5 pp -115.48 143.9 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.89 1.276 . . . . 73.25 109.577 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -144.31 142.9 30.71 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.67 0.388 . . . . 65.34 110.953 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.71 -18.08 48.93 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 114.635 0.614 . . . . 62.41 114.635 175.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.408 HD13 ' SD ' ' C' ' 9' ' ' MET . 38.5 pt -113.43 154.13 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 117.406 0.603 . . . . 75.42 112.227 -172.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -164.57 -178.68 5.5 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.163 0.985 . . . . 71.4 109.798 173.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.12 -123.5 33.24 Favored Glycine 0 C--N 1.352 1.458 0 O-C-N 123.427 0.454 . . . . 44.04 114.005 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 74.0 p -70.64 -32.25 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.048 0.939 . . . . 74.44 111.258 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -69.09 -36.15 77.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.342 0.657 . . . . 70.45 110.987 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' G' ' 453' ' ' GLY . 46.8 ttm -76.81 -32.89 57.94 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.496 -0.32 . . . . 74.24 110.267 174.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.89 -41.02 73.84 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.55 0.532 . . . . 72.23 110.275 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -81.24 -30.59 34.1 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.438 0.461 . . . . 74.51 111.705 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 23.0 t -62.09 -39.22 91.74 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.416 0.448 . . . . 74.42 110.666 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.32 -14.32 24.02 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.091 0.556 . . . . 62.1 110.718 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.05 -29.99 61.83 Favored Glycine 0 C--N 1.357 1.696 0 O-C-N 123.279 0.362 . . . . 55.43 113.886 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.09 -38.65 0.06 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.201 0.815 . . . . 64.53 113.201 -170.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -62.42 -52.45 63.5 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.906 0.482 . . . . 73.3 111.322 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.566 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 58.8 m -72.9 -46.19 8.7 Favored Pre-proline 0 CA--C 1.563 1.452 0 CA-C-O 118.732 -0.652 . . . . 74.02 112.289 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 64.6 Cg_exo -54.33 -28.5 53.48 Favored 'Trans proline' 0 C--N 1.398 3.14 0 C-N-CA 122.321 2.014 . . . . 73.45 114.306 171.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -69.65 -35.79 75.49 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.458 0.703 . . . . 75.22 109.774 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.438 HD12 ' NH1' ' A' ' 111' ' ' ARG . 27.8 mm -64.94 -41.8 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.509 -0.552 . . . . 61.15 109.509 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 39.8 mt -79.03 -27.95 43.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.063 0.945 . . . . 61.41 113.015 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -57.67 -49.82 91.59 Favored Pre-proline 0 CA--C 1.564 1.503 0 N-CA-C 114.337 1.236 . . . . 70.33 114.337 -171.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.93 -33.93 95.47 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 121.944 1.763 . . . . 74.11 112.905 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -69.19 -45.59 69.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.983 0.513 . . . . 53.32 110.502 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.25 -37.45 77.63 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.255 -0.884 . . . . 61.04 110.665 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -61.89 -58.94 6.0 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.863 -1.062 . . . . 60.45 110.621 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.03 78.66 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 110.137 -0.32 . . . . 51.2 110.137 -175.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.3 t -66.74 -28.65 68.58 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.974 0.509 . . . . 64.41 111.609 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.477 HD13 HG23 ' C' ' 64' ' ' VAL . 83.4 mt -77.13 -55.43 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 109.707 -0.479 . . . . 53.3 109.707 170.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.1 m -60.81 -28.62 68.92 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.211 1.005 . . . . 74.12 111.782 -170.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -68.84 -49.75 55.74 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.834 -0.802 . . . . 74.53 108.834 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.576 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.21 -34.84 75.75 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.561 1.144 . . . . 62.05 112.639 178.205 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.52 -48.16 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.743 0.817 . . . . 72.14 109.193 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.4 ' OG ' HG21 ' B' ' 115' ' ' THR . 41.9 t -67.85 -28.87 67.92 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.811 -1.086 . . . . 72.44 111.911 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -71.31 -43.95 66.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.578 -0.897 . . . . 62.12 108.578 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.86 3.27 61.34 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 123.901 0.751 . . . . 30.32 113.036 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 33.1 p 60.23 38.35 20.06 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.694 1.998 . . . . 71.34 113.898 170.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -94.4 149.8 37.21 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 108.655 -0.869 . . . . 62.21 108.655 166.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.31 176.71 0.35 Allowed 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.309 2.673 . . . . 72.1 115.376 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -59.85 122.16 13.54 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.325 1.05 . . . . 75.4 113.747 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.4 ' CD2' HG11 ' C' ' 64' ' ' VAL . 9.6 mp -112.66 86.26 2.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.218 1.007 . . . . 64.13 109.48 171.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -107.47 107.98 19.09 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.816 -0.809 . . . . 60.41 108.816 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.439 HD22 HD11 ' C' ' 42' ' ' LEU . 59.5 mt -73.38 142.83 46.98 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.643 -0.708 . . . . 74.35 110.519 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.67 148.32 94.95 Favored Pre-proline 0 CA--C 1.55 0.975 0 O-C-N 123.844 0.715 . . . . 75.12 110.111 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.496 ' HG3' HD12 ' A' ' 16' ' ' ILE . 37.4 Cg_exo -57.42 120.38 8.26 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.581 2.188 . . . . 75.34 112.221 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 98.7 t -97.52 119.51 45.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.296 -1.001 . . . . 75.43 108.296 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -77.93 73.12 4.5 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.761 0.663 . . . . 72.22 110.378 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -56.95 -41.05 77.6 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.558 0.743 . . . . 72.3 110.595 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -66.0 -49.49 67.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.069 -0.969 . . . . 71.23 111.762 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.02 96.22 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.959 0.787 . . . . 42.22 111.033 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.408 ' HB3' ' HE1' ' G' ' 461' ' ' PHE . 87.2 mt -70.29 -29.32 66.04 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.376 -0.829 . . . . 63.34 111.665 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.413 ' HA ' ' HB3' ' C' ' 140' ' ' TYR . 15.3 t80 -77.26 -25.99 52.05 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 110.062 -0.347 . . . . 74.32 110.062 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 94.2 mtp -72.03 -30.82 65.57 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.916 0.487 . . . . 62.04 110.118 172.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -70.19 -37.42 75.12 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 109.508 -0.553 . . . . 74.0 109.508 170.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' C' ' 143' ' ' GLN . 57.3 t80 -70.04 -88.35 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.394 1.077 . . . . 74.55 112.726 -175.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 55.93 -79.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.231 1.012 . . . . 75.2 111.527 -164.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -129.59 9.51 5.51 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.95 0.9 . . . . 60.23 112.003 -175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' C' ' 140' ' ' TYR . 10.4 pt20 -135.94 122.82 21.26 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.815 0.846 . . . . 64.24 109.878 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -65.96 84.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.06 0.544 . . . . 70.13 110.708 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.75 68.09 0.67 Allowed 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.962 0.905 . . . . 55.45 110.065 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.48 67.62 0.59 Allowed Glycine 0 C--N 1.341 0.842 0 CA-C-N 114.99 -1.005 . . . . 63.41 111.161 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.7 111.61 17.3 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.709 -0.478 . . . . 73.33 109.709 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.08 121.43 5.47 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 123.578 0.549 . . . . 65.31 112.275 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 23.4 p -139.04 41.2 2.12 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.084 0.954 . . . . 75.23 109.922 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -91.78 114.58 27.15 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.225 0.61 . . . . 74.23 110.167 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -79.29 142.27 36.29 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.202 0.601 . . . . 74.23 109.679 170.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -157.92 152.06 24.36 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.769 0.828 . . . . 73.12 108.9 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -65.63 98.02 0.35 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.225 0.61 . . . . 72.53 110.927 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -72.57 101.73 3.08 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.582 -0.896 . . . . 70.31 108.582 174.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.244 0 C-N-CA 125.05 1.34 . . . . 63.33 111.823 -173.406 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.392 -0.596 . . . . 60.22 109.392 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -115.83 89.18 3.05 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.657 0.783 . . . . 62.0 110.339 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.04 113.45 6.43 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.943 -0.762 . . . . 72.01 108.943 170.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -130.76 126.6 36.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.065 0.546 . . . . 74.11 110.592 -172.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -84.55 103.21 13.48 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.675 -0.861 . . . . 74.4 108.675 171.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' ASN . . . . . 0.596 ' HB3' HG23 ' B' ' 149' ' ' THR . 64.6 t-20 -81.47 70.87 8.43 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.841 0.829 . . . . 41.43 108.877 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -93.21 -12.76 29.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.667 0.787 . . . . 75.32 111.225 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.4 -21.96 41.74 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.85 0.86 . . . . 64.35 110.892 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 4.7 ttp -28.9 122.94 0.13 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 126.077 1.751 . . . . 72.11 113.594 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.1 m -116.6 147.38 41.92 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 122.967 0.507 . . . . 54.44 109.959 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.402 ' HZ ' HG13 ' D' ' 105' ' ' ILE . 74.9 t80 -152.68 94.31 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.654 -1.239 . . . . 61.5 107.654 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -123.18 116.84 24.08 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.516 0.727 . . . . 75.25 109.04 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.16 113.79 17.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.221 -1.029 . . . . 75.22 108.221 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -81.99 -22.93 36.31 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.604 0.761 . . . . 74.24 111.059 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -170.61 141.28 1.85 Allowed 'General case' 0 C--N 1.361 1.065 0 O-C-N 123.536 0.522 . . . . 71.11 111.234 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.404 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -119.7 133.93 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.683 -1.599 . . . . 54.14 106.683 169.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.448 ' HE1' HG13 ' D' ' 83' ' ' ILE . 20.7 p90 -163.13 163.08 25.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.407 0.622 . . . . 75.32 111.499 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -95.47 120.91 36.53 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.704 -0.85 . . . . 65.41 108.704 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 41.0 mtpt -83.92 -35.2 24.24 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.19 -0.67 . . . . 75.03 109.19 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.4 t70 -146.9 137.18 23.55 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.506 -1.225 . . . . 74.25 109.303 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.576 HG21 ' HE2' ' C' ' 117' ' ' MET . 78.5 mt -136.9 145.31 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.532 1.133 . . . . 71.12 107.976 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -146.77 135.98 22.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.11 0.964 . . . . 61.4 108.831 172.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.498 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.3 t80 -136.65 129.54 30.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 106.453 -1.684 . . . . 64.53 106.453 166.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 33.1 mt-10 -137.65 112.73 9.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.114 -1.069 . . . . 72.13 108.114 -172.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.88 88.34 2.89 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.568 -1.271 . . . . 71.12 107.568 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.08 -32.26 43.99 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.418 2.079 . . . . 55.12 112.695 -167.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.509 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 70.4 m-20 -113.94 14.42 18.48 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.969 0.908 . . . . 71.23 110.7 -177.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.471 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -18.6 -74.34 0.02 OUTLIER Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 116.566 2.061 . . . . 60.12 116.566 -166.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.497 ' HB3' HD11 ' C' ' 83' ' ' ILE . 84.3 Cg_endo -77.26 -20.08 12.94 Favored 'Trans proline' 0 C--N 1.382 2.324 0 CA-C-N 124.377 2.599 . . . . 74.14 114.246 -176.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -70.81 -39.16 73.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.192 0.997 . . . . 71.52 109.635 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.677 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.7 p -84.22 -24.34 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 115.675 -0.693 . . . . 63.11 112.172 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -66.68 -22.36 66.08 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 112.675 0.621 . . . . 71.3 112.675 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -61.71 -22.82 65.68 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.752 0.821 . . . . 63.31 110.849 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -88.69 96.23 10.57 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.5 1.12 . . . . 72.12 110.157 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.35 88.12 2.57 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.152 -0.476 . . . . 64.41 109.776 170.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -154.5 158.03 39.26 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.321 -0.992 . . . . 74.31 108.321 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.26 110.04 10.14 Favored Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 108.267 -1.012 . . . . 73.41 108.267 172.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -54.29 127.69 26.89 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.425 2.75 . . . . 72.11 113.584 -174.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 24.2 tt0 -56.61 111.84 1.12 Allowed 'General case' 0 C--N 1.368 1.387 0 O-C-N 124.208 0.942 . . . . 74.11 108.81 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' H' ' 467' ' ' ALA . 4.2 p -114.72 138.26 45.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.638 0.732 . . . . 70.11 110.437 -169.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -129.87 124.15 32.53 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 106.389 -1.708 . . . . 70.42 106.389 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 51.4 tp -95.19 120.45 35.43 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.163 -0.68 . . . . 75.14 109.163 -172.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.602 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 10.8 m-20 -106.23 140.09 39.72 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.617 1.167 . . . . 43.01 107.942 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.494 ' HB2' HD22 ' H' ' 460' ' ' LEU . 4.7 mp -134.47 168.21 19.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.27 0.557 . . . . 63.04 109.852 171.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 7.8 t70 -157.75 142.16 16.24 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.743 1.217 . . . . 50.44 107.726 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -114.8 144.42 43.53 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.405 0.621 . . . . 71.24 109.416 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.413 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.97 164.36 34.79 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.833 1.253 . . . . 74.31 107.815 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.5 p -168.85 158.47 8.9 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 123.599 0.562 . . . . 74.41 110.49 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 94.6 p -150.7 155.66 39.76 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.832 0.853 . . . . 71.13 109.704 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -91.34 119.0 31.0 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.55 -0.908 . . . . 64.43 108.55 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' D' ' 57' ' ' GLU . 58.7 mt -89.75 -40.52 12.45 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.195 0.598 . . . . 71.05 109.613 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.72 -171.24 3.48 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.964 0.906 . . . . 75.31 110.284 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 53' ' ' ASP . . . . . 0.42 ' HA ' ' OD1' ' H' ' 450' ' ' ASN . 3.4 m-20 -63.48 106.89 1.0 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.241 -0.891 . . . . 72.13 110.784 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 64.7 17.63 11.03 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.609 1.163 . . . . 63.53 112.168 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 91.0 t -109.52 105.13 18.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 107.122 -1.436 . . . . 73.3 107.122 170.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -121.98 126.73 49.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.261 -1.014 . . . . 75.34 108.261 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.464 ' HB2' HD11 ' D' ' 51' ' ' LEU . 19.3 tt0 -89.85 151.1 21.93 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.452 1.101 . . . . 61.44 108.707 174.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 91.4 t -131.81 128.52 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 C-N-CA 124.516 1.126 . . . . 55.33 108.11 172.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 57.7 t -104.87 130.51 55.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.331 1.052 . . . . 53.13 108.503 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.87 114.47 24.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.548 -0.908 . . . . 74.45 108.548 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.0 ttm-85 -96.36 101.3 12.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.194 -1.039 . . . . 72.42 108.194 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.5 t -100.84 103.67 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.57 -0.9 . . . . 54.14 108.57 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 6.0 m -100.64 137.3 39.22 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.063 0.945 . . . . 61.04 109.171 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.43 HG21 HG21 ' D' ' 114' ' ' ILE . 61.9 t -125.6 113.44 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.855 0.862 . . . . 71.14 109.516 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 12.6 m -103.11 119.53 39.02 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.765 -0.828 . . . . 53.41 108.765 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -135.81 152.06 50.7 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.917 0.487 . . . . 52.35 111.32 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 57.2 p -148.92 136.03 20.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.083 -0.508 . . . . 52.12 112.013 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.581 HD12 HG22 ' D' ' 31' ' ' VAL . 50.1 mt -102.49 96.36 6.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.46 1.104 . . . . 74.34 108.103 171.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.63 -139.1 20.49 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.129 -0.487 . . . . 63.24 113.11 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.05 0.76 46.98 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.91 0.484 . . . . 74.45 111.362 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -118.74 152.66 35.75 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.704 0.802 . . . . 73.31 109.286 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.7 m -73.63 139.68 45.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.75 0.42 . . . . 74.12 110.671 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.677 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.41 -69.83 0.66 Allowed 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.388 -0.824 . . . . 43.21 108.953 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -149.13 138.85 21.86 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.251 -0.886 . . . . 71.54 109.516 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.1 mt -111.78 132.43 54.67 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.359 1.463 . . . . 61.35 107.167 172.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.494 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.7 t -141.56 147.07 37.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.485 -0.561 . . . . 74.2 109.485 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -156.15 130.39 8.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.581 -0.526 . . . . 54.12 109.581 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.12 114.7 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.558 0.743 . . . . 52.35 109.127 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.534 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.27 86.56 6.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.567 -0.901 . . . . 72.01 108.567 170.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -78.7 100.76 7.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.237 -1.347 . . . . 64.34 108.901 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.07 146.57 20.46 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 116.1 -0.5 . . . . 73.55 112.16 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.443 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.9 130.45 4.34 Favored Glycine 0 CA--C 1.508 -0.358 0 N-CA-C 110.343 -1.103 . . . . 62.31 110.343 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.448 HG13 ' HE1' ' D' ' 17' ' ' TYR . 73.6 mt -89.41 122.85 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.722 -1.214 . . . . 61.24 107.722 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -118.2 145.28 45.09 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.906 0.882 . . . . 65.24 109.335 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 6.8 t -115.57 98.14 6.54 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.633 -1.247 . . . . 74.32 107.633 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 30.0 pt -129.92 137.12 57.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.18 -0.918 . . . . 72.15 110.099 -170.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.07 151.84 25.72 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.811 -0.631 . . . . 63.44 110.442 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.13 -13.17 60.41 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.131 -0.94 . . . . 14.32 113.444 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.572 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -95.71 136.86 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 121.463 0.649 . . . . 72.03 111.546 -170.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.5 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 44.8 mt-10 -143.02 -176.68 5.01 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.877 1.671 . . . . 75.14 109.685 -177.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.36 -128.06 27.22 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.347 -0.842 . . . . 21.0 113.425 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 46.0 m -85.45 -32.98 22.0 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.439 0.696 . . . . 61.4 111.031 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.582 HE22 HG21 ' B' ' 149' ' ' THR . 50.1 tt0 -63.33 -38.69 92.13 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.968 0.507 . . . . 74.14 111.977 -174.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.5 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 26.1 ptt? -61.09 -45.09 96.13 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.348 0.405 . . . . 74.11 110.914 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.76 91.99 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.406 0.622 . . . . 75.41 110.137 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -68.33 -23.19 64.68 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.188 1.395 . . . . 65.45 111.757 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.0 t -79.02 -51.93 8.92 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.663 -0.495 . . . . 60.23 109.663 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.45 -29.54 62.61 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.306 0.642 . . . . 61.24 111.911 -176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.19 4.93 30.12 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.825 0.69 . . . . 74.24 114.825 -170.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.4 -55.91 0.24 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 117.929 0.864 . . . . 60.34 111.767 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -71.75 -51.85 20.67 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.058 0.392 . . . . 72.42 112.058 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 68.8 m -65.06 -42.48 61.62 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-O 118.401 -0.809 . . . . 73.4 112.256 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.56 -37.95 94.6 Favored 'Trans proline' 0 C--N 1.397 3.102 0 C-N-CA 122.227 1.951 . . . . 73.14 113.317 166.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -67.42 -30.04 69.69 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.199 0.6 . . . . 72.33 111.143 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.402 HG13 ' HZ ' ' D' ' 11' ' ' PHE . 40.0 mm -66.54 -42.91 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.416 0.686 . . . . 54.3 110.225 171.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.443 HD21 ' HA3' ' D' ' 82' ' ' GLY . 87.5 mt -74.07 -20.83 60.16 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.056 -0.975 . . . . 62.25 111.906 -174.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -65.1 -43.12 65.48 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 114.192 1.182 . . . . 61.45 114.192 -172.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.01 -46.0 23.4 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.342 2.028 . . . . 65.42 114.073 169.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -72.13 -38.62 69.21 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.463 0.705 . . . . 75.43 111.597 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.85 89.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.369 0.668 . . . . 64.45 110.777 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.413 ' NH2' HG23 ' B' ' 105' ' ' ILE . 29.2 ttp180 -58.0 -48.99 78.37 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.392 1.077 . . . . 73.53 110.6 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -58.04 -46.81 84.75 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.201 0.938 . . . . 74.41 111.359 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -59.81 -44.5 93.98 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.027 0.829 . . . . 62.12 111.413 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.494 HG12 ' SG ' ' D' ' 76' ' ' CYS . 75.7 mt -65.35 -50.6 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.78 0.832 . . . . 42.43 111.046 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 57.3 m -55.14 -41.85 72.29 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 124.095 0.958 . . . . 53.41 111.402 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.9 t -67.26 -41.47 85.52 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.568 -1.196 . . . . 71.23 110.4 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -71.46 -28.96 64.32 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.845 0.458 . . . . 61.22 112.187 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' D' ' 123' ' ' PHE . 59.0 t -64.61 -46.44 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.204 0.602 . . . . 71.01 109.581 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.01 -27.24 62.6 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 116.076 -0.511 . . . . 74.33 110.998 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.2 mtt-85 -71.2 -35.04 71.42 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.332 0.653 . . . . 72.43 109.841 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.65 7.97 77.29 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 115.901 -0.59 . . . . 73.11 112.329 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p 59.14 25.34 13.83 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 126.35 1.86 . . . . 71.42 114.725 173.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.554 ' HB2' HG13 ' D' ' 118' ' ' VAL . 99.0 m-85 -87.52 155.69 53.77 Favored Pre-proline 0 CA--C 1.556 1.206 0 N-CA-C 108.607 -0.886 . . . . 75.54 108.607 169.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.72 146.92 96.49 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.635 2.223 . . . . 72.34 112.436 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -58.36 139.54 55.14 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.732 1.213 . . . . 71.34 113.026 -172.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.436 ' HG ' HD22 ' H' ' 468' ' ' LEU . 9.1 mp -114.47 112.36 22.86 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.705 0.802 . . . . 74.24 109.569 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.2 m-20 -102.35 92.67 4.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.35 -0.981 . . . . 65.11 108.35 172.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.18 115.45 7.66 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.374 -0.602 . . . . 74.12 109.374 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.3 138.99 97.31 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.306 0.642 . . . . 73.31 110.585 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -69.66 119.93 6.81 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.162 1.908 . . . . 33.54 111.073 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.7 150.74 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.325 0.65 . . . . 73.21 111.053 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -80.49 107.16 13.07 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.284 -0.871 . . . . 73.15 109.601 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -80.5 -31.68 37.11 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.321 0.648 . . . . 54.51 110.869 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.75 -52.35 65.81 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.194 1.398 . . . . 71.21 111.861 -168.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.33 79.54 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.136 0.898 . . . . 65.52 111.718 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.65 -25.6 56.98 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.258 -0.883 . . . . 55.41 111.285 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -61.45 -36.81 81.44 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.36 0.664 . . . . 75.22 110.647 175.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 32.9 mtt -67.32 -32.19 72.99 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.482 -0.781 . . . . 62.15 110.21 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 20.9 m120 -72.79 -29.82 63.59 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.534 -0.757 . . . . 71.3 111.023 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 140' ' ' TYR . . . . . 0.685 ' HB2' ' HB3' ' H' ' 461' ' ' PHE . 85.6 t80 -66.48 -39.65 88.87 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.88 0.872 . . . . 63.24 111.823 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 5.7 mp -67.54 -33.15 74.48 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.892 0.877 . . . . 52.33 111.689 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -91.64 33.79 1.01 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.785 0.834 . . . . 72.32 111.701 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 32.4 mm-40 -116.29 85.47 2.31 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.766 -0.827 . . . . 71.24 108.766 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -175.02 142.9 0.67 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.418 1.487 . . . . 74.12 108.127 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.75 0.92 20.73 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.073 0.397 . . . . 72.11 112.073 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.9 20.78 74.82 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.374 0.421 . . . . 44.0 112.502 -176.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -51.59 134.75 29.37 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.6 1.56 . . . . 65.22 113.231 -175.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.66 129.13 9.61 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.344 -0.844 . . . . 75.53 112.654 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 85.2 m -70.69 125.47 26.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.281 0.632 . . . . 73.0 110.593 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.18 159.87 15.76 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.199 1.4 . . . . 73.03 109.965 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -158.08 163.51 37.59 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.175 0.59 . . . . 72.02 110.843 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -156.14 120.39 4.51 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.713 0.805 . . . . 62.55 109.121 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -137.31 138.27 39.82 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.676 0.79 . . . . 74.15 109.638 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -133.52 -175.36 3.79 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 107.796 -1.187 . . . . 72.03 107.796 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 C-N-CA 123.429 0.691 . . . . 52.54 111.648 177.679 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 9.4 t30 . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 110.178 -0.304 . . . . 65.52 110.178 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 451' ' ' VAL . . . . . 0.626 HG12 HG13 ' E' ' 452' ' ' VAL . 68.9 t -127.04 -75.12 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.093 0.957 . . . . 75.44 108.896 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 452' ' ' VAL . . . . . 0.626 HG13 HG12 ' E' ' 451' ' ' VAL . 22.5 m -106.83 -177.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.201 0.6 . . . . 71.1 110.682 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 176.14 84.13 0.06 OUTLIER Glycine 0 C--N 1.343 0.924 0 N-CA-C 111.31 -0.716 . . . . 40.04 111.31 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 454' ' ' LEU . . . . . 0.675 HD13 ' HB3' ' A' ' 48' ' ' SER . 10.1 mp -85.66 169.12 13.78 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.393 0.677 . . . . 74.32 110.894 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 40.5 p -111.84 -172.46 2.04 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.271 1.028 . . . . 61.32 110.336 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.12 -49.83 74.33 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.842 0.857 . . . . 72.43 110.867 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -80.24 106.27 12.13 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.44 -0.8 . . . . 65.22 109.152 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 50.1 p -118.96 165.99 13.4 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.789 0.836 . . . . 74.55 109.215 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -143.12 -178.12 5.68 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.551 0.74 . . . . 74.43 109.659 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -154.07 129.81 10.07 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 106.84 -1.541 . . . . 73.45 106.84 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -73.16 19.87 0.09 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.616 1.566 . . . . 63.05 113.563 -173.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -158.82 110.13 2.12 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.122 -0.695 . . . . 75.04 109.122 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 9.5 t -87.25 -13.94 42.37 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.324 0.65 . . . . 42.15 110.865 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 464' ' ' MET . . . . . 0.439 ' SD ' HD23 ' A' ' 42' ' ' LEU . 42.0 ttm 77.71 145.18 0.09 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.341 1.856 . . . . 62.54 110.799 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -52.88 -37.1 60.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.417 1.087 . . . . 74.5 111.742 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 466' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 40' ' ' VAL . . . 63.25 78.67 0.28 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.788 1.235 . . . . 63.11 110.802 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -148.87 149.19 30.86 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.918 -1.037 . . . . 73.32 110.055 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 tt -161.04 -60.36 0.05 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 107.58 -1.267 . . . . 63.0 107.58 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 96.14 56.24 1.22 Allowed Glycine 0 C--N 1.346 1.109 0 CA-C-N 115.289 -0.869 . . . . 62.33 111.858 -176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.71 137.24 45.83 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.201 0.6 . . . . 74.55 109.895 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt . . . . . 0 C--O 1.248 1.007 0 C-N-CA 124.071 0.948 . . . . 65.05 109.796 -171.39 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 51.8 t30 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 121.203 0.525 . . . . 73.22 110.178 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' 451' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' B' ' 87' ' ' ALA . 7.1 p -132.9 5.87 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.196 0.998 . . . . 71.12 109.944 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 25.9 m -68.81 79.06 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.393 0 CA-C-O 122.626 1.203 . . . . 73.04 112.959 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -115.59 64.95 0.31 Allowed Glycine 0 C--N 1.34 0.755 0 CA-C-N 114.742 -1.117 . . . . 73.05 110.865 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 454' ' ' LEU . . . . . 0.52 ' HG ' ' HB3' ' F' ' 456' ' ' ASP . 43.0 tp -68.31 101.2 1.16 Allowed 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.571 0.748 . . . . 75.22 110.728 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 23.9 p -76.15 82.79 2.97 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.441 -0.948 . . . . 73.52 108.441 166.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 456' ' ' ASP . . . . . 0.52 ' HB3' ' HG ' ' F' ' 454' ' ' LEU . 9.7 p-10 -89.96 -170.62 2.86 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.571 -1.195 . . . . 73.3 110.643 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 68.76 88.82 0.11 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.332 1.453 . . . . 74.32 110.489 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 6.5 t -155.61 133.69 11.45 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.215 1.006 . . . . 75.23 109.113 174.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.11 154.34 40.42 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 109.355 -0.609 . . . . 75.21 109.355 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 460' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' B' ' 44' ' ' LEU . 4.6 mm? -70.88 95.26 1.13 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.803 0.811 . . . . 74.33 109.876 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -85.32 14.27 5.54 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.141 1.376 . . . . 72.43 112.521 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 462' ' ' TYR . . . . . 0.426 ' OH ' ' HA ' ' B' ' 43' ' ' ASP . 13.2 p90 -70.54 139.5 51.57 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 109.231 -0.655 . . . . 75.55 109.231 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 76.7 m -140.33 120.81 14.12 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.179 -0.675 . . . . 74.33 109.179 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 49.4 ttp -141.1 130.42 23.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.107 0.963 . . . . 60.13 108.524 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -72.9 -41.34 64.72 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.658 0.783 . . . . 73.12 112.293 -169.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -140.0 111.75 7.39 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.562 0.745 . . . . 65.01 109.513 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 467' ' ' ALA . . . . . 0.428 ' HB2' HD22 ' B' ' 42' ' ' LEU . . . -67.83 -40.5 83.74 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.36 0.664 . . . . 73.44 110.747 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 96.3 mt -137.58 151.63 48.57 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.331 1.052 . . . . 72.51 109.668 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . -86.0 60.21 4.64 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 111.666 -0.574 . . . . 72.23 111.666 174.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 4.4 pp -161.29 139.33 9.4 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.245 1.018 . . . . 74.41 108.736 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt . . . . . 0 C--O 1.251 1.141 0 C-N-CA 124.681 1.192 . . . . 72.41 108.312 -178.326 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 66.1 t30 . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 108.794 -0.817 . . . . 63.51 108.794 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.47 124.75 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 121.717 0.77 . . . . 55.32 110.375 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.1 133.96 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 106.985 -1.487 . . . . 53.03 106.985 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 453' ' ' GLY . . . . . 0.421 ' N ' ' SD ' ' C' ' 94' ' ' MET . . . -141.57 -15.5 0.41 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 115.074 0.79 . . . . 20.33 115.074 -169.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 3.8 tt -68.82 96.49 0.75 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.29 -1.004 . . . . 71.2 108.29 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 4.8 m -124.46 10.19 8.52 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.11 0.964 . . . . 74.22 109.421 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -153.3 136.13 15.38 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.578 0.751 . . . . 75.25 109.393 -175.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -124.82 103.57 8.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.281 1.033 . . . . 74.45 109.086 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 63.3 p -97.9 167.94 10.6 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.485 0.714 . . . . 61.4 111.141 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -84.2 162.48 20.18 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 109.016 -0.735 . . . . 53.14 109.016 171.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 460' ' ' LEU . . . . . 0.427 HD23 ' H ' ' C' ' 46' ' ' THR . 0.1 OUTLIER -66.45 125.83 26.92 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.417 -0.957 . . . . 75.31 108.417 174.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 461' ' ' PHE . . . . . 0.408 ' HE1' ' HB3' ' C' ' 136' ' ' LEU . 43.2 p90 -88.22 13.11 12.13 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.097 0.959 . . . . 74.35 111.651 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -163.39 111.39 1.22 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.035 0.534 . . . . 72.34 110.233 -171.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 26.3 m -83.58 -30.33 27.08 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.585 0.754 . . . . 75.42 111.895 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 464' ' ' MET . . . . . 0.64 ' SD ' HD12 ' C' ' 42' ' ' LEU . 0.0 OUTLIER 73.16 112.99 0.06 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.647 1.579 . . . . 74.42 110.515 -174.002 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -135.7 30.43 3.14 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.69 0.796 . . . . 71.21 109.367 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -78.02 131.76 37.5 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.755 -0.831 . . . . 71.23 108.755 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -65.54 105.46 1.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.22 0.608 . . . . 73.53 110.867 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -15.76 63.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.528 0.731 . . . . 73.5 111.57 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.91 -11.32 0.12 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.308 -0.717 . . . . 64.12 111.308 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 470' ' ' LEU . . . . . 0.529 HD13 ' HD2' ' C' ' 38' ' ' PRO . 77.2 mt -134.54 158.99 42.54 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.079 1.352 . . . . 74.55 109.818 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.555 1.148 0 N-CA-C 108.79 -0.818 . . . . 74.03 108.79 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 450' ' ' ASN . . . . . 0.42 ' OD1' ' HA ' ' D' ' 53' ' ' ASP . 86.8 m-20 . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.735 0.303 . . . . 71.13 110.625 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 451' ' ' VAL . . . . . 0.41 HG23 HG12 ' H' ' 452' ' ' VAL . 35.0 m -126.84 166.07 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.802 1.241 . . . . 62.14 108.82 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 452' ' ' VAL . . . . . 0.419 ' HA ' ' SD ' ' D' ' 94' ' ' MET 0.261 7.1 p 46.29 -73.1 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 C-N-CA 126.059 1.744 . . . . 73.42 115.595 178.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 77.01 43.32 17.34 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 118.44 0.564 . . . . 42.44 112.133 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.91 178.01 7.24 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.743 0.817 . . . . 71.1 112.906 -174.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 11.8 t -163.88 170.55 16.63 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 114.021 -1.445 . . . . 42.22 108.109 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 30.1 t70 70.42 160.03 0.2 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 124.374 1.07 . . . . 70.24 112.585 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -156.82 -156.68 0.63 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.79 1.236 . . . . 71.23 109.029 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 25.2 m 80.45 137.51 0.06 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.487 1.515 . . . . 74.11 111.619 175.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 27.1 t70 74.68 112.81 0.07 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.708 1.603 . . . . 65.31 111.416 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 460' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' D' ' 44' ' ' LEU . 30.2 tp -77.21 161.4 28.2 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.933 -0.576 . . . . 54.4 110.352 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 461' ' ' PHE . . . . . 0.685 ' HB3' ' HB2' ' D' ' 140' ' ' TYR . 1.9 p90 -94.2 8.11 42.87 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 125.119 1.368 . . . . 74.05 111.99 177.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -148.79 159.74 43.86 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.175 0.99 . . . . 74.24 109.118 -173.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 87.5 m -151.53 110.58 3.89 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.244 -1.021 . . . . 71.34 108.244 173.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 464' ' ' MET . . . . . 0.412 ' HG2' ' HA ' ' H' ' 467' ' ' ALA . 36.1 ttp -82.86 96.06 8.13 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.597 -0.519 . . . . 73.14 109.597 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -65.41 132.23 48.45 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.669 -1.151 . . . . 51.11 109.305 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . 78.44 -32.92 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.398 1.479 . . . . 75.05 112.205 -173.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 467' ' ' ALA . . . . . 0.439 ' HB3' HG13 ' D' ' 40' ' ' VAL . . . 68.26 -72.72 0.09 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.015 1.726 . . . . 74.41 112.425 172.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 468' ' ' LEU . . . . . 0.436 HD22 ' HG ' ' D' ' 126' ' ' LEU . 11.8 tp -84.38 6.31 23.68 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.887 0.875 . . . . 64.51 112.006 -175.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 78.45 32.64 41.73 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.064 -0.815 . . . . 71.1 111.064 -167.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 5.1 tt -99.12 85.97 3.34 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.916 -1.142 . . . . 63.3 107.916 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? . . . . . 0 CA--C 1.552 1.037 0 C-N-CA 123.57 0.748 . . . . 71.5 109.467 -178.222 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.495 ' SD ' ' HG2' ' A' ' 3' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.685 0.278 . . . . 75.44 110.339 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.1 m -147.37 89.51 1.79 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.774 -1.195 . . . . 74.1 107.774 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.495 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 16.4 mm-40 -89.45 59.53 4.83 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.833 0.825 . . . . 71.02 110.325 -173.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -115.68 68.29 0.72 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.87 -1.059 . . . . 73.31 109.589 -170.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -161.25 84.28 0.65 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.488 0.715 . . . . 71.51 110.085 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.54 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 3.4 t-20 -166.62 113.47 0.83 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.417 0.687 . . . . 72.2 110.495 173.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -157.13 121.09 4.25 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.016 0.926 . . . . 72.04 109.25 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 64.64 -75.58 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.166 1.387 . . . . 70.3 110.264 -172.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.614 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -140.8 165.55 27.19 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.687 1.195 . . . . 72.54 108.799 171.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' A' ' 6' ' ' ASN . 94.7 m -153.11 136.05 15.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.55 0.34 . . . . 63.11 110.986 -173.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.634 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 12.6 t80 -137.08 121.84 18.67 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.849 0.859 . . . . 75.53 108.923 172.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -136.45 108.38 7.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.398 0.679 . . . . 73.43 109.292 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.631 HG12 ' HD2' ' A' ' 84' ' ' PHE . 59.5 mt -80.66 109.46 15.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.508 -0.923 . . . . 73.14 108.508 172.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -74.41 -34.91 63.4 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.556 -0.747 . . . . 73.05 110.572 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -174.61 138.0 0.49 Allowed 'General case' 0 C--N 1.362 1.127 0 O-C-N 123.544 0.527 . . . . 74.32 110.624 -170.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.675 HD12 ' HG3' ' C' ' 130' ' ' PRO . 75.4 mt -123.3 133.79 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.75 0.82 . . . . 74.53 109.423 175.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -167.78 151.01 5.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.821 0.848 . . . . 65.14 110.557 -171.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.4 p -79.44 114.75 18.62 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.938 -0.764 . . . . 60.44 108.938 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -78.51 -33.34 48.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.162 -0.681 . . . . 73.25 109.162 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.8 t70 -147.72 132.72 18.18 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.973 -1.012 . . . . 45.42 109.584 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.42 141.49 45.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 107.237 -1.394 . . . . 70.42 107.237 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -145.91 132.55 19.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.627 0.727 . . . . 71.24 109.719 171.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 79.1 t80 -133.19 130.51 39.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.768 -1.567 . . . . 73.34 106.768 172.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.58 122.26 16.38 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.204 0.602 . . . . 41.55 109.456 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.12 78.47 68.96 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.539 -1.282 . . . . 73.21 107.539 174.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.3 -43.35 8.53 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.492 2.128 . . . . 71.32 110.734 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.406 ' O ' HG23 ' A' ' 31' ' ' VAL . 40.3 m-80 -88.62 20.55 3.37 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.386 -1.279 . . . . 71.43 111.423 -177.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.99 -45.93 88.03 Favored Pre-proline 0 CA--C 1.573 1.858 0 C-N-CA 123.71 0.804 . . . . 42.2 113.121 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 16.2 Cg_exo -68.82 -26.17 32.5 Favored 'Trans proline' 0 C--N 1.398 3.164 0 C-N-CA 121.666 1.577 . . . . 73.2 112.928 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -74.3 -37.42 63.66 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.292 0.637 . . . . 70.41 110.172 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.47 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 73.8 t -67.95 -32.94 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.229 1.012 . . . . 74.52 110.668 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -59.0 -27.95 65.92 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.198 0.999 . . . . 63.12 111.44 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -95.83 -48.62 5.67 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.677 0.791 . . . . 74.34 111.25 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 21.0 ptmt -81.66 164.68 21.65 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.909 0.483 . . . . 73.21 111.22 -175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.55 141.24 43.74 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.511 0.725 . . . . 74.14 111.876 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -92.34 83.78 5.07 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.092 -0.707 . . . . 74.33 109.092 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.97 62.07 44.35 Favored Pre-proline 0 N--CA 1.482 1.146 0 N-CA-C 108.235 -1.024 . . . . 72.42 108.235 172.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.54 157.29 28.65 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.441 2.094 . . . . 52.11 112.681 -167.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.21 109.77 22.46 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.53 -0.915 . . . . 73.42 108.53 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -83.5 115.24 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.394 -0.821 . . . . 74.3 109.781 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -104.12 144.41 31.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.87 0.868 . . . . 64.12 108.749 170.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.553 HD23 ' SD ' ' E' ' 464' ' ' MET . 23.7 tp -136.79 128.84 29.48 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.809 -1.182 . . . . 74.43 107.809 175.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -135.15 113.01 10.95 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.85 -1.167 . . . . 74.53 107.85 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.2 mt -98.08 121.72 40.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.263 0.625 . . . . 61.22 110.207 -173.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -126.76 147.69 49.97 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.201 1.001 . . . . 73.04 109.054 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.1 m -135.64 126.05 26.71 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.82 0.848 . . . . 72.25 109.761 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.57 109.72 8.86 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 122.941 0.496 . . . . 73.11 110.583 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 29.4 m -89.68 167.99 12.47 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.692 0.797 . . . . 75.12 109.928 175.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.415 ' OG ' ' HB3' ' A' ' 57' ' ' GLU . 86.8 p -160.46 154.05 22.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.505 0.722 . . . . 72.53 109.616 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -89.58 117.46 28.49 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.654 0.382 . . . . 71.35 110.297 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.49 HD12 HG23 ' A' ' 83' ' ' ILE . 78.0 mt -87.27 -46.64 9.52 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.574 0.702 . . . . 75.22 109.42 172.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.43 -176.64 5.39 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 114.421 -1.263 . . . . 42.15 108.777 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -65.81 110.07 2.7 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 109.176 -0.676 . . . . 73.45 109.176 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 74.43 -0.98 3.2 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 125.505 1.522 . . . . 73.31 112.886 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -100.25 113.85 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.048 -1.093 . . . . 73.1 108.048 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -125.66 129.96 50.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.702 0.801 . . . . 51.22 110.642 -172.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 41.2 tp10 -89.94 114.72 26.58 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.506 -0.924 . . . . 73.54 108.506 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 61.9 t -100.89 129.49 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 107.985 -1.117 . . . . 62.22 107.985 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.5 105.66 19.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.126 -1.064 . . . . 71.02 108.126 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.7 97.78 11.0 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 106.918 -1.512 . . . . 61.03 106.918 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -92.32 105.64 17.8 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.994 1.318 . . . . 72.3 109.762 -174.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.479 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.7 t -98.84 105.46 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.869 -0.789 . . . . 64.53 108.869 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -98.94 107.51 19.97 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.091 0.556 . . . . 75.44 110.2 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' A' ' 126' ' ' LEU . 98.4 t -106.02 125.94 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.323 0.649 . . . . 61.32 109.443 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.4 m -127.75 107.92 10.3 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.038 -0.727 . . . . 71.54 109.038 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.4 117.86 35.63 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.358 -1.349 . . . . 63.34 107.358 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.8 p -144.82 145.38 31.61 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.089 0.556 . . . . 63.01 109.883 -173.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -129.09 90.22 2.99 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.112 0.965 . . . . 70.44 109.184 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.69 -114.89 3.95 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.383 -0.826 . . . . 72.33 111.269 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.92 -26.85 14.91 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.22 -0.659 . . . . 61.23 109.22 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -85.92 117.46 24.79 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.668 0.387 . . . . 70.24 110.374 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.6 m -73.71 131.04 41.2 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.076 -0.713 . . . . 65.32 109.076 168.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -73.55 -58.27 3.42 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.999 -0.741 . . . . 72.02 108.999 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -156.62 159.05 38.11 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.133 -1.394 . . . . 64.34 110.191 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 32.3 tp -127.48 119.14 25.41 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 107.337 -1.357 . . . . 71.33 107.337 173.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 68.3 m -125.68 99.45 5.99 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.975 -0.75 . . . . 50.52 108.975 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -121.95 116.55 24.55 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.494 -0.928 . . . . 75.13 108.494 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.3 111.49 26.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 123.673 0.789 . . . . 75.41 109.392 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 43.0 mt-30 -85.21 86.22 7.4 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.499 -0.926 . . . . 52.42 108.499 171.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.461 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.5 tp-100 -76.55 118.34 19.11 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 114.78 -1.1 . . . . 64.42 108.172 178.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.17 160.22 13.49 Favored Glycine 0 C--O 1.24 0.512 0 O-C-N 123.533 0.521 . . . . 70.03 112.121 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.47 132.63 2.91 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.799 -0.92 . . . . 64.11 110.799 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.49 HG23 HD12 ' A' ' 51' ' ' LEU . 42.7 mt -81.19 115.69 24.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 174.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.634 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.5 m-85 -122.82 118.59 28.33 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.24 -0.652 . . . . 75.33 109.24 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 m -99.68 100.73 11.74 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.963 -0.755 . . . . 52.42 108.963 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.9 pt -108.95 125.36 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.665 0.786 . . . . 74.42 111.122 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.71 161.73 38.48 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.983 0.913 . . . . 73.31 109.937 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 80.17 2.0 88.55 Favored Glycine 0 N--CA 1.477 1.381 0 N-CA-C 114.674 0.629 . . . . 71.14 114.674 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.542 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -114.82 146.09 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 123.784 0.834 . . . . 72.04 109.73 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 15.9 tt0 -150.93 179.44 8.24 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.413 0.285 . . . . 74.14 110.494 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.459 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 71.83 -136.71 24.63 Favored Glycine 0 C--N 1.351 1.405 0 C-N-CA 123.374 0.512 . . . . 52.24 113.747 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.2 p -80.43 -15.85 55.82 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.034 0.934 . . . . 71.23 110.744 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -71.96 -37.24 69.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.326 1.051 . . . . 71.31 110.742 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.549 ' SD ' HG22 ' E' ' 451' ' ' VAL . 27.3 ptt? -73.32 -25.05 60.48 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.312 0.245 . . . . 64.33 111.016 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.6 -35.72 70.59 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.97 0.508 . . . . 71.03 109.908 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -66.52 -31.26 71.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.51 0.724 . . . . 74.2 111.27 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.542 ' SG ' HG13 ' A' ' 89' ' ' ILE . 72.1 m -57.21 -60.03 4.22 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.496 0.498 . . . . 62.42 111.179 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.476 HD21 HG21 ' E' ' 452' ' ' VAL . 3.8 pp -83.62 -12.06 56.51 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 112.541 0.571 . . . . 73.43 112.541 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.14 -15.2 26.56 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 119.476 -0.625 . . . . 51.52 114.399 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.29 -61.59 0.35 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.95 0.875 . . . . 72.23 111.725 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.17 -65.99 0.61 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.974 1.31 . . . . 72.33 112.759 -169.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.42 -39.39 19.9 Favored Pre-proline 0 CA--C 1.569 1.703 0 N-CA-C 113.379 0.881 . . . . 71.42 113.379 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.87 -29.57 88.38 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 121.683 1.589 . . . . 61.14 113.341 169.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -70.57 -28.09 64.63 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 122.6 0.36 . . . . 71.41 110.453 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.448 HG21 HD13 ' A' ' 13' ' ' ILE . 36.3 mm -56.39 -40.35 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.462 0.705 . . . . 73.14 110.15 172.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.461 HD22 ' HG3' ' A' ' 80' ' ' GLN . 80.4 mt -80.39 -22.55 41.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.861 -1.063 . . . . 62.45 112.675 -173.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.46 -44.92 97.09 Favored Pre-proline 0 CA--C 1.572 1.825 0 N-CA-C 113.591 0.96 . . . . 74.12 113.591 -172.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -59.73 -43.64 36.85 Favored 'Trans proline' 0 C--N 1.394 2.954 0 C-N-CA 122.041 1.828 . . . . 73.24 112.954 173.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -65.48 -36.91 85.27 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.153 0.581 . . . . 72.33 111.037 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.69 -37.92 70.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.91 -0.586 . . . . 63.41 110.751 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.534 ' NH1' HD12 ' C' ' 105' ' ' ILE . 35.0 ttm180 -53.88 -52.87 59.11 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 123.943 0.777 . . . . 75.42 110.03 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -59.78 -49.14 78.87 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.572 1.17 . . . . 72.11 111.311 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.466 ' O ' ' HE3' ' A' ' 117' ' ' MET . 34.3 t -56.28 -40.85 74.92 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.317 1.011 . . . . 72.11 110.59 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.479 HD11 ' HB ' ' A' ' 62' ' ' VAL . 96.3 mt -70.37 -47.87 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.942 0.897 . . . . 42.14 111.076 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.497 HG23 ' HG3' ' A' ' 125' ' ' GLN . 33.5 m -54.66 -38.03 66.43 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.433 0.693 . . . . 64.13 110.349 177.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.6 t -69.42 -40.78 77.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.865 -1.061 . . . . 71.23 109.634 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.466 ' HE3' ' O ' ' A' ' 113' ' ' CYS . 33.2 mmt -59.8 -44.56 93.9 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 120.957 0.408 . . . . 74.34 110.624 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 114' ' ' ILE . 57.3 t -67.79 -44.61 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.299 1.04 . . . . 70.45 111.118 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -72.97 -33.05 65.6 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.359 0.664 . . . . 62.51 111.642 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -71.36 -32.66 68.76 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.964 0.506 . . . . 62.51 109.658 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.79 -2.96 72.12 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 115.571 -0.741 . . . . 74.4 113.578 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.1 m 70.06 11.48 7.64 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.994 1.318 . . . . 72.21 111.487 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -82.86 142.9 45.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 N-CA-C 108.819 -0.808 . . . . 73.35 108.819 173.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -46.86 132.91 17.55 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.403 2.735 . . . . 74.55 113.592 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.497 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.3 tt0 -52.07 144.36 12.29 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.367 1.467 . . . . 64.51 114.108 -169.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.409 ' CD2' HG11 ' A' ' 64' ' ' VAL . 16.4 tp -121.1 104.12 9.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.281 1.432 . . . . 64.05 109.255 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -116.05 96.02 5.37 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.751 -0.833 . . . . 73.44 108.751 170.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.39 151.78 46.36 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.513 -0.767 . . . . 41.14 110.665 176.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.427 ' H ' ' HB3' ' E' ' 467' ' ' ALA . . . -72.59 152.28 91.63 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.672 0.789 . . . . 74.12 110.964 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.9 126.78 18.81 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.006 1.804 . . . . 64.11 111.918 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.2 t -99.05 115.69 40.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.534 -0.913 . . . . 74.14 108.534 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -81.7 81.61 7.69 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.958 -0.756 . . . . 74.34 108.958 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -59.74 -27.15 66.24 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.478 0.711 . . . . 71.32 111.601 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.92 -49.42 65.6 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.549 1.139 . . . . 74.22 111.032 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.56 -42.45 95.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.224 0.61 . . . . 73.13 110.474 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.9 mt -67.66 -25.2 65.6 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.688 -1.142 . . . . 74.32 111.711 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -78.45 -43.69 26.53 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.46 -0.57 . . . . 72.11 109.46 175.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.5 mmt -59.75 -49.11 79.01 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.687 0.617 . . . . 71.52 111.543 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.663 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 28.8 p30 -64.36 -35.81 82.08 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.806 0.691 . . . . 73.32 111.154 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -69.98 -40.3 75.43 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.415 0.686 . . . . 72.24 110.953 174.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.2 tp -66.9 -50.58 61.98 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.693 0.797 . . . . 63.55 111.874 -168.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -168.83 14.96 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.749 0.655 . . . . 62.52 109.865 -176.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.663 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 29.3 tt0 66.55 -71.88 0.09 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.092 1.357 . . . . 64.44 110.827 -173.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -116.76 108.19 15.57 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.386 0.674 . . . . 74.33 109.426 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.02 164.42 30.95 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.826 0.85 . . . . 71.21 110.406 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.28 72.76 0.06 OUTLIER Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.956 -0.458 . . . . 70.34 111.956 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -124.8 168.52 13.12 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.898 0.879 . . . . 74.45 110.675 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.13 -23.93 4.57 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.045 -0.525 . . . . 70.31 112.616 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 41.8 p -83.51 93.97 7.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.272 0.629 . . . . 60.32 110.292 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.81 -177.5 6.38 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.191 0.596 . . . . 62.32 110.909 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -159.86 -52.12 0.06 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.305 -0.998 . . . . 63.23 108.305 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -112.04 170.72 7.96 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.374 -1.284 . . . . 74.43 108.504 172.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -76.58 153.83 35.0 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.451 -0.574 . . . . 73.21 109.451 168.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.32 146.02 54.53 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.041 0.536 . . . . 53.14 111.058 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 C-N-CA 123.968 0.907 . . . . 74.21 110.776 -173.548 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' B' ' 53' ' ' ASP . 26.1 ptm . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.638 -0.504 . . . . 70.35 109.638 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p -71.93 89.2 1.08 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.19 -1.041 . . . . 72.43 108.19 168.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -90.77 82.29 5.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.997 0.903 . . . . 73.24 111.818 -173.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -100.67 120.72 40.48 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 105.088 -2.19 . . . . 74.1 105.088 162.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -121.6 63.15 0.91 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.826 0.822 . . . . 73.13 109.089 -172.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -164.01 167.99 19.78 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.29 1.436 . . . . 64.02 108.753 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -76.97 -2.54 34.32 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 122.118 -0.364 . . . . 71.1 111.729 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -61.62 -33.25 73.59 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.226 0.61 . . . . 73.31 110.494 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.466 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 24.5 ptm 55.77 171.68 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 126.572 1.949 . . . . 74.11 114.501 176.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 91.2 m -143.98 132.3 22.0 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.903 -1.147 . . . . 75.54 107.903 170.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -138.46 137.22 36.96 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.257 -1.016 . . . . 75.22 108.257 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -145.13 142.51 29.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.16 0.584 . . . . 74.31 110.328 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.2 mt -94.16 123.16 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.809 -1.182 . . . . 74.22 107.809 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -94.24 -31.45 14.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.075 0.55 . . . . 71.21 110.304 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -173.51 139.04 0.72 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 123.83 0.706 . . . . 74.2 109.458 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.2 mt -121.09 137.17 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 106.543 -1.651 . . . . 70.22 106.543 170.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -166.77 146.71 5.69 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.315 0.579 . . . . 63.03 111.397 -172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.9 m -74.0 126.97 31.68 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.223 -1.029 . . . . 72.33 108.223 168.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -95.16 -40.94 9.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.292 -0.633 . . . . 63.32 109.292 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 23.3 m-20 -144.55 133.49 22.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.776 -0.647 . . . . 73.45 110.375 -166.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.6 mm -127.85 142.96 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.248 1.019 . . . . 55.12 108.884 171.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.1 t -144.32 115.18 7.8 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.737 -1.209 . . . . 63.54 107.737 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -130.77 110.18 11.14 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 107.799 -1.185 . . . . 63.22 107.799 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.75 113.91 21.87 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.267 1.027 . . . . 72.54 108.921 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.99 82.67 7.09 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 106.958 -1.497 . . . . 55.14 106.958 169.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.13 -33.69 11.25 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.27 1.98 . . . . 74.25 112.176 -173.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.75 7.54 46.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.245 1.018 . . . . 74.44 110.544 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.6 -64.33 0.43 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 115.095 1.517 . . . . 70.14 115.095 -163.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.17 -22.85 29.64 Favored 'Trans proline' 0 C--N 1.39 2.746 0 C-N-CA 121.64 1.56 . . . . 41.13 112.817 -170.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -96.78 -20.88 17.9 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.493 0.717 . . . . 72.31 111.002 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' B' ' 68' ' ' LEU . 2.7 p -84.19 -20.73 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.52 0.328 . . . . 74.2 110.445 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -68.08 -24.21 65.03 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.543 0.737 . . . . 71.32 112.886 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -64.36 -15.11 59.8 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.542 0.337 . . . . 63.13 110.779 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -89.38 106.88 18.74 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.748 1.219 . . . . 75.04 109.711 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.04 89.35 7.97 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.277 0.631 . . . . 63.4 109.432 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -161.11 161.25 31.12 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.25 1.02 . . . . 73.11 108.829 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.469 HE22 ' HB3' ' F' ' 471' ' ' LYS . 68.5 mt-30 -85.83 104.32 5.07 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 108.723 -0.843 . . . . 71.51 108.723 173.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.494 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 16.6 Cg_endo -55.94 122.62 12.09 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 122.978 2.452 . . . . 73.42 111.801 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -62.71 109.17 1.33 Allowed 'General case' 0 C--O 1.243 0.741 0 O-C-N 123.759 0.662 . . . . 74.12 110.177 -175.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.561 HG13 HG13 ' B' ' 64' ' ' VAL . 65.9 t -87.01 128.68 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-N 115.045 -0.98 . . . . 70.13 111.231 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -106.42 118.03 35.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.77 1.628 . . . . 74.11 108.356 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.32 135.87 36.39 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.247 0.619 . . . . 35.34 110.244 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.852 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.5 m-20 -129.94 156.19 44.84 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.78 1.232 . . . . 62.53 109.084 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.546 HD13 ' HE2' ' B' ' 133' ' ' PHE . 45.5 mt -134.43 159.55 40.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.759 0.823 . . . . 71.25 109.31 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.3 t70 -159.74 112.91 2.19 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.375 -1.343 . . . . 44.21 107.375 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.1 p -116.88 119.98 37.06 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.83 0.452 . . . . 70.13 110.182 -175.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.42 161.83 25.17 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.397 1.079 . . . . 71.44 109.188 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m -142.26 165.92 26.12 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.447 -0.946 . . . . 74.4 108.447 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.7 p -150.08 136.21 18.74 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.828 0.451 . . . . 63.1 109.83 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -80.95 109.94 16.0 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.911 -0.403 . . . . 64.42 109.911 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.436 ' HB2' HG12 ' B' ' 55' ' ' VAL . 86.2 mt -76.48 -50.59 13.65 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.518 0.675 . . . . 72.34 109.226 172.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.91 -172.99 4.24 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.082 -0.963 . . . . 70.21 110.054 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' B' ' 1' ' ' MET . 52.4 m-20 -63.82 107.71 1.28 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.028 -0.987 . . . . 74.52 109.863 177.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 49.4 m-20 72.82 15.2 4.79 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.4 1.48 . . . . 74.21 111.642 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' B' ' 51' ' ' LEU . 75.6 t -115.51 122.15 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.348 1.059 . . . . 72.52 108.708 173.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -129.93 143.16 50.65 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.192 0.597 . . . . 74.23 111.21 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.482 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 4.6 tm-20 -103.65 100.19 10.01 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 106.809 -1.552 . . . . 63.32 106.809 171.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.0 t -90.98 139.52 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.601 0.76 . . . . 64.14 110.265 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.483 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 18.4 t -120.77 135.92 59.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.788 0.835 . . . . 71.05 109.867 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -118.17 107.47 13.99 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.604 -1.258 . . . . 73.54 107.604 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 23.1 ttm-85 -96.57 125.5 41.09 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.217 0.607 . . . . 75.12 109.69 172.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.549 ' HB ' HD11 ' B' ' 114' ' ' ILE . 14.6 t -117.0 119.81 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.565 -1.272 . . . . 65.13 107.565 169.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.852 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 62.3 m -100.49 148.07 25.18 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.639 0.776 . . . . 62.45 109.216 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.561 HG13 HG13 ' B' ' 40' ' ' VAL . 73.6 t -135.67 108.29 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.297 1.039 . . . . 63.22 108.359 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.0 m -95.82 137.84 34.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.92 -1.141 . . . . 64.32 107.92 167.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.72 150.43 32.08 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.729 -0.471 . . . . 63.43 109.729 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 50.8 p -150.89 136.72 18.14 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.493 0.496 . . . . 73.44 112.106 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.547 ' HB2' HG22 ' B' ' 31' ' ' VAL . 34.2 mt -104.95 121.41 43.68 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.336 1.054 . . . . 64.42 108.608 170.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.82 -116.98 5.01 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 115.672 -0.694 . . . . 33.43 112.341 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -122.34 23.4 9.76 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.359 1.064 . . . . 73.41 110.116 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -146.09 159.93 42.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.952 0.901 . . . . 71.14 109.961 -174.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 31.0 m -64.3 140.0 58.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.216 0.606 . . . . 70.34 111.292 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.423 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -100.97 -59.62 1.67 Allowed 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.665 -0.865 . . . . 61.45 108.665 171.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -154.35 152.29 30.05 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.788 -0.642 . . . . 63.22 110.684 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 33.3 mt -130.31 109.9 11.11 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 106.169 -1.789 . . . . 73.53 106.169 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.45 ' SG ' HG23 ' B' ' 114' ' ' ILE . 45.2 t -117.32 145.69 43.84 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.704 -0.85 . . . . 55.2 108.704 -175.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.3 tt0 -162.86 130.37 3.68 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.039 0.447 . . . . 62.45 110.046 -172.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 80.2 t -123.83 146.3 29.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.193 -0.912 . . . . 54.12 109.348 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 10.5 mt-30 -121.35 92.97 3.87 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 108.184 -1.043 . . . . 72.54 108.184 168.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.454 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 56.0 tp60 -83.65 100.27 10.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.169 -1.048 . . . . 74.54 108.169 174.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.63 170.13 36.43 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.204 -0.758 . . . . 74.32 111.204 175.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.62 127.33 1.45 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 112.311 -0.316 . . . . 72.11 112.311 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 62.5 mt -86.81 131.79 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.778 0.831 . . . . 64.1 109.125 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -136.56 164.54 27.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.104 0.962 . . . . 71.21 109.9 -175.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -129.19 108.97 10.76 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.125 -1.065 . . . . 74.42 108.125 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 40.2 pt -101.25 145.2 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.47 0.708 . . . . 61.44 110.839 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.34 160.55 38.61 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.876 0.871 . . . . 51.25 110.014 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 80.07 -69.93 3.01 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 123.573 0.545 . . . . 74.41 112.044 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' B' ' 97' ' ' CYS . 19.4 pt -54.39 127.86 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.744 1.218 . . . . 74.4 110.854 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.481 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 30.5 tt0 -149.59 156.02 41.25 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 110.204 -0.295 . . . . 74.41 110.204 -171.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.72 -109.71 2.94 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 112.139 -0.384 . . . . 75.04 112.139 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 42.4 m -79.6 -27.46 41.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.982 0.513 . . . . 75.42 110.649 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.481 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 40.7 mt-30 -66.3 -39.88 89.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 122.795 0.438 . . . . 74.5 110.525 -177.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -76.24 -29.54 57.57 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.988 -0.551 . . . . 74.41 110.505 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.51 -33.17 75.09 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.533 0.733 . . . . 70.34 110.501 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.446 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 17.6 t-80 -74.9 -20.35 59.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.826 1.25 . . . . 75.02 110.474 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.471 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 41.4 t -81.91 -68.51 0.69 Allowed 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.527 -0.546 . . . . 73.44 109.527 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 66.9 mt -66.95 -31.99 72.95 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.281 0.632 . . . . 70.53 112.567 -169.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.12 3.78 70.25 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-O 119.435 -0.647 . . . . 75.34 113.886 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -152.88 -65.95 0.16 Allowed 'General case' 0 C--N 1.357 0.895 0 CA-C-N 118.001 0.901 . . . . 64.41 112.553 -174.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.471 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 58.3 t80 -64.39 -47.42 79.3 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.725 0.81 . . . . 74.25 112.129 -174.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.446 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 87.7 m -60.17 -49.78 89.2 Favored Pre-proline 0 CA--C 1.566 1.562 0 C-N-CA 124.474 1.11 . . . . 63.33 111.908 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.503 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 50.8 Cg_exo -59.14 -34.77 98.63 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.068 1.846 . . . . 70.02 113.434 169.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -30.55 71.58 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.285 0.634 . . . . 71.32 110.874 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.93 -45.89 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.112 0.965 . . . . 73.31 110.565 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 49.8 mt -81.72 -12.71 58.5 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.908 -1.042 . . . . 72.4 112.065 -169.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.32 -49.08 94.51 Favored Pre-proline 0 CA--C 1.558 1.275 0 CA-C-O 117.645 -1.169 . . . . 74.13 113.502 -174.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.17 -35.84 98.37 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 121.951 1.768 . . . . 71.42 112.977 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.454 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 59.9 m-85 -68.96 -46.35 68.39 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.398 0.679 . . . . 74.11 109.851 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.03 88.59 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.611 0.764 . . . . 63.14 110.859 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.541 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 36.7 ttt180 -61.37 -54.81 38.9 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.174 1.389 . . . . 72.24 111.533 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.25 -36.05 82.84 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.541 0.736 . . . . 62.45 109.792 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.446 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.3 t -64.89 -39.31 93.33 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.526 -0.761 . . . . 45.43 111.171 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.549 HD11 ' HB ' ' B' ' 62' ' ' VAL . 70.3 mt -62.19 -54.57 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 109.633 -0.506 . . . . 75.52 109.633 174.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.478 HG21 ' OG ' ' C' ' 119' ' ' SER . 11.1 m -59.74 -30.67 68.99 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.33 1.019 . . . . 71.31 111.276 -173.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 41.7 t -60.63 -50.93 71.54 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 123.87 0.731 . . . . 71.03 109.541 173.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 7.9 mmt -68.19 -36.74 80.05 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.165 0.586 . . . . 65.0 111.453 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 114' ' ' ILE . 91.9 t -59.43 -43.42 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.056 0.942 . . . . 74.45 110.092 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.474 ' OG ' HG21 ' C' ' 115' ' ' THR . 45.9 t -71.46 -31.9 67.69 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.801 -1.09 . . . . 61.23 111.747 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.9 mtt-85 -65.8 -37.37 86.08 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 115.969 -0.56 . . . . 72.31 109.537 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.8 2.92 86.82 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.45 -0.639 . . . . 63.31 113.389 173.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 47.3 p 63.22 19.89 11.94 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 126.116 1.766 . . . . 62.51 114.182 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -81.75 153.51 70.33 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.249 0.62 . . . . 73.25 110.739 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.44 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 98.9 Cg_exo -48.77 162.62 0.36 Allowed 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 124.304 3.336 . . . . 63.12 115.67 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -61.62 128.9 38.49 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.701 1.2 . . . . 74.32 112.231 -169.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.422 HD23 HG21 ' B' ' 118' ' ' VAL . 35.5 tp -133.35 107.85 8.35 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.398 1.079 . . . . 62.22 109.202 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -124.37 134.72 53.06 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.457 0.703 . . . . 74.04 109.571 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.541 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.8 mm? -80.79 147.71 30.36 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.608 0.763 . . . . 52.14 111.075 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.87 146.63 46.5 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.738 0.815 . . . . 75.4 109.501 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.543 ' HG2' HD13 ' D' ' 16' ' ' ILE . 23.7 Cg_exo -64.12 102.75 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.414 2.076 . . . . 72.44 112.465 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 64.3 t -89.42 110.64 21.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.746 -1.205 . . . . 70.44 107.746 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -82.27 86.18 6.72 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.953 -1.128 . . . . 70.23 107.953 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.546 ' HE2' HD13 ' B' ' 44' ' ' LEU . 91.0 m-85 -54.8 -37.84 66.58 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.87 0.868 . . . . 75.03 110.728 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.45 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 16.7 t70 -61.86 -43.77 98.17 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.104 -1.407 . . . . 62.22 111.109 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.19 -42.94 62.16 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.59 0.756 . . . . 65.51 111.116 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.42 -16.03 60.39 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.223 0.453 . . . . 71.52 112.223 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -65.32 -33.84 76.91 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.221 0.608 . . . . 71.55 109.817 171.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 52.3 mtt -69.13 -37.19 78.19 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.538 0.735 . . . . 73.2 110.589 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -88.92 -13.41 39.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.224 0.61 . . . . 72.25 111.614 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.4 ' HD2' HD23 ' B' ' 141' ' ' LEU . 36.7 t80 -60.43 -45.76 92.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.96 0.904 . . . . 74.24 110.951 175.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.4 HD23 ' HD2' ' B' ' 140' ' ' TYR . 0.9 OUTLIER -121.67 21.89 10.7 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.88 -1.055 . . . . 74.4 112.138 -169.279 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -164.96 164.0 20.73 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.264 0.626 . . . . 72.31 109.751 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -73.98 -179.38 3.72 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.646 0.778 . . . . 73.24 111.616 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -139.0 117.83 12.35 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.966 -0.753 . . . . 74.25 108.966 173.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -75.42 85.65 2.55 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.217 -0.66 . . . . 73.44 109.217 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.81 81.61 1.0 Allowed Glycine 0 C--N 1.342 0.893 0 CA-C-N 115.531 -0.759 . . . . 72.53 111.554 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -126.12 142.43 51.53 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.683 0.793 . . . . 73.53 109.647 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.12 161.07 14.32 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.044 -0.98 . . . . 73.32 110.727 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 17.8 p -144.14 139.95 29.11 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.979 0.912 . . . . 45.31 109.32 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.88 126.93 29.73 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.875 -1.528 . . . . 74.14 106.875 169.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.76 96.73 1.9 Allowed 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.82 -1.548 . . . . 73.14 106.82 171.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' H' ' 450' ' ' ASN . 62.3 t60 -138.29 75.14 1.51 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.109 -1.441 . . . . 74.0 107.109 169.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -66.51 100.13 0.64 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.386 0.612 . . . . 73.02 109.505 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -89.9 -177.1 5.13 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 114.737 -1.12 . . . . 73.42 109.063 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.994 0 C-N-CA 123.471 0.708 . . . . 63.31 110.905 177.026 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 110.104 -0.332 . . . . 71.33 110.104 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' SER . . . . . 0.441 ' HB2' ' OD1' ' C' ' 5' ' ' ASN . 42.2 p -82.47 82.8 7.76 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.881 0.872 . . . . 54.12 109.555 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -74.88 -45.11 45.11 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.028 -0.987 . . . . 72.2 112.288 -171.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -128.04 95.11 4.09 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.803 -0.814 . . . . 72.03 108.803 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' ASN . . . . . 0.441 ' OD1' ' HB2' ' C' ' 2' ' ' SER . 60.9 m-20 -96.98 6.57 48.39 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.982 0.913 . . . . 70.41 111.447 -173.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ASN . . . . . 0.491 ' HB3' ' HA2' ' C' ' 88' ' ' GLY . 53.4 t-20 68.34 -84.93 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.201 1.0 . . . . 73.42 110.827 174.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 10.6 p -148.46 179.8 7.53 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.986 1.314 . . . . 75.33 109.066 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.464 ' HB2' HG23 ' C' ' 149' ' ' THR . 21.1 mm-40 -86.74 57.62 4.6 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.379 0.672 . . . . 74.41 110.591 176.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.478 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 27.7 ttt 53.88 112.37 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 126.139 1.775 . . . . 74.35 112.584 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 24.9 m -117.28 117.19 28.87 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.707 -0.849 . . . . 71.12 108.707 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -122.41 123.21 40.81 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.264 0.626 . . . . 73.53 109.671 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -143.72 133.91 24.39 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.055 0.942 . . . . 53.1 108.492 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 36.5 mt -81.22 126.43 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.76 -0.829 . . . . 72.34 108.76 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.541 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 29.4 mm-40 -88.0 -47.02 8.85 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.646 -0.707 . . . . 72.52 110.148 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -174.81 138.88 0.49 Allowed 'General case' 0 C--N 1.352 0.706 0 CA-C-N 115.373 -0.83 . . . . 53.32 109.441 -168.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -128.31 141.0 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 107.824 -1.176 . . . . 73.15 107.824 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -170.41 171.14 6.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.469 0.652 . . . . 64.5 110.885 -170.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -96.26 110.91 23.13 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.758 -0.83 . . . . 64.23 108.758 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -71.81 -34.26 69.21 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.933 -0.766 . . . . 62.12 108.933 173.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.5 t70 -146.52 146.51 30.53 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.072 -0.967 . . . . 72.44 109.295 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.3 mt -141.86 144.26 25.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.815 1.646 . . . . 73.22 106.912 175.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t -155.05 151.05 27.94 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.641 0.734 . . . . 70.24 110.433 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -148.67 148.63 30.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.197 -1.365 . . . . 75.2 107.354 171.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.594 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.5 mt-10 -143.77 139.25 29.3 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.003 0.921 . . . . 74.42 109.29 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.45 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -155.06 73.42 5.67 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 106.263 -1.754 . . . . 43.44 106.263 169.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.29 -10.88 16.19 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.147 1.898 . . . . 74.32 111.766 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -114.98 20.7 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.984 1.314 . . . . 71.2 109.306 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.465 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -55.82 -53.49 62.35 Favored Pre-proline 0 CA--C 1.561 1.385 0 N-CA-C 113.348 0.869 . . . . 73.32 113.348 -168.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.38 -42.38 68.25 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 121.752 1.635 . . . . 73.21 113.015 177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -70.84 -35.36 72.4 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.657 0.783 . . . . 74.42 112.444 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -79.5 -24.17 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 112.262 0.467 . . . . 64.21 112.262 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -68.99 -22.86 64.06 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.983 -0.448 . . . . 75.21 111.79 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -95.61 6.42 48.99 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.238 0.615 . . . . 72.33 111.048 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.403 ' HG2' HD13 ' C' ' 68' ' ' LEU . 2.8 tppp? -92.89 142.5 27.24 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.756 0.822 . . . . 72.32 111.562 -172.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -71.2 134.14 46.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.748 1.219 . . . . 64.15 109.618 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -84.75 102.36 12.94 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.961 0.726 . . . . 73.41 112.961 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -121.16 67.84 17.32 Favored Pre-proline 0 N--CA 1.484 1.263 0 N-CA-C 107.507 -1.294 . . . . 73.52 107.507 160.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -84.15 118.75 2.35 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 122.969 2.446 . . . . 73.42 112.951 -171.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -86.35 99.16 11.41 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.953 -1.128 . . . . 74.13 107.953 167.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 p -76.83 98.82 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.688 0.756 . . . . 72.11 109.35 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.8 101.48 13.29 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.506 -2.035 . . . . 74.32 105.506 169.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 9.0 tt -86.38 142.3 28.55 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.305 -1.368 . . . . 75.01 107.305 174.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.567 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.1 t70 -119.58 133.63 55.58 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.685 -0.857 . . . . 73.21 108.685 -173.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.0 mt -112.71 123.36 50.14 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.467 -0.938 . . . . 71.41 108.467 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.3 t70 -135.78 126.6 27.47 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.397 -1.334 . . . . 44.23 107.397 172.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -137.58 128.17 26.76 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.583 0.706 . . . . 70.3 109.699 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.05 152.27 46.08 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 113.93 -1.486 . . . . 71.24 107.523 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -140.43 145.38 36.93 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.838 -0.43 . . . . 73.33 109.838 -174.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -143.84 135.71 26.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.492 0.717 . . . . 52.25 110.433 -168.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -72.75 122.67 21.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.471 0.708 . . . . 74.12 110.741 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.611 HD11 HD12 ' C' ' 83' ' ' ILE . 36.1 mt -91.71 -45.8 8.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.473 -0.936 . . . . 64.24 108.473 172.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.01 178.29 8.83 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.323 -1.308 . . . . 73.54 108.901 174.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -74.19 134.12 42.75 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.062 -0.718 . . . . 63.54 109.062 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.465 ' HA ' HG11 ' G' ' 451' ' ' VAL . 63.4 m-20 69.16 -0.21 2.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.478 1.511 . . . . 75.12 113.114 -171.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.1 t -123.35 94.82 3.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 123.961 0.904 . . . . 64.35 108.701 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -116.11 125.35 52.25 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.961 -1.125 . . . . 70.52 107.961 -176.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.491 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.1 tt0 -82.26 138.21 34.66 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.686 0.794 . . . . 65.44 109.519 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 63.6 t -115.45 130.05 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.916 -0.772 . . . . 73.31 108.916 170.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 97.0 t -111.76 133.73 56.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.542 -1.281 . . . . 73.43 107.542 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.06 104.31 8.8 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.455 -0.943 . . . . 72.12 108.455 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.54 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 33.1 ttm-85 -95.48 108.7 20.94 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.583 -0.895 . . . . 62.44 108.583 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.546 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.8 t -109.38 122.52 64.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.834 -1.173 . . . . 74.54 107.834 172.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.3 m -124.55 114.66 19.7 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.091 0.556 . . . . 71.31 109.837 -174.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.562 HG11 HD11 ' C' ' 126' ' ' LEU . 78.1 t -99.25 107.82 21.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.761 -0.829 . . . . 71.34 108.761 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.522 HG23 HD23 ' C' ' 75' ' ' LEU . 1.6 m -99.46 106.83 18.91 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.374 -1.343 . . . . 71.5 107.374 174.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.54 124.19 46.8 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.239 -1.023 . . . . 70.44 108.239 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 59.7 m -134.72 163.69 29.22 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.928 0.394 . . . . 65.34 110.651 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.403 HD13 ' HG2' ' C' ' 34' ' ' LYS . 30.7 mt -124.3 15.22 9.02 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.093 1.357 . . . . 62.44 109.785 -173.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.54 -93.04 0.42 Allowed Glycine 0 C--N 1.344 1.013 0 N-CA-C 110.381 -1.088 . . . . 51.03 110.381 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -100.04 -30.76 11.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.108 0.963 . . . . 71.12 109.599 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -75.34 122.68 24.12 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.592 1.157 . . . . 73.25 110.715 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 78.8 m -78.37 125.84 29.93 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.803 -1.184 . . . . 54.44 107.803 162.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.706 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.44 -64.74 0.86 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.549 -0.908 . . . . 51.33 108.549 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.69 168.72 24.14 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.28 -0.873 . . . . 65.11 109.675 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.1 tm? -128.36 142.28 51.17 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.515 -1.661 . . . . 74.23 106.515 169.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 47.4 t -144.23 145.47 32.08 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 107.817 -1.179 . . . . 75.1 107.817 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -157.61 128.14 6.41 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.891 -0.411 . . . . 74.12 109.891 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.58 125.29 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 123.855 0.862 . . . . 71.51 108.79 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.54 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.5 mt-30 -103.75 86.86 2.68 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.531 -0.914 . . . . 52.21 108.531 173.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -78.46 97.91 5.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.676 -1.147 . . . . 74.32 108.949 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.27 149.16 24.74 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.291 -0.868 . . . . 72.52 110.98 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.514 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -153.81 117.12 0.78 Allowed Glycine 0 CA--C 1.502 -0.723 0 N-CA-C 110.891 -0.884 . . . . 72.42 110.891 -176.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.611 HD12 HD11 ' C' ' 51' ' ' LEU . 9.6 mm -81.97 119.55 31.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.461 -0.941 . . . . 73.25 108.461 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -125.21 118.58 26.36 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.837 -0.801 . . . . 71.25 108.837 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.2 m -77.54 103.21 7.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.156 -0.683 . . . . 62.3 109.156 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.546 HG12 HD21 ' C' ' 98' ' ' LEU . 1.7 pp -122.63 123.52 68.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 123.762 0.825 . . . . 71.41 110.143 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -127.25 162.04 27.15 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.554 1.142 . . . . 62.23 109.225 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 88' ' ' GLY . . . . . 0.491 ' HA2' ' HB3' ' C' ' 6' ' ' ASN . . . 88.68 -34.29 3.92 Favored Glycine 0 N--CA 1.473 1.133 0 N-CA-C 113.805 0.282 . . . . 73.11 113.805 173.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.472 HD11 ' HB ' ' C' ' 86' ' ' ILE . 28.0 pt -90.15 144.57 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.924 0.889 . . . . 62.42 111.07 -177.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -161.95 155.98 21.77 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.511 0.724 . . . . 63.52 110.079 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.72 -117.83 7.88 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.586 -0.734 . . . . 72.52 113.198 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.51 HG22 HD11 ' C' ' 141' ' ' LEU . 32.6 p -69.35 -25.07 64.01 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.001 0.92 . . . . 74.51 111.816 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -71.45 -52.34 19.0 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.591 0.757 . . . . 63.24 110.685 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.64 ' SD ' HG13 ' G' ' 452' ' ' VAL . 0.0 OUTLIER -69.59 -30.58 68.37 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.681 -0.69 . . . . 74.3 111.466 -174.382 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.13 -47.79 82.22 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 124.244 0.965 . . . . 74.3 110.692 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.439 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 10.5 t-160 -78.56 -35.56 45.82 Favored 'General case' 0 C--O 1.246 0.886 0 O-C-N 123.548 0.53 . . . . 62.31 111.994 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -58.65 -40.65 84.02 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.474 0.484 . . . . 74.54 110.665 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.55 HD12 HG11 ' G' ' 452' ' ' VAL . 31.0 mt -101.72 -10.68 19.75 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.994 0.518 . . . . 74.23 111.341 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.91 -30.55 63.31 Favored Glycine 0 C--N 1.355 1.584 0 N-CA-C 113.953 0.341 . . . . 53.32 113.953 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.63 -35.99 0.06 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.137 0.421 . . . . 71.22 112.137 -171.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -65.31 -43.49 90.91 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.318 1.447 . . . . 74.25 112.216 -176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -84.24 -42.59 0.74 Allowed Pre-proline 0 CA--C 1.567 1.601 0 CA-C-O 118.588 -0.72 . . . . 61.31 112.245 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -54.2 -25.55 38.5 Favored 'Trans proline' 0 C--N 1.397 3.113 0 C-N-CA 122.747 2.298 . . . . 72.12 114.095 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -61.37 -38.26 86.34 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.62 0.768 . . . . 60.01 110.822 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.534 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.5 mm -67.1 -39.88 84.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.196 -0.911 . . . . 73.24 110.306 177.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.514 HD21 ' HA3' ' C' ' 82' ' ' GLY . 60.5 mt -79.45 -22.75 43.73 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.943 0.897 . . . . 72.54 112.065 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -55.6 -52.8 69.02 Favored Pre-proline 0 CA--C 1.558 1.284 0 N-CA-C 114.08 1.141 . . . . 75.24 114.08 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.05 -29.01 65.85 Favored 'Trans proline' 0 C--N 1.386 2.531 0 CA-C-N 121.286 1.495 . . . . 72.03 112.637 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -70.29 -47.87 59.26 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.981 0.512 . . . . 75.34 109.674 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.82 -45.18 78.39 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.989 -1.005 . . . . 55.31 109.789 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.575 ' HG3' ' HB3' ' C' ' 128' ' ' LEU . 44.9 ttt-85 -56.21 -52.98 62.45 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.35 1.46 . . . . 71.12 111.708 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.28 -37.27 85.06 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.344 0.658 . . . . 75.31 110.483 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 21.1 t -71.36 -29.25 64.75 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 122.954 0.502 . . . . 73.32 111.628 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.546 HD11 ' HB ' ' C' ' 62' ' ' VAL . 98.0 mt -69.43 -52.34 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 109.342 -0.614 . . . . 52.24 109.342 173.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.474 HG21 ' OG ' ' B' ' 119' ' ' SER . 5.8 m -61.79 -31.16 71.36 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.58 0.752 . . . . 74.45 110.937 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.9 t -63.5 -52.68 60.2 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.433 0.693 . . . . 53.44 109.19 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.531 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.17 -38.01 84.97 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.263 1.025 . . . . 64.44 112.473 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' C' ' 114' ' ' ILE . 83.3 t -61.59 -48.35 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.656 0.783 . . . . 53.5 110.009 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.478 ' OG ' HG21 ' B' ' 115' ' ' THR . 41.7 t -67.23 -27.37 67.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.574 -1.194 . . . . 73.22 111.519 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -72.68 -40.75 66.02 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.181 0.592 . . . . 60.21 109.62 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -3.91 79.38 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.426 0.454 . . . . 51.42 112.747 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.1 p 62.95 33.78 14.66 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 126.853 2.061 . . . . 74.23 113.222 173.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.61 151.69 62.19 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.087 -1.079 . . . . 71.1 108.087 168.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -57.25 166.16 4.7 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.679 2.253 . . . . 72.35 113.6 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -46.44 138.24 5.89 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.344 1.457 . . . . 74.3 114.672 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.562 HD11 HG11 ' C' ' 64' ' ' VAL . 5.4 tt -119.84 85.29 2.35 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.91 -1.144 . . . . 61.54 107.91 169.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -92.17 94.59 9.28 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.225 -1.028 . . . . 74.23 108.225 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.575 ' HB3' ' HG3' ' C' ' 111' ' ' ARG . 16.7 tp -70.05 123.55 21.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.416 -0.811 . . . . 62.12 110.163 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.23 154.85 88.27 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 124.38 1.072 . . . . 60.44 111.402 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.675 ' HG3' HD12 ' A' ' 16' ' ' ILE . 45.9 Cg_exo -55.11 111.12 0.65 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.837 2.358 . . . . 54.24 113.291 172.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.55 115.74 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.443 -1.318 . . . . 61.11 107.443 167.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -82.13 86.62 6.58 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.775 -0.824 . . . . 70.44 108.775 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.466 ' HA ' ' HZ ' ' G' ' 461' ' ' PHE . 80.2 m-85 -62.63 -43.22 99.35 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.927 -1.033 . . . . 73.31 110.628 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.05 -42.99 93.73 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 114.049 -1.432 . . . . 70.43 111.27 -169.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.7 95.29 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 123.711 0.632 . . . . 74.44 111.676 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.04 -49.11 63.43 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.949 0.5 . . . . 74.24 110.021 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.439 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 3.0 t80 -69.49 -21.28 63.7 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 116.087 -0.506 . . . . 61.34 110.107 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 25.9 ttt -69.03 -32.25 71.63 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.717 0.407 . . . . 72.44 110.251 173.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -70.95 -38.83 72.85 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 110.068 -0.345 . . . . 73.34 110.068 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -64.23 -84.2 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.486 0.714 . . . . 73.05 110.696 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.51 HD11 HG22 ' C' ' 92' ' ' THR . 18.8 tp -125.22 134.66 52.26 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 120.861 0.362 . . . . 75.21 111.227 -175.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -145.3 168.62 20.02 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.616 1.166 . . . . 74.41 111.041 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.06 127.48 15.93 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 106.375 -1.713 . . . . 74.53 106.375 169.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -75.51 87.44 2.64 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.697 0.761 . . . . 72.55 110.232 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.66 159.58 35.51 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.064 1.346 . . . . 65.01 108.335 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.85 -124.02 1.86 Allowed Glycine 0 C--N 1.334 0.439 0 N-CA-C 111.344 -0.702 . . . . 62.04 111.344 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 62.12 -176.81 0.13 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.432 1.093 . . . . 54.3 111.461 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 168.55 138.19 2.41 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.913 -0.475 . . . . 51.45 111.913 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.464 HG23 ' HB2' ' C' ' 8' ' ' GLU . 23.2 p -90.65 169.51 10.94 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 123.469 0.708 . . . . 73.24 110.313 171.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.14 -177.87 4.18 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.014 0.926 . . . . 72.25 111.353 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -71.94 179.64 3.13 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.633 0.773 . . . . 64.52 111.089 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -59.84 -45.79 91.32 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.892 -0.595 . . . . 74.34 110.418 171.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.23 153.98 0.12 Allowed 'General case' 0 CA--C 1.561 1.375 0 O-C-N 124.906 1.379 . . . . 72.22 109.892 -177.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 72.88 128.49 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.548 1.539 . . . . 74.45 111.596 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.948 0 C-N-CA 123.537 0.735 . . . . 37.41 109.56 178.742 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 109.558 -0.534 . . . . 70.55 109.558 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 17.8 m -84.63 173.58 10.65 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.806 0.843 . . . . 63.11 110.222 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -80.97 160.59 24.58 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.001 0.521 . . . . 75.1 110.238 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -79.93 97.32 6.69 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.304 0.642 . . . . 74.31 109.548 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -65.9 149.88 49.5 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.882 0.473 . . . . 64.45 110.484 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -101.46 24.53 9.53 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.593 0.711 . . . . 73.45 111.214 -166.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -93.04 167.28 11.89 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.812 0.845 . . . . 71.11 109.707 170.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 61.89 104.65 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.643 1.177 . . . . 71.13 110.157 -171.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 2.9 ttp -32.95 122.79 0.38 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.901 0.88 . . . . 65.24 111.481 172.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.585 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 27.9 m -108.32 141.82 39.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.993 0.425 . . . . 54.12 111.106 -172.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -156.99 95.48 1.51 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.116 -1.439 . . . . 64.33 107.116 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -122.48 121.58 36.92 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.982 -0.747 . . . . 73.22 108.982 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.407 HD13 HG21 ' D' ' 105' ' ' ILE . 10.4 mt -84.75 121.61 37.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.046 -0.724 . . . . 55.31 109.046 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -87.04 -36.23 18.31 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 119.286 -0.387 . . . . 74.12 111.616 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -172.38 122.88 0.46 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 120.788 -0.365 . . . . 62.3 111.822 -164.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.543 HD13 ' HG2' ' B' ' 130' ' ' PRO . 1.7 mp -104.41 137.91 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.886 -1.153 . . . . 64.45 107.886 166.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.502 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 30.8 p90 -161.43 177.06 10.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.151 0.907 . . . . 73.34 111.223 178.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.3 p -108.71 126.05 52.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.798 -1.092 . . . . 74.24 108.959 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.502 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 24.9 mtpt -93.88 -12.72 28.29 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.575 -0.528 . . . . 74.13 109.575 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.4 t70 -169.8 136.02 1.52 Allowed 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.516 1.126 . . . . 74.04 108.66 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.531 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.4 mt -135.47 143.6 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.436 1.094 . . . . 75.04 108.403 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -142.69 134.98 27.56 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.249 1.02 . . . . 74.33 109.252 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.528 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.7 t80 -144.22 130.81 20.03 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.377 -1.712 . . . . 73.01 106.377 165.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.8 mt-10 -131.19 150.04 52.32 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.499 0.72 . . . . 73.42 109.377 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.12 76.86 10.21 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 106.939 -1.504 . . . . 74.11 106.939 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.78 -32.72 22.56 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.855 2.37 . . . . 63.14 112.326 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -96.62 0.09 49.38 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.078 -0.964 . . . . 72.22 110.864 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.14 -68.03 0.1 OUTLIER Pre-proline 0 CA--C 1.559 1.297 0 N-CA-C 115.64 1.718 . . . . 72.0 115.64 -160.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -78.04 -16.96 13.89 Favored 'Trans proline' 0 C--N 1.383 2.37 0 CA-C-N 122.655 1.984 . . . . 63.23 113.709 -172.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -74.7 -42.16 58.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.185 0.994 . . . . 74.33 109.394 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.567 HG22 HD12 ' D' ' 68' ' ' LEU . 9.2 p -83.82 -20.61 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 115.827 -0.624 . . . . 55.22 111.093 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -64.24 -16.92 63.0 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.208 0.603 . . . . 72.12 111.923 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -68.55 -2.93 9.96 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.83 0.852 . . . . 72.53 111.801 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 89.1 mttt -109.92 101.67 10.49 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 125.125 1.37 . . . . 75.11 109.809 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -84.35 83.34 8.02 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.444 0.64 . . . . 71.44 109.518 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -146.41 157.2 43.74 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.571 1.149 . . . . 73.4 108.735 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -77.09 105.37 2.4 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.67 -0.863 . . . . 65.54 108.67 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.26 119.07 5.93 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.13 2.553 . . . . 64.34 113.909 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.15 116.22 7.7 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.089 0.956 . . . . 74.04 109.101 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.525 HG12 ' HB2' ' D' ' 66' ' ' ALA . 27.6 m -101.96 119.57 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 121.665 0.745 . . . . 73.13 112.069 -169.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 107.98 18.83 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.123 -1.806 . . . . 72.45 106.123 167.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.556 ' H ' HD23 ' D' ' 42' ' ' LEU . 1.3 pt? -98.14 156.08 16.85 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.418 0.627 . . . . 72.54 110.795 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -141.08 146.56 37.28 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.575 1.15 . . . . 73.21 108.522 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.412 ' HB2' ' CE2' ' H' ' 462' ' ' TYR . 26.4 tp -127.28 131.98 50.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.709 0.804 . . . . 63.54 109.397 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.597 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.0 t70 -141.58 144.43 34.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.473 -0.936 . . . . 72.1 108.473 173.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.479 HG22 HD21 ' H' ' 460' ' ' LEU . 8.5 t -134.55 158.84 42.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.676 -0.49 . . . . 71.21 109.676 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.12 157.2 35.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.033 -0.985 . . . . 51.1 108.384 174.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.7 p -153.96 148.2 25.89 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.596 -0.52 . . . . 64.44 109.596 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 57.2 p -162.58 142.23 9.35 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.124 0.569 . . . . 71.42 110.236 -171.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -71.52 125.41 26.98 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.998 0.919 . . . . 74.5 111.353 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 mt -94.63 -35.47 12.19 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.102 0.561 . . . . 61.55 109.917 172.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.75 -171.45 3.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.792 0.837 . . . . 63.3 110.381 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -59.68 113.22 2.13 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.701 0.626 . . . . 64.14 110.508 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 65.24 13.29 8.66 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.927 1.291 . . . . 62.51 111.677 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 81.8 t -109.43 118.92 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.496 -0.927 . . . . 71.2 108.496 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -127.93 127.55 43.52 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.329 -0.989 . . . . 71.31 108.329 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -94.03 122.54 36.65 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.214 1.006 . . . . 72.22 108.648 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.11 124.57 53.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.714 -1.217 . . . . 73.22 107.714 172.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.549 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.3 t -100.56 127.59 53.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.654 -0.869 . . . . 55.02 108.654 171.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.03 117.38 33.85 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.309 -0.997 . . . . 54.34 108.309 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.597 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.3 ttm-85 -96.73 114.28 25.91 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.881 -1.525 . . . . 72.13 106.881 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.402 HG21 ' HB1' ' D' ' 110' ' ' ALA . 64.4 t -118.03 116.84 52.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.977 -1.12 . . . . 71.24 107.977 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 74.1 m -119.17 134.61 55.11 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.615 -0.721 . . . . 72.33 109.461 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 78.1 t -131.01 118.07 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.49 0.716 . . . . 73.34 109.905 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -112.39 97.29 6.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.462 1.105 . . . . 60.04 108.279 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.525 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -96.2 161.72 13.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.321 0.649 . . . . 63.02 111.318 -173.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 28.4 p -154.66 137.33 15.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.221 -0.899 . . . . 54.32 111.663 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.567 HD12 HG22 ' D' ' 31' ' ' VAL . 65.8 mt -101.28 96.56 7.27 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.675 -1.148 . . . . 74.23 108.104 168.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.24 -130.48 10.86 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.892 -0.594 . . . . 55.41 112.671 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.26 4.86 21.94 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.109 0.964 . . . . 71.33 112.156 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.45 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 6.4 tp10 -133.46 142.46 48.29 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.918 0.887 . . . . 73.55 110.742 -165.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.0 m -60.59 133.14 55.8 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.047 0.939 . . . . 75.55 111.309 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.431 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.06 -72.6 0.57 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.321 -0.992 . . . . 73.12 108.321 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -141.02 153.77 45.69 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 115.804 -0.635 . . . . 70.03 110.514 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 55.5 mt -114.68 151.09 34.2 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.397 1.079 . . . . 71.43 108.207 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.643 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.9 t -158.94 145.27 16.86 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.572 0.349 . . . . 71.42 110.721 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -155.75 122.7 5.35 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.448 0.699 . . . . 72.32 109.647 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.91 115.65 43.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 109.464 -0.569 . . . . 74.05 109.464 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.505 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -89.8 83.14 6.18 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.112 0.958 . . . . 65.11 108.775 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.42 91.87 5.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 113.619 -1.628 . . . . 63.51 108.997 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.23 141.95 17.15 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.635 -0.586 . . . . 73.41 111.635 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.54 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -140.07 130.14 4.54 Favored Glycine 0 C--O 1.228 -0.269 0 N-CA-C 111.49 -0.644 . . . . 54.42 111.49 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.7 mt -88.29 122.53 39.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.492 1.117 . . . . 62.52 108.977 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -123.74 156.98 35.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.303 0.641 . . . . 71.32 109.634 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.4 m -115.15 108.08 16.16 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.417 -0.957 . . . . 62.13 108.417 170.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.422 HD13 HD13 ' D' ' 98' ' ' LEU . 41.0 pt -105.75 139.84 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.486 0.714 . . . . 74.21 109.352 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -160.04 150.58 18.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.652 0.781 . . . . 60.03 109.74 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.43 -16.19 46.09 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.903 -0.387 . . . . 70.1 113.58 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' D' ' 94' ' ' MET . 43.2 pt -97.96 149.8 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.752 0.821 . . . . 72.32 109.822 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -168.3 177.68 5.29 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.165 0.586 . . . . 74.31 110.761 -168.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.07 -117.5 11.21 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.698 0.624 . . . . 74.32 112.817 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 19.3 m -92.27 -24.08 19.1 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.456 0.703 . . . . 71.45 110.861 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -61.16 -33.84 74.07 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.909 0.884 . . . . 74.35 111.164 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.505 ' HA ' HD12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -63.85 -33.98 76.9 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.099 -0.5 . . . . 72.42 111.332 177.379 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.477 ' HA ' HD22 ' H' ' 454' ' ' LEU . . . -77.32 -32.61 55.39 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.018 0.527 . . . . 74.34 110.758 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.4 t-80 -72.62 -26.38 61.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.755 0.822 . . . . 61.22 111.264 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -90.54 -50.37 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.931 0.493 . . . . 72.24 110.877 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.601 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 13.9 tp -82.42 -27.21 32.13 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.117 0.567 . . . . 75.4 111.68 -170.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.62 14.13 42.36 Favored Glycine 0 N--CA 1.477 1.379 0 CA-C-O 119.879 -0.401 . . . . 73.5 113.46 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -144.41 -64.41 0.36 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.929 0.492 . . . . 54.1 110.642 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -69.95 -40.11 75.66 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.677 0.391 . . . . 74.34 111.644 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.601 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 85.6 m -66.35 -47.27 59.92 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.405 -0.807 . . . . 73.33 112.152 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 78.1 Cg_exo -56.79 -32.62 92.14 Favored 'Trans proline' 0 C--N 1.4 3.237 0 C-N-CA 122.231 1.954 . . . . 73.24 113.386 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.46 -30.5 70.86 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.153 0.581 . . . . 63.02 111.678 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.407 HG21 HD13 ' D' ' 13' ' ' ILE . 95.2 mt -72.9 -37.25 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.72 0.808 . . . . 72.44 110.316 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.54 HD21 ' HA3' ' D' ' 82' ' ' GLY . 92.5 mt -75.66 -20.38 58.5 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.226 -0.897 . . . . 74.53 111.769 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -67.94 -43.47 37.09 Favored Pre-proline 0 CA--C 1.563 1.451 0 N-CA-C 113.763 1.023 . . . . 75.42 113.763 -171.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.69 -38.73 87.7 Favored 'Trans proline' 0 C--N 1.395 2.99 0 C-N-CA 121.931 1.754 . . . . 75.33 112.383 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -74.75 -32.74 62.17 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.902 0.751 . . . . 75.33 111.348 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.402 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -64.71 -53.93 39.46 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.224 -0.658 . . . . 62.03 109.224 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.431 HH12 ' HB3' ' D' ' 130' ' ' PRO . 40.5 ttp180 -58.14 -44.3 87.77 Favored 'General case' 0 C--O 1.212 -0.907 0 O-C-N 124.603 1.189 . . . . 64.32 110.509 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.17 -46.22 89.95 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.863 0.727 . . . . 74.3 111.137 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.82 -44.67 90.91 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.012 0.82 . . . . 65.14 110.339 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.643 HG12 ' SG ' ' D' ' 76' ' ' CYS . 69.0 mt -64.28 -52.29 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 124.033 0.833 . . . . 71.33 110.617 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 88.2 m -56.06 -43.68 78.14 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.679 1.192 . . . . 71.14 111.338 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.6 t -64.83 -41.63 95.58 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.995 -1.002 . . . . 43.33 109.978 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.8 mtm -69.85 -28.76 65.94 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.937 0.495 . . . . 61.34 111.917 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' D' ' 123' ' ' PHE . 54.7 t -70.72 -39.75 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.69 0.796 . . . . 71.1 110.419 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.2 p -76.66 -26.9 55.34 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.73 0.412 . . . . 52.32 110.729 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -73.78 -35.38 64.95 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.133 0.573 . . . . 74.15 109.475 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.95 -0.51 89.59 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 115.743 -0.662 . . . . 74.02 112.338 173.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.2 p 64.9 18.93 11.7 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.899 2.08 . . . . 71.44 114.327 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.417 ' HB2' HG13 ' D' ' 118' ' ' VAL . 96.3 m-85 -79.45 150.79 74.06 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 109.131 -0.692 . . . . 74.11 109.131 169.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.35 137.85 47.04 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.924 2.416 . . . . 52.22 112.771 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -55.74 143.36 31.11 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.915 1.286 . . . . 74.02 113.42 -168.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 50.0 tp -115.17 97.42 6.19 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.336 1.054 . . . . 70.41 109.716 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -104.16 89.65 3.33 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.731 -0.47 . . . . 72.53 109.731 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 36.4 tp -67.05 137.55 56.52 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.434 -0.803 . . . . 73.0 109.714 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.31 130.39 91.65 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.594 0.757 . . . . 62.25 111.113 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.431 ' HB3' HH12 ' D' ' 111' ' ' ARG . 56.6 Cg_endo -70.88 116.84 4.85 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.189 1.926 . . . . 72.03 110.756 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.03 124.39 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.554 0.742 . . . . 55.42 109.773 -171.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -73.9 96.28 2.59 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.659 -0.867 . . . . 73.24 108.659 171.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -68.38 -23.73 64.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.824 -0.625 . . . . 70.04 111.3 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.03 -54.85 41.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.277 1.031 . . . . 65.01 110.642 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.06 91.33 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.306 1.004 . . . . 74.03 111.144 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 16.6 tp -72.93 -22.18 60.77 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 115.85 -0.614 . . . . 73.33 111.634 -176.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -71.5 -35.94 70.94 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.852 0.861 . . . . 74.23 110.044 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 32.5 mtt -60.21 -43.25 96.13 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.546 0.738 . . . . 74.14 109.817 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -60.32 -45.95 91.62 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.847 0.859 . . . . 75.41 111.231 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -61.09 -41.22 96.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.069 0.948 . . . . 52.31 112.231 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 5.5 mp -65.96 -29.66 70.1 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.762 0.825 . . . . 74.3 111.286 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -78.81 0.53 26.65 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.408 0.683 . . . . 54.41 111.938 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -123.01 42.46 3.19 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.256 0.622 . . . . 73.01 109.713 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -171.53 150.18 2.76 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.741 0.816 . . . . 72.52 110.403 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.49 159.3 20.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.695 0.798 . . . . 71.34 110.761 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.08 102.72 1.03 Allowed Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.492 -0.776 . . . . 53.32 111.788 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.62 152.11 48.07 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 123.632 0.773 . . . . 71.04 109.831 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -75.74 91.91 0.89 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.748 -0.941 . . . . 61.45 110.748 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 75.2 m -56.11 139.43 47.2 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.75 0.82 . . . . 72.01 110.797 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -58.06 87.81 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 O-C-N 124.609 1.193 . . . . 75.13 112.816 -172.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -142.93 160.27 40.66 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.824 1.65 . . . . 73.04 107.918 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -85.92 76.42 9.86 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 108.638 -0.875 . . . . 71.21 108.638 175.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -89.45 174.99 7.49 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.887 0.875 . . . . 64.51 111.535 -173.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -93.36 96.26 9.83 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.36 -0.978 . . . . 75.33 108.36 170.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.388 0 C-N-CA 124.996 1.318 . . . . 73.14 111.213 179.807 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 109.125 -0.695 . . . . 75.21 109.125 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 451' ' ' VAL . . . . . 0.549 HG22 ' SD ' ' A' ' 94' ' ' MET . 7.2 p -74.49 -53.66 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 122.585 0.354 . . . . 71.5 111.857 -176.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 452' ' ' VAL . . . . . 0.521 HG22 ' H ' ' E' ' 454' ' ' LEU . 6.6 p -88.87 133.57 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.779 -0.822 . . . . 65.32 108.779 177.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -85.67 -15.24 66.19 Favored Glycine 0 N--CA 1.472 1.092 0 CA-C-O 119.796 -0.447 . . . . 61.3 113.299 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 454' ' ' LEU . . . . . 0.521 ' H ' HG22 ' E' ' 452' ' ' VAL . 34.0 tp 65.07 36.81 7.1 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.412 1.085 . . . . 74.22 109.427 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 24.5 m -65.87 96.42 0.3 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.409 -1.268 . . . . 55.53 111.028 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 32.9 t70 59.11 95.89 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.282 1.433 . . . . 73.34 111.573 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -98.96 17.13 20.36 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.393 -0.821 . . . . 63.23 110.977 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 11.7 m -76.08 78.49 2.92 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.287 0.635 . . . . 72.21 109.819 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -171.89 130.17 0.64 Allowed 'General case' 0 C--N 1.348 0.521 0 C-N-CA 124.668 1.187 . . . . 75.22 108.287 -177.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.56 108.05 6.93 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.838 -1.171 . . . . 73.41 107.838 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -60.36 -31.15 70.05 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.204 1.187 . . . . 75.53 114.204 -172.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -160.41 116.78 2.38 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.192 0.597 . . . . 74.0 109.674 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 14.1 t -93.89 -13.0 27.66 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.478 0.711 . . . . 74.14 112.167 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 464' ' ' MET . . . . . 0.553 ' SD ' HD23 ' A' ' 42' ' ' LEU . 24.5 ttt 72.31 153.0 0.13 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.253 1.421 . . . . 62.54 112.274 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -81.41 -68.24 0.71 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.381 -0.97 . . . . 60.41 108.381 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . 168.64 174.12 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.814 1.646 . . . . 53.25 109.814 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 467' ' ' ALA . . . . . 0.427 ' HB3' ' H ' ' A' ' 129' ' ' ALA . . . -157.36 121.82 4.35 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.006 0.522 . . . . 35.43 110.597 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 468' ' ' LEU . . . . . 0.434 HD13 HD12 ' E' ' 470' ' ' LEU . 0.5 OUTLIER -172.35 129.24 0.57 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.729 -1.212 . . . . 74.53 107.729 174.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -88.46 50.89 3.87 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 111.201 -0.76 . . . . 74.22 111.201 172.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 470' ' ' LEU . . . . . 0.434 HD12 HD13 ' E' ' 468' ' ' LEU . 5.6 tt -79.67 108.25 13.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.922 0.889 . . . . 73.21 109.51 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 79.0 tttt . . . . . 0 C--O 1.251 1.158 0 N-CA-C 108.829 -0.804 . . . . 52.22 108.829 170.878 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 54.3 t30 . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 121.334 0.588 . . . . 71.22 109.947 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 451' ' ' VAL . . . . . 0.418 ' HA ' ' HG3' ' B' ' 90' ' ' GLU . 15.6 m -96.61 16.11 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-N 115.127 -0.942 . . . . 64.11 112.559 -169.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.56 157.14 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 112.211 0.449 . . . . 63.22 112.211 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -178.49 -139.31 3.45 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.495 -0.775 . . . . 52.12 112.136 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 11.2 mp 56.83 72.68 0.49 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.362 1.065 . . . . 71.55 111.265 -173.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 14.6 t -113.18 0.4 14.9 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.835 -1.075 . . . . 75.51 109.844 172.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -123.4 152.69 41.31 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.13 0.972 . . . . 63.44 109.834 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -100.25 105.69 17.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.47 0.708 . . . . 71.45 111.012 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 40.0 p -78.46 126.52 30.88 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.552 0.741 . . . . 61.54 109.703 171.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -63.59 152.5 38.64 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.627 0.771 . . . . 71.33 110.942 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 42.6 tp -71.25 157.39 38.2 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.603 0.761 . . . . 73.24 110.238 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -144.14 142.85 30.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.206 0.603 . . . . 71.15 111.137 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -134.04 137.49 44.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.316 1.046 . . . . 74.3 110.088 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 29.2 m -140.71 79.39 1.7 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.713 -1.218 . . . . 72.41 107.713 170.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 26.5 ptm -150.74 136.11 17.84 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.09 -0.959 . . . . 72.44 109.653 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -107.59 133.38 52.13 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.248 1.019 . . . . 71.24 108.691 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . 67.91 125.79 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.755 1.222 . . . . 62.53 110.82 -169.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -64.12 -57.68 8.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.21 0.604 . . . . 60.3 110.556 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 468' ' ' LEU . . . . . 0.41 HD11 ' HB ' ' B' ' 40' ' ' VAL . 61.4 mt -136.27 -61.77 0.69 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.998 0.919 . . . . 73.13 109.557 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 103.4 56.09 0.79 Allowed Glycine 0 C--N 1.344 0.993 0 CA-C-N 114.862 -1.063 . . . . 73.33 110.506 -169.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 97.2 mt -69.94 141.08 53.11 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.216 0.606 . . . . 75.14 110.327 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 471' ' ' LYS . . . . . 0.543 ' HE3' ' HA ' ' F' ' 471' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.256 1.421 0 C-N-CA 123.199 0.6 . . . . 74.22 110.857 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 110.246 -0.279 . . . . 60.51 110.246 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' G' G ' 451' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' C' ' 54' ' ' ASP . 9.8 p -83.83 146.36 6.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.353 -0.98 . . . . 61.32 108.353 166.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 452' ' ' VAL . . . . . 0.64 HG13 ' SD ' ' C' ' 94' ' ' MET . 61.1 t 68.23 141.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 124.329 1.052 . . . . 62.23 112.853 176.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . -131.17 45.06 1.16 Allowed Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.125 -0.489 . . . . 61.41 112.566 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 454' ' ' LEU . . . . . 0.493 ' HG ' ' SD ' ' C' ' 94' ' ' MET . 18.1 mt -78.34 125.26 29.1 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.933 0.397 . . . . 74.33 110.819 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 10.1 t -153.92 28.64 0.47 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.467 1.107 . . . . 51.51 108.766 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -153.4 -65.17 0.15 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.741 -1.118 . . . . 74.24 109.219 -170.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.37 8.06 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 125.062 1.345 . . . . 51.43 113.58 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 6.9 m 65.81 163.12 0.16 Allowed 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 125.217 1.407 . . . . 61.23 111.663 -176.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.48 44.48 0.89 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.818 0.818 . . . . 65.23 110.059 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 51.12 -140.29 0.88 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.286 1.435 . . . . 70.25 111.312 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 461' ' ' PHE . . . . . 0.466 ' HZ ' ' HA ' ' C' ' 133' ' ' PHE . 33.2 p90 -163.54 -48.52 0.03 OUTLIER 'General case' 0 C--N 1.356 0.88 0 C-N-CA 122.932 0.493 . . . . 74.32 110.502 -177.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 34.7 t80 51.55 70.63 0.52 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.787 1.235 . . . . 73.23 111.066 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 11.5 t -75.84 -10.25 59.27 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.53 0.567 . . . . 71.53 112.53 -170.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 27.2 ptm -94.56 154.43 17.39 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.117 0.567 . . . . 70.11 110.409 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -150.76 12.27 0.69 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.894 0.878 . . . . 74.22 110.228 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -140.42 172.86 12.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.994 0.918 . . . . 71.12 110.337 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . 73.68 139.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.424 1.49 . . . . 62.02 111.944 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 468' ' ' LEU . . . . . 0.415 HD12 ' HG ' ' C' ' 126' ' ' LEU . 24.2 tp -150.6 -52.38 0.14 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.949 0.9 . . . . 70.0 109.912 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 119.83 -48.64 0.93 Allowed Glycine 0 N--CA 1.474 1.181 0 N-CA-C 109.703 -1.359 . . . . 53.45 109.703 -173.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 6.3 tt -66.37 -48.51 69.94 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.841 -1.54 . . . . 62.03 106.841 163.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 471' ' ' LYS . . . . . 0.459 ' HA ' ' HE3' ' G' ' 471' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.55 0.956 0 CA-C-N 115.119 -0.946 . . . . 75.55 108.948 173.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 450' ' ' ASN . . . . . 0.513 ' N ' HD21 ' H' ' 450' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 121.282 0.563 . . . . 51.45 110.151 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 26.8 m -81.17 -174.07 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.4 -0.818 . . . . 70.11 111.14 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 452' ' ' VAL . . . . . 0.505 HG13 ' HG2' ' D' ' 94' ' ' MET . 14.8 p -124.33 159.63 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.956 0.902 . . . . 65.23 109.787 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -133.31 158.84 23.38 Favored Glycine 0 C--O 1.243 0.668 0 N-CA-C 110.966 -0.854 . . . . 62.04 110.966 170.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 454' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' D' ' 95' ' ' ALA . 2.5 pt? -66.8 131.64 46.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.536 0.334 . . . . 54.51 110.686 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 10.4 t -115.86 -11.87 11.5 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.868 0.867 . . . . 71.34 110.467 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.56 126.35 27.23 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.076 0.95 . . . . 51.3 110.635 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -73.92 76.46 1.66 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.459 0.704 . . . . 72.14 109.169 175.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 12.8 t -92.98 141.93 27.86 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 108.921 -0.77 . . . . 72.24 108.921 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.04 153.53 41.69 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.68 0.392 . . . . 74.22 110.965 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 460' ' ' LEU . . . . . 0.479 HD21 HG22 ' D' ' 46' ' ' THR . 4.3 mm? -90.22 166.65 13.23 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.36 0.6 . . . . 70.52 111.124 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -135.79 133.64 38.11 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.148 -0.933 . . . . 75.01 111.161 -164.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 462' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' D' ' 44' ' ' LEU . 10.5 m-85 -135.05 98.83 4.1 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.309 1.043 . . . . 71.33 109.486 172.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 6.1 m -92.35 -3.37 55.44 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 121.288 0.566 . . . . 53.2 109.694 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 60.7 ttp -71.39 118.88 14.76 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 124.068 0.947 . . . . 72.15 109.834 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -93.75 30.79 1.72 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.823 0.849 . . . . 52.24 111.426 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -149.04 -179.8 7.3 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.954 0.902 . . . . 71.34 110.739 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -150.22 -63.83 0.21 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.807 0.843 . . . . 65.15 108.791 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.93 0.29 0.63 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.817 0.847 . . . . 74.32 110.432 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.01 -36.69 3.58 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 123.007 0.337 . . . . 61.23 113.071 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 63.67 67.42 0.63 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.878 1.271 . . . . 75.24 109.885 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm . . . . . 0 C--O 1.247 0.955 0 N-CA-C 108.875 -0.787 . . . . 73.33 108.875 177.034 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptp . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.455 -0.202 . . . . 73.43 110.455 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.3 t -165.57 116.6 1.08 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.024 -1.102 . . . . 63.41 108.024 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.08 112.34 7.16 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.407 0.622 . . . . 72.42 109.52 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -75.44 143.53 42.63 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.469 -0.787 . . . . 71.03 109.444 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -65.49 128.94 37.93 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.039 -0.726 . . . . 74.42 109.039 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -65.3 -69.34 0.3 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.048 -1.093 . . . . 73.25 108.048 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.0 m -156.16 83.36 1.0 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 107.416 -1.327 . . . . 70.33 107.416 163.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -160.16 153.86 22.63 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.78 0.832 . . . . 75.53 109.237 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 9' ' ' MET . 1.3 mpt? -65.47 158.41 26.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.41 1.084 . . . . 72.32 111.495 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 60.5 m -151.68 136.31 17.04 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.586 1.154 . . . . 62.33 108.048 170.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.611 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.0 t80 -135.88 129.53 32.44 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.298 -0.63 . . . . 64.05 109.298 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -143.43 117.01 9.17 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.639 -1.245 . . . . 71.34 107.639 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.485 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.1 mt -87.07 125.28 40.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.934 -0.765 . . . . 74.43 108.934 176.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.43 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -79.62 -43.86 22.08 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 124.05 0.844 . . . . 74.11 108.901 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -173.38 128.79 0.44 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 119.495 -0.288 . . . . 72.14 111.096 -168.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.7 mt -113.04 124.05 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 123.665 0.786 . . . . 75.12 109.427 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HE1' HG13 ' A' ' 83' ' ' ILE . 25.3 p90 -152.96 141.33 20.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.31 1.044 . . . . 73.2 110.423 -169.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.8 p -75.53 110.98 10.36 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.552 -0.536 . . . . 74.22 109.552 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.531 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 36.0 mtpt -75.96 -27.57 57.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.978 -0.378 . . . . 41.34 109.978 176.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.669 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.3 t70 -148.53 138.57 22.36 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.166 -0.924 . . . . 62.24 110.061 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 86.9 mt -134.77 142.32 40.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 125.629 1.572 . . . . 65.01 106.895 173.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -148.73 140.72 23.85 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 123.63 0.581 . . . . 64.32 109.972 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.523 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 77.0 t80 -143.05 127.07 17.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.255 -1.757 . . . . 75.21 106.255 173.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -137.64 121.37 17.47 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.91 -0.404 . . . . 61.12 109.91 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -129.83 77.24 77.15 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 107.997 -1.112 . . . . 71.23 107.997 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.43 -19.38 37.78 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.059 2.506 . . . . 72.33 112.188 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -120.17 28.91 7.78 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.88 0.872 . . . . 71.33 109.743 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -55.69 -46.84 99.67 Favored Pre-proline 0 CA--C 1.566 1.58 0 N-CA-C 113.45 0.907 . . . . 52.04 113.45 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.29 -13.23 18.88 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 122.2 1.933 . . . . 63.41 112.576 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -90.81 -34.27 15.37 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.745 0.818 . . . . 74.41 110.717 -173.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.554 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 35.9 m -77.78 -17.42 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.494 0.718 . . . . 75.34 111.416 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.584 ' HD1' HH11 ' B' ' 15' ' ' ARG . 75.2 t80 -60.26 -35.07 74.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.318 1.047 . . . . 74.13 110.145 165.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -86.73 -52.58 5.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.097 0.959 . . . . 55.33 111.65 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 17.7 ptpt -73.89 170.77 14.68 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.735 0.414 . . . . 64.13 111.419 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.93 128.21 35.13 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.105 -0.498 . . . . 71.24 109.663 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.3 t-105 -72.34 94.2 1.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 O-C-N 123.793 0.683 . . . . 72.22 109.861 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -128.45 84.85 61.97 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.58 1.152 . . . . 70.43 108.706 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 49.2 Cg_endo -87.49 165.25 7.94 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.351 2.034 . . . . 73.4 112.451 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -121.99 106.71 11.46 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.83 -1.174 . . . . 62.02 107.83 168.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.8 m -73.7 92.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-O 122.764 1.268 . . . . 42.24 110.761 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -95.05 124.55 39.16 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.516 -1.22 . . . . 72.34 109.315 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.639 ' H ' ' HB2' ' E' ' 465' ' ' LYS . 50.7 tp -120.52 115.56 23.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.412 0.685 . . . . 72.42 110.072 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 15.1 t70 -106.52 108.43 19.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.945 -1.132 . . . . 74.43 107.945 168.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 60' ' ' LEU . 1.2 tm? -97.59 119.2 35.72 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.584 -1.265 . . . . 53.13 107.584 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -127.08 151.11 49.06 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.508 1.123 . . . . 73.04 109.561 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.8 m -134.9 139.78 45.26 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.05 0.94 . . . . 72.02 109.541 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.28 153.6 51.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.913 1.285 . . . . 73.41 108.387 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 m -133.0 151.63 52.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.235 0.614 . . . . 74.1 109.669 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -150.36 121.47 7.74 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.651 -0.87 . . . . 73.21 108.651 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -79.67 125.55 29.78 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.902 0.382 . . . . 64.21 110.762 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.423 ' HB2' HG12 ' A' ' 55' ' ' VAL . 66.3 mt -93.37 -34.7 13.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.964 0.906 . . . . 74.11 111.448 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.498 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -164.19 -172.49 2.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.534 0.734 . . . . 60.32 110.866 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.05 116.98 5.83 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.431 0.693 . . . . 70.22 109.558 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 71.47 -7.19 1.24 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 125.412 1.485 . . . . 75.42 112.419 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 60.6 t -104.69 125.06 59.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 124.45 1.1 . . . . 73.44 109.1 -174.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -143.0 171.3 14.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.018 -0.734 . . . . 72.0 109.018 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -125.12 152.0 45.0 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.776 -0.824 . . . . 73.44 108.776 167.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.7 t -115.62 126.73 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 107.876 -1.157 . . . . 75.15 107.876 168.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.3 t -97.96 105.48 17.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.046 -1.094 . . . . 74.53 108.046 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 44' ' ' LEU . 42.7 tp -91.96 100.19 12.89 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.074 -0.714 . . . . 71.12 109.074 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -83.59 101.37 11.43 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.872 -0.788 . . . . 72.21 108.872 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.4 t -100.14 101.84 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.781 -1.192 . . . . 72.11 107.781 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.8 m -96.36 109.62 22.11 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.174 -0.676 . . . . 70.21 109.174 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.5 t -112.31 131.43 63.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.913 -1.143 . . . . 70.52 107.913 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -135.64 150.55 49.65 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.264 -1.013 . . . . 70.12 108.264 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -139.44 116.43 10.98 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.668 -1.234 . . . . 65.04 107.668 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.7 m -141.38 145.08 34.93 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.677 0.391 . . . . 53.11 111.793 -170.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.535 HD12 ' HZ3' ' A' ' 34' ' ' LYS . 3.2 tm? -94.79 87.53 5.04 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.708 -1.219 . . . . 73.03 107.708 170.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.5 -104.82 1.82 Allowed Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.791 -0.641 . . . . 53.44 112.583 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -95.36 -25.84 16.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.5 0.72 . . . . 71.32 110.771 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.55 123.08 29.39 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.789 0.435 . . . . 54.23 110.504 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 m -77.97 127.07 31.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.022 0.529 . . . . 72.34 110.121 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -80.43 -51.13 9.19 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.647 -0.871 . . . . 72.42 108.647 173.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -160.94 159.98 30.25 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.431 -1.259 . . . . 75.22 110.827 172.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 55.2 tp -129.84 143.03 50.6 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.289 1.435 . . . . 63.02 107.776 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.609 ' SG ' HG22 ' A' ' 118' ' ' VAL . 56.9 m -147.17 103.85 3.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.157 0.983 . . . . 51.22 109.099 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -128.54 127.46 42.42 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.654 -0.869 . . . . 73.14 108.654 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.5 t -128.75 110.96 22.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.732 -0.84 . . . . 74.23 108.732 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.669 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.3 mt-30 -85.26 85.67 7.44 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 108.449 -0.945 . . . . 74.2 108.449 171.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.516 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.1 tp-100 -76.51 102.17 5.93 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.096 -1.411 . . . . 75.34 109.035 -178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.89 164.96 37.74 Favored Glycine 0 C--N 1.337 0.639 0 N-CA-C 111.334 -0.706 . . . . 61.51 111.334 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.05 124.94 1.1 Allowed Glycine 0 CA--C 1.51 -0.272 0 N-CA-C 111.765 -0.534 . . . . 73.2 111.765 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.469 HG13 ' HE1' ' A' ' 17' ' ' TYR . 46.5 mt -81.13 126.06 39.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.275 -0.639 . . . . 64.21 109.275 176.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.611 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 37.3 m-85 -128.56 137.72 51.87 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.388 1.075 . . . . 74.14 108.135 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.5 m -107.77 115.9 30.98 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.726 -0.842 . . . . 63.41 108.726 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.42 HG21 HG21 ' E' ' 452' ' ' VAL . 17.4 tt -105.52 143.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.628 0.771 . . . . 75.32 110.484 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.49 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -161.68 146.41 13.12 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.754 0.821 . . . . 73.42 109.701 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.36 -32.45 6.81 Favored Glycine 0 C--N 1.341 0.84 0 O-C-N 123.541 0.526 . . . . 52.45 113.713 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.29 146.11 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.947 0.499 . . . . 65.24 112.179 -165.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -135.71 173.07 12.12 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.279 1.031 . . . . 72.14 110.46 -174.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.479 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 56.95 -115.66 6.78 Favored Glycine 0 C--N 1.356 1.666 0 N-CA-C 115.61 1.004 . . . . 63.52 115.61 170.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.5 p -66.17 -33.98 77.0 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.671 0.789 . . . . 75.42 111.159 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -70.17 -43.43 70.82 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.199 -0.91 . . . . 71.31 110.874 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.563 ' SD ' ' HA ' ' E' ' 452' ' ' VAL . 13.2 ptt? -66.04 -37.23 85.34 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.132 -0.692 . . . . 62.41 109.132 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.78 81.58 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 123.542 0.737 . . . . 72.3 110.628 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -64.87 -35.8 82.31 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.646 -0.706 . . . . 45.2 110.639 174.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 61.0 m -69.0 -41.66 77.5 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.013 0.525 . . . . 71.24 111.331 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 94' ' ' MET . 65.3 mt -78.9 -43.69 24.32 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.513 0.725 . . . . 73.53 111.885 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.72 4.01 53.3 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-O 119.268 -0.74 . . . . 73.41 114.472 -169.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.48 -57.91 0.23 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 118.075 0.938 . . . . 61.41 112.611 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.622 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 81.3 t80 -66.51 -53.92 29.66 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.996 0.918 . . . . 72.04 112.005 -168.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.3 m -72.98 -36.42 3.36 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.611 -0.709 . . . . 72.52 112.842 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -49.97 -41.35 48.31 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.405 2.07 . . . . 72.42 113.265 161.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -67.36 -32.96 74.25 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.652 0.781 . . . . 75.35 111.227 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.37 -45.25 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.225 0.61 . . . . 60.34 110.305 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.516 HD22 ' HG3' ' A' ' 80' ' ' GLN . 74.3 mt -74.85 -20.74 59.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.116 -0.947 . . . . 73.31 112.144 -175.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.566 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 61.9 t80 -62.3 -44.79 89.37 Favored Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 114.134 1.161 . . . . 74.03 114.134 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -59.54 -37.93 85.75 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 121.878 1.719 . . . . 75.21 112.988 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -70.15 -42.0 73.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.421 0.688 . . . . 75.24 111.029 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.07 -36.6 72.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.856 -0.611 . . . . 74.11 110.844 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.554 ' NH1' HD12 ' C' ' 105' ' ' ILE . 32.0 ttm180 -50.43 -56.41 11.57 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.353 1.033 . . . . 73.23 109.669 174.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -65.39 -43.39 90.81 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.345 1.028 . . . . 64.33 111.8 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.599 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.4 t -61.39 -24.82 66.77 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.048 0.539 . . . . 73.15 112.151 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.466 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.8 mt -84.93 -53.71 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.163 0.985 . . . . 72.2 109.821 172.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.501 HG23 ' HG3' ' A' ' 125' ' ' GLN . 85.5 m -53.33 -52.53 58.87 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.931 1.292 . . . . 55.1 112.521 -174.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.3 t -58.41 -44.55 89.09 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.398 -0.819 . . . . 75.51 110.646 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.523 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.3 ttp -66.15 -32.34 73.72 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.422 1.089 . . . . 45.33 111.644 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.609 HG22 ' SG ' ' A' ' 76' ' ' CYS . 87.1 t -70.39 -45.14 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.117 0.967 . . . . 75.11 110.423 174.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.8 m -68.08 -25.59 65.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.557 0.743 . . . . 71.42 111.596 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -72.55 -32.38 66.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.668 0.787 . . . . 74.13 109.541 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.93 0.34 83.08 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 124.005 0.816 . . . . 64.51 113.288 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.8 m 65.72 16.5 10.52 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.754 1.222 . . . . 74.5 111.199 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -86.8 153.83 55.3 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.79 0.836 . . . . 61.03 109.058 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -53.63 119.19 5.82 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 123.162 2.575 . . . . 75.51 112.343 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.501 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.9 tt0 -53.0 128.93 29.01 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.304 1.042 . . . . 74.15 111.627 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 pp -109.36 137.18 47.61 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.462 -0.94 . . . . 72.21 108.462 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -123.19 91.67 3.53 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.029 -1.471 . . . . 74.53 107.029 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.566 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -63.46 122.24 15.78 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.198 -0.91 . . . . 75.43 109.45 -173.599 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.64 140.17 96.96 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.223 0.609 . . . . 72.34 110.806 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.12 128.74 29.91 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.41 2.073 . . . . 73.02 111.754 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.3 t -97.82 137.01 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.972 -0.751 . . . . 73.34 108.972 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -77.1 69.04 3.33 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.569 1.148 . . . . 50.14 111.249 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -53.21 -43.6 67.36 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.139 0.976 . . . . 73.12 111.621 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -58.86 -51.64 69.13 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.226 0.953 . . . . 74.14 111.201 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.15 99.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.872 0.733 . . . . 51.34 111.582 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.29 -44.53 95.29 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.217 0.948 . . . . 73.0 110.269 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -72.99 -30.96 64.19 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 115.388 -0.824 . . . . 74.02 110.672 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.703 ' SD ' HD23 ' A' ' 141' ' ' LEU . 15.9 mmt -66.34 -26.04 67.1 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.26 0.624 . . . . 64.03 111.44 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -63.57 -31.09 72.15 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.745 0.818 . . . . 33.43 110.7 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.413 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 76.4 t80 -93.2 -36.64 12.51 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.375 1.07 . . . . 74.32 110.785 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.703 HD23 ' SD ' ' A' ' 138' ' ' MET . 20.4 tp -70.72 -21.32 62.57 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.348 1.059 . . . . 72.43 111.467 -172.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -142.83 29.01 1.54 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.073 0.949 . . . . 60.31 110.009 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -61.87 -30.82 71.12 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 120.906 0.384 . . . . 61.43 111.479 173.647 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -88.37 -45.76 9.73 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.221 1.008 . . . . 62.22 109.51 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.78 2.34 10.34 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.662 -0.699 . . . . 52.51 112.705 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.45 3.89 85.36 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.878 -0.401 . . . . 55.53 113.585 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.68 -55.68 7.25 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.356 0.663 . . . . 71.15 110.539 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.27 149.75 8.0 Favored Glycine 0 C--N 1.348 1.194 0 CA-C-N 115.959 -0.564 . . . . 63.03 112.714 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.7 m -94.5 -81.46 0.38 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.003 -0.74 . . . . 71.05 109.003 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 54.01 -161.8 0.13 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.368 1.067 . . . . 73.14 113.055 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 65.3 51.49 1.59 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.578 1.151 . . . . 75.4 109.212 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -148.92 3.82 0.63 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.615 -1.175 . . . . 73.24 110.76 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -72.34 -10.38 59.72 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 112.079 0.399 . . . . 75.05 112.079 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -112.89 157.44 21.42 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.783 0.833 . . . . 73.21 108.811 167.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.321 0 C-N-CA 123.623 0.769 . . . . 72.03 108.945 -178.676 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.56 ' SD ' ' HB2' ' B' ' 3' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 108.821 -0.807 . . . . 64.14 108.821 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 31.4 m -78.94 81.77 5.19 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.36 0.6 . . . . 43.41 109.841 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.56 ' HB2' ' SD ' ' B' ' 1' ' ' MET . 33.9 tt0 -134.96 173.9 11.2 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.106 0.963 . . . . 73.15 108.563 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -59.6 116.7 4.2 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.052 0.941 . . . . 62.13 111.345 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -67.88 -27.07 66.35 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.171 0.589 . . . . 70.11 110.971 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -72.05 92.3 1.3 Allowed 'General case' 0 C--N 1.352 0.691 0 N-CA-C 109.307 -0.627 . . . . 72.55 109.307 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.538 HG22 ' H ' ' B' ' 9' ' ' MET . 27.0 m -136.71 147.51 46.8 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.085 0.954 . . . . 73.22 108.514 176.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.03 -26.81 67.69 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.497 0.719 . . . . 72.33 111.476 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.538 ' H ' HG22 ' B' ' 7' ' ' THR . 15.8 ptm 54.55 170.78 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 127.485 2.314 . . . . 72.32 114.739 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.0 m -149.87 139.19 21.36 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.826 1.25 . . . . 74.11 107.946 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -137.46 142.94 41.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.014 0.525 . . . . 62.52 109.633 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -144.59 141.0 29.12 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.465 0.706 . . . . 73.53 109.755 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.465 HD11 HD13 ' B' ' 105' ' ' ILE . 31.6 mt -94.59 125.77 47.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 107.705 -1.22 . . . . 74.43 107.705 170.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -92.8 -41.25 10.2 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.618 -0.512 . . . . 75.24 109.618 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.584 HH11 ' HD1' ' A' ' 32' ' ' PHE . 58.9 ttt180 -168.92 132.86 1.43 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.613 -0.721 . . . . 72.12 109.562 -173.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.412 HD11 HD13 ' B' ' 13' ' ' ILE . 81.7 mt -114.84 135.32 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 106.595 -1.632 . . . . 61.15 106.595 170.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.454 ' HE1' HG13 ' B' ' 83' ' ' ILE . 19.2 p90 -165.52 139.97 4.79 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.229 0.538 . . . . 71.44 110.921 -172.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.4 m -73.4 125.57 28.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.052 -0.976 . . . . 73.32 108.929 174.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.418 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.4 mtpt -98.35 -27.81 13.94 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.478 0.711 . . . . 61.3 110.855 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.7 t70 -157.16 137.7 13.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.62 0.368 . . . . 64.02 110.837 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.6 mm -133.37 145.03 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.644 1.178 . . . . 70.24 108.963 174.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -141.31 141.57 33.89 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.723 1.209 . . . . 54.23 108.427 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.422 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 71.8 t80 -156.07 113.98 3.32 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.143 -1.058 . . . . 73.43 108.143 170.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.18 115.91 20.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.825 0.85 . . . . 71.5 109.213 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.453 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.92 86.31 3.02 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.141 -1.059 . . . . 75.44 108.141 172.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.65 -27.64 26.75 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 122.869 2.38 . . . . 64.44 112.73 -172.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -108.75 15.85 23.28 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.564 -0.731 . . . . 65.1 110.574 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.531 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -40.06 -61.7 1.06 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 115.122 1.527 . . . . 62.41 115.122 -164.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.95 -31.06 56.88 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 121.837 1.692 . . . . 64.34 112.735 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -74.81 -49.23 21.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.681 0.792 . . . . 71.43 110.923 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.698 HG22 HD12 ' B' ' 68' ' ' LEU . 8.6 p -67.97 -21.98 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.771 0.828 . . . . 73.3 112.281 -164.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -66.38 -8.12 23.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.444 0.697 . . . . 70.35 112.822 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.593 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 27.7 pt20 -58.25 -26.03 62.42 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.439 0.696 . . . . 71.24 111.575 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.593 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 90.6 mttt -104.16 105.07 15.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.898 0.879 . . . . 75.15 109.077 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.29 81.31 8.76 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.426 0.631 . . . . 72.55 109.298 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -152.69 156.99 40.25 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.839 -1.171 . . . . 64.44 107.839 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.439 ' HB2' HD21 ' F' ' 470' ' ' LEU . 8.3 mt-30 -79.7 110.59 16.23 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 107.318 -1.364 . . . . 43.41 107.318 175.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.477 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 18.1 Cg_endo -58.03 139.67 91.25 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 123.079 2.519 . . . . 74.52 114.484 -170.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -65.89 124.15 21.71 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 124.236 0.96 . . . . 71.32 109.471 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.485 HG21 HD13 ' F' ' 468' ' ' LEU . 31.0 m -103.68 165.28 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.782 0.833 . . . . 72.51 112.459 -171.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -134.24 114.54 13.15 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 106.386 -1.709 . . . . 74.21 106.386 172.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 5.8 mp -86.27 133.97 33.79 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.405 1.082 . . . . 74.35 108.324 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -149.03 111.72 4.79 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.622 -1.251 . . . . 75.31 107.622 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.97 167.81 10.5 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.069 0.462 . . . . 73.52 109.893 -173.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 26.0 t70 -160.99 141.12 11.02 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.483 1.113 . . . . 64.03 109.139 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 22.8 p -136.28 125.13 24.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.414 0.686 . . . . 71.21 109.62 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.16 154.34 46.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.445 1.098 . . . . 63.43 108.318 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.2 p -142.36 170.51 15.56 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.963 0.411 . . . . 74.43 111.22 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.21 137.52 17.53 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.18 -0.918 . . . . 72.44 109.154 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -82.02 126.29 31.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.935 0.494 . . . . 54.23 109.947 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 91.1 mt -93.28 -34.2 13.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.203 0.601 . . . . 74.23 110.396 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.99 -173.53 2.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.641 0.776 . . . . 71.01 110.707 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.98 127.84 34.08 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.749 -1.114 . . . . 75.32 109.192 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.613 ' HA ' HG21 ' F' ' 451' ' ' VAL . 5.4 m-20 67.72 0.03 2.13 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.537 1.135 . . . . 74.21 112.612 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 109.9 30.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 123.66 0.784 . . . . 73.25 109.005 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -123.52 137.93 54.67 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.441 -0.948 . . . . 72.14 108.441 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -108.68 106.33 16.33 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.284 -1.376 . . . . 64.34 107.284 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.561 HG22 ' HG ' ' B' ' 98' ' ' LEU . 86.7 t -92.27 142.42 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 O-C-N 124.101 0.876 . . . . 35.03 109.925 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.73 141.54 42.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.731 -0.84 . . . . 62.35 108.731 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -124.29 105.51 9.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.284 -1.376 . . . . 73.22 107.284 178.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 36.4 ttm180 -92.68 123.87 36.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.794 0.438 . . . . 74.42 109.889 171.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.456 ' HB ' HD11 ' B' ' 114' ' ' ILE . 44.3 t -114.57 108.55 25.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.552 -1.277 . . . . 72.15 107.552 170.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 27.5 m -95.07 135.98 35.96 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.719 -0.845 . . . . 72.24 108.719 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.48 129.76 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.915 0.886 . . . . 72.11 109.146 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 28.8 m -118.01 142.43 47.38 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 107.961 -1.126 . . . . 71.43 107.961 169.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -144.79 155.51 43.56 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 117.803 0.274 . . . . 60.13 110.595 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 39.7 p -155.14 138.87 16.14 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 124.154 0.909 . . . . 74.32 111.007 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.698 HD12 HG22 ' B' ' 31' ' ' VAL . 67.7 mt -96.65 107.03 19.41 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.301 -0.863 . . . . 55.24 108.749 170.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.29 -111.56 4.18 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 114.885 -1.052 . . . . 64.51 112.847 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -108.58 0.03 20.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.64 0.776 . . . . 74.41 110.978 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.474 ' HG3' HG23 ' B' ' 31' ' ' VAL . 12.1 pt-20 -118.49 142.67 47.36 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.73 -0.606 . . . . 72.13 110.182 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.7 m -63.94 134.84 55.85 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 123.16 0.584 . . . . 72.14 111.238 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.557 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -91.11 -65.97 0.97 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.253 -0.885 . . . . 74.22 108.644 174.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -150.45 158.19 43.88 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.518 -0.765 . . . . 65.0 111.046 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 58.2 mt -128.3 108.98 11.04 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.105 -1.813 . . . . 74.14 106.105 172.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.41 ' SG ' HG23 ' B' ' 114' ' ' ILE . 49.8 t -119.26 148.34 43.25 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.344 -0.613 . . . . 75.33 109.344 -176.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -160.4 134.71 7.35 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.152 -0.684 . . . . 65.11 109.152 -178.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.9 t -125.79 144.0 37.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.163 -0.926 . . . . 61.51 108.636 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.4 mt-30 -122.9 85.94 2.5 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.891 -1.151 . . . . 74.31 107.891 172.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.436 ' O ' HD13 ' B' ' 106' ' ' LEU . 7.0 tp-100 -80.01 101.08 8.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.199 -1.364 . . . . 74.3 108.623 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.418 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.74 167.92 27.35 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 111.558 -0.617 . . . . 71.11 111.558 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.41 130.76 2.2 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 112.099 -0.4 . . . . 65.22 112.099 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.454 HG13 ' HE1' ' B' ' 17' ' ' TYR . 61.1 mt -85.14 120.36 35.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.028 -1.101 . . . . 73.24 108.028 171.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -127.46 135.58 50.61 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.208 0.603 . . . . 64.41 109.54 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 68.2 m -97.93 109.33 22.11 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.019 0.527 . . . . 72.33 109.755 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.58 ' HB ' HG12 ' B' ' 89' ' ' ILE . 38.9 pt -102.47 122.66 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.316 1.046 . . . . 74.13 109.045 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.84 141.6 44.7 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.616 0.766 . . . . 63.13 109.612 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.53 -29.33 4.06 Favored Glycine 0 N--CA 1.473 1.157 0 CA-C-O 119.925 -0.375 . . . . 63.43 113.343 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.58 HG12 ' HB ' ' B' ' 86' ' ' ILE . 2.8 pp -56.23 132.53 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.874 0.87 . . . . 63.23 111.94 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 5.8 tp10 -160.43 161.4 32.96 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 120.922 0.391 . . . . 65.03 111.688 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.22 -95.65 1.56 Allowed Glycine 0 C--N 1.352 1.455 0 CA-C-N 115.484 -0.78 . . . . 53.45 111.286 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.2 m -105.22 -20.45 13.5 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.392 0.677 . . . . 62.43 110.247 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.427 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 95.3 mt-30 -61.66 -31.02 71.11 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.468 0.707 . . . . 62.4 111.319 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.495 ' HA ' HD13 ' B' ' 89' ' ' ILE . 21.5 ptt? -58.06 -44.88 87.72 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 123.985 0.803 . . . . 74.05 110.928 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.403 ' HB1' ' HZ ' ' B' ' 137' ' ' PHE . . . -76.16 -50.28 15.0 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 123.988 0.915 . . . . 53.51 109.679 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -60.13 -31.6 70.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.674 0.79 . . . . 61.24 111.88 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 11.7 t -73.38 -63.15 1.25 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.353 0.408 . . . . 72.24 110.262 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.722 HD13 ' HA3' ' F' ' 453' ' ' GLY . 10.3 tt -67.6 -39.2 84.77 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.323 0.49 . . . . 53.13 112.323 -172.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.42 3.34 57.88 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 114.965 0.746 . . . . 41.55 114.965 -168.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.48 -56.1 0.27 Allowed 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 117.675 0.737 . . . . 42.33 111.381 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -71.39 -46.64 59.79 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.584 0.754 . . . . 65.41 111.85 -171.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.478 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 75.1 m -65.86 -47.85 63.65 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 123.728 0.811 . . . . 71.24 111.363 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.4 Cg_exo -58.42 -32.88 97.23 Favored 'Trans proline' 0 C--N 1.398 3.143 0 C-N-CA 122.337 2.025 . . . . 72.15 113.629 168.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -62.03 -39.27 91.73 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.209 0.603 . . . . 62.2 110.316 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.465 HD13 HD11 ' B' ' 13' ' ' ILE . 69.4 mt -63.68 -45.03 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.576 0.75 . . . . 74.32 110.457 174.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.436 HD13 ' O ' ' B' ' 80' ' ' GLN . 87.1 mt -75.27 -18.36 60.09 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.891 -1.05 . . . . 61.15 112.192 -176.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.402 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 64.0 t80 -60.91 -51.09 81.88 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 117.784 -1.103 . . . . 61.12 113.563 -171.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 48.6 Cg_exo -59.16 -33.44 98.25 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 121.939 1.76 . . . . 60.41 112.949 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.411 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 78.7 m-85 -69.54 -47.36 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.334 0.654 . . . . 75.34 110.556 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.97 88.73 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.549 0.74 . . . . 71.12 110.531 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.701 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 53.3 ttt180 -60.46 -55.99 26.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.627 1.571 . . . . 73.25 111.028 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.72 -34.79 79.01 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 124.053 0.846 . . . . 65.11 110.128 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.9 t -67.04 -35.3 79.59 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 122.768 0.427 . . . . 64.42 111.825 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.456 HD11 ' HB ' ' B' ' 62' ' ' VAL . 64.5 mt -64.26 -52.96 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.986 -0.746 . . . . 73.41 108.986 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -59.44 -30.68 68.67 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 124.498 1.124 . . . . 74.43 111.769 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.9 t -66.65 -46.54 75.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.615 0.766 . . . . 60.42 110.277 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.2 mmt -68.25 -35.16 77.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.993 0.517 . . . . 71.32 110.663 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.482 HG13 ' HB2' ' B' ' 123' ' ' PHE . 68.9 t -58.13 -48.18 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.278 1.031 . . . . 74.52 110.437 172.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.472 ' HB3' HG21 ' C' ' 115' ' ' THR . 65.5 m -61.23 -35.89 78.44 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.444 -1.253 . . . . 74.52 112.042 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.599 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 74.4 mtt-85 -69.15 -37.11 78.07 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.421 -0.809 . . . . 71.01 110.1 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.51 11.23 59.43 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.749 0.656 . . . . 54.5 113.297 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 57.5 p 64.2 18.79 11.47 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.317 1.847 . . . . 75.32 114.687 172.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.482 ' HB2' HG13 ' B' ' 118' ' ' VAL . 98.8 m-85 -80.95 151.29 70.32 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 109.148 -0.686 . . . . 53.24 109.148 175.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.95 -160.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.68 2.92 . . . . 74.21 114.102 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -65.9 111.33 3.24 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 121.017 0.436 . . . . 75.11 110.76 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.412 HD21 ' HD2' ' B' ' 38' ' ' PRO . 4.0 mm? -122.63 84.7 2.3 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.392 -0.966 . . . . 74.4 108.392 171.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -92.7 128.04 38.41 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.328 -0.619 . . . . 62.14 109.328 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.701 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 32.9 tp -71.98 136.78 46.89 Favored 'General case' 0 CA--C 1.552 1.034 0 O-C-N 123.952 0.783 . . . . 61.44 109.785 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' F' ' 468' ' ' LEU . . . -72.06 151.98 92.69 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.127 0.571 . . . . 72.41 111.304 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.504 ' HG3' HD13 ' D' ' 16' ' ' ILE . 25.3 Cg_exo -61.3 102.9 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 122.311 2.007 . . . . 74.23 111.836 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.89 111.37 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.168 -1.049 . . . . 72.43 108.168 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -78.91 99.43 6.79 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.237 -1.023 . . . . 73.53 108.237 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -62.95 -48.03 80.62 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 123.371 0.42 . . . . 75.25 110.795 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.07 -41.74 90.35 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.369 1.068 . . . . 73.12 112.966 -166.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.29 -34.41 63.52 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.368 0.667 . . . . 73.32 111.347 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' F' ' 461' ' ' PHE . 8.8 mp -77.65 -32.15 53.12 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.232 0.613 . . . . 74.44 109.928 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.403 ' HZ ' ' HB1' ' B' ' 95' ' ' ALA . 92.7 t80 -70.69 -28.84 65.06 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.753 1.221 . . . . 73.12 110.452 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 21.1 ttt -53.73 -37.76 63.67 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.264 1.025 . . . . 70.12 110.85 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -78.26 -33.37 49.7 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.082 -1.417 . . . . 73.32 110.676 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -63.05 -26.43 68.84 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.22 1.008 . . . . 72.51 112.497 -175.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 20.1 mt -77.88 -6.03 52.94 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.086 0.773 . . . . 75.23 113.086 -166.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -161.27 157.65 25.93 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.868 0.867 . . . . 50.34 109.673 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -79.82 -19.19 49.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.978 0.511 . . . . 71.01 111.344 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -131.14 107.45 9.04 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.32 1.048 . . . . 61.14 108.882 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.52 110.5 13.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.651 0.78 . . . . 62.3 109.931 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -152.86 155.25 26.02 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.555 -0.618 . . . . 73.54 111.555 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.9 140.47 29.65 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.028 -1.101 . . . . 74.32 108.028 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.49 54.12 0.34 Allowed Glycine 0 C--N 1.35 1.319 0 C-N-CA 121.505 -0.379 . . . . 63.12 113.652 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 12.7 t -98.26 145.05 27.04 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.435 0.618 . . . . 52.03 109.634 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -100.98 92.47 5.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.097 -0.705 . . . . 73.41 109.097 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -70.64 96.73 1.24 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.928 -0.578 . . . . 72.12 109.874 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -142.28 98.15 3.26 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.579 -0.897 . . . . 73.21 108.579 173.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -144.06 112.44 6.45 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.466 -0.939 . . . . 64.13 108.466 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -100.84 146.04 27.8 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.388 0.675 . . . . 74.11 109.482 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.319 0 C-N-CA 123.896 0.879 . . . . 75.21 109.192 176.834 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.473 ' HG2' ' H ' ' C' ' 2' ' ' SER . 48.6 ttm . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 108.767 -0.827 . . . . 73.55 108.767 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 2' ' ' SER . . . . . 0.473 ' H ' ' HG2' ' C' ' 1' ' ' MET . 15.3 m -43.76 -46.09 7.49 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.923 1.689 . . . . 70.21 115.002 -171.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -89.66 24.09 2.44 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.082 0.553 . . . . 63.41 112.051 -173.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 69.54 0.51 2.97 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.877 1.271 . . . . 71.21 111.08 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -75.8 127.74 33.67 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 124.797 1.239 . . . . 71.34 109.812 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -162.48 -39.91 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.043 0.537 . . . . 74.45 109.885 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m 72.59 155.89 0.16 Allowed 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 125.439 1.496 . . . . 73.14 110.936 -177.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -59.05 -66.12 0.56 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.839 0.855 . . . . 71.31 109.476 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.9 ttt 56.14 115.06 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.753 1.621 . . . . 73.21 113.068 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 58.5 m -120.57 104.36 9.89 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.194 -1.039 . . . . 64.4 108.194 173.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.567 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 4.5 t80 -123.6 125.48 44.92 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.968 -0.753 . . . . 74.42 108.968 176.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -147.02 119.99 8.75 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.065 -1.087 . . . . 71.45 108.065 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.5 mt -74.08 122.25 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.901 -0.777 . . . . 54.42 108.901 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.678 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 14.9 mm100 -85.0 -45.74 11.86 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.173 -0.922 . . . . 72.23 110.508 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -174.16 126.02 0.34 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.032 -0.531 . . . . 73.34 110.31 -168.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.78 141.64 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 107.868 -1.16 . . . . 54.34 107.868 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.477 ' HB3' HG23 ' D' ' 122' ' ' THR . 27.0 p90 -173.15 168.43 4.75 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.306 0.574 . . . . 74.21 111.941 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -89.38 117.57 28.42 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.013 -0.736 . . . . 51.0 109.013 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -78.73 -35.47 44.73 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.506 -0.553 . . . . 75.5 109.506 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.426 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 13.9 t70 -146.62 147.83 31.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.127 -0.942 . . . . 71.0 109.323 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.0 mt -141.83 146.09 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.169 1.388 . . . . 62.21 107.394 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.7 t -158.11 149.35 21.13 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.355 0.597 . . . . 62.15 110.748 174.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -143.49 145.11 32.32 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.446 -1.316 . . . . 63.14 107.446 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.472 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.1 mt-10 -135.05 127.9 31.26 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.987 0.915 . . . . 75.24 109.926 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.72 72.7 7.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.591 1.557 . . . . 72.21 106.933 170.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.1 -39.94 21.96 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.763 2.309 . . . . 73.52 111.062 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -93.46 22.29 5.45 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 113.846 -1.525 . . . . 65.03 111.279 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.21 -56.08 5.79 Favored Pre-proline 0 CA--C 1.564 1.509 0 N-CA-C 114.135 1.161 . . . . 64.44 114.135 -173.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.42 -38.15 44.58 Favored 'Trans proline' 0 C--N 1.389 2.691 0 CA-C-N 121.77 1.668 . . . . 62.24 112.716 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -69.4 -38.42 77.94 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.596 0.759 . . . . 73.22 112.103 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.716 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.4 p -77.08 -22.26 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 N-CA-C 112.286 0.476 . . . . 61.23 112.286 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -68.1 -30.0 69.06 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.925 0.393 . . . . 74.33 110.87 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -99.82 31.67 3.17 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.255 0.622 . . . . 62.41 110.574 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -108.86 157.79 18.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.83 0.852 . . . . 63.11 109.746 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -61.61 121.36 12.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.062 -0.718 . . . . 74.12 109.062 168.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 58.7 t-105 -86.55 96.6 10.13 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.146 0.578 . . . . 72.03 110.478 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.479 ' H ' HD22 ' C' ' 68' ' ' LEU . 63.7 tt0 -144.72 78.48 12.88 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 108.585 -0.894 . . . . 62.13 108.585 170.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -85.67 139.96 6.89 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.74 2.293 . . . . 52.35 112.641 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.437 ' HB3' ' HE3' ' C' ' 41' ' ' LYS . 36.6 mt-10 -87.28 85.43 7.17 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.15 -1.796 . . . . 73.51 106.15 169.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.673 HG11 ' HB2' ' G' ' 468' ' ' LEU . 48.1 t -63.13 107.99 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.504 0 CA-C-N 114.698 -1.137 . . . . 75.14 108.655 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' C' ' 39' ' ' GLU . 99.2 mttt -125.12 104.8 8.73 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.008 0.923 . . . . 62.4 109.763 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.537 HD11 HD21 ' C' ' 126' ' ' LEU . 4.0 mm? -86.09 125.6 33.58 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.159 -0.928 . . . . 74.54 109.194 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -118.25 105.31 11.63 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.812 -1.181 . . . . 71.01 107.812 173.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 tt -107.57 122.31 46.42 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.464 -0.569 . . . . 60.21 109.464 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -124.27 142.54 51.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.969 1.308 . . . . 74.21 108.654 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.41 HG21 ' HG3' ' C' ' 103' ' ' PRO . 1.5 m -123.48 126.6 47.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.465 0.65 . . . . 73.21 109.597 173.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.55 170.33 8.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.275 -1.329 . . . . 70.32 107.872 171.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -165.0 156.84 15.34 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.048 -0.723 . . . . 64.44 109.048 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 49.9 p -156.64 136.75 12.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.845 0.458 . . . . 73.22 110.713 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -70.2 126.35 29.41 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.415 -0.587 . . . . 74.13 109.415 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' C' ' 57' ' ' GLU . 57.6 mt -97.47 -35.93 10.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.421 0.688 . . . . 73.31 110.336 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.0 -174.08 4.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.031 0.933 . . . . 74.23 110.455 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -62.29 106.73 0.78 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.237 -0.892 . . . . 75.42 109.874 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 68.68 11.03 8.21 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.498 1.119 . . . . 71.11 112.876 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 99.4 t -105.94 105.76 19.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.62 -1.252 . . . . 72.42 107.62 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -117.73 123.88 47.12 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.722 -0.844 . . . . 75.13 108.722 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.568 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.6 tt0 -85.54 143.87 28.25 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.748 0.819 . . . . 75.05 109.218 171.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 43.7 t -119.26 139.08 47.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 108.102 -1.073 . . . . 74.51 108.102 166.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.76 123.36 65.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 107.43 -1.322 . . . . 71.43 107.43 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.4 107.7 18.82 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.629 -0.878 . . . . 62.22 108.629 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.15 102.96 14.81 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.706 -0.85 . . . . 71.23 108.706 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.402 ' HB ' HD11 ' C' ' 114' ' ' ILE . 58.7 t -103.59 108.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.344 -0.984 . . . . 74.31 108.344 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.7 m -98.1 137.1 37.39 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.853 -1.166 . . . . 71.13 107.853 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.56 HG21 HG21 ' C' ' 114' ' ' ILE . 61.3 t -132.24 108.82 14.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.591 -0.522 . . . . 64.41 109.591 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -103.9 142.93 33.55 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.117 -0.947 . . . . 64.31 109.737 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.26 123.23 15.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.874 -1.528 . . . . 45.23 106.874 173.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 7.9 m -130.45 128.42 41.23 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.492 0.495 . . . . 61.32 109.968 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.479 HD22 ' H ' ' C' ' 37' ' ' GLN . 18.3 mt -86.93 47.57 1.52 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.4 1.08 . . . . 75.43 108.752 175.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.22 -109.47 3.71 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 110.091 -1.204 . . . . 61.5 110.091 -172.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.29 -26.46 17.31 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.292 1.037 . . . . 72.43 110.418 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -71.78 121.3 18.69 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.297 0.639 . . . . 71.34 110.028 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -68.63 126.37 29.47 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.65 -0.87 . . . . 75.03 108.65 168.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.716 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.6 -58.49 3.25 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.164 -1.05 . . . . 62.13 108.164 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.07 165.45 27.19 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.795 -1.093 . . . . 74.52 110.169 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.472 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.6 tm? -128.62 140.42 51.78 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.387 -1.708 . . . . 70.24 106.387 168.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.5 t -144.35 140.09 28.88 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.124 -1.065 . . . . 73.34 108.124 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -156.29 137.0 13.31 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 110.152 -0.314 . . . . 62.51 110.152 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -136.21 135.29 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.066 0.946 . . . . 61.14 108.833 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 41.9 mt-30 -107.07 94.62 5.2 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.259 1.023 . . . . 75.32 109.388 173.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.41 ' HG3' HD22 ' C' ' 106' ' ' LEU . 9.3 tp-100 -85.59 98.1 10.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.989 -1.005 . . . . 71.34 110.226 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.69 145.98 17.9 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 112.117 -0.393 . . . . 41.41 112.117 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.571 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.51 124.72 1.84 Allowed Glycine 0 CA--C 1.507 -0.441 0 N-CA-C 110.568 -1.013 . . . . 75.02 110.568 -174.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 4.8 mm -82.82 123.55 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.513 -0.921 . . . . 75.22 108.513 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.567 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 64.2 m-85 -129.32 120.7 26.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.222 0.609 . . . . 71.4 109.512 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -70.81 118.82 14.08 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.137 -0.69 . . . . 63.52 109.137 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' C' ' 94' ' ' MET . 4.7 tt -122.05 122.88 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.312 0.645 . . . . 61.52 110.313 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.605 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -156.57 168.89 26.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.493 0.717 . . . . 50.42 109.656 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.96 -54.45 4.3 Favored Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.045 0.355 . . . . 71.32 112.495 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 pt -83.01 156.1 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.408 1.083 . . . . 71.45 110.964 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.98 175.81 10.39 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.543 0.737 . . . . 54.15 110.635 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.11 -127.71 43.16 Favored Glycine 0 C--N 1.349 1.27 0 O-C-N 123.981 0.801 . . . . 73.14 114.128 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.676 ' HB ' ' HA ' ' C' ' 142' ' ' GLN . 41.4 p -70.07 -26.95 64.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.017 0.927 . . . . 61.05 111.97 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -68.49 -44.65 74.29 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.869 0.868 . . . . 74.32 110.705 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.792 ' HB2' HD11 ' C' ' 86' ' ' ILE . 3.6 ppp? -74.13 -33.75 63.66 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.729 -0.471 . . . . 61.33 109.729 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.503 ' HA ' HD21 ' G' ' 454' ' ' LEU . . . -60.4 -41.31 93.6 Favored 'General case' 0 C--N 1.36 1.046 0 O-C-N 124.242 0.964 . . . . 73.23 110.391 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -80.97 -33.9 33.49 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.046 0.841 . . . . 72.51 112.301 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.9 t -55.4 -38.44 68.92 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.444 0.465 . . . . 42.13 110.053 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.61 ' HB2' HD11 ' G' ' 454' ' ' LEU . 30.6 mt -101.46 -13.29 18.0 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.74 0.816 . . . . 73.35 111.609 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.55 -30.54 56.32 Favored Glycine 0 C--N 1.354 1.58 0 N-CA-C 114.982 0.753 . . . . 74.33 114.982 -174.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.61 -35.38 0.07 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.814 0.445 . . . . 72.51 110.774 -171.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -68.45 -50.15 54.69 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.958 1.303 . . . . 75.45 112.467 -177.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 66.7 m -71.89 -41.39 9.02 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.877 -0.582 . . . . 63.02 112.354 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.41 ' HG3' HG21 ' C' ' 46' ' ' THR . 73.3 Cg_exo -53.84 -32.0 64.8 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 122.561 2.174 . . . . 65.31 113.927 166.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -69.24 -34.81 75.38 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.363 0.665 . . . . 63.15 109.904 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.554 HD12 ' NH1' ' A' ' 111' ' ' ARG . 34.2 mm -62.86 -40.45 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 109.37 -0.604 . . . . 73.23 109.37 174.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.571 HD21 ' HA3' ' C' ' 82' ' ' GLY . 69.1 mt -82.26 -17.98 44.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.296 1.038 . . . . 72.21 112.449 -177.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -60.07 -50.36 86.65 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-O 117.911 -1.043 . . . . 75.11 113.662 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.31 -31.51 62.88 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 121.955 1.77 . . . . 71.52 112.818 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -70.24 -47.76 59.91 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.178 0.591 . . . . 64.23 110.556 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.95 84.3 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.346 -0.843 . . . . 31.41 109.948 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -59.93 -49.35 78.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.021 1.329 . . . . 75.51 110.855 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.41 -39.1 91.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.375 0.67 . . . . 74.1 110.517 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 19.6 t -66.79 -27.53 67.65 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.826 0.45 . . . . 65.44 111.659 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.61 HG23 ' SG ' ' C' ' 76' ' ' CYS . 63.5 mt -80.78 -43.46 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.218 0.607 . . . . 63.32 110.067 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.472 HG21 ' HB3' ' B' ' 119' ' ' SER . 5.7 m -61.16 -29.33 69.73 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.321 0.582 . . . . 61.34 110.373 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -72.92 -53.5 11.14 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.754 -1.112 . . . . 72.14 109.818 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.546 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.37 -39.09 92.04 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.954 0.902 . . . . 62.14 113.167 -175.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' C' ' 123' ' ' PHE . 78.3 t -64.99 -42.17 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.689 0.795 . . . . 73.12 110.184 175.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -69.46 -29.95 67.75 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.26 -0.882 . . . . 73.42 111.244 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.45 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 86.4 mtt-85 -68.5 -39.24 81.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.636 0.775 . . . . 72.3 108.921 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.32 1.47 81.09 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 123.908 0.755 . . . . 53.13 113.17 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 38.4 p 64.03 27.31 14.22 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.543 1.937 . . . . 70.33 113.941 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.413 ' HB2' HG13 ' C' ' 118' ' ' VAL . 93.4 m-85 -92.19 149.39 38.5 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 109.012 -0.736 . . . . 74.15 109.012 171.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -45.03 119.68 2.57 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.583 2.855 . . . . 74.12 113.128 170.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -59.9 155.9 15.51 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.81 1.244 . . . . 71.23 113.566 -170.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.537 HD21 HD11 ' C' ' 42' ' ' LEU . 34.3 tp -104.2 102.33 12.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.779 0.832 . . . . 75.51 109.89 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.76 89.77 4.46 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.951 -1.129 . . . . 73.31 107.951 168.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.03 134.39 43.01 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.628 -0.714 . . . . 74.34 110.282 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.96 151.6 96.14 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 124.111 0.964 . . . . 33.42 111.746 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.52 121.22 9.53 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.983 2.456 . . . . 73.22 112.683 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.452 HG21 ' HE1' ' G' ' 462' ' ' TYR . 11.5 t -102.95 137.6 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.966 -0.753 . . . . 71.02 108.966 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.443 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 89.9 m-20 -82.27 73.4 9.31 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.541 -0.54 . . . . 73.44 109.541 173.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -61.53 -43.64 98.5 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.386 -0.824 . . . . 71.54 109.481 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -64.07 -53.51 48.72 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 113.954 -1.475 . . . . 55.5 111.837 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -56.03 -38.4 70.51 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.487 1.117 . . . . 74.11 111.171 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.78 -45.0 79.84 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.213 -0.903 . . . . 75.32 110.693 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.527 ' HA ' ' HB3' ' C' ' 140' ' ' TYR . 13.3 t80 -70.26 -28.79 65.51 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.052 0.541 . . . . 70.21 110.422 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.788 ' HA ' ' HB3' ' C' ' 142' ' ' GLN . 49.3 mtp -72.74 -32.97 66.08 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.228 0.611 . . . . 73.24 110.834 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -74.71 -36.91 62.7 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.721 0.808 . . . . 64.24 110.986 170.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.527 ' HB3' ' HA ' ' C' ' 137' ' ' PHE . 31.1 t80 -67.19 -84.63 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.234 1.414 . . . . 74.34 111.081 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.44 ' HG ' HG22 ' C' ' 92' ' ' THR . 32.7 tp -133.28 83.45 2.06 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.416 0.627 . . . . 75.22 110.093 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.788 ' HB3' ' HA ' ' C' ' 138' ' ' MET . 19.9 tp60 -169.25 -44.6 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.949 1.3 . . . . 71.44 108.279 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 60.39 81.53 0.18 Allowed 'General case' 0 C--N 1.357 0.9 0 O-C-N 124.852 1.345 . . . . 75.41 109.578 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -146.93 -47.53 0.18 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.962 -0.563 . . . . 73.43 110.556 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 69.19 138.94 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.046 1.338 . . . . 73.52 112.64 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -178.68 73.39 0.07 OUTLIER Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.268 -0.423 . . . . 75.43 112.059 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -160.82 -44.1 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.471 0.708 . . . . 64.34 110.369 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 88.14 -151.81 23.13 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 115.553 -0.748 . . . . 61.21 111.599 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 44.2 p -79.05 102.06 8.18 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 118.022 0.911 . . . . 72.55 109.182 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -67.03 149.36 50.72 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.953 -0.758 . . . . 74.31 108.953 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.82 102.04 0.09 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.626 0.77 . . . . 73.02 111.327 -173.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -85.55 150.97 24.29 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.627 -0.715 . . . . 74.43 109.637 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -83.31 -176.83 6.51 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.683 0.793 . . . . 73.15 110.233 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.89 -40.8 91.9 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.565 0.746 . . . . 42.21 110.251 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 124.783 1.233 . . . . 74.44 111.046 178.049 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.265 -0.643 . . . . 71.52 109.265 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 57.7 m -70.86 82.83 0.65 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.33 0.652 . . . . 71.54 110.017 172.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -67.35 124.4 23.06 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.25 -0.886 . . . . 72.41 111.111 -173.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -69.34 89.31 0.48 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.051 -1.462 . . . . 72.21 107.051 162.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -66.5 161.22 23.37 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.896 -0.593 . . . . 71.33 110.469 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -53.69 150.9 6.66 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.166 0.986 . . . . 62.43 112.513 -172.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 42.5 p -76.97 9.64 2.82 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.355 1.062 . . . . 75.34 113.017 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -68.93 89.69 0.42 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.888 0.875 . . . . 71.23 109.45 171.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.0 ttp -33.63 125.86 0.41 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.409 1.484 . . . . 71.55 113.336 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 90.0 m -133.05 143.26 49.25 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.003 0.921 . . . . 72.21 108.79 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -159.95 90.13 0.9 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.56 -1.274 . . . . 72.33 107.56 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -118.78 116.91 27.53 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.24 -1.022 . . . . 72.33 108.24 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.444 HG21 HD11 ' D' ' 16' ' ' ILE . 13.7 mt -73.2 109.97 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.091 -0.707 . . . . 75.41 109.091 177.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -80.65 -37.85 30.18 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.449 0.7 . . . . 74.23 111.846 -173.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -168.9 139.01 2.3 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 117.414 0.097 . . . . 64.53 111.126 -168.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.504 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.4 mp -117.82 135.04 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.144 -1.428 . . . . 75.03 107.144 169.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -160.53 150.29 17.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.434 0.635 . . . . 71.24 111.798 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 64.3 p -86.5 113.56 22.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.949 -1.023 . . . . 74.2 109.18 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -81.31 -22.04 38.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.298 0.639 . . . . 73.14 110.554 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.476 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.6 t70 -160.39 142.39 12.74 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.151 -0.931 . . . . 74.05 109.042 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.546 HG21 ' HE2' ' C' ' 117' ' ' MET . 85.5 mt -138.65 143.54 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.116 -1.068 . . . . 71.21 108.116 175.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -143.54 133.12 23.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.754 0.822 . . . . 72.13 108.916 171.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.4 t80 -134.77 131.85 38.03 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.328 -1.73 . . . . 71.3 106.328 166.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 25.4 mt-10 -133.09 130.41 39.28 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.91 0.884 . . . . 75.44 108.83 -173.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -138.65 78.34 31.59 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.048 -1.093 . . . . 54.52 108.048 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.52 -31.29 21.87 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.896 2.397 . . . . 72.14 112.388 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -99.84 -1.29 37.86 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.457 -1.247 . . . . 72.31 110.971 -173.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.513 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -29.93 -67.2 0.14 Allowed Pre-proline 0 C--N 1.36 1.058 0 C-N-CA 126.517 1.927 . . . . 75.15 116.134 -160.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.405 ' HB3' HD11 ' C' ' 83' ' ' ILE . 80.9 Cg_endo -71.62 -29.64 15.83 Favored 'Trans proline' 0 C--N 1.375 1.959 0 CA-C-N 122.63 1.975 . . . . 72.13 113.318 -170.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -84.91 -23.44 28.87 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 117.678 0.217 . . . . 64.44 111.137 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.513 HG12 ' O ' ' D' ' 28' ' ' ALA . 8.9 p -80.6 -26.73 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 122.65 0.38 . . . . 74.34 110.444 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -61.71 -25.4 67.4 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.328 0.651 . . . . 74.13 112.436 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -53.21 -28.78 28.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.275 1.03 . . . . 75.23 111.509 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -84.1 101.52 11.87 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.139 0.975 . . . . 74.01 110.116 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.34 80.43 7.75 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.991 -1.004 . . . . 75.33 108.987 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.422 ' HD1' HD23 ' D' ' 68' ' ' LEU . 50.6 t-105 -142.98 156.47 44.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.85 1.26 . . . . 73.14 108.253 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -80.3 101.98 1.08 Allowed Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 108.066 -1.087 . . . . 61.12 108.066 174.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.92 119.72 6.5 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.084 2.523 . . . . 74.22 112.901 -167.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.84 112.86 2.73 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 123.957 0.785 . . . . 71.43 109.912 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' D' ' 66' ' ' ALA . 27.5 m -100.02 151.07 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.881 -1.054 . . . . 53.25 111.131 -172.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' H' ' 465' ' ' LYS . 23.5 tptp -118.08 117.96 30.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.118 -1.067 . . . . 73.13 108.118 173.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.0 tp -94.62 120.21 34.49 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.919 -0.771 . . . . 72.04 108.919 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.538 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.4 t70 -127.67 112.88 15.33 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.76 -1.2 . . . . 74.22 107.76 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 67.0 mt -96.16 129.08 43.56 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.003 0.521 . . . . 72.11 109.688 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.58 ' HA ' ' HG ' ' H' ' 460' ' ' LEU . 30.1 t70 -136.05 121.55 19.43 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.069 -0.715 . . . . 71.44 109.069 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.491 ' H ' HD21 ' H' ' 460' ' ' LEU . 10.1 t -105.84 168.28 9.22 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.519 0.675 . . . . 55.11 110.512 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -161.05 162.73 31.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.286 -1.325 . . . . 53.44 108.539 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 24.4 p -156.88 153.32 28.0 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.868 -0.79 . . . . 71.41 108.868 172.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 37.3 p -155.69 131.36 9.76 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.543 0.737 . . . . 73.42 109.544 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -73.6 127.96 34.2 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.928 0.491 . . . . 54.15 110.073 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' D' ' 57' ' ' GLU . 61.4 mt -92.64 -35.08 13.72 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.625 -0.509 . . . . 70.41 109.625 175.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.28 -178.48 3.63 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.359 1.063 . . . . 63.13 109.512 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -65.67 127.64 32.75 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.983 -0.747 . . . . 71.43 108.983 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.81 19.3 11.32 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.39 1.076 . . . . 73.44 112.105 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.97 124.28 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.846 0.858 . . . . 74.05 109.173 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.407 ' HD1' HD11 ' D' ' 86' ' ' ILE . 15.0 m-85 -133.57 131.7 40.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.485 0.714 . . . . 71.02 109.751 176.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.527 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.0 tt0 -92.43 120.12 32.62 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.19 -1.041 . . . . 64.2 108.19 167.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -100.9 140.3 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.929 -1.137 . . . . 70.4 107.929 170.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.525 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.8 t -122.76 129.18 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.468 -0.938 . . . . 62.42 108.468 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.45 116.68 32.27 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.163 -1.421 . . . . 63.45 107.163 170.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -104.94 101.86 11.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.942 -1.133 . . . . 73.34 107.942 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.28 137.66 21.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.663 -0.699 . . . . 61.15 109.156 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 32.6 m -117.93 142.16 47.65 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.516 0.727 . . . . 63.04 109.805 177.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.414 HG21 HG21 ' D' ' 114' ' ' ILE . 59.3 t -136.5 113.08 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.058 0.943 . . . . 71.32 109.457 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 89.9 m -106.56 108.92 20.67 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.507 -0.553 . . . . 64.14 109.507 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -106.54 158.45 16.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.185 0.594 . . . . 74.53 110.368 -176.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 4.8 p -153.73 140.73 19.3 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-O 121.438 0.637 . . . . 63.13 112.404 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.481 HD12 HG22 ' D' ' 31' ' ' VAL . 70.5 mt -111.57 116.25 30.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.799 1.24 . . . . 72.41 107.764 169.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.76 -120.78 8.29 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 123.563 0.539 . . . . 74.0 113.112 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -102.84 6.66 39.33 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.82 0.848 . . . . 65.34 111.408 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -135.21 162.13 33.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.83 0.452 . . . . 54.41 110.725 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 30.4 m -57.61 142.9 43.2 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.175 0.99 . . . . 71.03 111.45 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.37 -68.58 0.79 Allowed 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.049 -1.093 . . . . 45.01 108.049 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -141.15 149.17 41.15 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.963 -1.017 . . . . 71.14 109.472 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.6 mt -112.55 146.27 38.83 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.681 -1.229 . . . . 72.13 107.681 169.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.51 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.8 t -153.97 133.45 12.79 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.765 -0.458 . . . . 70.14 109.765 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -154.26 126.61 7.94 Favored 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.97 -0.381 . . . . 73.43 109.97 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 97.9 t -131.09 125.02 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.783 0.833 . . . . 71.55 110.16 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 37.7 mt-30 -87.71 86.33 7.17 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.795 -0.817 . . . . 73.24 108.795 168.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -81.43 92.15 6.4 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.234 -0.893 . . . . 75.44 109.503 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.96 162.59 27.58 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 111.951 -0.46 . . . . 72.31 111.951 178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.31 136.46 4.43 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.997 -0.441 . . . . 54.11 111.997 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.78 127.77 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.73 -0.841 . . . . 74.14 108.73 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.43 125.65 47.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.236 1.014 . . . . 60.34 108.915 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 6.4 t -87.98 97.16 10.8 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.086 -1.079 . . . . 52.13 108.086 176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.566 HD13 HG11 ' H' ' 452' ' ' VAL . 2.7 pp -111.32 139.03 37.3 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 C-N-CA 123.546 0.738 . . . . 73.12 110.154 -171.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -157.82 157.18 32.82 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.06 0.544 . . . . 72.53 109.643 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.03 17.99 77.49 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.329 0.393 . . . . 73.11 113.512 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.455 HD11 ' HB ' ' D' ' 86' ' ' ILE . 0.2 OUTLIER -126.68 134.41 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.817 0.847 . . . . 71.52 108.944 178.349 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.57 177.02 8.77 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.269 0.628 . . . . 64.4 111.136 -174.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.53 -111.36 2.06 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 124.284 0.99 . . . . 65.5 114.573 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.3 m -89.55 -27.05 20.52 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.712 0.805 . . . . 74.42 110.804 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -64.65 -41.03 96.4 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.314 0.645 . . . . 72.43 110.642 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.675 ' SD ' ' HA ' ' H' ' 452' ' ' VAL . 26.9 ptt? -69.21 -34.04 74.26 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 116.036 -0.529 . . . . 71.33 111.08 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.32 -32.29 64.49 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.286 0.634 . . . . 50.21 110.968 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -77.65 -34.93 52.96 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.427 1.091 . . . . 73.13 110.262 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.2 -51.68 11.6 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.859 -0.61 . . . . 51.42 111.091 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.489 HD23 ' SG ' ' D' ' 102' ' ' CYS . 83.8 mt -85.86 -24.29 26.76 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.948 0.499 . . . . 62.31 112.03 -172.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.84 -14.06 55.63 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.751 -0.472 . . . . 61.23 113.668 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.628 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -135.81 -59.2 0.76 Allowed 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 117.354 0.577 . . . . 21.14 111.89 -173.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -67.8 -41.19 83.55 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.098 0.559 . . . . 71.31 112.295 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.489 ' SG ' HD23 ' D' ' 98' ' ' LEU . 70.4 m -67.86 -45.77 43.41 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 118.483 -0.77 . . . . 75.24 112.321 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -56.5 -36.2 97.44 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.184 1.923 . . . . 51.21 112.909 168.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -65.36 -30.66 71.51 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.606 0.763 . . . . 72.22 111.558 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.422 HD13 HD11 ' D' ' 13' ' ' ILE . 80.0 mt -71.3 -39.27 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.192 0.997 . . . . 52.32 110.463 174.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -76.0 -19.51 58.62 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.441 -0.799 . . . . 52.12 111.527 -176.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -64.88 -43.56 69.05 Favored Pre-proline 0 CA--C 1.562 1.409 0 CA-C-O 117.987 -1.006 . . . . 74.01 113.603 -174.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -51.48 -43.8 47.72 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.241 1.961 . . . . 61.34 113.923 170.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -72.83 -37.52 67.42 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.33 0.652 . . . . 74.15 111.2 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.33 -48.26 80.6 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.44 0.696 . . . . 73.24 109.674 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -54.38 -49.57 69.54 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.875 1.359 . . . . 73.34 110.942 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.16 -45.62 92.61 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.24 0.963 . . . . 53.23 111.372 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.7 t -58.51 -44.87 89.63 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.873 0.733 . . . . 71.42 110.697 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.51 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.0 mt -60.04 -56.56 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.184 0.994 . . . . 73.12 110.743 175.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.7 m -55.21 -42.78 73.77 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.932 1.293 . . . . 74.35 111.561 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 36.8 t -66.18 -40.63 90.6 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 114.561 -1.2 . . . . 74.25 110.047 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.5 mtm -70.57 -30.79 67.59 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.961 0.505 . . . . 62.14 111.869 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.448 HG23 ' O ' ' D' ' 114' ' ' ILE . 73.8 t -64.05 -45.89 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.484 0.714 . . . . 53.55 109.947 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -74.97 -28.13 60.44 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.648 -0.706 . . . . 54.51 111.28 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -70.85 -34.01 71.21 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.236 -0.653 . . . . 60.23 109.236 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.66 11.09 62.63 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.924 0.765 . . . . 71.33 112.919 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.477 HG23 ' HB3' ' C' ' 17' ' ' TYR . 78.9 p 58.51 16.84 4.48 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 126.499 1.92 . . . . 73.4 114.606 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -80.16 146.88 63.8 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.096 -0.705 . . . . 73.04 109.096 171.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.53 133.2 25.92 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.291 2.661 . . . . 64.13 112.428 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -53.34 136.93 36.33 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.346 1.029 . . . . 72.33 112.589 -168.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.412 HD12 HD12 ' H' ' 468' ' ' LEU . 51.6 tp -108.37 107.33 17.86 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.488 -0.778 . . . . 72.44 109.74 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -101.23 96.22 7.05 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.4 -0.963 . . . . 72.01 108.4 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.37 122.22 15.68 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.851 0.46 . . . . 71.25 110.05 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.71 123.06 80.18 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 122.993 0.517 . . . . 53.34 109.844 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.89 122.84 11.83 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.626 2.217 . . . . 65.05 112.031 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 75.0 t -106.78 123.27 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.854 -0.795 . . . . 73.22 108.854 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -80.29 93.32 5.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.019 -0.734 . . . . 75.1 109.019 174.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -60.81 -28.07 68.51 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.545 0.738 . . . . 73.45 111.292 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.628 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 6.0 t70 -62.8 -50.08 72.42 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.423 1.089 . . . . 73.13 111.265 -173.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.66 -45.26 87.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.556 0.743 . . . . 65.2 111.408 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.66 -26.05 66.01 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.603 0.761 . . . . 71.11 111.603 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -67.27 -39.53 86.06 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.608 0.763 . . . . 71.14 110.447 175.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 31.0 mtt -61.28 -39.11 89.17 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.517 0.727 . . . . 74.41 109.821 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.462 ' HA ' ' HG3' ' D' ' 142' ' ' GLN . 19.3 m120 -63.9 -46.86 82.97 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.129 0.893 . . . . 74.35 111.052 175.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -54.57 -38.47 66.72 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.095 0.958 . . . . 73.11 111.256 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.9 mp -74.55 -39.85 62.06 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.203 0.601 . . . . 63.32 111.622 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.462 ' HG3' ' HA ' ' D' ' 139' ' ' ASN . 0.0 OUTLIER -86.33 11.4 12.33 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.093 0.775 . . . . 71.03 113.093 -174.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -118.99 87.83 2.81 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.469 0.652 . . . . 44.4 110.256 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -162.23 168.29 22.64 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.452 -1.249 . . . . 50.53 109.114 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.85 82.23 2.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.057 0.543 . . . . 63.52 110.151 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.34 65.72 3.78 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 115.687 -0.688 . . . . 60.04 111.707 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -157.63 -149.03 0.22 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.761 0.825 . . . . 60.42 109.298 -171.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -47.25 109.51 0.43 Allowed Glycine 0 C--N 1.364 2.123 0 C-N-CA 123.723 0.678 . . . . 73.51 113.529 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 17.5 m -73.78 87.06 1.72 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.68 1.192 . . . . 75.01 110.55 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -161.55 -168.45 1.99 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.209 1.004 . . . . 73.32 108.982 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.23 71.69 1.71 Allowed 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 121.914 0.864 . . . . 74.54 110.53 174.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -72.31 98.17 2.15 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.311 -0.859 . . . . 61.11 109.407 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -75.98 141.11 42.28 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 116.037 -0.529 . . . . 73.44 110.237 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -174.47 162.52 3.51 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.199 1.399 . . . . 74.15 108.517 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 N-CA-C 108.784 -0.821 . . . . 73.03 108.784 178.41 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 450' ' ' ASN . . . . . 0.543 ' N ' HD21 ' E' ' 450' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 110.175 -0.305 . . . . 62.24 110.175 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 451' ' ' VAL . . . . . 0.434 HG13 HG23 ' E' ' 452' ' ' VAL . 9.8 p -75.61 163.37 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 C-N-CA 123.354 0.661 . . . . 64.41 111.278 -172.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 452' ' ' VAL . . . . . 0.563 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 88.4 t 75.15 -76.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.837 0 C-N-CA 125.768 1.627 . . . . 74.23 111.398 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 60.81 46.67 94.06 Favored Glycine 0 C--N 1.343 0.951 0 O-C-N 123.19 0.306 . . . . 53.14 112.804 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.26 151.11 48.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.356 0.662 . . . . 73.1 111.708 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 14.1 p -113.97 -33.71 5.65 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.943 0.897 . . . . 62.11 109.577 168.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 26.1 t70 68.45 154.17 0.1 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.758 1.223 . . . . 74.41 112.154 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -124.16 -11.83 7.47 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.989 0.916 . . . . 62.13 111.549 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 30.7 m 58.62 88.01 0.07 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 124.533 1.133 . . . . 74.33 109.859 -173.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -161.65 137.05 7.56 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 116.311 -0.404 . . . . 75.12 110.301 -171.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 45.5 mt -138.91 177.37 7.94 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.772 0.829 . . . . 54.54 110.533 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.75 50.55 2.23 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.776 1.23 . . . . 74.1 110.419 -171.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -82.68 144.38 30.29 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.695 -0.684 . . . . 74.4 110.93 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 4.9 m -138.38 49.54 1.91 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 108.272 -1.01 . . . . 63.45 108.272 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 26.2 ptm -163.89 170.78 16.29 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.685 -1.143 . . . . 72.42 109.828 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 465' ' ' LYS . . . . . 0.641 ' HG2' ' H ' ' E' ' 466' ' ' ALA . 0.0 OUTLIER -127.5 -95.96 0.42 Allowed 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 108.698 -0.853 . . . . 65.31 108.698 167.691 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 466' ' ' ALA . . . . . 0.641 ' H ' ' HG2' ' E' ' 465' ' ' LYS . . . -163.79 164.36 23.65 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.767 0.827 . . . . 75.32 109.637 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -164.37 87.96 0.49 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.135 -1.061 . . . . 44.35 108.135 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 50.0 mt -93.41 -68.64 0.79 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.477 0.711 . . . . 74.4 110.568 -170.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 134.19 42.69 0.14 Allowed Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.404 -0.816 . . . . 61.24 111.326 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 43.1 mt -87.43 19.61 3.22 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.384 0.673 . . . . 71.13 111.985 -176.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? . . . . . 0 CA--C 1.555 1.172 0 N-CA-C 107.301 -1.37 . . . . 72.53 107.301 -178.413 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 450' ' ' ASN . . . . . 0.406 ' N ' HD21 ' F' ' 450' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.081 -0.711 . . . . 63.43 109.081 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 451' ' ' VAL . . . . . 0.613 HG21 ' HA ' ' B' ' 54' ' ' ASP . 14.8 p -158.2 143.12 7.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 C-N-CA 122.86 0.464 . . . . 74.4 110.395 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 12.1 p -173.03 166.34 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.69 1.196 . . . . 73.34 108.075 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 453' ' ' GLY . . . . . 0.722 ' HA3' HD13 ' B' ' 98' ' ' LEU . . . -104.23 -90.64 2.18 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.046 -0.822 . . . . 73.25 111.046 168.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 2.9 pp -160.17 -174.57 4.6 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.149 0.979 . . . . 54.54 109.726 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 12.1 t -145.0 30.22 1.17 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.987 0.899 . . . . 70.24 108.698 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -112.45 130.13 56.09 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.832 -1.076 . . . . 71.31 110.071 -169.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -161.28 29.81 0.14 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.129 0.972 . . . . 55.3 108.803 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 85.4 m -63.02 -44.98 94.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.167 0.987 . . . . 72.35 111.225 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -159.51 135.81 9.0 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.549 0.74 . . . . 74.5 109.491 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.54 123.69 27.81 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.414 0.685 . . . . 74.12 110.218 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 461' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' B' ' 136' ' ' LEU . 6.3 p90 -62.35 114.37 3.45 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.653 -1.158 . . . . 71.44 110.518 175.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -135.4 106.66 6.77 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.123 -0.695 . . . . 73.34 109.123 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 74.9 m -148.45 112.14 5.07 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.797 -1.186 . . . . 73.24 107.797 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 46.8 ttp -147.16 142.29 27.16 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.258 -0.645 . . . . 71.41 109.258 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -73.82 -17.79 61.03 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.21 1.004 . . . . 74.25 112.07 -170.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -126.55 167.63 15.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.971 0.908 . . . . 71.35 109.38 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -81.94 -40.4 22.32 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.678 0.391 . . . . 60.12 111.313 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 468' ' ' LEU . . . . . 0.485 HD13 HG21 ' B' ' 40' ' ' VAL . 21.3 tp -155.64 -45.73 0.08 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.983 0.513 . . . . 70.24 111.463 -174.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 95.71 41.92 3.74 Favored Glycine 0 N--CA 1.472 1.092 0 N-CA-C 110.599 -1.0 . . . . 64.41 110.599 -166.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 470' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' B' ' 37' ' ' GLN . 10.4 tt -78.51 -47.86 16.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.351 1.06 . . . . 71.34 109.811 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt . . . . . 0 C--O 1.252 1.232 0 N-CA-C 107.3 -1.37 . . . . 71.11 107.3 177.524 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 109.561 -0.533 . . . . 53.31 109.561 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 6.1 p -70.13 101.39 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 CA-C-O 121.835 0.826 . . . . 74.24 111.05 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 24.0 m -136.25 162.98 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.375 1.07 . . . . 71.44 110.5 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 148.55 69.65 0.01 OUTLIER Glycine 0 C--N 1.356 1.674 0 O-C-N 123.054 0.221 . . . . 74.15 113.167 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 454' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' C' ' 98' ' ' LEU . 94.4 mt -131.84 170.96 14.12 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.675 0.79 . . . . 71.23 111.06 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 9.9 t -70.28 137.6 50.87 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 116.194 -0.457 . . . . 61.11 110.444 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -89.29 49.95 1.85 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.957 0.903 . . . . 72.44 109.973 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 71.04 112.52 0.06 Allowed 'General case' 0 C--N 1.363 1.167 0 C-N-CA 125.903 1.681 . . . . 63.01 109.973 -174.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 15.3 t -141.15 -47.26 0.39 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.443 0.697 . . . . 70.35 109.897 168.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -175.27 166.78 3.41 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.245 1.018 . . . . 74.31 110.12 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -137.7 135.59 36.59 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.219 -1.03 . . . . 75.11 108.219 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -58.42 113.09 1.81 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.489 1.116 . . . . 61.35 111.408 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 462' ' ' TYR . . . . . 0.452 ' HE1' HG21 ' C' ' 131' ' ' VAL . 54.0 t80 -158.2 110.39 2.3 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.956 -0.386 . . . . 73.21 109.956 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 463' ' ' THR . . . . . 0.466 ' HA ' ' HE2' ' G' ' 465' ' ' LYS . 38.1 p -133.65 82.71 2.0 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.835 0.854 . . . . 53.31 110.748 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 31.5 mtm -135.99 -64.05 0.63 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.869 -0.789 . . . . 73.24 108.869 168.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 465' ' ' LYS . . . . . 0.481 ' HA ' ' H ' ' C' ' 42' ' ' LEU . 0.0 OUTLIER 64.92 -79.08 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.907 1.283 . . . . 74.44 111.368 -177.431 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -72.99 86.37 1.31 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.763 -0.458 . . . . 31.45 109.763 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -151.21 31.19 0.61 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.26 0.624 . . . . 71.5 111.811 -171.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 468' ' ' LEU . . . . . 0.673 ' HB2' HG11 ' C' ' 40' ' ' VAL . 4.7 tt -97.98 -66.8 0.88 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.222 -1.029 . . . . 73.41 108.222 175.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 132.19 2.2 4.23 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.495 -0.775 . . . . 75.41 113.048 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 470' ' ' LEU . . . . . 0.436 ' HG ' HD22 ' G' ' 468' ' ' LEU . 80.9 mt -69.0 133.04 47.62 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.589 0.694 . . . . 75.02 110.044 174.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 26.0 tptp . . . . . 0 C--O 1.249 1.072 0 C-N-CA 123.629 0.772 . . . . 70.13 109.059 -175.609 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.742 -0.466 . . . . 74.1 109.742 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 96.4 t -75.08 -67.82 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 107.348 -1.353 . . . . 61.42 107.348 168.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 452' ' ' VAL . . . . . 0.675 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 16.7 m -100.73 144.94 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 115.364 -0.834 . . . . 72.23 110.052 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -176.25 81.33 0.07 OUTLIER Glycine 0 C--N 1.34 0.804 0 O-C-N 123.478 0.486 . . . . 75.44 111.897 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 454' ' ' LEU . . . . . 0.426 HD21 HD12 ' D' ' 98' ' ' LEU . 1.5 pt? -147.64 133.7 19.28 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.929 0.892 . . . . 61.52 109.005 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 14.8 t -133.69 -1.52 3.07 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.875 0.47 . . . . 63.14 111.028 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -82.68 142.85 31.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.264 0.626 . . . . 64.42 110.099 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -74.88 -20.61 59.66 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.36 0.664 . . . . 63.43 111.376 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 27.8 m 72.62 128.76 0.04 OUTLIER 'General case' 0 C--N 1.364 1.23 0 C-N-CA 125.296 1.439 . . . . 75.11 111.045 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.88 121.19 14.51 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 122.756 0.422 . . . . 74.4 109.89 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 460' ' ' LEU . . . . . 0.58 ' HG ' ' HA ' ' D' ' 45' ' ' ASP . 4.5 mm? -65.23 149.4 50.0 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.164 0.983 . . . . 51.25 111.981 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -135.27 136.76 41.92 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 113.618 -1.628 . . . . 71.24 108.553 -172.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 90.2 t80 69.38 134.39 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.945 1.298 . . . . 72.11 112.176 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 14.3 t -156.11 133.03 10.48 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 108.783 -0.821 . . . . 75.53 108.783 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -134.59 159.86 39.88 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.783 0.433 . . . . 70.01 111.437 -170.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 465' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' D' ' 41' ' ' LYS . 4.3 ttmp? -83.16 -66.28 0.91 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.504 0.722 . . . . 72.04 109.702 173.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -69.5 90.49 0.54 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.596 0.758 . . . . 62.13 111.976 -171.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -102.83 33.49 3.2 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 114.798 -1.092 . . . . 75.5 109.876 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 468' ' ' LEU . . . . . 0.412 HD12 HD12 ' D' ' 126' ' ' LEU . 6.6 tt -166.98 -52.56 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 106.978 -1.49 . . . . 74.21 106.978 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.13 -30.83 3.8 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 114.418 -1.265 . . . . 65.2 110.443 -173.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 59.27 81.01 0.18 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 124.917 1.287 . . . . 73.12 110.815 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 94.6 mttt . . . . . 0 C--O 1.248 1.015 0 CA-C-N 115.247 -0.888 . . . . 60.54 109.676 -179.381 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 110.53 -0.174 . . . . 61.22 110.53 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m 57.81 37.81 27.13 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.26 1.024 . . . . 73.35 111.434 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 66.25 90.73 0.09 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.078 1.351 . . . . 71.45 111.204 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.02 134.55 40.96 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 107.499 -1.297 . . . . 74.52 107.499 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 73.29 117.38 0.05 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.183 1.393 . . . . 75.24 109.977 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -61.93 -64.95 0.77 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.442 0.697 . . . . 54.2 109.795 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 p -144.34 168.26 20.5 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.485 1.114 . . . . 43.21 109.409 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -157.04 133.01 9.54 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.328 -0.99 . . . . 62.32 108.328 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 83.7 mtp -145.24 137.91 26.1 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.264 1.026 . . . . 75.14 109.356 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 92.3 m -147.15 120.02 8.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.784 0.834 . . . . 55.32 108.845 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.58 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 13.7 t80 -137.93 126.83 24.01 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.958 0.503 . . . . 65.21 109.713 177.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -138.16 132.5 32.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.418 -1.327 . . . . 62.55 107.418 172.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.527 HG12 ' HD2' ' A' ' 84' ' ' PHE . 46.9 mt -92.76 116.82 34.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.188 -0.671 . . . . 71.41 109.188 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.6 -43.4 59.79 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 124.256 0.973 . . . . 70.11 108.909 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -173.71 129.73 0.42 Allowed 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.243 0.34 . . . . 73.43 111.007 -172.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.492 HD11 HD13 ' A' ' 13' ' ' ILE . 77.1 mt -113.87 139.74 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.954 0.902 . . . . 55.12 109.097 172.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -168.97 -179.78 3.79 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 124.537 1.148 . . . . 72.42 110.495 -170.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -110.15 126.38 54.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.42 -0.809 . . . . 65.23 109.466 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -80.54 -48.8 12.22 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.338 -0.615 . . . . 74.11 109.338 171.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 19.3 t70 -135.58 132.27 36.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.652 -0.704 . . . . 72.44 109.481 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.3 mt -123.21 141.66 42.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.239 -1.393 . . . . 54.03 107.239 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.0 t -144.64 139.07 27.8 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 123.576 0.547 . . . . 74.01 109.586 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.452 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.6 t80 -146.36 126.3 13.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.632 -1.618 . . . . 74.42 106.632 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 22.5 mt-10 -129.6 127.75 41.27 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.438 0.695 . . . . 61.32 109.511 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -137.95 73.93 44.97 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.976 -1.12 . . . . 74.12 107.976 170.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.3 -16.19 13.85 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.664 2.243 . . . . 73.25 110.795 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -105.35 13.54 30.2 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.973 1.309 . . . . 62.02 108.96 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -53.12 -47.93 93.98 Favored Pre-proline 0 CA--C 1.566 1.589 0 C-N-CA 124.935 1.294 . . . . 53.13 113.568 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 37.5 Cg_exo -64.17 -24.39 65.94 Favored 'Trans proline' 0 C--N 1.397 3.107 0 C-N-CA 122.131 1.887 . . . . 71.4 113.608 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -74.07 -42.44 60.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.172 0.589 . . . . 71.1 110.597 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.428 HG21 ' HE1' ' A' ' 123' ' ' PHE . 90.3 t -50.37 -33.54 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.735 1.214 . . . . 74.42 112.356 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -58.02 -39.9 79.51 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.427 1.091 . . . . 74.0 111.694 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -91.67 -23.21 19.88 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.244 1.018 . . . . 74.21 111.628 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 32.0 mmmt -80.4 147.59 30.94 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.402 0.681 . . . . 52.34 111.654 -175.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.34 129.0 35.97 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.404 -0.961 . . . . 65.24 108.404 170.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.509 ' HE1' ' HB3' ' E' ' 470' ' ' LEU . 69.8 t-105 -76.21 96.38 3.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.0 0.52 . . . . 74.44 110.85 -172.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -148.07 67.17 9.89 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 109.339 -0.615 . . . . 65.21 109.339 170.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.26 152.87 12.35 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.762 2.308 . . . . 74.1 111.589 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -97.0 106.44 18.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.452 -1.314 . . . . 73.52 107.452 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.07 98.19 4.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 116.016 -0.538 . . . . 63.44 109.984 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -78.73 113.45 16.8 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.09 -0.959 . . . . 73.52 108.478 170.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' E' ' 467' ' ' ALA . 46.1 tp -100.22 142.87 31.11 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.794 -1.188 . . . . 74.55 107.794 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.54 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 38.8 t70 -145.44 150.26 36.18 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.061 0.545 . . . . 74.23 109.834 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.2 mt -130.53 126.54 37.05 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.479 0.711 . . . . 71.25 110.49 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.673 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 10.5 m-20 -124.72 141.22 52.26 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.328 1.051 . . . . 64.34 109.499 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.441 ' HB ' HD23 ' E' ' 460' ' ' LEU . 87.5 m -134.8 131.12 37.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.008 0.523 . . . . 63.54 110.366 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.01 152.48 50.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.082 0.953 . . . . 55.04 109.383 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.425 ' HB2' HD11 ' A' ' 98' ' ' LEU . 22.4 t -123.45 153.92 39.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.452 0.701 . . . . 43.54 110.424 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.7 t -149.33 119.62 7.32 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.34 1.056 . . . . 72.33 108.695 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -78.42 106.59 10.46 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.482 -0.562 . . . . 44.34 109.482 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 57' ' ' GLU . 42.3 mt -82.0 -35.81 28.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.595 0.758 . . . . 55.41 110.224 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -164.48 -174.36 3.43 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.06 -0.973 . . . . 74.04 109.86 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.84 126.12 28.71 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.264 -1.013 . . . . 65.23 108.264 172.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 85' ' ' SER . 4.8 m-20 65.04 14.63 9.49 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.171 0.989 . . . . 74.23 111.4 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.9 t -128.64 104.88 12.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 N-CA-C 107.8 -1.185 . . . . 63.35 107.8 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.95 126.52 36.27 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.644 -0.707 . . . . 74.22 109.711 -170.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' HB2' HD11 ' A' ' 51' ' ' LEU . 21.0 tp10 -86.98 128.72 35.07 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 124.438 1.095 . . . . 70.24 109.225 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -128.02 120.32 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.379 -1.341 . . . . 65.44 107.379 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.5 t -110.97 118.51 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.778 0.831 . . . . 73.31 109.146 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.6 tp -100.06 108.11 20.2 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.88 -0.785 . . . . 74.12 108.88 172.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.673 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 27.5 ttp180 -87.18 104.98 16.88 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.543 -0.54 . . . . 75.31 109.543 173.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.1 t -94.39 104.75 16.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.119 -1.067 . . . . 74.31 108.119 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 30.7 m -96.27 135.87 37.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.728 0.811 . . . . 62.3 110.298 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.535 HG21 HG21 ' A' ' 114' ' ' ILE . 74.6 t -128.51 116.79 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.227 1.411 . . . . 62.25 108.544 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -120.95 123.36 42.27 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.209 -1.034 . . . . 55.53 108.209 172.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.84 113.78 21.1 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.839 -1.171 . . . . 52.33 107.839 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.6 t -144.76 143.85 30.88 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.902 0.481 . . . . 73.5 110.173 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -119.33 84.68 2.24 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.013 1.325 . . . . 74.21 108.961 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.14 -119.57 5.22 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.238 -0.892 . . . . 72.12 112.645 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -87.83 -18.98 28.09 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.435 0.694 . . . . 74.45 110.967 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.41 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 1.5 tp10 -94.07 120.27 34.09 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.468 -0.938 . . . . 70.32 108.468 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.3 m -87.35 143.5 27.22 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.114 0.415 . . . . 70.54 110.211 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.71 -66.41 0.89 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.356 -0.609 . . . . 72.12 109.356 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -161.49 174.23 13.71 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.199 -0.91 . . . . 75.42 110.985 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 64' ' ' VAL . 58.2 tp -137.81 137.41 38.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.852 1.261 . . . . 70.34 108.113 175.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.447 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 56.7 m -141.32 130.62 23.61 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.857 -1.164 . . . . 74.3 107.857 175.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -146.7 120.5 9.26 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.603 0.638 . . . . 73.53 109.739 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.84 113.39 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.36 0.664 . . . . 63.4 110.623 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -82.99 87.1 6.89 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.413 -0.958 . . . . 63.32 108.413 166.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.46 ' HG3' HD22 ' A' ' 106' ' ' LEU . 60.3 tp60 -77.19 102.71 6.75 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.304 -0.999 . . . . 62.54 108.304 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.07 143.58 17.1 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.603 -0.599 . . . . 71.34 111.603 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.93 121.89 1.56 Allowed Glycine 0 N--CA 1.451 -0.336 0 N-CA-C 111.041 -0.824 . . . . 72.1 111.041 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.5 mt -82.02 122.26 36.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.107 -1.071 . . . . 43.3 108.107 171.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.58 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.6 m-85 -127.64 119.59 26.24 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.993 0.917 . . . . 73.4 108.962 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 74.4 m -81.07 91.63 6.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.584 0.754 . . . . 71.41 109.692 169.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.5 tt -96.61 135.64 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 114.555 -1.202 . . . . 74.54 109.232 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -161.05 163.56 31.47 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.091 0.956 . . . . 75.1 110.109 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.42 -33.61 5.71 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 116.259 -0.428 . . . . 64.31 113.879 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.553 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.58 155.16 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.928 0.491 . . . . 74.45 111.043 -174.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.96 175.36 13.04 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.73 -1.123 . . . . 74.43 110.169 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.36 -142.49 34.15 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 116.022 -0.535 . . . . 71.54 111.892 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.1 p -70.17 -15.86 63.01 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.338 0.655 . . . . 73.33 111.581 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -75.18 -37.39 61.27 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.738 0.815 . . . . 64.22 111.137 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.626 ' SD ' HD23 ' E' ' 454' ' ' LEU . 0.0 OUTLIER -75.67 -28.64 58.79 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 110.132 -0.321 . . . . 74.21 110.132 173.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.92 -24.97 62.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.09 0.556 . . . . 72.41 110.458 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -68.17 -38.68 82.34 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 122.908 0.483 . . . . 71.22 109.847 171.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 68.8 m -65.86 -39.56 90.84 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.462 -0.335 . . . . 75.21 110.279 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.517 HD22 HD22 ' E' ' 454' ' ' LEU . 36.0 tp -66.69 -51.44 55.99 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.914 0.886 . . . . 73.15 111.91 -175.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.11 -26.84 10.76 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.558 -0.746 . . . . 70.22 114.075 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -111.41 -66.22 1.1 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.204 0.502 . . . . 53.03 112.034 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.622 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 72.2 t80 -68.77 -61.11 1.95 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.264 1.026 . . . . 74.04 112.766 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 94.2 m -67.6 -36.68 10.51 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 113.916 1.08 . . . . 70.41 113.916 -174.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.54 -31.34 50.92 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 121.548 1.499 . . . . 73.42 112.506 167.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.21 -28.47 68.77 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.521 0.328 . . . . 62.33 110.633 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.481 HG21 ' CD1' ' A' ' 13' ' ' ILE . 50.1 mm -62.53 -45.28 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.765 0.826 . . . . 73.11 109.86 171.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.46 HD22 ' HG3' ' A' ' 80' ' ' GLN . 80.0 mt -72.29 -27.0 62.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.977 0.911 . . . . 71.43 112.256 -175.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -57.7 -45.68 99.81 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 114.142 1.164 . . . . 73.03 114.142 -168.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -62.11 -38.81 53.67 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 121.978 1.785 . . . . 71.44 112.915 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -67.13 -39.38 86.59 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.302 0.641 . . . . 53.01 111.075 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.93 -43.49 71.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.31 0.644 . . . . 74.23 110.448 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -52.05 -48.07 64.8 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 124.421 1.075 . . . . 72.33 110.2 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.08 -47.94 75.5 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 124.089 0.868 . . . . 75.04 111.342 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.45 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.5 t -58.25 -27.68 64.21 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.833 0.708 . . . . 60.34 111.22 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.535 HG21 HG21 ' A' ' 64' ' ' VAL . 86.6 mt -77.46 -58.58 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.592 1.157 . . . . 63.51 110.287 174.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.7 m -57.36 -33.72 68.06 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 124.667 1.187 . . . . 74.54 111.344 -173.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -63.67 -49.02 74.81 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.848 0.859 . . . . 61.34 109.977 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.452 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 69.3 mtm -63.56 -34.12 77.1 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.389 0.676 . . . . 73.14 111.459 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -66.46 -46.0 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.196 0.998 . . . . 75.12 110.461 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.2 m -70.22 -28.67 65.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.442 0.697 . . . . 74.43 111.388 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -73.35 -31.69 64.1 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.428 0.691 . . . . 72.22 109.782 174.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.06 2.78 86.31 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.88 0.738 . . . . 75.0 112.735 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.5 m 68.5 16.73 9.13 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.918 1.287 . . . . 42.24 111.552 173.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.428 ' HE1' HG21 ' A' ' 31' ' ' VAL . 96.9 m-85 -78.85 156.29 77.44 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 109.011 -0.737 . . . . 74.03 109.011 171.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.73 163.8 17.75 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.486 2.124 . . . . 75.45 112.531 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -60.36 121.61 12.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.062 0.945 . . . . 75.52 110.998 -172.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.524 HD21 HG11 ' A' ' 64' ' ' VAL . 53.0 tp -106.16 93.92 4.88 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.743 -0.836 . . . . 61.04 108.743 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -107.1 85.27 2.11 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.889 -1.152 . . . . 73.15 107.889 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.429 ' HB2' HD22 ' A' ' 42' ' ' LEU . 4.0 pp -60.11 137.52 58.08 Favored 'General case' 0 C--O 1.251 1.178 0 CA-C-N 114.447 -1.251 . . . . 61.51 109.246 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.63 143.91 85.79 Favored Pre-proline 0 C--O 1.243 0.758 0 C-N-CA 123.162 0.585 . . . . 72.1 110.948 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.05 161.61 45.46 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 121.702 1.601 . . . . 75.33 110.214 170.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.86 130.22 18.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.675 -0.861 . . . . 73.04 108.675 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.461 ' HB2' ' HG3' ' C' ' 147' ' ' GLU . 37.4 t-20 -75.07 92.03 2.6 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.888 -0.596 . . . . 62.13 110.071 -174.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.558 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 83.9 m-85 -58.09 -35.51 71.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.86 0.864 . . . . 73.11 111.91 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.46 -50.73 72.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.531 0.733 . . . . 54.24 110.302 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.47 94.43 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.135 0.897 . . . . 71.33 111.434 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.72 -41.91 91.7 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.859 -0.61 . . . . 54.43 111.15 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -68.37 -32.26 72.22 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.029 -0.532 . . . . 54.43 109.578 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.4 ' SD ' HD23 ' A' ' 141' ' ' LEU . 15.9 mmt -59.55 -41.78 90.87 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.667 0.605 . . . . 52.31 110.835 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -56.34 -38.67 71.67 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 123.667 0.605 . . . . 73.11 111.134 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -75.38 -40.1 58.41 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.73 0.812 . . . . 73.24 111.036 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.4 HD23 ' SD ' ' A' ' 138' ' ' MET . 55.8 tp -70.05 -51.28 33.35 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.491 1.116 . . . . 64.0 112.805 -168.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -168.83 2.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.873 -0.603 . . . . 74.34 111.616 -169.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 59.51 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.696 1.598 . . . . 75.53 111.806 -168.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 145' ' ' ALA . 43.7 tt0 -152.9 179.07 9.0 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.135 0.974 . . . . 72.43 108.42 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.401 ' H ' ' HG2' ' A' ' 144' ' ' GLN . . . 67.61 11.72 8.51 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.505 1.122 . . . . 74.03 113.114 170.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.37 -10.17 86.22 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 112.652 -0.179 . . . . 61.24 112.652 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.31 114.64 6.94 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.845 0.858 . . . . 74.44 108.722 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -148.02 38.34 1.05 Allowed Glycine 0 C--N 1.343 0.933 0 N-CA-C 112.107 -0.397 . . . . 65.21 112.107 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.6 m -84.64 87.43 7.28 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.794 -0.817 . . . . 74.2 108.794 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -80.27 93.8 5.97 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.432 -0.804 . . . . 61.31 109.56 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.46 -22.21 65.5 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.008 0.923 . . . . 55.44 110.532 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -64.77 99.54 0.34 Allowed 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.87 0.868 . . . . 53.41 110.053 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -122.71 18.84 10.31 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.374 1.07 . . . . 54.11 110.153 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -143.67 124.15 13.97 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.062 0.545 . . . . 71.1 109.998 -174.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 N-CA-C 108.228 -1.027 . . . . 64.34 108.228 174.29 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.7 mtm . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 108.788 -0.819 . . . . 64.45 108.788 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 23.3 p -157.31 76.26 0.83 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.702 0.801 . . . . 73.31 108.849 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.61 ' HA ' ' HB1' ' B' ' 87' ' ' ALA . 4.5 mp0 -84.4 78.07 9.88 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.982 -1.008 . . . . 72.01 110.154 -176.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.33 103.14 15.39 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.65 -1.241 . . . . 74.51 107.65 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ASN . . . . . 0.504 ' HA ' ' HA2' ' B' ' 88' ' ' GLY . 3.6 p-10 -67.48 -30.54 70.27 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 113.687 0.995 . . . . 64.3 113.687 -166.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -65.25 152.33 43.97 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.163 0.585 . . . . 71.14 109.471 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 43.4 m -60.25 80.68 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.481 1.112 . . . . 74.42 111.93 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -147.15 -41.22 0.18 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.796 1.638 . . . . 74.45 106.807 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.525 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 23.2 ptm 54.92 170.5 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 127.342 2.257 . . . . 72.42 114.583 172.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.5 m -159.13 133.48 7.8 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.169 -0.923 . . . . 63.55 108.63 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.93 156.71 48.35 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.533 -0.543 . . . . 71.41 109.533 157.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -124.24 137.52 54.5 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 107.442 -1.318 . . . . 65.01 107.442 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.489 HD11 HD13 ' B' ' 105' ' ' ILE . 27.4 mt -78.92 117.45 24.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 107.708 -1.219 . . . . 73.01 107.708 176.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -78.23 -42.47 31.13 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.874 -0.787 . . . . 75.45 108.874 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -164.9 135.71 4.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.022 -0.99 . . . . 74.1 110.155 -170.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 85.5 mt -114.46 139.15 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 106.619 -1.623 . . . . 62.2 106.619 167.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -166.98 150.65 6.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.241 0.543 . . . . 75.03 111.524 -176.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 75.9 m -78.24 128.98 34.53 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.935 -1.029 . . . . 63.14 109.084 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 20.9 mttp -91.4 -46.24 8.12 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.661 0.784 . . . . 71.12 110.616 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 22.5 t70 -144.41 133.25 22.49 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.217 -0.447 . . . . 63.2 110.687 -165.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.8 mm -130.82 142.15 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.157 0.983 . . . . 74.12 109.114 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 81.5 p -139.2 144.45 38.52 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.376 -0.972 . . . . 72.33 108.376 170.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.1 t80 -145.81 134.13 21.81 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.971 -1.492 . . . . 73.44 106.971 163.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.645 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 36.7 mt-10 -136.89 127.24 26.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.518 -0.919 . . . . 63.02 108.518 -175.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.561 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -124.55 84.94 56.75 Favored Pre-proline 0 C--O 1.24 0.571 0 N-CA-C 107.69 -1.226 . . . . 72.22 107.69 171.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.71 -32.93 46.13 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.701 2.268 . . . . 52.34 111.394 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -104.45 10.71 35.12 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 117.873 -1.06 . . . . 71.43 110.793 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.617 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -29.64 -68.7 0.11 Allowed Pre-proline 0 N--CA 1.5 2.06 0 C-N-CA 125.355 1.462 . . . . 73.21 114.869 -170.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 11.6 Cg_exo -67.49 -21.21 46.83 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 122.199 1.933 . . . . 73.23 113.042 -171.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -96.81 -32.68 11.99 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.296 1.039 . . . . 71.15 112.434 -172.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.565 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.8 p -82.69 -19.7 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 122.683 0.393 . . . . 72.31 111.327 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -62.43 -25.41 67.95 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 113.976 1.102 . . . . 72.21 113.976 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -56.56 -25.62 52.83 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.081 0.552 . . . . 75.31 111.198 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.528 ' HB2' HD13 ' B' ' 68' ' ' LEU . 87.5 mttt -88.45 92.94 9.37 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.268 1.027 . . . . 74.14 109.435 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.24 91.25 6.17 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.099 -0.704 . . . . 63.02 109.099 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -163.32 156.82 19.4 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.837 0.855 . . . . 74.13 109.497 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.591 ' HB2' HD21 ' F' ' 470' ' ' LEU . 38.4 mt-30 -76.45 104.65 1.7 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.026 0.93 . . . . 70.41 108.649 171.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.607 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.2 Cg_endo -63.44 153.07 76.96 Favored 'Trans proline' 0 C--N 1.366 1.46 0 C-N-CA 123.137 2.558 . . . . 73.25 113.238 -176.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.8 118.6 7.38 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 123.778 0.674 . . . . 74.3 109.37 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.574 HG21 HD11 ' F' ' 468' ' ' LEU . 29.9 m -87.46 161.06 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 114.977 -1.011 . . . . 65.02 111.569 -176.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -149.26 107.77 3.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.521 -1.659 . . . . 75.14 106.521 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 mp -100.27 148.69 24.37 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.164 0.585 . . . . 74.43 110.313 -171.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -131.74 113.44 13.54 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.708 -1.219 . . . . 65.31 107.708 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.2 127.25 45.14 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 106.02 -1.844 . . . . 74.02 106.02 176.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.581 ' HA ' ' HG ' ' F' ' 460' ' ' LEU . 24.8 t70 -144.99 148.64 33.99 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.797 0.839 . . . . 72.02 109.364 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 37.0 p -134.91 118.55 17.04 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.23 0.612 . . . . 65.4 109.995 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.48 153.31 31.36 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.766 1.226 . . . . 73.32 108.325 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 77.6 p -143.75 166.14 25.71 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.183 0.447 . . . . 50.5 111.34 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.0 p -152.33 149.97 29.22 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.25 1.02 . . . . 73.34 109.22 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -93.8 124.6 37.91 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.546 -0.539 . . . . 64.43 109.546 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.29 -52.42 5.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.128 -0.693 . . . . 73.31 109.128 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.41 -175.59 4.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.206 1.003 . . . . 62.2 109.646 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.46 116.33 8.09 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.577 -0.738 . . . . 75.42 109.218 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 83.0 m-20 74.08 -3.37 2.54 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.27 1.428 . . . . 74.4 112.887 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 48.4 t -106.04 110.41 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.521 -0.918 . . . . 72.05 108.521 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.488 ' HE2' ' HB ' ' B' ' 86' ' ' ILE . 1.3 p90 -119.97 173.34 7.13 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.88 0.872 . . . . 73.34 109.65 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -143.08 110.97 5.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.047 -1.094 . . . . 72.14 108.047 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 55.8 t -91.52 145.28 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.184 0.994 . . . . 62.13 109.817 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.5 t -129.33 115.13 34.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.263 -1.014 . . . . 73.42 108.263 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.4 OUTLIER -97.09 110.71 23.2 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.623 -0.88 . . . . 70.44 108.623 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -95.18 118.67 32.37 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.661 0.785 . . . . 63.05 110.746 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.484 ' HB ' HD11 ' B' ' 114' ' ' ILE . 26.3 t -116.54 103.19 14.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.53 -1.285 . . . . 74.02 107.53 168.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.567 HG23 ' HB2' ' B' ' 77' ' ' GLU . 2.8 m -99.6 131.3 45.69 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.222 -0.659 . . . . 64.13 109.222 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -125.21 116.99 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.342 0.657 . . . . 64.52 109.944 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.6 m -99.53 142.98 30.3 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.762 0.825 . . . . 60.21 108.957 167.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.404 ' HB1' ' HG2' ' B' ' 38' ' ' PRO . . . -149.22 147.04 27.93 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.033 0.533 . . . . 70.32 110.36 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.445 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 23.8 p -146.93 130.6 16.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.702 0.401 . . . . 72.41 111.93 -174.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.607 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 25.2 mt -95.84 118.85 33.27 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.679 1.191 . . . . 74.34 109.772 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.73 -108.8 2.6 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 123.742 0.651 . . . . 72.5 112.307 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -118.63 1.59 11.66 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.211 1.004 . . . . 74.24 110.384 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -122.51 155.2 36.69 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.993 0.517 . . . . 74.55 109.936 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.1 m -63.37 134.98 56.66 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.82 0.7 . . . . 72.33 110.842 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.565 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.4 -64.84 1.06 Allowed 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.492 -1.299 . . . . 65.22 107.492 174.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -148.75 157.92 43.79 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.203 -0.908 . . . . 73.14 111.012 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.645 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 69.3 mt -130.18 143.57 50.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.589 -1.634 . . . . 62.52 106.589 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 41.9 t -155.28 156.67 35.96 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.644 -0.502 . . . . 71.02 109.644 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.567 ' HB2' HG23 ' B' ' 63' ' ' THR . 34.7 tt0 -160.27 136.17 8.46 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.123 -1.065 . . . . 71.12 108.123 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 93.4 t -124.06 141.53 43.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.622 -0.881 . . . . 73.44 108.622 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -120.57 89.6 3.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.581 -0.896 . . . . 73.52 108.581 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.563 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.6 tp-100 -83.3 99.09 9.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.678 -1.146 . . . . 72.2 108.821 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.84 169.95 35.9 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 116.19 -0.459 . . . . 53.51 111.968 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.36 129.86 1.97 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.68 -0.568 . . . . 61.12 111.68 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.3 mt -85.21 129.35 37.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.597 0.759 . . . . 71.52 109.227 172.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -131.92 139.76 48.82 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.947 -1.131 . . . . 74.23 107.947 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.3 m -112.71 97.87 6.85 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.867 -0.79 . . . . 73.45 108.867 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.498 HG21 HG13 ' F' ' 452' ' ' VAL . 17.4 tt -96.54 147.02 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.697 0.799 . . . . 72.21 111.097 -166.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.61 ' HB1' ' HA ' ' B' ' 3' ' ' GLU . . . -148.97 141.34 24.17 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.326 0.65 . . . . 65.33 110.396 -174.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' B' ' 5' ' ' ASN . . . 99.57 -63.2 0.69 Allowed Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.617 -0.719 . . . . 24.41 114.488 169.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.525 ' HB ' ' HB3' ' B' ' 9' ' ' MET . 17.2 tt -66.49 163.68 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.369 0 C-N-CA 124.042 0.937 . . . . 74.25 111.126 -173.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -158.91 175.47 13.53 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.085 0.402 . . . . 74.34 110.689 -172.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' B' ' 94' ' ' MET . . . 66.91 -132.2 31.26 Favored Glycine 0 C--N 1.355 1.59 0 C-N-CA 123.656 0.646 . . . . 34.33 114.446 169.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 46.3 m -75.9 -27.41 57.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.666 0.787 . . . . 72.42 110.947 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.486 ' HB3' HD11 ' B' ' 89' ' ' ILE . 52.1 mt-30 -68.63 -33.66 74.4 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.853 -0.612 . . . . 73.23 111.437 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.501 ' SD ' ' HA ' ' F' ' 452' ' ' VAL . 0.0 OUTLIER -71.26 -24.66 62.21 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.378 0.271 . . . . 54.32 110.734 176.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.52 78.28 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.114 0.566 . . . . 64.44 110.834 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -63.1 -29.95 71.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.3 -0.863 . . . . 75.44 110.976 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.481 ' SG ' HD12 ' B' ' 86' ' ' ILE . 49.2 t -74.67 -62.11 1.65 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.411 -0.359 . . . . 60.55 110.771 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.523 HD12 ' N ' ' B' ' 99' ' ' GLY . 3.0 pp -63.49 -32.79 74.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.126 0.788 . . . . 75.35 113.126 -173.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.523 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -92.25 -36.36 6.3 Favored Glycine 0 C--N 1.345 1.056 0 O-C-N 123.482 0.488 . . . . 50.3 113.273 -172.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.0 -53.76 2.15 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.615 0.598 . . . . 64.31 112.615 -167.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 51.7 t80 -72.03 -45.05 62.31 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.862 0.865 . . . . 75.1 111.617 -168.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.492 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 70.8 m -66.11 -49.68 54.86 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 123.6 0.76 . . . . 61.34 111.253 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 80.4 Cg_exo -53.63 -36.42 81.04 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 122.479 2.12 . . . . 71.32 114.203 168.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -57.44 -38.85 75.1 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 123.399 0.679 . . . . 72.2 110.709 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.489 HD13 HD11 ' B' ' 13' ' ' ILE . 80.5 mt -64.99 -43.4 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.117 0.967 . . . . 44.12 110.633 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 52.5 mt -83.23 -15.17 51.42 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.978 0.911 . . . . 75.22 112.043 -172.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -61.28 -49.32 88.46 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.023 -0.989 . . . . 70.42 113.558 -170.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.01 -31.01 83.85 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 121.729 1.619 . . . . 74.24 112.97 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.563 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 86.7 m-85 -67.92 -50.02 58.5 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.889 0.476 . . . . 71.11 110.207 176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.41 -40.51 78.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.831 0.852 . . . . 74.3 110.582 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.749 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 30.8 ttt180 -58.08 -56.67 19.05 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.39 1.476 . . . . 72.52 111.065 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.54 -34.81 78.61 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.937 0.773 . . . . 73.45 110.51 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.7 t -69.88 -40.32 75.75 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.209 0.603 . . . . 72.44 111.417 -176.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.484 HD11 ' HB ' ' B' ' 62' ' ' VAL . 70.5 mt -62.22 -53.54 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 109.563 -0.532 . . . . 54.43 109.563 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.414 HG21 ' OG ' ' C' ' 119' ' ' SER . 12.0 m -60.07 -30.08 68.99 Favored 'General case' 0 CA--C 1.554 1.124 0 O-C-N 124.539 1.149 . . . . 41.21 111.403 -175.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.7 t -64.66 -54.09 37.18 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.555 0.742 . . . . 61.31 110.022 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.4 mmt -67.26 -34.59 77.75 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.411 0.684 . . . . 75.32 111.991 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.96 -38.31 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.134 0.974 . . . . 61.15 110.463 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.421 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 11.8 t -78.07 -20.64 51.92 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.886 -0.597 . . . . 42.55 111.139 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.45 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 92.7 mtt-85 -69.24 -33.79 73.81 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.422 -0.584 . . . . 74.54 109.422 171.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.29 11.3 58.63 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.595 0.559 . . . . 71.52 112.698 168.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.7 p 58.98 31.44 21.36 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.637 1.975 . . . . 62.3 114.18 170.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -84.81 157.93 59.89 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.133 0.573 . . . . 74.44 110.133 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.38 -175.29 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.994 2.463 . . . . 75.42 113.349 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -61.7 114.41 3.28 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.3 -0.864 . . . . 73.3 112.149 -170.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 35.9 tp -110.23 84.76 1.98 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.331 -0.989 . . . . 71.44 108.331 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.23 93.79 8.43 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.284 -0.636 . . . . 71.31 109.284 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.749 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 22.7 tp -57.68 127.77 33.69 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.737 0.815 . . . . 70.13 111.421 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.57 153.77 94.79 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 124.509 1.124 . . . . 74.32 111.813 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.19 100.56 0.46 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.836 2.357 . . . . 61.32 112.162 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.92 108.93 20.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.073 -1.084 . . . . 61.24 108.073 172.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 60.9 t30 -94.08 95.21 8.86 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 107.686 -1.227 . . . . 53.2 107.686 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.78 -42.74 89.69 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 124.081 0.863 . . . . 65.41 109.501 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.36 -39.09 69.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.191 1.397 . . . . 73.54 112.843 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.423 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -63.92 -50.33 69.13 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.717 0.807 . . . . 54.54 111.304 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 82.6 mt -79.11 -28.91 43.01 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.254 -0.885 . . . . 61.43 111.305 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.518 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 78.5 t80 -69.88 -35.66 74.83 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.756 0.822 . . . . 74.42 109.947 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 14.4 tmm? -59.23 -34.11 71.81 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.073 0.949 . . . . 64.51 110.742 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -75.42 -35.58 60.96 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.612 0.765 . . . . 73.32 110.931 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -60.48 -29.41 69.04 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.594 1.158 . . . . 75.53 111.932 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 22.9 mt -85.16 -9.29 58.01 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.859 0.464 . . . . 65.34 111.781 -174.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -124.04 103.86 8.55 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.79 0.836 . . . . 75.14 108.94 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -83.83 58.37 4.62 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.142 0.973 . . . . 73.41 110.09 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -154.7 165.35 36.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.099 -0.955 . . . . 71.31 109.818 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.56 121.52 35.01 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.539 0.735 . . . . 73.24 110.432 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.65 173.7 53.93 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 123.393 0.433 . . . . 54.13 112.996 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -89.67 122.8 33.12 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.516 0.726 . . . . 64.0 110.55 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.27 111.33 0.52 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.887 -0.885 . . . . 61.03 110.887 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 12.1 t -113.86 -179.0 3.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.528 0.731 . . . . 64.42 110.632 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -111.3 124.1 51.55 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.101 -1.074 . . . . 55.42 108.101 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -74.78 146.51 42.05 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.513 -0.551 . . . . 73.5 109.513 174.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -65.6 87.99 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.124 0.97 . . . . 65.02 109.074 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -73.69 96.04 2.44 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.681 0.792 . . . . 74.11 109.852 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -117.46 144.51 44.96 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.744 0.817 . . . . 75.23 109.454 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.855 0 C-N-CA 123.909 0.884 . . . . 54.44 108.869 178.415 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 109.402 -0.592 . . . . 63.44 109.402 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 43.0 t -148.59 129.04 13.92 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.739 0.816 . . . . 55.12 108.989 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -149.34 146.44 27.52 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.062 0.545 . . . . 73.34 109.707 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -138.23 144.8 40.77 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.502 1.121 . . . . 74.22 108.344 175.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -88.89 -57.99 2.71 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.796 -0.446 . . . . 64.35 109.796 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -166.91 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.096 0.558 . . . . 73.12 110.54 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 28.7 m -73.91 84.13 1.71 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.304 0.642 . . . . 72.34 110.19 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -78.79 -59.91 2.59 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.743 -0.662 . . . . 64.31 109.289 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.514 ' SD ' ' HA ' ' C' ' 147' ' ' GLU . 53.7 ttm 61.44 116.02 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.729 1.611 . . . . 52.13 112.602 -178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m -127.43 97.06 4.75 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.336 -1.727 . . . . 71.13 106.336 172.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.45 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 9.0 t80 -124.64 117.48 24.37 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.013 0.525 . . . . 74.43 110.893 -175.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.483 ' HB2' ' HG3' ' C' ' 153' ' ' GLN . 49.5 tp60 -137.27 133.2 34.76 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.21 -1.404 . . . . 71.43 107.21 173.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.413 HD13 HG21 ' C' ' 105' ' ' ILE . 45.5 mt -74.36 118.57 20.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.567 -0.901 . . . . 72.31 108.567 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.511 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 1.4 mt-30 -77.09 -40.92 44.26 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.131 0.894 . . . . 73.3 109.892 -176.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -170.56 147.65 2.94 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 116.045 -0.525 . . . . 74.21 110.077 -173.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.46 137.4 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.791 -1.188 . . . . 63.11 107.791 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.474 ' HB3' HG23 ' D' ' 122' ' ' THR . 29.8 p90 -176.01 173.78 2.2 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.903 0.752 . . . . 75.35 111.228 -171.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -100.03 123.82 44.71 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.615 0.766 . . . . 62.51 109.594 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.425 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.0 mmtp -70.67 -48.94 52.28 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.821 -1.177 . . . . 75.44 107.821 168.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -135.37 143.12 45.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 113.863 -1.517 . . . . 53.41 110.283 -172.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.0 mt -137.89 146.97 26.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 126.077 1.751 . . . . 73.31 106.359 174.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -162.21 149.95 14.31 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.423 0.63 . . . . 54.25 110.405 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.449 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 93.7 t80 -140.35 139.19 35.32 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.661 -1.237 . . . . 64.43 107.661 171.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -136.23 128.83 30.61 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.509 0.724 . . . . 71.13 110.061 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.92 82.65 11.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 106.838 -1.541 . . . . 61.22 106.838 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.85 -26.1 38.53 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.974 2.449 . . . . 63.43 112.268 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -112.28 27.23 9.83 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 114.822 -1.081 . . . . 75.21 109.641 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.415 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -50.19 -58.62 9.08 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 114.449 1.277 . . . . 71.43 114.449 -170.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.57 -31.49 79.82 Favored 'Trans proline' 0 C--N 1.388 2.624 0 CA-C-N 121.891 1.711 . . . . 65.42 112.092 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -69.75 -43.06 73.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.354 1.062 . . . . 73.12 112.031 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.67 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.7 p -77.81 -24.87 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 123.04 0.536 . . . . 55.32 111.644 -173.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.0 -29.11 70.29 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.354 0.262 . . . . 54.32 111.664 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -104.78 36.18 2.52 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.202 0.601 . . . . 74.33 110.615 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -111.07 169.46 8.76 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.235 1.014 . . . . 71.23 109.969 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -68.42 130.57 43.28 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.03 0.532 . . . . 63.23 110.147 173.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -73.99 93.37 2.22 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.324 1.049 . . . . 70.34 109.224 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -150.24 59.25 3.54 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.302 0.641 . . . . 70.14 109.712 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.4 110.28 3.03 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.643 2.229 . . . . 74.12 111.768 -175.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -86.52 108.51 18.58 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.522 -0.918 . . . . 45.12 108.522 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.405 HG11 ' H ' ' G' ' 468' ' ' LEU . 7.4 p -84.53 142.33 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.308 1.043 . . . . 71.03 111.257 -171.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -130.57 119.45 22.55 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.875 -1.528 . . . . 74.21 106.875 174.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 30.1 tp -101.38 124.79 47.63 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 109.635 -0.506 . . . . 54.03 109.635 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.475 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.7 t70 -117.24 112.2 20.47 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.258 -1.016 . . . . 74.42 108.258 -176.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.438 HD13 ' HE1' ' C' ' 133' ' ' PHE . 79.9 mt -110.86 111.1 22.01 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.963 -0.754 . . . . 64.53 108.963 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -122.63 139.78 53.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.34 1.056 . . . . 75.12 108.674 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 m -126.8 126.37 43.28 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.511 0.672 . . . . 34.24 110.258 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.76 154.91 25.46 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.108 -1.406 . . . . 53.53 107.975 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.524 ' HB2' ' HE1' ' C' ' 56' ' ' TYR . 13.4 p -149.5 142.71 25.07 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.87 0.468 . . . . 72.32 109.871 -177.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.7 t -149.74 146.65 27.32 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.896 0.878 . . . . 75.31 110.162 -171.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -82.95 133.82 35.09 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.486 -0.561 . . . . 74.31 109.486 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.556 HD11 HD12 ' C' ' 83' ' ' ILE . 43.7 mt -106.53 -41.29 5.31 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.052 -0.722 . . . . 71.4 109.052 173.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.01 -175.65 5.54 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.731 -1.122 . . . . 34.41 109.963 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -67.22 119.08 11.52 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 114.973 -1.012 . . . . 64.44 109.679 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 65.34 8.21 4.79 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.017 1.327 . . . . 75.23 112.584 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -113.18 96.96 5.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 107.657 -1.238 . . . . 72.02 107.657 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.524 ' HE1' ' HB2' ' C' ' 48' ' ' SER . 1.6 t80 -114.87 129.51 56.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.652 -0.704 . . . . 71.05 109.597 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.504 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.7 tt0 -88.77 135.02 33.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.983 -1.008 . . . . 62.53 110.218 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.85 141.59 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.704 -1.221 . . . . 70.11 107.704 166.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -128.66 123.43 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.614 -1.254 . . . . 72.55 107.614 173.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.97 102.83 12.23 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.424 -1.325 . . . . 64.44 107.424 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 -85.86 122.85 30.51 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.947 -1.478 . . . . 75.12 108.443 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.6 t -117.73 126.04 74.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 107.735 -1.209 . . . . 73.43 107.735 169.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 13.0 m -126.75 115.88 20.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.61 -0.885 . . . . 72.5 108.61 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.534 HG11 HD11 ' C' ' 126' ' ' LEU . 65.2 t -102.67 120.57 52.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 109.012 -0.736 . . . . 61.13 109.012 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 16.3 m -103.52 142.83 33.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.382 -0.97 . . . . 52.33 108.382 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.44 118.25 13.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.545 -1.28 . . . . 64.43 107.545 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -132.29 134.01 44.75 Favored 'General case' 0 C--O 1.224 -0.262 0 O-C-N 123.855 0.722 . . . . 65.2 109.575 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 12.1 mt -86.2 28.01 0.87 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.809 1.243 . . . . 75.14 111.081 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.7 -104.84 1.53 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 110.453 -1.059 . . . . 32.34 110.453 -169.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -90.57 -30.89 16.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.908 0.883 . . . . 70.32 110.587 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -75.45 124.3 26.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.284 1.034 . . . . 72.33 110.206 172.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 18.0 m -80.68 125.61 30.25 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.789 -0.819 . . . . 44.21 108.789 167.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.67 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.82 -61.22 2.07 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.374 -0.602 . . . . 45.25 109.374 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -151.34 156.83 41.57 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.475 0.655 . . . . 73.42 111.237 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.447 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -127.79 142.2 51.37 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 106.75 -1.574 . . . . 61.45 106.75 172.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.447 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.4 t -148.07 141.07 24.87 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.597 -0.89 . . . . 74.31 108.597 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -147.35 133.72 19.62 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.123 -0.695 . . . . 74.41 109.123 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' C' ' 110' ' ' ALA . 59.8 t -135.97 113.75 14.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.569 1.147 . . . . 74.34 108.145 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -95.5 89.11 5.28 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.769 -0.826 . . . . 72.12 108.769 174.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -79.78 98.77 7.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.268 -0.878 . . . . 64.11 110.144 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.65 144.82 17.99 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-O 121.177 0.321 . . . . 52.53 112.45 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.58 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -146.2 128.17 2.98 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.346 -1.102 . . . . 73.52 110.346 -176.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.556 HD12 HD11 ' C' ' 51' ' ' LEU . 11.0 mm -88.32 122.68 40.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.36 -0.978 . . . . 71.45 108.36 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.45 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 62.0 m-85 -127.24 119.51 26.54 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.108 -0.701 . . . . 64.31 109.108 -175.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 31.2 p -82.96 109.64 17.25 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.797 -0.816 . . . . 61.51 108.797 176.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.578 HD13 HD21 ' C' ' 98' ' ' LEU . 32.9 pt -116.12 102.53 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-O 122.151 0.976 . . . . 61.54 110.276 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.16 158.65 30.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.106 0.962 . . . . 31.14 108.9 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.11 -18.67 34.96 Favored Glycine 0 C--N 1.344 0.986 0 N-CA-C 114.06 0.384 . . . . 62.52 114.06 173.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.19 158.74 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.381 1.072 . . . . 70.13 110.608 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -161.25 -177.26 5.91 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.119 0.567 . . . . 63.11 110.94 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.45 -116.19 8.83 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-N 115.308 -0.86 . . . . 73.02 113.78 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.6 p -70.23 -34.49 72.94 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.096 0.959 . . . . 74.44 111.24 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -70.25 -38.72 75.22 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.68 -0.691 . . . . 72.2 111.207 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 22.0 ptm -78.97 -25.55 43.44 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 119.588 -0.244 . . . . 72.54 110.697 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.47 85.53 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.646 -0.502 . . . . 63.23 109.646 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -75.73 -34.66 60.34 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.394 0.434 . . . . 64.45 111.673 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 40.3 t -59.0 -35.89 74.0 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.654 0.596 . . . . 71.04 110.661 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.578 HD21 HD13 ' C' ' 86' ' ' ILE . 51.3 mt -100.49 -16.3 17.59 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.273 0.629 . . . . 74.52 111.308 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.79 -30.5 57.72 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 114.491 0.556 . . . . 74.22 114.491 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.18 -39.09 0.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.861 0.464 . . . . 31.43 110.866 -168.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -66.07 -48.95 69.3 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.143 1.777 . . . . 64.54 112.718 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 51.0 m -73.12 -45.65 8.17 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 118.57 -0.728 . . . . 32.03 112.133 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -53.37 -30.78 54.24 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 122.602 2.201 . . . . 65.35 113.528 170.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -64.82 -40.69 95.61 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.862 0.865 . . . . 70.51 110.364 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.413 HG21 HD13 ' C' ' 13' ' ' ILE . 47.9 mm -60.71 -44.15 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.056 0.542 . . . . 74.53 109.795 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.58 HD21 ' HA3' ' C' ' 82' ' ' GLY . 88.0 mt -80.08 -26.81 39.46 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.907 -1.042 . . . . 75.43 112.764 -170.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -57.36 -48.55 97.12 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 117.575 -1.203 . . . . 72.13 113.534 -172.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.74 -37.96 94.92 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.356 2.037 . . . . 74.42 113.732 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -68.27 -44.68 75.03 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.844 0.458 . . . . 70.44 110.587 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.411 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -64.64 -38.3 90.53 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.803 -0.635 . . . . 62.54 110.78 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -57.16 -48.58 78.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.477 1.511 . . . . 72.13 110.834 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.35 -34.59 68.13 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.398 0.679 . . . . 62.12 110.69 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.5 t -69.11 -30.71 69.05 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.031 0.532 . . . . 45.42 111.287 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.517 HD11 ' HB ' ' C' ' 62' ' ' VAL . 97.7 mt -68.47 -51.36 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.439 0.696 . . . . 71.21 109.541 173.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.415 HG21 ' OG ' ' B' ' 119' ' ' SER . 10.5 m -60.25 -31.95 70.69 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.166 0.916 . . . . 71.43 111.104 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.9 t -64.51 -54.78 27.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.722 0.809 . . . . 55.03 109.465 174.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.449 ' HB3' ' HB2' ' C' ' 23' ' ' PHE . 0.0 OUTLIER -57.56 -42.52 83.19 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.741 1.216 . . . . 71.21 112.84 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' C' ' 123' ' ' PHE . 58.3 t -66.27 -41.74 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.105 0.962 . . . . 74.12 110.422 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.414 ' OG ' HG21 ' B' ' 115' ' ' THR . 32.7 t -70.64 -26.51 63.5 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.954 -0.567 . . . . 74.15 111.011 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.5 mtt-85 -70.93 -40.45 72.07 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.211 0.605 . . . . 73.54 109.439 175.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 121' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' C' ' 23' ' ' PHE . . . -82.57 1.26 88.22 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.87 0.731 . . . . 33.35 112.934 173.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 16.5 p 66.1 24.83 10.89 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.479 1.912 . . . . 50.34 113.931 170.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.477 ' HB2' HG13 ' C' ' 118' ' ' VAL . 79.7 m-85 -85.27 163.76 43.83 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.018 0.927 . . . . 62.41 110.056 172.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -54.67 124.18 15.54 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.979 2.453 . . . . 55.42 112.721 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.421 ' NE2' ' HB2' ' B' ' 119' ' ' SER . 47.1 mt-30 -60.49 137.89 58.09 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.074 0.549 . . . . 74.52 110.855 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.534 HD11 HG11 ' C' ' 64' ' ' VAL . 2.5 pt? -130.22 127.52 39.8 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.895 -0.593 . . . . 71.33 110.049 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -110.1 110.24 21.05 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.267 -1.012 . . . . 75.54 108.267 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.31 134.53 56.62 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 124.134 0.896 . . . . 71.44 110.99 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -70.81 147.07 94.05 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 123.857 0.723 . . . . 73.42 111.499 -175.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.456 ' HG3' HD12 ' A' ' 16' ' ' ILE . 9.7 Cg_exo -69.4 109.7 2.3 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.601 2.201 . . . . 72.41 111.905 176.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.494 HG11 ' SD ' ' G' ' 464' ' ' MET . 26.3 m -106.07 138.95 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.756 -0.831 . . . . 74.02 108.756 170.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -75.85 88.34 2.86 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.91 0.484 . . . . 75.12 110.204 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.438 ' HE1' HD13 ' C' ' 44' ' ' LEU . 98.5 m-85 -62.05 -48.32 80.76 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.664 -0.698 . . . . 75.31 110.429 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.12 -44.64 68.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.667 -1.151 . . . . 70.13 112.455 -170.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.65 87.85 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.242 0.964 . . . . 75.01 111.307 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 -50.4 70.92 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 124.439 1.087 . . . . 73.35 109.852 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -72.92 -24.58 60.84 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.834 -0.621 . . . . 74.2 110.282 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 26.6 ttt -75.35 -43.26 51.43 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.317 0.647 . . . . 72.1 111.124 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -69.15 -36.93 77.95 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.603 -0.517 . . . . 73.13 109.603 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -64.91 -84.58 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.78 1.232 . . . . 74.23 110.917 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -99.17 102.05 13.59 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.091 0.956 . . . . 74.32 108.933 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 66.0 108.87 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.594 1.558 . . . . 75.32 112.88 175.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -75.12 79.74 2.27 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.709 0.804 . . . . 65.34 109.049 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -163.1 141.61 8.27 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.513 0.725 . . . . 61.51 110.672 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.35 175.05 11.78 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.641 1.176 . . . . 55.22 108.719 172.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.19 99.97 1.08 Allowed Glycine 0 C--N 1.343 0.918 0 N-CA-C 112.001 -0.44 . . . . 72.14 112.001 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 147' ' ' GLU . . . . . 0.514 ' HA ' ' SD ' ' C' ' 9' ' ' MET . 7.0 pt-20 -72.0 144.53 48.8 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.76 0.824 . . . . 71.33 111.464 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -102.92 42.03 1.99 Allowed Glycine 0 C--N 1.348 1.228 0 CA-C-N 115.753 -0.658 . . . . 65.03 112.589 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 40.3 p -75.8 131.78 39.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.227 0.611 . . . . 73.04 109.942 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -135.38 96.76 3.53 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.795 0.438 . . . . 72.13 111.732 -170.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 59.87 -87.48 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.524 1.53 . . . . 63.51 111.544 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -80.97 -42.17 21.66 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.106 0.562 . . . . 72.11 110.606 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 153' ' ' GLN . . . . . 0.483 ' HG3' ' HB2' ' C' ' 12' ' ' GLN . 22.6 tp60 62.78 58.84 1.5 Allowed 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 122.462 1.125 . . . . 74.21 108.9 -171.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 65.83 14.27 9.46 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 113.501 -1.681 . . . . 53.54 112.658 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 C-N-CA 123.267 0.627 . . . . 38.17 109.835 178.559 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.472 -0.566 . . . . 73.22 109.472 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 69.4 p -149.96 118.26 6.42 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.917 -0.771 . . . . 65.23 108.917 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.62 162.73 40.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.525 0.73 . . . . 74.24 110.046 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -141.87 99.23 3.49 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.17 0.588 . . . . 70.31 110.032 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -112.62 81.61 1.51 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.086 -1.079 . . . . 73.04 108.086 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -89.12 30.34 0.97 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.636 -0.711 . . . . 71.0 111.039 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.1 t -67.54 -18.53 65.06 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.591 0.756 . . . . 74.3 111.121 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -79.06 -23.48 44.2 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.741 1.216 . . . . 75.32 111.617 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.542 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 11.8 tpt -27.63 125.07 0.09 Allowed 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 126.302 1.841 . . . . 74.22 115.18 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.6 m -146.26 144.33 29.79 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.007 0.923 . . . . 71.42 109.8 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -152.5 113.29 4.15 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.115 -1.069 . . . . 73.04 108.115 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -131.57 121.48 24.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.871 0.868 . . . . 63.34 108.751 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 23.7 mt -75.35 121.29 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.544 -0.91 . . . . 55.03 108.544 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -88.57 -31.49 18.61 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.188 0.595 . . . . 52.24 111.584 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -169.08 142.63 2.86 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.587 0.232 . . . . 73.23 111.526 -174.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.4 132.85 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 107.188 -1.412 . . . . 74.32 107.188 169.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.463 ' HE1' HG13 ' D' ' 83' ' ' ILE . 36.9 p90 -161.15 152.28 18.69 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.925 0.869 . . . . 75.22 111.438 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -88.47 116.13 26.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.428 -1.26 . . . . 74.42 108.975 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -83.56 -26.42 30.1 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.407 -0.59 . . . . 63.32 109.407 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -154.31 139.97 17.97 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.967 -1.015 . . . . 61.33 109.352 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.448 HG21 ' HE2' ' C' ' 117' ' ' MET . 38.5 mt -137.33 147.31 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.865 1.266 . . . . 71.24 107.851 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -156.27 143.29 18.91 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.348 0.595 . . . . 73.3 110.068 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.9 t80 -138.05 133.58 33.71 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.401 -1.703 . . . . 73.02 106.401 170.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.2 mt-10 -129.2 141.13 51.24 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.887 0.875 . . . . 73.13 109.061 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.98 81.27 39.86 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.166 -1.42 . . . . 70.41 107.166 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.79 -36.15 8.51 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.006 2.471 . . . . 73.25 113.012 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -104.84 17.66 23.74 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.709 0.804 . . . . 75.22 110.793 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -32.49 -64.79 0.23 Allowed Pre-proline 0 CA--C 1.564 1.488 0 N-CA-C 116.11 1.892 . . . . 65.05 116.11 -164.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.415 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 68.8 Cg_endo -77.91 -20.88 11.41 Favored 'Trans proline' 0 C--N 1.382 2.295 0 CA-C-N 122.896 2.07 . . . . 61.34 113.732 -176.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -72.9 -40.09 65.84 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.759 1.223 . . . . 72.2 109.884 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.769 HG21 ' HA ' ' D' ' 73' ' ' ALA . 14.6 p -83.59 -14.54 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.485 -0.78 . . . . 71.04 111.807 -175.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 20.0 m-85 -68.15 -15.99 63.81 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.666 -0.646 . . . . 73.12 111.862 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -67.29 -19.16 65.44 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.74 0.816 . . . . 64.55 110.971 173.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.497 ' HB2' HD13 ' D' ' 68' ' ' LEU . 28.3 mmtp -84.96 87.61 7.37 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.034 0.934 . . . . 64.0 108.847 174.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.54 68.06 10.3 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.737 0.78 . . . . 71.44 108.919 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 48.3 t-105 -142.19 158.46 43.71 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.984 0.913 . . . . 62.31 109.251 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -72.95 111.1 10.07 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.676 1.19 . . . . 54.3 110.031 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.83 141.73 55.07 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.927 2.418 . . . . 54.02 112.33 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.59 ' HB2' ' HB2' ' H' ' 470' ' ' LEU . 35.9 tt0 -75.67 124.72 27.71 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.153 -0.684 . . . . 75.45 109.153 173.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.663 HG13 HG13 ' D' ' 64' ' ' VAL . 59.2 t -97.93 107.67 20.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.831 -0.803 . . . . 41.13 108.831 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -95.28 118.5 32.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.433 -1.321 . . . . 72.31 107.433 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.608 HD23 ' SD ' ' H' ' 464' ' ' MET . 3.2 mm? -97.57 143.2 28.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.238 0.615 . . . . 64.21 110.326 -175.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.726 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.7 m-20 -127.45 112.36 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.576 -1.268 . . . . 70.23 107.576 169.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 88.2 mt -99.72 130.2 45.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.433 0.693 . . . . 70.54 110.114 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.447 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.2 t0 -144.87 149.76 35.9 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.51 1.124 . . . . 63.31 108.373 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -125.12 159.65 30.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.519 0.676 . . . . 55.41 110.257 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.496 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.96 154.28 37.99 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.818 -1.549 . . . . 72.23 106.818 172.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.7 p -167.64 152.97 7.13 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.853 0.297 . . . . 62.14 111.223 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.7 p -163.74 142.47 7.82 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.91 0.884 . . . . 65.51 109.707 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -75.92 121.05 22.11 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.231 -0.655 . . . . 55.14 109.231 176.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 49.4 mt -89.93 -38.61 13.55 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.855 0.36 . . . . 75.44 110.436 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.42 -176.07 5.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.053 -0.522 . . . . 73.22 110.438 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -69.49 118.51 12.45 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.229 0.611 . . . . 64.12 109.594 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 67.99 9.2 7.0 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.907 1.283 . . . . 63.01 111.856 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 66.2 t -113.44 119.1 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.327 0.651 . . . . 63.42 109.693 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -128.41 129.56 46.36 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.009 0.924 . . . . 75.24 108.79 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -96.53 138.96 33.33 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.953 0.901 . . . . 73.42 109.072 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -126.42 122.76 61.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 N-CA-C 108.113 -1.069 . . . . 64.15 108.113 173.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.559 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 23.6 t -99.11 137.62 26.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 123.693 0.797 . . . . 75.01 108.903 171.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.41 123.32 44.95 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.67 -0.863 . . . . 71.5 108.67 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.447 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.4 ttm-85 -98.6 113.67 25.82 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.086 -0.709 . . . . 74.42 109.086 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.8 t -112.74 113.35 43.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.778 -1.193 . . . . 65.15 107.778 170.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.726 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 48.5 m -111.74 136.8 50.51 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.817 0.847 . . . . 70.55 109.141 -177.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.663 HG13 HG13 ' D' ' 40' ' ' VAL . 78.0 t -130.13 108.34 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.419 1.088 . . . . 64.41 109.635 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 38.1 m -107.58 114.67 28.81 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.371 -0.974 . . . . 64.03 108.371 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.4 145.13 48.22 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.328 0.651 . . . . 72.32 110.533 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 50.6 p -129.67 147.76 51.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.972 0.909 . . . . 75.34 109.246 173.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' D' ' 34' ' ' LYS . 25.6 mt -118.5 108.75 15.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.389 1.076 . . . . 72.53 108.243 171.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 69' ' ' GLY . . . . . 0.443 ' H ' HD21 ' H' ' 470' ' ' LEU . . . 70.42 -126.11 15.18 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 123.686 0.617 . . . . 61.5 112.447 -176.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -90.61 2.36 55.92 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.31 0.644 . . . . 73.41 112.602 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -134.06 158.98 42.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.551 0.34 . . . . 70.33 111.354 -166.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.7 m -65.17 124.35 21.92 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.17 -0.923 . . . . 61.01 109.651 174.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.769 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -80.81 -72.8 0.4 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.158 -1.052 . . . . 52.33 108.158 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -155.45 139.48 16.41 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.477 -0.783 . . . . 52.01 110.036 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 37.0 mt -105.47 150.76 25.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.326 -1.306 . . . . 54.42 107.795 176.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.1 t -158.38 147.63 19.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.909 -0.404 . . . . 63.01 109.909 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.01 134.13 10.39 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.917 -0.771 . . . . 73.3 108.917 172.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.2 t -128.46 137.23 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.406 -0.961 . . . . 64.24 108.406 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -117.86 81.55 1.68 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.73 -1.211 . . . . 64.42 107.73 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 35.8 tp60 -80.06 96.48 6.49 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 112.961 -1.927 . . . . 64.34 109.802 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.63 143.17 17.58 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.676 -0.569 . . . . 62.33 111.676 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.66 130.81 5.38 Favored Glycine 0 C--O 1.228 -0.243 0 N-CA-C 111.214 -0.755 . . . . 74.1 111.214 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.463 HG13 ' HE1' ' D' ' 17' ' ' TYR . 70.8 mt -90.3 122.74 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.95 -1.13 . . . . 73.23 107.95 172.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -124.15 149.54 46.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.035 0.934 . . . . 70.32 109.049 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t -115.01 102.7 10.2 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.981 -1.118 . . . . 64.5 107.981 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.569 HG23 HD12 ' D' ' 89' ' ' ILE . 46.1 mt -108.81 128.03 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.988 0.915 . . . . 71.31 110.443 -171.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.18 157.31 42.51 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.961 0.905 . . . . 72.22 110.272 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.87 11.96 81.03 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.331 -0.395 . . . . 62.1 113.933 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.569 HD12 HG23 ' D' ' 86' ' ' ILE . 15.8 mt -111.42 127.65 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.062 0.945 . . . . 72.51 110.443 -173.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.04 164.1 34.12 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.228 1.011 . . . . 73.54 111.039 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.18 -131.57 11.34 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.54 -0.754 . . . . 31.24 113.569 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -75.79 -24.43 55.97 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.813 0.845 . . . . 75.12 111.487 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -65.15 -26.37 68.15 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.44 0.696 . . . . 73.43 110.724 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 54.3 mtp -54.31 -55.15 31.24 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.489 1.116 . . . . 73.12 110.831 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.71 -41.43 83.57 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.952 -1.022 . . . . 65.21 110.648 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.402 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 28.4 t-80 -65.9 -24.89 66.93 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.88 0.872 . . . . 60.12 111.742 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -80.38 -48.85 12.3 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.832 -0.432 . . . . 52.12 109.832 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.562 ' HB2' HG11 ' H' ' 452' ' ' VAL . 28.5 tp -67.72 -56.01 10.95 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.729 0.812 . . . . 75.14 112.452 -171.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.88 -0.1 51.98 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 114.654 0.621 . . . . 41.23 114.654 -168.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -124.84 -66.07 0.99 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.673 0.737 . . . . 43.43 110.88 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -65.88 -54.21 29.59 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.536 0.734 . . . . 75.43 111.763 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.2 m -62.69 -46.35 88.52 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.305 -0.855 . . . . 64.13 112.387 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.32 -36.6 97.21 Favored 'Trans proline' 0 C--N 1.393 2.909 0 C-N-CA 122.523 2.149 . . . . 70.32 113.378 168.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 104' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' D' ' 133' ' ' PHE . 64.3 t30 -71.09 -23.86 62.19 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.213 0.605 . . . . 73.54 110.77 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 29.7 mm -76.68 -36.51 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.961 0.904 . . . . 75.2 110.252 171.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.88 -18.62 53.63 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.31 0.644 . . . . 70.32 111.862 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -71.34 -37.94 6.2 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 113.901 1.074 . . . . 63.44 113.901 -173.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.99 -45.63 37.52 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 121.883 1.722 . . . . 71.21 112.281 168.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -70.61 -33.49 71.1 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.32 -0.855 . . . . 60.34 111.764 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.85 -51.48 54.99 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.301 0.64 . . . . 62.3 110.084 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -51.2 -52.32 45.52 Favored 'General case' 0 C--N 1.358 0.942 0 O-C-N 124.797 1.311 . . . . 73.43 110.309 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.38 -46.23 91.06 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.383 1.052 . . . . 73.45 111.839 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.6 t -58.97 -41.9 88.62 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.863 0.727 . . . . 64.44 110.659 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.477 HG23 ' SG ' ' D' ' 76' ' ' CYS . 80.4 mt -64.33 -56.08 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 123.996 0.81 . . . . 73.2 110.411 174.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 61.4 m -51.89 -44.55 63.79 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.816 1.247 . . . . 43.34 111.574 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.5 t -65.29 -42.0 93.58 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.912 -1.04 . . . . 71.3 110.201 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.4 mtm -68.58 -34.25 75.48 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.028 0.531 . . . . 65.4 111.772 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -66.99 -40.85 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.002 0.921 . . . . 55.41 110.099 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 77.7 p -76.66 -28.47 55.99 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.979 0.512 . . . . 74.35 111.012 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -73.68 -28.53 61.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.222 0.609 . . . . 72.41 109.633 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.18 3.64 86.66 Favored Glycine 0 C--N 1.351 1.381 0 O-C-N 123.837 0.71 . . . . 71.3 112.378 172.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.474 HG23 ' HB3' ' C' ' 17' ' ' TYR . 45.2 p 60.09 20.0 9.23 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 126.845 2.058 . . . . 64.31 114.181 175.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -79.61 157.23 74.9 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 123.13 0.572 . . . . 74.23 109.853 171.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.53 126.34 17.69 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.946 2.431 . . . . 73.54 112.367 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -56.05 138.99 48.3 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.425 1.09 . . . . 73.43 112.041 -174.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 32.5 mt -107.92 101.41 10.68 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.557 -0.535 . . . . 74.23 109.557 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -100.65 84.83 2.8 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.615 -1.254 . . . . 74.14 107.615 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -59.18 115.68 3.36 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 114.775 -1.102 . . . . 71.42 109.991 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.79 136.06 86.87 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 124.189 0.931 . . . . 45.11 110.191 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 24.3 Cg_exo -61.7 114.31 2.21 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.802 2.335 . . . . 62.01 112.55 -172.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.1 m -108.02 128.38 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.483 0.713 . . . . 75.01 109.243 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -85.84 103.98 15.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.632 0.773 . . . . 41.34 110.544 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' D' ' 104' ' ' ASN . 63.9 m-85 -66.5 -25.63 66.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.205 0.602 . . . . 70.44 112.041 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.468 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 2.5 m-20 -57.42 -58.67 7.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.892 0.877 . . . . 71.31 111.258 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.17 90.19 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.815 0.846 . . . . 62.0 111.713 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.88 -29.76 68.95 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.181 -0.918 . . . . 74.12 112.067 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -72.92 -34.94 66.91 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.537 0.735 . . . . 73.3 110.66 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 45.2 mtt -60.83 -39.77 90.28 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.528 -0.545 . . . . 74.43 109.528 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -64.92 -43.26 93.38 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.172 0.92 . . . . 62.3 110.843 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -55.38 -31.87 62.16 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.141 0.976 . . . . 73.11 111.398 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.95 -47.19 12.03 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.82 0.848 . . . . 53.32 111.969 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.89 9.09 28.94 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.698 0.629 . . . . 74.24 112.698 -171.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -117.87 87.25 2.68 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.545 -0.909 . . . . 65.22 108.545 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.35 157.61 17.75 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 113.795 -1.548 . . . . 75.44 108.596 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.64 -35.82 77.13 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.472 0.709 . . . . 70.45 111.637 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.0 158.88 9.56 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.955 -0.566 . . . . 70.01 112.009 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.72 118.13 26.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.94 0.896 . . . . 74.22 108.797 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.29 83.65 0.16 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.953 -0.859 . . . . 52.44 110.953 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 41.0 m -73.37 99.1 2.85 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.368 0.667 . . . . 74.01 110.499 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.12 131.3 44.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.739 0.816 . . . . 71.34 109.87 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -125.5 150.47 47.37 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.712 0.805 . . . . 70.14 110.903 -171.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 74.85 88.63 0.09 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.442 1.497 . . . . 52.52 111.496 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -139.04 27.71 2.36 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.27 -1.381 . . . . 64.23 107.27 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.78 95.42 0.67 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.667 1.187 . . . . 64.31 110.84 -167.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 124.053 0.941 . . . . 38.17 109.088 -177.984 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 108.861 -0.792 . . . . 71.14 108.861 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 451' ' ' VAL . . . . . 0.539 HG13 ' HA ' ' A' ' 87' ' ' ALA . 48.0 t -120.96 89.86 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.178 0.591 . . . . 75.45 110.764 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 59.3 t 65.53 133.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.443 1.097 . . . . 62.11 113.775 163.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -146.17 58.16 0.5 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.825 -0.51 . . . . 74.13 111.825 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 454' ' ' LEU . . . . . 0.626 HD23 ' SD ' ' A' ' 94' ' ' MET . 4.5 pp -117.06 155.65 28.9 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.395 0.678 . . . . 62.1 110.97 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 2.0 p -147.97 -48.66 0.16 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.797 1.239 . . . . 51.03 108.725 167.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.41 137.11 50.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.993 0.517 . . . . 74.41 110.8 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -157.94 97.41 1.54 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.914 0.886 . . . . 64.44 108.89 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 59.8 p -72.49 -67.47 0.55 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.667 -0.697 . . . . 70.25 111.265 -175.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -167.74 159.17 11.56 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.079 0.951 . . . . 72.11 109.045 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 460' ' ' LEU . . . . . 0.441 HD23 ' HB ' ' A' ' 46' ' ' THR . 1.4 tm? -68.39 122.96 19.49 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 108.787 -0.82 . . . . 70.31 108.787 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -44.04 -32.73 1.25 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 126.194 1.798 . . . . 71.43 115.123 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -136.86 111.58 8.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.311 0.645 . . . . 65.42 109.728 175.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 40.8 p -72.87 124.62 25.76 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.23 -1.026 . . . . 70.5 108.23 167.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 12.4 tpt -62.6 161.11 12.67 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.423 -0.584 . . . . 71.34 109.423 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.45 -65.44 0.68 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.227 -0.657 . . . . 74.01 109.227 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -86.62 174.48 8.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.19 0.596 . . . . 52.34 111.293 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 467' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -154.81 -56.7 0.1 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.547 0.739 . . . . 72.25 109.707 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -171.64 160.89 5.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.696 0.798 . . . . 74.15 109.839 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -99.54 82.6 0.56 Allowed Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.703 -0.559 . . . . 70.35 111.703 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 470' ' ' LEU . . . . . 0.509 ' HB3' ' HE1' ' A' ' 36' ' ' TRP . 35.2 mt -70.49 106.32 3.4 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.76 0.424 . . . . 72.13 110.313 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt . . . . . 0 C--O 1.25 1.091 0 N-CA-C 108.118 -1.067 . . . . 72.21 108.118 179.747 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 110.004 -0.369 . . . . 74.21 110.004 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' 451' ' ' VAL . . . . . 0.469 HG13 ' O ' ' B' ' 89' ' ' ILE . 40.9 t -67.9 -62.43 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 109.41 -0.589 . . . . 73.3 109.41 172.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 452' ' ' VAL . . . . . 0.501 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 19.2 m -83.26 156.98 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.083 -0.962 . . . . 75.34 111.671 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -164.58 56.99 0.27 Allowed Glycine 0 C--N 1.344 1.002 0 CA-C-N 115.846 -0.615 . . . . 61.43 112.939 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 454' ' ' LEU . . . . . 0.447 ' HB2' HD22 ' B' ' 98' ' ' LEU . 4.9 tt -72.17 111.97 7.85 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.665 -1.235 . . . . 75.44 107.665 172.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 43.0 m -147.06 -47.52 0.18 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.548 0.739 . . . . 70.11 109.622 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -115.45 173.11 6.69 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.655 0.782 . . . . 75.5 111.781 -173.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 58.58 26.48 14.45 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.415 1.486 . . . . 64.03 111.455 174.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 27.9 m -79.11 86.24 4.95 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.477 0.711 . . . . 74.13 110.053 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -125.84 113.68 17.56 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.151 -0.932 . . . . 54.14 108.814 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 460' ' ' LEU . . . . . 0.581 ' HG ' ' HA ' ' B' ' 45' ' ' ASP . 3.7 mm? -87.28 120.42 28.54 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.808 0.843 . . . . 72.41 108.804 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -88.66 44.82 1.23 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.069 1.347 . . . . 72.34 111.18 -173.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.63 112.31 18.29 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.666 0.786 . . . . 73.44 111.61 -173.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 18.9 p -139.34 105.97 5.35 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 107.047 -1.464 . . . . 73.43 107.047 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 26.6 ptm -141.68 153.42 44.68 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.03 0.443 . . . . 74.43 111.919 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -134.8 -75.14 0.46 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.641 1.176 . . . . 60.44 109.19 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 466' ' ' ALA . . . . . 0.686 ' HB1' ' HA ' ' F' ' 471' ' ' LYS . . . -91.58 112.06 23.82 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.07 0.948 . . . . 71.12 110.82 -171.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -164.41 -53.85 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.217 0.607 . . . . 70.23 111.946 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 468' ' ' LEU . . . . . 0.574 HD11 HG21 ' B' ' 40' ' ' VAL . 0.7 OUTLIER -85.16 63.94 8.39 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.935 0.874 . . . . 73.03 112.899 -167.052 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 90.61 -57.11 3.43 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.417 -1.073 . . . . 54.25 110.417 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 470' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' B' ' 37' ' ' GLN . 95.1 mt -65.43 113.07 3.86 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.06 -0.719 . . . . 74.12 109.06 169.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 471' ' ' LYS . . . . . 0.686 ' HA ' ' HB1' ' F' ' 466' ' ' ALA . 86.9 tttt . . . . . 0 C--O 1.25 1.098 0 C-N-CA 123.233 0.613 . . . . 63.55 109.467 -175.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.409 -0.589 . . . . 74.34 109.409 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 8.2 p -71.45 144.81 12.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 C-N-CA 123.148 0.579 . . . . 71.51 109.631 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 73.3 t 68.3 85.68 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 124.038 0.935 . . . . 55.22 109.851 -173.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 174.4 99.37 0.12 Allowed Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.288 -0.869 . . . . 44.05 111.837 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 5.9 mp -82.31 148.02 28.55 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.087 -0.708 . . . . 64.35 109.087 174.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 13.3 t -82.07 -28.77 32.19 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.765 0.426 . . . . 72.12 110.557 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -170.01 161.49 8.74 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.263 1.025 . . . . 65.43 109.374 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -97.44 -50.48 4.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.611 0.765 . . . . 74.21 112.008 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 23.3 m 66.86 157.86 0.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.636 1.174 . . . . 74.21 111.397 -171.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -74.92 73.15 2.14 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.241 -0.652 . . . . 74.05 109.241 173.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 22.7 tp 55.62 -93.82 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.866 1.266 . . . . 72.44 109.544 -168.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 33.5 p90 173.55 -27.25 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.503 1.521 . . . . 73.21 109.259 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -142.34 159.23 42.64 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.664 0.786 . . . . 54.13 110.33 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 12.3 t -151.65 164.49 36.8 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.666 1.186 . . . . 73.41 108.297 171.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 464' ' ' MET . . . . . 0.494 ' SD ' HG11 ' C' ' 131' ' ' VAL . 24.2 ptm -156.67 148.69 22.98 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.426 0.69 . . . . 72.11 109.612 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -102.82 -64.49 1.07 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.103 -0.703 . . . . 71.21 109.103 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -75.19 82.41 2.35 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.781 -1.099 . . . . 53.41 110.955 -173.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -77.32 -37.29 52.91 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.489 -0.778 . . . . 74.42 110.042 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 468' ' ' LEU . . . . . 0.405 ' H ' HG11 ' C' ' 40' ' ' VAL . 93.9 mt -140.19 169.35 17.84 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.498 1.119 . . . . 71.2 109.955 177.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -137.05 110.61 0.79 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 109.454 -1.458 . . . . 53.01 109.454 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 470' ' ' LEU . . . . . 0.417 ' H ' HD23 ' G' ' 470' ' ' LEU . 2.3 pt? -137.45 148.9 46.46 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.007 0.523 . . . . 60.41 111.225 -169.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? . . . . . 0 C--O 1.251 1.176 0 N-CA-C 107.04 -1.467 . . . . 71.53 107.04 179.073 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 109.727 -0.471 . . . . 75.12 109.727 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.11 -35.7 29.26 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 N-CA-C 109.546 -0.539 . . . . 73.24 109.546 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 452' ' ' VAL . . . . . 0.562 HG11 ' HB2' ' D' ' 98' ' ' LEU . 35.4 m -133.75 143.32 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 122.004 -0.435 . . . . 64.14 110.341 175.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -86.43 -14.26 66.37 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.371 -0.832 . . . . 55.14 112.939 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 91.6 mt 58.52 -144.99 0.57 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.004 0.922 . . . . 73.0 110.841 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 11.0 m 65.5 25.39 11.83 Favored 'General case' 0 C--N 1.364 1.199 0 CA-C-O 122.293 1.044 . . . . 62.51 110.056 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.57 -177.57 4.83 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.045 -0.979 . . . . 74.01 110.434 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -110.6 157.95 19.11 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.296 0.639 . . . . 75.31 111.493 -171.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 27.0 m -82.6 71.36 9.68 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.077 -0.965 . . . . 34.54 109.963 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 35.5 t70 179.46 127.85 0.07 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.531 -1.213 . . . . 65.13 109.336 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.52 -104.42 0.06 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.66 -0.496 . . . . 75.12 109.66 170.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -176.85 179.94 1.02 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.963 1.305 . . . . 74.13 108.108 -166.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 30.4 t80 58.2 78.09 0.26 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.352 1.061 . . . . 64.4 111.306 175.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 29.9 m -60.52 -26.36 66.81 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.185 -0.916 . . . . 32.03 110.545 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 464' ' ' MET . . . . . 0.608 ' SD ' HD23 ' D' ' 42' ' ' LEU . 17.2 ttt 75.07 151.68 0.12 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 125.879 1.671 . . . . 72.4 110.937 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 465' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' H' ' 465' ' ' LYS . 0.2 OUTLIER -88.51 28.89 1.05 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.356 1.062 . . . . 72.32 110.493 -173.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . 64.51 102.67 0.04 OUTLIER 'General case' 0 C--N 1.363 1.173 0 C-N-CA 125.399 1.48 . . . . 64.34 111.055 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 467' ' ' ALA . . . . . 0.588 ' HB3' ' HB ' ' D' ' 40' ' ' VAL . . . -65.66 138.34 57.92 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.326 0.65 . . . . 75.24 110.947 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 468' ' ' LEU . . . . . 0.463 HD12 HG23 ' D' ' 40' ' ' VAL . 70.5 mt 76.53 -59.48 0.5 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.539 1.535 . . . . 52.25 112.053 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 91.56 119.88 2.43 Favored Glycine 0 C--N 1.344 0.988 0 N-CA-C 112.402 -0.279 . . . . 74.14 112.402 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 470' ' ' LEU . . . . . 0.59 ' HB2' ' HB2' ' D' ' 39' ' ' GLU . 13.0 tp -89.82 101.18 13.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.156 0.583 . . . . 72.54 110.379 -175.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt . . . . . 0 C--O 1.252 1.226 0 N-CA-C 108.227 -1.027 . . . . 74.1 108.227 170.309 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.027 0 CA-C-O 121.477 0.656 . . . . 65.55 109.935 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 t -174.15 -54.07 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.904 0.881 . . . . 72.14 109.958 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -150.59 156.9 42.28 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.125 -0.943 . . . . 75.45 109.943 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -81.22 104.02 11.4 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 107.667 -1.235 . . . . 64.21 107.667 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -67.37 90.88 0.24 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.239 0.615 . . . . 72.32 110.244 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -101.43 -45.9 5.17 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.155 0.582 . . . . 62.12 109.708 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -76.18 93.84 3.43 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 109.309 -0.626 . . . . 53.11 109.309 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -63.13 -29.44 70.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.218 1.007 . . . . 74.12 110.191 174.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.0 ttp -73.64 134.07 43.57 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 114.86 -1.064 . . . . 74.31 110.348 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.9 m -150.79 125.82 9.87 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.904 0.882 . . . . 53.31 108.704 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.691 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 11.5 t80 -123.09 124.71 43.7 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.329 -0.989 . . . . 74.24 108.329 170.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -141.7 112.07 6.99 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.73 -0.668 . . . . 41.45 109.851 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.594 HG12 ' HD2' ' A' ' 84' ' ' PHE . 52.7 mt -83.05 113.87 22.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.804 -0.813 . . . . 72.3 108.804 173.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -81.34 -31.97 33.21 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.792 -0.64 . . . . 63.03 109.843 -177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -171.53 143.54 1.78 Allowed 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.008 0.193 . . . . 64.43 111.108 -173.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.86 126.92 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 124.251 1.02 . . . . 65.31 108.384 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -160.54 168.71 24.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.028 0.931 . . . . 75.12 110.698 -170.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.6 p -93.39 121.06 34.39 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.083 -0.71 . . . . 72.55 109.083 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -85.76 -26.07 26.03 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.037 -0.529 . . . . 72.11 109.675 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.2 t70 -152.77 142.59 22.06 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.934 -1.03 . . . . 72.13 110.197 -175.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.599 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 88.2 mt -146.19 141.72 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.728 1.611 . . . . 72.55 107.057 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -151.82 132.14 13.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.579 -0.526 . . . . 74.45 109.579 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 82.9 t80 -130.99 122.6 27.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.74 -1.578 . . . . 63.41 106.74 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -129.99 118.42 21.59 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.36 -0.607 . . . . 73.15 109.36 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.12 79.03 70.11 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.826 -1.175 . . . . 75.11 107.826 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.26 -33.05 40.61 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.052 2.501 . . . . 55.3 111.686 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.429 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 24.4 m120 -107.03 36.73 2.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.779 -1.1 . . . . 60.14 109.631 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.536 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -60.39 -44.58 96.28 Favored Pre-proline 0 CA--C 1.57 1.743 0 C-N-CA 124.537 1.135 . . . . 61.22 113.967 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.88 -20.85 11.46 Favored 'Trans proline' 0 C--N 1.385 2.468 0 CA-C-N 121.522 1.579 . . . . 74.13 112.876 172.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 61.7 m170 -77.67 -38.97 46.47 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.143 0.577 . . . . 72.14 110.876 -176.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.649 HG23 HD12 ' A' ' 68' ' ' LEU . 10.6 p -63.48 -27.7 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.989 0.916 . . . . 51.4 110.998 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.602 ' HD1' HH11 ' B' ' 15' ' ' ARG . 91.7 t80 -62.44 -35.57 79.7 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.315 1.046 . . . . 42.21 110.907 174.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -93.03 -25.43 17.95 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.641 0.776 . . . . 63.44 111.264 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HE2' HD22 ' A' ' 68' ' ' LEU . 53.9 mtpt -82.87 165.31 19.89 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.463 0.705 . . . . 72.45 111.489 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.472 ' O ' HD21 ' A' ' 68' ' ' LEU . 10.3 m-20 -80.77 128.66 33.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.178 0.991 . . . . 72.14 108.919 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -69.28 85.92 0.4 Allowed 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.37 0.605 . . . . 75.24 111.245 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -127.25 82.28 68.47 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.543 1.137 . . . . 74.32 108.647 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -85.11 152.52 10.95 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.418 2.079 . . . . 64.0 113.117 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' HB3' ' NZ ' ' A' ' 41' ' ' LYS . 63.1 mm-40 -105.6 85.49 2.25 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.865 -1.161 . . . . 70.25 107.865 176.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG22 ' HE3' ' E' ' 471' ' ' LYS . 27.6 m -82.5 93.83 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 122.323 1.059 . . . . 62.42 111.357 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 39' ' ' GLU . 13.7 mptt -98.17 136.05 38.94 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.912 -1.04 . . . . 72.0 108.61 169.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.476 ' HB2' ' HG ' ' E' ' 468' ' ' LEU . 37.2 tp -119.57 114.8 22.79 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.009 -0.737 . . . . 70.4 109.009 172.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -102.67 128.55 49.32 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.028 -1.101 . . . . 70.25 108.028 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' HB2' ' HG ' ' E' ' 460' ' ' LEU . 91.1 mt -107.35 143.03 36.22 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.625 -0.88 . . . . 62.53 108.625 175.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 26.2 t70 -143.29 130.46 20.79 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.987 -0.746 . . . . 64.34 108.987 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -105.77 131.09 53.54 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.065 -0.717 . . . . 74.33 109.065 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.6 127.37 38.86 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.658 0.783 . . . . 72.22 109.664 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.1 p -94.83 153.22 17.83 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.143 0.977 . . . . 55.44 110.214 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.9 t -150.39 127.39 11.15 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.872 -0.788 . . . . 62.34 108.872 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -103.01 106.7 17.27 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.282 -0.636 . . . . 75.3 109.282 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.584 HD11 ' HB2' ' A' ' 57' ' ' GLU . 65.6 mt -83.37 -30.47 27.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.047 0.539 . . . . 70.34 110.505 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -163.73 -177.98 5.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.12 -0.946 . . . . 53.44 109.748 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.43 126.27 28.76 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.518 -1.29 . . . . 62.54 107.518 164.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.429 ' HA ' HG12 ' E' ' 451' ' ' VAL . 0.8 OUTLIER 74.19 -3.85 2.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.272 1.029 . . . . 74.55 112.85 175.856 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 50.5 t -115.64 111.4 35.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 107.403 -1.332 . . . . 63.53 107.403 177.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -130.99 123.73 29.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.39 -0.596 . . . . 52.41 109.39 -172.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.584 ' HB2' HD11 ' A' ' 51' ' ' LEU . 45.3 tt0 -93.95 140.34 29.82 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.762 0.825 . . . . 73.15 109.404 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -119.29 143.43 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.483 -1.302 . . . . 54.24 107.483 170.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.03 117.74 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.967 -1.123 . . . . 72.54 107.967 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -99.54 106.8 18.84 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.215 -1.031 . . . . 73.22 108.215 178.221 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.569 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 62.9 ttt180 -84.34 105.89 15.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.063 0.945 . . . . 72.4 109.29 176.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.536 HG22 HD12 ' A' ' 60' ' ' LEU . 15.9 t -104.71 115.84 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.869 0.868 . . . . 61.53 109.003 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.3 m -110.71 112.71 24.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.091 0.957 . . . . 74.43 110.511 -175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 114' ' ' ILE . 53.0 t -102.89 107.35 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.888 0.875 . . . . 74.43 109.176 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.1 m -105.13 109.91 22.08 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.531 -0.915 . . . . 74.45 108.531 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.71 104.1 9.96 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.611 -0.885 . . . . 24.2 108.611 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.8 m -107.76 127.15 53.44 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.563 0.745 . . . . 71.1 109.13 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.649 HD12 HG23 ' A' ' 31' ' ' VAL . 2.2 tt -86.62 87.14 7.38 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 106.781 -1.563 . . . . 43.13 106.781 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.86 -98.7 1.32 Allowed Glycine 0 C--N 1.343 0.926 0 CA-C-N 114.51 -1.223 . . . . 70.44 110.632 -172.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -115.5 -12.54 11.65 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.124 0.97 . . . . 73.15 110.443 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.408 ' HB2' ' HZ3' ' A' ' 34' ' ' LYS . 11.1 mp0 -99.48 119.5 38.12 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.227 1.011 . . . . 70.43 109.671 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.3 m -61.82 122.44 15.39 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 123.459 0.474 . . . . 75.42 111.409 -178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.93 -55.67 5.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.045 -1.095 . . . . 75.13 108.045 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.511 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 51.7 p90 -158.95 150.43 20.56 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.854 -1.066 . . . . 71.32 110.601 175.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 64' ' ' VAL . 47.0 tp -131.1 107.57 9.14 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 107.741 -1.207 . . . . 54.14 107.741 176.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.511 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 60.4 m -109.74 99.78 8.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.659 0.784 . . . . 62.32 109.715 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -119.71 116.04 25.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.636 -0.876 . . . . 54.34 108.636 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.24 132.3 68.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 123.992 0.917 . . . . 64.55 109.29 -173.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 44.9 mt-30 -104.55 101.13 10.79 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 109.232 -0.655 . . . . 62.51 109.232 168.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -86.82 105.4 16.99 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.107 -1.072 . . . . 74.4 108.107 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.44 144.6 17.15 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 111.756 -0.538 . . . . 73.35 111.756 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.485 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.23 137.09 7.89 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.078 -0.809 . . . . 63.33 111.078 177.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.4 mt -89.08 123.58 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.844 -0.799 . . . . 62.41 108.844 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.691 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 34.8 m-85 -128.18 133.59 48.93 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.264 0.626 . . . . 74.32 109.654 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.3 t -100.89 114.31 28.05 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.67 -0.863 . . . . 74.24 108.67 176.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.31 142.31 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.831 0.852 . . . . 72.32 109.25 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HA ' HG21 ' E' ' 451' ' ' VAL . . . -160.49 152.35 19.97 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.088 0.955 . . . . 54.52 109.792 173.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.2 -17.19 57.82 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.558 0.536 . . . . 54.01 114.398 173.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.544 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -132.18 152.95 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.483 0.713 . . . . 73.31 109.874 178.586 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.492 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 17.9 tt0 -150.27 -179.05 6.88 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.845 0.858 . . . . 54.55 108.866 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 71.9 -135.58 23.2 Favored Glycine 0 C--N 1.35 1.359 0 C-N-CA 123.003 0.335 . . . . 71.1 113.888 176.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.2 p -79.32 -15.13 58.43 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.075 0.55 . . . . 73.12 110.918 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -74.96 -36.84 62.07 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.151 0.98 . . . . 74.42 110.532 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.625 ' SD ' ' HA ' ' E' ' 452' ' ' VAL . 12.9 ptt? -74.94 -25.13 58.67 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 110.259 -0.274 . . . . 64.32 110.259 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.45 -26.53 62.76 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.294 0.637 . . . . 73.2 110.26 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.484 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 27.5 t-80 -71.88 -34.56 69.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.069 0.548 . . . . 73.45 110.494 171.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.544 ' SG ' HG13 ' A' ' 89' ' ' ILE . 79.3 m -69.58 -61.27 1.85 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.454 0.302 . . . . 73.22 110.769 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' E' ' 454' ' ' LEU . 1.1 pp -76.21 -24.23 54.65 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.676 0.39 . . . . 70.33 111.194 -173.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.0 3.75 38.53 Favored Glycine 0 N--CA 1.476 1.325 0 CA-C-O 119.762 -0.466 . . . . 73.35 114.251 -171.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -147.49 -59.0 0.26 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 117.375 0.588 . . . . 24.34 111.755 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.424 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 84.6 t80 -70.74 -51.05 29.74 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.776 0.831 . . . . 75.35 112.511 -173.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.437 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 74.5 m -76.18 -34.2 1.38 Allowed Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 113.876 1.065 . . . . 75.14 113.876 -173.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.455 ' HB2' HD23 ' A' ' 60' ' ' LEU . 42.8 Cg_endo -69.12 -22.38 35.08 Favored 'Trans proline' 0 C--N 1.379 2.143 0 CA-C-N 121.596 1.606 . . . . 61.52 112.92 167.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -70.35 -31.36 68.6 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.389 0.676 . . . . 73.22 109.721 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 35.9 mm -57.08 -39.09 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.185 0.994 . . . . 74.12 110.962 171.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.485 HD21 ' HA3' ' A' ' 82' ' ' GLY . 54.0 mt -86.23 -16.99 35.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.788 0.835 . . . . 73.32 112.748 -172.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -64.79 -43.14 68.17 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 113.453 0.909 . . . . 73.15 113.453 -175.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.46 -36.25 78.44 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.058 1.839 . . . . 44.15 113.243 173.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -70.5 -40.06 73.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.347 0.659 . . . . 74.42 111.223 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.11 -40.55 86.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.299 0.64 . . . . 71.2 110.149 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.523 ' NH1' HD12 ' C' ' 105' ' ' ILE . 36.9 ttm180 -51.56 -55.52 18.68 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 124.334 1.021 . . . . 65.41 110.143 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.37 -47.31 86.41 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.367 1.042 . . . . 52.43 111.537 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.4 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 37.3 t -55.14 -45.01 75.6 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.93 0.769 . . . . 65.33 110.987 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.475 HG21 HG21 ' A' ' 64' ' ' VAL . 83.9 mt -64.69 -55.68 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.773 -1.103 . . . . 73.04 110.758 176.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -55.58 -37.35 67.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.985 0.914 . . . . 52.24 111.799 -175.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -66.79 -49.89 64.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.88 -1.055 . . . . 44.41 109.912 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 38.8 mtp -58.44 -37.18 74.89 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.773 0.829 . . . . 62.12 111.847 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 114' ' ' ILE . 98.2 t -65.69 -47.86 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.851 0.86 . . . . 73.14 110.263 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 p -74.98 -21.61 59.05 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.18 0.592 . . . . 72.04 111.876 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -73.0 -34.27 66.29 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.519 0.728 . . . . 72.51 109.362 172.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.82 0.66 76.95 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.894 0.746 . . . . 42.35 113.1 172.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.4 m 69.25 19.63 7.76 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 124.648 1.179 . . . . 75.31 111.141 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -86.97 150.46 50.08 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.627 0.771 . . . . 72.1 109.987 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.48 152.6 15.61 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.722 2.948 . . . . 71.32 114.374 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -57.67 140.92 50.05 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.238 1.015 . . . . 73.14 112.413 -172.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' E' ' 468' ' ' LEU . 16.8 tp -127.14 113.36 16.28 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.853 0.461 . . . . 45.24 110.558 -176.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -122.41 86.7 2.62 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.387 0.675 . . . . 71.25 109.206 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.69 ' H ' HD23 ' A' ' 128' ' ' LEU . 0.5 OUTLIER -65.61 131.06 45.44 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.278 0.631 . . . . 52.03 110.028 175.22 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.657 ' HB3' ' HB1' ' E' ' 466' ' ' ALA . . . -75.38 146.39 81.09 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 123.756 0.822 . . . . 71.21 111.847 -170.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.51 121.99 7.9 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 122.942 2.428 . . . . 75.21 112.548 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -108.39 134.73 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 109.217 -0.661 . . . . 71.25 109.217 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.403 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 52.5 t-20 -80.76 101.94 9.64 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.701 0.8 . . . . 72.12 109.355 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -66.9 -27.15 67.27 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.275 0.63 . . . . 62.4 111.596 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.538 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 5.1 m-20 -67.87 -37.49 81.88 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.836 0.855 . . . . 65.52 110.816 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.48 -37.24 84.66 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.893 0.746 . . . . 44.0 110.589 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 132' ' ' ASN . 84.3 mt -67.07 -45.14 78.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.655 0.782 . . . . 71.44 111.396 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -64.0 -39.49 94.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.507 -0.769 . . . . 73.2 109.322 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.418 ' SD ' HD23 ' A' ' 141' ' ' LEU . 13.7 tpt -64.39 -31.65 72.94 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 124.211 0.944 . . . . 63.41 110.668 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.641 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 88.8 m-20 -60.24 -42.36 95.12 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.316 0.646 . . . . 75.21 110.995 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -70.74 -39.24 73.44 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.632 -0.713 . . . . 74.1 110.998 174.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.418 HD23 ' SD ' ' A' ' 138' ' ' MET . 28.3 tp -68.56 -48.51 64.07 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.109 0.964 . . . . 75.33 111.99 -170.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -167.71 10.02 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 123.581 0.752 . . . . 70.41 110.937 -170.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.641 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 96.1 mt-30 61.76 -171.88 0.15 Allowed 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 124.411 1.084 . . . . 75.03 110.855 -167.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -67.12 95.05 0.38 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.03 -0.73 . . . . 75.53 109.03 174.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.6 123.08 41.08 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.452 -0.944 . . . . 72.34 108.452 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.96 106.28 0.64 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.344 -0.702 . . . . 62.12 111.344 -173.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -109.41 121.05 44.32 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.545 -0.909 . . . . 64.23 108.545 173.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -142.89 142.0 11.1 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.677 -0.569 . . . . 52.25 111.677 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -149.79 156.79 42.42 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.747 0.819 . . . . 53.1 109.881 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -128.21 110.74 12.71 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.521 0.677 . . . . 64.33 111.015 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -131.28 77.6 1.79 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 106.907 -1.516 . . . . 73.2 106.907 175.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -121.21 62.42 0.89 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.65 0.738 . . . . 74.23 109.775 -177.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -169.5 124.71 0.84 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 113.791 -1.549 . . . . 72.02 108.694 171.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -94.89 106.85 18.86 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.281 -1.378 . . . . 72.13 107.281 167.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.432 0 O-C-N 123.815 0.697 . . . . 61.41 110.785 -175.252 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.132 0.492 . . . . 54.31 110.838 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 51.1 p -131.92 147.06 52.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.459 1.104 . . . . 62.31 108.448 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.73 132.52 49.58 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.864 -0.791 . . . . 75.23 108.864 -172.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -138.1 116.27 11.79 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.66 0.384 . . . . 74.2 110.624 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -140.02 133.71 30.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.444 1.098 . . . . 72.44 108.444 170.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -90.09 14.8 11.48 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.404 0.682 . . . . 60.53 111.11 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 28.3 m -55.1 116.23 2.67 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.276 1.031 . . . . 70.23 110.326 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.06 87.16 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 124.357 1.036 . . . . 74.02 111.082 178.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.402 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 14.3 ptm 60.71 170.21 0.09 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.333 2.253 . . . . 55.1 114.87 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 95.5 m -158.05 127.92 6.02 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.28 1.832 . . . . 74.33 106.608 175.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -133.49 132.83 41.48 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.686 0.395 . . . . 74.41 110.317 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -140.09 142.08 36.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.34 0.656 . . . . 75.12 109.732 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.449 HD11 HD13 ' B' ' 105' ' ' ILE . 32.1 mt -95.64 120.68 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 107.989 -1.115 . . . . 73.35 107.989 170.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -85.2 -50.86 7.04 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.334 -0.617 . . . . 63.44 109.334 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.602 HH11 ' HD1' ' A' ' 32' ' ' PHE . 46.0 ttt180 -162.03 137.99 7.68 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.364 -0.834 . . . . 75.42 109.508 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 91.4 mt -114.99 145.46 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 106.77 -1.567 . . . . 74.33 106.77 171.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -165.61 141.24 5.1 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.931 0.396 . . . . 74.2 111.416 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 59.0 m -72.92 120.92 19.21 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.108 -1.071 . . . . 74.45 108.108 171.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.536 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 46.8 mtpt -92.67 -32.42 14.76 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.221 0.608 . . . . 73.53 111.267 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.9 t70 -153.93 137.8 16.25 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.064 0.228 . . . . 73.55 110.689 -171.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.8 mm -134.87 141.3 43.47 Favored 'Isoleucine or valine' 0 C--N 1.348 0.533 0 C-N-CA 124.834 1.254 . . . . 64.32 108.223 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.3 t -139.16 127.07 22.2 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.526 -1.286 . . . . 74.23 107.526 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.599 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.0 t80 -143.39 114.35 7.74 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.478 -0.934 . . . . 64.1 108.478 173.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -119.48 137.94 53.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.031 0.933 . . . . 65.35 108.817 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.01 81.04 71.17 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.461 -1.311 . . . . 74.54 107.461 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.87 -44.39 16.61 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.25 2.633 . . . . 71.33 113.356 -166.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.53 ' HB2' ' HB ' ' B' ' 31' ' ' VAL . 33.5 m-80 -100.25 15.49 27.41 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 117.905 -1.045 . . . . 72.4 110.792 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.424 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -30.17 -72.26 0.06 OUTLIER Pre-proline 0 N--CA 1.511 2.59 0 C-N-CA 125.927 1.691 . . . . 64.12 115.048 -165.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 33.9 Cg_endo -66.3 -21.61 54.25 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.462 2.108 . . . . 64.01 113.166 -172.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -83.11 -49.53 9.42 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.383 -0.826 . . . . 71.11 111.308 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.658 HG22 HD12 ' B' ' 68' ' ' LEU . 8.1 p -64.37 -19.61 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.133 0.973 . . . . 31.14 112.056 -166.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -61.37 -11.77 11.49 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 123.821 0.848 . . . . 75.35 112.319 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.607 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 24.7 pt20 -55.34 -40.27 71.03 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.08 1.352 . . . . 51.41 111.574 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.607 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 90.0 mttt -94.54 89.65 5.89 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.622 0.769 . . . . 65.43 108.925 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.32 86.91 2.51 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.388 -0.824 . . . . 64.25 109.641 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -154.16 155.15 34.81 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.087 1.355 . . . . 73.34 107.377 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -76.2 102.91 0.87 Allowed Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.559 -0.904 . . . . 63.53 108.559 170.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.524 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 34.6 Cg_endo -60.06 142.06 97.59 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 123.136 2.558 . . . . 62.53 113.098 -170.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.41 121.58 13.57 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 123.701 0.625 . . . . 74.41 109.441 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' B' ' 65' ' ' THR . 18.3 m -104.05 135.5 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.587 -0.733 . . . . 65.25 112.314 -171.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.592 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 54.1 tttp -106.1 103.48 12.97 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.597 -1.26 . . . . 63.54 107.597 170.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.644 ' H ' HD23 ' B' ' 42' ' ' LEU . 2.2 pt? -95.81 132.31 41.19 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.81 -0.811 . . . . 73.03 108.81 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 19.5 t70 -131.77 146.96 52.44 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.14 1.376 . . . . 73.32 109.123 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 tp -125.04 131.4 53.38 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.106 0.962 . . . . 75.45 109.724 -172.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -148.87 155.89 41.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.643 1.177 . . . . 71.13 108.822 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.5 p -134.93 130.41 35.81 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.452 0.701 . . . . 62.11 109.753 173.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.79 122.71 46.26 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.97 -1.122 . . . . 74.52 107.97 174.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.3 m -124.8 160.79 27.89 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 122.915 0.486 . . . . 74.11 109.865 -175.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 94.6 p -152.35 139.82 19.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.493 0.717 . . . . 73.13 110.064 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -82.19 105.26 13.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.27 0.628 . . . . 63.04 110.067 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 78.4 mt -72.23 -42.77 65.32 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.62 0.724 . . . . 74.11 109.603 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.37 -179.16 7.92 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.269 -1.332 . . . . 63.13 108.782 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.25 123.12 22.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.291 -1.003 . . . . 65.31 108.291 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 72.82 -5.4 1.89 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.517 1.527 . . . . 62.45 113.288 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -111.49 109.83 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 107.59 -1.263 . . . . 75.32 107.59 173.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.72 140.5 52.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.183 -0.673 . . . . 74.34 109.183 -173.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -99.7 133.65 43.74 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.149 -1.056 . . . . 74.31 108.149 172.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -115.69 139.58 41.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.2 -1.037 . . . . 75.41 108.2 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 33.0 t -126.54 120.83 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.62 -0.881 . . . . 64.04 108.62 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.66 113.13 25.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.125 -1.065 . . . . 63.04 108.125 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -100.65 122.43 43.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.806 0.442 . . . . 73.14 110.315 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -116.09 114.61 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 107.783 -1.192 . . . . 63.34 107.783 171.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 48.7 m -96.4 137.72 35.06 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.474 -0.935 . . . . 51.51 108.474 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 85.5 t -131.99 133.08 61.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.998 -0.742 . . . . 72.11 108.998 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 91.4 m -120.09 148.88 43.05 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.767 1.227 . . . . 72.23 107.721 175.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.45 134.65 21.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 122.858 0.463 . . . . 64.13 110.077 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.6 p -132.62 126.69 33.28 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.308 0.643 . . . . 61.33 110.751 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.658 HD12 HG22 ' B' ' 31' ' ' VAL . 41.2 mt -95.13 103.15 15.0 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 108.149 -1.056 . . . . 74.2 108.149 170.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.48 -109.78 3.1 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.008 -0.996 . . . . 73.34 111.206 -170.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -117.37 5.15 12.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.928 0.891 . . . . 64.23 111.583 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -116.17 149.21 39.44 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.185 -0.672 . . . . 75.4 109.185 175.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 65.7 m -72.89 134.0 44.63 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.192 0.308 . . . . 65.53 111.097 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.495 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -82.97 -68.21 0.72 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.249 -1.019 . . . . 64.4 108.249 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -144.25 158.94 43.46 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.811 -1.086 . . . . 63.21 110.395 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 94.8 mt -131.2 120.82 23.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.08 -1.822 . . . . 64.12 106.08 174.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 36.9 t -132.35 145.24 51.11 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.194 -0.669 . . . . 74.41 109.194 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -160.19 133.96 7.11 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.865 -0.791 . . . . 71.53 108.865 -175.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -128.01 146.39 33.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.87 0.868 . . . . 74.02 108.918 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 17.6 mt-30 -124.96 93.32 3.85 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.233 -1.025 . . . . 72.33 108.233 170.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.531 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -85.57 101.0 12.32 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.845 -1.071 . . . . 71.53 109.155 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.07 160.26 29.52 Favored Glycine 0 C--N 1.339 0.748 0 O-C-N 123.435 0.459 . . . . 65.11 112.047 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.18 130.42 2.34 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 119.952 -0.36 . . . . 73.11 112.22 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -84.54 126.09 40.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 108.806 -0.813 . . . . 74.24 108.806 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -132.37 134.18 44.86 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.282 1.033 . . . . 73.55 108.972 -176.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.6 m -102.06 103.08 13.65 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.822 0.849 . . . . 74.13 109.51 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.672 ' HB ' HD11 ' B' ' 89' ' ' ILE . 46.2 pt -103.92 135.33 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.496 0.719 . . . . 74.21 109.794 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -146.69 151.81 37.81 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.863 -0.792 . . . . 41.12 108.863 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 88.93 -62.16 3.66 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 112.109 -0.396 . . . . 61.11 112.109 -176.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.672 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -62.12 142.07 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.679 0.392 . . . . 72.44 111.781 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.84 167.73 26.61 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.969 0.907 . . . . 71.1 109.526 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.07 -113.62 5.28 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.794 0.684 . . . . 74.15 113.042 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 2.2 m -87.17 -17.49 32.57 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.609 -0.348 . . . . 44.32 111.26 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -65.61 -46.75 78.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.982 0.513 . . . . 65.23 110.262 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -24.42 57.03 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 116.058 -0.519 . . . . 74.44 110.529 177.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.77 98.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.33 0.586 . . . . 44.32 109.918 169.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -70.25 -30.91 68.08 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.31 1.044 . . . . 73.21 111.203 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.484 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 69.2 m -70.76 -67.68 0.49 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 110.247 -0.279 . . . . 63.32 110.247 174.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 59.3 mt -74.34 -21.93 59.46 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.585 0.587 . . . . 74.21 112.585 -168.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.95 3.09 41.2 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-O 119.522 -0.599 . . . . 60.54 114.302 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.48 -62.85 0.2 Allowed 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.789 0.795 . . . . 70.41 111.909 -177.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 89.4 t80 -68.18 -39.18 82.61 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.915 0.886 . . . . 72.14 112.372 -172.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.411 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 91.3 m -73.08 -46.36 8.22 Favored Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 123.693 0.797 . . . . 64.24 111.103 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.411 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 78.5 Cg_exo -55.87 -34.05 90.39 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.025 1.817 . . . . 53.31 113.727 167.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -59.6 -38.77 82.13 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.231 0.613 . . . . 72.24 110.799 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.449 HD13 HD11 ' B' ' 13' ' ' ILE . 70.4 mt -64.12 -42.99 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.06 0.944 . . . . 74.14 110.836 175.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 80' ' ' GLN . 74.1 mt -79.03 -19.73 50.73 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.657 -1.156 . . . . 71.33 112.399 -173.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -59.7 -47.41 97.59 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.179 1.177 . . . . 71.42 114.179 -171.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.96 -42.78 61.84 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.373 2.048 . . . . 73.13 113.788 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.531 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 82.5 m-85 -66.27 -48.63 69.81 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.839 -0.619 . . . . 64.43 110.421 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.96 -42.12 84.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.742 0.817 . . . . 63.54 110.908 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 49.5 ttt180 -61.86 -54.71 38.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.245 1.418 . . . . 64.41 110.995 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -67.17 -34.16 76.95 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 123.998 0.811 . . . . 73.24 110.147 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.6 t -68.18 -33.93 75.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.71 0.404 . . . . 74.24 111.088 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 70.9 mt -65.28 -52.01 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.415 -0.587 . . . . 65.34 109.415 171.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.0 m -60.01 -30.62 69.27 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 123.979 0.8 . . . . 75.53 111.543 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.2 t -63.63 -51.86 63.36 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 123.454 0.702 . . . . 52.23 109.858 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -68.59 -34.91 76.6 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.148 0.579 . . . . 64.11 110.985 -174.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.05 -43.04 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.736 0.815 . . . . 64.03 110.312 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.3 t -68.75 -30.19 68.75 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.393 -0.821 . . . . 52.24 111.598 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.8 mtt-85 -69.59 -43.4 72.88 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.547 -0.751 . . . . 75.54 109.612 176.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.21 -3.09 64.24 Favored Glycine 0 C--N 1.357 1.708 0 O-C-N 124.072 0.857 . . . . 55.45 112.924 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 28.2 p 62.18 25.87 15.5 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 126.506 1.922 . . . . 71.23 112.86 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -80.34 161.51 64.64 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 123.837 0.855 . . . . 54.43 110.729 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -49.41 157.86 1.95 Allowed 'Trans proline' 0 C--N 1.387 2.581 0 C-N-CA 123.742 2.961 . . . . 71.41 115.178 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -59.61 114.17 2.6 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.226 1.01 . . . . 52.31 111.306 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -119.1 108.97 15.35 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.657 -0.868 . . . . 65.35 108.657 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -124.02 134.44 53.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.511 -0.922 . . . . 75.22 108.511 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.429 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.3 mm? -77.02 147.42 36.78 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.299 0.639 . . . . 74.02 109.848 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.23 147.23 53.04 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 123.092 0.557 . . . . 62.52 109.667 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.33 110.78 0.85 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.151 2.568 . . . . 73.23 112.322 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.0 t -90.11 112.63 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.435 -0.95 . . . . 72.22 108.435 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -82.08 83.83 7.2 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.968 -1.123 . . . . 74.22 107.968 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -54.41 -42.26 70.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.288 1.035 . . . . 64.42 111.302 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.73 -43.09 80.79 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.408 1.083 . . . . 71.32 111.888 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.52 -54.25 45.64 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.316 0.646 . . . . 74.2 110.271 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.4 -29.37 70.43 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.613 -1.176 . . . . 54.2 111.47 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.457 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 75.2 t80 -65.54 -43.21 90.67 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.151 0.58 . . . . 54.14 110.433 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 60.4 mtt -64.83 -36.2 83.55 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.888 0.475 . . . . 54.04 110.674 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -82.96 -4.61 58.45 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.767 0.827 . . . . 71.21 111.464 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -83.12 -34.27 26.12 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.081 0.552 . . . . 74.12 109.668 173.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 12.7 mt -77.68 -6.27 53.33 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.621 -0.718 . . . . 75.35 111.38 -172.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -144.35 132.75 21.99 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.464 1.106 . . . . 54.41 108.153 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -79.44 68.75 5.54 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.713 0.768 . . . . 71.42 109.709 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -143.29 177.19 8.59 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.198 1.399 . . . . 72.03 108.541 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.38 97.59 2.88 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.014 0.526 . . . . 75.42 110.647 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.97 149.88 21.13 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 111.764 -0.534 . . . . 54.4 111.764 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -160.85 165.65 29.84 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.671 0.789 . . . . 62.22 110.412 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.31 85.45 0.14 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 111.393 -0.683 . . . . 63.43 111.393 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.6 p -85.15 110.44 19.0 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.164 0.586 . . . . 75.3 109.616 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -137.41 144.73 42.54 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.122 -1.807 . . . . 75.32 106.122 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -169.44 125.53 0.88 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.086 0.554 . . . . 75.44 109.75 -176.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -168.9 94.57 0.33 Allowed 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.54 0.736 . . . . 71.5 111.501 174.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.21 61.99 2.1 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 106.759 -1.571 . . . . 73.11 106.759 163.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.48 117.66 18.37 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.481 -1.236 . . . . 74.51 109.722 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 C-N-CA 123.733 0.813 . . . . 72.22 108.946 -178.648 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.844 -0.428 . . . . 74.24 109.844 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -139.08 -176.54 4.54 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 108.075 -1.083 . . . . 75.12 108.075 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.73 77.33 3.36 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.199 0.6 . . . . 54.25 109.691 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 57.15 68.7 0.82 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.083 1.353 . . . . 71.02 111.777 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -74.77 80.84 2.08 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.688 -0.856 . . . . 74.34 108.688 172.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -172.71 123.68 0.45 Allowed 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.769 -1.197 . . . . 61.21 107.769 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 45.8 p -72.68 -67.87 0.52 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.24 -0.652 . . . . 62.42 109.24 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 56.72 65.31 1.43 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.061 1.344 . . . . 74.24 111.896 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.475 ' HG3' HD12 ' C' ' 89' ' ' ILE . 54.4 ttm 57.33 113.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.817 1.647 . . . . 74.31 113.352 177.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 31.4 m -87.81 80.49 7.84 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.368 -0.975 . . . . 74.01 108.368 173.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.56 122.93 33.8 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.79 -1.095 . . . . 61.32 109.155 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -137.21 108.41 6.81 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.593 -1.262 . . . . 74.22 107.593 168.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.9 118.62 6.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.071 -1.085 . . . . 74.45 108.071 172.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.478 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.1 mm-40 -82.74 -48.84 10.4 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.705 0.628 . . . . 41.24 109.415 -178.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -170.19 124.46 0.74 Allowed 'General case' 0 C--N 1.354 0.78 0 CA-C-N 115.947 -0.569 . . . . 62.34 110.677 -172.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.1 mt -112.35 139.27 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 107.736 -1.209 . . . . 63.11 107.736 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -173.5 153.12 2.26 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.094 0.474 . . . . 74.45 110.435 -168.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.9 p -82.32 116.64 21.91 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.96 -0.755 . . . . 71.42 108.96 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.43 ' HG3' ' HA3' ' C' ' 81' ' ' GLY . 15.2 mtmt -83.58 -29.79 27.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.09 0.472 . . . . 75.53 109.947 176.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 27.4 t70 -144.37 138.68 27.97 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.132 -0.94 . . . . 75.42 109.354 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 87.0 mt -136.51 140.24 43.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.924 -1.509 . . . . 74.44 106.924 171.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -157.05 141.23 16.39 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.842 0.353 . . . . 72.31 110.155 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 86.8 t80 -136.44 148.2 47.62 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.489 -1.3 . . . . 75.42 107.489 171.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -145.08 118.12 8.84 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.0 0.92 . . . . 74.33 110.062 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.83 83.78 51.7 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 107.222 -1.399 . . . . 15.4 107.222 163.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.01 -27.89 19.94 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.331 2.021 . . . . 72.33 111.394 175.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -92.25 12.2 23.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.579 1.151 . . . . 74.22 110.747 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.81 -58.76 7.63 Favored Pre-proline 0 C--N 1.37 1.463 0 N-CA-C 114.698 1.37 . . . . 63.12 114.698 -165.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -62.98 -39.77 38.44 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 121.503 1.468 . . . . 51.14 112.171 -174.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -70.3 -34.96 73.36 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.787 -1.097 . . . . 71.33 112.233 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.692 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.3 p -80.6 -26.06 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 112.906 0.706 . . . . 72.32 112.906 -170.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -64.77 -20.48 66.39 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 113.29 0.848 . . . . 73.02 113.29 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -99.11 12.07 37.18 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.302 0.641 . . . . 73.11 111.286 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.726 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -88.06 146.32 25.52 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.276 -0.638 . . . . 61.35 109.276 172.799 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -57.98 119.18 6.3 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.116 -0.698 . . . . 73.44 109.116 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -67.8 93.17 0.38 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.803 0.841 . . . . 71.2 111.283 -173.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -148.99 69.1 9.81 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 124.839 1.255 . . . . 73.41 108.251 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -80.16 133.27 9.78 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.573 2.182 . . . . 73.44 111.152 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.09 105.11 15.59 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.107 -1.072 . . . . 74.42 108.107 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.55 113.56 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.36 -0.836 . . . . 70.21 110.329 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -111.17 110.7 21.34 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.183 -1.414 . . . . 72.41 107.183 170.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 40.4 tp -91.28 142.26 27.9 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.124 0.569 . . . . 71.31 109.7 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.42 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 20.1 t70 -131.95 117.75 18.86 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.823 -1.177 . . . . 73.31 107.823 175.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.6 mt -108.72 151.67 25.87 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.607 0.763 . . . . 63.33 109.953 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 30.0 t70 -157.6 150.19 22.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.198 0.599 . . . . 55.44 109.949 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -144.45 123.36 12.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.629 0.772 . . . . 54.22 110.117 176.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.78 135.11 54.44 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.619 -0.882 . . . . 73.14 108.619 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.4 p -131.2 142.31 50.17 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.239 0.616 . . . . 74.42 109.623 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 29.6 t -145.79 150.8 36.88 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.137 0.975 . . . . 73.13 109.532 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.75 138.77 41.46 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.957 -0.565 . . . . 74.44 109.829 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.632 HD11 HD12 ' C' ' 83' ' ' ILE . 62.6 mt -106.22 -43.26 4.85 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.681 -0.859 . . . . 74.34 108.681 169.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.66 -176.34 5.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.63 -1.168 . . . . 60.02 109.525 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 53' ' ' ASP . . . . . 0.479 ' HB3' ' HA ' ' G' ' 450' ' ' ASN . 12.2 m-20 -66.18 126.1 27.63 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.511 -0.768 . . . . 62.23 109.684 176.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 72.2 -1.82 2.78 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.31 1.444 . . . . 73.35 112.032 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -114.89 114.12 45.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 123.264 0.625 . . . . 55.11 109.418 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -124.84 135.3 52.78 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.063 0.945 . . . . 74.34 109.192 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.562 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.8 tt0 -92.6 123.97 36.29 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 124.154 0.909 . . . . 70.23 108.877 168.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 85.3 t -103.79 136.95 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.293 -1.003 . . . . 62.5 108.293 168.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -121.17 130.58 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.303 -1.369 . . . . 75.5 107.303 174.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.26 104.26 11.64 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.818 -1.178 . . . . 52.1 107.818 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.575 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 30.4 ttm-85 -88.39 126.19 35.09 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.241 -1.345 . . . . 74.22 108.297 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.597 ' HB ' HD11 ' C' ' 114' ' ' ILE . 21.5 t -123.58 128.22 74.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.583 -1.266 . . . . 64.41 107.583 173.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 9.8 m -128.37 112.0 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.746 -0.835 . . . . 71.44 108.746 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.455 HG21 HG21 ' C' ' 114' ' ' ILE . 51.7 t -104.84 116.02 47.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.92 -1.036 . . . . 71.25 108.788 -173.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.9 m -105.8 141.37 37.34 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.07 -0.715 . . . . 72.41 109.07 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.15 115.15 8.74 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.85 -1.167 . . . . 73.13 107.85 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.9 m -137.17 134.25 36.11 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.483 0.49 . . . . 54.53 109.833 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.726 HD13 ' HG2' ' C' ' 34' ' ' LYS . 0.5 OUTLIER -87.88 42.03 1.03 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.936 1.294 . . . . 61.22 108.596 177.135 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.27 -112.62 4.17 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.209 -0.756 . . . . 70.54 111.209 -171.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.56 -30.71 19.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.326 0.65 . . . . 71.25 109.485 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.15 110.53 3.02 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 115.222 -0.899 . . . . 64.44 109.032 173.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -77.95 125.49 29.42 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.001 -0.74 . . . . 74.05 109.001 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.692 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.85 -57.87 3.75 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.421 -1.325 . . . . 62.23 107.421 171.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -167.4 169.23 12.45 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 121.885 0.85 . . . . 71.13 111.939 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -133.77 141.63 47.57 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 105.947 -1.872 . . . . 72.11 105.947 170.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 47.4 t -151.34 113.44 4.53 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.963 -0.384 . . . . 44.32 109.963 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -117.02 127.62 54.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.478 0.311 . . . . 73.21 110.309 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.5 t -118.24 138.33 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.953 -1.129 . . . . 74.33 107.953 167.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.6 mt-30 -116.05 94.96 4.88 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 108.68 -0.859 . . . . 72.12 108.68 173.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.478 ' HG3' HD22 ' C' ' 106' ' ' LEU . 71.4 tp60 -79.79 102.64 9.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.954 -1.021 . . . . 62.33 109.903 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.43 ' HA3' ' HG3' ' C' ' 19' ' ' LYS . . . -85.58 151.85 25.75 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 111.759 -0.536 . . . . 72.51 111.759 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.59 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.37 118.47 0.86 Allowed Glycine 0 CA--C 1.506 -0.475 0 N-CA-C 111.697 -0.561 . . . . 71.34 111.697 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.632 HD12 HD11 ' C' ' 51' ' ' LEU . 8.8 mm -84.71 125.91 40.29 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 N-CA-C 108.764 -0.828 . . . . 70.51 108.764 173.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -134.24 120.08 19.55 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.673 -0.862 . . . . 73.22 108.673 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 61.1 p -91.07 118.82 30.71 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.189 -0.671 . . . . 71.44 109.189 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.749 HG21 ' SG ' ' C' ' 97' ' ' CYS . 1.8 pp -125.61 141.13 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.594 1.158 . . . . 72.43 111.356 -174.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.657 ' HA ' HG21 ' G' ' 451' ' ' VAL . . . -149.53 167.46 26.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.333 0.653 . . . . 75.43 110.326 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.64 -54.41 3.78 Favored Glycine 0 N--CA 1.475 1.269 0 N-CA-C 112.43 -0.268 . . . . 55.0 112.43 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.475 HD12 ' HG3' ' C' ' 9' ' ' MET . 0.2 OUTLIER -81.42 157.54 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.254 0.622 . . . . 75.12 110.564 177.555 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.79 178.63 8.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.851 0.46 . . . . 73.34 110.418 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.54 -114.1 5.58 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.718 0.637 . . . . 64.25 113.533 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -82.55 -20.08 37.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.672 0.789 . . . . 64.5 112.087 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.56 -42.92 61.01 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.513 -0.551 . . . . 73.15 109.513 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 23.9 ptm -74.23 -30.11 62.02 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 110.248 -0.278 . . . . 73.22 110.248 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.553 ' HA ' HD22 ' G' ' 454' ' ' LEU . . . -59.59 -43.69 93.59 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 123.489 0.493 . . . . 75.15 110.118 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -74.72 -35.83 62.67 Favored 'General case' 0 C--O 1.245 0.832 0 O-C-N 123.477 0.485 . . . . 72.43 111.78 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.749 ' SG ' HG21 ' C' ' 86' ' ' ILE . 53.3 t -56.6 -36.37 69.32 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.644 0.59 . . . . 70.41 110.558 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 24.4 mt -98.31 -18.06 18.56 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.856 0.862 . . . . 75.33 111.18 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.43 -29.62 55.44 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 115.015 0.766 . . . . 51.1 115.015 -172.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.94 -36.0 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.654 0.382 . . . . 63.14 111.081 -170.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -67.61 -45.8 74.39 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.216 1.406 . . . . 74.42 112.677 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.0 m -79.79 -40.41 1.37 Allowed Pre-proline 0 CA--C 1.557 1.247 0 CA-C-O 118.475 -0.774 . . . . 61.12 112.481 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -54.0 -27.58 45.92 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 122.249 1.966 . . . . 70.05 114.078 166.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -68.28 -37.9 81.14 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.679 0.792 . . . . 74.15 109.768 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.523 HD12 ' NH1' ' A' ' 111' ' ' ARG . 43.8 mm -68.94 -34.01 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.008 0.523 . . . . 73.11 109.983 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.59 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.4 mt -81.34 -27.3 35.01 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.917 0.887 . . . . 75.35 112.756 -177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -57.8 -48.52 97.03 Favored Pre-proline 0 CA--C 1.559 1.31 0 N-CA-C 113.959 1.096 . . . . 73.4 113.959 -174.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.94 -37.15 79.29 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 121.992 1.795 . . . . 74.42 113.056 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -66.69 -42.46 86.43 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.103 0.561 . . . . 61.11 110.895 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.56 99.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.539 0.736 . . . . 61.0 110.461 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.598 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 35.9 ttt180 -54.12 -56.47 17.85 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.464 1.506 . . . . 63.5 111.412 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.23 -35.43 77.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.733 0.413 . . . . 73.21 110.543 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 20.0 t -64.75 -33.58 76.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.957 0.503 . . . . 73.11 111.973 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.597 HD11 ' HB ' ' C' ' 62' ' ' VAL . 75.4 mt -76.75 -52.7 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.585 0.754 . . . . 74.4 110.231 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -60.94 -28.67 69.12 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.356 0.662 . . . . 71.03 111.38 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.2 t -67.31 -52.07 44.86 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.779 0.832 . . . . 51.4 109.156 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.547 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.37 -36.84 78.97 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.226 1.011 . . . . 71.25 112.338 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.498 HG11 HD13 ' C' ' 126' ' ' LEU . 78.3 t -66.53 -44.84 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.633 0.773 . . . . 72.33 109.904 175.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 40.4 t -69.2 -22.92 63.86 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.262 -0.881 . . . . 71.11 111.645 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.3 mtt-85 -75.65 -41.05 55.13 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.49 0.716 . . . . 75.15 109.082 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.01 -2.87 62.89 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 123.83 0.706 . . . . 63.44 112.498 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p 67.03 27.76 8.62 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.88 2.072 . . . . 74.12 113.611 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -83.8 153.45 64.13 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 108.813 -0.81 . . . . 73.53 108.813 168.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -60.67 178.49 0.47 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.149 2.566 . . . . 74.24 114.75 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -60.8 114.33 2.98 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 114.171 1.174 . . . . 54.21 114.171 -174.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.498 HD13 HG11 ' C' ' 118' ' ' VAL . 7.2 mp -112.2 89.49 3.08 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.81 -0.811 . . . . 73.41 108.81 163.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -91.32 112.68 24.69 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.513 -0.921 . . . . 53.54 108.513 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.598 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -65.0 126.29 27.55 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.618 0.767 . . . . 61.32 110.587 -177.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.21 149.18 81.82 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 124.423 1.089 . . . . 72.4 111.887 -173.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.07 105.3 0.32 Allowed 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.11 2.54 . . . . 73.32 113.212 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.6 111.33 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.707 -0.849 . . . . 73.54 108.707 171.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -87.22 90.31 8.31 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 108.622 -0.881 . . . . 65.11 108.622 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -60.36 -29.95 69.24 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.251 1.021 . . . . 63.22 111.261 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.56 -43.93 68.88 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.415 1.486 . . . . 75.01 112.915 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.61 82.97 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.348 1.03 . . . . 74.24 110.604 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 20.6 tp -71.72 -29.31 64.41 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.142 -0.935 . . . . 74.13 111.152 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -74.21 -26.13 60.08 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.639 0.375 . . . . 72.04 110.344 177.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 91.5 mtp -71.97 -32.28 67.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.582 0.353 . . . . 73.31 110.5 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -71.22 -46.51 61.0 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.882 0.473 . . . . 53.44 109.967 174.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -56.51 -82.87 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 124.651 1.18 . . . . 74.3 110.743 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' C' ' 145' ' ' ALA . 17.9 tp 64.52 -81.98 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.759 1.624 . . . . 50.51 108.997 -174.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 11.7 tm0? 179.3 -57.63 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.227 1.411 . . . . 73.01 107.397 166.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -93.53 -76.02 0.48 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.399 -0.819 . . . . 70.42 109.395 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -176.71 160.72 1.98 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.846 0.858 . . . . 74.53 110.45 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.502 ' HB2' HD22 ' C' ' 141' ' ' LEU . . . -126.15 153.5 44.51 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.058 0.943 . . . . 73.44 109.567 175.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.31 43.21 0.52 Allowed Glycine 0 C--N 1.347 1.163 0 O-C-N 123.043 0.215 . . . . 35.14 113.2 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -156.71 147.42 21.67 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.812 0.445 . . . . 55.13 110.48 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -142.67 -177.09 17.37 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 110.754 -0.938 . . . . 64.21 110.754 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 92.6 m -113.42 -96.69 0.44 Allowed 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.111 -0.7 . . . . 72.22 109.111 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 38.84 69.22 0.28 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.559 1.543 . . . . 71.54 113.608 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -93.4 142.88 26.83 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.119 -1.067 . . . . 75.14 108.119 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 152' ' ' HIS . . . . . 0.415 ' HD2' HD21 ' A' ' 141' ' ' LEU . 36.8 t-80 -150.12 117.25 5.99 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.597 0.359 . . . . 71.51 111.127 -170.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -95.5 129.37 42.69 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.505 -0.924 . . . . 71.11 108.505 160.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -79.47 74.43 6.1 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.826 0.822 . . . . 75.12 109.206 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-N 114.605 -1.18 . . . . 72.2 108.783 -178.18 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.423 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 109.99 -0.374 . . . . 73.42 109.99 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 18.0 m -91.92 -179.38 5.28 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.512 1.125 . . . . 64.15 110.941 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -78.1 83.23 4.4 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.409 0.624 . . . . 72.02 109.418 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' D' ' 5' ' ' ASN . 15.7 tp60 -149.82 -175.36 5.0 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 106.819 -1.549 . . . . 73.22 106.819 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 5' ' ' ASN . . . . . 0.417 ' H ' ' HG3' ' D' ' 4' ' ' GLN . 25.5 p-10 -64.2 -28.23 69.6 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 118.922 0.783 . . . . 74.05 109.687 167.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 70.13 103.17 0.06 Allowed 'General case' 0 C--N 1.36 1.05 0 C-N-CA 125.979 1.712 . . . . 63.41 109.66 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -72.93 146.26 46.23 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.501 -0.772 . . . . 74.54 110.46 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 73.21 -1.73 2.96 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.797 1.239 . . . . 74.14 113.318 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.587 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 6.1 ptm -36.46 153.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.313 1.227 . . . . 74.34 114.313 165.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 21.0 m -117.27 143.55 45.78 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.592 0.757 . . . . 75.04 110.905 177.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.545 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 71.1 t80 -162.58 97.7 0.98 Allowed 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.063 -1.458 . . . . 73.33 107.063 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -112.22 115.01 28.11 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.394 -1.336 . . . . 75.24 107.394 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.474 HD11 HD12 ' D' ' 105' ' ' ILE . 59.7 mt -73.59 119.31 20.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.384 -0.969 . . . . 75.43 108.384 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.46 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 5.3 mm-40 -85.34 -41.77 15.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.693 -0.685 . . . . 75.24 109.219 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -174.67 144.27 0.83 Allowed 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.251 0.345 . . . . 64.42 111.164 -167.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.469 HD11 HG21 ' D' ' 13' ' ' ILE . 4.1 mp -120.66 142.39 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.112 -1.44 . . . . 72.11 107.112 170.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -164.87 160.44 19.4 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.405 0.682 . . . . 75.54 111.121 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.8 p -93.15 116.48 29.07 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.325 -0.621 . . . . 72.13 109.325 173.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -85.38 -19.88 30.73 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.965 0.506 . . . . 75.42 110.105 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.1 t70 -160.31 140.03 11.15 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.782 0.833 . . . . 75.15 109.261 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.547 HG21 ' HE2' ' C' ' 117' ' ' MET . 98.6 mt -137.95 142.86 34.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.859 1.263 . . . . 74.21 107.701 175.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -141.6 136.23 30.81 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.957 0.903 . . . . 75.43 108.807 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.505 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 82.4 t80 -143.53 124.87 14.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.587 -1.634 . . . . 64.12 106.587 168.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 27.0 mt-10 -135.13 118.02 16.25 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.612 -0.884 . . . . 63.45 108.612 -173.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.59 82.39 9.97 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.729 -1.212 . . . . 65.23 107.729 174.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.47 -33.74 10.45 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.681 2.254 . . . . 64.13 113.183 -170.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -103.52 11.06 36.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.542 0.737 . . . . 65.53 110.666 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.441 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -30.66 -70.57 0.09 OUTLIER Pre-proline 0 CA--C 1.565 1.521 0 N-CA-C 116.276 1.954 . . . . 55.11 116.276 -160.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.46 -15.42 19.77 Favored 'Trans proline' 0 C--N 1.375 1.946 0 CA-C-N 123.55 2.304 . . . . 72.12 113.829 -173.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.79 -41.1 27.21 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.485 1.114 . . . . 52.34 110.044 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.5 p -79.96 -23.46 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 116.235 -0.439 . . . . 72.25 111.34 -173.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -63.19 -19.81 64.85 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.127 0.417 . . . . 72.33 112.127 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -61.47 -17.1 52.94 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.877 0.871 . . . . 75.32 111.947 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.419 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 37.6 mtmt -99.83 110.75 23.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.772 0.829 . . . . 61.5 111.09 174.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.49 93.85 9.47 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.576 -0.738 . . . . 62.13 109.722 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -157.39 157.07 33.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.432 1.093 . . . . 64.35 108.235 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.464 ' HG3' HD13 ' H' ' 470' ' ' LEU . 7.4 tp-100 -76.44 106.38 3.24 Favored Pre-proline 0 N--CA 1.477 0.908 0 N-CA-C 107.374 -1.343 . . . . 71.32 107.374 171.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.58 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 24.5 Cg_exo -63.21 137.31 60.5 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.796 2.331 . . . . 74.22 112.452 -167.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 7.4 mm-40 -56.93 109.72 0.69 Allowed 'General case' 0 C--N 1.361 1.075 0 O-C-N 124.082 0.864 . . . . 73.41 109.692 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.609 HG23 HG13 ' D' ' 64' ' ' VAL . 2.1 p -99.63 111.71 29.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 115.198 -0.91 . . . . 53.15 110.586 -171.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -86.49 111.86 20.97 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.366 -1.346 . . . . 72.21 107.366 169.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -95.79 151.86 19.0 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 108.961 -0.755 . . . . 73.44 108.961 173.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -151.44 154.12 35.99 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.438 -0.949 . . . . 70.0 108.438 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.682 ' HB2' HD13 ' H' ' 460' ' ' LEU . 89.6 mt -131.14 144.04 51.09 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.725 0.81 . . . . 72.4 109.711 -176.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.672 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.8 t70 -141.41 125.48 17.29 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.61 1.164 . . . . 64.43 108.234 175.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -104.66 145.38 30.42 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 109.215 -0.661 . . . . 71.15 109.215 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.99 142.69 24.61 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.158 -1.053 . . . . 74.44 108.158 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 47.6 p -141.94 159.92 41.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.602 0.637 . . . . 65.32 111.35 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -163.39 125.91 2.59 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.893 0.877 . . . . 64.53 109.668 -173.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -74.99 121.87 22.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.576 -0.528 . . . . 72.55 109.576 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' D' ' 57' ' ' GLU . 55.9 mt -96.36 -29.65 13.84 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.139 0.576 . . . . 74.14 111.283 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.21 -173.01 3.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.391 0.677 . . . . 41.0 110.45 -177.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.89 120.84 18.06 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.968 -1.014 . . . . 75.44 110.762 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 65.05 3.74 2.26 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.487 1.115 . . . . 74.21 112.005 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 51.5 t -117.0 124.2 72.73 Favored 'Isoleucine or valine' 0 C--N 1.349 0.575 0 C-N-CA 123.369 0.668 . . . . 64.51 109.572 -173.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -120.81 173.13 7.41 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.957 1.303 . . . . 74.2 109.99 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.538 ' HB2' HD11 ' D' ' 51' ' ' LEU . 33.4 tt0 -131.3 133.84 45.77 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.733 -1.576 . . . . 61.41 107.008 168.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.6 t -120.63 141.77 39.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.004 -1.11 . . . . 64.13 108.004 168.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 39.8 t -120.77 131.32 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.718 -1.216 . . . . 65.05 107.718 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.419 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -115.16 119.75 37.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.464 -0.939 . . . . 72.2 108.464 178.448 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.672 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.2 ttm180 -104.77 102.37 11.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.129 -1.063 . . . . 72.32 108.129 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.2 t -94.48 102.51 13.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.693 -1.225 . . . . 72.45 107.693 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 28.4 m -100.32 140.0 35.2 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.544 -0.753 . . . . 74.54 109.588 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.76 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 52.0 t -132.35 133.68 59.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.628 1.571 . . . . 54.43 108.6 -172.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.0 m -134.66 100.77 4.72 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.117 -1.068 . . . . 51.41 108.117 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -104.2 153.14 21.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.644 0.778 . . . . 62.24 110.868 -176.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 65.1 p -146.08 137.96 25.06 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.29 0.567 . . . . 70.13 111.909 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.509 HD12 HG22 ' D' ' 31' ' ' VAL . 53.3 mt -105.69 125.7 51.29 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.586 1.154 . . . . 72.21 108.131 170.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.03 -113.29 5.5 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.454 0.471 . . . . 75.23 112.728 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.96 5.32 13.94 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.346 0.659 . . . . 75.24 110.706 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.419 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 12.4 pt-20 -127.11 159.9 32.81 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.151 0.58 . . . . 73.22 110.276 -174.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -68.92 130.72 43.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.598 0.759 . . . . 61.15 111.95 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.525 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.99 -77.46 0.3 Allowed 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.82 -0.807 . . . . 74.32 108.82 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -141.33 147.57 38.32 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 121.227 0.537 . . . . 72.45 110.859 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 55.8 mt -117.85 140.03 50.27 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.805 -1.183 . . . . 61.15 107.805 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.76 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 33.0 m -141.21 144.7 34.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.118 0.967 . . . . 70.43 109.035 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -156.94 118.07 3.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.16 -1.052 . . . . 74.01 108.16 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.83 113.05 25.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 109.361 -0.607 . . . . 73.11 109.361 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -89.73 85.88 6.54 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.649 -0.871 . . . . 74.23 108.649 172.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -79.09 94.66 5.38 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.618 -1.174 . . . . 73.42 108.509 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.83 145.95 21.12 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.781 -0.528 . . . . 55.03 111.781 177.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.474 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -145.67 131.41 4.15 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.445 -0.662 . . . . 52.54 111.445 -176.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 43.6 mt -89.0 128.73 40.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 N-CA-C 108.248 -1.019 . . . . 73.42 108.248 176.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -135.08 123.9 23.91 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.175 0.59 . . . . 73.4 110.1 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 57.8 m -74.19 108.46 7.0 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.081 -0.711 . . . . 53.25 109.081 166.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.54 HD13 HD23 ' D' ' 98' ' ' LEU . 45.1 pt -105.22 138.29 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.355 0.662 . . . . 71.11 109.271 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.537 ' HA ' HG21 ' H' ' 451' ' ' VAL . . . -167.76 170.43 10.86 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.377 1.071 . . . . 73.23 108.934 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.19 -15.1 29.93 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-O 119.899 -0.39 . . . . 63.32 112.718 -177.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.401 HD11 ' HB ' ' D' ' 86' ' ' ILE . 1.5 pp -128.49 134.97 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.401 1.08 . . . . 72.42 109.631 -174.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -132.42 158.36 42.21 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.851 0.861 . . . . 73.43 109.726 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.08 -127.05 39.87 Favored Glycine 0 C--N 1.355 1.587 0 O-C-N 124.366 1.041 . . . . 41.12 114.426 172.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 75.1 p -63.17 -39.86 95.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.699 0.8 . . . . 73.31 111.257 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -73.76 -27.11 60.99 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.578 -0.737 . . . . 71.12 111.623 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.5 ' HG3' ' O ' ' H' ' 451' ' ' VAL . 18.3 tmm? -70.93 -44.72 65.54 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 109.516 -0.549 . . . . 70.5 109.516 172.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.04 -25.04 66.63 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.519 0.728 . . . . 44.24 111.462 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.2 t-160 -78.67 -38.51 39.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.785 0.834 . . . . 71.1 110.713 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -73.69 -27.29 61.14 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.258 0.623 . . . . 63.43 111.506 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.54 HD23 HD13 ' D' ' 86' ' ' ILE . 2.3 tm? -100.1 -54.01 2.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.311 1.044 . . . . 72.31 109.819 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.9 14.42 58.72 Favored Glycine 0 N--CA 1.472 1.065 0 CA-C-O 119.557 -0.579 . . . . 52.2 114.433 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.508 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -149.74 -55.44 0.17 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.574 0.687 . . . . 75.41 112.016 -178.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -72.6 -37.85 68.0 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 112.233 0.457 . . . . 74.13 112.233 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.545 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 96.6 m -61.94 -46.93 92.28 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 118.687 -0.673 . . . . 64.54 112.392 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.419 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 82.4 Cg_exo -52.06 -35.29 61.13 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.285 1.99 . . . . 74.41 114.325 167.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -68.67 -25.34 64.76 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 122.909 0.484 . . . . 60.43 112.079 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.474 HD12 HD11 ' D' ' 13' ' ' ILE . 23.8 mm -73.01 -40.05 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.706 0.765 . . . . 70.41 109.813 171.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.474 HD21 ' HA3' ' D' ' 82' ' ' GLY . 91.8 mt -77.27 -26.8 52.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.776 -1.102 . . . . 64.53 112.839 -173.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -62.83 -43.5 83.08 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 113.725 1.009 . . . . 72.33 113.725 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.42 -45.87 34.86 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.051 1.834 . . . . 74.31 113.949 171.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -72.26 -37.15 69.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.584 0.754 . . . . 73.0 111.342 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.41 90.2 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.906 0.882 . . . . 72.42 110.43 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.476 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 29.4 ttp180 -55.22 -52.71 62.48 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 114.523 -1.217 . . . . 75.22 110.181 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -60.16 -43.41 95.79 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.295 0.997 . . . . 73.34 111.629 -174.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.2 t -59.41 -43.97 92.93 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.512 0.508 . . . . 73.31 110.771 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.473 HG23 ' SG ' ' D' ' 76' ' ' CYS . 80.6 mt -64.8 -49.68 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.918 0.887 . . . . 74.22 110.987 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 23.2 m -56.31 -40.82 74.99 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.414 1.086 . . . . 61.15 111.192 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 14.4 t -66.59 -44.24 82.71 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 114.447 -1.251 . . . . 64.32 110.045 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.505 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.1 mtm -67.87 -32.01 72.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.904 0.482 . . . . 73.43 111.82 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' D' ' 114' ' ' ILE . 61.9 t -67.65 -42.7 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.681 0.793 . . . . 72.44 110.216 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.2 p -74.87 -29.95 61.17 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.829 0.451 . . . . 75.13 111.181 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -72.3 -36.73 69.02 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.622 0.769 . . . . 52.25 109.893 174.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.96 2.7 79.65 Favored Glycine 0 C--N 1.356 1.657 0 O-C-N 123.696 0.622 . . . . 74.24 112.427 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.3 p 62.28 23.26 13.75 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.819 2.048 . . . . 73.22 113.964 171.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.54 155.85 65.62 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 109.029 -0.73 . . . . 70.35 109.029 167.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.413 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 27.8 Cg_endo -60.79 142.24 97.15 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 122.39 2.06 . . . . 64.1 111.405 176.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -51.6 147.67 6.14 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.256 1.422 . . . . 72.2 113.669 -167.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.584 ' HA ' HD11 ' H' ' 468' ' ' LEU . 23.2 tp -122.61 98.82 6.09 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.003 0.521 . . . . 74.11 110.477 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -101.73 92.18 4.73 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.696 0.798 . . . . 71.24 109.849 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.476 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -64.38 118.52 8.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.453 0.701 . . . . 61.42 110.397 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -60.57 132.9 91.26 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 123.466 0.707 . . . . 70.11 111.021 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 4.7 Cg_exo -73.09 117.59 5.18 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.795 2.33 . . . . 71.43 111.287 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.61 145.36 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.016 0.526 . . . . 71.22 110.926 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -89.27 97.9 11.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.019 0.928 . . . . 51.05 109.946 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.504 ' HA ' HD12 ' D' ' 136' ' ' LEU . 7.5 t80 -76.19 -16.97 59.74 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.263 0.625 . . . . 65.32 111.183 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.508 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 13.1 m-20 -62.65 -49.23 75.96 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.325 0.65 . . . . 74.11 110.924 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.92 -45.87 89.29 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.643 0.59 . . . . 72.02 110.597 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' D' ' 133' ' ' PHE . 82.4 mt -58.56 -42.18 87.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.629 -1.169 . . . . 74.54 111.925 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -67.69 -43.76 79.38 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.649 0.78 . . . . 71.13 110.973 -178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 73.7 mtm -65.94 -27.83 68.46 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.591 0.356 . . . . 73.25 110.76 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -74.22 -34.12 63.59 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.044 -0.525 . . . . 73.12 110.779 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -66.13 -36.85 84.22 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.105 0.562 . . . . 74.52 111.095 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.6 mp -70.31 -30.4 67.38 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.065 0.546 . . . . 54.11 111.765 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.417 ' NE2' ' HA2' ' D' ' 148' ' ' GLY . 13.3 pt20 -91.3 10.06 28.87 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.753 0.421 . . . . 75.33 112.07 174.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -120.2 89.87 3.21 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.964 0.888 . . . . 74.14 110.069 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -144.86 -62.79 0.36 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 106.238 -1.764 . . . . 63.42 106.238 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.9 -14.61 25.85 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.242 1.017 . . . . 54.02 110.913 171.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.15 97.86 1.46 Allowed Glycine 0 C--N 1.352 1.435 0 O-C-N 123.532 0.52 . . . . 50.32 111.837 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.32 -179.82 5.87 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.08 0.952 . . . . 43.44 110.651 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 148' ' ' GLY . . . . . 0.417 ' HA2' ' NE2' ' D' ' 142' ' ' GLN . . . -146.5 124.76 2.07 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-O 119.879 -0.4 . . . . 61.22 112.341 -176.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 12.9 t -70.56 -20.15 62.81 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.591 0.756 . . . . 71.13 111.864 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 66.36 101.42 0.04 OUTLIER 'General case' 0 C--N 1.358 0.969 0 C-N-CA 125.425 1.49 . . . . 73.33 111.449 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.13 87.46 1.08 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.947 -0.76 . . . . 74.45 108.947 171.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -150.89 155.63 39.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 108.498 -0.927 . . . . 70.35 108.498 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 72.28 142.01 0.06 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.081 1.352 . . . . 75.53 110.159 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -69.98 81.33 0.48 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.509 -0.552 . . . . 71.11 109.509 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.864 0 C-N-CA 124.139 0.975 . . . . 65.53 109.741 -176.249 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.257 -0.275 . . . . 73.42 110.257 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 451' ' ' VAL . . . . . 0.469 HG21 ' HA ' ' A' ' 87' ' ' ALA . 7.9 p -176.92 -22.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 124.909 1.284 . . . . 71.51 109.573 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 452' ' ' VAL . . . . . 0.625 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 12.5 p -147.05 147.48 17.6 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 123.818 0.847 . . . . 62.0 109.951 -171.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 175.81 145.86 5.67 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.052 -0.522 . . . . 64.35 112.616 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 454' ' ' LEU . . . . . 0.484 ' HB3' HD11 ' A' ' 98' ' ' LEU . 9.6 tt -162.01 108.43 1.31 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 106.414 -1.698 . . . . 64.43 106.414 173.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 4.8 m -104.97 -10.41 17.26 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.603 0.761 . . . . 63.53 110.16 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -94.45 62.04 2.82 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.114 0.966 . . . . 74.12 110.244 -177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -86.84 -163.33 0.89 Allowed 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 115.33 -0.85 . . . . 61.15 110.644 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 11.3 m 69.23 52.0 0.49 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.765 1.226 . . . . 75.21 111.109 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -161.65 134.47 6.1 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.95 -1.477 . . . . 74.53 107.946 171.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 460' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -113.56 107.53 15.92 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 106.397 -1.705 . . . . 62.4 106.397 169.548 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -81.49 44.43 0.8 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.685 1.194 . . . . 73.44 111.912 -175.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 462' ' ' TYR . . . . . 0.483 ' HE2' ' SD ' ' E' ' 464' ' ' MET . 29.5 t80 -162.98 128.79 3.26 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.996 0.918 . . . . 74.04 109.205 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 1.7 t -80.45 110.42 15.9 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.255 -1.017 . . . . 74.13 108.255 171.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 464' ' ' MET . . . . . 0.496 ' HG3' ' HA ' ' E' ' 467' ' ' ALA . 12.8 tpt -65.87 87.23 0.09 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 121.986 0.898 . . . . 70.12 110.812 -173.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -77.79 -43.74 29.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.046 -1.434 . . . . 64.52 110.813 -174.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 466' ' ' ALA . . . . . 0.657 ' HB1' ' HB3' ' A' ' 129' ' ' ALA . . . -61.52 -43.25 99.2 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.124 -0.944 . . . . 42.23 110.226 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 467' ' ' ALA . . . . . 0.496 ' HA ' ' HG3' ' E' ' 464' ' ' MET . . . 49.76 -103.03 0.11 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.572 1.549 . . . . 54.41 113.303 177.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 468' ' ' LEU . . . . . 0.599 ' HB3' HD11 ' A' ' 126' ' ' LEU . 95.3 mt -134.69 119.97 18.93 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.596 0.758 . . . . 73.54 109.439 -166.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -83.52 92.26 1.66 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 111.45 -0.66 . . . . 52.5 111.45 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 6.4 tt -138.48 -59.77 0.62 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.557 -0.905 . . . . 71.2 108.557 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 471' ' ' LYS . . . . . 0.485 ' HE3' HG22 ' A' ' 40' ' ' VAL . 7.8 mtmp? . . . . . 0 C--O 1.256 1.404 0 C-N-CA 123.789 0.836 . . . . 73.21 110.022 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.657 -0.127 . . . . 74.43 110.657 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.75 -29.64 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 122.983 0.513 . . . . 75.12 111.334 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 452' ' ' VAL . . . . . 0.571 HG12 HD11 ' B' ' 86' ' ' ILE . 34.1 m -74.91 174.66 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.207 1.003 . . . . 74.11 113.425 -173.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 176.05 -94.67 0.1 OUTLIER Glycine 0 C--N 1.35 1.344 0 CA-C-O 119.368 -0.684 . . . . 75.51 111.713 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 64.89 98.44 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 124.976 1.31 . . . . 72.03 112.029 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 23.8 m -116.24 90.73 3.4 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.363 -0.606 . . . . 64.41 109.363 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -102.07 159.31 15.49 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.823 0.849 . . . . 70.22 110.572 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -167.96 150.59 5.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.504 1.122 . . . . 74.01 108.635 176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 18.7 m 74.56 161.89 0.25 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.633 1.173 . . . . 53.42 110.385 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -56.52 137.2 53.8 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.482 0.713 . . . . 71.32 110.395 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 74.3 mt -74.65 165.75 24.7 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.057 0.543 . . . . 74.1 111.662 -175.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -52.18 138.72 25.29 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.262 -1.335 . . . . 65.2 111.272 171.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.9 -56.19 0.77 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 109.106 -0.702 . . . . 73.32 109.106 175.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 14.7 m 73.18 -40.96 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.272 1.429 . . . . 75.21 113.617 172.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 464' ' ' MET . . . . . 0.418 ' SD ' ' O ' ' F' ' 464' ' ' MET . 3.0 ppp? -74.79 82.47 2.12 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 122.333 1.064 . . . . 61.45 111.366 -174.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.14 -23.05 62.0 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.8 -1.091 . . . . 74.11 109.109 171.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -78.03 83.1 4.34 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.277 -1.009 . . . . 73.44 108.277 165.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -86.81 -146.0 0.12 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.411 1.084 . . . . 71.31 110.255 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 6.3 tt -53.16 -43.42 67.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.758 0.823 . . . . 60.52 109.824 174.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 99.62 -21.11 46.7 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 115.825 -0.625 . . . . 74.43 112.74 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 61.73 -84.96 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.021 1.328 . . . . 72.44 110.715 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.16 0 N-CA-C 108.36 -0.978 . . . . 65.12 108.36 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 450' ' ' ASN . . . . . 0.479 ' HA ' ' HB3' ' C' ' 53' ' ' ASP . 16.2 p-10 . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 118.722 -0.656 . . . . 62.31 110.268 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 451' ' ' VAL . . . . . 0.657 HG21 ' HA ' ' C' ' 87' ' ' ALA . 62.2 t 26.18 75.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 126.622 1.969 . . . . 73.13 114.455 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 452' ' ' VAL . . . . . 0.409 HG13 ' O ' ' G' ' 450' ' ' ASN . 17.2 m -137.15 153.45 29.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 113.871 -1.513 . . . . 73.22 109.053 176.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 169.96 -49.07 0.2 Allowed Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.918 -0.473 . . . . 51.54 111.918 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 454' ' ' LEU . . . . . 0.553 HD22 ' HA ' ' C' ' 95' ' ' ALA . 49.6 tp -68.94 105.61 2.44 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 122.769 0.428 . . . . 73.35 109.942 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 2.9 m -126.5 28.57 5.92 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.46 1.104 . . . . 74.22 109.52 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.81 141.71 50.8 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.934 0.894 . . . . 73.13 108.825 173.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -85.35 -36.95 20.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.001 0.921 . . . . 40.23 109.895 -177.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 32.6 m 68.19 0.04 2.31 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.87 1.268 . . . . 74.41 111.248 -171.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 55.09 -85.4 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.921 1.288 . . . . 71.13 109.273 -164.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 56.7 tp -177.31 130.64 0.16 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.535 -1.654 . . . . 71.21 106.535 165.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -87.66 29.82 0.87 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.077 0.951 . . . . 65.51 111.008 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -144.13 104.44 4.12 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.877 -0.786 . . . . 74.5 108.877 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 53.3 p -63.39 -38.27 90.51 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 124.255 0.972 . . . . 74.32 110.189 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 464' ' ' MET . . . . . 0.433 ' SD ' ' HB2' ' G' ' 466' ' ' ALA . 0.3 OUTLIER 78.97 -43.14 0.32 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.59 1.956 . . . . 64.24 111.091 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 58.6 tttp 76.09 -70.26 0.15 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.964 1.706 . . . . 74.23 110.331 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 466' ' ' ALA . . . . . 0.433 ' HB2' ' SD ' ' G' ' 464' ' ' MET . . . 63.83 146.86 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.543 1.537 . . . . 74.2 112.704 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -159.74 89.9 0.9 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.516 -1.661 . . . . 71.32 106.516 170.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.67 147.86 47.06 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.582 -0.525 . . . . 74.41 109.582 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -80.64 61.11 4.53 Favored Glycine 0 C--N 1.346 1.086 0 O-C-N 123.536 0.523 . . . . 62.52 112.289 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 470' ' ' LEU . . . . . 0.442 HD11 ' HG ' ' C' ' 126' ' ' LEU . 60.2 mt -92.96 54.31 2.15 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.174 0.99 . . . . 74.14 108.776 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? . . . . . 0 C--O 1.249 1.04 0 N-CA-C 107.941 -1.133 . . . . 64.24 107.941 -169.33 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 . . . . . 0 N--CA 1.486 1.325 0 N-CA-C 108.856 -0.794 . . . . 73.54 108.856 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' H' H ' 451' ' ' VAL . . . . . 0.66 HG13 HG13 ' H' ' 452' ' ' VAL . 9.7 p -77.51 -41.76 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 122.311 0.244 . . . . 72.31 111.136 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 452' ' ' VAL . . . . . 0.66 HG13 HG13 ' H' ' 451' ' ' VAL . 25.1 m -94.5 -177.03 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 122.818 0.447 . . . . 70.42 111.988 -174.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 101.46 79.94 1.45 Allowed Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.661 -0.699 . . . . 72.25 112.623 169.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 1.4 pp -148.22 172.56 14.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.699 0.762 . . . . 74.3 111.845 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 19.8 p -139.51 143.21 37.35 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.376 1.87 . . . . 73.53 106.443 168.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.5 -57.98 10.42 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.176 0.591 . . . . 60.11 109.873 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 59.01 19.95 7.74 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.856 1.262 . . . . 73.52 112.653 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 15.2 t -144.92 158.1 43.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.973 0.509 . . . . 70.03 110.427 -175.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -111.66 -70.32 0.82 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.793 0.837 . . . . 72.35 109.253 -175.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 460' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' D' ' 44' ' ' LEU . 42.7 tp -161.92 146.47 12.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.39 1.076 . . . . 71.54 108.904 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -142.13 43.59 1.67 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.497 1.119 . . . . 75.22 109.29 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 462' ' ' TYR . . . . . 0.487 ' HB3' HD11 ' H' ' 460' ' ' LEU . 54.2 t80 -150.88 145.67 25.8 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.946 -1.024 . . . . 75.12 110.2 -175.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 90.5 m -140.9 139.48 34.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.198 0.999 . . . . 53.14 109.465 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 60.0 ttp -154.92 -46.32 0.08 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.63 0.772 . . . . 75.52 109.705 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 465' ' ' LYS . . . . . 0.615 ' HG2' ' H ' ' H' ' 466' ' ' ALA . 14.9 ttpt 68.98 -174.05 0.19 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.95 1.3 . . . . 71.5 108.568 -171.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 466' ' ' ALA . . . . . 0.615 ' H ' ' HG2' ' H' ' 465' ' ' LYS . . . 71.02 -170.77 0.16 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.819 0.848 . . . . 70.53 112.333 168.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 467' ' ' ALA . . . . . 0.406 ' HB3' HD12 ' H' ' 468' ' ' LEU . . . -167.15 -67.17 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.66 0.784 . . . . 74.31 109.743 177.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 468' ' ' LEU . . . . . 0.584 HD11 ' HA ' ' D' ' 126' ' ' LEU . 2.9 mp -88.3 -45.05 10.36 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.812 -0.631 . . . . 52.21 109.874 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.65 -23.46 0.64 Allowed Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.242 -0.89 . . . . 33.23 112.292 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 470' ' ' LEU . . . . . 0.464 HD13 ' HG3' ' D' ' 37' ' ' GLN . 3.1 mm? 63.15 63.71 0.9 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.348 1.059 . . . . 72.52 109.657 176.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp . . . . . 0 C--O 1.253 1.267 0 CA-C-N 114.9 -1.046 . . . . 65.41 109.153 -174.7 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 121.12 0.486 . . . . 73.32 109.809 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -147.88 144.96 28.46 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.879 1.271 . . . . 74.32 108.063 175.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.611 ' HG2' ' H ' ' A' ' 4' ' ' GLN . 33.6 tt0 65.88 -171.3 0.19 Allowed 'General case' 0 CA--C 1.567 1.602 0 O-C-N 124.242 0.964 . . . . 74.24 109.231 -176.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.611 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 24.3 tt0 -59.15 93.1 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.946 0.899 . . . . 61.03 110.014 170.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.02 -51.39 2.12 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.158 0.983 . . . . 64.25 108.921 -175.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -78.8 85.15 4.82 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.19 -0.67 . . . . 32.42 109.19 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.9 m -143.96 106.39 4.41 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.707 -1.22 . . . . 70.42 107.707 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -63.78 88.94 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 O-C-N 123.828 0.705 . . . . 62.43 109.859 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 mpt? 65.16 154.97 0.07 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.016 1.327 . . . . 73.3 111.824 -176.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.4 m -145.61 123.43 11.94 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.13 -1.063 . . . . 62.43 108.13 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.633 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.6 t80 -138.48 129.88 27.45 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.826 0.346 . . . . 71.4 110.472 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -153.23 108.64 3.24 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 107.811 -1.181 . . . . 75.24 107.811 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.427 HG12 ' HD2' ' A' ' 84' ' ' PHE . 52.8 mt -74.51 116.32 16.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.815 -0.439 . . . . 74.43 109.815 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -74.13 -42.11 60.52 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.072 0.858 . . . . 74.23 110.781 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -178.31 121.39 0.1 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.162 0.289 . . . . 70.34 110.734 -169.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 82.4 mt -106.96 129.56 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.717 0.807 . . . . 75.32 108.878 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.423 ' HB3' HG23 ' B' ' 122' ' ' THR . 34.0 p90 -163.06 148.39 11.7 Favored 'General case' 0 C--N 1.346 0.418 0 O-C-N 123.646 0.591 . . . . 74.21 111.653 -174.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.1 p -75.02 112.39 11.2 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.863 -0.608 . . . . 60.35 109.406 175.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 35.7 mtpt -80.79 -23.78 39.03 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.421 -0.354 . . . . 71.52 110.192 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.2 t70 -153.24 142.08 21.11 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.964 0.906 . . . . 75.51 110.393 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.6 mt -135.03 141.73 42.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 125.64 1.576 . . . . 72.12 107.574 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.7 t -145.72 112.42 5.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.141 0.576 . . . . 65.01 110.026 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 87.5 t80 -125.83 119.92 29.15 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.3 -1.0 . . . . 72.54 108.3 174.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -118.42 136.2 53.91 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.927 -0.768 . . . . 61.31 108.927 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.726 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -148.67 78.78 8.97 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 107.813 -1.18 . . . . 74.31 107.813 170.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.35 -29.93 5.76 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.698 2.265 . . . . 75.43 111.253 175.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -102.7 23.55 11.88 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.943 1.297 . . . . 73.55 109.909 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.726 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -58.82 -45.06 99.64 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 125.26 1.424 . . . . 75.01 112.327 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -64.81 -34.11 50.82 Favored 'Trans proline' 0 C--N 1.399 3.217 0 CA-C-N 120.995 1.391 . . . . 70.42 112.713 172.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.422 ' HA ' ' OE1' ' A' ' 33' ' ' GLN . 30.4 m170 -68.76 -16.23 63.74 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.527 0.731 . . . . 75.2 112.616 -171.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 28' ' ' ALA . 9.3 p -72.73 -19.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 122.438 0.295 . . . . 73.22 110.665 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -78.5 -29.03 46.41 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 108.412 -0.959 . . . . 53.12 108.412 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.422 ' OE1' ' HA ' ' A' ' 30' ' ' HIS . 1.0 OUTLIER -80.95 -54.78 5.27 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.931 -1.031 . . . . 63.31 110.737 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 30' ' ' HIS . 54.5 mtmt -84.78 171.43 12.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.093 0.957 . . . . 62.24 112.577 -173.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.29 153.2 21.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.848 0.859 . . . . 64.44 109.819 172.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.642 ' HE1' ' HB3' ' E' ' 470' ' ' LEU . 66.3 t-105 -85.2 94.05 8.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.42 0.688 . . . . 62.24 110.756 -173.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -127.37 83.56 65.71 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.175 0.99 . . . . 74.21 108.868 172.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -86.54 149.75 8.84 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.61 2.207 . . . . 73.23 112.72 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -99.09 91.66 5.11 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.613 -1.254 . . . . 54.4 107.613 168.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -66.34 99.06 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 CA-C-O 121.701 0.762 . . . . 65.1 110.388 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -108.16 113.35 26.42 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.531 -0.914 . . . . 54.25 108.531 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -107.06 145.23 32.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.54 0.736 . . . . 63.44 109.059 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -139.42 133.21 30.69 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.498 1.119 . . . . 54.53 108.484 174.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -119.48 123.15 43.32 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 109.059 -0.719 . . . . 73.13 109.059 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 24.3 m-20 -119.81 121.7 39.71 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.764 -0.828 . . . . 60.44 108.764 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.59 ' HB ' HD21 ' E' ' 460' ' ' LEU . 31.4 m -106.95 122.87 47.28 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.767 -0.827 . . . . 74.43 108.767 175.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.68 151.33 49.15 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.945 0.898 . . . . 41.24 108.66 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.5 m -132.8 155.87 48.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.178 -0.675 . . . . 75.23 109.178 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -148.03 128.96 14.41 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.78 0.432 . . . . 74.3 110.378 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -73.7 107.7 6.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.91 0.884 . . . . 72.42 109.839 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.1 mt -78.37 -41.26 33.88 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.751 -0.659 . . . . 70.12 109.512 175.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.65 -179.18 7.86 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.647 1.179 . . . . 53.23 108.752 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -61.98 113.26 2.71 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.672 0.389 . . . . 70.3 110.243 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 68.39 12.23 8.65 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.89 1.276 . . . . 64.12 112.28 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.48 110.7 33.16 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 N-CA-C 107.485 -1.302 . . . . 72.22 107.485 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -126.24 152.88 45.51 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.812 -0.81 . . . . 75.01 108.812 -174.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -117.84 153.58 33.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.658 -0.867 . . . . 73.42 108.658 167.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.5 t -117.98 125.24 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.24 -1.392 . . . . 75.05 107.24 167.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.86 107.61 22.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 124.099 0.96 . . . . 61.23 108.681 174.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.7 tp -99.78 101.85 13.13 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.871 -0.788 . . . . 74.03 108.871 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 14.4 ttm180 -84.42 102.75 13.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.187 -0.672 . . . . 64.32 109.187 175.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.8 t -95.32 102.33 13.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.279 -1.008 . . . . 74.15 108.279 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.4 m -98.25 119.46 36.95 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.047 0.939 . . . . 72.03 110.322 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.535 ' O ' HD12 ' A' ' 75' ' ' LEU . 97.9 t -115.51 123.84 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.926 0.89 . . . . 62.12 108.874 175.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 t -132.2 126.63 34.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.516 -0.92 . . . . 52.12 108.516 169.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -124.13 107.13 10.93 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.633 -0.877 . . . . 71.05 108.633 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.6 p -113.85 143.02 45.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.653 0.781 . . . . 40.12 111.021 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 68' ' ' LEU . 1.3 pt? -110.61 85.87 2.2 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.103 -1.073 . . . . 62.32 108.103 171.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.89 -125.57 8.03 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 114.66 -1.155 . . . . 71.54 110.932 -173.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -87.72 -26.87 22.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.593 0.697 . . . . 63.02 109.621 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -76.23 118.97 19.5 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 123.006 0.522 . . . . 53.23 110.779 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.7 m -77.19 132.42 38.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.192 -0.67 . . . . 63.24 109.192 171.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.03 -57.08 3.99 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.616 -0.883 . . . . 61.03 108.616 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.406 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 47.8 p90 -149.39 152.59 36.02 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.88 -1.055 . . . . 73.41 111.223 175.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.535 HD12 ' O ' ' A' ' 64' ' ' VAL . 40.9 tp -114.3 135.19 54.35 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.147 -1.427 . . . . 63.51 107.147 166.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.406 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 76.1 m -135.96 98.1 3.8 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.481 -0.933 . . . . 72.23 108.481 170.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -125.11 116.04 21.43 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.717 1.207 . . . . 75.43 108.379 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.4 t -128.73 115.69 38.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.765 0.826 . . . . 61.02 109.466 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 72.0 mt-30 -85.51 84.98 7.46 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 107.973 -1.121 . . . . 75.13 107.973 170.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.456 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.4 tp-100 -76.47 99.58 4.96 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.715 -1.13 . . . . 71.32 108.186 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.86 155.79 29.37 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 110.683 -0.967 . . . . 73.22 110.683 176.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.34 120.63 0.98 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.351 -1.1 . . . . 35.41 110.351 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.9 mt -81.5 122.22 36.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.109 -1.071 . . . . 71.04 108.109 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.633 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 43.8 m-85 -123.46 118.15 26.78 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.834 -1.173 . . . . 74.22 107.834 -176.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.0 t -84.69 104.0 14.28 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.52 -1.289 . . . . 64.23 107.52 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.85 139.97 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 116.118 -0.492 . . . . 63.41 110.874 -170.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.736 ' HA ' HG21 ' E' ' 451' ' ' VAL . . . -156.82 176.05 13.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.357 1.063 . . . . 52.13 110.239 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.02 -7.11 62.41 Favored Glycine 0 N--CA 1.475 1.235 0 N-CA-C 114.961 0.744 . . . . 71.23 114.961 172.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.574 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -138.75 158.21 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 117.885 0.843 . . . . 73.42 110.859 -177.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.37 174.48 14.8 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.965 0.506 . . . . 75.25 109.989 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.34 -127.52 26.72 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 114.528 0.571 . . . . 72.04 114.528 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.565 HG23 ' HB2' ' C' ' 153' ' ' GLN . 16.5 p -68.78 -20.89 64.36 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.196 0.598 . . . . 72.03 111.234 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -75.9 -42.99 47.41 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.659 0.784 . . . . 71.35 109.893 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' E' ' 452' ' ' VAL . 25.6 ptt? -72.97 -27.94 62.11 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 110.038 -0.356 . . . . 72.53 110.038 175.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.12 -27.71 65.81 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 115.803 -0.635 . . . . 72.02 110.269 173.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -78.31 -30.14 48.12 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.218 0.607 . . . . 74.03 111.125 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.574 ' SG ' HG13 ' A' ' 89' ' ' ILE . 70.9 m -61.86 -46.59 88.8 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.875 -0.602 . . . . 62.52 111.09 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -81.26 -24.57 37.23 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.096 -0.502 . . . . 73.0 110.605 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.24 -33.21 49.84 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 114.772 0.669 . . . . 75.35 114.772 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.53 -45.75 0.17 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.379 0.589 . . . . 71.03 112.091 -169.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 55.1 t80 -62.54 -64.47 0.91 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.512 1.125 . . . . 72.45 112.035 -168.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 92.7 m -78.6 -33.61 0.93 Allowed Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.428 1.27 . . . . 73.53 114.428 -174.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 35.4 Cg_endo -64.18 -30.77 64.91 Favored 'Trans proline' 0 C--N 1.394 2.959 0 CA-C-N 122.23 1.832 . . . . 73.11 112.841 171.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -69.29 -26.57 64.81 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.677 0.391 . . . . 71.42 110.882 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.61 -40.9 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 64.12 110.125 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.456 HD22 ' HG3' ' A' ' 80' ' ' GLN . 79.7 mt -80.6 -21.82 41.22 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.067 0.947 . . . . 71.15 112.613 -174.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -63.57 -44.27 80.58 Favored Pre-proline 0 CA--C 1.567 1.605 0 CA-C-O 117.64 -1.171 . . . . 74.54 113.229 -172.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.4 -34.48 76.55 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.112 1.874 . . . . 62.22 113.474 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -72.97 -41.25 64.58 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.211 0.605 . . . . 74.44 111.329 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.45 -38.2 74.47 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.994 0.518 . . . . 71.35 110.182 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.559 ' HA ' HD23 ' A' ' 128' ' ' LEU . 29.7 ttm180 -54.44 -51.15 65.86 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.203 1.001 . . . . 72.43 109.888 174.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.63 -48.39 77.49 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.485 1.116 . . . . 75.25 111.361 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.413 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.1 t -55.91 -44.58 78.41 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.047 0.842 . . . . 34.45 110.538 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 118' ' ' VAL . 74.5 mt -65.22 -50.5 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.526 1.13 . . . . 71.24 110.747 176.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.492 HG23 ' HG3' ' A' ' 125' ' ' GLN . 95.0 m -53.17 -46.07 68.77 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.835 0.854 . . . . 75.22 110.322 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -65.13 -46.23 81.84 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.922 -1.49 . . . . 65.1 109.527 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 37.5 mtp -59.43 -41.18 88.96 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.696 0.798 . . . . 64.54 111.865 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 114' ' ' ILE . 93.4 t -62.94 -45.61 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.912 0.885 . . . . 50.45 110.236 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.3 m -72.58 -27.45 62.19 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.447 -0.797 . . . . 32.31 111.831 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.605 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.9 mtt-85 -75.12 -31.72 61.18 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.492 0.717 . . . . 73.12 109.723 175.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.13 -0.7 86.62 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.58 -0.736 . . . . 64.11 112.878 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m 69.53 20.12 7.24 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.763 1.225 . . . . 54.34 111.047 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -89.67 146.87 36.44 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 123.45 0.7 . . . . 75.11 109.657 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.64 133.09 31.98 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.52 2.813 . . . . 71.24 113.517 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.492 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.6 tt0 -54.93 137.44 45.71 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.238 1.015 . . . . 63.22 113.24 -170.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.439 ' CD2' HG11 ' A' ' 64' ' ' VAL . 27.7 tp -119.82 102.4 8.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.859 1.264 . . . . 64.13 109.349 177.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -99.34 114.65 27.64 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.213 -1.403 . . . . 64.04 107.213 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 111' ' ' ARG . 3.7 mm? -62.53 132.9 54.0 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.099 0.559 . . . . 64.11 110.476 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.8 146.01 91.47 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.213 0.605 . . . . 62.54 110.776 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.562 ' HG3' ' HD2' ' C' ' 11' ' ' PHE . 34.2 Cg_endo -60.74 112.16 1.26 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.382 2.054 . . . . 64.13 111.323 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 80.6 t -99.92 113.91 36.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 108.473 -0.936 . . . . 50.31 108.473 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -78.79 85.95 4.75 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 108.767 -0.827 . . . . 74.42 108.767 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -64.02 -27.82 69.38 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.649 -0.705 . . . . 74.01 111.144 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.07 -48.45 76.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.801 0.84 . . . . 62.43 110.224 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.43 -57.01 12.8 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.003 -0.999 . . . . 65.33 110.463 175.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.2 mt -58.05 -36.73 73.19 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.562 1.145 . . . . 74.13 112.812 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.579 ' CE1' HD22 ' A' ' 141' ' ' LEU . 42.6 t80 -61.62 -50.81 71.08 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.772 0.67 . . . . 61.3 110.381 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 95.2 mmm -68.33 -26.39 65.58 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.909 -0.587 . . . . 62.2 110.612 -174.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.61 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 55.3 m-80 -63.07 -42.7 99.71 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.288 0.635 . . . . 62.34 110.659 170.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.626 ' HB2' ' HB3' ' E' ' 461' ' ' PHE . 0.1 OUTLIER -61.32 -46.23 91.13 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.147 0.979 . . . . 75.44 110.524 174.194 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 137' ' ' PHE . 19.9 tp -70.21 -50.25 41.88 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.37 -1.286 . . . . 75.34 112.926 -165.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.23 9.94 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.383 0.427 . . . . 63.11 110.162 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.61 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 75.5 mt-30 58.85 -171.83 0.11 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.312 1.045 . . . . 74.23 112.432 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.8 -174.03 4.66 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.594 1.158 . . . . 70.42 108.883 171.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.37 -59.95 0.09 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.321 0.648 . . . . 71.32 109.559 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.26 125.63 0.79 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 111.341 -0.703 . . . . 73.32 111.341 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -113.58 -29.44 7.16 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.081 0.953 . . . . 73.34 110.784 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.25 -104.14 3.12 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-O 119.058 -0.857 . . . . 41.0 112.012 -176.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.5 m 70.18 128.88 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.068 1.347 . . . . 64.13 109.735 -169.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -58.52 5.98 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 109.345 -0.613 . . . . 73.54 109.345 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.14 110.71 21.99 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.467 -0.938 . . . . 65.41 108.467 -177.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -164.92 172.11 13.23 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.482 1.113 . . . . 73.34 109.309 -176.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -81.28 -42.43 20.65 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.066 0.546 . . . . 71.13 110.666 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -73.93 170.88 14.49 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.937 0.895 . . . . 60.12 111.387 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.059 0 C-N-CA 123.581 0.752 . . . . 51.45 111.47 -173.477 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 95.0 mmm . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.267 -0.272 . . . . 70.21 110.267 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 44.3 p -75.5 78.68 2.53 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.54 -0.911 . . . . 60.13 108.54 170.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -166.34 140.78 4.33 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.692 -1.14 . . . . 75.41 109.465 -166.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -146.92 163.73 35.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.686 0.794 . . . . 63.4 109.094 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -115.31 171.85 7.44 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.348 0.659 . . . . 74.15 110.482 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -129.25 136.17 49.74 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.158 -1.053 . . . . 63.33 108.158 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -154.7 170.72 20.9 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.231 0.612 . . . . 73.5 110.294 -172.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.45 137.32 54.38 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.948 -0.76 . . . . 73.2 108.948 167.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.68 ' HE3' HD12 ' B' ' 89' ' ' ILE . 21.3 ptm 48.86 -174.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 126.823 2.049 . . . . 70.52 114.364 -177.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 66.2 m -136.81 114.33 11.01 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.932 -0.766 . . . . 74.24 108.932 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -136.11 137.35 40.94 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.712 -0.847 . . . . 64.34 108.712 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -148.5 140.8 24.16 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.562 0.745 . . . . 72.44 109.258 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.5 mt -90.32 113.55 26.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.434 -1.321 . . . . 73.24 107.434 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -76.22 -43.57 41.63 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.446 -0.576 . . . . 64.23 109.446 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -164.78 139.63 5.36 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.719 -0.673 . . . . 73.42 110.071 -175.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 88.2 mt -115.7 144.12 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 106.212 -1.773 . . . . 70.34 106.212 168.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.522 ' HE1' HG13 ' B' ' 83' ' ' ILE . 32.5 p90 -170.08 149.36 3.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.449 0.642 . . . . 75.11 111.648 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -77.81 125.71 29.76 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.872 -1.058 . . . . 64.52 109.347 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.451 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.3 mtpt -99.4 -21.51 15.96 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.872 0.869 . . . . 72.52 111.57 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -160.78 133.41 6.25 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.495 0.318 . . . . 64.0 110.441 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 40.8 mm -126.33 137.91 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.273 -1.01 . . . . 73.3 108.273 168.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 37.2 t -139.48 134.21 31.98 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.746 -1.205 . . . . 72.11 107.746 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -150.32 109.48 3.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.895 -1.15 . . . . 63.14 107.895 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -119.71 115.0 23.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.278 1.031 . . . . 74.02 108.895 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.45 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -109.39 86.64 4.44 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 108.486 -0.931 . . . . 60.15 108.486 172.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.41 -32.45 8.02 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.742 2.295 . . . . 73.15 113.011 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -104.2 14.68 29.93 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.713 0.805 . . . . 50.34 110.403 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.49 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -38.39 -60.79 0.97 Allowed Pre-proline 0 CA--C 1.562 1.437 0 N-CA-C 114.758 1.392 . . . . 62.23 114.758 -165.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 20.4 Cg_exo -63.24 -35.28 64.2 Favored 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 122.101 1.867 . . . . 74.15 112.504 -175.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -78.84 -47.01 17.43 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.168 -0.923 . . . . 71.21 111.593 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.673 HG22 HD12 ' B' ' 68' ' ' LEU . 9.1 p -62.4 -22.4 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.583 0.753 . . . . 72.44 112.332 -167.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -63.34 -13.95 44.64 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.988 0.915 . . . . 73.12 112.993 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.542 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 25.6 pt20 -60.36 -33.14 72.01 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.422 1.089 . . . . 72.42 111.585 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.542 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.3 mttt -96.18 86.18 4.18 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.585 0.754 . . . . 74.0 108.993 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -74.22 97.36 2.95 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 115.806 -0.634 . . . . 71.12 110.902 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -163.43 157.3 19.69 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.32 1.448 . . . . 74.25 108.179 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.462 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 48.5 mt-30 -72.85 108.74 4.85 Favored Pre-proline 0 C--N 1.356 0.861 0 N-CA-C 107.827 -1.175 . . . . 74.04 107.827 169.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.412 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.0 Cg_endo -60.18 147.06 94.85 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.796 2.331 . . . . 64.44 113.702 -167.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 11.3 tp10 -53.31 109.33 0.42 Allowed 'General case' 0 N--CA 1.484 1.246 0 O-C-N 124.349 1.031 . . . . 75.14 110.42 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.569 HG12 HD21 ' F' ' 470' ' ' LEU . 14.9 p -88.87 131.03 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 O-C-N 123.7 0.625 . . . . 73.12 110.625 -172.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -121.23 121.75 38.45 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.597 -1.26 . . . . 63.41 107.597 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -106.05 124.88 50.28 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.763 -0.828 . . . . 73.52 108.763 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.515 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.5 m-20 -122.16 111.33 16.84 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.398 -1.705 . . . . 64.02 106.398 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 87.3 mt -101.38 127.21 48.13 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.157 -1.053 . . . . 75.34 108.157 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -140.02 136.5 33.77 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.384 -1.339 . . . . 53.24 107.384 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.5 p -128.96 115.85 18.46 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.827 -0.434 . . . . 54.25 109.827 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.7 134.82 54.65 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.443 -1.317 . . . . 72.22 107.443 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.0 m -138.89 162.88 33.74 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.316 0.507 . . . . 62.3 111.312 -172.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.0 p -157.8 143.3 17.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.744 0.818 . . . . 75.1 110.888 -172.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -83.4 135.21 34.78 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.711 0.804 . . . . 75.03 109.77 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 mt -99.26 -40.88 7.72 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.205 0.526 . . . . 75.34 109.891 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.85 -178.45 7.32 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.906 -1.043 . . . . 73.35 109.997 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -71.63 122.28 20.28 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.468 -0.787 . . . . 74.32 109.289 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 74.0 -4.76 2.19 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 125.765 1.626 . . . . 75.3 112.04 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.3 110.16 30.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.51 -0.922 . . . . 51.04 108.51 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -125.25 140.22 53.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.617 -0.883 . . . . 72.5 108.617 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -122.78 115.05 21.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.243 -1.021 . . . . 71.33 108.243 -171.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 83.5 t -99.37 141.98 15.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 123.815 0.846 . . . . 70.33 109.617 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.15 119.34 58.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 109.046 -0.724 . . . . 64.51 109.046 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.94 129.42 40.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.013 -1.476 . . . . 74.11 107.013 175.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -121.75 109.9 15.27 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.818 0.847 . . . . 64.14 109.04 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 56.0 t -104.76 102.81 14.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.257 -1.386 . . . . 74.34 107.257 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 24.4 m -97.86 126.06 43.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.886 -0.783 . . . . 74.31 108.886 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.604 HG21 HG21 ' B' ' 114' ' ' ILE . 70.2 t -116.31 121.9 68.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 124.792 1.237 . . . . 63.44 108.27 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 62.9 m -113.29 137.1 52.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.815 -0.809 . . . . 72.45 108.815 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -144.03 146.15 32.68 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 122.628 0.371 . . . . 71.21 110.602 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.52 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 76.0 p -150.32 140.63 22.28 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.656 0.598 . . . . 64.34 111.306 -174.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.673 HD12 HG22 ' B' ' 31' ' ' VAL . 76.5 mt -102.51 109.66 21.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.198 -1.038 . . . . 64.01 108.198 170.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.75 -131.61 37.22 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 116.001 -0.545 . . . . 74.15 112.389 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -95.92 14.7 22.65 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.477 0.547 . . . . 72.02 112.477 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.508 ' HG3' HG23 ' B' ' 31' ' ' VAL . 12.6 pt-20 -126.7 141.0 51.98 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.961 0.505 . . . . 73.45 109.915 178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 48.2 m -70.51 127.51 32.95 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 123.289 0.635 . . . . 71.3 111.233 -175.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.562 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -80.28 -67.36 0.77 Allowed 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.454 -0.943 . . . . 61.42 108.454 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.496 ' HZ ' HD13 ' B' ' 126' ' ' LEU . 51.5 p90 -150.25 155.37 39.58 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-O 121.619 0.723 . . . . 72.51 111.869 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 33.7 mt -122.86 109.52 14.27 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.124 -1.806 . . . . 64.44 106.124 172.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' B' ' 114' ' ' ILE . 37.6 t -120.75 115.39 23.22 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.449 -0.574 . . . . 72.23 109.449 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -121.36 123.84 43.09 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.645 -1.242 . . . . 64.11 107.645 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.51 143.42 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.667 -0.864 . . . . 54.02 108.667 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -124.66 100.65 6.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.312 -0.858 . . . . 53.0 108.813 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.454 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 60.1 tp60 -90.25 105.81 18.06 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.224 -0.658 . . . . 72.43 109.224 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.451 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.13 164.74 26.17 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.799 -0.521 . . . . 63.43 111.799 175.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.67 128.3 1.92 Allowed Glycine 0 CA--C 1.52 0.365 0 CA-C-O 120.024 -0.32 . . . . 72.44 112.497 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.522 HG13 ' HE1' ' B' ' 17' ' ' TYR . 48.5 mt -84.37 123.83 39.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.966 -0.753 . . . . 71.05 108.966 172.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -133.12 136.55 45.88 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.015 . . . . 65.24 108.795 -175.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.9 m -103.51 108.57 19.89 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.346 0.659 . . . . 72.42 110.047 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.623 HD13 HD21 ' B' ' 98' ' ' LEU . 41.0 pt -100.11 132.03 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.251 1.02 . . . . 74.13 109.912 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.47 144.12 20.45 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 122.721 0.409 . . . . 55.31 110.057 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.75 -55.06 1.66 Allowed Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.808 -0.633 . . . . 74.31 112.164 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.68 HD12 ' HE3' ' B' ' 9' ' ' MET . 0.2 OUTLIER -72.57 155.06 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 75.45 111.255 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.27 167.37 28.85 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.127 -0.942 . . . . 73.11 109.502 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.07 -121.74 27.13 Favored Glycine 0 C--N 1.346 1.09 0 O-C-N 124.103 0.877 . . . . 70.33 114.589 172.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' THR . . . . . 0.419 HG23 HD13 ' B' ' 141' ' ' LEU . 89.8 m -71.89 -35.05 69.63 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.399 1.079 . . . . 70.35 111.784 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -70.51 -31.88 69.14 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 120.986 0.422 . . . . 54.34 110.373 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' F' ' 452' ' ' VAL . 49.3 ttp -74.08 -34.22 63.91 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.637 -0.71 . . . . 63.4 110.382 173.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.428 ' HA ' HD11 ' F' ' 454' ' ' LEU . . . -60.03 -41.93 93.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.198 0.599 . . . . 52.32 110.25 174.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -64.17 -25.36 68.05 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.578 1.151 . . . . 71.34 111.39 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -78.83 -59.2 2.88 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.993 0.517 . . . . 44.35 110.282 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.623 HD21 HD13 ' B' ' 86' ' ' ILE . 66.3 mt -72.63 -40.53 66.35 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.856 0.688 . . . . 72.52 112.856 -167.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.32 3.97 61.98 Favored Glycine 0 N--CA 1.469 0.859 0 CA-C-O 119.728 -0.484 . . . . 64.4 114.073 -173.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.608 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -143.37 -69.65 0.33 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.33 0.565 . . . . 62.21 111.386 -175.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.34 -43.49 96.42 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.702 1.201 . . . . 62.33 112.049 -172.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.423 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 94.4 m -66.39 -50.43 48.28 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 124.206 1.003 . . . . 74.31 111.562 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 78.1 Cg_exo -55.18 -35.17 90.27 Favored 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.187 1.925 . . . . 71.43 113.995 169.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.403 HD21 ' N ' ' B' ' 134' ' ' ASP . 63.4 m-80 -63.27 -33.59 75.84 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 118.159 0.436 . . . . 74.44 111.825 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 77.4 mt -66.06 -40.94 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.362 0.665 . . . . 74.05 110.408 175.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.7 mt -82.61 -20.82 35.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.192 0.997 . . . . 72.02 112.851 -172.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.2 -47.98 97.24 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-O 117.864 -1.065 . . . . 75.04 113.822 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.36 -32.78 89.7 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 121.993 1.796 . . . . 73.4 113.166 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.454 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 91.7 m-85 -70.37 -48.96 53.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.842 0.457 . . . . 72.21 110.133 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.62 -43.35 72.15 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.95 0.9 . . . . 71.11 110.251 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.545 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 35.9 ttt-85 -59.97 -55.03 39.1 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.322 1.449 . . . . 73.32 111.824 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.56 -33.81 76.78 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.766 0.827 . . . . 72.31 110.065 -175.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.605 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.1 t -72.16 -43.3 64.83 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.8 -0.636 . . . . 75.12 111.355 -176.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.604 HG21 HG21 ' B' ' 64' ' ' VAL . 99.1 mt -60.0 -53.59 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 109.819 -0.437 . . . . 72.1 109.819 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 86.8 m -59.32 -32.82 70.42 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 124.084 0.865 . . . . 74.12 111.41 -176.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.3 t -61.98 -47.42 84.89 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.297 0.639 . . . . 50.11 109.674 174.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.8 mmt -69.24 -34.42 74.77 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.17 0.588 . . . . 74.23 111.368 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 114' ' ' ILE . 92.4 t -60.83 -43.15 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.148 0.979 . . . . 71.03 109.924 174.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.0 t -68.22 -33.77 75.02 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.634 -1.166 . . . . 72.42 111.471 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.1 mtt-85 -66.95 -35.93 81.09 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.518 0.727 . . . . 71.41 110.152 177.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.09 9.51 60.44 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-O 119.483 -0.62 . . . . 61.24 113.361 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 17' ' ' TYR . 70.4 p 57.06 22.14 7.07 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 126.158 1.783 . . . . 74.01 113.72 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -78.79 149.26 73.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.796 -0.446 . . . . 61.14 109.796 175.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.462 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 28.7 Cg_endo -59.57 171.57 2.56 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.306 2.67 . . . . 63.12 113.672 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.428 HE21 HD22 ' B' ' 127' ' ' ASN . 51.9 tp60 -62.91 114.77 3.85 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.038 -0.983 . . . . 63.43 111.88 -167.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.496 HD13 ' HZ ' ' B' ' 74' ' ' PHE . 8.6 tt -135.78 106.64 6.62 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.961 -0.755 . . . . 61.02 108.961 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.428 HD22 HE21 ' B' ' 125' ' ' GLN . 78.9 m-20 -114.26 135.14 54.39 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.847 0.859 . . . . 75.12 109.843 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.545 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.5 mm? -72.24 124.73 25.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.198 -0.667 . . . . 74.35 109.198 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.611 ' HB3' ' SD ' ' F' ' 464' ' ' MET . . . -73.72 152.25 89.21 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.296 0.639 . . . . 73.42 110.962 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.17 110.1 1.28 Allowed 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 122.402 2.068 . . . . 61.33 112.947 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 31.2 t -100.71 111.0 29.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.106 -1.072 . . . . 72.24 108.106 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.409 ' O ' HD13 ' B' ' 136' ' ' LEU . 43.6 t-20 -85.05 90.29 7.81 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.459 -0.941 . . . . 63.12 108.459 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -57.04 -31.53 65.27 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.45 0.7 . . . . 74.31 111.321 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.608 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 11.7 t70 -73.11 -44.92 59.68 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.259 1.024 . . . . 72.31 111.054 -173.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.53 -39.0 93.27 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.075 0.95 . . . . 44.13 111.48 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' F' ' 461' ' ' PHE . 8.5 mp -75.1 -33.54 61.63 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.105 -0.952 . . . . 62.23 110.866 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.451 ' CZ ' HD21 ' B' ' 141' ' ' LEU . 69.3 t80 -64.82 -30.02 71.0 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.05 0.94 . . . . 53.25 111.645 -177.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 56.7 mtt -56.35 -36.43 68.76 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.693 0.797 . . . . 64.41 111.229 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -88.79 -19.04 26.51 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.218 1.007 . . . . 62.04 110.876 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -73.03 -19.79 61.13 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.609 0.764 . . . . 74.44 111.195 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.451 HD21 ' CZ ' ' B' ' 137' ' ' PHE . 40.0 mt -92.85 -8.3 43.84 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.886 0.699 . . . . 75.14 112.886 -172.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.413 HE22 ' HG3' ' B' ' 144' ' ' GLN . 0.0 OUTLIER -167.54 130.15 1.64 Allowed 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.445 -0.946 . . . . 71.31 108.445 -179.417 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -57.38 -40.05 77.36 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.195 0.998 . . . . 64.14 112.64 -172.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.413 ' HG3' HE22 ' B' ' 142' ' ' GLN . 25.5 pt20 -116.01 86.79 2.55 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.753 0.787 . . . . 74.54 110.19 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.62 139.94 47.7 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.836 -0.62 . . . . 64.32 110.196 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.46 160.6 54.09 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 114.993 0.757 . . . . 34.25 114.993 -170.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -73.93 171.82 12.74 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.607 1.163 . . . . 71.24 112.318 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.15 110.19 1.06 Allowed Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.289 -0.869 . . . . 72.31 111.179 177.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 71.4 p -110.29 127.53 55.06 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.814 0.846 . . . . 64.04 109.776 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -160.52 160.11 31.52 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.988 0.915 . . . . 63.42 109.004 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.31 111.88 1.93 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.956 0.502 . . . . 74.11 110.775 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' HIS . . . . . 0.571 ' HA ' ' HG2' ' D' ' 90' ' ' GLU . 28.8 p80 -142.96 114.01 7.71 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.022 -0.536 . . . . 63.41 110.698 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -160.49 76.76 0.6 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.425 1.49 . . . . 74.22 107.661 168.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -93.01 -179.76 5.2 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.241 -0.891 . . . . 71.11 109.291 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 C-N-CA 123.75 0.82 . . . . 37.62 109.191 -179.159 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 46.7 ttm . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.768 -0.456 . . . . 73.31 109.768 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 48.5 t -74.86 104.48 5.49 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.336 0.654 . . . . 74.04 110.529 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.0 100.18 0.3 Allowed 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.798 -0.637 . . . . 45.14 110.09 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -67.13 82.06 0.13 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.856 0.862 . . . . 64.04 109.048 172.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -91.21 151.5 20.91 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.337 -0.847 . . . . 64.2 109.618 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -66.45 149.06 50.98 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.285 0.634 . . . . 60.11 110.327 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 14.4 m -50.66 130.78 25.01 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.654 1.181 . . . . 64.43 110.94 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -55.86 97.03 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.845 0.858 . . . . 72.22 110.441 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 52.1 ttm 64.94 149.49 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 125.384 1.473 . . . . 73.14 112.281 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 51.6 m -127.11 89.93 3.06 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.062 -1.088 . . . . 62.23 108.062 171.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.562 ' HD2' ' HG3' ' A' ' 130' ' ' PRO . 64.4 t80 -107.81 122.95 47.81 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.354 -0.98 . . . . 72.21 108.354 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -139.1 117.85 12.3 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.382 0.673 . . . . 74.33 109.644 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.2 mt -73.22 127.11 34.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 108.856 -0.794 . . . . 53.1 108.856 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.599 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 14.8 mm100 -94.0 -46.22 7.24 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.466 -0.568 . . . . 72.03 109.466 173.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -170.97 141.32 1.69 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.602 -0.726 . . . . 75.34 109.418 -167.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.0 mt -136.13 130.25 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.295 -1.372 . . . . 72.14 107.295 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -166.34 157.81 13.34 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.154 0.502 . . . . 73.12 110.611 -164.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.8 p -88.56 117.29 27.41 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.45 -0.796 . . . . 74.3 109.047 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -86.88 -37.6 17.54 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.144 0.497 . . . . 71.24 109.893 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -138.35 127.72 24.59 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.13 -0.941 . . . . 75.44 109.137 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.5 mt -129.8 139.5 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.398 -1.334 . . . . 72.13 107.398 175.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -147.71 145.38 28.85 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.529 0.731 . . . . 74.01 109.678 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -143.12 134.44 26.05 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.469 -1.308 . . . . 74.02 107.469 168.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.4 mt-10 -129.11 126.98 40.53 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 124.326 1.05 . . . . 73.15 108.421 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.76 81.04 23.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 106.664 -1.606 . . . . 70.44 106.664 169.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -64.29 -31.58 62.96 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.966 2.444 . . . . 75.25 112.233 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -105.7 19.28 20.81 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.232 -0.895 . . . . 63.4 111.215 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.419 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -41.28 -62.15 1.14 Allowed Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 117.598 -1.191 . . . . 74.32 114.199 -167.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.0 -44.1 26.52 Favored 'Trans proline' 0 C--N 1.391 2.788 0 CA-C-N 121.977 1.742 . . . . 71.34 111.628 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -68.81 -31.71 70.91 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.016 0.926 . . . . 61.14 112.514 -174.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.709 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.5 p -80.5 -16.59 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 C-N-CA 122.731 0.413 . . . . 73.11 111.322 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -75.39 -22.55 57.39 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.563 0.345 . . . . 75.43 111.683 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -95.74 4.49 52.9 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.452 0.301 . . . . 62.31 111.113 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -91.5 151.64 20.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.444 0.697 . . . . 74.44 110.337 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -56.87 124.33 18.19 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 124.092 0.87 . . . . 51.02 110.303 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.9 t90 -84.58 93.39 8.35 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.784 -0.644 . . . . 62.43 110.273 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -145.24 76.98 13.12 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.182 -1.044 . . . . 50.24 108.182 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.8 128.88 6.09 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.687 2.258 . . . . 75.14 112.867 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -85.28 109.43 18.35 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.072 -1.455 . . . . 71.34 107.072 161.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 m -96.48 113.27 30.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.045 0.938 . . . . 75.13 110.571 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -119.65 112.41 19.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.892 1.277 . . . . 73.53 108.186 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.06 168.62 12.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.424 0.69 . . . . 63.13 111.632 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 29.5 t70 -145.5 105.52 4.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.19 0.596 . . . . 72.14 109.976 173.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.42 130.36 55.5 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.576 1.15 . . . . 73.13 109.38 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -156.49 153.88 29.48 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.461 0.705 . . . . 74.33 109.946 171.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -129.81 152.46 49.27 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.947 0.899 . . . . 70.41 110.239 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.7 167.43 22.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.257 1.023 . . . . 71.22 108.84 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.468 ' HB3' HG22 ' C' ' 58' ' ' VAL . 93.1 p -148.15 152.75 37.81 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.046 0.538 . . . . 65.51 109.912 174.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 27.4 p -143.87 135.05 25.67 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.493 0.717 . . . . 62.53 109.545 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -64.91 116.25 6.18 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.941 0.775 . . . . 71.22 109.59 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.634 HD11 HD12 ' C' ' 83' ' ' ILE . 94.5 mt -84.38 -39.72 18.71 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.349 0.595 . . . . 74.42 109.44 174.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.18 -174.84 5.02 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.291 -1.322 . . . . 72.15 109.663 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.84 113.75 2.67 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.986 -1.006 . . . . 71.45 109.954 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.4 ' HA ' HG13 ' G' ' 452' ' ' VAL . 4.3 m-20 69.97 4.43 4.79 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.94 1.296 . . . . 75.24 112.975 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -105.86 123.0 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.04 0.936 . . . . 65.11 109.444 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -111.91 161.43 16.41 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.694 0.759 . . . . 70.45 110.37 172.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.547 ' HB2' HD11 ' C' ' 51' ' ' LEU . 32.9 tt0 -123.67 111.82 16.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.949 -1.5 . . . . 65.13 106.949 166.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' C' ' 48' ' ' SER . 74.0 t -94.07 121.29 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.026 -1.102 . . . . 72.13 108.026 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.33 133.51 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.502 -0.925 . . . . 72.54 108.502 173.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -119.45 109.06 15.3 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.247 -1.02 . . . . 75.33 108.247 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -99.77 112.97 25.17 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.685 0.794 . . . . 73.3 109.784 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.3 t -106.4 130.93 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.259 1.024 . . . . 70.32 108.357 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 4.9 m -125.31 146.42 49.57 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.725 -0.843 . . . . 71.11 108.725 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -136.35 109.46 8.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.506 1.122 . . . . 75.31 108.644 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 22.1 m -99.25 140.83 32.83 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.512 -0.921 . . . . 74.2 108.512 171.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.11 105.71 5.83 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.825 -1.176 . . . . 71.45 107.825 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 52.3 m -119.67 133.17 55.75 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.698 -0.852 . . . . 53.55 108.698 177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 mt -82.68 51.34 1.86 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.263 1.425 . . . . 74.31 110.303 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.81 -76.68 0.31 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.504 -1.038 . . . . 64.14 110.504 -175.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.99 -31.7 2.12 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.701 1.2 . . . . 61.52 109.809 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -70.88 100.32 1.92 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.344 1.057 . . . . 75.14 110.257 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 72' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 49.8 m -66.64 125.13 24.82 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 118.007 0.367 . . . . 72.15 110.273 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.709 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -82.0 -55.02 4.84 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 114.982 -1.008 . . . . 31.42 109.161 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -161.14 176.08 11.69 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.259 1.028 . . . . 72.41 112.448 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.2 tm? -137.88 146.53 43.48 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 113.001 -1.909 . . . . 74.1 106.212 172.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.458 ' N ' HD13 ' C' ' 75' ' ' LEU . 44.1 t -148.3 143.39 26.89 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.614 -0.884 . . . . 74.41 108.614 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -155.89 137.12 13.84 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.718 0.294 . . . . 74.0 110.345 -177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.9 t -135.62 137.84 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.466 1.106 . . . . 72.34 108.751 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -115.31 94.55 4.77 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.329 -0.989 . . . . 51.53 108.329 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -79.44 98.55 6.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.489 -0.778 . . . . 74.5 109.452 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.24 143.4 22.87 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.208 -1.157 . . . . 70.22 110.208 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.488 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.84 117.23 0.88 Allowed Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 111.53 -0.628 . . . . 32.23 111.53 -174.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.634 HD12 HD11 ' C' ' 51' ' ' LEU . 6.4 mm -82.61 128.79 38.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 108.638 -0.875 . . . . 62.42 108.638 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -135.85 122.03 20.3 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.43 0.457 . . . . 72.03 110.109 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 22.1 m -79.48 107.55 12.33 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.059 -1.089 . . . . 70.35 108.059 169.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.68 143.83 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.069 0.547 . . . . 72.11 110.637 -175.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -158.5 166.28 32.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.314 1.046 . . . . 73.12 109.652 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.46 -34.58 4.4 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.984 -0.553 . . . . 75.4 112.896 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.17 140.42 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.731 0.813 . . . . 71.42 110.531 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -148.3 156.65 42.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.585 0.754 . . . . 75.4 109.712 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.81 -117.54 8.21 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 116.209 -0.45 . . . . 34.14 113.248 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 5.2 m -70.6 -33.53 71.16 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.036 0.934 . . . . 72.42 110.501 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -67.14 -39.9 86.66 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.732 -1.122 . . . . 73.4 110.085 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 39.6 ttp -78.11 -24.64 47.41 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.272 -0.876 . . . . 63.13 110.741 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.39 95.65 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 122.752 0.421 . . . . 71.1 110.435 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -75.94 -41.19 52.42 Favored 'General case' 0 C--O 1.248 0.979 0 N-CA-C 111.927 0.343 . . . . 75.32 111.927 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -55.61 -48.89 74.16 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.069 0.856 . . . . 73.41 110.543 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.449 HD23 ' SG ' ' C' ' 102' ' ' CYS . 34.9 mt -92.88 -14.26 27.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.277 0.631 . . . . 43.02 111.076 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.93 -29.39 65.07 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 123.329 0.49 . . . . 73.42 113.835 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -156.5 -39.83 0.08 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 113.13 0.789 . . . . 72.43 113.13 -166.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -66.04 -55.82 14.68 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.453 0.471 . . . . 72.54 111.184 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.545 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 37.8 m -64.52 -46.28 77.35 Favored Pre-proline 0 CA--C 1.563 1.478 0 C-N-CA 123.643 0.777 . . . . 42.32 112.943 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.56 -19.81 54.15 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 121.967 1.778 . . . . 74.54 113.967 174.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 104' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' C' ' 100' ' ' ALA . 0.2 OUTLIER -71.98 -28.41 63.4 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.714 -0.476 . . . . 71.31 109.714 176.189 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.71 -43.21 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.673 0.789 . . . . 73.31 109.67 171.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.488 HD21 ' HA3' ' C' ' 82' ' ' GLY . 66.0 mt -74.95 -28.2 60.49 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 114.886 -1.052 . . . . 52.22 112.133 -172.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -56.7 -50.2 89.31 Favored Pre-proline 0 CA--C 1.566 1.578 0 CA-C-O 117.34 -1.314 . . . . 74.43 114.243 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.54 -39.14 55.58 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 122.4 2.067 . . . . 72.11 113.367 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.472 ' HE2' HG21 ' A' ' 115' ' ' THR . 20.1 m-85 -67.94 -48.34 66.19 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.781 0.832 . . . . 72.51 110.405 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.15 -34.84 75.66 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.011 -0.995 . . . . 54.25 110.843 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -61.33 -56.53 19.42 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 124.12 0.968 . . . . 73.53 109.988 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.01 -30.33 71.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 123.724 0.64 . . . . 71.1 110.717 -175.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.5 t -73.91 -31.24 63.0 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.142 0.577 . . . . 73.32 110.884 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 58.7 mt -74.0 -50.33 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.945 0.498 . . . . 63.31 109.724 173.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 5.2 m -62.62 -30.27 71.23 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.013 0.925 . . . . 45.45 110.887 -175.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.3 t -65.5 -51.75 57.75 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.999 -0.741 . . . . 61.21 108.999 172.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.627 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.59 -36.65 76.67 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.541 1.136 . . . . 71.44 112.926 -179.619 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.708 HG11 HD23 ' C' ' 126' ' ' LEU . 95.0 t -71.72 -39.36 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.473 0.709 . . . . 74.23 109.775 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.5 t -70.77 -26.45 63.36 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.655 0.782 . . . . 51.24 111.234 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 78.2 mtt-85 -72.93 -42.49 63.41 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.744 -0.836 . . . . 75.43 108.744 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.1 -4.17 82.93 Favored Glycine 0 C--N 1.356 1.649 0 O-C-N 123.706 0.629 . . . . 70.33 112.942 173.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 23.4 p 66.83 25.84 9.48 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.633 1.973 . . . . 72.3 113.62 171.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.506 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 98.6 m-85 -86.49 166.08 29.7 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 123.841 0.857 . . . . 74.14 109.115 169.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 51.3 Cg_endo -62.67 178.31 1.01 Allowed 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 123.139 2.559 . . . . 51.31 114.708 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -59.67 112.22 1.73 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.877 1.271 . . . . 72.42 111.742 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.708 HD23 HG11 ' C' ' 118' ' ' VAL . 4.1 mm? -106.62 96.78 6.69 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.211 -0.663 . . . . 72.3 109.211 172.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -124.79 122.48 37.54 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.708 1.203 . . . . 74.01 108.539 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 14.8 tp -79.96 135.4 36.39 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.932 -0.395 . . . . 75.43 109.932 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.13 140.44 78.14 Favored Pre-proline 0 CA--C 1.547 0.849 0 O-C-N 124.45 1.094 . . . . 64.02 110.304 173.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.84 102.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.582 2.188 . . . . 51.23 112.676 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 50.0 t -95.74 111.17 25.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 106.675 -1.602 . . . . 53.25 106.675 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -76.24 83.22 3.03 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.633 -1.247 . . . . 74.53 107.633 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -56.43 -36.64 69.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.731 0.812 . . . . 62.12 110.825 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.7 -43.13 99.45 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 114.857 -1.065 . . . . 64.44 111.213 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.02 91.53 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.637 0.586 . . . . 62.52 110.952 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.1 mp -57.48 -50.66 72.33 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 123.97 0.794 . . . . 75.35 111.409 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.433 ' HA ' ' HB3' ' C' ' 140' ' ' TYR . 8.0 t80 -74.93 -20.82 59.53 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.347 0.659 . . . . 73.04 110.396 -177.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.415 ' O ' ' HB3' ' C' ' 142' ' ' GLN . 52.3 ttm -68.42 -55.4 12.03 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 122.806 0.442 . . . . 72.14 110.017 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -65.22 -35.06 79.89 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 122.443 0.297 . . . . 55.12 111.27 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.433 ' HB3' ' HA ' ' C' ' 137' ' ' PHE . 61.5 t80 -54.91 -83.67 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.807 1.243 . . . . 65.3 111.063 174.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 10.0 tp -98.67 87.3 3.75 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 109.546 -0.539 . . . . 74.32 109.546 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' C' ' 138' ' ' MET . 11.3 pt20 -133.63 133.9 42.53 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.646 0.778 . . . . 70.31 111.241 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -143.57 -56.37 0.39 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.389 -1.338 . . . . 52.44 107.389 169.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -79.5 104.32 10.02 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.963 -1.017 . . . . 41.21 109.382 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.31 -162.0 1.04 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.648 0.779 . . . . 72.44 111.007 -173.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.48 -143.04 3.83 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 110.556 -1.018 . . . . 70.52 110.556 175.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.54 147.56 27.61 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.6 -0.889 . . . . 74.45 108.6 175.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.87 121.84 17.77 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 123.745 0.653 . . . . 71.42 112.799 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 60.8 m -101.55 93.97 5.64 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.781 0.832 . . . . 41.34 110.53 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -87.55 160.57 18.17 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.551 0.74 . . . . 55.54 109.726 172.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -102.55 -174.87 2.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.266 0.626 . . . . 71.44 110.116 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -123.36 115.37 21.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.066 1.346 . . . . 75.22 108.714 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 153' ' ' GLN . . . . . 0.565 ' HB2' HG23 ' A' ' 92' ' ' THR . 8.6 tt0 -83.17 140.5 32.55 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.965 0.506 . . . . 62.41 110.567 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -148.83 135.33 19.53 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.045 -1.095 . . . . 65.21 108.045 171.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.383 0 N-CA-C 108.921 -0.77 . . . . 71.21 108.921 -176.797 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 109.283 -0.636 . . . . 74.25 109.283 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 32.8 t -74.75 85.38 2.16 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.014 -0.736 . . . . 75.14 109.014 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.65 178.68 7.86 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.231 -0.895 . . . . 73.4 111.307 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -117.67 75.73 1.01 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.951 0.882 . . . . 73.31 110.715 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -68.37 104.74 1.95 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.325 -0.852 . . . . 74.42 109.056 171.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -71.05 115.54 10.31 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.638 0.733 . . . . 62.02 109.987 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -99.1 -164.36 1.12 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.165 0.986 . . . . 62.54 108.712 172.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -72.3 165.77 23.8 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 109.056 -0.72 . . . . 53.32 109.056 167.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.565 ' HG3' HG23 ' D' ' 89' ' ' ILE . 4.9 ttp -32.26 123.56 0.32 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.132 0.973 . . . . 73.0 112.235 173.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 45.1 m -112.14 141.6 45.62 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.277 0.631 . . . . 73.44 109.737 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -175.13 102.01 0.08 Allowed 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.458 -2.053 . . . . 74.21 105.458 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -144.2 134.47 24.39 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.243 -0.89 . . . . 64.44 108.799 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.3 mt -84.25 122.6 38.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 115.203 -0.908 . . . . 72.13 109.182 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -90.07 -39.8 12.69 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 122.617 0.367 . . . . 74.13 111.315 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -166.56 127.79 1.71 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 111.755 0.28 . . . . 65.35 111.755 -167.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.75 136.13 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.343 -1.354 . . . . 72.11 107.343 167.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.41 ' HE1' HG13 ' D' ' 83' ' ' ILE . 25.1 p90 -156.51 164.38 38.29 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.771 0.796 . . . . 73.22 111.334 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 65.3 p -100.15 123.27 44.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.043 -0.981 . . . . 75.14 108.839 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -87.24 -36.01 18.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.67 0.748 . . . . 60.52 109.132 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 2.6 t70 -142.07 138.88 32.05 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.233 -1.349 . . . . 61.22 108.942 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.627 HG21 ' HE2' ' C' ' 117' ' ' MET . 82.3 mt -134.25 145.89 32.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.63 -1.248 . . . . 63.53 107.63 169.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -148.11 137.87 22.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.886 -0.783 . . . . 65.1 108.886 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.422 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.5 t80 -146.12 124.06 12.03 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.239 -1.393 . . . . 74.31 107.239 170.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -121.75 148.49 44.57 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.079 -0.711 . . . . 75.4 109.079 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.78 84.19 27.27 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 106.738 -1.578 . . . . 64.51 106.738 171.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.4 -46.08 6.16 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.198 2.598 . . . . 74.23 113.586 -167.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -104.95 28.0 7.6 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.703 0.801 . . . . 50.12 109.591 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.27 -66.72 0.34 Allowed Pre-proline 0 CA--C 1.565 1.528 0 N-CA-C 114.908 1.447 . . . . 75.31 114.908 -161.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.451 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.7 Cg_endo -73.8 -20.13 20.24 Favored 'Trans proline' 0 C--N 1.382 2.324 0 CA-C-N 122.533 1.94 . . . . 75.15 113.3 -174.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -73.88 -40.44 63.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.595 1.158 . . . . 62.14 110.328 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.463 HG21 ' HA ' ' D' ' 73' ' ' ALA . 4.0 p -85.54 -23.95 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 123.341 0.657 . . . . 64.11 111.803 -171.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -60.64 -22.09 63.46 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 123.286 0.634 . . . . 74.01 112.428 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -68.17 -10.3 53.19 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.579 0.752 . . . . 73.34 111.052 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -100.95 107.73 19.29 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.737 1.215 . . . . 73.24 110.246 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -93.27 91.87 7.44 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.293 0.637 . . . . 72.31 110.423 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.548 ' HZ3' ' H ' ' D' ' 69' ' ' GLY . 22.0 t90 -161.62 158.41 26.13 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.937 1.295 . . . . 63.41 108.127 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -69.31 108.03 2.74 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 107.999 -1.111 . . . . 74.03 107.999 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.74 124.23 15.75 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.967 2.444 . . . . 63.31 112.495 -173.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.617 ' HA ' ' HG ' ' H' ' 470' ' ' LEU . 44.5 tt0 -57.28 110.98 0.94 Allowed 'General case' 0 C--N 1.359 0.996 0 O-C-N 124.442 1.088 . . . . 70.32 110.244 -174.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.742 HG12 HD11 ' H' ' 470' ' ' LEU . 2.8 p -101.68 112.39 34.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 115.283 -0.871 . . . . 75.32 110.269 -172.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.55 109.82 18.79 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 104.908 -2.256 . . . . 74.34 104.908 165.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.454 HD21 HD11 ' D' ' 128' ' ' LEU . 5.4 tt -95.49 127.9 41.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.36 -1.348 . . . . 70.25 107.36 -170.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.523 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 10.0 t70 -130.17 147.0 51.85 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 123.542 0.527 . . . . 72.31 109.915 -176.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -127.99 153.02 47.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.584 0.753 . . . . 73.21 109.682 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -157.69 147.78 20.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.055 0.942 . . . . 73.2 108.828 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -127.73 160.85 30.42 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.409 -0.589 . . . . 72.33 109.409 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.477 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.05 166.77 31.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.755 -1.112 . . . . 63.52 108.661 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.408 ' O ' HG22 ' H' ' 455' ' ' THR . 21.8 p -165.72 161.31 18.01 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.609 0.764 . . . . 55.42 109.557 178.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.2 p -151.98 160.47 43.47 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.282 1.033 . . . . 72.45 109.238 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -98.81 120.65 39.6 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.995 -0.742 . . . . 72.35 108.995 171.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' D' ' 57' ' ' GLU . 59.2 mt -91.0 -41.3 11.18 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.124 0.488 . . . . 73.02 110.198 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -153.51 -172.44 4.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.754 0.822 . . . . 43.44 110.896 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.37 105.96 1.59 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 114.968 -1.015 . . . . 70.33 109.53 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 64.11 18.59 11.33 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.517 1.127 . . . . 74.23 112.404 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 98.1 t -117.83 120.44 64.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.587 0 N-CA-C 107.843 -1.169 . . . . 74.41 107.843 169.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -125.46 163.8 21.86 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.671 0.788 . . . . 73.35 109.411 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.523 ' HB2' HD11 ' D' ' 51' ' ' LEU . 22.2 tt0 -121.52 148.38 44.55 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 124.746 1.218 . . . . 72.51 107.714 169.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.1 t -129.75 119.28 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 106.896 -1.52 . . . . 75.31 106.896 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.522 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 41.4 t -99.38 125.29 52.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.987 -0.746 . . . . 73.4 108.987 176.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.64 124.86 49.61 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.702 -1.221 . . . . 64.3 107.702 175.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -118.98 95.66 4.91 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.987 -0.746 . . . . 74.42 108.987 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -91.24 123.1 43.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.078 -1.082 . . . . 75.4 108.078 174.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 24.0 m -111.15 144.06 40.9 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.25 0.548 . . . . 72.14 110.041 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.458 HG13 HG23 ' D' ' 40' ' ' VAL . 93.9 t -137.44 120.28 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.111 0.964 . . . . 74.22 109.503 -175.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 100.0 m -113.39 121.03 43.12 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 107.912 -1.144 . . . . 74.54 107.912 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.88 145.49 48.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.333 0.653 . . . . 51.3 110.319 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.456 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.8 m -146.83 129.96 16.48 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 123.526 0.516 . . . . 72.2 111.129 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 mt -92.86 92.6 7.98 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.945 -1.132 . . . . 74.31 107.945 173.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 69' ' ' GLY . . . . . 0.548 ' H ' ' HZ3' ' D' ' 36' ' ' TRP . . . 70.22 -114.77 5.67 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 114.571 -1.195 . . . . 54.31 113.382 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.15 6.37 40.36 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.299 0.852 . . . . 74.15 113.299 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.91 156.94 43.02 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.11 0.414 . . . . 54.33 110.222 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.5 m -67.29 136.89 55.59 Favored 'General case' 0 C--O 1.242 0.697 0 O-C-N 123.633 0.583 . . . . 65.44 110.694 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.463 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.34 -69.57 0.71 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.252 -1.34 . . . . 75.44 108.522 175.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -145.58 157.46 43.98 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 121.319 0.58 . . . . 72.22 109.958 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -131.96 144.58 50.91 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.255 -1.387 . . . . 72.33 107.255 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.563 ' SG ' HG12 ' D' ' 114' ' ' ILE . 43.6 t -158.22 136.68 11.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.336 0.254 . . . . 65.3 110.589 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -154.07 128.35 9.1 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.387 0.675 . . . . 73.21 109.32 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.2 118.39 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.382 0.673 . . . . 54.13 109.905 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.626 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.6 mt-30 -89.77 82.97 6.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.34 0.656 . . . . 61.33 109.307 169.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -80.37 91.86 5.73 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.963 1.305 . . . . 63.31 109.359 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.25 142.18 17.98 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.713 -0.555 . . . . 65.13 111.713 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.93 132.31 5.5 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 119.716 -0.491 . . . . 70.43 112.064 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.41 HG13 ' HE1' ' D' ' 17' ' ' TYR . 61.9 mt -89.17 131.23 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.379 0.672 . . . . 70.55 109.99 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -131.22 124.55 30.81 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.886 0.875 . . . . 70.31 109.341 175.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 71.5 m -83.75 111.7 19.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.088 -1.078 . . . . 73.12 108.088 168.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.461 HD12 ' SG ' ' D' ' 97' ' ' CYS . 5.5 tt -138.06 127.99 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 122.902 0.481 . . . . 63.01 111.117 -172.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.68 167.66 27.86 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.398 1.479 . . . . 54.25 109.099 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.05 11.51 63.11 Favored Glycine 0 N--CA 1.473 1.128 0 CA-C-O 119.463 -0.632 . . . . 75.42 113.66 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.565 HG23 ' HG3' ' D' ' 9' ' ' MET . 0.2 OUTLIER -141.8 169.22 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 125.079 1.352 . . . . 74.25 109.661 171.369 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.571 ' HG2' ' HA ' ' B' ' 152' ' ' HIS . 3.8 pt-20 -153.91 175.82 12.91 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.723 0.409 . . . . 63.24 111.912 -173.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.89 -107.42 0.71 Allowed Glycine 0 C--N 1.36 1.868 0 O-C-N 124.757 1.285 . . . . 64.31 115.263 164.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.0 p -66.04 -41.54 90.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.816 0.847 . . . . 72.13 110.974 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -74.72 -38.03 62.41 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.344 0.657 . . . . 65.21 111.685 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.608 ' SD ' ' HB ' ' H' ' 452' ' ' VAL . 23.9 ptt? -66.63 -34.46 77.92 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.867 0.365 . . . . 75.24 110.671 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.98 -42.65 69.4 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.907 -0.588 . . . . 73.22 109.646 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.408 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 49.8 t-80 -66.25 -26.41 67.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.421 1.088 . . . . 70.53 111.817 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 97' ' ' CYS . . . . . 0.461 ' SG ' HD12 ' D' ' 86' ' ' ILE . 25.3 t -91.12 -54.14 4.07 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.844 -0.122 . . . . 73.33 110.864 -176.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -72.31 -29.77 64.16 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.391 0.276 . . . . 72.42 111.494 -176.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.5 12.91 27.98 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.122 -0.821 . . . . 73.01 114.532 -172.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -154.46 -59.65 0.12 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.983 0.891 . . . . 62.41 112.207 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -68.59 -50.41 51.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.006 0.523 . . . . 73.43 111.499 -173.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 83.7 m -62.6 -45.71 88.78 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.11 0.964 . . . . 72.41 112.243 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -52.56 -40.79 71.58 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.203 1.935 . . . . 71.5 112.967 167.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -66.07 -29.87 70.28 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.256 0.622 . . . . 75.54 111.328 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.7 mm -69.59 -42.4 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.894 0.878 . . . . 61.52 110.436 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 62.8 mt -74.83 -16.28 60.7 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.224 -0.898 . . . . 61.23 111.67 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.423 ' HE2' ' HA ' ' D' ' 130' ' ' PRO . 27.6 t80 -68.07 -40.37 21.73 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.916 -1.04 . . . . 75.24 113.74 -169.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.39 -44.84 45.6 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.011 1.807 . . . . 45.23 112.895 167.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -69.24 -36.64 77.37 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.692 0.797 . . . . 73.12 111.783 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.07 -49.46 69.95 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.241 0.616 . . . . 64.42 109.717 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.492 HH12 ' HB3' ' D' ' 130' ' ' PRO . 26.5 ttp180 -55.99 -47.62 77.37 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 124.357 1.036 . . . . 73.03 110.946 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -62.13 -49.03 77.49 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.073 0.858 . . . . 65.22 111.534 -174.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.0 -41.86 83.98 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.053 0.846 . . . . 72.44 110.636 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.563 HG12 ' SG ' ' D' ' 76' ' ' CYS . 81.1 mt -60.4 -56.51 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 O-C-N 124.293 0.996 . . . . 70.55 110.79 173.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -58.21 -37.55 75.04 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.588 1.155 . . . . 75.52 111.372 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -66.78 -42.15 86.5 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.155 -0.93 . . . . 75.45 110.079 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.4 mtm -72.52 -27.11 62.04 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.809 0.444 . . . . 65.53 111.766 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.408 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.0 t -67.97 -42.14 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.458 0.703 . . . . 64.11 110.078 173.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.6 p -75.62 -29.44 59.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.813 0.445 . . . . 71.3 111.108 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -74.26 -33.84 63.41 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.245 0.618 . . . . 73.42 109.599 174.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.68 -2.25 90.62 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-N 115.746 -0.661 . . . . 53.02 112.237 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p 66.57 21.3 10.73 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.876 2.07 . . . . 44.43 113.904 170.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -82.62 156.77 67.95 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.452 0.701 . . . . 75.12 110.348 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.97 137.23 44.23 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.298 2.666 . . . . 63.14 112.138 173.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -54.66 136.77 45.18 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.359 1.037 . . . . 74.33 111.929 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -113.44 102.32 10.2 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.568 -0.901 . . . . 74.02 108.568 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -98.29 95.08 7.13 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.221 -1.4 . . . . 42.31 107.221 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.454 HD11 HD21 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -57.11 113.89 1.9 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.566 -1.197 . . . . 65.24 108.273 -176.316 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.88 122.65 70.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 123.963 0.789 . . . . 75.53 110.632 -171.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.492 ' HB3' HH12 ' D' ' 111' ' ' ARG . 59.1 Cg_endo -72.64 112.52 3.5 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.944 1.763 . . . . 63.51 111.427 -176.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.0 m -105.81 138.52 30.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 108.317 -0.994 . . . . 70.11 108.317 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -79.25 77.11 5.78 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.872 0.844 . . . . 62.01 109.726 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.608 ' HE2' HD11 ' H' ' 460' ' ' LEU . 86.5 t80 -56.71 -29.39 62.39 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.623 1.569 . . . . 70.3 111.64 -178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.658 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 21.7 t70 -60.51 -45.1 95.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.13 1.372 . . . . 75.54 110.747 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.07 -37.84 57.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.807 0.843 . . . . 63.31 111.329 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' H' ' 462' ' ' TYR . 9.8 mp -58.93 -31.23 68.48 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.33 0.652 . . . . 65.54 111.043 174.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -69.53 -41.77 75.52 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.986 0.914 . . . . 71.51 110.8 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 30.8 mtt -62.79 -36.28 82.61 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.393 0.677 . . . . 60.33 109.89 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.28 -36.15 78.95 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.938 -1.028 . . . . 74.24 111.176 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -68.5 -40.47 80.86 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.777 0.831 . . . . 75.41 111.748 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.88 -36.33 80.95 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.313 0.645 . . . . 72.33 111.537 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -89.47 37.55 0.87 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.074 0.549 . . . . 72.35 111.28 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -127.03 84.8 2.3 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.436 1.094 . . . . 52.25 109.641 172.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -143.07 13.71 1.85 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.47 1.108 . . . . 74.52 109.531 170.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.89 -58.68 0.32 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.797 0.839 . . . . 72.04 110.368 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 129.57 120.01 2.2 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-O 119.947 -0.363 . . . . 34.54 112.358 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -141.51 126.66 18.47 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.445 0.698 . . . . 74.3 110.176 -177.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.0 -84.83 0.07 OUTLIER Glycine 0 C--N 1.35 1.331 0 O-C-N 124.322 1.014 . . . . 64.43 112.804 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 4.4 t -69.76 97.69 1.12 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.133 0.973 . . . . 60.12 110.461 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -126.38 -37.92 2.16 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.653 1.181 . . . . 71.13 109.116 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -81.69 119.34 23.71 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.928 0.891 . . . . 64.2 109.138 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -82.83 95.86 8.05 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.043 -0.725 . . . . 72.24 109.043 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -63.71 88.93 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.83 1.252 . . . . 62.52 111.221 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -142.88 111.41 6.25 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.407 -0.96 . . . . 75.34 108.407 -176.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 N-CA-C 109.541 -0.54 . . . . 65.32 109.541 -174.463 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.444 -0.576 . . . . 71.25 109.444 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 451' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 87' ' ' ALA . 3.9 p -119.07 -63.1 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.113 0.565 . . . . 75.22 111.492 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 452' ' ' VAL . . . . . 0.462 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 43.3 t -92.11 89.8 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.256 -1.016 . . . . 55.34 108.256 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -80.29 60.08 4.53 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.367 -0.833 . . . . 74.34 113.197 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 65.2 tp -82.2 122.52 28.0 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 109.442 -0.577 . . . . 52.41 109.442 176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 44.6 m -139.65 136.11 33.96 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.243 -1.021 . . . . 53.41 108.243 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 10.7 t70 76.21 163.16 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.37 1.468 . . . . 74.41 111.501 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -83.96 161.86 20.65 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.948 0.899 . . . . 60.55 112.209 -174.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 51.2 m -147.51 141.16 25.57 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.227 1.011 . . . . 63.11 109.446 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.3 142.64 58.31 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.703 0.801 . . . . 71.4 111.026 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 460' ' ' LEU . . . . . 0.59 HD21 ' HB ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -89.0 144.51 26.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.698 0.761 . . . . 70.22 109.932 -177.116 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 461' ' ' PHE . . . . . 0.626 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 18.9 p90 -92.79 13.36 20.53 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.0 1.32 . . . . 65.13 112.956 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -66.19 108.15 2.19 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 120.744 0.307 . . . . 74.45 110.857 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 10.0 t -153.96 117.94 4.75 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.405 -0.816 . . . . 74.13 109.664 173.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -158.07 149.94 21.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.014 0.926 . . . . 75.24 109.352 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -85.23 80.91 9.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.695 -0.854 . . . . 71.22 108.695 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -80.34 152.73 28.79 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.343 -0.844 . . . . 55.22 111.549 -176.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -155.83 166.61 32.99 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.723 0.809 . . . . 71.04 110.049 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 468' ' ' LEU . . . . . 0.508 HD22 ' HG ' ' E' ' 470' ' ' LEU . 2.0 tt -157.67 -61.18 0.09 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 108.586 -0.894 . . . . 63.42 108.586 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 121.26 -107.61 1.25 Allowed Glycine 0 C--N 1.341 0.822 0 N-CA-C 110.043 -1.223 . . . . 73.42 110.043 -172.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 470' ' ' LEU . . . . . 0.642 ' HB3' ' HE1' ' A' ' 36' ' ' TRP . 75.8 mt 53.7 72.32 0.45 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 124.619 1.168 . . . . 75.25 110.456 -176.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? . . . . . 0 C--O 1.253 1.255 0 N-CA-C 107.94 -1.134 . . . . 75.03 107.94 -174.748 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' F' F ' 450' ' ' ASN . . . . . 0.578 ' N ' HD21 ' F' ' 450' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 108.899 -0.778 . . . . 75.0 108.899 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 451' ' ' VAL . . . . . 0.423 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 28.2 m -97.94 165.37 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 122.781 0.432 . . . . 70.32 110.603 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 452' ' ' VAL . . . . . 0.47 ' N ' ' SD ' ' B' ' 94' ' ' MET . 56.7 t 66.84 136.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 124.782 1.233 . . . . 63.44 111.251 -176.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -178.04 -157.68 19.3 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 111.678 -0.569 . . . . 32.35 111.678 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 454' ' ' LEU . . . . . 0.428 HD11 ' HA ' ' B' ' 95' ' ' ALA . 6.6 mp 64.93 -173.21 0.18 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.211 1.004 . . . . 63.52 111.248 178.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 11.7 t -157.3 179.32 9.37 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.707 0.403 . . . . 74.1 110.089 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -68.4 107.38 2.84 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.583 -0.895 . . . . 75.44 108.583 175.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -110.09 126.46 54.05 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.02 0.528 . . . . 65.01 110.654 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 16.7 p -92.19 -45.38 8.28 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.361 1.064 . . . . 52.51 110.797 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -75.39 80.68 2.45 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.33 0.586 . . . . 71.23 109.706 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 85.5 mt -97.1 157.58 15.85 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.356 -0.838 . . . . 70.43 111.001 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 461' ' ' PHE . . . . . 0.429 ' HB2' ' HB3' ' B' ' 136' ' ' LEU . 6.0 p90 -59.06 139.04 57.27 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 113.477 -1.692 . . . . 63.01 110.83 165.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -160.16 107.97 1.65 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.59 0.756 . . . . 72.31 109.043 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 4.3 t -151.37 66.85 0.89 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 122.866 1.317 . . . . 64.34 108.19 174.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 464' ' ' MET . . . . . 0.611 ' SD ' ' HB3' ' B' ' 129' ' ' ALA . 54.0 ttp -76.73 92.82 3.59 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.041 -1.436 . . . . 72.21 109.138 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -66.94 -32.55 73.88 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.07 0.948 . . . . 75.11 111.561 -176.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -66.47 -59.74 3.38 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.427 0.691 . . . . 63.24 110.869 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 467' ' ' ALA . . . . . 0.51 ' H ' ' HG2' ' F' ' 464' ' ' MET . . . 56.58 -170.29 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.821 1.248 . . . . 54.22 112.089 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -132.65 134.86 45.39 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.503 -0.554 . . . . 61.22 109.503 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . -81.91 119.12 4.78 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.587 -0.733 . . . . 71.3 112.005 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 470' ' ' LEU . . . . . 0.569 HD21 HG12 ' B' ' 40' ' ' VAL . 3.2 mm? -76.95 85.82 3.49 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.135 -0.691 . . . . 74.04 109.135 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 19.2 tptp . . . . . 0 CA--C 1.561 1.376 0 C-N-CA 125.767 1.627 . . . . 55.13 110.012 -172.432 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' G' G ' 450' ' ' ASN . . . . . 0.492 ' HB3' HG22 ' G' ' 452' ' ' VAL . 86.6 m-20 . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.849 -0.426 . . . . 72.25 109.849 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 4.0 p -73.89 -10.69 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.561 0.744 . . . . 72.52 111.554 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 452' ' ' VAL . . . . . 0.492 HG22 ' HB3' ' G' ' 450' ' ' ASN . 35.2 m -67.86 -179.33 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 124.136 0.974 . . . . 73.04 111.786 173.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 98.47 68.62 0.92 Allowed Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.421 -0.809 . . . . 62.3 112.082 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 454' ' ' LEU . . . . . 0.454 HD13 ' HB2' ' G' ' 457' ' ' GLN . 4.1 pp -87.44 138.17 31.71 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.333 -0.988 . . . . 74.13 108.333 169.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 63.0 m -83.56 -60.47 2.12 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 110.36 -0.237 . . . . 73.53 110.36 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -107.31 140.91 39.48 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.337 0.655 . . . . 64.3 111.473 -174.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 457' ' ' GLN . . . . . 0.598 ' HG2' ' H ' ' G' ' 458' ' ' THR . 31.6 tt0 -174.87 -175.88 0.93 Allowed 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 124.986 1.315 . . . . 74.54 108.098 175.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 458' ' ' THR . . . . . 0.598 ' H ' ' HG2' ' G' ' 457' ' ' GLN . 62.6 p 69.03 158.39 0.16 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 126.763 2.025 . . . . 73.03 112.147 -176.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 30.2 t70 59.11 76.19 0.36 Allowed 'General case' 0 C--N 1.355 0.831 0 C-N-CA 124.134 0.974 . . . . 73.32 108.869 -170.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.64 114.24 6.1 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.341 -1.355 . . . . 72.11 107.341 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -41.3 -48.14 3.57 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.913 1.285 . . . . 74.23 112.49 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 58.3 t80 48.91 81.17 0.05 Allowed 'General case' 0 C--N 1.362 1.11 0 C-N-CA 125.351 1.46 . . . . 75.23 111.672 175.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 14.8 t -86.19 -0.28 55.37 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.803 -0.635 . . . . 53.14 111.652 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 13.2 tpt -61.34 119.25 8.14 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.274 1.029 . . . . 71.04 110.299 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.23 -63.08 1.35 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.194 0.998 . . . . 65.13 110.634 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -61.52 109.71 1.26 Allowed 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.512 0.725 . . . . 70.42 110.287 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -69.6 -82.83 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 O-C-N 124.049 0.843 . . . . 72.13 109.842 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 468' ' ' LEU . . . . . 0.429 HD13 HD12 ' C' ' 126' ' ' LEU . 50.5 mt -141.58 178.24 7.59 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.195 0.998 . . . . 72.53 108.838 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -146.51 129.7 3.42 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-O 119.325 -0.708 . . . . 34.3 111.797 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 470' ' ' LEU . . . . . 0.499 HD21 HD22 ' C' ' 126' ' ' LEU . 24.0 mt -124.55 114.45 19.43 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 117.328 0.564 . . . . 73.22 110.605 177.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 N-CA-C 106.853 -1.536 . . . . 75.12 106.853 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 42.6 t30 . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.115 -0.698 . . . . 62.25 109.115 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 46.5 t -55.46 -57.81 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.943 0.897 . . . . 62.32 111.808 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 452' ' ' VAL . . . . . 0.608 ' HB ' ' SD ' ' D' ' 94' ' ' MET . 2.1 p -143.04 -80.93 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 122.89 0.476 . . . . 63.21 112.046 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 453' ' ' GLY . . . . . 0.528 ' H ' HG13 ' H' ' 452' ' ' VAL . . . 79.73 100.33 0.27 Allowed Glycine 0 C--N 1.35 1.35 0 N-CA-C 111.598 -0.601 . . . . 61.54 111.598 -168.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -140.83 144.03 35.13 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.33 0.565 . . . . 64.21 110.402 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 455' ' ' THR . . . . . 0.408 HG22 ' O ' ' D' ' 48' ' ' SER . 26.8 p -140.84 99.52 3.63 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.111 1.364 . . . . 63.44 108.852 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -147.89 133.79 19.11 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.549 0.34 . . . . 73.43 110.168 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -134.8 36.32 3.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.272 1.029 . . . . 64.04 109.651 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 21.4 m -80.98 87.43 5.99 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 122.176 -0.328 . . . . 72.21 110.259 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 12.7 t70 62.53 -171.5 0.16 Allowed 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.887 1.275 . . . . 71.12 110.463 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 460' ' ' LEU . . . . . 0.608 HD11 ' HE2' ' D' ' 133' ' ' PHE . 0.4 OUTLIER -139.41 137.73 35.9 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.828 -0.805 . . . . 54.03 108.828 175.257 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' H' H ' 461' ' ' PHE . . . . . 0.433 ' N ' HD13 ' H' ' 460' ' ' LEU . 19.9 p90 -87.04 18.67 3.45 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.116 1.366 . . . . 72.13 113.269 -172.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 462' ' ' TYR . . . . . 0.455 ' HA ' HD23 ' D' ' 136' ' ' LEU . 6.0 p90 -77.11 139.91 40.1 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.031 0.378 . . . . 72.45 110.444 -177.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 33.4 p -127.75 124.62 38.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.521 0.729 . . . . 64.41 109.756 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 464' ' ' MET . . . . . 0.425 ' HE2' ' HB3' ' H' ' 464' ' ' MET . 40.4 ttp -160.96 -81.74 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.585 0.754 . . . . 74.43 109.853 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? 58.04 75.75 0.37 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.048 0.939 . . . . 64.12 111.05 -172.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -167.87 -51.33 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.785 0.834 . . . . 54.23 109.553 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . 66.1 -80.9 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.389 1.476 . . . . 64.55 112.251 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 95.6 mt -133.51 -9.66 2.84 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.472 0.709 . . . . 61.22 112.132 -175.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.19 -37.36 3.41 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 111.785 -0.526 . . . . 50.54 111.785 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 470' ' ' LEU . . . . . 0.742 HD11 HG12 ' D' ' 40' ' ' VAL . 3.6 mm? 69.35 84.34 0.15 Allowed 'General case' 0 C--N 1.355 0.817 0 C-N-CA 125.497 1.519 . . . . 72.14 112.466 169.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 471' ' ' LYS . . . . . 0.4 ' HB3' ' NZ ' ' H' ' 471' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.126 0 N-CA-C 106.801 -1.555 . . . . 73.34 106.801 175.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.429 ' HB3' ' HB3' ' A' ' 6' ' ' ASN . 1.7 mpt? . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.78 0.324 . . . . 74.14 110.391 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 m -72.93 91.45 1.54 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.597 0.759 . . . . 72.44 109.007 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 64.76 -164.97 0.24 Allowed 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 124.522 1.129 . . . . 71.34 111.345 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 67.41 -81.26 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.613 1.565 . . . . 72.43 111.425 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -126.72 92.03 3.47 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.422 -0.955 . . . . 71.34 108.422 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.452 ' HB2' ' HG3' ' A' ' 8' ' ' GLU . 25.9 p-10 -155.36 -50.68 0.09 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.006 0.522 . . . . 74.44 110.176 176.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m 52.12 29.97 7.07 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.882 1.273 . . . . 52.14 111.902 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' A' ' 6' ' ' ASN . 42.7 mt-10 -65.05 -38.59 91.34 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.895 0.878 . . . . 74.32 111.103 -172.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.3 mtm -84.51 143.44 29.35 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.66 -0.7 . . . . 65.33 109.233 172.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.1 m -146.62 132.02 18.6 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.614 0.765 . . . . 61.12 109.865 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.651 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.4 t80 -133.25 132.87 41.96 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.647 -0.872 . . . . 65.52 108.647 173.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -147.39 116.64 6.94 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.682 -0.858 . . . . 74.52 108.682 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.463 HG12 ' HD2' ' A' ' 84' ' ' PHE . 50.7 mt -81.19 117.4 27.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.87 -0.789 . . . . 71.12 108.87 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -86.34 -40.37 15.52 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 123.742 0.651 . . . . 74.42 110.757 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -168.12 137.46 2.48 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 122.969 0.168 . . . . 74.55 110.744 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.593 HD12 ' HG3' ' C' ' 130' ' ' PRO . 88.6 mt -125.44 133.48 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.378 1.071 . . . . 72.52 108.584 177.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' HB3' HG23 ' B' ' 122' ' ' THR . 41.4 p90 -168.97 177.32 4.99 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 123.97 0.794 . . . . 75.44 111.355 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -102.2 122.96 45.19 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.05 -0.977 . . . . 74.3 108.749 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 31.3 mtpt -88.07 -45.21 10.36 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.316 -0.624 . . . . 65.43 109.316 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.3 t70 -134.34 125.67 28.08 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.507 -1.224 . . . . 72.02 108.288 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 58.9 mt -124.91 140.39 48.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.696 -1.594 . . . . 64.21 106.696 173.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -156.09 121.12 4.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.17 0.509 . . . . 74.53 109.727 171.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.474 ' H ' ' HB ' ' B' ' 21' ' ' ILE . 86.8 t80 -116.3 118.54 33.05 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 106.36 -1.718 . . . . 72.42 106.36 173.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -119.56 126.48 51.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.058 0.39 . . . . 51.43 110.145 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.17 75.64 23.15 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.685 -1.228 . . . . 54.33 107.685 169.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.56 -28.68 25.91 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.26 1.974 . . . . 62.42 110.405 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.454 ' O ' HG23 ' A' ' 31' ' ' VAL . 43.1 m-20 -93.33 12.41 24.81 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.196 -1.365 . . . . 71.13 110.898 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.73 -46.88 80.19 Favored Pre-proline 0 CA--C 1.571 1.752 0 C-N-CA 124.185 0.994 . . . . 70.4 113.607 -176.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.13 -21.77 20.05 Favored 'Trans proline' 0 C--N 1.396 3.073 0 C-N-CA 122.082 1.855 . . . . 75.31 113.651 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -71.65 -47.57 53.53 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.623 -0.51 . . . . 70.02 109.623 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.614 HG22 HD21 ' A' ' 68' ' ' LEU . 88.1 t -60.91 -33.88 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.738 1.215 . . . . 72.3 110.936 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.446 ' HD1' HH11 ' B' ' 15' ' ' ARG . 90.9 t80 -56.46 -39.52 73.3 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.643 1.177 . . . . 74.41 111.918 176.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -96.43 -35.15 11.26 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.652 0.781 . . . . 60.21 111.87 -172.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -83.15 170.63 14.54 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.596 0.758 . . . . 74.55 112.88 -172.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.63 115.86 9.36 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.825 0.85 . . . . 43.52 111.101 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -79.63 92.65 5.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.022 0.929 . . . . 71.42 109.966 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -140.51 75.83 26.09 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 107.38 -1.341 . . . . 72.2 107.38 172.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 67' ' ' SER . 24.6 Cg_endo -90.52 163.85 4.35 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.095 2.53 . . . . 72.4 113.98 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -126.32 118.39 24.97 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.04 -0.982 . . . . 64.33 108.534 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.69 110.05 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.602 0.761 . . . . 74.32 110.831 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -103.24 140.07 37.86 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.679 -0.86 . . . . 74.25 108.679 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.541 HD23 ' SD ' ' E' ' 464' ' ' MET . 64.7 tp -132.09 124.76 29.83 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.491 0.716 . . . . 73.1 109.701 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.452 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 64.4 m-20 -102.95 124.33 48.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.152 -1.055 . . . . 71.31 108.152 175.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.35 115.21 29.82 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.788 -1.56 . . . . 72.3 106.788 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 12.0 m-20 -132.07 124.6 29.53 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.096 -1.075 . . . . 62.32 108.096 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.541 ' HB ' HD21 ' E' ' 460' ' ' LEU . 53.9 m -115.35 121.94 44.36 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.404 -0.591 . . . . 71.23 109.404 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.76 140.86 48.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.182 0.993 . . . . 71.22 108.614 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.563 ' HB3' ' H ' ' E' ' 454' ' ' LEU . 37.0 t -130.59 163.92 26.06 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.358 0.599 . . . . 65.31 111.628 -173.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.2 t -148.91 121.62 8.64 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.198 -1.365 . . . . 74.44 108.256 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -71.67 107.89 4.74 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.822 0.849 . . . . 70.45 109.279 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.9 mt -78.52 -34.51 47.24 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.221 0.608 . . . . 71.34 110.281 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.54 -177.71 6.59 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.939 0.895 . . . . 72.25 109.878 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.72 119.44 14.86 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.412 -0.588 . . . . 75.33 109.412 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.748 ' HA ' ' HB ' ' E' ' 451' ' ' VAL . 42.7 m-20 67.34 20.15 10.04 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.084 1.354 . . . . 73.41 112.151 -174.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.12 124.05 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.414 1.086 . . . . 75.31 108.35 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.499 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -142.43 169.22 17.99 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.337 -0.616 . . . . 73.54 109.337 174.337 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -128.75 130.51 47.17 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.498 -0.927 . . . . 74.3 108.498 174.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.8 m -102.42 132.06 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.586 -0.894 . . . . 62.12 108.586 169.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.51 106.92 21.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 125.194 1.397 . . . . 73.41 107.68 177.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.7 tp -87.57 99.14 11.82 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.693 -0.685 . . . . 71.12 109.155 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.709 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 52.6 ttt-85 -84.38 105.24 15.06 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.805 -0.813 . . . . 75.14 108.805 174.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.507 HG21 ' HB1' ' A' ' 110' ' ' ALA . 1.7 m -112.95 106.58 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 108.37 -0.974 . . . . 62.23 108.37 175.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 25.6 m -109.83 112.01 23.79 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.451 1.1 . . . . 74.32 110.716 -167.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 78.2 t -101.74 110.97 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.52 0.728 . . . . 74.42 109.656 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -115.44 108.29 16.29 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.735 -0.839 . . . . 70.25 108.735 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.79 133.49 53.08 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.312 -0.995 . . . . 61.11 108.312 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 39.4 t -140.27 134.38 30.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.905 0.482 . . . . 71.11 110.595 -176.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.657 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -94.78 80.17 3.74 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.432 1.093 . . . . 74.43 108.436 172.807 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.06 -118.86 5.48 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.311 -0.858 . . . . 74.44 112.593 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -89.41 5.97 42.82 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.61 0.764 . . . . 73.3 111.368 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.439 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . 6.3 tp10 -116.84 112.92 21.77 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.636 -0.876 . . . . 73.23 108.636 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.0 m -73.75 130.08 39.24 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.541 0.609 . . . . 72.25 109.864 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.533 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.81 -59.96 2.53 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.433 0.693 . . . . 74.21 109.789 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -159.28 163.35 35.85 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 115.157 -0.928 . . . . 71.33 110.782 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 34.6 tp -135.68 106.38 6.55 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.751 -1.113 . . . . 74.23 108.172 175.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 118' ' ' VAL . 57.2 m -107.69 97.36 7.1 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.241 -0.651 . . . . 73.43 109.241 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -113.06 117.16 31.23 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.671 -1.233 . . . . 74.53 107.671 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.4 t -126.3 109.55 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.492 -0.776 . . . . 73.0 109.119 -175.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.579 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.3 mt-30 -90.34 86.23 6.42 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.866 -1.061 . . . . 63.35 108.608 171.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.49 ' HG3' HD22 ' A' ' 106' ' ' LEU . 53.4 tp60 -76.42 109.05 9.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.156 -1.384 . . . . 65.03 108.104 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.37 144.83 17.53 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.429 -0.668 . . . . 61.41 111.429 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.418 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -148.59 122.46 1.49 Allowed Glycine 0 CA--C 1.502 -0.746 0 N-CA-C 110.869 -0.892 . . . . 72.43 110.869 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.9 mt -80.93 121.77 35.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 108.406 -0.961 . . . . 75.25 108.406 175.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.651 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.2 m-85 -130.37 135.53 48.13 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.511 -0.922 . . . . 74.02 108.511 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.4 p -112.62 98.02 6.96 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.325 -0.62 . . . . 61.33 109.325 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.44 HD12 HD11 ' A' ' 89' ' ' ILE . 39.3 pt -99.52 149.8 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 115.733 -0.667 . . . . 73.33 109.469 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.58 147.73 14.02 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.413 0.685 . . . . 74.13 110.121 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.24 9.75 64.93 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 114.873 0.709 . . . . 62.41 114.873 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -123.39 153.36 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.748 0.819 . . . . 72.24 110.085 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 14.2 tt0 -160.78 179.4 8.55 Favored 'General case' 0 CA--C 1.557 1.228 0 O-C-N 123.251 0.345 . . . . 74.43 111.085 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.457 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 73.61 -133.62 17.85 Favored Glycine 0 C--N 1.351 1.38 0 C-N-CA 123.907 0.765 . . . . 71.32 113.838 177.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.0 p -64.86 -35.25 80.51 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.934 0.894 . . . . 72.44 110.961 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -64.96 -35.58 81.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.994 0.918 . . . . 75.04 110.846 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.571 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 28.1 ttt -62.37 -47.06 85.82 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.635 0.774 . . . . 75.1 110.904 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.71 -39.24 91.02 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.777 -0.647 . . . . 71.0 110.865 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -67.24 -31.86 72.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.287 1.035 . . . . 71.14 111.633 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 24.6 t -69.95 -29.27 66.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.991 0.424 . . . . 74.42 110.899 -175.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.593 HD13 ' HG ' ' E' ' 454' ' ' LEU . 1.8 tt -95.09 -32.68 12.99 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.75 -0.659 . . . . 63.42 110.235 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.2 -1.93 66.51 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-O 119.578 -0.568 . . . . 74.2 113.942 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -147.82 -64.54 0.26 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 117.827 0.813 . . . . 75.31 111.967 -176.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.435 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 51.1 t80 -56.22 -70.83 0.1 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.252 1.421 . . . . 73.33 113.607 -169.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.424 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 86.6 m -72.35 -35.64 3.4 Favored Pre-proline 0 CA--C 1.565 1.541 0 N-CA-C 114.894 1.442 . . . . 73.31 114.894 -173.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 37.8 Cg_endo -64.65 -26.12 61.38 Favored 'Trans proline' 0 C--N 1.392 2.866 0 CA-C-N 121.99 1.746 . . . . 72.15 113.103 173.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -72.53 -23.1 60.95 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.847 0.459 . . . . 74.21 111.217 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.3 mm -61.91 -40.58 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.092 0.472 . . . . 74.2 109.759 171.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.49 HD22 ' HG3' ' A' ' 80' ' ' GLN . 83.7 mt -82.82 -13.45 56.18 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.298 -0.864 . . . . 73.54 112.507 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.415 ' HE2' ' HA ' ' A' ' 130' ' ' PRO . 49.2 t80 -63.94 -43.23 74.73 Favored Pre-proline 0 CA--C 1.567 1.613 0 C-N-CA 123.709 0.804 . . . . 75.23 113.101 -174.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.56 -35.77 57.59 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 122.215 1.943 . . . . 60.55 113.904 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.2 -40.54 64.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.918 0.487 . . . . 74.11 110.79 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.507 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -69.81 -36.12 75.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.528 -0.76 . . . . 65.44 110.514 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.467 ' NH1' HD12 ' C' ' 105' ' ' ILE . 36.5 ttm180 -52.95 -53.07 55.09 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.292 0.995 . . . . 74.42 109.66 171.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.75 -44.61 95.74 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 124.385 1.053 . . . . 72.42 111.701 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 17.1 t -62.2 -45.3 93.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.474 0.71 . . . . 61.42 110.555 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.3 mt -60.97 -54.66 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.799 0.84 . . . . 74.22 110.016 175.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.586 HG23 ' HG3' ' A' ' 125' ' ' GLN . 85.0 m -48.55 -48.0 38.92 Favored 'General case' 0 C--O 1.248 1.024 0 C-N-CA 124.515 1.126 . . . . 64.43 111.585 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -64.31 -47.69 78.48 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.272 -1.331 . . . . 62.43 110.034 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 39.0 mtp -61.07 -41.04 95.9 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.183 0.993 . . . . 73.2 112.32 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 114' ' ' ILE . 98.3 t -62.2 -45.94 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.691 0.796 . . . . 73.25 109.954 177.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.0 m -70.68 -27.77 64.27 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.386 -0.825 . . . . 50.32 111.978 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -72.55 -30.14 64.17 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.505 0.722 . . . . 72.05 110.186 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.82 7.07 75.9 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.541 0.525 . . . . 40.12 112.981 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.1 m 69.41 12.23 8.24 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.772 1.229 . . . . 74.11 111.791 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.533 ' HE1' HG11 ' A' ' 31' ' ' VAL . 89.3 m-85 -81.1 152.35 71.14 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.177 0.591 . . . . 72.32 109.792 173.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.4 138.16 79.31 Favored 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 123.162 2.575 . . . . 71.44 112.224 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.586 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.5 tt0 -55.39 129.48 38.78 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 123.875 0.734 . . . . 75.23 111.654 -176.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.4 tp -110.4 116.76 32.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.945 -1.025 . . . . 71.02 109.566 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -118.84 101.87 8.38 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.723 -1.214 . . . . 63.42 107.723 172.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 pp -64.4 134.24 54.16 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 109.8 -0.445 . . . . 63.21 109.8 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.28 146.9 94.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.058 0.543 . . . . 62.04 110.46 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.415 ' HA ' ' HE2' ' A' ' 107' ' ' PHE . 36.3 Cg_exo -61.83 115.18 2.64 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.54 2.16 . . . . 54.23 111.38 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.35 121.08 48.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.986 -1.116 . . . . 75.01 107.986 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -71.98 95.81 1.63 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.801 -0.815 . . . . 73.34 108.801 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 94.3 m-85 -60.51 -31.61 70.66 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.67 0.788 . . . . 71.43 111.996 -177.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.66 -50.74 70.02 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.911 0.757 . . . . 61.03 109.921 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.11 90.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.574 0.75 . . . . 62.44 111.064 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.41 -34.18 77.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.738 0.815 . . . . 73.33 111.42 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -73.19 -34.6 66.07 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.187 0.595 . . . . 74.01 110.036 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.456 ' SD ' ' HA3' ' A' ' 146' ' ' GLY . 24.1 mmt -74.68 -23.73 58.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.041 0.536 . . . . 72.22 111.306 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 143' ' ' GLN . 82.4 m-20 -66.95 -31.12 71.48 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.26 0.624 . . . . 61.13 110.061 171.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -85.76 -45.11 11.93 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.312 -0.858 . . . . 71.44 110.474 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.4 tp -69.14 -45.96 68.79 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.617 1.167 . . . . 70.23 111.575 -170.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -146.77 12.37 1.13 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 120.968 0.413 . . . . 71.34 111.335 -172.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 2.1 mp0 69.04 -75.97 0.06 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.489 1.516 . . . . 53.2 112.689 176.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -128.95 65.75 1.44 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.47 0.652 . . . . 65.23 109.819 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -165.45 -160.73 0.48 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.572 -1.194 . . . . 60.13 109.704 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.456 ' HA3' ' SD ' ' A' ' 138' ' ' MET . . . 89.65 8.2 68.01 Favored Glycine 0 C--N 1.355 1.633 0 O-C-N 122.943 0.152 . . . . 71.22 113.316 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.402 ' O ' ' HB ' ' C' ' 149' ' ' THR . 11.2 pt-20 -81.57 134.44 35.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.246 1.018 . . . . 62.01 111.141 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.58 -147.62 25.56 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 116.31 -0.405 . . . . 72.33 112.667 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.1 m -139.71 160.32 40.14 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.921 0.888 . . . . 75.13 109.396 -176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -82.2 -159.05 0.28 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.926 0.891 . . . . 55.43 110.618 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 65.22 83.87 0.16 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.565 1.146 . . . . 64.14 110.438 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -141.03 32.17 1.76 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.311 -1.313 . . . . 74.42 108.524 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -83.2 72.36 10.16 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 108.371 -0.974 . . . . 73.44 108.371 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -66.11 -64.54 0.84 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.458 0.703 . . . . 63.42 111.337 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.048 0 CA-C-O 118.15 -0.928 . . . . 61.02 109.095 -179.597 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.54 ' SD ' ' HA ' ' F' ' 452' ' ' VAL . 90.5 mtp . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.192 -0.67 . . . . 62.54 109.192 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 42.4 t -163.17 -64.74 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.202 1.001 . . . . 72.32 108.969 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -166.42 133.73 2.65 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.132 -1.062 . . . . 73.52 108.132 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -75.13 87.56 2.42 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.536 1.16 . . . . 72.11 110.796 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -110.14 -32.64 6.93 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.154 -0.93 . . . . 64.21 110.903 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -77.68 90.9 4.0 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.16 -0.682 . . . . 74.21 109.16 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 17.4 m -75.77 -37.64 59.06 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.514 -1.221 . . . . 71.23 110.674 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -76.54 -20.62 56.69 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.742 -1.117 . . . . 73.35 111.089 -174.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 22.9 ptm 51.67 -168.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 126.507 1.923 . . . . 73.31 113.353 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 87.7 m -141.62 121.26 13.37 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.663 -1.236 . . . . 75.13 107.663 174.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.455 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 30.8 t80 -139.32 138.96 37.13 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.546 -0.909 . . . . 55.22 108.546 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -158.93 141.12 13.88 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.215 0.606 . . . . 73.31 109.674 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.418 HD13 HD11 ' B' ' 16' ' ' ILE . 54.1 mt -83.69 121.98 37.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.989 -1.115 . . . . 64.04 107.989 172.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -94.11 -43.8 8.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.204 0.602 . . . . 61.31 109.401 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.446 HH11 ' HD1' ' A' ' 32' ' ' PHE . 50.0 ttt180 -163.89 132.69 3.77 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.515 -0.766 . . . . 73.31 109.314 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.418 HD11 HD13 ' B' ' 13' ' ' ILE . 96.0 mt -115.02 141.29 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.237 -1.394 . . . . 63.35 107.237 169.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.428 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 33.1 p90 -164.73 157.27 16.44 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.837 0.711 . . . . 74.21 110.735 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.502 HG21 HD11 ' B' ' 21' ' ' ILE . 22.6 m -83.72 122.92 29.29 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.635 -1.246 . . . . 72.15 107.635 168.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.414 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 19.4 mtpp -84.15 -52.82 5.96 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.917 -0.772 . . . . 75.34 108.917 176.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 28.9 t70 -134.96 149.43 50.22 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.687 -0.688 . . . . 63.25 111.256 -170.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.502 HD11 HG21 ' B' ' 18' ' ' THR . 25.7 mm -139.81 144.74 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.528 1.531 . . . . 74.53 108.575 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -147.73 110.99 4.88 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.098 0.873 . . . . 75.44 108.667 166.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.477 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 85.7 t80 -119.81 113.06 20.03 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.204 -1.406 . . . . 72.3 107.204 170.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -122.95 124.23 42.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.611 0.764 . . . . 72.41 109.203 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.49 85.0 12.78 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.162 -1.421 . . . . 71.02 107.162 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.44 -36.83 19.02 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.886 2.39 . . . . 71.01 112.811 -169.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -105.5 17.26 24.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.887 0.875 . . . . 61.44 110.378 -176.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.435 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -41.59 -61.97 1.25 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 115.349 1.611 . . . . 63.52 115.349 -164.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.3 Cg_exo -66.97 -16.06 48.61 Favored 'Trans proline' 0 C--N 1.4 3.287 0 C-N-CA 122.314 2.01 . . . . 55.14 112.372 -170.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -97.73 -49.04 4.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.19 0.996 . . . . 74.11 111.408 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.516 HG22 HD12 ' B' ' 68' ' ' LEU . 9.8 p -64.38 -20.49 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.563 0.745 . . . . 51.23 112.333 -166.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -65.04 -17.76 64.73 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.45 0.908 . . . . 72.23 113.45 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -59.3 -25.52 64.21 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.114 0.566 . . . . 71.34 110.901 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -94.46 80.11 3.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.512 1.125 . . . . 65.35 108.674 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.3 93.25 3.4 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.294 0.569 . . . . 72.02 109.59 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -161.74 158.26 25.56 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.752 1.221 . . . . 70.35 107.988 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -60.43 106.15 0.71 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.903 0.881 . . . . 72.05 110.032 169.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.546 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 35.5 Cg_endo -64.35 124.71 13.79 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.872 1.714 . . . . 73.03 110.497 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -58.15 107.23 0.45 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 123.724 0.64 . . . . 61.42 110.126 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.569 HG22 HD21 ' F' ' 470' ' ' LEU . 28.5 m -96.68 150.52 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.744 0.783 . . . . 74.33 112.535 -173.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -119.42 115.12 23.44 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.253 -1.34 . . . . 64.23 107.657 170.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.544 HD21 HD23 ' F' ' 468' ' ' LEU . 3.9 mp -85.15 132.22 34.33 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.421 -1.326 . . . . 71.22 107.421 176.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 14.4 t70 -147.38 110.96 4.95 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 110.135 -0.32 . . . . 75.3 110.135 -177.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 mp -100.57 163.79 12.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.995 0.426 . . . . 72.31 110.211 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 17.7 t70 -158.43 139.25 12.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.712 1.205 . . . . 52.4 108.397 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 47.8 p -133.6 117.73 17.4 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.938 0.495 . . . . 71.53 110.452 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.64 162.8 17.44 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.632 1.173 . . . . 50.24 108.662 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.434 ' HB2' ' HD2' ' B' ' 56' ' ' TYR . 64.1 p -143.22 160.93 39.54 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.184 -0.672 . . . . 71.31 109.184 170.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.0 p -152.16 135.6 16.02 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.509 0.724 . . . . 64.33 109.426 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.33 124.95 29.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.08 0.552 . . . . 43.42 110.215 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 64.6 mt -86.96 -44.68 11.44 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.672 -0.492 . . . . 74.43 109.672 172.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.96 -175.63 5.47 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.675 -0.693 . . . . 62.24 111.098 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.48 124.32 21.02 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.524 -1.216 . . . . 73.04 109.443 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.427 ' H ' ' HB ' ' F' ' 451' ' ' VAL . 7.2 m-20 67.29 19.59 10.2 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.563 1.145 . . . . 72.13 111.663 178.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -131.27 125.82 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.166 0.986 . . . . 72.22 109.464 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.434 ' HD2' ' HB2' ' B' ' 48' ' ' SER . 0.2 OUTLIER -131.81 140.51 49.18 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.977 -0.749 . . . . 74.34 108.977 174.501 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -112.41 106.67 15.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.982 -1.488 . . . . 73.43 106.982 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.4 t -93.74 140.66 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.921 0.488 . . . . 62.21 109.924 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.3 t -116.77 135.34 57.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 124.41 1.084 . . . . 72.3 109.062 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.07 109.87 16.41 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.82 -1.178 . . . . 74.23 107.82 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.501 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.2 ttt180 -95.38 123.64 39.01 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.813 0.845 . . . . 75.12 109.727 173.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.514 ' HB ' HD11 ' B' ' 114' ' ' ILE . 15.2 t -118.34 123.85 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.347 -0.982 . . . . 64.54 108.347 171.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 39.6 m -107.85 140.78 40.43 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.676 1.19 . . . . 72.42 109.455 -178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.463 HG21 HG21 ' B' ' 114' ' ' ILE . 97.8 t -133.13 100.59 3.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 124.155 0.982 . . . . 64.11 108.715 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 70.8 m -84.0 138.88 32.88 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.023 -1.102 . . . . 52.31 108.023 167.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.554 ' HB2' HG12 ' B' ' 40' ' ' VAL . . . -147.69 149.39 32.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.985 0.357 . . . . 61.14 110.459 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 62.5 p -152.11 135.91 16.3 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.834 0.709 . . . . 70.51 111.541 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.546 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 43.6 mt -103.21 117.35 34.34 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.182 0.993 . . . . 75.12 108.942 173.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.04 -112.69 5.13 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.244 -0.889 . . . . 65.03 112.189 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -115.88 4.21 13.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.691 0.796 . . . . 75.31 111.703 -175.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -118.96 158.72 25.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.591 0.756 . . . . 73.25 110.012 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.5 m -64.56 138.25 58.3 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.615 0.572 . . . . 74.34 110.792 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.448 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -96.71 -65.11 0.99 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.337 -0.847 . . . . 72.21 108.811 171.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -149.82 155.29 39.83 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.368 -0.833 . . . . 74.05 109.721 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 41.4 mt -131.98 108.56 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.232 -1.766 . . . . 64.35 106.232 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.444 ' SG ' HG23 ' B' ' 114' ' ' ILE . 49.4 t -118.82 139.46 51.57 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.693 -0.854 . . . . 44.04 108.693 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -159.69 133.78 7.47 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.29 -0.633 . . . . 65.11 109.29 -173.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.7 t -124.62 146.48 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.126 -0.943 . . . . 73.33 109.019 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 29.1 mt-30 -122.3 84.12 2.21 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.076 -1.083 . . . . 71.15 108.076 171.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -81.75 101.06 9.88 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.721 -1.127 . . . . 73.31 109.473 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -92.2 167.78 30.58 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 111.9 -0.48 . . . . 44.35 111.9 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.87 126.81 1.66 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.109 -0.796 . . . . 54.12 111.109 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 65.6 mt -84.83 127.78 39.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.605 -0.887 . . . . 72.24 108.605 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -134.87 146.36 49.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.153 0.981 . . . . 72.04 108.618 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -99.94 106.9 18.76 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.883 -0.784 . . . . 63.3 108.883 170.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.661 ' HB ' HD11 ' B' ' 89' ' ' ILE . 48.4 pt -116.06 130.41 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.171 0.588 . . . . 62.51 110.239 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -149.52 159.9 43.92 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.559 0.744 . . . . 34.05 110.304 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.99 -54.32 4.73 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.741 -0.663 . . . . 55.41 112.692 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.661 HD11 ' HB ' ' B' ' 86' ' ' ILE . 17.6 pt -54.23 138.56 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.736 1.214 . . . . 65.52 112.798 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -162.8 172.5 15.11 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.793 -1.094 . . . . 71.43 109.749 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.42 -109.93 2.94 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.994 -0.548 . . . . 44.24 112.282 -173.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.2 m -89.61 -26.62 20.68 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.481 0.712 . . . . 63.44 110.946 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.511 ' HB3' HG22 ' B' ' 89' ' ' ILE . 48.5 mt-30 -58.52 -46.08 87.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.394 0.616 . . . . 71.02 110.049 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.552 ' HB2' HG21 ' F' ' 452' ' ' VAL . 0.0 OUTLIER -70.32 -35.29 73.55 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.584 -1.189 . . . . 65.05 110.507 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.72 -47.85 84.03 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 124.119 0.887 . . . . 62.42 109.954 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -62.24 -27.8 69.25 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.263 -1.335 . . . . 74.21 111.306 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 t -76.06 -66.93 0.73 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.008 0.523 . . . . 72.13 110.888 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 94' ' ' MET . 1.5 pp -71.83 -22.54 61.53 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 112.92 0.711 . . . . 64.41 112.92 -173.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.6 -1.21 53.04 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.553 -0.582 . . . . 33.43 114.058 -175.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.98 -64.43 0.19 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.608 0.704 . . . . 73.01 111.755 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -59.91 -55.03 39.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.314 1.045 . . . . 75.33 112.021 -168.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.482 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 92.1 m -59.52 -52.09 76.6 Favored Pre-proline 0 CA--C 1.568 1.665 0 C-N-CA 124.397 1.079 . . . . 72.05 112.097 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 71.1 Cg_exo -54.92 -40.5 85.23 Favored 'Trans proline' 0 C--N 1.404 3.485 0 C-N-CA 122.433 2.089 . . . . 72.45 114.393 172.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -63.89 -24.18 67.64 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.888 0.699 . . . . 73.43 112.888 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.53 -43.98 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.603 -0.517 . . . . 52.23 109.603 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 60.8 mt -76.71 -21.99 54.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.55 -1.205 . . . . 71.31 112.015 -173.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -60.57 -48.38 93.58 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 118.073 -0.965 . . . . 72.01 113.283 -171.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.28 -39.5 86.54 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.987 1.791 . . . . 63.24 113.277 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -66.57 -45.83 78.03 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.193 0.597 . . . . 75.32 110.684 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.88 -34.75 78.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.278 0.631 . . . . 64.2 111.045 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.721 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 39.1 ttt180 -63.62 -54.33 37.55 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.143 1.377 . . . . 64.11 111.178 -177.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.39 -33.9 76.74 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.716 0.635 . . . . 73.53 109.821 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.499 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.4 t -66.73 -31.52 72.23 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.146 0.578 . . . . 72.3 111.907 -177.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.582 HD12 HD22 ' B' ' 128' ' ' LEU . 80.5 mt -70.45 -58.66 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 109.033 -0.729 . . . . 75.51 109.033 172.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.6 m -59.02 -26.63 64.72 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 124.29 0.994 . . . . 51.42 111.825 -173.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 36.3 t -60.52 -56.6 19.36 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.205 1.002 . . . . 64.54 109.268 173.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.3 mmt -67.48 -34.21 76.69 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.655 0.782 . . . . 75.31 111.375 -173.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 114' ' ' ILE . 94.0 t -59.71 -49.69 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.958 0.903 . . . . 62.45 110.121 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.7 t -66.31 -34.75 78.7 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.651 -1.158 . . . . 60.45 111.363 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.403 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.6 mtt-85 -65.46 -35.84 82.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.388 0.675 . . . . 62.23 110.337 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.52 15.07 53.13 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 123.923 0.764 . . . . 51.12 112.96 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.503 HG23 ' HB3' ' A' ' 17' ' ' TYR . 69.3 p 54.37 26.78 7.33 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.959 1.704 . . . . 73.44 113.608 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -85.3 151.16 56.11 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.357 0.663 . . . . 63.22 110.906 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.61 167.71 1.34 Allowed 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 124.049 3.166 . . . . 64.12 115.315 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -63.85 114.83 4.31 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.036 -0.984 . . . . 65.2 112.548 -167.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 17.0 tp -116.28 98.49 6.62 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 115.432 -0.804 . . . . 64.12 109.501 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -97.37 95.96 8.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.25 -1.018 . . . . 75.43 108.25 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.721 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 31.8 tp -55.18 116.87 3.04 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.352 0.661 . . . . 73.53 110.69 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.62 146.18 88.17 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.886 0.874 . . . . 55.22 111.582 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -76.61 110.71 3.1 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.328 2.685 . . . . 75.5 111.923 -173.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.2 t -90.82 111.0 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 108.576 -0.898 . . . . 74.24 108.576 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -78.75 110.81 14.25 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.68 -0.859 . . . . 60.34 108.68 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -69.5 -48.66 59.86 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.581 0.55 . . . . 71.21 110.619 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -56.95 -40.78 77.08 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.187 0.995 . . . . 73.54 112.442 -171.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.43 -53.84 53.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.211 1.004 . . . . 70.12 111.384 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' F' ' 462' ' ' TYR . 6.5 mp -84.64 -11.98 54.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.493 -0.776 . . . . 74.1 111.664 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.404 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 66.7 t80 -71.38 -33.1 69.21 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.16 0.584 . . . . 53.44 110.272 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 59.9 mtm -63.47 -35.38 80.25 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.957 -0.565 . . . . 62.2 109.518 172.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.448 ' N ' HD22 ' B' ' 139' ' ' ASN . 0.7 OUTLIER -74.59 -16.44 60.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.774 0.83 . . . . 61.23 110.661 176.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -82.46 -34.97 27.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.263 0.625 . . . . 70.01 111.056 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 75.4 mt -81.86 -12.27 58.55 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 111.983 0.364 . . . . 74.53 111.983 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -156.94 130.51 8.1 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.317 1.047 . . . . 63.52 108.387 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -64.74 90.53 0.08 Allowed 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 121.903 0.858 . . . . 75.23 109.494 172.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -171.83 134.0 0.77 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.387 -1.278 . . . . 72.44 107.83 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.09 142.64 27.52 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.966 0.506 . . . . 54.52 110.596 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.01 46.24 1.2 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 110.871 -0.892 . . . . 70.44 110.871 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -65.46 149.1 50.6 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.51 1.124 . . . . 53.11 112.018 -176.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -122.68 147.34 16.83 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 110.759 -0.937 . . . . 72.42 110.759 174.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 67.1 p -71.86 93.55 1.34 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.19 -0.67 . . . . 61.42 109.19 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.54 71.23 2.45 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.375 1.083 . . . . 74.25 110.667 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -88.02 173.45 8.87 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.751 -1.113 . . . . 74.22 111.13 -175.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -150.2 104.43 3.26 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.648 -0.705 . . . . 73.12 109.617 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -111.48 115.39 29.15 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.63 -0.878 . . . . 75.13 108.63 174.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.18 163.48 28.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.767 0.827 . . . . 52.43 110.856 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.26 0 C-N-CA 123.805 0.842 . . . . 62.11 110.032 177.524 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttp . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.508 -0.553 . . . . 62.1 109.508 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 45.6 m 62.38 82.85 0.17 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.797 1.239 . . . . 65.02 111.265 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.93 34.92 0.51 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.268 1.027 . . . . 74.41 111.858 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -70.6 2.42 4.08 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.405 1.082 . . . . 65.43 112.446 174.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 65.0 t30 70.04 23.93 5.22 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.355 1.462 . . . . 71.13 110.939 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -83.71 -14.09 52.5 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.418 -0.81 . . . . 71.52 110.415 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 14.9 t -78.69 159.8 27.8 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 123.417 0.687 . . . . 73.42 110.382 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -99.4 72.78 1.83 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.411 0.684 . . . . 70.31 109.342 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 24.1 ttt 65.36 145.62 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.011 1.324 . . . . 73.52 112.949 175.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 32.4 m -85.56 95.9 9.47 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.029 -0.73 . . . . 73.31 109.029 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.546 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 3.5 t80 -121.14 124.2 44.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.487 0.715 . . . . 74.1 109.896 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -140.61 140.16 35.03 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.165 -1.05 . . . . 55.33 108.165 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 68.0 mt -85.96 129.74 37.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.159 -0.682 . . . . 74.05 109.159 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.486 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.4 mm100 -87.94 -45.43 10.24 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.64 0.776 . . . . 75.35 109.727 178.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -169.7 148.21 3.59 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.024 -0.534 . . . . 72.44 109.667 -172.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.4 mt -137.58 136.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.747 -1.205 . . . . 73.03 107.747 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.464 ' HB3' HG23 ' D' ' 122' ' ' THR . 28.9 p90 -169.74 161.03 9.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.007 0.432 . . . . 73.13 111.838 -172.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.9 p -80.39 108.06 13.7 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.095 -0.705 . . . . 54.3 109.095 170.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -68.34 -37.3 80.39 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.445 -0.576 . . . . 73.14 109.445 172.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 12.8 t70 -149.78 150.27 31.78 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.49 -0.777 . . . . 65.14 109.83 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.5 mt -141.63 146.94 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.34 1.456 . . . . 61.32 107.62 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -152.19 142.37 22.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.484 0.714 . . . . 73.12 109.563 173.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -142.9 137.86 29.8 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.618 -1.253 . . . . 75.45 107.618 170.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.08 121.68 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.365 1.066 . . . . 74.33 109.293 -172.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.34 69.11 13.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 106.12 -1.807 . . . . 74.41 106.12 165.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.22 -10.35 27.09 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.555 2.17 . . . . 34.4 112.178 -174.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -123.23 26.38 8.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.664 1.585 . . . . 70.35 109.774 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.61 -58.12 4.06 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 114.64 1.348 . . . . 72.31 114.64 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.57 -33.32 46.18 Favored 'Trans proline' 0 C--N 1.388 2.609 0 CA-C-N 121.844 1.694 . . . . 73.03 112.362 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -69.41 -37.53 77.51 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.846 0.859 . . . . 75.11 111.575 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.876 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -79.31 -26.33 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 112.513 0.56 . . . . 74.5 112.513 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.25 -31.87 73.24 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 112.212 0.449 . . . . 64.04 112.212 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -85.79 9.55 16.23 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.542 0.337 . . . . 72.04 111.881 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.62 166.1 11.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.484 0.714 . . . . 54.55 111.037 -175.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -58.2 127.53 32.58 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.003 0.921 . . . . 55.33 110.018 170.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.46 ' NE1' ' HG2' ' C' ' 124' ' ' PRO . 32.9 t90 -84.95 93.24 8.51 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.613 0.765 . . . . 73.21 109.831 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -150.47 78.73 7.59 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 108.51 -0.922 . . . . 74.23 108.51 164.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.501 ' HB3' ' HB1' ' C' ' 66' ' ' ALA . 16.6 Cg_exo -68.56 136.95 37.85 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.681 2.254 . . . . 41.43 112.183 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -86.21 93.43 9.04 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 105.359 -2.089 . . . . 61.21 105.359 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.406 HG23 ' HB1' ' G' ' 466' ' ' ALA . 17.0 m -68.6 131.41 33.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 115.368 -0.833 . . . . 60.1 109.755 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 tptt -134.9 129.62 34.64 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.526 -1.657 . . . . 74.13 106.526 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.579 HD12 ' SD ' ' G' ' 464' ' ' MET . 2.8 tm? -116.32 139.68 50.13 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.508 -0.923 . . . . 70.23 108.508 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.549 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.2 t70 -134.4 141.2 46.76 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.453 1.101 . . . . 55.32 108.971 -177.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 79.6 mt -132.11 137.15 47.61 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.309 1.044 . . . . 64.42 108.917 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.509 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 27.3 t70 -144.81 155.23 43.39 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.11 0.964 . . . . 71.13 109.201 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.659 ' H ' HD21 ' G' ' 460' ' ' LEU . 5.1 m -151.1 138.55 19.51 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.29 1.036 . . . . 62.43 109.577 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.67 173.92 10.17 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.742 1.217 . . . . 62.12 108.926 175.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -159.95 153.95 23.18 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.65 0.78 . . . . 71.14 110.039 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.8 p -155.3 137.54 14.8 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.258 0.623 . . . . 65.54 109.434 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.438 ' NE2' HG21 ' G' ' 452' ' ' VAL . 58.3 tt0 -77.32 118.8 20.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.053 -0.721 . . . . 71.42 109.053 174.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.575 HD11 HD12 ' C' ' 83' ' ' ILE . 54.1 mt -93.35 -43.16 8.92 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.348 -0.612 . . . . 72.33 109.348 176.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -148.79 -177.89 6.05 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.227 -0.897 . . . . 75.12 110.919 -177.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.91 123.8 21.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.722 -1.126 . . . . 73.54 109.101 175.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 61.27 18.81 9.55 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.444 1.098 . . . . 65.01 112.056 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 77.4 t -127.88 103.67 10.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 124.351 1.06 . . . . 64.12 109.238 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.503 ' HD1' HD11 ' C' ' 86' ' ' ILE . 24.7 m-85 -102.3 146.49 27.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.489 -0.778 . . . . 72.25 108.986 169.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.55 ' HB2' HD11 ' C' ' 51' ' ' LEU . 35.0 tt0 -94.35 129.07 41.18 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.408 -1.33 . . . . 70.42 107.408 160.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.408 HG11 ' HD3' ' C' ' 103' ' ' PRO . 42.4 t -106.27 143.4 17.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.993 -1.114 . . . . 74.3 107.993 165.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.0 t -121.28 140.66 44.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 107.931 -1.137 . . . . 75.25 107.931 172.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -129.71 106.97 9.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.553 -1.277 . . . . 72.15 107.553 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.509 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 58.7 ttt-85 -95.41 122.64 38.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.993 -1.458 . . . . 74.23 108.83 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.9 t -117.27 132.35 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.013 -1.106 . . . . 64.5 108.013 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.8 m -134.12 128.95 35.18 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.3 0.64 . . . . 74.22 109.715 -174.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.624 HG23 HD13 ' C' ' 114' ' ' ILE . 61.6 t -115.64 121.03 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.839 0.856 . . . . 74.54 109.712 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.7 m -100.81 145.36 28.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.476 0.71 . . . . 74.53 109.179 170.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 66' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' C' ' 38' ' ' PRO . . . -136.98 131.37 32.85 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.792 -1.188 . . . . 62.01 107.792 169.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.7 m -139.95 129.17 23.83 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 123.598 0.561 . . . . 72.11 110.266 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 37.1 mt -85.22 41.5 0.89 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.319 1.048 . . . . 64.01 109.704 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.73 -104.17 2.54 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 110.053 -1.219 . . . . 54.04 110.053 -170.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -93.8 -29.72 15.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.263 1.025 . . . . 65.52 110.003 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -73.14 120.17 18.4 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.823 0.849 . . . . 71.14 110.268 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 35.7 m -75.88 129.64 37.29 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.568 -0.53 . . . . 51.11 109.568 173.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.876 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.27 -60.95 2.07 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.398 -0.964 . . . . 73.22 108.398 170.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -158.09 173.77 16.23 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 114.417 -1.265 . . . . 63.34 111.436 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -138.89 130.04 26.79 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.572 -1.64 . . . . 70.23 106.572 162.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 46.0 t -128.35 138.73 52.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.946 -1.131 . . . . 74.43 107.946 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 77' ' ' GLU . . . . . 0.415 ' HG2' ' OE1' ' C' ' 79' ' ' GLN . 28.7 tt0 -154.54 129.07 9.19 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.522 -0.548 . . . . 75.52 109.522 -170.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' C' ' 61' ' ' ARG . 97.2 t -135.03 114.3 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.689 0.796 . . . . 54.41 109.921 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.415 ' OE1' ' HG2' ' C' ' 77' ' ' GLU . 1.7 mp0 -90.08 87.84 7.04 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.531 -0.915 . . . . 71.31 108.531 174.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -83.21 98.77 9.55 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.308 -0.86 . . . . 35.34 109.662 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.42 159.49 38.86 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.441 -0.664 . . . . 52.44 111.441 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.582 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -161.25 118.83 0.85 Allowed Glycine 0 CA--C 1.504 -0.614 0 N-CA-C 111.047 -0.821 . . . . 74.31 111.047 -177.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.575 HD12 HD11 ' C' ' 51' ' ' LEU . 6.9 mm -84.1 121.13 36.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.334 -0.987 . . . . 74.2 108.334 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.546 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 57.6 m-85 -126.58 118.46 24.89 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.421 -0.955 . . . . 75.32 108.421 -177.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 54.5 p -87.95 105.87 17.74 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.688 -0.856 . . . . 64.0 108.688 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.608 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -116.97 125.9 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.038 0.935 . . . . 73.22 109.341 -176.674 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.96 163.93 32.05 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.473 0.709 . . . . 43.51 110.697 -172.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.04 -41.99 2.88 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 115.519 -0.764 . . . . 71.14 113.111 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 46.9 mm -122.73 150.4 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.901 0.88 . . . . 70.41 110.421 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.433 ' HB3' ' HB ' ' G' ' 451' ' ' VAL . 12.5 pt-20 -145.52 -174.22 4.34 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.179 0.992 . . . . 73.41 111.544 -168.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.64 -138.17 25.62 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 115.414 -0.812 . . . . 74.13 113.778 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' C' ' 141' ' ' LEU . 53.5 p -61.87 -29.12 69.98 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.152 0.981 . . . . 71.54 111.113 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -70.04 -44.71 68.66 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.471 -1.24 . . . . 75.35 111.326 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -73.7 -30.45 62.88 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 110.17 -0.307 . . . . 64.23 110.17 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.4 81.11 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.134 0.574 . . . . 63.11 109.615 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -72.17 -41.05 67.49 Favored 'General case' 0 C--O 1.241 0.636 0 O-C-N 123.464 0.478 . . . . 71.14 110.935 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -59.5 -38.18 80.23 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.272 0.983 . . . . 70.13 111.119 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 37.4 mt -101.13 -23.48 14.46 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.356 0.662 . . . . 54.55 112.417 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.78 -23.74 57.2 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 116.138 -0.483 . . . . 61.52 114.107 -170.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.64 -43.47 0.1 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.148 0.499 . . . . 62.44 111.034 -171.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -66.34 -42.79 87.61 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.425 1.49 . . . . 75.11 112.729 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 33.8 m -73.76 -43.48 6.61 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-O 118.832 -0.604 . . . . 51.13 112.277 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.408 ' HD3' HG11 ' C' ' 58' ' ' VAL . 84.8 Cg_exo -51.22 -31.83 38.2 Favored 'Trans proline' 0 C--N 1.393 2.873 0 C-N-CA 122.361 2.041 . . . . 73.13 114.201 167.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 104' ' ' ASN . . . . . 0.446 ' ND2' ' HD1' ' C' ' 133' ' ' PHE . 10.1 m120 -64.17 -35.18 79.95 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.854 0.862 . . . . 74.42 111.712 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.467 HD12 ' NH1' ' A' ' 111' ' ' ARG . 50.8 mm -68.43 -38.69 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.281 0.563 . . . . 53.24 109.723 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.582 HD21 ' HA3' ' C' ' 82' ' ' GLY . 90.9 mt -80.56 -22.71 40.53 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.725 -1.125 . . . . 73.55 112.736 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.49 ' HZ ' HD22 ' C' ' 128' ' ' LEU . 45.7 t80 -59.48 -49.73 90.84 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-O 117.75 -1.119 . . . . 75.14 113.631 -173.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -53.02 -36.68 76.91 Favored 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 122.44 2.094 . . . . 72.42 114.006 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -69.3 -52.88 23.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.763 0.825 . . . . 71.32 110.763 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.3 81.66 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.148 -0.933 . . . . 62.21 111.142 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -59.11 -54.96 41.05 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.657 1.583 . . . . 72.51 110.814 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -67.75 -33.72 75.4 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.554 0.742 . . . . 75.41 110.251 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 28.1 t -68.58 -31.84 71.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.03 0.532 . . . . 74.11 111.496 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.624 HD13 HG23 ' C' ' 64' ' ' VAL . 64.2 mt -68.92 -52.44 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.129 -0.487 . . . . 65.14 109.993 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 3.6 m -65.49 -28.83 69.48 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 123.741 0.651 . . . . 72.42 111.24 -174.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 46.3 t -66.53 -49.31 66.92 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 123.771 0.828 . . . . 51.4 109.413 171.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.619 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.09 -40.72 86.16 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.804 1.242 . . . . 65.41 112.917 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.542 HG13 ' HB2' ' C' ' 123' ' ' PHE . 39.2 t -67.75 -42.48 86.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.323 1.049 . . . . 64.45 110.351 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.0 t -70.0 -27.22 64.51 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.716 -0.675 . . . . 51.2 111.154 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.481 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.1 mtt-85 -68.38 -36.85 79.78 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.807 0.843 . . . . 74.33 108.93 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.39 9.26 67.98 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 124.052 0.845 . . . . 51.23 112.834 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 57.0 p 55.52 36.61 27.5 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.614 1.565 . . . . 54.21 113.759 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.542 ' HB2' HG13 ' C' ' 118' ' ' VAL . 97.0 m-85 -96.64 158.03 34.32 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.916 0.887 . . . . 63.42 109.243 172.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.46 ' HG2' ' NE1' ' C' ' 36' ' ' TRP . 34.6 Cg_exo -61.52 157.7 40.21 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 122.993 2.462 . . . . 70.34 113.882 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -60.18 141.24 56.25 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.448 1.099 . . . . 73.23 113.184 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.626 ' HB3' ' HB2' ' G' ' 470' ' ' LEU . 0.5 OUTLIER -134.72 96.7 3.6 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.961 -1.018 . . . . 75.3 109.816 170.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -90.65 95.62 10.24 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.288 -1.005 . . . . 75.53 108.288 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.55 HD11 HD21 ' C' ' 42' ' ' LEU . 1.3 tt -60.49 129.36 41.21 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.498 1.119 . . . . 73.03 110.628 -172.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.86 148.72 98.44 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.373 0.669 . . . . 72.54 111.284 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.593 ' HG3' HD12 ' A' ' 16' ' ' ILE . 50.1 Cg_exo -54.29 117.56 4.06 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.783 2.322 . . . . 53.14 112.693 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.35 118.21 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.822 -0.807 . . . . 73.01 108.822 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.91 88.56 4.71 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.089 0.556 . . . . 73.44 109.935 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.446 ' HD1' ' ND2' ' C' ' 104' ' ' ASN . 96.8 m-85 -73.82 -45.25 52.49 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.072 -0.714 . . . . 73.14 109.072 174.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -66.98 -41.64 86.44 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.277 -1.328 . . . . 72.45 111.707 -168.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.86 94.19 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.755 -1.111 . . . . 63.12 112.075 -177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.31 -26.44 46.93 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 116.035 -0.53 . . . . 62.55 112.378 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -68.92 -25.51 64.62 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.717 0.407 . . . . 71.04 110.742 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 65.7 mtt -59.72 -41.61 91.24 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.336 0.655 . . . . 71.52 110.46 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -60.79 -37.3 81.46 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.655 0.782 . . . . 72.22 111.13 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -66.15 -85.06 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.306 1.043 . . . . 73.32 110.052 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.458 ' HB3' ' HB ' ' C' ' 92' ' ' THR . 72.2 mt -131.83 134.52 45.86 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.238 0.615 . . . . 74.54 110.25 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -160.43 163.55 32.97 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.547 1.139 . . . . 64.32 109.265 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -95.26 102.07 13.85 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.979 -0.749 . . . . 72.23 108.979 171.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -76.17 101.56 5.42 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.161 -1.051 . . . . 61.21 108.161 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -174.63 144.56 0.86 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.65 1.18 . . . . 72.03 109.007 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -165.75 142.11 7.46 Favored Glycine 0 C--N 1.343 0.972 0 O-C-N 123.407 0.442 . . . . 45.23 112.477 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -78.74 -178.41 5.94 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.563 0.745 . . . . 64.04 111.618 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -102.13 133.76 11.5 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 111.205 -0.758 . . . . 73.53 111.205 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 147' ' ' GLU . 12.6 t -135.81 175.23 9.79 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.732 0.813 . . . . 74.34 108.986 173.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -134.4 146.19 49.64 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 109.359 -0.608 . . . . 74.32 109.359 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.64 126.67 28.28 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.754 0.822 . . . . 72.02 109.066 171.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -141.36 86.75 2.03 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.387 -0.968 . . . . 74.34 108.387 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -71.8 104.76 3.53 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.241 -0.651 . . . . 74.41 109.241 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -151.23 132.41 14.44 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.258 1.023 . . . . 71.01 108.512 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 C-N-CA 123.711 0.805 . . . . 54.31 108.997 -178.848 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 120.767 0.317 . . . . 73.34 110.499 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 19.0 m -90.63 76.69 6.48 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.793 0.837 . . . . 71.11 109.672 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.93 104.68 11.6 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.644 -0.707 . . . . 74.4 109.889 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -73.68 -178.92 3.34 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.414 1.085 . . . . 70.44 111.733 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -136.68 145.61 44.95 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.754 0.822 . . . . 63.32 110.008 170.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -83.07 96.99 8.54 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-O 121.596 0.712 . . . . 75.34 110.454 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 98.2 m -145.0 146.84 32.09 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.533 1.133 . . . . 74.12 109.107 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -66.08 108.87 2.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.331 -1.359 . . . . 74.4 107.331 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 4.0 ttp -29.15 120.49 0.14 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 125.653 1.846 . . . . 75.41 112.907 -168.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 57.5 m -121.37 139.82 52.93 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.669 0.787 . . . . 72.13 109.371 -176.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -157.46 96.21 1.52 Allowed 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.879 -1.156 . . . . 70.25 107.879 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -113.67 130.15 56.45 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.292 -1.373 . . . . 63.22 107.292 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.511 HG21 HD11 ' D' ' 16' ' ' ILE . 39.9 mt -73.21 119.28 19.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.503 -0.925 . . . . 71.55 108.503 176.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -87.06 -30.97 20.76 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.462 0.476 . . . . 63.44 110.651 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -176.55 139.59 0.33 Allowed 'General case' 0 C--N 1.369 1.443 0 C-N-CA 122.483 0.313 . . . . 75.53 110.53 -170.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.511 HD11 HG21 ' D' ' 13' ' ' ILE . 3.1 mp -120.89 134.58 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.76 -1.2 . . . . 71.22 107.76 172.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -161.3 172.42 16.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.948 0.88 . . . . 71.0 111.919 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 45.7 p -104.34 124.3 48.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.758 -1.11 . . . . 72.21 109.221 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -94.55 -20.04 19.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.334 0.654 . . . . 73.43 110.186 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.721 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 3.7 t70 -158.66 135.18 9.39 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.139 -1.06 . . . . 34.42 108.139 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.619 HG21 ' HE2' ' C' ' 117' ' ' MET . 72.6 mt -135.9 145.33 31.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.068 -1.086 . . . . 73.33 108.068 175.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -151.21 144.1 24.51 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.897 0.748 . . . . 73.33 109.325 172.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.0 t80 -145.13 115.61 7.62 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 105.939 -1.875 . . . . 73.55 105.939 168.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 22.9 mt-10 -119.86 110.65 16.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.934 -0.765 . . . . 50.21 108.934 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.52 88.36 4.1 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.842 -1.17 . . . . 42.42 107.842 172.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.88 -28.78 7.48 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.744 2.296 . . . . 52.42 112.754 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -114.67 17.97 16.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.517 1.127 . . . . 73.13 109.96 -171.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.63 -67.53 0.33 Allowed Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 114.85 1.426 . . . . 50.31 114.85 -160.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.82 -15.62 23.81 Favored 'Trans proline' 0 C--N 1.39 2.722 0 CA-C-N 122.426 1.902 . . . . 54.1 113.54 -173.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -78.45 -45.2 22.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.45 1.1 . . . . 60.04 110.736 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.04 -24.59 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 CA-C-N 115.986 -0.552 . . . . 71.55 111.617 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -52.87 -31.27 38.61 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 123.797 0.839 . . . . 73.41 113.004 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -53.01 -24.28 9.21 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.627 1.171 . . . . 72.42 111.916 -176.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -83.41 96.38 8.53 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.441 1.096 . . . . 53.33 110.066 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -74.88 83.54 2.19 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.52 0.676 . . . . 63.41 110.078 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 -155.89 156.94 35.5 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.017 1.327 . . . . 73.05 107.915 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.425 ' O ' HD12 ' H' ' 470' ' ' LEU . 1.2 mp0 -82.21 112.2 34.02 Favored Pre-proline 0 N--CA 1.483 1.198 0 N-CA-C 109.147 -0.686 . . . . 71.32 109.147 173.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.1 124.85 16.87 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.416 2.744 . . . . 73.54 113.917 -173.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.683 ' HA ' ' HG ' ' H' ' 470' ' ' LEU . 38.5 mt-10 -62.1 120.36 10.73 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.021 1.329 . . . . 74.35 110.894 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.543 HG23 HG13 ' D' ' 64' ' ' VAL . 7.2 p -95.43 127.44 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.466 0.65 . . . . 70.14 110.882 -170.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -119.61 106.78 12.51 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 105.988 -1.856 . . . . 72.54 105.988 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.539 ' H ' HD23 ' D' ' 42' ' ' LEU . 1.3 pt? -110.72 134.44 52.47 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.945 0.498 . . . . 71.13 110.612 -170.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.72 126.4 52.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.455 0.702 . . . . 74.3 109.198 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -100.81 137.09 39.67 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.162 0.985 . . . . 74.51 109.75 -175.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.542 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.9 t70 -153.9 139.13 17.49 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.437 -0.949 . . . . 70.24 108.437 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.7 t -117.24 155.65 29.09 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.094 0.473 . . . . 71.12 110.095 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.54 176.22 11.54 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.42 1.088 . . . . 75.43 108.866 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.5 p -174.21 161.36 3.51 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.82 0.448 . . . . 43.14 111.989 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 28.4 t -157.04 124.04 5.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.605 1.162 . . . . 63.03 109.806 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -78.73 123.72 27.46 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.454 -0.573 . . . . 74.14 109.454 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 38.5 mt -94.08 -32.8 13.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.16 0.584 . . . . 71.11 109.954 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.62 -176.73 4.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.775 1.23 . . . . 52.03 108.922 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.71 135.05 36.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.093 -1.077 . . . . 54.42 108.093 171.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 74.28 -0.19 3.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.412 1.485 . . . . 63.44 111.605 -174.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.0 t -129.79 118.54 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.125 0.97 . . . . 72.51 108.782 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -141.86 128.55 20.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.702 -0.481 . . . . 73.12 109.702 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -94.23 140.26 30.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.893 0.877 . . . . 75.25 109.316 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -122.75 138.56 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.971 -1.122 . . . . 73.45 107.971 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.6 t -111.55 143.19 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.541 1.136 . . . . 65.03 108.388 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.51 123.58 41.58 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.506 -0.924 . . . . 71.02 108.506 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.542 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.4 ttm-85 -102.57 96.0 6.61 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.108 -1.071 . . . . 54.32 108.108 176.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 78.2 t -99.47 128.94 50.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.327 -0.99 . . . . 71.24 108.327 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 3.6 m -120.93 144.06 48.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.226 -1.027 . . . . 73.42 108.226 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.543 HG13 HG23 ' D' ' 40' ' ' VAL . 53.3 t -136.66 101.83 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.443 -1.317 . . . . 73.45 107.443 -174.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 88.5 m -107.33 97.69 7.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.17 0.988 . . . . 72.23 108.571 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.08 152.83 18.38 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.817 -0.628 . . . . 75.12 110.958 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.7 m -144.05 130.68 20.11 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.715 -0.675 . . . . 73.41 110.518 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 32.5 mt -91.82 101.09 13.68 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.833 -1.543 . . . . 73.13 106.833 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.71 -128.64 12.74 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.625 0.578 . . . . 61.44 112.383 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.3 5.73 43.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.826 0.85 . . . . 61.44 111.804 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -123.88 140.94 52.49 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.592 0.757 . . . . 73.34 110.604 -171.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.2 m -58.16 125.73 24.44 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.106 0.962 . . . . 71.12 110.721 175.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.476 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.14 -74.72 0.43 Allowed 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.908 -1.145 . . . . 75.35 107.908 175.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 74' ' ' PHE . . . . . 0.499 ' HZ ' HD22 ' D' ' 126' ' ' LEU . 54.4 p90 -140.86 154.3 46.12 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-O 121.543 0.687 . . . . 72.04 110.221 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 39.7 mt -115.86 147.25 41.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.352 -1.722 . . . . 71.4 106.352 172.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.525 ' SG ' HG12 ' D' ' 114' ' ' ILE . 23.5 t -160.25 127.79 4.53 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 109.681 -0.488 . . . . 71.41 109.681 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -142.27 124.14 15.21 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.623 -0.51 . . . . 73.45 109.623 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.19 122.7 62.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 C-N-CA 123.464 0.706 . . . . 72.43 109.641 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.721 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 21.1 mt-30 -88.12 88.92 7.79 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.159 -1.052 . . . . 71.54 108.159 164.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.13 101.0 8.52 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.406 -1.27 . . . . 72.33 108.903 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.74 148.25 20.3 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.853 -0.499 . . . . 53.42 111.853 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.481 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -147.54 128.99 3.07 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 111.371 -0.692 . . . . 62.11 111.371 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.9 mt -91.76 141.75 14.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.547 -0.909 . . . . 71.43 108.547 174.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -139.43 129.47 25.07 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.459 0.703 . . . . 44.11 110.09 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -74.24 99.12 3.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.145 0.578 . . . . 65.45 109.687 168.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 9.4 tt -122.02 118.63 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-O 121.364 0.602 . . . . 44.52 110.9 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.0 167.92 21.03 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.454 1.102 . . . . 54.44 109.31 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.4 24.94 66.88 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-O 119.906 -0.386 . . . . 74.1 113.439 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.28 156.41 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.981 0.912 . . . . 74.25 111.682 -175.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.28 171.73 4.71 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.412 1.085 . . . . 72.32 110.717 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.21 -118.65 12.9 Favored Glycine 0 C--N 1.355 1.629 0 N-CA-C 114.894 0.718 . . . . 74.03 114.894 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.2 m -82.64 -28.96 30.37 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.234 0.614 . . . . 74.02 110.599 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -66.76 -42.36 86.29 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.269 0.628 . . . . 64.42 111.335 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.578 ' SD ' ' HA ' ' H' ' 452' ' ' VAL . 25.9 ptt? -62.5 -39.45 93.52 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.878 -0.601 . . . . 53.11 110.244 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.77 74.53 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.543 0.737 . . . . 51.32 110.954 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -67.08 -30.36 70.38 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.76 0.824 . . . . 74.21 110.9 -176.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -79.92 -47.09 15.6 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.717 -0.674 . . . . 62.12 110.304 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' D' ' 94' ' ' MET . 4.7 tt -69.58 -55.25 10.63 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.29 1.036 . . . . 72.25 111.575 -168.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.97 10.82 73.65 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.964 -0.562 . . . . 64.32 114.09 -171.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.689 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -140.14 -65.85 0.45 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 117.346 0.573 . . . . 71.45 111.306 -175.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -70.8 -43.86 67.77 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.376 -0.829 . . . . 72.42 111.776 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -63.51 -50.02 75.11 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 124.012 0.925 . . . . 71.05 112.614 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.21 -21.9 30.78 Favored 'Trans proline' 0 C--N 1.397 3.114 0 C-N-CA 121.865 1.71 . . . . 75.13 112.907 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 104' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' D' ' 100' ' ' ALA . 0.2 OUTLIER -68.53 -32.8 73.0 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.989 0.516 . . . . 72.51 110.21 178.279 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 57.6 mt -67.6 -36.76 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 124.324 1.05 . . . . 62.12 110.643 173.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.481 HD21 ' HA3' ' D' ' 82' ' ' GLY . 89.2 mt -76.11 -18.17 59.28 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.126 -0.943 . . . . 75.33 112.392 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -68.21 -45.36 39.35 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 113.662 0.986 . . . . 74.43 113.662 -173.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -53.24 -38.87 82.1 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.324 2.016 . . . . 71.53 113.702 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -77.99 -33.35 51.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.703 0.801 . . . . 71.22 111.935 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.08 64.58 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.067 -0.716 . . . . 73.42 109.067 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -53.7 -48.08 69.9 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 124.813 1.321 . . . . 72.12 110.602 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.49 -52.13 66.52 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.329 0.652 . . . . 72.52 111.305 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.76 -44.33 77.55 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 124.081 0.863 . . . . 75.24 110.99 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.525 HG12 ' SG ' ' D' ' 76' ' ' CYS . 32.7 mt -62.26 -60.12 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.929 0.892 . . . . 70.01 110.855 174.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 93.7 m -51.67 -39.55 58.44 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.113 1.365 . . . . 75.11 112.214 -173.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 48.4 t -67.08 -44.49 79.92 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.018 -0.992 . . . . 51.0 110.022 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.41 ' HB2' ' HE3' ' D' ' 117' ' ' MET . 72.9 mtm -68.02 -26.41 65.88 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.174 0.59 . . . . 74.3 112.184 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' D' ' 114' ' ' ILE . 80.0 t -67.81 -45.59 83.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.75 0.82 . . . . 73.21 109.784 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.9 p -73.84 -26.85 60.79 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.843 -0.617 . . . . 74.12 111.054 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -70.16 -37.16 75.14 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.613 0.765 . . . . 74.1 109.481 173.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.48 11.2 61.92 Favored Glycine 0 C--N 1.357 1.704 0 O-C-N 123.986 0.804 . . . . 74.24 112.732 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.464 HG23 ' HB3' ' C' ' 17' ' ' TYR . 67.5 p 58.17 16.93 4.21 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 126.815 2.046 . . . . 72.54 115.093 174.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -79.49 146.98 66.97 Favored Pre-proline 0 C--O 1.243 0.719 0 N-CA-C 107.961 -1.125 . . . . 73.42 107.961 166.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.67 138.43 14.67 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 123.534 2.823 . . . . 74.35 112.757 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -64.68 120.04 11.68 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 123.767 0.667 . . . . 65.31 110.49 -174.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.499 HD22 ' HZ ' ' D' ' 74' ' ' PHE . 4.8 mp -104.63 101.96 11.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.959 -0.756 . . . . 72.33 108.959 -176.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -100.64 93.51 5.62 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.437 -0.949 . . . . 74.15 108.437 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.29 133.48 47.03 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.914 0.886 . . . . 71.31 110.23 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.693 ' HB3' ' HB1' ' H' ' 467' ' ' ALA . . . -66.3 137.65 95.6 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.885 0.474 . . . . 43.32 110.657 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.79 130.04 17.45 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.841 2.361 . . . . 64.21 112.339 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.71 140.74 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.423 0.689 . . . . 73.21 110.268 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -97.01 108.37 21.09 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.095 0.958 . . . . 75.33 109.73 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -76.51 -21.11 56.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.371 0.668 . . . . 64.35 111.401 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.689 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 9.9 t70 -65.81 -49.91 66.53 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.527 0.731 . . . . 75.12 111.744 -171.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.1 89.87 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.842 0.714 . . . . 74.41 111.372 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.7 mp -81.01 -17.19 51.15 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.535 -1.212 . . . . 75.41 111.732 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -77.19 -43.98 31.76 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.439 -0.578 . . . . 74.42 109.439 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 73.8 mtm -64.37 -32.31 73.87 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.79 -0.641 . . . . 72.43 110.775 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -71.49 -42.68 67.75 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.955 0.902 . . . . 74.21 109.54 172.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -59.49 -41.88 90.85 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.717 0.807 . . . . 74.22 112.296 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.71 -35.02 79.56 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.437 0.695 . . . . 62.3 112.02 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -88.3 10.8 18.5 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.792 0.437 . . . . 73.31 111.26 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -120.29 85.04 2.32 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.721 0.809 . . . . 74.34 109.346 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -162.18 134.17 5.52 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.112 1.365 . . . . 71.43 108.218 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.71 91.09 1.87 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 122.978 0.511 . . . . 72.11 109.759 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.7 176.79 45.98 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.28 -0.873 . . . . 54.43 113.248 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -171.52 136.35 0.98 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.081 0.953 . . . . 70.44 109.465 177.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -134.24 162.64 24.57 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.706 -0.558 . . . . 74.03 111.706 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 14.8 t -158.95 153.1 23.7 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.759 0.824 . . . . 72.52 109.362 176.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -155.81 116.89 3.87 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.519 0.327 . . . . 62.12 110.591 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -80.22 65.23 5.31 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.604 1.162 . . . . 74.2 110.234 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -68.23 113.19 5.64 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.586 1.154 . . . . 74.3 110.897 -174.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -119.75 114.39 22.08 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.324 0.65 . . . . 61.0 110.988 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -84.14 83.48 7.95 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.329 0.651 . . . . 53.52 111.231 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.295 0 C-N-CA 124.547 1.139 . . . . 73.43 108.797 175.342 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 55.8 t30 . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 109.753 -0.462 . . . . 74.24 109.753 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 451' ' ' VAL . . . . . 0.748 ' HB ' ' HA ' ' A' ' 54' ' ' ASP . 8.4 p -115.44 160.38 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.398 1.079 . . . . 73.12 108.94 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 452' ' ' VAL . . . . . 0.531 HG13 HD12 ' A' ' 98' ' ' LEU . 6.9 p -111.25 153.59 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.592 0.757 . . . . 64.13 110.468 -174.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -152.5 112.8 0.55 Allowed Glycine 0 C--N 1.357 1.703 0 CA-C-O 119.902 -0.388 . . . . 71.52 112.279 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 454' ' ' LEU . . . . . 0.593 ' HG ' HD13 ' A' ' 98' ' ' LEU . 73.0 mt -85.08 84.47 7.69 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 117.385 0.592 . . . . 73.13 109.612 173.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 8.9 m -77.43 -17.73 57.84 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-N 115.344 -0.844 . . . . 64.24 109.917 172.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -74.92 152.1 38.86 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.2 1.0 . . . . 75.41 110.563 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.07 91.64 3.55 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.631 0.772 . . . . 74.24 110.824 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 19.9 p -140.23 173.81 11.14 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.589 1.155 . . . . 61.42 108.998 170.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -68.99 152.57 45.1 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.086 -0.709 . . . . 62.33 109.086 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 460' ' ' LEU . . . . . 0.541 HD21 ' HB ' ' A' ' 46' ' ' THR . 79.2 mt -76.39 -62.83 1.49 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.192 0.52 . . . . 64.42 110.302 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 461' ' ' PHE . . . . . 0.402 ' H ' ' H ' ' E' ' 462' ' ' TYR . 0.9 OUTLIER -173.04 -9.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 114.952 -1.022 . . . . 73.11 112.241 -169.527 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 462' ' ' TYR . . . . . 0.402 ' H ' ' H ' ' E' ' 461' ' ' PHE . 88.8 t80 -168.34 122.24 0.9 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.125 0.421 . . . . 73.24 111.066 -168.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 31.8 m -97.18 131.32 44.04 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 107.816 -1.179 . . . . 54.34 107.816 165.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 464' ' ' MET . . . . . 0.541 ' SD ' HD23 ' A' ' 42' ' ' LEU . 28.4 ttt -96.45 114.26 25.91 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.922 0.489 . . . . 72.33 111.665 -171.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -96.82 110.74 23.16 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.393 -0.966 . . . . 61.41 108.393 167.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -83.31 -48.57 10.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.164 0.586 . . . . 45.4 110.929 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . 68.84 -63.03 0.37 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.821 1.648 . . . . 71.33 111.966 -173.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 2.0 tt 75.6 -64.98 0.34 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.212 1.805 . . . . 72.35 109.823 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 96.78 53.3 1.42 Allowed Glycine 0 C--N 1.342 0.876 0 N-CA-C 111.205 -0.758 . . . . 43.02 111.205 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.44 135.69 45.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.232 0.613 . . . . 71.23 110.424 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 59.7 pttt . . . . . 0 CA--C 1.565 1.546 0 C-N-CA 124.346 1.058 . . . . 75.3 109.26 177.929 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 14.6 m120 . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.718 0.294 . . . . 73.45 111.099 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' F' F ' 451' ' ' VAL . . . . . 0.427 ' HB ' ' H ' ' B' ' 54' ' ' ASP . 11.8 p -133.5 160.9 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.822 0.849 . . . . 74.04 109.194 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 452' ' ' VAL . . . . . 0.552 HG21 ' HB2' ' B' ' 94' ' ' MET . 32.1 m -67.64 173.86 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.466 1.106 . . . . 63.14 112.597 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -115.54 154.24 17.06 Favored Glycine 0 C--N 1.345 1.034 0 N-CA-C 111.495 -0.642 . . . . 62.24 111.495 173.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 67.2 tp -88.59 139.66 30.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.97 0.508 . . . . 74.22 109.812 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 17.6 p -76.8 159.03 30.43 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.257 1.023 . . . . 73.35 111.548 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.92 146.44 46.11 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.973 -1.012 . . . . 72.53 109.957 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 457' ' ' GLN . . . . . 0.462 ' HG2' ' HB2' ' F' ' 459' ' ' ASP . 35.0 tt0 59.2 87.7 0.08 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.088 1.355 . . . . 62.42 110.936 -175.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 32.0 p -66.55 -47.1 73.93 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.945 -0.57 . . . . 74.14 110.085 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 459' ' ' ASP . . . . . 0.462 ' HB2' ' HG2' ' F' ' 457' ' ' GLN . 34.8 t70 51.88 93.94 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 O-C-N 125.076 1.485 . . . . 75.13 112.15 169.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.12 108.89 2.82 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 122.427 1.108 . . . . 73.5 109.887 -174.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -67.35 0.67 2.71 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.396 2.278 . . . . 73.34 114.396 -175.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 462' ' ' TYR . . . . . 0.565 ' HA ' HD22 ' B' ' 136' ' ' LEU . 4.5 p90 -68.34 129.49 40.08 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-N 118.565 0.62 . . . . 72.2 110.2 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 33.8 m -96.48 -55.25 2.98 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.84 -1.17 . . . . 74.35 107.84 170.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 26.3 ttt 58.37 99.06 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.792 1.637 . . . . 75.5 112.595 173.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -79.57 -15.1 58.28 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.586 0.755 . . . . 70.33 112.708 -173.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -112.79 160.36 18.06 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.574 0.749 . . . . 62.14 110.223 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -96.62 -86.93 0.31 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.241 -0.652 . . . . 71.24 109.241 175.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 468' ' ' LEU . . . . . 0.544 HD23 HD21 ' B' ' 42' ' ' LEU . 2.3 pp -172.28 -30.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.627 0.771 . . . . 73.21 112.138 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 148.97 80.52 0.03 OUTLIER Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.518 -0.633 . . . . 43.23 111.518 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 470' ' ' LEU . . . . . 0.569 HD21 HG22 ' B' ' 40' ' ' VAL . 4.0 mm? -102.0 -65.7 0.97 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.175 0.59 . . . . 65.12 109.711 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 21.2 tptm . . . . . 0 CA--C 1.551 1.006 0 C-N-CA 123.2 0.6 . . . . 71.32 109.446 -176.86 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 43.1 t30 . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 121.221 0.534 . . . . 63.02 110.704 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' G' G ' 451' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' C' ' 90' ' ' GLU . 20.8 m -110.44 -12.44 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.702 1.201 . . . . 52.11 108.409 160.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 452' ' ' VAL . . . . . 0.438 HG21 ' NE2' ' C' ' 50' ' ' GLN . 18.2 m -68.22 163.56 3.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 C-N-CA 124.886 1.274 . . . . 63.45 112.035 -174.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 139.21 70.1 0.04 OUTLIER Glycine 0 C--N 1.342 0.899 0 CA-C-N 116.015 -0.539 . . . . 73.43 112.232 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 4.0 pp -134.66 154.21 51.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.711 0.805 . . . . 73.42 109.273 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 8.7 t -90.73 135.61 33.6 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 109.311 -0.625 . . . . 74.13 109.311 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -78.19 97.33 5.46 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.835 -0.802 . . . . 41.43 108.835 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 457' ' ' GLN . . . . . 0.429 ' HG2' ' H ' ' G' ' 458' ' ' THR . 32.5 tt0 -159.19 179.55 8.91 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.218 1.007 . . . . 71.01 108.708 -172.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 458' ' ' THR . . . . . 0.429 ' H ' ' HG2' ' G' ' 457' ' ' GLN . 21.8 m 80.12 118.58 0.05 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.131 1.772 . . . . 75.51 109.134 -175.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -84.8 46.9 1.31 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.135 0.974 . . . . 71.24 111.269 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 460' ' ' LEU . . . . . 0.659 HD21 ' H ' ' C' ' 46' ' ' THR . 3.3 mm? 71.51 179.45 0.24 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.781 1.233 . . . . 75.13 112.745 174.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -142.73 178.15 7.84 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 125.638 1.575 . . . . 72.41 107.969 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 92.7 t80 67.14 102.32 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.358 1.063 . . . . 61.41 111.838 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 83.0 m -84.2 109.91 18.12 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.97 -1.122 . . . . 52.53 107.97 168.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 464' ' ' MET . . . . . 0.579 ' SD ' HD12 ' C' ' 42' ' ' LEU . 24.5 ttt -71.83 142.33 49.62 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.323 -0.621 . . . . 71.14 109.323 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -82.49 11.77 5.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.742 0.817 . . . . 61.41 111.738 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 466' ' ' ALA . . . . . 0.406 ' HB1' HG23 ' C' ' 40' ' ' VAL . . . 61.79 81.67 0.19 Allowed 'General case' 0 C--N 1.36 1.043 0 C-N-CA 124.907 1.283 . . . . 62.42 111.189 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -147.66 83.36 1.53 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.853 -0.795 . . . . 61.32 108.853 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 468' ' ' LEU . . . . . 0.508 HD23 ' HB2' ' C' ' 42' ' ' LEU . 1.2 pp -124.62 17.95 8.79 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.009 0.924 . . . . 61.24 112.53 -170.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 101.95 -40.54 2.39 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-O 120.002 -0.332 . . . . 64.23 113.92 173.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 470' ' ' LEU . . . . . 0.626 ' HB2' ' HB3' ' C' ' 126' ' ' LEU . 61.5 tp -67.85 140.92 56.58 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.07 0.548 . . . . 72.24 110.567 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt . . . . . 0 C--O 1.251 1.153 0 C-N-CA 124.142 0.977 . . . . 75.5 110.174 -174.808 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 46.4 t30 . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.876 -0.416 . . . . 62.5 109.876 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' H' H ' 451' ' ' VAL . . . . . 0.494 HG23 HG13 ' H' ' 452' ' ' VAL . 17.5 m -108.95 -26.32 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.921 0.889 . . . . 75.32 110.966 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 452' ' ' VAL . . . . . 0.578 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 23.7 m -103.79 174.2 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.441 0.696 . . . . 70.51 112.073 -174.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -143.37 110.17 0.58 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 110.707 -0.957 . . . . 74.33 110.707 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.45 94.21 6.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.641 0.776 . . . . 73.42 110.134 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 5.8 t -91.82 61.9 4.24 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.499 1.142 . . . . 62.34 109.11 173.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.93 -127.41 0.05 Allowed 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 114.424 -1.262 . . . . 63.41 109.82 -177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 58.58 14.66 3.18 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 126.522 1.929 . . . . 72.24 114.047 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 19.5 p -107.39 -81.35 0.56 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.481 0.712 . . . . 72.23 111.054 -174.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -173.81 -174.38 0.94 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.236 1.015 . . . . 60.42 109.836 -176.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 460' ' ' LEU . . . . . 0.539 ' HG ' ' HA ' ' D' ' 45' ' ' ASP . 2.5 tm? -120.78 110.38 16.29 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.655 -1.239 . . . . 63.24 107.655 175.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 461' ' ' PHE . . . . . 0.414 ' O ' HD13 ' H' ' 460' ' ' LEU . 53.1 p90 -64.83 162.03 17.0 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.009 0.924 . . . . 71.01 111.578 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 18.2 t80 68.4 92.5 0.08 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.293 1.037 . . . . 73.13 110.295 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 23.4 m -72.02 -42.25 66.6 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.342 -0.845 . . . . 74.04 110.557 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 464' ' ' MET . . . . . 0.482 ' HE2' HD11 ' D' ' 42' ' ' LEU . 11.2 tpt 72.18 149.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.687 1.195 . . . . 65.41 112.871 170.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -140.61 -66.79 0.43 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.932 0.893 . . . . 73.53 110.463 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -133.47 153.98 51.17 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.139 0.576 . . . . 62.02 111.699 -173.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 467' ' ' ALA . . . . . 0.693 ' HB1' ' HB3' ' D' ' 129' ' ' ALA . . . -148.15 -49.81 0.17 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.764 1.226 . . . . 73.44 108.357 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 468' ' ' LEU . . . . . 0.449 HD23 ' N ' ' H' ' 469' ' ' GLY . 5.0 tt -74.15 142.9 45.47 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.08 -1.418 . . . . 52.34 107.35 169.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 469' ' ' GLY . . . . . 0.449 ' N ' HD23 ' H' ' 468' ' ' LEU . . . -81.52 81.83 1.62 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-O 120.006 -0.33 . . . . 61.51 112.619 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 470' ' ' LEU . . . . . 0.683 ' HG ' ' HA ' ' D' ' 39' ' ' GLU . 3.2 mm? -78.68 72.72 5.22 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.897 -0.779 . . . . 54.42 108.897 173.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt . . . . . 0 CA--C 1.549 0.919 0 CA-C-N 114.914 -1.039 . . . . 70.12 109.071 -173.336 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tpt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.77 0.319 . . . . 75.45 111.003 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.6 p -143.22 54.67 1.36 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.643 -0.873 . . . . 72.53 108.643 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.33 84.89 5.21 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.752 -1.113 . . . . 75.13 108.802 -168.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -131.09 -177.68 4.49 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.202 1.001 . . . . 75.44 110.113 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 63.03 43.75 6.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.187 0.995 . . . . 74.21 110.343 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -106.48 87.77 2.62 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.255 -0.884 . . . . 74.12 109.219 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 t -158.81 -50.22 0.06 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 116.088 -0.505 . . . . 64.21 111.742 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.33 -59.98 2.17 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.468 -0.938 . . . . 65.05 108.468 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.8 ttt -131.61 152.56 50.72 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.662 1.185 . . . . 75.2 107.982 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.7 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 31.3 m -140.48 127.99 21.42 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.848 0.859 . . . . 74.13 108.711 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.436 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 16.8 t80 -133.68 121.23 21.66 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.898 -1.149 . . . . 73.05 107.898 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -136.97 112.59 9.4 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.037 -0.727 . . . . 72.35 109.037 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.538 HG12 ' HD2' ' A' ' 84' ' ' PHE . 46.3 mt -81.98 114.96 23.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.42 -0.955 . . . . 72.4 108.42 171.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -80.34 -39.26 28.97 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.475 -0.784 . . . . 72.44 109.686 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -168.16 133.16 1.77 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 116.236 -0.438 . . . . 72.12 111.035 -167.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.449 HD11 HD13 ' A' ' 13' ' ' ILE . 91.5 mt -119.47 132.13 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.289 1.036 . . . . 54.14 108.304 173.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.402 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 24.7 p90 -164.22 176.72 8.94 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.709 0.766 . . . . 73.15 111.427 -171.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.6 p -109.3 118.07 35.72 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.978 -1.01 . . . . 51.14 109.112 177.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 36.9 mtpt -84.87 -26.69 27.18 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.441 -0.345 . . . . 75.41 110.328 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -152.28 132.33 13.45 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.507 -0.769 . . . . 65.25 109.083 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 62.7 mt -128.93 141.81 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.505 -1.294 . . . . 74.13 107.505 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.4 t -151.79 144.21 24.12 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 123.494 0.496 . . . . 72.33 110.831 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.477 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 59.1 t80 -144.6 128.83 17.75 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 106.712 -1.588 . . . . 74.11 106.712 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -135.83 110.72 8.78 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.638 -0.875 . . . . 63.33 108.638 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.84 85.97 8.33 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.99 -1.115 . . . . 63.42 107.99 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.67 -25.76 20.31 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.562 2.175 . . . . 64.33 111.939 -174.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -107.91 31.09 5.77 Favored 'General case' 0 C--O 1.206 -1.2 0 C-N-CA 123.784 0.834 . . . . 71.34 109.846 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -50.95 -53.98 42.12 Favored Pre-proline 0 CA--C 1.577 2.015 0 N-CA-C 113.64 0.978 . . . . 65.23 113.64 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 2.6 Cg_exo -79.58 -20.54 9.31 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.004 1.803 . . . . 75.41 113.106 173.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -88.0 -29.96 20.35 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.786 0.834 . . . . 72.14 112.131 -167.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.43 HG11 ' HE1' ' A' ' 123' ' ' PHE . 9.2 p -76.52 -13.83 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.101 0.96 . . . . 72.44 110.404 -175.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.49 -37.52 75.7 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.104 0.962 . . . . 74.25 110.857 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -73.54 -27.8 61.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.484 -0.78 . . . . 75.42 111.715 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -81.98 151.89 26.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.418 0.687 . . . . 64.12 112.219 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -64.04 140.48 58.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.617 0.767 . . . . 74.23 109.157 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.541 ' NE1' ' HB3' ' E' ' 470' ' ' LEU . 57.8 t-105 -80.28 80.66 6.68 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.74 0.781 . . . . 64.32 109.474 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -132.84 72.9 76.64 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.862 -1.063 . . . . 73.23 108.716 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -89.67 149.0 5.07 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.535 2.157 . . . . 70.23 112.002 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -96.41 117.73 31.47 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.259 -1.386 . . . . 73.53 107.259 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.79 112.33 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 123.423 0.689 . . . . 75.43 110.376 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 43' ' ' ASP . 25.7 ttpt -114.23 130.78 56.63 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.662 -0.866 . . . . 71.45 108.662 172.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.434 HD22 HD22 ' A' ' 128' ' ' LEU . 69.2 tp -96.46 109.98 22.43 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.663 -1.236 . . . . 73.52 107.663 173.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.446 ' HB2' ' HE3' ' A' ' 41' ' ' LYS . 21.9 t70 -102.99 107.71 18.61 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.086 -1.079 . . . . 62.13 108.086 -177.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -96.64 161.36 13.92 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.675 -0.491 . . . . 75.33 109.675 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.728 ' HA ' HD21 ' E' ' 460' ' ' LEU . 8.9 t0 -153.34 127.11 8.84 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.141 -0.689 . . . . 63.12 109.141 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -105.74 120.45 41.73 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.868 -0.79 . . . . 73.11 108.868 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.17 153.31 51.91 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.052 0.941 . . . . 43.12 108.759 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.0 m -127.2 156.9 41.11 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.856 0.462 . . . . 72.02 110.874 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 38.1 t -149.23 133.17 17.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.317 0.647 . . . . 72.4 110.139 -171.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -88.05 117.45 26.94 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.83 -0.433 . . . . 63.21 109.83 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 57' ' ' GLU . 48.8 mt -95.57 -36.19 11.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.373 0.669 . . . . 73.24 110.89 -176.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.76 -168.0 0.73 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.984 0.913 . . . . 51.42 111.016 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.26 112.83 3.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.504 1.122 . . . . 74.51 110.856 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 65.39 3.77 2.44 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 124.817 1.247 . . . . 74.1 112.792 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.7 t -104.44 115.28 46.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.051 -1.092 . . . . 53.42 108.051 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.07 168.15 12.73 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.445 -0.946 . . . . 73.11 108.445 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.524 ' HB2' HD11 ' A' ' 51' ' ' LEU . 44.7 tt0 -132.04 147.38 52.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.059 -0.973 . . . . 70.24 108.885 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.433 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 65.4 t -120.87 125.52 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.006 -1.479 . . . . 73.33 107.006 164.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.86 114.62 47.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.123 -1.066 . . . . 75.34 108.123 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.606 HD22 HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -96.69 109.5 22.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.377 -0.972 . . . . 74.33 108.377 178.456 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 66.1 ttp85 -83.17 103.86 12.9 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.592 -0.892 . . . . 62.04 108.592 172.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.707 HG21 ' HB1' ' A' ' 110' ' ' ALA . 2.5 m -103.5 103.81 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.631 0.729 . . . . 55.11 109.228 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 m -103.12 117.05 33.68 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.449 1.1 . . . . 63.23 110.096 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 56.1 t -101.09 109.44 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.834 0.854 . . . . 54.22 109.629 176.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.1 m -103.28 108.49 19.73 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.321 -0.622 . . . . 65.45 109.321 175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.47 106.91 14.51 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.017 0.927 . . . . 64.35 108.763 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 m -140.92 148.33 40.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.939 0.496 . . . . 72.31 110.519 -175.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.15 85.68 2.45 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.982 0.896 . . . . 63.3 109.083 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.14 -106.58 2.4 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 114.421 -1.263 . . . . 62.2 112.424 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -96.4 -26.08 15.47 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.331 1.052 . . . . 72.41 110.6 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -92.73 109.17 20.59 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.821 0.849 . . . . 75.13 109.682 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.8 m -72.7 123.88 24.19 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.323 -0.621 . . . . 70.33 109.323 171.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -58.33 5.7 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.065 0.853 . . . . 74.23 108.8 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -158.85 155.77 28.41 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.233 -1.349 . . . . 75.33 109.721 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 64' ' ' VAL . 64.0 tp -126.92 138.21 53.26 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.789 -1.189 . . . . 52.41 107.789 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.565 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 73.7 m -134.43 139.99 45.94 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.095 -1.076 . . . . 73.34 108.095 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -149.35 125.59 10.78 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 117.818 0.281 . . . . 63.55 110.251 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.88 112.0 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.771 0.829 . . . . 72.21 109.819 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.409 ' OE1' ' HG3' ' A' ' 61' ' ' ARG . 2.4 mp0 -87.29 84.32 7.24 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.473 -0.936 . . . . 73.33 108.473 173.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.414 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.2 tp-100 -76.65 95.31 3.94 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 114.629 -1.169 . . . . 73.11 108.678 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.28 143.92 17.21 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.073 -0.811 . . . . 60.51 111.073 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.54 130.87 4.25 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.115 -0.794 . . . . 62.23 111.115 -177.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.0 mt -81.93 123.36 38.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.73 -0.841 . . . . 74.12 108.73 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.538 ' HD2' HG12 ' A' ' 13' ' ' ILE . 32.1 m-85 -130.81 137.38 49.4 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.852 -0.796 . . . . 74.15 108.852 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 m -97.19 116.46 29.44 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.037 -0.727 . . . . 75.33 109.037 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.78 135.15 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.062 -1.088 . . . . 74.42 108.062 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.7 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -164.0 136.72 5.1 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.001 0.921 . . . . 61.5 109.182 169.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.65 -16.38 60.89 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 114.664 0.626 . . . . 33.03 114.664 173.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.512 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -114.03 135.4 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 117.645 0.722 . . . . 72.3 109.734 178.032 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -140.53 172.47 12.68 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.104 0.962 . . . . 73.01 109.998 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.69 -123.78 33.1 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.036 0.835 . . . . 64.2 114.57 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.425 ' HB ' HD11 ' A' ' 141' ' ' LEU . 51.1 p -78.35 -27.59 47.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.216 1.007 . . . . 63.35 111.583 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -68.34 -36.57 79.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.813 0.845 . . . . 75.3 109.97 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 48.3 ttm -69.44 -41.98 75.55 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 116.056 -0.52 . . . . 71.02 110.203 171.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.54 -30.12 69.56 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.988 0.515 . . . . 73.02 111.421 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -71.63 -36.43 70.75 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.244 0.618 . . . . 75.3 110.97 173.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.562 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 99.6 m -67.12 -63.09 1.13 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.815 0.446 . . . . 70.11 111.59 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.15 -17.92 61.33 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.273 0.471 . . . . 73.1 112.273 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.01 -11.96 38.23 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.262 -0.743 . . . . 63.11 114.415 -175.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.04 -52.56 0.19 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.153 0.976 . . . . 74.43 112.965 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.562 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 28.2 t80 -63.37 -56.37 16.9 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.752 1.221 . . . . 74.24 111.491 -172.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.8 m -77.67 -35.41 1.27 Allowed Pre-proline 0 CA--C 1.565 1.555 0 N-CA-C 113.245 0.832 . . . . 62.33 113.245 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.83 -39.73 57.85 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.364 2.043 . . . . 74.11 113.19 163.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -64.06 -35.16 79.82 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.073 0.549 . . . . 74.22 111.376 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.53 HG21 ' CD1' ' A' ' 13' ' ' ILE . 51.0 mm -63.25 -42.24 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.787 0.835 . . . . 72.04 110.645 176.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.414 HD22 ' HG3' ' A' ' 80' ' ' GLN . 85.5 mt -72.57 -30.06 64.09 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.08 -0.964 . . . . 72.21 112.068 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -58.36 -44.21 98.94 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 114.6 1.334 . . . . 63.14 114.6 -170.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.68 -39.84 84.5 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.191 1.927 . . . . 62.3 114.115 173.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -72.88 -40.0 65.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.231 0.613 . . . . 74.42 111.228 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.707 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.68 -40.1 88.4 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.525 -0.761 . . . . 74.43 110.489 176.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.435 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.3 ttm180 -54.15 -50.66 66.44 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.554 1.159 . . . . 75.21 110.292 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -66.86 -42.69 85.26 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.14 0.9 . . . . 72.41 111.559 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.579 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.2 t -61.46 -24.66 66.71 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.228 0.611 . . . . 74.01 111.622 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.434 HG21 HG21 ' A' ' 64' ' ' VAL . 96.7 mt -87.29 -44.19 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.4 1.08 . . . . 71.03 110.897 174.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 125' ' ' GLN . 87.7 m -62.64 -40.58 97.45 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.451 0.643 . . . . 74.23 111.244 -174.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.0 t -70.72 -41.01 72.46 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.191 -0.913 . . . . 73.53 109.595 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.477 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.2 ttm -58.4 -48.94 79.05 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.598 1.159 . . . . 73.35 112.079 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.73 -33.78 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.523 0.729 . . . . 64.31 110.734 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.4 t -72.71 -28.44 62.67 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.755 0.822 . . . . 71.5 111.191 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.1 mtt-85 -75.17 -30.24 60.66 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.545 0.738 . . . . 72.1 110.138 175.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.54 -2.17 79.27 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.794 0.684 . . . . 43.14 112.703 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.9 m 69.4 14.67 8.44 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.057 1.343 . . . . 54.43 111.596 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.43 ' HE1' HG11 ' A' ' 31' ' ' VAL . 94.0 m-85 -82.35 152.59 67.75 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 108.572 -0.899 . . . . 61.35 108.572 169.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.12 150.1 10.96 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.266 2.644 . . . . 74.25 114.064 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.7 tt0 -61.37 136.46 58.05 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.763 -0.653 . . . . 51.53 111.438 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.8 tp -117.01 102.02 8.99 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.824 -1.08 . . . . 73.24 108.857 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -97.96 104.33 16.35 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.948 -1.131 . . . . 74.1 107.948 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.434 HD22 HD22 ' A' ' 42' ' ' LEU . 89.8 mt -64.08 130.29 43.39 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.575 0.547 . . . . 62.32 109.797 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.28 138.53 97.18 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 119.086 -0.483 . . . . 74.05 110.268 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.07 115.52 2.55 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.472 2.115 . . . . 54.44 112.403 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.65 113.21 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.671 -1.233 . . . . 71.41 107.671 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -88.97 85.25 6.68 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.677 -0.86 . . . . 73.42 108.677 -175.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.509 ' HA ' HD12 ' A' ' 136' ' ' LEU . 93.1 m-85 -58.57 -32.64 69.11 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.52 1.128 . . . . 74.42 112.607 -174.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.41 -47.75 80.68 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.455 -0.793 . . . . 51.22 111.319 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.46 77.78 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.636 0.585 . . . . 50.35 109.997 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 133' ' ' PHE . 76.2 mt -54.95 -41.14 70.74 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 124.731 1.269 . . . . 75.35 112.238 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.449 ' HE2' HD22 ' A' ' 141' ' ' LEU . 44.5 t80 -74.78 -34.64 62.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.99 -0.55 . . . . 64.15 110.437 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 8.5 mmt -67.65 -32.96 74.01 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.567 0.347 . . . . 52.53 110.49 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -65.69 -26.53 67.82 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.59 0.756 . . . . 54.51 111.141 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -85.48 -57.66 2.98 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.799 0.44 . . . . 63.1 110.064 172.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.449 HD22 ' HE2' ' A' ' 137' ' ' PHE . 36.7 tp -63.63 -33.32 75.36 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.266 1.026 . . . . 64.3 112.546 -165.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.93 -6.06 0.6 Allowed 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 109.557 -0.534 . . . . 65.41 109.557 -164.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 67.72 -70.68 0.12 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.734 1.614 . . . . 73.22 111.263 -174.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -165.1 -69.33 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.695 0.398 . . . . 65.41 110.179 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 48.35 -155.41 0.08 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.637 1.175 . . . . 53.2 111.606 -170.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 123.19 95.41 1.2 Allowed Glycine 0 C--N 1.34 0.779 0 O-C-N 122.175 -0.328 . . . . 54.0 113.031 172.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -93.12 139.87 30.1 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 106.815 -1.55 . . . . 75.0 106.815 167.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.31 47.88 0.62 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 114.941 0.736 . . . . 72.23 114.941 -171.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.0 p -87.39 136.95 32.74 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.613 -0.884 . . . . 75.22 108.613 164.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.22 120.74 17.23 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.531 -0.914 . . . . 64.21 108.531 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -80.63 -70.57 0.52 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.678 0.391 . . . . 71.21 111.367 -174.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -59.58 97.48 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.02 0.825 . . . . 73.22 112.277 -166.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -68.91 119.11 12.72 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 115.634 -0.712 . . . . 63.32 109.631 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.29 94.63 0.11 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.834 0.854 . . . . 73.14 110.675 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 N-CA-C 108.485 -0.931 . . . . 62.34 108.485 174.073 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 108.69 -0.856 . . . . 54.43 108.69 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t -66.57 95.81 0.35 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.363 0.665 . . . . 74.15 111.329 -172.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -84.03 -64.22 1.2 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.205 0.602 . . . . 72.34 110.226 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -91.6 83.72 5.39 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.045 0.45 . . . . 74.44 110.256 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -87.97 25.88 1.47 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.297 0.639 . . . . 55.32 110.53 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -130.5 117.98 20.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.753 0.821 . . . . 72.24 108.838 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -167.52 158.51 11.46 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.104 0.962 . . . . 74.23 110.0 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -74.31 -30.16 61.93 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.747 0.819 . . . . 52.24 109.731 173.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 12.4 ptm 56.19 172.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 126.843 2.057 . . . . 71.2 113.67 -173.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 87.7 m -151.22 135.14 16.56 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.054 -1.091 . . . . 74.42 108.054 175.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -144.76 135.36 24.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.012 0.525 . . . . 73.13 109.939 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -154.45 125.46 7.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.819 0.848 . . . . 75.24 109.053 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.511 HD11 HD13 ' B' ' 105' ' ' ILE . 17.9 mt -77.97 118.4 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.606 -0.887 . . . . 43.52 108.606 171.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -91.49 -39.52 11.9 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.868 -0.419 . . . . 50.2 109.868 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -166.88 138.29 3.32 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.756 0.66 . . . . 72.33 109.731 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.416 HD11 HD13 ' B' ' 13' ' ' ILE . 96.7 mt -115.73 145.24 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 106.878 -1.527 . . . . 64.22 106.878 169.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -169.52 168.24 9.41 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.578 0.704 . . . . 64.3 111.578 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 86.4 m -96.51 131.92 42.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.251 -0.886 . . . . 62.41 108.668 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.424 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.8 mtpt -96.58 -36.31 10.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.497 0.719 . . . . 74.22 109.979 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -152.48 145.25 24.33 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.024 -0.534 . . . . 71.2 110.91 -172.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 41.3 mm -134.46 145.18 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.755 1.222 . . . . 73.0 109.104 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 23.0 t -145.94 134.63 22.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.128 -0.942 . . . . 73.43 108.896 172.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.457 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.4 t80 -149.3 109.77 4.21 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.885 -1.154 . . . . 74.1 107.885 170.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -117.3 114.77 24.07 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.542 -0.91 . . . . 71.02 108.542 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.7 87.61 2.92 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 107.848 -1.167 . . . . 74.54 107.848 169.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.65 -51.76 4.63 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.905 2.403 . . . . 65.04 112.462 -171.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -98.2 23.17 8.57 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.578 0.751 . . . . 53.1 110.957 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -33.17 -67.06 0.2 Allowed Pre-proline 0 N--CA 1.498 1.925 0 C-N-CA 125.327 1.451 . . . . 73.45 114.64 -168.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.93 -20.78 57.75 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.348 2.032 . . . . 50.42 113.013 -172.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -96.57 -28.47 14.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.889 0.876 . . . . 73.2 112.16 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' B' ' 73' ' ' ALA . 10.7 p -83.22 -18.35 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 122.633 0.373 . . . . 71.44 111.117 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -66.39 -15.34 63.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.102 0.779 . . . . 72.31 113.102 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.483 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -62.64 -24.52 67.65 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 120.935 0.398 . . . . 70.13 110.753 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.59 ' HB2' HD13 ' B' ' 68' ' ' LEU . 89.8 mttt -96.17 101.39 13.03 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.477 1.111 . . . . 75.33 109.498 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.61 80.9 5.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.498 0.719 . . . . 71.41 109.692 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -154.17 158.91 41.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.113 -0.949 . . . . 75.54 108.682 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -75.79 108.5 6.03 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 124.081 0.952 . . . . 64.13 109.929 174.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.598 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 43.3 Cg_endo -66.72 150.02 83.61 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.918 2.412 . . . . 74.33 112.778 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -58.66 108.11 0.6 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.686 0.616 . . . . 73.23 110.771 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.598 ' H ' HD21 ' F' ' 470' ' ' LEU . 81.4 t -89.86 120.99 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.975 -1.011 . . . . 51.24 110.28 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' F' ' 466' ' ' ALA . 29.9 ttpt -108.07 128.95 55.13 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.703 -1.221 . . . . 70.21 107.703 168.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.761 ' HB2' ' HB2' ' F' ' 467' ' ' ALA . 40.5 tp -90.7 148.44 22.6 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.831 -0.433 . . . . 73.12 109.831 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -148.11 141.11 24.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.393 1.077 . . . . 74.35 108.167 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 96.0 mt -135.42 142.74 45.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.484 0.714 . . . . 74.25 109.783 -175.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 6.2 m-20 -132.08 110.29 10.6 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.898 -1.149 . . . . 73.31 107.898 165.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 23.6 p -109.84 100.07 9.11 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.767 -0.827 . . . . 74.51 108.767 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.63 116.36 23.7 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.473 0.709 . . . . 51.13 109.28 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.408 ' HB3' HG22 ' B' ' 58' ' ' VAL . 20.2 p -100.84 162.78 12.67 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.949 0.9 . . . . 75.01 109.282 176.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.5 p -150.11 170.63 18.46 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.504 0.721 . . . . 61.31 109.641 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -113.45 107.67 16.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.499 0.72 . . . . 61.12 109.719 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.97 -38.15 64.28 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.955 0.502 . . . . 71.35 110.06 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -161.69 177.78 9.63 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.66 -1.154 . . . . 32.31 109.991 -174.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -63.48 119.21 9.32 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.704 -0.48 . . . . 63.13 109.704 174.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 71.99 -3.01 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.854 1.262 . . . . 73.34 112.779 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 97.8 t -105.09 112.5 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.812 -0.81 . . . . 71.33 108.812 175.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -126.94 139.64 52.91 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.151 0.58 . . . . 74.43 109.748 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -120.53 106.94 12.27 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.867 -0.79 . . . . 71.01 108.867 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' B' ' 48' ' ' SER . 96.7 t -92.91 122.44 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.656 1.182 . . . . 74.13 111.028 -177.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.83 115.03 45.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.726 -0.472 . . . . 74.03 109.726 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.22 120.27 37.27 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.579 -1.267 . . . . 72.55 107.579 174.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.447 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 13.4 ttm180 -109.0 127.74 54.34 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.23 -0.655 . . . . 71.44 109.23 172.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.49 103.73 14.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.038 -1.097 . . . . 71.45 108.038 174.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -102.61 130.81 49.6 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.393 -0.595 . . . . 63.04 109.393 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.613 HG11 HD21 ' B' ' 126' ' ' LEU . 92.1 t -122.37 112.48 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.359 1.063 . . . . 72.34 109.241 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.2 m -92.8 138.15 31.74 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.568 0.747 . . . . 32.43 109.361 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.76 142.88 24.09 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.813 0.445 . . . . 71.0 111.249 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.489 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 21.5 p -153.36 133.69 13.5 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.571 0.582 . . . . 73.13 112.571 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.598 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 52.8 mt -100.12 122.4 42.92 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.531 1.132 . . . . 64.23 111.183 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.25 -110.84 3.72 Favored Glycine 0 C--N 1.342 0.892 0 O-C-N 123.906 0.754 . . . . 62.24 113.042 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.09 5.27 20.04 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.616 0.766 . . . . 73.05 111.551 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -129.13 159.25 36.59 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.851 0.46 . . . . 64.31 110.74 -175.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 61.9 m -75.38 138.26 41.6 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.131 0.491 . . . . 72.13 110.706 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.589 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.57 -71.46 0.65 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.114 -1.069 . . . . 72.12 108.114 176.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -146.4 144.39 29.69 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.761 -0.654 . . . . 74.14 110.203 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.9 mt -123.41 112.46 17.57 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 106.656 -1.609 . . . . 73.31 106.656 174.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.497 ' SG ' HG23 ' B' ' 114' ' ' ILE . 35.6 t -116.93 154.95 29.94 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.071 -0.715 . . . . 74.34 109.071 -178.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.7 tt0 -163.97 137.22 5.31 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.012 -0.736 . . . . 63.3 109.012 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 75.4 t -133.71 146.01 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.267 1.027 . . . . 73.25 108.744 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -122.2 95.8 4.79 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.905 -0.776 . . . . 75.14 108.905 170.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -85.56 98.98 10.95 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.92 -0.771 . . . . 74.14 108.92 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.424 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -93.08 143.1 16.28 Favored Glycine 0 C--N 1.343 0.952 0 N-CA-C 111.187 -0.765 . . . . 72.32 111.187 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.417 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -143.52 127.0 2.93 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 112.165 -0.374 . . . . 61.24 112.165 -173.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 51.3 mt -85.93 127.91 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 109.11 -0.7 . . . . 74.44 109.11 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.33 157.21 47.49 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.818 1.247 . . . . 64.25 108.465 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 68.5 m -117.75 100.36 7.55 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.392 0.677 . . . . 71.34 109.41 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.536 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.5 pp -111.11 137.36 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.862 0.465 . . . . 53.21 110.001 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.55 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -154.53 166.91 31.82 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.015 0.926 . . . . 54.55 110.12 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.27 -59.27 4.81 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 111.46 -0.656 . . . . 75.33 111.46 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.536 HD11 ' HB ' ' B' ' 86' ' ' ILE . 15.4 pt -63.2 139.45 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 124.428 1.091 . . . . 42.12 110.892 171.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.499 ' HG3' ' HA ' ' F' ' 451' ' ' VAL . 32.2 tt0 -152.14 151.41 31.01 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.315 0.646 . . . . 73.3 110.2 -177.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.65 -111.86 4.11 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.959 -0.456 . . . . 25.54 111.959 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -80.53 -25.01 38.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.379 0.672 . . . . 70.24 110.812 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -68.79 -35.64 77.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.765 -0.652 . . . . 74.13 110.133 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -85.92 -23.57 26.94 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.598 -0.728 . . . . 65.35 110.598 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.02 77.19 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.967 0.413 . . . . 72.01 110.769 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 30.4 t-80 -68.3 -27.05 65.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.33 0.652 . . . . 74.35 110.823 176.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.437 ' SG ' HG21 ' B' ' 86' ' ' ILE . 18.9 t -81.19 -68.5 0.68 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.479 -0.563 . . . . 71.11 109.479 176.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.534 HD21 HG12 ' B' ' 86' ' ' ILE . 23.9 mt -69.57 -22.44 63.54 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.888 0.699 . . . . 73.01 112.888 -171.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.89 -11.17 47.41 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-O 119.53 -0.594 . . . . 44.44 113.772 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -138.37 -58.86 0.64 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.659 0.73 . . . . 43.44 112.317 -173.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -72.51 -41.69 65.63 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.941 0.496 . . . . 74.14 111.935 -172.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 86.3 m -68.66 -47.65 33.43 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.066 0.947 . . . . 72.14 111.489 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -56.78 -31.33 87.94 Favored 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 122.143 1.895 . . . . 70.42 113.582 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -62.34 -38.74 90.65 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 123.373 0.669 . . . . 73.22 110.673 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.511 HD13 HD11 ' B' ' 13' ' ' ILE . 68.0 mt -69.34 -44.11 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.789 0.836 . . . . 73.23 110.617 175.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.417 HD21 ' HA3' ' B' ' 82' ' ' GLY . 59.5 mt -73.64 -20.17 60.65 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.327 -0.851 . . . . 74.34 111.776 -176.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -62.33 -49.44 84.04 Favored Pre-proline 0 N--CA 1.481 1.105 0 N-CA-C 114.748 1.388 . . . . 71.51 114.748 -169.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.27 -32.19 82.07 Favored 'Trans proline' 0 C--N 1.377 2.077 0 CA-C-N 121.384 1.53 . . . . 73.3 112.474 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -66.58 -48.49 69.43 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.069 0.548 . . . . 72.13 110.363 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.05 -41.15 87.19 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.203 -0.908 . . . . 74.54 110.747 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -60.35 -56.29 23.22 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.487 1.115 . . . . 75.35 111.102 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.88 -35.29 80.67 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.032 0.533 . . . . 74.43 110.266 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.6 t -66.87 -37.44 84.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.879 0.472 . . . . 63.54 111.209 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.497 HG23 ' SG ' ' B' ' 76' ' ' CYS . 50.3 mt -63.22 -52.32 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.879 0.472 . . . . 74.13 110.05 172.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.451 HG21 ' OG ' ' C' ' 119' ' ' SER . 21.0 m -59.83 -31.94 70.2 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.885 0.874 . . . . 74.32 111.591 -177.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.8 t -64.8 -49.13 71.86 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.406 -0.816 . . . . 72.45 109.766 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -68.88 -31.77 70.94 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.078 0.551 . . . . 74.41 111.342 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.52 -43.71 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.776 0.83 . . . . 65.25 110.065 172.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.434 ' HA ' ' NE2' ' C' ' 125' ' ' GLN . 47.1 t -68.45 -31.91 71.56 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.642 -0.708 . . . . 71.24 111.499 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.579 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 76.1 mtt-85 -68.03 -41.85 81.47 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.894 -0.593 . . . . 71.23 109.728 176.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.62 1.24 86.55 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.704 0.627 . . . . 73.15 113.12 173.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 26.4 p 60.87 26.64 16.5 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.404 1.882 . . . . 71.42 113.822 171.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -80.09 162.3 62.41 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 123.819 0.848 . . . . 73.55 111.443 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -55.22 158.51 11.86 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 123.263 2.642 . . . . 72.34 113.242 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -58.81 134.51 56.94 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.148 -0.933 . . . . 64.43 112.528 -171.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.613 HD21 HG11 ' B' ' 64' ' ' VAL . 30.9 tp -130.2 109.99 11.23 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.314 -0.857 . . . . 65.12 108.976 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -122.11 120.05 33.13 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.303 -0.999 . . . . 74.54 108.303 171.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.575 HD11 HD22 ' B' ' 42' ' ' LEU . 39.6 tp -84.72 136.22 33.81 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.71 0.404 . . . . 74.42 109.975 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.35 145.08 84.95 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.885 0.874 . . . . 60.42 111.462 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.77 130.16 35.6 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.159 2.573 . . . . 74.54 113.064 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.15 113.16 28.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 114.807 -1.088 . . . . 55.33 108.381 172.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -74.47 79.83 1.93 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.163 -1.421 . . . . 72.32 107.163 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -54.7 -38.59 67.22 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.481 0.713 . . . . 74.04 111.24 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.94 -43.13 77.12 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.354 1.062 . . . . 75.52 111.742 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.97 38.83 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.935 0.894 . . . . 75.5 111.437 -176.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.541 ' HB2' ' HD2' ' F' ' 461' ' ' PHE . 1.5 mm? -79.54 -22.28 44.08 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 116.4 -0.364 . . . . 73.52 111.203 -174.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.473 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 73.1 t80 -65.11 -36.68 85.05 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.943 -0.392 . . . . 70.12 109.943 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 71.0 mtm -60.4 -36.04 77.17 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.416 0.448 . . . . 71.24 110.833 175.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -85.62 -18.62 32.77 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.644 0.778 . . . . 75.25 111.457 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -68.01 -32.8 73.43 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.285 1.034 . . . . 73.42 111.189 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 12.8 mt -89.37 9.26 26.83 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.034 -0.985 . . . . 75.03 111.232 -172.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -160.24 -159.36 0.7 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.837 1.255 . . . . 62.23 108.16 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -136.44 88.52 2.38 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 121.29 0.567 . . . . 63.22 109.546 167.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -135.54 174.87 10.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.056 0.942 . . . . 71.34 108.952 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -141.8 147.37 37.17 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.2 0.6 . . . . 71.21 110.548 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.55 177.4 45.31 Favored Glycine 0 C--N 1.35 1.319 0 O-C-N 123.593 0.558 . . . . 65.44 112.366 175.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -160.36 -179.04 7.36 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.63 0.772 . . . . 54.24 110.327 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.54 107.61 0.24 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.805 -0.442 . . . . 54.14 113.113 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 28.0 m -69.34 99.77 1.25 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.314 0.646 . . . . 62.44 109.821 171.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 150' ' ' GLU . . . . . 0.544 ' HG2' HG21 ' D' ' 10' ' ' THR . 47.6 mt-10 -78.45 87.34 4.45 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.578 -0.737 . . . . 74.24 110.808 -176.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -71.1 126.45 29.63 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.613 -0.721 . . . . 74.25 110.302 171.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -170.48 137.36 1.39 Allowed 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.671 1.188 . . . . 63.23 108.573 -177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.71 168.77 18.41 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.932 0.893 . . . . 73.42 110.355 178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -83.57 92.04 7.55 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.232 -0.655 . . . . 73.41 109.232 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-N 115.321 -0.854 . . . . 74.32 110.948 179.023 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 109.374 -0.602 . . . . 74.22 109.374 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 55.9 m -144.88 93.46 2.41 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.586 0.754 . . . . 64.34 110.26 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -120.91 124.97 46.26 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.306 -0.998 . . . . 75.54 108.306 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -80.24 107.18 12.83 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.477 -0.934 . . . . 72.0 108.477 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -69.92 -39.74 75.97 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.292 1.037 . . . . 65.25 110.675 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -78.3 87.6 4.35 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.399 -0.819 . . . . 73.55 108.932 174.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 6.8 t -148.61 116.95 6.49 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.85 0.86 . . . . 74.51 109.59 -175.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -81.46 132.41 35.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.044 0.538 . . . . 65.1 111.117 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.6 ttt 63.6 110.98 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.436 1.494 . . . . 74.34 111.756 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.615 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 89.5 m -101.29 101.32 11.97 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.125 -1.065 . . . . 60.53 108.125 171.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.497 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.5 t80 -108.6 122.87 47.99 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.735 -0.839 . . . . 75.04 108.735 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -136.67 128.28 28.74 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.493 -0.929 . . . . 75.04 108.493 172.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.454 HD13 HD11 ' C' ' 16' ' ' ILE . 61.1 mt -71.64 124.45 28.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.645 -0.872 . . . . 74.02 108.645 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -88.84 -46.42 8.96 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.098 0.559 . . . . 73.53 109.558 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -172.31 125.57 0.52 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.95 -0.568 . . . . 72.2 110.329 -171.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.454 HD11 HD13 ' C' ' 13' ' ' ILE . 91.3 mt -109.93 141.37 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 107.946 -1.131 . . . . 72.24 107.946 176.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.506 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 25.8 p90 -175.71 174.99 2.12 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.421 0.629 . . . . 71.31 110.775 -171.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -104.09 124.97 50.02 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.569 -0.741 . . . . 72.25 109.065 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.506 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 27.4 mmtp -69.88 -49.72 49.52 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.755 -1.202 . . . . 73.13 107.755 168.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -139.2 142.46 37.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 113.253 -1.794 . . . . 72.14 109.172 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.579 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.6 mt -138.79 142.67 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.292 -1.373 . . . . 41.03 107.292 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.1 t -156.81 150.44 24.54 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.459 0.647 . . . . 63.24 110.624 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.434 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 89.4 t80 -141.75 124.94 16.37 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.433 -1.321 . . . . 74.51 107.433 172.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 39.3 mt-10 -122.21 111.74 17.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.664 0.786 . . . . 65.12 109.516 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.92 82.04 69.18 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 107.641 -1.244 . . . . 71.45 107.641 170.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.1 -29.55 11.64 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.388 2.059 . . . . 73.41 111.824 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -99.38 19.41 15.59 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.842 0.857 . . . . 73.3 110.04 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.443 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -47.84 -55.16 18.62 Favored Pre-proline 0 CA--C 1.561 1.366 0 N-CA-C 113.793 1.034 . . . . 63.43 113.793 -171.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.513 ' HB3' HD13 ' D' ' 51' ' ' LEU . 36.3 Cg_exo -60.62 -43.39 32.94 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 121.644 1.562 . . . . 64.2 112.284 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -69.84 -30.09 67.5 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 113.861 -1.518 . . . . 73.34 112.663 -174.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.732 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.6 p -82.0 -22.06 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 112.282 0.475 . . . . 61.23 112.282 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -71.44 -23.94 61.93 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 122.246 -0.284 . . . . 73.35 111.706 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -87.19 10.58 16.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.33 0.652 . . . . 72.11 110.946 174.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.702 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -106.56 159.93 15.81 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.929 0.892 . . . . 51.21 109.818 176.081 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -73.11 121.24 19.9 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.503 0.721 . . . . 74.53 109.479 167.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -84.87 95.84 9.14 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.019 0.528 . . . . 73.11 110.171 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -142.74 75.98 17.85 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 108.162 -1.051 . . . . 71.44 108.162 166.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -87.24 156.18 8.19 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.898 2.398 . . . . 70.13 113.569 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.37 118.89 27.11 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 113.731 -1.577 . . . . 73.41 108.386 173.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.41 101.59 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 122.934 0.494 . . . . 62.54 110.003 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.476 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 2.3 mptp? -91.39 102.69 15.38 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 106.427 -1.694 . . . . 74.45 106.427 169.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' G' ' 464' ' ' MET . 50.1 tp -97.26 126.22 42.33 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.112 0.565 . . . . 73.32 110.086 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -120.38 136.13 54.81 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.366 1.066 . . . . 62.41 108.963 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.78 132.28 54.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.048 0.939 . . . . 72.45 108.657 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -130.76 151.65 50.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.176 0.991 . . . . 75.33 108.852 169.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.428 HG22 HD11 ' G' ' 460' ' ' LEU . 6.7 t -149.89 144.14 25.73 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.073 -0.714 . . . . 72.13 109.073 169.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.55 149.05 43.42 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.617 0.767 . . . . 73.04 108.939 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 28.5 p -127.21 142.78 51.4 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.346 0.658 . . . . 73.21 110.397 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.7 t -145.2 128.06 16.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.955 0.902 . . . . 72.31 109.369 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -70.34 119.68 14.89 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.522 0.729 . . . . 53.22 109.728 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.576 HD11 HD12 ' C' ' 83' ' ' ILE . 51.1 mt -92.3 -29.9 16.13 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.999 0.519 . . . . 61.14 109.753 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.35 179.22 7.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.429 1.092 . . . . 64.25 110.097 176.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.68 123.32 17.62 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.597 -0.729 . . . . 64.45 109.292 175.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.99 19.42 11.85 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.177 0.923 . . . . 74.04 111.706 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.69 115.31 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.695 -0.854 . . . . 74.35 108.695 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.504 ' HD2' HD11 ' C' ' 86' ' ' ILE . 1.0 OUTLIER -115.38 157.94 23.17 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.578 0.751 . . . . 72.21 109.057 175.182 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' C' ' 48' ' ' SER . 22.5 tt0 -116.34 120.45 38.91 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.334 -1.303 . . . . 54.31 107.506 170.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.4 t -107.75 135.22 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.606 -0.887 . . . . 62.03 108.606 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.57 108.45 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.918 -0.771 . . . . 73.01 108.918 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.57 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -86.45 108.7 18.63 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.519 -1.289 . . . . 75.4 107.519 175.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.5 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 24.0 ttm180 -95.94 119.64 34.8 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.435 -0.95 . . . . 74.24 108.435 173.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.497 ' HB ' HD11 ' C' ' 114' ' ' ILE . 29.1 t -111.94 130.95 64.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.01 -1.107 . . . . 72.43 108.01 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 13.3 m -126.92 121.73 32.58 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.654 -0.869 . . . . 71.43 108.654 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.688 HG11 HD21 ' C' ' 126' ' ' LEU . 22.1 t -112.19 116.7 53.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.244 -0.65 . . . . 64.42 109.244 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 3.5 m -102.1 137.32 40.52 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.543 -0.91 . . . . 74.24 108.543 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.1 118.62 21.78 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.307 -0.997 . . . . 64.32 108.307 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 13.3 m -133.58 130.64 38.67 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.521 0.513 . . . . 74.34 110.664 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.702 HD13 ' HG2' ' C' ' 34' ' ' LYS . 25.6 mt -86.81 45.63 1.28 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.238 1.415 . . . . 61.23 109.796 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.09 -85.21 0.49 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 110.476 -1.05 . . . . 65.25 110.476 -171.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.42 -29.13 5.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.486 0.715 . . . . 51.05 110.496 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 8.2 tp10 -63.17 118.72 8.33 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.072 0.949 . . . . 73.11 109.918 175.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -74.31 117.72 16.44 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.532 -0.914 . . . . 71.44 108.532 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.732 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.68 -55.05 7.4 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.333 -0.988 . . . . 74.23 108.333 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -164.99 163.46 20.76 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.91 -1.041 . . . . 74.34 110.288 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -130.31 142.43 50.54 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 105.803 -1.925 . . . . 74.21 105.803 172.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.481 ' SG ' HG23 ' C' ' 114' ' ' ILE . 50.1 t -144.63 142.91 30.47 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.316 -0.994 . . . . 73.12 108.316 174.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -150.29 127.82 11.53 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.433 -0.58 . . . . 74.23 109.433 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 74.8 t -127.73 136.23 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.559 1.144 . . . . 60.01 108.267 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.5 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 69.7 mt-30 -109.59 87.35 2.48 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.121 -1.066 . . . . 74.33 108.121 174.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -78.21 96.9 5.33 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.341 -0.845 . . . . 52.51 109.251 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.2 146.45 21.09 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.327 -0.851 . . . . 73.2 112.399 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.493 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.27 118.11 0.9 Allowed Glycine 0 C--O 1.238 0.373 0 N-CA-C 110.958 -0.857 . . . . 63.3 110.958 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.576 HD12 HD11 ' C' ' 51' ' ' LEU . 15.5 mm -82.22 131.29 34.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.725 -0.843 . . . . 62.04 108.725 176.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -134.75 120.06 18.98 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 123.615 0.572 . . . . 72.14 110.083 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.0 p -79.72 106.16 11.54 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.153 -1.055 . . . . 62.52 108.153 170.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.504 HD11 ' HD2' ' C' ' 56' ' ' TYR . 2.3 pp -116.11 142.82 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.178 0.991 . . . . 71.3 109.98 -172.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -149.88 158.21 43.94 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.884 0.474 . . . . 53.42 110.607 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.55 -29.01 6.46 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.218 -0.447 . . . . 63.12 113.963 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.639 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -84.67 164.68 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.123 0.569 . . . . 73.41 111.401 -176.306 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -164.55 148.48 9.28 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.879 0.872 . . . . 72.42 109.205 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.88 -115.07 7.43 Favored Glycine 0 C--N 1.351 1.389 0 O-C-N 123.79 0.681 . . . . 73.13 114.516 170.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 70.4 p -79.88 -26.99 40.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.783 0.833 . . . . 54.11 110.906 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.34 -38.8 85.45 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.455 0.702 . . . . 73.22 109.746 173.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.442 ' SD ' ' O ' ' G' ' 451' ' ' VAL . 40.4 ttp -73.11 -38.99 66.14 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.811 -0.632 . . . . 65.3 110.464 174.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 -40.69 85.51 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 123.776 0.672 . . . . 52.41 110.588 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.407 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 12.7 t-80 -79.1 -34.1 43.83 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 123.576 0.548 . . . . 72.13 112.029 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -53.96 -41.76 68.16 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.634 0.584 . . . . 74.21 110.533 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.99 -14.65 17.76 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.309 -0.859 . . . . 51.33 110.954 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.16 -21.9 64.25 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 114.086 0.395 . . . . 62.12 114.086 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.27 -45.03 0.09 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.489 0.552 . . . . 63.24 112.489 -171.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -67.54 -48.99 65.4 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.315 0.385 . . . . 72.33 111.439 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.497 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 94.5 m -64.58 -49.56 69.95 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 118.714 -0.66 . . . . 53.04 111.895 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.57 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 75.1 Cg_exo -56.55 -30.22 81.93 Favored 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 122.259 1.973 . . . . 63.24 114.309 170.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -64.64 -41.03 96.42 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.594 0.758 . . . . 62.53 110.589 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.435 HD12 ' NH1' ' A' ' 111' ' ' ARG . 39.3 mm -61.08 -45.23 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.557 -0.747 . . . . 71.04 110.173 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.493 HD21 ' HA3' ' C' ' 82' ' ' GLY . 71.8 mt -79.23 -16.6 56.26 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.193 -0.912 . . . . 74.22 112.418 -172.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -62.68 -48.32 86.12 Favored Pre-proline 0 CA--C 1.561 1.372 0 N-CA-C 114.194 1.183 . . . . 73.0 114.194 -172.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -59.06 -34.72 99.0 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 121.833 1.689 . . . . 52.33 112.94 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -71.2 -44.95 64.42 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.504 0.721 . . . . 75.25 110.831 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.14 -44.7 87.98 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.333 -0.848 . . . . 61.11 109.925 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -54.1 -54.62 36.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.705 1.202 . . . . 74.52 111.305 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.62 -29.39 68.7 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.269 0.628 . . . . 71.22 110.872 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.1 t -73.9 -37.0 64.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.998 0.519 . . . . 72.44 110.973 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.497 HD11 ' HB ' ' C' ' 62' ' ' VAL . 89.4 mt -67.81 -51.72 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.342 -0.614 . . . . 71.01 109.342 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 14.5 m -58.36 -31.84 67.99 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.613 0.765 . . . . 70.32 111.404 -177.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -62.42 -57.73 10.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.328 0.651 . . . . 75.1 109.599 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.569 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.77 -41.89 61.98 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.715 1.206 . . . . 52.54 112.843 177.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' C' ' 114' ' ' ILE . 95.7 t -67.48 -46.26 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.067 0.947 . . . . 62.44 110.758 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.451 ' OG ' HG21 ' B' ' 115' ' ' THR . 39.5 t -69.72 -26.42 64.32 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.556 -0.747 . . . . 72.35 111.281 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' D' ' 17' ' ' TYR . 78.1 mtt-85 -71.63 -42.11 68.02 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.467 0.707 . . . . 74.13 109.339 174.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.03 -3.11 67.6 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 123.759 0.662 . . . . 62.23 112.852 170.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p 65.5 30.82 10.56 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.828 2.051 . . . . 71.31 113.506 171.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -88.79 142.18 30.43 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 108.078 -1.082 . . . . 55.05 108.078 167.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.49 172.39 0.48 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 123.213 2.609 . . . . 73.53 115.732 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.434 ' NE2' ' HA ' ' B' ' 119' ' ' SER . 13.1 mm100 -46.19 135.0 8.16 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.746 1.619 . . . . 75.43 114.83 -169.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.688 HD21 HG11 ' C' ' 64' ' ' VAL . 43.7 tp -137.15 86.86 2.23 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.183 -1.371 . . . . 61.15 108.631 176.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -116.21 114.94 25.12 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.004 0.922 . . . . 71.42 109.105 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.09 137.3 38.15 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 122.588 0.355 . . . . 42.44 110.562 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.66 157.98 88.72 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 124.744 1.217 . . . . 74.33 111.272 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.73 111.67 0.65 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.233 2.622 . . . . 72.23 112.835 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.5 t -97.52 112.07 28.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.193 -0.669 . . . . 73.44 109.193 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.64 77.94 7.42 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.392 0.677 . . . . 55.04 109.744 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -60.14 -38.96 84.68 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.689 -0.687 . . . . 64.24 109.414 171.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -57.46 -35.28 69.95 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 114.095 -1.411 . . . . 64.12 112.745 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.64 -51.98 67.08 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 124.122 0.889 . . . . 74.35 111.134 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.8 mp -74.83 -35.01 62.43 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.836 -0.62 . . . . 63.45 111.435 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.407 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 2.2 t80 -75.5 -28.39 59.14 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.678 0.391 . . . . 73.31 110.566 -177.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -73.63 -31.39 63.5 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.455 0.702 . . . . 60.13 110.23 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -60.79 -38.39 85.16 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.081 0.552 . . . . 71.22 110.646 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -70.36 -87.21 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.699 -0.682 . . . . 74.4 109.399 169.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.5 ' HG ' ' HG2' ' C' ' 142' ' ' GLN . 56.4 tp 49.49 -89.63 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.862 1.265 . . . . 60.24 110.873 -171.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.5 ' HG2' ' HG ' ' C' ' 141' ' ' LEU . 30.0 pt20 179.99 167.69 1.27 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.969 1.308 . . . . 74.15 108.645 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -79.3 113.53 17.51 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.381 -0.599 . . . . 72.24 109.381 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -158.88 152.2 22.68 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.621 0.368 . . . . 44.52 111.531 -176.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.6 143.73 32.67 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.617 0.767 . . . . 61.01 109.915 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -119.26 179.37 16.7 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.336 0.397 . . . . 63.4 112.42 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.5 168.28 20.21 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.049 0.939 . . . . 70.1 109.403 177.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.9 107.66 0.48 Allowed Glycine 0 C--N 1.339 0.706 0 N-CA-C 111.13 -0.788 . . . . 61.11 111.13 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 82.2 m -149.66 91.45 1.81 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.446 1.099 . . . . 74.51 108.262 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.06 114.22 20.47 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.281 0.562 . . . . 73.25 109.967 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.49 103.98 16.15 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 106.728 -1.582 . . . . 72.1 106.728 168.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -108.74 85.8 2.17 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.311 0.577 . . . . 72.14 110.673 -175.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -81.69 148.56 28.93 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.645 -0.707 . . . . 75.14 109.096 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -158.2 126.11 5.25 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.866 -0.79 . . . . 74.41 108.866 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 C-N-CA 123.803 0.841 . . . . 52.32 109.502 -174.049 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.482 ' SD ' ' N ' ' D' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 110.518 -0.178 . . . . 43.35 110.518 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 37.2 t -161.21 179.29 8.48 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.046 0.938 . . . . 65.25 108.857 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.84 100.09 7.84 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.533 -0.914 . . . . 64.13 108.533 172.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -135.47 14.99 3.44 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.026 -0.988 . . . . 72.34 110.926 -171.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -112.31 19.88 17.26 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.989 0.915 . . . . 74.2 110.151 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -59.14 -44.21 92.05 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.32 1.048 . . . . 61.3 111.561 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.592 HG23 ' H ' ' D' ' 9' ' ' MET . 9.4 t -160.62 -166.23 1.59 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.375 1.07 . . . . 75.05 108.652 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -76.0 14.81 0.63 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.623 0.769 . . . . 74.35 111.562 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.592 ' H ' HG23 ' D' ' 7' ' ' THR . 5.3 ttp -30.16 136.41 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.745 1.618 . . . . 62.3 113.25 165.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.544 HG21 ' HG2' ' B' ' 150' ' ' GLU . 5.2 m -105.62 143.55 33.61 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.089 0.556 . . . . 43.35 109.652 176.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -148.53 96.46 2.6 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.306 -1.368 . . . . 72.23 107.306 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -119.25 122.42 41.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.378 -0.971 . . . . 64.14 108.378 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.446 HD11 HD13 ' D' ' 105' ' ' ILE . 41.2 mt -78.49 114.66 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.841 -1.17 . . . . 74.44 107.841 169.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -84.86 -38.73 19.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.356 0.262 . . . . 74.43 111.504 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -169.3 127.22 0.96 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 119.757 -0.163 . . . . 75.24 111.248 -166.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.41 HD11 HG21 ' D' ' 13' ' ' ILE . 2.4 mp -105.33 134.59 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.144 -1.428 . . . . 73.45 107.144 164.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 36.2 p90 -154.87 165.45 36.63 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.975 0.893 . . . . 64.32 111.033 174.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -98.54 117.97 34.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.337 -1.301 . . . . 65.22 109.46 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.44 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 33.2 mtpt -82.25 -33.68 29.12 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.729 -0.841 . . . . 74.21 108.729 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -143.95 144.53 31.74 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.535 -1.211 . . . . 51.15 109.398 173.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.569 HD13 ' HE3' ' C' ' 117' ' ' MET . 47.2 mt -133.73 141.25 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.41 -1.33 . . . . 62.31 107.41 172.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -144.1 137.1 27.3 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.955 0.902 . . . . 70.04 108.917 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.579 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.0 t80 -152.33 128.66 10.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.237 -1.764 . . . . 74.23 106.237 172.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -138.41 125.66 21.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.67 0.788 . . . . 74.33 109.354 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.29 83.8 60.59 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.257 -1.016 . . . . 73.03 108.257 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.42 -23.55 20.25 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.692 2.262 . . . . 53.14 112.62 -173.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 -106.84 1.69 24.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.569 0.748 . . . . 65.55 111.075 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.404 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -27.27 -66.64 0.11 Allowed Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 116.702 2.112 . . . . 53.21 116.702 -161.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.75 -22.29 9.12 Favored 'Trans proline' 0 C--N 1.38 2.229 0 CA-C-N 123.544 2.301 . . . . 72.14 113.718 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -70.73 -38.09 73.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.213 1.005 . . . . 73.22 109.291 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.515 HG22 HD12 ' D' ' 68' ' ' LEU . 9.9 p -84.92 -21.86 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 115.801 -0.636 . . . . 64.23 111.738 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -65.95 -20.36 66.18 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 112.418 0.525 . . . . 72.42 112.418 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.54 -22.15 64.89 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.296 0.638 . . . . 74.1 110.439 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -88.6 83.52 6.77 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.43 1.092 . . . . 70.12 108.396 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.23 93.2 5.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.552 -0.749 . . . . 44.42 110.099 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -160.36 158.28 29.36 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.3 1.04 . . . . 75.53 109.102 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.85 ' HG3' HD11 ' H' ' 470' ' ' LEU . 67.9 tp60 -65.92 107.42 1.53 Allowed Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 124.007 0.923 . . . . 62.43 109.548 171.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.92 117.29 4.3 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 122.964 2.443 . . . . 73.44 112.867 -167.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.492 ' HA ' HD13 ' H' ' 470' ' ' LEU . 0.4 OUTLIER -73.84 121.61 21.16 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.103 -0.703 . . . . 64.24 109.103 -175.764 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' D' ' 66' ' ' ALA . 14.5 m -107.86 151.05 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.492 0.717 . . . . 70.5 112.309 -168.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -109.37 125.3 52.23 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.709 -1.219 . . . . 75.24 107.709 164.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.565 ' HB2' ' SD ' ' H' ' 464' ' ' MET . 65.4 mt -97.03 133.89 41.11 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.796 -0.446 . . . . 74.31 109.796 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -145.65 128.45 16.31 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.452 -1.314 . . . . 51.23 107.452 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.85 159.18 42.21 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.418 0.627 . . . . 72.31 111.071 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.0 t70 -136.48 128.96 30.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.479 1.512 . . . . 61.22 108.304 -170.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.6 t -106.06 146.77 29.71 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.28 -0.637 . . . . 72.22 109.28 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.99 170.48 19.77 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.709 0.804 . . . . 72.55 109.032 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 88.9 p -162.9 155.2 18.59 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 123.163 0.289 . . . . 65.24 110.83 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 22.2 t -153.44 153.88 33.34 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.489 1.116 . . . . 72.23 109.726 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.96 136.99 32.72 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 109.542 -0.54 . . . . 64.41 109.542 172.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' C' ' 29' ' ' PRO . 26.7 mt -109.5 -34.64 6.45 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.156 0.583 . . . . 75.54 110.138 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -157.01 -178.62 7.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.937 0.895 . . . . 71.43 110.243 176.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.72 118.62 10.52 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.474 -0.785 . . . . 74.33 110.082 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 56.79 17.22 3.09 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 124.998 1.319 . . . . 73.31 113.036 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 77.9 t -118.51 110.29 29.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 106.696 -1.594 . . . . 73.4 106.696 171.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.477 ' HB2' HD11 ' D' ' 86' ' ' ILE . 6.0 t80 -120.7 161.26 21.72 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.431 -0.952 . . . . 64.5 108.431 -170.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -129.74 145.42 51.54 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.306 -0.861 . . . . 63.3 109.516 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.71 125.05 66.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.064 -1.458 . . . . 61.23 107.064 172.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 43.6 t -103.26 133.2 47.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.935 -0.765 . . . . 64.42 108.935 176.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.57 118.42 31.62 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.665 -0.865 . . . . 73.24 108.665 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.469 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.2 ttm-85 -104.27 96.05 6.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.253 -1.018 . . . . 74.41 108.253 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.35 125.21 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.874 -0.787 . . . . 51.43 108.874 174.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 5.9 m -118.07 134.01 55.38 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 123.633 0.583 . . . . 73.04 109.669 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.407 HG21 HG21 ' D' ' 114' ' ' ILE . 64.4 t -119.58 117.66 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.305 1.042 . . . . 72.24 108.914 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 31.9 m -105.91 94.1 5.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.885 0.874 . . . . 72.2 108.652 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -96.2 151.31 19.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.013 0.525 . . . . 61.4 111.337 -172.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.424 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 56.7 p -147.0 135.62 22.02 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.35 -0.841 . . . . 74.34 111.449 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.515 HD12 HG22 ' D' ' 31' ' ' VAL . 22.6 mt -96.56 94.42 7.35 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.518 -1.29 . . . . 74.32 107.518 167.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.77 -117.01 8.76 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.313 -0.858 . . . . 74.2 112.577 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -93.69 4.77 53.42 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.851 0.86 . . . . 74.15 111.914 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -118.9 140.29 50.22 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.013 0.525 . . . . 74.45 110.183 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.6 m -63.57 116.15 5.36 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 123.456 0.472 . . . . 52.31 110.255 174.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.488 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -77.24 -72.12 0.37 Allowed 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.949 -0.759 . . . . 51.21 108.949 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -142.03 153.42 44.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.573 -0.739 . . . . 74.52 109.935 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 79.2 mt -115.48 148.52 39.35 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.935 -1.506 . . . . 72.23 106.935 169.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.528 ' SG ' HG12 ' D' ' 114' ' ' ILE . 47.4 t -155.1 143.12 20.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.27 -0.641 . . . . 74.21 109.27 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -155.8 127.28 7.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.61 -0.515 . . . . 74.14 109.61 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.31 120.52 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 122.863 0.465 . . . . 74.24 110.125 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -89.48 83.57 6.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.977 -0.749 . . . . 72.3 108.977 171.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -79.7 91.55 5.28 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.789 -1.096 . . . . 71.43 108.78 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.84 143.23 18.92 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 110.96 -0.856 . . . . 75.12 110.96 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.517 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -135.31 130.77 5.54 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 112.059 -0.416 . . . . 74.25 112.059 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.44 HG13 ' HE1' ' D' ' 17' ' ' TYR . 43.5 mt -89.44 126.15 42.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 124.028 0.931 . . . . 71.21 109.026 174.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -127.76 125.57 40.15 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.532 -0.914 . . . . 64.11 108.532 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.5 t -86.45 111.17 20.29 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.652 -1.24 . . . . 65.13 107.652 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' D' ' 56' ' ' TYR . 0.9 OUTLIER -130.24 136.7 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.288 0.566 . . . . 74.02 110.538 -173.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.4 156.3 40.4 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.8 1.24 . . . . 74.4 107.882 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.28 20.92 79.46 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 121.117 -0.564 . . . . 62.4 112.322 -175.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 45.5 pt -109.8 152.35 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.057 0.943 . . . . 60.23 109.24 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -163.16 146.04 10.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.903 0.481 . . . . 72.33 110.912 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.91 -120.81 11.41 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.17 0.828 . . . . 51.02 115.17 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 24.2 p -70.08 -24.06 63.16 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.482 1.113 . . . . 73.51 112.272 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -64.19 -36.11 82.99 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.443 0.697 . . . . 62.33 110.211 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.667 ' SD ' ' HA ' ' H' ' 452' ' ' VAL . 19.4 mtm -68.25 -51.88 40.19 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.52 0.513 . . . . 72.3 110.318 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.33 70.92 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.067 0.547 . . . . 71.11 111.915 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 28.9 t-80 -72.68 -32.17 65.6 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.887 0.875 . . . . 75.23 111.161 176.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.4 t -78.31 -53.52 7.21 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.491 0.316 . . . . 63.41 111.258 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' D' ' 94' ' ' MET . 4.6 pp -95.3 -18.98 20.36 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.308 0.643 . . . . 74.31 112.163 -169.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.4 13.23 56.95 Favored Glycine 0 N--CA 1.473 1.152 0 CA-C-O 120.051 -0.305 . . . . 52.23 112.693 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.685 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -152.63 -71.03 0.15 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 111.969 0.359 . . . . 73.25 111.969 -176.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -73.11 -32.74 65.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 112.378 0.51 . . . . 73.33 112.378 -171.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -71.71 -43.89 11.73 Favored Pre-proline 0 CA--C 1.561 1.365 0 CA-C-O 118.48 -0.771 . . . . 74.34 111.791 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -52.95 -36.1 73.92 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.194 1.929 . . . . 75.14 113.287 164.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -67.84 -22.31 65.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.517 0.727 . . . . 74.31 111.586 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.446 HD13 HD11 ' D' ' 13' ' ' ILE . 87.1 mt -81.1 -40.24 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.415 1.086 . . . . 71.41 110.463 172.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.517 HD21 ' HA3' ' D' ' 82' ' ' GLY . 93.9 mt -73.03 -22.75 60.58 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.246 -0.888 . . . . 71.33 111.82 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -71.68 -40.34 8.31 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 124.263 1.025 . . . . 75.31 113.308 -171.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -52.58 -42.66 60.57 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.292 1.994 . . . . 74.51 114.243 166.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -74.82 -35.72 62.43 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.167 0.587 . . . . 71.13 111.482 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.65 -42.42 86.71 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.562 -0.533 . . . . 54.04 109.562 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.637 HH12 ' HB3' ' D' ' 130' ' ' PRO . 21.2 ttp180 -51.49 -56.71 11.85 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 124.805 1.316 . . . . 72.25 110.708 173.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -67.17 -37.76 84.27 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.346 1.028 . . . . 73.34 111.584 -171.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.39 -45.25 94.22 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.467 0.479 . . . . 74.01 110.445 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.528 HG12 ' SG ' ' D' ' 76' ' ' CYS . 96.6 mt -61.8 -53.64 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.036 -0.984 . . . . 71.2 110.706 174.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -56.39 -40.35 74.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.305 1.042 . . . . 53.24 111.525 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.4 t -66.48 -43.4 85.51 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 114.783 -1.099 . . . . 61.42 110.6 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.3 mtm -70.17 -26.24 63.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.705 0.402 . . . . 61.22 111.66 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' D' ' 114' ' ' ILE . 69.2 t -68.06 -45.23 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.566 0.746 . . . . 73.44 110.019 173.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.9 p -74.84 -26.21 59.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.816 0.446 . . . . 64.24 111.473 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -75.65 -34.71 60.52 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.204 0.601 . . . . 74.11 109.646 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.36 1.65 84.68 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.651 0.595 . . . . 73.02 112.303 171.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 44.6 p 61.04 21.23 11.62 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.073 2.149 . . . . 60.43 114.458 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -78.44 142.7 62.83 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 107.86 -1.163 . . . . 73.3 107.86 168.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -50.18 137.74 37.52 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.245 2.63 . . . . 71.21 113.192 176.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -50.22 135.49 21.19 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.842 1.257 . . . . 71.01 114.04 -164.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 18.7 tp -108.84 102.0 11.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.196 0.599 . . . . 50.3 110.675 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -100.35 96.91 7.75 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.368 0.604 . . . . 74.34 109.931 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.94 123.2 19.18 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.122 1.369 . . . . 50.21 111.357 -175.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.07 122.84 88.14 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.396 0.679 . . . . 73.13 110.385 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.637 ' HB3' HH12 ' D' ' 111' ' ' ARG . 74.2 Cg_endo -80.87 128.85 6.81 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.304 2.003 . . . . 62.11 112.674 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.39 146.1 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.497 0.719 . . . . 72.33 109.807 176.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -85.6 89.83 7.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.029 0.532 . . . . 75.13 109.566 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -59.21 -24.08 62.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.61 0.764 . . . . 71.12 112.344 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.685 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 9.8 t70 -60.23 -52.47 65.16 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.075 0.95 . . . . 71.34 110.7 -176.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.77 -40.04 69.55 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.127 -0.942 . . . . 71.12 111.359 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 91.4 mt -58.17 -34.5 70.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.627 0.771 . . . . 63.33 112.111 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -71.97 -49.06 40.47 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.377 0.671 . . . . 74.1 110.57 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 74.5 mtm -63.21 -34.53 77.84 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.76 0.424 . . . . 61.0 110.869 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -70.7 -35.96 73.01 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.964 0.506 . . . . 71.51 111.017 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -61.73 -42.88 99.54 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.702 0.401 . . . . 73.12 110.8 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.39 -30.22 71.27 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.563 0.745 . . . . 75.22 112.248 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -93.0 20.23 6.95 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.045 0.538 . . . . 74.44 112.328 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -122.2 81.65 1.86 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.025 0.53 . . . . 74.23 111.598 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -145.43 84.73 1.7 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.983 1.313 . . . . 75.44 108.278 166.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.82 137.04 9.56 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.356 0.663 . . . . 43.41 110.454 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.86 -14.79 82.22 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 111.779 -0.528 . . . . 73.35 111.779 170.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.27 138.2 41.71 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.125 0.97 . . . . 75.51 109.184 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.58 -178.65 29.98 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.669 0.605 . . . . 54.1 113.896 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 12.5 t -148.91 -152.07 0.42 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.502 -0.925 . . . . 73.4 108.502 -173.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -54.76 147.17 15.38 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.557 0.743 . . . . 64.52 110.758 172.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -77.61 78.15 4.12 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.485 0.659 . . . . 63.54 109.811 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -149.65 140.17 22.47 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.973 -1.012 . . . . 74.33 109.019 174.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -160.52 133.89 6.76 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.668 -0.864 . . . . 75.32 108.668 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -109.93 138.89 45.67 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.693 0.797 . . . . 72.23 109.332 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.919 0 C-N-CA 123.337 0.655 . . . . 71.44 111.506 -172.248 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 58.6 t30 . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.618 -0.512 . . . . 64.44 109.618 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 451' ' ' VAL . . . . . 0.682 HG11 ' HA ' ' A' ' 87' ' ' ALA . 11.5 p -113.12 -23.65 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.118 0.967 . . . . 71.11 109.899 176.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 18.9 m -63.08 150.12 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.706 1.202 . . . . 71.24 114.066 -167.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -168.75 -174.79 37.7 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.193 -0.912 . . . . 52.21 112.127 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -160.78 102.96 1.33 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 106.679 -1.6 . . . . 72.35 106.679 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 6.4 t -130.32 59.68 1.64 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 122.09 0.948 . . . . 73.12 110.223 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -160.13 129.79 5.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.987 -1.006 . . . . 74.11 109.608 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -131.37 106.47 8.28 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.353 -0.98 . . . . 74.12 108.353 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 15.3 t -148.33 150.35 33.44 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.456 -0.572 . . . . 75.32 109.456 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -85.01 66.01 9.54 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.601 -0.888 . . . . 71.32 108.601 174.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 460' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 45' ' ' ASP . 3.5 mm? 61.95 -171.55 0.16 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.753 1.221 . . . . 71.14 111.671 -176.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 461' ' ' PHE . . . . . 0.455 ' HD1' ' HB3' ' A' ' 136' ' ' LEU . 6.0 p90 -157.36 8.32 0.17 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.446 0.698 . . . . 71.4 111.04 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 462' ' ' TYR . . . . . 0.44 ' OH ' ' HA ' ' A' ' 43' ' ' ASP . 34.2 p90 -84.78 172.83 11.15 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.152 0.501 . . . . 64.23 110.856 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 9.9 t -121.43 -22.33 5.99 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.806 0.842 . . . . 62.33 110.262 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.07 -79.53 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.717 1.607 . . . . 75.13 109.129 -171.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 87.2 tttt 74.66 -24.55 0.21 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.608 1.563 . . . . 65.13 113.753 167.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -81.54 85.24 6.54 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.138 0.494 . . . . 61.33 110.201 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -73.66 120.41 19.22 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.457 -0.792 . . . . 71.55 109.401 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 468' ' ' LEU . . . . . 0.423 ' HB3' HD22 ' E' ' 470' ' ' LEU . 4.1 tt -69.89 -43.15 72.35 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.562 -0.903 . . . . 73.53 108.562 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.29 -48.14 2.64 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.826 -0.624 . . . . 52.03 112.027 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 470' ' ' LEU . . . . . 0.541 ' HB3' ' NE1' ' A' ' 36' ' ' TRP . 4.0 mm? 70.92 102.94 0.06 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.219 1.407 . . . . 60.14 110.86 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 96.2 mttt . . . . . 0 C--O 1.251 1.163 0 C-N-CA 124.702 1.201 . . . . 74.05 108.881 -177.832 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 14.2 m120 . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 108.626 -0.879 . . . . 73.35 108.626 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' F' F ' 451' ' ' VAL . . . . . 0.499 ' HA ' ' HG3' ' B' ' 90' ' ' GLU . 88.0 t -64.35 -46.01 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.39 0.676 . . . . 74.45 111.309 -173.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 15.5 m -52.44 134.03 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 113.916 1.08 . . . . 71.25 113.916 -173.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -163.93 47.16 0.31 Allowed Glycine 0 C--N 1.341 0.818 0 CA-C-N 115.046 -0.979 . . . . 72.4 110.858 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.15 124.01 26.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.401 0.68 . . . . 74.13 109.801 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 18.5 m -68.67 125.34 26.24 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 109.208 -0.664 . . . . 73.53 109.208 172.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -58.44 143.9 43.87 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.957 0.903 . . . . 61.31 112.529 -173.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -70.31 88.57 0.64 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.305 1.042 . . . . 70.34 111.881 -171.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 41.0 p -102.52 -144.43 0.36 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.165 0.986 . . . . 73.33 108.867 172.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.17 85.09 0.05 Allowed 'General case' 0 C--N 1.358 0.94 0 N-CA-C 108.962 -0.755 . . . . 71.43 108.962 170.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 460' ' ' LEU . . . . . 0.52 ' H ' HD23 ' F' ' 460' ' ' LEU . 2.2 pt? -75.65 127.62 33.46 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.803 -0.635 . . . . 74.21 110.708 -174.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 461' ' ' PHE . . . . . 0.541 ' HD2' ' HB2' ' B' ' 136' ' ' LEU . 93.7 m-85 69.09 -77.33 0.05 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.917 1.287 . . . . 73.42 113.289 170.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -132.54 173.01 11.76 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.551 0.691 . . . . 62.03 111.366 -171.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 12.0 m -132.57 54.44 1.95 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 107.659 -1.237 . . . . 73.24 107.659 171.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 53.1 mtm -70.7 -21.31 62.58 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.215 -0.902 . . . . 71.42 110.753 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 48.8 tttp 70.59 -76.08 0.07 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.557 1.143 . . . . 72.52 110.486 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 466' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' B' ' 41' ' ' LYS . . . -86.34 164.79 16.87 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.873 0.869 . . . . 72.33 110.746 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 467' ' ' ALA . . . . . 0.761 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -121.18 160.26 24.16 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.505 0.722 . . . . 73.22 109.834 174.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 7.3 mp 66.89 -76.4 0.05 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.667 1.187 . . . . 72.1 110.013 -173.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 132.41 -18.14 4.69 Favored Glycine 0 N--CA 1.476 1.35 0 N-CA-C 111.813 -0.515 . . . . 52.51 111.813 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 470' ' ' LEU . . . . . 0.598 HD21 ' H ' ' B' ' 40' ' ' VAL . 3.2 mm? 60.93 32.24 19.99 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.028 1.331 . . . . 74.43 111.063 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 C--O 1.252 1.195 0 C-N-CA 124.968 1.307 . . . . 53.42 107.77 -179.239 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 121.603 0.716 . . . . 63.15 109.246 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' G' G ' 451' ' ' VAL . . . . . 0.442 ' O ' ' SD ' ' C' ' 94' ' ' MET . 8.9 p -72.56 -11.66 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 114.695 -1.139 . . . . 74.14 111.423 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 452' ' ' VAL . . . . . 0.482 ' HA ' ' HE2' ' C' ' 56' ' ' TYR . 33.6 m -126.73 173.06 13.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 124.531 1.132 . . . . 72.53 110.001 174.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 109.76 79.31 1.08 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.735 -0.546 . . . . 62.44 111.735 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 79.8 mt -124.96 126.38 45.38 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.321 1.048 . . . . 72.42 108.232 169.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 58.5 p -78.85 -60.73 2.26 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 122.805 0.442 . . . . 70.03 111.162 -175.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -164.64 154.8 14.13 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.095 0.558 . . . . 73.42 110.172 -175.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -153.4 52.54 0.73 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.472 -0.936 . . . . 62.15 108.472 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 14.5 t -72.55 142.43 48.46 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.308 -0.86 . . . . 61.2 110.177 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 21.4 t70 66.11 108.11 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.383 1.073 . . . . 53.5 111.243 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 460' ' ' LEU . . . . . 0.428 HD11 HG22 ' C' ' 46' ' ' THR . 56.7 mt -93.48 166.59 12.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.277 0.561 . . . . 35.22 111.128 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -77.28 177.39 7.95 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.956 -1.02 . . . . 64.44 110.17 168.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 70.2 t80 64.23 76.57 0.34 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.215 1.006 . . . . 63.01 110.467 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 16.6 p -94.0 88.72 5.79 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.719 -0.845 . . . . 54.43 108.719 169.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 464' ' ' MET . . . . . 0.631 ' HB3' ' HB3' ' C' ' 42' ' ' LEU . 39.7 tpp -72.19 132.17 43.76 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.505 -0.771 . . . . 63.51 110.262 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -124.81 12.85 8.53 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.94 0.896 . . . . 73.21 111.378 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -144.69 -67.36 0.32 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.109 0.564 . . . . 54.24 110.474 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . 60.93 -79.93 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.228 1.411 . . . . 34.44 111.866 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 468' ' ' LEU . . . . . 0.434 HD12 HD12 ' C' ' 126' ' ' LEU . 84.3 mt -110.94 125.04 53.27 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.123 0.969 . . . . 73.22 109.654 -177.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -76.84 74.78 1.76 Allowed Glycine 0 C--N 1.345 1.057 0 N-CA-C 110.785 -0.926 . . . . 55.24 110.785 170.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 85.2 mt -73.29 90.66 1.65 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.978 0.911 . . . . 73.23 109.913 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.055 -0.974 . . . . 64.14 108.813 -178.229 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' H' H ' 450' ' ' ASN . . . . . 0.524 ' N ' HD21 ' H' ' 450' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.533 0.206 . . . . 75.34 111.027 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 11.8 p -96.5 -29.21 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 109.472 -0.566 . . . . 72.11 109.472 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 452' ' ' VAL . . . . . 0.667 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 11.0 p -82.04 147.8 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.524 0.73 . . . . 64.13 110.741 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 147.34 114.66 0.82 Allowed Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.843 -0.42 . . . . 35.12 112.621 174.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 454' ' ' LEU . . . . . 0.587 ' HG ' ' H ' ' H' ' 455' ' ' THR . 0.3 OUTLIER -123.13 -84.55 0.66 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.245 0.618 . . . . 72.42 109.365 174.518 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' H' H ' 455' ' ' THR . . . . . 0.587 ' H ' ' HG ' ' H' ' 454' ' ' LEU . 14.1 t 174.2 175.69 0.15 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.579 1.152 . . . . 73.24 109.275 -172.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -72.37 136.78 46.21 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.815 -0.809 . . . . 74.24 108.815 167.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 15.3 pm0 -136.33 39.1 2.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.738 0.415 . . . . 74.52 110.336 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 10.9 p -50.02 96.64 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.887 0.875 . . . . 74.34 112.242 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -176.62 174.52 1.84 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.166 1.786 . . . . 64.1 107.325 -174.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 14.8 tp -149.19 156.82 42.74 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.424 0.63 . . . . 74.4 110.843 173.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -101.59 -158.97 0.7 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.019 1.328 . . . . 74.13 108.911 167.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 28.3 t80 70.07 151.4 0.09 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.602 0.761 . . . . 74.23 112.555 169.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 51.4 m -131.66 125.28 31.74 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.743 0.817 . . . . 74.23 109.971 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 464' ' ' MET . . . . . 0.565 ' SD ' ' HB2' ' D' ' 42' ' ' LEU . 5.8 ptp -129.15 109.75 11.43 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.666 0.786 . . . . 64.2 110.016 175.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 465' ' ' LYS . . . . . 0.442 ' O ' ' HE2' ' H' ' 471' ' ' LYS . 30.9 ttmt -73.66 -46.7 44.97 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 107.319 -1.363 . . . . 72.43 107.319 164.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -72.18 160.87 31.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.195 -1.366 . . . . 74.43 111.837 -178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -118.08 -85.61 0.64 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.161 0.584 . . . . 74.3 111.303 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -163.02 56.14 0.19 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.876 0.846 . . . . 74.42 111.213 -167.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 96.04 -52.8 1.65 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.235 -1.146 . . . . 74.31 110.235 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 470' ' ' LEU . . . . . 0.85 HD11 ' HG3' ' D' ' 37' ' ' GLN . 83.8 mt -69.92 112.82 6.6 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 108.235 -1.024 . . . . 70.35 108.235 167.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 471' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' H' ' 465' ' ' LYS . 5.1 ttpm? . . . . . 0 CA--C 1.56 1.364 0 O-C-N 124.255 0.972 . . . . 73.14 110.68 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.897 -0.409 . . . . 65.34 109.897 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 m 64.6 -80.82 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.91 1.284 . . . . 52.23 111.364 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -102.43 93.17 5.02 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.813 -0.81 . . . . 64.13 108.813 172.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -84.3 -41.74 16.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.198 -1.038 . . . . 73.14 108.198 167.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -80.92 85.37 6.23 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 124.183 0.993 . . . . 72.42 109.113 174.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -78.99 132.8 36.79 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.968 -0.56 . . . . 72.44 109.772 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -141.61 155.36 45.74 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.181 0.992 . . . . 61.14 109.137 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -67.55 175.47 2.84 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.293 0.637 . . . . 74.21 109.907 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.4 mtt -61.64 129.15 39.67 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.633 -0.506 . . . . 61.12 109.633 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' C' ' 150' ' ' GLU . 75.6 m -141.42 121.09 13.4 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.482 0.713 . . . . 72.23 109.137 -170.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.522 ' HD1' HG22 ' C' ' 149' ' ' THR . 21.6 t80 -134.28 125.0 26.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.7 0.8 . . . . 74.05 109.32 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -137.93 135.71 36.33 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.145 -1.057 . . . . 75.11 108.145 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.594 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.5 mt -92.83 118.31 38.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.22 -1.03 . . . . 75.52 108.22 174.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -88.83 -30.21 19.12 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 124.003 0.814 . . . . 64.44 110.272 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -171.28 147.61 2.51 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 123.275 0.359 . . . . 74.15 110.721 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 84.6 mt -137.05 134.16 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.503 1.121 . . . . 75.34 108.058 173.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.542 ' HB3' HG23 ' B' ' 122' ' ' THR . 25.1 p90 -166.54 169.2 13.97 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.773 0.797 . . . . 74.12 112.193 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -89.36 122.75 32.89 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.303 -0.862 . . . . 72.12 108.778 170.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.461 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.6 mtpt -87.7 -18.65 29.03 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.926 -0.398 . . . . 74.22 109.926 173.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.1 t70 -161.73 144.73 12.09 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.102 0.961 . . . . 75.21 109.297 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.613 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 82.0 mt -140.49 142.52 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.813 1.645 . . . . 62.41 107.172 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -146.32 139.99 26.1 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.176 0.513 . . . . 61.02 110.147 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 89.1 t80 -141.44 127.15 19.1 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.204 -1.406 . . . . 71.22 107.204 173.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -133.87 122.43 23.18 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.734 -0.469 . . . . 74.41 109.734 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.02 74.53 79.72 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.278 -1.378 . . . . 74.34 107.278 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.57 -22.09 51.66 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.662 2.241 . . . . 70.25 112.543 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 21.1 m120 -120.01 34.81 5.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.124 0.97 . . . . 73.33 109.314 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.45 -54.21 37.39 Favored Pre-proline 0 CA--C 1.565 1.522 0 CA-C-O 118.128 -0.939 . . . . 44.32 113.4 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.97 -22.02 31.68 Favored 'Trans proline' 0 C--N 1.387 2.599 0 CA-C-N 121.607 1.609 . . . . 70.51 113.147 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 6.0 t-160 -82.03 -38.83 24.41 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.99 0.916 . . . . 63.13 110.885 -171.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 73' ' ' ALA . 34.2 m -69.43 -25.92 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.311 0.644 . . . . 74.24 111.957 -175.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -72.43 -24.51 61.23 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.192 0.597 . . . . 71.5 111.004 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -77.09 -49.07 16.12 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.687 0.795 . . . . 71.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -75.36 172.77 11.89 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.372 0.669 . . . . 75.12 111.779 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.56 116.96 4.74 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 123.444 0.698 . . . . 75.25 110.525 176.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -73.65 90.41 1.8 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.455 -0.793 . . . . 70.24 109.549 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -131.4 72.0 81.13 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.092 -1.077 . . . . 74.54 108.092 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.57 116.77 2.96 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.396 2.064 . . . . 62.32 111.245 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -94.78 111.46 23.24 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.658 -1.238 . . . . 63.13 107.658 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 m -85.71 127.82 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 114.458 -1.246 . . . . 50.32 112.013 -170.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -122.01 114.54 21.1 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.334 1.453 . . . . 75.02 107.805 177.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.578 ' HB3' ' HB3' ' E' ' 464' ' ' MET . 22.6 tp -110.44 113.73 26.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.032 0.533 . . . . 52.01 109.823 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -113.11 110.05 19.8 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.744 0.818 . . . . 64.11 108.902 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mp -97.88 155.35 17.1 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.179 -0.674 . . . . 75.03 109.179 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.9 t70 -148.83 146.76 28.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.432 1.093 . . . . 73.23 108.437 -174.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.2 m -141.89 134.44 28.25 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.614 0.765 . . . . 74.14 110.175 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.2 140.51 46.55 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.807 0.843 . . . . 74.32 110.61 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.464 ' HB3' HD21 ' A' ' 98' ' ' LEU . 39.5 p -92.16 152.97 19.62 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.029 0.932 . . . . 63.12 109.834 176.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -151.85 145.25 24.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.946 0.898 . . . . 61.12 109.178 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -113.44 137.76 51.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.976 -0.75 . . . . 63.23 108.976 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.3 mt -110.96 -36.42 5.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.496 0.718 . . . . 74.25 110.469 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -160.45 -176.85 5.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.388 0.675 . . . . 74.11 110.828 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.28 120.54 12.95 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.166 -1.05 . . . . 74.32 108.166 170.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 72.46 -5.91 1.71 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.778 1.231 . . . . 63.42 112.702 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 52.3 t -109.25 116.38 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.081 0.952 . . . . 65.22 108.832 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.78 162.56 28.17 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.26 0.624 . . . . 72.41 109.549 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -134.88 145.74 48.55 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.063 0.945 . . . . 72.54 109.732 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -131.6 147.57 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.5 -0.926 . . . . 75.1 108.5 166.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.13 117.3 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.728 0.811 . . . . 72.4 109.382 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.7 tp -97.91 103.28 15.2 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.874 -0.787 . . . . 51.32 108.874 173.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.612 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 27.3 ttp180 -88.26 112.99 23.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.3 0.64 . . . . 70.11 109.673 172.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.85 123.2 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.598 -0.89 . . . . 55.21 108.598 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -115.77 120.65 39.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.748 0.819 . . . . 70.4 110.061 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.446 ' O ' HD12 ' A' ' 75' ' ' LEU . 86.0 t -111.39 113.46 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.992 0.917 . . . . 51.04 110.007 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.2 m -112.06 105.6 14.03 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.82 -0.807 . . . . 64.13 108.82 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -111.38 105.36 13.97 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.198 -1.038 . . . . 70.55 108.198 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.3 p -128.85 131.29 47.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.49 0.716 . . . . 60.35 110.753 -174.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.715 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -91.83 87.15 6.14 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.564 -0.902 . . . . 71.4 108.564 175.371 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.15 -102.88 2.32 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 114.981 -1.009 . . . . 72.23 111.902 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.43 -26.12 12.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.994 0.517 . . . . 72.2 110.327 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -91.68 127.4 37.12 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.894 0.878 . . . . 52.42 109.159 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.7 m -87.4 134.56 33.56 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 122.643 0.377 . . . . 75.34 110.751 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.648 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -76.48 -61.09 2.07 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 124.283 0.989 . . . . 74.5 108.668 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -152.88 153.79 33.76 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.554 -1.203 . . . . 62.22 110.725 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 58.6 tp -122.18 136.73 54.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.849 -1.537 . . . . 71.31 106.849 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 85.8 m -140.05 103.39 4.61 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.187 0.595 . . . . 72.55 109.445 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.22 117.68 24.37 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.216 -0.661 . . . . 74.13 109.216 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -126.11 113.79 35.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 123.862 0.865 . . . . 74.34 109.683 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.612 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 50.0 mt-30 -85.38 84.86 7.51 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.65 -0.871 . . . . 73.12 108.65 170.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.403 ' O ' HD13 ' A' ' 106' ' ' LEU . 62.0 tp60 -79.84 100.87 8.21 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.367 -0.975 . . . . 72.33 108.367 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.12 144.79 17.36 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 111.335 -0.706 . . . . 71.42 111.335 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.535 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.02 128.43 4.22 Favored Glycine 0 CA--C 1.504 -0.639 0 N-CA-C 111.369 -0.692 . . . . 70.11 111.369 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.0 mt -82.22 119.63 32.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.406 -0.961 . . . . 74.23 108.406 172.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.594 ' HD2' HG12 ' A' ' 13' ' ' ILE . 26.9 m-85 -130.31 117.73 20.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.954 -1.128 . . . . 70.03 107.954 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 p -78.75 108.42 12.16 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.973 -1.121 . . . . 73.25 107.973 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.538 ' HB ' HD11 ' A' ' 89' ' ' ILE . 42.9 pt -119.19 139.45 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.361 0.664 . . . . 63.5 109.943 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.32 159.68 28.75 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.478 1.111 . . . . 73.11 109.522 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.54 4.0 89.05 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.926 -0.375 . . . . 40.34 113.879 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -120.46 136.58 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.284 -1.006 . . . . 72.22 108.284 172.268 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -141.22 173.6 11.33 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.34 1.056 . . . . 74.13 109.659 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.83 -133.14 51.33 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 123.948 0.78 . . . . 72.12 114.198 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.646 ' HB ' HD11 ' A' ' 141' ' ' LEU . 55.5 p -71.55 -24.82 62.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.01 0.924 . . . . 73.11 111.854 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -68.82 -44.11 74.18 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.582 0.753 . . . . 71.33 110.17 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 52.3 ttp -63.33 -48.4 78.18 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.956 -0.387 . . . . 62.42 109.956 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.9 -31.6 68.76 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.171 0.919 . . . . 55.23 112.034 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -73.98 -45.08 52.26 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.95 0.5 . . . . 70.41 110.62 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 78.7 m -66.55 -25.04 66.46 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.177 0.591 . . . . 40.14 111.575 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 48' ' ' SER . 6.0 tt -95.72 -42.5 8.34 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.459 1.103 . . . . 74.44 110.159 -173.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.77 4.31 53.3 Favored Glycine 0 N--CA 1.472 1.045 0 CA-C-N 115.945 -0.57 . . . . 74.24 113.681 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.6 -57.79 0.32 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.224 0.512 . . . . 74.42 111.772 -176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.496 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.2 t80 -70.68 -62.43 1.4 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.118 0.567 . . . . 75.11 112.395 -170.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.3 m -68.71 -33.09 4.06 Favored Pre-proline 0 CA--C 1.567 1.618 0 N-CA-C 114.369 1.248 . . . . 73.34 114.369 -173.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.02 -24.77 44.93 Favored 'Trans proline' 0 C--N 1.39 2.742 0 CA-C-N 121.725 1.652 . . . . 63.43 112.776 167.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -73.41 -26.56 61.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.776 -0.453 . . . . 73.34 109.776 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.5 mm -63.63 -36.52 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.466 0.707 . . . . 73.03 109.818 169.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.535 HD21 ' HA3' ' A' ' 82' ' ' GLY . 76.5 mt -79.97 -17.61 52.5 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.899 0.88 . . . . 63.32 111.932 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -64.69 -46.17 76.17 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 117.755 -1.117 . . . . 65.14 113.684 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.47 -33.88 67.24 Favored 'Trans proline' 0 C--N 1.389 2.675 0 CA-C-N 122.071 1.776 . . . . 74.14 112.838 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -70.53 -41.16 72.91 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.37 0.668 . . . . 70.21 111.239 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.98 -39.68 79.28 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.925 0.49 . . . . 75.21 110.405 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.474 ' NH1' HG23 ' C' ' 105' ' ' ILE . 36.5 ttm180 -53.2 -51.54 61.76 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 124.402 1.064 . . . . 54.22 109.611 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -66.59 -44.21 82.81 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.023 -0.989 . . . . 75.31 111.653 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.418 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.9 t -62.2 -33.99 75.6 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.174 0.59 . . . . 75.14 111.306 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 118' ' ' VAL . 83.3 mt -70.63 -55.97 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.112 0.965 . . . . 64.35 110.092 173.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.8 m -51.67 -43.43 62.69 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.697 1.199 . . . . 62.35 111.466 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -63.37 -47.07 83.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.906 -1.497 . . . . 54.41 110.268 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.429 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 69.0 mtm -63.13 -36.96 85.34 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.053 0.541 . . . . 62.31 111.722 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 114' ' ' ILE . 86.1 t -62.83 -47.2 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 123.507 0.723 . . . . 72.35 110.298 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.4 p -76.75 -20.25 56.71 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.153 0.581 . . . . 52.33 112.089 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -75.59 -34.89 60.66 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.005 -0.739 . . . . 72.31 109.005 172.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.43 -0.88 80.35 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.457 -0.792 . . . . 73.43 112.291 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.8 m 70.92 14.22 6.94 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 125.246 1.418 . . . . 25.24 111.578 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -77.91 157.43 79.02 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 123.619 0.767 . . . . 74.52 110.027 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.63 131.19 44.35 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.214 2.609 . . . . 71.05 111.897 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -55.24 126.41 24.78 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 124.414 1.071 . . . . 70.33 112.148 -170.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.8 tp -106.16 97.63 7.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.553 -0.748 . . . . 74.01 109.295 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.466 ' H ' ' HA3' ' E' ' 469' ' ' GLY . 80.4 m-20 -95.78 107.63 19.88 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.389 -1.337 . . . . 71.43 107.389 174.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.441 ' HB3' ' HG3' ' A' ' 111' ' ' ARG . 30.5 tp -72.03 126.81 30.71 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.441 -0.799 . . . . 64.22 110.213 -176.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.1 139.02 92.5 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.401 0.68 . . . . 41.01 110.441 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.58 128.46 28.36 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.906 2.404 . . . . 74.14 113.192 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 96.8 t -100.22 120.88 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.858 -0.793 . . . . 72.5 108.858 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -76.7 74.01 3.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.515 1.126 . . . . 65.03 110.932 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -56.36 -39.54 73.05 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.406 0.682 . . . . 74.34 111.862 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.8 -33.35 72.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.509 1.124 . . . . 73.22 111.864 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.46 -43.01 51.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.158 0.583 . . . . 65.42 110.168 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.5 -38.19 90.15 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.333 -0.849 . . . . 74.44 110.131 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -69.22 -38.62 78.64 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.294 -0.866 . . . . 72.02 109.949 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -41.06 85.87 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.213 1.005 . . . . 61.34 110.599 176.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.527 ' HA ' ' HB2' ' A' ' 143' ' ' GLN . 82.4 m-20 -66.76 -23.8 66.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.21 1.004 . . . . 72.42 112.048 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -91.9 -34.86 14.33 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.166 0.987 . . . . 73.34 110.896 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.646 HD11 ' HB ' ' A' ' 92' ' ' THR . 41.7 tp -67.93 -48.64 65.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.58 1.152 . . . . 55.11 112.829 -165.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -146.97 4.07 0.83 Allowed 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.225 0.328 . . . . 74.13 111.029 -174.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.527 ' HB2' ' HA ' ' A' ' 139' ' ' ASN . 21.1 mm-40 -107.39 175.74 5.39 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.736 0.814 . . . . 53.33 109.841 173.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -144.93 -32.9 0.39 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.349 -0.842 . . . . 71.12 109.516 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 68.55 -175.23 0.2 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.931 1.292 . . . . 72.11 111.398 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 72.97 -97.04 0.8 Allowed Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.73 -0.548 . . . . 73.24 111.73 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.59 81.88 5.32 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 122.355 1.074 . . . . 54.24 109.838 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.4 134.69 3.37 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 114.922 -1.035 . . . . 53.24 111.309 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 46.6 m -136.14 124.14 22.85 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.864 0.866 . . . . 75.43 108.956 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 70.07 151.37 0.09 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.615 1.166 . . . . 73.01 111.744 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.25 110.85 3.54 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.962 -1.125 . . . . 65.25 107.962 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -54.74 112.14 0.97 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.873 0.869 . . . . 64.44 111.428 -177.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -123.36 125.76 45.58 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.945 0.898 . . . . 73.32 108.752 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -142.45 120.58 12.17 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.242 1.017 . . . . 65.21 108.658 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.025 0 C-N-CA 123.51 0.724 . . . . 62.13 110.279 -177.561 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 110.23 -0.285 . . . . 75.32 110.23 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.4 p -90.21 110.18 21.23 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.322 -0.621 . . . . 62.23 109.322 175.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.64 107.45 2.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.252 0.621 . . . . 41.21 109.896 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -71.08 134.39 47.0 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.97 0.908 . . . . 63.03 111.304 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -98.31 145.65 26.46 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.545 -1.28 . . . . 61.21 107.545 171.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -64.33 116.28 5.89 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.946 0.499 . . . . 60.54 110.433 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -113.56 152.93 29.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.068 0.947 . . . . 51.32 110.236 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.7 -29.43 58.97 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.936 0.894 . . . . 73.31 110.503 171.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 6.0 ptm 50.76 168.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 127.692 2.397 . . . . 74.32 114.379 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 58.3 m -162.04 143.41 10.84 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.278 1.031 . . . . 74.23 108.367 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -148.27 157.05 43.26 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.444 0.64 . . . . 72.23 111.389 161.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -124.1 133.33 53.63 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.116 -1.439 . . . . 70.14 107.116 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.465 HD11 HD13 ' B' ' 105' ' ' ILE . 27.7 mt -77.0 123.96 34.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.902 -0.777 . . . . 52.24 108.902 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -83.01 -45.48 14.01 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.818 0.698 . . . . 70.45 109.911 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -170.32 130.98 0.94 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.931 -0.577 . . . . 63.53 110.279 -171.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.432 HD11 HD13 ' B' ' 13' ' ' ILE . 77.6 mt -113.91 139.47 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 107.408 -1.33 . . . . 75.35 107.408 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -161.93 152.73 17.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.576 0.703 . . . . 65.24 111.762 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 81.7 m -77.47 121.36 23.74 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.165 -1.379 . . . . 73.13 108.195 171.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.587 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.1 mtpt -93.62 -29.53 15.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.528 0.731 . . . . 71.22 110.453 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -160.69 139.25 10.1 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.363 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.515 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.6 mm -133.21 142.01 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.867 1.267 . . . . 52.22 108.802 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -138.56 129.99 27.41 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.493 -1.299 . . . . 75.41 107.493 171.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.613 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.7 t80 -142.78 132.4 23.84 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.294 -1.373 . . . . 64.4 107.294 170.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.29 148.43 51.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.686 -0.857 . . . . 73.45 108.686 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.789 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -142.85 77.67 16.25 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 107.538 -1.282 . . . . 74.23 107.538 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.83 -36.83 17.27 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.928 2.419 . . . . 72.33 112.265 -171.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -100.37 -0.94 37.27 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.598 0.759 . . . . 72.32 111.346 -174.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.789 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -36.67 -66.08 0.29 Allowed Pre-proline 0 N--CA 1.494 1.728 0 C-N-CA 125.834 1.653 . . . . 61.34 115.013 -165.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.09 -24.42 73.32 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.332 2.021 . . . . 73.42 113.305 -170.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -93.12 -32.21 14.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.367 0.667 . . . . 71.24 111.262 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.612 HG22 HD12 ' B' ' 68' ' ' LEU . 1.5 p -75.56 -20.81 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 122.895 0.478 . . . . 74.34 110.922 -172.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -66.4 -10.11 40.45 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.633 0.773 . . . . 74.23 112.952 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -61.73 -28.72 69.63 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.231 0.612 . . . . 72.34 110.266 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -90.44 96.84 10.85 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 124.34 1.056 . . . . 72.42 109.536 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.08 94.99 1.97 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.507 -0.923 . . . . 64.31 108.507 171.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.439 ' HZ3' ' H ' ' B' ' 69' ' ' GLY . 26.9 t90 -169.35 154.96 6.05 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.372 1.069 . . . . 74.45 108.844 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.416 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 0.1 OUTLIER -87.07 110.59 34.35 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.046 -1.094 . . . . 64.35 108.046 170.175 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.422 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 53.8 Cg_endo -68.69 143.24 55.52 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.817 2.345 . . . . 63.43 113.407 -170.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.5 107.96 0.75 Allowed 'General case' 0 C--O 1.242 0.663 0 O-C-N 124.281 0.988 . . . . 73.03 110.066 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.5 m -86.34 161.2 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.207 -0.906 . . . . 75.35 110.972 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.482 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 60.3 tttp -134.16 104.29 6.14 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.612 -1.255 . . . . 72.04 107.612 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.49 HD22 ' HG3' ' F' ' 464' ' ' MET . 5.5 mp -85.17 124.22 31.58 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.523 -0.917 . . . . 73.1 108.523 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -140.81 109.82 6.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.214 -1.402 . . . . 64.42 107.214 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.61 155.09 17.78 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.876 -0.787 . . . . 75.31 108.876 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -155.71 149.89 25.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.452 -1.249 . . . . 72.44 108.374 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -140.65 143.12 34.98 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.352 0.596 . . . . 72.34 111.099 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.43 148.48 37.85 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.942 1.297 . . . . 63.14 107.915 172.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 72.4 p -145.03 162.92 35.76 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.114 0.416 . . . . 74.1 111.456 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -151.84 147.82 27.08 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.906 0.882 . . . . 44.53 109.833 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.474 ' HB2' HG11 ' F' ' 452' ' ' VAL . 58.1 tt0 -84.04 131.36 34.82 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.331 0.652 . . . . 74.22 109.566 172.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 43.3 mt -93.66 -44.31 8.24 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.333 0.653 . . . . 73.22 109.509 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.62 -176.35 5.89 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.369 1.068 . . . . 74.05 110.177 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -69.47 120.35 15.13 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.713 -1.131 . . . . 64.3 109.346 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.77 16.75 10.62 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.3 1.04 . . . . 73.2 112.072 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 67.1 t -130.15 104.06 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.221 -1.029 . . . . 74.41 108.221 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -112.55 167.25 10.61 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.922 -1.14 . . . . 74.31 107.922 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -143.38 121.37 12.07 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.202 -1.036 . . . . 63.34 108.202 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -106.5 143.29 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.173 0.989 . . . . 61.32 109.39 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.508 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 35.6 t -116.78 144.53 24.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.977 -0.749 . . . . 64.35 108.977 176.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -127.71 110.06 12.28 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.143 -1.058 . . . . 72.32 108.143 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 36.1 ttm180 -94.36 122.3 36.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.841 0.856 . . . . 72.03 110.162 171.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 47.7 t -116.44 103.43 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.387 -1.338 . . . . 65.23 107.387 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.2 m -98.9 131.7 44.78 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.302 0.641 . . . . 73.11 109.542 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 91.5 t -123.49 130.02 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.023 0.929 . . . . 61.01 109.631 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.5 m -119.25 136.88 54.01 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 108.85 -0.796 . . . . 73.32 108.85 172.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.49 151.95 43.76 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.057 0.389 . . . . 65.42 110.917 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.5 p -152.22 132.77 13.87 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.175 0.922 . . . . 75.1 111.515 -173.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.612 HD12 HG22 ' B' ' 31' ' ' VAL . 77.4 mt -93.51 104.17 16.32 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.682 -1.229 . . . . 62.21 107.682 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.439 ' H ' ' HZ3' ' B' ' 36' ' ' TRP . . . 85.57 -110.7 3.47 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.462 -0.655 . . . . 54.03 111.462 -174.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.77 1.17 9.93 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.888 0.875 . . . . 73.52 110.419 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -113.55 150.87 32.36 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.034 -0.728 . . . . 70.13 109.034 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -62.16 139.11 58.48 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.822 0.702 . . . . 73.13 110.908 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.465 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -97.4 -67.78 0.83 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.545 -1.279 . . . . 65.24 107.545 170.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -145.18 160.61 41.18 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.005 -0.998 . . . . 74.54 109.993 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -135.0 138.64 44.16 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.471 -1.677 . . . . 63.03 106.471 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -150.04 157.87 43.58 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.876 0.369 . . . . 74.14 110.084 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -164.62 135.55 4.18 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.03 -1.1 . . . . 33.44 108.03 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.44 HG22 HD12 ' B' ' 21' ' ' ILE . 95.8 t -126.2 145.88 32.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.572 -0.899 . . . . 75.12 108.572 172.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.424 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 45.3 mt-30 -123.29 86.69 2.62 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.739 -0.837 . . . . 75.45 108.739 171.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.6 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 46.4 tp60 -83.26 101.43 11.25 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.955 -1.021 . . . . 73.43 109.424 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.587 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.55 169.9 34.74 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.894 -0.482 . . . . 55.42 111.894 175.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.26 137.12 4.57 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 111.304 -0.718 . . . . 43.45 111.304 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.3 mt -96.87 125.91 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.044 0.938 . . . . 70.11 108.529 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -128.3 131.26 48.67 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.662 -1.236 . . . . 72.11 107.662 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 45.0 m -97.96 89.82 4.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.463 -0.569 . . . . 72.21 109.463 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.467 ' HB ' HD12 ' B' ' 89' ' ' ILE . 1.6 pp -94.42 139.67 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.424 0.69 . . . . 74.42 111.527 -166.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.29 138.49 21.43 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.37 1.068 . . . . 75.42 109.294 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.4 -35.87 4.02 Favored Glycine 0 C--N 1.345 1.033 0 O-C-N 123.642 0.589 . . . . 62.41 113.307 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.467 HD12 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -54.64 137.48 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 C-N-CA 124.805 1.242 . . . . 71.41 112.752 -175.315 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -158.9 142.34 14.89 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.563 0.345 . . . . 75.44 111.282 175.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' B' ' 94' ' ' MET . . . 67.04 -121.92 17.57 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 114.573 0.589 . . . . 72.04 114.573 173.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 84.8 m -65.66 -33.21 75.36 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.645 0.778 . . . . 75.03 110.193 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -68.29 -39.26 82.14 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.34 -0.845 . . . . 74.41 110.202 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.638 ' HE2' HD22 ' F' ' 454' ' ' LEU . 17.5 ptm -78.79 -28.9 44.68 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 116.314 -0.403 . . . . 64.02 110.72 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.91 -30.55 62.65 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.2 0.6 . . . . 70.33 110.916 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -79.61 -33.48 41.48 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.092 0.957 . . . . 72.53 109.994 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.6 t -71.37 -65.15 0.79 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.587 0.755 . . . . 61.42 110.298 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.436 HD21 HG21 ' B' ' 86' ' ' ILE . 50.6 mt -80.45 -20.24 44.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.823 0.849 . . . . 71.23 112.395 -171.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.65 -13.16 41.75 Favored Glycine 0 N--CA 1.477 1.383 0 CA-C-O 119.646 -0.53 . . . . 71.12 114.363 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.93 -52.86 0.52 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 117.612 0.706 . . . . 74.32 111.688 -172.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -73.58 -38.47 65.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.047 0.539 . . . . 73.14 111.601 -173.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.41 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.4 m -70.43 -48.23 18.1 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-O 118.655 -0.688 . . . . 74.13 111.246 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.43 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 53.5 Cg_exo -55.86 -33.26 87.97 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.107 1.872 . . . . 70.4 113.701 168.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -59.52 -39.21 83.16 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.332 0.653 . . . . 72.12 111.644 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.465 HD13 HD11 ' B' ' 13' ' ' ILE . 79.8 mt -66.11 -41.06 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.09 0.956 . . . . 62.14 110.844 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 52.6 mt -80.13 -16.04 55.78 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.404 -0.817 . . . . 70.32 111.887 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -60.21 -48.8 93.26 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.198 0.999 . . . . 73.02 113.589 -172.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.553 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 33.3 Cg_endo -61.34 -34.08 88.0 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.141 1.894 . . . . 72.32 113.498 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.6 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 94.3 m-85 -67.39 -46.86 72.01 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.692 0.397 . . . . 75.3 110.234 177.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.45 86.08 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.47 -0.786 . . . . 41.21 111.112 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.568 ' HA ' HD23 ' B' ' 128' ' ' LEU . 29.0 mtp-105 -55.16 -61.39 2.35 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.376 1.07 . . . . 71.22 111.36 175.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.37 -27.85 69.29 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.07 0.856 . . . . 74.44 110.781 -173.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.515 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.5 t -73.32 -37.94 65.97 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.108 0.563 . . . . 73.02 111.048 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 71.2 mt -64.89 -51.86 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.449 -0.574 . . . . 73.44 109.449 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.537 HG21 ' OG ' ' C' ' 119' ' ' SER . 14.4 m -58.19 -34.63 70.56 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 124.406 1.067 . . . . 71.42 111.902 -176.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 25.7 t -58.86 -52.25 66.55 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 124.028 0.83 . . . . 74.53 109.46 175.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.2 mmt -69.28 -33.46 73.24 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.496 0.719 . . . . 75.32 111.417 -174.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.04 -44.33 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.974 0.91 . . . . 53.32 110.496 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -69.48 -32.17 70.9 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.178 -0.919 . . . . 61.45 111.209 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.1 mtt-85 -67.7 -37.97 83.02 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.393 -0.821 . . . . 72.32 109.357 175.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.43 4.14 64.86 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 124.161 0.913 . . . . 52.22 113.237 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.542 HG23 ' HB3' ' A' ' 17' ' ' TYR . 82.1 p 58.8 32.07 21.85 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.169 1.787 . . . . 70.54 113.12 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -95.47 154.25 39.36 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 124.203 1.001 . . . . 71.44 110.972 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.416 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 81.2 Cg_exo -49.92 158.77 1.97 Allowed 'Trans proline' 0 C--N 1.39 2.731 0 C-N-CA 124.299 3.333 . . . . 64.42 115.652 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -63.94 130.75 45.34 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 114.636 -1.166 . . . . 72.45 112.251 -172.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 68.6 tp -141.53 123.77 15.63 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.938 0.895 . . . . 52.44 109.709 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -130.49 136.36 48.9 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.209 -1.034 . . . . 74.43 108.209 168.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.568 HD23 ' HA ' ' B' ' 111' ' ' ARG . 1.9 mm? -82.93 119.66 24.7 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.457 -0.942 . . . . 64.21 108.457 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.02 150.37 71.64 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.183 0.593 . . . . 61.12 111.054 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.09 140.58 41.78 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.061 2.508 . . . . 75.14 112.817 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.575 HG21 ' HA ' ' F' ' 464' ' ' MET . 61.6 t -127.38 145.6 34.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.446 -1.316 . . . . 71.44 107.446 167.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -66.61 101.51 0.79 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.605 0.762 . . . . 61.45 110.902 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -61.11 -32.58 72.26 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.004 0.521 . . . . 75.11 110.126 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -69.78 -52.61 23.75 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.407 1.083 . . . . 60.13 111.193 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.19 -44.4 95.12 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 123.707 0.63 . . . . 52.2 111.184 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 66.7 mt -61.2 -37.48 83.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.959 0.504 . . . . 64.51 111.44 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.409 ' O ' ' HB3' ' B' ' 140' ' ' TYR . 72.4 t80 -68.17 -46.35 70.99 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.53 0.519 . . . . 73.43 110.733 -176.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 26.0 ptm -69.51 -25.42 64.03 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 117.772 0.26 . . . . 63.35 110.953 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -74.84 -29.26 61.0 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.63 0.772 . . . . 72.33 110.621 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' B' ' 137' ' ' PHE . 24.0 t80 -62.63 -38.24 89.49 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.445 0.698 . . . . 73.54 109.893 171.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 8.1 mt -81.21 -2.45 48.76 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.189 -0.914 . . . . 74.23 110.929 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 71.52 6.67 5.8 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.645 1.578 . . . . 62.3 111.89 -177.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -89.48 87.83 7.22 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.962 -0.755 . . . . 75.42 108.962 176.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -120.11 98.35 6.03 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.802 -1.185 . . . . 71.23 107.802 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.86 86.68 2.95 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.859 0.463 . . . . 64.31 110.163 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 146' ' ' GLY . . . . . 0.552 ' HA3' ' HG2' ' D' ' 8' ' ' GLU . . . 85.46 132.99 2.9 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.716 -0.675 . . . . 51.21 113.2 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -102.19 153.78 19.64 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.455 0.702 . . . . 73.4 109.948 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -73.48 109.6 2.85 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.968 -0.56 . . . . 32.42 112.053 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.1 t -80.79 172.0 14.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.943 0.897 . . . . 74.33 110.424 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -145.41 80.01 1.59 Allowed 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.694 0.759 . . . . 70.03 112.813 -170.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -75.01 84.1 2.26 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.629 0.771 . . . . 73.33 109.919 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -80.74 94.0 6.31 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.598 -0.728 . . . . 63.34 109.106 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 153' ' ' GLN . . . . . 0.682 ' HG3' ' HB3' ' D' ' 1' ' ' MET . 22.8 tm0? -66.47 130.96 44.96 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.475 -0.935 . . . . 74.12 108.475 173.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.95 111.31 6.24 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.062 0.545 . . . . 53.53 110.102 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 C-N-CA 124.022 0.929 . . . . 55.21 109.143 -177.012 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.343 0.592 . . . . 71.44 109.423 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -163.96 106.28 0.93 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.338 1.055 . . . . 71.22 108.631 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -151.57 -44.06 0.11 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.585 0.754 . . . . 61.24 109.988 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -119.69 21.08 12.17 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.229 1.012 . . . . 51.1 109.24 175.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -71.17 104.09 2.97 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.418 1.087 . . . . 60.23 110.3 -172.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 t30 65.72 95.65 0.06 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.861 0.865 . . . . 72.32 109.742 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 29.5 m -126.19 101.04 6.58 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.362 0.665 . . . . 74.23 110.622 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -71.79 105.97 3.97 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.241 -0.651 . . . . 73.31 109.241 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.432 ' SD ' HD13 ' C' ' 89' ' ' ILE . 60.6 ttp 64.75 113.82 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.214 1.406 . . . . 72.54 111.453 -172.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.596 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 43.6 m -93.28 91.38 7.21 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.84 -0.8 . . . . 73.04 108.84 173.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.562 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 6.0 t80 -110.03 124.81 52.11 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.827 -0.805 . . . . 74.22 108.827 174.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -145.83 134.19 21.87 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.601 0.76 . . . . 72.15 109.162 171.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 67.2 mt -78.17 122.44 33.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.323 -0.991 . . . . 73.31 108.323 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.622 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 17.2 mm100 -89.77 -42.19 11.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.217 -0.901 . . . . 73.41 110.639 -175.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.401 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 17.6 ttt180 -175.6 129.82 0.26 Allowed 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.384 0.427 . . . . 74.01 110.214 -168.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 66.5 mt -121.77 131.8 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.636 -0.876 . . . . 62.54 108.636 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.502 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 32.6 p90 -171.36 173.09 4.96 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.706 0.765 . . . . 73.44 111.311 -169.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.3 p -95.88 119.58 34.64 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.32 -0.855 . . . . 63.34 109.572 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.502 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 21.8 mmtp -65.32 -47.74 75.49 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 107.581 -1.266 . . . . 70.55 107.581 169.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 21.9 t70 -144.04 143.84 31.36 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 113.352 -1.749 . . . . 70.32 109.936 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.3 mt -129.96 144.36 38.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.475 -1.676 . . . . 73.4 106.475 172.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -152.53 147.25 25.98 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.35 0.595 . . . . 63.53 109.712 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -144.55 137.06 26.53 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.451 -1.314 . . . . 75.23 107.451 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -135.22 131.43 36.67 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.858 0.863 . . . . 74.51 109.352 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -154.28 76.63 5.65 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 106.799 -1.556 . . . . 61.3 106.799 172.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.66 -42.0 5.38 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.229 1.953 . . . . 75.31 111.429 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -96.96 29.04 3.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.525 1.13 . . . . 74.12 110.595 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.569 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -51.63 -55.87 25.97 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.201 -0.904 . . . . 42.52 113.408 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.5 -32.9 70.18 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 121.723 1.615 . . . . 73.34 112.684 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -67.99 -44.48 76.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.081 0.553 . . . . 54.14 110.859 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.753 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.8 p -77.17 -22.65 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 112.708 0.632 . . . . 72.22 112.708 -173.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -63.72 -33.6 76.02 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.22 0.452 . . . . 74.42 112.22 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -85.79 11.18 11.68 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.471 0.308 . . . . 60.12 111.572 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.799 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -89.95 158.51 17.36 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.505 0.722 . . . . 74.43 109.978 175.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -65.17 129.0 38.11 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.942 0.897 . . . . 73.53 109.791 165.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 58.9 t90 -82.03 94.16 7.12 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.386 0.674 . . . . 65.11 111.312 -172.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -141.39 76.15 21.65 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.644 0.778 . . . . 74.12 108.934 172.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -83.54 126.98 4.25 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.118 2.545 . . . . 51.43 113.252 -175.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.37 103.38 13.49 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.271 -1.381 . . . . 62.15 107.271 168.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 19.6 m -88.33 103.56 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.155 0.979 . . . . 61.42 110.855 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.541 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 82.7 tttt -93.87 104.11 16.19 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.802 -1.09 . . . . 74.33 108.644 177.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.13 136.72 32.82 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.351 -0.981 . . . . 74.21 108.351 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -130.88 105.34 7.7 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.927 -0.768 . . . . 54.12 108.927 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mp -103.19 135.02 45.63 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.239 -1.023 . . . . 52.2 108.239 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.424 ' HA ' ' HG ' ' G' ' 460' ' ' LEU . 24.6 t70 -151.44 155.48 38.67 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.515 0.726 . . . . 60.15 110.061 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -139.04 146.72 41.16 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.128 0.571 . . . . 75.34 109.719 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.84 146.66 43.71 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.153 0.981 . . . . 71.22 108.949 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.1 p -137.0 151.78 49.38 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.111 0.564 . . . . 53.45 110.297 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 86.4 p -149.41 157.94 43.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.854 0.862 . . . . 72.33 109.76 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -89.36 118.77 29.27 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.982 -0.747 . . . . 74.5 108.982 174.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.567 HD11 HD12 ' C' ' 83' ' ' ILE . 57.5 mt -90.8 -40.3 11.87 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.299 0.571 . . . . 55.54 109.779 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.71 177.82 10.28 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 114.395 -1.275 . . . . 62.12 108.95 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.64 119.56 14.06 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 109.264 -0.643 . . . . 63.15 109.264 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 66.92 21.81 10.27 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.545 1.138 . . . . 74.4 111.15 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 65.9 t -126.69 101.61 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.855 1.262 . . . . 73.14 108.158 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.58 ' HB2' HD11 ' C' ' 86' ' ' ILE . 0.2 OUTLIER -104.23 138.04 41.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.173 -0.677 . . . . 72.32 109.173 177.516 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.432 ' HB2' HD11 ' C' ' 51' ' ' LEU . 29.1 tt0 -85.57 137.75 32.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.577 -1.192 . . . . 70.35 108.667 166.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 t -122.18 139.54 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.682 -1.229 . . . . 64.41 107.682 167.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 49.6 t -131.79 131.94 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 108.545 -0.909 . . . . 73.54 108.545 175.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.21 109.35 21.01 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.802 -1.555 . . . . 65.2 106.802 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.443 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 5.8 tmm_? -99.5 105.73 17.67 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.748 -1.204 . . . . 64.42 107.748 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.466 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.3 t -107.77 138.37 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.478 -0.934 . . . . 64.21 108.478 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 35.7 m -134.04 121.22 21.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.35 -0.611 . . . . 74.03 109.35 171.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.594 HG11 HD13 ' C' ' 126' ' ' LEU . 59.7 t -106.35 111.72 36.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 114.885 -1.052 . . . . 73.45 109.014 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 7.0 m -103.36 142.72 33.74 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.213 -0.903 . . . . 72.11 109.42 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.88 120.71 19.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.716 -1.216 . . . . 74.32 107.716 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.6 m -140.44 128.0 21.5 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.565 0.541 . . . . 71.34 110.816 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.799 HD13 ' HG2' ' C' ' 34' ' ' LYS . 8.5 mt -89.27 31.63 0.89 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.174 1.39 . . . . 62.33 110.813 -176.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.67 -105.42 0.95 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 109.808 -1.317 . . . . 44.4 109.808 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.13 -18.08 17.87 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.981 0.913 . . . . 55.01 110.053 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.515 ' HG2' ' NZ ' ' C' ' 34' ' ' LYS . 5.7 tp10 -76.37 119.17 19.88 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.898 0.879 . . . . 73.22 109.515 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 44.8 m -76.98 128.42 34.48 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.261 -0.644 . . . . 74.24 109.261 172.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.753 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -78.39 -56.39 4.49 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.287 -1.005 . . . . 71.44 108.287 170.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 74' ' ' PHE . . . . . 0.549 ' HZ ' HD11 ' C' ' 126' ' ' LEU . 41.5 p90 -163.83 174.31 11.71 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.359 0.663 . . . . 71.24 110.716 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.12 107.68 5.07 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.37 -1.344 . . . . 72.23 107.37 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -110.58 143.43 41.0 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.827 -0.805 . . . . 62.3 108.827 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.81 134.39 15.44 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.348 0.659 . . . . 63.24 109.646 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.1 t -135.89 119.54 24.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 124.281 1.032 . . . . 64.01 109.19 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.443 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 54.3 mt-30 -92.17 88.27 6.43 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.58 -0.896 . . . . 72.3 108.58 170.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -79.64 99.49 7.39 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.736 -0.665 . . . . 44.52 109.785 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.22 144.2 16.97 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 116.416 -0.356 . . . . 71.52 112.518 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.569 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.23 135.4 5.35 Favored Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 110.536 -1.026 . . . . 41.34 110.536 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 8.8 mm -94.8 127.01 47.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.429 -0.952 . . . . 72.22 108.429 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.562 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 47.0 m-85 -134.22 118.38 17.55 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.251 -0.648 . . . . 71.41 109.251 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 53.8 m -75.7 132.92 40.84 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.219 -0.66 . . . . 73.04 109.219 175.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' C' ' 56' ' ' TYR . 1.1 pp -134.38 107.23 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.189 0.996 . . . . 74.35 109.219 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.596 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -130.25 157.71 41.75 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.898 -0.779 . . . . 72.42 108.898 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.22 -42.8 3.02 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 123.15 0.281 . . . . 53.44 113.22 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.432 HD13 ' SD ' ' C' ' 9' ' ' MET . 46.4 pt -93.26 169.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.544 0.738 . . . . 71.54 110.445 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -170.47 171.88 6.29 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 124.012 0.82 . . . . 73.33 109.622 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.87 -123.64 7.53 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.777 -0.457 . . . . 64.21 112.755 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 69.1 p -68.44 -29.24 67.84 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.418 0.687 . . . . 52.1 111.234 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -64.16 -51.23 64.85 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.244 1.017 . . . . 62.52 110.645 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 21.2 ptm -74.01 -28.18 61.32 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.284 0.365 . . . . 72.4 110.564 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.522 ' HA ' HD21 ' G' ' 454' ' ' LEU . . . -58.11 -43.98 87.45 Favored 'General case' 0 C--N 1.362 1.135 0 O-C-N 123.682 0.614 . . . . 41.4 109.594 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -77.61 -42.05 36.38 Favored 'General case' 0 C--O 1.245 0.863 0 O-C-N 123.562 0.539 . . . . 64.34 111.809 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -61.79 -39.03 90.25 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.058 0.849 . . . . 61.4 110.693 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.488 HD11 HG12 ' C' ' 86' ' ' ILE . 33.5 mt -101.3 -17.01 16.75 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 122.888 0.475 . . . . 65.14 111.74 -177.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 99' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' C' ' 137' ' ' PHE . . . -77.2 -29.2 56.9 Favored Glycine 0 C--N 1.354 1.583 0 N-CA-C 114.558 0.583 . . . . 55.21 114.558 -175.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.12 -36.09 0.09 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 120.805 0.336 . . . . 63.14 111.736 -169.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.53 -45.88 74.43 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.267 1.427 . . . . 75.31 112.125 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 55.5 m -76.68 -42.56 2.98 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 118.625 -0.702 . . . . 71.01 112.734 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.31 -27.35 57.03 Favored 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 122.194 1.929 . . . . 65.12 113.832 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -66.74 -36.92 83.6 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.519 0.727 . . . . 64.01 110.845 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.474 HG23 ' NH1' ' A' ' 111' ' ' ARG . 44.2 mm -63.18 -38.28 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.352 0.661 . . . . 62.01 109.617 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.569 HD21 ' HA3' ' C' ' 82' ' ' GLY . 90.9 mt -81.83 -18.12 45.04 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.808 -1.087 . . . . 71.02 112.765 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -60.49 -48.67 92.99 Favored Pre-proline 0 CA--C 1.561 1.371 0 N-CA-C 114.133 1.16 . . . . 74.24 114.133 -172.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -62.85 -34.11 73.26 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.845 1.697 . . . . 63.23 112.7 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -70.05 -45.64 66.67 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.47 0.708 . . . . 72.4 111.013 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.38 95.79 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 115.834 -0.621 . . . . 71.11 109.613 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.533 ' HG3' HD23 ' C' ' 128' ' ' LEU . 65.3 ttt180 -57.45 -52.85 63.73 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 124.599 1.187 . . . . 62.21 111.341 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.43 -31.33 71.44 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.921 0.488 . . . . 65.43 110.584 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.8 t -73.06 -34.5 66.3 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.965 0.506 . . . . 71.44 111.132 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.466 HD11 ' HB ' ' C' ' 62' ' ' VAL . 83.8 mt -68.59 -53.71 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.261 0.624 . . . . 52.12 109.591 174.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.3 m -63.19 -28.27 69.93 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.205 1.002 . . . . 71.21 111.389 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.8 t -64.05 -51.93 61.79 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.359 0.663 . . . . 72.15 109.417 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.575 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.55 -32.13 73.04 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.3 1.04 . . . . 70.21 112.766 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.574 HG21 HD12 ' C' ' 126' ' ' LEU . 71.7 t -67.02 -46.59 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.664 0.786 . . . . 54.44 110.095 174.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.537 ' OG ' HG21 ' B' ' 115' ' ' THR . 36.9 t -63.51 -34.86 78.71 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.045 -0.979 . . . . 74.54 111.445 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -69.29 -43.57 73.57 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.305 -0.861 . . . . 71.11 109.355 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.75 -4.87 72.41 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.783 0.677 . . . . 60.53 112.802 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.5 p 61.9 34.83 16.7 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.776 2.03 . . . . 55.34 113.138 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.426 ' HB2' HG13 ' C' ' 118' ' ' VAL . 83.5 m-85 -88.09 159.74 47.56 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.397 1.079 . . . . 73.22 109.704 171.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.1 164.34 8.53 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 123.373 2.715 . . . . 71.41 114.639 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -55.32 133.22 49.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.871 1.268 . . . . 61.23 113.001 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.594 HD13 HG11 ' C' ' 64' ' ' VAL . 36.2 mt -117.38 108.77 15.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.794 0.837 . . . . 65.34 109.607 170.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.7 110.97 22.52 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.491 -0.929 . . . . 70.14 108.491 174.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.533 HD23 ' HG3' ' C' ' 111' ' ' ARG . 3.7 mm? -76.6 133.14 39.74 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.627 -0.509 . . . . 75.41 109.627 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.08 139.6 82.45 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 124.054 0.846 . . . . 74.12 111.133 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.58 96.43 0.42 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.647 2.231 . . . . 73.31 111.99 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.23 116.05 39.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.482 -1.303 . . . . 70.2 107.482 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -78.19 79.28 4.65 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.584 -0.895 . . . . 61.22 108.584 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -55.8 -34.22 65.12 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.867 0.867 . . . . 73.53 110.814 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -60.48 -51.29 70.09 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.854 1.262 . . . . 62.24 111.451 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.1 -38.8 92.39 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.046 0.539 . . . . 31.15 111.088 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.35 -27.8 67.43 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.374 -0.83 . . . . 55.04 111.338 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.411 ' CE2' ' HA3' ' C' ' 99' ' ' GLY . 3.4 t80 -81.93 -31.28 31.41 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.283 0.633 . . . . 71.2 110.179 176.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 26.1 ttt -71.22 -39.59 71.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.384 0.674 . . . . 51.44 110.61 -173.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -73.1 -35.93 66.68 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.637 -0.711 . . . . 60.53 110.818 171.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -63.2 -85.13 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.816 1.246 . . . . 75.0 111.089 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -119.58 81.89 1.79 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.753 0.821 . . . . 74.25 109.146 -177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -166.54 -91.56 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 107.832 -1.173 . . . . 64.21 107.832 169.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -138.91 -78.3 0.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.036 -0.728 . . . . 74.52 109.036 169.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -149.83 158.62 44.34 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.522 0.729 . . . . 75.21 110.237 -171.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -163.5 -177.4 5.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.656 0.782 . . . . 73.43 110.76 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.24 29.37 45.65 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 115.669 -0.696 . . . . 54.24 112.828 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.25 -66.82 0.68 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.111 0.964 . . . . 74.12 111.361 -173.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.25 19.2 44.55 Favored Glycine 0 C--N 1.355 1.594 0 CA-C-N 116.648 -0.251 . . . . 71.3 113.121 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.522 HG22 ' HD1' ' A' ' 11' ' ' PHE . 59.1 p -126.2 160.65 29.68 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.055 0.942 . . . . 71.11 110.01 -177.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 150' ' ' GLU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 8.5 tp10 -153.88 128.32 9.22 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.335 -0.987 . . . . 73.11 108.335 173.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.13 101.95 0.96 Allowed 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.24 -1.022 . . . . 45.4 108.24 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -70.71 88.31 0.71 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.521 -0.918 . . . . 71.44 108.521 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -140.72 83.11 1.88 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.296 -2.113 . . . . 72.11 105.296 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -69.53 137.78 52.75 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.039 -0.982 . . . . 72.44 110.364 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 C-N-CA 123.345 0.658 . . . . 70.42 110.157 -176.384 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.682 ' HB3' ' HG3' ' B' ' 153' ' ' GLN . 12.0 tpt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 108.591 -0.892 . . . . 74.04 108.591 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -78.77 80.82 5.11 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.777 0.831 . . . . 63.34 110.335 -176.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.63 99.63 1.7 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 107.485 -1.302 . . . . 63.0 107.485 174.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -56.17 99.03 0.03 OUTLIER 'General case' 0 C--N 1.359 0.995 0 C-N-CA 124.098 0.959 . . . . 63.1 111.984 -168.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -67.7 101.59 1.07 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.732 -1.122 . . . . 73.22 109.032 173.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -79.06 70.97 5.5 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.593 0.757 . . . . 72.23 109.509 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -171.87 -156.46 0.1 Allowed 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.723 1.209 . . . . 65.11 107.992 -169.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.552 ' HG2' ' HA3' ' B' ' 146' ' ' GLY . 9.2 mp0 -77.08 131.68 38.49 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.007 0.923 . . . . 63.22 109.87 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.554 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 20.9 ptm -33.59 147.72 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.392 1.477 . . . . 72.12 114.476 168.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 86.5 m -118.15 141.83 48.08 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.365 0.666 . . . . 65.54 110.207 175.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -156.25 103.83 2.2 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.355 -1.35 . . . . 64.35 107.355 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -125.86 147.28 49.5 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.417 -0.957 . . . . 74.52 108.417 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.503 HG21 HD11 ' D' ' 16' ' ' ILE . 8.7 mt -95.85 129.51 45.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.71 -0.848 . . . . 74.21 108.71 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -87.08 -37.35 17.5 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.457 0.703 . . . . 73.12 111.711 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -167.82 124.71 1.12 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.004 0.372 . . . . 72.0 112.004 -170.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.503 HD11 HG21 ' D' ' 13' ' ' ILE . 2.0 mp -104.15 132.49 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.133 -1.432 . . . . 63.51 107.133 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.439 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 21.6 p90 -162.91 153.21 16.32 Favored 'General case' 0 C--N 1.337 0.061 0 O-C-N 123.652 0.595 . . . . 75.43 110.908 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -84.32 123.33 30.06 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.874 -0.787 . . . . 62.12 108.874 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.439 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.8 mtpt -92.25 -22.91 19.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.46 -0.57 . . . . 73.31 109.46 175.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.3 t70 -152.52 140.24 19.9 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.612 0.765 . . . . 74.45 109.496 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.575 HG21 ' HE2' ' C' ' 117' ' ' MET . 78.0 mt -139.83 145.6 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.805 -1.183 . . . . 74.24 107.805 174.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 58.6 m -148.5 121.45 8.78 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.431 1.093 . . . . 72.51 109.718 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.542 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 92.6 t80 -124.13 117.68 25.18 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.296 -1.742 . . . . 72.43 106.296 166.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.578 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 31.6 mt-10 -127.92 109.29 11.45 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.62 -0.511 . . . . 64.14 109.62 -174.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.41 85.91 17.04 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 108.099 -1.075 . . . . 62.05 108.099 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.83 -26.93 15.19 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.502 2.134 . . . . 75.34 112.092 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -104.24 8.37 36.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.884 0.874 . . . . 74.31 110.259 -174.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.428 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -32.99 -68.68 0.15 Allowed Pre-proline 0 CA--C 1.567 1.617 0 N-CA-C 116.32 1.97 . . . . 72.45 116.32 -165.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.459 ' HB3' HD11 ' C' ' 83' ' ' ILE . 75.7 Cg_endo -73.06 -21.49 20.55 Favored 'Trans proline' 0 C--N 1.384 2.423 0 CA-C-N 123.598 2.321 . . . . 65.44 113.699 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -74.47 -39.84 62.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.823 1.249 . . . . 72.12 110.004 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.4 p -83.67 -24.74 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.076 0.55 . . . . 64.11 112.274 -170.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.92 -19.03 63.84 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 122.867 0.467 . . . . 73.5 112.157 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -69.03 0.06 5.07 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.348 1.059 . . . . 73.14 111.933 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -110.72 100.85 9.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.881 1.272 . . . . 74.21 109.949 168.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.31 90.01 4.96 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.341 0.591 . . . . 74.44 109.598 171.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' D' ' 39' ' ' GLU . 19.7 t90 -154.32 156.11 36.34 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.1 -1.444 . . . . 64.14 107.1 174.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -70.58 107.88 2.98 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.398 -1.334 . . . . 75.41 107.398 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.458 ' O ' HG13 ' D' ' 40' ' ' VAL . 50.6 Cg_exo -55.21 125.55 19.53 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.89 2.394 . . . . 62.11 111.473 -171.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.464 ' HB2' ' CH2' ' D' ' 36' ' ' TRP . 34.1 tt0 -58.48 110.66 1.02 Allowed 'General case' 0 C--N 1.353 0.756 0 O-C-N 124.172 0.92 . . . . 74.43 109.667 -177.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.585 HG22 HD11 ' H' ' 470' ' ' LEU . 16.2 m -98.25 122.36 49.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 121.607 0.717 . . . . 74.23 110.455 -171.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.421 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 53.3 tttm -86.27 132.28 34.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 106.392 -1.707 . . . . 63.22 106.392 165.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.601 HD22 ' SD ' ' H' ' 464' ' ' MET . 0.4 OUTLIER -126.21 109.15 12.0 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.326 -0.99 . . . . 54.03 108.326 -169.008 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -127.41 149.75 49.94 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.387 1.075 . . . . 64.04 108.387 -176.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.51 HD21 HD21 ' D' ' 60' ' ' LEU . 8.4 tt -139.43 139.25 37.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.076 -0.713 . . . . 73.21 109.076 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -133.54 139.7 46.75 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.384 1.474 . . . . 61.11 107.31 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -105.82 164.73 11.71 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.074 -0.713 . . . . 74.1 109.074 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.54 160.55 40.61 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.879 0.872 . . . . 73.11 108.899 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -159.15 151.22 20.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.053 0.541 . . . . 70.1 110.046 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.2 p -160.64 129.84 4.88 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.053 0.941 . . . . 74.33 109.167 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -73.93 133.64 43.09 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.19 0.596 . . . . 62.32 110.251 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 54.2 mt -100.76 -34.5 9.81 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.248 0.619 . . . . 42.22 110.717 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.96 -176.24 5.38 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.807 0.843 . . . . 54.54 109.974 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.85 121.62 14.48 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.108 -0.951 . . . . 74.31 109.933 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 65.61 2.93 2.23 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.886 1.275 . . . . 75.22 113.101 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.0 t -112.67 116.41 52.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.327 -0.99 . . . . 72.34 108.327 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -133.53 130.48 38.53 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.091 -1.077 . . . . 74.42 108.091 -171.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -98.65 143.81 28.62 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.923 0.889 . . . . 74.52 109.48 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 54.8 t -120.04 137.66 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.78 -1.193 . . . . 63.22 107.78 166.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.476 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.3 t -116.0 126.58 73.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.788 -1.19 . . . . 71.25 107.788 175.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.51 HD21 HD21 ' D' ' 44' ' ' LEU . 0.0 OUTLIER -104.17 117.41 34.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.619 -0.882 . . . . 60.11 108.619 -177.268 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -102.84 96.35 6.78 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.66 -0.867 . . . . 72.43 108.66 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 50.7 t -96.31 130.22 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.21 -1.033 . . . . 55.03 108.21 170.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 19.2 m -128.9 132.99 47.73 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.273 0.629 . . . . 43.11 110.446 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 69.1 t -126.29 112.39 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.736 1.214 . . . . 74.43 109.555 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 30.7 m -103.1 96.04 6.52 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.493 0.717 . . . . 44.32 109.301 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.13 153.83 17.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.95 0.5 . . . . 71.22 111.2 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.444 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.6 p -152.37 127.63 9.86 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.925 -0.579 . . . . 71.03 111.276 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.412 HD12 HG22 ' D' ' 31' ' ' VAL . 25.2 mt -95.76 101.71 13.43 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.967 -1.123 . . . . 73.41 107.967 170.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 69' ' ' GLY . . . . . 0.442 ' H ' ' HZ3' ' D' ' 36' ' ' TRP . . . 68.14 -118.6 9.63 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 123.63 0.581 . . . . 42.14 113.797 177.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.76 5.3 46.63 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.629 0.771 . . . . 71.34 113.053 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.21 164.49 32.11 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 120.89 0.376 . . . . 75.14 110.791 -174.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.1 m -68.15 132.03 46.47 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.045 -0.98 . . . . 73.13 110.697 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -86.74 -71.98 0.53 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.711 -1.218 . . . . 75.33 107.711 174.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -141.43 151.37 43.35 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 121.318 0.58 . . . . 73.35 110.436 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 72.2 mt -111.41 146.37 37.29 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.565 -1.272 . . . . 71.03 107.565 171.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.511 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.2 m -146.69 132.46 18.97 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.876 0.87 . . . . 74.31 108.686 -174.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -155.7 126.24 6.81 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.138 -1.06 . . . . 73.03 108.138 170.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.1 t -131.15 115.28 29.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 108.911 -0.774 . . . . 75.34 108.911 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 70.7 mt-30 -93.1 85.59 5.12 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.966 -0.753 . . . . 71.11 108.966 173.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.09 97.11 6.71 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.516 -1.22 . . . . 64.33 109.022 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.7 144.03 20.22 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.862 -0.495 . . . . 71.23 111.862 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.416 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -140.06 130.04 4.5 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 111.037 -0.825 . . . . 41.43 111.037 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.409 HG13 ' HE1' ' D' ' 17' ' ' TYR . 54.5 mt -90.54 123.95 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.989 -1.115 . . . . 71.04 107.989 177.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -123.95 136.06 54.07 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.638 0.775 . . . . 75.35 110.13 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 20.8 m -93.3 112.08 23.91 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.442 -0.947 . . . . 73.42 108.442 171.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 31.4 pt -108.19 122.27 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-O 121.19 0.519 . . . . 73.24 110.211 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -147.47 154.41 40.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.529 1.132 . . . . 51.32 109.072 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 81.23 -19.63 7.98 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 114.054 0.382 . . . . 61.4 114.054 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -127.3 154.49 37.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 124.448 1.099 . . . . 72.13 109.332 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' H' ' 450' ' ' ASN . 0.0 OUTLIER -163.49 159.39 22.03 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 123.632 0.582 . . . . 75.34 110.695 -174.013 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.61 -99.16 0.08 OUTLIER Glycine 0 C--N 1.355 1.597 0 O-C-N 124.218 0.949 . . . . 71.35 114.763 170.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 25.6 m -68.42 -44.38 75.12 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.246 1.018 . . . . 54.03 111.453 -174.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.581 HE21 ' HB2' ' D' ' 152' ' ' HIS . 7.2 tp-100 -72.61 -29.54 63.58 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.056 -0.52 . . . . 73.34 110.563 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.442 ' SD ' ' HA ' ' H' ' 452' ' ' VAL . 35.1 ttp -60.25 -34.97 74.45 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 123.662 0.601 . . . . 75.03 110.35 174.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.16 82.07 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 122.306 -0.247 . . . . 31.14 111.438 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -80.08 -43.94 20.9 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.284 0.634 . . . . 61.42 111.945 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 43.8 t -74.29 -42.57 59.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.361 0.664 . . . . 74.44 110.703 -172.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.542 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 15.0 tp -87.93 -33.84 18.32 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.362 1.065 . . . . 70.15 110.45 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.22 -26.09 29.37 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-N 116.356 -0.383 . . . . 72.23 113.948 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.18 -57.88 2.04 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 117.186 0.493 . . . . 70.55 111.389 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -70.13 -33.83 72.3 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.553 0.575 . . . . 64.45 112.553 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 69.4 m -67.36 -49.55 42.49 Favored Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 118.477 -0.773 . . . . 52.32 111.825 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.38 -30.06 90.13 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 121.864 1.71 . . . . 62.41 113.727 168.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -64.78 -37.98 89.44 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.516 0.726 . . . . 73.0 110.118 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.4 HG21 HD13 ' D' ' 13' ' ' ILE . 30.5 mm -62.94 -45.48 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.722 0.809 . . . . 64.12 110.873 173.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.416 HD21 ' HA3' ' D' ' 82' ' ' GLY . 83.2 mt -77.25 -18.18 57.82 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.926 -1.034 . . . . 71.22 112.399 -170.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -69.69 -42.12 18.15 Favored Pre-proline 0 N--CA 1.486 1.329 0 N-CA-C 113.914 1.079 . . . . 70.01 113.914 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.69 -41.75 60.12 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.033 1.822 . . . . 52.23 113.107 169.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -75.36 -35.15 61.17 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.975 0.91 . . . . 73.41 111.6 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.24 -46.55 67.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.01 0.524 . . . . 64.34 110.192 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -53.67 -49.12 68.67 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.751 1.282 . . . . 65.41 110.73 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.72 -45.77 92.54 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.308 1.005 . . . . 75.33 111.977 -175.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.4 t -63.15 -39.57 95.06 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.63 0.581 . . . . 54.22 111.231 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.457 ' O ' HG23 ' D' ' 118' ' ' VAL . 86.2 mt -59.76 -55.49 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.554 0.741 . . . . 62.05 110.093 172.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 38.3 m -56.68 -40.16 75.08 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.804 1.242 . . . . 74.41 112.005 -174.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -68.35 -40.62 81.48 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.06 -0.973 . . . . 74.33 110.561 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 68.5 mtm -68.33 -33.2 73.88 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.611 0.365 . . . . 71.21 111.524 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.8 t -63.65 -43.46 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.601 0.761 . . . . 64.34 110.36 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.89 -30.93 61.45 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 116.178 -0.464 . . . . 65.31 111.206 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -74.18 -26.15 60.12 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.205 0.602 . . . . 73.11 110.32 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.44 7.96 74.94 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.646 0.591 . . . . 63.2 112.404 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.447 HG23 ' HB3' ' C' ' 17' ' ' TYR . 44.3 p 61.11 17.21 7.84 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.514 1.926 . . . . 62.32 114.81 174.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.09 150.97 72.44 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 109.558 -0.534 . . . . 72.44 109.558 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.6 127.87 22.04 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.116 2.544 . . . . 53.01 111.448 171.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -51.65 145.31 9.39 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.676 1.235 . . . . 74.41 113.007 -171.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.427 HD13 HG11 ' D' ' 40' ' ' VAL . 56.8 tp -117.05 106.19 13.11 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.692 -0.686 . . . . 73.44 109.538 -175.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -101.95 104.19 14.87 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.037 -0.727 . . . . 74.41 109.037 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.82 118.35 13.5 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.156 -0.683 . . . . 65.45 109.156 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 135.76 89.24 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.214 0.605 . . . . 75.31 110.137 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.84 119.34 6.35 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.63 2.22 . . . . 72.32 112.314 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 82.8 t -108.85 115.55 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.083 0.953 . . . . 74.32 108.916 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -77.79 113.2 15.42 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.943 0.497 . . . . 54.24 110.037 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -72.22 -35.88 68.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.684 0.793 . . . . 72.24 111.509 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.47 -50.35 74.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.412 1.085 . . . . 71.11 111.739 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.31 71.51 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.156 0.582 . . . . 54.23 110.636 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 34.4 mt -63.3 -23.76 67.56 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.41 0.684 . . . . 43.3 112.571 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -69.11 -39.45 78.93 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.654 0.782 . . . . 71.13 110.238 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 32.2 mtt -65.84 -28.9 69.32 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.135 -0.939 . . . . 72.3 110.131 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -70.31 -38.46 74.94 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.345 0.658 . . . . 60.12 110.662 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -62.36 -41.31 98.5 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.354 0.662 . . . . 70.35 111.288 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.9 mp -74.88 -29.02 60.88 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.552 0.741 . . . . 72.13 112.243 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -83.49 0.72 45.16 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 117.61 0.186 . . . . 74.22 111.19 177.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -121.23 46.91 1.94 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.13 0.572 . . . . 71.34 109.787 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -167.59 145.31 4.55 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.707 0.803 . . . . 74.24 109.859 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.39 78.38 5.91 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.508 0.67 . . . . 64.52 109.48 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.51 57.16 0.06 OUTLIER Glycine 0 C--N 1.344 1.026 0 CA-C-N 114.868 -1.06 . . . . 54.52 110.778 -177.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -73.82 90.23 1.87 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 121.879 0.847 . . . . 74.35 110.983 -178.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -121.53 79.9 0.34 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.1 -1.2 . . . . 71.12 110.1 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 76.1 p -108.53 151.91 25.46 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.582 0.753 . . . . 73.52 110.133 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -144.12 154.12 42.86 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.794 0.838 . . . . 71.24 108.85 174.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.37 -87.6 0.3 Allowed 'General case' 0 CA--C 1.558 1.266 0 CA-C-O 118.17 -0.919 . . . . 62.11 111.114 -175.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 152' ' ' HIS . . . . . 0.581 ' HB2' HE21 ' D' ' 93' ' ' GLN . 57.0 m170 43.45 67.58 0.63 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.282 1.433 . . . . 75.21 112.983 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.26 14.09 0.99 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.674 -0.693 . . . . 71.01 111.385 -175.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -64.6 102.95 0.61 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.697 0.799 . . . . 75.55 110.659 -172.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 C-N-CA 124.291 1.036 . . . . 75.23 108.209 -176.38 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 450' ' ' ASN . . . . . 0.568 ' N ' HD21 ' E' ' 450' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 109.123 -0.695 . . . . 65.11 109.123 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 62.0 t -140.21 -48.58 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.561 1.144 . . . . 74.34 108.571 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.4 150.53 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.401 1.08 . . . . 73.5 109.486 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -153.65 -71.82 0.01 OUTLIER Glycine 0 C--N 1.339 0.704 0 N-CA-C 110.494 -1.042 . . . . 73.25 110.494 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 10.6 mp 67.88 146.02 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.543 1.537 . . . . 73.21 112.145 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 61.6 p -70.44 110.46 5.36 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.265 -0.879 . . . . 51.24 108.694 170.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.69 178.29 5.53 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.218 0.607 . . . . 75.4 110.138 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 62.59 16.69 9.02 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 124.292 1.037 . . . . 70.33 112.221 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 48.6 m -90.13 -33.44 16.25 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.957 0.903 . . . . 74.12 110.539 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.47 -163.86 0.26 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.408 1.083 . . . . 74.52 110.355 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 53.6 tp -80.26 141.84 35.16 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.123 -1.066 . . . . 74.31 108.123 165.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -85.27 35.27 0.59 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.433 1.093 . . . . 74.42 111.229 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -168.73 143.89 3.36 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.967 0.907 . . . . 61.15 109.698 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 27.1 p -132.27 127.65 36.14 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.314 1.046 . . . . 75.14 108.232 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 464' ' ' MET . . . . . 0.578 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 52.8 tpp -80.16 136.46 36.51 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.858 0.463 . . . . 63.3 111.158 -174.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -142.47 86.54 1.96 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.262 -1.385 . . . . 72.0 107.262 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -159.29 169.51 23.9 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.296 -0.866 . . . . 72.2 110.241 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -67.42 113.21 5.1 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.789 0.835 . . . . 71.41 110.985 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 79.0 mt -94.9 -175.42 3.55 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.265 1.026 . . . . 74.32 109.691 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 469' ' ' GLY . . . . . 0.466 ' HA3' ' H ' ' A' ' 127' ' ' ASN . . . -48.35 -83.62 0.03 OUTLIER Glycine 0 N--CA 1.483 1.814 0 N-CA-C 115.429 0.932 . . . . 74.22 115.429 -173.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 58.14 20.14 6.73 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.371 1.069 . . . . 75.35 112.486 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 25.3 pttm . . . . . 0 C--O 1.262 1.734 0 C-N-CA 124.584 1.154 . . . . 74.14 109.427 179.595 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 109.853 -0.425 . . . . 74.04 109.853 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 33.4 m -82.04 -24.16 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 122.98 0.512 . . . . 64.13 110.063 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 452' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' B' ' 50' ' ' GLN . 86.1 t -92.39 133.12 34.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.998 0.919 . . . . 74.55 109.534 174.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 171.72 62.44 0.04 OUTLIER Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.362 -0.695 . . . . 74.14 111.362 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 454' ' ' LEU . . . . . 0.638 HD22 ' HE2' ' B' ' 94' ' ' MET . 2.4 pt? -148.6 155.39 41.02 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.324 0.65 . . . . 71.04 109.755 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 41.7 p -108.87 122.65 47.63 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.969 -1.123 . . . . 74.14 107.969 171.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -73.42 151.03 41.28 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.491 0.317 . . . . 71.21 110.291 176.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -92.77 122.76 35.49 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 109.166 -0.679 . . . . 51.54 109.166 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 28.8 m -86.84 54.43 3.17 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.457 1.122 . . . . 75.25 108.638 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -168.96 90.1 0.22 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.183 -1.371 . . . . 64.44 107.943 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 460' ' ' LEU . . . . . 0.707 HD12 ' HB2' ' F' ' 462' ' ' TYR . 0.2 OUTLIER -77.57 121.96 24.62 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.725 -1.213 . . . . 55.55 107.725 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -81.04 48.05 1.07 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.907 1.283 . . . . 71.33 110.662 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 462' ' ' TYR . . . . . 0.707 ' HB2' HD12 ' F' ' 460' ' ' LEU . 7.2 t80 -85.3 94.55 8.96 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.94 -1.133 . . . . 74.32 107.94 -175.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 37.0 p -59.29 -57.96 10.72 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.979 0.8 . . . . 54.42 110.593 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 464' ' ' MET . . . . . 0.575 ' HA ' HG21 ' B' ' 131' ' ' VAL . 0.0 OUTLIER 67.88 111.03 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.198 1.399 . . . . 74.25 111.474 174.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -113.82 -25.18 8.75 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.275 0.63 . . . . 74.11 111.796 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -84.14 67.54 9.77 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.405 0.622 . . . . 75.44 111.475 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -72.88 151.2 42.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.467 0.707 . . . . 54.22 110.158 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 468' ' ' LEU . . . . . 0.601 ' H ' HD23 ' F' ' 468' ' ' LEU . 1.9 pt? -73.29 -1.9 19.8 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.008 0.523 . . . . 73.11 111.731 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 96.64 -41.09 2.43 Favored Glycine 0 C--N 1.357 1.744 0 C-N-CA 123.053 0.359 . . . . 75.43 113.134 171.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 61.13 29.82 19.05 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.66 1.184 . . . . 75.53 111.95 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.078 0 N-CA-C 107.862 -1.162 . . . . 71.52 107.862 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 110.195 -0.298 . . . . 71.13 110.195 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 4.4 t 58.45 71.07 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.997 0 C-N-CA 124.806 1.242 . . . . 74.54 110.352 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.32 147.9 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.459 1.103 . . . . 74.24 110.387 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 141.01 32.79 0.14 Allowed Glycine 0 C--N 1.354 1.535 0 N-CA-C 114.462 0.545 . . . . 62.01 114.462 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 454' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' C' ' 95' ' ' ALA . 8.4 mp -110.0 165.18 11.93 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 117.565 0.683 . . . . 71.31 111.403 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 9.7 m 53.41 51.64 14.97 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.12 1.368 . . . . 72.1 110.411 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -93.47 -34.41 13.42 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 114.763 -1.108 . . . . 73.44 108.589 172.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -116.25 129.52 56.33 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.495 1.118 . . . . 74.43 108.306 166.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 89.2 m -84.0 95.93 8.7 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.275 0.63 . . . . 62.1 109.51 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -139.26 118.71 12.91 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.749 0.82 . . . . 75.52 109.028 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 460' ' ' LEU . . . . . 0.424 ' HG ' ' HA ' ' C' ' 45' ' ' ASP . 1.0 OUTLIER -118.51 110.82 17.85 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.08 -1.452 . . . . 75.21 107.08 176.714 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -76.69 140.48 40.89 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.761 0.824 . . . . 75.41 110.085 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 72.5 t80 72.77 143.19 0.06 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.885 1.274 . . . . 74.01 112.571 172.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 12.8 t -157.7 170.57 22.08 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.255 1.022 . . . . 75.21 109.219 172.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 71.2 mtm -121.18 120.04 34.08 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.658 0.783 . . . . 62.23 110.43 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -113.39 124.26 52.03 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.537 -1.283 . . . . 73.52 107.537 172.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . 71.55 -17.14 0.35 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 124.882 1.273 . . . . 74.11 113.425 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -92.43 95.4 9.63 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.587 0.755 . . . . 53.44 110.817 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 1.4 tt -156.26 144.2 19.6 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 107.23 -1.396 . . . . 71.33 107.23 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -62.56 82.92 0.03 OUTLIER Glycine 0 C--N 1.35 1.332 0 O-C-N 123.581 0.55 . . . . 51.11 111.867 170.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 4.5 tt -158.93 -48.86 0.06 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.782 1.633 . . . . 70.4 107.323 -175.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 63.3 tttp . . . . . 0 C--O 1.247 0.966 0 C-N-CA 124.687 1.195 . . . . 72.1 107.995 179.545 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' H' H ' 450' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' D' ' 90' ' ' GLU . 53.8 t-20 . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 109.143 -0.688 . . . . 73.14 109.143 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 451' ' ' VAL . . . . . 0.588 HG13 HG13 ' H' ' 452' ' ' VAL . 14.3 p -60.57 -32.32 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.716 1.206 . . . . 64.34 111.028 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 452' ' ' VAL . . . . . 0.588 HG13 HG13 ' H' ' 451' ' ' VAL . 32.1 m -113.79 158.84 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.321 1.048 . . . . 74.31 110.56 177.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 160.09 10.83 0.04 OUTLIER Glycine 0 N--CA 1.471 0.988 0 CA-C-N 115.821 -0.627 . . . . 61.43 112.966 -176.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 454' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' H' ' 456' ' ' ASP . 56.3 tp -91.55 128.87 37.55 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.787 0.835 . . . . 70.43 108.83 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 35.5 p -85.6 28.25 0.78 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.945 0.898 . . . . 54.23 111.334 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 456' ' ' ASP . . . . . 0.401 ' H ' ' HG ' ' H' ' 454' ' ' LEU . 19.1 t70 66.91 154.94 0.09 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.309 1.444 . . . . 71.31 112.153 -176.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -108.11 114.48 28.42 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.502 0.721 . . . . 72.44 109.569 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 20.7 p -90.5 152.08 21.09 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 123.918 0.887 . . . . 75.32 108.913 172.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 23.4 t70 67.31 174.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.224 0.952 . . . . 73.1 109.435 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.72 144.48 20.44 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.809 -0.812 . . . . 55.53 108.809 169.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -80.08 40.1 0.46 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 126.803 2.041 . . . . 70.42 111.737 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -72.14 90.34 1.2 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.004 0.922 . . . . 72.52 110.613 -170.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 24.0 m -102.15 82.67 2.24 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.204 1.001 . . . . 71.32 109.165 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 464' ' ' MET . . . . . 0.601 ' SD ' HD22 ' D' ' 42' ' ' LEU . 27.4 ttt -84.71 99.48 10.87 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.696 -0.853 . . . . 51.35 108.696 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -72.1 -32.3 66.87 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.955 0.902 . . . . 72.33 112.161 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -130.14 139.11 50.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.198 0.599 . . . . 73.34 110.273 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -118.04 175.3 5.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.803 1.241 . . . . 63.32 108.369 173.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -58.19 -28.21 64.58 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.837 0.855 . . . . 73.51 112.588 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 108.07 115.19 3.87 Favored Glycine 0 C--N 1.354 1.556 0 N-CA-C 110.831 -0.907 . . . . 30.44 110.831 -176.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 470' ' ' LEU . . . . . 0.585 HD11 HG22 ' D' ' 40' ' ' VAL . 3.5 mm? -88.66 74.33 8.43 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.403 0.681 . . . . 75.33 111.074 -174.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 124.602 1.161 . . . . 54.01 108.199 173.604 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.432 ' N ' ' HA ' ' C' ' 150' ' ' GLU . 66.0 mtt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.211 -0.292 . . . . 73.14 110.211 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 p -162.57 -47.72 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.906 0.482 . . . . 75.21 112.036 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 67.97 29.72 6.35 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.483 1.113 . . . . 62.34 110.431 -162.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -101.77 99.58 9.83 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.472 0.709 . . . . 73.53 110.015 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -86.54 160.71 18.87 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 108.125 -1.065 . . . . 53.45 108.125 170.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.25 -38.26 88.57 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.457 0.703 . . . . 73.5 111.112 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 9' ' ' MET . 13.4 m 70.68 156.74 0.16 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.358 1.463 . . . . 52.33 111.791 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.56 -27.54 68.7 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.278 0.631 . . . . 71.22 111.024 173.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.568 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -110.79 168.12 9.72 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.845 0.858 . . . . 71.52 109.501 170.438 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.7 m -145.69 139.79 26.8 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.0 0.52 . . . . 72.04 109.82 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.695 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 17.3 t80 -127.14 131.07 50.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.303 1.041 . . . . 64.01 109.191 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 26.5 tp60 -147.79 107.34 3.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.276 0.631 . . . . 71.45 110.052 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.598 HG12 ' HD2' ' A' ' 84' ' ' PHE . 60.7 mt -75.02 120.58 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.586 -0.524 . . . . 71.02 109.586 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -89.63 -36.99 14.96 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 124.079 0.862 . . . . 73.04 110.027 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -169.15 146.0 3.52 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 110.454 -0.202 . . . . 73.01 110.454 -171.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 97.6 mt -137.9 128.37 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 124.544 1.138 . . . . 73.35 108.058 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.465 ' HB3' HG23 ' B' ' 122' ' ' THR . 44.3 p90 -167.83 154.63 8.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.716 0.806 . . . . 73.12 111.205 -172.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.7 p -75.14 112.82 11.79 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.238 -0.652 . . . . 73.22 109.238 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HG3' ' HA3' ' A' ' 81' ' ' GLY . 32.6 mtpt -71.61 -34.35 69.78 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.251 -0.431 . . . . 63.42 110.481 174.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -153.79 148.65 26.57 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.056 -0.974 . . . . 73.4 109.111 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 80.9 mt -138.19 148.77 24.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 C-N-CA 124.947 1.299 . . . . 63.31 108.043 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 17.9 t -147.14 142.3 27.19 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.892 0.877 . . . . 74.42 109.93 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.544 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.3 t80 -153.06 132.88 13.2 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.625 1.17 . . . . 71.41 107.859 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -139.85 135.1 32.59 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.499 1.119 . . . . 72.0 108.34 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.06 87.46 48.39 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 108.32 -0.993 . . . . 74.13 108.32 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.458 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 37.3 Cg_exo -64.09 -48.65 4.7 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.608 2.872 . . . . 74.1 113.107 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -91.96 24.43 3.24 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.784 0.834 . . . . 74.13 111.169 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.571 ' HB1' ' HE2' ' B' ' 17' ' ' TYR . . . -53.07 -48.91 90.23 Favored Pre-proline 0 CA--C 1.568 1.638 0 N-CA-C 114.837 1.421 . . . . 65.14 114.837 -173.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.47 -19.73 16.62 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 121.742 1.628 . . . . 75.3 111.94 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -100.64 -13.42 18.56 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.074 -0.966 . . . . 75.1 112.29 -170.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.56 -26.04 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.798 0.839 . . . . 51.15 112.055 -169.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -78.9 -33.77 45.28 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.988 -1.006 . . . . 52.41 110.413 176.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -82.43 -32.19 29.14 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.917 0.887 . . . . 74.34 111.568 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.97 161.1 26.89 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.299 -0.63 . . . . 73.23 109.299 175.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.36 134.67 56.16 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.145 0.578 . . . . 74.53 110.059 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -95.69 85.88 4.26 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.343 0.657 . . . . 63.3 110.715 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.55 ' H ' HD12 ' A' ' 68' ' ' LEU . 79.7 mt-30 -135.58 68.53 66.74 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 123.648 0.779 . . . . 75.24 109.005 169.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -78.72 159.21 28.18 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.169 1.913 . . . . 74.24 111.867 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -106.73 105.69 15.85 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.042 -1.095 . . . . 61.3 108.042 173.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 p -74.62 93.35 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 122.363 1.078 . . . . 73.13 110.274 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 49.4 mtpt -85.82 115.56 23.54 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.347 -1.297 . . . . 53.51 108.279 172.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.541 HD23 ' HG3' ' E' ' 464' ' ' MET . 67.3 tp -116.05 134.8 54.56 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.146 -0.687 . . . . 75.22 109.146 174.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.662 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 32.4 t70 -128.62 146.68 50.79 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.301 1.04 . . . . 72.32 109.168 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.2 mt -128.45 125.09 37.79 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.184 0.994 . . . . 74.55 108.496 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 21.8 t0 -129.2 148.97 51.18 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.101 0.96 . . . . 55.22 109.413 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.565 ' HB ' HD21 ' E' ' 460' ' ' LEU . 59.0 m -144.14 138.42 28.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.252 1.021 . . . . 72.53 109.923 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.9 138.59 18.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.02 0.928 . . . . 64.34 109.324 169.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.6 m -90.36 162.42 15.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.138 0.575 . . . . 73.45 110.199 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.8 t -148.8 119.61 7.58 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.384 1.073 . . . . 63.42 108.231 -174.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -78.65 120.31 23.15 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.808 -0.442 . . . . 70.0 109.808 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.0 mt -92.17 -44.99 8.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.738 -0.838 . . . . 54.12 108.738 171.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.12 -178.88 6.75 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.157 -1.383 . . . . 71.44 108.88 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -74.57 133.34 42.24 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.897 -1.149 . . . . 73.31 107.897 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 70.27 -8.66 0.83 Allowed 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 125.489 1.516 . . . . 72.21 112.871 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.7 t -110.76 106.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 N-CA-C 108.863 -0.791 . . . . 74.23 108.863 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -130.36 121.65 26.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.732 0.777 . . . . 74.51 109.202 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -93.37 121.83 35.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 124.903 1.281 . . . . 64.12 109.396 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.07 132.97 45.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.898 -1.149 . . . . 52.14 107.898 176.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.6 t -120.1 115.59 47.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.585 -0.895 . . . . 42.52 108.585 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 tt -94.33 116.64 29.05 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.277 -1.008 . . . . 62.1 108.277 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.744 ' HG3' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -93.01 102.13 14.48 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.816 -0.809 . . . . 74.13 108.816 172.487 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.514 HG11 ' HB1' ' A' ' 110' ' ' ALA . 2.4 p -99.61 110.17 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 108.998 -0.742 . . . . 74.14 108.998 176.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.662 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 33.8 m -95.99 133.58 40.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.282 1.033 . . . . 71.2 109.055 -176.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.4 t -130.99 115.72 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 107.981 -1.118 . . . . 74.32 107.981 -174.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 16.8 m -127.39 108.24 10.67 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.732 -0.84 . . . . 74.32 108.732 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.61 103.44 14.26 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 106.828 -1.545 . . . . 75.24 106.828 171.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.4 p -136.71 127.4 27.14 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.181 0.592 . . . . 75.41 110.39 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.55 HD12 ' H ' ' A' ' 37' ' ' GLN . 6.4 tt -89.71 88.22 7.3 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 106.844 -1.539 . . . . 73.34 106.844 173.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.29 -83.86 0.97 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.257 -0.737 . . . . 62.41 111.257 178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -119.84 -26.25 5.68 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.87 0.868 . . . . 52.33 110.866 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -82.26 101.65 10.65 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.372 0.269 . . . . 72.44 111.016 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 26' ' ' PRO . 61.6 m -70.35 112.8 6.93 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.334 0.654 . . . . 64.23 109.842 173.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.61 -59.4 4.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.174 0.989 . . . . 71.13 109.476 171.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -149.16 160.92 42.93 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.997 -1.002 . . . . 73.24 111.029 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 64' ' ' VAL . 49.1 tp -141.33 133.66 28.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.548 1.539 . . . . 63.11 107.3 -175.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.55 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 35.0 m -147.28 120.29 8.79 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 118.807 0.73 . . . . 55.14 110.381 -171.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 9.5 mp0 -128.09 128.8 45.56 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.012 -1.107 . . . . 72.44 108.012 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.7 t -131.24 110.67 18.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.34 -0.615 . . . . 73.31 109.34 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.744 ' HG3' ' HG3' ' A' ' 61' ' ' ARG . 15.5 mp0 -85.04 79.43 9.63 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.474 -1.306 . . . . 75.22 107.474 174.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.44 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.4 tp-100 -78.21 97.27 5.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.801 -1.185 . . . . 63.41 107.801 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 19' ' ' LYS . . . -93.91 147.2 18.49 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.041 -0.823 . . . . 34.14 111.041 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.41 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -148.78 126.87 2.37 Favored Glycine 0 CA--C 1.499 -0.929 0 N-CA-C 110.264 -1.134 . . . . 64.32 110.264 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 60.6 mt -82.38 114.28 23.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.653 -0.869 . . . . 72.23 108.653 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.695 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.6 m-85 -122.46 119.14 30.08 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.66 -0.867 . . . . 75.32 108.66 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 23.1 t -84.63 91.13 7.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.064 -0.717 . . . . 73.13 109.064 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -100.39 128.48 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.502 0.668 . . . . 55.32 109.23 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.89 154.75 44.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.939 1.296 . . . . 55.14 108.496 -175.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 84.19 9.54 81.93 Favored Glycine 0 N--CA 1.48 1.618 0 C-N-CA 121.673 -0.299 . . . . 41.31 113.715 172.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.533 HG22 ' HB3' ' A' ' 93' ' ' GLN . 0.9 OUTLIER -127.17 138.2 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.269 1.028 . . . . 61.51 110.772 -174.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -142.43 173.26 11.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.226 1.011 . . . . 73.01 109.707 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.92 -117.16 10.67 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.703 -0.681 . . . . 55.01 113.524 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.643 ' HB ' HD11 ' A' ' 141' ' ' LEU . 29.3 p -86.64 -26.63 24.27 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.702 0.801 . . . . 71.35 112.365 175.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.533 ' HB3' HG22 ' A' ' 89' ' ' ILE . 16.5 mm100 -60.09 -43.97 95.15 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.44 0.696 . . . . 73.31 110.512 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.537 ' SD ' ' HB ' ' E' ' 452' ' ' VAL . 24.7 ptt? -62.85 -40.37 97.24 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.249 -0.887 . . . . 74.13 110.888 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.7 -26.04 62.34 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.616 0.766 . . . . 65.41 110.568 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -78.09 -30.47 49.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.243 0.617 . . . . 73.31 110.514 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.478 ' SG ' HG21 ' A' ' 89' ' ' ILE . 72.0 m -70.74 -64.84 0.82 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.48 -0.327 . . . . 61.42 110.531 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.51 -9.19 53.26 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.206 0.817 . . . . 71.32 113.206 -171.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.6 3.53 32.49 Favored Glycine 0 N--CA 1.48 1.631 0 CA-C-O 119.791 -0.449 . . . . 74.11 113.635 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.65 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.25 -64.05 0.31 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.287 0.543 . . . . 75.14 111.414 -176.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.471 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 84.2 t80 -70.5 -51.65 27.44 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.244 -0.889 . . . . 62.44 111.588 -172.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -72.9 -36.11 3.26 Favored Pre-proline 0 CA--C 1.566 1.564 0 N-CA-C 113.859 1.059 . . . . 63.04 113.859 -172.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.495 ' HA ' HD12 ' A' ' 106' ' ' LEU . 30.4 Cg_endo -65.39 -26.9 55.24 Favored 'Trans proline' 0 C--N 1.39 2.727 0 CA-C-N 121.732 1.654 . . . . 73.05 112.507 167.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.84 -25.86 62.14 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.505 0.322 . . . . 64.52 110.252 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -62.84 -36.49 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.467 0.707 . . . . 71.22 109.926 170.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 103' ' ' PRO . 65.5 mt -78.11 -23.23 47.96 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.298 1.039 . . . . 70.1 112.36 -178.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -61.81 -43.48 87.59 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 117.797 -1.097 . . . . 73.33 113.672 -172.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.56 -38.75 60.08 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.124 1.883 . . . . 74.35 113.076 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -69.44 -41.45 76.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.374 0.669 . . . . 75.14 111.057 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.514 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -67.61 -42.41 82.42 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.499 0.719 . . . . 73.14 110.128 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.589 ' HA ' HD23 ' A' ' 128' ' ' LEU . 29.8 ttm180 -51.17 -53.33 35.77 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.833 1.333 . . . . 55.0 110.256 175.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -66.16 -42.33 89.13 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.436 1.085 . . . . 73.12 111.214 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.4 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.9 t -60.88 -34.77 75.15 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.249 0.619 . . . . 74.42 111.398 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 81.0 mt -73.75 -51.66 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.815 0.846 . . . . 51.23 109.837 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.564 HG23 ' HG3' ' A' ' 125' ' ' GLN . 95.4 m -52.35 -51.28 59.71 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.334 1.054 . . . . 52.12 111.359 -174.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -65.42 -44.0 88.75 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.117 -1.401 . . . . 73.01 110.461 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.544 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 43.0 ttp -67.2 -35.45 79.64 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.03 0.932 . . . . 64.1 111.9 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.91 -40.39 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.246 1.018 . . . . 71.34 110.037 174.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -71.71 -25.42 62.07 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.952 0.901 . . . . 73.53 111.304 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -76.29 -25.92 55.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.756 0.822 . . . . 74.0 109.605 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.04 0.12 88.95 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.826 0.704 . . . . 75.23 112.712 171.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.3 m 67.88 15.98 9.61 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.848 1.259 . . . . 74.15 111.679 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.96 156.71 69.62 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.373 0.669 . . . . 73.13 109.365 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.85 141.96 92.76 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.476 2.117 . . . . 71.12 111.554 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.564 ' HG3' HG23 ' A' ' 115' ' ' THR . 29.7 tt0 -55.03 134.77 49.25 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.192 0.933 . . . . 72.43 111.78 -175.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.7 tp -118.69 98.97 6.49 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.492 -0.776 . . . . 74.34 110.287 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -100.18 113.21 25.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.379 -1.341 . . . . 64.12 107.379 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.589 HD23 ' HA ' ' A' ' 111' ' ' ARG . 2.6 mm? -72.85 128.41 35.43 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.149 0.58 . . . . 71.2 109.522 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -56.03 135.48 73.92 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.632 0.773 . . . . 50.4 111.235 -178.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.534 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 42.8 Cg_exo -58.08 98.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.727 2.285 . . . . 74.15 112.762 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 129' ' ' ALA . 95.3 t -100.18 113.99 37.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.371 -0.974 . . . . 73.24 108.371 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -84.74 102.4 12.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.671 0.388 . . . . 73.43 110.045 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -63.67 -25.28 68.14 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.927 0.891 . . . . 70.21 111.468 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.65 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 7.2 t70 -65.96 -48.71 70.42 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.111 0.882 . . . . 74.52 110.432 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.37 -39.57 94.89 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.61 0.764 . . . . 70.52 111.334 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.94 -40.73 83.22 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.15 -0.932 . . . . 74.04 111.081 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -68.0 -38.45 82.65 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.191 -0.913 . . . . 72.32 109.5 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.77 -39.58 74.31 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 124.228 0.955 . . . . 73.32 110.624 177.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 88.7 m-20 -59.24 -52.24 66.55 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.684 0.794 . . . . 73.53 111.08 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -64.83 -36.36 84.07 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.778 0.831 . . . . 73.53 111.416 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.643 HD11 ' HB ' ' A' ' 92' ' ' THR . 48.7 tp -69.93 -50.91 37.4 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.593 1.157 . . . . 64.25 111.888 -171.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -162.96 -3.14 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.312 0.645 . . . . 62.14 110.776 -169.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 36.1 tt0 69.94 133.56 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.623 1.569 . . . . 72.23 110.378 -165.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.83 178.5 8.15 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 122.043 -0.41 . . . . 64.24 111.27 176.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.63 143.89 26.06 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.417 0.687 . . . . 52.32 109.993 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.99 79.94 0.37 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.647 -0.581 . . . . 54.31 111.647 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -79.7 135.78 36.62 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.801 0.84 . . . . 73.52 111.517 -171.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.76 105.3 0.27 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 110.068 -1.213 . . . . 51.12 110.068 175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -98.47 131.19 44.92 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.0 0.52 . . . . 73.22 110.829 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -80.29 154.37 27.87 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.528 0.731 . . . . 64.0 110.817 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' C' ' 90' ' ' GLU . 5.0 tp10 -176.03 139.2 0.37 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.997 1.319 . . . . 72.24 108.698 176.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -155.42 124.5 6.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.947 0.403 . . . . 75.02 111.447 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -115.92 -158.02 0.67 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.161 1.385 . . . . 61.33 108.399 173.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -143.63 114.93 7.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.159 0.584 . . . . 53.21 109.579 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 C-N-CA 123.906 0.882 . . . . 65.23 110.665 -178.566 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 44.9 ttm . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.568 -0.531 . . . . 74.32 109.568 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 34.5 t -73.39 130.69 40.69 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.237 -0.653 . . . . 64.5 109.237 174.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -76.68 128.53 34.85 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.682 -0.488 . . . . 74.15 109.682 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -78.17 143.66 37.04 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.554 -0.536 . . . . 72.24 109.554 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -70.59 148.82 47.73 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.732 0.813 . . . . 65.03 110.766 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' B' ' 88' ' ' GLY . 4.1 m-20 -63.34 123.59 19.1 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.561 1.144 . . . . 74.03 110.305 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -126.4 160.28 30.9 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.576 0.75 . . . . 75.24 110.429 -174.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 82.39 -59.65 0.18 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 126.387 1.875 . . . . 75.52 112.41 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.514 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 8.8 ptm 59.11 168.93 0.06 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 127.064 2.146 . . . . 70.44 113.471 -171.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m -159.01 138.16 11.34 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.439 1.096 . . . . 72.52 108.579 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.97 157.42 43.41 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.485 0.66 . . . . 74.44 110.21 160.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -125.45 139.11 53.92 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 107.757 -1.201 . . . . 72.11 107.757 172.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.496 HD11 HD13 ' B' ' 105' ' ' ILE . 50.4 mt -76.66 120.41 26.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.482 -0.932 . . . . 62.11 108.482 173.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -83.5 -39.61 20.25 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.075 -0.713 . . . . 75.01 109.075 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -165.73 135.78 3.51 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.597 -0.729 . . . . 74.34 110.277 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.479 HD11 HD13 ' B' ' 13' ' ' ILE . 79.9 mt -114.96 140.73 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 106.411 -1.7 . . . . 73.52 106.411 168.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.571 ' HE2' ' HB1' ' A' ' 28' ' ' ALA . 36.4 p90 -171.49 170.62 5.74 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.597 0.713 . . . . 73.15 112.041 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.684 HG21 HD11 ' B' ' 21' ' ' ILE . 24.8 m -98.11 130.72 44.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.546 -1.206 . . . . 71.3 108.792 174.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -96.26 -34.47 11.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.875 0.87 . . . . 73.11 110.407 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -148.98 136.34 20.19 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.792 -0.64 . . . . 71.02 110.555 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.684 HD11 HG21 ' B' ' 18' ' ' THR . 47.0 mm -127.98 138.62 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.222 1.009 . . . . 65.43 108.915 171.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 39.8 t -135.66 129.55 32.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.228 1.411 . . . . 71.12 107.217 174.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.4 t80 -139.7 119.79 13.65 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 107.155 -1.424 . . . . 54.04 107.155 168.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.52 113.83 19.26 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.249 -0.648 . . . . 72.2 109.249 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.644 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.59 84.55 1.95 Allowed Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 107.556 -1.276 . . . . 74.11 107.556 166.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.19 -22.83 18.66 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.748 2.299 . . . . 60.22 111.385 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.413 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 89.2 m-20 -116.55 7.81 13.78 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.664 1.186 . . . . 62.23 110.898 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.644 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -29.02 -62.62 0.21 Allowed Pre-proline 0 N--CA 1.491 1.576 0 C-N-CA 126.244 1.817 . . . . 71.25 115.186 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 21.2 Cg_exo -61.9 -49.47 6.69 Favored 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 122.183 1.922 . . . . 75.2 112.122 -170.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 77.4 m80 -88.92 -11.9 43.19 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.052 -0.977 . . . . 73.31 112.251 -171.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.718 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.4 p -81.08 -23.36 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 CA-C-N 118.303 0.501 . . . . 72.05 110.525 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -64.77 -18.96 65.53 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.929 0.892 . . . . 64.24 113.331 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.9 pt20 -66.21 -23.3 66.41 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.882 0.473 . . . . 63.42 111.043 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -83.98 95.67 8.61 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.295 0.638 . . . . 55.44 109.589 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.38 83.32 1.93 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.922 0.889 . . . . 75.12 109.352 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.414 ' HZ3' ' H ' ' B' ' 69' ' ' GLY . 28.3 t90 -159.08 155.93 28.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.947 -1.024 . . . . 71.33 109.156 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -83.03 108.31 12.22 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.057 0.943 . . . . 73.0 108.502 169.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.556 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 55.6 Cg_endo -68.66 129.53 18.97 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.418 2.079 . . . . 72.32 112.294 -173.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.89 123.48 18.14 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 123.897 0.748 . . . . 73.4 110.164 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.517 HG11 HD21 ' B' ' 126' ' ' LEU . 33.0 m -104.0 150.68 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.463 0.705 . . . . 75.3 111.785 -169.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -133.57 119.85 20.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.542 -0.91 . . . . 74.42 108.542 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.22 144.26 25.47 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.782 0.833 . . . . 73.4 109.625 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.665 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 10.2 m-20 -136.08 115.32 12.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.716 1.207 . . . . 55.15 108.368 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.9 149.47 23.37 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.415 -0.587 . . . . 74.11 109.415 177.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.9 t70 -155.62 114.23 3.48 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.353 -0.98 . . . . 74.12 108.353 177.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -113.7 103.85 11.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.23 0.612 . . . . 71.22 109.656 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.24 118.46 32.35 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.638 0.775 . . . . 62.34 109.281 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 14.0 p -102.82 162.28 13.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.983 0.513 . . . . 63.54 110.755 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -151.82 136.84 17.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.057 0.943 . . . . 73.52 109.33 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -80.87 112.25 18.08 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.358 0.663 . . . . 75.12 109.721 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' B' ' 57' ' ' GLU . 75.3 mt -81.39 -54.06 5.78 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.31 0.576 . . . . 44.44 111.023 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.409 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -144.34 -163.74 1.75 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.372 1.069 . . . . 74.3 109.362 -176.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.42 100.95 0.53 Allowed 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.966 0.791 . . . . 74.04 109.432 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 22.1 m-20 62.13 15.7 7.65 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.582 1.153 . . . . 55.44 112.839 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 95.5 t -104.39 123.89 58.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 106.085 -1.82 . . . . 73.03 106.085 169.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.91 167.22 21.61 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.944 -0.761 . . . . 74.12 108.944 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.528 ' HB2' HD11 ' B' ' 51' ' ' LEU . 12.1 tt0 -124.38 120.7 32.87 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.608 -0.886 . . . . 71.51 108.608 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.1 t -88.19 137.72 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.714 -0.847 . . . . 62.23 108.714 170.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 56.3 t -120.88 110.39 28.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.484 -0.932 . . . . 71.32 108.484 175.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.05 99.08 11.45 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.712 -1.218 . . . . 74.24 107.712 177.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.485 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 13.2 ttm180 -87.27 113.11 22.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.595 -0.729 . . . . 64.1 109.429 170.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.54 123.84 63.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.764 -1.198 . . . . 73.13 107.764 170.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.665 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 6.9 m -118.55 134.75 54.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.926 -0.768 . . . . 54.44 108.926 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.464 HG23 HD13 ' B' ' 114' ' ' ILE . 88.1 t -122.45 127.92 75.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 123.964 0.906 . . . . 72.33 108.636 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.5 m -112.22 147.57 35.92 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 124.265 1.026 . . . . 60.21 108.739 172.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.23 147.21 33.29 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.439 0.696 . . . . 74.45 109.831 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.1 p -137.48 125.99 23.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.408 0.683 . . . . 72.11 110.381 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.653 HD12 HG22 ' B' ' 31' ' ' VAL . 42.2 mt -93.18 99.88 12.37 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 106.979 -1.489 . . . . 75.53 106.979 171.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.414 ' H ' ' HZ3' ' B' ' 36' ' ' TRP . . . 77.58 -118.55 5.06 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.492 -0.776 . . . . 72.45 112.651 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -103.33 14.77 30.77 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.128 0.971 . . . . 74.14 111.076 -171.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.413 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.9 pt-20 -147.84 156.49 42.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.721 0.808 . . . . 74.43 110.209 -173.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 86.7 m -66.26 135.83 55.0 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.698 0.624 . . . . 50.11 110.755 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.718 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -89.68 -62.57 1.44 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.584 -0.895 . . . . 73.43 108.584 174.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -150.92 157.88 43.46 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.095 -1.411 . . . . 54.4 109.96 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -132.34 138.63 47.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.766 -1.568 . . . . 61.31 106.766 175.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.424 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 49.8 t -142.65 151.01 40.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.467 -0.938 . . . . 42.04 108.467 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 44.8 tt0 -161.96 126.91 3.4 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.717 -0.845 . . . . 72.54 108.717 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.68 144.07 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 123.84 0.856 . . . . 61.24 108.934 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -115.16 91.2 3.54 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.36 -0.978 . . . . 73.53 108.36 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -81.19 97.63 7.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.545 -0.909 . . . . 73.03 108.545 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.96 142.7 16.14 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.129 -0.788 . . . . 74.25 111.129 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.85 128.86 3.58 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.123 -0.791 . . . . 74.33 111.123 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.7 mt -87.98 126.86 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.843 0.857 . . . . 63.24 109.837 175.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -134.47 134.6 41.72 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.501 -1.296 . . . . 72.33 107.501 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -109.38 93.02 4.29 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.036 0.535 . . . . 74.13 110.205 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 30.0 pt -94.38 144.85 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.327 0.584 . . . . 73.01 112.445 -167.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.79 146.86 19.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.915 1.286 . . . . 75.45 107.926 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 102.4 -25.85 26.21 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-O 119.884 -0.398 . . . . 64.41 113.761 176.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' B' ' 94' ' ' MET . 5.4 pt -84.31 165.56 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 117.48 0.64 . . . . 71.44 111.664 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -171.8 175.32 3.96 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.047 1.339 . . . . 74.41 108.726 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.21 -125.6 8.25 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.931 -0.468 . . . . 54.24 111.931 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.2 m -103.32 -13.14 16.81 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.511 0.724 . . . . 71.24 109.434 170.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -62.34 -27.78 69.29 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.148 0.979 . . . . 74.01 109.971 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.702 ' SD ' HG12 ' F' ' 451' ' ' VAL . 25.4 ptt? -71.06 -37.39 72.49 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.54 -0.754 . . . . 75.23 110.789 171.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.04 -21.24 59.17 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 115.451 -0.795 . . . . 74.02 110.766 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -76.99 -28.43 55.08 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.12 0.568 . . . . 71.22 111.425 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.24 -37.69 75.39 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.834 0.709 . . . . 72.15 110.052 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -102.8 -9.12 20.23 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.736 0.814 . . . . 74.52 111.819 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.32 -25.39 57.26 Favored Glycine 0 N--CA 1.475 1.265 0 C-N-CA 123.677 0.656 . . . . 75.12 112.728 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.47 -56.52 0.11 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.096 -0.552 . . . . 71.14 110.975 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -55.24 -54.81 38.7 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.604 1.162 . . . . 73.21 112.187 -168.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 78.9 m -69.62 -48.74 23.23 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 118.191 -0.909 . . . . 62.25 112.032 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -50.81 -35.79 49.83 Favored 'Trans proline' 0 C--N 1.399 3.195 0 C-N-CA 122.61 2.207 . . . . 73.22 113.929 170.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -75.15 -23.87 57.87 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.531 0.732 . . . . 72.1 111.701 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.496 HD13 HD11 ' B' ' 13' ' ' ILE . 83.2 mt -70.01 -44.14 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.089 -0.708 . . . . 63.32 109.089 168.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -80.6 -21.46 41.57 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.831 -1.077 . . . . 74.11 112.448 -173.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -62.48 -46.11 89.49 Favored Pre-proline 0 N--CA 1.487 1.394 0 N-CA-C 113.754 1.02 . . . . 62.22 113.754 -169.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.83 -35.71 98.17 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.859 1.706 . . . . 74.52 112.817 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -68.66 -45.31 72.11 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.991 0.517 . . . . 74.43 110.066 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.52 -37.53 78.56 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.689 0.796 . . . . 54.13 110.487 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -62.33 -57.88 9.71 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.29 1.036 . . . . 71.52 110.694 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -65.34 -28.88 69.61 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.988 0.805 . . . . 70.11 110.655 -173.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.488 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.3 t -75.09 -36.05 61.74 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.903 0.481 . . . . 74.42 111.377 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.464 HD13 HG23 ' B' ' 64' ' ' VAL . 81.7 mt -66.96 -52.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.671 -0.492 . . . . 61.11 109.671 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.458 HG21 ' OG ' ' C' ' 119' ' ' SER . 28.6 m -58.24 -33.56 69.49 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 124.339 1.024 . . . . 75.41 111.568 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 22.7 t -58.49 -53.94 52.62 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 123.813 0.696 . . . . 63.33 109.85 175.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.6 mmt -69.64 -35.22 75.03 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.493 0.717 . . . . 73.53 111.723 -171.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.98 -45.58 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.635 0.774 . . . . 71.22 110.428 174.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.41 ' OG ' HG21 ' C' ' 115' ' ' THR . 47.0 t -68.6 -32.58 72.56 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.969 -1.014 . . . . 65.42 111.357 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.7 mtt-85 -65.62 -37.2 85.93 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.552 -0.749 . . . . 74.0 109.389 175.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.37 5.0 65.2 Favored Glycine 0 C--N 1.357 1.72 0 O-C-N 124.213 0.946 . . . . 63.15 113.511 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.465 HG23 ' HB3' ' A' ' 17' ' ' TYR . 82.3 p 57.28 35.63 26.34 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.827 1.651 . . . . 72.34 112.96 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -95.26 162.53 24.43 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.83 0.852 . . . . 73.3 110.214 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.24 159.84 7.37 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 123.717 2.944 . . . . 72.32 114.19 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -66.4 117.39 8.57 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.058 -0.973 . . . . 72.54 111.757 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.517 HD21 HG11 ' B' ' 40' ' ' VAL . 10.2 mp -120.13 127.42 52.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.146 0.978 . . . . 73.15 109.455 173.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -123.75 134.8 53.61 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.539 -0.911 . . . . 44.33 108.539 168.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.08 125.72 27.57 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.004 0.922 . . . . 75.31 109.892 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.28 151.14 87.75 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 124.011 0.924 . . . . 70.41 111.5 -176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.23 120.33 7.47 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.008 2.472 . . . . 71.44 112.431 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.9 t -118.33 112.7 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.941 -1.133 . . . . 54.11 107.941 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -79.13 84.86 5.07 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.838 -0.801 . . . . 63.55 108.838 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.72 -23.55 67.22 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.571 0.748 . . . . 75.02 111.83 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.07 -48.66 62.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.771 0.828 . . . . 71.11 110.696 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.43 95.39 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.683 -1.144 . . . . 75.3 110.306 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -71.53 -31.21 66.79 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.254 -1.339 . . . . 74.54 111.868 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.615 ' CE1' HD11 ' B' ' 141' ' ' LEU . 51.4 t80 -69.77 -23.03 63.3 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.717 0.407 . . . . 74.21 110.723 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 82.8 mtp -71.69 -35.81 70.39 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.089 0.471 . . . . 74.12 110.09 174.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -76.8 -15.55 59.7 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.805 0.842 . . . . 63.11 110.882 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -67.54 -32.83 73.88 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.561 1.145 . . . . 62.2 110.724 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.615 HD11 ' CE1' ' B' ' 137' ' ' PHE . 24.4 mt -111.66 -6.26 14.38 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.912 0.885 . . . . 64.53 112.71 -163.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -154.18 170.01 22.23 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.489 -0.93 . . . . 74.03 108.489 -172.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -48.37 119.94 3.32 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.175 0.99 . . . . 75.41 110.295 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -49.96 99.5 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.963 1.305 . . . . 64.44 111.691 -172.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.51 40.42 1.16 Allowed 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.116 0.967 . . . . 64.31 109.844 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.94 57.45 5.07 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.751 -0.659 . . . . 31.14 111.463 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -76.29 89.31 3.14 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.965 0.906 . . . . 73.13 108.991 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.32 69.1 2.83 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 114.756 -1.111 . . . . 45.12 110.833 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.3 m -70.5 83.11 0.59 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.776 -0.824 . . . . 64.0 108.776 175.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -80.34 83.77 6.12 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.965 -1.016 . . . . 51.51 109.764 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -87.49 120.5 28.86 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.675 -1.232 . . . . 74.42 107.675 170.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -83.68 -9.38 58.9 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.78 0.432 . . . . 74.44 111.63 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 57.43 -168.7 0.11 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.423 1.089 . . . . 65.41 110.851 -174.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -139.79 92.96 2.6 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.55 -0.908 . . . . 62.4 108.55 171.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.907 0 C-N-CA 124.623 1.169 . . . . 64.54 110.751 -174.997 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 109.99 -0.374 . . . . 50.34 109.99 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 63.0 m -150.91 101.23 2.88 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.47 1.108 . . . . 75.1 108.456 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.76 135.84 41.73 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.966 0.506 . . . . 63.41 109.684 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -102.16 105.72 16.46 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.443 0.697 . . . . 72.03 109.993 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -152.27 142.49 22.39 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.055 0.942 . . . . 53.54 108.902 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -146.71 9.93 1.04 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.668 0.787 . . . . 75.52 110.173 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 77.3 p -74.71 -16.12 60.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.542 0.737 . . . . 72.14 111.366 -176.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.64 60.15 6.05 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 108.199 -1.037 . . . . 73.05 108.199 175.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 58.3 ttp 53.95 113.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 126.09 1.756 . . . . 74.3 113.351 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 10.6 m -92.55 108.35 19.91 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.943 -1.132 . . . . 62.34 107.943 167.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.933 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 62.5 t80 -123.41 121.33 35.48 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.655 -1.239 . . . . 64.41 107.655 174.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -137.21 122.76 19.69 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.168 -0.679 . . . . 63.42 109.168 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.04 125.35 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.807 -0.812 . . . . 73.05 108.807 172.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.564 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 29.3 mm-40 -91.97 -42.85 9.78 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.695 0.798 . . . . 71.31 109.306 175.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -175.61 138.58 0.39 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.63 -0.878 . . . . 64.22 108.63 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -127.91 141.67 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.862 -1.162 . . . . 60.14 107.862 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -170.57 161.18 7.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.714 0.768 . . . . 74.1 111.582 -171.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 18' ' ' THR . . . . . 0.457 HG21 ' SG ' ' C' ' 113' ' ' CYS . 68.3 p -83.95 107.47 16.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.753 -1.112 . . . . 71.3 108.338 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -68.81 -41.67 78.31 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.309 -0.996 . . . . 72.51 108.309 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 26.8 t70 -139.27 142.32 37.76 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 114.381 -1.282 . . . . 74.01 109.555 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.617 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.4 mt -135.99 145.35 31.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.548 1.539 . . . . 72.02 106.911 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -154.28 149.36 26.87 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.463 0.705 . . . . 73.42 109.504 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -155.82 109.01 2.71 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.2 -1.037 . . . . 74.21 108.2 174.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -119.3 111.9 18.78 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.266 0.626 . . . . 72.51 110.352 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -110.64 87.64 6.85 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 106.732 -1.581 . . . . 65.34 106.732 169.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.15 -23.65 24.39 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.698 2.266 . . . . 71.3 112.299 -170.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -121.39 29.71 7.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.367 1.067 . . . . 51.44 109.546 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.479 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -49.68 -53.54 40.54 Favored Pre-proline 0 CA--C 1.562 1.426 0 N-CA-C 114.031 1.123 . . . . 53.12 114.031 -171.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.468 ' HB3' HD13 ' D' ' 51' ' ' LEU . 26.3 Cg_exo -60.52 -48.72 10.55 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 121.671 1.581 . . . . 74.33 112.091 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -69.99 -27.08 64.42 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.244 -1.344 . . . . 63.3 112.27 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.767 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -79.54 -26.95 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 112.557 0.577 . . . . 72.53 112.557 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -68.19 -27.39 66.35 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.01 0.374 . . . . 73.21 112.01 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -89.9 9.62 26.95 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.441 0.696 . . . . 62.24 111.797 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.6 176.57 5.97 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.585 0.754 . . . . 65.31 110.065 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -76.93 124.37 27.65 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.47 0.708 . . . . 74.51 109.367 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.48 ' HE1' HD12 ' G' ' 470' ' ' LEU . 50.7 t90 -85.15 84.84 7.56 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.711 0.804 . . . . 75.14 111.157 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -142.56 79.92 14.88 Favored Pre-proline 0 N--CA 1.478 0.943 0 N-CA-C 107.334 -1.358 . . . . 74.54 107.334 164.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.42 139.95 14.9 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.678 2.252 . . . . 75.51 112.922 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.73 104.92 14.23 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 106.19 -1.781 . . . . 63.24 106.19 165.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.507 ' HB ' HD12 ' G' ' 468' ' ' LEU . 5.8 m -93.46 102.74 13.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.197 -1.365 . . . . 73.24 110.791 -169.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.546 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 54.4 mttp -91.84 111.13 22.54 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.489 -0.778 . . . . 75.23 109.005 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.547 ' HB3' ' HG ' ' G' ' 468' ' ' LEU . 3.5 pp -86.41 157.22 19.89 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.515 -0.55 . . . . 75.55 109.515 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.641 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.6 t70 -151.75 137.32 17.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.044 -1.095 . . . . 55.13 108.044 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.417 HD22 HD12 ' G' ' 460' ' ' LEU . 6.2 tt -137.97 137.2 37.7 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.556 -0.905 . . . . 73.32 108.556 177.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -148.21 125.58 11.6 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.973 1.309 . . . . 71.22 108.596 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m -114.22 126.35 54.95 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.431 0.634 . . . . 74.44 110.342 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.23 141.05 52.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.862 1.265 . . . . 73.25 107.805 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -152.24 143.68 23.39 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.851 0.46 . . . . 73.15 110.46 -170.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 80.5 p -148.43 151.93 36.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.211 0.605 . . . . 60.51 111.23 -171.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -79.22 136.89 37.2 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.466 0.706 . . . . 73.15 110.269 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.607 HD11 ' HB2' ' C' ' 57' ' ' GLU . 29.8 mt -110.12 -34.42 6.39 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.53 0.732 . . . . 71.04 110.245 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -154.47 179.82 8.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.36 0.664 . . . . 54.45 110.242 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -58.46 112.93 1.75 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.719 0.808 . . . . 64.51 109.907 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 64.12 9.82 5.0 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.672 1.189 . . . . 63.15 113.473 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 94.2 t -105.59 116.25 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.558 -1.275 . . . . 50.13 107.558 172.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.423 ' HB2' HD11 ' C' ' 86' ' ' ILE . 39.8 t80 -134.09 124.21 25.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.013 -0.736 . . . . 73.53 109.013 -175.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.607 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.3 tt0 -83.42 139.01 33.23 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.92 0.888 . . . . 74.41 109.635 175.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.403 HG11 ' HD3' ' C' ' 103' ' ' PRO . 42.0 t -120.05 135.33 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 124.185 0.994 . . . . 64.55 108.496 166.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.578 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 59.1 t -115.84 144.55 23.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.543 -0.91 . . . . 64.25 108.543 175.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.4 104.64 8.56 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.197 -1.038 . . . . 75.02 108.197 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -88.16 117.46 27.07 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.79 -1.189 . . . . 63.4 107.79 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.483 HG11 HD21 ' C' ' 128' ' ' LEU . 21.4 t -118.88 118.85 59.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.741 -1.207 . . . . 71.23 107.741 175.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.641 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.9 m -122.3 122.32 38.81 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.579 0.752 . . . . 71.35 109.54 -173.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.751 HG13 HD13 ' G' ' 468' ' ' LEU . 99.5 t -110.36 122.16 64.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.083 1.353 . . . . 71.23 109.258 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.6 m -117.55 144.17 45.38 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.446 -0.946 . . . . 71.24 108.446 175.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.28 128.47 19.81 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.482 -0.933 . . . . 65.15 108.482 176.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 21.4 m -142.91 129.3 20.03 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.092 0.557 . . . . 54.32 110.586 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 49.0 mt -87.67 32.95 0.71 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.174 1.39 . . . . 74.54 111.334 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 -100.72 1.41 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.41 -1.076 . . . . 74.55 110.41 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.64 -31.09 17.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.808 0.843 . . . . 71.04 109.953 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -76.62 120.23 21.53 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.276 1.03 . . . . 74.14 110.092 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.2 m -78.14 126.18 30.44 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.561 -0.903 . . . . 71.51 108.561 168.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.767 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -60.98 2.06 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.589 -0.893 . . . . 74.21 108.589 173.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -163.61 172.49 14.25 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.068 0.937 . . . . 74.24 111.83 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.407 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.6 tm? -135.8 145.57 46.65 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 105.863 -1.902 . . . . 74.44 105.863 172.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.415 ' SG ' HG23 ' C' ' 114' ' ' ILE . 41.8 t -147.98 150.42 33.96 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.059 -1.089 . . . . 74.32 108.059 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.99 132.83 8.5 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.759 -0.46 . . . . 74.25 109.759 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.52 114.1 22.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.263 -1.014 . . . . 62.53 108.263 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 68.4 mt-30 -94.15 85.12 4.59 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.401 -0.963 . . . . 62.32 108.401 173.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -78.33 97.4 5.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.053 -1.431 . . . . 72.14 110.324 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -89.37 161.13 29.81 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 116.465 -0.334 . . . . 71.01 112.382 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.513 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -163.16 123.06 1.15 Allowed Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 111.058 -0.817 . . . . 73.24 111.058 -175.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.58 HD12 HD11 ' C' ' 51' ' ' LEU . 6.2 mm -82.26 125.92 39.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.532 -0.914 . . . . 74.42 108.532 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -131.6 119.74 21.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.166 0.587 . . . . 70.45 110.257 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 71.9 m -80.66 111.89 17.52 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.934 -0.765 . . . . 52.25 108.934 170.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.74 HG12 HD21 ' C' ' 98' ' ' LEU . 1.2 pp -117.06 139.31 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.225 1.01 . . . . 63.5 110.317 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.07 172.68 13.46 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.409 1.084 . . . . 73.23 110.514 -172.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.93 -59.67 3.55 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 116.179 -0.464 . . . . 71.24 112.086 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.81 157.57 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.756 0.823 . . . . 75.11 109.475 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.595 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 13.3 pt-20 -145.53 -170.8 3.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.0 0.52 . . . . 74.42 109.925 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.82 -121.73 24.26 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 114.621 0.608 . . . . 72.15 114.621 174.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 62.6 p -73.33 -34.27 65.58 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.792 0.837 . . . . 73.51 110.555 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -70.14 -32.7 70.81 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.243 1.017 . . . . 64.25 109.981 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.595 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 39.4 ttp -79.61 -33.13 41.8 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.836 -1.074 . . . . 61.42 110.838 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.45 84.17 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.369 0.604 . . . . 40.43 109.913 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 49.2 t-80 -65.42 -29.21 69.88 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.562 -1.199 . . . . 72.23 111.478 175.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.3 -60.81 2.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.057 0.543 . . . . 72.22 110.448 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.74 HD21 HG12 ' C' ' 86' ' ' ILE . 92.9 mt -74.16 -33.81 63.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.074 0.95 . . . . 54.22 112.696 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.35 8.79 77.08 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-O 119.475 -0.625 . . . . 72.04 113.551 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -156.87 -66.23 0.1 Allowed 'General case' 0 C--N 1.357 0.916 0 CA-C-N 117.724 0.762 . . . . 52.44 112.874 -172.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' C' ' 104' ' ' ASN . 87.9 t80 -63.89 -34.8 78.76 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.286 0.634 . . . . 75.42 112.328 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.933 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 56.2 m -72.75 -46.28 9.18 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.69 -0.671 . . . . 74.04 111.148 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 83.2 Cg_exo -52.99 -32.95 60.25 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.312 2.008 . . . . 75.54 113.791 164.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 104' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' C' ' 101' ' ' TYR . 5.1 m-20 -60.09 -39.83 87.49 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 123.158 0.583 . . . . 62.32 110.911 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.447 HD12 ' NH1' ' A' ' 111' ' ' ARG . 40.2 mm -66.5 -45.22 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 115.954 -0.567 . . . . 64.51 110.198 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.513 HD21 ' HA3' ' C' ' 82' ' ' GLY . 42.3 mt -75.88 -16.39 60.06 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.433 -0.803 . . . . 74.53 111.986 -174.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -59.92 -52.7 71.76 Favored Pre-proline 0 CA--C 1.566 1.583 0 C-N-CA 125.035 1.334 . . . . 60.12 113.811 -172.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.18 -31.38 64.34 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 121.948 1.765 . . . . 62.51 112.784 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.514 ' HE2' HG21 ' A' ' 115' ' ' THR . 90.3 m-85 -69.09 -47.6 64.78 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.188 0.595 . . . . 74.33 110.546 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.37 -41.85 85.66 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.179 -0.918 . . . . 71.13 109.925 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.412 HH21 ' ND2' ' C' ' 127' ' ' ASN . 51.7 ttt180 -56.08 -57.72 10.97 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 124.437 1.086 . . . . 71.34 111.126 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -66.93 -30.93 71.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.181 0.593 . . . . 54.44 111.036 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.457 ' SG ' HG21 ' C' ' 18' ' ' THR . 9.6 t -70.5 -34.1 71.95 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.779 0.432 . . . . 72.34 110.971 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.564 HG21 HG21 ' C' ' 64' ' ' VAL . 88.4 mt -69.34 -51.24 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.277 -0.638 . . . . 52.31 109.277 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.41 HG21 ' OG ' ' B' ' 119' ' ' SER . 13.7 m -58.43 -33.53 69.79 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.05 0.94 . . . . 72.12 111.286 -174.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 28.3 t -62.9 -54.85 32.32 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.834 -1.075 . . . . 52.24 109.13 173.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.523 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.96 -40.05 72.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.91 1.284 . . . . 74.32 112.639 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.3 t -63.34 -47.72 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.956 0.902 . . . . 73.45 109.691 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.458 ' OG ' HG21 ' B' ' 115' ' ' THR . 48.4 t -69.95 -27.98 65.19 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.238 -0.892 . . . . 63.02 111.93 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' C' ' 116' ' ' SER . 84.3 mtt-85 -70.65 -43.68 68.67 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.688 0.795 . . . . 75.42 109.29 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.15 5.86 65.39 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.955 -1.02 . . . . 65.3 112.522 172.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 64.8 p 61.66 29.76 18.28 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.175 1.79 . . . . 65.51 113.757 168.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.408 ' HB2' HG13 ' C' ' 118' ' ' VAL . 95.6 m-85 -86.62 152.53 54.56 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 108.981 -0.748 . . . . 75.31 108.981 169.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.43 173.26 3.58 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.258 2.639 . . . . 71.32 114.649 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -50.79 130.92 25.75 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.308 1.443 . . . . 75.31 114.043 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' G' ' 468' ' ' LEU . 3.1 tm? -133.88 112.6 11.43 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.388 -1.338 . . . . 71.0 107.388 177.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 127' ' ' ASN . . . . . 0.412 ' ND2' HH21 ' C' ' 111' ' ' ARG . 28.7 m120 -133.16 132.15 41.26 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.497 0.719 . . . . 73.21 109.99 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.483 HD21 HG11 ' C' ' 62' ' ' VAL . 6.8 mp -86.07 125.93 33.81 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.765 0.826 . . . . 74.41 110.11 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.45 ' HB3' ' SD ' ' G' ' 464' ' ' MET . . . -79.86 155.67 75.32 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 124.75 1.22 . . . . 61.34 111.18 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.03 113.93 1.79 Allowed 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 123.361 2.708 . . . . 74.32 113.522 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.39 113.38 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.786 0.834 . . . . 74.22 109.279 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -76.38 91.05 3.25 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.689 0.795 . . . . 74.32 110.473 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -68.55 -33.06 73.43 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 110.062 -0.348 . . . . 72.55 110.062 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.511 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 12.7 p-10 -65.02 -45.83 83.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.527 1.131 . . . . 74.52 111.447 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.53 -37.09 71.18 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.372 0.669 . . . . 73.53 110.897 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.26 -18.45 55.32 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.23 -0.895 . . . . 70.35 112.347 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -59.84 -17.78 39.05 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.096 0.558 . . . . 71.33 111.626 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 22.3 mmt -51.25 -42.27 60.91 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.688 0.795 . . . . 73.44 111.185 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -66.83 -36.39 82.25 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.153 0.581 . . . . 73.2 111.43 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -68.87 -86.52 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.827 0.851 . . . . 71.33 110.69 174.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 88.3 mt 56.1 -84.7 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.588 1.155 . . . . 62.44 110.861 -172.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -167.11 -83.39 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.727 -0.842 . . . . 72.14 108.727 176.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.45 -50.6 3.11 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 107.521 -1.288 . . . . 73.33 107.521 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -55.58 124.09 16.18 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.249 -1.341 . . . . 70.32 110.636 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.3 108.6 21.18 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.571 0.748 . . . . 52.13 109.96 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.3 93.0 1.2 Allowed Glycine 0 C--N 1.337 0.639 0 N-CA-C 110.239 -1.144 . . . . 75.13 110.239 171.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.04 142.95 32.91 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.073 0.549 . . . . 74.53 109.764 -175.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.1 -33.15 0.1 OUTLIER Glycine 0 C--N 1.347 1.163 0 CA-C-N 115.943 -0.571 . . . . 74.4 112.463 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 28.3 p -133.19 108.77 9.0 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.771 0.828 . . . . 65.22 109.779 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 150' ' ' GLU . . . . . 0.432 ' HA ' ' N ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -89.78 126.66 35.76 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 109.278 -0.638 . . . . 64.34 109.278 178.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.58 13.01 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.06 1.344 . . . . 73.24 110.855 -172.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.01 142.02 35.54 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.627 0.771 . . . . 72.15 111.003 -172.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -78.92 89.76 4.73 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.345 1.058 . . . . 71.44 109.872 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -129.88 123.0 29.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.306 1.042 . . . . 75.41 108.917 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 N-CA-C 109.54 -0.541 . . . . 63.23 109.54 -177.261 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.74 0.305 . . . . 63.53 110.563 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 47.3 t -129.72 94.17 3.68 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.414 0.685 . . . . 54.41 109.241 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.85 114.52 23.56 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.151 -0.685 . . . . 73.2 109.151 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -89.31 83.13 6.43 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.248 -1.019 . . . . 73.44 108.248 175.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -65.33 114.3 4.68 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.026 -0.988 . . . . 74.4 110.125 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -74.06 79.27 1.72 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 122.348 1.07 . . . . 62.41 110.509 -176.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 33.4 m -108.04 140.94 40.47 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.824 -1.08 . . . . 72.43 109.355 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -70.88 109.11 4.84 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.116 -1.068 . . . . 72.21 108.116 170.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.8 ttp -30.41 123.93 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 125.325 1.641 . . . . 74.24 113.783 -173.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 22.5 m -114.16 142.36 46.34 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.072 -1.085 . . . . 75.11 108.072 171.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -157.19 91.28 1.17 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.951 -1.5 . . . . 72.4 106.951 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -113.43 114.71 26.96 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.341 -0.985 . . . . 65.21 108.341 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.475 HG21 HD11 ' D' ' 16' ' ' ILE . 12.6 mt -75.27 114.76 15.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.014 -1.106 . . . . 63.0 108.014 174.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -89.96 -32.27 16.88 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.423 0.452 . . . . 71.0 111.096 -178.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -172.76 146.42 1.61 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.062 0.226 . . . . 74.22 111.555 -170.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.475 HD11 HG21 ' D' ' 13' ' ' ILE . 2.9 mp -126.56 132.27 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 105.79 -1.929 . . . . 71.1 105.79 170.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.409 ' HE1' HG13 ' D' ' 83' ' ' ILE . 28.8 p90 -158.53 150.92 21.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.203 1.001 . . . . 74.44 111.03 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -84.23 119.22 24.78 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.222 -1.808 . . . . 55.31 108.487 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -95.08 -28.53 15.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.34 -0.615 . . . . 63.44 109.34 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.1 t70 -145.16 128.74 17.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.583 -1.189 . . . . 73.03 108.232 175.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.523 HG21 ' HE2' ' C' ' 117' ' ' MET . 73.4 mt -129.92 137.72 55.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.401 -1.333 . . . . 74.24 107.401 172.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -138.24 139.42 39.22 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.438 1.095 . . . . 75.24 108.312 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.617 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -150.61 129.45 12.46 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.093 -1.447 . . . . 74.21 107.093 170.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.7 mt-10 -131.26 150.98 51.92 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.895 0.878 . . . . 75.31 109.178 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.23 78.21 19.2 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 106.946 -1.501 . . . . 44.12 106.946 173.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.8 -22.88 17.18 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.78 2.32 . . . . 74.13 113.596 -170.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -108.15 16.34 23.39 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.102 0.561 . . . . 73.13 110.256 176.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.1 -66.92 0.29 Allowed Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 115.581 1.697 . . . . 53.54 115.581 -160.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.437 ' HB3' HD11 ' C' ' 83' ' ' ILE . 96.2 Cg_endo -74.15 -20.51 18.93 Favored 'Trans proline' 0 C--N 1.387 2.568 0 CA-C-N 122.435 1.905 . . . . 73.14 112.717 -173.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -74.26 -41.05 61.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.148 1.379 . . . . 72.11 110.445 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' D' ' 73' ' ' ALA . 3.6 p -84.04 -20.92 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 115.883 -0.599 . . . . 63.54 111.066 -170.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -62.74 -22.08 66.29 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.076 0.551 . . . . 74.42 112.433 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -65.75 -18.0 65.02 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.489 0.715 . . . . 64.52 111.06 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -84.09 102.55 12.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.489 1.115 . . . . 65.13 108.972 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -84.56 89.42 7.44 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.373 -0.603 . . . . 52.32 109.373 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.442 ' HZ2' ' H ' ' H' ' 471' ' ' LYS . 39.1 t-105 -168.5 158.85 9.84 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.618 1.167 . . . . 71.43 109.368 176.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -72.13 109.8 6.56 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 108.315 -0.994 . . . . 71.41 108.315 169.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.52 125.91 20.07 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.307 2.671 . . . . 64.34 113.329 -173.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.02 115.66 2.75 Favored 'General case' 0 C--N 1.361 1.101 0 O-C-N 124.484 1.115 . . . . 70.04 109.61 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.597 HG23 HG13 ' D' ' 64' ' ' VAL . 3.0 p -96.66 112.76 29.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-O 121.86 0.838 . . . . 64.31 110.562 -170.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -101.91 151.24 22.34 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.846 -1.07 . . . . 65.44 108.258 167.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.45 HD21 HD12 ' D' ' 128' ' ' LEU . 5.3 mp -131.49 136.12 47.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.771 0.428 . . . . 73.42 110.637 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.652 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 30.4 m-20 -107.79 150.28 27.19 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 107.376 -1.342 . . . . 74.55 107.376 165.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.456 HD22 ' CD1' ' H' ' 462' ' ' TYR . 18.8 tp -137.36 131.27 31.87 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.584 0.23 . . . . 70.33 110.993 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 34.3 m-20 -138.87 158.42 44.24 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.61 1.164 . . . . 73.21 108.711 170.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.0 t -124.48 175.35 7.2 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.601 0.761 . . . . 72.34 109.189 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -161.34 163.99 30.38 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.9 0.88 . . . . 74.44 109.448 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 71.9 p -150.26 153.0 35.42 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.617 0.767 . . . . 73.4 109.264 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.7 p -156.62 140.41 16.11 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.485 0.714 . . . . 72.11 110.262 -174.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -91.56 116.43 28.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.511 0.724 . . . . 64.52 109.064 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' C' ' 29' ' ' PRO . 26.8 mt -98.5 -42.17 7.43 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.093 0.473 . . . . 71.23 110.297 -173.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.16 176.02 10.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.431 1.093 . . . . 55.33 108.097 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.08 130.61 41.33 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.581 -0.526 . . . . 71.14 109.581 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 61.42 11.0 3.45 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 124.425 1.09 . . . . 64.24 112.813 -171.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.67 114.37 43.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 108.211 -1.033 . . . . 75.22 108.211 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.46 ' HE2' ' H ' ' H' ' 453' ' ' GLY . 0.1 OUTLIER -111.12 164.66 12.61 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.175 -1.046 . . . . 73.04 108.175 -175.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.437 ' HB2' HD11 ' D' ' 51' ' ' LEU . 62.3 tt0 -131.04 150.89 51.94 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.838 -0.801 . . . . 73.24 108.838 169.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.61 141.87 42.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.795 1.238 . . . . 61.21 107.874 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 47.2 t -128.1 126.41 66.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.778 -1.194 . . . . 64.24 107.778 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.08 120.9 43.35 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.074 -1.084 . . . . 63.31 108.074 -175.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.417 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 22.3 ttm-85 -100.99 97.63 8.18 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.583 -0.895 . . . . 64.4 108.583 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.19 123.93 47.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.619 -1.252 . . . . 74.4 107.619 167.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.652 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 12.9 m -118.74 130.37 55.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.959 -0.756 . . . . 72.43 108.959 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.597 HG13 HG23 ' D' ' 40' ' ' VAL . 94.2 t -117.48 121.1 66.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.106 0.962 . . . . 61.11 109.157 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.1 m -116.01 104.0 11.15 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.083 -1.08 . . . . 62.22 108.083 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.27 150.57 24.32 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.641 -0.709 . . . . 64.24 110.493 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 55.1 p -143.96 142.19 30.6 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.705 0.628 . . . . 73.03 111.053 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 21.4 mt -110.32 104.37 13.15 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 124.633 1.173 . . . . 62.55 109.191 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.03 -112.9 3.55 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.443 -0.663 . . . . 71.31 111.443 -177.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -117.52 14.32 14.53 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.249 0.619 . . . . 72.41 111.488 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.58 156.04 45.52 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.071 0.548 . . . . 74.4 110.59 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.5 m -63.4 127.28 30.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.09 0.956 . . . . 63.24 111.502 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.504 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -86.03 -75.78 0.36 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.842 -0.799 . . . . 73.2 108.842 174.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.29 139.46 35.5 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-O 121.349 0.595 . . . . 75.55 110.03 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 80.6 mt -103.54 147.37 27.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.912 -1.144 . . . . 74.03 107.912 171.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.548 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.6 t -158.02 146.66 19.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 122.914 0.486 . . . . 71.22 109.859 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -156.2 134.28 11.29 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 108.858 -0.793 . . . . 51.41 108.858 171.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.32 114.75 24.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 109.104 -0.702 . . . . 75.12 109.104 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.452 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 72.3 mt-30 -89.08 83.23 6.54 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.295 -1.002 . . . . 53.14 108.295 171.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -80.96 99.22 8.29 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.457 -1.702 . . . . 75.25 109.946 -175.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.08 163.62 29.3 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.441 -0.345 . . . . 73.44 112.483 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.467 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -161.96 132.87 2.94 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 111.883 -0.487 . . . . 73.13 111.883 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.409 HG13 ' HE1' ' D' ' 17' ' ' TYR . 43.7 mt -88.93 130.41 38.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 123.822 0.849 . . . . 71.12 109.311 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -133.85 124.23 26.13 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.356 0.662 . . . . 73.52 110.04 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -83.41 105.5 14.41 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.594 -0.891 . . . . 64.52 108.594 170.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.434 HD13 HD13 ' D' ' 98' ' ' LEU . 47.8 pt -109.78 141.93 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 122.985 0.514 . . . . 75.35 110.855 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.467 ' HA ' HG21 ' H' ' 451' ' ' VAL . . . -154.35 159.88 41.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.309 1.044 . . . . 52.24 109.354 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.04 10.59 81.16 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 115.009 0.764 . . . . 54.43 115.009 173.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 24.0 pt -124.06 135.07 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.596 0.758 . . . . 71.22 109.549 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.73 164.9 28.95 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.517 0.727 . . . . 73.14 110.682 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.14 -121.9 25.57 Favored Glycine 0 C--N 1.353 1.481 0 O-C-N 124.091 0.87 . . . . 75.24 114.393 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 12.5 t -72.04 -32.4 67.07 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.691 0.796 . . . . 53.4 111.44 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -71.62 -35.28 70.39 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.167 0.587 . . . . 73.01 110.706 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.445 ' HE1' ' HB2' ' H' ' 454' ' ' LEU . 1.6 tmt? -66.56 -47.48 72.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.295 -0.866 . . . . 73.35 110.154 175.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.54 -28.37 69.89 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.21 -0.905 . . . . 63.43 111.479 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -76.47 -46.51 26.5 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.939 0.896 . . . . 71.31 110.869 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.71 -42.48 73.97 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.013 -0.54 . . . . 75.23 111.296 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.548 HD23 HD22 ' H' ' 454' ' ' LEU . 12.4 tp -84.51 -36.21 22.38 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 122.68 0.392 . . . . 73.23 111.195 -173.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.0 -23.09 42.65 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.036 -0.529 . . . . 55.25 113.705 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.572 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -122.17 -56.34 1.83 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.23 0.515 . . . . 70.53 111.949 -175.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 101' ' ' TYR . . . . . 0.413 ' O ' HG12 ' D' ' 105' ' ' ILE . 63.7 t80 -66.76 -43.36 84.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 111.841 0.312 . . . . 74.32 111.841 -173.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 98.8 m -65.85 -47.83 63.88 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.053 -0.975 . . . . 72.14 112.912 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.463 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.3 Cg_exo -57.0 -36.22 99.25 Favored 'Trans proline' 0 C--N 1.4 3.263 0 C-N-CA 121.847 1.698 . . . . 72.31 112.7 170.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -65.1 -31.22 72.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.851 0.86 . . . . 71.34 111.119 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.413 HG12 ' O ' ' D' ' 101' ' ' TYR . 46.3 mm -68.25 -40.89 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.502 0.721 . . . . 75.32 110.164 173.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.467 HD21 ' HA3' ' D' ' 82' ' ' GLY . 63.3 mt -77.96 -21.82 50.4 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.252 -0.886 . . . . 75.2 111.856 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -64.27 -41.29 59.44 Favored Pre-proline 0 CA--C 1.566 1.562 0 N-CA-C 114.098 1.147 . . . . 71.31 114.098 -172.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -51.19 -43.38 49.05 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.263 1.975 . . . . 71.02 113.56 170.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -72.51 -37.89 68.26 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.57 -0.741 . . . . 72.13 111.03 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.22 -45.11 93.16 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.498 0.719 . . . . 71.23 110.528 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -57.28 -51.85 67.71 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.416 1.072 . . . . 74.01 110.395 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.02 -44.65 96.25 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.175 0.922 . . . . 72.13 112.009 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -54.59 -48.14 72.5 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.91 0.756 . . . . 70.44 110.359 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.548 HG12 ' SG ' ' D' ' 76' ' ' CYS . 82.2 mt -60.4 -54.85 29.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 CA-C-N 114.502 -1.226 . . . . 60.41 110.38 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.0 m -55.39 -39.92 70.75 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.301 1.04 . . . . 73.3 111.806 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -68.05 -41.93 81.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.005 -0.998 . . . . 73.21 110.566 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -70.01 -29.19 66.19 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.8 0.44 . . . . 72.42 111.828 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' D' ' 114' ' ' ILE . 65.9 t -66.12 -45.1 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 123.961 0.904 . . . . 72.44 109.834 175.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.0 p -74.49 -28.93 61.22 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.992 -0.549 . . . . 72.35 111.251 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 -72.86 -33.5 66.14 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.429 0.692 . . . . 73.21 109.809 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.47 2.01 86.28 Favored Glycine 0 C--N 1.355 1.603 0 CA-C-N 115.769 -0.65 . . . . 53.31 112.165 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.8 p 64.37 18.98 11.62 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 127.142 2.177 . . . . 63.23 113.984 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -80.02 147.38 65.57 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 108.587 -0.894 . . . . 70.41 108.587 168.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.87 148.8 91.19 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.083 1.855 . . . . 63.41 111.463 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -57.8 139.84 53.09 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.723 1.209 . . . . 32.41 113.883 -165.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.487 HD11 HG21 ' D' ' 40' ' ' VAL . 42.2 tp -109.09 102.59 11.55 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.055 -0.975 . . . . 74.02 109.678 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -100.91 104.39 15.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.266 0.626 . . . . 74.11 109.385 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.45 HD12 HD21 ' D' ' 42' ' ' LEU . 3.0 mm? -74.56 118.62 17.72 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.16 0.584 . . . . 65.42 109.441 175.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.9 136.35 72.89 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.691 0.796 . . . . 72.4 111.368 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.83 118.97 5.81 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.217 1.945 . . . . 75.14 110.76 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.5 p -107.38 136.75 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.521 0.728 . . . . 53.43 110.028 -173.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -76.73 76.27 3.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.688 -1.227 . . . . 73.44 107.688 169.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.442 ' HE2' HD21 ' D' ' 44' ' ' LEU . 87.4 t80 -59.98 -33.15 71.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.075 -1.421 . . . . 74.41 112.006 -172.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.572 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 17.4 t70 -60.27 -34.8 74.24 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.656 1.182 . . . . 63.45 111.392 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.18 -37.92 84.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.16 -0.927 . . . . 44.21 111.716 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.6 mp -64.21 -33.34 75.58 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.707 0.803 . . . . 42.25 110.956 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.45 ' HD1' ' HZ ' ' H' ' 461' ' ' PHE . 61.3 t80 -65.9 -30.73 71.37 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.121 0.969 . . . . 75.34 111.808 -178.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 49.6 mtt -60.71 -23.82 65.19 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.826 0.85 . . . . 51.32 112.136 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -75.59 -42.13 52.82 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.266 0.626 . . . . 72.33 110.847 176.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -58.66 -38.06 77.34 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.026 0.93 . . . . 74.33 111.329 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.429 HD11 ' CE2' ' D' ' 137' ' ' PHE . 5.2 mp -60.4 -31.05 70.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.97 0.908 . . . . 75.04 111.767 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -89.21 1.32 55.85 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.554 0.741 . . . . 64.22 111.586 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -138.15 77.19 1.62 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.057 0.943 . . . . 53.11 109.574 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -162.05 139.52 8.55 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.613 0.765 . . . . 64.45 110.015 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.88 178.33 8.42 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.543 0.737 . . . . 75.04 110.232 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 98.72 175.61 32.34 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 116.01 -0.541 . . . . 71.54 111.965 -174.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -166.53 152.04 8.22 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.278 0.631 . . . . 65.35 111.155 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -92.94 85.65 1.15 Allowed Glycine 0 C--N 1.342 0.915 0 N-CA-C 110.524 -1.03 . . . . 61.02 110.524 172.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 11.4 m -76.27 79.44 3.05 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.358 0.599 . . . . 73.42 110.303 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -86.88 104.06 15.86 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.7 -0.682 . . . . 72.21 109.308 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -82.92 72.78 9.99 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.845 -1.169 . . . . 63.24 107.845 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -78.4 80.13 4.81 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.379 -0.828 . . . . 63.32 109.831 -171.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -96.66 102.62 14.43 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.924 -0.769 . . . . 71.01 108.924 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -65.85 140.34 58.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.632 0.773 . . . . 75.12 109.645 173.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 C-N-CA 123.455 0.702 . . . . 63.44 109.786 -174.382 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 8.3 t30 . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.172 -0.677 . . . . 70.43 109.172 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 28.3 m -82.23 -35.21 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 122.943 0.497 . . . . 73.44 111.333 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 452' ' ' VAL . . . . . 0.537 ' HB ' ' SD ' ' A' ' 94' ' ' MET . 5.2 m -137.34 149.39 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.223 0.609 . . . . 73.43 109.748 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -130.84 83.45 0.31 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.038 -0.825 . . . . 72.43 111.038 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 2.4 pp -131.99 141.59 49.33 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.684 0.794 . . . . 65.43 110.279 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 40.6 p -131.16 66.99 1.52 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.084 0.954 . . . . 71.03 109.669 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -78.62 134.78 37.15 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.431 -0.804 . . . . 74.31 109.201 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -108.93 -70.19 0.82 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.553 0.741 . . . . 75.42 111.174 -173.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 52.6 m -148.97 162.01 40.76 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.095 0.958 . . . . 73.34 110.088 -175.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 87.98 142.38 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 127.193 2.197 . . . . 63.31 111.481 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 460' ' ' LEU . . . . . 0.565 HD21 ' HB ' ' A' ' 46' ' ' THR . 49.5 mt -126.08 175.64 7.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.219 1.008 . . . . 72.21 109.199 168.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -95.37 24.54 5.01 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.884 1.274 . . . . 74.13 110.79 -177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -141.58 135.58 30.21 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.099 0.56 . . . . 75.02 110.265 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 10.2 t -125.05 146.95 49.2 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.705 1.202 . . . . 75.22 108.251 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 464' ' ' MET . . . . . 0.541 ' HG3' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -99.54 105.26 17.13 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.358 -0.608 . . . . 74.34 109.358 -176.35 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -115.33 -2.12 12.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.267 1.027 . . . . 73.01 111.133 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.03 72.07 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.495 0.718 . . . . 64.53 111.541 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . 62.42 178.69 0.13 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.542 1.137 . . . . 72.13 112.517 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 90.1 mt -133.61 -50.76 0.85 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.436 0.694 . . . . 63.32 110.2 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 79.25 63.5 2.04 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 110.882 -0.887 . . . . 51.52 110.882 -172.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.8 122.71 17.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.692 0.797 . . . . 65.32 110.978 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.556 1.18 0 N-CA-C 108.131 -1.063 . . . . 73.12 108.131 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 108.958 -0.756 . . . . 72.41 108.958 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' F' F ' 451' ' ' VAL . . . . . 0.702 HG12 ' SD ' ' B' ' 94' ' ' MET . 59.0 t -67.96 -61.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 122.876 0.47 . . . . 73.41 110.862 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 29.9 m -72.18 157.53 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.269 0.628 . . . . 55.34 111.338 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -147.02 -66.06 0.01 OUTLIER Glycine 0 C--N 1.353 1.514 0 N-CA-C 111.594 -0.602 . . . . 62.23 111.594 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 11.0 mp 69.6 -178.52 0.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 125.112 1.365 . . . . 54.41 113.953 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 9.7 t -154.02 164.63 38.13 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 113.952 -1.476 . . . . 52.32 108.885 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.42 113.55 5.38 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.042 0.937 . . . . 71.01 110.678 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -129.71 137.9 50.84 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.985 0.914 . . . . 73.44 109.97 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 47.2 m -102.97 124.54 48.67 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.988 0.915 . . . . 62.25 109.779 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 69.87 146.33 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.083 1.353 . . . . 73.25 111.967 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 91.2 mt -128.76 -61.9 1.04 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.275 -1.009 . . . . 70.23 108.275 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -176.52 161.38 2.16 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.27 1.428 . . . . 72.21 109.534 -173.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.21 -71.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.85 -0.796 . . . . 74.35 108.85 172.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 5.6 m 57.77 39.31 27.22 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.405 1.082 . . . . 60.2 110.723 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 41.7 ttm -73.16 110.21 7.28 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.137 -0.938 . . . . 72.35 109.458 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -69.53 -51.6 34.17 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.084 0.954 . . . . 71.44 111.489 -171.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -127.4 164.94 20.74 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.871 0.868 . . . . 73.41 109.155 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -59.27 168.63 1.39 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.111 0.964 . . . . 41.12 113.551 -172.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 468' ' ' LEU . . . . . 0.474 HD12 ' N ' ' F' ' 469' ' ' GLY . 2.2 pp -55.94 -25.15 42.07 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.931 0.892 . . . . 75.14 112.254 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 469' ' ' GLY . . . . . 0.474 ' N ' HD12 ' F' ' 468' ' ' LEU . . . -168.77 -80.9 0.05 OUTLIER Glycine 0 C--N 1.344 0.979 0 N-CA-C 109.862 -1.295 . . . . 72.21 109.862 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 19.0 tp 59.56 73.02 0.5 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.536 1.135 . . . . 64.0 110.517 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 62.2 tttp . . . . . 0 C--O 1.254 1.303 0 C-N-CA 123.14 0.576 . . . . 74.32 109.95 -173.692 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' G' G ' 450' ' ' ASN . . . . . 0.531 HD21 ' N ' ' G' ' 450' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 121.679 0.752 . . . . 64.41 109.46 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 451' ' ' VAL . . . . . 0.539 HG23 HG23 ' G' ' 452' ' ' VAL . 7.9 m -153.78 -165.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.775 1.23 . . . . 62.54 109.97 -173.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 452' ' ' VAL . . . . . 0.539 HG23 HG23 ' G' ' 451' ' ' VAL . 60.4 t 67.69 116.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.28 0 C-N-CA 126.219 1.807 . . . . 75.15 111.124 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 162.7 63.55 0.02 OUTLIER Glycine 0 C--N 1.345 1.066 0 N-CA-C 111.67 -0.572 . . . . 60.42 111.67 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 7.1 mp -95.5 109.76 21.92 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.21 -1.033 . . . . 42.21 108.21 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 23.0 p -58.92 -48.62 80.8 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.622 0.769 . . . . 64.33 111.693 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -119.4 156.29 30.41 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.17 0.588 . . . . 74.25 110.598 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -122.22 2.99 9.82 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.951 1.3 . . . . 74.02 109.952 168.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 20.5 m -76.33 140.96 41.69 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.27 1.028 . . . . 75.02 110.817 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 70.77 131.4 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.663 1.585 . . . . 75.42 111.931 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 460' ' ' LEU . . . . . 0.417 HD12 HD22 ' C' ' 44' ' ' LEU . 0.1 OUTLIER -151.19 101.41 2.85 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 106.833 -1.543 . . . . 74.35 106.833 166.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.85 154.1 12.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.152 1.381 . . . . 72.14 113.312 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -149.55 87.29 1.5 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.458 -1.312 . . . . 74.31 107.458 171.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 11.9 t -85.43 14.32 5.61 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.854 0.861 . . . . 73.13 112.363 -168.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 464' ' ' MET . . . . . 0.45 ' SD ' ' HB3' ' C' ' 129' ' ' ALA . 55.4 ttp -66.75 95.4 0.35 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.482 -0.562 . . . . 43.13 109.482 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -66.07 -20.82 66.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.638 1.175 . . . . 75.14 111.372 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -59.02 -21.4 59.01 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 124.026 0.931 . . . . 74.41 111.519 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 467' ' ' ALA . . . . . 0.412 ' HA ' HD23 ' C' ' 42' ' ' LEU . . . 53.71 83.01 0.08 Allowed 'General case' 0 C--N 1.364 1.207 0 C-N-CA 125.189 1.395 . . . . 72.1 111.506 173.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 468' ' ' LEU . . . . . 0.751 HD13 HG13 ' C' ' 64' ' ' VAL . 96.1 mt 56.75 -83.02 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.462 1.105 . . . . 73.33 112.54 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.72 -148.14 11.61 Favored Glycine 0 C--O 1.239 0.41 0 N-CA-C 109.653 -1.379 . . . . 44.44 109.653 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 470' ' ' LEU . . . . . 0.48 HD12 ' HE1' ' C' ' 36' ' ' TRP . 2.6 mm? 70.36 -21.56 0.18 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 125.289 1.436 . . . . 72.21 114.009 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 125.369 1.468 . . . . 72.24 112.108 171.946 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 7.7 p30 . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 121.345 0.593 . . . . 72.23 109.929 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' H' H ' 451' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' D' ' 87' ' ' ALA . 69.6 t -99.49 -13.27 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.729 0.811 . . . . 73.31 109.4 170.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 452' ' ' VAL . . . . . . . . . . . . . 25.3 m -112.17 159.0 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.505 0.722 . . . . 72.4 111.126 -176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 453' ' ' GLY . . . . . 0.46 ' H ' ' HE2' ' D' ' 56' ' ' TYR . . . 116.22 50.89 0.41 Allowed Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.706 -0.679 . . . . 70.52 112.294 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 454' ' ' LEU . . . . . 0.548 HD22 HD23 ' D' ' 98' ' ' LEU . 59.9 tp -73.38 142.43 47.0 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.917 0.487 . . . . 61.15 110.341 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 22.5 p -73.04 82.77 1.25 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.849 -0.797 . . . . 65.22 108.849 168.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.35 131.13 47.27 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.442 -0.799 . . . . 42.24 110.918 -176.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.98 128.31 11.3 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.119 -1.437 . . . . 70.03 107.119 -175.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 47.7 p -73.31 -54.1 9.19 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.922 0.489 . . . . 64.31 111.417 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.85 117.55 5.15 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.017 0.927 . . . . 55.11 110.757 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.99 128.1 35.64 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.09 0.472 . . . . 75.32 110.075 -170.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 461' ' ' PHE . . . . . 0.45 ' HZ ' ' HD1' ' D' ' 137' ' ' PHE . 21.3 p90 -51.82 144.39 11.44 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.256 1.823 . . . . 70.53 112.23 173.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 462' ' ' TYR . . . . . 0.456 ' CD1' HD22 ' D' ' 44' ' ' LEU . 14.8 t80 -147.94 63.14 1.12 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.368 -0.975 . . . . 72.22 108.368 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 42.8 p -77.56 80.93 4.03 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.752 -1.113 . . . . 71.52 109.778 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 59.8 mtp -126.98 153.47 45.84 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.99 0.916 . . . . 74.24 110.396 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -131.44 174.89 9.62 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 114.249 -1.341 . . . . 75.32 108.626 174.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . 64.49 -77.19 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.568 1.147 . . . . 75.23 110.9 -173.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . 70.78 -64.48 0.37 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.516 1.526 . . . . 63.24 111.777 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 468' ' ' LEU . . . . . 0.523 ' HB3' HD22 ' H' ' 470' ' ' LEU . 7.2 tt -147.49 147.58 30.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 106.364 -1.717 . . . . 62.44 106.364 171.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 469' ' ' GLY . . . . . 0.464 ' N ' HD23 ' H' ' 468' ' ' LEU . . . -76.47 75.05 1.65 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 123.073 0.233 . . . . 72.14 113.127 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 470' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' H' ' 468' ' ' LEU . 1.7 pt? -146.33 150.62 36.08 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.582 0.753 . . . . 65.02 110.065 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 471' ' ' LYS . . . . . 0.442 ' H ' ' HZ2' ' D' ' 36' ' ' TRP . 10.0 mtmp? . . . . . 0 C--O 1.253 1.266 0 N-CA-C 107.02 -1.474 . . . . 70.31 107.02 168.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.399 -0.593 . . . . 64.34 109.399 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.4 m -84.66 15.24 3.95 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.481 0.919 . . . . 64.54 113.481 -168.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -72.18 90.53 1.22 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.662 -0.496 . . . . 75.34 109.662 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -89.46 161.36 16.3 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.404 -0.816 . . . . 75.44 109.696 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -72.98 -70.9 0.33 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.275 -1.009 . . . . 72.22 108.275 171.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 61.35 -65.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.856 1.662 . . . . 74.51 114.028 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 m -39.43 125.64 1.72 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.055 1.742 . . . . 71.32 112.491 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -61.63 -37.38 83.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.449 1.1 . . . . 72.43 110.435 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.411 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.4 mpt? -74.58 164.0 27.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.549 -1.205 . . . . 73.41 109.921 171.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m -140.21 127.7 21.46 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.985 -1.117 . . . . 52.11 107.985 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -137.81 134.92 35.76 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.529 -0.915 . . . . 73.34 108.529 172.583 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -149.96 110.96 4.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.215 -1.032 . . . . 65.42 108.215 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.443 HG21 ' HG2' ' C' ' 130' ' ' PRO . 32.7 mt -78.14 110.38 13.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.59 -0.892 . . . . 73.55 108.59 176.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -80.08 -32.62 39.26 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.957 -1.02 . . . . 74.0 110.175 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -177.44 126.25 0.14 Allowed 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.375 0.422 . . . . 74.14 110.415 -172.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.435 HD12 ' HG3' ' C' ' 130' ' ' PRO . 93.8 mt -113.52 130.99 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.424 -0.954 . . . . 72.15 108.424 169.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -160.18 154.31 23.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.334 1.054 . . . . 54.1 109.561 -172.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.5 p -79.84 120.27 23.86 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.937 -0.764 . . . . 74.01 108.937 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -81.0 -31.23 34.74 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.04 0.448 . . . . 65.21 109.855 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -153.26 143.57 22.41 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.774 -1.103 . . . . 64.11 109.537 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -133.86 145.1 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.852 1.261 . . . . 72.32 108.122 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -144.82 134.38 23.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.346 0.593 . . . . 73.21 109.471 171.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -134.56 131.13 37.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.184 -1.784 . . . . 75.1 106.184 162.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -134.33 142.07 47.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.974 -0.75 . . . . 63.45 108.974 171.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.45 79.08 55.39 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 106.459 -1.682 . . . . 62.53 106.459 169.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.2 -15.23 35.39 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.486 2.124 . . . . 52.13 110.329 174.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -112.44 28.01 9.15 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.848 1.259 . . . . 74.15 111.139 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.663 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -60.12 -54.54 54.27 Favored Pre-proline 0 CA--C 1.575 1.907 0 CA-C-O 118.933 -0.556 . . . . 72.43 111.344 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.663 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 11.6 Cg_exo -76.48 -14.93 17.85 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 122.192 1.928 . . . . 74.34 113.373 173.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -69.88 -53.28 18.75 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 109.633 -0.506 . . . . 73.53 109.633 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.567 HG11 ' HE1' ' A' ' 123' ' ' PHE . 12.1 p -64.44 -23.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.783 0.833 . . . . 62.01 111.424 -175.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -58.09 -40.4 81.03 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.607 0.763 . . . . 64.43 110.4 171.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -90.64 -30.3 17.24 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.327 1.051 . . . . 72.02 111.021 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 14.1 mmmm -84.0 172.16 12.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.275 1.03 . . . . 71.11 111.38 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.453 ' HB2' HE21 ' A' ' 37' ' ' GLN . 1.6 m-20 -89.23 148.59 23.52 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.675 0.79 . . . . 71.54 109.818 172.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.404 ' CZ2' ' HG3' ' A' ' 38' ' ' PRO . 68.8 t-105 -79.59 90.94 5.15 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.234 0.614 . . . . 74.42 109.761 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.453 HE21 ' HB2' ' A' ' 35' ' ' ASP . 46.5 mt-30 -132.37 42.03 0.81 Allowed Pre-proline 0 CA--C 1.574 1.869 0 C-N-CA 123.313 0.645 . . . . 74.54 112.69 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.487 ' HG2' ' HB2' ' E' ' 470' ' ' LEU . 45.0 Cg_endo -81.47 140.03 11.76 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.308 2.006 . . . . 72.4 113.564 -171.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -98.69 99.96 11.13 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.764 -1.199 . . . . 65.23 107.764 168.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' E' ' 467' ' ' ALA . 48.8 t -83.13 93.33 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 115.619 -0.719 . . . . 64.53 109.999 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -78.4 153.03 31.91 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.869 0.366 . . . . 74.25 110.375 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.1 tp -122.2 130.2 52.98 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.387 -0.824 . . . . 60.1 109.969 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -130.98 146.84 52.51 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.562 1.145 . . . . 64.34 107.916 172.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.552 HD22 HD21 ' A' ' 60' ' ' LEU . 85.2 mt -129.53 148.53 51.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.468 0.707 . . . . 62.32 109.845 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.713 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 14.9 m-20 -132.48 140.14 48.25 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.183 0.993 . . . . 71.44 109.1 172.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.735 ' H ' HD21 ' E' ' 460' ' ' LEU . 24.0 m -108.22 126.2 52.53 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.062 1.345 . . . . 54.43 108.488 174.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.16 146.16 51.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.593 0.757 . . . . 54.45 109.163 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.5 m -134.45 158.51 43.72 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.847 0.459 . . . . 70.11 111.045 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 40.2 t -154.44 129.49 9.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.451 1.1 . . . . 71.31 108.605 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -84.48 107.75 16.9 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.15 -0.685 . . . . 51.13 109.15 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.0 mt -79.57 -38.43 34.1 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.986 0.515 . . . . 55.44 110.372 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.19 -177.03 6.25 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.495 -0.775 . . . . 74.22 110.315 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.13 111.82 2.37 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.875 0.87 . . . . 64.45 109.95 174.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 65.28 17.23 10.92 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.053 1.341 . . . . 75.11 112.873 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.79 116.7 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.223 -1.029 . . . . 71.02 108.223 169.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -110.7 167.57 10.13 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.603 1.192 . . . . 71.45 111.501 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 9.6 tp10 -128.78 126.43 39.92 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 112.393 -2.185 . . . . 50.11 105.661 169.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.24 131.27 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 107.482 -1.303 . . . . 62.32 107.482 173.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 21.9 t -119.49 115.52 47.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 124.128 0.971 . . . . 54.23 108.656 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.552 HD21 HD22 ' A' ' 44' ' ' LEU . 3.7 tt -88.19 98.01 11.32 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.322 -1.733 . . . . 64.31 106.322 167.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.713 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 46.8 ttt-85 -85.61 101.97 13.16 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.952 -1.129 . . . . 65.41 107.952 174.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.486 HG11 ' HB1' ' A' ' 110' ' ' ALA . 2.3 p -105.02 124.26 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.294 0.637 . . . . 41.22 110.291 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.0 m -108.13 130.84 55.09 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 123.846 0.858 . . . . 74.32 109.593 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.41 ' O ' HD12 ' A' ' 75' ' ' LEU . 45.9 t -126.32 122.65 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.02 1.328 . . . . 74.13 107.973 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 t -128.88 120.59 26.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.018 0.527 . . . . 71.54 109.68 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -105.15 110.18 22.45 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.589 -0.893 . . . . 41.54 108.589 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.3 p -124.88 126.89 46.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.862 0.465 . . . . 74.14 111.403 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.521 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -104.62 84.78 2.22 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.806 -1.183 . . . . 52.23 107.806 166.843 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.94 -117.32 5.08 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.386 -0.824 . . . . 23.02 111.846 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -87.94 -23.22 23.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.056 0.542 . . . . 71.23 109.889 175.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.53 134.87 35.57 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.026 0.93 . . . . 74.22 110.725 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.3 m -83.15 154.37 24.33 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.072 0.949 . . . . 73.5 109.148 168.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.9 -61.18 1.4 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.197 -1.038 . . . . 51.31 108.197 164.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -151.07 170.36 19.58 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.53 -1.214 . . . . 73.51 110.722 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 64' ' ' VAL . 51.2 tp -138.83 129.22 25.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.043 1.337 . . . . 64.45 107.729 177.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.3 m -136.07 117.6 14.83 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.809 0.844 . . . . 74.15 108.761 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -138.79 115.38 10.59 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.274 -0.639 . . . . 61.33 109.274 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.7 t -123.99 115.72 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.202 1.001 . . . . 62.41 109.498 -171.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.631 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 17.3 mt-30 -87.85 82.43 7.3 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.156 -1.053 . . . . 73.44 108.156 169.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -76.4 115.5 16.2 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.022 -1.103 . . . . 73.2 108.022 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.14 170.85 13.59 Favored Glycine 0 C--O 1.242 0.618 0 CA-C-O 121.227 0.348 . . . . 64.1 112.255 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.51 136.05 3.97 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.144 -0.528 . . . . 74.33 112.0 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.5 mt -81.1 122.84 36.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 108.131 -1.063 . . . . 72.43 108.131 169.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.496 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.3 m-85 -130.95 118.49 20.74 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.717 -0.846 . . . . 71.12 108.717 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.5 p -94.98 118.11 31.27 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.896 -0.779 . . . . 74.24 108.896 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.416 ' HB ' HD11 ' A' ' 89' ' ' ILE . 2.8 pp -128.55 157.11 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.137 0.975 . . . . 31.2 110.624 -174.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.48 154.01 13.71 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.975 0.91 . . . . 74.32 109.947 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.4 9.63 61.51 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 113.752 0.261 . . . . 73.32 113.752 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.629 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -133.19 145.09 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.937 0.895 . . . . 65.21 109.934 178.707 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.534 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.6 tt0 -156.13 174.13 15.82 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.15 0.58 . . . . 65.41 109.819 177.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.534 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 60.07 -116.94 9.81 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.678 0.656 . . . . 65.34 113.444 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.4 p -71.55 -27.01 62.87 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.745 0.818 . . . . 75.41 110.934 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -71.02 -36.2 72.3 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.762 0.825 . . . . 61.5 110.432 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.414 ' HA ' ' SG ' ' A' ' 97' ' ' CYS . 49.3 ttm -73.11 -37.17 66.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.068 0.547 . . . . 72.43 110.09 175.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 -24.69 66.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.792 -0.64 . . . . 71.43 110.231 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.528 ' NE2' ' HB3' ' A' ' 100' ' ' ALA . 9.8 t-160 -83.38 -25.95 30.91 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.562 0.745 . . . . 44.21 111.204 176.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.629 ' SG ' HG13 ' A' ' 89' ' ' ILE . 74.0 m -56.86 -43.21 80.98 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.004 0.431 . . . . 73.44 110.492 175.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -90.73 -20.74 22.09 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.567 -0.742 . . . . 70.24 111.268 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -38.56 41.8 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 114.071 0.388 . . . . 74.11 114.071 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.528 ' HB3' ' NE2' ' A' ' 96' ' ' HIS . . . -150.88 -47.12 0.12 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 117.508 0.654 . . . . 52.23 112.004 -175.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.413 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 31.2 t80 -45.08 -70.24 0.11 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 126.053 1.741 . . . . 74.42 112.865 -175.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.1 m -81.29 -34.53 0.73 Allowed Pre-proline 0 CA--C 1.572 1.79 0 N-CA-C 115.462 1.653 . . . . 64.24 115.462 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.447 ' O ' HD12 ' A' ' 60' ' ' LEU . 37.4 Cg_endo -63.88 -34.74 59.27 Favored 'Trans proline' 0 C--N 1.399 3.231 0 CA-C-N 122.701 2.0 . . . . 61.32 112.619 175.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -66.56 -26.62 67.21 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 120.716 0.293 . . . . 60.22 111.299 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.06 -43.44 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.67 0.788 . . . . 75.53 110.18 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.03 -14.66 59.42 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.061 0.944 . . . . 74.34 112.479 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.16 -49.38 84.93 Favored Pre-proline 0 CA--C 1.565 1.555 0 N-CA-C 113.486 0.921 . . . . 74.44 113.486 -171.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.1 -32.3 75.09 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 121.929 1.753 . . . . 71.34 112.572 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -74.48 -37.63 63.13 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.694 0.798 . . . . 71.02 111.58 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.486 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -70.26 -45.15 67.02 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.843 0.457 . . . . 54.34 110.099 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.41 ' NH1' HD12 ' C' ' 105' ' ' ILE . 31.9 ttm180 -54.2 -47.73 71.79 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.365 1.041 . . . . 64.12 110.342 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.27 -46.38 89.06 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.139 0.9 . . . . 74.02 111.725 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 117' ' ' MET . 37.1 t -59.81 -38.39 81.82 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.408 0.683 . . . . 72.44 110.537 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.2 mt -70.82 -47.84 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.034 0.934 . . . . 73.35 110.896 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -54.41 -38.16 65.91 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.791 0.836 . . . . 74.1 110.343 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.6 t -65.86 -47.01 76.34 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.325 -1.307 . . . . 75.53 110.253 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 34.0 mmt -57.18 -48.21 79.32 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.159 0.583 . . . . 71.32 111.246 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 114' ' ' ILE . 58.6 t -64.27 -48.63 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.443 1.097 . . . . 72.03 111.046 -175.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -69.97 -29.57 66.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.33 0.652 . . . . 74.23 112.209 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -71.11 -28.33 64.23 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.832 0.453 . . . . 75.4 110.255 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.48 7.97 66.65 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-O 119.755 -0.469 . . . . 55.34 113.126 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.492 ' HB ' HH21 ' B' ' 15' ' ' ARG . 15.7 m 68.28 15.01 9.3 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.776 1.231 . . . . 72.14 111.245 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.567 ' HE1' HG11 ' A' ' 31' ' ' VAL . 63.6 m-85 -89.54 144.5 32.12 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.451 -0.944 . . . . 72.12 108.451 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.37 142.89 88.12 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.822 2.348 . . . . 65.34 111.898 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.25 138.45 16.47 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.391 1.076 . . . . 70.31 112.486 -175.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.1 tp -115.6 103.03 10.31 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.732 -1.122 . . . . 60.33 110.062 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -111.47 96.85 6.35 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.044 -1.095 . . . . 73.3 108.044 168.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.9 151.28 47.86 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.422 -0.808 . . . . 73.5 110.056 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.69 145.72 95.21 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.745 0.818 . . . . 74.3 111.73 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -57.68 127.62 26.0 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.832 2.355 . . . . 73.44 112.657 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 93.8 t -102.04 115.97 44.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 124.457 1.103 . . . . 71.14 109.243 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -84.86 93.62 8.55 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.521 -0.918 . . . . 72.53 108.521 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -65.06 -27.36 68.73 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.657 0.783 . . . . 73.02 111.801 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -66.72 -47.15 73.21 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.935 0.494 . . . . 72.43 110.175 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.04 -50.88 71.92 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.114 0.884 . . . . 73.24 109.912 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.479 ' HB3' ' CD1' ' E' ' 461' ' ' PHE . 52.2 mt -62.29 -38.42 89.3 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.647 -1.16 . . . . 72.41 112.343 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.564 ' CE1' HD22 ' A' ' 141' ' ' LEU . 30.2 t80 -65.82 -46.78 77.33 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.361 0.665 . . . . 74.41 110.472 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.404 ' SD ' HD23 ' A' ' 141' ' ' LEU . 94.2 mmm -70.62 -26.76 63.63 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.913 -0.585 . . . . 71.03 110.624 -175.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 93.4 m-20 -58.57 -38.9 78.86 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.719 0.808 . . . . 73.52 111.014 171.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.567 ' HB2' ' HB3' ' E' ' 461' ' ' PHE . 0.4 OUTLIER -70.61 -48.01 57.27 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.522 1.129 . . . . 73.42 111.048 173.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.564 HD22 ' CE1' ' A' ' 137' ' ' PHE . 23.0 tp -70.13 -38.89 75.65 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 113.941 -1.481 . . . . 64.22 113.626 -166.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -158.24 5.02 0.12 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.442 0.697 . . . . 74.24 111.442 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 28.6 tt0 62.92 -153.29 0.34 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.222 1.009 . . . . 75.45 108.957 -165.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.496 ' H ' ' HG2' ' A' ' 143' ' ' GLN . 78.2 mt-30 65.49 82.98 0.17 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.823 0.849 . . . . 74.42 111.221 171.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.22 62.91 7.71 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 122.172 0.987 . . . . 72.34 109.135 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.33 -163.56 31.66 Favored Glycine 0 C--O 1.243 0.69 0 CA-C-N 114.307 -1.315 . . . . 73.13 111.322 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 56.53 -90.7 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.502 1.121 . . . . 72.21 109.813 -170.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 55.92 27.6 51.08 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 115.047 0.779 . . . . 64.45 115.047 172.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -147.19 160.57 42.31 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.383 0.673 . . . . 63.32 110.185 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -152.29 138.52 18.37 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.807 0.843 . . . . 73.22 109.251 175.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -107.09 139.93 40.73 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.994 0.918 . . . . 62.4 109.163 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -132.02 21.95 4.52 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.829 0.852 . . . . 73.01 112.081 -169.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -84.51 55.39 3.37 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.546 0.689 . . . . 71.41 112.042 -177.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.81 104.37 2.88 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.037 0.535 . . . . 64.24 109.95 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.274 0 C-N-CA 123.942 0.897 . . . . 60.01 110.414 179.224 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 109.873 -0.417 . . . . 72.51 109.873 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.9 m -146.66 -171.31 3.72 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.537 1.135 . . . . 60.13 109.702 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' B' ' 4' ' ' GLN . 14.6 tt0 -138.9 172.15 13.28 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.643 0.777 . . . . 61.23 109.058 175.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.481 ' H ' ' HG2' ' B' ' 3' ' ' GLU . 37.0 mt-30 -81.24 -23.69 37.88 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.446 0.698 . . . . 73.23 109.949 175.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 17.8 m120 70.38 95.3 0.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.559 1.544 . . . . 55.32 113.1 172.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -77.09 86.64 3.58 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.294 0.638 . . . . 72.4 109.505 172.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 14.4 t -161.7 176.7 10.67 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.677 0.791 . . . . 73.13 109.898 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.7 123.11 17.04 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.192 -1.04 . . . . 63.35 108.192 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.6 ptm 46.74 -168.46 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.548 1.539 . . . . 75.44 112.784 -171.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 56.0 m -147.57 129.09 14.98 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.875 -1.157 . . . . 72.34 107.875 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -147.37 140.97 25.54 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.801 -0.814 . . . . 72.3 108.801 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -153.0 141.21 20.5 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.17 -0.678 . . . . 62.11 109.17 175.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 mt -85.86 121.26 37.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.179 -1.045 . . . . 71.34 108.179 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -88.08 -42.45 12.38 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.527 0.517 . . . . 63.52 109.931 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.492 HH21 ' HB ' ' A' ' 122' ' ' THR . 65.5 ttt180 -167.8 133.76 2.01 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.765 -0.652 . . . . 74.21 109.695 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.0 mt -115.15 140.48 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.025 -1.472 . . . . 60.2 107.025 168.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.497 ' CE2' ' HB1' ' A' ' 28' ' ' ALA . 34.8 p90 -164.25 158.34 18.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.881 0.848 . . . . 74.24 111.544 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 96.9 m -83.6 120.84 26.45 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.43 -1.259 . . . . 74.24 108.545 171.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.412 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 35.8 mtpt -88.43 -33.38 17.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.44 0.696 . . . . 74.32 110.423 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.5 t70 -150.82 135.94 17.62 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.739 -0.664 . . . . 72.3 110.826 -171.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.42 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.2 mm -127.98 139.79 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.617 1.167 . . . . 74.12 108.678 166.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 43.5 t -140.93 131.34 25.21 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.077 -1.083 . . . . 72.54 108.077 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -141.89 115.4 9.01 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.861 -1.163 . . . . 54.13 107.861 170.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 36.5 mt-10 -118.26 112.54 20.22 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.902 -1.148 . . . . 60.24 107.902 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.487 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.83 83.23 1.22 Allowed Pre-proline 0 C--O 1.24 0.575 0 N-CA-C 106.311 -1.737 . . . . 72.1 106.311 164.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.91 -13.74 29.25 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 122.459 2.106 . . . . 74.23 112.139 -171.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -123.59 12.48 9.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.075 0.95 . . . . 61.42 110.774 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.512 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -34.86 -62.7 0.4 Allowed Pre-proline 0 N--CA 1.501 2.096 0 N-CA-C 114.456 1.28 . . . . 74.1 114.456 -170.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 25.9 Cg_exo -61.18 -36.3 81.35 Favored 'Trans proline' 0 C--N 1.396 3.067 0 C-N-CA 122.154 1.903 . . . . 61.32 113.429 -174.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -92.1 -18.8 23.06 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.891 0.7 . . . . 74.4 112.891 -173.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.717 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.6 p -83.12 -19.91 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 118.69 0.677 . . . . 72.14 111.422 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -67.91 -14.38 62.92 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 112.94 0.719 . . . . 72.33 112.94 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.489 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.8 pt20 -60.49 -26.32 66.73 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.125 0.488 . . . . 41.41 110.371 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.489 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 88.2 mttt -101.66 87.65 3.21 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.535 1.134 . . . . 73.51 108.728 175.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -79.54 101.98 8.57 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.315 -0.624 . . . . 71.33 109.315 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -172.66 158.01 3.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.48 1.112 . . . . 74.11 108.877 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.533 ' HG2' ' HB2' ' B' ' 124' ' ' PRO . 47.6 mt-30 -64.65 107.59 1.47 Allowed Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.948 0.899 . . . . 74.14 109.123 168.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.61 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.7 Cg_endo -59.14 160.86 17.67 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 123.351 2.7 . . . . 71.55 113.653 -176.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -59.81 103.02 0.18 Allowed 'General case' 0 C--N 1.35 0.614 0 N-CA-C 107.722 -1.214 . . . . 71.32 107.722 169.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.0 m -91.55 161.22 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.3 -0.864 . . . . 65.04 110.509 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -135.71 113.75 11.27 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.398 -1.334 . . . . 75.12 107.398 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.592 HD12 ' HB3' ' F' ' 468' ' ' LEU . 4.1 tt -85.2 126.2 33.46 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.692 -1.595 . . . . 73.33 106.692 173.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.72 144.79 26.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.942 -1.132 . . . . 52.35 107.942 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -146.63 160.02 42.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.061 0.544 . . . . 52.35 110.145 174.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -143.65 150.17 38.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.037 0.935 . . . . 63.3 109.335 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -125.52 115.26 19.93 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.007 0.923 . . . . 73.51 109.85 -174.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.02 161.66 19.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.479 1.112 . . . . 60.11 108.501 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 77.4 p -145.37 162.84 36.3 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.538 0.335 . . . . 64.11 110.351 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -154.49 136.19 14.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.684 0.794 . . . . 75.24 109.543 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -89.89 116.06 27.68 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.924 -0.398 . . . . 73.13 109.924 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 24.5 mt -80.25 -52.15 8.07 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.146 0.978 . . . . 72.54 110.741 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.32 -168.53 2.56 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.42 1.088 . . . . 73.42 109.013 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -63.05 100.8 0.23 Allowed 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.492 0.495 . . . . 73.12 110.205 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 63.62 16.16 9.47 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.064 1.345 . . . . 75.25 113.227 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 69.1 t -103.44 101.12 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 105.065 -2.198 . . . . 62.05 105.065 167.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -118.97 168.93 10.34 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.388 -0.967 . . . . 73.3 108.388 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -144.9 111.86 5.91 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.433 -0.951 . . . . 62.31 108.433 -171.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -96.27 137.78 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 O-C-N 124.029 0.831 . . . . 61.32 109.471 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 37.3 t -113.48 117.64 56.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.808 0.843 . . . . 64.35 109.274 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.39 110.73 23.23 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.317 -1.364 . . . . 75.31 107.317 173.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -100.31 128.85 46.28 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.794 -0.817 . . . . 74.13 108.794 173.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.52 ' HB ' HD11 ' B' ' 114' ' ' ILE . 11.4 t -126.91 123.7 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.024 -1.102 . . . . 65.12 108.024 172.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -118.81 134.52 55.1 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.704 0.802 . . . . 72.1 110.807 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.432 HG21 HG21 ' B' ' 114' ' ' ILE . 66.8 t -120.26 101.77 11.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.488 1.515 . . . . 74.22 108.452 177.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 90.5 m -84.65 135.28 34.24 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.883 -1.155 . . . . 70.21 107.883 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.22 141.48 26.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.935 0.334 . . . . 63.1 111.325 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.469 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 58.2 p -148.84 135.3 19.49 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.226 0.61 . . . . 65.31 111.341 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.61 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 24.1 mt -96.67 115.3 27.21 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 124.395 1.078 . . . . 73.23 109.995 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.32 -108.44 2.36 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 115.477 -0.783 . . . . 61.51 112.492 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -116.19 2.1 13.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.404 0.681 . . . . 52.21 110.982 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -116.2 145.28 43.23 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.438 -0.578 . . . . 71.32 109.438 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 51.2 m -64.74 135.91 56.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.972 0.509 . . . . 63.35 110.778 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.717 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.29 -64.26 1.13 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.339 -0.986 . . . . 55.22 108.339 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -154.11 154.7 34.07 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.79 -1.096 . . . . 62.42 109.827 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.41 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 41.6 mt -131.95 108.7 9.55 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.917 -1.883 . . . . 73.54 105.917 176.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.4 t -118.26 143.38 46.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.48 -0.933 . . . . 74.2 108.48 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -157.14 129.31 7.29 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.627 -0.879 . . . . 72.43 108.627 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' B' ' 113' ' ' CYS . 81.1 t -123.42 146.35 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.638 0.775 . . . . 65.11 109.148 176.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.2 mt-30 -123.58 96.17 4.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.405 -0.961 . . . . 64.21 108.405 169.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.0 tp-100 -86.47 99.52 11.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.503 -0.925 . . . . 74.15 108.503 174.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.23 167.96 33.34 Favored Glycine 0 C--O 1.244 0.734 0 N-CA-C 110.906 -0.877 . . . . 42.44 110.906 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.19 125.46 1.42 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 112.299 -0.32 . . . . 74.11 112.299 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 53.0 mt -85.85 128.91 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.02 0.928 . . . . 70.52 108.982 172.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -134.62 158.87 42.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.617 1.167 . . . . 74.42 108.366 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.6 m -131.83 129.26 40.23 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.854 -0.795 . . . . 63.41 108.854 171.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 13.9 tt -139.9 145.54 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.093 0.557 . . . . 55.11 110.686 -175.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.17 164.24 34.54 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.45 1.1 . . . . 70.21 109.162 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.21 -25.23 15.3 Favored Glycine 0 N--CA 1.475 1.264 0 CA-C-O 121.039 0.244 . . . . 15.11 112.502 -175.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 17.3 tt -88.91 133.03 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.722 1.209 . . . . 72.34 111.849 -167.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -149.6 -176.47 5.42 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.193 1.397 . . . . 65.01 109.219 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.05 -134.11 27.01 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 114.897 -1.047 . . . . 61.32 113.162 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 61.0 m -73.39 -29.19 62.44 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.175 0.99 . . . . 74.25 111.417 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -57.96 -33.34 68.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.562 0.745 . . . . 64.11 111.863 -171.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 22.9 ptm -60.4 -39.84 88.78 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.705 0.802 . . . . 73.21 111.194 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.81 -32.45 59.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.834 0.854 . . . . 54.23 110.319 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -68.57 -28.3 66.84 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.014 -0.994 . . . . 72.55 111.303 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.498 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 48.9 t -75.4 -66.61 0.75 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.089 0.555 . . . . 74.2 110.162 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.95 -26.42 65.05 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.123 0.569 . . . . 73.3 111.967 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.87 -9.8 62.1 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-O 119.489 -0.617 . . . . 60.03 114.462 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.59 -56.21 0.13 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.818 0.809 . . . . 60.21 113.177 -167.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 92.7 t80 -67.6 -49.48 62.91 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.366 0.667 . . . . 72.32 111.899 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.486 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.1 m -61.96 -51.51 74.66 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.646 0.779 . . . . 74.2 111.604 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 89.0 Cg_exo -53.5 -35.34 75.97 Favored 'Trans proline' 0 C--N 1.4 3.262 0 C-N-CA 122.547 2.165 . . . . 64.4 114.332 172.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -58.63 -43.87 89.83 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 123.359 0.664 . . . . 63.23 110.612 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mt -59.71 -41.0 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.167 0.987 . . . . 73.31 110.912 177.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 46.9 mt -84.5 -17.05 40.29 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.236 1.014 . . . . 73.45 112.207 -172.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -58.83 -50.07 89.97 Favored Pre-proline 0 CA--C 1.556 1.182 0 N-CA-C 114.02 1.119 . . . . 73.35 114.02 -170.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.49 -34.33 92.95 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.03 1.82 . . . . 62.44 113.12 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.504 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 74.4 m-85 -65.69 -50.45 64.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.001 0.52 . . . . 74.4 110.091 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.16 81.47 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.818 0.847 . . . . 70.13 111.197 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.414 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 36.0 ttt180 -63.89 -53.5 49.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.409 1.483 . . . . 73.03 111.18 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.92 -38.43 90.96 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.874 0.734 . . . . 75.12 109.71 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.454 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.2 t -66.63 -36.66 83.11 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.511 -0.768 . . . . 71.32 111.958 -174.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.52 HD11 ' HB ' ' B' ' 62' ' ' VAL . 66.3 mt -62.11 -56.59 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 109.104 -0.702 . . . . 71.41 109.104 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.8 m -60.85 -25.61 66.78 Favored 'General case' 0 CA--C 1.556 1.21 0 O-C-N 124.334 1.021 . . . . 70.04 111.648 -173.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.9 t -68.3 -46.19 70.98 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.7 0.8 . . . . 75.11 110.261 175.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 7.9 mmt -72.54 -34.65 67.69 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.89 0.476 . . . . 74.12 111.063 -177.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 114' ' ' ILE . 93.8 t -57.53 -44.22 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.231 1.013 . . . . 73.42 109.567 171.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.5 t -70.74 -30.88 67.53 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.427 -1.26 . . . . 72.51 112.07 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' B' ' 116' ' ' SER . 89.1 mtt-85 -69.8 -36.03 75.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.983 0.513 . . . . 63.1 110.036 177.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.64 1.95 84.34 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.592 0.558 . . . . 54.52 112.559 171.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 26.7 p 62.18 30.77 17.75 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.687 1.995 . . . . 73.24 113.0 172.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -85.16 155.05 60.63 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.667 0.787 . . . . 74.2 110.095 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.533 ' HB2' ' HG2' ' B' ' 37' ' ' GLN . 48.0 Cg_exo -57.15 168.82 2.38 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.231 2.621 . . . . 74.1 114.537 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.417 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 63.9 tp60 -56.85 133.42 54.44 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.573 1.149 . . . . 75.14 112.065 -172.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.47 102.48 6.65 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.269 -1.012 . . . . 53.13 108.269 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.53 101.31 12.21 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.611 0.764 . . . . 74.5 109.553 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.414 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 0.2 OUTLIER -61.28 129.35 40.83 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 109.259 -0.645 . . . . 71.23 109.259 179.451 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.684 ' HB3' ' SD ' ' F' ' 464' ' ' MET . . . -77.64 152.13 80.47 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 123.625 0.77 . . . . 64.55 111.941 -173.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.426 ' HG2' ' HB ' ' D' ' 13' ' ' ILE . 6.2 Cg_endo -81.26 109.69 2.16 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.25 2.633 . . . . 50.23 112.137 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 t -115.06 112.4 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.19 -0.67 . . . . 61.01 109.19 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' B' ' 136' ' ' LEU . 56.2 t-20 -85.24 112.85 21.12 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.905 -0.776 . . . . 74.4 108.905 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -89.86 -27.47 19.9 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.01 0.744 . . . . 72.21 113.01 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -73.77 -42.71 60.68 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 118.602 0.637 . . . . 73.42 111.416 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.2 89.25 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.542 0.737 . . . . 60.15 110.307 172.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' B' ' 132' ' ' ASN . 0.9 OUTLIER -68.78 -33.5 73.98 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.079 0.951 . . . . 75.32 110.25 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.522 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 80.3 t80 -60.69 -35.57 76.61 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.429 0.692 . . . . 74.34 110.767 -175.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 23.4 mmt -62.24 -36.88 83.37 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.044 0.449 . . . . 75.52 111.242 176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -76.28 -29.43 57.4 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.79 0.836 . . . . 72.3 111.017 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -60.13 -32.1 70.69 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.39 1.076 . . . . 75.34 110.965 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 7.0 mt -89.02 11.19 19.0 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.9 0.88 . . . . 72.35 110.864 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 61.85 19.44 10.64 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.071 1.348 . . . . 74.11 111.953 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -85.46 135.09 33.99 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.966 0.507 . . . . 74.31 110.695 -176.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -116.4 105.13 12.17 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.478 -1.304 . . . . 70.12 107.478 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.11 123.91 14.08 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.691 1.196 . . . . 61.21 111.004 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.47 76.2 0.51 Allowed Glycine 0 C--N 1.351 1.385 0 O-C-N 123.958 0.786 . . . . 23.14 112.776 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -164.05 63.55 0.15 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.909 1.284 . . . . 74.14 108.999 -175.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.13 56.84 4.86 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.468 -0.787 . . . . 52.35 112.094 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 5.7 t -116.34 132.97 56.52 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.637 1.175 . . . . 55.42 108.564 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -169.34 158.96 8.42 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.273 -0.64 . . . . 74.33 109.273 -171.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.35 151.74 44.91 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.668 0.747 . . . . 73.35 110.595 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -126.94 4.84 6.54 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.657 -1.156 . . . . 72.32 108.691 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -162.78 149.96 13.25 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 125.034 1.334 . . . . 72.3 108.307 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -74.68 86.77 2.16 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.731 0.776 . . . . 75.15 109.713 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.854 0 CA-C-N 115.541 -0.754 . . . . 44.42 109.491 179.115 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 35.1 ttm . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 108.907 -0.775 . . . . 60.34 108.907 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.1 p -111.6 83.84 1.85 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 107.877 -1.157 . . . . 64.42 107.877 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -102.47 -27.23 12.91 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.849 -1.069 . . . . 73.34 111.719 -169.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -149.31 110.35 4.36 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.252 0.621 . . . . 74.2 109.632 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -152.37 146.63 25.49 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.452 1.101 . . . . 73.15 109.477 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 63.52 15.17 8.62 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.051 1.34 . . . . 73.33 112.837 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 32.2 p -74.31 100.07 3.65 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.605 0.762 . . . . 74.12 109.1 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.55 87.96 0.67 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.851 0.86 . . . . 63.14 111.018 -173.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 27.6 ttt 64.2 114.86 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.681 1.592 . . . . 71.51 112.648 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 90.9 m -101.88 99.67 9.9 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.93 -0.766 . . . . 72.12 108.93 171.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -94.31 140.83 29.29 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.535 -0.757 . . . . 74.35 109.387 175.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -152.63 136.05 15.92 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.536 -0.542 . . . . 65.11 109.536 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.14 127.84 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.517 -0.92 . . . . 74.51 108.517 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.497 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 14.4 mm100 -89.8 -47.47 7.88 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.207 -0.664 . . . . 73.24 109.207 174.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -175.0 134.41 0.34 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.798 -0.637 . . . . 62.23 109.836 -170.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.8 mt -117.34 144.98 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.791 -1.189 . . . . 73.34 107.791 176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.431 ' CE2' ' HG2' ' C' ' 19' ' ' LYS . 36.7 p90 -171.53 161.72 6.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.506 0.669 . . . . 73.24 111.301 -174.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.9 p -88.63 112.51 23.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.876 -1.157 . . . . 73.32 107.876 169.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' C' ' 17' ' ' TYR . 18.1 mttt -67.44 -48.97 65.67 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 122.24 1.019 . . . . 73.21 108.345 171.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.34 133.37 36.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 113.599 -1.637 . . . . 74.13 109.045 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 79.6 mt -124.49 141.31 45.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.692 -1.596 . . . . 60.53 106.692 172.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -153.92 147.61 25.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.398 0.618 . . . . 53.34 110.997 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 81.7 t80 -146.37 132.12 18.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 106.899 -1.519 . . . . 71.42 106.899 169.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -132.54 124.93 29.4 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.729 0.811 . . . . 73.14 109.35 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.41 79.87 29.03 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.06 -1.459 . . . . 54.31 107.06 172.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.72 -26.74 19.05 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.748 2.299 . . . . 71.14 111.569 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -102.43 17.6 23.16 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.283 1.033 . . . . 73.41 110.218 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.419 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -47.96 -59.63 5.53 Favored Pre-proline 0 C--N 1.371 1.512 0 N-CA-C 114.774 1.398 . . . . 62.4 114.774 -166.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 23.7 Cg_exo -61.14 -42.36 36.53 Favored 'Trans proline' 0 C--N 1.393 2.917 0 CA-C-N 121.834 1.691 . . . . 55.04 111.919 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -69.73 -33.16 72.1 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.402 -1.272 . . . . 71.13 112.232 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.699 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.0 p -79.43 -21.6 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 O-C-N 122.094 -0.379 . . . . 63.13 111.867 -176.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -69.83 -22.18 63.31 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.762 0.425 . . . . 61.14 111.742 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -97.29 19.46 13.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.671 0.388 . . . . 74.14 111.295 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.761 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.76 149.83 21.41 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.902 -0.777 . . . . 75.33 108.902 170.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -69.41 129.7 40.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.88 -0.785 . . . . 70.45 108.88 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.401 ' HZ2' HD22 ' G' ' 470' ' ' LEU . 82.6 t90 -68.51 109.72 3.85 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.165 0.586 . . . . 73.34 111.418 -172.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -163.08 70.19 1.93 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.948 0.899 . . . . 54.41 108.879 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -88.52 128.5 2.12 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.94 2.427 . . . . 62.3 112.818 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.442 ' HB3' ' HE2' ' C' ' 41' ' ' LYS . 26.4 mt-10 -84.68 94.96 8.76 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.381 -0.97 . . . . 74.11 108.381 168.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 m -74.7 99.17 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-N 114.419 -1.264 . . . . 64.53 110.314 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' C' ' 39' ' ' GLU . 73.4 mmtt -92.76 103.35 15.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.76 -1.109 . . . . 72.14 108.497 177.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.498 HD21 HG13 ' C' ' 62' ' ' VAL . 7.3 tt -95.04 136.71 35.03 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.913 -0.773 . . . . 74.22 108.913 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -118.4 112.73 20.37 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.253 1.421 . . . . 73.2 107.739 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.571 HD23 HD12 ' G' ' 460' ' ' LEU . 14.7 tp -104.14 133.96 48.2 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.926 -0.768 . . . . 75.11 108.926 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.4 t70 -140.47 149.33 42.4 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.045 0.938 . . . . 70.24 109.153 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.524 ' O ' ' HB3' ' G' ' 457' ' ' GLN . 7.9 m -132.57 130.36 40.21 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 123.505 0.722 . . . . 64.22 109.301 169.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.37 153.23 26.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.933 1.293 . . . . 71.22 108.241 175.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 17.8 p -149.85 140.92 22.97 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.711 -0.477 . . . . 74.4 109.711 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -161.16 150.81 16.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.878 0.871 . . . . 73.31 109.453 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -86.08 132.7 33.98 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.936 -0.394 . . . . 73.1 109.936 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.559 HD11 HD12 ' C' ' 83' ' ' ILE . 50.0 mt -98.88 -38.41 9.04 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.426 0.69 . . . . 74.32 109.269 173.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.63 178.0 10.77 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.229 1.012 . . . . 70.52 109.635 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.89 123.17 17.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.94 0.496 . . . . 73.34 109.891 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 71.38 -8.77 0.98 Allowed 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 126.316 1.846 . . . . 72.05 113.311 -173.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -95.27 97.5 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.77 -0.826 . . . . 61.53 108.77 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.611 ' HE1' ' HA ' ' G' ' 452' ' ' VAL . 0.2 OUTLIER -105.66 124.54 49.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.132 -0.692 . . . . 72.41 109.132 -179.227 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.43 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.4 tt0 -90.16 135.4 33.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.163 0.585 . . . . 74.1 109.715 173.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.34 141.34 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.502 1.121 . . . . 73.35 107.979 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.7 t -127.49 129.27 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 107.662 -1.236 . . . . 74.21 107.662 172.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.17 102.81 11.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.575 -1.269 . . . . 73.01 107.575 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -84.22 127.83 34.19 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.037 -0.983 . . . . 74.41 108.388 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.498 HG13 HD21 ' C' ' 42' ' ' LEU . 40.9 t -124.45 121.06 60.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 107.123 -1.436 . . . . 75.23 107.123 168.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 9.5 m -124.98 115.36 20.44 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.479 -0.563 . . . . 71.14 109.479 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.413 HG23 HD13 ' C' ' 114' ' ' ILE . 81.2 t -99.92 107.96 21.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.298 -1.001 . . . . 62.33 108.298 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 55.6 m -96.18 139.82 31.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.276 -1.75 . . . . 73.54 106.276 169.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.75 116.19 11.99 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.527 -1.286 . . . . 63.12 107.527 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.6 m -127.08 168.39 14.67 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.031 -0.729 . . . . 70.53 109.031 175.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.761 HD13 ' HG2' ' C' ' 34' ' ' LYS . 5.6 mt -123.47 21.41 9.43 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.535 1.134 . . . . 53.3 109.004 -174.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.72 -99.76 1.0 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.66 -1.376 . . . . 64.42 109.66 -166.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -90.89 -31.62 16.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.418 0.687 . . . . 74.15 110.64 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -85.36 120.17 26.54 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.059 0.943 . . . . 63.53 110.875 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 40.5 m -73.55 125.78 28.76 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.744 -0.465 . . . . 63.54 109.744 170.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.699 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.0 -61.86 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.091 0.869 . . . . 41.23 109.003 171.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 74' ' ' PHE . . . . . 0.476 ' HZ ' HD21 ' C' ' 126' ' ' LEU . 54.6 p90 -164.86 176.08 9.03 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.708 0.766 . . . . 71.23 111.739 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -130.41 144.77 51.6 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 106.508 -1.664 . . . . 74.24 106.508 168.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.456 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.8 t -152.47 111.65 3.86 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.085 -0.709 . . . . 64.42 109.085 174.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.69 133.86 55.5 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.822 -0.436 . . . . 62.35 109.822 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 56.1 t -124.95 135.05 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.735 0.814 . . . . 63.2 108.846 168.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -111.99 90.4 3.33 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.835 -1.172 . . . . 64.15 107.835 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.05 96.59 6.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.427 -0.806 . . . . 65.41 109.403 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.63 146.8 20.92 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.218 -0.753 . . . . 73.05 111.218 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.527 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.36 117.5 0.85 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.312 -1.115 . . . . 72.22 110.312 -175.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.559 HD12 HD11 ' C' ' 51' ' ' LEU . 10.7 mm -82.88 126.54 40.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 107.714 -1.217 . . . . 72.42 107.714 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -133.13 121.28 22.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.481 0.713 . . . . 74.44 109.378 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.6 p -85.24 111.07 19.51 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.204 -0.665 . . . . 63.15 109.204 174.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 49.4 pt -114.68 141.17 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.088 0.955 . . . . 71.4 108.975 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -144.95 164.42 31.19 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.399 0.68 . . . . 24.23 110.004 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.75 -55.8 0.72 Allowed Glycine 0 C--N 1.341 0.82 0 O-C-N 123.512 0.508 . . . . 60.11 113.137 172.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.48 170.52 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 112.577 0.584 . . . . 72.43 112.577 -173.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.484 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 17.1 pt-20 -151.97 -172.64 4.28 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.941 0.897 . . . . 70.55 109.819 172.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.49 -137.92 16.96 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-O 119.338 -0.701 . . . . 42.13 113.231 172.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 25.3 p -63.49 -33.58 75.89 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.895 0.878 . . . . 53.22 111.402 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.65 -48.53 81.32 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.242 1.017 . . . . 71.04 110.064 176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.484 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 35.8 ttp -72.97 -30.09 63.57 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.613 -1.176 . . . . 74.31 110.845 176.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.58 -35.13 73.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.912 0.485 . . . . 74.12 110.23 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -78.67 -33.16 47.26 Favored 'General case' 0 C--O 1.242 0.702 0 O-C-N 123.693 0.621 . . . . 63.33 111.827 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 39.8 t -57.23 -39.28 75.18 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.412 0.445 . . . . 31.2 110.442 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.8 mt -95.21 -19.54 19.96 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.794 0.837 . . . . 71.13 110.348 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.99 -29.4 54.32 Favored Glycine 0 C--N 1.349 1.252 0 C-N-CA 123.559 0.6 . . . . 73.42 114.036 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.03 -41.94 0.08 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.601 0.593 . . . . 55.34 112.601 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -61.85 -57.54 11.4 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.222 0.609 . . . . 72.11 111.961 -173.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 97.0 m -66.64 -46.6 57.35 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.927 0.891 . . . . 54.12 112.45 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.58 -35.92 69.14 Favored 'Trans proline' 0 C--N 1.401 3.328 0 C-N-CA 122.428 2.085 . . . . 75.53 113.388 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -67.75 -35.65 79.09 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.763 0.825 . . . . 64.42 110.463 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.41 HD12 ' NH1' ' A' ' 111' ' ' ARG . 46.8 mm -63.73 -39.5 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 122.863 0.465 . . . . 70.4 109.995 174.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.527 HD21 ' HA3' ' C' ' 82' ' ' GLY . 83.2 mt -85.78 -22.82 27.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.098 0.959 . . . . 74.43 112.847 -173.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -60.29 -46.59 97.69 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 124.984 1.314 . . . . 74.52 113.787 -172.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.614 ' HA ' ' HD3' ' C' ' 111' ' ' ARG . 35.2 Cg_exo -63.55 -34.53 63.95 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 122.307 2.005 . . . . 73.31 113.463 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -67.49 -44.59 78.15 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.752 0.421 . . . . 75.43 110.142 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.37 78.49 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 115.285 -0.871 . . . . 61.24 110.891 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.744 ' HG2' ' HG ' ' C' ' 128' ' ' LEU . 21.3 mtp-105 -56.88 -62.32 1.82 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.784 0.833 . . . . 65.42 110.707 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.51 -30.13 71.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.243 0.617 . . . . 71.43 111.286 -172.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.5 t -74.07 -32.85 63.46 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.073 0.549 . . . . 64.31 111.502 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.44 HG23 ' SG ' ' C' ' 76' ' ' CYS . 66.4 mt -73.71 -49.81 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.274 0.63 . . . . 74.22 109.846 172.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 90.6 m -57.26 -37.79 72.88 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.343 1.057 . . . . 75.34 111.407 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -63.72 -48.07 78.54 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.34 -0.846 . . . . 75.21 109.622 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.674 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.59 -37.89 88.0 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.617 1.167 . . . . 65.13 112.991 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.445 HG21 HD11 ' C' ' 126' ' ' LEU . 78.5 t -68.36 -43.28 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.657 0.783 . . . . 72.44 110.611 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -66.19 -30.42 70.89 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 115.018 -0.992 . . . . 72.34 110.604 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -71.86 -34.29 69.1 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 123.69 0.796 . . . . 63.31 109.455 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.69 5.58 77.8 Favored Glycine 0 C--N 1.353 1.484 0 O-C-N 123.73 0.644 . . . . 74.12 113.04 174.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.451 HG23 ' HB3' ' D' ' 17' ' ' TYR . 75.5 p 60.62 23.36 13.13 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.524 1.93 . . . . 72.21 113.974 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.444 ' HB2' HG13 ' C' ' 118' ' ' VAL . 90.1 m-85 -85.06 156.56 60.41 Favored Pre-proline 0 CA--C 1.555 1.145 0 N-CA-C 108.739 -0.837 . . . . 64.02 108.739 170.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.11 155.35 40.05 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.195 2.597 . . . . 53.2 113.129 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.417 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 52.3 mm-40 -60.13 131.39 50.68 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.978 0.911 . . . . 75.12 112.017 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.523 ' HB3' ' HG ' ' G' ' 470' ' ' LEU . 2.9 pp -144.67 126.82 15.63 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.819 0.848 . . . . 71.34 108.809 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -127.7 124.88 38.95 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.537 -1.653 . . . . 63.32 106.537 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.744 ' HG ' ' HG2' ' C' ' 111' ' ' ARG . 0.0 OUTLIER -75.82 130.12 38.08 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.475 -0.565 . . . . 71.5 109.475 -171.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.57 154.39 93.31 Favored Pre-proline 0 CA--C 1.551 1.001 0 O-C-N 124.726 1.266 . . . . 72.31 112.589 -170.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.443 ' HG2' HG21 ' A' ' 13' ' ' ILE . 7.6 Cg_exo -68.79 115.2 3.83 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.372 2.048 . . . . 73.01 111.749 175.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 51.0 t -99.12 134.28 38.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.084 -1.45 . . . . 62.21 107.084 168.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -73.65 73.34 1.49 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.219 0.608 . . . . 65.23 110.358 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -60.75 -39.63 89.45 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.448 0.699 . . . . 74.21 110.656 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' C' ' 138' ' ' MET . 10.7 m-20 -61.61 -49.36 76.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.299 -0.864 . . . . 71.14 111.606 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.49 87.67 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.88 0.737 . . . . 54.2 111.183 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.434 ' HB2' ' HE1' ' G' ' 461' ' ' PHE . 93.8 mt -67.71 -34.8 77.6 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.543 -0.753 . . . . 74.41 111.894 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -79.72 -22.01 43.86 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.663 0.385 . . . . 61.04 110.677 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 66.1 mtt -65.54 -26.54 67.93 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.361 0.664 . . . . 74.21 110.921 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -63.45 -37.79 88.66 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.53 0.732 . . . . 54.21 111.177 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -56.02 -81.0 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.025 0.93 . . . . 74.11 110.674 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 2.3 pp -67.8 -179.6 1.19 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.385 0.674 . . . . 64.52 111.668 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.86 159.3 37.0 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.969 0.508 . . . . 73.11 110.227 176.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.68 -179.73 7.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.884 0.874 . . . . 73.43 110.312 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -146.05 156.17 43.29 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.102 0.961 . . . . 73.24 108.967 171.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.99 147.8 11.55 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.635 0.774 . . . . 63.5 110.015 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.0 60.49 0.48 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.94 -0.464 . . . . 60.43 111.94 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.04 135.54 47.31 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.265 -1.013 . . . . 71.13 108.265 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 169.5 43.13 0.03 OUTLIER Glycine 0 C--N 1.338 0.679 0 N-CA-C 111.066 -0.814 . . . . 72.41 111.066 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.1 t -139.94 132.95 29.46 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.165 0.586 . . . . 71.52 109.969 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.29 -172.04 3.72 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.355 1.062 . . . . 62.32 109.498 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -157.71 112.88 2.72 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.046 -0.724 . . . . 73.24 109.046 172.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -73.57 86.98 1.61 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.974 -0.75 . . . . 71.04 108.974 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -107.69 101.18 10.5 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.331 -0.618 . . . . 74.41 109.331 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -149.51 104.97 3.41 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.46 -0.941 . . . . 64.32 108.46 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 C-N-CA 123.892 0.877 . . . . 74.35 110.011 -179.156 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.823 -0.436 . . . . 74.23 109.823 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 42.0 p -167.95 112.79 0.66 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.31 1.044 . . . . 64.43 109.631 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -66.4 114.78 5.68 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.473 -0.566 . . . . 54.21 109.473 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -172.33 -76.91 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.012 0.925 . . . . 74.21 108.59 -173.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 5' ' ' ASN . . . . . 0.415 ' H ' ' H ' ' D' ' 6' ' ' ASN . 2.5 p-10 -168.96 0.91 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.12 1.768 . . . . 61.43 108.744 173.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 6' ' ' ASN . . . . . 0.415 ' H ' ' H ' ' D' ' 5' ' ' ASN . 5.4 t30 -61.41 152.26 30.19 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 124.249 1.02 . . . . 71.11 108.948 167.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 19.2 m -65.38 88.34 0.08 Allowed 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 121.442 0.639 . . . . 71.35 112.285 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -98.29 -13.66 20.64 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.501 1.12 . . . . 65.3 108.394 166.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.9 tpt -28.44 126.42 0.09 Allowed 'General case' 0 C--N 1.37 1.472 0 C-N-CA 127.318 2.247 . . . . 71.24 113.663 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 61.6 m -129.23 138.79 51.89 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.676 0.79 . . . . 62.52 111.066 -173.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -154.47 93.01 1.55 Allowed 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.579 -1.637 . . . . 74.51 106.579 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -113.23 126.87 55.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.177 -0.675 . . . . 71.42 109.177 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.426 ' HB ' ' HG2' ' B' ' 130' ' ' PRO . 10.2 mt -87.56 119.87 35.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.062 -1.088 . . . . 74.3 108.062 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -85.62 -28.52 24.72 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 123.643 0.589 . . . . 60.43 111.125 -175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -172.4 121.03 0.42 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 110.399 -0.223 . . . . 52.23 110.399 -166.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.4 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.2 mp -106.02 133.49 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 107.328 -1.36 . . . . 74.05 107.328 169.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.451 ' HB3' HG23 ' C' ' 122' ' ' THR . 42.6 p90 -162.63 174.18 12.93 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 122.007 0.908 . . . . 75.44 112.045 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 18' ' ' THR . . . . . 0.511 HG21 HD11 ' D' ' 21' ' ' ILE . 74.9 p -104.57 124.18 48.86 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.188 -1.369 . . . . 65.43 109.188 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 36.4 mtpt -93.86 -18.49 21.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.418 0.687 . . . . 53.24 109.559 177.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.7 t70 -162.12 135.17 6.06 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 124.377 1.071 . . . . 73.52 108.989 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.674 HD13 ' HE3' ' C' ' 117' ' ' MET . 86.8 mt -136.16 133.86 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.602 1.161 . . . . 64.22 108.076 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 57.8 m -137.59 113.46 9.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.413 1.085 . . . . 64.4 109.655 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.521 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 83.8 t80 -116.82 117.12 28.86 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.353 -1.721 . . . . 72.35 106.353 163.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.4 mt-10 -126.3 111.33 14.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.422 0.689 . . . . 72.01 109.357 -175.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.17 87.31 7.17 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.272 -1.01 . . . . 71.25 108.272 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -75.54 -32.61 4.67 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.7 2.267 . . . . 72.31 113.01 -171.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 44.6 m-20 -100.42 9.09 43.11 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.557 0.743 . . . . 71.43 110.161 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.434 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -28.06 -69.79 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 116.18 1.919 . . . . 72.12 116.18 -161.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.405 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 68.4 Cg_endo -77.41 -19.6 13.08 Favored 'Trans proline' 0 C--N 1.383 2.353 0 CA-C-N 123.558 2.306 . . . . 70.22 113.765 -174.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 5.9 t-160 -70.18 -43.07 71.54 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.366 1.066 . . . . 52.34 109.13 173.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.567 HG21 ' HA ' ' D' ' 73' ' ' ALA . 6.3 p -84.28 -15.65 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.81 0.844 . . . . 71.32 111.398 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.405 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.8 m-85 -70.4 -19.69 62.99 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 120.784 0.325 . . . . 54.34 111.38 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -72.66 -12.44 61.04 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.413 -0.812 . . . . 71.31 111.069 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -83.26 84.51 7.47 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.208 1.003 . . . . 64.01 108.885 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -77.46 80.43 3.95 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.457 0.646 . . . . 71.21 109.282 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -156.23 163.8 39.12 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.501 -1.227 . . . . 73.24 108.842 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -89.99 108.18 24.23 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.204 1.002 . . . . 74.12 109.65 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.85 158.09 30.51 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 123.329 2.686 . . . . 73.34 114.302 -174.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.581 ' HB2' ' HB3' ' H' ' 470' ' ' LEU . 8.7 tp10 -79.82 157.31 27.06 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.356 1.062 . . . . 74.45 110.736 177.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.83 118.47 57.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.178 -0.675 . . . . 73.22 109.178 172.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -117.65 114.04 22.79 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.819 0.847 . . . . 51.03 108.832 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.35 126.33 43.82 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.113 0.565 . . . . 72.41 111.034 -172.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -124.97 120.09 30.6 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.959 1.304 . . . . 65.52 107.654 170.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt -110.95 146.03 37.33 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.728 0.411 . . . . 73.33 110.093 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 34.5 t70 -147.82 151.5 36.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.651 1.18 . . . . 75.51 108.342 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -132.16 163.73 27.88 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.735 0.414 . . . . 75.3 110.432 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.673 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.93 175.21 13.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.371 1.068 . . . . 60.1 109.512 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.578 ' HB3' HD21 ' D' ' 98' ' ' LEU . 50.5 p -168.5 157.25 8.69 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.81 0.844 . . . . 61.33 110.573 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 88.5 p -153.2 154.56 34.95 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.962 0.905 . . . . 72.11 109.038 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -94.59 116.97 29.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.728 -0.842 . . . . 75.22 108.728 170.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 42.7 mt -93.38 -30.01 15.32 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 110.02 -0.363 . . . . 73.44 110.02 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.83 -174.84 4.1 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.444 0.698 . . . . 72.42 111.2 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -67.09 116.47 7.94 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.661 -1.154 . . . . 71.44 109.455 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 66.02 5.5 3.56 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.867 1.267 . . . . 73.12 112.567 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 78.8 t -110.18 120.05 60.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 108.545 -0.909 . . . . 75.35 108.545 176.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -135.26 131.27 36.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.752 -0.833 . . . . 73.52 108.752 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -89.81 148.01 23.46 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.698 0.799 . . . . 63.35 109.355 173.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.8 t -125.49 139.87 50.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 124.737 1.215 . . . . 74.23 107.867 170.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.673 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 77.8 t -118.69 135.37 59.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.282 -1.007 . . . . 73.32 108.282 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 121.01 39.39 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.785 -0.82 . . . . 74.54 108.785 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 24.8 ttm-85 -103.38 96.0 6.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.048 -1.093 . . . . 64.22 108.048 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 74.5 t -97.81 119.0 45.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.295 -1.002 . . . . 52.11 108.295 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 14.2 m -119.77 129.87 54.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.846 -1.07 . . . . 55.33 108.541 -172.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 67.2 t -122.47 128.97 75.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 124.837 1.255 . . . . 73.24 108.261 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 95.9 m -122.34 120.63 34.58 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.199 -1.037 . . . . 63.21 108.199 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.71 151.94 39.95 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.472 -0.785 . . . . 75.31 110.08 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.463 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 19.7 p -149.6 125.37 10.47 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.293 -0.867 . . . . 65.41 109.368 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 12.0 mt -92.83 114.21 26.7 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.221 1.008 . . . . 74.31 108.931 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.92 -110.1 2.94 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.966 -0.854 . . . . 75.01 110.966 -174.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 5.94 8.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.013 0.925 . . . . 74.42 110.844 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -123.02 155.41 36.91 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.539 0.736 . . . . 74.32 109.788 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -60.51 129.98 44.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.851 0.86 . . . . 75.41 111.979 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.567 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.96 -72.74 0.55 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.756 -1.201 . . . . 72.04 107.756 176.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -145.57 146.36 31.36 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.216 -0.902 . . . . 73.4 110.217 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.7 mt -114.34 143.58 44.65 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.534 1.134 . . . . 73.45 108.134 175.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.551 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 23.7 m -142.09 137.49 31.03 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.832 0.853 . . . . 72.23 109.232 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -154.41 121.0 5.45 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.799 -1.186 . . . . 72.44 107.799 170.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.7 t -130.8 115.23 29.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.684 -0.858 . . . . 63.02 108.684 -175.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -88.49 85.37 6.84 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.431 -0.952 . . . . 72.21 108.431 172.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -78.61 96.77 5.58 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.248 -1.342 . . . . 62.24 108.771 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.85 143.12 17.4 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 115.827 -0.624 . . . . 74.43 111.867 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -140.75 129.64 4.22 Favored Glycine 0 C--N 1.329 0.187 0 N-CA-C 110.685 -0.966 . . . . 72.53 110.685 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.0 mt -90.15 129.43 41.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.321 -0.992 . . . . 73.14 108.321 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -128.92 153.46 47.49 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.71 0.404 . . . . 74.15 111.06 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -114.88 105.65 13.25 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.806 1.242 . . . . 65.23 108.097 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.35 122.76 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.125 0.57 . . . . 52.31 110.305 -175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.08 141.94 24.67 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.316 1.046 . . . . 34.42 108.48 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.94 -20.13 29.35 Favored Glycine 0 N--CA 1.468 0.825 0 O-C-N 123.116 0.26 . . . . 60.02 112.59 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 32.9 pt -131.95 147.0 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.414 0.686 . . . . 74.44 109.17 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.07 163.48 33.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.807 0.843 . . . . 73.51 111.317 -176.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.64 -127.52 31.37 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.173 -0.921 . . . . 65.14 114.264 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.1 m -74.32 -30.63 62.14 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.192 0.997 . . . . 74.12 111.135 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -65.46 -34.83 79.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.32 0.648 . . . . 75.34 109.977 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.676 ' HG3' HG12 ' H' ' 451' ' ' VAL . 1.2 tmt? -83.62 -26.17 30.18 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.534 -0.757 . . . . 71.12 110.817 175.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.08 -23.16 67.09 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.86 0.362 . . . . 52.02 110.612 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -70.48 -43.6 69.42 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.672 0.789 . . . . 72.34 110.557 168.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -63.59 -46.83 84.03 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.933 0.493 . . . . 63.14 110.966 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' D' ' 48' ' ' SER . 7.3 tt -77.2 -46.26 23.88 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.838 0.855 . . . . 72.21 109.785 -175.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.37 -12.69 83.58 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.83 -0.623 . . . . 71.34 114.149 -172.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.49 -61.03 0.65 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.424 0.612 . . . . 74.4 112.546 -172.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -67.06 -39.7 86.95 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 112.639 0.607 . . . . 75.14 112.639 -172.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.445 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 97.7 m -68.91 -48.94 28.15 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 118.547 -0.739 . . . . 71.25 111.086 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 71.0 Cg_exo -55.74 -35.11 92.81 Favored 'Trans proline' 0 C--N 1.399 3.209 0 C-N-CA 122.413 2.075 . . . . 65.5 113.169 168.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -63.36 -37.37 87.02 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.338 0.655 . . . . 74.25 110.276 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.5 mm -67.58 -43.42 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.664 0.786 . . . . 64.35 110.703 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' D' ' 82' ' ' GLY . 95.1 mt -75.08 -16.71 60.55 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.382 -0.826 . . . . 72.24 111.809 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -69.64 -43.08 21.07 Favored Pre-proline 0 CA--C 1.56 1.334 0 CA-C-O 118.209 -0.9 . . . . 73.43 113.274 -170.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -53.15 -44.74 46.37 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.2 1.934 . . . . 74.52 112.964 168.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.49 -36.09 76.19 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.665 0.786 . . . . 71.05 111.817 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.94 -54.66 31.11 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.49 0.716 . . . . 55.14 109.678 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -49.56 -49.46 46.28 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 125.068 1.48 . . . . 65.44 111.038 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -64.79 -44.0 91.39 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 124.132 0.895 . . . . 55.21 111.608 -173.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.0 t -60.33 -43.7 96.18 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.511 0.507 . . . . 75.44 110.717 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.493 HG21 HG21 ' D' ' 64' ' ' VAL . 77.3 mt -59.42 -56.97 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.399 1.08 . . . . 74.02 110.057 173.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.3 m -59.07 -35.35 73.22 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.205 1.402 . . . . 61.12 112.053 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -69.27 -43.85 73.06 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.643 -0.708 . . . . 72.44 109.753 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 72.3 mtm -67.38 -31.82 72.3 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.974 0.51 . . . . 64.05 111.875 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.477 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.6 t -62.69 -45.37 98.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.976 0.91 . . . . 72.53 110.334 175.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.8 p -73.59 -32.08 63.93 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 116.126 -0.488 . . . . 44.05 111.136 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -70.67 -31.78 68.82 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.633 0.773 . . . . 72.55 110.509 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.06 8.84 76.96 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-N 115.491 -0.777 . . . . 73.42 112.419 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 28.3 p 63.94 18.45 11.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.494 1.918 . . . . 74.54 114.231 171.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.82 147.69 49.28 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.198 0.599 . . . . 74.01 109.446 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.42 124.07 13.43 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.358 2.705 . . . . 72.42 112.932 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -61.86 130.09 44.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.955 1.302 . . . . 61.23 112.092 -173.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 71.2 mt -119.09 112.5 19.62 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.015 0.926 . . . . 60.04 109.12 -176.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -100.79 103.06 14.27 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.749 -0.834 . . . . 70.12 108.749 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 29.2 tp -68.91 135.85 51.67 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.679 -1.146 . . . . 70.33 112.053 -169.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.31 135.9 93.46 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 122.989 0.516 . . . . 61.24 110.428 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -64.04 136.41 52.23 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.719 2.279 . . . . 75.44 111.925 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.85 123.19 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.563 0.745 . . . . 64.34 109.211 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -82.66 92.59 7.19 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.954 -0.758 . . . . 43.12 108.954 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -67.23 -35.76 80.26 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.982 -0.554 . . . . 70.23 110.555 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.62 -53.51 57.25 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.575 1.15 . . . . 71.41 112.789 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.82 93.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.116 0.566 . . . . 35.42 110.973 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' D' ' 139' ' ' ASN . 33.4 tp -76.2 -17.77 59.37 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.592 -0.731 . . . . 64.54 111.951 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.428 ' O ' HD13 ' D' ' 141' ' ' LEU . 89.8 t80 -64.48 -40.42 95.64 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.398 -0.593 . . . . 74.14 109.398 171.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 30.8 mtt -68.39 -37.01 79.99 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.999 -1.0 . . . . 75.13 109.981 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.421 ' HB2' HD12 ' D' ' 136' ' ' LEU . 2.5 m-20 -69.64 -34.17 73.64 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.36 -0.836 . . . . 71.34 110.661 176.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -69.22 -40.66 77.83 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.412 0.685 . . . . 71.22 111.059 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.428 HD13 ' O ' ' D' ' 137' ' ' PHE . 6.4 mp -63.73 -30.86 71.91 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.399 0.68 . . . . 75.1 111.911 -177.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -91.67 18.09 7.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.926 0.49 . . . . 75.43 111.841 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 30.6 mm-40 -119.01 90.5 3.35 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.9 0.88 . . . . 74.32 109.114 176.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.5 113.07 6.29 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 106.112 -1.81 . . . . 75.02 106.112 175.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.5 87.45 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.092 0.957 . . . . 51.03 111.397 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.44 -171.34 23.77 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 111.014 -0.834 . . . . 65.21 111.014 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -166.76 117.88 0.94 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.032 0.533 . . . . 72.25 110.037 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.54 152.27 37.26 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.647 0.592 . . . . 45.13 111.851 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 35.9 p -66.93 154.35 41.28 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.874 0.87 . . . . 73.5 111.553 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -57.05 136.73 56.33 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.646 1.179 . . . . 72.14 112.373 -175.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -110.29 66.59 0.63 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.625 0.77 . . . . 74.1 109.632 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -66.74 97.75 0.48 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.538 -0.755 . . . . 72.43 109.756 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.48 179.39 5.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.978 0.911 . . . . 71.43 109.596 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -134.71 84.03 2.07 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.664 -0.865 . . . . 73.3 108.664 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.887 0 C-N-CA 123.993 0.917 . . . . 44.51 109.26 -179.658 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 53.0 t30 . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 108.993 -0.743 . . . . 73.11 108.993 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 65.5 t -90.91 -31.3 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 115.351 -0.84 . . . . 75.42 109.396 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 31.3 m -54.53 144.97 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.203 1.001 . . . . 74.21 113.229 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -140.86 -40.9 0.08 OUTLIER Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.171 -0.922 . . . . 71.13 111.378 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 1.5 tt 66.01 99.33 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.062 1.345 . . . . 74.42 109.861 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 71.8 p -75.98 168.62 19.7 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.277 0.631 . . . . 74.34 110.162 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -58.88 115.66 3.26 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.24 0.616 . . . . 65.31 109.514 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -63.04 100.77 0.23 Allowed 'General case' 0 C--N 1.353 0.723 0 CA-C-O 121.598 0.713 . . . . 74.12 109.412 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 21.7 m -61.35 148.74 40.42 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 114.812 -1.085 . . . . 72.54 110.32 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -51.13 147.65 5.19 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.504 0.722 . . . . 70.14 109.972 174.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 460' ' ' LEU . . . . . 0.735 HD21 ' H ' ' A' ' 46' ' ' THR . 4.0 mm? -65.05 126.04 26.79 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.972 0.891 . . . . 72.42 112.849 -166.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 461' ' ' PHE . . . . . 0.567 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 3.2 p90 -70.58 -3.97 20.8 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.308 -1.769 . . . . 73.14 112.165 170.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -60.45 98.0 0.06 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.029 0.932 . . . . 75.01 109.722 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 14.7 p -121.14 61.35 0.91 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.018 1.327 . . . . 63.21 109.372 -176.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 50.9 ttp -154.01 105.58 2.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.514 -1.221 . . . . 62.44 108.72 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -82.63 84.7 7.19 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.407 -0.96 . . . . 74.05 108.407 172.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -77.7 72.34 4.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.754 0.822 . . . . 65.2 109.858 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 467' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 40' ' ' VAL . . . -96.69 115.27 27.15 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.328 -0.851 . . . . 60.01 109.048 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.91 -38.25 90.21 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.656 0.598 . . . . 70.5 110.938 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 64.92 65.52 2.91 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.451 -0.795 . . . . 72.42 111.852 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 470' ' ' LEU . . . . . 0.487 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . 90.8 mt -64.01 113.91 3.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.553 0.741 . . . . 63.25 109.465 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 23.3 tptm . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.439 -0.791 . . . . 73.41 109.394 -170.6 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.219 0.533 . . . . 60.15 109.843 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.29 -3.78 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.656 1.183 . . . . 74.45 111.602 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 35.5 m -101.83 165.55 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.054 0.942 . . . . 63.03 111.383 -177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 151.67 173.28 21.29 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 116.22 -0.446 . . . . 74.41 111.986 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 92.2 mt -122.77 165.39 16.66 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.943 0.897 . . . . 62.43 110.843 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 40.9 p -71.09 -57.08 4.87 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.663 -0.699 . . . . 73.15 109.427 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 26.6 t70 171.49 -41.91 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.201 1.8 . . . . 54.55 108.056 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.29 78.44 0.21 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.561 1.545 . . . . 74.21 109.161 -176.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 25.2 m -93.39 118.94 31.92 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.344 1.058 . . . . 73.42 108.842 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 64.92 104.92 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.431 1.092 . . . . 70.24 110.721 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.3 108.98 0.77 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.28 0.632 . . . . 74.44 111.476 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 461' ' ' PHE . . . . . 0.431 ' HB2' HD22 ' B' ' 136' ' ' LEU . 14.2 p90 -61.11 108.09 0.84 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.961 -1.018 . . . . 73.04 109.319 172.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -146.58 107.34 4.12 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.834 -0.621 . . . . 73.25 109.329 -172.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 47.0 p -124.8 87.27 2.69 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.806 0.843 . . . . 73.14 109.396 176.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 464' ' ' MET . . . . . 0.684 ' SD ' ' HB3' ' B' ' 129' ' ' ALA . 64.0 ttp -102.68 112.12 24.74 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.344 -0.984 . . . . 73.04 108.344 175.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -70.13 -50.28 42.2 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.886 0.875 . . . . 64.44 110.434 -172.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -89.85 170.72 10.16 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.147 0.579 . . . . 74.14 111.039 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -86.77 169.37 12.67 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.903 0.481 . . . . 63.04 110.08 173.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 468' ' ' LEU . . . . . 0.68 ' H ' HD23 ' F' ' 468' ' ' LEU . 1.3 pt? -84.79 71.45 10.85 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.753 0.787 . . . . 74.22 110.872 -176.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 79.55 -56.03 4.45 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.255 -0.884 . . . . 71.21 112.805 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 4.6 tt -62.62 107.43 0.95 Allowed 'General case' 0 C--N 1.348 0.513 0 N-CA-C 107.825 -1.176 . . . . 72.5 107.825 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 53.8 pttt . . . . . 0 C--O 1.249 1.029 0 C-N-CA 124.268 1.027 . . . . 74.14 109.528 176.514 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 59.8 t30 . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.998 -0.371 . . . . 74.53 109.998 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' G' G ' 451' ' ' VAL . . . . . 0.441 ' O ' ' SD ' ' C' ' 94' ' ' MET . 8.9 p -157.64 13.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 122.608 0.363 . . . . 74.31 110.542 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 452' ' ' VAL . . . . . 0.611 ' HA ' ' HE1' ' C' ' 56' ' ' TYR . 27.4 m -130.01 154.02 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 113.098 0.777 . . . . 64.42 113.098 -174.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . -168.2 -147.37 5.31 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 113.938 -1.483 . . . . 54.12 110.108 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 7.7 mp 53.87 90.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.474 1.11 . . . . 73.44 112.642 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 42.9 p -108.63 8.7 27.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.138 0.975 . . . . 61.42 110.471 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.92 96.37 2.92 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.013 0.925 . . . . 71.01 108.912 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 457' ' ' GLN . . . . . 0.524 ' HB3' ' O ' ' C' ' 46' ' ' THR . 23.0 mp0 -113.13 61.47 0.64 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.793 0.837 . . . . 72.21 108.943 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 73.0 p -117.83 136.12 53.63 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.256 0.622 . . . . 70.54 110.182 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 53.74 80.95 0.1 Allowed 'General case' 0 C--O 1.243 0.741 0 C-N-CA 125.02 1.328 . . . . 72.3 111.78 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 460' ' ' LEU . . . . . 0.571 HD12 HD23 ' C' ' 44' ' ' LEU . 1.5 tm? -71.9 120.65 17.79 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.984 -1.488 . . . . 63.13 106.984 174.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 461' ' ' PHE . . . . . 0.434 ' HE1' ' HB2' ' C' ' 136' ' ' LEU . 15.1 p90 -51.65 116.08 1.94 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.851 1.26 . . . . 62.35 110.943 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -141.18 95.36 2.82 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.84 -1.17 . . . . 70.01 107.84 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 42.6 m -121.88 115.41 22.55 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.651 0.78 . . . . 73.15 109.998 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 52.1 mtt -111.19 -175.01 2.6 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.239 1.016 . . . . 74.31 109.295 170.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -81.18 -6.57 59.0 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.444 -0.798 . . . . 74.11 111.39 174.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -142.32 -77.05 0.26 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.434 0.694 . . . . 52.54 109.777 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -171.34 -55.45 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.449 1.1 . . . . 73.34 108.607 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 tt -148.46 -64.36 0.24 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 106.445 -1.687 . . . . 71.12 106.445 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 97.9 -178.91 32.47 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.018 -0.992 . . . . 74.12 111.804 -174.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 470' ' ' LEU . . . . . 0.523 ' HG ' ' HB3' ' C' ' 126' ' ' LEU . 6.0 tt -167.13 -61.02 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 106.833 -1.543 . . . . 62.11 106.833 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.554 1.097 0 N-CA-C 106.562 -1.644 . . . . 71.24 106.562 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 . . . . . 0 C--O 1.243 0.715 0 N-CA-C 110.226 -0.287 . . . . 61.01 110.226 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' H' H ' 451' ' ' VAL . . . . . 0.676 HG12 ' HG3' ' D' ' 94' ' ' MET . 40.1 t -60.33 -53.86 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.219 0.949 . . . . 75.32 109.442 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 452' ' ' VAL . . . . . . . . . . . . . 18.2 m -71.93 154.96 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 115.973 -0.558 . . . . 62.33 111.625 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -150.96 57.42 0.45 Allowed Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.023 -0.535 . . . . 72.05 111.998 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 454' ' ' LEU . . . . . 0.543 HD11 HD22 ' D' ' 98' ' ' LEU . 2.4 mm? -77.29 107.59 9.81 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.399 -0.593 . . . . 65.23 109.399 177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 14.8 m -66.45 -54.83 19.74 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 123.793 0.683 . . . . 70.42 110.644 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -174.93 149.1 1.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.062 0.945 . . . . 72.24 109.91 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -81.84 77.9 8.61 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.625 0.726 . . . . 74.33 109.388 173.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 13.8 p -76.34 -66.78 0.76 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.8 -1.091 . . . . 63.24 111.291 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -164.66 149.46 9.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.646 0.779 . . . . 75.34 109.931 -171.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 460' ' ' LEU . . . . . 0.498 ' HG ' ' HA ' ' D' ' 45' ' ' ASP . 4.4 mm? -87.6 100.07 12.52 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 123.559 0.744 . . . . 71.01 109.656 175.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -59.42 108.6 0.73 Allowed 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 114.813 -1.085 . . . . 62.44 110.024 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -159.16 126.0 4.66 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.44 -0.948 . . . . 72.51 108.44 168.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 23.6 m -83.35 -69.96 0.6 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.407 -1.331 . . . . 74.43 107.407 171.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 464' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' H' ' 465' ' ' LYS . 0.0 OUTLIER 65.61 138.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.079 1.352 . . . . 73.11 112.132 172.833 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' H' H ' 465' ' ' LYS . . . . . 0.411 ' N ' ' SD ' ' H' ' 464' ' ' MET . 39.4 ttpt -159.89 105.96 1.6 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.716 0.407 . . . . 71.01 110.593 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -164.01 32.64 0.08 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.779 0.831 . . . . 63.42 110.816 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -68.34 140.61 55.91 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.009 0.524 . . . . 62.25 110.163 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 4.2 mp -83.89 -6.96 59.53 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.443 0.697 . . . . 71.43 112.04 -174.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 76.01 39.87 31.63 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.132 0.27 . . . . 63.33 113.186 173.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 470' ' ' LEU . . . . . 0.581 ' HB3' ' HB2' ' D' ' 39' ' ' GLU . 7.7 tt -73.0 -54.28 9.0 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.307 -0.997 . . . . 72.01 108.307 168.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 471' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' H' ' 471' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-N 114.15 -1.386 . . . . 75.43 108.999 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptm . . . . . 0 C--O 1.24 0.568 0 CA-C-O 121.429 0.633 . . . . 71.22 110.126 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m -146.43 155.46 42.58 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.217 1.007 . . . . 63.44 109.271 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.02 145.29 26.33 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.872 0.869 . . . . 61.22 109.695 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -73.8 109.06 7.01 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.943 0.497 . . . . 62.35 109.844 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -77.14 153.46 34.19 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.347 -0.612 . . . . 53.23 109.347 172.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -68.42 -20.54 64.66 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.603 0.761 . . . . 71.02 111.261 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 p -86.78 7.38 27.13 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.865 0.866 . . . . 70.45 112.584 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.583 ' HG3' ' HG3' ' A' ' 9' ' ' MET . 10.2 pt-20 -54.94 -39.52 68.95 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.888 0.875 . . . . 44.24 112.722 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.583 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 58.0 mtt -84.72 137.61 33.12 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.7 0.8 . . . . 53.51 109.718 -177.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 68.9 m -143.43 132.81 23.37 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.655 0.782 . . . . 74.55 109.388 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.68 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.6 t80 -136.44 131.63 34.33 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.745 1.218 . . . . 62.44 108.951 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.536 HE22 ' HB2' ' C' ' 151' ' ' GLU . 43.9 tp60 -138.93 117.93 12.5 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.013 0.925 . . . . 73.34 108.652 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.532 HG12 ' HD2' ' A' ' 84' ' ' PHE . 39.1 mt -84.19 110.91 19.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.549 -0.908 . . . . 74.15 108.549 172.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -78.07 -40.03 39.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.991 0.807 . . . . 73.11 110.132 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -169.84 143.77 2.68 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 121.137 -0.225 . . . . 65.44 111.125 -171.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.533 HD12 ' HG3' ' C' ' 130' ' ' PRO . 94.2 mt -135.71 128.31 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.121 -1.066 . . . . 63.03 108.121 175.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' HB3' HG23 ' B' ' 122' ' ' THR . 28.7 p90 -165.62 150.21 8.57 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.177 0.991 . . . . 70.31 110.37 -169.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -75.32 114.91 14.4 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.978 -0.749 . . . . 52.01 108.978 173.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 37.5 mtpt -81.74 -28.36 33.39 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.297 -0.631 . . . . 71.12 109.297 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.1 t70 -149.08 138.52 21.67 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.235 -0.893 . . . . 74.23 109.723 174.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.11 150.43 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 107.257 -1.386 . . . . 74.15 107.257 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.0 t -158.23 146.4 18.62 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.387 0.429 . . . . 63.45 109.972 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 82.4 t80 -137.72 141.07 41.02 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.262 -1.384 . . . . 75.51 107.262 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 50.7 mt-10 -139.13 133.55 31.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.374 0.67 . . . . 74.02 109.39 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -147.32 73.39 11.88 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 107.235 -1.394 . . . . 63.33 107.235 171.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.51 -22.25 18.57 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.63 2.22 . . . . 74.44 111.779 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -112.27 32.8 5.29 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.019 1.328 . . . . 42.35 109.367 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -60.47 -46.75 97.44 Favored Pre-proline 0 CA--C 1.571 1.763 0 N-CA-C 113.054 0.761 . . . . 70.4 113.054 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 25.4 Cg_exo -66.61 -19.28 54.26 Favored 'Trans proline' 0 C--N 1.393 2.909 0 C-N-CA 122.002 1.801 . . . . 72.31 113.216 172.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -79.93 -48.86 12.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.398 0.679 . . . . 71.25 110.892 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 7.8 p -68.43 -18.93 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.963 0.505 . . . . 54.34 110.71 -178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -62.2 -39.63 93.39 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.108 0.963 . . . . 73.15 111.29 175.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -95.06 -13.14 25.44 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.591 0.756 . . . . 71.54 111.552 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 31.9 mmtp -83.19 167.93 17.26 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.24 0.616 . . . . 72.54 111.928 177.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -83.85 137.27 33.77 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.92 0.888 . . . . 71.04 109.819 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -77.68 86.77 3.96 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.469 0.652 . . . . 72.53 109.86 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -138.34 73.77 42.63 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 107.652 -1.24 . . . . 75.04 107.652 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 37.2 Cg_endo -91.05 166.06 3.75 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.48 2.12 . . . . 72.22 113.506 -174.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -99.58 105.51 17.39 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.06 -1.459 . . . . 74.54 107.06 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' E' ' 467' ' ' ALA . 16.4 m -73.13 90.87 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-O 122.728 1.251 . . . . 70.02 110.78 -178.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 65' ' ' THR . 29.8 mmmt -94.91 118.09 31.21 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.899 -1.046 . . . . 71.43 108.887 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.9 tp -116.77 127.2 54.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.25 -1.389 . . . . 72.04 107.25 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HB2' HG22 ' A' ' 63' ' ' THR . 6.7 m-20 -123.54 122.91 39.41 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.334 -1.358 . . . . 71.3 107.334 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.412 ' HG ' HG22 ' A' ' 62' ' ' VAL . 6.3 tt -128.75 136.46 50.59 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.75 -0.833 . . . . 75.42 108.75 -169.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 28.8 t70 -143.75 145.35 32.33 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.993 1.317 . . . . 73.03 108.431 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.0 m -114.35 133.77 55.45 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.262 -1.014 . . . . 73.2 108.262 171.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.96 143.15 50.65 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.881 -0.785 . . . . 71.15 108.881 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.8 m -127.8 152.54 47.66 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.077 0.551 . . . . 72.14 111.017 -170.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.6 p -159.44 140.36 12.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.724 0.64 . . . . 72.11 110.123 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -87.18 109.22 19.32 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.304 -0.628 . . . . 74.31 109.304 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 57' ' ' GLU . 82.7 mt -78.95 -41.63 28.87 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.229 0.538 . . . . 52.54 109.984 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.454 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -150.99 176.86 10.72 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.228 -1.027 . . . . 73.31 108.228 177.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -60.58 117.54 5.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.13 -0.693 . . . . 63.52 109.13 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 72.58 13.1 5.39 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.731 1.212 . . . . 72.45 112.317 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.454 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 49.1 t -118.93 125.17 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.395 -0.965 . . . . 60.44 108.395 176.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.404 ' HE1' HG12 ' E' ' 452' ' ' VAL . 5.5 m-85 -123.55 153.34 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.549 0.69 . . . . 73.54 111.582 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' A' ' 51' ' ' LEU . 8.4 tp10 -118.05 114.15 22.69 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.186 -1.783 . . . . 73.22 106.186 166.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.74 122.37 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 107.782 -1.192 . . . . 75.43 107.782 169.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -99.31 123.21 51.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.175 -1.046 . . . . 61.04 108.175 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 tp -86.74 96.83 10.3 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 106.754 -1.572 . . . . 60.42 106.754 173.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.597 ' HG2' ' HG3' ' A' ' 79' ' ' GLN . 0.8 OUTLIER -85.77 101.95 13.23 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.526 -1.216 . . . . 65.34 107.908 -175.161 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.412 HG22 ' HG ' ' A' ' 44' ' ' LEU . 62.1 t -125.08 137.97 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.067 0.547 . . . . 73.04 109.689 -174.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.428 HG22 ' HB2' ' A' ' 43' ' ' ASP . 7.5 t -138.53 145.63 40.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.348 0.659 . . . . 73.12 110.003 172.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 93.2 t -120.11 111.57 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.915 0.886 . . . . 70.41 108.614 177.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 20.7 m -105.52 107.91 19.15 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.199 -0.667 . . . . 74.41 109.199 173.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.64 104.64 15.02 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.736 -1.209 . . . . 53.33 107.736 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 25.0 m -117.27 123.53 46.81 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.954 -0.387 . . . . 73.13 109.954 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.72 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -90.26 86.33 6.48 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.049 0.928 . . . . 74.14 108.895 -178.372 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.29 -95.94 1.8 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 114.434 -1.257 . . . . 62.51 110.853 -174.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -114.73 -25.78 8.12 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.277 0.631 . . . . 73.31 111.455 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -87.72 134.07 33.73 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.772 0.829 . . . . 65.24 110.693 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 49.4 m -84.96 135.07 34.2 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 120.923 0.392 . . . . 71.05 110.74 174.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.21 -61.61 1.85 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.83 1.252 . . . . 71.44 109.425 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -147.07 165.16 30.75 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.888 -1.051 . . . . 73.24 111.456 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 61.6 tp -135.65 108.79 7.71 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.028 -1.442 . . . . 72.31 107.561 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.429 ' SG ' HG22 ' A' ' 118' ' ' VAL . 90.0 m -108.35 104.38 13.74 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.269 0.628 . . . . 62.15 109.596 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 63' ' ' THR . 37.9 tt0 -124.13 117.28 24.29 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.171 0.988 . . . . 73.44 110.269 -169.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.1 t -133.69 112.83 17.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 123.7 0.8 . . . . 72.1 109.808 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.597 ' HG3' ' HG2' ' A' ' 61' ' ' ARG . 2.2 mp0 -89.68 84.22 6.3 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.657 1.183 . . . . 72.33 107.953 173.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -82.68 100.85 10.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.754 -1.112 . . . . 63.11 109.387 -175.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.13 151.91 20.99 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.45 0.469 . . . . 73.34 112.33 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.531 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -146.3 125.49 2.26 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.657 -0.577 . . . . 44.44 111.657 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.8 mt -81.45 118.13 28.68 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.252 -1.018 . . . . 72.34 108.252 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.68 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 41.1 m-85 -131.27 126.97 36.79 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.793 0.837 . . . . 74.3 108.971 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.3 m -83.75 115.64 22.31 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.379 1.072 . . . . 60.41 109.878 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 94' ' ' MET . 6.0 tt -97.14 136.68 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.246 1.019 . . . . 74.32 109.063 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -160.72 137.56 8.91 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.359 0.264 . . . . 62.14 111.368 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.97 -32.2 6.51 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.86 -0.609 . . . . 64.33 114.515 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -133.15 148.03 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 116.931 0.366 . . . . 70.41 111.693 -165.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 9.5 tt0 -134.99 -176.8 4.37 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.042 0.937 . . . . 72.25 109.18 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.501 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.94 -130.67 36.22 Favored Glycine 0 C--N 1.353 1.501 0 C-N-CA 123.178 0.418 . . . . 73.05 113.951 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.0 p -74.08 -21.71 59.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.537 0.735 . . . . 54.42 111.472 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.24 -49.68 47.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.446 0.698 . . . . 73.43 109.841 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.474 ' HB2' HD11 ' A' ' 86' ' ' ILE . 25.7 ptm -65.71 -32.13 73.52 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 116.189 -0.46 . . . . 41.13 110.269 177.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.624 ' HA ' HD12 ' E' ' 454' ' ' LEU . . . -63.68 -37.79 88.66 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 124.044 0.84 . . . . 62.33 111.388 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 51.9 t-80 -69.43 -36.53 76.74 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.562 0.745 . . . . 75.24 111.301 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.8 m -73.27 -43.49 60.98 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.213 0.53 . . . . 70.25 111.008 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.489 HD22 HD13 ' E' ' 454' ' ' LEU . 6.9 tt -83.05 -38.38 22.63 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.337 1.055 . . . . 62.31 110.495 -169.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.97 3.78 52.31 Favored Glycine 0 N--CA 1.473 1.12 0 CA-C-N 116.111 -0.495 . . . . 74.43 114.259 -171.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.543 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -139.76 -62.77 0.51 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 117.452 0.626 . . . . 32.43 111.573 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.479 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 83.5 t80 -68.38 -55.28 12.51 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.977 0.911 . . . . 75.44 112.508 -170.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 76.0 m -72.05 -36.35 4.1 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 114.605 1.335 . . . . 52.41 114.605 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.56 -21.34 46.23 Favored 'Trans proline' 0 C--N 1.386 2.536 0 CA-C-N 121.787 1.674 . . . . 74.44 112.921 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -75.1 -28.64 60.33 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.069 0.548 . . . . 72.0 110.658 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.7 mm -59.9 -37.53 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.566 0.747 . . . . 74.15 109.9 172.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.531 HD21 ' HA3' ' A' ' 82' ' ' GLY . 83.5 mt -78.35 -21.19 49.88 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.308 1.043 . . . . 74.04 112.527 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -61.22 -45.62 95.5 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.936 -1.03 . . . . 75.3 113.636 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.99 -34.57 80.48 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 121.929 1.753 . . . . 73.32 113.27 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.42 -43.4 66.82 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.573 0.749 . . . . 71.24 111.193 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.9 -41.08 75.18 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.095 0.558 . . . . 73.51 110.333 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.473 ' NH1' HG23 ' C' ' 105' ' ' ILE . 30.8 ttm180 -52.38 -52.81 51.55 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.158 0.983 . . . . 64.44 109.494 174.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.15 -52.52 65.37 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 124.637 1.211 . . . . 75.1 111.471 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 117' ' ' MET . 40.4 t -55.82 -50.09 71.48 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 124.38 1.05 . . . . 71.03 110.621 -176.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.4 mt -58.77 -50.64 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 124.07 0.948 . . . . 72.24 110.985 177.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.41 HG23 ' HG3' ' A' ' 125' ' ' GLN . 86.5 m -51.92 -46.06 64.52 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.814 0.846 . . . . 54.4 110.65 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -64.09 -41.51 97.28 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 113.967 -1.469 . . . . 74.15 109.579 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 64.4 mmm -61.4 -42.5 98.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.182 0.593 . . . . 64.45 111.1 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 114' ' ' ILE . 57.8 t -62.05 -48.69 87.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.807 0.843 . . . . 64.52 110.091 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.0 p -71.75 -26.51 62.48 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.342 0.657 . . . . 45.5 111.956 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -70.76 -32.36 69.48 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.158 0.583 . . . . 72.12 109.996 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.75 -0.44 87.97 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.543 0.527 . . . . 34.53 112.987 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m 69.36 19.42 7.7 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 125.207 1.403 . . . . 71.42 111.217 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -86.06 150.8 53.33 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.542 -0.91 . . . . 73.1 108.542 171.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.91 143.12 92.78 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.721 2.281 . . . . 63.42 111.482 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.41 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.1 tt0 -57.63 136.67 56.83 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.469 0.708 . . . . 72.34 112.398 -171.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.638 HD13 ' HG ' ' E' ' 470' ' ' LEU . 29.1 tp -120.42 99.93 6.85 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.656 1.182 . . . . 73.23 109.335 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -99.8 101.47 12.63 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.606 -0.887 . . . . 73.04 108.606 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.17 117.72 5.91 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.057 -0.72 . . . . 72.04 109.057 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.23 142.58 86.01 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.373 0.669 . . . . 73.4 110.744 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.68 119.22 6.34 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.85 2.366 . . . . 74.15 112.826 -174.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.2 t -99.21 112.76 32.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 107.626 -1.25 . . . . 64.13 107.626 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -83.39 91.34 7.32 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 108.339 -0.985 . . . . 74.15 108.339 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -64.93 -24.58 67.57 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.659 -0.7 . . . . 74.34 111.489 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.543 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 8.6 t70 -69.7 -50.29 45.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.73 0.812 . . . . 72.41 110.066 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.16 -45.68 93.65 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.541 1.136 . . . . 64.01 110.87 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.24 -30.89 70.04 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.925 -1.034 . . . . 64.02 111.919 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -70.66 -35.43 72.86 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 123.366 0.416 . . . . 73.53 109.914 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 32.4 tpp -63.1 -38.94 93.18 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 123.719 0.637 . . . . 70.55 110.492 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -63.87 -33.46 75.74 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.163 -0.926 . . . . 71.44 110.906 175.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -81.65 -32.99 31.6 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.197 0.999 . . . . 71.31 111.113 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 42.9 tp -67.24 -49.52 64.16 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.916 0.886 . . . . 74.32 111.969 -164.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.41 ' HG2' ' HA ' ' A' ' 147' ' ' GLU . 27.2 tt0 -159.07 5.08 0.1 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.678 0.621 . . . . 74.04 112.678 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -73.95 -17.51 61.0 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 109.152 -0.685 . . . . 73.45 109.152 168.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -59.23 164.06 3.41 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 125.162 1.385 . . . . 53.2 110.853 169.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.19 -24.08 25.21 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.358 1.063 . . . . 63.31 112.705 176.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.04 67.86 2.93 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-N 116.075 -0.511 . . . . 70.02 112.348 172.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.41 ' HA ' ' HG2' ' A' ' 142' ' ' GLN . 12.4 pt-20 -76.78 -172.86 2.42 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.321 1.048 . . . . 72.33 110.717 177.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 148.87 91.79 0.1 OUTLIER Glycine 0 C--N 1.344 1.023 0 C-N-CA 121.215 -0.517 . . . . 60.13 113.649 174.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.6 m -133.02 -91.42 0.38 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.657 -1.238 . . . . 71.14 107.657 171.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 165.69 -70.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 126.044 1.738 . . . . 72.14 107.61 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -171.59 -154.59 0.09 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 106.877 -1.527 . . . . 72.34 106.877 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -124.51 86.06 2.51 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.431 -0.952 . . . . 74.2 108.431 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -81.32 105.48 12.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.784 0.834 . . . . 64.0 109.562 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -83.49 -54.66 4.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.2 0.6 . . . . 74.44 111.008 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.239 0 CA-C-O 118.329 -0.843 . . . . 43.41 109.226 179.642 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.608 -0.516 . . . . 72.04 109.608 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 23.8 t -166.34 159.11 14.49 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.581 0.752 . . . . 65.01 109.645 176.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.515 ' HG3' ' H ' ' B' ' 4' ' ' GLN . 4.1 pt-20 -153.46 -92.6 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.81 0.844 . . . . 71.04 109.883 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.515 ' H ' ' HG3' ' B' ' 3' ' ' GLU . 26.9 tp60 57.15 90.98 0.04 OUTLIER 'General case' 0 C--N 1.364 1.202 0 C-N-CA 125.216 1.407 . . . . 74.04 111.771 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -79.3 163.87 24.56 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.957 -0.565 . . . . 74.41 109.716 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -68.28 106.07 2.34 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.212 -1.033 . . . . 70.13 108.212 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -132.81 156.33 47.33 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 123.905 0.882 . . . . 60.22 109.451 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -72.18 -41.06 67.44 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.197 -0.91 . . . . 70.53 109.238 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.437 ' HB2' HD12 ' B' ' 89' ' ' ILE . 18.3 ptm 50.85 -177.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 126.287 1.835 . . . . 51.44 112.384 -170.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 89.6 m -155.54 117.37 4.06 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 119.169 -0.443 . . . . 71.05 110.011 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . 0.266 0.3 OUTLIER -154.96 155.29 33.96 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.265 0.353 . . . . 61.43 110.951 147.246 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -126.88 140.86 52.03 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 107.702 -1.222 . . . . 70.1 107.702 170.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.533 HD11 HD13 ' B' ' 105' ' ' ILE . 30.4 mt -78.47 122.85 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.618 -0.719 . . . . 65.32 109.32 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -86.42 -49.92 7.26 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.883 0.74 . . . . 71.34 109.69 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -158.53 129.88 6.47 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.605 -0.725 . . . . 75.21 110.074 -171.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.468 HD11 HD13 ' B' ' 13' ' ' ILE . 94.8 mt -116.45 119.15 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 106.807 -1.553 . . . . 72.32 106.807 172.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -151.89 143.54 23.59 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.246 0.546 . . . . 74.2 110.942 -168.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -72.46 124.62 25.55 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.937 -1.029 . . . . 60.22 108.714 172.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.502 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.7 mtpt -95.01 -36.76 11.43 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.533 0.733 . . . . 70.32 110.319 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.0 t70 -157.07 141.08 16.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.602 -0.272 . . . . 72.52 110.984 -167.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' B' ' 78' ' ' VAL . 40.7 mm -141.13 148.08 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.118 1.367 . . . . 75.42 108.866 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 41.6 t -144.42 139.15 28.2 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.555 1.142 . . . . 64.34 108.13 170.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -145.01 114.21 7.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.665 -1.606 . . . . 70.11 106.665 170.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -124.85 112.51 16.74 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.825 0.45 . . . . 75.23 109.893 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.35 86.65 8.31 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 108.225 -1.028 . . . . 70.0 108.225 172.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.1 -35.29 11.92 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.916 2.41 . . . . 74.24 113.033 -173.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -102.87 19.33 19.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.587 0.755 . . . . 72.34 110.611 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.592 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -40.31 -65.48 0.44 Allowed Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 125.183 1.393 . . . . 75.25 113.836 -166.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 52.6 Cg_exo -53.54 -38.56 83.73 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.838 2.359 . . . . 75.24 114.018 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.412 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 52.8 m80 -87.48 -35.77 18.04 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.317 -0.856 . . . . 74.34 112.406 -170.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.576 HG22 HD12 ' B' ' 68' ' ' LEU . 11.1 p -69.99 -17.44 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.699 0.4 . . . . 64.42 111.425 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -68.7 -10.73 58.07 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 113.512 0.93 . . . . 62.12 113.512 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.7 pt20 -66.52 -25.13 66.53 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 122.811 0.444 . . . . 71.42 110.843 174.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -91.81 88.97 6.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.161 0.984 . . . . 70.1 108.747 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.51 76.79 6.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.823 0.849 . . . . 73.51 109.712 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -154.39 160.9 41.92 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.556 1.142 . . . . 70.13 108.37 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -75.15 107.41 3.93 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 124.833 1.253 . . . . 65.34 109.634 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.598 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 12.5 Cg_endo -59.95 133.71 52.19 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.103 2.536 . . . . 72.14 112.834 -175.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -57.7 114.59 2.34 Favored 'General case' 0 C--N 1.361 1.091 0 O-C-N 124.138 0.899 . . . . 74.22 111.051 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.23 156.75 3.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 114.775 -1.102 . . . . 63.1 111.485 -173.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -145.87 121.49 10.45 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.943 -1.503 . . . . 73.12 106.943 169.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.2 mp -86.22 155.39 20.73 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.11 -0.7 . . . . 61.32 109.11 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 27.2 t70 -144.6 145.2 31.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.981 -1.489 . . . . 75.44 106.981 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.89 135.85 29.89 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.146 -0.687 . . . . 75.3 109.146 -169.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.0 t70 -145.69 140.0 26.95 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.2 1.4 . . . . 70.15 108.254 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 74.8 p -134.26 141.31 46.94 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.987 -0.746 . . . . 63.52 108.987 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.44 120.68 4.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.41 0.684 . . . . 71.04 109.881 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 57.3 p -99.4 168.75 9.8 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.981 0.513 . . . . 74.54 109.911 176.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 86.5 p -151.15 135.87 17.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.06 0.544 . . . . 73.33 109.927 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -82.5 103.44 12.04 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.297 -0.631 . . . . 71.03 109.297 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' B' ' 57' ' ' GLU . 58.8 mt -75.02 -53.79 8.3 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.418 0.628 . . . . 62.33 110.629 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.88 -170.61 3.57 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.754 -1.112 . . . . 72.3 109.375 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -64.73 109.84 2.18 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.815 0.697 . . . . 51.32 109.72 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 13.3 m-20 71.97 1.55 3.96 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.123 1.369 . . . . 72.04 112.667 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -104.69 122.63 57.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.08 -1.081 . . . . 54.51 108.08 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.492 ' HE2' ' HB3' ' B' ' 98' ' ' LEU . 0.1 OUTLIER -135.98 154.64 51.02 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.034 -0.728 . . . . 71.45 109.034 178.468 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.672 ' HB2' HD11 ' B' ' 51' ' ' LEU . 12.5 tm-20 -123.29 110.53 15.31 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.672 -1.233 . . . . 75.43 107.672 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 95.0 t -89.81 141.35 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 O-C-N 123.777 0.673 . . . . 73.15 109.446 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.5 t -117.22 145.45 22.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 108.675 -0.861 . . . . 74.02 108.675 176.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.458 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -128.66 104.72 7.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.619 -1.252 . . . . 73.01 107.619 178.291 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.456 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 33.1 ttt180 -94.03 113.47 25.45 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.582 0.753 . . . . 64.34 110.596 173.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.19 104.36 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.258 -1.016 . . . . 65.31 108.258 171.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 41.3 m -96.34 142.0 28.99 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.534 -0.913 . . . . 63.44 108.534 175.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.455 HG11 HD21 ' B' ' 126' ' ' LEU . 90.4 t -136.5 136.01 48.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.507 -0.923 . . . . 75.4 108.507 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 74.6 m -122.48 137.7 54.79 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.599 -0.889 . . . . 73.41 108.599 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -141.64 141.83 33.4 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.617 0.767 . . . . 64.3 109.684 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.508 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 57.5 p -145.03 133.5 21.91 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.959 -0.564 . . . . 62.55 111.908 -173.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.598 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.1 mt -94.06 106.89 18.85 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.17 0.988 . . . . 74.14 109.033 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.49 -111.8 4.34 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 114.887 -1.051 . . . . 65.52 111.909 -173.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -107.64 5.36 26.8 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.81 0.844 . . . . 73.52 111.813 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -124.72 144.8 50.03 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.039 0.382 . . . . 61.14 111.237 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 99.8 m -64.72 119.92 11.48 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 123.817 0.698 . . . . 74.43 110.524 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.543 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -81.55 -65.63 0.99 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.712 -1.131 . . . . 72.43 108.02 176.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -144.2 150.75 38.49 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-O 121.723 0.773 . . . . 74.13 111.457 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 74.7 mt -115.03 142.19 46.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.086 -1.82 . . . . 73.1 106.086 166.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.541 ' SG ' HG23 ' B' ' 114' ' ' ILE . 49.7 t -147.55 146.8 29.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.804 -0.813 . . . . 73.01 108.804 176.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -160.7 136.39 8.14 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.512 -0.551 . . . . 74.01 109.512 -173.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.435 ' HA ' HD13 ' B' ' 21' ' ' ILE . 98.1 t -131.23 145.15 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 123.863 0.865 . . . . 73.43 109.203 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 42.2 mt-30 -122.71 88.49 2.94 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.076 -1.083 . . . . 74.54 108.076 171.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.4 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 11.2 tp-100 -81.24 101.62 9.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.783 -1.099 . . . . 61.13 109.157 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.502 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -95.75 163.06 23.44 Favored Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.677 -0.569 . . . . 73.44 111.677 176.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.74 127.41 1.9 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.114 -0.795 . . . . 74.14 111.114 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.89 127.2 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 109.045 -0.724 . . . . 73.23 109.045 172.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.421 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 24.0 m-85 -132.02 153.93 49.88 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 107.227 -1.397 . . . . 61.15 107.227 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 59.0 m -122.48 91.21 3.45 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.825 0.45 . . . . 72.14 110.41 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.429 HD11 HD11 ' B' ' 89' ' ' ILE . 15.4 tt -94.82 145.81 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.844 0.858 . . . . 73.43 112.474 -166.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.47 161.14 40.07 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 124.709 1.204 . . . . 65.21 108.999 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.06 -68.17 0.39 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.095 -0.502 . . . . 52.42 113.207 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.65 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -90.38 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 121.418 0.628 . . . . 71.33 112.03 -173.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.453 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 33.2 tt0 -156.94 179.38 9.35 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.826 1.25 . . . . 54.15 108.26 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.453 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 72.4 -123.55 9.27 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 117.676 0.217 . . . . 61.42 112.621 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 32.2 m -93.41 -18.16 22.67 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.323 0.649 . . . . 70.11 111.436 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -68.08 -33.87 75.35 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 122.081 -0.387 . . . . 74.34 110.289 173.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' F' ' 452' ' ' VAL . 0.0 OUTLIER -77.56 -29.31 52.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.26 0.224 . . . . 75.33 110.477 173.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.471 ' HB1' ' HZ ' ' B' ' 137' ' ' PHE . . . -60.14 -40.78 91.01 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-O 121.403 0.621 . . . . 62.41 109.922 176.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 40.6 t-80 -64.12 -29.51 70.63 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.713 -1.13 . . . . 74.31 111.395 175.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.408 ' SG ' HD12 ' B' ' 86' ' ' ILE . 37.9 t -70.83 -66.11 0.65 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 110.312 -0.255 . . . . 75.41 110.312 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.691 HD23 ' HB ' ' F' ' 452' ' ' VAL . 0.4 OUTLIER -72.23 -23.83 61.29 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.56 0.948 . . . . 62.31 113.56 -174.356 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.92 1.07 56.45 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 119.651 -0.527 . . . . 61.11 113.346 -174.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.595 ' HA ' ' HB3' ' B' ' 133' ' ' PHE . . . -152.06 -62.43 0.17 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.413 0.523 . . . . 61.4 112.413 -175.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -66.65 -42.52 86.52 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.187 0.995 . . . . 75.13 111.89 -170.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.492 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 73.2 m -71.25 -50.58 11.07 Favored Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 124.332 1.053 . . . . 70.43 111.069 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 65.3 Cg_exo -57.16 -30.86 88.7 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.115 1.876 . . . . 73.01 114.014 170.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -59.13 -43.01 91.98 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 123.65 0.78 . . . . 75.33 110.298 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.533 HD13 HD11 ' B' ' 13' ' ' ILE . 73.8 mt -62.9 -41.37 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 115.09 -0.959 . . . . 53.55 110.889 176.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.15 -22.93 38.62 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.953 -1.022 . . . . 70.1 112.314 -172.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -58.72 -49.03 95.66 Favored Pre-proline 0 N--CA 1.486 1.333 0 N-CA-C 114.205 1.187 . . . . 71.32 114.205 -170.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -55.95 -36.82 96.36 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.029 1.819 . . . . 60.31 113.937 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.4 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 78.7 m-85 -67.43 -46.59 72.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.158 0.583 . . . . 73.51 110.601 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.54 88.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.686 0.794 . . . . 71.23 110.856 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.659 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 34.6 ttt180 -61.21 -54.69 41.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.632 1.573 . . . . 75.23 111.014 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -38.12 89.9 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.36 0.664 . . . . 61.31 110.021 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.475 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.8 t -66.63 -33.89 76.66 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 116.18 -0.464 . . . . 73.3 111.535 -176.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.541 HG23 ' SG ' ' B' ' 76' ' ' CYS . 62.6 mt -66.46 -52.05 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 109.896 -0.409 . . . . 75.31 109.896 175.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.45 HG21 ' OG ' ' C' ' 119' ' ' SER . 5.1 m -62.5 -30.57 71.37 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.732 0.645 . . . . 50.12 111.487 -176.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.5 t -61.3 -49.92 75.09 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.449 0.7 . . . . 74.23 109.376 174.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.0 mmt -58.44 -44.87 89.33 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.637 0.775 . . . . 63.42 111.03 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.11 -45.49 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.291 1.036 . . . . 64.54 111.269 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.0 t -63.45 -37.48 87.44 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.307 -0.86 . . . . 42.22 111.476 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.5 mtt-85 -66.16 -36.19 82.46 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.751 -1.113 . . . . 72.21 109.949 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.43 9.74 66.52 Favored Glycine 0 C--N 1.356 1.678 0 O-C-N 123.93 0.769 . . . . 65.31 113.898 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.445 HG23 ' HB3' ' A' ' 17' ' ' TYR . 72.4 p 54.76 35.38 23.89 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.781 1.632 . . . . 75.41 113.222 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -99.31 153.58 37.71 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.171 0.588 . . . . 70.22 110.342 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -50.82 158.6 2.89 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 123.868 3.046 . . . . 72.42 115.187 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -63.33 119.66 10.09 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.655 1.182 . . . . 71.51 112.699 -170.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.455 HD21 HG11 ' B' ' 64' ' ' VAL . 55.9 tp -108.54 102.75 11.8 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.064 -0.717 . . . . 74.53 109.064 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -100.21 105.29 16.86 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.22 -0.659 . . . . 70.41 109.22 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.659 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -73.33 113.0 9.92 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.037 -0.727 . . . . 71.53 109.037 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.09 149.94 96.18 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.922 0.889 . . . . 74.31 110.752 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.488 ' HG3' HD11 ' D' ' 16' ' ' ILE . 55.6 Cg_endo -66.37 123.35 11.04 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.441 2.094 . . . . 31.42 112.383 -175.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.8 111.61 24.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.306 -1.368 . . . . 73.43 107.306 172.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -76.97 86.56 3.5 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.63 -1.248 . . . . 73.51 107.63 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.595 ' HB3' ' HA ' ' B' ' 100' ' ' ALA . 97.7 m-85 -55.37 -42.65 74.22 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.895 0.878 . . . . 74.23 111.529 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.72 -42.43 97.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.361 1.064 . . . . 74.44 111.696 -174.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.04 -52.81 31.14 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.586 0.754 . . . . 74.33 110.283 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.25 -18.62 61.8 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.112 -0.949 . . . . 63.24 112.282 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.494 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 72.1 t80 -70.75 -40.52 72.66 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.329 0.651 . . . . 62.55 109.757 174.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 65.6 mtt -65.84 -26.44 67.66 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.739 0.416 . . . . 71.05 110.571 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -73.75 -29.18 62.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.835 0.854 . . . . 62.14 109.529 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.418 ' HD1' ' HB3' ' F' ' 461' ' ' PHE . 47.5 t80 -71.94 -32.63 67.51 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.421 1.088 . . . . 73.11 110.874 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 32.4 mt -80.08 0.1 33.42 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.73 0.812 . . . . 72.11 112.546 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -151.67 -168.41 3.07 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.415 -0.957 . . . . 65.31 108.415 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -123.95 22.01 8.91 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.104 0.562 . . . . 64.55 110.675 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -142.41 147.95 37.02 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.186 0.594 . . . . 45.32 110.666 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -173.43 -170.59 0.62 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.129 1.371 . . . . 75.24 108.991 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.83 -178.04 20.9 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 112.701 -0.16 . . . . 44.24 112.701 174.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.99 129.41 27.83 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.364 1.066 . . . . 72.02 108.964 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.16 100.83 0.52 Allowed Glycine 0 C--N 1.338 0.658 0 N-CA-C 111.004 -0.838 . . . . 64.02 111.004 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 14.4 t -148.48 157.02 43.2 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.145 0.578 . . . . 54.21 109.838 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -94.08 122.85 37.03 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.861 -0.609 . . . . 75.42 109.394 174.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -70.96 83.27 0.67 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 107.573 -1.269 . . . . 72.41 107.573 167.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -94.48 128.73 41.25 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.644 -0.707 . . . . 72.13 110.379 -173.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.49 -178.25 4.17 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.165 0.986 . . . . 52.11 110.018 174.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.06 -76.82 0.6 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.921 0.888 . . . . 54.3 109.044 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 C-N-CA 124.476 1.11 . . . . 44.12 108.487 -176.766 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.473 -0.566 . . . . 72.42 109.473 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 26.9 t -159.57 78.49 0.71 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.217 -1.031 . . . . 73.0 108.217 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -90.14 58.72 4.21 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.812 0.845 . . . . 60.01 109.496 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 63.97 -79.36 0.03 OUTLIER 'General case' 0 C--N 1.357 0.893 0 C-N-CA 125.212 1.405 . . . . 61.43 110.727 -176.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -159.92 -56.09 0.06 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.742 -1.207 . . . . 63.13 107.742 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 63.29 -163.94 0.26 Allowed 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 124.776 1.23 . . . . 72.2 109.394 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.432 HG22 ' HG3' ' C' ' 8' ' ' GLU . 54.2 m 69.29 151.1 0.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.467 1.107 . . . . 72.04 111.677 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.432 ' HG3' HG22 ' C' ' 7' ' ' THR . 49.6 mt-10 73.84 173.33 0.28 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.071 1.348 . . . . 71.31 111.798 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 28.0 ttt 63.67 112.25 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.183 1.393 . . . . 73.31 110.149 -171.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 40.2 m -126.3 105.16 8.61 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.711 -1.218 . . . . 73.1 107.711 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.522 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 3.2 t80 -116.14 119.85 37.12 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.127 -0.942 . . . . 74.21 108.578 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -136.47 131.9 34.64 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 107.981 -1.118 . . . . 61.22 107.981 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 63.8 mt -76.59 120.33 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.556 -0.905 . . . . 71.03 108.556 173.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.654 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 10.8 mm100 -82.71 -42.31 18.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.075 -0.966 . . . . 63.02 109.106 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -170.94 149.31 2.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.639 -0.71 . . . . 73.33 109.703 -170.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.5 mt -138.3 133.77 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.645 -1.243 . . . . 65.11 107.645 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.423 ' HB3' HG23 ' D' ' 122' ' ' THR . 31.5 p90 -169.77 172.04 6.98 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.847 0.832 . . . . 74.01 111.77 -172.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -97.27 123.14 40.98 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.094 -0.957 . . . . 71.02 109.101 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.416 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.9 mmtp -71.21 -50.46 32.85 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 122.755 1.264 . . . . 73.5 107.631 168.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -134.92 141.88 46.41 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 112.517 -2.129 . . . . 71.23 108.889 -168.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 74.2 mt -137.95 142.03 36.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 106.024 -1.843 . . . . 55.34 106.024 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -155.99 150.15 25.49 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.316 0.579 . . . . 74.54 110.439 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -150.87 134.95 16.77 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.526 -1.287 . . . . 64.32 107.526 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.69 124.27 19.58 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.737 0.815 . . . . 75.34 109.499 -171.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.62 79.02 7.37 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 107.517 -1.29 . . . . 71.45 107.517 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.93 -42.71 61.5 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.026 2.484 . . . . 64.14 111.494 174.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -91.53 29.76 1.44 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.11 -1.404 . . . . 71.54 110.362 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.94 -58.91 8.71 Favored Pre-proline 0 N--CA 1.487 1.405 0 CA-C-O 118.084 -0.96 . . . . 74.41 113.046 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.33 -33.41 58.97 Favored 'Trans proline' 0 C--N 1.388 2.62 0 CA-C-N 121.735 1.655 . . . . 71.21 111.898 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -68.48 -37.63 80.3 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.202 1.401 . . . . 64.41 112.496 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.813 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.9 p -82.02 -23.51 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.372 0.269 . . . . 65.33 111.68 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -68.07 -35.83 78.85 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.877 0.37 . . . . 73.43 110.561 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -89.37 12.38 16.42 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.815 0.846 . . . . 71.43 111.062 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -101.27 160.51 14.35 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.154 0.982 . . . . 72.32 109.621 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.48 114.19 9.29 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.461 0.704 . . . . 60.42 109.91 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -78.84 100.95 7.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.879 0.872 . . . . 73.33 111.155 -174.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.545 ' H ' HD22 ' C' ' 68' ' ' LEU . 10.8 pt20 -149.9 78.42 8.14 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 124.107 0.963 . . . . 75.0 109.535 171.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -87.3 128.31 2.6 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.351 2.034 . . . . 73.31 112.571 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -86.27 91.5 8.49 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 106.075 -1.824 . . . . 65.25 106.075 165.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 18.0 m -72.49 131.81 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.737 -1.119 . . . . 64.22 111.831 -171.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -113.77 102.89 10.66 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.548 -1.279 . . . . 50.33 107.548 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -87.98 152.49 22.01 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.167 -0.679 . . . . 64.43 109.167 170.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.568 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.5 t70 -137.45 104.65 5.42 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.584 -0.895 . . . . 75.44 108.584 177.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 85.6 mt -92.65 113.09 25.28 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.839 -1.171 . . . . 63.12 107.839 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.3 t70 -122.27 153.7 38.55 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.856 1.262 . . . . 71.5 109.399 178.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.439 HG22 HD21 ' G' ' 460' ' ' LEU . 5.3 t -143.87 154.2 43.12 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.119 -0.697 . . . . 73.22 109.119 173.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' G' ' 457' ' ' GLN . . . -153.12 135.93 15.37 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.16 0.984 . . . . 51.24 109.097 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.459 ' HB3' HG22 ' C' ' 58' ' ' VAL . 29.6 p -125.71 142.18 51.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.363 0.665 . . . . 72.4 109.665 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.7 p -153.43 140.33 19.16 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.393 0.677 . . . . 73.14 110.766 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -72.18 127.14 31.62 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.955 0.902 . . . . 64.43 111.104 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' C' ' 57' ' ' GLU . 55.7 mt -96.06 -44.3 7.39 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.018 0.927 . . . . 72.22 109.708 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.25 -176.57 5.28 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.771 -1.104 . . . . 60.34 109.807 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.73 108.07 0.93 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.689 0.796 . . . . 72.2 110.369 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 70.63 1.6 3.76 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.745 1.618 . . . . 73.43 112.974 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 68.5 t -98.16 118.43 44.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.86 -0.793 . . . . 73.24 108.86 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -108.83 158.74 17.38 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.182 0.992 . . . . 73.04 110.28 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.586 ' HB2' HD11 ' C' ' 51' ' ' LEU . 24.6 tt0 -119.41 130.81 55.48 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 112.884 -1.962 . . . . 73.34 107.285 169.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.459 HG22 ' HB3' ' C' ' 48' ' ' SER . 76.0 t -115.28 126.4 72.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.877 -0.786 . . . . 60.24 108.877 170.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.486 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 88.0 t -105.79 130.36 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 107.788 -1.19 . . . . 73.01 107.788 171.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.41 103.75 10.43 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.837 -1.542 . . . . 54.22 106.837 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.423 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.9 ttm-85 -84.27 123.18 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.15 -1.386 . . . . 71.44 108.47 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -116.46 118.58 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.973 -1.121 . . . . 73.21 107.973 169.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 42.3 m -110.72 141.81 43.5 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.087 0.955 . . . . 63.24 108.628 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.706 HG11 HD11 ' C' ' 126' ' ' LEU . 55.8 t -126.1 127.65 71.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 108.663 -0.866 . . . . 24.44 108.663 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -115.81 137.37 52.15 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.22 -1.4 . . . . 74.44 107.22 167.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.51 114.39 14.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.187 -1.412 . . . . 62.42 107.187 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.6 m -134.75 134.08 40.6 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.562 0.539 . . . . 55.51 110.027 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.545 HD22 ' H ' ' C' ' 37' ' ' GLN . 12.5 mt -90.91 23.04 3.33 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 126.005 1.722 . . . . 73.14 110.133 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.39 -87.8 0.51 Allowed Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.024 -0.83 . . . . 65.53 111.024 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.2 -30.51 18.49 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.572 0.749 . . . . 71.31 110.326 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -92.97 118.36 31.07 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.455 0.702 . . . . 55.33 110.429 -173.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -77.44 122.4 25.14 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.614 -0.884 . . . . 71.13 108.614 169.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.813 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.5 -54.24 7.91 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.298 -0.865 . . . . 73.21 109.461 176.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -167.24 157.05 10.8 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.283 -0.871 . . . . 75.04 110.909 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.419 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -118.0 144.99 45.08 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 106.365 -1.717 . . . . 64.4 106.365 168.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.43 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.8 t -148.78 149.45 31.4 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.504 -0.924 . . . . 63.14 108.504 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -159.22 130.25 6.08 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.374 0.421 . . . . 54.32 110.073 175.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.5 t -125.54 131.6 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.891 0.876 . . . . 72.52 108.646 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -109.32 87.53 2.52 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.605 -1.257 . . . . 70.14 107.605 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.407 ' HG3' HD22 ' C' ' 106' ' ' LEU . 8.8 tp-100 -79.42 96.77 6.14 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.483 -0.78 . . . . 64.3 110.357 -175.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -97.7 143.23 16.58 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 112.306 -0.317 . . . . 61.22 112.306 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.99 140.62 8.53 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 110.357 -1.097 . . . . 71.1 110.357 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.654 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.7 mm -91.39 122.7 43.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.553 -0.906 . . . . 62.42 108.553 -178.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.522 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 63.8 m-85 -127.46 119.33 25.85 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.201 -1.037 . . . . 64.12 108.201 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 39.9 p -84.46 125.49 32.41 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.066 0.546 . . . . 75.33 109.563 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.624 HD13 HD11 ' C' ' 98' ' ' LEU . 39.0 pt -116.51 135.33 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.214 0.606 . . . . 70.11 109.776 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -153.45 151.29 29.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.947 0.899 . . . . 74.14 109.321 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.15 -57.74 4.26 Favored Glycine 0 N--CA 1.474 1.188 0 N-CA-C 112.243 -0.343 . . . . 72.43 112.243 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -85.48 156.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.869 0.868 . . . . 73.41 111.834 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.549 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 11.9 pt-20 -161.42 -175.74 4.97 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.416 -0.811 . . . . 74.34 110.421 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.1 -119.75 18.43 Favored Glycine 0 C--N 1.352 1.47 0 O-C-N 123.902 0.751 . . . . 61.44 113.845 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.482 ' HB ' HD11 ' C' ' 141' ' ' LEU . 47.3 p -72.94 -33.32 65.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.246 1.019 . . . . 72.51 111.171 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -67.9 -34.9 77.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.736 0.815 . . . . 72.04 110.903 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.549 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 55.3 ttp -75.35 -41.77 55.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.837 0.855 . . . . 72.34 110.396 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.37 -41.04 75.54 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.076 0.86 . . . . 50.04 110.086 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 18.7 t-160 -76.39 -43.2 41.68 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 124.05 0.844 . . . . 74.24 111.811 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -55.68 -40.25 72.06 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 123.956 0.785 . . . . 72.55 110.648 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.624 HD11 HD13 ' C' ' 86' ' ' ILE . 22.0 mt -101.71 -14.9 17.17 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.748 0.819 . . . . 71.51 111.632 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 99' ' ' GLY . . . . . 0.623 ' HA2' HG21 ' G' ' 458' ' ' THR . . . -76.87 -30.89 55.24 Favored Glycine 0 C--N 1.355 1.615 0 N-CA-C 114.77 0.668 . . . . 55.33 114.77 -176.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.2 -36.32 0.06 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.07 0.396 . . . . 62.41 112.07 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -59.2 -49.59 77.29 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 125.231 1.412 . . . . 71.14 112.535 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 88.1 m -77.94 -41.99 2.17 Favored Pre-proline 0 CA--C 1.563 1.464 0 CA-C-O 118.727 -0.654 . . . . 63.21 112.575 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.08 -33.44 34.98 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.449 2.099 . . . . 74.44 114.558 168.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.33 -26.68 63.87 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.581 0.752 . . . . 71.23 110.458 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.473 HG23 ' NH1' ' A' ' 111' ' ' ARG . 48.0 mm -68.71 -39.36 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.829 0.852 . . . . 62.35 109.725 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.407 HD22 ' HG3' ' C' ' 80' ' ' GLN . 35.8 mt -80.64 -23.82 39.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.668 1.187 . . . . 74.4 112.597 -174.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -57.3 -49.25 94.95 Favored Pre-proline 0 CA--C 1.563 1.45 0 N-CA-C 114.212 1.19 . . . . 75.12 114.212 -173.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.41 -37.64 96.82 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 121.945 1.764 . . . . 62.11 113.223 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -66.36 -49.01 68.34 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.837 0.855 . . . . 73.43 111.178 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.09 -38.97 84.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.289 -0.868 . . . . 65.43 110.628 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -58.54 -55.71 31.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.564 1.146 . . . . 74.42 110.8 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.29 -33.08 75.13 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.852 0.461 . . . . 75.13 110.39 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 33.4 t -71.16 -31.4 67.64 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.009 0.524 . . . . 64.55 111.48 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.43 HG23 ' SG ' ' C' ' 76' ' ' CYS . 76.9 mt -73.2 -54.04 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.523 -0.547 . . . . 75.21 109.523 172.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 4.7 m -62.46 -27.82 69.39 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.166 0.587 . . . . 73.34 111.271 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.6 t -61.33 -53.66 53.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.626 0.771 . . . . 54.12 109.094 169.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.57 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.28 -35.23 75.06 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.791 1.236 . . . . 73.44 112.46 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' C' ' 123' ' ' PHE . 75.0 t -65.67 -45.27 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.683 0.793 . . . . 73.5 109.622 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.45 ' OG ' HG21 ' B' ' 115' ' ' THR . 42.3 t -68.69 -28.55 66.95 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.001 0.813 . . . . 32.45 111.449 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.469 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 82.7 mtt-85 -70.74 -43.11 69.52 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.503 0.721 . . . . 72.21 109.211 176.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.09 -3.79 82.13 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 124.287 0.992 . . . . 51.52 112.24 172.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 65.82 26.55 11.18 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 127.026 2.13 . . . . 74.44 113.588 170.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.411 ' HB2' HG13 ' C' ' 118' ' ' VAL . 92.1 m-85 -82.8 156.62 67.56 Favored Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 109.021 -0.733 . . . . 73.25 109.021 171.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.14 175.1 2.72 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.909 2.406 . . . . 73.25 114.285 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -56.84 137.56 54.78 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.784 1.031 . . . . 74.22 113.784 -171.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.706 HD11 HG11 ' C' ' 64' ' ' VAL . 3.0 tt -126.9 87.03 2.59 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.662 -1.154 . . . . 70.55 108.278 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -107.89 109.66 21.23 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.21 0.604 . . . . 73.4 109.846 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -74.73 135.63 41.79 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 122.918 0.487 . . . . 73.1 110.762 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.26 151.38 87.86 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.894 0.877 . . . . 74.1 110.241 174.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.533 ' HG3' HD12 ' A' ' 16' ' ' ILE . 24.6 Cg_exo -60.93 103.34 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.816 2.344 . . . . 53.23 112.794 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.416 HG12 ' HG3' ' G' ' 464' ' ' MET . 17.9 m -98.46 111.13 27.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.244 -1.021 . . . . 61.44 108.244 168.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -75.72 84.57 2.72 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.32 -0.854 . . . . 74.41 109.196 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -54.39 -44.82 72.61 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.752 0.658 . . . . 75.55 110.121 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.74 -47.53 85.29 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.574 -1.194 . . . . 61.52 111.682 -174.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.27 87.01 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.345 0.658 . . . . 55.4 111.209 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' G' ' 462' ' ' TYR . 87.5 mt -62.96 -42.49 99.84 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.776 -0.647 . . . . 64.53 111.422 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.621 ' HA ' ' HB3' ' C' ' 140' ' ' TYR . 10.1 t80 -71.89 -26.48 62.34 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.935 0.494 . . . . 74.14 110.807 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 25.3 ttt -60.09 -45.77 91.83 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 122.769 0.428 . . . . 61.33 109.943 174.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -72.04 -35.61 69.4 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.974 0.91 . . . . 73.02 111.474 175.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.621 ' HB3' ' HA ' ' C' ' 137' ' ' PHE . 84.8 t80 -66.32 -84.81 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.082 0.953 . . . . 74.54 109.801 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.482 HD11 ' HB ' ' C' ' 92' ' ' THR . 23.2 tp 70.09 -76.4 0.06 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.697 1.599 . . . . 70.15 109.696 -175.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -138.05 2.04 2.31 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 124.067 0.947 . . . . 64.43 110.859 170.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -117.83 169.0 9.96 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.639 1.176 . . . . 71.34 109.067 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -52.75 148.48 7.33 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.171 0.989 . . . . 74.14 112.892 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' C' ' 140' ' ' TYR . . . -115.22 127.61 55.62 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.331 1.052 . . . . 44.01 109.999 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -155.72 70.08 0.28 Allowed Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.956 -0.458 . . . . 72.41 111.956 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -147.91 123.13 10.21 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.468 0.707 . . . . 73.43 109.708 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.32 147.3 5.16 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.391 0.432 . . . . 54.4 112.715 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 18.0 p -89.65 172.09 9.19 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.119 0.968 . . . . 72.0 110.657 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -119.49 159.07 25.0 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.796 0.838 . . . . 44.33 111.796 -170.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 151' ' ' GLU . . . . . 0.536 ' HB2' HE22 ' A' ' 12' ' ' GLN . 13.9 tp10 -145.24 146.57 31.75 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.925 0.49 . . . . 72.14 110.888 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -119.78 27.35 8.76 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.434 1.094 . . . . 70.04 112.25 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -64.92 132.69 50.03 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.192 0.451 . . . . 43.3 111.066 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -92.0 114.17 26.63 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.461 0.704 . . . . 71.01 109.332 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 155' ' ' ALA . . . . . 0.534 ' H ' ' HA3' ' G' ' 469' ' ' GLY . . . . . . . . 0 CA--C 1.562 1.418 0 C-N-CA 124.339 1.055 . . . . 55.23 109.096 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 109.108 -0.701 . . . . 64.12 109.108 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 23.4 m -119.88 147.74 44.34 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.044 0.937 . . . . 72.14 110.006 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -131.05 106.64 8.52 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.533 0.733 . . . . 63.34 109.374 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -94.18 80.98 4.03 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.739 -0.837 . . . . 64.12 108.739 171.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -158.46 147.33 18.93 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.723 -1.214 . . . . 45.44 107.723 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -71.92 84.21 0.95 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.537 0.684 . . . . 74.5 109.739 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -118.16 -170.63 1.92 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.952 1.301 . . . . 65.42 108.119 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -68.08 -14.87 63.31 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.169 0.803 . . . . 71.31 113.169 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 10.4 tpt -34.31 123.79 0.5 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.714 0.805 . . . . 52.12 111.46 159.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 37.1 m -133.55 142.34 48.13 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.088 0.555 . . . . 75.42 110.024 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -158.14 97.01 1.49 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.87 -1.529 . . . . 74.12 106.87 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -134.46 149.82 50.77 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.828 -0.805 . . . . 70.23 108.828 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.464 HD11 HG21 ' D' ' 105' ' ' ILE . 4.5 mt -92.87 130.48 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.404 -0.591 . . . . 70.32 109.404 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -86.73 -35.22 19.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.055 0.542 . . . . 52.23 110.5 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -174.54 130.56 0.35 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.488 0.315 . . . . 65.2 111.091 -172.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.488 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.5 mp -107.47 140.78 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.747 -1.205 . . . . 74.13 107.747 172.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -162.65 158.62 23.44 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.733 0.646 . . . . 71.15 111.679 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.8 p -93.59 118.85 31.89 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.169 -0.923 . . . . 72.55 109.56 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -90.28 -20.59 22.76 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 116.045 -0.525 . . . . 75.41 109.923 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.1 t70 -157.02 132.36 9.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.517 -0.765 . . . . 75.3 109.821 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.57 HG21 ' HE2' ' C' ' 117' ' ' MET . 60.4 mt -135.9 147.06 28.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 124.548 1.139 . . . . 41.31 107.982 171.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -153.52 115.68 4.35 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.82 0.7 . . . . 53.1 110.142 171.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -110.21 134.22 52.44 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.487 -1.671 . . . . 72.33 106.487 166.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.718 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 31.4 mt-10 -140.0 120.21 13.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.777 0.831 . . . . 72.02 108.959 -173.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.05 89.43 50.75 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.845 -1.169 . . . . 75.34 107.845 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.3 -46.8 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.103 2.536 . . . . 73.13 111.795 -174.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 26.3 m-20 -98.2 34.93 1.85 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.256 1.023 . . . . 71.14 109.01 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.8 -66.86 0.53 Allowed Pre-proline 0 CA--C 1.567 1.614 0 N-CA-C 114.101 1.149 . . . . 70.14 114.101 -162.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.428 ' HB3' HD11 ' C' ' 83' ' ' ILE . 95.1 Cg_endo -76.03 -20.28 15.04 Favored 'Trans proline' 0 C--N 1.384 2.447 0 CA-C-N 122.705 2.002 . . . . 75.34 113.02 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.413 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 6.6 t-160 -64.49 -47.65 78.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.575 1.55 . . . . 73.51 109.746 176.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.707 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.1 p -85.26 -23.94 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 CA-C-N 114.821 -1.081 . . . . 73.01 112.194 -168.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -60.79 -30.45 70.05 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 123.355 0.662 . . . . 73.31 112.765 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -60.08 -24.06 64.3 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.931 -1.031 . . . . 62.03 111.166 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -86.84 85.14 7.25 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.365 1.066 . . . . 75.44 108.775 173.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.15 82.08 3.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.419 0.628 . . . . 72.22 110.414 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -142.17 157.88 44.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.012 1.325 . . . . 53.45 107.759 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -68.22 107.69 2.15 Favored Pre-proline 0 CA--C 1.555 1.139 0 N-CA-C 108.635 -0.876 . . . . 71.32 108.635 172.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.412 ' O ' HG13 ' D' ' 40' ' ' VAL . 35.8 Cg_exo -59.93 120.96 9.06 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.122 2.548 . . . . 73.41 112.157 -168.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.47 ' HA ' ' HG ' ' H' ' 470' ' ' LEU . 46.9 mt-10 -67.15 111.78 4.1 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 123.943 0.777 . . . . 51.34 109.983 -175.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.608 HG12 ' HB2' ' D' ' 66' ' ' ALA . 35.9 m -104.5 142.49 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.109 -0.951 . . . . 75.23 110.745 -173.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.49 136.93 40.51 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.912 -1.144 . . . . 72.05 107.912 162.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.4 112.42 24.35 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.168 -1.049 . . . . 71.12 108.168 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -127.54 123.13 35.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.331 -0.989 . . . . 73.1 108.331 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.406 ' H ' HD22 ' H' ' 460' ' ' LEU . 6.0 mp -116.05 160.81 19.79 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.446 0.641 . . . . 71.34 110.047 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -149.73 151.6 33.92 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.202 -1.407 . . . . 64.23 107.202 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -128.37 154.18 46.26 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.464 -0.569 . . . . 71.3 109.464 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.69 157.75 43.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.983 0.913 . . . . 72.51 109.402 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.4 m -149.01 153.44 37.91 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.332 0.653 . . . . 50.52 109.968 175.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.8 t -152.67 126.01 8.69 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.669 0.788 . . . . 73.13 109.757 -169.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -78.01 118.33 20.19 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.78 0.432 . . . . 75.32 109.842 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.472 HD11 ' HB2' ' D' ' 57' ' ' GLU . 67.0 mt -91.72 -42.09 10.34 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.579 -0.526 . . . . 54.2 109.579 176.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.62 -174.95 5.09 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.872 -1.058 . . . . 73.32 110.05 -176.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.11 117.86 9.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.924 -1.035 . . . . 64.24 110.031 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 64.39 18.01 11.09 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.501 1.126 . . . . 71.01 111.68 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.98 119.25 59.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 124.228 1.011 . . . . 64.25 108.356 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.403 ' CD1' HD11 ' D' ' 86' ' ' ILE . 14.6 m-85 -132.44 127.33 35.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.501 -0.926 . . . . 74.11 108.501 175.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.472 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.1 tt0 -90.21 121.65 32.43 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.656 1.183 . . . . 72.4 108.897 169.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 74.3 t -102.27 142.37 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.542 -0.91 . . . . 64.41 108.542 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.455 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.6 t -121.91 130.76 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.463 -0.94 . . . . 65.41 108.463 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -110.59 119.85 40.52 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.442 -1.318 . . . . 71.1 107.442 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -98.02 96.6 8.26 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.034 -1.099 . . . . 74.42 108.034 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.9 t -93.44 120.01 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.012 -1.107 . . . . 74.55 108.012 171.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -119.18 140.87 49.46 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.432 0.693 . . . . 75.51 109.601 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.49 HG11 HD11 ' D' ' 126' ' ' LEU . 91.5 t -136.51 122.26 28.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 125.031 1.333 . . . . 55.44 108.276 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 93.3 m -119.51 112.63 19.6 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.743 -0.836 . . . . 55.21 108.743 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -111.02 154.82 23.64 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.855 0.862 . . . . 52.3 110.293 -172.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 34.0 p -149.8 134.14 17.35 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.783 0.677 . . . . 63.43 111.415 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.455 ' HB2' HG22 ' D' ' 31' ' ' VAL . 48.1 mt -113.19 122.62 48.04 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.933 1.293 . . . . 71.14 107.855 171.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.4 -112.46 3.48 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.999 -0.44 . . . . 63.32 111.999 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 4.08 9.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.118 0.967 . . . . 73.52 110.036 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -126.15 163.0 24.08 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.64 0.776 . . . . 70.24 110.392 -170.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.0 m -61.91 125.41 23.76 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 124.22 0.95 . . . . 74.03 111.801 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.707 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -81.13 -72.87 0.4 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.339 -0.985 . . . . 44.12 108.339 171.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 74' ' ' PHE . . . . . 0.525 ' HZ ' HD12 ' D' ' 126' ' ' LEU . 48.1 p90 -144.7 160.45 41.18 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.559 0.695 . . . . 65.41 110.311 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.718 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 64.8 mt -122.58 141.4 51.74 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.451 -1.685 . . . . 74.15 106.451 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.579 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.8 t -153.49 136.66 15.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.782 -0.451 . . . . 64.21 109.782 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.8 130.82 11.02 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.619 0.768 . . . . 74.23 108.936 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.8 t -129.44 114.19 30.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.532 -0.914 . . . . 74.13 108.532 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.0 mt-30 -89.9 84.75 6.24 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 122.045 0.926 . . . . 73.53 109.07 171.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.86 101.41 8.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 113.474 -1.694 . . . . 75.0 110.146 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.87 161.37 29.36 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.957 -0.457 . . . . 71.01 111.957 175.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.22 134.92 3.58 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.942 -0.863 . . . . 43.03 110.942 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.1 mt -87.33 128.51 39.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 124.101 0.96 . . . . 51.34 108.93 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -128.12 126.59 41.42 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.237 0.615 . . . . 63.3 110.175 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.4 m -81.13 102.45 10.28 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.984 -0.747 . . . . 73.4 108.984 169.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.538 HD13 HD11 ' D' ' 98' ' ' LEU . 44.7 pt -109.7 140.99 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.195 0.998 . . . . 70.23 110.689 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.9 159.16 34.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.836 0.854 . . . . 65.34 109.448 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.98 -0.36 89.08 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 114.349 0.499 . . . . 32.21 114.349 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.521 HD11 HD12 ' D' ' 86' ' ' ILE . 29.0 pt -105.37 147.86 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.473 0.709 . . . . 74.04 110.389 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.1 146.65 28.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.117 0.567 . . . . 73.21 111.588 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.65 -113.5 2.78 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 124.254 0.931 . . . . 74.35 115.143 175.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.9 p -64.43 -33.22 75.36 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.693 1.197 . . . . 64.04 111.6 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -65.64 -31.11 71.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.486 0.715 . . . . 75.05 111.032 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.683 ' HB3' HD23 ' H' ' 454' ' ' LEU . 55.9 mtm -67.97 -45.79 73.19 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.614 0.365 . . . . 70.31 110.128 174.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.12 -37.36 82.53 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.074 0.55 . . . . 74.42 111.317 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -71.15 -38.8 72.2 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.86 0.864 . . . . 44.43 111.078 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -72.75 -51.11 20.47 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.377 -0.374 . . . . 45.33 111.632 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.596 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.2 mm? -86.06 -28.52 24.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.422 0.689 . . . . 74.11 111.041 -174.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.95 -22.97 47.35 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 114.242 0.457 . . . . 71.51 114.242 -176.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -129.04 -56.6 1.18 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.983 0.513 . . . . 75.23 111.479 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 101' ' ' TYR . . . . . 0.548 ' HA ' HD22 ' D' ' 104' ' ' ASN . 63.2 t80 -70.63 -34.88 72.57 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 112.839 0.681 . . . . 73.13 112.839 -172.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.596 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 75.7 m -69.57 -49.45 21.77 Favored Pre-proline 0 CA--C 1.569 1.679 0 CA-C-O 118.562 -0.732 . . . . 63.12 111.625 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 84.1 Cg_exo -55.25 -30.3 71.14 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 122.565 2.176 . . . . 52.34 114.48 170.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 104' ' ' ASN . . . . . 0.548 HD22 ' HA ' ' D' ' 101' ' ' TYR . 72.9 m-20 -53.96 -40.26 66.69 Favored 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 123.584 0.754 . . . . 75.24 111.857 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.464 HG21 HD11 ' D' ' 13' ' ' ILE . 36.2 mt -78.69 -40.65 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.899 0.88 . . . . 63.41 110.761 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.2 mt -72.36 -20.82 61.39 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.506 -0.77 . . . . 73.11 111.973 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -68.22 -45.3 39.23 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.035 0.934 . . . . 73.24 113.119 -173.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -50.05 -45.77 31.4 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.591 2.194 . . . . 72.12 114.415 169.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.16 -41.57 77.07 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.446 0.698 . . . . 64.44 111.32 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.34 95.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.723 0.809 . . . . 73.23 110.51 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.461 ' HA ' HD23 ' D' ' 128' ' ' LEU . 29.5 ttp180 -59.72 -51.23 70.68 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.41 -1.268 . . . . 74.54 110.385 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.64 -45.81 92.45 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 124.528 1.143 . . . . 75.53 111.154 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.55 -41.34 80.77 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.01 0.819 . . . . 73.45 110.856 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.579 HG12 ' SG ' ' D' ' 76' ' ' CYS . 76.3 mt -63.05 -56.34 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 123.74 0.65 . . . . 64.5 110.262 173.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.3 m -53.7 -39.38 65.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.409 1.083 . . . . 33.42 111.682 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -66.15 -46.28 78.01 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.83 -1.077 . . . . 64.33 109.867 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.3 mtm -69.34 -30.21 68.19 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.002 0.521 . . . . 73.23 112.317 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.49 HG13 ' HB2' ' D' ' 123' ' ' PHE . 72.7 t -66.02 -45.32 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.461 0.704 . . . . 71.52 109.209 175.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -71.51 -33.03 68.87 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 123.391 0.432 . . . . 72.13 110.822 -178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -69.97 -33.03 71.54 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.927 0.891 . . . . 74.22 110.089 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.8 3.28 86.08 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 123.884 0.74 . . . . 73.53 112.463 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.423 HG23 ' HB3' ' C' ' 17' ' ' TYR . 36.4 p 63.1 23.77 14.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.721 2.008 . . . . 33.24 114.446 171.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.49 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.6 m-85 -86.74 151.5 52.68 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 108.924 -0.769 . . . . 73.01 108.924 170.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.07 145.92 31.97 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.352 2.701 . . . . 71.01 113.792 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -54.76 140.19 36.95 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.352 1.061 . . . . 72.22 113.668 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.532 ' HA ' HD11 ' H' ' 468' ' ' LEU . 4.8 tt -119.75 106.69 12.36 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.482 -0.932 . . . . 71.32 108.482 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -108.95 111.57 23.31 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.843 -0.799 . . . . 55.21 108.843 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' D' ' 111' ' ' ARG . 3.1 mm? -73.69 120.28 19.06 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.97 -0.752 . . . . 75.13 108.97 171.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.43 ' H ' ' HA ' ' H' ' 467' ' ' ALA . . . -67.28 137.93 94.14 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 109.812 -0.44 . . . . 64.12 109.812 175.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.85 115.03 3.26 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.385 2.056 . . . . 43.42 111.548 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.7 m -108.04 152.8 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.436 0.694 . . . . 75.32 110.09 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -81.51 96.18 7.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.399 -0.819 . . . . 73.02 109.121 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -63.49 -31.64 72.86 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.653 0.381 . . . . 74.23 111.22 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.429 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 54.9 m-20 -62.09 -57.82 10.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.531 0.732 . . . . 74.11 111.564 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.61 96.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.642 0.777 . . . . 64.44 111.17 -176.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 5.0 mp -67.23 -28.18 67.85 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.16 -0.927 . . . . 73.24 111.797 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -68.72 -34.4 75.56 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.004 0.922 . . . . 74.05 111.333 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 44.4 mtt -68.1 -26.18 65.69 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.169 0.588 . . . . 62.22 110.852 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 22.2 m120 -73.99 -19.78 60.54 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.093 0.557 . . . . 73.44 111.674 176.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 140' ' ' TYR . . . . . 0.484 ' HB2' ' HB2' ' H' ' 461' ' ' PHE . 68.8 t80 -80.81 -40.03 25.66 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.047 0.539 . . . . 65.14 111.56 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.0 -27.95 69.18 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.223 1.009 . . . . 63.34 111.554 -177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -90.23 17.47 7.06 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 123.876 0.87 . . . . 62.35 112.105 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 53.4 mt-30 -119.23 88.59 2.96 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.839 0.856 . . . . 54.12 108.76 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -165.3 103.12 0.74 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.269 -0.878 . . . . 73.2 109.292 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 64.5 -74.25 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.79 1.636 . . . . 62.55 113.157 175.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.8 -140.57 2.96 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 111.852 -0.499 . . . . 74.23 111.852 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -143.88 172.15 13.24 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.737 0.815 . . . . 73.53 110.829 -175.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.05 -135.14 2.48 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.871 -0.604 . . . . 73.4 111.706 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.2 m -99.17 25.87 6.43 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.547 0.739 . . . . 74.34 109.864 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 56.43 77.58 0.24 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.715 1.206 . . . . 52.22 111.21 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.82 79.39 0.87 Allowed 'General case' 0 CA--C 1.549 0.942 0 CA-C-O 122.696 1.236 . . . . 50.15 108.737 171.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -80.75 97.1 7.16 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.059 -1.428 . . . . 73.42 109.578 -171.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -72.3 126.73 30.53 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.333 -0.988 . . . . 73.25 108.333 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -121.26 150.35 41.49 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.521 0.728 . . . . 71.43 110.532 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.834 0 C-N-CA 124.06 0.944 . . . . 55.2 108.483 -179.264 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 109.343 -0.614 . . . . 62.14 109.343 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 13.1 m -114.7 86.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-O 122.326 1.06 . . . . 70.04 108.773 171.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 452' ' ' VAL . . . . . 0.404 HG12 ' HE1' ' A' ' 56' ' ' TYR . 34.3 m -125.03 144.25 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 115.096 -0.956 . . . . 52.54 110.255 -172.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 163.25 -169.23 38.29 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 115.602 -0.727 . . . . 54.2 111.639 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 454' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 95' ' ' ALA . 2.7 tt 65.66 66.31 0.52 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.969 1.307 . . . . 65.2 109.975 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 85.3 m -157.58 110.05 2.41 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.417 1.087 . . . . 65.14 108.834 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -158.22 -54.97 0.07 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.239 -1.022 . . . . 72.03 108.239 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -150.1 129.08 12.59 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.563 -0.902 . . . . 71.14 108.563 173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 76.3 p -92.56 27.27 2.35 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.087 0.955 . . . . 55.31 111.948 -174.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -70.39 106.84 3.54 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.55 0.74 . . . . 70.35 109.205 178.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 460' ' ' LEU . . . . . 0.559 ' H ' HD23 ' E' ' 460' ' ' LEU . 2.6 pt? -120.35 -178.61 3.73 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.602 0.715 . . . . 74.01 111.744 -167.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -86.13 158.05 19.88 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.164 1.386 . . . . 72.14 111.119 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -166.45 134.46 2.78 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.463 1.105 . . . . 74.54 109.147 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 28.8 p -132.96 -77.95 0.49 Allowed 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 123.126 0.571 . . . . 61.21 111.267 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 94.8 mmm 66.66 -75.41 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.515 1.526 . . . . 61.44 111.501 -171.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 61.21 41.97 12.73 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.626 1.17 . . . . 64.34 111.269 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -151.68 176.87 10.95 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.705 0.802 . . . . 44.33 110.359 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 467' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' A' ' 40' ' ' VAL . . . -81.02 17.42 1.23 Allowed 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.892 0.877 . . . . 72.34 112.106 177.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 53.1 mt 68.37 -71.67 0.11 Allowed 'General case' 0 C--N 1.368 1.397 0 C-N-CA 126.413 1.885 . . . . 65.02 110.568 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -171.54 26.15 0.09 OUTLIER Glycine 0 C--N 1.341 0.828 0 O-C-N 123.922 0.764 . . . . 64.31 112.053 175.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 470' ' ' LEU . . . . . 0.638 ' HG ' HD13 ' A' ' 126' ' ' LEU . 70.4 mt -105.72 139.02 40.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.779 0.832 . . . . 70.2 109.936 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 58.4 pttt . . . . . 0 C--O 1.256 1.409 0 C-N-CA 123.526 0.73 . . . . 74.21 109.416 171.347 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 108.944 -0.762 . . . . 73.25 108.944 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' F' F ' 451' ' ' VAL . . . . . 0.445 HG13 HG22 ' F' ' 452' ' ' VAL . 14.5 p -60.36 -24.38 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.604 0.762 . . . . 74.11 112.248 -173.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 452' ' ' VAL . . . . . 0.691 ' HB ' HD23 ' B' ' 98' ' ' LEU . 2.8 m -148.67 159.08 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.107 0.963 . . . . 75.23 111.371 176.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 453' ' ' GLY . . . . . 0.525 ' H ' HD21 ' B' ' 98' ' ' LEU . . . 179.03 91.96 0.08 OUTLIER Glycine 0 C--N 1.357 1.736 0 CA-C-N 115.342 -0.844 . . . . 54.21 112.187 176.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 454' ' ' LEU . . . . . 0.484 ' HB2' HD22 ' B' ' 98' ' ' LEU . 30.0 tp -88.16 132.14 34.45 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.45 0.7 . . . . 45.52 110.418 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 41.0 m -149.52 144.54 26.33 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.193 0.997 . . . . 75.31 108.467 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -100.01 143.65 29.97 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.34 0.656 . . . . 72.3 110.309 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -72.37 -39.75 67.82 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.589 0.756 . . . . 44.14 110.263 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 19.6 p -145.86 -59.09 0.32 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.401 1.08 . . . . 72.13 109.015 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -151.75 165.94 32.89 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.534 1.134 . . . . 71.0 108.49 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.85 140.16 39.34 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.177 -0.675 . . . . 71.04 109.177 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 461' ' ' PHE . . . . . 0.418 ' HB3' ' HD1' ' B' ' 140' ' ' TYR . 48.7 p90 -67.19 135.75 53.97 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.534 0.734 . . . . 70.4 112.06 -174.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -141.33 119.49 12.08 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.869 -1.16 . . . . 63.35 107.869 172.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 22.3 p -134.8 -41.04 0.76 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.007 0.923 . . . . 41.23 108.901 173.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 25.8 ttt 69.54 -78.75 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.443 1.497 . . . . 51.24 110.181 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -172.66 -58.92 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.872 1.269 . . . . 65.3 108.153 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -163.19 -63.38 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.827 0.851 . . . . 75.3 108.873 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -155.71 -178.27 7.17 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.845 1.258 . . . . 62.43 109.059 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 5.8 tt -80.34 -47.52 14.36 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.175 -0.676 . . . . 75.02 109.175 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.61 72.41 1.21 Allowed Glycine 0 C--N 1.341 0.832 0 N-CA-C 110.799 -0.92 . . . . 64.25 110.799 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 88.4 mt -80.95 96.73 7.17 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.25 0.62 . . . . 72.44 109.623 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? . . . . . 0 CA--C 1.56 1.337 0 C-N-CA 125.048 1.339 . . . . 63.31 108.924 -177.028 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 16.5 m120 . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 109.935 -0.394 . . . . 65.21 109.935 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' G' G ' 451' ' ' VAL . . . . . 0.401 HG22 ' HB3' ' C' ' 90' ' ' GLU . 45.5 t -70.43 160.14 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 N-CA-C 108.287 -1.005 . . . . 60.51 108.287 171.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 452' ' ' VAL . . . . . 0.422 ' N ' ' SD ' ' C' ' 94' ' ' MET . 60.8 t 71.3 120.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.207 1.403 . . . . 65.41 111.603 -174.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 139.74 80.33 0.07 OUTLIER Glycine 0 C--N 1.35 1.352 0 N-CA-C 112.382 -0.287 . . . . 60.02 112.382 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 454' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' C' ' 98' ' ' LEU . 8.6 mp -102.0 -175.96 2.99 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.99 0.916 . . . . 54.34 110.774 177.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 22.3 p -80.58 156.67 26.33 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.714 1.206 . . . . 72.15 110.431 175.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -58.91 122.41 13.57 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.568 0.747 . . . . 75.2 111.166 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 457' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 61.3 tp60 78.19 -48.02 0.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.44 1.896 . . . . 74.32 112.744 176.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 458' ' ' THR . . . . . 0.623 HG21 ' HA2' ' C' ' 99' ' ' GLY . 27.6 m 68.31 89.22 0.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.713 1.205 . . . . 75.34 108.829 -163.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.24 156.5 37.17 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.283 -0.872 . . . . 61.42 111.233 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 460' ' ' LEU . . . . . 0.495 ' HB3' ' HD1' ' G' ' 462' ' ' TYR . 4.2 mm? -100.37 168.67 9.61 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.872 0.844 . . . . 74.52 111.197 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -164.0 26.37 0.08 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 113.958 -1.474 . . . . 73.32 109.06 -162.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 462' ' ' TYR . . . . . 0.515 ' HA ' HD13 ' C' ' 136' ' ' LEU . 19.0 p90 -74.37 83.75 1.94 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.335 1.064 . . . . 75.21 110.96 -170.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 36.0 p -85.01 85.12 7.52 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.24 -0.891 . . . . 63.42 109.797 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 464' ' ' MET . . . . . 0.416 ' HG3' HG12 ' C' ' 131' ' ' VAL . 16.3 tmm? -121.84 147.27 46.19 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.939 -0.763 . . . . 74.2 108.939 177.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 465' ' ' LYS . . . . . 0.444 ' HA ' ' HE3' ' G' ' 465' ' ' LYS . 1.4 tpmt? -58.48 -60.87 3.12 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.712 1.205 . . . . 72.25 112.981 -168.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -110.64 -147.05 0.41 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.784 0.834 . . . . 63.32 110.447 -171.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -150.33 -55.86 0.17 Allowed 'General case' 0 C--O 1.242 0.685 0 N-CA-C 107.961 -1.126 . . . . 70.52 107.961 175.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -167.58 -164.23 0.56 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.807 -1.542 . . . . 50.54 108.494 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 469' ' ' GLY . . . . . 0.534 ' HA3' ' H ' ' C' ' 155' ' ' ALA . . . -83.76 -97.62 0.59 Allowed Glycine 0 C--N 1.349 1.297 0 CA-C-O 119.587 -0.563 . . . . 61.32 112.333 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 60.8 mt 55.8 77.06 0.25 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.94 1.296 . . . . 53.22 112.187 -173.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.35 0 CA-C-O 118.532 -0.747 . . . . 63.1 109.452 172.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 450' ' ' ASN . . . . . 0.476 ' ND2' HG13 ' H' ' 451' ' ' VAL . 1.7 t30 . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 109.972 -0.381 . . . . 71.55 109.972 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 451' ' ' VAL . . . . . 0.669 HG23 HG23 ' H' ' 452' ' ' VAL . 27.7 m -114.78 -179.87 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 123.005 0.522 . . . . 72.42 111.175 175.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 452' ' ' VAL . . . . . 0.669 HG23 HG23 ' H' ' 451' ' ' VAL . 22.4 t 74.01 132.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.388 1.875 . . . . 34.2 112.114 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -161.82 95.36 0.13 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.185 -1.166 . . . . 31.01 110.185 174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 454' ' ' LEU . . . . . 0.683 HD23 ' HB3' ' D' ' 94' ' ' MET . 3.1 pp -127.72 170.13 13.06 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.311 0.577 . . . . 75.21 111.083 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 40.1 p -97.35 162.86 13.14 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.556 -1.202 . . . . 72.43 109.439 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.57 81.46 1.09 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.182 0.993 . . . . 60.01 111.386 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 51.38 -150.94 0.26 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.882 1.273 . . . . 72.2 113.445 168.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 4.4 t -158.84 -54.31 0.06 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.543 0.337 . . . . 72.42 111.422 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -175.56 166.61 3.24 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.597 0.759 . . . . 65.41 109.674 -171.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 460' ' ' LEU . . . . . 0.406 HD22 ' H ' ' D' ' 44' ' ' LEU . 39.1 tp -66.99 151.48 47.57 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.13 0.572 . . . . 64.22 109.847 172.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 461' ' ' PHE . . . . . 0.484 ' HB2' ' HB2' ' D' ' 140' ' ' TYR . 17.2 p90 -124.27 16.38 9.07 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.373 0.879 . . . . 73.32 113.373 -168.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 462' ' ' TYR . . . . . 0.427 ' HE2' ' SD ' ' H' ' 464' ' ' MET . 21.3 p90 -165.65 156.77 13.88 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 120.807 0.337 . . . . 73.31 111.323 178.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 56.8 m -91.59 103.66 16.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.588 0.755 . . . . 70.5 109.343 173.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 464' ' ' MET . . . . . 0.427 ' SD ' ' HE2' ' H' ' 462' ' ' TYR . 14.2 tpt -77.44 105.56 8.65 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.359 0.663 . . . . 73.12 110.073 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -117.42 -50.72 2.53 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.587 1.155 . . . . 54.3 109.252 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -72.6 98.24 2.29 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 114.339 -1.301 . . . . 75.11 110.177 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 467' ' ' ALA . . . . . 0.43 ' HA ' ' H ' ' D' ' 129' ' ' ALA . . . -153.72 -67.48 0.14 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.536 -0.757 . . . . 73.14 109.594 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 468' ' ' LEU . . . . . 0.532 HD11 ' HA ' ' D' ' 126' ' ' LEU . 3.4 mm? -99.37 -53.24 3.28 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.125 0.97 . . . . 75.25 109.584 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.04 -36.08 3.79 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.551 -0.749 . . . . 71.05 112.66 -174.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 470' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' D' ' 39' ' ' GLU . 2.8 mm? 58.5 39.96 24.43 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.213 1.405 . . . . 62.32 110.562 -178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? . . . . . 0 CA--C 1.555 1.173 0 CA-C-N 114.401 -1.272 . . . . 73.25 110.366 -177.356 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.5 mtp . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 109.386 -0.598 . . . . 44.5 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.0 p -150.84 113.15 4.61 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.297 -1.001 . . . . 73.4 108.297 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.85 157.0 34.16 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.806 0.842 . . . . 75.33 111.402 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -138.86 136.53 35.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.416 0.686 . . . . 74.44 109.749 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -135.39 -7.94 2.24 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.607 0.763 . . . . 73.23 111.184 -169.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -70.85 88.43 0.74 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.217 0.532 . . . . 74.45 110.457 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -81.87 -38.07 25.96 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.859 0.863 . . . . 54.33 109.597 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -73.27 139.07 45.89 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.063 -0.971 . . . . 71.45 110.154 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.492 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 4.5 ppp? -72.33 158.59 35.52 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.658 -0.701 . . . . 74.14 111.614 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.3 m -143.99 136.76 27.16 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.896 0.879 . . . . 72.22 109.071 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.623 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.6 t80 -136.21 129.71 32.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.062 -0.718 . . . . 71.42 109.062 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 48.1 tp60 -149.87 109.6 4.05 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.947 0.899 . . . . 73.53 109.04 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.539 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.4 mt -78.59 112.53 16.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.408 -0.96 . . . . 61.13 108.408 174.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.9 -41.83 25.35 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.825 -0.625 . . . . 61.23 109.317 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -171.19 123.57 0.59 Allowed 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.157 0.286 . . . . 75.31 111.185 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.615 HD12 ' HG3' ' C' ' 130' ' ' PRO . 72.2 mt -111.95 136.26 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.74 0.816 . . . . 64.32 109.166 174.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 24.9 p90 -166.52 177.8 6.45 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.204 0.94 . . . . 70.01 110.928 -171.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -103.08 120.23 40.3 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.459 -0.791 . . . . 61.22 109.01 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 27.2 mtpt -84.77 -38.42 19.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.404 -0.591 . . . . 73.2 109.404 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.719 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.7 t70 -138.97 136.28 35.22 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.063 -0.971 . . . . 74.31 109.534 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 49.7 mt -133.55 146.68 31.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.116 -1.438 . . . . 74.11 107.116 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.1 t -155.16 145.71 22.17 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.636 0.585 . . . . 54.23 109.811 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.449 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.6 t80 -145.89 131.72 19.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.926 -1.509 . . . . 73.22 106.926 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -138.72 129.96 27.05 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.721 -0.844 . . . . 72.41 108.721 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -129.43 81.41 70.1 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.316 -0.994 . . . . 74.51 108.316 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.26 -25.91 25.8 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.024 2.482 . . . . 70.22 112.986 -172.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 31' ' ' VAL . 51.4 m-80 -114.67 24.11 12.1 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.411 0.685 . . . . 64.15 110.445 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -52.1 -49.31 85.13 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 113.705 1.002 . . . . 73.24 113.705 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.54 -21.83 18.99 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 121.982 1.788 . . . . 74.22 111.964 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -80.1 -23.04 41.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.98 -1.009 . . . . 74.21 111.006 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 86.2 t -59.96 -24.65 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.637 0.775 . . . . 74.15 111.3 177.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -56.96 -38.85 73.54 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.852 0.861 . . . . 63.21 111.188 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -93.11 -20.92 20.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.497 0.719 . . . . 72.44 110.921 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.533 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 30.7 mmmt -79.86 143.41 34.34 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.62 0.768 . . . . 73.24 111.468 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.27 121.12 20.8 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.34 -0.985 . . . . 72.03 108.34 168.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -68.88 89.91 0.42 Allowed 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.472 0.482 . . . . 71.52 110.689 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -144.13 81.55 11.48 Favored Pre-proline 0 C--O 1.245 0.834 0 N-CA-C 107.519 -1.289 . . . . 74.5 107.519 167.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 95.5 Cg_endo -81.94 157.66 18.13 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.693 2.262 . . . . 73.43 112.798 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.413 ' HB3' ' HE3' ' A' ' 41' ' ' LYS . 16.6 mm-40 -95.74 99.97 11.74 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.084 -1.08 . . . . 75.55 108.084 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.2 m -71.21 94.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-O 122.292 1.044 . . . . 72.21 110.776 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 39' ' ' GLU . 97.6 mttt -110.03 135.63 50.56 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.753 -1.112 . . . . 74.12 109.443 -177.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.523 ' HB3' ' H ' ' E' ' 466' ' ' ALA . 39.5 tp -136.15 126.6 26.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.076 0.55 . . . . 65.42 110.737 -175.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.412 ' HA ' ' OH ' ' E' ' 462' ' ' TYR . 16.7 m-20 -126.42 131.29 51.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.83 0.852 . . . . 62.33 109.397 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.64 HD22 HG12 ' A' ' 62' ' ' VAL . 54.5 mt -119.69 134.33 55.27 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.413 0.685 . . . . 61.03 110.518 -175.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 8.2 m-20 -125.8 141.15 52.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.799 1.24 . . . . 74.43 108.188 173.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.5 m -126.32 129.85 49.66 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.006 -0.739 . . . . 73.31 109.006 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.58 153.95 50.5 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.438 1.095 . . . . 63.45 108.491 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB3' HD12 ' E' ' 454' ' ' LEU . 26.7 t -126.72 152.95 46.14 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 120.911 0.386 . . . . 53.24 110.17 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.5 t -149.45 121.41 8.22 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.386 1.074 . . . . 63.5 108.766 -176.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -74.28 125.85 29.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.092 0.557 . . . . 73.31 109.69 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.5 mt -95.49 -34.42 12.08 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.316 0.646 . . . . 75.12 110.421 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.0 177.36 10.83 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.08 0.952 . . . . 74.33 109.268 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -66.22 125.75 26.53 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.287 -0.634 . . . . 73.35 109.287 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 70.82 3.59 4.67 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.056 1.343 . . . . 73.42 112.142 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.75 115.0 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.251 1.021 . . . . 63.4 108.621 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -126.77 156.29 41.46 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.59 0.756 . . . . 74.1 109.604 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -130.19 142.85 50.54 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.266 -1.013 . . . . 62.4 108.266 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.51 139.91 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 108.241 -1.022 . . . . 75.31 108.241 165.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -112.41 107.34 22.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 107.824 -1.176 . . . . 65.24 107.824 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.8 tp -88.94 100.76 13.45 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.332 -0.849 . . . . 61.12 109.11 178.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 14.0 ttm-85 -84.46 107.89 16.96 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.65 -0.704 . . . . 62.22 109.155 175.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.64 HG12 HD22 ' A' ' 44' ' ' LEU . 19.8 m -103.96 130.22 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 123.857 0.863 . . . . 70.13 109.559 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.1 m -121.26 116.36 24.74 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.641 0.777 . . . . 72.24 110.075 -176.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.3 t -116.14 121.45 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.486 1.114 . . . . 64.41 108.83 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.6 m -126.71 124.9 40.85 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.347 -0.983 . . . . 63.44 108.347 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -125.56 105.24 8.89 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.163 -0.68 . . . . 72.32 109.163 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 42.4 t -116.73 128.86 55.73 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.377 0.671 . . . . 73.41 111.207 -173.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' A' ' 73' ' ' ALA . 5.1 mp -89.92 86.37 6.6 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.223 -1.399 . . . . 75.3 107.223 175.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.08 -104.88 2.07 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.512 -1.035 . . . . 73.41 110.512 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -109.23 -14.02 14.55 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.179 0.592 . . . . 75.34 110.534 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -85.48 95.97 9.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.934 0.894 . . . . 75.43 110.118 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 26.5 m -67.44 125.46 26.21 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 123.441 0.463 . . . . 43.24 110.535 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.491 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -78.01 -54.06 6.72 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.318 -0.856 . . . . 61.01 109.003 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -146.59 155.47 42.5 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.429 -1.26 . . . . 63.44 110.878 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.7 tp -133.48 132.07 40.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.527 -1.657 . . . . 54.33 106.527 176.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 85.1 m -133.92 110.44 9.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.342 -0.614 . . . . 74.22 109.342 -174.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -124.38 117.07 23.63 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.044 0.938 . . . . 71.35 109.118 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.4 ' O ' HG22 ' A' ' 62' ' ' VAL . 75.3 t -132.91 111.33 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.221 0.608 . . . . 74.21 109.817 -173.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.719 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 26.3 mt-30 -87.81 87.12 7.27 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 108.609 -0.886 . . . . 75.4 108.609 167.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.408 ' HG3' HD22 ' A' ' 106' ' ' LEU . 62.8 tp60 -76.91 116.63 17.75 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.919 -1.037 . . . . 63.43 108.448 176.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.84 144.25 18.35 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.56 -0.616 . . . . 71.2 111.56 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.477 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.99 134.22 6.06 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 111.167 -0.773 . . . . 74.51 111.167 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.3 mt -82.89 115.43 25.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.645 -0.872 . . . . 52.31 108.645 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.623 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.4 m-85 -122.29 117.7 26.74 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.857 0.863 . . . . 74.23 108.937 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 12.6 m -90.81 89.94 7.7 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.321 -0.992 . . . . 52.24 108.321 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.7 pt -109.74 139.72 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.347 -0.842 . . . . 62.51 110.766 -172.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.8 168.95 25.56 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.846 -1.07 . . . . 64.11 109.695 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 81.11 9.61 85.93 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.606 0.566 . . . . 74.05 114.039 174.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.15 153.69 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.126 0.57 . . . . 64.24 110.603 -176.616 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -160.43 -172.48 3.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.669 0.788 . . . . 73.23 110.506 -171.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.1 -143.34 48.47 Favored Glycine 0 C--N 1.359 1.824 0 O-C-N 123.537 0.523 . . . . 43.41 112.636 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.9 t -86.44 -11.24 52.39 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 122.866 0.466 . . . . 74.45 111.038 166.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -33.99 74.83 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.925 0.89 . . . . 73.24 109.827 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -31.71 70.8 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.375 0.27 . . . . 63.45 110.966 173.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.68 -28.18 55.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.65 0.78 . . . . 61.21 110.826 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 43.8 t-80 -69.73 -29.36 66.71 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.136 0.574 . . . . 64.5 110.313 170.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 78.0 m -69.69 -49.34 54.39 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.489 0.316 . . . . 71.32 110.928 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 pp -85.16 -18.93 32.65 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.017 0.527 . . . . 52.14 112.339 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.69 3.87 27.63 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-O 119.782 -0.455 . . . . 63.11 114.117 -173.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -148.09 -63.57 0.26 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.33 0.565 . . . . 74.45 111.378 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -61.66 -66.0 0.6 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.367 1.467 . . . . 72.11 112.826 -168.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.401 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 95.9 m -73.9 -37.98 3.6 Favored Pre-proline 0 CA--C 1.569 1.675 0 N-CA-C 114.701 1.371 . . . . 44.13 114.701 -175.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 35.8 Cg_endo -64.55 -24.53 63.18 Favored 'Trans proline' 0 C--N 1.388 2.626 0 CA-C-N 121.837 1.692 . . . . 71.34 113.369 173.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -69.43 -29.78 67.57 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.017 0.527 . . . . 72.55 110.13 177.656 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.4 mm -62.66 -40.66 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.443 0.697 . . . . 53.15 110.184 176.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.477 HD21 ' HA3' ' A' ' 82' ' ' GLY . 96.3 mt -79.53 -19.24 50.06 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.166 0.986 . . . . 74.13 112.967 -175.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -59.4 -47.74 97.38 Favored Pre-proline 0 CA--C 1.569 1.693 0 N-CA-C 113.584 0.957 . . . . 74.44 113.584 -172.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.9 -37.05 57.08 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.061 1.841 . . . . 74.33 113.096 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -67.31 -40.22 85.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.319 0.648 . . . . 74.12 111.153 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.474 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.59 -42.65 86.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.151 0.58 . . . . 64.44 110.137 177.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -50.31 -53.68 26.92 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.475 1.11 . . . . 75.42 110.506 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -68.65 -38.05 80.14 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.394 -0.821 . . . . 63.2 111.433 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.37 -34.18 74.89 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.107 0.48 . . . . 74.14 111.095 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 118' ' ' VAL . 60.7 mt -69.49 -57.25 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.132 -0.94 . . . . 71.22 109.624 172.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -55.35 -37.07 67.01 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.869 1.268 . . . . 74.21 111.923 -172.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.4 t -65.38 -50.3 66.05 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.117 -0.947 . . . . 73.51 109.903 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.449 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 67.6 mtm -62.27 -37.84 87.04 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.173 0.589 . . . . 74.34 111.454 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 114' ' ' ILE . 99.3 t -59.57 -49.12 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.676 0.79 . . . . 75.41 110.062 176.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.3 m -69.74 -29.78 67.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.537 -0.756 . . . . 72.54 111.615 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -72.8 -26.96 61.7 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.638 0.775 . . . . 72.21 110.126 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.87 6.64 77.84 Favored Glycine 0 C--N 1.354 1.563 0 O-C-N 123.685 0.616 . . . . 34.24 112.913 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.478 ' HB ' HH21 ' B' ' 15' ' ' ARG . 22.9 m 67.66 15.48 9.72 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.534 1.134 . . . . 71.01 111.175 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.463 ' HE1' HG21 ' A' ' 31' ' ' VAL . 63.6 m-85 -87.82 140.93 31.36 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 108.546 -0.909 . . . . 62.12 108.546 174.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -49.45 148.23 11.4 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.267 2.645 . . . . 75.32 113.25 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -59.63 129.46 42.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.5 0.72 . . . . 73.11 112.236 -173.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.51 HD13 ' HB2' ' E' ' 470' ' ' LEU . 41.8 tp -110.18 101.55 10.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.121 0.968 . . . . 65.21 109.844 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -102.25 103.79 14.3 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.142 -1.059 . . . . 71.31 108.142 171.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.61 154.58 41.31 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.661 0.384 . . . . 73.32 110.575 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.418 ' HB3' ' SD ' ' E' ' 464' ' ' MET . . . -69.56 142.84 92.17 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.363 0.665 . . . . 54.44 111.079 -175.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.33 127.91 13.14 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.343 2.029 . . . . 72.44 112.771 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' E' ' 464' ' ' MET . 76.8 t -102.28 115.06 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.856 0.862 . . . . 75.03 108.878 175.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -92.14 85.91 5.62 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.671 -1.233 . . . . 70.23 107.671 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 91.8 m-85 -59.05 -31.6 69.01 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.745 -1.116 . . . . 52.43 113.203 -169.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.12 -36.67 83.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.351 0.26 . . . . 74.34 111.419 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.62 -38.17 89.19 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.109 0.563 . . . . 73.34 110.895 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.586 HD13 ' HA ' ' E' ' 462' ' ' TYR . 97.6 mt -66.5 -39.38 88.69 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.211 -0.904 . . . . 64.1 111.311 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -68.61 -25.91 65.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.998 -0.546 . . . . 73.35 110.833 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 17.0 mmt -60.71 -34.3 74.18 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.04 0.536 . . . . 50.31 111.665 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -66.32 -24.09 66.47 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.841 0.856 . . . . 61.22 111.612 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -91.84 -44.64 8.83 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.837 0.855 . . . . 73.14 110.78 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.4 tp -68.18 -46.08 71.67 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.484 1.114 . . . . 70.44 112.361 -171.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.549 ' HB3' ' HG2' ' A' ' 144' ' ' GLN . 1.4 mm-40 -145.62 4.06 1.0 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.949 0.499 . . . . 74.54 110.555 -172.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 62.68 20.63 12.19 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.654 1.181 . . . . 71.25 111.567 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.549 ' HG2' ' HB3' ' A' ' 142' ' ' GLN . 73.0 mm-40 -95.19 163.45 13.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.211 0.604 . . . . 75.13 110.18 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.41 33.55 1.23 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.023 0.929 . . . . 72.14 110.817 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.2 -61.49 4.71 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 116.027 -0.533 . . . . 71.43 111.921 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 62.57 97.36 0.03 OUTLIER 'General case' 0 C--N 1.357 0.907 0 C-N-CA 125.251 1.42 . . . . 75.43 110.773 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -108.05 113.69 3.95 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.095 -0.802 . . . . 72.34 111.095 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.9 m -68.15 101.91 1.25 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.146 0.578 . . . . 72.41 110.23 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.74 133.15 35.16 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.145 -0.934 . . . . 74.42 109.478 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.411 ' HB3' ' NE2' ' C' ' 142' ' ' GLN . 39.0 tt0 -144.57 139.63 28.26 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.53 -1.285 . . . . 75.4 107.53 171.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -71.3 87.68 0.84 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.621 0.768 . . . . 72.12 111.824 -170.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' C' ' 141' ' ' LEU . 59.6 tp60 -84.76 105.45 15.56 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.5 -1.296 . . . . 74.21 107.5 163.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -78.36 84.91 4.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.175 0.59 . . . . 72.31 109.601 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.289 0 CA-C-N 115.443 -0.799 . . . . 71.21 109.585 178.603 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.7 mtt . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.575 -0.528 . . . . 73.43 109.575 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 44.8 m -140.74 -49.13 0.43 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.471 0.708 . . . . 75.42 110.233 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.18 135.32 54.35 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 109.866 -0.42 . . . . 72.21 109.866 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -150.36 103.18 3.12 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.979 0.419 . . . . 63.22 110.64 -177.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -104.59 163.63 12.34 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.95 1.3 . . . . 73.42 108.65 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -148.61 172.72 14.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.836 0.854 . . . . 60.1 109.743 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.8 m -82.55 84.97 7.05 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.346 -0.983 . . . . 73.22 108.346 167.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -74.59 -66.9 0.68 Allowed 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.241 -0.891 . . . . 74.14 108.863 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.546 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 23.2 ptm 42.55 -165.14 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.989 1.715 . . . . 73.41 112.663 -171.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 81.0 m -153.78 137.88 16.45 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.415 -1.328 . . . . 73.42 107.415 173.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -150.79 142.14 23.33 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.991 -0.374 . . . . 71.2 109.991 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -159.11 141.94 14.28 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 123.919 0.762 . . . . 63.43 109.644 169.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.545 HD13 HD11 ' B' ' 16' ' ' ILE . 45.8 mt -80.26 125.39 39.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.877 -0.786 . . . . 65.45 108.877 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -96.3 -35.52 11.2 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.343 0.657 . . . . 74.45 109.609 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.478 HH21 ' HB ' ' A' ' 122' ' ' THR . 56.6 ttt180 -170.66 131.92 0.91 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.529 -0.76 . . . . 72.33 109.557 -176.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.545 HD11 HD13 ' B' ' 13' ' ' ILE . 87.2 mt -114.89 136.33 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 106.641 -1.614 . . . . 64.31 106.641 168.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -166.48 162.97 17.17 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.695 0.622 . . . . 61.14 111.306 -174.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.646 HG21 HD11 ' B' ' 21' ' ' ILE . 27.5 m -98.32 127.4 44.24 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.444 -0.947 . . . . 71.13 108.444 176.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -98.05 -23.72 15.64 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.745 0.818 . . . . 73.45 111.018 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 9.3 t70 -158.78 139.33 12.55 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.142 0.276 . . . . 70.3 111.188 -170.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.646 HD11 HG21 ' B' ' 18' ' ' THR . 40.8 mm -135.79 149.15 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.598 1.159 . . . . 74.04 108.754 175.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 17.7 m -146.89 143.62 28.67 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.524 1.13 . . . . 73.23 109.082 165.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -152.2 108.77 3.45 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.662 -1.236 . . . . 72.33 107.662 169.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -122.08 118.18 28.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.262 1.025 . . . . 72.12 108.399 -174.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -116.45 84.22 14.41 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.264 1.026 . . . . 72.11 108.549 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.23 -40.49 19.34 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.872 2.381 . . . . 62.43 112.585 -174.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -96.67 13.8 27.09 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.987 -1.006 . . . . 70.11 111.078 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.44 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -40.29 -62.75 0.85 Allowed Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 115.086 1.513 . . . . 71.42 115.086 -164.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 6.7 Cg_exo -69.4 -25.58 30.13 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 121.721 1.614 . . . . 61.13 112.204 -171.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 69.7 m80 -95.44 -25.43 16.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.865 -1.061 . . . . 73.32 111.731 -170.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.672 HG22 HD12 ' B' ' 68' ' ' LEU . 8.7 p -83.9 -18.25 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.995 0.518 . . . . 64.03 110.981 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -61.11 -30.91 70.64 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.309 0.855 . . . . 73.34 113.309 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 28.7 pt20 -61.27 -18.12 56.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.831 0.452 . . . . 72.12 111.608 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -92.29 82.87 4.97 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.146 0.978 . . . . 71.15 108.865 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -86.52 90.83 8.36 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.281 -0.637 . . . . 72.53 109.281 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.7 t-105 -158.15 156.12 30.32 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.898 1.279 . . . . 71.11 107.988 174.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.553 ' HB3' HD22 ' F' ' 470' ' ' LEU . 20.9 mm-40 -59.79 104.76 0.47 Allowed Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.991 1.316 . . . . 71.11 111.295 173.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.616 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 60.9 Cg_endo -74.45 128.17 11.71 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.689 2.26 . . . . 64.01 112.415 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.88 125.74 24.81 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 123.565 0.541 . . . . 74.12 109.911 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.592 HG12 ' HB2' ' B' ' 66' ' ' ALA . 25.2 m -104.67 153.32 6.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.848 -0.615 . . . . 70.5 111.014 -176.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.462 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 79.4 tttt -108.71 117.98 35.59 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.789 -1.189 . . . . 75.33 107.789 169.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.501 HD21 ' HB1' ' F' ' 467' ' ' ALA . 0.6 OUTLIER -96.38 140.67 30.7 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.877 0.471 . . . . 74.21 110.23 176.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.558 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 6.1 t70 -145.42 155.85 43.4 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.616 -0.883 . . . . 74.23 108.616 -177.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' F' ' 461' ' ' PHE . 1.5 pt? -115.51 163.12 16.22 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.596 0.712 . . . . 75.34 110.771 -175.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.581 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.0 t70 -163.64 111.3 1.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.19 -1.411 . . . . 74.31 107.19 167.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.6 p -128.73 125.34 37.74 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.167 0.587 . . . . 71.54 110.239 -172.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.66 159.47 41.89 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.034 0.934 . . . . 41.23 109.932 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.9 p -133.29 159.24 40.84 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.138 0.575 . . . . 73.41 109.678 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 98.1 p -153.1 140.75 19.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.173 0.589 . . . . 71.34 109.582 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -89.01 115.84 26.86 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.882 0.473 . . . . 70.01 109.996 176.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.96 -39.91 17.56 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.682 0.793 . . . . 64.23 109.207 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.43 -176.51 5.83 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.594 1.158 . . . . 74.12 109.717 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -67.43 126.15 28.37 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.851 -0.613 . . . . 62.32 110.033 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' B' ' 85' ' ' SER . 7.2 m-20 69.02 -9.95 0.55 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.093 1.757 . . . . 74.34 112.487 -173.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.9 t -105.63 104.13 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.789 -0.819 . . . . 62.4 108.789 -172.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -115.18 168.08 10.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.413 -1.267 . . . . 74.4 108.979 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -143.64 117.43 9.3 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.848 -1.168 . . . . 74.14 107.848 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.88 144.71 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.591 1.156 . . . . 75.54 109.247 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.5 t -127.82 119.82 52.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.088 -0.708 . . . . 62.13 109.088 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -98.28 114.7 27.08 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.642 -1.614 . . . . 71.54 106.642 172.109 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.581 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 3.7 ttt180 -111.56 125.89 54.4 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.409 -0.589 . . . . 73.34 109.409 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 49.5 t -114.3 116.21 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.681 1.192 . . . . 74.22 108.429 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.8 m -97.61 137.03 37.14 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.18 -0.674 . . . . 75.44 109.18 173.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 76.9 t -133.02 126.22 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.859 0.864 . . . . 60.24 109.529 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 91.9 m -124.66 107.16 10.7 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.373 0.669 . . . . 75.11 110.236 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.592 ' HB2' HG12 ' B' ' 40' ' ' VAL . . . -106.5 151.83 24.47 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.217 0.607 . . . . 75.23 110.992 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 57.0 p -153.24 139.86 18.85 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.051 -0.977 . . . . 73.24 110.497 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.672 HD12 HG22 ' B' ' 31' ' ' VAL . 48.5 mt -107.87 102.33 11.54 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.28 1.032 . . . . 74.23 109.201 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.08 -110.18 3.2 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.609 -0.723 . . . . 72.12 112.733 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.94 2.81 46.81 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.637 0.775 . . . . 71.31 111.138 -169.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.07 158.13 43.9 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.967 0.507 . . . . 75.11 110.875 -170.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -65.82 143.71 57.31 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.955 0.785 . . . . 75.12 111.171 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.471 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -96.18 -70.22 0.72 Allowed 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.508 -0.923 . . . . 71.02 108.508 169.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -148.6 153.03 37.77 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.167 -0.924 . . . . 70.45 109.466 -173.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 23.4 mt -131.12 109.44 10.46 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.538 -1.282 . . . . 52.14 107.538 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.0 t -119.96 147.32 44.9 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.816 -0.439 . . . . 63.44 109.816 -175.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -157.6 133.69 9.47 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 109.486 -0.561 . . . . 63.44 109.486 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 89.6 t -129.62 148.52 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.4 0.68 . . . . 73.11 109.474 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.0 mt-30 -118.33 98.9 6.51 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.75 -1.204 . . . . 73.53 107.75 166.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -85.89 99.55 11.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.1 -1.074 . . . . 74.1 108.1 171.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.68 169.81 35.98 Favored Glycine 0 C--O 1.242 0.626 0 N-CA-C 111.228 -0.749 . . . . 62.15 111.228 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.42 127.74 1.59 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 112.111 -0.396 . . . . 73.22 112.111 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 46.8 mt -84.53 120.78 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 107.727 -1.212 . . . . 71.15 107.727 171.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -128.41 135.11 49.06 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.84 0.856 . . . . 75.35 109.211 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 67.5 m -93.91 117.25 29.84 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 110.045 -0.354 . . . . 54.32 110.045 172.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.597 HD13 HD21 ' B' ' 98' ' ' LEU . 45.3 pt -117.11 146.81 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.821 1.248 . . . . 70.21 110.025 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.637 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -152.69 161.37 42.65 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.391 1.077 . . . . 75.55 108.62 170.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 84.86 -28.76 4.38 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 113.794 0.278 . . . . 62.13 113.794 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.89 140.06 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 124.608 1.163 . . . . 71.0 112.209 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.539 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 36.0 tt0 -162.71 144.81 10.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.25 0.62 . . . . 65.22 110.175 -177.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.39 -113.3 5.58 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.578 0.548 . . . . 61.24 113.768 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 88.4 m -82.14 -24.32 35.13 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.609 0.764 . . . . 73.35 111.17 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.539 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 44.2 mt-30 -60.52 -43.87 96.66 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.044 0.537 . . . . 61.24 111.271 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -65.02 -36.49 84.55 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.41 0.444 . . . . 54.44 110.269 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.67 -37.35 86.26 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.229 1.012 . . . . 75.13 111.157 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -82.68 -29.36 29.99 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.234 0.614 . . . . 73.03 110.858 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -67.09 -64.39 0.86 Allowed 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.661 0.601 . . . . 74.51 110.177 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.597 HD21 HD13 ' B' ' 86' ' ' ILE . 60.2 mt -81.76 -18.57 43.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.837 0.455 . . . . 71.03 111.173 -176.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.46 -35.53 11.85 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.427 0.454 . . . . 55.24 113.955 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.451 ' HB1' ' HD1' ' B' ' 133' ' ' PHE . . . -134.99 -41.16 0.75 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.033 0.753 . . . . 65.4 113.033 -167.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -77.44 -48.61 16.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.659 0.784 . . . . 74.43 111.277 -170.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.48 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 86.5 m -64.88 -48.0 73.17 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.684 0.794 . . . . 71.53 110.859 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 53.4 Cg_exo -58.05 -30.29 89.69 Favored 'Trans proline' 0 C--N 1.397 3.105 0 C-N-CA 122.085 1.856 . . . . 74.51 114.339 170.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -61.06 -42.17 97.98 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 123.084 0.554 . . . . 64.24 110.856 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.88 -40.94 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 115.357 -0.838 . . . . 24.33 110.105 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.3 mt -77.65 -20.99 52.89 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.729 -1.123 . . . . 73.2 112.125 -174.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -59.71 -50.65 85.8 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 114.269 1.211 . . . . 73.34 114.269 -171.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.87 -31.74 95.96 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 121.755 1.637 . . . . 72.54 113.087 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -73.32 -47.21 44.4 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.462 0.705 . . . . 73.33 110.965 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.99 -43.07 81.34 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.287 0.635 . . . . 60.42 110.291 175.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -60.08 -51.2 70.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.371 1.468 . . . . 75.14 111.204 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.82 -34.91 79.24 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.12 0.568 . . . . 62.42 109.794 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.8 t -70.71 -34.85 72.37 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.962 0.505 . . . . 73.33 111.665 -177.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.476 ' O ' HG23 ' B' ' 118' ' ' VAL . 58.8 mt -65.34 -55.87 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 109.178 -0.675 . . . . 71.51 109.178 173.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 15.5 m -59.76 -27.5 66.58 Favored 'General case' 0 CA--C 1.552 1.043 0 O-C-N 124.001 0.813 . . . . 71.0 111.557 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -64.07 -51.02 66.05 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.341 0.657 . . . . 64.21 109.77 174.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -69.24 -35.04 75.72 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.082 0.553 . . . . 63.11 111.125 -175.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.9 t -59.16 -46.75 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.554 0.741 . . . . 61.3 109.697 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.4 t -67.12 -30.83 70.94 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.749 -1.114 . . . . 62.42 111.811 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.449 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -70.21 -38.65 75.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.834 -0.621 . . . . 55.31 110.12 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.06 1.88 83.17 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.85 0.719 . . . . 70.51 112.695 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 27.1 p 61.84 25.47 15.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.69 1.996 . . . . 51.35 113.302 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -80.51 155.01 74.09 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 123.568 0.747 . . . . 65.13 110.953 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -50.48 158.6 2.57 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.809 3.006 . . . . 65.11 115.042 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -61.16 119.58 8.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.536 1.134 . . . . 75.21 112.531 -168.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.4 tp -110.18 127.15 54.77 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.269 0.628 . . . . 62.54 109.854 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.06 126.13 38.76 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.587 0.755 . . . . 61.01 109.093 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.9 131.1 34.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.419 -0.585 . . . . 70.45 109.419 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.62 152.02 96.37 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.748 0.819 . . . . 75.3 111.365 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.09 109.12 0.87 Allowed 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.621 2.214 . . . . 44.4 111.464 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 24.1 t -91.21 115.53 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.39 -0.596 . . . . 53.52 109.39 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.451 ' O ' HD13 ' B' ' 136' ' ' LEU . 57.4 t-20 -72.7 90.72 1.41 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.198 0.599 . . . . 74.02 109.561 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.451 ' HD1' ' HB1' ' B' ' 100' ' ' ALA . 33.1 p90 -57.22 -32.93 67.01 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.97 0.908 . . . . 73.02 112.708 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -82.87 -41.31 19.13 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.389 0.676 . . . . 72.42 112.387 -168.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.33 61.99 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.125 0.57 . . . . 73.33 110.944 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.665 ' HG ' ' HB ' ' F' ' 463' ' ' THR . 6.7 mp -74.92 -30.67 61.32 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.672 -0.695 . . . . 73.12 109.868 172.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.625 ' CE1' HD11 ' B' ' 141' ' ' LEU . 59.6 t80 -70.79 -25.93 63.1 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.46 -0.791 . . . . 72.44 110.159 173.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 18.5 ttt -65.19 -36.51 84.43 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.939 0.496 . . . . 73.44 110.283 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -73.07 -32.22 64.88 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.729 -0.669 . . . . 75.54 110.502 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.506 ' HE1' ' HB2' ' F' ' 457' ' ' GLN . 81.4 t80 -56.57 -34.24 66.94 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.367 1.067 . . . . 73.35 111.23 176.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.625 HD11 ' CE1' ' B' ' 137' ' ' PHE . 7.8 mt -105.81 -11.19 16.34 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.528 0.566 . . . . 74.3 112.528 -173.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.01 141.41 18.69 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.602 -0.518 . . . . 72.24 109.602 -169.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.31 -48.67 69.58 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.107 1.363 . . . . 74.25 111.448 -170.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -114.71 92.59 4.0 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.826 0.851 . . . . 70.23 110.328 -171.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.19 137.63 36.71 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.193 -0.669 . . . . 51.44 109.193 170.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.14 74.43 1.22 Allowed Glycine 0 C--N 1.35 1.359 0 O-C-N 123.495 0.497 . . . . 73.11 112.54 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -73.22 155.5 39.49 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.688 0.795 . . . . 72.43 110.919 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 158.09 177.46 31.2 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 116.199 -0.455 . . . . 65.21 113.263 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 2.6 t -145.96 88.2 1.8 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.324 1.049 . . . . 75.51 108.509 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -94.56 99.27 11.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.506 -0.77 . . . . 72.32 109.655 -177.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.443 ' HA ' ' OG1' ' D' ' 10' ' ' THR . 48.1 mt-10 -89.47 121.4 31.67 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.295 -0.866 . . . . 65.33 109.664 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -123.5 83.05 2.08 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.335 0.654 . . . . 64.13 111.239 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -80.08 118.43 21.79 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.307 -0.86 . . . . 74.35 108.965 169.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -129.97 145.0 51.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.621 0.769 . . . . 54.31 109.079 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 C-N-CA 124.278 1.031 . . . . 70.23 108.969 179.248 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 60.4 mtt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.185 -0.672 . . . . 54.25 109.185 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -105.87 73.26 0.99 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.69 -0.855 . . . . 73.13 108.69 176.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -88.86 103.59 16.14 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.29 -0.868 . . . . 75.22 110.609 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 61.22 91.03 0.06 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.751 1.22 . . . . 63.15 112.287 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -93.07 -76.59 0.47 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.005 -1.109 . . . . 74.1 108.005 170.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.06 35.84 17.3 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.048 1.339 . . . . 72.23 111.268 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 23.9 m -80.87 80.53 7.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.633 0.773 . . . . 75.34 109.743 -175.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -102.86 82.39 2.11 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.096 -0.957 . . . . 71.52 108.595 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 26.4 ttt 62.11 111.0 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.512 1.525 . . . . 71.43 111.459 -173.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 27.0 m -111.35 84.09 1.88 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.9 -1.148 . . . . 60.4 107.9 174.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -93.55 118.64 31.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.16 -0.927 . . . . 74.25 108.637 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -138.12 135.37 35.68 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.48 -1.304 . . . . 72.4 107.48 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.2 mt -74.81 121.17 25.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.401 -0.963 . . . . 64.02 108.401 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.514 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 19.6 mm-40 -83.68 -44.05 14.9 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 123.888 0.743 . . . . 71.2 109.051 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -177.42 137.52 0.21 Allowed 'General case' 0 C--N 1.359 1.001 0 CA-C-N 115.491 -0.777 . . . . 73.1 109.72 -173.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.3 mt -124.46 143.8 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.008 -1.108 . . . . 75.04 108.008 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.476 ' OH ' HD11 ' C' ' 83' ' ' ILE . 30.7 p90 -171.43 165.13 7.02 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.36 0.6 . . . . 64.43 111.923 -172.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -92.64 107.67 19.39 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.967 -1.015 . . . . 73.04 109.191 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -68.38 -39.97 81.56 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.672 0.749 . . . . 54.14 109.548 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.471 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 19.3 t70 -143.28 139.36 30.12 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 113.918 -1.492 . . . . 75.5 109.192 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 96.4 mt -137.05 143.13 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 106.704 -1.591 . . . . 65.11 106.704 172.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -149.44 147.84 28.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.096 0.474 . . . . 54.23 110.001 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -147.46 135.32 21.18 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.45 -1.315 . . . . 72.2 107.45 169.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.596 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 33.7 mt-10 -138.13 111.3 7.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.561 0.745 . . . . 73.04 109.742 -170.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.11 74.02 11.0 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.445 -1.316 . . . . 73.32 107.445 166.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.46 -28.72 21.51 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.58 2.187 . . . . 73.42 111.163 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -88.22 14.49 9.25 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.957 -1.474 . . . . 72.43 111.787 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -44.83 -54.49 12.95 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 114.184 1.179 . . . . 63.42 114.184 -174.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.23 -37.08 85.55 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 121.916 1.744 . . . . 54.23 113.175 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -69.05 -45.1 71.26 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.836 0.854 . . . . 71.43 111.818 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.756 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -76.53 -22.28 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 113.156 0.798 . . . . 74.25 113.156 -174.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -65.49 -31.53 72.65 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.58 0.585 . . . . 72.24 112.58 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -94.84 11.55 31.19 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.355 0.662 . . . . 73.34 111.667 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -85.14 160.55 19.91 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.981 0.912 . . . . 73.42 110.688 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.92 115.38 3.37 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.339 0.656 . . . . 71.23 109.372 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -84.72 91.75 8.03 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.355 0.597 . . . . 54.25 110.01 -177.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -143.46 79.95 13.49 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 106.756 -1.572 . . . . 72.22 106.756 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' C' ' 67' ' ' SER . 6.4 Cg_exo -80.35 149.92 19.48 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 123.029 2.486 . . . . 62.54 113.619 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -108.03 110.79 22.58 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 107.064 -1.458 . . . . 64.11 107.064 169.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 m -80.43 124.11 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.334 0.588 . . . . 73.22 110.292 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 1.8 tmtp? -125.03 102.52 7.55 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.376 -1.713 . . . . 74.21 106.376 171.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.707 ' HB3' ' HB2' ' G' ' 464' ' ' MET . 4.2 tt -108.44 121.71 45.52 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.968 -1.864 . . . . 71.11 105.968 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -122.72 117.06 24.83 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.88 -0.415 . . . . 74.41 109.88 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.556 ' HB3' HD23 ' G' ' 460' ' ' LEU . 89.4 mt -92.23 150.93 20.61 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.677 0.791 . . . . 72.3 109.322 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 12.7 t70 -151.32 142.77 23.48 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.235 -1.024 . . . . 61.34 108.235 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -126.75 139.51 53.07 Favored 'General case' 0 C--O 1.249 1.072 0 N-CA-C 108.607 -0.886 . . . . 75.15 108.607 172.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.91 141.92 21.27 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.896 -1.149 . . . . 54.32 107.896 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 16.5 p -148.1 156.8 43.03 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 120.853 0.359 . . . . 64.33 110.844 -171.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 95.5 p -144.12 158.64 43.6 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.723 0.809 . . . . 63.22 110.014 -172.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -94.46 130.91 40.65 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.797 -0.816 . . . . 75.5 108.797 172.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.649 HD11 HD12 ' C' ' 83' ' ' ILE . 39.1 mt -99.79 -42.6 6.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.335 0.654 . . . . 43.1 110.489 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -152.67 -172.25 4.18 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.322 -0.853 . . . . 74.51 110.245 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.67 105.87 1.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.013 -0.994 . . . . 70.1 109.826 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 70.06 3.69 4.48 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.01 1.324 . . . . 71.23 113.13 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 56.1 t -100.76 122.78 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.109 -1.071 . . . . 55.53 108.109 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -138.25 124.39 20.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.01 -0.541 . . . . 61.35 109.736 -166.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' C' ' 51' ' ' LEU . 41.1 tt0 -84.83 137.8 32.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.561 0.745 . . . . 73.53 109.496 174.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.51 129.57 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.791 -1.189 . . . . 73.4 107.791 170.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.4 148.24 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.693 0.797 . . . . 73.14 109.109 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.09 111.92 14.02 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.481 -1.303 . . . . 60.24 107.481 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.6 tmm_? -98.42 107.13 19.52 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 107.731 -1.211 . . . . 75.43 107.731 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 t -103.62 123.11 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.186 -1.042 . . . . 74.11 108.186 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -111.83 141.55 45.32 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.021 -0.733 . . . . 65.11 109.021 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.625 HG21 HG21 ' C' ' 114' ' ' ILE . 91.1 t -131.84 123.21 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.515 1.126 . . . . 75.1 108.146 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 12.8 m -124.69 141.84 51.82 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.795 0.838 . . . . 65.13 108.764 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.69 123.98 16.72 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.235 -1.394 . . . . 61.12 107.235 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 60.4 m -133.3 158.22 43.49 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.6 0.714 . . . . 71.34 111.312 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 mt -121.35 39.85 3.73 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.356 1.463 . . . . 64.01 107.338 -171.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.29 -111.6 3.88 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 109.507 -1.437 . . . . 75.35 109.507 -166.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -90.48 -31.08 16.93 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.105 0.562 . . . . 72.21 110.389 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -70.67 106.91 3.69 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.026 0.93 . . . . 71.32 109.911 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.7 m -72.83 126.73 30.61 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.94 -0.763 . . . . 61.43 108.94 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.756 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.92 -58.23 4.1 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.029 -0.73 . . . . 63.04 109.029 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -159.43 163.8 35.1 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.536 -0.756 . . . . 74.41 110.897 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -128.27 144.84 51.16 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 106.517 -1.66 . . . . 72.13 106.517 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.46 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.3 t -149.42 147.11 27.87 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.334 -0.987 . . . . 75.02 108.334 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.43 135.28 10.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.72 0.295 . . . . 74.14 110.48 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' C' ' 110' ' ' ALA . 50.4 t -135.33 114.77 17.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 124.332 1.053 . . . . 74.33 108.704 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 65.4 mt-30 -97.35 89.9 4.89 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.143 -0.688 . . . . 54.53 109.143 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.1 tp-100 -79.39 102.47 8.72 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.053 -0.976 . . . . 52.33 110.498 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.96 157.14 31.89 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 116.202 -0.454 . . . . 51.31 112.035 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.589 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -160.81 116.64 0.73 Allowed Glycine 0 CA--C 1.508 -0.369 0 N-CA-C 111.72 -0.552 . . . . 74.24 111.72 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.649 HD12 HD11 ' C' ' 51' ' ' LEU . 7.4 mm -82.7 127.28 39.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.727 -0.842 . . . . 62.3 108.727 177.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -132.12 141.05 49.01 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.758 0.823 . . . . 64.24 109.082 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 13.5 p -83.73 122.92 29.29 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.142 -0.688 . . . . 65.3 109.142 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 46.6 pt -120.86 133.14 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.602 0.761 . . . . 63.11 109.804 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -163.63 159.68 21.99 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.302 1.041 . . . . 35.43 108.704 176.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.33 -57.6 4.22 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 112.713 -0.155 . . . . 70.54 112.713 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.407 ' H ' HG13 ' C' ' 89' ' ' ILE . 2.7 pp -88.57 163.76 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.184 0.594 . . . . 71.0 111.687 -177.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -165.85 163.21 18.71 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.673 0.789 . . . . 51.42 110.392 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.92 -114.96 7.03 Favored Glycine 0 C--N 1.355 1.594 0 C-N-CA 123.44 0.543 . . . . 43.12 113.703 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -63.34 -40.47 97.37 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.731 0.812 . . . . 63.31 111.574 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -76.59 -32.1 57.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.675 0.39 . . . . 74.15 110.861 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 41.5 ttm -76.99 -28.71 55.19 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.274 0.358 . . . . 65.53 110.817 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.63 91.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.441 -0.577 . . . . 51.14 109.441 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -77.33 -25.22 50.92 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.308 0.38 . . . . 62.14 111.718 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.05 -52.18 66.47 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.542 0.526 . . . . 74.31 109.733 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 pp -81.99 -20.53 38.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.931 0.492 . . . . 74.34 110.882 176.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.27 -29.19 56.74 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 114.482 0.553 . . . . 75.24 114.482 -173.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.14 -43.52 0.06 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.918 0.71 . . . . 73.32 112.918 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -59.42 -46.08 89.73 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.477 0.711 . . . . 74.24 112.309 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.411 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 81.1 m -78.92 -46.87 1.74 Allowed Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.699 0.8 . . . . 71.31 111.396 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.411 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 53.0 Cg_exo -55.86 -26.3 56.92 Favored 'Trans proline' 0 C--N 1.399 3.185 0 C-N-CA 122.402 2.068 . . . . 74.3 113.831 169.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.33 -43.37 97.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.561 1.145 . . . . 73.32 109.936 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.0 mm -64.05 -45.21 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 114.84 -1.073 . . . . 71.22 109.789 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.589 HD21 ' HA3' ' C' ' 82' ' ' GLY . 86.4 mt -75.72 -25.18 56.39 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.149 -0.932 . . . . 72.0 112.812 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -56.22 -53.42 63.87 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 113.78 1.029 . . . . 71.21 113.78 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.69 -29.63 88.77 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 121.725 1.617 . . . . 75.52 113.387 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -68.94 -48.71 62.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.781 0.433 . . . . 63.13 110.478 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.23 -31.11 72.17 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.461 -0.791 . . . . 71.31 110.773 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.674 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 46.6 ttt180 -63.42 -58.86 5.71 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.472 1.509 . . . . 54.21 111.146 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -31.91 73.36 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.686 0.394 . . . . 74.21 110.262 -177.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -65.29 -31.34 72.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.141 0.576 . . . . 62.11 111.579 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.625 HG21 HG21 ' C' ' 64' ' ' VAL . 84.8 mt -74.89 -56.61 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 116.154 -0.475 . . . . 71.54 109.933 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 3.3 m -62.7 -27.72 69.45 Favored 'General case' 0 CA--C 1.553 1.066 0 O-C-N 123.688 0.617 . . . . 61.4 111.412 -172.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -62.39 -51.34 67.98 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.349 0.66 . . . . 74.32 109.304 170.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.668 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.79 -39.61 89.53 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.333 1.053 . . . . 61.33 112.435 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' C' ' 114' ' ' ILE . 60.4 t -59.91 -47.88 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.436 0.694 . . . . 73.52 109.422 176.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -66.31 -32.42 73.81 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.494 -1.23 . . . . 65.43 111.755 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -67.8 -35.02 77.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.31 0.644 . . . . 74.21 109.879 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.39 10.84 69.91 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.928 0.767 . . . . 41.21 112.888 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.45 HG23 ' HB3' ' D' ' 17' ' ' TYR . 46.6 p 54.84 37.26 28.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.058 1.743 . . . . 73.34 113.752 177.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -95.65 153.48 39.41 Favored Pre-proline 0 N--CA 1.477 0.911 0 N-CA-C 108.196 -1.038 . . . . 71.4 108.196 168.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -64.76 168.9 12.47 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.5 2.134 . . . . 75.12 112.688 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -54.44 113.33 1.24 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.353 1.061 . . . . 73.35 113.412 -174.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.721 HD12 HD11 ' G' ' 470' ' ' LEU . 5.5 tt -113.87 87.03 2.53 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.307 -1.368 . . . . 64.22 107.307 167.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -95.47 127.47 41.54 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.23 -1.026 . . . . 73.34 108.23 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.68 HD12 HD11 ' C' ' 42' ' ' LEU . 2.3 mm? -73.62 132.15 42.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.552 0.741 . . . . 75.2 109.546 -174.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.62 153.47 75.91 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.518 0.727 . . . . 42.3 110.606 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.615 ' HG3' HD12 ' A' ' 16' ' ' ILE . 50.2 Cg_exo -51.58 115.68 2.25 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.771 2.314 . . . . 52.13 112.73 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.464 HG21 HD11 ' C' ' 44' ' ' LEU . 85.0 t -97.95 122.58 49.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.199 -0.667 . . . . 63.41 109.199 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -83.88 76.11 10.05 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.17 0.588 . . . . 75.11 109.497 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -60.51 -44.67 95.77 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 122.116 0.96 . . . . 72.32 109.038 170.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -65.09 -50.0 67.81 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 113.184 -1.825 . . . . 75.23 112.366 -172.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.67 88.32 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.814 0.696 . . . . 43.24 111.825 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -42.93 74.38 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.762 -1.108 . . . . 70.34 109.82 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.47 -23.92 61.12 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.739 0.416 . . . . 75.03 111.285 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 67.4 mtt -70.63 -46.84 62.57 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.049 -0.722 . . . . 73.23 109.049 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -57.71 -37.62 73.83 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.871 0.868 . . . . 73.23 111.117 175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -53.5 -77.44 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.39 1.476 . . . . 71.41 109.96 172.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.547 ' HA ' ' HG2' ' A' ' 153' ' ' GLN . 96.4 mt -49.63 -88.29 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.411 1.084 . . . . 43.31 113.007 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.411 ' NE2' ' HB3' ' A' ' 151' ' ' GLU . 20.3 pt20 -176.48 21.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.361 1.065 . . . . 75.24 110.101 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 59.58 88.24 0.07 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.702 1.601 . . . . 73.24 112.293 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -85.23 101.25 12.35 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.871 0.868 . . . . 73.04 108.677 175.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.55 116.49 14.19 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.996 0.518 . . . . 72.55 110.56 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.67 78.89 1.45 Allowed Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.453 -0.659 . . . . 74.44 111.453 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -74.97 145.37 42.6 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.166 0.586 . . . . 62.25 111.009 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -122.16 123.13 5.33 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 111.111 -0.796 . . . . 74.4 111.111 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 40.9 p -66.06 126.03 27.33 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.313 0.645 . . . . 61.52 110.251 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -84.93 145.62 27.67 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.453 0.644 . . . . 71.34 110.858 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -136.1 153.65 51.24 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 107.16 -1.422 . . . . 72.33 107.16 165.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -78.84 75.74 5.34 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.337 0.589 . . . . 74.22 109.541 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -139.39 142.24 37.53 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.916 1.286 . . . . 74.2 108.689 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -141.45 154.58 45.65 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.859 0.864 . . . . 55.31 108.828 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.374 0 N-CA-C 109.321 -0.622 . . . . 71.24 109.321 179.26 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 CA--C 1.551 0.991 0 CA-C-O 121.54 0.686 . . . . 74.51 111.321 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -89.84 109.39 20.4 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.408 -0.96 . . . . 74.24 108.408 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -159.76 -58.89 0.06 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.063 0.545 . . . . 64.15 110.32 -174.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -76.88 103.26 6.73 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.543 -0.753 . . . . 70.32 110.817 -172.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -147.74 138.7 23.4 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.12 0.968 . . . . 63.34 108.893 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 6' ' ' ASN . . . . . 0.608 ' HB2' ' HB2' ' D' ' 9' ' ' MET . 28.3 p-10 -133.84 99.59 4.5 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.879 0.847 . . . . 71.15 110.545 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -120.05 -22.83 6.53 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.926 0.89 . . . . 74.43 109.417 170.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -91.32 -25.86 19.22 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.323 1.049 . . . . 71.24 111.285 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.608 ' HB2' ' HB2' ' D' ' 6' ' ' ASN . 8.1 ttp -31.84 130.56 0.14 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.579 1.952 . . . . 73.24 114.187 175.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.443 ' OG1' ' HA ' ' B' ' 151' ' ' GLU . 24.6 m -120.79 119.98 34.3 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.232 1.013 . . . . 75.55 108.733 172.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -148.23 102.21 3.34 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.506 -1.294 . . . . 71.35 107.506 172.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -126.1 115.91 20.56 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.763 -1.199 . . . . 73.02 107.763 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.436 HD13 HG21 ' D' ' 105' ' ' ILE . 13.7 mt -72.33 115.76 13.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 N-CA-C 108.247 -1.02 . . . . 75.41 108.247 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -88.01 -29.53 20.65 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.722 -0.672 . . . . 75.0 110.783 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -179.54 141.13 0.15 Allowed 'General case' 0 C--N 1.366 1.315 0 C-N-CA 122.34 0.256 . . . . 74.22 110.411 -170.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.409 HD11 HG21 ' D' ' 13' ' ' ILE . 3.7 mp -122.46 135.79 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.256 -1.387 . . . . 53.41 107.256 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.45 ' HB3' HG23 ' C' ' 122' ' ' THR . 34.7 p90 -165.86 174.02 10.0 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-O 121.654 0.74 . . . . 75.13 112.258 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -105.06 120.17 40.84 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.735 -1.12 . . . . 62.41 108.912 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -89.91 -21.47 22.47 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.307 0.643 . . . . 73.4 109.805 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.673 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.0 t70 -155.37 139.36 16.37 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.081 -0.963 . . . . 71.03 108.856 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.668 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.3 mt -137.53 142.77 35.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.56 -1.274 . . . . 74.43 107.56 172.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -149.07 130.09 14.39 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.543 -0.91 . . . . 73.11 108.543 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.411 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 85.5 t80 -136.78 126.23 25.09 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.992 -1.484 . . . . 75.11 106.992 170.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.5 mt-10 -130.82 138.3 49.82 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.74 -0.837 . . . . 74.34 108.74 -175.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.77 82.86 67.81 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 106.97 -1.492 . . . . 74.51 106.97 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.08 -32.4 27.92 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.196 2.597 . . . . 61.43 113.034 -169.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -111.77 26.53 10.53 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.308 0.643 . . . . 75.52 109.385 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.04 -70.09 0.16 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 114.746 1.387 . . . . 50.41 114.746 -161.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.536 ' HB3' HD11 ' C' ' 83' ' ' ILE . 65.2 Cg_endo -77.04 -16.35 15.91 Favored 'Trans proline' 0 C--N 1.38 2.198 0 CA-C-N 122.401 1.893 . . . . 71.13 113.612 -172.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -76.13 -41.71 49.2 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.597 1.159 . . . . 74.45 110.327 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.48 HG22 HD12 ' D' ' 68' ' ' LEU . 6.6 p -82.66 -25.29 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 115.649 -0.705 . . . . 73.22 111.138 -170.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -61.5 -20.78 63.59 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.761 0.824 . . . . 75.34 113.004 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -60.86 -26.29 67.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.425 0.69 . . . . 75.01 110.945 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -91.72 86.4 5.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.941 0.897 . . . . 70.15 109.113 168.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -76.91 88.73 3.48 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.664 -0.698 . . . . 74.33 109.631 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -155.78 158.34 37.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.515 1.126 . . . . 75.44 108.489 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.559 ' HG3' HD12 ' H' ' 470' ' ' LEU . 29.8 tp60 -69.09 106.1 1.32 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.891 0.876 . . . . 65.32 108.966 174.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.571 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 35.4 Cg_exo -63.17 141.15 81.6 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.664 2.243 . . . . 60.0 113.287 -171.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 8.5 mm-40 -58.73 111.35 1.24 Allowed 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.051 0.844 . . . . 70.51 110.2 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.498 HG13 ' O ' ' D' ' 38' ' ' PRO . 16.1 m -101.4 128.02 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.656 0.741 . . . . 75.33 111.83 -170.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -106.55 112.76 25.9 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.821 1.248 . . . . 72.01 107.913 171.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.64 ' H ' HD23 ' D' ' 42' ' ' LEU . 1.8 pt? -95.98 112.92 24.52 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.039 -1.097 . . . . 73.35 108.039 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -114.84 113.21 23.91 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.667 -1.235 . . . . 71.23 107.667 174.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.646 HD13 ' H ' ' D' ' 44' ' ' LEU . 0.0 OUTLIER -110.34 155.48 22.06 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.904 0.882 . . . . 74.02 109.247 -176.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.589 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -158.64 152.65 23.7 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.528 0.731 . . . . 64.11 109.983 -177.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -109.87 167.59 10.05 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.617 -0.512 . . . . 64.41 109.617 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.47 160.52 36.85 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.795 0.838 . . . . 71.55 108.866 173.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -146.4 151.52 37.59 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.656 0.382 . . . . 72.12 110.736 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.7 t -165.55 122.13 1.42 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.582 0.753 . . . . 53.03 109.873 -171.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -82.42 117.71 22.67 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.809 -0.441 . . . . 61.55 109.809 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.2 mt -97.63 -24.98 15.28 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.162 0.585 . . . . 72.24 110.71 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.62 -178.54 6.27 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.482 0.713 . . . . 54.13 111.037 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.51 114.3 4.78 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.475 -1.239 . . . . 33.14 109.791 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.14 21.18 11.62 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.302 1.041 . . . . 63.3 111.795 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 66.3 t -118.82 128.72 75.65 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 N-CA-C 108.159 -1.052 . . . . 72.11 108.159 170.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.443 ' HB2' HD11 ' D' ' 86' ' ' ILE . 0.4 OUTLIER -122.27 172.7 8.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.054 0.93 . . . . 65.11 110.287 174.386 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.9 tt0 -132.31 138.54 47.86 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.255 -1.793 . . . . 74.11 107.577 169.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.27 138.63 47.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.513 -1.292 . . . . 72.12 107.513 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 47.6 t -119.57 128.67 75.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.077 -1.083 . . . . 53.03 108.077 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.416 HD23 ' O ' ' D' ' 45' ' ' ASP . 0.1 OUTLIER -99.1 116.45 31.35 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.25 -1.019 . . . . 63.21 108.25 175.771 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.618 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 2.4 tmm_? -99.71 96.29 7.51 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.652 -1.61 . . . . 75.44 106.652 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.579 HG21 ' HB1' ' D' ' 110' ' ' ALA . 37.0 t -107.96 125.63 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.599 -0.889 . . . . 74.44 108.599 -177.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 20.8 m -130.26 135.29 47.96 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.366 0.667 . . . . 52.04 109.398 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 63.9 t -122.3 109.33 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.858 0.863 . . . . 65.33 109.257 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.1 m -95.39 111.54 23.4 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.832 -0.803 . . . . 44.14 108.832 170.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -115.28 149.84 37.18 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.48 0.712 . . . . 71.43 110.771 -173.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.404 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.1 m -149.32 132.28 16.17 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 123.778 0.674 . . . . 55.31 111.603 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.48 HD12 HG22 ' D' ' 31' ' ' VAL . 30.5 mt -96.24 109.35 21.84 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.554 -0.906 . . . . 61.45 108.554 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.38 -114.57 4.99 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 123.678 0.612 . . . . 54.05 113.02 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.57 16.53 20.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.57 0.748 . . . . 52.45 111.386 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -137.23 161.22 36.78 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.219 0.607 . . . . 74.31 109.785 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 19.5 m -69.62 138.9 53.47 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.561 0.538 . . . . 74.22 111.239 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.469 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -95.72 -70.64 0.7 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.955 0.902 . . . . 73.24 109.375 173.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -144.72 138.45 27.23 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 121.136 0.493 . . . . 73.2 110.286 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.7 mt -111.37 109.83 20.0 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.027 -1.101 . . . . 74.23 108.027 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.542 ' SG ' HG23 ' D' ' 114' ' ' ILE . 53.3 t -118.78 140.64 49.62 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.473 0.709 . . . . 65.34 109.406 -177.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -155.57 134.5 12.06 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.28 0.632 . . . . 72.42 109.629 175.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.18 119.06 18.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.929 0.892 . . . . 51.24 108.873 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.673 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.7 83.71 6.26 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.2 -1.037 . . . . 73.44 108.2 168.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.31 94.35 5.46 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.29 -1.323 . . . . 74.52 109.0 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.9 142.67 16.67 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.985 -0.446 . . . . 64.14 111.985 -178.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.523 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.15 130.02 4.14 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.542 -1.023 . . . . 62.21 110.542 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 39.0 mt -90.82 136.75 23.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.422 -0.955 . . . . 74.23 108.422 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -138.86 131.83 29.51 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.26 0.624 . . . . 64.13 109.84 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -80.17 109.31 14.51 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.772 -0.825 . . . . 54.21 108.772 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.537 HD13 HG12 ' H' ' 451' ' ' VAL . 1.6 pp -119.83 133.88 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.648 0.779 . . . . 74.34 111.81 -171.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.24 169.0 9.49 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.434 1.094 . . . . 72.42 109.207 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.18 11.46 84.89 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 115.368 0.907 . . . . 74.5 115.368 169.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.42 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -119.81 143.35 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 117.837 0.819 . . . . 73.52 110.059 177.117 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.2 -174.42 4.37 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.717 0.807 . . . . 73.41 111.072 -176.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.93 -120.85 14.86 Favored Glycine 0 C--N 1.357 1.728 0 O-C-N 123.455 0.472 . . . . 40.31 113.0 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 29.7 m -88.82 -28.65 20.28 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.213 0.605 . . . . 74.13 110.333 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -62.85 -30.23 71.35 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.273 1.029 . . . . 73.03 111.857 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 12.1 ptm -68.65 -29.39 67.87 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.079 0.552 . . . . 74.51 111.574 177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.54 -36.26 24.15 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.586 0.754 . . . . 73.35 110.651 174.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -70.02 -41.32 74.46 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.214 1.005 . . . . 74.22 111.61 -174.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.6 t -65.94 -50.33 64.76 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.099 0.56 . . . . 74.52 110.66 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 18.2 tp -76.95 -31.36 56.53 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 115.715 -0.675 . . . . 73.04 111.104 -173.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.28 -26.94 10.47 Favored Glycine 0 C--N 1.354 1.541 0 N-CA-C 114.931 0.732 . . . . 51.5 114.931 -170.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.37 -49.63 1.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 117.609 0.704 . . . . 53.2 112.118 -171.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -69.95 -48.29 58.96 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.26 0.624 . . . . 72.2 111.932 -173.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 92.6 m -61.44 -48.18 91.5 Favored Pre-proline 0 CA--C 1.564 1.502 0 CA-C-O 118.509 -0.758 . . . . 72.52 112.15 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.3 -35.68 91.96 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.113 1.875 . . . . 70.11 113.765 170.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -63.85 -39.74 94.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.993 0.517 . . . . 73.55 110.424 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.436 HG21 HD13 ' D' ' 13' ' ' ILE . 49.0 mm -60.51 -40.64 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.568 0.699 . . . . 61.42 110.544 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.523 HD21 ' HA3' ' D' ' 82' ' ' GLY . 96.1 mt -76.34 -19.17 58.47 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.84 -1.073 . . . . 74.51 112.061 -175.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -65.33 -43.8 65.68 Favored Pre-proline 0 CA--C 1.564 1.498 0 N-CA-C 114.189 1.181 . . . . 72.22 114.189 -170.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.63 -42.06 71.77 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 122.1 1.867 . . . . 52.34 113.432 172.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -73.68 -35.2 65.17 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.742 0.817 . . . . 65.55 111.808 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.579 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -61.51 -51.03 70.33 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.519 0.728 . . . . 44.42 109.592 176.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 31.4 ttp180 -54.92 -52.22 63.63 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 113.891 -1.504 . . . . 75.42 110.586 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.84 -48.0 81.05 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 124.023 0.827 . . . . 74.34 111.703 -174.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.9 t -59.9 -42.56 94.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.898 0.479 . . . . 54.25 111.169 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.542 HG23 ' SG ' ' D' ' 76' ' ' CYS . 70.3 mt -60.5 -52.53 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.927 0.891 . . . . 54.11 110.528 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 39.5 m -56.55 -44.88 81.33 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 125.063 1.345 . . . . 73.01 111.573 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 25.7 t -64.54 -41.36 96.4 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.696 -1.138 . . . . 51.41 110.457 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.427 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 71.8 mtm -70.56 -34.02 71.76 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.698 0.399 . . . . 64.22 111.749 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.425 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.7 t -63.12 -43.62 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.304 0.642 . . . . 64.43 110.044 176.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.4 p -72.45 -31.17 65.22 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 116.054 -0.521 . . . . 74.41 111.196 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.3 mtt-85 -71.46 -32.56 68.46 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.494 0.718 . . . . 73.33 110.411 175.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.29 7.22 79.42 Favored Glycine 0 C--N 1.351 1.405 0 O-C-N 123.67 0.606 . . . . 55.35 112.072 175.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 66.2 p 63.08 13.59 6.91 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.88 2.072 . . . . 73.12 114.309 173.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -79.26 149.82 73.21 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 108.543 -0.91 . . . . 75.24 108.543 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -48.25 122.08 7.05 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.075 2.517 . . . . 73.44 112.755 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -49.49 135.87 17.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.395 1.478 . . . . 62.41 112.345 -171.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 29.5 tp -108.16 95.9 5.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.941 0.496 . . . . 64.41 110.736 -169.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.634 ' H ' HD21 ' H' ' 468' ' ' LEU . 85.6 m-20 -103.4 87.74 2.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.674 0.79 . . . . 71.52 109.062 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.421 HD11 HD13 ' D' ' 42' ' ' LEU . 39.1 tp -71.68 133.63 45.77 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.014 -0.993 . . . . 63.15 110.549 -176.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.05 141.07 98.01 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 123.131 0.573 . . . . 73.33 110.892 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -61.4 130.98 33.98 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.666 2.244 . . . . 64.44 111.868 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 80.0 t -108.58 120.84 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.424 0.689 . . . . 41.53 109.77 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -82.99 91.37 7.15 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.591 -0.892 . . . . 73.41 108.591 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -66.72 -35.1 79.33 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.798 -0.637 . . . . 70.12 110.632 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' D' ' 138' ' ' MET . 6.0 m-20 -52.39 -52.14 55.24 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.201 1.4 . . . . 52.51 112.743 -173.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.68 75.26 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.19 0.596 . . . . 44.54 111.518 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -68.46 -28.5 67.1 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.569 -0.741 . . . . 64.43 111.19 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.467 ' O ' HD13 ' D' ' 141' ' ' LEU . 90.4 t80 -62.17 -42.76 99.57 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.968 0.907 . . . . 73.33 110.555 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 37.5 mtt -66.55 -40.49 89.09 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.118 0.567 . . . . 72.22 110.87 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 63.8 t30 -72.88 -33.08 65.84 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.897 -0.592 . . . . 72.31 110.523 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -62.65 -38.13 89.06 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.208 1.003 . . . . 64.2 111.764 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.467 HD13 ' O ' ' D' ' 137' ' ' PHE . 8.1 mp -70.93 -37.09 72.86 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.365 0.666 . . . . 74.34 111.997 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -87.39 39.64 0.88 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.185 0.594 . . . . 63.12 112.002 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 87.1 mm-40 -118.66 87.67 2.77 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.676 0.79 . . . . 72.2 109.578 -175.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -172.58 162.82 5.24 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.184 0.994 . . . . 70.15 110.093 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.21 139.96 58.14 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.898 0.479 . . . . 61.44 111.028 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 153.83 59.91 0.01 OUTLIER Glycine 0 C--N 1.345 1.046 0 CA-C-N 116.353 -0.385 . . . . 53.21 112.16 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.25 144.14 30.85 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.015 0.526 . . . . 51.51 110.538 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -93.71 48.56 2.3 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.173 -0.467 . . . . 63.13 112.081 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 48.1 p -95.63 87.09 4.6 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.49 0.716 . . . . 42.34 109.48 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.41 159.38 42.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.366 -0.833 . . . . 71.13 110.346 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -167.64 -64.13 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.866 -1.161 . . . . 72.54 107.866 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -178.1 143.38 0.3 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.496 1.518 . . . . 70.22 107.736 174.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -107.82 -72.58 0.72 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 106.327 -1.731 . . . . 63.31 106.327 169.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 41.92 70.14 0.3 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.748 1.619 . . . . 64.35 113.675 163.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.207 0 C-N-CA 122.724 0.41 . . . . 74.2 109.968 -177.51 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 111.594 0.22 . . . . 71.54 111.594 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.0 -57.82 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.367 0.667 . . . . 73.42 110.794 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 29.2 m -113.86 112.93 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-O 121.374 0.607 . . . . 74.15 111.675 -171.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -87.3 65.78 3.59 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 116.238 -0.437 . . . . 44.11 112.274 -176.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 454' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 48' ' ' SER . 75.4 mt -72.5 114.1 10.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.035 0.534 . . . . 71.44 109.942 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 8.9 t -138.87 -40.94 0.48 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.302 0.641 . . . . 74.01 110.055 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -91.08 -24.96 19.86 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.985 0.914 . . . . 73.4 111.3 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -56.9 114.72 2.22 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.317 1.047 . . . . 74.53 110.352 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 85.0 m -139.82 -51.43 0.51 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.399 1.08 . . . . 73.44 109.886 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.11 132.1 35.12 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.487 0.715 . . . . 72.44 111.002 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -105.9 122.74 46.75 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.764 -1.198 . . . . 65.12 107.764 172.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -88.5 136.7 32.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.415 0.686 . . . . 73.3 109.741 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 462' ' ' TYR . . . . . 0.586 ' HA ' HD13 ' A' ' 136' ' ' LEU . 13.6 p90 -163.29 120.21 1.84 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.074 0.95 . . . . 70.21 108.586 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 36.3 m -69.52 -45.83 67.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.026 0.53 . . . . 71.12 110.797 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 464' ' ' MET . . . . . 0.565 ' HB3' HG22 ' A' ' 131' ' ' VAL . 5.2 tmm? -72.89 96.77 2.15 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.472 -0.936 . . . . 74.34 108.472 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -130.02 131.0 45.67 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.856 -1.164 . . . . 73.3 107.856 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 466' ' ' ALA . . . . . 0.523 ' H ' ' HB3' ' A' ' 42' ' ' LEU . . . 61.11 -158.12 0.33 Allowed 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.344 1.028 . . . . 71.34 110.169 -174.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . 58.68 31.31 21.0 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.499 0.72 . . . . 34.3 111.219 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 468' ' ' LEU . . . . . 0.503 HD21 HD22 ' A' ' 42' ' ' LEU . 38.1 mt -67.46 148.77 51.1 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.06 -0.973 . . . . 74.41 109.566 -177.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -52.21 -84.81 0.02 OUTLIER Glycine 0 C--N 1.354 1.543 0 O-C-N 124.551 1.157 . . . . 52.3 113.444 -173.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 470' ' ' LEU . . . . . 0.51 ' HB2' HD13 ' A' ' 126' ' ' LEU . 24.9 tp 63.82 150.64 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.974 1.309 . . . . 74.01 112.219 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? . . . . . 0 CA--C 1.554 1.119 0 N-CA-C 107.499 -1.297 . . . . 71.53 107.499 173.887 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' F' F ' 450' ' ' ASN . . . . . 0.526 ' N ' HD21 ' F' ' 450' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 110.387 -0.227 . . . . 71.31 110.387 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.56 -69.06 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.44 0.696 . . . . 74.22 109.201 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 35.0 m -128.49 157.61 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.844 1.257 . . . . 73.12 108.603 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -98.95 -49.64 1.59 Allowed Glycine 0 N--CA 1.468 0.785 0 N-CA-C 111.164 -0.774 . . . . 72.43 111.164 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 25.5 tp 48.27 62.42 2.53 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.662 1.585 . . . . 75.4 111.415 -173.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 46.3 p -102.34 35.23 2.48 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.543 -1.208 . . . . 74.35 109.461 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.7 -156.33 0.13 Allowed 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.359 1.064 . . . . 44.23 109.07 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 457' ' ' GLN . . . . . 0.506 ' HB2' ' HE1' ' B' ' 140' ' ' TYR . 23.1 mt-30 -62.31 -56.34 19.4 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.167 0.587 . . . . 72.45 109.803 174.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 12.8 m 62.26 8.92 2.95 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.83 1.252 . . . . 72.24 111.166 -172.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.27 103.65 16.3 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 124.534 1.134 . . . . 75.35 109.461 -173.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 460' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' B' ' 100' ' ' ALA . 1.6 pp -167.6 103.16 0.5 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.981 0.912 . . . . 72.11 108.8 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 461' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' B' ' 44' ' ' LEU . 3.2 m-85 179.01 154.56 0.43 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.52 1.528 . . . . 65.34 109.577 170.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 462' ' ' TYR . . . . . 0.445 ' HB3' HD13 ' B' ' 42' ' ' LEU . 59.3 m-85 64.15 10.2 5.31 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.335 1.454 . . . . 63.43 113.155 173.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 463' ' ' THR . . . . . 0.665 ' HB ' ' HG ' ' B' ' 136' ' ' LEU . 9.0 m -76.65 72.4 3.3 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.178 -1.045 . . . . 72.03 108.178 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -151.83 163.21 39.68 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.932 -1.031 . . . . 75.41 109.779 -168.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -115.55 145.44 42.64 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.131 0.972 . . . . 63.21 108.462 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . 58.95 69.96 0.69 Allowed 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.125 0.89 . . . . 74.0 109.179 -168.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 467' ' ' ALA . . . . . 0.501 ' HB1' HD21 ' B' ' 42' ' ' LEU . . . -66.3 -16.36 63.98 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.749 -1.114 . . . . 71.11 113.389 -169.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 2.7 tt -154.28 -71.78 0.13 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.927 -0.768 . . . . 70.2 108.927 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 87.99 66.73 1.31 Allowed Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.589 -0.604 . . . . 63.04 111.589 -174.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 470' ' ' LEU . . . . . 0.553 HD22 ' HB3' ' B' ' 37' ' ' GLN . 91.3 mt -67.59 98.0 0.65 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.801 0.84 . . . . 75.54 110.824 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 62.1 tttm . . . . . 0 C--O 1.252 1.217 0 N-CA-C 108.579 -0.897 . . . . 70.5 108.579 -175.942 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 37.7 t30 . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 109.083 -0.71 . . . . 74.15 109.083 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.46 -59.94 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.273 0.629 . . . . 74.02 109.645 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 11.3 p -157.87 149.24 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 115.821 -0.627 . . . . 73.43 110.597 -171.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . -119.71 111.4 2.02 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 109.039 -1.624 . . . . 74.33 109.039 169.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 38.6 tp -75.12 130.53 39.4 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.485 0.642 . . . . 70.54 111.322 -172.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 37.7 m -67.82 149.41 49.92 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.696 0.799 . . . . 60.54 109.576 170.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -61.35 87.49 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.011 0.524 . . . . 70.52 110.93 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.61 -60.07 2.52 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.476 -0.935 . . . . 73.42 108.476 175.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 29.7 m 58.86 79.43 0.22 Allowed 'General case' 0 C--O 1.247 0.957 0 O-C-N 124.525 1.141 . . . . 65.43 110.739 174.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -171.13 151.03 3.11 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.706 -1.133 . . . . 75.5 109.438 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 460' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' C' ' 44' ' ' LEU . 24.9 tp -153.8 123.83 6.88 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.493 -0.928 . . . . 72.24 108.493 169.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -52.91 -28.51 23.65 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.679 1.591 . . . . 64.24 113.87 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -85.09 89.18 7.56 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 122.743 0.417 . . . . 75.44 110.663 -171.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 86.0 m -99.57 127.8 45.67 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.569 -0.9 . . . . 62.34 108.569 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 464' ' ' MET . . . . . 0.707 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . 63.4 mtp -107.05 126.83 52.86 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.012 0.925 . . . . 73.34 110.296 -173.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -112.5 -8.32 13.86 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 108.494 -0.928 . . . . 75.44 108.494 162.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -117.06 129.57 56.08 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.202 1.001 . . . . 72.34 109.291 175.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -160.66 -47.25 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.088 0.955 . . . . 74.44 109.606 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.64 -49.35 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 116.08 -0.509 . . . . 75.24 110.956 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 105.95 -33.9 6.15 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 119.495 -0.614 . . . . 71.01 114.084 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 470' ' ' LEU . . . . . 0.721 HD11 HD12 ' C' ' 126' ' ' LEU . 88.2 mt 67.59 9.23 6.91 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 124.848 1.259 . . . . 74.11 112.053 -174.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 94.7 mttt . . . . . 0 C--O 1.254 1.317 0 C-N-CA 124.056 0.942 . . . . 61.52 109.193 -176.647 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 108.579 -0.897 . . . . 71.12 108.579 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' H' H ' 451' ' ' VAL . . . . . 0.537 HG12 HD13 ' D' ' 86' ' ' ILE . 21.2 t -61.73 -45.81 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 124.153 0.981 . . . . 73.15 109.68 175.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 452' ' ' VAL . . . . . 0.415 ' HA ' ' CE1' ' D' ' 56' ' ' TYR . 2.6 p -133.31 141.93 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 114.309 -1.314 . . . . 71.43 110.338 -173.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 112.11 -7.01 27.11 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.894 -0.594 . . . . 73.41 112.932 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 39.3 tp -94.21 131.92 39.3 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.203 -0.666 . . . . 73.13 109.203 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 13.5 t -139.35 10.86 2.54 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.023 0.44 . . . . 54.15 110.496 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -147.02 163.92 34.69 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.002 0.521 . . . . 51.33 109.939 -169.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.99 120.06 41.13 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.759 1.224 . . . . 75.54 109.067 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 25.5 p -69.72 -69.17 0.36 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.987 0.515 . . . . 72.15 110.635 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -169.94 150.67 3.9 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.484 0.713 . . . . 73.43 110.11 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.54 -169.47 2.65 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.272 1.029 . . . . 74.11 111.029 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -159.16 7.46 0.11 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.47 0.708 . . . . 74.23 112.305 -171.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -119.12 134.84 54.96 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.886 0.766 . . . . 63.41 112.182 -175.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 30.4 p -138.75 153.85 48.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.728 1.611 . . . . 72.32 108.224 174.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 464' ' ' MET . . . . . 0.486 ' HB3' HD21 ' D' ' 42' ' ' LEU . 55.6 ttp -155.94 141.77 18.01 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.621 -0.511 . . . . 72.43 109.621 173.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -67.73 -58.65 4.28 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.607 0.763 . . . . 75.43 111.633 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -151.43 167.05 29.17 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.084 0.554 . . . . 74.3 110.726 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -129.43 166.9 18.66 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.17 0.988 . . . . 41.33 110.157 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 468' ' ' LEU . . . . . 0.634 HD21 ' H ' ' D' ' 127' ' ' ASN . 6.0 mp 59.27 -157.71 0.32 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.375 1.07 . . . . 62.42 111.206 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . -80.79 27.83 2.91 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 113.607 0.203 . . . . 73.22 113.607 173.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 470' ' ' LEU . . . . . 0.559 HD12 ' HG3' ' D' ' 37' ' ' GLN . 4.8 tt -89.92 101.16 13.86 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 107.882 -1.155 . . . . 74.45 107.882 177.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? . . . . . 0 C--O 1.253 1.266 0 N-CA-C 107.324 -1.361 . . . . 63.13 107.324 171.323 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptm . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 111.093 0.034 . . . . 75.2 111.093 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 t 178.66 115.23 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.088 1.355 . . . . 74.03 107.546 164.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.61 88.16 2.28 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.87 -1.159 . . . . 73.34 107.87 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -145.18 103.68 3.88 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.871 1.268 . . . . 72.01 108.197 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -121.13 170.54 9.45 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.863 0.865 . . . . 73.31 110.469 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -153.26 21.45 0.56 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.912 0.863 . . . . 62.41 109.411 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.8 p -78.88 82.86 5.04 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.264 -0.88 . . . . 74.24 110.892 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.26 130.84 44.58 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.083 -0.962 . . . . 65.31 109.867 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.57 ' HG2' HD12 ' A' ' 89' ' ' ILE . 80.3 mtp -134.39 171.31 14.46 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.809 0.814 . . . . 64.14 111.651 -174.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.7 m -139.26 102.16 4.43 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 106.125 -1.806 . . . . 75.43 106.125 164.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.611 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.6 t80 -114.49 129.96 56.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.001 -1.0 . . . . 75.42 109.213 -171.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -140.99 108.84 5.67 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.36 -0.978 . . . . 75.11 108.36 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.551 HG12 ' HD2' ' A' ' 84' ' ' PHE . 55.0 mt -81.16 116.94 26.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.971 -0.751 . . . . 71.43 108.971 173.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.486 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -73.82 -40.77 63.11 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.634 -0.712 . . . . 75.24 109.301 -178.683 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -173.64 122.96 0.35 Allowed 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.299 0.374 . . . . 62.52 111.384 -171.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.561 HD12 ' HG3' ' C' ' 130' ' ' PRO . 71.3 mt -106.43 133.83 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.067 -0.716 . . . . 74.42 109.067 173.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB3' HG23 ' B' ' 122' ' ' THR . 33.2 p90 -163.76 178.86 7.53 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.882 0.873 . . . . 41.44 110.901 -173.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.9 p -106.2 116.26 31.63 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.951 -0.759 . . . . 74.11 108.951 176.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 22.7 mtpt -81.26 -29.71 34.31 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.422 -0.585 . . . . 73.13 109.422 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.3 t70 -146.84 141.75 26.95 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.719 -1.128 . . . . 45.25 109.697 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 88.0 mt -139.05 141.26 36.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 125.616 1.566 . . . . 74.32 106.807 171.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -147.96 136.85 21.94 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.184 0.516 . . . . 62.43 109.986 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.592 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.4 t80 -135.26 126.23 27.69 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.682 -1.229 . . . . 75.45 107.682 171.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.81 119.88 24.1 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.885 0.474 . . . . 74.14 110.159 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -132.93 80.4 60.71 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 107.367 -1.345 . . . . 62.24 107.367 170.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.66 -19.38 12.87 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.68 2.253 . . . . 74.34 111.192 175.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.496 ' O ' HG23 ' A' ' 31' ' ' VAL . 91.0 m-20 -103.94 16.98 25.08 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.294 1.038 . . . . 62.34 110.56 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.583 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -55.25 -46.6 99.66 Favored Pre-proline 0 CA--C 1.57 1.725 0 C-N-CA 123.54 0.736 . . . . 52.12 112.277 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.52 6.1 4.69 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 122.318 2.012 . . . . 72.43 113.383 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -100.78 -40.25 7.42 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.125 0.57 . . . . 75.2 109.8 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 27' ' ' ASN . 98.6 t -66.78 -34.39 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.716 0.806 . . . . 62.23 111.34 -175.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.457 ' CE1' ' HG3' ' A' ' 33' ' ' GLN . 1.1 p90 -65.82 -26.14 67.54 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 120.898 0.38 . . . . 75.12 111.029 -177.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.457 ' HG3' ' CE1' ' A' ' 32' ' ' PHE . 49.2 mt-30 -87.08 -44.11 11.79 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.372 0.669 . . . . 62.13 111.068 177.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HE3' HD11 ' A' ' 68' ' ' LEU . 53.4 mtmt -82.86 168.55 17.0 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.086 0.47 . . . . 73.54 112.251 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.24 131.96 41.69 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.009 -0.996 . . . . 61.15 110.535 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -77.44 98.62 5.35 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.589 1.156 . . . . 73.1 110.256 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -139.01 75.66 34.78 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 108.879 -0.786 . . . . 75.45 108.879 172.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -84.96 152.81 11.19 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.554 2.169 . . . . 72.54 112.863 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -118.33 108.76 15.48 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.603 -1.258 . . . . 73.05 107.603 172.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.523 HG21 ' HG ' ' E' ' 468' ' ' LEU . 22.6 m -82.54 135.41 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.609 0.764 . . . . 74.24 111.649 -171.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -123.28 113.28 18.67 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.895 -1.15 . . . . 73.14 107.895 174.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.421 HD23 ' HB3' ' E' ' 464' ' ' MET . 64.7 tp -110.46 116.72 31.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.045 0.538 . . . . 75.51 110.078 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.497 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 31.5 t70 -103.15 132.93 49.04 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 109.029 -0.73 . . . . 75.14 109.029 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' E' ' 464' ' ' MET . 85.5 mt -110.47 132.4 54.21 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.459 -0.941 . . . . 73.33 108.459 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.749 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 16.9 t70 -145.39 153.17 40.92 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.907 0.483 . . . . 62.2 110.068 177.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.447 ' O ' HG22 ' E' ' 458' ' ' THR . 26.6 m -127.71 139.39 52.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.667 1.187 . . . . 71.21 108.659 177.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.57 123.69 25.58 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.491 -0.559 . . . . 45.2 109.491 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.457 ' HB2' ' HA ' ' E' ' 456' ' ' ASP . 17.6 m -88.11 152.21 22.17 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.333 -0.617 . . . . 24.25 109.333 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -160.42 122.52 3.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.368 0.667 . . . . 73.21 109.819 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -81.04 139.12 35.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.026 0.53 . . . . 73.43 110.239 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.448 HD12 HG23 ' A' ' 83' ' ' ILE . 83.7 mt -117.49 -28.76 5.99 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.522 0.729 . . . . 61.22 110.138 176.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.2 -177.35 4.92 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.08 0.952 . . . . 62.24 109.374 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.18 128.22 35.57 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.269 -0.641 . . . . 54.22 109.269 173.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 69.38 2.42 3.7 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.204 1.402 . . . . 74.33 112.309 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.87 116.43 52.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 123.923 0.889 . . . . 71.23 109.389 -177.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.16 125.59 23.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.987 0.915 . . . . 74.24 108.678 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -93.83 145.39 24.64 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.632 -0.877 . . . . 63.22 108.632 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -111.58 138.26 40.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.995 -1.113 . . . . 54.4 107.995 172.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -114.73 106.78 21.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.021 -1.103 . . . . 72.4 108.021 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.7 tp -88.09 105.91 17.81 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.656 -0.868 . . . . 74.35 108.656 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.749 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 59.1 mtt85 -83.75 121.94 27.98 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.838 -0.801 . . . . 64.42 108.838 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.627 HG21 ' HB1' ' A' ' 110' ' ' ALA . 2.1 m -127.61 101.52 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.644 -0.873 . . . . 75.03 108.644 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 86.6 m -98.13 108.54 21.27 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.344 1.057 . . . . 72.13 109.87 -175.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.424 HG21 HG21 ' A' ' 114' ' ' ILE . 85.0 t -103.03 113.65 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.42 -0.585 . . . . 34.15 109.42 176.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.9 m -123.6 107.05 11.09 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.071 -0.714 . . . . 72.1 109.071 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.25 125.1 53.79 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.977 -0.749 . . . . 64.43 108.977 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.4 p -120.95 130.38 53.83 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.535 0.734 . . . . 70.44 110.161 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 68' ' ' LEU . 2.7 pt? -90.4 48.31 1.54 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 122.278 1.037 . . . . 64.41 109.661 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.78 -125.34 6.36 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 114.915 -1.039 . . . . 22.11 111.071 -170.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.27 -28.34 23.83 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 117.48 0.64 . . . . 75.31 109.73 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -86.12 134.5 33.81 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.85 0.86 . . . . 74.12 110.571 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 m -74.72 133.4 42.04 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.649 0.593 . . . . 62.33 109.869 172.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.83 -51.88 9.1 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.891 0.877 . . . . 71.3 108.963 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -155.92 157.08 35.7 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.447 -1.252 . . . . 52.22 111.551 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 62.8 tp -121.97 109.76 14.99 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.403 -1.332 . . . . 70.32 107.403 166.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 80.1 m -107.28 97.36 7.13 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.939 -1.134 . . . . 72.33 107.939 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -122.13 115.8 23.08 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.36 -0.978 . . . . 52.41 108.36 -173.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.7 t -126.22 136.11 61.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.49 -0.777 . . . . 73.13 109.184 -172.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 24.5 mt-30 -110.28 91.17 3.55 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.826 -0.805 . . . . 64.24 108.826 167.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -77.18 113.17 14.63 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.867 -1.16 . . . . 63.15 107.867 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.72 142.19 16.12 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 112.198 -0.361 . . . . 22.32 112.198 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.41 141.54 10.86 Favored Glycine 0 CA--C 1.505 -0.557 0 N-CA-C 110.743 -0.943 . . . . 75.02 110.743 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 14' ' ' GLN . 36.2 mt -88.63 124.45 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.868 -0.79 . . . . 74.44 108.868 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.611 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 39.0 m-85 -129.3 128.97 44.27 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.706 0.802 . . . . 74.04 109.522 -171.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.2 t -89.05 120.84 30.82 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.912 -0.774 . . . . 61.25 108.912 174.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.1 pt -95.84 129.24 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.437 0.695 . . . . 74.23 109.898 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.03 158.9 7.34 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.934 0.894 . . . . 71.41 111.164 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 103.18 -33.38 6.63 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 115.771 -0.649 . . . . 61.15 113.494 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.57 HD12 ' HG2' ' A' ' 9' ' ' MET . 0.2 OUTLIER -137.62 170.7 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.837 0.855 . . . . 71.13 109.905 -177.25 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.95 173.33 11.61 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.524 0.73 . . . . 70.14 109.449 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.28 -145.09 43.81 Favored Glycine 0 C--N 1.351 1.387 0 C-N-CA 122.648 0.166 . . . . 53.41 113.498 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.549 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 23.3 p -72.64 -14.85 61.69 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.802 0.841 . . . . 73.15 111.921 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -68.07 -38.36 82.3 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.968 -0.753 . . . . 61.42 108.968 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.451 ' SD ' HG22 ' E' ' 451' ' ' VAL . 38.1 ttp -82.93 -35.49 26.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.485 0.714 . . . . 70.15 111.054 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.549 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -63.21 -26.5 68.83 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.942 0.497 . . . . 73.51 110.631 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.401 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 18.4 t-80 -66.38 -50.35 63.78 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.502 1.121 . . . . 74.31 110.506 169.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 71.0 m -67.2 -27.31 67.15 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.852 0.461 . . . . 73.03 112.1 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.88 -41.82 12.95 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.14 0.976 . . . . 74.02 109.589 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.84 2.18 56.9 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-O 119.469 -0.628 . . . . 75.43 114.585 -171.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.447 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -138.37 -62.06 0.58 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.608 0.704 . . . . 70.1 111.262 -177.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.44 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 80.6 t80 -62.75 -49.72 73.91 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.729 0.812 . . . . 71.41 111.736 -175.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 89.6 m -71.1 -39.64 8.49 Favored Pre-proline 0 CA--C 1.571 1.76 0 N-CA-C 114.101 1.148 . . . . 45.23 114.101 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.38 -24.4 50.09 Favored 'Trans proline' 0 C--N 1.387 2.571 0 CA-C-N 121.742 1.658 . . . . 63.41 112.826 167.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -27.57 61.76 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.907 -0.405 . . . . 75.05 109.907 177.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.8 mm -60.25 -40.7 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.911 0.884 . . . . 73.44 109.818 170.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.5 mt -80.07 -17.22 53.25 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.066 0.947 . . . . 62.32 112.338 -175.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -63.75 -45.22 81.78 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 113.916 1.08 . . . . 71.44 113.916 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.46 -39.51 65.36 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 121.596 1.53 . . . . 73.34 112.701 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -69.47 -38.48 77.73 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.379 0.672 . . . . 75.14 111.085 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.627 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.85 -41.73 86.87 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.816 -0.629 . . . . 63.24 110.39 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.581 ' HA ' HD21 ' A' ' 128' ' ' LEU . 40.9 ttm180 -54.78 -50.47 68.41 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 124.7 1.25 . . . . 74.13 110.29 177.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -63.65 -42.69 98.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.485 1.116 . . . . 72.23 111.397 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 117' ' ' MET . 27.6 t -60.93 -37.4 82.18 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 123.695 0.622 . . . . 45.34 110.61 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.424 HG21 HG21 ' A' ' 64' ' ' VAL . 78.5 mt -71.61 -43.05 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.483 1.113 . . . . 73.34 110.561 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.406 HG23 ' HG3' ' A' ' 125' ' ' GLN . 24.0 m -61.6 -33.99 74.86 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.731 0.776 . . . . 64.44 109.94 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.7 t -70.93 -40.09 72.27 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.712 -1.131 . . . . 74.33 109.864 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.592 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 18.4 mmt -59.08 -48.38 81.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.308 0.643 . . . . 65.35 111.626 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.1 m -68.13 -42.14 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 O-C-N 123.448 0.467 . . . . 74.24 111.43 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.9 m -69.01 -35.71 76.97 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.054 0.541 . . . . 72.22 111.692 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.515 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 95.2 mtt-85 -70.55 -35.19 72.98 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.896 0.479 . . . . 72.13 110.029 175.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.14 19.72 20.65 Favored Glycine 0 C--N 1.354 1.57 0 CA-C-O 119.14 -0.811 . . . . 75.05 114.32 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' B' ' 17' ' ' TYR . 2.4 t 61.4 10.73 3.3 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 127.16 2.184 . . . . 63.44 114.311 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -86.52 150.54 51.5 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 108.542 -0.91 . . . . 72.21 108.542 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.55 159.03 21.29 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.395 2.063 . . . . 62.52 112.2 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.406 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.1 tt0 -60.83 142.97 55.65 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.071 0.549 . . . . 72.03 112.308 -177.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.3 tp -128.15 121.8 30.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.117 0.967 . . . . 73.41 109.938 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -124.7 109.66 13.4 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.681 -0.859 . . . . 71.12 108.681 173.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.757 ' H ' HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -73.23 126.34 29.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 109.101 -0.703 . . . . 70.23 109.101 173.662 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.13 151.22 27.1 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 124.895 1.278 . . . . 61.21 112.715 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 110.23 0.65 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.805 2.337 . . . . 73.14 112.54 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 81.7 t -99.37 113.09 33.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.072 -1.084 . . . . 70.42 108.072 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -85.27 81.65 8.7 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.433 -0.951 . . . . 73.5 108.433 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -56.27 -31.9 64.02 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.456 0.702 . . . . 72.3 111.407 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.447 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 9.8 t70 -63.31 -48.3 78.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.546 1.138 . . . . 73.3 110.706 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.69 92.61 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.994 0.918 . . . . 44.31 111.445 176.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.7 mt -69.53 -34.6 74.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.731 0.812 . . . . 70.02 111.878 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.96 -38.48 79.44 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.652 -0.87 . . . . 63.31 108.652 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 10.4 mmt -60.35 -43.58 96.37 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 124.109 0.881 . . . . 62.34 111.195 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -58.47 -36.96 74.52 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.279 0.632 . . . . 72.31 110.853 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -77.87 -33.25 52.18 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.652 1.181 . . . . 71.4 111.216 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.6 -52.17 28.5 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.556 1.143 . . . . 74.14 111.6 -173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 172.12 -15.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.747 1.219 . . . . 72.44 110.899 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -69.92 159.65 33.31 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 122.032 0.92 . . . . 73.44 111.771 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -147.69 -32.7 0.27 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 113.837 -1.529 . . . . 72.12 108.811 -173.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.77 -42.54 33.69 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.451 -1.25 . . . . 61.13 112.081 -173.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.28 -133.27 2.85 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.974 -0.348 . . . . 70.03 113.092 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -65.64 -43.99 87.78 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.155 0.982 . . . . 65.35 110.332 -176.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.74 151.52 12.58 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 114.635 -1.166 . . . . 54.54 111.138 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.1 m -125.26 9.89 7.99 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 121.489 0.661 . . . . 73.44 109.281 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -80.25 151.7 29.47 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.844 0.858 . . . . 75.33 111.007 -170.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 71.53 178.5 0.25 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.066 1.346 . . . . 75.42 113.326 -175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -141.65 177.89 7.84 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.647 -1.615 . . . . 61.22 108.403 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -75.01 85.64 2.3 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.896 -1.15 . . . . 71.14 107.896 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.28 -48.2 44.22 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.594 -0.73 . . . . 70.23 109.759 -177.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-N 115.205 -0.907 . . . . 72.04 108.942 170.495 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.479 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.556 0.217 . . . . 74.22 110.594 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.7 t -120.01 128.22 53.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.457 0.703 . . . . 42.44 109.679 176.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.0 -25.96 59.38 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.469 1.108 . . . . 72.45 112.479 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -70.93 -24.67 62.49 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.992 0.917 . . . . 70.55 112.336 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 32.99 78.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 125.923 1.689 . . . . 73.41 113.679 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -72.6 -171.63 0.85 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.069 1.347 . . . . 75.44 109.528 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -77.26 63.41 2.48 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 123.27 1.51 . . . . 70.2 109.162 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -110.13 -149.65 0.45 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.874 -1.512 . . . . 54.35 108.763 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.597 ' HB3' HG23 ' B' ' 89' ' ' ILE . 23.2 ptm 57.18 -173.73 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 125.594 1.558 . . . . 75.45 114.396 170.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 85.0 m -135.4 108.62 7.75 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.544 -0.91 . . . . 64.21 108.544 172.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -114.42 143.25 45.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.215 0.606 . . . . 63.44 109.848 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -149.72 140.81 22.99 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.289 0.636 . . . . 72.4 109.749 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.64 123.49 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.75 -1.204 . . . . 65.22 107.75 172.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.414 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 14.0 mm100 -86.23 -50.65 6.81 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.233 -0.654 . . . . 75.31 109.233 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -170.12 133.24 1.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.508 -0.769 . . . . 74.51 109.704 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.04 138.76 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 107.87 -1.159 . . . . 74.32 107.87 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.446 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 33.7 p90 -165.11 164.65 20.27 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 122.304 1.049 . . . . 73.03 112.379 -177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 74.3 m -87.73 130.08 34.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.938 -1.483 . . . . 73.41 108.063 169.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.405 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 40.5 mtpt -98.02 -36.62 10.06 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.381 0.672 . . . . 64.2 110.302 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -149.99 132.21 15.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.814 -0.63 . . . . 55.44 110.545 -170.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.454 HD12 HG22 ' B' ' 78' ' ' VAL . 48.8 mm -128.3 141.97 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.116 0.966 . . . . 75.43 108.553 171.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -142.34 130.67 22.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.227 -1.397 . . . . 73.12 107.227 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.417 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.0 t80 -144.99 109.85 5.06 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.585 -1.265 . . . . 71.12 107.585 170.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -120.89 123.42 42.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.54 -0.911 . . . . 72.03 108.54 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.96 87.16 2.25 Favored Pre-proline 0 C--O 1.242 0.68 0 N-CA-C 106.722 -1.584 . . . . 51.5 106.722 171.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.85 -36.1 19.26 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.639 2.226 . . . . 74.02 112.735 -165.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -110.83 22.25 15.57 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.86 0.864 . . . . 61.25 110.423 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -36.29 -64.93 0.34 Allowed Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 115.195 1.554 . . . . 42.33 115.195 -162.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.7 Cg_exo -66.21 -30.28 46.28 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 121.828 1.685 . . . . 53.12 112.682 -173.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.419 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 65.8 m80 -93.32 -15.87 25.29 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.373 -0.831 . . . . 74.42 112.284 -174.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.732 HG21 ' HA ' ' B' ' 73' ' ' ALA . 7.5 p -85.93 -30.12 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 117.93 0.332 . . . . 73.55 110.529 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -61.2 -19.54 61.73 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.742 0.817 . . . . 75.12 113.081 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.1 pt20 -64.85 -15.7 62.22 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.99 0.516 . . . . 75.23 111.594 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -99.57 97.58 8.55 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.109 0.964 . . . . 50.41 109.024 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -79.65 91.72 5.28 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.281 0.563 . . . . 74.05 109.796 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -164.36 159.81 20.13 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.322 1.049 . . . . 72.43 108.993 -174.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.8 pm0 -82.52 109.74 17.93 Favored Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 109.217 -0.661 . . . . 72.21 109.217 173.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.483 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 35.3 Cg_endo -62.41 127.38 20.75 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.815 2.343 . . . . 53.42 113.074 -171.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -56.73 120.16 7.37 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.294 0.996 . . . . 73.31 110.969 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.481 HG11 HD11 ' B' ' 126' ' ' LEU . 29.6 m -96.18 163.03 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.159 -0.928 . . . . 43.43 113.19 -168.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.549 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 81.8 tttt -148.88 137.46 21.19 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.982 1.713 . . . . 72.2 107.512 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.412 ' HB3' HD11 ' B' ' 44' ' ' LEU . 2.6 mm? -105.25 131.41 52.74 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.119 -0.697 . . . . 71.32 109.119 176.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.8 t70 -124.29 110.71 14.95 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 106.697 -1.594 . . . . 73.43 106.697 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.426 ' HB2' HD21 ' F' ' 460' ' ' LEU . 0.5 OUTLIER -114.98 129.26 56.68 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.832 -0.803 . . . . 74.04 108.832 -165.422 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 20.7 m-20 -130.65 112.79 13.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.035 0.534 . . . . 73.12 109.841 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 28.6 p -107.15 102.27 11.61 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.217 -1.031 . . . . 51.41 108.217 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.19 119.15 26.74 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.241 1.016 . . . . 73.23 109.321 -174.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.524 ' HB3' HG22 ' B' ' 58' ' ' VAL . 16.6 p -100.3 161.62 13.49 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.615 0.766 . . . . 73.01 109.931 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 81.2 p -151.07 137.21 18.35 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.5 0.72 . . . . 64.11 109.355 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -81.9 118.35 22.87 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.206 0.602 . . . . 74.42 109.788 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.17 -43.72 15.86 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.959 -0.756 . . . . 73.15 108.959 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.64 177.37 11.3 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.186 -1.37 . . . . 60.54 108.923 174.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.92 130.78 43.76 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.895 -0.78 . . . . 65.22 108.895 178.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 75.28 -4.45 2.37 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 125.056 1.343 . . . . 71.54 112.424 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -117.56 109.18 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.759 0.824 . . . . 65.05 109.332 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -125.56 138.61 53.96 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.401 -0.592 . . . . 71.32 109.401 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -119.07 107.09 13.07 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.092 -1.077 . . . . 72.32 108.092 -172.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' B' ' 48' ' ' SER . 85.8 t -94.3 135.13 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.991 0.916 . . . . 74.21 110.617 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.15 130.08 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.385 -0.969 . . . . 72.33 108.385 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.84 112.81 23.34 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.112 -1.07 . . . . 70.53 108.112 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.406 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 36.8 ttm180 -99.83 127.49 45.99 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.412 0.685 . . . . 73.12 109.829 173.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' B' ' 114' ' ' ILE . 46.0 t -123.12 102.64 11.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 106.67 -1.604 . . . . 74.34 106.67 167.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.5 m -99.44 126.25 45.32 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.346 -0.613 . . . . 75.32 109.346 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.522 HG11 HD21 ' B' ' 126' ' ' LEU . 60.3 t -108.94 105.43 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 123.298 0.639 . . . . 70.31 109.721 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 42.0 m -84.02 137.42 33.61 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.966 -1.124 . . . . 62.22 107.966 167.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.442 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -149.02 143.43 26.09 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.51 0.324 . . . . 44.23 110.182 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 49.4 p -146.0 134.23 21.7 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.579 0.549 . . . . 52.2 111.373 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.659 HD12 HG22 ' B' ' 31' ' ' VAL . 39.2 mt -93.35 109.94 21.49 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.511 -0.922 . . . . 62.21 108.511 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.67 -108.8 2.6 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.866 -1.061 . . . . 71.03 111.713 -170.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.95 3.97 10.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.045 0.938 . . . . 75.53 111.905 -175.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -115.03 149.78 36.92 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.436 -0.579 . . . . 72.41 109.436 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.2 m -67.31 133.26 49.33 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.936 0.398 . . . . 54.35 111.161 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.732 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -90.46 -64.07 1.19 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.962 -1.017 . . . . 74.53 109.234 176.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -150.02 154.68 38.6 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.316 -0.856 . . . . 73.34 110.393 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.0 mt -128.79 110.77 12.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.669 -1.604 . . . . 74.45 106.669 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.9 t -117.57 155.69 29.38 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.856 -0.794 . . . . 75.22 108.856 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -163.55 130.67 3.39 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.836 -0.801 . . . . 74.54 108.836 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.454 HG22 HD12 ' B' ' 21' ' ' ILE . 88.3 t -124.07 141.32 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.593 -0.891 . . . . 73.32 108.593 172.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -123.04 88.42 2.92 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.89 -0.782 . . . . 44.22 108.89 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.405 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 57.6 tp60 -79.76 100.82 8.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.141 -0.936 . . . . 72.13 109.102 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.31 143.69 16.88 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.744 -0.542 . . . . 74.42 111.744 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.534 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -145.81 127.13 2.72 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.135 -0.786 . . . . 70.51 111.135 -172.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 14.3 mt -91.2 129.68 41.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 123.918 0.887 . . . . 62.43 108.617 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -137.71 133.68 34.47 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.889 -0.782 . . . . 53.21 108.889 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.8 m -93.42 109.19 20.77 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.953 -0.758 . . . . 70.32 108.953 172.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 pt -112.92 117.83 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.228 1.011 . . . . 71.22 109.118 -174.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -129.84 152.72 49.02 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.18 0.592 . . . . 61.21 110.791 -175.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.43 -60.22 4.32 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.824 0.702 . . . . 63.0 112.522 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.597 HG23 ' HB3' ' B' ' 9' ' ' MET . 2.8 pp -67.12 145.29 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.351 0.661 . . . . 60.25 112.391 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -166.32 174.51 9.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.186 0.595 . . . . 74.54 109.561 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.6 -112.29 3.91 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 112.217 -0.353 . . . . 75.55 112.217 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 92' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' B' ' 95' ' ' ALA . 31.6 m -78.13 -29.53 48.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.142 0.496 . . . . 74.4 110.742 176.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -69.99 -33.81 72.53 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.34 -0.391 . . . . 74.02 110.575 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.524 ' HB2' HG13 ' F' ' 452' ' ' VAL . 0.0 OUTLIER -74.86 -30.81 61.46 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.957 -0.565 . . . . 62.45 110.212 178.391 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' B' ' 92' ' ' THR . . . -59.83 -38.45 82.05 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.45 0.7 . . . . 64.22 110.032 171.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -76.08 -36.31 59.01 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.284 1.034 . . . . 71.05 111.608 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.64 -57.36 6.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 123.593 0.558 . . . . 65.13 109.846 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.3 mp -79.62 -15.83 56.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.94 0.496 . . . . 65.45 111.521 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.39 -15.02 48.98 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.41 0.524 . . . . 65.24 114.41 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.35 -56.74 0.32 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 117.341 0.57 . . . . 52.34 111.879 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -68.5 -52.56 30.97 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.835 0.854 . . . . 62.13 112.001 -167.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.452 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 92.2 m -63.04 -49.07 83.05 Favored Pre-proline 0 CA--C 1.565 1.542 0 C-N-CA 124.319 1.047 . . . . 74.31 112.13 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.0 Cg_exo -58.49 -34.07 98.48 Favored 'Trans proline' 0 C--N 1.398 3.15 0 C-N-CA 122.095 1.864 . . . . 74.33 113.559 171.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.24 -37.62 83.72 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.374 0.67 . . . . 75.25 111.747 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 45.4 mt -63.9 -41.72 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.843 0.857 . . . . 72.34 110.759 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.534 HD21 ' HA3' ' B' ' 82' ' ' GLY . 51.2 mt -80.19 -19.91 45.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.348 1.059 . . . . 54.32 112.311 -173.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -59.7 -49.38 92.1 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.278 1.214 . . . . 75.51 114.278 -171.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -61.67 -33.7 85.58 Favored 'Trans proline' 0 C--N 1.381 2.258 0 CA-C-N 121.452 1.554 . . . . 73.34 112.618 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.405 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 84.5 m-85 -68.06 -46.0 72.3 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 123.662 0.601 . . . . 63.51 110.087 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.25 -47.1 84.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.521 0.729 . . . . 73.24 110.22 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -54.26 -55.36 28.97 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.129 1.372 . . . . 75.32 111.581 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.02 -35.04 79.48 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.854 0.721 . . . . 75.01 110.389 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.515 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 6.8 t -69.03 -37.63 78.73 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.95 -0.568 . . . . 74.32 111.227 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.522 HD11 ' HB ' ' B' ' 62' ' ' VAL . 58.5 mt -63.2 -55.33 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.715 -0.476 . . . . 74.14 109.715 174.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.533 HG21 ' OG ' ' C' ' 119' ' ' SER . 18.9 m -59.0 -34.01 71.36 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 124.468 1.105 . . . . 74.42 111.404 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.5 t -57.98 -52.21 66.46 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.423 -0.808 . . . . 64.43 109.503 174.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 9.9 mmt -66.83 -38.19 85.95 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.333 0.653 . . . . 74.44 111.748 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.421 HG23 ' O ' ' B' ' 114' ' ' ILE . 91.2 t -58.9 -46.12 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.087 0.955 . . . . 73.32 110.303 176.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 45.3 t -70.99 -33.06 70.05 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.605 -1.18 . . . . 74.23 111.433 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' B' ' 116' ' ' SER . 90.8 mtt-85 -63.84 -36.84 85.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.106 0.563 . . . . 74.44 110.089 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.1 14.32 53.94 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-O 119.43 -0.65 . . . . 53.44 113.322 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.45 HG23 ' HB3' ' A' ' 17' ' ' TYR . 82.5 p 55.93 26.9 10.35 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.917 1.687 . . . . 71.45 113.636 176.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -87.06 153.01 54.07 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 123.609 0.764 . . . . 74.22 110.55 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 161.06 2.16 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 124.17 3.247 . . . . 72.44 115.271 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.51 HE21 ' ND2' ' B' ' 127' ' ' ASN . 63.7 tp60 -63.05 140.56 58.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.925 0.89 . . . . 74.53 111.982 -171.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.522 HD21 HG11 ' B' ' 64' ' ' VAL . 13.7 tp -146.05 117.67 8.07 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.906 -0.588 . . . . 72.3 109.433 -173.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.51 ' ND2' HE21 ' B' ' 125' ' ' GLN . 26.4 m-80 -130.98 135.12 47.34 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.422 0.689 . . . . 74.35 110.06 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.73 130.87 34.31 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.825 0.85 . . . . 72.13 110.012 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.75 152.53 59.89 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.247 1.019 . . . . 63.54 111.285 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.804 ' HG2' HD13 ' D' ' 16' ' ' ILE . 20.5 Cg_exo -65.94 133.58 34.09 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.701 2.267 . . . . 74.01 112.81 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.415 HG21 ' N ' ' F' ' 464' ' ' MET . 16.1 t -121.22 115.12 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.126 -1.064 . . . . 73.34 108.126 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -80.45 82.23 6.53 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 109.684 -0.487 . . . . 75.12 109.684 -178.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -60.15 -27.24 66.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.882 0.873 . . . . 74.31 111.325 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -54.6 -47.74 73.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.986 1.314 . . . . 72.44 111.365 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.87 -37.95 85.41 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.706 -0.679 . . . . 64.21 111.274 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.19 -19.06 60.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.551 0.74 . . . . 74.35 111.317 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.665 ' CE1' HD11 ' B' ' 141' ' ' LEU . 66.3 t80 -67.16 -26.4 66.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.932 0.493 . . . . 73.33 111.51 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 26.2 mmt -63.08 -35.96 81.99 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.348 0.594 . . . . 61.2 110.248 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' B' ' 145' ' ' ALA . 2.8 m-20 -79.06 -17.43 55.25 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.129 -0.941 . . . . 71.35 110.717 -178.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.578 ' HB2' ' HE1' ' F' ' 461' ' ' PHE . 46.2 t80 -68.43 -25.94 65.27 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.841 0.856 . . . . 75.4 111.496 174.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.665 HD11 ' CE1' ' B' ' 137' ' ' PHE . 15.3 mt -110.66 -6.58 14.8 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.97 0.908 . . . . 75.32 111.771 -168.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -155.61 137.09 14.09 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 123.415 0.447 . . . . 72.2 109.809 -173.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -70.48 80.72 0.57 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.794 0.807 . . . . 63.43 109.807 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -144.38 179.01 7.52 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.587 0.755 . . . . 72.35 110.647 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.417 ' HA ' HD22 ' B' ' 139' ' ' ASN . . . -154.42 151.82 29.45 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.335 -0.848 . . . . 74.23 109.719 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.07 174.63 51.15 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 116.084 -0.507 . . . . 61.15 112.197 171.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -100.82 152.79 20.09 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.448 0.699 . . . . 73.3 110.259 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.34 -163.47 34.67 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.099 -0.5 . . . . 65.52 113.445 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 58.6 m -140.03 -60.02 0.54 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.444 -0.947 . . . . 64.41 108.444 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 68.05 -65.16 0.26 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.713 1.605 . . . . 75.02 112.378 174.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -70.17 132.83 46.38 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.562 0.745 . . . . 73.24 110.105 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -130.16 151.79 50.3 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.266 0.626 . . . . 72.31 109.454 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -76.08 92.66 3.22 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.433 0.635 . . . . 71.32 109.762 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -81.72 92.89 6.69 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.769 -1.105 . . . . 61.35 109.675 -175.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 C-N-CA 123.896 0.879 . . . . 73.13 108.988 -177.603 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.632 -0.507 . . . . 71.5 109.632 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m -145.32 121.82 11.03 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.877 0.871 . . . . 73.02 109.158 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.03 33.46 0.91 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.377 0.671 . . . . 53.11 109.795 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.428 ' HB2' ' HA ' ' C' ' 7' ' ' THR . 42.3 mt-30 69.67 -165.77 0.17 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.979 1.312 . . . . 75.22 110.633 -172.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -101.07 -72.06 0.69 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.37 0.668 . . . . 72.34 109.4 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -86.51 -12.83 47.75 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.457 0.703 . . . . 43.01 110.512 175.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.428 ' HA ' ' HB2' ' C' ' 4' ' ' GLN . 2.7 m 63.22 32.92 14.67 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 124.569 1.148 . . . . 62.31 112.359 173.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.06 26.57 9.41 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.618 0.767 . . . . 61.54 112.112 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 55.4 ttp 66.39 136.63 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.823 1.249 . . . . 74.24 113.252 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -86.96 99.7 12.07 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 108.268 -1.012 . . . . 52.13 108.268 170.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.487 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.7 t80 -118.77 126.69 52.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.413 0.685 . . . . 64.43 109.743 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -146.59 133.58 20.28 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 109.111 -0.7 . . . . 73.4 109.111 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -71.95 118.73 17.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.351 -0.981 . . . . 44.44 108.351 170.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.615 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.4 mm100 -83.49 -49.22 9.49 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.415 0.447 . . . . 55.21 109.969 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -169.51 127.15 0.93 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 116.382 -0.372 . . . . 75.52 110.524 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -107.85 148.76 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 107.867 -1.161 . . . . 65.12 107.867 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' C' ' 19' ' ' LYS . 32.1 p90 -174.53 167.8 3.85 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.401 0.619 . . . . 74.44 111.223 -174.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.1 p -96.55 111.62 23.68 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.135 -1.061 . . . . 64.14 108.135 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' C' ' 17' ' ' TYR . 19.0 mttt -68.77 -47.6 65.79 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.812 -1.181 . . . . 61.13 107.812 170.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.2 t70 -133.55 139.68 46.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 113.558 -1.655 . . . . 65.23 109.69 -169.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.6 mt -140.97 143.78 27.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.898 -1.89 . . . . 64.11 105.898 174.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.0 t -158.09 148.46 20.42 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.278 -0.638 . . . . 54.22 109.278 173.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -147.64 130.95 16.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.122 -1.436 . . . . 62.31 107.122 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -133.47 126.47 31.2 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.001 0.52 . . . . 64.34 109.731 -176.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.39 80.86 18.56 Favored Pre-proline 0 C--O 1.242 0.705 0 N-CA-C 106.683 -1.599 . . . . 74.42 106.683 168.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.48 -12.49 29.5 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.73 2.286 . . . . 51.22 112.083 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -121.11 25.0 9.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.474 1.51 . . . . 71.21 109.628 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -46.38 -55.78 12.94 Favored Pre-proline 0 CA--C 1.563 1.46 0 N-CA-C 114.093 1.146 . . . . 71.44 114.093 -168.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 51.4 Cg_exo -56.67 -41.24 77.87 Favored 'Trans proline' 0 C--N 1.385 2.485 0 CA-C-N 121.829 1.689 . . . . 74.1 112.888 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -69.3 -33.76 73.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.082 -0.508 . . . . 71.41 112.091 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.87 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.4 p -79.03 -24.52 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 112.716 0.636 . . . . 71.1 112.716 176.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -67.34 -30.64 70.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.877 -0.514 . . . . 74.55 112.278 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -87.5 34.11 0.7 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.245 0.618 . . . . 61.53 111.071 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.54 153.8 41.56 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.568 0.747 . . . . 65.22 111.534 -172.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.5 118.06 13.84 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.709 -0.849 . . . . 73.55 108.709 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.526 ' HE1' ' HB3' ' G' ' 470' ' ' LEU . 74.9 t-105 -77.8 99.15 5.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.438 0.695 . . . . 72.22 110.681 -176.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -156.21 74.6 4.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.851 -0.796 . . . . 62.44 108.851 171.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -92.36 161.76 3.04 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.882 2.388 . . . . 63.44 114.029 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.37 95.38 10.18 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.766 -1.198 . . . . 61.32 107.766 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.4 t -80.26 98.48 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 115.358 -0.837 . . . . 74.15 109.841 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -106.77 110.11 22.19 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.405 -0.961 . . . . 74.22 108.405 174.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 mp -85.77 144.65 27.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.249 -1.76 . . . . 74.12 106.249 167.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -123.88 111.94 16.66 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.708 -0.849 . . . . 73.22 108.708 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 90.8 mt -93.88 142.01 27.86 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.082 0.553 . . . . 72.0 110.032 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.2 t70 -157.79 161.14 38.4 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.65 1.18 . . . . 71.21 108.343 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.1 t -146.57 135.0 21.95 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.028 0.442 . . . . 72.42 110.491 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.83 156.25 32.33 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.221 1.008 . . . . 64.33 108.738 172.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.452 ' HB2' ' CE2' ' C' ' 56' ' ' TYR . 63.8 p -160.74 151.99 19.1 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.334 0.253 . . . . 74.44 111.563 -173.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -161.21 142.66 11.7 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.847 0.859 . . . . 73.34 110.307 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.24 136.34 39.68 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.776 -0.453 . . . . 72.54 109.776 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.492 HD11 HD12 ' C' ' 83' ' ' ILE . 39.8 mt -108.95 -44.97 3.87 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.346 0.658 . . . . 74.32 109.701 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.41 -173.07 3.84 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.669 -0.696 . . . . 71.11 111.045 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -67.86 108.59 3.05 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.136 -0.938 . . . . 70.21 110.392 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 63.42 24.65 14.24 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.792 1.237 . . . . 61.25 111.512 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.29 114.47 45.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.361 -0.977 . . . . 74.23 108.361 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.452 ' CE2' ' HB2' ' C' ' 48' ' ' SER . 35.5 t80 -126.22 124.99 41.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.564 -0.902 . . . . 74.12 108.564 -176.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.466 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.9 tt0 -82.09 141.64 32.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.027 -0.988 . . . . 71.15 109.929 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.28 142.22 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.487 1.115 . . . . 65.41 108.196 169.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.08 133.33 60.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.836 -0.801 . . . . 53.54 108.836 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.43 114.88 29.33 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.911 -1.144 . . . . 75.34 107.911 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.557 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 41.5 ttm-85 -99.29 117.53 33.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.033 -0.729 . . . . 74.42 109.033 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.582 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.4 t -118.57 133.57 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.299 -1.001 . . . . 74.11 108.299 172.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 14.8 m -131.55 114.85 15.36 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.258 -0.645 . . . . 72.43 109.258 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.597 HG11 HD21 ' C' ' 126' ' ' LEU . 21.8 t -99.51 128.84 50.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.847 -0.798 . . . . 73.45 108.847 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.1 m -122.87 140.4 53.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.803 -1.184 . . . . 74.53 107.803 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 66' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' C' ' 73' ' ' ALA . . . -132.03 113.13 13.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.763 -1.199 . . . . 64.43 107.763 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.2 m -113.69 122.58 47.57 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.356 0.598 . . . . 63.44 110.173 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 mt -92.1 24.63 3.2 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.042 1.337 . . . . 73.24 109.52 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.1 -108.52 2.6 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 110.569 -1.012 . . . . 71.43 110.569 -170.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.63 -27.37 20.22 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.587 0.755 . . . . 73.33 110.276 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -79.42 119.26 22.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.685 0.794 . . . . 74.13 109.331 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 39.4 m -87.53 130.81 34.59 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.159 -0.682 . . . . 64.35 109.159 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.87 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.79 -61.61 1.75 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.249 0.619 . . . . 70.32 110.613 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -156.92 170.52 22.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.54 -0.755 . . . . 74.35 110.858 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -142.47 116.82 9.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.216 -1.401 . . . . 64.21 107.216 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.423 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -124.78 119.35 28.64 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.079 0.552 . . . . 64.12 109.751 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -121.94 125.67 46.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.684 0.394 . . . . 71.04 110.019 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.87 137.19 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.01 0.924 . . . . 63.5 108.817 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.9 mt-30 -115.56 95.41 5.14 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.635 -0.876 . . . . 65.0 108.635 172.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -79.71 100.25 7.8 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.626 -1.17 . . . . 74.21 110.081 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.45 149.34 27.32 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 116.194 -0.457 . . . . 75.55 112.071 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.553 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -157.03 122.2 1.15 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 111.713 -0.555 . . . . 34.43 111.713 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.615 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.9 mm -88.99 124.52 41.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.788 -0.819 . . . . 72.13 108.788 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.487 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 53.0 m-85 -131.44 118.82 20.75 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.074 0.549 . . . . 71.2 109.945 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 66.8 m -80.9 118.72 22.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.777 -0.823 . . . . 71.33 108.777 171.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 pp -135.05 141.32 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.849 0.86 . . . . 53.12 110.119 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.0 142.87 17.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.176 0.59 . . . . 51.13 110.522 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.94 -23.43 35.65 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.506 0.504 . . . . 75.23 114.264 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.568 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -89.82 153.55 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.451 0.7 . . . . 63.32 110.813 178.803 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -160.06 -179.07 7.46 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.344 -0.844 . . . . 71.42 110.221 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.85 -112.44 3.81 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.864 0.728 . . . . 41.12 114.249 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.451 HG23 ' HB3' ' C' ' 145' ' ' ALA . 21.2 p -68.89 -43.02 76.14 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.178 0.991 . . . . 72.3 111.292 178.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -66.47 -37.44 85.13 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.856 -0.611 . . . . 64.33 111.418 -174.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -72.86 -39.96 66.07 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 110.364 -0.235 . . . . 73.21 110.364 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.13 -44.27 92.04 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 123.533 0.52 . . . . 74.44 110.81 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -80.39 -34.05 36.61 Favored 'General case' 0 C--O 1.245 0.864 0 O-C-N 123.411 0.444 . . . . 73.54 112.128 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.442 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 42.4 t -59.3 -37.16 77.03 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 123.425 0.453 . . . . 72.53 110.101 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 32.1 mt -93.94 -22.83 18.34 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.866 0.866 . . . . 75.11 111.033 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -31.65 57.98 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 115.077 0.791 . . . . 54.51 115.077 -172.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.65 -35.43 0.05 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.217 0.451 . . . . 32.01 112.217 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.442 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 45.5 t80 -60.18 -50.96 71.61 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.442 1.497 . . . . 62.3 112.567 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 61.4 m -75.41 -44.24 4.37 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-O 118.319 -0.848 . . . . 52.2 112.258 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -53.91 -26.71 41.13 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 122.001 1.801 . . . . 62.14 113.66 170.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -68.33 -34.91 76.97 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.514 0.725 . . . . 74.23 111.166 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -64.01 -36.51 77.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.356 0.662 . . . . 64.21 109.983 175.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.553 HD21 ' HA3' ' C' ' 82' ' ' GLY . 63.4 mt -84.94 -15.3 44.85 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.058 . . . . 71.52 112.265 -176.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.33 -48.57 90.88 Favored Pre-proline 0 CA--C 1.56 1.36 0 N-CA-C 114.115 1.154 . . . . 52.41 114.115 -173.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.82 -33.13 76.89 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 121.877 1.718 . . . . 61.34 112.767 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -71.5 -46.69 59.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.612 -0.722 . . . . 71.21 110.327 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.23 -41.9 76.43 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 115.321 -0.854 . . . . 63.31 109.847 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -56.21 -60.34 3.64 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.47 1.106 . . . . 71.33 111.718 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.02 -29.08 68.79 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.941 0.496 . . . . 70.04 111.237 -173.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 24.3 t -69.95 -35.87 74.84 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.009 0.524 . . . . 75.31 111.219 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.582 HD11 ' HB ' ' C' ' 62' ' ' VAL . 94.9 mt -72.92 -47.24 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.631 0.772 . . . . 70.13 110.036 174.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.0 m -61.0 -34.58 75.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.022 0.929 . . . . 75.54 111.125 -177.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -62.49 -51.72 66.32 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 115.351 -0.84 . . . . 52.25 109.59 174.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.549 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.46 -35.56 76.16 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.626 1.17 . . . . 72.32 112.867 -179.074 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.525 HG13 ' HB2' ' C' ' 123' ' ' PHE . 68.3 t -67.1 -44.99 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.548 0.739 . . . . 53.22 110.465 176.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.533 ' OG ' HG21 ' B' ' 115' ' ' THR . 47.3 t -66.8 -31.35 71.92 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.733 -0.667 . . . . 63.01 111.186 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' D' ' 17' ' ' TYR . 83.3 mtt-85 -67.29 -46.06 74.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.414 0.686 . . . . 74.31 109.391 176.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.21 -0.8 67.13 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.683 0.614 . . . . 62.11 113.24 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 34.2 p 64.6 27.96 13.27 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.742 2.017 . . . . 74.32 114.19 170.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.525 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.7 m-85 -83.73 155.67 65.04 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.529 0.731 . . . . 75.53 109.737 172.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -53.16 173.58 0.15 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 124.072 3.181 . . . . 75.5 115.573 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -55.6 132.97 50.13 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.728 1.211 . . . . 61.34 112.851 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.597 HD21 HG11 ' C' ' 64' ' ' VAL . 17.4 tp -135.14 102.48 5.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.929 -1.137 . . . . 73.04 107.929 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -123.42 126.81 47.46 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.105 0.562 . . . . 45.21 110.221 -175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mp -77.01 117.11 18.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.312 0.645 . . . . 71.52 109.379 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.79 162.36 58.82 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.507 1.123 . . . . 75.12 111.506 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.561 ' HG3' HD12 ' A' ' 16' ' ' ILE . 51.2 Cg_exo -55.19 103.61 0.11 Allowed 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.407 2.071 . . . . 45.13 112.152 169.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 89.0 t -97.99 113.24 32.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.57 0.748 . . . . 75.35 109.533 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -90.68 59.81 4.32 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.669 0.747 . . . . 63.03 110.025 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.484 ' HD1' ' H ' ' C' ' 133' ' ' PHE . 1.2 p90 -78.44 -14.21 59.48 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.214 -0.903 . . . . 64.41 110.066 175.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -75.47 -49.04 20.03 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.642 0.777 . . . . 71.45 109.818 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.66 74.17 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.524 -0.762 . . . . 73.32 110.622 174.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.17 -42.8 83.65 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.311 -0.859 . . . . 62.41 110.415 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -64.97 -31.45 72.7 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.488 0.315 . . . . 65.25 110.81 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -49.38 65.56 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 122.876 0.471 . . . . 72.41 110.195 -177.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -71.99 -33.67 68.29 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 122.672 0.389 . . . . 71.33 111.697 177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -51.41 -80.8 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.318 1.047 . . . . 73.12 109.515 169.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.471 ' HG ' ' H ' ' C' ' 143' ' ' GLN . 27.4 tp 68.66 158.47 0.16 Allowed 'General case' 0 C--N 1.36 1.039 0 C-N-CA 124.889 1.276 . . . . 74.44 111.048 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -152.11 20.54 0.67 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.286 0.565 . . . . 71.35 109.975 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.471 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 9.1 tp-100 -161.86 110.87 1.5 Allowed 'General case' 0 C--N 1.35 0.602 0 CA-C-N 115.621 -0.718 . . . . 75.24 109.675 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -74.94 97.05 3.26 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-O 121.687 0.756 . . . . 70.43 110.04 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.451 ' HB3' HG23 ' C' ' 92' ' ' THR . . . -158.71 -172.63 3.9 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.334 -0.848 . . . . 63.5 110.531 -172.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 122.43 6.26 8.17 Favored Glycine 0 N--CA 1.474 1.21 0 C-N-CA 123.207 0.432 . . . . 73.42 112.478 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -75.62 94.39 3.19 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.401 0.68 . . . . 53.41 109.411 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 167.5 95.79 0.1 Allowed Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.762 -0.654 . . . . 63.21 111.903 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 84.8 m -141.15 107.16 5.17 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.141 0.976 . . . . 73.12 109.118 176.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -149.31 135.18 18.83 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 122.928 0.491 . . . . 71.25 109.835 175.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.61 101.64 2.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.464 1.106 . . . . 74.44 110.669 -170.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -127.31 116.57 20.74 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.784 0.834 . . . . 71.21 109.241 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -165.26 102.74 0.74 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 106.726 -1.583 . . . . 62.34 106.726 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -104.43 -0.24 28.22 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.957 0.903 . . . . 64.31 110.96 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 C-N-CA 125.468 1.507 . . . . 74.22 111.365 -178.976 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.603 -0.518 . . . . 62.42 109.603 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -173.63 75.65 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.93 -1.137 . . . . 73.32 107.93 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -80.45 119.11 22.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.749 -0.66 . . . . 71.24 110.412 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -135.37 116.21 14.06 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.961 0.905 . . . . 70.33 108.695 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -146.03 137.8 25.02 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.532 0.733 . . . . 62.33 109.702 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -126.8 120.07 28.42 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.232 -1.025 . . . . 52.34 108.232 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -66.51 -28.11 68.3 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.33 0.652 . . . . 73.15 111.322 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.02 1.93 11.79 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.089 0.956 . . . . 70.01 111.199 -178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.52 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.3 tpt -33.26 124.94 0.39 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.549 1.14 . . . . 75.2 112.698 163.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 94.3 m -148.86 140.88 23.84 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.844 0.857 . . . . 71.3 109.749 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.415 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 47.7 t80 -151.81 88.21 1.39 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.297 -1.372 . . . . 73.23 107.297 174.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -114.05 121.84 45.08 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.103 -1.073 . . . . 72.32 108.103 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.518 HD13 HG21 ' D' ' 105' ' ' ILE . 9.4 mt -86.98 128.47 39.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 116.213 -0.449 . . . . 65.12 110.117 -171.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -90.79 -39.74 12.2 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.437 0.695 . . . . 62.42 112.096 -173.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -175.08 122.19 0.22 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 112.219 0.452 . . . . 71.21 112.219 -167.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.804 HD13 ' HG2' ' B' ' 130' ' ' PRO . 1.5 mp -108.9 134.23 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.708 -0.849 . . . . 71.14 108.708 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.51 ' HE1' HG13 ' D' ' 83' ' ' ILE . 27.8 p90 -159.65 159.43 33.05 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 124.16 0.912 . . . . 74.35 110.487 -172.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -94.78 114.24 26.11 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.638 -0.71 . . . . 71.11 109.552 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.462 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 3.8 mtpp -77.84 -26.71 49.63 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.23 -0.656 . . . . 64.44 109.23 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -160.74 144.74 13.71 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.847 -1.069 . . . . 74.15 109.864 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.549 HG21 ' HE2' ' C' ' 117' ' ' MET . 68.0 mt -140.16 148.62 22.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 125.549 1.54 . . . . 55.43 107.388 174.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 26.9 t -156.08 119.44 4.3 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.226 0.61 . . . . 71.4 109.612 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.417 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.6 t80 -125.63 118.38 25.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.849 1.26 . . . . 74.31 107.879 173.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -124.16 135.96 53.86 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.124 -0.695 . . . . 74.12 109.124 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.48 86.36 39.21 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.442 -1.318 . . . . 63.54 107.442 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -66.61 -39.04 16.84 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.803 2.336 . . . . 62.42 113.115 -170.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 82.1 m-20 -101.3 17.33 22.86 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.869 0.868 . . . . 72.23 110.732 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.24 -70.81 0.12 Allowed Pre-proline 0 CA--C 1.562 1.424 0 N-CA-C 115.69 1.737 . . . . 61.43 115.69 -162.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.69 -18.79 14.96 Favored 'Trans proline' 0 C--N 1.382 2.328 0 CA-C-N 123.531 2.297 . . . . 60.44 113.198 -172.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.447 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 11.2 t-160 -68.1 -47.64 67.65 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.794 1.238 . . . . 73.21 109.347 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.6 p -83.17 -20.21 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.241 1.016 . . . . 63.2 111.838 -172.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -63.52 -32.19 73.57 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.175 0.512 . . . . 62.21 111.431 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -67.42 -10.48 51.75 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.969 -1.014 . . . . 71.32 111.544 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -96.17 84.74 3.84 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.119 0.967 . . . . 73.44 109.17 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.89 82.79 5.91 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.679 0.792 . . . . 64.32 109.866 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.4 t-105 -147.46 163.1 37.59 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.821 0.848 . . . . 74.43 109.665 -175.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.95 109.26 4.86 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.474 1.11 . . . . 75.05 110.438 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.39 144.04 25.44 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.795 2.33 . . . . 74.01 112.242 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' H' ' 470' ' ' LEU . 44.5 tt0 -90.03 135.62 33.54 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.874 -0.787 . . . . 65.21 108.874 171.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.52 ' HB ' HG13 ' D' ' 64' ' ' VAL . 32.9 m -105.78 127.67 60.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 123.045 0.538 . . . . 75.34 109.555 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -87.42 114.03 23.66 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.923 -1.51 . . . . 61.41 106.923 172.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.472 ' O ' HD12 ' D' ' 42' ' ' LEU . 2.9 pp -94.75 117.81 30.73 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.011 0.91 . . . . 72.02 109.28 -174.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -122.96 112.54 17.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.726 -1.583 . . . . 73.41 106.726 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.93 152.34 22.09 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.159 0.584 . . . . 51.32 109.712 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.0 t70 -151.02 156.28 40.81 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.756 1.222 . . . . 74.24 108.367 174.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -138.95 156.71 47.03 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.372 0.669 . . . . 73.2 109.464 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.409 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.47 177.86 10.78 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.283 0.633 . . . . 72.21 110.282 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.6 p -163.19 164.82 25.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.485 0.714 . . . . 53.22 111.2 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 91.1 p -156.36 132.71 10.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.402 1.081 . . . . 54.32 108.744 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -86.37 117.99 25.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.404 -0.591 . . . . 62.4 109.404 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.08 -25.42 16.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.084 0.554 . . . . 72.32 110.629 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.49 -178.68 5.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.392 1.077 . . . . 50.41 109.496 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.49 137.05 49.92 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.88 -0.785 . . . . 73.42 108.88 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.704 ' HA ' HG11 ' H' ' 451' ' ' VAL . 17.4 m-20 61.2 10.8 3.16 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.095 0.958 . . . . 72.23 112.772 -177.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -123.78 124.79 70.03 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 C-N-CA 124.63 1.172 . . . . 61.23 108.47 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.576 ' HD2' HD11 ' D' ' 86' ' ' ILE . 8.1 m-85 -128.29 158.59 37.76 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.399 -0.963 . . . . 75.43 108.399 171.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -125.9 128.04 46.95 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 105.729 -1.952 . . . . 72.55 105.729 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.45 141.23 31.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.598 -0.89 . . . . 65.11 108.598 -174.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 48.2 t -121.3 134.04 65.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 O-C-N 123.852 0.72 . . . . 64.23 109.136 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -117.49 121.89 42.23 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.18 -1.415 . . . . 74.35 107.18 174.139 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 15.7 ttm-85 -105.6 102.65 12.1 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.765 -0.828 . . . . 73.04 108.765 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 71.9 t -99.76 113.39 34.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.549 -0.908 . . . . 63.14 108.549 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 11.8 m -114.61 134.36 55.11 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.263 0.625 . . . . 73.03 109.377 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 78.8 t -131.67 102.44 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.344 1.457 . . . . 72.51 108.623 -171.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 96.5 m -103.36 95.8 6.33 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.323 -0.991 . . . . 74.23 108.323 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.56 159.94 14.62 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.059 0.456 . . . . 63.13 111.843 -172.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 53.3 p -145.47 142.93 29.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.135 -0.939 . . . . 72.12 110.912 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.472 ' HA ' HD11 ' H' ' 470' ' ' LEU . 14.9 mt -113.09 114.59 27.06 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.597 1.159 . . . . 64.41 108.711 169.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.96 -112.39 4.55 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.672 0.608 . . . . 61.24 112.857 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -106.94 3.75 26.49 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.289 0.636 . . . . 74.34 112.092 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -135.81 167.6 20.86 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.654 0.381 . . . . 74.43 110.677 -172.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.0 m -70.06 132.18 45.47 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.608 -0.724 . . . . 74.2 110.942 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.579 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -90.32 -76.46 0.43 Allowed 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.913 -1.143 . . . . 63.34 107.913 174.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -142.22 136.84 30.28 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 121.242 0.544 . . . . 62.41 111.641 -176.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 63.3 mt -104.34 140.29 38.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.124 1.369 . . . . 71.52 107.63 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.679 ' SG ' HG12 ' D' ' 114' ' ' ILE . 50.5 t -154.15 143.09 21.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.038 0.535 . . . . 43.43 109.615 -175.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -155.89 131.84 9.91 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.262 -1.014 . . . . 74.34 108.262 172.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.0 t -131.94 114.78 25.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.248 -0.649 . . . . 73.15 109.248 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -88.17 82.48 7.12 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.094 -1.076 . . . . 64.35 108.094 169.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -79.86 96.43 6.34 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.694 -1.594 . . . . 71.14 108.744 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.11 164.24 25.92 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.132 -0.486 . . . . 55.35 112.075 177.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.2 135.06 3.71 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 112.562 -0.215 . . . . 64.12 112.562 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.51 HG13 ' HE1' ' D' ' 17' ' ' TYR . 45.3 mt -89.79 129.66 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.343 1.057 . . . . 72.43 108.875 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -129.84 147.21 51.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.395 1.078 . . . . 75.4 110.321 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.1 m -108.01 109.78 21.33 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.555 -0.906 . . . . 74.22 108.555 171.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.576 HD11 ' HD2' ' D' ' 56' ' ' TYR . 19.2 pt -115.94 136.64 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.529 0.732 . . . . 71.52 110.942 -173.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -154.54 159.54 40.99 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.195 0.998 . . . . 75.34 109.115 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 80.01 -12.37 30.78 Favored Glycine 0 N--CA 1.478 1.457 0 N-CA-C 114.257 0.463 . . . . 75.14 114.257 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.466 ' O ' HG23 ' H' ' 451' ' ' VAL . 10.6 pt -123.09 142.1 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.424 1.089 . . . . 74.41 109.165 -178.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.585 ' HB3' ' HA ' ' H' ' 451' ' ' VAL . 6.3 pt-20 -165.83 164.55 18.66 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.506 0.722 . . . . 74.51 110.781 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.89 -114.72 7.11 Favored Glycine 0 C--N 1.354 1.56 0 O-C-N 123.851 0.719 . . . . 75.4 112.254 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.9 m -67.85 -37.79 82.3 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.492 0.717 . . . . 73.34 110.421 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -70.22 -28.78 65.54 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.602 0.761 . . . . 64.51 112.572 -177.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.557 ' HE1' HD22 ' H' ' 454' ' ' LEU . 18.5 tmm? -83.54 -32.03 26.08 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.25 -0.278 . . . . 73.04 110.25 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 -33.92 76.92 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.276 0.56 . . . . 71.42 110.379 169.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.429 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.1 t-80 -73.58 -20.28 60.66 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.994 1.317 . . . . 74.12 111.14 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -88.01 -53.83 4.54 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.435 0.294 . . . . 64.33 110.712 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.444 HD22 ' SD ' ' D' ' 94' ' ' MET . 9.8 mp -74.57 -32.92 62.55 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.659 0.783 . . . . 73.22 111.77 -173.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.19 14.54 61.13 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 119.072 -0.849 . . . . 74.44 113.311 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -157.58 -69.66 0.1 Allowed 'General case' 0 C--N 1.356 0.871 0 CA-C-N 118.212 1.006 . . . . 65.11 112.846 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -68.14 -39.61 82.62 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.818 0.447 . . . . 65.53 112.057 -171.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.415 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 74.8 m -69.5 -46.3 26.73 Favored Pre-proline 0 CA--C 1.557 1.242 0 CA-C-O 118.372 -0.823 . . . . 73.52 111.516 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.463 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 97.9 Cg_exo -51.29 -36.97 58.94 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 122.314 2.01 . . . . 75.22 113.373 165.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -65.83 -29.81 70.33 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.025 0.53 . . . . 64.54 111.792 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.518 HG21 HD13 ' D' ' 13' ' ' ILE . 46.2 mm -68.96 -44.81 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.521 -0.548 . . . . 73.33 109.521 171.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -77.05 -14.98 59.75 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.99 -1.005 . . . . 72.05 112.021 -173.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -73.73 -40.1 4.94 Favored Pre-proline 0 CA--C 1.561 1.395 0 N-CA-C 113.924 1.083 . . . . 61.45 113.924 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.7 -39.35 88.38 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 121.742 1.628 . . . . 73.24 112.782 169.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -72.67 -35.33 67.68 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.612 0.765 . . . . 73.31 110.985 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.1 -51.46 67.81 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.657 -0.701 . . . . 73.42 109.359 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 29.7 ttp-105 -54.34 -50.24 67.87 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.794 1.309 . . . . 53.51 110.874 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -64.11 -46.04 85.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.861 0.865 . . . . 71.45 111.898 -173.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.7 t -59.47 -40.42 86.86 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.994 0.809 . . . . 54.32 110.507 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.679 HG12 ' SG ' ' D' ' 76' ' ' CYS . 95.4 mt -63.01 -56.06 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.111 0.964 . . . . 61.21 110.35 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -55.36 -37.01 66.95 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.574 1.15 . . . . 64.11 111.376 -174.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.4 t -68.73 -46.23 69.43 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.009 -0.996 . . . . 61.24 110.144 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.8 mtm -68.21 -29.24 68.03 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.783 0.433 . . . . 62.41 111.897 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' D' ' 123' ' ' PHE . 54.7 t -68.7 -41.75 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.788 0.835 . . . . 63.54 110.266 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.6 p -74.88 -32.11 61.77 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.615 0.366 . . . . 63.12 110.909 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -70.43 -34.8 72.88 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.469 0.708 . . . . 63.42 109.82 174.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.51 5.61 82.89 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 115.345 -0.843 . . . . 54.32 112.537 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 26.6 p 63.04 16.32 9.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.407 1.883 . . . . 63.0 114.84 171.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.426 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.8 m-85 -80.71 153.82 73.22 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.462 0.705 . . . . 51.35 109.292 170.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.02 141.83 94.08 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.73 2.287 . . . . 62.04 113.083 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.76 134.92 47.85 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.865 1.266 . . . . 74.24 112.555 -174.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -110.01 107.13 16.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.109 -1.071 . . . . 42.03 108.109 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -99.22 89.06 4.1 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.911 -0.774 . . . . 72.44 108.911 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.49 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 44.0 tp -70.53 115.83 10.15 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.936 -1.029 . . . . 75.11 109.787 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.96 133.44 87.14 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 123.459 0.704 . . . . 70.4 111.396 -176.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 16.7 Cg_exo -66.71 113.35 2.71 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.626 2.217 . . . . 63.43 111.161 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 61.1 t -106.43 128.11 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.532 0.733 . . . . 71.23 109.045 -175.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -78.29 98.23 5.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.529 0.732 . . . . 73.42 109.713 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -63.46 -22.42 66.88 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.169 0.588 . . . . 72.4 111.855 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.426 ' O ' ' HG3' ' D' ' 138' ' ' MET . 10.9 m-20 -61.87 -48.56 79.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.321 0.648 . . . . 63.11 111.689 177.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.41 -45.77 89.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.551 0.74 . . . . 72.4 111.702 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.49 -31.8 72.19 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.934 -0.575 . . . . 74.25 111.128 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.418 ' O ' HD13 ' D' ' 141' ' ' LEU . 89.4 t80 -65.29 -43.19 91.92 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.248 0.619 . . . . 75.21 110.179 176.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 35.2 mtt -63.59 -40.4 96.84 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.278 0.631 . . . . 55.43 110.1 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.36 -40.59 96.93 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 124.026 0.829 . . . . 74.4 110.842 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -63.16 -40.08 96.53 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.337 0.655 . . . . 75.44 111.507 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.418 HD13 ' O ' ' D' ' 137' ' ' PHE . 7.1 mp -66.22 -36.26 82.58 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.541 0.736 . . . . 72.14 111.6 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -89.55 9.14 27.79 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.107 0.563 . . . . 73.34 111.307 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -121.22 87.51 2.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.207 1.003 . . . . 73.4 109.513 -176.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -148.39 23.68 1.02 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.76 0.791 . . . . 44.12 109.746 174.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.91 -44.04 0.07 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.084 1.354 . . . . 62.13 107.603 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -163.92 176.22 39.97 Favored Glycine 0 C--O 1.241 0.564 0 CA-C-N 113.716 -1.583 . . . . 71.34 109.528 169.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.64 100.65 0.92 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.582 -0.525 . . . . 71.15 109.582 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.51 158.04 46.88 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.631 -0.713 . . . . 73.02 112.777 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 24.3 m -129.44 80.25 1.95 Allowed 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.852 -0.795 . . . . 60.41 108.852 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.03 137.17 24.61 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.77 -1.105 . . . . 75.41 108.664 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -155.87 111.12 2.96 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.604 -1.628 . . . . 60.4 106.604 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -147.24 72.85 1.27 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.782 -1.192 . . . . 53.25 107.782 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -84.04 9.0 13.55 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.083 -0.962 . . . . 72.3 111.181 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -52.9 107.99 0.28 Allowed 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.513 1.125 . . . . 41.42 110.633 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.868 0.867 . . . . 75.21 109.787 -173.527 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 67.0 t30 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.974 0.416 . . . . 74.54 110.074 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' 451' ' ' VAL . . . . . 0.451 HG22 ' SD ' ' A' ' 94' ' ' MET . 8.1 p -67.62 121.13 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 121.521 0.677 . . . . 70.3 109.819 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.72 142.79 19.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 C-N-CA 124.822 1.249 . . . . 71.55 108.96 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -157.11 172.33 34.61 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.562 -1.015 . . . . 73.33 110.562 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 35.8 tp 64.24 113.4 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.672 1.189 . . . . 63.3 110.784 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 5.7 m -63.45 142.38 58.41 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.863 0.465 . . . . 73.15 110.262 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 456' ' ' ASP . . . . . 0.457 ' HA ' ' HB2' ' A' ' 48' ' ' SER . 6.9 m-20 -61.94 153.12 30.21 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.906 0.482 . . . . 71.42 110.336 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 71.13 166.75 0.3 Allowed 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.727 1.211 . . . . 64.34 110.227 -164.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 458' ' ' THR . . . . . 0.591 HG23 HD22 ' E' ' 460' ' ' LEU . 12.5 t -158.87 154.45 26.06 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.239 0.543 . . . . 74.42 111.13 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.82 7.69 44.78 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 124.318 1.047 . . . . 74.04 109.507 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 460' ' ' LEU . . . . . 0.591 HD22 HG23 ' E' ' 458' ' ' THR . 4.1 mm? 67.02 -176.33 0.2 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.255 1.422 . . . . 54.41 112.407 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -137.46 -13.49 1.53 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.853 1.261 . . . . 75.13 110.174 176.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -167.79 137.89 2.73 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 124.012 0.925 . . . . 74.24 109.73 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 80.6 p -116.01 134.96 54.41 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.229 -1.397 . . . . 64.35 107.229 169.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 464' ' ' MET . . . . . 0.478 ' HB2' HD11 ' A' ' 44' ' ' LEU . 7.2 tmm? -72.41 -75.43 0.14 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.597 -0.89 . . . . 75.41 108.597 -178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 42.6 tttm 47.52 -87.42 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.332 1.453 . . . . 73.31 113.147 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . 49.66 -87.98 0.01 OUTLIER 'General case' 0 C--N 1.363 1.185 0 C-N-CA 125.058 1.343 . . . . 74.55 112.738 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . 171.5 152.74 0.06 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.431 1.892 . . . . 73.43 108.57 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 468' ' ' LEU . . . . . 0.523 ' HG ' HG21 ' A' ' 40' ' ' VAL . 4.4 pp -168.09 168.2 11.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.007 0.923 . . . . 74.03 109.344 168.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -126.18 140.22 11.94 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.769 -0.65 . . . . 75.13 111.553 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 5.3 mp -78.42 -62.16 1.77 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.306 -1.368 . . . . 72.43 107.306 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 471' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' E' ' 471' ' ' LYS . 33.3 mmtt . . . . . 0 C--O 1.252 1.219 0 C-N-CA 128.469 2.708 . . . . 72.5 106.367 163.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.796 -0.446 . . . . 73.04 109.796 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 50.6 t 58.75 90.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 124.421 1.076 . . . . 62.05 108.992 -170.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 452' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' B' ' 94' ' ' MET . 60.0 t 73.52 165.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.767 1.227 . . . . 72.22 109.569 -169.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 170.4 149.79 6.59 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 121.916 -0.49 . . . . 73.55 113.625 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 3.9 pp -167.04 155.61 9.98 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.931 1.293 . . . . 75.3 109.312 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 14.1 m -99.68 -67.42 0.85 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 122.893 0.477 . . . . 63.02 109.781 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -167.58 96.44 0.46 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.327 -0.852 . . . . 73.25 110.633 -170.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 178.89 63.2 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.572 1.549 . . . . 61.42 107.488 166.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 60.4 p -118.36 106.08 12.38 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.2 -0.909 . . . . 75.24 110.251 -174.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -143.18 130.4 20.86 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.165 -1.05 . . . . 74.34 108.165 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 460' ' ' LEU . . . . . 0.485 ' H ' HD23 ' F' ' 460' ' ' LEU . 2.6 pt? -80.37 -173.0 3.81 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.616 0.766 . . . . 72.03 110.588 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 461' ' ' PHE . . . . . 0.578 ' HE1' ' HB2' ' B' ' 140' ' ' TYR . 8.2 m-85 -72.34 -72.41 0.24 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.786 0.834 . . . . 74.02 108.944 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 15.0 t80 178.18 134.55 0.08 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.03 1.332 . . . . 41.43 107.42 176.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 463' ' ' THR . . . . . 0.405 ' H ' ' HG ' ' B' ' 44' ' ' LEU . 17.9 m -91.34 74.01 6.12 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.342 0.591 . . . . 64.1 110.346 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 464' ' ' MET . . . . . 0.415 ' N ' HG21 ' B' ' 131' ' ' VAL . 33.7 tpp -177.24 152.26 0.85 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.025 1.33 . . . . 62.43 109.018 168.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -64.79 -56.67 12.09 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.573 0.749 . . . . 74.24 109.846 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -152.06 -66.82 0.17 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.432 -0.951 . . . . 72.31 108.432 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -118.35 160.05 22.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.241 1.016 . . . . 34.44 108.67 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 7.2 tt -66.96 -35.17 79.38 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.153 0.581 . . . . 73.42 110.34 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.19 -55.77 0.35 Allowed Glycine 0 CA--C 1.507 -0.413 0 N-CA-C 110.051 -1.22 . . . . 74.3 110.051 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 470' ' ' LEU . . . . . 0.644 ' H ' HD23 ' F' ' 470' ' ' LEU . 1.3 pt? -76.81 100.11 5.38 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.664 -0.768 . . . . 51.25 110.219 176.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.244 0.809 0 N-CA-C 107.07 -1.455 . . . . 73.35 107.07 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 34.4 t30 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 110.124 -0.324 . . . . 70.05 110.124 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' G' G ' 451' ' ' VAL . . . . . 0.412 HG13 HG22 ' G' ' 452' ' ' VAL . 9.2 p -71.17 -40.99 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 123.419 0.688 . . . . 71.12 111.69 -174.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 452' ' ' VAL . . . . . 0.412 HG22 HG13 ' G' ' 451' ' ' VAL . 27.6 m -144.28 144.8 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.211 0.605 . . . . 72.43 111.046 -175.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 144.27 77.08 0.03 OUTLIER Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.638 -0.585 . . . . 74.04 111.638 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.14 123.72 29.23 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.229 0.612 . . . . 63.54 110.441 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 17.6 p -82.68 -61.01 1.99 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.823 0.849 . . . . 74.03 110.036 175.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 18.2 t70 68.02 120.52 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.13 1.372 . . . . 61.32 113.149 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -140.12 23.5 2.38 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.507 1.123 . . . . 71.14 110.711 175.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 87.1 m -144.03 136.01 26.37 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.07 0.548 . . . . 70.3 110.176 -174.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.47 171.17 7.79 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.995 0.518 . . . . 75.11 110.266 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.17 122.08 17.04 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.65 -0.87 . . . . 64.45 108.65 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -68.07 4.01 1.39 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.762 1.225 . . . . 75.44 114.097 -175.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 462' ' ' TYR . . . . . 0.414 ' CE2' ' HB2' ' G' ' 464' ' ' MET . 21.5 t80 -148.36 122.94 9.8 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.139 -0.689 . . . . 74.32 109.139 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 8.9 t -104.61 -43.66 5.09 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.336 0.655 . . . . 53.32 109.701 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 464' ' ' MET . . . . . 0.414 ' HB2' ' CE2' ' G' ' 462' ' ' TYR . 53.4 ttp 68.53 93.78 0.08 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.078 1.351 . . . . 53.33 111.753 -174.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -106.54 -51.53 2.93 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.598 -0.89 . . . . 74.44 108.598 170.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -73.0 83.7 1.25 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.326 -0.852 . . . . 40.22 110.447 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -159.33 -63.05 0.07 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.124 0.97 . . . . 55.43 108.827 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 77.5 mt -101.26 110.79 22.86 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.576 -1.193 . . . . 74.14 108.555 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -74.68 -51.51 8.03 Favored Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.365 -0.694 . . . . 73.43 111.365 175.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 470' ' ' LEU . . . . . 0.526 ' HB3' ' HE1' ' C' ' 36' ' ' TRP . 30.2 mt 57.69 103.69 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.89 1.676 . . . . 63.4 111.593 -176.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.376 -0.829 . . . . 64.4 111.064 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 450' ' ' ASN . . . . . 0.575 ' N ' HD21 ' H' ' 450' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 108.2 -1.037 . . . . 74.33 108.2 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 451' ' ' VAL . . . . . 0.704 HG11 ' HA ' ' D' ' 54' ' ' ASP . 11.3 p -59.07 -38.24 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.1 0.96 . . . . 72.22 111.292 -177.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 452' ' ' VAL . . . . . . . . . . . . . 33.3 m -67.78 163.28 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.578 1.151 . . . . 73.5 112.526 -175.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 94.78 97.92 1.67 Allowed Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.623 -0.717 . . . . 42.03 112.64 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 454' ' ' LEU . . . . . 0.557 HD22 ' HE1' ' D' ' 94' ' ' MET . 2.5 pt? -137.34 170.26 16.38 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.807 0.843 . . . . 73.12 109.403 173.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 26.9 m -70.47 144.96 51.26 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 109.443 -0.577 . . . . 75.44 109.443 172.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -58.47 103.82 0.18 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.67 -0.492 . . . . 65.12 109.67 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -69.83 83.74 0.47 Allowed 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 122.504 1.145 . . . . 74.43 110.833 -176.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 31.4 p -116.04 12.23 15.56 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.908 -1.497 . . . . 54.21 109.681 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -111.54 108.22 17.66 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.088 0.955 . . . . 74.33 109.629 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.16 84.89 6.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.201 1.0 . . . . 55.02 109.793 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -57.03 -19.9 21.34 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 113.42 -1.718 . . . . 74.04 112.217 169.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -65.67 101.7 0.65 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.185 -1.043 . . . . 74.45 108.185 171.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 4.8 t -140.35 76.23 1.55 Allowed 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 122.046 0.927 . . . . 65.35 110.048 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.47 166.43 33.3 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.266 -0.879 . . . . 75.45 110.002 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -160.32 134.49 7.29 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.003 -1.11 . . . . 74.24 108.003 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -161.39 -159.42 0.64 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.509 0.724 . . . . 52.03 110.395 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . 78.05 -77.05 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.425 1.49 . . . . 63.34 112.131 172.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 468' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' D' ' 39' ' ' GLU . 0.6 OUTLIER -131.46 136.68 48.14 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.343 0.657 . . . . 73.55 110.451 -174.725 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . -127.18 19.07 6.08 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.44 -0.645 . . . . 62.32 114.254 -173.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 470' ' ' LEU . . . . . 0.56 ' HB2' ' HB2' ' D' ' 39' ' ' GLU . 12.7 tp 63.14 18.16 10.73 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 124.795 1.238 . . . . 71.13 111.337 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 23.4 tptm . . . . . 0 C--O 1.248 1.006 0 N-CA-C 107.527 -1.286 . . . . 74.22 107.527 -170.567 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.8 m . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 108.252 -1.018 . . . . 72.31 108.252 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.612 ' HA ' HG22 ' A' ' 86' ' ' ILE . 72.8 t80 -130.41 114.13 15.19 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.695 -1.224 . . . . 74.22 107.695 170.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -134.18 134.58 42.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.418 -0.956 . . . . 71.52 108.418 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.429 ' CD1' HG21 ' A' ' 105' ' ' ILE . 14.6 mt -84.99 112.32 21.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 108.485 -0.932 . . . . 73.54 108.485 174.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.27 -39.77 65.13 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.515 -0.92 . . . . 63.54 108.515 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -172.17 148.28 2.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 116.591 -0.277 . . . . 55.43 110.622 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.7 mt -132.16 129.06 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.101 -1.074 . . . . 73.41 108.101 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.437 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 33.1 p90 -168.37 147.99 4.57 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 124.209 0.943 . . . . 73.21 110.562 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -75.68 112.53 12.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.865 -1.061 . . . . 33.05 109.121 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 37.7 mtpt -82.08 -27.51 32.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.955 0.407 . . . . 71.13 109.951 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.642 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 19.5 t70 -143.7 140.02 29.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.008 -0.997 . . . . 70.04 109.885 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.4 mt -137.15 140.91 41.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 107.204 -1.406 . . . . 70.34 107.204 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -147.77 134.5 19.99 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.78 -0.822 . . . . 70.14 108.78 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.575 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 55.2 t80 -140.09 121.6 15.15 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.834 -1.173 . . . . 73.42 107.834 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.98 110.2 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.809 -0.811 . . . . 53.44 108.809 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.726 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -126.05 76.14 71.85 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 107.246 -1.391 . . . . 72.33 107.246 170.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.451 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 72.7 Cg_endo -74.42 -30.87 7.79 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.33 2.02 . . . . 70.15 110.697 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.451 ' ND2' ' HG2' ' A' ' 26' ' ' PRO . 30.5 m-80 -101.16 19.57 17.32 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.216 1.006 . . . . 71.3 110.112 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.726 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -52.98 -48.26 92.44 Favored Pre-proline 0 CA--C 1.571 1.762 0 C-N-CA 123.694 0.798 . . . . 54.22 111.87 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.36 -17.38 16.71 Favored 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 121.88 1.72 . . . . 72.32 113.609 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -69.99 -49.21 53.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.974 0.509 . . . . 72.25 109.771 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.66 HG21 ' HA ' ' A' ' 73' ' ' ALA . 42.7 t -72.55 -20.18 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.861 0.864 . . . . 73.21 111.21 -175.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.406 ' HB2' ' NH1' ' B' ' 15' ' ' ARG . 81.3 t80 -60.21 -34.4 73.59 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.367 0.667 . . . . 73.03 110.447 168.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -94.18 -24.39 17.53 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.362 1.065 . . . . 72.34 110.977 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 32.9 mmtp -75.89 170.89 15.37 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.486 0.714 . . . . 71.31 110.304 172.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -81.31 138.43 35.7 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.973 -1.121 . . . . 54.32 107.973 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 41.5 t-105 -76.43 83.76 3.16 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.709 0.766 . . . . 75.3 110.443 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -129.82 77.63 76.5 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.863 1.265 . . . . 70.01 108.751 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 39.1 Cg_endo -93.03 146.38 2.42 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.55 2.167 . . . . 62.44 113.074 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 28.1 tt0 -97.87 95.73 7.72 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.766 -0.827 . . . . 72.42 108.766 172.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.36 91.21 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.499 0.666 . . . . 62.12 109.747 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -101.18 128.92 47.06 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.088 -0.708 . . . . 71.33 109.088 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.476 HD11 HG13 ' A' ' 62' ' ' VAL . 45.6 tp -98.2 146.6 25.45 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.707 -0.849 . . . . 45.14 108.707 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.653 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.4 m-20 -134.46 109.35 8.68 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.269 -1.382 . . . . 73.32 107.269 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -96.99 120.37 37.21 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.847 -0.427 . . . . 75.35 109.847 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -128.37 143.97 51.07 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.991 -1.115 . . . . 53.14 107.991 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.1 m -133.44 142.22 48.21 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.104 0.562 . . . . 64.33 110.085 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -130.36 152.93 49.23 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.809 1.244 . . . . 53.03 109.217 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.3 t -127.49 151.61 48.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.622 0.769 . . . . 54.55 109.744 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.7 t -153.31 128.3 9.63 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.576 0.75 . . . . 64.24 110.176 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -101.38 108.01 19.5 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.139 -0.689 . . . . 75.43 109.139 174.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.464 HD12 HG23 ' A' ' 83' ' ' ILE . 79.2 mt -88.43 -35.25 17.18 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.931 0.492 . . . . 64.04 110.696 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -159.62 -179.64 8.07 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 124.029 0.831 . . . . 41.44 110.461 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -67.41 116.65 8.4 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.721 -1.127 . . . . 73.35 109.136 171.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 67.54 11.21 8.26 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.728 1.211 . . . . 71.11 113.157 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 62.1 t -115.54 111.6 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.376 -1.342 . . . . 61.01 107.376 171.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -130.78 141.93 50.38 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.894 -0.78 . . . . 72.1 108.894 -171.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -123.13 134.32 54.21 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.135 0.974 . . . . 73.03 109.213 -173.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.74 131.04 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 108.015 -1.106 . . . . 62.2 108.015 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 46.8 t -116.06 110.15 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.867 -0.79 . . . . 62.24 108.867 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.1 tp -90.26 105.71 17.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.487 -0.56 . . . . 75.24 109.487 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.451 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 51.8 ttt180 -85.07 101.69 12.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.504 0.722 . . . . 63.1 109.298 173.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.476 HG13 HD11 ' A' ' 42' ' ' LEU . 48.4 t -95.37 102.09 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.097 -1.075 . . . . 51.43 108.097 175.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.653 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 56.4 m -96.98 110.31 22.88 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.513 0.725 . . . . 63.43 109.051 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.615 HG21 HG21 ' A' ' 114' ' ' ILE . 41.9 t -102.92 137.28 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.392 -0.966 . . . . 72.05 108.392 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 t -143.09 150.5 39.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.863 -0.421 . . . . 73.33 109.863 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -138.67 109.61 6.75 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.823 -1.177 . . . . 71.1 107.823 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.8 p -135.04 127.04 29.65 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.416 0.687 . . . . 74.31 110.188 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.23 78.67 6.51 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.24 -1.393 . . . . 64.23 107.24 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.55 -91.42 0.66 Allowed Glycine 0 C--N 1.349 1.25 0 CA-C-N 115.142 -0.935 . . . . 73.11 112.783 173.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -91.91 -26.53 18.4 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.914 0.886 . . . . 71.02 111.823 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -113.55 129.92 56.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.721 0.408 . . . . 72.34 110.955 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 59.0 m -88.65 124.81 34.45 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.487 0.715 . . . . 64.3 110.289 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.66 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -70.59 -56.58 6.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.883 0.873 . . . . 75.45 110.071 175.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -155.83 158.77 38.64 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.617 -1.174 . . . . 73.35 111.128 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 tp -134.29 124.51 25.99 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.369 1.468 . . . . 75.44 107.217 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.441 ' SG ' HG12 ' A' ' 118' ' ' VAL . 61.6 m -132.22 99.96 4.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.111 0.964 . . . . 55.41 109.005 -174.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -123.68 127.39 48.13 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.527 0.731 . . . . 53.22 109.704 -171.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.2 t -135.63 113.85 15.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 123.445 0.698 . . . . 72.23 109.764 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.642 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.7 mt-30 -84.18 83.91 7.8 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.304 -0.998 . . . . 70.44 108.304 169.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.84 97.59 4.59 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.524 -1.216 . . . . 71.43 108.844 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.49 150.24 23.3 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.664 -0.574 . . . . 33.33 111.664 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.542 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -143.89 122.49 1.84 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.905 -0.878 . . . . 64.22 110.905 173.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.464 HG23 HD12 ' A' ' 51' ' ' LEU . 35.7 mt -82.02 130.52 35.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.801 -1.185 . . . . 74.14 107.801 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -127.67 122.64 33.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.85 -0.796 . . . . 64.41 108.85 -176.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -89.44 91.62 8.79 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.453 -0.943 . . . . 74.32 108.453 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.612 HG22 ' HA ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -126.74 155.62 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.175 0.59 . . . . 73.41 110.186 -175.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.56 170.72 8.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.156 0.982 . . . . 70.41 109.509 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.5 -32.34 6.08 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 123.675 0.61 . . . . 70.14 113.336 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.58 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.44 156.62 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.86 0.864 . . . . 74.05 109.748 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -163.35 177.39 8.98 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.456 0.702 . . . . 71.12 109.403 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.66 -130.51 23.07 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 114.097 0.399 . . . . 62.13 114.097 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.0 p -76.44 -35.57 58.43 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.56 1.144 . . . . 71.2 111.577 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -59.87 -43.92 94.46 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.963 0.905 . . . . 73.21 110.111 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.482 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 65.6 ttp -72.48 -36.01 68.32 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.005 -0.998 . . . . 63.52 110.848 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.23 -29.67 68.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.037 0.535 . . . . 55.21 110.883 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -69.15 -46.46 67.55 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.016 0.527 . . . . 64.25 110.94 168.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.5 m -59.98 -65.15 0.73 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 122.321 0.248 . . . . 60.24 110.824 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 94' ' ' MET . 2.0 pp -73.5 -21.64 60.35 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.028 0.751 . . . . 74.14 113.028 -176.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.419 ' N ' HD12 ' A' ' 98' ' ' LEU . . . -101.56 -4.53 52.47 Favored Glycine 0 N--CA 1.475 1.268 0 CA-C-O 119.599 -0.556 . . . . 63.41 113.577 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.32 -60.75 0.42 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.239 0.519 . . . . 41.25 111.612 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.58 -45.57 65.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.018 0.527 . . . . 74.45 111.991 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.3 m -67.76 -45.74 44.55 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.122 0.969 . . . . 73.22 111.943 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.95 -26.55 58.8 Favored 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 121.549 1.499 . . . . 74.24 112.576 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -70.09 -30.42 67.64 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.771 0.428 . . . . 73.34 110.307 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.429 HG21 ' CD1' ' A' ' 13' ' ' ILE . 41.7 mm -67.53 -41.43 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.79 0.836 . . . . 74.02 109.988 171.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.542 HD21 ' HA3' ' A' ' 82' ' ' GLY . 69.9 mt -74.99 -22.13 58.72 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.302 -0.863 . . . . 71.51 111.453 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -63.34 -43.49 79.85 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 117.464 -1.255 . . . . 72.13 114.233 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.1 -40.41 77.25 Favored 'Trans proline' 0 C--N 1.387 2.56 0 CA-C-N 122.093 1.783 . . . . 64.54 112.765 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -66.02 -44.64 84.13 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.453 0.701 . . . . 74.31 111.463 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.83 84.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.178 0.591 . . . . 73.41 110.711 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.414 ' NH1' HD12 ' C' ' 105' ' ' ILE . 26.8 ttm180 -50.79 -54.62 22.07 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.552 1.158 . . . . 72.21 109.76 174.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -67.01 -38.99 86.95 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.402 1.064 . . . . 53.05 111.833 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.561 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.2 t -62.06 -27.8 69.15 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.015 0.526 . . . . 72.4 111.019 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.615 HG21 HG21 ' A' ' 64' ' ' VAL . 97.5 mt -87.52 -41.09 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.227 1.411 . . . . 64.11 111.027 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 49.3 m -64.46 -44.48 90.95 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.482 0.713 . . . . 72.43 110.508 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.8 t -65.77 -40.89 92.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.794 -1.093 . . . . 51.24 109.93 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.575 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.7 ttm -59.58 -47.17 86.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.366 1.066 . . . . 63.02 111.903 -177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.441 HG12 ' SG ' ' A' ' 76' ' ' CYS . 20.5 m -66.02 -39.45 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.251 0.345 . . . . 61.43 110.317 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.0 m -67.45 -32.57 73.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.42 0.688 . . . . 73.01 111.362 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.622 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 86.5 mtt-85 -71.47 -31.5 67.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.518 0.727 . . . . 74.12 110.018 174.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.54 3.56 86.26 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.614 -0.721 . . . . 63.44 113.519 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.0 m 62.28 47.27 5.5 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 123.545 1.64 . . . . 73.34 110.797 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -116.75 137.64 23.89 Favored Pre-proline 0 C--O 1.246 0.92 0 CA-C-N 114.055 -1.429 . . . . 74.35 107.18 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.55 144.28 10.67 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.283 2.656 . . . . 73.33 113.705 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -55.98 132.38 49.76 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 124.357 1.036 . . . . 54.05 112.403 -173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 tp -118.97 100.69 7.52 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.143 -0.935 . . . . 72.12 109.68 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -98.03 107.3 19.74 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.839 -1.171 . . . . 74.44 107.839 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.46 139.31 58.76 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.169 0.587 . . . . 63.41 109.73 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.18 145.57 98.03 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 122.886 0.474 . . . . 52.35 110.673 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.406 ' HG3' ' HD2' ' C' ' 11' ' ' PHE . 37.0 Cg_endo -62.84 107.84 0.67 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.083 1.855 . . . . 64.2 111.269 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 89.9 t -98.99 113.76 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.488 -0.93 . . . . 54.24 108.488 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -84.21 89.02 7.25 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.236 -1.024 . . . . 73.21 108.236 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -59.9 -29.67 68.5 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.645 0.778 . . . . 75.51 111.52 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.17 -44.39 72.31 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.699 1.2 . . . . 73.23 110.681 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.12 -45.36 92.38 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.992 0.808 . . . . 70.55 110.181 175.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.86 -37.04 80.74 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.164 -0.926 . . . . 73.11 111.212 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -68.86 -34.52 75.59 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.326 -0.852 . . . . 75.44 109.941 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.6 mmt . . . . . 0 N--CA 1.485 1.286 0 O-C-N 123.679 0.612 . . . . 71.53 111.124 177.48 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 60.5 m . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 109.382 -0.599 . . . . 73.43 109.382 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.37 156.75 42.54 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.479 0.657 . . . . 72.51 110.039 155.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.444 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -126.31 135.15 51.15 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.639 -1.245 . . . . 52.13 107.639 173.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.459 HD13 HD11 ' B' ' 16' ' ' ILE . 51.0 mt -68.63 116.08 8.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.319 -0.993 . . . . 75.11 108.319 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -86.87 -36.41 18.44 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.235 -0.893 . . . . 71.42 109.45 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.406 ' NH1' ' HB2' ' A' ' 32' ' ' PHE . 75.2 ttt180 -167.33 133.71 2.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.894 -1.048 . . . . 62.33 109.715 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.489 ' H ' ' ND2' ' D' ' 127' ' ' ASN . 88.8 mt -115.61 135.08 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 105.809 -1.923 . . . . 73.22 105.809 166.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.402 ' HE1' HG13 ' B' ' 83' ' ' ILE . 10.0 p90 -168.4 151.04 5.32 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.213 0.53 . . . . 75.11 111.059 -174.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.669 HG21 HD11 ' B' ' 21' ' ' ILE . 17.8 m -82.62 129.84 35.01 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.942 -0.762 . . . . 75.33 108.942 175.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -97.89 -30.56 12.67 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.354 0.662 . . . . 72.51 110.721 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 11.8 t70 -145.09 139.11 27.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.428 -0.351 . . . . 72.24 110.232 -175.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.669 HD11 HG21 ' B' ' 18' ' ' THR . 33.3 mm -131.17 139.53 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 106.768 -1.568 . . . . 74.33 106.768 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.8 t -147.6 138.25 23.29 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.32 -0.993 . . . . 52.11 108.32 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.0 t80 -154.71 110.38 3.15 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.662 -1.236 . . . . 72.44 107.662 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -117.95 114.42 23.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.627 1.171 . . . . 72.21 108.09 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.727 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -111.82 83.78 4.93 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.348 -0.982 . . . . 72.43 108.348 175.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.97 -34.26 6.69 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.775 2.316 . . . . 64.01 112.94 -170.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -98.14 -2.61 39.59 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.921 0.888 . . . . 54.15 111.426 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.727 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -35.83 -63.02 0.43 Allowed Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 125.867 1.667 . . . . 61.54 114.803 -165.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 37.9 Cg_exo -54.97 -31.02 72.24 Favored 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 122.775 2.316 . . . . 75.0 113.794 -173.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -96.78 -34.49 11.3 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.692 -1.14 . . . . 74.51 111.404 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.592 HG22 HD12 ' B' ' 68' ' ' LEU . 5.6 p -74.45 -18.63 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 122.336 0.254 . . . . 75.32 111.672 -171.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.95 -15.49 62.24 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.619 0.768 . . . . 72.2 112.855 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -57.25 -29.98 64.26 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.425 0.69 . . . . 73.03 110.473 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -95.38 98.66 10.73 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 124.623 1.169 . . . . 74.23 109.025 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -83.36 92.92 7.64 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.41 0.684 . . . . 74.15 109.725 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -162.94 156.26 19.71 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.762 0.825 . . . . 75.03 109.347 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.05 105.44 0.85 Allowed Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 124.524 1.13 . . . . 74.45 110.676 170.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.523 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 40.3 Cg_endo -67.37 137.58 43.71 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.597 2.198 . . . . 62.53 112.115 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 11.9 tp10 -59.23 121.46 11.43 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 124.187 0.929 . . . . 72.22 112.099 -169.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 73.2 t -85.94 132.47 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.968 0.907 . . . . 73.1 110.23 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.563 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 12.9 tmtt? -131.9 117.29 18.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.275 -1.75 . . . . 74.13 106.275 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.463 HD22 HD11 ' B' ' 128' ' ' LEU . 40.4 tp -93.98 150.56 20.25 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.154 0.502 . . . . 73.24 111.188 -172.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.722 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.8 m-20 -140.59 143.64 35.39 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.694 -1.225 . . . . 63.55 107.694 171.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.0 125.94 16.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.926 -1.139 . . . . 73.13 107.926 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 12.2 m-20 -127.04 150.42 49.45 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.026 -1.102 . . . . 63.0 108.026 171.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.0 p -135.72 124.46 23.87 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.943 0.401 . . . . 72.3 110.817 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.19 164.08 16.77 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.542 1.537 . . . . 74.5 109.493 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 22.2 p -145.07 168.67 19.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.482 1.113 . . . . 70.53 109.104 170.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 97.4 p -151.23 168.47 24.63 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.156 0.582 . . . . 75.42 109.815 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -116.53 110.2 18.26 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.731 -1.211 . . . . 64.14 107.731 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 24.6 mt -88.02 -55.51 3.72 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.1 0.953 . . . . 73.2 108.777 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.67 -179.32 5.85 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 113.431 -1.713 . . . . 42.31 108.053 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.32 130.36 40.58 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 116.158 -0.474 . . . . 73.02 110.627 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 67.03 -1.19 1.48 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.969 1.708 . . . . 64.23 112.724 -172.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.2 t -103.61 104.11 16.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 108.074 -1.084 . . . . 74.31 108.074 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -114.19 140.45 48.53 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.026 -1.101 . . . . 71.42 108.026 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -119.87 104.67 10.39 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.212 -1.033 . . . . 71.42 108.212 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 72.3 t -89.08 140.09 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.358 0.663 . . . . 62.42 110.589 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.464 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 38.0 t -118.28 118.9 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.797 0.839 . . . . 75.15 109.403 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.5 OUTLIER -93.82 122.98 36.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.203 -1.406 . . . . 73.44 107.203 174.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 46.8 ttt180 -110.27 122.14 46.96 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.403 0.681 . . . . 72.11 109.486 175.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 13.6 t -117.62 131.36 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 107.67 -1.233 . . . . 72.54 107.67 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.722 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.1 m -127.07 130.28 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.758 -0.83 . . . . 74.52 108.758 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.33 116.39 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.844 -0.799 . . . . 73.24 108.844 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 89.2 m -99.05 138.46 36.13 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.917 -1.142 . . . . 70.12 107.917 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.17 147.36 30.42 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 122.437 0.295 . . . . 71.31 110.593 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 54.9 p -151.66 135.74 16.6 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 124.125 0.891 . . . . 72.45 111.383 -174.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.592 HD12 HG22 ' B' ' 31' ' ' VAL . 56.1 mt -95.45 110.44 22.49 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.947 0.899 . . . . 62.33 109.477 174.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.43 -111.12 3.43 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.581 -1.19 . . . . 73.13 111.764 -169.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -119.06 2.57 11.47 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.802 0.841 . . . . 73.22 110.905 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -112.66 148.96 33.56 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.888 -0.782 . . . . 75.23 108.888 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.6 m -61.6 140.42 58.14 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.55 0.531 . . . . 53.11 110.874 -176.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.76 -67.14 0.86 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.676 -1.231 . . . . 63.12 107.676 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -148.1 158.07 43.86 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.969 -1.014 . . . . 64.5 109.862 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 41.7 mt -132.6 109.42 9.73 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 106.365 -1.717 . . . . 61.31 106.365 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 39.3 t -120.77 117.04 26.41 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.27 0.487 . . . . 50.14 110.05 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.4 tt0 -122.28 132.67 54.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.22 1.008 . . . . 65.11 108.736 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 75.5 t -128.48 147.64 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.111 -0.7 . . . . 74.01 109.111 173.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.534 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.8 mt-30 -125.36 102.99 7.68 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.094 -0.706 . . . . 62.53 109.094 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -90.44 104.78 17.32 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.658 -0.868 . . . . 64.25 108.658 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.59 171.11 37.62 Favored Glycine 0 C--O 1.243 0.68 0 N-CA-C 111.364 -0.694 . . . . 71.34 111.364 174.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.67 130.65 2.15 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 112.121 -0.392 . . . . 71.45 112.121 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.402 HG13 ' HE1' ' B' ' 17' ' ' TYR . 39.3 mt -89.89 127.47 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.334 0.653 . . . . 74.43 109.32 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -135.15 132.92 38.61 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.393 -1.336 . . . . 71.44 107.393 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m -101.62 90.97 4.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.705 0.402 . . . . 72.55 110.787 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.532 ' HB ' HD11 ' B' ' 89' ' ' ILE . 16.1 pt -96.25 145.25 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.494 0.718 . . . . 64.44 111.614 -167.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.77 157.16 32.85 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.279 1.031 . . . . 72.31 109.96 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.02 -39.31 2.94 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 123.378 0.513 . . . . 71.01 113.657 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.64 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -79.12 146.65 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.062 0.545 . . . . 65.4 111.237 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -162.95 162.62 26.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.046 0.841 . . . . 74.42 109.506 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.99 -118.13 9.28 Favored Glycine 0 N--CA 1.474 1.171 0 CA-C-N 115.976 -0.556 . . . . 44.12 113.553 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 99.5 m -69.63 -33.48 72.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.663 0.785 . . . . 72.11 110.708 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -66.74 -38.98 87.74 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.264 0.625 . . . . 62.31 111.466 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -32.92 60.49 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.357 0.263 . . . . 75.22 111.29 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.27 75.13 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.495 -0.775 . . . . 44.12 110.103 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -72.36 -34.85 68.29 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.034 0.933 . . . . 63.24 110.677 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -68.11 -67.5 0.46 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.498 0.499 . . . . 64.12 110.812 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.417 HD21 HD13 ' B' ' 86' ' ' ILE . 68.2 mt -81.84 -16.51 50.57 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 111.873 0.323 . . . . 61.34 111.873 -173.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.13 -9.69 55.49 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 114.57 0.588 . . . . 70.41 114.57 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.99 -56.3 0.25 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.382 0.591 . . . . 73.22 111.722 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -71.7 -48.53 46.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.709 0.804 . . . . 71.43 112.06 -169.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 98.6 m -61.27 -47.23 94.81 Favored Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 124.158 0.983 . . . . 63.23 111.777 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.421 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 76.1 Cg_exo -56.03 -41.17 79.75 Favored 'Trans proline' 0 C--N 1.395 3.0 0 C-N-CA 122.406 2.071 . . . . 70.32 113.587 167.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -62.73 -29.37 70.62 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.482 0.713 . . . . 74.22 111.914 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.52 HG23 ' NH2' ' D' ' 111' ' ' ARG . 77.7 mt -69.63 -41.65 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.85 0.86 . . . . 74.35 110.748 173.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.76 -19.52 57.52 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.981 -1.009 . . . . 62.12 112.255 -173.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -56.71 -48.58 96.99 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 114.872 1.434 . . . . 74.51 114.872 -170.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.77 -37.53 95.49 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.457 2.104 . . . . 72.11 113.828 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -71.25 -43.03 68.06 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.661 -0.699 . . . . 54.21 110.369 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -40.57 87.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.597 0.759 . . . . 74.33 110.776 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -60.53 -53.11 61.42 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.192 0.997 . . . . 45.33 111.212 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.23 -33.25 75.56 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.459 0.704 . . . . 61.31 110.397 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.622 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -67.89 -42.91 80.49 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.804 0.842 . . . . 74.14 111.658 177.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.63 -51.51 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.77 -0.456 . . . . 45.02 109.77 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.48 HG21 ' OG ' ' C' ' 119' ' ' SER . 19.8 m -60.13 -34.35 73.41 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.873 0.869 . . . . 32.23 111.646 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.4 t -60.34 -48.01 83.59 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.732 0.645 . . . . 54.21 110.075 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -74.77 -31.29 61.73 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.446 0.698 . . . . 63.52 111.524 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.08 -39.4 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.894 0.878 . . . . 64.04 110.559 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.407 ' OG ' HG21 ' C' ' 115' ' ' THR . 30.4 t -65.28 -40.64 94.13 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.84 0.856 . . . . 75.14 111.065 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.561 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 78.0 mtt-85 -66.24 -33.49 75.87 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 114.843 -1.071 . . . . 52.14 110.128 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.12 7.42 75.34 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-O 119.361 -0.688 . . . . 54.53 113.677 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.437 HG23 ' HB3' ' A' ' 17' ' ' TYR . 80.6 p 56.12 29.68 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.905 1.682 . . . . 73.23 113.537 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -93.24 154.76 41.47 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.025 0.93 . . . . 75.24 110.787 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.23 165.94 1.91 Allowed 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 123.909 3.073 . . . . 71.23 115.556 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.454 HE21 ' ND2' ' B' ' 127' ' ' ASN . 64.0 tp60 -63.58 137.62 58.19 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.461 1.104 . . . . 73.31 113.191 -168.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.99 112.31 15.09 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 107.753 -1.202 . . . . 75.51 107.753 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.454 ' ND2' HE21 ' B' ' 125' ' ' GLN . 67.8 m-80 -130.53 109.54 10.76 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.589 -0.893 . . . . 53.54 108.589 172.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.463 HD11 HD22 ' B' ' 42' ' ' LEU . 33.6 tp -82.87 137.41 34.28 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.637 0.375 . . . . 65.24 110.397 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.32 144.75 92.47 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.148 0.979 . . . . 63.43 111.415 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.449 ' HG3' HD13 ' D' ' 16' ' ' ILE . 33.3 Cg_endo -61.64 109.2 0.72 Allowed 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.897 2.398 . . . . 75.22 112.298 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -89.83 111.9 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.615 -0.884 . . . . 74.43 108.615 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -78.5 87.93 4.47 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.22 -1.03 . . . . 45.42 108.22 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -59.06 -36.72 75.53 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.519 0.727 . . . . 73.43 111.339 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.12 -40.85 95.07 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.581 1.152 . . . . 73.25 111.998 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.85 -47.27 66.37 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.738 0.815 . . . . 62.13 110.855 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.89 -20.75 59.59 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.535 -0.757 . . . . 73.02 110.873 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 94.4 t80 . . . . . 0 N--CA 1.475 0.796 0 C-N-CA 123.588 0.755 . . . . 74.52 110.112 173.08 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 36.4 m . . . . . 0 C--O 1.223 -0.331 0 N-CA-C 108.613 -0.884 . . . . 72.42 108.613 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.406 ' HD2' ' HG3' ' A' ' 130' ' ' PRO . 60.2 t80 -115.57 126.48 54.28 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.801 -0.814 . . . . 75.53 108.801 176.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -140.68 125.45 18.11 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.875 -0.787 . . . . 71.14 108.875 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.418 ' HA ' ' HD2' ' C' ' 84' ' ' PHE . 56.1 mt -66.44 123.94 20.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.81 -0.811 . . . . 73.45 108.81 171.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -89.63 -48.74 7.09 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.157 -0.683 . . . . 71.32 109.157 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -174.33 125.89 0.33 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 115.565 -0.743 . . . . 74.13 110.404 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -109.46 143.22 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 107.919 -1.141 . . . . 63.12 107.919 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.432 ' HE1' HG12 ' C' ' 83' ' ' ILE . 25.1 p90 -176.25 169.58 2.73 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.406 0.622 . . . . 70.03 111.007 -173.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -93.02 114.59 27.18 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.318 -0.856 . . . . 61.14 109.533 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.633 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -68.34 -34.09 75.46 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.814 -0.81 . . . . 72.33 108.814 175.089 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -154.19 146.45 23.83 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.945 -1.479 . . . . 75.12 109.618 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.7 mt -140.61 144.37 27.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 125.607 1.563 . . . . 73.14 106.846 175.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -154.04 149.32 27.05 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.51 0.672 . . . . 65.23 110.116 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -153.68 125.16 7.57 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.159 -1.423 . . . . 41.52 107.159 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -132.23 109.96 10.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.062 0.545 . . . . 62.04 109.724 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.59 79.58 73.43 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 106.716 -1.587 . . . . 53.13 106.716 168.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.74 -25.34 28.8 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.767 2.311 . . . . 71.51 112.001 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -106.1 17.57 23.34 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.214 1.406 . . . . 72.42 110.932 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.404 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -42.89 -57.57 4.83 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 114.864 1.431 . . . . 15.15 114.864 -167.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.17 -36.63 68.22 Favored 'Trans proline' 0 C--N 1.391 2.774 0 CA-C-N 122.24 1.836 . . . . 74.34 112.529 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -69.09 -39.09 79.22 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.446 0.698 . . . . 74.12 111.637 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.813 HG21 ' HA ' ' C' ' 73' ' ' ALA . 2.9 p -79.39 -20.79 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 N-CA-C 112.412 0.523 . . . . 63.42 112.412 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -67.91 -31.71 71.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.545 0.572 . . . . 74.33 112.545 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -88.35 15.25 8.01 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.874 0.47 . . . . 73.54 111.057 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.43 161.34 13.83 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.954 0.902 . . . . 71.33 110.544 -176.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.92 126.85 30.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.624 0.77 . . . . 63.1 109.798 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 59.9 t90 -76.0 107.14 8.0 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.654 0.782 . . . . 74.32 109.847 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.56 73.16 2.87 Favored Pre-proline 0 CA--C 1.555 1.138 0 N-CA-C 107.328 -1.36 . . . . 54.04 107.328 173.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.59 134.18 8.59 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.092 2.528 . . . . 64.24 113.949 -174.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -87.38 95.13 9.9 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 106.345 -1.724 . . . . 74.24 106.345 168.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 m -75.88 96.23 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 122.275 1.036 . . . . 73.21 109.815 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.428 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 40.2 ttmt -100.8 103.09 14.3 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.582 -1.19 . . . . 64.01 108.082 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.8 mp -88.32 132.54 34.37 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 107.783 -1.191 . . . . 63.42 107.783 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.4 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.1 t70 -117.63 104.72 11.3 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.469 -1.308 . . . . 73.31 107.469 173.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 84.3 mt -95.58 143.23 27.05 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.305 -0.861 . . . . 60.42 109.236 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.2 t70 -148.33 144.27 27.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.993 0.917 . . . . 65.24 108.954 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 t -138.42 124.75 20.46 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.648 -0.871 . . . . 64.42 108.648 172.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.07 145.3 45.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.782 -0.821 . . . . 70.42 108.782 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -130.49 156.0 45.52 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.989 0.516 . . . . 63.31 111.115 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 29.5 t -144.8 139.84 28.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.369 1.067 . . . . 75.03 109.587 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -88.86 118.32 28.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.963 -1.125 . . . . 71.34 107.963 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.625 HD11 HD12 ' C' ' 83' ' ' ILE . 62.2 mt -90.0 -48.84 6.95 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.802 0.811 . . . . 72.03 109.362 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.18 -177.85 5.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 113.996 -1.456 . . . . 50.01 108.501 170.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.41 110.73 1.16 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.442 1.089 . . . . 72.14 110.703 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 22.6 m-20 68.3 9.28 7.14 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 125.386 1.474 . . . . 71.04 113.367 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.7 t -93.1 107.53 19.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 107.198 -1.408 . . . . 72.0 107.198 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -102.08 122.37 43.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.149 -1.387 . . . . 74.15 108.088 -164.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -105.01 122.57 46.13 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.944 -1.132 . . . . 75.44 107.944 173.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -114.99 141.06 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 108.515 -0.92 . . . . 73.13 108.515 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.417 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 87.2 t -128.99 139.75 51.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.811 -0.811 . . . . 63.53 108.811 174.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.81 105.95 11.21 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.524 -1.287 . . . . 73.42 107.524 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.615 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 23.3 ttm-85 -93.58 107.7 19.52 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.603 -0.888 . . . . 72.31 108.603 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.448 ' HB ' HD11 ' C' ' 114' ' ' ILE . 24.1 t -107.11 120.42 58.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.438 -0.949 . . . . 74.34 108.438 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 43.6 m -117.68 131.53 56.62 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.23 -0.656 . . . . 45.4 109.23 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.405 HG23 HD13 ' C' ' 114' ' ' ILE . 60.2 t -108.41 125.28 65.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.972 -0.751 . . . . 54.03 108.972 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 6.6 m -118.38 123.93 46.47 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.515 -0.92 . . . . 72.12 108.515 173.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.92 99.65 7.23 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.493 -1.299 . . . . 62.13 107.493 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.9 m -108.18 120.6 42.83 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 109.7 -0.482 . . . . 72.5 109.7 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 8.7 mt -84.92 49.29 1.7 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.182 1.393 . . . . 75.43 109.589 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.79 -98.85 1.81 Allowed Glycine 0 C--N 1.35 1.317 0 N-CA-C 110.557 -1.017 . . . . 50.22 110.557 -174.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.39 -30.28 12.29 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.319 1.048 . . . . 61.23 109.97 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -79.78 120.07 23.55 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 124.348 1.059 . . . . 73.5 110.581 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 86.8 m -85.29 127.12 34.21 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 119.057 0.844 . . . . 72.33 109.764 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.813 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.85 -56.81 5.06 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.653 1.181 . . . . 70.53 110.101 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . 0.437 ' HZ ' HD22 ' C' ' 126' ' ' LEU . 33.0 p90 -157.4 164.52 37.43 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.287 -0.869 . . . . 75.04 112.284 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -128.25 105.29 8.25 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.636 -1.616 . . . . 73.33 106.636 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.9 t -109.41 148.69 30.7 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.974 -0.75 . . . . 74.24 108.974 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -156.42 136.81 13.04 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.414 -0.587 . . . . 71.22 109.414 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.0 t -133.93 135.02 55.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.89 -1.152 . . . . 70.24 107.89 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -111.5 89.42 3.05 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.952 -1.129 . . . . 65.02 107.952 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -78.99 100.27 7.23 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.061 -0.972 . . . . 74.5 110.04 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.633 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -89.24 169.07 35.79 Favored Glycine 0 C--O 1.242 0.636 0 CA-C-N 115.728 -0.669 . . . . 71.11 112.799 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.448 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -168.06 118.51 0.79 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.384 -0.686 . . . . 41.22 111.384 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.625 HD12 HD11 ' C' ' 51' ' ' LEU . 12.9 mm -84.01 133.44 29.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 108.821 -0.807 . . . . 61.43 108.821 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.418 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 45.3 m-85 -141.09 122.68 15.13 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.639 0.775 . . . . 72.23 109.337 -177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 53.0 p -79.84 127.31 32.07 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.09 -1.078 . . . . 62.12 108.09 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.54 HD11 HD11 ' C' ' 89' ' ' ILE . 9.6 tt -141.91 143.09 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-O 121.036 0.446 . . . . 54.02 111.714 -170.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.78 169.18 24.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.344 1.058 . . . . 64.44 109.649 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.07 -46.34 1.19 Allowed Glycine 0 N--CA 1.471 1.012 0 CA-C-N 116.458 -0.337 . . . . 74.24 113.878 171.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.54 HD11 HD11 ' C' ' 86' ' ' ILE . 0.2 OUTLIER -113.39 146.77 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 122.935 0.494 . . . . 75.25 110.236 -176.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -146.83 -177.89 5.9 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.786 0.434 . . . . 73.11 111.008 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.25 -122.6 11.29 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 115.753 -0.658 . . . . 61.42 113.078 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 79.9 p -70.53 -23.79 62.7 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.589 0.756 . . . . 62.34 110.929 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -73.68 -32.16 63.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.661 0.785 . . . . 72.01 110.746 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 55.5 ttp -66.78 -40.64 88.24 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.086 -0.709 . . . . 71.12 109.086 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.27 -36.3 83.68 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.563 -0.744 . . . . 73.05 111.383 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -76.86 -21.02 55.61 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.576 0.35 . . . . 74.14 111.607 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.9 t -61.28 -54.5 43.25 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.63 0.372 . . . . 35.15 110.097 173.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -75.66 -22.14 57.01 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.102 0.561 . . . . 75.12 111.147 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.55 -26.41 65.5 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 114.889 0.716 . . . . 34.43 114.889 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.56 -60.21 0.08 Allowed 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 112.494 0.553 . . . . 72.01 112.494 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -52.71 -47.76 67.08 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 124.154 0.909 . . . . 73.12 112.604 -167.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.9 m -78.4 -48.44 1.89 Allowed Pre-proline 0 CA--C 1.561 1.379 0 CA-C-O 117.78 -1.105 . . . . 63.51 112.422 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.57 -32.51 44.4 Favored 'Trans proline' 0 C--N 1.403 3.402 0 C-N-CA 122.197 1.931 . . . . 62.03 113.636 170.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -66.71 -38.04 85.91 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.278 1.031 . . . . 64.43 111.417 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.414 HD12 ' NH1' ' A' ' 111' ' ' ARG . 36.7 mm -64.5 -45.65 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 109.488 -0.56 . . . . 65.02 109.488 173.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.448 HD21 ' HA3' ' C' ' 82' ' ' GLY . 74.5 mt -78.48 -18.6 54.59 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.03 -0.987 . . . . 64.41 112.493 -172.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.404 ' HE1' HD13 ' C' ' 128' ' ' LEU . 79.0 t80 -59.0 -50.99 85.04 Favored Pre-proline 0 CA--C 1.56 1.358 0 N-CA-C 114.233 1.197 . . . . 71.54 114.233 -171.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.36 -32.48 72.13 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.789 1.659 . . . . 74.14 112.518 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -67.65 -45.15 76.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.15 0.58 . . . . 70.53 110.195 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.54 -45.2 89.39 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.918 0.887 . . . . 45.34 110.519 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -57.7 -54.74 43.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.634 1.174 . . . . 72.14 111.117 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -67.18 -33.05 74.57 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.299 0.64 . . . . 71.44 110.877 -173.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.2 t -69.5 -32.21 70.93 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.888 0.475 . . . . 53.14 110.932 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.448 HD11 ' HB ' ' C' ' 62' ' ' VAL . 74.7 mt -71.31 -53.32 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.59 -0.522 . . . . 51.42 109.59 173.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.407 HG21 ' OG ' ' B' ' 119' ' ' SER . 14.5 m -60.73 -29.68 69.52 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.74 0.816 . . . . 70.25 111.326 -173.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 31.7 t -61.78 -54.54 40.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.235 -0.893 . . . . 72.31 109.155 171.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.492 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.73 -37.66 79.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.794 1.238 . . . . 72.01 112.867 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.485 HG11 HD13 ' C' ' 126' ' ' LEU . 85.6 t -64.49 -46.7 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.59 0.756 . . . . 73.32 109.8 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.48 ' OG ' HG21 ' B' ' 115' ' ' THR . 34.7 t -66.28 -32.71 74.29 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.985 -1.007 . . . . 50.1 111.473 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.421 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 74.6 mtt-85 -66.49 -41.16 89.33 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.408 0.683 . . . . 71.33 109.481 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.23 7.81 62.85 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.706 -0.679 . . . . 75.22 112.989 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 77.4 p 57.96 33.32 23.06 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.906 1.682 . . . . 74.05 113.661 171.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -91.08 163.13 30.52 Favored Pre-proline 0 CA--C 1.565 1.526 0 C-N-CA 124.231 1.012 . . . . 61.22 108.86 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.11 172.75 3.75 Favored 'Trans proline' 0 C--N 1.39 2.729 0 C-N-CA 122.997 2.465 . . . . 60.1 113.82 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -62.48 112.74 2.59 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.945 0.898 . . . . 75.25 112.669 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.485 HD13 HG11 ' C' ' 118' ' ' VAL . 8.9 mp -110.98 112.0 23.51 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.431 -0.952 . . . . 64.2 108.431 169.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -124.59 131.29 53.48 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.498 0.719 . . . . 53.04 109.223 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.404 HD13 ' HE1' ' C' ' 107' ' ' PHE . 1.4 tt -79.33 131.2 36.06 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.333 -0.617 . . . . 65.31 109.333 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.17 150.75 91.82 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.235 1.014 . . . . 51.15 111.433 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.07 103.29 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.382 2.055 . . . . 73.11 112.533 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 90.6 t -97.22 111.23 26.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.663 -0.866 . . . . 75.42 108.663 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -82.96 83.81 7.67 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 108.042 -1.096 . . . . 74.44 108.042 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -59.36 -22.47 61.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.11 0.564 . . . . 73.41 111.87 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -63.19 -56.2 18.72 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.692 0.797 . . . . 64.44 110.848 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.11 -38.58 79.93 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.725 1.266 . . . . 71.43 110.641 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 74.8 mt -74.19 -29.5 61.78 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.493 -1.23 . . . . 63.43 111.675 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 19.5 t80 . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 110.142 -0.318 . . . . 75.22 110.142 179.928 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 89.3 m . . . . . 0 C--O 1.239 0.531 0 CA-C-O 120.945 0.402 . . . . 62.13 110.022 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -164.01 91.34 0.63 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.785 -1.561 . . . . 74.05 106.785 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -112.84 114.06 26.42 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.868 -1.16 . . . . 71.01 107.868 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.58 105.57 4.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.678 -0.86 . . . . 64.44 108.678 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -77.38 -37.85 51.23 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.172 -0.467 . . . . 63.11 111.892 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -166.2 144.1 5.48 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 111.786 0.291 . . . . 71.44 111.786 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.449 HD13 ' HG3' ' B' ' 130' ' ' PRO . 1.7 mp -121.86 134.12 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 106.016 -1.846 . . . . 62.14 106.016 167.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -161.44 163.18 30.64 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.9 0.857 . . . . 74.13 111.489 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -95.01 119.72 34.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.267 -1.333 . . . . 55.45 108.924 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -88.96 -22.34 23.1 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.568 -0.53 . . . . 70.11 109.568 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.609 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.2 t70 -155.67 139.4 16.11 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 114.933 -1.031 . . . . 64.22 109.8 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.492 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.0 mt -143.62 136.78 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.938 1.295 . . . . 74.42 107.553 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.6 t -146.76 109.25 4.53 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.807 -0.812 . . . . 63.2 108.807 174.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.601 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.8 t80 -114.22 128.28 56.29 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.991 -1.114 . . . . 73.41 107.991 168.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.14 127.14 40.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.516 0.727 . . . . 75.11 109.324 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.31 87.42 2.05 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 106.559 -1.645 . . . . 62.22 106.559 165.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.55 -41.72 18.82 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.276 1.984 . . . . 72.42 112.505 -166.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -111.09 15.2 21.75 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.125 0.97 . . . . 75.24 109.979 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.488 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -18.61 -70.26 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 117.227 2.306 . . . . 74.35 117.227 -168.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 64.6 Cg_endo -77.14 -23.75 10.15 Favored 'Trans proline' 0 C--N 1.382 2.329 0 CA-C-N 123.953 2.447 . . . . 74.13 113.772 -173.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -72.88 -36.54 67.37 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.631 0.772 . . . . 74.44 109.218 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' D' ' 73' ' ' ALA . 6.8 p -83.26 -19.13 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.229 0 CA-C-N 115.731 -0.668 . . . . 62.13 110.694 -176.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.6 m-85 -70.01 -19.02 63.34 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.835 0.454 . . . . 75.42 111.928 175.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -55.3 -34.09 63.84 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.817 0.698 . . . . 64.14 110.073 172.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.425 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 42.1 mtmt -91.88 78.02 5.42 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.583 -1.19 . . . . 75.33 109.095 168.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.01 82.0 3.53 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.836 0.827 . . . . 73.14 109.493 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -147.84 157.96 43.79 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.532 -1.213 . . . . 74.4 108.79 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -63.8 106.89 1.04 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.133 0.973 . . . . 74.31 108.979 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.506 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 23.1 Cg_exo -65.82 146.0 82.16 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.754 2.302 . . . . 62.45 112.196 -172.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -63.27 110.97 2.06 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.164 -1.05 . . . . 74.02 108.164 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.14 146.07 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-O 121.427 0.632 . . . . 74.15 111.225 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -129.59 118.94 22.8 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.401 -2.074 . . . . 70.42 105.401 172.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -97.01 145.37 26.01 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.633 -0.877 . . . . 75.43 108.633 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.558 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.8 m-20 -129.29 143.34 50.81 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.024 -0.732 . . . . 74.25 109.024 172.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -119.38 136.42 54.29 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.232 -1.025 . . . . 71.12 108.232 173.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 37.9 t70 -138.37 131.5 30.05 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.274 -1.38 . . . . 70.14 107.274 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -104.09 148.12 26.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.221 0.534 . . . . 62.44 109.57 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.58 165.41 33.4 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.897 -1.047 . . . . 53.31 108.536 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 31.1 p -164.77 155.97 15.01 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.179 0.592 . . . . 62.41 110.151 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 32.0 t -151.62 123.95 8.29 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.317 0.647 . . . . 71.35 110.626 -171.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -73.4 116.65 14.21 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.179 -1.045 . . . . 72.02 108.179 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' D' ' 57' ' ' GLU . 60.1 mt -91.79 -41.11 10.84 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.302 0.572 . . . . 75.51 110.11 -177.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.17 -175.09 5.25 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.449 -1.251 . . . . 41.32 109.261 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -66.27 124.91 23.97 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 123.731 0.644 . . . . 74.5 109.434 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 63.77 0.59 0.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.84 1.256 . . . . 50.11 113.887 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.9 t -108.29 114.11 45.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 107.728 -1.212 . . . . 61.44 107.728 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 129.33 37.12 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.195 -1.039 . . . . 75.14 108.195 -170.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.48 ' HB2' HD11 ' D' ' 51' ' ' LEU . 30.2 tt0 -99.82 147.47 25.46 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.325 1.05 . . . . 53.24 109.4 177.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.16 127.47 73.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.378 -1.342 . . . . 72.41 107.378 170.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.433 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 61.8 t -109.58 109.95 30.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.994 -0.743 . . . . 73.22 108.994 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.85 119.35 30.98 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.789 -0.819 . . . . 74.21 108.789 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.539 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 47.7 ttm-85 -98.74 109.98 22.66 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.88 -1.156 . . . . 73.55 107.88 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.51 HG21 ' HB1' ' D' ' 110' ' ' ALA . 38.8 t -115.06 118.77 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.787 -0.819 . . . . 72.51 108.787 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 12.0 m -115.46 144.31 44.02 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.487 1.115 . . . . 74.53 109.381 -171.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.483 HG21 HD21 ' D' ' 126' ' ' LEU . 58.5 t -139.01 103.82 2.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.18 0.992 . . . . 72.04 108.919 172.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 99.9 m -97.47 120.19 37.38 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.25 -1.019 . . . . 71.51 108.25 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -122.37 154.93 37.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.659 0.784 . . . . 72.4 110.925 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 54.7 m -150.6 139.69 21.1 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.562 0.539 . . . . 70.12 112.127 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.433 HD12 HG22 ' D' ' 31' ' ' VAL . 11.7 mt -110.7 121.05 44.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.054 1.342 . . . . 64.12 108.977 171.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.0 -113.28 4.27 Favored Glycine 0 C--N 1.341 0.829 0 O-C-N 123.338 0.399 . . . . 72.11 112.72 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.12 5.86 18.81 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.103 0.961 . . . . 74.11 110.898 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.425 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 15.8 pt-20 -132.13 158.75 40.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.86 0.464 . . . . 63.23 110.613 -174.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 65.4 m -71.39 138.48 49.19 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 116.061 -0.518 . . . . 41.32 110.603 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.624 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.19 -68.67 0.78 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.891 0.876 . . . . 43.24 109.624 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -146.36 145.96 30.49 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 121.551 0.691 . . . . 74.21 110.25 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -120.24 141.03 50.31 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.658 1.583 . . . . 74.22 106.956 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.564 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.4 t -153.79 139.0 17.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.56 -0.534 . . . . 72.43 109.56 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -156.9 132.16 9.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.41 -0.589 . . . . 75.33 109.41 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.06 120.15 46.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.756 0.823 . . . . 75.21 109.277 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.609 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.3 mt-30 -89.43 86.82 6.87 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.647 -0.872 . . . . 72.31 108.647 169.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -80.03 94.4 5.93 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.695 -1.139 . . . . 63.12 108.917 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.09 143.34 18.07 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.926 -0.47 . . . . 34.4 111.926 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.558 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -140.64 131.5 5.01 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.714 -0.554 . . . . 64.13 111.714 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -94.67 125.13 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.719 0.808 . . . . 73.23 109.447 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -132.18 125.11 30.4 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.052 0.941 . . . . 71.34 109.743 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.6 m -87.76 104.15 16.29 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.524 -0.547 . . . . 72.54 109.524 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.438 HD12 ' SD ' ' D' ' 94' ' ' MET . 39.9 pt -107.08 141.19 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.902 0.881 . . . . 63.43 110.807 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -169.14 165.96 10.95 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.976 0.91 . . . . 75.33 110.889 173.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.72 -19.62 19.39 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.197 -0.456 . . . . 71.13 112.925 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.489 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -118.97 149.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.084 0.953 . . . . 71.24 108.691 177.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -154.32 160.06 41.54 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.336 0.495 . . . . 73.42 112.336 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.36 -121.31 24.98 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 114.791 -1.095 . . . . 74.12 113.51 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.7 p -71.12 -31.98 68.44 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.892 0.877 . . . . 72.33 111.484 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -69.59 -40.34 76.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.761 0.425 . . . . 70.33 110.109 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.438 ' SD ' HD12 ' D' ' 86' ' ' ILE . 7.1 tmm? -72.45 -37.65 68.48 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.382 -0.826 . . . . 64.11 109.777 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.74 71.27 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.031 0.532 . . . . 70.34 111.507 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.408 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.7 t-160 -69.49 -39.39 77.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.129 0.972 . . . . 63.23 110.16 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -68.85 -50.31 50.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.808 -0.633 . . . . 74.22 110.435 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.68 -25.21 44.78 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.554 0.742 . . . . 73.12 111.645 -168.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.12 11.23 37.22 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-O 119.607 -0.552 . . . . 42.43 113.543 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -149.36 -58.25 0.2 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.184 0.492 . . . . 74.21 111.227 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -70.7 -46.95 62.17 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.272 0.629 . . . . 64.53 111.689 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.401 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 55.1 m -67.37 -44.21 45.75 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.503 -0.76 . . . . 71.1 111.693 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 76.9 Cg_exo -56.52 -32.82 90.96 Favored 'Trans proline' 0 C--N 1.394 2.922 0 C-N-CA 122.479 2.119 . . . . 63.13 113.423 165.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -71.34 -25.32 62.34 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.002 0.521 . . . . 72.32 111.216 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 64.0 mt -77.12 -34.47 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.894 0.877 . . . . 75.23 110.138 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.558 HD21 ' HA3' ' D' ' 82' ' ' GLY . 95.9 mt -76.77 -22.71 53.37 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.561 -0.745 . . . . 73.51 111.724 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -67.41 -42.05 35.74 Favored Pre-proline 0 CA--C 1.565 1.557 0 N-CA-C 113.941 1.089 . . . . 74.11 113.941 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -60.41 -40.49 57.32 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.097 1.865 . . . . 60.21 112.71 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -73.06 -33.71 65.83 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.586 0.754 . . . . 72.33 111.511 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.51 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -63.79 -53.12 55.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.641 0.776 . . . . 75.2 109.523 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.52 ' NH2' HG23 ' B' ' 105' ' ' ILE . 28.5 ttp180 -54.65 -48.57 72.15 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 124.895 1.372 . . . . 75.01 110.588 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -60.33 -46.3 90.4 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.155 0.909 . . . . 72.31 111.651 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.02 -42.08 93.59 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.788 0.68 . . . . 73.1 110.719 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.564 HG23 ' SG ' ' D' ' 76' ' ' CYS . 72.2 mt -64.17 -50.66 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 124.174 0.921 . . . . 72.23 110.988 174.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 41.5 m -57.32 -42.42 81.81 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.808 1.243 . . . . 74.34 110.831 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -65.31 -41.61 93.87 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.264 -1.334 . . . . 74.25 110.446 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.41 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 73.3 mtm -71.6 -31.06 66.51 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.198 0.444 . . . . 52.33 112.198 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.73 -42.06 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.328 0.651 . . . . 74.42 109.842 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 84.6 p -76.22 -27.08 56.67 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.876 0.47 . . . . 54.02 111.531 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -75.83 -34.2 60.1 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.002 0.521 . . . . 72.15 110.057 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.72 89.41 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.981 -0.554 . . . . 53.02 111.962 171.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 38.5 p 64.01 19.57 11.81 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.153 2.181 . . . . 62.14 114.077 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -78.4 149.39 75.4 Favored Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 108.549 -0.908 . . . . 71.13 108.549 170.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.34 137.35 71.4 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.817 2.345 . . . . 71.55 112.113 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -55.55 146.21 21.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.793 1.237 . . . . 71.2 113.247 -164.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.483 HD21 HG21 ' D' ' 64' ' ' VAL . 38.3 tp -116.48 94.21 4.53 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.256 -0.884 . . . . 71.13 109.328 -176.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 88.0 m-20 -104.82 91.48 3.85 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.563 -0.903 . . . . 74.52 108.563 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 23.6 tp -73.66 133.54 43.44 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.409 -0.814 . . . . 75.11 110.314 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.19 146.02 99.0 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.582 0.753 . . . . 55.34 111.167 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.4 124.33 3.63 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.329 2.019 . . . . 74.44 111.048 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 99.3 t -107.27 133.48 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.032 -0.531 . . . . 73.41 109.594 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -79.35 88.61 4.97 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.007 -0.738 . . . . 72.23 109.007 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -65.21 -24.87 67.48 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.759 -1.109 . . . . 72.24 111.469 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.95 -52.67 63.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.884 0.873 . . . . 71.53 110.593 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.02 -37.59 66.87 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.348 -0.842 . . . . 60.23 111.721 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.25 -31.33 72.07 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 115.616 -0.72 . . . . 75.42 110.162 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 84.4 t80 . . . . . 0 N--CA 1.485 1.312 0 C-N-CA 123.811 0.845 . . . . 63.44 110.653 176.581 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.6 m . . . . . 0 C--O 1.239 0.501 0 N-CA-C 108.732 -0.84 . . . . 61.52 108.732 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.488 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 35.9 t80 -136.31 111.91 9.34 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.32 -0.992 . . . . 71.24 108.32 170.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -136.47 124.56 22.96 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.549 -0.908 . . . . 41.32 108.549 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.568 HD11 HG21 ' A' ' 105' ' ' ILE . 50.3 mt -89.45 112.04 23.82 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.781 -0.822 . . . . 73.14 108.781 172.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -74.29 -38.59 63.32 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 124.412 1.07 . . . . 65.41 109.523 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -167.07 140.87 3.72 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.829 -0.623 . . . . 73.01 110.568 -169.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.484 HD11 HD13 ' A' ' 13' ' ' ILE . 79.6 mt -128.72 135.1 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.054 -1.091 . . . . 73.41 108.054 172.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.413 ' HB3' HG23 ' B' ' 122' ' ' THR . 33.0 p90 -162.98 151.24 13.99 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 124.18 0.925 . . . . 74.34 110.249 -176.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -74.64 121.93 22.39 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.842 -0.799 . . . . 74.15 108.842 172.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 27.7 mtpt -82.07 -32.61 30.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.716 -0.475 . . . . 72.54 109.716 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.6 t70 -147.72 141.53 25.73 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.057 -0.974 . . . . 73.31 109.462 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.52 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 70.1 mt -136.67 147.67 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.138 1.375 . . . . 53.13 107.494 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.554 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 40.4 t -157.23 149.45 22.81 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.305 0.642 . . . . 44.22 109.699 172.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.482 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 88.8 t80 -151.53 124.53 8.65 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.368 -1.716 . . . . 71.43 106.368 177.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -129.41 114.27 15.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.73 0.412 . . . . 71.33 109.954 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.28 77.0 67.54 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 108.018 -1.105 . . . . 53.43 108.018 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.68 -29.01 20.13 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.203 1.935 . . . . 73.04 110.354 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.403 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 72.3 m-20 -100.94 24.64 9.0 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.139 1.376 . . . . 74.3 110.072 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -56.98 -42.59 97.17 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 124.536 1.134 . . . . 72.32 112.742 170.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.3 -24.61 14.24 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 121.87 1.713 . . . . 71.02 112.52 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -72.86 -33.7 66.27 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.223 0.609 . . . . 73.13 111.184 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.621 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 9.8 p -68.33 -25.36 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 123.52 0.513 . . . . 54.01 111.049 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -69.8 -33.66 72.66 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.241 1.016 . . . . 43.43 110.118 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -92.27 -33.73 14.53 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.76 0.824 . . . . 73.34 111.562 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.621 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -82.67 171.77 13.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.189 0.595 . . . . 73.42 110.364 176.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -86.2 138.96 31.48 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.009 0.524 . . . . 70.44 110.687 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.6 t-105 -76.26 87.0 3.08 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 121.506 0.669 . . . . 63.13 110.205 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -125.52 79.68 66.94 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 108.341 -0.985 . . . . 63.42 108.341 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -86.39 138.65 5.61 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.104 2.536 . . . . 54.32 114.248 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -112.04 110.71 21.16 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 106.334 -1.728 . . . . 73.41 106.334 166.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.7 m -112.97 134.87 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.917 0.887 . . . . 72.51 111.619 -165.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -121.69 149.18 43.61 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.719 0.808 . . . . 64.23 110.171 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.9 tp -127.32 109.29 11.65 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.035 0.934 . . . . 65.33 108.505 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -106.58 118.5 36.82 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.673 -0.862 . . . . 73.43 108.673 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.409 HD11 HD11 ' A' ' 60' ' ' LEU . 9.8 tt -116.04 141.62 47.88 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 122.788 0.435 . . . . 61.5 110.216 -177.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -143.23 132.56 23.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.934 1.293 . . . . 72.12 108.91 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.0 m -109.94 135.9 50.07 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.116 0.967 . . . . 75.01 108.631 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.01 129.67 40.41 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.716 0.806 . . . . 60.14 109.917 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.5 p -93.73 152.07 19.2 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.001 0.52 . . . . 73.44 110.545 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 43.3 t -150.03 151.96 34.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.19 0.996 . . . . 64.21 108.379 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -112.46 116.14 29.81 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.121 -0.696 . . . . 73.52 109.121 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.0 mt -92.04 -33.45 14.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.532 0.733 . . . . 71.24 110.421 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.67 178.67 10.07 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.32 -0.855 . . . . 70.43 109.968 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.59 121.77 14.7 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.198 -0.668 . . . . 73.04 109.198 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 69.25 9.53 7.38 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.602 1.161 . . . . 75.1 112.199 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.21 115.93 51.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 108.74 -0.837 . . . . 73.31 108.74 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -112.74 127.33 56.11 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.426 0.69 . . . . 72.43 110.022 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 44.9 tt0 -91.78 127.74 37.35 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.876 -1.056 . . . . 73.44 108.795 169.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.412 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 64.7 t -108.77 122.5 63.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.714 -1.217 . . . . 71.14 107.714 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.9 t -104.37 107.04 21.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.896 -1.15 . . . . 63.24 107.896 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.409 HD11 HD11 ' A' ' 44' ' ' LEU . 43.6 tp -87.85 98.96 11.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.53 -0.915 . . . . 64.34 108.53 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -84.99 110.59 19.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.438 -0.801 . . . . 71.02 109.447 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.4 t -112.84 107.72 23.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.64 -0.874 . . . . 72.22 108.64 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.7 m -95.29 125.71 40.1 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.117 0.967 . . . . 75.44 108.984 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.727 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 26.5 t -118.43 135.52 58.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 124.721 1.209 . . . . 60.01 108.901 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 t -141.31 138.16 32.94 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.23 0.612 . . . . 74.32 109.542 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.58 103.3 6.79 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.947 0.899 . . . . 62.42 108.933 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.2 p -111.24 124.77 52.89 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.009 0.523 . . . . 65.23 109.92 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 73' ' ' ALA . 8.6 mp -96.82 85.34 3.78 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.063 -1.088 . . . . 64.01 108.063 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.18 -105.62 2.91 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 114.413 -1.267 . . . . 54.55 110.472 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -105.85 -24.73 12.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.821 0.848 . . . . 75.24 110.402 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.403 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 22.4 tt0 -96.55 120.33 36.66 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.416 0.687 . . . . 65.54 111.088 -176.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.624 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 57.1 m -75.93 126.86 31.8 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.265 1.026 . . . . 73.2 110.959 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -69.61 -57.99 4.5 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.147 0.579 . . . . 31.15 109.806 174.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -145.77 157.67 43.91 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 114.719 -1.128 . . . . 75.15 111.419 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 64' ' ' VAL . 66.0 tp -129.74 146.29 51.5 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.677 -1.601 . . . . 70.21 107.439 177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.727 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.0 m -141.8 141.12 33.16 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.526 -0.916 . . . . 71.32 108.526 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 8.2 tp10 -147.22 120.96 9.22 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.792 -0.818 . . . . 61.52 108.792 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -135.23 110.22 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.706 -0.479 . . . . 75.55 109.706 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 68.5 mt-30 -91.48 82.87 5.35 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.183 -1.043 . . . . 72.21 108.183 172.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -75.74 106.88 7.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.834 -1.075 . . . . 73.14 109.386 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.98 151.83 20.08 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 112.02 -0.432 . . . . 51.45 112.02 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.02 141.58 10.05 Favored Glycine 0 C--O 1.239 0.442 0 N-CA-C 111.246 -0.742 . . . . 54.13 111.246 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mt -90.65 118.78 36.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.613 -0.884 . . . . 75.02 108.613 173.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.491 ' HD2' HG12 ' A' ' 13' ' ' ILE . 17.7 m-85 -124.08 118.91 28.01 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.559 -0.904 . . . . 63.25 108.559 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.4 p -90.56 110.23 21.36 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 108.473 -0.936 . . . . 51.34 108.473 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.468 ' HB ' HD11 ' A' ' 89' ' ' ILE . 2.8 pp -112.57 150.5 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.361 0.665 . . . . 74.13 111.422 -171.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.54 159.91 38.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.913 0.885 . . . . 72.54 109.534 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.27 4.94 84.89 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 123.533 0.52 . . . . 72.01 114.137 170.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.538 HG22 HE21 ' A' ' 93' ' ' GLN . 2.6 pp -134.42 148.65 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.97 0.908 . . . . 64.01 109.537 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.47 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 19.3 tt0 -166.89 175.5 7.67 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.962 0.505 . . . . 74.14 110.363 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.47 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 62.04 -134.89 46.14 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.44 0.543 . . . . 73.22 113.741 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.9 p -71.3 -24.6 62.17 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.618 0.767 . . . . 65.31 111.682 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.538 HE21 HG22 ' A' ' 89' ' ' ILE . 28.5 tt0 -72.28 -37.94 68.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.156 0.583 . . . . 74.42 110.07 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.428 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 48.2 ttm -62.6 -42.35 99.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.944 0.498 . . . . 71.22 110.374 172.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.11 -33.58 65.25 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.937 0.773 . . . . 70.22 111.143 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -76.03 -36.47 59.1 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 116.046 -0.524 . . . . 73.23 111.262 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 64.5 m -62.05 -57.58 11.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.798 0.439 . . . . 61.43 111.064 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 pp -91.11 -9.13 46.75 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.433 0.693 . . . . 70.24 112.583 -176.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.86 3.67 30.42 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 119.893 -0.393 . . . . 64.42 113.788 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.17 -63.13 0.35 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.318 0.559 . . . . 62.35 111.31 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.488 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 75.2 t80 -61.94 -58.78 6.58 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.25 -0.887 . . . . 73.43 111.886 -173.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.9 m -70.24 -34.92 4.43 Favored Pre-proline 0 CA--C 1.569 1.697 0 N-CA-C 114.128 1.159 . . . . 62.44 114.128 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -52.63 -42.9 59.28 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.24 1.96 . . . . 53.12 112.492 163.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -67.44 -28.32 67.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.247 0.619 . . . . 75.21 111.197 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.568 HG21 HD11 ' A' ' 13' ' ' ILE . 47.4 mm -67.96 -45.44 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.814 0.845 . . . . 73.5 110.468 173.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.19 -18.07 60.81 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.838 -0.619 . . . . 75.02 111.63 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -62.35 -44.44 88.1 Favored Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 124.273 1.029 . . . . 74.34 113.715 -170.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.32 -36.43 79.14 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.1 1.867 . . . . 65.45 113.268 172.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -68.22 -43.02 78.93 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.474 0.71 . . . . 63.13 111.516 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.24 83.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.092 0.557 . . . . 71.43 109.95 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -52.03 -51.43 57.47 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 124.164 0.915 . . . . 75.01 110.151 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.66 -45.85 84.97 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.036 0.935 . . . . 64.12 111.307 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.0 t -59.84 -34.13 72.69 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.047 0.539 . . . . 51.41 111.37 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.462 HG21 HG21 ' A' ' 64' ' ' VAL . 81.6 mt -74.41 -54.54 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.749 0.82 . . . . 65.43 109.848 175.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.496 HG23 ' HG3' ' A' ' 125' ' ' GLN . 89.3 m -48.81 -45.39 40.25 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.909 1.284 . . . . 65.5 111.66 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -63.48 -46.37 86.46 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.811 -1.086 . . . . 45.53 109.95 -175.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 64.1 mtm -64.38 -38.46 91.09 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.144 0.578 . . . . 71.23 111.201 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.8 t -64.69 -43.09 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.569 0.748 . . . . 72.3 110.391 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.8 m -73.61 -32.4 64.06 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.532 0.733 . . . . 74.12 111.159 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -72.33 -30.17 64.5 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.653 0.781 . . . . 70.5 109.672 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.67 -2.89 90.2 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 124.028 0.83 . . . . 74.22 112.788 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m 66.98 25.39 9.33 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 122.479 1.133 . . . . 74.13 110.838 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.425 ' CE1' HG11 ' A' ' 31' ' ' VAL . 96.6 m-85 -91.26 155.68 44.28 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 115.451 -0.795 . . . . 70.45 109.524 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.02 124.61 15.12 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.77 2.313 . . . . 62.1 112.024 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.496 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.3 tt0 -54.76 134.81 47.78 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 124.214 0.947 . . . . 73.35 112.184 -173.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.0 tp -112.03 116.52 30.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.85 -1.068 . . . . 73.44 109.502 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -130.98 100.12 5.13 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.285 -1.005 . . . . 74.52 108.285 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.74 151.14 43.81 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.86 0.464 . . . . 64.24 110.255 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.55 150.61 89.11 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 123.139 0.576 . . . . 62.33 110.601 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.11 120.0 7.05 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.652 2.235 . . . . 71.01 110.472 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.56 124.43 54.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.657 -0.868 . . . . 70.32 108.657 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 135' ' ' ALA . 58.4 t30 -77.02 88.53 3.55 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.982 0.801 . . . . 73.34 109.683 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -64.31 -24.12 67.54 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.146 -0.934 . . . . 72.32 111.05 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.2 -52.71 64.42 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 123.896 0.747 . . . . 71.44 110.107 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.422 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -60.8 -50.79 72.02 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 124.018 0.824 . . . . 70.55 110.285 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -54.36 -43.88 71.71 Favored 'General case' 0 C--O 1.243 0.726 0 O-C-N 124.503 1.127 . . . . 70.43 111.857 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -72.52 -41.45 65.87 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 116.113 -0.494 . . . . 65.34 109.868 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.3 mtp . . . . . 0 C--O 1.218 -0.603 0 CA-C-O 119.28 -0.391 . . . . 71.31 111.483 -175.022 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.4 m . . . . . 0 C--O 1.242 0.693 0 N-CA-C 107.936 -1.135 . . . . 72.34 107.936 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.11 156.76 43.67 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.083 0.468 . . . . 63.14 109.971 160.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -125.96 141.19 52.08 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.072 -0.967 . . . . 70.01 108.645 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.604 HD11 HD13 ' B' ' 105' ' ' ILE . 48.7 mt -84.69 121.5 36.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.525 -0.917 . . . . 75.11 108.525 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -88.06 -38.26 15.59 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.601 0.563 . . . . 75.34 110.196 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -170.52 131.14 0.9 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.986 -0.552 . . . . 75.31 109.92 -170.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.7 mt -114.94 140.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 107.153 -1.425 . . . . 53.43 107.153 170.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -167.34 145.54 4.81 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.353 0.597 . . . . 64.3 112.376 -174.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.1 m -75.02 124.88 27.77 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.475 -1.238 . . . . 75.21 109.158 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -98.08 -36.28 10.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.953 0.501 . . . . 74.04 110.391 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 17.8 t70 -147.76 133.66 19.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.51 -0.314 . . . . 70.21 110.643 -168.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.1 mm -133.55 145.95 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.756 1.222 . . . . 72.1 108.842 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.0 t -147.1 136.25 22.5 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.655 1.182 . . . . 50.21 108.147 173.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.52 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -147.84 113.91 5.83 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.925 -1.139 . . . . 71.42 107.925 172.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -119.07 119.25 33.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.071 0.948 . . . . 73.2 108.562 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.629 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.3 85.1 2.57 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 108.189 -1.041 . . . . 72.53 108.189 168.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -65.94 -35.94 32.8 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 122.997 2.465 . . . . 53.12 112.028 -173.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -106.28 9.86 31.89 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.856 -1.065 . . . . 61.15 110.68 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.629 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -25.2 -66.16 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.061 0 C-N-CA 126.287 1.835 . . . . 70.32 115.162 -174.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 10.5 Cg_exo -67.2 -30.79 37.24 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 122.362 2.042 . . . . 74.44 112.168 -169.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -96.57 -30.16 13.45 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.019 -0.991 . . . . 64.14 112.053 -170.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.684 HG21 ' HA ' ' B' ' 73' ' ' ALA . 10.7 p -72.4 -19.74 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 122.471 0.308 . . . . 45.31 111.132 -174.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -63.73 -14.11 49.51 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.574 0.75 . . . . 71.41 112.295 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -64.01 -22.93 67.14 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.57 0.748 . . . . 60.0 111.794 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.92 100.97 12.34 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.022 0.929 . . . . 74.03 109.353 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.47 95.98 4.6 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.636 -0.505 . . . . 72.33 109.636 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -166.61 155.86 11.05 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.67 0.788 . . . . 74.43 109.237 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -75.37 105.1 1.73 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.006 -0.738 . . . . 72.02 109.006 170.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.492 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 21.1 Cg_endo -58.89 127.48 24.52 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.692 2.261 . . . . 73.33 112.202 -171.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -51.56 126.16 16.67 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.376 1.047 . . . . 71.21 110.225 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.635 HG13 HG13 ' B' ' 64' ' ' VAL . 89.6 t -106.22 139.58 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.363 0.665 . . . . 75.43 110.911 -171.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -108.02 125.72 51.88 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.821 -1.178 . . . . 63.23 107.821 162.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -85.04 137.86 32.8 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.451 -0.944 . . . . 71.32 108.451 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.1 t70 -133.2 135.65 45.19 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.51 -1.293 . . . . 72.31 107.51 175.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.59 127.45 27.46 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.226 -1.028 . . . . 34.31 108.226 -177.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.49 145.75 34.02 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.069 -1.456 . . . . 73.14 107.069 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 34.6 p -127.86 120.1 27.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.012 -0.736 . . . . 75.21 109.012 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.43 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -119.95 116.14 25.19 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.747 0.819 . . . . 73.21 108.886 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -113.87 170.58 8.16 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.751 0.421 . . . . 64.24 111.616 -172.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 87.2 p -152.8 143.89 23.08 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.786 0.834 . . . . 74.34 110.251 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -83.13 136.14 34.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.198 0.599 . . . . 70.25 109.785 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 58.7 mt -101.67 -46.71 4.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.557 0.743 . . . . 60.01 110.645 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.07 -169.47 2.96 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.305 -0.862 . . . . 51.41 111.156 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -62.98 105.67 0.71 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.01 -0.996 . . . . 64.34 110.343 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 64.11 11.69 6.41 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.277 1.031 . . . . 73.31 112.026 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.4 112.2 37.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 106.567 -1.642 . . . . 74.22 106.567 173.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -133.85 137.94 45.32 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.491 -0.929 . . . . 75.11 108.491 -173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -107.89 137.09 46.51 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.483 0.713 . . . . 74.31 109.641 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.84 143.01 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.53 -0.915 . . . . 55.33 108.53 171.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 40.4 t -125.67 125.17 68.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 109.088 -0.708 . . . . 74.31 109.088 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.4 HD22 HG23 ' B' ' 62' ' ' VAL . 0.2 OUTLIER -102.54 112.33 25.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.71 -1.132 . . . . 72.14 108.572 -174.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -97.62 110.98 23.44 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.587 0.755 . . . . 71.23 110.627 174.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.4 HG23 HD22 ' B' ' 60' ' ' LEU . 39.2 t -107.06 104.46 17.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.968 -1.123 . . . . 73.33 107.968 170.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 9.5 m -99.21 130.77 45.53 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.761 -0.829 . . . . 72.13 108.761 174.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.635 HG13 HG13 ' B' ' 40' ' ' VAL . 43.4 t -118.13 127.33 75.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 123.907 0.883 . . . . 73.51 108.93 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 87.9 m -109.75 137.85 46.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.403 -0.962 . . . . 75.11 108.403 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -146.61 145.86 30.22 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 122.844 0.457 . . . . 60.23 109.812 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.5 p -151.61 138.05 18.59 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.309 -0.86 . . . . 52.14 110.663 -172.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.667 HD12 HG22 ' B' ' 31' ' ' VAL . 60.4 mt -103.78 124.3 48.65 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.916 0.886 . . . . 71.14 109.923 174.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.51 -108.55 2.46 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 123.636 0.585 . . . . 61.51 112.733 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.61 5.0 12.36 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.854 0.862 . . . . 71.45 111.399 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -119.71 156.61 30.18 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.97 0.508 . . . . 71.54 110.019 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.2 m -68.3 137.84 55.0 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.595 0.56 . . . . 73.2 110.459 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.684 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -91.64 -65.01 1.04 Allowed 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.478 -1.304 . . . . 62.42 107.478 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -150.88 161.56 42.45 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.088 -0.96 . . . . 74.0 110.244 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.8 mt -132.85 111.56 11.19 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.047 -1.464 . . . . 64.44 107.047 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.2 t -118.86 153.45 34.52 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.005 -0.739 . . . . 51.44 109.005 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -160.64 131.39 5.44 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.875 -0.787 . . . . 75.42 108.875 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.2 t -128.09 145.29 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.679 -0.86 . . . . 51.54 108.679 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.54 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.0 mt-30 -126.37 95.96 4.54 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.999 -0.741 . . . . 73.42 108.999 172.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -86.2 104.01 15.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.167 -0.924 . . . . 73.14 109.895 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -87.44 153.85 25.55 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 111.673 -0.571 . . . . 52.33 111.673 176.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -154.02 127.11 2.06 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 111.417 -0.673 . . . . 75.12 111.417 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 62.7 mt -86.87 126.04 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.6 0.76 . . . . 73.14 109.68 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -131.74 132.07 43.54 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 107.713 -1.217 . . . . 54.33 107.713 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 31.6 m -102.95 91.66 4.23 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.194 -0.669 . . . . 73.2 109.194 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.572 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -94.79 142.58 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 115.859 -0.61 . . . . 72.35 110.939 -167.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.07 158.31 42.83 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.328 1.051 . . . . 73.44 109.399 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.47 -56.71 3.87 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.705 -0.68 . . . . 54.3 111.801 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.494 HD11 ' HB ' ' B' ' 86' ' ' ILE . 11.4 pt -69.13 149.7 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.81 0.844 . . . . 74.43 112.168 177.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -159.16 176.15 12.58 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 125.481 1.512 . . . . 72.22 107.588 171.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.09 -129.78 50.06 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.392 0.433 . . . . 62.53 112.716 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -83.38 -19.26 36.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.609 0.364 . . . . 52.21 111.719 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -72.89 -25.98 61.27 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.785 -0.45 . . . . 71.41 109.785 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 24.1 ttt -78.85 -33.57 45.78 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.127 -0.488 . . . . 71.52 110.12 170.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.17 -29.83 70.03 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.219 0.608 . . . . 54.03 111.001 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -69.2 -39.4 78.65 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.463 0.705 . . . . 63.21 111.414 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.8 t -66.87 -66.19 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.267 -0.879 . . . . 42.53 109.81 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 38.8 mt -70.18 -27.31 64.42 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.555 0.742 . . . . 71.3 112.098 -172.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.25 -12.61 58.48 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.574 0.546 . . . . 64.3 114.298 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.51 -55.36 0.39 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.58 0.69 . . . . 72.04 112.282 -173.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.431 ' OH ' ' HB3' ' D' ' 130' ' ' PRO . 66.2 t80 -75.86 -48.17 22.57 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.392 0.516 . . . . 75.44 112.392 -169.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.434 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 88.1 m -59.3 -50.09 89.31 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 123.676 0.791 . . . . 73.44 111.567 176.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 69.9 Cg_exo -55.22 -36.3 93.02 Favored 'Trans proline' 0 C--N 1.389 2.683 0 C-N-CA 121.968 1.779 . . . . 62.14 113.561 169.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.16 -40.63 90.58 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 123.185 0.594 . . . . 73.43 110.643 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.604 HD13 HD11 ' B' ' 13' ' ' ILE . 67.6 mt -63.79 -43.61 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.599 0.76 . . . . 63.33 110.404 175.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.449 HD21 ' HA3' ' B' ' 82' ' ' GLY . 65.9 mt -78.66 -18.89 53.72 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.064 -0.971 . . . . 74.34 112.034 -174.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -58.49 -51.83 79.01 Favored Pre-proline 0 N--CA 1.482 1.162 0 N-CA-C 113.963 1.097 . . . . 75.25 113.963 -170.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.95 -32.23 92.25 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 121.671 1.58 . . . . 62.22 113.312 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -66.05 -50.63 63.47 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.286 0.634 . . . . 74.33 110.472 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.16 -40.09 84.5 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.2 -0.909 . . . . 74.53 110.812 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -65.56 -49.02 70.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.506 1.523 . . . . 53.53 110.939 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -68.27 -34.53 76.34 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.81 -0.632 . . . . 53.54 109.842 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.7 t -67.99 -34.32 76.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.777 0.431 . . . . 74.01 111.223 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.465 ' O ' HG23 ' B' ' 118' ' ' VAL . 66.6 mt -63.83 -56.48 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.662 -0.495 . . . . 53.03 109.662 172.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.1 m -60.42 -26.02 66.39 Favored 'General case' 0 CA--C 1.554 1.131 0 O-C-N 123.973 0.796 . . . . 55.0 111.473 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.0 t -62.99 -50.45 70.69 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.225 0.61 . . . . 62.43 109.836 173.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -71.57 -32.1 67.7 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.414 0.686 . . . . 62.05 111.079 -176.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 114' ' ' ILE . 87.6 t -61.98 -44.62 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.65 0.78 . . . . 64.32 109.55 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.6 t -65.37 -35.76 81.93 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.039 -0.982 . . . . 60.14 111.368 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.0 mtt-85 -68.06 -32.17 72.32 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.475 -0.784 . . . . 62.42 110.323 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.87 8.12 77.29 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.952 0.783 . . . . 75.53 112.965 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 17' ' ' TYR . 61.5 p 54.77 27.42 8.82 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.15 1.78 . . . . 74.14 113.626 176.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -83.43 154.74 66.16 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.397 0.679 . . . . 73.55 110.09 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -55.99 157.42 16.89 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.083 2.522 . . . . 55.33 113.223 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -64.56 113.77 3.92 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.369 -0.832 . . . . 73.23 111.38 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.1 mt -121.09 119.51 32.64 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.899 -0.778 . . . . 53.21 108.899 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -115.0 112.98 23.5 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.806 -0.813 . . . . 64.32 108.806 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.35 143.26 56.06 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.33 0.652 . . . . 55.34 111.353 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.56 150.9 64.16 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.843 0.857 . . . . 63.41 110.687 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.23 145.3 17.02 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.879 2.386 . . . . 71.43 111.775 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.31 118.59 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.246 -1.02 . . . . 63.52 108.246 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -79.8 83.37 5.75 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.618 -0.512 . . . . 61.14 109.618 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -64.45 -24.28 67.57 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.528 0.731 . . . . 74.1 111.962 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.56 -52.05 55.28 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.523 0.729 . . . . 74.51 110.268 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.16 95.26 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.937 0.895 . . . . 71.23 110.938 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 89.9 mt -74.07 -20.89 60.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.075 -0.966 . . . . 61.53 112.028 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 61.0 t80 . . . . . 0 N--CA 1.477 0.9 0 C-N-CA 122.625 0.37 . . . . 64.02 110.732 177.865 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.466 0.328 0 N-CA-C 108.206 -1.035 . . . . 74.35 108.206 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.611 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.1 t80 -120.23 126.32 50.34 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.808 -0.812 . . . . 74.02 108.808 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -142.51 109.05 5.34 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.385 -0.968 . . . . 74.02 108.385 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -73.82 122.11 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.158 -0.682 . . . . 64.45 109.158 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.569 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.8 mm-40 -86.47 -42.26 13.73 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.179 -0.919 . . . . 74.54 110.35 -175.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -175.56 139.93 0.45 Allowed 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.614 0.571 . . . . 74.55 109.523 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.0 mt -131.56 133.87 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.463 -0.94 . . . . 71.21 108.463 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.522 ' HB3' HG23 ' D' ' 122' ' ' THR . 27.3 p90 -170.64 172.61 5.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.691 0.758 . . . . 73.13 111.565 -169.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -96.07 118.5 32.79 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.382 -0.827 . . . . 72.32 109.16 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.454 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.8 mmtp -65.78 -48.16 72.73 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 122.33 1.062 . . . . 61.02 108.156 169.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.438 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.5 t70 -139.82 146.25 39.16 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 113.814 -1.539 . . . . 74.04 109.884 -172.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.59 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 80.5 mt -140.39 140.93 33.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 106.701 -1.592 . . . . 74.01 106.701 174.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -159.25 149.84 19.51 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.173 0.511 . . . . 75.31 110.663 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.2 t80 -148.49 136.96 21.34 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.918 -1.141 . . . . 70.32 107.918 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.67 118.65 18.4 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.695 0.798 . . . . 63.41 109.754 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.92 76.87 45.2 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 106.356 -1.72 . . . . 62.51 106.356 165.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.07 -40.61 11.29 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.738 2.292 . . . . 74.33 111.199 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.03 21.12 3.27 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.628 -1.169 . . . . 73.22 111.417 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.412 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -44.65 -57.83 6.18 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 114.39 1.256 . . . . 65.33 114.39 -171.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.4 -36.43 66.67 Favored 'Trans proline' 0 C--N 1.385 2.459 0 CA-C-N 121.744 1.658 . . . . 60.31 112.397 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -70.07 -35.42 74.2 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.372 0.669 . . . . 74.31 112.135 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.5 p -79.6 -24.49 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 N-CA-C 111.886 0.328 . . . . 72.41 111.886 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.59 -30.2 69.75 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.617 0.367 . . . . 72.35 111.867 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -86.67 11.45 12.92 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.905 0.482 . . . . 74.45 111.12 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.799 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.99 160.05 14.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.231 1.012 . . . . 65.41 109.563 170.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -71.48 131.44 43.31 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.514 0.725 . . . . 63.14 110.561 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.532 ' NE1' ' HG3' ' C' ' 124' ' ' PRO . 31.5 t90 -73.86 91.91 2.02 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.424 -0.807 . . . . 72.22 111.297 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -147.04 74.43 11.98 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 107.444 -1.317 . . . . 75.33 107.444 169.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -85.15 137.14 6.04 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.732 2.288 . . . . 54.45 112.717 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -86.06 110.07 19.27 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.268 -1.012 . . . . 72.51 108.268 171.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -84.6 100.47 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-O 122.532 1.158 . . . . 74.14 110.978 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -95.74 103.29 15.16 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.784 -1.098 . . . . 74.52 108.279 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.52 134.75 36.73 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.25 -0.648 . . . . 72.32 109.25 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -127.67 136.08 51.1 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.352 -0.981 . . . . 55.42 108.352 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 tp -129.22 135.12 48.4 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.438 0.695 . . . . 72.04 109.683 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.412 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 27.5 t70 -149.04 153.06 37.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.883 0.873 . . . . 72.25 109.664 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -146.19 153.39 40.58 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.155 0.582 . . . . 72.21 109.441 170.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.55 160.54 39.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.248 1.019 . . . . 63.01 109.011 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -144.43 155.67 43.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.461 0.704 . . . . 54.24 109.223 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.5 p -157.4 153.78 27.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.601 0.76 . . . . 60.53 109.353 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -95.8 118.05 31.72 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.993 -0.743 . . . . 60.24 108.993 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' C' ' 57' ' ' GLU . 60.5 mt -89.37 -34.92 16.34 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.179 0.592 . . . . 75.43 110.337 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.3 -170.06 2.16 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.645 0.778 . . . . 50.2 111.004 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.91 111.44 1.66 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.85 0.86 . . . . 42.14 110.417 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 70.79 -5.75 1.4 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.344 1.458 . . . . 71.52 112.564 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.0 t -93.77 105.7 17.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.456 -0.942 . . . . 73.54 108.456 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -118.79 122.96 43.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.542 -0.754 . . . . 73.31 109.357 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.486 ' HB2' HD11 ' C' ' 51' ' ' LEU . 35.4 tt0 -84.36 144.7 28.65 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.532 0.733 . . . . 72.31 110.294 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -131.14 140.55 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.259 -1.015 . . . . 70.12 108.259 167.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.427 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 90.9 t -130.95 130.83 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.067 -1.086 . . . . 75.13 108.067 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.96 109.42 21.41 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.456 -1.313 . . . . 63.51 107.456 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.412 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.2 tmm_? -101.65 106.77 17.86 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.127 -1.064 . . . . 65.14 108.127 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.621 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.7 t -107.96 137.55 38.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.88 -1.156 . . . . 75.01 107.88 175.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -132.48 121.93 24.11 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.171 -0.678 . . . . 71.01 109.171 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 64.8 t -111.51 110.33 31.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 124.18 0.992 . . . . 73.11 108.9 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.487 HG23 HD23 ' C' ' 75' ' ' LEU . 4.0 m -108.85 108.28 19.0 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.226 0.61 . . . . 72.03 109.38 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.04 123.47 45.98 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.828 -0.804 . . . . 74.44 108.828 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.6 m -137.83 130.47 29.67 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.949 0.5 . . . . 65.23 111.046 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.799 HD13 ' HG2' ' C' ' 34' ' ' LYS . 6.6 mt -84.81 33.99 0.53 Allowed 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 125.255 1.422 . . . . 74.55 110.723 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.62 -100.13 1.84 Allowed Glycine 0 C--N 1.352 1.427 0 N-CA-C 111.052 -0.819 . . . . 74.22 111.052 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.61 -31.89 18.36 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.474 -0.565 . . . . 75.45 109.474 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.02 120.87 24.78 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.725 0.81 . . . . 63.31 109.13 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.5 m -76.73 128.7 35.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.981 -0.748 . . . . 61.13 108.981 169.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.747 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.08 -57.78 4.2 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.424 -0.954 . . . . 75.12 108.424 173.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -165.65 173.72 10.52 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.309 -0.86 . . . . 73.55 110.768 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.487 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -133.24 144.23 49.63 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.089 -1.448 . . . . 60.03 107.089 172.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.454 ' SG ' HG23 ' C' ' 114' ' ' ILE . 46.6 t -146.31 139.65 25.87 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.158 -1.053 . . . . 70.05 108.158 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -151.6 133.65 15.1 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.517 -0.549 . . . . 73.43 109.517 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.4 t -134.99 138.89 48.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.26 1.024 . . . . 75.12 108.474 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -114.17 88.17 2.79 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.258 -1.015 . . . . 72.42 108.258 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.401 ' HG3' HD22 ' C' ' 106' ' ' LEU . 9.5 tp-100 -79.1 97.77 6.27 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.175 -0.92 . . . . 74.43 110.197 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -98.74 144.13 17.03 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-O 121.199 0.333 . . . . 51.13 113.035 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.432 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -145.09 132.81 4.84 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.514 -1.034 . . . . 52.44 110.514 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 15.3 mm -88.97 123.7 41.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 108.394 -0.965 . . . . 71.35 108.394 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.611 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 51.2 m-85 -130.4 116.14 17.86 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.159 0.583 . . . . 71.51 109.787 -173.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 74.0 m -84.0 108.51 17.0 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.684 -0.487 . . . . 31.33 109.684 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.523 ' HB ' HD11 ' C' ' 89' ' ' ILE . 2.7 pp -117.06 138.61 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.949 0.899 . . . . 74.32 110.25 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.34 158.14 43.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.162 0.985 . . . . 64.33 109.554 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.39 -30.41 5.26 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 113.892 0.317 . . . . 73.22 113.892 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.567 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -105.72 150.2 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 121.23 0.538 . . . . 75.1 111.792 -176.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.91 -170.79 3.73 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.784 -1.098 . . . . 75.55 108.505 166.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.05 -124.45 30.33 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 114.112 0.405 . . . . 74.22 114.112 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 74.1 p -76.35 -29.53 57.26 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.834 0.853 . . . . 63.03 111.806 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.87 -42.46 85.56 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.592 -0.521 . . . . 74.42 109.592 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 28.1 ttt -74.66 -33.12 62.45 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.857 -0.61 . . . . 72.12 110.807 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.62 -48.69 69.09 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.75 0.657 . . . . 52.23 109.706 174.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.434 ' NE2' ' HA ' ' C' ' 134' ' ' ASP . 11.6 t-80 -77.62 -35.16 52.99 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.857 0.723 . . . . 75.42 111.492 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.412 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 51.8 t -56.86 -36.79 70.46 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.849 0.718 . . . . 74.52 110.407 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 23.9 mt -101.07 -15.22 17.5 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.877 0.871 . . . . 71.52 110.917 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.76 -30.41 48.27 Favored Glycine 0 C--N 1.352 1.42 0 N-CA-C 114.842 0.697 . . . . 74.34 114.842 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.83 -36.88 0.06 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.938 0.495 . . . . 54.01 110.859 -172.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.412 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 70.4 t80 -66.88 -44.29 81.29 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.38 1.472 . . . . 74.42 112.282 -175.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 23.3 m -77.12 -47.91 2.6 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 123.394 0.678 . . . . 72.24 111.836 174.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -53.96 -28.85 51.37 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.138 1.892 . . . . 74.1 114.273 171.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -68.35 -39.56 81.81 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 123.109 0.564 . . . . 62.43 109.939 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 42.3 mm -59.92 -39.44 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.439 -0.578 . . . . 63.22 109.439 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.432 HD21 ' HA3' ' C' ' 82' ' ' GLY . 76.7 mt -85.52 -12.77 50.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.599 1.16 . . . . 75.33 112.501 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -63.37 -51.4 68.32 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 113.784 1.031 . . . . 73.42 113.784 -171.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -66.79 -30.99 40.26 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 121.731 1.621 . . . . 51.22 112.263 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -67.82 -46.25 72.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.457 0.703 . . . . 74.42 110.935 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.31 93.02 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.482 0.713 . . . . 60.13 109.806 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -53.15 -60.26 3.51 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.293 0.995 . . . . 62.33 110.938 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -62.56 -29.4 70.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.614 0.766 . . . . 74.15 110.945 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.432 ' SG ' HG12 ' C' ' 21' ' ' ILE . 8.3 t -72.55 -44.48 62.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.774 0.43 . . . . 74.11 110.832 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.621 HD11 ' HB ' ' C' ' 62' ' ' VAL . 85.5 mt -64.88 -50.09 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.31 0.644 . . . . 73.54 110.333 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.4 m -64.21 -29.34 70.45 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.413 -0.812 . . . . 75.1 110.741 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 28.1 t -65.54 -52.62 51.15 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.987 0.515 . . . . 74.03 109.71 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.436 ' HB3' ' HB2' ' C' ' 23' ' ' PHE . 0.0 OUTLIER -54.15 -46.86 72.37 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.472 1.109 . . . . 54.5 112.026 178.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.576 HG11 HD13 ' C' ' 126' ' ' LEU . 71.2 t -65.97 -43.41 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.45 -0.796 . . . . 72.21 111.157 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.9 t -61.08 -36.94 81.0 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.445 0.698 . . . . 63.43 111.167 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -69.71 -32.02 70.36 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.134 -0.939 . . . . 65.12 110.329 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.08 7.05 76.98 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.894 0.746 . . . . 61.53 112.958 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.412 HG23 ' HB3' ' D' ' 17' ' ' TYR . 53.2 p 57.7 28.63 16.1 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 126.37 1.868 . . . . 71.14 113.751 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.5 ' HB2' HG13 ' C' ' 118' ' ' VAL . 93.2 m-85 -91.98 163.44 27.48 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 108.914 -0.772 . . . . 65.43 108.914 170.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.532 ' HG3' ' NE1' ' C' ' 36' ' ' TRP . 56.5 Cg_endo -64.06 -178.93 0.67 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.934 2.423 . . . . 73.33 114.641 -174.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -61.2 128.89 38.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.945 -1.025 . . . . 74.41 111.683 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.576 HD13 HG11 ' C' ' 118' ' ' VAL . 6.7 mp -134.81 86.49 2.26 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.445 -0.946 . . . . 72.14 108.445 170.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -99.77 123.68 44.27 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.089 -0.708 . . . . 64.14 109.089 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -64.93 118.87 9.69 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.782 -0.821 . . . . 63.43 108.782 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.02 141.25 93.75 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.727 0.811 . . . . 75.04 111.318 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.442 ' HB3' HD12 ' A' ' 16' ' ' ILE . 14.8 Cg_endo -58.05 103.74 0.16 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.436 2.091 . . . . 73.43 112.094 174.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 29.2 t -95.46 140.82 16.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.642 -1.614 . . . . 75.32 106.642 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -77.36 66.77 3.18 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.345 -0.613 . . . . 34.33 109.345 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -54.33 -43.12 70.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.912 0.885 . . . . 72.22 111.183 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.434 ' HA ' ' NE2' ' C' ' 96' ' ' HIS . 7.8 m-20 -66.49 -41.93 88.17 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.89 -1.05 . . . . 61.42 112.484 -175.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.91 -43.08 72.43 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.799 0.687 . . . . 64.42 110.398 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.05 -21.15 60.84 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.027 -0.988 . . . . 63.31 111.9 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.0 t80 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.902 -0.407 . . . . 72.01 109.902 172.76 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 121.18 0.515 . . . . 73.14 110.991 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -158.7 89.86 0.98 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.727 -1.582 . . . . 74.4 106.727 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -116.69 116.36 27.39 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.584 -0.895 . . . . 74.44 108.584 -176.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.42 HG21 HD11 ' D' ' 16' ' ' ILE . 14.7 mt -82.48 117.55 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.569 -0.9 . . . . 74.21 108.569 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.56 -34.8 46.76 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.992 0.517 . . . . 73.13 111.37 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -169.2 130.92 1.17 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 111.631 0.234 . . . . 73.22 111.631 -168.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.446 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.6 mp -115.02 134.4 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.075 -1.454 . . . . 62.02 107.075 173.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.412 ' HB3' HG23 ' C' ' 122' ' ' THR . 36.4 p90 -165.52 170.3 14.52 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.811 0.815 . . . . 75.13 111.868 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -102.52 123.15 45.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.265 -1.334 . . . . 73.34 108.817 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -93.25 -18.45 22.48 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.114 -0.494 . . . . 75.35 110.011 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -156.39 136.12 12.52 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.329 -0.989 . . . . 73.15 108.329 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.426 ' CD1' ' HE3' ' C' ' 117' ' ' MET . 17.5 mt -134.59 138.77 49.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.627 -1.249 . . . . 70.54 107.627 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -144.67 133.87 22.9 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.353 0.661 . . . . 54.33 109.773 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.59 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 70.5 t80 -144.67 127.48 16.3 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.56 -1.644 . . . . 72.44 106.56 167.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.5 mt-10 -134.89 126.64 29.13 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.638 0.775 . . . . 71.01 109.357 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.54 85.14 25.82 Favored Pre-proline 0 C--O 1.242 0.673 0 N-CA-C 107.953 -1.129 . . . . 73.44 107.953 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.22 -40.47 11.18 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.909 2.406 . . . . 70.22 112.482 -171.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -107.73 27.59 9.04 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 123.871 0.868 . . . . 74.32 109.789 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.74 -68.57 0.22 Allowed Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 115.284 1.586 . . . . 73.14 115.284 -161.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.57 -19.97 16.2 Favored 'Trans proline' 0 C--N 1.382 2.299 0 CA-C-N 122.394 1.891 . . . . 72.35 113.385 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.439 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 8.5 t-160 -74.81 -38.79 61.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.534 1.133 . . . . 71.42 110.698 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' D' ' 73' ' ' ALA . 10.7 p -84.38 -25.24 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 122.789 0.435 . . . . 70.22 111.694 -172.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -58.43 -27.99 64.84 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.371 0.669 . . . . 75.13 112.359 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.439 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 72.1 mt-30 -53.73 -31.33 47.86 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.786 1.234 . . . . 74.11 111.541 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -87.51 96.95 10.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.984 0.913 . . . . 74.45 109.135 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -81.33 88.58 6.08 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.992 -0.549 . . . . 53.54 110.946 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -163.15 162.64 25.68 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.664 0.786 . . . . 71.33 109.153 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 1.3 mp0 -73.47 116.35 50.5 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 109.238 -0.652 . . . . 63.34 109.238 171.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.716 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 77.5 Cg_exo -56.55 138.97 86.61 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.94 3.094 . . . . 74.12 113.971 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.11 111.73 1.44 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.025 0.828 . . . . 71.12 109.372 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.496 HG23 HG13 ' D' ' 64' ' ' VAL . 7.3 p -103.79 135.35 41.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.357 -0.838 . . . . 73.45 110.917 -168.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -115.52 132.39 56.64 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.326 1.05 . . . . 72.44 108.346 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.408 HD21 ' HG ' ' D' ' 44' ' ' LEU . 8.5 tt -98.17 126.23 43.54 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.955 0.502 . . . . 73.44 109.746 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.521 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.8 m-20 -133.49 116.08 15.54 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.898 -1.149 . . . . 74.01 107.898 171.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.408 ' HG ' HD21 ' D' ' 42' ' ' LEU . 91.6 mt -113.88 142.34 46.23 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.153 0.581 . . . . 73.2 109.988 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.459 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.2 t70 -141.8 154.89 45.52 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.947 -1.131 . . . . 75.42 107.947 173.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -127.68 164.4 22.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.104 0.561 . . . . 55.14 109.712 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.542 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.24 161.79 42.1 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.784 0.834 . . . . 52.3 109.627 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 37.3 p -159.1 151.84 21.83 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.099 0.559 . . . . 72.53 109.726 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.4 p -157.93 139.23 13.51 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.36 0.664 . . . . 71.44 109.707 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -79.13 119.37 22.15 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.553 -0.536 . . . . 72.24 109.553 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.7 mt -90.15 -34.63 15.78 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.86 -0.793 . . . . 72.4 108.86 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.16 -178.95 5.36 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.224 1.01 . . . . 63.22 109.672 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.64 122.17 17.48 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.221 -0.899 . . . . 65.21 109.197 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 72.16 12.46 5.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.394 1.478 . . . . 74.41 112.402 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.6 t -128.98 117.6 44.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 123.972 0.909 . . . . 41.32 108.879 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -132.88 130.08 39.25 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.398 1.079 . . . . 74.1 108.703 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.5 ' HB2' HD11 ' D' ' 51' ' ' LEU . 18.5 tt0 -91.83 142.29 27.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.972 -0.751 . . . . 61.42 108.972 170.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -123.08 142.31 40.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.421 -1.326 . . . . 74.14 107.421 172.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 45.9 t -126.37 132.09 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.807 -0.812 . . . . 72.53 108.807 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.32 120.39 42.25 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.705 -0.85 . . . . 75.35 108.705 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.459 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 33.3 ttm-85 -102.94 98.45 8.41 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.312 -0.996 . . . . 64.4 108.312 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -100.2 123.37 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.859 -0.793 . . . . 51.44 108.859 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 15.4 m -119.13 141.82 48.47 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.496 0.718 . . . . 75.22 109.85 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.496 HG13 HG23 ' D' ' 40' ' ' VAL . 75.6 t -136.64 103.29 3.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.0 1.32 . . . . 55.25 108.561 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 83.4 m -100.9 113.72 26.93 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.349 -0.982 . . . . 61.33 108.349 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -122.55 142.82 50.21 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.726 0.811 . . . . 72.1 109.857 -174.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 23.5 m -144.13 134.39 24.41 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.652 0.595 . . . . 72.1 111.795 -176.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.621 HD12 HG22 ' D' ' 31' ' ' VAL . 48.9 mt -106.23 123.34 47.88 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.325 1.05 . . . . 63.15 109.198 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.56 -124.56 36.41 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 115.155 -0.93 . . . . 61.2 113.609 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.89 6.47 47.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 71.02 112.326 -175.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.0 165.1 26.79 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.668 0.387 . . . . 75.13 110.875 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 34.7 m -68.23 138.07 55.28 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.762 0.663 . . . . 70.33 110.473 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.775 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -90.33 -70.69 0.66 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.342 -0.984 . . . . 60.14 108.342 173.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -147.63 140.6 24.96 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.576 -0.738 . . . . 72.33 109.605 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 88.1 mt -109.62 143.18 39.7 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.49 -1.3 . . . . 63.52 107.49 172.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.545 ' SG ' HG23 ' D' ' 114' ' ' ILE . 38.7 t -158.05 137.19 11.63 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.231 -0.285 . . . . 53.22 110.231 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.59 133.27 13.01 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.945 -0.761 . . . . 74.31 108.945 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.7 t -128.77 138.02 55.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.572 -0.899 . . . . 72.35 108.572 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -116.32 87.35 2.67 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.096 -1.075 . . . . 65.22 108.096 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.14 103.95 10.37 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.347 -1.297 . . . . 72.24 108.944 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.09 141.39 15.96 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.314 -0.714 . . . . 73.43 111.314 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.475 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -139.86 130.02 4.53 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.681 -0.968 . . . . 73.05 110.681 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 58.7 mt -92.57 115.95 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.717 -0.846 . . . . 54.1 108.717 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -116.33 125.55 52.28 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.931 0.892 . . . . 53.12 109.692 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -104.39 109.29 21.09 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.481 0.712 . . . . 73.34 109.353 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -110.78 144.14 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.244 0.617 . . . . 54.34 109.866 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.45 127.07 8.73 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.789 -0.819 . . . . 74.42 108.789 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.36 -20.51 42.25 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.398 -0.681 . . . . 64.35 111.398 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mp -98.41 130.75 46.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.231 1.013 . . . . 74.22 108.341 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -160.47 173.8 15.03 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.442 0.697 . . . . 74.13 110.7 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.01 -133.82 49.17 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 124.023 0.827 . . . . 72.32 113.879 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.1 m -63.35 -31.73 72.97 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.706 0.803 . . . . 52.22 110.73 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -69.34 -33.66 73.44 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.74 0.816 . . . . 73.03 110.945 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.488 ' SD ' HD12 ' D' ' 98' ' ' LEU . 17.5 tmm? -72.74 -37.61 67.66 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.263 0.625 . . . . 63.3 110.389 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.31 95.94 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.61 0.719 . . . . 40.15 110.55 171.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -71.53 -29.53 64.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.899 1.28 . . . . 61.22 111.405 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -81.12 -52.26 7.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.811 0.445 . . . . 62.14 110.874 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.488 HD12 ' SD ' ' D' ' 94' ' ' MET . 92.6 mt -84.35 -27.9 27.39 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.995 0.518 . . . . 70.42 111.697 -171.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.02 7.41 58.8 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.677 -0.513 . . . . 63.23 114.138 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -150.29 -61.3 0.2 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.393 0.597 . . . . 72.42 111.232 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -69.7 -41.65 75.1 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.034 0.534 . . . . 73.34 112.145 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.444 ' SG ' HD23 ' D' ' 98' ' ' LEU . 88.5 m -65.35 -45.97 70.48 Favored Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 123.62 0.768 . . . . 64.42 112.38 -178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -53.1 -36.89 78.51 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.155 1.903 . . . . 70.03 113.177 167.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -67.77 -30.89 70.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.099 0.56 . . . . 64.24 111.438 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.0 -37.33 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.276 0.631 . . . . 63.12 110.584 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.475 HD21 ' HA3' ' D' ' 82' ' ' GLY . 92.7 mt -77.49 -19.77 55.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.057 0.943 . . . . 72.33 111.997 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.64 ' HZ ' HD22 ' D' ' 128' ' ' LEU . 40.5 t80 -64.65 -43.64 71.01 Favored Pre-proline 0 CA--C 1.56 1.327 0 N-CA-C 114.347 1.24 . . . . 73.11 114.347 -170.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -54.35 -45.51 40.42 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 121.952 1.768 . . . . 74.33 112.491 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -70.0 -35.59 74.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.041 0.936 . . . . 75.32 111.759 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.71 67.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.269 0.628 . . . . 60.32 110.502 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.445 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.2 ttp180 -58.48 -49.09 78.61 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.253 -0.885 . . . . 54.42 110.534 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.52 -46.63 87.53 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.136 0.897 . . . . 72.45 111.477 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.8 t -57.73 -42.15 83.28 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.739 0.65 . . . . 63.15 110.639 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.545 HG23 ' SG ' ' D' ' 76' ' ' CYS . 67.8 mt -61.67 -57.11 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.608 0.763 . . . . 73.01 110.56 174.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.548 HG23 ' HG3' ' D' ' 125' ' ' GLN . 86.4 m -51.67 -44.68 63.15 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.721 1.208 . . . . 75.31 112.061 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.7 t -63.95 -42.59 97.26 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.196 -0.911 . . . . 63.42 109.999 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.9 mtm -69.81 -34.39 73.62 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.999 0.52 . . . . 61.42 111.469 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 114' ' ' ILE . 66.8 t -62.06 -44.89 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.612 0.765 . . . . 52.1 109.934 175.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.1 p -72.73 -30.48 64.21 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.981 0.512 . . . . 62.34 111.089 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -72.07 -29.76 64.45 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.466 0.706 . . . . 74.45 110.455 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.34 10.14 74.35 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.798 0.686 . . . . 51.41 112.556 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.522 HG23 ' HB3' ' C' ' 17' ' ' TYR . 73.0 p 56.85 20.78 5.49 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 126.68 1.992 . . . . 73.23 114.082 177.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.02 150.16 71.26 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 109.067 -0.716 . . . . 75.21 109.067 168.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.9 132.1 47.74 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.471 2.114 . . . . 75.41 111.202 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.548 ' HG3' HG23 ' D' ' 115' ' ' THR . 5.5 tt0 -51.78 127.19 20.1 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 124.464 1.102 . . . . 61.54 112.674 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.19 116.49 28.45 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.04 -1.096 . . . . 75.11 108.04 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -115.65 122.19 44.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.694 0.798 . . . . 72.41 109.524 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.64 HD22 ' HZ ' ' D' ' 107' ' ' PHE . 1.5 tt -74.9 129.71 38.13 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 108.967 -0.753 . . . . 73.43 108.967 173.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.18 157.75 79.91 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.395 1.078 . . . . 31.22 111.974 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.431 ' HB3' ' OH ' ' B' ' 101' ' ' TYR . 87.0 Cg_exo -50.01 107.82 0.18 Allowed 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 123.246 2.631 . . . . 73.32 113.284 172.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 84.0 t -109.59 116.24 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.542 0.737 . . . . 73.2 109.051 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -90.06 105.66 17.95 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.42 -0.585 . . . . 65.52 109.42 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -78.72 -20.18 50.64 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.571 0.748 . . . . 51.4 111.067 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . 0.436 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 6.5 t70 -65.17 -52.38 55.37 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.929 0.892 . . . . 74.12 110.66 -174.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.97 -34.89 76.06 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.288 -0.869 . . . . 71.22 111.034 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 47.3 tp -63.08 -35.26 79.65 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 114.986 -1.006 . . . . 63.4 111.407 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 89.2 t80 . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 123.573 0.749 . . . . 73.54 110.687 175.904 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.301 -0.629 . . . . 64.14 109.301 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.698 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 6.2 t80 -139.03 132.68 30.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.038 0.935 . . . . 73.01 108.62 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -149.98 103.56 3.22 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.528 -0.916 . . . . 72.12 108.528 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.555 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.3 mt -70.36 112.05 4.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.335 -0.987 . . . . 71.5 108.335 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -81.04 -31.14 34.65 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 124.237 0.961 . . . . 71.44 110.277 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -174.36 147.44 1.16 Allowed 'General case' 0 C--N 1.355 0.835 0 O-C-N 123.626 0.579 . . . . 73.52 110.228 -173.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.7 mt -137.02 133.6 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.878 -1.156 . . . . 74.34 107.878 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' HB3' HG23 ' B' ' 122' ' ' THR . 43.2 p90 -168.59 154.39 6.71 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 123.915 0.759 . . . . 72.04 111.412 -174.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -74.57 116.57 15.41 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.011 -0.737 . . . . 70.13 109.011 172.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -78.19 -42.86 30.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.368 -0.604 . . . . 74.11 109.368 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.594 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 7.0 m-20 -136.65 131.91 34.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.934 -1.03 . . . . 73.23 109.235 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.0 mt -128.18 141.06 47.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.09 -1.448 . . . . 73.23 107.09 172.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -152.51 120.78 6.29 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.199 -0.667 . . . . 75.32 109.199 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 87.3 t80 -123.78 130.6 52.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.274 -1.38 . . . . 75.45 107.274 174.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -126.48 153.01 45.68 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.023 -1.102 . . . . 74.54 108.023 172.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.51 79.16 10.6 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.486 -1.301 . . . . 72.43 107.486 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.21 -40.34 77.1 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.332 2.688 . . . . 54.23 112.843 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.563 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 39.0 m-80 -109.22 39.68 2.01 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.28 -0.873 . . . . 72.43 109.767 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.54 -45.55 98.76 Favored Pre-proline 0 CA--C 1.565 1.536 0 C-N-CA 123.939 0.896 . . . . 65.3 113.079 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -71.79 -22.03 24.21 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 121.826 1.684 . . . . 75.13 112.29 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 42.0 m170 -86.91 -24.63 24.76 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.621 0.768 . . . . 64.01 112.333 -174.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.7 p -72.19 -25.21 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.759 0.424 . . . . 72.45 110.409 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.1 -31.78 70.74 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.528 0.731 . . . . 64.04 110.607 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -78.57 -47.75 16.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.101 0.96 . . . . 72.1 110.424 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -83.02 151.53 25.79 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.856 0.862 . . . . 73.23 110.757 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.36 146.04 53.61 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.616 -0.512 . . . . 64.11 109.616 170.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -70.7 85.15 0.65 Allowed 'General case' 0 C--N 1.351 0.662 0 CA-C-O 121.468 0.651 . . . . 73.12 109.752 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.98 78.78 75.77 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 106.451 -1.685 . . . . 74.35 106.451 173.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -89.89 -173.44 0.71 Allowed 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.453 2.102 . . . . 64.25 112.543 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -141.03 108.81 5.65 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.811 -1.551 . . . . 71.34 106.811 167.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 66' ' ' ALA . 22.1 m -96.5 135.81 29.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.317 0.58 . . . . 73.42 111.301 -172.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -120.71 145.47 47.45 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.284 -1.006 . . . . 73.24 108.284 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 tp -124.1 126.16 45.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.201 -0.666 . . . . 71.43 109.201 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.545 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.7 m-20 -113.95 144.1 43.62 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.106 -1.072 . . . . 54.02 108.106 170.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.18 146.65 37.22 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.353 -0.61 . . . . 71.05 109.353 169.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -152.06 147.96 27.11 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.195 0.598 . . . . 72.51 110.007 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 98' ' ' LEU . 80.0 m -118.49 128.95 55.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.276 1.03 . . . . 73.33 109.353 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.55 151.55 51.89 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.411 0.684 . . . . 74.03 109.156 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.0 m -118.09 157.52 26.72 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.326 0.651 . . . . 73.12 109.967 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -149.27 121.09 8.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.736 0.814 . . . . 72.05 109.342 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -84.49 103.2 13.43 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.612 -0.884 . . . . 61.14 108.612 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.15 -34.77 23.97 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.414 -0.812 . . . . 71.32 110.373 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.42 -176.56 5.97 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 124.268 0.98 . . . . 71.13 109.723 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.48 115.15 4.38 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.702 0.626 . . . . 71.13 110.073 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 62.67 26.53 15.7 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.44 1.496 . . . . 73.34 112.78 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -117.79 118.36 58.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-N 114.706 -1.134 . . . . 72.12 108.743 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.599 ' HD2' HD11 ' A' ' 86' ' ' ILE . 23.8 m-85 -125.11 124.97 43.0 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.478 0.711 . . . . 71.2 109.991 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.26 126.44 37.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.277 -1.008 . . . . 73.45 108.277 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.413 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 92.7 t -100.78 130.35 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.33 -1.359 . . . . 74.15 107.33 171.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.1 t -107.56 107.68 23.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 107.874 -1.158 . . . . 63.03 107.874 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.27 99.86 12.02 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.381 -1.34 . . . . 73.33 107.381 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 37.8 ttt180 -85.74 119.61 26.25 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.22 -0.9 . . . . 60.44 109.641 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.5 t -112.13 140.77 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.561 -0.903 . . . . 74.23 108.561 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 17.9 m -130.92 129.31 42.03 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.739 -0.837 . . . . 72.4 108.739 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.53 HG21 HG21 ' A' ' 114' ' ' ILE . 74.2 t -127.84 126.32 66.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.958 -1.497 . . . . 60.43 106.958 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 14.7 t -136.71 145.97 45.32 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.593 -0.891 . . . . 61.51 108.593 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.423 ' HB2' HG12 ' A' ' 40' ' ' VAL . . . -144.07 123.81 13.37 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.548 -0.908 . . . . 72.23 108.548 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 p -127.18 133.67 50.26 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.447 0.699 . . . . 74.44 110.607 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.581 HD13 ' HB2' ' A' ' 73' ' ' ALA . 7.6 mp -86.16 77.19 9.63 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.152 -1.795 . . . . 64.33 106.152 169.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.79 -115.69 4.81 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 114.515 -1.22 . . . . 65.31 111.082 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -87.98 -20.34 25.99 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.908 0.883 . . . . 71.3 110.319 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -80.06 100.98 8.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.754 0.822 . . . . 73.01 109.951 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.9 m -68.06 120.19 13.88 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 110.174 -0.306 . . . . 75.2 110.174 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.581 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -71.68 -55.42 7.74 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.84 -0.8 . . . . 63.41 108.84 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -160.64 165.79 30.03 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 115.524 -0.762 . . . . 73.13 111.708 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.7 tp -141.6 108.07 5.3 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.516 -1.22 . . . . 73.02 108.205 173.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.46 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 58.7 m -107.35 116.68 32.36 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.104 0.962 . . . . 74.2 109.898 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -134.0 126.04 29.41 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.151 -0.685 . . . . 72.41 109.151 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.4 t -133.38 110.28 14.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 124.292 1.037 . . . . 75.4 109.215 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.594 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 19.6 mt-30 -84.64 84.03 7.81 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.086 -1.079 . . . . 55.23 108.086 171.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -79.33 99.92 7.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.345 -1.298 . . . . 73.11 108.685 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.14 157.81 18.39 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 112.073 -0.411 . . . . 65.14 112.073 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.403 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -154.51 131.06 3.05 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 110.849 -0.9 . . . . 72.25 110.849 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -81.12 125.21 39.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.499 -0.926 . . . . 72.21 108.499 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.698 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 30.8 m-85 -131.06 119.95 22.73 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.845 -0.798 . . . . 63.13 108.845 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -91.8 108.63 20.05 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.286 -1.005 . . . . 64.0 108.286 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.599 HD11 ' HD2' ' A' ' 56' ' ' TYR . 2.6 pp -118.65 147.61 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.541 0.737 . . . . 75.34 110.533 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.34 176.92 6.36 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.137 0.975 . . . . 74.34 110.0 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.25 -24.58 21.61 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.854 -0.612 . . . . 53.02 113.583 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -136.39 148.83 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.501 0.72 . . . . 73.05 110.954 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.68 175.01 9.96 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.875 0.87 . . . . 70.21 109.365 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.37 -128.69 13.64 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 123.459 0.552 . . . . 63.13 112.386 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.4 p -68.84 -22.06 64.25 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.261 1.024 . . . . 63.01 111.958 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -68.45 -51.07 47.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.846 0.858 . . . . 74.33 110.68 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.498 ' SD ' HD13 ' A' ' 86' ' ' ILE . 41.5 ttp -78.08 -23.03 48.15 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 116.275 -0.42 . . . . 73.21 110.402 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -37.7 86.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.154 0.582 . . . . 61.34 110.199 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -67.72 -35.15 78.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.544 0.738 . . . . 62.4 110.85 174.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 76.8 m -62.1 -54.07 46.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.756 0.423 . . . . 71.5 110.582 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.402 ' O ' HG21 ' A' ' 46' ' ' THR . 3.7 pp -73.16 -34.5 66.08 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.771 0.428 . . . . 75.24 111.39 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.67 -2.0 56.39 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 114.905 0.722 . . . . 70.3 114.905 -168.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -148.75 -61.75 0.24 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.649 0.724 . . . . 74.3 112.727 -175.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -72.17 -61.91 1.62 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.106 0.963 . . . . 72.33 112.709 -165.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 72.7 m -67.65 -34.96 7.24 Favored Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 114.026 1.121 . . . . 75.43 114.026 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 27.9 Cg_endo -64.64 -31.09 59.97 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 121.769 1.646 . . . . 74.13 113.357 167.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 25.8 t-20 -67.89 -29.92 69.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.097 0.559 . . . . 61.13 110.206 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.15 -42.81 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.845 0.858 . . . . 61.32 110.573 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.403 HD21 ' HA3' ' A' ' 82' ' ' GLY . 42.9 mt -82.16 -20.79 37.2 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.474 1.11 . . . . 72.53 112.575 -173.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.77 -44.77 91.91 Favored Pre-proline 0 CA--C 1.572 1.805 0 C-N-CA 124.033 0.933 . . . . 73.5 113.437 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -64.73 -32.38 57.02 Favored 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 122.36 2.04 . . . . 75.44 113.434 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -70.8 -40.66 72.4 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.144 0.577 . . . . 71.23 110.933 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.37 -38.8 78.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.968 0.507 . . . . 74.41 110.49 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.424 ' HB2' HD11 ' A' ' 128' ' ' LEU . 36.0 ttm180 -51.09 -56.25 13.58 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.088 0.867 . . . . 73.5 109.517 172.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -59.11 -47.74 84.16 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.609 1.164 . . . . 74.21 112.163 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.06 -44.89 87.71 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.999 0.812 . . . . 53.55 110.975 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.53 HG21 HG21 ' A' ' 64' ' ' VAL . 96.6 mt -67.53 -49.05 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.039 0.936 . . . . 71.44 110.586 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.51 HG23 ' HG3' ' A' ' 125' ' ' GLN . 36.3 m -53.25 -40.72 64.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.146 0.978 . . . . 75.41 111.208 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.28 -47.82 66.64 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.989 -1.005 . . . . 73.53 110.018 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 42.5 mtp -60.92 -41.09 95.51 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 124.077 0.951 . . . . 72.01 111.686 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.8 t -65.62 -44.15 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.17 0.988 . . . . 64.04 110.339 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.9 t -68.53 -31.82 71.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.6 0.76 . . . . 64.52 111.313 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -72.69 -29.94 63.82 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.38 0.672 . . . . 70.02 110.075 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.52 2.64 84.99 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 123.69 0.619 . . . . 71.44 112.896 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.3 m 68.0 22.9 8.35 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.768 1.227 . . . . 74.52 111.151 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -91.93 150.88 41.4 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 123.355 0.662 . . . . 70.14 109.222 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.46 139.48 90.8 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.577 2.184 . . . . 71.33 112.575 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.51 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.0 tt0 -57.73 150.04 20.63 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.814 1.246 . . . . 71.43 112.682 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 pp -126.65 137.46 53.29 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.846 -1.168 . . . . 75.02 107.846 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.453 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 86.6 m-20 -135.69 84.05 2.06 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.751 -1.203 . . . . 41.43 107.751 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 111' ' ' ARG . 2.7 pp -65.1 135.62 55.75 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.146 -0.479 . . . . 71.3 110.645 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.17 140.81 98.06 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 123.069 0.548 . . . . 42.23 110.068 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.75 126.92 22.63 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.196 1.931 . . . . 64.32 111.384 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 91.3 t -97.46 113.86 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 106.62 -1.622 . . . . 60.1 106.62 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -75.48 83.93 2.56 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.946 -1.131 . . . . 70.11 107.946 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -60.4 -33.41 72.45 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.108 -0.951 . . . . 74.04 110.589 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.05 -40.46 90.98 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.074 0.95 . . . . 63.12 110.98 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.06 -50.55 61.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.254 0.621 . . . . 75.51 110.259 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.0 mt -64.04 -42.15 97.17 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.22 -0.9 . . . . 63.53 111.573 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -66.49 -41.02 89.56 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.237 -0.892 . . . . 72.45 109.375 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.359 0.994 0 O-C-N 123.897 0.748 . . . . 71.33 109.774 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.638 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 70.6 m . . . . . 0 C--O 1.241 0.637 0 N-CA-C 107.122 -1.436 . . . . 64.52 107.122 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -139.39 141.49 37.55 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.759 0.423 . . . . 75.01 110.252 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -144.67 138.12 27.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.592 0.757 . . . . 71.13 109.906 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.94 126.78 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.048 -1.093 . . . . 73.43 108.048 171.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -95.35 -50.32 5.07 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.699 0.4 . . . . 72.24 110.079 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -161.72 131.07 4.56 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.531 -0.544 . . . . 74.33 109.531 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.2 mt -115.35 131.95 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 107.924 -1.139 . . . . 72.03 107.924 171.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -156.85 138.28 13.92 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.41 0.684 . . . . 71.4 110.144 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.5 m -72.23 121.84 20.04 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.478 -0.934 . . . . 55.42 108.478 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.426 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.8 mtpt -95.33 -23.5 17.17 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.433 0.693 . . . . 71.01 111.042 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -161.69 141.03 9.97 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.399 0.437 . . . . 74.12 110.732 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 33.7 mm -134.23 144.46 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.159 1.384 . . . . 73.3 108.765 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -138.55 139.95 38.87 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.591 -1.186 . . . . 73.21 107.974 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 85.2 t80 -152.58 130.61 11.84 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.637 -1.246 . . . . 74.53 107.637 166.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 49.0 mt-10 -140.45 116.7 10.61 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.645 0.778 . . . . 61.12 108.918 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.674 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -105.29 84.29 1.07 Allowed Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 106.922 -1.51 . . . . 54.0 106.922 165.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.39 -23.83 20.03 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.954 2.436 . . . . 70.32 111.97 -170.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 78.3 m-20 -116.93 6.71 13.07 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 114.433 -1.258 . . . . 75.03 110.368 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.674 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -29.13 -66.05 0.15 Allowed Pre-proline 0 C--N 1.38 1.899 0 C-N-CA 126.163 1.785 . . . . 55.01 114.787 -171.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.8 Cg_exo -64.78 -29.46 59.29 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 122.585 2.19 . . . . 64.43 112.509 -169.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -46.47 14.52 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.364 -0.835 . . . . 72.23 110.752 176.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.597 HG22 HD12 ' B' ' 68' ' ' LEU . 2.7 p -70.31 -17.85 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.147 0.579 . . . . 64.2 111.986 -166.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -69.37 -11.64 60.99 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 112.654 0.613 . . . . 73.35 112.654 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -77.28 -3.42 39.74 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.191 0.596 . . . . 73.0 110.877 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.7 105.35 15.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.907 1.283 . . . . 75.01 110.093 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.93 91.91 7.7 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.842 0.857 . . . . 65.21 109.729 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -161.92 155.57 21.3 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.918 0.887 . . . . 72.4 108.922 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -81.97 102.95 1.78 Allowed Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 107.201 -1.407 . . . . 74.14 107.201 170.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.67 133.35 31.54 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.555 2.17 . . . . 52.45 112.308 -171.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -69.23 129.54 40.11 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 123.855 0.722 . . . . 54.44 110.026 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' B' ' 66' ' ' ALA . 74.9 t -106.13 129.84 58.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.49 1.116 . . . . 74.31 109.968 -171.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -103.98 112.66 25.74 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 105.84 -1.911 . . . . 72.2 105.84 167.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.58 153.23 18.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.921 -1.036 . . . . 71.25 108.784 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.6 t70 -144.59 110.62 5.44 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.022 -0.732 . . . . 75.24 109.022 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -109.04 134.89 51.08 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.14 -1.059 . . . . 74.04 108.14 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -159.54 156.24 27.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.395 0.678 . . . . 75.35 109.377 170.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.6 p -124.82 128.33 48.54 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.352 0.661 . . . . 50.14 109.833 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.5 158.19 21.94 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.738 -1.208 . . . . 74.11 107.738 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.434 ' HB3' HD21 ' B' ' 98' ' ' LEU . 13.3 p -142.27 168.78 18.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.53 0.332 . . . . 60.13 111.107 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 2.1 m -148.53 136.06 20.52 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.424 -0.954 . . . . 53.12 108.424 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -90.36 100.53 13.35 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.416 -0.957 . . . . 63.52 108.416 170.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.21 -33.44 59.26 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.637 -0.71 . . . . 75.43 109.911 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.02 -175.35 3.33 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.147 -0.933 . . . . 72.52 110.696 -177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.28 122.22 16.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.371 -1.286 . . . . 71.02 109.154 173.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 66.62 14.65 9.85 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.926 0.891 . . . . 51.22 112.379 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -118.5 119.78 62.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 123.642 0.777 . . . . 74.11 109.032 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -112.64 152.78 28.56 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.641 0.776 . . . . 72.41 110.172 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 6.8 tm-20 -124.66 97.18 5.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.508 -1.664 . . . . 75.21 106.508 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.401 HG22 ' HG ' ' B' ' 98' ' ' LEU . 90.4 t -86.51 143.99 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.048 -0.978 . . . . 71.34 109.792 -175.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -131.95 112.43 20.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.432 -0.951 . . . . 74.35 108.432 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.439 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -93.64 118.72 31.75 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.465 -1.309 . . . . 70.02 107.465 177.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 69.3 ttt-85 -107.43 110.07 21.94 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.975 0.51 . . . . 74.53 109.719 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.407 ' HB ' HD11 ' B' ' 114' ' ' ILE . 22.8 t -108.11 104.31 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.982 -1.118 . . . . 64.04 107.982 173.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 11.1 m -100.54 137.37 39.04 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.116 -0.698 . . . . 63.51 109.116 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.661 HG21 HG21 ' B' ' 114' ' ' ILE . 50.3 t -123.82 126.49 72.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.982 1.313 . . . . 64.11 108.822 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 52.4 m -125.09 139.01 54.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.476 -1.305 . . . . 72.23 107.476 170.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' B' ' 40' ' ' VAL . . . -146.03 151.6 38.01 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.605 -0.517 . . . . 64.44 109.605 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 27.7 p -149.07 139.57 22.51 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 123.699 0.624 . . . . 60.3 112.132 -174.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.597 HD12 HG22 ' B' ' 31' ' ' VAL . 86.3 mt -106.08 102.22 11.66 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.639 1.176 . . . . 72.24 108.328 172.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.02 -131.5 12.46 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.786 -0.643 . . . . 44.44 112.541 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -86.97 3.81 44.3 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.384 1.073 . . . . 70.2 112.446 -175.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.493 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.9 pt-20 -132.16 155.61 47.89 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.957 0.503 . . . . 71.21 111.095 -175.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.6 m -67.1 137.3 56.26 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.891 0.744 . . . . 74.24 110.85 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.439 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -91.06 -67.29 0.86 Allowed 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.697 -1.223 . . . . 75.35 107.697 173.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -144.3 145.59 32.1 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 121.407 0.622 . . . . 73.1 110.626 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 94.1 mt -117.14 149.46 40.32 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.309 1.444 . . . . 72.53 107.281 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.531 ' SG ' HG23 ' B' ' 114' ' ' ILE . 42.5 t -158.15 158.53 34.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.659 -0.867 . . . . 63.02 108.659 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -165.73 133.54 2.96 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.994 -1.113 . . . . 63.45 107.994 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.468 HG23 HG12 ' B' ' 114' ' ' ILE . 94.2 t -124.88 141.32 45.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.615 -0.883 . . . . 62.44 108.615 174.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -119.63 84.19 2.16 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.3 -1.37 . . . . 63.22 107.3 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.77 99.33 7.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.357 -1.292 . . . . 64.43 109.079 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.426 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -96.0 171.41 28.52 Favored Glycine 0 C--O 1.245 0.788 0 CA-C-N 115.774 -0.648 . . . . 72.25 112.006 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.54 130.88 1.94 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 112.029 -0.429 . . . . 64.13 112.029 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 63.8 mt -83.73 127.29 39.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 108.293 -1.003 . . . . 75.41 108.293 170.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -136.08 143.28 44.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.646 0.778 . . . . 65.31 109.163 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -104.05 125.3 50.29 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.691 0.796 . . . . 72.1 109.014 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.622 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.8 pp -119.23 145.01 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.217 1.007 . . . . 55.42 110.103 -176.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.638 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.04 162.11 41.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.584 0.754 . . . . 75.33 110.119 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.72 -57.13 5.05 Favored Glycine 0 C--N 1.354 1.567 0 O-C-N 123.683 0.614 . . . . 60.24 112.854 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.622 HD11 ' HB ' ' B' ' 86' ' ' ILE . 11.8 pt -58.19 148.39 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.762 1.225 . . . . 74.43 112.178 174.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.514 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 31.2 tt0 -160.84 152.52 19.56 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.999 -1.0 . . . . 74.4 109.843 -175.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.8 -112.76 4.08 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 112.206 -0.358 . . . . 63.32 112.206 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.9 m -92.51 -16.98 25.08 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.895 0.478 . . . . 63.32 111.139 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.514 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 45.6 mt-30 -59.76 -39.22 84.09 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.268 0.627 . . . . 64.4 110.725 175.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.584 ' HA ' HD12 ' B' ' 89' ' ' ILE . 26.2 ptt? -74.71 -25.25 59.01 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.647 -0.706 . . . . 52.04 110.993 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.33 -33.5 71.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.412 0.685 . . . . 64.11 110.466 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -65.4 -39.19 91.89 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.548 0.739 . . . . 73.32 110.685 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.48 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 44.5 t -70.42 -58.06 4.13 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.758 -0.655 . . . . 65.43 110.547 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' B' ' 48' ' ' SER . 7.8 tt -65.13 -43.74 90.91 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.425 0.69 . . . . 65.21 111.38 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.19 -26.03 49.68 Favored Glycine 0 C--N 1.341 0.839 0 O-C-N 123.763 0.664 . . . . 61.1 114.238 -170.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.59 -53.17 1.25 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.215 0.508 . . . . 41.24 112.328 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.48 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 79.7 t80 -71.33 -45.72 62.29 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.565 0.746 . . . . 72.12 112.626 -169.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.533 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 81.0 m -67.82 -49.0 39.93 Favored Pre-proline 0 CA--C 1.565 1.551 0 C-N-CA 123.702 0.801 . . . . 73.13 110.424 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 66.8 Cg_exo -57.07 -30.04 85.36 Favored 'Trans proline' 0 C--N 1.399 3.229 0 C-N-CA 122.844 2.363 . . . . 74.52 113.898 169.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -62.55 -41.54 98.97 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.593 0.757 . . . . 73.3 109.803 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.79 -44.26 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.626 0.77 . . . . 73.21 110.063 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.3 mt -78.92 -15.76 57.9 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.029 0.932 . . . . 70.34 112.583 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -62.21 -51.82 71.34 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 118.102 -0.951 . . . . 72.03 113.348 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.27 -34.97 87.0 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 121.825 1.684 . . . . 74.12 112.515 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -62.73 -50.46 71.02 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.906 0.883 . . . . 75.32 110.911 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.41 97.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.789 0.836 . . . . 71.52 110.631 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -59.2 -54.34 48.03 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.636 1.574 . . . . 74.41 111.131 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.54 -30.66 70.36 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.193 0.597 . . . . 74.13 110.037 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.567 ' SG ' HD11 ' B' ' 21' ' ' ILE . 1.8 t -69.98 -28.42 65.52 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.745 0.418 . . . . 73.52 111.595 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.661 HG21 HG21 ' B' ' 64' ' ' VAL . 45.8 mt -76.03 -54.48 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 109.176 -0.676 . . . . 74.22 109.176 172.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.43 HG21 ' OG ' ' C' ' 119' ' ' SER . 23.5 m -54.2 -33.43 58.2 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.623 1.202 . . . . 71.01 111.568 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 24.8 t -60.42 -54.17 48.81 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 115.24 -0.891 . . . . 62.43 109.589 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.1 mmt -68.94 -35.33 76.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.7 0.8 . . . . 61.21 111.482 -173.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.422 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.3 t -60.63 -46.08 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.0 0.92 . . . . 74.33 109.811 174.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 34.8 t -72.59 -28.86 63.05 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.651 -1.159 . . . . 64.42 111.383 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.2 mtt-85 -68.75 -35.39 77.03 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.524 0.73 . . . . 65.51 109.533 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.71 11.13 57.73 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 124.119 0.887 . . . . 74.32 112.816 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.467 HG23 ' HB3' ' A' ' 17' ' ' TYR . 75.6 p 56.58 24.12 8.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.235 1.814 . . . . 74.13 113.631 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -84.52 154.81 62.55 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 123.326 0.65 . . . . 71.42 110.34 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.35 169.94 5.88 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.955 2.437 . . . . 72.4 113.778 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -63.62 131.18 47.18 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.01 -0.995 . . . . 74.04 112.211 -166.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.2 tp -135.11 111.54 9.81 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.859 0.863 . . . . 75.31 109.043 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -134.2 114.74 13.39 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.345 0.658 . . . . 73.34 109.272 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.27 141.75 55.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.794 0.837 . . . . 72.34 111.086 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.46 144.07 96.06 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.412 0.685 . . . . 75.44 110.365 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -69.32 100.54 0.77 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.405 2.07 . . . . 75.4 111.339 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.48 110.76 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.587 -0.894 . . . . 74.54 108.587 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -78.96 83.92 5.02 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.987 -1.116 . . . . 73.33 107.987 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -52.67 -39.11 61.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.578 1.151 . . . . 61.0 112.871 -172.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.41 -34.59 75.64 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.483 1.113 . . . . 72.03 112.396 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.79 -41.07 60.68 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.43 0.692 . . . . 64.41 110.863 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -70.13 -29.77 66.79 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.467 -0.788 . . . . 74.43 110.072 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 80.9 t80 . . . . . 0 N--CA 1.469 0.525 0 C-N-CA 123.976 0.91 . . . . 73.24 110.469 179.377 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 29.2 m . . . . . 0 C--O 1.236 0.362 0 N-CA-C 106.654 -1.61 . . . . 73.31 106.654 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -104.04 122.33 45.05 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.831 -1.077 . . . . 70.15 109.479 -172.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -137.05 108.12 6.74 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 107.289 -1.374 . . . . 75.02 107.289 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 42.8 mt -67.73 119.17 12.94 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 108.112 -1.07 . . . . 44.33 108.112 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.652 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.7 mm-40 -78.34 -48.88 14.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.791 0.682 . . . . 73.14 109.431 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.453 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 25.2 ttt180 -172.24 138.65 0.98 Allowed 'General case' 0 C--N 1.349 0.58 0 CA-C-N 115.526 -0.761 . . . . 75.01 110.271 -169.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.3 mt -120.78 139.42 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.56 -1.274 . . . . 65.41 107.56 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -172.99 166.68 5.06 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.257 0.551 . . . . 73.1 111.015 -172.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -94.12 124.8 38.36 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.634 -0.712 . . . . 65.25 109.287 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.605 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.0 OUTLIER -81.61 -49.06 10.96 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.985 -1.487 . . . . 44.43 106.985 173.561 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.2 t70 -135.7 132.65 37.17 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.198 -1.819 . . . . 70.41 109.068 -168.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.5 mt -135.17 141.41 42.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.828 -1.545 . . . . 73.24 106.828 173.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.4 t -159.51 150.36 19.51 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.443 0.639 . . . . 73.32 110.597 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -145.71 139.8 26.78 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.336 -1.357 . . . . 74.1 107.336 174.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.84 120.3 12.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.644 0.778 . . . . 73.24 109.476 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.82 87.15 36.49 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 107.047 -1.464 . . . . 74.31 107.047 168.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.61 -38.34 25.28 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.077 2.518 . . . . 71.53 111.828 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -102.24 29.35 5.19 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.19 -1.368 . . . . 62.12 110.069 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.41 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -51.85 -55.6 28.85 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.457 1.103 . . . . 71.2 113.926 -171.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 33.5 Cg_exo -57.67 -44.9 37.27 Favored 'Trans proline' 0 C--N 1.39 2.747 0 CA-C-N 121.714 1.648 . . . . 62.31 112.927 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -69.95 -35.29 74.38 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.718 0.807 . . . . 72.51 112.238 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.751 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.9 p -78.23 -23.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.823 0.449 . . . . 72.52 111.874 -172.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -69.15 -33.27 73.17 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.627 0.251 . . . . 74.14 110.494 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -94.4 38.9 1.09 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.598 0.759 . . . . 73.02 110.374 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.714 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -119.96 141.71 49.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.749 1.22 . . . . 75.41 109.533 174.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.59 99.99 1.38 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.063 -1.088 . . . . 60.41 108.063 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -80.6 115.15 19.96 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.675 0.75 . . . . 75.23 112.548 -171.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -122.2 79.05 43.82 Favored Pre-proline 0 CA--C 1.555 1.137 0 N-CA-C 106.843 -1.54 . . . . 74.0 106.843 162.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.1 128.19 7.21 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.363 2.709 . . . . 65.3 112.946 -172.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -84.82 89.24 7.5 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.435 -1.32 . . . . 70.15 107.435 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.37 99.8 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.017 -1.447 . . . . 55.41 109.168 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.517 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 57.2 tttm -92.75 112.54 24.53 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.723 -0.843 . . . . 73.44 108.723 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.65 125.05 34.15 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.064 -0.717 . . . . 61.23 109.064 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.428 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.9 t70 -121.49 131.06 53.93 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.919 -1.141 . . . . 74.13 107.919 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 45.5 mt -120.6 147.04 45.74 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.827 -1.175 . . . . 74.21 107.827 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 22.8 t70 -157.48 152.77 26.09 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.235 0.614 . . . . 62.5 109.725 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 11.2 m -137.41 128.02 26.84 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.631 0.729 . . . . 72.51 110.045 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.83 161.68 16.66 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.151 -1.386 . . . . 72.24 108.554 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 20.3 p -159.31 151.36 20.87 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.858 0.361 . . . . 43.34 111.165 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 86.4 p -145.14 142.68 29.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.131 0.972 . . . . 64.55 108.747 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -82.87 118.06 23.17 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.426 -0.583 . . . . 71.43 109.426 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.611 HD11 HD12 ' C' ' 83' ' ' ILE . 38.6 mt -92.59 -40.05 10.99 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.609 0.763 . . . . 73.13 109.248 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.5 -175.73 5.49 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.263 1.025 . . . . 74.43 109.348 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.31 108.85 1.71 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.544 -0.753 . . . . 64.11 109.925 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 32.6 m-20 71.8 5.87 5.49 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.55 1.54 . . . . 74.43 112.668 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -103.23 97.78 6.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.964 -1.125 . . . . 70.14 107.964 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -103.43 137.82 41.0 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.46 0.704 . . . . 72.51 110.097 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.525 ' HB2' HD11 ' C' ' 51' ' ' LEU . 22.1 tt0 -81.9 108.99 15.85 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.745 -1.576 . . . . 64.13 106.745 164.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 50.9 t -96.97 137.26 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 108.166 -1.05 . . . . 72.43 108.166 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.447 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 52.1 t -127.4 129.88 70.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.235 -1.024 . . . . 71.34 108.235 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.7 104.5 13.51 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.831 -1.544 . . . . 63.33 106.831 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.554 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 9.2 ttm180 -90.27 120.79 31.71 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.862 -1.063 . . . . 72.43 108.326 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.28 123.93 71.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.836 -1.172 . . . . 72.03 107.836 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 27.0 m -126.03 123.67 38.95 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.612 -0.885 . . . . 54.22 108.612 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.745 HG11 HD21 ' C' ' 126' ' ' LEU . 34.2 t -114.03 120.87 64.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 108.795 -0.817 . . . . 55.32 108.795 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 30.8 m -101.19 143.86 30.76 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.641 0.776 . . . . 75.11 108.967 172.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.67 107.86 6.08 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.12 -1.437 . . . . 74.51 107.12 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.2 m -128.02 131.72 49.16 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.519 -0.549 . . . . 72.43 109.519 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.714 HD13 ' HG2' ' C' ' 34' ' ' LYS . 25.0 mt -85.15 43.18 0.99 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.281 1.832 . . . . 75.13 110.045 -176.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.62 -88.68 0.68 Allowed Glycine 0 C--N 1.343 0.919 0 N-CA-C 110.303 -1.119 . . . . 71.41 110.303 -170.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -118.5 -20.09 8.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.816 0.846 . . . . 71.53 110.746 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -77.48 100.48 6.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.739 0.816 . . . . 74.23 109.143 172.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.7 m -66.85 120.26 13.26 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 118.922 0.783 . . . . 72.41 109.197 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.751 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.67 -52.36 18.3 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 124.095 0.872 . . . . 74.22 108.984 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -166.56 167.4 15.52 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.617 -1.174 . . . . 55.14 110.843 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -133.9 139.43 46.17 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 106.309 -1.737 . . . . 74.23 106.309 171.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.4 t -146.53 117.82 7.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.298 -0.631 . . . . 63.11 109.298 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -125.57 126.55 44.97 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 122.954 0.502 . . . . 73.43 109.909 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -120.46 132.46 70.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.338 -0.986 . . . . 63.34 108.338 167.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.554 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 69.0 mt-30 -106.08 94.66 5.29 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.587 -1.264 . . . . 72.1 107.587 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -84.2 105.73 15.28 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.532 -0.758 . . . . 64.03 109.701 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.605 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -95.64 163.73 23.86 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-O 121.609 0.56 . . . . 74.0 112.858 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.518 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -164.38 126.6 1.53 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.013 -1.235 . . . . 75.11 110.013 -177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 14.0 mm -85.23 128.77 38.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.125 -1.065 . . . . 74.43 108.125 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.11 119.41 20.91 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.392 -0.595 . . . . 75.14 109.392 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -83.95 107.58 16.41 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.162 -1.051 . . . . 72.1 108.162 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.447 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.4 pp -122.45 142.87 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.102 0.961 . . . . 73.24 110.144 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.92 169.53 21.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.628 0.771 . . . . 22.24 110.512 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.89 -44.21 1.52 Allowed Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.104 -0.498 . . . . 51.22 111.944 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.605 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -109.38 149.6 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.114 0.965 . . . . 63.03 109.234 178.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 11.7 pt-20 -143.01 172.59 12.5 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.652 0.263 . . . . 73.3 111.456 -171.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.81 -129.47 48.37 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.201 -0.909 . . . . 73.31 112.486 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -66.86 -19.32 65.71 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.671 0.788 . . . . 62.33 112.08 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -78.31 -35.26 48.0 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.404 0.681 . . . . 61.41 110.421 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.567 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 10.9 tmm? -72.63 -38.53 67.71 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.427 -0.953 . . . . 72.14 108.427 172.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.87 -32.8 71.05 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 115.248 -0.887 . . . . 62.13 110.558 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -77.37 -34.54 55.0 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.374 0.421 . . . . 73.12 110.918 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 15.2 t -63.29 -34.97 78.85 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.005 0.815 . . . . 63.54 109.913 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -99.15 -12.46 20.45 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.99 0.516 . . . . 65.44 111.969 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.29 -31.51 59.2 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 114.562 0.585 . . . . 51.12 114.562 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.9 -38.09 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.797 0.439 . . . . 73.43 111.042 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -56.93 -41.81 78.91 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 125.419 1.488 . . . . 74.54 112.209 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.2 m -82.26 -48.59 0.89 Allowed Pre-proline 0 CA--C 1.569 1.708 0 N-CA-C 112.897 0.703 . . . . 64.33 112.897 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.98 -29.85 28.83 Favored 'Trans proline' 0 C--N 1.392 2.855 0 C-N-CA 123.21 2.607 . . . . 73.04 115.131 172.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.24 -35.41 80.74 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.907 0.883 . . . . 63.35 110.836 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.422 HG23 ' NH1' ' A' ' 111' ' ' ARG . 40.9 mm -64.71 -40.3 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 115.511 -0.768 . . . . 75.13 109.585 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.518 HD21 ' HA3' ' C' ' 82' ' ' GLY . 53.5 mt -83.55 -18.14 39.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.652 1.181 . . . . 71.32 112.14 -175.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -56.75 -51.34 82.16 Favored Pre-proline 0 CA--C 1.56 1.352 0 N-CA-C 114.132 1.16 . . . . 75.41 114.132 -173.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.427 ' HA ' HH11 ' C' ' 111' ' ' ARG . 18.3 Cg_exo -66.15 -32.16 43.58 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 121.607 1.538 . . . . 61.3 112.778 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -65.63 -46.92 77.43 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.542 0.737 . . . . 74.45 110.503 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.04 -42.65 90.73 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.051 0.94 . . . . 73.32 110.679 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.427 HH11 ' HA ' ' C' ' 108' ' ' PRO . 27.6 mtp-105 -57.03 -55.93 28.33 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.333 1.02 . . . . 75.14 111.051 176.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.12 -29.91 70.8 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.139 0.576 . . . . 74.21 110.628 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 10.6 t -74.39 -33.13 62.96 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.265 0.626 . . . . 51.04 111.303 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.409 ' O ' HG23 ' C' ' 118' ' ' VAL . 71.5 mt -72.76 -51.29 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.037 0.535 . . . . 72.44 109.654 173.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 25.8 m -59.99 -32.96 71.33 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.094 0.957 . . . . 75.13 111.349 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.0 t -61.57 -51.51 68.26 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.189 -0.671 . . . . 65.33 109.189 172.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.583 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.69 -35.54 78.3 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.703 1.201 . . . . 65.12 112.914 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.409 HG23 ' O ' ' C' ' 114' ' ' ILE . 98.4 t -66.55 -47.13 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.52 0.728 . . . . 74.01 109.925 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.43 ' OG ' HG21 ' B' ' 115' ' ' THR . 48.4 t -66.18 -32.19 73.47 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.93 -1.032 . . . . 74.1 111.091 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.01 -35.53 74.44 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.73 0.812 . . . . 63.4 109.399 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 4.33 79.46 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.878 0.736 . . . . 74.33 112.873 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 60.0 p 59.38 25.55 14.28 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.509 1.924 . . . . 72.11 114.08 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -87.82 152.87 51.92 Favored Pre-proline 0 CA--C 1.557 1.237 0 N-CA-C 107.567 -1.272 . . . . 63.43 107.567 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.69 -179.81 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.729 2.286 . . . . 73.12 113.739 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -49.66 130.63 21.07 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.664 1.186 . . . . 64.41 112.89 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.745 HD21 HG11 ' C' ' 64' ' ' VAL . 14.3 tp -148.84 85.28 1.48 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.29 -1.004 . . . . 72.3 108.29 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -116.31 129.79 56.45 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.159 -1.052 . . . . 65.12 108.159 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 21.4 tp -76.18 132.69 40.11 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 109.78 -0.452 . . . . 71.43 109.78 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.1 154.91 75.78 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.243 1.017 . . . . 74.32 111.15 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -50.11 101.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.907 2.405 . . . . 72.4 112.867 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 80.8 t -96.55 110.69 25.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.217 -1.031 . . . . 55.1 108.217 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -87.12 86.14 7.27 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.898 -1.149 . . . . 54.13 107.898 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -60.55 -31.4 70.51 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.303 0.641 . . . . 52.11 110.227 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.7 -36.94 79.13 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.336 1.054 . . . . 63.23 112.263 -165.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.45 74.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.98 0.912 . . . . 72.02 111.188 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.29 -23.97 34.92 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.182 -0.917 . . . . 74.41 111.452 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 3.3 t80 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.011 0.434 . . . . 65.21 109.997 173.083 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.6 m . . . . . 0 C--O 1.241 0.618 0 N-CA-C 107.506 -1.294 . . . . 73.52 107.506 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -148.53 110.77 4.64 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.077 -1.453 . . . . 74.35 107.077 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -132.81 141.67 48.59 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.183 -1.043 . . . . 64.43 108.183 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.61 HD11 HD13 ' D' ' 105' ' ' ILE . 19.4 mt -98.45 133.3 41.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.164 -1.05 . . . . 74.44 108.164 171.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -96.96 -45.65 6.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.403 0.681 . . . . 63.22 111.574 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -172.16 120.5 0.43 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 118.008 0.367 . . . . 73.52 111.874 -163.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.505 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -104.96 135.6 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.417 -1.327 . . . . 73.33 107.417 171.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -159.7 167.06 29.24 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.156 0.91 . . . . 60.42 111.205 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . 0.495 HG21 HD11 ' D' ' 21' ' ' ILE . 81.2 p -99.53 117.16 33.31 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.078 -1.419 . . . . 74.22 109.327 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -88.06 -20.05 26.28 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.343 -0.844 . . . . 74.22 109.04 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.3 t70 -159.0 132.69 7.44 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.515 -1.22 . . . . 72.41 109.185 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.583 HD13 ' HE3' ' C' ' 117' ' ' MET . 79.7 mt -134.66 144.26 35.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 124.931 1.292 . . . . 51.53 107.553 174.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -147.46 136.6 22.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.337 1.055 . . . . 63.34 108.579 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.493 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.5 t80 -148.98 126.92 11.9 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.281 -1.748 . . . . 72.44 106.281 170.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -134.51 128.63 33.75 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.854 0.862 . . . . 74.15 109.372 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.67 81.27 60.91 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 107.881 -1.155 . . . . 64.3 107.881 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.92 -23.48 10.71 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.989 2.46 . . . . 35.42 113.604 -172.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -108.4 11.34 27.11 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.346 0.658 . . . . 61.03 109.966 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -36.85 -67.84 0.23 Allowed Pre-proline 0 CA--C 1.564 1.516 0 C-N-CA 126.371 1.868 . . . . 65.11 115.794 -161.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.01 -19.18 16.03 Favored 'Trans proline' 0 C--N 1.38 2.196 0 CA-C-N 123.124 2.151 . . . . 75.53 113.839 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -73.04 -43.06 62.48 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.917 0.887 . . . . 74.23 109.68 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.6 p -82.92 -16.12 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 CA-C-N 115.708 -0.678 . . . . 54.22 111.045 -172.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -68.4 -22.9 64.6 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.23 0.456 . . . . 71.24 112.23 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -65.94 -12.64 56.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.646 0.779 . . . . 71.42 110.744 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -98.44 92.91 5.89 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.396 1.078 . . . . 51.14 108.702 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -82.56 74.93 9.49 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.485 0.659 . . . . 63.13 109.697 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -137.43 156.23 48.41 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.129 -1.063 . . . . 73.44 108.129 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.434 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 1.8 mp0 -76.65 109.23 8.12 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.016 0.927 . . . . 63.14 108.921 174.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 21.6 Cg_exo -65.73 123.35 11.25 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 123.375 2.717 . . . . 41.11 113.432 -168.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -62.38 115.34 4.12 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.315 -0.624 . . . . 51.53 109.315 173.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.522 HG21 HG13 ' D' ' 64' ' ' VAL . 7.2 p -122.2 145.2 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.895 -1.048 . . . . 74.23 110.77 -170.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -117.26 147.9 42.13 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.978 0.911 . . . . 74.52 108.75 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.526 HD21 HG13 ' D' ' 62' ' ' VAL . 6.0 tt -121.34 125.61 47.43 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.339 -0.985 . . . . 74.54 108.339 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.612 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 29.3 t70 -108.11 137.49 46.01 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.941 0.896 . . . . 61.32 109.237 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 tp -113.14 140.45 47.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.651 0.78 . . . . 64.53 110.643 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.9 t70 -148.2 131.11 16.16 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.233 -1.395 . . . . 65.44 107.233 165.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.1 t -106.99 153.82 22.01 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.464 -0.939 . . . . 72.21 108.464 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.654 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.03 164.55 35.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.493 -0.929 . . . . 63.1 108.493 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 18.5 p -169.74 154.54 5.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.561 0.744 . . . . 75.1 109.806 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -154.22 142.61 20.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.784 0.834 . . . . 63.13 109.574 -166.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.11 118.66 28.99 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.644 -0.502 . . . . 75.3 109.644 175.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' D' ' 57' ' ' GLU . 49.6 mt -94.54 -42.02 9.04 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.351 0.66 . . . . 62.42 110.037 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.0 -174.75 4.89 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 124.013 0.925 . . . . 64.35 110.236 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -63.7 109.16 1.61 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.707 -1.133 . . . . 72.55 110.071 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 60.96 23.6 13.72 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.19 0.996 . . . . 55.24 111.906 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.52 121.79 67.9 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 124.758 1.223 . . . . 64.41 108.193 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -135.89 132.36 36.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.708 0.803 . . . . 65.05 109.311 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.537 ' HB2' HD11 ' D' ' 51' ' ' LEU . 30.4 tt0 -86.15 148.81 25.51 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 124.431 1.082 . . . . 53.04 108.98 169.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.2 t -125.96 124.77 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 107.653 -1.24 . . . . 75.33 107.653 168.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.4 t -99.64 128.29 51.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.26 -1.015 . . . . 70.35 108.26 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.54 115.58 30.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.502 -0.925 . . . . 74.44 108.502 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 45.9 ttm-85 -96.61 100.72 12.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.803 -1.184 . . . . 54.55 107.803 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.526 HG13 HD21 ' D' ' 42' ' ' LEU . 75.9 t -100.67 126.0 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.561 -0.903 . . . . 73.52 108.561 170.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 46.9 m -114.48 139.9 49.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.867 -0.79 . . . . 73.12 108.867 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.522 HG13 HG21 ' D' ' 40' ' ' VAL . 70.9 t -131.98 115.17 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.846 1.258 . . . . 75.04 108.213 -176.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 50.0 m -125.03 99.02 5.93 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.992 0.917 . . . . 75.23 109.227 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -101.59 158.84 15.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.669 0.787 . . . . 71.11 111.27 -175.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 50.8 p -149.92 133.31 16.51 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.669 -0.696 . . . . 65.34 111.548 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 34.9 mt -107.76 107.98 18.98 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.22 -1.4 . . . . 72.1 107.22 170.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.11 -133.3 12.35 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.934 -0.467 . . . . 72.4 111.934 -173.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -98.22 4.59 48.87 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.459 0.704 . . . . 72.31 111.401 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -120.23 165.23 15.09 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.922 0.489 . . . . 74.31 110.435 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -61.64 131.0 48.57 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.198 -0.91 . . . . 70.04 111.449 175.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.451 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.49 -74.88 0.43 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.732 -1.21 . . . . 72.53 107.732 166.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . 0.48 ' HZ ' HD12 ' D' ' 126' ' ' LEU . 48.9 p90 -139.7 138.98 36.45 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.118 0.485 . . . . 73.31 109.875 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 83.3 mt -110.43 144.0 39.88 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.601 1.16 . . . . 61.44 108.159 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.607 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.2 t -159.05 146.61 17.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.848 0.459 . . . . 44.51 110.409 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -155.62 134.72 12.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.577 0.751 . . . . 72.14 108.984 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 89.5 t -133.31 121.57 42.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.892 -0.781 . . . . 63.03 108.892 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.9 mt-30 -88.11 83.25 7.01 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.812 -1.181 . . . . 71.3 107.812 167.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -79.52 93.44 5.43 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.702 -1.59 . . . . 71.11 108.663 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -84.3 157.32 33.14 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.624 -0.716 . . . . 73.44 112.059 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.474 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -152.47 130.06 2.95 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.198 -0.761 . . . . 63.41 111.198 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.461 HG23 HD12 ' D' ' 51' ' ' LEU . 61.1 mt -89.84 128.74 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 123.883 0.873 . . . . 63.52 108.646 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -126.8 152.46 46.91 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.211 1.005 . . . . 75.23 109.388 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 52.3 m -115.39 107.81 15.7 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.167 0.987 . . . . 73.33 108.423 170.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 28.5 pt -125.24 116.88 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.533 0.733 . . . . 75.44 109.444 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.07 136.39 38.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.54 0.736 . . . . 74.23 110.459 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.09 -19.82 13.26 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 115.47 0.948 . . . . 72.31 115.47 172.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.532 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -125.51 150.5 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 117.659 0.729 . . . . 72.34 110.979 -171.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.427 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 0.0 OUTLIER -151.57 166.09 32.27 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.237 0.458 . . . . 75.14 112.237 -172.2 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.48 -116.81 8.25 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 114.693 -1.139 . . . . 52.43 114.677 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.4 p -64.4 -47.43 79.22 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.96 0.904 . . . . 75.35 111.981 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -74.22 -24.08 59.28 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 116.306 -0.406 . . . . 54.01 111.014 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.427 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 0.8 OUTLIER -65.63 -49.2 69.58 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.695 -0.483 . . . . 73.11 109.695 174.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.96 -37.16 86.4 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.689 0.796 . . . . 53.25 110.861 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -65.91 -30.3 70.87 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.838 0.855 . . . . 74.52 111.392 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -82.57 -51.9 7.34 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.342 -0.39 . . . . 74.31 110.544 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 tp -80.09 -31.13 39.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.798 0.439 . . . . 60.12 111.76 -168.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.04 13.96 55.81 Favored Glycine 0 N--CA 1.473 1.142 0 CA-C-N 115.982 -0.554 . . . . 61.13 113.362 -174.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -148.64 -63.67 0.24 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.812 0.445 . . . . 72.14 110.927 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -73.86 -43.0 59.97 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.242 0.617 . . . . 71.03 112.2 -172.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 97.3 m -63.55 -49.74 76.27 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 118.343 -0.836 . . . . 54.34 111.758 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.09 -20.74 43.68 Favored 'Trans proline' 0 C--N 1.399 3.213 0 C-N-CA 121.811 1.674 . . . . 44.32 113.131 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -71.18 -30.83 66.89 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.974 0.51 . . . . 61.02 110.769 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.61 HD13 HD11 ' D' ' 13' ' ' ILE . 63.7 mt -67.54 -39.27 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.943 0.897 . . . . 74.45 110.074 171.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.474 HD21 ' HA3' ' D' ' 82' ' ' GLY . 85.6 mt -77.19 -19.68 56.42 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.07 -0.968 . . . . 74.31 111.917 -175.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -70.38 -41.09 12.77 Favored Pre-proline 0 CA--C 1.563 1.449 0 N-CA-C 113.936 1.088 . . . . 61.24 113.936 -171.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.82 -40.96 82.54 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.192 1.928 . . . . 74.02 113.0 169.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -70.61 -35.49 73.01 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.742 0.817 . . . . 75.31 111.831 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -52.92 55.51 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.504 -0.554 . . . . 72.53 109.504 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 30.8 ttp-105 -52.27 -49.22 64.53 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.517 1.136 . . . . 64.01 111.098 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.79 -44.55 77.11 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.994 0.809 . . . . 63.33 111.252 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.95 -44.34 78.36 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.328 0.585 . . . . 62.05 110.636 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.607 HG12 ' SG ' ' D' ' 76' ' ' CYS . 78.3 mt -68.15 -51.37 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.582 -1.19 . . . . 72.33 110.959 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 52.7 m -51.56 -45.54 63.09 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.491 1.116 . . . . 70.42 111.174 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.7 t -62.26 -44.11 97.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.837 -1.074 . . . . 63.11 109.754 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.412 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 78.1 mtm -68.92 -31.38 70.25 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.222 0.609 . . . . 74.52 112.264 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' D' ' 114' ' ' ILE . 67.6 t -72.07 -38.83 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.85 0.86 . . . . 72.51 109.982 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.6 p -75.65 -29.49 59.14 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.112 0.565 . . . . 74.23 110.676 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -72.73 -34.91 67.38 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.697 0.799 . . . . 54.21 109.502 173.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 -1.71 88.0 Favored Glycine 0 C--N 1.356 1.688 0 CA-C-N 115.594 -0.73 . . . . 44.22 111.934 172.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p 64.84 19.3 11.8 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 127.219 2.207 . . . . 73.01 114.039 170.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -78.97 152.98 77.5 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.163 0.585 . . . . 75.25 109.429 170.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.52 126.1 17.08 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.117 2.545 . . . . 74.52 112.756 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -60.43 120.33 9.71 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 123.804 0.842 . . . . 53.13 110.981 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.48 HD12 ' HZ ' ' D' ' 74' ' ' PHE . 80.7 mt -117.58 108.56 15.61 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.482 -0.933 . . . . 73.02 108.482 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.6 95.43 6.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.859 -1.163 . . . . 72.54 107.859 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.497 ' HG ' HD12 ' D' ' 42' ' ' LEU . 3.2 mm? -63.82 125.92 25.93 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.182 -0.917 . . . . 72.55 110.044 -175.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.6 139.86 58.82 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 124.072 0.857 . . . . 53.13 111.11 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.33 137.34 55.45 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.225 1.95 . . . . 73.42 110.923 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 67.0 t -106.17 110.85 32.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.4 -0.963 . . . . 63.43 108.4 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -72.76 88.81 1.32 Allowed 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.569 -0.9 . . . . 64.11 108.569 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -61.95 -31.23 71.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.773 -1.103 . . . . 72.03 110.86 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . 0.4 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 3.9 t70 -55.83 -50.25 71.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.143 1.377 . . . . 73.42 112.169 -173.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.36 -45.48 83.94 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.477 -0.783 . . . . 62.11 111.956 -174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -22.98 56.33 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.921 -0.581 . . . . 73.01 110.485 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 N--CA 1.479 1.011 0 C-N-CA 123.841 0.856 . . . . 72.43 111.004 178.541 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.6 m . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 108.959 -0.756 . . . . 52.4 108.959 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -136.86 130.06 31.18 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.166 0.986 . . . . 63.34 108.544 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -146.62 135.21 22.09 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.667 -0.864 . . . . 72.44 108.667 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.466 ' CD1' HG21 ' A' ' 105' ' ' ILE . 13.0 mt -91.05 119.02 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.726 -0.842 . . . . 62.14 108.726 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -81.82 -40.65 22.22 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 123.525 0.516 . . . . 61.22 110.299 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -170.02 131.38 1.02 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.576 -0.283 . . . . 75.04 110.604 -169.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.455 HD12 ' HG3' ' C' ' 130' ' ' PRO . 87.8 mt -121.32 132.88 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.728 -0.841 . . . . 74.11 108.728 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.504 ' HB3' HG23 ' B' ' 122' ' ' THR . 34.5 p90 -166.14 151.87 8.78 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.922 0.764 . . . . 64.13 110.812 -175.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -80.25 106.88 12.6 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.732 -1.122 . . . . 60.24 109.027 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -73.06 -28.59 62.4 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.223 -0.444 . . . . 52.34 110.395 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -148.57 140.06 23.48 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.065 -0.97 . . . . 41.42 109.226 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.13 142.81 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 107.537 -1.283 . . . . 71.54 107.537 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -143.13 147.86 35.65 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.115 0.483 . . . . 74.0 109.73 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 83.4 t80 -150.07 114.51 5.21 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.032 -1.469 . . . . 64.23 107.032 174.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -124.34 110.36 14.48 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.838 -0.43 . . . . 52.12 109.838 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.44 84.81 19.12 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 124.052 0.941 . . . . 64.52 108.559 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.49 -32.38 12.34 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.513 2.142 . . . . 75.51 110.826 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 85.3 m-20 -102.62 28.87 5.68 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.604 1.162 . . . . 70.11 109.812 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.429 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.3 -46.34 99.09 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.529 0.731 . . . . 53.3 111.999 173.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -83.95 5.63 6.23 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.049 1.833 . . . . 31.03 112.756 172.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 54.7 m170 -104.47 -17.5 14.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.335 0.654 . . . . 72.44 111.903 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 28' ' ' ALA . 11.3 p -71.04 -31.07 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.47 0.544 . . . . 71.53 112.47 -170.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -80.15 -33.03 38.82 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.39 0.276 . . . . 73.12 110.813 -172.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -76.92 -24.36 52.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.939 -0.573 . . . . 74.32 110.167 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -83.53 151.61 25.32 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.758 0.823 . . . . 71.15 110.536 171.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.03 140.25 40.29 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.727 -0.842 . . . . 74.52 108.727 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -79.31 95.6 5.74 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.181 0.515 . . . . 71.53 111.083 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -126.92 83.81 64.86 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.41 1.084 . . . . 75.13 109.112 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.32 139.93 29.76 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.421 2.081 . . . . 74.21 112.726 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -106.82 100.52 10.02 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.252 -1.388 . . . . 71.43 107.252 172.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.8 m -76.26 101.25 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 CA-C-O 122.113 0.959 . . . . 72.13 111.432 -174.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -110.4 114.11 27.3 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.328 -1.36 . . . . 71.54 107.328 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 tp -120.43 136.84 54.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.085 0.554 . . . . 74.12 110.677 -172.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.583 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.1 m-20 -121.22 140.07 52.53 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.961 1.304 . . . . 52.14 108.22 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.555 HD21 ' HE1' ' A' ' 133' ' ' PHE . 7.7 tt -142.47 120.3 11.95 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.643 -0.873 . . . . 73.41 108.643 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -136.45 145.68 45.48 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.841 0.856 . . . . 74.11 110.243 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 m -113.19 135.07 54.22 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.291 1.036 . . . . 44.41 108.71 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.77 132.25 45.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.556 0.742 . . . . 54.32 109.433 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.4 m -90.99 152.49 20.67 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.597 0.759 . . . . 74.21 111.225 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 42.1 t -154.45 131.55 11.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.848 0.859 . . . . 71.02 109.329 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -112.18 111.92 23.15 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.748 -0.834 . . . . 74.53 108.748 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.5 mt -86.89 -39.68 15.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.257 0.623 . . . . 60.42 110.389 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.23 -174.99 4.33 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.008 0.923 . . . . 73.1 109.656 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.63 104.75 0.3 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.769 0.827 . . . . 72.21 109.744 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 66.54 9.75 6.82 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.125 1.37 . . . . 75.43 112.639 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.34 101.69 12.44 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 105.35 -2.093 . . . . 63.33 105.35 168.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -116.79 151.21 36.96 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.503 -1.226 . . . . 74.14 109.081 -164.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 43.7 tt0 -132.78 138.63 47.21 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.275 0.63 . . . . 63.33 110.031 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.6 t -119.85 130.98 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.106 -1.072 . . . . 70.03 108.106 171.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.4 t -115.69 109.6 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.134 0.973 . . . . 54.04 108.604 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.0 tp -89.2 101.42 14.08 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.055 -0.72 . . . . 63.03 109.055 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 ttp85 -85.4 107.51 17.41 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.051 -0.722 . . . . 75.43 109.051 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.426 HG13 HD11 ' A' ' 114' ' ' ILE . 3.1 p -113.52 121.87 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 108.93 -0.767 . . . . 72.13 108.93 176.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.6 m -116.49 135.45 53.82 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.586 0.754 . . . . 74.5 109.407 -177.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 126' ' ' LEU . 64.8 t -124.61 132.99 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 124.38 1.072 . . . . 70.24 108.634 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.3 m -131.21 120.55 23.43 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.049 -0.723 . . . . 75.02 109.049 173.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.41 122.52 44.02 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.677 -0.86 . . . . 75.33 108.677 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 t -130.18 146.72 51.83 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.916 0.886 . . . . 72.43 110.228 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.4 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -101.58 87.15 3.1 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 107.123 -1.436 . . . . 63.4 107.123 167.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.73 -105.09 3.23 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 114.835 -1.075 . . . . 41.14 110.518 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.54 -20.61 11.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.805 0.842 . . . . 74.55 110.616 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.05 104.89 9.99 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.831 0.853 . . . . 70.22 109.271 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.3 m -71.31 121.2 18.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.157 0.583 . . . . 72.34 110.732 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.01 -53.51 20.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.783 0.833 . . . . 53.53 109.38 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -150.22 158.08 43.77 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.502 -1.226 . . . . 75.12 111.618 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 64' ' ' VAL . 66.9 tp -125.57 140.89 52.36 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.371 1.468 . . . . 70.11 107.282 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.4 m -142.34 113.29 7.5 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.378 0.671 . . . . 73.01 109.585 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -127.05 120.52 29.18 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.272 -0.64 . . . . 65.14 109.272 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.4 t -127.63 110.64 22.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 123.665 0.786 . . . . 74.24 109.348 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -85.05 81.4 8.89 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.73 -1.211 . . . . 75.52 107.73 171.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -76.88 94.96 3.99 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.074 -0.967 . . . . 74.33 108.633 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.06 151.08 21.36 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 115.376 -0.829 . . . . 74.34 111.589 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.97 128.5 2.8 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.139 -0.784 . . . . 71.22 111.139 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -81.15 115.82 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.789 -0.819 . . . . 62.12 108.789 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -114.8 118.7 34.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.048 0.939 . . . . 74.32 109.586 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.9 m -85.36 103.7 14.51 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.63 -0.878 . . . . 72.22 108.63 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.9 pp -116.04 153.91 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.12 0.568 . . . . 61.14 110.812 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.55 149.98 5.89 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.615 1.166 . . . . 72.4 109.429 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.23 -26.75 23.45 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 122.856 0.265 . . . . 43.23 113.715 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.591 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.92 138.85 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.502 0.721 . . . . 72.24 110.321 -176.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 10.6 tt0 -152.59 174.4 14.0 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.89 0.476 . . . . 75.31 109.857 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.416 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 66.83 -127.7 28.33 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 116.344 -0.389 . . . . 63.25 112.248 -174.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -72.5 -21.07 61.25 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.464 0.706 . . . . 73.12 111.313 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -70.77 -45.26 65.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.503 0.721 . . . . 71.03 110.851 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.523 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 23.3 ttt -71.95 -37.34 69.99 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.347 -0.388 . . . . 71.32 110.013 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.88 72.19 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.346 0.404 . . . . 65.44 110.587 174.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 59.3 t-80 -71.74 -33.74 68.96 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.381 0.672 . . . . 73.32 110.706 173.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -66.55 -61.81 1.79 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 110.047 -0.353 . . . . 61.21 110.047 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.462 HD23 ' HG2' ' A' ' 94' ' ' MET . 4.2 pp -74.13 -24.62 59.45 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.449 0.7 . . . . 71.02 112.547 -174.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.44 1.08 37.14 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-O 119.538 -0.59 . . . . 65.2 114.28 -173.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -141.36 -65.34 0.43 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 117.533 0.667 . . . . 65.14 111.052 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 105' ' ' ILE . 48.3 t80 -66.63 -46.49 75.63 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 112.797 0.666 . . . . 62.24 112.797 -171.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -68.66 -47.37 34.07 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 124.064 0.945 . . . . 73.53 112.723 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.51 -26.8 69.97 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 121.823 1.682 . . . . 62.03 112.185 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -65.91 -37.83 87.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.158 0.583 . . . . 63.22 110.937 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.466 HG21 ' CD1' ' A' ' 13' ' ' ILE . 47.2 mm -66.34 -45.67 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.301 0.641 . . . . 72.14 110.046 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.6 mt -73.89 -23.37 59.56 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.381 -0.827 . . . . 73.34 111.918 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -60.69 -49.14 91.02 Favored Pre-proline 0 CA--C 1.563 1.451 0 N-CA-C 113.968 1.099 . . . . 50.05 113.968 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -63.11 -34.83 67.96 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.11 1.874 . . . . 62.25 112.841 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -67.52 -40.23 85.11 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.126 0.57 . . . . 75.54 110.872 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.42 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -69.77 -36.21 75.56 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.401 0.681 . . . . 65.33 110.79 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.606 ' HA ' HD21 ' A' ' 128' ' ' LEU . 38.1 ttm180 -57.15 -53.82 53.72 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 124.031 0.832 . . . . 71.4 109.715 176.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -57.76 -48.02 80.84 Favored 'General case' 0 C--N 1.348 0.531 0 O-C-N 124.563 1.164 . . . . 75.12 111.229 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 117' ' ' MET . 24.0 t -53.29 -47.84 68.87 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.334 1.021 . . . . 75.42 110.462 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.426 HD11 HG13 ' A' ' 62' ' ' VAL . 93.6 mt -68.55 -38.42 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.327 1.051 . . . . 63.32 111.176 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.2 m -64.34 -34.23 77.68 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.263 0.554 . . . . 75.43 110.115 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 t -74.24 -36.93 63.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.881 -0.599 . . . . 71.41 109.701 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 74.6 mmm -60.36 -46.98 88.03 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.98 0.512 . . . . 75.11 110.739 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.0 m -69.41 -39.68 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.571 -0.74 . . . . 74.22 110.826 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.8 m -67.23 -34.59 77.79 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.867 0.467 . . . . 73.31 111.639 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.542 HH12 ' HG3' ' B' ' 112' ' ' GLU . 86.8 mtt-85 -74.34 -28.92 61.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.225 0.61 . . . . 71.11 110.191 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.88 -4.74 88.49 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 123.758 0.661 . . . . 31.22 113.183 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.4 m 65.92 41.14 3.86 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 123.586 1.66 . . . . 73.32 111.132 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.89 151.61 43.62 Favored Pre-proline 0 C--O 1.244 0.772 0 CA-C-N 113.917 -1.492 . . . . 74.34 108.514 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -53.06 142.33 54.53 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.897 2.398 . . . . 55.13 112.697 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.06 145.88 24.39 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.987 0.804 . . . . 73.4 112.124 -177.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.476 ' CD2' HG11 ' A' ' 64' ' ' VAL . 18.4 tp -128.4 115.99 19.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.727 -1.124 . . . . 72.5 110.391 -175.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -120.8 89.29 3.1 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.248 -1.019 . . . . 63.44 108.248 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.703 ' H ' HD23 ' A' ' 128' ' ' LEU . 1.0 OUTLIER -64.38 129.58 40.47 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 116.057 -0.519 . . . . 73.23 109.779 176.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.82 144.65 85.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.494 1.118 . . . . 54.32 112.077 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -65.63 113.09 2.37 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.366 2.044 . . . . 71.43 110.844 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.05 127.56 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.595 -0.891 . . . . 72.23 108.595 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.44 HD21 ' HB3' ' A' ' 134' ' ' ASP . 0.2 OUTLIER -80.44 89.87 5.62 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.582 -0.735 . . . . 71.31 109.387 -172.212 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.555 ' HE1' HD21 ' A' ' 44' ' ' LEU . 97.3 m-85 -60.25 -37.43 80.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.147 0.979 . . . . 61.44 111.762 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.44 ' HB3' HD21 ' A' ' 132' ' ' ASN . 20.1 t70 -56.24 -51.14 69.18 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.975 0.797 . . . . 71.4 110.317 176.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.45 97.65 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 124.345 1.028 . . . . 71.43 111.28 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -57.53 -45.66 84.76 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.914 0.759 . . . . 72.31 111.215 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -67.69 -37.9 82.94 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.802 -0.635 . . . . 73.05 110.025 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.5 mmt . . . . . 0 N--CA 1.477 0.911 0 O-C-N 123.973 0.795 . . . . 73.31 111.763 -178.7 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 99.2 m . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 108.262 -1.014 . . . . 74.24 108.262 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -136.06 127.54 28.63 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.195 -1.039 . . . . 64.13 108.195 169.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -147.24 134.11 20.16 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.117 -0.697 . . . . 75.01 109.117 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.55 HD11 HD13 ' B' ' 105' ' ' ILE . 26.9 mt -86.84 122.03 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.439 -0.948 . . . . 54.05 108.439 172.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -95.23 -30.6 13.91 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.127 0.571 . . . . 73.14 110.177 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -172.72 138.05 0.82 Allowed 'General case' 0 C--N 1.353 0.725 0 O-C-N 123.642 0.589 . . . . 72.33 110.124 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.406 HD11 HD13 ' B' ' 13' ' ' ILE . 89.0 mt -118.74 137.66 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 106.922 -1.51 . . . . 70.14 106.922 171.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.449 ' HE1' HG13 ' B' ' 83' ' ' ILE . 10.8 p90 -167.17 143.61 4.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.249 0.547 . . . . 74.04 112.376 -173.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.4 m -73.56 125.64 28.44 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.134 -0.939 . . . . 53.13 108.73 169.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.404 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 47.9 mtpt -97.52 -31.74 12.17 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.698 0.799 . . . . 75.2 110.698 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 21.1 t70 -155.72 143.2 19.47 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.45 -0.341 . . . . 71.14 111.025 -174.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.479 HD11 ' SG ' ' B' ' 113' ' ' CYS . 42.6 mm -139.54 143.3 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.988 1.315 . . . . 72.22 109.007 177.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.1 t -142.45 120.8 12.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.83 -1.077 . . . . 73.45 108.452 167.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -121.24 124.26 44.22 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.479 -1.304 . . . . 73.4 107.479 168.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.638 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 34.3 mt-10 -128.61 117.33 21.04 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.532 1.133 . . . . 54.34 108.381 -174.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -108.18 86.57 3.35 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 108.002 -1.11 . . . . 75.45 108.002 171.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -65.11 -47.88 4.19 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.057 2.504 . . . . 72.23 113.17 -167.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -107.34 28.19 8.34 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.035 0.934 . . . . 73.22 109.764 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.506 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -39.44 -63.15 0.68 Allowed Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 114.985 1.476 . . . . 72.04 114.985 -163.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 12.1 Cg_exo -68.45 -24.24 36.74 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.137 1.891 . . . . 65.15 112.896 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -92.69 -28.04 16.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.756 0.822 . . . . 74.12 112.555 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' B' ' 73' ' ' ALA . 13.4 p -81.95 -18.96 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 120.69 0.281 . . . . 73.44 111.472 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -64.89 -17.27 64.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 113.164 0.802 . . . . 75.1 113.164 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -66.93 -21.17 65.99 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.206 0.602 . . . . 71.13 111.385 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.491 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 86.1 mttt -94.05 107.38 19.3 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.813 0.845 . . . . 74.32 109.177 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -87.21 86.06 7.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.954 0.501 . . . . 74.02 110.566 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -164.64 158.11 17.55 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.902 0.881 . . . . 72.02 109.161 173.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.22 109.23 5.89 Favored Pre-proline 0 C--N 1.354 0.792 0 N-CA-C 109.087 -0.709 . . . . 75.3 109.087 169.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.639 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 13.1 Cg_endo -56.34 146.61 72.05 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.017 2.478 . . . . 52.43 111.842 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -61.32 102.51 0.23 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 123.826 0.704 . . . . 71.53 109.181 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.418 HG23 ' O ' ' B' ' 38' ' ' PRO . 85.1 t -92.81 120.31 41.94 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 115.607 -0.724 . . . . 60.12 109.576 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -121.08 119.19 31.73 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.904 -1.517 . . . . 64.4 106.904 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 pp -93.96 160.56 14.67 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.251 0.548 . . . . 61.41 111.065 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.704 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 3.2 m-20 -123.67 129.57 51.32 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.773 -1.195 . . . . 64.43 107.773 173.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 tt -100.38 128.62 46.4 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.36 -1.348 . . . . 71.22 107.36 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -145.93 121.43 10.38 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.496 0.718 . . . . 34.12 109.689 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 43.3 p -120.65 122.79 41.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.62 0.368 . . . . 73.45 110.255 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.78 154.77 33.72 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.523 1.129 . . . . 72.13 108.327 172.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.3 p -144.77 168.06 21.11 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.909 0.385 . . . . 73.43 111.061 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.2 p -153.47 169.91 22.02 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.354 1.061 . . . . 61.3 109.337 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -114.26 136.35 53.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.706 0.802 . . . . 73.11 110.339 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 86.4 mt -99.41 -39.22 8.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.281 0.633 . . . . 63.33 110.727 174.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.54 -177.09 5.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.637 0.775 . . . . 75.14 110.287 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -68.95 123.64 21.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.409 -0.814 . . . . 71.31 109.126 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 69.8 9.62 7.22 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.569 1.147 . . . . 75.21 112.161 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.7 t -124.34 110.72 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 107.862 -1.162 . . . . 54.51 107.862 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.44 ' CD2' HD13 ' B' ' 98' ' ' LEU . 5.8 t80 -125.28 154.13 42.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.769 -0.826 . . . . 75.33 108.769 -177.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -130.62 110.02 11.08 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.439 -0.949 . . . . 74.21 108.439 -168.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.48 145.26 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.961 0.904 . . . . 72.4 109.948 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.8 t -128.4 114.73 35.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 121.37 0.605 . . . . 72.22 109.537 176.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -94.15 111.51 23.24 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.578 -1.268 . . . . 75.23 107.578 176.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -105.31 129.72 53.59 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.274 0.559 . . . . 75.23 109.868 171.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.426 ' HB ' HD11 ' B' ' 114' ' ' ILE . 21.2 t -124.32 119.78 57.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.831 -1.174 . . . . 74.22 107.831 174.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.704 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 95.5 m -98.18 148.87 23.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.274 -1.01 . . . . 40.31 108.274 175.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.704 HG21 HG21 ' B' ' 114' ' ' ILE . 42.7 t -134.67 125.6 46.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.55 1.14 . . . . 65.43 108.284 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 99.5 m -123.97 139.69 53.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.589 -0.893 . . . . 52.44 108.589 172.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -136.62 145.49 44.94 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 123.652 0.595 . . . . 44.23 110.275 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.1 p -136.13 126.98 27.51 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.638 0.586 . . . . 65.21 111.153 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.639 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 19.8 mt -100.86 112.13 24.49 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.292 -1.003 . . . . 73.23 108.292 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.09 -114.16 5.89 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 124.003 0.815 . . . . 64.23 112.168 -174.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -110.58 4.39 20.25 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.316 0.646 . . . . 73.15 111.304 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -122.41 160.45 25.45 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.999 0.52 . . . . 72.22 110.438 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -75.2 138.15 41.76 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 123.501 0.501 . . . . 53.43 110.079 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.809 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.59 -64.07 1.15 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.371 0.668 . . . . 64.42 109.536 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -144.31 155.33 43.77 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.737 0.78 . . . . 74.21 110.877 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.638 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 82.1 mt -128.02 135.55 50.03 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.74 1.616 . . . . 73.41 106.761 173.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.418 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 38.9 t -145.07 148.4 33.63 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.993 -0.743 . . . . 54.23 108.993 175.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -158.98 126.97 5.06 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.215 -0.661 . . . . 74.31 109.215 -172.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' B' ' 113' ' ' CYS . 65.5 t -124.37 147.37 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 115.401 -0.818 . . . . 63.42 109.419 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -124.8 86.63 2.59 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.249 -1.019 . . . . 73.04 108.249 170.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -80.05 103.03 9.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.717 -0.674 . . . . 73.3 109.486 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.15 164.5 28.51 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 112.042 -0.423 . . . . 51.42 112.042 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.32 134.86 3.79 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.94 -0.464 . . . . 62.24 111.94 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.449 HG13 ' HE1' ' B' ' 17' ' ' TYR . 59.0 mt -91.93 124.52 44.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.982 0.913 . . . . 53.55 109.056 174.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -131.69 135.97 47.29 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.253 0.621 . . . . 72.13 110.029 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.7 m -91.36 115.05 27.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.428 1.091 . . . . 73.24 109.198 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.735 HD13 HD11 ' B' ' 98' ' ' LEU . 35.7 pt -115.96 130.37 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.665 0.786 . . . . 74.01 110.83 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.549 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.78 167.4 30.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.599 0.76 . . . . 64.32 109.586 170.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.09 -56.77 5.08 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 111.5 -0.64 . . . . 71.44 111.5 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.455 HD11 ' HB ' ' B' ' 86' ' ' ILE . 2.8 pp -75.96 163.67 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.17 0.988 . . . . 73.23 111.246 175.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -168.59 157.32 8.58 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.628 0.58 . . . . 73.24 110.628 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.97 -116.03 7.37 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.533 0.521 . . . . 52.44 113.548 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 97.1 m -65.43 -36.1 82.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.88 0.872 . . . . 74.15 111.016 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -66.02 -41.79 90.53 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.689 0.796 . . . . 74.41 110.06 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 47.5 ttp -66.72 -36.65 82.97 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.608 -1.178 . . . . 73.4 110.931 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.19 -32.11 68.47 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.171 0.588 . . . . 61.34 110.572 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -69.96 -29.17 66.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.567 0.747 . . . . 35.23 110.676 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -77.57 -66.78 0.79 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.945 -0.57 . . . . 63.11 110.196 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.735 HD11 HD13 ' B' ' 86' ' ' ILE . 66.5 mt -78.43 -26.4 46.29 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.956 0.902 . . . . 71.32 112.92 -168.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.07 0.81 64.48 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-O 119.749 -0.473 . . . . 61.35 113.453 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 -66.21 0.25 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.28 0.54 . . . . 64.43 112.024 -174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -64.89 -42.39 94.82 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.769 0.827 . . . . 73.34 112.432 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.479 ' SG ' HD23 ' B' ' 98' ' ' LEU . 84.4 m -68.83 -47.44 32.0 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 124.288 1.035 . . . . 73.03 111.725 -177.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.448 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 86.8 Cg_exo -51.9 -39.75 68.02 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.321 2.014 . . . . 64.2 113.326 167.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -61.67 -31.96 72.11 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 112.709 0.633 . . . . 54.33 112.709 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.55 HD13 HD11 ' B' ' 13' ' ' ILE . 61.6 mt -67.85 -41.28 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.384 0.674 . . . . 63.33 110.156 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 66.8 mt -82.78 -19.47 37.7 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.871 -1.059 . . . . 70.02 111.867 -173.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.415 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 57.6 t80 -61.28 -45.22 95.14 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 114.166 1.173 . . . . 72.04 114.166 -170.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 18.2 Cg_endo -58.91 -38.01 90.54 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.089 1.859 . . . . 70.21 112.851 175.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -65.26 -46.26 81.24 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.374 0.67 . . . . 73.11 110.933 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.15 90.01 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.511 -0.768 . . . . 51.15 110.9 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -59.6 -60.52 3.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.495 1.118 . . . . 74.23 110.677 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.542 ' HG3' HH12 ' A' ' 120' ' ' ARG . 12.4 tp10 -58.45 -31.85 68.16 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.399 1.08 . . . . 62.04 111.075 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.546 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.4 t -71.67 -40.33 69.68 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 119.364 -0.351 . . . . 52.23 110.848 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.704 HG21 HG21 ' B' ' 64' ' ' VAL . 88.5 mt -65.1 -55.0 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 109.305 -0.628 . . . . 61.4 109.305 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 13.6 m -58.06 -34.61 70.29 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 124.367 1.042 . . . . 75.42 111.592 -173.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.7 t -61.52 -51.1 70.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 115.913 -0.585 . . . . 64.53 110.03 176.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.5 mmt -66.77 -38.64 86.98 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 123.645 0.59 . . . . 65.41 111.103 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 89.3 t -58.61 -44.56 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.998 0.919 . . . . 72.3 110.515 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 35.2 t -71.26 -30.54 66.42 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.011 -0.995 . . . . 60.11 111.56 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.7 mtt-85 -70.06 -28.91 65.83 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.515 0.726 . . . . 74.4 110.232 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -87.32 9.35 73.41 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 124.02 0.825 . . . . 64.4 112.737 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 17' ' ' TYR . 58.9 p 55.84 31.65 18.08 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.018 1.727 . . . . 54.21 112.941 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -92.09 155.2 43.16 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 123.734 0.814 . . . . 73.21 109.971 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.17 156.96 6.98 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.713 2.942 . . . . 63.1 114.843 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.495 HE21 ' ND2' ' B' ' 127' ' ' ASN . 64.3 tp60 -60.39 130.43 46.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.095 0.958 . . . . 73.54 111.09 -174.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -141.61 95.36 2.81 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.601 -0.518 . . . . 73.32 109.601 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.495 ' ND2' HE21 ' B' ' 125' ' ' GLN . 55.3 m-80 -94.5 136.55 34.67 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.684 -0.858 . . . . 71.33 108.684 169.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.47 140.33 39.8 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.502 0.721 . . . . 72.53 110.508 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.86 146.1 92.76 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.066 0.946 . . . . 33.43 111.737 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.91 97.67 0.49 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.282 2.654 . . . . 73.42 111.71 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 62.1 t -91.01 110.39 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.142 -1.058 . . . . 65.23 108.142 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -84.87 98.46 10.33 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.805 -1.183 . . . . 75.14 107.805 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -57.99 -48.57 79.6 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.983 0.802 . . . . 75.1 111.357 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.97 -37.23 76.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.195 0.998 . . . . 74.3 112.547 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.66 -47.34 78.85 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.756 0.822 . . . . 64.4 111.549 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -81.81 -24.77 35.72 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.847 -0.615 . . . . 74.01 110.369 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 79.4 t80 . . . . . 0 N--CA 1.47 0.552 0 C-N-CA 123.511 0.724 . . . . 74.43 109.727 175.732 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 70.3 m . . . . . 0 C--O 1.236 0.359 0 N-CA-C 108.354 -0.98 . . . . 62.21 108.354 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.555 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.8 t80 -124.52 128.06 48.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.539 0.736 . . . . 74.42 109.101 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -146.54 128.04 15.04 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.82 0.7 . . . . 63.24 109.605 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 95.4 mt -68.46 124.66 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.416 -0.957 . . . . 73.0 108.416 168.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.574 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 36.4 mm-40 -93.28 -47.46 6.9 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.425 0.69 . . . . 74.05 110.192 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -175.24 124.44 0.24 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.59 -0.732 . . . . 64.14 110.013 -169.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.9 143.46 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 108.381 -0.97 . . . . 41.05 108.381 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.502 ' CE2' ' HD2' ' C' ' 19' ' ' LYS . 28.5 p90 -170.92 166.7 7.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.1 0.476 . . . . 72.33 110.77 -175.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.9 p -88.32 112.43 22.83 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.273 -0.876 . . . . 73.44 109.203 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.502 ' HD2' ' CE2' ' C' ' 17' ' ' TYR . 19.3 mmmt -64.97 -46.54 81.09 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.661 -1.237 . . . . 73.15 107.661 170.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.607 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.0 t70 -141.53 143.61 33.86 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 113.334 -1.757 . . . . 65.01 109.908 -170.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 59.0 mt -141.12 145.32 25.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 106.474 -1.676 . . . . 54.12 106.474 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.7 t -157.45 149.62 22.58 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.366 0.603 . . . . 75.04 109.984 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 84.1 t80 -149.55 116.72 6.03 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.017 -1.475 . . . . 72.21 107.017 172.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -120.78 111.1 17.15 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.162 0.585 . . . . 55.41 110.192 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.85 74.56 63.81 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.769 -1.567 . . . . 73.42 106.769 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.58 -15.87 30.53 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.652 2.234 . . . . 43.34 111.806 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -111.45 24.4 12.85 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.543 1.137 . . . . 74.15 109.623 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.487 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -51.27 -49.42 81.86 Favored Pre-proline 0 CA--C 1.562 1.404 0 N-CA-C 114.239 1.199 . . . . 71.42 114.239 -172.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.459 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 35.3 Cg_exo -60.13 -43.3 36.61 Favored 'Trans proline' 0 C--N 1.38 2.214 0 CA-C-N 122.021 1.757 . . . . 63.33 112.206 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -69.15 -30.0 68.14 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.826 -1.079 . . . . 71.51 112.053 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.83 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.4 p -79.78 -28.33 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 N-CA-C 111.858 0.318 . . . . 73.32 111.858 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -70.34 -31.68 69.06 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 120.791 0.329 . . . . 73.31 111.268 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -84.98 7.49 21.08 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.511 0.724 . . . . 74.21 111.228 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.75 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.07 164.43 13.95 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.343 1.057 . . . . 72.03 110.445 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . 0.402 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 9.8 t70 -85.31 104.17 14.91 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.929 -1.138 . . . . 55.44 107.929 167.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.6 t90 -70.09 87.83 0.58 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.923 1.289 . . . . 74.34 111.335 -171.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -123.03 79.12 51.26 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 124.479 1.111 . . . . 72.52 108.55 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.57 138.98 30.47 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.638 2.226 . . . . 54.35 114.495 -171.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.12 115.94 22.65 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.606 -1.628 . . . . 71.32 106.606 164.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.13 118.63 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.489 -0.778 . . . . 61.43 110.079 -163.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.506 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 87.3 tttt -127.22 134.1 50.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.824 0.85 . . . . 73.32 109.102 176.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 50.9 tp -126.0 129.37 49.07 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.016 -0.735 . . . . 72.54 109.016 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.3 t70 -118.84 133.5 55.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.618 -1.252 . . . . 75.11 107.618 175.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.432 HD13 ' HE2' ' C' ' 133' ' ' PHE . 87.4 mt -124.8 136.01 53.46 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.836 -1.172 . . . . 72.53 107.836 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 15.6 t70 -141.96 151.29 42.41 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.503 0.721 . . . . 71.31 109.371 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -134.92 151.9 51.28 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.896 -0.779 . . . . 73.53 108.896 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.19 170.4 20.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.672 0.789 . . . . 73.32 109.273 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.409 ' HB2' ' CE2' ' C' ' 56' ' ' TYR . 78.0 p -159.64 153.09 22.43 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.265 0.226 . . . . 70.24 111.346 -176.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 84.2 p -149.59 147.44 28.14 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.943 0.897 . . . . 62.4 109.991 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -89.76 121.16 31.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.175 0.59 . . . . 53.13 109.587 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.613 HD11 HD12 ' C' ' 83' ' ' ILE . 20.5 mt -95.32 -39.26 10.13 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.329 0.652 . . . . 74.04 109.759 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.73 -172.45 3.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.77 0.828 . . . . 72.04 110.261 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.27 111.51 1.57 Allowed 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.255 0.972 . . . . 75.43 109.953 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 70.06 -6.02 1.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.711 1.205 . . . . 74.43 112.733 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 68.1 t -94.22 95.79 5.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 106.833 -1.543 . . . . 70.24 106.833 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' C' ' 48' ' ' SER . 12.1 t80 -118.17 124.59 48.34 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.141 -0.936 . . . . 70.22 108.845 -172.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.548 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.3 tt0 -85.5 138.95 31.87 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 123.263 0.625 . . . . 72.03 110.587 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 42.6 t -116.81 142.16 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.925 -1.139 . . . . 64.42 107.925 165.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 85.8 t -127.83 130.73 70.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.99 -1.115 . . . . 51.32 107.99 172.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.23 107.67 18.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.451 -0.944 . . . . 71.11 108.451 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.446 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 49.5 ttm-85 -86.56 134.95 33.61 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.795 -1.093 . . . . 62.32 109.192 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.04 118.54 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.029 -1.1 . . . . 72.34 108.029 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.1 m -121.46 122.42 39.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.635 -0.876 . . . . 65.22 108.635 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.608 HG11 HD11 ' C' ' 126' ' ' LEU . 14.5 t -115.55 129.35 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.52 -0.918 . . . . 73.32 108.52 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 5.6 m -121.7 115.94 23.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.787 0.835 . . . . 72.43 108.871 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.59 120.82 43.64 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.79 -1.189 . . . . 75.04 107.79 172.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 45.3 m -122.2 169.07 11.26 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.578 0.751 . . . . 74.44 109.605 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.75 HD13 ' HG2' ' C' ' 34' ' ' LYS . 85.1 mt -132.24 15.68 4.59 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.577 1.151 . . . . 65.22 109.818 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.44 -91.08 0.59 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.253 -0.739 . . . . 42.24 111.253 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -89.91 -27.98 19.51 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.438 0.695 . . . . 74.13 109.878 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 4.3 tp10 -94.96 121.91 37.07 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.912 1.285 . . . . 72.35 110.357 -175.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.7 m -77.56 126.06 30.3 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.369 -0.975 . . . . 72.21 108.369 165.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.83 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -64.75 -60.91 2.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.284 1.04 . . . . 75.02 108.809 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -161.65 161.82 29.7 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-N 112.707 -2.042 . . . . 72.42 108.989 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.406 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -126.3 140.71 52.31 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 105.855 -1.906 . . . . 71.53 105.855 167.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.497 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.8 t -138.09 132.41 32.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.833 -1.173 . . . . 71.31 107.833 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.62 136.45 27.46 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.67 -0.863 . . . . 71.1 108.67 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -146.25 132.97 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 124.603 1.161 . . . . 74.34 108.507 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.607 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 39.9 mt-30 -118.58 94.9 4.63 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.966 -1.124 . . . . 74.14 107.966 173.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -81.69 104.28 11.97 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.888 -1.051 . . . . 60.41 109.819 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.8 157.29 35.6 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.991 -0.444 . . . . 73.52 111.991 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.502 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -159.63 117.81 0.79 Allowed Glycine 0 CA--C 1.501 -0.795 0 N-CA-C 110.83 -0.908 . . . . 62.4 110.83 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.613 HD12 HD11 ' C' ' 51' ' ' LEU . 10.5 mm -84.84 121.29 36.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.175 -1.046 . . . . 51.13 108.175 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.555 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 53.0 m-85 -128.67 118.33 22.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.774 -0.824 . . . . 62.52 108.774 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 54.8 m -77.79 108.21 10.85 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.515 -0.92 . . . . 65.11 108.515 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 45.4 pt -114.94 131.25 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.65 0.78 . . . . 74.11 109.217 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -146.98 152.3 38.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.148 0.979 . . . . 52.12 109.312 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.59 -23.1 17.55 Favored Glycine 0 N--CA 1.479 1.502 0 N-CA-C 113.941 0.336 . . . . 73.22 113.941 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.5 HG22 HE21 ' C' ' 93' ' ' GLN . 28.7 pt -103.05 152.11 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.803 0.841 . . . . 72.13 110.532 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 15.8 pt-20 -166.44 177.97 6.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.697 0.799 . . . . 70.23 109.49 173.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.31 -125.67 34.4 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.592 0.557 . . . . 51.23 113.661 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 82.4 p -72.26 -28.35 63.07 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.498 0.719 . . . . 54.45 111.075 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.5 HE21 HG22 ' C' ' 89' ' ' ILE . 27.8 mt-30 -65.15 -44.55 88.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.588 0.755 . . . . 54.15 110.032 174.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.516 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 22.0 ttt -62.57 -46.17 89.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.214 -0.903 . . . . 60.54 110.472 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.83 -50.27 61.19 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 124.245 0.966 . . . . 64.11 111.613 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -76.2 -32.38 58.94 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 123.377 0.423 . . . . 74.51 111.954 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.547 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.3 t -59.44 -36.13 75.34 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.312 0.383 . . . . 70.11 110.463 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 34.2 mt -96.13 -20.39 18.66 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.83 0.852 . . . . 74.22 110.882 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.93 -31.52 57.89 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.036 -0.529 . . . . 73.2 113.875 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.47 -39.48 0.06 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.628 0.251 . . . . 73.32 111.616 -169.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.547 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 42.6 t80 -65.39 -43.53 90.36 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.461 1.505 . . . . 75.34 113.158 -172.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 66.3 m -81.57 -44.89 1.11 Allowed Pre-proline 0 N--CA 1.486 1.336 0 CA-C-O 118.717 -0.659 . . . . 54.32 111.787 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.04 -27.0 34.39 Favored 'Trans proline' 0 C--N 1.394 2.954 0 C-N-CA 122.516 2.144 . . . . 73.31 113.738 169.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -59.76 -42.9 94.3 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.393 1.077 . . . . 63.52 111.027 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -66.1 -33.47 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 115.437 -0.801 . . . . 71.42 110.376 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.502 HD21 ' HA3' ' C' ' 82' ' ' GLY . 62.6 mt -91.25 -25.16 19.62 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.88 0.872 . . . . 72.15 112.389 -171.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -54.38 -50.53 84.5 Favored Pre-proline 0 CA--C 1.557 1.237 0 CA-C-O 117.966 -1.016 . . . . 42.51 113.682 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.35 -37.83 96.27 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.29 1.993 . . . . 31.24 113.184 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -68.24 -47.32 68.11 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.364 0.666 . . . . 73.23 110.974 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.51 79.56 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.258 -0.883 . . . . 72.3 110.612 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -60.72 -53.21 60.19 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.117 1.367 . . . . 63.32 111.026 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . 0.41 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.2 tm-20 -67.38 -34.02 76.42 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 123.656 0.598 . . . . 61.45 110.316 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.2 t -64.58 -36.76 85.28 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.481 0.488 . . . . 74.4 110.764 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.497 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 77.8 mt -67.67 -50.37 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.3 0.64 . . . . 73.45 110.31 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.6 m -62.47 -30.1 71.01 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.561 0.744 . . . . 71.34 111.374 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -69.68 -50.62 42.09 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 109.142 -0.688 . . . . 74.31 109.142 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.405 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.59 -44.62 66.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.21 1.004 . . . . 65.35 112.063 176.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.5 HG13 ' HB2' ' C' ' 123' ' ' PHE . 88.4 t -63.58 -46.58 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.915 0.886 . . . . 74.32 110.868 177.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 36.6 t -63.54 -33.49 75.71 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.873 0.869 . . . . 72.51 111.795 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -73.34 -39.35 65.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.838 0.855 . . . . 74.51 109.761 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.82 -2.15 69.61 Favored Glycine 0 C--N 1.352 1.468 0 O-C-N 123.832 0.707 . . . . 73.11 112.587 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 61.75 28.49 17.54 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 126.77 2.028 . . . . 74.04 113.302 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.5 ' HB2' HG13 ' C' ' 118' ' ' VAL . 78.4 m-85 -81.84 156.62 69.97 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.272 -1.01 . . . . 72.3 108.272 171.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.26 171.25 2.48 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.727 2.285 . . . . 73.0 113.622 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -51.26 136.45 24.62 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.731 1.212 . . . . 63.35 114.036 -173.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.608 HD11 HG11 ' C' ' 64' ' ' VAL . 7.0 tt -127.32 91.73 3.37 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 106.764 -1.569 . . . . 54.11 106.764 171.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -100.5 105.61 17.07 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.851 -0.796 . . . . 72.24 108.851 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.02 125.58 25.9 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.144 -1.058 . . . . 74.13 108.144 175.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.07 148.64 98.34 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 122.84 0.456 . . . . 75.41 111.29 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.455 ' HG3' HD12 ' A' ' 16' ' ' ILE . 34.8 Cg_exo -57.55 106.78 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.872 2.381 . . . . 45.24 112.172 174.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 23.3 m -112.21 119.66 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.402 0.681 . . . . 72.45 109.924 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -91.87 93.61 8.91 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.904 -0.776 . . . . 73.04 108.904 -176.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.432 ' HE2' HD13 ' C' ' 44' ' ' LEU . 91.7 m-85 -61.09 -40.04 92.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.484 0.714 . . . . 65.53 111.026 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.45 -43.9 96.39 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.342 -0.845 . . . . 61.2 112.226 -175.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.91 -33.72 72.24 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.89 0.744 . . . . 63.51 111.396 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 2.1 tt -79.86 -46.07 17.52 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.69 -0.485 . . . . 74.33 109.69 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 22.7 t80 . . . . . 0 N--CA 1.489 1.479 0 C-N-CA 122.88 0.472 . . . . 74.43 111.364 -176.721 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.239 0.549 0 CA-C-O 121.486 0.66 . . . . 40.24 110.497 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.464 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 55.0 t80 -163.21 88.48 0.59 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.031 -1.84 . . . . 71.31 106.031 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -119.27 115.35 23.98 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.202 -1.407 . . . . 73.4 107.202 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.407 HG21 HD11 ' D' ' 16' ' ' ILE . 16.4 mt -72.63 120.58 21.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.75 -0.833 . . . . 62.53 108.75 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -86.22 -34.0 20.58 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.402 0.681 . . . . 75.44 110.825 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -171.38 134.01 0.86 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.1 0.25 . . . . 73.35 111.663 -172.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.413 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.7 mp -113.24 134.68 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 107.493 -1.299 . . . . 72.11 107.493 171.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.413 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 36.6 p90 -166.56 174.5 8.79 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.901 0.858 . . . . 65.35 112.022 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -102.64 120.04 39.87 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.196 -1.366 . . . . 43.43 109.049 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.459 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.4 mtpt -81.16 -36.96 29.56 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.127 -0.694 . . . . 73.4 109.127 175.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 12.5 t70 -144.89 145.27 31.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.951 -1.022 . . . . 71.21 109.436 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.405 HG21 ' HE2' ' C' ' 117' ' ' MET . 73.9 mt -139.2 150.44 23.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.819 1.248 . . . . 61.03 107.811 175.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 13.0 t -155.29 145.78 22.07 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.678 0.791 . . . . 73.44 109.422 174.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.421 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.2 t80 -150.1 124.1 9.37 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.948 -1.501 . . . . 72.22 106.948 170.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 2.2 mp0 -122.0 152.51 39.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.079 0.552 . . . . 75.01 109.595 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.738 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -140.67 82.21 16.05 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.799 -1.186 . . . . 75.35 107.799 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.79 -34.25 11.44 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.035 2.49 . . . . 73.02 113.608 -171.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -107.82 8.63 28.81 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.319 0.648 . . . . 71.04 110.523 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.738 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -36.69 -64.88 0.35 Allowed Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 116.416 2.006 . . . . 42.34 116.416 -156.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -81.31 -13.41 11.13 Favored 'Trans proline' 0 C--N 1.371 1.756 0 CA-C-N 122.437 1.906 . . . . 74.11 113.65 -172.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -76.26 -42.88 44.26 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.182 0.993 . . . . 74.44 108.709 168.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.465 HG12 ' O ' ' D' ' 28' ' ' ALA . 6.5 p -81.86 -18.37 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 123.36 0.664 . . . . 64.45 111.547 -173.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -67.63 -15.1 63.48 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.965 0.728 . . . . 73.35 112.965 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -66.98 -13.15 61.59 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.674 0.79 . . . . 75.32 110.548 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -103.59 80.25 1.77 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.357 1.463 . . . . 73.04 109.005 173.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.6 82.92 5.64 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.972 -0.751 . . . . 63.3 108.972 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 t-105 -149.46 157.66 43.48 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.595 1.158 . . . . 75.2 108.231 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -71.76 104.99 1.11 Allowed Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 108.963 -0.754 . . . . 74.34 108.963 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.423 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 22.4 Cg_exo -66.23 140.91 60.7 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.928 2.418 . . . . 74.11 113.089 -169.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.41 112.83 1.36 Allowed 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.493 1.121 . . . . 73.51 109.24 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.617 HG23 HG13 ' D' ' 64' ' ' VAL . 2.5 p -98.18 115.0 37.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.626 -0.715 . . . . 73.01 110.752 -170.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -99.41 110.38 22.88 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.017 -1.475 . . . . 75.41 107.017 163.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.414 ' O ' HD12 ' D' ' 42' ' ' LEU . 1.1 pp -95.27 121.44 36.92 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.774 -1.195 . . . . 73.4 107.774 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.729 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 20.3 m-20 -106.05 145.61 31.19 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.064 -0.971 . . . . 75.53 108.38 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.5 130.07 39.97 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.424 -0.954 . . . . 75.31 108.424 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.7 t70 -132.05 143.42 50.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.109 -1.812 . . . . 72.31 106.109 170.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -135.72 155.93 49.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.649 -0.871 . . . . 71.41 108.649 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.07 173.29 14.04 Favored 'General case' 0 C--O 1.239 0.546 0 O-C-N 123.943 0.777 . . . . 52.53 109.854 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.588 ' HB2' ' HE1' ' D' ' 56' ' ' TYR . 19.9 p -155.61 151.23 27.27 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.655 0.782 . . . . 73.3 109.388 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 28.8 t -164.99 119.1 1.28 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.427 0.691 . . . . 64.35 109.545 -170.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -78.96 131.67 36.42 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.452 -0.573 . . . . 65.45 109.452 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.44 HD13 ' HB3' ' C' ' 29' ' ' PRO . 43.2 mt -102.24 -26.96 13.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.934 0.494 . . . . 70.24 111.101 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -168.09 -173.54 2.08 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.438 0.695 . . . . 55.24 110.629 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.05 111.98 10.82 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.984 -0.747 . . . . 64.24 108.984 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 76.09 4.01 3.73 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.777 1.631 . . . . 60.54 112.009 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 73.5 t -109.11 125.04 66.23 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 N-CA-C 108.032 -1.099 . . . . 70.34 108.032 169.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.588 ' HE1' ' HB2' ' D' ' 48' ' ' SER . 4.3 t80 -139.85 150.21 44.37 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.173 -1.047 . . . . 64.52 108.173 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -125.13 147.37 49.05 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.517 0.727 . . . . 74.43 109.973 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -124.3 141.83 43.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.959 -1.126 . . . . 73.42 107.959 171.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.476 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 53.4 t -118.37 139.17 46.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.185 -1.043 . . . . 74.41 108.185 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -123.69 113.68 18.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.652 -1.24 . . . . 63.4 107.652 179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -96.4 97.4 9.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.994 -1.113 . . . . 52.41 107.994 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 t -98.1 118.67 45.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.133 -1.062 . . . . 75.14 108.133 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.729 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.8 m -119.73 143.78 47.6 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.27 1.028 . . . . 64.34 108.47 -172.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.617 HG13 HG23 ' D' ' 40' ' ' VAL . 92.9 t -130.78 103.23 7.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.55 -0.907 . . . . 73.14 108.55 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 52.3 m -92.87 111.99 23.79 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.392 -0.966 . . . . 72.33 108.392 169.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -116.05 154.47 29.86 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.071 0.549 . . . . 73.13 110.518 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.449 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.9 m -148.41 135.48 20.17 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.606 0.566 . . . . 72.54 111.421 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.91 99.55 10.04 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.377 1.071 . . . . 74.22 108.451 173.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.71 -114.23 5.51 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.727 -0.67 . . . . 75.51 113.724 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.21 3.44 49.37 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.878 0.695 . . . . 73.43 112.878 -172.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -151.87 161.45 42.64 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 122.298 -0.251 . . . . 62.44 110.953 -168.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.2 m -63.74 137.1 57.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.053 0.941 . . . . 43.25 111.482 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.449 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -93.01 -73.59 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.184 -1.043 . . . . 70.42 108.184 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -140.49 143.4 35.45 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 121.429 0.633 . . . . 74.43 110.513 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 75.8 mt -109.28 141.99 40.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.202 -1.406 . . . . 61.31 107.202 173.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.58 ' SG ' HG23 ' D' ' 114' ' ' ILE . 51.6 t -151.73 143.55 23.73 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.271 -0.64 . . . . 74.41 109.271 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -155.72 136.5 13.48 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.203 -0.665 . . . . 72.33 109.203 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.75 114.04 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.847 -0.797 . . . . 65.01 108.847 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -88.56 81.68 7.07 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.267 -1.012 . . . . 71.3 108.267 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -78.12 99.46 6.17 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.102 -1.408 . . . . 74.14 109.32 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.01 148.97 18.65 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 111.549 -0.62 . . . . 44.34 111.549 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.9 132.01 4.7 Favored Glycine 0 C--N 1.335 0.513 0 N-CA-C 111.746 -0.542 . . . . 74.34 111.746 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.4 mt -90.28 128.79 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.044 0.938 . . . . 73.24 108.871 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.99 123.43 25.86 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.273 1.029 . . . . 74.01 109.672 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -76.56 105.67 7.76 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.176 -0.676 . . . . 74.42 109.176 168.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.574 HD13 HD21 ' D' ' 98' ' ' LEU . 48.3 pt -116.62 144.37 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 122.922 0.489 . . . . 63.4 110.163 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.2 158.8 19.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.852 0.861 . . . . 72.3 109.371 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.75 21.7 79.52 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 116.486 -0.325 . . . . 63.51 113.621 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' D' ' 86' ' ' ILE . 23.9 pt -128.52 127.43 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.383 0.673 . . . . 63.11 110.0 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.81 154.1 46.09 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.483 1.113 . . . . 74.41 109.777 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.24 -117.84 11.62 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.43 -0.805 . . . . 72.44 114.562 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 19.2 m -65.56 -36.6 84.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.404 0.682 . . . . 71.12 111.612 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -77.09 -40.57 45.53 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.24 -0.436 . . . . 70.24 111.911 -172.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.494 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -64.8 -35.74 82.08 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 120.785 0.326 . . . . 75.25 110.465 178.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . 0.494 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -65.04 -49.48 69.98 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 115.381 -0.827 . . . . 44.12 109.736 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -59.97 -35.53 75.18 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.717 0.636 . . . . 73.5 111.391 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -64.82 -50.6 66.07 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.076 0.551 . . . . 71.52 111.239 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.574 HD21 HD13 ' D' ' 86' ' ' ILE . 75.7 mt -92.33 -28.42 16.95 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.801 0.667 . . . . 75.13 112.801 -169.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.81 -4.24 57.96 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-O 119.761 -0.466 . . . . 55.52 113.953 -174.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -142.9 -59.41 0.43 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.104 0.452 . . . . 52.12 111.365 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . 0.41 ' O ' HG12 ' D' ' 105' ' ' ILE . 46.5 t80 -70.56 -39.89 73.68 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.487 0.551 . . . . 72.4 112.487 -171.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.464 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 97.5 m -69.86 -46.84 23.98 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.313 -0.851 . . . . 71.31 111.611 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.4 Cg_exo -55.24 -34.19 87.34 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.004 1.803 . . . . 71.44 112.736 169.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -64.05 -40.83 97.16 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.404 0.681 . . . . 71.43 110.41 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.41 HG12 ' O ' ' D' ' 101' ' ' TYR . 46.9 mm -63.2 -37.22 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.517 0.727 . . . . 72.43 110.659 174.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.23 -19.46 43.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.156 0.982 . . . . 72.23 112.237 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -65.91 -44.73 63.08 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 114.03 1.122 . . . . 74.14 114.03 -171.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.04 -44.62 38.02 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.282 1.988 . . . . 65.13 112.835 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -69.27 -34.72 75.2 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.384 -0.825 . . . . 65.32 111.263 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.55 -53.39 56.9 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.738 0.815 . . . . 72.24 110.341 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 30.0 ttp180 -53.39 -46.51 69.68 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 124.814 1.321 . . . . 74.11 111.292 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -63.38 -49.99 71.64 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.265 0.978 . . . . 52.35 111.29 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.7 t -57.22 -41.57 79.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.11 0.881 . . . . 74.22 111.018 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.58 HG23 ' SG ' ' D' ' 76' ' ' CYS . 70.2 mt -61.01 -56.41 18.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 123.788 0.835 . . . . 72.24 110.6 174.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.488 HG23 ' HG3' ' D' ' 125' ' ' GLN . 85.1 m -53.4 -43.57 68.02 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.437 1.095 . . . . 65.34 111.706 -175.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 40.1 t -65.07 -43.07 93.4 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.947 -1.024 . . . . 64.12 110.478 -177.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.4 mtm -68.92 -32.6 72.34 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.833 0.453 . . . . 75.14 111.573 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 114' ' ' ILE . 73.3 t -65.75 -42.41 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.675 0.79 . . . . 72.25 110.299 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -73.14 -27.73 61.84 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 122.686 0.394 . . . . 52.04 111.157 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' D' ' 116' ' ' SER . 80.3 mtt-85 -72.04 -33.95 68.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.595 0.758 . . . . 75.44 109.913 173.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.23 0.27 89.38 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.901 0.75 . . . . 60.41 112.0 174.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 19.2 p 64.4 19.82 11.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.599 1.959 . . . . 63.22 113.711 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -84.8 150.37 55.89 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 108.609 -0.886 . . . . 52.4 108.609 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.47 141.5 51.33 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 123.246 2.631 . . . . 52.34 113.546 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.488 ' HG3' HG23 ' D' ' 115' ' ' THR . 32.2 tt0 -51.0 140.44 15.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.905 1.282 . . . . 70.35 112.675 -172.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.457 HD11 HG21 ' D' ' 40' ' ' VAL . 0.3 OUTLIER -125.09 97.15 5.12 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.541 -0.911 . . . . 70.43 108.541 -175.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -99.0 110.37 22.99 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.868 -0.79 . . . . 71.24 108.868 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.479 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -69.39 113.41 6.69 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.656 -0.868 . . . . 73.01 108.656 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.73 140.6 97.84 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.042 0.537 . . . . 71.03 110.957 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.08 118.42 5.32 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.63 2.22 . . . . 54.0 111.778 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.73 123.17 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.522 0.729 . . . . 65.43 109.407 -176.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -85.17 79.32 9.61 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.572 -0.899 . . . . 65.52 108.572 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -83.56 -14.66 51.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.568 -0.742 . . . . 72.32 110.588 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . 0.405 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 2.3 m-20 -52.77 -53.55 46.58 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.969 0.908 . . . . 63.44 111.789 173.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.12 77.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.962 0.905 . . . . 52.22 111.691 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.1 -22.44 45.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.952 -1.022 . . . . 75.54 111.256 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 84.6 t80 . . . . . 0 N--CA 1.475 0.775 0 C-N-CA 123.403 0.681 . . . . 75.04 110.119 176.714 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 87.7 m . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 107.906 -1.146 . . . . 71.13 107.906 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -134.55 138.67 44.81 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.821 0.848 . . . . 62.01 108.758 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -152.8 127.61 9.54 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.429 0.692 . . . . 70.42 109.466 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.3 mt -83.39 115.74 26.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.302 -0.999 . . . . 75.41 108.302 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -81.51 -38.59 26.03 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.478 0.486 . . . . 61.22 109.864 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -170.11 124.07 0.73 Allowed 'General case' 0 C--N 1.356 0.875 0 CA-C-O 119.684 -0.198 . . . . 74.3 110.783 -167.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.481 HD12 ' HG3' ' C' ' 130' ' ' PRO . 46.8 mt -111.68 134.79 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.157 -1.053 . . . . 75.31 108.157 172.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HB3' HG23 ' B' ' 122' ' ' THR . 44.1 p90 -166.55 167.33 15.6 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.878 0.847 . . . . 70.24 111.272 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -91.3 110.69 21.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.732 -1.122 . . . . 72.24 108.138 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -70.95 -46.92 61.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.96 -0.756 . . . . 73.23 108.96 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.66 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 6.0 m-20 -133.5 132.97 41.63 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.598 -1.183 . . . . 75.2 109.256 -176.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -127.67 139.71 51.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 106.678 -1.601 . . . . 72.32 106.678 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -149.84 107.34 3.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 123.655 0.597 . . . . 70.21 109.718 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 60.0 t80 -111.2 113.7 26.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.707 -1.59 . . . . 53.53 106.707 171.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.0 114.37 22.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.319 -0.623 . . . . 65.32 109.319 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.72 80.56 70.26 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 107.613 -1.255 . . . . 72.12 107.613 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.76 -11.4 20.14 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.469 2.112 . . . . 71.25 111.214 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -107.72 20.84 18.29 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.874 1.269 . . . . 63.03 108.772 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.46 -45.02 99.71 Favored Pre-proline 0 CA--C 1.571 1.786 0 N-CA-C 114.43 1.271 . . . . 45.41 114.43 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -88.01 -8.44 5.78 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 121.678 1.585 . . . . 73.43 112.99 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.44 ' HA ' HE21 ' A' ' 33' ' ' GLN . 18.1 t-160 -94.88 -15.53 23.6 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.215 1.006 . . . . 60.22 110.354 -175.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.533 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 8.8 p -77.01 -25.93 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.731 0.812 . . . . 74.12 110.205 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -66.68 -29.82 69.91 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.801 0.84 . . . . 63.53 110.113 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.44 HE21 ' HA ' ' A' ' 30' ' ' HIS . 48.6 mt-30 -78.94 -34.95 44.01 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.025 0.93 . . . . 64.12 111.612 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 31' ' ' VAL . 16.2 ptpt -82.87 169.2 16.33 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.115 0.413 . . . . 75.3 112.115 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -85.01 127.03 34.02 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.648 -0.871 . . . . 74.41 108.648 167.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -70.29 88.55 0.64 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.21 1.004 . . . . 75.31 111.594 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.457 ' HB2' HD13 ' A' ' 68' ' ' LEU . 98.5 mt-30 -132.88 76.78 70.01 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.141 0.976 . . . . 74.43 109.403 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -89.04 126.38 1.68 Allowed 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.339 2.026 . . . . 74.13 112.358 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.99 109.89 22.21 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.492 -1.299 . . . . 74.33 107.492 170.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.78 107.24 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 115.131 -0.94 . . . . 62.25 110.907 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -79.77 114.69 18.89 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.289 -1.004 . . . . 70.41 108.289 165.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.0 tp -98.24 111.55 23.84 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.302 -0.999 . . . . 64.33 108.302 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -116.11 129.49 56.36 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.055 -1.091 . . . . 62.12 108.055 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 tt -119.33 129.89 55.09 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.281 -1.007 . . . . 63.24 108.281 -171.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 18.7 t70 -130.34 155.28 46.62 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.13 0.972 . . . . 71.41 109.532 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.0 m -141.78 131.87 24.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.564 1.146 . . . . 75.32 109.207 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.1 148.64 45.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.973 0.909 . . . . 75.33 109.423 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.4 p -109.41 161.68 15.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.568 0.747 . . . . 51.31 109.313 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.1 p -152.95 138.08 17.35 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.134 0.574 . . . . 54.01 109.853 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.448 ' HA ' ' HD1' ' A' ' 56' ' ' TYR . 46.9 tt0 -91.25 114.83 27.47 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.944 0.498 . . . . 74.33 109.975 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 57' ' ' GLU . 18.9 mt -89.25 -43.42 10.98 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.832 -0.803 . . . . 51.11 108.832 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -150.67 -179.33 7.16 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 113.989 -1.459 . . . . 64.22 108.662 174.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.57 113.64 6.26 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.39 -0.596 . . . . 75.53 109.39 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 66.3 21.55 10.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.337 1.455 . . . . 74.45 112.101 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 60.3 t -121.33 102.08 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 106.759 -1.571 . . . . 70.32 106.759 167.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.448 ' HD1' ' HA ' ' A' ' 50' ' ' GLN . 18.7 m-85 -127.05 143.35 51.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.951 0.501 . . . . 73.41 110.014 -170.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' A' ' 51' ' ' LEU . 34.7 tt0 -114.89 137.91 51.41 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.782 0.833 . . . . 75.25 109.523 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.5 t -103.89 126.85 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.824 -1.176 . . . . 71.1 107.824 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.4 t -102.22 107.46 21.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.524 -0.917 . . . . 75.1 108.524 174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 tp -88.83 101.42 14.01 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.949 -0.759 . . . . 71.03 108.949 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.697 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 23.8 mtm105 -89.5 100.95 13.64 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.039 0.536 . . . . 74.54 109.619 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.518 HG21 ' HB1' ' A' ' 110' ' ' ALA . 2.5 m -113.25 108.48 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.154 0.581 . . . . 62.1 109.543 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -108.89 148.51 30.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.523 0.729 . . . . 53.42 110.741 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.423 ' O ' HD12 ' A' ' 75' ' ' LEU . 70.6 t -129.23 112.29 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 125.307 1.443 . . . . 72.22 108.067 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.7 m -102.6 104.2 14.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.562 -0.903 . . . . 53.21 108.562 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.84 109.57 21.35 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.562 -1.273 . . . . 74.1 107.562 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.7 p -147.39 140.93 25.49 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.18 0.514 . . . . 63.41 111.405 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' A' ' 37' ' ' GLN . 38.2 tp -90.39 68.64 6.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.828 1.251 . . . . 70.32 107.668 169.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.51 -89.71 0.63 Allowed Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.046 -0.979 . . . . 42.25 111.951 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.8 -26.01 14.17 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.2 1.0 . . . . 73.32 110.123 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -96.98 94.89 7.45 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.407 -0.815 . . . . 72.45 109.177 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.8 m -65.39 134.77 54.22 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.824 0.85 . . . . 63.51 111.99 -174.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.87 -64.54 1.16 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.874 -0.788 . . . . 70.51 108.874 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -157.06 174.14 15.96 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.166 -0.925 . . . . 75.14 110.937 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 64' ' ' VAL . 61.7 tp -140.2 130.36 25.02 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.973 1.309 . . . . 63.24 107.634 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.427 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 84.7 m -138.44 113.4 9.2 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.466 0.706 . . . . 41.2 110.204 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -132.74 126.76 33.21 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.897 -0.779 . . . . 73.1 108.897 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -129.17 119.15 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.513 -0.767 . . . . 75.04 109.362 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.66 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 44.9 mt-30 -91.05 89.77 7.56 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.877 -1.056 . . . . 63.35 108.286 172.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.422 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.9 tp-100 -78.73 105.71 10.22 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.149 -0.932 . . . . 70.04 109.29 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.97 160.03 27.03 Favored Glycine 0 C--O 1.242 0.613 0 N-CA-C 111.317 -0.713 . . . . 74.54 111.317 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.47 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -162.43 121.91 1.06 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.003 -1.239 . . . . 52.01 110.003 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.418 HG23 HD12 ' A' ' 51' ' ' LEU . 59.3 mt -79.23 123.74 36.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.625 -0.88 . . . . 71.03 108.625 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -126.41 119.0 26.14 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.081 -0.711 . . . . 73.22 109.081 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 p -91.62 119.2 31.31 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.066 -1.087 . . . . 71.24 108.066 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.765 HD13 HD11 ' A' ' 89' ' ' ILE . 2.4 pp -126.54 161.59 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.589 0.755 . . . . 51.5 111.559 -171.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.605 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -167.72 155.28 8.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.376 1.071 . . . . 74.3 109.721 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.16 8.26 86.92 Favored Glycine 0 N--CA 1.475 1.249 0 N-CA-C 114.501 0.56 . . . . 64.4 114.501 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.765 HD11 HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -114.99 153.85 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.2 1.0 . . . . 71.11 109.153 178.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.414 ' H ' ' HB2' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -164.87 171.27 14.34 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.12 -1.067 . . . . 70.24 108.12 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.38 -114.54 1.47 Allowed Glycine 0 CA--C 1.542 1.721 0 N-CA-C 114.685 0.634 . . . . 71.41 114.685 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p -70.68 -29.72 66.12 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.267 1.027 . . . . 63.22 112.173 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.414 ' HB2' ' H ' ' A' ' 90' ' ' GLU . 69.7 mm-40 -65.86 -44.63 84.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.45 0.7 . . . . 75.03 110.865 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -71.43 -34.17 70.06 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.22 -0.445 . . . . 72.42 110.467 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -33.51 76.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.099 0.56 . . . . 74.21 110.618 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.526 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 63.9 t-80 -71.49 -21.69 61.9 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.739 0.816 . . . . 71.44 110.728 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 78.3 m -79.12 -60.27 2.44 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.401 -0.592 . . . . 72.54 109.401 172.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.14 -32.84 73.48 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.169 0.987 . . . . 75.32 112.423 -173.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.47 4.13 29.56 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 119.356 -0.691 . . . . 32.11 114.055 -172.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.1 -66.73 0.34 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.882 0.841 . . . . 61.44 111.782 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.413 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 76.1 t80 -70.65 -58.32 3.79 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.241 0.616 . . . . 73.12 112.478 -169.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.65 -46.28 98.59 Favored Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 113.517 0.932 . . . . 74.21 113.517 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.09 -26.49 65.5 Favored 'Trans proline' 0 C--N 1.399 3.185 0 C-N-CA 121.846 1.697 . . . . 71.23 112.636 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -68.22 -39.76 82.29 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.382 0.673 . . . . 54.33 110.601 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.8 mm -61.7 -43.43 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.893 0.877 . . . . 64.24 110.13 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.422 HD22 ' HG3' ' A' ' 80' ' ' GLN . 83.0 mt -77.94 -22.22 49.89 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.889 -1.05 . . . . 72.52 112.219 -174.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -61.46 -47.25 93.87 Favored Pre-proline 0 CA--C 1.567 1.62 0 N-CA-C 113.788 1.033 . . . . 65.03 113.788 -170.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.12 -37.0 66.66 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.143 1.895 . . . . 73.4 113.139 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -70.37 -39.98 74.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.639 0.776 . . . . 75.23 110.418 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.518 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -65.38 -43.11 91.77 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.388 -0.823 . . . . 41.51 110.549 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.474 ' NH1' HD12 ' C' ' 105' ' ' ILE . 31.8 ttm180 -55.14 -50.85 68.23 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 124.46 1.1 . . . . 62.53 110.33 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -59.86 -47.46 85.67 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.604 1.19 . . . . 75.35 111.343 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 117' ' ' MET . 36.1 t -61.7 -41.47 97.65 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 123.912 0.757 . . . . 64.14 110.643 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.487 HD11 HG23 ' A' ' 62' ' ' VAL . 96.1 mt -64.3 -50.23 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.895 0.878 . . . . 75.42 110.43 176.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 78.4 m -53.6 -45.03 69.91 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.839 0.855 . . . . 74.25 110.604 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -66.74 -38.77 87.3 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.165 -1.38 . . . . 73.54 110.228 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 30.9 mmt -58.61 -47.13 85.38 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.283 0.633 . . . . 74.15 111.235 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 114' ' ' ILE . 62.2 t -61.97 -43.64 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-N 114.897 -1.047 . . . . 72.22 110.408 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.1 m -73.29 -29.8 62.97 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.612 0.765 . . . . 40.0 111.917 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.492 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 93.9 mtt-85 -77.41 -25.31 50.67 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.207 0.603 . . . . 74.01 110.413 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.99 2.8 87.15 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.576 0.547 . . . . 40.43 112.758 171.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.9 m 68.01 16.79 9.56 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.908 1.283 . . . . 74.52 111.268 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -81.74 144.94 53.1 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 108.914 -0.773 . . . . 72.43 108.914 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.14 134.72 44.14 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.058 2.505 . . . . 64.41 112.226 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -52.75 141.95 19.94 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.369 1.068 . . . . 63.42 113.558 -171.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.0 tp -119.4 127.08 52.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.815 1.246 . . . . 75.32 109.766 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -135.9 102.39 5.04 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.492 -0.929 . . . . 71.33 108.492 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.0 pt? -68.45 151.59 46.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.535 0.734 . . . . 72.31 111.031 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.94 146.46 98.27 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.196 0.999 . . . . 70.24 111.23 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -67.1 123.63 11.17 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.558 2.172 . . . . 71.41 112.347 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 98.7 t -101.25 113.56 37.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 123.971 0.908 . . . . 71.44 108.619 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -87.84 97.39 10.89 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.631 -0.878 . . . . 73.43 108.631 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -66.48 -21.14 66.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.315 1.046 . . . . 75.13 111.685 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.86 -48.77 62.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.413 1.085 . . . . 73.52 110.88 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.14 -40.02 88.34 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.83 0.707 . . . . 73.34 110.348 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.49 -39.9 85.22 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.081 -0.963 . . . . 72.43 111.369 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -67.08 -36.74 82.65 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.38 -0.6 . . . . 74.22 109.38 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.0 mmt . . . . . 0 N--CA 1.471 0.612 0 O-C-N 124.023 0.827 . . . . 75.33 111.176 177.234 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.238 0.481 0 N-CA-C 109.2 -0.667 . . . . 62.22 109.2 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -126.91 114.7 18.21 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.181 -1.415 . . . . 71.13 107.181 164.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.462 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -128.76 118.34 22.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.452 0.701 . . . . 75.52 109.268 -177.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 59.2 mt -77.77 116.48 21.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.902 -1.147 . . . . 65.24 107.902 169.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -85.72 -47.27 9.93 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.115 -0.698 . . . . 74.42 109.115 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -161.62 136.4 7.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.319 -0.855 . . . . 63.44 109.447 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 86.2 mt -115.89 140.76 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 106.392 -1.707 . . . . 51.13 106.392 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -166.3 171.18 12.37 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.392 0.615 . . . . 64.25 111.553 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.47 HG21 HD11 ' B' ' 21' ' ' ILE . 58.4 m -98.53 128.24 44.78 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.112 -0.949 . . . . 75.43 108.719 170.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.44 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 19.4 mtpp -86.96 -37.28 17.72 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.996 0.919 . . . . 43.25 109.465 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -151.93 139.45 19.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.178 -0.465 . . . . 75.44 112.059 -173.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.47 HD11 HG21 ' B' ' 18' ' ' THR . 39.6 mm -124.24 141.1 45.57 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 124.965 1.306 . . . . 51.45 108.809 170.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.4 t -140.55 136.72 33.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.485 -1.234 . . . . 64.34 108.116 176.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.5 t80 -158.59 111.01 2.27 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 107.62 -1.252 . . . . 75.51 107.62 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -131.34 117.45 18.94 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.844 0.858 . . . . 65.54 109.269 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.593 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -109.94 85.83 4.42 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.166 0.987 . . . . 75.13 108.821 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.64 -32.38 24.23 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.759 2.306 . . . . 73.35 112.546 -170.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -108.9 8.41 26.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.535 0.734 . . . . 73.33 111.249 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.593 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -34.48 -65.25 0.26 Allowed Pre-proline 0 N--CA 1.503 2.204 0 C-N-CA 125.526 1.53 . . . . 74.52 114.852 -167.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.8 Cg_exo -69.88 -19.41 35.58 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.284 1.99 . . . . 64.25 112.836 -168.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -95.48 -34.11 12.19 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.32 -0.854 . . . . 72.32 110.07 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.482 HG22 HD12 ' B' ' 68' ' ' LEU . 2.0 p -71.85 -24.29 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.859 0.464 . . . . 72.02 110.703 -173.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -67.62 -3.51 9.18 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.928 0.891 . . . . 73.25 112.989 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.56 -19.55 65.28 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 120.796 0.331 . . . . 74.34 110.294 170.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.441 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 86.3 mttt -105.35 92.74 4.33 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.581 1.153 . . . . 72.43 108.576 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.55 87.55 7.41 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.353 0.597 . . . . 75.32 110.221 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -165.43 159.08 16.6 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.803 1.241 . . . . 75.04 108.181 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.438 ' HG3' ' HB2' ' B' ' 124' ' ' PRO . 17.0 mp0 -59.5 110.65 2.9 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 123.852 0.861 . . . . 75.53 109.934 172.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.655 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.0 Cg_endo -60.24 140.71 93.48 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.908 2.405 . . . . 74.21 112.603 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -51.58 107.84 0.22 Allowed 'General case' 0 C--N 1.357 0.928 0 O-C-N 124.471 1.107 . . . . 71.41 110.561 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 31.3 m -87.5 155.04 3.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.157 -0.929 . . . . 65.02 111.454 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.64 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 48.9 tttp -139.39 107.69 5.8 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.308 -1.367 . . . . 44.23 107.308 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.26 124.37 33.8 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.502 -0.555 . . . . 54.01 109.502 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.568 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 23.6 t70 -130.18 154.45 47.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.242 1.417 . . . . 72.34 107.838 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.71 147.29 35.4 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.701 -0.481 . . . . 53.1 109.701 -170.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.598 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 23.4 t70 -146.91 114.14 6.24 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.912 -0.773 . . . . 71.52 108.912 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.2 p -114.95 108.29 16.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.23 0.612 . . . . 73.13 110.697 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.16 162.65 17.14 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.827 1.251 . . . . 32.12 108.689 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.0 p -137.44 162.28 34.08 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.271 0.628 . . . . 70.21 109.468 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 97.8 p -150.41 136.48 18.55 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.855 0.462 . . . . 54.31 110.199 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -87.02 110.41 20.04 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.311 -0.626 . . . . 64.44 109.311 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 27.5 mt -82.42 -41.94 19.23 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.908 -0.587 . . . . 72.31 109.669 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.73 -172.31 4.01 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.51 -1.223 . . . . 74.33 110.303 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.03 105.52 0.41 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.782 -1.099 . . . . 55.44 110.723 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 66.76 16.43 10.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.952 1.301 . . . . 75.51 112.322 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -105.49 110.05 29.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.765 -1.198 . . . . 71.42 107.765 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.52 140.23 52.48 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.508 0.67 . . . . 75.34 109.675 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -116.04 104.11 11.24 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.356 -1.35 . . . . 74.11 107.356 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 90.8 t -85.4 139.68 17.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 CA-C-N 114.632 -1.167 . . . . 74.03 109.635 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.83 120.04 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 123.585 0.754 . . . . 61.33 109.116 -176.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -107.42 106.29 16.62 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.78 -1.193 . . . . 71.32 107.78 178.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.598 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 34.6 ttm180 -98.87 118.81 36.46 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.157 0.583 . . . . 72.54 109.616 170.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.617 ' HB ' HD11 ' B' ' 114' ' ' ILE . 29.3 t -107.84 108.64 25.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.621 -1.251 . . . . 73.0 107.621 169.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 41.7 m -97.11 122.57 40.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.519 -0.549 . . . . 64.3 109.519 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.712 HG21 HG21 ' B' ' 114' ' ' ILE . 79.5 t -115.83 103.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 124.046 0.939 . . . . 52.42 110.111 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 99.7 m -91.23 145.09 24.95 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.559 -0.904 . . . . 71.13 108.559 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -145.85 148.73 33.19 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.463 0.305 . . . . 62.35 111.027 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.1 p -153.41 130.62 11.18 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.808 -0.633 . . . . 61.24 110.801 -175.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.655 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 35.0 mt -98.68 112.73 24.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.924 0.89 . . . . 71.04 108.978 175.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.48 -114.54 6.96 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 115.211 -0.904 . . . . 65.45 112.342 -172.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -109.09 11.65 25.57 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.226 0.611 . . . . 71.45 112.282 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -128.29 150.14 50.19 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.199 0.6 . . . . 74.41 110.079 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 37.5 m -66.38 135.19 53.98 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.474 0.484 . . . . 62.25 110.594 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.466 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -91.16 -62.32 1.47 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.283 -1.006 . . . . 74.1 108.283 174.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -151.4 162.88 40.16 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.202 -0.908 . . . . 74.42 110.17 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -132.91 109.35 9.53 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.976 -1.491 . . . . 52.33 106.976 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' B' ' 114' ' ' ILE . 51.2 t -118.3 156.43 28.89 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.69 0.796 . . . . 61.4 109.267 -174.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.0 tt0 -165.81 139.87 4.53 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.7 -0.852 . . . . 64.14 108.7 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' B' ' 113' ' ' CYS . 72.3 t -131.67 141.66 45.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.656 -1.239 . . . . 73.42 107.656 172.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -122.31 87.62 2.78 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.753 -0.832 . . . . 74.42 108.753 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.34 99.48 7.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.551 -0.75 . . . . 73.4 109.014 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.44 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.97 144.29 16.55 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.635 -0.986 . . . . 60.23 110.635 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.42 130.43 4.1 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.491 -0.644 . . . . 75.25 111.491 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.0 mt -85.15 125.77 40.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 123.945 0.898 . . . . 74.43 109.208 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -136.54 135.45 38.49 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.29 1.036 . . . . 64.22 108.565 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 41.9 m -101.99 106.6 17.54 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.802 -0.814 . . . . 52.14 108.802 176.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.407 HG21 ' SG ' ' B' ' 97' ' ' CYS . 31.2 pt -110.66 125.15 67.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.776 0.83 . . . . 64.2 109.906 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.45 162.06 41.65 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.753 0.821 . . . . 60.34 109.331 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.18 -47.8 3.9 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.476 0.485 . . . . 75.31 112.636 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 31.1 pt -70.18 152.28 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.838 0.855 . . . . 71.13 110.644 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -162.85 163.86 26.29 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.363 0.665 . . . . 74.31 109.96 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.4 -113.65 3.71 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.438 0.461 . . . . 71.4 112.407 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 87.7 m -84.97 -26.74 26.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.182 0.515 . . . . 64.11 110.745 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -73.43 -28.89 62.22 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.831 -0.622 . . . . 75.22 110.663 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.404 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 0.0 OUTLIER -72.7 -33.75 66.68 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 109.589 -0.522 . . . . 71.3 109.589 173.234 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.55 -39.08 84.96 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.905 0.882 . . . . 71.01 110.891 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -62.65 -31.23 72.06 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.681 -1.145 . . . . 72.53 110.808 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.407 ' SG ' HG21 ' B' ' 86' ' ' ILE . 25.2 t -72.06 -66.35 0.66 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.924 -0.58 . . . . 60.4 110.367 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.441 HD12 ' N ' ' B' ' 99' ' ' GLY . 1.6 pp -68.93 -26.74 65.23 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.589 0.959 . . . . 75.22 113.589 -171.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . 0.441 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -104.56 3.05 42.55 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-O 119.52 -0.6 . . . . 74.22 114.242 -171.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.86 -61.16 0.18 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 117.429 0.615 . . . . 71.31 111.176 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -66.92 -52.38 43.82 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.338 1.055 . . . . 72.35 111.908 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.428 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 92.6 m -62.34 -50.38 79.68 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.371 1.068 . . . . 73.53 111.788 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.7 Cg_exo -56.36 -36.65 97.4 Favored 'Trans proline' 0 C--N 1.401 3.305 0 C-N-CA 122.045 1.83 . . . . 71.22 113.295 170.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -66.59 -29.56 69.64 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.008 0.523 . . . . 62.53 111.004 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.431 HG23 ' NH2' ' D' ' 111' ' ' ARG . 93.0 mt -68.49 -45.51 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.87 0.868 . . . . 73.01 110.244 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.405 ' HB2' HD12 ' B' ' 60' ' ' LEU . 56.2 mt -76.39 -20.93 56.66 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.975 -1.011 . . . . 73.02 111.833 -173.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -59.91 -48.79 93.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-O 117.661 -1.162 . . . . 73.0 113.419 -171.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -56.36 -38.69 94.73 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.124 1.882 . . . . 74.4 113.231 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -66.83 -47.64 71.38 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.158 0.583 . . . . 74.24 110.335 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.407 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -59.81 -40.27 87.81 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.593 0.757 . . . . 74.14 110.656 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.539 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 36.0 ttt180 -61.75 -52.3 64.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.334 1.454 . . . . 73.35 111.138 -176.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.74 -37.74 88.5 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.958 0.786 . . . . 62.22 109.916 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.492 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 5.1 t -67.38 -38.31 84.55 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.656 0.598 . . . . 75.42 111.796 -173.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.712 HG21 HG21 ' B' ' 64' ' ' VAL . 61.1 mt -66.74 -51.47 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 109.388 -0.597 . . . . 74.51 109.388 176.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.471 HG21 ' OG ' ' C' ' 119' ' ' SER . 88.9 m -54.91 -37.74 66.74 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.898 1.374 . . . . 75.52 110.848 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 46.7 t -63.43 -44.19 95.27 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 115.361 -0.836 . . . . 53.21 110.018 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.422 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 30.7 mmt -62.91 -43.07 99.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.337 0.398 . . . . 73.53 110.93 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.511 HG23 ' O ' ' B' ' 114' ' ' ILE . 48.4 t -58.96 -47.16 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.242 1.017 . . . . 55.43 109.605 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.532 ' HB3' HG21 ' C' ' 115' ' ' THR . 71.8 m -65.49 -34.54 78.51 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.261 -1.336 . . . . 70.15 112.062 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -68.87 -35.0 76.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.395 -0.821 . . . . 72.53 110.093 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -86.99 10.99 66.15 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 124.135 0.897 . . . . 52.51 112.957 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 17' ' ' TYR . 67.0 p 56.74 23.61 8.12 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.992 1.717 . . . . 52.32 113.628 176.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.47 149.99 62.44 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 122.797 0.439 . . . . 64.12 109.996 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.438 ' HB2' ' HG3' ' B' ' 37' ' ' GLN . 51.2 Cg_exo -55.29 164.76 3.57 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.736 2.958 . . . . 74.51 114.906 -177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -57.73 121.39 10.32 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.308 1.043 . . . . 71.23 112.895 -166.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 9.5 tt -128.54 123.85 34.52 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.075 -1.083 . . . . 70.41 108.075 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -134.98 127.1 29.89 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.611 0.764 . . . . 74.12 109.004 172.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.539 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -68.79 137.74 54.24 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.483 0.713 . . . . 50.41 109.919 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.03 138.4 61.07 Favored Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 123.625 0.578 . . . . 54.41 110.576 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.04 122.98 7.52 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.881 2.387 . . . . 55.41 112.847 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 t -116.2 112.08 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.42 -0.956 . . . . 43.41 108.42 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -76.68 88.71 3.35 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.461 -0.94 . . . . 74.53 108.461 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -59.51 -37.8 79.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.093 -0.958 . . . . 73.24 112.345 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.22 -43.59 87.79 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.978 0.911 . . . . 73.23 112.688 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.03 -53.64 29.28 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.537 0.735 . . . . 71.12 110.725 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.0 -14.72 61.07 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.282 -0.872 . . . . 71.44 111.433 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 84.2 t80 . . . . . 0 N--CA 1.476 0.837 0 O-C-N 123.396 0.435 . . . . 74.44 109.937 173.738 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 28.5 m . . . . . 0 CA--C 1.536 0.437 0 N-CA-C 107.632 -1.247 . . . . 52.02 107.632 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -97.44 128.45 44.24 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.491 -0.929 . . . . 73.41 108.491 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -153.88 125.74 7.74 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.18 0.592 . . . . 65.21 109.723 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.442 HD13 HD11 ' C' ' 16' ' ' ILE . 50.1 mt -75.75 132.57 32.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.857 -0.794 . . . . 61.42 108.857 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.499 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 26.0 mm-40 -101.11 -39.52 7.64 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.593 0.757 . . . . 74.53 109.899 174.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -169.67 146.62 3.32 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.526 -0.546 . . . . 71.22 109.526 -172.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.442 HD11 HD13 ' C' ' 13' ' ' ILE . 89.8 mt -137.03 134.08 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.143 -1.058 . . . . 73.5 108.143 175.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.413 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 43.4 p90 -170.85 164.29 7.81 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.155 0.502 . . . . 71.4 110.904 -167.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -87.26 114.53 23.96 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.328 -0.851 . . . . 61.44 108.855 173.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.413 ' HD2' ' HE2' ' C' ' 17' ' ' TYR . 19.2 mmmt -64.02 -39.89 95.12 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.915 0.864 . . . . 75.13 109.139 172.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -160.4 144.98 14.38 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 113.696 -1.593 . . . . 75.22 108.349 -172.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 88.9 mt -133.78 146.99 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.585 -1.265 . . . . 73.41 107.585 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.8 t -151.92 149.76 29.29 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.471 0.653 . . . . 63.55 110.267 172.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 82.7 t80 -150.75 117.85 5.94 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 107.275 -1.38 . . . . 73.01 107.275 173.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.97 111.99 17.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.512 0.725 . . . . 75.53 109.882 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.88 82.34 60.94 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.25 -1.019 . . . . 60.22 108.25 169.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -65.17 -25.78 57.73 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.013 2.476 . . . . 75.32 112.712 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -102.31 13.02 35.73 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.154 0.982 . . . . 62.4 110.605 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.468 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -45.18 -58.42 5.74 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 114.703 1.371 . . . . 73.23 114.703 -165.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.549 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 23.5 Cg_endo -60.04 -43.22 37.78 Favored 'Trans proline' 0 C--N 1.383 2.382 0 CA-C-N 122.129 1.796 . . . . 70.13 111.817 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -71.67 -28.42 63.73 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.963 0.905 . . . . 75.35 112.674 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.761 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.7 p -80.25 -22.26 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.57 0.348 . . . . 65.14 111.567 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -72.91 -21.24 60.93 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.005 0.522 . . . . 74.24 111.783 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -102.1 6.5 40.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.734 0.814 . . . . 74.11 110.906 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.823 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -83.77 161.53 20.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.444 0.698 . . . . 63.24 110.546 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 7.2 m-20 -57.76 112.27 1.41 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.32 1.048 . . . . 74.33 109.646 168.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -73.57 88.45 1.67 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.028 0.531 . . . . 73.12 110.553 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -150.16 74.22 9.15 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.393 -0.966 . . . . 50.2 108.393 169.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -74.57 164.48 33.74 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.75 2.3 . . . . 74.22 112.87 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -115.8 94.38 4.66 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.374 -1.714 . . . . 74.14 106.374 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 90.9 t -73.38 98.4 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.548 -0.751 . . . . 73.12 109.256 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -101.5 107.39 18.68 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.912 -1.144 . . . . 72.21 107.912 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.07 138.48 31.41 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.273 0.559 . . . . 74.11 111.282 -174.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.577 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.2 t70 -130.74 132.86 45.58 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.11 1.364 . . . . 62.5 108.614 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.401 HD13 HG11 ' C' ' 131' ' ' VAL . 52.0 mt -123.05 131.9 53.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.845 -1.169 . . . . 74.45 107.845 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -144.4 144.58 31.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.322 0.649 . . . . 71.35 109.421 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -151.48 153.41 34.57 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 122.898 0.479 . . . . 55.33 110.101 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.95 168.86 24.97 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.432 -0.804 . . . . 54.14 109.564 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.4 p -129.9 151.22 50.7 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.882 0.873 . . . . 42.13 109.499 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 80.7 p -143.68 128.13 17.94 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.373 1.069 . . . . 73.1 108.197 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -76.94 116.43 17.6 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.36 -0.607 . . . . 64.43 109.36 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 HD12 ' C' ' 83' ' ' ILE . 75.3 mt -89.64 -39.7 13.05 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.0 -0.741 . . . . 63.04 109.0 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 -175.49 5.43 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.646 -1.161 . . . . 71.53 110.432 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.24 116.93 5.9 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.661 -1.154 . . . . 71.33 109.85 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 61.97 20.11 11.28 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.369 1.068 . . . . 63.53 112.136 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.8 t -119.72 116.43 50.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.535 -0.913 . . . . 74.13 108.535 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.38 125.9 44.15 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.077 0.951 . . . . 74.3 109.059 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.451 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.0 tt0 -83.6 132.55 34.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.911 -1.144 . . . . 75.44 107.911 164.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 56.1 t -112.43 139.71 35.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.088 -1.078 . . . . 74.42 108.088 166.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.402 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 47.1 t -121.44 124.88 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.792 -0.818 . . . . 64.31 108.792 171.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' C' ' 107' ' ' PHE . 1.1 tm? -104.42 106.09 16.45 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.712 -1.218 . . . . 61.33 107.712 172.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.517 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 0.8 OUTLIER -101.16 115.13 29.78 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.72 -1.127 . . . . 74.2 109.492 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.553 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.7 t -101.91 134.95 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.375 -0.972 . . . . 61.42 108.375 174.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -121.87 136.88 54.95 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.665 -0.865 . . . . 51.32 108.665 172.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.68 HG11 HD11 ' C' ' 126' ' ' LEU . 46.5 t -127.83 118.37 48.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 123.655 0.782 . . . . 65.42 109.329 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.453 HG23 HD23 ' C' ' 75' ' ' LEU . 3.2 m -102.53 144.63 30.71 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.011 -0.737 . . . . 64.43 109.011 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.17 114.22 9.0 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.391 -0.966 . . . . 71.15 108.391 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -131.2 142.33 50.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.413 0.685 . . . . 32.31 109.868 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.823 HD13 ' HG2' ' C' ' 34' ' ' LYS . 4.7 mt -94.34 16.81 14.14 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.949 1.3 . . . . 74.11 110.779 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.27 -87.71 0.35 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.78 -1.328 . . . . 62.41 109.78 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.53 -26.68 8.93 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.133 0.973 . . . . 72.44 110.567 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -82.77 119.0 23.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.707 0.803 . . . . 71.01 109.344 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -73.83 127.14 32.03 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.601 -0.518 . . . . 62.1 109.601 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.761 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.13 -54.76 7.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.162 -0.681 . . . . 63.44 109.162 173.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -169.28 173.39 6.69 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.335 -0.848 . . . . 74.23 110.924 176.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.453 HD23 HG23 ' C' ' 65' ' ' THR . 3.1 tm? -142.82 112.8 7.04 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.22 -1.4 . . . . 61.31 107.22 175.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -108.1 145.76 33.62 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.515 -0.92 . . . . 74.44 108.515 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -153.86 134.15 13.39 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.895 -0.78 . . . . 62.33 108.895 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 64.8 t -132.41 115.34 25.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.013 0.925 . . . . 75.41 108.898 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.517 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 57.8 mt-30 -93.53 89.9 6.46 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.32 -0.993 . . . . 64.34 108.32 174.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.7 102.16 13.96 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.152 0.581 . . . . 54.22 110.121 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.84 167.59 44.31 Favored Glycine 0 C--O 1.24 0.531 0 CA-C-O 121.175 0.319 . . . . 74.43 112.699 175.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -170.39 119.57 0.81 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.155 -0.778 . . . . 65.02 111.155 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.629 HD12 HD11 ' C' ' 51' ' ' LEU . 12.0 mm -82.9 132.35 31.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 109.129 -0.693 . . . . 74.21 109.129 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -134.28 119.89 19.28 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.322 0.649 . . . . 73.42 109.678 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 13.1 p -82.14 102.04 10.81 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.17 -1.048 . . . . 72.23 108.17 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.451 ' O ' HD12 ' C' ' 86' ' ' ILE . 2.5 pp -121.74 126.4 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 123.689 0.796 . . . . 74.32 110.982 -173.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.41 156.52 46.53 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.658 0.783 . . . . 65.34 109.899 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.42 -26.13 17.22 Favored Glycine 0 N--CA 1.476 1.314 0 N-CA-C 114.329 0.492 . . . . 71.12 114.329 172.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.626 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -87.28 145.81 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.056 0.543 . . . . 73.23 110.523 178.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.48 170.27 18.41 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.109 -0.95 . . . . 63.51 108.601 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.22 -119.27 6.86 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 124.118 0.887 . . . . 54.4 115.042 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 1.6 m -71.66 -32.35 67.79 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.641 1.176 . . . . 71.03 111.122 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -65.58 -43.16 90.64 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.466 0.707 . . . . 70.22 109.883 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 37.1 ttp -68.11 -40.73 82.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.17 -0.923 . . . . 74.41 110.593 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.8 -42.78 76.11 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 124.315 1.009 . . . . 61.42 110.697 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -83.14 -35.62 25.43 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.612 0.57 . . . . 63.11 111.956 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -58.0 -42.31 84.93 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.897 0.748 . . . . 64.1 110.62 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 21.9 mt -98.43 -24.91 14.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.266 -0.879 . . . . 63.22 110.686 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.61 -21.36 79.51 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.471 0.482 . . . . 55.45 114.174 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -158.26 -42.79 0.06 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.722 1.008 . . . . 75.45 113.722 -167.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.86 -46.63 74.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.915 0.486 . . . . 72.0 111.212 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.46 -49.06 54.3 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 124.254 1.022 . . . . 62.02 111.994 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -52.12 -34.44 58.15 Favored 'Trans proline' 0 C--N 1.399 3.186 0 C-N-CA 123.156 2.571 . . . . 62.0 114.654 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -60.23 -34.03 73.1 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.837 0.855 . . . . 71.11 111.722 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.474 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.9 mm -70.4 -37.33 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.183 0.593 . . . . 73.05 110.189 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.437 HD21 ' HA3' ' C' ' 82' ' ' GLY . 53.1 mt -87.73 -24.79 23.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.035 0.934 . . . . 72.53 112.587 -170.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.472 ' HA ' HD12 ' C' ' 60' ' ' LEU . 63.7 t80 -56.63 -48.74 96.64 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 117.812 -1.089 . . . . 74.04 113.853 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -55.33 -38.03 94.12 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 122.388 2.059 . . . . 72.21 113.234 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -67.25 -46.29 74.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.696 0.798 . . . . 74.02 110.467 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.43 ' O ' HG13 ' C' ' 114' ' ' ILE . . . -63.14 -38.99 93.35 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.669 -0.696 . . . . 74.35 110.878 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -57.25 -49.41 76.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.731 1.212 . . . . 65.21 111.079 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.63 -37.6 82.71 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 123.603 0.564 . . . . 60.33 110.084 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.3 t -68.18 -29.58 68.48 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.087 0.555 . . . . 73.05 111.443 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.553 HD11 ' HB ' ' C' ' 62' ' ' VAL . 74.1 mt -71.28 -50.45 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 108.949 -0.76 . . . . 53.34 108.949 172.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.532 HG21 ' HB3' ' B' ' 119' ' ' SER . 23.2 m -58.64 -35.12 72.01 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.679 0.792 . . . . 64.11 111.179 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.0 t -67.0 -54.14 24.63 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 123.813 0.845 . . . . 74.43 109.124 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.642 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.24 -38.71 80.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.487 1.115 . . . . 71.24 112.89 -177.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' C' ' 123' ' ' PHE . 67.1 t -65.98 -46.28 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.75 0.82 . . . . 72.41 110.165 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.471 ' OG ' HG21 ' B' ' 115' ' ' THR . 45.1 t -71.12 -24.12 62.22 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.617 -0.72 . . . . 73.14 111.582 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -69.44 -44.08 72.01 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.546 -0.909 . . . . 60.23 108.546 173.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.67 -1.59 72.34 Favored Glycine 0 C--N 1.357 1.744 0 O-C-N 123.712 0.632 . . . . 74.32 112.901 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 26.7 p 60.65 37.2 19.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.656 1.982 . . . . 64.11 113.359 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.458 ' HB2' HG13 ' C' ' 118' ' ' VAL . 91.4 m-85 -89.37 162.75 36.06 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-N 115.199 -0.909 . . . . 70.2 108.702 166.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.27 167.59 7.5 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.88 2.387 . . . . 75.44 113.301 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -51.66 131.69 30.19 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.706 1.202 . . . . 73.43 112.836 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.68 HD11 HG11 ' C' ' 64' ' ' VAL . 3.8 tt -136.3 85.08 2.12 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.306 -0.861 . . . . 63.35 108.918 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -95.48 124.22 39.41 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.818 -1.179 . . . . 54.52 107.818 171.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.05 134.9 47.44 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 108.487 -0.931 . . . . 71.42 108.487 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.5 152.39 34.32 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.311 1.044 . . . . 75.54 112.19 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.481 ' HG3' HD12 ' A' ' 16' ' ' ILE . 35.7 Cg_exo -56.33 92.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 122.566 2.177 . . . . 63.23 112.407 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.401 HG11 HD13 ' C' ' 44' ' ' LEU . 54.8 t -98.57 109.86 24.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 108.833 -0.803 . . . . 64.11 108.833 177.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -93.44 88.54 5.98 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.124 -1.436 . . . . 74.23 107.124 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -58.07 -32.79 68.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.495 0.718 . . . . 73.24 110.647 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.551 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 16.0 t70 -61.0 -39.03 88.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.878 0.871 . . . . 52.12 111.395 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.2 -39.22 71.91 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.244 0.617 . . . . 44.41 110.948 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 97.2 mt -67.79 -33.82 75.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.814 0.845 . . . . 72.43 112.232 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.0 t80 . . . . . 0 N--CA 1.48 1.066 0 C-N-CA 122.434 0.294 . . . . 73.3 110.994 -177.315 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 C--O 1.236 0.385 0 N-CA-C 108.845 -0.798 . . . . 72.41 108.845 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -165.81 92.08 0.51 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.479 -1.304 . . . . 73.35 107.479 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -123.32 117.16 24.61 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.277 -1.379 . . . . 74.03 107.277 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.503 HG21 HD11 ' D' ' 16' ' ' ILE . 27.8 mt -65.89 117.28 6.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.511 0 N-CA-C 108.798 -0.815 . . . . 74.45 108.798 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -83.79 -32.94 25.1 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 123.628 0.58 . . . . 72.21 111.111 -170.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -178.73 129.05 0.11 Allowed 'General case' 0 C--N 1.363 1.188 0 O-C-N 123.032 0.207 . . . . 73.44 110.705 -167.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.503 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -108.53 136.06 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.313 -1.365 . . . . 62.21 107.313 166.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.455 ' HE1' HG13 ' D' ' 83' ' ' ILE . 29.9 p90 -158.7 162.91 37.22 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.972 0.795 . . . . 74.34 111.055 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 56.9 p -97.8 114.39 26.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.033 -0.985 . . . . 62.24 109.442 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.549 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.5 mtpt -80.13 -22.85 41.62 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.592 -0.731 . . . . 75.43 109.786 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.2 t70 -163.04 139.49 7.27 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.755 -1.111 . . . . 52.12 109.236 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.642 HG21 ' HE2' ' C' ' 117' ' ' MET . 77.3 mt -134.9 146.67 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.565 1.146 . . . . 54.11 108.539 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -146.34 125.2 12.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.706 0.802 . . . . 74.54 109.801 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.498 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 80.7 t80 -123.85 132.65 53.8 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 106.889 -1.522 . . . . 64.01 106.889 163.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 41.6 mt-10 -131.82 134.9 46.29 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.033 -0.729 . . . . 72.11 109.033 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.73 82.29 68.98 Favored Pre-proline 0 C--O 1.242 0.703 0 N-CA-C 106.076 -1.824 . . . . 74.45 106.076 168.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.57 -36.02 35.49 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.515 2.143 . . . . 75.22 111.751 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 48.9 m-20 -105.76 11.21 32.3 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.106 0.962 . . . . 72.13 110.684 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.477 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -18.53 -72.65 0.02 OUTLIER Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 116.287 1.958 . . . . 61.22 116.287 -166.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.479 ' HB3' HD11 ' C' ' 83' ' ' ILE . 49.1 Cg_endo -79.02 -16.42 12.52 Favored 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 123.771 2.383 . . . . 65.11 114.078 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.507 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 5.9 t-160 -76.45 -37.45 56.94 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.431 1.093 . . . . 74.51 109.793 174.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.743 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.4 p -83.51 -23.94 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 116.108 -0.496 . . . . 71.35 111.642 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -67.46 -18.16 64.97 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 122.537 0.335 . . . . 71.01 111.811 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.507 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 75.7 mt-30 -57.76 -29.66 64.98 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.303 1.041 . . . . 74.33 110.778 175.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -95.41 91.8 6.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.981 0.913 . . . . 72.14 109.279 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.56 70.92 10.35 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 122.531 1.157 . . . . 72.12 109.296 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -130.92 161.43 31.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.287 -1.324 . . . . 75.24 108.269 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.99 107.9 2.04 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.121 0.968 . . . . 74.33 109.411 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.472 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 35.5 Cg_exo -61.72 122.33 10.86 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.206 2.604 . . . . 74.04 112.667 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 40.8 tt0 -57.0 114.94 2.33 Favored 'General case' 0 C--N 1.359 0.995 0 O-C-N 124.092 0.87 . . . . 74.05 110.025 -177.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.3 135.27 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.525 0.73 . . . . 72.2 111.556 -170.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -114.19 132.63 56.03 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 106.975 -1.491 . . . . 72.55 106.975 170.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.87 129.59 55.07 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.086 0.554 . . . . 72.0 110.161 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.578 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 17.5 t70 -112.92 128.83 56.58 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.634 1.174 . . . . 64.55 108.864 173.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 41.2 tp -98.92 133.45 43.19 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.542 -0.54 . . . . 71.11 109.542 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.3 t0 -153.52 155.8 36.89 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.734 -1.209 . . . . 55.24 107.734 174.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.7 t -145.96 169.27 18.96 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 122.909 0.484 . . . . 74.23 110.116 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.588 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.05 166.56 33.11 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.711 1.204 . . . . 74.42 108.521 173.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.412 ' HB2' ' CE2' ' D' ' 56' ' ' TYR . 64.9 p -173.25 153.24 2.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.885 0.474 . . . . 64.45 111.058 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 45.5 p -168.78 143.29 3.18 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.317 1.047 . . . . 73.43 109.654 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -83.8 125.25 31.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.137 0.575 . . . . 72.4 110.333 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.0 mt -96.13 -35.36 11.36 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.266 0.626 . . . . 72.12 111.298 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -155.12 -177.21 6.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.064 0.545 . . . . 61.03 110.71 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.37 120.25 8.41 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 123.91 0.756 . . . . 72.25 109.914 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.54 3.52 1.5 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.114 1.366 . . . . 75.41 112.521 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 92.6 t -109.78 119.45 58.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.141 -1.059 . . . . 72.33 108.141 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' D' ' 48' ' ' SER . 28.6 t80 -134.41 131.24 37.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.407 -0.815 . . . . 75.34 108.969 -173.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.451 ' HB2' HD11 ' D' ' 51' ' ' LEU . 17.3 tt0 -96.64 132.26 42.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.625 -0.716 . . . . 54.23 109.189 173.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.428 HG11 ' HD3' ' D' ' 103' ' ' PRO . 64.0 t -116.6 125.46 73.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.225 -1.398 . . . . 74.32 107.225 167.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 44.1 t -102.64 138.54 26.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.862 -0.792 . . . . 71.42 108.862 172.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.2 127.23 54.05 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.619 -1.252 . . . . 72.43 107.619 170.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.529 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 3.9 tmm_? -111.42 95.95 5.82 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.831 -1.174 . . . . 75.31 107.831 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 65.7 t -96.51 132.83 39.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.006 -0.997 . . . . 64.1 108.967 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 16.7 m -127.39 133.91 49.97 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.283 0.563 . . . . 74.14 109.502 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.02 102.41 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.534 1.533 . . . . 72.34 107.999 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 42.1 m -105.32 98.37 8.08 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.851 0.86 . . . . 60.43 109.448 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -104.72 149.86 25.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.856 0.462 . . . . 70.44 111.033 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.45 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 53.3 p -147.5 134.5 20.3 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.604 -0.725 . . . . 55.22 110.556 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.555 HD12 HG22 ' D' ' 31' ' ' VAL . 27.3 mt -98.76 110.94 23.46 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.308 -0.997 . . . . 72.22 108.308 174.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.76 -112.66 4.37 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 123.634 0.584 . . . . 73.25 112.812 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.94 16.8 16.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.407 1.083 . . . . 73.14 110.409 -172.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.425 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 12.8 pt-20 -141.22 155.33 46.05 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.466 0.706 . . . . 54.24 109.366 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -68.06 138.3 55.7 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 120.949 0.404 . . . . 64.33 110.527 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.743 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.96 -68.84 0.76 Allowed 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.535 -0.913 . . . . 62.11 108.535 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . 0.469 ' HZ ' HD13 ' D' ' 126' ' ' LEU . 50.2 p90 -152.96 149.24 28.0 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.61 -0.723 . . . . 73.22 110.252 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.6 mt -119.05 119.45 34.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.333 1.053 . . . . 73.52 108.234 175.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.449 ' SG ' ' HD1' ' D' ' 23' ' ' PHE . 1.3 m -121.9 104.92 9.89 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.167 0.987 . . . . 53.01 109.692 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -127.19 120.8 29.63 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.407 -0.96 . . . . 60.42 108.407 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -131.88 126.34 56.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 109.616 -0.512 . . . . 43.1 109.616 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.529 ' HG2' ' HG2' ' D' ' 61' ' ' ARG . 52.1 mt-30 -88.41 81.5 7.2 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.15 -1.056 . . . . 73.44 108.15 168.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.56 92.4 5.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.316 -1.311 . . . . 64.13 109.194 -178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.89 147.17 20.24 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.843 -0.617 . . . . 52.23 112.18 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.512 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.2 129.29 3.84 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 111.321 -0.712 . . . . 41.42 111.321 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.455 HG13 ' HE1' ' D' ' 17' ' ' TYR . 48.2 mt -93.78 140.47 16.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.066 0.946 . . . . 73.14 108.55 173.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -139.86 132.03 28.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.541 0.736 . . . . 72.21 109.018 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.6 m -87.5 94.91 9.84 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.633 -0.877 . . . . 72.23 108.633 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.411 HD12 ' SG ' ' D' ' 97' ' ' CYS . 2.3 tt -126.68 139.31 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 124.56 1.144 . . . . 75.3 110.103 -173.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.93 168.39 26.9 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.525 0.73 . . . . 70.34 111.752 -173.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.1 22.37 65.8 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 115.397 -0.819 . . . . 31.52 113.9 174.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.82 144.03 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.006 0.923 . . . . 55.31 110.665 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -142.64 161.88 36.93 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.856 0.862 . . . . 73.13 111.385 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.41 -122.39 29.67 Favored Glycine 0 C--N 1.355 1.597 0 O-C-N 124.606 1.191 . . . . 74.44 115.075 169.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.1 p -67.64 -26.18 66.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.807 0.843 . . . . 74.32 111.443 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -80.76 -38.68 28.18 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.193 0.597 . . . . 61.43 111.667 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 28.0 ptm -68.19 -34.61 76.6 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.471 -0.566 . . . . 74.42 109.471 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.74 -45.77 85.06 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.108 0.563 . . . . 64.22 110.245 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 11.4 t-80 -60.35 -44.51 95.49 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.655 1.182 . . . . 75.33 111.658 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . 0.411 ' SG ' HD12 ' D' ' 86' ' ' ILE . 16.2 t -76.14 -45.09 35.31 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.862 -173.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.61 -33.28 28.0 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.335 0.495 . . . . 72.15 112.335 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.21 -0.04 54.26 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 119.542 -0.588 . . . . 75.14 113.994 -173.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.447 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -141.99 -61.11 0.46 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.45 0.625 . . . . 74.24 111.429 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . 0.45 ' O ' HG12 ' D' ' 105' ' ' ILE . 72.6 t80 -66.21 -41.03 90.69 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.879 0.472 . . . . 71.1 112.202 -174.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.44 -45.87 19.24 Favored Pre-proline 0 CA--C 1.559 1.31 0 CA-C-O 118.277 -0.868 . . . . 53.3 111.091 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HD3' HG11 ' D' ' 58' ' ' VAL . 86.5 Cg_exo -53.27 -33.74 66.78 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 122.358 2.039 . . . . 52.11 113.438 166.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -67.28 -35.29 79.18 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.441 0.697 . . . . 64.11 110.038 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.45 HG12 ' O ' ' D' ' 101' ' ' TYR . 40.7 mm -70.34 -36.15 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.092 0.957 . . . . 75.32 110.733 174.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.512 HD21 ' HA3' ' D' ' 82' ' ' GLY . 96.5 mt -78.73 -21.09 48.58 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.851 0.86 . . . . 75.52 112.276 -176.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -66.77 -42.4 43.98 Favored Pre-proline 0 CA--C 1.562 1.414 0 CA-C-O 117.939 -1.029 . . . . 73.45 113.515 -172.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.44 -39.41 87.79 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 122.163 1.909 . . . . 73.41 113.133 170.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -74.8 -36.74 62.46 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.721 0.808 . . . . 71.44 111.872 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.85 73.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.222 -0.658 . . . . 73.04 109.222 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.431 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.6 ttp180 -57.47 -45.14 85.14 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 114.17 -1.377 . . . . 74.43 110.668 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.93 -51.76 62.94 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.944 0.778 . . . . 75.33 111.652 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -55.62 -40.71 72.49 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 123.822 0.701 . . . . 71.33 110.591 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.448 ' O ' HG23 ' D' ' 118' ' ' VAL . 54.9 mt -64.36 -53.5 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.836 1.254 . . . . 65.31 111.407 174.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.9 m -59.08 -36.77 75.66 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.356 1.062 . . . . 71.11 111.037 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -65.78 -44.32 86.14 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.885 -1.052 . . . . 74.23 109.842 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 66.0 mtm -69.34 -29.84 67.75 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.825 0.45 . . . . 75.52 111.9 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' D' ' 123' ' ' PHE . 76.0 t -64.36 -47.85 87.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.585 0.754 . . . . 72.33 110.049 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.5 p -69.71 -34.24 73.62 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.081 -0.509 . . . . 75.21 110.71 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -68.72 -33.05 73.28 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.637 0.775 . . . . 53.02 110.293 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.98 11.04 73.34 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.67 0.606 . . . . 74.05 112.636 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 63.9 p 57.33 32.16 21.31 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 126.044 1.738 . . . . 73.53 114.53 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.468 ' HB2' HG13 ' D' ' 118' ' ' VAL . 98.5 m-85 -95.89 150.8 37.8 Favored Pre-proline 0 N--CA 1.478 0.941 0 N-CA-C 108.323 -0.991 . . . . 64.41 108.323 168.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -59.94 147.37 93.03 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.659 2.239 . . . . 54.22 111.375 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -60.25 142.12 55.04 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 124.05 0.844 . . . . 73.54 112.794 -166.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.469 HD13 ' HZ ' ' D' ' 74' ' ' PHE . 0.8 OUTLIER -122.81 104.73 9.47 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.4 1.08 . . . . 64.13 109.263 -175.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -124.3 95.06 4.4 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.698 0.799 . . . . 71.35 109.665 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.35 139.38 54.21 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.803 -0.443 . . . . 62.41 109.803 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.73 136.94 93.04 Favored Pre-proline 0 CA--C 1.549 0.936 0 O-C-N 123.815 0.697 . . . . 45.22 109.669 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -68.09 133.01 27.59 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.271 1.981 . . . . 72.43 110.244 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.88 131.94 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.251 -0.648 . . . . 75.01 109.251 -170.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -77.64 89.81 3.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.745 -0.835 . . . . 54.31 108.745 172.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -64.01 -28.71 69.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.653 0.781 . . . . 63.53 111.297 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . 0.447 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 2.0 m-20 -56.83 -55.88 28.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.295 1.438 . . . . 65.44 112.966 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.95 -47.23 87.39 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.279 0.632 . . . . 72.34 111.446 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 mp -66.31 -29.16 69.32 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.86 -1.064 . . . . 54.1 111.36 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 85.4 t80 . . . . . 0 N--CA 1.477 0.875 0 C-N-CA 124.038 0.935 . . . . 72.31 111.265 179.492 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 90.9 m . . . . . 0 C--O 1.24 0.563 0 N-CA-C 109.21 -0.663 . . . . 75.01 109.21 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.586 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.3 t80 -137.44 135.14 36.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.804 -0.813 . . . . 75.42 108.804 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -150.08 117.46 6.08 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.084 -1.08 . . . . 52.32 108.084 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.455 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.6 mt -80.87 118.24 28.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.813 -0.81 . . . . 71.51 108.813 175.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.9 -40.54 31.96 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.851 -0.796 . . . . 64.01 108.851 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -169.47 145.96 3.32 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.48 -0.327 . . . . 73.22 110.845 -176.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.536 HD12 ' HG3' ' C' ' 130' ' ' PRO . 84.4 mt -129.55 136.25 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 124.303 1.041 . . . . 73.15 108.726 172.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -169.53 177.81 4.45 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.017 0.927 . . . . 74.34 111.029 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -99.66 123.62 44.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.316 -0.624 . . . . 61.23 109.316 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -84.27 -28.86 26.89 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 110.011 -0.366 . . . . 74.21 110.011 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -152.75 146.27 24.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.502 -0.772 . . . . 74.5 109.692 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.06 142.44 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.391 1.476 . . . . 55.44 107.045 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -149.89 144.29 25.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.047 0.451 . . . . 75.11 110.181 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.58 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 92.7 t80 -150.21 129.42 12.79 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.888 -1.523 . . . . 62.54 106.888 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.62 127.83 39.76 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.608 0.763 . . . . 64.21 109.247 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.496 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -132.36 79.81 64.76 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 107.156 -1.424 . . . . 73.41 107.156 171.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.25 -16.6 24.89 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.485 2.123 . . . . 70.41 111.364 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -107.44 13.89 26.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.699 1.199 . . . . 75.41 109.533 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.496 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -57.18 -45.71 99.9 Favored Pre-proline 0 CA--C 1.569 1.685 0 N-CA-C 114.258 1.207 . . . . 72.24 114.258 -170.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.62 -24.12 18.95 Favored 'Trans proline' 0 C--N 1.388 2.624 0 C-N-CA 121.818 1.679 . . . . 70.42 113.243 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -91.21 -21.88 20.9 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.62 0.768 . . . . 75.11 112.031 -171.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.465 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 12.0 p -69.77 -28.57 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.646 0.779 . . . . 72.05 111.722 -175.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -68.12 -36.21 79.36 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.828 0.851 . . . . 72.15 110.761 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -77.26 -46.45 23.06 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.328 -0.851 . . . . 74.33 111.346 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.603 ' NZ ' ' HG3' ' A' ' 71' ' ' GLU . 64.9 pttt -76.26 164.64 25.86 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.563 0.345 . . . . 74.23 110.165 176.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.98 141.21 36.19 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.869 0.467 . . . . 70.43 110.223 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -79.13 99.31 6.91 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.485 0.714 . . . . 65.42 109.593 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 35.6 tt0 -149.97 67.05 8.32 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.1 -0.704 . . . . 65.23 109.1 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.62 158.98 9.24 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.711 2.274 . . . . 65.41 113.162 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -94.67 99.68 11.75 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.194 -1.41 . . . . 71.41 107.194 170.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.4 m -78.06 93.72 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 114.576 -1.193 . . . . 65.33 110.816 -173.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 56.2 mttm -91.17 113.41 25.67 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.477 -1.238 . . . . 52.32 108.41 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.7 tp -116.67 119.01 34.15 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.145 -0.687 . . . . 71.34 109.145 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -130.06 151.05 51.02 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.64 0.776 . . . . 72.34 109.302 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.62 HD23 HG22 ' A' ' 62' ' ' VAL . 3.0 tm? -132.26 141.1 48.88 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.707 0.803 . . . . 64.41 109.208 -173.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.416 ' H ' HD22 ' A' ' 44' ' ' LEU . 32.3 t70 -135.47 119.71 17.78 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.264 1.026 . . . . 62.53 109.145 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.2 m -111.72 130.17 55.87 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.126 0.97 . . . . 74.5 109.122 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.93 152.47 51.06 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.512 -0.921 . . . . 62.11 108.512 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.2 t -125.78 152.07 45.89 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.651 -0.5 . . . . 74.42 109.651 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 t -150.65 133.12 15.61 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.921 0.889 . . . . 61.33 109.084 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -77.85 131.45 37.54 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.501 -0.555 . . . . 73.34 109.501 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.437 HD12 HG23 ' A' ' 83' ' ' ILE . 70.8 mt -107.12 -41.98 5.0 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.865 0.866 . . . . 74.21 109.705 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.87 -175.01 4.64 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.678 -1.146 . . . . 74.21 109.272 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.69 114.11 3.11 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.427 0.691 . . . . 65.25 110.457 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.75 12.67 7.84 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.414 1.086 . . . . 74.24 112.105 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.1 t -101.68 112.56 35.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 124.909 1.284 . . . . 71.5 107.92 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -125.17 126.7 45.66 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.718 0.807 . . . . 71.02 109.292 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -101.94 126.91 48.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.74 -1.118 . . . . 75.11 108.477 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 m -100.89 133.33 44.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.99 -1.115 . . . . 73.05 107.99 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.62 110.68 26.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 107.972 -1.122 . . . . 63.14 107.972 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.0 tp -90.51 98.41 11.76 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.042 -0.725 . . . . 73.54 109.042 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.8 ttp85 -95.81 100.87 12.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.635 0.774 . . . . 64.22 109.712 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.62 HG22 HD23 ' A' ' 44' ' ' LEU . 12.3 t -97.15 117.29 41.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.219 -1.03 . . . . 75.04 108.219 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.0 t -107.55 141.89 38.29 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.734 0.778 . . . . 53.41 109.936 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 59.0 t -131.29 109.34 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.755 1.622 . . . . 41.32 107.641 -173.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 26.7 m -110.65 107.73 17.41 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.793 -0.818 . . . . 54.55 108.793 175.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.63 104.69 14.05 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 106.996 -1.483 . . . . 72.33 106.996 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.8 p -149.56 127.79 12.08 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.691 0.396 . . . . 74.3 110.569 -172.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -90.12 84.55 6.13 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.886 -0.783 . . . . 73.42 108.886 177.247 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.38 -104.8 1.81 Allowed Glycine 0 C--N 1.35 1.307 0 CA-C-N 115.065 -0.97 . . . . 61.54 112.283 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -97.28 -5.23 37.19 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.587 0.755 . . . . 74.45 110.314 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.603 ' HG3' ' NZ ' ' A' ' 34' ' ' LYS . 36.1 tp10 -112.22 94.65 5.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.606 1.162 . . . . 64.34 108.97 -169.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -71.45 138.41 49.0 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.424 0.289 . . . . 65.31 111.273 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.28 -59.45 2.25 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.944 0.898 . . . . 43.42 108.943 173.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -157.41 174.9 14.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.306 -0.861 . . . . 62.42 111.324 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -140.55 138.82 34.79 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.176 1.39 . . . . 75.25 107.896 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.493 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.9 m -141.28 139.51 33.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.96 0.904 . . . . 61.45 109.064 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -150.74 122.5 8.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.206 0.457 . . . . 44.54 109.826 174.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.3 t -122.35 132.85 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 123.875 0.87 . . . . 72.14 109.592 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.57 HE21 ' N ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -109.01 86.75 2.34 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.357 1.063 . . . . 74.03 108.293 174.413 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.09 103.18 8.85 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.96 -1.018 . . . . 71.14 108.462 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.39 142.84 16.38 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 111.368 -0.693 . . . . 65.33 111.368 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.546 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -140.61 123.51 2.38 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 111.142 -0.783 . . . . 30.21 111.142 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.437 HG23 HD12 ' A' ' 51' ' ' LEU . 44.1 mt -80.69 118.45 28.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.838 -0.801 . . . . 75.34 108.838 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.586 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 42.1 m-85 -125.22 119.35 28.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.887 0.475 . . . . 74.02 109.901 -176.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 m -86.82 105.0 16.71 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.845 -0.798 . . . . 63.4 108.845 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.554 ' HB ' HD11 ' A' ' 89' ' ' ILE . 43.5 pt -107.23 143.92 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.434 0.694 . . . . 73.4 110.75 -175.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.595 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -156.84 156.51 33.31 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.973 0.909 . . . . 74.32 109.778 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.0 7.04 87.63 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.897 0.719 . . . . 71.24 114.897 173.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.554 HD11 ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -122.31 156.21 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 108.686 -0.857 . . . . 54.22 108.686 172.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -157.61 173.95 16.09 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.242 0.617 . . . . 63.11 109.359 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.46 -136.64 47.38 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.514 0.509 . . . . 64.32 114.153 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -80.71 -16.14 54.69 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.537 0.735 . . . . 74.51 111.215 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' A' ' 96' ' ' HIS . 35.4 tt0 -67.64 -36.45 80.8 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.002 0.921 . . . . 52.25 109.598 171.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 34.2 ttp -76.83 -33.23 57.94 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.905 -1.043 . . . . 73.44 110.922 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -28.31 69.19 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.034 0.445 . . . . 71.54 110.583 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.409 ' HB3' ' O ' ' A' ' 93' ' ' GLN . 50.3 t-80 -64.57 -37.02 86.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.355 -0.839 . . . . 73.44 110.526 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 64.1 m -64.75 -35.74 82.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 122.871 0.469 . . . . 75.04 110.87 177.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 tt -72.96 -49.92 26.4 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.088 0.555 . . . . 71.23 109.983 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.15 4.8 52.28 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 115.059 0.784 . . . . 73.34 115.059 -165.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -145.57 -65.95 0.31 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.188 0.994 . . . . 62.3 112.201 -175.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.565 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 69.0 t80 -69.33 -66.6 0.56 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.927 -1.033 . . . . 62.41 113.402 -166.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.451 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 85.8 m -67.6 -35.06 7.46 Favored Pre-proline 0 CA--C 1.566 1.571 0 N-CA-C 114.079 1.14 . . . . 64.3 114.079 -174.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 27.9 Cg_endo -62.76 -30.15 77.76 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 122.015 1.81 . . . . 65.21 112.91 168.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -71.72 -27.86 63.3 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.091 0.556 . . . . 75.12 110.982 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.6 mm -59.31 -41.96 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-O 121.441 0.639 . . . . 74.13 109.872 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.546 HD21 ' HA3' ' A' ' 82' ' ' GLY . 84.1 mt -83.34 -16.24 46.89 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.035 -0.984 . . . . 73.13 112.581 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.79 -43.53 69.63 Favored Pre-proline 0 CA--C 1.561 1.366 0 N-CA-C 113.819 1.044 . . . . 74.12 113.819 -172.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -59.6 -37.55 87.65 Favored 'Trans proline' 0 C--N 1.387 2.574 0 CA-C-N 121.745 1.659 . . . . 64.24 112.7 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -69.89 -43.03 72.6 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.579 -0.737 . . . . 74.32 111.284 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.23 -39.24 82.37 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.13 0.572 . . . . 55.02 110.573 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.546 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.8 ttm180 -49.75 -55.1 15.23 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.645 1.215 . . . . 61.4 109.887 174.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -66.64 -44.09 82.9 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.055 -0.975 . . . . 71.5 111.569 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.1 t -60.43 -26.17 66.52 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.09 0.556 . . . . 63.12 111.844 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' A' ' 62' ' ' VAL . 95.6 mt -83.25 -52.23 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.75 0.82 . . . . 75.34 109.759 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.4 m -54.88 -50.88 67.62 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.818 0.847 . . . . 45.24 111.631 -173.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 47.1 t -59.6 -45.18 92.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.745 -1.116 . . . . 44.21 110.441 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 45.6 ttp -68.66 -35.05 76.72 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.073 0.949 . . . . 74.24 111.695 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.66 -41.26 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.096 0.958 . . . . 74.32 109.785 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.7 m -72.56 -24.41 61.11 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.334 -0.848 . . . . 70.12 111.467 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.45 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.8 mtt-85 -73.76 -30.95 63.07 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.521 0.729 . . . . 63.32 109.665 174.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.06 -1.64 80.28 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.658 -0.701 . . . . 41.01 112.637 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.8 m 69.16 21.0 7.4 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 125.161 1.384 . . . . 71.32 111.223 175.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.15 158.71 69.37 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 115.274 -0.875 . . . . 71.34 109.335 170.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.55 144.97 91.06 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.277 1.985 . . . . 72.02 111.54 173.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -59.35 134.53 57.09 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.621 0.768 . . . . 75.23 111.92 -173.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -117.32 102.46 9.27 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.211 -0.904 . . . . 70.42 109.803 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -102.03 108.04 19.35 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.12 -1.067 . . . . 73.14 108.12 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.16 117.34 10.68 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.066 -0.716 . . . . 64.41 109.066 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.33 139.14 96.39 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 122.841 0.456 . . . . 51.21 110.883 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -53.04 106.66 0.16 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.04 2.494 . . . . 74.13 111.877 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.46 133.06 42.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.578 0.704 . . . . 65.24 109.293 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -82.04 71.93 9.09 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.462 -1.245 . . . . 60.2 112.126 -170.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.509 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 35.2 m-85 -53.68 -41.05 66.47 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.612 0.765 . . . . 70.33 111.582 177.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 138' ' ' MET . 7.0 m-20 -68.85 -42.05 77.63 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.007 -0.997 . . . . 63.01 111.401 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.02 81.09 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.073 0.549 . . . . 62.53 110.981 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.53 -38.41 80.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.738 -1.119 . . . . 74.41 110.511 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -73.82 -37.64 64.81 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.539 -0.755 . . . . 65.44 110.347 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 20.1 mmt . . . . . 0 N--CA 1.491 1.622 0 C-N-CA 123.357 0.663 . . . . 74.55 111.551 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 72.3 m . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 108.041 -1.096 . . . . 74.42 108.041 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.34 157.63 44.59 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.73 0.3 . . . . 73.11 110.798 163.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.545 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -123.03 121.4 35.98 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 107.634 -1.247 . . . . 75.53 107.634 177.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 36.2 mt -71.71 119.87 18.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.572 -0.899 . . . . 74.13 108.572 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.542 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 84.2 mm-40 -82.54 -39.33 22.49 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.185 -0.916 . . . . 72.53 109.913 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.5 ttt85 -174.06 134.89 0.45 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.101 -0.954 . . . . 74.31 109.583 -174.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -114.69 140.01 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 106.623 -1.621 . . . . 71.54 106.623 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -166.63 155.39 10.59 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.465 0.65 . . . . 64.04 111.639 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.402 HG21 HD11 ' B' ' 21' ' ' ILE . 96.2 m -83.19 127.01 33.24 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.684 -1.144 . . . . 71.03 109.059 171.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.467 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.0 mtpt -98.4 -22.22 16.17 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.68 0.792 . . . . 73.12 110.916 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -164.65 137.58 4.81 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 123.423 0.452 . . . . 42.04 110.86 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.452 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.2 mm -127.0 144.94 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.796 1.238 . . . . 70.42 109.276 173.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.474 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.1 t -145.04 138.88 27.03 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.464 -1.244 . . . . 74.52 107.66 174.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -153.98 123.03 6.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.277 -1.379 . . . . 72.12 107.277 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -124.21 138.22 54.43 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.144 -0.687 . . . . 75.34 109.144 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.31 83.87 64.05 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 106.723 -1.584 . . . . 73.35 106.723 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.15 -36.42 29.13 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.026 2.484 . . . . 74.12 112.998 -169.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -105.37 17.15 24.43 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.366 0.666 . . . . 60.33 110.588 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.629 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -36.28 -65.76 0.3 Allowed Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 115.002 1.482 . . . . 70.11 115.002 -164.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 23.1 Cg_exo -62.5 -24.99 75.61 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 122.527 2.151 . . . . 75.33 113.05 -174.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.457 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 63.4 m80 -95.25 -28.65 14.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.869 -1.06 . . . . 72.21 112.291 -173.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.745 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.2 p -78.85 -20.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 120.952 0.406 . . . . 73.25 111.34 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -67.75 -11.89 59.38 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.309 0.855 . . . . 62.31 113.309 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.9 pt20 -63.89 -34.48 78.05 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.016 0.527 . . . . 72.43 110.804 176.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -83.86 101.43 11.65 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.581 0.752 . . . . 73.14 109.582 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -85.51 90.08 7.87 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.092 -0.707 . . . . 74.33 109.092 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -157.85 158.46 35.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.706 1.202 . . . . 73.51 108.363 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -83.37 103.24 2.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.214 1.006 . . . . 73.35 108.476 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.89 135.37 66.38 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.373 2.715 . . . . 60.21 113.496 -168.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.3 125.8 25.05 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 123.908 0.755 . . . . 71.43 109.487 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.45 128.21 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.579 0.752 . . . . 60.35 112.078 -165.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -107.52 129.66 54.94 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.584 1.154 . . . . 53.53 108.458 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.5 146.67 23.61 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.314 -0.995 . . . . 65.44 108.314 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 21.9 t70 -140.21 112.31 7.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.342 -0.985 . . . . 73.21 108.342 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 74.0 mt -100.16 149.9 23.06 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.737 -0.468 . . . . 74.52 109.737 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' B' ' 61' ' ' ARG . 20.6 t70 -153.19 114.82 4.25 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.714 0.805 . . . . 74.04 109.275 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -110.38 114.41 27.84 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.209 0.604 . . . . 71.42 110.39 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.67 155.38 30.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.388 1.075 . . . . 21.41 108.729 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.3 p -144.19 164.45 30.68 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.439 0.296 . . . . 72.42 110.939 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -158.1 139.03 13.12 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.542 0.737 . . . . 72.44 109.939 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -80.83 113.89 19.34 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.46 0.704 . . . . 63.53 109.786 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.02 -42.68 37.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.835 0.454 . . . . 60.02 110.619 176.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.6 -175.32 5.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.273 -0.876 . . . . 73.43 110.25 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.03 117.22 3.78 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.376 -0.829 . . . . 73.33 109.862 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 71.3 1.0 3.65 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.708 1.203 . . . . 75.11 112.494 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.403 HG22 ' OG ' ' B' ' 85' ' ' SER . 48.0 t -104.72 114.55 44.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 124.725 1.21 . . . . 62.04 107.927 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -123.29 140.57 52.88 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.039 -1.097 . . . . 74.1 108.039 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -116.12 107.47 14.95 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.353 -1.351 . . . . 74.23 107.353 -174.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 99.3 t -89.22 143.37 11.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 C-N-CA 124.467 1.107 . . . . 73.01 109.461 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.408 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 36.5 t -125.95 128.64 72.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.543 -0.91 . . . . 60.22 108.543 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -114.1 108.02 16.43 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.8 -1.185 . . . . 73.02 107.8 -177.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.499 ' HD2' ' HB3' ' B' ' 45' ' ' ASP . 38.1 ttm180 -93.44 123.59 36.84 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.676 -0.49 . . . . 74.33 109.676 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.455 ' HB ' HD11 ' B' ' 114' ' ' ILE . 44.2 t -118.29 103.12 14.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.284 -1.376 . . . . 62.14 107.284 168.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 15.7 m -98.33 126.52 43.87 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.967 -0.753 . . . . 53.31 108.967 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.496 HG21 HG21 ' B' ' 114' ' ' ILE . 58.0 t -113.75 120.2 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 123.975 0.91 . . . . 71.24 109.774 -176.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 77.9 m -109.74 135.74 50.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.631 -0.877 . . . . 63.15 108.631 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.27 142.88 27.66 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.278 0.631 . . . . 74.24 109.599 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.456 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 37.1 p -148.05 137.09 22.02 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.223 -0.444 . . . . 71.41 111.999 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.672 HD12 HG22 ' B' ' 31' ' ' VAL . 39.1 mt -96.2 104.83 16.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.039 0.936 . . . . 74.23 110.053 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.2 -113.46 5.9 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.151 -0.932 . . . . 54.31 113.143 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -107.98 21.89 16.75 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.713 0.805 . . . . 74.51 110.945 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -140.77 157.77 44.92 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.755 -0.591 . . . . 62.35 109.854 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 38.1 m -73.54 135.42 43.97 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.805 -0.443 . . . . 64.45 109.805 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.745 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -90.99 -66.2 0.95 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.56 -1.274 . . . . 64.11 107.56 174.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -150.18 161.87 41.57 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.844 0.83 . . . . 61.24 110.689 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.0 149.85 50.24 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.946 1.698 . . . . 60.52 106.76 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.429 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 48.6 t -154.91 159.82 40.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.551 -0.537 . . . . 70.23 109.551 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.474 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 38.7 tt0 -164.44 129.58 2.76 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.486 -0.931 . . . . 42.12 108.486 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 78.7 t -124.2 142.24 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 107.993 -1.114 . . . . 74.35 107.993 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -123.03 84.47 2.27 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.15 -1.055 . . . . 72.52 108.15 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.536 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.2 tp-100 -80.27 100.42 8.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.731 -1.122 . . . . 73.44 109.215 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.467 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -89.77 165.8 32.31 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.415 -0.674 . . . . 42.02 111.415 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.426 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -166.01 134.41 3.28 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.154 -0.779 . . . . 61.02 111.154 -175.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 24.5 mt -97.87 127.35 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.955 0.902 . . . . 71.04 108.727 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -131.78 133.66 44.98 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 107.793 -1.188 . . . . 74.03 107.793 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.403 ' OG ' HG22 ' B' ' 55' ' ' VAL . 40.4 m -110.76 94.27 4.91 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.593 -0.521 . . . . 74.43 109.593 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.49 ' HB ' HD11 ' B' ' 89' ' ' ILE . 32.5 pt -95.88 138.42 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.396 0.678 . . . . 72.51 111.65 -167.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.54 149.87 33.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.386 1.074 . . . . 64.14 109.299 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.29 -31.21 8.92 Favored Glycine 0 N--CA 1.473 1.131 0 C-N-CA 123.256 0.455 . . . . 71.11 112.821 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.49 HD11 ' HB ' ' B' ' 86' ' ' ILE . 9.7 pt -91.48 151.22 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.787 0.835 . . . . 61.34 111.7 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.96 148.83 17.44 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.655 -1.157 . . . . 73.22 108.749 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.17 -132.85 13.96 Favored Glycine 0 C--N 1.343 0.96 0 O-C-N 123.352 0.407 . . . . 62.23 112.608 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.4 m -74.54 -20.5 59.94 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.197 0.599 . . . . 71.11 112.183 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -59.87 -45.05 93.71 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.721 0.772 . . . . 61.42 109.804 170.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.49 ' HA ' HD12 ' B' ' 89' ' ' ILE . 9.8 tmm? -72.43 -38.07 68.44 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.37 -1.287 . . . . 64.53 110.57 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.0 -40.58 70.26 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.552 0.691 . . . . 70.24 110.593 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -71.38 -41.8 69.21 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.586 -1.188 . . . . 72.34 111.346 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.2 t -66.51 -60.1 3.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.955 0.502 . . . . 74.51 111.394 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.86 -41.18 78.78 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.824 0.849 . . . . 72.34 110.305 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.11 -34.39 41.87 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.318 0.387 . . . . 74.43 114.045 -171.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.43 -50.72 1.76 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 112.545 0.572 . . . . 62.13 112.545 -168.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -73.78 -35.78 64.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.692 0.797 . . . . 71.54 112.22 -171.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 97.1 m -70.83 -48.53 14.97 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 123.228 0.611 . . . . 71.04 111.053 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.485 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 75.3 Cg_exo -55.36 -34.82 90.17 Favored 'Trans proline' 0 C--N 1.399 3.232 0 C-N-CA 122.272 1.982 . . . . 65.41 113.542 168.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -58.72 -39.56 81.21 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.657 0.783 . . . . 75.12 110.758 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.61 -41.4 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.963 0.905 . . . . 72.1 110.791 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.426 HD21 ' HA3' ' B' ' 82' ' ' GLY . 59.8 mt -81.26 -16.15 53.47 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.683 0.793 . . . . 74.11 112.098 -173.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -61.8 -47.95 90.6 Favored Pre-proline 0 CA--C 1.558 1.285 0 N-CA-C 113.987 1.106 . . . . 74.32 113.987 -171.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.07 -34.46 89.9 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 121.744 1.63 . . . . 72.33 113.054 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.536 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 88.3 m-85 -65.05 -46.8 79.73 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.507 0.504 . . . . 73.24 110.32 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.6 96.92 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.532 0.733 . . . . 71.22 110.585 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -57.74 -55.93 28.54 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.203 1.001 . . . . 64.3 110.688 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.06 -34.56 77.85 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.866 0.728 . . . . 74.41 110.489 -175.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' B' ' 117' ' ' MET . 2.7 t -69.96 -38.07 76.01 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.029 -0.532 . . . . 51.43 111.18 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.496 HG21 HG21 ' B' ' 64' ' ' VAL . 72.5 mt -65.73 -54.84 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.29 0.636 . . . . 70.12 109.665 174.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.9 m -61.6 -26.46 67.99 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 124.215 0.947 . . . . 52.41 111.647 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.6 t -61.73 -55.57 28.86 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.476 0.711 . . . . 75.32 109.199 171.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -66.45 -33.73 76.36 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.693 0.797 . . . . 72.52 111.716 -174.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.8 t -59.49 -48.65 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.048 0.939 . . . . 73.41 110.272 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.727 ' HB2' HE21 ' C' ' 125' ' ' GLN . 13.0 t -76.37 -21.0 56.63 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.277 -0.874 . . . . 71.2 111.216 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.7 mtt-85 -67.65 -41.71 83.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.852 -0.796 . . . . 72.15 108.852 172.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.7 -0.47 80.53 Favored Glycine 0 C--N 1.36 1.879 0 O-C-N 123.767 0.667 . . . . 61.44 113.018 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 62.33 42.26 9.36 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.762 2.025 . . . . 72.34 113.061 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -97.65 159.66 30.51 Favored Pre-proline 0 CA--C 1.56 1.346 0 C-N-CA 124.04 0.936 . . . . 75.22 110.158 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -62.74 178.41 1.0 Allowed 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.516 2.81 . . . . 63.24 114.637 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.62 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 23.5 tp60 -66.17 114.94 5.66 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.875 -1.057 . . . . 62.51 112.491 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 7.4 mp -116.76 91.31 3.55 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.145 -0.687 . . . . 73.34 109.145 167.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.448 HD21 ' HA ' ' C' ' 122' ' ' THR . 77.8 m-20 -92.5 107.1 18.96 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.155 -1.054 . . . . 73.32 108.155 170.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 18.4 tp -71.71 126.02 28.62 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 123.64 0.587 . . . . 74.42 110.677 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.06 144.55 98.83 Favored Pre-proline 0 CA--C 1.55 0.954 0 O-C-N 124.702 1.251 . . . . 65.02 110.96 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.442 ' HG3' HD11 ' D' ' 16' ' ' ILE . 28.2 Cg_endo -61.67 112.39 1.46 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.239 2.626 . . . . 72.35 111.396 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.29 107.26 17.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 106.136 -1.801 . . . . 44.2 106.136 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -82.46 82.2 7.99 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 107.236 -1.394 . . . . 74.43 107.236 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -63.69 -27.59 69.32 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.695 -1.139 . . . . 74.54 110.068 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.43 -44.05 92.4 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.225 1.41 . . . . 63.1 111.424 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.32 -39.63 78.1 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.547 0.739 . . . . 53.25 110.322 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 85.7 mt -72.83 -23.84 60.82 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.381 -0.827 . . . . 61.32 110.734 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 51.3 t80 . . . . . 0 N--CA 1.48 1.026 0 C-N-CA 124.002 0.921 . . . . 73.44 110.889 -179.803 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 98.4 m . . . . . 0 C--O 1.241 0.608 0 N-CA-C 107.642 -1.244 . . . . 74.14 107.642 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.435 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.2 t80 -124.99 119.29 28.3 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.916 -1.142 . . . . 74.04 107.916 171.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -141.02 125.21 17.37 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 107.25 -1.389 . . . . 73.15 107.25 170.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.469 HD13 HD11 ' C' ' 16' ' ' ILE . 61.2 mt -74.35 120.53 23.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.103 -0.703 . . . . 31.33 109.103 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.564 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 16.3 mm-40 -86.94 -35.24 19.0 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.808 -1.087 . . . . 71.4 109.454 -176.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -174.16 147.79 1.26 Allowed 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.659 0.599 . . . . 63.44 109.987 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.469 HD11 HD13 ' C' ' 13' ' ' ILE . 92.1 mt -138.39 134.66 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.871 -1.159 . . . . 74.1 107.871 174.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.462 ' HB3' HG23 ' D' ' 122' ' ' THR . 34.0 p90 -171.59 168.94 6.21 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.602 0.715 . . . . 71.33 111.728 -169.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -93.28 114.68 27.19 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.217 -0.901 . . . . 72.43 109.034 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.406 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 10.2 mmmm -68.82 -39.82 79.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.037 0.922 . . . . 73.24 108.875 168.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.0 t70 -145.33 140.18 27.55 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 113.991 -1.459 . . . . 71.54 109.819 -173.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 81.2 mt -135.25 145.92 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.504 -1.665 . . . . 65.44 106.504 170.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -156.59 149.12 23.51 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.008 0.432 . . . . 73.54 110.242 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -141.97 131.11 23.33 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.705 -1.22 . . . . 72.22 107.705 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -135.28 115.9 13.79 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.507 1.123 . . . . 73.01 108.046 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' C' ' 28' ' ' ALA . . . -108.32 91.8 8.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 105.195 -2.15 . . . . 64.32 105.195 167.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.02 -36.52 97.98 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.244 2.629 . . . . 73.42 112.942 -167.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -125.41 43.16 3.12 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.762 -1.108 . . . . 73.14 108.915 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.472 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -42.61 -60.68 2.06 Favored Pre-proline 0 CA--C 1.568 1.671 0 N-CA-C 115.213 1.56 . . . . 72.03 115.213 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 19.2 Cg_exo -62.35 -39.14 48.82 Favored 'Trans proline' 0 C--N 1.391 2.801 0 CA-C-N 122.02 1.757 . . . . 72.11 112.088 -178.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -68.76 -33.77 74.45 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.033 -1.44 . . . . 73.52 111.991 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.914 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.5 p -81.82 -27.54 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 122.947 0.499 . . . . 70.11 111.99 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -68.24 -34.19 75.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.738 0.415 . . . . 74.01 111.758 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -86.55 7.06 27.77 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 122.894 0.477 . . . . 72.44 111.299 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.91 170.2 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.88 0.872 . . . . 73.41 109.944 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.45 129.25 37.89 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.676 0.791 . . . . 74.32 110.377 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 31.3 t90 -79.97 88.37 5.34 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.861 0.865 . . . . 74.34 110.186 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.487 ' H ' HD22 ' C' ' 68' ' ' LEU . 0.6 OUTLIER -144.35 73.39 15.88 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 107.353 -1.351 . . . . 73.43 107.353 174.177 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -76.67 119.05 5.03 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.05 2.5 . . . . 75.51 113.698 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.63 88.12 7.32 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.95 -1.5 . . . . 64.35 106.95 166.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.1 136.73 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 114.36 -1.291 . . . . 72.31 110.17 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -128.82 110.27 12.0 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.2 1.0 . . . . 75.21 108.864 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.78 122.56 29.3 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.146 -1.057 . . . . 70.34 108.146 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -120.23 132.05 55.19 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.101 -1.074 . . . . 75.21 108.101 174.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.58 HD21 ' HE1' ' C' ' 133' ' ' PHE . 15.3 tp -125.5 152.61 44.75 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.666 -0.865 . . . . 70.04 108.666 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.4 t70 -151.66 147.95 27.35 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.871 0.869 . . . . 70.32 108.982 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -146.22 133.2 20.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.82 0.848 . . . . 72.11 109.691 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.45 161.75 36.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.636 1.174 . . . . 64.31 107.978 171.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 16.7 m -138.55 151.58 47.44 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.866 -0.79 . . . . 74.12 108.866 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 17.9 p -142.19 128.62 20.08 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.733 0.813 . . . . 73.34 109.263 -170.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -73.88 118.26 16.63 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.728 -0.669 . . . . 62.14 110.146 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' C' ' 57' ' ' GLU . 32.8 mt -92.5 -31.69 15.15 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.081 -0.711 . . . . 64.3 109.081 172.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.85 -179.38 7.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.394 1.078 . . . . 75.52 110.457 176.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -62.87 119.11 8.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.214 -0.903 . . . . 64.33 109.467 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 7.1 m-20 65.32 17.98 11.19 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.226 1.011 . . . . 71.1 112.234 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 74.1 t -124.41 115.65 45.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 108.218 -1.03 . . . . 61.42 108.218 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -128.82 131.48 47.74 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.935 0.894 . . . . 75.43 109.5 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.608 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.3 tt0 -83.75 114.94 21.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.775 -1.102 . . . . 71.41 108.135 166.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.47 HG11 ' HD3' ' C' ' 103' ' ' PRO . 76.2 t -96.03 137.87 22.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.671 -0.863 . . . . 41.25 108.671 173.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.95 131.8 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.171 -1.048 . . . . 72.42 108.171 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.458 HD21 HD11 ' C' ' 44' ' ' LEU . 1.0 OUTLIER -121.12 104.57 9.87 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.212 -1.403 . . . . 64.51 107.212 176.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.491 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 2.7 ttm180 -93.94 121.89 35.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.426 -1.261 . . . . 73.34 108.954 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.8 t -116.11 120.41 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.729 -1.212 . . . . 61.1 107.729 174.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 29.4 m -124.34 114.2 19.22 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.985 0.914 . . . . 63.2 108.714 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.642 HG11 HD11 ' C' ' 126' ' ' LEU . 43.8 t -107.56 120.1 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.857 -0.794 . . . . 73.43 108.857 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.4 m -104.54 150.6 24.48 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.669 -0.863 . . . . 75.34 108.669 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' C' ' 73' ' ' ALA . . . -141.86 137.16 31.23 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.361 -0.977 . . . . 73.42 108.361 172.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.2 m -145.1 133.47 21.8 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.23 0.612 . . . . 71.34 110.132 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.487 HD22 ' H ' ' C' ' 37' ' ' GLN . 18.2 mt -85.28 53.78 2.87 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.643 1.177 . . . . 54.11 108.999 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.82 -87.05 0.55 Allowed Glycine 0 C--N 1.342 0.867 0 N-CA-C 110.111 -1.195 . . . . 45.23 110.111 -167.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -125.55 -13.74 6.47 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.124 0.97 . . . . 51.51 111.664 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -76.24 116.59 17.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.253 0.621 . . . . 61.02 109.721 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.5 m -74.85 122.26 23.1 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.416 0.553 . . . . 71.15 110.083 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.914 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.89 -61.9 1.73 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.788 -1.096 . . . . 71.45 108.709 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -155.03 173.95 15.86 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 114.574 -1.193 . . . . 54.33 111.768 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.51 139.59 26.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 104.958 -2.238 . . . . 62.42 104.958 169.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.9 t -149.04 111.55 4.74 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.026 -0.731 . . . . 72.42 109.026 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -117.84 127.39 53.82 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.0 0.52 . . . . 73.41 109.82 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.97 114.03 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.137 0.975 . . . . 73.42 108.6 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.539 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 74.1 mt-30 -92.34 91.0 7.48 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.864 -0.791 . . . . 71.34 108.864 173.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.468 ' HG3' HD22 ' C' ' 106' ' ' LEU . 7.9 tp-100 -80.95 99.71 8.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.122 -0.945 . . . . 71.3 109.76 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.8 145.61 17.86 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.786 -0.526 . . . . 74.33 111.786 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.14 133.22 4.28 Favored Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 110.775 -0.93 . . . . 74.04 110.775 -175.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.595 HD12 HD11 ' C' ' 51' ' ' LEU . 8.7 mm -87.52 120.57 36.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 108.452 -0.944 . . . . 63.54 108.452 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.435 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 63.1 m-85 -127.79 126.22 41.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.455 0.702 . . . . 40.13 109.184 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 59.2 p -82.81 122.95 28.88 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.596 -0.89 . . . . 72.33 108.596 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.621 ' HB ' HD11 ' C' ' 89' ' ' ILE . 47.0 pt -117.24 142.36 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.892 0.877 . . . . 72.14 109.983 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.54 159.4 21.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.73 0.812 . . . . 62.34 109.194 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.04 -38.19 3.16 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 121.401 0.445 . . . . 72.11 113.27 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.621 HD11 ' HB ' ' C' ' 86' ' ' ILE . 1.8 pp -78.72 149.13 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.258 1.023 . . . . 73.33 109.079 175.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.587 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 11.4 tp10 -146.17 146.02 30.68 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.968 0.507 . . . . 72.43 110.384 -172.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.34 -111.57 2.14 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 124.039 0.837 . . . . 64.12 113.903 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 7.1 m -63.7 -34.61 78.25 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.283 1.033 . . . . 75.43 111.219 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.587 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 38.8 mt-30 -70.85 -32.6 69.66 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.857 0.863 . . . . 75.22 111.158 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.452 ' SD ' HD12 ' C' ' 98' ' ' LEU . 17.4 tmm? -73.86 -43.78 57.52 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.689 -0.485 . . . . 63.21 109.689 176.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.65 70.64 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.224 -0.898 . . . . 73.3 110.806 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -67.49 -46.29 73.37 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.347 1.059 . . . . 70.44 110.651 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.574 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 44.7 t -64.4 -40.41 95.75 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 123.905 0.753 . . . . 72.13 111.157 -176.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.483 HD21 HD13 ' C' ' 86' ' ' ILE . 77.0 mt -90.27 -34.65 15.67 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.648 0.61 . . . . 72.24 112.648 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.87 -7.19 64.69 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-O 119.619 -0.545 . . . . 44.42 114.363 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.22 -55.22 0.16 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.718 0.771 . . . . 54.45 111.697 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.574 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 55.7 t80 -67.79 -35.73 79.18 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.326 1.45 . . . . 73.42 112.526 -172.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 35.1 m -80.52 -43.74 1.33 Allowed Pre-proline 0 N--CA 1.485 1.294 0 CA-C-O 118.924 -0.56 . . . . 74.04 112.377 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.47 ' HD3' HG11 ' C' ' 58' ' ' VAL . 72.9 Cg_exo -50.33 -30.74 27.56 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.871 2.38 . . . . 72.31 114.257 166.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -60.95 -39.4 89.39 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.296 1.038 . . . . 75.44 110.334 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.546 HD12 ' NH1' ' A' ' 111' ' ' ARG . 40.8 mm -72.03 -40.3 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.719 0.807 . . . . 74.44 110.461 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.468 HD22 ' HG3' ' C' ' 80' ' ' GLN . 83.6 mt -78.93 -23.54 44.61 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.23 1.012 . . . . 74.52 112.644 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -59.67 -50.79 85.16 Favored Pre-proline 0 CA--C 1.556 1.173 0 N-CA-C 114.021 1.119 . . . . 61.15 114.021 -172.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.5 -35.44 96.74 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.088 1.859 . . . . 72.24 113.11 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -68.41 -50.04 55.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.587 0.755 . . . . 74.13 110.981 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.84 -37.44 84.48 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.532 -0.758 . . . . 73.11 111.042 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -58.15 -55.19 38.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.906 1.282 . . . . 72.24 110.817 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -66.97 -29.5 69.37 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.228 0.611 . . . . 75.12 110.58 -176.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.436 ' SG ' HG12 ' C' ' 21' ' ' ILE . 34.5 t -73.23 -32.19 64.6 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.23 0.612 . . . . 72.2 111.542 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' C' ' 62' ' ' VAL . 86.1 mt -71.23 -46.28 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.42 0.688 . . . . 74.22 109.483 172.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 23.1 m -61.34 -36.33 79.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.775 0.83 . . . . 70.13 111.33 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 37.7 t -60.19 -49.62 76.92 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.336 -0.847 . . . . 65.23 109.416 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.506 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.59 -32.62 74.3 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.586 1.155 . . . . 74.53 113.078 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' C' ' 123' ' ' PHE . 53.0 t -74.81 -35.39 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.437 0.695 . . . . 63.22 110.522 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 36.7 t -67.9 -35.86 79.2 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.576 0.75 . . . . 71.12 110.857 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' C' ' 116' ' ' SER . 71.7 mtt-85 -67.66 -43.76 79.48 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.435 -0.802 . . . . 73.33 109.613 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.87 1.21 84.88 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 123.737 0.648 . . . . 54.34 112.857 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.448 ' HA ' HD21 ' B' ' 127' ' ' ASN . 67.3 p 62.83 25.5 15.11 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.337 1.855 . . . . 52.31 114.823 167.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.468 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.8 m-85 -84.71 157.4 60.86 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 108.75 -0.833 . . . . 73.01 108.75 167.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.62 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 79.9 Cg_exo -51.61 142.28 40.51 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.93 2.42 . . . . 74.13 113.364 175.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.727 HE21 ' HB2' ' B' ' 119' ' ' SER . 14.7 mm100 -55.78 138.19 48.36 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.375 1.047 . . . . 71.41 113.015 -172.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.642 HD11 HG11 ' C' ' 64' ' ' VAL . 8.2 tt -104.58 114.79 29.24 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.5 -1.227 . . . . 71.14 108.778 -173.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -119.02 100.0 7.08 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.785 -0.821 . . . . 73.13 108.785 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.91 135.47 46.54 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.494 0.717 . . . . 75.34 109.946 -175.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.68 153.25 91.21 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.997 0.919 . . . . 63.22 111.411 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.536 ' HG3' HD12 ' A' ' 16' ' ' ILE . 31.6 Cg_exo -58.48 109.25 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.254 1.97 . . . . 54.33 112.06 172.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 91.0 t -96.28 110.73 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.031 -1.47 . . . . 70.51 107.031 173.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -83.01 94.1 7.7 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.916 -1.142 . . . . 74.44 107.916 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.58 ' HE1' HD21 ' C' ' 44' ' ' LEU . 84.8 m-85 -63.25 -38.79 92.54 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.151 0.98 . . . . 72.04 111.881 -175.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.21 -37.24 80.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.905 0.882 . . . . 74.34 111.35 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.93 -27.89 43.77 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.967 0.507 . . . . 70.01 110.373 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 54.0 tp -74.61 -26.25 59.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.257 0.623 . . . . 61.31 110.218 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 68.9 t80 . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 123.917 0.887 . . . . 74.53 111.775 -175.918 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 40.4 m . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 109.2 -0.667 . . . . 64.13 109.2 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.518 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 54.7 t80 -164.22 89.82 0.56 Allowed 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.013 -1.847 . . . . 72.44 106.013 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -128.41 130.67 47.99 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.725 -0.843 . . . . 74.42 108.725 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -90.83 110.98 22.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.123 -1.066 . . . . 52.25 108.123 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -73.86 -31.27 63.09 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.295 0.372 . . . . 74.24 110.711 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -168.68 131.68 1.4 Allowed 'General case' 0 C--N 1.349 0.547 0 O-C-N 123.268 0.355 . . . . 64.24 110.669 -169.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.477 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.0 mp -116.36 128.75 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 105.846 -1.909 . . . . 75.12 105.846 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.437 ' HE1' HG13 ' D' ' 83' ' ' ILE . 40.3 p90 -156.2 160.41 39.81 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.053 0.93 . . . . 71.21 112.477 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -91.33 118.43 30.51 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 113.738 -1.574 . . . . 73.42 108.887 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.0 mtpt -82.3 -37.37 25.89 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.632 -0.713 . . . . 63.25 109.404 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -150.24 139.06 20.85 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.106 -1.406 . . . . 61.1 109.125 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.506 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.9 mt -137.92 147.75 25.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.919 1.287 . . . . 74.15 108.118 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.6 t -148.15 126.23 12.11 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.622 0.769 . . . . 75.1 109.48 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.537 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 66.6 t80 -121.19 133.19 55.17 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.205 -1.406 . . . . 75.03 107.205 164.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.718 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.7 mt-10 -134.84 136.7 42.66 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.34 1.056 . . . . 72.24 108.343 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.21 83.74 63.12 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.46 -1.311 . . . . 51.13 107.46 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.92 -52.95 2.41 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.05 2.5 . . . . 63.4 112.967 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.577 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 5.1 m-20 -102.18 19.69 18.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.287 0.635 . . . . 62.32 109.64 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.499 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -23.85 -75.24 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 116.535 2.05 . . . . 64.41 116.535 -167.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.447 ' HB3' HD11 ' C' ' 83' ' ' ILE . 83.8 Cg_endo -77.28 -16.7 15.31 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 124.033 2.476 . . . . 64.32 113.539 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.435 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 0.2 OUTLIER -71.16 -44.45 65.49 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.209 1.004 . . . . 44.51 108.557 172.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' D' ' 27' ' ' ASN . 9.8 p -82.63 -20.74 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.466 0.706 . . . . 72.12 111.351 -168.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.84 -14.14 62.71 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.61 0.364 . . . . 63.14 111.599 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -67.27 -14.48 62.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.703 0.801 . . . . 71.22 110.925 174.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.423 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 97.4 mttt -97.79 101.63 13.18 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.855 1.262 . . . . 75.13 109.202 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -85.38 93.07 8.64 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.314 -0.625 . . . . 72.32 109.314 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -162.52 156.95 21.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.704 0.801 . . . . 72.45 109.192 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -76.52 105.45 2.33 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.386 -0.968 . . . . 72.5 108.386 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.05 124.97 17.16 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.002 2.468 . . . . 73.44 112.316 -170.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.52 114.83 4.62 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.864 0.727 . . . . 64.33 109.827 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.405 HG21 HD11 ' D' ' 126' ' ' LEU . 27.5 m -102.29 149.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.877 0.871 . . . . 73.4 112.018 -171.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' D' ' 64' ' ' VAL . 46.1 tptt -120.7 120.36 35.46 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.1 1.36 . . . . 71.51 107.866 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.5 HD21 HD12 ' D' ' 128' ' ' LEU . 7.2 mp -97.85 121.06 39.31 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.077 -0.712 . . . . 73.45 109.077 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.577 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 14.6 t70 -108.61 120.48 42.58 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.117 -1.068 . . . . 72.1 108.117 170.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 tt -106.43 127.79 53.56 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.506 -0.924 . . . . 70.52 108.506 -174.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.2 t70 -134.97 148.19 49.94 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.339 1.056 . . . . 73.12 108.434 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -120.19 152.21 38.01 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.999 0.52 . . . . 64.1 109.626 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.98 171.21 17.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.371 1.068 . . . . 71.14 108.252 174.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -174.62 161.66 3.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.065 0.546 . . . . 72.2 110.939 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.7 p -159.22 147.81 18.05 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.381 0.672 . . . . 45.32 109.93 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -87.0 127.06 35.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.474 -0.565 . . . . 74.1 109.474 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 67.6 mt -97.86 -38.62 9.37 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.289 0.635 . . . . 74.55 110.862 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.75 -173.74 4.66 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.567 0.747 . . . . 61.01 110.566 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.91 105.51 1.04 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.02 -0.991 . . . . 63.42 110.444 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 68.36 18.98 9.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.915 1.286 . . . . 71.2 111.554 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -110.77 123.08 66.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 N-CA-C 107.454 -1.313 . . . . 71.44 107.454 167.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -136.86 129.77 30.76 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.255 -0.646 . . . . 75.21 109.255 -176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -91.13 144.38 25.69 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.214 1.005 . . . . 74.52 109.624 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.0 t -123.12 145.64 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.079 1.352 . . . . 72.43 107.629 171.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 45.6 t -127.53 144.91 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.096 0.958 . . . . 51.22 108.914 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -127.7 122.09 32.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.863 -1.162 . . . . 72.1 107.863 178.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 37.0 ttm-85 -102.63 97.48 7.67 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.483 -0.932 . . . . 74.04 108.483 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.14 104.25 15.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.339 -0.985 . . . . 74.04 108.339 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.3 m -97.9 146.36 25.54 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.263 -0.88 . . . . 72.11 108.842 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 53.8 t -140.37 109.03 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.397 1.079 . . . . 75.35 108.841 -177.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -102.57 110.8 22.85 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.72 -0.845 . . . . 72.34 108.72 171.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.0 157.24 17.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.033 0.533 . . . . 73.33 110.48 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 21.6 p -154.64 130.97 10.43 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.449 0.642 . . . . 62.24 112.01 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.471 HD12 HG22 ' D' ' 31' ' ' VAL . 25.1 mt -97.91 101.62 13.16 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.384 -1.28 . . . . 62.43 107.876 170.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.97 -123.22 7.29 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.599 -0.728 . . . . 63.41 112.591 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.75 5.63 48.95 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.304 0.642 . . . . 62.14 112.341 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.423 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 13.0 pt-20 -129.09 160.14 33.75 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.207 0.603 . . . . 73.1 109.801 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -67.17 139.46 57.45 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.565 0.541 . . . . 61.11 110.412 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.563 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -92.89 -65.25 1.01 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.324 -0.853 . . . . 74.33 108.952 175.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -145.93 167.76 22.51 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.144 -0.935 . . . . 74.22 109.641 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.718 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.0 mt -132.14 140.38 48.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.404 -1.332 . . . . 72.53 107.404 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.504 ' SG ' HG23 ' D' ' 114' ' ' ILE . 1.2 m -144.91 139.51 27.67 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.022 0.929 . . . . 64.21 108.717 -177.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -158.2 130.19 6.88 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.007 -0.738 . . . . 72.42 109.007 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 62.8 t -134.87 117.5 22.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 109.258 -0.645 . . . . 60.33 109.258 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -89.58 85.48 6.5 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.612 0.72 . . . . 70.1 109.072 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -80.02 101.5 8.72 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.211 -1.359 . . . . 72.42 109.541 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.87 160.69 23.34 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.416 -0.673 . . . . 22.4 111.416 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.45 132.91 3.66 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.118 -0.793 . . . . 61.31 111.118 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.437 HG13 ' HE1' ' D' ' 17' ' ' TYR . 64.7 mt -87.69 124.56 41.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.152 0.981 . . . . 75.13 108.361 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -122.66 123.7 41.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.413 0.285 . . . . 62.12 110.368 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 48.5 m -83.49 110.19 17.99 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.745 -1.205 . . . . 52.51 107.745 164.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.406 HG22 ' HA ' ' D' ' 11' ' ' PHE . 15.6 pt -130.25 145.31 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.909 0.884 . . . . 52.05 110.617 -170.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.28 167.46 25.87 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.863 0.865 . . . . 42.25 109.913 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.73 -18.89 13.14 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 114.285 0.474 . . . . 62.1 114.285 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 pt -112.2 126.89 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.848 0.859 . . . . 62.24 109.113 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.53 164.33 30.44 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.068 0.547 . . . . 72.44 110.676 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' D' ' 94' ' ' MET . . . 66.47 -129.29 30.93 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.582 0.552 . . . . 71.23 113.94 175.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.4 m -70.52 -29.4 65.88 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.501 0.721 . . . . 72.5 111.452 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.68 -43.57 98.48 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.978 0.911 . . . . 74.24 111.444 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' D' ' 91' ' ' GLY . 0.0 OUTLIER -73.67 -31.83 63.66 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 116.244 -0.434 . . . . 52.24 110.746 179.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.64 88.06 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.998 0.519 . . . . 73.41 111.063 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 12.6 t-80 -64.71 -31.79 73.17 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.786 0.835 . . . . 63.24 111.054 176.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.9 t -79.71 -49.6 11.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.516 0.326 . . . . 61.15 110.783 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.468 HD23 ' SG ' ' D' ' 102' ' ' CYS . 84.3 mt -79.28 -29.37 42.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.692 0.797 . . . . 73.35 112.238 -169.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.37 6.65 63.5 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 119.792 -0.449 . . . . 73.1 113.183 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -148.26 -67.94 0.23 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.258 0.529 . . . . 53.41 111.955 -177.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . 0.418 ' O ' HG12 ' D' ' 105' ' ' ILE . 66.9 t80 -64.86 -37.77 88.74 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 112.467 0.544 . . . . 74.51 112.467 -172.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.518 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 85.9 m -70.65 -48.47 16.28 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-O 118.599 -0.715 . . . . 44.21 111.461 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.481 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 75.2 Cg_exo -55.96 -33.18 88.39 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.013 1.809 . . . . 71.02 113.185 167.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.56 -35.71 81.64 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.251 0.621 . . . . 73.43 111.169 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.418 HG12 ' O ' ' D' ' 101' ' ' TYR . 36.6 mm -67.84 -40.09 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.601 0.76 . . . . 73.14 110.523 174.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.7 mt -79.04 -16.93 56.14 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.642 -0.708 . . . . 73.22 111.514 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.31 -41.32 24.24 Favored Pre-proline 0 N--CA 1.485 1.317 0 N-CA-C 114.437 1.273 . . . . 71.51 114.437 -172.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.45 -39.21 92.85 Favored 'Trans proline' 0 C--N 1.385 2.476 0 CA-C-N 121.769 1.667 . . . . 63.33 112.74 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -71.16 -40.46 71.28 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.52 0.728 . . . . 75.43 110.95 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.79 -44.59 96.63 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.875 0.87 . . . . 55.45 110.639 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.517 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 19.8 ttp180 -59.92 -53.5 57.11 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.335 -1.302 . . . . 64.15 110.198 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.47 -42.77 99.72 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.28 0.988 . . . . 72.55 111.724 -172.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.8 t -58.52 -40.55 83.22 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.688 0.618 . . . . 64.23 110.875 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.504 HG23 ' SG ' ' D' ' 76' ' ' CYS . 84.3 mt -66.95 -50.3 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.626 0.77 . . . . 52.13 110.622 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -54.91 -43.86 73.67 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.213 1.005 . . . . 70.24 111.529 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.7 t -66.91 -42.02 86.11 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.48 -1.237 . . . . 74.51 110.519 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.537 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 71.9 mtm -66.12 -37.35 85.5 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.856 0.463 . . . . 73.32 111.638 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.423 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.0 t -63.21 -44.57 99.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.117 0.967 . . . . 71.33 110.479 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -73.57 -31.02 63.39 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 116.038 -0.528 . . . . 71.2 111.381 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -71.82 -30.3 65.34 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.205 0.602 . . . . 65.32 110.094 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.97 11.38 69.38 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.715 0.635 . . . . 62.13 112.663 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.462 HG23 ' HB3' ' C' ' 17' ' ' TYR . 66.2 p 58.15 21.93 8.54 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 126.446 1.899 . . . . 71.55 114.244 175.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -84.32 147.85 51.23 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 108.818 -0.808 . . . . 61.43 108.818 169.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.5 135.22 47.51 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 123.067 2.512 . . . . 74.33 112.488 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -50.63 140.91 13.52 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.957 1.303 . . . . 71.42 113.003 -170.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.405 HD11 HG21 ' D' ' 40' ' ' VAL . 55.2 tp -122.34 100.87 7.18 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.44 0.696 . . . . 72.33 110.713 -176.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -99.67 101.16 12.26 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.093 -1.077 . . . . 63.1 108.093 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.517 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.7 mm? -69.23 114.27 7.34 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.338 0.655 . . . . 71.3 109.517 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.09 132.72 83.96 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.177 0.591 . . . . 72.01 111.414 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.463 ' HB3' HH12 ' D' ' 111' ' ' ARG . 58.6 Cg_endo -72.85 126.1 11.04 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.252 1.968 . . . . 71.13 111.185 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.82 141.79 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.797 0.839 . . . . 71.43 110.065 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -77.68 103.15 7.44 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.403 -0.962 . . . . 72.02 108.403 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -72.0 -40.56 68.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.801 0.441 . . . . 74.45 110.492 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.29 -53.46 56.53 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.905 0.882 . . . . 71.53 112.668 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.33 99.08 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.28 0.632 . . . . 63.31 111.165 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.41 -27.65 67.25 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.204 -0.907 . . . . 60.41 111.6 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 84.1 t80 . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 123.465 0.706 . . . . 73.24 110.423 177.607 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.24 0.589 0 N-CA-C 109.341 -0.614 . . . . 64.44 109.341 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.661 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 10.1 t80 -135.99 129.37 31.97 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.954 0.902 . . . . 75.24 108.607 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -149.68 127.56 11.82 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.706 0.803 . . . . 64.35 109.155 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.573 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.1 mt -95.34 119.21 43.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.896 -0.779 . . . . 72.54 108.896 173.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -88.69 -34.29 17.26 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 123.46 0.475 . . . . 70.43 110.184 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -166.87 126.16 1.45 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 116.414 -0.357 . . . . 70.33 111.141 -166.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.496 HD12 ' HG3' ' C' ' 130' ' ' PRO . 73.4 mt -120.3 138.51 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 124.37 1.068 . . . . 75.04 108.969 173.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -158.37 176.08 12.9 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.288 0.992 . . . . 71.1 111.511 -171.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.0 p -106.13 119.4 39.11 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.657 -1.238 . . . . 72.24 107.657 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -80.02 -48.58 13.09 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.841 -0.8 . . . . 71.2 108.841 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 22.7 m-20 -134.55 125.23 26.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.611 -1.177 . . . . 61.34 109.014 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 79.3 mt -117.62 144.28 25.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 106.775 -1.565 . . . . 61.0 106.775 173.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 43.2 t -152.41 142.16 21.95 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.102 0.477 . . . . 60.22 109.777 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 35.4 t80 -144.33 124.09 13.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.802 -1.555 . . . . 62.23 106.802 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.97 111.55 10.51 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.312 -0.996 . . . . 72.53 108.312 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.22 81.71 17.24 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.903 0.881 . . . . 74.41 109.274 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 72' ' ' THR . 22.0 Cg_exo -66.99 -14.46 43.76 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.077 2.518 . . . . 75.32 112.328 174.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.5 ' HB2' ' HA ' ' A' ' 73' ' ' ALA . 21.9 m-80 -117.35 30.15 7.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.853 0.861 . . . . 63.13 110.395 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.52 98.23 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 123.717 0.807 . . . . 53.3 113.006 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -85.12 -24.8 1.95 Allowed 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 121.644 1.563 . . . . 63.31 113.188 169.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.479 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 58.9 m170 -70.97 -34.72 71.7 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.123 0.569 . . . . 73.55 110.922 -173.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -55.86 -31.77 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.495 1.118 . . . . 72.44 112.388 -175.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.67 -32.82 70.22 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.652 0.781 . . . . 64.33 111.347 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -88.84 -45.2 9.93 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.132 0.973 . . . . 74.43 111.647 -174.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 16.1 ptpt -83.32 173.59 11.44 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.821 0.848 . . . . 72.14 111.548 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -74.27 142.7 45.24 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.565 0.746 . . . . 53.11 111.514 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -93.2 78.65 4.52 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.522 0.677 . . . . 70.33 109.832 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -125.86 79.98 67.83 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.363 -0.977 . . . . 74.43 108.363 169.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -84.15 136.23 6.72 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.354 2.036 . . . . 73.52 112.315 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -96.44 102.05 13.77 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.154 -1.424 . . . . 60.34 107.154 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.7 p -76.87 100.1 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 115.451 -0.795 . . . . 74.12 109.98 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 63.3 mttp -78.98 111.02 14.76 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.74 -1.208 . . . . 70.1 107.74 164.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.495 HD13 HG22 ' A' ' 64' ' ' VAL . 33.4 tp -109.48 133.31 53.23 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.895 -1.15 . . . . 71.42 107.895 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.408 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 24.4 t70 -135.93 129.42 32.18 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.91 -0.774 . . . . 75.41 108.91 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.2 mt -112.12 132.05 55.09 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.903 0.881 . . . . 73.5 109.013 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.76 147.73 52.46 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.709 0.803 . . . . 73.45 108.85 172.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.0 m -131.49 131.78 43.73 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.553 0.741 . . . . 53.22 109.825 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.82 154.34 50.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.144 0.978 . . . . 72.21 110.115 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 26.5 t -131.87 155.77 47.26 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.731 0.413 . . . . 73.41 110.284 174.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.7 p -148.76 141.21 24.27 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.572 0.749 . . . . 74.41 109.911 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -81.68 106.68 13.81 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.734 0.414 . . . . 74.35 110.479 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' A' ' 57' ' ' GLU . 34.1 mt -83.3 -36.3 24.58 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.263 -0.643 . . . . 71.11 109.263 173.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.82 177.27 11.6 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.765 1.226 . . . . 71.33 108.647 173.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -68.5 116.31 8.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.012 -0.736 . . . . 63.23 109.012 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 70.6 12.24 7.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.811 1.244 . . . . 75.1 112.476 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 42.8 t -120.38 112.41 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 107.71 -1.218 . . . . 65.12 107.71 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.81 134.43 45.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.464 0.706 . . . . 74.45 110.469 -169.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.6 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.5 tt0 -88.17 137.5 32.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.503 -0.925 . . . . 74.44 108.503 173.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.9 136.67 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.517 -1.29 . . . . 72.41 107.517 168.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.6 111.64 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.18 0.992 . . . . 71.13 108.69 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -92.23 102.3 14.81 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.168 -1.049 . . . . 65.21 108.168 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -84.33 106.76 16.19 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.002 -0.74 . . . . 75.3 109.002 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.404 HG11 HD11 ' A' ' 128' ' ' LEU . 43.0 t -104.35 103.97 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.834 -0.802 . . . . 54.32 108.834 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.59 HG22 ' HG3' ' A' ' 77' ' ' GLU . 74.9 p -100.35 111.96 24.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.487 0.715 . . . . 44.51 109.977 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.495 HG22 HD13 ' A' ' 42' ' ' LEU . 92.3 t -102.9 113.83 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.059 0.944 . . . . 74.14 108.858 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 10.8 m -116.66 105.62 12.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.741 -0.837 . . . . 75.12 108.741 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.27 106.36 18.01 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 106.378 -1.712 . . . . 71.42 106.378 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 p -149.29 128.67 12.97 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.822 0.702 . . . . 71.45 110.171 -168.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.6 tp -91.3 87.22 6.39 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.678 -0.86 . . . . 52.3 108.678 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.45 -93.31 1.86 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 114.849 -1.069 . . . . 33.14 111.724 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -113.62 -27.24 7.92 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.031 0.532 . . . . 73.4 111.526 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -79.58 106.62 11.75 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 122.421 0.288 . . . . 73.24 110.226 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.418 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 26.8 m -76.1 116.53 16.89 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.682 -0.69 . . . . 73.1 109.327 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . . . -68.03 -50.87 52.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.911 0.884 . . . . 72.43 108.768 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.463 ' HB2' ' HE1' ' A' ' 23' ' ' PHE . 47.3 p90 -156.78 147.58 21.74 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.982 -1.463 . . . . 74.33 109.863 173.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 53.8 tp -123.02 107.85 12.26 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 107.622 -1.251 . . . . 75.33 107.622 175.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.434 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 79.8 m -106.85 99.31 8.88 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.296 0.639 . . . . 72.32 109.729 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.59 ' HG3' HG22 ' A' ' 63' ' ' THR . 32.4 tt0 -115.08 118.28 32.94 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.901 0.88 . . . . 72.52 109.309 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.4 t -130.2 109.27 17.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.617 0.722 . . . . 74.33 109.459 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -86.44 80.26 8.72 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.137 -1.392 . . . . 71.25 108.147 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -76.93 111.65 12.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.875 -1.057 . . . . 73.3 108.622 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.17 144.07 17.03 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.829 -0.508 . . . . 71.31 111.829 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.0 145.11 15.55 Favored Glycine 0 C--O 1.236 0.247 0 N-CA-C 111.283 -0.727 . . . . 63.5 111.283 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.4 mt -81.32 123.38 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 108.488 -0.93 . . . . 73.21 108.488 173.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.661 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.1 m-85 -130.18 116.35 18.31 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.804 -0.813 . . . . 71.04 108.804 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.7 p -85.7 102.98 14.08 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.203 -1.036 . . . . 75.53 108.203 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.0 pt -115.36 130.98 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.908 0.883 . . . . 74.41 109.096 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.22 147.0 30.99 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.908 0.883 . . . . 55.15 109.963 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.66 1.56 57.58 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 115.007 0.763 . . . . 62.44 115.007 171.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.53 154.72 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 118.105 0.952 . . . . 74.53 111.369 -176.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.6 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 10.8 tt0 -155.02 -174.68 5.08 Favored 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 123.931 0.892 . . . . 64.4 109.3 173.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.6 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 73.2 -139.02 26.24 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 123.331 0.491 . . . . 63.42 114.188 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.1 p -73.88 -20.88 60.28 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.441 0.696 . . . . 62.21 111.233 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -66.48 -48.14 70.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.854 0.862 . . . . 61.11 110.114 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 91' ' ' GLY . 24.7 ptt? -70.03 -30.95 68.37 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 116.136 -0.484 . . . . 63.43 110.342 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.24 -34.55 77.69 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.158 0.583 . . . . 64.45 110.56 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -71.85 -35.88 69.97 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.39 -0.823 . . . . 65.03 110.11 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.502 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 49.9 t -66.88 -43.29 83.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.962 0.505 . . . . 72.13 111.346 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.83 -38.19 23.37 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.258 -0.428 . . . . 74.43 110.785 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.91 3.03 57.06 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 114.365 0.506 . . . . 65.4 114.365 -169.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -146.87 -60.24 0.29 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.182 0.491 . . . . 51.2 111.577 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.502 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 77.2 t80 -68.89 -49.56 57.2 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.25 1.02 . . . . 71.33 113.126 -166.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.08 -34.46 0.95 Allowed Pre-proline 0 CA--C 1.565 1.55 0 N-CA-C 113.513 0.931 . . . . 74.11 113.513 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.24 -21.11 55.39 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 121.601 1.534 . . . . 42.14 113.184 165.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 3.6 m120 -62.1 -38.69 89.85 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 118.197 0.453 . . . . 73.31 110.211 169.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.0 mm -63.04 -45.37 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 O-C-N 124.004 0.815 . . . . 74.13 110.138 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.56 -20.13 51.27 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.01 0.924 . . . . 74.43 112.781 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -62.8 -45.32 87.65 Favored Pre-proline 0 CA--C 1.569 1.705 0 N-CA-C 113.719 1.007 . . . . 75.32 113.719 -173.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -63.71 -36.15 53.65 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.1 1.867 . . . . 64.01 113.459 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -71.11 -40.45 71.46 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.018 0.527 . . . . 72.42 111.156 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.62 -43.97 83.33 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.307 0.643 . . . . 72.2 110.003 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HG3' ' H ' ' A' ' 128' ' ' LEU . 38.1 ttm180 -51.59 -51.43 55.64 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.612 1.195 . . . . 62.44 110.509 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.22 -41.9 96.81 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.439 1.087 . . . . 74.21 111.556 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.17 -29.42 69.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 116.095 -0.502 . . . . 72.44 111.412 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.6 mt -78.63 -40.14 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.359 1.063 . . . . 61.44 110.331 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.467 HG23 ' HG3' ' A' ' 125' ' ' GLN . 34.4 m -66.53 -43.55 84.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.46 0.648 . . . . 75.4 110.638 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.5 t -64.43 -44.44 91.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.033 -0.985 . . . . 74.52 109.519 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.434 ' SD ' ' HA ' ' A' ' 76' ' ' CYS . 43.2 ttm -60.27 -46.53 89.48 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.229 1.012 . . . . 52.52 112.242 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 123' ' ' PHE . 7.2 p -69.71 -31.05 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.133 0.573 . . . . 62.45 110.616 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.2 m -77.06 -29.73 55.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.425 0.69 . . . . 71.41 111.213 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -70.77 -31.92 68.87 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.626 0.77 . . . . 74.44 109.832 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.23 -2.26 90.4 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-N 115.779 -0.646 . . . . 62.02 113.209 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.9 m 65.34 36.53 6.86 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-O 122.824 1.297 . . . . 73.21 110.939 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.473 ' HB2' HG22 ' A' ' 118' ' ' VAL . 95.9 m-85 -104.91 164.39 15.26 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.308 1.043 . . . . 63.23 108.904 171.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -59.59 153.35 55.83 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 122.322 2.014 . . . . 63.23 112.504 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.467 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.7 tt0 -63.77 139.12 58.74 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.447 0.699 . . . . 61.02 111.16 -177.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.6 tp -131.3 116.42 17.58 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.307 -0.861 . . . . 73.42 109.093 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -121.03 117.83 28.25 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.252 -1.018 . . . . 74.43 108.252 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.438 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 85.9 mt -59.78 122.32 13.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.312 0.645 . . . . 65.3 110.082 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -61.57 128.65 90.4 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-O 119.17 -0.443 . . . . 63.12 109.881 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 26.3 Cg_exo -64.18 100.23 0.31 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.657 2.238 . . . . 61.2 111.584 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.3 m -100.06 138.0 25.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-N 115.623 -0.717 . . . . 43.24 109.441 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -83.1 87.46 6.91 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.079 -0.964 . . . . 74.42 109.046 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.497 ' HA ' HD12 ' A' ' 136' ' ' LEU . 58.4 m-85 -56.03 -27.49 53.38 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.642 0.777 . . . . 74.31 112.559 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.21 -51.29 61.88 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.017 0.527 . . . . 72.05 110.25 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.52 85.63 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.007 0.817 . . . . 60.34 110.896 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 133' ' ' PHE . 61.1 mt -67.52 -38.68 84.62 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.159 0.983 . . . . 74.02 111.06 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.7 -38.54 86.94 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.716 -0.675 . . . . 74.45 109.495 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 19.8 mmt . . . . . 0 C--N 1.348 0.517 0 O-C-N 124.221 0.951 . . . . 61.2 110.34 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 87.1 m . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.457 -0.572 . . . . 64.41 109.457 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -129.52 137.64 50.9 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.588 -0.893 . . . . 72.12 108.588 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -149.92 130.79 14.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.084 -0.71 . . . . 72.14 109.084 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.453 HD11 HD13 ' B' ' 105' ' ' ILE . 20.6 mt -76.52 118.09 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.738 -1.208 . . . . 74.34 107.738 166.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -86.22 -49.36 7.77 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.665 -0.865 . . . . 72.22 108.665 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.411 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 74.1 ttt180 -164.99 138.27 4.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.867 -1.061 . . . . 72.21 109.069 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.9 mt -115.6 141.92 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.321 -0.992 . . . . 74.13 108.321 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -164.12 147.2 9.45 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.767 0.427 . . . . 73.21 111.321 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.698 HG21 HD11 ' B' ' 21' ' ' ILE . 24.5 m -78.57 130.45 35.95 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.197 -1.038 . . . . 71.34 108.197 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -93.17 -47.48 6.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.58 0.752 . . . . 71.33 110.083 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.33 141.05 39.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.162 -0.927 . . . . 62.33 110.856 -171.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.698 HD11 HG21 ' B' ' 18' ' ' THR . 48.4 mm -131.44 144.91 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.914 1.286 . . . . 74.03 108.26 171.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.517 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.7 t -145.63 129.12 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.077 -1.453 . . . . 72.42 107.077 173.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.3 t80 -143.31 107.04 4.63 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 106.517 -1.66 . . . . 74.42 106.517 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -118.1 112.51 20.3 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.079 -1.082 . . . . 73.34 108.079 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.3 85.46 2.15 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.939 -1.504 . . . . 61.54 106.939 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.96 -26.21 26.88 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.92 2.413 . . . . 64.35 112.156 -166.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -114.4 15.47 17.94 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.979 -1.009 . . . . 62.45 110.34 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.88 -61.99 0.97 Allowed Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 115.19 1.552 . . . . 64.31 115.19 -163.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.62 -27.05 39.14 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 121.831 1.687 . . . . 74.22 113.023 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -89.01 -38.87 14.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.994 0.518 . . . . 71.22 111.733 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.787 HG21 ' HA ' ' B' ' 73' ' ' ALA . 13.3 p -69.71 -16.09 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.209 0.604 . . . . 72.42 111.128 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -68.33 -4.07 13.18 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.483 0.713 . . . . 74.54 112.791 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.503 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.4 pt20 -68.34 -23.41 64.7 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.919 0.487 . . . . 72.12 110.219 168.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.503 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 86.7 mttt -107.88 79.02 1.23 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.829 1.251 . . . . 74.13 108.648 177.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -80.12 86.51 5.55 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.717 0.77 . . . . 75.34 109.35 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.0 t-105 -150.87 155.9 40.12 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.891 1.276 . . . . 72.34 107.594 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -70.76 99.99 0.26 Allowed Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 125.916 1.686 . . . . 74.42 110.576 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.621 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 49.0 Cg_endo -67.65 137.43 42.32 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.557 2.171 . . . . 73.23 112.535 -173.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -54.89 123.33 13.11 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.04 0.838 . . . . 73.54 109.764 173.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -104.33 157.19 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.443 0.64 . . . . 73.11 111.682 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -142.14 127.7 19.04 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.565 -1.643 . . . . 54.15 106.565 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.586 ' H ' HD23 ' B' ' 42' ' ' LEU . 2.6 pt? -104.41 151.88 22.98 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.834 0.453 . . . . 73.42 110.607 -175.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -143.19 116.19 8.85 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.603 -0.888 . . . . 75.45 108.603 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 mt -99.26 156.9 16.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.716 0.406 . . . . 33.51 110.166 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.487 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 11.6 m-20 -141.57 111.39 6.63 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.121 -1.066 . . . . 75.51 108.121 167.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -109.82 104.06 12.95 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.74 -0.467 . . . . 71.51 109.74 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.84 152.78 34.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.237 1.015 . . . . 62.34 109.434 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -137.58 161.84 35.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.033 0.533 . . . . 73.03 109.916 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -163.32 160.85 24.22 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.059 0.543 . . . . 73.41 110.241 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -91.47 123.03 34.58 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.124 0.57 . . . . 75.34 110.273 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 81.1 mt -87.33 -43.77 11.9 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.718 0.807 . . . . 72.03 109.107 167.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.61 -170.54 3.11 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.58 -1.191 . . . . 74.51 110.033 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.98 111.95 2.38 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.598 -0.728 . . . . 73.2 110.429 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 43.7 m-20 70.23 0.38 3.14 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.256 1.423 . . . . 74.0 112.838 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.8 t -104.18 102.88 14.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.526 -0.916 . . . . 62.02 108.526 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -99.73 146.99 25.92 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.64 -1.164 . . . . 74.31 109.643 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -109.4 116.55 32.03 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.465 -1.309 . . . . 51.42 107.465 165.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.437 HG11 ' HD3' ' B' ' 103' ' ' PRO . 52.3 t -96.01 143.37 12.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.526 -0.916 . . . . 75.32 108.526 172.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.2 t -131.89 137.36 55.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.959 -0.756 . . . . 65.41 108.959 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.85 109.59 14.38 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.176 -1.416 . . . . 75.44 107.176 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 40.7 ttm180 -95.25 130.94 41.8 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.543 -0.54 . . . . 61.21 109.543 170.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 37.0 t -120.62 106.13 18.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.192 -1.41 . . . . 74.34 107.192 169.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -96.13 146.62 24.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.11 -1.07 . . . . 75.15 108.11 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 71.1 t -138.4 130.12 37.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.284 1.034 . . . . 73.31 108.466 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 98.3 m -117.39 136.95 52.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.385 -0.969 . . . . 70.51 108.385 172.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.12 143.79 50.25 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.473 0.483 . . . . 74.11 110.289 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 44.3 p -133.68 127.03 32.05 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 123.959 0.787 . . . . 74.22 110.771 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.621 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 34.1 mt -105.88 114.64 28.9 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.116 0.966 . . . . 74.4 108.697 171.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.37 -111.73 3.94 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.537 -1.025 . . . . 54.42 110.537 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.23 4.58 11.28 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.527 0.731 . . . . 72.13 111.027 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -114.47 160.64 18.97 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.424 0.69 . . . . 75.31 109.583 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.3 m -72.24 135.07 45.94 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.543 -0.54 . . . . 64.43 109.543 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.787 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -88.72 -59.62 2.18 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.411 -0.959 . . . . 52.22 108.411 175.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.638 ' HZ ' HD11 ' B' ' 126' ' ' LEU . 52.5 p90 -151.96 170.08 20.74 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 113.973 -1.467 . . . . 74.32 109.821 176.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.7 mt -133.05 138.86 46.9 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.878 -1.897 . . . . 72.33 105.878 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' B' ' 114' ' ' ILE . 38.0 t -141.1 150.95 43.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.882 -0.784 . . . . 63.53 108.882 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.8 tt0 -164.37 132.55 3.45 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.034 -0.728 . . . . 62.21 109.034 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 98.6 t -128.94 147.67 33.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.474 -0.936 . . . . 74.33 108.474 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -123.15 93.13 3.86 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.293 -1.002 . . . . 73.13 108.293 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.481 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.9 tp-100 -82.79 100.89 10.58 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.702 -1.135 . . . . 54.32 109.014 177.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.51 163.73 31.36 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 111.02 -0.832 . . . . 74.44 111.02 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.3 128.23 1.73 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.936 -0.866 . . . . 52.24 110.936 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 30.8 mt -84.6 133.65 28.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.619 0.768 . . . . 62.01 109.077 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' B' ' 102' ' ' CYS . 22.8 m-85 -138.04 135.52 35.96 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.033 -0.728 . . . . 75.0 109.033 174.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -97.44 107.97 20.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.57 0.748 . . . . 73.3 108.995 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 43.0 pt -111.79 145.06 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.758 0.823 . . . . 74.14 110.377 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -144.32 158.1 43.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.702 0.801 . . . . 74.24 109.741 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.08 -65.14 4.12 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.557 0.536 . . . . 63.45 112.574 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.42 HD11 ' HB ' ' B' ' 86' ' ' ILE . 25.7 pt -58.15 144.01 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.225 1.01 . . . . 52.45 112.491 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -150.66 149.88 30.4 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.246 -0.888 . . . . 72.33 109.458 -171.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.3 -115.6 8.13 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.905 0.753 . . . . 54.13 113.013 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 24.7 m -67.14 -31.43 71.87 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.824 0.85 . . . . 73.14 112.003 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.93 -47.82 73.43 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.191 0.596 . . . . 74.11 110.81 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.538 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 12.3 ptp -72.91 -29.47 63.16 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-O 119.077 -0.487 . . . . 73.4 110.113 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.89 -32.16 71.63 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.824 0.45 . . . . 52.04 111.053 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.42 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 28.0 t-80 -72.42 -30.44 64.62 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.961 0.504 . . . . 62.23 110.971 174.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.595 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 85.9 m -76.71 -71.69 0.38 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 110.385 -0.228 . . . . 74.2 110.385 176.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.4 pp -71.42 -14.41 62.15 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.384 0.883 . . . . 60.54 113.384 -171.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.89 0.33 36.04 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-O 119.488 -0.618 . . . . 71.12 113.93 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -152.42 -62.1 0.16 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.741 0.771 . . . . 61.52 112.4 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.595 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 90.0 t80 -70.18 -47.28 62.25 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.101 0.96 . . . . 74.52 112.205 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.465 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 71.5 m -62.7 -49.15 84.01 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.15 0.98 . . . . 65.23 111.428 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 86.3 Cg_exo -54.05 -35.33 81.0 Favored 'Trans proline' 0 C--N 1.397 3.099 0 C-N-CA 122.043 1.829 . . . . 64.35 114.128 167.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -62.9 -37.26 86.25 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 123.202 0.601 . . . . 75.13 110.468 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.453 HD13 HD11 ' B' ' 13' ' ' ILE . 68.1 mt -66.18 -41.83 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.958 0.903 . . . . 74.33 110.458 174.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 67.5 mt -78.73 -19.19 52.92 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.427 -0.806 . . . . 55.12 112.12 -175.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -58.79 -49.15 94.98 Favored Pre-proline 0 N--CA 1.483 1.214 0 CA-C-O 117.829 -1.081 . . . . 72.04 113.515 -171.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.41 -38.26 89.39 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.194 1.929 . . . . 74.55 113.723 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.481 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 83.4 m-85 -68.53 -48.66 63.75 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 123.516 0.51 . . . . 73.42 110.527 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.34 -42.25 91.04 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.557 0.743 . . . . 74.53 111.304 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 54.3 ttt-85 -61.58 -53.22 59.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.802 1.641 . . . . 73.25 110.946 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -68.27 -30.27 69.26 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.987 0.805 . . . . 64.12 110.198 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.489 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.4 t -69.0 -41.11 78.26 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.833 0.453 . . . . 73.43 111.131 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.462 HG23 ' SG ' ' B' ' 76' ' ' CYS . 73.0 mt -60.55 -52.4 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.609 -0.515 . . . . 74.54 109.609 172.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.4 HG21 ' OG ' ' C' ' 119' ' ' SER . 62.9 m -56.12 -34.45 66.09 Favored 'General case' 0 CA--C 1.554 1.124 0 O-C-N 124.477 1.111 . . . . 70.34 111.988 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.6 t -66.72 -49.06 67.26 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 123.229 0.612 . . . . 65.4 109.873 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.503 ' SD ' HG21 ' A' ' 21' ' ' ILE . 34.5 mmt -61.5 -41.41 97.25 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.095 0.558 . . . . 72.21 111.155 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 78.2 t -62.77 -43.7 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.427 1.091 . . . . 70.34 110.851 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.8 t -65.65 -36.84 84.83 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.821 -1.081 . . . . 72.0 111.607 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -67.69 -36.74 81.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.026 -0.988 . . . . 61.41 110.47 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.51 6.99 59.35 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.334 -0.703 . . . . 63.24 113.084 176.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 72.0 p 59.38 22.0 10.38 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.378 1.871 . . . . 61.14 113.332 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -85.13 151.79 57.56 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.61 0.764 . . . . 73.4 109.963 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.36 156.98 3.5 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 124.242 3.294 . . . . 73.44 116.328 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -65.86 117.8 8.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.229 -1.35 . . . . 73.11 111.844 -173.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.638 HD11 ' HZ ' ' B' ' 74' ' ' PHE . 22.5 mt -113.44 120.26 40.42 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.029 -0.73 . . . . 54.32 109.029 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -123.21 96.22 4.91 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 107.895 -1.15 . . . . 72.54 107.895 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.549 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.1 mm? -61.72 149.82 38.56 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.825 0.85 . . . . 73.43 112.334 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.63 151.25 87.02 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.987 0.915 . . . . 64.21 110.659 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.95 104.81 1.41 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.501 2.134 . . . . 72.13 111.634 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.0 t -90.57 108.66 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.277 -1.008 . . . . 62.44 108.277 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -90.07 98.36 11.73 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.1 -1.074 . . . . 71.01 108.1 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -61.92 -32.97 73.42 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.289 -0.869 . . . . 74.53 111.41 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.33 -39.3 78.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.716 1.207 . . . . 71.01 111.823 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.17 -41.17 90.67 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.312 0.645 . . . . 51.41 110.207 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.28 -37.27 85.05 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.685 -1.143 . . . . 72.55 110.965 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 60.3 t80 . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 123.64 0.776 . . . . 73.3 110.668 -178.268 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.735 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 64.4 m . . . . . 0 C--O 1.24 0.556 0 N-CA-C 108.04 -1.096 . . . . 64.12 108.04 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.566 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 44.9 t80 -102.02 128.93 48.24 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.556 -0.905 . . . . 72.04 108.556 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -137.56 126.35 23.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.949 -0.76 . . . . 72.11 108.949 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 83.8 mt -77.38 122.17 31.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.659 -0.867 . . . . 73.03 108.659 172.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -91.15 -39.22 12.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.228 -0.896 . . . . 63.43 109.712 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -172.59 144.75 1.48 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.101 -0.703 . . . . 70.04 109.101 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 92.3 mt -134.07 137.69 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.769 -1.197 . . . . 72.11 107.769 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.453 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 32.2 p90 -169.58 171.94 7.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.872 0.844 . . . . 73.43 111.458 -173.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.1 p -96.77 118.35 33.02 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.222 -0.899 . . . . 72.5 109.061 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.543 ' HE3' ' HA3' ' C' ' 81' ' ' GLY . 21.5 mmtp -67.37 -48.97 65.88 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.66 -1.237 . . . . 74.41 107.66 171.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -137.61 142.92 41.25 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 112.974 -1.921 . . . . 72.32 109.6 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.498 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 76.0 mt -136.5 144.07 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 106.283 -1.747 . . . . 71.12 106.283 172.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -160.51 146.92 15.39 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.372 0.606 . . . . 73.41 110.824 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -139.03 135.13 33.91 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.2 -1.407 . . . . 75.12 107.2 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.431 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 38.8 mt-10 -135.36 114.45 12.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.729 0.812 . . . . 64.21 109.988 -176.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.86 83.88 33.63 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 107.112 -1.44 . . . . 61.22 107.112 170.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -70.34 -19.85 32.83 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.048 2.499 . . . . 72.44 112.684 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -116.33 24.85 11.07 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.775 1.23 . . . . 72.34 110.06 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.87 -57.66 5.68 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 114.483 1.29 . . . . 73.31 114.483 -169.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.3 -36.56 55.74 Favored 'Trans proline' 0 C--N 1.388 2.655 0 CA-C-N 121.542 1.586 . . . . 71.24 112.172 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.534 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 68.3 t60 -69.9 -32.99 71.61 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.417 -0.81 . . . . 64.24 112.36 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.754 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.0 p -81.54 -22.12 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 N-CA-C 112.731 0.641 . . . . 44.44 112.731 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -64.33 -23.79 67.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.628 -0.67 . . . . 72.34 112.682 175.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.6 pt20 -88.48 8.32 28.56 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.952 0.501 . . . . 73.23 111.301 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' C' ' 31' ' ' VAL . 1.1 mptm? -92.52 177.87 5.99 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 122.255 1.026 . . . . 64.15 113.24 -172.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -87.47 114.04 23.72 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 112.905 -1.952 . . . . 73.23 108.074 168.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 51.5 t90 -84.48 71.32 10.73 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.742 0.782 . . . . 72.21 110.939 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -132.92 69.59 79.01 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 123.966 0.906 . . . . 63.15 109.034 170.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -87.95 158.05 7.3 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.046 2.497 . . . . 62.23 113.73 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.97 96.43 8.84 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 107.284 -1.376 . . . . 64.51 107.284 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 m -79.28 128.25 38.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-O 121.705 0.764 . . . . 63.35 110.373 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -132.65 113.54 13.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.503 1.121 . . . . 62.31 108.338 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.439 HD11 HD22 ' C' ' 128' ' ' LEU . 72.2 mt -86.0 158.79 19.78 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.825 -0.806 . . . . 75.23 108.825 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.7 t70 -137.4 105.14 5.58 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.602 -1.258 . . . . 73.32 107.602 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.27 129.49 43.58 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.044 -0.724 . . . . 75.33 109.044 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -144.24 125.01 14.16 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.57 -0.9 . . . . 74.32 108.57 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 5.2 t -116.46 139.78 50.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.447 -0.575 . . . . 61.3 109.447 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.45 135.61 37.03 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.106 0.962 . . . . 71.01 108.406 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 13.0 p -136.38 151.12 49.21 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 109.314 -0.625 . . . . 54.5 109.314 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 70.0 p -156.65 143.73 18.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.369 0.668 . . . . 74.03 109.765 -174.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -78.93 118.1 20.63 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.326 0.65 . . . . 64.13 109.991 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' C' ' 57' ' ' GLU . 68.8 mt -89.26 -29.73 19.0 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.05 0.54 . . . . 72.32 110.13 174.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.47 172.67 16.81 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.787 1.235 . . . . 45.53 109.034 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -57.37 128.58 37.75 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.842 -0.799 . . . . 72.11 108.842 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 69.48 -1.85 2.1 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.42 1.088 . . . . 73.05 113.015 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -111.95 117.56 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.338 0.655 . . . . 72.14 109.373 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -124.85 126.46 45.61 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.041 0.936 . . . . 51.4 109.983 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.574 ' HB2' HD11 ' C' ' 51' ' ' LEU . 21.5 tt0 -83.62 133.0 34.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.936 -1.135 . . . . 73.42 107.936 165.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.47 140.35 47.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 N-CA-C 108.842 -0.799 . . . . 65.35 108.842 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 81.6 t -124.56 133.18 70.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.838 1.255 . . . . 72.11 107.629 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.2 104.81 8.71 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.237 -1.394 . . . . 71.1 107.237 174.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.464 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 1.9 ttm180 -86.69 130.01 34.65 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 113.886 -1.506 . . . . 61.21 109.127 177.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.1 124.81 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.458 -1.312 . . . . 73.01 107.458 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 32.7 m -124.52 131.18 53.49 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.855 -0.794 . . . . 64.52 108.855 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.477 HG23 HD13 ' C' ' 114' ' ' ILE . 23.4 t -107.49 126.65 63.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.003 -0.74 . . . . 55.13 109.003 173.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.411 HG23 HD23 ' C' ' 75' ' ' LEU . 5.2 m -116.25 145.43 43.15 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.935 -1.135 . . . . 75.43 107.935 173.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.54 128.02 20.08 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.053 -0.721 . . . . 41.51 109.053 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.8 m -128.01 126.03 40.54 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 123.196 0.598 . . . . 73.0 110.141 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 39.5 mt -88.47 37.7 0.84 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.589 1.156 . . . . 65.31 110.198 172.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.6 -96.08 1.52 Allowed Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.374 -1.09 . . . . 70.35 110.374 -173.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -107.1 -5.46 18.01 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.313 1.045 . . . . 65.03 110.839 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.43 ' HG2' ' HZ3' ' C' ' 34' ' ' LYS . 4.0 tp10 -103.17 121.14 42.04 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.526 1.131 . . . . 63.11 109.062 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 35.6 m -69.32 126.95 31.36 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.779 0.718 . . . . 70.45 109.07 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.754 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.42 -54.64 6.44 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.093 -0.706 . . . . 55.21 109.093 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -169.08 168.87 9.79 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 114.836 -1.074 . . . . 74.22 111.097 175.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -140.08 143.83 36.51 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 106.883 -1.525 . . . . 64.5 106.883 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.404 ' N ' HD13 ' C' ' 75' ' ' LEU . 43.8 t -153.24 116.19 4.55 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.726 -0.472 . . . . 63.12 109.726 175.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -117.6 133.01 56.41 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.722 0.409 . . . . 74.31 110.086 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 84.6 t -126.57 138.07 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.225 1.01 . . . . 64.34 108.39 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.464 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 66.7 mt-30 -115.11 97.14 6.04 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.349 -0.982 . . . . 72.32 108.349 173.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -86.63 104.52 16.13 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.572 0.749 . . . . 62.22 110.683 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.543 ' HA3' ' HE3' ' C' ' 19' ' ' LYS . . . -110.42 143.78 16.96 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 121.532 -0.366 . . . . 73.02 112.729 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.03 142.06 10.22 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 111.361 -0.696 . . . . 53.3 111.361 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' D' ' 29' ' ' PRO . 14.4 mm -90.72 126.39 43.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.557 -0.905 . . . . 72.55 108.557 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -132.27 128.76 38.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.955 0.902 . . . . 55.13 109.19 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.8 p -96.78 126.1 41.7 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 109.225 -0.657 . . . . 55.33 109.225 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.402 ' O ' HD12 ' C' ' 86' ' ' ILE . 2.5 pp -115.48 143.9 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.89 1.276 . . . . 73.25 109.577 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -144.31 142.9 30.71 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.67 0.388 . . . . 65.34 110.953 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.71 -18.08 48.93 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 114.635 0.614 . . . . 62.41 114.635 175.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.452 HG22 HE21 ' C' ' 93' ' ' GLN . 38.5 pt -113.43 154.13 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 117.406 0.603 . . . . 75.42 112.227 -172.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -164.57 -178.68 5.5 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.163 0.985 . . . . 71.4 109.798 173.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.12 -123.5 33.24 Favored Glycine 0 C--N 1.352 1.458 0 O-C-N 123.427 0.454 . . . . 44.04 114.005 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 74.0 p -70.64 -32.25 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.048 0.939 . . . . 74.44 111.258 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.452 HE21 HG22 ' C' ' 89' ' ' ILE . 27.9 mt-30 -69.09 -36.15 77.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.342 0.657 . . . . 70.45 110.987 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 46.8 ttm -76.81 -32.89 57.94 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.496 -0.32 . . . . 74.24 110.267 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.89 -41.02 73.84 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.55 0.532 . . . . 72.23 110.275 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -81.24 -30.59 34.1 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.438 0.461 . . . . 74.51 111.705 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 23.0 t -62.09 -39.22 91.74 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.416 0.448 . . . . 74.42 110.666 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.32 -14.32 24.02 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.091 0.556 . . . . 62.1 110.718 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.05 -29.99 61.83 Favored Glycine 0 C--N 1.357 1.696 0 O-C-N 123.279 0.362 . . . . 55.43 113.886 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.09 -38.65 0.06 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.201 0.815 . . . . 64.53 113.201 -170.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -62.42 -52.45 63.5 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.906 0.482 . . . . 73.3 111.322 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.566 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 58.8 m -72.9 -46.19 8.7 Favored Pre-proline 0 CA--C 1.563 1.452 0 CA-C-O 118.732 -0.652 . . . . 74.02 112.289 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 64.6 Cg_exo -54.33 -28.5 53.48 Favored 'Trans proline' 0 C--N 1.398 3.14 0 C-N-CA 122.321 2.014 . . . . 73.45 114.306 171.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -69.65 -35.79 75.49 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.458 0.703 . . . . 75.22 109.774 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.438 HD12 ' NH1' ' A' ' 111' ' ' ARG . 27.8 mm -64.94 -41.8 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.509 -0.552 . . . . 61.15 109.509 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 39.8 mt -79.03 -27.95 43.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.063 0.945 . . . . 61.41 113.015 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -57.67 -49.82 91.59 Favored Pre-proline 0 CA--C 1.564 1.503 0 N-CA-C 114.337 1.236 . . . . 70.33 114.337 -171.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.93 -33.93 95.47 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 121.944 1.763 . . . . 74.11 112.905 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -69.19 -45.59 69.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.983 0.513 . . . . 53.32 110.502 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.25 -37.45 77.63 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.255 -0.884 . . . . 61.04 110.665 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -61.89 -58.94 6.0 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.863 -1.062 . . . . 60.45 110.621 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.03 78.66 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 110.137 -0.32 . . . . 51.2 110.137 -175.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.3 t -66.74 -28.65 68.58 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.974 0.509 . . . . 64.41 111.609 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.477 HD13 HG23 ' C' ' 64' ' ' VAL . 83.4 mt -77.13 -55.43 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 109.707 -0.479 . . . . 53.3 109.707 170.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.1 m -60.81 -28.62 68.92 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.211 1.005 . . . . 74.12 111.782 -170.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -68.84 -49.75 55.74 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.834 -0.802 . . . . 74.53 108.834 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.576 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.21 -34.84 75.75 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.561 1.144 . . . . 62.05 112.639 178.205 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.52 -48.16 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.743 0.817 . . . . 72.14 109.193 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.4 ' OG ' HG21 ' B' ' 115' ' ' THR . 41.9 t -67.85 -28.87 67.92 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.811 -1.086 . . . . 72.44 111.911 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -71.31 -43.95 66.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.578 -0.897 . . . . 62.12 108.578 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.86 3.27 61.34 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 123.901 0.751 . . . . 30.32 113.036 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 33.1 p 60.23 38.35 20.06 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.694 1.998 . . . . 71.34 113.898 170.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -94.4 149.8 37.21 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 108.655 -0.869 . . . . 62.21 108.655 166.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.31 176.71 0.35 Allowed 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.309 2.673 . . . . 72.1 115.376 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -59.85 122.16 13.54 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.325 1.05 . . . . 75.4 113.747 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.4 ' CD2' HG11 ' C' ' 64' ' ' VAL . 9.6 mp -112.66 86.26 2.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.218 1.007 . . . . 64.13 109.48 171.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -107.47 107.98 19.09 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.816 -0.809 . . . . 60.41 108.816 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.439 HD22 HD11 ' C' ' 42' ' ' LEU . 59.5 mt -73.38 142.83 46.98 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.643 -0.708 . . . . 74.35 110.519 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.67 148.32 94.95 Favored Pre-proline 0 CA--C 1.55 0.975 0 O-C-N 123.844 0.715 . . . . 75.12 110.111 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.496 ' HG3' HD12 ' A' ' 16' ' ' ILE . 37.4 Cg_exo -57.42 120.38 8.26 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.581 2.188 . . . . 75.34 112.221 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 98.7 t -97.52 119.51 45.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.296 -1.001 . . . . 75.43 108.296 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -77.93 73.12 4.5 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.761 0.663 . . . . 72.22 110.378 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -56.95 -41.05 77.6 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.558 0.743 . . . . 72.3 110.595 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -66.0 -49.49 67.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.069 -0.969 . . . . 71.23 111.762 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.02 96.22 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.959 0.787 . . . . 42.22 111.033 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.29 -29.32 66.04 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.376 -0.829 . . . . 63.34 111.665 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 15.3 t80 . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 110.062 -0.347 . . . . 74.32 110.062 177.873 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.238 0.463 0 N-CA-C 109.959 -0.386 . . . . 54.44 109.959 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.402 ' HZ ' HG13 ' D' ' 105' ' ' ILE . 74.9 t80 -152.68 94.31 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.654 -1.239 . . . . 61.5 107.654 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -123.18 116.84 24.08 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.516 0.727 . . . . 75.25 109.04 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.16 113.79 17.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.221 -1.029 . . . . 75.22 108.221 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -81.99 -22.93 36.31 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.604 0.761 . . . . 74.24 111.059 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -170.61 141.28 1.85 Allowed 'General case' 0 C--N 1.361 1.065 0 O-C-N 123.536 0.522 . . . . 71.11 111.234 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.404 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -119.7 133.93 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.683 -1.599 . . . . 54.14 106.683 169.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.448 ' HE1' HG13 ' D' ' 83' ' ' ILE . 20.7 p90 -163.13 163.08 25.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.407 0.622 . . . . 75.32 111.499 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -95.47 120.91 36.53 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.704 -0.85 . . . . 65.41 108.704 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 41.0 mtpt -83.92 -35.2 24.24 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.19 -0.67 . . . . 75.03 109.19 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.4 t70 -146.9 137.18 23.55 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.506 -1.225 . . . . 74.25 109.303 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.576 HG21 ' HE2' ' C' ' 117' ' ' MET . 78.5 mt -136.9 145.31 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.532 1.133 . . . . 71.12 107.976 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -146.77 135.98 22.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.11 0.964 . . . . 61.4 108.831 172.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.498 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.3 t80 -136.65 129.54 30.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 106.453 -1.684 . . . . 64.53 106.453 166.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 33.1 mt-10 -137.65 112.73 9.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.114 -1.069 . . . . 72.13 108.114 -172.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.88 88.34 2.89 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.568 -1.271 . . . . 71.12 107.568 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.08 -32.26 43.99 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.418 2.079 . . . . 55.12 112.695 -167.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.509 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 70.4 m-20 -113.94 14.42 18.48 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.969 0.908 . . . . 71.23 110.7 -177.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.471 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -18.6 -74.34 0.02 OUTLIER Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 116.566 2.061 . . . . 60.12 116.566 -166.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.497 ' HB3' HD11 ' C' ' 83' ' ' ILE . 84.3 Cg_endo -77.26 -20.08 12.94 Favored 'Trans proline' 0 C--N 1.382 2.324 0 CA-C-N 124.377 2.599 . . . . 74.14 114.246 -176.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -70.81 -39.16 73.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.192 0.997 . . . . 71.52 109.635 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.677 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.7 p -84.22 -24.34 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 115.675 -0.693 . . . . 63.11 112.172 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -66.68 -22.36 66.08 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 112.675 0.621 . . . . 71.3 112.675 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -61.71 -22.82 65.68 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.752 0.821 . . . . 63.31 110.849 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -88.69 96.23 10.57 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.5 1.12 . . . . 72.12 110.157 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.35 88.12 2.57 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.152 -0.476 . . . . 64.41 109.776 170.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -154.5 158.03 39.26 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.321 -0.992 . . . . 74.31 108.321 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -76.26 110.04 10.14 Favored Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 108.267 -1.012 . . . . 73.41 108.267 172.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -54.29 127.69 26.89 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.425 2.75 . . . . 72.11 113.584 -174.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 24.2 tt0 -56.61 111.84 1.12 Allowed 'General case' 0 C--N 1.368 1.387 0 O-C-N 124.208 0.942 . . . . 74.11 108.81 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.72 138.26 45.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.638 0.732 . . . . 70.11 110.437 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -129.87 124.15 32.53 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 106.389 -1.708 . . . . 70.42 106.389 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 51.4 tp -95.19 120.45 35.43 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.163 -0.68 . . . . 75.14 109.163 -172.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.602 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 10.8 m-20 -106.23 140.09 39.72 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.617 1.167 . . . . 43.01 107.942 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.47 168.21 19.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.27 0.557 . . . . 63.04 109.852 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 7.8 t70 -157.75 142.16 16.24 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.743 1.217 . . . . 50.44 107.726 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -114.8 144.42 43.53 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.405 0.621 . . . . 71.24 109.416 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.413 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.97 164.36 34.79 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.833 1.253 . . . . 74.31 107.815 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.5 p -168.85 158.47 8.9 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 123.599 0.562 . . . . 74.41 110.49 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 94.6 p -150.7 155.66 39.76 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.832 0.853 . . . . 71.13 109.704 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -91.34 119.0 31.0 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.55 -0.908 . . . . 64.43 108.55 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' D' ' 57' ' ' GLU . 58.7 mt -89.75 -40.52 12.45 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.195 0.598 . . . . 71.05 109.613 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.72 -171.24 3.48 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.964 0.906 . . . . 75.31 110.284 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.48 106.89 1.0 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.241 -0.891 . . . . 72.13 110.784 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 64.7 17.63 11.03 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.609 1.163 . . . . 63.53 112.168 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 91.0 t -109.52 105.13 18.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 107.122 -1.436 . . . . 73.3 107.122 170.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -121.98 126.73 49.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.261 -1.014 . . . . 75.34 108.261 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.464 ' HB2' HD11 ' D' ' 51' ' ' LEU . 19.3 tt0 -89.85 151.1 21.93 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.452 1.101 . . . . 61.44 108.707 174.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 91.4 t -131.81 128.52 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 C-N-CA 124.516 1.126 . . . . 55.33 108.11 172.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 57.7 t -104.87 130.51 55.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.331 1.052 . . . . 53.13 108.503 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.87 114.47 24.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.548 -0.908 . . . . 74.45 108.548 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.0 ttm-85 -96.36 101.3 12.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.194 -1.039 . . . . 72.42 108.194 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.5 t -100.84 103.67 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.57 -0.9 . . . . 54.14 108.57 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 6.0 m -100.64 137.3 39.22 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.063 0.945 . . . . 61.04 109.171 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.43 HG21 HG21 ' D' ' 114' ' ' ILE . 61.9 t -125.6 113.44 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.855 0.862 . . . . 71.14 109.516 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 12.6 m -103.11 119.53 39.02 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.765 -0.828 . . . . 53.41 108.765 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -135.81 152.06 50.7 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.917 0.487 . . . . 52.35 111.32 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 57.2 p -148.92 136.03 20.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.083 -0.508 . . . . 52.12 112.013 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.581 HD12 HG22 ' D' ' 31' ' ' VAL . 50.1 mt -102.49 96.36 6.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.46 1.104 . . . . 74.34 108.103 171.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.63 -139.1 20.49 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.129 -0.487 . . . . 63.24 113.11 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.05 0.76 46.98 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.91 0.484 . . . . 74.45 111.362 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -118.74 152.66 35.75 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.704 0.802 . . . . 73.31 109.286 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.7 m -73.63 139.68 45.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.75 0.42 . . . . 74.12 110.671 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.677 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.41 -69.83 0.66 Allowed 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.388 -0.824 . . . . 43.21 108.953 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -149.13 138.85 21.86 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.251 -0.886 . . . . 71.54 109.516 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.1 mt -111.78 132.43 54.67 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.359 1.463 . . . . 61.35 107.167 172.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.494 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.7 t -141.56 147.07 37.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.485 -0.561 . . . . 74.2 109.485 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -156.15 130.39 8.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.581 -0.526 . . . . 54.12 109.581 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.12 114.7 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.558 0.743 . . . . 52.35 109.127 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.534 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.27 86.56 6.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.567 -0.901 . . . . 72.01 108.567 170.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -78.7 100.76 7.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.237 -1.347 . . . . 64.34 108.901 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.07 146.57 20.46 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 116.1 -0.5 . . . . 73.55 112.16 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.443 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.9 130.45 4.34 Favored Glycine 0 CA--C 1.508 -0.358 0 N-CA-C 110.343 -1.103 . . . . 62.31 110.343 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.448 HG13 ' HE1' ' D' ' 17' ' ' TYR . 73.6 mt -89.41 122.85 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.722 -1.214 . . . . 61.24 107.722 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -118.2 145.28 45.09 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.906 0.882 . . . . 65.24 109.335 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 6.8 t -115.57 98.14 6.54 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.633 -1.247 . . . . 74.32 107.633 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 30.0 pt -129.92 137.12 57.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.18 -0.918 . . . . 72.15 110.099 -170.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.07 151.84 25.72 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.811 -0.631 . . . . 63.44 110.442 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.13 -13.17 60.41 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.131 -0.94 . . . . 14.32 113.444 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.572 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -95.71 136.86 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 121.463 0.649 . . . . 72.03 111.546 -170.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.5 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 44.8 mt-10 -143.02 -176.68 5.01 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.877 1.671 . . . . 75.14 109.685 -177.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.36 -128.06 27.22 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.347 -0.842 . . . . 21.0 113.425 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 46.0 m -85.45 -32.98 22.0 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.439 0.696 . . . . 61.4 111.031 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.33 -38.69 92.13 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.968 0.507 . . . . 74.14 111.977 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.5 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 26.1 ptt? -61.09 -45.09 96.13 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.348 0.405 . . . . 74.11 110.914 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.76 91.99 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.406 0.622 . . . . 75.41 110.137 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -68.33 -23.19 64.68 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.188 1.395 . . . . 65.45 111.757 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.0 t -79.02 -51.93 8.92 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.663 -0.495 . . . . 60.23 109.663 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.45 -29.54 62.61 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.306 0.642 . . . . 61.24 111.911 -176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.19 4.93 30.12 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.825 0.69 . . . . 74.24 114.825 -170.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.4 -55.91 0.24 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 117.929 0.864 . . . . 60.34 111.767 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -71.75 -51.85 20.67 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.058 0.392 . . . . 72.42 112.058 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 68.8 m -65.06 -42.48 61.62 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-O 118.401 -0.809 . . . . 73.4 112.256 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.56 -37.95 94.6 Favored 'Trans proline' 0 C--N 1.397 3.102 0 C-N-CA 122.227 1.951 . . . . 73.14 113.317 166.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -67.42 -30.04 69.69 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.199 0.6 . . . . 72.33 111.143 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.402 HG13 ' HZ ' ' D' ' 11' ' ' PHE . 40.0 mm -66.54 -42.91 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.416 0.686 . . . . 54.3 110.225 171.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.443 HD21 ' HA3' ' D' ' 82' ' ' GLY . 87.5 mt -74.07 -20.83 60.16 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.056 -0.975 . . . . 62.25 111.906 -174.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -65.1 -43.12 65.48 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 114.192 1.182 . . . . 61.45 114.192 -172.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.01 -46.0 23.4 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.342 2.028 . . . . 65.42 114.073 169.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -72.13 -38.62 69.21 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.463 0.705 . . . . 75.43 111.597 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.85 89.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.369 0.668 . . . . 64.45 110.777 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.413 ' NH2' HG23 ' B' ' 105' ' ' ILE . 29.2 ttp180 -58.0 -48.99 78.37 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.392 1.077 . . . . 73.53 110.6 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -58.04 -46.81 84.75 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.201 0.938 . . . . 74.41 111.359 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -59.81 -44.5 93.98 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.027 0.829 . . . . 62.12 111.413 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.494 HG12 ' SG ' ' D' ' 76' ' ' CYS . 75.7 mt -65.35 -50.6 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.78 0.832 . . . . 42.43 111.046 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 57.3 m -55.14 -41.85 72.29 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 124.095 0.958 . . . . 53.41 111.402 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.9 t -67.26 -41.47 85.52 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.568 -1.196 . . . . 71.23 110.4 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -71.46 -28.96 64.32 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.845 0.458 . . . . 61.22 112.187 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' D' ' 123' ' ' PHE . 59.0 t -64.61 -46.44 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.204 0.602 . . . . 71.01 109.581 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.01 -27.24 62.6 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 116.076 -0.511 . . . . 74.33 110.998 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.2 mtt-85 -71.2 -35.04 71.42 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.332 0.653 . . . . 72.43 109.841 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.65 7.97 77.29 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 115.901 -0.59 . . . . 73.11 112.329 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p 59.14 25.34 13.83 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 126.35 1.86 . . . . 71.42 114.725 173.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.554 ' HB2' HG13 ' D' ' 118' ' ' VAL . 99.0 m-85 -87.52 155.69 53.77 Favored Pre-proline 0 CA--C 1.556 1.206 0 N-CA-C 108.607 -0.886 . . . . 75.54 108.607 169.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.72 146.92 96.49 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.635 2.223 . . . . 72.34 112.436 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -58.36 139.54 55.14 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.732 1.213 . . . . 71.34 113.026 -172.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 9.1 mp -114.47 112.36 22.86 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.705 0.802 . . . . 74.24 109.569 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.2 m-20 -102.35 92.67 4.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.35 -0.981 . . . . 65.11 108.35 172.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.18 115.45 7.66 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.374 -0.602 . . . . 74.12 109.374 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.3 138.99 97.31 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.306 0.642 . . . . 73.31 110.585 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -69.66 119.93 6.81 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.162 1.908 . . . . 33.54 111.073 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.7 150.74 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.325 0.65 . . . . 73.21 111.053 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -80.49 107.16 13.07 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.284 -0.871 . . . . 73.15 109.601 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -80.5 -31.68 37.11 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.321 0.648 . . . . 54.51 110.869 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.75 -52.35 65.81 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.194 1.398 . . . . 71.21 111.861 -168.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.33 79.54 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.136 0.898 . . . . 65.52 111.718 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.65 -25.6 56.98 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.258 -0.883 . . . . 55.41 111.285 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 88.3 t80 . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 123.36 0.664 . . . . 75.22 110.647 175.08 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.7 m . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 120.684 0.278 . . . . 63.11 110.986 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.634 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 12.6 t80 -137.08 121.84 18.67 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.849 0.859 . . . . 75.53 108.923 172.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -136.45 108.38 7.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.398 0.679 . . . . 73.43 109.292 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.631 HG12 ' HD2' ' A' ' 84' ' ' PHE . 59.5 mt -80.66 109.46 15.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.508 -0.923 . . . . 73.14 108.508 172.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -74.41 -34.91 63.4 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.556 -0.747 . . . . 73.05 110.572 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -174.61 138.0 0.49 Allowed 'General case' 0 C--N 1.362 1.127 0 O-C-N 123.544 0.527 . . . . 74.32 110.624 -170.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.675 HD12 ' HG3' ' C' ' 130' ' ' PRO . 75.4 mt -123.3 133.79 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.75 0.82 . . . . 74.53 109.423 175.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -167.78 151.01 5.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.821 0.848 . . . . 65.14 110.557 -171.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.4 p -79.44 114.75 18.62 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.938 -0.764 . . . . 60.44 108.938 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -78.51 -33.34 48.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.162 -0.681 . . . . 73.25 109.162 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.8 t70 -147.72 132.72 18.18 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.973 -1.012 . . . . 45.42 109.584 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.42 141.49 45.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 107.237 -1.394 . . . . 70.42 107.237 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -145.91 132.55 19.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.627 0.727 . . . . 71.24 109.719 171.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 79.1 t80 -133.19 130.51 39.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.768 -1.567 . . . . 73.34 106.768 172.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.58 122.26 16.38 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.204 0.602 . . . . 41.55 109.456 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.12 78.47 68.96 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.539 -1.282 . . . . 73.21 107.539 174.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.3 -43.35 8.53 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.492 2.128 . . . . 71.32 110.734 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.406 ' O ' HG23 ' A' ' 31' ' ' VAL . 40.3 m-80 -88.62 20.55 3.37 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.386 -1.279 . . . . 71.43 111.423 -177.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.99 -45.93 88.03 Favored Pre-proline 0 CA--C 1.573 1.858 0 C-N-CA 123.71 0.804 . . . . 42.2 113.121 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 16.2 Cg_exo -68.82 -26.17 32.5 Favored 'Trans proline' 0 C--N 1.398 3.164 0 C-N-CA 121.666 1.577 . . . . 73.2 112.928 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -74.3 -37.42 63.66 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.292 0.637 . . . . 70.41 110.172 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.47 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 73.8 t -67.95 -32.94 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.229 1.012 . . . . 74.52 110.668 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -59.0 -27.95 65.92 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.198 0.999 . . . . 63.12 111.44 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -95.83 -48.62 5.67 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.677 0.791 . . . . 74.34 111.25 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 21.0 ptmt -81.66 164.68 21.65 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.909 0.483 . . . . 73.21 111.22 -175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.55 141.24 43.74 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.511 0.725 . . . . 74.14 111.876 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -92.34 83.78 5.07 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.092 -0.707 . . . . 74.33 109.092 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.97 62.07 44.35 Favored Pre-proline 0 N--CA 1.482 1.146 0 N-CA-C 108.235 -1.024 . . . . 72.42 108.235 172.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.54 157.29 28.65 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.441 2.094 . . . . 52.11 112.681 -167.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.21 109.77 22.46 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.53 -0.915 . . . . 73.42 108.53 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -83.5 115.24 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.394 -0.821 . . . . 74.3 109.781 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -104.12 144.41 31.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.87 0.868 . . . . 64.12 108.749 170.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 23.7 tp -136.79 128.84 29.48 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.809 -1.182 . . . . 74.43 107.809 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -135.15 113.01 10.95 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.85 -1.167 . . . . 74.53 107.85 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.2 mt -98.08 121.72 40.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.263 0.625 . . . . 61.22 110.207 -173.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -126.76 147.69 49.97 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.201 1.001 . . . . 73.04 109.054 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.1 m -135.64 126.05 26.71 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.82 0.848 . . . . 72.25 109.761 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.57 109.72 8.86 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 122.941 0.496 . . . . 73.11 110.583 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 29.4 m -89.68 167.99 12.47 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.692 0.797 . . . . 75.12 109.928 175.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.415 ' OG ' ' HB3' ' A' ' 57' ' ' GLU . 86.8 p -160.46 154.05 22.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.505 0.722 . . . . 72.53 109.616 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -89.58 117.46 28.49 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.654 0.382 . . . . 71.35 110.297 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.49 HD12 HG23 ' A' ' 83' ' ' ILE . 78.0 mt -87.27 -46.64 9.52 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.574 0.702 . . . . 75.22 109.42 172.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.43 -176.64 5.39 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 114.421 -1.263 . . . . 42.15 108.777 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -65.81 110.07 2.7 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 109.176 -0.676 . . . . 73.45 109.176 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 74.43 -0.98 3.2 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 125.505 1.522 . . . . 73.31 112.886 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -100.25 113.85 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.048 -1.093 . . . . 73.1 108.048 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -125.66 129.96 50.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.702 0.801 . . . . 51.22 110.642 -172.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.415 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 41.2 tp10 -89.94 114.72 26.58 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.506 -0.924 . . . . 73.54 108.506 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 61.9 t -100.89 129.49 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 107.985 -1.117 . . . . 62.22 107.985 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.5 105.66 19.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.126 -1.064 . . . . 71.02 108.126 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.7 97.78 11.0 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 106.918 -1.512 . . . . 61.03 106.918 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -92.32 105.64 17.8 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.994 1.318 . . . . 72.3 109.762 -174.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.479 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.7 t -98.84 105.46 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.869 -0.789 . . . . 64.53 108.869 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -98.94 107.51 19.97 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.091 0.556 . . . . 75.44 110.2 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' A' ' 126' ' ' LEU . 98.4 t -106.02 125.94 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.323 0.649 . . . . 61.32 109.443 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.4 m -127.75 107.92 10.3 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.038 -0.727 . . . . 71.54 109.038 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.4 117.86 35.63 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.358 -1.349 . . . . 63.34 107.358 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.8 p -144.82 145.38 31.61 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.089 0.556 . . . . 63.01 109.883 -173.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -129.09 90.22 2.99 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.112 0.965 . . . . 70.44 109.184 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.69 -114.89 3.95 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.383 -0.826 . . . . 72.33 111.269 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.92 -26.85 14.91 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.22 -0.659 . . . . 61.23 109.22 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -85.92 117.46 24.79 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.668 0.387 . . . . 70.24 110.374 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.6 m -73.71 131.04 41.2 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.076 -0.713 . . . . 65.32 109.076 168.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -73.55 -58.27 3.42 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.999 -0.741 . . . . 72.02 108.999 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -156.62 159.05 38.11 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.133 -1.394 . . . . 64.34 110.191 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 32.3 tp -127.48 119.14 25.41 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 107.337 -1.357 . . . . 71.33 107.337 173.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 68.3 m -125.68 99.45 5.99 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.975 -0.75 . . . . 50.52 108.975 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -121.95 116.55 24.55 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.494 -0.928 . . . . 75.13 108.494 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.3 111.49 26.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 123.673 0.789 . . . . 75.41 109.392 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 43.0 mt-30 -85.21 86.22 7.4 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.499 -0.926 . . . . 52.42 108.499 171.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.461 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.5 tp-100 -76.55 118.34 19.11 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 114.78 -1.1 . . . . 64.42 108.172 178.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.17 160.22 13.49 Favored Glycine 0 C--O 1.24 0.512 0 O-C-N 123.533 0.521 . . . . 70.03 112.121 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.47 132.63 2.91 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.799 -0.92 . . . . 64.11 110.799 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.49 HG23 HD12 ' A' ' 51' ' ' LEU . 42.7 mt -81.19 115.69 24.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 174.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.634 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.5 m-85 -122.82 118.59 28.33 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.24 -0.652 . . . . 75.33 109.24 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 m -99.68 100.73 11.74 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.963 -0.755 . . . . 52.42 108.963 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.9 pt -108.95 125.36 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.665 0.786 . . . . 74.42 111.122 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.71 161.73 38.48 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.983 0.913 . . . . 73.31 109.937 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.17 2.0 88.55 Favored Glycine 0 N--CA 1.477 1.381 0 N-CA-C 114.674 0.629 . . . . 71.14 114.674 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.542 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -114.82 146.09 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 123.784 0.834 . . . . 72.04 109.73 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 15.9 tt0 -150.93 179.44 8.24 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.413 0.285 . . . . 74.14 110.494 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.459 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 71.83 -136.71 24.63 Favored Glycine 0 C--N 1.351 1.405 0 C-N-CA 123.374 0.512 . . . . 52.24 113.747 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.2 p -80.43 -15.85 55.82 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.034 0.934 . . . . 71.23 110.744 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -71.96 -37.24 69.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.326 1.051 . . . . 71.31 110.742 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -73.32 -25.05 60.48 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.312 0.245 . . . . 64.33 111.016 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.6 -35.72 70.59 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.97 0.508 . . . . 71.03 109.908 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -66.52 -31.26 71.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.51 0.724 . . . . 74.2 111.27 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.542 ' SG ' HG13 ' A' ' 89' ' ' ILE . 72.1 m -57.21 -60.03 4.22 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.496 0.498 . . . . 62.42 111.179 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -83.62 -12.06 56.51 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 112.541 0.571 . . . . 73.43 112.541 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.14 -15.2 26.56 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 119.476 -0.625 . . . . 51.52 114.399 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.29 -61.59 0.35 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.95 0.875 . . . . 72.23 111.725 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.17 -65.99 0.61 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.974 1.31 . . . . 72.33 112.759 -169.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.42 -39.39 19.9 Favored Pre-proline 0 CA--C 1.569 1.703 0 N-CA-C 113.379 0.881 . . . . 71.42 113.379 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.87 -29.57 88.38 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 121.683 1.589 . . . . 61.14 113.341 169.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -70.57 -28.09 64.63 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 122.6 0.36 . . . . 71.41 110.453 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.448 HG21 HD13 ' A' ' 13' ' ' ILE . 36.3 mm -56.39 -40.35 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.462 0.705 . . . . 73.14 110.15 172.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.461 HD22 ' HG3' ' A' ' 80' ' ' GLN . 80.4 mt -80.39 -22.55 41.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.861 -1.063 . . . . 62.45 112.675 -173.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.46 -44.92 97.09 Favored Pre-proline 0 CA--C 1.572 1.825 0 N-CA-C 113.591 0.96 . . . . 74.12 113.591 -172.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -59.73 -43.64 36.85 Favored 'Trans proline' 0 C--N 1.394 2.954 0 C-N-CA 122.041 1.828 . . . . 73.24 112.954 173.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -65.48 -36.91 85.27 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.153 0.581 . . . . 72.33 111.037 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.69 -37.92 70.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.91 -0.586 . . . . 63.41 110.751 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.534 ' NH1' HD12 ' C' ' 105' ' ' ILE . 35.0 ttm180 -53.88 -52.87 59.11 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 123.943 0.777 . . . . 75.42 110.03 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -59.78 -49.14 78.87 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.572 1.17 . . . . 72.11 111.311 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.497 ' O ' ' HE3' ' A' ' 117' ' ' MET . 34.3 t -56.28 -40.85 74.92 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.317 1.011 . . . . 72.11 110.59 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.479 HD11 ' HB ' ' A' ' 62' ' ' VAL . 96.3 mt -70.37 -47.87 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.942 0.897 . . . . 42.14 111.076 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.497 HG23 ' HG3' ' A' ' 125' ' ' GLN . 33.5 m -54.66 -38.03 66.43 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.433 0.693 . . . . 64.13 110.349 177.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.6 t -69.42 -40.78 77.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.865 -1.061 . . . . 71.23 109.634 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.497 ' HE3' ' O ' ' A' ' 113' ' ' CYS . 33.2 mmt -59.8 -44.56 93.9 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 120.957 0.408 . . . . 74.34 110.624 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 114' ' ' ILE . 57.3 t -67.79 -44.61 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.299 1.04 . . . . 70.45 111.118 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -72.97 -33.05 65.6 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.359 0.664 . . . . 62.51 111.642 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -71.36 -32.66 68.76 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.964 0.506 . . . . 62.51 109.658 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.79 -2.96 72.12 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 115.571 -0.741 . . . . 74.4 113.578 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.1 m 70.06 11.48 7.64 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.994 1.318 . . . . 72.21 111.487 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -82.86 142.9 45.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 N-CA-C 108.819 -0.808 . . . . 73.35 108.819 173.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -46.86 132.91 17.55 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.403 2.735 . . . . 74.55 113.592 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.497 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.3 tt0 -52.07 144.36 12.29 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.367 1.467 . . . . 64.51 114.108 -169.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.409 ' CD2' HG11 ' A' ' 64' ' ' VAL . 16.4 tp -121.1 104.12 9.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.281 1.432 . . . . 64.05 109.255 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -116.05 96.02 5.37 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.751 -0.833 . . . . 73.44 108.751 170.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.39 151.78 46.36 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.513 -0.767 . . . . 41.14 110.665 176.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.59 152.28 91.63 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.672 0.789 . . . . 74.12 110.964 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.9 126.78 18.81 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.006 1.804 . . . . 64.11 111.918 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.2 t -99.05 115.69 40.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.534 -0.913 . . . . 74.14 108.534 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -81.7 81.61 7.69 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.958 -0.756 . . . . 74.34 108.958 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -59.74 -27.15 66.24 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.478 0.711 . . . . 71.32 111.601 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.92 -49.42 65.6 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.549 1.139 . . . . 74.22 111.032 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.56 -42.45 95.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.224 0.61 . . . . 73.13 110.474 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.9 mt -67.66 -25.2 65.6 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.688 -1.142 . . . . 74.32 111.711 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -78.45 -43.69 26.53 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.46 -0.57 . . . . 72.11 109.46 175.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.5 mmt . . . . . 0 N--CA 1.485 1.29 0 O-C-N 123.687 0.617 . . . . 71.52 111.543 -177.323 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 91.2 m . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 107.903 -1.147 . . . . 75.54 107.903 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -138.46 137.22 36.96 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.257 -1.016 . . . . 75.22 108.257 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -145.13 142.51 29.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.16 0.584 . . . . 74.31 110.328 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.2 mt -94.16 123.16 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.809 -1.182 . . . . 74.22 107.809 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.44 HE22 HG13 ' B' ' 55' ' ' VAL . 50.2 mt-30 -94.24 -31.45 14.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.075 0.55 . . . . 71.21 110.304 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -173.51 139.04 0.72 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 123.83 0.706 . . . . 74.2 109.458 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.2 mt -121.09 137.17 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 106.543 -1.651 . . . . 70.22 106.543 170.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -166.77 146.71 5.69 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.315 0.579 . . . . 63.03 111.397 -172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.9 m -74.0 126.97 31.68 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.223 -1.029 . . . . 72.33 108.223 168.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -95.16 -40.94 9.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.292 -0.633 . . . . 63.32 109.292 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 23.3 m-20 -144.55 133.49 22.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.776 -0.647 . . . . 73.45 110.375 -166.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.6 mm -127.85 142.96 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.248 1.019 . . . . 55.12 108.884 171.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.1 t -144.32 115.18 7.8 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.737 -1.209 . . . . 63.54 107.737 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -130.77 110.18 11.14 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 107.799 -1.185 . . . . 63.22 107.799 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.75 113.91 21.87 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.267 1.027 . . . . 72.54 108.921 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.99 82.67 7.09 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 106.958 -1.497 . . . . 55.14 106.958 169.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.13 -33.69 11.25 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.27 1.98 . . . . 74.25 112.176 -173.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.75 7.54 46.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.245 1.018 . . . . 74.44 110.544 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.6 -64.33 0.43 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 115.095 1.517 . . . . 70.14 115.095 -163.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.17 -22.85 29.64 Favored 'Trans proline' 0 C--N 1.39 2.746 0 C-N-CA 121.64 1.56 . . . . 41.13 112.817 -170.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -96.78 -20.88 17.9 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.493 0.717 . . . . 72.31 111.002 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' B' ' 68' ' ' LEU . 2.7 p -84.19 -20.73 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.52 0.328 . . . . 74.2 110.445 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -68.08 -24.21 65.03 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.543 0.737 . . . . 71.32 112.886 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -64.36 -15.11 59.8 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.542 0.337 . . . . 63.13 110.779 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -89.38 106.88 18.74 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.748 1.219 . . . . 75.04 109.711 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.04 89.35 7.97 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.277 0.631 . . . . 63.4 109.432 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -161.11 161.25 31.12 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.25 1.02 . . . . 73.11 108.829 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.44 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 68.5 mt-30 -85.83 104.32 5.07 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 108.723 -0.843 . . . . 71.51 108.723 173.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.494 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 16.6 Cg_endo -55.94 122.62 12.09 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 122.978 2.452 . . . . 73.42 111.801 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -62.71 109.17 1.33 Allowed 'General case' 0 C--O 1.243 0.741 0 O-C-N 123.759 0.662 . . . . 74.12 110.177 -175.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.561 HG13 HG13 ' B' ' 64' ' ' VAL . 65.9 t -87.01 128.68 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-N 115.045 -0.98 . . . . 70.13 111.231 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -106.42 118.03 35.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.77 1.628 . . . . 74.11 108.356 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.32 135.87 36.39 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.247 0.619 . . . . 35.34 110.244 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.852 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.5 m-20 -129.94 156.19 44.84 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.78 1.232 . . . . 62.53 109.084 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.546 HD13 ' HE2' ' B' ' 133' ' ' PHE . 45.5 mt -134.43 159.55 40.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.759 0.823 . . . . 71.25 109.31 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.3 t70 -159.74 112.91 2.19 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.375 -1.343 . . . . 44.21 107.375 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.1 p -116.88 119.98 37.06 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.83 0.452 . . . . 70.13 110.182 -175.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.42 161.83 25.17 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.397 1.079 . . . . 71.44 109.188 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m -142.26 165.92 26.12 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.447 -0.946 . . . . 74.4 108.447 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.7 p -150.08 136.21 18.74 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.828 0.451 . . . . 63.1 109.83 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -80.95 109.94 16.0 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.911 -0.403 . . . . 64.42 109.911 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.436 ' HB2' HG12 ' B' ' 55' ' ' VAL . 86.2 mt -76.48 -50.59 13.65 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.518 0.675 . . . . 72.34 109.226 172.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.91 -172.99 4.24 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.082 -0.963 . . . . 70.21 110.054 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -63.82 107.71 1.28 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.028 -0.987 . . . . 74.52 109.863 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 49.4 m-20 72.82 15.2 4.79 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.4 1.48 . . . . 74.21 111.642 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.44 HG13 HE22 ' B' ' 14' ' ' GLN . 75.6 t -115.51 122.15 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.348 1.059 . . . . 72.52 108.708 173.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -129.93 143.16 50.65 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.192 0.597 . . . . 74.23 111.21 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.482 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 4.6 tm-20 -103.65 100.19 10.01 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 106.809 -1.552 . . . . 63.32 106.809 171.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.0 t -90.98 139.52 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.601 0.76 . . . . 64.14 110.265 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.483 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 18.4 t -120.77 135.92 59.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.788 0.835 . . . . 71.05 109.867 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -118.17 107.47 13.99 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.604 -1.258 . . . . 73.54 107.604 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 23.1 ttm-85 -96.57 125.5 41.09 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.217 0.607 . . . . 75.12 109.69 172.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.549 ' HB ' HD11 ' B' ' 114' ' ' ILE . 14.6 t -117.0 119.81 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.565 -1.272 . . . . 65.13 107.565 169.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.852 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 62.3 m -100.49 148.07 25.18 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.639 0.776 . . . . 62.45 109.216 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.561 HG13 HG13 ' B' ' 40' ' ' VAL . 73.6 t -135.67 108.29 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.297 1.039 . . . . 63.22 108.359 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.0 m -95.82 137.84 34.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.92 -1.141 . . . . 64.32 107.92 167.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.72 150.43 32.08 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.729 -0.471 . . . . 63.43 109.729 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 50.8 p -150.89 136.72 18.14 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.493 0.496 . . . . 73.44 112.106 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.547 ' HB2' HG22 ' B' ' 31' ' ' VAL . 34.2 mt -104.95 121.41 43.68 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.336 1.054 . . . . 64.42 108.608 170.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.82 -116.98 5.01 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 115.672 -0.694 . . . . 33.43 112.341 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -122.34 23.4 9.76 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.359 1.064 . . . . 73.41 110.116 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -146.09 159.93 42.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.952 0.901 . . . . 71.14 109.961 -174.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 31.0 m -64.3 140.0 58.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.216 0.606 . . . . 70.34 111.292 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.423 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -100.97 -59.62 1.67 Allowed 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.665 -0.865 . . . . 61.45 108.665 171.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -154.35 152.29 30.05 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.788 -0.642 . . . . 63.22 110.684 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 33.3 mt -130.31 109.9 11.11 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 106.169 -1.789 . . . . 73.53 106.169 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.45 ' SG ' HG23 ' B' ' 114' ' ' ILE . 45.2 t -117.32 145.69 43.84 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.704 -0.85 . . . . 55.2 108.704 -175.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.3 tt0 -162.86 130.37 3.68 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.039 0.447 . . . . 62.45 110.046 -172.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 80.2 t -123.83 146.3 29.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.193 -0.912 . . . . 54.12 109.348 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 10.5 mt-30 -121.35 92.97 3.87 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 108.184 -1.043 . . . . 72.54 108.184 168.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.454 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.3 tp-100 -83.65 100.27 10.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.169 -1.048 . . . . 74.54 108.169 174.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.63 170.13 36.43 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.204 -0.758 . . . . 74.32 111.204 175.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.62 127.33 1.45 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 112.311 -0.316 . . . . 72.11 112.311 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 62.5 mt -86.81 131.79 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.778 0.831 . . . . 64.1 109.125 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -136.56 164.54 27.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.104 0.962 . . . . 71.21 109.9 -175.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -129.19 108.97 10.76 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.125 -1.065 . . . . 74.42 108.125 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 40.2 pt -101.25 145.2 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.47 0.708 . . . . 61.44 110.839 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.34 160.55 38.61 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.876 0.871 . . . . 51.25 110.014 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.07 -69.93 3.01 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 123.573 0.545 . . . . 74.41 112.044 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' B' ' 97' ' ' CYS . 19.4 pt -54.39 127.86 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.744 1.218 . . . . 74.4 110.854 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.481 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 30.5 tt0 -149.59 156.02 41.25 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 110.204 -0.295 . . . . 74.41 110.204 -171.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.72 -109.71 2.94 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 112.139 -0.384 . . . . 75.04 112.139 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 42.4 m -79.6 -27.46 41.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.982 0.513 . . . . 75.42 110.649 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.481 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 40.7 mt-30 -66.3 -39.88 89.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 122.795 0.438 . . . . 74.5 110.525 -177.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -76.24 -29.54 57.57 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.988 -0.551 . . . . 74.41 110.505 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.51 -33.17 75.09 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.533 0.733 . . . . 70.34 110.501 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.446 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 17.6 t-80 -74.9 -20.35 59.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.826 1.25 . . . . 75.02 110.474 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.471 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 41.4 t -81.91 -68.51 0.69 Allowed 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.527 -0.546 . . . . 73.44 109.527 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 66.9 mt -66.95 -31.99 72.95 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.281 0.632 . . . . 70.53 112.567 -169.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.12 3.78 70.25 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-O 119.435 -0.647 . . . . 75.34 113.886 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -152.88 -65.95 0.16 Allowed 'General case' 0 C--N 1.357 0.895 0 CA-C-N 118.001 0.901 . . . . 64.41 112.553 -174.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.471 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 58.3 t80 -64.39 -47.42 79.3 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.725 0.81 . . . . 74.25 112.129 -174.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.446 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 87.7 m -60.17 -49.78 89.2 Favored Pre-proline 0 CA--C 1.566 1.562 0 C-N-CA 124.474 1.11 . . . . 63.33 111.908 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.503 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 50.8 Cg_exo -59.14 -34.77 98.63 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.068 1.846 . . . . 70.02 113.434 169.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -30.55 71.58 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.285 0.634 . . . . 71.32 110.874 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.93 -45.89 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.112 0.965 . . . . 73.31 110.565 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 49.8 mt -81.72 -12.71 58.5 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.908 -1.042 . . . . 72.4 112.065 -169.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.32 -49.08 94.51 Favored Pre-proline 0 CA--C 1.558 1.275 0 CA-C-O 117.645 -1.169 . . . . 74.13 113.502 -174.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.17 -35.84 98.37 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 121.951 1.768 . . . . 71.42 112.977 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.454 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 59.9 m-85 -68.96 -46.35 68.39 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.398 0.679 . . . . 74.11 109.851 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.03 88.59 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.611 0.764 . . . . 63.14 110.859 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.541 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 36.7 ttt180 -61.37 -54.81 38.9 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.174 1.389 . . . . 72.24 111.533 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.25 -36.05 82.84 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.541 0.736 . . . . 62.45 109.792 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.446 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.3 t -64.89 -39.31 93.33 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.526 -0.761 . . . . 45.43 111.171 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.549 HD11 ' HB ' ' B' ' 62' ' ' VAL . 70.3 mt -62.19 -54.57 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 109.633 -0.506 . . . . 75.52 109.633 174.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.478 HG21 ' OG ' ' C' ' 119' ' ' SER . 11.1 m -59.74 -30.67 68.99 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.33 1.019 . . . . 71.31 111.276 -173.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 41.7 t -60.63 -50.93 71.54 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 123.87 0.731 . . . . 71.03 109.541 173.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 7.9 mmt -68.19 -36.74 80.05 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.165 0.586 . . . . 65.0 111.453 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 114' ' ' ILE . 91.9 t -59.43 -43.42 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.056 0.942 . . . . 74.45 110.092 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.474 ' OG ' HG21 ' C' ' 115' ' ' THR . 45.9 t -71.46 -31.9 67.69 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.801 -1.09 . . . . 61.23 111.747 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.9 mtt-85 -65.8 -37.37 86.08 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 115.969 -0.56 . . . . 72.31 109.537 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.8 2.92 86.82 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.45 -0.639 . . . . 63.31 113.389 173.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 47.3 p 63.22 19.89 11.94 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 126.116 1.766 . . . . 62.51 114.182 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -81.75 153.51 70.33 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.249 0.62 . . . . 73.25 110.739 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.44 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 98.9 Cg_exo -48.77 162.62 0.36 Allowed 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 124.304 3.336 . . . . 63.12 115.67 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -61.62 128.9 38.49 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.701 1.2 . . . . 74.32 112.231 -169.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.422 HD23 HG21 ' B' ' 118' ' ' VAL . 35.5 tp -133.35 107.85 8.35 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.398 1.079 . . . . 62.22 109.202 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -124.37 134.72 53.06 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.457 0.703 . . . . 74.04 109.571 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.541 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.8 mm? -80.79 147.71 30.36 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.608 0.763 . . . . 52.14 111.075 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.87 146.63 46.5 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.738 0.815 . . . . 75.4 109.501 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.543 ' HG2' HD13 ' D' ' 16' ' ' ILE . 23.7 Cg_exo -64.12 102.75 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.414 2.076 . . . . 72.44 112.465 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 64.3 t -89.42 110.64 21.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.746 -1.205 . . . . 70.44 107.746 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -82.27 86.18 6.72 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.953 -1.128 . . . . 70.23 107.953 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.546 ' HE2' HD13 ' B' ' 44' ' ' LEU . 91.0 m-85 -54.8 -37.84 66.58 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.87 0.868 . . . . 75.03 110.728 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . 0.45 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 16.7 t70 -61.86 -43.77 98.17 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.104 -1.407 . . . . 62.22 111.109 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.19 -42.94 62.16 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.59 0.756 . . . . 65.51 111.116 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.42 -16.03 60.39 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.223 0.453 . . . . 71.52 112.223 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 63.4 t80 . . . . . 0 N--CA 1.483 1.205 0 C-N-CA 123.221 0.608 . . . . 71.55 109.817 171.641 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 24.9 m . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 108.707 -0.849 . . . . 71.12 108.707 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -122.41 123.21 40.81 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.264 0.626 . . . . 73.53 109.671 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -143.72 133.91 24.39 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.055 0.942 . . . . 53.1 108.492 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 36.5 mt -81.22 126.43 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.76 -0.829 . . . . 72.34 108.76 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.541 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 29.4 mm-40 -88.0 -47.02 8.85 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.646 -0.707 . . . . 72.52 110.148 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -174.81 138.88 0.49 Allowed 'General case' 0 C--N 1.352 0.706 0 CA-C-N 115.373 -0.83 . . . . 53.32 109.441 -168.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -128.31 141.0 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 107.824 -1.176 . . . . 73.15 107.824 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -170.41 171.14 6.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.469 0.652 . . . . 64.5 110.885 -170.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -96.26 110.91 23.13 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.758 -0.83 . . . . 64.23 108.758 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -71.81 -34.26 69.21 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.933 -0.766 . . . . 62.12 108.933 173.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.5 t70 -146.52 146.51 30.53 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.072 -0.967 . . . . 72.44 109.295 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.3 mt -141.86 144.26 25.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.815 1.646 . . . . 73.22 106.912 175.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t -155.05 151.05 27.94 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.641 0.734 . . . . 70.24 110.433 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -148.67 148.63 30.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.197 -1.365 . . . . 75.2 107.354 171.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.594 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.5 mt-10 -143.77 139.25 29.3 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.003 0.921 . . . . 74.42 109.29 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.45 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -155.06 73.42 5.67 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 106.263 -1.754 . . . . 43.44 106.263 169.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.29 -10.88 16.19 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.147 1.898 . . . . 74.32 111.766 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -114.98 20.7 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.984 1.314 . . . . 71.2 109.306 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.465 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -55.82 -53.49 62.35 Favored Pre-proline 0 CA--C 1.561 1.385 0 N-CA-C 113.348 0.869 . . . . 73.32 113.348 -168.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.38 -42.38 68.25 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 121.752 1.635 . . . . 73.21 113.015 177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -70.84 -35.36 72.4 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.657 0.783 . . . . 74.42 112.444 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -79.5 -24.17 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 112.262 0.467 . . . . 64.21 112.262 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -68.99 -22.86 64.06 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.983 -0.448 . . . . 75.21 111.79 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -95.61 6.42 48.99 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.238 0.615 . . . . 72.33 111.048 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.403 ' HG2' HD13 ' C' ' 68' ' ' LEU . 2.8 tppp? -92.89 142.5 27.24 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.756 0.822 . . . . 72.32 111.562 -172.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -71.2 134.14 46.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.748 1.219 . . . . 64.15 109.618 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -84.75 102.36 12.94 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.961 0.726 . . . . 73.41 112.961 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -121.16 67.84 17.32 Favored Pre-proline 0 N--CA 1.484 1.263 0 N-CA-C 107.507 -1.294 . . . . 73.52 107.507 160.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -84.15 118.75 2.35 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 122.969 2.446 . . . . 73.42 112.951 -171.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -86.35 99.16 11.41 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.953 -1.128 . . . . 74.13 107.953 167.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 p -76.83 98.82 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.688 0.756 . . . . 72.11 109.35 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.8 101.48 13.29 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.506 -2.035 . . . . 74.32 105.506 169.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 9.0 tt -86.38 142.3 28.55 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.305 -1.368 . . . . 75.01 107.305 174.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.567 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.1 t70 -119.58 133.63 55.58 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.685 -0.857 . . . . 73.21 108.685 -173.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.0 mt -112.71 123.36 50.14 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.467 -0.938 . . . . 71.41 108.467 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.3 t70 -135.78 126.6 27.47 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.397 -1.334 . . . . 44.23 107.397 172.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -137.58 128.17 26.76 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.583 0.706 . . . . 70.3 109.699 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.05 152.27 46.08 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 113.93 -1.486 . . . . 71.24 107.523 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -140.43 145.38 36.93 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.838 -0.43 . . . . 73.33 109.838 -174.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -143.84 135.71 26.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.492 0.717 . . . . 52.25 110.433 -168.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -72.75 122.67 21.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.471 0.708 . . . . 74.12 110.741 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.611 HD11 HD12 ' C' ' 83' ' ' ILE . 36.1 mt -91.71 -45.8 8.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.473 -0.936 . . . . 64.24 108.473 172.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.01 178.29 8.83 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.323 -1.308 . . . . 73.54 108.901 174.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -74.19 134.12 42.75 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.062 -0.718 . . . . 63.54 109.062 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 69.16 -0.21 2.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.478 1.511 . . . . 75.12 113.114 -171.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.1 t -123.35 94.82 3.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 123.961 0.904 . . . . 64.35 108.701 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -116.11 125.35 52.25 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.961 -1.125 . . . . 70.52 107.961 -176.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.491 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.1 tt0 -82.26 138.21 34.66 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.686 0.794 . . . . 65.44 109.519 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 63.6 t -115.45 130.05 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.916 -0.772 . . . . 73.31 108.916 170.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 97.0 t -111.76 133.73 56.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.542 -1.281 . . . . 73.43 107.542 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.06 104.31 8.8 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.455 -0.943 . . . . 72.12 108.455 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.54 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 33.1 ttm-85 -95.48 108.7 20.94 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.583 -0.895 . . . . 62.44 108.583 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.546 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.8 t -109.38 122.52 64.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.834 -1.173 . . . . 74.54 107.834 172.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.3 m -124.55 114.66 19.7 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.091 0.556 . . . . 71.31 109.837 -174.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.562 HG11 HD11 ' C' ' 126' ' ' LEU . 78.1 t -99.25 107.82 21.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.761 -0.829 . . . . 71.34 108.761 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.522 HG23 HD23 ' C' ' 75' ' ' LEU . 1.6 m -99.46 106.83 18.91 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.374 -1.343 . . . . 71.5 107.374 174.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.54 124.19 46.8 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.239 -1.023 . . . . 70.44 108.239 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 59.7 m -134.72 163.69 29.22 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.928 0.394 . . . . 65.34 110.651 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.403 HD13 ' HG2' ' C' ' 34' ' ' LYS . 30.7 mt -124.3 15.22 9.02 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.093 1.357 . . . . 62.44 109.785 -173.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.54 -93.04 0.42 Allowed Glycine 0 C--N 1.344 1.013 0 N-CA-C 110.381 -1.088 . . . . 51.03 110.381 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -100.04 -30.76 11.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.108 0.963 . . . . 71.12 109.599 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -75.34 122.68 24.12 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.592 1.157 . . . . 73.25 110.715 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 78.8 m -78.37 125.84 29.93 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.803 -1.184 . . . . 54.44 107.803 162.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.706 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.44 -64.74 0.86 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.549 -0.908 . . . . 51.33 108.549 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.69 168.72 24.14 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.28 -0.873 . . . . 65.11 109.675 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.1 tm? -128.36 142.28 51.17 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.515 -1.661 . . . . 74.23 106.515 169.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 47.4 t -144.23 145.47 32.08 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 107.817 -1.179 . . . . 75.1 107.817 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -157.61 128.14 6.41 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.891 -0.411 . . . . 74.12 109.891 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.58 125.29 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 123.855 0.862 . . . . 71.51 108.79 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.54 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.5 mt-30 -103.75 86.86 2.68 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.531 -0.914 . . . . 52.21 108.531 173.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -78.46 97.91 5.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.676 -1.147 . . . . 74.32 108.949 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.27 149.16 24.74 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.291 -0.868 . . . . 72.52 110.98 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.514 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -153.81 117.12 0.78 Allowed Glycine 0 CA--C 1.502 -0.723 0 N-CA-C 110.891 -0.884 . . . . 72.42 110.891 -176.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.611 HD12 HD11 ' C' ' 51' ' ' LEU . 9.6 mm -81.97 119.55 31.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.461 -0.941 . . . . 73.25 108.461 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -125.21 118.58 26.36 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.837 -0.801 . . . . 71.25 108.837 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.2 m -77.54 103.21 7.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.156 -0.683 . . . . 62.3 109.156 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.546 HG12 HD21 ' C' ' 98' ' ' LEU . 1.7 pp -122.63 123.52 68.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 123.762 0.825 . . . . 71.41 110.143 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.25 162.04 27.15 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.554 1.142 . . . . 62.23 109.225 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.68 -34.29 3.92 Favored Glycine 0 N--CA 1.473 1.133 0 N-CA-C 113.805 0.282 . . . . 73.11 113.805 173.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.476 HG22 HE21 ' C' ' 93' ' ' GLN . 28.0 pt -90.15 144.57 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.924 0.889 . . . . 62.42 111.07 -177.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -161.95 155.98 21.77 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.511 0.724 . . . . 63.52 110.079 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.72 -117.83 7.88 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.586 -0.734 . . . . 72.52 113.198 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 32.6 p -69.35 -25.07 64.01 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.001 0.92 . . . . 74.51 111.816 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.476 HE21 HG22 ' C' ' 89' ' ' ILE . 25.4 mt-30 -71.45 -52.34 19.0 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.591 0.757 . . . . 63.24 110.685 176.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -30.58 68.37 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.681 -0.69 . . . . 74.3 111.466 -174.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.13 -47.79 82.22 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 124.244 0.965 . . . . 74.3 110.692 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.439 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 10.5 t-160 -78.56 -35.56 45.82 Favored 'General case' 0 C--O 1.246 0.886 0 O-C-N 123.548 0.53 . . . . 62.31 111.994 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -58.65 -40.65 84.02 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.474 0.484 . . . . 74.54 110.665 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.546 HD21 HG12 ' C' ' 86' ' ' ILE . 31.0 mt -101.72 -10.68 19.75 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.994 0.518 . . . . 74.23 111.341 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.91 -30.55 63.31 Favored Glycine 0 C--N 1.355 1.584 0 N-CA-C 113.953 0.341 . . . . 53.32 113.953 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.63 -35.99 0.06 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.137 0.421 . . . . 71.22 112.137 -171.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -65.31 -43.49 90.91 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.318 1.447 . . . . 74.25 112.216 -176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -84.24 -42.59 0.74 Allowed Pre-proline 0 CA--C 1.567 1.601 0 CA-C-O 118.588 -0.72 . . . . 61.31 112.245 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -54.2 -25.55 38.5 Favored 'Trans proline' 0 C--N 1.397 3.113 0 C-N-CA 122.747 2.298 . . . . 72.12 114.095 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -61.37 -38.26 86.34 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.62 0.768 . . . . 60.01 110.822 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.534 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.5 mm -67.1 -39.88 84.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.196 -0.911 . . . . 73.24 110.306 177.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.514 HD21 ' HA3' ' C' ' 82' ' ' GLY . 60.5 mt -79.45 -22.75 43.73 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.943 0.897 . . . . 72.54 112.065 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -55.6 -52.8 69.02 Favored Pre-proline 0 CA--C 1.558 1.284 0 N-CA-C 114.08 1.141 . . . . 75.24 114.08 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.05 -29.01 65.85 Favored 'Trans proline' 0 C--N 1.386 2.531 0 CA-C-N 121.286 1.495 . . . . 72.03 112.637 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -70.29 -47.87 59.26 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.981 0.512 . . . . 75.34 109.674 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.82 -45.18 78.39 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.989 -1.005 . . . . 55.31 109.789 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.575 ' HG3' ' HB3' ' C' ' 128' ' ' LEU . 44.9 ttt-85 -56.21 -52.98 62.45 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.35 1.46 . . . . 71.12 111.708 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.28 -37.27 85.06 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.344 0.658 . . . . 75.31 110.483 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 21.1 t -71.36 -29.25 64.75 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 122.954 0.502 . . . . 73.32 111.628 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.546 HD11 ' HB ' ' C' ' 62' ' ' VAL . 98.0 mt -69.43 -52.34 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 109.342 -0.614 . . . . 52.24 109.342 173.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.474 HG21 ' OG ' ' B' ' 119' ' ' SER . 5.8 m -61.79 -31.16 71.36 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.58 0.752 . . . . 74.45 110.937 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.9 t -63.5 -52.68 60.2 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.433 0.693 . . . . 53.44 109.19 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.531 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.17 -38.01 84.97 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.263 1.025 . . . . 64.44 112.473 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' C' ' 114' ' ' ILE . 83.3 t -61.59 -48.35 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.656 0.783 . . . . 53.5 110.009 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.478 ' OG ' HG21 ' B' ' 115' ' ' THR . 41.7 t -67.23 -27.37 67.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.574 -1.194 . . . . 73.22 111.519 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -72.68 -40.75 66.02 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.181 0.592 . . . . 60.21 109.62 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -3.91 79.38 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.426 0.454 . . . . 51.42 112.747 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.1 p 62.95 33.78 14.66 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 126.853 2.061 . . . . 74.23 113.222 173.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.61 151.69 62.19 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.087 -1.079 . . . . 71.1 108.087 168.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -57.25 166.16 4.7 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.679 2.253 . . . . 72.35 113.6 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -46.44 138.24 5.89 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.344 1.457 . . . . 74.3 114.672 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.562 HD11 HG11 ' C' ' 64' ' ' VAL . 5.4 tt -119.84 85.29 2.35 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.91 -1.144 . . . . 61.54 107.91 169.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -92.17 94.59 9.28 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.225 -1.028 . . . . 74.23 108.225 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.575 ' HB3' ' HG3' ' C' ' 111' ' ' ARG . 16.7 tp -70.05 123.55 21.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.416 -0.811 . . . . 62.12 110.163 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.23 154.85 88.27 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 124.38 1.072 . . . . 60.44 111.402 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.675 ' HG3' HD12 ' A' ' 16' ' ' ILE . 45.9 Cg_exo -55.11 111.12 0.65 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.837 2.358 . . . . 54.24 113.291 172.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.55 115.74 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.443 -1.318 . . . . 61.11 107.443 167.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -82.13 86.62 6.58 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.775 -0.824 . . . . 70.44 108.775 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -62.63 -43.22 99.35 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.927 -1.033 . . . . 73.31 110.628 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.05 -42.99 93.73 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 114.049 -1.432 . . . . 70.43 111.27 -169.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.7 95.29 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 123.711 0.632 . . . . 74.44 111.676 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.04 -49.11 63.43 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.949 0.5 . . . . 74.24 110.021 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . 0.439 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 3.0 t80 . . . . . 0 CA--C 1.555 1.139 0 CA-C-N 116.087 -0.506 . . . . 61.34 110.107 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.585 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 27.9 m . . . . . 0 C--O 1.237 0.433 0 CA-C-O 120.993 0.425 . . . . 54.12 111.106 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -156.99 95.48 1.51 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.116 -1.439 . . . . 64.33 107.116 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -122.48 121.58 36.92 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.982 -0.747 . . . . 73.22 108.982 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.407 HD13 HG21 ' D' ' 105' ' ' ILE . 10.4 mt -84.75 121.61 37.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.046 -0.724 . . . . 55.31 109.046 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -87.04 -36.23 18.31 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 119.286 -0.387 . . . . 74.12 111.616 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -172.38 122.88 0.46 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 120.788 -0.365 . . . . 62.3 111.822 -164.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.543 HD13 ' HG2' ' B' ' 130' ' ' PRO . 1.7 mp -104.41 137.91 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.886 -1.153 . . . . 64.45 107.886 166.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.502 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 30.8 p90 -161.43 177.06 10.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.151 0.907 . . . . 73.34 111.223 178.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.3 p -108.71 126.05 52.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.798 -1.092 . . . . 74.24 108.959 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.502 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 24.9 mtpt -93.88 -12.72 28.29 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.575 -0.528 . . . . 74.13 109.575 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.4 t70 -169.8 136.02 1.52 Allowed 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.516 1.126 . . . . 74.04 108.66 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.531 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.4 mt -135.47 143.6 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.436 1.094 . . . . 75.04 108.403 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -142.69 134.98 27.56 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.249 1.02 . . . . 74.33 109.252 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.528 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.7 t80 -144.22 130.81 20.03 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.377 -1.712 . . . . 73.01 106.377 165.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.8 mt-10 -131.19 150.04 52.32 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.499 0.72 . . . . 73.42 109.377 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.12 76.86 10.21 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 106.939 -1.504 . . . . 74.11 106.939 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.78 -32.72 22.56 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.855 2.37 . . . . 63.14 112.326 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -96.62 0.09 49.38 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.078 -0.964 . . . . 72.22 110.864 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.14 -68.03 0.1 OUTLIER Pre-proline 0 CA--C 1.559 1.297 0 N-CA-C 115.64 1.718 . . . . 72.0 115.64 -160.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -78.04 -16.96 13.89 Favored 'Trans proline' 0 C--N 1.383 2.37 0 CA-C-N 122.655 1.984 . . . . 63.23 113.709 -172.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -74.7 -42.16 58.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.185 0.994 . . . . 74.33 109.394 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.567 HG22 HD12 ' D' ' 68' ' ' LEU . 9.2 p -83.82 -20.61 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 115.827 -0.624 . . . . 55.22 111.093 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -64.24 -16.92 63.0 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.208 0.603 . . . . 72.12 111.923 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -68.55 -2.93 9.96 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.83 0.852 . . . . 72.53 111.801 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 89.1 mttt -109.92 101.67 10.49 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 125.125 1.37 . . . . 75.11 109.809 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -84.35 83.34 8.02 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.444 0.64 . . . . 71.44 109.518 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -146.41 157.2 43.74 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.571 1.149 . . . . 73.4 108.735 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -77.09 105.37 2.4 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.67 -0.863 . . . . 65.54 108.67 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.26 119.07 5.93 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.13 2.553 . . . . 64.34 113.909 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.15 116.22 7.7 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.089 0.956 . . . . 74.04 109.101 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.525 HG12 ' HB2' ' D' ' 66' ' ' ALA . 27.6 m -101.96 119.57 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 121.665 0.745 . . . . 73.13 112.069 -169.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 107.98 18.83 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.123 -1.806 . . . . 72.45 106.123 167.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.556 ' H ' HD23 ' D' ' 42' ' ' LEU . 1.3 pt? -98.14 156.08 16.85 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.418 0.627 . . . . 72.54 110.795 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -141.08 146.56 37.28 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.575 1.15 . . . . 73.21 108.522 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 26.4 tp -127.28 131.98 50.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.709 0.804 . . . . 63.54 109.397 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.597 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.0 t70 -141.58 144.43 34.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.473 -0.936 . . . . 72.1 108.473 173.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.5 t -134.55 158.84 42.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.676 -0.49 . . . . 71.21 109.676 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.12 157.2 35.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.033 -0.985 . . . . 51.1 108.384 174.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.7 p -153.96 148.2 25.89 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.596 -0.52 . . . . 64.44 109.596 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 57.2 p -162.58 142.23 9.35 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.124 0.569 . . . . 71.42 110.236 -171.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -71.52 125.41 26.98 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.998 0.919 . . . . 74.5 111.353 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 mt -94.63 -35.47 12.19 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.102 0.561 . . . . 61.55 109.917 172.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.75 -171.45 3.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.792 0.837 . . . . 63.3 110.381 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -59.68 113.22 2.13 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.701 0.626 . . . . 64.14 110.508 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 65.24 13.29 8.66 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.927 1.291 . . . . 62.51 111.677 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 81.8 t -109.43 118.92 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.496 -0.927 . . . . 71.2 108.496 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -127.93 127.55 43.52 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.329 -0.989 . . . . 71.31 108.329 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -94.03 122.54 36.65 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.214 1.006 . . . . 72.22 108.648 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.11 124.57 53.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.714 -1.217 . . . . 73.22 107.714 172.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.549 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.3 t -100.56 127.59 53.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.654 -0.869 . . . . 55.02 108.654 171.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.03 117.38 33.85 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.309 -0.997 . . . . 54.34 108.309 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.597 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.3 ttm-85 -96.73 114.28 25.91 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.881 -1.525 . . . . 72.13 106.881 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.402 HG21 ' HB1' ' D' ' 110' ' ' ALA . 64.4 t -118.03 116.84 52.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.977 -1.12 . . . . 71.24 107.977 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 74.1 m -119.17 134.61 55.11 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.615 -0.721 . . . . 72.33 109.461 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 78.1 t -131.01 118.07 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.49 0.716 . . . . 73.34 109.905 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -112.39 97.29 6.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.462 1.105 . . . . 60.04 108.279 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.525 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -96.2 161.72 13.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.321 0.649 . . . . 63.02 111.318 -173.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 28.4 p -154.66 137.33 15.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.221 -0.899 . . . . 54.32 111.663 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.567 HD12 HG22 ' D' ' 31' ' ' VAL . 65.8 mt -101.28 96.56 7.27 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.675 -1.148 . . . . 74.23 108.104 168.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.24 -130.48 10.86 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.892 -0.594 . . . . 55.41 112.671 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.26 4.86 21.94 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.109 0.964 . . . . 71.33 112.156 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.45 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 6.4 tp10 -133.46 142.46 48.29 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.918 0.887 . . . . 73.55 110.742 -165.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.0 m -60.59 133.14 55.8 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.047 0.939 . . . . 75.55 111.309 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.431 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.06 -72.6 0.57 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.321 -0.992 . . . . 73.12 108.321 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -141.02 153.77 45.69 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 115.804 -0.635 . . . . 70.03 110.514 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 55.5 mt -114.68 151.09 34.2 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.397 1.079 . . . . 71.43 108.207 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.643 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.9 t -158.94 145.27 16.86 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.572 0.349 . . . . 71.42 110.721 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -155.75 122.7 5.35 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.448 0.699 . . . . 72.32 109.647 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.91 115.65 43.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 109.464 -0.569 . . . . 74.05 109.464 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.505 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -89.8 83.14 6.18 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.112 0.958 . . . . 65.11 108.775 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.42 91.87 5.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 113.619 -1.628 . . . . 63.51 108.997 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.23 141.95 17.15 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.635 -0.586 . . . . 73.41 111.635 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.54 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -140.07 130.14 4.54 Favored Glycine 0 C--O 1.228 -0.269 0 N-CA-C 111.49 -0.644 . . . . 54.42 111.49 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.7 mt -88.29 122.53 39.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.492 1.117 . . . . 62.52 108.977 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -123.74 156.98 35.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.303 0.641 . . . . 71.32 109.634 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.4 m -115.15 108.08 16.16 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.417 -0.957 . . . . 62.13 108.417 170.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.422 HD13 HD13 ' D' ' 98' ' ' LEU . 41.0 pt -105.75 139.84 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.486 0.714 . . . . 74.21 109.352 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -160.04 150.58 18.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.652 0.781 . . . . 60.03 109.74 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.43 -16.19 46.09 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.903 -0.387 . . . . 70.1 113.58 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' D' ' 94' ' ' MET . 43.2 pt -97.96 149.8 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.752 0.821 . . . . 72.32 109.822 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -168.3 177.68 5.29 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.165 0.586 . . . . 74.31 110.761 -168.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.07 -117.5 11.21 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.698 0.624 . . . . 74.32 112.817 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 19.3 m -92.27 -24.08 19.1 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.456 0.703 . . . . 71.45 110.861 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -61.16 -33.84 74.07 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.909 0.884 . . . . 74.35 111.164 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.505 ' HA ' HD12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -63.85 -33.98 76.9 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.099 -0.5 . . . . 72.42 111.332 177.379 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.32 -32.61 55.39 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.018 0.527 . . . . 74.34 110.758 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.4 t-80 -72.62 -26.38 61.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.755 0.822 . . . . 61.22 111.264 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -90.54 -50.37 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.931 0.493 . . . . 72.24 110.877 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.601 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 13.9 tp -82.42 -27.21 32.13 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.117 0.567 . . . . 75.4 111.68 -170.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.62 14.13 42.36 Favored Glycine 0 N--CA 1.477 1.379 0 CA-C-O 119.879 -0.401 . . . . 73.5 113.46 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -144.41 -64.41 0.36 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.929 0.492 . . . . 54.1 110.642 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -69.95 -40.11 75.66 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.677 0.391 . . . . 74.34 111.644 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.601 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 85.6 m -66.35 -47.27 59.92 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.405 -0.807 . . . . 73.33 112.152 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 78.1 Cg_exo -56.79 -32.62 92.14 Favored 'Trans proline' 0 C--N 1.4 3.237 0 C-N-CA 122.231 1.954 . . . . 73.24 113.386 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.46 -30.5 70.86 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.153 0.581 . . . . 63.02 111.678 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.407 HG21 HD13 ' D' ' 13' ' ' ILE . 95.2 mt -72.9 -37.25 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.72 0.808 . . . . 72.44 110.316 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.54 HD21 ' HA3' ' D' ' 82' ' ' GLY . 92.5 mt -75.66 -20.38 58.5 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.226 -0.897 . . . . 74.53 111.769 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -67.94 -43.47 37.09 Favored Pre-proline 0 CA--C 1.563 1.451 0 N-CA-C 113.763 1.023 . . . . 75.42 113.763 -171.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.69 -38.73 87.7 Favored 'Trans proline' 0 C--N 1.395 2.99 0 C-N-CA 121.931 1.754 . . . . 75.33 112.383 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -74.75 -32.74 62.17 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.902 0.751 . . . . 75.33 111.348 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.402 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -64.71 -53.93 39.46 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.224 -0.658 . . . . 62.03 109.224 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.431 HH12 ' HB3' ' D' ' 130' ' ' PRO . 40.5 ttp180 -58.14 -44.3 87.77 Favored 'General case' 0 C--O 1.212 -0.907 0 O-C-N 124.603 1.189 . . . . 64.32 110.509 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.17 -46.22 89.95 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.863 0.727 . . . . 74.3 111.137 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.82 -44.67 90.91 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.012 0.82 . . . . 65.14 110.339 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.643 HG12 ' SG ' ' D' ' 76' ' ' CYS . 69.0 mt -64.28 -52.29 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 124.033 0.833 . . . . 71.33 110.617 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 88.2 m -56.06 -43.68 78.14 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.679 1.192 . . . . 71.14 111.338 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.6 t -64.83 -41.63 95.58 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.995 -1.002 . . . . 43.33 109.978 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.8 mtm -69.85 -28.76 65.94 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.937 0.495 . . . . 61.34 111.917 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' D' ' 123' ' ' PHE . 54.7 t -70.72 -39.75 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.69 0.796 . . . . 71.1 110.419 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.2 p -76.66 -26.9 55.34 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.73 0.412 . . . . 52.32 110.729 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -73.78 -35.38 64.95 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.133 0.573 . . . . 74.15 109.475 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.95 -0.51 89.59 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 115.743 -0.662 . . . . 74.02 112.338 173.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.2 p 64.9 18.93 11.7 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.899 2.08 . . . . 71.44 114.327 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.417 ' HB2' HG13 ' D' ' 118' ' ' VAL . 96.3 m-85 -79.45 150.79 74.06 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 109.131 -0.692 . . . . 74.11 109.131 169.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.35 137.85 47.04 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.924 2.416 . . . . 52.22 112.771 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -55.74 143.36 31.11 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.915 1.286 . . . . 74.02 113.42 -168.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 50.0 tp -115.17 97.42 6.19 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.336 1.054 . . . . 70.41 109.716 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -104.16 89.65 3.33 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.731 -0.47 . . . . 72.53 109.731 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 36.4 tp -67.05 137.55 56.52 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.434 -0.803 . . . . 73.0 109.714 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.31 130.39 91.65 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.594 0.757 . . . . 62.25 111.113 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.431 ' HB3' HH12 ' D' ' 111' ' ' ARG . 56.6 Cg_endo -70.88 116.84 4.85 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.189 1.926 . . . . 72.03 110.756 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.03 124.39 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.554 0.742 . . . . 55.42 109.773 -171.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -73.9 96.28 2.59 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.659 -0.867 . . . . 73.24 108.659 171.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -68.38 -23.73 64.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.824 -0.625 . . . . 70.04 111.3 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.03 -54.85 41.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.277 1.031 . . . . 65.01 110.642 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.06 91.33 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.306 1.004 . . . . 74.03 111.144 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 16.6 tp -72.93 -22.18 60.77 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 115.85 -0.614 . . . . 73.33 111.634 -176.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 78.4 t80 . . . . . 0 N--CA 1.483 1.199 0 C-N-CA 123.852 0.861 . . . . 74.23 110.044 176.059 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 60.5 m . . . . . 0 C--O 1.244 0.787 0 N-CA-C 108.048 -1.093 . . . . 62.33 108.048 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.611 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.0 t80 -135.88 129.53 32.44 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.298 -0.63 . . . . 64.05 109.298 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -143.43 117.01 9.17 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.639 -1.245 . . . . 71.34 107.639 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.485 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.1 mt -87.07 125.28 40.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.934 -0.765 . . . . 74.43 108.934 176.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.43 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -79.62 -43.86 22.08 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 124.05 0.844 . . . . 74.11 108.901 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -173.38 128.79 0.44 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 119.495 -0.288 . . . . 72.14 111.096 -168.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.7 mt -113.04 124.05 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 123.665 0.786 . . . . 75.12 109.427 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HE1' HG13 ' A' ' 83' ' ' ILE . 25.3 p90 -152.96 141.33 20.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.31 1.044 . . . . 73.2 110.423 -169.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.8 p -75.53 110.98 10.36 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.552 -0.536 . . . . 74.22 109.552 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.531 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 36.0 mtpt -75.96 -27.57 57.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.978 -0.378 . . . . 41.34 109.978 176.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.669 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.3 t70 -148.53 138.57 22.36 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.166 -0.924 . . . . 62.24 110.061 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 86.9 mt -134.77 142.32 40.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 125.629 1.572 . . . . 65.01 106.895 173.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -148.73 140.72 23.85 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 123.63 0.581 . . . . 64.32 109.972 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.523 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 77.0 t80 -143.05 127.07 17.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.255 -1.757 . . . . 75.21 106.255 173.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -137.64 121.37 17.47 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.91 -0.404 . . . . 61.12 109.91 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -129.83 77.24 77.15 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 107.997 -1.112 . . . . 71.23 107.997 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.43 -19.38 37.78 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.059 2.506 . . . . 72.33 112.188 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -120.17 28.91 7.78 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.88 0.872 . . . . 71.33 109.743 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -55.69 -46.84 99.67 Favored Pre-proline 0 CA--C 1.566 1.58 0 N-CA-C 113.45 0.907 . . . . 52.04 113.45 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.29 -13.23 18.88 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 122.2 1.933 . . . . 63.41 112.576 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -90.81 -34.27 15.37 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.745 0.818 . . . . 74.41 110.717 -173.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.554 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 35.9 m -77.78 -17.42 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.494 0.718 . . . . 75.34 111.416 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.584 ' HD1' HH11 ' B' ' 15' ' ' ARG . 75.2 t80 -60.26 -35.07 74.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.318 1.047 . . . . 74.13 110.145 165.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -86.73 -52.58 5.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.097 0.959 . . . . 55.33 111.65 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 17.7 ptpt -73.89 170.77 14.68 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.735 0.414 . . . . 64.13 111.419 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.93 128.21 35.13 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.105 -0.498 . . . . 71.24 109.663 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.3 t-105 -72.34 94.2 1.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 O-C-N 123.793 0.683 . . . . 72.22 109.861 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -128.45 84.85 61.97 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.58 1.152 . . . . 70.43 108.706 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 49.2 Cg_endo -87.49 165.25 7.94 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.351 2.034 . . . . 73.4 112.451 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -121.99 106.71 11.46 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.83 -1.174 . . . . 62.02 107.83 168.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.8 m -73.7 92.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-O 122.764 1.268 . . . . 42.24 110.761 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -95.05 124.55 39.16 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.516 -1.22 . . . . 72.34 109.315 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.416 HD22 HD11 ' A' ' 128' ' ' LEU . 50.7 tp -120.52 115.56 23.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.412 0.685 . . . . 72.42 110.072 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 15.1 t70 -106.52 108.43 19.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.945 -1.132 . . . . 74.43 107.945 168.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 60' ' ' LEU . 1.2 tm? -97.59 119.2 35.72 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.584 -1.265 . . . . 53.13 107.584 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -127.08 151.11 49.06 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.508 1.123 . . . . 73.04 109.561 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.8 m -134.9 139.78 45.26 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.05 0.94 . . . . 72.02 109.541 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.28 153.6 51.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.913 1.285 . . . . 73.41 108.387 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 m -133.0 151.63 52.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.235 0.614 . . . . 74.1 109.669 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -150.36 121.47 7.74 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.651 -0.87 . . . . 73.21 108.651 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -79.67 125.55 29.78 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.902 0.382 . . . . 64.21 110.762 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.423 ' HB2' HG12 ' A' ' 55' ' ' VAL . 66.3 mt -93.37 -34.7 13.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.964 0.906 . . . . 74.11 111.448 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.498 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -164.19 -172.49 2.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.534 0.734 . . . . 60.32 110.866 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.05 116.98 5.83 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.431 0.693 . . . . 70.22 109.558 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 71.47 -7.19 1.24 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 125.412 1.485 . . . . 75.42 112.419 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 60.6 t -104.69 125.06 59.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 124.45 1.1 . . . . 73.44 109.1 -174.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -143.0 171.3 14.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.018 -0.734 . . . . 72.0 109.018 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -125.12 152.0 45.0 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.776 -0.824 . . . . 73.44 108.776 167.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.7 t -115.62 126.73 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 107.876 -1.157 . . . . 75.15 107.876 168.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.3 t -97.96 105.48 17.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.046 -1.094 . . . . 74.53 108.046 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 44' ' ' LEU . 42.7 tp -91.96 100.19 12.89 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.074 -0.714 . . . . 71.12 109.074 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -83.59 101.37 11.43 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.872 -0.788 . . . . 72.21 108.872 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.4 t -100.14 101.84 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.781 -1.192 . . . . 72.11 107.781 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.8 m -96.36 109.62 22.11 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.174 -0.676 . . . . 70.21 109.174 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.5 t -112.31 131.43 63.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.913 -1.143 . . . . 70.52 107.913 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -135.64 150.55 49.65 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.264 -1.013 . . . . 70.12 108.264 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -139.44 116.43 10.98 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.668 -1.234 . . . . 65.04 107.668 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.7 m -141.38 145.08 34.93 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.677 0.391 . . . . 53.11 111.793 -170.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.535 HD12 ' HZ3' ' A' ' 34' ' ' LYS . 3.2 tm? -94.79 87.53 5.04 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.708 -1.219 . . . . 73.03 107.708 170.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.5 -104.82 1.82 Allowed Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.791 -0.641 . . . . 53.44 112.583 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -95.36 -25.84 16.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.5 0.72 . . . . 71.32 110.771 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.55 123.08 29.39 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.789 0.435 . . . . 54.23 110.504 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 m -77.97 127.07 31.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.022 0.529 . . . . 72.34 110.121 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -80.43 -51.13 9.19 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.647 -0.871 . . . . 72.42 108.647 173.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -160.94 159.98 30.25 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.431 -1.259 . . . . 75.22 110.827 172.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 55.2 tp -129.84 143.03 50.6 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.289 1.435 . . . . 63.02 107.776 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.609 ' SG ' HG22 ' A' ' 118' ' ' VAL . 56.9 m -147.17 103.85 3.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.157 0.983 . . . . 51.22 109.099 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -128.54 127.46 42.42 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.654 -0.869 . . . . 73.14 108.654 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.5 t -128.75 110.96 22.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.732 -0.84 . . . . 74.23 108.732 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.669 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.3 mt-30 -85.26 85.67 7.44 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 108.449 -0.945 . . . . 74.2 108.449 171.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.516 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.1 tp-100 -76.51 102.17 5.93 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.096 -1.411 . . . . 75.34 109.035 -178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.89 164.96 37.74 Favored Glycine 0 C--N 1.337 0.639 0 N-CA-C 111.334 -0.706 . . . . 61.51 111.334 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.05 124.94 1.1 Allowed Glycine 0 CA--C 1.51 -0.272 0 N-CA-C 111.765 -0.534 . . . . 73.2 111.765 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.469 HG13 ' HE1' ' A' ' 17' ' ' TYR . 46.5 mt -81.13 126.06 39.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.275 -0.639 . . . . 64.21 109.275 176.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.611 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 37.3 m-85 -128.56 137.72 51.87 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.388 1.075 . . . . 74.14 108.135 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.5 m -107.77 115.9 30.98 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.726 -0.842 . . . . 63.41 108.726 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.4 tt -105.52 143.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.628 0.771 . . . . 75.32 110.484 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.49 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -161.68 146.41 13.12 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.754 0.821 . . . . 73.42 109.701 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.36 -32.45 6.81 Favored Glycine 0 C--N 1.341 0.84 0 O-C-N 123.541 0.526 . . . . 52.45 113.713 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.29 146.11 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.947 0.499 . . . . 65.24 112.179 -165.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -135.71 173.07 12.12 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.279 1.031 . . . . 72.14 110.46 -174.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.479 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 56.95 -115.66 6.78 Favored Glycine 0 C--N 1.356 1.666 0 N-CA-C 115.61 1.004 . . . . 63.52 115.61 170.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.5 p -66.17 -33.98 77.0 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.671 0.789 . . . . 75.42 111.159 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -70.17 -43.43 70.82 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.199 -0.91 . . . . 71.31 110.874 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.513 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 13.2 ptt? -66.04 -37.23 85.34 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.132 -0.692 . . . . 62.41 109.132 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.78 81.58 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 123.542 0.737 . . . . 72.3 110.628 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -64.87 -35.8 82.31 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.646 -0.706 . . . . 45.2 110.639 174.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 61.0 m -69.0 -41.66 77.5 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.013 0.525 . . . . 71.24 111.331 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 94' ' ' MET . 65.3 mt -78.9 -43.69 24.32 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.513 0.725 . . . . 73.53 111.885 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.72 4.01 53.3 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-O 119.268 -0.74 . . . . 73.41 114.472 -169.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.48 -57.91 0.23 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 118.075 0.938 . . . . 61.41 112.611 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.622 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 81.3 t80 -66.51 -53.92 29.66 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.996 0.918 . . . . 72.04 112.005 -168.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.3 m -72.98 -36.42 3.36 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.611 -0.709 . . . . 72.52 112.842 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -49.97 -41.35 48.31 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.405 2.07 . . . . 72.42 113.265 161.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -67.36 -32.96 74.25 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.652 0.781 . . . . 75.35 111.227 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.37 -45.25 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.225 0.61 . . . . 60.34 110.305 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.516 HD22 ' HG3' ' A' ' 80' ' ' GLN . 74.3 mt -74.85 -20.74 59.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.116 -0.947 . . . . 73.31 112.144 -175.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.566 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 61.9 t80 -62.3 -44.79 89.37 Favored Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 114.134 1.161 . . . . 74.03 114.134 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -59.54 -37.93 85.75 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 121.878 1.719 . . . . 75.21 112.988 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -70.15 -42.0 73.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.421 0.688 . . . . 75.24 111.029 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.07 -36.6 72.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.856 -0.611 . . . . 74.11 110.844 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.554 ' NH1' HD12 ' C' ' 105' ' ' ILE . 32.0 ttm180 -50.43 -56.41 11.57 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.353 1.033 . . . . 73.23 109.669 174.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -65.39 -43.39 90.81 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.345 1.028 . . . . 64.33 111.8 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.599 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.4 t -61.39 -24.82 66.77 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.048 0.539 . . . . 73.15 112.151 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.466 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.8 mt -84.93 -53.71 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.163 0.985 . . . . 72.2 109.821 172.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.501 HG23 ' HG3' ' A' ' 125' ' ' GLN . 85.5 m -53.33 -52.53 58.87 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.931 1.292 . . . . 55.1 112.521 -174.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.3 t -58.41 -44.55 89.09 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.398 -0.819 . . . . 75.51 110.646 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.523 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.3 ttp -66.15 -32.34 73.72 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.422 1.089 . . . . 45.33 111.644 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.609 HG22 ' SG ' ' A' ' 76' ' ' CYS . 87.1 t -70.39 -45.14 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.117 0.967 . . . . 75.11 110.423 174.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.8 m -68.08 -25.59 65.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.557 0.743 . . . . 71.42 111.596 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -72.55 -32.38 66.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.668 0.787 . . . . 74.13 109.541 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.93 0.34 83.08 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 124.005 0.816 . . . . 64.51 113.288 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.8 m 65.72 16.5 10.52 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.754 1.222 . . . . 74.5 111.199 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -86.8 153.83 55.3 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.79 0.836 . . . . 61.03 109.058 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -53.63 119.19 5.82 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 123.162 2.575 . . . . 75.51 112.343 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.501 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.9 tt0 -53.0 128.93 29.01 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.304 1.042 . . . . 74.15 111.627 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 pp -109.36 137.18 47.61 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.462 -0.94 . . . . 72.21 108.462 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -123.19 91.67 3.53 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.029 -1.471 . . . . 74.53 107.029 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.566 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -63.46 122.24 15.78 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.198 -0.91 . . . . 75.43 109.45 -173.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.64 140.17 96.96 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.223 0.609 . . . . 72.34 110.806 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.12 128.74 29.91 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.41 2.073 . . . . 73.02 111.754 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.3 t -97.82 137.01 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.972 -0.751 . . . . 73.34 108.972 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.442 HD22 ' HB3' ' A' ' 135' ' ' ALA . 1.8 p-10 -77.1 69.04 3.33 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.569 1.148 . . . . 50.14 111.249 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -53.21 -43.6 67.36 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.139 0.976 . . . . 73.12 111.621 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -58.86 -51.64 69.13 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.226 0.953 . . . . 74.14 111.201 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.442 ' HB3' HD22 ' A' ' 132' ' ' ASN . . . -62.97 -41.15 99.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.872 0.733 . . . . 51.34 111.582 -176.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.29 -44.53 95.29 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.217 0.948 . . . . 73.0 110.269 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -72.99 -30.96 64.19 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 115.388 -0.824 . . . . 74.02 110.672 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 15.9 mmt . . . . . 0 N--CA 1.484 1.258 0 C-N-CA 123.26 0.624 . . . . 64.03 111.44 179.828 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 C--O 1.238 0.491 0 N-CA-C 107.946 -1.131 . . . . 74.11 107.946 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -137.46 142.94 41.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.014 0.525 . . . . 62.52 109.633 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -144.59 141.0 29.12 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.465 0.706 . . . . 73.53 109.755 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.465 HD11 HD13 ' B' ' 105' ' ' ILE . 31.6 mt -94.59 125.77 47.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 107.705 -1.22 . . . . 74.43 107.705 170.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -92.8 -41.25 10.2 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.618 -0.512 . . . . 75.24 109.618 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.584 HH11 ' HD1' ' A' ' 32' ' ' PHE . 58.9 ttt180 -168.92 132.86 1.43 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.613 -0.721 . . . . 72.12 109.562 -173.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.453 HD12 HD22 ' D' ' 127' ' ' ASN . 81.7 mt -114.84 135.32 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 106.595 -1.632 . . . . 61.15 106.595 170.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.454 ' HE1' HG13 ' B' ' 83' ' ' ILE . 19.2 p90 -165.52 139.97 4.79 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.229 0.538 . . . . 71.44 110.921 -172.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.4 m -73.4 125.57 28.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.052 -0.976 . . . . 73.32 108.929 174.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.418 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.4 mtpt -98.35 -27.81 13.94 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.478 0.711 . . . . 61.3 110.855 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.7 t70 -157.16 137.7 13.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.62 0.368 . . . . 64.02 110.837 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.6 mm -133.37 145.03 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.644 1.178 . . . . 70.24 108.963 174.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -141.31 141.57 33.89 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.723 1.209 . . . . 54.23 108.427 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.422 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 71.8 t80 -156.07 113.98 3.32 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.143 -1.058 . . . . 73.43 108.143 170.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.18 115.91 20.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.825 0.85 . . . . 71.5 109.213 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.453 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.92 86.31 3.02 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.141 -1.059 . . . . 75.44 108.141 172.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.65 -27.64 26.75 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 122.869 2.38 . . . . 64.44 112.73 -172.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -108.75 15.85 23.28 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.564 -0.731 . . . . 65.1 110.574 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.531 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -40.06 -61.7 1.06 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 115.122 1.527 . . . . 62.41 115.122 -164.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.95 -31.06 56.88 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 121.837 1.692 . . . . 64.34 112.735 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -74.81 -49.23 21.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.681 0.792 . . . . 71.43 110.923 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.698 HG22 HD12 ' B' ' 68' ' ' LEU . 8.6 p -67.97 -21.98 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.771 0.828 . . . . 73.3 112.281 -164.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -66.38 -8.12 23.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.444 0.697 . . . . 70.35 112.822 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.593 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 27.7 pt20 -58.25 -26.03 62.42 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.439 0.696 . . . . 71.24 111.575 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.593 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 90.6 mttt -104.16 105.07 15.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.898 0.879 . . . . 75.15 109.077 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.29 81.31 8.76 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.426 0.631 . . . . 72.55 109.298 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -152.69 156.99 40.25 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.839 -1.171 . . . . 64.44 107.839 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -79.7 110.59 16.23 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 107.318 -1.364 . . . . 43.41 107.318 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.477 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 18.1 Cg_endo -58.03 139.67 91.25 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 123.079 2.519 . . . . 74.52 114.484 -170.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -65.89 124.15 21.71 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 124.236 0.96 . . . . 71.32 109.471 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' B' ' 66' ' ' ALA . 31.0 m -103.68 165.28 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.782 0.833 . . . . 72.51 112.459 -171.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -134.24 114.54 13.15 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 106.386 -1.709 . . . . 74.21 106.386 172.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 5.8 mp -86.27 133.97 33.79 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.405 1.082 . . . . 74.35 108.324 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -149.03 111.72 4.79 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.622 -1.251 . . . . 75.31 107.622 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.97 167.81 10.5 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.069 0.462 . . . . 73.52 109.893 -173.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 26.0 t70 -160.99 141.12 11.02 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.483 1.113 . . . . 64.03 109.139 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 22.8 p -136.28 125.13 24.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.414 0.686 . . . . 71.21 109.62 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.16 154.34 46.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.445 1.098 . . . . 63.43 108.318 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.2 p -142.36 170.51 15.56 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.963 0.411 . . . . 74.43 111.22 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.21 137.52 17.53 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.18 -0.918 . . . . 72.44 109.154 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -82.02 126.29 31.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.935 0.494 . . . . 54.23 109.947 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 91.1 mt -93.28 -34.2 13.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.203 0.601 . . . . 74.23 110.396 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.99 -173.53 2.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.641 0.776 . . . . 71.01 110.707 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.98 127.84 34.08 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.749 -1.114 . . . . 75.32 109.192 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 67.72 0.03 2.13 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.537 1.135 . . . . 74.21 112.612 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 109.9 30.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 123.66 0.784 . . . . 73.25 109.005 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -123.52 137.93 54.67 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.441 -0.948 . . . . 72.14 108.441 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -108.68 106.33 16.33 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.284 -1.376 . . . . 64.34 107.284 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.561 HG22 ' HG ' ' B' ' 98' ' ' LEU . 86.7 t -92.27 142.42 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 O-C-N 124.101 0.876 . . . . 35.03 109.925 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.73 141.54 42.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.731 -0.84 . . . . 62.35 108.731 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -124.29 105.51 9.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.284 -1.376 . . . . 73.22 107.284 178.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 36.4 ttm180 -92.68 123.87 36.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.794 0.438 . . . . 74.42 109.889 171.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.456 ' HB ' HD11 ' B' ' 114' ' ' ILE . 44.3 t -114.57 108.55 25.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.552 -1.277 . . . . 72.15 107.552 170.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 27.5 m -95.07 135.98 35.96 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.719 -0.845 . . . . 72.24 108.719 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.48 129.76 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.915 0.886 . . . . 72.11 109.146 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 28.8 m -118.01 142.43 47.38 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 107.961 -1.126 . . . . 71.43 107.961 169.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -144.79 155.51 43.56 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 117.803 0.274 . . . . 60.13 110.595 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 39.7 p -155.14 138.87 16.14 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 124.154 0.909 . . . . 74.32 111.007 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.698 HD12 HG22 ' B' ' 31' ' ' VAL . 67.7 mt -96.65 107.03 19.41 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.301 -0.863 . . . . 55.24 108.749 170.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.29 -111.56 4.18 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 114.885 -1.052 . . . . 64.51 112.847 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -108.58 0.03 20.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.64 0.776 . . . . 74.41 110.978 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.474 ' HG3' HG23 ' B' ' 31' ' ' VAL . 12.1 pt-20 -118.49 142.67 47.36 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.73 -0.606 . . . . 72.13 110.182 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.7 m -63.94 134.84 55.85 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 123.16 0.584 . . . . 72.14 111.238 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.557 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -91.11 -65.97 0.97 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.253 -0.885 . . . . 74.22 108.644 174.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -150.45 158.19 43.88 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.518 -0.765 . . . . 65.0 111.046 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 58.2 mt -128.3 108.98 11.04 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.105 -1.813 . . . . 74.14 106.105 172.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.41 ' SG ' HG23 ' B' ' 114' ' ' ILE . 49.8 t -119.26 148.34 43.25 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.344 -0.613 . . . . 75.33 109.344 -176.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -160.4 134.71 7.35 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.152 -0.684 . . . . 65.11 109.152 -178.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.9 t -125.79 144.0 37.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.163 -0.926 . . . . 61.51 108.636 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.4 mt-30 -122.9 85.94 2.5 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.891 -1.151 . . . . 74.31 107.891 172.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.436 ' O ' HD13 ' B' ' 106' ' ' LEU . 7.0 tp-100 -80.01 101.08 8.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.199 -1.364 . . . . 74.3 108.623 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.418 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.74 167.92 27.35 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 111.558 -0.617 . . . . 71.11 111.558 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.41 130.76 2.2 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 112.099 -0.4 . . . . 65.22 112.099 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.454 HG13 ' HE1' ' B' ' 17' ' ' TYR . 61.1 mt -85.14 120.36 35.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.028 -1.101 . . . . 73.24 108.028 171.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -127.46 135.58 50.61 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.208 0.603 . . . . 64.41 109.54 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 68.2 m -97.93 109.33 22.11 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.019 0.527 . . . . 72.33 109.755 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.58 ' HB ' HG12 ' B' ' 89' ' ' ILE . 38.9 pt -102.47 122.66 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.316 1.046 . . . . 74.13 109.045 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.84 141.6 44.7 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.616 0.766 . . . . 63.13 109.612 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.53 -29.33 4.06 Favored Glycine 0 N--CA 1.473 1.157 0 CA-C-O 119.925 -0.375 . . . . 63.43 113.343 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.58 HG12 ' HB ' ' B' ' 86' ' ' ILE . 2.8 pp -56.23 132.53 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.874 0.87 . . . . 63.23 111.94 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 5.8 tp10 -160.43 161.4 32.96 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 120.922 0.391 . . . . 65.03 111.688 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.22 -95.65 1.56 Allowed Glycine 0 C--N 1.352 1.455 0 CA-C-N 115.484 -0.78 . . . . 53.45 111.286 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.2 m -105.22 -20.45 13.5 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.392 0.677 . . . . 62.43 110.247 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.427 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 95.3 mt-30 -61.66 -31.02 71.11 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.468 0.707 . . . . 62.4 111.319 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.495 ' HA ' HD13 ' B' ' 89' ' ' ILE . 21.5 ptt? -58.06 -44.88 87.72 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 123.985 0.803 . . . . 74.05 110.928 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . 0.403 ' HB1' ' HZ ' ' B' ' 137' ' ' PHE . . . -76.16 -50.28 15.0 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 123.988 0.915 . . . . 53.51 109.679 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -60.13 -31.6 70.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.674 0.79 . . . . 61.24 111.88 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 11.7 t -73.38 -63.15 1.25 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.353 0.408 . . . . 72.24 110.262 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.561 ' HG ' HG22 ' B' ' 58' ' ' VAL . 10.3 tt -67.6 -39.2 84.77 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.323 0.49 . . . . 53.13 112.323 -172.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.42 3.34 57.88 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 114.965 0.746 . . . . 41.55 114.965 -168.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.48 -56.1 0.27 Allowed 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 117.675 0.737 . . . . 42.33 111.381 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -71.39 -46.64 59.79 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.584 0.754 . . . . 65.41 111.85 -171.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.478 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 75.1 m -65.86 -47.85 63.65 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 123.728 0.811 . . . . 71.24 111.363 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.4 Cg_exo -58.42 -32.88 97.23 Favored 'Trans proline' 0 C--N 1.398 3.143 0 C-N-CA 122.337 2.025 . . . . 72.15 113.629 168.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -62.03 -39.27 91.73 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.209 0.603 . . . . 62.2 110.316 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.465 HD13 HD11 ' B' ' 13' ' ' ILE . 69.4 mt -63.68 -45.03 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.576 0.75 . . . . 74.32 110.457 174.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.436 HD13 ' O ' ' B' ' 80' ' ' GLN . 87.1 mt -75.27 -18.36 60.09 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.891 -1.05 . . . . 61.15 112.192 -176.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.402 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 64.0 t80 -60.91 -51.09 81.88 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 117.784 -1.103 . . . . 61.12 113.563 -171.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 48.6 Cg_exo -59.16 -33.44 98.25 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 121.939 1.76 . . . . 60.41 112.949 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.411 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 78.7 m-85 -69.54 -47.36 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.334 0.654 . . . . 75.34 110.556 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.97 88.73 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.549 0.74 . . . . 71.12 110.531 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.701 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 53.3 ttt180 -60.46 -55.99 26.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.627 1.571 . . . . 73.25 111.028 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.72 -34.79 79.01 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 124.053 0.846 . . . . 65.11 110.128 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.9 t -67.04 -35.3 79.59 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 122.768 0.427 . . . . 64.42 111.825 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.456 HD11 ' HB ' ' B' ' 62' ' ' VAL . 64.5 mt -64.26 -52.96 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.986 -0.746 . . . . 73.41 108.986 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -59.44 -30.68 68.67 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 124.498 1.124 . . . . 74.43 111.769 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.9 t -66.65 -46.54 75.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.615 0.766 . . . . 60.42 110.277 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.2 mmt -68.25 -35.16 77.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.993 0.517 . . . . 71.32 110.663 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.482 HG13 ' HB2' ' B' ' 123' ' ' PHE . 68.9 t -58.13 -48.18 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.278 1.031 . . . . 74.52 110.437 172.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.472 ' HB3' HG21 ' C' ' 115' ' ' THR . 65.5 m -61.23 -35.89 78.44 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.444 -1.253 . . . . 74.52 112.042 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.599 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 74.4 mtt-85 -69.15 -37.11 78.07 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.421 -0.809 . . . . 71.01 110.1 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.51 11.23 59.43 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.749 0.656 . . . . 54.5 113.297 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 57.5 p 64.2 18.79 11.47 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.317 1.847 . . . . 75.32 114.687 172.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.482 ' HB2' HG13 ' B' ' 118' ' ' VAL . 98.8 m-85 -80.95 151.29 70.32 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 109.148 -0.686 . . . . 53.24 109.148 175.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.95 -160.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.68 2.92 . . . . 74.21 114.102 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -65.9 111.33 3.24 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 121.017 0.436 . . . . 75.11 110.76 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.412 HD21 ' HD2' ' B' ' 38' ' ' PRO . 4.0 mm? -122.63 84.7 2.3 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.392 -0.966 . . . . 74.4 108.392 171.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -92.7 128.04 38.41 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.328 -0.619 . . . . 62.14 109.328 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.701 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 32.9 tp -71.98 136.78 46.89 Favored 'General case' 0 CA--C 1.552 1.034 0 O-C-N 123.952 0.783 . . . . 61.44 109.785 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.06 151.98 92.69 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.127 0.571 . . . . 72.41 111.304 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.504 ' HG3' HD13 ' D' ' 16' ' ' ILE . 25.3 Cg_exo -61.3 102.9 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 122.311 2.007 . . . . 74.23 111.836 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.89 111.37 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.168 -1.049 . . . . 72.43 108.168 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -78.91 99.43 6.79 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.237 -1.023 . . . . 73.53 108.237 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -62.95 -48.03 80.62 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 123.371 0.42 . . . . 75.25 110.795 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.07 -41.74 90.35 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.369 1.068 . . . . 73.12 112.966 -166.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.29 -34.41 63.52 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.368 0.667 . . . . 73.32 111.347 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.8 mp -77.65 -32.15 53.12 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.232 0.613 . . . . 74.44 109.928 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . 0.403 ' HZ ' ' HB1' ' B' ' 95' ' ' ALA . 92.7 t80 . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 124.753 1.221 . . . . 73.12 110.452 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 58.5 m . . . . . 0 C--O 1.239 0.522 0 N-CA-C 108.194 -1.039 . . . . 64.4 108.194 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.567 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 4.5 t80 -123.6 125.48 44.92 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.968 -0.753 . . . . 74.42 108.968 176.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.43 HE21 HE22 ' C' ' 14' ' ' GLN . 23.4 tt0 -147.02 119.99 8.75 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.065 -1.087 . . . . 71.45 108.065 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.5 mt -74.08 122.25 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.901 -0.777 . . . . 54.42 108.901 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.678 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.3 mm-40 -85.0 -45.74 11.86 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.173 -0.922 . . . . 72.23 110.508 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -174.16 126.02 0.34 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.032 -0.531 . . . . 73.34 110.31 -168.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.78 141.64 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 107.868 -1.16 . . . . 54.34 107.868 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.477 ' HB3' HG23 ' D' ' 122' ' ' THR . 27.0 p90 -173.15 168.43 4.75 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.306 0.574 . . . . 74.21 111.941 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -89.38 117.57 28.42 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.013 -0.736 . . . . 51.0 109.013 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -78.73 -35.47 44.73 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.506 -0.553 . . . . 75.5 109.506 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.426 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 13.9 t70 -146.62 147.83 31.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.127 -0.942 . . . . 71.0 109.323 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.0 mt -141.83 146.09 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.169 1.388 . . . . 62.21 107.394 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.7 t -158.11 149.35 21.13 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.355 0.597 . . . . 62.15 110.748 174.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -143.49 145.11 32.32 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.446 -1.316 . . . . 63.14 107.446 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.472 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.1 mt-10 -135.05 127.9 31.26 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.987 0.915 . . . . 75.24 109.926 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.72 72.7 7.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.591 1.557 . . . . 72.21 106.933 170.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.1 -39.94 21.96 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.763 2.309 . . . . 73.52 111.062 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -93.46 22.29 5.45 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 113.846 -1.525 . . . . 65.03 111.279 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.21 -56.08 5.79 Favored Pre-proline 0 CA--C 1.564 1.509 0 N-CA-C 114.135 1.161 . . . . 64.44 114.135 -173.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.42 -38.15 44.58 Favored 'Trans proline' 0 C--N 1.389 2.691 0 CA-C-N 121.77 1.668 . . . . 62.24 112.716 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -69.4 -38.42 77.94 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.596 0.759 . . . . 73.22 112.103 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.716 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.4 p -77.08 -22.26 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 N-CA-C 112.286 0.476 . . . . 61.23 112.286 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -68.1 -30.0 69.06 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.925 0.393 . . . . 74.33 110.87 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -99.82 31.67 3.17 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.255 0.622 . . . . 62.41 110.574 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -108.86 157.79 18.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.83 0.852 . . . . 63.11 109.746 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -61.61 121.36 12.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.062 -0.718 . . . . 74.12 109.062 168.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 58.7 t-105 -86.55 96.6 10.13 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.146 0.578 . . . . 72.03 110.478 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.479 ' H ' HD22 ' C' ' 68' ' ' LEU . 63.7 tt0 -144.72 78.48 12.88 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 108.585 -0.894 . . . . 62.13 108.585 170.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -85.67 139.96 6.89 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.74 2.293 . . . . 52.35 112.641 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . 0.437 ' HB3' ' HE3' ' C' ' 41' ' ' LYS . 36.6 mt-10 -87.28 85.43 7.17 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.15 -1.796 . . . . 73.51 106.15 169.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 48.1 t -63.13 107.99 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.504 0 CA-C-N 114.698 -1.137 . . . . 75.14 108.655 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' C' ' 39' ' ' GLU . 99.2 mttt -125.12 104.8 8.73 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.008 0.923 . . . . 62.4 109.763 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.537 HD11 HD21 ' C' ' 126' ' ' LEU . 4.0 mm? -86.09 125.6 33.58 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.159 -0.928 . . . . 74.54 109.194 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -118.25 105.31 11.63 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.812 -1.181 . . . . 71.01 107.812 173.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 tt -107.57 122.31 46.42 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.464 -0.569 . . . . 60.21 109.464 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -124.27 142.54 51.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.969 1.308 . . . . 74.21 108.654 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . 0.41 HG21 ' HG3' ' C' ' 103' ' ' PRO . 1.5 m -123.48 126.6 47.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.465 0.65 . . . . 73.21 109.597 173.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.55 170.33 8.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.275 -1.329 . . . . 70.32 107.872 171.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -165.0 156.84 15.34 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.048 -0.723 . . . . 64.44 109.048 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 49.9 p -156.64 136.75 12.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.845 0.458 . . . . 73.22 110.713 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -70.2 126.35 29.41 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.415 -0.587 . . . . 74.13 109.415 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' C' ' 57' ' ' GLU . 57.6 mt -97.47 -35.93 10.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.421 0.688 . . . . 73.31 110.336 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.0 -174.08 4.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.031 0.933 . . . . 74.23 110.455 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -62.29 106.73 0.78 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.237 -0.892 . . . . 75.42 109.874 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 68.68 11.03 8.21 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.498 1.119 . . . . 71.11 112.876 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 99.4 t -105.94 105.76 19.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.62 -1.252 . . . . 72.42 107.62 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -117.73 123.88 47.12 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.722 -0.844 . . . . 75.13 108.722 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.568 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.6 tt0 -85.54 143.87 28.25 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.748 0.819 . . . . 75.05 109.218 171.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 43.7 t -119.26 139.08 47.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 108.102 -1.073 . . . . 74.51 108.102 166.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.76 123.36 65.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 107.43 -1.322 . . . . 71.43 107.43 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.4 107.7 18.82 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.629 -0.878 . . . . 62.22 108.629 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.15 102.96 14.81 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.706 -0.85 . . . . 71.23 108.706 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.402 ' HB ' HD11 ' C' ' 114' ' ' ILE . 58.7 t -103.59 108.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.344 -0.984 . . . . 74.31 108.344 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.7 m -98.1 137.1 37.39 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.853 -1.166 . . . . 71.13 107.853 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.56 HG21 HG21 ' C' ' 114' ' ' ILE . 61.3 t -132.24 108.82 14.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.591 -0.522 . . . . 64.41 109.591 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -103.9 142.93 33.55 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.117 -0.947 . . . . 64.31 109.737 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.26 123.23 15.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.874 -1.528 . . . . 45.23 106.874 173.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 7.9 m -130.45 128.42 41.23 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.492 0.495 . . . . 61.32 109.968 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.479 HD22 ' H ' ' C' ' 37' ' ' GLN . 18.3 mt -86.93 47.57 1.52 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.4 1.08 . . . . 75.43 108.752 175.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.22 -109.47 3.71 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 110.091 -1.204 . . . . 61.5 110.091 -172.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.29 -26.46 17.31 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.292 1.037 . . . . 72.43 110.418 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -71.78 121.3 18.69 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.297 0.639 . . . . 71.34 110.028 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -68.63 126.37 29.47 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.65 -0.87 . . . . 75.03 108.65 168.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.716 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.6 -58.49 3.25 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.164 -1.05 . . . . 62.13 108.164 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.07 165.45 27.19 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.795 -1.093 . . . . 74.52 110.169 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.472 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.6 tm? -128.62 140.42 51.78 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.387 -1.708 . . . . 70.24 106.387 168.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.5 t -144.35 140.09 28.88 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.124 -1.065 . . . . 73.34 108.124 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -156.29 137.0 13.31 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 110.152 -0.314 . . . . 62.51 110.152 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -136.21 135.29 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.066 0.946 . . . . 61.14 108.833 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 41.9 mt-30 -107.07 94.62 5.2 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.259 1.023 . . . . 75.32 109.388 173.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.41 ' HG3' HD22 ' C' ' 106' ' ' LEU . 9.3 tp-100 -85.59 98.1 10.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.989 -1.005 . . . . 71.34 110.226 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.69 145.98 17.9 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 112.117 -0.393 . . . . 41.41 112.117 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.571 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.51 124.72 1.84 Allowed Glycine 0 CA--C 1.507 -0.441 0 N-CA-C 110.568 -1.013 . . . . 75.02 110.568 -174.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 4.8 mm -82.82 123.55 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.513 -0.921 . . . . 75.22 108.513 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.567 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 64.2 m-85 -129.32 120.7 26.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.222 0.609 . . . . 71.4 109.512 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -70.81 118.82 14.08 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.137 -0.69 . . . . 63.52 109.137 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' C' ' 94' ' ' MET . 4.7 tt -122.05 122.88 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.312 0.645 . . . . 61.52 110.313 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.605 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -156.57 168.89 26.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.493 0.717 . . . . 50.42 109.656 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.96 -54.45 4.3 Favored Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.045 0.355 . . . . 71.32 112.495 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 pt -83.01 156.1 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.408 1.083 . . . . 71.45 110.964 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.98 175.81 10.39 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.543 0.737 . . . . 54.15 110.635 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.11 -127.71 43.16 Favored Glycine 0 C--N 1.349 1.27 0 O-C-N 123.981 0.801 . . . . 73.14 114.128 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p -70.07 -26.95 64.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.017 0.927 . . . . 61.05 111.97 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -68.49 -44.65 74.29 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.869 0.868 . . . . 74.32 110.705 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.792 ' HB2' HD11 ' C' ' 86' ' ' ILE . 3.6 ppp? -74.13 -33.75 63.66 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.729 -0.471 . . . . 61.33 109.729 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.31 93.6 Favored 'General case' 0 C--N 1.36 1.046 0 O-C-N 124.242 0.964 . . . . 73.23 110.391 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -80.97 -33.9 33.49 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.046 0.841 . . . . 72.51 112.301 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.9 t -55.4 -38.44 68.92 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.444 0.465 . . . . 42.13 110.053 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 30.6 mt -101.46 -13.29 18.0 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.74 0.816 . . . . 73.35 111.609 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.55 -30.54 56.32 Favored Glycine 0 C--N 1.354 1.58 0 N-CA-C 114.982 0.753 . . . . 74.33 114.982 -174.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.61 -35.38 0.07 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.814 0.445 . . . . 72.51 110.774 -171.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -68.45 -50.15 54.69 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.958 1.303 . . . . 75.45 112.467 -177.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 66.7 m -71.89 -41.39 9.02 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.877 -0.582 . . . . 63.02 112.354 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.41 ' HG3' HG21 ' C' ' 46' ' ' THR . 73.3 Cg_exo -53.84 -32.0 64.8 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 122.561 2.174 . . . . 65.31 113.927 166.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -69.24 -34.81 75.38 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.363 0.665 . . . . 63.15 109.904 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.554 HD12 ' NH1' ' A' ' 111' ' ' ARG . 34.2 mm -62.86 -40.45 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 109.37 -0.604 . . . . 73.23 109.37 174.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.571 HD21 ' HA3' ' C' ' 82' ' ' GLY . 69.1 mt -82.26 -17.98 44.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.296 1.038 . . . . 72.21 112.449 -177.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -60.07 -50.36 86.65 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-O 117.911 -1.043 . . . . 75.11 113.662 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.31 -31.51 62.88 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 121.955 1.77 . . . . 71.52 112.818 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -70.24 -47.76 59.91 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.178 0.591 . . . . 64.23 110.556 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.95 84.3 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.346 -0.843 . . . . 31.41 109.948 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -59.93 -49.35 78.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.021 1.329 . . . . 75.51 110.855 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.41 -39.1 91.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.375 0.67 . . . . 74.1 110.517 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 19.6 t -66.79 -27.53 67.65 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.826 0.45 . . . . 65.44 111.659 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.61 HG23 ' SG ' ' C' ' 76' ' ' CYS . 63.5 mt -80.78 -43.46 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.218 0.607 . . . . 63.32 110.067 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.472 HG21 ' HB3' ' B' ' 119' ' ' SER . 5.7 m -61.16 -29.33 69.73 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.321 0.582 . . . . 61.34 110.373 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -72.92 -53.5 11.14 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.754 -1.112 . . . . 72.14 109.818 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.546 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.37 -39.09 92.04 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.954 0.902 . . . . 62.14 113.167 -175.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' C' ' 123' ' ' PHE . 78.3 t -64.99 -42.17 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.689 0.795 . . . . 73.12 110.184 175.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -69.46 -29.95 67.75 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.26 -0.882 . . . . 73.42 111.244 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.45 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 86.4 mtt-85 -68.5 -39.24 81.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.636 0.775 . . . . 72.3 108.921 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.32 1.47 81.09 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 123.908 0.755 . . . . 53.13 113.17 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 38.4 p 64.03 27.31 14.22 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.543 1.937 . . . . 70.33 113.941 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.413 ' HB2' HG13 ' C' ' 118' ' ' VAL . 93.4 m-85 -92.19 149.39 38.5 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 109.012 -0.736 . . . . 74.15 109.012 171.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -45.03 119.68 2.57 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.583 2.855 . . . . 74.12 113.128 170.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -59.9 155.9 15.51 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.81 1.244 . . . . 71.23 113.566 -170.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.537 HD21 HD11 ' C' ' 42' ' ' LEU . 34.3 tp -104.2 102.33 12.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.779 0.832 . . . . 75.51 109.89 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.76 89.77 4.46 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.951 -1.129 . . . . 73.31 107.951 168.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.03 134.39 43.01 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.628 -0.714 . . . . 74.34 110.282 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.96 151.6 96.14 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 124.111 0.964 . . . . 33.42 111.746 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.52 121.22 9.53 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.983 2.456 . . . . 73.22 112.683 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 t -102.95 137.6 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.966 -0.753 . . . . 71.02 108.966 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.443 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 89.9 m-20 -82.27 73.4 9.31 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.541 -0.54 . . . . 73.44 109.541 173.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -61.53 -43.64 98.5 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.386 -0.824 . . . . 71.54 109.481 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -64.07 -53.51 48.72 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 113.954 -1.475 . . . . 55.5 111.837 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -56.03 -38.4 70.51 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.487 1.117 . . . . 74.11 111.171 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.78 -45.0 79.84 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.213 -0.903 . . . . 75.32 110.693 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.488 1.458 0 C-N-CA 123.052 0.541 . . . . 70.21 110.422 179.466 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 90.0 m . . . . . 0 C--O 1.239 0.508 0 N-CA-C 108.79 -0.818 . . . . 72.21 108.79 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -159.95 90.13 0.9 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.56 -1.274 . . . . 72.33 107.56 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -118.78 116.91 27.53 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.24 -1.022 . . . . 72.33 108.24 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.444 HG21 HD11 ' D' ' 16' ' ' ILE . 13.7 mt -73.2 109.97 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.091 -0.707 . . . . 75.41 109.091 177.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -80.65 -37.85 30.18 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.449 0.7 . . . . 74.23 111.846 -173.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -168.9 139.01 2.3 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 117.414 0.097 . . . . 64.53 111.126 -168.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.504 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.4 mp -117.82 135.04 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.144 -1.428 . . . . 75.03 107.144 169.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -160.53 150.29 17.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.434 0.635 . . . . 71.24 111.798 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 64.3 p -86.5 113.56 22.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.949 -1.023 . . . . 74.2 109.18 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -81.31 -22.04 38.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.298 0.639 . . . . 73.14 110.554 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.476 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.6 t70 -160.39 142.39 12.74 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.151 -0.931 . . . . 74.05 109.042 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.546 HG21 ' HE2' ' C' ' 117' ' ' MET . 85.5 mt -138.65 143.54 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.116 -1.068 . . . . 71.21 108.116 175.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -143.54 133.12 23.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.754 0.822 . . . . 72.13 108.916 171.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.4 t80 -134.77 131.85 38.03 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.328 -1.73 . . . . 71.3 106.328 166.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 25.4 mt-10 -133.09 130.41 39.28 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.91 0.884 . . . . 75.44 108.83 -173.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -138.65 78.34 31.59 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.048 -1.093 . . . . 54.52 108.048 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.52 -31.29 21.87 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.896 2.397 . . . . 72.14 112.388 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -99.84 -1.29 37.86 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.457 -1.247 . . . . 72.31 110.971 -173.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.513 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -29.93 -67.2 0.14 Allowed Pre-proline 0 C--N 1.36 1.058 0 C-N-CA 126.517 1.927 . . . . 75.15 116.134 -160.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.405 ' HB3' HD11 ' C' ' 83' ' ' ILE . 80.9 Cg_endo -71.62 -29.64 15.83 Favored 'Trans proline' 0 C--N 1.375 1.959 0 CA-C-N 122.63 1.975 . . . . 72.13 113.318 -170.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.454 ' HA ' HE21 ' D' ' 33' ' ' GLN . 5.8 p-80 -84.91 -23.44 28.87 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 117.678 0.217 . . . . 64.44 111.137 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.513 HG12 ' O ' ' D' ' 28' ' ' ALA . 8.9 p -80.6 -26.73 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 122.65 0.38 . . . . 74.34 110.444 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -61.71 -25.4 67.4 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.328 0.651 . . . . 74.13 112.436 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.454 HE21 ' HA ' ' D' ' 30' ' ' HIS . 74.3 mt-30 -53.21 -28.78 28.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.275 1.03 . . . . 75.23 111.509 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -84.1 101.52 11.87 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.139 0.975 . . . . 74.01 110.116 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.34 80.43 7.75 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.991 -1.004 . . . . 75.33 108.987 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.422 ' HD1' HD23 ' D' ' 68' ' ' LEU . 50.6 t-105 -142.98 156.47 44.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.85 1.26 . . . . 73.14 108.253 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -80.3 101.98 1.08 Allowed Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 108.066 -1.087 . . . . 61.12 108.066 174.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.92 119.72 6.5 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.084 2.523 . . . . 74.22 112.901 -167.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.84 112.86 2.73 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 123.957 0.785 . . . . 71.43 109.912 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' D' ' 66' ' ' ALA . 27.5 m -100.02 151.07 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.881 -1.054 . . . . 53.25 111.131 -172.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -118.08 117.96 30.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.118 -1.067 . . . . 73.13 108.118 173.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.0 tp -94.62 120.21 34.49 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.919 -0.771 . . . . 72.04 108.919 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.538 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.4 t70 -127.67 112.88 15.33 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.76 -1.2 . . . . 74.22 107.76 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 67.0 mt -96.16 129.08 43.56 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.003 0.521 . . . . 72.11 109.688 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -136.05 121.55 19.43 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.069 -0.715 . . . . 71.44 109.069 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -105.84 168.28 9.22 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.519 0.675 . . . . 55.11 110.512 -177.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -161.05 162.73 31.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.286 -1.325 . . . . 53.44 108.539 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 24.4 p -156.88 153.32 28.0 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.868 -0.79 . . . . 71.41 108.868 172.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 37.3 p -155.69 131.36 9.76 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.543 0.737 . . . . 73.42 109.544 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -73.6 127.96 34.2 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.928 0.491 . . . . 54.15 110.073 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' D' ' 57' ' ' GLU . 61.4 mt -92.64 -35.08 13.72 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.625 -0.509 . . . . 70.41 109.625 175.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.28 -178.48 3.63 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.359 1.063 . . . . 63.13 109.512 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -65.67 127.64 32.75 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.983 -0.747 . . . . 71.43 108.983 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.81 19.3 11.32 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.39 1.076 . . . . 73.44 112.105 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.97 124.28 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.846 0.858 . . . . 74.05 109.173 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.407 ' HD1' HD11 ' D' ' 86' ' ' ILE . 15.0 m-85 -133.57 131.7 40.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.485 0.714 . . . . 71.02 109.751 176.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.527 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.0 tt0 -92.43 120.12 32.62 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.19 -1.041 . . . . 64.2 108.19 167.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -100.9 140.3 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.929 -1.137 . . . . 70.4 107.929 170.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.525 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.8 t -122.76 129.18 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.468 -0.938 . . . . 62.42 108.468 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.45 116.68 32.27 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.163 -1.421 . . . . 63.45 107.163 170.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -104.94 101.86 11.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.942 -1.133 . . . . 73.34 107.942 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.28 137.66 21.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.663 -0.699 . . . . 61.15 109.156 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 32.6 m -117.93 142.16 47.65 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.516 0.727 . . . . 63.04 109.805 177.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.414 HG21 HG21 ' D' ' 114' ' ' ILE . 59.3 t -136.5 113.08 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.058 0.943 . . . . 71.32 109.457 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 89.9 m -106.56 108.92 20.67 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.507 -0.553 . . . . 64.14 109.507 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -106.54 158.45 16.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.185 0.594 . . . . 74.53 110.368 -176.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 4.8 p -153.73 140.73 19.3 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-O 121.438 0.637 . . . . 63.13 112.404 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.481 HD12 HG22 ' D' ' 31' ' ' VAL . 70.5 mt -111.57 116.25 30.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.799 1.24 . . . . 72.41 107.764 169.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.76 -120.78 8.29 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 123.563 0.539 . . . . 74.0 113.112 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -102.84 6.66 39.33 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.82 0.848 . . . . 65.34 111.408 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -135.21 162.13 33.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.83 0.452 . . . . 54.41 110.725 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 30.4 m -57.61 142.9 43.2 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.175 0.99 . . . . 71.03 111.45 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.37 -68.58 0.79 Allowed 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.049 -1.093 . . . . 45.01 108.049 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -141.15 149.17 41.15 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.963 -1.017 . . . . 71.14 109.472 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.6 mt -112.55 146.27 38.83 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.681 -1.229 . . . . 72.13 107.681 169.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.51 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.8 t -153.97 133.45 12.79 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.765 -0.458 . . . . 70.14 109.765 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -154.26 126.61 7.94 Favored 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.97 -0.381 . . . . 73.43 109.97 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 97.9 t -131.09 125.02 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.783 0.833 . . . . 71.55 110.16 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 37.7 mt-30 -87.71 86.33 7.17 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.795 -0.817 . . . . 73.24 108.795 168.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -81.43 92.15 6.4 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.234 -0.893 . . . . 75.44 109.503 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.96 162.59 27.58 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 111.951 -0.46 . . . . 72.31 111.951 178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.31 136.46 4.43 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.997 -0.441 . . . . 54.11 111.997 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.78 127.77 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.73 -0.841 . . . . 74.14 108.73 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.43 125.65 47.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.236 1.014 . . . . 60.34 108.915 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 6.4 t -87.98 97.16 10.8 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.086 -1.079 . . . . 52.13 108.086 176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.455 ' HB ' HD11 ' D' ' 89' ' ' ILE . 2.7 pp -111.32 139.03 37.3 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 C-N-CA 123.546 0.738 . . . . 73.12 110.154 -171.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -157.82 157.18 32.82 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.06 0.544 . . . . 72.53 109.643 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.03 17.99 77.49 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.329 0.393 . . . . 73.11 113.512 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.455 HD11 ' HB ' ' D' ' 86' ' ' ILE . 0.2 OUTLIER -126.68 134.41 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.817 0.847 . . . . 71.52 108.944 178.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.57 177.02 8.77 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.269 0.628 . . . . 64.4 111.136 -174.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.53 -111.36 2.06 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 124.284 0.99 . . . . 65.5 114.573 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.3 m -89.55 -27.05 20.52 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.712 0.805 . . . . 74.42 110.804 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -64.65 -41.03 96.4 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.314 0.645 . . . . 72.43 110.642 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -69.21 -34.04 74.26 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 116.036 -0.529 . . . . 71.33 111.08 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.32 -32.29 64.49 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.286 0.634 . . . . 50.21 110.968 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -77.65 -34.93 52.96 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.427 1.091 . . . . 73.13 110.262 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.2 -51.68 11.6 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.859 -0.61 . . . . 51.42 111.091 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.489 HD23 ' SG ' ' D' ' 102' ' ' CYS . 83.8 mt -85.86 -24.29 26.76 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.948 0.499 . . . . 62.31 112.03 -172.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.84 -14.06 55.63 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.751 -0.472 . . . . 61.23 113.668 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.628 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -135.81 -59.2 0.76 Allowed 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 117.354 0.577 . . . . 21.14 111.89 -173.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -67.8 -41.19 83.55 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.098 0.559 . . . . 71.31 112.295 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.489 ' SG ' HD23 ' D' ' 98' ' ' LEU . 70.4 m -67.86 -45.77 43.41 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 118.483 -0.77 . . . . 75.24 112.321 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -56.5 -36.2 97.44 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.184 1.923 . . . . 51.21 112.909 168.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -65.36 -30.66 71.51 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.606 0.763 . . . . 72.22 111.558 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.422 HD13 HD11 ' D' ' 13' ' ' ILE . 80.0 mt -71.3 -39.27 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.192 0.997 . . . . 52.32 110.463 174.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -76.0 -19.51 58.62 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.441 -0.799 . . . . 52.12 111.527 -176.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -64.88 -43.56 69.05 Favored Pre-proline 0 CA--C 1.562 1.409 0 CA-C-O 117.987 -1.006 . . . . 74.01 113.603 -174.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -51.48 -43.8 47.72 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.241 1.961 . . . . 61.34 113.923 170.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -72.83 -37.52 67.42 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.33 0.652 . . . . 74.15 111.2 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.33 -48.26 80.6 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.44 0.696 . . . . 73.24 109.674 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -54.38 -49.57 69.54 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.875 1.359 . . . . 73.34 110.942 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.16 -45.62 92.61 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.24 0.963 . . . . 53.23 111.372 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.7 t -58.51 -44.87 89.63 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.873 0.733 . . . . 71.42 110.697 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.51 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.0 mt -60.04 -56.56 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.184 0.994 . . . . 73.12 110.743 175.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.7 m -55.21 -42.78 73.77 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.932 1.293 . . . . 74.35 111.561 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 36.8 t -66.18 -40.63 90.6 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 114.561 -1.2 . . . . 74.25 110.047 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.5 mtm -70.57 -30.79 67.59 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.961 0.505 . . . . 62.14 111.869 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.448 HG23 ' O ' ' D' ' 114' ' ' ILE . 73.8 t -64.05 -45.89 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.484 0.714 . . . . 53.55 109.947 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -74.97 -28.13 60.44 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.648 -0.706 . . . . 54.51 111.28 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -70.85 -34.01 71.21 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.236 -0.653 . . . . 60.23 109.236 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.66 11.09 62.63 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.924 0.765 . . . . 71.33 112.919 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.477 HG23 ' HB3' ' C' ' 17' ' ' TYR . 78.9 p 58.51 16.84 4.48 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 126.499 1.92 . . . . 73.4 114.606 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -80.16 146.88 63.8 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.096 -0.705 . . . . 73.04 109.096 171.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.53 133.2 25.92 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.291 2.661 . . . . 64.13 112.428 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -53.34 136.93 36.33 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.346 1.029 . . . . 72.33 112.589 -168.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 51.6 tp -108.37 107.33 17.86 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.488 -0.778 . . . . 72.44 109.74 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.453 HD22 HD12 ' B' ' 16' ' ' ILE . 11.6 m120 -101.23 96.22 7.05 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.4 -0.963 . . . . 72.01 108.4 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.37 122.22 15.68 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.851 0.46 . . . . 71.25 110.05 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.71 123.06 80.18 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 122.993 0.517 . . . . 53.34 109.844 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.89 122.84 11.83 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.626 2.217 . . . . 65.05 112.031 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 75.0 t -106.78 123.27 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.854 -0.795 . . . . 73.22 108.854 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -80.29 93.32 5.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.019 -0.734 . . . . 75.1 109.019 174.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -60.81 -28.07 68.51 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.545 0.738 . . . . 73.45 111.292 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . 0.628 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 6.0 t70 -62.8 -50.08 72.42 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.423 1.089 . . . . 73.13 111.265 -173.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.66 -45.26 87.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.556 0.743 . . . . 65.2 111.408 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.66 -26.05 66.01 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.603 0.761 . . . . 71.11 111.603 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 90.5 t80 . . . . . 0 N--CA 1.478 0.973 0 C-N-CA 123.608 0.763 . . . . 71.14 110.447 175.591 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 92.3 m . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 108.845 -0.798 . . . . 55.32 108.845 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.58 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 13.7 t80 -137.93 126.83 24.01 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.958 0.503 . . . . 65.21 109.713 177.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -138.16 132.5 32.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.418 -1.327 . . . . 62.55 107.418 172.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.527 HG12 ' HD2' ' A' ' 84' ' ' PHE . 46.9 mt -92.76 116.82 34.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.188 -0.671 . . . . 71.41 109.188 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.6 -43.4 59.79 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 124.256 0.973 . . . . 70.11 108.909 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -173.71 129.73 0.42 Allowed 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.243 0.34 . . . . 73.43 111.007 -172.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.492 HD11 HD13 ' A' ' 13' ' ' ILE . 77.1 mt -113.87 139.74 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.954 0.902 . . . . 55.12 109.097 172.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -168.97 -179.78 3.79 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 124.537 1.148 . . . . 72.42 110.495 -170.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -110.15 126.38 54.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.42 -0.809 . . . . 65.23 109.466 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -80.54 -48.8 12.22 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.338 -0.615 . . . . 74.11 109.338 171.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 19.3 t70 -135.58 132.27 36.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.652 -0.704 . . . . 72.44 109.481 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.3 mt -123.21 141.66 42.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.239 -1.393 . . . . 54.03 107.239 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.0 t -144.64 139.07 27.8 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 123.576 0.547 . . . . 74.01 109.586 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.452 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.6 t80 -146.36 126.3 13.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.632 -1.618 . . . . 74.42 106.632 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 22.5 mt-10 -129.6 127.75 41.27 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.438 0.695 . . . . 61.32 109.511 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -137.95 73.93 44.97 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.976 -1.12 . . . . 74.12 107.976 170.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.3 -16.19 13.85 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.664 2.243 . . . . 73.25 110.795 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -105.35 13.54 30.2 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.973 1.309 . . . . 62.02 108.96 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -53.12 -47.93 93.98 Favored Pre-proline 0 CA--C 1.566 1.589 0 C-N-CA 124.935 1.294 . . . . 53.13 113.568 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 37.5 Cg_exo -64.17 -24.39 65.94 Favored 'Trans proline' 0 C--N 1.397 3.107 0 C-N-CA 122.131 1.887 . . . . 71.4 113.608 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -74.07 -42.44 60.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.172 0.589 . . . . 71.1 110.597 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.428 HG21 ' HE1' ' A' ' 123' ' ' PHE . 90.3 t -50.37 -33.54 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.735 1.214 . . . . 74.42 112.356 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -58.02 -39.9 79.51 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.427 1.091 . . . . 74.0 111.694 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -91.67 -23.21 19.88 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.244 1.018 . . . . 74.21 111.628 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 32.0 mmmt -80.4 147.59 30.94 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.402 0.681 . . . . 52.34 111.654 -175.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.34 129.0 35.97 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.404 -0.961 . . . . 65.24 108.404 170.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -76.21 96.38 3.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.0 0.52 . . . . 74.44 110.85 -172.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -148.07 67.17 9.89 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 109.339 -0.615 . . . . 65.21 109.339 170.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.26 152.87 12.35 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.762 2.308 . . . . 74.1 111.589 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -97.0 106.44 18.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.452 -1.314 . . . . 73.52 107.452 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.07 98.19 4.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 116.016 -0.538 . . . . 63.44 109.984 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -78.73 113.45 16.8 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.09 -0.959 . . . . 73.52 108.478 170.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.429 HD22 ' HB2' ' A' ' 128' ' ' LEU . 46.1 tp -100.22 142.87 31.11 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.794 -1.188 . . . . 74.55 107.794 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.54 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 38.8 t70 -145.44 150.26 36.18 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.061 0.545 . . . . 74.23 109.834 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.2 mt -130.53 126.54 37.05 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.479 0.711 . . . . 71.25 110.49 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.673 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 10.5 m-20 -124.72 141.22 52.26 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.328 1.051 . . . . 64.34 109.499 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.5 m -134.8 131.12 37.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.008 0.523 . . . . 63.54 110.366 175.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.01 152.48 50.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.082 0.953 . . . . 55.04 109.383 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.425 ' HB2' HD11 ' A' ' 98' ' ' LEU . 22.4 t -123.45 153.92 39.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.452 0.701 . . . . 43.54 110.424 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.7 t -149.33 119.62 7.32 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.34 1.056 . . . . 72.33 108.695 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -78.42 106.59 10.46 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.482 -0.562 . . . . 44.34 109.482 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 57' ' ' GLU . 42.3 mt -82.0 -35.81 28.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.595 0.758 . . . . 55.41 110.224 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -164.48 -174.36 3.43 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.06 -0.973 . . . . 74.04 109.86 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.84 126.12 28.71 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.264 -1.013 . . . . 65.23 108.264 172.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 85' ' ' SER . 4.8 m-20 65.04 14.63 9.49 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.171 0.989 . . . . 74.23 111.4 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.9 t -128.64 104.88 12.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 N-CA-C 107.8 -1.185 . . . . 63.35 107.8 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.95 126.52 36.27 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.644 -0.707 . . . . 74.22 109.711 -170.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.461 ' HB2' HD11 ' A' ' 51' ' ' LEU . 21.0 tp10 -86.98 128.72 35.07 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 124.438 1.095 . . . . 70.24 109.225 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -128.02 120.32 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.379 -1.341 . . . . 65.44 107.379 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.5 t -110.97 118.51 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.778 0.831 . . . . 73.31 109.146 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.6 tp -100.06 108.11 20.2 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.88 -0.785 . . . . 74.12 108.88 172.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.673 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 27.5 ttp180 -87.18 104.98 16.88 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.543 -0.54 . . . . 75.31 109.543 173.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.1 t -94.39 104.75 16.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.119 -1.067 . . . . 74.31 108.119 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 30.7 m -96.27 135.87 37.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.728 0.811 . . . . 62.3 110.298 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.535 HG21 HG21 ' A' ' 114' ' ' ILE . 74.6 t -128.51 116.79 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.227 1.411 . . . . 62.25 108.544 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -120.95 123.36 42.27 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.209 -1.034 . . . . 55.53 108.209 172.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.84 113.78 21.1 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.839 -1.171 . . . . 52.33 107.839 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.6 t -144.76 143.85 30.88 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.902 0.481 . . . . 73.5 110.173 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -119.33 84.68 2.24 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.013 1.325 . . . . 74.21 108.961 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.14 -119.57 5.22 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.238 -0.892 . . . . 72.12 112.645 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -87.83 -18.98 28.09 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.435 0.694 . . . . 74.45 110.967 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.41 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 1.5 tp10 -94.07 120.27 34.09 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.468 -0.938 . . . . 70.32 108.468 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.3 m -87.35 143.5 27.22 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.114 0.415 . . . . 70.54 110.211 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.71 -66.41 0.89 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.356 -0.609 . . . . 72.12 109.356 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -161.49 174.23 13.71 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.199 -0.91 . . . . 75.42 110.985 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 64' ' ' VAL . 58.2 tp -137.81 137.41 38.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.852 1.261 . . . . 70.34 108.113 175.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.447 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 56.7 m -141.32 130.62 23.61 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.857 -1.164 . . . . 74.3 107.857 175.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -146.7 120.5 9.26 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.603 0.638 . . . . 73.53 109.739 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.84 113.39 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.36 0.664 . . . . 63.4 110.623 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -82.99 87.1 6.89 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.413 -0.958 . . . . 63.32 108.413 166.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.46 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.1 tp-100 -77.19 102.71 6.75 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.304 -0.999 . . . . 62.54 108.304 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.07 143.58 17.1 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.603 -0.599 . . . . 71.34 111.603 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.93 121.89 1.56 Allowed Glycine 0 N--CA 1.451 -0.336 0 N-CA-C 111.041 -0.824 . . . . 72.1 111.041 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.5 mt -82.02 122.26 36.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.107 -1.071 . . . . 43.3 108.107 171.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.58 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.6 m-85 -127.64 119.59 26.24 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.993 0.917 . . . . 73.4 108.962 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 74.4 m -81.07 91.63 6.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.584 0.754 . . . . 71.41 109.692 169.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.5 tt -96.61 135.64 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 114.555 -1.202 . . . . 74.54 109.232 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -161.05 163.56 31.47 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.091 0.956 . . . . 75.1 110.109 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.42 -33.61 5.71 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 116.259 -0.428 . . . . 64.31 113.879 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.553 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.58 155.16 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.928 0.491 . . . . 74.45 111.043 -174.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.96 175.36 13.04 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.73 -1.123 . . . . 74.43 110.169 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.36 -142.49 34.15 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 116.022 -0.535 . . . . 71.54 111.892 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.1 p -70.17 -15.86 63.01 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.338 0.655 . . . . 73.33 111.581 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -75.18 -37.39 61.27 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.738 0.815 . . . . 64.22 111.137 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -28.64 58.79 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 110.132 -0.321 . . . . 74.21 110.132 173.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.92 -24.97 62.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.09 0.556 . . . . 72.41 110.458 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -68.17 -38.68 82.34 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 122.908 0.483 . . . . 71.22 109.847 171.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 68.8 m -65.86 -39.56 90.84 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.462 -0.335 . . . . 75.21 110.279 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.425 HD11 ' HB2' ' A' ' 48' ' ' SER . 36.0 tp -66.69 -51.44 55.99 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.914 0.886 . . . . 73.15 111.91 -175.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.11 -26.84 10.76 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.558 -0.746 . . . . 70.22 114.075 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -111.41 -66.22 1.1 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.204 0.502 . . . . 53.03 112.034 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.622 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 72.2 t80 -68.77 -61.11 1.95 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.264 1.026 . . . . 74.04 112.766 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 94.2 m -67.6 -36.68 10.51 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 113.916 1.08 . . . . 70.41 113.916 -174.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.54 -31.34 50.92 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 121.548 1.499 . . . . 73.42 112.506 167.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.21 -28.47 68.77 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.521 0.328 . . . . 62.33 110.633 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.481 HG21 ' CD1' ' A' ' 13' ' ' ILE . 50.1 mm -62.53 -45.28 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.765 0.826 . . . . 73.11 109.86 171.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.46 HD22 ' HG3' ' A' ' 80' ' ' GLN . 80.0 mt -72.29 -27.0 62.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.977 0.911 . . . . 71.43 112.256 -175.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -57.7 -45.68 99.81 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 114.142 1.164 . . . . 73.03 114.142 -168.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -62.11 -38.81 53.67 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 121.978 1.785 . . . . 71.44 112.915 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -67.13 -39.38 86.59 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.302 0.641 . . . . 53.01 111.075 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.93 -43.49 71.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.31 0.644 . . . . 74.23 110.448 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -52.05 -48.07 64.8 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 124.421 1.075 . . . . 72.33 110.2 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.08 -47.94 75.5 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 124.089 0.868 . . . . 75.04 111.342 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.45 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.5 t -58.25 -27.68 64.21 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.833 0.708 . . . . 60.34 111.22 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.535 HG21 HG21 ' A' ' 64' ' ' VAL . 86.6 mt -77.46 -58.58 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.592 1.157 . . . . 63.51 110.287 174.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.7 m -57.36 -33.72 68.06 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 124.667 1.187 . . . . 74.54 111.344 -173.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -63.67 -49.02 74.81 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.848 0.859 . . . . 61.34 109.977 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.452 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 69.3 mtm -63.56 -34.12 77.1 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.389 0.676 . . . . 73.14 111.459 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -66.46 -46.0 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.196 0.998 . . . . 75.12 110.461 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.2 m -70.22 -28.67 65.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.442 0.697 . . . . 74.43 111.388 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -73.35 -31.69 64.1 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.428 0.691 . . . . 72.22 109.782 174.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.06 2.78 86.31 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.88 0.738 . . . . 75.0 112.735 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.5 m 68.5 16.73 9.13 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.918 1.287 . . . . 42.24 111.552 173.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.428 ' HE1' HG21 ' A' ' 31' ' ' VAL . 96.9 m-85 -78.85 156.29 77.44 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 109.011 -0.737 . . . . 74.03 109.011 171.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.73 163.8 17.75 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.486 2.124 . . . . 75.45 112.531 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -60.36 121.61 12.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.062 0.945 . . . . 75.52 110.998 -172.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.524 HD21 HG11 ' A' ' 64' ' ' VAL . 53.0 tp -106.16 93.92 4.88 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.743 -0.836 . . . . 61.04 108.743 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.481 HD21 ' N ' ' C' ' 16' ' ' ILE . 71.4 m-20 -107.1 85.27 2.11 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.889 -1.152 . . . . 73.15 107.889 173.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.429 ' HB2' HD22 ' A' ' 42' ' ' LEU . 4.0 pp -60.11 137.52 58.08 Favored 'General case' 0 C--O 1.251 1.178 0 CA-C-N 114.447 -1.251 . . . . 61.51 109.246 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.63 143.91 85.79 Favored Pre-proline 0 C--O 1.243 0.758 0 C-N-CA 123.162 0.585 . . . . 72.1 110.948 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.05 161.61 45.46 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 121.702 1.601 . . . . 75.33 110.214 170.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.86 130.22 18.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.675 -0.861 . . . . 73.04 108.675 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -75.07 92.03 2.6 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.888 -0.596 . . . . 62.13 110.071 -174.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.558 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 83.9 m-85 -58.09 -35.51 71.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.86 0.864 . . . . 73.11 111.91 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.46 -50.73 72.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.531 0.733 . . . . 54.24 110.302 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.47 94.43 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.135 0.897 . . . . 71.33 111.434 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.72 -41.91 91.7 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.859 -0.61 . . . . 54.43 111.15 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -68.37 -32.26 72.22 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.029 -0.532 . . . . 54.43 109.578 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 15.9 mmt . . . . . 0 N--CA 1.475 0.811 0 O-C-N 123.667 0.605 . . . . 52.31 110.835 177.676 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.5 m . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 108.63 -0.878 . . . . 63.55 108.63 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.93 156.71 48.35 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.533 -0.543 . . . . 71.41 109.533 157.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -124.24 137.52 54.5 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 107.442 -1.318 . . . . 65.01 107.442 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.489 HD11 HD13 ' B' ' 105' ' ' ILE . 27.4 mt -78.92 117.45 24.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 107.708 -1.219 . . . . 73.01 107.708 176.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -78.23 -42.47 31.13 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.874 -0.787 . . . . 75.45 108.874 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -164.9 135.71 4.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.022 -0.99 . . . . 74.1 110.155 -170.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 85.5 mt -114.46 139.15 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 106.619 -1.623 . . . . 62.2 106.619 167.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -166.98 150.65 6.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.241 0.543 . . . . 75.03 111.524 -176.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 75.9 m -78.24 128.98 34.53 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.935 -1.029 . . . . 63.14 109.084 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 20.9 mttp -91.4 -46.24 8.12 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.661 0.784 . . . . 71.12 110.616 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 22.5 t70 -144.41 133.25 22.49 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.217 -0.447 . . . . 63.2 110.687 -165.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.8 mm -130.82 142.15 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.157 0.983 . . . . 74.12 109.114 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 81.5 p -139.2 144.45 38.52 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.376 -0.972 . . . . 72.33 108.376 170.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.1 t80 -145.81 134.13 21.81 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.971 -1.492 . . . . 73.44 106.971 163.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.645 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 36.7 mt-10 -136.89 127.24 26.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.518 -0.919 . . . . 63.02 108.518 -175.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.561 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -124.55 84.94 56.75 Favored Pre-proline 0 C--O 1.24 0.571 0 N-CA-C 107.69 -1.226 . . . . 72.22 107.69 171.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.71 -32.93 46.13 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.701 2.268 . . . . 52.34 111.394 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -104.45 10.71 35.12 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 117.873 -1.06 . . . . 71.43 110.793 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.617 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -29.64 -68.7 0.11 Allowed Pre-proline 0 N--CA 1.5 2.06 0 C-N-CA 125.355 1.462 . . . . 73.21 114.869 -170.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 11.6 Cg_exo -67.49 -21.21 46.83 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 122.199 1.933 . . . . 73.23 113.042 -171.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -96.81 -32.68 11.99 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.296 1.039 . . . . 71.15 112.434 -172.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.565 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.8 p -82.69 -19.7 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 122.683 0.393 . . . . 72.31 111.327 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -62.43 -25.41 67.95 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 113.976 1.102 . . . . 72.21 113.976 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -56.56 -25.62 52.83 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.081 0.552 . . . . 75.31 111.198 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.528 ' HB2' HD13 ' B' ' 68' ' ' LEU . 87.5 mttt -88.45 92.94 9.37 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.268 1.027 . . . . 74.14 109.435 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.24 91.25 6.17 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.099 -0.704 . . . . 63.02 109.099 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -163.32 156.82 19.4 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.837 0.855 . . . . 74.13 109.497 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -76.45 104.65 1.7 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.026 0.93 . . . . 70.41 108.649 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.607 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.2 Cg_endo -63.44 153.07 76.96 Favored 'Trans proline' 0 C--N 1.366 1.46 0 C-N-CA 123.137 2.558 . . . . 73.25 113.238 -176.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.8 118.6 7.38 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 123.778 0.674 . . . . 74.3 109.37 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.46 161.06 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 114.977 -1.011 . . . . 65.02 111.569 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -149.26 107.77 3.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.521 -1.659 . . . . 75.14 106.521 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 mp -100.27 148.69 24.37 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.164 0.585 . . . . 74.43 110.313 -171.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -131.74 113.44 13.54 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.708 -1.219 . . . . 65.31 107.708 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.2 127.25 45.14 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 106.02 -1.844 . . . . 74.02 106.02 176.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -144.99 148.64 33.99 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.797 0.839 . . . . 72.02 109.364 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 37.0 p -134.91 118.55 17.04 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.23 0.612 . . . . 65.4 109.995 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.48 153.31 31.36 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.766 1.226 . . . . 73.32 108.325 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 77.6 p -143.75 166.14 25.71 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.183 0.447 . . . . 50.5 111.34 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.0 p -152.33 149.97 29.22 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.25 1.02 . . . . 73.34 109.22 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -93.8 124.6 37.91 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.546 -0.539 . . . . 64.43 109.546 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.29 -52.42 5.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.128 -0.693 . . . . 73.31 109.128 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.41 -175.59 4.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.206 1.003 . . . . 62.2 109.646 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.46 116.33 8.09 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.577 -0.738 . . . . 75.42 109.218 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 83.0 m-20 74.08 -3.37 2.54 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.27 1.428 . . . . 74.4 112.887 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 48.4 t -106.04 110.41 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.521 -0.918 . . . . 72.05 108.521 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.488 ' HE2' ' HB ' ' B' ' 86' ' ' ILE . 1.3 p90 -119.97 173.34 7.13 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.88 0.872 . . . . 73.34 109.65 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -143.08 110.97 5.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.047 -1.094 . . . . 72.14 108.047 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 55.8 t -91.52 145.28 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.184 0.994 . . . . 62.13 109.817 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.5 t -129.33 115.13 34.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.263 -1.014 . . . . 73.42 108.263 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.4 OUTLIER -97.09 110.71 23.2 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.623 -0.88 . . . . 70.44 108.623 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -95.18 118.67 32.37 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.661 0.785 . . . . 63.05 110.746 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.484 ' HB ' HD11 ' B' ' 114' ' ' ILE . 26.3 t -116.54 103.19 14.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.53 -1.285 . . . . 74.02 107.53 168.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.567 HG23 ' HB2' ' B' ' 77' ' ' GLU . 2.8 m -99.6 131.3 45.69 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.222 -0.659 . . . . 64.13 109.222 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -125.21 116.99 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.342 0.657 . . . . 64.52 109.944 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.6 m -99.53 142.98 30.3 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.762 0.825 . . . . 60.21 108.957 167.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.404 ' HB1' ' HG2' ' B' ' 38' ' ' PRO . . . -149.22 147.04 27.93 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.033 0.533 . . . . 70.32 110.36 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.445 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 23.8 p -146.93 130.6 16.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.702 0.401 . . . . 72.41 111.93 -174.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.607 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 25.2 mt -95.84 118.85 33.27 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.679 1.191 . . . . 74.34 109.772 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.73 -108.8 2.6 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 123.742 0.651 . . . . 72.5 112.307 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -118.63 1.59 11.66 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.211 1.004 . . . . 74.24 110.384 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -122.51 155.2 36.69 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.993 0.517 . . . . 74.55 109.936 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.1 m -63.37 134.98 56.66 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.82 0.7 . . . . 72.33 110.842 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.565 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.4 -64.84 1.06 Allowed 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.492 -1.299 . . . . 65.22 107.492 174.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -148.75 157.92 43.79 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.203 -0.908 . . . . 73.14 111.012 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.645 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 69.3 mt -130.18 143.57 50.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.589 -1.634 . . . . 62.52 106.589 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 41.9 t -155.28 156.67 35.96 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.644 -0.502 . . . . 71.02 109.644 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.567 ' HB2' HG23 ' B' ' 63' ' ' THR . 34.7 tt0 -160.27 136.17 8.46 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.123 -1.065 . . . . 71.12 108.123 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 93.4 t -124.06 141.53 43.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.622 -0.881 . . . . 73.44 108.622 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -120.57 89.6 3.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.581 -0.896 . . . . 73.52 108.581 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.563 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.6 tp-100 -83.3 99.09 9.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.678 -1.146 . . . . 72.2 108.821 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.84 169.95 35.9 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 116.19 -0.459 . . . . 53.51 111.968 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.36 129.86 1.97 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.68 -0.568 . . . . 61.12 111.68 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.3 mt -85.21 129.35 37.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.597 0.759 . . . . 71.52 109.227 172.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -131.92 139.76 48.82 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.947 -1.131 . . . . 74.23 107.947 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.3 m -112.71 97.87 6.85 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.867 -0.79 . . . . 73.45 108.867 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.488 ' HB ' ' HE2' ' B' ' 56' ' ' TYR . 17.4 tt -96.54 147.02 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.697 0.799 . . . . 72.21 111.097 -166.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.97 141.34 24.17 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.326 0.65 . . . . 65.33 110.396 -174.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.57 -63.2 0.69 Allowed Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.617 -0.719 . . . . 24.41 114.488 169.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' B' ' 93' ' ' GLN . 17.2 tt -66.49 163.68 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.369 0 C-N-CA 124.042 0.937 . . . . 74.25 111.126 -173.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -158.91 175.47 13.53 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.085 0.402 . . . . 74.34 110.689 -172.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' B' ' 94' ' ' MET . . . 66.91 -132.2 31.26 Favored Glycine 0 C--N 1.355 1.59 0 C-N-CA 123.656 0.646 . . . . 34.33 114.446 169.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 46.3 m -75.9 -27.41 57.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.666 0.787 . . . . 72.42 110.947 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.486 ' HB3' HD11 ' B' ' 89' ' ' ILE . 52.1 mt-30 -68.63 -33.66 74.4 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.853 -0.612 . . . . 73.23 111.437 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' B' ' 91' ' ' GLY . 0.0 OUTLIER -71.26 -24.66 62.21 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.378 0.271 . . . . 54.32 110.734 176.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.52 78.28 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.114 0.566 . . . . 64.44 110.834 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -63.1 -29.95 71.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.3 -0.863 . . . . 75.44 110.976 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.481 ' SG ' HD12 ' B' ' 86' ' ' ILE . 49.2 t -74.67 -62.11 1.65 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.411 -0.359 . . . . 60.55 110.771 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.523 HD12 ' N ' ' B' ' 99' ' ' GLY . 3.0 pp -63.49 -32.79 74.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.126 0.788 . . . . 75.35 113.126 -173.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . 0.523 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -92.25 -36.36 6.3 Favored Glycine 0 C--N 1.345 1.056 0 O-C-N 123.482 0.488 . . . . 50.3 113.273 -172.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.0 -53.76 2.15 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.615 0.598 . . . . 64.31 112.615 -167.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 51.7 t80 -72.03 -45.05 62.31 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.862 0.865 . . . . 75.1 111.617 -168.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.492 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 70.8 m -66.11 -49.68 54.86 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 123.6 0.76 . . . . 61.34 111.253 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 80.4 Cg_exo -53.63 -36.42 81.04 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 122.479 2.12 . . . . 71.32 114.203 168.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -57.44 -38.85 75.1 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 123.399 0.679 . . . . 72.2 110.709 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.489 HD13 HD11 ' B' ' 13' ' ' ILE . 80.5 mt -64.99 -43.4 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.117 0.967 . . . . 44.12 110.633 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 52.5 mt -83.23 -15.17 51.42 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.978 0.911 . . . . 75.22 112.043 -172.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -61.28 -49.32 88.46 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.023 -0.989 . . . . 70.42 113.558 -170.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.01 -31.01 83.85 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 121.729 1.619 . . . . 74.24 112.97 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.563 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 86.7 m-85 -67.92 -50.02 58.5 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.889 0.476 . . . . 71.11 110.207 176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.41 -40.51 78.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.831 0.852 . . . . 74.3 110.582 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.749 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 30.8 ttt180 -58.08 -56.67 19.05 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.39 1.476 . . . . 72.52 111.065 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.54 -34.81 78.61 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.937 0.773 . . . . 73.45 110.51 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.7 t -69.88 -40.32 75.75 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.209 0.603 . . . . 72.44 111.417 -176.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.484 HD11 ' HB ' ' B' ' 62' ' ' VAL . 70.5 mt -62.22 -53.54 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 109.563 -0.532 . . . . 54.43 109.563 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.414 HG21 ' OG ' ' C' ' 119' ' ' SER . 12.0 m -60.07 -30.08 68.99 Favored 'General case' 0 CA--C 1.554 1.124 0 O-C-N 124.539 1.149 . . . . 41.21 111.403 -175.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.7 t -64.66 -54.09 37.18 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.555 0.742 . . . . 61.31 110.022 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.4 mmt -67.26 -34.59 77.75 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.411 0.684 . . . . 75.32 111.991 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.96 -38.31 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.134 0.974 . . . . 61.15 110.463 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.421 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 11.8 t -78.07 -20.64 51.92 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.886 -0.597 . . . . 42.55 111.139 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.45 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 92.7 mtt-85 -69.24 -33.79 73.81 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.422 -0.584 . . . . 74.54 109.422 171.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.29 11.3 58.63 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.595 0.559 . . . . 71.52 112.698 168.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.7 p 58.98 31.44 21.36 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.637 1.975 . . . . 62.3 114.18 170.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -84.81 157.93 59.89 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.133 0.573 . . . . 74.44 110.133 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.38 -175.29 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.994 2.463 . . . . 75.42 113.349 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -61.7 114.41 3.28 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.3 -0.864 . . . . 73.3 112.149 -170.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 35.9 tp -110.23 84.76 1.98 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.331 -0.989 . . . . 71.44 108.331 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.23 93.79 8.43 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.284 -0.636 . . . . 71.31 109.284 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.749 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 22.7 tp -57.68 127.77 33.69 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.737 0.815 . . . . 70.13 111.421 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.57 153.77 94.79 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 124.509 1.124 . . . . 74.32 111.813 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.19 100.56 0.46 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.836 2.357 . . . . 61.32 112.162 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.92 108.93 20.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.073 -1.084 . . . . 61.24 108.073 172.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 60.9 t30 -94.08 95.21 8.86 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 107.686 -1.227 . . . . 53.2 107.686 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.78 -42.74 89.69 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 124.081 0.863 . . . . 65.41 109.501 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.36 -39.09 69.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.191 1.397 . . . . 73.54 112.843 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.423 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -63.92 -50.33 69.13 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.717 0.807 . . . . 54.54 111.304 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 82.6 mt -79.11 -28.91 43.01 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.254 -0.885 . . . . 61.43 111.305 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 78.5 t80 . . . . . 0 N--CA 1.479 0.982 0 C-N-CA 123.756 0.822 . . . . 74.42 109.947 179.629 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m . . . . . 0 C--O 1.237 0.41 0 N-CA-C 106.336 -1.727 . . . . 71.13 106.336 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.45 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 9.0 t80 -124.64 117.48 24.37 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.013 0.525 . . . . 74.43 110.893 -175.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -137.27 133.2 34.76 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.21 -1.404 . . . . 71.43 107.21 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.413 HD13 HG21 ' C' ' 105' ' ' ILE . 45.5 mt -74.36 118.57 20.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.567 -0.901 . . . . 72.31 108.567 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.511 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 1.4 mt-30 -77.09 -40.92 44.26 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.131 0.894 . . . . 73.3 109.892 -176.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -170.56 147.65 2.94 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 116.045 -0.525 . . . . 74.21 110.077 -173.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.481 ' N ' HD21 ' A' ' 127' ' ' ASN . 96.6 mt -135.46 137.4 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.791 -1.188 . . . . 63.11 107.791 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.474 ' HB3' HG23 ' D' ' 122' ' ' THR . 29.8 p90 -176.01 173.78 2.2 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.903 0.752 . . . . 75.35 111.228 -171.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -100.03 123.82 44.71 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.615 0.766 . . . . 62.51 109.594 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.425 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.0 mmtp -70.67 -48.94 52.28 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.821 -1.177 . . . . 75.44 107.821 168.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -135.37 143.12 45.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 113.863 -1.517 . . . . 53.41 110.283 -172.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.0 mt -137.89 146.97 26.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 126.077 1.751 . . . . 73.31 106.359 174.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -162.21 149.95 14.31 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.423 0.63 . . . . 54.25 110.405 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.449 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 93.7 t80 -140.35 139.19 35.32 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.661 -1.237 . . . . 64.43 107.661 171.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -136.23 128.83 30.61 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.509 0.724 . . . . 71.13 110.061 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.92 82.65 11.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 106.838 -1.541 . . . . 61.22 106.838 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.85 -26.1 38.53 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.974 2.449 . . . . 63.43 112.268 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -112.28 27.23 9.83 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 114.822 -1.081 . . . . 75.21 109.641 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.415 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -50.19 -58.62 9.08 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 114.449 1.277 . . . . 71.43 114.449 -170.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.57 -31.49 79.82 Favored 'Trans proline' 0 C--N 1.388 2.624 0 CA-C-N 121.891 1.711 . . . . 65.42 112.092 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -69.75 -43.06 73.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.354 1.062 . . . . 73.12 112.031 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.67 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.7 p -77.81 -24.87 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 123.04 0.536 . . . . 55.32 111.644 -173.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.0 -29.11 70.29 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.354 0.262 . . . . 54.32 111.664 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -104.78 36.18 2.52 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.202 0.601 . . . . 74.33 110.615 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -111.07 169.46 8.76 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.235 1.014 . . . . 71.23 109.969 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -68.42 130.57 43.28 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.03 0.532 . . . . 63.23 110.147 173.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -73.99 93.37 2.22 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.324 1.049 . . . . 70.34 109.224 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -150.24 59.25 3.54 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.302 0.641 . . . . 70.14 109.712 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.4 110.28 3.03 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.643 2.229 . . . . 74.12 111.768 -175.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -86.52 108.51 18.58 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.522 -0.918 . . . . 45.12 108.522 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.53 142.33 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.308 1.043 . . . . 71.03 111.257 -171.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -130.57 119.45 22.55 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.875 -1.528 . . . . 74.21 106.875 174.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 30.1 tp -101.38 124.79 47.63 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 109.635 -0.506 . . . . 54.03 109.635 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.475 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.7 t70 -117.24 112.2 20.47 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.258 -1.016 . . . . 74.42 108.258 -176.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.438 HD13 ' HE1' ' C' ' 133' ' ' PHE . 79.9 mt -110.86 111.1 22.01 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.963 -0.754 . . . . 64.53 108.963 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -122.63 139.78 53.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.34 1.056 . . . . 75.12 108.674 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 m -126.8 126.37 43.28 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.511 0.672 . . . . 34.24 110.258 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.76 154.91 25.46 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.108 -1.406 . . . . 53.53 107.975 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.524 ' HB2' ' HE1' ' C' ' 56' ' ' TYR . 13.4 p -149.5 142.71 25.07 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.87 0.468 . . . . 72.32 109.871 -177.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.7 t -149.74 146.65 27.32 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.896 0.878 . . . . 75.31 110.162 -171.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -82.95 133.82 35.09 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.486 -0.561 . . . . 74.31 109.486 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.556 HD11 HD12 ' C' ' 83' ' ' ILE . 43.7 mt -106.53 -41.29 5.31 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.052 -0.722 . . . . 71.4 109.052 173.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.01 -175.65 5.54 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.731 -1.122 . . . . 34.41 109.963 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -67.22 119.08 11.52 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 114.973 -1.012 . . . . 64.44 109.679 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 65.34 8.21 4.79 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.017 1.327 . . . . 75.23 112.584 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -113.18 96.96 5.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 107.657 -1.238 . . . . 72.02 107.657 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.524 ' HE1' ' HB2' ' C' ' 48' ' ' SER . 1.6 t80 -114.87 129.51 56.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.652 -0.704 . . . . 71.05 109.597 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.504 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.7 tt0 -88.77 135.02 33.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.983 -1.008 . . . . 62.53 110.218 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.85 141.59 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.704 -1.221 . . . . 70.11 107.704 166.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -128.66 123.43 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.614 -1.254 . . . . 72.55 107.614 173.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.97 102.83 12.23 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.424 -1.325 . . . . 64.44 107.424 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 -85.86 122.85 30.51 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.947 -1.478 . . . . 75.12 108.443 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.6 t -117.73 126.04 74.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 107.735 -1.209 . . . . 73.43 107.735 169.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 13.0 m -126.75 115.88 20.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.61 -0.885 . . . . 72.5 108.61 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.534 HG11 HD11 ' C' ' 126' ' ' LEU . 65.2 t -102.67 120.57 52.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 109.012 -0.736 . . . . 61.13 109.012 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 16.3 m -103.52 142.83 33.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.382 -0.97 . . . . 52.33 108.382 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.44 118.25 13.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.545 -1.28 . . . . 64.43 107.545 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -132.29 134.01 44.75 Favored 'General case' 0 C--O 1.224 -0.262 0 O-C-N 123.855 0.722 . . . . 65.2 109.575 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 12.1 mt -86.2 28.01 0.87 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.809 1.243 . . . . 75.14 111.081 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.7 -104.84 1.53 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 110.453 -1.059 . . . . 32.34 110.453 -169.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -90.57 -30.89 16.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.908 0.883 . . . . 70.32 110.587 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -75.45 124.3 26.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.284 1.034 . . . . 72.33 110.206 172.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 18.0 m -80.68 125.61 30.25 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.789 -0.819 . . . . 44.21 108.789 167.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.67 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.82 -61.22 2.07 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.374 -0.602 . . . . 45.25 109.374 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -151.34 156.83 41.57 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.475 0.655 . . . . 73.42 111.237 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.447 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -127.79 142.2 51.37 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 106.75 -1.574 . . . . 61.45 106.75 172.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.447 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.4 t -148.07 141.07 24.87 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.597 -0.89 . . . . 74.31 108.597 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -147.35 133.72 19.62 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.123 -0.695 . . . . 74.41 109.123 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' C' ' 110' ' ' ALA . 59.8 t -135.97 113.75 14.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.569 1.147 . . . . 74.34 108.145 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -95.5 89.11 5.28 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.769 -0.826 . . . . 72.12 108.769 174.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -79.78 98.77 7.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.268 -0.878 . . . . 64.11 110.144 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.65 144.82 17.99 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-O 121.177 0.321 . . . . 52.53 112.45 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.58 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -146.2 128.17 2.98 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.346 -1.102 . . . . 73.52 110.346 -176.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.556 HD12 HD11 ' C' ' 51' ' ' LEU . 11.0 mm -88.32 122.68 40.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.36 -0.978 . . . . 71.45 108.36 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.45 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 62.0 m-85 -127.24 119.51 26.54 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.108 -0.701 . . . . 64.31 109.108 -175.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 31.2 p -82.96 109.64 17.25 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.797 -0.816 . . . . 61.51 108.797 176.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.578 HD13 HD21 ' C' ' 98' ' ' LEU . 32.9 pt -116.12 102.53 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-O 122.151 0.976 . . . . 61.54 110.276 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.16 158.65 30.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.106 0.962 . . . . 31.14 108.9 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.11 -18.67 34.96 Favored Glycine 0 C--N 1.344 0.986 0 N-CA-C 114.06 0.384 . . . . 62.52 114.06 173.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.19 158.74 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.381 1.072 . . . . 70.13 110.608 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -161.25 -177.26 5.91 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.119 0.567 . . . . 63.11 110.94 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.45 -116.19 8.83 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-N 115.308 -0.86 . . . . 73.02 113.78 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.6 p -70.23 -34.49 72.94 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.096 0.959 . . . . 74.44 111.24 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -70.25 -38.72 75.22 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.68 -0.691 . . . . 72.2 111.207 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 22.0 ptm -78.97 -25.55 43.44 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 119.588 -0.244 . . . . 72.54 110.697 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.47 85.53 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.646 -0.502 . . . . 63.23 109.646 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -75.73 -34.66 60.34 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.394 0.434 . . . . 64.45 111.673 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 40.3 t -59.0 -35.89 74.0 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.654 0.596 . . . . 71.04 110.661 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.578 HD21 HD13 ' C' ' 86' ' ' ILE . 51.3 mt -100.49 -16.3 17.59 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.273 0.629 . . . . 74.52 111.308 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.79 -30.5 57.72 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 114.491 0.556 . . . . 74.22 114.491 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.18 -39.09 0.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.861 0.464 . . . . 31.43 110.866 -168.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -66.07 -48.95 69.3 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.143 1.777 . . . . 64.54 112.718 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 51.0 m -73.12 -45.65 8.17 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 118.57 -0.728 . . . . 32.03 112.133 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -53.37 -30.78 54.24 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 122.602 2.201 . . . . 65.35 113.528 170.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -64.82 -40.69 95.61 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.862 0.865 . . . . 70.51 110.364 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.413 HG21 HD13 ' C' ' 13' ' ' ILE . 47.9 mm -60.71 -44.15 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.056 0.542 . . . . 74.53 109.795 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.58 HD21 ' HA3' ' C' ' 82' ' ' GLY . 88.0 mt -80.08 -26.81 39.46 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.907 -1.042 . . . . 75.43 112.764 -170.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -57.36 -48.55 97.12 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 117.575 -1.203 . . . . 72.13 113.534 -172.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.74 -37.96 94.92 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.356 2.037 . . . . 74.42 113.732 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -68.27 -44.68 75.03 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.844 0.458 . . . . 70.44 110.587 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.411 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -64.64 -38.3 90.53 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.803 -0.635 . . . . 62.54 110.78 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -57.16 -48.58 78.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.477 1.511 . . . . 72.13 110.834 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.35 -34.59 68.13 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.398 0.679 . . . . 62.12 110.69 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.5 t -69.11 -30.71 69.05 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.031 0.532 . . . . 45.42 111.287 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.517 HD11 ' HB ' ' C' ' 62' ' ' VAL . 97.7 mt -68.47 -51.36 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.439 0.696 . . . . 71.21 109.541 173.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.415 HG21 ' OG ' ' B' ' 119' ' ' SER . 10.5 m -60.25 -31.95 70.69 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.166 0.916 . . . . 71.43 111.104 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.9 t -64.51 -54.78 27.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.722 0.809 . . . . 55.03 109.465 174.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.449 ' HB3' ' HB2' ' C' ' 23' ' ' PHE . 0.0 OUTLIER -57.56 -42.52 83.19 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.741 1.216 . . . . 71.21 112.84 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' C' ' 123' ' ' PHE . 58.3 t -66.27 -41.74 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.105 0.962 . . . . 74.12 110.422 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.414 ' OG ' HG21 ' B' ' 115' ' ' THR . 32.7 t -70.64 -26.51 63.5 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.954 -0.567 . . . . 74.15 111.011 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.5 mtt-85 -70.93 -40.45 72.07 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.211 0.605 . . . . 73.54 109.439 175.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' C' ' 23' ' ' PHE . . . -82.57 1.26 88.22 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.87 0.731 . . . . 33.35 112.934 173.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 16.5 p 66.1 24.83 10.89 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.479 1.912 . . . . 50.34 113.931 170.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.477 ' HB2' HG13 ' C' ' 118' ' ' VAL . 79.7 m-85 -85.27 163.76 43.83 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.018 0.927 . . . . 62.41 110.056 172.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -54.67 124.18 15.54 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.979 2.453 . . . . 55.42 112.721 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.421 ' NE2' ' HB2' ' B' ' 119' ' ' SER . 47.1 mt-30 -60.49 137.89 58.09 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.074 0.549 . . . . 74.52 110.855 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.534 HD11 HG11 ' C' ' 64' ' ' VAL . 2.5 pt? -130.22 127.52 39.8 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.895 -0.593 . . . . 71.33 110.049 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -110.1 110.24 21.05 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.267 -1.012 . . . . 75.54 108.267 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.31 134.53 56.62 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 124.134 0.896 . . . . 71.44 110.99 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -70.81 147.07 94.05 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 123.857 0.723 . . . . 73.42 111.499 -175.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.456 ' HG3' HD12 ' A' ' 16' ' ' ILE . 9.7 Cg_exo -69.4 109.7 2.3 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.601 2.201 . . . . 72.41 111.905 176.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 m -106.07 138.95 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.756 -0.831 . . . . 74.02 108.756 170.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -75.85 88.34 2.86 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.91 0.484 . . . . 75.12 110.204 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.438 ' HE1' HD13 ' C' ' 44' ' ' LEU . 98.5 m-85 -62.05 -48.32 80.76 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.664 -0.698 . . . . 75.31 110.429 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.12 -44.64 68.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.667 -1.151 . . . . 70.13 112.455 -170.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.65 87.85 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.242 0.964 . . . . 75.01 111.307 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 -50.4 70.92 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 124.439 1.087 . . . . 73.35 109.852 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 4.5 t80 . . . . . 0 CA--C 1.554 1.132 0 CA-C-N 115.834 -0.621 . . . . 74.2 110.282 -178.488 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.544 0.724 0 N-CA-C 109.8 -0.444 . . . . 71.42 109.8 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -152.5 113.29 4.15 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.115 -1.069 . . . . 73.04 108.115 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -131.57 121.48 24.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.871 0.868 . . . . 63.34 108.751 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 23.7 mt -75.35 121.29 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.544 -0.91 . . . . 55.03 108.544 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.432 HE22 HG22 ' D' ' 55' ' ' VAL . 54.3 mt-30 -88.57 -31.49 18.61 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.188 0.595 . . . . 52.24 111.584 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -169.08 142.63 2.86 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.587 0.232 . . . . 73.23 111.526 -174.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.4 132.85 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 107.188 -1.412 . . . . 74.32 107.188 169.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.463 ' HE1' HG13 ' D' ' 83' ' ' ILE . 36.9 p90 -161.15 152.28 18.69 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.925 0.869 . . . . 75.22 111.438 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -88.47 116.13 26.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.428 -1.26 . . . . 74.42 108.975 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -83.56 -26.42 30.1 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.407 -0.59 . . . . 63.32 109.407 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -154.31 139.97 17.97 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.967 -1.015 . . . . 61.33 109.352 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.448 HG21 ' HE2' ' C' ' 117' ' ' MET . 38.5 mt -137.33 147.31 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.865 1.266 . . . . 71.24 107.851 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -156.27 143.29 18.91 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.348 0.595 . . . . 73.3 110.068 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.9 t80 -138.05 133.58 33.71 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.401 -1.703 . . . . 73.02 106.401 170.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.2 mt-10 -129.2 141.13 51.24 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.887 0.875 . . . . 73.13 109.061 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.98 81.27 39.86 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.166 -1.42 . . . . 70.41 107.166 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.79 -36.15 8.51 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.006 2.471 . . . . 73.25 113.012 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -104.84 17.66 23.74 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.709 0.804 . . . . 75.22 110.793 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -32.49 -64.79 0.23 Allowed Pre-proline 0 CA--C 1.564 1.488 0 N-CA-C 116.11 1.892 . . . . 65.05 116.11 -164.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.415 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 68.8 Cg_endo -77.91 -20.88 11.41 Favored 'Trans proline' 0 C--N 1.382 2.295 0 CA-C-N 122.896 2.07 . . . . 61.34 113.732 -176.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -72.9 -40.09 65.84 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.759 1.223 . . . . 72.2 109.884 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.769 HG21 ' HA ' ' D' ' 73' ' ' ALA . 14.6 p -83.59 -14.54 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.485 -0.78 . . . . 71.04 111.807 -175.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 20.0 m-85 -68.15 -15.99 63.81 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.666 -0.646 . . . . 73.12 111.862 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -67.29 -19.16 65.44 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.74 0.816 . . . . 64.55 110.971 173.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.497 ' HB2' HD13 ' D' ' 68' ' ' LEU . 28.3 mmtp -84.96 87.61 7.37 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.034 0.934 . . . . 64.0 108.847 174.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.54 68.06 10.3 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.737 0.78 . . . . 71.44 108.919 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 48.3 t-105 -142.19 158.46 43.71 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.984 0.913 . . . . 62.31 109.251 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -72.95 111.1 10.07 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.676 1.19 . . . . 54.3 110.031 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.83 141.73 55.07 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.927 2.418 . . . . 54.02 112.33 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.67 124.72 27.71 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.153 -0.684 . . . . 75.45 109.153 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.663 HG13 HG13 ' D' ' 64' ' ' VAL . 59.2 t -97.93 107.67 20.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.831 -0.803 . . . . 41.13 108.831 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -95.28 118.5 32.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.433 -1.321 . . . . 72.31 107.433 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.57 143.2 28.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.238 0.615 . . . . 64.21 110.326 -175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.726 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.7 m-20 -127.45 112.36 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.576 -1.268 . . . . 70.23 107.576 169.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 88.2 mt -99.72 130.2 45.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.433 0.693 . . . . 70.54 110.114 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.447 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.2 t0 -144.87 149.76 35.9 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.51 1.124 . . . . 63.31 108.373 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -125.12 159.65 30.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.519 0.676 . . . . 55.41 110.257 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.496 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.96 154.28 37.99 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.818 -1.549 . . . . 72.23 106.818 172.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.7 p -167.64 152.97 7.13 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.853 0.297 . . . . 62.14 111.223 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.7 p -163.74 142.47 7.82 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.91 0.884 . . . . 65.51 109.707 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -75.92 121.05 22.11 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.231 -0.655 . . . . 55.14 109.231 176.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 49.4 mt -89.93 -38.61 13.55 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.855 0.36 . . . . 75.44 110.436 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.42 -176.07 5.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.053 -0.522 . . . . 73.22 110.438 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -69.49 118.51 12.45 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.229 0.611 . . . . 64.12 109.594 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 67.99 9.2 7.0 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.907 1.283 . . . . 63.01 111.856 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.432 HG22 HE22 ' D' ' 14' ' ' GLN . 66.2 t -113.44 119.1 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.327 0.651 . . . . 63.42 109.693 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -128.41 129.56 46.36 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.009 0.924 . . . . 75.24 108.79 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -96.53 138.96 33.33 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.953 0.901 . . . . 73.42 109.072 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -126.42 122.76 61.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 N-CA-C 108.113 -1.069 . . . . 64.15 108.113 173.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.559 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 23.6 t -99.11 137.62 26.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 123.693 0.797 . . . . 75.01 108.903 171.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.41 123.32 44.95 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.67 -0.863 . . . . 71.5 108.67 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.447 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.4 ttm-85 -98.6 113.67 25.82 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.086 -0.709 . . . . 74.42 109.086 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.8 t -112.74 113.35 43.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.778 -1.193 . . . . 65.15 107.778 170.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.726 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 48.5 m -111.74 136.8 50.51 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.817 0.847 . . . . 70.55 109.141 -177.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.663 HG13 HG13 ' D' ' 40' ' ' VAL . 78.0 t -130.13 108.34 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.419 1.088 . . . . 64.41 109.635 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 38.1 m -107.58 114.67 28.81 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.371 -0.974 . . . . 64.03 108.371 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.4 145.13 48.22 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.328 0.651 . . . . 72.32 110.533 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 50.6 p -129.67 147.76 51.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.972 0.909 . . . . 75.34 109.246 173.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' D' ' 34' ' ' LYS . 25.6 mt -118.5 108.75 15.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.389 1.076 . . . . 72.53 108.243 171.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.42 -126.11 15.18 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 123.686 0.617 . . . . 61.5 112.447 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -90.61 2.36 55.92 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.31 0.644 . . . . 73.41 112.602 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -134.06 158.98 42.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.551 0.34 . . . . 70.33 111.354 -166.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.7 m -65.17 124.35 21.92 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.17 -0.923 . . . . 61.01 109.651 174.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.769 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -80.81 -72.8 0.4 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.158 -1.052 . . . . 52.33 108.158 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -155.45 139.48 16.41 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.477 -0.783 . . . . 52.01 110.036 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 37.0 mt -105.47 150.76 25.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.326 -1.306 . . . . 54.42 107.795 176.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.1 t -158.38 147.63 19.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.909 -0.404 . . . . 63.01 109.909 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.01 134.13 10.39 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.917 -0.771 . . . . 73.3 108.917 172.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.2 t -128.46 137.23 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.406 -0.961 . . . . 64.24 108.406 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -117.86 81.55 1.68 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.73 -1.211 . . . . 64.42 107.73 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -80.06 96.48 6.49 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 112.961 -1.927 . . . . 64.34 109.802 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.63 143.17 17.58 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.676 -0.569 . . . . 62.33 111.676 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.66 130.81 5.38 Favored Glycine 0 C--O 1.228 -0.243 0 N-CA-C 111.214 -0.755 . . . . 74.1 111.214 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.463 HG13 ' HE1' ' D' ' 17' ' ' TYR . 70.8 mt -90.3 122.74 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.95 -1.13 . . . . 73.23 107.95 172.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -124.15 149.54 46.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.035 0.934 . . . . 70.32 109.049 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t -115.01 102.7 10.2 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.981 -1.118 . . . . 64.5 107.981 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.569 HG23 HD12 ' D' ' 89' ' ' ILE . 46.1 mt -108.81 128.03 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.988 0.915 . . . . 71.31 110.443 -171.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.18 157.31 42.51 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.961 0.905 . . . . 72.22 110.272 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.87 11.96 81.03 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.331 -0.395 . . . . 62.1 113.933 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.569 HD12 HG23 ' D' ' 86' ' ' ILE . 15.8 mt -111.42 127.65 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.062 0.945 . . . . 72.51 110.443 -173.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.04 164.1 34.12 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.228 1.011 . . . . 73.54 111.039 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.18 -131.57 11.34 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.54 -0.754 . . . . 31.24 113.569 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -75.79 -24.43 55.97 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.813 0.845 . . . . 75.12 111.487 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -65.15 -26.37 68.15 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.44 0.696 . . . . 73.43 110.724 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 54.3 mtp -54.31 -55.15 31.24 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.489 1.116 . . . . 73.12 110.831 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.71 -41.43 83.57 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.952 -1.022 . . . . 65.21 110.648 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.402 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 28.4 t-80 -65.9 -24.89 66.93 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.88 0.872 . . . . 60.12 111.742 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -80.38 -48.85 12.3 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.832 -0.432 . . . . 52.12 109.832 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 28.5 tp -67.72 -56.01 10.95 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.729 0.812 . . . . 75.14 112.452 -171.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.88 -0.1 51.98 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 114.654 0.621 . . . . 41.23 114.654 -168.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -124.84 -66.07 0.99 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.673 0.737 . . . . 43.43 110.88 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -65.88 -54.21 29.59 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.536 0.734 . . . . 75.43 111.763 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.2 m -62.69 -46.35 88.52 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.305 -0.855 . . . . 64.13 112.387 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.32 -36.6 97.21 Favored 'Trans proline' 0 C--N 1.393 2.909 0 C-N-CA 122.523 2.149 . . . . 70.32 113.378 168.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' D' ' 133' ' ' PHE . 64.3 t30 -71.09 -23.86 62.19 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.213 0.605 . . . . 73.54 110.77 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 29.7 mm -76.68 -36.51 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.961 0.904 . . . . 75.2 110.252 171.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.88 -18.62 53.63 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.31 0.644 . . . . 70.32 111.862 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -71.34 -37.94 6.2 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 113.901 1.074 . . . . 63.44 113.901 -173.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.99 -45.63 37.52 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 121.883 1.722 . . . . 71.21 112.281 168.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -70.61 -33.49 71.1 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.32 -0.855 . . . . 60.34 111.764 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.85 -51.48 54.99 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.301 0.64 . . . . 62.3 110.084 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -51.2 -52.32 45.52 Favored 'General case' 0 C--N 1.358 0.942 0 O-C-N 124.797 1.311 . . . . 73.43 110.309 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.38 -46.23 91.06 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.383 1.052 . . . . 73.45 111.839 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.6 t -58.97 -41.9 88.62 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.863 0.727 . . . . 64.44 110.659 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.477 HG23 ' SG ' ' D' ' 76' ' ' CYS . 80.4 mt -64.33 -56.08 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 123.996 0.81 . . . . 73.2 110.411 174.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 61.4 m -51.89 -44.55 63.79 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.816 1.247 . . . . 43.34 111.574 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.5 t -65.29 -42.0 93.58 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.912 -1.04 . . . . 71.3 110.201 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.4 mtm -68.58 -34.25 75.48 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.028 0.531 . . . . 65.4 111.772 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -66.99 -40.85 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.002 0.921 . . . . 55.41 110.099 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 77.7 p -76.66 -28.47 55.99 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.979 0.512 . . . . 74.35 111.012 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -73.68 -28.53 61.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.222 0.609 . . . . 72.41 109.633 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.18 3.64 86.66 Favored Glycine 0 C--N 1.351 1.381 0 O-C-N 123.837 0.71 . . . . 71.3 112.378 172.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.474 HG23 ' HB3' ' C' ' 17' ' ' TYR . 45.2 p 60.09 20.0 9.23 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 126.845 2.058 . . . . 64.31 114.181 175.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -79.61 157.23 74.9 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 123.13 0.572 . . . . 74.23 109.853 171.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.53 126.34 17.69 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.946 2.431 . . . . 73.54 112.367 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -56.05 138.99 48.3 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.425 1.09 . . . . 73.43 112.041 -174.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 32.5 mt -107.92 101.41 10.68 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.557 -0.535 . . . . 74.23 109.557 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -100.65 84.83 2.8 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.615 -1.254 . . . . 74.14 107.615 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -59.18 115.68 3.36 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 114.775 -1.102 . . . . 71.42 109.991 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.79 136.06 86.87 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 124.189 0.931 . . . . 45.11 110.191 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 24.3 Cg_exo -61.7 114.31 2.21 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.802 2.335 . . . . 62.01 112.55 -172.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.1 m -108.02 128.38 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.483 0.713 . . . . 75.01 109.243 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -85.84 103.98 15.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.632 0.773 . . . . 41.34 110.544 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' D' ' 104' ' ' ASN . 63.9 m-85 -66.5 -25.63 66.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.205 0.602 . . . . 70.44 112.041 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . 0.468 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 2.5 m-20 -57.42 -58.67 7.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.892 0.877 . . . . 71.31 111.258 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.17 90.19 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.815 0.846 . . . . 62.0 111.713 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.88 -29.76 68.95 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.181 -0.918 . . . . 74.12 112.067 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.7 t80 . . . . . 0 N--CA 1.485 1.283 0 C-N-CA 123.537 0.735 . . . . 73.3 110.66 178.434 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.9 m . . . . . 0 C--O 1.24 0.565 0 N-CA-C 108.704 -0.85 . . . . 53.31 108.704 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.691 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 11.5 t80 -123.09 124.71 43.7 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.329 -0.989 . . . . 74.24 108.329 170.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -141.7 112.07 6.99 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.73 -0.668 . . . . 41.45 109.851 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.594 HG12 ' HD2' ' A' ' 84' ' ' PHE . 52.7 mt -83.05 113.87 22.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.804 -0.813 . . . . 72.3 108.804 173.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -81.34 -31.97 33.21 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.792 -0.64 . . . . 63.03 109.843 -177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -171.53 143.54 1.78 Allowed 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.008 0.193 . . . . 64.43 111.108 -173.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.86 126.92 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 124.251 1.02 . . . . 65.31 108.384 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -160.54 168.71 24.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.028 0.931 . . . . 75.12 110.698 -170.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.6 p -93.39 121.06 34.39 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.083 -0.71 . . . . 72.55 109.083 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -85.76 -26.07 26.03 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.037 -0.529 . . . . 72.11 109.675 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.2 t70 -152.77 142.59 22.06 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.934 -1.03 . . . . 72.13 110.197 -175.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.599 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 88.2 mt -146.19 141.72 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.728 1.611 . . . . 72.55 107.057 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -151.82 132.14 13.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.579 -0.526 . . . . 74.45 109.579 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 82.9 t80 -130.99 122.6 27.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.74 -1.578 . . . . 63.41 106.74 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -129.99 118.42 21.59 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.36 -0.607 . . . . 73.15 109.36 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.12 79.03 70.11 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.826 -1.175 . . . . 75.11 107.826 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.26 -33.05 40.61 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.052 2.501 . . . . 55.3 111.686 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.429 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 47.5 m-80 -107.03 36.73 2.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.779 -1.1 . . . . 60.14 109.631 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.536 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -60.39 -44.58 96.28 Favored Pre-proline 0 CA--C 1.57 1.743 0 C-N-CA 124.537 1.135 . . . . 61.22 113.967 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.88 -20.85 11.46 Favored 'Trans proline' 0 C--N 1.385 2.468 0 CA-C-N 121.522 1.579 . . . . 74.13 112.876 172.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 61.7 m170 -77.67 -38.97 46.47 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.143 0.577 . . . . 72.14 110.876 -176.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.649 HG23 HD12 ' A' ' 68' ' ' LEU . 10.6 p -63.48 -27.7 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.989 0.916 . . . . 51.4 110.998 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.602 ' HD1' HH11 ' B' ' 15' ' ' ARG . 91.7 t80 -62.44 -35.57 79.7 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.315 1.046 . . . . 42.21 110.907 174.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -93.03 -25.43 17.95 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.641 0.776 . . . . 63.44 111.264 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HE2' HD22 ' A' ' 68' ' ' LEU . 53.9 mtpt -82.87 165.31 19.89 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.463 0.705 . . . . 72.45 111.489 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.472 ' O ' HD21 ' A' ' 68' ' ' LEU . 10.3 m-20 -80.77 128.66 33.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.178 0.991 . . . . 72.14 108.919 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -69.28 85.92 0.4 Allowed 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.37 0.605 . . . . 75.24 111.245 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -127.25 82.28 68.47 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.543 1.137 . . . . 74.32 108.647 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -85.11 152.52 10.95 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.418 2.079 . . . . 64.0 113.117 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.435 ' HB3' ' NZ ' ' A' ' 41' ' ' LYS . 63.1 mm-40 -105.6 85.49 2.25 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.865 -1.161 . . . . 70.25 107.865 176.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -82.5 93.83 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 122.323 1.059 . . . . 62.42 111.357 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 39' ' ' GLU . 13.7 mptt -98.17 136.05 38.94 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.912 -1.04 . . . . 72.0 108.61 169.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.419 HD13 HG22 ' A' ' 64' ' ' VAL . 37.2 tp -119.57 114.8 22.79 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.009 -0.737 . . . . 70.4 109.009 172.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -102.67 128.55 49.32 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.028 -1.101 . . . . 70.25 108.028 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.1 mt -107.35 143.03 36.22 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.625 -0.88 . . . . 62.53 108.625 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 26.2 t70 -143.29 130.46 20.79 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.987 -0.746 . . . . 64.34 108.987 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -105.77 131.09 53.54 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.065 -0.717 . . . . 74.33 109.065 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.6 127.37 38.86 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.658 0.783 . . . . 72.22 109.664 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.1 p -94.83 153.22 17.83 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.143 0.977 . . . . 55.44 110.214 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.9 t -150.39 127.39 11.15 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.872 -0.788 . . . . 62.34 108.872 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -103.01 106.7 17.27 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.282 -0.636 . . . . 75.3 109.282 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.584 HD11 ' HB2' ' A' ' 57' ' ' GLU . 65.6 mt -83.37 -30.47 27.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.047 0.539 . . . . 70.34 110.505 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -163.73 -177.98 5.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.12 -0.946 . . . . 53.44 109.748 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.43 126.27 28.76 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.518 -1.29 . . . . 62.54 107.518 164.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 74.19 -3.85 2.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.272 1.029 . . . . 74.55 112.85 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 50.5 t -115.64 111.4 35.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 107.403 -1.332 . . . . 63.53 107.403 177.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -130.99 123.73 29.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.39 -0.596 . . . . 52.41 109.39 -172.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.584 ' HB2' HD11 ' A' ' 51' ' ' LEU . 45.3 tt0 -93.95 140.34 29.82 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.762 0.825 . . . . 73.15 109.404 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -119.29 143.43 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.483 -1.302 . . . . 54.24 107.483 170.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.03 117.74 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.967 -1.123 . . . . 72.54 107.967 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -99.54 106.8 18.84 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.215 -1.031 . . . . 73.22 108.215 178.221 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.569 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 62.9 ttt180 -84.34 105.89 15.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.063 0.945 . . . . 72.4 109.29 176.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.536 HG22 HD12 ' A' ' 60' ' ' LEU . 15.9 t -104.71 115.84 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.869 0.868 . . . . 61.53 109.003 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.3 m -110.71 112.71 24.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.091 0.957 . . . . 74.43 110.511 -175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 114' ' ' ILE . 53.0 t -102.89 107.35 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.888 0.875 . . . . 74.43 109.176 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.1 m -105.13 109.91 22.08 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.531 -0.915 . . . . 74.45 108.531 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.71 104.1 9.96 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.611 -0.885 . . . . 24.2 108.611 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.8 m -107.76 127.15 53.44 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.563 0.745 . . . . 71.1 109.13 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.649 HD12 HG23 ' A' ' 31' ' ' VAL . 2.2 tt -86.62 87.14 7.38 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 106.781 -1.563 . . . . 43.13 106.781 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.86 -98.7 1.32 Allowed Glycine 0 C--N 1.343 0.926 0 CA-C-N 114.51 -1.223 . . . . 70.44 110.632 -172.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -115.5 -12.54 11.65 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.124 0.97 . . . . 73.15 110.443 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.408 ' HB2' ' HZ3' ' A' ' 34' ' ' LYS . 11.1 mp0 -99.48 119.5 38.12 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.227 1.011 . . . . 70.43 109.671 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.3 m -61.82 122.44 15.39 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 123.459 0.474 . . . . 75.42 111.409 -178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.93 -55.67 5.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.045 -1.095 . . . . 75.13 108.045 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.511 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 51.7 p90 -158.95 150.43 20.56 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.854 -1.066 . . . . 71.32 110.601 175.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 64' ' ' VAL . 47.0 tp -131.1 107.57 9.14 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 107.741 -1.207 . . . . 54.14 107.741 176.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.511 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 60.4 m -109.74 99.78 8.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.659 0.784 . . . . 62.32 109.715 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -119.71 116.04 25.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.636 -0.876 . . . . 54.34 108.636 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.24 132.3 68.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 123.992 0.917 . . . . 64.55 109.29 -173.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 44.9 mt-30 -104.55 101.13 10.79 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 109.232 -0.655 . . . . 62.51 109.232 168.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -86.82 105.4 16.99 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.107 -1.072 . . . . 74.4 108.107 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.44 144.6 17.15 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 111.756 -0.538 . . . . 73.35 111.756 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.485 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.23 137.09 7.89 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.078 -0.809 . . . . 63.33 111.078 177.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.4 mt -89.08 123.58 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.844 -0.799 . . . . 62.41 108.844 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.691 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 34.8 m-85 -128.18 133.59 48.93 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.264 0.626 . . . . 74.32 109.654 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.3 t -100.89 114.31 28.05 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.67 -0.863 . . . . 74.24 108.67 176.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.31 142.31 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.831 0.852 . . . . 72.32 109.25 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.49 152.35 19.97 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.088 0.955 . . . . 54.52 109.792 173.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.2 -17.19 57.82 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.558 0.536 . . . . 54.01 114.398 173.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.544 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -132.18 152.95 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.483 0.713 . . . . 73.31 109.874 178.586 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.492 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 17.9 tt0 -150.27 -179.05 6.88 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.845 0.858 . . . . 54.55 108.866 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 71.9 -135.58 23.2 Favored Glycine 0 C--N 1.35 1.359 0 C-N-CA 123.003 0.335 . . . . 71.1 113.888 176.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.2 p -79.32 -15.13 58.43 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.075 0.55 . . . . 73.12 110.918 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -74.96 -36.84 62.07 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.151 0.98 . . . . 74.42 110.532 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.492 ' SD ' ' HA ' ' A' ' 90' ' ' GLU . 12.9 ptt? -74.94 -25.13 58.67 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 110.259 -0.274 . . . . 64.32 110.259 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.45 -26.53 62.76 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.294 0.637 . . . . 73.2 110.26 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.484 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 27.5 t-80 -71.88 -34.56 69.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.069 0.548 . . . . 73.45 110.494 171.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.544 ' SG ' HG13 ' A' ' 89' ' ' ILE . 79.3 m -69.58 -61.27 1.85 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.454 0.302 . . . . 73.22 110.769 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -76.21 -24.23 54.65 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.676 0.39 . . . . 70.33 111.194 -173.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.0 3.75 38.53 Favored Glycine 0 N--CA 1.476 1.325 0 CA-C-O 119.762 -0.466 . . . . 73.35 114.251 -171.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -147.49 -59.0 0.26 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 117.375 0.588 . . . . 24.34 111.755 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.424 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 84.6 t80 -70.74 -51.05 29.74 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.776 0.831 . . . . 75.35 112.511 -173.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.437 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 74.5 m -76.18 -34.2 1.38 Allowed Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 113.876 1.065 . . . . 75.14 113.876 -173.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.455 ' HB2' HD23 ' A' ' 60' ' ' LEU . 42.8 Cg_endo -69.12 -22.38 35.08 Favored 'Trans proline' 0 C--N 1.379 2.143 0 CA-C-N 121.596 1.606 . . . . 61.52 112.92 167.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -70.35 -31.36 68.6 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.389 0.676 . . . . 73.22 109.721 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 35.9 mm -57.08 -39.09 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.185 0.994 . . . . 74.12 110.962 171.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.485 HD21 ' HA3' ' A' ' 82' ' ' GLY . 54.0 mt -86.23 -16.99 35.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.788 0.835 . . . . 73.32 112.748 -172.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -64.79 -43.14 68.17 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 113.453 0.909 . . . . 73.15 113.453 -175.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.46 -36.25 78.44 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.058 1.839 . . . . 44.15 113.243 173.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -70.5 -40.06 73.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.347 0.659 . . . . 74.42 111.223 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.11 -40.55 86.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.299 0.64 . . . . 71.2 110.149 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.523 ' NH1' HD12 ' C' ' 105' ' ' ILE . 36.9 ttm180 -51.56 -55.52 18.68 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 124.334 1.021 . . . . 65.41 110.143 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.37 -47.31 86.41 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.367 1.042 . . . . 52.43 111.537 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.4 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 37.3 t -55.14 -45.01 75.6 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.93 0.769 . . . . 65.33 110.987 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.475 HG21 HG21 ' A' ' 64' ' ' VAL . 83.9 mt -64.69 -55.68 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.773 -1.103 . . . . 73.04 110.758 176.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -55.58 -37.35 67.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.985 0.914 . . . . 52.24 111.799 -175.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -66.79 -49.89 64.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.88 -1.055 . . . . 44.41 109.912 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 38.8 mtp -58.44 -37.18 74.89 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.773 0.829 . . . . 62.12 111.847 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 114' ' ' ILE . 98.2 t -65.69 -47.86 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.851 0.86 . . . . 73.14 110.263 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 p -74.98 -21.61 59.05 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.18 0.592 . . . . 72.04 111.876 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -73.0 -34.27 66.29 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.519 0.728 . . . . 72.51 109.362 172.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.82 0.66 76.95 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.894 0.746 . . . . 42.35 113.1 172.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.4 m 69.25 19.63 7.76 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 124.648 1.179 . . . . 75.31 111.141 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -86.97 150.46 50.08 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.627 0.771 . . . . 72.1 109.987 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.48 152.6 15.61 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.722 2.948 . . . . 71.32 114.374 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -57.67 140.92 50.05 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.238 1.015 . . . . 73.14 112.413 -172.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.8 tp -127.14 113.36 16.28 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.853 0.461 . . . . 45.24 110.558 -176.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -122.41 86.7 2.62 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.387 0.675 . . . . 71.25 109.206 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.69 ' H ' HD23 ' A' ' 128' ' ' LEU . 0.5 OUTLIER -65.61 131.06 45.44 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.278 0.631 . . . . 52.03 110.028 175.22 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.38 146.39 81.09 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 123.756 0.822 . . . . 71.21 111.847 -170.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.51 121.99 7.9 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 122.942 2.428 . . . . 75.21 112.548 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -108.39 134.73 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 109.217 -0.661 . . . . 71.25 109.217 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.403 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 52.5 t-20 -80.76 101.94 9.64 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.701 0.8 . . . . 72.12 109.355 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -66.9 -27.15 67.27 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.275 0.63 . . . . 62.4 111.596 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.538 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 5.1 m-20 -67.87 -37.49 81.88 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.836 0.855 . . . . 65.52 110.816 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.48 -37.24 84.66 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.893 0.746 . . . . 44.0 110.589 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 132' ' ' ASN . 84.3 mt -67.07 -45.14 78.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.655 0.782 . . . . 71.44 111.396 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -64.0 -39.49 94.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.507 -0.769 . . . . 73.2 109.322 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 CA--C 1.543 0.69 0 O-C-N 124.211 0.944 . . . . 63.41 110.668 -178.355 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 95.5 m . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 106.608 -1.627 . . . . 74.33 106.608 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -133.49 132.83 41.48 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.686 0.395 . . . . 74.41 110.317 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -140.09 142.08 36.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.34 0.656 . . . . 75.12 109.732 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.449 HD11 HD13 ' B' ' 105' ' ' ILE . 32.1 mt -95.64 120.68 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 107.989 -1.115 . . . . 73.35 107.989 170.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -85.2 -50.86 7.04 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.334 -0.617 . . . . 63.44 109.334 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.602 HH11 ' HD1' ' A' ' 32' ' ' PHE . 46.0 ttt180 -162.03 137.99 7.68 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.364 -0.834 . . . . 75.42 109.508 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 91.4 mt -114.99 145.46 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 106.77 -1.567 . . . . 74.33 106.77 171.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -165.61 141.24 5.1 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.931 0.396 . . . . 74.2 111.416 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 59.0 m -72.92 120.92 19.21 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.108 -1.071 . . . . 74.45 108.108 171.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.536 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 46.8 mtpt -92.67 -32.42 14.76 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.221 0.608 . . . . 73.53 111.267 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.9 t70 -153.93 137.8 16.25 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.064 0.228 . . . . 73.55 110.689 -171.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.8 mm -134.87 141.3 43.47 Favored 'Isoleucine or valine' 0 C--N 1.348 0.533 0 C-N-CA 124.834 1.254 . . . . 64.32 108.223 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.3 t -139.16 127.07 22.2 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.526 -1.286 . . . . 74.23 107.526 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.599 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.0 t80 -143.39 114.35 7.74 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.478 -0.934 . . . . 64.1 108.478 173.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -119.48 137.94 53.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.031 0.933 . . . . 65.35 108.817 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.01 81.04 71.17 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.461 -1.311 . . . . 74.54 107.461 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.87 -44.39 16.61 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.25 2.633 . . . . 71.33 113.356 -166.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.53 ' HB2' ' HB ' ' B' ' 31' ' ' VAL . 33.5 m-80 -100.25 15.49 27.41 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 117.905 -1.045 . . . . 72.4 110.792 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.424 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -30.17 -72.26 0.06 OUTLIER Pre-proline 0 N--CA 1.511 2.59 0 C-N-CA 125.927 1.691 . . . . 64.12 115.048 -165.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 33.9 Cg_endo -66.3 -21.61 54.25 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.462 2.108 . . . . 64.01 113.166 -172.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -83.11 -49.53 9.42 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.383 -0.826 . . . . 71.11 111.308 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.658 HG22 HD12 ' B' ' 68' ' ' LEU . 8.1 p -64.37 -19.61 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.133 0.973 . . . . 31.14 112.056 -166.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -61.37 -11.77 11.49 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 123.821 0.848 . . . . 75.35 112.319 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.607 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 24.7 pt20 -55.34 -40.27 71.03 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.08 1.352 . . . . 51.41 111.574 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.607 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 90.0 mttt -94.54 89.65 5.89 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.622 0.769 . . . . 65.43 108.925 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.32 86.91 2.51 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.388 -0.824 . . . . 64.25 109.641 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -154.16 155.15 34.81 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.087 1.355 . . . . 73.34 107.377 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -76.2 102.91 0.87 Allowed Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.559 -0.904 . . . . 63.53 108.559 170.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.524 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 34.6 Cg_endo -60.06 142.06 97.59 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 123.136 2.558 . . . . 62.53 113.098 -170.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.41 121.58 13.57 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 123.701 0.625 . . . . 74.41 109.441 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' B' ' 65' ' ' THR . 18.3 m -104.05 135.5 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.587 -0.733 . . . . 65.25 112.314 -171.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.592 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 54.1 tttp -106.1 103.48 12.97 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.597 -1.26 . . . . 63.54 107.597 170.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.644 ' H ' HD23 ' B' ' 42' ' ' LEU . 2.2 pt? -95.81 132.31 41.19 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.81 -0.811 . . . . 73.03 108.81 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 19.5 t70 -131.77 146.96 52.44 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.14 1.376 . . . . 73.32 109.123 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 tp -125.04 131.4 53.38 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.106 0.962 . . . . 75.45 109.724 -172.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -148.87 155.89 41.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.643 1.177 . . . . 71.13 108.822 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.5 p -134.93 130.41 35.81 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.452 0.701 . . . . 62.11 109.753 173.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.79 122.71 46.26 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.97 -1.122 . . . . 74.52 107.97 174.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.3 m -124.8 160.79 27.89 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 122.915 0.486 . . . . 74.11 109.865 -175.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 94.6 p -152.35 139.82 19.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.493 0.717 . . . . 73.13 110.064 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -82.19 105.26 13.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.27 0.628 . . . . 63.04 110.067 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 78.4 mt -72.23 -42.77 65.32 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.62 0.724 . . . . 74.11 109.603 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.37 -179.16 7.92 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.269 -1.332 . . . . 63.13 108.782 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.25 123.12 22.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.291 -1.003 . . . . 65.31 108.291 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 72.82 -5.4 1.89 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.517 1.527 . . . . 62.45 113.288 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -111.49 109.83 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 107.59 -1.263 . . . . 75.32 107.59 173.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.72 140.5 52.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.183 -0.673 . . . . 74.34 109.183 -173.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -99.7 133.65 43.74 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.149 -1.056 . . . . 74.31 108.149 172.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -115.69 139.58 41.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.2 -1.037 . . . . 75.41 108.2 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 33.0 t -126.54 120.83 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.62 -0.881 . . . . 64.04 108.62 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.66 113.13 25.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.125 -1.065 . . . . 63.04 108.125 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -100.65 122.43 43.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.806 0.442 . . . . 73.14 110.315 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -116.09 114.61 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 107.783 -1.192 . . . . 63.34 107.783 171.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 48.7 m -96.4 137.72 35.06 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.474 -0.935 . . . . 51.51 108.474 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 85.5 t -131.99 133.08 61.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.998 -0.742 . . . . 72.11 108.998 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 91.4 m -120.09 148.88 43.05 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.767 1.227 . . . . 72.23 107.721 175.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.45 134.65 21.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 122.858 0.463 . . . . 64.13 110.077 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.6 p -132.62 126.69 33.28 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.308 0.643 . . . . 61.33 110.751 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.658 HD12 HG22 ' B' ' 31' ' ' VAL . 41.2 mt -95.13 103.15 15.0 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 108.149 -1.056 . . . . 74.2 108.149 170.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.48 -109.78 3.1 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.008 -0.996 . . . . 73.34 111.206 -170.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -117.37 5.15 12.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.928 0.891 . . . . 64.23 111.583 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -116.17 149.21 39.44 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.185 -0.672 . . . . 75.4 109.185 175.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 65.7 m -72.89 134.0 44.63 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.192 0.308 . . . . 65.53 111.097 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.495 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -82.97 -68.21 0.72 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.249 -1.019 . . . . 64.4 108.249 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -144.25 158.94 43.46 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.811 -1.086 . . . . 63.21 110.395 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 94.8 mt -131.2 120.82 23.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.08 -1.822 . . . . 64.12 106.08 174.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 36.9 t -132.35 145.24 51.11 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.194 -0.669 . . . . 74.41 109.194 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -160.19 133.96 7.11 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.865 -0.791 . . . . 71.53 108.865 -175.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -128.01 146.39 33.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.87 0.868 . . . . 74.02 108.918 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 17.6 mt-30 -124.96 93.32 3.85 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.233 -1.025 . . . . 72.33 108.233 170.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.531 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -85.57 101.0 12.32 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.845 -1.071 . . . . 71.53 109.155 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.07 160.26 29.52 Favored Glycine 0 C--N 1.339 0.748 0 O-C-N 123.435 0.459 . . . . 65.11 112.047 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.18 130.42 2.34 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 119.952 -0.36 . . . . 73.11 112.22 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -84.54 126.09 40.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 108.806 -0.813 . . . . 74.24 108.806 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -132.37 134.18 44.86 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.282 1.033 . . . . 73.55 108.972 -176.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.6 m -102.06 103.08 13.65 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.822 0.849 . . . . 74.13 109.51 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.672 ' HB ' HD11 ' B' ' 89' ' ' ILE . 46.2 pt -103.92 135.33 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.496 0.719 . . . . 74.21 109.794 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -146.69 151.81 37.81 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.863 -0.792 . . . . 41.12 108.863 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.93 -62.16 3.66 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 112.109 -0.396 . . . . 61.11 112.109 -176.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.672 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -62.12 142.07 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.679 0.392 . . . . 72.44 111.781 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.84 167.73 26.61 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.969 0.907 . . . . 71.1 109.526 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.07 -113.62 5.28 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.794 0.684 . . . . 74.15 113.042 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 2.2 m -87.17 -17.49 32.57 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.609 -0.348 . . . . 44.32 111.26 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -65.61 -46.75 78.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.982 0.513 . . . . 65.23 110.262 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -24.42 57.03 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 116.058 -0.519 . . . . 74.44 110.529 177.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.77 98.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.33 0.586 . . . . 44.32 109.918 169.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -70.25 -30.91 68.08 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.31 1.044 . . . . 73.21 111.203 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.484 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 69.2 m -70.76 -67.68 0.49 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 110.247 -0.279 . . . . 63.32 110.247 174.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 59.3 mt -74.34 -21.93 59.46 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.585 0.587 . . . . 74.21 112.585 -168.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.95 3.09 41.2 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-O 119.522 -0.599 . . . . 60.54 114.302 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.48 -62.85 0.2 Allowed 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.789 0.795 . . . . 70.41 111.909 -177.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 89.4 t80 -68.18 -39.18 82.61 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.915 0.886 . . . . 72.14 112.372 -172.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.411 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 91.3 m -73.08 -46.36 8.22 Favored Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 123.693 0.797 . . . . 64.24 111.103 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.411 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 78.5 Cg_exo -55.87 -34.05 90.39 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.025 1.817 . . . . 53.31 113.727 167.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -59.6 -38.77 82.13 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.231 0.613 . . . . 72.24 110.799 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.449 HD13 HD11 ' B' ' 13' ' ' ILE . 70.4 mt -64.12 -42.99 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.06 0.944 . . . . 74.14 110.836 175.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 80' ' ' GLN . 74.1 mt -79.03 -19.73 50.73 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.657 -1.156 . . . . 71.33 112.399 -173.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -59.7 -47.41 97.59 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.179 1.177 . . . . 71.42 114.179 -171.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.96 -42.78 61.84 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.373 2.048 . . . . 73.13 113.788 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.531 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 82.5 m-85 -66.27 -48.63 69.81 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.839 -0.619 . . . . 64.43 110.421 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.96 -42.12 84.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.742 0.817 . . . . 63.54 110.908 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 49.5 ttt180 -61.86 -54.71 38.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.245 1.418 . . . . 64.41 110.995 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -67.17 -34.16 76.95 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 123.998 0.811 . . . . 73.24 110.147 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.6 t -68.18 -33.93 75.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.71 0.404 . . . . 74.24 111.088 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 70.9 mt -65.28 -52.01 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.415 -0.587 . . . . 65.34 109.415 171.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.0 m -60.01 -30.62 69.27 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 123.979 0.8 . . . . 75.53 111.543 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.2 t -63.63 -51.86 63.36 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 123.454 0.702 . . . . 52.23 109.858 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -68.59 -34.91 76.6 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.148 0.579 . . . . 64.11 110.985 -174.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.05 -43.04 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.736 0.815 . . . . 64.03 110.312 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.3 t -68.75 -30.19 68.75 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.393 -0.821 . . . . 52.24 111.598 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.8 mtt-85 -69.59 -43.4 72.88 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.547 -0.751 . . . . 75.54 109.612 176.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.21 -3.09 64.24 Favored Glycine 0 C--N 1.357 1.708 0 O-C-N 124.072 0.857 . . . . 55.45 112.924 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 28.2 p 62.18 25.87 15.5 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 126.506 1.922 . . . . 71.23 112.86 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -80.34 161.51 64.64 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 123.837 0.855 . . . . 54.43 110.729 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -49.41 157.86 1.95 Allowed 'Trans proline' 0 C--N 1.387 2.581 0 C-N-CA 123.742 2.961 . . . . 71.41 115.178 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -59.61 114.17 2.6 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.226 1.01 . . . . 52.31 111.306 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -119.1 108.97 15.35 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.657 -0.868 . . . . 65.35 108.657 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -124.02 134.44 53.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.511 -0.922 . . . . 75.22 108.511 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.429 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.3 mm? -77.02 147.42 36.78 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.299 0.639 . . . . 74.02 109.848 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.23 147.23 53.04 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 123.092 0.557 . . . . 62.52 109.667 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.33 110.78 0.85 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.151 2.568 . . . . 73.23 112.322 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.0 t -90.11 112.63 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.435 -0.95 . . . . 72.22 108.435 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -82.08 83.83 7.2 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.968 -1.123 . . . . 74.22 107.968 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -54.41 -42.26 70.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.288 1.035 . . . . 64.42 111.302 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.73 -43.09 80.79 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.408 1.083 . . . . 71.32 111.888 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.52 -54.25 45.64 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.316 0.646 . . . . 74.2 110.271 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.4 -29.37 70.43 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.613 -1.176 . . . . 54.2 111.47 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 75.2 t80 . . . . . 0 C--N 1.349 0.559 0 C-N-CA 123.151 0.58 . . . . 54.14 110.433 177.774 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 31.4 m . . . . . 0 C--O 1.237 0.395 0 N-CA-C 108.368 -0.975 . . . . 74.01 108.368 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.56 122.93 33.8 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.79 -1.095 . . . . 61.32 109.155 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.483 ' HA ' HE21 ' C' ' 12' ' ' GLN . 0.1 OUTLIER -137.21 108.41 6.81 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.593 -1.262 . . . . 74.22 107.593 168.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.9 118.62 6.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.071 -1.085 . . . . 74.45 108.071 172.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.478 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.1 mm-40 -82.74 -48.84 10.4 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.705 0.628 . . . . 41.24 109.415 -178.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -170.19 124.46 0.74 Allowed 'General case' 0 C--N 1.354 0.78 0 CA-C-N 115.947 -0.569 . . . . 62.34 110.677 -172.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.1 mt -112.35 139.27 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 107.736 -1.209 . . . . 63.11 107.736 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -173.5 153.12 2.26 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.094 0.474 . . . . 74.45 110.435 -168.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.9 p -82.32 116.64 21.91 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.96 -0.755 . . . . 71.42 108.96 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.43 ' HG3' ' HA3' ' C' ' 81' ' ' GLY . 15.2 mtmt -83.58 -29.79 27.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.09 0.472 . . . . 75.53 109.947 176.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 27.4 t70 -144.37 138.68 27.97 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.132 -0.94 . . . . 75.42 109.354 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 87.0 mt -136.51 140.24 43.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.924 -1.509 . . . . 74.44 106.924 171.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -157.05 141.23 16.39 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.842 0.353 . . . . 72.31 110.155 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 86.8 t80 -136.44 148.2 47.62 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.489 -1.3 . . . . 75.42 107.489 171.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -145.08 118.12 8.84 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.0 0.92 . . . . 74.33 110.062 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.83 83.78 51.7 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 107.222 -1.399 . . . . 15.4 107.222 163.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.01 -27.89 19.94 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.331 2.021 . . . . 72.33 111.394 175.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -92.25 12.2 23.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.579 1.151 . . . . 74.22 110.747 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.81 -58.76 7.63 Favored Pre-proline 0 C--N 1.37 1.463 0 N-CA-C 114.698 1.37 . . . . 63.12 114.698 -165.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -62.98 -39.77 38.44 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 121.503 1.468 . . . . 51.14 112.171 -174.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -70.3 -34.96 73.36 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.787 -1.097 . . . . 71.33 112.233 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.692 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.3 p -80.6 -26.06 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 112.906 0.706 . . . . 72.32 112.906 -170.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -64.77 -20.48 66.39 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 113.29 0.848 . . . . 73.02 113.29 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -99.11 12.07 37.18 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.302 0.641 . . . . 73.11 111.286 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.726 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -88.06 146.32 25.52 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.276 -0.638 . . . . 61.35 109.276 172.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -57.98 119.18 6.3 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.116 -0.698 . . . . 73.44 109.116 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -67.8 93.17 0.38 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.803 0.841 . . . . 71.2 111.283 -173.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -148.99 69.1 9.81 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 124.839 1.255 . . . . 73.41 108.251 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -80.16 133.27 9.78 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.573 2.182 . . . . 73.44 111.152 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.09 105.11 15.59 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.107 -1.072 . . . . 74.42 108.107 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.55 113.56 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.36 -0.836 . . . . 70.21 110.329 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -111.17 110.7 21.34 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.183 -1.414 . . . . 72.41 107.183 170.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 40.4 tp -91.28 142.26 27.9 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.124 0.569 . . . . 71.31 109.7 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.42 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 20.1 t70 -131.95 117.75 18.86 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.823 -1.177 . . . . 73.31 107.823 175.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.6 mt -108.72 151.67 25.87 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.607 0.763 . . . . 63.33 109.953 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 30.0 t70 -157.6 150.19 22.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.198 0.599 . . . . 55.44 109.949 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -144.45 123.36 12.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.629 0.772 . . . . 54.22 110.117 176.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.78 135.11 54.44 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.619 -0.882 . . . . 73.14 108.619 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.4 p -131.2 142.31 50.17 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.239 0.616 . . . . 74.42 109.623 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 29.6 t -145.79 150.8 36.88 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.137 0.975 . . . . 73.13 109.532 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.75 138.77 41.46 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.957 -0.565 . . . . 74.44 109.829 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.632 HD11 HD12 ' C' ' 83' ' ' ILE . 62.6 mt -106.22 -43.26 4.85 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.681 -0.859 . . . . 74.34 108.681 169.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.66 -176.34 5.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.63 -1.168 . . . . 60.02 109.525 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -66.18 126.1 27.63 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.511 -0.768 . . . . 62.23 109.684 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 72.2 -1.82 2.78 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.31 1.444 . . . . 73.35 112.032 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -114.89 114.12 45.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 123.264 0.625 . . . . 55.11 109.418 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -124.84 135.3 52.78 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.063 0.945 . . . . 74.34 109.192 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.562 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.8 tt0 -92.6 123.97 36.29 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 124.154 0.909 . . . . 70.23 108.877 168.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 85.3 t -103.79 136.95 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.293 -1.003 . . . . 62.5 108.293 168.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -121.17 130.58 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.303 -1.369 . . . . 75.5 107.303 174.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.26 104.26 11.64 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.818 -1.178 . . . . 52.1 107.818 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.575 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 30.4 ttm-85 -88.39 126.19 35.09 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.241 -1.345 . . . . 74.22 108.297 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.597 ' HB ' HD11 ' C' ' 114' ' ' ILE . 21.5 t -123.58 128.22 74.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.583 -1.266 . . . . 64.41 107.583 173.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 9.8 m -128.37 112.0 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.746 -0.835 . . . . 71.44 108.746 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.455 HG21 HG21 ' C' ' 114' ' ' ILE . 51.7 t -104.84 116.02 47.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.92 -1.036 . . . . 71.25 108.788 -173.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.9 m -105.8 141.37 37.34 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.07 -0.715 . . . . 72.41 109.07 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.15 115.15 8.74 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.85 -1.167 . . . . 73.13 107.85 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.9 m -137.17 134.25 36.11 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.483 0.49 . . . . 54.53 109.833 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.726 HD13 ' HG2' ' C' ' 34' ' ' LYS . 0.5 OUTLIER -87.88 42.03 1.03 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.936 1.294 . . . . 61.22 108.596 177.135 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.27 -112.62 4.17 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.209 -0.756 . . . . 70.54 111.209 -171.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.56 -30.71 19.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.326 0.65 . . . . 71.25 109.485 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.15 110.53 3.02 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 115.222 -0.899 . . . . 64.44 109.032 173.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -77.95 125.49 29.42 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.001 -0.74 . . . . 74.05 109.001 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.692 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.85 -57.87 3.75 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.421 -1.325 . . . . 62.23 107.421 171.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -167.4 169.23 12.45 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 121.885 0.85 . . . . 71.13 111.939 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -133.77 141.63 47.57 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 105.947 -1.872 . . . . 72.11 105.947 170.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 47.4 t -151.34 113.44 4.53 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.963 -0.384 . . . . 44.32 109.963 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -117.02 127.62 54.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.478 0.311 . . . . 73.21 110.309 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.5 t -118.24 138.33 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.953 -1.129 . . . . 74.33 107.953 167.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.6 mt-30 -116.05 94.96 4.88 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 108.68 -0.859 . . . . 72.12 108.68 173.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.478 ' HG3' HD22 ' C' ' 106' ' ' LEU . 9.4 tp-100 -79.79 102.64 9.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.954 -1.021 . . . . 62.33 109.903 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.43 ' HA3' ' HG3' ' C' ' 19' ' ' LYS . . . -85.58 151.85 25.75 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 111.759 -0.536 . . . . 72.51 111.759 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.59 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.37 118.47 0.86 Allowed Glycine 0 CA--C 1.506 -0.475 0 N-CA-C 111.697 -0.561 . . . . 71.34 111.697 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.632 HD12 HD11 ' C' ' 51' ' ' LEU . 8.8 mm -84.71 125.91 40.29 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 N-CA-C 108.764 -0.828 . . . . 70.51 108.764 173.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -134.24 120.08 19.55 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.673 -0.862 . . . . 73.22 108.673 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 61.1 p -91.07 118.82 30.71 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.189 -0.671 . . . . 71.44 109.189 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.749 HG21 ' SG ' ' C' ' 97' ' ' CYS . 1.8 pp -125.61 141.13 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.594 1.158 . . . . 72.43 111.356 -174.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.508 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -149.53 167.46 26.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.333 0.653 . . . . 75.43 110.326 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.64 -54.41 3.78 Favored Glycine 0 N--CA 1.475 1.269 0 N-CA-C 112.43 -0.268 . . . . 55.0 112.43 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.4 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -81.42 157.54 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.254 0.622 . . . . 75.12 110.564 177.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.79 178.63 8.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.851 0.46 . . . . 73.34 110.418 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.54 -114.1 5.58 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.718 0.637 . . . . 64.25 113.533 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -82.55 -20.08 37.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.672 0.789 . . . . 64.5 112.087 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.56 -42.92 61.01 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.513 -0.551 . . . . 73.15 109.513 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 23.9 ptm -74.23 -30.11 62.02 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 110.248 -0.278 . . . . 73.22 110.248 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.69 93.59 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 123.489 0.493 . . . . 75.15 110.118 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -74.72 -35.83 62.67 Favored 'General case' 0 C--O 1.245 0.832 0 O-C-N 123.477 0.485 . . . . 72.43 111.78 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.749 ' SG ' HG21 ' C' ' 86' ' ' ILE . 53.3 t -56.6 -36.37 69.32 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.644 0.59 . . . . 70.41 110.558 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 24.4 mt -98.31 -18.06 18.56 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.856 0.862 . . . . 75.33 111.18 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.43 -29.62 55.44 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 115.015 0.766 . . . . 51.1 115.015 -172.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.94 -36.0 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.654 0.382 . . . . 63.14 111.081 -170.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -67.61 -45.8 74.39 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.216 1.406 . . . . 74.42 112.677 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.0 m -79.79 -40.41 1.37 Allowed Pre-proline 0 CA--C 1.557 1.247 0 CA-C-O 118.475 -0.774 . . . . 61.12 112.481 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -54.0 -27.58 45.92 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 122.249 1.966 . . . . 70.05 114.078 166.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -68.28 -37.9 81.14 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.679 0.792 . . . . 74.15 109.768 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.523 HD12 ' NH1' ' A' ' 111' ' ' ARG . 43.8 mm -68.94 -34.01 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.008 0.523 . . . . 73.11 109.983 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.59 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.4 mt -81.34 -27.3 35.01 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.917 0.887 . . . . 75.35 112.756 -177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -57.8 -48.52 97.03 Favored Pre-proline 0 CA--C 1.559 1.31 0 N-CA-C 113.959 1.096 . . . . 73.4 113.959 -174.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.94 -37.15 79.29 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 121.992 1.795 . . . . 74.42 113.056 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -66.69 -42.46 86.43 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.103 0.561 . . . . 61.11 110.895 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.56 99.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.539 0.736 . . . . 61.0 110.461 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.598 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 35.9 ttt180 -54.12 -56.47 17.85 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.464 1.506 . . . . 63.5 111.412 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.23 -35.43 77.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.733 0.413 . . . . 73.21 110.543 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 20.0 t -64.75 -33.58 76.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.957 0.503 . . . . 73.11 111.973 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.597 HD11 ' HB ' ' C' ' 62' ' ' VAL . 75.4 mt -76.75 -52.7 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.585 0.754 . . . . 74.4 110.231 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -60.94 -28.67 69.12 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.356 0.662 . . . . 71.03 111.38 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.2 t -67.31 -52.07 44.86 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.779 0.832 . . . . 51.4 109.156 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.547 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.37 -36.84 78.97 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.226 1.011 . . . . 71.25 112.338 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.498 HG11 HD13 ' C' ' 126' ' ' LEU . 78.3 t -66.53 -44.84 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.633 0.773 . . . . 72.33 109.904 175.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 40.4 t -69.2 -22.92 63.86 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.262 -0.881 . . . . 71.11 111.645 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.3 mtt-85 -75.65 -41.05 55.13 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.49 0.716 . . . . 75.15 109.082 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.01 -2.87 62.89 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 123.83 0.706 . . . . 63.44 112.498 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p 67.03 27.76 8.62 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.88 2.072 . . . . 74.12 113.611 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -83.8 153.45 64.13 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 108.813 -0.81 . . . . 73.53 108.813 168.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -60.67 178.49 0.47 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.149 2.566 . . . . 74.24 114.75 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -60.8 114.33 2.98 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 114.171 1.174 . . . . 54.21 114.171 -174.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.498 HD13 HG11 ' C' ' 118' ' ' VAL . 7.2 mp -112.2 89.49 3.08 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.81 -0.811 . . . . 73.41 108.81 163.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -91.32 112.68 24.69 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.513 -0.921 . . . . 53.54 108.513 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.598 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -65.0 126.29 27.55 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.618 0.767 . . . . 61.32 110.587 -177.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.21 149.18 81.82 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 124.423 1.089 . . . . 72.4 111.887 -173.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.07 105.3 0.32 Allowed 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.11 2.54 . . . . 73.32 113.212 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.6 111.33 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.707 -0.849 . . . . 73.54 108.707 171.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -87.22 90.31 8.31 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 108.622 -0.881 . . . . 65.11 108.622 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -60.36 -29.95 69.24 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.251 1.021 . . . . 63.22 111.261 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.56 -43.93 68.88 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.415 1.486 . . . . 75.01 112.915 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.61 82.97 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.348 1.03 . . . . 74.24 110.604 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 20.6 tp -71.72 -29.31 64.41 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.142 -0.935 . . . . 74.13 111.152 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 12.2 t80 . . . . . 0 N--CA 1.487 1.396 0 C-N-CA 122.639 0.375 . . . . 72.04 110.344 177.008 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 21.0 m . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.403 0.621 . . . . 75.04 110.905 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.545 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 71.1 t80 -162.58 97.7 0.98 Allowed 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.063 -1.458 . . . . 73.33 107.063 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -112.22 115.01 28.11 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.394 -1.336 . . . . 75.24 107.394 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.474 HD11 HD12 ' D' ' 105' ' ' ILE . 59.7 mt -73.59 119.31 20.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.384 -0.969 . . . . 75.43 108.384 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.46 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 9.5 mm100 -85.34 -41.77 15.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.693 -0.685 . . . . 75.24 109.219 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -174.67 144.27 0.83 Allowed 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.251 0.345 . . . . 64.42 111.164 -167.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.469 HD11 HG21 ' D' ' 13' ' ' ILE . 4.1 mp -120.66 142.39 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.112 -1.44 . . . . 72.11 107.112 170.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -164.87 160.44 19.4 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.405 0.682 . . . . 75.54 111.121 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.8 p -93.15 116.48 29.07 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.325 -0.621 . . . . 72.13 109.325 173.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -85.38 -19.88 30.73 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.965 0.506 . . . . 75.42 110.105 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.1 t70 -160.31 140.03 11.15 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.782 0.833 . . . . 75.15 109.261 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.547 HG21 ' HE2' ' C' ' 117' ' ' MET . 98.6 mt -137.95 142.86 34.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.859 1.263 . . . . 74.21 107.701 175.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -141.6 136.23 30.81 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.957 0.903 . . . . 75.43 108.807 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.505 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 82.4 t80 -143.53 124.87 14.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.587 -1.634 . . . . 64.12 106.587 168.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 27.0 mt-10 -135.13 118.02 16.25 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.612 -0.884 . . . . 63.45 108.612 -173.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.59 82.39 9.97 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.729 -1.212 . . . . 65.23 107.729 174.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.47 -33.74 10.45 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.681 2.254 . . . . 64.13 113.183 -170.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -103.52 11.06 36.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.542 0.737 . . . . 65.53 110.666 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.441 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -30.66 -70.57 0.09 OUTLIER Pre-proline 0 CA--C 1.565 1.521 0 N-CA-C 116.276 1.954 . . . . 55.11 116.276 -160.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.46 -15.42 19.77 Favored 'Trans proline' 0 C--N 1.375 1.946 0 CA-C-N 123.55 2.304 . . . . 72.12 113.829 -173.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -79.79 -41.1 27.21 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.485 1.114 . . . . 52.34 110.044 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.5 p -79.96 -23.46 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 116.235 -0.439 . . . . 72.25 111.34 -173.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -63.19 -19.81 64.85 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.127 0.417 . . . . 72.33 112.127 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -61.47 -17.1 52.94 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.877 0.871 . . . . 75.32 111.947 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.419 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 37.6 mtmt -99.83 110.75 23.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.772 0.829 . . . . 61.5 111.09 174.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.49 93.85 9.47 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.576 -0.738 . . . . 62.13 109.722 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -157.39 157.07 33.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.432 1.093 . . . . 64.35 108.235 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -76.44 106.38 3.24 Favored Pre-proline 0 N--CA 1.477 0.908 0 N-CA-C 107.374 -1.343 . . . . 71.32 107.374 171.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.58 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 24.5 Cg_exo -63.21 137.31 60.5 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.796 2.331 . . . . 74.22 112.452 -167.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 7.4 mm-40 -56.93 109.72 0.69 Allowed 'General case' 0 C--N 1.361 1.075 0 O-C-N 124.082 0.864 . . . . 73.41 109.692 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.609 HG23 HG13 ' D' ' 64' ' ' VAL . 2.1 p -99.63 111.71 29.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 115.198 -0.91 . . . . 53.15 110.586 -171.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -86.49 111.86 20.97 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.366 -1.346 . . . . 72.21 107.366 169.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -95.79 151.86 19.0 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 108.961 -0.755 . . . . 73.44 108.961 173.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -151.44 154.12 35.99 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.438 -0.949 . . . . 70.0 108.438 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 89.6 mt -131.14 144.04 51.09 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.725 0.81 . . . . 72.4 109.711 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.672 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.8 t70 -141.41 125.48 17.29 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.61 1.164 . . . . 64.43 108.234 175.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -104.66 145.38 30.42 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 109.215 -0.661 . . . . 71.15 109.215 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.99 142.69 24.61 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.158 -1.053 . . . . 74.44 108.158 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 47.6 p -141.94 159.92 41.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.602 0.637 . . . . 65.32 111.35 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -163.39 125.91 2.59 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.893 0.877 . . . . 64.53 109.668 -173.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -74.99 121.87 22.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.576 -0.528 . . . . 72.55 109.576 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' D' ' 57' ' ' GLU . 55.9 mt -96.36 -29.65 13.84 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.139 0.576 . . . . 74.14 111.283 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.21 -173.01 3.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.391 0.677 . . . . 41.0 110.45 -177.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.89 120.84 18.06 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.968 -1.014 . . . . 75.44 110.762 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 65.05 3.74 2.26 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.487 1.115 . . . . 74.21 112.005 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 51.5 t -117.0 124.2 72.73 Favored 'Isoleucine or valine' 0 C--N 1.349 0.575 0 C-N-CA 123.369 0.668 . . . . 64.51 109.572 -173.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -120.81 173.13 7.41 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.957 1.303 . . . . 74.2 109.99 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.538 ' HB2' HD11 ' D' ' 51' ' ' LEU . 33.4 tt0 -131.3 133.84 45.77 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.733 -1.576 . . . . 61.41 107.008 168.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.6 t -120.63 141.77 39.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.004 -1.11 . . . . 64.13 108.004 168.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 39.8 t -120.77 131.32 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.718 -1.216 . . . . 65.05 107.718 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.419 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -115.16 119.75 37.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.464 -0.939 . . . . 72.2 108.464 178.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.672 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.2 ttm180 -104.77 102.37 11.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.129 -1.063 . . . . 72.32 108.129 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.2 t -94.48 102.51 13.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.693 -1.225 . . . . 72.45 107.693 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 28.4 m -100.32 140.0 35.2 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.544 -0.753 . . . . 74.54 109.588 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.76 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 52.0 t -132.35 133.68 59.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.628 1.571 . . . . 54.43 108.6 -172.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.0 m -134.66 100.77 4.72 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.117 -1.068 . . . . 51.41 108.117 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -104.2 153.14 21.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.644 0.778 . . . . 62.24 110.868 -176.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 65.1 p -146.08 137.96 25.06 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.29 0.567 . . . . 70.13 111.909 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.509 HD12 HG22 ' D' ' 31' ' ' VAL . 53.3 mt -105.69 125.7 51.29 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.586 1.154 . . . . 72.21 108.131 170.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.03 -113.29 5.5 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.454 0.471 . . . . 75.23 112.728 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.96 5.32 13.94 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.346 0.659 . . . . 75.24 110.706 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.419 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 12.4 pt-20 -127.11 159.9 32.81 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.151 0.58 . . . . 73.22 110.276 -174.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -68.92 130.72 43.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.598 0.759 . . . . 61.15 111.95 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.525 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.99 -77.46 0.3 Allowed 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.82 -0.807 . . . . 74.32 108.82 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -141.33 147.57 38.32 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 121.227 0.537 . . . . 72.45 110.859 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 55.8 mt -117.85 140.03 50.27 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.805 -1.183 . . . . 61.15 107.805 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.76 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 33.0 m -141.21 144.7 34.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.118 0.967 . . . . 70.43 109.035 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -156.94 118.07 3.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.16 -1.052 . . . . 74.01 108.16 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.83 113.05 25.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 109.361 -0.607 . . . . 73.11 109.361 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -89.73 85.88 6.54 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.649 -0.871 . . . . 74.23 108.649 172.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -79.09 94.66 5.38 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.618 -1.174 . . . . 73.42 108.509 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.83 145.95 21.12 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.781 -0.528 . . . . 55.03 111.781 177.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.474 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -145.67 131.41 4.15 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.445 -0.662 . . . . 52.54 111.445 -176.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 43.6 mt -89.0 128.73 40.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 N-CA-C 108.248 -1.019 . . . . 73.42 108.248 176.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -135.08 123.9 23.91 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.175 0.59 . . . . 73.4 110.1 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 57.8 m -74.19 108.46 7.0 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.081 -0.711 . . . . 53.25 109.081 166.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.54 HD13 HD23 ' D' ' 98' ' ' LEU . 45.1 pt -105.22 138.29 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.355 0.662 . . . . 71.11 109.271 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -167.76 170.43 10.86 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.377 1.071 . . . . 73.23 108.934 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.19 -15.1 29.93 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-O 119.899 -0.39 . . . . 63.32 112.718 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.401 HD11 ' HB ' ' D' ' 86' ' ' ILE . 1.5 pp -128.49 134.97 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.401 1.08 . . . . 72.42 109.631 -174.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -132.42 158.36 42.21 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.851 0.861 . . . . 73.43 109.726 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.08 -127.05 39.87 Favored Glycine 0 C--N 1.355 1.587 0 O-C-N 124.366 1.041 . . . . 41.12 114.426 172.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 75.1 p -63.17 -39.86 95.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.699 0.8 . . . . 73.31 111.257 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -73.76 -27.11 60.99 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.578 -0.737 . . . . 71.12 111.623 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 18.3 tmm? -70.93 -44.72 65.54 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 109.516 -0.549 . . . . 70.5 109.516 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.04 -25.04 66.63 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.519 0.728 . . . . 44.24 111.462 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.2 t-160 -78.67 -38.51 39.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.785 0.834 . . . . 71.1 110.713 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -73.69 -27.29 61.14 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.258 0.623 . . . . 63.43 111.506 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.54 HD23 HD13 ' D' ' 86' ' ' ILE . 2.3 tm? -100.1 -54.01 2.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.311 1.044 . . . . 72.31 109.819 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.9 14.42 58.72 Favored Glycine 0 N--CA 1.472 1.065 0 CA-C-O 119.557 -0.579 . . . . 52.2 114.433 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.508 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -149.74 -55.44 0.17 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.574 0.687 . . . . 75.41 112.016 -178.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -72.6 -37.85 68.0 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 112.233 0.457 . . . . 74.13 112.233 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.545 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 96.6 m -61.94 -46.93 92.28 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 118.687 -0.673 . . . . 64.54 112.392 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.419 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 82.4 Cg_exo -52.06 -35.29 61.13 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.285 1.99 . . . . 74.41 114.325 167.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -68.67 -25.34 64.76 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 122.909 0.484 . . . . 60.43 112.079 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.474 HD12 HD11 ' D' ' 13' ' ' ILE . 23.8 mm -73.01 -40.05 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.706 0.765 . . . . 70.41 109.813 171.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.474 HD21 ' HA3' ' D' ' 82' ' ' GLY . 91.8 mt -77.27 -26.8 52.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.776 -1.102 . . . . 64.53 112.839 -173.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -62.83 -43.5 83.08 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 113.725 1.009 . . . . 72.33 113.725 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.42 -45.87 34.86 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.051 1.834 . . . . 74.31 113.949 171.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -72.26 -37.15 69.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.584 0.754 . . . . 73.0 111.342 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.41 90.2 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.906 0.882 . . . . 72.42 110.43 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.476 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 29.4 ttp180 -55.22 -52.71 62.48 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 114.523 -1.217 . . . . 75.22 110.181 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -60.16 -43.41 95.79 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.295 0.997 . . . . 73.34 111.629 -174.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.2 t -59.41 -43.97 92.93 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.512 0.508 . . . . 73.31 110.771 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.473 HG23 ' SG ' ' D' ' 76' ' ' CYS . 80.6 mt -64.8 -49.68 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.918 0.887 . . . . 74.22 110.987 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 23.2 m -56.31 -40.82 74.99 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.414 1.086 . . . . 61.15 111.192 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 14.4 t -66.59 -44.24 82.71 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 114.447 -1.251 . . . . 64.32 110.045 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.505 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.1 mtm -67.87 -32.01 72.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.904 0.482 . . . . 73.43 111.82 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' D' ' 114' ' ' ILE . 61.9 t -67.65 -42.7 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.681 0.793 . . . . 72.44 110.216 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.2 p -74.87 -29.95 61.17 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.829 0.451 . . . . 75.13 111.181 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -72.3 -36.73 69.02 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.622 0.769 . . . . 52.25 109.893 174.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.96 2.7 79.65 Favored Glycine 0 C--N 1.356 1.657 0 O-C-N 123.696 0.622 . . . . 74.24 112.427 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.3 p 62.28 23.26 13.75 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.819 2.048 . . . . 73.22 113.964 171.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.54 155.85 65.62 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 109.029 -0.73 . . . . 70.35 109.029 167.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.413 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 27.8 Cg_endo -60.79 142.24 97.15 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 122.39 2.06 . . . . 64.1 111.405 176.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -51.6 147.67 6.14 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.256 1.422 . . . . 72.2 113.669 -167.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.431 HD11 HG21 ' D' ' 40' ' ' VAL . 23.2 tp -122.61 98.82 6.09 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.003 0.521 . . . . 74.11 110.477 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -101.73 92.18 4.73 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.696 0.798 . . . . 71.24 109.849 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.476 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -64.38 118.52 8.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.453 0.701 . . . . 61.42 110.397 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -60.57 132.9 91.26 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 123.466 0.707 . . . . 70.11 111.021 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 4.7 Cg_exo -73.09 117.59 5.18 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.795 2.33 . . . . 71.43 111.287 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.61 145.36 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.016 0.526 . . . . 71.22 110.926 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -89.27 97.9 11.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.019 0.928 . . . . 51.05 109.946 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . 0.504 ' HA ' HD12 ' D' ' 136' ' ' LEU . 7.5 t80 -76.19 -16.97 59.74 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.263 0.625 . . . . 65.32 111.183 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . 0.508 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 13.1 m-20 -62.65 -49.23 75.96 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.325 0.65 . . . . 74.11 110.924 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.92 -45.87 89.29 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.643 0.59 . . . . 72.02 110.597 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' D' ' 133' ' ' PHE . 82.4 mt -58.56 -42.18 87.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.629 -1.169 . . . . 74.54 111.925 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 85.1 t80 . . . . . 0 N--CA 1.475 0.819 0 C-N-CA 123.649 0.78 . . . . 71.13 110.973 -178.227 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.466 0.373 0 N-CA-C 108.13 -1.063 . . . . 62.43 108.13 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.633 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.6 t80 -138.48 129.88 27.45 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.826 0.346 . . . . 71.4 110.472 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -153.23 108.64 3.24 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 107.811 -1.181 . . . . 75.24 107.811 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.427 HG12 ' HD2' ' A' ' 84' ' ' PHE . 52.8 mt -74.51 116.32 16.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.815 -0.439 . . . . 74.43 109.815 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -74.13 -42.11 60.52 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.072 0.858 . . . . 74.23 110.781 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -178.31 121.39 0.1 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.162 0.289 . . . . 70.34 110.734 -169.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 82.4 mt -106.96 129.56 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.717 0.807 . . . . 75.32 108.878 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.423 ' HB3' HG23 ' B' ' 122' ' ' THR . 34.0 p90 -163.06 148.39 11.7 Favored 'General case' 0 C--N 1.346 0.418 0 O-C-N 123.646 0.591 . . . . 74.21 111.653 -174.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.1 p -75.02 112.39 11.2 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.863 -0.608 . . . . 60.35 109.406 175.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 35.7 mtpt -80.79 -23.78 39.03 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.421 -0.354 . . . . 71.52 110.192 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.2 t70 -153.24 142.08 21.11 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.964 0.906 . . . . 75.51 110.393 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.6 mt -135.03 141.73 42.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 125.64 1.576 . . . . 72.12 107.574 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.7 t -145.72 112.42 5.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.141 0.576 . . . . 65.01 110.026 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 87.5 t80 -125.83 119.92 29.15 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.3 -1.0 . . . . 72.54 108.3 174.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -118.42 136.2 53.91 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.927 -0.768 . . . . 61.31 108.927 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.726 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -148.67 78.78 8.97 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 107.813 -1.18 . . . . 74.31 107.813 170.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.35 -29.93 5.76 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.698 2.265 . . . . 75.43 111.253 175.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -102.7 23.55 11.88 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.943 1.297 . . . . 73.55 109.909 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.726 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -58.82 -45.06 99.64 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 125.26 1.424 . . . . 75.01 112.327 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -64.81 -34.11 50.82 Favored 'Trans proline' 0 C--N 1.399 3.217 0 CA-C-N 120.995 1.391 . . . . 70.42 112.713 172.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.422 ' HA ' ' OE1' ' A' ' 33' ' ' GLN . 30.4 m170 -68.76 -16.23 63.74 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.527 0.731 . . . . 75.2 112.616 -171.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 28' ' ' ALA . 9.3 p -72.73 -19.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 122.438 0.295 . . . . 73.22 110.665 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -78.5 -29.03 46.41 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 108.412 -0.959 . . . . 53.12 108.412 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.422 ' OE1' ' HA ' ' A' ' 30' ' ' HIS . 1.0 OUTLIER -80.95 -54.78 5.27 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.931 -1.031 . . . . 63.31 110.737 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 30' ' ' HIS . 54.5 mtmt -84.78 171.43 12.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.093 0.957 . . . . 62.24 112.577 -173.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.29 153.2 21.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.848 0.859 . . . . 64.44 109.819 172.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -85.2 94.05 8.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.42 0.688 . . . . 62.24 110.756 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -127.37 83.56 65.71 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.175 0.99 . . . . 74.21 108.868 172.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -86.54 149.75 8.84 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.61 2.207 . . . . 73.23 112.72 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -99.09 91.66 5.11 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.613 -1.254 . . . . 54.4 107.613 168.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -66.34 99.06 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 CA-C-O 121.701 0.762 . . . . 65.1 110.388 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -108.16 113.35 26.42 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.531 -0.914 . . . . 54.25 108.531 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -107.06 145.23 32.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.54 0.736 . . . . 63.44 109.059 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -139.42 133.21 30.69 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.498 1.119 . . . . 54.53 108.484 174.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -119.48 123.15 43.32 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 109.059 -0.719 . . . . 73.13 109.059 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 24.3 m-20 -119.81 121.7 39.71 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.764 -0.828 . . . . 60.44 108.764 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.4 m -106.95 122.87 47.28 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.767 -0.827 . . . . 74.43 108.767 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.68 151.33 49.15 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.945 0.898 . . . . 41.24 108.66 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.5 m -132.8 155.87 48.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.178 -0.675 . . . . 75.23 109.178 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -148.03 128.96 14.41 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.78 0.432 . . . . 74.3 110.378 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -73.7 107.7 6.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.91 0.884 . . . . 72.42 109.839 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.1 mt -78.37 -41.26 33.88 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.751 -0.659 . . . . 70.12 109.512 175.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.65 -179.18 7.86 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.647 1.179 . . . . 53.23 108.752 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -61.98 113.26 2.71 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.672 0.389 . . . . 70.3 110.243 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 68.39 12.23 8.65 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.89 1.276 . . . . 64.12 112.28 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.48 110.7 33.16 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 N-CA-C 107.485 -1.302 . . . . 72.22 107.485 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -126.24 152.88 45.51 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.812 -0.81 . . . . 75.01 108.812 -174.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -117.84 153.58 33.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.658 -0.867 . . . . 73.42 108.658 167.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.5 t -117.98 125.24 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.24 -1.392 . . . . 75.05 107.24 167.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.86 107.61 22.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 124.099 0.96 . . . . 61.23 108.681 174.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.7 tp -99.78 101.85 13.13 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.871 -0.788 . . . . 74.03 108.871 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 14.4 ttm180 -84.42 102.75 13.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.187 -0.672 . . . . 64.32 109.187 175.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.8 t -95.32 102.33 13.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.279 -1.008 . . . . 74.15 108.279 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.4 m -98.25 119.46 36.95 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.047 0.939 . . . . 72.03 110.322 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.535 ' O ' HD12 ' A' ' 75' ' ' LEU . 97.9 t -115.51 123.84 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.926 0.89 . . . . 62.12 108.874 175.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 t -132.2 126.63 34.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.516 -0.92 . . . . 52.12 108.516 169.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -124.13 107.13 10.93 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.633 -0.877 . . . . 71.05 108.633 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.6 p -113.85 143.02 45.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.653 0.781 . . . . 40.12 111.021 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 68' ' ' LEU . 1.3 pt? -110.61 85.87 2.2 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.103 -1.073 . . . . 62.32 108.103 171.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.89 -125.57 8.03 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 114.66 -1.155 . . . . 71.54 110.932 -173.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -87.72 -26.87 22.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.593 0.697 . . . . 63.02 109.621 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -76.23 118.97 19.5 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 123.006 0.522 . . . . 53.23 110.779 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.7 m -77.19 132.42 38.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.192 -0.67 . . . . 63.24 109.192 171.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.03 -57.08 3.99 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.616 -0.883 . . . . 61.03 108.616 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.406 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 47.8 p90 -149.39 152.59 36.02 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.88 -1.055 . . . . 73.41 111.223 175.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.535 HD12 ' O ' ' A' ' 64' ' ' VAL . 40.9 tp -114.3 135.19 54.35 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.147 -1.427 . . . . 63.51 107.147 166.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.406 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 76.1 m -135.96 98.1 3.8 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.481 -0.933 . . . . 72.23 108.481 170.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -125.11 116.04 21.43 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.717 1.207 . . . . 75.43 108.379 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.4 t -128.73 115.69 38.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.765 0.826 . . . . 61.02 109.466 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 72.0 mt-30 -85.51 84.98 7.46 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 107.973 -1.121 . . . . 75.13 107.973 170.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.456 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.4 tp-100 -76.47 99.58 4.96 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.715 -1.13 . . . . 71.32 108.186 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.86 155.79 29.37 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 110.683 -0.967 . . . . 73.22 110.683 176.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.34 120.63 0.98 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.351 -1.1 . . . . 35.41 110.351 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.9 mt -81.5 122.22 36.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.109 -1.071 . . . . 71.04 108.109 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.633 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 43.8 m-85 -123.46 118.15 26.78 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.834 -1.173 . . . . 74.22 107.834 -176.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.0 t -84.69 104.0 14.28 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.52 -1.289 . . . . 64.23 107.52 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.85 139.97 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 116.118 -0.492 . . . . 63.41 110.874 -170.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.82 176.05 13.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.357 1.063 . . . . 52.13 110.239 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.02 -7.11 62.41 Favored Glycine 0 N--CA 1.475 1.235 0 N-CA-C 114.961 0.744 . . . . 71.23 114.961 172.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.574 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -138.75 158.21 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 117.885 0.843 . . . . 73.42 110.859 -177.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.37 174.48 14.8 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.965 0.506 . . . . 75.25 109.989 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.34 -127.52 26.72 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 114.528 0.571 . . . . 72.04 114.528 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.5 p -68.78 -20.89 64.36 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.196 0.598 . . . . 72.03 111.234 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -75.9 -42.99 47.41 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.659 0.784 . . . . 71.35 109.893 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -72.97 -27.94 62.11 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 110.038 -0.356 . . . . 72.53 110.038 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.12 -27.71 65.81 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 115.803 -0.635 . . . . 72.02 110.269 173.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -78.31 -30.14 48.12 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.218 0.607 . . . . 74.03 111.125 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.574 ' SG ' HG13 ' A' ' 89' ' ' ILE . 70.9 m -61.86 -46.59 88.8 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.875 -0.602 . . . . 62.52 111.09 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -81.26 -24.57 37.23 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.096 -0.502 . . . . 73.0 110.605 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.24 -33.21 49.84 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 114.772 0.669 . . . . 75.35 114.772 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.53 -45.75 0.17 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.379 0.589 . . . . 71.03 112.091 -169.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 55.1 t80 -62.54 -64.47 0.91 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.512 1.125 . . . . 72.45 112.035 -168.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 92.7 m -78.6 -33.61 0.93 Allowed Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.428 1.27 . . . . 73.53 114.428 -174.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 35.4 Cg_endo -64.18 -30.77 64.91 Favored 'Trans proline' 0 C--N 1.394 2.959 0 CA-C-N 122.23 1.832 . . . . 73.11 112.841 171.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -69.29 -26.57 64.81 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.677 0.391 . . . . 71.42 110.882 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.61 -40.9 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 64.12 110.125 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.456 HD22 ' HG3' ' A' ' 80' ' ' GLN . 79.7 mt -80.6 -21.82 41.22 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.067 0.947 . . . . 71.15 112.613 -174.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -63.57 -44.27 80.58 Favored Pre-proline 0 CA--C 1.567 1.605 0 CA-C-O 117.64 -1.171 . . . . 74.54 113.229 -172.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.4 -34.48 76.55 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.112 1.874 . . . . 62.22 113.474 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -72.97 -41.25 64.58 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.211 0.605 . . . . 74.44 111.329 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.45 -38.2 74.47 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.994 0.518 . . . . 71.35 110.182 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.559 ' HA ' HD23 ' A' ' 128' ' ' LEU . 29.7 ttm180 -54.44 -51.15 65.86 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.203 1.001 . . . . 72.43 109.888 174.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.63 -48.39 77.49 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.485 1.116 . . . . 75.25 111.361 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.413 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.1 t -55.91 -44.58 78.41 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.047 0.842 . . . . 34.45 110.538 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 118' ' ' VAL . 74.5 mt -65.22 -50.5 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.526 1.13 . . . . 71.24 110.747 176.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.492 HG23 ' HG3' ' A' ' 125' ' ' GLN . 95.0 m -53.17 -46.07 68.77 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.835 0.854 . . . . 75.22 110.322 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -65.13 -46.23 81.84 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.922 -1.49 . . . . 65.1 109.527 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 37.5 mtp -59.43 -41.18 88.96 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.696 0.798 . . . . 64.54 111.865 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 114' ' ' ILE . 93.4 t -62.94 -45.61 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.912 0.885 . . . . 50.45 110.236 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.3 m -72.58 -27.45 62.19 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.447 -0.797 . . . . 32.31 111.831 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.605 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.9 mtt-85 -75.12 -31.72 61.18 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.492 0.717 . . . . 73.12 109.723 175.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.13 -0.7 86.62 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.58 -0.736 . . . . 64.11 112.878 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m 69.53 20.12 7.24 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.763 1.225 . . . . 54.34 111.047 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -89.67 146.87 36.44 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 123.45 0.7 . . . . 75.11 109.657 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.64 133.09 31.98 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.52 2.813 . . . . 71.24 113.517 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.492 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.6 tt0 -54.93 137.44 45.71 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.238 1.015 . . . . 63.22 113.24 -170.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.439 ' CD2' HG11 ' A' ' 64' ' ' VAL . 27.7 tp -119.82 102.4 8.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.859 1.264 . . . . 64.13 109.349 177.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -99.34 114.65 27.64 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.213 -1.403 . . . . 64.04 107.213 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 111' ' ' ARG . 3.7 mm? -62.53 132.9 54.0 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.099 0.559 . . . . 64.11 110.476 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.8 146.01 91.47 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.213 0.605 . . . . 62.54 110.776 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.562 ' HG3' ' HD2' ' C' ' 11' ' ' PHE . 34.2 Cg_endo -60.74 112.16 1.26 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.382 2.054 . . . . 64.13 111.323 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 80.6 t -99.92 113.91 36.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 108.473 -0.936 . . . . 50.31 108.473 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -78.79 85.95 4.75 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 108.767 -0.827 . . . . 74.42 108.767 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -64.02 -27.82 69.38 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.649 -0.705 . . . . 74.01 111.144 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.07 -48.45 76.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.801 0.84 . . . . 62.43 110.224 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.43 -57.01 12.8 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.003 -0.999 . . . . 65.33 110.463 175.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.2 mt -58.05 -36.73 73.19 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.562 1.145 . . . . 74.13 112.812 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -61.62 -50.81 71.08 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.772 0.67 . . . . 61.3 110.381 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 95.2 mmm . . . . . 0 CA--C 1.551 0.987 0 CA-C-N 115.909 -0.587 . . . . 62.2 110.612 -174.348 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 66.2 m . . . . . 0 C--O 1.239 0.537 0 N-CA-C 108.932 -0.766 . . . . 74.24 108.932 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -136.11 137.35 40.94 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.712 -0.847 . . . . 64.34 108.712 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -148.5 140.8 24.16 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.562 0.745 . . . . 72.44 109.258 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.5 mt -90.32 113.55 26.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.434 -1.321 . . . . 73.24 107.434 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -76.22 -43.57 41.63 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.446 -0.576 . . . . 64.23 109.446 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -164.78 139.63 5.36 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.719 -0.673 . . . . 73.42 110.071 -175.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 88.2 mt -115.7 144.12 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 106.212 -1.773 . . . . 70.34 106.212 168.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.522 ' HE1' HG13 ' B' ' 83' ' ' ILE . 32.5 p90 -170.08 149.36 3.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.449 0.642 . . . . 75.11 111.648 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -77.81 125.71 29.76 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.872 -1.058 . . . . 64.52 109.347 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.451 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.3 mtpt -99.4 -21.51 15.96 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.872 0.869 . . . . 72.52 111.57 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -160.78 133.41 6.25 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.495 0.318 . . . . 64.0 110.441 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 40.8 mm -126.33 137.91 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.273 -1.01 . . . . 73.3 108.273 168.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 37.2 t -139.48 134.21 31.98 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.746 -1.205 . . . . 72.11 107.746 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -150.32 109.48 3.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.895 -1.15 . . . . 63.14 107.895 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -119.71 115.0 23.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.278 1.031 . . . . 74.02 108.895 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.45 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -109.39 86.64 4.44 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 108.486 -0.931 . . . . 60.15 108.486 172.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.41 -32.45 8.02 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.742 2.295 . . . . 73.15 113.011 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -104.2 14.68 29.93 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.713 0.805 . . . . 50.34 110.403 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.49 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -38.39 -60.79 0.97 Allowed Pre-proline 0 CA--C 1.562 1.437 0 N-CA-C 114.758 1.392 . . . . 62.23 114.758 -165.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 20.4 Cg_exo -63.24 -35.28 64.2 Favored 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 122.101 1.867 . . . . 74.15 112.504 -175.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -78.84 -47.01 17.43 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.168 -0.923 . . . . 71.21 111.593 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.673 HG22 HD12 ' B' ' 68' ' ' LEU . 9.1 p -62.4 -22.4 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.583 0.753 . . . . 72.44 112.332 -167.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -63.34 -13.95 44.64 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.988 0.915 . . . . 73.12 112.993 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.542 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 25.6 pt20 -60.36 -33.14 72.01 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.422 1.089 . . . . 72.42 111.585 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.542 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.3 mttt -96.18 86.18 4.18 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.585 0.754 . . . . 74.0 108.993 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -74.22 97.36 2.95 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 115.806 -0.634 . . . . 71.12 110.902 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -163.43 157.3 19.69 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.32 1.448 . . . . 74.25 108.179 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.462 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 14.4 mt-30 -72.85 108.74 4.85 Favored Pre-proline 0 C--N 1.356 0.861 0 N-CA-C 107.827 -1.175 . . . . 74.04 107.827 169.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.412 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.0 Cg_endo -60.18 147.06 94.85 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.796 2.331 . . . . 64.44 113.702 -167.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 11.3 tp10 -53.31 109.33 0.42 Allowed 'General case' 0 N--CA 1.484 1.246 0 O-C-N 124.349 1.031 . . . . 75.14 110.42 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.87 131.03 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 O-C-N 123.7 0.625 . . . . 73.12 110.625 -172.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -121.23 121.75 38.45 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.597 -1.26 . . . . 63.41 107.597 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -106.05 124.88 50.28 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.763 -0.828 . . . . 73.52 108.763 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.515 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.5 m-20 -122.16 111.33 16.84 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.398 -1.705 . . . . 64.02 106.398 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 87.3 mt -101.38 127.21 48.13 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.157 -1.053 . . . . 75.34 108.157 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -140.02 136.5 33.77 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.384 -1.339 . . . . 53.24 107.384 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.5 p -128.96 115.85 18.46 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.827 -0.434 . . . . 54.25 109.827 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.7 134.82 54.65 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.443 -1.317 . . . . 72.22 107.443 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.0 m -138.89 162.88 33.74 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.316 0.507 . . . . 62.3 111.312 -172.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.0 p -157.8 143.3 17.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.744 0.818 . . . . 75.1 110.888 -172.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -83.4 135.21 34.78 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.711 0.804 . . . . 75.03 109.77 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 mt -99.26 -40.88 7.72 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.205 0.526 . . . . 75.34 109.891 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.85 -178.45 7.32 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.906 -1.043 . . . . 73.35 109.997 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -71.63 122.28 20.28 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.468 -0.787 . . . . 74.32 109.289 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 74.0 -4.76 2.19 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 125.765 1.626 . . . . 75.3 112.04 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.3 110.16 30.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.51 -0.922 . . . . 51.04 108.51 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -125.25 140.22 53.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.617 -0.883 . . . . 72.5 108.617 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -122.78 115.05 21.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.243 -1.021 . . . . 71.33 108.243 -171.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 83.5 t -99.37 141.98 15.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 123.815 0.846 . . . . 70.33 109.617 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.15 119.34 58.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 109.046 -0.724 . . . . 64.51 109.046 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.94 129.42 40.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.013 -1.476 . . . . 74.11 107.013 175.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -121.75 109.9 15.27 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.818 0.847 . . . . 64.14 109.04 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 56.0 t -104.76 102.81 14.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.257 -1.386 . . . . 74.34 107.257 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 24.4 m -97.86 126.06 43.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.886 -0.783 . . . . 74.31 108.886 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.604 HG21 HG21 ' B' ' 114' ' ' ILE . 70.2 t -116.31 121.9 68.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 124.792 1.237 . . . . 63.44 108.27 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 62.9 m -113.29 137.1 52.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.815 -0.809 . . . . 72.45 108.815 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -144.03 146.15 32.68 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 122.628 0.371 . . . . 71.21 110.602 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.52 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 76.0 p -150.32 140.63 22.28 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.656 0.598 . . . . 64.34 111.306 -174.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.673 HD12 HG22 ' B' ' 31' ' ' VAL . 76.5 mt -102.51 109.66 21.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.198 -1.038 . . . . 64.01 108.198 170.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.75 -131.61 37.22 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 116.001 -0.545 . . . . 74.15 112.389 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -95.92 14.7 22.65 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.477 0.547 . . . . 72.02 112.477 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.508 ' HG3' HG23 ' B' ' 31' ' ' VAL . 12.6 pt-20 -126.7 141.0 51.98 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.961 0.505 . . . . 73.45 109.915 178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 48.2 m -70.51 127.51 32.95 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 123.289 0.635 . . . . 71.3 111.233 -175.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.562 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -80.28 -67.36 0.77 Allowed 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.454 -0.943 . . . . 61.42 108.454 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.496 ' HZ ' HD13 ' B' ' 126' ' ' LEU . 51.5 p90 -150.25 155.37 39.58 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-O 121.619 0.723 . . . . 72.51 111.869 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 33.7 mt -122.86 109.52 14.27 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.124 -1.806 . . . . 64.44 106.124 172.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' B' ' 114' ' ' ILE . 37.6 t -120.75 115.39 23.22 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.449 -0.574 . . . . 72.23 109.449 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -121.36 123.84 43.09 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.645 -1.242 . . . . 64.11 107.645 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.51 143.42 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.667 -0.864 . . . . 54.02 108.667 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -124.66 100.65 6.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.312 -0.858 . . . . 53.0 108.813 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.454 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.7 tp-100 -90.25 105.81 18.06 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.224 -0.658 . . . . 72.43 109.224 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.451 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.13 164.74 26.17 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.799 -0.521 . . . . 63.43 111.799 175.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.67 128.3 1.92 Allowed Glycine 0 CA--C 1.52 0.365 0 CA-C-O 120.024 -0.32 . . . . 72.44 112.497 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.522 HG13 ' HE1' ' B' ' 17' ' ' TYR . 48.5 mt -84.37 123.83 39.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.966 -0.753 . . . . 71.05 108.966 172.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -133.12 136.55 45.88 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.015 . . . . 65.24 108.795 -175.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.9 m -103.51 108.57 19.89 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.346 0.659 . . . . 72.42 110.047 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.623 HD13 HD21 ' B' ' 98' ' ' LEU . 41.0 pt -100.11 132.03 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.251 1.02 . . . . 74.13 109.912 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.47 144.12 20.45 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 122.721 0.409 . . . . 55.31 110.057 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.75 -55.06 1.66 Allowed Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.808 -0.633 . . . . 74.31 112.164 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.457 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -72.57 155.06 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 75.45 111.255 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.27 167.37 28.85 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.127 -0.942 . . . . 73.11 109.502 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.07 -121.74 27.13 Favored Glycine 0 C--N 1.346 1.09 0 O-C-N 124.103 0.877 . . . . 70.33 114.589 172.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 89.8 m -71.89 -35.05 69.63 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.399 1.079 . . . . 70.35 111.784 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -70.51 -31.88 69.14 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 120.986 0.422 . . . . 54.34 110.373 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 49.3 ttp -74.08 -34.22 63.91 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.637 -0.71 . . . . 63.4 110.382 173.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.93 93.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.198 0.599 . . . . 52.32 110.25 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -64.17 -25.36 68.05 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.578 1.151 . . . . 71.34 111.39 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -78.83 -59.2 2.88 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.993 0.517 . . . . 44.35 110.282 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.623 HD21 HD13 ' B' ' 86' ' ' ILE . 66.3 mt -72.63 -40.53 66.35 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.856 0.688 . . . . 72.52 112.856 -167.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.32 3.97 61.98 Favored Glycine 0 N--CA 1.469 0.859 0 CA-C-O 119.728 -0.484 . . . . 64.4 114.073 -173.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.608 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -143.37 -69.65 0.33 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.33 0.565 . . . . 62.21 111.386 -175.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.34 -43.49 96.42 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.702 1.201 . . . . 62.33 112.049 -172.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.423 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 94.4 m -66.39 -50.43 48.28 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 124.206 1.003 . . . . 74.31 111.562 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 78.1 Cg_exo -55.18 -35.17 90.27 Favored 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.187 1.925 . . . . 71.43 113.995 169.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.403 HD21 ' N ' ' B' ' 134' ' ' ASP . 63.4 m-80 -63.27 -33.59 75.84 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 118.159 0.436 . . . . 74.44 111.825 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 77.4 mt -66.06 -40.94 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.362 0.665 . . . . 74.05 110.408 175.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.7 mt -82.61 -20.82 35.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.192 0.997 . . . . 72.02 112.851 -172.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.2 -47.98 97.24 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-O 117.864 -1.065 . . . . 75.04 113.822 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.36 -32.78 89.7 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 121.993 1.796 . . . . 73.4 113.166 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.454 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 91.7 m-85 -70.37 -48.96 53.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.842 0.457 . . . . 72.21 110.133 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.62 -43.35 72.15 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.95 0.9 . . . . 71.11 110.251 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.545 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 35.9 ttt-85 -59.97 -55.03 39.1 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.322 1.449 . . . . 73.32 111.824 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.56 -33.81 76.78 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.766 0.827 . . . . 72.31 110.065 -175.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.605 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.1 t -72.16 -43.3 64.83 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.8 -0.636 . . . . 75.12 111.355 -176.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.604 HG21 HG21 ' B' ' 64' ' ' VAL . 99.1 mt -60.0 -53.59 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 109.819 -0.437 . . . . 72.1 109.819 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 86.8 m -59.32 -32.82 70.42 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 124.084 0.865 . . . . 74.12 111.41 -176.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.3 t -61.98 -47.42 84.89 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.297 0.639 . . . . 50.11 109.674 174.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.8 mmt -69.24 -34.42 74.77 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.17 0.588 . . . . 74.23 111.368 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 114' ' ' ILE . 92.4 t -60.83 -43.15 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.148 0.979 . . . . 71.03 109.924 174.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.0 t -68.22 -33.77 75.02 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.634 -1.166 . . . . 72.42 111.471 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.1 mtt-85 -66.95 -35.93 81.09 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.518 0.727 . . . . 71.41 110.152 177.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.09 9.51 60.44 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-O 119.483 -0.62 . . . . 61.24 113.361 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 17' ' ' TYR . 70.4 p 57.06 22.14 7.07 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 126.158 1.783 . . . . 74.01 113.72 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -78.79 149.26 73.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.796 -0.446 . . . . 61.14 109.796 175.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.462 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 28.7 Cg_endo -59.57 171.57 2.56 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.306 2.67 . . . . 63.12 113.672 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.429 ' NE2' HD21 ' B' ' 127' ' ' ASN . 51.9 tp60 -62.91 114.77 3.85 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.038 -0.983 . . . . 63.43 111.88 -167.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.496 HD13 ' HZ ' ' B' ' 74' ' ' PHE . 8.6 tt -135.78 106.64 6.62 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.961 -0.755 . . . . 61.02 108.961 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.429 HD21 ' NE2' ' B' ' 125' ' ' GLN . 12.9 m120 -114.26 135.14 54.39 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.847 0.859 . . . . 75.12 109.843 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.545 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.5 mm? -72.24 124.73 25.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.198 -0.667 . . . . 74.35 109.198 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.72 152.25 89.21 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.296 0.639 . . . . 73.42 110.962 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.17 110.1 1.28 Allowed 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 122.402 2.068 . . . . 61.33 112.947 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 31.2 t -100.71 111.0 29.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.106 -1.072 . . . . 72.24 108.106 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . 0.409 ' O ' HD13 ' B' ' 136' ' ' LEU . 43.6 t-20 -85.05 90.29 7.81 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.459 -0.941 . . . . 63.12 108.459 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -57.04 -31.53 65.27 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.45 0.7 . . . . 74.31 111.321 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . 0.608 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 11.7 t70 -73.11 -44.92 59.68 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.259 1.024 . . . . 72.31 111.054 -173.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.53 -39.0 93.27 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.075 0.95 . . . . 44.13 111.48 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . 0.409 HD13 ' O ' ' B' ' 132' ' ' ASN . 8.5 mp -75.1 -33.54 61.63 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.105 -0.952 . . . . 62.23 110.866 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 69.3 t80 . . . . . 0 N--CA 1.48 1.031 0 C-N-CA 124.05 0.94 . . . . 53.25 111.645 -177.248 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 51.6 m . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 108.062 -1.088 . . . . 62.23 108.062 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.562 ' HD2' ' HG3' ' A' ' 130' ' ' PRO . 64.4 t80 -107.81 122.95 47.81 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.354 -0.98 . . . . 72.21 108.354 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -139.1 117.85 12.3 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.382 0.673 . . . . 74.33 109.644 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.2 mt -73.22 127.11 34.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 108.856 -0.794 . . . . 53.1 108.856 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.599 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.3 mm-40 -94.0 -46.22 7.24 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.466 -0.568 . . . . 72.03 109.466 173.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -170.97 141.32 1.69 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.602 -0.726 . . . . 75.34 109.418 -167.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.0 mt -136.13 130.25 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.295 -1.372 . . . . 72.14 107.295 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -166.34 157.81 13.34 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.154 0.502 . . . . 73.12 110.611 -164.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.8 p -88.56 117.29 27.41 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.45 -0.796 . . . . 74.3 109.047 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -86.88 -37.6 17.54 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.144 0.497 . . . . 71.24 109.893 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -138.35 127.72 24.59 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.13 -0.941 . . . . 75.44 109.137 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.5 mt -129.8 139.5 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.398 -1.334 . . . . 72.13 107.398 175.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -147.71 145.38 28.85 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.529 0.731 . . . . 74.01 109.678 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -143.12 134.44 26.05 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.469 -1.308 . . . . 74.02 107.469 168.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.4 mt-10 -129.11 126.98 40.53 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 124.326 1.05 . . . . 73.15 108.421 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.76 81.04 23.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 106.664 -1.606 . . . . 70.44 106.664 169.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -64.29 -31.58 62.96 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.966 2.444 . . . . 75.25 112.233 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -105.7 19.28 20.81 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.232 -0.895 . . . . 63.4 111.215 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.419 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -41.28 -62.15 1.14 Allowed Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 117.598 -1.191 . . . . 74.32 114.199 -167.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.0 -44.1 26.52 Favored 'Trans proline' 0 C--N 1.391 2.788 0 CA-C-N 121.977 1.742 . . . . 71.34 111.628 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -68.81 -31.71 70.91 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.016 0.926 . . . . 61.14 112.514 -174.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.709 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.5 p -80.5 -16.59 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 C-N-CA 122.731 0.413 . . . . 73.11 111.322 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -75.39 -22.55 57.39 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.563 0.345 . . . . 75.43 111.683 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -95.74 4.49 52.9 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.452 0.301 . . . . 62.31 111.113 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -91.5 151.64 20.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.444 0.697 . . . . 74.44 110.337 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -56.87 124.33 18.19 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 124.092 0.87 . . . . 51.02 110.303 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.9 t90 -84.58 93.39 8.35 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.784 -0.644 . . . . 62.43 110.273 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -145.24 76.98 13.12 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.182 -1.044 . . . . 50.24 108.182 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.8 128.88 6.09 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.687 2.258 . . . . 75.14 112.867 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -85.28 109.43 18.35 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.072 -1.455 . . . . 71.34 107.072 161.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 m -96.48 113.27 30.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.045 0.938 . . . . 75.13 110.571 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -119.65 112.41 19.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.892 1.277 . . . . 73.53 108.186 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.06 168.62 12.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.424 0.69 . . . . 63.13 111.632 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 29.5 t70 -145.5 105.52 4.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.19 0.596 . . . . 72.14 109.976 173.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.42 130.36 55.5 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.576 1.15 . . . . 73.13 109.38 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -156.49 153.88 29.48 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.461 0.705 . . . . 74.33 109.946 171.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -129.81 152.46 49.27 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.947 0.899 . . . . 70.41 110.239 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.7 167.43 22.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.257 1.023 . . . . 71.22 108.84 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.468 ' HB3' HG22 ' C' ' 58' ' ' VAL . 93.1 p -148.15 152.75 37.81 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.046 0.538 . . . . 65.51 109.912 174.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 27.4 p -143.87 135.05 25.67 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.493 0.717 . . . . 62.53 109.545 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -64.91 116.25 6.18 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.941 0.775 . . . . 71.22 109.59 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.634 HD11 HD12 ' C' ' 83' ' ' ILE . 94.5 mt -84.38 -39.72 18.71 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.349 0.595 . . . . 74.42 109.44 174.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.18 -174.84 5.02 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.291 -1.322 . . . . 72.15 109.663 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.84 113.75 2.67 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.986 -1.006 . . . . 71.45 109.954 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 69.97 4.43 4.79 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.94 1.296 . . . . 75.24 112.975 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -105.86 123.0 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.04 0.936 . . . . 65.11 109.444 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -111.91 161.43 16.41 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.694 0.759 . . . . 70.45 110.37 172.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.547 ' HB2' HD11 ' C' ' 51' ' ' LEU . 32.9 tt0 -123.67 111.82 16.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.949 -1.5 . . . . 65.13 106.949 166.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' C' ' 48' ' ' SER . 74.0 t -94.07 121.29 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.026 -1.102 . . . . 72.13 108.026 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.33 133.51 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.502 -0.925 . . . . 72.54 108.502 173.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -119.45 109.06 15.3 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.247 -1.02 . . . . 75.33 108.247 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -99.77 112.97 25.17 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.685 0.794 . . . . 73.3 109.784 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.3 t -106.4 130.93 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.259 1.024 . . . . 70.32 108.357 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 4.9 m -125.31 146.42 49.57 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.725 -0.843 . . . . 71.11 108.725 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -136.35 109.46 8.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.506 1.122 . . . . 75.31 108.644 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 22.1 m -99.25 140.83 32.83 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.512 -0.921 . . . . 74.2 108.512 171.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.11 105.71 5.83 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.825 -1.176 . . . . 71.45 107.825 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 52.3 m -119.67 133.17 55.75 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.698 -0.852 . . . . 53.55 108.698 177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 mt -82.68 51.34 1.86 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.263 1.425 . . . . 74.31 110.303 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.81 -76.68 0.31 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.504 -1.038 . . . . 64.14 110.504 -175.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.99 -31.7 2.12 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.701 1.2 . . . . 61.52 109.809 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -70.88 100.32 1.92 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.344 1.057 . . . . 75.14 110.257 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 49.8 m -66.64 125.13 24.82 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 118.007 0.367 . . . . 72.15 110.273 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.709 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -82.0 -55.02 4.84 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 114.982 -1.008 . . . . 31.42 109.161 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -161.14 176.08 11.69 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.259 1.028 . . . . 72.41 112.448 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.2 tm? -137.88 146.53 43.48 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 113.001 -1.909 . . . . 74.1 106.212 172.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.458 ' N ' HD13 ' C' ' 75' ' ' LEU . 44.1 t -148.3 143.39 26.89 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.614 -0.884 . . . . 74.41 108.614 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -155.89 137.12 13.84 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.718 0.294 . . . . 74.0 110.345 -177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.9 t -135.62 137.84 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.466 1.106 . . . . 72.34 108.751 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -115.31 94.55 4.77 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.329 -0.989 . . . . 51.53 108.329 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -79.44 98.55 6.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.489 -0.778 . . . . 74.5 109.452 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.24 143.4 22.87 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.208 -1.157 . . . . 70.22 110.208 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.488 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.84 117.23 0.88 Allowed Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 111.53 -0.628 . . . . 32.23 111.53 -174.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.634 HD12 HD11 ' C' ' 51' ' ' LEU . 6.4 mm -82.61 128.79 38.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 108.638 -0.875 . . . . 62.42 108.638 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -135.85 122.03 20.3 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.43 0.457 . . . . 72.03 110.109 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 22.1 m -79.48 107.55 12.33 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.059 -1.089 . . . . 70.35 108.059 169.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.68 143.83 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.069 0.547 . . . . 72.11 110.637 -175.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -158.5 166.28 32.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.314 1.046 . . . . 73.12 109.652 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.46 -34.58 4.4 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.984 -0.553 . . . . 75.4 112.896 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.17 140.42 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.731 0.813 . . . . 71.42 110.531 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -148.3 156.65 42.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.585 0.754 . . . . 75.4 109.712 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.81 -117.54 8.21 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 116.209 -0.45 . . . . 34.14 113.248 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 5.2 m -70.6 -33.53 71.16 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.036 0.934 . . . . 72.42 110.501 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -67.14 -39.9 86.66 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.732 -1.122 . . . . 73.4 110.085 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 39.6 ttp -78.11 -24.64 47.41 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.272 -0.876 . . . . 63.13 110.741 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.39 95.65 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 122.752 0.421 . . . . 71.1 110.435 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -75.94 -41.19 52.42 Favored 'General case' 0 C--O 1.248 0.979 0 N-CA-C 111.927 0.343 . . . . 75.32 111.927 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -55.61 -48.89 74.16 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.069 0.856 . . . . 73.41 110.543 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.449 HD23 ' SG ' ' C' ' 102' ' ' CYS . 34.9 mt -92.88 -14.26 27.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.277 0.631 . . . . 43.02 111.076 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.93 -29.39 65.07 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 123.329 0.49 . . . . 73.42 113.835 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -156.5 -39.83 0.08 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 113.13 0.789 . . . . 72.43 113.13 -166.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -66.04 -55.82 14.68 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.453 0.471 . . . . 72.54 111.184 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.545 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 37.8 m -64.52 -46.28 77.35 Favored Pre-proline 0 CA--C 1.563 1.478 0 C-N-CA 123.643 0.777 . . . . 42.32 112.943 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.56 -19.81 54.15 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 121.967 1.778 . . . . 74.54 113.967 174.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' C' ' 100' ' ' ALA . 0.2 OUTLIER -71.98 -28.41 63.4 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.714 -0.476 . . . . 71.31 109.714 176.189 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.71 -43.21 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.673 0.789 . . . . 73.31 109.67 171.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.488 HD21 ' HA3' ' C' ' 82' ' ' GLY . 66.0 mt -74.95 -28.2 60.49 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 114.886 -1.052 . . . . 52.22 112.133 -172.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -56.7 -50.2 89.31 Favored Pre-proline 0 CA--C 1.566 1.578 0 CA-C-O 117.34 -1.314 . . . . 74.43 114.243 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.54 -39.14 55.58 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 122.4 2.067 . . . . 72.11 113.367 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.472 ' HE2' HG21 ' A' ' 115' ' ' THR . 20.1 m-85 -67.94 -48.34 66.19 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.781 0.832 . . . . 72.51 110.405 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.15 -34.84 75.66 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.011 -0.995 . . . . 54.25 110.843 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -61.33 -56.53 19.42 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 124.12 0.968 . . . . 73.53 109.988 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.01 -30.33 71.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 123.724 0.64 . . . . 71.1 110.717 -175.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.5 t -73.91 -31.24 63.0 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.142 0.577 . . . . 73.32 110.884 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 58.7 mt -74.0 -50.33 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.945 0.498 . . . . 63.31 109.724 173.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 5.2 m -62.62 -30.27 71.23 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.013 0.925 . . . . 45.45 110.887 -175.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.3 t -65.5 -51.75 57.75 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.999 -0.741 . . . . 61.21 108.999 172.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.627 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.59 -36.65 76.67 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.541 1.136 . . . . 71.44 112.926 -179.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.708 HG11 HD23 ' C' ' 126' ' ' LEU . 95.0 t -71.72 -39.36 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.473 0.709 . . . . 74.23 109.775 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.5 t -70.77 -26.45 63.36 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.655 0.782 . . . . 51.24 111.234 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 78.2 mtt-85 -72.93 -42.49 63.41 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.744 -0.836 . . . . 75.43 108.744 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.1 -4.17 82.93 Favored Glycine 0 C--N 1.356 1.649 0 O-C-N 123.706 0.629 . . . . 70.33 112.942 173.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 23.4 p 66.83 25.84 9.48 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.633 1.973 . . . . 72.3 113.62 171.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.506 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 98.6 m-85 -86.49 166.08 29.7 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 123.841 0.857 . . . . 74.14 109.115 169.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 51.3 Cg_endo -62.67 178.31 1.01 Allowed 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 123.139 2.559 . . . . 51.31 114.708 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -59.67 112.22 1.73 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.877 1.271 . . . . 72.42 111.742 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.708 HD23 HG11 ' C' ' 118' ' ' VAL . 4.1 mm? -106.62 96.78 6.69 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.211 -0.663 . . . . 72.3 109.211 172.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -124.79 122.48 37.54 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.708 1.203 . . . . 74.01 108.539 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 14.8 tp -79.96 135.4 36.39 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.932 -0.395 . . . . 75.43 109.932 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.13 140.44 78.14 Favored Pre-proline 0 CA--C 1.547 0.849 0 O-C-N 124.45 1.094 . . . . 64.02 110.304 173.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.84 102.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.582 2.188 . . . . 51.23 112.676 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 50.0 t -95.74 111.17 25.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 106.675 -1.602 . . . . 53.25 106.675 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -76.24 83.22 3.03 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.633 -1.247 . . . . 74.53 107.633 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -56.43 -36.64 69.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.731 0.812 . . . . 62.12 110.825 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.7 -43.13 99.45 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 114.857 -1.065 . . . . 64.44 111.213 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.02 91.53 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.637 0.586 . . . . 62.52 110.952 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.1 mp -57.48 -50.66 72.33 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 123.97 0.794 . . . . 75.35 111.409 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 123.347 0.659 . . . . 73.04 110.396 -177.834 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 C--O 1.236 0.39 0 N-CA-C 109.737 -0.468 . . . . 73.44 109.737 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -175.13 102.01 0.08 Allowed 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.458 -2.053 . . . . 74.21 105.458 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -144.2 134.47 24.39 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.243 -0.89 . . . . 64.44 108.799 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.3 mt -84.25 122.6 38.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 115.203 -0.908 . . . . 72.13 109.182 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -90.07 -39.8 12.69 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 122.617 0.367 . . . . 74.13 111.315 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -166.56 127.79 1.71 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 111.755 0.28 . . . . 65.35 111.755 -167.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.75 136.13 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.343 -1.354 . . . . 72.11 107.343 167.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.41 ' HE1' HG13 ' D' ' 83' ' ' ILE . 25.1 p90 -156.51 164.38 38.29 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.771 0.796 . . . . 73.22 111.334 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 65.3 p -100.15 123.27 44.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.043 -0.981 . . . . 75.14 108.839 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -87.24 -36.01 18.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.67 0.748 . . . . 60.52 109.132 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 2.6 t70 -142.07 138.88 32.05 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.233 -1.349 . . . . 61.22 108.942 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.627 HG21 ' HE2' ' C' ' 117' ' ' MET . 82.3 mt -134.25 145.89 32.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.63 -1.248 . . . . 63.53 107.63 169.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -148.11 137.87 22.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.886 -0.783 . . . . 65.1 108.886 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.422 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.5 t80 -146.12 124.06 12.03 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.239 -1.393 . . . . 74.31 107.239 170.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -121.75 148.49 44.57 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.079 -0.711 . . . . 75.4 109.079 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.78 84.19 27.27 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 106.738 -1.578 . . . . 64.51 106.738 171.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.4 -46.08 6.16 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.198 2.598 . . . . 74.23 113.586 -167.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -104.95 28.0 7.6 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.703 0.801 . . . . 50.12 109.591 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.27 -66.72 0.34 Allowed Pre-proline 0 CA--C 1.565 1.528 0 N-CA-C 114.908 1.447 . . . . 75.31 114.908 -161.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.451 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.7 Cg_endo -73.8 -20.13 20.24 Favored 'Trans proline' 0 C--N 1.382 2.324 0 CA-C-N 122.533 1.94 . . . . 75.15 113.3 -174.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -73.88 -40.44 63.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.595 1.158 . . . . 62.14 110.328 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.463 HG21 ' HA ' ' D' ' 73' ' ' ALA . 4.0 p -85.54 -23.95 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 123.341 0.657 . . . . 64.11 111.803 -171.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -60.64 -22.09 63.46 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 123.286 0.634 . . . . 74.01 112.428 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -68.17 -10.3 53.19 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.579 0.752 . . . . 73.34 111.052 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -100.95 107.73 19.29 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.737 1.215 . . . . 73.24 110.246 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -93.27 91.87 7.44 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.293 0.637 . . . . 72.31 110.423 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.548 ' HZ3' ' H ' ' D' ' 69' ' ' GLY . 22.0 t90 -161.62 158.41 26.13 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.937 1.295 . . . . 63.41 108.127 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.443 HE21 ' HD2' ' D' ' 38' ' ' PRO . 29.1 tp60 -69.31 108.03 2.74 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 107.999 -1.111 . . . . 74.03 107.999 169.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.443 ' HD2' HE21 ' D' ' 37' ' ' GLN . 51.2 Cg_exo -56.74 124.23 15.75 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.967 2.444 . . . . 63.31 112.495 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -57.28 110.98 0.94 Allowed 'General case' 0 C--N 1.359 0.996 0 O-C-N 124.442 1.088 . . . . 70.32 110.244 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.458 HG23 HG13 ' D' ' 64' ' ' VAL . 2.8 p -101.68 112.39 34.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 115.283 -0.871 . . . . 75.32 110.269 -172.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.55 109.82 18.79 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 104.908 -2.256 . . . . 74.34 104.908 165.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.454 HD21 HD11 ' D' ' 128' ' ' LEU . 5.4 tt -95.49 127.9 41.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.36 -1.348 . . . . 70.25 107.36 -170.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.523 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 10.0 t70 -130.17 147.0 51.85 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 123.542 0.527 . . . . 72.31 109.915 -176.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -127.99 153.02 47.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.584 0.753 . . . . 73.21 109.682 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -157.69 147.78 20.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.055 0.942 . . . . 73.2 108.828 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -127.73 160.85 30.42 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.409 -0.589 . . . . 72.33 109.409 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.477 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.05 166.77 31.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.755 -1.112 . . . . 63.52 108.661 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 21.8 p -165.72 161.31 18.01 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.609 0.764 . . . . 55.42 109.557 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.2 p -151.98 160.47 43.47 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.282 1.033 . . . . 72.45 109.238 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -98.81 120.65 39.6 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.995 -0.742 . . . . 72.35 108.995 171.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' D' ' 57' ' ' GLU . 59.2 mt -91.0 -41.3 11.18 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.124 0.488 . . . . 73.02 110.198 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -153.51 -172.44 4.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.754 0.822 . . . . 43.44 110.896 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.37 105.96 1.59 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 114.968 -1.015 . . . . 70.33 109.53 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 64.11 18.59 11.33 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.517 1.127 . . . . 74.23 112.404 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 98.1 t -117.83 120.44 64.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.587 0 N-CA-C 107.843 -1.169 . . . . 74.41 107.843 169.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -125.46 163.8 21.86 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.671 0.788 . . . . 73.35 109.411 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.523 ' HB2' HD11 ' D' ' 51' ' ' LEU . 22.2 tt0 -121.52 148.38 44.55 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 124.746 1.218 . . . . 72.51 107.714 169.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.1 t -129.75 119.28 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 106.896 -1.52 . . . . 75.31 106.896 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.522 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 41.4 t -99.38 125.29 52.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.987 -0.746 . . . . 73.4 108.987 176.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.64 124.86 49.61 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.702 -1.221 . . . . 64.3 107.702 175.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -118.98 95.66 4.91 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.987 -0.746 . . . . 74.42 108.987 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -91.24 123.1 43.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.078 -1.082 . . . . 75.4 108.078 174.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 24.0 m -111.15 144.06 40.9 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.25 0.548 . . . . 72.14 110.041 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.458 HG13 HG23 ' D' ' 40' ' ' VAL . 93.9 t -137.44 120.28 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.111 0.964 . . . . 74.22 109.503 -175.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 100.0 m -113.39 121.03 43.12 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 107.912 -1.144 . . . . 74.54 107.912 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.88 145.49 48.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.333 0.653 . . . . 51.3 110.319 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.456 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.8 m -146.83 129.96 16.48 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 123.526 0.516 . . . . 72.2 111.129 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 mt -92.86 92.6 7.98 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.945 -1.132 . . . . 74.31 107.945 173.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . 0.548 ' H ' ' HZ3' ' D' ' 36' ' ' TRP . . . 70.22 -114.77 5.67 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 114.571 -1.195 . . . . 54.31 113.382 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.15 6.37 40.36 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.299 0.852 . . . . 74.15 113.299 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.91 156.94 43.02 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.11 0.414 . . . . 54.33 110.222 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.5 m -67.29 136.89 55.59 Favored 'General case' 0 C--O 1.242 0.697 0 O-C-N 123.633 0.583 . . . . 65.44 110.694 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.463 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.34 -69.57 0.71 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.252 -1.34 . . . . 75.44 108.522 175.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -145.58 157.46 43.98 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 121.319 0.58 . . . . 72.22 109.958 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -131.96 144.58 50.91 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.255 -1.387 . . . . 72.33 107.255 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.563 ' SG ' HG12 ' D' ' 114' ' ' ILE . 43.6 t -158.22 136.68 11.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.336 0.254 . . . . 65.3 110.589 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -154.07 128.35 9.1 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.387 0.675 . . . . 73.21 109.32 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.2 118.39 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.382 0.673 . . . . 54.13 109.905 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.626 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.6 mt-30 -89.77 82.97 6.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.34 0.656 . . . . 61.33 109.307 169.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -80.37 91.86 5.73 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.963 1.305 . . . . 63.31 109.359 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.25 142.18 17.98 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.713 -0.555 . . . . 65.13 111.713 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.93 132.31 5.5 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 119.716 -0.491 . . . . 70.43 112.064 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.41 HG13 ' HE1' ' D' ' 17' ' ' TYR . 61.9 mt -89.17 131.23 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.379 0.672 . . . . 70.55 109.99 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -131.22 124.55 30.81 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.886 0.875 . . . . 70.31 109.341 175.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 71.5 m -83.75 111.7 19.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.088 -1.078 . . . . 73.12 108.088 168.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.461 HD12 ' SG ' ' D' ' 97' ' ' CYS . 5.5 tt -138.06 127.99 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 122.902 0.481 . . . . 63.01 111.117 -172.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.68 167.66 27.86 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.398 1.479 . . . . 54.25 109.099 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.05 11.51 63.11 Favored Glycine 0 N--CA 1.473 1.128 0 CA-C-O 119.463 -0.632 . . . . 75.42 113.66 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.8 169.22 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 125.079 1.352 . . . . 74.25 109.661 171.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -153.91 175.82 12.91 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.723 0.409 . . . . 63.24 111.912 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.89 -107.42 0.71 Allowed Glycine 0 C--N 1.36 1.868 0 O-C-N 124.757 1.285 . . . . 64.31 115.263 164.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.0 p -66.04 -41.54 90.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.816 0.847 . . . . 72.13 110.974 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -74.72 -38.03 62.41 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.344 0.657 . . . . 65.21 111.685 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -66.63 -34.46 77.92 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.867 0.365 . . . . 75.24 110.671 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.98 -42.65 69.4 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.907 -0.588 . . . . 73.22 109.646 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.408 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 49.8 t-80 -66.25 -26.41 67.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.421 1.088 . . . . 70.53 111.817 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . 0.461 ' SG ' HD12 ' D' ' 86' ' ' ILE . 25.3 t -91.12 -54.14 4.07 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.844 -0.122 . . . . 73.33 110.864 -176.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -72.31 -29.77 64.16 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.391 0.276 . . . . 72.42 111.494 -176.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.5 12.91 27.98 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.122 -0.821 . . . . 73.01 114.532 -172.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -154.46 -59.65 0.12 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.983 0.891 . . . . 62.41 112.207 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -68.59 -50.41 51.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.006 0.523 . . . . 73.43 111.499 -173.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 83.7 m -62.6 -45.71 88.78 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.11 0.964 . . . . 72.41 112.243 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -52.56 -40.79 71.58 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.203 1.935 . . . . 71.5 112.967 167.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -66.07 -29.87 70.28 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.256 0.622 . . . . 75.54 111.328 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.7 mm -69.59 -42.4 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.894 0.878 . . . . 61.52 110.436 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 62.8 mt -74.83 -16.28 60.7 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.224 -0.898 . . . . 61.23 111.67 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.423 ' HE2' ' HA ' ' D' ' 130' ' ' PRO . 27.6 t80 -68.07 -40.37 21.73 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.916 -1.04 . . . . 75.24 113.74 -169.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.39 -44.84 45.6 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.011 1.807 . . . . 45.23 112.895 167.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -69.24 -36.64 77.37 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.692 0.797 . . . . 73.12 111.783 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.07 -49.46 69.95 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.241 0.616 . . . . 64.42 109.717 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.492 HH12 ' HB3' ' D' ' 130' ' ' PRO . 26.5 ttp180 -55.99 -47.62 77.37 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 124.357 1.036 . . . . 73.03 110.946 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -62.13 -49.03 77.49 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.073 0.858 . . . . 65.22 111.534 -174.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.0 -41.86 83.98 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.053 0.846 . . . . 72.44 110.636 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.563 HG12 ' SG ' ' D' ' 76' ' ' CYS . 81.1 mt -60.4 -56.51 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 O-C-N 124.293 0.996 . . . . 70.55 110.79 173.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -58.21 -37.55 75.04 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.588 1.155 . . . . 75.52 111.372 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -66.78 -42.15 86.5 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.155 -0.93 . . . . 75.45 110.079 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.4 mtm -72.52 -27.11 62.04 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.809 0.444 . . . . 65.53 111.766 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.408 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.0 t -67.97 -42.14 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.458 0.703 . . . . 64.11 110.078 173.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.6 p -75.62 -29.44 59.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.813 0.445 . . . . 71.3 111.108 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -74.26 -33.84 63.41 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.245 0.618 . . . . 73.42 109.599 174.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.68 -2.25 90.62 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-N 115.746 -0.661 . . . . 53.02 112.237 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p 66.57 21.3 10.73 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.876 2.07 . . . . 44.43 113.904 170.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -82.62 156.77 67.95 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.452 0.701 . . . . 75.12 110.348 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.97 137.23 44.23 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.298 2.666 . . . . 63.14 112.138 173.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -54.66 136.77 45.18 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.359 1.037 . . . . 74.33 111.929 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -113.44 102.32 10.2 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.568 -0.901 . . . . 74.02 108.568 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -98.29 95.08 7.13 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.221 -1.4 . . . . 42.31 107.221 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.454 HD11 HD21 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -57.11 113.89 1.9 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.566 -1.197 . . . . 65.24 108.273 -176.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.88 122.65 70.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 123.963 0.789 . . . . 75.53 110.632 -171.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.492 ' HB3' HH12 ' D' ' 111' ' ' ARG . 59.1 Cg_endo -72.64 112.52 3.5 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.944 1.763 . . . . 63.51 111.427 -176.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.0 m -105.81 138.52 30.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 108.317 -0.994 . . . . 70.11 108.317 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -79.25 77.11 5.78 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.872 0.844 . . . . 62.01 109.726 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -56.71 -29.39 62.39 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.623 1.569 . . . . 70.3 111.64 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . 0.658 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 21.7 t70 -60.51 -45.1 95.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.13 1.372 . . . . 75.54 110.747 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.07 -37.84 57.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.807 0.843 . . . . 63.31 111.329 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 9.8 mp -58.93 -31.23 68.48 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.33 0.652 . . . . 65.54 111.043 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.6 t80 . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 123.986 0.914 . . . . 71.51 110.8 177.715 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.1 m . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.865 -0.42 . . . . 61.12 109.865 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.651 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.4 t80 -133.25 132.87 41.96 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.647 -0.872 . . . . 65.52 108.647 173.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -147.39 116.64 6.94 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.682 -0.858 . . . . 74.52 108.682 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.463 HG12 ' HD2' ' A' ' 84' ' ' PHE . 50.7 mt -81.19 117.4 27.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.87 -0.789 . . . . 71.12 108.87 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -86.34 -40.37 15.52 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 123.742 0.651 . . . . 74.42 110.757 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -168.12 137.46 2.48 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 122.969 0.168 . . . . 74.55 110.744 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.593 HD12 ' HG3' ' C' ' 130' ' ' PRO . 88.6 mt -125.44 133.48 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.378 1.071 . . . . 72.52 108.584 177.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' HB3' HG23 ' B' ' 122' ' ' THR . 41.4 p90 -168.97 177.32 4.99 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 123.97 0.794 . . . . 75.44 111.355 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -102.2 122.96 45.19 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.05 -0.977 . . . . 74.3 108.749 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 31.3 mtpt -88.07 -45.21 10.36 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.316 -0.624 . . . . 65.43 109.316 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.3 t70 -134.34 125.67 28.08 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.507 -1.224 . . . . 72.02 108.288 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 58.9 mt -124.91 140.39 48.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.696 -1.594 . . . . 64.21 106.696 173.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -156.09 121.12 4.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.17 0.509 . . . . 74.53 109.727 171.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.474 ' H ' ' HB ' ' B' ' 21' ' ' ILE . 86.8 t80 -116.3 118.54 33.05 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 106.36 -1.718 . . . . 72.42 106.36 173.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -119.56 126.48 51.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.058 0.39 . . . . 51.43 110.145 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.17 75.64 23.15 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.685 -1.228 . . . . 54.33 107.685 169.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.56 -28.68 25.91 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.26 1.974 . . . . 62.42 110.405 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.454 ' O ' HG23 ' A' ' 31' ' ' VAL . 43.1 m-20 -93.33 12.41 24.81 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.196 -1.365 . . . . 71.13 110.898 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.73 -46.88 80.19 Favored Pre-proline 0 CA--C 1.571 1.752 0 C-N-CA 124.185 0.994 . . . . 70.4 113.607 -176.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.13 -21.77 20.05 Favored 'Trans proline' 0 C--N 1.396 3.073 0 C-N-CA 122.082 1.855 . . . . 75.31 113.651 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -71.65 -47.57 53.53 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.623 -0.51 . . . . 70.02 109.623 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.614 HG22 HD21 ' A' ' 68' ' ' LEU . 88.1 t -60.91 -33.88 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.738 1.215 . . . . 72.3 110.936 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.446 ' HD1' HH11 ' B' ' 15' ' ' ARG . 90.9 t80 -56.46 -39.52 73.3 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.643 1.177 . . . . 74.41 111.918 176.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -96.43 -35.15 11.26 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.652 0.781 . . . . 60.21 111.87 -172.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -83.15 170.63 14.54 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.596 0.758 . . . . 74.55 112.88 -172.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.63 115.86 9.36 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.825 0.85 . . . . 43.52 111.101 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -79.63 92.65 5.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.022 0.929 . . . . 71.42 109.966 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -140.51 75.83 26.09 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 107.38 -1.341 . . . . 72.2 107.38 172.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 67' ' ' SER . 24.6 Cg_endo -90.52 163.85 4.35 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.095 2.53 . . . . 72.4 113.98 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -126.32 118.39 24.97 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.04 -0.982 . . . . 64.33 108.534 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.69 110.05 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.602 0.761 . . . . 74.32 110.831 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -103.24 140.07 37.86 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.679 -0.86 . . . . 74.25 108.679 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 63' ' ' THR . 64.7 tp -132.09 124.76 29.83 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.491 0.716 . . . . 73.1 109.701 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.452 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 64.4 m-20 -102.95 124.33 48.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.152 -1.055 . . . . 71.31 108.152 175.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.35 115.21 29.82 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.788 -1.56 . . . . 72.3 106.788 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 12.0 m-20 -132.07 124.6 29.53 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.096 -1.075 . . . . 62.32 108.096 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.9 m -115.35 121.94 44.36 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.404 -0.591 . . . . 71.23 109.404 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.76 140.86 48.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.182 0.993 . . . . 71.22 108.614 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.559 ' HB2' HD21 ' A' ' 98' ' ' LEU . 37.0 t -130.59 163.92 26.06 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.358 0.599 . . . . 65.31 111.628 -173.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.2 t -148.91 121.62 8.64 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.198 -1.365 . . . . 74.44 108.256 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -71.67 107.89 4.74 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.822 0.849 . . . . 70.45 109.279 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.9 mt -78.52 -34.51 47.24 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.221 0.608 . . . . 71.34 110.281 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.54 -177.71 6.59 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.939 0.895 . . . . 72.25 109.878 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.72 119.44 14.86 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.412 -0.588 . . . . 75.33 109.412 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 67.34 20.15 10.04 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.084 1.354 . . . . 73.41 112.151 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.12 124.05 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.414 1.086 . . . . 75.31 108.35 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.499 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -142.43 169.22 17.99 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.337 -0.616 . . . . 73.54 109.337 174.337 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -128.75 130.51 47.17 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.498 -0.927 . . . . 74.3 108.498 174.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.8 m -102.42 132.06 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.586 -0.894 . . . . 62.12 108.586 169.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.51 106.92 21.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 125.194 1.397 . . . . 73.41 107.68 177.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.7 tp -87.57 99.14 11.82 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.693 -0.685 . . . . 71.12 109.155 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.709 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 52.6 ttt-85 -84.38 105.24 15.06 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.805 -0.813 . . . . 75.14 108.805 174.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.507 HG21 ' HB1' ' A' ' 110' ' ' ALA . 1.7 m -112.95 106.58 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 108.37 -0.974 . . . . 62.23 108.37 175.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 25.6 m -109.83 112.01 23.79 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.451 1.1 . . . . 74.32 110.716 -167.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 78.2 t -101.74 110.97 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.52 0.728 . . . . 74.42 109.656 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -115.44 108.29 16.29 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.735 -0.839 . . . . 70.25 108.735 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.79 133.49 53.08 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.312 -0.995 . . . . 61.11 108.312 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 39.4 t -140.27 134.38 30.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.905 0.482 . . . . 71.11 110.595 -176.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.657 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -94.78 80.17 3.74 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.432 1.093 . . . . 74.43 108.436 172.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.06 -118.86 5.48 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.311 -0.858 . . . . 74.44 112.593 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -89.41 5.97 42.82 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.61 0.764 . . . . 73.3 111.368 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.439 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . 6.3 tp10 -116.84 112.92 21.77 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.636 -0.876 . . . . 73.23 108.636 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.0 m -73.75 130.08 39.24 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.541 0.609 . . . . 72.25 109.864 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.533 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.81 -59.96 2.53 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.433 0.693 . . . . 74.21 109.789 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -159.28 163.35 35.85 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 115.157 -0.928 . . . . 71.33 110.782 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 34.6 tp -135.68 106.38 6.55 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.751 -1.113 . . . . 74.23 108.172 175.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 118' ' ' VAL . 57.2 m -107.69 97.36 7.1 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.241 -0.651 . . . . 73.43 109.241 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -113.06 117.16 31.23 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.671 -1.233 . . . . 74.53 107.671 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.4 t -126.3 109.55 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.492 -0.776 . . . . 73.0 109.119 -175.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.579 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.3 mt-30 -90.34 86.23 6.42 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.866 -1.061 . . . . 63.35 108.608 171.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.49 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.1 tp-100 -76.42 109.05 9.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.156 -1.384 . . . . 65.03 108.104 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.37 144.83 17.53 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.429 -0.668 . . . . 61.41 111.429 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.418 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -148.59 122.46 1.49 Allowed Glycine 0 CA--C 1.502 -0.746 0 N-CA-C 110.869 -0.892 . . . . 72.43 110.869 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.9 mt -80.93 121.77 35.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 108.406 -0.961 . . . . 75.25 108.406 175.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.651 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.2 m-85 -130.37 135.53 48.13 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.511 -0.922 . . . . 74.02 108.511 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.4 p -112.62 98.02 6.96 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.325 -0.62 . . . . 61.33 109.325 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.44 HD12 HD11 ' A' ' 89' ' ' ILE . 39.3 pt -99.52 149.8 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 115.733 -0.667 . . . . 73.33 109.469 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.58 147.73 14.02 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.413 0.685 . . . . 74.13 110.121 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.24 9.75 64.93 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 114.873 0.709 . . . . 62.41 114.873 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -123.39 153.36 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.748 0.819 . . . . 72.24 110.085 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 14.2 tt0 -160.78 179.4 8.55 Favored 'General case' 0 CA--C 1.557 1.228 0 O-C-N 123.251 0.345 . . . . 74.43 111.085 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.457 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 73.61 -133.62 17.85 Favored Glycine 0 C--N 1.351 1.38 0 C-N-CA 123.907 0.765 . . . . 71.32 113.838 177.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.0 p -64.86 -35.25 80.51 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.934 0.894 . . . . 72.44 110.961 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -64.96 -35.58 81.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.994 0.918 . . . . 75.04 110.846 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.571 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 28.1 ttt -62.37 -47.06 85.82 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.635 0.774 . . . . 75.1 110.904 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.71 -39.24 91.02 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.777 -0.647 . . . . 71.0 110.865 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -67.24 -31.86 72.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.287 1.035 . . . . 71.14 111.633 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 24.6 t -69.95 -29.27 66.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.991 0.424 . . . . 74.42 110.899 -175.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 48' ' ' SER . 1.8 tt -95.09 -32.68 12.99 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.75 -0.659 . . . . 63.42 110.235 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.2 -1.93 66.51 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-O 119.578 -0.568 . . . . 74.2 113.942 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -147.82 -64.54 0.26 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 117.827 0.813 . . . . 75.31 111.967 -176.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.435 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 51.1 t80 -56.22 -70.83 0.1 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.252 1.421 . . . . 73.33 113.607 -169.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.424 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 86.6 m -72.35 -35.64 3.4 Favored Pre-proline 0 CA--C 1.565 1.541 0 N-CA-C 114.894 1.442 . . . . 73.31 114.894 -173.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 37.8 Cg_endo -64.65 -26.12 61.38 Favored 'Trans proline' 0 C--N 1.392 2.866 0 CA-C-N 121.99 1.746 . . . . 72.15 113.103 173.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -72.53 -23.1 60.95 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.847 0.459 . . . . 74.21 111.217 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.3 mm -61.91 -40.58 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.092 0.472 . . . . 74.2 109.759 171.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.49 HD22 ' HG3' ' A' ' 80' ' ' GLN . 83.7 mt -82.82 -13.45 56.18 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.298 -0.864 . . . . 73.54 112.507 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.415 ' HE2' ' HA ' ' A' ' 130' ' ' PRO . 49.2 t80 -63.94 -43.23 74.73 Favored Pre-proline 0 CA--C 1.567 1.613 0 C-N-CA 123.709 0.804 . . . . 75.23 113.101 -174.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.56 -35.77 57.59 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 122.215 1.943 . . . . 60.55 113.904 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.2 -40.54 64.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.918 0.487 . . . . 74.11 110.79 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.507 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -69.81 -36.12 75.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.528 -0.76 . . . . 65.44 110.514 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.467 ' NH1' HD12 ' C' ' 105' ' ' ILE . 36.5 ttm180 -52.95 -53.07 55.09 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.292 0.995 . . . . 74.42 109.66 171.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.75 -44.61 95.74 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 124.385 1.053 . . . . 72.42 111.701 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 17.1 t -62.2 -45.3 93.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.474 0.71 . . . . 61.42 110.555 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.3 mt -60.97 -54.66 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.799 0.84 . . . . 74.22 110.016 175.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.586 HG23 ' HG3' ' A' ' 125' ' ' GLN . 85.0 m -48.55 -48.0 38.92 Favored 'General case' 0 C--O 1.248 1.024 0 C-N-CA 124.515 1.126 . . . . 64.43 111.585 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -64.31 -47.69 78.48 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.272 -1.331 . . . . 62.43 110.034 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 39.0 mtp -61.07 -41.04 95.9 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.183 0.993 . . . . 73.2 112.32 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 114' ' ' ILE . 98.3 t -62.2 -45.94 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.691 0.796 . . . . 73.25 109.954 177.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.0 m -70.68 -27.77 64.27 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.386 -0.825 . . . . 50.32 111.978 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -72.55 -30.14 64.17 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.505 0.722 . . . . 72.05 110.186 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.82 7.07 75.9 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.541 0.525 . . . . 40.12 112.981 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.1 m 69.41 12.23 8.24 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.772 1.229 . . . . 74.11 111.791 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.533 ' HE1' HG11 ' A' ' 31' ' ' VAL . 89.3 m-85 -81.1 152.35 71.14 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.177 0.591 . . . . 72.32 109.792 173.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.4 138.16 79.31 Favored 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 123.162 2.575 . . . . 71.44 112.224 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.586 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.5 tt0 -55.39 129.48 38.78 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 123.875 0.734 . . . . 75.23 111.654 -176.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.4 tp -110.4 116.76 32.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.945 -1.025 . . . . 71.02 109.566 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -118.84 101.87 8.38 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.723 -1.214 . . . . 63.42 107.723 172.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 pp -64.4 134.24 54.16 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 109.8 -0.445 . . . . 63.21 109.8 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.28 146.9 94.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.058 0.543 . . . . 62.04 110.46 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.415 ' HA ' ' HE2' ' A' ' 107' ' ' PHE . 36.3 Cg_exo -61.83 115.18 2.64 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.54 2.16 . . . . 54.23 111.38 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.35 121.08 48.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.986 -1.116 . . . . 75.01 107.986 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -71.98 95.81 1.63 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.801 -0.815 . . . . 73.34 108.801 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 94.3 m-85 -60.51 -31.61 70.66 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.67 0.788 . . . . 71.43 111.996 -177.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.66 -50.74 70.02 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.911 0.757 . . . . 61.03 109.921 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.11 90.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.574 0.75 . . . . 62.44 111.064 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.41 -34.18 77.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.738 0.815 . . . . 73.33 111.42 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -73.19 -34.6 66.07 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.187 0.595 . . . . 74.01 110.036 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 123.041 0.536 . . . . 72.22 111.306 -179.539 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 87.7 m . . . . . 0 C--O 1.235 0.321 0 N-CA-C 107.663 -1.236 . . . . 75.13 107.663 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.455 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 30.8 t80 -139.32 138.96 37.13 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.546 -0.909 . . . . 55.22 108.546 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -158.93 141.12 13.88 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.215 0.606 . . . . 73.31 109.674 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.418 HD13 HD11 ' B' ' 16' ' ' ILE . 54.1 mt -83.69 121.98 37.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.989 -1.115 . . . . 64.04 107.989 172.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -94.11 -43.8 8.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.204 0.602 . . . . 61.31 109.401 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.446 HH11 ' HD1' ' A' ' 32' ' ' PHE . 50.0 ttt180 -163.89 132.69 3.77 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.515 -0.766 . . . . 73.31 109.314 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.418 HD11 HD13 ' B' ' 13' ' ' ILE . 96.0 mt -115.02 141.29 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.237 -1.394 . . . . 63.35 107.237 169.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.428 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 33.1 p90 -164.73 157.27 16.44 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.837 0.711 . . . . 74.21 110.735 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.502 HG21 HD11 ' B' ' 21' ' ' ILE . 22.6 m -83.72 122.92 29.29 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.635 -1.246 . . . . 72.15 107.635 168.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.414 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 19.4 mtpp -84.15 -52.82 5.96 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.917 -0.772 . . . . 75.34 108.917 176.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 28.9 t70 -134.96 149.43 50.22 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.687 -0.688 . . . . 63.25 111.256 -170.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.502 HD11 HG21 ' B' ' 18' ' ' THR . 25.7 mm -139.81 144.74 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.528 1.531 . . . . 74.53 108.575 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -147.73 110.99 4.88 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.098 0.873 . . . . 75.44 108.667 166.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.477 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 85.7 t80 -119.81 113.06 20.03 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.204 -1.406 . . . . 72.3 107.204 170.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -122.95 124.23 42.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.611 0.764 . . . . 72.41 109.203 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.49 85.0 12.78 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.162 -1.421 . . . . 71.02 107.162 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.44 -36.83 19.02 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.886 2.39 . . . . 71.01 112.811 -169.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -105.5 17.26 24.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.887 0.875 . . . . 61.44 110.378 -176.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.435 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -41.59 -61.97 1.25 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 115.349 1.611 . . . . 63.52 115.349 -164.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.3 Cg_exo -66.97 -16.06 48.61 Favored 'Trans proline' 0 C--N 1.4 3.287 0 C-N-CA 122.314 2.01 . . . . 55.14 112.372 -170.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -97.73 -49.04 4.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.19 0.996 . . . . 74.11 111.408 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.516 HG22 HD12 ' B' ' 68' ' ' LEU . 9.8 p -64.38 -20.49 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.563 0.745 . . . . 51.23 112.333 -166.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -65.04 -17.76 64.73 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.45 0.908 . . . . 72.23 113.45 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -59.3 -25.52 64.21 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.114 0.566 . . . . 71.34 110.901 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -94.46 80.11 3.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.512 1.125 . . . . 65.35 108.674 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.3 93.25 3.4 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.294 0.569 . . . . 72.02 109.59 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -161.74 158.26 25.56 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.752 1.221 . . . . 70.35 107.988 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -60.43 106.15 0.71 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.903 0.881 . . . . 72.05 110.032 169.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.546 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 35.5 Cg_endo -64.35 124.71 13.79 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.872 1.714 . . . . 73.03 110.497 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -58.15 107.23 0.45 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 123.724 0.64 . . . . 61.42 110.126 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' B' ' 66' ' ' ALA . 28.5 m -96.68 150.52 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.744 0.783 . . . . 74.33 112.535 -173.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -119.42 115.12 23.44 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.253 -1.34 . . . . 64.23 107.657 170.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 mp -85.15 132.22 34.33 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.421 -1.326 . . . . 71.22 107.421 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 14.4 t70 -147.38 110.96 4.95 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 110.135 -0.32 . . . . 75.3 110.135 -177.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 mp -100.57 163.79 12.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.995 0.426 . . . . 72.31 110.211 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 17.7 t70 -158.43 139.25 12.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.712 1.205 . . . . 52.4 108.397 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 47.8 p -133.6 117.73 17.4 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.938 0.495 . . . . 71.53 110.452 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.64 162.8 17.44 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.632 1.173 . . . . 50.24 108.662 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.434 ' HB2' ' HD2' ' B' ' 56' ' ' TYR . 64.1 p -143.22 160.93 39.54 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.184 -0.672 . . . . 71.31 109.184 170.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.0 p -152.16 135.6 16.02 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.509 0.724 . . . . 64.33 109.426 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.33 124.95 29.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.08 0.552 . . . . 43.42 110.215 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 64.6 mt -86.96 -44.68 11.44 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.672 -0.492 . . . . 74.43 109.672 172.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.96 -175.63 5.47 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.675 -0.693 . . . . 62.24 111.098 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.48 124.32 21.02 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.524 -1.216 . . . . 73.04 109.443 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 67.29 19.59 10.2 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.563 1.145 . . . . 72.13 111.663 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -131.27 125.82 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.166 0.986 . . . . 72.22 109.464 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.434 ' HD2' ' HB2' ' B' ' 48' ' ' SER . 0.2 OUTLIER -131.81 140.51 49.18 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.977 -0.749 . . . . 74.34 108.977 174.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -112.41 106.67 15.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.982 -1.488 . . . . 73.43 106.982 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.4 t -93.74 140.66 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.921 0.488 . . . . 62.21 109.924 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.3 t -116.77 135.34 57.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 124.41 1.084 . . . . 72.3 109.062 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.07 109.87 16.41 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.82 -1.178 . . . . 74.23 107.82 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.501 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.2 ttt180 -95.38 123.64 39.01 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.813 0.845 . . . . 75.12 109.727 173.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.514 ' HB ' HD11 ' B' ' 114' ' ' ILE . 15.2 t -118.34 123.85 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.347 -0.982 . . . . 64.54 108.347 171.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 39.6 m -107.85 140.78 40.43 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.676 1.19 . . . . 72.42 109.455 -178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.463 HG21 HG21 ' B' ' 114' ' ' ILE . 97.8 t -133.13 100.59 3.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 124.155 0.982 . . . . 64.11 108.715 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 70.8 m -84.0 138.88 32.88 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.023 -1.102 . . . . 52.31 108.023 167.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.554 ' HB2' HG12 ' B' ' 40' ' ' VAL . . . -147.69 149.39 32.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.985 0.357 . . . . 61.14 110.459 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 62.5 p -152.11 135.91 16.3 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.834 0.709 . . . . 70.51 111.541 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.546 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 43.6 mt -103.21 117.35 34.34 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.182 0.993 . . . . 75.12 108.942 173.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.04 -112.69 5.13 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.244 -0.889 . . . . 65.03 112.189 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -115.88 4.21 13.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.691 0.796 . . . . 75.31 111.703 -175.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -118.96 158.72 25.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.591 0.756 . . . . 73.25 110.012 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.5 m -64.56 138.25 58.3 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.615 0.572 . . . . 74.34 110.792 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.448 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -96.71 -65.11 0.99 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.337 -0.847 . . . . 72.21 108.811 171.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -149.82 155.29 39.83 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.368 -0.833 . . . . 74.05 109.721 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 41.4 mt -131.98 108.56 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.232 -1.766 . . . . 64.35 106.232 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.444 ' SG ' HG23 ' B' ' 114' ' ' ILE . 49.4 t -118.82 139.46 51.57 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.693 -0.854 . . . . 44.04 108.693 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -159.69 133.78 7.47 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.29 -0.633 . . . . 65.11 109.29 -173.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.7 t -124.62 146.48 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.126 -0.943 . . . . 73.33 109.019 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 29.1 mt-30 -122.3 84.12 2.21 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.076 -1.083 . . . . 71.15 108.076 171.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -81.75 101.06 9.88 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.721 -1.127 . . . . 73.31 109.473 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -92.2 167.78 30.58 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 111.9 -0.48 . . . . 44.35 111.9 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.87 126.81 1.66 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.109 -0.796 . . . . 54.12 111.109 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 65.6 mt -84.83 127.78 39.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.605 -0.887 . . . . 72.24 108.605 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -134.87 146.36 49.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.153 0.981 . . . . 72.04 108.618 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -99.94 106.9 18.76 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.883 -0.784 . . . . 63.3 108.883 170.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.661 ' HB ' HD11 ' B' ' 89' ' ' ILE . 48.4 pt -116.06 130.41 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.171 0.588 . . . . 62.51 110.239 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -149.52 159.9 43.92 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.559 0.744 . . . . 34.05 110.304 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.99 -54.32 4.73 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.741 -0.663 . . . . 55.41 112.692 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.661 HD11 ' HB ' ' B' ' 86' ' ' ILE . 17.6 pt -54.23 138.56 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.736 1.214 . . . . 65.52 112.798 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -162.8 172.5 15.11 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.793 -1.094 . . . . 71.43 109.749 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.42 -109.93 2.94 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.994 -0.548 . . . . 44.24 112.282 -173.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.2 m -89.61 -26.62 20.68 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.481 0.712 . . . . 63.44 110.946 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.511 ' HB3' HG22 ' B' ' 89' ' ' ILE . 48.5 mt-30 -58.52 -46.08 87.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.394 0.616 . . . . 71.02 110.049 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.416 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 0.0 OUTLIER -70.32 -35.29 73.55 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.584 -1.189 . . . . 65.05 110.507 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.72 -47.85 84.03 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 124.119 0.887 . . . . 62.42 109.954 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -62.24 -27.8 69.25 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.263 -1.335 . . . . 74.21 111.306 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 t -76.06 -66.93 0.73 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.008 0.523 . . . . 72.13 110.888 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 94' ' ' MET . 1.5 pp -71.83 -22.54 61.53 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 112.92 0.711 . . . . 64.41 112.92 -173.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.6 -1.21 53.04 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.553 -0.582 . . . . 33.43 114.058 -175.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.98 -64.43 0.19 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.608 0.704 . . . . 73.01 111.755 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -59.91 -55.03 39.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.314 1.045 . . . . 75.33 112.021 -168.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.482 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 92.1 m -59.52 -52.09 76.6 Favored Pre-proline 0 CA--C 1.568 1.665 0 C-N-CA 124.397 1.079 . . . . 72.05 112.097 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 71.1 Cg_exo -54.92 -40.5 85.23 Favored 'Trans proline' 0 C--N 1.404 3.485 0 C-N-CA 122.433 2.089 . . . . 72.45 114.393 172.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -63.89 -24.18 67.64 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.888 0.699 . . . . 73.43 112.888 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.53 -43.98 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.603 -0.517 . . . . 52.23 109.603 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 60.8 mt -76.71 -21.99 54.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.55 -1.205 . . . . 71.31 112.015 -173.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -60.57 -48.38 93.58 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 118.073 -0.965 . . . . 72.01 113.283 -171.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.28 -39.5 86.54 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.987 1.791 . . . . 63.24 113.277 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -66.57 -45.83 78.03 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.193 0.597 . . . . 75.32 110.684 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.88 -34.75 78.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.278 0.631 . . . . 64.2 111.045 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.721 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 39.1 ttt180 -63.62 -54.33 37.55 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.143 1.377 . . . . 64.11 111.178 -177.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.39 -33.9 76.74 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.716 0.635 . . . . 73.53 109.821 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.499 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.4 t -66.73 -31.52 72.23 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.146 0.578 . . . . 72.3 111.907 -177.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.582 HD12 HD22 ' B' ' 128' ' ' LEU . 80.5 mt -70.45 -58.66 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 109.033 -0.729 . . . . 75.51 109.033 172.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.6 m -59.02 -26.63 64.72 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 124.29 0.994 . . . . 51.42 111.825 -173.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 36.3 t -60.52 -56.6 19.36 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.205 1.002 . . . . 64.54 109.268 173.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.3 mmt -67.48 -34.21 76.69 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.655 0.782 . . . . 75.31 111.375 -173.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 114' ' ' ILE . 94.0 t -59.71 -49.69 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.958 0.903 . . . . 62.45 110.121 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.7 t -66.31 -34.75 78.7 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.651 -1.158 . . . . 60.45 111.363 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.403 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.6 mtt-85 -65.46 -35.84 82.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.388 0.675 . . . . 62.23 110.337 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.52 15.07 53.13 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 123.923 0.764 . . . . 51.12 112.96 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.503 HG23 ' HB3' ' A' ' 17' ' ' TYR . 69.3 p 54.37 26.78 7.33 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.959 1.704 . . . . 73.44 113.608 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -85.3 151.16 56.11 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.357 0.663 . . . . 63.22 110.906 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.61 167.71 1.34 Allowed 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 124.049 3.166 . . . . 64.12 115.315 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -63.85 114.83 4.31 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.036 -0.984 . . . . 65.2 112.548 -167.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 17.0 tp -116.28 98.49 6.62 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 115.432 -0.804 . . . . 64.12 109.501 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -97.37 95.96 8.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.25 -1.018 . . . . 75.43 108.25 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.721 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 31.8 tp -55.18 116.87 3.04 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.352 0.661 . . . . 73.53 110.69 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.62 146.18 88.17 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.886 0.874 . . . . 55.22 111.582 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -76.61 110.71 3.1 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.328 2.685 . . . . 75.5 111.923 -173.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.2 t -90.82 111.0 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 108.576 -0.898 . . . . 74.24 108.576 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -78.75 110.81 14.25 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.68 -0.859 . . . . 60.34 108.68 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -69.5 -48.66 59.86 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.581 0.55 . . . . 71.21 110.619 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -56.95 -40.78 77.08 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.187 0.995 . . . . 73.54 112.442 -171.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.43 -53.84 53.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.211 1.004 . . . . 70.12 111.384 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.5 mp -84.64 -11.98 54.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.493 -0.776 . . . . 74.1 111.664 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 66.7 t80 . . . . . 0 N--CA 1.48 1.026 0 C-N-CA 123.16 0.584 . . . . 53.44 110.272 -179.921 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 32.4 m . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 109.029 -0.73 . . . . 73.31 109.029 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.546 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 3.5 t80 -121.14 124.2 44.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.487 0.715 . . . . 74.1 109.896 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.425 HE21 HE22 ' C' ' 14' ' ' GLN . 27.3 tt0 -140.61 140.16 35.03 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.165 -1.05 . . . . 55.33 108.165 170.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 68.0 mt -85.96 129.74 37.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.159 -0.682 . . . . 74.05 109.159 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.486 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.1 mm-40 -87.94 -45.43 10.24 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.64 0.776 . . . . 75.35 109.727 178.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -169.7 148.21 3.59 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.024 -0.534 . . . . 72.44 109.667 -172.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.4 mt -137.58 136.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.747 -1.205 . . . . 73.03 107.747 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.464 ' HB3' HG23 ' D' ' 122' ' ' THR . 28.9 p90 -169.74 161.03 9.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.007 0.432 . . . . 73.13 111.838 -172.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.9 p -80.39 108.06 13.7 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.095 -0.705 . . . . 54.3 109.095 170.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -68.34 -37.3 80.39 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.445 -0.576 . . . . 73.14 109.445 172.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 12.8 t70 -149.78 150.27 31.78 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.49 -0.777 . . . . 65.14 109.83 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.5 mt -141.63 146.94 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.34 1.456 . . . . 61.32 107.62 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -152.19 142.37 22.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.484 0.714 . . . . 73.12 109.563 173.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -142.9 137.86 29.8 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.618 -1.253 . . . . 75.45 107.618 170.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.08 121.68 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.365 1.066 . . . . 74.33 109.293 -172.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.34 69.11 13.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 106.12 -1.807 . . . . 74.41 106.12 165.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.22 -10.35 27.09 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.555 2.17 . . . . 34.4 112.178 -174.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -123.23 26.38 8.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.664 1.585 . . . . 70.35 109.774 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.61 -58.12 4.06 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 114.64 1.348 . . . . 72.31 114.64 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.57 -33.32 46.18 Favored 'Trans proline' 0 C--N 1.388 2.609 0 CA-C-N 121.844 1.694 . . . . 73.03 112.362 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -69.41 -37.53 77.51 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.846 0.859 . . . . 75.11 111.575 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.876 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -79.31 -26.33 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 112.513 0.56 . . . . 74.5 112.513 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.25 -31.87 73.24 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 112.212 0.449 . . . . 64.04 112.212 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -85.79 9.55 16.23 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.542 0.337 . . . . 72.04 111.881 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.62 166.1 11.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.484 0.714 . . . . 54.55 111.037 -175.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -58.2 127.53 32.58 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.003 0.921 . . . . 55.33 110.018 170.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.46 ' NE1' ' HG2' ' C' ' 124' ' ' PRO . 32.9 t90 -84.95 93.24 8.51 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.613 0.765 . . . . 73.21 109.831 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -150.47 78.73 7.59 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 108.51 -0.922 . . . . 74.23 108.51 164.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.501 ' HB3' ' HB1' ' C' ' 66' ' ' ALA . 16.6 Cg_exo -68.56 136.95 37.85 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.681 2.254 . . . . 41.43 112.183 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -86.21 93.43 9.04 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 105.359 -2.089 . . . . 61.21 105.359 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 17.0 m -68.6 131.41 33.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 115.368 -0.833 . . . . 60.1 109.755 -176.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 tptt -134.9 129.62 34.64 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.526 -1.657 . . . . 74.13 106.526 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.55 HD21 HD11 ' C' ' 128' ' ' LEU . 2.8 tm? -116.32 139.68 50.13 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.508 -0.923 . . . . 70.23 108.508 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.549 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.2 t70 -134.4 141.2 46.76 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.453 1.101 . . . . 55.32 108.971 -177.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 79.6 mt -132.11 137.15 47.61 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.309 1.044 . . . . 64.42 108.917 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.509 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 27.3 t70 -144.81 155.23 43.39 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.11 0.964 . . . . 71.13 109.201 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 5.1 m -151.1 138.55 19.51 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.29 1.036 . . . . 62.43 109.577 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.67 173.92 10.17 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.742 1.217 . . . . 62.12 108.926 175.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -159.95 153.95 23.18 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.65 0.78 . . . . 71.14 110.039 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.8 p -155.3 137.54 14.8 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.258 0.623 . . . . 65.54 109.434 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -77.32 118.8 20.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.053 -0.721 . . . . 71.42 109.053 174.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.575 HD11 HD12 ' C' ' 83' ' ' ILE . 54.1 mt -93.35 -43.16 8.92 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.348 -0.612 . . . . 72.33 109.348 176.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -148.79 -177.89 6.05 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.227 -0.897 . . . . 75.12 110.919 -177.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.91 123.8 21.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.722 -1.126 . . . . 73.54 109.101 175.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 61.27 18.81 9.55 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.444 1.098 . . . . 65.01 112.056 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 77.4 t -127.88 103.67 10.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 124.351 1.06 . . . . 64.12 109.238 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.503 ' HD1' HD11 ' C' ' 86' ' ' ILE . 24.7 m-85 -102.3 146.49 27.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.489 -0.778 . . . . 72.25 108.986 169.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.55 ' HB2' HD11 ' C' ' 51' ' ' LEU . 35.0 tt0 -94.35 129.07 41.18 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.408 -1.33 . . . . 70.42 107.408 160.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.408 HG11 ' HD3' ' C' ' 103' ' ' PRO . 42.4 t -106.27 143.4 17.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.993 -1.114 . . . . 74.3 107.993 165.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.0 t -121.28 140.66 44.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 107.931 -1.137 . . . . 75.25 107.931 172.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -129.71 106.97 9.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.553 -1.277 . . . . 72.15 107.553 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.509 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 58.7 ttt-85 -95.41 122.64 38.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.993 -1.458 . . . . 74.23 108.83 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.9 t -117.27 132.35 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.013 -1.106 . . . . 64.5 108.013 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.8 m -134.12 128.95 35.18 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.3 0.64 . . . . 74.22 109.715 -174.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.624 HG23 HD13 ' C' ' 114' ' ' ILE . 61.6 t -115.64 121.03 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.839 0.856 . . . . 74.54 109.712 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.7 m -100.81 145.36 28.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.476 0.71 . . . . 74.53 109.179 170.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' C' ' 38' ' ' PRO . . . -136.98 131.37 32.85 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.792 -1.188 . . . . 62.01 107.792 169.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.7 m -139.95 129.17 23.83 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 123.598 0.561 . . . . 72.11 110.266 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 37.1 mt -85.22 41.5 0.89 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.319 1.048 . . . . 64.01 109.704 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.73 -104.17 2.54 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 110.053 -1.219 . . . . 54.04 110.053 -170.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -93.8 -29.72 15.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.263 1.025 . . . . 65.52 110.003 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -73.14 120.17 18.4 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.823 0.849 . . . . 71.14 110.268 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 35.7 m -75.88 129.64 37.29 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.568 -0.53 . . . . 51.11 109.568 173.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.876 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.27 -60.95 2.07 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.398 -0.964 . . . . 73.22 108.398 170.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -158.09 173.77 16.23 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 114.417 -1.265 . . . . 63.34 111.436 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -138.89 130.04 26.79 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.572 -1.64 . . . . 70.23 106.572 162.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 46.0 t -128.35 138.73 52.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.946 -1.131 . . . . 74.43 107.946 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . 0.415 ' HG2' ' OE1' ' C' ' 79' ' ' GLN . 28.7 tt0 -154.54 129.07 9.19 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.522 -0.548 . . . . 75.52 109.522 -170.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' C' ' 61' ' ' ARG . 97.2 t -135.03 114.3 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.689 0.796 . . . . 54.41 109.921 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.415 ' OE1' ' HG2' ' C' ' 77' ' ' GLU . 1.7 mp0 -90.08 87.84 7.04 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.531 -0.915 . . . . 71.31 108.531 174.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -83.21 98.77 9.55 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.308 -0.86 . . . . 35.34 109.662 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.42 159.49 38.86 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.441 -0.664 . . . . 52.44 111.441 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.582 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -161.25 118.83 0.85 Allowed Glycine 0 CA--C 1.504 -0.614 0 N-CA-C 111.047 -0.821 . . . . 74.31 111.047 -177.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.575 HD12 HD11 ' C' ' 51' ' ' LEU . 6.9 mm -84.1 121.13 36.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.334 -0.987 . . . . 74.2 108.334 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.546 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 57.6 m-85 -126.58 118.46 24.89 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.421 -0.955 . . . . 75.32 108.421 -177.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 54.5 p -87.95 105.87 17.74 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.688 -0.856 . . . . 64.0 108.688 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.608 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -116.97 125.9 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.038 0.935 . . . . 73.22 109.341 -176.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.96 163.93 32.05 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.473 0.709 . . . . 43.51 110.697 -172.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.04 -41.99 2.88 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 115.519 -0.764 . . . . 71.14 113.111 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 46.9 mm -122.73 150.4 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.901 0.88 . . . . 70.41 110.421 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -145.52 -174.22 4.34 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.179 0.992 . . . . 73.41 111.544 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.64 -138.17 25.62 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 115.414 -0.812 . . . . 74.13 113.778 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 53.5 p -61.87 -29.12 69.98 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.152 0.981 . . . . 71.54 111.113 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -70.04 -44.71 68.66 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.471 -1.24 . . . . 75.35 111.326 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -73.7 -30.45 62.88 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 110.17 -0.307 . . . . 64.23 110.17 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.4 81.11 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.134 0.574 . . . . 63.11 109.615 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -72.17 -41.05 67.49 Favored 'General case' 0 C--O 1.241 0.636 0 O-C-N 123.464 0.478 . . . . 71.14 110.935 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -59.5 -38.18 80.23 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.272 0.983 . . . . 70.13 111.119 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 37.4 mt -101.13 -23.48 14.46 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.356 0.662 . . . . 54.55 112.417 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.78 -23.74 57.2 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 116.138 -0.483 . . . . 61.52 114.107 -170.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.64 -43.47 0.1 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.148 0.499 . . . . 62.44 111.034 -171.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -66.34 -42.79 87.61 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.425 1.49 . . . . 75.11 112.729 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 33.8 m -73.76 -43.48 6.61 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-O 118.832 -0.604 . . . . 51.13 112.277 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.408 ' HD3' HG11 ' C' ' 58' ' ' VAL . 84.8 Cg_exo -51.22 -31.83 38.2 Favored 'Trans proline' 0 C--N 1.393 2.873 0 C-N-CA 122.361 2.041 . . . . 73.13 114.201 167.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' C' ' 134' ' ' ASP . 74.7 m-20 -64.17 -35.18 79.95 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.854 0.862 . . . . 74.42 111.712 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.467 HD12 ' NH1' ' A' ' 111' ' ' ARG . 50.8 mm -68.43 -38.69 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.281 0.563 . . . . 53.24 109.723 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.582 HD21 ' HA3' ' C' ' 82' ' ' GLY . 90.9 mt -80.56 -22.71 40.53 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.725 -1.125 . . . . 73.55 112.736 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.49 ' HZ ' HD22 ' C' ' 128' ' ' LEU . 45.7 t80 -59.48 -49.73 90.84 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-O 117.75 -1.119 . . . . 75.14 113.631 -173.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -53.02 -36.68 76.91 Favored 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 122.44 2.094 . . . . 72.42 114.006 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -69.3 -52.88 23.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.763 0.825 . . . . 71.32 110.763 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.3 81.66 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.148 -0.933 . . . . 62.21 111.142 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -59.11 -54.96 41.05 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.657 1.583 . . . . 72.51 110.814 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -67.75 -33.72 75.4 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.554 0.742 . . . . 75.41 110.251 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 28.1 t -68.58 -31.84 71.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.03 0.532 . . . . 74.11 111.496 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.624 HD13 HG23 ' C' ' 64' ' ' VAL . 64.2 mt -68.92 -52.44 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.129 -0.487 . . . . 65.14 109.993 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 3.6 m -65.49 -28.83 69.48 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 123.741 0.651 . . . . 72.42 111.24 -174.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 46.3 t -66.53 -49.31 66.92 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 123.771 0.828 . . . . 51.4 109.413 171.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.619 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.09 -40.72 86.16 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.804 1.242 . . . . 65.41 112.917 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.542 HG13 ' HB2' ' C' ' 123' ' ' PHE . 39.2 t -67.75 -42.48 86.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.323 1.049 . . . . 64.45 110.351 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.0 t -70.0 -27.22 64.51 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.716 -0.675 . . . . 51.2 111.154 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.481 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.1 mtt-85 -68.38 -36.85 79.78 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.807 0.843 . . . . 74.33 108.93 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.39 9.26 67.98 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 124.052 0.845 . . . . 51.23 112.834 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 57.0 p 55.52 36.61 27.5 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.614 1.565 . . . . 54.21 113.759 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.542 ' HB2' HG13 ' C' ' 118' ' ' VAL . 97.0 m-85 -96.64 158.03 34.32 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.916 0.887 . . . . 63.42 109.243 172.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.46 ' HG2' ' NE1' ' C' ' 36' ' ' TRP . 34.6 Cg_exo -61.52 157.7 40.21 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 122.993 2.462 . . . . 70.34 113.882 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -60.18 141.24 56.25 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.448 1.099 . . . . 73.23 113.184 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.54 HD22 HG11 ' C' ' 64' ' ' VAL . 0.5 OUTLIER -134.72 96.7 3.6 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.961 -1.018 . . . . 75.3 109.816 170.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -90.65 95.62 10.24 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.288 -1.005 . . . . 75.53 108.288 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.55 HD11 HD21 ' C' ' 42' ' ' LEU . 1.3 tt -60.49 129.36 41.21 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.498 1.119 . . . . 73.03 110.628 -172.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.86 148.72 98.44 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.373 0.669 . . . . 72.54 111.284 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.593 ' HG3' HD12 ' A' ' 16' ' ' ILE . 50.1 Cg_exo -54.29 117.56 4.06 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.783 2.322 . . . . 53.14 112.693 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.35 118.21 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.822 -0.807 . . . . 73.01 108.822 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.91 88.56 4.71 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.089 0.556 . . . . 73.44 109.935 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -73.82 -45.25 52.49 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.072 -0.714 . . . . 73.14 109.072 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.513 ' HB2' ' ND2' ' C' ' 104' ' ' ASN . 20.6 t70 -66.98 -41.64 86.44 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.277 -1.328 . . . . 72.45 111.707 -168.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.86 94.19 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.755 -1.111 . . . . 63.12 112.075 -177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.31 -26.44 46.93 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 116.035 -0.53 . . . . 62.55 112.378 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 11.2 t80 . . . . . 0 N--CA 1.484 1.263 0 C-N-CA 122.717 0.407 . . . . 71.04 110.742 179.404 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 57.5 m . . . . . 0 C--O 1.238 0.461 0 N-CA-C 109.371 -0.603 . . . . 72.13 109.371 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -157.46 96.21 1.52 Allowed 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.879 -1.156 . . . . 70.25 107.879 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -113.67 130.15 56.45 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.292 -1.373 . . . . 63.22 107.292 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.511 HG21 HD11 ' D' ' 16' ' ' ILE . 39.9 mt -73.21 119.28 19.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.503 -0.925 . . . . 71.55 108.503 176.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -87.06 -30.97 20.76 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.462 0.476 . . . . 63.44 110.651 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -176.55 139.59 0.33 Allowed 'General case' 0 C--N 1.369 1.443 0 C-N-CA 122.483 0.313 . . . . 75.53 110.53 -170.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.511 HD11 HG21 ' D' ' 13' ' ' ILE . 3.1 mp -120.89 134.58 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.76 -1.2 . . . . 71.22 107.76 172.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -161.3 172.42 16.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.948 0.88 . . . . 71.0 111.919 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 45.7 p -104.34 124.3 48.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.758 -1.11 . . . . 72.21 109.221 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -94.55 -20.04 19.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.334 0.654 . . . . 73.43 110.186 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.721 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 3.7 t70 -158.66 135.18 9.39 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.139 -1.06 . . . . 34.42 108.139 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.619 HG21 ' HE2' ' C' ' 117' ' ' MET . 72.6 mt -135.9 145.33 31.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.068 -1.086 . . . . 73.33 108.068 175.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -151.21 144.1 24.51 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.897 0.748 . . . . 73.33 109.325 172.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.0 t80 -145.13 115.61 7.62 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 105.939 -1.875 . . . . 73.55 105.939 168.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 22.9 mt-10 -119.86 110.65 16.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.934 -0.765 . . . . 50.21 108.934 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.52 88.36 4.1 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.842 -1.17 . . . . 42.42 107.842 172.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.88 -28.78 7.48 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.744 2.296 . . . . 52.42 112.754 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -114.67 17.97 16.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.517 1.127 . . . . 73.13 109.96 -171.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.63 -67.53 0.33 Allowed Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 114.85 1.426 . . . . 50.31 114.85 -160.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.82 -15.62 23.81 Favored 'Trans proline' 0 C--N 1.39 2.722 0 CA-C-N 122.426 1.902 . . . . 54.1 113.54 -173.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -78.45 -45.2 22.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.45 1.1 . . . . 60.04 110.736 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.04 -24.59 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 CA-C-N 115.986 -0.552 . . . . 71.55 111.617 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -52.87 -31.27 38.61 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 123.797 0.839 . . . . 73.41 113.004 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -53.01 -24.28 9.21 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.627 1.171 . . . . 72.42 111.916 -176.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -83.41 96.38 8.53 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.441 1.096 . . . . 53.33 110.066 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -74.88 83.54 2.19 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.52 0.676 . . . . 63.41 110.078 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 -155.89 156.94 35.5 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.017 1.327 . . . . 73.05 107.915 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -82.21 112.2 34.02 Favored Pre-proline 0 N--CA 1.483 1.198 0 N-CA-C 109.147 -0.686 . . . . 71.32 109.147 173.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.1 124.85 16.87 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.416 2.744 . . . . 73.54 113.917 -173.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -62.1 120.36 10.73 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.021 1.329 . . . . 74.35 110.894 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.543 HG23 HG13 ' D' ' 64' ' ' VAL . 7.2 p -95.43 127.44 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.466 0.65 . . . . 70.14 110.882 -170.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -119.61 106.78 12.51 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 105.988 -1.856 . . . . 72.54 105.988 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.539 ' H ' HD23 ' D' ' 42' ' ' LEU . 1.3 pt? -110.72 134.44 52.47 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.945 0.498 . . . . 71.13 110.612 -170.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.72 126.4 52.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.455 0.702 . . . . 74.3 109.198 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -100.81 137.09 39.67 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.162 0.985 . . . . 74.51 109.75 -175.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.542 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.9 t70 -153.9 139.13 17.49 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.437 -0.949 . . . . 70.24 108.437 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.7 t -117.24 155.65 29.09 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.094 0.473 . . . . 71.12 110.095 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.54 176.22 11.54 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.42 1.088 . . . . 75.43 108.866 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.5 p -174.21 161.36 3.51 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.82 0.448 . . . . 43.14 111.989 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 28.4 t -157.04 124.04 5.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.605 1.162 . . . . 63.03 109.806 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -78.73 123.72 27.46 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.454 -0.573 . . . . 74.14 109.454 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 38.5 mt -94.08 -32.8 13.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.16 0.584 . . . . 71.11 109.954 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.62 -176.73 4.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.775 1.23 . . . . 52.03 108.922 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.71 135.05 36.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.093 -1.077 . . . . 54.42 108.093 171.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 74.28 -0.19 3.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.412 1.485 . . . . 63.44 111.605 -174.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.0 t -129.79 118.54 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.125 0.97 . . . . 72.51 108.782 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -141.86 128.55 20.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.702 -0.481 . . . . 73.12 109.702 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -94.23 140.26 30.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.893 0.877 . . . . 75.25 109.316 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -122.75 138.56 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.971 -1.122 . . . . 73.45 107.971 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.6 t -111.55 143.19 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.541 1.136 . . . . 65.03 108.388 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.51 123.58 41.58 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.506 -0.924 . . . . 71.02 108.506 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.542 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.4 ttm-85 -102.57 96.0 6.61 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.108 -1.071 . . . . 54.32 108.108 176.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 78.2 t -99.47 128.94 50.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.327 -0.99 . . . . 71.24 108.327 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 3.6 m -120.93 144.06 48.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.226 -1.027 . . . . 73.42 108.226 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.543 HG13 HG23 ' D' ' 40' ' ' VAL . 53.3 t -136.66 101.83 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.443 -1.317 . . . . 73.45 107.443 -174.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 88.5 m -107.33 97.69 7.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.17 0.988 . . . . 72.23 108.571 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.08 152.83 18.38 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.817 -0.628 . . . . 75.12 110.958 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.7 m -144.05 130.68 20.11 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.715 -0.675 . . . . 73.41 110.518 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 32.5 mt -91.82 101.09 13.68 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.833 -1.543 . . . . 73.13 106.833 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.71 -128.64 12.74 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.625 0.578 . . . . 61.44 112.383 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.3 5.73 43.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.826 0.85 . . . . 61.44 111.804 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -123.88 140.94 52.49 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.592 0.757 . . . . 73.34 110.604 -171.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.2 m -58.16 125.73 24.44 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.106 0.962 . . . . 71.12 110.721 175.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.476 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.14 -74.72 0.43 Allowed 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.908 -1.145 . . . . 75.35 107.908 175.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . 0.499 ' HZ ' HD22 ' D' ' 126' ' ' LEU . 54.4 p90 -140.86 154.3 46.12 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-O 121.543 0.687 . . . . 72.04 110.221 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 39.7 mt -115.86 147.25 41.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.352 -1.722 . . . . 71.4 106.352 172.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.525 ' SG ' HG12 ' D' ' 114' ' ' ILE . 23.5 t -160.25 127.79 4.53 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 109.681 -0.488 . . . . 71.41 109.681 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -142.27 124.14 15.21 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.623 -0.51 . . . . 73.45 109.623 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.19 122.7 62.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 C-N-CA 123.464 0.706 . . . . 72.43 109.641 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.721 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 21.1 mt-30 -88.12 88.92 7.79 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.159 -1.052 . . . . 71.54 108.159 164.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.13 101.0 8.52 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.406 -1.27 . . . . 72.33 108.903 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.74 148.25 20.3 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.853 -0.499 . . . . 53.42 111.853 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.481 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -147.54 128.99 3.07 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 111.371 -0.692 . . . . 62.11 111.371 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.9 mt -91.76 141.75 14.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.547 -0.909 . . . . 71.43 108.547 174.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -139.43 129.47 25.07 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.459 0.703 . . . . 44.11 110.09 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -74.24 99.12 3.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.145 0.578 . . . . 65.45 109.687 168.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 9.4 tt -122.02 118.63 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-O 121.364 0.602 . . . . 44.52 110.9 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.0 167.92 21.03 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.454 1.102 . . . . 54.44 109.31 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.4 24.94 66.88 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-O 119.906 -0.386 . . . . 74.1 113.439 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.28 156.41 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.981 0.912 . . . . 74.25 111.682 -175.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.28 171.73 4.71 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.412 1.085 . . . . 72.32 110.717 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.21 -118.65 12.9 Favored Glycine 0 C--N 1.355 1.629 0 N-CA-C 114.894 0.718 . . . . 74.03 114.894 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.2 m -82.64 -28.96 30.37 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.234 0.614 . . . . 74.02 110.599 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -66.76 -42.36 86.29 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.269 0.628 . . . . 64.42 111.335 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.412 ' O ' ' HB2' ' D' ' 98' ' ' LEU . 25.9 ptt? -62.5 -39.45 93.52 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.878 -0.601 . . . . 53.11 110.244 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.77 74.53 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.543 0.737 . . . . 51.32 110.954 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -67.08 -30.36 70.38 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.76 0.824 . . . . 74.21 110.9 -176.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -79.92 -47.09 15.6 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.717 -0.674 . . . . 62.12 110.304 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' D' ' 94' ' ' MET . 4.7 tt -69.58 -55.25 10.63 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.29 1.036 . . . . 72.25 111.575 -168.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.97 10.82 73.65 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.964 -0.562 . . . . 64.32 114.09 -171.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.689 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -140.14 -65.85 0.45 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 117.346 0.573 . . . . 71.45 111.306 -175.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -70.8 -43.86 67.77 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.376 -0.829 . . . . 72.42 111.776 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -63.51 -50.02 75.11 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 124.012 0.925 . . . . 71.05 112.614 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.21 -21.9 30.78 Favored 'Trans proline' 0 C--N 1.397 3.114 0 C-N-CA 121.865 1.71 . . . . 75.13 112.907 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' D' ' 100' ' ' ALA . 0.2 OUTLIER -68.53 -32.8 73.0 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.989 0.516 . . . . 72.51 110.21 178.279 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 57.6 mt -67.6 -36.76 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 124.324 1.05 . . . . 62.12 110.643 173.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.481 HD21 ' HA3' ' D' ' 82' ' ' GLY . 89.2 mt -76.11 -18.17 59.28 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.126 -0.943 . . . . 75.33 112.392 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -68.21 -45.36 39.35 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 113.662 0.986 . . . . 74.43 113.662 -173.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -53.24 -38.87 82.1 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.324 2.016 . . . . 71.53 113.702 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -77.99 -33.35 51.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.703 0.801 . . . . 71.22 111.935 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.08 64.58 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.067 -0.716 . . . . 73.42 109.067 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -53.7 -48.08 69.9 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 124.813 1.321 . . . . 72.12 110.602 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.49 -52.13 66.52 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.329 0.652 . . . . 72.52 111.305 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.76 -44.33 77.55 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 124.081 0.863 . . . . 75.24 110.99 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.525 HG12 ' SG ' ' D' ' 76' ' ' CYS . 32.7 mt -62.26 -60.12 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.929 0.892 . . . . 70.01 110.855 174.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 93.7 m -51.67 -39.55 58.44 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.113 1.365 . . . . 75.11 112.214 -173.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 48.4 t -67.08 -44.49 79.92 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.018 -0.992 . . . . 51.0 110.022 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.41 ' HB2' ' HE3' ' D' ' 117' ' ' MET . 72.9 mtm -68.02 -26.41 65.88 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.174 0.59 . . . . 74.3 112.184 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' D' ' 114' ' ' ILE . 80.0 t -67.81 -45.59 83.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.75 0.82 . . . . 73.21 109.784 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.9 p -73.84 -26.85 60.79 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.843 -0.617 . . . . 74.12 111.054 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -70.16 -37.16 75.14 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.613 0.765 . . . . 74.1 109.481 173.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.48 11.2 61.92 Favored Glycine 0 C--N 1.357 1.704 0 O-C-N 123.986 0.804 . . . . 74.24 112.732 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.464 HG23 ' HB3' ' C' ' 17' ' ' TYR . 67.5 p 58.17 16.93 4.21 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 126.815 2.046 . . . . 72.54 115.093 174.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -79.49 146.98 66.97 Favored Pre-proline 0 C--O 1.243 0.719 0 N-CA-C 107.961 -1.125 . . . . 73.42 107.961 166.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.67 138.43 14.67 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 123.534 2.823 . . . . 74.35 112.757 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -64.68 120.04 11.68 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 123.767 0.667 . . . . 65.31 110.49 -174.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.499 HD22 ' HZ ' ' D' ' 74' ' ' PHE . 4.8 mp -104.63 101.96 11.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.959 -0.756 . . . . 72.33 108.959 -176.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -100.64 93.51 5.62 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.437 -0.949 . . . . 74.15 108.437 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.29 133.48 47.03 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.914 0.886 . . . . 71.31 110.23 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.3 137.65 95.6 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.885 0.474 . . . . 43.32 110.657 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.79 130.04 17.45 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.841 2.361 . . . . 64.21 112.339 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.71 140.74 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.423 0.689 . . . . 73.21 110.268 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -97.01 108.37 21.09 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.095 0.958 . . . . 75.33 109.73 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -76.51 -21.11 56.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.371 0.668 . . . . 64.35 111.401 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . 0.689 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 9.9 t70 -65.81 -49.91 66.53 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.527 0.731 . . . . 75.12 111.744 -171.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.1 89.87 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.842 0.714 . . . . 74.41 111.372 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.7 mp -81.01 -17.19 51.15 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.535 -1.212 . . . . 75.41 111.732 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 81.8 t80 . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 109.439 -0.578 . . . . 74.42 109.439 173.136 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.7 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 31.3 m . . . . . 0 C--O 1.239 0.538 0 N-CA-C 108.711 -0.848 . . . . 74.13 108.711 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.436 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 16.8 t80 -133.68 121.23 21.66 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.898 -1.149 . . . . 73.05 107.898 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -136.97 112.59 9.4 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.037 -0.727 . . . . 72.35 109.037 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.538 HG12 ' HD2' ' A' ' 84' ' ' PHE . 46.3 mt -81.98 114.96 23.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.42 -0.955 . . . . 72.4 108.42 171.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -80.34 -39.26 28.97 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.475 -0.784 . . . . 72.44 109.686 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -168.16 133.16 1.77 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 116.236 -0.438 . . . . 72.12 111.035 -167.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.449 HD11 HD13 ' A' ' 13' ' ' ILE . 91.5 mt -119.47 132.13 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.289 1.036 . . . . 54.14 108.304 173.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.402 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 24.7 p90 -164.22 176.72 8.94 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.709 0.766 . . . . 73.15 111.427 -171.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.6 p -109.3 118.07 35.72 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.978 -1.01 . . . . 51.14 109.112 177.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 36.9 mtpt -84.87 -26.69 27.18 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.441 -0.345 . . . . 75.41 110.328 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -152.28 132.33 13.45 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.507 -0.769 . . . . 65.25 109.083 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 62.7 mt -128.93 141.81 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.505 -1.294 . . . . 74.13 107.505 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.4 t -151.79 144.21 24.12 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 123.494 0.496 . . . . 72.33 110.831 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.477 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 59.1 t80 -144.6 128.83 17.75 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 106.712 -1.588 . . . . 74.11 106.712 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -135.83 110.72 8.78 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.638 -0.875 . . . . 63.33 108.638 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.84 85.97 8.33 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.99 -1.115 . . . . 63.42 107.99 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.67 -25.76 20.31 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.562 2.175 . . . . 64.33 111.939 -174.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -107.91 31.09 5.77 Favored 'General case' 0 C--O 1.206 -1.2 0 C-N-CA 123.784 0.834 . . . . 71.34 109.846 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -50.95 -53.98 42.12 Favored Pre-proline 0 CA--C 1.577 2.015 0 N-CA-C 113.64 0.978 . . . . 65.23 113.64 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 2.6 Cg_exo -79.58 -20.54 9.31 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.004 1.803 . . . . 75.41 113.106 173.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -88.0 -29.96 20.35 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.786 0.834 . . . . 72.14 112.131 -167.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.43 HG11 ' HE1' ' A' ' 123' ' ' PHE . 9.2 p -76.52 -13.83 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.101 0.96 . . . . 72.44 110.404 -175.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.49 -37.52 75.7 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.104 0.962 . . . . 74.25 110.857 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -73.54 -27.8 61.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.484 -0.78 . . . . 75.42 111.715 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -81.98 151.89 26.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.418 0.687 . . . . 64.12 112.219 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -64.04 140.48 58.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.617 0.767 . . . . 74.23 109.157 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -80.28 80.66 6.68 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.74 0.781 . . . . 64.32 109.474 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -132.84 72.9 76.64 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.862 -1.063 . . . . 73.23 108.716 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -89.67 149.0 5.07 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.535 2.157 . . . . 70.23 112.002 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -96.41 117.73 31.47 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.259 -1.386 . . . . 73.53 107.259 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.79 112.33 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 123.423 0.689 . . . . 75.43 110.376 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 43' ' ' ASP . 25.7 ttpt -114.23 130.78 56.63 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.662 -0.866 . . . . 71.45 108.662 172.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.434 HD22 HD22 ' A' ' 128' ' ' LEU . 69.2 tp -96.46 109.98 22.43 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.663 -1.236 . . . . 73.52 107.663 173.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.446 ' HB2' ' HE3' ' A' ' 41' ' ' LYS . 21.9 t70 -102.99 107.71 18.61 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.086 -1.079 . . . . 62.13 108.086 -177.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -96.64 161.36 13.92 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.675 -0.491 . . . . 75.33 109.675 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.611 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 8.9 t0 -153.34 127.11 8.84 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.141 -0.689 . . . . 63.12 109.141 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -105.74 120.45 41.73 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.868 -0.79 . . . . 73.11 108.868 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.17 153.31 51.91 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.052 0.941 . . . . 43.12 108.759 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.0 m -127.2 156.9 41.11 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.856 0.462 . . . . 72.02 110.874 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 38.1 t -149.23 133.17 17.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.317 0.647 . . . . 72.4 110.139 -171.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -88.05 117.45 26.94 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.83 -0.433 . . . . 63.21 109.83 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 57' ' ' GLU . 48.8 mt -95.57 -36.19 11.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.373 0.669 . . . . 73.24 110.89 -176.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.76 -168.0 0.73 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.984 0.913 . . . . 51.42 111.016 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.26 112.83 3.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.504 1.122 . . . . 74.51 110.856 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 65.39 3.77 2.44 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 124.817 1.247 . . . . 74.1 112.792 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.7 t -104.44 115.28 46.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.051 -1.092 . . . . 53.42 108.051 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.07 168.15 12.73 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.445 -0.946 . . . . 73.11 108.445 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.524 ' HB2' HD11 ' A' ' 51' ' ' LEU . 44.7 tt0 -132.04 147.38 52.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.059 -0.973 . . . . 70.24 108.885 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.433 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 65.4 t -120.87 125.52 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.006 -1.479 . . . . 73.33 107.006 164.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.86 114.62 47.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.123 -1.066 . . . . 75.34 108.123 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.606 HD22 HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -96.69 109.5 22.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.377 -0.972 . . . . 74.33 108.377 178.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 66.1 ttp85 -83.17 103.86 12.9 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.592 -0.892 . . . . 62.04 108.592 172.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.707 HG21 ' HB1' ' A' ' 110' ' ' ALA . 2.5 m -103.5 103.81 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.631 0.729 . . . . 55.11 109.228 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 m -103.12 117.05 33.68 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.449 1.1 . . . . 63.23 110.096 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 56.1 t -101.09 109.44 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.834 0.854 . . . . 54.22 109.629 176.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.1 m -103.28 108.49 19.73 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.321 -0.622 . . . . 65.45 109.321 175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.47 106.91 14.51 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.017 0.927 . . . . 64.35 108.763 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 m -140.92 148.33 40.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.939 0.496 . . . . 72.31 110.519 -175.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.15 85.68 2.45 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.982 0.896 . . . . 63.3 109.083 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.14 -106.58 2.4 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 114.421 -1.263 . . . . 62.2 112.424 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -96.4 -26.08 15.47 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.331 1.052 . . . . 72.41 110.6 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -92.73 109.17 20.59 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.821 0.849 . . . . 75.13 109.682 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.8 m -72.7 123.88 24.19 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.323 -0.621 . . . . 70.33 109.323 171.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -58.33 5.7 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.065 0.853 . . . . 74.23 108.8 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -158.85 155.77 28.41 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.233 -1.349 . . . . 75.33 109.721 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 64' ' ' VAL . 64.0 tp -126.92 138.21 53.26 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.789 -1.189 . . . . 52.41 107.789 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.565 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 73.7 m -134.43 139.99 45.94 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.095 -1.076 . . . . 73.34 108.095 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -149.35 125.59 10.78 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 117.818 0.281 . . . . 63.55 110.251 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.88 112.0 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.771 0.829 . . . . 72.21 109.819 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.409 ' OE1' ' HG3' ' A' ' 61' ' ' ARG . 2.4 mp0 -87.29 84.32 7.24 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.473 -0.936 . . . . 73.33 108.473 173.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.414 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.2 tp-100 -76.65 95.31 3.94 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 114.629 -1.169 . . . . 73.11 108.678 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.28 143.92 17.21 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.073 -0.811 . . . . 60.51 111.073 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.54 130.87 4.25 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.115 -0.794 . . . . 62.23 111.115 -177.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.0 mt -81.93 123.36 38.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.73 -0.841 . . . . 74.12 108.73 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.538 ' HD2' HG12 ' A' ' 13' ' ' ILE . 32.1 m-85 -130.81 137.38 49.4 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.852 -0.796 . . . . 74.15 108.852 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 m -97.19 116.46 29.44 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.037 -0.727 . . . . 75.33 109.037 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.78 135.15 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.062 -1.088 . . . . 74.42 108.062 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.7 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -164.0 136.72 5.1 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.001 0.921 . . . . 61.5 109.182 169.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.65 -16.38 60.89 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 114.664 0.626 . . . . 33.03 114.664 173.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.512 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -114.03 135.4 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 117.645 0.722 . . . . 72.3 109.734 178.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -140.53 172.47 12.68 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.104 0.962 . . . . 73.01 109.998 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.69 -123.78 33.1 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.036 0.835 . . . . 64.2 114.57 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.1 p -78.35 -27.59 47.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.216 1.007 . . . . 63.35 111.583 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.432 HE21 ' HA ' ' A' ' 89' ' ' ILE . 29.3 tt0 -68.34 -36.57 79.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.813 0.845 . . . . 75.3 109.97 175.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 48.3 ttm -69.44 -41.98 75.55 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 116.056 -0.52 . . . . 71.02 110.203 171.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.54 -30.12 69.56 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.988 0.515 . . . . 73.02 111.421 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -71.63 -36.43 70.75 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.244 0.618 . . . . 75.3 110.97 173.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.562 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 99.6 m -67.12 -63.09 1.13 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.815 0.446 . . . . 70.11 111.59 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.15 -17.92 61.33 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.273 0.471 . . . . 73.1 112.273 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.01 -11.96 38.23 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.262 -0.743 . . . . 63.11 114.415 -175.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.04 -52.56 0.19 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.153 0.976 . . . . 74.43 112.965 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.562 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 28.2 t80 -63.37 -56.37 16.9 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.752 1.221 . . . . 74.24 111.491 -172.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.8 m -77.67 -35.41 1.27 Allowed Pre-proline 0 CA--C 1.565 1.555 0 N-CA-C 113.245 0.832 . . . . 62.33 113.245 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.83 -39.73 57.85 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.364 2.043 . . . . 74.11 113.19 163.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -64.06 -35.16 79.82 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.073 0.549 . . . . 74.22 111.376 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.53 HG21 ' CD1' ' A' ' 13' ' ' ILE . 51.0 mm -63.25 -42.24 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.787 0.835 . . . . 72.04 110.645 176.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.414 HD22 ' HG3' ' A' ' 80' ' ' GLN . 85.5 mt -72.57 -30.06 64.09 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.08 -0.964 . . . . 72.21 112.068 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -58.36 -44.21 98.94 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 114.6 1.334 . . . . 63.14 114.6 -170.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.68 -39.84 84.5 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.191 1.927 . . . . 62.3 114.115 173.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -72.88 -40.0 65.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.231 0.613 . . . . 74.42 111.228 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.707 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.68 -40.1 88.4 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.525 -0.761 . . . . 74.43 110.489 176.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.435 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.3 ttm180 -54.15 -50.66 66.44 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.554 1.159 . . . . 75.21 110.292 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -66.86 -42.69 85.26 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.14 0.9 . . . . 72.41 111.559 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.579 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.2 t -61.46 -24.66 66.71 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.228 0.611 . . . . 74.01 111.622 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.434 HG21 HG21 ' A' ' 64' ' ' VAL . 96.7 mt -87.29 -44.19 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.4 1.08 . . . . 71.03 110.897 174.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 125' ' ' GLN . 87.7 m -62.64 -40.58 97.45 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.451 0.643 . . . . 74.23 111.244 -174.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.0 t -70.72 -41.01 72.46 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.191 -0.913 . . . . 73.53 109.595 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.477 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.2 ttm -58.4 -48.94 79.05 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.598 1.159 . . . . 73.35 112.079 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.73 -33.78 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.523 0.729 . . . . 64.31 110.734 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.4 t -72.71 -28.44 62.67 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.755 0.822 . . . . 71.5 111.191 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.1 mtt-85 -75.17 -30.24 60.66 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.545 0.738 . . . . 72.1 110.138 175.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.54 -2.17 79.27 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.794 0.684 . . . . 43.14 112.703 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.9 m 69.4 14.67 8.44 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.057 1.343 . . . . 54.43 111.596 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.43 ' HE1' HG11 ' A' ' 31' ' ' VAL . 94.0 m-85 -82.35 152.59 67.75 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 108.572 -0.899 . . . . 61.35 108.572 169.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.12 150.1 10.96 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.266 2.644 . . . . 74.25 114.064 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.7 tt0 -61.37 136.46 58.05 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.763 -0.653 . . . . 51.53 111.438 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.8 tp -117.01 102.02 8.99 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.824 -1.08 . . . . 73.24 108.857 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -97.96 104.33 16.35 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.948 -1.131 . . . . 74.1 107.948 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.434 HD22 HD22 ' A' ' 42' ' ' LEU . 89.8 mt -64.08 130.29 43.39 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.575 0.547 . . . . 62.32 109.797 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.28 138.53 97.18 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 119.086 -0.483 . . . . 74.05 110.268 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.07 115.52 2.55 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.472 2.115 . . . . 54.44 112.403 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.65 113.21 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.671 -1.233 . . . . 71.41 107.671 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.491 ' ND2' ' H ' ' A' ' 135' ' ' ALA . 5.4 t30 -88.97 85.25 6.68 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.677 -0.86 . . . . 73.42 108.677 -175.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.509 ' HA ' HD12 ' A' ' 136' ' ' LEU . 93.1 m-85 -58.57 -32.64 69.11 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.52 1.128 . . . . 74.42 112.607 -174.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.41 -47.75 80.68 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.455 -0.793 . . . . 51.22 111.319 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.491 ' H ' ' ND2' ' A' ' 132' ' ' ASN . . . -59.06 -49.46 77.78 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.636 0.585 . . . . 50.35 109.997 176.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 133' ' ' PHE . 76.2 mt -54.95 -41.14 70.74 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 124.731 1.269 . . . . 75.35 112.238 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -74.78 -34.64 62.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.99 -0.55 . . . . 64.15 110.437 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 8.5 mmt . . . . . 0 N--CA 1.48 1.062 0 C-N-CA 122.567 0.347 . . . . 52.53 110.49 177.837 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 87.7 m . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 108.054 -1.091 . . . . 74.42 108.054 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -144.76 135.36 24.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.012 0.525 . . . . 73.13 109.939 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -154.45 125.46 7.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.819 0.848 . . . . 75.24 109.053 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.511 HD11 HD13 ' B' ' 105' ' ' ILE . 17.9 mt -77.97 118.4 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.606 -0.887 . . . . 43.52 108.606 171.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -91.49 -39.52 11.9 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.868 -0.419 . . . . 50.2 109.868 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -166.88 138.29 3.32 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.756 0.66 . . . . 72.33 109.731 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.416 HD11 HD13 ' B' ' 13' ' ' ILE . 96.7 mt -115.73 145.24 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 106.878 -1.527 . . . . 64.22 106.878 169.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -169.52 168.24 9.41 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.578 0.704 . . . . 64.3 111.578 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 86.4 m -96.51 131.92 42.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.251 -0.886 . . . . 62.41 108.668 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.424 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.8 mtpt -96.58 -36.31 10.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.497 0.719 . . . . 74.22 109.979 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -152.48 145.25 24.33 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.024 -0.534 . . . . 71.2 110.91 -172.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 41.3 mm -134.46 145.18 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.755 1.222 . . . . 73.0 109.104 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 23.0 t -145.94 134.63 22.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.128 -0.942 . . . . 73.43 108.896 172.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.457 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.4 t80 -149.3 109.77 4.21 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.885 -1.154 . . . . 74.1 107.885 170.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -117.3 114.77 24.07 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.542 -0.91 . . . . 71.02 108.542 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.7 87.61 2.92 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 107.848 -1.167 . . . . 74.54 107.848 169.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.65 -51.76 4.63 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.905 2.403 . . . . 65.04 112.462 -171.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.497 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 72.3 m-20 -98.2 23.17 8.57 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.578 0.751 . . . . 53.1 110.957 -176.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -33.17 -67.06 0.2 Allowed Pre-proline 0 N--CA 1.498 1.925 0 C-N-CA 125.327 1.451 . . . . 73.45 114.64 -168.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.93 -20.78 57.75 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.348 2.032 . . . . 50.42 113.013 -172.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -96.57 -28.47 14.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.889 0.876 . . . . 73.2 112.16 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' B' ' 73' ' ' ALA . 10.7 p -83.22 -18.35 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 122.633 0.373 . . . . 71.44 111.117 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -66.39 -15.34 63.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.102 0.779 . . . . 72.31 113.102 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.483 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -62.64 -24.52 67.65 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 120.935 0.398 . . . . 70.13 110.753 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.59 ' HB2' HD13 ' B' ' 68' ' ' LEU . 89.8 mttt -96.17 101.39 13.03 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.477 1.111 . . . . 75.33 109.498 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.61 80.9 5.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.498 0.719 . . . . 71.41 109.692 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -154.17 158.91 41.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.113 -0.949 . . . . 75.54 108.682 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -75.79 108.5 6.03 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 124.081 0.952 . . . . 64.13 109.929 174.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.598 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 43.3 Cg_endo -66.72 150.02 83.61 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.918 2.412 . . . . 74.33 112.778 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -58.66 108.11 0.6 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.686 0.616 . . . . 73.23 110.771 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.463 HG13 HG13 ' B' ' 64' ' ' VAL . 81.4 t -89.86 120.99 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.975 -1.011 . . . . 51.24 110.28 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -108.07 128.95 55.13 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.703 -1.221 . . . . 70.21 107.703 168.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.575 HD22 HD11 ' B' ' 128' ' ' LEU . 40.5 tp -90.7 148.44 22.6 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.831 -0.433 . . . . 73.12 109.831 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -148.11 141.11 24.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.393 1.077 . . . . 74.35 108.167 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 96.0 mt -135.42 142.74 45.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.484 0.714 . . . . 74.25 109.783 -175.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 6.2 m-20 -132.08 110.29 10.6 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.898 -1.149 . . . . 73.31 107.898 165.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 23.6 p -109.84 100.07 9.11 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.767 -0.827 . . . . 74.51 108.767 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.63 116.36 23.7 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.473 0.709 . . . . 51.13 109.28 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.408 ' HB3' HG22 ' B' ' 58' ' ' VAL . 20.2 p -100.84 162.78 12.67 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.949 0.9 . . . . 75.01 109.282 176.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.5 p -150.11 170.63 18.46 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.504 0.721 . . . . 61.31 109.641 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -113.45 107.67 16.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.499 0.72 . . . . 61.12 109.719 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.97 -38.15 64.28 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.955 0.502 . . . . 71.35 110.06 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -161.69 177.78 9.63 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.66 -1.154 . . . . 32.31 109.991 -174.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -63.48 119.21 9.32 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.704 -0.48 . . . . 63.13 109.704 174.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 71.99 -3.01 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.854 1.262 . . . . 73.34 112.779 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 97.8 t -105.09 112.5 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.812 -0.81 . . . . 71.33 108.812 175.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -126.94 139.64 52.91 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.151 0.58 . . . . 74.43 109.748 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -120.53 106.94 12.27 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.867 -0.79 . . . . 71.01 108.867 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' B' ' 48' ' ' SER . 96.7 t -92.91 122.44 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.656 1.182 . . . . 74.13 111.028 -177.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.83 115.03 45.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.726 -0.472 . . . . 74.03 109.726 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.22 120.27 37.27 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.579 -1.267 . . . . 72.55 107.579 174.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.447 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 13.4 ttm180 -109.0 127.74 54.34 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.23 -0.655 . . . . 71.44 109.23 172.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.49 103.73 14.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.038 -1.097 . . . . 71.45 108.038 174.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -102.61 130.81 49.6 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.393 -0.595 . . . . 63.04 109.393 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.613 HG11 HD21 ' B' ' 126' ' ' LEU . 92.1 t -122.37 112.48 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.359 1.063 . . . . 72.34 109.241 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.2 m -92.8 138.15 31.74 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.568 0.747 . . . . 32.43 109.361 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.76 142.88 24.09 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.813 0.445 . . . . 71.0 111.249 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.489 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 21.5 p -153.36 133.69 13.5 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.571 0.582 . . . . 73.13 112.571 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.598 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 52.8 mt -100.12 122.4 42.92 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.531 1.132 . . . . 64.23 111.183 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.25 -110.84 3.72 Favored Glycine 0 C--N 1.342 0.892 0 O-C-N 123.906 0.754 . . . . 62.24 113.042 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.09 5.27 20.04 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.616 0.766 . . . . 73.05 111.551 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.497 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.9 pt-20 -129.13 159.25 36.59 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.851 0.46 . . . . 64.31 110.74 -175.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 61.9 m -75.38 138.26 41.6 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.131 0.491 . . . . 72.13 110.706 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.589 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.57 -71.46 0.65 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.114 -1.069 . . . . 72.12 108.114 176.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -146.4 144.39 29.69 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.761 -0.654 . . . . 74.14 110.203 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.9 mt -123.41 112.46 17.57 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 106.656 -1.609 . . . . 73.31 106.656 174.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.497 ' SG ' HG23 ' B' ' 114' ' ' ILE . 35.6 t -116.93 154.95 29.94 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.071 -0.715 . . . . 74.34 109.071 -178.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.7 tt0 -163.97 137.22 5.31 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.012 -0.736 . . . . 63.3 109.012 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 75.4 t -133.71 146.01 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.267 1.027 . . . . 73.25 108.744 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -122.2 95.8 4.79 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.905 -0.776 . . . . 75.14 108.905 170.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -85.56 98.98 10.95 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.92 -0.771 . . . . 74.14 108.92 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.424 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -93.08 143.1 16.28 Favored Glycine 0 C--N 1.343 0.952 0 N-CA-C 111.187 -0.765 . . . . 72.32 111.187 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.417 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -143.52 127.0 2.93 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 112.165 -0.374 . . . . 61.24 112.165 -173.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 51.3 mt -85.93 127.91 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 109.11 -0.7 . . . . 74.44 109.11 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.33 157.21 47.49 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.818 1.247 . . . . 64.25 108.465 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 68.5 m -117.75 100.36 7.55 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.392 0.677 . . . . 71.34 109.41 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.536 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.5 pp -111.11 137.36 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.862 0.465 . . . . 53.21 110.001 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.55 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -154.53 166.91 31.82 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.015 0.926 . . . . 54.55 110.12 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.27 -59.27 4.81 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 111.46 -0.656 . . . . 75.33 111.46 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.536 HD11 ' HB ' ' B' ' 86' ' ' ILE . 15.4 pt -63.2 139.45 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 124.428 1.091 . . . . 42.12 110.892 171.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -152.14 151.41 31.01 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.315 0.646 . . . . 73.3 110.2 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.65 -111.86 4.11 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.959 -0.456 . . . . 25.54 111.959 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -80.53 -25.01 38.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.379 0.672 . . . . 70.24 110.812 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -68.79 -35.64 77.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.765 -0.652 . . . . 74.13 110.133 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -85.92 -23.57 26.94 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.598 -0.728 . . . . 65.35 110.598 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.02 77.19 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.967 0.413 . . . . 72.01 110.769 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 30.4 t-80 -68.3 -27.05 65.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.33 0.652 . . . . 74.35 110.823 176.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.437 ' SG ' HG21 ' B' ' 86' ' ' ILE . 18.9 t -81.19 -68.5 0.68 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.479 -0.563 . . . . 71.11 109.479 176.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.534 HD21 HG12 ' B' ' 86' ' ' ILE . 23.9 mt -69.57 -22.44 63.54 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.888 0.699 . . . . 73.01 112.888 -171.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.89 -11.17 47.41 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-O 119.53 -0.594 . . . . 44.44 113.772 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -138.37 -58.86 0.64 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.659 0.73 . . . . 43.44 112.317 -173.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -72.51 -41.69 65.63 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.941 0.496 . . . . 74.14 111.935 -172.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 86.3 m -68.66 -47.65 33.43 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.066 0.947 . . . . 72.14 111.489 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -56.78 -31.33 87.94 Favored 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 122.143 1.895 . . . . 70.42 113.582 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -62.34 -38.74 90.65 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 123.373 0.669 . . . . 73.22 110.673 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.511 HD13 HD11 ' B' ' 13' ' ' ILE . 68.0 mt -69.34 -44.11 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.789 0.836 . . . . 73.23 110.617 175.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.417 HD21 ' HA3' ' B' ' 82' ' ' GLY . 59.5 mt -73.64 -20.17 60.65 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.327 -0.851 . . . . 74.34 111.776 -176.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -62.33 -49.44 84.04 Favored Pre-proline 0 N--CA 1.481 1.105 0 N-CA-C 114.748 1.388 . . . . 71.51 114.748 -169.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.27 -32.19 82.07 Favored 'Trans proline' 0 C--N 1.377 2.077 0 CA-C-N 121.384 1.53 . . . . 73.3 112.474 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -66.58 -48.49 69.43 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.069 0.548 . . . . 72.13 110.363 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.05 -41.15 87.19 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.203 -0.908 . . . . 74.54 110.747 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -60.35 -56.29 23.22 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.487 1.115 . . . . 75.35 111.102 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.88 -35.29 80.67 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.032 0.533 . . . . 74.43 110.266 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.6 t -66.87 -37.44 84.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.879 0.472 . . . . 63.54 111.209 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.497 HG23 ' SG ' ' B' ' 76' ' ' CYS . 50.3 mt -63.22 -52.32 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.879 0.472 . . . . 74.13 110.05 172.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.451 HG21 ' OG ' ' C' ' 119' ' ' SER . 21.0 m -59.83 -31.94 70.2 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.885 0.874 . . . . 74.32 111.591 -177.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.8 t -64.8 -49.13 71.86 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.406 -0.816 . . . . 72.45 109.766 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -68.88 -31.77 70.94 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.078 0.551 . . . . 74.41 111.342 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.52 -43.71 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.776 0.83 . . . . 65.25 110.065 172.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.1 t -68.45 -31.91 71.56 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.642 -0.708 . . . . 71.24 111.499 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.579 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 76.1 mtt-85 -68.03 -41.85 81.47 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.894 -0.593 . . . . 71.23 109.728 176.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.62 1.24 86.55 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.704 0.627 . . . . 73.15 113.12 173.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 26.4 p 60.87 26.64 16.5 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.404 1.882 . . . . 71.42 113.822 171.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -80.09 162.3 62.41 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 123.819 0.848 . . . . 73.55 111.443 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -55.22 158.51 11.86 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 123.263 2.642 . . . . 72.34 113.242 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.451 HE21 ' ND2' ' B' ' 127' ' ' ASN . 66.2 tp60 -58.81 134.51 56.94 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.148 -0.933 . . . . 64.43 112.528 -171.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.613 HD21 HG11 ' B' ' 64' ' ' VAL . 30.9 tp -130.2 109.99 11.23 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.314 -0.857 . . . . 65.12 108.976 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.451 ' ND2' HE21 ' B' ' 125' ' ' GLN . 64.8 m-80 -122.11 120.05 33.13 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.303 -0.999 . . . . 74.54 108.303 171.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.575 HD11 HD22 ' B' ' 42' ' ' LEU . 39.6 tp -84.72 136.22 33.81 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.71 0.404 . . . . 74.42 109.975 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.35 145.08 84.95 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.885 0.874 . . . . 60.42 111.462 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.77 130.16 35.6 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.159 2.573 . . . . 74.54 113.064 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.15 113.16 28.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 114.807 -1.088 . . . . 55.33 108.381 172.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -74.47 79.83 1.93 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.163 -1.421 . . . . 72.32 107.163 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -54.7 -38.59 67.22 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.481 0.713 . . . . 74.04 111.24 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.94 -43.13 77.12 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.354 1.062 . . . . 75.52 111.742 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.97 38.83 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.935 0.894 . . . . 75.5 111.437 -176.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -79.54 -22.28 44.08 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 116.4 -0.364 . . . . 73.52 111.203 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 73.1 t80 . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 109.943 -0.392 . . . . 70.12 109.943 178.914 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.615 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 89.5 m . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 108.125 -1.065 . . . . 60.53 108.125 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.497 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.5 t80 -108.6 122.87 47.99 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.735 -0.839 . . . . 75.04 108.735 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -136.67 128.28 28.74 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.493 -0.929 . . . . 75.04 108.493 172.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.454 HD13 HD11 ' C' ' 16' ' ' ILE . 61.1 mt -71.64 124.45 28.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.645 -0.872 . . . . 74.02 108.645 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -88.84 -46.42 8.96 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.098 0.559 . . . . 73.53 109.558 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -172.31 125.57 0.52 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.95 -0.568 . . . . 72.2 110.329 -171.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.454 HD11 HD13 ' C' ' 13' ' ' ILE . 91.3 mt -109.93 141.37 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 107.946 -1.131 . . . . 72.24 107.946 176.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.506 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 25.8 p90 -175.71 174.99 2.12 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.421 0.629 . . . . 71.31 110.775 -171.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -104.09 124.97 50.02 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.569 -0.741 . . . . 72.25 109.065 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.506 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 27.4 mmtp -69.88 -49.72 49.52 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.755 -1.202 . . . . 73.13 107.755 168.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -139.2 142.46 37.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 113.253 -1.794 . . . . 72.14 109.172 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.579 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.6 mt -138.79 142.67 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.292 -1.373 . . . . 41.03 107.292 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.1 t -156.81 150.44 24.54 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.459 0.647 . . . . 63.24 110.624 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.434 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 89.4 t80 -141.75 124.94 16.37 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.433 -1.321 . . . . 74.51 107.433 172.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 39.3 mt-10 -122.21 111.74 17.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.664 0.786 . . . . 65.12 109.516 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.92 82.04 69.18 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 107.641 -1.244 . . . . 71.45 107.641 170.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.1 -29.55 11.64 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.388 2.059 . . . . 73.41 111.824 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -99.38 19.41 15.59 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.842 0.857 . . . . 73.3 110.04 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.443 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -47.84 -55.16 18.62 Favored Pre-proline 0 CA--C 1.561 1.366 0 N-CA-C 113.793 1.034 . . . . 63.43 113.793 -171.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.513 ' HB3' HD13 ' D' ' 51' ' ' LEU . 36.3 Cg_exo -60.62 -43.39 32.94 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 121.644 1.562 . . . . 64.2 112.284 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -69.84 -30.09 67.5 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 113.861 -1.518 . . . . 73.34 112.663 -174.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.732 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.6 p -82.0 -22.06 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 112.282 0.475 . . . . 61.23 112.282 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -71.44 -23.94 61.93 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 122.246 -0.284 . . . . 73.35 111.706 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -87.19 10.58 16.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.33 0.652 . . . . 72.11 110.946 174.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.702 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -106.56 159.93 15.81 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.929 0.892 . . . . 51.21 109.818 176.081 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -73.11 121.24 19.9 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.503 0.721 . . . . 74.53 109.479 167.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -84.87 95.84 9.14 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.019 0.528 . . . . 73.11 110.171 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -142.74 75.98 17.85 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 108.162 -1.051 . . . . 71.44 108.162 166.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -87.24 156.18 8.19 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.898 2.398 . . . . 70.13 113.569 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.37 118.89 27.11 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 113.731 -1.577 . . . . 73.41 108.386 173.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.41 101.59 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 122.934 0.494 . . . . 62.54 110.003 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.476 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 2.3 mptp? -91.39 102.69 15.38 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 106.427 -1.694 . . . . 74.45 106.427 169.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 50.1 tp -97.26 126.22 42.33 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.112 0.565 . . . . 73.32 110.086 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -120.38 136.13 54.81 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.366 1.066 . . . . 62.41 108.963 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.78 132.28 54.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.048 0.939 . . . . 72.45 108.657 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -130.76 151.65 50.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.176 0.991 . . . . 75.33 108.852 169.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -149.89 144.14 25.73 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.073 -0.714 . . . . 72.13 109.073 169.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.55 149.05 43.42 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.617 0.767 . . . . 73.04 108.939 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 28.5 p -127.21 142.78 51.4 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.346 0.658 . . . . 73.21 110.397 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.7 t -145.2 128.06 16.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.955 0.902 . . . . 72.31 109.369 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -70.34 119.68 14.89 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.522 0.729 . . . . 53.22 109.728 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.576 HD11 HD12 ' C' ' 83' ' ' ILE . 51.1 mt -92.3 -29.9 16.13 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.999 0.519 . . . . 61.14 109.753 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.35 179.22 7.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.429 1.092 . . . . 64.25 110.097 176.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.68 123.32 17.62 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.597 -0.729 . . . . 64.45 109.292 175.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.99 19.42 11.85 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.177 0.923 . . . . 74.04 111.706 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.69 115.31 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.695 -0.854 . . . . 74.35 108.695 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.504 ' HD2' HD11 ' C' ' 86' ' ' ILE . 1.0 OUTLIER -115.38 157.94 23.17 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.578 0.751 . . . . 72.21 109.057 175.182 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' C' ' 48' ' ' SER . 22.5 tt0 -116.34 120.45 38.91 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.334 -1.303 . . . . 54.31 107.506 170.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.4 t -107.75 135.22 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.606 -0.887 . . . . 62.03 108.606 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.57 108.45 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.918 -0.771 . . . . 73.01 108.918 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.57 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -86.45 108.7 18.63 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.519 -1.289 . . . . 75.4 107.519 175.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.5 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 24.0 ttm180 -95.94 119.64 34.8 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.435 -0.95 . . . . 74.24 108.435 173.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.497 ' HB ' HD11 ' C' ' 114' ' ' ILE . 29.1 t -111.94 130.95 64.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.01 -1.107 . . . . 72.43 108.01 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 13.3 m -126.92 121.73 32.58 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.654 -0.869 . . . . 71.43 108.654 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.688 HG11 HD21 ' C' ' 126' ' ' LEU . 22.1 t -112.19 116.7 53.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.244 -0.65 . . . . 64.42 109.244 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 3.5 m -102.1 137.32 40.52 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.543 -0.91 . . . . 74.24 108.543 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.1 118.62 21.78 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.307 -0.997 . . . . 64.32 108.307 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 13.3 m -133.58 130.64 38.67 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.521 0.513 . . . . 74.34 110.664 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.702 HD13 ' HG2' ' C' ' 34' ' ' LYS . 25.6 mt -86.81 45.63 1.28 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.238 1.415 . . . . 61.23 109.796 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.09 -85.21 0.49 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 110.476 -1.05 . . . . 65.25 110.476 -171.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.42 -29.13 5.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.486 0.715 . . . . 51.05 110.496 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 8.2 tp10 -63.17 118.72 8.33 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.072 0.949 . . . . 73.11 109.918 175.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -74.31 117.72 16.44 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.532 -0.914 . . . . 71.44 108.532 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.732 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.68 -55.05 7.4 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.333 -0.988 . . . . 74.23 108.333 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -164.99 163.46 20.76 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.91 -1.041 . . . . 74.34 110.288 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -130.31 142.43 50.54 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 105.803 -1.925 . . . . 74.21 105.803 172.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.481 ' SG ' HG23 ' C' ' 114' ' ' ILE . 50.1 t -144.63 142.91 30.47 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.316 -0.994 . . . . 73.12 108.316 174.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -150.29 127.82 11.53 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.433 -0.58 . . . . 74.23 109.433 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 74.8 t -127.73 136.23 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.559 1.144 . . . . 60.01 108.267 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.5 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 69.7 mt-30 -109.59 87.35 2.48 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.121 -1.066 . . . . 74.33 108.121 174.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -78.21 96.9 5.33 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.341 -0.845 . . . . 52.51 109.251 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.2 146.45 21.09 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.327 -0.851 . . . . 73.2 112.399 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.493 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.27 118.11 0.9 Allowed Glycine 0 C--O 1.238 0.373 0 N-CA-C 110.958 -0.857 . . . . 63.3 110.958 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.576 HD12 HD11 ' C' ' 51' ' ' LEU . 15.5 mm -82.22 131.29 34.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.725 -0.843 . . . . 62.04 108.725 176.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -134.75 120.06 18.98 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 123.615 0.572 . . . . 72.14 110.083 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.0 p -79.72 106.16 11.54 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.153 -1.055 . . . . 62.52 108.153 170.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.504 HD11 ' HD2' ' C' ' 56' ' ' TYR . 2.3 pp -116.11 142.82 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.178 0.991 . . . . 71.3 109.98 -172.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -149.88 158.21 43.94 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.884 0.474 . . . . 53.42 110.607 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.55 -29.01 6.46 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.218 -0.447 . . . . 63.12 113.963 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.639 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -84.67 164.68 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.123 0.569 . . . . 73.41 111.401 -176.306 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -164.55 148.48 9.28 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.879 0.872 . . . . 72.42 109.205 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.88 -115.07 7.43 Favored Glycine 0 C--N 1.351 1.389 0 O-C-N 123.79 0.681 . . . . 73.13 114.516 170.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 70.4 p -79.88 -26.99 40.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.783 0.833 . . . . 54.11 110.906 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -67.34 -38.8 85.45 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.455 0.702 . . . . 73.22 109.746 173.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 40.4 ttp -73.11 -38.99 66.14 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.811 -0.632 . . . . 65.3 110.464 174.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 -40.69 85.51 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 123.776 0.672 . . . . 52.41 110.588 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.407 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 12.7 t-80 -79.1 -34.1 43.83 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 123.576 0.548 . . . . 72.13 112.029 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -53.96 -41.76 68.16 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.634 0.584 . . . . 74.21 110.533 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.99 -14.65 17.76 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.309 -0.859 . . . . 51.33 110.954 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.16 -21.9 64.25 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 114.086 0.395 . . . . 62.12 114.086 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.27 -45.03 0.09 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.489 0.552 . . . . 63.24 112.489 -171.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -67.54 -48.99 65.4 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.315 0.385 . . . . 72.33 111.439 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.497 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 94.5 m -64.58 -49.56 69.95 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 118.714 -0.66 . . . . 53.04 111.895 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.57 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 75.1 Cg_exo -56.55 -30.22 81.93 Favored 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 122.259 1.973 . . . . 63.24 114.309 170.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -64.64 -41.03 96.42 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.594 0.758 . . . . 62.53 110.589 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.435 HD12 ' NH1' ' A' ' 111' ' ' ARG . 39.3 mm -61.08 -45.23 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.557 -0.747 . . . . 71.04 110.173 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.493 HD21 ' HA3' ' C' ' 82' ' ' GLY . 71.8 mt -79.23 -16.6 56.26 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.193 -0.912 . . . . 74.22 112.418 -172.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -62.68 -48.32 86.12 Favored Pre-proline 0 CA--C 1.561 1.372 0 N-CA-C 114.194 1.183 . . . . 73.0 114.194 -172.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -59.06 -34.72 99.0 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 121.833 1.689 . . . . 52.33 112.94 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -71.2 -44.95 64.42 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.504 0.721 . . . . 75.25 110.831 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.14 -44.7 87.98 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.333 -0.848 . . . . 61.11 109.925 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -54.1 -54.62 36.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.705 1.202 . . . . 74.52 111.305 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.62 -29.39 68.7 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.269 0.628 . . . . 71.22 110.872 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.1 t -73.9 -37.0 64.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.998 0.519 . . . . 72.44 110.973 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.497 HD11 ' HB ' ' C' ' 62' ' ' VAL . 89.4 mt -67.81 -51.72 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.342 -0.614 . . . . 71.01 109.342 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 14.5 m -58.36 -31.84 67.99 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.613 0.765 . . . . 70.32 111.404 -177.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -62.42 -57.73 10.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.328 0.651 . . . . 75.1 109.599 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.569 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.77 -41.89 61.98 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.715 1.206 . . . . 52.54 112.843 177.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' C' ' 114' ' ' ILE . 95.7 t -67.48 -46.26 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.067 0.947 . . . . 62.44 110.758 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.451 ' OG ' HG21 ' B' ' 115' ' ' THR . 39.5 t -69.72 -26.42 64.32 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.556 -0.747 . . . . 72.35 111.281 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' D' ' 17' ' ' TYR . 78.1 mtt-85 -71.63 -42.11 68.02 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.467 0.707 . . . . 74.13 109.339 174.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.03 -3.11 67.6 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 123.759 0.662 . . . . 62.23 112.852 170.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p 65.5 30.82 10.56 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.828 2.051 . . . . 71.31 113.506 171.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -88.79 142.18 30.43 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 108.078 -1.082 . . . . 55.05 108.078 167.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.49 172.39 0.48 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 123.213 2.609 . . . . 73.53 115.732 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -46.19 135.0 8.16 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.746 1.619 . . . . 75.43 114.83 -169.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.688 HD21 HG11 ' C' ' 64' ' ' VAL . 43.7 tp -137.15 86.86 2.23 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.183 -1.371 . . . . 61.15 108.631 176.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -116.21 114.94 25.12 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.004 0.922 . . . . 71.42 109.105 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.09 137.3 38.15 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 122.588 0.355 . . . . 42.44 110.562 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.66 157.98 88.72 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 124.744 1.217 . . . . 74.33 111.272 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.73 111.67 0.65 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.233 2.622 . . . . 72.23 112.835 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.5 t -97.52 112.07 28.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.193 -0.669 . . . . 73.44 109.193 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.64 77.94 7.42 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.392 0.677 . . . . 55.04 109.744 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -60.14 -38.96 84.68 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.689 -0.687 . . . . 64.24 109.414 171.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -57.46 -35.28 69.95 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 114.095 -1.411 . . . . 64.12 112.745 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.64 -51.98 67.08 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 124.122 0.889 . . . . 74.35 111.134 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.8 mp -74.83 -35.01 62.43 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.836 -0.62 . . . . 63.45 111.435 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . 0.407 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 2.2 t80 . . . . . 0 CA--C 1.551 1.011 0 C-N-CA 122.678 0.391 . . . . 73.31 110.566 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 C--O 1.239 0.542 0 N-CA-C 109.652 -0.499 . . . . 43.35 109.652 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -148.53 96.46 2.6 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.306 -1.368 . . . . 72.23 107.306 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -119.25 122.42 41.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.378 -0.971 . . . . 64.14 108.378 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.446 HD11 HD13 ' D' ' 105' ' ' ILE . 41.2 mt -78.49 114.66 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.841 -1.17 . . . . 74.44 107.841 169.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -84.86 -38.73 19.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.356 0.262 . . . . 74.43 111.504 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -169.3 127.22 0.96 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 119.757 -0.163 . . . . 75.24 111.248 -166.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.41 HD11 HG21 ' D' ' 13' ' ' ILE . 2.4 mp -105.33 134.59 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.144 -1.428 . . . . 73.45 107.144 164.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 36.2 p90 -154.87 165.45 36.63 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.975 0.893 . . . . 64.32 111.033 174.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -98.54 117.97 34.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.337 -1.301 . . . . 65.22 109.46 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.44 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 33.2 mtpt -82.25 -33.68 29.12 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.729 -0.841 . . . . 74.21 108.729 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -143.95 144.53 31.74 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.535 -1.211 . . . . 51.15 109.398 173.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.569 HD13 ' HE3' ' C' ' 117' ' ' MET . 47.2 mt -133.73 141.25 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.41 -1.33 . . . . 62.31 107.41 172.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -144.1 137.1 27.3 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.955 0.902 . . . . 70.04 108.917 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.579 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.0 t80 -152.33 128.66 10.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.237 -1.764 . . . . 74.23 106.237 172.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -138.41 125.66 21.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.67 0.788 . . . . 74.33 109.354 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.29 83.8 60.59 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.257 -1.016 . . . . 73.03 108.257 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.42 -23.55 20.25 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.692 2.262 . . . . 53.14 112.62 -173.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 -106.84 1.69 24.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.569 0.748 . . . . 65.55 111.075 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.404 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -27.27 -66.64 0.11 Allowed Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 116.702 2.112 . . . . 53.21 116.702 -161.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.75 -22.29 9.12 Favored 'Trans proline' 0 C--N 1.38 2.229 0 CA-C-N 123.544 2.301 . . . . 72.14 113.718 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -70.73 -38.09 73.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.213 1.005 . . . . 73.22 109.291 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.515 HG22 HD12 ' D' ' 68' ' ' LEU . 9.9 p -84.92 -21.86 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 115.801 -0.636 . . . . 64.23 111.738 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -65.95 -20.36 66.18 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 112.418 0.525 . . . . 72.42 112.418 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.54 -22.15 64.89 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.296 0.638 . . . . 74.1 110.439 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -88.6 83.52 6.77 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.43 1.092 . . . . 70.12 108.396 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.23 93.2 5.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.552 -0.749 . . . . 44.42 110.099 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -160.36 158.28 29.36 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.3 1.04 . . . . 75.53 109.102 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -65.92 107.42 1.53 Allowed Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 124.007 0.923 . . . . 62.43 109.548 171.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.92 117.29 4.3 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 122.964 2.443 . . . . 73.44 112.867 -167.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.84 121.61 21.16 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.103 -0.703 . . . . 64.24 109.103 -175.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' D' ' 66' ' ' ALA . 14.5 m -107.86 151.05 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.492 0.717 . . . . 70.5 112.309 -168.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -109.37 125.3 52.23 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.709 -1.219 . . . . 75.24 107.709 164.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 65.4 mt -97.03 133.89 41.11 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.796 -0.446 . . . . 74.31 109.796 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -145.65 128.45 16.31 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.452 -1.314 . . . . 51.23 107.452 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.85 159.18 42.21 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.418 0.627 . . . . 72.31 111.071 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.0 t70 -136.48 128.96 30.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.479 1.512 . . . . 61.22 108.304 -170.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.6 t -106.06 146.77 29.71 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.28 -0.637 . . . . 72.22 109.28 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.99 170.48 19.77 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.709 0.804 . . . . 72.55 109.032 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 88.9 p -162.9 155.2 18.59 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 123.163 0.289 . . . . 65.24 110.83 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 22.2 t -153.44 153.88 33.34 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.489 1.116 . . . . 72.23 109.726 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.96 136.99 32.72 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 109.542 -0.54 . . . . 64.41 109.542 172.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' C' ' 29' ' ' PRO . 26.7 mt -109.5 -34.64 6.45 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.156 0.583 . . . . 75.54 110.138 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -157.01 -178.62 7.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.937 0.895 . . . . 71.43 110.243 176.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.72 118.62 10.52 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.474 -0.785 . . . . 74.33 110.082 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 56.79 17.22 3.09 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 124.998 1.319 . . . . 73.31 113.036 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 77.9 t -118.51 110.29 29.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 106.696 -1.594 . . . . 73.4 106.696 171.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.477 ' HB2' HD11 ' D' ' 86' ' ' ILE . 6.0 t80 -120.7 161.26 21.72 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.431 -0.952 . . . . 64.5 108.431 -170.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -129.74 145.42 51.54 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.306 -0.861 . . . . 63.3 109.516 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.71 125.05 66.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.064 -1.458 . . . . 61.23 107.064 172.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 43.6 t -103.26 133.2 47.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.935 -0.765 . . . . 64.42 108.935 176.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.57 118.42 31.62 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.665 -0.865 . . . . 73.24 108.665 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.469 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.2 ttm-85 -104.27 96.05 6.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.253 -1.018 . . . . 74.41 108.253 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.35 125.21 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.874 -0.787 . . . . 51.43 108.874 174.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 5.9 m -118.07 134.01 55.38 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 123.633 0.583 . . . . 73.04 109.669 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.407 HG21 HG21 ' D' ' 114' ' ' ILE . 64.4 t -119.58 117.66 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.305 1.042 . . . . 72.24 108.914 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 31.9 m -105.91 94.1 5.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.885 0.874 . . . . 72.2 108.652 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -96.2 151.31 19.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.013 0.525 . . . . 61.4 111.337 -172.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.424 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 56.7 p -147.0 135.62 22.02 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.35 -0.841 . . . . 74.34 111.449 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.515 HD12 HG22 ' D' ' 31' ' ' VAL . 22.6 mt -96.56 94.42 7.35 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.518 -1.29 . . . . 74.32 107.518 167.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.77 -117.01 8.76 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.313 -0.858 . . . . 74.2 112.577 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -93.69 4.77 53.42 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.851 0.86 . . . . 74.15 111.914 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -118.9 140.29 50.22 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.013 0.525 . . . . 74.45 110.183 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.6 m -63.57 116.15 5.36 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 123.456 0.472 . . . . 52.31 110.255 174.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.488 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -77.24 -72.12 0.37 Allowed 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.949 -0.759 . . . . 51.21 108.949 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -142.03 153.42 44.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.573 -0.739 . . . . 74.52 109.935 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 79.2 mt -115.48 148.52 39.35 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.935 -1.506 . . . . 72.23 106.935 169.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.528 ' SG ' HG12 ' D' ' 114' ' ' ILE . 47.4 t -155.1 143.12 20.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.27 -0.641 . . . . 74.21 109.27 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -155.8 127.28 7.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.61 -0.515 . . . . 74.14 109.61 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.31 120.52 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 122.863 0.465 . . . . 74.24 110.125 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -89.48 83.57 6.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.977 -0.749 . . . . 72.3 108.977 171.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -79.7 91.55 5.28 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.789 -1.096 . . . . 71.43 108.78 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.84 143.23 18.92 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 110.96 -0.856 . . . . 75.12 110.96 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.517 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -135.31 130.77 5.54 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 112.059 -0.416 . . . . 74.25 112.059 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.44 HG13 ' HE1' ' D' ' 17' ' ' TYR . 43.5 mt -89.44 126.15 42.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 124.028 0.931 . . . . 71.21 109.026 174.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -127.76 125.57 40.15 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.532 -0.914 . . . . 64.11 108.532 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.5 t -86.45 111.17 20.29 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.652 -1.24 . . . . 65.13 107.652 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' D' ' 56' ' ' TYR . 0.9 OUTLIER -130.24 136.7 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.288 0.566 . . . . 74.02 110.538 -173.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.4 156.3 40.4 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.8 1.24 . . . . 74.4 107.882 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.28 20.92 79.46 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 121.117 -0.564 . . . . 62.4 112.322 -175.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 45.5 pt -109.8 152.35 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.057 0.943 . . . . 60.23 109.24 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -163.16 146.04 10.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.903 0.481 . . . . 72.33 110.912 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.91 -120.81 11.41 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.17 0.828 . . . . 51.02 115.17 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 24.2 p -70.08 -24.06 63.16 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.482 1.113 . . . . 73.51 112.272 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -64.19 -36.11 82.99 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.443 0.697 . . . . 62.33 110.211 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.441 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 19.4 mtm -68.25 -51.88 40.19 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.52 0.513 . . . . 72.3 110.318 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.33 70.92 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.067 0.547 . . . . 71.11 111.915 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 28.9 t-80 -72.68 -32.17 65.6 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.887 0.875 . . . . 75.23 111.161 176.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.4 t -78.31 -53.52 7.21 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.491 0.316 . . . . 63.41 111.258 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' D' ' 94' ' ' MET . 4.6 pp -95.3 -18.98 20.36 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.308 0.643 . . . . 74.31 112.163 -169.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.4 13.23 56.95 Favored Glycine 0 N--CA 1.473 1.152 0 CA-C-O 120.051 -0.305 . . . . 52.23 112.693 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.685 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -152.63 -71.03 0.15 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 111.969 0.359 . . . . 73.25 111.969 -176.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -73.11 -32.74 65.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 112.378 0.51 . . . . 73.33 112.378 -171.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -71.71 -43.89 11.73 Favored Pre-proline 0 CA--C 1.561 1.365 0 CA-C-O 118.48 -0.771 . . . . 74.34 111.791 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -52.95 -36.1 73.92 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.194 1.929 . . . . 75.14 113.287 164.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -67.84 -22.31 65.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.517 0.727 . . . . 74.31 111.586 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.446 HD13 HD11 ' D' ' 13' ' ' ILE . 87.1 mt -81.1 -40.24 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.415 1.086 . . . . 71.41 110.463 172.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.517 HD21 ' HA3' ' D' ' 82' ' ' GLY . 93.9 mt -73.03 -22.75 60.58 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.246 -0.888 . . . . 71.33 111.82 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -71.68 -40.34 8.31 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 124.263 1.025 . . . . 75.31 113.308 -171.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -52.58 -42.66 60.57 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.292 1.994 . . . . 74.51 114.243 166.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -74.82 -35.72 62.43 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.167 0.587 . . . . 71.13 111.482 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.65 -42.42 86.71 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.562 -0.533 . . . . 54.04 109.562 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.637 HH12 ' HB3' ' D' ' 130' ' ' PRO . 21.2 ttp180 -51.49 -56.71 11.85 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 124.805 1.316 . . . . 72.25 110.708 173.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -67.17 -37.76 84.27 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.346 1.028 . . . . 73.34 111.584 -171.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.39 -45.25 94.22 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.467 0.479 . . . . 74.01 110.445 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.528 HG12 ' SG ' ' D' ' 76' ' ' CYS . 96.6 mt -61.8 -53.64 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.036 -0.984 . . . . 71.2 110.706 174.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -56.39 -40.35 74.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.305 1.042 . . . . 53.24 111.525 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.4 t -66.48 -43.4 85.51 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 114.783 -1.099 . . . . 61.42 110.6 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.3 mtm -70.17 -26.24 63.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.705 0.402 . . . . 61.22 111.66 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' D' ' 114' ' ' ILE . 69.2 t -68.06 -45.23 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.566 0.746 . . . . 73.44 110.019 173.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.9 p -74.84 -26.21 59.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.816 0.446 . . . . 64.24 111.473 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -75.65 -34.71 60.52 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.204 0.601 . . . . 74.11 109.646 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.36 1.65 84.68 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.651 0.595 . . . . 73.02 112.303 171.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 44.6 p 61.04 21.23 11.62 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.073 2.149 . . . . 60.43 114.458 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -78.44 142.7 62.83 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 107.86 -1.163 . . . . 73.3 107.86 168.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -50.18 137.74 37.52 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.245 2.63 . . . . 71.21 113.192 176.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -50.22 135.49 21.19 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.842 1.257 . . . . 71.01 114.04 -164.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 18.7 tp -108.84 102.0 11.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.196 0.599 . . . . 50.3 110.675 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -100.35 96.91 7.75 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.368 0.604 . . . . 74.34 109.931 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.94 123.2 19.18 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.122 1.369 . . . . 50.21 111.357 -175.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.07 122.84 88.14 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.396 0.679 . . . . 73.13 110.385 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.637 ' HB3' HH12 ' D' ' 111' ' ' ARG . 74.2 Cg_endo -80.87 128.85 6.81 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.304 2.003 . . . . 62.11 112.674 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.39 146.1 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.497 0.719 . . . . 72.33 109.807 176.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -85.6 89.83 7.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.029 0.532 . . . . 75.13 109.566 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -59.21 -24.08 62.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.61 0.764 . . . . 71.12 112.344 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . 0.685 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 9.8 t70 -60.23 -52.47 65.16 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.075 0.95 . . . . 71.34 110.7 -176.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.77 -40.04 69.55 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.127 -0.942 . . . . 71.12 111.359 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 91.4 mt -58.17 -34.5 70.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.627 0.771 . . . . 63.33 112.111 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.4 t80 . . . . . 0 N--CA 1.474 0.767 0 C-N-CA 123.377 0.671 . . . . 74.1 110.57 178.5 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.236 0.371 0 N-CA-C 109.137 -0.69 . . . . 72.23 109.137 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.488 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 21.6 t80 -134.28 125.0 26.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.7 0.8 . . . . 74.05 109.32 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -137.93 135.71 36.33 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.145 -1.057 . . . . 75.11 108.145 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.594 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.5 mt -92.83 118.31 38.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.22 -1.03 . . . . 75.52 108.22 174.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -88.83 -30.21 19.12 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 124.003 0.814 . . . . 64.44 110.272 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -171.28 147.61 2.51 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 123.275 0.359 . . . . 74.15 110.721 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 84.6 mt -137.05 134.16 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.503 1.121 . . . . 75.34 108.058 173.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.542 ' HB3' HG23 ' B' ' 122' ' ' THR . 25.1 p90 -166.54 169.2 13.97 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.773 0.797 . . . . 74.12 112.193 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -89.36 122.75 32.89 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.303 -0.862 . . . . 72.12 108.778 170.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.461 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.6 mtpt -87.7 -18.65 29.03 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.926 -0.398 . . . . 74.22 109.926 173.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.1 t70 -161.73 144.73 12.09 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.102 0.961 . . . . 75.21 109.297 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.613 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 82.0 mt -140.49 142.52 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.813 1.645 . . . . 62.41 107.172 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -146.32 139.99 26.1 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.176 0.513 . . . . 61.02 110.147 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 89.1 t80 -141.44 127.15 19.1 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.204 -1.406 . . . . 71.22 107.204 173.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -133.87 122.43 23.18 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.734 -0.469 . . . . 74.41 109.734 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.02 74.53 79.72 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.278 -1.378 . . . . 74.34 107.278 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.57 -22.09 51.66 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.662 2.241 . . . . 70.25 112.543 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 42.6 m-80 -120.01 34.81 5.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.124 0.97 . . . . 73.33 109.314 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.45 -54.21 37.39 Favored Pre-proline 0 CA--C 1.565 1.522 0 CA-C-O 118.128 -0.939 . . . . 44.32 113.4 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.97 -22.02 31.68 Favored 'Trans proline' 0 C--N 1.387 2.599 0 CA-C-N 121.607 1.609 . . . . 70.51 113.147 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 6.0 t-160 -82.03 -38.83 24.41 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.99 0.916 . . . . 63.13 110.885 -171.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 73' ' ' ALA . 34.2 m -69.43 -25.92 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.311 0.644 . . . . 74.24 111.957 -175.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -72.43 -24.51 61.23 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.192 0.597 . . . . 71.5 111.004 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -77.09 -49.07 16.12 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.687 0.795 . . . . 71.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -75.36 172.77 11.89 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.372 0.669 . . . . 75.12 111.779 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.56 116.96 4.74 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 123.444 0.698 . . . . 75.25 110.525 176.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -73.65 90.41 1.8 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.455 -0.793 . . . . 70.24 109.549 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -131.4 72.0 81.13 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.092 -1.077 . . . . 74.54 108.092 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.57 116.77 2.96 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.396 2.064 . . . . 62.32 111.245 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -94.78 111.46 23.24 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.658 -1.238 . . . . 63.13 107.658 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 m -85.71 127.82 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 114.458 -1.246 . . . . 50.32 112.013 -170.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -122.01 114.54 21.1 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.334 1.453 . . . . 75.02 107.805 177.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.6 tp -110.44 113.73 26.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.032 0.533 . . . . 52.01 109.823 -175.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -113.11 110.05 19.8 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.744 0.818 . . . . 64.11 108.902 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mp -97.88 155.35 17.1 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.179 -0.674 . . . . 75.03 109.179 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.9 t70 -148.83 146.76 28.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.432 1.093 . . . . 73.23 108.437 -174.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.2 m -141.89 134.44 28.25 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.614 0.765 . . . . 74.14 110.175 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.2 140.51 46.55 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.807 0.843 . . . . 74.32 110.61 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.464 ' HB3' HD21 ' A' ' 98' ' ' LEU . 39.5 p -92.16 152.97 19.62 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.029 0.932 . . . . 63.12 109.834 176.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -151.85 145.25 24.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.946 0.898 . . . . 61.12 109.178 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -113.44 137.76 51.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.976 -0.75 . . . . 63.23 108.976 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.3 mt -110.96 -36.42 5.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.496 0.718 . . . . 74.25 110.469 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -160.45 -176.85 5.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.388 0.675 . . . . 74.11 110.828 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.28 120.54 12.95 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.166 -1.05 . . . . 74.32 108.166 170.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 72.46 -5.91 1.71 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.778 1.231 . . . . 63.42 112.702 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 52.3 t -109.25 116.38 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.081 0.952 . . . . 65.22 108.832 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.78 162.56 28.17 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.26 0.624 . . . . 72.41 109.549 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -134.88 145.74 48.55 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.063 0.945 . . . . 72.54 109.732 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -131.6 147.57 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.5 -0.926 . . . . 75.1 108.5 166.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.13 117.3 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.728 0.811 . . . . 72.4 109.382 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.7 tp -97.91 103.28 15.2 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.874 -0.787 . . . . 51.32 108.874 173.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.612 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 27.3 ttp180 -88.26 112.99 23.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.3 0.64 . . . . 70.11 109.673 172.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.85 123.2 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.598 -0.89 . . . . 55.21 108.598 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -115.77 120.65 39.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.748 0.819 . . . . 70.4 110.061 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.446 ' O ' HD12 ' A' ' 75' ' ' LEU . 86.0 t -111.39 113.46 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.992 0.917 . . . . 51.04 110.007 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.2 m -112.06 105.6 14.03 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.82 -0.807 . . . . 64.13 108.82 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -111.38 105.36 13.97 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.198 -1.038 . . . . 70.55 108.198 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.3 p -128.85 131.29 47.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.49 0.716 . . . . 60.35 110.753 -174.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.715 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -91.83 87.15 6.14 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.564 -0.902 . . . . 71.4 108.564 175.371 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.15 -102.88 2.32 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 114.981 -1.009 . . . . 72.23 111.902 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.43 -26.12 12.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.994 0.517 . . . . 72.2 110.327 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -91.68 127.4 37.12 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.894 0.878 . . . . 52.42 109.159 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.7 m -87.4 134.56 33.56 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 122.643 0.377 . . . . 75.34 110.751 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.648 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -76.48 -61.09 2.07 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 124.283 0.989 . . . . 74.5 108.668 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -152.88 153.79 33.76 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.554 -1.203 . . . . 62.22 110.725 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 58.6 tp -122.18 136.73 54.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.849 -1.537 . . . . 71.31 106.849 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 85.8 m -140.05 103.39 4.61 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.187 0.595 . . . . 72.55 109.445 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.22 117.68 24.37 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.216 -0.661 . . . . 74.13 109.216 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -126.11 113.79 35.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 123.862 0.865 . . . . 74.34 109.683 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.612 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 50.0 mt-30 -85.38 84.86 7.51 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.65 -0.871 . . . . 73.12 108.65 170.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.403 ' O ' HD13 ' A' ' 106' ' ' LEU . 8.1 tp-100 -79.84 100.87 8.21 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.367 -0.975 . . . . 72.33 108.367 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.12 144.79 17.36 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 111.335 -0.706 . . . . 71.42 111.335 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.535 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.02 128.43 4.22 Favored Glycine 0 CA--C 1.504 -0.639 0 N-CA-C 111.369 -0.692 . . . . 70.11 111.369 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.0 mt -82.22 119.63 32.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.406 -0.961 . . . . 74.23 108.406 172.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.594 ' HD2' HG12 ' A' ' 13' ' ' ILE . 26.9 m-85 -130.31 117.73 20.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.954 -1.128 . . . . 70.03 107.954 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 p -78.75 108.42 12.16 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.973 -1.121 . . . . 73.25 107.973 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.538 ' HB ' HD11 ' A' ' 89' ' ' ILE . 42.9 pt -119.19 139.45 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.361 0.664 . . . . 63.5 109.943 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.32 159.68 28.75 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.478 1.111 . . . . 73.11 109.522 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.54 4.0 89.05 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.926 -0.375 . . . . 40.34 113.879 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -120.46 136.58 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.284 -1.006 . . . . 72.22 108.284 172.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -141.22 173.6 11.33 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.34 1.056 . . . . 74.13 109.659 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.83 -133.14 51.33 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 123.948 0.78 . . . . 72.12 114.198 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.5 p -71.55 -24.82 62.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.01 0.924 . . . . 73.11 111.854 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -68.82 -44.11 74.18 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.582 0.753 . . . . 71.33 110.17 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 52.3 ttp -63.33 -48.4 78.18 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.956 -0.387 . . . . 62.42 109.956 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.9 -31.6 68.76 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.171 0.919 . . . . 55.23 112.034 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -73.98 -45.08 52.26 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.95 0.5 . . . . 70.41 110.62 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 78.7 m -66.55 -25.04 66.46 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.177 0.591 . . . . 40.14 111.575 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 48' ' ' SER . 6.0 tt -95.72 -42.5 8.34 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.459 1.103 . . . . 74.44 110.159 -173.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.77 4.31 53.3 Favored Glycine 0 N--CA 1.472 1.045 0 CA-C-N 115.945 -0.57 . . . . 74.24 113.681 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.6 -57.79 0.32 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.224 0.512 . . . . 74.42 111.772 -176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.496 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.2 t80 -70.68 -62.43 1.4 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.118 0.567 . . . . 75.11 112.395 -170.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.3 m -68.71 -33.09 4.06 Favored Pre-proline 0 CA--C 1.567 1.618 0 N-CA-C 114.369 1.248 . . . . 73.34 114.369 -173.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.02 -24.77 44.93 Favored 'Trans proline' 0 C--N 1.39 2.742 0 CA-C-N 121.725 1.652 . . . . 63.43 112.776 167.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -73.41 -26.56 61.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.776 -0.453 . . . . 73.34 109.776 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.5 mm -63.63 -36.52 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.466 0.707 . . . . 73.03 109.818 169.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.535 HD21 ' HA3' ' A' ' 82' ' ' GLY . 76.5 mt -79.97 -17.61 52.5 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.899 0.88 . . . . 63.32 111.932 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -64.69 -46.17 76.17 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 117.755 -1.117 . . . . 65.14 113.684 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.47 -33.88 67.24 Favored 'Trans proline' 0 C--N 1.389 2.675 0 CA-C-N 122.071 1.776 . . . . 74.14 112.838 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -70.53 -41.16 72.91 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.37 0.668 . . . . 70.21 111.239 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.98 -39.68 79.28 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.925 0.49 . . . . 75.21 110.405 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.474 ' NH1' HG23 ' C' ' 105' ' ' ILE . 36.5 ttm180 -53.2 -51.54 61.76 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 124.402 1.064 . . . . 54.22 109.611 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -66.59 -44.21 82.81 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.023 -0.989 . . . . 75.31 111.653 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.418 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.9 t -62.2 -33.99 75.6 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.174 0.59 . . . . 75.14 111.306 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 118' ' ' VAL . 83.3 mt -70.63 -55.97 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.112 0.965 . . . . 64.35 110.092 173.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.8 m -51.67 -43.43 62.69 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.697 1.199 . . . . 62.35 111.466 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -63.37 -47.07 83.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.906 -1.497 . . . . 54.41 110.268 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.429 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 69.0 mtm -63.13 -36.96 85.34 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.053 0.541 . . . . 62.31 111.722 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 114' ' ' ILE . 86.1 t -62.83 -47.2 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 123.507 0.723 . . . . 72.35 110.298 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.4 p -76.75 -20.25 56.71 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.153 0.581 . . . . 52.33 112.089 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -75.59 -34.89 60.66 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.005 -0.739 . . . . 72.31 109.005 172.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.43 -0.88 80.35 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.457 -0.792 . . . . 73.43 112.291 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.8 m 70.92 14.22 6.94 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 125.246 1.418 . . . . 25.24 111.578 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -77.91 157.43 79.02 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 123.619 0.767 . . . . 74.52 110.027 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.63 131.19 44.35 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.214 2.609 . . . . 71.05 111.897 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -55.24 126.41 24.78 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 124.414 1.071 . . . . 70.33 112.148 -170.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.8 tp -106.16 97.63 7.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.553 -0.748 . . . . 74.01 109.295 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 80.4 m-20 -95.78 107.63 19.88 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.389 -1.337 . . . . 71.43 107.389 174.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.441 ' HB3' ' HG3' ' A' ' 111' ' ' ARG . 30.5 tp -72.03 126.81 30.71 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.441 -0.799 . . . . 64.22 110.213 -176.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.1 139.02 92.5 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.401 0.68 . . . . 41.01 110.441 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.58 128.46 28.36 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.906 2.404 . . . . 74.14 113.192 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 96.8 t -100.22 120.88 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.858 -0.793 . . . . 72.5 108.858 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.478 HD22 ' HB3' ' A' ' 135' ' ' ALA . 1.3 p-10 -76.7 74.01 3.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.515 1.126 . . . . 65.03 110.932 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -56.36 -39.54 73.05 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.406 0.682 . . . . 74.34 111.862 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.8 -33.35 72.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.509 1.124 . . . . 73.22 111.864 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.478 ' HB3' HD22 ' A' ' 132' ' ' ASN . . . -75.46 -43.01 51.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.158 0.583 . . . . 65.42 110.168 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.5 -38.19 90.15 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.333 -0.849 . . . . 74.44 110.131 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -69.22 -38.62 78.64 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.294 -0.866 . . . . 72.02 109.949 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 C-N-CA 124.213 1.005 . . . . 61.34 110.599 176.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 C--O 1.243 0.748 0 N-CA-C 108.367 -0.975 . . . . 74.23 108.367 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -148.27 157.05 43.26 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.444 0.64 . . . . 72.23 111.389 161.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -124.1 133.33 53.63 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.116 -1.439 . . . . 70.14 107.116 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.465 HD11 HD13 ' B' ' 105' ' ' ILE . 27.7 mt -77.0 123.96 34.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.902 -0.777 . . . . 52.24 108.902 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -83.01 -45.48 14.01 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.818 0.698 . . . . 70.45 109.911 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -170.32 130.98 0.94 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.931 -0.577 . . . . 63.53 110.279 -171.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.432 HD11 HD13 ' B' ' 13' ' ' ILE . 77.6 mt -113.91 139.47 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 107.408 -1.33 . . . . 75.35 107.408 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -161.93 152.73 17.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.576 0.703 . . . . 65.24 111.762 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 81.7 m -77.47 121.36 23.74 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.165 -1.379 . . . . 73.13 108.195 171.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.587 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.1 mtpt -93.62 -29.53 15.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.528 0.731 . . . . 71.22 110.453 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -160.69 139.25 10.1 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.363 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.515 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.6 mm -133.21 142.01 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.867 1.267 . . . . 52.22 108.802 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -138.56 129.99 27.41 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.493 -1.299 . . . . 75.41 107.493 171.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.613 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.7 t80 -142.78 132.4 23.84 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.294 -1.373 . . . . 64.4 107.294 170.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.29 148.43 51.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.686 -0.857 . . . . 73.45 108.686 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.789 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -142.85 77.67 16.25 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 107.538 -1.282 . . . . 74.23 107.538 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.83 -36.83 17.27 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.928 2.419 . . . . 72.33 112.265 -171.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -100.37 -0.94 37.27 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.598 0.759 . . . . 72.32 111.346 -174.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.789 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -36.67 -66.08 0.29 Allowed Pre-proline 0 N--CA 1.494 1.728 0 C-N-CA 125.834 1.653 . . . . 61.34 115.013 -165.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.09 -24.42 73.32 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.332 2.021 . . . . 73.42 113.305 -170.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -93.12 -32.21 14.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.367 0.667 . . . . 71.24 111.262 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.612 HG22 HD12 ' B' ' 68' ' ' LEU . 1.5 p -75.56 -20.81 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 122.895 0.478 . . . . 74.34 110.922 -172.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -66.4 -10.11 40.45 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.633 0.773 . . . . 74.23 112.952 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -61.73 -28.72 69.63 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.231 0.612 . . . . 72.34 110.266 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -90.44 96.84 10.85 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 124.34 1.056 . . . . 72.42 109.536 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.08 94.99 1.97 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.507 -0.923 . . . . 64.31 108.507 171.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.439 ' HZ3' ' H ' ' B' ' 69' ' ' GLY . 26.9 t90 -169.35 154.96 6.05 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.372 1.069 . . . . 74.45 108.844 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.416 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 0.1 OUTLIER -87.07 110.59 34.35 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.046 -1.094 . . . . 64.35 108.046 170.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.422 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 53.8 Cg_endo -68.69 143.24 55.52 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.817 2.345 . . . . 63.43 113.407 -170.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.5 107.96 0.75 Allowed 'General case' 0 C--O 1.242 0.663 0 O-C-N 124.281 0.988 . . . . 73.03 110.066 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.5 m -86.34 161.2 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.207 -0.906 . . . . 75.35 110.972 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.482 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 60.3 tttp -134.16 104.29 6.14 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.612 -1.255 . . . . 72.04 107.612 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.17 124.22 31.58 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.523 -0.917 . . . . 73.1 108.523 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -140.81 109.82 6.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.214 -1.402 . . . . 64.42 107.214 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.61 155.09 17.78 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.876 -0.787 . . . . 75.31 108.876 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -155.71 149.89 25.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.452 -1.249 . . . . 72.44 108.374 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -140.65 143.12 34.98 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.352 0.596 . . . . 72.34 111.099 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.43 148.48 37.85 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.942 1.297 . . . . 63.14 107.915 172.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 72.4 p -145.03 162.92 35.76 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.114 0.416 . . . . 74.1 111.456 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -151.84 147.82 27.08 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.906 0.882 . . . . 44.53 109.833 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -84.04 131.36 34.82 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.331 0.652 . . . . 74.22 109.566 172.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 43.3 mt -93.66 -44.31 8.24 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.333 0.653 . . . . 73.22 109.509 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.62 -176.35 5.89 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.369 1.068 . . . . 74.05 110.177 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -69.47 120.35 15.13 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.713 -1.131 . . . . 64.3 109.346 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.77 16.75 10.62 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.3 1.04 . . . . 73.2 112.072 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 67.1 t -130.15 104.06 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.221 -1.029 . . . . 74.41 108.221 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -112.55 167.25 10.61 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.922 -1.14 . . . . 74.31 107.922 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -143.38 121.37 12.07 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.202 -1.036 . . . . 63.34 108.202 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -106.5 143.29 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.173 0.989 . . . . 61.32 109.39 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.508 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 35.6 t -116.78 144.53 24.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.977 -0.749 . . . . 64.35 108.977 176.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -127.71 110.06 12.28 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.143 -1.058 . . . . 72.32 108.143 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 36.1 ttm180 -94.36 122.3 36.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.841 0.856 . . . . 72.03 110.162 171.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 47.7 t -116.44 103.43 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.387 -1.338 . . . . 65.23 107.387 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.2 m -98.9 131.7 44.78 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.302 0.641 . . . . 73.11 109.542 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 91.5 t -123.49 130.02 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.023 0.929 . . . . 61.01 109.631 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.5 m -119.25 136.88 54.01 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 108.85 -0.796 . . . . 73.32 108.85 172.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.49 151.95 43.76 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.057 0.389 . . . . 65.42 110.917 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.5 p -152.22 132.77 13.87 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.175 0.922 . . . . 75.1 111.515 -173.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.612 HD12 HG22 ' B' ' 31' ' ' VAL . 77.4 mt -93.51 104.17 16.32 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.682 -1.229 . . . . 62.21 107.682 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.439 ' H ' ' HZ3' ' B' ' 36' ' ' TRP . . . 85.57 -110.7 3.47 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.462 -0.655 . . . . 54.03 111.462 -174.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.77 1.17 9.93 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.888 0.875 . . . . 73.52 110.419 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -113.55 150.87 32.36 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.034 -0.728 . . . . 70.13 109.034 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -62.16 139.11 58.48 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.822 0.702 . . . . 73.13 110.908 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.465 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -97.4 -67.78 0.83 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.545 -1.279 . . . . 65.24 107.545 170.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -145.18 160.61 41.18 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.005 -0.998 . . . . 74.54 109.993 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -135.0 138.64 44.16 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.471 -1.677 . . . . 63.03 106.471 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -150.04 157.87 43.58 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.876 0.369 . . . . 74.14 110.084 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -164.62 135.55 4.18 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.03 -1.1 . . . . 33.44 108.03 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.44 HG22 HD12 ' B' ' 21' ' ' ILE . 95.8 t -126.2 145.88 32.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.572 -0.899 . . . . 75.12 108.572 172.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.424 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 45.3 mt-30 -123.29 86.69 2.62 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.739 -0.837 . . . . 75.45 108.739 171.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.6 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.0 tp-100 -83.26 101.43 11.25 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.955 -1.021 . . . . 73.43 109.424 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.587 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.55 169.9 34.74 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.894 -0.482 . . . . 55.42 111.894 175.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.26 137.12 4.57 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 111.304 -0.718 . . . . 43.45 111.304 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.3 mt -96.87 125.91 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.044 0.938 . . . . 70.11 108.529 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -128.3 131.26 48.67 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.662 -1.236 . . . . 72.11 107.662 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 45.0 m -97.96 89.82 4.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.463 -0.569 . . . . 72.21 109.463 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.467 ' HB ' HD12 ' B' ' 89' ' ' ILE . 1.6 pp -94.42 139.67 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.424 0.69 . . . . 74.42 111.527 -166.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.29 138.49 21.43 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.37 1.068 . . . . 75.42 109.294 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.4 -35.87 4.02 Favored Glycine 0 C--N 1.345 1.033 0 O-C-N 123.642 0.589 . . . . 62.41 113.307 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.467 HD12 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -54.64 137.48 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 C-N-CA 124.805 1.242 . . . . 71.41 112.752 -175.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -158.9 142.34 14.89 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.563 0.345 . . . . 75.44 111.282 175.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' B' ' 94' ' ' MET . . . 67.04 -121.92 17.57 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 114.573 0.589 . . . . 72.04 114.573 173.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 84.8 m -65.66 -33.21 75.36 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.645 0.778 . . . . 75.03 110.193 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -68.29 -39.26 82.14 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.34 -0.845 . . . . 74.41 110.202 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' B' ' 91' ' ' GLY . 17.5 ptm -78.79 -28.9 44.68 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 116.314 -0.403 . . . . 64.02 110.72 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.91 -30.55 62.65 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.2 0.6 . . . . 70.33 110.916 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -79.61 -33.48 41.48 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.092 0.957 . . . . 72.53 109.994 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.6 t -71.37 -65.15 0.79 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.587 0.755 . . . . 61.42 110.298 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.436 HD21 HG21 ' B' ' 86' ' ' ILE . 50.6 mt -80.45 -20.24 44.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.823 0.849 . . . . 71.23 112.395 -171.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.65 -13.16 41.75 Favored Glycine 0 N--CA 1.477 1.383 0 CA-C-O 119.646 -0.53 . . . . 71.12 114.363 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.93 -52.86 0.52 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 117.612 0.706 . . . . 74.32 111.688 -172.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -73.58 -38.47 65.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.047 0.539 . . . . 73.14 111.601 -173.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.41 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.4 m -70.43 -48.23 18.1 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-O 118.655 -0.688 . . . . 74.13 111.246 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.43 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 53.5 Cg_exo -55.86 -33.26 87.97 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.107 1.872 . . . . 70.4 113.701 168.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -59.52 -39.21 83.16 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.332 0.653 . . . . 72.12 111.644 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.465 HD13 HD11 ' B' ' 13' ' ' ILE . 79.8 mt -66.11 -41.06 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.09 0.956 . . . . 62.14 110.844 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 52.6 mt -80.13 -16.04 55.78 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.404 -0.817 . . . . 70.32 111.887 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -60.21 -48.8 93.26 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.198 0.999 . . . . 73.02 113.589 -172.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.553 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 33.3 Cg_endo -61.34 -34.08 88.0 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.141 1.894 . . . . 72.32 113.498 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.6 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 94.3 m-85 -67.39 -46.86 72.01 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.692 0.397 . . . . 75.3 110.234 177.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.45 86.08 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.47 -0.786 . . . . 41.21 111.112 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.568 ' HA ' HD23 ' B' ' 128' ' ' LEU . 29.0 mtp-105 -55.16 -61.39 2.35 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.376 1.07 . . . . 71.22 111.36 175.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.37 -27.85 69.29 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.07 0.856 . . . . 74.44 110.781 -173.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.515 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.5 t -73.32 -37.94 65.97 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.108 0.563 . . . . 73.02 111.048 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 71.2 mt -64.89 -51.86 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.449 -0.574 . . . . 73.44 109.449 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.537 HG21 ' OG ' ' C' ' 119' ' ' SER . 14.4 m -58.19 -34.63 70.56 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 124.406 1.067 . . . . 71.42 111.902 -176.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 25.7 t -58.86 -52.25 66.55 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 124.028 0.83 . . . . 74.53 109.46 175.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.2 mmt -69.28 -33.46 73.24 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.496 0.719 . . . . 75.32 111.417 -174.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.04 -44.33 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.974 0.91 . . . . 53.32 110.496 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -69.48 -32.17 70.9 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.178 -0.919 . . . . 61.45 111.209 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.1 mtt-85 -67.7 -37.97 83.02 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.393 -0.821 . . . . 72.32 109.357 175.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.43 4.14 64.86 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 124.161 0.913 . . . . 52.22 113.237 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.542 HG23 ' HB3' ' A' ' 17' ' ' TYR . 82.1 p 58.8 32.07 21.85 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.169 1.787 . . . . 70.54 113.12 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -95.47 154.25 39.36 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 124.203 1.001 . . . . 71.44 110.972 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.416 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 81.2 Cg_exo -49.92 158.77 1.97 Allowed 'Trans proline' 0 C--N 1.39 2.731 0 C-N-CA 124.299 3.333 . . . . 64.42 115.652 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.515 HE21 ' ND2' ' B' ' 127' ' ' ASN . 67.6 tp60 -63.94 130.75 45.34 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 114.636 -1.166 . . . . 72.45 112.251 -172.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 68.6 tp -141.53 123.77 15.63 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.938 0.895 . . . . 52.44 109.709 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.515 ' ND2' HE21 ' B' ' 125' ' ' GLN . 51.0 m-80 -130.49 136.36 48.9 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.209 -1.034 . . . . 74.43 108.209 168.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.568 HD23 ' HA ' ' B' ' 111' ' ' ARG . 1.9 mm? -82.93 119.66 24.7 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.457 -0.942 . . . . 64.21 108.457 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.02 150.37 71.64 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.183 0.593 . . . . 61.12 111.054 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.09 140.58 41.78 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.061 2.508 . . . . 75.14 112.817 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.38 145.6 34.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.446 -1.316 . . . . 71.44 107.446 167.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -66.61 101.51 0.79 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.605 0.762 . . . . 61.45 110.902 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -61.11 -32.58 72.26 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.004 0.521 . . . . 75.11 110.126 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -69.78 -52.61 23.75 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.407 1.083 . . . . 60.13 111.193 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.19 -44.4 95.12 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 123.707 0.63 . . . . 52.2 111.184 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 66.7 mt -61.2 -37.48 83.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.959 0.504 . . . . 64.51 111.44 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 72.4 t80 . . . . . 0 N--CA 1.472 0.627 0 O-C-N 123.53 0.519 . . . . 73.43 110.733 -176.913 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.596 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 43.6 m . . . . . 0 C--O 1.242 0.674 0 N-CA-C 108.84 -0.8 . . . . 73.04 108.84 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.562 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 6.0 t80 -110.03 124.81 52.11 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.827 -0.805 . . . . 74.22 108.827 174.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -145.83 134.19 21.87 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.601 0.76 . . . . 72.15 109.162 171.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 67.2 mt -78.17 122.44 33.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.323 -0.991 . . . . 73.31 108.323 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.622 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 82.4 mm-40 -89.77 -42.19 11.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.217 -0.901 . . . . 73.41 110.639 -175.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.401 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 17.6 ttt180 -175.6 129.82 0.26 Allowed 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.384 0.427 . . . . 74.01 110.214 -168.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 66.5 mt -121.77 131.8 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.636 -0.876 . . . . 62.54 108.636 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.502 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 32.6 p90 -171.36 173.09 4.96 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.706 0.765 . . . . 73.44 111.311 -169.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.3 p -95.88 119.58 34.64 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.32 -0.855 . . . . 63.34 109.572 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.502 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 21.8 mmtp -65.32 -47.74 75.49 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 107.581 -1.266 . . . . 70.55 107.581 169.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 21.9 t70 -144.04 143.84 31.36 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 113.352 -1.749 . . . . 70.32 109.936 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.3 mt -129.96 144.36 38.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.475 -1.676 . . . . 73.4 106.475 172.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -152.53 147.25 25.98 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.35 0.595 . . . . 63.53 109.712 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -144.55 137.06 26.53 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.451 -1.314 . . . . 75.23 107.451 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -135.22 131.43 36.67 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.858 0.863 . . . . 74.51 109.352 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -154.28 76.63 5.65 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 106.799 -1.556 . . . . 61.3 106.799 172.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.66 -42.0 5.38 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.229 1.953 . . . . 75.31 111.429 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -96.96 29.04 3.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.525 1.13 . . . . 74.12 110.595 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.569 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -51.63 -55.87 25.97 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.201 -0.904 . . . . 42.52 113.408 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.5 -32.9 70.18 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 121.723 1.615 . . . . 73.34 112.684 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -67.99 -44.48 76.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.081 0.553 . . . . 54.14 110.859 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.753 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.8 p -77.17 -22.65 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 112.708 0.632 . . . . 72.22 112.708 -173.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -63.72 -33.6 76.02 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.22 0.452 . . . . 74.42 112.22 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -85.79 11.18 11.68 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.471 0.308 . . . . 60.12 111.572 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.799 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -89.95 158.51 17.36 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.505 0.722 . . . . 74.43 109.978 175.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -65.17 129.0 38.11 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.942 0.897 . . . . 73.53 109.791 165.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 58.9 t90 -82.03 94.16 7.12 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.386 0.674 . . . . 65.11 111.312 -172.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -141.39 76.15 21.65 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.644 0.778 . . . . 74.12 108.934 172.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -83.54 126.98 4.25 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.118 2.545 . . . . 51.43 113.252 -175.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.37 103.38 13.49 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.271 -1.381 . . . . 62.15 107.271 168.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 19.6 m -88.33 103.56 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.155 0.979 . . . . 61.42 110.855 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.541 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 82.7 tttt -93.87 104.11 16.19 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.802 -1.09 . . . . 74.33 108.644 177.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.13 136.72 32.82 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.351 -0.981 . . . . 74.21 108.351 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -130.88 105.34 7.7 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.927 -0.768 . . . . 54.12 108.927 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mp -103.19 135.02 45.63 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.239 -1.023 . . . . 52.2 108.239 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -151.44 155.48 38.67 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.515 0.726 . . . . 60.15 110.061 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -139.04 146.72 41.16 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.128 0.571 . . . . 75.34 109.719 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.84 146.66 43.71 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.153 0.981 . . . . 71.22 108.949 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.1 p -137.0 151.78 49.38 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.111 0.564 . . . . 53.45 110.297 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 86.4 p -149.41 157.94 43.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.854 0.862 . . . . 72.33 109.76 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -89.36 118.77 29.27 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.982 -0.747 . . . . 74.5 108.982 174.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.567 HD11 HD12 ' C' ' 83' ' ' ILE . 57.5 mt -90.8 -40.3 11.87 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.299 0.571 . . . . 55.54 109.779 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.71 177.82 10.28 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 114.395 -1.275 . . . . 62.12 108.95 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.64 119.56 14.06 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 109.264 -0.643 . . . . 63.15 109.264 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 66.92 21.81 10.27 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.545 1.138 . . . . 74.4 111.15 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 65.9 t -126.69 101.61 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.855 1.262 . . . . 73.14 108.158 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.58 ' HB2' HD11 ' C' ' 86' ' ' ILE . 0.2 OUTLIER -104.23 138.04 41.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.173 -0.677 . . . . 72.32 109.173 177.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.432 ' HB2' HD11 ' C' ' 51' ' ' LEU . 29.1 tt0 -85.57 137.75 32.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.577 -1.192 . . . . 70.35 108.667 166.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 t -122.18 139.54 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.682 -1.229 . . . . 64.41 107.682 167.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 49.6 t -131.79 131.94 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 108.545 -0.909 . . . . 73.54 108.545 175.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.21 109.35 21.01 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.802 -1.555 . . . . 65.2 106.802 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.443 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 5.8 tmm_? -99.5 105.73 17.67 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.748 -1.204 . . . . 64.42 107.748 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.466 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.3 t -107.77 138.37 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.478 -0.934 . . . . 64.21 108.478 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 35.7 m -134.04 121.22 21.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.35 -0.611 . . . . 74.03 109.35 171.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.594 HG11 HD13 ' C' ' 126' ' ' LEU . 59.7 t -106.35 111.72 36.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 114.885 -1.052 . . . . 73.45 109.014 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 7.0 m -103.36 142.72 33.74 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.213 -0.903 . . . . 72.11 109.42 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.88 120.71 19.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.716 -1.216 . . . . 74.32 107.716 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.6 m -140.44 128.0 21.5 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.565 0.541 . . . . 71.34 110.816 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.799 HD13 ' HG2' ' C' ' 34' ' ' LYS . 8.5 mt -89.27 31.63 0.89 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.174 1.39 . . . . 62.33 110.813 -176.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.67 -105.42 0.95 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 109.808 -1.317 . . . . 44.4 109.808 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.13 -18.08 17.87 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.981 0.913 . . . . 55.01 110.053 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.515 ' HG2' ' NZ ' ' C' ' 34' ' ' LYS . 5.7 tp10 -76.37 119.17 19.88 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.898 0.879 . . . . 73.22 109.515 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 44.8 m -76.98 128.42 34.48 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.261 -0.644 . . . . 74.24 109.261 172.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.753 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -78.39 -56.39 4.49 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.287 -1.005 . . . . 71.44 108.287 170.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . 0.549 ' HZ ' HD11 ' C' ' 126' ' ' LEU . 41.5 p90 -163.83 174.31 11.71 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.359 0.663 . . . . 71.24 110.716 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.12 107.68 5.07 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.37 -1.344 . . . . 72.23 107.37 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -110.58 143.43 41.0 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.827 -0.805 . . . . 62.3 108.827 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.81 134.39 15.44 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.348 0.659 . . . . 63.24 109.646 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.1 t -135.89 119.54 24.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 124.281 1.032 . . . . 64.01 109.19 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.443 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 54.3 mt-30 -92.17 88.27 6.43 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.58 -0.896 . . . . 72.3 108.58 170.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -79.64 99.49 7.39 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.736 -0.665 . . . . 44.52 109.785 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.22 144.2 16.97 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 116.416 -0.356 . . . . 71.52 112.518 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.569 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.23 135.4 5.35 Favored Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 110.536 -1.026 . . . . 41.34 110.536 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 8.8 mm -94.8 127.01 47.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.429 -0.952 . . . . 72.22 108.429 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.562 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 47.0 m-85 -134.22 118.38 17.55 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.251 -0.648 . . . . 71.41 109.251 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 53.8 m -75.7 132.92 40.84 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.219 -0.66 . . . . 73.04 109.219 175.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' C' ' 56' ' ' TYR . 1.1 pp -134.38 107.23 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.189 0.996 . . . . 74.35 109.219 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.596 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -130.25 157.71 41.75 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.898 -0.779 . . . . 72.42 108.898 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.22 -42.8 3.02 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 123.15 0.281 . . . . 53.44 113.22 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 46.4 pt -93.26 169.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.544 0.738 . . . . 71.54 110.445 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -170.47 171.88 6.29 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 124.012 0.82 . . . . 73.33 109.622 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.87 -123.64 7.53 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.777 -0.457 . . . . 64.21 112.755 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 69.1 p -68.44 -29.24 67.84 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.418 0.687 . . . . 52.1 111.234 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -64.16 -51.23 64.85 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.244 1.017 . . . . 62.52 110.645 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 21.2 ptm -74.01 -28.18 61.32 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.284 0.365 . . . . 72.4 110.564 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.11 -43.98 87.45 Favored 'General case' 0 C--N 1.362 1.135 0 O-C-N 123.682 0.614 . . . . 41.4 109.594 173.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -77.61 -42.05 36.38 Favored 'General case' 0 C--O 1.245 0.863 0 O-C-N 123.562 0.539 . . . . 64.34 111.809 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -61.79 -39.03 90.25 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.058 0.849 . . . . 61.4 110.693 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.488 HD11 HG12 ' C' ' 86' ' ' ILE . 33.5 mt -101.3 -17.01 16.75 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 122.888 0.475 . . . . 65.14 111.74 -177.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' C' ' 137' ' ' PHE . . . -77.2 -29.2 56.9 Favored Glycine 0 C--N 1.354 1.583 0 N-CA-C 114.558 0.583 . . . . 55.21 114.558 -175.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.12 -36.09 0.09 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 120.805 0.336 . . . . 63.14 111.736 -169.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.53 -45.88 74.43 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.267 1.427 . . . . 75.31 112.125 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 55.5 m -76.68 -42.56 2.98 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 118.625 -0.702 . . . . 71.01 112.734 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.31 -27.35 57.03 Favored 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 122.194 1.929 . . . . 65.12 113.832 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -66.74 -36.92 83.6 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.519 0.727 . . . . 64.01 110.845 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.474 HG23 ' NH1' ' A' ' 111' ' ' ARG . 44.2 mm -63.18 -38.28 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.352 0.661 . . . . 62.01 109.617 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.569 HD21 ' HA3' ' C' ' 82' ' ' GLY . 90.9 mt -81.83 -18.12 45.04 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.808 -1.087 . . . . 71.02 112.765 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -60.49 -48.67 92.99 Favored Pre-proline 0 CA--C 1.561 1.371 0 N-CA-C 114.133 1.16 . . . . 74.24 114.133 -172.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -62.85 -34.11 73.26 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.845 1.697 . . . . 63.23 112.7 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -70.05 -45.64 66.67 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.47 0.708 . . . . 72.4 111.013 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.38 95.79 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 115.834 -0.621 . . . . 71.11 109.613 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.533 ' HG3' HD23 ' C' ' 128' ' ' LEU . 65.3 ttt180 -57.45 -52.85 63.73 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 124.599 1.187 . . . . 62.21 111.341 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.43 -31.33 71.44 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.921 0.488 . . . . 65.43 110.584 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.8 t -73.06 -34.5 66.3 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.965 0.506 . . . . 71.44 111.132 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.466 HD11 ' HB ' ' C' ' 62' ' ' VAL . 83.8 mt -68.59 -53.71 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.261 0.624 . . . . 52.12 109.591 174.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.3 m -63.19 -28.27 69.93 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.205 1.002 . . . . 71.21 111.389 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.8 t -64.05 -51.93 61.79 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.359 0.663 . . . . 72.15 109.417 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.575 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.55 -32.13 73.04 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.3 1.04 . . . . 70.21 112.766 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.574 HG21 HD12 ' C' ' 126' ' ' LEU . 71.7 t -67.02 -46.59 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.664 0.786 . . . . 54.44 110.095 174.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.537 ' OG ' HG21 ' B' ' 115' ' ' THR . 36.9 t -63.51 -34.86 78.71 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.045 -0.979 . . . . 74.54 111.445 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -69.29 -43.57 73.57 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.305 -0.861 . . . . 71.11 109.355 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.75 -4.87 72.41 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.783 0.677 . . . . 60.53 112.802 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.5 p 61.9 34.83 16.7 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.776 2.03 . . . . 55.34 113.138 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.426 ' HB2' HG13 ' C' ' 118' ' ' VAL . 83.5 m-85 -88.09 159.74 47.56 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.397 1.079 . . . . 73.22 109.704 171.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.1 164.34 8.53 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 123.373 2.715 . . . . 71.41 114.639 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -55.32 133.22 49.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.871 1.268 . . . . 61.23 113.001 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.594 HD13 HG11 ' C' ' 64' ' ' VAL . 36.2 mt -117.38 108.77 15.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.794 0.837 . . . . 65.34 109.607 170.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.7 110.97 22.52 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.491 -0.929 . . . . 70.14 108.491 174.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.533 HD23 ' HG3' ' C' ' 111' ' ' ARG . 3.7 mm? -76.6 133.14 39.74 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.627 -0.509 . . . . 75.41 109.627 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.08 139.6 82.45 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 124.054 0.846 . . . . 74.12 111.133 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.58 96.43 0.42 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.647 2.231 . . . . 73.31 111.99 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.23 116.05 39.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.482 -1.303 . . . . 70.2 107.482 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -78.19 79.28 4.65 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.584 -0.895 . . . . 61.22 108.584 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -55.8 -34.22 65.12 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.867 0.867 . . . . 73.53 110.814 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -60.48 -51.29 70.09 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.854 1.262 . . . . 62.24 111.451 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.1 -38.8 92.39 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.046 0.539 . . . . 31.15 111.088 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.35 -27.8 67.43 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.374 -0.83 . . . . 55.04 111.338 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . 0.411 ' CE2' ' HA3' ' C' ' 99' ' ' GLY . 3.4 t80 . . . . . 0 N--CA 1.486 1.362 0 C-N-CA 123.283 0.633 . . . . 71.2 110.179 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 86.5 m . . . . . 0 CA--C 1.538 0.481 0 CA-C-O 121.237 0.541 . . . . 65.54 110.207 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -156.25 103.83 2.2 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.355 -1.35 . . . . 64.35 107.355 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -125.86 147.28 49.5 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.417 -0.957 . . . . 74.52 108.417 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.503 HG21 HD11 ' D' ' 16' ' ' ILE . 8.7 mt -95.85 129.51 45.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.71 -0.848 . . . . 74.21 108.71 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -87.08 -37.35 17.5 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.457 0.703 . . . . 73.12 111.711 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -167.82 124.71 1.12 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.004 0.372 . . . . 72.0 112.004 -170.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.503 HD11 HG21 ' D' ' 13' ' ' ILE . 2.0 mp -104.15 132.49 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.133 -1.432 . . . . 63.51 107.133 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.439 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 21.6 p90 -162.91 153.21 16.32 Favored 'General case' 0 C--N 1.337 0.061 0 O-C-N 123.652 0.595 . . . . 75.43 110.908 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -84.32 123.33 30.06 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.874 -0.787 . . . . 62.12 108.874 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.439 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.8 mtpt -92.25 -22.91 19.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.46 -0.57 . . . . 73.31 109.46 175.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.3 t70 -152.52 140.24 19.9 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.612 0.765 . . . . 74.45 109.496 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.575 HG21 ' HE2' ' C' ' 117' ' ' MET . 78.0 mt -139.83 145.6 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.805 -1.183 . . . . 74.24 107.805 174.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 58.6 m -148.5 121.45 8.78 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.431 1.093 . . . . 72.51 109.718 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.542 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 92.6 t80 -124.13 117.68 25.18 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.296 -1.742 . . . . 72.43 106.296 166.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.578 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 31.6 mt-10 -127.92 109.29 11.45 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.62 -0.511 . . . . 64.14 109.62 -174.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.41 85.91 17.04 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 108.099 -1.075 . . . . 62.05 108.099 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.83 -26.93 15.19 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.502 2.134 . . . . 75.34 112.092 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -104.24 8.37 36.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.884 0.874 . . . . 74.31 110.259 -174.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.428 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -32.99 -68.68 0.15 Allowed Pre-proline 0 CA--C 1.567 1.617 0 N-CA-C 116.32 1.97 . . . . 72.45 116.32 -165.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.459 ' HB3' HD11 ' C' ' 83' ' ' ILE . 75.7 Cg_endo -73.06 -21.49 20.55 Favored 'Trans proline' 0 C--N 1.384 2.423 0 CA-C-N 123.598 2.321 . . . . 65.44 113.699 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -74.47 -39.84 62.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.823 1.249 . . . . 72.12 110.004 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.4 p -83.67 -24.74 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.076 0.55 . . . . 64.11 112.274 -170.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.92 -19.03 63.84 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 122.867 0.467 . . . . 73.5 112.157 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -69.03 0.06 5.07 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.348 1.059 . . . . 73.14 111.933 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -110.72 100.85 9.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.881 1.272 . . . . 74.21 109.949 168.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.31 90.01 4.96 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.341 0.591 . . . . 74.44 109.598 171.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' D' ' 39' ' ' GLU . 19.7 t90 -154.32 156.11 36.34 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.1 -1.444 . . . . 64.14 107.1 174.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -70.58 107.88 2.98 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.398 -1.334 . . . . 75.41 107.398 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.458 ' O ' HG13 ' D' ' 40' ' ' VAL . 50.6 Cg_exo -55.21 125.55 19.53 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.89 2.394 . . . . 62.11 111.473 -171.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.464 ' HB2' ' CH2' ' D' ' 36' ' ' TRP . 34.1 tt0 -58.48 110.66 1.02 Allowed 'General case' 0 C--N 1.353 0.756 0 O-C-N 124.172 0.92 . . . . 74.43 109.667 -177.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.458 HG13 ' O ' ' D' ' 38' ' ' PRO . 16.2 m -98.25 122.36 49.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 121.607 0.717 . . . . 74.23 110.455 -171.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.421 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 53.3 tttm -86.27 132.28 34.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 106.392 -1.707 . . . . 63.22 106.392 165.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.21 109.15 12.0 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.326 -0.99 . . . . 54.03 108.326 -169.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -127.41 149.75 49.94 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.387 1.075 . . . . 64.04 108.387 -176.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.51 HD21 HD21 ' D' ' 60' ' ' LEU . 8.4 tt -139.43 139.25 37.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.076 -0.713 . . . . 73.21 109.076 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -133.54 139.7 46.75 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.384 1.474 . . . . 61.11 107.31 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -105.82 164.73 11.71 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.074 -0.713 . . . . 74.1 109.074 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.54 160.55 40.61 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.879 0.872 . . . . 73.11 108.899 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -159.15 151.22 20.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.053 0.541 . . . . 70.1 110.046 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.2 p -160.64 129.84 4.88 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.053 0.941 . . . . 74.33 109.167 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -73.93 133.64 43.09 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.19 0.596 . . . . 62.32 110.251 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 54.2 mt -100.76 -34.5 9.81 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.248 0.619 . . . . 42.22 110.717 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.96 -176.24 5.38 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.807 0.843 . . . . 54.54 109.974 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.85 121.62 14.48 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.108 -0.951 . . . . 74.31 109.933 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 65.61 2.93 2.23 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.886 1.275 . . . . 75.22 113.101 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.0 t -112.67 116.41 52.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.327 -0.99 . . . . 72.34 108.327 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -133.53 130.48 38.53 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.091 -1.077 . . . . 74.42 108.091 -171.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -98.65 143.81 28.62 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.923 0.889 . . . . 74.52 109.48 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 54.8 t -120.04 137.66 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.78 -1.193 . . . . 63.22 107.78 166.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.476 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.3 t -116.0 126.58 73.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.788 -1.19 . . . . 71.25 107.788 175.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.51 HD21 HD21 ' D' ' 44' ' ' LEU . 0.0 OUTLIER -104.17 117.41 34.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.619 -0.882 . . . . 60.11 108.619 -177.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -102.84 96.35 6.78 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.66 -0.867 . . . . 72.43 108.66 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 50.7 t -96.31 130.22 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.21 -1.033 . . . . 55.03 108.21 170.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 19.2 m -128.9 132.99 47.73 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.273 0.629 . . . . 43.11 110.446 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 69.1 t -126.29 112.39 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.736 1.214 . . . . 74.43 109.555 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 30.7 m -103.1 96.04 6.52 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.493 0.717 . . . . 44.32 109.301 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.13 153.83 17.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.95 0.5 . . . . 71.22 111.2 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.444 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.6 p -152.37 127.63 9.86 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.925 -0.579 . . . . 71.03 111.276 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.412 HD12 HG22 ' D' ' 31' ' ' VAL . 25.2 mt -95.76 101.71 13.43 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.967 -1.123 . . . . 73.41 107.967 170.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . 0.442 ' H ' ' HZ3' ' D' ' 36' ' ' TRP . . . 68.14 -118.6 9.63 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 123.63 0.581 . . . . 42.14 113.797 177.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.76 5.3 46.63 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.629 0.771 . . . . 71.34 113.053 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.21 164.49 32.11 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 120.89 0.376 . . . . 75.14 110.791 -174.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.1 m -68.15 132.03 46.47 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.045 -0.98 . . . . 73.13 110.697 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -86.74 -71.98 0.53 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.711 -1.218 . . . . 75.33 107.711 174.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -141.43 151.37 43.35 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 121.318 0.58 . . . . 73.35 110.436 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 72.2 mt -111.41 146.37 37.29 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.565 -1.272 . . . . 71.03 107.565 171.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.511 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.2 m -146.69 132.46 18.97 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.876 0.87 . . . . 74.31 108.686 -174.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -155.7 126.24 6.81 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.138 -1.06 . . . . 73.03 108.138 170.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.1 t -131.15 115.28 29.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 108.911 -0.774 . . . . 75.34 108.911 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 70.7 mt-30 -93.1 85.59 5.12 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.966 -0.753 . . . . 71.11 108.966 173.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.09 97.11 6.71 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.516 -1.22 . . . . 64.33 109.022 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.7 144.03 20.22 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.862 -0.495 . . . . 71.23 111.862 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.416 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -140.06 130.04 4.5 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 111.037 -0.825 . . . . 41.43 111.037 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.409 HG13 ' HE1' ' D' ' 17' ' ' TYR . 54.5 mt -90.54 123.95 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.989 -1.115 . . . . 71.04 107.989 177.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -123.95 136.06 54.07 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.638 0.775 . . . . 75.35 110.13 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 20.8 m -93.3 112.08 23.91 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.442 -0.947 . . . . 73.42 108.442 171.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 31.4 pt -108.19 122.27 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-O 121.19 0.519 . . . . 73.24 110.211 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -147.47 154.41 40.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.529 1.132 . . . . 51.32 109.072 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.23 -19.63 7.98 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 114.054 0.382 . . . . 61.4 114.054 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -127.3 154.49 37.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 124.448 1.099 . . . . 72.13 109.332 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.49 159.39 22.03 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 123.632 0.582 . . . . 75.34 110.695 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.61 -99.16 0.08 OUTLIER Glycine 0 C--N 1.355 1.597 0 O-C-N 124.218 0.949 . . . . 71.35 114.763 170.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 25.6 m -68.42 -44.38 75.12 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.246 1.018 . . . . 54.03 111.453 -174.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -72.61 -29.54 63.58 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.056 -0.52 . . . . 73.34 110.563 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 35.1 ttp -60.25 -34.97 74.45 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 123.662 0.601 . . . . 75.03 110.35 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.16 82.07 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 122.306 -0.247 . . . . 31.14 111.438 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -80.08 -43.94 20.9 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.284 0.634 . . . . 61.42 111.945 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 43.8 t -74.29 -42.57 59.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.361 0.664 . . . . 74.44 110.703 -172.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.542 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 15.0 tp -87.93 -33.84 18.32 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.362 1.065 . . . . 70.15 110.45 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.22 -26.09 29.37 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-N 116.356 -0.383 . . . . 72.23 113.948 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.18 -57.88 2.04 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 117.186 0.493 . . . . 70.55 111.389 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -70.13 -33.83 72.3 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.553 0.575 . . . . 64.45 112.553 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 69.4 m -67.36 -49.55 42.49 Favored Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 118.477 -0.773 . . . . 52.32 111.825 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.38 -30.06 90.13 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 121.864 1.71 . . . . 62.41 113.727 168.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -64.78 -37.98 89.44 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.516 0.726 . . . . 73.0 110.118 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.4 HG21 HD13 ' D' ' 13' ' ' ILE . 30.5 mm -62.94 -45.48 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.722 0.809 . . . . 64.12 110.873 173.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.416 HD21 ' HA3' ' D' ' 82' ' ' GLY . 83.2 mt -77.25 -18.18 57.82 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.926 -1.034 . . . . 71.22 112.399 -170.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -69.69 -42.12 18.15 Favored Pre-proline 0 N--CA 1.486 1.329 0 N-CA-C 113.914 1.079 . . . . 70.01 113.914 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.69 -41.75 60.12 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.033 1.822 . . . . 52.23 113.107 169.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -75.36 -35.15 61.17 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.975 0.91 . . . . 73.41 111.6 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.24 -46.55 67.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.01 0.524 . . . . 64.34 110.192 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -53.67 -49.12 68.67 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.751 1.282 . . . . 65.41 110.73 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.72 -45.77 92.54 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.308 1.005 . . . . 75.33 111.977 -175.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.4 t -63.15 -39.57 95.06 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.63 0.581 . . . . 54.22 111.231 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.457 ' O ' HG23 ' D' ' 118' ' ' VAL . 86.2 mt -59.76 -55.49 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.554 0.741 . . . . 62.05 110.093 172.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 38.3 m -56.68 -40.16 75.08 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.804 1.242 . . . . 74.41 112.005 -174.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -68.35 -40.62 81.48 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.06 -0.973 . . . . 74.33 110.561 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 68.5 mtm -68.33 -33.2 73.88 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.611 0.365 . . . . 71.21 111.524 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.8 t -63.65 -43.46 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.601 0.761 . . . . 64.34 110.36 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.89 -30.93 61.45 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 116.178 -0.464 . . . . 65.31 111.206 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -74.18 -26.15 60.12 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.205 0.602 . . . . 73.11 110.32 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.44 7.96 74.94 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.646 0.591 . . . . 63.2 112.404 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.447 HG23 ' HB3' ' C' ' 17' ' ' TYR . 44.3 p 61.11 17.21 7.84 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.514 1.926 . . . . 62.32 114.81 174.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.09 150.97 72.44 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 109.558 -0.534 . . . . 72.44 109.558 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.6 127.87 22.04 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.116 2.544 . . . . 53.01 111.448 171.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -51.65 145.31 9.39 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.676 1.235 . . . . 74.41 113.007 -171.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.427 HD13 HG11 ' D' ' 40' ' ' VAL . 56.8 tp -117.05 106.19 13.11 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.692 -0.686 . . . . 73.44 109.538 -175.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -101.95 104.19 14.87 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.037 -0.727 . . . . 74.41 109.037 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.82 118.35 13.5 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.156 -0.683 . . . . 65.45 109.156 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 135.76 89.24 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.214 0.605 . . . . 75.31 110.137 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.84 119.34 6.35 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.63 2.22 . . . . 72.32 112.314 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 82.8 t -108.85 115.55 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.083 0.953 . . . . 74.32 108.916 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -77.79 113.2 15.42 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.943 0.497 . . . . 54.24 110.037 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -72.22 -35.88 68.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.684 0.793 . . . . 72.24 111.509 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.47 -50.35 74.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.412 1.085 . . . . 71.11 111.739 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.31 71.51 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.156 0.582 . . . . 54.23 110.636 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 34.4 mt -63.3 -23.76 67.56 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.41 0.684 . . . . 43.3 112.571 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 88.4 t80 . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 123.654 0.782 . . . . 71.13 110.238 178.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 109.82 -0.437 . . . . 72.04 109.82 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.695 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 17.3 t80 -127.14 131.07 50.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.303 1.041 . . . . 64.01 109.191 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 26.5 tp60 -147.79 107.34 3.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.276 0.631 . . . . 71.45 110.052 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.598 HG12 ' HD2' ' A' ' 84' ' ' PHE . 60.7 mt -75.02 120.58 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.586 -0.524 . . . . 71.02 109.586 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -89.63 -36.99 14.96 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 124.079 0.862 . . . . 73.04 110.027 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -169.15 146.0 3.52 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 110.454 -0.202 . . . . 73.01 110.454 -171.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 97.6 mt -137.9 128.37 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 124.544 1.138 . . . . 73.35 108.058 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.465 ' HB3' HG23 ' B' ' 122' ' ' THR . 44.3 p90 -167.83 154.63 8.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.716 0.806 . . . . 73.12 111.205 -172.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.7 p -75.14 112.82 11.79 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.238 -0.652 . . . . 73.22 109.238 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HG3' ' HA3' ' A' ' 81' ' ' GLY . 32.6 mtpt -71.61 -34.35 69.78 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.251 -0.431 . . . . 63.42 110.481 174.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -153.79 148.65 26.57 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.056 -0.974 . . . . 73.4 109.111 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 80.9 mt -138.19 148.77 24.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 C-N-CA 124.947 1.299 . . . . 63.31 108.043 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 17.9 t -147.14 142.3 27.19 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.892 0.877 . . . . 74.42 109.93 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.544 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.3 t80 -153.06 132.88 13.2 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.625 1.17 . . . . 71.41 107.859 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -139.85 135.1 32.59 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.499 1.119 . . . . 72.0 108.34 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.06 87.46 48.39 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 108.32 -0.993 . . . . 74.13 108.32 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.458 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 37.3 Cg_exo -64.09 -48.65 4.7 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.608 2.872 . . . . 74.1 113.107 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -91.96 24.43 3.24 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.784 0.834 . . . . 74.13 111.169 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.571 ' HB1' ' HE2' ' B' ' 17' ' ' TYR . . . -53.07 -48.91 90.23 Favored Pre-proline 0 CA--C 1.568 1.638 0 N-CA-C 114.837 1.421 . . . . 65.14 114.837 -173.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.47 -19.73 16.62 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 121.742 1.628 . . . . 75.3 111.94 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -100.64 -13.42 18.56 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.074 -0.966 . . . . 75.1 112.29 -170.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.56 -26.04 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.798 0.839 . . . . 51.15 112.055 -169.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -78.9 -33.77 45.28 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.988 -1.006 . . . . 52.41 110.413 176.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -82.43 -32.19 29.14 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.917 0.887 . . . . 74.34 111.568 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.97 161.1 26.89 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.299 -0.63 . . . . 73.23 109.299 175.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.36 134.67 56.16 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.145 0.578 . . . . 74.53 110.059 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -95.69 85.88 4.26 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.343 0.657 . . . . 63.3 110.715 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.55 ' H ' HD12 ' A' ' 68' ' ' LEU . 79.7 mt-30 -135.58 68.53 66.74 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 123.648 0.779 . . . . 75.24 109.005 169.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -78.72 159.21 28.18 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.169 1.913 . . . . 74.24 111.867 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -106.73 105.69 15.85 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.042 -1.095 . . . . 61.3 108.042 173.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 p -74.62 93.35 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 122.363 1.078 . . . . 73.13 110.274 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 49.4 mtpt -85.82 115.56 23.54 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.347 -1.297 . . . . 53.51 108.279 172.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.3 tp -116.05 134.8 54.56 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.146 -0.687 . . . . 75.22 109.146 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.662 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 32.4 t70 -128.62 146.68 50.79 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.301 1.04 . . . . 72.32 109.168 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.2 mt -128.45 125.09 37.79 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.184 0.994 . . . . 74.55 108.496 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 21.8 t0 -129.2 148.97 51.18 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.101 0.96 . . . . 55.22 109.413 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.0 m -144.14 138.42 28.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.252 1.021 . . . . 72.53 109.923 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.9 138.59 18.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.02 0.928 . . . . 64.34 109.324 169.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.6 m -90.36 162.42 15.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.138 0.575 . . . . 73.45 110.199 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.8 t -148.8 119.61 7.58 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.384 1.073 . . . . 63.42 108.231 -174.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -78.65 120.31 23.15 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.808 -0.442 . . . . 70.0 109.808 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.0 mt -92.17 -44.99 8.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.738 -0.838 . . . . 54.12 108.738 171.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.12 -178.88 6.75 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.157 -1.383 . . . . 71.44 108.88 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -74.57 133.34 42.24 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.897 -1.149 . . . . 73.31 107.897 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 70.27 -8.66 0.83 Allowed 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 125.489 1.516 . . . . 72.21 112.871 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.7 t -110.76 106.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 N-CA-C 108.863 -0.791 . . . . 74.23 108.863 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -130.36 121.65 26.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.732 0.777 . . . . 74.51 109.202 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -93.37 121.83 35.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 124.903 1.281 . . . . 64.12 109.396 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.07 132.97 45.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.898 -1.149 . . . . 52.14 107.898 176.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.6 t -120.1 115.59 47.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.585 -0.895 . . . . 42.52 108.585 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 tt -94.33 116.64 29.05 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.277 -1.008 . . . . 62.1 108.277 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.744 ' HG3' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -93.01 102.13 14.48 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.816 -0.809 . . . . 74.13 108.816 172.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.514 HG11 ' HB1' ' A' ' 110' ' ' ALA . 2.4 p -99.61 110.17 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 108.998 -0.742 . . . . 74.14 108.998 176.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.662 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 33.8 m -95.99 133.58 40.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.282 1.033 . . . . 71.2 109.055 -176.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.4 t -130.99 115.72 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 107.981 -1.118 . . . . 74.32 107.981 -174.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 16.8 m -127.39 108.24 10.67 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.732 -0.84 . . . . 74.32 108.732 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.61 103.44 14.26 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 106.828 -1.545 . . . . 75.24 106.828 171.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.4 p -136.71 127.4 27.14 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.181 0.592 . . . . 75.41 110.39 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.55 HD12 ' H ' ' A' ' 37' ' ' GLN . 6.4 tt -89.71 88.22 7.3 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 106.844 -1.539 . . . . 73.34 106.844 173.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.29 -83.86 0.97 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.257 -0.737 . . . . 62.41 111.257 178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -119.84 -26.25 5.68 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.87 0.868 . . . . 52.33 110.866 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -82.26 101.65 10.65 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.372 0.269 . . . . 72.44 111.016 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 26' ' ' PRO . 61.6 m -70.35 112.8 6.93 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.334 0.654 . . . . 64.23 109.842 173.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.61 -59.4 4.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.174 0.989 . . . . 71.13 109.476 171.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -149.16 160.92 42.93 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.997 -1.002 . . . . 73.24 111.029 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 64' ' ' VAL . 49.1 tp -141.33 133.66 28.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.548 1.539 . . . . 63.11 107.3 -175.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.55 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 35.0 m -147.28 120.29 8.79 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 118.807 0.73 . . . . 55.14 110.381 -171.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 9.5 mp0 -128.09 128.8 45.56 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.012 -1.107 . . . . 72.44 108.012 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.7 t -131.24 110.67 18.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.34 -0.615 . . . . 73.31 109.34 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.744 ' HG3' ' HG3' ' A' ' 61' ' ' ARG . 15.5 mp0 -85.04 79.43 9.63 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.474 -1.306 . . . . 75.22 107.474 174.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.44 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.4 tp-100 -78.21 97.27 5.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.801 -1.185 . . . . 63.41 107.801 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 19' ' ' LYS . . . -93.91 147.2 18.49 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.041 -0.823 . . . . 34.14 111.041 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.41 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -148.78 126.87 2.37 Favored Glycine 0 CA--C 1.499 -0.929 0 N-CA-C 110.264 -1.134 . . . . 64.32 110.264 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 60.6 mt -82.38 114.28 23.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.653 -0.869 . . . . 72.23 108.653 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.695 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.6 m-85 -122.46 119.14 30.08 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.66 -0.867 . . . . 75.32 108.66 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 23.1 t -84.63 91.13 7.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.064 -0.717 . . . . 73.13 109.064 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -100.39 128.48 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.502 0.668 . . . . 55.32 109.23 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.89 154.75 44.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.939 1.296 . . . . 55.14 108.496 -175.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.19 9.54 81.93 Favored Glycine 0 N--CA 1.48 1.618 0 C-N-CA 121.673 -0.299 . . . . 41.31 113.715 172.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.533 HG22 ' HB3' ' A' ' 93' ' ' GLN . 0.9 OUTLIER -127.17 138.2 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.269 1.028 . . . . 61.51 110.772 -174.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -142.43 173.26 11.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.226 1.011 . . . . 73.01 109.707 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.92 -117.16 10.67 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.703 -0.681 . . . . 55.01 113.524 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.3 p -86.64 -26.63 24.27 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.702 0.801 . . . . 71.35 112.365 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.533 ' HB3' HG22 ' A' ' 89' ' ' ILE . 16.5 mm100 -60.09 -43.97 95.15 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.44 0.696 . . . . 73.31 110.512 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -62.85 -40.37 97.24 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.249 -0.887 . . . . 74.13 110.888 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.7 -26.04 62.34 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.616 0.766 . . . . 65.41 110.568 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -78.09 -30.47 49.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.243 0.617 . . . . 73.31 110.514 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.478 ' SG ' HG21 ' A' ' 89' ' ' ILE . 72.0 m -70.74 -64.84 0.82 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.48 -0.327 . . . . 61.42 110.531 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.51 -9.19 53.26 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.206 0.817 . . . . 71.32 113.206 -171.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.6 3.53 32.49 Favored Glycine 0 N--CA 1.48 1.631 0 CA-C-O 119.791 -0.449 . . . . 74.11 113.635 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.65 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.25 -64.05 0.31 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.287 0.543 . . . . 75.14 111.414 -176.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.471 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 84.2 t80 -70.5 -51.65 27.44 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.244 -0.889 . . . . 62.44 111.588 -172.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -72.9 -36.11 3.26 Favored Pre-proline 0 CA--C 1.566 1.564 0 N-CA-C 113.859 1.059 . . . . 63.04 113.859 -172.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.495 ' HA ' HD12 ' A' ' 106' ' ' LEU . 30.4 Cg_endo -65.39 -26.9 55.24 Favored 'Trans proline' 0 C--N 1.39 2.727 0 CA-C-N 121.732 1.654 . . . . 73.05 112.507 167.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.548 HD21 ' HA ' ' A' ' 132' ' ' ASN . 25.8 t-20 -71.84 -25.86 62.14 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.505 0.322 . . . . 64.52 110.252 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -62.84 -36.49 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.467 0.707 . . . . 71.22 109.926 170.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 103' ' ' PRO . 65.5 mt -78.11 -23.23 47.96 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.298 1.039 . . . . 70.1 112.36 -178.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -61.81 -43.48 87.59 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 117.797 -1.097 . . . . 73.33 113.672 -172.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.56 -38.75 60.08 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.124 1.883 . . . . 74.35 113.076 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -69.44 -41.45 76.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.374 0.669 . . . . 75.14 111.057 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.514 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -67.61 -42.41 82.42 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.499 0.719 . . . . 73.14 110.128 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.589 ' HA ' HD23 ' A' ' 128' ' ' LEU . 29.8 ttm180 -51.17 -53.33 35.77 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.833 1.333 . . . . 55.0 110.256 175.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -66.16 -42.33 89.13 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.436 1.085 . . . . 73.12 111.214 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.4 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.9 t -60.88 -34.77 75.15 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.249 0.619 . . . . 74.42 111.398 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 81.0 mt -73.75 -51.66 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.815 0.846 . . . . 51.23 109.837 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.564 HG23 ' HG3' ' A' ' 125' ' ' GLN . 95.4 m -52.35 -51.28 59.71 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.334 1.054 . . . . 52.12 111.359 -174.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -65.42 -44.0 88.75 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.117 -1.401 . . . . 73.01 110.461 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.544 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 43.0 ttp -67.2 -35.45 79.64 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.03 0.932 . . . . 64.1 111.9 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.91 -40.39 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.246 1.018 . . . . 71.34 110.037 174.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -71.71 -25.42 62.07 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.952 0.901 . . . . 73.53 111.304 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -76.29 -25.92 55.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.756 0.822 . . . . 74.0 109.605 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.04 0.12 88.95 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.826 0.704 . . . . 75.23 112.712 171.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.3 m 67.88 15.98 9.61 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.848 1.259 . . . . 74.15 111.679 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.96 156.71 69.62 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.373 0.669 . . . . 73.13 109.365 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.85 141.96 92.76 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.476 2.117 . . . . 71.12 111.554 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.564 ' HG3' HG23 ' A' ' 115' ' ' THR . 29.7 tt0 -55.03 134.77 49.25 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.192 0.933 . . . . 72.43 111.78 -175.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.7 tp -118.69 98.97 6.49 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.492 -0.776 . . . . 74.34 110.287 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -100.18 113.21 25.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.379 -1.341 . . . . 64.12 107.379 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.589 HD23 ' HA ' ' A' ' 111' ' ' ARG . 2.6 mm? -72.85 128.41 35.43 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.149 0.58 . . . . 71.2 109.522 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -56.03 135.48 73.92 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.632 0.773 . . . . 50.4 111.235 -178.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.534 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 42.8 Cg_exo -58.08 98.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.727 2.285 . . . . 74.15 112.762 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 129' ' ' ALA . 95.3 t -100.18 113.99 37.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.371 -0.974 . . . . 73.24 108.371 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.548 ' HA ' HD21 ' A' ' 104' ' ' ASN . 53.6 t30 -84.74 102.4 12.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.671 0.388 . . . . 73.43 110.045 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -63.67 -25.28 68.14 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.927 0.891 . . . . 70.21 111.468 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.65 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 7.2 t70 -65.96 -48.71 70.42 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.111 0.882 . . . . 74.52 110.432 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.37 -39.57 94.89 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.61 0.764 . . . . 70.52 111.334 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.94 -40.73 83.22 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.15 -0.932 . . . . 74.04 111.081 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -68.0 -38.45 82.65 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.191 -0.913 . . . . 72.32 109.5 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.354 0.765 0 O-C-N 124.228 0.955 . . . . 73.32 110.624 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 108.579 -0.897 . . . . 72.52 108.579 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.97 157.42 43.41 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.485 0.66 . . . . 74.44 110.21 160.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -125.45 139.11 53.92 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 107.757 -1.201 . . . . 72.11 107.757 172.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.496 HD11 HD13 ' B' ' 105' ' ' ILE . 50.4 mt -76.66 120.41 26.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.482 -0.932 . . . . 62.11 108.482 173.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -83.5 -39.61 20.25 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.075 -0.713 . . . . 75.01 109.075 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -165.73 135.78 3.51 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.597 -0.729 . . . . 74.34 110.277 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.479 HD11 HD13 ' B' ' 13' ' ' ILE . 79.9 mt -114.96 140.73 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 106.411 -1.7 . . . . 73.52 106.411 168.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.571 ' HE2' ' HB1' ' A' ' 28' ' ' ALA . 36.4 p90 -171.49 170.62 5.74 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.597 0.713 . . . . 73.15 112.041 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.684 HG21 HD11 ' B' ' 21' ' ' ILE . 24.8 m -98.11 130.72 44.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.546 -1.206 . . . . 71.3 108.792 174.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -96.26 -34.47 11.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.875 0.87 . . . . 73.11 110.407 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -148.98 136.34 20.19 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.792 -0.64 . . . . 71.02 110.555 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.684 HD11 HG21 ' B' ' 18' ' ' THR . 47.0 mm -127.98 138.62 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.222 1.009 . . . . 65.43 108.915 171.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 39.8 t -135.66 129.55 32.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.228 1.411 . . . . 71.12 107.217 174.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.4 t80 -139.7 119.79 13.65 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 107.155 -1.424 . . . . 54.04 107.155 168.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.52 113.83 19.26 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.249 -0.648 . . . . 72.2 109.249 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.644 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.59 84.55 1.95 Allowed Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 107.556 -1.276 . . . . 74.11 107.556 166.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.19 -22.83 18.66 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.748 2.299 . . . . 60.22 111.385 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.413 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 89.2 m-20 -116.55 7.81 13.78 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.664 1.186 . . . . 62.23 110.898 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.644 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -29.02 -62.62 0.21 Allowed Pre-proline 0 N--CA 1.491 1.576 0 C-N-CA 126.244 1.817 . . . . 71.25 115.186 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 21.2 Cg_exo -61.9 -49.47 6.69 Favored 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 122.183 1.922 . . . . 75.2 112.122 -170.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 77.4 m80 -88.92 -11.9 43.19 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.052 -0.977 . . . . 73.31 112.251 -171.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.718 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.4 p -81.08 -23.36 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 CA-C-N 118.303 0.501 . . . . 72.05 110.525 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -64.77 -18.96 65.53 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.929 0.892 . . . . 64.24 113.331 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.9 pt20 -66.21 -23.3 66.41 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.882 0.473 . . . . 63.42 111.043 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -83.98 95.67 8.61 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.295 0.638 . . . . 55.44 109.589 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.38 83.32 1.93 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.922 0.889 . . . . 75.12 109.352 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.414 ' HZ3' ' H ' ' B' ' 69' ' ' GLY . 28.3 t90 -159.08 155.93 28.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.947 -1.024 . . . . 71.33 109.156 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -83.03 108.31 12.22 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.057 0.943 . . . . 73.0 108.502 169.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.556 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 55.6 Cg_endo -68.66 129.53 18.97 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.418 2.079 . . . . 72.32 112.294 -173.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.89 123.48 18.14 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 123.897 0.748 . . . . 73.4 110.164 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.517 HG11 HD21 ' B' ' 126' ' ' LEU . 33.0 m -104.0 150.68 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.463 0.705 . . . . 75.3 111.785 -169.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -133.57 119.85 20.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.542 -0.91 . . . . 74.42 108.542 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.22 144.26 25.47 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.782 0.833 . . . . 73.4 109.625 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.665 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 10.2 m-20 -136.08 115.32 12.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.716 1.207 . . . . 55.15 108.368 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.9 149.47 23.37 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.415 -0.587 . . . . 74.11 109.415 177.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.9 t70 -155.62 114.23 3.48 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.353 -0.98 . . . . 74.12 108.353 177.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -113.7 103.85 11.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.23 0.612 . . . . 71.22 109.656 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.24 118.46 32.35 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.638 0.775 . . . . 62.34 109.281 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 14.0 p -102.82 162.28 13.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.983 0.513 . . . . 63.54 110.755 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -151.82 136.84 17.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.057 0.943 . . . . 73.52 109.33 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -80.87 112.25 18.08 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.358 0.663 . . . . 75.12 109.721 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' B' ' 57' ' ' GLU . 75.3 mt -81.39 -54.06 5.78 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.31 0.576 . . . . 44.44 111.023 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.409 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -144.34 -163.74 1.75 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.372 1.069 . . . . 74.3 109.362 -176.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.42 100.95 0.53 Allowed 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.966 0.791 . . . . 74.04 109.432 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 22.1 m-20 62.13 15.7 7.65 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.582 1.153 . . . . 55.44 112.839 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 95.5 t -104.39 123.89 58.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 106.085 -1.82 . . . . 73.03 106.085 169.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.91 167.22 21.61 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.944 -0.761 . . . . 74.12 108.944 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.528 ' HB2' HD11 ' B' ' 51' ' ' LEU . 12.1 tt0 -124.38 120.7 32.87 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.608 -0.886 . . . . 71.51 108.608 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.1 t -88.19 137.72 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.714 -0.847 . . . . 62.23 108.714 170.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 56.3 t -120.88 110.39 28.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.484 -0.932 . . . . 71.32 108.484 175.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.05 99.08 11.45 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.712 -1.218 . . . . 74.24 107.712 177.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.485 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 13.2 ttm180 -87.27 113.11 22.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.595 -0.729 . . . . 64.1 109.429 170.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.54 123.84 63.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.764 -1.198 . . . . 73.13 107.764 170.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.665 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 6.9 m -118.55 134.75 54.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.926 -0.768 . . . . 54.44 108.926 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.464 HG23 HD13 ' B' ' 114' ' ' ILE . 88.1 t -122.45 127.92 75.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 123.964 0.906 . . . . 72.33 108.636 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.5 m -112.22 147.57 35.92 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 124.265 1.026 . . . . 60.21 108.739 172.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.23 147.21 33.29 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.439 0.696 . . . . 74.45 109.831 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.1 p -137.48 125.99 23.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.408 0.683 . . . . 72.11 110.381 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.653 HD12 HG22 ' B' ' 31' ' ' VAL . 42.2 mt -93.18 99.88 12.37 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 106.979 -1.489 . . . . 75.53 106.979 171.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.414 ' H ' ' HZ3' ' B' ' 36' ' ' TRP . . . 77.58 -118.55 5.06 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.492 -0.776 . . . . 72.45 112.651 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -103.33 14.77 30.77 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.128 0.971 . . . . 74.14 111.076 -171.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.413 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.9 pt-20 -147.84 156.49 42.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.721 0.808 . . . . 74.43 110.209 -173.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 86.7 m -66.26 135.83 55.0 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.698 0.624 . . . . 50.11 110.755 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.718 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -89.68 -62.57 1.44 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.584 -0.895 . . . . 73.43 108.584 174.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -150.92 157.88 43.46 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.095 -1.411 . . . . 54.4 109.96 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -132.34 138.63 47.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.766 -1.568 . . . . 61.31 106.766 175.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.424 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 49.8 t -142.65 151.01 40.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.467 -0.938 . . . . 42.04 108.467 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 44.8 tt0 -161.96 126.91 3.4 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.717 -0.845 . . . . 72.54 108.717 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.68 144.07 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 123.84 0.856 . . . . 61.24 108.934 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -115.16 91.2 3.54 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.36 -0.978 . . . . 73.53 108.36 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -81.19 97.63 7.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.545 -0.909 . . . . 73.03 108.545 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.96 142.7 16.14 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.129 -0.788 . . . . 74.25 111.129 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.85 128.86 3.58 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.123 -0.791 . . . . 74.33 111.123 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.7 mt -87.98 126.86 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.843 0.857 . . . . 63.24 109.837 175.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -134.47 134.6 41.72 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.501 -1.296 . . . . 72.33 107.501 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -109.38 93.02 4.29 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.036 0.535 . . . . 74.13 110.205 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 30.0 pt -94.38 144.85 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.327 0.584 . . . . 73.01 112.445 -167.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.79 146.86 19.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.915 1.286 . . . . 75.45 107.926 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.4 -25.85 26.21 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-O 119.884 -0.398 . . . . 64.41 113.761 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' B' ' 94' ' ' MET . 5.4 pt -84.31 165.56 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 117.48 0.64 . . . . 71.44 111.664 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -171.8 175.32 3.96 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.047 1.339 . . . . 74.41 108.726 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.21 -125.6 8.25 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.931 -0.468 . . . . 54.24 111.931 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.2 m -103.32 -13.14 16.81 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.511 0.724 . . . . 71.24 109.434 170.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -62.34 -27.78 69.29 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.148 0.979 . . . . 74.01 109.971 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.599 ' HA ' HD12 ' B' ' 89' ' ' ILE . 25.4 ptt? -71.06 -37.39 72.49 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.54 -0.754 . . . . 75.23 110.789 171.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.04 -21.24 59.17 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 115.451 -0.795 . . . . 74.02 110.766 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -76.99 -28.43 55.08 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.12 0.568 . . . . 71.22 111.425 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.24 -37.69 75.39 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.834 0.709 . . . . 72.15 110.052 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -102.8 -9.12 20.23 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.736 0.814 . . . . 74.52 111.819 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.32 -25.39 57.26 Favored Glycine 0 N--CA 1.475 1.265 0 C-N-CA 123.677 0.656 . . . . 75.12 112.728 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.47 -56.52 0.11 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.096 -0.552 . . . . 71.14 110.975 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -55.24 -54.81 38.7 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.604 1.162 . . . . 73.21 112.187 -168.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 78.9 m -69.62 -48.74 23.23 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 118.191 -0.909 . . . . 62.25 112.032 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -50.81 -35.79 49.83 Favored 'Trans proline' 0 C--N 1.399 3.195 0 C-N-CA 122.61 2.207 . . . . 73.22 113.929 170.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -75.15 -23.87 57.87 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.531 0.732 . . . . 72.1 111.701 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.496 HD13 HD11 ' B' ' 13' ' ' ILE . 83.2 mt -70.01 -44.14 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.089 -0.708 . . . . 63.32 109.089 168.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -80.6 -21.46 41.57 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.831 -1.077 . . . . 74.11 112.448 -173.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -62.48 -46.11 89.49 Favored Pre-proline 0 N--CA 1.487 1.394 0 N-CA-C 113.754 1.02 . . . . 62.22 113.754 -169.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.83 -35.71 98.17 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.859 1.706 . . . . 74.52 112.817 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -68.66 -45.31 72.11 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.991 0.517 . . . . 74.43 110.066 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.52 -37.53 78.56 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.689 0.796 . . . . 54.13 110.487 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -62.33 -57.88 9.71 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.29 1.036 . . . . 71.52 110.694 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -65.34 -28.88 69.61 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.988 0.805 . . . . 70.11 110.655 -173.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.488 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.3 t -75.09 -36.05 61.74 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.903 0.481 . . . . 74.42 111.377 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.464 HD13 HG23 ' B' ' 64' ' ' VAL . 81.7 mt -66.96 -52.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.671 -0.492 . . . . 61.11 109.671 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.458 HG21 ' OG ' ' C' ' 119' ' ' SER . 28.6 m -58.24 -33.56 69.49 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 124.339 1.024 . . . . 75.41 111.568 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 22.7 t -58.49 -53.94 52.62 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 123.813 0.696 . . . . 63.33 109.85 175.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.6 mmt -69.64 -35.22 75.03 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.493 0.717 . . . . 73.53 111.723 -171.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.98 -45.58 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.635 0.774 . . . . 71.22 110.428 174.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.41 ' OG ' HG21 ' C' ' 115' ' ' THR . 47.0 t -68.6 -32.58 72.56 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.969 -1.014 . . . . 65.42 111.357 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.7 mtt-85 -65.62 -37.2 85.93 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.552 -0.749 . . . . 74.0 109.389 175.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.37 5.0 65.2 Favored Glycine 0 C--N 1.357 1.72 0 O-C-N 124.213 0.946 . . . . 63.15 113.511 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.465 HG23 ' HB3' ' A' ' 17' ' ' TYR . 82.3 p 57.28 35.63 26.34 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.827 1.651 . . . . 72.34 112.96 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -95.26 162.53 24.43 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.83 0.852 . . . . 73.3 110.214 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.24 159.84 7.37 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 123.717 2.944 . . . . 72.32 114.19 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.515 HE21 ' ND2' ' B' ' 127' ' ' ASN . 67.9 tp60 -66.4 117.39 8.57 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.058 -0.973 . . . . 72.54 111.757 -176.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.517 HD21 HG11 ' B' ' 40' ' ' VAL . 10.2 mp -120.13 127.42 52.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.146 0.978 . . . . 73.15 109.455 173.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.515 ' ND2' HE21 ' B' ' 125' ' ' GLN . 50.7 m-80 -123.75 134.8 53.61 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.539 -0.911 . . . . 44.33 108.539 168.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.08 125.72 27.57 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.004 0.922 . . . . 75.31 109.892 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.28 151.14 87.75 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 124.011 0.924 . . . . 70.41 111.5 -176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.23 120.33 7.47 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.008 2.472 . . . . 71.44 112.431 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.9 t -118.33 112.7 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.941 -1.133 . . . . 54.11 107.941 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -79.13 84.86 5.07 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.838 -0.801 . . . . 63.55 108.838 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.72 -23.55 67.22 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.571 0.748 . . . . 75.02 111.83 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.07 -48.66 62.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.771 0.828 . . . . 71.11 110.696 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.43 95.39 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.683 -1.144 . . . . 75.3 110.306 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -71.53 -31.21 66.79 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.254 -1.339 . . . . 74.54 111.868 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 51.4 t80 . . . . . 0 N--CA 1.48 1.036 0 C-N-CA 122.717 0.407 . . . . 74.21 110.723 -176.622 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 10.6 m . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 107.943 -1.132 . . . . 62.34 107.943 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.933 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 62.5 t80 -123.41 121.33 35.48 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.655 -1.239 . . . . 64.41 107.655 174.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -137.21 122.76 19.69 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.168 -0.679 . . . . 63.42 109.168 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.04 125.35 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.807 -0.812 . . . . 73.05 108.807 172.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.564 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 29.3 mm-40 -91.97 -42.85 9.78 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.695 0.798 . . . . 71.31 109.306 175.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -175.61 138.58 0.39 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.63 -0.878 . . . . 64.22 108.63 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -127.91 141.67 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.862 -1.162 . . . . 60.14 107.862 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -170.57 161.18 7.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.714 0.768 . . . . 74.1 111.582 -171.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.457 HG21 ' SG ' ' C' ' 113' ' ' CYS . 68.3 p -83.95 107.47 16.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.753 -1.112 . . . . 71.3 108.338 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -68.81 -41.67 78.31 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.309 -0.996 . . . . 72.51 108.309 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 26.8 t70 -139.27 142.32 37.76 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 114.381 -1.282 . . . . 74.01 109.555 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.617 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.4 mt -135.99 145.35 31.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.548 1.539 . . . . 72.02 106.911 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -154.28 149.36 26.87 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.463 0.705 . . . . 73.42 109.504 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -155.82 109.01 2.71 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.2 -1.037 . . . . 74.21 108.2 174.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -119.3 111.9 18.78 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.266 0.626 . . . . 72.51 110.352 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -110.64 87.64 6.85 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 106.732 -1.581 . . . . 65.34 106.732 169.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.15 -23.65 24.39 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.698 2.266 . . . . 71.3 112.299 -170.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -121.39 29.71 7.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.367 1.067 . . . . 51.44 109.546 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.479 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -49.68 -53.54 40.54 Favored Pre-proline 0 CA--C 1.562 1.426 0 N-CA-C 114.031 1.123 . . . . 53.12 114.031 -171.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.468 ' HB3' HD13 ' D' ' 51' ' ' LEU . 26.3 Cg_exo -60.52 -48.72 10.55 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 121.671 1.581 . . . . 74.33 112.091 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -69.99 -27.08 64.42 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.244 -1.344 . . . . 63.3 112.27 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.767 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -79.54 -26.95 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 112.557 0.577 . . . . 72.53 112.557 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -68.19 -27.39 66.35 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.01 0.374 . . . . 73.21 112.01 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -89.9 9.62 26.95 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.441 0.696 . . . . 62.24 111.797 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.6 176.57 5.97 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.585 0.754 . . . . 65.31 110.065 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -76.93 124.37 27.65 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.47 0.708 . . . . 74.51 109.367 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 50.7 t90 -85.15 84.84 7.56 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.711 0.804 . . . . 75.14 111.157 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -142.56 79.92 14.88 Favored Pre-proline 0 N--CA 1.478 0.943 0 N-CA-C 107.334 -1.358 . . . . 74.54 107.334 164.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.42 139.95 14.9 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.678 2.252 . . . . 75.51 112.922 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.73 104.92 14.23 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 106.19 -1.781 . . . . 63.24 106.19 165.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 m -93.46 102.74 13.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.197 -1.365 . . . . 73.24 110.791 -169.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.546 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 54.4 mttp -91.84 111.13 22.54 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.489 -0.778 . . . . 75.23 109.005 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 pp -86.41 157.22 19.89 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.515 -0.55 . . . . 75.55 109.515 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.641 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.6 t70 -151.75 137.32 17.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.044 -1.095 . . . . 55.13 108.044 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 tt -137.97 137.2 37.7 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.556 -0.905 . . . . 73.32 108.556 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -148.21 125.58 11.6 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.973 1.309 . . . . 71.22 108.596 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m -114.22 126.35 54.95 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.431 0.634 . . . . 74.44 110.342 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.23 141.05 52.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.862 1.265 . . . . 73.25 107.805 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -152.24 143.68 23.39 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.851 0.46 . . . . 73.15 110.46 -170.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 80.5 p -148.43 151.93 36.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.211 0.605 . . . . 60.51 111.23 -171.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -79.22 136.89 37.2 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.466 0.706 . . . . 73.15 110.269 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.607 HD11 ' HB2' ' C' ' 57' ' ' GLU . 29.8 mt -110.12 -34.42 6.39 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.53 0.732 . . . . 71.04 110.245 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -154.47 179.82 8.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.36 0.664 . . . . 54.45 110.242 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -58.46 112.93 1.75 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.719 0.808 . . . . 64.51 109.907 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 64.12 9.82 5.0 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.672 1.189 . . . . 63.15 113.473 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 94.2 t -105.59 116.25 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.558 -1.275 . . . . 50.13 107.558 172.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.423 ' HB2' HD11 ' C' ' 86' ' ' ILE . 39.8 t80 -134.09 124.21 25.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.013 -0.736 . . . . 73.53 109.013 -175.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.607 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.3 tt0 -83.42 139.01 33.23 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.92 0.888 . . . . 74.41 109.635 175.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.403 HG11 ' HD3' ' C' ' 103' ' ' PRO . 42.0 t -120.05 135.33 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 124.185 0.994 . . . . 64.55 108.496 166.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.578 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 59.1 t -115.84 144.55 23.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.543 -0.91 . . . . 64.25 108.543 175.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.4 104.64 8.56 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.197 -1.038 . . . . 75.02 108.197 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -88.16 117.46 27.07 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.79 -1.189 . . . . 63.4 107.79 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.483 HG11 HD21 ' C' ' 128' ' ' LEU . 21.4 t -118.88 118.85 59.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.741 -1.207 . . . . 71.23 107.741 175.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.641 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.9 m -122.3 122.32 38.81 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.579 0.752 . . . . 71.35 109.54 -173.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.564 HG21 HG21 ' C' ' 114' ' ' ILE . 99.5 t -110.36 122.16 64.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.083 1.353 . . . . 71.23 109.258 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.6 m -117.55 144.17 45.38 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.446 -0.946 . . . . 71.24 108.446 175.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.28 128.47 19.81 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.482 -0.933 . . . . 65.15 108.482 176.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 21.4 m -142.91 129.3 20.03 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.092 0.557 . . . . 54.32 110.586 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 49.0 mt -87.67 32.95 0.71 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.174 1.39 . . . . 74.54 111.334 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 -100.72 1.41 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.41 -1.076 . . . . 74.55 110.41 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.64 -31.09 17.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.808 0.843 . . . . 71.04 109.953 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -76.62 120.23 21.53 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.276 1.03 . . . . 74.14 110.092 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.2 m -78.14 126.18 30.44 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.561 -0.903 . . . . 71.51 108.561 168.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.767 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -60.98 2.06 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.589 -0.893 . . . . 74.21 108.589 173.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -163.61 172.49 14.25 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.068 0.937 . . . . 74.24 111.83 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.407 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.6 tm? -135.8 145.57 46.65 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 105.863 -1.902 . . . . 74.44 105.863 172.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.415 ' SG ' HG23 ' C' ' 114' ' ' ILE . 41.8 t -147.98 150.42 33.96 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.059 -1.089 . . . . 74.32 108.059 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.99 132.83 8.5 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.759 -0.46 . . . . 74.25 109.759 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.52 114.1 22.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.263 -1.014 . . . . 62.53 108.263 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 68.4 mt-30 -94.15 85.12 4.59 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.401 -0.963 . . . . 62.32 108.401 173.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -78.33 97.4 5.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.053 -1.431 . . . . 72.14 110.324 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -89.37 161.13 29.81 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 116.465 -0.334 . . . . 71.01 112.382 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.513 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -163.16 123.06 1.15 Allowed Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 111.058 -0.817 . . . . 73.24 111.058 -175.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.58 HD12 HD11 ' C' ' 51' ' ' LEU . 6.2 mm -82.26 125.92 39.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.532 -0.914 . . . . 74.42 108.532 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -131.6 119.74 21.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.166 0.587 . . . . 70.45 110.257 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 71.9 m -80.66 111.89 17.52 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.934 -0.765 . . . . 52.25 108.934 170.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.74 HG12 HD21 ' C' ' 98' ' ' LEU . 1.2 pp -117.06 139.31 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.225 1.01 . . . . 63.5 110.317 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.07 172.68 13.46 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.409 1.084 . . . . 73.23 110.514 -172.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.93 -59.67 3.55 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 116.179 -0.464 . . . . 71.24 112.086 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.81 157.57 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.756 0.823 . . . . 75.11 109.475 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.595 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 13.3 pt-20 -145.53 -170.8 3.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.0 0.52 . . . . 74.42 109.925 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.82 -121.73 24.26 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 114.621 0.608 . . . . 72.15 114.621 174.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 62.6 p -73.33 -34.27 65.58 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.792 0.837 . . . . 73.51 110.555 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -70.14 -32.7 70.81 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.243 1.017 . . . . 64.25 109.981 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.595 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 39.4 ttp -79.61 -33.13 41.8 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.836 -1.074 . . . . 61.42 110.838 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.45 84.17 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.369 0.604 . . . . 40.43 109.913 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 49.2 t-80 -65.42 -29.21 69.88 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.562 -1.199 . . . . 72.23 111.478 175.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.3 -60.81 2.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.057 0.543 . . . . 72.22 110.448 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.74 HD21 HG12 ' C' ' 86' ' ' ILE . 92.9 mt -74.16 -33.81 63.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.074 0.95 . . . . 54.22 112.696 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.35 8.79 77.08 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-O 119.475 -0.625 . . . . 72.04 113.551 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -156.87 -66.23 0.1 Allowed 'General case' 0 C--N 1.357 0.916 0 CA-C-N 117.724 0.762 . . . . 52.44 112.874 -172.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' C' ' 104' ' ' ASN . 87.9 t80 -63.89 -34.8 78.76 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.286 0.634 . . . . 75.42 112.328 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.933 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 56.2 m -72.75 -46.28 9.18 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.69 -0.671 . . . . 74.04 111.148 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 83.2 Cg_exo -52.99 -32.95 60.25 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.312 2.008 . . . . 75.54 113.791 164.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' C' ' 101' ' ' TYR . 5.1 m-20 -60.09 -39.83 87.49 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 123.158 0.583 . . . . 62.32 110.911 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.447 HD12 ' NH1' ' A' ' 111' ' ' ARG . 40.2 mm -66.5 -45.22 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 115.954 -0.567 . . . . 64.51 110.198 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.513 HD21 ' HA3' ' C' ' 82' ' ' GLY . 42.3 mt -75.88 -16.39 60.06 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.433 -0.803 . . . . 74.53 111.986 -174.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -59.92 -52.7 71.76 Favored Pre-proline 0 CA--C 1.566 1.583 0 C-N-CA 125.035 1.334 . . . . 60.12 113.811 -172.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.18 -31.38 64.34 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 121.948 1.765 . . . . 62.51 112.784 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.514 ' HE2' HG21 ' A' ' 115' ' ' THR . 90.3 m-85 -69.09 -47.6 64.78 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.188 0.595 . . . . 74.33 110.546 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.37 -41.85 85.66 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.179 -0.918 . . . . 71.13 109.925 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -56.08 -57.72 10.97 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 124.437 1.086 . . . . 71.34 111.126 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -66.93 -30.93 71.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.181 0.593 . . . . 54.44 111.036 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.457 ' SG ' HG21 ' C' ' 18' ' ' THR . 9.6 t -70.5 -34.1 71.95 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.779 0.432 . . . . 72.34 110.971 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.564 HG21 HG21 ' C' ' 64' ' ' VAL . 88.4 mt -69.34 -51.24 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.277 -0.638 . . . . 52.31 109.277 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.41 HG21 ' OG ' ' B' ' 119' ' ' SER . 13.7 m -58.43 -33.53 69.79 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.05 0.94 . . . . 72.12 111.286 -174.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 28.3 t -62.9 -54.85 32.32 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.834 -1.075 . . . . 52.24 109.13 173.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.523 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.96 -40.05 72.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.91 1.284 . . . . 74.32 112.639 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.3 t -63.34 -47.72 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.956 0.902 . . . . 73.45 109.691 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.458 ' OG ' HG21 ' B' ' 115' ' ' THR . 48.4 t -69.95 -27.98 65.19 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.238 -0.892 . . . . 63.02 111.93 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' C' ' 116' ' ' SER . 84.3 mtt-85 -70.65 -43.68 68.67 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.688 0.795 . . . . 75.42 109.29 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.15 5.86 65.39 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.955 -1.02 . . . . 65.3 112.522 172.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 64.8 p 61.66 29.76 18.28 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.175 1.79 . . . . 65.51 113.757 168.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.408 ' HB2' HG13 ' C' ' 118' ' ' VAL . 95.6 m-85 -86.62 152.53 54.56 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 108.981 -0.748 . . . . 75.31 108.981 169.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.43 173.26 3.58 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.258 2.639 . . . . 71.32 114.649 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -50.79 130.92 25.75 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.308 1.443 . . . . 75.31 114.043 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -133.88 112.6 11.43 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.388 -1.338 . . . . 71.0 107.388 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -133.16 132.15 41.26 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.497 0.719 . . . . 73.21 109.99 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.483 HD21 HG11 ' C' ' 62' ' ' VAL . 6.8 mp -86.07 125.93 33.81 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.765 0.826 . . . . 74.41 110.11 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.86 155.67 75.32 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 124.75 1.22 . . . . 61.34 111.18 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.03 113.93 1.79 Allowed 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 123.361 2.708 . . . . 74.32 113.522 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.39 113.38 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.786 0.834 . . . . 74.22 109.279 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -76.38 91.05 3.25 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.689 0.795 . . . . 74.32 110.473 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -68.55 -33.06 73.43 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 110.062 -0.348 . . . . 72.55 110.062 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.511 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 12.7 p-10 -65.02 -45.83 83.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.527 1.131 . . . . 74.52 111.447 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.53 -37.09 71.18 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.372 0.669 . . . . 73.53 110.897 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.26 -18.45 55.32 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.23 -0.895 . . . . 70.35 112.347 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 57.1 t80 . . . . . 0 N--CA 1.493 1.721 0 C-N-CA 123.096 0.558 . . . . 71.33 111.626 -178.887 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.237 0.433 0 N-CA-C 108.072 -1.085 . . . . 75.11 108.072 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -157.19 91.28 1.17 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.951 -1.5 . . . . 72.4 106.951 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -113.43 114.71 26.96 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.341 -0.985 . . . . 65.21 108.341 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.475 HG21 HD11 ' D' ' 16' ' ' ILE . 12.6 mt -75.27 114.76 15.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.014 -1.106 . . . . 63.0 108.014 174.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -89.96 -32.27 16.88 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.423 0.452 . . . . 71.0 111.096 -178.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -172.76 146.42 1.61 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.062 0.226 . . . . 74.22 111.555 -170.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.475 HD11 HG21 ' D' ' 13' ' ' ILE . 2.9 mp -126.56 132.27 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 105.79 -1.929 . . . . 71.1 105.79 170.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.409 ' HE1' HG13 ' D' ' 83' ' ' ILE . 28.8 p90 -158.53 150.92 21.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.203 1.001 . . . . 74.44 111.03 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -84.23 119.22 24.78 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.222 -1.808 . . . . 55.31 108.487 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -95.08 -28.53 15.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.34 -0.615 . . . . 63.44 109.34 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.1 t70 -145.16 128.74 17.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.583 -1.189 . . . . 73.03 108.232 175.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.523 HG21 ' HE2' ' C' ' 117' ' ' MET . 73.4 mt -129.92 137.72 55.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.401 -1.333 . . . . 74.24 107.401 172.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -138.24 139.42 39.22 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.438 1.095 . . . . 75.24 108.312 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.617 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -150.61 129.45 12.46 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.093 -1.447 . . . . 74.21 107.093 170.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.7 mt-10 -131.26 150.98 51.92 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.895 0.878 . . . . 75.31 109.178 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.23 78.21 19.2 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 106.946 -1.501 . . . . 44.12 106.946 173.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.8 -22.88 17.18 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.78 2.32 . . . . 74.13 113.596 -170.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -108.15 16.34 23.39 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.102 0.561 . . . . 73.13 110.256 176.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.1 -66.92 0.29 Allowed Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 115.581 1.697 . . . . 53.54 115.581 -160.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.437 ' HB3' HD11 ' C' ' 83' ' ' ILE . 96.2 Cg_endo -74.15 -20.51 18.93 Favored 'Trans proline' 0 C--N 1.387 2.568 0 CA-C-N 122.435 1.905 . . . . 73.14 112.717 -173.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -74.26 -41.05 61.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.148 1.379 . . . . 72.11 110.445 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' D' ' 73' ' ' ALA . 3.6 p -84.04 -20.92 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 115.883 -0.599 . . . . 63.54 111.066 -170.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -62.74 -22.08 66.29 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.076 0.551 . . . . 74.42 112.433 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -65.75 -18.0 65.02 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.489 0.715 . . . . 64.52 111.06 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -84.09 102.55 12.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.489 1.115 . . . . 65.13 108.972 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -84.56 89.42 7.44 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.373 -0.603 . . . . 52.32 109.373 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.1 t-105 -168.5 158.85 9.84 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.618 1.167 . . . . 71.43 109.368 176.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -72.13 109.8 6.56 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 108.315 -0.994 . . . . 71.41 108.315 169.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.52 125.91 20.07 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.307 2.671 . . . . 64.34 113.329 -173.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.02 115.66 2.75 Favored 'General case' 0 C--N 1.361 1.101 0 O-C-N 124.484 1.115 . . . . 70.04 109.61 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.597 HG23 HG13 ' D' ' 64' ' ' VAL . 3.0 p -96.66 112.76 29.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-O 121.86 0.838 . . . . 64.31 110.562 -170.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -101.91 151.24 22.34 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.846 -1.07 . . . . 65.44 108.258 167.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.45 HD21 HD12 ' D' ' 128' ' ' LEU . 5.3 mp -131.49 136.12 47.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.771 0.428 . . . . 73.42 110.637 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.652 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 30.4 m-20 -107.79 150.28 27.19 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 107.376 -1.342 . . . . 74.55 107.376 165.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.456 HD11 HD21 ' D' ' 60' ' ' LEU . 18.8 tp -137.36 131.27 31.87 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.584 0.23 . . . . 70.33 110.993 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 34.3 m-20 -138.87 158.42 44.24 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.61 1.164 . . . . 73.21 108.711 170.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.0 t -124.48 175.35 7.2 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.601 0.761 . . . . 72.34 109.189 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -161.34 163.99 30.38 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.9 0.88 . . . . 74.44 109.448 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 71.9 p -150.26 153.0 35.42 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.617 0.767 . . . . 73.4 109.264 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.7 p -156.62 140.41 16.11 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.485 0.714 . . . . 72.11 110.262 -174.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -91.56 116.43 28.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.511 0.724 . . . . 64.52 109.064 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' C' ' 29' ' ' PRO . 26.8 mt -98.5 -42.17 7.43 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.093 0.473 . . . . 71.23 110.297 -173.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.16 176.02 10.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.431 1.093 . . . . 55.33 108.097 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.08 130.61 41.33 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.581 -0.526 . . . . 71.14 109.581 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 61.42 11.0 3.45 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 124.425 1.09 . . . . 64.24 112.813 -171.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.67 114.37 43.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 108.211 -1.033 . . . . 75.22 108.211 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.12 164.66 12.61 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.175 -1.046 . . . . 73.04 108.175 -175.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.437 ' HB2' HD11 ' D' ' 51' ' ' LEU . 62.3 tt0 -131.04 150.89 51.94 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.838 -0.801 . . . . 73.24 108.838 169.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.61 141.87 42.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.795 1.238 . . . . 61.21 107.874 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 47.2 t -128.1 126.41 66.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.778 -1.194 . . . . 64.24 107.778 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.08 120.9 43.35 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.074 -1.084 . . . . 63.31 108.074 -175.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.417 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 22.3 ttm-85 -100.99 97.63 8.18 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.583 -0.895 . . . . 64.4 108.583 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.19 123.93 47.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.619 -1.252 . . . . 74.4 107.619 167.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.652 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 12.9 m -118.74 130.37 55.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.959 -0.756 . . . . 72.43 108.959 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.597 HG13 HG23 ' D' ' 40' ' ' VAL . 94.2 t -117.48 121.1 66.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.106 0.962 . . . . 61.11 109.157 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.1 m -116.01 104.0 11.15 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.083 -1.08 . . . . 62.22 108.083 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.27 150.57 24.32 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.641 -0.709 . . . . 64.24 110.493 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 55.1 p -143.96 142.19 30.6 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.705 0.628 . . . . 73.03 111.053 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 21.4 mt -110.32 104.37 13.15 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 124.633 1.173 . . . . 62.55 109.191 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.03 -112.9 3.55 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.443 -0.663 . . . . 71.31 111.443 -177.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -117.52 14.32 14.53 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.249 0.619 . . . . 72.41 111.488 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.58 156.04 45.52 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.071 0.548 . . . . 74.4 110.59 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.5 m -63.4 127.28 30.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.09 0.956 . . . . 63.24 111.502 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.504 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -86.03 -75.78 0.36 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.842 -0.799 . . . . 73.2 108.842 174.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.29 139.46 35.5 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-O 121.349 0.595 . . . . 75.55 110.03 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 80.6 mt -103.54 147.37 27.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.912 -1.144 . . . . 74.03 107.912 171.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.548 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.6 t -158.02 146.66 19.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 122.914 0.486 . . . . 71.22 109.859 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -156.2 134.28 11.29 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 108.858 -0.793 . . . . 51.41 108.858 171.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.32 114.75 24.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 109.104 -0.702 . . . . 75.12 109.104 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.452 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 72.3 mt-30 -89.08 83.23 6.54 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.295 -1.002 . . . . 53.14 108.295 171.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -80.96 99.22 8.29 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.457 -1.702 . . . . 75.25 109.946 -175.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.08 163.62 29.3 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.441 -0.345 . . . . 73.44 112.483 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.467 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -161.96 132.87 2.94 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 111.883 -0.487 . . . . 73.13 111.883 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.409 HG13 ' HE1' ' D' ' 17' ' ' TYR . 43.7 mt -88.93 130.41 38.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 123.822 0.849 . . . . 71.12 109.311 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -133.85 124.23 26.13 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.356 0.662 . . . . 73.52 110.04 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -83.41 105.5 14.41 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.594 -0.891 . . . . 64.52 108.594 170.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.434 HD13 HD13 ' D' ' 98' ' ' LEU . 47.8 pt -109.78 141.93 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 122.985 0.514 . . . . 75.35 110.855 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.35 159.88 41.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.309 1.044 . . . . 52.24 109.354 176.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.04 10.59 81.16 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 115.009 0.764 . . . . 54.43 115.009 173.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 24.0 pt -124.06 135.07 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.596 0.758 . . . . 71.22 109.549 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.73 164.9 28.95 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.517 0.727 . . . . 73.14 110.682 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.14 -121.9 25.57 Favored Glycine 0 C--N 1.353 1.481 0 O-C-N 124.091 0.87 . . . . 75.24 114.393 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 12.5 t -72.04 -32.4 67.07 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.691 0.796 . . . . 53.4 111.44 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -71.62 -35.28 70.39 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.167 0.587 . . . . 73.01 110.706 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -66.56 -47.48 72.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.295 -0.866 . . . . 73.35 110.154 175.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.54 -28.37 69.89 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.21 -0.905 . . . . 63.43 111.479 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -76.47 -46.51 26.5 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.939 0.896 . . . . 71.31 110.869 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.71 -42.48 73.97 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.013 -0.54 . . . . 75.23 111.296 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.434 HD13 HD13 ' D' ' 86' ' ' ILE . 12.4 tp -84.51 -36.21 22.38 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 122.68 0.392 . . . . 73.23 111.195 -173.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.0 -23.09 42.65 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.036 -0.529 . . . . 55.25 113.705 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.572 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -122.17 -56.34 1.83 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.23 0.515 . . . . 70.53 111.949 -175.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . 0.413 ' O ' HG12 ' D' ' 105' ' ' ILE . 63.7 t80 -66.76 -43.36 84.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 111.841 0.312 . . . . 74.32 111.841 -173.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 98.8 m -65.85 -47.83 63.88 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.053 -0.975 . . . . 72.14 112.912 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.463 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.3 Cg_exo -57.0 -36.22 99.25 Favored 'Trans proline' 0 C--N 1.4 3.263 0 C-N-CA 121.847 1.698 . . . . 72.31 112.7 170.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -65.1 -31.22 72.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.851 0.86 . . . . 71.34 111.119 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.413 HG12 ' O ' ' D' ' 101' ' ' TYR . 46.3 mm -68.25 -40.89 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.502 0.721 . . . . 75.32 110.164 173.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.467 HD21 ' HA3' ' D' ' 82' ' ' GLY . 63.3 mt -77.96 -21.82 50.4 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.252 -0.886 . . . . 75.2 111.856 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -64.27 -41.29 59.44 Favored Pre-proline 0 CA--C 1.566 1.562 0 N-CA-C 114.098 1.147 . . . . 71.31 114.098 -172.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -51.19 -43.38 49.05 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.263 1.975 . . . . 71.02 113.56 170.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -72.51 -37.89 68.26 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.57 -0.741 . . . . 72.13 111.03 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.22 -45.11 93.16 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.498 0.719 . . . . 71.23 110.528 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -57.28 -51.85 67.71 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.416 1.072 . . . . 74.01 110.395 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.02 -44.65 96.25 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.175 0.922 . . . . 72.13 112.009 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -54.59 -48.14 72.5 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.91 0.756 . . . . 70.44 110.359 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.548 HG12 ' SG ' ' D' ' 76' ' ' CYS . 82.2 mt -60.4 -54.85 29.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 CA-C-N 114.502 -1.226 . . . . 60.41 110.38 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.0 m -55.39 -39.92 70.75 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.301 1.04 . . . . 73.3 111.806 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -68.05 -41.93 81.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.005 -0.998 . . . . 73.21 110.566 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -70.01 -29.19 66.19 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.8 0.44 . . . . 72.42 111.828 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' D' ' 114' ' ' ILE . 65.9 t -66.12 -45.1 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 123.961 0.904 . . . . 72.44 109.834 175.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.0 p -74.49 -28.93 61.22 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.992 -0.549 . . . . 72.35 111.251 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 -72.86 -33.5 66.14 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.429 0.692 . . . . 73.21 109.809 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.47 2.01 86.28 Favored Glycine 0 C--N 1.355 1.603 0 CA-C-N 115.769 -0.65 . . . . 53.31 112.165 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.8 p 64.37 18.98 11.62 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 127.142 2.177 . . . . 63.23 113.984 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -80.02 147.38 65.57 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 108.587 -0.894 . . . . 70.41 108.587 168.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.87 148.8 91.19 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.083 1.855 . . . . 63.41 111.463 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -57.8 139.84 53.09 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.723 1.209 . . . . 32.41 113.883 -165.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.487 HD11 HG21 ' D' ' 40' ' ' VAL . 42.2 tp -109.09 102.59 11.55 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.055 -0.975 . . . . 74.02 109.678 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -100.91 104.39 15.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.266 0.626 . . . . 74.11 109.385 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.45 HD12 HD21 ' D' ' 42' ' ' LEU . 3.0 mm? -74.56 118.62 17.72 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.16 0.584 . . . . 65.42 109.441 175.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.9 136.35 72.89 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.691 0.796 . . . . 72.4 111.368 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.83 118.97 5.81 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.217 1.945 . . . . 75.14 110.76 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.5 p -107.38 136.75 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.521 0.728 . . . . 53.43 110.028 -173.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 55.0 t30 -76.73 76.27 3.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.688 -1.227 . . . . 73.44 107.688 169.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . 0.442 ' HE2' HD21 ' D' ' 44' ' ' LEU . 87.4 t80 -59.98 -33.15 71.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.075 -1.421 . . . . 74.41 112.006 -172.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . 0.572 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 17.4 t70 -60.27 -34.8 74.24 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.656 1.182 . . . . 63.45 111.392 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.486 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -67.18 -37.92 84.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.16 -0.927 . . . . 44.21 111.716 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.6 mp -64.21 -33.34 75.58 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.707 0.803 . . . . 42.25 110.956 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 N--CA 1.482 1.162 0 C-N-CA 124.121 0.969 . . . . 75.34 111.808 -178.109 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m . . . . . 0 N--CA 1.462 0.173 0 N-CA-C 107.985 -1.117 . . . . 52.11 107.985 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -137.81 134.92 35.76 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.529 -0.915 . . . . 73.34 108.529 172.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -149.96 110.96 4.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.215 -1.032 . . . . 65.42 108.215 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.443 HG21 ' HG2' ' C' ' 130' ' ' PRO . 32.7 mt -78.14 110.38 13.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.59 -0.892 . . . . 73.55 108.59 176.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -80.08 -32.62 39.26 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.957 -1.02 . . . . 74.0 110.175 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -177.44 126.25 0.14 Allowed 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.375 0.422 . . . . 74.14 110.415 -172.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.435 HD12 ' HG3' ' C' ' 130' ' ' PRO . 93.8 mt -113.52 130.99 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.424 -0.954 . . . . 72.15 108.424 169.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -160.18 154.31 23.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.334 1.054 . . . . 54.1 109.561 -172.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.5 p -79.84 120.27 23.86 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.937 -0.764 . . . . 74.01 108.937 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -81.0 -31.23 34.74 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.04 0.448 . . . . 65.21 109.855 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -153.26 143.57 22.41 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.774 -1.103 . . . . 64.11 109.537 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -133.86 145.1 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.852 1.261 . . . . 72.32 108.122 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -144.82 134.38 23.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.346 0.593 . . . . 73.21 109.471 171.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -134.56 131.13 37.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.184 -1.784 . . . . 75.1 106.184 162.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -134.33 142.07 47.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.974 -0.75 . . . . 63.45 108.974 171.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.45 79.08 55.39 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 106.459 -1.682 . . . . 62.53 106.459 169.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.2 -15.23 35.39 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.486 2.124 . . . . 52.13 110.329 174.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -112.44 28.01 9.15 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.848 1.259 . . . . 74.15 111.139 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.663 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -60.12 -54.54 54.27 Favored Pre-proline 0 CA--C 1.575 1.907 0 CA-C-O 118.933 -0.556 . . . . 72.43 111.344 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.663 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 11.6 Cg_exo -76.48 -14.93 17.85 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 122.192 1.928 . . . . 74.34 113.373 173.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -69.88 -53.28 18.75 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 109.633 -0.506 . . . . 73.53 109.633 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.567 HG11 ' HE1' ' A' ' 123' ' ' PHE . 12.1 p -64.44 -23.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.783 0.833 . . . . 62.01 111.424 -175.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -58.09 -40.4 81.03 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.607 0.763 . . . . 64.43 110.4 171.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -90.64 -30.3 17.24 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.327 1.051 . . . . 72.02 111.021 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 14.1 mmmm -84.0 172.16 12.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.275 1.03 . . . . 71.11 111.38 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.23 148.59 23.52 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.675 0.79 . . . . 71.54 109.818 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.404 ' CZ2' ' HG3' ' A' ' 38' ' ' PRO . 68.8 t-105 -79.59 90.94 5.15 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.234 0.614 . . . . 74.42 109.761 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -132.37 42.03 0.81 Allowed Pre-proline 0 CA--C 1.574 1.869 0 C-N-CA 123.313 0.645 . . . . 74.54 112.69 -176.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 45.0 Cg_endo -81.47 140.03 11.76 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.308 2.006 . . . . 72.4 113.564 -171.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -98.69 99.96 11.13 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.764 -1.199 . . . . 65.23 107.764 168.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.13 93.33 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 115.619 -0.719 . . . . 64.53 109.999 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -78.4 153.03 31.91 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.869 0.366 . . . . 74.25 110.375 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.1 tp -122.2 130.2 52.98 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.387 -0.824 . . . . 60.1 109.969 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -130.98 146.84 52.51 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.562 1.145 . . . . 64.34 107.916 172.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.552 HD22 HD21 ' A' ' 60' ' ' LEU . 85.2 mt -129.53 148.53 51.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.468 0.707 . . . . 62.32 109.845 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.713 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 14.9 m-20 -132.48 140.14 48.25 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.183 0.993 . . . . 71.44 109.1 172.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.0 m -108.22 126.2 52.53 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.062 1.345 . . . . 54.43 108.488 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.16 146.16 51.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.593 0.757 . . . . 54.45 109.163 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.5 m -134.45 158.51 43.72 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.847 0.459 . . . . 70.11 111.045 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 40.2 t -154.44 129.49 9.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.451 1.1 . . . . 71.31 108.605 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -84.48 107.75 16.9 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.15 -0.685 . . . . 51.13 109.15 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.0 mt -79.57 -38.43 34.1 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.986 0.515 . . . . 55.44 110.372 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.19 -177.03 6.25 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.495 -0.775 . . . . 74.22 110.315 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.13 111.82 2.37 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.875 0.87 . . . . 64.45 109.95 174.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 65.28 17.23 10.92 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.053 1.341 . . . . 75.11 112.873 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.79 116.7 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.223 -1.029 . . . . 71.02 108.223 169.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -110.7 167.57 10.13 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.603 1.192 . . . . 71.45 111.501 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 9.6 tp10 -128.78 126.43 39.92 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 112.393 -2.185 . . . . 50.11 105.661 169.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.24 131.27 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 107.482 -1.303 . . . . 62.32 107.482 173.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 21.9 t -119.49 115.52 47.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 124.128 0.971 . . . . 54.23 108.656 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.552 HD21 HD22 ' A' ' 44' ' ' LEU . 3.7 tt -88.19 98.01 11.32 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.322 -1.733 . . . . 64.31 106.322 167.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.713 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 46.8 ttt-85 -85.61 101.97 13.16 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.952 -1.129 . . . . 65.41 107.952 174.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.486 HG11 ' HB1' ' A' ' 110' ' ' ALA . 2.3 p -105.02 124.26 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.294 0.637 . . . . 41.22 110.291 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.0 m -108.13 130.84 55.09 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 123.846 0.858 . . . . 74.32 109.593 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.41 ' O ' HD12 ' A' ' 75' ' ' LEU . 45.9 t -126.32 122.65 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.02 1.328 . . . . 74.13 107.973 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 t -128.88 120.59 26.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.018 0.527 . . . . 71.54 109.68 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -105.15 110.18 22.45 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.589 -0.893 . . . . 41.54 108.589 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.3 p -124.88 126.89 46.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.862 0.465 . . . . 74.14 111.403 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.521 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -104.62 84.78 2.22 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.806 -1.183 . . . . 52.23 107.806 166.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.94 -117.32 5.08 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.386 -0.824 . . . . 23.02 111.846 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -87.94 -23.22 23.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.056 0.542 . . . . 71.23 109.889 175.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.53 134.87 35.57 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.026 0.93 . . . . 74.22 110.725 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.3 m -83.15 154.37 24.33 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.072 0.949 . . . . 73.5 109.148 168.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.9 -61.18 1.4 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.197 -1.038 . . . . 51.31 108.197 164.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -151.07 170.36 19.58 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.53 -1.214 . . . . 73.51 110.722 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 64' ' ' VAL . 51.2 tp -138.83 129.22 25.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.043 1.337 . . . . 64.45 107.729 177.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.3 m -136.07 117.6 14.83 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.809 0.844 . . . . 74.15 108.761 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -138.79 115.38 10.59 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.274 -0.639 . . . . 61.33 109.274 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.7 t -123.99 115.72 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.202 1.001 . . . . 62.41 109.498 -171.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.631 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 17.3 mt-30 -87.85 82.43 7.3 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.156 -1.053 . . . . 73.44 108.156 169.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.4 115.5 16.2 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.022 -1.103 . . . . 73.2 108.022 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.14 170.85 13.59 Favored Glycine 0 C--O 1.242 0.618 0 CA-C-O 121.227 0.348 . . . . 64.1 112.255 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.51 136.05 3.97 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.144 -0.528 . . . . 74.33 112.0 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.5 mt -81.1 122.84 36.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 108.131 -1.063 . . . . 72.43 108.131 169.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.496 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.3 m-85 -130.95 118.49 20.74 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.717 -0.846 . . . . 71.12 108.717 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.5 p -94.98 118.11 31.27 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.896 -0.779 . . . . 74.24 108.896 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.416 ' HB ' HD11 ' A' ' 89' ' ' ILE . 2.8 pp -128.55 157.11 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.137 0.975 . . . . 31.2 110.624 -174.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.48 154.01 13.71 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.975 0.91 . . . . 74.32 109.947 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.4 9.63 61.51 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 113.752 0.261 . . . . 73.32 113.752 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.629 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -133.19 145.09 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.937 0.895 . . . . 65.21 109.934 178.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.534 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.6 tt0 -156.13 174.13 15.82 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.15 0.58 . . . . 65.41 109.819 177.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.534 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 60.07 -116.94 9.81 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.678 0.656 . . . . 65.34 113.444 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.4 p -71.55 -27.01 62.87 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.745 0.818 . . . . 75.41 110.934 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -71.02 -36.2 72.3 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.762 0.825 . . . . 61.5 110.432 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.414 ' HA ' ' SG ' ' A' ' 97' ' ' CYS . 49.3 ttm -73.11 -37.17 66.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.068 0.547 . . . . 72.43 110.09 175.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 -24.69 66.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.792 -0.64 . . . . 71.43 110.231 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.528 ' NE2' ' HB3' ' A' ' 100' ' ' ALA . 9.8 t-160 -83.38 -25.95 30.91 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.562 0.745 . . . . 44.21 111.204 176.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.629 ' SG ' HG13 ' A' ' 89' ' ' ILE . 74.0 m -56.86 -43.21 80.98 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.004 0.431 . . . . 73.44 110.492 175.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -90.73 -20.74 22.09 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.567 -0.742 . . . . 70.24 111.268 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -38.56 41.8 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 114.071 0.388 . . . . 74.11 114.071 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.528 ' HB3' ' NE2' ' A' ' 96' ' ' HIS . . . -150.88 -47.12 0.12 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 117.508 0.654 . . . . 52.23 112.004 -175.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.413 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 31.2 t80 -45.08 -70.24 0.11 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 126.053 1.741 . . . . 74.42 112.865 -175.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.1 m -81.29 -34.53 0.73 Allowed Pre-proline 0 CA--C 1.572 1.79 0 N-CA-C 115.462 1.653 . . . . 64.24 115.462 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.447 ' O ' HD12 ' A' ' 60' ' ' LEU . 37.4 Cg_endo -63.88 -34.74 59.27 Favored 'Trans proline' 0 C--N 1.399 3.231 0 CA-C-N 122.701 2.0 . . . . 61.32 112.619 175.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -66.56 -26.62 67.21 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 120.716 0.293 . . . . 60.22 111.299 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.06 -43.44 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.67 0.788 . . . . 75.53 110.18 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.03 -14.66 59.42 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.061 0.944 . . . . 74.34 112.479 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.16 -49.38 84.93 Favored Pre-proline 0 CA--C 1.565 1.555 0 N-CA-C 113.486 0.921 . . . . 74.44 113.486 -171.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.1 -32.3 75.09 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 121.929 1.753 . . . . 71.34 112.572 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -74.48 -37.63 63.13 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.694 0.798 . . . . 71.02 111.58 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.486 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -70.26 -45.15 67.02 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.843 0.457 . . . . 54.34 110.099 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.41 ' NH1' HD12 ' C' ' 105' ' ' ILE . 31.9 ttm180 -54.2 -47.73 71.79 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.365 1.041 . . . . 64.12 110.342 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.27 -46.38 89.06 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.139 0.9 . . . . 74.02 111.725 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 117' ' ' MET . 37.1 t -59.81 -38.39 81.82 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.408 0.683 . . . . 72.44 110.537 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.2 mt -70.82 -47.84 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.034 0.934 . . . . 73.35 110.896 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -54.41 -38.16 65.91 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.791 0.836 . . . . 74.1 110.343 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.6 t -65.86 -47.01 76.34 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.325 -1.307 . . . . 75.53 110.253 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 34.0 mmt -57.18 -48.21 79.32 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.159 0.583 . . . . 71.32 111.246 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 114' ' ' ILE . 58.6 t -64.27 -48.63 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.443 1.097 . . . . 72.03 111.046 -175.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -69.97 -29.57 66.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.33 0.652 . . . . 74.23 112.209 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -71.11 -28.33 64.23 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.832 0.453 . . . . 75.4 110.255 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.48 7.97 66.65 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-O 119.755 -0.469 . . . . 55.34 113.126 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.492 ' HB ' HH21 ' B' ' 15' ' ' ARG . 15.7 m 68.28 15.01 9.3 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.776 1.231 . . . . 72.14 111.245 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.567 ' HE1' HG11 ' A' ' 31' ' ' VAL . 63.6 m-85 -89.54 144.5 32.12 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.451 -0.944 . . . . 72.12 108.451 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.37 142.89 88.12 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.822 2.348 . . . . 65.34 111.898 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.25 138.45 16.47 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.391 1.076 . . . . 70.31 112.486 -175.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.1 tp -115.6 103.03 10.31 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.732 -1.122 . . . . 60.33 110.062 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.432 HD21 ' HB ' ' C' ' 16' ' ' ILE . 79.1 m-20 -111.47 96.85 6.35 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.044 -1.095 . . . . 73.3 108.044 168.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.9 151.28 47.86 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.422 -0.808 . . . . 73.5 110.056 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.69 145.72 95.21 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.745 0.818 . . . . 74.3 111.73 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -57.68 127.62 26.0 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.832 2.355 . . . . 73.44 112.657 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 93.8 t -102.04 115.97 44.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 124.457 1.103 . . . . 71.14 109.243 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -84.86 93.62 8.55 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.521 -0.918 . . . . 72.53 108.521 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -65.06 -27.36 68.73 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.657 0.783 . . . . 73.02 111.801 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -66.72 -47.15 73.21 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.935 0.494 . . . . 72.43 110.175 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.04 -50.88 71.92 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.114 0.884 . . . . 73.24 109.912 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.2 mt -62.29 -38.42 89.3 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.647 -1.16 . . . . 72.41 112.343 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -65.82 -46.78 77.33 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.361 0.665 . . . . 74.41 110.472 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 CA--C 1.543 0.699 0 CA-C-N 115.913 -0.585 . . . . 71.03 110.624 -175.626 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 56.0 m . . . . . 0 N--CA 1.468 0.442 0 N-CA-C 107.875 -1.157 . . . . 72.34 107.875 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -147.37 140.97 25.54 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.801 -0.814 . . . . 72.3 108.801 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -153.0 141.21 20.5 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.17 -0.678 . . . . 62.11 109.17 175.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 mt -85.86 121.26 37.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.179 -1.045 . . . . 71.34 108.179 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -88.08 -42.45 12.38 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.527 0.517 . . . . 63.52 109.931 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.492 HH21 ' HB ' ' A' ' 122' ' ' THR . 65.5 ttt180 -167.8 133.76 2.01 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.765 -0.652 . . . . 74.21 109.695 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.0 mt -115.15 140.48 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.025 -1.472 . . . . 60.2 107.025 168.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.497 ' CE2' ' HB1' ' A' ' 28' ' ' ALA . 34.8 p90 -164.25 158.34 18.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.881 0.848 . . . . 74.24 111.544 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 96.9 m -83.6 120.84 26.45 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.43 -1.259 . . . . 74.24 108.545 171.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.412 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 35.8 mtpt -88.43 -33.38 17.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.44 0.696 . . . . 74.32 110.423 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.5 t70 -150.82 135.94 17.62 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.739 -0.664 . . . . 72.3 110.826 -171.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.42 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.2 mm -127.98 139.79 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.617 1.167 . . . . 74.12 108.678 166.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 43.5 t -140.93 131.34 25.21 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.077 -1.083 . . . . 72.54 108.077 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -141.89 115.4 9.01 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.861 -1.163 . . . . 54.13 107.861 170.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 36.5 mt-10 -118.26 112.54 20.22 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.902 -1.148 . . . . 60.24 107.902 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.487 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.83 83.23 1.22 Allowed Pre-proline 0 C--O 1.24 0.575 0 N-CA-C 106.311 -1.737 . . . . 72.1 106.311 164.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.91 -13.74 29.25 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 122.459 2.106 . . . . 74.23 112.139 -171.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -123.59 12.48 9.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.075 0.95 . . . . 61.42 110.774 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.512 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -34.86 -62.7 0.4 Allowed Pre-proline 0 N--CA 1.501 2.096 0 N-CA-C 114.456 1.28 . . . . 74.1 114.456 -170.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 25.9 Cg_exo -61.18 -36.3 81.35 Favored 'Trans proline' 0 C--N 1.396 3.067 0 C-N-CA 122.154 1.903 . . . . 61.32 113.429 -174.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -92.1 -18.8 23.06 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.891 0.7 . . . . 74.4 112.891 -173.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.717 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.6 p -83.12 -19.91 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 118.69 0.677 . . . . 72.14 111.422 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -67.91 -14.38 62.92 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 112.94 0.719 . . . . 72.33 112.94 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.489 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.8 pt20 -60.49 -26.32 66.73 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.125 0.488 . . . . 41.41 110.371 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.489 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 88.2 mttt -101.66 87.65 3.21 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.535 1.134 . . . . 73.51 108.728 175.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -79.54 101.98 8.57 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.315 -0.624 . . . . 71.33 109.315 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -172.66 158.01 3.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.48 1.112 . . . . 74.11 108.877 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.533 ' HG2' ' HB2' ' B' ' 124' ' ' PRO . 47.6 mt-30 -64.65 107.59 1.47 Allowed Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.948 0.899 . . . . 74.14 109.123 168.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.61 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.7 Cg_endo -59.14 160.86 17.67 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 123.351 2.7 . . . . 71.55 113.653 -176.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -59.81 103.02 0.18 Allowed 'General case' 0 C--N 1.35 0.614 0 N-CA-C 107.722 -1.214 . . . . 71.32 107.722 169.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.0 m -91.55 161.22 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.3 -0.864 . . . . 65.04 110.509 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -135.71 113.75 11.27 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.398 -1.334 . . . . 75.12 107.398 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 tt -85.2 126.2 33.46 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.692 -1.595 . . . . 73.33 106.692 173.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.72 144.79 26.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.942 -1.132 . . . . 52.35 107.942 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -146.63 160.02 42.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.061 0.544 . . . . 52.35 110.145 174.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -143.65 150.17 38.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.037 0.935 . . . . 63.3 109.335 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -125.52 115.26 19.93 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.007 0.923 . . . . 73.51 109.85 -174.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.02 161.66 19.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.479 1.112 . . . . 60.11 108.501 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 77.4 p -145.37 162.84 36.3 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.538 0.335 . . . . 64.11 110.351 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -154.49 136.19 14.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.684 0.794 . . . . 75.24 109.543 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -89.89 116.06 27.68 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.924 -0.398 . . . . 73.13 109.924 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 24.5 mt -80.25 -52.15 8.07 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.146 0.978 . . . . 72.54 110.741 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.32 -168.53 2.56 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.42 1.088 . . . . 73.42 109.013 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -63.05 100.8 0.23 Allowed 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.492 0.495 . . . . 73.12 110.205 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 63.62 16.16 9.47 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.064 1.345 . . . . 75.25 113.227 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 69.1 t -103.44 101.12 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 105.065 -2.198 . . . . 62.05 105.065 167.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -118.97 168.93 10.34 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.388 -0.967 . . . . 73.3 108.388 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -144.9 111.86 5.91 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.433 -0.951 . . . . 62.31 108.433 -171.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -96.27 137.78 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 O-C-N 124.029 0.831 . . . . 61.32 109.471 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 37.3 t -113.48 117.64 56.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.808 0.843 . . . . 64.35 109.274 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.39 110.73 23.23 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.317 -1.364 . . . . 75.31 107.317 173.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -100.31 128.85 46.28 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.794 -0.817 . . . . 74.13 108.794 173.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.52 ' HB ' HD11 ' B' ' 114' ' ' ILE . 11.4 t -126.91 123.7 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.024 -1.102 . . . . 65.12 108.024 172.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -118.81 134.52 55.1 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.704 0.802 . . . . 72.1 110.807 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.432 HG21 HG21 ' B' ' 114' ' ' ILE . 66.8 t -120.26 101.77 11.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.488 1.515 . . . . 74.22 108.452 177.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 90.5 m -84.65 135.28 34.24 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.883 -1.155 . . . . 70.21 107.883 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.22 141.48 26.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.935 0.334 . . . . 63.1 111.325 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.469 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 58.2 p -148.84 135.3 19.49 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.226 0.61 . . . . 65.31 111.341 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.61 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 24.1 mt -96.67 115.3 27.21 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 124.395 1.078 . . . . 73.23 109.995 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.32 -108.44 2.36 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 115.477 -0.783 . . . . 61.51 112.492 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -116.19 2.1 13.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.404 0.681 . . . . 52.21 110.982 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -116.2 145.28 43.23 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.438 -0.578 . . . . 71.32 109.438 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 51.2 m -64.74 135.91 56.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.972 0.509 . . . . 63.35 110.778 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.717 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.29 -64.26 1.13 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.339 -0.986 . . . . 55.22 108.339 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -154.11 154.7 34.07 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.79 -1.096 . . . . 62.42 109.827 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.41 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 41.6 mt -131.95 108.7 9.55 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.917 -1.883 . . . . 73.54 105.917 176.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.4 t -118.26 143.38 46.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.48 -0.933 . . . . 74.2 108.48 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -157.14 129.31 7.29 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.627 -0.879 . . . . 72.43 108.627 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' B' ' 113' ' ' CYS . 81.1 t -123.42 146.35 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.638 0.775 . . . . 65.11 109.148 176.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.2 mt-30 -123.58 96.17 4.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.405 -0.961 . . . . 64.21 108.405 169.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.0 tp-100 -86.47 99.52 11.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.503 -0.925 . . . . 74.15 108.503 174.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.23 167.96 33.34 Favored Glycine 0 C--O 1.244 0.734 0 N-CA-C 110.906 -0.877 . . . . 42.44 110.906 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.19 125.46 1.42 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 112.299 -0.32 . . . . 74.11 112.299 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 53.0 mt -85.85 128.91 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.02 0.928 . . . . 70.52 108.982 172.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -134.62 158.87 42.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.617 1.167 . . . . 74.42 108.366 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.6 m -131.83 129.26 40.23 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.854 -0.795 . . . . 63.41 108.854 171.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 13.9 tt -139.9 145.54 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.093 0.557 . . . . 55.11 110.686 -175.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.17 164.24 34.54 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.45 1.1 . . . . 70.21 109.162 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.21 -25.23 15.3 Favored Glycine 0 N--CA 1.475 1.264 0 CA-C-O 121.039 0.244 . . . . 15.11 112.502 -175.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 17.3 tt -88.91 133.03 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.722 1.209 . . . . 72.34 111.849 -167.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -149.6 -176.47 5.42 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.193 1.397 . . . . 65.01 109.219 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.05 -134.11 27.01 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 114.897 -1.047 . . . . 61.32 113.162 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 61.0 m -73.39 -29.19 62.44 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.175 0.99 . . . . 74.25 111.417 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -57.96 -33.34 68.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.562 0.745 . . . . 64.11 111.863 -171.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 22.9 ptm -60.4 -39.84 88.78 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.705 0.802 . . . . 73.21 111.194 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.81 -32.45 59.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.834 0.854 . . . . 54.23 110.319 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -68.57 -28.3 66.84 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.014 -0.994 . . . . 72.55 111.303 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.498 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 48.9 t -75.4 -66.61 0.75 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.089 0.555 . . . . 74.2 110.162 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.95 -26.42 65.05 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.123 0.569 . . . . 73.3 111.967 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.87 -9.8 62.1 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-O 119.489 -0.617 . . . . 60.03 114.462 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.59 -56.21 0.13 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.818 0.809 . . . . 60.21 113.177 -167.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 92.7 t80 -67.6 -49.48 62.91 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.366 0.667 . . . . 72.32 111.899 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.486 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.1 m -61.96 -51.51 74.66 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.646 0.779 . . . . 74.2 111.604 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 89.0 Cg_exo -53.5 -35.34 75.97 Favored 'Trans proline' 0 C--N 1.4 3.262 0 C-N-CA 122.547 2.165 . . . . 64.4 114.332 172.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -58.63 -43.87 89.83 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 123.359 0.664 . . . . 63.23 110.612 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mt -59.71 -41.0 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.167 0.987 . . . . 73.31 110.912 177.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 46.9 mt -84.5 -17.05 40.29 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.236 1.014 . . . . 73.45 112.207 -172.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -58.83 -50.07 89.97 Favored Pre-proline 0 CA--C 1.556 1.182 0 N-CA-C 114.02 1.119 . . . . 73.35 114.02 -170.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.49 -34.33 92.95 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.03 1.82 . . . . 62.44 113.12 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.504 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 74.4 m-85 -65.69 -50.45 64.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.001 0.52 . . . . 74.4 110.091 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.16 81.47 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.818 0.847 . . . . 70.13 111.197 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.414 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 36.0 ttt180 -63.89 -53.5 49.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.409 1.483 . . . . 73.03 111.18 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.92 -38.43 90.96 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.874 0.734 . . . . 75.12 109.71 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.454 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.2 t -66.63 -36.66 83.11 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.511 -0.768 . . . . 71.32 111.958 -174.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.52 HD11 ' HB ' ' B' ' 62' ' ' VAL . 66.3 mt -62.11 -56.59 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 109.104 -0.702 . . . . 71.41 109.104 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.8 m -60.85 -25.61 66.78 Favored 'General case' 0 CA--C 1.556 1.21 0 O-C-N 124.334 1.021 . . . . 70.04 111.648 -173.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.9 t -68.3 -46.19 70.98 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.7 0.8 . . . . 75.11 110.261 175.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 7.9 mmt -72.54 -34.65 67.69 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.89 0.476 . . . . 74.12 111.063 -177.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 114' ' ' ILE . 93.8 t -57.53 -44.22 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.231 1.013 . . . . 73.42 109.567 171.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.5 t -70.74 -30.88 67.53 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.427 -1.26 . . . . 72.51 112.07 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' B' ' 116' ' ' SER . 89.1 mtt-85 -69.8 -36.03 75.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.983 0.513 . . . . 63.1 110.036 177.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.64 1.95 84.34 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.592 0.558 . . . . 54.52 112.559 171.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 26.7 p 62.18 30.77 17.75 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.687 1.995 . . . . 73.24 113.0 172.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -85.16 155.05 60.63 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.667 0.787 . . . . 74.2 110.095 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.533 ' HB2' ' HG2' ' B' ' 37' ' ' GLN . 48.0 Cg_exo -57.15 168.82 2.38 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.231 2.621 . . . . 74.1 114.537 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.417 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 63.9 tp60 -56.85 133.42 54.44 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.573 1.149 . . . . 75.14 112.065 -172.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.47 102.48 6.65 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.269 -1.012 . . . . 53.13 108.269 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.53 101.31 12.21 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.611 0.764 . . . . 74.5 109.553 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.414 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 0.2 OUTLIER -61.28 129.35 40.83 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 109.259 -0.645 . . . . 71.23 109.259 179.451 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.64 152.13 80.47 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 123.625 0.77 . . . . 64.55 111.941 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.426 ' HG2' ' HB ' ' D' ' 13' ' ' ILE . 6.2 Cg_endo -81.26 109.69 2.16 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.25 2.633 . . . . 50.23 112.137 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 t -115.06 112.4 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.19 -0.67 . . . . 61.01 109.19 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' B' ' 136' ' ' LEU . 56.2 t-20 -85.24 112.85 21.12 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.905 -0.776 . . . . 74.4 108.905 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -89.86 -27.47 19.9 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.01 0.744 . . . . 72.21 113.01 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -73.77 -42.71 60.68 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 118.602 0.637 . . . . 73.42 111.416 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.2 89.25 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.542 0.737 . . . . 60.15 110.307 172.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' B' ' 132' ' ' ASN . 0.9 OUTLIER -68.78 -33.5 73.98 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.079 0.951 . . . . 75.32 110.25 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 80.3 t80 . . . . . 0 N--CA 1.475 0.79 0 C-N-CA 123.429 0.692 . . . . 74.34 110.767 -175.643 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 90.9 m . . . . . 0 C--O 1.239 0.51 0 N-CA-C 108.93 -0.766 . . . . 72.12 108.93 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -94.31 140.83 29.29 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.535 -0.757 . . . . 74.35 109.387 175.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.63 136.05 15.92 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.536 -0.542 . . . . 65.11 109.536 172.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.14 127.84 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.517 -0.92 . . . . 74.51 108.517 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.497 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.8 mm-40 -89.8 -47.47 7.88 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.207 -0.664 . . . . 73.24 109.207 174.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -175.0 134.41 0.34 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.798 -0.637 . . . . 62.23 109.836 -170.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.432 ' HB ' HD21 ' A' ' 127' ' ' ASN . 84.8 mt -117.34 144.98 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.791 -1.189 . . . . 73.34 107.791 176.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.431 ' CE2' ' HG2' ' C' ' 19' ' ' LYS . 36.7 p90 -171.53 161.72 6.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.506 0.669 . . . . 73.24 111.301 -174.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.9 p -88.63 112.51 23.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.876 -1.157 . . . . 73.32 107.876 169.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' C' ' 17' ' ' TYR . 18.1 mttt -67.44 -48.97 65.67 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 122.24 1.019 . . . . 73.21 108.345 171.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.34 133.37 36.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 113.599 -1.637 . . . . 74.13 109.045 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 79.6 mt -124.49 141.31 45.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.692 -1.596 . . . . 60.53 106.692 172.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -153.92 147.61 25.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.398 0.618 . . . . 53.34 110.997 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 81.7 t80 -146.37 132.12 18.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 106.899 -1.519 . . . . 71.42 106.899 169.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -132.54 124.93 29.4 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.729 0.811 . . . . 73.14 109.35 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.41 79.87 29.03 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.06 -1.459 . . . . 54.31 107.06 172.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.72 -26.74 19.05 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.748 2.299 . . . . 71.14 111.569 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -102.43 17.6 23.16 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.283 1.033 . . . . 73.41 110.218 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.419 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -47.96 -59.63 5.53 Favored Pre-proline 0 C--N 1.371 1.512 0 N-CA-C 114.774 1.398 . . . . 62.4 114.774 -166.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 23.7 Cg_exo -61.14 -42.36 36.53 Favored 'Trans proline' 0 C--N 1.393 2.917 0 CA-C-N 121.834 1.691 . . . . 55.04 111.919 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -69.73 -33.16 72.1 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.402 -1.272 . . . . 71.13 112.232 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.699 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.0 p -79.43 -21.6 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 O-C-N 122.094 -0.379 . . . . 63.13 111.867 -176.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -69.83 -22.18 63.31 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.762 0.425 . . . . 61.14 111.742 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -97.29 19.46 13.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.671 0.388 . . . . 74.14 111.295 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.761 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.76 149.83 21.41 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.902 -0.777 . . . . 75.33 108.902 170.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -69.41 129.7 40.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.88 -0.785 . . . . 70.45 108.88 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -68.51 109.72 3.85 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.165 0.586 . . . . 73.34 111.418 -172.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -163.08 70.19 1.93 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.948 0.899 . . . . 54.41 108.879 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -88.52 128.5 2.12 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.94 2.427 . . . . 62.3 112.818 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . 0.442 ' HB3' ' HE2' ' C' ' 41' ' ' LYS . 26.4 mt-10 -84.68 94.96 8.76 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.381 -0.97 . . . . 74.11 108.381 168.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 m -74.7 99.17 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-N 114.419 -1.264 . . . . 64.53 110.314 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' C' ' 39' ' ' GLU . 73.4 mmtt -92.76 103.35 15.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.76 -1.109 . . . . 72.14 108.497 177.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.498 HD21 HG13 ' C' ' 62' ' ' VAL . 7.3 tt -95.04 136.71 35.03 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.913 -0.773 . . . . 74.22 108.913 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -118.4 112.73 20.37 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.253 1.421 . . . . 73.2 107.739 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp -104.14 133.96 48.2 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.926 -0.768 . . . . 75.11 108.926 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.4 t70 -140.47 149.33 42.4 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.045 0.938 . . . . 70.24 109.153 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 7.9 m -132.57 130.36 40.21 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 123.505 0.722 . . . . 64.22 109.301 169.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.37 153.23 26.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.933 1.293 . . . . 71.22 108.241 175.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 17.8 p -149.85 140.92 22.97 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.711 -0.477 . . . . 74.4 109.711 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -161.16 150.81 16.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.878 0.871 . . . . 73.31 109.453 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -86.08 132.7 33.98 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.936 -0.394 . . . . 73.1 109.936 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.559 HD11 HD12 ' C' ' 83' ' ' ILE . 50.0 mt -98.88 -38.41 9.04 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.426 0.69 . . . . 74.32 109.269 173.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.63 178.0 10.77 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.229 1.012 . . . . 70.52 109.635 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.89 123.17 17.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.94 0.496 . . . . 73.34 109.891 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 71.38 -8.77 0.98 Allowed 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 126.316 1.846 . . . . 72.05 113.311 -173.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -95.27 97.5 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.77 -0.826 . . . . 61.53 108.77 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.66 124.54 49.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.132 -0.692 . . . . 72.41 109.132 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.43 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.4 tt0 -90.16 135.4 33.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.163 0.585 . . . . 74.1 109.715 173.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.34 141.34 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.502 1.121 . . . . 73.35 107.979 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.7 t -127.49 129.27 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 107.662 -1.236 . . . . 74.21 107.662 172.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.17 102.81 11.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.575 -1.269 . . . . 73.01 107.575 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -84.22 127.83 34.19 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.037 -0.983 . . . . 74.41 108.388 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.498 HG13 HD21 ' C' ' 42' ' ' LEU . 40.9 t -124.45 121.06 60.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 107.123 -1.436 . . . . 75.23 107.123 168.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 9.5 m -124.98 115.36 20.44 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.479 -0.563 . . . . 71.14 109.479 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.413 HG23 HD13 ' C' ' 114' ' ' ILE . 81.2 t -99.92 107.96 21.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.298 -1.001 . . . . 62.33 108.298 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 55.6 m -96.18 139.82 31.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.276 -1.75 . . . . 73.54 106.276 169.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.75 116.19 11.99 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.527 -1.286 . . . . 63.12 107.527 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.6 m -127.08 168.39 14.67 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.031 -0.729 . . . . 70.53 109.031 175.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.761 HD13 ' HG2' ' C' ' 34' ' ' LYS . 5.6 mt -123.47 21.41 9.43 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.535 1.134 . . . . 53.3 109.004 -174.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.72 -99.76 1.0 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.66 -1.376 . . . . 64.42 109.66 -166.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -90.89 -31.62 16.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.418 0.687 . . . . 74.15 110.64 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -85.36 120.17 26.54 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.059 0.943 . . . . 63.53 110.875 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 40.5 m -73.55 125.78 28.76 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.744 -0.465 . . . . 63.54 109.744 170.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.699 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.0 -61.86 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.091 0.869 . . . . 41.23 109.003 171.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . 0.476 ' HZ ' HD21 ' C' ' 126' ' ' LEU . 54.6 p90 -164.86 176.08 9.03 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.708 0.766 . . . . 71.23 111.739 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -130.41 144.77 51.6 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 106.508 -1.664 . . . . 74.24 106.508 168.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.456 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.8 t -152.47 111.65 3.86 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.085 -0.709 . . . . 64.42 109.085 174.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.69 133.86 55.5 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.822 -0.436 . . . . 62.35 109.822 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 56.1 t -124.95 135.05 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.735 0.814 . . . . 63.2 108.846 168.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -111.99 90.4 3.33 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.835 -1.172 . . . . 64.15 107.835 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.05 96.59 6.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.427 -0.806 . . . . 65.41 109.403 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.63 146.8 20.92 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.218 -0.753 . . . . 73.05 111.218 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.527 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.36 117.5 0.85 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.312 -1.115 . . . . 72.22 110.312 -175.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.559 HD12 HD11 ' C' ' 51' ' ' LEU . 10.7 mm -82.88 126.54 40.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 107.714 -1.217 . . . . 72.42 107.714 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -133.13 121.28 22.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.481 0.713 . . . . 74.44 109.378 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.6 p -85.24 111.07 19.51 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.204 -0.665 . . . . 63.15 109.204 174.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 49.4 pt -114.68 141.17 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.088 0.955 . . . . 71.4 108.975 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.95 164.42 31.19 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.399 0.68 . . . . 24.23 110.004 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.75 -55.8 0.72 Allowed Glycine 0 C--N 1.341 0.82 0 O-C-N 123.512 0.508 . . . . 60.11 113.137 172.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.48 170.52 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 112.577 0.584 . . . . 72.43 112.577 -173.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.484 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 17.1 pt-20 -151.97 -172.64 4.28 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.941 0.897 . . . . 70.55 109.819 172.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.49 -137.92 16.96 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-O 119.338 -0.701 . . . . 42.13 113.231 172.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 25.3 p -63.49 -33.58 75.89 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.895 0.878 . . . . 53.22 111.402 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -59.65 -48.53 81.32 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.242 1.017 . . . . 71.04 110.064 176.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.484 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 35.8 ttp -72.97 -30.09 63.57 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.613 -1.176 . . . . 74.31 110.845 176.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.58 -35.13 73.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.912 0.485 . . . . 74.12 110.23 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -78.67 -33.16 47.26 Favored 'General case' 0 C--O 1.242 0.702 0 O-C-N 123.693 0.621 . . . . 63.33 111.827 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 39.8 t -57.23 -39.28 75.18 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.412 0.445 . . . . 31.2 110.442 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.8 mt -95.21 -19.54 19.96 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.794 0.837 . . . . 71.13 110.348 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.99 -29.4 54.32 Favored Glycine 0 C--N 1.349 1.252 0 C-N-CA 123.559 0.6 . . . . 73.42 114.036 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.03 -41.94 0.08 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.601 0.593 . . . . 55.34 112.601 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -61.85 -57.54 11.4 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.222 0.609 . . . . 72.11 111.961 -173.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 97.0 m -66.64 -46.6 57.35 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.927 0.891 . . . . 54.12 112.45 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.58 -35.92 69.14 Favored 'Trans proline' 0 C--N 1.401 3.328 0 C-N-CA 122.428 2.085 . . . . 75.53 113.388 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -67.75 -35.65 79.09 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.763 0.825 . . . . 64.42 110.463 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.41 HD12 ' NH1' ' A' ' 111' ' ' ARG . 46.8 mm -63.73 -39.5 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 122.863 0.465 . . . . 70.4 109.995 174.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.527 HD21 ' HA3' ' C' ' 82' ' ' GLY . 83.2 mt -85.78 -22.82 27.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.098 0.959 . . . . 74.43 112.847 -173.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -60.29 -46.59 97.69 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 124.984 1.314 . . . . 74.52 113.787 -172.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.614 ' HA ' ' HD3' ' C' ' 111' ' ' ARG . 35.2 Cg_exo -63.55 -34.53 63.95 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 122.307 2.005 . . . . 73.31 113.463 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -67.49 -44.59 78.15 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.752 0.421 . . . . 75.43 110.142 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.37 78.49 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 115.285 -0.871 . . . . 61.24 110.891 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.744 ' HG2' ' HG ' ' C' ' 128' ' ' LEU . 21.3 mtp-105 -56.88 -62.32 1.82 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.784 0.833 . . . . 65.42 110.707 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.51 -30.13 71.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.243 0.617 . . . . 71.43 111.286 -172.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.5 t -74.07 -32.85 63.46 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.073 0.549 . . . . 64.31 111.502 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.44 HG23 ' SG ' ' C' ' 76' ' ' CYS . 66.4 mt -73.71 -49.81 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.274 0.63 . . . . 74.22 109.846 172.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 90.6 m -57.26 -37.79 72.88 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.343 1.057 . . . . 75.34 111.407 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -63.72 -48.07 78.54 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.34 -0.846 . . . . 75.21 109.622 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.674 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.59 -37.89 88.0 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.617 1.167 . . . . 65.13 112.991 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.445 HG21 HD11 ' C' ' 126' ' ' LEU . 78.5 t -68.36 -43.28 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.657 0.783 . . . . 72.44 110.611 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -66.19 -30.42 70.89 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 115.018 -0.992 . . . . 72.34 110.604 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -71.86 -34.29 69.1 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 123.69 0.796 . . . . 63.31 109.455 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.69 5.58 77.8 Favored Glycine 0 C--N 1.353 1.484 0 O-C-N 123.73 0.644 . . . . 74.12 113.04 174.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.451 HG23 ' HB3' ' D' ' 17' ' ' TYR . 75.5 p 60.62 23.36 13.13 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.524 1.93 . . . . 72.21 113.974 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.444 ' HB2' HG13 ' C' ' 118' ' ' VAL . 90.1 m-85 -85.06 156.56 60.41 Favored Pre-proline 0 CA--C 1.555 1.145 0 N-CA-C 108.739 -0.837 . . . . 64.02 108.739 170.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.11 155.35 40.05 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.195 2.597 . . . . 53.2 113.129 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.417 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 52.3 mm-40 -60.13 131.39 50.68 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.978 0.911 . . . . 75.12 112.017 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.476 HD21 ' HZ ' ' C' ' 74' ' ' PHE . 2.9 pp -144.67 126.82 15.63 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.819 0.848 . . . . 71.34 108.809 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -127.7 124.88 38.95 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.537 -1.653 . . . . 63.32 106.537 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.744 ' HG ' ' HG2' ' C' ' 111' ' ' ARG . 0.0 OUTLIER -75.82 130.12 38.08 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.475 -0.565 . . . . 71.5 109.475 -171.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.57 154.39 93.31 Favored Pre-proline 0 CA--C 1.551 1.001 0 O-C-N 124.726 1.266 . . . . 72.31 112.589 -170.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.443 ' HG2' HG21 ' A' ' 13' ' ' ILE . 7.6 Cg_exo -68.79 115.2 3.83 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.372 2.048 . . . . 73.01 111.749 175.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 51.0 t -99.12 134.28 38.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.084 -1.45 . . . . 62.21 107.084 168.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -73.65 73.34 1.49 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.219 0.608 . . . . 65.23 110.358 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -60.75 -39.63 89.45 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.448 0.699 . . . . 74.21 110.656 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -61.61 -49.36 76.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.299 -0.864 . . . . 71.14 111.606 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.49 87.67 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.88 0.737 . . . . 54.2 111.183 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 93.8 mt -67.71 -34.8 77.6 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.543 -0.753 . . . . 74.41 111.894 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 10.6 t80 . . . . . 0 N--CA 1.486 1.327 0 C-N-CA 122.663 0.385 . . . . 61.04 110.677 -178.663 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 61.6 m . . . . . 0 C--O 1.236 0.354 0 CA-C-O 121.463 0.649 . . . . 62.52 111.066 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -154.47 93.01 1.55 Allowed 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.579 -1.637 . . . . 74.51 106.579 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -113.23 126.87 55.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.177 -0.675 . . . . 71.42 109.177 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.426 ' HB ' ' HG2' ' B' ' 130' ' ' PRO . 10.2 mt -87.56 119.87 35.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.062 -1.088 . . . . 74.3 108.062 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -85.62 -28.52 24.72 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 123.643 0.589 . . . . 60.43 111.125 -175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -172.4 121.03 0.42 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 110.399 -0.223 . . . . 52.23 110.399 -166.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.4 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.2 mp -106.02 133.49 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 107.328 -1.36 . . . . 74.05 107.328 169.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.451 ' HB3' HG23 ' C' ' 122' ' ' THR . 42.6 p90 -162.63 174.18 12.93 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 122.007 0.908 . . . . 75.44 112.045 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . 0.511 HG21 HD11 ' D' ' 21' ' ' ILE . 74.9 p -104.57 124.18 48.86 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.188 -1.369 . . . . 65.43 109.188 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 36.4 mtpt -93.86 -18.49 21.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.418 0.687 . . . . 53.24 109.559 177.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.7 t70 -162.12 135.17 6.06 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 124.377 1.071 . . . . 73.52 108.989 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.674 HD13 ' HE3' ' C' ' 117' ' ' MET . 86.8 mt -136.16 133.86 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.602 1.161 . . . . 64.22 108.076 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 57.8 m -137.59 113.46 9.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.413 1.085 . . . . 64.4 109.655 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.521 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 83.8 t80 -116.82 117.12 28.86 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.353 -1.721 . . . . 72.35 106.353 163.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.4 mt-10 -126.3 111.33 14.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.422 0.689 . . . . 72.01 109.357 -175.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.17 87.31 7.17 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.272 -1.01 . . . . 71.25 108.272 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -75.54 -32.61 4.67 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.7 2.267 . . . . 72.31 113.01 -171.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 44.6 m-20 -100.42 9.09 43.11 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.557 0.743 . . . . 71.43 110.161 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.434 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -28.06 -69.79 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 116.18 1.919 . . . . 72.12 116.18 -161.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.405 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 68.4 Cg_endo -77.41 -19.6 13.08 Favored 'Trans proline' 0 C--N 1.383 2.353 0 CA-C-N 123.558 2.306 . . . . 70.22 113.765 -174.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.504 ' HA ' HE21 ' D' ' 33' ' ' GLN . 5.9 t-160 -70.18 -43.07 71.54 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.366 1.066 . . . . 52.34 109.13 173.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.567 HG21 ' HA ' ' D' ' 73' ' ' ALA . 6.3 p -84.28 -15.65 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.81 0.844 . . . . 71.32 111.398 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.405 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.8 m-85 -70.4 -19.69 62.99 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 120.784 0.325 . . . . 54.34 111.38 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.504 HE21 ' HA ' ' D' ' 30' ' ' HIS . 43.1 mt-30 -72.66 -12.44 61.04 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.413 -0.812 . . . . 71.31 111.069 176.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -83.26 84.51 7.47 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.208 1.003 . . . . 64.01 108.885 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -77.46 80.43 3.95 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.457 0.646 . . . . 71.21 109.282 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -156.23 163.8 39.12 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.501 -1.227 . . . . 73.24 108.842 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.474 ' NE2' HD21 ' D' ' 126' ' ' LEU . 23.7 tp60 -89.99 108.18 24.23 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.204 1.002 . . . . 74.12 109.65 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.419 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 34.8 Cg_exo -59.85 158.09 30.51 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 123.329 2.686 . . . . 73.34 114.302 -174.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -79.82 157.31 27.06 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.356 1.062 . . . . 74.45 110.736 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.83 118.47 57.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.178 -0.675 . . . . 73.22 109.178 172.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -117.65 114.04 22.79 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.819 0.847 . . . . 51.03 108.832 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.35 126.33 43.82 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.113 0.565 . . . . 72.41 111.034 -172.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -124.97 120.09 30.6 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.959 1.304 . . . . 65.52 107.654 170.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt -110.95 146.03 37.33 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.728 0.411 . . . . 73.33 110.093 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 34.5 t70 -147.82 151.5 36.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.651 1.18 . . . . 75.51 108.342 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -132.16 163.73 27.88 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.735 0.414 . . . . 75.3 110.432 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.673 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.93 175.21 13.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.371 1.068 . . . . 60.1 109.512 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.578 ' HB3' HD21 ' D' ' 98' ' ' LEU . 50.5 p -168.5 157.25 8.69 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.81 0.844 . . . . 61.33 110.573 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 88.5 p -153.2 154.56 34.95 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.962 0.905 . . . . 72.11 109.038 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -94.59 116.97 29.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.728 -0.842 . . . . 75.22 108.728 170.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 42.7 mt -93.38 -30.01 15.32 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 110.02 -0.363 . . . . 73.44 110.02 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.83 -174.84 4.1 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.444 0.698 . . . . 72.42 111.2 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -67.09 116.47 7.94 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.661 -1.154 . . . . 71.44 109.455 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 66.02 5.5 3.56 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.867 1.267 . . . . 73.12 112.567 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 78.8 t -110.18 120.05 60.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 108.545 -0.909 . . . . 75.35 108.545 176.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -135.26 131.27 36.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.752 -0.833 . . . . 73.52 108.752 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -89.81 148.01 23.46 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.698 0.799 . . . . 63.35 109.355 173.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.8 t -125.49 139.87 50.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 124.737 1.215 . . . . 74.23 107.867 170.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.673 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 77.8 t -118.69 135.37 59.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.282 -1.007 . . . . 73.32 108.282 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 121.01 39.39 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.785 -0.82 . . . . 74.54 108.785 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 24.8 ttm-85 -103.38 96.0 6.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.048 -1.093 . . . . 64.22 108.048 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 74.5 t -97.81 119.0 45.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.295 -1.002 . . . . 52.11 108.295 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 14.2 m -119.77 129.87 54.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.846 -1.07 . . . . 55.33 108.541 -172.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 67.2 t -122.47 128.97 75.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 124.837 1.255 . . . . 73.24 108.261 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 95.9 m -122.34 120.63 34.58 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.199 -1.037 . . . . 63.21 108.199 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.71 151.94 39.95 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.472 -0.785 . . . . 75.31 110.08 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.463 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 19.7 p -149.6 125.37 10.47 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.293 -0.867 . . . . 65.41 109.368 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 12.0 mt -92.83 114.21 26.7 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.221 1.008 . . . . 74.31 108.931 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.92 -110.1 2.94 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.966 -0.854 . . . . 75.01 110.966 -174.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 5.94 8.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.013 0.925 . . . . 74.42 110.844 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -123.02 155.41 36.91 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.539 0.736 . . . . 74.32 109.788 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -60.51 129.98 44.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.851 0.86 . . . . 75.41 111.979 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.567 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.96 -72.74 0.55 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.756 -1.201 . . . . 72.04 107.756 176.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -145.57 146.36 31.36 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.216 -0.902 . . . . 73.4 110.217 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.7 mt -114.34 143.58 44.65 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.534 1.134 . . . . 73.45 108.134 175.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.551 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 23.7 m -142.09 137.49 31.03 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.832 0.853 . . . . 72.23 109.232 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -154.41 121.0 5.45 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.799 -1.186 . . . . 72.44 107.799 170.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.7 t -130.8 115.23 29.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.684 -0.858 . . . . 63.02 108.684 -175.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -88.49 85.37 6.84 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.431 -0.952 . . . . 72.21 108.431 172.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -78.61 96.77 5.58 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.248 -1.342 . . . . 62.24 108.771 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.85 143.12 17.4 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 115.827 -0.624 . . . . 74.43 111.867 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -140.75 129.64 4.22 Favored Glycine 0 C--N 1.329 0.187 0 N-CA-C 110.685 -0.966 . . . . 72.53 110.685 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.0 mt -90.15 129.43 41.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.321 -0.992 . . . . 73.14 108.321 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -128.92 153.46 47.49 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.71 0.404 . . . . 74.15 111.06 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -114.88 105.65 13.25 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.806 1.242 . . . . 65.23 108.097 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.35 122.76 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.125 0.57 . . . . 52.31 110.305 -175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.08 141.94 24.67 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.316 1.046 . . . . 34.42 108.48 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.94 -20.13 29.35 Favored Glycine 0 N--CA 1.468 0.825 0 O-C-N 123.116 0.26 . . . . 60.02 112.59 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 32.9 pt -131.95 147.0 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.414 0.686 . . . . 74.44 109.17 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.07 163.48 33.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.807 0.843 . . . . 73.51 111.317 -176.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.64 -127.52 31.37 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.173 -0.921 . . . . 65.14 114.264 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.1 m -74.32 -30.63 62.14 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.192 0.997 . . . . 74.12 111.135 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -65.46 -34.83 79.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.32 0.648 . . . . 75.34 109.977 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -83.62 -26.17 30.18 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.534 -0.757 . . . . 71.12 110.817 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.08 -23.16 67.09 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.86 0.362 . . . . 52.02 110.612 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -70.48 -43.6 69.42 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.672 0.789 . . . . 72.34 110.557 168.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -63.59 -46.83 84.03 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.933 0.493 . . . . 63.14 110.966 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' D' ' 48' ' ' SER . 7.3 tt -77.2 -46.26 23.88 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.838 0.855 . . . . 72.21 109.785 -175.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.37 -12.69 83.58 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.83 -0.623 . . . . 71.34 114.149 -172.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.49 -61.03 0.65 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.424 0.612 . . . . 74.4 112.546 -172.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -67.06 -39.7 86.95 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 112.639 0.607 . . . . 75.14 112.639 -172.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.445 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 97.7 m -68.91 -48.94 28.15 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 118.547 -0.739 . . . . 71.25 111.086 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 71.0 Cg_exo -55.74 -35.11 92.81 Favored 'Trans proline' 0 C--N 1.399 3.209 0 C-N-CA 122.413 2.075 . . . . 65.5 113.169 168.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -63.36 -37.37 87.02 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.338 0.655 . . . . 74.25 110.276 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.5 mm -67.58 -43.42 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.664 0.786 . . . . 64.35 110.703 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' D' ' 82' ' ' GLY . 95.1 mt -75.08 -16.71 60.55 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.382 -0.826 . . . . 72.24 111.809 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -69.64 -43.08 21.07 Favored Pre-proline 0 CA--C 1.56 1.334 0 CA-C-O 118.209 -0.9 . . . . 73.43 113.274 -170.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -53.15 -44.74 46.37 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.2 1.934 . . . . 74.52 112.964 168.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.49 -36.09 76.19 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.665 0.786 . . . . 71.05 111.817 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.94 -54.66 31.11 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.49 0.716 . . . . 55.14 109.678 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -49.56 -49.46 46.28 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 125.068 1.48 . . . . 65.44 111.038 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -64.79 -44.0 91.39 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 124.132 0.895 . . . . 55.21 111.608 -173.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.0 t -60.33 -43.7 96.18 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.511 0.507 . . . . 75.44 110.717 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.493 HG21 HG21 ' D' ' 64' ' ' VAL . 77.3 mt -59.42 -56.97 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.399 1.08 . . . . 74.02 110.057 173.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.3 m -59.07 -35.35 73.22 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.205 1.402 . . . . 61.12 112.053 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -69.27 -43.85 73.06 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.643 -0.708 . . . . 72.44 109.753 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 72.3 mtm -67.38 -31.82 72.3 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.974 0.51 . . . . 64.05 111.875 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.477 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.6 t -62.69 -45.37 98.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.976 0.91 . . . . 72.53 110.334 175.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.8 p -73.59 -32.08 63.93 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 116.126 -0.488 . . . . 44.05 111.136 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -70.67 -31.78 68.82 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.633 0.773 . . . . 72.55 110.509 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.06 8.84 76.96 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-N 115.491 -0.777 . . . . 73.42 112.419 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 28.3 p 63.94 18.45 11.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.494 1.918 . . . . 74.54 114.231 171.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.82 147.69 49.28 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.198 0.599 . . . . 74.01 109.446 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.42 124.07 13.43 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.358 2.705 . . . . 72.42 112.932 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -61.86 130.09 44.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.955 1.302 . . . . 61.23 112.092 -173.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.474 HD21 ' NE2' ' D' ' 37' ' ' GLN . 71.2 mt -119.09 112.5 19.62 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.015 0.926 . . . . 60.04 109.12 -176.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -100.79 103.06 14.27 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.749 -0.834 . . . . 70.12 108.749 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 29.2 tp -68.91 135.85 51.67 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.679 -1.146 . . . . 70.33 112.053 -169.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.31 135.9 93.46 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 122.989 0.516 . . . . 61.24 110.428 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -64.04 136.41 52.23 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.719 2.279 . . . . 75.44 111.925 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.85 123.19 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.563 0.745 . . . . 64.34 109.211 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -82.66 92.59 7.19 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.954 -0.758 . . . . 43.12 108.954 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -67.23 -35.76 80.26 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.982 -0.554 . . . . 70.23 110.555 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.62 -53.51 57.25 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.575 1.15 . . . . 71.41 112.789 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.82 93.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.116 0.566 . . . . 35.42 110.973 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 33.4 tp -76.2 -17.77 59.37 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.592 -0.731 . . . . 64.54 111.951 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 89.8 t80 . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 109.398 -0.593 . . . . 74.14 109.398 171.569 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 68.9 m . . . . . 0 C--O 1.241 0.611 0 N-CA-C 109.388 -0.597 . . . . 74.55 109.388 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.68 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.6 t80 -136.44 131.63 34.33 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.745 1.218 . . . . 62.44 108.951 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -138.93 117.93 12.5 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.013 0.925 . . . . 73.34 108.652 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.532 HG12 ' HD2' ' A' ' 84' ' ' PHE . 39.1 mt -84.19 110.91 19.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.549 -0.908 . . . . 74.15 108.549 172.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -78.07 -40.03 39.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.991 0.807 . . . . 73.11 110.132 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -169.84 143.77 2.68 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 121.137 -0.225 . . . . 65.44 111.125 -171.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.533 HD12 ' HG3' ' C' ' 130' ' ' PRO . 94.2 mt -135.71 128.31 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.121 -1.066 . . . . 63.03 108.121 175.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' HB3' HG23 ' B' ' 122' ' ' THR . 28.7 p90 -165.62 150.21 8.57 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.177 0.991 . . . . 70.31 110.37 -169.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -75.32 114.91 14.4 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.978 -0.749 . . . . 52.01 108.978 173.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 37.5 mtpt -81.74 -28.36 33.39 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.297 -0.631 . . . . 71.12 109.297 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.1 t70 -149.08 138.52 21.67 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.235 -0.893 . . . . 74.23 109.723 174.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.11 150.43 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 107.257 -1.386 . . . . 74.15 107.257 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.0 t -158.23 146.4 18.62 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.387 0.429 . . . . 63.45 109.972 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 82.4 t80 -137.72 141.07 41.02 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.262 -1.384 . . . . 75.51 107.262 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 50.7 mt-10 -139.13 133.55 31.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.374 0.67 . . . . 74.02 109.39 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -147.32 73.39 11.88 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 107.235 -1.394 . . . . 63.33 107.235 171.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.51 -22.25 18.57 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.63 2.22 . . . . 74.44 111.779 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.408 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 94.2 m-20 -112.27 32.8 5.29 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.019 1.328 . . . . 42.35 109.367 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -60.47 -46.75 97.44 Favored Pre-proline 0 CA--C 1.571 1.763 0 N-CA-C 113.054 0.761 . . . . 70.4 113.054 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 25.4 Cg_exo -66.61 -19.28 54.26 Favored 'Trans proline' 0 C--N 1.393 2.909 0 C-N-CA 122.002 1.801 . . . . 72.31 113.216 172.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -79.93 -48.86 12.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.398 0.679 . . . . 71.25 110.892 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 7.8 p -68.43 -18.93 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.963 0.505 . . . . 54.34 110.71 -178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -62.2 -39.63 93.39 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.108 0.963 . . . . 73.15 111.29 175.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -95.06 -13.14 25.44 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.591 0.756 . . . . 71.54 111.552 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 31.9 mmtp -83.19 167.93 17.26 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.24 0.616 . . . . 72.54 111.928 177.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -83.85 137.27 33.77 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.92 0.888 . . . . 71.04 109.819 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -77.68 86.77 3.96 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.469 0.652 . . . . 72.53 109.86 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -138.34 73.77 42.63 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 107.652 -1.24 . . . . 75.04 107.652 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 37.2 Cg_endo -91.05 166.06 3.75 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.48 2.12 . . . . 72.22 113.506 -174.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -99.58 105.51 17.39 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.06 -1.459 . . . . 74.54 107.06 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.13 90.87 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-O 122.728 1.251 . . . . 70.02 110.78 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 65' ' ' THR . 29.8 mmmt -94.91 118.09 31.21 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.899 -1.046 . . . . 71.43 108.887 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.9 tp -116.77 127.2 54.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.25 -1.389 . . . . 72.04 107.25 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HB2' HG22 ' A' ' 63' ' ' THR . 6.7 m-20 -123.54 122.91 39.41 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.334 -1.358 . . . . 71.3 107.334 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.412 ' HG ' HG22 ' A' ' 62' ' ' VAL . 6.3 tt -128.75 136.46 50.59 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.75 -0.833 . . . . 75.42 108.75 -169.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 28.8 t70 -143.75 145.35 32.33 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.993 1.317 . . . . 73.03 108.431 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.0 m -114.35 133.77 55.45 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.262 -1.014 . . . . 73.2 108.262 171.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.96 143.15 50.65 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.881 -0.785 . . . . 71.15 108.881 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.8 m -127.8 152.54 47.66 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.077 0.551 . . . . 72.14 111.017 -170.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.6 p -159.44 140.36 12.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.724 0.64 . . . . 72.11 110.123 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -87.18 109.22 19.32 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.304 -0.628 . . . . 74.31 109.304 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 57' ' ' GLU . 82.7 mt -78.95 -41.63 28.87 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.229 0.538 . . . . 52.54 109.984 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.454 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -150.99 176.86 10.72 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.228 -1.027 . . . . 73.31 108.228 177.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -60.58 117.54 5.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.13 -0.693 . . . . 63.52 109.13 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 72.58 13.1 5.39 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.731 1.212 . . . . 72.45 112.317 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.454 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 49.1 t -118.93 125.17 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.395 -0.965 . . . . 60.44 108.395 176.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -123.55 153.34 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.549 0.69 . . . . 73.54 111.582 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' A' ' 51' ' ' LEU . 8.4 tp10 -118.05 114.15 22.69 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.186 -1.783 . . . . 73.22 106.186 166.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.74 122.37 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 107.782 -1.192 . . . . 75.43 107.782 169.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -99.31 123.21 51.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.175 -1.046 . . . . 61.04 108.175 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 tp -86.74 96.83 10.3 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 106.754 -1.572 . . . . 60.42 106.754 173.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.597 ' HG2' ' HG3' ' A' ' 79' ' ' GLN . 0.8 OUTLIER -85.77 101.95 13.23 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.526 -1.216 . . . . 65.34 107.908 -175.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.412 HG22 ' HG ' ' A' ' 44' ' ' LEU . 62.1 t -125.08 137.97 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.067 0.547 . . . . 73.04 109.689 -174.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.428 HG22 ' HB2' ' A' ' 43' ' ' ASP . 7.5 t -138.53 145.63 40.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.348 0.659 . . . . 73.12 110.003 172.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 93.2 t -120.11 111.57 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.915 0.886 . . . . 70.41 108.614 177.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 20.7 m -105.52 107.91 19.15 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.199 -0.667 . . . . 74.41 109.199 173.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.64 104.64 15.02 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.736 -1.209 . . . . 53.33 107.736 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 25.0 m -117.27 123.53 46.81 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.954 -0.387 . . . . 73.13 109.954 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.72 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -90.26 86.33 6.48 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.049 0.928 . . . . 74.14 108.895 -178.372 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.29 -95.94 1.8 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 114.434 -1.257 . . . . 62.51 110.853 -174.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -114.73 -25.78 8.12 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.277 0.631 . . . . 73.31 111.455 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.408 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 29.8 tt0 -87.72 134.07 33.73 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.772 0.829 . . . . 65.24 110.693 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 49.4 m -84.96 135.07 34.2 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 120.923 0.392 . . . . 71.05 110.74 174.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.21 -61.61 1.85 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.83 1.252 . . . . 71.44 109.425 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -147.07 165.16 30.75 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.888 -1.051 . . . . 73.24 111.456 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 61.6 tp -135.65 108.79 7.71 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.028 -1.442 . . . . 72.31 107.561 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.429 ' SG ' HG22 ' A' ' 118' ' ' VAL . 90.0 m -108.35 104.38 13.74 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.269 0.628 . . . . 62.15 109.596 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.47 ' HG2' HE22 ' A' ' 79' ' ' GLN . 37.9 tt0 -124.13 117.28 24.29 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.171 0.988 . . . . 73.44 110.269 -169.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.1 t -133.69 112.83 17.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 123.7 0.8 . . . . 72.1 109.808 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.597 ' HG3' ' HG2' ' A' ' 61' ' ' ARG . 2.7 mp0 -89.68 84.22 6.3 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.657 1.183 . . . . 72.33 107.953 173.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -82.68 100.85 10.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.754 -1.112 . . . . 63.11 109.387 -175.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.13 151.91 20.99 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.45 0.469 . . . . 73.34 112.33 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.531 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -146.3 125.49 2.26 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.657 -0.577 . . . . 44.44 111.657 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.8 mt -81.45 118.13 28.68 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.252 -1.018 . . . . 72.34 108.252 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.68 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 41.1 m-85 -131.27 126.97 36.79 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.793 0.837 . . . . 74.3 108.971 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.3 m -83.75 115.64 22.31 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.379 1.072 . . . . 60.41 109.878 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 94' ' ' MET . 6.0 tt -97.14 136.68 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.246 1.019 . . . . 74.32 109.063 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -160.72 137.56 8.91 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.359 0.264 . . . . 62.14 111.368 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.97 -32.2 6.51 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.86 -0.609 . . . . 64.33 114.515 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -133.15 148.03 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 116.931 0.366 . . . . 70.41 111.693 -165.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.501 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 9.5 tt0 -134.99 -176.8 4.37 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.042 0.937 . . . . 72.25 109.18 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.501 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.94 -130.67 36.22 Favored Glycine 0 C--N 1.353 1.501 0 C-N-CA 123.178 0.418 . . . . 73.05 113.951 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.0 p -74.08 -21.71 59.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.537 0.735 . . . . 54.42 111.472 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.24 -49.68 47.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.446 0.698 . . . . 73.43 109.841 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.474 ' HB2' HD11 ' A' ' 86' ' ' ILE . 25.7 ptm -65.71 -32.13 73.52 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 116.189 -0.46 . . . . 41.13 110.269 177.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.79 88.66 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 124.044 0.84 . . . . 62.33 111.388 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 51.9 t-80 -69.43 -36.53 76.74 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.562 0.745 . . . . 75.24 111.301 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.8 m -73.27 -43.49 60.98 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.213 0.53 . . . . 70.25 111.008 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 tt -83.05 -38.38 22.63 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.337 1.055 . . . . 62.31 110.495 -169.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.97 3.78 52.31 Favored Glycine 0 N--CA 1.473 1.12 0 CA-C-N 116.111 -0.495 . . . . 74.43 114.259 -171.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.543 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -139.76 -62.77 0.51 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 117.452 0.626 . . . . 32.43 111.573 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.479 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 83.5 t80 -68.38 -55.28 12.51 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.977 0.911 . . . . 75.44 112.508 -170.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 76.0 m -72.05 -36.35 4.1 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 114.605 1.335 . . . . 52.41 114.605 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.56 -21.34 46.23 Favored 'Trans proline' 0 C--N 1.386 2.536 0 CA-C-N 121.787 1.674 . . . . 74.44 112.921 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -75.1 -28.64 60.33 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.069 0.548 . . . . 72.0 110.658 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.7 mm -59.9 -37.53 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.566 0.747 . . . . 74.15 109.9 172.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.531 HD21 ' HA3' ' A' ' 82' ' ' GLY . 83.5 mt -78.35 -21.19 49.88 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.308 1.043 . . . . 74.04 112.527 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -61.22 -45.62 95.5 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.936 -1.03 . . . . 75.3 113.636 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.99 -34.57 80.48 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 121.929 1.753 . . . . 73.32 113.27 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.42 -43.4 66.82 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.573 0.749 . . . . 71.24 111.193 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.9 -41.08 75.18 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.095 0.558 . . . . 73.51 110.333 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.473 ' NH1' HG23 ' C' ' 105' ' ' ILE . 30.8 ttm180 -52.38 -52.81 51.55 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.158 0.983 . . . . 64.44 109.494 174.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.15 -52.52 65.37 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 124.637 1.211 . . . . 75.1 111.471 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 117' ' ' MET . 40.4 t -55.82 -50.09 71.48 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 124.38 1.05 . . . . 71.03 110.621 -176.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.4 mt -58.77 -50.64 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 124.07 0.948 . . . . 72.24 110.985 177.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.41 HG23 ' HG3' ' A' ' 125' ' ' GLN . 86.5 m -51.92 -46.06 64.52 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.814 0.846 . . . . 54.4 110.65 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -64.09 -41.51 97.28 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 113.967 -1.469 . . . . 74.15 109.579 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 64.4 mmm -61.4 -42.5 98.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.182 0.593 . . . . 64.45 111.1 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 114' ' ' ILE . 57.8 t -62.05 -48.69 87.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.807 0.843 . . . . 64.52 110.091 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.0 p -71.75 -26.51 62.48 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.342 0.657 . . . . 45.5 111.956 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -70.76 -32.36 69.48 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.158 0.583 . . . . 72.12 109.996 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.75 -0.44 87.97 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.543 0.527 . . . . 34.53 112.987 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m 69.36 19.42 7.7 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 125.207 1.403 . . . . 71.42 111.217 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -86.06 150.8 53.33 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.542 -0.91 . . . . 73.1 108.542 171.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.91 143.12 92.78 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.721 2.281 . . . . 63.42 111.482 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.41 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.1 tt0 -57.63 136.67 56.83 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.469 0.708 . . . . 72.34 112.398 -171.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.459 ' HB3' HG21 ' A' ' 118' ' ' VAL . 29.1 tp -120.42 99.93 6.85 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.656 1.182 . . . . 73.23 109.335 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -99.8 101.47 12.63 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.606 -0.887 . . . . 73.04 108.606 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.17 117.72 5.91 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.057 -0.72 . . . . 72.04 109.057 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.23 142.58 86.01 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.373 0.669 . . . . 73.4 110.744 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.68 119.22 6.34 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.85 2.366 . . . . 74.15 112.826 -174.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.2 t -99.21 112.76 32.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 107.626 -1.25 . . . . 64.13 107.626 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -83.39 91.34 7.32 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 108.339 -0.985 . . . . 74.15 108.339 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -64.93 -24.58 67.57 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.659 -0.7 . . . . 74.34 111.489 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.543 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 8.6 t70 -69.7 -50.29 45.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.73 0.812 . . . . 72.41 110.066 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.16 -45.68 93.65 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.541 1.136 . . . . 64.01 110.87 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.24 -30.89 70.04 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.925 -1.034 . . . . 64.02 111.919 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -70.66 -35.43 72.86 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 123.366 0.416 . . . . 73.53 109.914 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 32.4 tpp . . . . . 0 N--CA 1.483 1.22 0 O-C-N 123.719 0.637 . . . . 70.55 110.492 176.315 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 89.6 m . . . . . 0 N--CA 1.472 0.657 0 CA-C-O 119.169 -0.443 . . . . 71.05 110.011 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . 0.266 0.3 OUTLIER -154.96 155.29 33.96 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.265 0.353 . . . . 61.43 110.951 147.246 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -126.88 140.86 52.03 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 107.702 -1.222 . . . . 70.1 107.702 170.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.533 HD11 HD13 ' B' ' 105' ' ' ILE . 30.4 mt -78.47 122.85 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.618 -0.719 . . . . 65.32 109.32 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -86.42 -49.92 7.26 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.883 0.74 . . . . 71.34 109.69 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -158.53 129.88 6.47 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.605 -0.725 . . . . 75.21 110.074 -171.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.468 HD11 HD13 ' B' ' 13' ' ' ILE . 94.8 mt -116.45 119.15 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 106.807 -1.553 . . . . 72.32 106.807 172.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -151.89 143.54 23.59 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.246 0.546 . . . . 74.2 110.942 -168.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -72.46 124.62 25.55 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.937 -1.029 . . . . 60.22 108.714 172.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.502 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.7 mtpt -95.01 -36.76 11.43 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.533 0.733 . . . . 70.32 110.319 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.0 t70 -157.07 141.08 16.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.602 -0.272 . . . . 72.52 110.984 -167.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' B' ' 78' ' ' VAL . 40.7 mm -141.13 148.08 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.118 1.367 . . . . 75.42 108.866 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 41.6 t -144.42 139.15 28.2 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.555 1.142 . . . . 64.34 108.13 170.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -145.01 114.21 7.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.665 -1.606 . . . . 70.11 106.665 170.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -124.85 112.51 16.74 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.825 0.45 . . . . 75.23 109.893 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.35 86.65 8.31 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 108.225 -1.028 . . . . 70.0 108.225 172.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.1 -35.29 11.92 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.916 2.41 . . . . 74.24 113.033 -173.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -102.87 19.33 19.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.587 0.755 . . . . 72.34 110.611 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.592 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -40.31 -65.48 0.44 Allowed Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 125.183 1.393 . . . . 75.25 113.836 -166.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 52.6 Cg_exo -53.54 -38.56 83.73 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.838 2.359 . . . . 75.24 114.018 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.412 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 52.8 m80 -87.48 -35.77 18.04 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.317 -0.856 . . . . 74.34 112.406 -170.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.576 HG22 HD12 ' B' ' 68' ' ' LEU . 11.1 p -69.99 -17.44 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.699 0.4 . . . . 64.42 111.425 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -68.7 -10.73 58.07 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 113.512 0.93 . . . . 62.12 113.512 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.7 pt20 -66.52 -25.13 66.53 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 122.811 0.444 . . . . 71.42 110.843 174.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -91.81 88.97 6.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.161 0.984 . . . . 70.1 108.747 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.51 76.79 6.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.823 0.849 . . . . 73.51 109.712 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -154.39 160.9 41.92 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.556 1.142 . . . . 70.13 108.37 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -75.15 107.41 3.93 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 124.833 1.253 . . . . 65.34 109.634 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.598 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 12.5 Cg_endo -59.95 133.71 52.19 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.103 2.536 . . . . 72.14 112.834 -175.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -57.7 114.59 2.34 Favored 'General case' 0 C--N 1.361 1.091 0 O-C-N 124.138 0.899 . . . . 74.22 111.051 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.23 156.75 3.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 114.775 -1.102 . . . . 63.1 111.485 -173.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -145.87 121.49 10.45 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.943 -1.503 . . . . 73.12 106.943 169.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.2 mp -86.22 155.39 20.73 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.11 -0.7 . . . . 61.32 109.11 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 27.2 t70 -144.6 145.2 31.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.981 -1.489 . . . . 75.44 106.981 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.89 135.85 29.89 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.146 -0.687 . . . . 75.3 109.146 -169.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.0 t70 -145.69 140.0 26.95 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.2 1.4 . . . . 70.15 108.254 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 74.8 p -134.26 141.31 46.94 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.987 -0.746 . . . . 63.52 108.987 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.44 120.68 4.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.41 0.684 . . . . 71.04 109.881 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 57.3 p -99.4 168.75 9.8 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.981 0.513 . . . . 74.54 109.911 176.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 86.5 p -151.15 135.87 17.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.06 0.544 . . . . 73.33 109.927 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -82.5 103.44 12.04 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.297 -0.631 . . . . 71.03 109.297 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' B' ' 57' ' ' GLU . 58.8 mt -75.02 -53.79 8.3 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.418 0.628 . . . . 62.33 110.629 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.88 -170.61 3.57 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.754 -1.112 . . . . 72.3 109.375 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -64.73 109.84 2.18 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.815 0.697 . . . . 51.32 109.72 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 13.3 m-20 71.97 1.55 3.96 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.123 1.369 . . . . 72.04 112.667 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -104.69 122.63 57.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.08 -1.081 . . . . 54.51 108.08 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.492 ' HE2' ' HB3' ' B' ' 98' ' ' LEU . 0.1 OUTLIER -135.98 154.64 51.02 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.034 -0.728 . . . . 71.45 109.034 178.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.672 ' HB2' HD11 ' B' ' 51' ' ' LEU . 12.5 tm-20 -123.29 110.53 15.31 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.672 -1.233 . . . . 75.43 107.672 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 95.0 t -89.81 141.35 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 O-C-N 123.777 0.673 . . . . 73.15 109.446 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.5 t -117.22 145.45 22.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 108.675 -0.861 . . . . 74.02 108.675 176.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.458 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -128.66 104.72 7.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.619 -1.252 . . . . 73.01 107.619 178.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.456 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 33.1 ttt180 -94.03 113.47 25.45 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.582 0.753 . . . . 64.34 110.596 173.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.19 104.36 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.258 -1.016 . . . . 65.31 108.258 171.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 41.3 m -96.34 142.0 28.99 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.534 -0.913 . . . . 63.44 108.534 175.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.455 HG11 HD21 ' B' ' 126' ' ' LEU . 90.4 t -136.5 136.01 48.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.507 -0.923 . . . . 75.4 108.507 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 74.6 m -122.48 137.7 54.79 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.599 -0.889 . . . . 73.41 108.599 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -141.64 141.83 33.4 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.617 0.767 . . . . 64.3 109.684 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.508 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 57.5 p -145.03 133.5 21.91 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.959 -0.564 . . . . 62.55 111.908 -173.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.598 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.1 mt -94.06 106.89 18.85 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.17 0.988 . . . . 74.14 109.033 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.49 -111.8 4.34 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 114.887 -1.051 . . . . 65.52 111.909 -173.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -107.64 5.36 26.8 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.81 0.844 . . . . 73.52 111.813 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -124.72 144.8 50.03 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.039 0.382 . . . . 61.14 111.237 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 99.8 m -64.72 119.92 11.48 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 123.817 0.698 . . . . 74.43 110.524 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.543 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -81.55 -65.63 0.99 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.712 -1.131 . . . . 72.43 108.02 176.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -144.2 150.75 38.49 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-O 121.723 0.773 . . . . 74.13 111.457 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 74.7 mt -115.03 142.19 46.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.086 -1.82 . . . . 73.1 106.086 166.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.541 ' SG ' HG23 ' B' ' 114' ' ' ILE . 49.7 t -147.55 146.8 29.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.804 -0.813 . . . . 73.01 108.804 176.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -160.7 136.39 8.14 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.512 -0.551 . . . . 74.01 109.512 -173.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.435 ' HA ' HD13 ' B' ' 21' ' ' ILE . 98.1 t -131.23 145.15 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 123.863 0.865 . . . . 73.43 109.203 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 42.2 mt-30 -122.71 88.49 2.94 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.076 -1.083 . . . . 74.54 108.076 171.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.4 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 11.2 tp-100 -81.24 101.62 9.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.783 -1.099 . . . . 61.13 109.157 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.502 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -95.75 163.06 23.44 Favored Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.677 -0.569 . . . . 73.44 111.677 176.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.74 127.41 1.9 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.114 -0.795 . . . . 74.14 111.114 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.89 127.2 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 109.045 -0.724 . . . . 73.23 109.045 172.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.421 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 24.0 m-85 -132.02 153.93 49.88 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 107.227 -1.397 . . . . 61.15 107.227 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 59.0 m -122.48 91.21 3.45 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.825 0.45 . . . . 72.14 110.41 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.429 HD11 HD11 ' B' ' 89' ' ' ILE . 15.4 tt -94.82 145.81 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.844 0.858 . . . . 73.43 112.474 -166.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.47 161.14 40.07 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 124.709 1.204 . . . . 65.21 108.999 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.06 -68.17 0.39 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.095 -0.502 . . . . 52.42 113.207 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.65 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -90.38 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 121.418 0.628 . . . . 71.33 112.03 -173.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.453 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 33.2 tt0 -156.94 179.38 9.35 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.826 1.25 . . . . 54.15 108.26 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.453 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 72.4 -123.55 9.27 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 117.676 0.217 . . . . 61.42 112.621 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 32.2 m -93.41 -18.16 22.67 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.323 0.649 . . . . 70.11 111.436 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -68.08 -33.87 75.35 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 122.081 -0.387 . . . . 74.34 110.289 173.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -29.31 52.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.26 0.224 . . . . 75.33 110.477 173.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . 0.471 ' HB1' ' HZ ' ' B' ' 137' ' ' PHE . . . -60.14 -40.78 91.01 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-O 121.403 0.621 . . . . 62.41 109.922 176.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 40.6 t-80 -64.12 -29.51 70.63 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.713 -1.13 . . . . 74.31 111.395 175.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.408 ' SG ' HD12 ' B' ' 86' ' ' ILE . 37.9 t -70.83 -66.11 0.65 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 110.312 -0.255 . . . . 75.41 110.312 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.492 ' HB3' ' HE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -72.23 -23.83 61.29 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.56 0.948 . . . . 62.31 113.56 -174.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.92 1.07 56.45 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 119.651 -0.527 . . . . 61.11 113.346 -174.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.595 ' HA ' ' HB3' ' B' ' 133' ' ' PHE . . . -152.06 -62.43 0.17 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.413 0.523 . . . . 61.4 112.413 -175.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -66.65 -42.52 86.52 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.187 0.995 . . . . 75.13 111.89 -170.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.492 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 73.2 m -71.25 -50.58 11.07 Favored Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 124.332 1.053 . . . . 70.43 111.069 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 65.3 Cg_exo -57.16 -30.86 88.7 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.115 1.876 . . . . 73.01 114.014 170.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -59.13 -43.01 91.98 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 123.65 0.78 . . . . 75.33 110.298 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.533 HD13 HD11 ' B' ' 13' ' ' ILE . 73.8 mt -62.9 -41.37 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 115.09 -0.959 . . . . 53.55 110.889 176.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.15 -22.93 38.62 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.953 -1.022 . . . . 70.1 112.314 -172.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -58.72 -49.03 95.66 Favored Pre-proline 0 N--CA 1.486 1.333 0 N-CA-C 114.205 1.187 . . . . 71.32 114.205 -170.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -55.95 -36.82 96.36 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.029 1.819 . . . . 60.31 113.937 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.4 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 78.7 m-85 -67.43 -46.59 72.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.158 0.583 . . . . 73.51 110.601 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.54 88.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.686 0.794 . . . . 71.23 110.856 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.659 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 34.6 ttt180 -61.21 -54.69 41.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.632 1.573 . . . . 75.23 111.014 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -38.12 89.9 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.36 0.664 . . . . 61.31 110.021 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.475 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.8 t -66.63 -33.89 76.66 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 116.18 -0.464 . . . . 73.3 111.535 -176.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.541 HG23 ' SG ' ' B' ' 76' ' ' CYS . 62.6 mt -66.46 -52.05 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 109.896 -0.409 . . . . 75.31 109.896 175.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.45 HG21 ' OG ' ' C' ' 119' ' ' SER . 5.1 m -62.5 -30.57 71.37 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.732 0.645 . . . . 50.12 111.487 -176.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.5 t -61.3 -49.92 75.09 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.449 0.7 . . . . 74.23 109.376 174.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.0 mmt -58.44 -44.87 89.33 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.637 0.775 . . . . 63.42 111.03 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.11 -45.49 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.291 1.036 . . . . 64.54 111.269 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.0 t -63.45 -37.48 87.44 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.307 -0.86 . . . . 42.22 111.476 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.5 mtt-85 -66.16 -36.19 82.46 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.751 -1.113 . . . . 72.21 109.949 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.43 9.74 66.52 Favored Glycine 0 C--N 1.356 1.678 0 O-C-N 123.93 0.769 . . . . 65.31 113.898 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.445 HG23 ' HB3' ' A' ' 17' ' ' TYR . 72.4 p 54.76 35.38 23.89 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.781 1.632 . . . . 75.41 113.222 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -99.31 153.58 37.71 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.171 0.588 . . . . 70.22 110.342 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -50.82 158.6 2.89 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 123.868 3.046 . . . . 72.42 115.187 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -63.33 119.66 10.09 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.655 1.182 . . . . 71.51 112.699 -170.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.455 HD21 HG11 ' B' ' 64' ' ' VAL . 55.9 tp -108.54 102.75 11.8 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.064 -0.717 . . . . 74.53 109.064 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -100.21 105.29 16.86 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.22 -0.659 . . . . 70.41 109.22 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.659 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -73.33 113.0 9.92 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.037 -0.727 . . . . 71.53 109.037 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.09 149.94 96.18 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.922 0.889 . . . . 74.31 110.752 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.488 ' HG3' HD11 ' D' ' 16' ' ' ILE . 55.6 Cg_endo -66.37 123.35 11.04 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.441 2.094 . . . . 31.42 112.383 -175.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.8 111.61 24.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.306 -1.368 . . . . 73.43 107.306 172.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -76.97 86.56 3.5 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.63 -1.248 . . . . 73.51 107.63 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.595 ' HB3' ' HA ' ' B' ' 100' ' ' ALA . 97.7 m-85 -55.37 -42.65 74.22 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.895 0.878 . . . . 74.23 111.529 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.72 -42.43 97.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.361 1.064 . . . . 74.44 111.696 -174.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.04 -52.81 31.14 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.586 0.754 . . . . 74.33 110.283 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.25 -18.62 61.8 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.112 -0.949 . . . . 63.24 112.282 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . 0.471 ' HZ ' ' HB1' ' B' ' 95' ' ' ALA . 72.1 t80 . . . . . 0 N--CA 1.471 0.582 0 C-N-CA 123.329 0.651 . . . . 62.55 109.757 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 40.2 m . . . . . 0 C--O 1.24 0.576 0 N-CA-C 107.711 -1.218 . . . . 73.1 107.711 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.522 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 3.2 t80 -116.14 119.85 37.12 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.127 -0.942 . . . . 74.21 108.578 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -136.47 131.9 34.64 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 107.981 -1.118 . . . . 61.22 107.981 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 63.8 mt -76.59 120.33 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.556 -0.905 . . . . 71.03 108.556 173.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.654 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.6 mm-40 -82.71 -42.31 18.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.075 -0.966 . . . . 63.02 109.106 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -170.94 149.31 2.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.639 -0.71 . . . . 73.33 109.703 -170.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.5 mt -138.3 133.77 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.645 -1.243 . . . . 65.11 107.645 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.423 ' HB3' HG23 ' D' ' 122' ' ' THR . 31.5 p90 -169.77 172.04 6.98 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.847 0.832 . . . . 74.01 111.77 -172.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -97.27 123.14 40.98 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.094 -0.957 . . . . 71.02 109.101 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.416 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.9 mmtp -71.21 -50.46 32.85 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 122.755 1.264 . . . . 73.5 107.631 168.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -134.92 141.88 46.41 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 112.517 -2.129 . . . . 71.23 108.889 -168.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 74.2 mt -137.95 142.03 36.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 106.024 -1.843 . . . . 55.34 106.024 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -155.99 150.15 25.49 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.316 0.579 . . . . 74.54 110.439 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -150.87 134.95 16.77 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.526 -1.287 . . . . 64.32 107.526 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.69 124.27 19.58 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.737 0.815 . . . . 75.34 109.499 -171.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.62 79.02 7.37 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 107.517 -1.29 . . . . 71.45 107.517 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.93 -42.71 61.5 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.026 2.484 . . . . 64.14 111.494 174.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -91.53 29.76 1.44 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.11 -1.404 . . . . 71.54 110.362 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.94 -58.91 8.71 Favored Pre-proline 0 N--CA 1.487 1.405 0 CA-C-O 118.084 -0.96 . . . . 74.41 113.046 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.33 -33.41 58.97 Favored 'Trans proline' 0 C--N 1.388 2.62 0 CA-C-N 121.735 1.655 . . . . 71.21 111.898 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -68.48 -37.63 80.3 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.202 1.401 . . . . 64.41 112.496 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.813 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.9 p -82.02 -23.51 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.372 0.269 . . . . 65.33 111.68 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -68.07 -35.83 78.85 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.877 0.37 . . . . 73.43 110.561 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -89.37 12.38 16.42 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.815 0.846 . . . . 71.43 111.062 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -101.27 160.51 14.35 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.154 0.982 . . . . 72.32 109.621 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.48 114.19 9.29 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.461 0.704 . . . . 60.42 109.91 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -78.84 100.95 7.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.879 0.872 . . . . 73.33 111.155 -174.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.545 ' H ' HD22 ' C' ' 68' ' ' LEU . 10.8 pt20 -149.9 78.42 8.14 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 124.107 0.963 . . . . 75.0 109.535 171.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -87.3 128.31 2.6 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.351 2.034 . . . . 73.31 112.571 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -86.27 91.5 8.49 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 106.075 -1.824 . . . . 65.25 106.075 165.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 18.0 m -72.49 131.81 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.737 -1.119 . . . . 64.22 111.831 -171.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -113.77 102.89 10.66 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.548 -1.279 . . . . 50.33 107.548 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -87.98 152.49 22.01 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.167 -0.679 . . . . 64.43 109.167 170.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.568 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.5 t70 -137.45 104.65 5.42 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.584 -0.895 . . . . 75.44 108.584 177.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 85.6 mt -92.65 113.09 25.28 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.839 -1.171 . . . . 63.12 107.839 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.3 t70 -122.27 153.7 38.55 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.856 1.262 . . . . 71.5 109.399 178.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 5.3 t -143.87 154.2 43.12 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.119 -0.697 . . . . 73.22 109.119 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.12 135.93 15.37 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.16 0.984 . . . . 51.24 109.097 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.459 ' HB3' HG22 ' C' ' 58' ' ' VAL . 29.6 p -125.71 142.18 51.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.363 0.665 . . . . 72.4 109.665 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.7 p -153.43 140.33 19.16 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.393 0.677 . . . . 73.14 110.766 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -72.18 127.14 31.62 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.955 0.902 . . . . 64.43 111.104 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' C' ' 57' ' ' GLU . 55.7 mt -96.06 -44.3 7.39 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.018 0.927 . . . . 72.22 109.708 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.25 -176.57 5.28 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.771 -1.104 . . . . 60.34 109.807 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.73 108.07 0.93 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.689 0.796 . . . . 72.2 110.369 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 70.63 1.6 3.76 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.745 1.618 . . . . 73.43 112.974 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 68.5 t -98.16 118.43 44.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.86 -0.793 . . . . 73.24 108.86 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -108.83 158.74 17.38 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.182 0.992 . . . . 73.04 110.28 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.586 ' HB2' HD11 ' C' ' 51' ' ' LEU . 24.6 tt0 -119.41 130.81 55.48 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 112.884 -1.962 . . . . 73.34 107.285 169.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.459 HG22 ' HB3' ' C' ' 48' ' ' SER . 76.0 t -115.28 126.4 72.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.877 -0.786 . . . . 60.24 108.877 170.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.486 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 88.0 t -105.79 130.36 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 107.788 -1.19 . . . . 73.01 107.788 171.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.41 103.75 10.43 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.837 -1.542 . . . . 54.22 106.837 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.423 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.9 ttm-85 -84.27 123.18 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.15 -1.386 . . . . 71.44 108.47 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -116.46 118.58 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.973 -1.121 . . . . 73.21 107.973 169.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 42.3 m -110.72 141.81 43.5 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.087 0.955 . . . . 63.24 108.628 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.706 HG11 HD11 ' C' ' 126' ' ' LEU . 55.8 t -126.1 127.65 71.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 108.663 -0.866 . . . . 24.44 108.663 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -115.81 137.37 52.15 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.22 -1.4 . . . . 74.44 107.22 167.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.51 114.39 14.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.187 -1.412 . . . . 62.42 107.187 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.6 m -134.75 134.08 40.6 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.562 0.539 . . . . 55.51 110.027 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.545 HD22 ' H ' ' C' ' 37' ' ' GLN . 12.5 mt -90.91 23.04 3.33 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 126.005 1.722 . . . . 73.14 110.133 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.39 -87.8 0.51 Allowed Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.024 -0.83 . . . . 65.53 111.024 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.2 -30.51 18.49 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.572 0.749 . . . . 71.31 110.326 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -92.97 118.36 31.07 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.455 0.702 . . . . 55.33 110.429 -173.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -77.44 122.4 25.14 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.614 -0.884 . . . . 71.13 108.614 169.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.813 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.5 -54.24 7.91 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.298 -0.865 . . . . 73.21 109.461 176.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -167.24 157.05 10.8 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.283 -0.871 . . . . 75.04 110.909 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.419 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -118.0 144.99 45.08 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 106.365 -1.717 . . . . 64.4 106.365 168.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.43 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.8 t -148.78 149.45 31.4 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.504 -0.924 . . . . 63.14 108.504 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -159.22 130.25 6.08 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.374 0.421 . . . . 54.32 110.073 175.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.5 t -125.54 131.6 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.891 0.876 . . . . 72.52 108.646 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -109.32 87.53 2.52 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.605 -1.257 . . . . 70.14 107.605 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.407 ' HG3' HD22 ' C' ' 106' ' ' LEU . 8.8 tp-100 -79.42 96.77 6.14 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.483 -0.78 . . . . 64.3 110.357 -175.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -97.7 143.23 16.58 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 112.306 -0.317 . . . . 61.22 112.306 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.99 140.62 8.53 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 110.357 -1.097 . . . . 71.1 110.357 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.654 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.7 mm -91.39 122.7 43.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.553 -0.906 . . . . 62.42 108.553 -178.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.522 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 63.8 m-85 -127.46 119.33 25.85 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.201 -1.037 . . . . 64.12 108.201 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 39.9 p -84.46 125.49 32.41 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.066 0.546 . . . . 75.33 109.563 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.624 HD13 HD11 ' C' ' 98' ' ' LEU . 39.0 pt -116.51 135.33 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.214 0.606 . . . . 70.11 109.776 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -153.45 151.29 29.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.947 0.899 . . . . 74.14 109.321 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.15 -57.74 4.26 Favored Glycine 0 N--CA 1.474 1.188 0 N-CA-C 112.243 -0.343 . . . . 72.43 112.243 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -85.48 156.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.869 0.868 . . . . 73.41 111.834 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.549 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 11.9 pt-20 -161.42 -175.74 4.97 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.416 -0.811 . . . . 74.34 110.421 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.1 -119.75 18.43 Favored Glycine 0 C--N 1.352 1.47 0 O-C-N 123.902 0.751 . . . . 61.44 113.845 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.3 p -72.94 -33.32 65.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.246 1.019 . . . . 72.51 111.171 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -67.9 -34.9 77.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.736 0.815 . . . . 72.04 110.903 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.549 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 55.3 ttp -75.35 -41.77 55.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.837 0.855 . . . . 72.34 110.396 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.37 -41.04 75.54 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.076 0.86 . . . . 50.04 110.086 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 18.7 t-160 -76.39 -43.2 41.68 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 124.05 0.844 . . . . 74.24 111.811 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -55.68 -40.25 72.06 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 123.956 0.785 . . . . 72.55 110.648 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.624 HD11 HD13 ' C' ' 86' ' ' ILE . 22.0 mt -101.71 -14.9 17.17 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.748 0.819 . . . . 71.51 111.632 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.87 -30.89 55.24 Favored Glycine 0 C--N 1.355 1.615 0 N-CA-C 114.77 0.668 . . . . 55.33 114.77 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.2 -36.32 0.06 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.07 0.396 . . . . 62.41 112.07 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -59.2 -49.59 77.29 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 125.231 1.412 . . . . 71.14 112.535 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 88.1 m -77.94 -41.99 2.17 Favored Pre-proline 0 CA--C 1.563 1.464 0 CA-C-O 118.727 -0.654 . . . . 63.21 112.575 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.08 -33.44 34.98 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.449 2.099 . . . . 74.44 114.558 168.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.33 -26.68 63.87 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.581 0.752 . . . . 71.23 110.458 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.473 HG23 ' NH1' ' A' ' 111' ' ' ARG . 48.0 mm -68.71 -39.36 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.829 0.852 . . . . 62.35 109.725 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.407 HD22 ' HG3' ' C' ' 80' ' ' GLN . 35.8 mt -80.64 -23.82 39.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.668 1.187 . . . . 74.4 112.597 -174.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -57.3 -49.25 94.95 Favored Pre-proline 0 CA--C 1.563 1.45 0 N-CA-C 114.212 1.19 . . . . 75.12 114.212 -173.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.41 -37.64 96.82 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 121.945 1.764 . . . . 62.11 113.223 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -66.36 -49.01 68.34 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.837 0.855 . . . . 73.43 111.178 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.09 -38.97 84.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.289 -0.868 . . . . 65.43 110.628 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -58.54 -55.71 31.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.564 1.146 . . . . 74.42 110.8 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.29 -33.08 75.13 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.852 0.461 . . . . 75.13 110.39 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 33.4 t -71.16 -31.4 67.64 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.009 0.524 . . . . 64.55 111.48 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.43 HG23 ' SG ' ' C' ' 76' ' ' CYS . 76.9 mt -73.2 -54.04 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.523 -0.547 . . . . 75.21 109.523 172.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 4.7 m -62.46 -27.82 69.39 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.166 0.587 . . . . 73.34 111.271 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.6 t -61.33 -53.66 53.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.626 0.771 . . . . 54.12 109.094 169.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.57 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.28 -35.23 75.06 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.791 1.236 . . . . 73.44 112.46 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' C' ' 123' ' ' PHE . 75.0 t -65.67 -45.27 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.683 0.793 . . . . 73.5 109.622 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.45 ' OG ' HG21 ' B' ' 115' ' ' THR . 42.3 t -68.69 -28.55 66.95 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.001 0.813 . . . . 32.45 111.449 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.469 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 82.7 mtt-85 -70.74 -43.11 69.52 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.503 0.721 . . . . 72.21 109.211 176.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.09 -3.79 82.13 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 124.287 0.992 . . . . 51.52 112.24 172.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 65.82 26.55 11.18 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 127.026 2.13 . . . . 74.44 113.588 170.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.411 ' HB2' HG13 ' C' ' 118' ' ' VAL . 92.1 m-85 -82.8 156.62 67.56 Favored Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 109.021 -0.733 . . . . 73.25 109.021 171.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.14 175.1 2.72 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.909 2.406 . . . . 73.25 114.285 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -56.84 137.56 54.78 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.784 1.031 . . . . 74.22 113.784 -171.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.706 HD11 HG11 ' C' ' 64' ' ' VAL . 3.0 tt -126.9 87.03 2.59 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.662 -1.154 . . . . 70.55 108.278 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -107.89 109.66 21.23 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.21 0.604 . . . . 73.4 109.846 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -74.73 135.63 41.79 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 122.918 0.487 . . . . 73.1 110.762 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.26 151.38 87.86 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.894 0.877 . . . . 74.1 110.241 174.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.533 ' HG3' HD12 ' A' ' 16' ' ' ILE . 24.6 Cg_exo -60.93 103.34 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.816 2.344 . . . . 53.23 112.794 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 17.9 m -98.46 111.13 27.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.244 -1.021 . . . . 61.44 108.244 168.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -75.72 84.57 2.72 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.32 -0.854 . . . . 74.41 109.196 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -54.39 -44.82 72.61 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.752 0.658 . . . . 75.55 110.121 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.74 -47.53 85.29 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.574 -1.194 . . . . 61.52 111.682 -174.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.27 87.01 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.345 0.658 . . . . 55.4 111.209 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.96 -42.49 99.84 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.776 -0.647 . . . . 64.53 111.422 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . 0.414 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 10.1 t80 . . . . . 0 N--CA 1.487 1.405 0 C-N-CA 122.935 0.494 . . . . 74.14 110.807 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 37.1 m . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.067 0.46 . . . . 75.42 110.024 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -158.14 97.01 1.49 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.87 -1.529 . . . . 74.12 106.87 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -134.46 149.82 50.77 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.828 -0.805 . . . . 70.23 108.828 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.464 HD11 HG21 ' D' ' 105' ' ' ILE . 4.5 mt -92.87 130.48 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.404 -0.591 . . . . 70.32 109.404 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -86.73 -35.22 19.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.055 0.542 . . . . 52.23 110.5 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -174.54 130.56 0.35 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.488 0.315 . . . . 65.2 111.091 -172.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.488 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.5 mp -107.47 140.78 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.747 -1.205 . . . . 74.13 107.747 172.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -162.65 158.62 23.44 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.733 0.646 . . . . 71.15 111.679 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.8 p -93.59 118.85 31.89 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.169 -0.923 . . . . 72.55 109.56 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -90.28 -20.59 22.76 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 116.045 -0.525 . . . . 75.41 109.923 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.1 t70 -157.02 132.36 9.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.517 -0.765 . . . . 75.3 109.821 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.57 HG21 ' HE2' ' C' ' 117' ' ' MET . 60.4 mt -135.9 147.06 28.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 124.548 1.139 . . . . 41.31 107.982 171.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -153.52 115.68 4.35 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.82 0.7 . . . . 53.1 110.142 171.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -110.21 134.22 52.44 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.487 -1.671 . . . . 72.33 106.487 166.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.718 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 31.4 mt-10 -140.0 120.21 13.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.777 0.831 . . . . 72.02 108.959 -173.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.05 89.43 50.75 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.845 -1.169 . . . . 75.34 107.845 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.3 -46.8 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.103 2.536 . . . . 73.13 111.795 -174.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 26.3 m-20 -98.2 34.93 1.85 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.256 1.023 . . . . 71.14 109.01 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.8 -66.86 0.53 Allowed Pre-proline 0 CA--C 1.567 1.614 0 N-CA-C 114.101 1.149 . . . . 70.14 114.101 -162.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.428 ' HB3' HD11 ' C' ' 83' ' ' ILE . 95.1 Cg_endo -76.03 -20.28 15.04 Favored 'Trans proline' 0 C--N 1.384 2.447 0 CA-C-N 122.705 2.002 . . . . 75.34 113.02 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.413 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 6.6 t-160 -64.49 -47.65 78.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.575 1.55 . . . . 73.51 109.746 176.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.707 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.1 p -85.26 -23.94 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 CA-C-N 114.821 -1.081 . . . . 73.01 112.194 -168.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -60.79 -30.45 70.05 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 123.355 0.662 . . . . 73.31 112.765 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -60.08 -24.06 64.3 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.931 -1.031 . . . . 62.03 111.166 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -86.84 85.14 7.25 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.365 1.066 . . . . 75.44 108.775 173.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.15 82.08 3.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.419 0.628 . . . . 72.22 110.414 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -142.17 157.88 44.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.012 1.325 . . . . 53.45 107.759 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -68.22 107.69 2.15 Favored Pre-proline 0 CA--C 1.555 1.139 0 N-CA-C 108.635 -0.876 . . . . 71.32 108.635 172.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.412 ' O ' HG13 ' D' ' 40' ' ' VAL . 35.8 Cg_exo -59.93 120.96 9.06 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.122 2.548 . . . . 73.41 112.157 -168.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.15 111.78 4.1 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 123.943 0.777 . . . . 51.34 109.983 -175.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.608 HG12 ' HB2' ' D' ' 66' ' ' ALA . 35.9 m -104.5 142.49 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.109 -0.951 . . . . 75.23 110.745 -173.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.49 136.93 40.51 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.912 -1.144 . . . . 72.05 107.912 162.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.4 112.42 24.35 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.168 -1.049 . . . . 71.12 108.168 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -127.54 123.13 35.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.331 -0.989 . . . . 73.1 108.331 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.05 160.81 19.79 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.446 0.641 . . . . 71.34 110.047 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -149.73 151.6 33.92 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.202 -1.407 . . . . 64.23 107.202 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -128.37 154.18 46.26 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.464 -0.569 . . . . 71.3 109.464 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.69 157.75 43.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.983 0.913 . . . . 72.51 109.402 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.4 m -149.01 153.44 37.91 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.332 0.653 . . . . 50.52 109.968 175.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.8 t -152.67 126.01 8.69 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.669 0.788 . . . . 73.13 109.757 -169.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -78.01 118.33 20.19 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.78 0.432 . . . . 75.32 109.842 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.472 HD11 ' HB2' ' D' ' 57' ' ' GLU . 67.0 mt -91.72 -42.09 10.34 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.579 -0.526 . . . . 54.2 109.579 176.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.62 -174.95 5.09 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.872 -1.058 . . . . 73.32 110.05 -176.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.11 117.86 9.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.924 -1.035 . . . . 64.24 110.031 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 64.39 18.01 11.09 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.501 1.126 . . . . 71.01 111.68 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.98 119.25 59.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 124.228 1.011 . . . . 64.25 108.356 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.403 ' CD1' HD11 ' D' ' 86' ' ' ILE . 14.6 m-85 -132.44 127.33 35.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.501 -0.926 . . . . 74.11 108.501 175.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.472 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.1 tt0 -90.21 121.65 32.43 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.656 1.183 . . . . 72.4 108.897 169.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 74.3 t -102.27 142.37 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.542 -0.91 . . . . 64.41 108.542 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.455 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.6 t -121.91 130.76 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.463 -0.94 . . . . 65.41 108.463 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -110.59 119.85 40.52 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.442 -1.318 . . . . 71.1 107.442 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -98.02 96.6 8.26 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.034 -1.099 . . . . 74.42 108.034 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.9 t -93.44 120.01 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.012 -1.107 . . . . 74.55 108.012 171.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -119.18 140.87 49.46 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.432 0.693 . . . . 75.51 109.601 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.49 HG11 HD11 ' D' ' 126' ' ' LEU . 91.5 t -136.51 122.26 28.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 125.031 1.333 . . . . 55.44 108.276 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 93.3 m -119.51 112.63 19.6 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.743 -0.836 . . . . 55.21 108.743 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -111.02 154.82 23.64 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.855 0.862 . . . . 52.3 110.293 -172.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 34.0 p -149.8 134.14 17.35 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.783 0.677 . . . . 63.43 111.415 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.455 ' HB2' HG22 ' D' ' 31' ' ' VAL . 48.1 mt -113.19 122.62 48.04 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.933 1.293 . . . . 71.14 107.855 171.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.4 -112.46 3.48 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.999 -0.44 . . . . 63.32 111.999 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 4.08 9.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.118 0.967 . . . . 73.52 110.036 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -126.15 163.0 24.08 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.64 0.776 . . . . 70.24 110.392 -170.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.0 m -61.91 125.41 23.76 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 124.22 0.95 . . . . 74.03 111.801 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.707 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -81.13 -72.87 0.4 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.339 -0.985 . . . . 44.12 108.339 171.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . 0.525 ' HZ ' HD12 ' D' ' 126' ' ' LEU . 48.1 p90 -144.7 160.45 41.18 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.559 0.695 . . . . 65.41 110.311 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.718 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 64.8 mt -122.58 141.4 51.74 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.451 -1.685 . . . . 74.15 106.451 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.579 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.8 t -153.49 136.66 15.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.782 -0.451 . . . . 64.21 109.782 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.8 130.82 11.02 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.619 0.768 . . . . 74.23 108.936 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.8 t -129.44 114.19 30.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.532 -0.914 . . . . 74.13 108.532 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.0 mt-30 -89.9 84.75 6.24 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 122.045 0.926 . . . . 73.53 109.07 171.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.86 101.41 8.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 113.474 -1.694 . . . . 75.0 110.146 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.87 161.37 29.36 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.957 -0.457 . . . . 71.01 111.957 175.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.22 134.92 3.58 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.942 -0.863 . . . . 43.03 110.942 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.1 mt -87.33 128.51 39.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 124.101 0.96 . . . . 51.34 108.93 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -128.12 126.59 41.42 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.237 0.615 . . . . 63.3 110.175 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.4 m -81.13 102.45 10.28 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.984 -0.747 . . . . 73.4 108.984 169.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.538 HD13 HD11 ' D' ' 98' ' ' LEU . 44.7 pt -109.7 140.99 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.195 0.998 . . . . 70.23 110.689 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.9 159.16 34.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.836 0.854 . . . . 65.34 109.448 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.98 -0.36 89.08 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 114.349 0.499 . . . . 32.21 114.349 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.521 HD11 HD12 ' D' ' 86' ' ' ILE . 29.0 pt -105.37 147.86 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.473 0.709 . . . . 74.04 110.389 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.1 146.65 28.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.117 0.567 . . . . 73.21 111.588 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.65 -113.5 2.78 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 124.254 0.931 . . . . 74.35 115.143 175.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.9 p -64.43 -33.22 75.36 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.693 1.197 . . . . 64.04 111.6 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -65.64 -31.11 71.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.486 0.715 . . . . 75.05 111.032 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 55.9 mtm -67.97 -45.79 73.19 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.614 0.365 . . . . 70.31 110.128 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.12 -37.36 82.53 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.074 0.55 . . . . 74.42 111.317 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -71.15 -38.8 72.2 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.86 0.864 . . . . 44.43 111.078 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -72.75 -51.11 20.47 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.377 -0.374 . . . . 45.33 111.632 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.596 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.2 mm? -86.06 -28.52 24.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.422 0.689 . . . . 74.11 111.041 -174.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.95 -22.97 47.35 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 114.242 0.457 . . . . 71.51 114.242 -176.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -129.04 -56.6 1.18 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.983 0.513 . . . . 75.23 111.479 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . 0.548 ' HA ' HD22 ' D' ' 104' ' ' ASN . 63.2 t80 -70.63 -34.88 72.57 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 112.839 0.681 . . . . 73.13 112.839 -172.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.596 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 75.7 m -69.57 -49.45 21.77 Favored Pre-proline 0 CA--C 1.569 1.679 0 CA-C-O 118.562 -0.732 . . . . 63.12 111.625 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 84.1 Cg_exo -55.25 -30.3 71.14 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 122.565 2.176 . . . . 52.34 114.48 170.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . 0.548 HD22 ' HA ' ' D' ' 101' ' ' TYR . 72.9 m-20 -53.96 -40.26 66.69 Favored 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 123.584 0.754 . . . . 75.24 111.857 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.464 HG21 HD11 ' D' ' 13' ' ' ILE . 36.2 mt -78.69 -40.65 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.899 0.88 . . . . 63.41 110.761 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.2 mt -72.36 -20.82 61.39 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.506 -0.77 . . . . 73.11 111.973 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -68.22 -45.3 39.23 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.035 0.934 . . . . 73.24 113.119 -173.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -50.05 -45.77 31.4 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.591 2.194 . . . . 72.12 114.415 169.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.16 -41.57 77.07 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.446 0.698 . . . . 64.44 111.32 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.34 95.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.723 0.809 . . . . 73.23 110.51 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.461 ' HA ' HD23 ' D' ' 128' ' ' LEU . 29.5 ttp180 -59.72 -51.23 70.68 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.41 -1.268 . . . . 74.54 110.385 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.64 -45.81 92.45 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 124.528 1.143 . . . . 75.53 111.154 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.55 -41.34 80.77 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.01 0.819 . . . . 73.45 110.856 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.579 HG12 ' SG ' ' D' ' 76' ' ' CYS . 76.3 mt -63.05 -56.34 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 123.74 0.65 . . . . 64.5 110.262 173.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.3 m -53.7 -39.38 65.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.409 1.083 . . . . 33.42 111.682 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -66.15 -46.28 78.01 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.83 -1.077 . . . . 64.33 109.867 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.3 mtm -69.34 -30.21 68.19 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.002 0.521 . . . . 73.23 112.317 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.49 HG13 ' HB2' ' D' ' 123' ' ' PHE . 72.7 t -66.02 -45.32 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.461 0.704 . . . . 71.52 109.209 175.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -71.51 -33.03 68.87 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 123.391 0.432 . . . . 72.13 110.822 -178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -69.97 -33.03 71.54 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.927 0.891 . . . . 74.22 110.089 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.8 3.28 86.08 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 123.884 0.74 . . . . 73.53 112.463 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.423 HG23 ' HB3' ' C' ' 17' ' ' TYR . 36.4 p 63.1 23.77 14.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.721 2.008 . . . . 33.24 114.446 171.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.49 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.6 m-85 -86.74 151.5 52.68 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 108.924 -0.769 . . . . 73.01 108.924 170.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.07 145.92 31.97 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.352 2.701 . . . . 71.01 113.792 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -54.76 140.19 36.95 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.352 1.061 . . . . 72.22 113.668 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.525 HD12 ' HZ ' ' D' ' 74' ' ' PHE . 4.8 tt -119.75 106.69 12.36 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.482 -0.932 . . . . 71.32 108.482 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -108.95 111.57 23.31 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.843 -0.799 . . . . 55.21 108.843 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' D' ' 111' ' ' ARG . 3.1 mm? -73.69 120.28 19.06 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.97 -0.752 . . . . 75.13 108.97 171.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.28 137.93 94.14 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 109.812 -0.44 . . . . 64.12 109.812 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.85 115.03 3.26 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.385 2.056 . . . . 43.42 111.548 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.7 m -108.04 152.8 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.436 0.694 . . . . 75.32 110.09 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -81.51 96.18 7.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.399 -0.819 . . . . 73.02 109.121 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -63.49 -31.64 72.86 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.653 0.381 . . . . 74.23 111.22 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . 0.429 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 54.9 m-20 -62.09 -57.82 10.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.531 0.732 . . . . 74.11 111.564 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.61 96.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.642 0.777 . . . . 64.44 111.17 -176.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 5.0 mp -67.23 -28.18 67.85 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.16 -0.927 . . . . 73.24 111.797 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.7 t80 . . . . . 0 N--CA 1.486 1.352 0 C-N-CA 124.004 0.922 . . . . 74.05 111.333 175.691 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 109.071 -0.714 . . . . 72.22 109.071 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.623 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.6 t80 -136.21 129.71 32.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.062 -0.718 . . . . 71.42 109.062 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 48.1 tp60 -149.87 109.6 4.05 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.947 0.899 . . . . 73.53 109.04 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.539 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.4 mt -78.59 112.53 16.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.408 -0.96 . . . . 61.13 108.408 174.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.9 -41.83 25.35 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.825 -0.625 . . . . 61.23 109.317 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -171.19 123.57 0.59 Allowed 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.157 0.286 . . . . 75.31 111.185 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.615 HD12 ' HG3' ' C' ' 130' ' ' PRO . 72.2 mt -111.95 136.26 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.74 0.816 . . . . 64.32 109.166 174.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 24.9 p90 -166.52 177.8 6.45 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.204 0.94 . . . . 70.01 110.928 -171.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -103.08 120.23 40.3 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.459 -0.791 . . . . 61.22 109.01 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 27.2 mtpt -84.77 -38.42 19.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.404 -0.591 . . . . 73.2 109.404 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.719 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.7 t70 -138.97 136.28 35.22 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.063 -0.971 . . . . 74.31 109.534 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 49.7 mt -133.55 146.68 31.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.116 -1.438 . . . . 74.11 107.116 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.1 t -155.16 145.71 22.17 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.636 0.585 . . . . 54.23 109.811 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.449 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.6 t80 -145.89 131.72 19.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.926 -1.509 . . . . 73.22 106.926 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -138.72 129.96 27.05 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.721 -0.844 . . . . 72.41 108.721 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -129.43 81.41 70.1 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.316 -0.994 . . . . 74.51 108.316 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.26 -25.91 25.8 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.024 2.482 . . . . 70.22 112.986 -172.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 31' ' ' VAL . 51.4 m-80 -114.67 24.11 12.1 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.411 0.685 . . . . 64.15 110.445 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -52.1 -49.31 85.13 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 113.705 1.002 . . . . 73.24 113.705 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.54 -21.83 18.99 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 121.982 1.788 . . . . 74.22 111.964 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -80.1 -23.04 41.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.98 -1.009 . . . . 74.21 111.006 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 86.2 t -59.96 -24.65 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.637 0.775 . . . . 74.15 111.3 177.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -56.96 -38.85 73.54 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.852 0.861 . . . . 63.21 111.188 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -93.11 -20.92 20.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.497 0.719 . . . . 72.44 110.921 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.533 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 30.7 mmmt -79.86 143.41 34.34 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.62 0.768 . . . . 73.24 111.468 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.27 121.12 20.8 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.34 -0.985 . . . . 72.03 108.34 168.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -68.88 89.91 0.42 Allowed 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.472 0.482 . . . . 71.52 110.689 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -144.13 81.55 11.48 Favored Pre-proline 0 C--O 1.245 0.834 0 N-CA-C 107.519 -1.289 . . . . 74.5 107.519 167.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 95.5 Cg_endo -81.94 157.66 18.13 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.693 2.262 . . . . 73.43 112.798 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.413 ' HB3' ' HE3' ' A' ' 41' ' ' LYS . 16.6 mm-40 -95.74 99.97 11.74 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.084 -1.08 . . . . 75.55 108.084 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.2 m -71.21 94.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-O 122.292 1.044 . . . . 72.21 110.776 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 39' ' ' GLU . 97.6 mttt -110.03 135.63 50.56 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.753 -1.112 . . . . 74.12 109.443 -177.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.5 tp -136.15 126.6 26.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.076 0.55 . . . . 65.42 110.737 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -126.42 131.29 51.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.83 0.852 . . . . 62.33 109.397 173.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.64 HD22 HG12 ' A' ' 62' ' ' VAL . 54.5 mt -119.69 134.33 55.27 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.413 0.685 . . . . 61.03 110.518 -175.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 8.2 m-20 -125.8 141.15 52.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.799 1.24 . . . . 74.43 108.188 173.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.5 m -126.32 129.85 49.66 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.006 -0.739 . . . . 73.31 109.006 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.58 153.95 50.5 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.438 1.095 . . . . 63.45 108.491 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.7 t -126.72 152.95 46.14 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 120.911 0.386 . . . . 53.24 110.17 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.5 t -149.45 121.41 8.22 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.386 1.074 . . . . 63.5 108.766 -176.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -74.28 125.85 29.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.092 0.557 . . . . 73.31 109.69 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.5 mt -95.49 -34.42 12.08 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.316 0.646 . . . . 75.12 110.421 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.0 177.36 10.83 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.08 0.952 . . . . 74.33 109.268 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -66.22 125.75 26.53 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.287 -0.634 . . . . 73.35 109.287 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 70.82 3.59 4.67 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.056 1.343 . . . . 73.42 112.142 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.75 115.0 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.251 1.021 . . . . 63.4 108.621 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -126.77 156.29 41.46 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.59 0.756 . . . . 74.1 109.604 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -130.19 142.85 50.54 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.266 -1.013 . . . . 62.4 108.266 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.51 139.91 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 108.241 -1.022 . . . . 75.31 108.241 165.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -112.41 107.34 22.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 107.824 -1.176 . . . . 65.24 107.824 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.8 tp -88.94 100.76 13.45 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.332 -0.849 . . . . 61.12 109.11 178.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 14.0 ttm-85 -84.46 107.89 16.96 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.65 -0.704 . . . . 62.22 109.155 175.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.64 HG12 HD22 ' A' ' 44' ' ' LEU . 19.8 m -103.96 130.22 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 123.857 0.863 . . . . 70.13 109.559 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.1 m -121.26 116.36 24.74 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.641 0.777 . . . . 72.24 110.075 -176.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.3 t -116.14 121.45 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.486 1.114 . . . . 64.41 108.83 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.6 m -126.71 124.9 40.85 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.347 -0.983 . . . . 63.44 108.347 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -125.56 105.24 8.89 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.163 -0.68 . . . . 72.32 109.163 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 42.4 t -116.73 128.86 55.73 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.377 0.671 . . . . 73.41 111.207 -173.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' A' ' 73' ' ' ALA . 5.1 mp -89.92 86.37 6.6 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.223 -1.399 . . . . 75.3 107.223 175.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.08 -104.88 2.07 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.512 -1.035 . . . . 73.41 110.512 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -109.23 -14.02 14.55 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.179 0.592 . . . . 75.34 110.534 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -85.48 95.97 9.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.934 0.894 . . . . 75.43 110.118 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 26.5 m -67.44 125.46 26.21 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 123.441 0.463 . . . . 43.24 110.535 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.491 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -78.01 -54.06 6.72 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.318 -0.856 . . . . 61.01 109.003 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -146.59 155.47 42.5 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.429 -1.26 . . . . 63.44 110.878 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.7 tp -133.48 132.07 40.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.527 -1.657 . . . . 54.33 106.527 176.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 85.1 m -133.92 110.44 9.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.342 -0.614 . . . . 74.22 109.342 -174.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -124.38 117.07 23.63 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.044 0.938 . . . . 71.35 109.118 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.4 ' O ' HG22 ' A' ' 62' ' ' VAL . 75.3 t -132.91 111.33 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.221 0.608 . . . . 74.21 109.817 -173.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.719 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 26.3 mt-30 -87.81 87.12 7.27 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 108.609 -0.886 . . . . 75.4 108.609 167.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.408 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.9 tp-100 -76.91 116.63 17.75 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.919 -1.037 . . . . 63.43 108.448 176.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.84 144.25 18.35 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.56 -0.616 . . . . 71.2 111.56 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.477 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.99 134.22 6.06 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 111.167 -0.773 . . . . 74.51 111.167 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.3 mt -82.89 115.43 25.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.645 -0.872 . . . . 52.31 108.645 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.623 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.4 m-85 -122.29 117.7 26.74 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.857 0.863 . . . . 74.23 108.937 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 12.6 m -90.81 89.94 7.7 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.321 -0.992 . . . . 52.24 108.321 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.7 pt -109.74 139.72 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.347 -0.842 . . . . 62.51 110.766 -172.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.8 168.95 25.56 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.846 -1.07 . . . . 64.11 109.695 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.11 9.61 85.93 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.606 0.566 . . . . 74.05 114.039 174.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.15 153.69 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.126 0.57 . . . . 64.24 110.603 -176.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -160.43 -172.48 3.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.669 0.788 . . . . 73.23 110.506 -171.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.1 -143.34 48.47 Favored Glycine 0 C--N 1.359 1.824 0 O-C-N 123.537 0.523 . . . . 43.41 112.636 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.9 t -86.44 -11.24 52.39 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 122.866 0.466 . . . . 74.45 111.038 166.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -33.99 74.83 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.925 0.89 . . . . 73.24 109.827 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -31.71 70.8 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.375 0.27 . . . . 63.45 110.966 173.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.68 -28.18 55.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.65 0.78 . . . . 61.21 110.826 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 43.8 t-80 -69.73 -29.36 66.71 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.136 0.574 . . . . 64.5 110.313 170.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 78.0 m -69.69 -49.34 54.39 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.489 0.316 . . . . 71.32 110.928 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 pp -85.16 -18.93 32.65 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.017 0.527 . . . . 52.14 112.339 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.69 3.87 27.63 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-O 119.782 -0.455 . . . . 63.11 114.117 -173.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -148.09 -63.57 0.26 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.33 0.565 . . . . 74.45 111.378 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -61.66 -66.0 0.6 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.367 1.467 . . . . 72.11 112.826 -168.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.401 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 95.9 m -73.9 -37.98 3.6 Favored Pre-proline 0 CA--C 1.569 1.675 0 N-CA-C 114.701 1.371 . . . . 44.13 114.701 -175.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 35.8 Cg_endo -64.55 -24.53 63.18 Favored 'Trans proline' 0 C--N 1.388 2.626 0 CA-C-N 121.837 1.692 . . . . 71.34 113.369 173.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -69.43 -29.78 67.57 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.017 0.527 . . . . 72.55 110.13 177.656 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.4 mm -62.66 -40.66 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.443 0.697 . . . . 53.15 110.184 176.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.477 HD21 ' HA3' ' A' ' 82' ' ' GLY . 96.3 mt -79.53 -19.24 50.06 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.166 0.986 . . . . 74.13 112.967 -175.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -59.4 -47.74 97.38 Favored Pre-proline 0 CA--C 1.569 1.693 0 N-CA-C 113.584 0.957 . . . . 74.44 113.584 -172.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.9 -37.05 57.08 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.061 1.841 . . . . 74.33 113.096 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -67.31 -40.22 85.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.319 0.648 . . . . 74.12 111.153 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.474 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.59 -42.65 86.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.151 0.58 . . . . 64.44 110.137 177.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -50.31 -53.68 26.92 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.475 1.11 . . . . 75.42 110.506 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -68.65 -38.05 80.14 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.394 -0.821 . . . . 63.2 111.433 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.37 -34.18 74.89 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.107 0.48 . . . . 74.14 111.095 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 118' ' ' VAL . 60.7 mt -69.49 -57.25 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.132 -0.94 . . . . 71.22 109.624 172.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -55.35 -37.07 67.01 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.869 1.268 . . . . 74.21 111.923 -172.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.4 t -65.38 -50.3 66.05 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.117 -0.947 . . . . 73.51 109.903 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.449 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 67.6 mtm -62.27 -37.84 87.04 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.173 0.589 . . . . 74.34 111.454 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 114' ' ' ILE . 99.3 t -59.57 -49.12 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.676 0.79 . . . . 75.41 110.062 176.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.3 m -69.74 -29.78 67.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.537 -0.756 . . . . 72.54 111.615 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -72.8 -26.96 61.7 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.638 0.775 . . . . 72.21 110.126 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.87 6.64 77.84 Favored Glycine 0 C--N 1.354 1.563 0 O-C-N 123.685 0.616 . . . . 34.24 112.913 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.478 ' HB ' HH21 ' B' ' 15' ' ' ARG . 22.9 m 67.66 15.48 9.72 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.534 1.134 . . . . 71.01 111.175 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.463 ' HE1' HG21 ' A' ' 31' ' ' VAL . 63.6 m-85 -87.82 140.93 31.36 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 108.546 -0.909 . . . . 62.12 108.546 174.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -49.45 148.23 11.4 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.267 2.645 . . . . 75.32 113.25 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -59.63 129.46 42.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.5 0.72 . . . . 73.11 112.236 -173.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -110.18 101.55 10.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.121 0.968 . . . . 65.21 109.844 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -102.25 103.79 14.3 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.142 -1.059 . . . . 71.31 108.142 171.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.61 154.58 41.31 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.661 0.384 . . . . 73.32 110.575 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.56 142.84 92.17 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.363 0.665 . . . . 54.44 111.079 -175.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.33 127.91 13.14 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.343 2.029 . . . . 72.44 112.771 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 76.8 t -102.28 115.06 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.856 0.862 . . . . 75.03 108.878 175.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -92.14 85.91 5.62 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.671 -1.233 . . . . 70.23 107.671 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 91.8 m-85 -59.05 -31.6 69.01 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.745 -1.116 . . . . 52.43 113.203 -169.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.12 -36.67 83.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.351 0.26 . . . . 74.34 111.419 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.62 -38.17 89.19 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.109 0.563 . . . . 73.34 110.895 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.5 -39.38 88.69 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.211 -0.904 . . . . 64.1 111.311 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -68.61 -25.91 65.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.998 -0.546 . . . . 73.35 110.833 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 17.0 mmt . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 123.04 0.536 . . . . 50.31 111.665 177.945 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 81.0 m . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 107.415 -1.328 . . . . 73.42 107.415 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -150.79 142.14 23.33 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.991 -0.374 . . . . 71.2 109.991 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -159.11 141.94 14.28 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 123.919 0.762 . . . . 63.43 109.644 169.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.545 HD13 HD11 ' B' ' 16' ' ' ILE . 45.8 mt -80.26 125.39 39.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.877 -0.786 . . . . 65.45 108.877 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -96.3 -35.52 11.2 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.343 0.657 . . . . 74.45 109.609 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.478 HH21 ' HB ' ' A' ' 122' ' ' THR . 56.6 ttt180 -170.66 131.92 0.91 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.529 -0.76 . . . . 72.33 109.557 -176.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.545 HD11 HD13 ' B' ' 13' ' ' ILE . 87.2 mt -114.89 136.33 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 106.641 -1.614 . . . . 64.31 106.641 168.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -166.48 162.97 17.17 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.695 0.622 . . . . 61.14 111.306 -174.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.646 HG21 HD11 ' B' ' 21' ' ' ILE . 27.5 m -98.32 127.4 44.24 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.444 -0.947 . . . . 71.13 108.444 176.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -98.05 -23.72 15.64 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.745 0.818 . . . . 73.45 111.018 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 9.3 t70 -158.78 139.33 12.55 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.142 0.276 . . . . 70.3 111.188 -170.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.646 HD11 HG21 ' B' ' 18' ' ' THR . 40.8 mm -135.79 149.15 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.598 1.159 . . . . 74.04 108.754 175.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 17.7 m -146.89 143.62 28.67 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.524 1.13 . . . . 73.23 109.082 165.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -152.2 108.77 3.45 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.662 -1.236 . . . . 72.33 107.662 169.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -122.08 118.18 28.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.262 1.025 . . . . 72.12 108.399 -174.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -116.45 84.22 14.41 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.264 1.026 . . . . 72.11 108.549 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.23 -40.49 19.34 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.872 2.381 . . . . 62.43 112.585 -174.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 87.3 m-20 -96.67 13.8 27.09 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.987 -1.006 . . . . 70.11 111.078 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.44 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -40.29 -62.75 0.85 Allowed Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 115.086 1.513 . . . . 71.42 115.086 -164.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 6.7 Cg_exo -69.4 -25.58 30.13 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 121.721 1.614 . . . . 61.13 112.204 -171.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 69.7 m80 -95.44 -25.43 16.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.865 -1.061 . . . . 73.32 111.731 -170.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.672 HG22 HD12 ' B' ' 68' ' ' LEU . 8.7 p -83.9 -18.25 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.995 0.518 . . . . 64.03 110.981 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -61.11 -30.91 70.64 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.309 0.855 . . . . 73.34 113.309 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 28.7 pt20 -61.27 -18.12 56.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.831 0.452 . . . . 72.12 111.608 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -92.29 82.87 4.97 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.146 0.978 . . . . 71.15 108.865 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -86.52 90.83 8.36 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.281 -0.637 . . . . 72.53 109.281 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.7 t-105 -158.15 156.12 30.32 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.898 1.279 . . . . 71.11 107.988 174.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -59.79 104.76 0.47 Allowed Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.991 1.316 . . . . 71.11 111.295 173.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.616 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 60.9 Cg_endo -74.45 128.17 11.71 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.689 2.26 . . . . 64.01 112.415 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.88 125.74 24.81 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 123.565 0.541 . . . . 74.12 109.911 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.592 HG12 ' HB2' ' B' ' 66' ' ' ALA . 25.2 m -104.67 153.32 6.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.848 -0.615 . . . . 70.5 111.014 -176.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.462 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 79.4 tttt -108.71 117.98 35.59 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.789 -1.189 . . . . 75.33 107.789 169.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.38 140.67 30.7 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.877 0.471 . . . . 74.21 110.23 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.558 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 6.1 t70 -145.42 155.85 43.4 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.616 -0.883 . . . . 74.23 108.616 -177.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.484 ' H ' HD23 ' B' ' 44' ' ' LEU . 1.5 pt? -115.51 163.12 16.22 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.596 0.712 . . . . 75.34 110.771 -175.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.581 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.0 t70 -163.64 111.3 1.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.19 -1.411 . . . . 74.31 107.19 167.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.6 p -128.73 125.34 37.74 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.167 0.587 . . . . 71.54 110.239 -172.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.66 159.47 41.89 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.034 0.934 . . . . 41.23 109.932 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.9 p -133.29 159.24 40.84 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.138 0.575 . . . . 73.41 109.678 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 98.1 p -153.1 140.75 19.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.173 0.589 . . . . 71.34 109.582 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -89.01 115.84 26.86 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.882 0.473 . . . . 70.01 109.996 176.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.96 -39.91 17.56 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.682 0.793 . . . . 64.23 109.207 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.43 -176.51 5.83 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.594 1.158 . . . . 74.12 109.717 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -67.43 126.15 28.37 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.851 -0.613 . . . . 62.32 110.033 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' B' ' 85' ' ' SER . 7.2 m-20 69.02 -9.95 0.55 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.093 1.757 . . . . 74.34 112.487 -173.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.9 t -105.63 104.13 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.789 -0.819 . . . . 62.4 108.789 -172.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -115.18 168.08 10.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.413 -1.267 . . . . 74.4 108.979 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -143.64 117.43 9.3 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.848 -1.168 . . . . 74.14 107.848 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.88 144.71 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.591 1.156 . . . . 75.54 109.247 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.5 t -127.82 119.82 52.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.088 -0.708 . . . . 62.13 109.088 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -98.28 114.7 27.08 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.642 -1.614 . . . . 71.54 106.642 172.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.581 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 3.7 ttt180 -111.56 125.89 54.4 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.409 -0.589 . . . . 73.34 109.409 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 49.5 t -114.3 116.21 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.681 1.192 . . . . 74.22 108.429 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.8 m -97.61 137.03 37.14 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.18 -0.674 . . . . 75.44 109.18 173.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 76.9 t -133.02 126.22 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.859 0.864 . . . . 60.24 109.529 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 91.9 m -124.66 107.16 10.7 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.373 0.669 . . . . 75.11 110.236 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.592 ' HB2' HG12 ' B' ' 40' ' ' VAL . . . -106.5 151.83 24.47 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.217 0.607 . . . . 75.23 110.992 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 57.0 p -153.24 139.86 18.85 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.051 -0.977 . . . . 73.24 110.497 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.672 HD12 HG22 ' B' ' 31' ' ' VAL . 48.5 mt -107.87 102.33 11.54 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.28 1.032 . . . . 74.23 109.201 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.08 -110.18 3.2 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.609 -0.723 . . . . 72.12 112.733 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.94 2.81 46.81 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.637 0.775 . . . . 71.31 111.138 -169.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.41 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.1 pt-20 -144.07 158.13 43.9 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.967 0.507 . . . . 75.11 110.875 -170.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -65.82 143.71 57.31 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.955 0.785 . . . . 75.12 111.171 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.471 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -96.18 -70.22 0.72 Allowed 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.508 -0.923 . . . . 71.02 108.508 169.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -148.6 153.03 37.77 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.167 -0.924 . . . . 70.45 109.466 -173.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 23.4 mt -131.12 109.44 10.46 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.538 -1.282 . . . . 52.14 107.538 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.0 t -119.96 147.32 44.9 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.816 -0.439 . . . . 63.44 109.816 -175.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -157.6 133.69 9.47 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 109.486 -0.561 . . . . 63.44 109.486 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 89.6 t -129.62 148.52 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.4 0.68 . . . . 73.11 109.474 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.0 mt-30 -118.33 98.9 6.51 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.75 -1.204 . . . . 73.53 107.75 166.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -85.89 99.55 11.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.1 -1.074 . . . . 74.1 108.1 171.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.68 169.81 35.98 Favored Glycine 0 C--O 1.242 0.626 0 N-CA-C 111.228 -0.749 . . . . 62.15 111.228 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.42 127.74 1.59 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 112.111 -0.396 . . . . 73.22 112.111 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 46.8 mt -84.53 120.78 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 107.727 -1.212 . . . . 71.15 107.727 171.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -128.41 135.11 49.06 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.84 0.856 . . . . 75.35 109.211 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 67.5 m -93.91 117.25 29.84 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 110.045 -0.354 . . . . 54.32 110.045 172.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.597 HD13 HD21 ' B' ' 98' ' ' LEU . 45.3 pt -117.11 146.81 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.821 1.248 . . . . 70.21 110.025 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.637 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -152.69 161.37 42.65 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.391 1.077 . . . . 75.55 108.62 170.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.86 -28.76 4.38 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 113.794 0.278 . . . . 62.13 113.794 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.89 140.06 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 124.608 1.163 . . . . 71.0 112.209 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.539 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 36.0 tt0 -162.71 144.81 10.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.25 0.62 . . . . 65.22 110.175 -177.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.39 -113.3 5.58 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.578 0.548 . . . . 61.24 113.768 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 88.4 m -82.14 -24.32 35.13 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.609 0.764 . . . . 73.35 111.17 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.539 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 44.2 mt-30 -60.52 -43.87 96.66 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.044 0.537 . . . . 61.24 111.271 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -65.02 -36.49 84.55 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.41 0.444 . . . . 54.44 110.269 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.67 -37.35 86.26 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.229 1.012 . . . . 75.13 111.157 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -82.68 -29.36 29.99 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.234 0.614 . . . . 73.03 110.858 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -67.09 -64.39 0.86 Allowed 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.661 0.601 . . . . 74.51 110.177 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.597 HD21 HD13 ' B' ' 86' ' ' ILE . 60.2 mt -81.76 -18.57 43.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.837 0.455 . . . . 71.03 111.173 -176.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.46 -35.53 11.85 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.427 0.454 . . . . 55.24 113.955 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.451 ' HB1' ' HD1' ' B' ' 133' ' ' PHE . . . -134.99 -41.16 0.75 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.033 0.753 . . . . 65.4 113.033 -167.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -77.44 -48.61 16.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.659 0.784 . . . . 74.43 111.277 -170.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.48 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 86.5 m -64.88 -48.0 73.17 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.684 0.794 . . . . 71.53 110.859 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 53.4 Cg_exo -58.05 -30.29 89.69 Favored 'Trans proline' 0 C--N 1.397 3.105 0 C-N-CA 122.085 1.856 . . . . 74.51 114.339 170.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -61.06 -42.17 97.98 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 123.084 0.554 . . . . 64.24 110.856 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.88 -40.94 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 115.357 -0.838 . . . . 24.33 110.105 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.3 mt -77.65 -20.99 52.89 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.729 -1.123 . . . . 73.2 112.125 -174.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -59.71 -50.65 85.8 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 114.269 1.211 . . . . 73.34 114.269 -171.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.87 -31.74 95.96 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 121.755 1.637 . . . . 72.54 113.087 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -73.32 -47.21 44.4 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.462 0.705 . . . . 73.33 110.965 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.99 -43.07 81.34 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.287 0.635 . . . . 60.42 110.291 175.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -60.08 -51.2 70.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.371 1.468 . . . . 75.14 111.204 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.82 -34.91 79.24 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.12 0.568 . . . . 62.42 109.794 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.8 t -70.71 -34.85 72.37 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.962 0.505 . . . . 73.33 111.665 -177.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.476 ' O ' HG23 ' B' ' 118' ' ' VAL . 58.8 mt -65.34 -55.87 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 109.178 -0.675 . . . . 71.51 109.178 173.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 15.5 m -59.76 -27.5 66.58 Favored 'General case' 0 CA--C 1.552 1.043 0 O-C-N 124.001 0.813 . . . . 71.0 111.557 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -64.07 -51.02 66.05 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.341 0.657 . . . . 64.21 109.77 174.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -69.24 -35.04 75.72 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.082 0.553 . . . . 63.11 111.125 -175.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.9 t -59.16 -46.75 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.554 0.741 . . . . 61.3 109.697 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.4 t -67.12 -30.83 70.94 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.749 -1.114 . . . . 62.42 111.811 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.449 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -70.21 -38.65 75.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.834 -0.621 . . . . 55.31 110.12 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.06 1.88 83.17 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.85 0.719 . . . . 70.51 112.695 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 27.1 p 61.84 25.47 15.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.69 1.996 . . . . 51.35 113.302 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -80.51 155.01 74.09 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 123.568 0.747 . . . . 65.13 110.953 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -50.48 158.6 2.57 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.809 3.006 . . . . 65.11 115.042 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.407 ' HG3' HD21 ' B' ' 127' ' ' ASN . 60.7 tp60 -61.16 119.58 8.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.536 1.134 . . . . 75.21 112.531 -168.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.4 tp -110.18 127.15 54.77 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.269 0.628 . . . . 62.54 109.854 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.407 HD21 ' HG3' ' B' ' 125' ' ' GLN . 40.6 m-80 -129.06 126.13 38.76 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.587 0.755 . . . . 61.01 109.093 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.9 131.1 34.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.419 -0.585 . . . . 70.45 109.419 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.62 152.02 96.37 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.748 0.819 . . . . 75.3 111.365 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.09 109.12 0.87 Allowed 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.621 2.214 . . . . 44.4 111.464 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 24.1 t -91.21 115.53 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.39 -0.596 . . . . 53.52 109.39 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . 0.451 ' O ' HD13 ' B' ' 136' ' ' LEU . 57.4 t-20 -72.7 90.72 1.41 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.198 0.599 . . . . 74.02 109.561 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.451 ' HD1' ' HB1' ' B' ' 100' ' ' ALA . 33.1 p90 -57.22 -32.93 67.01 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.97 0.908 . . . . 73.02 112.708 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -82.87 -41.31 19.13 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.389 0.676 . . . . 72.42 112.387 -168.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.33 61.99 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.125 0.57 . . . . 73.33 110.944 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . 0.451 HD13 ' O ' ' B' ' 132' ' ' ASN . 6.7 mp -74.92 -30.67 61.32 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.672 -0.695 . . . . 73.12 109.868 172.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 59.6 t80 . . . . . 0 CA--C 1.552 1.027 0 CA-C-N 115.46 -0.791 . . . . 72.44 110.159 173.293 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 107.9 -1.148 . . . . 60.4 107.9 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -93.55 118.64 31.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.16 -0.927 . . . . 74.25 108.637 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -138.12 135.37 35.68 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.48 -1.304 . . . . 72.4 107.48 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.2 mt -74.81 121.17 25.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.401 -0.963 . . . . 64.02 108.401 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.514 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 19.6 mm-40 -83.68 -44.05 14.9 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 123.888 0.743 . . . . 71.2 109.051 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -177.42 137.52 0.21 Allowed 'General case' 0 C--N 1.359 1.001 0 CA-C-N 115.491 -0.777 . . . . 73.1 109.72 -173.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.3 mt -124.46 143.8 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.008 -1.108 . . . . 75.04 108.008 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.476 ' OH ' HD11 ' C' ' 83' ' ' ILE . 30.7 p90 -171.43 165.13 7.02 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.36 0.6 . . . . 64.43 111.923 -172.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -92.64 107.67 19.39 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.967 -1.015 . . . . 73.04 109.191 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -68.38 -39.97 81.56 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.672 0.749 . . . . 54.14 109.548 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.471 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 19.3 t70 -143.28 139.36 30.12 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 113.918 -1.492 . . . . 75.5 109.192 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 96.4 mt -137.05 143.13 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 106.704 -1.591 . . . . 65.11 106.704 172.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -149.44 147.84 28.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.096 0.474 . . . . 54.23 110.001 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -147.46 135.32 21.18 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.45 -1.315 . . . . 72.2 107.45 169.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.596 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 33.7 mt-10 -138.13 111.3 7.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.561 0.745 . . . . 73.04 109.742 -170.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.11 74.02 11.0 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.445 -1.316 . . . . 73.32 107.445 166.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.46 -28.72 21.51 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.58 2.187 . . . . 73.42 111.163 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -88.22 14.49 9.25 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.957 -1.474 . . . . 72.43 111.787 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -44.83 -54.49 12.95 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 114.184 1.179 . . . . 63.42 114.184 -174.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.23 -37.08 85.55 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 121.916 1.744 . . . . 54.23 113.175 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -69.05 -45.1 71.26 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.836 0.854 . . . . 71.43 111.818 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.756 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -76.53 -22.28 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 113.156 0.798 . . . . 74.25 113.156 -174.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -65.49 -31.53 72.65 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.58 0.585 . . . . 72.24 112.58 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -94.84 11.55 31.19 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.355 0.662 . . . . 73.34 111.667 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -85.14 160.55 19.91 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.981 0.912 . . . . 73.42 110.688 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.92 115.38 3.37 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.339 0.656 . . . . 71.23 109.372 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -84.72 91.75 8.03 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.355 0.597 . . . . 54.25 110.01 -177.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -143.46 79.95 13.49 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 106.756 -1.572 . . . . 72.22 106.756 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' C' ' 67' ' ' SER . 6.4 Cg_exo -80.35 149.92 19.48 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 123.029 2.486 . . . . 62.54 113.619 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -108.03 110.79 22.58 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 107.064 -1.458 . . . . 64.11 107.064 169.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 m -80.43 124.11 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.334 0.588 . . . . 73.22 110.292 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 1.8 tmtp? -125.03 102.52 7.55 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.376 -1.713 . . . . 74.21 106.376 171.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.68 HD11 HD12 ' C' ' 128' ' ' LEU . 4.2 tt -108.44 121.71 45.52 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.968 -1.864 . . . . 71.11 105.968 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -122.72 117.06 24.83 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.88 -0.415 . . . . 74.41 109.88 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.464 HD11 HG21 ' C' ' 131' ' ' VAL . 89.4 mt -92.23 150.93 20.61 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.677 0.791 . . . . 72.3 109.322 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 12.7 t70 -151.32 142.77 23.48 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.235 -1.024 . . . . 61.34 108.235 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -126.75 139.51 53.07 Favored 'General case' 0 C--O 1.249 1.072 0 N-CA-C 108.607 -0.886 . . . . 75.15 108.607 172.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.91 141.92 21.27 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.896 -1.149 . . . . 54.32 107.896 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 16.5 p -148.1 156.8 43.03 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 120.853 0.359 . . . . 64.33 110.844 -171.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 95.5 p -144.12 158.64 43.6 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.723 0.809 . . . . 63.22 110.014 -172.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -94.46 130.91 40.65 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.797 -0.816 . . . . 75.5 108.797 172.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.649 HD11 HD12 ' C' ' 83' ' ' ILE . 39.1 mt -99.79 -42.6 6.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.335 0.654 . . . . 43.1 110.489 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -152.67 -172.25 4.18 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.322 -0.853 . . . . 74.51 110.245 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.67 105.87 1.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.013 -0.994 . . . . 70.1 109.826 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 70.06 3.69 4.48 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.01 1.324 . . . . 71.23 113.13 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 56.1 t -100.76 122.78 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.109 -1.071 . . . . 55.53 108.109 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -138.25 124.39 20.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.01 -0.541 . . . . 61.35 109.736 -166.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' C' ' 51' ' ' LEU . 41.1 tt0 -84.83 137.8 32.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.561 0.745 . . . . 73.53 109.496 174.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.51 129.57 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.791 -1.189 . . . . 73.4 107.791 170.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.4 148.24 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.693 0.797 . . . . 73.14 109.109 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.09 111.92 14.02 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.481 -1.303 . . . . 60.24 107.481 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.6 tmm_? -98.42 107.13 19.52 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 107.731 -1.211 . . . . 75.43 107.731 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 t -103.62 123.11 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.186 -1.042 . . . . 74.11 108.186 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -111.83 141.55 45.32 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.021 -0.733 . . . . 65.11 109.021 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.625 HG21 HG21 ' C' ' 114' ' ' ILE . 91.1 t -131.84 123.21 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.515 1.126 . . . . 75.1 108.146 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 12.8 m -124.69 141.84 51.82 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.795 0.838 . . . . 65.13 108.764 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.69 123.98 16.72 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.235 -1.394 . . . . 61.12 107.235 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 60.4 m -133.3 158.22 43.49 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.6 0.714 . . . . 71.34 111.312 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 mt -121.35 39.85 3.73 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.356 1.463 . . . . 64.01 107.338 -171.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.29 -111.6 3.88 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 109.507 -1.437 . . . . 75.35 109.507 -166.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -90.48 -31.08 16.93 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.105 0.562 . . . . 72.21 110.389 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -70.67 106.91 3.69 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.026 0.93 . . . . 71.32 109.911 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.7 m -72.83 126.73 30.61 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.94 -0.763 . . . . 61.43 108.94 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.756 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.92 -58.23 4.1 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.029 -0.73 . . . . 63.04 109.029 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -159.43 163.8 35.1 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.536 -0.756 . . . . 74.41 110.897 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -128.27 144.84 51.16 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 106.517 -1.66 . . . . 72.13 106.517 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.46 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.3 t -149.42 147.11 27.87 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.334 -0.987 . . . . 75.02 108.334 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.43 135.28 10.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.72 0.295 . . . . 74.14 110.48 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' C' ' 110' ' ' ALA . 50.4 t -135.33 114.77 17.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 124.332 1.053 . . . . 74.33 108.704 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 65.4 mt-30 -97.35 89.9 4.89 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.143 -0.688 . . . . 54.53 109.143 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.1 tp-100 -79.39 102.47 8.72 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.053 -0.976 . . . . 52.33 110.498 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.96 157.14 31.89 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 116.202 -0.454 . . . . 51.31 112.035 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.589 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -160.81 116.64 0.73 Allowed Glycine 0 CA--C 1.508 -0.369 0 N-CA-C 111.72 -0.552 . . . . 74.24 111.72 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.649 HD12 HD11 ' C' ' 51' ' ' LEU . 7.4 mm -82.7 127.28 39.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.727 -0.842 . . . . 62.3 108.727 177.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -132.12 141.05 49.01 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.758 0.823 . . . . 64.24 109.082 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 13.5 p -83.73 122.92 29.29 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.142 -0.688 . . . . 65.3 109.142 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 46.6 pt -120.86 133.14 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.602 0.761 . . . . 63.11 109.804 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.63 159.68 21.99 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.302 1.041 . . . . 35.43 108.704 176.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.33 -57.6 4.22 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 112.713 -0.155 . . . . 70.54 112.713 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.407 ' H ' HG13 ' C' ' 89' ' ' ILE . 2.7 pp -88.57 163.76 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.184 0.594 . . . . 71.0 111.687 -177.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -165.85 163.21 18.71 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.673 0.789 . . . . 51.42 110.392 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.92 -114.96 7.03 Favored Glycine 0 C--N 1.355 1.594 0 C-N-CA 123.44 0.543 . . . . 43.12 113.703 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -63.34 -40.47 97.37 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.731 0.812 . . . . 63.31 111.574 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -76.59 -32.1 57.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.675 0.39 . . . . 74.15 110.861 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 41.5 ttm -76.99 -28.71 55.19 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.274 0.358 . . . . 65.53 110.817 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.63 91.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.441 -0.577 . . . . 51.14 109.441 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -77.33 -25.22 50.92 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.308 0.38 . . . . 62.14 111.718 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.05 -52.18 66.47 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.542 0.526 . . . . 74.31 109.733 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 pp -81.99 -20.53 38.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.931 0.492 . . . . 74.34 110.882 176.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.27 -29.19 56.74 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 114.482 0.553 . . . . 75.24 114.482 -173.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.14 -43.52 0.06 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.918 0.71 . . . . 73.32 112.918 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -59.42 -46.08 89.73 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.477 0.711 . . . . 74.24 112.309 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.411 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 81.1 m -78.92 -46.87 1.74 Allowed Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.699 0.8 . . . . 71.31 111.396 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.411 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 53.0 Cg_exo -55.86 -26.3 56.92 Favored 'Trans proline' 0 C--N 1.399 3.185 0 C-N-CA 122.402 2.068 . . . . 74.3 113.831 169.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.33 -43.37 97.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.561 1.145 . . . . 73.32 109.936 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.0 mm -64.05 -45.21 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 114.84 -1.073 . . . . 71.22 109.789 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.589 HD21 ' HA3' ' C' ' 82' ' ' GLY . 86.4 mt -75.72 -25.18 56.39 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.149 -0.932 . . . . 72.0 112.812 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -56.22 -53.42 63.87 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 113.78 1.029 . . . . 71.21 113.78 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.69 -29.63 88.77 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 121.725 1.617 . . . . 75.52 113.387 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -68.94 -48.71 62.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.781 0.433 . . . . 63.13 110.478 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.23 -31.11 72.17 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.461 -0.791 . . . . 71.31 110.773 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.674 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 46.6 ttt180 -63.42 -58.86 5.71 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.472 1.509 . . . . 54.21 111.146 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -31.91 73.36 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.686 0.394 . . . . 74.21 110.262 -177.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -65.29 -31.34 72.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.141 0.576 . . . . 62.11 111.579 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.625 HG21 HG21 ' C' ' 64' ' ' VAL . 84.8 mt -74.89 -56.61 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 116.154 -0.475 . . . . 71.54 109.933 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 3.3 m -62.7 -27.72 69.45 Favored 'General case' 0 CA--C 1.553 1.066 0 O-C-N 123.688 0.617 . . . . 61.4 111.412 -172.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -62.39 -51.34 67.98 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.349 0.66 . . . . 74.32 109.304 170.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.668 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.79 -39.61 89.53 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.333 1.053 . . . . 61.33 112.435 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' C' ' 114' ' ' ILE . 60.4 t -59.91 -47.88 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.436 0.694 . . . . 73.52 109.422 176.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -66.31 -32.42 73.81 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.494 -1.23 . . . . 65.43 111.755 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -67.8 -35.02 77.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.31 0.644 . . . . 74.21 109.879 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.39 10.84 69.91 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.928 0.767 . . . . 41.21 112.888 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.45 HG23 ' HB3' ' D' ' 17' ' ' TYR . 46.6 p 54.84 37.26 28.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.058 1.743 . . . . 73.34 113.752 177.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -95.65 153.48 39.41 Favored Pre-proline 0 N--CA 1.477 0.911 0 N-CA-C 108.196 -1.038 . . . . 71.4 108.196 168.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -64.76 168.9 12.47 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.5 2.134 . . . . 75.12 112.688 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -54.44 113.33 1.24 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.353 1.061 . . . . 73.35 113.412 -174.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 5.5 tt -113.87 87.03 2.53 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.307 -1.368 . . . . 64.22 107.307 167.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -95.47 127.47 41.54 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.23 -1.026 . . . . 73.34 108.23 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.68 HD12 HD11 ' C' ' 42' ' ' LEU . 2.3 mm? -73.62 132.15 42.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.552 0.741 . . . . 75.2 109.546 -174.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.62 153.47 75.91 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.518 0.727 . . . . 42.3 110.606 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.615 ' HG3' HD12 ' A' ' 16' ' ' ILE . 50.2 Cg_exo -51.58 115.68 2.25 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.771 2.314 . . . . 52.13 112.73 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.464 HG21 HD11 ' C' ' 44' ' ' LEU . 85.0 t -97.95 122.58 49.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.199 -0.667 . . . . 63.41 109.199 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -83.88 76.11 10.05 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.17 0.588 . . . . 75.11 109.497 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -60.51 -44.67 95.77 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 122.116 0.96 . . . . 72.32 109.038 170.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -65.09 -50.0 67.81 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 113.184 -1.825 . . . . 75.23 112.366 -172.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.67 88.32 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.814 0.696 . . . . 43.24 111.825 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -42.93 74.38 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.762 -1.108 . . . . 70.34 109.82 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 4.8 t80 . . . . . 0 N--CA 1.483 1.199 0 C-N-CA 122.739 0.416 . . . . 75.03 111.285 -175.719 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.6 m . . . . . 0 C--O 1.241 0.62 0 N-CA-C 108.733 -0.84 . . . . 75.55 108.733 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -148.23 102.21 3.34 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.506 -1.294 . . . . 71.35 107.506 172.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -126.1 115.91 20.56 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.763 -1.199 . . . . 73.02 107.763 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.436 HD13 HG21 ' D' ' 105' ' ' ILE . 13.7 mt -72.33 115.76 13.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 N-CA-C 108.247 -1.02 . . . . 75.41 108.247 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -88.01 -29.53 20.65 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.722 -0.672 . . . . 75.0 110.783 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -179.54 141.13 0.15 Allowed 'General case' 0 C--N 1.366 1.315 0 C-N-CA 122.34 0.256 . . . . 74.22 110.411 -170.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.409 HD11 HG21 ' D' ' 13' ' ' ILE . 3.7 mp -122.46 135.79 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.256 -1.387 . . . . 53.41 107.256 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.45 ' HB3' HG23 ' C' ' 122' ' ' THR . 34.7 p90 -165.86 174.02 10.0 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-O 121.654 0.74 . . . . 75.13 112.258 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -105.06 120.17 40.84 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.735 -1.12 . . . . 62.41 108.912 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -89.91 -21.47 22.47 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.307 0.643 . . . . 73.4 109.805 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.673 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.0 t70 -155.37 139.36 16.37 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.081 -0.963 . . . . 71.03 108.856 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.668 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.3 mt -137.53 142.77 35.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.56 -1.274 . . . . 74.43 107.56 172.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -149.07 130.09 14.39 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.543 -0.91 . . . . 73.11 108.543 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.411 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 85.5 t80 -136.78 126.23 25.09 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.992 -1.484 . . . . 75.11 106.992 170.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.5 mt-10 -130.82 138.3 49.82 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.74 -0.837 . . . . 74.34 108.74 -175.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.77 82.86 67.81 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 106.97 -1.492 . . . . 74.51 106.97 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.08 -32.4 27.92 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.196 2.597 . . . . 61.43 113.034 -169.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -111.77 26.53 10.53 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.308 0.643 . . . . 75.52 109.385 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.04 -70.09 0.16 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 114.746 1.387 . . . . 50.41 114.746 -161.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.536 ' HB3' HD11 ' C' ' 83' ' ' ILE . 65.2 Cg_endo -77.04 -16.35 15.91 Favored 'Trans proline' 0 C--N 1.38 2.198 0 CA-C-N 122.401 1.893 . . . . 71.13 113.612 -172.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -76.13 -41.71 49.2 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.597 1.159 . . . . 74.45 110.327 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.48 HG22 HD12 ' D' ' 68' ' ' LEU . 6.6 p -82.66 -25.29 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 115.649 -0.705 . . . . 73.22 111.138 -170.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -61.5 -20.78 63.59 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.761 0.824 . . . . 75.34 113.004 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -60.86 -26.29 67.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.425 0.69 . . . . 75.01 110.945 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -91.72 86.4 5.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.941 0.897 . . . . 70.15 109.113 168.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -76.91 88.73 3.48 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.664 -0.698 . . . . 74.33 109.631 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -155.78 158.34 37.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.515 1.126 . . . . 75.44 108.489 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -69.09 106.1 1.32 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.891 0.876 . . . . 65.32 108.966 174.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.571 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 35.4 Cg_exo -63.17 141.15 81.6 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.664 2.243 . . . . 60.0 113.287 -171.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 8.5 mm-40 -58.73 111.35 1.24 Allowed 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.051 0.844 . . . . 70.51 110.2 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.498 HG13 ' O ' ' D' ' 38' ' ' PRO . 16.1 m -101.4 128.02 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.656 0.741 . . . . 75.33 111.83 -170.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -106.55 112.76 25.9 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.821 1.248 . . . . 72.01 107.913 171.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.64 ' H ' HD23 ' D' ' 42' ' ' LEU . 1.8 pt? -95.98 112.92 24.52 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.039 -1.097 . . . . 73.35 108.039 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -114.84 113.21 23.91 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.667 -1.235 . . . . 71.23 107.667 174.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.646 HD13 ' H ' ' D' ' 44' ' ' LEU . 0.0 OUTLIER -110.34 155.48 22.06 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.904 0.882 . . . . 74.02 109.247 -176.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.589 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -158.64 152.65 23.7 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.528 0.731 . . . . 64.11 109.983 -177.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -109.87 167.59 10.05 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.617 -0.512 . . . . 64.41 109.617 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.47 160.52 36.85 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.795 0.838 . . . . 71.55 108.866 173.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -146.4 151.52 37.59 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.656 0.382 . . . . 72.12 110.736 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.7 t -165.55 122.13 1.42 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.582 0.753 . . . . 53.03 109.873 -171.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -82.42 117.71 22.67 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.809 -0.441 . . . . 61.55 109.809 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.2 mt -97.63 -24.98 15.28 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.162 0.585 . . . . 72.24 110.71 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.62 -178.54 6.27 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.482 0.713 . . . . 54.13 111.037 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.51 114.3 4.78 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.475 -1.239 . . . . 33.14 109.791 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.14 21.18 11.62 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.302 1.041 . . . . 63.3 111.795 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 66.3 t -118.82 128.72 75.65 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 N-CA-C 108.159 -1.052 . . . . 72.11 108.159 170.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.443 ' HB2' HD11 ' D' ' 86' ' ' ILE . 0.4 OUTLIER -122.27 172.7 8.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.054 0.93 . . . . 65.11 110.287 174.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.9 tt0 -132.31 138.54 47.86 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.255 -1.793 . . . . 74.11 107.577 169.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.27 138.63 47.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.513 -1.292 . . . . 72.12 107.513 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 47.6 t -119.57 128.67 75.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.077 -1.083 . . . . 53.03 108.077 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.416 HD23 ' O ' ' D' ' 45' ' ' ASP . 0.1 OUTLIER -99.1 116.45 31.35 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.25 -1.019 . . . . 63.21 108.25 175.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.618 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 2.4 tmm_? -99.71 96.29 7.51 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.652 -1.61 . . . . 75.44 106.652 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.579 HG21 ' HB1' ' D' ' 110' ' ' ALA . 37.0 t -107.96 125.63 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.599 -0.889 . . . . 74.44 108.599 -177.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 20.8 m -130.26 135.29 47.96 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.366 0.667 . . . . 52.04 109.398 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 63.9 t -122.3 109.33 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.858 0.863 . . . . 65.33 109.257 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.1 m -95.39 111.54 23.4 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.832 -0.803 . . . . 44.14 108.832 170.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -115.28 149.84 37.18 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.48 0.712 . . . . 71.43 110.771 -173.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.404 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.1 m -149.32 132.28 16.17 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 123.778 0.674 . . . . 55.31 111.603 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.48 HD12 HG22 ' D' ' 31' ' ' VAL . 30.5 mt -96.24 109.35 21.84 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.554 -0.906 . . . . 61.45 108.554 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.38 -114.57 4.99 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 123.678 0.612 . . . . 54.05 113.02 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.57 16.53 20.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.57 0.748 . . . . 52.45 111.386 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -137.23 161.22 36.78 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.219 0.607 . . . . 74.31 109.785 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 19.5 m -69.62 138.9 53.47 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.561 0.538 . . . . 74.22 111.239 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.469 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -95.72 -70.64 0.7 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.955 0.902 . . . . 73.24 109.375 173.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -144.72 138.45 27.23 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 121.136 0.493 . . . . 73.2 110.286 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.7 mt -111.37 109.83 20.0 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.027 -1.101 . . . . 74.23 108.027 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.542 ' SG ' HG23 ' D' ' 114' ' ' ILE . 53.3 t -118.78 140.64 49.62 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.473 0.709 . . . . 65.34 109.406 -177.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -155.57 134.5 12.06 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.28 0.632 . . . . 72.42 109.629 175.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.18 119.06 18.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.929 0.892 . . . . 51.24 108.873 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.673 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.7 83.71 6.26 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.2 -1.037 . . . . 73.44 108.2 168.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.31 94.35 5.46 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.29 -1.323 . . . . 74.52 109.0 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.9 142.67 16.67 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.985 -0.446 . . . . 64.14 111.985 -178.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.523 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.15 130.02 4.14 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.542 -1.023 . . . . 62.21 110.542 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 39.0 mt -90.82 136.75 23.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.422 -0.955 . . . . 74.23 108.422 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -138.86 131.83 29.51 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.26 0.624 . . . . 64.13 109.84 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -80.17 109.31 14.51 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.772 -0.825 . . . . 54.21 108.772 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.443 HD11 ' HB2' ' D' ' 56' ' ' TYR . 1.6 pp -119.83 133.88 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.648 0.779 . . . . 74.34 111.81 -171.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.24 169.0 9.49 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.434 1.094 . . . . 72.42 109.207 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.18 11.46 84.89 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 115.368 0.907 . . . . 74.5 115.368 169.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.42 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -119.81 143.35 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 117.837 0.819 . . . . 73.52 110.059 177.117 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.2 -174.42 4.37 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.717 0.807 . . . . 73.41 111.072 -176.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.93 -120.85 14.86 Favored Glycine 0 C--N 1.357 1.728 0 O-C-N 123.455 0.472 . . . . 40.31 113.0 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 29.7 m -88.82 -28.65 20.28 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.213 0.605 . . . . 74.13 110.333 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -62.85 -30.23 71.35 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.273 1.029 . . . . 73.03 111.857 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 12.1 ptm -68.65 -29.39 67.87 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.079 0.552 . . . . 74.51 111.574 177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.54 -36.26 24.15 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.586 0.754 . . . . 73.35 110.651 174.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -70.02 -41.32 74.46 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.214 1.005 . . . . 74.22 111.61 -174.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.6 t -65.94 -50.33 64.76 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.099 0.56 . . . . 74.52 110.66 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 18.2 tp -76.95 -31.36 56.53 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 115.715 -0.675 . . . . 73.04 111.104 -173.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.28 -26.94 10.47 Favored Glycine 0 C--N 1.354 1.541 0 N-CA-C 114.931 0.732 . . . . 51.5 114.931 -170.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.37 -49.63 1.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 117.609 0.704 . . . . 53.2 112.118 -171.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -69.95 -48.29 58.96 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.26 0.624 . . . . 72.2 111.932 -173.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 92.6 m -61.44 -48.18 91.5 Favored Pre-proline 0 CA--C 1.564 1.502 0 CA-C-O 118.509 -0.758 . . . . 72.52 112.15 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.3 -35.68 91.96 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.113 1.875 . . . . 70.11 113.765 170.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -63.85 -39.74 94.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.993 0.517 . . . . 73.55 110.424 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.436 HG21 HD13 ' D' ' 13' ' ' ILE . 49.0 mm -60.51 -40.64 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.568 0.699 . . . . 61.42 110.544 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.523 HD21 ' HA3' ' D' ' 82' ' ' GLY . 96.1 mt -76.34 -19.17 58.47 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.84 -1.073 . . . . 74.51 112.061 -175.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -65.33 -43.8 65.68 Favored Pre-proline 0 CA--C 1.564 1.498 0 N-CA-C 114.189 1.181 . . . . 72.22 114.189 -170.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.63 -42.06 71.77 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 122.1 1.867 . . . . 52.34 113.432 172.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -73.68 -35.2 65.17 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.742 0.817 . . . . 65.55 111.808 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.579 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -61.51 -51.03 70.33 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.519 0.728 . . . . 44.42 109.592 176.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 31.4 ttp180 -54.92 -52.22 63.63 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 113.891 -1.504 . . . . 75.42 110.586 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.84 -48.0 81.05 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 124.023 0.827 . . . . 74.34 111.703 -174.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.9 t -59.9 -42.56 94.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.898 0.479 . . . . 54.25 111.169 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.542 HG23 ' SG ' ' D' ' 76' ' ' CYS . 70.3 mt -60.5 -52.53 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.927 0.891 . . . . 54.11 110.528 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 39.5 m -56.55 -44.88 81.33 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 125.063 1.345 . . . . 73.01 111.573 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 25.7 t -64.54 -41.36 96.4 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.696 -1.138 . . . . 51.41 110.457 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.427 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 71.8 mtm -70.56 -34.02 71.76 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.698 0.399 . . . . 64.22 111.749 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.425 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.7 t -63.12 -43.62 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.304 0.642 . . . . 64.43 110.044 176.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.4 p -72.45 -31.17 65.22 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 116.054 -0.521 . . . . 74.41 111.196 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.3 mtt-85 -71.46 -32.56 68.46 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.494 0.718 . . . . 73.33 110.411 175.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.29 7.22 79.42 Favored Glycine 0 C--N 1.351 1.405 0 O-C-N 123.67 0.606 . . . . 55.35 112.072 175.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 66.2 p 63.08 13.59 6.91 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.88 2.072 . . . . 73.12 114.309 173.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -79.26 149.82 73.21 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 108.543 -0.91 . . . . 75.24 108.543 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -48.25 122.08 7.05 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.075 2.517 . . . . 73.44 112.755 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -49.49 135.87 17.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.395 1.478 . . . . 62.41 112.345 -171.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 29.5 tp -108.16 95.9 5.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.941 0.496 . . . . 64.41 110.736 -169.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.434 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 85.6 m-20 -103.4 87.74 2.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.674 0.79 . . . . 71.52 109.062 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.421 HD11 HD13 ' D' ' 42' ' ' LEU . 39.1 tp -71.68 133.63 45.77 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.014 -0.993 . . . . 63.15 110.549 -176.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.05 141.07 98.01 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 123.131 0.573 . . . . 73.33 110.892 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -61.4 130.98 33.98 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.666 2.244 . . . . 64.44 111.868 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 80.0 t -108.58 120.84 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.424 0.689 . . . . 41.53 109.77 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -82.99 91.37 7.15 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.591 -0.892 . . . . 73.41 108.591 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -66.72 -35.1 79.33 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.798 -0.637 . . . . 70.12 110.632 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.39 -52.14 55.24 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.201 1.4 . . . . 52.51 112.743 -173.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.68 75.26 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.19 0.596 . . . . 44.54 111.518 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -68.46 -28.5 67.1 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.569 -0.741 . . . . 64.43 111.19 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 90.4 t80 . . . . . 0 N--CA 1.475 0.816 0 C-N-CA 123.968 0.907 . . . . 73.33 110.555 176.634 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 C--O 1.237 0.438 0 N-CA-C 106.125 -1.806 . . . . 75.43 106.125 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.611 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.6 t80 -114.49 129.96 56.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.001 -1.0 . . . . 75.42 109.213 -171.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -140.99 108.84 5.67 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.36 -0.978 . . . . 75.11 108.36 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.551 HG12 ' HD2' ' A' ' 84' ' ' PHE . 55.0 mt -81.16 116.94 26.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.971 -0.751 . . . . 71.43 108.971 173.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.486 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -73.82 -40.77 63.11 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.634 -0.712 . . . . 75.24 109.301 -178.683 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -173.64 122.96 0.35 Allowed 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.299 0.374 . . . . 62.52 111.384 -171.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.561 HD12 ' HG3' ' C' ' 130' ' ' PRO . 71.3 mt -106.43 133.83 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.067 -0.716 . . . . 74.42 109.067 173.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB3' HG23 ' B' ' 122' ' ' THR . 33.2 p90 -163.76 178.86 7.53 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.882 0.873 . . . . 41.44 110.901 -173.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.9 p -106.2 116.26 31.63 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.951 -0.759 . . . . 74.11 108.951 176.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 22.7 mtpt -81.26 -29.71 34.31 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.422 -0.585 . . . . 73.13 109.422 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.3 t70 -146.84 141.75 26.95 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.719 -1.128 . . . . 45.25 109.697 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 88.0 mt -139.05 141.26 36.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 125.616 1.566 . . . . 74.32 106.807 171.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -147.96 136.85 21.94 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.184 0.516 . . . . 62.43 109.986 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.592 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.4 t80 -135.26 126.23 27.69 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.682 -1.229 . . . . 75.45 107.682 171.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.81 119.88 24.1 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.885 0.474 . . . . 74.14 110.159 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -132.93 80.4 60.71 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 107.367 -1.345 . . . . 62.24 107.367 170.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.66 -19.38 12.87 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.68 2.253 . . . . 74.34 111.192 175.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.496 ' O ' HG23 ' A' ' 31' ' ' VAL . 91.0 m-20 -103.94 16.98 25.08 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.294 1.038 . . . . 62.34 110.56 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.583 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -55.25 -46.6 99.66 Favored Pre-proline 0 CA--C 1.57 1.725 0 C-N-CA 123.54 0.736 . . . . 52.12 112.277 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.52 6.1 4.69 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 122.318 2.012 . . . . 72.43 113.383 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -100.78 -40.25 7.42 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.125 0.57 . . . . 75.2 109.8 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 27' ' ' ASN . 98.6 t -66.78 -34.39 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.716 0.806 . . . . 62.23 111.34 -175.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.457 ' CE1' ' HG3' ' A' ' 33' ' ' GLN . 1.1 p90 -65.82 -26.14 67.54 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 120.898 0.38 . . . . 75.12 111.029 -177.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.457 ' HG3' ' CE1' ' A' ' 32' ' ' PHE . 49.2 mt-30 -87.08 -44.11 11.79 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.372 0.669 . . . . 62.13 111.068 177.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HE3' HD11 ' A' ' 68' ' ' LEU . 53.4 mtmt -82.86 168.55 17.0 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.086 0.47 . . . . 73.54 112.251 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.24 131.96 41.69 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.009 -0.996 . . . . 61.15 110.535 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -77.44 98.62 5.35 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.589 1.156 . . . . 73.1 110.256 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -139.01 75.66 34.78 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 108.879 -0.786 . . . . 75.45 108.879 172.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -84.96 152.81 11.19 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.554 2.169 . . . . 72.54 112.863 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -118.33 108.76 15.48 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.603 -1.258 . . . . 73.05 107.603 172.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.6 m -82.54 135.41 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.609 0.764 . . . . 74.24 111.649 -171.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -123.28 113.28 18.67 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.895 -1.15 . . . . 73.14 107.895 174.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.7 tp -110.46 116.72 31.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.045 0.538 . . . . 75.51 110.078 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.497 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 31.5 t70 -103.15 132.93 49.04 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 109.029 -0.73 . . . . 75.14 109.029 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.5 mt -110.47 132.4 54.21 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.459 -0.941 . . . . 73.33 108.459 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.749 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 16.9 t70 -145.39 153.17 40.92 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.907 0.483 . . . . 62.2 110.068 177.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.6 m -127.71 139.39 52.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.667 1.187 . . . . 71.21 108.659 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.57 123.69 25.58 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.491 -0.559 . . . . 45.2 109.491 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.6 m -88.11 152.21 22.17 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.333 -0.617 . . . . 24.25 109.333 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -160.42 122.52 3.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.368 0.667 . . . . 73.21 109.819 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -81.04 139.12 35.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.026 0.53 . . . . 73.43 110.239 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.448 HD12 HG23 ' A' ' 83' ' ' ILE . 83.7 mt -117.49 -28.76 5.99 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.522 0.729 . . . . 61.22 110.138 176.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.2 -177.35 4.92 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.08 0.952 . . . . 62.24 109.374 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.18 128.22 35.57 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.269 -0.641 . . . . 54.22 109.269 173.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 69.38 2.42 3.7 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.204 1.402 . . . . 74.33 112.309 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.87 116.43 52.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 123.923 0.889 . . . . 71.23 109.389 -177.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.16 125.59 23.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.987 0.915 . . . . 74.24 108.678 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -93.83 145.39 24.64 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.632 -0.877 . . . . 63.22 108.632 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -111.58 138.26 40.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.995 -1.113 . . . . 54.4 107.995 172.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -114.73 106.78 21.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.021 -1.103 . . . . 72.4 108.021 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.7 tp -88.09 105.91 17.81 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.656 -0.868 . . . . 74.35 108.656 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.749 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 59.1 mtt85 -83.75 121.94 27.98 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.838 -0.801 . . . . 64.42 108.838 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.627 HG21 ' HB1' ' A' ' 110' ' ' ALA . 2.1 m -127.61 101.52 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.644 -0.873 . . . . 75.03 108.644 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 86.6 m -98.13 108.54 21.27 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.344 1.057 . . . . 72.13 109.87 -175.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.424 HG21 HG21 ' A' ' 114' ' ' ILE . 85.0 t -103.03 113.65 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.42 -0.585 . . . . 34.15 109.42 176.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.9 m -123.6 107.05 11.09 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.071 -0.714 . . . . 72.1 109.071 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.25 125.1 53.79 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.977 -0.749 . . . . 64.43 108.977 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.4 p -120.95 130.38 53.83 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.535 0.734 . . . . 70.44 110.161 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 68' ' ' LEU . 2.7 pt? -90.4 48.31 1.54 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 122.278 1.037 . . . . 64.41 109.661 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.78 -125.34 6.36 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 114.915 -1.039 . . . . 22.11 111.071 -170.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.27 -28.34 23.83 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 117.48 0.64 . . . . 75.31 109.73 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -86.12 134.5 33.81 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.85 0.86 . . . . 74.12 110.571 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 m -74.72 133.4 42.04 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.649 0.593 . . . . 62.33 109.869 172.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.83 -51.88 9.1 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.891 0.877 . . . . 71.3 108.963 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -155.92 157.08 35.7 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.447 -1.252 . . . . 52.22 111.551 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 62.8 tp -121.97 109.76 14.99 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.403 -1.332 . . . . 70.32 107.403 166.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 80.1 m -107.28 97.36 7.13 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.939 -1.134 . . . . 72.33 107.939 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -122.13 115.8 23.08 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.36 -0.978 . . . . 52.41 108.36 -173.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.7 t -126.22 136.11 61.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.49 -0.777 . . . . 73.13 109.184 -172.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 24.5 mt-30 -110.28 91.17 3.55 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.826 -0.805 . . . . 64.24 108.826 167.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -77.18 113.17 14.63 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.867 -1.16 . . . . 63.15 107.867 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.72 142.19 16.12 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 112.198 -0.361 . . . . 22.32 112.198 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.41 141.54 10.86 Favored Glycine 0 CA--C 1.505 -0.557 0 N-CA-C 110.743 -0.943 . . . . 75.02 110.743 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 14' ' ' GLN . 36.2 mt -88.63 124.45 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.868 -0.79 . . . . 74.44 108.868 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.611 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 39.0 m-85 -129.3 128.97 44.27 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.706 0.802 . . . . 74.04 109.522 -171.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.2 t -89.05 120.84 30.82 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.912 -0.774 . . . . 61.25 108.912 174.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.1 pt -95.84 129.24 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.437 0.695 . . . . 74.23 109.898 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.03 158.9 7.34 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.934 0.894 . . . . 71.41 111.164 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.18 -33.38 6.63 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 115.771 -0.649 . . . . 61.15 113.494 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -137.62 170.7 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.837 0.855 . . . . 71.13 109.905 -177.25 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.95 173.33 11.61 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.524 0.73 . . . . 70.14 109.449 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.28 -145.09 43.81 Favored Glycine 0 C--N 1.351 1.387 0 C-N-CA 122.648 0.166 . . . . 53.41 113.498 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.549 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 23.3 p -72.64 -14.85 61.69 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.802 0.841 . . . . 73.15 111.921 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -68.07 -38.36 82.3 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.968 -0.753 . . . . 61.42 108.968 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 38.1 ttp -82.93 -35.49 26.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.485 0.714 . . . . 70.15 111.054 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.549 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -63.21 -26.5 68.83 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.942 0.497 . . . . 73.51 110.631 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.401 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 18.4 t-80 -66.38 -50.35 63.78 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.502 1.121 . . . . 74.31 110.506 169.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 71.0 m -67.2 -27.31 67.15 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.852 0.461 . . . . 73.03 112.1 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.88 -41.82 12.95 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.14 0.976 . . . . 74.02 109.589 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.84 2.18 56.9 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-O 119.469 -0.628 . . . . 75.43 114.585 -171.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.447 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -138.37 -62.06 0.58 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.608 0.704 . . . . 70.1 111.262 -177.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.44 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 80.6 t80 -62.75 -49.72 73.91 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.729 0.812 . . . . 71.41 111.736 -175.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 89.6 m -71.1 -39.64 8.49 Favored Pre-proline 0 CA--C 1.571 1.76 0 N-CA-C 114.101 1.148 . . . . 45.23 114.101 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.38 -24.4 50.09 Favored 'Trans proline' 0 C--N 1.387 2.571 0 CA-C-N 121.742 1.658 . . . . 63.41 112.826 167.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -27.57 61.76 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.907 -0.405 . . . . 75.05 109.907 177.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.8 mm -60.25 -40.7 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.911 0.884 . . . . 73.44 109.818 170.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.5 mt -80.07 -17.22 53.25 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.066 0.947 . . . . 62.32 112.338 -175.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -63.75 -45.22 81.78 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 113.916 1.08 . . . . 71.44 113.916 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.46 -39.51 65.36 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 121.596 1.53 . . . . 73.34 112.701 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -69.47 -38.48 77.73 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.379 0.672 . . . . 75.14 111.085 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.627 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.85 -41.73 86.87 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.816 -0.629 . . . . 63.24 110.39 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.581 ' HA ' HD21 ' A' ' 128' ' ' LEU . 40.9 ttm180 -54.78 -50.47 68.41 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 124.7 1.25 . . . . 74.13 110.29 177.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -63.65 -42.69 98.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.485 1.116 . . . . 72.23 111.397 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 117' ' ' MET . 27.6 t -60.93 -37.4 82.18 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 123.695 0.622 . . . . 45.34 110.61 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.424 HG21 HG21 ' A' ' 64' ' ' VAL . 78.5 mt -71.61 -43.05 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.483 1.113 . . . . 73.34 110.561 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.406 HG23 ' HG3' ' A' ' 125' ' ' GLN . 24.0 m -61.6 -33.99 74.86 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.731 0.776 . . . . 64.44 109.94 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.7 t -70.93 -40.09 72.27 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.712 -1.131 . . . . 74.33 109.864 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.592 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 18.4 mmt -59.08 -48.38 81.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.308 0.643 . . . . 65.35 111.626 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.1 m -68.13 -42.14 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 O-C-N 123.448 0.467 . . . . 74.24 111.43 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.9 m -69.01 -35.71 76.97 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.054 0.541 . . . . 72.22 111.692 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.515 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 95.2 mtt-85 -70.55 -35.19 72.98 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.896 0.479 . . . . 72.13 110.029 175.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.14 19.72 20.65 Favored Glycine 0 C--N 1.354 1.57 0 CA-C-O 119.14 -0.811 . . . . 75.05 114.32 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' B' ' 17' ' ' TYR . 2.4 t 61.4 10.73 3.3 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 127.16 2.184 . . . . 63.44 114.311 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -86.52 150.54 51.5 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 108.542 -0.91 . . . . 72.21 108.542 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.55 159.03 21.29 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.395 2.063 . . . . 62.52 112.2 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.406 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.1 tt0 -60.83 142.97 55.65 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.071 0.549 . . . . 72.03 112.308 -177.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.3 tp -128.15 121.8 30.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.117 0.967 . . . . 73.41 109.938 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -124.7 109.66 13.4 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.681 -0.859 . . . . 71.12 108.681 173.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.757 ' H ' HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -73.23 126.34 29.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 109.101 -0.703 . . . . 70.23 109.101 173.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.13 151.22 27.1 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 124.895 1.278 . . . . 61.21 112.715 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 110.23 0.65 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.805 2.337 . . . . 73.14 112.54 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 81.7 t -99.37 113.09 33.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.072 -1.084 . . . . 70.42 108.072 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -85.27 81.65 8.7 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.433 -0.951 . . . . 73.5 108.433 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -56.27 -31.9 64.02 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.456 0.702 . . . . 72.3 111.407 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.447 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 9.8 t70 -63.31 -48.3 78.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.546 1.138 . . . . 73.3 110.706 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.69 92.61 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.994 0.918 . . . . 44.31 111.445 176.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.7 mt -69.53 -34.6 74.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.731 0.812 . . . . 70.02 111.878 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.96 -38.48 79.44 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.652 -0.87 . . . . 63.31 108.652 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 10.4 mmt . . . . . 0 CA--C 1.545 0.764 0 O-C-N 124.109 0.881 . . . . 62.34 111.195 177.129 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 85.0 m . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 108.544 -0.91 . . . . 64.21 108.544 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -114.42 143.25 45.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.215 0.606 . . . . 63.44 109.848 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -149.72 140.81 22.99 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.289 0.636 . . . . 72.4 109.749 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.64 123.49 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.75 -1.204 . . . . 65.22 107.75 172.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.414 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 14.0 mm100 -86.23 -50.65 6.81 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.233 -0.654 . . . . 75.31 109.233 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -170.12 133.24 1.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.508 -0.769 . . . . 74.51 109.704 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.04 138.76 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 107.87 -1.159 . . . . 74.32 107.87 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.446 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 33.7 p90 -165.11 164.65 20.27 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 122.304 1.049 . . . . 73.03 112.379 -177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 74.3 m -87.73 130.08 34.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.938 -1.483 . . . . 73.41 108.063 169.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.405 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 40.5 mtpt -98.02 -36.62 10.06 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.381 0.672 . . . . 64.2 110.302 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -149.99 132.21 15.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.814 -0.63 . . . . 55.44 110.545 -170.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.454 HD12 HG22 ' B' ' 78' ' ' VAL . 48.8 mm -128.3 141.97 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.116 0.966 . . . . 75.43 108.553 171.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -142.34 130.67 22.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.227 -1.397 . . . . 73.12 107.227 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.417 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.0 t80 -144.99 109.85 5.06 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.585 -1.265 . . . . 71.12 107.585 170.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -120.89 123.42 42.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.54 -0.911 . . . . 72.03 108.54 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.96 87.16 2.25 Favored Pre-proline 0 C--O 1.242 0.68 0 N-CA-C 106.722 -1.584 . . . . 51.5 106.722 171.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.85 -36.1 19.26 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.639 2.226 . . . . 74.02 112.735 -165.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -110.83 22.25 15.57 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.86 0.864 . . . . 61.25 110.423 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -36.29 -64.93 0.34 Allowed Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 115.195 1.554 . . . . 42.33 115.195 -162.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.7 Cg_exo -66.21 -30.28 46.28 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 121.828 1.685 . . . . 53.12 112.682 -173.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.419 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 65.8 m80 -93.32 -15.87 25.29 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.373 -0.831 . . . . 74.42 112.284 -174.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.732 HG21 ' HA ' ' B' ' 73' ' ' ALA . 7.5 p -85.93 -30.12 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 117.93 0.332 . . . . 73.55 110.529 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -61.2 -19.54 61.73 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.742 0.817 . . . . 75.12 113.081 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.1 pt20 -64.85 -15.7 62.22 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.99 0.516 . . . . 75.23 111.594 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -99.57 97.58 8.55 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.109 0.964 . . . . 50.41 109.024 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -79.65 91.72 5.28 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.281 0.563 . . . . 74.05 109.796 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -164.36 159.81 20.13 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.322 1.049 . . . . 72.43 108.993 -174.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.8 pm0 -82.52 109.74 17.93 Favored Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 109.217 -0.661 . . . . 72.21 109.217 173.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.483 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 35.3 Cg_endo -62.41 127.38 20.75 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.815 2.343 . . . . 53.42 113.074 -171.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -56.73 120.16 7.37 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.294 0.996 . . . . 73.31 110.969 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.481 HG11 HD11 ' B' ' 126' ' ' LEU . 29.6 m -96.18 163.03 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.159 -0.928 . . . . 43.43 113.19 -168.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.549 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 81.8 tttt -148.88 137.46 21.19 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.982 1.713 . . . . 72.2 107.512 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.412 ' HB3' HD11 ' B' ' 44' ' ' LEU . 2.6 mm? -105.25 131.41 52.74 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.119 -0.697 . . . . 71.32 109.119 176.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.8 t70 -124.29 110.71 14.95 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 106.697 -1.594 . . . . 73.43 106.697 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' B' ' 42' ' ' LEU . 0.5 OUTLIER -114.98 129.26 56.68 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.832 -0.803 . . . . 74.04 108.832 -165.422 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 20.7 m-20 -130.65 112.79 13.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.035 0.534 . . . . 73.12 109.841 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 28.6 p -107.15 102.27 11.61 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.217 -1.031 . . . . 51.41 108.217 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.19 119.15 26.74 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.241 1.016 . . . . 73.23 109.321 -174.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.524 ' HB3' HG22 ' B' ' 58' ' ' VAL . 16.6 p -100.3 161.62 13.49 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.615 0.766 . . . . 73.01 109.931 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 81.2 p -151.07 137.21 18.35 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.5 0.72 . . . . 64.11 109.355 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -81.9 118.35 22.87 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.206 0.602 . . . . 74.42 109.788 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.17 -43.72 15.86 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.959 -0.756 . . . . 73.15 108.959 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.64 177.37 11.3 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.186 -1.37 . . . . 60.54 108.923 174.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.92 130.78 43.76 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.895 -0.78 . . . . 65.22 108.895 178.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 75.28 -4.45 2.37 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 125.056 1.343 . . . . 71.54 112.424 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -117.56 109.18 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.759 0.824 . . . . 65.05 109.332 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -125.56 138.61 53.96 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.401 -0.592 . . . . 71.32 109.401 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -119.07 107.09 13.07 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.092 -1.077 . . . . 72.32 108.092 -172.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' B' ' 48' ' ' SER . 85.8 t -94.3 135.13 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.991 0.916 . . . . 74.21 110.617 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.15 130.08 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.385 -0.969 . . . . 72.33 108.385 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.84 112.81 23.34 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.112 -1.07 . . . . 70.53 108.112 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.406 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 36.8 ttm180 -99.83 127.49 45.99 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.412 0.685 . . . . 73.12 109.829 173.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' B' ' 114' ' ' ILE . 46.0 t -123.12 102.64 11.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 106.67 -1.604 . . . . 74.34 106.67 167.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.5 m -99.44 126.25 45.32 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.346 -0.613 . . . . 75.32 109.346 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.522 HG11 HD21 ' B' ' 126' ' ' LEU . 60.3 t -108.94 105.43 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 123.298 0.639 . . . . 70.31 109.721 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 42.0 m -84.02 137.42 33.61 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.966 -1.124 . . . . 62.22 107.966 167.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.442 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -149.02 143.43 26.09 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.51 0.324 . . . . 44.23 110.182 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 49.4 p -146.0 134.23 21.7 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.579 0.549 . . . . 52.2 111.373 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.659 HD12 HG22 ' B' ' 31' ' ' VAL . 39.2 mt -93.35 109.94 21.49 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.511 -0.922 . . . . 62.21 108.511 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.67 -108.8 2.6 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.866 -1.061 . . . . 71.03 111.713 -170.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.95 3.97 10.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.045 0.938 . . . . 75.53 111.905 -175.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -115.03 149.78 36.92 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.436 -0.579 . . . . 72.41 109.436 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.2 m -67.31 133.26 49.33 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.936 0.398 . . . . 54.35 111.161 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.732 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -90.46 -64.07 1.19 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.962 -1.017 . . . . 74.53 109.234 176.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -150.02 154.68 38.6 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.316 -0.856 . . . . 73.34 110.393 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.0 mt -128.79 110.77 12.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.669 -1.604 . . . . 74.45 106.669 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.9 t -117.57 155.69 29.38 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.856 -0.794 . . . . 75.22 108.856 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -163.55 130.67 3.39 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.836 -0.801 . . . . 74.54 108.836 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.454 HG22 HD12 ' B' ' 21' ' ' ILE . 88.3 t -124.07 141.32 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.593 -0.891 . . . . 73.32 108.593 172.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -123.04 88.42 2.92 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.89 -0.782 . . . . 44.22 108.89 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.405 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -79.76 100.82 8.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.141 -0.936 . . . . 72.13 109.102 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.31 143.69 16.88 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.744 -0.542 . . . . 74.42 111.744 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.534 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -145.81 127.13 2.72 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.135 -0.786 . . . . 70.51 111.135 -172.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 14.3 mt -91.2 129.68 41.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 123.918 0.887 . . . . 62.43 108.617 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -137.71 133.68 34.47 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.889 -0.782 . . . . 53.21 108.889 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.8 m -93.42 109.19 20.77 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.953 -0.758 . . . . 70.32 108.953 172.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 pt -112.92 117.83 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.228 1.011 . . . . 71.22 109.118 -174.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -129.84 152.72 49.02 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.18 0.592 . . . . 61.21 110.791 -175.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.43 -60.22 4.32 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.824 0.702 . . . . 63.0 112.522 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -67.12 145.29 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.351 0.661 . . . . 60.25 112.391 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -166.32 174.51 9.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.186 0.595 . . . . 74.54 109.561 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.6 -112.29 3.91 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 112.217 -0.353 . . . . 75.55 112.217 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' B' ' 95' ' ' ALA . 31.6 m -78.13 -29.53 48.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.142 0.496 . . . . 74.4 110.742 176.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -69.99 -33.81 72.53 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.34 -0.391 . . . . 74.02 110.575 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -30.81 61.46 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.957 -0.565 . . . . 62.45 110.212 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' B' ' 92' ' ' THR . . . -59.83 -38.45 82.05 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.45 0.7 . . . . 64.22 110.032 171.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -76.08 -36.31 59.01 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.284 1.034 . . . . 71.05 111.608 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.64 -57.36 6.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 123.593 0.558 . . . . 65.13 109.846 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.3 mp -79.62 -15.83 56.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.94 0.496 . . . . 65.45 111.521 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.39 -15.02 48.98 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.41 0.524 . . . . 65.24 114.41 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.35 -56.74 0.32 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 117.341 0.57 . . . . 52.34 111.879 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -68.5 -52.56 30.97 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.835 0.854 . . . . 62.13 112.001 -167.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.452 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 92.2 m -63.04 -49.07 83.05 Favored Pre-proline 0 CA--C 1.565 1.542 0 C-N-CA 124.319 1.047 . . . . 74.31 112.13 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.0 Cg_exo -58.49 -34.07 98.48 Favored 'Trans proline' 0 C--N 1.398 3.15 0 C-N-CA 122.095 1.864 . . . . 74.33 113.559 171.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.24 -37.62 83.72 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.374 0.67 . . . . 75.25 111.747 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 45.4 mt -63.9 -41.72 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.843 0.857 . . . . 72.34 110.759 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.534 HD21 ' HA3' ' B' ' 82' ' ' GLY . 51.2 mt -80.19 -19.91 45.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.348 1.059 . . . . 54.32 112.311 -173.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -59.7 -49.38 92.1 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.278 1.214 . . . . 75.51 114.278 -171.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -61.67 -33.7 85.58 Favored 'Trans proline' 0 C--N 1.381 2.258 0 CA-C-N 121.452 1.554 . . . . 73.34 112.618 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.405 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 84.5 m-85 -68.06 -46.0 72.3 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 123.662 0.601 . . . . 63.51 110.087 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.25 -47.1 84.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.521 0.729 . . . . 73.24 110.22 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -54.26 -55.36 28.97 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.129 1.372 . . . . 75.32 111.581 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.02 -35.04 79.48 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.854 0.721 . . . . 75.01 110.389 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.515 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 6.8 t -69.03 -37.63 78.73 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.95 -0.568 . . . . 74.32 111.227 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.522 HD11 ' HB ' ' B' ' 62' ' ' VAL . 58.5 mt -63.2 -55.33 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.715 -0.476 . . . . 74.14 109.715 174.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.533 HG21 ' OG ' ' C' ' 119' ' ' SER . 18.9 m -59.0 -34.01 71.36 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 124.468 1.105 . . . . 74.42 111.404 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.5 t -57.98 -52.21 66.46 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.423 -0.808 . . . . 64.43 109.503 174.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 9.9 mmt -66.83 -38.19 85.95 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.333 0.653 . . . . 74.44 111.748 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.421 HG23 ' O ' ' B' ' 114' ' ' ILE . 91.2 t -58.9 -46.12 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.087 0.955 . . . . 73.32 110.303 176.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 45.3 t -70.99 -33.06 70.05 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.605 -1.18 . . . . 74.23 111.433 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' B' ' 116' ' ' SER . 90.8 mtt-85 -63.84 -36.84 85.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.106 0.563 . . . . 74.44 110.089 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.1 14.32 53.94 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-O 119.43 -0.65 . . . . 53.44 113.322 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.45 HG23 ' HB3' ' A' ' 17' ' ' TYR . 82.5 p 55.93 26.9 10.35 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.917 1.687 . . . . 71.45 113.636 176.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -87.06 153.01 54.07 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 123.609 0.764 . . . . 74.22 110.55 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 161.06 2.16 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 124.17 3.247 . . . . 72.44 115.271 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.51 HE21 ' ND2' ' B' ' 127' ' ' ASN . 63.7 tp60 -63.05 140.56 58.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.925 0.89 . . . . 74.53 111.982 -171.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.522 HD21 HG11 ' B' ' 64' ' ' VAL . 13.7 tp -146.05 117.67 8.07 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.906 -0.588 . . . . 72.3 109.433 -173.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.51 ' ND2' HE21 ' B' ' 125' ' ' GLN . 26.4 m-80 -130.98 135.12 47.34 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.422 0.689 . . . . 74.35 110.06 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.73 130.87 34.31 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.825 0.85 . . . . 72.13 110.012 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.75 152.53 59.89 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.247 1.019 . . . . 63.54 111.285 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.804 ' HG2' HD13 ' D' ' 16' ' ' ILE . 20.5 Cg_exo -65.94 133.58 34.09 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.701 2.267 . . . . 74.01 112.81 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.1 t -121.22 115.12 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.126 -1.064 . . . . 73.34 108.126 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -80.45 82.23 6.53 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 109.684 -0.487 . . . . 75.12 109.684 -178.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -60.15 -27.24 66.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.882 0.873 . . . . 74.31 111.325 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -54.6 -47.74 73.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.986 1.314 . . . . 72.44 111.365 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.87 -37.95 85.41 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.706 -0.679 . . . . 64.21 111.274 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.19 -19.06 60.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.551 0.74 . . . . 74.35 111.317 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 66.3 t80 . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 122.932 0.493 . . . . 73.33 111.51 -176.517 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 108.268 -1.012 . . . . 52.13 108.268 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.487 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.7 t80 -118.77 126.69 52.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.413 0.685 . . . . 64.43 109.743 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -146.59 133.58 20.28 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 109.111 -0.7 . . . . 73.4 109.111 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -71.95 118.73 17.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.351 -0.981 . . . . 44.44 108.351 170.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.615 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 29.8 mm-40 -83.49 -49.22 9.49 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.415 0.447 . . . . 55.21 109.969 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -169.51 127.15 0.93 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 116.382 -0.372 . . . . 75.52 110.524 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -107.85 148.76 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 107.867 -1.161 . . . . 65.12 107.867 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' C' ' 19' ' ' LYS . 32.1 p90 -174.53 167.8 3.85 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.401 0.619 . . . . 74.44 111.223 -174.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.1 p -96.55 111.62 23.68 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.135 -1.061 . . . . 64.14 108.135 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' C' ' 17' ' ' TYR . 19.0 mttt -68.77 -47.6 65.79 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.812 -1.181 . . . . 61.13 107.812 170.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.2 t70 -133.55 139.68 46.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 113.558 -1.655 . . . . 65.23 109.69 -169.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.6 mt -140.97 143.78 27.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.898 -1.89 . . . . 64.11 105.898 174.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.0 t -158.09 148.46 20.42 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.278 -0.638 . . . . 54.22 109.278 173.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -147.64 130.95 16.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.122 -1.436 . . . . 62.31 107.122 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -133.47 126.47 31.2 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.001 0.52 . . . . 64.34 109.731 -176.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.39 80.86 18.56 Favored Pre-proline 0 C--O 1.242 0.705 0 N-CA-C 106.683 -1.599 . . . . 74.42 106.683 168.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.48 -12.49 29.5 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.73 2.286 . . . . 51.22 112.083 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -121.11 25.0 9.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.474 1.51 . . . . 71.21 109.628 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -46.38 -55.78 12.94 Favored Pre-proline 0 CA--C 1.563 1.46 0 N-CA-C 114.093 1.146 . . . . 71.44 114.093 -168.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 51.4 Cg_exo -56.67 -41.24 77.87 Favored 'Trans proline' 0 C--N 1.385 2.485 0 CA-C-N 121.829 1.689 . . . . 74.1 112.888 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -69.3 -33.76 73.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.082 -0.508 . . . . 71.41 112.091 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.87 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.4 p -79.03 -24.52 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 112.716 0.636 . . . . 71.1 112.716 176.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -67.34 -30.64 70.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.877 -0.514 . . . . 74.55 112.278 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -87.5 34.11 0.7 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.245 0.618 . . . . 61.53 111.071 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.54 153.8 41.56 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.568 0.747 . . . . 65.22 111.534 -172.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.5 118.06 13.84 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.709 -0.849 . . . . 73.55 108.709 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -77.8 99.15 5.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.438 0.695 . . . . 72.22 110.681 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -156.21 74.6 4.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.851 -0.796 . . . . 62.44 108.851 171.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -92.36 161.76 3.04 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.882 2.388 . . . . 63.44 114.029 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.37 95.38 10.18 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.766 -1.198 . . . . 61.32 107.766 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.4 t -80.26 98.48 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 115.358 -0.837 . . . . 74.15 109.841 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -106.77 110.11 22.19 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.405 -0.961 . . . . 74.22 108.405 174.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 mp -85.77 144.65 27.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.249 -1.76 . . . . 74.12 106.249 167.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -123.88 111.94 16.66 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.708 -0.849 . . . . 73.22 108.708 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 90.8 mt -93.88 142.01 27.86 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.082 0.553 . . . . 72.0 110.032 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.2 t70 -157.79 161.14 38.4 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.65 1.18 . . . . 71.21 108.343 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.1 t -146.57 135.0 21.95 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.028 0.442 . . . . 72.42 110.491 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.83 156.25 32.33 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.221 1.008 . . . . 64.33 108.738 172.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.452 ' HB2' ' CE2' ' C' ' 56' ' ' TYR . 63.8 p -160.74 151.99 19.1 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.334 0.253 . . . . 74.44 111.563 -173.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -161.21 142.66 11.7 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.847 0.859 . . . . 73.34 110.307 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.24 136.34 39.68 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.776 -0.453 . . . . 72.54 109.776 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.492 HD11 HD12 ' C' ' 83' ' ' ILE . 39.8 mt -108.95 -44.97 3.87 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.346 0.658 . . . . 74.32 109.701 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.41 -173.07 3.84 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.669 -0.696 . . . . 71.11 111.045 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -67.86 108.59 3.05 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.136 -0.938 . . . . 70.21 110.392 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 63.42 24.65 14.24 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.792 1.237 . . . . 61.25 111.512 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.29 114.47 45.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.361 -0.977 . . . . 74.23 108.361 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.452 ' CE2' ' HB2' ' C' ' 48' ' ' SER . 35.5 t80 -126.22 124.99 41.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.564 -0.902 . . . . 74.12 108.564 -176.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.466 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.9 tt0 -82.09 141.64 32.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.027 -0.988 . . . . 71.15 109.929 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.28 142.22 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.487 1.115 . . . . 65.41 108.196 169.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.08 133.33 60.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.836 -0.801 . . . . 53.54 108.836 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.43 114.88 29.33 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.911 -1.144 . . . . 75.34 107.911 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.557 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 41.5 ttm-85 -99.29 117.53 33.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.033 -0.729 . . . . 74.42 109.033 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.582 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.4 t -118.57 133.57 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.299 -1.001 . . . . 74.11 108.299 172.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 14.8 m -131.55 114.85 15.36 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.258 -0.645 . . . . 72.43 109.258 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.597 HG11 HD21 ' C' ' 126' ' ' LEU . 21.8 t -99.51 128.84 50.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.847 -0.798 . . . . 73.45 108.847 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.1 m -122.87 140.4 53.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.803 -1.184 . . . . 74.53 107.803 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' C' ' 73' ' ' ALA . . . -132.03 113.13 13.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.763 -1.199 . . . . 64.43 107.763 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.2 m -113.69 122.58 47.57 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.356 0.598 . . . . 63.44 110.173 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 mt -92.1 24.63 3.2 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.042 1.337 . . . . 73.24 109.52 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.1 -108.52 2.6 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 110.569 -1.012 . . . . 71.43 110.569 -170.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.63 -27.37 20.22 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.587 0.755 . . . . 73.33 110.276 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -79.42 119.26 22.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.685 0.794 . . . . 74.13 109.331 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 39.4 m -87.53 130.81 34.59 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.159 -0.682 . . . . 64.35 109.159 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.87 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.79 -61.61 1.75 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.249 0.619 . . . . 70.32 110.613 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -156.92 170.52 22.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.54 -0.755 . . . . 74.35 110.858 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -142.47 116.82 9.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.216 -1.401 . . . . 64.21 107.216 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.423 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -124.78 119.35 28.64 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.079 0.552 . . . . 64.12 109.751 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -121.94 125.67 46.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.684 0.394 . . . . 71.04 110.019 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.87 137.19 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.01 0.924 . . . . 63.5 108.817 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.9 mt-30 -115.56 95.41 5.14 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.635 -0.876 . . . . 65.0 108.635 172.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -79.71 100.25 7.8 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.626 -1.17 . . . . 74.21 110.081 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.45 149.34 27.32 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 116.194 -0.457 . . . . 75.55 112.071 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.553 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -157.03 122.2 1.15 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 111.713 -0.555 . . . . 34.43 111.713 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.615 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.9 mm -88.99 124.52 41.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.788 -0.819 . . . . 72.13 108.788 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.487 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 53.0 m-85 -131.44 118.82 20.75 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.074 0.549 . . . . 71.2 109.945 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 66.8 m -80.9 118.72 22.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.777 -0.823 . . . . 71.33 108.777 171.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 pp -135.05 141.32 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.849 0.86 . . . . 53.12 110.119 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.0 142.87 17.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.176 0.59 . . . . 51.13 110.522 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.94 -23.43 35.65 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.506 0.504 . . . . 75.23 114.264 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.568 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -89.82 153.55 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.451 0.7 . . . . 63.32 110.813 178.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -160.06 -179.07 7.46 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.344 -0.844 . . . . 71.42 110.221 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.85 -112.44 3.81 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.864 0.728 . . . . 41.12 114.249 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 21.2 p -68.89 -43.02 76.14 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.178 0.991 . . . . 72.3 111.292 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.47 -37.44 85.13 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.856 -0.611 . . . . 64.33 111.418 -174.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -72.86 -39.96 66.07 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 110.364 -0.235 . . . . 73.21 110.364 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.13 -44.27 92.04 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 123.533 0.52 . . . . 74.44 110.81 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -80.39 -34.05 36.61 Favored 'General case' 0 C--O 1.245 0.864 0 O-C-N 123.411 0.444 . . . . 73.54 112.128 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.442 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 42.4 t -59.3 -37.16 77.03 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 123.425 0.453 . . . . 72.53 110.101 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 32.1 mt -93.94 -22.83 18.34 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.866 0.866 . . . . 75.11 111.033 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -31.65 57.98 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 115.077 0.791 . . . . 54.51 115.077 -172.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.65 -35.43 0.05 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.217 0.451 . . . . 32.01 112.217 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.442 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 45.5 t80 -60.18 -50.96 71.61 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.442 1.497 . . . . 62.3 112.567 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 61.4 m -75.41 -44.24 4.37 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-O 118.319 -0.848 . . . . 52.2 112.258 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -53.91 -26.71 41.13 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 122.001 1.801 . . . . 62.14 113.66 170.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -68.33 -34.91 76.97 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.514 0.725 . . . . 74.23 111.166 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -64.01 -36.51 77.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.356 0.662 . . . . 64.21 109.983 175.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.553 HD21 ' HA3' ' C' ' 82' ' ' GLY . 63.4 mt -84.94 -15.3 44.85 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.058 . . . . 71.52 112.265 -176.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.33 -48.57 90.88 Favored Pre-proline 0 CA--C 1.56 1.36 0 N-CA-C 114.115 1.154 . . . . 52.41 114.115 -173.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.82 -33.13 76.89 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 121.877 1.718 . . . . 61.34 112.767 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -71.5 -46.69 59.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.612 -0.722 . . . . 71.21 110.327 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.23 -41.9 76.43 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 115.321 -0.854 . . . . 63.31 109.847 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -56.21 -60.34 3.64 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.47 1.106 . . . . 71.33 111.718 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.02 -29.08 68.79 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.941 0.496 . . . . 70.04 111.237 -173.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 24.3 t -69.95 -35.87 74.84 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.009 0.524 . . . . 75.31 111.219 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.582 HD11 ' HB ' ' C' ' 62' ' ' VAL . 94.9 mt -72.92 -47.24 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.631 0.772 . . . . 70.13 110.036 174.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.0 m -61.0 -34.58 75.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.022 0.929 . . . . 75.54 111.125 -177.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -62.49 -51.72 66.32 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 115.351 -0.84 . . . . 52.25 109.59 174.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.549 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.46 -35.56 76.16 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.626 1.17 . . . . 72.32 112.867 -179.074 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.525 HG13 ' HB2' ' C' ' 123' ' ' PHE . 68.3 t -67.1 -44.99 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.548 0.739 . . . . 53.22 110.465 176.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.533 ' OG ' HG21 ' B' ' 115' ' ' THR . 47.3 t -66.8 -31.35 71.92 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.733 -0.667 . . . . 63.01 111.186 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' D' ' 17' ' ' TYR . 83.3 mtt-85 -67.29 -46.06 74.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.414 0.686 . . . . 74.31 109.391 176.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.21 -0.8 67.13 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.683 0.614 . . . . 62.11 113.24 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 34.2 p 64.6 27.96 13.27 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.742 2.017 . . . . 74.32 114.19 170.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.525 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.7 m-85 -83.73 155.67 65.04 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.529 0.731 . . . . 75.53 109.737 172.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -53.16 173.58 0.15 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 124.072 3.181 . . . . 75.5 115.573 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -55.6 132.97 50.13 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.728 1.211 . . . . 61.34 112.851 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.597 HD21 HG11 ' C' ' 64' ' ' VAL . 17.4 tp -135.14 102.48 5.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.929 -1.137 . . . . 73.04 107.929 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -123.42 126.81 47.46 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.105 0.562 . . . . 45.21 110.221 -175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mp -77.01 117.11 18.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.312 0.645 . . . . 71.52 109.379 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.79 162.36 58.82 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.507 1.123 . . . . 75.12 111.506 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.561 ' HG3' HD12 ' A' ' 16' ' ' ILE . 51.2 Cg_exo -55.19 103.61 0.11 Allowed 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.407 2.071 . . . . 45.13 112.152 169.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 89.0 t -97.99 113.24 32.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.57 0.748 . . . . 75.35 109.533 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -90.68 59.81 4.32 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.669 0.747 . . . . 63.03 110.025 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.484 ' HD1' ' H ' ' C' ' 133' ' ' PHE . 1.2 p90 -78.44 -14.21 59.48 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.214 -0.903 . . . . 64.41 110.066 175.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -75.47 -49.04 20.03 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.642 0.777 . . . . 71.45 109.818 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.66 74.17 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.524 -0.762 . . . . 73.32 110.622 174.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.17 -42.8 83.65 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.311 -0.859 . . . . 62.41 110.415 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 16.9 t80 . . . . . 0 N--CA 1.487 1.423 0 C-N-CA 122.488 0.315 . . . . 65.25 110.81 179.762 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 94.3 m . . . . . 0 C--O 1.24 0.559 0 N-CA-C 109.749 -0.463 . . . . 71.3 109.749 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.415 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 47.7 t80 -151.81 88.21 1.39 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.297 -1.372 . . . . 73.23 107.297 174.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -114.05 121.84 45.08 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.103 -1.073 . . . . 72.32 108.103 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.518 HD13 HG21 ' D' ' 105' ' ' ILE . 9.4 mt -86.98 128.47 39.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 116.213 -0.449 . . . . 65.12 110.117 -171.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.425 ' NE2' HG22 ' D' ' 83' ' ' ILE . 51.0 mt-30 -90.79 -39.74 12.2 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.437 0.695 . . . . 62.42 112.096 -173.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -175.08 122.19 0.22 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 112.219 0.452 . . . . 71.21 112.219 -167.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.804 HD13 ' HG2' ' B' ' 130' ' ' PRO . 1.5 mp -108.9 134.23 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.708 -0.849 . . . . 71.14 108.708 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.51 ' HE1' HG13 ' D' ' 83' ' ' ILE . 27.8 p90 -159.65 159.43 33.05 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 124.16 0.912 . . . . 74.35 110.487 -172.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -94.78 114.24 26.11 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.638 -0.71 . . . . 71.11 109.552 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.462 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 3.8 mtpp -77.84 -26.71 49.63 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.23 -0.656 . . . . 64.44 109.23 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.56 ' HB3' HE21 ' D' ' 79' ' ' GLN . 20.2 t70 -160.74 144.74 13.71 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.847 -1.069 . . . . 74.15 109.864 177.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.549 HG21 ' HE2' ' C' ' 117' ' ' MET . 68.0 mt -140.16 148.62 22.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 125.549 1.54 . . . . 55.43 107.388 174.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 26.9 t -156.08 119.44 4.3 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.226 0.61 . . . . 71.4 109.612 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.417 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.6 t80 -125.63 118.38 25.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.849 1.26 . . . . 74.31 107.879 173.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -124.16 135.96 53.86 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.124 -0.695 . . . . 74.12 109.124 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.48 86.36 39.21 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.442 -1.318 . . . . 63.54 107.442 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -66.61 -39.04 16.84 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.803 2.336 . . . . 62.42 113.115 -170.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 82.1 m-20 -101.3 17.33 22.86 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.869 0.868 . . . . 72.23 110.732 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.24 -70.81 0.12 Allowed Pre-proline 0 CA--C 1.562 1.424 0 N-CA-C 115.69 1.737 . . . . 61.43 115.69 -162.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.69 -18.79 14.96 Favored 'Trans proline' 0 C--N 1.382 2.328 0 CA-C-N 123.531 2.297 . . . . 60.44 113.198 -172.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.447 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 11.2 t-160 -68.1 -47.64 67.65 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.794 1.238 . . . . 73.21 109.347 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.6 p -83.17 -20.21 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.241 1.016 . . . . 63.2 111.838 -172.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -63.52 -32.19 73.57 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.175 0.512 . . . . 62.21 111.431 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -67.42 -10.48 51.75 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.969 -1.014 . . . . 71.32 111.544 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -96.17 84.74 3.84 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.119 0.967 . . . . 73.44 109.17 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.89 82.79 5.91 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.679 0.792 . . . . 64.32 109.866 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.4 t-105 -147.46 163.1 37.59 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.821 0.848 . . . . 74.43 109.665 -175.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -70.95 109.26 4.86 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.474 1.11 . . . . 75.05 110.438 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.39 144.04 25.44 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.795 2.33 . . . . 74.01 112.242 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -90.03 135.62 33.54 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.874 -0.787 . . . . 65.21 108.874 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.52 ' HB ' HG13 ' D' ' 64' ' ' VAL . 32.9 m -105.78 127.67 60.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 123.045 0.538 . . . . 75.34 109.555 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -87.42 114.03 23.66 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.923 -1.51 . . . . 61.41 106.923 172.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.472 ' O ' HD12 ' D' ' 42' ' ' LEU . 2.9 pp -94.75 117.81 30.73 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.011 0.91 . . . . 72.02 109.28 -174.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -122.96 112.54 17.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.726 -1.583 . . . . 73.41 106.726 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.93 152.34 22.09 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.159 0.584 . . . . 51.32 109.712 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.0 t70 -151.02 156.28 40.81 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.756 1.222 . . . . 74.24 108.367 174.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -138.95 156.71 47.03 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.372 0.669 . . . . 73.2 109.464 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.409 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.47 177.86 10.78 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.283 0.633 . . . . 72.21 110.282 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.6 p -163.19 164.82 25.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.485 0.714 . . . . 53.22 111.2 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 91.1 p -156.36 132.71 10.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.402 1.081 . . . . 54.32 108.744 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -86.37 117.99 25.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.404 -0.591 . . . . 62.4 109.404 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.08 -25.42 16.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.084 0.554 . . . . 72.32 110.629 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.49 -178.68 5.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.392 1.077 . . . . 50.41 109.496 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.49 137.05 49.92 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.88 -0.785 . . . . 73.42 108.88 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 61.2 10.8 3.16 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.095 0.958 . . . . 72.23 112.772 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -123.78 124.79 70.03 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 C-N-CA 124.63 1.172 . . . . 61.23 108.47 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.576 ' HD2' HD11 ' D' ' 86' ' ' ILE . 8.1 m-85 -128.29 158.59 37.76 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.399 -0.963 . . . . 75.43 108.399 171.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -125.9 128.04 46.95 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 105.729 -1.952 . . . . 72.55 105.729 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.45 141.23 31.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.598 -0.89 . . . . 65.11 108.598 -174.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 48.2 t -121.3 134.04 65.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 O-C-N 123.852 0.72 . . . . 64.23 109.136 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -117.49 121.89 42.23 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.18 -1.415 . . . . 74.35 107.18 174.139 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 15.7 ttm-85 -105.6 102.65 12.1 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.765 -0.828 . . . . 73.04 108.765 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 71.9 t -99.76 113.39 34.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.549 -0.908 . . . . 63.14 108.549 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 11.8 m -114.61 134.36 55.11 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.263 0.625 . . . . 73.03 109.377 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 78.8 t -131.67 102.44 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.344 1.457 . . . . 72.51 108.623 -171.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 96.5 m -103.36 95.8 6.33 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.323 -0.991 . . . . 74.23 108.323 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.56 159.94 14.62 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.059 0.456 . . . . 63.13 111.843 -172.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 53.3 p -145.47 142.93 29.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.135 -0.939 . . . . 72.12 110.912 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 mt -113.09 114.59 27.06 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.597 1.159 . . . . 64.41 108.711 169.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.96 -112.39 4.55 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.672 0.608 . . . . 61.24 112.857 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -106.94 3.75 26.49 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.289 0.636 . . . . 74.34 112.092 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -135.81 167.6 20.86 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.654 0.381 . . . . 74.43 110.677 -172.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.0 m -70.06 132.18 45.47 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.608 -0.724 . . . . 74.2 110.942 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.579 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -90.32 -76.46 0.43 Allowed 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.913 -1.143 . . . . 63.34 107.913 174.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -142.22 136.84 30.28 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 121.242 0.544 . . . . 62.41 111.641 -176.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 63.3 mt -104.34 140.29 38.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.124 1.369 . . . . 71.52 107.63 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.679 ' SG ' HG12 ' D' ' 114' ' ' ILE . 50.5 t -154.15 143.09 21.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.038 0.535 . . . . 43.43 109.615 -175.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -155.89 131.84 9.91 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.262 -1.014 . . . . 74.34 108.262 172.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.0 t -131.94 114.78 25.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.248 -0.649 . . . . 73.15 109.248 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.56 HE21 ' HB3' ' D' ' 20' ' ' ASP . 5.0 mt-30 -88.17 82.48 7.12 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.094 -1.076 . . . . 64.35 108.094 169.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -79.86 96.43 6.34 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.694 -1.594 . . . . 71.14 108.744 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.11 164.24 25.92 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.132 -0.486 . . . . 55.35 112.075 177.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.2 135.06 3.71 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 112.562 -0.215 . . . . 64.12 112.562 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.51 HG13 ' HE1' ' D' ' 17' ' ' TYR . 45.3 mt -89.79 129.66 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.343 1.057 . . . . 72.43 108.875 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -129.84 147.21 51.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.395 1.078 . . . . 75.4 110.321 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.1 m -108.01 109.78 21.33 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.555 -0.906 . . . . 74.22 108.555 171.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.576 HD11 ' HD2' ' D' ' 56' ' ' TYR . 19.2 pt -115.94 136.64 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.529 0.732 . . . . 71.52 110.942 -173.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -154.54 159.54 40.99 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.195 0.998 . . . . 75.34 109.115 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.01 -12.37 30.78 Favored Glycine 0 N--CA 1.478 1.457 0 N-CA-C 114.257 0.463 . . . . 75.14 114.257 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.6 pt -123.09 142.1 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.424 1.089 . . . . 74.41 109.165 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 6.3 pt-20 -165.83 164.55 18.66 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.506 0.722 . . . . 74.51 110.781 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.89 -114.72 7.11 Favored Glycine 0 C--N 1.354 1.56 0 O-C-N 123.851 0.719 . . . . 75.4 112.254 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.9 m -67.85 -37.79 82.3 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.492 0.717 . . . . 73.34 110.421 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -70.22 -28.78 65.54 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.602 0.761 . . . . 64.51 112.572 -177.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.51 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 18.5 tmm? -83.54 -32.03 26.08 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.25 -0.278 . . . . 73.04 110.25 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 -33.92 76.92 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.276 0.56 . . . . 71.42 110.379 169.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.429 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.1 t-80 -73.58 -20.28 60.66 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.994 1.317 . . . . 74.12 111.14 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -88.01 -53.83 4.54 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.435 0.294 . . . . 64.33 110.712 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.444 HD22 ' SD ' ' D' ' 94' ' ' MET . 9.8 mp -74.57 -32.92 62.55 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.659 0.783 . . . . 73.22 111.77 -173.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.19 14.54 61.13 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 119.072 -0.849 . . . . 74.44 113.311 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -157.58 -69.66 0.1 Allowed 'General case' 0 C--N 1.356 0.871 0 CA-C-N 118.212 1.006 . . . . 65.11 112.846 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -68.14 -39.61 82.62 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.818 0.447 . . . . 65.53 112.057 -171.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.415 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 74.8 m -69.5 -46.3 26.73 Favored Pre-proline 0 CA--C 1.557 1.242 0 CA-C-O 118.372 -0.823 . . . . 73.52 111.516 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.463 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 97.9 Cg_exo -51.29 -36.97 58.94 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 122.314 2.01 . . . . 75.22 113.373 165.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -65.83 -29.81 70.33 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.025 0.53 . . . . 64.54 111.792 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.518 HG21 HD13 ' D' ' 13' ' ' ILE . 46.2 mm -68.96 -44.81 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.521 -0.548 . . . . 73.33 109.521 171.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -77.05 -14.98 59.75 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.99 -1.005 . . . . 72.05 112.021 -173.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -73.73 -40.1 4.94 Favored Pre-proline 0 CA--C 1.561 1.395 0 N-CA-C 113.924 1.083 . . . . 61.45 113.924 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.7 -39.35 88.38 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 121.742 1.628 . . . . 73.24 112.782 169.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -72.67 -35.33 67.68 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.612 0.765 . . . . 73.31 110.985 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.1 -51.46 67.81 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.657 -0.701 . . . . 73.42 109.359 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 29.7 ttp-105 -54.34 -50.24 67.87 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.794 1.309 . . . . 53.51 110.874 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -64.11 -46.04 85.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.861 0.865 . . . . 71.45 111.898 -173.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.7 t -59.47 -40.42 86.86 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.994 0.809 . . . . 54.32 110.507 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.679 HG12 ' SG ' ' D' ' 76' ' ' CYS . 95.4 mt -63.01 -56.06 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.111 0.964 . . . . 61.21 110.35 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -55.36 -37.01 66.95 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.574 1.15 . . . . 64.11 111.376 -174.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.4 t -68.73 -46.23 69.43 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.009 -0.996 . . . . 61.24 110.144 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.8 mtm -68.21 -29.24 68.03 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.783 0.433 . . . . 62.41 111.897 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' D' ' 123' ' ' PHE . 54.7 t -68.7 -41.75 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.788 0.835 . . . . 63.54 110.266 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.6 p -74.88 -32.11 61.77 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.615 0.366 . . . . 63.12 110.909 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -70.43 -34.8 72.88 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.469 0.708 . . . . 63.42 109.82 174.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.51 5.61 82.89 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 115.345 -0.843 . . . . 54.32 112.537 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 26.6 p 63.04 16.32 9.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.407 1.883 . . . . 63.0 114.84 171.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.426 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.8 m-85 -80.71 153.82 73.22 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.462 0.705 . . . . 51.35 109.292 170.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.02 141.83 94.08 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.73 2.287 . . . . 62.04 113.083 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.76 134.92 47.85 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.865 1.266 . . . . 74.24 112.555 -174.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -110.01 107.13 16.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.109 -1.071 . . . . 42.03 108.109 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -99.22 89.06 4.1 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.911 -0.774 . . . . 72.44 108.911 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.49 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 44.0 tp -70.53 115.83 10.15 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.936 -1.029 . . . . 75.11 109.787 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.96 133.44 87.14 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 123.459 0.704 . . . . 70.4 111.396 -176.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 16.7 Cg_exo -66.71 113.35 2.71 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.626 2.217 . . . . 63.43 111.161 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 61.1 t -106.43 128.11 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.532 0.733 . . . . 71.23 109.045 -175.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -78.29 98.23 5.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.529 0.732 . . . . 73.42 109.713 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -63.46 -22.42 66.88 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.169 0.588 . . . . 72.4 111.855 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -61.87 -48.56 79.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.321 0.648 . . . . 63.11 111.689 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.41 -45.77 89.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.551 0.74 . . . . 72.4 111.702 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.49 -31.8 72.19 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.934 -0.575 . . . . 74.25 111.128 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 89.4 t80 . . . . . 0 N--CA 1.485 1.3 0 C-N-CA 123.248 0.619 . . . . 75.21 110.179 176.311 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 110.104 -0.332 . . . . 74.12 110.104 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m -70.31 86.47 0.6 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.515 0.726 . . . . 73.44 110.45 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.74 115.72 28.97 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.495 -1.298 . . . . 74.53 107.495 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -124.76 13.75 8.61 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.141 0.576 . . . . 74.31 112.199 -167.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -151.45 -84.82 0.08 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.976 -0.379 . . . . 61.31 109.976 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 171.63 108.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.376 1.47 . . . . 54.23 107.056 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -66.14 128.68 37.04 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 108.996 -0.742 . . . . 65.51 108.996 170.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -88.52 158.44 18.31 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.178 0.591 . . . . 65.15 110.433 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 15.5 ptp -49.59 133.94 20.3 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 124.416 1.086 . . . . 53.13 113.061 -176.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.8 m -152.67 138.64 18.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.142 1.377 . . . . 72.31 108.252 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.612 ' HA ' HG22 ' A' ' 86' ' ' ILE . 72.8 t80 -130.41 114.13 15.19 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.695 -1.224 . . . . 74.22 107.695 170.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -134.18 134.58 42.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.418 -0.956 . . . . 71.52 108.418 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.429 ' CD1' HG21 ' A' ' 105' ' ' ILE . 14.6 mt -84.99 112.32 21.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 108.485 -0.932 . . . . 73.54 108.485 174.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.27 -39.77 65.13 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.515 -0.92 . . . . 63.54 108.515 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -172.17 148.28 2.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 116.591 -0.277 . . . . 55.43 110.622 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.7 mt -132.16 129.06 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.101 -1.074 . . . . 73.41 108.101 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.437 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 33.1 p90 -168.37 147.99 4.57 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 124.209 0.943 . . . . 73.21 110.562 -176.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -75.68 112.53 12.15 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.865 -1.061 . . . . 33.05 109.121 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 37.7 mtpt -82.08 -27.51 32.88 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.955 0.407 . . . . 71.13 109.951 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.642 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 19.5 t70 -143.7 140.02 29.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.008 -0.997 . . . . 70.04 109.885 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.4 mt -137.15 140.91 41.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 107.204 -1.406 . . . . 70.34 107.204 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -147.77 134.5 19.99 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.78 -0.822 . . . . 70.14 108.78 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.575 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 55.2 t80 -140.09 121.6 15.15 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.834 -1.173 . . . . 73.42 107.834 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.98 110.2 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.809 -0.811 . . . . 53.44 108.809 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.726 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -126.05 76.14 71.85 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 107.246 -1.391 . . . . 72.33 107.246 170.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.451 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 72.7 Cg_endo -74.42 -30.87 7.79 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.33 2.02 . . . . 70.15 110.697 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.451 ' ND2' ' HG2' ' A' ' 26' ' ' PRO . 30.5 m-80 -101.16 19.57 17.32 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.216 1.006 . . . . 71.3 110.112 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.726 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -52.98 -48.26 92.44 Favored Pre-proline 0 CA--C 1.571 1.762 0 C-N-CA 123.694 0.798 . . . . 54.22 111.87 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.36 -17.38 16.71 Favored 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 121.88 1.72 . . . . 72.32 113.609 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -69.99 -49.21 53.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.974 0.509 . . . . 72.25 109.771 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.66 HG21 ' HA ' ' A' ' 73' ' ' ALA . 42.7 t -72.55 -20.18 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.861 0.864 . . . . 73.21 111.21 -175.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.406 ' HB2' ' NH1' ' B' ' 15' ' ' ARG . 81.3 t80 -60.21 -34.4 73.59 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.367 0.667 . . . . 73.03 110.447 168.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -94.18 -24.39 17.53 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.362 1.065 . . . . 72.34 110.977 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 32.9 mmtp -75.89 170.89 15.37 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.486 0.714 . . . . 71.31 110.304 172.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -81.31 138.43 35.7 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.973 -1.121 . . . . 54.32 107.973 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 41.5 t-105 -76.43 83.76 3.16 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.709 0.766 . . . . 75.3 110.443 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -129.82 77.63 76.5 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.863 1.265 . . . . 70.01 108.751 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 39.1 Cg_endo -93.03 146.38 2.42 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.55 2.167 . . . . 62.44 113.074 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 28.1 tt0 -97.87 95.73 7.72 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.766 -0.827 . . . . 72.42 108.766 172.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.36 91.21 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.499 0.666 . . . . 62.12 109.747 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -101.18 128.92 47.06 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.088 -0.708 . . . . 71.33 109.088 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.476 HD11 HG13 ' A' ' 62' ' ' VAL . 45.6 tp -98.2 146.6 25.45 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.707 -0.849 . . . . 45.14 108.707 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.653 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.4 m-20 -134.46 109.35 8.68 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.269 -1.382 . . . . 73.32 107.269 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -96.99 120.37 37.21 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.847 -0.427 . . . . 75.35 109.847 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -128.37 143.97 51.07 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.991 -1.115 . . . . 53.14 107.991 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.1 m -133.44 142.22 48.21 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.104 0.562 . . . . 64.33 110.085 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -130.36 152.93 49.23 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.809 1.244 . . . . 53.03 109.217 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.3 t -127.49 151.61 48.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.622 0.769 . . . . 54.55 109.744 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.7 t -153.31 128.3 9.63 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.576 0.75 . . . . 64.24 110.176 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -101.38 108.01 19.5 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.139 -0.689 . . . . 75.43 109.139 174.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.464 HD12 HG23 ' A' ' 83' ' ' ILE . 79.2 mt -88.43 -35.25 17.18 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.931 0.492 . . . . 64.04 110.696 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -159.62 -179.64 8.07 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 124.029 0.831 . . . . 41.44 110.461 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -67.41 116.65 8.4 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.721 -1.127 . . . . 73.35 109.136 171.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.722 ' HA ' HG12 ' E' ' 451' ' ' VAL . 3.5 m-20 67.54 11.21 8.26 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.728 1.211 . . . . 71.11 113.157 -177.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 62.1 t -115.54 111.6 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.376 -1.342 . . . . 61.01 107.376 171.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.43 ' CD2' HG12 ' E' ' 452' ' ' VAL . 1.6 t80 -130.78 141.93 50.38 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.894 -0.78 . . . . 72.1 108.894 -171.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -123.13 134.32 54.21 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.135 0.974 . . . . 73.03 109.213 -173.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.74 131.04 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 108.015 -1.106 . . . . 62.2 108.015 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 46.8 t -116.06 110.15 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.867 -0.79 . . . . 62.24 108.867 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.1 tp -90.26 105.71 17.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.487 -0.56 . . . . 75.24 109.487 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.451 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 51.8 ttt180 -85.07 101.69 12.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.504 0.722 . . . . 63.1 109.298 173.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.476 HG13 HD11 ' A' ' 42' ' ' LEU . 48.4 t -95.37 102.09 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 108.097 -1.075 . . . . 51.43 108.097 175.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.653 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 56.4 m -96.98 110.31 22.88 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.513 0.725 . . . . 63.43 109.051 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.615 HG21 HG21 ' A' ' 114' ' ' ILE . 41.9 t -102.92 137.28 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.392 -0.966 . . . . 72.05 108.392 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 t -143.09 150.5 39.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.863 -0.421 . . . . 73.33 109.863 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -138.67 109.61 6.75 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.823 -1.177 . . . . 71.1 107.823 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.8 p -135.04 127.04 29.65 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.416 0.687 . . . . 74.31 110.188 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -90.23 78.67 6.51 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.24 -1.393 . . . . 64.23 107.24 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.55 -91.42 0.66 Allowed Glycine 0 C--N 1.349 1.25 0 CA-C-N 115.142 -0.935 . . . . 73.11 112.783 173.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -91.91 -26.53 18.4 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.914 0.886 . . . . 71.02 111.823 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -113.55 129.92 56.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.721 0.408 . . . . 72.34 110.955 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 59.0 m -88.65 124.81 34.45 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.487 0.715 . . . . 64.3 110.289 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.66 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -70.59 -56.58 6.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.883 0.873 . . . . 75.45 110.071 175.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -155.83 158.77 38.64 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.617 -1.174 . . . . 73.35 111.128 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 tp -134.29 124.51 25.99 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.369 1.468 . . . . 75.44 107.217 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.441 ' SG ' HG12 ' A' ' 118' ' ' VAL . 61.6 m -132.22 99.96 4.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.111 0.964 . . . . 55.41 109.005 -174.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -123.68 127.39 48.13 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.527 0.731 . . . . 53.22 109.704 -171.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.2 t -135.63 113.85 15.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 123.445 0.698 . . . . 72.23 109.764 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.642 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.7 mt-30 -84.18 83.91 7.8 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.304 -0.998 . . . . 70.44 108.304 169.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.84 97.59 4.59 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.524 -1.216 . . . . 71.43 108.844 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.49 150.24 23.3 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 111.664 -0.574 . . . . 33.33 111.664 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.542 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -143.89 122.49 1.84 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.905 -0.878 . . . . 64.22 110.905 173.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.464 HG23 HD12 ' A' ' 51' ' ' LEU . 35.7 mt -82.02 130.52 35.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.801 -1.185 . . . . 74.14 107.801 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -127.67 122.64 33.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.85 -0.796 . . . . 64.41 108.85 -176.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -89.44 91.62 8.79 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.453 -0.943 . . . . 74.32 108.453 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.612 HG22 ' HA ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -126.74 155.62 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.175 0.59 . . . . 73.41 110.186 -175.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' MET . . . -169.56 170.72 8.01 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.156 0.982 . . . . 70.41 109.509 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.5 -32.34 6.08 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 123.675 0.61 . . . . 70.14 113.336 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.58 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.44 156.62 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.86 0.864 . . . . 74.05 109.748 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -163.35 177.39 8.98 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.456 0.702 . . . . 71.12 109.403 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.66 -130.51 23.07 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 114.097 0.399 . . . . 62.13 114.097 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.0 p -76.44 -35.57 58.43 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.56 1.144 . . . . 71.2 111.577 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -59.87 -43.92 94.46 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.963 0.905 . . . . 73.21 110.111 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.519 ' SD ' HG22 ' E' ' 451' ' ' VAL . 65.6 ttp -72.48 -36.01 68.32 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.005 -0.998 . . . . 63.52 110.848 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.23 -29.67 68.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.037 0.535 . . . . 55.21 110.883 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -69.15 -46.46 67.55 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.016 0.527 . . . . 64.25 110.94 168.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.5 m -59.98 -65.15 0.73 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 122.321 0.248 . . . . 60.24 110.824 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 94' ' ' MET . 2.0 pp -73.5 -21.64 60.35 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.028 0.751 . . . . 74.14 113.028 -176.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.419 ' N ' HD12 ' A' ' 98' ' ' LEU . . . -101.56 -4.53 52.47 Favored Glycine 0 N--CA 1.475 1.268 0 CA-C-O 119.599 -0.556 . . . . 63.41 113.577 -173.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.32 -60.75 0.42 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.239 0.519 . . . . 41.25 111.612 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.58 -45.57 65.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.018 0.527 . . . . 74.45 111.991 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.3 m -67.76 -45.74 44.55 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.122 0.969 . . . . 73.22 111.943 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.95 -26.55 58.8 Favored 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 121.549 1.499 . . . . 74.24 112.576 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -70.09 -30.42 67.64 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 122.771 0.428 . . . . 73.34 110.307 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.429 HG21 ' CD1' ' A' ' 13' ' ' ILE . 41.7 mm -67.53 -41.43 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.79 0.836 . . . . 74.02 109.988 171.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.542 HD21 ' HA3' ' A' ' 82' ' ' GLY . 69.9 mt -74.99 -22.13 58.72 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.302 -0.863 . . . . 71.51 111.453 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -63.34 -43.49 79.85 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 117.464 -1.255 . . . . 72.13 114.233 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.1 -40.41 77.25 Favored 'Trans proline' 0 C--N 1.387 2.56 0 CA-C-N 122.093 1.783 . . . . 64.54 112.765 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -66.02 -44.64 84.13 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.453 0.701 . . . . 74.31 111.463 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.83 84.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.178 0.591 . . . . 73.41 110.711 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.414 ' NH1' HD12 ' C' ' 105' ' ' ILE . 26.8 ttm180 -50.79 -54.62 22.07 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.552 1.158 . . . . 72.21 109.76 174.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -67.01 -38.99 86.95 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.402 1.064 . . . . 53.05 111.833 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.561 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.2 t -62.06 -27.8 69.15 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.015 0.526 . . . . 72.4 111.019 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.615 HG21 HG21 ' A' ' 64' ' ' VAL . 97.5 mt -87.52 -41.09 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.227 1.411 . . . . 64.11 111.027 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 49.3 m -64.46 -44.48 90.95 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.482 0.713 . . . . 72.43 110.508 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.8 t -65.77 -40.89 92.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.794 -1.093 . . . . 51.24 109.93 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.575 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.7 ttm -59.58 -47.17 86.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.366 1.066 . . . . 63.02 111.903 -177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.441 HG12 ' SG ' ' A' ' 76' ' ' CYS . 20.5 m -66.02 -39.45 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.251 0.345 . . . . 61.43 110.317 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.0 m -67.45 -32.57 73.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.42 0.688 . . . . 73.01 111.362 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.622 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 86.5 mtt-85 -71.47 -31.5 67.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.518 0.727 . . . . 74.12 110.018 174.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.54 3.56 86.26 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.614 -0.721 . . . . 63.44 113.519 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.0 m 62.28 47.27 5.5 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 123.545 1.64 . . . . 73.34 110.797 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -116.75 137.64 23.89 Favored Pre-proline 0 C--O 1.246 0.92 0 CA-C-N 114.055 -1.429 . . . . 74.35 107.18 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.55 144.28 10.67 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.283 2.656 . . . . 73.33 113.705 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -55.98 132.38 49.76 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 124.357 1.036 . . . . 54.05 112.403 -173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 tp -118.97 100.69 7.52 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.143 -0.935 . . . . 72.12 109.68 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -98.03 107.3 19.74 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.839 -1.171 . . . . 74.44 107.839 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.46 139.31 58.76 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.169 0.587 . . . . 63.41 109.73 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.18 145.57 98.03 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 122.886 0.474 . . . . 52.35 110.673 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.406 ' HG3' ' HD2' ' C' ' 11' ' ' PHE . 37.0 Cg_endo -62.84 107.84 0.67 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.083 1.855 . . . . 64.2 111.269 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 89.9 t -98.99 113.76 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.488 -0.93 . . . . 54.24 108.488 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -84.21 89.02 7.25 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.236 -1.024 . . . . 73.21 108.236 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -59.9 -29.67 68.5 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.645 0.778 . . . . 75.51 111.52 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' C' ' 147' ' ' GLU . 5.2 m-20 -69.17 -44.39 72.31 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.699 1.2 . . . . 73.23 110.681 -177.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.12 -45.36 92.38 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.992 0.808 . . . . 70.55 110.181 175.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.417 ' HA ' HD22 ' A' ' 139' ' ' ASN . 95.2 mt -60.86 -37.04 80.74 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.164 -0.926 . . . . 73.11 111.212 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -68.86 -34.52 75.59 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.326 -0.852 . . . . 75.44 109.941 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.6 mmt -61.89 -35.46 78.42 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.679 0.612 . . . . 71.53 111.124 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.542 ' HA ' ' H ' ' A' ' 144' ' ' GLN . 61.7 m-80 -66.29 -40.25 89.93 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.943 -0.571 . . . . 74.31 110.888 176.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -73.54 -31.63 63.76 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.181 0.592 . . . . 72.11 111.113 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.45 HD21 ' O ' ' C' ' 150' ' ' GLU . 24.8 tp -66.89 -49.45 65.58 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.892 1.277 . . . . 74.52 111.006 -171.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -172.14 30.75 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 108.91 -0.774 . . . . 74.44 108.91 -174.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 59.81 78.75 0.26 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.441 0.697 . . . . 72.13 110.184 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.542 ' H ' ' HA ' ' A' ' 139' ' ' ASN . 91.2 mt-30 76.1 -43.77 0.48 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.573 1.549 . . . . 72.32 111.689 -176.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 67.56 -77.48 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.382 1.473 . . . . 53.15 111.344 172.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.72 -93.97 0.66 Allowed Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.34 -1.104 . . . . 73.43 110.34 173.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.429 ' H ' ' HA3' ' C' ' 148' ' ' GLY . 6.8 tp10 66.55 157.79 0.12 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.727 1.611 . . . . 74.22 112.059 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.34 32.53 62.37 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.247 -0.433 . . . . 32.54 112.487 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.1 t -84.0 10.33 10.18 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.92 0.888 . . . . 65.1 111.22 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.555 ' HA ' ' HB3' ' C' ' 145' ' ' ALA . 0.2 OUTLIER -63.13 92.24 0.05 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.038 0.935 . . . . 73.33 109.449 -177.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -56.94 -39.33 74.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.113 1.365 . . . . 73.23 111.272 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.415 ' HE1' ' HG3' ' C' ' 93' ' ' GLN . 55.4 t60 62.55 82.51 0.18 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.603 1.189 . . . . 73.23 111.506 173.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -127.77 123.5 35.45 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.278 -1.008 . . . . 73.24 108.278 170.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.678 ' HA ' ' HA ' ' C' ' 142' ' ' GLN . 7.8 p-10 -75.64 165.6 24.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.11 0.564 . . . . 74.22 110.488 176.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 N-CA-C 108.427 -0.953 . . . . 72.34 108.427 173.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.418 -0.216 . . . . 74.24 110.418 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 24.7 m -74.66 83.03 2.07 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.534 0.733 . . . . 54.54 110.48 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -96.08 60.58 2.04 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.572 0.701 . . . . 62.2 109.685 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -130.24 135.49 48.18 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.942 -1.026 . . . . 72.14 108.306 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -130.77 -171.82 2.66 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.584 0.754 . . . . 63.01 110.248 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 37.3 t30 65.08 106.38 0.03 OUTLIER 'General case' 0 C--N 1.362 1.122 0 C-N-CA 124.61 1.164 . . . . 75.43 110.628 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 37.8 p -77.68 76.84 4.21 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.681 0.753 . . . . 62.54 110.631 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -99.76 -71.56 0.69 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.909 -1.515 . . . . 72.44 106.909 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 7.9 ptm 47.45 167.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 127.804 2.441 . . . . 72.02 114.398 -172.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 60.5 m -165.09 134.37 3.51 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.382 -0.599 . . . . 73.43 109.382 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.37 156.75 42.54 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.479 0.657 . . . . 72.51 110.039 155.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.444 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -126.31 135.15 51.15 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.639 -1.245 . . . . 52.13 107.639 173.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.459 HD13 HD11 ' B' ' 16' ' ' ILE . 51.0 mt -68.63 116.08 8.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.319 -0.993 . . . . 75.11 108.319 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -86.87 -36.41 18.44 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.235 -0.893 . . . . 71.42 109.45 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.406 ' NH1' ' HB2' ' A' ' 32' ' ' PHE . 75.2 ttt180 -167.33 133.71 2.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.894 -1.048 . . . . 62.33 109.715 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.489 ' H ' ' ND2' ' D' ' 127' ' ' ASN . 88.8 mt -115.61 135.08 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 105.809 -1.923 . . . . 73.22 105.809 166.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.402 ' HE1' HG13 ' B' ' 83' ' ' ILE . 10.0 p90 -168.4 151.04 5.32 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.213 0.53 . . . . 75.11 111.059 -174.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.669 HG21 HD11 ' B' ' 21' ' ' ILE . 17.8 m -82.62 129.84 35.01 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.942 -0.762 . . . . 75.33 108.942 175.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -97.89 -30.56 12.67 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.354 0.662 . . . . 72.51 110.721 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 11.8 t70 -145.09 139.11 27.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.428 -0.351 . . . . 72.24 110.232 -175.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.669 HD11 HG21 ' B' ' 18' ' ' THR . 33.3 mm -131.17 139.53 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 106.768 -1.568 . . . . 74.33 106.768 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.8 t -147.6 138.25 23.29 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.32 -0.993 . . . . 52.11 108.32 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.0 t80 -154.71 110.38 3.15 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.662 -1.236 . . . . 72.44 107.662 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -117.95 114.42 23.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.627 1.171 . . . . 72.21 108.09 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.727 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -111.82 83.78 4.93 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.348 -0.982 . . . . 72.43 108.348 175.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.97 -34.26 6.69 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.775 2.316 . . . . 64.01 112.94 -170.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -98.14 -2.61 39.59 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.921 0.888 . . . . 54.15 111.426 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.727 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -35.83 -63.02 0.43 Allowed Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 125.867 1.667 . . . . 61.54 114.803 -165.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 37.9 Cg_exo -54.97 -31.02 72.24 Favored 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 122.775 2.316 . . . . 75.0 113.794 -173.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -96.78 -34.49 11.3 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.692 -1.14 . . . . 74.51 111.404 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.592 HG22 HD12 ' B' ' 68' ' ' LEU . 5.6 p -74.45 -18.63 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 122.336 0.254 . . . . 75.32 111.672 -171.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.95 -15.49 62.24 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.619 0.768 . . . . 72.2 112.855 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -57.25 -29.98 64.26 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.425 0.69 . . . . 73.03 110.473 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -95.38 98.66 10.73 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 124.623 1.169 . . . . 74.23 109.025 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -83.36 92.92 7.64 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.41 0.684 . . . . 74.15 109.725 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -162.94 156.26 19.71 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.762 0.825 . . . . 75.03 109.347 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.449 ' HB3' HD22 ' F' ' 470' ' ' LEU . 0.0 OUTLIER -67.05 105.44 0.85 Allowed Pre-proline 0 CA--C 1.562 1.405 0 C-N-CA 124.524 1.13 . . . . 74.45 110.676 170.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.523 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 40.3 Cg_endo -67.37 137.58 43.71 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.597 2.198 . . . . 62.53 112.115 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 11.9 tp10 -59.23 121.46 11.43 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 124.187 0.929 . . . . 72.22 112.099 -169.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.661 HG23 HD11 ' F' ' 470' ' ' LEU . 73.2 t -85.94 132.47 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.968 0.907 . . . . 73.1 110.23 -172.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.563 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 12.9 tmtt? -131.9 117.29 18.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.275 -1.75 . . . . 74.13 106.275 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.463 HD22 HD11 ' B' ' 128' ' ' LEU . 40.4 tp -93.98 150.56 20.25 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.154 0.502 . . . . 73.24 111.188 -172.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.722 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.8 m-20 -140.59 143.64 35.39 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.694 -1.225 . . . . 63.55 107.694 171.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.503 HD12 ' HG ' ' F' ' 460' ' ' LEU . 0.4 OUTLIER -143.0 125.94 16.21 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.926 -1.139 . . . . 73.13 107.926 -177.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 12.2 m-20 -127.04 150.42 49.45 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.026 -1.102 . . . . 63.0 108.026 171.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.0 p -135.72 124.46 23.87 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.943 0.401 . . . . 72.3 110.817 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.19 164.08 16.77 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.542 1.537 . . . . 74.5 109.493 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 22.2 p -145.07 168.67 19.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.482 1.113 . . . . 70.53 109.104 170.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 97.4 p -151.23 168.47 24.63 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.156 0.582 . . . . 75.42 109.815 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -116.53 110.2 18.26 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.731 -1.211 . . . . 64.14 107.731 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 24.6 mt -88.02 -55.51 3.72 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.1 0.953 . . . . 73.2 108.777 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.67 -179.32 5.85 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 113.431 -1.713 . . . . 42.31 108.053 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.32 130.36 40.58 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 116.158 -0.474 . . . . 73.02 110.627 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 67.03 -1.19 1.48 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.969 1.708 . . . . 64.23 112.724 -172.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.2 t -103.61 104.11 16.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 108.074 -1.084 . . . . 74.31 108.074 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.657 ' HH ' ' N ' ' F' ' 450' ' ' ASN . 16.7 m-85 -114.19 140.45 48.53 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.026 -1.101 . . . . 71.42 108.026 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -119.87 104.67 10.39 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.212 -1.033 . . . . 71.42 108.212 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 72.3 t -89.08 140.09 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.358 0.663 . . . . 62.42 110.589 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.464 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 38.0 t -118.28 118.9 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.797 0.839 . . . . 75.15 109.403 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.5 OUTLIER -93.82 122.98 36.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.203 -1.406 . . . . 73.44 107.203 174.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 46.8 ttt180 -110.27 122.14 46.96 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.403 0.681 . . . . 72.11 109.486 175.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 13.6 t -117.62 131.36 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 107.67 -1.233 . . . . 72.54 107.67 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.722 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.1 m -127.07 130.28 49.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.758 -0.83 . . . . 74.52 108.758 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.33 116.39 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.844 -0.799 . . . . 73.24 108.844 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 89.2 m -99.05 138.46 36.13 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.917 -1.142 . . . . 70.12 107.917 174.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.17 147.36 30.42 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 122.437 0.295 . . . . 71.31 110.593 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 54.9 p -151.66 135.74 16.6 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 124.125 0.891 . . . . 72.45 111.383 -174.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.592 HD12 HG22 ' B' ' 31' ' ' VAL . 56.1 mt -95.45 110.44 22.49 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.947 0.899 . . . . 62.33 109.477 174.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.43 -111.12 3.43 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.581 -1.19 . . . . 73.13 111.764 -169.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -119.06 2.57 11.47 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.802 0.841 . . . . 73.22 110.905 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -112.66 148.96 33.56 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.888 -0.782 . . . . 75.23 108.888 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.6 m -61.6 140.42 58.14 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.55 0.531 . . . . 53.11 110.874 -176.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.76 -67.14 0.86 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.676 -1.231 . . . . 63.12 107.676 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -148.1 158.07 43.86 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.969 -1.014 . . . . 64.5 109.862 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 41.7 mt -132.6 109.42 9.73 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 106.365 -1.717 . . . . 61.31 106.365 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 39.3 t -120.77 117.04 26.41 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.27 0.487 . . . . 50.14 110.05 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.4 tt0 -122.28 132.67 54.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.22 1.008 . . . . 65.11 108.736 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 75.5 t -128.48 147.64 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.111 -0.7 . . . . 74.01 109.111 173.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.534 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.8 mt-30 -125.36 102.99 7.68 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.094 -0.706 . . . . 62.53 109.094 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -90.44 104.78 17.32 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.658 -0.868 . . . . 64.25 108.658 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.59 171.11 37.62 Favored Glycine 0 C--O 1.243 0.68 0 N-CA-C 111.364 -0.694 . . . . 71.34 111.364 174.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.67 130.65 2.15 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 112.121 -0.392 . . . . 71.45 112.121 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.402 HG13 ' HE1' ' B' ' 17' ' ' TYR . 39.3 mt -89.89 127.47 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.334 0.653 . . . . 74.43 109.32 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -135.15 132.92 38.61 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.393 -1.336 . . . . 71.44 107.393 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.4 m -101.62 90.97 4.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.705 0.402 . . . . 72.55 110.787 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.532 ' HB ' HD11 ' B' ' 89' ' ' ILE . 16.1 pt -96.25 145.25 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.494 0.718 . . . . 64.44 111.614 -167.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.77 157.16 32.85 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.279 1.031 . . . . 72.31 109.96 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.02 -39.31 2.94 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 123.378 0.513 . . . . 71.01 113.657 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.64 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -79.12 146.65 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.062 0.545 . . . . 65.4 111.237 178.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -162.95 162.62 26.21 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.046 0.841 . . . . 74.42 109.506 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.99 -118.13 9.28 Favored Glycine 0 N--CA 1.474 1.171 0 CA-C-N 115.976 -0.556 . . . . 44.12 113.553 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 99.5 m -69.63 -33.48 72.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.663 0.785 . . . . 72.11 110.708 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -66.74 -38.98 87.74 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.264 0.625 . . . . 62.31 111.466 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -32.92 60.49 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.357 0.263 . . . . 75.22 111.29 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.27 75.13 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.495 -0.775 . . . . 44.12 110.103 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -72.36 -34.85 68.29 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.034 0.933 . . . . 63.24 110.677 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -68.11 -67.5 0.46 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.498 0.499 . . . . 64.12 110.812 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.426 HD12 HD13 ' F' ' 454' ' ' LEU . 68.2 mt -81.84 -16.51 50.57 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 111.873 0.323 . . . . 61.34 111.873 -173.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.512 ' HA2' ' NE2' ' F' ' 457' ' ' GLN . . . -97.13 -9.69 55.49 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 114.57 0.588 . . . . 70.41 114.57 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.99 -56.3 0.25 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.382 0.591 . . . . 73.22 111.722 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -71.7 -48.53 46.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.709 0.804 . . . . 71.43 112.06 -169.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 98.6 m -61.27 -47.23 94.81 Favored Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 124.158 0.983 . . . . 63.23 111.777 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.421 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 76.1 Cg_exo -56.03 -41.17 79.75 Favored 'Trans proline' 0 C--N 1.395 3.0 0 C-N-CA 122.406 2.071 . . . . 70.32 113.587 167.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -62.73 -29.37 70.62 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.482 0.713 . . . . 74.22 111.914 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.52 HG23 ' NH2' ' D' ' 111' ' ' ARG . 77.7 mt -69.63 -41.65 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.85 0.86 . . . . 74.35 110.748 173.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.76 -19.52 57.52 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.981 -1.009 . . . . 62.12 112.255 -173.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -56.71 -48.58 96.99 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 114.872 1.434 . . . . 74.51 114.872 -170.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.77 -37.53 95.49 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.457 2.104 . . . . 72.11 113.828 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -71.25 -43.03 68.06 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.661 -0.699 . . . . 54.21 110.369 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -40.57 87.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.597 0.759 . . . . 74.33 110.776 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -60.53 -53.11 61.42 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.192 0.997 . . . . 45.33 111.212 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.23 -33.25 75.56 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.459 0.704 . . . . 61.31 110.397 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.622 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -67.89 -42.91 80.49 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.804 0.842 . . . . 74.14 111.658 177.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 66.4 mt -60.63 -51.51 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 109.77 -0.456 . . . . 45.02 109.77 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.48 HG21 ' OG ' ' C' ' 119' ' ' SER . 19.8 m -60.13 -34.35 73.41 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.873 0.869 . . . . 32.23 111.646 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.4 t -60.34 -48.01 83.59 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.732 0.645 . . . . 54.21 110.075 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -74.77 -31.29 61.73 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.446 0.698 . . . . 63.52 111.524 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.08 -39.4 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.894 0.878 . . . . 64.04 110.559 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.407 ' OG ' HG21 ' C' ' 115' ' ' THR . 30.4 t -65.28 -40.64 94.13 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.84 0.856 . . . . 75.14 111.065 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.561 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 78.0 mtt-85 -66.24 -33.49 75.87 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 114.843 -1.071 . . . . 52.14 110.128 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.12 7.42 75.34 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-O 119.361 -0.688 . . . . 54.53 113.677 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.437 HG23 ' HB3' ' A' ' 17' ' ' TYR . 80.6 p 56.12 29.68 15.05 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.905 1.682 . . . . 73.23 113.537 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -93.24 154.76 41.47 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.025 0.93 . . . . 75.24 110.787 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.23 165.94 1.91 Allowed 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 123.909 3.073 . . . . 71.23 115.556 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.454 HE21 ' ND2' ' B' ' 127' ' ' ASN . 64.0 tp60 -63.58 137.62 58.19 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.461 1.104 . . . . 73.31 113.191 -168.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.99 112.31 15.09 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 107.753 -1.202 . . . . 75.51 107.753 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.454 ' ND2' HE21 ' B' ' 125' ' ' GLN . 67.8 m-80 -130.53 109.54 10.76 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.589 -0.893 . . . . 53.54 108.589 172.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.463 HD11 HD22 ' B' ' 42' ' ' LEU . 33.6 tp -82.87 137.41 34.28 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.637 0.375 . . . . 65.24 110.397 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.32 144.75 92.47 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.148 0.979 . . . . 63.43 111.415 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.449 ' HG3' HD13 ' D' ' 16' ' ' ILE . 33.3 Cg_endo -61.64 109.2 0.72 Allowed 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.897 2.398 . . . . 75.22 112.298 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -89.83 111.9 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.615 -0.884 . . . . 74.43 108.615 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -78.5 87.93 4.47 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.22 -1.03 . . . . 45.42 108.22 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -59.06 -36.72 75.53 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.519 0.727 . . . . 73.43 111.339 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -65.12 -40.85 95.07 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.581 1.152 . . . . 73.25 111.998 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.85 -47.27 66.37 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.738 0.815 . . . . 62.13 110.855 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.89 -20.75 59.59 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.535 -0.757 . . . . 73.02 110.873 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.441 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 94.4 t80 -66.9 -44.26 81.27 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.588 0.755 . . . . 74.52 110.112 173.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.75 -36.71 74.79 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.83 0.852 . . . . 73.33 110.633 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -76.61 -28.21 56.03 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.282 -0.872 . . . . 65.41 111.45 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -65.36 -33.9 77.05 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.999 0.92 . . . . 75.0 111.336 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 31.4 mt -76.21 -3.47 36.58 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.596 0.759 . . . . 72.12 111.48 -174.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -122.33 -37.2 2.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.388 1.075 . . . . 74.15 109.587 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 50.99 64.99 1.61 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.806 1.242 . . . . 74.04 110.425 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -166.58 161.73 16.14 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.757 -1.11 . . . . 51.55 110.212 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.26 151.36 36.81 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.452 0.701 . . . . 74.54 111.017 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.97 139.44 32.73 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 123.582 0.551 . . . . 54.12 113.202 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -97.76 107.57 20.09 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.785 -0.82 . . . . 74.41 108.785 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -144.78 37.79 1.33 Allowed Glycine 0 C--N 1.342 0.899 0 N-CA-C 111.471 -0.651 . . . . 75.2 111.471 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 28.0 m -58.17 106.21 0.35 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.428 1.091 . . . . 74.25 110.936 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.7 173.71 11.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.928 0.491 . . . . 72.34 110.424 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -132.14 85.12 2.21 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.732 0.777 . . . . 43.35 109.158 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -68.45 -46.43 69.86 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.434 -0.803 . . . . 71.13 109.754 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 50.5 80.33 0.08 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.024 1.33 . . . . 61.23 111.809 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -108.31 109.44 20.77 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.46 -1.246 . . . . 44.32 108.769 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.735 0 C-N-CA 123.537 0.735 . . . . 63.14 109.141 -177.968 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.921 0.391 . . . . 73.21 110.676 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 39.8 m -146.33 150.24 35.35 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.881 0.873 . . . . 74.14 109.365 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -78.6 88.47 4.52 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.684 0.793 . . . . 72.42 109.102 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -96.28 108.11 20.56 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.735 0.814 . . . . 72.25 111.272 -171.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 9.6 t30 57.33 92.52 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.42 1.488 . . . . 75.33 112.348 174.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -64.41 -36.13 83.16 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.068 0.947 . . . . 43.44 111.991 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 25.1 m -84.69 79.9 9.44 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.602 0.715 . . . . 75.32 110.795 -170.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -118.93 -31.79 4.66 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.289 1.035 . . . . 63.21 109.537 171.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.465 ' HG3' HD12 ' C' ' 89' ' ' ILE . 24.8 ttt 64.05 112.61 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.269 1.428 . . . . 74.4 111.948 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 36.4 m -88.07 91.15 8.66 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 108.613 -0.884 . . . . 72.42 108.613 174.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.406 ' HD2' ' HG3' ' A' ' 130' ' ' PRO . 60.2 t80 -115.57 126.48 54.28 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.801 -0.814 . . . . 75.53 108.801 176.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -140.68 125.45 18.11 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.875 -0.787 . . . . 71.14 108.875 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.418 ' HA ' ' HD2' ' C' ' 84' ' ' PHE . 56.1 mt -66.44 123.94 20.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.81 -0.811 . . . . 73.45 108.81 171.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -89.63 -48.74 7.09 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.157 -0.683 . . . . 71.32 109.157 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -174.33 125.89 0.33 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 115.565 -0.743 . . . . 74.13 110.404 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -109.46 143.22 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 107.919 -1.141 . . . . 63.12 107.919 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.432 ' HE1' HG12 ' C' ' 83' ' ' ILE . 25.1 p90 -176.25 169.58 2.73 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.406 0.622 . . . . 70.03 111.007 -173.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -93.02 114.59 27.18 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.318 -0.856 . . . . 61.14 109.533 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.633 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -68.34 -34.09 75.46 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.814 -0.81 . . . . 72.33 108.814 175.089 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -154.19 146.45 23.83 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.945 -1.479 . . . . 75.12 109.618 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.7 mt -140.61 144.37 27.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 125.607 1.563 . . . . 73.14 106.846 175.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -154.04 149.32 27.05 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.51 0.672 . . . . 65.23 110.116 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -153.68 125.16 7.57 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.159 -1.423 . . . . 41.52 107.159 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -132.23 109.96 10.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.062 0.545 . . . . 62.04 109.724 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.59 79.58 73.43 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 106.716 -1.587 . . . . 53.13 106.716 168.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.74 -25.34 28.8 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.767 2.311 . . . . 71.51 112.001 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -106.1 17.57 23.34 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.214 1.406 . . . . 72.42 110.932 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.404 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -42.89 -57.57 4.83 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 114.864 1.431 . . . . 15.15 114.864 -167.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.17 -36.63 68.22 Favored 'Trans proline' 0 C--N 1.391 2.774 0 CA-C-N 122.24 1.836 . . . . 74.34 112.529 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -69.09 -39.09 79.22 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.446 0.698 . . . . 74.12 111.637 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.813 HG21 ' HA ' ' C' ' 73' ' ' ALA . 2.9 p -79.39 -20.79 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 N-CA-C 112.412 0.523 . . . . 63.42 112.412 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -67.91 -31.71 71.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.545 0.572 . . . . 74.33 112.545 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -88.35 15.25 8.01 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.874 0.47 . . . . 73.54 111.057 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.43 161.34 13.83 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.954 0.902 . . . . 71.33 110.544 -176.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.92 126.85 30.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.624 0.77 . . . . 63.1 109.798 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.4 ' HZ2' HD22 ' G' ' 470' ' ' LEU . 59.9 t90 -76.0 107.14 8.0 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.654 0.782 . . . . 74.32 109.847 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.56 73.16 2.87 Favored Pre-proline 0 CA--C 1.555 1.138 0 N-CA-C 107.328 -1.36 . . . . 54.04 107.328 173.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.552 ' HG2' HD13 ' G' ' 470' ' ' LEU . 2.7 Cg_endo -81.59 134.18 8.59 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.092 2.528 . . . . 64.24 113.949 -174.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -87.38 95.13 9.9 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 106.345 -1.724 . . . . 74.24 106.345 168.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 m -75.88 96.23 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 122.275 1.036 . . . . 73.21 109.815 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.428 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 40.2 ttmt -100.8 103.09 14.3 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.582 -1.19 . . . . 64.01 108.082 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.65 HD21 HD21 ' G' ' 468' ' ' LEU . 5.8 mp -88.32 132.54 34.37 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 107.783 -1.191 . . . . 63.42 107.783 174.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.4 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.1 t70 -117.63 104.72 11.3 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.469 -1.308 . . . . 73.31 107.469 173.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 84.3 mt -95.58 143.23 27.05 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.305 -0.861 . . . . 60.42 109.236 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.2 t70 -148.33 144.27 27.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.993 0.917 . . . . 65.24 108.954 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 t -138.42 124.75 20.46 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.648 -0.871 . . . . 64.42 108.648 172.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.07 145.3 45.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.782 -0.821 . . . . 70.42 108.782 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -130.49 156.0 45.52 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.989 0.516 . . . . 63.31 111.115 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 29.5 t -144.8 139.84 28.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.369 1.067 . . . . 75.03 109.587 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.405 ' HB2' ' HB2' ' G' ' 454' ' ' LEU . 37.5 tp60 -88.86 118.32 28.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.963 -1.125 . . . . 71.34 107.963 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.625 HD11 HD12 ' C' ' 83' ' ' ILE . 62.2 mt -90.0 -48.84 6.95 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.802 0.811 . . . . 72.03 109.362 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.18 -177.85 5.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 113.996 -1.456 . . . . 50.01 108.501 170.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.41 110.73 1.16 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.442 1.089 . . . . 72.14 110.703 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 22.6 m-20 68.3 9.28 7.14 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 125.386 1.474 . . . . 71.04 113.367 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.7 t -93.1 107.53 19.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 107.198 -1.408 . . . . 72.0 107.198 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.45 ' CD1' HG11 ' G' ' 452' ' ' VAL . 2.5 t80 -102.08 122.37 43.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.149 -1.387 . . . . 74.15 108.088 -164.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -105.01 122.57 46.13 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.944 -1.132 . . . . 75.44 107.944 173.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -114.99 141.06 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 108.515 -0.92 . . . . 73.13 108.515 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.417 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 87.2 t -128.99 139.75 51.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.811 -0.811 . . . . 63.53 108.811 174.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.81 105.95 11.21 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.524 -1.287 . . . . 73.42 107.524 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.615 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 23.3 ttm-85 -93.58 107.7 19.52 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.603 -0.888 . . . . 72.31 108.603 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.448 ' HB ' HD11 ' C' ' 114' ' ' ILE . 24.1 t -107.11 120.42 58.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.438 -0.949 . . . . 74.34 108.438 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 43.6 m -117.68 131.53 56.62 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.23 -0.656 . . . . 45.4 109.23 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.405 HG23 HD13 ' C' ' 114' ' ' ILE . 60.2 t -108.41 125.28 65.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.972 -0.751 . . . . 54.03 108.972 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 6.6 m -118.38 123.93 46.47 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.515 -0.92 . . . . 72.12 108.515 173.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.92 99.65 7.23 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.493 -1.299 . . . . 62.13 107.493 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.9 m -108.18 120.6 42.83 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 109.7 -0.482 . . . . 72.5 109.7 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 8.7 mt -84.92 49.29 1.7 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.182 1.393 . . . . 75.43 109.589 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.79 -98.85 1.81 Allowed Glycine 0 C--N 1.35 1.317 0 N-CA-C 110.557 -1.017 . . . . 50.22 110.557 -174.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.39 -30.28 12.29 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.319 1.048 . . . . 61.23 109.97 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -79.78 120.07 23.55 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 124.348 1.059 . . . . 73.5 110.581 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 86.8 m -85.29 127.12 34.21 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 119.057 0.844 . . . . 72.33 109.764 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.813 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.85 -56.81 5.06 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.653 1.181 . . . . 70.53 110.101 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . 0.437 ' HZ ' HD22 ' C' ' 126' ' ' LEU . 33.0 p90 -157.4 164.52 37.43 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.287 -0.869 . . . . 75.04 112.284 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -128.25 105.29 8.25 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.636 -1.616 . . . . 73.33 106.636 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.9 t -109.41 148.69 30.7 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.974 -0.75 . . . . 74.24 108.974 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -156.42 136.81 13.04 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.414 -0.587 . . . . 71.22 109.414 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.0 t -133.93 135.02 55.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.89 -1.152 . . . . 70.24 107.89 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -111.5 89.42 3.05 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.952 -1.129 . . . . 65.02 107.952 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -78.99 100.27 7.23 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.061 -0.972 . . . . 74.5 110.04 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.633 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -89.24 169.07 35.79 Favored Glycine 0 C--O 1.242 0.636 0 CA-C-N 115.728 -0.669 . . . . 71.11 112.799 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.448 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -168.06 118.51 0.79 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.384 -0.686 . . . . 41.22 111.384 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.625 HD12 HD11 ' C' ' 51' ' ' LEU . 12.9 mm -84.01 133.44 29.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 108.821 -0.807 . . . . 61.43 108.821 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.418 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 45.3 m-85 -141.09 122.68 15.13 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.639 0.775 . . . . 72.23 109.337 -177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 53.0 p -79.84 127.31 32.07 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.09 -1.078 . . . . 62.12 108.09 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.54 HD11 HD11 ' C' ' 89' ' ' ILE . 9.6 tt -141.91 143.09 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-O 121.036 0.446 . . . . 54.02 111.714 -170.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.78 169.18 24.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.344 1.058 . . . . 64.44 109.649 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.07 -46.34 1.19 Allowed Glycine 0 N--CA 1.471 1.012 0 CA-C-N 116.458 -0.337 . . . . 74.24 113.878 171.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.54 HD11 HD11 ' C' ' 86' ' ' ILE . 0.2 OUTLIER -113.39 146.77 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 122.935 0.494 . . . . 75.25 110.236 -176.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -146.83 -177.89 5.9 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.786 0.434 . . . . 73.11 111.008 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.25 -122.6 11.29 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 115.753 -0.658 . . . . 61.42 113.078 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 79.9 p -70.53 -23.79 62.7 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.589 0.756 . . . . 62.34 110.929 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.415 ' HG3' ' HE1' ' A' ' 152' ' ' HIS . 19.7 mt-30 -73.68 -32.16 63.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.661 0.785 . . . . 72.01 110.746 176.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 55.5 ttp -66.78 -40.64 88.24 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.086 -0.709 . . . . 71.12 109.086 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.27 -36.3 83.68 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.563 -0.744 . . . . 73.05 111.383 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -76.86 -21.02 55.61 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.576 0.35 . . . . 74.14 111.607 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.9 t -61.28 -54.5 43.25 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.63 0.372 . . . . 35.15 110.097 173.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.511 HD13 ' HG3' ' G' ' 457' ' ' GLN . 4.5 pp -75.66 -22.14 57.01 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.102 0.561 . . . . 75.12 111.147 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.55 -26.41 65.5 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 114.889 0.716 . . . . 34.43 114.889 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.56 -60.21 0.08 Allowed 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 112.494 0.553 . . . . 72.01 112.494 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -52.71 -47.76 67.08 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 124.154 0.909 . . . . 73.12 112.604 -167.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.9 m -78.4 -48.44 1.89 Allowed Pre-proline 0 CA--C 1.561 1.379 0 CA-C-O 117.78 -1.105 . . . . 63.51 112.422 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.57 -32.51 44.4 Favored 'Trans proline' 0 C--N 1.403 3.402 0 C-N-CA 122.197 1.931 . . . . 62.03 113.636 170.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -66.71 -38.04 85.91 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.278 1.031 . . . . 64.43 111.417 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.414 HD12 ' NH1' ' A' ' 111' ' ' ARG . 36.7 mm -64.5 -45.65 95.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 109.488 -0.56 . . . . 65.02 109.488 173.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.448 HD21 ' HA3' ' C' ' 82' ' ' GLY . 74.5 mt -78.48 -18.6 54.59 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.03 -0.987 . . . . 64.41 112.493 -172.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.404 ' HE1' HD13 ' C' ' 128' ' ' LEU . 79.0 t80 -59.0 -50.99 85.04 Favored Pre-proline 0 CA--C 1.56 1.358 0 N-CA-C 114.233 1.197 . . . . 71.54 114.233 -171.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.36 -32.48 72.13 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.789 1.659 . . . . 74.14 112.518 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -67.65 -45.15 76.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.15 0.58 . . . . 70.53 110.195 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.54 -45.2 89.39 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.918 0.887 . . . . 45.34 110.519 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -57.7 -54.74 43.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.634 1.174 . . . . 72.14 111.117 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -67.18 -33.05 74.57 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.299 0.64 . . . . 71.44 110.877 -173.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.2 t -69.5 -32.21 70.93 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.888 0.475 . . . . 53.14 110.932 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.448 HD11 ' HB ' ' C' ' 62' ' ' VAL . 74.7 mt -71.31 -53.32 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.59 -0.522 . . . . 51.42 109.59 173.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.407 HG21 ' OG ' ' B' ' 119' ' ' SER . 14.5 m -60.73 -29.68 69.52 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.74 0.816 . . . . 70.25 111.326 -173.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 31.7 t -61.78 -54.54 40.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.235 -0.893 . . . . 72.31 109.155 171.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.492 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.73 -37.66 79.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.794 1.238 . . . . 72.01 112.867 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.485 HG11 HD13 ' C' ' 126' ' ' LEU . 85.6 t -64.49 -46.7 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.59 0.756 . . . . 73.32 109.8 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.48 ' OG ' HG21 ' B' ' 115' ' ' THR . 34.7 t -66.28 -32.71 74.29 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.985 -1.007 . . . . 50.1 111.473 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.421 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 74.6 mtt-85 -66.49 -41.16 89.33 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.408 0.683 . . . . 71.33 109.481 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.23 7.81 62.85 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.706 -0.679 . . . . 75.22 112.989 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 77.4 p 57.96 33.32 23.06 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.906 1.682 . . . . 74.05 113.661 171.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -91.08 163.13 30.52 Favored Pre-proline 0 CA--C 1.565 1.526 0 C-N-CA 124.231 1.012 . . . . 61.22 108.86 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.11 172.75 3.75 Favored 'Trans proline' 0 C--N 1.39 2.729 0 C-N-CA 122.997 2.465 . . . . 60.1 113.82 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -62.48 112.74 2.59 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.945 0.898 . . . . 75.25 112.669 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.503 HD11 HD11 ' G' ' 470' ' ' LEU . 8.9 mp -110.98 112.0 23.51 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.431 -0.952 . . . . 64.2 108.431 169.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -124.59 131.29 53.48 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.498 0.719 . . . . 53.04 109.223 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.404 HD13 ' HE1' ' C' ' 107' ' ' PHE . 1.4 tt -79.33 131.2 36.06 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.333 -0.617 . . . . 65.31 109.333 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.17 150.75 91.82 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.235 1.014 . . . . 51.15 111.433 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.07 103.29 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.382 2.055 . . . . 73.11 112.533 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 90.6 t -97.22 111.23 26.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.663 -0.866 . . . . 75.42 108.663 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -82.96 83.81 7.67 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 108.042 -1.096 . . . . 74.44 108.042 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -59.36 -22.47 61.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.11 0.564 . . . . 73.41 111.87 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.444 ' O ' ' HG3' ' C' ' 138' ' ' MET . 33.7 m-20 -63.19 -56.2 18.72 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.692 0.797 . . . . 64.44 110.848 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.11 -38.58 79.93 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 124.725 1.266 . . . . 71.43 110.641 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 74.8 mt -74.19 -29.5 61.78 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.493 -1.23 . . . . 63.43 111.675 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -75.45 -28.69 59.41 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 110.142 -0.318 . . . . 75.22 110.142 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 60.7 mtt -63.95 -34.86 78.92 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.252 0.621 . . . . 50.5 111.876 -176.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -71.7 -37.11 70.71 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.204 0.315 . . . . 72.43 110.383 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -67.2 -81.7 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.552 1.141 . . . . 71.43 110.064 176.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 52.4 tp -127.06 135.42 50.76 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.575 0.75 . . . . 62.14 110.26 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.678 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 45.0 tt0 65.26 93.94 0.06 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.181 1.393 . . . . 73.25 112.407 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -69.34 88.14 0.45 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.281 -1.007 . . . . 74.34 108.281 166.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -77.37 136.76 38.46 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.455 -1.248 . . . . 74.52 110.443 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.555 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . . . -84.23 159.8 20.91 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.085 0.554 . . . . 71.35 110.447 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.67 -151.73 5.86 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 114.27 0.468 . . . . 74.02 114.27 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 134' ' ' ASP . 3.5 mp0 -81.81 152.23 27.03 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.213 0.605 . . . . 61.22 109.544 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . 0.429 ' HA3' ' H ' ' A' ' 147' ' ' GLU . . . -84.54 62.86 4.5 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.744 -0.542 . . . . 70.0 111.744 177.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 58.3 p -78.4 112.92 15.92 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.236 1.015 . . . . 73.34 111.176 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.45 ' O ' HD21 ' A' ' 141' ' ' LEU . 41.1 tt0 -89.57 159.03 17.39 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.291 0.636 . . . . 62.0 109.709 176.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -92.32 107.13 18.98 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.513 -1.291 . . . . 72.44 107.513 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -171.16 133.37 0.86 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.297 0.639 . . . . 53.03 110.867 171.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -157.09 131.89 8.8 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.109 -0.701 . . . . 74.12 109.109 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -138.59 133.35 32.39 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.699 0.8 . . . . 73.32 109.042 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 N-CA-C 108.894 -0.78 . . . . 72.03 108.894 -176.719 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.748 -0.464 . . . . 71.23 109.748 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 40.4 m -84.39 69.02 10.45 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.878 0.847 . . . . 71.42 109.661 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -99.6 142.89 30.49 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.37 -1.286 . . . . 71.45 110.874 -172.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 53.04 71.19 0.51 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.233 1.413 . . . . 75.34 111.819 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -69.93 109.01 4.26 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.226 -0.897 . . . . 75.52 109.47 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -111.93 79.12 1.18 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.48 0.712 . . . . 63.42 109.637 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.8 t -155.89 66.4 0.6 Allowed 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.425 -1.324 . . . . 74.44 107.425 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 67.03 147.42 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.56 1.544 . . . . 73.04 110.842 -168.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.3 ttp -34.43 125.45 0.5 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.864 1.266 . . . . 65.23 112.654 171.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 89.3 m -114.81 139.73 49.5 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.034 0.534 . . . . 62.13 110.022 176.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -164.01 91.34 0.63 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.785 -1.561 . . . . 74.05 106.785 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -112.84 114.06 26.42 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.868 -1.16 . . . . 71.01 107.868 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.58 105.57 4.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.678 -0.86 . . . . 64.44 108.678 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -77.38 -37.85 51.23 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 116.172 -0.467 . . . . 63.11 111.892 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -166.2 144.1 5.48 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 111.786 0.291 . . . . 71.44 111.786 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.449 HD13 ' HG3' ' B' ' 130' ' ' PRO . 1.7 mp -121.86 134.12 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 106.016 -1.846 . . . . 62.14 106.016 167.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -161.44 163.18 30.64 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.9 0.857 . . . . 74.13 111.489 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -95.01 119.72 34.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.267 -1.333 . . . . 55.45 108.924 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -88.96 -22.34 23.1 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.568 -0.53 . . . . 70.11 109.568 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.609 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.2 t70 -155.67 139.4 16.11 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 114.933 -1.031 . . . . 64.22 109.8 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.492 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.0 mt -143.62 136.78 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.938 1.295 . . . . 74.42 107.553 174.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.6 t -146.76 109.25 4.53 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.807 -0.812 . . . . 63.2 108.807 174.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.601 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.8 t80 -114.22 128.28 56.29 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.991 -1.114 . . . . 73.41 107.991 168.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.14 127.14 40.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.516 0.727 . . . . 75.11 109.324 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.31 87.42 2.05 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 106.559 -1.645 . . . . 62.22 106.559 165.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.55 -41.72 18.82 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.276 1.984 . . . . 72.42 112.505 -166.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -111.09 15.2 21.75 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.125 0.97 . . . . 75.24 109.979 -174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.488 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -18.61 -70.26 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 117.227 2.306 . . . . 74.35 117.227 -168.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 64.6 Cg_endo -77.14 -23.75 10.15 Favored 'Trans proline' 0 C--N 1.382 2.329 0 CA-C-N 123.953 2.447 . . . . 74.13 113.772 -173.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -72.88 -36.54 67.37 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.631 0.772 . . . . 74.44 109.218 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' D' ' 73' ' ' ALA . 6.8 p -83.26 -19.13 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.229 0 CA-C-N 115.731 -0.668 . . . . 62.13 110.694 -176.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.6 m-85 -70.01 -19.02 63.34 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.835 0.454 . . . . 75.42 111.928 175.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -55.3 -34.09 63.84 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.817 0.698 . . . . 64.14 110.073 172.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.425 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 42.1 mtmt -91.88 78.02 5.42 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.583 -1.19 . . . . 75.33 109.095 168.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.01 82.0 3.53 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.836 0.827 . . . . 73.14 109.493 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -147.84 157.96 43.79 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.532 -1.213 . . . . 74.4 108.79 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -63.8 106.89 1.04 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.133 0.973 . . . . 74.31 108.979 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.506 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 23.1 Cg_exo -65.82 146.0 82.16 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.754 2.302 . . . . 62.45 112.196 -172.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -63.27 110.97 2.06 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.164 -1.05 . . . . 74.02 108.164 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.14 146.07 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-O 121.427 0.632 . . . . 74.15 111.225 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' H' ' 465' ' ' LYS . 8.0 tmtt? -129.59 118.94 22.8 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.401 -2.074 . . . . 70.42 105.401 172.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -97.01 145.37 26.01 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.633 -0.877 . . . . 75.43 108.633 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.558 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.8 m-20 -129.29 143.34 50.81 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.024 -0.732 . . . . 74.25 109.024 172.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -119.38 136.42 54.29 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.232 -1.025 . . . . 71.12 108.232 173.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 37.9 t70 -138.37 131.5 30.05 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.274 -1.38 . . . . 70.14 107.274 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -104.09 148.12 26.63 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.221 0.534 . . . . 62.44 109.57 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.58 165.41 33.4 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.897 -1.047 . . . . 53.31 108.536 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 31.1 p -164.77 155.97 15.01 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.179 0.592 . . . . 62.41 110.151 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 32.0 t -151.62 123.95 8.29 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.317 0.647 . . . . 71.35 110.626 -171.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -73.4 116.65 14.21 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.179 -1.045 . . . . 72.02 108.179 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' D' ' 57' ' ' GLU . 60.1 mt -91.79 -41.11 10.84 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.302 0.572 . . . . 75.51 110.11 -177.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.17 -175.09 5.25 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.449 -1.251 . . . . 41.32 109.261 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -66.27 124.91 23.97 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 123.731 0.644 . . . . 74.5 109.434 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 63.77 0.59 0.93 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.84 1.256 . . . . 50.11 113.887 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.9 t -108.29 114.11 45.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 107.728 -1.212 . . . . 61.44 107.728 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 129.33 37.12 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.195 -1.039 . . . . 75.14 108.195 -170.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.48 ' HB2' HD11 ' D' ' 51' ' ' LEU . 30.2 tt0 -99.82 147.47 25.46 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.325 1.05 . . . . 53.24 109.4 177.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.16 127.47 73.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.378 -1.342 . . . . 72.41 107.378 170.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.433 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 61.8 t -109.58 109.95 30.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.994 -0.743 . . . . 73.22 108.994 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.85 119.35 30.98 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.789 -0.819 . . . . 74.21 108.789 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.539 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 47.7 ttm-85 -98.74 109.98 22.66 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.88 -1.156 . . . . 73.55 107.88 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.51 HG21 ' HB1' ' D' ' 110' ' ' ALA . 38.8 t -115.06 118.77 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.787 -0.819 . . . . 72.51 108.787 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 12.0 m -115.46 144.31 44.02 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.487 1.115 . . . . 74.53 109.381 -171.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.483 HG21 HD21 ' D' ' 126' ' ' LEU . 58.5 t -139.01 103.82 2.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.18 0.992 . . . . 72.04 108.919 172.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 99.9 m -97.47 120.19 37.38 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.25 -1.019 . . . . 71.51 108.25 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -122.37 154.93 37.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.659 0.784 . . . . 72.4 110.925 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 54.7 m -150.6 139.69 21.1 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.562 0.539 . . . . 70.12 112.127 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.433 HD12 HG22 ' D' ' 31' ' ' VAL . 11.7 mt -110.7 121.05 44.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.054 1.342 . . . . 64.12 108.977 171.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.0 -113.28 4.27 Favored Glycine 0 C--N 1.341 0.829 0 O-C-N 123.338 0.399 . . . . 72.11 112.72 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.12 5.86 18.81 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.103 0.961 . . . . 74.11 110.898 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.425 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 15.8 pt-20 -132.13 158.75 40.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.86 0.464 . . . . 63.23 110.613 -174.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 65.4 m -71.39 138.48 49.19 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 116.061 -0.518 . . . . 41.32 110.603 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.624 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.19 -68.67 0.78 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.891 0.876 . . . . 43.24 109.624 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -146.36 145.96 30.49 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-O 121.551 0.691 . . . . 74.21 110.25 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -120.24 141.03 50.31 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.658 1.583 . . . . 74.22 106.956 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.564 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.4 t -153.79 139.0 17.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.56 -0.534 . . . . 72.43 109.56 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -156.9 132.16 9.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.41 -0.589 . . . . 75.33 109.41 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.06 120.15 46.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.756 0.823 . . . . 75.21 109.277 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.609 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.3 mt-30 -89.43 86.82 6.87 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.647 -0.872 . . . . 72.31 108.647 169.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -80.03 94.4 5.93 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.695 -1.139 . . . . 63.12 108.917 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.09 143.34 18.07 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.926 -0.47 . . . . 34.4 111.926 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.558 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -140.64 131.5 5.01 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.714 -0.554 . . . . 64.13 111.714 -177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -94.67 125.13 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.719 0.808 . . . . 73.23 109.447 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -132.18 125.11 30.4 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.052 0.941 . . . . 71.34 109.743 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.6 m -87.76 104.15 16.29 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 109.524 -0.547 . . . . 72.54 109.524 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.438 HD12 ' SD ' ' D' ' 94' ' ' MET . 39.9 pt -107.08 141.19 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.902 0.881 . . . . 63.43 110.807 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -169.14 165.96 10.95 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.976 0.91 . . . . 75.33 110.889 173.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.72 -19.62 19.39 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.197 -0.456 . . . . 71.13 112.925 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.489 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -118.97 149.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.084 0.953 . . . . 71.24 108.691 177.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -154.32 160.06 41.54 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.336 0.495 . . . . 73.42 112.336 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.36 -121.31 24.98 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 114.791 -1.095 . . . . 74.12 113.51 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.7 p -71.12 -31.98 68.44 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.892 0.877 . . . . 72.33 111.484 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -69.59 -40.34 76.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.761 0.425 . . . . 70.33 110.109 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.438 ' SD ' HD12 ' D' ' 86' ' ' ILE . 7.1 tmm? -72.45 -37.65 68.48 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.382 -0.826 . . . . 64.11 109.777 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.74 71.27 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.031 0.532 . . . . 70.34 111.507 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.408 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.7 t-160 -69.49 -39.39 77.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.129 0.972 . . . . 63.23 110.16 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -68.85 -50.31 50.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.808 -0.633 . . . . 74.22 110.435 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 tp -78.68 -25.21 44.78 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.554 0.742 . . . . 73.12 111.645 -168.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.12 11.23 37.22 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-O 119.607 -0.552 . . . . 42.43 113.543 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -149.36 -58.25 0.2 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.184 0.492 . . . . 74.21 111.227 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -70.7 -46.95 62.17 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.272 0.629 . . . . 64.53 111.689 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.401 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 55.1 m -67.37 -44.21 45.75 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.503 -0.76 . . . . 71.1 111.693 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 76.9 Cg_exo -56.52 -32.82 90.96 Favored 'Trans proline' 0 C--N 1.394 2.922 0 C-N-CA 122.479 2.119 . . . . 63.13 113.423 165.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -71.34 -25.32 62.34 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.002 0.521 . . . . 72.32 111.216 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 64.0 mt -77.12 -34.47 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.894 0.877 . . . . 75.23 110.138 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.558 HD21 ' HA3' ' D' ' 82' ' ' GLY . 95.9 mt -76.77 -22.71 53.37 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.561 -0.745 . . . . 73.51 111.724 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -67.41 -42.05 35.74 Favored Pre-proline 0 CA--C 1.565 1.557 0 N-CA-C 113.941 1.089 . . . . 74.11 113.941 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -60.41 -40.49 57.32 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.097 1.865 . . . . 60.21 112.71 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -73.06 -33.71 65.83 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.586 0.754 . . . . 72.33 111.511 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.51 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -63.79 -53.12 55.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.641 0.776 . . . . 75.2 109.523 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.52 ' NH2' HG23 ' B' ' 105' ' ' ILE . 28.5 ttp180 -54.65 -48.57 72.15 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 124.895 1.372 . . . . 75.01 110.588 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -60.33 -46.3 90.4 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.155 0.909 . . . . 72.31 111.651 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.02 -42.08 93.59 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.788 0.68 . . . . 73.1 110.719 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.564 HG23 ' SG ' ' D' ' 76' ' ' CYS . 72.2 mt -64.17 -50.66 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 124.174 0.921 . . . . 72.23 110.988 174.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 41.5 m -57.32 -42.42 81.81 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.808 1.243 . . . . 74.34 110.831 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -65.31 -41.61 93.87 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.264 -1.334 . . . . 74.25 110.446 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.41 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 73.3 mtm -71.6 -31.06 66.51 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.198 0.444 . . . . 52.33 112.198 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.73 -42.06 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.328 0.651 . . . . 74.42 109.842 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 84.6 p -76.22 -27.08 56.67 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.876 0.47 . . . . 54.02 111.531 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -75.83 -34.2 60.1 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.002 0.521 . . . . 72.15 110.057 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.72 89.41 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.981 -0.554 . . . . 53.02 111.962 171.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 38.5 p 64.01 19.57 11.81 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.153 2.181 . . . . 62.14 114.077 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -78.4 149.39 75.4 Favored Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 108.549 -0.908 . . . . 71.13 108.549 170.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.34 137.35 71.4 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.817 2.345 . . . . 71.55 112.113 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -55.55 146.21 21.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.793 1.237 . . . . 71.2 113.247 -164.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.483 HD21 HG21 ' D' ' 64' ' ' VAL . 38.3 tp -116.48 94.21 4.53 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.256 -0.884 . . . . 71.13 109.328 -176.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 88.0 m-20 -104.82 91.48 3.85 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.563 -0.903 . . . . 74.52 108.563 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 23.6 tp -73.66 133.54 43.44 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.409 -0.814 . . . . 75.11 110.314 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.19 146.02 99.0 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.582 0.753 . . . . 55.34 111.167 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.4 124.33 3.63 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.329 2.019 . . . . 74.44 111.048 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 99.3 t -107.27 133.48 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.032 -0.531 . . . . 73.41 109.594 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -79.35 88.61 4.97 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.007 -0.738 . . . . 72.23 109.007 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -65.21 -24.87 67.48 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.759 -1.109 . . . . 72.24 111.469 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.95 -52.67 63.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.884 0.873 . . . . 71.53 110.593 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.02 -37.59 66.87 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.348 -0.842 . . . . 60.23 111.721 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.25 -31.33 72.07 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 115.616 -0.72 . . . . 75.42 110.162 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.404 ' O ' HD13 ' D' ' 141' ' ' LEU . 84.4 t80 -63.68 -39.88 95.41 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.811 0.845 . . . . 63.44 110.653 176.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 30.8 mtt -63.44 -46.16 87.57 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.222 0.609 . . . . 72.23 109.708 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.427 ' HA ' HE21 ' D' ' 142' ' ' GLN . 79.5 m-20 -74.15 -20.82 60.1 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.167 -0.924 . . . . 60.1 111.674 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -73.27 -39.98 64.96 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.915 0.886 . . . . 74.42 110.247 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.404 HD13 ' O ' ' D' ' 137' ' ' PHE . 6.6 mp -65.41 -38.01 88.66 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.323 0.649 . . . . 74.42 111.794 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.427 HE21 ' HA ' ' D' ' 139' ' ' ASN . 23.2 pt20 -86.73 32.96 0.65 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.579 0.585 . . . . 75.31 112.579 -174.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -119.15 91.39 3.54 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.319 0.648 . . . . 75.52 110.33 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -147.87 85.62 1.56 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.095 0.958 . . . . 71.32 108.513 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.57 141.57 18.24 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.565 -0.743 . . . . 54.45 110.195 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -116.14 8.03 18.64 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.735 -0.48 . . . . 72.3 113.669 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -84.5 149.92 25.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.552 0.741 . . . . 64.03 110.848 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.82 90.04 2.15 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 116.559 -0.291 . . . . 61.05 112.384 176.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 26.4 m -68.35 99.04 0.89 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.618 0.767 . . . . 74.21 110.642 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -80.96 97.53 7.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.411 0.684 . . . . 71.33 109.515 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -88.16 -68.02 0.79 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.021 0.928 . . . . 62.24 110.931 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 60.6 99.84 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.311 1.044 . . . . 72.52 110.585 -173.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -129.22 101.35 5.97 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.913 0.885 . . . . 74.42 109.014 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -79.36 155.41 28.44 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.815 -0.439 . . . . 74.14 109.815 172.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 N-CA-C 108.37 -0.974 . . . . 72.2 108.37 -178.846 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 110.15 -0.315 . . . . 54.35 110.15 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . 0.722 HG12 ' HA ' ' A' ' 54' ' ' ASP . 8.9 p -168.0 29.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.391 0 CA-C-O 122.785 1.279 . . . . 54.51 108.52 -174.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . 0.43 HG12 ' CD2' ' A' ' 56' ' ' TYR . 28.9 m -132.53 -171.73 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 115.056 -0.974 . . . . 64.31 111.736 -162.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 99.7 21.59 14.06 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 114.346 0.498 . . . . 43.35 114.346 170.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 6.2 mp -99.39 -175.87 3.13 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 117.477 0.639 . . . . 74.43 111.074 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 12.9 t -141.4 178.79 7.18 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.967 0.907 . . . . 71.14 109.367 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -81.81 165.53 20.8 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.937 0.895 . . . . 62.11 109.817 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' E' ' 460' ' ' LEU . 17.1 pt20 -154.04 131.87 11.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.068 0.547 . . . . 70.45 110.008 174.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 53.0 p -69.66 94.83 0.82 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.784 0.834 . . . . 62.01 109.454 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 7.5 t70 73.47 146.69 0.08 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.381 1.472 . . . . 64.21 111.587 -172.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . 0.438 ' HA ' ' NE2' ' E' ' 457' ' ' GLN . 95.2 mt -74.69 -71.87 0.32 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.599 -0.728 . . . . 71.34 109.363 170.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -175.37 18.86 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.884 0.874 . . . . 71.35 111.504 -171.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -162.12 130.99 4.28 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 111.667 0.247 . . . . 64.33 111.667 -168.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 4.7 p -95.46 -60.19 1.72 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.894 0.878 . . . . 53.44 110.782 175.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . 0.413 ' HB3' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER 82.11 125.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 126.509 1.924 . . . . 75.41 109.874 -170.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.44 98.67 7.42 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.579 -0.897 . . . . 73.22 108.579 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -81.46 152.5 27.34 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.043 0.537 . . . . 43.23 110.852 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -158.82 93.96 1.2 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.43 -0.582 . . . . 54.14 109.43 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . 0.571 ' HB2' ' HG ' ' E' ' 470' ' ' LEU . 77.1 mt -82.95 -179.98 7.6 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.543 -0.753 . . . . 72.14 109.65 175.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -82.27 55.75 4.96 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.752 -0.539 . . . . 63.34 111.752 173.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' E' ' 468' ' ' LEU . 62.7 mt -85.11 86.86 7.35 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 123.443 0.697 . . . . 72.01 109.575 -175.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt . . . . . 0 C--O 1.247 0.939 0 CA-C-N 114.721 -1.127 . . . . 74.23 108.52 -178.294 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . 0.657 ' N ' ' HH ' ' B' ' 56' ' ' TYR . 52.4 m-20 . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 109.593 -0.521 . . . . 71.52 109.593 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . 0.409 HG23 HG13 ' F' ' 452' ' ' VAL . 30.5 m -68.29 -30.27 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 120.656 0.265 . . . . 55.3 110.654 171.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . 0.409 HG13 HG23 ' F' ' 451' ' ' VAL . 23.1 m -139.18 170.42 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.647 1.179 . . . . 75.4 109.563 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -174.54 118.16 0.66 Allowed Glycine 0 C--N 1.344 1.003 0 N-CA-C 111.358 -0.697 . . . . 45.42 111.358 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . 0.426 HD13 HD12 ' B' ' 98' ' ' LEU . 7.6 mp -86.67 167.38 14.55 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.532 0.733 . . . . 65.14 110.999 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 6.2 m -70.86 -15.99 62.67 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.856 0.863 . . . . 73.32 110.512 173.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 5.9 t70 74.11 68.82 0.1 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 125.707 1.603 . . . . 75.13 108.831 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . 0.512 ' NE2' ' HA2' ' B' ' 99' ' ' GLY . 4.5 pm0 -58.8 93.76 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.013 -1.449 . . . . 64.53 112.001 -171.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 29.6 m -67.1 -44.09 80.85 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.593 -1.185 . . . . 73.24 109.075 171.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -87.67 115.31 25.02 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.754 -1.112 . . . . 73.04 109.637 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . 0.503 ' HG ' HD12 ' B' ' 44' ' ' LEU . 4.6 mm? -92.88 -169.73 2.25 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.672 0.789 . . . . 72.3 111.622 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -134.0 14.08 3.93 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.684 1.194 . . . . 75.32 111.579 -168.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -73.05 112.61 9.24 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 121.412 0.625 . . . . 70.43 110.731 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 20.7 p -126.21 137.92 53.59 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.268 1.027 . . . . 53.22 109.548 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 49.5 ttm -151.44 122.31 7.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.599 0.76 . . . . 75.01 109.656 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -85.22 72.53 10.73 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.455 -0.943 . . . . 64.15 108.455 171.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . 179.79 -178.4 0.4 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.828 1.251 . . . . 74.5 109.783 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -133.87 -169.44 2.31 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.227 1.011 . . . . 62.12 109.3 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . 0.47 HD13 HG21 ' B' ' 40' ' ' VAL . 8.5 tt -65.33 -35.81 82.11 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.875 0.47 . . . . 62.14 110.243 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.12 54.47 1.87 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 110.792 -0.923 . . . . 72.1 110.792 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . 0.661 HD11 HG23 ' B' ' 40' ' ' VAL . 77.5 mt -67.36 95.75 0.46 Allowed 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.893 0.877 . . . . 74.5 110.848 -178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--O 1.25 1.085 0 N-CA-C 108.242 -1.021 . . . . 74.45 108.242 175.621 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 110.207 -0.294 . . . . 75.14 110.207 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.29 -63.75 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 123.949 0.9 . . . . 62.32 111.142 -174.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . 0.45 HG11 ' CD1' ' C' ' 56' ' ' TYR . 52.4 t -94.59 131.69 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.509 0.723 . . . . 73.42 112.232 -167.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . -135.42 79.62 0.32 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 110.879 -0.888 . . . . 63.03 110.879 172.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . 0.405 ' HB2' ' HB2' ' C' ' 50' ' ' GLN . 92.5 mt -66.76 131.04 45.09 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.605 0.762 . . . . 71.11 112.207 -178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 34.0 p -100.53 -73.16 0.65 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.779 0.832 . . . . 53.02 109.182 171.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -167.19 173.44 9.04 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.557 0.743 . . . . 72.23 109.843 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . 0.511 ' HG3' HD13 ' C' ' 98' ' ' LEU . 0.0 OUTLIER -146.08 128.07 15.52 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 107.421 -1.326 . . . . 54.4 107.421 -178.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 22.7 p -135.02 11.79 3.6 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.297 0.851 . . . . 75.3 113.297 -173.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -121.1 122.62 40.45 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 118.431 0.559 . . . . 61.42 111.365 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.54 85.69 2.38 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.866 -0.79 . . . . 62.05 108.866 167.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -51.54 -33.56 32.62 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.068 1.347 . . . . 60.24 112.667 171.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -78.27 102.02 7.44 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.39 -0.596 . . . . 52.24 109.39 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 81.3 p -86.04 -6.16 59.08 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.197 0.999 . . . . 74.32 111.904 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 74.43 123.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.56 1.544 . . . . 74.14 111.07 174.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -131.77 25.06 4.69 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.361 0.664 . . . . 71.4 110.571 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -138.46 154.47 48.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.96 0.504 . . . . 63.23 110.984 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -102.31 175.36 5.54 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.214 -0.903 . . . . 72.52 110.615 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . 0.65 HD21 HD21 ' C' ' 42' ' ' LEU . 96.1 mt -97.34 24.49 6.45 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.03 0.932 . . . . 73.34 111.835 -176.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 85.67 -8.14 73.6 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.185 -0.461 . . . . 32.12 112.922 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . 0.552 HD13 ' HG2' ' C' ' 38' ' ' PRO . 42.9 mt -82.78 156.19 23.82 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 122.792 0.437 . . . . 72.22 110.537 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt . . . . . 0 C--O 1.246 0.9 0 C-N-CA 124.474 1.11 . . . . 74.35 108.976 172.802 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.326 -0.62 . . . . 62.13 109.326 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 56.7 t -128.95 -65.56 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.494 0.718 . . . . 61.42 109.14 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.39 -176.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.205 0.602 . . . . 70.22 111.553 -175.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . 0.457 ' H ' HD22 ' H' ' 454' ' ' LEU . . . 152.43 57.01 0.01 OUTLIER Glycine 0 C--N 1.35 1.324 0 N-CA-C 111.576 -0.61 . . . . 63.52 111.576 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . 0.457 HD22 ' H ' ' H' ' 453' ' ' GLY . 3.2 mm? -90.44 160.52 15.99 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.632 0.773 . . . . 72.23 111.828 -174.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 4.7 t -159.32 74.75 0.64 Allowed 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 114.304 -1.317 . . . . 71.3 108.327 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -86.26 150.88 24.06 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.014 -0.994 . . . . 61.34 111.726 -172.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -134.76 156.78 48.24 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.508 1.123 . . . . 65.55 108.948 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 77.0 p -72.83 -28.0 62.28 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.893 0.477 . . . . 73.23 110.859 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -89.73 132.49 35.16 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.331 -0.988 . . . . 61.15 108.331 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -157.76 135.15 10.34 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 122.943 0.497 . . . . 64.5 109.863 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 64.51 -80.75 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.159 1.383 . . . . 75.35 113.715 168.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -152.9 176.93 11.3 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.74 0.816 . . . . 72.24 111.094 -173.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 44.6 p -119.16 -57.62 2.0 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.892 0.877 . . . . 34.12 110.995 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 64.4 mtt 59.2 104.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.405 1.482 . . . . 64.11 113.255 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . 0.453 ' HA ' ' HG2' ' D' ' 41' ' ' LYS . 40.1 ttmt -113.95 59.38 0.67 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.543 -0.91 . . . . 74.21 108.543 174.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -176.27 -75.47 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.698 -1.137 . . . . 52.55 108.676 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . 56.14 -174.1 0.06 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.297 1.039 . . . . 72.3 112.284 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . 0.435 HD21 HD12 ' D' ' 126' ' ' LEU . 84.3 mt 56.32 -81.59 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.277 1.431 . . . . 65.53 113.547 172.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 134.57 72.31 0.08 OUTLIER Glycine 0 C--N 1.345 1.052 0 N-CA-C 108.696 -1.762 . . . . 62.34 108.696 -167.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.43 115.75 5.43 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.603 0.761 . . . . 61.01 109.204 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 13.3 mptt . . . . . 0 N--CA 1.483 1.198 0 C-N-CA 123.899 0.88 . . . . 65.11 110.495 -178.155 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.487 1.375 0 N-CA-C 108.914 -0.773 . . . . 72.53 108.914 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.4 p 56.59 97.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.708 1.603 . . . . 63.21 112.471 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -84.81 149.77 25.49 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 116.169 -0.469 . . . . 73.52 110.382 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -100.26 56.07 0.92 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.749 -0.834 . . . . 53.43 108.749 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 9' ' ' MET . 8.7 t30 -67.0 105.74 1.73 Allowed 'General case' 0 C--N 1.347 0.476 0 CA-C-N 115.323 -0.853 . . . . 54.32 109.224 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -69.16 -79.41 0.06 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.781 -0.822 . . . . 65.24 108.781 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.0 p -146.04 0.36 0.83 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.105 0.562 . . . . 72.5 110.931 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.14 -45.39 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.119 0.568 . . . . 74.33 110.379 -174.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.501 ' O ' ' HA ' ' A' ' 5' ' ' ASN . 20.3 ptp -85.32 144.03 28.32 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.123 0.569 . . . . 70.13 109.868 -174.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.6 m -140.94 134.28 29.72 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.732 -0.84 . . . . 61.52 108.732 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.488 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 35.9 t80 -136.31 111.91 9.34 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.32 -0.992 . . . . 71.24 108.32 170.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.751 ' HG2' ' HB3' ' C' ' 150' ' ' GLU . 41.1 tp60 -136.47 124.56 22.96 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.549 -0.908 . . . . 41.32 108.549 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.568 HD11 HG21 ' A' ' 105' ' ' ILE . 50.3 mt -89.45 112.04 23.82 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.781 -0.822 . . . . 73.14 108.781 172.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -74.29 -38.59 63.32 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 124.412 1.07 . . . . 65.41 109.523 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -167.07 140.87 3.72 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.829 -0.623 . . . . 73.01 110.568 -169.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.484 HD11 HD13 ' A' ' 13' ' ' ILE . 79.6 mt -128.72 135.1 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.054 -1.091 . . . . 73.41 108.054 172.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.413 ' HB3' HG23 ' B' ' 122' ' ' THR . 33.0 p90 -162.98 151.24 13.99 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 124.18 0.925 . . . . 74.34 110.249 -176.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -74.64 121.93 22.39 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.842 -0.799 . . . . 74.15 108.842 172.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 27.7 mtpt -82.07 -32.61 30.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.716 -0.475 . . . . 72.54 109.716 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.6 t70 -147.72 141.53 25.73 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.057 -0.974 . . . . 73.31 109.462 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.52 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 70.1 mt -136.67 147.67 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.138 1.375 . . . . 53.13 107.494 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.554 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 40.4 t -157.23 149.45 22.81 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.305 0.642 . . . . 44.22 109.699 172.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.482 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 88.8 t80 -151.53 124.53 8.65 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.368 -1.716 . . . . 71.43 106.368 177.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -129.41 114.27 15.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.73 0.412 . . . . 71.33 109.954 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.28 77.0 67.54 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 108.018 -1.105 . . . . 53.43 108.018 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.68 -29.01 20.13 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.203 1.935 . . . . 73.04 110.354 176.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.403 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 72.3 m-20 -100.94 24.64 9.0 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.139 1.376 . . . . 74.3 110.072 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -56.98 -42.59 97.17 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 124.536 1.134 . . . . 72.32 112.742 170.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.3 -24.61 14.24 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 121.87 1.713 . . . . 71.02 112.52 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -72.86 -33.7 66.27 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.223 0.609 . . . . 73.13 111.184 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.621 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 9.8 p -68.33 -25.36 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 123.52 0.513 . . . . 54.01 111.049 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -69.8 -33.66 72.66 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.241 1.016 . . . . 43.43 110.118 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -92.27 -33.73 14.53 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.76 0.824 . . . . 73.34 111.562 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.621 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -82.67 171.77 13.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.189 0.595 . . . . 73.42 110.364 176.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -86.2 138.96 31.48 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.009 0.524 . . . . 70.44 110.687 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.452 ' HZ2' HD13 ' E' ' 470' ' ' LEU . 77.6 t-105 -76.26 87.0 3.08 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 121.506 0.669 . . . . 63.13 110.205 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -125.52 79.68 66.94 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 108.341 -0.985 . . . . 63.42 108.341 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -86.39 138.65 5.61 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.104 2.536 . . . . 54.32 114.248 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -112.04 110.71 21.16 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 106.334 -1.728 . . . . 73.41 106.334 166.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.502 HG11 HD11 ' E' ' 470' ' ' LEU . 16.7 m -112.97 134.87 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.917 0.887 . . . . 72.51 111.619 -165.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -121.69 149.18 43.61 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.719 0.808 . . . . 64.23 110.171 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.486 ' HB2' ' HG ' ' E' ' 468' ' ' LEU . 46.9 tp -127.32 109.29 11.65 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.035 0.934 . . . . 65.33 108.505 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -106.58 118.5 36.82 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.673 -0.862 . . . . 73.43 108.673 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.409 HD11 HD11 ' A' ' 60' ' ' LEU . 9.8 tt -116.04 141.62 47.88 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 122.788 0.435 . . . . 61.5 110.216 -177.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -143.23 132.56 23.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.934 1.293 . . . . 72.12 108.91 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.47 ' H ' HD21 ' E' ' 460' ' ' LEU . 90.0 m -109.94 135.9 50.07 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.116 0.967 . . . . 75.01 108.631 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.01 129.67 40.41 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.716 0.806 . . . . 60.14 109.917 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.5 p -93.73 152.07 19.2 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.001 0.52 . . . . 73.44 110.545 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 43.3 t -150.03 151.96 34.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.19 0.996 . . . . 64.21 108.379 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -112.46 116.14 29.81 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.121 -0.696 . . . . 73.52 109.121 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.0 mt -92.04 -33.45 14.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.532 0.733 . . . . 71.24 110.421 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.67 178.67 10.07 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.32 -0.855 . . . . 70.43 109.968 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.59 121.77 14.7 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.198 -0.668 . . . . 73.04 109.198 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 69.25 9.53 7.38 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.602 1.161 . . . . 75.1 112.199 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.21 115.93 51.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 108.74 -0.837 . . . . 73.31 108.74 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -112.74 127.33 56.11 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.426 0.69 . . . . 72.43 110.022 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 44.9 tt0 -91.78 127.74 37.35 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.876 -1.056 . . . . 73.44 108.795 169.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.412 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 64.7 t -108.77 122.5 63.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.714 -1.217 . . . . 71.14 107.714 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.9 t -104.37 107.04 21.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.896 -1.15 . . . . 63.24 107.896 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.409 HD11 HD11 ' A' ' 44' ' ' LEU . 43.6 tp -87.85 98.96 11.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.53 -0.915 . . . . 64.34 108.53 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -84.99 110.59 19.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.438 -0.801 . . . . 71.02 109.447 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.4 t -112.84 107.72 23.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.64 -0.874 . . . . 72.22 108.64 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.7 m -95.29 125.71 40.1 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.117 0.967 . . . . 75.44 108.984 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.727 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 26.5 t -118.43 135.52 58.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 124.721 1.209 . . . . 60.01 108.901 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 t -141.31 138.16 32.94 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.23 0.612 . . . . 74.32 109.542 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.58 103.3 6.79 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.947 0.899 . . . . 62.42 108.933 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.2 p -111.24 124.77 52.89 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.009 0.523 . . . . 65.23 109.92 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 73' ' ' ALA . 8.6 mp -96.82 85.34 3.78 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.063 -1.088 . . . . 64.01 108.063 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.18 -105.62 2.91 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 114.413 -1.267 . . . . 54.55 110.472 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -105.85 -24.73 12.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.821 0.848 . . . . 75.24 110.402 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.403 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 22.4 tt0 -96.55 120.33 36.66 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.416 0.687 . . . . 65.54 111.088 -176.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.624 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 57.1 m -75.93 126.86 31.8 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.265 1.026 . . . . 73.2 110.959 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -69.61 -57.99 4.5 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.147 0.579 . . . . 31.15 109.806 174.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -145.77 157.67 43.91 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 114.719 -1.128 . . . . 75.15 111.419 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 64' ' ' VAL . 66.0 tp -129.74 146.29 51.5 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.677 -1.601 . . . . 70.21 107.439 177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.727 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.0 m -141.8 141.12 33.16 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.526 -0.916 . . . . 71.32 108.526 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 8.2 tp10 -147.22 120.96 9.22 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.792 -0.818 . . . . 61.52 108.792 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -135.23 110.22 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.706 -0.479 . . . . 75.55 109.706 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 68.5 mt-30 -91.48 82.87 5.35 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.183 -1.043 . . . . 72.21 108.183 172.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -75.74 106.88 7.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.834 -1.075 . . . . 73.14 109.386 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.98 151.83 20.08 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 112.02 -0.432 . . . . 51.45 112.02 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.02 141.58 10.05 Favored Glycine 0 C--O 1.239 0.442 0 N-CA-C 111.246 -0.742 . . . . 54.13 111.246 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mt -90.65 118.78 36.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 N-CA-C 108.613 -0.884 . . . . 75.02 108.613 173.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.491 ' HD2' HG12 ' A' ' 13' ' ' ILE . 17.7 m-85 -124.08 118.91 28.01 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.559 -0.904 . . . . 63.25 108.559 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.4 p -90.56 110.23 21.36 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 108.473 -0.936 . . . . 51.34 108.473 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.468 ' HB ' HD11 ' A' ' 89' ' ' ILE . 2.8 pp -112.57 150.5 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.361 0.665 . . . . 74.13 111.422 -171.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.446 ' HA ' HG21 ' E' ' 451' ' ' VAL . . . -156.54 159.91 38.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.913 0.885 . . . . 72.54 109.534 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 77.27 4.94 84.89 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 123.533 0.52 . . . . 72.01 114.137 170.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.538 HG22 HE21 ' A' ' 93' ' ' GLN . 2.6 pp -134.42 148.65 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.97 0.908 . . . . 64.01 109.537 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.47 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 19.3 tt0 -166.89 175.5 7.67 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.962 0.505 . . . . 74.14 110.363 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.47 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 62.04 -134.89 46.14 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.44 0.543 . . . . 73.22 113.741 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.9 p -71.3 -24.6 62.17 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.618 0.767 . . . . 65.31 111.682 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.538 HE21 HG22 ' A' ' 89' ' ' ILE . 28.5 tt0 -72.28 -37.94 68.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.156 0.583 . . . . 74.42 110.07 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.428 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 48.2 ttm -62.6 -42.35 99.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.944 0.498 . . . . 71.22 110.374 172.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.11 -33.58 65.25 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.937 0.773 . . . . 70.22 111.143 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -76.03 -36.47 59.1 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 116.046 -0.524 . . . . 73.23 111.262 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 64.5 m -62.05 -57.58 11.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.798 0.439 . . . . 61.43 111.064 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.529 HD21 HD11 ' E' ' 454' ' ' LEU . 1.7 pp -91.11 -9.13 46.75 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.433 0.693 . . . . 70.24 112.583 -176.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.86 3.67 30.42 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 119.893 -0.393 . . . . 64.42 113.788 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.17 -63.13 0.35 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.318 0.559 . . . . 62.35 111.31 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.488 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 75.2 t80 -61.94 -58.78 6.58 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.25 -0.887 . . . . 73.43 111.886 -173.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.9 m -70.24 -34.92 4.43 Favored Pre-proline 0 CA--C 1.569 1.697 0 N-CA-C 114.128 1.159 . . . . 62.44 114.128 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -52.63 -42.9 59.28 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.24 1.96 . . . . 53.12 112.492 163.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -67.44 -28.32 67.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.247 0.619 . . . . 75.21 111.197 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.568 HG21 HD11 ' A' ' 13' ' ' ILE . 47.4 mm -67.96 -45.44 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.814 0.845 . . . . 73.5 110.468 173.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.19 -18.07 60.81 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.838 -0.619 . . . . 75.02 111.63 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -62.35 -44.44 88.1 Favored Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 124.273 1.029 . . . . 74.34 113.715 -170.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.32 -36.43 79.14 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.1 1.867 . . . . 65.45 113.268 172.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -68.22 -43.02 78.93 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.474 0.71 . . . . 63.13 111.516 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.24 83.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.092 0.557 . . . . 71.43 109.95 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -52.03 -51.43 57.47 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 124.164 0.915 . . . . 75.01 110.151 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.66 -45.85 84.97 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.036 0.935 . . . . 64.12 111.307 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.0 t -59.84 -34.13 72.69 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.047 0.539 . . . . 51.41 111.37 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.462 HG21 HG21 ' A' ' 64' ' ' VAL . 81.6 mt -74.41 -54.54 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.749 0.82 . . . . 65.43 109.848 175.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.496 HG23 ' HG3' ' A' ' 125' ' ' GLN . 89.3 m -48.81 -45.39 40.25 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.909 1.284 . . . . 65.5 111.66 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -63.48 -46.37 86.46 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.811 -1.086 . . . . 45.53 109.95 -175.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 64.1 mtm -64.38 -38.46 91.09 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.144 0.578 . . . . 71.23 111.201 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.8 t -64.69 -43.09 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.569 0.748 . . . . 72.3 110.391 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.8 m -73.61 -32.4 64.06 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.532 0.733 . . . . 74.12 111.159 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -72.33 -30.17 64.5 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.653 0.781 . . . . 70.5 109.672 174.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.67 -2.89 90.2 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 124.028 0.83 . . . . 74.22 112.788 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m 66.98 25.39 9.33 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 122.479 1.133 . . . . 74.13 110.838 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.425 ' CE1' HG11 ' A' ' 31' ' ' VAL . 96.6 m-85 -91.26 155.68 44.28 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 115.451 -0.795 . . . . 70.45 109.524 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.02 124.61 15.12 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.77 2.313 . . . . 62.1 112.024 173.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.496 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.3 tt0 -54.76 134.81 47.78 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 124.214 0.947 . . . . 73.35 112.184 -173.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.538 HD13 HD23 ' E' ' 470' ' ' LEU . 19.0 tp -112.03 116.52 30.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.85 -1.068 . . . . 73.44 109.502 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -130.98 100.12 5.13 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.285 -1.005 . . . . 74.52 108.285 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.74 151.14 43.81 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.86 0.464 . . . . 64.24 110.255 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.55 150.61 89.11 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 123.139 0.576 . . . . 62.33 110.601 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.11 120.0 7.05 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.652 2.235 . . . . 71.01 110.472 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.56 124.43 54.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.657 -0.868 . . . . 70.32 108.657 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 135' ' ' ALA . 58.4 t30 -77.02 88.53 3.55 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.982 0.801 . . . . 73.34 109.683 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -64.31 -24.12 67.54 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.146 -0.934 . . . . 72.32 111.05 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.2 -52.71 64.42 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 123.896 0.747 . . . . 71.44 110.107 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.422 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -60.8 -50.79 72.02 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 124.018 0.824 . . . . 70.55 110.285 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -54.36 -43.88 71.71 Favored 'General case' 0 C--O 1.243 0.726 0 O-C-N 124.503 1.127 . . . . 70.43 111.857 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -72.52 -41.45 65.87 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 116.113 -0.494 . . . . 65.34 109.868 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.641 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 22.3 mtp -69.08 -25.91 64.67 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-O 119.28 -0.391 . . . . 71.31 111.483 -175.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -59.57 -31.69 69.67 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.596 0.758 . . . . 45.21 110.3 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -85.85 -41.52 14.92 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.204 1.001 . . . . 64.21 110.758 174.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.641 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 63.3 tp -67.88 -50.65 55.17 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.359 1.063 . . . . 74.55 112.431 -169.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.43 ' HG3' ' HB3' ' A' ' 145' ' ' ALA . 6.4 tp-100 -163.83 25.33 0.08 Allowed 'General case' 0 CA--C 1.556 1.19 0 CA-C-O 121.597 0.713 . . . . 65.31 109.85 -173.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 64.67 -74.88 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.519 1.528 . . . . 74.32 112.451 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.4 tm0? -134.39 -38.26 0.84 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.237 0.615 . . . . 72.02 109.366 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.43 ' HB3' ' HG3' ' A' ' 142' ' ' GLN . . . -60.05 138.28 57.9 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.287 0.635 . . . . 63.23 111.375 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.23 70.46 0.06 OUTLIER Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.137 -0.785 . . . . 72.25 111.137 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -148.18 154.13 39.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.697 0.799 . . . . 62.54 109.018 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 174.01 75.2 0.05 OUTLIER Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.042 -0.823 . . . . 74.14 111.042 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 35.7 p -60.66 94.49 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.825 0.85 . . . . 65.22 111.227 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -103.01 100.21 10.13 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.245 1.018 . . . . 73.0 108.526 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.27 158.36 36.01 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.424 0.689 . . . . 70.54 110.906 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -115.21 94.29 4.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.733 -0.667 . . . . 73.43 109.546 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -79.21 124.61 28.52 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.405 -0.816 . . . . 74.41 109.567 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -66.86 -24.94 66.19 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.304 0.642 . . . . 74.41 111.344 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 C-N-CA 124.543 1.137 . . . . 73.01 111.055 175.578 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.952 0.405 . . . . 74.23 110.8 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.8 p -142.68 139.43 31.17 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.858 -0.526 . . . . 72.44 110.536 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.98 134.14 34.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.881 0.472 . . . . 73.33 110.126 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.88 118.79 3.13 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.38 -0.97 . . . . 62.33 108.38 176.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -134.29 -7.19 2.61 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.031 0.933 . . . . 75.42 110.918 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -69.18 122.98 19.9 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.719 0.807 . . . . 72.24 109.89 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 35.1 p -69.8 95.3 0.89 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.382 0.673 . . . . 44.13 111.47 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -131.64 172.35 12.36 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.877 0.871 . . . . 72.12 110.802 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.2 ptm 52.9 167.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 127.698 2.399 . . . . 71.53 114.04 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.4 m -167.4 140.26 3.4 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.767 1.227 . . . . 72.34 107.936 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.11 156.76 43.67 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.083 0.468 . . . . 63.14 109.971 160.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -125.96 141.19 52.08 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.072 -0.967 . . . . 70.01 108.645 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.604 HD11 HD13 ' B' ' 105' ' ' ILE . 48.7 mt -84.69 121.5 36.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.525 -0.917 . . . . 75.11 108.525 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -88.06 -38.26 15.59 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.601 0.563 . . . . 75.34 110.196 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -170.52 131.14 0.9 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.986 -0.552 . . . . 75.31 109.92 -170.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.7 mt -114.94 140.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 107.153 -1.425 . . . . 53.43 107.153 170.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -167.34 145.54 4.81 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.353 0.597 . . . . 64.3 112.376 -174.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.1 m -75.02 124.88 27.77 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.475 -1.238 . . . . 75.21 109.158 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -98.08 -36.28 10.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.953 0.501 . . . . 74.04 110.391 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 17.8 t70 -147.76 133.66 19.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.51 -0.314 . . . . 70.21 110.643 -168.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.1 mm -133.55 145.95 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.756 1.222 . . . . 72.1 108.842 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.0 t -147.1 136.25 22.5 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.655 1.182 . . . . 50.21 108.147 173.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.52 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -147.84 113.91 5.83 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.925 -1.139 . . . . 71.42 107.925 172.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -119.07 119.25 33.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.071 0.948 . . . . 73.2 108.562 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.629 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.3 85.1 2.57 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 108.189 -1.041 . . . . 72.53 108.189 168.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -65.94 -35.94 32.8 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 122.997 2.465 . . . . 53.12 112.028 -173.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -106.28 9.86 31.89 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.856 -1.065 . . . . 61.15 110.68 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.629 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -25.2 -66.16 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.061 0 C-N-CA 126.287 1.835 . . . . 70.32 115.162 -174.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 10.5 Cg_exo -67.2 -30.79 37.24 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 122.362 2.042 . . . . 74.44 112.168 -169.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -96.57 -30.16 13.45 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.019 -0.991 . . . . 64.14 112.053 -170.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.684 HG21 ' HA ' ' B' ' 73' ' ' ALA . 10.7 p -72.4 -19.74 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 122.471 0.308 . . . . 45.31 111.132 -174.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -63.73 -14.11 49.51 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.574 0.75 . . . . 71.41 112.295 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -64.01 -22.93 67.14 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.57 0.748 . . . . 60.0 111.794 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.92 100.97 12.34 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.022 0.929 . . . . 74.03 109.353 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.47 95.98 4.6 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.636 -0.505 . . . . 72.33 109.636 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -166.61 155.86 11.05 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.67 0.788 . . . . 74.43 109.237 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.409 ' HB3' HD13 ' F' ' 470' ' ' LEU . 46.4 mt-30 -75.37 105.1 1.73 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.006 -0.738 . . . . 72.02 109.006 170.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.492 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 21.1 Cg_endo -58.89 127.48 24.52 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.692 2.261 . . . . 73.33 112.202 -171.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -51.56 126.16 16.67 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.376 1.047 . . . . 71.21 110.225 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.635 HG13 HG13 ' B' ' 64' ' ' VAL . 89.6 t -106.22 139.58 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.363 0.665 . . . . 75.43 110.911 -171.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -108.02 125.72 51.88 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.821 -1.178 . . . . 63.23 107.821 162.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 mp -85.04 137.86 32.8 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.451 -0.944 . . . . 71.32 108.451 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.1 t70 -133.2 135.65 45.19 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.51 -1.293 . . . . 72.31 107.51 175.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.594 HD12 HD12 ' F' ' 460' ' ' LEU . 0.2 OUTLIER -136.59 127.45 27.46 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.226 -1.028 . . . . 34.31 108.226 -177.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.49 145.75 34.02 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.069 -1.456 . . . . 73.14 107.069 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 34.6 p -127.86 120.1 27.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.012 -0.736 . . . . 75.21 109.012 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.43 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -119.95 116.14 25.19 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.747 0.819 . . . . 73.21 108.886 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -113.87 170.58 8.16 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.751 0.421 . . . . 64.24 111.616 -172.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 87.2 p -152.8 143.89 23.08 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.786 0.834 . . . . 74.34 110.251 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -83.13 136.14 34.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.198 0.599 . . . . 70.25 109.785 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 58.7 mt -101.67 -46.71 4.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.557 0.743 . . . . 60.01 110.645 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.07 -169.47 2.96 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.305 -0.862 . . . . 51.41 111.156 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -62.98 105.67 0.71 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.01 -0.996 . . . . 64.34 110.343 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 64.11 11.69 6.41 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.277 1.031 . . . . 73.31 112.026 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.4 112.2 37.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 106.567 -1.642 . . . . 74.22 106.567 173.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -133.85 137.94 45.32 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.491 -0.929 . . . . 75.11 108.491 -173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -107.89 137.09 46.51 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.483 0.713 . . . . 74.31 109.641 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.1 t -109.84 143.01 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.53 -0.915 . . . . 55.33 108.53 171.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 40.4 t -125.67 125.17 68.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 109.088 -0.708 . . . . 74.31 109.088 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.4 HD22 HG23 ' B' ' 62' ' ' VAL . 0.2 OUTLIER -102.54 112.33 25.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.71 -1.132 . . . . 72.14 108.572 -174.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -97.62 110.98 23.44 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.587 0.755 . . . . 71.23 110.627 174.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.4 HG23 HD22 ' B' ' 60' ' ' LEU . 39.2 t -107.06 104.46 17.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.968 -1.123 . . . . 73.33 107.968 170.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 9.5 m -99.21 130.77 45.53 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.761 -0.829 . . . . 72.13 108.761 174.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.635 HG13 HG13 ' B' ' 40' ' ' VAL . 43.4 t -118.13 127.33 75.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 123.907 0.883 . . . . 73.51 108.93 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 87.9 m -109.75 137.85 46.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.403 -0.962 . . . . 75.11 108.403 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -146.61 145.86 30.22 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 122.844 0.457 . . . . 60.23 109.812 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.5 p -151.61 138.05 18.59 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.309 -0.86 . . . . 52.14 110.663 -172.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.667 HD12 HG22 ' B' ' 31' ' ' VAL . 60.4 mt -103.78 124.3 48.65 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.916 0.886 . . . . 71.14 109.923 174.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.51 -108.55 2.46 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 123.636 0.585 . . . . 61.51 112.733 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.61 5.0 12.36 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.854 0.862 . . . . 71.45 111.399 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -119.71 156.61 30.18 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.97 0.508 . . . . 71.54 110.019 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.2 m -68.3 137.84 55.0 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.595 0.56 . . . . 73.2 110.459 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.684 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -91.64 -65.01 1.04 Allowed 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.478 -1.304 . . . . 62.42 107.478 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -150.88 161.56 42.45 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.088 -0.96 . . . . 74.0 110.244 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.8 mt -132.85 111.56 11.19 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.047 -1.464 . . . . 64.44 107.047 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.2 t -118.86 153.45 34.52 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.005 -0.739 . . . . 51.44 109.005 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -160.64 131.39 5.44 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.875 -0.787 . . . . 75.42 108.875 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.2 t -128.09 145.29 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.679 -0.86 . . . . 51.54 108.679 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.54 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.0 mt-30 -126.37 95.96 4.54 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.999 -0.741 . . . . 73.42 108.999 172.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -86.2 104.01 15.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.167 -0.924 . . . . 73.14 109.895 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -87.44 153.85 25.55 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 111.673 -0.571 . . . . 52.33 111.673 176.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -154.02 127.11 2.06 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 111.417 -0.673 . . . . 75.12 111.417 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 62.7 mt -86.87 126.04 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.6 0.76 . . . . 73.14 109.68 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -131.74 132.07 43.54 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 107.713 -1.217 . . . . 54.33 107.713 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 31.6 m -102.95 91.66 4.23 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.194 -0.669 . . . . 73.2 109.194 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.572 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -94.79 142.58 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 115.859 -0.61 . . . . 72.35 110.939 -167.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.07 158.31 42.83 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.328 1.051 . . . . 73.44 109.399 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.47 -56.71 3.87 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.705 -0.68 . . . . 54.3 111.801 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.494 HD11 ' HB ' ' B' ' 86' ' ' ILE . 11.4 pt -69.13 149.7 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.81 0.844 . . . . 74.43 112.168 177.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -159.16 176.15 12.58 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 125.481 1.512 . . . . 72.22 107.588 171.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.09 -129.78 50.06 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.392 0.433 . . . . 62.53 112.716 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -83.38 -19.26 36.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.609 0.364 . . . . 52.21 111.719 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -72.89 -25.98 61.27 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.785 -0.45 . . . . 71.41 109.785 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 24.1 ttt -78.85 -33.57 45.78 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.127 -0.488 . . . . 71.52 110.12 170.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.17 -29.83 70.03 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.219 0.608 . . . . 54.03 111.001 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -69.2 -39.4 78.65 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.463 0.705 . . . . 63.21 111.414 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.8 t -66.87 -66.19 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.267 -0.879 . . . . 42.53 109.81 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 38.8 mt -70.18 -27.31 64.42 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.555 0.742 . . . . 71.3 112.098 -172.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.25 -12.61 58.48 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.574 0.546 . . . . 64.3 114.298 -174.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.51 -55.36 0.39 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.58 0.69 . . . . 72.04 112.282 -173.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.431 ' OH ' ' HB3' ' D' ' 130' ' ' PRO . 66.2 t80 -75.86 -48.17 22.57 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.392 0.516 . . . . 75.44 112.392 -169.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.434 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 88.1 m -59.3 -50.09 89.31 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 123.676 0.791 . . . . 73.44 111.567 176.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 69.9 Cg_exo -55.22 -36.3 93.02 Favored 'Trans proline' 0 C--N 1.389 2.683 0 C-N-CA 121.968 1.779 . . . . 62.14 113.561 169.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -60.16 -40.63 90.58 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 123.185 0.594 . . . . 73.43 110.643 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.604 HD13 HD11 ' B' ' 13' ' ' ILE . 67.6 mt -63.79 -43.61 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.599 0.76 . . . . 63.33 110.404 175.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.449 HD21 ' HA3' ' B' ' 82' ' ' GLY . 65.9 mt -78.66 -18.89 53.72 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.064 -0.971 . . . . 74.34 112.034 -174.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -58.49 -51.83 79.01 Favored Pre-proline 0 N--CA 1.482 1.162 0 N-CA-C 113.963 1.097 . . . . 75.25 113.963 -170.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.95 -32.23 92.25 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 121.671 1.58 . . . . 62.22 113.312 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -66.05 -50.63 63.47 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.286 0.634 . . . . 74.33 110.472 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.16 -40.09 84.5 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.2 -0.909 . . . . 74.53 110.812 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -65.56 -49.02 70.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.506 1.523 . . . . 53.53 110.939 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -68.27 -34.53 76.34 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.81 -0.632 . . . . 53.54 109.842 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.7 t -67.99 -34.32 76.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.777 0.431 . . . . 74.01 111.223 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.465 ' O ' HG23 ' B' ' 118' ' ' VAL . 66.6 mt -63.83 -56.48 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.662 -0.495 . . . . 53.03 109.662 172.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.1 m -60.42 -26.02 66.39 Favored 'General case' 0 CA--C 1.554 1.131 0 O-C-N 123.973 0.796 . . . . 55.0 111.473 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.0 t -62.99 -50.45 70.69 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.225 0.61 . . . . 62.43 109.836 173.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -71.57 -32.1 67.7 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.414 0.686 . . . . 62.05 111.079 -176.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 114' ' ' ILE . 87.6 t -61.98 -44.62 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.65 0.78 . . . . 64.32 109.55 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.6 t -65.37 -35.76 81.93 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.039 -0.982 . . . . 60.14 111.368 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.0 mtt-85 -68.06 -32.17 72.32 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.475 -0.784 . . . . 62.42 110.323 176.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.87 8.12 77.29 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.952 0.783 . . . . 75.53 112.965 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 17' ' ' TYR . 61.5 p 54.77 27.42 8.82 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.15 1.78 . . . . 74.14 113.626 176.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -83.43 154.74 66.16 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.397 0.679 . . . . 73.55 110.09 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -55.99 157.42 16.89 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.083 2.522 . . . . 55.33 113.223 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -64.56 113.77 3.92 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.369 -0.832 . . . . 73.23 111.38 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.461 HD22 HD22 ' F' ' 470' ' ' LEU . 49.1 mt -121.09 119.51 32.64 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.899 -0.778 . . . . 53.21 108.899 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.421 ' O ' HD21 ' F' ' 468' ' ' LEU . 29.1 m-80 -115.0 112.98 23.5 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.806 -0.813 . . . . 64.32 108.806 -177.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.35 143.26 56.06 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.33 0.652 . . . . 55.34 111.353 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.56 150.9 64.16 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.843 0.857 . . . . 63.41 110.687 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.23 145.3 17.02 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.879 2.386 . . . . 71.43 111.775 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.31 118.59 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 108.246 -1.02 . . . . 63.52 108.246 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -79.8 83.37 5.75 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.618 -0.512 . . . . 61.14 109.618 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -64.45 -24.28 67.57 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.528 0.731 . . . . 74.1 111.962 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.56 -52.05 55.28 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.523 0.729 . . . . 74.51 110.268 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.16 95.26 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.937 0.895 . . . . 71.23 110.938 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 89.9 mt -74.07 -20.89 60.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.075 -0.966 . . . . 61.53 112.028 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.599 ' CE1' HD11 ' B' ' 141' ' ' LEU . 61.0 t80 -65.96 -29.91 70.39 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.625 0.37 . . . . 64.02 110.732 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 53.8 mtt -72.03 -30.63 65.39 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 109.732 -0.47 . . . . 71.43 109.732 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -80.88 -23.17 39.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.788 0.835 . . . . 64.33 110.694 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' B' ' 137' ' ' PHE . 39.5 t80 -62.08 -21.06 64.65 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.749 1.219 . . . . 71.52 111.236 171.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.599 HD11 ' CE1' ' B' ' 137' ' ' PHE . 30.2 mt -118.28 12.4 13.42 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.35 1.06 . . . . 75.21 110.806 -172.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -140.7 173.95 11.0 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.107 0.963 . . . . 75.14 110.095 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -144.71 8.19 1.29 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.813 0.845 . . . . 72.12 109.843 168.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -82.22 119.72 24.44 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 123.618 0.767 . . . . 74.1 109.86 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.18 124.4 31.13 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.407 -0.59 . . . . 33.04 109.407 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.7 72.85 2.71 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.322 0.389 . . . . 72.43 112.926 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -76.5 108.93 9.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.299 0.639 . . . . 73.13 109.712 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -111.03 -131.62 5.93 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.178 -0.769 . . . . 51.24 111.178 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.628 ' H ' ' HB ' ' D' ' 7' ' ' THR . 86.3 m -156.81 92.18 1.27 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.833 0.853 . . . . 71.54 108.903 173.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . 0.571 ' HB3' ' HB2' ' D' ' 8' ' ' GLU . 0.0 OUTLIER -77.7 163.27 26.33 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.723 -0.473 . . . . 63.12 109.723 173.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -163.96 130.67 3.2 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.121 -0.696 . . . . 55.34 109.121 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -90.92 132.65 35.81 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 122.836 0.454 . . . . 75.23 110.377 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -110.93 158.01 19.23 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.913 -1.143 . . . . 71.13 107.913 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -138.6 129.18 26.22 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.501 -0.555 . . . . 74.35 109.501 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 C-N-CA 123.625 0.77 . . . . 75.42 110.212 179.838 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.732 0.301 . . . . 72.24 110.818 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -145.03 95.45 2.69 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 106.874 -1.528 . . . . 74.33 106.874 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -62.86 -55.77 23.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.977 0.911 . . . . 53.03 110.213 -174.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -165.45 86.93 0.39 Allowed 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.694 -1.139 . . . . 73.23 108.57 172.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -74.17 90.85 2.08 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.842 -0.799 . . . . 72.52 108.842 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -62.37 91.6 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.015 0.926 . . . . 71.13 110.146 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 31.2 m -98.72 97.84 9.03 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.415 -0.958 . . . . 61.41 108.415 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.92 120.21 13.84 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 106.82 -1.548 . . . . 72.3 106.82 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 26.7 ttt 63.98 113.41 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.591 1.182 . . . . 71.14 110.12 -162.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 59.5 m -127.93 117.56 21.98 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.206 -1.035 . . . . 74.35 108.206 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.611 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.1 t80 -120.23 126.32 50.34 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.808 -0.812 . . . . 74.02 108.808 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -142.51 109.05 5.34 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.385 -0.968 . . . . 74.02 108.385 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -73.82 122.11 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.158 -0.682 . . . . 64.45 109.158 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.569 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.8 mm-40 -86.47 -42.26 13.73 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.179 -0.919 . . . . 74.54 110.35 -175.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -175.56 139.93 0.45 Allowed 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.614 0.571 . . . . 74.55 109.523 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.0 mt -131.56 133.87 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.463 -0.94 . . . . 71.21 108.463 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.522 ' HB3' HG23 ' D' ' 122' ' ' THR . 27.3 p90 -170.64 172.61 5.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.691 0.758 . . . . 73.13 111.565 -169.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -96.07 118.5 32.79 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.382 -0.827 . . . . 72.32 109.16 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.454 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.8 mmtp -65.78 -48.16 72.73 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 122.33 1.062 . . . . 61.02 108.156 169.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.438 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.5 t70 -139.82 146.25 39.16 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 113.814 -1.539 . . . . 74.04 109.884 -172.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.59 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 80.5 mt -140.39 140.93 33.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 106.701 -1.592 . . . . 74.01 106.701 174.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -159.25 149.84 19.51 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.173 0.511 . . . . 75.31 110.663 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.2 t80 -148.49 136.96 21.34 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.918 -1.141 . . . . 70.32 107.918 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.67 118.65 18.4 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.695 0.798 . . . . 63.41 109.754 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.92 76.87 45.2 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 106.356 -1.72 . . . . 62.51 106.356 165.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.07 -40.61 11.29 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.738 2.292 . . . . 74.33 111.199 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.03 21.12 3.27 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.628 -1.169 . . . . 73.22 111.417 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.412 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -44.65 -57.83 6.18 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 114.39 1.256 . . . . 65.33 114.39 -171.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.4 -36.43 66.67 Favored 'Trans proline' 0 C--N 1.385 2.459 0 CA-C-N 121.744 1.658 . . . . 60.31 112.397 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -70.07 -35.42 74.2 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.372 0.669 . . . . 74.31 112.135 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.5 p -79.6 -24.49 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 N-CA-C 111.886 0.328 . . . . 72.41 111.886 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.59 -30.2 69.75 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.617 0.367 . . . . 72.35 111.867 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -86.67 11.45 12.92 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.905 0.482 . . . . 74.45 111.12 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.799 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.99 160.05 14.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.231 1.012 . . . . 65.41 109.563 170.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -71.48 131.44 43.31 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.514 0.725 . . . . 63.14 110.561 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.532 ' NE1' ' HG3' ' C' ' 124' ' ' PRO . 31.5 t90 -73.86 91.91 2.02 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.424 -0.807 . . . . 72.22 111.297 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.539 ' HG2' ' HD2' ' G' ' 471' ' ' LYS . 9.1 tm0? -147.04 74.43 11.98 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 107.444 -1.317 . . . . 75.33 107.444 169.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -85.15 137.14 6.04 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.732 2.288 . . . . 54.45 112.717 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -86.06 110.07 19.27 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.268 -1.012 . . . . 72.51 108.268 171.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' G' ' 468' ' ' LEU . 15.9 m -84.6 100.47 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-O 122.532 1.158 . . . . 74.14 110.978 -176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -95.74 103.29 15.16 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.784 -1.098 . . . . 74.52 108.279 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.52 134.75 36.73 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.25 -0.648 . . . . 72.32 109.25 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -127.67 136.08 51.1 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.352 -0.981 . . . . 55.42 108.352 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 tp -129.22 135.12 48.4 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.438 0.695 . . . . 72.04 109.683 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.412 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 27.5 t70 -149.04 153.06 37.31 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.883 0.873 . . . . 72.25 109.664 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -146.19 153.39 40.58 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.155 0.582 . . . . 72.21 109.441 170.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.55 160.54 39.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.248 1.019 . . . . 63.01 109.011 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 26.4 p -144.43 155.67 43.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.461 0.704 . . . . 54.24 109.223 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.5 p -157.4 153.78 27.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.601 0.76 . . . . 60.53 109.353 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -95.8 118.05 31.72 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.993 -0.743 . . . . 60.24 108.993 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' C' ' 57' ' ' GLU . 60.5 mt -89.37 -34.92 16.34 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.179 0.592 . . . . 75.43 110.337 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.3 -170.06 2.16 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.645 0.778 . . . . 50.2 111.004 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.91 111.44 1.66 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.85 0.86 . . . . 42.14 110.417 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 70.79 -5.75 1.4 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.344 1.458 . . . . 71.52 112.564 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.0 t -93.77 105.7 17.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.456 -0.942 . . . . 73.54 108.456 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -118.79 122.96 43.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.542 -0.754 . . . . 73.31 109.357 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.486 ' HB2' HD11 ' C' ' 51' ' ' LEU . 35.4 tt0 -84.36 144.7 28.65 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.532 0.733 . . . . 72.31 110.294 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -131.14 140.55 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.259 -1.015 . . . . 70.12 108.259 167.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.427 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 90.9 t -130.95 130.83 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.067 -1.086 . . . . 75.13 108.067 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.96 109.42 21.41 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.456 -1.313 . . . . 63.51 107.456 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.412 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.2 tmm_? -101.65 106.77 17.86 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.127 -1.064 . . . . 65.14 108.127 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.621 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.7 t -107.96 137.55 38.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.88 -1.156 . . . . 75.01 107.88 175.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -132.48 121.93 24.11 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.171 -0.678 . . . . 71.01 109.171 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 64.8 t -111.51 110.33 31.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 124.18 0.992 . . . . 73.11 108.9 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.487 HG23 HD23 ' C' ' 75' ' ' LEU . 4.0 m -108.85 108.28 19.0 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.226 0.61 . . . . 72.03 109.38 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.04 123.47 45.98 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.828 -0.804 . . . . 74.44 108.828 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.6 m -137.83 130.47 29.67 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.949 0.5 . . . . 65.23 111.046 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.799 HD13 ' HG2' ' C' ' 34' ' ' LYS . 6.6 mt -84.81 33.99 0.53 Allowed 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 125.255 1.422 . . . . 74.55 110.723 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.62 -100.13 1.84 Allowed Glycine 0 C--N 1.352 1.427 0 N-CA-C 111.052 -0.819 . . . . 74.22 111.052 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.61 -31.89 18.36 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.474 -0.565 . . . . 75.45 109.474 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.02 120.87 24.78 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.725 0.81 . . . . 63.31 109.13 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.5 m -76.73 128.7 35.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.981 -0.748 . . . . 61.13 108.981 169.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.747 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.08 -57.78 4.2 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.424 -0.954 . . . . 75.12 108.424 173.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -165.65 173.72 10.52 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.309 -0.86 . . . . 73.55 110.768 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.487 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -133.24 144.23 49.63 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.089 -1.448 . . . . 60.03 107.089 172.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.454 ' SG ' HG23 ' C' ' 114' ' ' ILE . 46.6 t -146.31 139.65 25.87 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.158 -1.053 . . . . 70.05 108.158 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -151.6 133.65 15.1 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.517 -0.549 . . . . 73.43 109.517 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.4 t -134.99 138.89 48.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.26 1.024 . . . . 75.12 108.474 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -114.17 88.17 2.79 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.258 -1.015 . . . . 72.42 108.258 172.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.401 ' HG3' HD22 ' C' ' 106' ' ' LEU . 9.5 tp-100 -79.1 97.77 6.27 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.175 -0.92 . . . . 74.43 110.197 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -98.74 144.13 17.03 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-O 121.199 0.333 . . . . 51.13 113.035 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.432 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -145.09 132.81 4.84 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.514 -1.034 . . . . 52.44 110.514 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 15.3 mm -88.97 123.7 41.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 108.394 -0.965 . . . . 71.35 108.394 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.611 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 51.2 m-85 -130.4 116.14 17.86 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.159 0.583 . . . . 71.51 109.787 -173.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 74.0 m -84.0 108.51 17.0 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.684 -0.487 . . . . 31.33 109.684 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.523 ' HB ' HD11 ' C' ' 89' ' ' ILE . 2.7 pp -117.06 138.61 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.949 0.899 . . . . 74.32 110.25 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.34 158.14 43.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.162 0.985 . . . . 64.33 109.554 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.39 -30.41 5.26 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 113.892 0.317 . . . . 73.22 113.892 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.567 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -105.72 150.2 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 121.23 0.538 . . . . 75.1 111.792 -176.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.91 -170.79 3.73 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.784 -1.098 . . . . 75.55 108.505 166.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.401 ' HA2' HG23 ' G' ' 455' ' ' THR . . . 64.05 -124.45 30.33 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 114.112 0.405 . . . . 74.22 114.112 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.518 ' HB ' HD21 ' C' ' 141' ' ' LEU . 74.1 p -76.35 -29.53 57.26 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.834 0.853 . . . . 63.03 111.806 -175.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.87 -42.46 85.56 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.592 -0.521 . . . . 74.42 109.592 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.557 ' SD ' ' HA ' ' G' ' 452' ' ' VAL . 28.1 ttt -74.66 -33.12 62.45 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.857 -0.61 . . . . 72.12 110.807 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.62 -48.69 69.09 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.75 0.657 . . . . 52.23 109.706 174.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.434 ' NE2' ' HA ' ' C' ' 134' ' ' ASP . 11.6 t-80 -77.62 -35.16 52.99 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.857 0.723 . . . . 75.42 111.492 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.412 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 51.8 t -56.86 -36.79 70.46 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.849 0.718 . . . . 74.52 110.407 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.451 HD12 HD13 ' G' ' 454' ' ' LEU . 23.9 mt -101.07 -15.22 17.5 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.877 0.871 . . . . 71.52 110.917 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.76 -30.41 48.27 Favored Glycine 0 C--N 1.352 1.42 0 N-CA-C 114.842 0.697 . . . . 74.34 114.842 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.83 -36.88 0.06 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.938 0.495 . . . . 54.01 110.859 -172.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.412 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 70.4 t80 -66.88 -44.29 81.29 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.38 1.472 . . . . 74.42 112.282 -175.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 23.3 m -77.12 -47.91 2.6 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 123.394 0.678 . . . . 72.24 111.836 174.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -53.96 -28.85 51.37 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.138 1.892 . . . . 74.1 114.273 171.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -68.35 -39.56 81.81 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 123.109 0.564 . . . . 62.43 109.939 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 42.3 mm -59.92 -39.44 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.439 -0.578 . . . . 63.22 109.439 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.432 HD21 ' HA3' ' C' ' 82' ' ' GLY . 76.7 mt -85.52 -12.77 50.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.599 1.16 . . . . 75.33 112.501 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -63.37 -51.4 68.32 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 113.784 1.031 . . . . 73.42 113.784 -171.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -66.79 -30.99 40.26 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 121.731 1.621 . . . . 51.22 112.263 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -67.82 -46.25 72.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.457 0.703 . . . . 74.42 110.935 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.31 93.02 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.482 0.713 . . . . 60.13 109.806 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -53.15 -60.26 3.51 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.293 0.995 . . . . 62.33 110.938 174.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -62.56 -29.4 70.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.614 0.766 . . . . 74.15 110.945 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.432 ' SG ' HG12 ' C' ' 21' ' ' ILE . 8.3 t -72.55 -44.48 62.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.774 0.43 . . . . 74.11 110.832 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.621 HD11 ' HB ' ' C' ' 62' ' ' VAL . 85.5 mt -64.88 -50.09 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.31 0.644 . . . . 73.54 110.333 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.4 m -64.21 -29.34 70.45 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.413 -0.812 . . . . 75.1 110.741 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 28.1 t -65.54 -52.62 51.15 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.987 0.515 . . . . 74.03 109.71 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.436 ' HB3' ' HB2' ' C' ' 23' ' ' PHE . 0.0 OUTLIER -54.15 -46.86 72.37 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.472 1.109 . . . . 54.5 112.026 178.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.576 HG11 HD13 ' C' ' 126' ' ' LEU . 71.2 t -65.97 -43.41 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.45 -0.796 . . . . 72.21 111.157 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.9 t -61.08 -36.94 81.0 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.445 0.698 . . . . 63.43 111.167 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -69.71 -32.02 70.36 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.134 -0.939 . . . . 65.12 110.329 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.08 7.05 76.98 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.894 0.746 . . . . 61.53 112.958 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.412 HG23 ' HB3' ' D' ' 17' ' ' TYR . 53.2 p 57.7 28.63 16.1 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 126.37 1.868 . . . . 71.14 113.751 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.5 ' HB2' HG13 ' C' ' 118' ' ' VAL . 93.2 m-85 -91.98 163.44 27.48 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 108.914 -0.772 . . . . 65.43 108.914 170.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.532 ' HG3' ' NE1' ' C' ' 36' ' ' TRP . 56.5 Cg_endo -64.06 -178.93 0.67 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.934 2.423 . . . . 73.33 114.641 -174.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -61.2 128.89 38.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.945 -1.025 . . . . 74.41 111.683 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.576 HD13 HG11 ' C' ' 118' ' ' VAL . 6.7 mp -134.81 86.49 2.26 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.445 -0.946 . . . . 72.14 108.445 170.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -99.77 123.68 44.27 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.089 -0.708 . . . . 64.14 109.089 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -64.93 118.87 9.69 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.782 -0.821 . . . . 63.43 108.782 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.02 141.25 93.75 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.727 0.811 . . . . 75.04 111.318 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.442 ' HB3' HD12 ' A' ' 16' ' ' ILE . 14.8 Cg_endo -58.05 103.74 0.16 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.436 2.091 . . . . 73.43 112.094 174.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.448 HG22 ' SD ' ' G' ' 464' ' ' MET . 29.2 t -95.46 140.82 16.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.642 -1.614 . . . . 75.32 106.642 174.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -77.36 66.77 3.18 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.345 -0.613 . . . . 34.33 109.345 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -54.33 -43.12 70.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.912 0.885 . . . . 72.22 111.183 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.434 ' HA ' ' NE2' ' C' ' 96' ' ' HIS . 7.8 m-20 -66.49 -41.93 88.17 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.89 -1.05 . . . . 61.42 112.484 -175.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.91 -43.08 72.43 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.799 0.687 . . . . 64.42 110.398 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.05 -21.15 60.84 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.027 -0.988 . . . . 63.31 111.9 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -82.48 -34.6 27.98 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.902 -0.407 . . . . 72.01 109.902 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 37.1 tpp -64.86 -46.64 80.97 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.206 -0.452 . . . . 44.44 110.938 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -72.15 -35.18 68.98 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.47 -0.786 . . . . 74.14 110.933 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -56.5 -86.93 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.149 0.979 . . . . 74.45 109.81 171.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.518 HD21 ' HB ' ' C' ' 92' ' ' THR . 1.1 tm? 62.74 -75.44 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.977 1.311 . . . . 42.44 109.838 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -151.4 42.06 0.73 Allowed 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 107.78 -1.193 . . . . 73.13 107.78 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -152.25 168.08 26.51 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.048 1.339 . . . . 75.22 108.091 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -78.73 146.57 33.84 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 122.797 0.439 . . . . 75.54 110.567 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.592 ' HB3' HG21 ' G' ' 463' ' ' THR . . . -82.07 171.1 14.75 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.556 0.742 . . . . 72.14 110.656 175.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.97 -106.55 2.34 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 111.301 -0.72 . . . . 62.22 111.301 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 59.72 -171.3 0.13 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.831 1.252 . . . . 74.45 112.838 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.02 -111.02 0.44 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.623 -1.391 . . . . 73.31 109.623 170.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.3 t 177.65 169.54 0.66 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.73 1.212 . . . . 72.44 109.905 170.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.751 ' HB3' ' HG2' ' A' ' 12' ' ' GLN . 31.7 tt0 -155.5 100.78 2.14 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.92 0.888 . . . . 64.22 108.939 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 62.24 178.88 0.13 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.585 1.154 . . . . 74.54 112.796 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -168.04 178.65 4.99 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.581 1.153 . . . . 74.12 109.684 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.9 pm0 -67.88 178.13 1.88 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.812 0.845 . . . . 71.31 110.824 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -64.15 -64.8 0.79 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 120.925 0.393 . . . . 63.14 110.422 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.824 0 CA-C-N 115.427 -0.806 . . . . 74.31 109.208 -174.349 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.784 0.326 . . . . 62.15 110.946 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 56.0 m -126.93 95.88 4.45 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.389 0.675 . . . . 72.53 109.6 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.13 151.13 28.43 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.546 -0.538 . . . . 74.33 109.546 176.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -167.07 157.43 11.4 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.983 0.913 . . . . 63.25 109.812 -173.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -157.65 144.38 18.0 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.994 -0.743 . . . . 55.1 108.994 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.434 HD22 ' N ' ' D' ' 6' ' ' ASN . 0.9 OUTLIER -98.86 99.2 10.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.351 -0.981 . . . . 72.41 108.351 178.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.628 ' HB ' ' H ' ' B' ' 149' ' ' THR . 18.1 p -66.01 -60.97 2.32 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.112 0.565 . . . . 61.04 109.908 174.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' B' ' 150' ' ' GLU . 50.7 mt-10 -128.64 74.04 1.54 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.88 0.872 . . . . 64.43 108.821 171.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.429 ' HG2' HD11 ' D' ' 89' ' ' ILE . 7.0 ttp -33.21 126.39 0.35 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.026 1.33 . . . . 55.21 112.759 170.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 87.9 m -124.95 135.6 52.97 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.18 0.515 . . . . 73.14 110.991 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -158.7 89.86 0.98 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.727 -1.582 . . . . 74.4 106.727 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -116.69 116.36 27.39 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.584 -0.895 . . . . 74.44 108.584 -176.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.42 HG21 HD11 ' D' ' 16' ' ' ILE . 14.7 mt -82.48 117.55 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.569 -0.9 . . . . 74.21 108.569 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.56 -34.8 46.76 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.992 0.517 . . . . 73.13 111.37 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -169.2 130.92 1.17 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 111.631 0.234 . . . . 73.22 111.631 -168.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.446 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.6 mp -115.02 134.4 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.075 -1.454 . . . . 62.02 107.075 173.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.412 ' HB3' HG23 ' C' ' 122' ' ' THR . 36.4 p90 -165.52 170.3 14.52 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.811 0.815 . . . . 75.13 111.868 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -102.52 123.15 45.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.265 -1.334 . . . . 73.34 108.817 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -93.25 -18.45 22.48 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.114 -0.494 . . . . 75.35 110.011 177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -156.39 136.12 12.52 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.329 -0.989 . . . . 73.15 108.329 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.426 ' CD1' ' HE3' ' C' ' 117' ' ' MET . 17.5 mt -134.59 138.77 49.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.627 -1.249 . . . . 70.54 107.627 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -144.67 133.87 22.9 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.353 0.661 . . . . 54.33 109.773 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.59 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 70.5 t80 -144.67 127.48 16.3 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.56 -1.644 . . . . 72.44 106.56 167.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.5 mt-10 -134.89 126.64 29.13 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.638 0.775 . . . . 71.01 109.357 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.54 85.14 25.82 Favored Pre-proline 0 C--O 1.242 0.673 0 N-CA-C 107.953 -1.129 . . . . 73.44 107.953 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.22 -40.47 11.18 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.909 2.406 . . . . 70.22 112.482 -171.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -107.73 27.59 9.04 Favored 'General case' 0 C--O 1.216 -0.687 0 C-N-CA 123.871 0.868 . . . . 74.32 109.789 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.74 -68.57 0.22 Allowed Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 115.284 1.586 . . . . 73.14 115.284 -161.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.57 -19.97 16.2 Favored 'Trans proline' 0 C--N 1.382 2.299 0 CA-C-N 122.394 1.891 . . . . 72.35 113.385 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.439 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 8.5 t-160 -74.81 -38.79 61.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.534 1.133 . . . . 71.42 110.698 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' D' ' 73' ' ' ALA . 10.7 p -84.38 -25.24 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 122.789 0.435 . . . . 70.22 111.694 -172.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -58.43 -27.99 64.84 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.371 0.669 . . . . 75.13 112.359 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.439 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 72.1 mt-30 -53.73 -31.33 47.86 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.786 1.234 . . . . 74.11 111.541 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -87.51 96.95 10.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.984 0.913 . . . . 74.45 109.135 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -81.33 88.58 6.08 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.992 -0.549 . . . . 53.54 110.946 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -163.15 162.64 25.68 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.664 0.786 . . . . 71.33 109.153 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 1.3 mp0 -73.47 116.35 50.5 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 109.238 -0.652 . . . . 63.34 109.238 171.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.716 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 77.5 Cg_exo -56.55 138.97 86.61 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.94 3.094 . . . . 74.12 113.971 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.11 111.73 1.44 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.025 0.828 . . . . 71.12 109.372 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.496 HG23 HG13 ' D' ' 64' ' ' VAL . 7.3 p -103.79 135.35 41.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.357 -0.838 . . . . 73.45 110.917 -168.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -115.52 132.39 56.64 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.326 1.05 . . . . 72.44 108.346 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.657 ' HB2' HD23 ' H' ' 468' ' ' LEU . 8.5 tt -98.17 126.23 43.54 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.955 0.502 . . . . 73.44 109.746 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.521 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.8 m-20 -133.49 116.08 15.54 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.898 -1.149 . . . . 74.01 107.898 171.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.408 ' HG ' HD21 ' D' ' 42' ' ' LEU . 91.6 mt -113.88 142.34 46.23 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.153 0.581 . . . . 73.2 109.988 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.459 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.2 t70 -141.8 154.89 45.52 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.947 -1.131 . . . . 75.42 107.947 173.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.466 ' HB ' HD23 ' H' ' 460' ' ' LEU . 13.4 t -127.68 164.4 22.16 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.104 0.561 . . . . 55.14 109.712 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.542 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.24 161.79 42.1 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.784 0.834 . . . . 52.3 109.627 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 37.3 p -159.1 151.84 21.83 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.099 0.559 . . . . 72.53 109.726 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.4 p -157.93 139.23 13.51 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.36 0.664 . . . . 71.44 109.707 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -79.13 119.37 22.15 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.553 -0.536 . . . . 72.24 109.553 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.7 mt -90.15 -34.63 15.78 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.86 -0.793 . . . . 72.4 108.86 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.16 -178.95 5.36 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.224 1.01 . . . . 63.22 109.672 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.64 122.17 17.48 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.221 -0.899 . . . . 65.21 109.197 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 72.16 12.46 5.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.394 1.478 . . . . 74.41 112.402 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.6 t -128.98 117.6 44.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 123.972 0.909 . . . . 41.32 108.879 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' H' ' 454' ' ' LEU . 5.5 m-85 -132.88 130.08 39.25 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.398 1.079 . . . . 74.1 108.703 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.5 ' HB2' HD11 ' D' ' 51' ' ' LEU . 18.5 tt0 -91.83 142.29 27.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.972 -0.751 . . . . 61.42 108.972 170.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -123.08 142.31 40.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 107.421 -1.326 . . . . 74.14 107.421 172.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 45.9 t -126.37 132.09 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.807 -0.812 . . . . 72.53 108.807 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.32 120.39 42.25 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.705 -0.85 . . . . 75.35 108.705 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.459 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 33.3 ttm-85 -102.94 98.45 8.41 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.312 -0.996 . . . . 64.4 108.312 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -100.2 123.37 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.859 -0.793 . . . . 51.44 108.859 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 15.4 m -119.13 141.82 48.47 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.496 0.718 . . . . 75.22 109.85 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.496 HG13 HG23 ' D' ' 40' ' ' VAL . 75.6 t -136.64 103.29 3.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.0 1.32 . . . . 55.25 108.561 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 83.4 m -100.9 113.72 26.93 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.349 -0.982 . . . . 61.33 108.349 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -122.55 142.82 50.21 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.726 0.811 . . . . 72.1 109.857 -174.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 23.5 m -144.13 134.39 24.41 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 123.652 0.595 . . . . 72.1 111.795 -176.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.621 HD12 HG22 ' D' ' 31' ' ' VAL . 48.9 mt -106.23 123.34 47.88 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.325 1.05 . . . . 63.15 109.198 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.56 -124.56 36.41 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 115.155 -0.93 . . . . 61.2 113.609 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.89 6.47 47.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 71.02 112.326 -175.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.0 165.1 26.79 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.668 0.387 . . . . 75.13 110.875 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 34.7 m -68.23 138.07 55.28 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.762 0.663 . . . . 70.33 110.473 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.775 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -90.33 -70.69 0.66 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.342 -0.984 . . . . 60.14 108.342 173.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -147.63 140.6 24.96 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.576 -0.738 . . . . 72.33 109.605 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 88.1 mt -109.62 143.18 39.7 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.49 -1.3 . . . . 63.52 107.49 172.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.545 ' SG ' HG23 ' D' ' 114' ' ' ILE . 38.7 t -158.05 137.19 11.63 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.231 -0.285 . . . . 53.22 110.231 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.59 133.27 13.01 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.945 -0.761 . . . . 74.31 108.945 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.7 t -128.77 138.02 55.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.572 -0.899 . . . . 72.35 108.572 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -116.32 87.35 2.67 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.096 -1.075 . . . . 65.22 108.096 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.14 103.95 10.37 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.347 -1.297 . . . . 72.24 108.944 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.09 141.39 15.96 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.314 -0.714 . . . . 73.43 111.314 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.475 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -139.86 130.02 4.53 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.681 -0.968 . . . . 73.05 110.681 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 58.7 mt -92.57 115.95 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.717 -0.846 . . . . 54.1 108.717 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -116.33 125.55 52.28 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.931 0.892 . . . . 53.12 109.692 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -104.39 109.29 21.09 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.481 0.712 . . . . 73.34 109.353 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.461 HD11 HG12 ' H' ' 452' ' ' VAL . 2.4 pp -110.78 144.14 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.244 0.617 . . . . 54.34 109.866 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.45 127.07 8.73 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.789 -0.819 . . . . 74.42 108.789 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.36 -20.51 42.25 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.398 -0.681 . . . . 64.35 111.398 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.429 HD11 ' HG2' ' D' ' 9' ' ' MET . 3.5 mp -98.41 130.75 46.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.231 1.013 . . . . 74.22 108.341 -176.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.692 ' HB3' HG22 ' H' ' 451' ' ' VAL . 8.4 pt-20 -160.47 173.8 15.03 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.442 0.697 . . . . 74.13 110.7 -174.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.01 -133.82 49.17 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 124.023 0.827 . . . . 72.32 113.879 174.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.1 m -63.35 -31.73 72.97 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.706 0.803 . . . . 52.22 110.73 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -69.34 -33.66 73.44 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.74 0.816 . . . . 73.03 110.945 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.488 ' SD ' HD12 ' D' ' 98' ' ' LEU . 17.5 tmm? -72.74 -37.61 67.66 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.263 0.625 . . . . 63.3 110.389 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.31 95.94 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.61 0.719 . . . . 40.15 110.55 171.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -71.53 -29.53 64.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.899 1.28 . . . . 61.22 111.405 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -81.12 -52.26 7.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.811 0.445 . . . . 62.14 110.874 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.488 HD12 ' SD ' ' D' ' 94' ' ' MET . 92.6 mt -84.35 -27.9 27.39 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.995 0.518 . . . . 70.42 111.697 -171.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.02 7.41 58.8 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.677 -0.513 . . . . 63.23 114.138 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -150.29 -61.3 0.2 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.393 0.597 . . . . 72.42 111.232 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -69.7 -41.65 75.1 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.034 0.534 . . . . 73.34 112.145 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.444 ' SG ' HD23 ' D' ' 98' ' ' LEU . 88.5 m -65.35 -45.97 70.48 Favored Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 123.62 0.768 . . . . 64.42 112.38 -178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -53.1 -36.89 78.51 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.155 1.903 . . . . 70.03 113.177 167.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -67.77 -30.89 70.45 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.099 0.56 . . . . 64.24 111.438 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.0 -37.33 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.276 0.631 . . . . 63.12 110.584 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.475 HD21 ' HA3' ' D' ' 82' ' ' GLY . 92.7 mt -77.49 -19.77 55.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.057 0.943 . . . . 72.33 111.997 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.64 ' HZ ' HD22 ' D' ' 128' ' ' LEU . 40.5 t80 -64.65 -43.64 71.01 Favored Pre-proline 0 CA--C 1.56 1.327 0 N-CA-C 114.347 1.24 . . . . 73.11 114.347 -170.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -54.35 -45.51 40.42 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 121.952 1.768 . . . . 74.33 112.491 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -70.0 -35.59 74.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.041 0.936 . . . . 75.32 111.759 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.71 67.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.269 0.628 . . . . 60.32 110.502 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.445 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.2 ttp180 -58.48 -49.09 78.61 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.253 -0.885 . . . . 54.42 110.534 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.52 -46.63 87.53 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.136 0.897 . . . . 72.45 111.477 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.8 t -57.73 -42.15 83.28 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.739 0.65 . . . . 63.15 110.639 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.545 HG23 ' SG ' ' D' ' 76' ' ' CYS . 67.8 mt -61.67 -57.11 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.608 0.763 . . . . 73.01 110.56 174.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.548 HG23 ' HG3' ' D' ' 125' ' ' GLN . 86.4 m -51.67 -44.68 63.15 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.721 1.208 . . . . 75.31 112.061 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.7 t -63.95 -42.59 97.26 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.196 -0.911 . . . . 63.42 109.999 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.9 mtm -69.81 -34.39 73.62 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.999 0.52 . . . . 61.42 111.469 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 114' ' ' ILE . 66.8 t -62.06 -44.89 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.612 0.765 . . . . 52.1 109.934 175.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.1 p -72.73 -30.48 64.21 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.981 0.512 . . . . 62.34 111.089 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -72.07 -29.76 64.45 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.466 0.706 . . . . 74.45 110.455 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.34 10.14 74.35 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.798 0.686 . . . . 51.41 112.556 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.522 HG23 ' HB3' ' C' ' 17' ' ' TYR . 73.0 p 56.85 20.78 5.49 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 126.68 1.992 . . . . 73.23 114.082 177.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.02 150.16 71.26 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 109.067 -0.716 . . . . 75.21 109.067 168.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.9 132.1 47.74 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.471 2.114 . . . . 75.41 111.202 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.548 ' HG3' HG23 ' D' ' 115' ' ' THR . 5.5 tt0 -51.78 127.19 20.1 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 124.464 1.102 . . . . 61.54 112.674 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.19 116.49 28.45 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.04 -1.096 . . . . 75.11 108.04 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -115.65 122.19 44.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.694 0.798 . . . . 72.41 109.524 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.64 HD22 ' HZ ' ' D' ' 107' ' ' PHE . 1.5 tt -74.9 129.71 38.13 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 108.967 -0.753 . . . . 73.43 108.967 173.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.18 157.75 79.91 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.395 1.078 . . . . 31.22 111.974 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.431 ' HB3' ' OH ' ' B' ' 101' ' ' TYR . 87.0 Cg_exo -50.01 107.82 0.18 Allowed 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 123.246 2.631 . . . . 73.32 113.284 172.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 84.0 t -109.59 116.24 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.542 0.737 . . . . 73.2 109.051 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -90.06 105.66 17.95 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.42 -0.585 . . . . 65.52 109.42 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -78.72 -20.18 50.64 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.571 0.748 . . . . 51.4 111.067 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.436 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 6.5 t70 -65.17 -52.38 55.37 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.929 0.892 . . . . 74.12 110.66 -174.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.492 ' HA ' ' SD ' ' D' ' 138' ' ' MET . . . -68.97 -34.89 76.06 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.288 -0.869 . . . . 71.22 111.034 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' H' ' 462' ' ' TYR . 47.3 tp -63.08 -35.26 79.65 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 114.986 -1.006 . . . . 63.4 111.407 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -64.26 -37.33 87.11 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.573 0.749 . . . . 73.54 110.687 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.492 ' SD ' ' HA ' ' D' ' 135' ' ' ALA . 35.5 mtt -63.49 -39.57 94.79 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.671 -0.695 . . . . 73.12 109.596 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -61.68 -39.75 92.54 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.993 0.917 . . . . 74.4 111.389 176.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -64.41 -34.95 79.37 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.86 0.864 . . . . 73.24 111.021 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.5 mp -76.62 -30.93 57.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.336 0.654 . . . . 70.23 111.877 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -91.3 44.16 1.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.51 0.671 . . . . 75.04 111.081 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -119.56 49.17 1.4 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.857 0.863 . . . . 74.31 108.767 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -170.86 -52.0 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.302 -1.317 . . . . 63.54 109.723 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -174.85 96.6 0.08 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.549 1.14 . . . . 73.45 108.793 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -153.78 41.04 0.66 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 112.094 -0.403 . . . . 63.43 112.094 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.41 179.92 6.07 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.172 0.989 . . . . 74.24 109.388 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.73 22.67 71.97 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 112.323 -0.311 . . . . 53.43 112.323 -174.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 47.6 p -81.8 88.09 6.32 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.436 1.094 . . . . 54.14 110.63 -173.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -144.7 103.1 3.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.457 1.103 . . . . 74.44 108.596 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -85.1 -22.47 28.89 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.232 0.613 . . . . 72.11 110.051 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 23.7 m170 71.71 162.89 0.26 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.333 1.453 . . . . 75.33 111.306 -176.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.6 106.87 5.55 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.654 -0.703 . . . . 64.11 110.157 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -77.61 -32.68 53.67 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.783 -0.644 . . . . 64.21 110.444 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 C-N-CA 124.077 0.951 . . . . 54.52 108.759 -174.297 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 121.037 0.446 . . . . 74.34 110.115 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . 0.446 HG21 ' HA ' ' A' ' 87' ' ' ALA . 15.5 m -118.72 87.99 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.346 -1.724 . . . . 75.34 106.346 161.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.95 169.76 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.016 1.326 . . . . 63.3 108.626 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 158.44 -82.82 0.14 Allowed Glycine 0 C--N 1.344 0.983 0 C-N-CA 121.437 -0.411 . . . . 15.41 113.313 172.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . 0.529 HD11 HD21 ' A' ' 98' ' ' LEU . 6.8 mp 58.62 -98.53 0.09 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.306 1.042 . . . . 75.21 110.335 -170.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 3.6 m 63.78 -3.42 0.43 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 124.818 1.247 . . . . 64.15 113.491 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -85.91 -25.1 26.33 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.135 0.974 . . . . 52.43 110.877 -172.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 72.86 141.55 0.06 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.725 1.61 . . . . 74.31 111.12 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 8.6 t -132.18 137.11 47.49 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.715 0.806 . . . . 74.02 108.836 175.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -118.23 5.48 11.93 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.693 0.797 . . . . 54.11 110.121 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . 0.47 HD21 ' H ' ' A' ' 46' ' ' THR . 3.9 mm? 68.83 160.88 0.19 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.044 1.338 . . . . 72.42 112.534 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -147.31 26.45 1.06 Allowed 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.411 -1.268 . . . . 75.51 109.38 -169.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -72.85 91.88 1.55 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.762 -0.829 . . . . 73.4 108.762 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 32.4 p -71.32 -81.56 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.462 -0.79 . . . . 71.12 111.051 -174.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 82.9 mmm 51.19 87.18 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.403 1.081 . . . . 63.3 111.663 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -63.29 -38.01 89.49 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.774 0.429 . . . . 74.25 110.407 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -94.21 101.23 13.2 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.492 -1.299 . . . . 70.41 107.492 163.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -68.41 -58.71 3.94 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.478 0.711 . . . . 63.53 111.31 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . 0.494 HD22 HD11 ' A' ' 126' ' ' LEU . 81.7 mt -130.03 156.84 43.83 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.967 0.907 . . . . 74.11 109.066 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -131.85 105.34 0.61 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.981 -0.847 . . . . 73.12 110.981 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . 0.538 HD23 HD13 ' A' ' 126' ' ' LEU . 2.1 pp -151.79 153.31 34.01 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.549 0.739 . . . . 62.15 109.985 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 26.6 tptp . . . . . 0 C--O 1.253 1.269 0 N-CA-C 108.434 -0.95 . . . . 73.22 108.434 174.683 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 121.151 0.501 . . . . 71.42 110.147 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' B' ' 89' ' ' ILE . 18.7 m -81.03 -15.38 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.971 0.908 . . . . 75.01 112.609 -171.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 13.7 m -70.05 140.92 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 122.688 0.395 . . . . 72.43 111.938 -171.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 163.96 76.19 0.03 OUTLIER Glycine 0 C--N 1.345 1.076 0 N-CA-C 111.737 -0.545 . . . . 65.11 111.737 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 65.9 tp -147.17 143.25 28.09 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.74 0.816 . . . . 74.44 110.023 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 41.2 m -96.32 133.2 40.99 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.799 -0.815 . . . . 60.13 108.799 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -138.15 -171.85 3.13 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.81 -0.811 . . . . 70.51 108.81 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 72.1 66.08 0.13 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.043 1.337 . . . . 72.54 109.215 -175.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 32.7 m -146.52 141.71 27.3 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.247 -1.342 . . . . 53.13 108.397 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.72 120.36 7.7 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.29 0.636 . . . . 74.31 110.175 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . 0.594 HD12 HD12 ' B' ' 44' ' ' LEU . 40.7 mt -83.66 162.89 20.6 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.706 0.765 . . . . 70.31 112.111 -174.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -80.33 153.72 28.22 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.063 -1.426 . . . . 64.14 112.025 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -129.89 -177.44 4.29 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.745 1.218 . . . . 71.33 110.057 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 15.3 t -151.13 -1.13 0.36 Allowed 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.932 -1.031 . . . . 74.11 109.949 171.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' F' ' 466' ' ' ALA . 15.0 tmm? -80.49 84.71 6.04 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.562 -0.903 . . . . 60.12 108.562 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -75.87 79.09 2.78 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.676 -0.693 . . . . 72.21 109.527 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . 0.513 ' HB3' ' SD ' ' F' ' 464' ' ' MET . . . -175.26 178.23 1.73 Allowed 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.563 1.145 . . . . 74.03 110.094 -177.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -75.35 -57.26 4.0 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.035 -0.728 . . . . 71.22 109.035 172.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . 0.599 HD13 HD21 ' F' ' 470' ' ' LEU . 6.1 tt -162.73 -48.58 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.421 -0.955 . . . . 72.41 108.421 175.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 106.71 50.99 0.82 Allowed Glycine 0 N--CA 1.469 0.856 0 N-CA-C 110.413 -1.075 . . . . 55.42 110.413 -172.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . 0.599 HD21 HD13 ' F' ' 468' ' ' LEU . 90.2 mt -75.82 -67.64 0.65 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.734 0.814 . . . . 62.2 110.488 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? . . . . . 0 CA--C 1.56 1.336 0 C-N-CA 125.079 1.352 . . . . 71.4 110.086 179.276 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 109.253 -0.647 . . . . 74.44 109.253 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . 0.648 HG22 HG23 ' G' ' 452' ' ' VAL . 7.1 p -164.07 136.48 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 124.503 1.121 . . . . 64.43 109.29 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . 0.648 HG23 HG22 ' G' ' 451' ' ' VAL . 95.9 t 56.66 92.15 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 125.064 1.345 . . . . 61.1 111.818 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . 0.446 ' N ' ' SD ' ' C' ' 94' ' ' MET . . . -157.6 70.23 0.26 Allowed Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.769 -0.932 . . . . 44.22 110.769 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . 0.451 HD13 HD12 ' C' ' 98' ' ' LEU . 62.3 tp -63.39 109.37 1.58 Allowed 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.229 0.612 . . . . 62.44 110.067 178.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . 0.401 HG23 ' HA2' ' C' ' 91' ' ' GLY . 23.6 p -69.2 167.52 16.06 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.815 -0.63 . . . . 54.13 111.217 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.63 107.77 17.68 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.871 -0.604 . . . . 72.52 109.861 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -109.18 134.95 51.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.728 -0.842 . . . . 70.11 108.728 171.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 30.5 p -78.06 78.93 4.54 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 123.861 0.865 . . . . 75.33 110.242 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 62.19 -174.23 0.14 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.703 1.201 . . . . 62.31 111.968 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 77.8 mt -79.1 138.21 37.83 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.305 -0.628 . . . . 74.41 109.305 171.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -47.01 -53.48 12.37 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.714 1.206 . . . . 73.12 111.077 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 33.7 t80 38.55 51.48 1.69 Allowed 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 125.634 1.574 . . . . 75.44 111.567 -173.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . 0.592 HG21 ' HB3' ' C' ' 145' ' ' ALA . 10.4 p -80.81 15.22 1.84 Allowed 'General case' 0 CA--C 1.555 1.173 0 CA-C-N 114.773 -1.103 . . . . 70.15 112.302 -173.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . 0.448 ' SD ' HG22 ' C' ' 131' ' ' VAL . 55.4 ttp -82.28 -14.75 54.93 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.023 0.929 . . . . 75.3 111.237 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 10.6 mptt 70.35 -73.79 0.09 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.3 1.44 . . . . 74.41 109.645 -174.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -149.6 174.37 12.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.629 1.172 . . . . 43.43 109.552 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -144.13 -171.39 3.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.658 0.783 . . . . 32.23 110.28 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . 0.517 ' HB2' HG21 ' C' ' 40' ' ' VAL . 91.3 mt 68.78 -171.11 0.18 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.751 1.22 . . . . 71.32 112.007 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.61 82.48 0.05 OUTLIER Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.148 -1.181 . . . . 74.53 110.148 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 71.5 mt -86.67 54.87 3.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.399 0.679 . . . . 53.24 111.571 -175.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . 0.539 ' HD2' ' HG2' ' C' ' 37' ' ' GLN . 62.7 tttp . . . . . 0 CA--C 1.551 0.99 0 C-N-CA 125.25 1.42 . . . . 71.12 108.064 173.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 119.558 -0.258 . . . . 60.22 110.634 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . 0.692 HG22 ' HB3' ' D' ' 90' ' ' GLU . 4.1 p -65.73 -16.43 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 123.625 0.77 . . . . 75.21 112.898 -166.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . 0.461 HG12 HD11 ' D' ' 86' ' ' ILE . 15.5 m -79.27 175.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.932 0.893 . . . . 75.12 113.253 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 158.11 60.78 0.01 OUTLIER Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.177 -0.92 . . . . 74.35 111.732 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . 0.484 ' HB3' ' CE1' ' D' ' 56' ' ' TYR . 62.3 tp -94.14 139.94 30.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.153 0.581 . . . . 74.13 110.978 -176.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 11.8 t -153.31 153.2 32.16 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.659 1.184 . . . . 74.44 109.27 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 60.8 85.98 0.11 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.745 1.218 . . . . 64.42 111.981 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -96.89 103.04 14.93 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.183 -1.043 . . . . 73.03 108.183 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 30.5 m -64.76 150.3 47.65 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.63 0.772 . . . . 75.4 110.514 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.36 146.28 7.26 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.618 0.767 . . . . 65.11 110.762 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . 0.466 HD23 ' HB ' ' D' ' 46' ' ' THR . 0.7 OUTLIER -64.96 107.2 1.42 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 108.189 -1.041 . . . . 64.43 108.189 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -80.26 66.24 5.68 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.752 -1.567 . . . . 72.34 111.307 -173.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . 0.487 ' HB2' HD21 ' D' ' 136' ' ' LEU . 57.8 t80 -157.53 111.85 2.64 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.918 -0.771 . . . . 74.31 108.918 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 68.3 p -109.45 16.69 22.1 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.759 0.824 . . . . 73.4 110.783 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . 0.555 ' HB2' HD13 ' D' ' 42' ' ' LEU . 34.9 tpp 70.4 144.3 0.06 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.248 1.419 . . . . 61.43 111.871 -176.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.19 -53.15 27.01 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.343 -0.844 . . . . 64.14 110.582 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -150.85 -74.23 0.15 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.798 0.439 . . . . 50.21 110.815 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -129.11 136.34 50.08 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.503 0.721 . . . . 75.22 109.908 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . 0.657 HD23 ' HB2' ' D' ' 42' ' ' LEU . 2.8 pp -91.11 -17.34 26.33 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.259 0.466 . . . . 75.24 112.259 -177.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.38 54.46 0.04 OUTLIER Glycine 0 N--CA 1.464 0.539 0 N-CA-C 111.546 -0.622 . . . . 52.44 111.546 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 6.5 tt -159.3 118.45 2.94 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.38 -1.341 . . . . 64.11 107.38 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt . . . . . 0 C--O 1.25 1.112 0 N-CA-C 108.789 -0.819 . . . . 74.31 108.789 175.034 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.674 0.273 . . . . 71.25 110.486 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t -119.58 70.53 0.85 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.944 0.897 . . . . 44.14 108.676 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -74.17 108.09 6.75 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.786 -1.097 . . . . 70.34 109.769 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -100.32 109.93 22.14 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.272 1.029 . . . . 72.24 108.977 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -78.56 133.12 37.37 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.062 -0.718 . . . . 73.14 109.062 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.607 ' ND2' ' HA ' ' C' ' 147' ' ' GLU . 1.2 p-10 -154.1 108.07 2.99 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.534 0.734 . . . . 72.51 110.55 -175.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 p -142.11 92.52 2.44 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.831 0.852 . . . . 75.33 108.961 171.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.37 -41.71 10.74 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.426 -0.583 . . . . 72.32 109.426 174.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -95.78 165.73 12.15 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.279 0.632 . . . . 74.5 110.036 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.5 m -147.35 128.3 14.5 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.972 0.909 . . . . 64.14 109.301 169.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.698 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 6.2 t80 -139.03 132.68 30.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.038 0.935 . . . . 73.01 108.62 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -149.98 103.56 3.22 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.528 -0.916 . . . . 72.12 108.528 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.555 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.3 mt -70.36 112.05 4.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.335 -0.987 . . . . 71.5 108.335 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -81.04 -31.14 34.65 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 124.237 0.961 . . . . 71.44 110.277 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -174.36 147.44 1.16 Allowed 'General case' 0 C--N 1.355 0.835 0 O-C-N 123.626 0.579 . . . . 73.52 110.228 -173.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.7 mt -137.02 133.6 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.878 -1.156 . . . . 74.34 107.878 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' HB3' HG23 ' B' ' 122' ' ' THR . 43.2 p90 -168.59 154.39 6.71 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 123.915 0.759 . . . . 72.04 111.412 -174.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -74.57 116.57 15.41 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.011 -0.737 . . . . 70.13 109.011 172.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -78.19 -42.86 30.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.368 -0.604 . . . . 74.11 109.368 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.594 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 7.0 m-20 -136.65 131.91 34.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.934 -1.03 . . . . 73.23 109.235 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.0 mt -128.18 141.06 47.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.09 -1.448 . . . . 73.23 107.09 172.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -152.51 120.78 6.29 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.199 -0.667 . . . . 75.32 109.199 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 87.3 t80 -123.78 130.6 52.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.274 -1.38 . . . . 75.45 107.274 174.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -126.48 153.01 45.68 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.023 -1.102 . . . . 74.54 108.023 172.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.51 79.16 10.6 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.486 -1.301 . . . . 72.43 107.486 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.21 -40.34 77.1 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.332 2.688 . . . . 54.23 112.843 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.563 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 39.0 m-80 -109.22 39.68 2.01 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.28 -0.873 . . . . 72.43 109.767 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.54 -45.55 98.76 Favored Pre-proline 0 CA--C 1.565 1.536 0 C-N-CA 123.939 0.896 . . . . 65.3 113.079 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -71.79 -22.03 24.21 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 121.826 1.684 . . . . 75.13 112.29 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 42.0 m170 -86.91 -24.63 24.76 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.621 0.768 . . . . 64.01 112.333 -174.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.7 p -72.19 -25.21 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.759 0.424 . . . . 72.45 110.409 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -69.1 -31.78 70.74 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.528 0.731 . . . . 64.04 110.607 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -78.57 -47.75 16.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.101 0.96 . . . . 72.1 110.424 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -83.02 151.53 25.79 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.856 0.862 . . . . 73.23 110.757 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.36 146.04 53.61 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.616 -0.512 . . . . 64.11 109.616 170.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.441 ' HE1' HD22 ' E' ' 470' ' ' LEU . 65.0 t-105 -70.7 85.15 0.65 Allowed 'General case' 0 C--N 1.351 0.662 0 CA-C-O 121.468 0.651 . . . . 73.12 109.752 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.98 78.78 75.77 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 106.451 -1.685 . . . . 74.35 106.451 173.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -89.89 -173.44 0.71 Allowed 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.453 2.102 . . . . 64.25 112.543 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -141.03 108.81 5.65 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.811 -1.551 . . . . 71.34 106.811 167.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.478 HG11 ' HB2' ' E' ' 470' ' ' LEU . 22.1 m -96.5 135.81 29.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.317 0.58 . . . . 73.42 111.301 -172.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -120.71 145.47 47.45 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.284 -1.006 . . . . 73.24 108.284 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 tp -124.1 126.16 45.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.201 -0.666 . . . . 71.43 109.201 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.545 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.7 m-20 -113.95 144.1 43.62 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.106 -1.072 . . . . 54.02 108.106 170.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.18 146.65 37.22 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.353 -0.61 . . . . 71.05 109.353 169.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -152.06 147.96 27.11 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.195 0.598 . . . . 72.51 110.007 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.421 ' HB ' HD11 ' E' ' 460' ' ' LEU . 80.0 m -118.49 128.95 55.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.276 1.03 . . . . 73.33 109.353 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.55 151.55 51.89 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.411 0.684 . . . . 74.03 109.156 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.0 m -118.09 157.52 26.72 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.326 0.651 . . . . 73.12 109.967 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -149.27 121.09 8.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.736 0.814 . . . . 72.05 109.342 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -84.49 103.2 13.43 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.612 -0.884 . . . . 61.14 108.612 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.15 -34.77 23.97 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.414 -0.812 . . . . 71.32 110.373 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.42 -176.56 5.97 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 124.268 0.98 . . . . 71.13 109.723 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.48 115.15 4.38 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.702 0.626 . . . . 71.13 110.073 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 62.67 26.53 15.7 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.44 1.496 . . . . 73.34 112.78 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -117.79 118.36 58.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-N 114.706 -1.134 . . . . 72.12 108.743 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.599 ' HD2' HD11 ' A' ' 86' ' ' ILE . 23.8 m-85 -125.11 124.97 43.0 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.478 0.711 . . . . 71.2 109.991 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.26 126.44 37.35 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.277 -1.008 . . . . 73.45 108.277 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.413 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 92.7 t -100.78 130.35 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.33 -1.359 . . . . 74.15 107.33 171.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.1 t -107.56 107.68 23.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 107.874 -1.158 . . . . 63.03 107.874 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.27 99.86 12.02 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.381 -1.34 . . . . 73.33 107.381 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 37.8 ttt180 -85.74 119.61 26.25 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.22 -0.9 . . . . 60.44 109.641 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.5 t -112.13 140.77 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.561 -0.903 . . . . 74.23 108.561 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 17.9 m -130.92 129.31 42.03 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.739 -0.837 . . . . 72.4 108.739 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.53 HG21 HG21 ' A' ' 114' ' ' ILE . 74.2 t -127.84 126.32 66.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.958 -1.497 . . . . 60.43 106.958 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 14.7 t -136.71 145.97 45.32 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.593 -0.891 . . . . 61.51 108.593 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.423 ' HB2' HG12 ' A' ' 40' ' ' VAL . . . -144.07 123.81 13.37 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.548 -0.908 . . . . 72.23 108.548 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 p -127.18 133.67 50.26 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.447 0.699 . . . . 74.44 110.607 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.581 HD13 ' HB2' ' A' ' 73' ' ' ALA . 7.6 mp -86.16 77.19 9.63 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.152 -1.795 . . . . 64.33 106.152 169.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.79 -115.69 4.81 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 114.515 -1.22 . . . . 65.31 111.082 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -87.98 -20.34 25.99 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.908 0.883 . . . . 71.3 110.319 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -80.06 100.98 8.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.754 0.822 . . . . 73.01 109.951 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.9 m -68.06 120.19 13.88 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 110.174 -0.306 . . . . 75.2 110.174 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.581 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -71.68 -55.42 7.74 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.84 -0.8 . . . . 63.41 108.84 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -160.64 165.79 30.03 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 115.524 -0.762 . . . . 73.13 111.708 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.7 tp -141.6 108.07 5.3 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.516 -1.22 . . . . 73.02 108.205 173.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.46 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 58.7 m -107.35 116.68 32.36 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.104 0.962 . . . . 74.2 109.898 177.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -134.0 126.04 29.41 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.151 -0.685 . . . . 72.41 109.151 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.4 t -133.38 110.28 14.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 124.292 1.037 . . . . 75.4 109.215 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.594 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 19.6 mt-30 -84.64 84.03 7.81 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.086 -1.079 . . . . 55.23 108.086 171.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -79.33 99.92 7.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.345 -1.298 . . . . 73.11 108.685 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.14 157.81 18.39 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 112.073 -0.411 . . . . 65.14 112.073 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.403 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -154.51 131.06 3.05 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 110.849 -0.9 . . . . 72.25 110.849 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -81.12 125.21 39.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.499 -0.926 . . . . 72.21 108.499 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.698 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 30.8 m-85 -131.06 119.95 22.73 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.845 -0.798 . . . . 63.13 108.845 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -91.8 108.63 20.05 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.286 -1.005 . . . . 64.0 108.286 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.599 HD11 ' HD2' ' A' ' 56' ' ' TYR . 2.6 pp -118.65 147.61 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.541 0.737 . . . . 75.34 110.533 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.34 176.92 6.36 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.137 0.975 . . . . 74.34 110.0 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.25 -24.58 21.61 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.854 -0.612 . . . . 53.02 113.583 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -136.39 148.83 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.501 0.72 . . . . 73.05 110.954 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.68 175.01 9.96 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.875 0.87 . . . . 70.21 109.365 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.37 -128.69 13.64 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 123.459 0.552 . . . . 63.13 112.386 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.607 ' HB ' HD11 ' A' ' 141' ' ' LEU . 61.4 p -68.84 -22.06 64.25 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.261 1.024 . . . . 63.01 111.958 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -68.45 -51.07 47.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.846 0.858 . . . . 74.33 110.68 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.498 ' SD ' HD13 ' A' ' 86' ' ' ILE . 41.5 ttp -78.08 -23.03 48.15 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 116.275 -0.42 . . . . 73.21 110.402 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -37.7 86.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.154 0.582 . . . . 61.34 110.199 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -67.72 -35.15 78.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.544 0.738 . . . . 62.4 110.85 174.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 76.8 m -62.1 -54.07 46.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.756 0.423 . . . . 71.5 110.582 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.442 HD22 HD13 ' E' ' 454' ' ' LEU . 3.7 pp -73.16 -34.5 66.08 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.771 0.428 . . . . 75.24 111.39 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.67 -2.0 56.39 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 114.905 0.722 . . . . 70.3 114.905 -168.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -148.75 -61.75 0.24 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.649 0.724 . . . . 74.3 112.727 -175.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -72.17 -61.91 1.62 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.106 0.963 . . . . 72.33 112.709 -165.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 72.7 m -67.65 -34.96 7.24 Favored Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 114.026 1.121 . . . . 75.43 114.026 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 27.9 Cg_endo -64.64 -31.09 59.97 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 121.769 1.646 . . . . 74.13 113.357 167.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 25.8 t-20 -67.89 -29.92 69.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.097 0.559 . . . . 61.13 110.206 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.15 -42.81 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.845 0.858 . . . . 61.32 110.573 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.403 HD21 ' HA3' ' A' ' 82' ' ' GLY . 42.9 mt -82.16 -20.79 37.2 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.474 1.11 . . . . 72.53 112.575 -173.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.77 -44.77 91.91 Favored Pre-proline 0 CA--C 1.572 1.805 0 C-N-CA 124.033 0.933 . . . . 73.5 113.437 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -64.73 -32.38 57.02 Favored 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 122.36 2.04 . . . . 75.44 113.434 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -70.8 -40.66 72.4 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.144 0.577 . . . . 71.23 110.933 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.37 -38.8 78.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.968 0.507 . . . . 74.41 110.49 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.424 ' HB2' HD11 ' A' ' 128' ' ' LEU . 36.0 ttm180 -51.09 -56.25 13.58 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.088 0.867 . . . . 73.5 109.517 172.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -59.11 -47.74 84.16 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.609 1.164 . . . . 74.21 112.163 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.06 -44.89 87.71 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.999 0.812 . . . . 53.55 110.975 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.53 HG21 HG21 ' A' ' 64' ' ' VAL . 96.6 mt -67.53 -49.05 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.039 0.936 . . . . 71.44 110.586 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.51 HG23 ' HG3' ' A' ' 125' ' ' GLN . 36.3 m -53.25 -40.72 64.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.146 0.978 . . . . 75.41 111.208 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.28 -47.82 66.64 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.989 -1.005 . . . . 73.53 110.018 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 42.5 mtp -60.92 -41.09 95.51 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 124.077 0.951 . . . . 72.01 111.686 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.8 t -65.62 -44.15 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.17 0.988 . . . . 64.04 110.339 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.9 t -68.53 -31.82 71.32 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.6 0.76 . . . . 64.52 111.313 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -72.69 -29.94 63.82 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.38 0.672 . . . . 70.02 110.075 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.52 2.64 84.99 Favored Glycine 0 C--N 1.357 1.718 0 O-C-N 123.69 0.619 . . . . 71.44 112.896 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.3 m 68.0 22.9 8.35 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.768 1.227 . . . . 74.52 111.151 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -91.93 150.88 41.4 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 123.355 0.662 . . . . 70.14 109.222 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.46 139.48 90.8 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.577 2.184 . . . . 71.33 112.575 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.51 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.0 tt0 -57.73 150.04 20.63 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.814 1.246 . . . . 71.43 112.682 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.541 ' HA ' ' HA3' ' E' ' 469' ' ' GLY . 2.9 pp -126.65 137.46 53.29 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.846 -1.168 . . . . 75.02 107.846 173.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.453 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 86.6 m-20 -135.69 84.05 2.06 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.751 -1.203 . . . . 41.43 107.751 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 111' ' ' ARG . 2.7 pp -65.1 135.62 55.75 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.146 -0.479 . . . . 71.3 110.645 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.17 140.81 98.06 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 123.069 0.548 . . . . 42.23 110.068 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.75 126.92 22.63 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.196 1.931 . . . . 64.32 111.384 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 91.3 t -97.46 113.86 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 106.62 -1.622 . . . . 60.1 106.62 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -75.48 83.93 2.56 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.946 -1.131 . . . . 70.11 107.946 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -60.4 -33.41 72.45 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.108 -0.951 . . . . 74.04 110.589 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.05 -40.46 90.98 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.074 0.95 . . . . 63.12 110.98 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.06 -50.55 61.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.254 0.621 . . . . 75.51 110.259 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.0 mt -64.04 -42.15 97.17 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.22 -0.9 . . . . 63.53 111.573 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -66.49 -41.02 89.56 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.237 -0.892 . . . . 72.45 109.375 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.413 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -66.05 -36.64 83.77 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 123.897 0.748 . . . . 71.33 109.774 -177.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -57.55 -39.57 76.97 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.019 0.528 . . . . 73.01 111.214 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -73.64 -39.67 64.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.137 0.575 . . . . 75.44 110.738 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.607 HD11 ' HB ' ' A' ' 92' ' ' THR . 64.5 tp -61.69 -46.48 89.53 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.744 1.218 . . . . 74.43 111.814 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -175.45 -18.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.285 0.634 . . . . 73.12 110.941 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 54.67 75.23 0.31 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.047 1.739 . . . . 64.54 110.909 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -144.01 88.92 1.99 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.358 -0.837 . . . . 71.1 109.193 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.0 160.16 20.09 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 124.479 1.112 . . . . 71.11 110.349 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -144.99 147.53 18.76 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 111.7 -0.56 . . . . 74.45 111.7 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.2 133.36 29.6 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 107.899 -1.148 . . . . 72.41 107.899 -177.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.41 41.15 0.28 Allowed Glycine 0 C--N 1.345 1.028 0 CA-C-O 119.711 -0.494 . . . . 62.42 113.426 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.3 p -69.49 98.75 1.16 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.975 0.387 . . . . 65.33 111.081 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -81.02 163.89 22.91 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.079 0.951 . . . . 75.24 109.318 171.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.59 139.62 39.55 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 109.31 -0.626 . . . . 74.13 109.31 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -89.1 3.61 51.23 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.797 0.839 . . . . 73.11 112.293 -173.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 67.23 -168.38 0.2 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.58 1.152 . . . . 74.34 110.619 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -76.52 128.42 34.73 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.972 -0.751 . . . . 53.04 108.972 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 N-CA-C 108.921 -0.77 . . . . 71.13 108.921 -177.325 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 109.196 -0.668 . . . . 53.23 109.196 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 37.5 p -135.21 62.89 1.63 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.76 0.824 . . . . 73.11 110.457 -176.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -78.28 104.07 8.63 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 107.857 -1.164 . . . . 65.41 107.857 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -122.62 79.05 1.59 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.334 0.654 . . . . 75.51 109.549 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -73.99 138.98 44.49 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.466 -0.568 . . . . 70.34 109.466 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -81.24 136.44 35.82 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.175 0.59 . . . . 74.15 109.583 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.4 t -78.23 149.51 33.63 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 123.549 0.531 . . . . 71.32 109.855 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.18 -143.84 0.32 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 107.779 -1.193 . . . . 55.52 107.779 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.561 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 12.2 ptm 59.41 171.26 0.07 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.548 1.939 . . . . 71.24 114.435 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.638 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 70.6 m -150.85 136.86 18.3 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 125.346 1.458 . . . . 64.52 107.122 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -139.39 141.49 37.55 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.759 0.423 . . . . 75.01 110.252 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -144.67 138.12 27.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.592 0.757 . . . . 71.13 109.906 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.94 126.78 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.048 -1.093 . . . . 73.43 108.048 171.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -95.35 -50.32 5.07 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.699 0.4 . . . . 72.24 110.079 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -161.72 131.07 4.56 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.531 -0.544 . . . . 74.33 109.531 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.2 mt -115.35 131.95 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 107.924 -1.139 . . . . 72.03 107.924 171.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -156.85 138.28 13.92 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.41 0.684 . . . . 71.4 110.144 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.5 m -72.23 121.84 20.04 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.478 -0.934 . . . . 55.42 108.478 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.426 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.8 mtpt -95.33 -23.5 17.17 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.433 0.693 . . . . 71.01 111.042 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -161.69 141.03 9.97 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.399 0.437 . . . . 74.12 110.732 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 33.7 mm -134.23 144.46 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.159 1.384 . . . . 73.3 108.765 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -138.55 139.95 38.87 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.591 -1.186 . . . . 73.21 107.974 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 85.2 t80 -152.58 130.61 11.84 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.637 -1.246 . . . . 74.53 107.637 166.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 49.0 mt-10 -140.45 116.7 10.61 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.645 0.778 . . . . 61.12 108.918 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.674 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -105.29 84.29 1.07 Allowed Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 106.922 -1.51 . . . . 54.0 106.922 165.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.39 -23.83 20.03 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.954 2.436 . . . . 70.32 111.97 -170.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 78.3 m-20 -116.93 6.71 13.07 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 114.433 -1.258 . . . . 75.03 110.368 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.674 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -29.13 -66.05 0.15 Allowed Pre-proline 0 C--N 1.38 1.899 0 C-N-CA 126.163 1.785 . . . . 55.01 114.787 -171.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.8 Cg_exo -64.78 -29.46 59.29 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 122.585 2.19 . . . . 64.43 112.509 -169.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -46.47 14.52 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.364 -0.835 . . . . 72.23 110.752 176.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.597 HG22 HD12 ' B' ' 68' ' ' LEU . 2.7 p -70.31 -17.85 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.147 0.579 . . . . 64.2 111.986 -166.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -69.37 -11.64 60.99 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 112.654 0.613 . . . . 73.35 112.654 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -77.28 -3.42 39.74 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.191 0.596 . . . . 73.0 110.877 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.7 105.35 15.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.907 1.283 . . . . 75.01 110.093 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.93 91.91 7.7 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.842 0.857 . . . . 65.21 109.729 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -161.92 155.57 21.3 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.918 0.887 . . . . 72.4 108.922 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.502 ' HG3' HD13 ' F' ' 470' ' ' LEU . 7.9 tp60 -81.97 102.95 1.78 Allowed Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 107.201 -1.407 . . . . 74.14 107.201 170.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.67 133.35 31.54 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.555 2.17 . . . . 52.45 112.308 -171.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.405 ' HA ' HD21 ' F' ' 470' ' ' LEU . 35.5 tt0 -69.23 129.54 40.11 Favored 'General case' 0 C--N 1.355 0.817 0 O-C-N 123.855 0.722 . . . . 54.44 110.026 -175.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.668 ' H ' HD21 ' F' ' 470' ' ' LEU . 74.9 t -106.13 129.84 58.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.49 1.116 . . . . 74.31 109.968 -171.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -103.98 112.66 25.74 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 105.84 -1.911 . . . . 72.2 105.84 167.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.58 153.23 18.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.921 -1.036 . . . . 71.25 108.784 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.6 t70 -144.59 110.62 5.44 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.022 -0.732 . . . . 75.24 109.022 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -109.04 134.89 51.08 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.14 -1.059 . . . . 74.04 108.14 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -159.54 156.24 27.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.395 0.678 . . . . 75.35 109.377 170.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.6 p -124.82 128.33 48.54 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.352 0.661 . . . . 50.14 109.833 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.5 158.19 21.94 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.738 -1.208 . . . . 74.11 107.738 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.434 ' HB3' HD21 ' B' ' 98' ' ' LEU . 13.3 p -142.27 168.78 18.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.53 0.332 . . . . 60.13 111.107 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 2.1 m -148.53 136.06 20.52 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.424 -0.954 . . . . 53.12 108.424 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -90.36 100.53 13.35 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.416 -0.957 . . . . 63.52 108.416 170.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.21 -33.44 59.26 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.637 -0.71 . . . . 75.43 109.911 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.02 -175.35 3.33 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.147 -0.933 . . . . 72.52 110.696 -177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.28 122.22 16.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.371 -1.286 . . . . 71.02 109.154 173.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 66.62 14.65 9.85 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.926 0.891 . . . . 51.22 112.379 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -118.5 119.78 62.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 123.642 0.777 . . . . 74.11 109.032 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -112.64 152.78 28.56 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.641 0.776 . . . . 72.41 110.172 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 6.8 tm-20 -124.66 97.18 5.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.508 -1.664 . . . . 75.21 106.508 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.401 HG22 ' HG ' ' B' ' 98' ' ' LEU . 90.4 t -86.51 143.99 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.048 -0.978 . . . . 71.34 109.792 -175.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -131.95 112.43 20.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.432 -0.951 . . . . 74.35 108.432 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.439 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -93.64 118.72 31.75 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.465 -1.309 . . . . 70.02 107.465 177.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 69.3 ttt-85 -107.43 110.07 21.94 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.975 0.51 . . . . 74.53 109.719 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.407 ' HB ' HD11 ' B' ' 114' ' ' ILE . 22.8 t -108.11 104.31 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.982 -1.118 . . . . 64.04 107.982 173.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 11.1 m -100.54 137.37 39.04 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.116 -0.698 . . . . 63.51 109.116 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.661 HG21 HG21 ' B' ' 114' ' ' ILE . 50.3 t -123.82 126.49 72.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.982 1.313 . . . . 64.11 108.822 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 52.4 m -125.09 139.01 54.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.476 -1.305 . . . . 72.23 107.476 170.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' B' ' 40' ' ' VAL . . . -146.03 151.6 38.01 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.605 -0.517 . . . . 64.44 109.605 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 27.7 p -149.07 139.57 22.51 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 123.699 0.624 . . . . 60.3 112.132 -174.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.597 HD12 HG22 ' B' ' 31' ' ' VAL . 86.3 mt -106.08 102.22 11.66 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.639 1.176 . . . . 72.24 108.328 172.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.02 -131.5 12.46 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.786 -0.643 . . . . 44.44 112.541 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -86.97 3.81 44.3 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.384 1.073 . . . . 70.2 112.446 -175.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.493 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.9 pt-20 -132.16 155.61 47.89 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.957 0.503 . . . . 71.21 111.095 -175.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.6 m -67.1 137.3 56.26 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.891 0.744 . . . . 74.24 110.85 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.439 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -91.06 -67.29 0.86 Allowed 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.697 -1.223 . . . . 75.35 107.697 173.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -144.3 145.59 32.1 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-O 121.407 0.622 . . . . 73.1 110.626 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 94.1 mt -117.14 149.46 40.32 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.309 1.444 . . . . 72.53 107.281 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.531 ' SG ' HG23 ' B' ' 114' ' ' ILE . 42.5 t -158.15 158.53 34.81 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.659 -0.867 . . . . 63.02 108.659 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -165.73 133.54 2.96 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.994 -1.113 . . . . 63.45 107.994 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.468 HG23 HG12 ' B' ' 114' ' ' ILE . 94.2 t -124.88 141.32 45.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.615 -0.883 . . . . 62.44 108.615 174.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -119.63 84.19 2.16 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.3 -1.37 . . . . 63.22 107.3 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.77 99.33 7.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.357 -1.292 . . . . 64.43 109.079 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.426 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -96.0 171.41 28.52 Favored Glycine 0 C--O 1.245 0.788 0 CA-C-N 115.774 -0.648 . . . . 72.25 112.006 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.54 130.88 1.94 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 112.029 -0.429 . . . . 64.13 112.029 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 63.8 mt -83.73 127.29 39.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 108.293 -1.003 . . . . 75.41 108.293 170.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -136.08 143.28 44.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.646 0.778 . . . . 65.31 109.163 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -104.05 125.3 50.29 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.691 0.796 . . . . 72.1 109.014 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.622 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.8 pp -119.23 145.01 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.217 1.007 . . . . 55.42 110.103 -176.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.638 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.04 162.11 41.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.584 0.754 . . . . 75.33 110.119 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.72 -57.13 5.05 Favored Glycine 0 C--N 1.354 1.567 0 O-C-N 123.683 0.614 . . . . 60.24 112.854 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.622 HD11 ' HB ' ' B' ' 86' ' ' ILE . 11.8 pt -58.19 148.39 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.762 1.225 . . . . 74.43 112.178 174.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.514 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 31.2 tt0 -160.84 152.52 19.56 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.999 -1.0 . . . . 74.4 109.843 -175.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.8 -112.76 4.08 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 112.206 -0.358 . . . . 63.32 112.206 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.9 m -92.51 -16.98 25.08 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.895 0.478 . . . . 63.32 111.139 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.514 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 45.6 mt-30 -59.76 -39.22 84.09 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.268 0.627 . . . . 64.4 110.725 175.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.584 ' HA ' HD12 ' B' ' 89' ' ' ILE . 26.2 ptt? -74.71 -25.25 59.01 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.647 -0.706 . . . . 52.04 110.993 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.33 -33.5 71.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.412 0.685 . . . . 64.11 110.466 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -65.4 -39.19 91.89 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.548 0.739 . . . . 73.32 110.685 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.48 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 44.5 t -70.42 -58.06 4.13 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.758 -0.655 . . . . 65.43 110.547 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' B' ' 48' ' ' SER . 7.8 tt -65.13 -43.74 90.91 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.425 0.69 . . . . 65.21 111.38 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.19 -26.03 49.68 Favored Glycine 0 C--N 1.341 0.839 0 O-C-N 123.763 0.664 . . . . 61.1 114.238 -170.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.59 -53.17 1.25 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.215 0.508 . . . . 41.24 112.328 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.48 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 79.7 t80 -71.33 -45.72 62.29 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.565 0.746 . . . . 72.12 112.626 -169.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.533 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 81.0 m -67.82 -49.0 39.93 Favored Pre-proline 0 CA--C 1.565 1.551 0 C-N-CA 123.702 0.801 . . . . 73.13 110.424 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 66.8 Cg_exo -57.07 -30.04 85.36 Favored 'Trans proline' 0 C--N 1.399 3.229 0 C-N-CA 122.844 2.363 . . . . 74.52 113.898 169.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -62.55 -41.54 98.97 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.593 0.757 . . . . 73.3 109.803 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.79 -44.26 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.626 0.77 . . . . 73.21 110.063 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.3 mt -78.92 -15.76 57.9 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.029 0.932 . . . . 70.34 112.583 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -62.21 -51.82 71.34 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 118.102 -0.951 . . . . 72.03 113.348 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.27 -34.97 87.0 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 121.825 1.684 . . . . 74.12 112.515 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -62.73 -50.46 71.02 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.906 0.883 . . . . 75.32 110.911 177.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.41 97.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.789 0.836 . . . . 71.52 110.631 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -59.2 -54.34 48.03 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.636 1.574 . . . . 74.41 111.131 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.54 -30.66 70.36 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.193 0.597 . . . . 74.13 110.037 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.567 ' SG ' HD11 ' B' ' 21' ' ' ILE . 1.8 t -69.98 -28.42 65.52 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.745 0.418 . . . . 73.52 111.595 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.661 HG21 HG21 ' B' ' 64' ' ' VAL . 45.8 mt -76.03 -54.48 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 109.176 -0.676 . . . . 74.22 109.176 172.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.43 HG21 ' OG ' ' C' ' 119' ' ' SER . 23.5 m -54.2 -33.43 58.2 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.623 1.202 . . . . 71.01 111.568 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 24.8 t -60.42 -54.17 48.81 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 115.24 -0.891 . . . . 62.43 109.589 175.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.1 mmt -68.94 -35.33 76.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.7 0.8 . . . . 61.21 111.482 -173.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.422 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.3 t -60.63 -46.08 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.0 0.92 . . . . 74.33 109.811 174.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 34.8 t -72.59 -28.86 63.05 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.651 -1.159 . . . . 64.42 111.383 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.2 mtt-85 -68.75 -35.39 77.03 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.524 0.73 . . . . 65.51 109.533 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.71 11.13 57.73 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 124.119 0.887 . . . . 74.32 112.816 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.467 HG23 ' HB3' ' A' ' 17' ' ' TYR . 75.6 p 56.58 24.12 8.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.235 1.814 . . . . 74.13 113.631 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -84.52 154.81 62.55 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 123.326 0.65 . . . . 71.42 110.34 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.35 169.94 5.88 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.955 2.437 . . . . 72.4 113.778 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -63.62 131.18 47.18 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.01 -0.995 . . . . 74.04 112.211 -166.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.2 tp -135.11 111.54 9.81 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.859 0.863 . . . . 75.31 109.043 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -134.2 114.74 13.39 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.345 0.658 . . . . 73.34 109.272 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.419 HD13 HD23 ' F' ' 468' ' ' LEU . 4.2 mm? -60.27 141.75 55.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.794 0.837 . . . . 72.34 111.086 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.46 144.07 96.06 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.412 0.685 . . . . 75.44 110.365 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -69.32 100.54 0.77 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.405 2.07 . . . . 75.4 111.339 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.48 110.76 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.587 -0.894 . . . . 74.54 108.587 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -78.96 83.92 5.02 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.987 -1.116 . . . . 73.33 107.987 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -52.67 -39.11 61.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.578 1.151 . . . . 61.0 112.871 -172.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.41 -34.59 75.64 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.483 1.113 . . . . 72.03 112.396 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.79 -41.07 60.68 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.43 0.692 . . . . 64.41 110.863 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -70.13 -29.77 66.79 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.467 -0.788 . . . . 74.43 110.072 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.47 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 80.9 t80 -68.76 -33.35 73.75 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.976 0.91 . . . . 73.24 110.469 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -39.34 83.78 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.437 0.637 . . . . 75.01 109.837 177.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -88.57 -12.09 43.73 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.922 -1.035 . . . . 65.54 110.704 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -71.07 -33.99 70.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.397 0.679 . . . . 75.3 110.193 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 40.7 mt -82.71 -6.23 59.28 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 114.914 -1.039 . . . . 73.35 111.901 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.51 ' HG3' ' HG2' ' B' ' 144' ' ' GLN . 7.1 tp60 -151.2 115.73 5.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.81 -0.811 . . . . 64.52 108.81 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -84.46 49.84 1.76 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.46 1.104 . . . . 45.31 111.602 -168.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.51 ' HG2' ' HG3' ' B' ' 142' ' ' GLN . 20.2 pt20 -158.49 170.81 21.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.449 1.1 . . . . 65.02 109.519 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.92 138.33 50.84 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.865 0.866 . . . . 61.1 109.145 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.52 137.74 23.06 Favored Glycine 0 C--N 1.348 1.227 0 O-C-N 123.531 0.519 . . . . 73.11 111.848 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.53 106.21 1.38 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.643 0.777 . . . . 73.22 110.346 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.4 148.71 46.58 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.782 0.676 . . . . 74.4 112.355 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.2 t -84.38 49.71 1.73 Allowed 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 122.304 1.049 . . . . 63.12 109.959 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -67.41 95.48 0.45 Allowed 'General case' 0 C--O 1.244 0.764 0 CA-C-N 114.276 -1.329 . . . . 73.01 110.865 -168.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.7 118.79 14.97 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 123.56 0.538 . . . . 74.14 109.661 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -88.27 -13.98 39.55 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.314 -0.857 . . . . 70.44 110.731 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -81.71 109.22 15.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.69 0.796 . . . . 73.21 109.768 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.36 158.84 33.24 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.946 0.898 . . . . 74.44 110.834 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.165 0 C-N-CA 124.479 1.112 . . . . 64.24 111.311 -177.053 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.405 -0.591 . . . . 74.53 109.405 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 35.2 m -72.64 125.89 28.56 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.565 0.746 . . . . 61.54 111.277 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.24 90.28 3.3 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.994 0.917 . . . . 72.42 110.535 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -95.32 126.81 40.89 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.087 0.555 . . . . 74.55 110.242 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -124.25 114.23 19.33 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.106 0.962 . . . . 75.32 108.652 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -131.1 -81.41 0.53 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.376 0.67 . . . . 64.12 111.106 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 27.1 p -106.17 -4.31 20.4 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.347 0.659 . . . . 70.43 112.766 -170.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -86.49 53.2 2.72 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.312 0.645 . . . . 62.42 111.432 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.475 ' HG3' HD12 ' C' ' 89' ' ' ILE . 1.4 mpt? 61.31 126.13 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.286 1.434 . . . . 75.53 112.352 -175.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 29.2 m -85.78 78.72 9.49 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.654 -1.61 . . . . 73.31 106.654 167.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -104.04 122.33 45.05 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.831 -1.077 . . . . 70.15 109.479 -172.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -137.05 108.12 6.74 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 107.289 -1.374 . . . . 75.02 107.289 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 42.8 mt -67.73 119.17 12.94 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 108.112 -1.07 . . . . 44.33 108.112 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.652 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.7 mm-40 -78.34 -48.88 14.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.791 0.682 . . . . 73.14 109.431 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.453 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 25.2 ttt180 -172.24 138.65 0.98 Allowed 'General case' 0 C--N 1.349 0.58 0 CA-C-N 115.526 -0.761 . . . . 75.01 110.271 -169.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.3 mt -120.78 139.42 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.56 -1.274 . . . . 65.41 107.56 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -172.99 166.68 5.06 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.257 0.551 . . . . 73.1 111.015 -172.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -94.12 124.8 38.36 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.634 -0.712 . . . . 65.25 109.287 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.605 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.0 OUTLIER -81.61 -49.06 10.96 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.985 -1.487 . . . . 44.43 106.985 173.561 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.2 t70 -135.7 132.65 37.17 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.198 -1.819 . . . . 70.41 109.068 -168.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.5 mt -135.17 141.41 42.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.828 -1.545 . . . . 73.24 106.828 173.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.4 t -159.51 150.36 19.51 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.443 0.639 . . . . 73.32 110.597 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -145.71 139.8 26.78 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.336 -1.357 . . . . 74.1 107.336 174.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.84 120.3 12.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.644 0.778 . . . . 73.24 109.476 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.82 87.15 36.49 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 107.047 -1.464 . . . . 74.31 107.047 168.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.61 -38.34 25.28 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.077 2.518 . . . . 71.53 111.828 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -102.24 29.35 5.19 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.19 -1.368 . . . . 62.12 110.069 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.41 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -51.85 -55.6 28.85 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.457 1.103 . . . . 71.2 113.926 -171.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 33.5 Cg_exo -57.67 -44.9 37.27 Favored 'Trans proline' 0 C--N 1.39 2.747 0 CA-C-N 121.714 1.648 . . . . 62.31 112.927 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -69.95 -35.29 74.38 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.718 0.807 . . . . 72.51 112.238 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.751 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.9 p -78.23 -23.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.823 0.449 . . . . 72.52 111.874 -172.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -69.15 -33.27 73.17 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.627 0.251 . . . . 74.14 110.494 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -94.4 38.9 1.09 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.598 0.759 . . . . 73.02 110.374 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.714 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -119.96 141.71 49.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.749 1.22 . . . . 75.41 109.533 174.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.59 99.99 1.38 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.063 -1.088 . . . . 60.41 108.063 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -80.6 115.15 19.96 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.675 0.75 . . . . 75.23 112.548 -171.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -122.2 79.05 43.82 Favored Pre-proline 0 CA--C 1.555 1.137 0 N-CA-C 106.843 -1.54 . . . . 74.0 106.843 162.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.1 128.19 7.21 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.363 2.709 . . . . 65.3 112.946 -172.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -84.82 89.24 7.5 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.435 -1.32 . . . . 70.15 107.435 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.37 99.8 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.017 -1.447 . . . . 55.41 109.168 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.517 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 57.2 tttm -92.75 112.54 24.53 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.723 -0.843 . . . . 73.44 108.723 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.741 HD11 HD11 ' G' ' 468' ' ' LEU . 3.0 mm? -87.65 125.05 34.15 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.064 -0.717 . . . . 61.23 109.064 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.428 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.9 t70 -121.49 131.06 53.93 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.919 -1.141 . . . . 74.13 107.919 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.561 ' HB2' HD11 ' G' ' 460' ' ' LEU . 45.5 mt -120.6 147.04 45.74 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.827 -1.175 . . . . 74.21 107.827 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 22.8 t70 -157.48 152.77 26.09 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.235 0.614 . . . . 62.5 109.725 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 11.2 m -137.41 128.02 26.84 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.631 0.729 . . . . 72.51 110.045 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.83 161.68 16.66 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.151 -1.386 . . . . 72.24 108.554 176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 20.3 p -159.31 151.36 20.87 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.858 0.361 . . . . 43.34 111.165 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 86.4 p -145.14 142.68 29.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.131 0.972 . . . . 64.55 108.747 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -82.87 118.06 23.17 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.426 -0.583 . . . . 71.43 109.426 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.611 HD11 HD12 ' C' ' 83' ' ' ILE . 38.6 mt -92.59 -40.05 10.99 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.609 0.763 . . . . 73.13 109.248 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.5 -175.73 5.49 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.263 1.025 . . . . 74.43 109.348 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.31 108.85 1.71 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.544 -0.753 . . . . 64.11 109.925 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 32.6 m-20 71.8 5.87 5.49 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.55 1.54 . . . . 74.43 112.668 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -103.23 97.78 6.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.964 -1.125 . . . . 70.14 107.964 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.437 ' HE2' HG12 ' G' ' 452' ' ' VAL . 51.0 m-85 -103.43 137.82 41.0 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.46 0.704 . . . . 72.51 110.097 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.525 ' HB2' HD11 ' C' ' 51' ' ' LEU . 22.1 tt0 -81.9 108.99 15.85 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.745 -1.576 . . . . 64.13 106.745 164.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 50.9 t -96.97 137.26 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 108.166 -1.05 . . . . 72.43 108.166 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.447 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 52.1 t -127.4 129.88 70.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.235 -1.024 . . . . 71.34 108.235 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.7 104.5 13.51 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.831 -1.544 . . . . 63.33 106.831 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.554 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 9.2 ttm180 -90.27 120.79 31.71 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.862 -1.063 . . . . 72.43 108.326 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.28 123.93 71.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.836 -1.172 . . . . 72.03 107.836 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 27.0 m -126.03 123.67 38.95 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.612 -0.885 . . . . 54.22 108.612 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.745 HG11 HD21 ' C' ' 126' ' ' LEU . 34.2 t -114.03 120.87 64.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 108.795 -0.817 . . . . 55.32 108.795 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 30.8 m -101.19 143.86 30.76 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.641 0.776 . . . . 75.11 108.967 172.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.67 107.86 6.08 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.12 -1.437 . . . . 74.51 107.12 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.2 m -128.02 131.72 49.16 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.519 -0.549 . . . . 72.43 109.519 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.714 HD13 ' HG2' ' C' ' 34' ' ' LYS . 25.0 mt -85.15 43.18 0.99 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.281 1.832 . . . . 75.13 110.045 -176.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.62 -88.68 0.68 Allowed Glycine 0 C--N 1.343 0.919 0 N-CA-C 110.303 -1.119 . . . . 71.41 110.303 -170.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -118.5 -20.09 8.55 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.816 0.846 . . . . 71.53 110.746 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -77.48 100.48 6.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.739 0.816 . . . . 74.23 109.143 172.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.7 m -66.85 120.26 13.26 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 118.922 0.783 . . . . 72.41 109.197 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.751 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.67 -52.36 18.3 Favored 'General case' 0 C--O 1.24 0.594 0 O-C-N 124.095 0.872 . . . . 74.22 108.984 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -166.56 167.4 15.52 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.617 -1.174 . . . . 55.14 110.843 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -133.9 139.43 46.17 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 106.309 -1.737 . . . . 74.23 106.309 171.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.4 t -146.53 117.82 7.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.298 -0.631 . . . . 63.11 109.298 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -125.57 126.55 44.97 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 122.954 0.502 . . . . 73.43 109.909 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -120.46 132.46 70.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.338 -0.986 . . . . 63.34 108.338 167.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.554 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 69.0 mt-30 -106.08 94.66 5.29 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.587 -1.264 . . . . 72.1 107.587 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -84.2 105.73 15.28 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.532 -0.758 . . . . 64.03 109.701 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.605 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -95.64 163.73 23.86 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-O 121.609 0.56 . . . . 74.0 112.858 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.518 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -164.38 126.6 1.53 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.013 -1.235 . . . . 75.11 110.013 -177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 14.0 mm -85.23 128.77 38.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.125 -1.065 . . . . 74.43 108.125 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.11 119.41 20.91 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.392 -0.595 . . . . 75.14 109.392 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -83.95 107.58 16.41 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.162 -1.051 . . . . 72.1 108.162 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.447 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.4 pp -122.45 142.87 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.102 0.961 . . . . 73.24 110.144 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.479 ' HA ' HG21 ' G' ' 451' ' ' VAL . . . -161.92 169.53 21.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.628 0.771 . . . . 22.24 110.512 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.89 -44.21 1.52 Allowed Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.104 -0.498 . . . . 51.22 111.944 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.605 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -109.38 149.6 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.114 0.965 . . . . 63.03 109.234 178.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 11.7 pt-20 -143.01 172.59 12.5 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.652 0.263 . . . . 73.3 111.456 -171.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.81 -129.47 48.37 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.201 -0.909 . . . . 73.31 112.486 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -66.86 -19.32 65.71 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.671 0.788 . . . . 62.33 112.08 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -78.31 -35.26 48.0 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.404 0.681 . . . . 61.41 110.421 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.567 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 10.9 tmm? -72.63 -38.53 67.71 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.427 -0.953 . . . . 72.14 108.427 172.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.87 -32.8 71.05 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 115.248 -0.887 . . . . 62.13 110.558 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -77.37 -34.54 55.0 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.374 0.421 . . . . 73.12 110.918 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 15.2 t -63.29 -34.97 78.85 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.005 0.815 . . . . 63.54 109.913 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -99.15 -12.46 20.45 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.99 0.516 . . . . 65.44 111.969 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.29 -31.51 59.2 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 114.562 0.585 . . . . 51.12 114.562 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.9 -38.09 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.797 0.439 . . . . 73.43 111.042 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -56.93 -41.81 78.91 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 125.419 1.488 . . . . 74.54 112.209 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.2 m -82.26 -48.59 0.89 Allowed Pre-proline 0 CA--C 1.569 1.708 0 N-CA-C 112.897 0.703 . . . . 64.33 112.897 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.98 -29.85 28.83 Favored 'Trans proline' 0 C--N 1.392 2.855 0 C-N-CA 123.21 2.607 . . . . 73.04 115.131 172.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.24 -35.41 80.74 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.907 0.883 . . . . 63.35 110.836 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.422 HG23 ' NH1' ' A' ' 111' ' ' ARG . 40.9 mm -64.71 -40.3 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 115.511 -0.768 . . . . 75.13 109.585 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.518 HD21 ' HA3' ' C' ' 82' ' ' GLY . 53.5 mt -83.55 -18.14 39.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.652 1.181 . . . . 71.32 112.14 -175.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -56.75 -51.34 82.16 Favored Pre-proline 0 CA--C 1.56 1.352 0 N-CA-C 114.132 1.16 . . . . 75.41 114.132 -173.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.427 ' HA ' HH11 ' C' ' 111' ' ' ARG . 18.3 Cg_exo -66.15 -32.16 43.58 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 121.607 1.538 . . . . 61.3 112.778 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -65.63 -46.92 77.43 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.542 0.737 . . . . 74.45 110.503 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.04 -42.65 90.73 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.051 0.94 . . . . 73.32 110.679 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.427 HH11 ' HA ' ' C' ' 108' ' ' PRO . 27.6 mtp-105 -57.03 -55.93 28.33 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.333 1.02 . . . . 75.14 111.051 176.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.12 -29.91 70.8 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.139 0.576 . . . . 74.21 110.628 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 10.6 t -74.39 -33.13 62.96 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.265 0.626 . . . . 51.04 111.303 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.409 ' O ' HG23 ' C' ' 118' ' ' VAL . 71.5 mt -72.76 -51.29 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.037 0.535 . . . . 72.44 109.654 173.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 25.8 m -59.99 -32.96 71.33 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.094 0.957 . . . . 75.13 111.349 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.0 t -61.57 -51.51 68.26 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.189 -0.671 . . . . 65.33 109.189 172.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.583 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.69 -35.54 78.3 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.703 1.201 . . . . 65.12 112.914 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.409 HG23 ' O ' ' C' ' 114' ' ' ILE . 98.4 t -66.55 -47.13 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.52 0.728 . . . . 74.01 109.925 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.43 ' OG ' HG21 ' B' ' 115' ' ' THR . 48.4 t -66.18 -32.19 73.47 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.93 -1.032 . . . . 74.1 111.091 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.01 -35.53 74.44 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.73 0.812 . . . . 63.4 109.399 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 4.33 79.46 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.878 0.736 . . . . 74.33 112.873 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 60.0 p 59.38 25.55 14.28 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.509 1.924 . . . . 72.11 114.08 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -87.82 152.87 51.92 Favored Pre-proline 0 CA--C 1.557 1.237 0 N-CA-C 107.567 -1.272 . . . . 63.43 107.567 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.69 -179.81 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.729 2.286 . . . . 73.12 113.739 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -49.66 130.63 21.07 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.664 1.186 . . . . 64.41 112.89 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.745 HD21 HG11 ' C' ' 64' ' ' VAL . 14.3 tp -148.84 85.28 1.48 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.29 -1.004 . . . . 72.3 108.29 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -116.31 129.79 56.45 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.159 -1.052 . . . . 65.12 108.159 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 21.4 tp -76.18 132.69 40.11 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 109.78 -0.452 . . . . 71.43 109.78 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.1 154.91 75.78 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.243 1.017 . . . . 74.32 111.15 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -50.11 101.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.907 2.405 . . . . 72.4 112.867 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 80.8 t -96.55 110.69 25.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.217 -1.031 . . . . 55.1 108.217 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -87.12 86.14 7.27 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.898 -1.149 . . . . 54.13 107.898 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -60.55 -31.4 70.51 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.303 0.641 . . . . 52.11 110.227 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' C' ' 138' ' ' MET . 6.8 t70 -68.7 -36.94 79.13 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.336 1.054 . . . . 63.23 112.263 -165.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.45 74.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.98 0.912 . . . . 72.02 111.188 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.29 -23.97 34.92 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.182 -0.917 . . . . 74.41 111.452 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -81.73 -15.17 55.21 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.011 0.434 . . . . 65.21 109.997 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.581 ' HB3' HE21 ' C' ' 142' ' ' GLN . 67.2 mtt -71.66 -32.1 67.53 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.577 -0.527 . . . . 74.2 109.577 168.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -65.33 -34.92 79.45 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.183 0.593 . . . . 71.34 110.347 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -56.35 -82.74 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 109.005 -0.739 . . . . 72.12 109.005 168.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 8.0 tt -134.25 107.16 7.51 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.127 0.489 . . . . 55.33 109.978 172.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.581 HE21 ' HB3' ' C' ' 138' ' ' MET . 8.1 tt0 -110.67 -56.04 2.4 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 106.861 -1.533 . . . . 65.41 106.861 160.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -174.72 -49.83 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.071 -1.422 . . . . 72.22 109.217 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -169.13 -60.77 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.888 -1.523 . . . . 71.54 106.888 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.88 164.78 0.18 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.052 1.341 . . . . 74.3 113.222 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.77 -36.03 0.18 Allowed Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.763 -0.653 . . . . 40.51 111.604 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . 0.607 ' HA ' ' ND2' ' A' ' 6' ' ' ASN . 1.9 tm-20 -72.19 139.16 48.07 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 109.181 -0.674 . . . . 62.33 109.181 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.59 -10.68 8.03 Favored Glycine 0 C--N 1.345 1.051 0 O-C-N 123.663 0.602 . . . . 62.44 112.584 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 45.3 p 54.16 -170.88 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.836 1.655 . . . . 72.33 113.858 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -147.88 -172.37 4.03 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.026 0.93 . . . . 74.32 110.388 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -153.5 83.48 1.18 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.283 0.633 . . . . 63.01 110.015 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -175.75 139.95 0.43 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.321 1.448 . . . . 74.15 108.473 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -100.76 32.54 3.1 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.531 0.732 . . . . 54.42 111.857 -171.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -76.21 78.97 3.0 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.96 -0.756 . . . . 70.31 108.96 175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 N-CA-C 108.618 -0.882 . . . . 53.3 108.618 177.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.434 ' HG3' ' HA ' ' D' ' 151' ' ' GLU . 1.5 mpt? . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 108.344 -0.984 . . . . 74.41 108.344 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . 0.412 ' H ' ' H ' ' D' ' 3' ' ' GLU . 12.8 p -176.55 7.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.078 0.951 . . . . 73.15 111.955 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . 0.412 ' H ' ' H ' ' D' ' 2' ' ' SER . 1.4 tm-20 -79.11 131.43 36.24 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.514 0.725 . . . . 60.45 109.394 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.434 ' HA ' ' ND2' ' H' ' 450' ' ' ASN . 25.7 pt20 -138.83 27.79 2.41 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.806 0.669 . . . . 65.31 112.806 -161.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.76 128.47 35.63 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.472 -0.566 . . . . 65.41 109.472 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -158.2 151.51 23.13 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.196 0.522 . . . . 63.44 110.848 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.522 HG22 ' H ' ' D' ' 8' ' ' GLU . 2.6 m -134.96 -161.05 1.11 Allowed 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 125.481 1.512 . . . . 60.32 106.955 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.522 ' H ' HG22 ' D' ' 7' ' ' THR . 42.7 tt0 -65.44 136.32 56.32 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.135 0.88 . . . . 74.14 109.452 167.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 11.3 ttp -33.71 127.0 0.39 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.977 1.311 . . . . 73.22 113.247 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.6 m -130.05 140.92 50.78 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.506 -1.294 . . . . 73.52 107.506 172.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -148.53 110.77 4.64 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.077 -1.453 . . . . 74.35 107.077 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -132.81 141.67 48.59 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.183 -1.043 . . . . 64.43 108.183 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.61 HD11 HD13 ' D' ' 105' ' ' ILE . 19.4 mt -98.45 133.3 41.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.164 -1.05 . . . . 74.44 108.164 171.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -96.96 -45.65 6.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.403 0.681 . . . . 63.22 111.574 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -172.16 120.5 0.43 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 118.008 0.367 . . . . 73.52 111.874 -163.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.505 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -104.96 135.6 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.417 -1.327 . . . . 73.33 107.417 171.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -159.7 167.06 29.24 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.156 0.91 . . . . 60.42 111.205 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . 0.495 HG21 HD11 ' D' ' 21' ' ' ILE . 81.2 p -99.53 117.16 33.31 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.078 -1.419 . . . . 74.22 109.327 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -88.06 -20.05 26.28 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.343 -0.844 . . . . 74.22 109.04 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.3 t70 -159.0 132.69 7.44 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.515 -1.22 . . . . 72.41 109.185 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.583 HD13 ' HE3' ' C' ' 117' ' ' MET . 79.7 mt -134.66 144.26 35.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 124.931 1.292 . . . . 51.53 107.553 174.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -147.46 136.6 22.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.337 1.055 . . . . 63.34 108.579 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.493 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.5 t80 -148.98 126.92 11.9 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.281 -1.748 . . . . 72.44 106.281 170.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -134.51 128.63 33.75 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.854 0.862 . . . . 74.15 109.372 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.67 81.27 60.91 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 107.881 -1.155 . . . . 64.3 107.881 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.92 -23.48 10.71 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.989 2.46 . . . . 35.42 113.604 -172.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -108.4 11.34 27.11 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.346 0.658 . . . . 61.03 109.966 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -36.85 -67.84 0.23 Allowed Pre-proline 0 CA--C 1.564 1.516 0 C-N-CA 126.371 1.868 . . . . 65.11 115.794 -161.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.01 -19.18 16.03 Favored 'Trans proline' 0 C--N 1.38 2.196 0 CA-C-N 123.124 2.151 . . . . 75.53 113.839 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -73.04 -43.06 62.48 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.917 0.887 . . . . 74.23 109.68 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.6 p -82.92 -16.12 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 CA-C-N 115.708 -0.678 . . . . 54.22 111.045 -172.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -68.4 -22.9 64.6 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.23 0.456 . . . . 71.24 112.23 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -65.94 -12.64 56.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.646 0.779 . . . . 71.42 110.744 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -98.44 92.91 5.89 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.396 1.078 . . . . 51.14 108.702 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -82.56 74.93 9.49 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.485 0.659 . . . . 63.13 109.697 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -137.43 156.23 48.41 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.129 -1.063 . . . . 73.44 108.129 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.696 ' HB3' HD13 ' H' ' 470' ' ' LEU . 1.8 mp0 -76.65 109.23 8.12 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.016 0.927 . . . . 63.14 108.921 174.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 21.6 Cg_exo -65.73 123.35 11.25 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 123.375 2.717 . . . . 41.11 113.432 -168.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -62.38 115.34 4.12 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.315 -0.624 . . . . 51.53 109.315 173.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.522 HG21 HG13 ' D' ' 64' ' ' VAL . 7.2 p -122.2 145.2 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.895 -1.048 . . . . 74.23 110.77 -170.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -117.26 147.9 42.13 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.978 0.911 . . . . 74.52 108.75 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.526 HD21 HG13 ' D' ' 62' ' ' VAL . 6.0 tt -121.34 125.61 47.43 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.339 -0.985 . . . . 74.54 108.339 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.612 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 29.3 t70 -108.11 137.49 46.01 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.941 0.896 . . . . 61.32 109.237 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 tp -113.14 140.45 47.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.651 0.78 . . . . 64.53 110.643 -175.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.9 t70 -148.2 131.11 16.16 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.233 -1.395 . . . . 65.44 107.233 165.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.1 t -106.99 153.82 22.01 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.464 -0.939 . . . . 72.21 108.464 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.654 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.03 164.55 35.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.493 -0.929 . . . . 63.1 108.493 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 18.5 p -169.74 154.54 5.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.561 0.744 . . . . 75.1 109.806 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -154.22 142.61 20.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.784 0.834 . . . . 63.13 109.574 -166.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.11 118.66 28.99 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.644 -0.502 . . . . 75.3 109.644 175.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' D' ' 57' ' ' GLU . 49.6 mt -94.54 -42.02 9.04 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.351 0.66 . . . . 62.42 110.037 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.0 -174.75 4.89 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 124.013 0.925 . . . . 64.35 110.236 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -63.7 109.16 1.61 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.707 -1.133 . . . . 72.55 110.071 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 60.96 23.6 13.72 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.19 0.996 . . . . 55.24 111.906 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.52 121.79 67.9 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 124.758 1.223 . . . . 64.41 108.193 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -135.89 132.36 36.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.708 0.803 . . . . 65.05 109.311 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.537 ' HB2' HD11 ' D' ' 51' ' ' LEU . 30.4 tt0 -86.15 148.81 25.51 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 124.431 1.082 . . . . 53.04 108.98 169.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.2 t -125.96 124.77 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 107.653 -1.24 . . . . 75.33 107.653 168.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.4 t -99.64 128.29 51.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.26 -1.015 . . . . 70.35 108.26 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.54 115.58 30.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.502 -0.925 . . . . 74.44 108.502 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 45.9 ttm-85 -96.61 100.72 12.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.803 -1.184 . . . . 54.55 107.803 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.526 HG13 HD21 ' D' ' 42' ' ' LEU . 75.9 t -100.67 126.0 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.561 -0.903 . . . . 73.52 108.561 170.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 46.9 m -114.48 139.9 49.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.867 -0.79 . . . . 73.12 108.867 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.522 HG13 HG21 ' D' ' 40' ' ' VAL . 70.9 t -131.98 115.17 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.846 1.258 . . . . 75.04 108.213 -176.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 50.0 m -125.03 99.02 5.93 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.992 0.917 . . . . 75.23 109.227 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -101.59 158.84 15.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.669 0.787 . . . . 71.11 111.27 -175.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 50.8 p -149.92 133.31 16.51 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.669 -0.696 . . . . 65.34 111.548 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 34.9 mt -107.76 107.98 18.98 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.22 -1.4 . . . . 72.1 107.22 170.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.11 -133.3 12.35 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.934 -0.467 . . . . 72.4 111.934 -173.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -98.22 4.59 48.87 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.459 0.704 . . . . 72.31 111.401 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -120.23 165.23 15.09 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.922 0.489 . . . . 74.31 110.435 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -61.64 131.0 48.57 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.198 -0.91 . . . . 70.04 111.449 175.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.451 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.49 -74.88 0.43 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.732 -1.21 . . . . 72.53 107.732 166.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . 0.48 ' HZ ' HD12 ' D' ' 126' ' ' LEU . 48.9 p90 -139.7 138.98 36.45 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.118 0.485 . . . . 73.31 109.875 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 83.3 mt -110.43 144.0 39.88 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.601 1.16 . . . . 61.44 108.159 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.607 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.2 t -159.05 146.61 17.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.848 0.459 . . . . 44.51 110.409 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -155.62 134.72 12.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.577 0.751 . . . . 72.14 108.984 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 89.5 t -133.31 121.57 42.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.892 -0.781 . . . . 63.03 108.892 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.9 mt-30 -88.11 83.25 7.01 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.812 -1.181 . . . . 71.3 107.812 167.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -79.52 93.44 5.43 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.702 -1.59 . . . . 71.11 108.663 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -84.3 157.32 33.14 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.624 -0.716 . . . . 73.44 112.059 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.474 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -152.47 130.06 2.95 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.198 -0.761 . . . . 63.41 111.198 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.461 HG23 HD12 ' D' ' 51' ' ' LEU . 61.1 mt -89.84 128.74 41.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 123.883 0.873 . . . . 63.52 108.646 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -126.8 152.46 46.91 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.211 1.005 . . . . 75.23 109.388 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 52.3 m -115.39 107.81 15.7 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.167 0.987 . . . . 73.33 108.423 170.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 28.5 pt -125.24 116.88 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.533 0.733 . . . . 75.44 109.444 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' H' ' 451' ' ' VAL . . . -137.07 136.39 38.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.54 0.736 . . . . 74.23 110.459 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.435 ' HA2' ' H ' ' D' ' 7' ' ' THR . . . 116.09 -19.82 13.26 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 115.47 0.948 . . . . 72.31 115.47 172.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.532 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -125.51 150.5 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 117.659 0.729 . . . . 72.34 110.979 -171.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.427 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 0.0 OUTLIER -151.57 166.09 32.27 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.237 0.458 . . . . 75.14 112.237 -172.2 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.48 -116.81 8.25 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-N 114.693 -1.139 . . . . 52.43 114.677 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.4 p -64.4 -47.43 79.22 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.96 0.904 . . . . 75.35 111.981 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -74.22 -24.08 59.28 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 116.306 -0.406 . . . . 54.01 111.014 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.427 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 0.8 OUTLIER -65.63 -49.2 69.58 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.695 -0.483 . . . . 73.11 109.695 174.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.96 -37.16 86.4 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.689 0.796 . . . . 53.25 110.861 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -65.91 -30.3 70.87 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.838 0.855 . . . . 74.52 111.392 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -82.57 -51.9 7.34 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.342 -0.39 . . . . 74.31 110.544 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 tp -80.09 -31.13 39.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.798 0.439 . . . . 60.12 111.76 -168.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.04 13.96 55.81 Favored Glycine 0 N--CA 1.473 1.142 0 CA-C-N 115.982 -0.554 . . . . 61.13 113.362 -174.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -148.64 -63.67 0.24 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.812 0.445 . . . . 72.14 110.927 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -73.86 -43.0 59.97 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.242 0.617 . . . . 71.03 112.2 -172.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 97.3 m -63.55 -49.74 76.27 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 118.343 -0.836 . . . . 54.34 111.758 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.09 -20.74 43.68 Favored 'Trans proline' 0 C--N 1.399 3.213 0 C-N-CA 121.811 1.674 . . . . 44.32 113.131 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -71.18 -30.83 66.89 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.974 0.51 . . . . 61.02 110.769 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.61 HD13 HD11 ' D' ' 13' ' ' ILE . 63.7 mt -67.54 -39.27 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.943 0.897 . . . . 74.45 110.074 171.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.474 HD21 ' HA3' ' D' ' 82' ' ' GLY . 85.6 mt -77.19 -19.68 56.42 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.07 -0.968 . . . . 74.31 111.917 -175.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -70.38 -41.09 12.77 Favored Pre-proline 0 CA--C 1.563 1.449 0 N-CA-C 113.936 1.088 . . . . 61.24 113.936 -171.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.82 -40.96 82.54 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.192 1.928 . . . . 74.02 113.0 169.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -70.61 -35.49 73.01 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.742 0.817 . . . . 75.31 111.831 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -52.92 55.51 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.504 -0.554 . . . . 72.53 109.504 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 30.8 ttp-105 -52.27 -49.22 64.53 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.517 1.136 . . . . 64.01 111.098 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.79 -44.55 77.11 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.994 0.809 . . . . 63.33 111.252 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.95 -44.34 78.36 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.328 0.585 . . . . 62.05 110.636 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.607 HG12 ' SG ' ' D' ' 76' ' ' CYS . 78.3 mt -68.15 -51.37 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 114.582 -1.19 . . . . 72.33 110.959 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 52.7 m -51.56 -45.54 63.09 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.491 1.116 . . . . 70.42 111.174 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.7 t -62.26 -44.11 97.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.837 -1.074 . . . . 63.11 109.754 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.412 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 78.1 mtm -68.92 -31.38 70.25 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.222 0.609 . . . . 74.52 112.264 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' D' ' 114' ' ' ILE . 67.6 t -72.07 -38.83 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.85 0.86 . . . . 72.51 109.982 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.6 p -75.65 -29.49 59.14 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.112 0.565 . . . . 74.23 110.676 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -72.73 -34.91 67.38 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.697 0.799 . . . . 54.21 109.502 173.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 -1.71 88.0 Favored Glycine 0 C--N 1.356 1.688 0 CA-C-N 115.594 -0.73 . . . . 44.22 111.934 172.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p 64.84 19.3 11.8 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 127.219 2.207 . . . . 73.01 114.039 170.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -78.97 152.98 77.5 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.163 0.585 . . . . 75.25 109.429 170.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.52 126.1 17.08 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.117 2.545 . . . . 74.52 112.756 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -60.43 120.33 9.71 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 123.804 0.842 . . . . 53.13 110.981 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.48 HD12 ' HZ ' ' D' ' 74' ' ' PHE . 80.7 mt -117.58 108.56 15.61 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.482 -0.933 . . . . 73.02 108.482 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.6 95.43 6.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.859 -1.163 . . . . 72.54 107.859 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.497 ' HG ' HD12 ' D' ' 42' ' ' LEU . 3.2 mm? -63.82 125.92 25.93 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.182 -0.917 . . . . 72.55 110.044 -175.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.6 139.86 58.82 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 124.072 0.857 . . . . 53.13 111.11 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.33 137.34 55.45 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.225 1.95 . . . . 73.42 110.923 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 67.0 t -106.17 110.85 32.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.4 -0.963 . . . . 63.43 108.4 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -72.76 88.81 1.32 Allowed 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.569 -0.9 . . . . 64.11 108.569 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -61.95 -31.23 71.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.773 -1.103 . . . . 72.03 110.86 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.4 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 3.9 t70 -55.83 -50.25 71.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.143 1.377 . . . . 73.42 112.169 -173.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.36 -45.48 83.94 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.477 -0.783 . . . . 62.11 111.956 -174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -22.98 56.33 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.921 -0.581 . . . . 73.01 110.485 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -68.89 -31.88 71.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.841 0.856 . . . . 72.43 111.004 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.412 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 33.5 mtt -59.06 -47.31 85.7 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.48 -0.782 . . . . 74.12 109.593 174.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -63.22 -40.57 97.85 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.982 0.913 . . . . 52.41 111.608 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -58.55 -39.88 81.48 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.091 0.956 . . . . 70.2 111.266 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.56 -28.34 62.76 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.476 0.711 . . . . 63.12 111.796 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' D' ' 138' ' ' MET . 20.5 mt-30 -81.8 -1.01 45.86 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.91 0.484 . . . . 63.22 111.988 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -140.49 45.23 1.84 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.888 0.475 . . . . 72.42 110.284 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -173.54 120.8 0.33 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.392 0.677 . . . . 72.21 109.879 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.88 168.93 10.0 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.87 0.868 . . . . 74.43 110.224 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.91 134.89 3.38 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.802 -0.519 . . . . 42.54 111.802 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -111.17 132.04 54.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.426 0.691 . . . . 74.24 111.2 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -113.81 -148.38 9.95 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.141 -1.184 . . . . 52.51 110.141 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 10.6 t -170.7 176.67 4.16 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 124.075 0.95 . . . . 75.32 109.503 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.5 177.4 4.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.573 0.349 . . . . 64.43 110.523 169.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . 0.434 ' HA ' ' HG3' ' D' ' 1' ' ' MET . 0.5 OUTLIER -140.22 79.16 1.69 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.918 -0.401 . . . . 74.53 109.918 -177.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -160.45 159.53 31.01 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.783 1.233 . . . . 72.11 109.619 164.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -141.86 0.7 1.43 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.161 0.985 . . . . 61.14 108.401 164.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.77 115.71 8.43 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.544 1.138 . . . . 52.03 110.373 -174.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 C-N-CA 124.173 0.989 . . . . 52.23 108.446 177.437 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.996 0.427 . . . . 73.51 110.944 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.92 -30.69 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 124.233 1.013 . . . . 53.41 112.059 -173.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . 0.461 HG12 ' CE2' ' A' ' 56' ' ' TYR . 31.2 m -55.49 162.14 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 115.416 1.636 . . . . 73.33 115.416 -172.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 158.15 -71.36 0.24 Allowed Glycine 0 C--N 1.342 0.888 0 CA-C-N 114.029 -1.441 . . . . 60.24 110.314 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . 0.442 HD13 HD22 ' A' ' 98' ' ' LEU . 20.6 mt 64.18 175.0 0.18 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.992 1.717 . . . . 63.13 112.823 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 21.3 p -108.4 138.55 44.51 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.427 1.091 . . . . 74.41 109.058 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -63.27 -44.58 94.7 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.929 0.768 . . . . 74.4 109.755 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -70.25 122.04 18.76 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.76 -1.109 . . . . 74.23 109.477 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 72.4 m -124.59 -56.53 1.59 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.144 0.578 . . . . 72.3 109.643 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 34.8 t70 60.95 98.96 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.836 1.254 . . . . 74.35 111.219 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . 0.421 HD11 ' HB ' ' A' ' 46' ' ' THR . 4.2 mm? -81.6 169.89 16.5 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.641 0.734 . . . . 74.13 111.178 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -133.38 144.6 49.69 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 114.284 -1.325 . . . . 64.32 109.31 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -150.67 109.3 3.83 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.684 0.794 . . . . 72.32 109.525 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 18.4 p -143.91 100.56 3.6 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.855 0.862 . . . . 65.04 109.473 171.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 27.2 ptm -156.77 166.59 32.96 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.501 -0.925 . . . . 74.12 108.501 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' E' ' 465' ' ' LYS . 0.3 OUTLIER -81.44 106.06 13.1 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.721 -1.214 . . . . 74.2 107.721 177.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -70.98 78.04 0.65 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.373 1.069 . . . . 63.21 110.126 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -103.92 -51.21 3.21 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.039 -1.097 . . . . 63.32 108.039 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 45.3 mt 69.79 -75.11 0.07 Allowed 'General case' 0 C--N 1.367 1.33 0 C-N-CA 125.46 1.504 . . . . 74.33 110.002 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 126' ' ' LEU . . . -162.16 16.05 0.15 Allowed Glycine 0 N--CA 1.48 1.581 0 N-CA-C 110.013 -1.235 . . . . 63.21 110.013 170.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . 0.478 ' HB2' HG11 ' A' ' 40' ' ' VAL . 51.1 mt -138.69 -163.26 1.44 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.51 1.924 . . . . 64.11 107.447 -170.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 117.736 -1.125 . . . . 71.12 108.442 172.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 10.4 t30 . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 122.072 0.939 . . . . 73.52 109.296 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.6 146.54 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.15 0.98 . . . . 73.45 108.632 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 75.6 t 71.13 118.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.681 1.192 . . . . 64.41 111.64 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 154.45 60.71 0.01 OUTLIER Glycine 0 C--N 1.346 1.102 0 CA-C-N 116.018 -0.537 . . . . 55.4 112.365 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 2.6 pp -137.99 130.99 30.09 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 109.567 -0.531 . . . . 61.32 109.567 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 32.8 m -155.95 85.34 1.02 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.662 1.185 . . . . 64.45 108.03 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -126.27 98.51 5.49 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.644 0.778 . . . . 75.01 109.954 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -74.09 100.39 3.61 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.202 -1.407 . . . . 64.54 107.202 170.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 20.1 m -143.92 167.16 22.98 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.272 1.029 . . . . 72.23 108.653 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -49.59 109.61 0.29 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.571 1.148 . . . . 71.41 111.163 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.11 119.67 12.43 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.98 -0.748 . . . . 73.11 108.98 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -52.83 111.65 0.7 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.839 1.256 . . . . 51.42 111.414 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -149.34 49.63 0.96 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.047 -0.524 . . . . 75.14 109.924 -174.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 67.0 m -65.71 91.12 0.13 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.51 -0.552 . . . . 73.02 109.51 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 16.8 tmm? -164.92 -55.59 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.338 -1.356 . . . . 62.43 107.338 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp 73.01 -26.22 0.19 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 125.301 1.44 . . . . 74.54 114.239 168.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -75.9 179.03 5.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.336 0.655 . . . . 43.15 110.505 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -98.82 -95.73 0.23 Allowed 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 119.392 -0.337 . . . . 65.01 110.403 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . 0.419 HD23 HD13 ' B' ' 128' ' ' LEU . 1.2 pp -172.29 43.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.497 0.719 . . . . 41.43 110.856 -169.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 95.8 -34.21 5.04 Favored Glycine 0 N--CA 1.483 1.788 0 CA-C-N 115.745 -0.662 . . . . 53.45 111.689 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . 0.668 HD21 ' H ' ' B' ' 40' ' ' VAL . 16.1 tp -49.1 -51.09 33.8 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.172 1.789 . . . . 53.2 112.244 169.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.248 1.013 0 N-CA-C 108.944 -0.761 . . . . 64.33 108.944 -173.287 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 . . . . . 0 CA--C 1.54 0.572 0 CA-C-O 119.43 -0.319 . . . . 53.51 111.311 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' C' ' 87' ' ' ALA . 19.1 m -89.66 4.83 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 122.847 0.459 . . . . 62.51 111.883 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . 0.437 HG12 ' HE2' ' C' ' 56' ' ' TYR . 27.2 m -52.0 139.41 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 C-N-CA 123.522 0.729 . . . . 74.51 111.351 174.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 163.83 108.98 0.22 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.928 -0.869 . . . . 73.53 110.928 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 22.8 tp -136.77 100.17 4.25 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.318 0.647 . . . . 71.35 109.468 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 7.8 p -78.79 118.64 21.04 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.205 -1.035 . . . . 64.52 108.205 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -76.81 160.44 29.26 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.402 0.681 . . . . 74.31 111.657 -173.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . 0.437 ' HG2' ' HB3' ' G' ' 459' ' ' ASP . 53.6 tt0 -158.18 100.73 1.71 Allowed 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.453 -1.314 . . . . 73.5 107.453 166.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 27.3 p -73.89 77.98 1.63 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.701 0.763 . . . . 70.11 109.413 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . 0.437 ' HB3' ' HG2' ' G' ' 457' ' ' GLN . 25.7 t70 -162.75 119.68 1.95 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.482 -1.235 . . . . 62.03 108.119 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' C' ' 44' ' ' LEU . 0.5 OUTLIER -97.46 126.77 42.92 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.054 -0.721 . . . . 74.44 109.054 -176.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -94.71 -172.09 2.64 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.06 1.344 . . . . 70.33 111.476 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 86.1 t80 68.92 103.58 0.06 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.829 1.252 . . . . 74.2 111.362 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 28.9 p -82.46 98.04 8.7 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.153 0.581 . . . . 72.31 109.676 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 15.2 tpt -77.19 146.21 37.17 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.987 0.515 . . . . 72.52 110.193 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -143.64 162.7 35.25 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.373 1.069 . . . . 71.35 109.591 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . 71.01 147.5 0.08 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.26 1.424 . . . . 60.34 112.768 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -76.22 143.21 41.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.573 0.749 . . . . 64.12 109.977 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . 0.741 HD11 HD11 ' C' ' 42' ' ' LEU . 65.4 mt -68.17 -56.09 10.01 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.649 0.78 . . . . 74.43 111.901 -174.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -162.17 28.16 0.26 Allowed Glycine 0 N--CA 1.469 0.866 0 CA-C-N 115.755 -0.657 . . . . 75.04 111.647 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -110.05 125.69 53.21 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.646 0.778 . . . . 75.51 109.502 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 59.2 tttm . . . . . 0 C--O 1.249 1.032 0 N-CA-C 107.211 -1.403 . . . . 75.54 107.211 -179.178 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' D' ' 4' ' ' GLN . 21.6 t-20 . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 112.193 0.442 . . . . 63.33 112.193 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' D' ' 87' ' ' ALA . 47.2 t -76.39 70.81 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-O 121.946 0.879 . . . . 53.32 111.088 -175.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -155.49 145.0 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.882 1.273 . . . . 62.21 108.041 174.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 178.85 43.82 0.07 OUTLIER Glycine 0 N--CA 1.461 0.361 0 N-CA-C 110.356 -1.098 . . . . 53.33 110.356 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 66.5 mt -82.23 148.08 28.6 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.2 0.6 . . . . 74.3 110.229 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 27.3 p -92.02 -54.73 3.72 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.985 0.914 . . . . 72.21 109.198 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -164.41 161.12 21.36 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.903 0.881 . . . . 74.02 109.637 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -129.77 98.49 4.82 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.17 0.988 . . . . 71.24 110.308 -177.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 2.4 p -145.83 -152.22 0.42 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.045 1.338 . . . . 74.44 108.025 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.15 135.87 57.85 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.122 -0.696 . . . . 72.53 109.122 167.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 95.0 mt -85.22 -56.67 3.42 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.586 -0.734 . . . . 72.13 110.866 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -175.56 18.75 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 123.391 0.676 . . . . 61.25 111.836 -168.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -76.44 89.64 3.23 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.849 -0.426 . . . . 73.51 109.849 -169.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 29.4 m -96.67 -73.85 0.59 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.904 0.881 . . . . 52.33 110.667 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 59.4 mtt 63.9 146.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.897 1.279 . . . . 70.52 111.442 -166.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -89.39 -9.78 49.02 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 111.98 0.363 . . . . 74.44 111.98 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -152.68 -178.26 6.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.831 0.852 . . . . 54.44 110.072 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -63.64 -64.51 0.88 Allowed 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.215 -0.661 . . . . 75.35 109.215 173.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -172.2 -31.24 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 O-C-N 124.244 0.965 . . . . 75.34 110.347 170.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 72.91 70.47 1.22 Allowed Glycine 0 C--N 1.359 1.858 0 O-C-N 123.19 0.306 . . . . 45.3 112.388 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . 0.696 HD13 ' HB3' ' D' ' 37' ' ' GLN . 23.7 mt -70.62 98.2 1.46 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.932 0.893 . . . . 74.23 111.71 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt . . . . . 0 C--O 1.254 1.301 0 C-N-CA 124.94 1.296 . . . . 64.11 110.774 176.288 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.035 -0.358 . . . . 74.52 110.035 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.7 p -81.72 143.11 32.08 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.094 0.957 . . . . 73.2 110.221 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -124.32 148.35 47.52 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.855 0.462 . . . . 71.42 109.941 -176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.18 85.79 3.02 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.456 -0.942 . . . . 62.23 108.456 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -132.01 86.34 2.33 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.296 -1.372 . . . . 72.13 107.296 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -67.93 -17.15 64.37 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.751 -1.113 . . . . 72.11 111.342 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 m -67.41 123.64 20.95 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.289 0.635 . . . . 74.05 109.911 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.76 -55.97 26.8 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.852 0.72 . . . . 75.43 110.968 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.5 mtp -72.07 134.67 45.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.233 -0.44 . . . . 74.25 109.883 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.6 m -141.81 121.86 13.74 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.959 -0.756 . . . . 52.4 108.959 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -136.86 130.06 31.18 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.166 0.986 . . . . 63.34 108.544 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -146.62 135.21 22.09 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.667 -0.864 . . . . 72.44 108.667 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.466 ' CD1' HG21 ' A' ' 105' ' ' ILE . 13.0 mt -91.05 119.02 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.726 -0.842 . . . . 62.14 108.726 173.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -81.82 -40.65 22.22 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 123.525 0.516 . . . . 61.22 110.299 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -170.02 131.38 1.02 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.576 -0.283 . . . . 75.04 110.604 -169.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.455 HD12 ' HG3' ' C' ' 130' ' ' PRO . 87.8 mt -121.32 132.88 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.728 -0.841 . . . . 74.11 108.728 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' HB3' HG23 ' B' ' 122' ' ' THR . 34.5 p90 -166.14 151.87 8.78 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.922 0.764 . . . . 64.13 110.812 -175.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -80.25 106.88 12.6 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.732 -1.122 . . . . 60.24 109.027 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -73.06 -28.59 62.4 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.223 -0.444 . . . . 52.34 110.395 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -148.57 140.06 23.48 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.065 -0.97 . . . . 41.42 109.226 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.13 142.81 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 107.537 -1.283 . . . . 71.54 107.537 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -143.13 147.86 35.65 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.115 0.483 . . . . 74.0 109.73 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 83.4 t80 -150.07 114.51 5.21 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.032 -1.469 . . . . 64.23 107.032 174.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -124.34 110.36 14.48 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.838 -0.43 . . . . 52.12 109.838 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.44 84.81 19.12 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 124.052 0.941 . . . . 64.52 108.559 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.49 -32.38 12.34 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.513 2.142 . . . . 75.51 110.826 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 85.3 m-20 -102.62 28.87 5.68 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.604 1.162 . . . . 70.11 109.812 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.429 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.3 -46.34 99.09 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.529 0.731 . . . . 53.3 111.999 173.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -83.95 5.63 6.23 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.049 1.833 . . . . 31.03 112.756 172.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 54.7 m170 -104.47 -17.5 14.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.335 0.654 . . . . 72.44 111.903 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 28' ' ' ALA . 11.3 p -71.04 -31.07 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.47 0.544 . . . . 71.53 112.47 -170.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -80.15 -33.03 38.82 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.39 0.276 . . . . 73.12 110.813 -172.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -76.92 -24.36 52.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.939 -0.573 . . . . 74.32 110.167 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -83.53 151.61 25.32 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.758 0.823 . . . . 71.15 110.536 171.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.03 140.25 40.29 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.727 -0.842 . . . . 74.52 108.727 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -79.31 95.6 5.74 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.181 0.515 . . . . 71.53 111.083 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -126.92 83.81 64.86 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.41 1.084 . . . . 75.13 109.112 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.32 139.93 29.76 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.421 2.081 . . . . 74.21 112.726 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -106.82 100.52 10.02 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.252 -1.388 . . . . 71.43 107.252 172.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.8 m -76.26 101.25 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 CA-C-O 122.113 0.959 . . . . 72.13 111.432 -174.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -110.4 114.11 27.3 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.328 -1.36 . . . . 71.54 107.328 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.491 HD22 HD21 ' E' ' 468' ' ' LEU . 52.6 tp -120.43 136.84 54.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.085 0.554 . . . . 74.12 110.677 -172.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.583 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.1 m-20 -121.22 140.07 52.53 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.961 1.304 . . . . 52.14 108.22 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.555 HD21 ' HE1' ' A' ' 133' ' ' PHE . 7.7 tt -142.47 120.3 11.95 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.643 -0.873 . . . . 73.41 108.643 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -136.45 145.68 45.48 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.841 0.856 . . . . 74.11 110.243 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 m -113.19 135.07 54.22 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.291 1.036 . . . . 44.41 108.71 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.77 132.25 45.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.556 0.742 . . . . 54.32 109.433 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.4 m -90.99 152.49 20.67 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.597 0.759 . . . . 74.21 111.225 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 42.1 t -154.45 131.55 11.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.848 0.859 . . . . 71.02 109.329 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -112.18 111.92 23.15 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.748 -0.834 . . . . 74.53 108.748 176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.5 mt -86.89 -39.68 15.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.257 0.623 . . . . 60.42 110.389 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.23 -174.99 4.33 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.008 0.923 . . . . 73.1 109.656 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.63 104.75 0.3 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.769 0.827 . . . . 72.21 109.744 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 66.54 9.75 6.82 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.125 1.37 . . . . 75.43 112.639 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.34 101.69 12.44 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 105.35 -2.093 . . . . 63.33 105.35 168.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -116.79 151.21 36.96 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.503 -1.226 . . . . 74.14 109.081 -164.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 43.7 tt0 -132.78 138.63 47.21 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.275 0.63 . . . . 63.33 110.031 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.6 t -119.85 130.98 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.106 -1.072 . . . . 70.03 108.106 171.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.4 t -115.69 109.6 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.134 0.973 . . . . 54.04 108.604 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.0 tp -89.2 101.42 14.08 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.055 -0.72 . . . . 63.03 109.055 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 ttp85 -85.4 107.51 17.41 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.051 -0.722 . . . . 75.43 109.051 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG13 HD11 ' A' ' 114' ' ' ILE . 3.1 p -113.52 121.87 66.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 108.93 -0.767 . . . . 72.13 108.93 176.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.6 m -116.49 135.45 53.82 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.586 0.754 . . . . 74.5 109.407 -177.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 126' ' ' LEU . 64.8 t -124.61 132.99 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 124.38 1.072 . . . . 70.24 108.634 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.3 m -131.21 120.55 23.43 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.049 -0.723 . . . . 75.02 109.049 173.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.41 122.52 44.02 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.677 -0.86 . . . . 75.33 108.677 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 t -130.18 146.72 51.83 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.916 0.886 . . . . 72.43 110.228 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.4 ' N ' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -101.58 87.15 3.1 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 107.123 -1.436 . . . . 63.4 107.123 167.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.73 -105.09 3.23 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 114.835 -1.075 . . . . 41.14 110.518 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.54 -20.61 11.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.805 0.842 . . . . 74.55 110.616 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.05 104.89 9.99 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.831 0.853 . . . . 70.22 109.271 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.3 m -71.31 121.2 18.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.157 0.583 . . . . 72.34 110.732 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.01 -53.51 20.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.783 0.833 . . . . 53.53 109.38 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -150.22 158.08 43.77 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.502 -1.226 . . . . 75.12 111.618 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 64' ' ' VAL . 66.9 tp -125.57 140.89 52.36 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.371 1.468 . . . . 70.11 107.282 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.4 m -142.34 113.29 7.5 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.378 0.671 . . . . 73.01 109.585 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -127.05 120.52 29.18 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.272 -0.64 . . . . 65.14 109.272 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.4 t -127.63 110.64 22.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 123.665 0.786 . . . . 74.24 109.348 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -85.05 81.4 8.89 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.73 -1.211 . . . . 75.52 107.73 171.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -76.88 94.96 3.99 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.074 -0.967 . . . . 74.33 108.633 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.06 151.08 21.36 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 115.376 -0.829 . . . . 74.34 111.589 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.97 128.5 2.8 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.139 -0.784 . . . . 71.22 111.139 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -81.15 115.82 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.789 -0.819 . . . . 62.12 108.789 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -114.8 118.7 34.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.048 0.939 . . . . 74.32 109.586 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.9 m -85.36 103.7 14.51 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.63 -0.878 . . . . 72.22 108.63 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.9 pp -116.04 153.91 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.12 0.568 . . . . 61.14 110.812 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.55 149.98 5.89 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.615 1.166 . . . . 72.4 109.429 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.23 -26.75 23.45 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 122.856 0.265 . . . . 43.23 113.715 172.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.591 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.92 138.85 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.502 0.721 . . . . 72.24 110.321 -176.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 10.6 tt0 -152.59 174.4 14.0 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.89 0.476 . . . . 75.31 109.857 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.416 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 66.83 -127.7 28.33 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 116.344 -0.389 . . . . 63.25 112.248 -174.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -72.5 -21.07 61.25 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.464 0.706 . . . . 73.12 111.313 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -70.77 -45.26 65.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.503 0.721 . . . . 71.03 110.851 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.523 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 23.3 ttt -71.95 -37.34 69.99 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.347 -0.388 . . . . 71.32 110.013 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.88 72.19 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.346 0.404 . . . . 65.44 110.587 174.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 59.3 t-80 -71.74 -33.74 68.96 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.381 0.672 . . . . 73.32 110.706 173.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -66.55 -61.81 1.79 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 110.047 -0.353 . . . . 61.21 110.047 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.462 HD23 ' HG2' ' A' ' 94' ' ' MET . 4.2 pp -74.13 -24.62 59.45 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.449 0.7 . . . . 71.02 112.547 -174.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.44 1.08 37.14 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-O 119.538 -0.59 . . . . 65.2 114.28 -173.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -141.36 -65.34 0.43 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 117.533 0.667 . . . . 65.14 111.052 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 105' ' ' ILE . 48.3 t80 -66.63 -46.49 75.63 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 112.797 0.666 . . . . 62.24 112.797 -171.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -68.66 -47.37 34.07 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 124.064 0.945 . . . . 73.53 112.723 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.51 -26.8 69.97 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 121.823 1.682 . . . . 62.03 112.185 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -65.91 -37.83 87.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.158 0.583 . . . . 63.22 110.937 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.466 HG21 ' CD1' ' A' ' 13' ' ' ILE . 47.2 mm -66.34 -45.67 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.301 0.641 . . . . 72.14 110.046 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.6 mt -73.89 -23.37 59.56 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.381 -0.827 . . . . 73.34 111.918 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -60.69 -49.14 91.02 Favored Pre-proline 0 CA--C 1.563 1.451 0 N-CA-C 113.968 1.099 . . . . 50.05 113.968 -171.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -63.11 -34.83 67.96 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.11 1.874 . . . . 62.25 112.841 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -67.52 -40.23 85.11 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.126 0.57 . . . . 75.54 110.872 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.42 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -69.77 -36.21 75.56 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.401 0.681 . . . . 65.33 110.79 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.606 ' HA ' HD21 ' A' ' 128' ' ' LEU . 38.1 ttm180 -57.15 -53.82 53.72 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 124.031 0.832 . . . . 71.4 109.715 176.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -57.76 -48.02 80.84 Favored 'General case' 0 C--N 1.348 0.531 0 O-C-N 124.563 1.164 . . . . 75.12 111.229 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 117' ' ' MET . 24.0 t -53.29 -47.84 68.87 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.334 1.021 . . . . 75.42 110.462 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.426 HD11 HG13 ' A' ' 62' ' ' VAL . 93.6 mt -68.55 -38.42 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.327 1.051 . . . . 63.32 111.176 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.2 m -64.34 -34.23 77.68 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.263 0.554 . . . . 75.43 110.115 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.9 t -74.24 -36.93 63.93 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.881 -0.599 . . . . 71.41 109.701 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 74.6 mmm -60.36 -46.98 88.03 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.98 0.512 . . . . 75.11 110.739 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.0 m -69.41 -39.68 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.571 -0.74 . . . . 74.22 110.826 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.8 m -67.23 -34.59 77.79 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.867 0.467 . . . . 73.31 111.639 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.542 HH12 ' HG3' ' B' ' 112' ' ' GLU . 86.8 mtt-85 -74.34 -28.92 61.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.225 0.61 . . . . 71.11 110.191 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.88 -4.74 88.49 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 123.758 0.661 . . . . 31.22 113.183 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.4 m 65.92 41.14 3.86 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 123.586 1.66 . . . . 73.32 111.132 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -111.89 151.61 43.62 Favored Pre-proline 0 C--O 1.244 0.772 0 CA-C-N 113.917 -1.492 . . . . 74.34 108.514 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -53.06 142.33 54.53 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.897 2.398 . . . . 55.13 112.697 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.06 145.88 24.39 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.987 0.804 . . . . 73.4 112.124 -177.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.476 ' CD2' HG11 ' A' ' 64' ' ' VAL . 18.4 tp -128.4 115.99 19.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.727 -1.124 . . . . 72.5 110.391 -175.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -120.8 89.29 3.1 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.248 -1.019 . . . . 63.44 108.248 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.703 ' H ' HD23 ' A' ' 128' ' ' LEU . 1.0 OUTLIER -64.38 129.58 40.47 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 116.057 -0.519 . . . . 73.23 109.779 176.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.82 144.65 85.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.494 1.118 . . . . 54.32 112.077 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -65.63 113.09 2.37 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.366 2.044 . . . . 71.43 110.844 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.05 127.56 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.595 -0.891 . . . . 72.23 108.595 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.44 HD21 ' HB3' ' A' ' 134' ' ' ASP . 0.2 OUTLIER -80.44 89.87 5.62 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.582 -0.735 . . . . 71.31 109.387 -172.212 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.555 ' HE1' HD21 ' A' ' 44' ' ' LEU . 97.3 m-85 -60.25 -37.43 80.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.147 0.979 . . . . 61.44 111.762 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.44 ' HB3' HD21 ' A' ' 132' ' ' ASN . 20.1 t70 -56.24 -51.14 69.18 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.975 0.797 . . . . 71.4 110.317 176.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.45 97.65 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 124.345 1.028 . . . . 71.43 111.28 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -57.53 -45.66 84.76 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.914 0.759 . . . . 72.31 111.215 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -67.69 -37.9 82.94 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.802 -0.635 . . . . 73.05 110.025 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.5 mmt -58.16 -35.43 71.53 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.973 0.795 . . . . 73.31 111.763 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -60.77 -47.42 86.41 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 123.713 0.633 . . . . 74.51 110.999 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -73.93 -32.93 63.75 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.623 -0.717 . . . . 74.54 111.247 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.06 -46.52 77.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.232 1.013 . . . . 71.32 110.738 -173.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.437 ' H ' ' H ' ' A' ' 143' ' ' GLN . 0.3 OUTLIER -167.32 -14.22 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.895 -0.593 . . . . 72.23 110.129 -174.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.586 ' HG2' ' HG2' ' C' ' 151' ' ' GLU . 57.7 tt0 59.07 92.45 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.482 1.513 . . . . 61.43 110.154 -164.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.556 ' HA ' ' HB3' ' C' ' 151' ' ' GLU . 14.1 pt20 -171.84 172.81 4.71 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.277 0.56 . . . . 72.53 111.633 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.462 ' HB3' ' H ' ' C' ' 150' ' ' GLU . . . -81.26 143.67 32.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.521 -1.218 . . . . 72.31 108.343 165.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.51 45.43 0.92 Allowed Glycine 0 N--CA 1.467 0.716 0 N-CA-C 112.255 -0.338 . . . . 61.42 112.255 -175.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -159.93 134.93 7.94 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.083 0.553 . . . . 74.1 110.629 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -115.89 -147.26 8.94 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 110.702 -0.959 . . . . 61.12 110.702 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.1 m -124.97 146.79 49.22 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.455 -0.943 . . . . 70.32 108.455 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.76 133.74 49.78 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.244 -0.65 . . . . 72.45 109.244 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -58.97 -28.31 66.2 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.199 0.999 . . . . 73.22 111.624 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -65.08 97.58 0.25 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.676 0.751 . . . . 63.31 110.089 168.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -79.06 -175.72 4.72 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.847 -1.07 . . . . 52.54 109.441 168.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -136.51 143.16 43.6 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.079 -0.712 . . . . 72.43 109.079 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 C-N-CA 123.309 0.643 . . . . 72.25 109.498 178.917 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 86.8 mtp . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 109.291 -0.633 . . . . 74.22 109.291 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 44.6 p -80.27 92.13 5.71 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.598 0.759 . . . . 74.41 110.224 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -77.62 86.73 3.93 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.457 -1.312 . . . . 62.11 107.457 174.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.44 136.32 56.97 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.815 -0.629 . . . . 70.31 110.802 -171.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -125.23 99.93 6.3 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.015 -1.106 . . . . 73.43 108.015 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -89.44 -33.8 16.69 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.3 -0.864 . . . . 65.11 110.986 -172.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.2 t -64.2 -24.07 67.54 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.302 0.641 . . . . 71.32 111.297 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -92.64 -37.93 12.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.415 0.686 . . . . 71.23 110.148 175.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.406 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 24.5 ptm 43.52 -156.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.628 1.571 . . . . 64.25 112.491 -176.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 99.2 m -152.27 120.11 6.15 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.262 -1.014 . . . . 74.24 108.262 168.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -136.06 127.54 28.63 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.195 -1.039 . . . . 64.13 108.195 169.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -147.24 134.11 20.16 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.117 -0.697 . . . . 75.01 109.117 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.55 HD11 HD13 ' B' ' 105' ' ' ILE . 26.9 mt -86.84 122.03 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.439 -0.948 . . . . 54.05 108.439 172.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -95.23 -30.6 13.91 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.127 0.571 . . . . 73.14 110.177 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -172.72 138.05 0.82 Allowed 'General case' 0 C--N 1.353 0.725 0 O-C-N 123.642 0.589 . . . . 72.33 110.124 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.406 HD11 HD13 ' B' ' 13' ' ' ILE . 89.0 mt -118.74 137.66 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 106.922 -1.51 . . . . 70.14 106.922 171.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.449 ' HE1' HG13 ' B' ' 83' ' ' ILE . 10.8 p90 -167.17 143.61 4.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.249 0.547 . . . . 74.04 112.376 -173.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.4 m -73.56 125.64 28.44 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.134 -0.939 . . . . 53.13 108.73 169.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.404 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 47.9 mtpt -97.52 -31.74 12.17 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.698 0.799 . . . . 75.2 110.698 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 21.1 t70 -155.72 143.2 19.47 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.45 -0.341 . . . . 71.14 111.025 -174.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.479 HD11 ' SG ' ' B' ' 113' ' ' CYS . 42.6 mm -139.54 143.3 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.988 1.315 . . . . 72.22 109.007 177.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.1 t -142.45 120.8 12.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.83 -1.077 . . . . 73.45 108.452 167.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -121.24 124.26 44.22 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.479 -1.304 . . . . 73.4 107.479 168.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.638 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 34.3 mt-10 -128.61 117.33 21.04 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.532 1.133 . . . . 54.34 108.381 -174.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -108.18 86.57 3.35 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 108.002 -1.11 . . . . 75.45 108.002 171.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -65.11 -47.88 4.19 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.057 2.504 . . . . 72.23 113.17 -167.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -107.34 28.19 8.34 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.035 0.934 . . . . 73.22 109.764 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.506 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -39.44 -63.15 0.68 Allowed Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 114.985 1.476 . . . . 72.04 114.985 -163.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 12.1 Cg_exo -68.45 -24.24 36.74 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 122.137 1.891 . . . . 65.15 112.896 -173.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -92.69 -28.04 16.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.756 0.822 . . . . 74.12 112.555 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' B' ' 73' ' ' ALA . 13.4 p -81.95 -18.96 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 120.69 0.281 . . . . 73.44 111.472 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -64.89 -17.27 64.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 113.164 0.802 . . . . 75.1 113.164 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -66.93 -21.17 65.99 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.206 0.602 . . . . 71.13 111.385 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.491 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 86.1 mttt -94.05 107.38 19.3 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.813 0.845 . . . . 74.32 109.177 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -87.21 86.06 7.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.954 0.501 . . . . 74.02 110.566 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -164.64 158.11 17.55 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.902 0.881 . . . . 72.02 109.161 173.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.514 ' HB3' HD22 ' F' ' 470' ' ' LEU . 42.0 mt-30 -73.22 109.23 5.89 Favored Pre-proline 0 C--N 1.354 0.792 0 N-CA-C 109.087 -0.709 . . . . 75.3 109.087 169.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.639 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 13.1 Cg_endo -56.34 146.61 72.05 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.017 2.478 . . . . 52.43 111.842 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -61.32 102.51 0.23 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 123.826 0.704 . . . . 71.53 109.181 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.418 HG23 ' O ' ' B' ' 38' ' ' PRO . 85.1 t -92.81 120.31 41.94 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 115.607 -0.724 . . . . 60.12 109.576 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -121.08 119.19 31.73 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.904 -1.517 . . . . 64.4 106.904 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 pp -93.96 160.56 14.67 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.251 0.548 . . . . 61.41 111.065 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.704 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 3.2 m-20 -123.67 129.57 51.32 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.773 -1.195 . . . . 64.43 107.773 173.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 tt -100.38 128.62 46.4 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.36 -1.348 . . . . 71.22 107.36 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.422 ' HA ' HD23 ' F' ' 460' ' ' LEU . 24.1 t70 -145.93 121.43 10.38 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.496 0.718 . . . . 34.12 109.689 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 43.3 p -120.65 122.79 41.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.62 0.368 . . . . 73.45 110.255 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.78 154.77 33.72 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.523 1.129 . . . . 72.13 108.327 172.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.3 p -144.77 168.06 21.11 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.909 0.385 . . . . 73.43 111.061 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.2 p -153.47 169.91 22.02 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.354 1.061 . . . . 61.3 109.337 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -114.26 136.35 53.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.706 0.802 . . . . 73.11 110.339 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 86.4 mt -99.41 -39.22 8.48 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.281 0.633 . . . . 63.33 110.727 174.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.54 -177.09 5.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.637 0.775 . . . . 75.14 110.287 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -68.95 123.64 21.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.409 -0.814 . . . . 71.31 109.126 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 69.8 9.62 7.22 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.569 1.147 . . . . 75.21 112.161 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.7 t -124.34 110.72 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 107.862 -1.162 . . . . 54.51 107.862 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.44 ' CD2' HD13 ' B' ' 98' ' ' LEU . 5.8 t80 -125.28 154.13 42.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.769 -0.826 . . . . 75.33 108.769 -177.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -130.62 110.02 11.08 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.439 -0.949 . . . . 74.21 108.439 -168.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.48 145.26 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.961 0.904 . . . . 72.4 109.948 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.8 t -128.4 114.73 35.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 121.37 0.605 . . . . 72.22 109.537 176.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -94.15 111.51 23.24 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.578 -1.268 . . . . 75.23 107.578 176.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -105.31 129.72 53.59 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.274 0.559 . . . . 75.23 109.868 171.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.426 ' HB ' HD11 ' B' ' 114' ' ' ILE . 21.2 t -124.32 119.78 57.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.831 -1.174 . . . . 74.22 107.831 174.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.704 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 95.5 m -98.18 148.87 23.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.274 -1.01 . . . . 40.31 108.274 175.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.704 HG21 HG21 ' B' ' 114' ' ' ILE . 42.7 t -134.67 125.6 46.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.55 1.14 . . . . 65.43 108.284 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 99.5 m -123.97 139.69 53.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.589 -0.893 . . . . 52.44 108.589 172.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -136.62 145.49 44.94 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 123.652 0.595 . . . . 44.23 110.275 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.1 p -136.13 126.98 27.51 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.638 0.586 . . . . 65.21 111.153 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.639 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 19.8 mt -100.86 112.13 24.49 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.292 -1.003 . . . . 73.23 108.292 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.09 -114.16 5.89 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 124.003 0.815 . . . . 64.23 112.168 -174.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -110.58 4.39 20.25 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.316 0.646 . . . . 73.15 111.304 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -122.41 160.45 25.45 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.999 0.52 . . . . 72.22 110.438 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -75.2 138.15 41.76 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 123.501 0.501 . . . . 53.43 110.079 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.809 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.59 -64.07 1.15 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.371 0.668 . . . . 64.42 109.536 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -144.31 155.33 43.77 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.737 0.78 . . . . 74.21 110.877 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.638 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 82.1 mt -128.02 135.55 50.03 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.74 1.616 . . . . 73.41 106.761 173.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.418 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 38.9 t -145.07 148.4 33.63 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.993 -0.743 . . . . 54.23 108.993 175.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -158.98 126.97 5.06 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.215 -0.661 . . . . 74.31 109.215 -172.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' B' ' 113' ' ' CYS . 65.5 t -124.37 147.37 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 115.401 -0.818 . . . . 63.42 109.419 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -124.8 86.63 2.59 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.249 -1.019 . . . . 73.04 108.249 170.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -80.05 103.03 9.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.717 -0.674 . . . . 73.3 109.486 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.15 164.5 28.51 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 112.042 -0.423 . . . . 51.42 112.042 176.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.32 134.86 3.79 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.94 -0.464 . . . . 62.24 111.94 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.449 HG13 ' HE1' ' B' ' 17' ' ' TYR . 59.0 mt -91.93 124.52 44.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.982 0.913 . . . . 53.55 109.056 174.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -131.69 135.97 47.29 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.253 0.621 . . . . 72.13 110.029 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.7 m -91.36 115.05 27.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.428 1.091 . . . . 73.24 109.198 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.735 HD13 HD11 ' B' ' 98' ' ' LEU . 35.7 pt -115.96 130.37 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.665 0.786 . . . . 74.01 110.83 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.549 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.78 167.4 30.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.599 0.76 . . . . 64.32 109.586 170.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.09 -56.77 5.08 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 111.5 -0.64 . . . . 71.44 111.5 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.455 HD11 ' HB ' ' B' ' 86' ' ' ILE . 2.8 pp -75.96 163.67 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.17 0.988 . . . . 73.23 111.246 175.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -168.59 157.32 8.58 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.628 0.58 . . . . 73.24 110.628 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.97 -116.03 7.37 Favored Glycine 0 C--N 1.353 1.511 0 O-C-N 123.533 0.521 . . . . 52.44 113.548 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 97.1 m -65.43 -36.1 82.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.88 0.872 . . . . 74.15 111.016 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -66.02 -41.79 90.53 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.689 0.796 . . . . 74.41 110.06 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 47.5 ttp -66.72 -36.65 82.97 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.608 -1.178 . . . . 73.4 110.931 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.19 -32.11 68.47 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.171 0.588 . . . . 61.34 110.572 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -69.96 -29.17 66.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.567 0.747 . . . . 35.23 110.676 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -77.57 -66.78 0.79 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.945 -0.57 . . . . 63.11 110.196 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.735 HD11 HD13 ' B' ' 86' ' ' ILE . 66.5 mt -78.43 -26.4 46.29 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.956 0.902 . . . . 71.32 112.92 -168.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.07 0.81 64.48 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-O 119.749 -0.473 . . . . 61.35 113.453 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 -66.21 0.25 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.28 0.54 . . . . 64.43 112.024 -174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -64.89 -42.39 94.82 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.769 0.827 . . . . 73.34 112.432 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.479 ' SG ' HD23 ' B' ' 98' ' ' LEU . 84.4 m -68.83 -47.44 32.0 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 124.288 1.035 . . . . 73.03 111.725 -177.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.448 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 86.8 Cg_exo -51.9 -39.75 68.02 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.321 2.014 . . . . 64.2 113.326 167.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -61.67 -31.96 72.11 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 112.709 0.633 . . . . 54.33 112.709 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.55 HD13 HD11 ' B' ' 13' ' ' ILE . 61.6 mt -67.85 -41.28 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.384 0.674 . . . . 63.33 110.156 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 66.8 mt -82.78 -19.47 37.7 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.871 -1.059 . . . . 70.02 111.867 -173.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.415 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 57.6 t80 -61.28 -45.22 95.14 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 114.166 1.173 . . . . 72.04 114.166 -170.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 18.2 Cg_endo -58.91 -38.01 90.54 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.089 1.859 . . . . 70.21 112.851 175.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -65.26 -46.26 81.24 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.374 0.67 . . . . 73.11 110.933 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.15 90.01 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.511 -0.768 . . . . 51.15 110.9 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -59.6 -60.52 3.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.495 1.118 . . . . 74.23 110.677 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.542 ' HG3' HH12 ' A' ' 120' ' ' ARG . 12.4 tp10 -58.45 -31.85 68.16 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.399 1.08 . . . . 62.04 111.075 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.546 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.4 t -71.67 -40.33 69.68 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 119.364 -0.351 . . . . 52.23 110.848 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.704 HG21 HG21 ' B' ' 64' ' ' VAL . 88.5 mt -65.1 -55.0 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 109.305 -0.628 . . . . 61.4 109.305 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 13.6 m -58.06 -34.61 70.29 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 124.367 1.042 . . . . 75.42 111.592 -173.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.7 t -61.52 -51.1 70.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 115.913 -0.585 . . . . 64.53 110.03 176.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.5 mmt -66.77 -38.64 86.98 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 123.645 0.59 . . . . 65.41 111.103 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 89.3 t -58.61 -44.56 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.998 0.919 . . . . 72.3 110.515 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 35.2 t -71.26 -30.54 66.42 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.011 -0.995 . . . . 60.11 111.56 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.7 mtt-85 -70.06 -28.91 65.83 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.515 0.726 . . . . 74.4 110.232 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -87.32 9.35 73.41 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 124.02 0.825 . . . . 64.4 112.737 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 17' ' ' TYR . 58.9 p 55.84 31.65 18.08 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.018 1.727 . . . . 54.21 112.941 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -92.09 155.2 43.16 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 123.734 0.814 . . . . 73.21 109.971 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.17 156.96 6.98 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.713 2.942 . . . . 63.1 114.843 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.495 HE21 ' ND2' ' B' ' 127' ' ' ASN . 64.3 tp60 -60.39 130.43 46.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.095 0.958 . . . . 73.54 111.09 -174.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.515 HD21 HD13 ' F' ' 468' ' ' LEU . 2.9 tm? -141.61 95.36 2.81 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.601 -0.518 . . . . 73.32 109.601 -174.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.495 ' ND2' HE21 ' B' ' 125' ' ' GLN . 55.3 m-80 -94.5 136.55 34.67 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.684 -0.858 . . . . 71.33 108.684 169.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.47 140.33 39.8 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.502 0.721 . . . . 72.53 110.508 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.86 146.1 92.76 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.066 0.946 . . . . 33.43 111.737 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.91 97.67 0.49 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.282 2.654 . . . . 73.42 111.71 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 62.1 t -91.01 110.39 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.142 -1.058 . . . . 65.23 108.142 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -84.87 98.46 10.33 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.805 -1.183 . . . . 75.14 107.805 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -57.99 -48.57 79.6 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.983 0.802 . . . . 75.1 111.357 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.97 -37.23 76.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.195 0.998 . . . . 74.3 112.547 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.66 -47.34 78.85 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.756 0.822 . . . . 64.4 111.549 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -81.81 -24.77 35.72 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.847 -0.615 . . . . 74.01 110.369 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.497 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 79.4 t80 -69.61 -30.06 67.72 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.511 0.724 . . . . 74.43 109.727 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -63.41 -37.55 87.72 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.194 0.521 . . . . 53.11 109.692 175.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -79.66 -11.23 59.87 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.309 -0.859 . . . . 62.12 111.543 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -72.26 -36.46 69.05 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.199 -0.667 . . . . 75.13 109.199 169.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 12.5 mt -86.99 -10.93 51.95 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.396 -0.82 . . . . 71.14 110.928 -175.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 176.26 94.31 0.01 OUTLIER 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.266 1.426 . . . . 71.35 107.836 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -70.89 97.52 1.43 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.473 -0.566 . . . . 64.12 109.473 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -159.98 110.23 1.87 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.415 -0.812 . . . . 74.41 109.059 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.59 105.43 11.83 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 109.712 -0.477 . . . . 73.35 109.712 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.28 178.34 52.82 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 116.503 -0.317 . . . . 75.34 112.986 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.429 ' HG2' HG23 ' B' ' 149' ' ' THR . 37.0 tt0 -151.09 97.94 2.51 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.377 -0.601 . . . . 73.21 109.377 -177.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.5 77.99 2.05 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.744 -0.662 . . . . 61.44 113.054 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.429 HG23 ' HG2' ' B' ' 147' ' ' GLU . 46.1 p -96.2 127.49 42.26 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.175 0.59 . . . . 72.11 109.914 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.36 -178.52 5.26 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.849 0.859 . . . . 74.14 109.971 175.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -150.35 108.31 3.72 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.982 0.513 . . . . 54.32 110.258 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -104.41 92.48 4.34 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 109.175 -0.676 . . . . 75.03 109.175 176.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -61.88 134.19 56.37 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.828 0.851 . . . . 63.41 110.804 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -64.33 126.31 27.38 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 123.172 0.589 . . . . 73.24 110.696 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 C-N-CA 125.165 1.386 . . . . 73.1 108.354 176.02 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.837 0.351 . . . . 75.22 110.677 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 33.4 t -174.83 129.17 0.31 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.738 0.815 . . . . 74.11 109.216 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -133.46 86.26 2.28 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.723 0.809 . . . . 62.34 109.266 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -78.81 104.14 9.23 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.153 0.502 . . . . 71.22 110.266 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -148.05 51.72 1.03 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.281 1.032 . . . . 75.45 108.366 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -90.07 55.25 3.05 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.105 -0.702 . . . . 35.44 109.105 176.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 3.3 p -63.8 -30.07 71.2 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.524 1.129 . . . . 73.42 112.245 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -83.8 80.37 9.16 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.081 -0.711 . . . . 73.41 109.081 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.404 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 27.5 ttt 64.8 115.21 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.445 1.498 . . . . 75.03 112.922 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 70.3 m -103.1 109.14 20.6 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.354 -0.98 . . . . 62.21 108.354 170.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.555 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.8 t80 -124.52 128.06 48.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.539 0.736 . . . . 74.42 109.101 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -146.54 128.04 15.04 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.82 0.7 . . . . 63.24 109.605 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 95.4 mt -68.46 124.66 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.416 -0.957 . . . . 73.0 108.416 168.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.574 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 36.4 mm-40 -93.28 -47.46 6.9 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.425 0.69 . . . . 74.05 110.192 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -175.24 124.44 0.24 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.59 -0.732 . . . . 64.14 110.013 -169.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.9 143.46 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 108.381 -0.97 . . . . 41.05 108.381 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.502 ' CE2' ' HD2' ' C' ' 19' ' ' LYS . 28.5 p90 -170.92 166.7 7.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.1 0.476 . . . . 72.33 110.77 -175.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.9 p -88.32 112.43 22.83 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.273 -0.876 . . . . 73.44 109.203 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.502 ' HD2' ' CE2' ' C' ' 17' ' ' TYR . 19.3 mmmt -64.97 -46.54 81.09 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.661 -1.237 . . . . 73.15 107.661 170.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.607 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.0 t70 -141.53 143.61 33.86 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 113.334 -1.757 . . . . 65.01 109.908 -170.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 59.0 mt -141.12 145.32 25.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 106.474 -1.676 . . . . 54.12 106.474 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.7 t -157.45 149.62 22.58 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.366 0.603 . . . . 75.04 109.984 175.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 84.1 t80 -149.55 116.72 6.03 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.017 -1.475 . . . . 72.21 107.017 172.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -120.78 111.1 17.15 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.162 0.585 . . . . 55.41 110.192 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.85 74.56 63.81 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.769 -1.567 . . . . 73.42 106.769 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.58 -15.87 30.53 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.652 2.234 . . . . 43.34 111.806 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -111.45 24.4 12.85 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.543 1.137 . . . . 74.15 109.623 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.487 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -51.27 -49.42 81.86 Favored Pre-proline 0 CA--C 1.562 1.404 0 N-CA-C 114.239 1.199 . . . . 71.42 114.239 -172.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.459 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 35.3 Cg_exo -60.13 -43.3 36.61 Favored 'Trans proline' 0 C--N 1.38 2.214 0 CA-C-N 122.021 1.757 . . . . 63.33 112.206 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -69.15 -30.0 68.14 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.826 -1.079 . . . . 71.51 112.053 -177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.83 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.4 p -79.78 -28.33 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 N-CA-C 111.858 0.318 . . . . 73.32 111.858 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -70.34 -31.68 69.06 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 120.791 0.329 . . . . 73.31 111.268 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -84.98 7.49 21.08 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.511 0.724 . . . . 74.21 111.228 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.75 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.07 164.43 13.95 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.343 1.057 . . . . 72.03 110.445 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . 0.402 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 9.8 t70 -85.31 104.17 14.91 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.929 -1.138 . . . . 55.44 107.929 167.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.6 t90 -70.09 87.83 0.58 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.923 1.289 . . . . 74.34 111.335 -171.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -123.03 79.12 51.26 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 124.479 1.111 . . . . 72.52 108.55 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.57 138.98 30.47 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.638 2.226 . . . . 54.35 114.495 -171.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -84.12 115.94 22.65 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.606 -1.628 . . . . 71.32 106.606 164.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.474 HG12 ' HB1' ' G' ' 466' ' ' ALA . 2.6 t -95.13 118.63 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.489 -0.778 . . . . 61.43 110.079 -163.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.506 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 87.3 tttt -127.22 134.1 50.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.824 0.85 . . . . 73.32 109.102 176.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.42 HD23 ' HB3' ' G' ' 464' ' ' MET . 50.9 tp -126.0 129.37 49.07 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.016 -0.735 . . . . 72.54 109.016 175.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.3 t70 -118.84 133.5 55.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.618 -1.252 . . . . 75.11 107.618 175.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.567 ' HB3' HD13 ' G' ' 460' ' ' LEU . 87.4 mt -124.8 136.01 53.46 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.836 -1.172 . . . . 72.53 107.836 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 15.6 t70 -141.96 151.29 42.41 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.503 0.721 . . . . 71.31 109.371 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -134.92 151.9 51.28 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.896 -0.779 . . . . 73.53 108.896 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.19 170.4 20.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.672 0.789 . . . . 73.32 109.273 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.409 ' HB2' ' CE2' ' C' ' 56' ' ' TYR . 78.0 p -159.64 153.09 22.43 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.265 0.226 . . . . 70.24 111.346 -176.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 84.2 p -149.59 147.44 28.14 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.943 0.897 . . . . 62.4 109.991 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -89.76 121.16 31.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.175 0.59 . . . . 53.13 109.587 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.613 HD11 HD12 ' C' ' 83' ' ' ILE . 20.5 mt -95.32 -39.26 10.13 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.329 0.652 . . . . 74.04 109.759 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.73 -172.45 3.51 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.77 0.828 . . . . 72.04 110.261 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.27 111.51 1.57 Allowed 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.255 0.972 . . . . 75.43 109.953 175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 70.06 -6.02 1.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.711 1.205 . . . . 74.43 112.733 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 68.1 t -94.22 95.79 5.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 106.833 -1.543 . . . . 70.24 106.833 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' C' ' 48' ' ' SER . 12.1 t80 -118.17 124.59 48.34 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.141 -0.936 . . . . 70.22 108.845 -172.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.548 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.3 tt0 -85.5 138.95 31.87 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 123.263 0.625 . . . . 72.03 110.587 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 42.6 t -116.81 142.16 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.925 -1.139 . . . . 64.42 107.925 165.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 85.8 t -127.83 130.73 70.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.99 -1.115 . . . . 51.32 107.99 172.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.23 107.67 18.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.451 -0.944 . . . . 71.11 108.451 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.446 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 49.5 ttm-85 -86.56 134.95 33.61 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.795 -1.093 . . . . 62.32 109.192 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.04 118.54 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.029 -1.1 . . . . 72.34 108.029 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.1 m -121.46 122.42 39.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.635 -0.876 . . . . 65.22 108.635 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.608 HG11 HD11 ' C' ' 126' ' ' LEU . 14.5 t -115.55 129.35 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.52 -0.918 . . . . 73.32 108.52 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 5.6 m -121.7 115.94 23.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.787 0.835 . . . . 72.43 108.871 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.59 120.82 43.64 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.79 -1.189 . . . . 75.04 107.79 172.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 45.3 m -122.2 169.07 11.26 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.578 0.751 . . . . 74.44 109.605 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.75 HD13 ' HG2' ' C' ' 34' ' ' LYS . 85.1 mt -132.24 15.68 4.59 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.577 1.151 . . . . 65.22 109.818 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.44 -91.08 0.59 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 111.253 -0.739 . . . . 42.24 111.253 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -89.91 -27.98 19.51 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.438 0.695 . . . . 74.13 109.878 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 4.3 tp10 -94.96 121.91 37.07 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.912 1.285 . . . . 72.35 110.357 -175.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.7 m -77.56 126.06 30.3 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.369 -0.975 . . . . 72.21 108.369 165.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.83 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -64.75 -60.91 2.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.284 1.04 . . . . 75.02 108.809 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -161.65 161.82 29.7 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-N 112.707 -2.042 . . . . 72.42 108.989 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.406 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -126.3 140.71 52.31 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 105.855 -1.906 . . . . 71.53 105.855 167.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.497 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.8 t -138.09 132.41 32.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.833 -1.173 . . . . 71.31 107.833 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.62 136.45 27.46 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.67 -0.863 . . . . 71.1 108.67 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -146.25 132.97 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 124.603 1.161 . . . . 74.34 108.507 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.607 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 39.9 mt-30 -118.58 94.9 4.63 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.966 -1.124 . . . . 74.14 107.966 173.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -81.69 104.28 11.97 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.888 -1.051 . . . . 60.41 109.819 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.8 157.29 35.6 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.991 -0.444 . . . . 73.52 111.991 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.502 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -159.63 117.81 0.79 Allowed Glycine 0 CA--C 1.501 -0.795 0 N-CA-C 110.83 -0.908 . . . . 62.4 110.83 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.613 HD12 HD11 ' C' ' 51' ' ' LEU . 10.5 mm -84.84 121.29 36.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.175 -1.046 . . . . 51.13 108.175 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.555 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 53.0 m-85 -128.67 118.33 22.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.774 -0.824 . . . . 62.52 108.774 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 54.8 m -77.79 108.21 10.85 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.515 -0.92 . . . . 65.11 108.515 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 45.4 pt -114.94 131.25 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.65 0.78 . . . . 74.11 109.217 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -146.98 152.3 38.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.148 0.979 . . . . 52.12 109.312 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.59 -23.1 17.55 Favored Glycine 0 N--CA 1.479 1.502 0 N-CA-C 113.941 0.336 . . . . 73.22 113.941 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.5 HG22 HE21 ' C' ' 93' ' ' GLN . 28.7 pt -103.05 152.11 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.803 0.841 . . . . 72.13 110.532 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 15.8 pt-20 -166.44 177.97 6.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.697 0.799 . . . . 70.23 109.49 173.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.31 -125.67 34.4 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.592 0.557 . . . . 51.23 113.661 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.424 HG22 ' HG2' ' C' ' 142' ' ' GLN . 82.4 p -72.26 -28.35 63.07 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.498 0.719 . . . . 54.45 111.075 -177.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.5 HE21 HG22 ' C' ' 89' ' ' ILE . 27.8 mt-30 -65.15 -44.55 88.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.588 0.755 . . . . 54.15 110.032 174.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.516 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 22.0 ttt -62.57 -46.17 89.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.214 -0.903 . . . . 60.54 110.472 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.83 -50.27 61.19 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 124.245 0.966 . . . . 64.11 111.613 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -76.2 -32.38 58.94 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 123.377 0.423 . . . . 74.51 111.954 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.547 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.3 t -59.44 -36.13 75.34 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.312 0.383 . . . . 70.11 110.463 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 34.2 mt -96.13 -20.39 18.66 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.83 0.852 . . . . 74.22 110.882 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.93 -31.52 57.89 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.036 -0.529 . . . . 73.2 113.875 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.47 -39.48 0.06 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.628 0.251 . . . . 73.32 111.616 -169.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.547 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 42.6 t80 -65.39 -43.53 90.36 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.461 1.505 . . . . 75.34 113.158 -172.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 66.3 m -81.57 -44.89 1.11 Allowed Pre-proline 0 N--CA 1.486 1.336 0 CA-C-O 118.717 -0.659 . . . . 54.32 111.787 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.04 -27.0 34.39 Favored 'Trans proline' 0 C--N 1.394 2.954 0 C-N-CA 122.516 2.144 . . . . 73.31 113.738 169.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -59.76 -42.9 94.3 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.393 1.077 . . . . 63.52 111.027 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -66.1 -33.47 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 115.437 -0.801 . . . . 71.42 110.376 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.502 HD21 ' HA3' ' C' ' 82' ' ' GLY . 62.6 mt -91.25 -25.16 19.62 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.88 0.872 . . . . 72.15 112.389 -171.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -54.38 -50.53 84.5 Favored Pre-proline 0 CA--C 1.557 1.237 0 CA-C-O 117.966 -1.016 . . . . 42.51 113.682 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.35 -37.83 96.27 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.29 1.993 . . . . 31.24 113.184 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -68.24 -47.32 68.11 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.364 0.666 . . . . 73.23 110.974 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.51 79.56 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.258 -0.883 . . . . 72.3 110.612 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -60.72 -53.21 60.19 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.117 1.367 . . . . 63.32 111.026 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . 0.41 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.2 tm-20 -67.38 -34.02 76.42 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 123.656 0.598 . . . . 61.45 110.316 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.2 t -64.58 -36.76 85.28 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.481 0.488 . . . . 74.4 110.764 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.497 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 77.8 mt -67.67 -50.37 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.3 0.64 . . . . 73.45 110.31 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.6 m -62.47 -30.1 71.01 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.561 0.744 . . . . 71.34 111.374 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -69.68 -50.62 42.09 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 109.142 -0.688 . . . . 74.31 109.142 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.405 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.59 -44.62 66.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.21 1.004 . . . . 65.35 112.063 176.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.5 HG13 ' HB2' ' C' ' 123' ' ' PHE . 88.4 t -63.58 -46.58 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.915 0.886 . . . . 74.32 110.868 177.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 36.6 t -63.54 -33.49 75.71 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.873 0.869 . . . . 72.51 111.795 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -73.34 -39.35 65.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.838 0.855 . . . . 74.51 109.761 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.82 -2.15 69.61 Favored Glycine 0 C--N 1.352 1.468 0 O-C-N 123.832 0.707 . . . . 73.11 112.587 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 61.75 28.49 17.54 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 126.77 2.028 . . . . 74.04 113.302 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.5 ' HB2' HG13 ' C' ' 118' ' ' VAL . 78.4 m-85 -81.84 156.62 69.97 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.272 -1.01 . . . . 72.3 108.272 171.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.26 171.25 2.48 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.727 2.285 . . . . 73.0 113.622 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -51.26 136.45 24.62 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.731 1.212 . . . . 63.35 114.036 -173.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.608 HD11 HG11 ' C' ' 64' ' ' VAL . 7.0 tt -127.32 91.73 3.37 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 106.764 -1.569 . . . . 54.11 106.764 171.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -100.5 105.61 17.07 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.851 -0.796 . . . . 72.24 108.851 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.02 125.58 25.9 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.144 -1.058 . . . . 74.13 108.144 175.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.07 148.64 98.34 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 122.84 0.456 . . . . 75.41 111.29 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.455 ' HG3' HD12 ' A' ' 16' ' ' ILE . 34.8 Cg_exo -57.55 106.78 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.872 2.381 . . . . 45.24 112.172 174.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 23.3 m -112.21 119.66 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.402 0.681 . . . . 72.45 109.924 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -91.87 93.61 8.91 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.904 -0.776 . . . . 73.04 108.904 -176.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.432 ' HE2' HD13 ' C' ' 44' ' ' LEU . 91.7 m-85 -61.09 -40.04 92.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.484 0.714 . . . . 65.53 111.026 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' C' ' 138' ' ' MET . 9.7 m-20 -60.45 -43.9 96.39 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.342 -0.845 . . . . 61.2 112.226 -175.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.91 -33.72 72.24 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.89 0.744 . . . . 63.51 111.396 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.485 ' HA ' HD21 ' C' ' 139' ' ' ASN . 2.1 tt -79.86 -46.07 17.52 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 109.69 -0.485 . . . . 74.33 109.69 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.432 ' HD2' ' CE2' ' G' ' 461' ' ' PHE . 22.7 t80 -59.71 -31.38 69.54 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.88 0.472 . . . . 74.43 111.364 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 66.7 mtt -63.04 -60.42 3.46 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.736 -0.665 . . . . 74.14 111.512 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . 0.485 HD21 ' HA ' ' C' ' 136' ' ' LEU . 12.0 p30 -63.05 -33.72 76.03 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.571 0.348 . . . . 73.43 111.243 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -51.63 -84.57 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.468 1.507 . . . . 74.21 110.406 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 pp -175.93 160.76 2.37 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.716 0.806 . . . . 75.12 111.755 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.424 ' HG2' HG22 ' C' ' 92' ' ' THR . 79.2 mt-30 62.47 98.46 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.145 1.378 . . . . 63.44 113.173 171.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -121.48 175.71 6.05 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.651 0.78 . . . . 73.14 111.516 -174.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -73.01 140.08 47.08 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 114.703 -1.135 . . . . 63.55 109.53 169.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.23 97.9 11.27 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.954 0.502 . . . . 65.21 110.088 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.72 132.47 13.12 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.262 -0.735 . . . . 60.32 111.262 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -76.62 -19.78 57.44 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.702 0.801 . . . . 74.24 112.651 -172.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.04 -111.51 1.92 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.372 -0.291 . . . . 72.44 112.372 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 3.6 t -148.69 83.65 1.47 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.949 0.881 . . . . 64.41 110.2 -175.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.462 ' H ' ' HB3' ' A' ' 145' ' ' ALA . 1.6 mp0 -92.56 174.49 7.25 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.862 0.865 . . . . 53.3 110.501 174.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . 0.586 ' HG2' ' HG2' ' A' ' 143' ' ' GLN . 10.1 tp10 69.14 109.76 0.05 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.356 1.462 . . . . 50.24 109.502 -172.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -73.64 -95.79 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.763 0.825 . . . . 70.14 112.126 -170.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 174.47 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.132 -1.432 . . . . 73.25 107.132 -166.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -79.22 105.08 10.29 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.102 -0.703 . . . . 74.11 109.102 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.305 0 C-N-CA 123.918 0.887 . . . . 72.51 110.637 -178.894 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 43.3 tpp . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.762 -0.458 . . . . 72.25 109.762 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 58.6 m -137.06 129.26 29.58 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.065 0.946 . . . . 62.0 110.038 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.17 152.75 40.51 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.551 0.741 . . . . 44.24 109.728 174.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -128.71 143.27 50.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.044 0.538 . . . . 63.53 110.642 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -133.63 150.61 51.59 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.504 0.722 . . . . 71.33 109.84 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -141.23 103.89 4.52 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.807 -0.812 . . . . 72.22 108.807 174.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 78.1 p -105.04 -172.1 2.04 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.148 0.979 . . . . 74.33 108.718 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.49 158.23 12.57 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 118.56 -0.733 . . . . 72.35 110.046 169.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 3.5 ttp 19.61 118.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 126.395 1.878 . . . . 74.34 114.483 -168.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 23.7 m -107.08 139.34 41.64 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.252 -0.905 . . . . 40.24 110.497 -174.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.464 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 55.0 t80 -163.21 88.48 0.59 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.031 -1.84 . . . . 71.31 106.031 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -119.27 115.35 23.98 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.202 -1.407 . . . . 73.4 107.202 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.407 HG21 HD11 ' D' ' 16' ' ' ILE . 16.4 mt -72.63 120.58 21.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.75 -0.833 . . . . 62.53 108.75 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -86.22 -34.0 20.58 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.402 0.681 . . . . 75.44 110.825 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -171.38 134.01 0.86 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.1 0.25 . . . . 73.35 111.663 -172.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.413 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.7 mp -113.24 134.68 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 107.493 -1.299 . . . . 72.11 107.493 171.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.413 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 36.6 p90 -166.56 174.5 8.79 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.901 0.858 . . . . 65.35 112.022 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -102.64 120.04 39.87 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.196 -1.366 . . . . 43.43 109.049 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.459 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.4 mtpt -81.16 -36.96 29.56 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.127 -0.694 . . . . 73.4 109.127 175.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 12.5 t70 -144.89 145.27 31.51 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.951 -1.022 . . . . 71.21 109.436 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.405 HG21 ' HE2' ' C' ' 117' ' ' MET . 73.9 mt -139.2 150.44 23.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.819 1.248 . . . . 61.03 107.811 175.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 13.0 t -155.29 145.78 22.07 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.678 0.791 . . . . 73.44 109.422 174.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.421 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.2 t80 -150.1 124.1 9.37 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.948 -1.501 . . . . 72.22 106.948 170.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 2.2 mp0 -122.0 152.51 39.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.079 0.552 . . . . 75.01 109.595 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.738 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -140.67 82.21 16.05 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.799 -1.186 . . . . 75.35 107.799 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.79 -34.25 11.44 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.035 2.49 . . . . 73.02 113.608 -171.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -107.82 8.63 28.81 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.319 0.648 . . . . 71.04 110.523 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.738 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -36.69 -64.88 0.35 Allowed Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 116.416 2.006 . . . . 42.34 116.416 -156.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -81.31 -13.41 11.13 Favored 'Trans proline' 0 C--N 1.371 1.756 0 CA-C-N 122.437 1.906 . . . . 74.11 113.65 -172.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -76.26 -42.88 44.26 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.182 0.993 . . . . 74.44 108.709 168.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.465 HG12 ' O ' ' D' ' 28' ' ' ALA . 6.5 p -81.86 -18.37 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 123.36 0.664 . . . . 64.45 111.547 -173.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -67.63 -15.1 63.48 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.965 0.728 . . . . 73.35 112.965 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -66.98 -13.15 61.59 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.674 0.79 . . . . 75.32 110.548 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -103.59 80.25 1.77 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.357 1.463 . . . . 73.04 109.005 173.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.6 82.92 5.64 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.972 -0.751 . . . . 63.3 108.972 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 t-105 -149.46 157.66 43.48 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.595 1.158 . . . . 75.2 108.231 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.634 ' HG3' HD11 ' H' ' 470' ' ' LEU . 30.5 tp60 -71.76 104.99 1.11 Allowed Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 108.963 -0.754 . . . . 74.34 108.963 176.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.423 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 22.4 Cg_exo -66.23 140.91 60.7 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.928 2.418 . . . . 74.11 113.089 -169.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.41 112.83 1.36 Allowed 'General case' 0 C--N 1.355 0.84 0 O-C-N 124.493 1.121 . . . . 73.51 109.24 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.617 HG23 HG13 ' D' ' 64' ' ' VAL . 2.5 p -98.18 115.0 37.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.626 -0.715 . . . . 73.01 110.752 -170.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -99.41 110.38 22.88 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.017 -1.475 . . . . 75.41 107.017 163.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.414 ' O ' HD12 ' D' ' 42' ' ' LEU . 1.1 pp -95.27 121.44 36.92 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.774 -1.195 . . . . 73.4 107.774 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.729 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 20.3 m-20 -106.05 145.61 31.19 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.064 -0.971 . . . . 75.53 108.38 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.5 130.07 39.97 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.424 -0.954 . . . . 75.31 108.424 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.7 t70 -132.05 143.42 50.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.109 -1.812 . . . . 72.31 106.109 170.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -135.72 155.93 49.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.649 -0.871 . . . . 71.41 108.649 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.07 173.29 14.04 Favored 'General case' 0 C--O 1.239 0.546 0 O-C-N 123.943 0.777 . . . . 52.53 109.854 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.588 ' HB2' ' HE1' ' D' ' 56' ' ' TYR . 19.9 p -155.61 151.23 27.27 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.655 0.782 . . . . 73.3 109.388 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 28.8 t -164.99 119.1 1.28 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.427 0.691 . . . . 64.35 109.545 -170.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -78.96 131.67 36.42 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.452 -0.573 . . . . 65.45 109.452 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.44 HD13 ' HB3' ' C' ' 29' ' ' PRO . 43.2 mt -102.24 -26.96 13.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.934 0.494 . . . . 70.24 111.101 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -168.09 -173.54 2.08 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.438 0.695 . . . . 55.24 110.629 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -75.05 111.98 10.82 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.984 -0.747 . . . . 64.24 108.984 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 76.09 4.01 3.73 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.777 1.631 . . . . 60.54 112.009 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 73.5 t -109.11 125.04 66.23 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 N-CA-C 108.032 -1.099 . . . . 70.34 108.032 169.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.588 ' HE1' ' HB2' ' D' ' 48' ' ' SER . 4.3 t80 -139.85 150.21 44.37 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.173 -1.047 . . . . 64.52 108.173 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -125.13 147.37 49.05 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.517 0.727 . . . . 74.43 109.973 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -124.3 141.83 43.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.959 -1.126 . . . . 73.42 107.959 171.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.476 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 53.4 t -118.37 139.17 46.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.185 -1.043 . . . . 74.41 108.185 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -123.69 113.68 18.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.652 -1.24 . . . . 63.4 107.652 179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -96.4 97.4 9.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.994 -1.113 . . . . 52.41 107.994 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 t -98.1 118.67 45.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.133 -1.062 . . . . 75.14 108.133 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.729 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.8 m -119.73 143.78 47.6 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.27 1.028 . . . . 64.34 108.47 -172.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.617 HG13 HG23 ' D' ' 40' ' ' VAL . 92.9 t -130.78 103.23 7.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.55 -0.907 . . . . 73.14 108.55 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 52.3 m -92.87 111.99 23.79 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.392 -0.966 . . . . 72.33 108.392 169.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -116.05 154.47 29.86 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.071 0.549 . . . . 73.13 110.518 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.449 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.9 m -148.41 135.48 20.17 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.606 0.566 . . . . 72.54 111.421 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.91 99.55 10.04 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.377 1.071 . . . . 74.22 108.451 173.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.71 -114.23 5.51 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.727 -0.67 . . . . 75.51 113.724 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.21 3.44 49.37 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.878 0.695 . . . . 73.43 112.878 -172.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -151.87 161.45 42.64 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 122.298 -0.251 . . . . 62.44 110.953 -168.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.2 m -63.74 137.1 57.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.053 0.941 . . . . 43.25 111.482 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.449 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -93.01 -73.59 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.184 -1.043 . . . . 70.42 108.184 174.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -140.49 143.4 35.45 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 121.429 0.633 . . . . 74.43 110.513 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 75.8 mt -109.28 141.99 40.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.202 -1.406 . . . . 61.31 107.202 173.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.58 ' SG ' HG23 ' D' ' 114' ' ' ILE . 51.6 t -151.73 143.55 23.73 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.271 -0.64 . . . . 74.41 109.271 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -155.72 136.5 13.48 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.203 -0.665 . . . . 72.33 109.203 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.75 114.04 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.847 -0.797 . . . . 65.01 108.847 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -88.56 81.68 7.07 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.267 -1.012 . . . . 71.3 108.267 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -78.12 99.46 6.17 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.102 -1.408 . . . . 74.14 109.32 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.01 148.97 18.65 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 111.549 -0.62 . . . . 44.34 111.549 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.9 132.01 4.7 Favored Glycine 0 C--N 1.335 0.513 0 N-CA-C 111.746 -0.542 . . . . 74.34 111.746 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.4 mt -90.28 128.79 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.044 0.938 . . . . 73.24 108.871 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -132.99 123.43 25.86 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.273 1.029 . . . . 74.01 109.672 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -76.56 105.67 7.76 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.176 -0.676 . . . . 74.42 109.176 168.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.574 HD13 HD21 ' D' ' 98' ' ' LEU . 48.3 pt -116.62 144.37 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 122.922 0.489 . . . . 63.4 110.163 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.2 158.8 19.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.852 0.861 . . . . 72.3 109.371 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.75 21.7 79.52 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 116.486 -0.325 . . . . 63.51 113.621 176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' D' ' 86' ' ' ILE . 23.9 pt -128.52 127.43 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.383 0.673 . . . . 63.11 110.0 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.81 154.1 46.09 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.483 1.113 . . . . 74.41 109.777 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.24 -117.84 11.62 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.43 -0.805 . . . . 72.44 114.562 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 19.2 m -65.56 -36.6 84.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.404 0.682 . . . . 71.12 111.612 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -77.09 -40.57 45.53 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.24 -0.436 . . . . 70.24 111.911 -172.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.713 ' SD ' HG21 ' H' ' 452' ' ' VAL . 0.0 OUTLIER -64.8 -35.74 82.08 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 120.785 0.326 . . . . 75.25 110.465 178.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.494 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -65.04 -49.48 69.98 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 115.381 -0.827 . . . . 44.12 109.736 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -59.97 -35.53 75.18 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.717 0.636 . . . . 73.5 111.391 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -64.82 -50.6 66.07 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.076 0.551 . . . . 71.52 111.239 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.574 HD21 HD13 ' D' ' 86' ' ' ILE . 75.7 mt -92.33 -28.42 16.95 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.801 0.667 . . . . 75.13 112.801 -169.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.81 -4.24 57.96 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-O 119.761 -0.466 . . . . 55.52 113.953 -174.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -142.9 -59.41 0.43 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.104 0.452 . . . . 52.12 111.365 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . 0.41 ' O ' HG12 ' D' ' 105' ' ' ILE . 46.5 t80 -70.56 -39.89 73.68 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.487 0.551 . . . . 72.4 112.487 -171.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.464 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 97.5 m -69.86 -46.84 23.98 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.313 -0.851 . . . . 71.31 111.611 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.4 Cg_exo -55.24 -34.19 87.34 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.004 1.803 . . . . 71.44 112.736 169.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -64.05 -40.83 97.16 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.404 0.681 . . . . 71.43 110.41 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.41 HG12 ' O ' ' D' ' 101' ' ' TYR . 46.9 mm -63.2 -37.22 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.517 0.727 . . . . 72.43 110.659 174.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.1 mt -81.23 -19.46 43.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.156 0.982 . . . . 72.23 112.237 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -65.91 -44.73 63.08 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 114.03 1.122 . . . . 74.14 114.03 -171.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.04 -44.62 38.02 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.282 1.988 . . . . 65.13 112.835 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -69.27 -34.72 75.2 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.384 -0.825 . . . . 65.32 111.263 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.55 -53.39 56.9 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.738 0.815 . . . . 72.24 110.341 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 30.0 ttp180 -53.39 -46.51 69.68 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 124.814 1.321 . . . . 74.11 111.292 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -63.38 -49.99 71.64 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.265 0.978 . . . . 52.35 111.29 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.7 t -57.22 -41.57 79.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.11 0.881 . . . . 74.22 111.018 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.58 HG23 ' SG ' ' D' ' 76' ' ' CYS . 70.2 mt -61.01 -56.41 18.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 123.788 0.835 . . . . 72.24 110.6 174.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.488 HG23 ' HG3' ' D' ' 125' ' ' GLN . 85.1 m -53.4 -43.57 68.02 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.437 1.095 . . . . 65.34 111.706 -175.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 40.1 t -65.07 -43.07 93.4 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.947 -1.024 . . . . 64.12 110.478 -177.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.4 mtm -68.92 -32.6 72.34 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.833 0.453 . . . . 75.14 111.573 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 114' ' ' ILE . 73.3 t -65.75 -42.41 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.675 0.79 . . . . 72.25 110.299 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -73.14 -27.73 61.84 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 122.686 0.394 . . . . 52.04 111.157 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' D' ' 116' ' ' SER . 80.3 mtt-85 -72.04 -33.95 68.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.595 0.758 . . . . 75.44 109.913 173.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.23 0.27 89.38 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.901 0.75 . . . . 60.41 112.0 174.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 19.2 p 64.4 19.82 11.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.599 1.959 . . . . 63.22 113.711 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -84.8 150.37 55.89 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 108.609 -0.886 . . . . 52.4 108.609 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.47 141.5 51.33 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 123.246 2.631 . . . . 52.34 113.546 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.488 ' HG3' HG23 ' D' ' 115' ' ' THR . 32.2 tt0 -51.0 140.44 15.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.905 1.282 . . . . 70.35 112.675 -172.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.457 HD11 HG21 ' D' ' 40' ' ' VAL . 0.3 OUTLIER -125.09 97.15 5.12 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.541 -0.911 . . . . 70.43 108.541 -175.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -99.0 110.37 22.99 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.868 -0.79 . . . . 71.24 108.868 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.479 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -69.39 113.41 6.69 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.656 -0.868 . . . . 73.01 108.656 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.73 140.6 97.84 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.042 0.537 . . . . 71.03 110.957 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.08 118.42 5.32 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.63 2.22 . . . . 54.0 111.778 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.73 123.17 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.522 0.729 . . . . 65.43 109.407 -176.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -85.17 79.32 9.61 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.572 -0.899 . . . . 65.52 108.572 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -83.56 -14.66 51.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.568 -0.742 . . . . 72.32 110.588 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' D' ' 138' ' ' MET . 2.3 m-20 -52.77 -53.55 46.58 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.969 0.908 . . . . 63.44 111.789 173.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.12 77.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.962 0.905 . . . . 52.22 111.691 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.1 -22.44 45.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.952 -1.022 . . . . 75.54 111.256 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.506 ' O ' HD13 ' D' ' 141' ' ' LEU . 84.6 t80 -70.51 -40.21 73.67 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.403 0.681 . . . . 75.04 110.119 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.453 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 35.0 mtt -62.55 -35.76 80.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.467 0.707 . . . . 64.11 110.137 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -76.12 -40.18 53.45 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.131 -0.94 . . . . 74.03 110.434 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -58.59 -35.14 71.95 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.009 1.323 . . . . 73.51 110.874 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.506 HD13 ' O ' ' D' ' 137' ' ' PHE . 2.8 mp -62.93 -37.14 85.84 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.232 1.013 . . . . 74.1 111.342 176.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -85.1 3.22 39.88 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.099 0.559 . . . . 74.5 111.751 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -119.37 49.11 1.39 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.828 0.823 . . . . 62.44 109.714 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -157.85 -171.22 3.45 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.361 -1.29 . . . . 53.24 108.789 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.17 58.52 3.55 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.312 0.645 . . . . 34.2 110.787 178.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.46 39.39 3.0 Favored Glycine 0 C--N 1.354 1.537 0 C-N-CA 123.341 0.496 . . . . 41.2 113.049 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -152.36 134.45 14.96 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.382 -1.34 . . . . 72.4 107.382 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.11 62.79 0.2 Allowed Glycine 0 C--N 1.342 0.893 0 O-C-N 123.24 0.337 . . . . 54.53 112.313 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 6.3 t -79.02 167.48 21.03 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 109.605 -0.517 . . . . 52.32 109.605 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -102.74 146.06 28.8 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.577 0.751 . . . . 75.25 109.926 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -71.03 125.25 26.35 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.43 -0.952 . . . . 64.4 108.43 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.52 154.97 37.09 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.567 0.542 . . . . 72.24 110.742 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -63.1 91.57 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.836 0.826 . . . . 73.3 110.848 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -143.12 73.88 1.42 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.121 1.368 . . . . 62.44 107.999 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-N 114.965 -1.016 . . . . 63.51 109.035 -175.826 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 51.5 t30 . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 121.275 0.559 . . . . 74.23 110.106 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 79.7 t -135.89 -45.48 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.992 1.717 . . . . 74.21 107.847 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.78 147.47 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 114.751 -1.113 . . . . 73.52 111.857 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 167.79 -43.94 0.24 Allowed Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.44 -0.345 . . . . 64.4 112.443 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 7.3 mp 66.29 -177.99 0.2 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.01 1.324 . . . . 72.54 112.11 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 5.2 t -155.69 87.35 1.08 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.818 0.847 . . . . 73.4 109.242 175.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 66.17 103.76 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.587 1.155 . . . . 51.01 111.814 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -63.43 -43.4 97.56 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.244 -0.65 . . . . 71.25 109.244 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 27.0 m 65.78 -77.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.816 1.646 . . . . 73.21 113.301 169.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -142.47 140.73 32.0 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.156 0.982 . . . . 64.22 109.838 -171.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -99.75 111.85 24.15 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 106.702 -1.592 . . . . 71.24 106.702 169.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -77.25 66.22 2.99 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.62 1.168 . . . . 74.22 111.59 -173.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -86.81 124.6 33.22 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.432 -0.803 . . . . 73.13 109.101 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 12.6 t -153.12 128.57 9.95 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.736 -0.838 . . . . 72.4 108.736 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 55.8 ttp -172.32 149.8 2.28 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.216 1.006 . . . . 73.14 108.397 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -64.84 132.66 50.08 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.047 0.539 . . . . 61.34 110.555 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -68.68 88.66 0.36 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.352 0.596 . . . . 73.05 109.97 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -152.66 103.67 2.81 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.139 -0.937 . . . . 72.34 108.89 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . 0.491 HD21 HD22 ' A' ' 42' ' ' LEU . 59.1 mt -114.15 150.32 34.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.437 0.695 . . . . 73.42 109.947 -177.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -76.6 78.65 1.31 Allowed Glycine 0 C--N 1.349 1.285 0 O-C-N 123.401 0.438 . . . . 72.33 112.18 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 6.8 tt -145.1 132.0 20.19 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.528 -1.286 . . . . 63.42 107.528 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.559 1.32 0 C-N-CA 123.797 0.839 . . . . 73.23 109.995 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 110.348 -0.242 . . . . 42.14 110.348 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 33.3 t -81.79 72.63 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.891 0.876 . . . . 71.41 110.041 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 15.8 m -155.42 -179.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 125.205 1.402 . . . . 51.53 110.004 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 105.61 40.46 2.03 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-N 116.576 -0.284 . . . . 63.33 112.662 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.57 109.84 16.39 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.383 0.673 . . . . 74.3 109.33 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 70.1 p -76.35 149.29 37.01 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.766 0.827 . . . . 75.24 110.449 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -72.74 167.56 20.6 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.12 0.568 . . . . 60.15 109.711 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . 0.589 ' HA ' HE21 ' F' ' 457' ' ' GLN . 0.0 OUTLIER -133.49 121.56 22.36 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.636 -0.505 . . . . 73.02 109.636 -177.436 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 5.2 t -64.15 -39.09 93.27 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.85 0.86 . . . . 72.1 111.324 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.47 102.59 5.58 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.013 0.925 . . . . 74.33 108.989 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' B' ' 45' ' ' ASP . 4.3 mm? -71.76 144.27 49.27 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.23 0.538 . . . . 72.22 109.934 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -74.48 112.37 10.59 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.674 -1.148 . . . . 73.34 110.695 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -162.76 151.64 14.85 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.821 0.849 . . . . 73.33 108.96 169.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 8.5 t -140.77 130.59 24.38 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.748 -0.834 . . . . 73.15 108.748 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . 0.577 ' SD ' ' HA ' ' F' ' 468' ' ' LEU . 31.5 ttp -162.61 90.91 0.73 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.795 -0.817 . . . . 74.41 108.795 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -90.19 26.96 1.75 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.473 1.109 . . . . 72.42 111.797 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -131.89 25.28 4.65 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.359 1.063 . . . . 53.35 109.86 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . 69.47 -68.53 0.19 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.711 1.604 . . . . 74.43 110.507 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . 0.577 ' HA ' ' SD ' ' F' ' 464' ' ' MET . 6.0 tt -151.95 -61.08 0.16 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.577 -1.268 . . . . 73.13 107.577 173.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 175.34 41.03 0.05 OUTLIER Glycine 0 C--N 1.349 1.294 0 CA-C-N 116.126 -0.488 . . . . 61.34 112.077 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . 0.514 HD22 ' HB3' ' B' ' 37' ' ' GLN . 2.7 pp -153.2 21.84 0.56 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.009 0.924 . . . . 73.24 110.222 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? . . . . . 0 C--O 1.25 1.11 0 N-CA-C 107.375 -1.342 . . . . 71.3 107.375 -174.822 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.59 -0.152 . . . . 51.3 110.59 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . 0.428 HG13 HG13 ' G' ' 452' ' ' VAL . 7.5 p -72.12 -32.24 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.662 0.785 . . . . 63.32 110.944 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . 0.428 HG13 HG13 ' G' ' 451' ' ' VAL . 27.3 m -126.81 150.87 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.454 1.102 . . . . 54.45 110.237 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 119.28 43.53 0.51 Allowed Glycine 0 C--N 1.348 1.215 0 N-CA-C 114.003 0.361 . . . . 62.33 114.003 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 44.4 tp -77.1 88.68 3.6 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.822 -0.807 . . . . 64.45 108.822 172.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 31.2 p -85.61 -8.08 58.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.721 0.808 . . . . 73.2 110.986 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -68.52 97.02 0.74 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.935 0.894 . . . . 73.54 110.176 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -73.43 83.62 1.47 Allowed 'General case' 0 C--N 1.349 0.557 0 N-CA-C 109.099 -0.704 . . . . 73.31 109.099 173.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 40.0 p -99.83 128.42 45.93 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.179 -0.919 . . . . 72.02 109.374 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.65 144.38 52.04 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.658 -0.868 . . . . 73.02 108.658 170.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . 0.567 HD13 ' HB3' ' C' ' 44' ' ' LEU . 2.4 tt -68.79 103.49 1.78 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 107.902 -1.147 . . . . 73.12 107.902 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . 0.432 ' CE2' ' HD2' ' C' ' 137' ' ' PHE . 31.0 p90 -33.76 -36.25 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 128.112 2.565 . . . . 74.51 114.646 175.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -76.28 105.37 7.29 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.942 -0.762 . . . . 72.5 108.942 -178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 26.3 m -76.24 -52.93 9.01 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.316 0.646 . . . . 74.1 110.069 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . 0.42 ' HB3' HD23 ' C' ' 42' ' ' LEU . 0.0 OUTLIER 70.71 133.6 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.579 1.552 . . . . 73.42 110.315 -175.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -75.15 4.18 7.33 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.926 0.713 . . . . 75.13 112.926 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . 0.474 ' HB1' HG12 ' C' ' 40' ' ' VAL . . . 57.53 57.89 4.09 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.705 1.202 . . . . 71.24 111.469 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -109.28 105.24 14.57 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.632 -0.713 . . . . 71.04 109.348 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . 0.716 ' HB2' HD22 ' G' ' 470' ' ' LEU . 42.9 mt -116.32 -11.44 11.24 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.81 0.844 . . . . 64.31 111.549 -173.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 71.11 60.62 4.38 Favored Glycine 0 C--N 1.356 1.654 0 O-C-N 123.523 0.514 . . . . 62.45 111.932 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . 0.716 HD22 ' HB2' ' G' ' 468' ' ' LEU . 2.4 pt? -126.8 18.5 7.29 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.628 0.771 . . . . 60.5 110.654 -172.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp . . . . . 0 CA--C 1.564 1.5 0 CA-C-O 117.555 -1.212 . . . . 73.22 110.9 175.965 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.008 -0.368 . . . . 61.44 110.008 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.78 -47.35 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 124.111 0.964 . . . . 61.1 110.041 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . 0.713 HG21 ' SD ' ' D' ' 94' ' ' MET . 7.4 p -168.72 151.03 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 114.191 -1.368 . . . . 51.24 110.39 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -143.64 58.34 0.54 Allowed Glycine 0 C--N 1.335 0.514 0 N-CA-C 109.077 -1.609 . . . . 73.32 109.077 167.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . 0.508 ' H ' HG22 ' H' ' 452' ' ' VAL . 2.3 pt? -58.94 159.7 6.76 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.34 1.056 . . . . 73.44 111.496 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 90.6 m -57.69 121.56 10.69 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 109.574 -0.528 . . . . 75.55 109.574 173.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -56.64 104.95 0.17 Allowed 'General case' 0 CA--C 1.541 0.617 0 O-C-N 124.161 0.913 . . . . 75.13 109.87 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -68.98 106.81 2.88 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.616 0.766 . . . . 61.12 109.018 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 60.7 p -81.4 -45.43 16.1 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.705 0.802 . . . . 55.41 110.646 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.48 148.93 21.94 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.03 0.932 . . . . 74.02 110.35 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.67 54.96 1.89 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.763 -0.828 . . . . 63.22 108.763 173.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 23.1 p90 29.24 -60.44 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 129.189 2.996 . . . . 71.01 118.059 168.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 77.13 170.42 0.23 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.649 1.58 . . . . 75.04 111.604 -170.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 9.7 t -162.15 -9.71 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.755 0.65 . . . . 64.0 112.755 -169.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -103.33 -167.69 1.41 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.77 0.428 . . . . 73.51 111.104 -171.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . 0.42 ' HG2' ' H ' ' H' ' 466' ' ' ALA . 30.7 ttmt -123.91 -156.36 0.71 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 107.846 -1.168 . . . . 71.34 107.846 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . 0.42 ' H ' ' HG2' ' H' ' 465' ' ' LYS . . . -62.4 97.41 0.09 Allowed 'General case' 0 C--N 1.363 1.159 0 CA-C-N 118.89 0.768 . . . . 63.11 110.539 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -60.36 -42.74 96.41 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.231 1.013 . . . . 72.1 112.943 -170.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . 0.406 HD22 ' HG ' ' H' ' 470' ' ' LEU . 4.9 tt -77.15 -35.33 56.15 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 109.164 -0.68 . . . . 74.14 109.164 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 103.72 15.45 22.52 Favored Glycine 0 N--CA 1.472 1.096 0 CA-C-O 119.84 -0.422 . . . . 73.35 113.256 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . 0.634 HD11 ' HG3' ' D' ' 37' ' ' GLN . 84.2 mt -79.7 84.6 5.5 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.738 -0.838 . . . . 72.54 108.738 173.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 92.1 mttt . . . . . 0 C--O 1.248 1.018 0 C-N-CA 123.802 0.841 . . . . 70.52 109.006 -176.691 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 109.699 -0.482 . . . . 53.32 109.699 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.3 m -82.24 124.15 29.67 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.412 0.685 . . . . 70.24 110.742 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -145.08 34.23 1.1 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.799 0.84 . . . . 64.35 109.576 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -71.71 136.14 47.09 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.42 0.688 . . . . 73.33 109.406 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -74.32 85.38 1.95 Allowed 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.746 0.784 . . . . 74.22 110.637 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -84.44 87.47 7.23 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.169 -0.923 . . . . 72.11 108.961 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 m -75.61 -46.72 30.08 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.714 0.805 . . . . 64.35 111.804 -167.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -122.7 -52.81 1.9 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.612 0.765 . . . . 73.14 109.084 171.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.2 mtt -90.44 176.5 6.68 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.412 -1.267 . . . . 53.1 110.632 -172.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 87.7 m -148.84 124.19 10.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.666 1.186 . . . . 71.13 107.906 173.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -134.55 138.67 44.81 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.821 0.848 . . . . 62.01 108.758 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -152.8 127.61 9.54 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.429 0.692 . . . . 70.42 109.466 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.3 mt -83.39 115.74 26.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.302 -0.999 . . . . 75.41 108.302 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -81.51 -38.59 26.03 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.478 0.486 . . . . 61.22 109.864 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -170.11 124.07 0.73 Allowed 'General case' 0 C--N 1.356 0.875 0 CA-C-O 119.684 -0.198 . . . . 74.3 110.783 -167.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.481 HD12 ' HG3' ' C' ' 130' ' ' PRO . 46.8 mt -111.68 134.79 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.157 -1.053 . . . . 75.31 108.157 172.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HB3' HG23 ' B' ' 122' ' ' THR . 44.1 p90 -166.55 167.33 15.6 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.878 0.847 . . . . 70.24 111.272 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -91.3 110.69 21.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.732 -1.122 . . . . 72.24 108.138 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -70.95 -46.92 61.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.96 -0.756 . . . . 73.23 108.96 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.66 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 6.0 m-20 -133.5 132.97 41.63 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.598 -1.183 . . . . 75.2 109.256 -176.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -127.67 139.71 51.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 106.678 -1.601 . . . . 72.32 106.678 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -149.84 107.34 3.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 123.655 0.597 . . . . 70.21 109.718 175.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 60.0 t80 -111.2 113.7 26.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.707 -1.59 . . . . 53.53 106.707 171.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.0 114.37 22.43 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.319 -0.623 . . . . 65.32 109.319 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.72 80.56 70.26 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 107.613 -1.255 . . . . 72.12 107.613 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.76 -11.4 20.14 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.469 2.112 . . . . 71.25 111.214 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -107.72 20.84 18.29 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.874 1.269 . . . . 63.03 108.772 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.46 -45.02 99.71 Favored Pre-proline 0 CA--C 1.571 1.786 0 N-CA-C 114.43 1.271 . . . . 45.41 114.43 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -88.01 -8.44 5.78 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 121.678 1.585 . . . . 73.43 112.99 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.44 ' HA ' HE21 ' A' ' 33' ' ' GLN . 18.1 t-160 -94.88 -15.53 23.6 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.215 1.006 . . . . 60.22 110.354 -175.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.533 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 8.8 p -77.01 -25.93 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.731 0.812 . . . . 74.12 110.205 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -66.68 -29.82 69.91 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.801 0.84 . . . . 63.53 110.113 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.44 HE21 ' HA ' ' A' ' 30' ' ' HIS . 48.6 mt-30 -78.94 -34.95 44.01 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.025 0.93 . . . . 64.12 111.612 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 31' ' ' VAL . 16.2 ptpt -82.87 169.2 16.33 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.115 0.413 . . . . 75.3 112.115 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -85.01 127.03 34.02 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.648 -0.871 . . . . 74.41 108.648 167.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -70.29 88.55 0.64 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.21 1.004 . . . . 75.31 111.594 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.457 ' HB2' HD13 ' A' ' 68' ' ' LEU . 98.5 mt-30 -132.88 76.78 70.01 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.141 0.976 . . . . 74.43 109.403 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -89.04 126.38 1.68 Allowed 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.339 2.026 . . . . 74.13 112.358 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.99 109.89 22.21 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.492 -1.299 . . . . 74.33 107.492 170.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.78 107.24 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 115.131 -0.94 . . . . 62.25 110.907 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -79.77 114.69 18.89 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.289 -1.004 . . . . 70.41 108.289 165.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.0 tp -98.24 111.55 23.84 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.302 -0.999 . . . . 64.33 108.302 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -116.11 129.49 56.36 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.055 -1.091 . . . . 62.12 108.055 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 tt -119.33 129.89 55.09 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.281 -1.007 . . . . 63.24 108.281 -171.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 18.7 t70 -130.34 155.28 46.62 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.13 0.972 . . . . 71.41 109.532 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.627 ' H ' HD21 ' E' ' 460' ' ' LEU . 90.0 m -141.78 131.87 24.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.564 1.146 . . . . 75.32 109.207 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.1 148.64 45.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.973 0.909 . . . . 75.33 109.423 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.4 p -109.41 161.68 15.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.568 0.747 . . . . 51.31 109.313 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.1 p -152.95 138.08 17.35 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.134 0.574 . . . . 54.01 109.853 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.448 ' HA ' ' HD1' ' A' ' 56' ' ' TYR . 46.9 tt0 -91.25 114.83 27.47 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.944 0.498 . . . . 74.33 109.975 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 57' ' ' GLU . 18.9 mt -89.25 -43.42 10.98 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.832 -0.803 . . . . 51.11 108.832 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -150.67 -179.33 7.16 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 113.989 -1.459 . . . . 64.22 108.662 174.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' E' ' 450' ' ' ASN . 2.4 m-20 -68.57 113.64 6.26 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.39 -0.596 . . . . 75.53 109.39 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 66.3 21.55 10.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.337 1.455 . . . . 74.45 112.101 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 60.3 t -121.33 102.08 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 106.759 -1.571 . . . . 70.32 106.759 167.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.448 ' HD1' ' HA ' ' A' ' 50' ' ' GLN . 18.7 m-85 -127.05 143.35 51.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.951 0.501 . . . . 73.41 110.014 -170.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' A' ' 51' ' ' LEU . 34.7 tt0 -114.89 137.91 51.41 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.782 0.833 . . . . 75.25 109.523 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.5 t -103.89 126.85 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.824 -1.176 . . . . 71.1 107.824 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.4 t -102.22 107.46 21.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.524 -0.917 . . . . 75.1 108.524 174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 tp -88.83 101.42 14.01 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.949 -0.759 . . . . 71.03 108.949 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.697 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 23.8 mtm105 -89.5 100.95 13.64 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.039 0.536 . . . . 74.54 109.619 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.518 HG21 ' HB1' ' A' ' 110' ' ' ALA . 2.5 m -113.25 108.48 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.154 0.581 . . . . 62.1 109.543 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 t -108.89 148.51 30.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.523 0.729 . . . . 53.42 110.741 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.423 ' O ' HD12 ' A' ' 75' ' ' LEU . 70.6 t -129.23 112.29 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 125.307 1.443 . . . . 72.22 108.067 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.7 m -102.6 104.2 14.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.562 -0.903 . . . . 53.21 108.562 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.84 109.57 21.35 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.562 -1.273 . . . . 74.1 107.562 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.7 p -147.39 140.93 25.49 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.18 0.514 . . . . 63.41 111.405 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' A' ' 37' ' ' GLN . 38.2 tp -90.39 68.64 6.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.828 1.251 . . . . 70.32 107.668 169.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.51 -89.71 0.63 Allowed Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.046 -0.979 . . . . 42.25 111.951 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.8 -26.01 14.17 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.2 1.0 . . . . 73.32 110.123 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -96.98 94.89 7.45 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.407 -0.815 . . . . 72.45 109.177 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.8 m -65.39 134.77 54.22 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.824 0.85 . . . . 63.51 111.99 -174.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.87 -64.54 1.16 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.874 -0.788 . . . . 70.51 108.874 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -157.06 174.14 15.96 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.166 -0.925 . . . . 75.14 110.937 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 64' ' ' VAL . 61.7 tp -140.2 130.36 25.02 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.973 1.309 . . . . 63.24 107.634 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.427 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 84.7 m -138.44 113.4 9.2 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.466 0.706 . . . . 41.2 110.204 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -132.74 126.76 33.21 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.897 -0.779 . . . . 73.1 108.897 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -129.17 119.15 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.513 -0.767 . . . . 75.04 109.362 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.66 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 44.9 mt-30 -91.05 89.77 7.56 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.877 -1.056 . . . . 63.35 108.286 172.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.422 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.9 tp-100 -78.73 105.71 10.22 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.149 -0.932 . . . . 70.04 109.29 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.97 160.03 27.03 Favored Glycine 0 C--O 1.242 0.613 0 N-CA-C 111.317 -0.713 . . . . 74.54 111.317 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.47 ' H ' ' HG3' ' A' ' 57' ' ' GLU . . . -162.43 121.91 1.06 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.003 -1.239 . . . . 52.01 110.003 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.418 HG23 HD12 ' A' ' 51' ' ' LEU . 59.3 mt -79.23 123.74 36.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.625 -0.88 . . . . 71.03 108.625 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -126.41 119.0 26.14 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.081 -0.711 . . . . 73.22 109.081 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 p -91.62 119.2 31.31 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.066 -1.087 . . . . 71.24 108.066 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.765 HD13 HD11 ' A' ' 89' ' ' ILE . 2.4 pp -126.54 161.59 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.589 0.755 . . . . 51.5 111.559 -171.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.605 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -167.72 155.28 8.63 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.376 1.071 . . . . 74.3 109.721 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.16 8.26 86.92 Favored Glycine 0 N--CA 1.475 1.249 0 N-CA-C 114.501 0.56 . . . . 64.4 114.501 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.765 HD11 HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -114.99 153.85 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.2 1.0 . . . . 71.11 109.153 178.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.414 ' H ' ' HB2' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -164.87 171.27 14.34 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.12 -1.067 . . . . 70.24 108.12 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.38 -114.54 1.47 Allowed Glycine 0 CA--C 1.542 1.721 0 N-CA-C 114.685 0.634 . . . . 71.41 114.685 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p -70.68 -29.72 66.12 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.267 1.027 . . . . 63.22 112.173 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.414 ' HB2' ' H ' ' A' ' 90' ' ' GLU . 69.7 mm-40 -65.86 -44.63 84.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.45 0.7 . . . . 75.03 110.865 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -71.43 -34.17 70.06 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.22 -0.445 . . . . 72.42 110.467 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -33.51 76.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.099 0.56 . . . . 74.21 110.618 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.526 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 63.9 t-80 -71.49 -21.69 61.9 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.739 0.816 . . . . 71.44 110.728 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 78.3 m -79.12 -60.27 2.44 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.401 -0.592 . . . . 72.54 109.401 172.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.14 -32.84 73.48 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.169 0.987 . . . . 75.32 112.423 -173.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.47 4.13 29.56 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 119.356 -0.691 . . . . 32.11 114.055 -172.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.1 -66.73 0.34 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.882 0.841 . . . . 61.44 111.782 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.413 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 76.1 t80 -70.65 -58.32 3.79 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.241 0.616 . . . . 73.12 112.478 -169.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.65 -46.28 98.59 Favored Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 113.517 0.932 . . . . 74.21 113.517 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.09 -26.49 65.5 Favored 'Trans proline' 0 C--N 1.399 3.185 0 C-N-CA 121.846 1.697 . . . . 71.23 112.636 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -68.22 -39.76 82.29 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.382 0.673 . . . . 54.33 110.601 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.8 mm -61.7 -43.43 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.893 0.877 . . . . 64.24 110.13 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.422 HD22 ' HG3' ' A' ' 80' ' ' GLN . 83.0 mt -77.94 -22.22 49.89 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.889 -1.05 . . . . 72.52 112.219 -174.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -61.46 -47.25 93.87 Favored Pre-proline 0 CA--C 1.567 1.62 0 N-CA-C 113.788 1.033 . . . . 65.03 113.788 -170.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.12 -37.0 66.66 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.143 1.895 . . . . 73.4 113.139 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -70.37 -39.98 74.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.639 0.776 . . . . 75.23 110.418 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.518 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -65.38 -43.11 91.77 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.388 -0.823 . . . . 41.51 110.549 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.474 ' NH1' HD12 ' C' ' 105' ' ' ILE . 31.8 ttm180 -55.14 -50.85 68.23 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 124.46 1.1 . . . . 62.53 110.33 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -59.86 -47.46 85.67 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.604 1.19 . . . . 75.35 111.343 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 117' ' ' MET . 36.1 t -61.7 -41.47 97.65 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 123.912 0.757 . . . . 64.14 110.643 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.487 HD11 HG23 ' A' ' 62' ' ' VAL . 96.1 mt -64.3 -50.23 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.895 0.878 . . . . 75.42 110.43 176.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 78.4 m -53.6 -45.03 69.91 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.839 0.855 . . . . 74.25 110.604 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -66.74 -38.77 87.3 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.165 -1.38 . . . . 73.54 110.228 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 30.9 mmt -58.61 -47.13 85.38 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.283 0.633 . . . . 74.15 111.235 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 114' ' ' ILE . 62.2 t -61.97 -43.64 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-N 114.897 -1.047 . . . . 72.22 110.408 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.1 m -73.29 -29.8 62.97 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.612 0.765 . . . . 40.0 111.917 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.492 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 93.9 mtt-85 -77.41 -25.31 50.67 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.207 0.603 . . . . 74.01 110.413 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.99 2.8 87.15 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.576 0.547 . . . . 40.43 112.758 171.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.9 m 68.01 16.79 9.56 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.908 1.283 . . . . 74.52 111.268 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -81.74 144.94 53.1 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 108.914 -0.773 . . . . 72.43 108.914 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.14 134.72 44.14 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.058 2.505 . . . . 64.41 112.226 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -52.75 141.95 19.94 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.369 1.068 . . . . 63.42 113.558 -171.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.0 tp -119.4 127.08 52.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.815 1.246 . . . . 75.32 109.766 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -135.9 102.39 5.04 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.492 -0.929 . . . . 71.33 108.492 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.0 pt? -68.45 151.59 46.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.535 0.734 . . . . 72.31 111.031 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.94 146.46 98.27 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.196 0.999 . . . . 70.24 111.23 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -67.1 123.63 11.17 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.558 2.172 . . . . 71.41 112.347 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 98.7 t -101.25 113.56 37.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 123.971 0.908 . . . . 71.44 108.619 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -87.84 97.39 10.89 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.631 -0.878 . . . . 73.43 108.631 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -66.48 -21.14 66.18 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.315 1.046 . . . . 75.13 111.685 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -68.86 -48.77 62.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.413 1.085 . . . . 73.52 110.88 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.14 -40.02 88.34 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.83 0.707 . . . . 73.34 110.348 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.49 -39.9 85.22 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.081 -0.963 . . . . 72.43 111.369 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -67.08 -36.74 82.65 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.38 -0.6 . . . . 74.22 109.38 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.0 mmt -64.46 -35.11 79.87 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.023 0.827 . . . . 75.33 111.176 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 42.2 m-80 -60.0 -45.1 93.84 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.993 0.517 . . . . 64.12 110.787 173.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -68.26 -42.82 79.05 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.066 0.546 . . . . 71.05 110.759 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.51 -47.26 70.48 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.323 1.049 . . . . 72.32 111.568 -167.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -163.71 17.77 0.07 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.888 -0.596 . . . . 73.0 111.53 -172.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.662 ' HG2' ' HG3' ' A' ' 144' ' ' GLN . 50.6 tt0 64.97 -77.27 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.429 1.092 . . . . 51.15 110.189 -170.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.662 ' HG3' ' HG2' ' A' ' 143' ' ' GLN . 0.9 OUTLIER -163.28 155.5 18.03 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.827 0.851 . . . . 71.03 110.795 177.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -168.84 -77.25 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.12 0.968 . . . . 65.21 108.853 172.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 52.95 -121.12 14.32 Favored Glycine 0 C--N 1.36 1.864 0 O-C-N 124.115 0.885 . . . . 63.43 113.148 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -118.76 -178.54 3.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.307 1.043 . . . . 62.4 109.247 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 151.81 51.08 0.01 OUTLIER Glycine 0 C--N 1.345 1.053 0 C-N-CA 121.674 -0.298 . . . . 42.33 113.211 177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.3 t -161.96 156.97 23.04 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 122.946 0.499 . . . . 71.23 110.338 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -161.82 102.89 1.17 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.11 -1.07 . . . . 73.32 108.11 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -67.43 114.77 6.37 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.638 0.775 . . . . 70.12 111.672 -170.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -114.87 127.32 55.64 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.492 -1.299 . . . . 63.15 107.492 168.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -66.97 85.66 0.13 Allowed 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.961 0.886 . . . . 44.24 111.118 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -92.54 125.77 37.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.862 -1.063 . . . . 73.14 109.474 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 C-N-CA 123.653 0.781 . . . . 63.41 109.822 -176.358 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 108.44 -0.948 . . . . 74.54 108.44 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 28.8 p -141.68 81.21 1.76 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.13 0.572 . . . . 63.23 110.467 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -156.68 162.2 39.83 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.846 0.858 . . . . 75.01 109.325 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -157.05 162.82 39.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.394 0.678 . . . . 74.42 110.298 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -77.05 88.87 3.57 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.825 -0.805 . . . . 70.13 108.825 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -154.99 157.67 38.01 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.9 0.381 . . . . 71.12 110.92 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 38.9 p -63.97 -11.18 26.32 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.931 1.293 . . . . 74.22 112.214 174.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -55.55 -47.46 76.31 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.703 0.801 . . . . 73.23 110.935 169.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.546 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 19.7 ptm 53.8 177.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.174 1.79 . . . . 62.22 114.765 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 63.7 m -149.05 130.68 14.95 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.641 -1.163 . . . . 62.22 109.2 170.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -126.91 114.7 18.21 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.181 -1.415 . . . . 71.13 107.181 164.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.462 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -128.76 118.34 22.64 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.452 0.701 . . . . 75.52 109.268 -177.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 59.2 mt -77.77 116.48 21.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.902 -1.147 . . . . 65.24 107.902 169.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -85.72 -47.27 9.93 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.115 -0.698 . . . . 74.42 109.115 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -161.62 136.4 7.21 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.319 -0.855 . . . . 63.44 109.447 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 86.2 mt -115.89 140.76 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 106.392 -1.707 . . . . 51.13 106.392 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -166.3 171.18 12.37 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.392 0.615 . . . . 64.25 111.553 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.47 HG21 HD11 ' B' ' 21' ' ' ILE . 58.4 m -98.53 128.24 44.78 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.112 -0.949 . . . . 75.43 108.719 170.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.44 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 19.4 mtpp -86.96 -37.28 17.72 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.996 0.919 . . . . 43.25 109.465 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -151.93 139.45 19.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.178 -0.465 . . . . 75.44 112.059 -173.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.47 HD11 HG21 ' B' ' 18' ' ' THR . 39.6 mm -124.24 141.1 45.57 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 124.965 1.306 . . . . 51.45 108.809 170.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.4 t -140.55 136.72 33.14 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.485 -1.234 . . . . 64.34 108.116 176.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.5 t80 -158.59 111.01 2.27 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 107.62 -1.252 . . . . 75.51 107.62 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -131.34 117.45 18.94 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.844 0.858 . . . . 65.54 109.269 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.593 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -109.94 85.83 4.42 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.166 0.987 . . . . 75.13 108.821 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.64 -32.38 24.23 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.759 2.306 . . . . 73.35 112.546 -170.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -108.9 8.41 26.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.535 0.734 . . . . 73.33 111.249 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.593 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -34.48 -65.25 0.26 Allowed Pre-proline 0 N--CA 1.503 2.204 0 C-N-CA 125.526 1.53 . . . . 74.52 114.852 -167.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.8 Cg_exo -69.88 -19.41 35.58 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.284 1.99 . . . . 64.25 112.836 -168.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -95.48 -34.11 12.19 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.32 -0.854 . . . . 72.32 110.07 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.482 HG22 HD12 ' B' ' 68' ' ' LEU . 2.0 p -71.85 -24.29 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.859 0.464 . . . . 72.02 110.703 -173.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -67.62 -3.51 9.18 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.928 0.891 . . . . 73.25 112.989 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.56 -19.55 65.28 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 120.796 0.331 . . . . 74.34 110.294 170.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.441 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 86.3 mttt -105.35 92.74 4.33 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.581 1.153 . . . . 72.43 108.576 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.55 87.55 7.41 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.353 0.597 . . . . 75.32 110.221 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -165.43 159.08 16.6 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.803 1.241 . . . . 75.04 108.181 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.438 ' HG3' ' HB2' ' B' ' 124' ' ' PRO . 17.0 mp0 -59.5 110.65 2.9 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 123.852 0.861 . . . . 75.53 109.934 172.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.655 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.0 Cg_endo -60.24 140.71 93.48 Favored 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 122.908 2.405 . . . . 74.21 112.603 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -51.58 107.84 0.22 Allowed 'General case' 0 C--N 1.357 0.928 0 O-C-N 124.471 1.107 . . . . 71.41 110.561 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 31.3 m -87.5 155.04 3.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.157 -0.929 . . . . 65.02 111.454 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.64 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 48.9 tttp -139.39 107.69 5.8 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.308 -1.367 . . . . 44.23 107.308 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.26 124.37 33.8 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.502 -0.555 . . . . 54.01 109.502 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.568 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 23.6 t70 -130.18 154.45 47.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.242 1.417 . . . . 72.34 107.838 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.433 ' HB2' ' CD2' ' F' ' 462' ' ' TYR . 0.2 OUTLIER -142.71 147.29 35.4 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.701 -0.481 . . . . 53.1 109.701 -170.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.598 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 23.4 t70 -146.91 114.14 6.24 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.912 -0.773 . . . . 71.52 108.912 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.2 p -114.95 108.29 16.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.23 0.612 . . . . 73.13 110.697 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.16 162.65 17.14 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.827 1.251 . . . . 32.12 108.689 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.0 p -137.44 162.28 34.08 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.271 0.628 . . . . 70.21 109.468 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 97.8 p -150.41 136.48 18.55 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.855 0.462 . . . . 54.31 110.199 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -87.02 110.41 20.04 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.311 -0.626 . . . . 64.44 109.311 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 27.5 mt -82.42 -41.94 19.23 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.908 -0.587 . . . . 72.31 109.669 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.73 -172.31 4.01 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.51 -1.223 . . . . 74.33 110.303 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.03 105.52 0.41 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.782 -1.099 . . . . 55.44 110.723 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 66.76 16.43 10.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.952 1.301 . . . . 75.51 112.322 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -105.49 110.05 29.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.765 -1.198 . . . . 71.42 107.765 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.52 140.23 52.48 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.508 0.67 . . . . 75.34 109.675 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -116.04 104.11 11.24 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.356 -1.35 . . . . 74.11 107.356 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 90.8 t -85.4 139.68 17.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 CA-C-N 114.632 -1.167 . . . . 74.03 109.635 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.83 120.04 62.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 123.585 0.754 . . . . 61.33 109.116 -176.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -107.42 106.29 16.62 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.78 -1.193 . . . . 71.32 107.78 178.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.598 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 34.6 ttm180 -98.87 118.81 36.46 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.157 0.583 . . . . 72.54 109.616 170.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.617 ' HB ' HD11 ' B' ' 114' ' ' ILE . 29.3 t -107.84 108.64 25.76 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.621 -1.251 . . . . 73.0 107.621 169.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 41.7 m -97.11 122.57 40.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.519 -0.549 . . . . 64.3 109.519 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.712 HG21 HG21 ' B' ' 114' ' ' ILE . 79.5 t -115.83 103.3 14.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 124.046 0.939 . . . . 52.42 110.111 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 99.7 m -91.23 145.09 24.95 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.559 -0.904 . . . . 71.13 108.559 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -145.85 148.73 33.19 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.463 0.305 . . . . 62.35 111.027 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.1 p -153.41 130.62 11.18 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.808 -0.633 . . . . 61.24 110.801 -175.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.655 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 35.0 mt -98.68 112.73 24.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.924 0.89 . . . . 71.04 108.978 175.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.48 -114.54 6.96 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 115.211 -0.904 . . . . 65.45 112.342 -172.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -109.09 11.65 25.57 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.226 0.611 . . . . 71.45 112.282 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -128.29 150.14 50.19 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.199 0.6 . . . . 74.41 110.079 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 37.5 m -66.38 135.19 53.98 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.474 0.484 . . . . 62.25 110.594 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.466 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -91.16 -62.32 1.47 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.283 -1.006 . . . . 74.1 108.283 174.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -151.4 162.88 40.16 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.202 -0.908 . . . . 74.42 110.17 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -132.91 109.35 9.53 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.976 -1.491 . . . . 52.33 106.976 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' B' ' 114' ' ' ILE . 51.2 t -118.3 156.43 28.89 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.69 0.796 . . . . 61.4 109.267 -174.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.0 tt0 -165.81 139.87 4.53 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.7 -0.852 . . . . 64.14 108.7 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' B' ' 113' ' ' CYS . 72.3 t -131.67 141.66 45.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.656 -1.239 . . . . 73.42 107.656 172.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -122.31 87.62 2.78 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.753 -0.832 . . . . 74.42 108.753 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.34 99.48 7.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.551 -0.75 . . . . 73.4 109.014 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.44 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.97 144.29 16.55 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.635 -0.986 . . . . 60.23 110.635 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.42 130.43 4.1 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.491 -0.644 . . . . 75.25 111.491 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.0 mt -85.15 125.77 40.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 123.945 0.898 . . . . 74.43 109.208 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -136.54 135.45 38.49 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.29 1.036 . . . . 64.22 108.565 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 41.9 m -101.99 106.6 17.54 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.802 -0.814 . . . . 52.14 108.802 176.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.407 HG21 ' SG ' ' B' ' 97' ' ' CYS . 31.2 pt -110.66 125.15 67.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.776 0.83 . . . . 64.2 109.906 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.45 162.06 41.65 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.753 0.821 . . . . 60.34 109.331 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.18 -47.8 3.9 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.476 0.485 . . . . 75.31 112.636 -177.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 31.1 pt -70.18 152.28 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.838 0.855 . . . . 71.13 110.644 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -162.85 163.86 26.29 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.363 0.665 . . . . 74.31 109.96 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.4 -113.65 3.71 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.438 0.461 . . . . 71.4 112.407 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 87.7 m -84.97 -26.74 26.95 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.182 0.515 . . . . 64.11 110.745 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -73.43 -28.89 62.22 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.831 -0.622 . . . . 75.22 110.663 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.518 ' SD ' HG22 ' F' ' 452' ' ' VAL . 0.0 OUTLIER -72.7 -33.75 66.68 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 109.589 -0.522 . . . . 71.3 109.589 173.234 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.55 -39.08 84.96 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.905 0.882 . . . . 71.01 110.891 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -62.65 -31.23 72.06 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.681 -1.145 . . . . 72.53 110.808 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.407 ' SG ' HG21 ' B' ' 86' ' ' ILE . 25.2 t -72.06 -66.35 0.66 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.924 -0.58 . . . . 60.4 110.367 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.441 HD12 ' N ' ' B' ' 99' ' ' GLY . 1.6 pp -68.93 -26.74 65.23 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.589 0.959 . . . . 75.22 113.589 -171.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.441 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -104.56 3.05 42.55 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-O 119.52 -0.6 . . . . 74.22 114.242 -171.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.86 -61.16 0.18 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 117.429 0.615 . . . . 71.31 111.176 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -66.92 -52.38 43.82 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.338 1.055 . . . . 72.35 111.908 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.428 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 92.6 m -62.34 -50.38 79.68 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.371 1.068 . . . . 73.53 111.788 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.7 Cg_exo -56.36 -36.65 97.4 Favored 'Trans proline' 0 C--N 1.401 3.305 0 C-N-CA 122.045 1.83 . . . . 71.22 113.295 170.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -66.59 -29.56 69.64 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.008 0.523 . . . . 62.53 111.004 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.431 HG23 ' NH2' ' D' ' 111' ' ' ARG . 93.0 mt -68.49 -45.51 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.87 0.868 . . . . 73.01 110.244 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.405 ' HB2' HD12 ' B' ' 60' ' ' LEU . 56.2 mt -76.39 -20.93 56.66 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.975 -1.011 . . . . 73.02 111.833 -173.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -59.91 -48.79 93.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-O 117.661 -1.162 . . . . 73.0 113.419 -171.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -56.36 -38.69 94.73 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.124 1.882 . . . . 74.4 113.231 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -66.83 -47.64 71.38 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.158 0.583 . . . . 74.24 110.335 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.407 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -59.81 -40.27 87.81 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.593 0.757 . . . . 74.14 110.656 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.539 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 36.0 ttt180 -61.75 -52.3 64.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.334 1.454 . . . . 73.35 111.138 -176.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.74 -37.74 88.5 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.958 0.786 . . . . 62.22 109.916 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.492 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 5.1 t -67.38 -38.31 84.55 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.656 0.598 . . . . 75.42 111.796 -173.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.712 HG21 HG21 ' B' ' 64' ' ' VAL . 61.1 mt -66.74 -51.47 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 109.388 -0.597 . . . . 74.51 109.388 176.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.471 HG21 ' OG ' ' C' ' 119' ' ' SER . 88.9 m -54.91 -37.74 66.74 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.898 1.374 . . . . 75.52 110.848 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 46.7 t -63.43 -44.19 95.27 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-N 115.361 -0.836 . . . . 53.21 110.018 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.422 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 30.7 mmt -62.91 -43.07 99.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.337 0.398 . . . . 73.53 110.93 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.511 HG23 ' O ' ' B' ' 114' ' ' ILE . 48.4 t -58.96 -47.16 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.242 1.017 . . . . 55.43 109.605 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.532 ' HB3' HG21 ' C' ' 115' ' ' THR . 71.8 m -65.49 -34.54 78.51 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.261 -1.336 . . . . 70.15 112.062 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -68.87 -35.0 76.37 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.395 -0.821 . . . . 72.53 110.093 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -86.99 10.99 66.15 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 124.135 0.897 . . . . 52.51 112.957 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 17' ' ' TYR . 67.0 p 56.74 23.61 8.12 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.992 1.717 . . . . 52.32 113.628 176.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.47 149.99 62.44 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 122.797 0.439 . . . . 64.12 109.996 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.438 ' HB2' ' HG3' ' B' ' 37' ' ' GLN . 51.2 Cg_exo -55.29 164.76 3.57 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.736 2.958 . . . . 74.51 114.906 -177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -57.73 121.39 10.32 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.308 1.043 . . . . 71.23 112.895 -166.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.624 ' HG ' HD11 ' F' ' 468' ' ' LEU . 9.5 tt -128.54 123.85 34.52 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.075 -1.083 . . . . 70.41 108.075 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -134.98 127.1 29.89 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.611 0.764 . . . . 74.12 109.004 172.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.539 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -68.79 137.74 54.24 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.483 0.713 . . . . 50.41 109.919 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.03 138.4 61.07 Favored Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 123.625 0.578 . . . . 54.41 110.576 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.04 122.98 7.52 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.881 2.387 . . . . 55.41 112.847 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 t -116.2 112.08 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.42 -0.956 . . . . 43.41 108.42 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -76.68 88.71 3.35 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.461 -0.94 . . . . 74.53 108.461 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -59.51 -37.8 79.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.093 -0.958 . . . . 73.24 112.345 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.22 -43.59 87.79 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.978 0.911 . . . . 73.23 112.688 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.03 -53.64 29.28 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.537 0.735 . . . . 71.12 110.725 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.0 -14.72 61.07 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.282 -0.872 . . . . 71.44 111.433 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.495 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 84.2 t80 -71.67 -42.95 66.86 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.396 0.435 . . . . 74.44 109.937 173.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 61.9 mtt -62.16 -33.78 75.15 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.024 0.53 . . . . 73.4 110.601 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -79.38 -25.7 42.11 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.582 -0.735 . . . . 62.5 111.272 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.407 ' OH ' ' HB2' ' F' ' 459' ' ' ASP . 62.8 t80 -64.03 -28.5 69.84 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.289 0.636 . . . . 75.02 111.334 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 17.5 mt -83.56 5.83 22.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.478 0.711 . . . . 74.33 111.453 -174.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -143.78 153.34 42.31 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.386 1.074 . . . . 74.11 108.819 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -89.46 11.75 18.44 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.735 0.414 . . . . 72.53 111.598 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -113.37 151.85 30.74 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.505 0.722 . . . . 74.23 109.89 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.98 160.22 43.0 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.645 0.778 . . . . 64.34 110.226 -177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.95 171.78 28.95 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.745 -0.661 . . . . 74.4 112.589 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -152.66 102.22 2.69 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.569 -0.9 . . . . 73.31 108.569 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -134.46 52.23 0.81 Allowed Glycine 0 CA--C 1.504 -0.628 0 N-CA-C 109.661 -1.376 . . . . 73.35 109.661 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 1.8 m -118.76 30.54 7.13 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.638 -0.781 . . . . 75.31 109.839 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.82 174.65 11.12 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.879 -0.6 . . . . 62.04 109.783 175.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.32 133.43 35.23 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.288 0.565 . . . . 70.54 110.475 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -163.51 137.64 5.92 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.7 1.2 . . . . 65.2 108.428 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -129.18 117.92 21.56 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.25 0.62 . . . . 64.22 110.087 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -143.7 99.17 3.36 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.802 0.841 . . . . 74.44 109.217 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . 0.409 ' HA ' ' NE2' ' D' ' 50' ' ' GLN . . . . . . . . 0 C--O 1.256 1.415 0 C-N-CA 123.675 0.79 . . . . 72.33 109.745 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.77 -0.456 . . . . 74.45 109.77 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m 72.63 20.42 3.8 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.369 1.467 . . . . 74.24 111.808 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -77.35 102.32 6.72 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.895 0.878 . . . . 73.33 110.546 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -140.45 116.68 10.59 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.652 0.781 . . . . 74.32 109.397 168.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -103.58 120.87 41.74 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.131 0.972 . . . . 73.14 108.873 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -76.74 86.78 3.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.851 -0.796 . . . . 45.45 108.851 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 37.7 p -65.07 -29.28 70.16 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.99 0.916 . . . . 50.13 112.049 -174.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.69 77.95 4.2 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.63 0.772 . . . . 74.31 109.634 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.6 ttt 65.42 111.73 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 126.13 1.772 . . . . 71.32 112.299 -173.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 28.5 m -103.69 96.58 6.81 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.632 -1.247 . . . . 52.02 107.632 170.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -97.44 128.45 44.24 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.491 -0.929 . . . . 73.41 108.491 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -153.88 125.74 7.74 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.18 0.592 . . . . 65.21 109.723 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.442 HD13 HD11 ' C' ' 16' ' ' ILE . 50.1 mt -75.75 132.57 32.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.857 -0.794 . . . . 61.42 108.857 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.499 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 26.0 mm-40 -101.11 -39.52 7.64 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.593 0.757 . . . . 74.53 109.899 174.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.407 HH12 ' HG3' ' E' ' 471' ' ' LYS . 24.6 ttt85 -169.67 146.62 3.32 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.526 -0.546 . . . . 71.22 109.526 -172.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.442 HD11 HD13 ' C' ' 13' ' ' ILE . 89.8 mt -137.03 134.08 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.143 -1.058 . . . . 73.5 108.143 175.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.413 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 43.4 p90 -170.85 164.29 7.81 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.155 0.502 . . . . 71.4 110.904 -167.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -87.26 114.53 23.96 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.328 -0.851 . . . . 61.44 108.855 173.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.413 ' HD2' ' HE2' ' C' ' 17' ' ' TYR . 19.2 mmmt -64.02 -39.89 95.12 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.915 0.864 . . . . 75.13 109.139 172.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -160.4 144.98 14.38 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 113.696 -1.593 . . . . 75.22 108.349 -172.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 88.9 mt -133.78 146.99 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.585 -1.265 . . . . 73.41 107.585 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.8 t -151.92 149.76 29.29 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.471 0.653 . . . . 63.55 110.267 172.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 82.7 t80 -150.75 117.85 5.94 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 107.275 -1.38 . . . . 73.01 107.275 173.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.97 111.99 17.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.512 0.725 . . . . 75.53 109.882 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.88 82.34 60.94 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.25 -1.019 . . . . 60.22 108.25 169.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -65.17 -25.78 57.73 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.013 2.476 . . . . 75.32 112.712 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -102.31 13.02 35.73 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.154 0.982 . . . . 62.4 110.605 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.468 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -45.18 -58.42 5.74 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 114.703 1.371 . . . . 73.23 114.703 -165.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.549 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 23.5 Cg_endo -60.04 -43.22 37.78 Favored 'Trans proline' 0 C--N 1.383 2.382 0 CA-C-N 122.129 1.796 . . . . 70.13 111.817 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -71.67 -28.42 63.73 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.963 0.905 . . . . 75.35 112.674 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.761 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.7 p -80.25 -22.26 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.57 0.348 . . . . 65.14 111.567 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -72.91 -21.24 60.93 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.005 0.522 . . . . 74.24 111.783 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -102.1 6.5 40.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.734 0.814 . . . . 74.11 110.906 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.823 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -83.77 161.53 20.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.444 0.698 . . . . 63.24 110.546 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 7.2 m-20 -57.76 112.27 1.41 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.32 1.048 . . . . 74.33 109.646 168.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -73.57 88.45 1.67 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.028 0.531 . . . . 73.12 110.553 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -150.16 74.22 9.15 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.393 -0.966 . . . . 50.2 108.393 169.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.58 ' HD2' HD21 ' G' ' 470' ' ' LEU . 9.5 Cg_exo -74.57 164.48 33.74 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.75 2.3 . . . . 74.22 112.87 173.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -115.8 94.38 4.66 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.374 -1.714 . . . . 74.14 106.374 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.431 HG23 HD22 ' G' ' 470' ' ' LEU . 90.9 t -73.38 98.4 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.548 -0.751 . . . . 73.12 109.256 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -101.5 107.39 18.68 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.912 -1.144 . . . . 72.21 107.912 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.07 138.48 31.41 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.273 0.559 . . . . 74.11 111.282 -174.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.577 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.2 t70 -130.74 132.86 45.58 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.11 1.364 . . . . 62.5 108.614 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.401 HD13 HG11 ' C' ' 131' ' ' VAL . 52.0 mt -123.05 131.9 53.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.845 -1.169 . . . . 74.45 107.845 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.521 ' HA ' ' HG ' ' G' ' 460' ' ' LEU . 19.2 t70 -144.4 144.58 31.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.322 0.649 . . . . 71.35 109.421 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.433 HG22 HD21 ' G' ' 460' ' ' LEU . 15.3 t -151.48 153.41 34.57 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 122.898 0.479 . . . . 55.33 110.101 175.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.95 168.86 24.97 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.432 -0.804 . . . . 54.14 109.564 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.4 p -129.9 151.22 50.7 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.882 0.873 . . . . 42.13 109.499 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 80.7 p -143.68 128.13 17.94 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.373 1.069 . . . . 73.1 108.197 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -76.94 116.43 17.6 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.36 -0.607 . . . . 64.43 109.36 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 HD12 ' C' ' 83' ' ' ILE . 75.3 mt -89.64 -39.7 13.05 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.0 -0.741 . . . . 63.04 109.0 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 -175.49 5.43 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.646 -1.161 . . . . 71.53 110.432 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.24 116.93 5.9 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.661 -1.154 . . . . 71.33 109.85 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 61.97 20.11 11.28 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.369 1.068 . . . . 63.53 112.136 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.8 t -119.72 116.43 50.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.535 -0.913 . . . . 74.13 108.535 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.621 ' HE2' ' HB ' ' G' ' 452' ' ' VAL . 0.6 OUTLIER -125.38 125.9 44.15 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.077 0.951 . . . . 74.3 109.059 -179.263 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.451 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.0 tt0 -83.6 132.55 34.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.911 -1.144 . . . . 75.44 107.911 164.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 56.1 t -112.43 139.71 35.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.088 -1.078 . . . . 74.42 108.088 166.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.402 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 47.1 t -121.44 124.88 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.792 -0.818 . . . . 64.31 108.792 171.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' C' ' 107' ' ' PHE . 1.1 tm? -104.42 106.09 16.45 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.712 -1.218 . . . . 61.33 107.712 172.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.517 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 0.8 OUTLIER -101.16 115.13 29.78 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.72 -1.127 . . . . 74.2 109.492 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.553 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.7 t -101.91 134.95 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.375 -0.972 . . . . 61.42 108.375 174.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -121.87 136.88 54.95 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.665 -0.865 . . . . 51.32 108.665 172.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.68 HG11 HD11 ' C' ' 126' ' ' LEU . 46.5 t -127.83 118.37 48.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 123.655 0.782 . . . . 65.42 109.329 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.453 HG23 HD23 ' C' ' 75' ' ' LEU . 3.2 m -102.53 144.63 30.71 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.011 -0.737 . . . . 64.43 109.011 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.17 114.22 9.0 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.391 -0.966 . . . . 71.15 108.391 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -131.2 142.33 50.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.413 0.685 . . . . 32.31 109.868 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.823 HD13 ' HG2' ' C' ' 34' ' ' LYS . 4.7 mt -94.34 16.81 14.14 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.949 1.3 . . . . 74.11 110.779 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.27 -87.71 0.35 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.78 -1.328 . . . . 62.41 109.78 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.53 -26.68 8.93 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.133 0.973 . . . . 72.44 110.567 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -82.77 119.0 23.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.707 0.803 . . . . 71.01 109.344 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -73.83 127.14 32.03 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.601 -0.518 . . . . 62.1 109.601 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.761 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.13 -54.76 7.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.162 -0.681 . . . . 63.44 109.162 173.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -169.28 173.39 6.69 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.335 -0.848 . . . . 74.23 110.924 176.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.453 HD23 HG23 ' C' ' 65' ' ' THR . 3.1 tm? -142.82 112.8 7.04 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.22 -1.4 . . . . 61.31 107.22 175.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -108.1 145.76 33.62 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.515 -0.92 . . . . 74.44 108.515 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -153.86 134.15 13.39 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.895 -0.78 . . . . 62.33 108.895 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 64.8 t -132.41 115.34 25.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.013 0.925 . . . . 75.41 108.898 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.517 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 57.8 mt-30 -93.53 89.9 6.46 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.32 -0.993 . . . . 64.34 108.32 174.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.7 102.16 13.96 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.152 0.581 . . . . 54.22 110.121 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.84 167.59 44.31 Favored Glycine 0 C--O 1.24 0.531 0 CA-C-O 121.175 0.319 . . . . 74.43 112.699 175.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -170.39 119.57 0.81 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.155 -0.778 . . . . 65.02 111.155 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.629 HD12 HD11 ' C' ' 51' ' ' LEU . 12.0 mm -82.9 132.35 31.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 109.129 -0.693 . . . . 74.21 109.129 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -134.28 119.89 19.28 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.322 0.649 . . . . 73.42 109.678 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 13.1 p -82.14 102.04 10.81 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.17 -1.048 . . . . 72.23 108.17 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.451 ' O ' HD12 ' C' ' 86' ' ' ILE . 2.5 pp -121.74 126.4 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 123.689 0.796 . . . . 74.32 110.982 -173.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.41 156.52 46.53 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.658 0.783 . . . . 65.34 109.899 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.42 -26.13 17.22 Favored Glycine 0 N--CA 1.476 1.314 0 N-CA-C 114.329 0.492 . . . . 71.12 114.329 172.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.626 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -87.28 145.81 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.056 0.543 . . . . 73.23 110.523 178.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.48 170.27 18.41 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.109 -0.95 . . . . 63.51 108.601 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.22 -119.27 6.86 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 124.118 0.887 . . . . 54.4 115.042 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 1.6 m -71.66 -32.35 67.79 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.641 1.176 . . . . 71.03 111.122 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -65.58 -43.16 90.64 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.466 0.707 . . . . 70.22 109.883 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.685 ' SD ' ' HA ' ' G' ' 452' ' ' VAL . 37.1 ttp -68.11 -40.73 82.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.17 -0.923 . . . . 74.41 110.593 175.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.8 -42.78 76.11 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 124.315 1.009 . . . . 61.42 110.697 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -83.14 -35.62 25.43 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.612 0.57 . . . . 63.11 111.956 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -58.0 -42.31 84.93 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.897 0.748 . . . . 64.1 110.62 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 21.9 mt -98.43 -24.91 14.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.266 -0.879 . . . . 63.22 110.686 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.61 -21.36 79.51 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.471 0.482 . . . . 55.45 114.174 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -158.26 -42.79 0.06 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.722 1.008 . . . . 75.45 113.722 -167.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.86 -46.63 74.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.915 0.486 . . . . 72.0 111.212 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.46 -49.06 54.3 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 124.254 1.022 . . . . 62.02 111.994 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -52.12 -34.44 58.15 Favored 'Trans proline' 0 C--N 1.399 3.186 0 C-N-CA 123.156 2.571 . . . . 62.0 114.654 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -60.23 -34.03 73.1 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.837 0.855 . . . . 71.11 111.722 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.474 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.9 mm -70.4 -37.33 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.183 0.593 . . . . 73.05 110.189 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.437 HD21 ' HA3' ' C' ' 82' ' ' GLY . 53.1 mt -87.73 -24.79 23.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.035 0.934 . . . . 72.53 112.587 -170.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.472 ' HA ' HD12 ' C' ' 60' ' ' LEU . 63.7 t80 -56.63 -48.74 96.64 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 117.812 -1.089 . . . . 74.04 113.853 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -55.33 -38.03 94.12 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 122.388 2.059 . . . . 72.21 113.234 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -67.25 -46.29 74.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.696 0.798 . . . . 74.02 110.467 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.43 ' O ' HG13 ' C' ' 114' ' ' ILE . . . -63.14 -38.99 93.35 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.669 -0.696 . . . . 74.35 110.878 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -57.25 -49.41 76.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.731 1.212 . . . . 65.21 111.079 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.63 -37.6 82.71 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 123.603 0.564 . . . . 60.33 110.084 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.3 t -68.18 -29.58 68.48 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.087 0.555 . . . . 73.05 111.443 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.553 HD11 ' HB ' ' C' ' 62' ' ' VAL . 74.1 mt -71.28 -50.45 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 108.949 -0.76 . . . . 53.34 108.949 172.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.532 HG21 ' HB3' ' B' ' 119' ' ' SER . 23.2 m -58.64 -35.12 72.01 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.679 0.792 . . . . 64.11 111.179 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.0 t -67.0 -54.14 24.63 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 123.813 0.845 . . . . 74.43 109.124 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.642 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.24 -38.71 80.7 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.487 1.115 . . . . 71.24 112.89 -177.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' C' ' 123' ' ' PHE . 67.1 t -65.98 -46.28 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.75 0.82 . . . . 72.41 110.165 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.471 ' OG ' HG21 ' B' ' 115' ' ' THR . 45.1 t -71.12 -24.12 62.22 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.617 -0.72 . . . . 73.14 111.582 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -69.44 -44.08 72.01 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.546 -0.909 . . . . 60.23 108.546 173.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.67 -1.59 72.34 Favored Glycine 0 C--N 1.357 1.744 0 O-C-N 123.712 0.632 . . . . 74.32 112.901 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 26.7 p 60.65 37.2 19.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.656 1.982 . . . . 64.11 113.359 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.458 ' HB2' HG13 ' C' ' 118' ' ' VAL . 91.4 m-85 -89.37 162.75 36.06 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-N 115.199 -0.909 . . . . 70.2 108.702 166.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.27 167.59 7.5 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.88 2.387 . . . . 75.44 113.301 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -51.66 131.69 30.19 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.706 1.202 . . . . 73.43 112.836 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.68 HD11 HG11 ' C' ' 64' ' ' VAL . 3.8 tt -136.3 85.08 2.12 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.306 -0.861 . . . . 63.35 108.918 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . 0.518 ' H ' HD21 ' G' ' 468' ' ' LEU . 14.2 m120 -95.48 124.22 39.41 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.818 -1.179 . . . . 54.52 107.818 171.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.05 134.9 47.44 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 108.487 -0.931 . . . . 71.42 108.487 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' G' ' 467' ' ' ALA . . . -57.5 152.39 34.32 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.311 1.044 . . . . 75.54 112.19 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.481 ' HG3' HD12 ' A' ' 16' ' ' ILE . 35.7 Cg_exo -56.33 92.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 122.566 2.177 . . . . 63.23 112.407 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.401 HG11 HD13 ' C' ' 44' ' ' LEU . 54.8 t -98.57 109.86 24.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 108.833 -0.803 . . . . 64.11 108.833 177.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -93.44 88.54 5.98 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.124 -1.436 . . . . 74.23 107.124 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -58.07 -32.79 68.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.495 0.718 . . . . 73.24 110.647 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.551 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 16.0 t70 -61.0 -39.03 88.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.878 0.871 . . . . 52.12 111.395 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.2 -39.22 71.91 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.244 0.617 . . . . 44.41 110.948 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 97.2 mt -67.79 -33.82 75.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.814 0.845 . . . . 72.43 112.232 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -74.3 -16.29 60.93 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.434 0.294 . . . . 73.3 110.994 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 91.4 mtp -73.27 -30.22 63.29 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.525 0.33 . . . . 71.14 111.003 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -71.35 -35.76 71.27 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 110.012 -0.366 . . . . 72.53 110.012 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.447 ' OH ' ' HA ' ' G' ' 458' ' ' THR . 75.5 t80 -71.51 -84.93 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 123.676 0.79 . . . . 74.3 110.129 169.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 23.0 tp 70.45 -77.1 0.06 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.819 1.648 . . . . 75.13 111.146 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -153.48 -67.49 0.15 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.554 0.742 . . . . 63.0 109.342 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -108.94 22.02 16.46 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.816 0.847 . . . . 75.22 109.848 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . 0.281 0.7 OUTLIER 58.21 163.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 127.114 2.166 . . . . 65.31 115.461 179.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -163.2 162.94 25.67 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.076 1.35 . . . . 52.51 109.352 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.17 65.5 0.01 OUTLIER Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.512 -0.635 . . . . 73.44 111.512 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.89 173.41 11.54 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.948 0.899 . . . . 75.22 110.715 -176.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 123.51 -168.87 15.67 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.607 -0.724 . . . . 73.12 111.773 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 14.0 t -137.59 173.56 11.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.758 0.823 . . . . 74.02 109.303 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -146.13 156.56 43.52 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.101 0.561 . . . . 72.52 111.131 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -162.22 150.09 14.4 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.351 1.06 . . . . 73.21 108.715 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . 0.458 ' CD2' ' HB2' ' C' ' 154' ' ' ASP . 18.5 t60 -167.15 96.5 0.5 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.633 -0.506 . . . . 63.21 109.633 -176.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -98.97 86.25 3.43 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 122.07 0.938 . . . . 74.03 108.49 170.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . 0.458 ' HB2' ' CD2' ' C' ' 152' ' ' HIS . 12.4 t70 -78.01 155.93 30.43 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.369 -0.832 . . . . 71.25 110.916 -172.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . 0.504 ' HB3' HG12 ' E' ' 451' ' ' VAL . . . . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.262 -0.875 . . . . 74.32 109.869 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.805 -0.443 . . . . 74.21 109.805 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 41.5 m -136.57 161.36 36.11 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.323 1.049 . . . . 53.42 109.035 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.01 167.54 23.76 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.94 0.896 . . . . 73.52 109.963 -175.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -68.85 139.92 55.2 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.441 0.697 . . . . 64.52 110.869 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -89.22 79.94 7.0 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.873 0.844 . . . . 72.24 109.726 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -59.84 112.01 1.68 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.089 -0.96 . . . . 64.21 108.886 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.8 m -143.28 114.79 8.04 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 122.412 0.285 . . . . 65.32 110.701 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -84.55 133.09 34.45 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 105.387 -2.079 . . . . 61.21 105.387 151.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 4.9 ttp -29.54 122.78 0.15 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 125.101 1.501 . . . . 62.0 113.503 -173.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.1 m -111.55 146.49 37.24 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.845 -0.798 . . . . 72.41 108.845 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -165.81 92.08 0.51 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.479 -1.304 . . . . 73.35 107.479 173.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -123.32 117.16 24.61 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.277 -1.379 . . . . 74.03 107.277 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.503 HG21 HD11 ' D' ' 16' ' ' ILE . 27.8 mt -65.89 117.28 6.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.511 0 N-CA-C 108.798 -0.815 . . . . 74.45 108.798 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -83.79 -32.94 25.1 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 123.628 0.58 . . . . 72.21 111.111 -170.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -178.73 129.05 0.11 Allowed 'General case' 0 C--N 1.363 1.188 0 O-C-N 123.032 0.207 . . . . 73.44 110.705 -167.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.503 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -108.53 136.06 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.313 -1.365 . . . . 62.21 107.313 166.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.455 ' HE1' HG13 ' D' ' 83' ' ' ILE . 29.9 p90 -158.7 162.91 37.22 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.972 0.795 . . . . 74.34 111.055 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 56.9 p -97.8 114.39 26.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.033 -0.985 . . . . 62.24 109.442 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.549 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.5 mtpt -80.13 -22.85 41.62 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.592 -0.731 . . . . 75.43 109.786 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.2 t70 -163.04 139.49 7.27 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.755 -1.111 . . . . 52.12 109.236 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.642 HG21 ' HE2' ' C' ' 117' ' ' MET . 77.3 mt -134.9 146.67 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.565 1.146 . . . . 54.11 108.539 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -146.34 125.2 12.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.706 0.802 . . . . 74.54 109.801 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.498 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 80.7 t80 -123.85 132.65 53.8 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 106.889 -1.522 . . . . 64.01 106.889 163.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 41.6 mt-10 -131.82 134.9 46.29 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.033 -0.729 . . . . 72.11 109.033 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.73 82.29 68.98 Favored Pre-proline 0 C--O 1.242 0.703 0 N-CA-C 106.076 -1.824 . . . . 74.45 106.076 168.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.57 -36.02 35.49 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.515 2.143 . . . . 75.22 111.751 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 48.9 m-20 -105.76 11.21 32.3 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.106 0.962 . . . . 72.13 110.684 -176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.477 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -18.53 -72.65 0.02 OUTLIER Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 116.287 1.958 . . . . 61.22 116.287 -166.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.479 ' HB3' HD11 ' C' ' 83' ' ' ILE . 49.1 Cg_endo -79.02 -16.42 12.52 Favored 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 123.771 2.383 . . . . 65.11 114.078 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.507 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 5.9 t-160 -76.45 -37.45 56.94 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.431 1.093 . . . . 74.51 109.793 174.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.743 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.4 p -83.51 -23.94 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 116.108 -0.496 . . . . 71.35 111.642 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -67.46 -18.16 64.97 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 122.537 0.335 . . . . 71.01 111.811 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.507 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 75.7 mt-30 -57.76 -29.66 64.98 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.303 1.041 . . . . 74.33 110.778 175.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -95.41 91.8 6.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.981 0.913 . . . . 72.14 109.279 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.56 70.92 10.35 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 122.531 1.157 . . . . 72.12 109.296 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -130.92 161.43 31.9 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.287 -1.324 . . . . 75.24 108.269 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.524 ' HB3' HD22 ' H' ' 470' ' ' LEU . 2.0 mp0 -66.99 107.9 2.04 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.121 0.968 . . . . 74.33 109.411 174.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.472 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 35.5 Cg_exo -61.72 122.33 10.86 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 123.206 2.604 . . . . 74.04 112.667 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 40.8 tt0 -57.0 114.94 2.33 Favored 'General case' 0 C--N 1.359 0.995 0 O-C-N 124.092 0.87 . . . . 74.05 110.025 -177.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.478 HG11 HD12 ' H' ' 468' ' ' LEU . 7.6 p -98.3 135.27 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.525 0.73 . . . . 72.2 111.556 -170.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -114.19 132.63 56.03 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 106.975 -1.491 . . . . 72.55 106.975 170.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.87 129.59 55.07 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.086 0.554 . . . . 72.0 110.161 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.578 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 17.5 t70 -112.92 128.83 56.58 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.634 1.174 . . . . 64.55 108.864 173.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 41.2 tp -98.92 133.45 43.19 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.542 -0.54 . . . . 71.11 109.542 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.3 t0 -153.52 155.8 36.89 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.734 -1.209 . . . . 55.24 107.734 174.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.652 HG23 ' HB2' ' H' ' 456' ' ' ASP . 13.7 t -145.96 169.27 18.96 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 122.909 0.484 . . . . 74.23 110.116 -177.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.588 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.05 166.56 33.11 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.711 1.204 . . . . 74.42 108.521 173.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.412 ' HB2' ' CE2' ' D' ' 56' ' ' TYR . 64.9 p -173.25 153.24 2.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.885 0.474 . . . . 64.45 111.058 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 45.5 p -168.78 143.29 3.18 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.317 1.047 . . . . 73.43 109.654 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' B' ' 155' ' ' ALA . 61.4 tt0 -83.8 125.25 31.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.137 0.575 . . . . 72.4 110.333 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.0 mt -96.13 -35.36 11.36 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.266 0.626 . . . . 72.12 111.298 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -155.12 -177.21 6.37 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.064 0.545 . . . . 61.03 110.71 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.37 120.25 8.41 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 123.91 0.756 . . . . 72.25 109.914 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.54 3.52 1.5 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.114 1.366 . . . . 75.41 112.521 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 92.6 t -109.78 119.45 58.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.141 -1.059 . . . . 72.33 108.141 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' D' ' 48' ' ' SER . 28.6 t80 -134.41 131.24 37.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.407 -0.815 . . . . 75.34 108.969 -173.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.451 ' HB2' HD11 ' D' ' 51' ' ' LEU . 17.3 tt0 -96.64 132.26 42.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.625 -0.716 . . . . 54.23 109.189 173.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.428 HG11 ' HD3' ' D' ' 103' ' ' PRO . 64.0 t -116.6 125.46 73.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.225 -1.398 . . . . 74.32 107.225 167.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 44.1 t -102.64 138.54 26.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.862 -0.792 . . . . 71.42 108.862 172.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.2 127.23 54.05 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.619 -1.252 . . . . 72.43 107.619 170.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.529 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 3.9 tmm_? -111.42 95.95 5.82 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.831 -1.174 . . . . 75.31 107.831 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 65.7 t -96.51 132.83 39.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.006 -0.997 . . . . 64.1 108.967 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 16.7 m -127.39 133.91 49.97 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.283 0.563 . . . . 74.14 109.502 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.02 102.41 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.534 1.533 . . . . 72.34 107.999 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 42.1 m -105.32 98.37 8.08 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.851 0.86 . . . . 60.43 109.448 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -104.72 149.86 25.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.856 0.462 . . . . 70.44 111.033 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.45 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 53.3 p -147.5 134.5 20.3 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.604 -0.725 . . . . 55.22 110.556 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.555 HD12 HG22 ' D' ' 31' ' ' VAL . 27.3 mt -98.76 110.94 23.46 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.308 -0.997 . . . . 72.22 108.308 174.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.76 -112.66 4.37 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 123.634 0.584 . . . . 73.25 112.812 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.94 16.8 16.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.407 1.083 . . . . 73.14 110.409 -172.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.425 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 12.8 pt-20 -141.22 155.33 46.05 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.466 0.706 . . . . 54.24 109.366 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -68.06 138.3 55.7 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 120.949 0.404 . . . . 64.33 110.527 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.743 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.96 -68.84 0.76 Allowed 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.535 -0.913 . . . . 62.11 108.535 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . 0.469 ' HZ ' HD13 ' D' ' 126' ' ' LEU . 50.2 p90 -152.96 149.24 28.0 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.61 -0.723 . . . . 73.22 110.252 -177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.6 mt -119.05 119.45 34.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.333 1.053 . . . . 73.52 108.234 175.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.449 ' SG ' ' HD1' ' D' ' 23' ' ' PHE . 1.3 m -121.9 104.92 9.89 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.167 0.987 . . . . 53.01 109.692 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -127.19 120.8 29.63 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.407 -0.96 . . . . 60.42 108.407 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -131.88 126.34 56.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 109.616 -0.512 . . . . 43.1 109.616 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.529 ' HG2' ' HG2' ' D' ' 61' ' ' ARG . 52.1 mt-30 -88.41 81.5 7.2 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.15 -1.056 . . . . 73.44 108.15 168.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.56 92.4 5.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.316 -1.311 . . . . 64.13 109.194 -178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.89 147.17 20.24 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.843 -0.617 . . . . 52.23 112.18 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.512 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.2 129.29 3.84 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 111.321 -0.712 . . . . 41.42 111.321 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.455 HG13 ' HE1' ' D' ' 17' ' ' TYR . 48.2 mt -93.78 140.47 16.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.066 0.946 . . . . 73.14 108.55 173.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -139.86 132.03 28.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.541 0.736 . . . . 72.21 109.018 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.6 m -87.5 94.91 9.84 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.633 -0.877 . . . . 72.23 108.633 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.604 HG23 HG11 ' H' ' 452' ' ' VAL . 2.3 tt -126.68 139.31 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 124.56 1.144 . . . . 75.3 110.103 -173.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.93 168.39 26.9 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.525 0.73 . . . . 70.34 111.752 -173.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.1 22.37 65.8 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 115.397 -0.819 . . . . 31.52 113.9 174.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.82 144.03 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.006 0.923 . . . . 55.31 110.665 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -142.64 161.88 36.93 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.856 0.862 . . . . 73.13 111.385 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.41 -122.39 29.67 Favored Glycine 0 C--N 1.355 1.597 0 O-C-N 124.606 1.191 . . . . 74.44 115.075 169.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.1 p -67.64 -26.18 66.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.807 0.843 . . . . 74.32 111.443 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -80.76 -38.68 28.18 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.193 0.597 . . . . 61.43 111.667 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 28.0 ptm -68.19 -34.61 76.6 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.471 -0.566 . . . . 74.42 109.471 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.74 -45.77 85.06 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.108 0.563 . . . . 64.22 110.245 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 11.4 t-80 -60.35 -44.51 95.49 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.655 1.182 . . . . 75.33 111.658 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . 0.411 ' SG ' HD12 ' D' ' 86' ' ' ILE . 16.2 t -76.14 -45.09 35.31 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.862 -173.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.61 -33.28 28.0 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.335 0.495 . . . . 72.15 112.335 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.21 -0.04 54.26 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 119.542 -0.588 . . . . 75.14 113.994 -173.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.447 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -141.99 -61.11 0.46 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.45 0.625 . . . . 74.24 111.429 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . 0.45 ' O ' HG12 ' D' ' 105' ' ' ILE . 72.6 t80 -66.21 -41.03 90.69 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.879 0.472 . . . . 71.1 112.202 -174.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.44 -45.87 19.24 Favored Pre-proline 0 CA--C 1.559 1.31 0 CA-C-O 118.277 -0.868 . . . . 53.3 111.091 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HD3' HG11 ' D' ' 58' ' ' VAL . 86.5 Cg_exo -53.27 -33.74 66.78 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 122.358 2.039 . . . . 52.11 113.438 166.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -67.28 -35.29 79.18 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.441 0.697 . . . . 64.11 110.038 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.45 HG12 ' O ' ' D' ' 101' ' ' TYR . 40.7 mm -70.34 -36.15 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.092 0.957 . . . . 75.32 110.733 174.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.512 HD21 ' HA3' ' D' ' 82' ' ' GLY . 96.5 mt -78.73 -21.09 48.58 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.851 0.86 . . . . 75.52 112.276 -176.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -66.77 -42.4 43.98 Favored Pre-proline 0 CA--C 1.562 1.414 0 CA-C-O 117.939 -1.029 . . . . 73.45 113.515 -172.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.44 -39.41 87.79 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 122.163 1.909 . . . . 73.41 113.133 170.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -74.8 -36.74 62.46 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.721 0.808 . . . . 71.44 111.872 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.85 73.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.222 -0.658 . . . . 73.04 109.222 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.431 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.6 ttp180 -57.47 -45.14 85.14 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 114.17 -1.377 . . . . 74.43 110.668 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.93 -51.76 62.94 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.944 0.778 . . . . 75.33 111.652 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -55.62 -40.71 72.49 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 123.822 0.701 . . . . 71.33 110.591 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.448 ' O ' HG23 ' D' ' 118' ' ' VAL . 54.9 mt -64.36 -53.5 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.836 1.254 . . . . 65.31 111.407 174.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.9 m -59.08 -36.77 75.66 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.356 1.062 . . . . 71.11 111.037 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -65.78 -44.32 86.14 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.885 -1.052 . . . . 74.23 109.842 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 66.0 mtm -69.34 -29.84 67.75 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.825 0.45 . . . . 75.52 111.9 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' D' ' 123' ' ' PHE . 76.0 t -64.36 -47.85 87.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.585 0.754 . . . . 72.33 110.049 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.5 p -69.71 -34.24 73.62 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.081 -0.509 . . . . 75.21 110.71 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -68.72 -33.05 73.28 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.637 0.775 . . . . 53.02 110.293 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.98 11.04 73.34 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.67 0.606 . . . . 74.05 112.636 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 63.9 p 57.33 32.16 21.31 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 126.044 1.738 . . . . 73.53 114.53 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.468 ' HB2' HG13 ' D' ' 118' ' ' VAL . 98.5 m-85 -95.89 150.8 37.8 Favored Pre-proline 0 N--CA 1.478 0.941 0 N-CA-C 108.323 -0.991 . . . . 64.41 108.323 168.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -59.94 147.37 93.03 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.659 2.239 . . . . 54.22 111.375 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -60.25 142.12 55.04 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 124.05 0.844 . . . . 73.54 112.794 -166.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.469 HD13 ' HZ ' ' D' ' 74' ' ' PHE . 0.8 OUTLIER -122.81 104.73 9.47 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.4 1.08 . . . . 64.13 109.263 -175.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -124.3 95.06 4.4 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.698 0.799 . . . . 71.35 109.665 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.35 139.38 54.21 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.803 -0.443 . . . . 62.41 109.803 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.73 136.94 93.04 Favored Pre-proline 0 CA--C 1.549 0.936 0 O-C-N 123.815 0.697 . . . . 45.22 109.669 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -68.09 133.01 27.59 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.271 1.981 . . . . 72.43 110.244 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.88 131.94 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.251 -0.648 . . . . 75.01 109.251 -170.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -77.64 89.81 3.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.745 -0.835 . . . . 54.31 108.745 172.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -64.01 -28.71 69.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.653 0.781 . . . . 63.53 111.297 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.447 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 2.0 m-20 -56.83 -55.88 28.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.295 1.438 . . . . 65.44 112.966 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.95 -47.23 87.39 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.279 0.632 . . . . 72.34 111.446 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 mp -66.31 -29.16 69.32 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.86 -1.064 . . . . 54.1 111.36 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.419 ' HD1' ' HE1' ' H' ' 461' ' ' PHE . 85.4 t80 -67.48 -38.99 85.21 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.038 0.935 . . . . 72.31 111.265 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 38.1 mtt -63.24 -37.41 87.13 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.621 -0.718 . . . . 72.35 110.112 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -65.31 -44.22 88.55 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.959 -1.019 . . . . 74.15 110.429 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -62.87 -36.33 82.92 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.136 0.975 . . . . 71.42 111.937 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.4 mp -67.41 -27.4 67.05 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.423 0.689 . . . . 72.13 111.644 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -84.0 9.63 11.91 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.357 0.663 . . . . 62.4 111.388 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -129.99 46.11 2.7 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.07 0.948 . . . . 74.24 109.943 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -162.42 121.53 2.27 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.565 0.746 . . . . 74.23 109.913 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.32 173.06 6.96 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.262 1.025 . . . . 51.4 110.233 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.67 122.57 0.92 Allowed Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.249 -0.741 . . . . 74.13 111.249 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -81.81 166.66 19.8 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.642 0.777 . . . . 75.51 110.659 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.8 159.24 52.6 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 115.939 -0.573 . . . . 53.11 113.431 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 41.3 m -112.04 98.72 7.54 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.963 0.905 . . . . 62.22 109.501 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.12 177.58 4.81 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.5 0.72 . . . . 53.01 110.318 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -135.05 170.6 15.66 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.264 1.026 . . . . 73.34 109.548 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -157.47 116.08 3.21 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.308 0.643 . . . . 74.33 109.781 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -75.38 105.68 6.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.19 0.596 . . . . 72.34 109.424 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.7 133.0 38.84 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.778 -0.823 . . . . 74.21 108.778 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.398 0 N-CA-C 109.033 -0.728 . . . . 50.12 109.033 177.783 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 53' ' ' ASP . 47.6 t30 . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.996 -0.372 . . . . 73.11 109.996 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . 0.504 HG12 ' HB3' ' C' ' 155' ' ' ALA . 10.2 m -77.36 -26.44 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.37 0.605 . . . . 71.13 109.492 172.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 10.9 p -143.03 164.52 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 124.572 1.149 . . . . 74.12 108.722 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -144.41 151.42 23.47 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 111.261 -0.736 . . . . 62.41 111.261 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 67.6 mt -85.52 13.37 6.95 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.803 0.841 . . . . 63.54 113.159 -172.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 41.5 p -77.86 72.22 4.38 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 121.351 0.596 . . . . 72.44 110.701 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -170.12 157.27 6.34 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.893 1.277 . . . . 43.33 108.278 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 16.1 mp0 -97.96 149.71 22.13 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.241 0.616 . . . . 74.44 109.96 -173.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 59.1 m -123.06 -64.19 1.19 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.466 0.706 . . . . 64.35 110.209 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 30.1 t70 63.17 163.15 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.824 1.25 . . . . 75.22 112.422 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . 0.627 HD21 ' H ' ' A' ' 46' ' ' THR . 3.8 mm? -88.72 128.45 35.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.482 0.713 . . . . 73.41 110.099 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -123.85 16.17 9.38 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.704 1.202 . . . . 70.54 110.349 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -76.2 143.47 41.05 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.252 0.621 . . . . 75.41 110.001 -176.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 24.6 m -84.5 -75.31 0.35 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.806 -0.813 . . . . 63.13 108.806 174.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.19 113.27 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.528 1.531 . . . . 73.32 112.353 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -152.43 85.47 1.26 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.439 -0.949 . . . . 72.02 108.439 173.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -151.23 106.7 3.35 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.486 -0.779 . . . . 63.01 109.527 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -75.93 172.78 12.13 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.401 0.681 . . . . 74.52 110.496 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 3.1 pp -151.98 166.04 32.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.143 0.577 . . . . 71.51 110.656 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -120.55 154.65 16.39 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.757 -0.656 . . . . 34.23 111.762 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -96.44 142.29 28.72 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.516 1.126 . . . . 75.12 109.101 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . 0.407 ' HG3' HH12 ' C' ' 15' ' ' ARG . 54.5 tptt . . . . . 0 CA--C 1.558 1.264 0 N-CA-C 108.223 -1.028 . . . . 75.51 108.223 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.608 0.242 . . . . 74.53 111.484 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . 0.527 HG12 HG23 ' F' ' 452' ' ' VAL . 46.9 t -73.61 144.8 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.609 0.764 . . . . 75.31 109.371 176.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . 0.527 HG23 HG12 ' F' ' 451' ' ' VAL . 92.4 t 72.68 142.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 125.068 1.347 . . . . 70.5 111.986 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -146.65 36.43 1.25 Allowed Glycine 0 C--N 1.342 0.902 0 N-CA-C 110.764 -0.934 . . . . 32.43 110.764 172.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 36.3 tp -92.11 140.98 29.1 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.335 0.654 . . . . 71.51 111.277 -173.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 25.6 p -100.41 -65.83 0.94 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.123 0.969 . . . . 63.15 110.144 172.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -163.06 5.13 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.326 0.65 . . . . 74.22 111.699 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -63.62 -28.74 70.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.119 0.968 . . . . 74.04 113.212 -167.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 10.9 p -61.17 120.21 9.89 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.665 0.786 . . . . 71.42 111.823 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . 0.407 ' HB2' ' OH ' ' B' ' 140' ' ' TYR . 17.5 m-20 -85.74 136.62 33.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.38 0.672 . . . . 74.2 109.202 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 37.9 tp -99.99 123.12 43.88 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.694 -0.484 . . . . 55.15 109.694 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -51.89 -58.22 7.11 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.754 1.622 . . . . 65.41 111.888 176.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . 0.433 ' CD2' ' HB2' ' B' ' 44' ' ' LEU . 1.0 OUTLIER 42.04 -141.52 0.11 Allowed 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 125.723 1.609 . . . . 70.21 111.596 -178.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 3.4 m 58.18 43.06 21.09 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.36 1.064 . . . . 71.24 111.768 166.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.8 151.74 40.49 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.781 0.832 . . . . 72.15 111.14 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.54 -37.67 81.98 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.045 0.938 . . . . 64.53 112.015 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -81.49 85.41 6.5 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.459 -0.941 . . . . 61.32 108.459 172.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -70.08 -42.5 72.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.193 0.597 . . . . 54.34 110.784 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . 0.624 HD11 ' HG ' ' B' ' 126' ' ' LEU . 5.0 tt -167.73 -59.1 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.095 -1.076 . . . . 64.35 108.095 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 87.82 57.66 1.91 Allowed Glycine 0 C--N 1.348 1.206 0 N-CA-C 110.555 -1.018 . . . . 61.12 110.555 -169.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . 0.595 ' H ' HD23 ' F' ' 470' ' ' LEU . 1.5 pt? -97.68 -8.08 29.51 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.02 0.928 . . . . 63.31 111.268 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? . . . . . 0 C--O 1.249 1.076 0 C-N-CA 124.043 0.937 . . . . 74.21 109.511 175.408 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.112 -0.699 . . . . 71.23 109.112 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 85.9 t 70.49 -71.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 124.948 1.299 . . . . 71.1 111.227 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . 0.685 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 27.5 m -83.59 158.25 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.181 0.992 . . . . 72.23 111.733 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 140.95 68.33 0.03 OUTLIER Glycine 0 C--N 1.347 1.15 0 N-CA-C 111.702 -0.559 . . . . 74.54 111.702 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 6.8 tt -78.53 -48.45 15.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.403 0.681 . . . . 75.44 110.738 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 11.4 m -56.9 93.05 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 O-C-N 124.293 0.996 . . . . 63.22 112.448 -167.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 29.1 t70 177.51 131.23 0.06 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.572 1.949 . . . . 73.14 106.903 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 59.96 -156.29 0.34 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.807 0.843 . . . . 74.5 110.187 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . 0.447 ' HA ' ' OH ' ' C' ' 140' ' ' TYR . 34.6 m 76.43 126.82 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.952 1.301 . . . . 75.43 112.205 170.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.82 147.12 42.4 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.865 0.866 . . . . 53.43 109.335 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' C' ' 45' ' ' ASP . 0.1 OUTLIER -82.59 140.24 33.34 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.043 -1.095 . . . . 63.13 108.043 173.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . 0.416 ' H ' HD13 ' G' ' 460' ' ' LEU . 32.2 p90 -133.03 175.65 9.19 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.305 1.042 . . . . 75.12 110.231 -173.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 7.4 t80 73.2 107.74 0.07 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.305 1.442 . . . . 74.53 111.515 171.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 86.2 m -89.59 -71.22 0.62 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.433 0.693 . . . . 63.3 110.133 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 39.0 ttp 69.0 153.76 0.11 Allowed 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.059 1.344 . . . . 64.54 112.171 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -159.86 5.44 0.09 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.8 0.84 . . . . 75.32 111.003 168.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -75.95 80.04 2.83 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.186 0.594 . . . . 63.55 109.649 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' C' ' 129' ' ' ALA . . . -161.46 157.15 24.62 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.272 -0.877 . . . . 74.14 110.425 -176.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . 0.518 HD21 ' H ' ' C' ' 127' ' ' ASN . 79.1 mt 70.26 161.22 0.22 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.269 1.428 . . . . 54.43 113.108 170.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -90.19 46.9 3.08 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-N 115.139 -0.937 . . . . 54.23 111.312 171.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . 0.58 HD21 ' HD2' ' C' ' 38' ' ' PRO . 6.2 tt -138.95 -69.15 0.43 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.406 -1.331 . . . . 61.14 107.406 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 58.2 mttp . . . . . 0 CA--C 1.562 1.405 0 O-C-N 124.671 1.232 . . . . 74.32 110.92 -177.351 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 108.801 -0.814 . . . . 71.21 108.801 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 13.6 p -70.42 -28.46 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.72 0.771 . . . . 71.31 109.711 172.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . 0.604 HG11 HG23 ' D' ' 86' ' ' ILE . 11.9 m -134.91 124.95 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.718 1.207 . . . . 74.43 109.374 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 159.74 116.78 0.45 Allowed Glycine 0 C--N 1.349 1.254 0 CA-C-O 119.662 -0.521 . . . . 74.25 112.409 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -156.86 158.43 36.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.474 0.71 . . . . 63.1 109.935 173.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 22.8 m -85.24 137.9 32.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.226 0.611 . . . . 51.2 109.592 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . 0.652 ' HB2' HG23 ' D' ' 46' ' ' THR . 5.0 p-10 -98.67 149.86 22.37 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.362 1.065 . . . . 52.14 110.391 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -131.8 155.29 48.01 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.741 0.816 . . . . 71.14 109.565 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 68.6 p -73.22 -59.38 2.73 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.285 0.634 . . . . 72.32 110.887 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -85.83 88.07 7.5 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.705 0.802 . . . . 72.32 110.142 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 94.5 mt -90.48 -66.32 0.94 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.709 -0.678 . . . . 73.25 110.129 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . 0.419 ' HE1' ' HD1' ' D' ' 137' ' ' PHE . 13.3 p90 -171.11 146.25 2.38 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.195 0.998 . . . . 74.33 109.624 -171.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -167.6 87.98 0.27 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.906 0.384 . . . . 73.23 110.512 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 9.0 t -113.04 105.33 13.34 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 107.711 -1.218 . . . . 72.41 107.711 166.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . 0.526 ' HG3' ' HB2' ' H' ' 467' ' ' ALA . 14.4 tpt -110.47 124.69 52.25 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.45 -0.796 . . . . 63.02 109.707 -169.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -133.12 145.83 51.05 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.07 -1.085 . . . . 52.53 108.07 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . 63.4 40.26 8.58 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.262 1.025 . . . . 45.24 110.131 -174.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . 0.526 ' HB2' ' HG3' ' H' ' 464' ' ' MET . . . -77.84 -164.6 0.53 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.723 -1.126 . . . . 53.44 110.365 175.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . 0.478 HD12 HG11 ' D' ' 40' ' ' VAL . 94.7 mt -68.23 -56.83 7.28 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.585 -0.524 . . . . 54.32 109.585 171.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 54.91 32.07 55.55 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 124.119 0.887 . . . . 64.21 113.22 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' D' ' 37' ' ' GLN . 2.3 pp -76.04 -30.92 58.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.558 0.743 . . . . 64.4 111.802 -168.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . 0.456 ' NZ ' ' HB3' ' H' ' 471' ' ' LYS . 2.6 ttpm? . . . . . 0 CA--C 1.569 1.679 0 C-N-CA 124.681 1.192 . . . . 64.33 112.07 171.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptp . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 109.861 -0.422 . . . . 63.53 109.861 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 p -164.17 92.78 0.67 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.411 1.085 . . . . 43.31 108.498 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -82.22 163.45 21.87 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.785 0.834 . . . . 65.34 111.17 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 64.04 -179.39 0.16 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.885 1.274 . . . . 73.3 112.336 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -70.05 170.36 11.55 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.593 -0.521 . . . . 72.24 109.593 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.1 t30 73.08 82.72 0.13 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.349 1.06 . . . . 74.54 108.67 -171.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -99.2 158.57 15.6 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.087 0.955 . . . . 62.24 110.335 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 54.53 -84.93 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.707 1.203 . . . . 74.25 111.464 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -69.66 150.25 47.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.734 0.813 . . . . 74.3 110.208 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 90.9 m -145.65 131.29 18.89 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.893 0.877 . . . . 75.01 109.21 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.586 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.3 t80 -137.44 135.14 36.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.804 -0.813 . . . . 75.42 108.804 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -150.08 117.46 6.08 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.084 -1.08 . . . . 52.32 108.084 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.455 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.6 mt -80.87 118.24 28.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.813 -0.81 . . . . 71.51 108.813 175.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.9 -40.54 31.96 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.851 -0.796 . . . . 64.01 108.851 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -169.47 145.96 3.32 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.48 -0.327 . . . . 73.22 110.845 -176.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.536 HD12 ' HG3' ' C' ' 130' ' ' PRO . 84.4 mt -129.55 136.25 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 124.303 1.041 . . . . 73.15 108.726 172.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -169.53 177.81 4.45 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.017 0.927 . . . . 74.34 111.029 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -99.66 123.62 44.1 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.316 -0.624 . . . . 61.23 109.316 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -84.27 -28.86 26.89 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 110.011 -0.366 . . . . 74.21 110.011 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -152.75 146.27 24.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.502 -0.772 . . . . 74.5 109.692 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 84.5 mt -138.06 142.44 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.391 1.476 . . . . 55.44 107.045 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -149.89 144.29 25.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.047 0.451 . . . . 75.11 110.181 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.58 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 92.7 t80 -150.21 129.42 12.79 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.888 -1.523 . . . . 62.54 106.888 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.62 127.83 39.76 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.608 0.763 . . . . 64.21 109.247 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.496 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -132.36 79.81 64.76 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 107.156 -1.424 . . . . 73.41 107.156 171.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.25 -16.6 24.89 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.485 2.123 . . . . 70.41 111.364 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -107.44 13.89 26.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.699 1.199 . . . . 75.41 109.533 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.496 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -57.18 -45.71 99.9 Favored Pre-proline 0 CA--C 1.569 1.685 0 N-CA-C 114.258 1.207 . . . . 72.24 114.258 -170.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.62 -24.12 18.95 Favored 'Trans proline' 0 C--N 1.388 2.624 0 C-N-CA 121.818 1.679 . . . . 70.42 113.243 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -91.21 -21.88 20.9 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.62 0.768 . . . . 75.11 112.031 -171.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.465 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 12.0 p -69.77 -28.57 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.646 0.779 . . . . 72.05 111.722 -175.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -68.12 -36.21 79.36 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.828 0.851 . . . . 72.15 110.761 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -77.26 -46.45 23.06 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.328 -0.851 . . . . 74.33 111.346 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.603 ' NZ ' ' HG3' ' A' ' 71' ' ' GLU . 64.9 pttt -76.26 164.64 25.86 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.563 0.345 . . . . 74.23 110.165 176.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.98 141.21 36.19 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.869 0.467 . . . . 70.43 110.223 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -79.13 99.31 6.91 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.485 0.714 . . . . 65.42 109.593 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 35.6 tt0 -149.97 67.05 8.32 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.1 -0.704 . . . . 65.23 109.1 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.62 158.98 9.24 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.711 2.274 . . . . 65.41 113.162 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -94.67 99.68 11.75 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.194 -1.41 . . . . 71.41 107.194 170.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.428 HG11 HD12 ' E' ' 468' ' ' LEU . 18.4 m -78.06 93.72 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 114.576 -1.193 . . . . 65.33 110.816 -173.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 56.2 mttm -91.17 113.41 25.67 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.477 -1.238 . . . . 52.32 108.41 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.623 HD23 ' SD ' ' E' ' 464' ' ' MET . 58.7 tp -116.67 119.01 34.15 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.145 -0.687 . . . . 71.34 109.145 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -130.06 151.05 51.02 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.64 0.776 . . . . 72.34 109.302 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.62 HD23 HG22 ' A' ' 62' ' ' VAL . 3.0 tm? -132.26 141.1 48.88 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.707 0.803 . . . . 64.41 109.208 -173.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.416 ' H ' HD22 ' A' ' 44' ' ' LEU . 32.3 t70 -135.47 119.71 17.78 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.264 1.026 . . . . 62.53 109.145 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.501 ' H ' HD21 ' E' ' 460' ' ' LEU . 67.2 m -111.72 130.17 55.87 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.126 0.97 . . . . 74.5 109.122 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.93 152.47 51.06 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.512 -0.921 . . . . 62.11 108.512 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.2 t -125.78 152.07 45.89 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.651 -0.5 . . . . 74.42 109.651 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 t -150.65 133.12 15.61 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.921 0.889 . . . . 61.33 109.084 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -77.85 131.45 37.54 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.501 -0.555 . . . . 73.34 109.501 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.437 HD12 HG23 ' A' ' 83' ' ' ILE . 70.8 mt -107.12 -41.98 5.0 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.865 0.866 . . . . 74.21 109.705 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.87 -175.01 4.64 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.678 -1.146 . . . . 74.21 109.272 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.69 114.11 3.11 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.427 0.691 . . . . 65.25 110.457 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.75 12.67 7.84 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.414 1.086 . . . . 74.24 112.105 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.1 t -101.68 112.56 35.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 124.909 1.284 . . . . 71.5 107.92 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -125.17 126.7 45.66 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.718 0.807 . . . . 71.02 109.292 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -101.94 126.91 48.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.74 -1.118 . . . . 75.11 108.477 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 m -100.89 133.33 44.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.99 -1.115 . . . . 73.05 107.99 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.62 110.68 26.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 107.972 -1.122 . . . . 63.14 107.972 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.0 tp -90.51 98.41 11.76 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.042 -0.725 . . . . 73.54 109.042 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.8 ttp85 -95.81 100.87 12.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.635 0.774 . . . . 64.22 109.712 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.62 HG22 HD23 ' A' ' 44' ' ' LEU . 12.3 t -97.15 117.29 41.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.219 -1.03 . . . . 75.04 108.219 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.0 t -107.55 141.89 38.29 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.734 0.778 . . . . 53.41 109.936 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 59.0 t -131.29 109.34 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.755 1.622 . . . . 41.32 107.641 -173.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 26.7 m -110.65 107.73 17.41 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.793 -0.818 . . . . 54.55 108.793 175.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.63 104.69 14.05 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 106.996 -1.483 . . . . 72.33 106.996 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.8 p -149.56 127.79 12.08 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.691 0.396 . . . . 74.3 110.569 -172.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -90.12 84.55 6.13 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.886 -0.783 . . . . 73.42 108.886 177.247 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.38 -104.8 1.81 Allowed Glycine 0 C--N 1.35 1.307 0 CA-C-N 115.065 -0.97 . . . . 61.54 112.283 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -97.28 -5.23 37.19 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.587 0.755 . . . . 74.45 110.314 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.603 ' HG3' ' NZ ' ' A' ' 34' ' ' LYS . 36.1 tp10 -112.22 94.65 5.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.606 1.162 . . . . 64.34 108.97 -169.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -71.45 138.41 49.0 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.424 0.289 . . . . 65.31 111.273 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.28 -59.45 2.25 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.944 0.898 . . . . 43.42 108.943 173.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -157.41 174.9 14.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.306 -0.861 . . . . 62.42 111.324 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -140.55 138.82 34.79 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.176 1.39 . . . . 75.25 107.896 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.493 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.9 m -141.28 139.51 33.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.96 0.904 . . . . 61.45 109.064 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -150.74 122.5 8.08 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.206 0.457 . . . . 44.54 109.826 174.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.3 t -122.35 132.85 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 123.875 0.87 . . . . 72.14 109.592 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.57 HE21 ' N ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -109.01 86.75 2.34 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.357 1.063 . . . . 74.03 108.293 174.413 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.09 103.18 8.85 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.96 -1.018 . . . . 71.14 108.462 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.39 142.84 16.38 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 111.368 -0.693 . . . . 65.33 111.368 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.546 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -140.61 123.51 2.38 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 111.142 -0.783 . . . . 30.21 111.142 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.437 HG23 HD12 ' A' ' 51' ' ' LEU . 44.1 mt -80.69 118.45 28.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.838 -0.801 . . . . 75.34 108.838 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.586 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 42.1 m-85 -125.22 119.35 28.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.887 0.475 . . . . 74.02 109.901 -176.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 m -86.82 105.0 16.71 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.845 -0.798 . . . . 63.4 108.845 174.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.554 ' HB ' HD11 ' A' ' 89' ' ' ILE . 43.5 pt -107.23 143.92 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.434 0.694 . . . . 73.4 110.75 -175.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.595 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -156.84 156.51 33.31 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.973 0.909 . . . . 74.32 109.778 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.419 ' H ' HG11 ' E' ' 451' ' ' VAL . . . 78.0 7.04 87.63 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.897 0.719 . . . . 71.24 114.897 173.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.554 HD11 ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -122.31 156.21 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 108.686 -0.857 . . . . 54.22 108.686 172.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -157.61 173.95 16.09 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.242 0.617 . . . . 63.11 109.359 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.46 -136.64 47.38 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.514 0.509 . . . . 64.32 114.153 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -80.71 -16.14 54.69 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.537 0.735 . . . . 74.51 111.215 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' A' ' 96' ' ' HIS . 35.4 tt0 -67.64 -36.45 80.8 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.002 0.921 . . . . 52.25 109.598 171.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 34.2 ttp -76.83 -33.23 57.94 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.905 -1.043 . . . . 73.44 110.922 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -28.31 69.19 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.034 0.445 . . . . 71.54 110.583 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.409 ' HB3' ' O ' ' A' ' 93' ' ' GLN . 50.3 t-80 -64.57 -37.02 86.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.355 -0.839 . . . . 73.44 110.526 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 64.1 m -64.75 -35.74 82.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 122.871 0.469 . . . . 75.04 110.87 177.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.42 HD12 HD11 ' E' ' 454' ' ' LEU . 6.8 tt -72.96 -49.92 26.4 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.088 0.555 . . . . 71.23 109.983 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.15 4.8 52.28 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 115.059 0.784 . . . . 73.34 115.059 -165.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -145.57 -65.95 0.31 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.188 0.994 . . . . 62.3 112.201 -175.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.565 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 69.0 t80 -69.33 -66.6 0.56 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.927 -1.033 . . . . 62.41 113.402 -166.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.451 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 85.8 m -67.6 -35.06 7.46 Favored Pre-proline 0 CA--C 1.566 1.571 0 N-CA-C 114.079 1.14 . . . . 64.3 114.079 -174.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 27.9 Cg_endo -62.76 -30.15 77.76 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 122.015 1.81 . . . . 65.21 112.91 168.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -71.72 -27.86 63.3 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.091 0.556 . . . . 75.12 110.982 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.6 mm -59.31 -41.96 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-O 121.441 0.639 . . . . 74.13 109.872 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.546 HD21 ' HA3' ' A' ' 82' ' ' GLY . 84.1 mt -83.34 -16.24 46.89 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.035 -0.984 . . . . 73.13 112.581 -174.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.79 -43.53 69.63 Favored Pre-proline 0 CA--C 1.561 1.366 0 N-CA-C 113.819 1.044 . . . . 74.12 113.819 -172.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -59.6 -37.55 87.65 Favored 'Trans proline' 0 C--N 1.387 2.574 0 CA-C-N 121.745 1.659 . . . . 64.24 112.7 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -69.89 -43.03 72.6 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.579 -0.737 . . . . 74.32 111.284 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.23 -39.24 82.37 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.13 0.572 . . . . 55.02 110.573 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.546 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.8 ttm180 -49.75 -55.1 15.23 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.645 1.215 . . . . 61.4 109.887 174.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -66.64 -44.09 82.9 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.055 -0.975 . . . . 71.5 111.569 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.1 t -60.43 -26.17 66.52 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.09 0.556 . . . . 63.12 111.844 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' A' ' 62' ' ' VAL . 95.6 mt -83.25 -52.23 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.75 0.82 . . . . 75.34 109.759 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.4 m -54.88 -50.88 67.62 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.818 0.847 . . . . 45.24 111.631 -173.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 47.1 t -59.6 -45.18 92.69 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.745 -1.116 . . . . 44.21 110.441 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 45.6 ttp -68.66 -35.05 76.72 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.073 0.949 . . . . 74.24 111.695 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.66 -41.26 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.096 0.958 . . . . 74.32 109.785 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.7 m -72.56 -24.41 61.11 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.334 -0.848 . . . . 70.12 111.467 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.45 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.8 mtt-85 -73.76 -30.95 63.07 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.521 0.729 . . . . 63.32 109.665 174.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.06 -1.64 80.28 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.658 -0.701 . . . . 41.01 112.637 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.8 m 69.16 21.0 7.4 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 125.161 1.384 . . . . 71.32 111.223 175.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.15 158.71 69.37 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 115.274 -0.875 . . . . 71.34 109.335 170.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.55 144.97 91.06 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.277 1.985 . . . . 72.02 111.54 173.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -59.35 134.53 57.09 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.621 0.768 . . . . 75.23 111.92 -173.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -117.32 102.46 9.27 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.211 -0.904 . . . . 70.42 109.803 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -102.03 108.04 19.35 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.12 -1.067 . . . . 73.14 108.12 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.16 117.34 10.68 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.066 -0.716 . . . . 64.41 109.066 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.33 139.14 96.39 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 122.841 0.456 . . . . 51.21 110.883 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -53.04 106.66 0.16 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.04 2.494 . . . . 74.13 111.877 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.46 133.06 42.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.578 0.704 . . . . 65.24 109.293 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -82.04 71.93 9.09 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.462 -1.245 . . . . 60.2 112.126 -170.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.509 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 35.2 m-85 -53.68 -41.05 66.47 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.612 0.765 . . . . 70.33 111.582 177.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 138' ' ' MET . 7.0 m-20 -68.85 -42.05 77.63 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.007 -0.997 . . . . 63.01 111.401 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.02 81.09 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.073 0.549 . . . . 62.53 110.981 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.53 -38.41 80.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.738 -1.119 . . . . 74.41 110.511 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.453 ' HE2' HD13 ' A' ' 141' ' ' LEU . 56.3 t80 -73.82 -37.64 64.81 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.539 -0.755 . . . . 65.44 110.347 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.48 ' SD ' HD23 ' A' ' 141' ' ' LEU . 20.1 mmt -61.26 -33.52 73.67 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.357 0.663 . . . . 74.55 111.551 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -54.35 -45.9 72.83 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.09 0.956 . . . . 63.4 110.575 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -77.36 -37.45 52.19 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.108 -0.951 . . . . 74.03 110.983 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.48 HD23 ' SD ' ' A' ' 138' ' ' MET . 32.7 tp -65.87 -49.68 67.24 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.871 0.868 . . . . 64.4 111.564 -168.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' C' ' 153' ' ' GLN . 35.5 tt0 -168.89 25.38 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 O-C-N 123.92 0.762 . . . . 71.42 109.646 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 71.53 -64.89 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.426 1.49 . . . . 54.15 111.861 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -139.43 132.79 30.05 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.497 1.119 . . . . 74.14 109.323 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' C' ' 152' ' ' HIS . . . -165.23 107.14 0.8 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.665 0.786 . . . . 74.21 110.046 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -174.37 -172.32 39.42 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.114 -0.394 . . . . 74.23 112.114 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.729 ' HG2' ' HA ' ' C' ' 149' ' ' THR . 10.5 tp10 -161.3 156.17 23.6 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.151 0.98 . . . . 71.22 109.857 -178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.89 151.46 39.15 Favored Glycine 0 C--N 1.353 1.483 0 N-CA-C 112.262 -0.335 . . . . 62.51 112.262 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.7 p -85.64 148.84 25.71 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.707 0.803 . . . . 74.01 110.676 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -68.05 130.25 42.37 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.386 0.674 . . . . 74.54 110.175 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -117.97 119.88 36.15 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.859 0.864 . . . . 75.42 111.229 -174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -151.09 90.6 1.62 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.03 1.332 . . . . 63.01 107.872 168.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -81.15 69.47 7.76 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 108.675 -0.861 . . . . 72.14 108.675 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.465 ' H ' HD11 ' C' ' 141' ' ' LEU . 25.2 t70 -83.06 -22.99 33.35 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.918 -1.037 . . . . 75.43 110.535 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.96 0 C-N-CA 124.439 1.096 . . . . 73.33 108.723 177.903 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 110.281 -0.266 . . . . 72.24 110.281 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 23.9 m -77.46 99.96 5.84 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.705 0.802 . . . . 74.42 110.058 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -92.77 126.18 37.73 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.292 1.037 . . . . 73.21 111.102 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -89.58 91.22 8.59 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.193 0.597 . . . . 75.35 109.793 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -85.02 97.15 9.67 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.772 -0.455 . . . . 70.2 109.772 174.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -81.31 147.14 30.03 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.605 -0.887 . . . . 72.51 108.605 175.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.7 t -65.69 134.73 53.83 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 109.956 -0.387 . . . . 63.12 109.956 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -105.49 156.26 18.38 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.718 0.807 . . . . 63.51 110.295 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.42 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 5.1 ptm 65.1 168.2 0.19 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 127.727 2.411 . . . . 72.32 114.382 175.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 72.3 m -169.36 143.23 2.83 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.685 1.594 . . . . 74.42 108.041 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.34 157.63 44.59 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.73 0.3 . . . . 73.11 110.798 163.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.545 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -123.03 121.4 35.98 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 107.634 -1.247 . . . . 75.53 107.634 177.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 36.2 mt -71.71 119.87 18.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.572 -0.899 . . . . 74.13 108.572 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.542 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 84.2 mm-40 -82.54 -39.33 22.49 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.185 -0.916 . . . . 72.53 109.913 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.5 ttt85 -174.06 134.89 0.45 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.101 -0.954 . . . . 74.31 109.583 -174.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -114.69 140.01 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 106.623 -1.621 . . . . 71.54 106.623 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -166.63 155.39 10.59 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.465 0.65 . . . . 64.04 111.639 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.402 HG21 HD11 ' B' ' 21' ' ' ILE . 96.2 m -83.19 127.01 33.24 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.684 -1.144 . . . . 71.03 109.059 171.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.467 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.0 mtpt -98.4 -22.22 16.17 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.68 0.792 . . . . 73.12 110.916 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -164.65 137.58 4.81 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 123.423 0.452 . . . . 42.04 110.86 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.452 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.2 mm -127.0 144.94 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.796 1.238 . . . . 70.42 109.276 173.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.474 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.1 t -145.04 138.88 27.03 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.464 -1.244 . . . . 74.52 107.66 174.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -153.98 123.03 6.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.277 -1.379 . . . . 72.12 107.277 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -124.21 138.22 54.43 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.144 -0.687 . . . . 75.34 109.144 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.31 83.87 64.05 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 106.723 -1.584 . . . . 73.35 106.723 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.15 -36.42 29.13 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.026 2.484 . . . . 74.12 112.998 -169.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -105.37 17.15 24.43 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.366 0.666 . . . . 60.33 110.588 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.629 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -36.28 -65.76 0.3 Allowed Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 115.002 1.482 . . . . 70.11 115.002 -164.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 23.1 Cg_exo -62.5 -24.99 75.61 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 122.527 2.151 . . . . 75.33 113.05 -174.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.457 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 63.4 m80 -95.25 -28.65 14.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.869 -1.06 . . . . 72.21 112.291 -173.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.745 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.2 p -78.85 -20.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 120.952 0.406 . . . . 73.25 111.34 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -67.75 -11.89 59.38 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.309 0.855 . . . . 62.31 113.309 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.9 pt20 -63.89 -34.48 78.05 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.016 0.527 . . . . 72.43 110.804 176.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -83.86 101.43 11.65 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.581 0.752 . . . . 73.14 109.582 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -85.51 90.08 7.87 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.092 -0.707 . . . . 74.33 109.092 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -157.85 158.46 35.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.706 1.202 . . . . 73.51 108.363 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -83.37 103.24 2.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.214 1.006 . . . . 73.35 108.476 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.89 135.37 66.38 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.373 2.715 . . . . 60.21 113.496 -168.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.3 125.8 25.05 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 123.908 0.755 . . . . 71.43 109.487 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.599 HG11 ' HG ' ' F' ' 468' ' ' LEU . 2.4 p -123.45 128.21 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.579 0.752 . . . . 60.35 112.078 -165.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -107.52 129.66 54.94 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.584 1.154 . . . . 53.53 108.458 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.5 146.67 23.61 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.314 -0.995 . . . . 65.44 108.314 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 21.9 t70 -140.21 112.31 7.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.342 -0.985 . . . . 73.21 108.342 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 74.0 mt -100.16 149.9 23.06 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.737 -0.468 . . . . 74.52 109.737 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' B' ' 61' ' ' ARG . 20.6 t70 -153.19 114.82 4.25 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.714 0.805 . . . . 74.04 109.275 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -110.38 114.41 27.84 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.209 0.604 . . . . 71.42 110.39 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.67 155.38 30.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.388 1.075 . . . . 21.41 108.729 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.3 p -144.19 164.45 30.68 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.439 0.296 . . . . 72.42 110.939 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -158.1 139.03 13.12 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.542 0.737 . . . . 72.44 109.939 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -80.83 113.89 19.34 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.46 0.704 . . . . 63.53 109.786 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.02 -42.68 37.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.835 0.454 . . . . 60.02 110.619 176.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.6 -175.32 5.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.273 -0.876 . . . . 73.43 110.25 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.03 117.22 3.78 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.376 -0.829 . . . . 73.33 109.862 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 71.3 1.0 3.65 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.708 1.203 . . . . 75.11 112.494 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.403 HG22 ' OG ' ' B' ' 85' ' ' SER . 48.0 t -104.72 114.55 44.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 124.725 1.21 . . . . 62.04 107.927 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -123.29 140.57 52.88 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.039 -1.097 . . . . 74.1 108.039 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -116.12 107.47 14.95 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.353 -1.351 . . . . 74.23 107.353 -174.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 99.3 t -89.22 143.37 11.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 C-N-CA 124.467 1.107 . . . . 73.01 109.461 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.408 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 36.5 t -125.95 128.64 72.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.543 -0.91 . . . . 60.22 108.543 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -114.1 108.02 16.43 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.8 -1.185 . . . . 73.02 107.8 -177.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.499 ' HD2' ' HB3' ' B' ' 45' ' ' ASP . 38.1 ttm180 -93.44 123.59 36.84 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.676 -0.49 . . . . 74.33 109.676 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.455 ' HB ' HD11 ' B' ' 114' ' ' ILE . 44.2 t -118.29 103.12 14.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.284 -1.376 . . . . 62.14 107.284 168.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 15.7 m -98.33 126.52 43.87 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.967 -0.753 . . . . 53.31 108.967 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.496 HG21 HG21 ' B' ' 114' ' ' ILE . 58.0 t -113.75 120.2 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 123.975 0.91 . . . . 71.24 109.774 -176.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 77.9 m -109.74 135.74 50.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.631 -0.877 . . . . 63.15 108.631 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.27 142.88 27.66 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.278 0.631 . . . . 74.24 109.599 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.456 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 37.1 p -148.05 137.09 22.02 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.223 -0.444 . . . . 71.41 111.999 -171.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.672 HD12 HG22 ' B' ' 31' ' ' VAL . 39.1 mt -96.2 104.83 16.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.039 0.936 . . . . 74.23 110.053 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.2 -113.46 5.9 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.151 -0.932 . . . . 54.31 113.143 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -107.98 21.89 16.75 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.713 0.805 . . . . 74.51 110.945 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -140.77 157.77 44.92 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.755 -0.591 . . . . 62.35 109.854 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 38.1 m -73.54 135.42 43.97 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.805 -0.443 . . . . 64.45 109.805 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.745 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -90.99 -66.2 0.95 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.56 -1.274 . . . . 64.11 107.56 174.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -150.18 161.87 41.57 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.844 0.83 . . . . 61.24 110.689 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.0 149.85 50.24 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.946 1.698 . . . . 60.52 106.76 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.429 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 48.6 t -154.91 159.82 40.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.551 -0.537 . . . . 70.23 109.551 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.474 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 38.7 tt0 -164.44 129.58 2.76 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.486 -0.931 . . . . 42.12 108.486 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 78.7 t -124.2 142.24 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 107.993 -1.114 . . . . 74.35 107.993 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -123.03 84.47 2.27 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.15 -1.055 . . . . 72.52 108.15 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.536 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.2 tp-100 -80.27 100.42 8.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.731 -1.122 . . . . 73.44 109.215 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.467 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -89.77 165.8 32.31 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.415 -0.674 . . . . 42.02 111.415 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.426 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -166.01 134.41 3.28 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.154 -0.779 . . . . 61.02 111.154 -175.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 24.5 mt -97.87 127.35 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.955 0.902 . . . . 71.04 108.727 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -131.78 133.66 44.98 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 107.793 -1.188 . . . . 74.03 107.793 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.403 ' OG ' HG22 ' B' ' 55' ' ' VAL . 40.4 m -110.76 94.27 4.91 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.593 -0.521 . . . . 74.43 109.593 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.49 ' HB ' HD11 ' B' ' 89' ' ' ILE . 32.5 pt -95.88 138.42 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 123.396 0.678 . . . . 72.51 111.65 -167.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.54 149.87 33.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.386 1.074 . . . . 64.14 109.299 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 101.29 -31.21 8.92 Favored Glycine 0 N--CA 1.473 1.131 0 C-N-CA 123.256 0.455 . . . . 71.11 112.821 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.49 HD11 ' HB ' ' B' ' 86' ' ' ILE . 9.7 pt -91.48 151.22 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.787 0.835 . . . . 61.34 111.7 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.96 148.83 17.44 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.655 -1.157 . . . . 73.22 108.749 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.17 -132.85 13.96 Favored Glycine 0 C--N 1.343 0.96 0 O-C-N 123.352 0.407 . . . . 62.23 112.608 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.4 m -74.54 -20.5 59.94 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.197 0.599 . . . . 71.11 112.183 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -59.87 -45.05 93.71 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.721 0.772 . . . . 61.42 109.804 170.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.49 ' HA ' HD12 ' B' ' 89' ' ' ILE . 9.8 tmm? -72.43 -38.07 68.44 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.37 -1.287 . . . . 64.53 110.57 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.0 -40.58 70.26 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.552 0.691 . . . . 70.24 110.593 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -71.38 -41.8 69.21 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.586 -1.188 . . . . 72.34 111.346 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.2 t -66.51 -60.1 3.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.955 0.502 . . . . 74.51 111.394 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.541 HD22 HD23 ' F' ' 454' ' ' LEU . 6.9 tt -68.86 -41.18 78.78 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.824 0.849 . . . . 72.34 110.305 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.11 -34.39 41.87 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.318 0.387 . . . . 74.43 114.045 -171.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.43 -50.72 1.76 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 112.545 0.572 . . . . 62.13 112.545 -168.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -73.78 -35.78 64.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.692 0.797 . . . . 71.54 112.22 -171.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 97.1 m -70.83 -48.53 14.97 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 123.228 0.611 . . . . 71.04 111.053 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.485 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 75.3 Cg_exo -55.36 -34.82 90.17 Favored 'Trans proline' 0 C--N 1.399 3.232 0 C-N-CA 122.272 1.982 . . . . 65.41 113.542 168.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -58.72 -39.56 81.21 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.657 0.783 . . . . 75.12 110.758 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.61 -41.4 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.963 0.905 . . . . 72.1 110.791 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.426 HD21 ' HA3' ' B' ' 82' ' ' GLY . 59.8 mt -81.26 -16.15 53.47 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.683 0.793 . . . . 74.11 112.098 -173.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -61.8 -47.95 90.6 Favored Pre-proline 0 CA--C 1.558 1.285 0 N-CA-C 113.987 1.106 . . . . 74.32 113.987 -171.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.07 -34.46 89.9 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 121.744 1.63 . . . . 72.33 113.054 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.536 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 88.3 m-85 -65.05 -46.8 79.73 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.507 0.504 . . . . 73.24 110.32 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.6 96.92 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.532 0.733 . . . . 71.22 110.585 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -57.74 -55.93 28.54 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.203 1.001 . . . . 64.3 110.688 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.06 -34.56 77.85 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.866 0.728 . . . . 74.41 110.489 -175.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' B' ' 117' ' ' MET . 2.7 t -69.96 -38.07 76.01 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.029 -0.532 . . . . 51.43 111.18 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.496 HG21 HG21 ' B' ' 64' ' ' VAL . 72.5 mt -65.73 -54.84 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.29 0.636 . . . . 70.12 109.665 174.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.9 m -61.6 -26.46 67.99 Favored 'General case' 0 CA--C 1.552 1.055 0 O-C-N 124.215 0.947 . . . . 52.41 111.647 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.6 t -61.73 -55.57 28.86 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.476 0.711 . . . . 75.32 109.199 171.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -66.45 -33.73 76.36 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.693 0.797 . . . . 72.52 111.716 -174.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.8 t -59.49 -48.65 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.048 0.939 . . . . 73.41 110.272 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.727 ' HB2' HE21 ' C' ' 125' ' ' GLN . 13.0 t -76.37 -21.0 56.63 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.277 -0.874 . . . . 71.2 111.216 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.7 mtt-85 -67.65 -41.71 83.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.852 -0.796 . . . . 72.15 108.852 172.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.7 -0.47 80.53 Favored Glycine 0 C--N 1.36 1.879 0 O-C-N 123.767 0.667 . . . . 61.44 113.018 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 62.33 42.26 9.36 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.762 2.025 . . . . 72.34 113.061 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -97.65 159.66 30.51 Favored Pre-proline 0 CA--C 1.56 1.346 0 C-N-CA 124.04 0.936 . . . . 75.22 110.158 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -62.74 178.41 1.0 Allowed 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.516 2.81 . . . . 63.24 114.637 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.62 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 23.5 tp60 -66.17 114.94 5.66 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.875 -1.057 . . . . 62.51 112.491 -174.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.512 ' HA ' HD11 ' F' ' 468' ' ' LEU . 7.4 mp -116.76 91.31 3.55 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.145 -0.687 . . . . 73.34 109.145 167.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.448 HD21 ' HA ' ' C' ' 122' ' ' THR . 77.8 m-20 -92.5 107.1 18.96 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.155 -1.054 . . . . 73.32 108.155 170.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 18.4 tp -71.71 126.02 28.62 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 123.64 0.587 . . . . 74.42 110.677 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.06 144.55 98.83 Favored Pre-proline 0 CA--C 1.55 0.954 0 O-C-N 124.702 1.251 . . . . 65.02 110.96 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.442 ' HG3' HD11 ' D' ' 16' ' ' ILE . 28.2 Cg_endo -61.67 112.39 1.46 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.239 2.626 . . . . 72.35 111.396 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -88.29 107.26 17.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 106.136 -1.801 . . . . 44.2 106.136 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -82.46 82.2 7.99 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 107.236 -1.394 . . . . 74.43 107.236 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -63.69 -27.59 69.32 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.695 -1.139 . . . . 74.54 110.068 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.43 -44.05 92.4 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.225 1.41 . . . . 63.1 111.424 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.32 -39.63 78.1 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.547 0.739 . . . . 53.25 110.322 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 85.7 mt -72.83 -23.84 60.82 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.381 -0.827 . . . . 61.32 110.734 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.497 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 51.3 t80 -69.82 -24.56 63.49 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.002 0.921 . . . . 73.44 110.889 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 68.0 mtm -61.79 -31.59 71.82 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.395 0.678 . . . . 73.31 110.869 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.5 ' HA ' HE21 ' B' ' 142' ' ' GLN . 19.8 m-80 -76.88 -18.5 58.28 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.386 1.074 . . . . 75.03 111.296 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -76.41 -30.3 57.4 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.477 0.711 . . . . 73.45 110.25 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 21.2 mt -95.82 18.61 12.8 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.115 -0.948 . . . . 72.33 111.977 -169.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.5 HE21 ' HA ' ' B' ' 139' ' ' ASN . 86.6 mm-40 -68.97 84.66 0.33 Allowed 'General case' 0 C--N 1.353 0.743 0 CA-C-O 121.341 0.591 . . . . 74.14 110.05 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -172.9 -50.65 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.909 1.284 . . . . 75.31 108.306 -176.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.18 75.2 1.06 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.337 -0.986 . . . . 72.24 108.337 175.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.44 38.67 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.731 1.212 . . . . 73.32 109.21 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.27 77.14 1.21 Allowed Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.502 -0.772 . . . . 74.51 111.971 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.71 96.17 1.57 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.136 0.974 . . . . 64.44 110.39 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.83 132.42 9.87 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.844 -0.616 . . . . 73.32 111.717 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.9 t -166.37 136.01 3.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.072 0.949 . . . . 65.02 109.556 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.24 131.35 53.58 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.304 -0.628 . . . . 70.21 109.304 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -157.37 132.91 9.16 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.536 -1.283 . . . . 72.33 107.536 176.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -172.22 77.09 0.05 OUTLIER 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.581 -1.266 . . . . 74.55 107.581 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.9 84.43 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 122.178 0.99 . . . . 73.23 111.633 173.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -101.69 130.22 48.02 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.197 0.999 . . . . 72.12 109.001 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 C-N-CA 124.203 1.001 . . . . 74.22 108.87 -178.947 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 108.228 -1.026 . . . . 74.22 108.228 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 69.3 m 60.78 -175.87 0.11 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.775 1.23 . . . . 64.13 111.399 -168.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -149.91 77.62 1.33 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.923 -0.769 . . . . 73.14 108.923 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -95.47 90.2 5.69 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.981 -1.859 . . . . 73.01 105.981 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -56.07 124.88 19.28 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.623 0.769 . . . . 65.32 110.541 -174.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -66.62 98.37 0.51 Allowed 'General case' 0 CA--C 1.547 0.859 0 O-C-N 123.896 0.748 . . . . 74.21 109.769 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 12.7 t -86.9 0.22 55.38 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.234 1.014 . . . . 71.14 110.839 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -102.28 55.06 0.79 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.302 1.041 . . . . 74.52 108.879 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 89.8 mtp 64.82 114.67 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.344 1.858 . . . . 54.42 113.52 -176.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 98.4 m -123.28 113.67 19.19 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.015 -1.448 . . . . 74.14 107.642 170.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.435 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.2 t80 -124.99 119.29 28.3 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.916 -1.142 . . . . 74.04 107.916 171.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -141.02 125.21 17.37 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 107.25 -1.389 . . . . 73.15 107.25 170.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.469 HD13 HD11 ' C' ' 16' ' ' ILE . 61.2 mt -74.35 120.53 23.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.103 -0.703 . . . . 31.33 109.103 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.564 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 16.3 mm-40 -86.94 -35.24 19.0 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.808 -1.087 . . . . 71.4 109.454 -176.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -174.16 147.79 1.26 Allowed 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.659 0.599 . . . . 63.44 109.987 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.469 HD11 HD13 ' C' ' 13' ' ' ILE . 92.1 mt -138.39 134.66 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.871 -1.159 . . . . 74.1 107.871 174.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.462 ' HB3' HG23 ' D' ' 122' ' ' THR . 34.0 p90 -171.59 168.94 6.21 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.602 0.715 . . . . 71.33 111.728 -169.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -93.28 114.68 27.19 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.217 -0.901 . . . . 72.43 109.034 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.406 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 10.2 mmmm -68.82 -39.82 79.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.037 0.922 . . . . 73.24 108.875 168.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.0 t70 -145.33 140.18 27.55 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 113.991 -1.459 . . . . 71.54 109.819 -173.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 81.2 mt -135.25 145.92 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 106.504 -1.665 . . . . 65.44 106.504 170.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -156.59 149.12 23.51 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.008 0.432 . . . . 73.54 110.242 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -141.97 131.11 23.33 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.705 -1.22 . . . . 72.22 107.705 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -135.28 115.9 13.79 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.507 1.123 . . . . 73.01 108.046 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' C' ' 28' ' ' ALA . . . -108.32 91.8 8.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 105.195 -2.15 . . . . 64.32 105.195 167.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.02 -36.52 97.98 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.244 2.629 . . . . 73.42 112.942 -167.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -125.41 43.16 3.12 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.762 -1.108 . . . . 73.14 108.915 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.472 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -42.61 -60.68 2.06 Favored Pre-proline 0 CA--C 1.568 1.671 0 N-CA-C 115.213 1.56 . . . . 72.03 115.213 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 19.2 Cg_exo -62.35 -39.14 48.82 Favored 'Trans proline' 0 C--N 1.391 2.801 0 CA-C-N 122.02 1.757 . . . . 72.11 112.088 -178.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -68.76 -33.77 74.45 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.033 -1.44 . . . . 73.52 111.991 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.914 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.5 p -81.82 -27.54 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 122.947 0.499 . . . . 70.11 111.99 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -68.24 -34.19 75.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.738 0.415 . . . . 74.01 111.758 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -86.55 7.06 27.77 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 122.894 0.477 . . . . 72.44 111.299 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.91 170.2 9.46 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.88 0.872 . . . . 73.41 109.944 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.45 129.25 37.89 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.676 0.791 . . . . 74.32 110.377 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 31.3 t90 -79.97 88.37 5.34 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.861 0.865 . . . . 74.34 110.186 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.487 ' H ' HD22 ' C' ' 68' ' ' LEU . 0.6 OUTLIER -144.35 73.39 15.88 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 107.353 -1.351 . . . . 73.43 107.353 174.177 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.417 ' HG2' HD12 ' G' ' 470' ' ' LEU . 8.7 Cg_exo -76.67 119.05 5.03 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.05 2.5 . . . . 75.51 113.698 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.63 88.12 7.32 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.95 -1.5 . . . . 64.35 106.95 166.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.693 HG21 HD12 ' G' ' 468' ' ' LEU . 14.4 p -79.1 136.73 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 114.36 -1.291 . . . . 72.31 110.17 -175.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -128.82 110.27 12.0 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.2 1.0 . . . . 75.21 108.864 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.48 ' H ' ' HA ' ' G' ' 465' ' ' LYS . 6.4 mp -84.78 122.56 29.3 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.146 -1.057 . . . . 70.34 108.146 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -120.23 132.05 55.19 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.101 -1.074 . . . . 75.21 108.101 174.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.58 HD21 ' HE1' ' C' ' 133' ' ' PHE . 15.3 tp -125.5 152.61 44.75 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.666 -0.865 . . . . 70.04 108.666 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.4 t70 -151.66 147.95 27.35 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.871 0.869 . . . . 70.32 108.982 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -146.22 133.2 20.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.82 0.848 . . . . 72.11 109.691 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.45 161.75 36.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.636 1.174 . . . . 64.31 107.978 171.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.426 ' HB2' ' HG ' ' G' ' 454' ' ' LEU . 16.7 m -138.55 151.58 47.44 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.866 -0.79 . . . . 74.12 108.866 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 17.9 p -142.19 128.62 20.08 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.733 0.813 . . . . 73.34 109.263 -170.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -73.88 118.26 16.63 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.728 -0.669 . . . . 62.14 110.146 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' C' ' 57' ' ' GLU . 32.8 mt -92.5 -31.69 15.15 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.081 -0.711 . . . . 64.3 109.081 172.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.85 -179.38 7.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.394 1.078 . . . . 75.52 110.457 176.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -62.87 119.11 8.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.214 -0.903 . . . . 64.33 109.467 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 7.1 m-20 65.32 17.98 11.19 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.226 1.011 . . . . 71.1 112.234 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 74.1 t -124.41 115.65 45.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 N-CA-C 108.218 -1.03 . . . . 61.42 108.218 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -128.82 131.48 47.74 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.935 0.894 . . . . 75.43 109.5 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.608 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.3 tt0 -83.75 114.94 21.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.775 -1.102 . . . . 71.41 108.135 166.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.47 HG11 ' HD3' ' C' ' 103' ' ' PRO . 76.2 t -96.03 137.87 22.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.671 -0.863 . . . . 41.25 108.671 173.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.95 131.8 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.171 -1.048 . . . . 72.42 108.171 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.458 HD21 HD11 ' C' ' 44' ' ' LEU . 1.0 OUTLIER -121.12 104.57 9.87 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.212 -1.403 . . . . 64.51 107.212 176.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.491 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 2.7 ttm180 -93.94 121.89 35.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.426 -1.261 . . . . 73.34 108.954 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.8 t -116.11 120.41 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.729 -1.212 . . . . 61.1 107.729 174.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 29.4 m -124.34 114.2 19.22 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.985 0.914 . . . . 63.2 108.714 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.642 HG11 HD11 ' C' ' 126' ' ' LEU . 43.8 t -107.56 120.1 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.857 -0.794 . . . . 73.43 108.857 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.4 m -104.54 150.6 24.48 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.669 -0.863 . . . . 75.34 108.669 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' C' ' 73' ' ' ALA . . . -141.86 137.16 31.23 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.361 -0.977 . . . . 73.42 108.361 172.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.2 m -145.1 133.47 21.8 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.23 0.612 . . . . 71.34 110.132 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.487 HD22 ' H ' ' C' ' 37' ' ' GLN . 18.2 mt -85.28 53.78 2.87 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.643 1.177 . . . . 54.11 108.999 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.82 -87.05 0.55 Allowed Glycine 0 C--N 1.342 0.867 0 N-CA-C 110.111 -1.195 . . . . 45.23 110.111 -167.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -125.55 -13.74 6.47 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.124 0.97 . . . . 51.51 111.664 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -76.24 116.59 17.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.253 0.621 . . . . 61.02 109.721 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.5 m -74.85 122.26 23.1 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.416 0.553 . . . . 71.15 110.083 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.914 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.89 -61.9 1.73 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.788 -1.096 . . . . 71.45 108.709 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -155.03 173.95 15.86 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 114.574 -1.193 . . . . 54.33 111.768 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -145.51 139.59 26.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 104.958 -2.238 . . . . 62.42 104.958 169.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.9 t -149.04 111.55 4.74 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.026 -0.731 . . . . 72.42 109.026 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -117.84 127.39 53.82 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.0 0.52 . . . . 73.41 109.82 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.97 114.03 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.137 0.975 . . . . 73.42 108.6 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.539 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 74.1 mt-30 -92.34 91.0 7.48 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.864 -0.791 . . . . 71.34 108.864 173.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.468 ' HG3' HD22 ' C' ' 106' ' ' LEU . 7.9 tp-100 -80.95 99.71 8.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.122 -0.945 . . . . 71.3 109.76 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.8 145.61 17.86 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.786 -0.526 . . . . 74.33 111.786 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.14 133.22 4.28 Favored Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 110.775 -0.93 . . . . 74.04 110.775 -175.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.595 HD12 HD11 ' C' ' 51' ' ' LEU . 8.7 mm -87.52 120.57 36.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 108.452 -0.944 . . . . 63.54 108.452 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.435 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 63.1 m-85 -127.79 126.22 41.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.455 0.702 . . . . 40.13 109.184 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 59.2 p -82.81 122.95 28.88 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.596 -0.89 . . . . 72.33 108.596 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.621 ' HB ' HD11 ' C' ' 89' ' ' ILE . 47.0 pt -117.24 142.36 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.892 0.877 . . . . 72.14 109.983 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -163.54 159.4 21.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.73 0.812 . . . . 62.34 109.194 175.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.04 -38.19 3.16 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 121.401 0.445 . . . . 72.11 113.27 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.621 HD11 ' HB ' ' C' ' 86' ' ' ILE . 1.8 pp -78.72 149.13 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.258 1.023 . . . . 73.33 109.079 175.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.587 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 11.4 tp10 -146.17 146.02 30.68 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.968 0.507 . . . . 72.43 110.384 -172.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.34 -111.57 2.14 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 124.039 0.837 . . . . 64.12 113.903 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 7.1 m -63.7 -34.61 78.25 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.283 1.033 . . . . 75.43 111.219 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.587 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 38.8 mt-30 -70.85 -32.6 69.66 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.857 0.863 . . . . 75.22 111.158 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.544 ' HG3' HG22 ' G' ' 451' ' ' VAL . 17.4 tmm? -73.86 -43.78 57.52 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.689 -0.485 . . . . 63.21 109.689 176.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.65 70.64 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.224 -0.898 . . . . 73.3 110.806 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -67.49 -46.29 73.37 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.347 1.059 . . . . 70.44 110.651 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.574 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 44.7 t -64.4 -40.41 95.75 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 123.905 0.753 . . . . 72.13 111.157 -176.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.483 HD21 HD13 ' C' ' 86' ' ' ILE . 77.0 mt -90.27 -34.65 15.67 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.648 0.61 . . . . 72.24 112.648 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.87 -7.19 64.69 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-O 119.619 -0.545 . . . . 44.42 114.363 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.22 -55.22 0.16 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.718 0.771 . . . . 54.45 111.697 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.574 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 55.7 t80 -67.79 -35.73 79.18 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.326 1.45 . . . . 73.42 112.526 -172.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 35.1 m -80.52 -43.74 1.33 Allowed Pre-proline 0 N--CA 1.485 1.294 0 CA-C-O 118.924 -0.56 . . . . 74.04 112.377 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.47 ' HD3' HG11 ' C' ' 58' ' ' VAL . 72.9 Cg_exo -50.33 -30.74 27.56 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.871 2.38 . . . . 72.31 114.257 166.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -60.95 -39.4 89.39 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.296 1.038 . . . . 75.44 110.334 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.546 HD12 ' NH1' ' A' ' 111' ' ' ARG . 40.8 mm -72.03 -40.3 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.719 0.807 . . . . 74.44 110.461 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.468 HD22 ' HG3' ' C' ' 80' ' ' GLN . 83.6 mt -78.93 -23.54 44.61 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.23 1.012 . . . . 74.52 112.644 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -59.67 -50.79 85.16 Favored Pre-proline 0 CA--C 1.556 1.173 0 N-CA-C 114.021 1.119 . . . . 61.15 114.021 -172.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.5 -35.44 96.74 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.088 1.859 . . . . 72.24 113.11 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -68.41 -50.04 55.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.587 0.755 . . . . 74.13 110.981 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.84 -37.44 84.48 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.532 -0.758 . . . . 73.11 111.042 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -58.15 -55.19 38.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.906 1.282 . . . . 72.24 110.817 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -66.97 -29.5 69.37 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.228 0.611 . . . . 75.12 110.58 -176.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.436 ' SG ' HG12 ' C' ' 21' ' ' ILE . 34.5 t -73.23 -32.19 64.6 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.23 0.612 . . . . 72.2 111.542 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' C' ' 62' ' ' VAL . 86.1 mt -71.23 -46.28 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.42 0.688 . . . . 74.22 109.483 172.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 23.1 m -61.34 -36.33 79.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.775 0.83 . . . . 70.13 111.33 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 37.7 t -60.19 -49.62 76.92 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.336 -0.847 . . . . 65.23 109.416 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.506 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.59 -32.62 74.3 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.586 1.155 . . . . 74.53 113.078 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' C' ' 123' ' ' PHE . 53.0 t -74.81 -35.39 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.437 0.695 . . . . 63.22 110.522 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 36.7 t -67.9 -35.86 79.2 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.576 0.75 . . . . 71.12 110.857 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' C' ' 116' ' ' SER . 71.7 mtt-85 -67.66 -43.76 79.48 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.435 -0.802 . . . . 73.33 109.613 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.87 1.21 84.88 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 123.737 0.648 . . . . 54.34 112.857 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.448 ' HA ' HD21 ' B' ' 127' ' ' ASN . 67.3 p 62.83 25.5 15.11 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.337 1.855 . . . . 52.31 114.823 167.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.468 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.8 m-85 -84.71 157.4 60.86 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 108.75 -0.833 . . . . 73.01 108.75 167.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.62 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 79.9 Cg_exo -51.61 142.28 40.51 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.93 2.42 . . . . 74.13 113.364 175.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.727 HE21 ' HB2' ' B' ' 119' ' ' SER . 14.7 mm100 -55.78 138.19 48.36 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.375 1.047 . . . . 71.41 113.015 -172.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.642 HD11 HG11 ' C' ' 64' ' ' VAL . 8.2 tt -104.58 114.79 29.24 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.5 -1.227 . . . . 71.14 108.778 -173.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -119.02 100.0 7.08 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.785 -0.821 . . . . 73.13 108.785 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.452 HD22 HD21 ' G' ' 468' ' ' LEU . 0.1 OUTLIER -71.91 135.47 46.54 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.494 0.717 . . . . 75.34 109.946 -175.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.68 153.25 91.21 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.997 0.919 . . . . 63.22 111.411 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.536 ' HG3' HD12 ' A' ' 16' ' ' ILE . 31.6 Cg_exo -58.48 109.25 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.254 1.97 . . . . 54.33 112.06 172.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 91.0 t -96.28 110.73 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.031 -1.47 . . . . 70.51 107.031 173.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -83.01 94.1 7.7 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.916 -1.142 . . . . 74.44 107.916 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.58 ' HE1' HD21 ' C' ' 44' ' ' LEU . 84.8 m-85 -63.25 -38.79 92.54 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.151 0.98 . . . . 72.04 111.881 -175.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.21 -37.24 80.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.905 0.882 . . . . 74.34 111.35 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.93 -27.89 43.77 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.967 0.507 . . . . 70.01 110.373 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 54.0 tp -74.61 -26.25 59.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.257 0.623 . . . . 61.31 110.218 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.42 ' HA ' ' HE1' ' G' ' 461' ' ' PHE . 68.9 t80 -61.05 -51.07 70.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.917 0.887 . . . . 74.53 111.775 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 26.5 ptm -57.12 -27.28 61.68 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.349 0.66 . . . . 73.44 112.705 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -56.96 -30.72 64.32 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.968 1.307 . . . . 71.35 113.286 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -155.23 0.02 OUTLIER 'General case' 0 CA--C 1.573 1.857 0 C-N-CA 123.205 0.602 . . . . 74.5 111.463 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' C' ' 144' ' ' GLN . 16.3 tp 71.82 131.56 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.689 1.195 . . . . 53.25 112.25 167.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -69.88 -61.26 1.85 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.206 -0.664 . . . . 71.11 109.206 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -98.05 87.79 4.05 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.871 -0.604 . . . . 71.11 110.069 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.474 ' HA ' HD23 ' C' ' 141' ' ' LEU . 73.0 mt-30 -73.79 158.45 34.56 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.706 0.402 . . . . 61.53 110.509 172.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.25 151.64 45.3 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.591 0.756 . . . . 73.55 109.645 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.94 167.52 51.17 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.736 0.648 . . . . 70.1 112.554 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -134.99 99.15 4.2 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.289 0.545 . . . . 72.33 110.321 -171.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.65 91.83 1.09 Allowed Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.823 -0.626 . . . . 55.24 112.018 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.729 ' HA ' ' HG2' ' A' ' 147' ' ' GLU . 40.0 p -90.01 105.6 17.92 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.263 0.625 . . . . 75.41 110.176 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -76.56 124.55 27.77 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.515 -0.55 . . . . 73.3 109.515 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.8 108.48 2.99 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.585 -0.895 . . . . 65.44 108.585 171.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . 0.491 ' HB3' ' HA ' ' A' ' 145' ' ' ALA . 54.1 t-80 -74.93 82.31 2.19 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.516 -0.92 . . . . 73.21 108.516 174.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.487 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 59.7 tt0 -99.38 103.34 15.14 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.015 0.526 . . . . 50.44 109.725 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -84.04 86.31 7.22 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.637 -0.875 . . . . 54.55 108.637 172.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.213 0 CA-C-N 115.081 -0.963 . . . . 63.12 110.162 179.313 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 109.854 -0.424 . . . . 64.1 109.854 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -82.46 85.59 6.9 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.21 -0.663 . . . . 55.12 109.21 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.56 131.49 34.37 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.243 -0.651 . . . . 74.22 109.243 -175.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -139.07 161.59 37.0 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.016 0.526 . . . . 75.4 112.076 -170.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -170.68 112.33 0.4 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 106.632 -1.618 . . . . 65.23 106.632 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -78.58 147.56 33.67 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.195 0.452 . . . . 62.33 111.097 -172.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.509 HG22 ' H ' ' D' ' 8' ' ' GLU . 0.8 OUTLIER -99.46 -166.02 1.3 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 124.256 1.022 . . . . 72.41 108.773 178.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.509 ' H ' HG22 ' D' ' 7' ' ' THR . 42.9 mm-40 -62.67 -86.88 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 109.246 -0.65 . . . . 51.41 109.246 171.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -37.15 136.47 0.42 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.275 0.63 . . . . 60.11 112.067 157.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 40.4 m -143.29 140.89 30.82 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.2 -0.667 . . . . 64.13 109.2 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.518 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 54.7 t80 -164.22 89.82 0.56 Allowed 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.013 -1.847 . . . . 72.44 106.013 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -128.41 130.67 47.99 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.725 -0.843 . . . . 74.42 108.725 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -90.83 110.98 22.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.123 -1.066 . . . . 52.25 108.123 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -73.86 -31.27 63.09 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.295 0.372 . . . . 74.24 110.711 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -168.68 131.68 1.4 Allowed 'General case' 0 C--N 1.349 0.547 0 O-C-N 123.268 0.355 . . . . 64.24 110.669 -169.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.477 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.0 mp -116.36 128.75 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 105.846 -1.909 . . . . 75.12 105.846 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.437 ' HE1' HG13 ' D' ' 83' ' ' ILE . 40.3 p90 -156.2 160.41 39.81 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.053 0.93 . . . . 71.21 112.477 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -91.33 118.43 30.51 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 113.738 -1.574 . . . . 73.42 108.887 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.0 mtpt -82.3 -37.37 25.89 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.632 -0.713 . . . . 63.25 109.404 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -150.24 139.06 20.85 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.106 -1.406 . . . . 61.1 109.125 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.506 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.9 mt -137.92 147.75 25.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.919 1.287 . . . . 74.15 108.118 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.6 t -148.15 126.23 12.11 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.622 0.769 . . . . 75.1 109.48 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.537 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 66.6 t80 -121.19 133.19 55.17 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.205 -1.406 . . . . 75.03 107.205 164.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.718 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.7 mt-10 -134.84 136.7 42.66 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.34 1.056 . . . . 72.24 108.343 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.21 83.74 63.12 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.46 -1.311 . . . . 51.13 107.46 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.92 -52.95 2.41 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.05 2.5 . . . . 63.4 112.967 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.577 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 5.1 m-20 -102.18 19.69 18.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.287 0.635 . . . . 62.32 109.64 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.499 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -23.85 -75.24 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 116.535 2.05 . . . . 64.41 116.535 -167.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.447 ' HB3' HD11 ' C' ' 83' ' ' ILE . 83.8 Cg_endo -77.28 -16.7 15.31 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 124.033 2.476 . . . . 64.32 113.539 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.435 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 0.2 OUTLIER -71.16 -44.45 65.49 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.209 1.004 . . . . 44.51 108.557 172.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' D' ' 27' ' ' ASN . 9.8 p -82.63 -20.74 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.466 0.706 . . . . 72.12 111.351 -168.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.84 -14.14 62.71 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.61 0.364 . . . . 63.14 111.599 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -67.27 -14.48 62.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.703 0.801 . . . . 71.22 110.925 174.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.423 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 97.4 mttt -97.79 101.63 13.18 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.855 1.262 . . . . 75.13 109.202 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -85.38 93.07 8.64 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.314 -0.625 . . . . 72.32 109.314 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -162.52 156.95 21.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.704 0.801 . . . . 72.45 109.192 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -76.52 105.45 2.33 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.386 -0.968 . . . . 72.5 108.386 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.05 124.97 17.16 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.002 2.468 . . . . 73.44 112.316 -170.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.52 114.83 4.62 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.864 0.727 . . . . 64.33 109.827 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.405 HG21 HD11 ' D' ' 126' ' ' LEU . 27.5 m -102.29 149.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.877 0.871 . . . . 73.4 112.018 -171.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' D' ' 64' ' ' VAL . 46.1 tptt -120.7 120.36 35.46 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.1 1.36 . . . . 71.51 107.866 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.5 HD21 HD12 ' D' ' 128' ' ' LEU . 7.2 mp -97.85 121.06 39.31 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.077 -0.712 . . . . 73.45 109.077 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.577 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 14.6 t70 -108.61 120.48 42.58 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.117 -1.068 . . . . 72.1 108.117 170.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 tt -106.43 127.79 53.56 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.506 -0.924 . . . . 70.52 108.506 -174.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.2 t70 -134.97 148.19 49.94 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.339 1.056 . . . . 73.12 108.434 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -120.19 152.21 38.01 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.999 0.52 . . . . 64.1 109.626 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.98 171.21 17.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.371 1.068 . . . . 71.14 108.252 174.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -174.62 161.66 3.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.065 0.546 . . . . 72.2 110.939 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.7 p -159.22 147.81 18.05 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.381 0.672 . . . . 45.32 109.93 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -87.0 127.06 35.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.474 -0.565 . . . . 74.1 109.474 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 67.6 mt -97.86 -38.62 9.37 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.289 0.635 . . . . 74.55 110.862 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.75 -173.74 4.66 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.567 0.747 . . . . 61.01 110.566 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.91 105.51 1.04 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.02 -0.991 . . . . 63.42 110.444 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 68.36 18.98 9.04 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.915 1.286 . . . . 71.2 111.554 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -110.77 123.08 66.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 N-CA-C 107.454 -1.313 . . . . 71.44 107.454 167.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.402 ' CG ' HG11 ' H' ' 452' ' ' VAL . 28.0 t80 -136.86 129.77 30.76 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.255 -0.646 . . . . 75.21 109.255 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -91.13 144.38 25.69 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.214 1.005 . . . . 74.52 109.624 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.0 t -123.12 145.64 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.079 1.352 . . . . 72.43 107.629 171.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 45.6 t -127.53 144.91 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.096 0.958 . . . . 51.22 108.914 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -127.7 122.09 32.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.863 -1.162 . . . . 72.1 107.863 178.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 37.0 ttm-85 -102.63 97.48 7.67 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.483 -0.932 . . . . 74.04 108.483 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 66.7 t -94.14 104.25 15.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.339 -0.985 . . . . 74.04 108.339 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.3 m -97.9 146.36 25.54 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.263 -0.88 . . . . 72.11 108.842 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 53.8 t -140.37 109.03 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.397 1.079 . . . . 75.35 108.841 -177.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -102.57 110.8 22.85 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.72 -0.845 . . . . 72.34 108.72 171.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.0 157.24 17.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.033 0.533 . . . . 73.33 110.48 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 21.6 p -154.64 130.97 10.43 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.449 0.642 . . . . 62.24 112.01 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.471 HD12 HG22 ' D' ' 31' ' ' VAL . 25.1 mt -97.91 101.62 13.16 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.384 -1.28 . . . . 62.43 107.876 170.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.97 -123.22 7.29 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.599 -0.728 . . . . 63.41 112.591 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.75 5.63 48.95 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.304 0.642 . . . . 62.14 112.341 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.423 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 13.0 pt-20 -129.09 160.14 33.75 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.207 0.603 . . . . 73.1 109.801 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -67.17 139.46 57.45 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.565 0.541 . . . . 61.11 110.412 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.563 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -92.89 -65.25 1.01 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.324 -0.853 . . . . 74.33 108.952 175.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -145.93 167.76 22.51 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.144 -0.935 . . . . 74.22 109.641 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.718 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.0 mt -132.14 140.38 48.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.404 -1.332 . . . . 72.53 107.404 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.504 ' SG ' HG23 ' D' ' 114' ' ' ILE . 1.2 m -144.91 139.51 27.67 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.022 0.929 . . . . 64.21 108.717 -177.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -158.2 130.19 6.88 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.007 -0.738 . . . . 72.42 109.007 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 62.8 t -134.87 117.5 22.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 109.258 -0.645 . . . . 60.33 109.258 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -89.58 85.48 6.5 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.612 0.72 . . . . 70.1 109.072 170.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -80.02 101.5 8.72 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.211 -1.359 . . . . 72.42 109.541 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.87 160.69 23.34 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.416 -0.673 . . . . 22.4 111.416 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.45 132.91 3.66 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.118 -0.793 . . . . 61.31 111.118 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.437 HG13 ' HE1' ' D' ' 17' ' ' TYR . 64.7 mt -87.69 124.56 41.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.152 0.981 . . . . 75.13 108.361 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -122.66 123.7 41.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.413 0.285 . . . . 62.12 110.368 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 48.5 m -83.49 110.19 17.99 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.745 -1.205 . . . . 52.51 107.745 164.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.496 HG13 HG11 ' H' ' 451' ' ' VAL . 15.6 pt -130.25 145.31 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.909 0.884 . . . . 52.05 110.617 -170.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.28 167.46 25.87 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.863 0.865 . . . . 42.25 109.913 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.73 -18.89 13.14 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 114.285 0.474 . . . . 62.1 114.285 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 34.0 pt -112.2 126.89 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.848 0.859 . . . . 62.24 109.113 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.53 164.33 30.44 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.068 0.547 . . . . 72.44 110.676 -175.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' D' ' 94' ' ' MET . . . 66.47 -129.29 30.93 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.582 0.552 . . . . 71.23 113.94 175.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.4 m -70.52 -29.4 65.88 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.501 0.721 . . . . 72.5 111.452 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.68 -43.57 98.48 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.978 0.911 . . . . 74.24 111.444 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' D' ' 91' ' ' GLY . 0.0 OUTLIER -73.67 -31.83 63.66 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 116.244 -0.434 . . . . 52.24 110.746 179.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.64 88.06 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.998 0.519 . . . . 73.41 111.063 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 12.6 t-80 -64.71 -31.79 73.17 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.786 0.835 . . . . 63.24 111.054 176.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.9 t -79.71 -49.6 11.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.516 0.326 . . . . 61.15 110.783 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.468 HD23 ' SG ' ' D' ' 102' ' ' CYS . 84.3 mt -79.28 -29.37 42.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.692 0.797 . . . . 73.35 112.238 -169.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.37 6.65 63.5 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 119.792 -0.449 . . . . 73.1 113.183 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -148.26 -67.94 0.23 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.258 0.529 . . . . 53.41 111.955 -177.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . 0.418 ' O ' HG12 ' D' ' 105' ' ' ILE . 66.9 t80 -64.86 -37.77 88.74 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 112.467 0.544 . . . . 74.51 112.467 -172.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.518 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 85.9 m -70.65 -48.47 16.28 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-O 118.599 -0.715 . . . . 44.21 111.461 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.481 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 75.2 Cg_exo -55.96 -33.18 88.39 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.013 1.809 . . . . 71.02 113.185 167.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.56 -35.71 81.64 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.251 0.621 . . . . 73.43 111.169 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.418 HG12 ' O ' ' D' ' 101' ' ' TYR . 36.6 mm -67.84 -40.09 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.601 0.76 . . . . 73.14 110.523 174.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.7 mt -79.04 -16.93 56.14 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.642 -0.708 . . . . 73.22 111.514 -175.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -68.31 -41.32 24.24 Favored Pre-proline 0 N--CA 1.485 1.317 0 N-CA-C 114.437 1.273 . . . . 71.51 114.437 -172.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.45 -39.21 92.85 Favored 'Trans proline' 0 C--N 1.385 2.476 0 CA-C-N 121.769 1.667 . . . . 63.33 112.74 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -71.16 -40.46 71.28 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.52 0.728 . . . . 75.43 110.95 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.79 -44.59 96.63 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.875 0.87 . . . . 55.45 110.639 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.517 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 19.8 ttp180 -59.92 -53.5 57.11 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.335 -1.302 . . . . 64.15 110.198 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.47 -42.77 99.72 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.28 0.988 . . . . 72.55 111.724 -172.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.8 t -58.52 -40.55 83.22 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.688 0.618 . . . . 64.23 110.875 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.504 HG23 ' SG ' ' D' ' 76' ' ' CYS . 84.3 mt -66.95 -50.3 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.626 0.77 . . . . 52.13 110.622 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -54.91 -43.86 73.67 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.213 1.005 . . . . 70.24 111.529 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.7 t -66.91 -42.02 86.11 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.48 -1.237 . . . . 74.51 110.519 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.537 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 71.9 mtm -66.12 -37.35 85.5 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.856 0.463 . . . . 73.32 111.638 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.423 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.0 t -63.21 -44.57 99.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.117 0.967 . . . . 71.33 110.479 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -73.57 -31.02 63.39 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 116.038 -0.528 . . . . 71.2 111.381 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -71.82 -30.3 65.34 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.205 0.602 . . . . 65.32 110.094 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.97 11.38 69.38 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.715 0.635 . . . . 62.13 112.663 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.462 HG23 ' HB3' ' C' ' 17' ' ' TYR . 66.2 p 58.15 21.93 8.54 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 126.446 1.899 . . . . 71.55 114.244 175.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -84.32 147.85 51.23 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 108.818 -0.808 . . . . 61.43 108.818 169.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.5 135.22 47.51 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 123.067 2.512 . . . . 74.33 112.488 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -50.63 140.91 13.52 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.957 1.303 . . . . 71.42 113.003 -170.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.45 ' HA ' HD11 ' H' ' 468' ' ' LEU . 55.2 tp -122.34 100.87 7.18 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.44 0.696 . . . . 72.33 110.713 -176.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.531 ' H ' HD11 ' H' ' 468' ' ' LEU . 74.0 m-20 -99.67 101.16 12.26 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.093 -1.077 . . . . 63.1 108.093 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.517 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.7 mm? -69.23 114.27 7.34 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.338 0.655 . . . . 71.3 109.517 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.401 ' HB3' ' SD ' ' H' ' 464' ' ' MET . . . -58.09 132.72 83.96 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.177 0.591 . . . . 72.01 111.414 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.463 ' HB3' HH12 ' D' ' 111' ' ' ARG . 58.6 Cg_endo -72.85 126.1 11.04 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.252 1.968 . . . . 71.13 111.185 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.82 141.79 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.797 0.839 . . . . 71.43 110.065 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -77.68 103.15 7.44 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.403 -0.962 . . . . 72.02 108.403 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -72.0 -40.56 68.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.801 0.441 . . . . 74.45 110.492 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' D' ' 138' ' ' MET . 5.8 m-20 -61.29 -53.46 56.53 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.905 0.882 . . . . 71.53 112.668 -172.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.33 99.08 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.28 0.632 . . . . 63.31 111.165 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.41 -27.65 67.25 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.204 -0.907 . . . . 60.41 111.6 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.457 ' O ' HD13 ' D' ' 141' ' ' LEU . 84.1 t80 -72.02 -40.06 68.72 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.465 0.706 . . . . 73.24 110.423 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 36.6 mtt -64.16 -36.76 85.11 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.272 0.629 . . . . 73.03 110.11 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.401 ' HA ' HE21 ' D' ' 142' ' ' GLN . 83.5 m-20 -70.56 -41.6 72.24 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.2 -0.909 . . . . 74.11 110.402 175.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -61.42 -34.63 75.71 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.215 1.006 . . . . 75.31 111.427 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.457 HD13 ' O ' ' D' ' 137' ' ' PHE . 1.2 mp -59.45 -34.33 72.39 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.722 0.809 . . . . 71.55 111.339 175.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' D' ' 139' ' ' ASN . 40.7 mt-30 -87.98 0.71 55.57 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.855 0.862 . . . . 72.5 111.567 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -121.71 90.66 3.35 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.001 0.92 . . . . 64.14 109.647 -175.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.04 160.07 42.39 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.789 0.836 . . . . 63.42 109.521 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.57 91.43 1.42 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.311 0.644 . . . . 72.0 110.248 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.08 -156.32 31.48 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.828 -0.624 . . . . 45.03 112.001 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -129.3 123.35 31.63 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.843 0.857 . . . . 71.14 109.874 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.1 61.58 4.28 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 111.283 -0.727 . . . . 73.12 111.283 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.3 t -62.04 142.84 57.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.072 0.949 . . . . 53.11 111.089 -175.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.74 141.29 19.84 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.004 0.522 . . . . 71.05 109.872 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -105.73 134.35 48.99 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.328 -1.36 . . . . 60.44 107.328 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -137.13 94.86 3.0 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.637 0.775 . . . . 71.21 108.958 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -64.49 129.45 39.91 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 122.877 0.471 . . . . 74.22 110.653 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -108.6 6.47 25.96 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.554 0.741 . . . . 73.15 110.753 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.217 0 C-N-CA 123.622 0.769 . . . . 74.14 109.992 179.759 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.444 0.164 . . . . 74.11 110.624 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . 0.595 HG13 HG13 ' E' ' 452' ' ' VAL . 7.4 p -76.23 -42.79 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 122.835 0.454 . . . . 65.24 111.226 -177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . 0.595 HG13 HG13 ' E' ' 451' ' ' VAL . 15.6 m -99.89 111.11 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.051 0.54 . . . . 75.51 111.511 -171.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -73.88 -62.11 3.09 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-N 115.739 -0.664 . . . . 51.42 111.728 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . 0.42 HD11 HD12 ' A' ' 98' ' ' LEU . 2.2 tm? 56.21 92.69 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.489 1.516 . . . . 63.33 112.084 170.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 15.2 t -77.57 171.36 15.03 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.989 0.515 . . . . 71.44 110.414 174.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -73.06 81.12 1.23 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.187 0.595 . . . . 73.41 110.026 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -81.68 130.63 35.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.029 -0.73 . . . . 54.51 109.029 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 15.0 t -137.34 -174.82 3.86 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.923 0.889 . . . . 60.53 109.189 -174.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 31.0 t70 70.25 112.54 0.05 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.52 1.128 . . . . 72.43 110.429 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . 0.501 HD21 ' H ' ' A' ' 46' ' ' THR . 4.3 mm? -98.42 132.64 43.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.357 0.663 . . . . 52.55 109.677 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -86.17 27.36 0.92 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.02 1.328 . . . . 72.14 110.503 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -74.87 130.94 40.3 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.46 0.704 . . . . 74.15 110.552 -174.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 8.9 t -167.73 143.78 4.04 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.519 1.127 . . . . 63.3 108.602 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . 0.623 ' SD ' HD23 ' A' ' 42' ' ' LEU . 22.7 ptm -144.51 113.23 6.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.513 0.725 . . . . 61.01 109.173 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -107.32 99.36 8.89 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.359 -0.978 . . . . 61.03 108.359 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -167.52 -33.94 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.788 0.835 . . . . 74.3 110.554 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . 69.68 173.22 0.3 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.036 1.334 . . . . 51.04 112.205 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . 0.428 HD12 HG11 ' A' ' 40' ' ' VAL . 88.8 mt -90.12 -62.1 1.54 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.134 0.574 . . . . 71.51 110.894 -174.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 93.91 40.96 4.49 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 115.528 -0.76 . . . . 33.01 112.63 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 91.3 mt -68.71 -53.82 19.81 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.718 -1.216 . . . . 64.23 107.718 167.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt . . . . . 0 CA--C 1.549 0.928 0 C-N-CA 125.757 1.623 . . . . 75.11 107.46 169.827 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 57.9 t30 . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 108.364 -0.976 . . . . 72.41 108.364 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . 0.563 HG23 HG22 ' F' ' 452' ' ' VAL . 21.6 m -61.6 -44.61 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 123.404 0.44 . . . . 71.15 111.78 -177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . 0.563 HG22 HG23 ' F' ' 451' ' ' VAL . 23.5 m -138.95 -59.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 112.706 0.632 . . . . 74.1 112.706 -172.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . 0.428 ' N ' HG23 ' F' ' 452' ' ' VAL . . . 72.48 63.19 2.99 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.236 -1.146 . . . . 44.2 110.236 -163.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . 0.541 HD23 HD22 ' B' ' 98' ' ' LEU . 58.4 tp -66.8 131.09 45.21 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 122.761 0.425 . . . . 64.23 110.431 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 7.3 t -145.22 126.29 14.62 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.957 0.903 . . . . 72.4 108.934 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -169.05 136.75 1.9 Allowed 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.125 -1.435 . . . . 73.11 107.125 173.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -147.64 72.78 1.25 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.829 0.823 . . . . 75.41 109.606 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 7.6 p -106.45 -75.75 0.62 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.703 -1.135 . . . . 73.12 108.44 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -178.54 -174.9 0.41 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 125.502 1.521 . . . . 72.44 108.161 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . 0.453 HD21 ' HA ' ' B' ' 45' ' ' ASP . 2.0 pt? -137.65 148.79 46.05 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.237 0.615 . . . . 75.44 109.451 177.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -72.89 146.16 46.36 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.588 1.155 . . . . 74.23 111.697 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -132.13 67.4 1.53 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.288 -1.375 . . . . 72.33 107.288 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 28.8 m -80.26 84.34 5.95 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.014 -0.994 . . . . 75.44 108.37 174.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . 0.45 ' SD ' ' HA ' ' F' ' 467' ' ' ALA . 39.0 tpp -91.01 146.85 23.5 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.101 -0.954 . . . . 75.2 110.796 -172.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.5 -63.11 0.9 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.169 0.988 . . . . 64.33 109.435 -175.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -82.94 -30.6 28.22 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.271 0.628 . . . . 34.3 111.565 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . 0.45 ' HA ' ' SD ' ' F' ' 464' ' ' MET . . . 68.84 -77.49 0.05 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.321 1.448 . . . . 54.32 111.569 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . 0.599 ' HG ' HG11 ' B' ' 40' ' ' VAL . 2.6 tm? -147.43 -25.49 0.38 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.093 0.957 . . . . 73.24 108.948 -174.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' F' ' 468' ' ' LEU . . . 94.11 -58.55 2.05 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 110.009 -1.236 . . . . 72.1 110.009 -168.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 10.4 tp 55.9 74.97 0.36 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.034 1.334 . . . . 73.31 109.578 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--O 1.253 1.239 0 CA-C-O 118.562 -0.732 . . . . 63.34 109.959 -174.546 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 110.284 -0.265 . . . . 73.24 110.284 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . 0.544 HG22 ' HG3' ' C' ' 94' ' ' MET . 15.0 p -87.21 114.97 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 122.01 0.91 . . . . 72.32 111.312 -170.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 19.7 m -141.03 -168.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.806 1.242 . . . . 61.3 109.305 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 86.81 58.53 1.9 Allowed Glycine 0 C--N 1.342 0.909 0 CA-C-O 121.125 0.292 . . . . 63.21 112.733 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' C' ' 48' ' ' SER . 3.4 tm? -88.38 121.26 30.58 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.616 -1.253 . . . . 71.23 107.616 173.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 9.9 t -89.11 136.23 33.13 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 109.938 -0.393 . . . . 63.24 109.938 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -77.44 98.76 5.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.235 -0.439 . . . . 62.51 110.375 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -88.77 88.19 7.51 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.763 -1.199 . . . . 73.44 107.763 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 31.5 p -63.49 -37.65 88.13 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.423 1.089 . . . . 64.21 112.069 -173.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -78.73 84.59 4.8 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 109.109 -0.7 . . . . 74.32 109.109 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.28 110.39 5.22 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.615 -0.883 . . . . 73.45 108.615 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . 0.42 ' HE1' ' HA ' ' C' ' 137' ' ' PHE . 16.6 p90 -52.74 83.76 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 126.117 1.767 . . . . 63.43 111.941 173.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -137.89 90.95 2.53 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.682 -0.859 . . . . 75.1 108.682 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 41.6 p -92.48 82.63 4.87 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.995 -0.742 . . . . 73.24 108.995 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 52.3 ttm -163.74 117.16 1.49 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.172 -1.048 . . . . 64.24 108.172 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . 0.48 ' HA ' ' H ' ' C' ' 42' ' ' LEU . 65.1 mttm -129.56 -60.03 1.06 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.208 0.603 . . . . 61.42 109.847 -178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -90.07 85.33 6.28 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.955 -0.757 . . . . 71.5 108.955 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -129.41 6.4 5.27 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.633 0.773 . . . . 53.03 111.209 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . 0.693 HD12 HG21 ' C' ' 40' ' ' VAL . 82.3 mt -117.78 124.04 47.44 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.632 0.773 . . . . 71.24 109.059 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -80.86 61.92 4.47 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 110.919 -0.872 . . . . 61.53 110.919 172.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . 0.417 HD12 ' HG2' ' C' ' 38' ' ' PRO . 0.2 OUTLIER -95.14 31.13 1.97 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.541 1.136 . . . . 74.15 108.215 -176.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt . . . . . 0 C--O 1.255 1.36 0 C-N-CA 125.024 1.33 . . . . 64.21 108.904 -172.205 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 20.2 m120 . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.628 -0.508 . . . . 72.25 109.628 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . 0.719 HG13 HG13 ' H' ' 452' ' ' VAL . 9.7 p -54.55 -32.77 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 124.182 0.993 . . . . 74.01 112.789 -174.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . 0.719 HG13 HG13 ' H' ' 451' ' ' VAL . 20.1 m -114.37 151.7 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.629 0.728 . . . . 73.12 112.449 -172.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -158.82 28.71 0.42 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-N 114.115 -1.402 . . . . 61.52 111.065 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.55 127.52 42.62 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.253 0.621 . . . . 74.31 109.847 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 38.2 p -78.02 -4.79 48.93 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.917 0.887 . . . . 74.44 111.658 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 31.8 t70 73.46 148.94 0.09 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.71 1.604 . . . . 74.03 111.059 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' H' ' 458' ' ' THR . 17.6 tt0 -152.53 141.11 20.8 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.333 0.653 . . . . 72.24 109.381 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . 0.414 ' O ' ' HG2' ' H' ' 457' ' ' GLN . 13.4 t -86.77 151.36 23.45 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.392 -0.966 . . . . 74.13 108.392 166.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 71.66 155.7 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.035 1.334 . . . . 72.41 111.456 -174.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . 0.49 ' HG ' ' H ' ' H' ' 461' ' ' PHE . 1.8 pt? -162.17 -73.57 0.05 Allowed 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.62 -0.718 . . . . 72.43 109.833 175.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . 0.49 ' H ' ' HG ' ' H' ' 460' ' ' LEU . 30.3 p90 -176.8 157.42 1.51 Allowed 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.561 1.144 . . . . 72.12 109.362 -171.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -162.56 120.02 2.04 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.726 0.81 . . . . 73.2 109.476 167.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 34.5 m -152.16 106.52 3.17 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.72 0.808 . . . . 72.15 109.017 170.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' D' ' 129' ' ' ALA . 16.4 tmm? -149.48 113.86 5.24 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.21 -1.033 . . . . 74.01 108.21 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -90.25 118.85 30.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.363 0.665 . . . . 74.24 110.48 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . 72.32 97.39 0.07 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.005 1.322 . . . . 75.32 112.424 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -72.85 -53.83 10.4 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.847 -0.615 . . . . 61.13 109.85 174.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . 0.531 HD11 ' H ' ' D' ' 127' ' ' ASN . 87.6 mt -132.28 28.18 4.41 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.154 1.382 . . . . 74.1 108.676 173.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 79.08 -73.57 2.31 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.763 -0.535 . . . . 61.43 111.763 -170.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 64.19 95.77 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.091 1.356 . . . . 73.52 110.986 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 23.1 tptm . . . . . 0 CA--C 1.559 1.325 0 C-N-CA 124.534 1.134 . . . . 74.43 111.246 173.557 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptm . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.183 -0.303 . . . . 73.21 110.183 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.9 m -94.6 78.95 3.78 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.604 0.762 . . . . 53.43 109.38 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -99.21 81.89 2.63 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.296 -0.866 . . . . 74.23 108.805 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.83 88.58 6.78 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.721 -1.127 . . . . 73.42 109.242 174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -66.27 116.22 7.08 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.035 -0.529 . . . . 71.55 110.824 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.9 t30 60.91 -90.47 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.407 1.483 . . . . 51.42 112.587 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 m -78.99 80.8 5.31 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.761 0.791 . . . . 63.54 110.352 -168.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -80.98 104.05 11.22 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.686 -1.143 . . . . 75.14 109.023 176.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.27 174.06 12.39 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.633 -1.167 . . . . 65.43 109.717 -175.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m -141.56 137.25 31.83 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.432 0.693 . . . . 64.44 109.341 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.661 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 10.1 t80 -135.99 129.37 31.97 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.954 0.902 . . . . 75.24 108.607 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -149.68 127.56 11.82 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.706 0.803 . . . . 64.35 109.155 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.573 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.1 mt -95.34 119.21 43.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.896 -0.779 . . . . 72.54 108.896 173.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -88.69 -34.29 17.26 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 123.46 0.475 . . . . 70.43 110.184 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -166.87 126.16 1.45 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 116.414 -0.357 . . . . 70.33 111.141 -166.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.496 HD12 ' HG3' ' C' ' 130' ' ' PRO . 73.4 mt -120.3 138.51 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 124.37 1.068 . . . . 75.04 108.969 173.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -158.37 176.08 12.9 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 124.288 0.992 . . . . 71.1 111.511 -171.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.0 p -106.13 119.4 39.11 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.657 -1.238 . . . . 72.24 107.657 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -80.02 -48.58 13.09 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.841 -0.8 . . . . 71.2 108.841 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 22.7 m-20 -134.55 125.23 26.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.611 -1.177 . . . . 61.34 109.014 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 79.3 mt -117.62 144.28 25.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 106.775 -1.565 . . . . 61.0 106.775 173.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 43.2 t -152.41 142.16 21.95 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.102 0.477 . . . . 60.22 109.777 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 35.4 t80 -144.33 124.09 13.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.802 -1.555 . . . . 62.23 106.802 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.97 111.55 10.51 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.312 -0.996 . . . . 72.53 108.312 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.22 81.71 17.24 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.903 0.881 . . . . 74.41 109.274 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 72' ' ' THR . 22.0 Cg_exo -66.99 -14.46 43.76 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.077 2.518 . . . . 75.32 112.328 174.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.5 ' HB2' ' HA ' ' A' ' 73' ' ' ALA . 21.9 m-80 -117.35 30.15 7.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.853 0.861 . . . . 63.13 110.395 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.52 98.23 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 123.717 0.807 . . . . 53.3 113.006 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -85.12 -24.8 1.95 Allowed 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 121.644 1.563 . . . . 63.31 113.188 169.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.479 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 58.9 m170 -70.97 -34.72 71.7 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.123 0.569 . . . . 73.55 110.922 -173.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -55.86 -31.77 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.495 1.118 . . . . 72.44 112.388 -175.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.67 -32.82 70.22 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.652 0.781 . . . . 64.33 111.347 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -88.84 -45.2 9.93 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.132 0.973 . . . . 74.43 111.647 -174.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 16.1 ptpt -83.32 173.59 11.44 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.821 0.848 . . . . 72.14 111.548 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -74.27 142.7 45.24 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.565 0.746 . . . . 53.11 111.514 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -93.2 78.65 4.52 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.522 0.677 . . . . 70.33 109.832 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -125.86 79.98 67.83 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.363 -0.977 . . . . 74.43 108.363 169.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -84.15 136.23 6.72 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.354 2.036 . . . . 73.52 112.315 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -96.44 102.05 13.77 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.154 -1.424 . . . . 60.34 107.154 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.421 ' O ' ' HB1' ' E' ' 466' ' ' ALA . 5.7 p -76.87 100.1 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 115.451 -0.795 . . . . 74.12 109.98 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 63.3 mttp -78.98 111.02 14.76 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.74 -1.208 . . . . 70.1 107.74 164.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.495 HD13 HG22 ' A' ' 64' ' ' VAL . 33.4 tp -109.48 133.31 53.23 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.895 -1.15 . . . . 71.42 107.895 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.408 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 24.4 t70 -135.93 129.42 32.18 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.91 -0.774 . . . . 75.41 108.91 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.2 mt -112.12 132.05 55.09 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.903 0.881 . . . . 73.5 109.013 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.76 147.73 52.46 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.709 0.803 . . . . 73.45 108.85 172.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.0 m -131.49 131.78 43.73 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.553 0.741 . . . . 53.22 109.825 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.82 154.34 50.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.144 0.978 . . . . 72.21 110.115 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.675 ' HB3' HD13 ' E' ' 454' ' ' LEU . 26.5 t -131.87 155.77 47.26 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.731 0.413 . . . . 73.41 110.284 174.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.7 p -148.76 141.21 24.27 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.572 0.749 . . . . 74.41 109.911 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -81.68 106.68 13.81 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.734 0.414 . . . . 74.35 110.479 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' A' ' 57' ' ' GLU . 34.1 mt -83.3 -36.3 24.58 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.263 -0.643 . . . . 71.11 109.263 173.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.82 177.27 11.6 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.765 1.226 . . . . 71.33 108.647 173.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -68.5 116.31 8.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.012 -0.736 . . . . 63.23 109.012 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 70.6 12.24 7.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.811 1.244 . . . . 75.1 112.476 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 42.8 t -120.38 112.41 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 107.71 -1.218 . . . . 65.12 107.71 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.81 134.43 45.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.464 0.706 . . . . 74.45 110.469 -169.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.6 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.5 tt0 -88.17 137.5 32.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.503 -0.925 . . . . 74.44 108.503 173.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.9 136.67 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.517 -1.29 . . . . 72.41 107.517 168.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.6 111.64 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.18 0.992 . . . . 71.13 108.69 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.3 tp -92.23 102.3 14.81 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.168 -1.049 . . . . 65.21 108.168 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -84.33 106.76 16.19 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.002 -0.74 . . . . 75.3 109.002 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.404 HG11 HD11 ' A' ' 128' ' ' LEU . 43.0 t -104.35 103.97 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.834 -0.802 . . . . 54.32 108.834 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.59 HG22 ' HG3' ' A' ' 77' ' ' GLU . 74.9 p -100.35 111.96 24.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.487 0.715 . . . . 44.51 109.977 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.495 HG22 HD13 ' A' ' 42' ' ' LEU . 92.3 t -102.9 113.83 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.059 0.944 . . . . 74.14 108.858 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 10.8 m -116.66 105.62 12.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.741 -0.837 . . . . 75.12 108.741 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.27 106.36 18.01 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 106.378 -1.712 . . . . 71.42 106.378 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 p -149.29 128.67 12.97 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.822 0.702 . . . . 71.45 110.171 -168.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.6 tp -91.3 87.22 6.39 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.678 -0.86 . . . . 52.3 108.678 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.45 -93.31 1.86 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 114.849 -1.069 . . . . 33.14 111.724 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -113.62 -27.24 7.92 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.031 0.532 . . . . 73.4 111.526 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -79.58 106.62 11.75 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 122.421 0.288 . . . . 73.24 110.226 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.418 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 26.8 m -76.1 116.53 16.89 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.682 -0.69 . . . . 73.1 109.327 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . . . -68.03 -50.87 52.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.911 0.884 . . . . 72.43 108.768 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.463 ' HB2' ' HE1' ' A' ' 23' ' ' PHE . 47.3 p90 -156.78 147.58 21.74 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.982 -1.463 . . . . 74.33 109.863 173.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 53.8 tp -123.02 107.85 12.26 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 107.622 -1.251 . . . . 75.33 107.622 175.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.434 ' HA ' ' SD ' ' A' ' 117' ' ' MET . 79.8 m -106.85 99.31 8.88 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.296 0.639 . . . . 72.32 109.729 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.59 ' HG3' HG22 ' A' ' 63' ' ' THR . 32.4 tt0 -115.08 118.28 32.94 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.901 0.88 . . . . 72.52 109.309 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.4 t -130.2 109.27 17.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.617 0.722 . . . . 74.33 109.459 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -86.44 80.26 8.72 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.137 -1.392 . . . . 71.25 108.147 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -76.93 111.65 12.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.875 -1.057 . . . . 73.3 108.622 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.17 144.07 17.03 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.829 -0.508 . . . . 71.31 111.829 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.0 145.11 15.55 Favored Glycine 0 C--O 1.236 0.247 0 N-CA-C 111.283 -0.727 . . . . 63.5 111.283 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.4 mt -81.32 123.38 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 108.488 -0.93 . . . . 73.21 108.488 173.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.661 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.1 m-85 -130.18 116.35 18.31 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.804 -0.813 . . . . 71.04 108.804 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.7 p -85.7 102.98 14.08 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.203 -1.036 . . . . 75.53 108.203 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.0 pt -115.36 130.98 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.908 0.883 . . . . 74.41 109.096 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.22 147.0 30.99 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.908 0.883 . . . . 55.15 109.963 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.66 1.56 57.58 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 115.007 0.763 . . . . 62.44 115.007 171.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.53 154.72 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 118.105 0.952 . . . . 74.53 111.369 -176.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.6 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 10.8 tt0 -155.02 -174.68 5.08 Favored 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 123.931 0.892 . . . . 64.4 109.3 173.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.6 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 73.2 -139.02 26.24 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 123.331 0.491 . . . . 63.42 114.188 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.1 p -73.88 -20.88 60.28 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.441 0.696 . . . . 62.21 111.233 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -66.48 -48.14 70.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.854 0.862 . . . . 61.11 110.114 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 91' ' ' GLY . 24.7 ptt? -70.03 -30.95 68.37 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 116.136 -0.484 . . . . 63.43 110.342 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.24 -34.55 77.69 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.158 0.583 . . . . 64.45 110.56 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -71.85 -35.88 69.97 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.39 -0.823 . . . . 65.03 110.11 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.502 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 49.9 t -66.88 -43.29 83.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.962 0.505 . . . . 72.13 111.346 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.424 HD22 HD11 ' E' ' 454' ' ' LEU . 3.6 pp -82.83 -38.19 23.37 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.258 -0.428 . . . . 74.43 110.785 -175.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.91 3.03 57.06 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 114.365 0.506 . . . . 65.4 114.365 -169.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -146.87 -60.24 0.29 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.182 0.491 . . . . 51.2 111.577 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.502 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 77.2 t80 -68.89 -49.56 57.2 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.25 1.02 . . . . 71.33 113.126 -166.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.08 -34.46 0.95 Allowed Pre-proline 0 CA--C 1.565 1.55 0 N-CA-C 113.513 0.931 . . . . 74.11 113.513 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.24 -21.11 55.39 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 121.601 1.534 . . . . 42.14 113.184 165.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 3.6 m120 -62.1 -38.69 89.85 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 118.197 0.453 . . . . 73.31 110.211 169.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.0 mm -63.04 -45.37 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 O-C-N 124.004 0.815 . . . . 74.13 110.138 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.56 -20.13 51.27 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.01 0.924 . . . . 74.43 112.781 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -62.8 -45.32 87.65 Favored Pre-proline 0 CA--C 1.569 1.705 0 N-CA-C 113.719 1.007 . . . . 75.32 113.719 -173.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -63.71 -36.15 53.65 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.1 1.867 . . . . 64.01 113.459 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -71.11 -40.45 71.46 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.018 0.527 . . . . 72.42 111.156 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.62 -43.97 83.33 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.307 0.643 . . . . 72.2 110.003 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' HG3' ' H ' ' A' ' 128' ' ' LEU . 38.1 ttm180 -51.59 -51.43 55.64 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.612 1.195 . . . . 62.44 110.509 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.22 -41.9 96.81 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.439 1.087 . . . . 74.21 111.556 -175.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.17 -29.42 69.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 116.095 -0.502 . . . . 72.44 111.412 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.6 mt -78.63 -40.14 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.359 1.063 . . . . 61.44 110.331 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.467 HG23 ' HG3' ' A' ' 125' ' ' GLN . 34.4 m -66.53 -43.55 84.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 121.46 0.648 . . . . 75.4 110.638 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.5 t -64.43 -44.44 91.19 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.033 -0.985 . . . . 74.52 109.519 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.434 ' SD ' ' HA ' ' A' ' 76' ' ' CYS . 43.2 ttm -60.27 -46.53 89.48 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.229 1.012 . . . . 52.52 112.242 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 123' ' ' PHE . 7.2 p -69.71 -31.05 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.133 0.573 . . . . 62.45 110.616 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.2 m -77.06 -29.73 55.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.425 0.69 . . . . 71.41 111.213 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -70.77 -31.92 68.87 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.626 0.77 . . . . 74.44 109.832 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.23 -2.26 90.4 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-N 115.779 -0.646 . . . . 62.02 113.209 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.9 m 65.34 36.53 6.86 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-O 122.824 1.297 . . . . 73.21 110.939 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.473 ' HB2' HG22 ' A' ' 118' ' ' VAL . 95.9 m-85 -104.91 164.39 15.26 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.308 1.043 . . . . 63.23 108.904 171.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -59.59 153.35 55.83 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 122.322 2.014 . . . . 63.23 112.504 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.467 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.7 tt0 -63.77 139.12 58.74 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.447 0.699 . . . . 61.02 111.16 -177.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.6 tp -131.3 116.42 17.58 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.307 -0.861 . . . . 73.42 109.093 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -121.03 117.83 28.25 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.252 -1.018 . . . . 74.43 108.252 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.438 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 85.9 mt -59.78 122.32 13.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.312 0.645 . . . . 65.3 110.082 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -61.57 128.65 90.4 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-O 119.17 -0.443 . . . . 63.12 109.881 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 26.3 Cg_exo -64.18 100.23 0.31 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.657 2.238 . . . . 61.2 111.584 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.3 m -100.06 138.0 25.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-N 115.623 -0.717 . . . . 43.24 109.441 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -83.1 87.46 6.91 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.079 -0.964 . . . . 74.42 109.046 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.497 ' HA ' HD12 ' A' ' 136' ' ' LEU . 58.4 m-85 -56.03 -27.49 53.38 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.642 0.777 . . . . 74.31 112.559 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.21 -51.29 61.88 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.017 0.527 . . . . 72.05 110.25 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.52 85.63 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.007 0.817 . . . . 60.34 110.896 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 133' ' ' PHE . 61.1 mt -67.52 -38.68 84.62 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.159 0.983 . . . . 74.02 111.06 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.7 -38.54 86.94 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.716 -0.675 . . . . 74.45 109.495 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 19.8 mmt -63.18 -41.6 99.24 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 124.221 0.951 . . . . 61.2 110.34 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.63 ' HA ' ' HB3' ' A' ' 143' ' ' GLN . 52.9 m-80 -54.22 -47.25 72.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 123.743 0.652 . . . . 70.32 110.403 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -67.36 -37.11 82.68 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.177 -0.92 . . . . 52.01 111.303 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.02 -56.03 8.01 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.992 0.917 . . . . 63.22 112.304 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -166.06 -11.62 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 123.955 0.902 . . . . 75.44 112.479 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.63 ' HB3' ' HA ' ' A' ' 139' ' ' ASN . 0.8 OUTLIER -65.59 107.36 1.7 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.519 0.728 . . . . 73.21 109.609 -174.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -134.98 -163.87 1.44 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.938 1.295 . . . . 63.12 109.025 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.3 94.16 0.08 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.041 0.448 . . . . 72.43 110.4 175.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.72 119.29 0.69 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 110.923 -0.871 . . . . 44.54 110.923 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -110.12 133.19 53.47 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.233 0.613 . . . . 71.34 111.627 -171.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -92.53 93.64 1.8 Allowed Glycine 0 C--N 1.351 1.393 0 N-CA-C 112.161 -0.376 . . . . 71.44 112.161 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.3 m -134.09 161.0 36.07 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.959 0.903 . . . . 63.11 110.099 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.18 175.87 5.67 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.336 0.654 . . . . 74.24 111.236 175.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -124.2 -15.41 6.77 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.592 0.757 . . . . 74.54 111.787 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -166.12 141.37 4.68 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.833 -0.803 . . . . 63.12 108.833 -174.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -166.24 94.11 0.53 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.299 -1.0 . . . . 75.35 108.299 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -122.94 -71.47 0.72 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.658 0.783 . . . . 71.04 109.06 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.883 0 N-CA-C 107.751 -1.203 . . . . 55.12 107.751 175.272 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.438 -0.579 . . . . 61.22 109.438 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 65.5 p -136.14 160.28 39.13 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.203 0.601 . . . . 75.14 111.071 -176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.11 117.82 35.07 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.026 -0.731 . . . . 60.13 109.026 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -80.27 -25.64 39.36 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.486 0.715 . . . . 73.23 111.368 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -80.43 88.78 5.59 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.401 0.62 . . . . 62.41 109.559 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -102.27 82.65 2.22 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.461 -0.94 . . . . 63.15 108.461 173.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -84.29 -42.73 15.53 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.288 -0.869 . . . . 73.41 109.76 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -119.19 -42.8 2.66 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.798 -0.637 . . . . 64.34 112.393 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.413 ' SD ' HG23 ' B' ' 89' ' ' ILE . 0.8 OUTLIER 66.48 164.62 0.19 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.437 1.095 . . . . 70.15 111.287 -167.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 87.1 m -155.28 133.9 11.92 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.199 0.999 . . . . 64.41 109.457 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -129.52 137.64 50.9 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.588 -0.893 . . . . 72.12 108.588 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -149.92 130.79 14.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.084 -0.71 . . . . 72.14 109.084 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.453 HD11 HD13 ' B' ' 105' ' ' ILE . 20.6 mt -76.52 118.09 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.738 -1.208 . . . . 74.34 107.738 166.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -86.22 -49.36 7.77 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.665 -0.865 . . . . 72.22 108.665 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.411 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 74.1 ttt180 -164.99 138.27 4.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.867 -1.061 . . . . 72.21 109.069 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.9 mt -115.6 141.92 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.321 -0.992 . . . . 74.13 108.321 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -164.12 147.2 9.45 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.767 0.427 . . . . 73.21 111.321 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.698 HG21 HD11 ' B' ' 21' ' ' ILE . 24.5 m -78.57 130.45 35.95 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.197 -1.038 . . . . 71.34 108.197 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -93.17 -47.48 6.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.58 0.752 . . . . 71.33 110.083 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.33 141.05 39.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.162 -0.927 . . . . 62.33 110.856 -171.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.698 HD11 HG21 ' B' ' 18' ' ' THR . 48.4 mm -131.44 144.91 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.914 1.286 . . . . 74.03 108.26 171.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.517 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.7 t -145.63 129.12 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.077 -1.453 . . . . 72.42 107.077 173.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.3 t80 -143.31 107.04 4.63 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 106.517 -1.66 . . . . 74.42 106.517 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -118.1 112.51 20.3 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.079 -1.082 . . . . 73.34 108.079 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.3 85.46 2.15 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.939 -1.504 . . . . 61.54 106.939 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.96 -26.21 26.88 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.92 2.413 . . . . 64.35 112.156 -166.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -114.4 15.47 17.94 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.979 -1.009 . . . . 62.45 110.34 -175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.88 -61.99 0.97 Allowed Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 115.19 1.552 . . . . 64.31 115.19 -163.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.62 -27.05 39.14 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 121.831 1.687 . . . . 74.22 113.023 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -89.01 -38.87 14.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.994 0.518 . . . . 71.22 111.733 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.787 HG21 ' HA ' ' B' ' 73' ' ' ALA . 13.3 p -69.71 -16.09 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.209 0.604 . . . . 72.42 111.128 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -68.33 -4.07 13.18 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.483 0.713 . . . . 74.54 112.791 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.503 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.4 pt20 -68.34 -23.41 64.7 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.919 0.487 . . . . 72.12 110.219 168.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.503 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 86.7 mttt -107.88 79.02 1.23 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.829 1.251 . . . . 74.13 108.648 177.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -80.12 86.51 5.55 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.717 0.77 . . . . 75.34 109.35 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.0 t-105 -150.87 155.9 40.12 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.891 1.276 . . . . 72.34 107.594 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -70.76 99.99 0.26 Allowed Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 125.916 1.686 . . . . 74.42 110.576 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.621 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 49.0 Cg_endo -67.65 137.43 42.32 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.557 2.171 . . . . 73.23 112.535 -173.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -54.89 123.33 13.11 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.04 0.838 . . . . 73.54 109.764 173.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -104.33 157.19 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.443 0.64 . . . . 73.11 111.682 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -142.14 127.7 19.04 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.565 -1.643 . . . . 54.15 106.565 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.586 ' H ' HD23 ' B' ' 42' ' ' LEU . 2.6 pt? -104.41 151.88 22.98 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.834 0.453 . . . . 73.42 110.607 -175.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.426 ' HA ' ' OH ' ' F' ' 462' ' ' TYR . 13.0 t70 -143.19 116.19 8.85 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.603 -0.888 . . . . 75.45 108.603 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.43 ' O ' ' HG ' ' F' ' 460' ' ' LEU . 63.7 mt -99.26 156.9 16.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.716 0.406 . . . . 33.51 110.166 -174.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.487 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 11.6 m-20 -141.57 111.39 6.63 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.121 -1.066 . . . . 75.51 108.121 167.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -109.82 104.06 12.95 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.74 -0.467 . . . . 71.51 109.74 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.84 152.78 34.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.237 1.015 . . . . 62.34 109.434 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 m -137.58 161.84 35.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.033 0.533 . . . . 73.03 109.916 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -163.32 160.85 24.22 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.059 0.543 . . . . 73.41 110.241 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -91.47 123.03 34.58 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.124 0.57 . . . . 75.34 110.273 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 81.1 mt -87.33 -43.77 11.9 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.718 0.807 . . . . 72.03 109.107 167.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.61 -170.54 3.11 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.58 -1.191 . . . . 74.51 110.033 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.98 111.95 2.38 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.598 -0.728 . . . . 73.2 110.429 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 43.7 m-20 70.23 0.38 3.14 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.256 1.423 . . . . 74.0 112.838 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.8 t -104.18 102.88 14.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.526 -0.916 . . . . 62.02 108.526 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -99.73 146.99 25.92 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.64 -1.164 . . . . 74.31 109.643 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -109.4 116.55 32.03 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.465 -1.309 . . . . 51.42 107.465 165.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.437 HG11 ' HD3' ' B' ' 103' ' ' PRO . 52.3 t -96.01 143.37 12.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.526 -0.916 . . . . 75.32 108.526 172.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.2 t -131.89 137.36 55.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.959 -0.756 . . . . 65.41 108.959 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.85 109.59 14.38 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.176 -1.416 . . . . 75.44 107.176 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 40.7 ttm180 -95.25 130.94 41.8 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.543 -0.54 . . . . 61.21 109.543 170.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 37.0 t -120.62 106.13 18.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.192 -1.41 . . . . 74.34 107.192 169.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -96.13 146.62 24.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.11 -1.07 . . . . 75.15 108.11 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 71.1 t -138.4 130.12 37.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.284 1.034 . . . . 73.31 108.466 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 98.3 m -117.39 136.95 52.81 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.385 -0.969 . . . . 70.51 108.385 172.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.12 143.79 50.25 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.473 0.483 . . . . 74.11 110.289 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 44.3 p -133.68 127.03 32.05 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 123.959 0.787 . . . . 74.22 110.771 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.621 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 34.1 mt -105.88 114.64 28.9 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.116 0.966 . . . . 74.4 108.697 171.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.37 -111.73 3.94 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.537 -1.025 . . . . 54.42 110.537 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.23 4.58 11.28 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.527 0.731 . . . . 72.13 111.027 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -114.47 160.64 18.97 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.424 0.69 . . . . 75.31 109.583 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.3 m -72.24 135.07 45.94 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.543 -0.54 . . . . 64.43 109.543 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.787 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -88.72 -59.62 2.18 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.411 -0.959 . . . . 52.22 108.411 175.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.638 ' HZ ' HD11 ' B' ' 126' ' ' LEU . 52.5 p90 -151.96 170.08 20.74 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 113.973 -1.467 . . . . 74.32 109.821 176.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.7 mt -133.05 138.86 46.9 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.878 -1.897 . . . . 72.33 105.878 173.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' B' ' 114' ' ' ILE . 38.0 t -141.1 150.95 43.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.882 -0.784 . . . . 63.53 108.882 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.8 tt0 -164.37 132.55 3.45 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.034 -0.728 . . . . 62.21 109.034 -175.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 98.6 t -128.94 147.67 33.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.474 -0.936 . . . . 74.33 108.474 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -123.15 93.13 3.86 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.293 -1.002 . . . . 73.13 108.293 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.481 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.9 tp-100 -82.79 100.89 10.58 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.702 -1.135 . . . . 54.32 109.014 177.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.51 163.73 31.36 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 111.02 -0.832 . . . . 74.44 111.02 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.3 128.23 1.73 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.936 -0.866 . . . . 52.24 110.936 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 30.8 mt -84.6 133.65 28.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.619 0.768 . . . . 62.01 109.077 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' B' ' 102' ' ' CYS . 22.8 m-85 -138.04 135.52 35.96 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.033 -0.728 . . . . 75.0 109.033 174.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -97.44 107.97 20.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.57 0.748 . . . . 73.3 108.995 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 43.0 pt -111.79 145.06 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.758 0.823 . . . . 74.14 110.377 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.511 ' HA ' HG11 ' F' ' 451' ' ' VAL . . . -144.32 158.1 43.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.702 0.801 . . . . 74.24 109.741 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.08 -65.14 4.12 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.557 0.536 . . . . 63.45 112.574 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.42 HD11 ' HB ' ' B' ' 86' ' ' ILE . 25.7 pt -58.15 144.01 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.225 1.01 . . . . 52.45 112.491 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -150.66 149.88 30.4 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.246 -0.888 . . . . 72.33 109.458 -171.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.3 -115.6 8.13 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.905 0.753 . . . . 54.13 113.013 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 24.7 m -67.14 -31.43 71.87 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.824 0.85 . . . . 73.14 112.003 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -65.93 -47.82 73.43 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.191 0.596 . . . . 74.11 110.81 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.538 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 12.3 ptp -72.91 -29.47 63.16 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-O 119.077 -0.487 . . . . 73.4 110.113 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.89 -32.16 71.63 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.824 0.45 . . . . 52.04 111.053 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.42 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 28.0 t-80 -72.42 -30.44 64.62 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.961 0.504 . . . . 62.23 110.971 174.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.595 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 85.9 m -76.71 -71.69 0.38 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 110.385 -0.228 . . . . 74.2 110.385 176.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.4 pp -71.42 -14.41 62.15 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.384 0.883 . . . . 60.54 113.384 -171.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.89 0.33 36.04 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-O 119.488 -0.618 . . . . 71.12 113.93 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -152.42 -62.1 0.16 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.741 0.771 . . . . 61.52 112.4 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.595 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 90.0 t80 -70.18 -47.28 62.25 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.101 0.96 . . . . 74.52 112.205 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.465 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 71.5 m -62.7 -49.15 84.01 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.15 0.98 . . . . 65.23 111.428 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 86.3 Cg_exo -54.05 -35.33 81.0 Favored 'Trans proline' 0 C--N 1.397 3.099 0 C-N-CA 122.043 1.829 . . . . 64.35 114.128 167.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -62.9 -37.26 86.25 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 123.202 0.601 . . . . 75.13 110.468 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.453 HD13 HD11 ' B' ' 13' ' ' ILE . 68.1 mt -66.18 -41.83 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.958 0.903 . . . . 74.33 110.458 174.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 67.5 mt -78.73 -19.19 52.92 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.427 -0.806 . . . . 55.12 112.12 -175.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -58.79 -49.15 94.98 Favored Pre-proline 0 N--CA 1.483 1.214 0 CA-C-O 117.829 -1.081 . . . . 72.04 113.515 -171.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.41 -38.26 89.39 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.194 1.929 . . . . 74.55 113.723 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.481 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 83.4 m-85 -68.53 -48.66 63.75 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 123.516 0.51 . . . . 73.42 110.527 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.34 -42.25 91.04 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.557 0.743 . . . . 74.53 111.304 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 54.3 ttt-85 -61.58 -53.22 59.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.802 1.641 . . . . 73.25 110.946 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -68.27 -30.27 69.26 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.987 0.805 . . . . 64.12 110.198 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.489 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.4 t -69.0 -41.11 78.26 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.833 0.453 . . . . 73.43 111.131 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.462 HG23 ' SG ' ' B' ' 76' ' ' CYS . 73.0 mt -60.55 -52.4 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.609 -0.515 . . . . 74.54 109.609 172.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.4 HG21 ' OG ' ' C' ' 119' ' ' SER . 62.9 m -56.12 -34.45 66.09 Favored 'General case' 0 CA--C 1.554 1.124 0 O-C-N 124.477 1.111 . . . . 70.34 111.988 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.6 t -66.72 -49.06 67.26 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 123.229 0.612 . . . . 65.4 109.873 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.503 ' SD ' HG21 ' A' ' 21' ' ' ILE . 34.5 mmt -61.5 -41.41 97.25 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.095 0.558 . . . . 72.21 111.155 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 78.2 t -62.77 -43.7 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.427 1.091 . . . . 70.34 110.851 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.8 t -65.65 -36.84 84.83 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.821 -1.081 . . . . 72.0 111.607 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -67.69 -36.74 81.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.026 -0.988 . . . . 61.41 110.47 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.51 6.99 59.35 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.334 -0.703 . . . . 63.24 113.084 176.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 72.0 p 59.38 22.0 10.38 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.378 1.871 . . . . 61.14 113.332 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -85.13 151.79 57.56 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.61 0.764 . . . . 73.4 109.963 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.36 156.98 3.5 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 124.242 3.294 . . . . 73.44 116.328 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -65.86 117.8 8.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.229 -1.35 . . . . 73.11 111.844 -173.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.638 HD11 ' HZ ' ' B' ' 74' ' ' PHE . 22.5 mt -113.44 120.26 40.42 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.029 -0.73 . . . . 54.32 109.029 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -123.21 96.22 4.91 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 107.895 -1.15 . . . . 72.54 107.895 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.549 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.1 mm? -61.72 149.82 38.56 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.825 0.85 . . . . 73.43 112.334 -168.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.63 151.25 87.02 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.987 0.915 . . . . 64.21 110.659 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.95 104.81 1.41 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.501 2.134 . . . . 72.13 111.634 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.0 t -90.57 108.66 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.277 -1.008 . . . . 62.44 108.277 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -90.07 98.36 11.73 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.1 -1.074 . . . . 71.01 108.1 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -61.92 -32.97 73.42 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.289 -0.869 . . . . 74.53 111.41 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.33 -39.3 78.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.716 1.207 . . . . 71.01 111.823 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.17 -41.17 90.67 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.312 0.645 . . . . 51.41 110.207 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.28 -37.27 85.05 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.685 -1.143 . . . . 72.55 110.965 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.466 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 60.3 t80 -69.32 -36.49 77.02 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.64 0.776 . . . . 73.3 110.668 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -62.37 -38.27 88.9 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.116 0.567 . . . . 44.33 110.291 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -75.44 -28.24 59.24 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.475 -0.784 . . . . 74.43 110.854 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -61.36 -44.75 96.64 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.074 0.549 . . . . 62.44 110.501 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 15.5 mt -83.63 -9.63 58.76 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.549 -0.75 . . . . 71.23 111.756 -171.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -139.76 111.29 7.18 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.299 0.639 . . . . 71.4 109.947 -172.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -70.4 -28.47 65.1 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.42 -0.585 . . . . 73.22 109.42 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -57.01 97.79 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.088 0.955 . . . . 74.42 110.155 173.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.69 130.18 36.48 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.748 -0.834 . . . . 65.01 108.748 172.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.71 146.37 4.4 Favored Glycine 0 C--O 1.241 0.542 0 N-CA-C 111.072 -0.811 . . . . 70.52 111.072 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -164.78 175.83 9.31 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.116 0.566 . . . . 73.35 110.158 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 141.99 176.94 16.62 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 116.065 -0.516 . . . . 74.05 112.179 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.596 HG23 ' HB3' ' D' ' 6' ' ' ASN . 3.0 t -141.97 144.54 33.76 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.428 0.691 . . . . 73.41 110.727 -173.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.46 130.22 34.96 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.803 -0.814 . . . . 74.3 108.803 172.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.524 ' HG2' ' H ' ' B' ' 152' ' ' HIS . 29.6 tt0 -155.01 -176.41 5.92 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.534 -0.914 . . . . 52.14 108.534 -172.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . 0.524 ' H ' ' HG2' ' B' ' 151' ' ' GLU . 68.9 m80 -132.24 135.09 46.04 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.636 -0.665 . . . . 73.12 109.679 175.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -75.75 113.86 13.69 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.977 0.911 . . . . 72.42 109.353 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -65.03 -70.27 0.24 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 109.172 -0.677 . . . . 74.32 109.172 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 N-CA-C 108.326 -0.99 . . . . 74.52 108.326 -178.06 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 109.931 -0.396 . . . . 73.24 109.931 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 10.4 m -68.15 97.17 0.68 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.847 0.859 . . . . 54.13 110.295 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -119.35 156.69 29.6 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.837 0.855 . . . . 54.12 109.972 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -154.72 -70.12 0.13 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.042 -0.526 . . . . 62.55 110.03 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -91.53 58.64 3.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.549 0.739 . . . . 61.1 110.411 -173.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -79.95 -47.21 15.37 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.922 0.889 . . . . 74.25 108.978 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -157.93 150.76 22.79 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 114.262 -1.336 . . . . 73.45 108.545 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.04 140.27 48.92 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.931 -0.766 . . . . 74.23 108.931 172.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.408 ' SD ' HD13 ' C' ' 89' ' ' ILE . 45.7 ttp 63.26 112.53 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.977 1.311 . . . . 74.52 110.875 -167.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.735 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 64.4 m -101.0 97.26 7.85 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.04 -1.096 . . . . 64.12 108.04 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.566 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 44.9 t80 -102.02 128.93 48.24 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.556 -0.905 . . . . 72.04 108.556 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -137.56 126.35 23.94 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.949 -0.76 . . . . 72.11 108.949 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 83.8 mt -77.38 122.17 31.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.659 -0.867 . . . . 73.03 108.659 172.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -91.15 -39.22 12.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.228 -0.896 . . . . 63.43 109.712 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -172.59 144.75 1.48 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.101 -0.703 . . . . 70.04 109.101 -173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 92.3 mt -134.07 137.69 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.769 -1.197 . . . . 72.11 107.769 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.453 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 32.2 p90 -169.58 171.94 7.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.872 0.844 . . . . 73.43 111.458 -173.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.1 p -96.77 118.35 33.02 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.222 -0.899 . . . . 72.5 109.061 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.543 ' HE3' ' HA3' ' C' ' 81' ' ' GLY . 21.5 mmtp -67.37 -48.97 65.88 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.66 -1.237 . . . . 74.41 107.66 171.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -137.61 142.92 41.25 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 112.974 -1.921 . . . . 72.32 109.6 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.498 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 76.0 mt -136.5 144.07 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 106.283 -1.747 . . . . 71.12 106.283 172.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -160.51 146.92 15.39 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.372 0.606 . . . . 73.41 110.824 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -139.03 135.13 33.91 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.2 -1.407 . . . . 75.12 107.2 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.431 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 38.8 mt-10 -135.36 114.45 12.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.729 0.812 . . . . 64.21 109.988 -176.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.86 83.88 33.63 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 107.112 -1.44 . . . . 61.22 107.112 170.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -70.34 -19.85 32.83 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.048 2.499 . . . . 72.44 112.684 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -116.33 24.85 11.07 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.775 1.23 . . . . 72.34 110.06 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.87 -57.66 5.68 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 114.483 1.29 . . . . 73.31 114.483 -169.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.3 -36.56 55.74 Favored 'Trans proline' 0 C--N 1.388 2.655 0 CA-C-N 121.542 1.586 . . . . 71.24 112.172 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.534 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 68.3 t60 -69.9 -32.99 71.61 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.417 -0.81 . . . . 64.24 112.36 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.754 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.0 p -81.54 -22.12 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 N-CA-C 112.731 0.641 . . . . 44.44 112.731 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -64.33 -23.79 67.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.628 -0.67 . . . . 72.34 112.682 175.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.6 pt20 -88.48 8.32 28.56 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 122.952 0.501 . . . . 73.23 111.301 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' C' ' 31' ' ' VAL . 1.1 mptm? -92.52 177.87 5.99 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 122.255 1.026 . . . . 64.15 113.24 -172.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -87.47 114.04 23.72 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 112.905 -1.952 . . . . 73.23 108.074 168.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.473 ' CZ2' HD11 ' G' ' 470' ' ' LEU . 51.5 t90 -84.48 71.32 10.73 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.742 0.782 . . . . 72.21 110.939 -174.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -132.92 69.59 79.01 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 123.966 0.906 . . . . 63.15 109.034 170.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.529 ' HD2' HD13 ' G' ' 470' ' ' LEU . 9.8 Cg_endo -87.95 158.05 7.3 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.046 2.497 . . . . 62.23 113.73 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.97 96.43 8.84 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 107.284 -1.376 . . . . 64.51 107.284 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 m -79.28 128.25 38.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-O 121.705 0.764 . . . . 63.35 110.373 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -132.65 113.54 13.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.503 1.121 . . . . 62.31 108.338 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.64 HD12 ' SD ' ' G' ' 464' ' ' MET . 72.2 mt -86.0 158.79 19.78 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.825 -0.806 . . . . 75.23 108.825 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.7 t70 -137.4 105.14 5.58 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.602 -1.258 . . . . 73.32 107.602 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.27 129.49 43.58 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.044 -0.724 . . . . 75.33 109.044 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -144.24 125.01 14.16 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.57 -0.9 . . . . 74.32 108.57 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.427 ' H ' HD23 ' G' ' 460' ' ' LEU . 5.2 t -116.46 139.78 50.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.447 -0.575 . . . . 61.3 109.447 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.45 135.61 37.03 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.106 0.962 . . . . 71.01 108.406 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 13.0 p -136.38 151.12 49.21 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 109.314 -0.625 . . . . 54.5 109.314 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 70.0 p -156.65 143.73 18.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.369 0.668 . . . . 74.03 109.765 -174.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -78.93 118.1 20.63 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.326 0.65 . . . . 64.13 109.991 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' C' ' 57' ' ' GLU . 68.8 mt -89.26 -29.73 19.0 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.05 0.54 . . . . 72.32 110.13 174.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.47 172.67 16.81 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.787 1.235 . . . . 45.53 109.034 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -57.37 128.58 37.75 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.842 -0.799 . . . . 72.11 108.842 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 69.48 -1.85 2.1 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.42 1.088 . . . . 73.05 113.015 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -111.95 117.56 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.338 0.655 . . . . 72.14 109.373 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -124.85 126.46 45.61 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.041 0.936 . . . . 51.4 109.983 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.574 ' HB2' HD11 ' C' ' 51' ' ' LEU . 21.5 tt0 -83.62 133.0 34.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.936 -1.135 . . . . 73.42 107.936 165.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.47 140.35 47.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 N-CA-C 108.842 -0.799 . . . . 65.35 108.842 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 81.6 t -124.56 133.18 70.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 124.838 1.255 . . . . 72.11 107.629 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.2 104.81 8.71 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.237 -1.394 . . . . 71.1 107.237 174.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.464 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 1.9 ttm180 -86.69 130.01 34.65 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 113.886 -1.506 . . . . 61.21 109.127 177.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.1 124.81 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.458 -1.312 . . . . 73.01 107.458 171.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 32.7 m -124.52 131.18 53.49 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.855 -0.794 . . . . 64.52 108.855 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.477 HG23 HD13 ' C' ' 114' ' ' ILE . 23.4 t -107.49 126.65 63.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.003 -0.74 . . . . 55.13 109.003 173.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.411 HG23 HD23 ' C' ' 75' ' ' LEU . 5.2 m -116.25 145.43 43.15 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.935 -1.135 . . . . 75.43 107.935 173.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.54 128.02 20.08 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.053 -0.721 . . . . 41.51 109.053 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.8 m -128.01 126.03 40.54 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 123.196 0.598 . . . . 73.0 110.141 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 39.5 mt -88.47 37.7 0.84 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.589 1.156 . . . . 65.31 110.198 172.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.6 -96.08 1.52 Allowed Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.374 -1.09 . . . . 70.35 110.374 -173.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -107.1 -5.46 18.01 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.313 1.045 . . . . 65.03 110.839 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.43 ' HG2' ' HZ3' ' C' ' 34' ' ' LYS . 4.0 tp10 -103.17 121.14 42.04 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.526 1.131 . . . . 63.11 109.062 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 35.6 m -69.32 126.95 31.36 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.779 0.718 . . . . 70.45 109.07 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.754 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.42 -54.64 6.44 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.093 -0.706 . . . . 55.21 109.093 175.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -169.08 168.87 9.79 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 114.836 -1.074 . . . . 74.22 111.097 175.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -140.08 143.83 36.51 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 106.883 -1.525 . . . . 64.5 106.883 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.404 ' N ' HD13 ' C' ' 75' ' ' LEU . 43.8 t -153.24 116.19 4.55 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.726 -0.472 . . . . 63.12 109.726 175.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -117.6 133.01 56.41 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.722 0.409 . . . . 74.31 110.086 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 84.6 t -126.57 138.07 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.225 1.01 . . . . 64.34 108.39 168.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.464 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 66.7 mt-30 -115.11 97.14 6.04 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.349 -0.982 . . . . 72.32 108.349 173.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -86.63 104.52 16.13 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.572 0.749 . . . . 62.22 110.683 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.543 ' HA3' ' HE3' ' C' ' 19' ' ' LYS . . . -110.42 143.78 16.96 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 121.532 -0.366 . . . . 73.02 112.729 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.03 142.06 10.22 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 111.361 -0.696 . . . . 53.3 111.361 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' D' ' 29' ' ' PRO . 14.4 mm -90.72 126.39 43.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.557 -0.905 . . . . 72.55 108.557 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -132.27 128.76 38.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.955 0.902 . . . . 55.13 109.19 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.8 p -96.78 126.1 41.7 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 109.225 -0.657 . . . . 55.33 109.225 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.402 ' O ' HD12 ' C' ' 86' ' ' ILE . 2.5 pp -115.48 143.9 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.89 1.276 . . . . 73.25 109.577 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -144.31 142.9 30.71 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.67 0.388 . . . . 65.34 110.953 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.71 -18.08 48.93 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 114.635 0.614 . . . . 62.41 114.635 175.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.452 HG22 HE21 ' C' ' 93' ' ' GLN . 38.5 pt -113.43 154.13 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 117.406 0.603 . . . . 75.42 112.227 -172.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -164.57 -178.68 5.5 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.163 0.985 . . . . 71.4 109.798 173.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.12 -123.5 33.24 Favored Glycine 0 C--N 1.352 1.458 0 O-C-N 123.427 0.454 . . . . 44.04 114.005 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 74.0 p -70.64 -32.25 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.048 0.939 . . . . 74.44 111.258 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.452 HE21 HG22 ' C' ' 89' ' ' ILE . 27.9 mt-30 -69.09 -36.15 77.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.342 0.657 . . . . 70.45 110.987 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' G' ' 453' ' ' GLY . 46.8 ttm -76.81 -32.89 57.94 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.496 -0.32 . . . . 74.24 110.267 174.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.89 -41.02 73.84 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.55 0.532 . . . . 72.23 110.275 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -81.24 -30.59 34.1 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 123.438 0.461 . . . . 74.51 111.705 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 23.0 t -62.09 -39.22 91.74 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.416 0.448 . . . . 74.42 110.666 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.32 -14.32 24.02 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.091 0.556 . . . . 62.1 110.718 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.05 -29.99 61.83 Favored Glycine 0 C--N 1.357 1.696 0 O-C-N 123.279 0.362 . . . . 55.43 113.886 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.09 -38.65 0.06 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.201 0.815 . . . . 64.53 113.201 -170.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -62.42 -52.45 63.5 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.906 0.482 . . . . 73.3 111.322 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.566 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 58.8 m -72.9 -46.19 8.7 Favored Pre-proline 0 CA--C 1.563 1.452 0 CA-C-O 118.732 -0.652 . . . . 74.02 112.289 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 64.6 Cg_exo -54.33 -28.5 53.48 Favored 'Trans proline' 0 C--N 1.398 3.14 0 C-N-CA 122.321 2.014 . . . . 73.45 114.306 171.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -69.65 -35.79 75.49 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.458 0.703 . . . . 75.22 109.774 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.438 HD12 ' NH1' ' A' ' 111' ' ' ARG . 27.8 mm -64.94 -41.8 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.509 -0.552 . . . . 61.15 109.509 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 39.8 mt -79.03 -27.95 43.23 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.063 0.945 . . . . 61.41 113.015 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -57.67 -49.82 91.59 Favored Pre-proline 0 CA--C 1.564 1.503 0 N-CA-C 114.337 1.236 . . . . 70.33 114.337 -171.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.93 -33.93 95.47 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 121.944 1.763 . . . . 74.11 112.905 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -69.19 -45.59 69.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.983 0.513 . . . . 53.32 110.502 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.25 -37.45 77.63 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.255 -0.884 . . . . 61.04 110.665 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -61.89 -58.94 6.0 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.863 -1.062 . . . . 60.45 110.621 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.03 78.66 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 110.137 -0.32 . . . . 51.2 110.137 -175.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.3 t -66.74 -28.65 68.58 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.974 0.509 . . . . 64.41 111.609 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.477 HD13 HG23 ' C' ' 64' ' ' VAL . 83.4 mt -77.13 -55.43 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 109.707 -0.479 . . . . 53.3 109.707 170.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.1 m -60.81 -28.62 68.92 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.211 1.005 . . . . 74.12 111.782 -170.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -68.84 -49.75 55.74 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.834 -0.802 . . . . 74.53 108.834 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.576 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.21 -34.84 75.75 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.561 1.144 . . . . 62.05 112.639 178.205 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.52 -48.16 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.743 0.817 . . . . 72.14 109.193 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.4 ' OG ' HG21 ' B' ' 115' ' ' THR . 41.9 t -67.85 -28.87 67.92 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.811 -1.086 . . . . 72.44 111.911 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -71.31 -43.95 66.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.578 -0.897 . . . . 62.12 108.578 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.86 3.27 61.34 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 123.901 0.751 . . . . 30.32 113.036 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 33.1 p 60.23 38.35 20.06 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.694 1.998 . . . . 71.34 113.898 170.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -94.4 149.8 37.21 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 108.655 -0.869 . . . . 62.21 108.655 166.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.31 176.71 0.35 Allowed 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.309 2.673 . . . . 72.1 115.376 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -59.85 122.16 13.54 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.325 1.05 . . . . 75.4 113.747 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.4 ' CD2' HG11 ' C' ' 64' ' ' VAL . 9.6 mp -112.66 86.26 2.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.218 1.007 . . . . 64.13 109.48 171.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -107.47 107.98 19.09 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.816 -0.809 . . . . 60.41 108.816 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.439 HD22 HD11 ' C' ' 42' ' ' LEU . 59.5 mt -73.38 142.83 46.98 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.643 -0.708 . . . . 74.35 110.519 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.67 148.32 94.95 Favored Pre-proline 0 CA--C 1.55 0.975 0 O-C-N 123.844 0.715 . . . . 75.12 110.111 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.496 ' HG3' HD12 ' A' ' 16' ' ' ILE . 37.4 Cg_exo -57.42 120.38 8.26 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.581 2.188 . . . . 75.34 112.221 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 98.7 t -97.52 119.51 45.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.296 -1.001 . . . . 75.43 108.296 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -77.93 73.12 4.5 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.761 0.663 . . . . 72.22 110.378 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -56.95 -41.05 77.6 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.558 0.743 . . . . 72.3 110.595 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -66.0 -49.49 67.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.069 -0.969 . . . . 71.23 111.762 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.02 96.22 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.959 0.787 . . . . 42.22 111.033 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.408 ' HB3' ' HE1' ' G' ' 461' ' ' PHE . 87.2 mt -70.29 -29.32 66.04 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.376 -0.829 . . . . 63.34 111.665 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.413 ' HA ' ' HB3' ' C' ' 140' ' ' TYR . 15.3 t80 -77.26 -25.99 52.05 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 110.062 -0.347 . . . . 74.32 110.062 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 94.2 mtp -72.03 -30.82 65.57 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.916 0.487 . . . . 62.04 110.118 172.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -70.19 -37.42 75.12 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 109.508 -0.553 . . . . 74.0 109.508 170.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' C' ' 143' ' ' GLN . 57.3 t80 -70.04 -88.35 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.394 1.077 . . . . 74.55 112.726 -175.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 55.93 -79.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.231 1.012 . . . . 75.2 111.527 -164.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -129.59 9.51 5.51 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.95 0.9 . . . . 60.23 112.003 -175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' C' ' 140' ' ' TYR . 10.4 pt20 -135.94 122.82 21.26 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.815 0.846 . . . . 64.24 109.878 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -65.96 84.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.06 0.544 . . . . 70.13 110.708 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.75 68.09 0.67 Allowed 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.962 0.905 . . . . 55.45 110.065 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.48 67.62 0.59 Allowed Glycine 0 C--N 1.341 0.842 0 CA-C-N 114.99 -1.005 . . . . 63.41 111.161 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.7 111.61 17.3 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.709 -0.478 . . . . 73.33 109.709 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.08 121.43 5.47 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 123.578 0.549 . . . . 65.31 112.275 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 23.4 p -139.04 41.2 2.12 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.084 0.954 . . . . 75.23 109.922 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -91.78 114.58 27.15 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.225 0.61 . . . . 74.23 110.167 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -79.29 142.27 36.29 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.202 0.601 . . . . 74.23 109.679 170.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -157.92 152.06 24.36 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.769 0.828 . . . . 73.12 108.9 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -65.63 98.02 0.35 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.225 0.61 . . . . 72.53 110.927 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -72.57 101.73 3.08 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.582 -0.896 . . . . 70.31 108.582 174.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.244 0 C-N-CA 125.05 1.34 . . . . 63.33 111.823 -173.406 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.392 -0.596 . . . . 60.22 109.392 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -115.83 89.18 3.05 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.657 0.783 . . . . 62.0 110.339 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.04 113.45 6.43 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.943 -0.762 . . . . 72.01 108.943 170.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -130.76 126.6 36.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.065 0.546 . . . . 74.11 110.592 -172.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -84.55 103.21 13.48 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.675 -0.861 . . . . 74.4 108.675 171.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.596 ' HB3' HG23 ' B' ' 149' ' ' THR . 64.6 t-20 -81.47 70.87 8.43 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.841 0.829 . . . . 41.43 108.877 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 30.7 p -93.21 -12.76 29.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.667 0.787 . . . . 75.32 111.225 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.4 -21.96 41.74 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.85 0.86 . . . . 64.35 110.892 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 4.7 ttp -28.9 122.94 0.13 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 126.077 1.751 . . . . 72.11 113.594 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.1 m -116.6 147.38 41.92 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 122.967 0.507 . . . . 54.44 109.959 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.402 ' HZ ' HG13 ' D' ' 105' ' ' ILE . 74.9 t80 -152.68 94.31 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.654 -1.239 . . . . 61.5 107.654 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -123.18 116.84 24.08 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.516 0.727 . . . . 75.25 109.04 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.16 113.79 17.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.221 -1.029 . . . . 75.22 108.221 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -81.99 -22.93 36.31 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.604 0.761 . . . . 74.24 111.059 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -170.61 141.28 1.85 Allowed 'General case' 0 C--N 1.361 1.065 0 O-C-N 123.536 0.522 . . . . 71.11 111.234 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.404 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -119.7 133.93 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.683 -1.599 . . . . 54.14 106.683 169.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.448 ' HE1' HG13 ' D' ' 83' ' ' ILE . 20.7 p90 -163.13 163.08 25.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.407 0.622 . . . . 75.32 111.499 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -95.47 120.91 36.53 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.704 -0.85 . . . . 65.41 108.704 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 41.0 mtpt -83.92 -35.2 24.24 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.19 -0.67 . . . . 75.03 109.19 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.4 t70 -146.9 137.18 23.55 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.506 -1.225 . . . . 74.25 109.303 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.576 HG21 ' HE2' ' C' ' 117' ' ' MET . 78.5 mt -136.9 145.31 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.532 1.133 . . . . 71.12 107.976 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -146.77 135.98 22.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.11 0.964 . . . . 61.4 108.831 172.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.498 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.3 t80 -136.65 129.54 30.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 106.453 -1.684 . . . . 64.53 106.453 166.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 33.1 mt-10 -137.65 112.73 9.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.114 -1.069 . . . . 72.13 108.114 -172.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.88 88.34 2.89 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.568 -1.271 . . . . 71.12 107.568 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.08 -32.26 43.99 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.418 2.079 . . . . 55.12 112.695 -167.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.509 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 70.4 m-20 -113.94 14.42 18.48 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.969 0.908 . . . . 71.23 110.7 -177.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.471 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -18.6 -74.34 0.02 OUTLIER Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 116.566 2.061 . . . . 60.12 116.566 -166.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.497 ' HB3' HD11 ' C' ' 83' ' ' ILE . 84.3 Cg_endo -77.26 -20.08 12.94 Favored 'Trans proline' 0 C--N 1.382 2.324 0 CA-C-N 124.377 2.599 . . . . 74.14 114.246 -176.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -70.81 -39.16 73.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.192 0.997 . . . . 71.52 109.635 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.677 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.7 p -84.22 -24.34 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 115.675 -0.693 . . . . 63.11 112.172 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -66.68 -22.36 66.08 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 112.675 0.621 . . . . 71.3 112.675 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -61.71 -22.82 65.68 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.752 0.821 . . . . 63.31 110.849 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -88.69 96.23 10.57 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.5 1.12 . . . . 72.12 110.157 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.35 88.12 2.57 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.152 -0.476 . . . . 64.41 109.776 170.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -154.5 158.03 39.26 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.321 -0.992 . . . . 74.31 108.321 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -76.26 110.04 10.14 Favored Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 108.267 -1.012 . . . . 73.41 108.267 172.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -54.29 127.69 26.89 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.425 2.75 . . . . 72.11 113.584 -174.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 24.2 tt0 -56.61 111.84 1.12 Allowed 'General case' 0 C--N 1.368 1.387 0 O-C-N 124.208 0.942 . . . . 74.11 108.81 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' H' ' 467' ' ' ALA . 4.2 p -114.72 138.26 45.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.638 0.732 . . . . 70.11 110.437 -169.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -129.87 124.15 32.53 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 106.389 -1.708 . . . . 70.42 106.389 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 51.4 tp -95.19 120.45 35.43 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.163 -0.68 . . . . 75.14 109.163 -172.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.602 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 10.8 m-20 -106.23 140.09 39.72 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.617 1.167 . . . . 43.01 107.942 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.494 ' HB2' HD22 ' H' ' 460' ' ' LEU . 4.7 mp -134.47 168.21 19.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.27 0.557 . . . . 63.04 109.852 171.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 7.8 t70 -157.75 142.16 16.24 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.743 1.217 . . . . 50.44 107.726 177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -114.8 144.42 43.53 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.405 0.621 . . . . 71.24 109.416 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.413 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.97 164.36 34.79 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.833 1.253 . . . . 74.31 107.815 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.5 p -168.85 158.47 8.9 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 123.599 0.562 . . . . 74.41 110.49 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 94.6 p -150.7 155.66 39.76 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.832 0.853 . . . . 71.13 109.704 -174.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -91.34 119.0 31.0 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.55 -0.908 . . . . 64.43 108.55 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' D' ' 57' ' ' GLU . 58.7 mt -89.75 -40.52 12.45 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.195 0.598 . . . . 71.05 109.613 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.72 -171.24 3.48 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.964 0.906 . . . . 75.31 110.284 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . 0.42 ' HA ' ' OD1' ' H' ' 450' ' ' ASN . 3.4 m-20 -63.48 106.89 1.0 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.241 -0.891 . . . . 72.13 110.784 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 64.7 17.63 11.03 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.609 1.163 . . . . 63.53 112.168 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 91.0 t -109.52 105.13 18.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 107.122 -1.436 . . . . 73.3 107.122 170.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -121.98 126.73 49.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.261 -1.014 . . . . 75.34 108.261 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.464 ' HB2' HD11 ' D' ' 51' ' ' LEU . 19.3 tt0 -89.85 151.1 21.93 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.452 1.101 . . . . 61.44 108.707 174.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 91.4 t -131.81 128.52 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 C-N-CA 124.516 1.126 . . . . 55.33 108.11 172.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 57.7 t -104.87 130.51 55.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.331 1.052 . . . . 53.13 108.503 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.87 114.47 24.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.548 -0.908 . . . . 74.45 108.548 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.0 ttm-85 -96.36 101.3 12.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.194 -1.039 . . . . 72.42 108.194 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.5 t -100.84 103.67 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.57 -0.9 . . . . 54.14 108.57 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 6.0 m -100.64 137.3 39.22 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.063 0.945 . . . . 61.04 109.171 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.43 HG21 HG21 ' D' ' 114' ' ' ILE . 61.9 t -125.6 113.44 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.855 0.862 . . . . 71.14 109.516 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 12.6 m -103.11 119.53 39.02 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.765 -0.828 . . . . 53.41 108.765 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -135.81 152.06 50.7 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.917 0.487 . . . . 52.35 111.32 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 57.2 p -148.92 136.03 20.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.083 -0.508 . . . . 52.12 112.013 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.581 HD12 HG22 ' D' ' 31' ' ' VAL . 50.1 mt -102.49 96.36 6.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.46 1.104 . . . . 74.34 108.103 171.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.63 -139.1 20.49 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.129 -0.487 . . . . 63.24 113.11 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.05 0.76 46.98 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.91 0.484 . . . . 74.45 111.362 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -118.74 152.66 35.75 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.704 0.802 . . . . 73.31 109.286 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.7 m -73.63 139.68 45.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.75 0.42 . . . . 74.12 110.671 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.677 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.41 -69.83 0.66 Allowed 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.388 -0.824 . . . . 43.21 108.953 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -149.13 138.85 21.86 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.251 -0.886 . . . . 71.54 109.516 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.1 mt -111.78 132.43 54.67 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.359 1.463 . . . . 61.35 107.167 172.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.494 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.7 t -141.56 147.07 37.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.485 -0.561 . . . . 74.2 109.485 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -156.15 130.39 8.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.581 -0.526 . . . . 54.12 109.581 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.12 114.7 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.558 0.743 . . . . 52.35 109.127 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.534 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.27 86.56 6.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.567 -0.901 . . . . 72.01 108.567 170.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -78.7 100.76 7.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.237 -1.347 . . . . 64.34 108.901 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.07 146.57 20.46 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 116.1 -0.5 . . . . 73.55 112.16 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.443 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.9 130.45 4.34 Favored Glycine 0 CA--C 1.508 -0.358 0 N-CA-C 110.343 -1.103 . . . . 62.31 110.343 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.448 HG13 ' HE1' ' D' ' 17' ' ' TYR . 73.6 mt -89.41 122.85 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.722 -1.214 . . . . 61.24 107.722 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -118.2 145.28 45.09 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.906 0.882 . . . . 65.24 109.335 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 6.8 t -115.57 98.14 6.54 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.633 -1.247 . . . . 74.32 107.633 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 30.0 pt -129.92 137.12 57.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.18 -0.918 . . . . 72.15 110.099 -170.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.07 151.84 25.72 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.811 -0.631 . . . . 63.44 110.442 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.13 -13.17 60.41 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.131 -0.94 . . . . 14.32 113.444 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.572 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -95.71 136.86 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 121.463 0.649 . . . . 72.03 111.546 -170.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.5 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 44.8 mt-10 -143.02 -176.68 5.01 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.877 1.671 . . . . 75.14 109.685 -177.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.36 -128.06 27.22 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.347 -0.842 . . . . 21.0 113.425 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 46.0 m -85.45 -32.98 22.0 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.439 0.696 . . . . 61.4 111.031 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.582 HE22 HG21 ' B' ' 149' ' ' THR . 50.1 tt0 -63.33 -38.69 92.13 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.968 0.507 . . . . 74.14 111.977 -174.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.5 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 26.1 ptt? -61.09 -45.09 96.13 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.348 0.405 . . . . 74.11 110.914 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.76 91.99 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.406 0.622 . . . . 75.41 110.137 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -68.33 -23.19 64.68 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.188 1.395 . . . . 65.45 111.757 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.0 t -79.02 -51.93 8.92 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.663 -0.495 . . . . 60.23 109.663 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.45 -29.54 62.61 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.306 0.642 . . . . 61.24 111.911 -176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.19 4.93 30.12 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.825 0.69 . . . . 74.24 114.825 -170.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.4 -55.91 0.24 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 117.929 0.864 . . . . 60.34 111.767 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -71.75 -51.85 20.67 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.058 0.392 . . . . 72.42 112.058 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 68.8 m -65.06 -42.48 61.62 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-O 118.401 -0.809 . . . . 73.4 112.256 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.56 -37.95 94.6 Favored 'Trans proline' 0 C--N 1.397 3.102 0 C-N-CA 122.227 1.951 . . . . 73.14 113.317 166.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -67.42 -30.04 69.69 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.199 0.6 . . . . 72.33 111.143 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.402 HG13 ' HZ ' ' D' ' 11' ' ' PHE . 40.0 mm -66.54 -42.91 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.416 0.686 . . . . 54.3 110.225 171.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.443 HD21 ' HA3' ' D' ' 82' ' ' GLY . 87.5 mt -74.07 -20.83 60.16 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.056 -0.975 . . . . 62.25 111.906 -174.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -65.1 -43.12 65.48 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 114.192 1.182 . . . . 61.45 114.192 -172.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.01 -46.0 23.4 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.342 2.028 . . . . 65.42 114.073 169.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -72.13 -38.62 69.21 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.463 0.705 . . . . 75.43 111.597 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.85 89.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.369 0.668 . . . . 64.45 110.777 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.413 ' NH2' HG23 ' B' ' 105' ' ' ILE . 29.2 ttp180 -58.0 -48.99 78.37 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.392 1.077 . . . . 73.53 110.6 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -58.04 -46.81 84.75 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.201 0.938 . . . . 74.41 111.359 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -59.81 -44.5 93.98 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.027 0.829 . . . . 62.12 111.413 -178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.494 HG12 ' SG ' ' D' ' 76' ' ' CYS . 75.7 mt -65.35 -50.6 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.78 0.832 . . . . 42.43 111.046 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 57.3 m -55.14 -41.85 72.29 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 124.095 0.958 . . . . 53.41 111.402 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.9 t -67.26 -41.47 85.52 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.568 -1.196 . . . . 71.23 110.4 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -71.46 -28.96 64.32 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.845 0.458 . . . . 61.22 112.187 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' D' ' 123' ' ' PHE . 59.0 t -64.61 -46.44 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.204 0.602 . . . . 71.01 109.581 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.01 -27.24 62.6 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 116.076 -0.511 . . . . 74.33 110.998 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.2 mtt-85 -71.2 -35.04 71.42 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.332 0.653 . . . . 72.43 109.841 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.65 7.97 77.29 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 115.901 -0.59 . . . . 73.11 112.329 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p 59.14 25.34 13.83 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 126.35 1.86 . . . . 71.42 114.725 173.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.554 ' HB2' HG13 ' D' ' 118' ' ' VAL . 99.0 m-85 -87.52 155.69 53.77 Favored Pre-proline 0 CA--C 1.556 1.206 0 N-CA-C 108.607 -0.886 . . . . 75.54 108.607 169.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.72 146.92 96.49 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.635 2.223 . . . . 72.34 112.436 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -58.36 139.54 55.14 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.732 1.213 . . . . 71.34 113.026 -172.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.436 ' HG ' HD22 ' H' ' 468' ' ' LEU . 9.1 mp -114.47 112.36 22.86 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.705 0.802 . . . . 74.24 109.569 173.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.2 m-20 -102.35 92.67 4.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.35 -0.981 . . . . 65.11 108.35 172.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.18 115.45 7.66 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.374 -0.602 . . . . 74.12 109.374 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.3 138.99 97.31 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.306 0.642 . . . . 73.31 110.585 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -69.66 119.93 6.81 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.162 1.908 . . . . 33.54 111.073 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.7 150.74 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.325 0.65 . . . . 73.21 111.053 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -80.49 107.16 13.07 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.284 -0.871 . . . . 73.15 109.601 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -80.5 -31.68 37.11 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.321 0.648 . . . . 54.51 110.869 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.75 -52.35 65.81 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.194 1.398 . . . . 71.21 111.861 -168.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.33 79.54 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.136 0.898 . . . . 65.52 111.718 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.533 ' HA ' HD22 ' D' ' 139' ' ' ASN . 3.2 mm? -75.65 -25.6 56.98 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.258 -0.883 . . . . 55.41 111.285 -174.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -61.45 -36.81 81.44 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.36 0.664 . . . . 75.22 110.647 175.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 32.9 mtt -67.32 -32.19 72.99 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.482 -0.781 . . . . 62.15 110.21 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.533 HD22 ' HA ' ' D' ' 136' ' ' LEU . 50.0 m-80 -72.79 -29.82 63.59 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.534 -0.757 . . . . 71.3 111.023 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . 0.685 ' HB2' ' HB3' ' H' ' 461' ' ' PHE . 85.6 t80 -66.48 -39.65 88.87 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.88 0.872 . . . . 63.24 111.823 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 5.7 mp -67.54 -33.15 74.48 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.892 0.877 . . . . 52.33 111.689 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -91.64 33.79 1.01 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.785 0.834 . . . . 72.32 111.701 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 32.4 mm-40 -116.29 85.47 2.31 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.766 -0.827 . . . . 71.24 108.766 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -175.02 142.9 0.67 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.418 1.487 . . . . 74.12 108.127 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.75 0.92 20.73 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.073 0.397 . . . . 72.11 112.073 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.9 20.78 74.82 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.374 0.421 . . . . 44.0 112.502 -176.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -51.59 134.75 29.37 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.6 1.56 . . . . 65.22 113.231 -175.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.66 129.13 9.61 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.344 -0.844 . . . . 75.53 112.654 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 85.2 m -70.69 125.47 26.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.281 0.632 . . . . 73.0 110.593 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.18 159.87 15.76 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.199 1.4 . . . . 73.03 109.965 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -158.08 163.51 37.59 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.175 0.59 . . . . 72.02 110.843 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -156.14 120.39 4.51 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.713 0.805 . . . . 62.55 109.121 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -137.31 138.27 39.82 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.676 0.79 . . . . 74.15 109.638 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -133.52 -175.36 3.79 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 107.796 -1.187 . . . . 72.03 107.796 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 C-N-CA 123.429 0.691 . . . . 52.54 111.648 177.679 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 9.4 t30 . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 110.178 -0.304 . . . . 65.52 110.178 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . 0.626 HG12 HG13 ' E' ' 452' ' ' VAL . 68.9 t -127.04 -75.12 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.093 0.957 . . . . 75.44 108.896 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . 0.626 HG13 HG12 ' E' ' 451' ' ' VAL . 22.5 m -106.83 -177.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.201 0.6 . . . . 71.1 110.682 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 176.14 84.13 0.06 OUTLIER Glycine 0 C--N 1.343 0.924 0 N-CA-C 111.31 -0.716 . . . . 40.04 111.31 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . 0.675 HD13 ' HB3' ' A' ' 48' ' ' SER . 10.1 mp -85.66 169.12 13.78 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.393 0.677 . . . . 74.32 110.894 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 40.5 p -111.84 -172.46 2.04 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.271 1.028 . . . . 61.32 110.336 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.12 -49.83 74.33 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.842 0.857 . . . . 72.43 110.867 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -80.24 106.27 12.13 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.44 -0.8 . . . . 65.22 109.152 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 50.1 p -118.96 165.99 13.4 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.789 0.836 . . . . 74.55 109.215 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -143.12 -178.12 5.68 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.551 0.74 . . . . 74.43 109.659 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -154.07 129.81 10.07 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 106.84 -1.541 . . . . 73.45 106.84 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -73.16 19.87 0.09 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.616 1.566 . . . . 63.05 113.563 -173.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -158.82 110.13 2.12 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.122 -0.695 . . . . 75.04 109.122 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 9.5 t -87.25 -13.94 42.37 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.324 0.65 . . . . 42.15 110.865 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . 0.439 ' SD ' HD23 ' A' ' 42' ' ' LEU . 42.0 ttm 77.71 145.18 0.09 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.341 1.856 . . . . 62.54 110.799 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -52.88 -37.1 60.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.417 1.087 . . . . 74.5 111.742 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 40' ' ' VAL . . . 63.25 78.67 0.28 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.788 1.235 . . . . 63.11 110.802 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -148.87 149.19 30.86 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.918 -1.037 . . . . 73.32 110.055 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 tt -161.04 -60.36 0.05 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 107.58 -1.267 . . . . 63.0 107.58 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 96.14 56.24 1.22 Allowed Glycine 0 C--N 1.346 1.109 0 CA-C-N 115.289 -0.869 . . . . 62.33 111.858 -176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.71 137.24 45.83 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.201 0.6 . . . . 74.55 109.895 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt . . . . . 0 C--O 1.248 1.007 0 C-N-CA 124.071 0.948 . . . . 65.05 109.796 -171.39 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 51.8 t30 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 121.203 0.525 . . . . 73.22 110.178 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' B' ' 87' ' ' ALA . 7.1 p -132.9 5.87 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.196 0.998 . . . . 71.12 109.944 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 25.9 m -68.81 79.06 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.393 0 CA-C-O 122.626 1.203 . . . . 73.04 112.959 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -115.59 64.95 0.31 Allowed Glycine 0 C--N 1.34 0.755 0 CA-C-N 114.742 -1.117 . . . . 73.05 110.865 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . 0.52 ' HG ' ' HB3' ' F' ' 456' ' ' ASP . 43.0 tp -68.31 101.2 1.16 Allowed 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.571 0.748 . . . . 75.22 110.728 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 23.9 p -76.15 82.79 2.97 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.441 -0.948 . . . . 73.52 108.441 166.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . 0.52 ' HB3' ' HG ' ' F' ' 454' ' ' LEU . 9.7 p-10 -89.96 -170.62 2.86 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.571 -1.195 . . . . 73.3 110.643 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 68.76 88.82 0.11 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.332 1.453 . . . . 74.32 110.489 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 6.5 t -155.61 133.69 11.45 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.215 1.006 . . . . 75.23 109.113 174.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.11 154.34 40.42 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 109.355 -0.609 . . . . 75.21 109.355 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' B' ' 44' ' ' LEU . 4.6 mm? -70.88 95.26 1.13 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.803 0.811 . . . . 74.33 109.876 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -85.32 14.27 5.54 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.141 1.376 . . . . 72.43 112.521 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . 0.426 ' OH ' ' HA ' ' B' ' 43' ' ' ASP . 13.2 p90 -70.54 139.5 51.57 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 109.231 -0.655 . . . . 75.55 109.231 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 76.7 m -140.33 120.81 14.12 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.179 -0.675 . . . . 74.33 109.179 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 49.4 ttp -141.1 130.42 23.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.107 0.963 . . . . 60.13 108.524 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -72.9 -41.34 64.72 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.658 0.783 . . . . 73.12 112.293 -169.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -140.0 111.75 7.39 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.562 0.745 . . . . 65.01 109.513 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . 0.428 ' HB2' HD22 ' B' ' 42' ' ' LEU . . . -67.83 -40.5 83.74 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.36 0.664 . . . . 73.44 110.747 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 96.3 mt -137.58 151.63 48.57 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.331 1.052 . . . . 72.51 109.668 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . -86.0 60.21 4.64 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 111.666 -0.574 . . . . 72.23 111.666 174.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 4.4 pp -161.29 139.33 9.4 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.245 1.018 . . . . 74.41 108.736 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt . . . . . 0 C--O 1.251 1.141 0 C-N-CA 124.681 1.192 . . . . 72.41 108.312 -178.326 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 66.1 t30 . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 108.794 -0.817 . . . . 63.51 108.794 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.47 124.75 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 121.717 0.77 . . . . 55.32 110.375 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.1 133.96 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 106.985 -1.487 . . . . 53.03 106.985 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . 0.421 ' N ' ' SD ' ' C' ' 94' ' ' MET . . . -141.57 -15.5 0.41 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 115.074 0.79 . . . . 20.33 115.074 -169.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 3.8 tt -68.82 96.49 0.75 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.29 -1.004 . . . . 71.2 108.29 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 4.8 m -124.46 10.19 8.52 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.11 0.964 . . . . 74.22 109.421 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -153.3 136.13 15.38 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.578 0.751 . . . . 75.25 109.393 -175.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -124.82 103.57 8.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.281 1.033 . . . . 74.45 109.086 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 63.3 p -97.9 167.94 10.6 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.485 0.714 . . . . 61.4 111.141 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -84.2 162.48 20.18 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 109.016 -0.735 . . . . 53.14 109.016 171.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . 0.427 HD23 ' H ' ' C' ' 46' ' ' THR . 0.1 OUTLIER -66.45 125.83 26.92 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.417 -0.957 . . . . 75.31 108.417 174.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . 0.408 ' HE1' ' HB3' ' C' ' 136' ' ' LEU . 43.2 p90 -88.22 13.11 12.13 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.097 0.959 . . . . 74.35 111.651 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -163.39 111.39 1.22 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.035 0.534 . . . . 72.34 110.233 -171.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 26.3 m -83.58 -30.33 27.08 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.585 0.754 . . . . 75.42 111.895 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . 0.64 ' SD ' HD12 ' C' ' 42' ' ' LEU . 0.0 OUTLIER 73.16 112.99 0.06 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.647 1.579 . . . . 74.42 110.515 -174.002 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -135.7 30.43 3.14 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.69 0.796 . . . . 71.21 109.367 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -78.02 131.76 37.5 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.755 -0.831 . . . . 71.23 108.755 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -65.54 105.46 1.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.22 0.608 . . . . 73.53 110.867 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -15.76 63.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.528 0.731 . . . . 73.5 111.57 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.91 -11.32 0.12 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.308 -0.717 . . . . 64.12 111.308 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . 0.529 HD13 ' HD2' ' C' ' 38' ' ' PRO . 77.2 mt -134.54 158.99 42.54 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.079 1.352 . . . . 74.55 109.818 178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.555 1.148 0 N-CA-C 108.79 -0.818 . . . . 74.03 108.79 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . 0.42 ' OD1' ' HA ' ' D' ' 53' ' ' ASP . 86.8 m-20 . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.735 0.303 . . . . 71.13 110.625 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . 0.41 HG23 HG12 ' H' ' 452' ' ' VAL . 35.0 m -126.84 166.07 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.802 1.241 . . . . 62.14 108.82 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . 0.419 ' HA ' ' SD ' ' D' ' 94' ' ' MET 0.261 7.1 p 46.29 -73.1 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 C-N-CA 126.059 1.744 . . . . 73.42 115.595 178.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 77.01 43.32 17.34 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 118.44 0.564 . . . . 42.44 112.133 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.91 178.01 7.24 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.743 0.817 . . . . 71.1 112.906 -174.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 11.8 t -163.88 170.55 16.63 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 114.021 -1.445 . . . . 42.22 108.109 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 30.1 t70 70.42 160.03 0.2 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 124.374 1.07 . . . . 70.24 112.585 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -156.82 -156.68 0.63 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.79 1.236 . . . . 71.23 109.029 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 25.2 m 80.45 137.51 0.06 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.487 1.515 . . . . 74.11 111.619 175.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 27.1 t70 74.68 112.81 0.07 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.708 1.603 . . . . 65.31 111.416 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' D' ' 44' ' ' LEU . 30.2 tp -77.21 161.4 28.2 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.933 -0.576 . . . . 54.4 110.352 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . 0.685 ' HB3' ' HB2' ' D' ' 140' ' ' TYR . 1.9 p90 -94.2 8.11 42.87 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 125.119 1.368 . . . . 74.05 111.99 177.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -148.79 159.74 43.86 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.175 0.99 . . . . 74.24 109.118 -173.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 87.5 m -151.53 110.58 3.89 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.244 -1.021 . . . . 71.34 108.244 173.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . 0.412 ' HG2' ' HA ' ' H' ' 467' ' ' ALA . 36.1 ttp -82.86 96.06 8.13 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.597 -0.519 . . . . 73.14 109.597 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -65.41 132.23 48.45 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.669 -1.151 . . . . 51.11 109.305 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . 78.44 -32.92 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.398 1.479 . . . . 75.05 112.205 -173.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . 0.439 ' HB3' HG13 ' D' ' 40' ' ' VAL . . . 68.26 -72.72 0.09 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.015 1.726 . . . . 74.41 112.425 172.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . 0.436 HD22 ' HG ' ' D' ' 126' ' ' LEU . 11.8 tp -84.38 6.31 23.68 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.887 0.875 . . . . 64.51 112.006 -175.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 78.45 32.64 41.73 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.064 -0.815 . . . . 71.1 111.064 -167.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 5.1 tt -99.12 85.97 3.34 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.916 -1.142 . . . . 63.3 107.916 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? . . . . . 0 CA--C 1.552 1.037 0 C-N-CA 123.57 0.748 . . . . 71.5 109.467 -178.222 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.495 ' SD ' ' HG2' ' A' ' 3' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.685 0.278 . . . . 75.44 110.339 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.1 m -147.37 89.51 1.79 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.774 -1.195 . . . . 74.1 107.774 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.495 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 16.4 mm-40 -89.45 59.53 4.83 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.833 0.825 . . . . 71.02 110.325 -173.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -115.68 68.29 0.72 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.87 -1.059 . . . . 73.31 109.589 -170.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -161.25 84.28 0.65 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.488 0.715 . . . . 71.51 110.085 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.54 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 3.4 t-20 -166.62 113.47 0.83 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.417 0.687 . . . . 72.2 110.495 173.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -157.13 121.09 4.25 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.016 0.926 . . . . 72.04 109.25 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 64.64 -75.58 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.166 1.387 . . . . 70.3 110.264 -172.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.614 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -140.8 165.55 27.19 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.687 1.195 . . . . 72.54 108.799 171.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' A' ' 6' ' ' ASN . 94.7 m -153.11 136.05 15.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.55 0.34 . . . . 63.11 110.986 -173.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.634 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 12.6 t80 -137.08 121.84 18.67 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.849 0.859 . . . . 75.53 108.923 172.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -136.45 108.38 7.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.398 0.679 . . . . 73.43 109.292 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.631 HG12 ' HD2' ' A' ' 84' ' ' PHE . 59.5 mt -80.66 109.46 15.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.508 -0.923 . . . . 73.14 108.508 172.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -74.41 -34.91 63.4 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.556 -0.747 . . . . 73.05 110.572 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -174.61 138.0 0.49 Allowed 'General case' 0 C--N 1.362 1.127 0 O-C-N 123.544 0.527 . . . . 74.32 110.624 -170.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.675 HD12 ' HG3' ' C' ' 130' ' ' PRO . 75.4 mt -123.3 133.79 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.75 0.82 . . . . 74.53 109.423 175.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -167.78 151.01 5.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.821 0.848 . . . . 65.14 110.557 -171.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.4 p -79.44 114.75 18.62 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.938 -0.764 . . . . 60.44 108.938 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -78.51 -33.34 48.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.162 -0.681 . . . . 73.25 109.162 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.8 t70 -147.72 132.72 18.18 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.973 -1.012 . . . . 45.42 109.584 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.42 141.49 45.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 107.237 -1.394 . . . . 70.42 107.237 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -145.91 132.55 19.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.627 0.727 . . . . 71.24 109.719 171.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 79.1 t80 -133.19 130.51 39.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.768 -1.567 . . . . 73.34 106.768 172.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.58 122.26 16.38 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.204 0.602 . . . . 41.55 109.456 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.12 78.47 68.96 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.539 -1.282 . . . . 73.21 107.539 174.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.3 -43.35 8.53 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.492 2.128 . . . . 71.32 110.734 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.406 ' O ' HG23 ' A' ' 31' ' ' VAL . 40.3 m-80 -88.62 20.55 3.37 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.386 -1.279 . . . . 71.43 111.423 -177.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.99 -45.93 88.03 Favored Pre-proline 0 CA--C 1.573 1.858 0 C-N-CA 123.71 0.804 . . . . 42.2 113.121 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 16.2 Cg_exo -68.82 -26.17 32.5 Favored 'Trans proline' 0 C--N 1.398 3.164 0 C-N-CA 121.666 1.577 . . . . 73.2 112.928 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -74.3 -37.42 63.66 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.292 0.637 . . . . 70.41 110.172 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.47 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 73.8 t -67.95 -32.94 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.229 1.012 . . . . 74.52 110.668 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -59.0 -27.95 65.92 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.198 0.999 . . . . 63.12 111.44 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -95.83 -48.62 5.67 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.677 0.791 . . . . 74.34 111.25 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 21.0 ptmt -81.66 164.68 21.65 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.909 0.483 . . . . 73.21 111.22 -175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.55 141.24 43.74 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.511 0.725 . . . . 74.14 111.876 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -92.34 83.78 5.07 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.092 -0.707 . . . . 74.33 109.092 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.97 62.07 44.35 Favored Pre-proline 0 N--CA 1.482 1.146 0 N-CA-C 108.235 -1.024 . . . . 72.42 108.235 172.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.54 157.29 28.65 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.441 2.094 . . . . 52.11 112.681 -167.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.21 109.77 22.46 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.53 -0.915 . . . . 73.42 108.53 171.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.2 p -83.5 115.24 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.394 -0.821 . . . . 74.3 109.781 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -104.12 144.41 31.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.87 0.868 . . . . 64.12 108.749 170.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.553 HD23 ' SD ' ' E' ' 464' ' ' MET . 23.7 tp -136.79 128.84 29.48 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.809 -1.182 . . . . 74.43 107.809 175.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -135.15 113.01 10.95 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.85 -1.167 . . . . 74.53 107.85 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.2 mt -98.08 121.72 40.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.263 0.625 . . . . 61.22 110.207 -173.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -126.76 147.69 49.97 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.201 1.001 . . . . 73.04 109.054 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.1 m -135.64 126.05 26.71 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.82 0.848 . . . . 72.25 109.761 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.57 109.72 8.86 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 122.941 0.496 . . . . 73.11 110.583 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 29.4 m -89.68 167.99 12.47 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.692 0.797 . . . . 75.12 109.928 175.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.415 ' OG ' ' HB3' ' A' ' 57' ' ' GLU . 86.8 p -160.46 154.05 22.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.505 0.722 . . . . 72.53 109.616 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -89.58 117.46 28.49 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.654 0.382 . . . . 71.35 110.297 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.49 HD12 HG23 ' A' ' 83' ' ' ILE . 78.0 mt -87.27 -46.64 9.52 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.574 0.702 . . . . 75.22 109.42 172.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.43 -176.64 5.39 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 114.421 -1.263 . . . . 42.15 108.777 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -65.81 110.07 2.7 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 109.176 -0.676 . . . . 73.45 109.176 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 74.43 -0.98 3.2 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 125.505 1.522 . . . . 73.31 112.886 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -100.25 113.85 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.048 -1.093 . . . . 73.1 108.048 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -125.66 129.96 50.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.702 0.801 . . . . 51.22 110.642 -172.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 41.2 tp10 -89.94 114.72 26.58 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.506 -0.924 . . . . 73.54 108.506 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 61.9 t -100.89 129.49 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 107.985 -1.117 . . . . 62.22 107.985 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.5 105.66 19.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.126 -1.064 . . . . 71.02 108.126 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.7 97.78 11.0 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 106.918 -1.512 . . . . 61.03 106.918 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -92.32 105.64 17.8 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.994 1.318 . . . . 72.3 109.762 -174.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.479 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.7 t -98.84 105.46 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.869 -0.789 . . . . 64.53 108.869 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -98.94 107.51 19.97 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.091 0.556 . . . . 75.44 110.2 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' A' ' 126' ' ' LEU . 98.4 t -106.02 125.94 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.323 0.649 . . . . 61.32 109.443 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.4 m -127.75 107.92 10.3 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.038 -0.727 . . . . 71.54 109.038 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.4 117.86 35.63 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.358 -1.349 . . . . 63.34 107.358 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.8 p -144.82 145.38 31.61 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.089 0.556 . . . . 63.01 109.883 -173.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -129.09 90.22 2.99 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.112 0.965 . . . . 70.44 109.184 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.69 -114.89 3.95 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.383 -0.826 . . . . 72.33 111.269 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.92 -26.85 14.91 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.22 -0.659 . . . . 61.23 109.22 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -85.92 117.46 24.79 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.668 0.387 . . . . 70.24 110.374 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.6 m -73.71 131.04 41.2 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.076 -0.713 . . . . 65.32 109.076 168.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -73.55 -58.27 3.42 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.999 -0.741 . . . . 72.02 108.999 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -156.62 159.05 38.11 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.133 -1.394 . . . . 64.34 110.191 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 32.3 tp -127.48 119.14 25.41 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 107.337 -1.357 . . . . 71.33 107.337 173.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 68.3 m -125.68 99.45 5.99 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.975 -0.75 . . . . 50.52 108.975 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -121.95 116.55 24.55 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.494 -0.928 . . . . 75.13 108.494 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.3 111.49 26.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 123.673 0.789 . . . . 75.41 109.392 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 43.0 mt-30 -85.21 86.22 7.4 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.499 -0.926 . . . . 52.42 108.499 171.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.461 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.5 tp-100 -76.55 118.34 19.11 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 114.78 -1.1 . . . . 64.42 108.172 178.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.17 160.22 13.49 Favored Glycine 0 C--O 1.24 0.512 0 O-C-N 123.533 0.521 . . . . 70.03 112.121 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.47 132.63 2.91 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.799 -0.92 . . . . 64.11 110.799 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.49 HG23 HD12 ' A' ' 51' ' ' LEU . 42.7 mt -81.19 115.69 24.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 174.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.634 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.5 m-85 -122.82 118.59 28.33 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.24 -0.652 . . . . 75.33 109.24 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 m -99.68 100.73 11.74 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.963 -0.755 . . . . 52.42 108.963 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.9 pt -108.95 125.36 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.665 0.786 . . . . 74.42 111.122 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.71 161.73 38.48 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.983 0.913 . . . . 73.31 109.937 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 80.17 2.0 88.55 Favored Glycine 0 N--CA 1.477 1.381 0 N-CA-C 114.674 0.629 . . . . 71.14 114.674 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.542 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -114.82 146.09 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 123.784 0.834 . . . . 72.04 109.73 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 15.9 tt0 -150.93 179.44 8.24 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.413 0.285 . . . . 74.14 110.494 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.459 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 71.83 -136.71 24.63 Favored Glycine 0 C--N 1.351 1.405 0 C-N-CA 123.374 0.512 . . . . 52.24 113.747 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.2 p -80.43 -15.85 55.82 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.034 0.934 . . . . 71.23 110.744 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -71.96 -37.24 69.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.326 1.051 . . . . 71.31 110.742 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.549 ' SD ' HG22 ' E' ' 451' ' ' VAL . 27.3 ptt? -73.32 -25.05 60.48 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.312 0.245 . . . . 64.33 111.016 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.6 -35.72 70.59 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.97 0.508 . . . . 71.03 109.908 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -66.52 -31.26 71.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.51 0.724 . . . . 74.2 111.27 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.542 ' SG ' HG13 ' A' ' 89' ' ' ILE . 72.1 m -57.21 -60.03 4.22 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.496 0.498 . . . . 62.42 111.179 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.476 HD21 HG21 ' E' ' 452' ' ' VAL . 3.8 pp -83.62 -12.06 56.51 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 112.541 0.571 . . . . 73.43 112.541 -176.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.14 -15.2 26.56 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 119.476 -0.625 . . . . 51.52 114.399 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.29 -61.59 0.35 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.95 0.875 . . . . 72.23 111.725 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.17 -65.99 0.61 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.974 1.31 . . . . 72.33 112.759 -169.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.42 -39.39 19.9 Favored Pre-proline 0 CA--C 1.569 1.703 0 N-CA-C 113.379 0.881 . . . . 71.42 113.379 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.87 -29.57 88.38 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 121.683 1.589 . . . . 61.14 113.341 169.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -70.57 -28.09 64.63 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 122.6 0.36 . . . . 71.41 110.453 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.448 HG21 HD13 ' A' ' 13' ' ' ILE . 36.3 mm -56.39 -40.35 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.462 0.705 . . . . 73.14 110.15 172.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.461 HD22 ' HG3' ' A' ' 80' ' ' GLN . 80.4 mt -80.39 -22.55 41.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.861 -1.063 . . . . 62.45 112.675 -173.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.46 -44.92 97.09 Favored Pre-proline 0 CA--C 1.572 1.825 0 N-CA-C 113.591 0.96 . . . . 74.12 113.591 -172.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -59.73 -43.64 36.85 Favored 'Trans proline' 0 C--N 1.394 2.954 0 C-N-CA 122.041 1.828 . . . . 73.24 112.954 173.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -65.48 -36.91 85.27 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.153 0.581 . . . . 72.33 111.037 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.69 -37.92 70.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.91 -0.586 . . . . 63.41 110.751 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.534 ' NH1' HD12 ' C' ' 105' ' ' ILE . 35.0 ttm180 -53.88 -52.87 59.11 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 123.943 0.777 . . . . 75.42 110.03 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -59.78 -49.14 78.87 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 124.572 1.17 . . . . 72.11 111.311 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.466 ' O ' ' HE3' ' A' ' 117' ' ' MET . 34.3 t -56.28 -40.85 74.92 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.317 1.011 . . . . 72.11 110.59 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.479 HD11 ' HB ' ' A' ' 62' ' ' VAL . 96.3 mt -70.37 -47.87 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.942 0.897 . . . . 42.14 111.076 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.497 HG23 ' HG3' ' A' ' 125' ' ' GLN . 33.5 m -54.66 -38.03 66.43 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.433 0.693 . . . . 64.13 110.349 177.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.6 t -69.42 -40.78 77.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.865 -1.061 . . . . 71.23 109.634 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.466 ' HE3' ' O ' ' A' ' 113' ' ' CYS . 33.2 mmt -59.8 -44.56 93.9 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 120.957 0.408 . . . . 74.34 110.624 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 114' ' ' ILE . 57.3 t -67.79 -44.61 85.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.299 1.04 . . . . 70.45 111.118 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -72.97 -33.05 65.6 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.359 0.664 . . . . 62.51 111.642 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -71.36 -32.66 68.76 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.964 0.506 . . . . 62.51 109.658 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.79 -2.96 72.12 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 115.571 -0.741 . . . . 74.4 113.578 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.1 m 70.06 11.48 7.64 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.994 1.318 . . . . 72.21 111.487 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -82.86 142.9 45.54 Favored Pre-proline 0 CA--C 1.553 1.089 0 N-CA-C 108.819 -0.808 . . . . 73.35 108.819 173.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -46.86 132.91 17.55 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.403 2.735 . . . . 74.55 113.592 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.497 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.3 tt0 -52.07 144.36 12.29 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.367 1.467 . . . . 64.51 114.108 -169.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.409 ' CD2' HG11 ' A' ' 64' ' ' VAL . 16.4 tp -121.1 104.12 9.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.281 1.432 . . . . 64.05 109.255 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -116.05 96.02 5.37 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.751 -0.833 . . . . 73.44 108.751 170.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.39 151.78 46.36 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.513 -0.767 . . . . 41.14 110.665 176.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.427 ' H ' ' HB3' ' E' ' 467' ' ' ALA . . . -72.59 152.28 91.63 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.672 0.789 . . . . 74.12 110.964 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.9 126.78 18.81 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.006 1.804 . . . . 64.11 111.918 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.2 t -99.05 115.69 40.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.534 -0.913 . . . . 74.14 108.534 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -81.7 81.61 7.69 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.958 -0.756 . . . . 74.34 108.958 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -59.74 -27.15 66.24 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.478 0.711 . . . . 71.32 111.601 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.92 -49.42 65.6 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.549 1.139 . . . . 74.22 111.032 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.56 -42.45 95.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.224 0.61 . . . . 73.13 110.474 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 69.9 mt -67.66 -25.2 65.6 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.688 -1.142 . . . . 74.32 111.711 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -78.45 -43.69 26.53 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.46 -0.57 . . . . 72.11 109.46 175.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.5 mmt -59.75 -49.11 79.01 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.687 0.617 . . . . 71.52 111.543 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.663 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 28.8 p30 -64.36 -35.81 82.08 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.806 0.691 . . . . 73.32 111.154 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -69.98 -40.3 75.43 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.415 0.686 . . . . 72.24 110.953 174.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.2 tp -66.9 -50.58 61.98 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.693 0.797 . . . . 63.55 111.874 -168.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -168.83 14.96 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.749 0.655 . . . . 62.52 109.865 -176.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.663 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 29.3 tt0 66.55 -71.88 0.09 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.092 1.357 . . . . 64.44 110.827 -173.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -116.76 108.19 15.57 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.386 0.674 . . . . 74.33 109.426 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.02 164.42 30.95 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.826 0.85 . . . . 71.21 110.406 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.28 72.76 0.06 OUTLIER Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.956 -0.458 . . . . 70.34 111.956 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -124.8 168.52 13.12 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.898 0.879 . . . . 74.45 110.675 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.13 -23.93 4.57 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.045 -0.525 . . . . 70.31 112.616 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 41.8 p -83.51 93.97 7.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.272 0.629 . . . . 60.32 110.292 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.81 -177.5 6.38 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.191 0.596 . . . . 62.32 110.909 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -159.86 -52.12 0.06 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.305 -0.998 . . . . 63.23 108.305 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -112.04 170.72 7.96 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.374 -1.284 . . . . 74.43 108.504 172.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -76.58 153.83 35.0 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.451 -0.574 . . . . 73.21 109.451 168.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.32 146.02 54.53 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.041 0.536 . . . . 53.14 111.058 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 C-N-CA 123.968 0.907 . . . . 74.21 110.776 -173.548 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' B' ' 53' ' ' ASP . 26.1 ptm . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.638 -0.504 . . . . 70.35 109.638 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p -71.93 89.2 1.08 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.19 -1.041 . . . . 72.43 108.19 168.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -90.77 82.29 5.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.997 0.903 . . . . 73.24 111.818 -173.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -100.67 120.72 40.48 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 105.088 -2.19 . . . . 74.1 105.088 162.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -121.6 63.15 0.91 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.826 0.822 . . . . 73.13 109.089 -172.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -164.01 167.99 19.78 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.29 1.436 . . . . 64.02 108.753 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -76.97 -2.54 34.32 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 122.118 -0.364 . . . . 71.1 111.729 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -61.62 -33.25 73.59 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.226 0.61 . . . . 73.31 110.494 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.466 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 24.5 ptm 55.77 171.68 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 126.572 1.949 . . . . 74.11 114.501 176.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 91.2 m -143.98 132.3 22.0 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.903 -1.147 . . . . 75.54 107.903 170.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -138.46 137.22 36.96 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.257 -1.016 . . . . 75.22 108.257 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -145.13 142.51 29.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.16 0.584 . . . . 74.31 110.328 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.2 mt -94.16 123.16 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.809 -1.182 . . . . 74.22 107.809 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.44 HE22 HG13 ' B' ' 55' ' ' VAL . 50.2 mt-30 -94.24 -31.45 14.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.075 0.55 . . . . 71.21 110.304 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -173.51 139.04 0.72 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 123.83 0.706 . . . . 74.2 109.458 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.2 mt -121.09 137.17 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 106.543 -1.651 . . . . 70.22 106.543 170.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -166.77 146.71 5.69 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.315 0.579 . . . . 63.03 111.397 -172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.9 m -74.0 126.97 31.68 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.223 -1.029 . . . . 72.33 108.223 168.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -95.16 -40.94 9.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.292 -0.633 . . . . 63.32 109.292 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 23.3 m-20 -144.55 133.49 22.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.776 -0.647 . . . . 73.45 110.375 -166.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.6 mm -127.85 142.96 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.248 1.019 . . . . 55.12 108.884 171.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.1 t -144.32 115.18 7.8 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.737 -1.209 . . . . 63.54 107.737 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -130.77 110.18 11.14 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 107.799 -1.185 . . . . 63.22 107.799 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.75 113.91 21.87 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.267 1.027 . . . . 72.54 108.921 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.99 82.67 7.09 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 106.958 -1.497 . . . . 55.14 106.958 169.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.13 -33.69 11.25 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.27 1.98 . . . . 74.25 112.176 -173.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.75 7.54 46.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.245 1.018 . . . . 74.44 110.544 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.6 -64.33 0.43 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 115.095 1.517 . . . . 70.14 115.095 -163.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.17 -22.85 29.64 Favored 'Trans proline' 0 C--N 1.39 2.746 0 C-N-CA 121.64 1.56 . . . . 41.13 112.817 -170.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -96.78 -20.88 17.9 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.493 0.717 . . . . 72.31 111.002 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' B' ' 68' ' ' LEU . 2.7 p -84.19 -20.73 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.52 0.328 . . . . 74.2 110.445 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -68.08 -24.21 65.03 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.543 0.737 . . . . 71.32 112.886 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -64.36 -15.11 59.8 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.542 0.337 . . . . 63.13 110.779 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -89.38 106.88 18.74 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.748 1.219 . . . . 75.04 109.711 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.04 89.35 7.97 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.277 0.631 . . . . 63.4 109.432 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -161.11 161.25 31.12 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.25 1.02 . . . . 73.11 108.829 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.469 HE22 ' HB3' ' F' ' 471' ' ' LYS . 68.5 mt-30 -85.83 104.32 5.07 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 108.723 -0.843 . . . . 71.51 108.723 173.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.494 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 16.6 Cg_endo -55.94 122.62 12.09 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 122.978 2.452 . . . . 73.42 111.801 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -62.71 109.17 1.33 Allowed 'General case' 0 C--O 1.243 0.741 0 O-C-N 123.759 0.662 . . . . 74.12 110.177 -175.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.561 HG13 HG13 ' B' ' 64' ' ' VAL . 65.9 t -87.01 128.68 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-N 115.045 -0.98 . . . . 70.13 111.231 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -106.42 118.03 35.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.77 1.628 . . . . 74.11 108.356 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.32 135.87 36.39 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.247 0.619 . . . . 35.34 110.244 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.852 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.5 m-20 -129.94 156.19 44.84 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.78 1.232 . . . . 62.53 109.084 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.546 HD13 ' HE2' ' B' ' 133' ' ' PHE . 45.5 mt -134.43 159.55 40.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.759 0.823 . . . . 71.25 109.31 178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.3 t70 -159.74 112.91 2.19 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.375 -1.343 . . . . 44.21 107.375 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.1 p -116.88 119.98 37.06 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.83 0.452 . . . . 70.13 110.182 -175.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.42 161.83 25.17 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.397 1.079 . . . . 71.44 109.188 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m -142.26 165.92 26.12 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.447 -0.946 . . . . 74.4 108.447 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.7 p -150.08 136.21 18.74 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.828 0.451 . . . . 63.1 109.83 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -80.95 109.94 16.0 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.911 -0.403 . . . . 64.42 109.911 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.436 ' HB2' HG12 ' B' ' 55' ' ' VAL . 86.2 mt -76.48 -50.59 13.65 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.518 0.675 . . . . 72.34 109.226 172.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.91 -172.99 4.24 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.082 -0.963 . . . . 70.21 110.054 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' B' ' 1' ' ' MET . 52.4 m-20 -63.82 107.71 1.28 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.028 -0.987 . . . . 74.52 109.863 177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 49.4 m-20 72.82 15.2 4.79 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.4 1.48 . . . . 74.21 111.642 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.44 HG13 HE22 ' B' ' 14' ' ' GLN . 75.6 t -115.51 122.15 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.348 1.059 . . . . 72.52 108.708 173.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -129.93 143.16 50.65 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.192 0.597 . . . . 74.23 111.21 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.482 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 4.6 tm-20 -103.65 100.19 10.01 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 106.809 -1.552 . . . . 63.32 106.809 171.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.0 t -90.98 139.52 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.601 0.76 . . . . 64.14 110.265 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.483 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 18.4 t -120.77 135.92 59.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.788 0.835 . . . . 71.05 109.867 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -118.17 107.47 13.99 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.604 -1.258 . . . . 73.54 107.604 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 23.1 ttm-85 -96.57 125.5 41.09 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.217 0.607 . . . . 75.12 109.69 172.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.549 ' HB ' HD11 ' B' ' 114' ' ' ILE . 14.6 t -117.0 119.81 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.565 -1.272 . . . . 65.13 107.565 169.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.852 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 62.3 m -100.49 148.07 25.18 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.639 0.776 . . . . 62.45 109.216 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.561 HG13 HG13 ' B' ' 40' ' ' VAL . 73.6 t -135.67 108.29 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.297 1.039 . . . . 63.22 108.359 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.0 m -95.82 137.84 34.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.92 -1.141 . . . . 64.32 107.92 167.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.72 150.43 32.08 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.729 -0.471 . . . . 63.43 109.729 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 50.8 p -150.89 136.72 18.14 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.493 0.496 . . . . 73.44 112.106 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.547 ' HB2' HG22 ' B' ' 31' ' ' VAL . 34.2 mt -104.95 121.41 43.68 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.336 1.054 . . . . 64.42 108.608 170.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.82 -116.98 5.01 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 115.672 -0.694 . . . . 33.43 112.341 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -122.34 23.4 9.76 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.359 1.064 . . . . 73.41 110.116 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -146.09 159.93 42.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.952 0.901 . . . . 71.14 109.961 -174.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 31.0 m -64.3 140.0 58.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.216 0.606 . . . . 70.34 111.292 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.423 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -100.97 -59.62 1.67 Allowed 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.665 -0.865 . . . . 61.45 108.665 171.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -154.35 152.29 30.05 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.788 -0.642 . . . . 63.22 110.684 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 33.3 mt -130.31 109.9 11.11 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 106.169 -1.789 . . . . 73.53 106.169 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.45 ' SG ' HG23 ' B' ' 114' ' ' ILE . 45.2 t -117.32 145.69 43.84 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.704 -0.85 . . . . 55.2 108.704 -175.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.3 tt0 -162.86 130.37 3.68 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.039 0.447 . . . . 62.45 110.046 -172.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 80.2 t -123.83 146.3 29.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.193 -0.912 . . . . 54.12 109.348 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 10.5 mt-30 -121.35 92.97 3.87 Favored 'General case' 0 N--CA 1.461 0.096 0 N-CA-C 108.184 -1.043 . . . . 72.54 108.184 168.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.454 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.3 tp-100 -83.65 100.27 10.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.169 -1.048 . . . . 74.54 108.169 174.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.63 170.13 36.43 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.204 -0.758 . . . . 74.32 111.204 175.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.62 127.33 1.45 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 112.311 -0.316 . . . . 72.11 112.311 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 62.5 mt -86.81 131.79 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.778 0.831 . . . . 64.1 109.125 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -136.56 164.54 27.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.104 0.962 . . . . 71.21 109.9 -175.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -129.19 108.97 10.76 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.125 -1.065 . . . . 74.42 108.125 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 40.2 pt -101.25 145.2 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.47 0.708 . . . . 61.44 110.839 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.34 160.55 38.61 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.876 0.871 . . . . 51.25 110.014 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 80.07 -69.93 3.01 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 123.573 0.545 . . . . 74.41 112.044 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' B' ' 97' ' ' CYS . 19.4 pt -54.39 127.86 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.744 1.218 . . . . 74.4 110.854 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.481 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 30.5 tt0 -149.59 156.02 41.25 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 110.204 -0.295 . . . . 74.41 110.204 -171.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.72 -109.71 2.94 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 112.139 -0.384 . . . . 75.04 112.139 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 42.4 m -79.6 -27.46 41.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.982 0.513 . . . . 75.42 110.649 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.481 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 40.7 mt-30 -66.3 -39.88 89.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 122.795 0.438 . . . . 74.5 110.525 -177.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -76.24 -29.54 57.57 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.988 -0.551 . . . . 74.41 110.505 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.51 -33.17 75.09 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.533 0.733 . . . . 70.34 110.501 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.446 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 17.6 t-80 -74.9 -20.35 59.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.826 1.25 . . . . 75.02 110.474 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.471 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 41.4 t -81.91 -68.51 0.69 Allowed 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.527 -0.546 . . . . 73.44 109.527 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 66.9 mt -66.95 -31.99 72.95 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.281 0.632 . . . . 70.53 112.567 -169.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.12 3.78 70.25 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-O 119.435 -0.647 . . . . 75.34 113.886 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -152.88 -65.95 0.16 Allowed 'General case' 0 C--N 1.357 0.895 0 CA-C-N 118.001 0.901 . . . . 64.41 112.553 -174.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.471 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 58.3 t80 -64.39 -47.42 79.3 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.725 0.81 . . . . 74.25 112.129 -174.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.446 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 87.7 m -60.17 -49.78 89.2 Favored Pre-proline 0 CA--C 1.566 1.562 0 C-N-CA 124.474 1.11 . . . . 63.33 111.908 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.503 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 50.8 Cg_exo -59.14 -34.77 98.63 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.068 1.846 . . . . 70.02 113.434 169.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -30.55 71.58 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.285 0.634 . . . . 71.32 110.874 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.93 -45.89 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.112 0.965 . . . . 73.31 110.565 171.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 49.8 mt -81.72 -12.71 58.5 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.908 -1.042 . . . . 72.4 112.065 -169.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -59.32 -49.08 94.51 Favored Pre-proline 0 CA--C 1.558 1.275 0 CA-C-O 117.645 -1.169 . . . . 74.13 113.502 -174.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.17 -35.84 98.37 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 121.951 1.768 . . . . 71.42 112.977 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.454 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 59.9 m-85 -68.96 -46.35 68.39 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.398 0.679 . . . . 74.11 109.851 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.03 88.59 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.611 0.764 . . . . 63.14 110.859 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.541 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 36.7 ttt180 -61.37 -54.81 38.9 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.174 1.389 . . . . 72.24 111.533 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.25 -36.05 82.84 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.541 0.736 . . . . 62.45 109.792 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.446 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.3 t -64.89 -39.31 93.33 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.526 -0.761 . . . . 45.43 111.171 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.549 HD11 ' HB ' ' B' ' 62' ' ' VAL . 70.3 mt -62.19 -54.57 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 109.633 -0.506 . . . . 75.52 109.633 174.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.478 HG21 ' OG ' ' C' ' 119' ' ' SER . 11.1 m -59.74 -30.67 68.99 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.33 1.019 . . . . 71.31 111.276 -173.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 41.7 t -60.63 -50.93 71.54 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 123.87 0.731 . . . . 71.03 109.541 173.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 7.9 mmt -68.19 -36.74 80.05 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.165 0.586 . . . . 65.0 111.453 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 114' ' ' ILE . 91.9 t -59.43 -43.42 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.056 0.942 . . . . 74.45 110.092 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.474 ' OG ' HG21 ' C' ' 115' ' ' THR . 45.9 t -71.46 -31.9 67.69 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.801 -1.09 . . . . 61.23 111.747 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.9 mtt-85 -65.8 -37.37 86.08 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 115.969 -0.56 . . . . 72.31 109.537 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.8 2.92 86.82 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.45 -0.639 . . . . 63.31 113.389 173.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 47.3 p 63.22 19.89 11.94 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 126.116 1.766 . . . . 62.51 114.182 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -81.75 153.51 70.33 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.249 0.62 . . . . 73.25 110.739 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.44 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 98.9 Cg_exo -48.77 162.62 0.36 Allowed 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 124.304 3.336 . . . . 63.12 115.67 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -61.62 128.9 38.49 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.701 1.2 . . . . 74.32 112.231 -169.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.422 HD23 HG21 ' B' ' 118' ' ' VAL . 35.5 tp -133.35 107.85 8.35 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.398 1.079 . . . . 62.22 109.202 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -124.37 134.72 53.06 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.457 0.703 . . . . 74.04 109.571 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.541 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.8 mm? -80.79 147.71 30.36 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.608 0.763 . . . . 52.14 111.075 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.87 146.63 46.5 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.738 0.815 . . . . 75.4 109.501 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.543 ' HG2' HD13 ' D' ' 16' ' ' ILE . 23.7 Cg_exo -64.12 102.75 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.414 2.076 . . . . 72.44 112.465 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 64.3 t -89.42 110.64 21.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.746 -1.205 . . . . 70.44 107.746 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -82.27 86.18 6.72 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.953 -1.128 . . . . 70.23 107.953 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.546 ' HE2' HD13 ' B' ' 44' ' ' LEU . 91.0 m-85 -54.8 -37.84 66.58 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.87 0.868 . . . . 75.03 110.728 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.45 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 16.7 t70 -61.86 -43.77 98.17 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.104 -1.407 . . . . 62.22 111.109 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.19 -42.94 62.16 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.59 0.756 . . . . 65.51 111.116 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.42 -16.03 60.39 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.223 0.453 . . . . 71.52 112.223 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -65.32 -33.84 76.91 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.221 0.608 . . . . 71.55 109.817 171.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 52.3 mtt -69.13 -37.19 78.19 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.538 0.735 . . . . 73.2 110.589 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -88.92 -13.41 39.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.224 0.61 . . . . 72.25 111.614 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.4 ' HD2' HD23 ' B' ' 141' ' ' LEU . 36.7 t80 -60.43 -45.76 92.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.96 0.904 . . . . 74.24 110.951 175.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.4 HD23 ' HD2' ' B' ' 140' ' ' TYR . 0.9 OUTLIER -121.67 21.89 10.7 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.88 -1.055 . . . . 74.4 112.138 -169.279 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -164.96 164.0 20.73 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.264 0.626 . . . . 72.31 109.751 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -73.98 -179.38 3.72 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.646 0.778 . . . . 73.24 111.616 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -139.0 117.83 12.35 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.966 -0.753 . . . . 74.25 108.966 173.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -75.42 85.65 2.55 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.217 -0.66 . . . . 73.44 109.217 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.81 81.61 1.0 Allowed Glycine 0 C--N 1.342 0.893 0 CA-C-N 115.531 -0.759 . . . . 72.53 111.554 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -126.12 142.43 51.53 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.683 0.793 . . . . 73.53 109.647 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.12 161.07 14.32 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.044 -0.98 . . . . 73.32 110.727 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 17.8 p -144.14 139.95 29.11 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.979 0.912 . . . . 45.31 109.32 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.88 126.93 29.73 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.875 -1.528 . . . . 74.14 106.875 169.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.76 96.73 1.9 Allowed 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.82 -1.548 . . . . 73.14 106.82 171.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' H' ' 450' ' ' ASN . 62.3 t60 -138.29 75.14 1.51 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.109 -1.441 . . . . 74.0 107.109 169.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -66.51 100.13 0.64 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.386 0.612 . . . . 73.02 109.505 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -89.9 -177.1 5.13 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 114.737 -1.12 . . . . 73.42 109.063 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.994 0 C-N-CA 123.471 0.708 . . . . 63.31 110.905 177.026 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 110.104 -0.332 . . . . 71.33 110.104 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . 0.441 ' HB2' ' OD1' ' C' ' 5' ' ' ASN . 42.2 p -82.47 82.8 7.76 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.881 0.872 . . . . 54.12 109.555 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -74.88 -45.11 45.11 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.028 -0.987 . . . . 72.2 112.288 -171.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -128.04 95.11 4.09 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.803 -0.814 . . . . 72.03 108.803 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.441 ' OD1' ' HB2' ' C' ' 2' ' ' SER . 60.9 m-20 -96.98 6.57 48.39 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.982 0.913 . . . . 70.41 111.447 -173.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.491 ' HB3' ' HA2' ' C' ' 88' ' ' GLY . 53.4 t-20 68.34 -84.93 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.201 1.0 . . . . 73.42 110.827 174.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 10.6 p -148.46 179.8 7.53 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.986 1.314 . . . . 75.33 109.066 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.464 ' HB2' HG23 ' C' ' 149' ' ' THR . 21.1 mm-40 -86.74 57.62 4.6 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.379 0.672 . . . . 74.41 110.591 176.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.478 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 27.7 ttt 53.88 112.37 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 126.139 1.775 . . . . 74.35 112.584 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 24.9 m -117.28 117.19 28.87 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.707 -0.849 . . . . 71.12 108.707 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -122.41 123.21 40.81 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.264 0.626 . . . . 73.53 109.671 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -143.72 133.91 24.39 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.055 0.942 . . . . 53.1 108.492 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 36.5 mt -81.22 126.43 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.76 -0.829 . . . . 72.34 108.76 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.541 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 29.4 mm-40 -88.0 -47.02 8.85 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.646 -0.707 . . . . 72.52 110.148 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -174.81 138.88 0.49 Allowed 'General case' 0 C--N 1.352 0.706 0 CA-C-N 115.373 -0.83 . . . . 53.32 109.441 -168.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -128.31 141.0 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 107.824 -1.176 . . . . 73.15 107.824 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -170.41 171.14 6.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.469 0.652 . . . . 64.5 110.885 -170.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -96.26 110.91 23.13 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.758 -0.83 . . . . 64.23 108.758 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -71.81 -34.26 69.21 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.933 -0.766 . . . . 62.12 108.933 173.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.5 t70 -146.52 146.51 30.53 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.072 -0.967 . . . . 72.44 109.295 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.3 mt -141.86 144.26 25.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.815 1.646 . . . . 73.22 106.912 175.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t -155.05 151.05 27.94 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.641 0.734 . . . . 70.24 110.433 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -148.67 148.63 30.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.197 -1.365 . . . . 75.2 107.354 171.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.594 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.5 mt-10 -143.77 139.25 29.3 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.003 0.921 . . . . 74.42 109.29 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.45 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -155.06 73.42 5.67 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 106.263 -1.754 . . . . 43.44 106.263 169.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.29 -10.88 16.19 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.147 1.898 . . . . 74.32 111.766 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -114.98 20.7 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.984 1.314 . . . . 71.2 109.306 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.465 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -55.82 -53.49 62.35 Favored Pre-proline 0 CA--C 1.561 1.385 0 N-CA-C 113.348 0.869 . . . . 73.32 113.348 -168.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.38 -42.38 68.25 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 121.752 1.635 . . . . 73.21 113.015 177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -70.84 -35.36 72.4 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.657 0.783 . . . . 74.42 112.444 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -79.5 -24.17 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 112.262 0.467 . . . . 64.21 112.262 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -68.99 -22.86 64.06 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.983 -0.448 . . . . 75.21 111.79 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -95.61 6.42 48.99 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.238 0.615 . . . . 72.33 111.048 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.403 ' HG2' HD13 ' C' ' 68' ' ' LEU . 2.8 tppp? -92.89 142.5 27.24 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.756 0.822 . . . . 72.32 111.562 -172.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -71.2 134.14 46.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.748 1.219 . . . . 64.15 109.618 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -84.75 102.36 12.94 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.961 0.726 . . . . 73.41 112.961 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -121.16 67.84 17.32 Favored Pre-proline 0 N--CA 1.484 1.263 0 N-CA-C 107.507 -1.294 . . . . 73.52 107.507 160.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -84.15 118.75 2.35 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 122.969 2.446 . . . . 73.42 112.951 -171.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -86.35 99.16 11.41 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.953 -1.128 . . . . 74.13 107.953 167.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 p -76.83 98.82 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.688 0.756 . . . . 72.11 109.35 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.8 101.48 13.29 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.506 -2.035 . . . . 74.32 105.506 169.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 9.0 tt -86.38 142.3 28.55 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.305 -1.368 . . . . 75.01 107.305 174.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.567 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.1 t70 -119.58 133.63 55.58 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.685 -0.857 . . . . 73.21 108.685 -173.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.0 mt -112.71 123.36 50.14 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.467 -0.938 . . . . 71.41 108.467 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.3 t70 -135.78 126.6 27.47 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.397 -1.334 . . . . 44.23 107.397 172.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -137.58 128.17 26.76 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.583 0.706 . . . . 70.3 109.699 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.05 152.27 46.08 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 113.93 -1.486 . . . . 71.24 107.523 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -140.43 145.38 36.93 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.838 -0.43 . . . . 73.33 109.838 -174.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -143.84 135.71 26.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.492 0.717 . . . . 52.25 110.433 -168.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.477 HE22 ' HA ' ' G' ' 450' ' ' ASN . 61.4 tt0 -72.75 122.67 21.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.471 0.708 . . . . 74.12 110.741 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.611 HD11 HD12 ' C' ' 83' ' ' ILE . 36.1 mt -91.71 -45.8 8.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.473 -0.936 . . . . 64.24 108.473 172.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.01 178.29 8.83 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.323 -1.308 . . . . 73.54 108.901 174.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -74.19 134.12 42.75 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.062 -0.718 . . . . 63.54 109.062 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.465 ' HA ' HG11 ' G' ' 451' ' ' VAL . 63.4 m-20 69.16 -0.21 2.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.478 1.511 . . . . 75.12 113.114 -171.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.1 t -123.35 94.82 3.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 123.961 0.904 . . . . 64.35 108.701 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -116.11 125.35 52.25 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.961 -1.125 . . . . 70.52 107.961 -176.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.491 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.1 tt0 -82.26 138.21 34.66 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.686 0.794 . . . . 65.44 109.519 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 63.6 t -115.45 130.05 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.916 -0.772 . . . . 73.31 108.916 170.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 97.0 t -111.76 133.73 56.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.542 -1.281 . . . . 73.43 107.542 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.06 104.31 8.8 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.455 -0.943 . . . . 72.12 108.455 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.54 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 33.1 ttm-85 -95.48 108.7 20.94 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.583 -0.895 . . . . 62.44 108.583 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.546 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.8 t -109.38 122.52 64.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.834 -1.173 . . . . 74.54 107.834 172.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.3 m -124.55 114.66 19.7 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.091 0.556 . . . . 71.31 109.837 -174.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.562 HG11 HD11 ' C' ' 126' ' ' LEU . 78.1 t -99.25 107.82 21.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.761 -0.829 . . . . 71.34 108.761 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.522 HG23 HD23 ' C' ' 75' ' ' LEU . 1.6 m -99.46 106.83 18.91 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.374 -1.343 . . . . 71.5 107.374 174.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.54 124.19 46.8 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.239 -1.023 . . . . 70.44 108.239 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 59.7 m -134.72 163.69 29.22 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.928 0.394 . . . . 65.34 110.651 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.403 HD13 ' HG2' ' C' ' 34' ' ' LYS . 30.7 mt -124.3 15.22 9.02 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.093 1.357 . . . . 62.44 109.785 -173.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.54 -93.04 0.42 Allowed Glycine 0 C--N 1.344 1.013 0 N-CA-C 110.381 -1.088 . . . . 51.03 110.381 -172.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -100.04 -30.76 11.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.108 0.963 . . . . 71.12 109.599 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -75.34 122.68 24.12 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.592 1.157 . . . . 73.25 110.715 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 78.8 m -78.37 125.84 29.93 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.803 -1.184 . . . . 54.44 107.803 162.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.706 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.44 -64.74 0.86 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.549 -0.908 . . . . 51.33 108.549 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.69 168.72 24.14 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.28 -0.873 . . . . 65.11 109.675 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.1 tm? -128.36 142.28 51.17 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.515 -1.661 . . . . 74.23 106.515 169.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 47.4 t -144.23 145.47 32.08 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 107.817 -1.179 . . . . 75.1 107.817 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -157.61 128.14 6.41 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.891 -0.411 . . . . 74.12 109.891 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.58 125.29 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 123.855 0.862 . . . . 71.51 108.79 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.54 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.5 mt-30 -103.75 86.86 2.68 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.531 -0.914 . . . . 52.21 108.531 173.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -78.46 97.91 5.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.676 -1.147 . . . . 74.32 108.949 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.27 149.16 24.74 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.291 -0.868 . . . . 72.52 110.98 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.514 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -153.81 117.12 0.78 Allowed Glycine 0 CA--C 1.502 -0.723 0 N-CA-C 110.891 -0.884 . . . . 72.42 110.891 -176.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.611 HD12 HD11 ' C' ' 51' ' ' LEU . 9.6 mm -81.97 119.55 31.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.461 -0.941 . . . . 73.25 108.461 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -125.21 118.58 26.36 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.837 -0.801 . . . . 71.25 108.837 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.2 m -77.54 103.21 7.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.156 -0.683 . . . . 62.3 109.156 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.546 HG12 HD21 ' C' ' 98' ' ' LEU . 1.7 pp -122.63 123.52 68.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 123.762 0.825 . . . . 71.41 110.143 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -127.25 162.04 27.15 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.554 1.142 . . . . 62.23 109.225 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . 0.491 ' HA2' ' HB3' ' C' ' 6' ' ' ASN . . . 88.68 -34.29 3.92 Favored Glycine 0 N--CA 1.473 1.133 0 N-CA-C 113.805 0.282 . . . . 73.11 113.805 173.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.476 HG22 HE21 ' C' ' 93' ' ' GLN . 28.0 pt -90.15 144.57 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.924 0.889 . . . . 62.42 111.07 -177.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -161.95 155.98 21.77 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.511 0.724 . . . . 63.52 110.079 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.72 -117.83 7.88 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.586 -0.734 . . . . 72.52 113.198 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.51 HG22 HD11 ' C' ' 141' ' ' LEU . 32.6 p -69.35 -25.07 64.01 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.001 0.92 . . . . 74.51 111.816 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.476 HE21 HG22 ' C' ' 89' ' ' ILE . 25.4 mt-30 -71.45 -52.34 19.0 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.591 0.757 . . . . 63.24 110.685 176.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.64 ' SD ' HG13 ' G' ' 452' ' ' VAL . 0.0 OUTLIER -69.59 -30.58 68.37 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.681 -0.69 . . . . 74.3 111.466 -174.382 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.13 -47.79 82.22 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 124.244 0.965 . . . . 74.3 110.692 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.439 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 10.5 t-160 -78.56 -35.56 45.82 Favored 'General case' 0 C--O 1.246 0.886 0 O-C-N 123.548 0.53 . . . . 62.31 111.994 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -58.65 -40.65 84.02 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.474 0.484 . . . . 74.54 110.665 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.55 HD12 HG11 ' G' ' 452' ' ' VAL . 31.0 mt -101.72 -10.68 19.75 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.994 0.518 . . . . 74.23 111.341 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.91 -30.55 63.31 Favored Glycine 0 C--N 1.355 1.584 0 N-CA-C 113.953 0.341 . . . . 53.32 113.953 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.63 -35.99 0.06 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.137 0.421 . . . . 71.22 112.137 -171.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -65.31 -43.49 90.91 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.318 1.447 . . . . 74.25 112.216 -176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -84.24 -42.59 0.74 Allowed Pre-proline 0 CA--C 1.567 1.601 0 CA-C-O 118.588 -0.72 . . . . 61.31 112.245 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -54.2 -25.55 38.5 Favored 'Trans proline' 0 C--N 1.397 3.113 0 C-N-CA 122.747 2.298 . . . . 72.12 114.095 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -61.37 -38.26 86.34 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.62 0.768 . . . . 60.01 110.822 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.534 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.5 mm -67.1 -39.88 84.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.196 -0.911 . . . . 73.24 110.306 177.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.514 HD21 ' HA3' ' C' ' 82' ' ' GLY . 60.5 mt -79.45 -22.75 43.73 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.943 0.897 . . . . 72.54 112.065 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -55.6 -52.8 69.02 Favored Pre-proline 0 CA--C 1.558 1.284 0 N-CA-C 114.08 1.141 . . . . 75.24 114.08 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.05 -29.01 65.85 Favored 'Trans proline' 0 C--N 1.386 2.531 0 CA-C-N 121.286 1.495 . . . . 72.03 112.637 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -70.29 -47.87 59.26 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.981 0.512 . . . . 75.34 109.674 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -55.82 -45.18 78.39 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.989 -1.005 . . . . 55.31 109.789 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.575 ' HG3' ' HB3' ' C' ' 128' ' ' LEU . 44.9 ttt-85 -56.21 -52.98 62.45 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.35 1.46 . . . . 71.12 111.708 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.28 -37.27 85.06 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.344 0.658 . . . . 75.31 110.483 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 21.1 t -71.36 -29.25 64.75 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 122.954 0.502 . . . . 73.32 111.628 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.546 HD11 ' HB ' ' C' ' 62' ' ' VAL . 98.0 mt -69.43 -52.34 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 109.342 -0.614 . . . . 52.24 109.342 173.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.474 HG21 ' OG ' ' B' ' 119' ' ' SER . 5.8 m -61.79 -31.16 71.36 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.58 0.752 . . . . 74.45 110.937 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.9 t -63.5 -52.68 60.2 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.433 0.693 . . . . 53.44 109.19 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.531 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.17 -38.01 84.97 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.263 1.025 . . . . 64.44 112.473 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' C' ' 114' ' ' ILE . 83.3 t -61.59 -48.35 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.656 0.783 . . . . 53.5 110.009 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.478 ' OG ' HG21 ' B' ' 115' ' ' THR . 41.7 t -67.23 -27.37 67.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.574 -1.194 . . . . 73.22 111.519 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -72.68 -40.75 66.02 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.181 0.592 . . . . 60.21 109.62 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -3.91 79.38 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.426 0.454 . . . . 51.42 112.747 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.1 p 62.95 33.78 14.66 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 126.853 2.061 . . . . 74.23 113.222 173.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.61 151.69 62.19 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.087 -1.079 . . . . 71.1 108.087 168.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -57.25 166.16 4.7 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.679 2.253 . . . . 72.35 113.6 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -46.44 138.24 5.89 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.344 1.457 . . . . 74.3 114.672 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.562 HD11 HG11 ' C' ' 64' ' ' VAL . 5.4 tt -119.84 85.29 2.35 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.91 -1.144 . . . . 61.54 107.91 169.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -92.17 94.59 9.28 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.225 -1.028 . . . . 74.23 108.225 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.575 ' HB3' ' HG3' ' C' ' 111' ' ' ARG . 16.7 tp -70.05 123.55 21.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.416 -0.811 . . . . 62.12 110.163 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.23 154.85 88.27 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 124.38 1.072 . . . . 60.44 111.402 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.675 ' HG3' HD12 ' A' ' 16' ' ' ILE . 45.9 Cg_exo -55.11 111.12 0.65 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.837 2.358 . . . . 54.24 113.291 172.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.55 115.74 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.443 -1.318 . . . . 61.11 107.443 167.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -82.13 86.62 6.58 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.775 -0.824 . . . . 70.44 108.775 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.466 ' HA ' ' HZ ' ' G' ' 461' ' ' PHE . 80.2 m-85 -62.63 -43.22 99.35 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.927 -1.033 . . . . 73.31 110.628 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.05 -42.99 93.73 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 114.049 -1.432 . . . . 70.43 111.27 -169.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.7 95.29 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 123.711 0.632 . . . . 74.44 111.676 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.04 -49.11 63.43 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.949 0.5 . . . . 74.24 110.021 -176.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.439 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 3.0 t80 -69.49 -21.28 63.7 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 116.087 -0.506 . . . . 61.34 110.107 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 25.9 ttt -69.03 -32.25 71.63 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.717 0.407 . . . . 72.44 110.251 173.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -70.95 -38.83 72.85 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 110.068 -0.345 . . . . 73.34 110.068 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -64.23 -84.2 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.486 0.714 . . . . 73.05 110.696 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.51 HD11 HG22 ' C' ' 92' ' ' THR . 18.8 tp -125.22 134.66 52.26 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 120.861 0.362 . . . . 75.21 111.227 -175.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -145.3 168.62 20.02 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.616 1.166 . . . . 74.41 111.041 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.06 127.48 15.93 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 106.375 -1.713 . . . . 74.53 106.375 169.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -75.51 87.44 2.64 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.697 0.761 . . . . 72.55 110.232 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.66 159.58 35.51 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.064 1.346 . . . . 65.01 108.335 173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.85 -124.02 1.86 Allowed Glycine 0 C--N 1.334 0.439 0 N-CA-C 111.344 -0.702 . . . . 62.04 111.344 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 62.12 -176.81 0.13 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.432 1.093 . . . . 54.3 111.461 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 168.55 138.19 2.41 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.913 -0.475 . . . . 51.45 111.913 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.464 HG23 ' HB2' ' C' ' 8' ' ' GLU . 23.2 p -90.65 169.51 10.94 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 123.469 0.708 . . . . 73.24 110.313 171.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.14 -177.87 4.18 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.014 0.926 . . . . 72.25 111.353 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -71.94 179.64 3.13 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.633 0.773 . . . . 64.52 111.089 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -59.84 -45.79 91.32 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.892 -0.595 . . . . 74.34 110.418 171.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.23 153.98 0.12 Allowed 'General case' 0 CA--C 1.561 1.375 0 O-C-N 124.906 1.379 . . . . 72.22 109.892 -177.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 72.88 128.49 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.548 1.539 . . . . 74.45 111.596 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.948 0 C-N-CA 123.537 0.735 . . . . 37.41 109.56 178.742 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 109.558 -0.534 . . . . 70.55 109.558 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 17.8 m -84.63 173.58 10.65 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.806 0.843 . . . . 63.11 110.222 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -80.97 160.59 24.58 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.001 0.521 . . . . 75.1 110.238 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -79.93 97.32 6.69 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.304 0.642 . . . . 74.31 109.548 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -65.9 149.88 49.5 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.882 0.473 . . . . 64.45 110.484 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -101.46 24.53 9.53 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.593 0.711 . . . . 73.45 111.214 -166.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -93.04 167.28 11.89 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.812 0.845 . . . . 71.11 109.707 170.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 61.89 104.65 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.643 1.177 . . . . 71.13 110.157 -171.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 2.9 ttp -32.95 122.79 0.38 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.901 0.88 . . . . 65.24 111.481 172.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.585 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 27.9 m -108.32 141.82 39.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.993 0.425 . . . . 54.12 111.106 -172.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -156.99 95.48 1.51 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.116 -1.439 . . . . 64.33 107.116 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -122.48 121.58 36.92 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.982 -0.747 . . . . 73.22 108.982 -177.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.407 HD13 HG21 ' D' ' 105' ' ' ILE . 10.4 mt -84.75 121.61 37.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.046 -0.724 . . . . 55.31 109.046 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -87.04 -36.23 18.31 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 119.286 -0.387 . . . . 74.12 111.616 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -172.38 122.88 0.46 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 120.788 -0.365 . . . . 62.3 111.822 -164.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.543 HD13 ' HG2' ' B' ' 130' ' ' PRO . 1.7 mp -104.41 137.91 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.886 -1.153 . . . . 64.45 107.886 166.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.502 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 30.8 p90 -161.43 177.06 10.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.151 0.907 . . . . 73.34 111.223 178.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.3 p -108.71 126.05 52.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.798 -1.092 . . . . 74.24 108.959 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.502 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 24.9 mtpt -93.88 -12.72 28.29 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.575 -0.528 . . . . 74.13 109.575 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.4 t70 -169.8 136.02 1.52 Allowed 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.516 1.126 . . . . 74.04 108.66 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.531 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.4 mt -135.47 143.6 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.436 1.094 . . . . 75.04 108.403 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -142.69 134.98 27.56 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.249 1.02 . . . . 74.33 109.252 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.528 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.7 t80 -144.22 130.81 20.03 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.377 -1.712 . . . . 73.01 106.377 165.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.8 mt-10 -131.19 150.04 52.32 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.499 0.72 . . . . 73.42 109.377 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.12 76.86 10.21 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 106.939 -1.504 . . . . 74.11 106.939 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.78 -32.72 22.56 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.855 2.37 . . . . 63.14 112.326 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -96.62 0.09 49.38 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.078 -0.964 . . . . 72.22 110.864 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.14 -68.03 0.1 OUTLIER Pre-proline 0 CA--C 1.559 1.297 0 N-CA-C 115.64 1.718 . . . . 72.0 115.64 -160.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -78.04 -16.96 13.89 Favored 'Trans proline' 0 C--N 1.383 2.37 0 CA-C-N 122.655 1.984 . . . . 63.23 113.709 -172.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -74.7 -42.16 58.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.185 0.994 . . . . 74.33 109.394 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.567 HG22 HD12 ' D' ' 68' ' ' LEU . 9.2 p -83.82 -20.61 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 115.827 -0.624 . . . . 55.22 111.093 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -64.24 -16.92 63.0 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.208 0.603 . . . . 72.12 111.923 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -68.55 -2.93 9.96 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.83 0.852 . . . . 72.53 111.801 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 89.1 mttt -109.92 101.67 10.49 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 125.125 1.37 . . . . 75.11 109.809 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -84.35 83.34 8.02 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.444 0.64 . . . . 71.44 109.518 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -146.41 157.2 43.74 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.571 1.149 . . . . 73.4 108.735 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -77.09 105.37 2.4 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.67 -0.863 . . . . 65.54 108.67 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.26 119.07 5.93 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.13 2.553 . . . . 64.34 113.909 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.15 116.22 7.7 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.089 0.956 . . . . 74.04 109.101 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.525 HG12 ' HB2' ' D' ' 66' ' ' ALA . 27.6 m -101.96 119.57 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 121.665 0.745 . . . . 73.13 112.069 -169.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 107.98 18.83 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.123 -1.806 . . . . 72.45 106.123 167.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.556 ' H ' HD23 ' D' ' 42' ' ' LEU . 1.3 pt? -98.14 156.08 16.85 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.418 0.627 . . . . 72.54 110.795 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -141.08 146.56 37.28 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.575 1.15 . . . . 73.21 108.522 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.412 ' HB2' ' CE2' ' H' ' 462' ' ' TYR . 26.4 tp -127.28 131.98 50.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.709 0.804 . . . . 63.54 109.397 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.597 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.0 t70 -141.58 144.43 34.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.473 -0.936 . . . . 72.1 108.473 173.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.479 HG22 HD21 ' H' ' 460' ' ' LEU . 8.5 t -134.55 158.84 42.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.676 -0.49 . . . . 71.21 109.676 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.12 157.2 35.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.033 -0.985 . . . . 51.1 108.384 174.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.7 p -153.96 148.2 25.89 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 109.596 -0.52 . . . . 64.44 109.596 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 57.2 p -162.58 142.23 9.35 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.124 0.569 . . . . 71.42 110.236 -171.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -71.52 125.41 26.98 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.998 0.919 . . . . 74.5 111.353 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 mt -94.63 -35.47 12.19 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.102 0.561 . . . . 61.55 109.917 172.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.75 -171.45 3.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.792 0.837 . . . . 63.3 110.381 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -59.68 113.22 2.13 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.701 0.626 . . . . 64.14 110.508 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 65.24 13.29 8.66 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.927 1.291 . . . . 62.51 111.677 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 81.8 t -109.43 118.92 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.496 -0.927 . . . . 71.2 108.496 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -127.93 127.55 43.52 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.329 -0.989 . . . . 71.31 108.329 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -94.03 122.54 36.65 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.214 1.006 . . . . 72.22 108.648 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.11 124.57 53.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 107.714 -1.217 . . . . 73.22 107.714 172.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.549 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.3 t -100.56 127.59 53.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.654 -0.869 . . . . 55.02 108.654 171.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.03 117.38 33.85 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.309 -0.997 . . . . 54.34 108.309 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.597 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.3 ttm-85 -96.73 114.28 25.91 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.881 -1.525 . . . . 72.13 106.881 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.402 HG21 ' HB1' ' D' ' 110' ' ' ALA . 64.4 t -118.03 116.84 52.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.977 -1.12 . . . . 71.24 107.977 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 74.1 m -119.17 134.61 55.11 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.615 -0.721 . . . . 72.33 109.461 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 78.1 t -131.01 118.07 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.49 0.716 . . . . 73.34 109.905 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -112.39 97.29 6.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.462 1.105 . . . . 60.04 108.279 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.525 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -96.2 161.72 13.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.321 0.649 . . . . 63.02 111.318 -173.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 28.4 p -154.66 137.33 15.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.221 -0.899 . . . . 54.32 111.663 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.567 HD12 HG22 ' D' ' 31' ' ' VAL . 65.8 mt -101.28 96.56 7.27 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.675 -1.148 . . . . 74.23 108.104 168.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.24 -130.48 10.86 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.892 -0.594 . . . . 55.41 112.671 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.26 4.86 21.94 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.109 0.964 . . . . 71.33 112.156 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.45 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 6.4 tp10 -133.46 142.46 48.29 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.918 0.887 . . . . 73.55 110.742 -165.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.0 m -60.59 133.14 55.8 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.047 0.939 . . . . 75.55 111.309 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.431 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.06 -72.6 0.57 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.321 -0.992 . . . . 73.12 108.321 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -141.02 153.77 45.69 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 115.804 -0.635 . . . . 70.03 110.514 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 55.5 mt -114.68 151.09 34.2 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.397 1.079 . . . . 71.43 108.207 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.643 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.9 t -158.94 145.27 16.86 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.572 0.349 . . . . 71.42 110.721 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -155.75 122.7 5.35 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.448 0.699 . . . . 72.32 109.647 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.91 115.65 43.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 109.464 -0.569 . . . . 74.05 109.464 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.505 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -89.8 83.14 6.18 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.112 0.958 . . . . 65.11 108.775 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.42 91.87 5.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 113.619 -1.628 . . . . 63.51 108.997 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.23 141.95 17.15 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.635 -0.586 . . . . 73.41 111.635 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.54 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -140.07 130.14 4.54 Favored Glycine 0 C--O 1.228 -0.269 0 N-CA-C 111.49 -0.644 . . . . 54.42 111.49 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.7 mt -88.29 122.53 39.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.492 1.117 . . . . 62.52 108.977 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -123.74 156.98 35.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.303 0.641 . . . . 71.32 109.634 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.4 m -115.15 108.08 16.16 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.417 -0.957 . . . . 62.13 108.417 170.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.422 HD13 HD13 ' D' ' 98' ' ' LEU . 41.0 pt -105.75 139.84 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.486 0.714 . . . . 74.21 109.352 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -160.04 150.58 18.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.652 0.781 . . . . 60.03 109.74 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.43 -16.19 46.09 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.903 -0.387 . . . . 70.1 113.58 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' D' ' 94' ' ' MET . 43.2 pt -97.96 149.8 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.752 0.821 . . . . 72.32 109.822 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -168.3 177.68 5.29 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.165 0.586 . . . . 74.31 110.761 -168.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.07 -117.5 11.21 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.698 0.624 . . . . 74.32 112.817 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 19.3 m -92.27 -24.08 19.1 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.456 0.703 . . . . 71.45 110.861 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -61.16 -33.84 74.07 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.909 0.884 . . . . 74.35 111.164 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.505 ' HA ' HD12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -63.85 -33.98 76.9 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.099 -0.5 . . . . 72.42 111.332 177.379 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.477 ' HA ' HD22 ' H' ' 454' ' ' LEU . . . -77.32 -32.61 55.39 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.018 0.527 . . . . 74.34 110.758 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.4 t-80 -72.62 -26.38 61.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.755 0.822 . . . . 61.22 111.264 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -90.54 -50.37 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.931 0.493 . . . . 72.24 110.877 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.601 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 13.9 tp -82.42 -27.21 32.13 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.117 0.567 . . . . 75.4 111.68 -170.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.62 14.13 42.36 Favored Glycine 0 N--CA 1.477 1.379 0 CA-C-O 119.879 -0.401 . . . . 73.5 113.46 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -144.41 -64.41 0.36 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.929 0.492 . . . . 54.1 110.642 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -69.95 -40.11 75.66 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.677 0.391 . . . . 74.34 111.644 -176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.601 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 85.6 m -66.35 -47.27 59.92 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.405 -0.807 . . . . 73.33 112.152 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 78.1 Cg_exo -56.79 -32.62 92.14 Favored 'Trans proline' 0 C--N 1.4 3.237 0 C-N-CA 122.231 1.954 . . . . 73.24 113.386 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.46 -30.5 70.86 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.153 0.581 . . . . 63.02 111.678 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.407 HG21 HD13 ' D' ' 13' ' ' ILE . 95.2 mt -72.9 -37.25 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.72 0.808 . . . . 72.44 110.316 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.54 HD21 ' HA3' ' D' ' 82' ' ' GLY . 92.5 mt -75.66 -20.38 58.5 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.226 -0.897 . . . . 74.53 111.769 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -67.94 -43.47 37.09 Favored Pre-proline 0 CA--C 1.563 1.451 0 N-CA-C 113.763 1.023 . . . . 75.42 113.763 -171.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.69 -38.73 87.7 Favored 'Trans proline' 0 C--N 1.395 2.99 0 C-N-CA 121.931 1.754 . . . . 75.33 112.383 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -74.75 -32.74 62.17 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.902 0.751 . . . . 75.33 111.348 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.402 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -64.71 -53.93 39.46 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.224 -0.658 . . . . 62.03 109.224 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.431 HH12 ' HB3' ' D' ' 130' ' ' PRO . 40.5 ttp180 -58.14 -44.3 87.77 Favored 'General case' 0 C--O 1.212 -0.907 0 O-C-N 124.603 1.189 . . . . 64.32 110.509 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.17 -46.22 89.95 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.863 0.727 . . . . 74.3 111.137 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.82 -44.67 90.91 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.012 0.82 . . . . 65.14 110.339 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.643 HG12 ' SG ' ' D' ' 76' ' ' CYS . 69.0 mt -64.28 -52.29 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 124.033 0.833 . . . . 71.33 110.617 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 88.2 m -56.06 -43.68 78.14 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.679 1.192 . . . . 71.14 111.338 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.6 t -64.83 -41.63 95.58 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.995 -1.002 . . . . 43.33 109.978 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.8 mtm -69.85 -28.76 65.94 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.937 0.495 . . . . 61.34 111.917 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' D' ' 123' ' ' PHE . 54.7 t -70.72 -39.75 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.69 0.796 . . . . 71.1 110.419 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.2 p -76.66 -26.9 55.34 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.73 0.412 . . . . 52.32 110.729 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -73.78 -35.38 64.95 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.133 0.573 . . . . 74.15 109.475 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.95 -0.51 89.59 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 115.743 -0.662 . . . . 74.02 112.338 173.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.2 p 64.9 18.93 11.7 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.899 2.08 . . . . 71.44 114.327 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.417 ' HB2' HG13 ' D' ' 118' ' ' VAL . 96.3 m-85 -79.45 150.79 74.06 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 109.131 -0.692 . . . . 74.11 109.131 169.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.35 137.85 47.04 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.924 2.416 . . . . 52.22 112.771 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -55.74 143.36 31.11 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.915 1.286 . . . . 74.02 113.42 -168.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 50.0 tp -115.17 97.42 6.19 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.336 1.054 . . . . 70.41 109.716 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -104.16 89.65 3.33 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.731 -0.47 . . . . 72.53 109.731 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 36.4 tp -67.05 137.55 56.52 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.434 -0.803 . . . . 73.0 109.714 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.31 130.39 91.65 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.594 0.757 . . . . 62.25 111.113 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.431 ' HB3' HH12 ' D' ' 111' ' ' ARG . 56.6 Cg_endo -70.88 116.84 4.85 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.189 1.926 . . . . 72.03 110.756 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.03 124.39 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.554 0.742 . . . . 55.42 109.773 -171.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -73.9 96.28 2.59 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.659 -0.867 . . . . 73.24 108.659 171.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -68.38 -23.73 64.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.824 -0.625 . . . . 70.04 111.3 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.03 -54.85 41.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.277 1.031 . . . . 65.01 110.642 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.5 -43.06 91.33 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.306 1.004 . . . . 74.03 111.144 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' D' ' 139' ' ' ASN . 16.6 tp -72.93 -22.18 60.77 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 115.85 -0.614 . . . . 73.33 111.634 -176.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -71.5 -35.94 70.94 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.852 0.861 . . . . 74.23 110.044 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 32.5 mtt -60.21 -43.25 96.13 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.546 0.738 . . . . 74.14 109.817 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.404 HD22 ' HA ' ' D' ' 136' ' ' LEU . 46.7 m-80 -60.32 -45.95 91.62 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.847 0.859 . . . . 75.41 111.231 175.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -61.09 -41.22 96.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.069 0.948 . . . . 52.31 112.231 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 5.5 mp -65.96 -29.66 70.1 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.762 0.825 . . . . 74.3 111.286 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -78.81 0.53 26.65 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.408 0.683 . . . . 54.41 111.938 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -123.01 42.46 3.19 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.256 0.622 . . . . 73.01 109.713 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -171.53 150.18 2.76 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.741 0.816 . . . . 72.52 110.403 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.49 159.3 20.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.695 0.798 . . . . 71.34 110.761 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.08 102.72 1.03 Allowed Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.492 -0.776 . . . . 53.32 111.788 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.62 152.11 48.07 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 123.632 0.773 . . . . 71.04 109.831 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -75.74 91.91 0.89 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.748 -0.941 . . . . 61.45 110.748 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 75.2 m -56.11 139.43 47.2 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.75 0.82 . . . . 72.01 110.797 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -58.06 87.81 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 O-C-N 124.609 1.193 . . . . 75.13 112.816 -172.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -142.93 160.27 40.66 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.824 1.65 . . . . 73.04 107.918 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -85.92 76.42 9.86 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 108.638 -0.875 . . . . 71.21 108.638 175.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -89.45 174.99 7.49 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.887 0.875 . . . . 64.51 111.535 -173.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -93.36 96.26 9.83 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.36 -0.978 . . . . 75.33 108.36 170.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.388 0 C-N-CA 124.996 1.318 . . . . 73.14 111.213 179.807 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 109.125 -0.695 . . . . 75.21 109.125 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . 0.549 HG22 ' SD ' ' A' ' 94' ' ' MET . 7.2 p -74.49 -53.66 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 122.585 0.354 . . . . 71.5 111.857 -176.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . 0.521 HG22 ' H ' ' E' ' 454' ' ' LEU . 6.6 p -88.87 133.57 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.779 -0.822 . . . . 65.32 108.779 177.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -85.67 -15.24 66.19 Favored Glycine 0 N--CA 1.472 1.092 0 CA-C-O 119.796 -0.447 . . . . 61.3 113.299 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . 0.521 ' H ' HG22 ' E' ' 452' ' ' VAL . 34.0 tp 65.07 36.81 7.1 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.412 1.085 . . . . 74.22 109.427 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 24.5 m -65.87 96.42 0.3 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.409 -1.268 . . . . 55.53 111.028 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 32.9 t70 59.11 95.89 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.282 1.433 . . . . 73.34 111.573 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -98.96 17.13 20.36 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.393 -0.821 . . . . 63.23 110.977 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 11.7 m -76.08 78.49 2.92 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.287 0.635 . . . . 72.21 109.819 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -171.89 130.17 0.64 Allowed 'General case' 0 C--N 1.348 0.521 0 C-N-CA 124.668 1.187 . . . . 75.22 108.287 -177.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.56 108.05 6.93 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.838 -1.171 . . . . 73.41 107.838 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -60.36 -31.15 70.05 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.204 1.187 . . . . 75.53 114.204 -172.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -160.41 116.78 2.38 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.192 0.597 . . . . 74.0 109.674 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 14.1 t -93.89 -13.0 27.66 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.478 0.711 . . . . 74.14 112.167 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . 0.553 ' SD ' HD23 ' A' ' 42' ' ' LEU . 24.5 ttt 72.31 153.0 0.13 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.253 1.421 . . . . 62.54 112.274 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -81.41 -68.24 0.71 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.381 -0.97 . . . . 60.41 108.381 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . 168.64 174.12 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.814 1.646 . . . . 53.25 109.814 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . 0.427 ' HB3' ' H ' ' A' ' 129' ' ' ALA . . . -157.36 121.82 4.35 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.006 0.522 . . . . 35.43 110.597 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . 0.434 HD13 HD12 ' E' ' 470' ' ' LEU . 0.5 OUTLIER -172.35 129.24 0.57 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.729 -1.212 . . . . 74.53 107.729 174.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -88.46 50.89 3.87 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 111.201 -0.76 . . . . 74.22 111.201 172.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . 0.434 HD12 HD13 ' E' ' 468' ' ' LEU . 5.6 tt -79.67 108.25 13.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.922 0.889 . . . . 73.21 109.51 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 79.0 tttt . . . . . 0 C--O 1.251 1.158 0 N-CA-C 108.829 -0.804 . . . . 52.22 108.829 170.878 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 54.3 t30 . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 121.334 0.588 . . . . 71.22 109.947 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . 0.418 ' HA ' ' HG3' ' B' ' 90' ' ' GLU . 15.6 m -96.61 16.11 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-N 115.127 -0.942 . . . . 64.11 112.559 -169.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.56 157.14 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 112.211 0.449 . . . . 63.22 112.211 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -178.49 -139.31 3.45 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.495 -0.775 . . . . 52.12 112.136 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 11.2 mp 56.83 72.68 0.49 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.362 1.065 . . . . 71.55 111.265 -173.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 14.6 t -113.18 0.4 14.9 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.835 -1.075 . . . . 75.51 109.844 172.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -123.4 152.69 41.31 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.13 0.972 . . . . 63.44 109.834 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -100.25 105.69 17.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.47 0.708 . . . . 71.45 111.012 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 40.0 p -78.46 126.52 30.88 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.552 0.741 . . . . 61.54 109.703 171.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -63.59 152.5 38.64 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.627 0.771 . . . . 71.33 110.942 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 42.6 tp -71.25 157.39 38.2 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.603 0.761 . . . . 73.24 110.238 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -144.14 142.85 30.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.206 0.603 . . . . 71.15 111.137 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -134.04 137.49 44.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.316 1.046 . . . . 74.3 110.088 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 29.2 m -140.71 79.39 1.7 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.713 -1.218 . . . . 72.41 107.713 170.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 26.5 ptm -150.74 136.11 17.84 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.09 -0.959 . . . . 72.44 109.653 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -107.59 133.38 52.13 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.248 1.019 . . . . 71.24 108.691 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . 67.91 125.79 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.755 1.222 . . . . 62.53 110.82 -169.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -64.12 -57.68 8.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.21 0.604 . . . . 60.3 110.556 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . 0.41 HD11 ' HB ' ' B' ' 40' ' ' VAL . 61.4 mt -136.27 -61.77 0.69 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.998 0.919 . . . . 73.13 109.557 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 103.4 56.09 0.79 Allowed Glycine 0 C--N 1.344 0.993 0 CA-C-N 114.862 -1.063 . . . . 73.33 110.506 -169.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 97.2 mt -69.94 141.08 53.11 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.216 0.606 . . . . 75.14 110.327 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . 0.543 ' HE3' ' HA ' ' F' ' 471' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.256 1.421 0 C-N-CA 123.199 0.6 . . . . 74.22 110.857 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . 0.477 ' HA ' HE22 ' C' ' 50' ' ' GLN . 77.5 m-20 . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 110.246 -0.279 . . . . 60.51 110.246 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' C' ' 54' ' ' ASP . 9.8 p -83.83 146.36 6.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.353 -0.98 . . . . 61.32 108.353 166.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . 0.64 HG13 ' SD ' ' C' ' 94' ' ' MET . 61.1 t 68.23 141.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 124.329 1.052 . . . . 62.23 112.853 176.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . -131.17 45.06 1.16 Allowed Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.125 -0.489 . . . . 61.41 112.566 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . 0.493 ' HG ' ' SD ' ' C' ' 94' ' ' MET . 18.1 mt -78.34 125.26 29.1 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.933 0.397 . . . . 74.33 110.819 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 10.1 t -153.92 28.64 0.47 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.467 1.107 . . . . 51.51 108.766 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -153.4 -65.17 0.15 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.741 -1.118 . . . . 74.24 109.219 -170.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.37 8.06 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 125.062 1.345 . . . . 51.43 113.58 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 6.9 m 65.81 163.12 0.16 Allowed 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 125.217 1.407 . . . . 61.23 111.663 -176.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.48 44.48 0.89 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.818 0.818 . . . . 65.23 110.059 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 51.12 -140.29 0.88 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.286 1.435 . . . . 70.25 111.312 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . 0.466 ' HZ ' ' HA ' ' C' ' 133' ' ' PHE . 33.2 p90 -163.54 -48.52 0.03 OUTLIER 'General case' 0 C--N 1.356 0.88 0 C-N-CA 122.932 0.493 . . . . 74.32 110.502 -177.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 34.7 t80 51.55 70.63 0.52 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.787 1.235 . . . . 73.23 111.066 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 11.5 t -75.84 -10.25 59.27 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.53 0.567 . . . . 71.53 112.53 -170.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 27.2 ptm -94.56 154.43 17.39 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.117 0.567 . . . . 70.11 110.409 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -150.76 12.27 0.69 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.894 0.878 . . . . 74.22 110.228 174.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -140.42 172.86 12.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.994 0.918 . . . . 71.12 110.337 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . 73.68 139.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.424 1.49 . . . . 62.02 111.944 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . 0.415 HD12 ' HG ' ' C' ' 126' ' ' LEU . 24.2 tp -150.6 -52.38 0.14 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.949 0.9 . . . . 70.0 109.912 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 119.83 -48.64 0.93 Allowed Glycine 0 N--CA 1.474 1.181 0 N-CA-C 109.703 -1.359 . . . . 53.45 109.703 -173.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 6.3 tt -66.37 -48.51 69.94 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.841 -1.54 . . . . 62.03 106.841 163.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . 0.459 ' HA ' ' HE3' ' G' ' 471' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.55 0.956 0 CA-C-N 115.119 -0.946 . . . . 75.55 108.948 173.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' B' ' 152' ' ' HIS . 2.3 m-20 . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 121.282 0.563 . . . . 51.45 110.151 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 26.8 m -81.17 -174.07 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.4 -0.818 . . . . 70.11 111.14 175.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . 0.505 HG13 ' HG2' ' D' ' 94' ' ' MET . 14.8 p -124.33 159.63 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.956 0.902 . . . . 65.23 109.787 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -133.31 158.84 23.38 Favored Glycine 0 C--O 1.243 0.668 0 N-CA-C 110.966 -0.854 . . . . 62.04 110.966 170.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' D' ' 95' ' ' ALA . 2.5 pt? -66.8 131.64 46.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.536 0.334 . . . . 54.51 110.686 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 10.4 t -115.86 -11.87 11.5 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.868 0.867 . . . . 71.34 110.467 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.56 126.35 27.23 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.076 0.95 . . . . 51.3 110.635 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -73.92 76.46 1.66 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.459 0.704 . . . . 72.14 109.169 175.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 12.8 t -92.98 141.93 27.86 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 108.921 -0.77 . . . . 72.24 108.921 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.04 153.53 41.69 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.68 0.392 . . . . 74.22 110.965 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . 0.479 HD21 HG22 ' D' ' 46' ' ' THR . 4.3 mm? -90.22 166.65 13.23 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.36 0.6 . . . . 70.52 111.124 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -135.79 133.64 38.11 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.148 -0.933 . . . . 75.01 111.161 -164.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' D' ' 44' ' ' LEU . 10.5 m-85 -135.05 98.83 4.1 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.309 1.043 . . . . 71.33 109.486 172.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 6.1 m -92.35 -3.37 55.44 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 121.288 0.566 . . . . 53.2 109.694 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 60.7 ttp -71.39 118.88 14.76 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 124.068 0.947 . . . . 72.15 109.834 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -93.75 30.79 1.72 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.823 0.849 . . . . 52.24 111.426 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -149.04 -179.8 7.3 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.954 0.902 . . . . 71.34 110.739 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -150.22 -63.83 0.21 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.807 0.843 . . . . 65.15 108.791 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -147.93 0.29 0.63 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.817 0.847 . . . . 74.32 110.432 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.01 -36.69 3.58 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 123.007 0.337 . . . . 61.23 113.071 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 63.67 67.42 0.63 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.878 1.271 . . . . 75.24 109.885 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm . . . . . 0 C--O 1.247 0.955 0 N-CA-C 108.875 -0.787 . . . . 73.33 108.875 177.034 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptp . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.455 -0.202 . . . . 73.43 110.455 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.3 t -165.57 116.6 1.08 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.024 -1.102 . . . . 63.41 108.024 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.08 112.34 7.16 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.407 0.622 . . . . 72.42 109.52 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -75.44 143.53 42.63 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.469 -0.787 . . . . 71.03 109.444 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -65.49 128.94 37.93 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.039 -0.726 . . . . 74.42 109.039 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -65.3 -69.34 0.3 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.048 -1.093 . . . . 73.25 108.048 176.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.0 m -156.16 83.36 1.0 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 107.416 -1.327 . . . . 70.33 107.416 163.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -160.16 153.86 22.63 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.78 0.832 . . . . 75.53 109.237 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 9' ' ' MET . 1.3 mpt? -65.47 158.41 26.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.41 1.084 . . . . 72.32 111.495 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 60.5 m -151.68 136.31 17.04 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.586 1.154 . . . . 62.33 108.048 170.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.611 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.0 t80 -135.88 129.53 32.44 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.298 -0.63 . . . . 64.05 109.298 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -143.43 117.01 9.17 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.639 -1.245 . . . . 71.34 107.639 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.485 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.1 mt -87.07 125.28 40.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.934 -0.765 . . . . 74.43 108.934 176.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.43 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -79.62 -43.86 22.08 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 124.05 0.844 . . . . 74.11 108.901 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -173.38 128.79 0.44 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 119.495 -0.288 . . . . 72.14 111.096 -168.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.7 mt -113.04 124.05 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 123.665 0.786 . . . . 75.12 109.427 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HE1' HG13 ' A' ' 83' ' ' ILE . 25.3 p90 -152.96 141.33 20.65 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.31 1.044 . . . . 73.2 110.423 -169.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.8 p -75.53 110.98 10.36 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.552 -0.536 . . . . 74.22 109.552 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.531 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 36.0 mtpt -75.96 -27.57 57.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.978 -0.378 . . . . 41.34 109.978 176.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.669 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.3 t70 -148.53 138.57 22.36 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.166 -0.924 . . . . 62.24 110.061 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 86.9 mt -134.77 142.32 40.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 125.629 1.572 . . . . 65.01 106.895 173.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.9 t -148.73 140.72 23.85 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 123.63 0.581 . . . . 64.32 109.972 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.523 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 77.0 t80 -143.05 127.07 17.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.255 -1.757 . . . . 75.21 106.255 173.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -137.64 121.37 17.47 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.91 -0.404 . . . . 61.12 109.91 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -129.83 77.24 77.15 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 107.997 -1.112 . . . . 71.23 107.997 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.43 -19.38 37.78 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.059 2.506 . . . . 72.33 112.188 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -120.17 28.91 7.78 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.88 0.872 . . . . 71.33 109.743 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -55.69 -46.84 99.67 Favored Pre-proline 0 CA--C 1.566 1.58 0 N-CA-C 113.45 0.907 . . . . 52.04 113.45 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.29 -13.23 18.88 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 122.2 1.933 . . . . 63.41 112.576 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -90.81 -34.27 15.37 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.745 0.818 . . . . 74.41 110.717 -173.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.554 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 35.9 m -77.78 -17.42 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.494 0.718 . . . . 75.34 111.416 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.584 ' HD1' HH11 ' B' ' 15' ' ' ARG . 75.2 t80 -60.26 -35.07 74.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.318 1.047 . . . . 74.13 110.145 165.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -86.73 -52.58 5.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.097 0.959 . . . . 55.33 111.65 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 17.7 ptpt -73.89 170.77 14.68 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.735 0.414 . . . . 64.13 111.419 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.93 128.21 35.13 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.105 -0.498 . . . . 71.24 109.663 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.3 t-105 -72.34 94.2 1.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 O-C-N 123.793 0.683 . . . . 72.22 109.861 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -128.45 84.85 61.97 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.58 1.152 . . . . 70.43 108.706 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 49.2 Cg_endo -87.49 165.25 7.94 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.351 2.034 . . . . 73.4 112.451 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -121.99 106.71 11.46 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.83 -1.174 . . . . 62.02 107.83 168.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.8 m -73.7 92.75 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-O 122.764 1.268 . . . . 42.24 110.761 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -95.05 124.55 39.16 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.516 -1.22 . . . . 72.34 109.315 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.639 ' H ' ' HB2' ' E' ' 465' ' ' LYS . 50.7 tp -120.52 115.56 23.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.412 0.685 . . . . 72.42 110.072 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 15.1 t70 -106.52 108.43 19.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.945 -1.132 . . . . 74.43 107.945 168.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 60' ' ' LEU . 1.2 tm? -97.59 119.2 35.72 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.584 -1.265 . . . . 53.13 107.584 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -127.08 151.11 49.06 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.508 1.123 . . . . 73.04 109.561 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.8 m -134.9 139.78 45.26 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.05 0.94 . . . . 72.02 109.541 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.28 153.6 51.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.913 1.285 . . . . 73.41 108.387 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 m -133.0 151.63 52.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.235 0.614 . . . . 74.1 109.669 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -150.36 121.47 7.74 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.651 -0.87 . . . . 73.21 108.651 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -79.67 125.55 29.78 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.902 0.382 . . . . 64.21 110.762 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.423 ' HB2' HG12 ' A' ' 55' ' ' VAL . 66.3 mt -93.37 -34.7 13.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.964 0.906 . . . . 74.11 111.448 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.498 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -164.19 -172.49 2.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.534 0.734 . . . . 60.32 110.866 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.05 116.98 5.83 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.431 0.693 . . . . 70.22 109.558 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 71.47 -7.19 1.24 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 125.412 1.485 . . . . 75.42 112.419 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 60.6 t -104.69 125.06 59.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 124.45 1.1 . . . . 73.44 109.1 -174.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -143.0 171.3 14.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.018 -0.734 . . . . 72.0 109.018 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -125.12 152.0 45.0 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.776 -0.824 . . . . 73.44 108.776 167.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.7 t -115.62 126.73 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 107.876 -1.157 . . . . 75.15 107.876 168.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.3 t -97.96 105.48 17.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.046 -1.094 . . . . 74.53 108.046 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 44' ' ' LEU . 42.7 tp -91.96 100.19 12.89 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.074 -0.714 . . . . 71.12 109.074 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -83.59 101.37 11.43 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.872 -0.788 . . . . 72.21 108.872 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.4 t -100.14 101.84 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.781 -1.192 . . . . 72.11 107.781 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.8 m -96.36 109.62 22.11 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.174 -0.676 . . . . 70.21 109.174 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.5 t -112.31 131.43 63.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.913 -1.143 . . . . 70.52 107.913 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -135.64 150.55 49.65 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.264 -1.013 . . . . 70.12 108.264 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -139.44 116.43 10.98 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.668 -1.234 . . . . 65.04 107.668 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.7 m -141.38 145.08 34.93 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.677 0.391 . . . . 53.11 111.793 -170.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.535 HD12 ' HZ3' ' A' ' 34' ' ' LYS . 3.2 tm? -94.79 87.53 5.04 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.708 -1.219 . . . . 73.03 107.708 170.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.5 -104.82 1.82 Allowed Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.791 -0.641 . . . . 53.44 112.583 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -95.36 -25.84 16.13 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.5 0.72 . . . . 71.32 110.771 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.55 123.08 29.39 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.789 0.435 . . . . 54.23 110.504 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 m -77.97 127.07 31.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.022 0.529 . . . . 72.34 110.121 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -80.43 -51.13 9.19 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.647 -0.871 . . . . 72.42 108.647 173.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -160.94 159.98 30.25 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.431 -1.259 . . . . 75.22 110.827 172.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 55.2 tp -129.84 143.03 50.6 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.289 1.435 . . . . 63.02 107.776 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.609 ' SG ' HG22 ' A' ' 118' ' ' VAL . 56.9 m -147.17 103.85 3.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.157 0.983 . . . . 51.22 109.099 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -128.54 127.46 42.42 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.654 -0.869 . . . . 73.14 108.654 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.5 t -128.75 110.96 22.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.732 -0.84 . . . . 74.23 108.732 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.669 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.3 mt-30 -85.26 85.67 7.44 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 108.449 -0.945 . . . . 74.2 108.449 171.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.516 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.1 tp-100 -76.51 102.17 5.93 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.096 -1.411 . . . . 75.34 109.035 -178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.89 164.96 37.74 Favored Glycine 0 C--N 1.337 0.639 0 N-CA-C 111.334 -0.706 . . . . 61.51 111.334 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.05 124.94 1.1 Allowed Glycine 0 CA--C 1.51 -0.272 0 N-CA-C 111.765 -0.534 . . . . 73.2 111.765 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.469 HG13 ' HE1' ' A' ' 17' ' ' TYR . 46.5 mt -81.13 126.06 39.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.275 -0.639 . . . . 64.21 109.275 176.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.611 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 37.3 m-85 -128.56 137.72 51.87 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.388 1.075 . . . . 74.14 108.135 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.5 m -107.77 115.9 30.98 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.726 -0.842 . . . . 63.41 108.726 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.42 HG21 HG21 ' E' ' 452' ' ' VAL . 17.4 tt -105.52 143.61 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.628 0.771 . . . . 75.32 110.484 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.49 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -161.68 146.41 13.12 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.754 0.821 . . . . 73.42 109.701 176.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.36 -32.45 6.81 Favored Glycine 0 C--N 1.341 0.84 0 O-C-N 123.541 0.526 . . . . 52.45 113.713 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.29 146.11 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.947 0.499 . . . . 65.24 112.179 -165.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -135.71 173.07 12.12 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.279 1.031 . . . . 72.14 110.46 -174.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.479 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 56.95 -115.66 6.78 Favored Glycine 0 C--N 1.356 1.666 0 N-CA-C 115.61 1.004 . . . . 63.52 115.61 170.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.5 p -66.17 -33.98 77.0 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.671 0.789 . . . . 75.42 111.159 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -70.17 -43.43 70.82 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.199 -0.91 . . . . 71.31 110.874 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.563 ' SD ' ' HA ' ' E' ' 452' ' ' VAL . 13.2 ptt? -66.04 -37.23 85.34 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.132 -0.692 . . . . 62.41 109.132 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.78 81.58 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 123.542 0.737 . . . . 72.3 110.628 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -64.87 -35.8 82.31 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.646 -0.706 . . . . 45.2 110.639 174.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 61.0 m -69.0 -41.66 77.5 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.013 0.525 . . . . 71.24 111.331 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 94' ' ' MET . 65.3 mt -78.9 -43.69 24.32 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.513 0.725 . . . . 73.53 111.885 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.72 4.01 53.3 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-O 119.268 -0.74 . . . . 73.41 114.472 -169.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.48 -57.91 0.23 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 118.075 0.938 . . . . 61.41 112.611 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.622 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 81.3 t80 -66.51 -53.92 29.66 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.996 0.918 . . . . 72.04 112.005 -168.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.3 m -72.98 -36.42 3.36 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.611 -0.709 . . . . 72.52 112.842 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -49.97 -41.35 48.31 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.405 2.07 . . . . 72.42 113.265 161.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -67.36 -32.96 74.25 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.652 0.781 . . . . 75.35 111.227 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.37 -45.25 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.225 0.61 . . . . 60.34 110.305 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.516 HD22 ' HG3' ' A' ' 80' ' ' GLN . 74.3 mt -74.85 -20.74 59.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.116 -0.947 . . . . 73.31 112.144 -175.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.566 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 61.9 t80 -62.3 -44.79 89.37 Favored Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 114.134 1.161 . . . . 74.03 114.134 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -59.54 -37.93 85.75 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 121.878 1.719 . . . . 75.21 112.988 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -70.15 -42.0 73.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.421 0.688 . . . . 75.24 111.029 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.07 -36.6 72.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.856 -0.611 . . . . 74.11 110.844 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.554 ' NH1' HD12 ' C' ' 105' ' ' ILE . 32.0 ttm180 -50.43 -56.41 11.57 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.353 1.033 . . . . 73.23 109.669 174.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -65.39 -43.39 90.81 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.345 1.028 . . . . 64.33 111.8 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.599 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.4 t -61.39 -24.82 66.77 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.048 0.539 . . . . 73.15 112.151 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.466 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.8 mt -84.93 -53.71 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.163 0.985 . . . . 72.2 109.821 172.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.501 HG23 ' HG3' ' A' ' 125' ' ' GLN . 85.5 m -53.33 -52.53 58.87 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.931 1.292 . . . . 55.1 112.521 -174.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.3 t -58.41 -44.55 89.09 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.398 -0.819 . . . . 75.51 110.646 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.523 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.3 ttp -66.15 -32.34 73.72 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.422 1.089 . . . . 45.33 111.644 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.609 HG22 ' SG ' ' A' ' 76' ' ' CYS . 87.1 t -70.39 -45.14 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.117 0.967 . . . . 75.11 110.423 174.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.8 m -68.08 -25.59 65.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.557 0.743 . . . . 71.42 111.596 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -72.55 -32.38 66.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.668 0.787 . . . . 74.13 109.541 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.93 0.34 83.08 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 124.005 0.816 . . . . 64.51 113.288 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.8 m 65.72 16.5 10.52 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.754 1.222 . . . . 74.5 111.199 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -86.8 153.83 55.3 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.79 0.836 . . . . 61.03 109.058 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -53.63 119.19 5.82 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 123.162 2.575 . . . . 75.51 112.343 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.501 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.9 tt0 -53.0 128.93 29.01 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.304 1.042 . . . . 74.15 111.627 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 pp -109.36 137.18 47.61 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.462 -0.94 . . . . 72.21 108.462 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -123.19 91.67 3.53 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.029 -1.471 . . . . 74.53 107.029 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.566 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -63.46 122.24 15.78 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.198 -0.91 . . . . 75.43 109.45 -173.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.64 140.17 96.96 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.223 0.609 . . . . 72.34 110.806 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.12 128.74 29.91 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.41 2.073 . . . . 73.02 111.754 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.3 t -97.82 137.01 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.972 -0.751 . . . . 73.34 108.972 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.442 HD22 ' HB3' ' A' ' 135' ' ' ALA . 1.8 p-10 -77.1 69.04 3.33 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.569 1.148 . . . . 50.14 111.249 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -53.21 -43.6 67.36 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.139 0.976 . . . . 73.12 111.621 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -58.86 -51.64 69.13 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.226 0.953 . . . . 74.14 111.201 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.442 ' HB3' HD22 ' A' ' 132' ' ' ASN . . . -62.97 -41.15 99.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.872 0.733 . . . . 51.34 111.582 -176.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.29 -44.53 95.29 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.217 0.948 . . . . 73.0 110.269 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -72.99 -30.96 64.19 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 115.388 -0.824 . . . . 74.02 110.672 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.703 ' SD ' HD23 ' A' ' 141' ' ' LEU . 15.9 mmt -66.34 -26.04 67.1 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.26 0.624 . . . . 64.03 111.44 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -63.57 -31.09 72.15 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.745 0.818 . . . . 33.43 110.7 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.413 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 76.4 t80 -93.2 -36.64 12.51 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.375 1.07 . . . . 74.32 110.785 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.703 HD23 ' SD ' ' A' ' 138' ' ' MET . 20.4 tp -70.72 -21.32 62.57 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.348 1.059 . . . . 72.43 111.467 -172.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -142.83 29.01 1.54 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.073 0.949 . . . . 60.31 110.009 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -61.87 -30.82 71.12 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 120.906 0.384 . . . . 61.43 111.479 173.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -88.37 -45.76 9.73 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.221 1.008 . . . . 62.22 109.51 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.78 2.34 10.34 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.662 -0.699 . . . . 52.51 112.705 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.45 3.89 85.36 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.878 -0.401 . . . . 55.53 113.585 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.68 -55.68 7.25 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.356 0.663 . . . . 71.15 110.539 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.27 149.75 8.0 Favored Glycine 0 C--N 1.348 1.194 0 CA-C-N 115.959 -0.564 . . . . 63.03 112.714 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.7 m -94.5 -81.46 0.38 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.003 -0.74 . . . . 71.05 109.003 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 54.01 -161.8 0.13 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.368 1.067 . . . . 73.14 113.055 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 65.3 51.49 1.59 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.578 1.151 . . . . 75.4 109.212 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -148.92 3.82 0.63 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.615 -1.175 . . . . 73.24 110.76 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -72.34 -10.38 59.72 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 112.079 0.399 . . . . 75.05 112.079 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -112.89 157.44 21.42 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.783 0.833 . . . . 73.21 108.811 167.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.321 0 C-N-CA 123.623 0.769 . . . . 72.03 108.945 -178.676 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.56 ' SD ' ' HB2' ' B' ' 3' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 108.821 -0.807 . . . . 64.14 108.821 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 31.4 m -78.94 81.77 5.19 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.36 0.6 . . . . 43.41 109.841 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.56 ' HB2' ' SD ' ' B' ' 1' ' ' MET . 33.9 tt0 -134.96 173.9 11.2 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.106 0.963 . . . . 73.15 108.563 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -59.6 116.7 4.2 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.052 0.941 . . . . 62.13 111.345 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -67.88 -27.07 66.35 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.171 0.589 . . . . 70.11 110.971 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -72.05 92.3 1.3 Allowed 'General case' 0 C--N 1.352 0.691 0 N-CA-C 109.307 -0.627 . . . . 72.55 109.307 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.538 HG22 ' H ' ' B' ' 9' ' ' MET . 27.0 m -136.71 147.51 46.8 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.085 0.954 . . . . 73.22 108.514 176.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.03 -26.81 67.69 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.497 0.719 . . . . 72.33 111.476 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.538 ' H ' HG22 ' B' ' 7' ' ' THR . 15.8 ptm 54.55 170.78 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 127.485 2.314 . . . . 72.32 114.739 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.0 m -149.87 139.19 21.36 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.826 1.25 . . . . 74.11 107.946 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -137.46 142.94 41.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.014 0.525 . . . . 62.52 109.633 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -144.59 141.0 29.12 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.465 0.706 . . . . 73.53 109.755 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.465 HD11 HD13 ' B' ' 105' ' ' ILE . 31.6 mt -94.59 125.77 47.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 107.705 -1.22 . . . . 74.43 107.705 170.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -92.8 -41.25 10.2 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.618 -0.512 . . . . 75.24 109.618 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.584 HH11 ' HD1' ' A' ' 32' ' ' PHE . 58.9 ttt180 -168.92 132.86 1.43 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.613 -0.721 . . . . 72.12 109.562 -173.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.453 HD12 HD22 ' D' ' 127' ' ' ASN . 81.7 mt -114.84 135.32 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 106.595 -1.632 . . . . 61.15 106.595 170.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.454 ' HE1' HG13 ' B' ' 83' ' ' ILE . 19.2 p90 -165.52 139.97 4.79 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.229 0.538 . . . . 71.44 110.921 -172.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.4 m -73.4 125.57 28.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.052 -0.976 . . . . 73.32 108.929 174.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.418 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.4 mtpt -98.35 -27.81 13.94 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.478 0.711 . . . . 61.3 110.855 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.7 t70 -157.16 137.7 13.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.62 0.368 . . . . 64.02 110.837 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.6 mm -133.37 145.03 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.644 1.178 . . . . 70.24 108.963 174.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -141.31 141.57 33.89 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.723 1.209 . . . . 54.23 108.427 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.422 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 71.8 t80 -156.07 113.98 3.32 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.143 -1.058 . . . . 73.43 108.143 170.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -126.18 115.91 20.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.825 0.85 . . . . 71.5 109.213 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.453 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.92 86.31 3.02 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.141 -1.059 . . . . 75.44 108.141 172.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.65 -27.64 26.75 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 122.869 2.38 . . . . 64.44 112.73 -172.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -108.75 15.85 23.28 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 118.564 -0.731 . . . . 65.1 110.574 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.531 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -40.06 -61.7 1.06 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 115.122 1.527 . . . . 62.41 115.122 -164.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.95 -31.06 56.88 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 121.837 1.692 . . . . 64.34 112.735 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -74.81 -49.23 21.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.681 0.792 . . . . 71.43 110.923 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.698 HG22 HD12 ' B' ' 68' ' ' LEU . 8.6 p -67.97 -21.98 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.771 0.828 . . . . 73.3 112.281 -164.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -66.38 -8.12 23.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.444 0.697 . . . . 70.35 112.822 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.593 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 27.7 pt20 -58.25 -26.03 62.42 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.439 0.696 . . . . 71.24 111.575 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.593 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 90.6 mttt -104.16 105.07 15.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.898 0.879 . . . . 75.15 109.077 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.29 81.31 8.76 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.426 0.631 . . . . 72.55 109.298 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -152.69 156.99 40.25 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.839 -1.171 . . . . 64.44 107.839 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.439 ' HB2' HD21 ' F' ' 470' ' ' LEU . 8.3 mt-30 -79.7 110.59 16.23 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 107.318 -1.364 . . . . 43.41 107.318 175.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.477 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 18.1 Cg_endo -58.03 139.67 91.25 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 123.079 2.519 . . . . 74.52 114.484 -170.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -65.89 124.15 21.71 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 124.236 0.96 . . . . 71.32 109.471 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.485 HG21 HD13 ' F' ' 468' ' ' LEU . 31.0 m -103.68 165.28 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.782 0.833 . . . . 72.51 112.459 -171.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -134.24 114.54 13.15 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 106.386 -1.709 . . . . 74.21 106.386 172.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 5.8 mp -86.27 133.97 33.79 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.405 1.082 . . . . 74.35 108.324 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -149.03 111.72 4.79 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.622 -1.251 . . . . 75.31 107.622 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.97 167.81 10.5 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.069 0.462 . . . . 73.52 109.893 -173.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 26.0 t70 -160.99 141.12 11.02 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.483 1.113 . . . . 64.03 109.139 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 22.8 p -136.28 125.13 24.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.414 0.686 . . . . 71.21 109.62 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.16 154.34 46.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.445 1.098 . . . . 63.43 108.318 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.2 p -142.36 170.51 15.56 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.963 0.411 . . . . 74.43 111.22 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.21 137.52 17.53 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.18 -0.918 . . . . 72.44 109.154 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -82.02 126.29 31.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.935 0.494 . . . . 54.23 109.947 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 91.1 mt -93.28 -34.2 13.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.203 0.601 . . . . 74.23 110.396 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.99 -173.53 2.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.641 0.776 . . . . 71.01 110.707 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.98 127.84 34.08 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.749 -1.114 . . . . 75.32 109.192 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.613 ' HA ' HG21 ' F' ' 451' ' ' VAL . 5.4 m-20 67.72 0.03 2.13 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.537 1.135 . . . . 74.21 112.612 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 109.9 30.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 123.66 0.784 . . . . 73.25 109.005 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -123.52 137.93 54.67 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.441 -0.948 . . . . 72.14 108.441 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -108.68 106.33 16.33 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.284 -1.376 . . . . 64.34 107.284 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.561 HG22 ' HG ' ' B' ' 98' ' ' LEU . 86.7 t -92.27 142.42 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 O-C-N 124.101 0.876 . . . . 35.03 109.925 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.73 141.54 42.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.731 -0.84 . . . . 62.35 108.731 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -124.29 105.51 9.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.284 -1.376 . . . . 73.22 107.284 178.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 36.4 ttm180 -92.68 123.87 36.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.794 0.438 . . . . 74.42 109.889 171.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.456 ' HB ' HD11 ' B' ' 114' ' ' ILE . 44.3 t -114.57 108.55 25.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.552 -1.277 . . . . 72.15 107.552 170.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 27.5 m -95.07 135.98 35.96 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.719 -0.845 . . . . 72.24 108.719 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.48 129.76 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.915 0.886 . . . . 72.11 109.146 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 28.8 m -118.01 142.43 47.38 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 107.961 -1.126 . . . . 71.43 107.961 169.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -144.79 155.51 43.56 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 117.803 0.274 . . . . 60.13 110.595 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 39.7 p -155.14 138.87 16.14 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 124.154 0.909 . . . . 74.32 111.007 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.698 HD12 HG22 ' B' ' 31' ' ' VAL . 67.7 mt -96.65 107.03 19.41 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.301 -0.863 . . . . 55.24 108.749 170.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.29 -111.56 4.18 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 114.885 -1.052 . . . . 64.51 112.847 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -108.58 0.03 20.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.64 0.776 . . . . 74.41 110.978 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.474 ' HG3' HG23 ' B' ' 31' ' ' VAL . 12.1 pt-20 -118.49 142.67 47.36 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.73 -0.606 . . . . 72.13 110.182 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.7 m -63.94 134.84 55.85 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 123.16 0.584 . . . . 72.14 111.238 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.557 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -91.11 -65.97 0.97 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.253 -0.885 . . . . 74.22 108.644 174.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -150.45 158.19 43.88 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.518 -0.765 . . . . 65.0 111.046 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 58.2 mt -128.3 108.98 11.04 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.105 -1.813 . . . . 74.14 106.105 172.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.41 ' SG ' HG23 ' B' ' 114' ' ' ILE . 49.8 t -119.26 148.34 43.25 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.344 -0.613 . . . . 75.33 109.344 -176.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -160.4 134.71 7.35 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.152 -0.684 . . . . 65.11 109.152 -178.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.9 t -125.79 144.0 37.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.163 -0.926 . . . . 61.51 108.636 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.4 mt-30 -122.9 85.94 2.5 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.891 -1.151 . . . . 74.31 107.891 172.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.436 ' O ' HD13 ' B' ' 106' ' ' LEU . 7.0 tp-100 -80.01 101.08 8.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.199 -1.364 . . . . 74.3 108.623 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.418 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.74 167.92 27.35 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 111.558 -0.617 . . . . 71.11 111.558 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.41 130.76 2.2 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 112.099 -0.4 . . . . 65.22 112.099 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.454 HG13 ' HE1' ' B' ' 17' ' ' TYR . 61.1 mt -85.14 120.36 35.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.028 -1.101 . . . . 73.24 108.028 171.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -127.46 135.58 50.61 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.208 0.603 . . . . 64.41 109.54 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 68.2 m -97.93 109.33 22.11 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.019 0.527 . . . . 72.33 109.755 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.58 ' HB ' HG12 ' B' ' 89' ' ' ILE . 38.9 pt -102.47 122.66 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.316 1.046 . . . . 74.13 109.045 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.84 141.6 44.7 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.616 0.766 . . . . 63.13 109.612 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.53 -29.33 4.06 Favored Glycine 0 N--CA 1.473 1.157 0 CA-C-O 119.925 -0.375 . . . . 63.43 113.343 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.58 HG12 ' HB ' ' B' ' 86' ' ' ILE . 2.8 pp -56.23 132.53 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.874 0.87 . . . . 63.23 111.94 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.427 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 5.8 tp10 -160.43 161.4 32.96 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 120.922 0.391 . . . . 65.03 111.688 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.22 -95.65 1.56 Allowed Glycine 0 C--N 1.352 1.455 0 CA-C-N 115.484 -0.78 . . . . 53.45 111.286 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.2 m -105.22 -20.45 13.5 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.392 0.677 . . . . 62.43 110.247 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.427 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 95.3 mt-30 -61.66 -31.02 71.11 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.468 0.707 . . . . 62.4 111.319 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.495 ' HA ' HD13 ' B' ' 89' ' ' ILE . 21.5 ptt? -58.06 -44.88 87.72 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 123.985 0.803 . . . . 74.05 110.928 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.403 ' HB1' ' HZ ' ' B' ' 137' ' ' PHE . . . -76.16 -50.28 15.0 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 123.988 0.915 . . . . 53.51 109.679 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -60.13 -31.6 70.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.674 0.79 . . . . 61.24 111.88 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 11.7 t -73.38 -63.15 1.25 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.353 0.408 . . . . 72.24 110.262 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.722 HD13 ' HA3' ' F' ' 453' ' ' GLY . 10.3 tt -67.6 -39.2 84.77 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.323 0.49 . . . . 53.13 112.323 -172.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.42 3.34 57.88 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 114.965 0.746 . . . . 41.55 114.965 -168.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.48 -56.1 0.27 Allowed 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 117.675 0.737 . . . . 42.33 111.381 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -71.39 -46.64 59.79 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.584 0.754 . . . . 65.41 111.85 -171.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.478 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 75.1 m -65.86 -47.85 63.65 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 123.728 0.811 . . . . 71.24 111.363 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.4 Cg_exo -58.42 -32.88 97.23 Favored 'Trans proline' 0 C--N 1.398 3.143 0 C-N-CA 122.337 2.025 . . . . 72.15 113.629 168.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -62.03 -39.27 91.73 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.209 0.603 . . . . 62.2 110.316 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.465 HD13 HD11 ' B' ' 13' ' ' ILE . 69.4 mt -63.68 -45.03 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.576 0.75 . . . . 74.32 110.457 174.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.436 HD13 ' O ' ' B' ' 80' ' ' GLN . 87.1 mt -75.27 -18.36 60.09 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.891 -1.05 . . . . 61.15 112.192 -176.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.402 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 64.0 t80 -60.91 -51.09 81.88 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 117.784 -1.103 . . . . 61.12 113.563 -171.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 48.6 Cg_exo -59.16 -33.44 98.25 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 121.939 1.76 . . . . 60.41 112.949 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.411 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 78.7 m-85 -69.54 -47.36 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.334 0.654 . . . . 75.34 110.556 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.97 88.73 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.549 0.74 . . . . 71.12 110.531 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.701 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 53.3 ttt180 -60.46 -55.99 26.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.627 1.571 . . . . 73.25 111.028 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.72 -34.79 79.01 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 124.053 0.846 . . . . 65.11 110.128 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.9 t -67.04 -35.3 79.59 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 122.768 0.427 . . . . 64.42 111.825 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.456 HD11 ' HB ' ' B' ' 62' ' ' VAL . 64.5 mt -64.26 -52.96 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.986 -0.746 . . . . 73.41 108.986 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -59.44 -30.68 68.67 Favored 'General case' 0 CA--C 1.553 1.07 0 O-C-N 124.498 1.124 . . . . 74.43 111.769 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.9 t -66.65 -46.54 75.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.615 0.766 . . . . 60.42 110.277 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.2 mmt -68.25 -35.16 77.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.993 0.517 . . . . 71.32 110.663 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.482 HG13 ' HB2' ' B' ' 123' ' ' PHE . 68.9 t -58.13 -48.18 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.278 1.031 . . . . 74.52 110.437 172.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.472 ' HB3' HG21 ' C' ' 115' ' ' THR . 65.5 m -61.23 -35.89 78.44 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.444 -1.253 . . . . 74.52 112.042 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.599 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 74.4 mtt-85 -69.15 -37.11 78.07 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.421 -0.809 . . . . 71.01 110.1 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.51 11.23 59.43 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.749 0.656 . . . . 54.5 113.297 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 57.5 p 64.2 18.79 11.47 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.317 1.847 . . . . 75.32 114.687 172.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.482 ' HB2' HG13 ' B' ' 118' ' ' VAL . 98.8 m-85 -80.95 151.29 70.32 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 109.148 -0.686 . . . . 53.24 109.148 175.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.95 -160.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.68 2.92 . . . . 74.21 114.102 -175.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -65.9 111.33 3.24 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 121.017 0.436 . . . . 75.11 110.76 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.412 HD21 ' HD2' ' B' ' 38' ' ' PRO . 4.0 mm? -122.63 84.7 2.3 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.392 -0.966 . . . . 74.4 108.392 171.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -92.7 128.04 38.41 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.328 -0.619 . . . . 62.14 109.328 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.701 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 32.9 tp -71.98 136.78 46.89 Favored 'General case' 0 CA--C 1.552 1.034 0 O-C-N 123.952 0.783 . . . . 61.44 109.785 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' F' ' 468' ' ' LEU . . . -72.06 151.98 92.69 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.127 0.571 . . . . 72.41 111.304 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.504 ' HG3' HD13 ' D' ' 16' ' ' ILE . 25.3 Cg_exo -61.3 102.9 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 122.311 2.007 . . . . 74.23 111.836 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.89 111.37 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.168 -1.049 . . . . 72.43 108.168 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -78.91 99.43 6.79 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.237 -1.023 . . . . 73.53 108.237 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -62.95 -48.03 80.62 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 123.371 0.42 . . . . 75.25 110.795 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.07 -41.74 90.35 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.369 1.068 . . . . 73.12 112.966 -166.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.29 -34.41 63.52 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.368 0.667 . . . . 73.32 111.347 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' F' ' 461' ' ' PHE . 8.8 mp -77.65 -32.15 53.12 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.232 0.613 . . . . 74.44 109.928 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.403 ' HZ ' ' HB1' ' B' ' 95' ' ' ALA . 92.7 t80 -70.69 -28.84 65.06 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.753 1.221 . . . . 73.12 110.452 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 21.1 ttt -53.73 -37.76 63.67 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.264 1.025 . . . . 70.12 110.85 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -78.26 -33.37 49.7 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.082 -1.417 . . . . 73.32 110.676 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -63.05 -26.43 68.84 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.22 1.008 . . . . 72.51 112.497 -175.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 20.1 mt -77.88 -6.03 52.94 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.086 0.773 . . . . 75.23 113.086 -166.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.468 HE21 ' HA ' ' B' ' 145' ' ' ALA . 8.6 pt20 -161.27 157.65 25.93 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.868 0.867 . . . . 50.34 109.673 -175.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -79.82 -19.19 49.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.978 0.511 . . . . 71.01 111.344 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -131.14 107.45 9.04 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.32 1.048 . . . . 61.14 108.882 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.468 ' HA ' HE21 ' B' ' 142' ' ' GLN . . . -126.52 110.5 13.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.651 0.78 . . . . 62.3 109.931 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -152.86 155.25 26.02 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.555 -0.618 . . . . 73.54 111.555 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.9 140.47 29.65 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.028 -1.101 . . . . 74.32 108.028 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.49 54.12 0.34 Allowed Glycine 0 C--N 1.35 1.319 0 C-N-CA 121.505 -0.379 . . . . 63.12 113.652 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 12.7 t -98.26 145.05 27.04 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.435 0.618 . . . . 52.03 109.634 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -100.98 92.47 5.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.097 -0.705 . . . . 73.41 109.097 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -70.64 96.73 1.24 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.928 -0.578 . . . . 72.12 109.874 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -142.28 98.15 3.26 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.579 -0.897 . . . . 73.21 108.579 173.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -144.06 112.44 6.45 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.466 -0.939 . . . . 64.13 108.466 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -100.84 146.04 27.8 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.388 0.675 . . . . 74.11 109.482 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.319 0 C-N-CA 123.896 0.879 . . . . 75.21 109.192 176.834 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.473 ' HG2' ' H ' ' C' ' 2' ' ' SER . 48.6 ttm . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 108.767 -0.827 . . . . 73.55 108.767 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . 0.473 ' H ' ' HG2' ' C' ' 1' ' ' MET . 15.3 m -43.76 -46.09 7.49 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.923 1.689 . . . . 70.21 115.002 -171.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -89.66 24.09 2.44 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.082 0.553 . . . . 63.41 112.051 -173.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 69.54 0.51 2.97 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.877 1.271 . . . . 71.21 111.08 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -75.8 127.74 33.67 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 124.797 1.239 . . . . 71.34 109.812 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -162.48 -39.91 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.043 0.537 . . . . 74.45 109.885 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m 72.59 155.89 0.16 Allowed 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 125.439 1.496 . . . . 73.14 110.936 -177.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -59.05 -66.12 0.56 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.839 0.855 . . . . 71.31 109.476 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.9 ttt 56.14 115.06 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.753 1.621 . . . . 73.21 113.068 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 58.5 m -120.57 104.36 9.89 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.194 -1.039 . . . . 64.4 108.194 173.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.567 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 4.5 t80 -123.6 125.48 44.92 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.968 -0.753 . . . . 74.42 108.968 176.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.43 HE21 HE22 ' C' ' 14' ' ' GLN . 23.4 tt0 -147.02 119.99 8.75 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.065 -1.087 . . . . 71.45 108.065 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.5 mt -74.08 122.25 26.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.901 -0.777 . . . . 54.42 108.901 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.678 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.3 mm-40 -85.0 -45.74 11.86 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.173 -0.922 . . . . 72.23 110.508 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -174.16 126.02 0.34 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.032 -0.531 . . . . 73.34 110.31 -168.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.78 141.64 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 107.868 -1.16 . . . . 54.34 107.868 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.477 ' HB3' HG23 ' D' ' 122' ' ' THR . 27.0 p90 -173.15 168.43 4.75 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.306 0.574 . . . . 74.21 111.941 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -89.38 117.57 28.42 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.013 -0.736 . . . . 51.0 109.013 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -78.73 -35.47 44.73 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.506 -0.553 . . . . 75.5 109.506 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.426 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 13.9 t70 -146.62 147.83 31.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.127 -0.942 . . . . 71.0 109.323 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.0 mt -141.83 146.09 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.169 1.388 . . . . 62.21 107.394 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.7 t -158.11 149.35 21.13 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.355 0.597 . . . . 62.15 110.748 174.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -143.49 145.11 32.32 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.446 -1.316 . . . . 63.14 107.446 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.472 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.1 mt-10 -135.05 127.9 31.26 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.987 0.915 . . . . 75.24 109.926 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.72 72.7 7.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.591 1.557 . . . . 72.21 106.933 170.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.1 -39.94 21.96 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.763 2.309 . . . . 73.52 111.062 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -93.46 22.29 5.45 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 113.846 -1.525 . . . . 65.03 111.279 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.21 -56.08 5.79 Favored Pre-proline 0 CA--C 1.564 1.509 0 N-CA-C 114.135 1.161 . . . . 64.44 114.135 -173.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.42 -38.15 44.58 Favored 'Trans proline' 0 C--N 1.389 2.691 0 CA-C-N 121.77 1.668 . . . . 62.24 112.716 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -69.4 -38.42 77.94 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.596 0.759 . . . . 73.22 112.103 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.716 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.4 p -77.08 -22.26 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 N-CA-C 112.286 0.476 . . . . 61.23 112.286 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -68.1 -30.0 69.06 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 120.925 0.393 . . . . 74.33 110.87 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -99.82 31.67 3.17 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.255 0.622 . . . . 62.41 110.574 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -108.86 157.79 18.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.83 0.852 . . . . 63.11 109.746 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -61.61 121.36 12.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.062 -0.718 . . . . 74.12 109.062 168.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 58.7 t-105 -86.55 96.6 10.13 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.146 0.578 . . . . 72.03 110.478 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.479 ' H ' HD22 ' C' ' 68' ' ' LEU . 63.7 tt0 -144.72 78.48 12.88 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 108.585 -0.894 . . . . 62.13 108.585 170.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -85.67 139.96 6.89 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.74 2.293 . . . . 52.35 112.641 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.437 ' HB3' ' HE3' ' C' ' 41' ' ' LYS . 36.6 mt-10 -87.28 85.43 7.17 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.15 -1.796 . . . . 73.51 106.15 169.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.673 HG11 ' HB2' ' G' ' 468' ' ' LEU . 48.1 t -63.13 107.99 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.504 0 CA-C-N 114.698 -1.137 . . . . 75.14 108.655 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' C' ' 39' ' ' GLU . 99.2 mttt -125.12 104.8 8.73 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.008 0.923 . . . . 62.4 109.763 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.537 HD11 HD21 ' C' ' 126' ' ' LEU . 4.0 mm? -86.09 125.6 33.58 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.159 -0.928 . . . . 74.54 109.194 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -118.25 105.31 11.63 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.812 -1.181 . . . . 71.01 107.812 173.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 tt -107.57 122.31 46.42 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.464 -0.569 . . . . 60.21 109.464 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -124.27 142.54 51.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.969 1.308 . . . . 74.21 108.654 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.41 HG21 ' HG3' ' C' ' 103' ' ' PRO . 1.5 m -123.48 126.6 47.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.465 0.65 . . . . 73.21 109.597 173.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.55 170.33 8.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.275 -1.329 . . . . 70.32 107.872 171.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -165.0 156.84 15.34 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.048 -0.723 . . . . 64.44 109.048 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 49.9 p -156.64 136.75 12.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.845 0.458 . . . . 73.22 110.713 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -70.2 126.35 29.41 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.415 -0.587 . . . . 74.13 109.415 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' C' ' 57' ' ' GLU . 57.6 mt -97.47 -35.93 10.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.421 0.688 . . . . 73.31 110.336 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.0 -174.08 4.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.031 0.933 . . . . 74.23 110.455 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -62.29 106.73 0.78 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.237 -0.892 . . . . 75.42 109.874 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 68.68 11.03 8.21 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.498 1.119 . . . . 71.11 112.876 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 99.4 t -105.94 105.76 19.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.62 -1.252 . . . . 72.42 107.62 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -117.73 123.88 47.12 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.722 -0.844 . . . . 75.13 108.722 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.568 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.6 tt0 -85.54 143.87 28.25 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.748 0.819 . . . . 75.05 109.218 171.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 43.7 t -119.26 139.08 47.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 108.102 -1.073 . . . . 74.51 108.102 166.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.76 123.36 65.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 107.43 -1.322 . . . . 71.43 107.43 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.4 107.7 18.82 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.629 -0.878 . . . . 62.22 108.629 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.15 102.96 14.81 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.706 -0.85 . . . . 71.23 108.706 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.402 ' HB ' HD11 ' C' ' 114' ' ' ILE . 58.7 t -103.59 108.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.344 -0.984 . . . . 74.31 108.344 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.7 m -98.1 137.1 37.39 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.853 -1.166 . . . . 71.13 107.853 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.56 HG21 HG21 ' C' ' 114' ' ' ILE . 61.3 t -132.24 108.82 14.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.591 -0.522 . . . . 64.41 109.591 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -103.9 142.93 33.55 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.117 -0.947 . . . . 64.31 109.737 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.26 123.23 15.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.874 -1.528 . . . . 45.23 106.874 173.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 7.9 m -130.45 128.42 41.23 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.492 0.495 . . . . 61.32 109.968 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.479 HD22 ' H ' ' C' ' 37' ' ' GLN . 18.3 mt -86.93 47.57 1.52 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.4 1.08 . . . . 75.43 108.752 175.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.22 -109.47 3.71 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 110.091 -1.204 . . . . 61.5 110.091 -172.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.29 -26.46 17.31 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.292 1.037 . . . . 72.43 110.418 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -71.78 121.3 18.69 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.297 0.639 . . . . 71.34 110.028 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -68.63 126.37 29.47 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.65 -0.87 . . . . 75.03 108.65 168.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.716 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.6 -58.49 3.25 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.164 -1.05 . . . . 62.13 108.164 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.07 165.45 27.19 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.795 -1.093 . . . . 74.52 110.169 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.472 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.6 tm? -128.62 140.42 51.78 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.387 -1.708 . . . . 70.24 106.387 168.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.5 t -144.35 140.09 28.88 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.124 -1.065 . . . . 73.34 108.124 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -156.29 137.0 13.31 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 110.152 -0.314 . . . . 62.51 110.152 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -136.21 135.29 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.066 0.946 . . . . 61.14 108.833 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.426 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 41.9 mt-30 -107.07 94.62 5.2 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.259 1.023 . . . . 75.32 109.388 173.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.41 ' HG3' HD22 ' C' ' 106' ' ' LEU . 9.3 tp-100 -85.59 98.1 10.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.989 -1.005 . . . . 71.34 110.226 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.69 145.98 17.9 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 112.117 -0.393 . . . . 41.41 112.117 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.571 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.51 124.72 1.84 Allowed Glycine 0 CA--C 1.507 -0.441 0 N-CA-C 110.568 -1.013 . . . . 75.02 110.568 -174.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 4.8 mm -82.82 123.55 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.513 -0.921 . . . . 75.22 108.513 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.567 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 64.2 m-85 -129.32 120.7 26.08 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.222 0.609 . . . . 71.4 109.512 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -70.81 118.82 14.08 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.137 -0.69 . . . . 63.52 109.137 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' C' ' 94' ' ' MET . 4.7 tt -122.05 122.88 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.312 0.645 . . . . 61.52 110.313 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.605 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -156.57 168.89 26.02 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.493 0.717 . . . . 50.42 109.656 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.96 -54.45 4.3 Favored Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.045 0.355 . . . . 71.32 112.495 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 pt -83.01 156.1 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.408 1.083 . . . . 71.45 110.964 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.98 175.81 10.39 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.543 0.737 . . . . 54.15 110.635 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.11 -127.71 43.16 Favored Glycine 0 C--N 1.349 1.27 0 O-C-N 123.981 0.801 . . . . 73.14 114.128 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.676 ' HB ' ' HA ' ' C' ' 142' ' ' GLN . 41.4 p -70.07 -26.95 64.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.017 0.927 . . . . 61.05 111.97 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -68.49 -44.65 74.29 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.869 0.868 . . . . 74.32 110.705 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.792 ' HB2' HD11 ' C' ' 86' ' ' ILE . 3.6 ppp? -74.13 -33.75 63.66 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.729 -0.471 . . . . 61.33 109.729 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.503 ' HA ' HD21 ' G' ' 454' ' ' LEU . . . -60.4 -41.31 93.6 Favored 'General case' 0 C--N 1.36 1.046 0 O-C-N 124.242 0.964 . . . . 73.23 110.391 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -80.97 -33.9 33.49 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.046 0.841 . . . . 72.51 112.301 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.9 t -55.4 -38.44 68.92 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.444 0.465 . . . . 42.13 110.053 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.61 ' HB2' HD11 ' G' ' 454' ' ' LEU . 30.6 mt -101.46 -13.29 18.0 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.74 0.816 . . . . 73.35 111.609 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.55 -30.54 56.32 Favored Glycine 0 C--N 1.354 1.58 0 N-CA-C 114.982 0.753 . . . . 74.33 114.982 -174.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.61 -35.38 0.07 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.814 0.445 . . . . 72.51 110.774 -171.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -68.45 -50.15 54.69 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.958 1.303 . . . . 75.45 112.467 -177.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 66.7 m -71.89 -41.39 9.02 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.877 -0.582 . . . . 63.02 112.354 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.41 ' HG3' HG21 ' C' ' 46' ' ' THR . 73.3 Cg_exo -53.84 -32.0 64.8 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 122.561 2.174 . . . . 65.31 113.927 166.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -69.24 -34.81 75.38 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.363 0.665 . . . . 63.15 109.904 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.554 HD12 ' NH1' ' A' ' 111' ' ' ARG . 34.2 mm -62.86 -40.45 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 109.37 -0.604 . . . . 73.23 109.37 174.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.571 HD21 ' HA3' ' C' ' 82' ' ' GLY . 69.1 mt -82.26 -17.98 44.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.296 1.038 . . . . 72.21 112.449 -177.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -60.07 -50.36 86.65 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-O 117.911 -1.043 . . . . 75.11 113.662 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.31 -31.51 62.88 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 121.955 1.77 . . . . 71.52 112.818 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -70.24 -47.76 59.91 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.178 0.591 . . . . 64.23 110.556 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.49 -45.95 84.3 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.346 -0.843 . . . . 31.41 109.948 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -59.93 -49.35 78.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.021 1.329 . . . . 75.51 110.855 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.41 -39.1 91.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.375 0.67 . . . . 74.1 110.517 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 19.6 t -66.79 -27.53 67.65 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.826 0.45 . . . . 65.44 111.659 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.61 HG23 ' SG ' ' C' ' 76' ' ' CYS . 63.5 mt -80.78 -43.46 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.218 0.607 . . . . 63.32 110.067 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.472 HG21 ' HB3' ' B' ' 119' ' ' SER . 5.7 m -61.16 -29.33 69.73 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.321 0.582 . . . . 61.34 110.373 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 39.0 t -72.92 -53.5 11.14 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.754 -1.112 . . . . 72.14 109.818 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.546 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.37 -39.09 92.04 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.954 0.902 . . . . 62.14 113.167 -175.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' C' ' 123' ' ' PHE . 78.3 t -64.99 -42.17 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.689 0.795 . . . . 73.12 110.184 175.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -69.46 -29.95 67.75 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.26 -0.882 . . . . 73.42 111.244 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.45 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 86.4 mtt-85 -68.5 -39.24 81.36 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.636 0.775 . . . . 72.3 108.921 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.32 1.47 81.09 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 123.908 0.755 . . . . 53.13 113.17 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 38.4 p 64.03 27.31 14.22 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.543 1.937 . . . . 70.33 113.941 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.413 ' HB2' HG13 ' C' ' 118' ' ' VAL . 93.4 m-85 -92.19 149.39 38.5 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 109.012 -0.736 . . . . 74.15 109.012 171.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -45.03 119.68 2.57 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.583 2.855 . . . . 74.12 113.128 170.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -59.9 155.9 15.51 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.81 1.244 . . . . 71.23 113.566 -170.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.537 HD21 HD11 ' C' ' 42' ' ' LEU . 34.3 tp -104.2 102.33 12.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.779 0.832 . . . . 75.51 109.89 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.76 89.77 4.46 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.951 -1.129 . . . . 73.31 107.951 168.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.03 134.39 43.01 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.628 -0.714 . . . . 74.34 110.282 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.96 151.6 96.14 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 124.111 0.964 . . . . 33.42 111.746 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.52 121.22 9.53 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.983 2.456 . . . . 73.22 112.683 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.452 HG21 ' HE1' ' G' ' 462' ' ' TYR . 11.5 t -102.95 137.6 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.966 -0.753 . . . . 71.02 108.966 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.443 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 89.9 m-20 -82.27 73.4 9.31 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.541 -0.54 . . . . 73.44 109.541 173.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -61.53 -43.64 98.5 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.386 -0.824 . . . . 71.54 109.481 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -64.07 -53.51 48.72 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 113.954 -1.475 . . . . 55.5 111.837 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -56.03 -38.4 70.51 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.487 1.117 . . . . 74.11 111.171 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.78 -45.0 79.84 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.213 -0.903 . . . . 75.32 110.693 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.527 ' HA ' ' HB3' ' C' ' 140' ' ' TYR . 13.3 t80 -70.26 -28.79 65.51 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.052 0.541 . . . . 70.21 110.422 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.788 ' HA ' ' HB3' ' C' ' 142' ' ' GLN . 49.3 mtp -72.74 -32.97 66.08 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.228 0.611 . . . . 73.24 110.834 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -74.71 -36.91 62.7 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.721 0.808 . . . . 64.24 110.986 170.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.527 ' HB3' ' HA ' ' C' ' 137' ' ' PHE . 31.1 t80 -67.19 -84.63 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.234 1.414 . . . . 74.34 111.081 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.44 ' HG ' HG22 ' C' ' 92' ' ' THR . 32.7 tp -133.28 83.45 2.06 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.416 0.627 . . . . 75.22 110.093 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.788 ' HB3' ' HA ' ' C' ' 138' ' ' MET . 19.9 tp60 -169.25 -44.6 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.949 1.3 . . . . 71.44 108.279 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 60.39 81.53 0.18 Allowed 'General case' 0 C--N 1.357 0.9 0 O-C-N 124.852 1.345 . . . . 75.41 109.578 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -146.93 -47.53 0.18 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.962 -0.563 . . . . 73.43 110.556 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 69.19 138.94 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.046 1.338 . . . . 73.52 112.64 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -178.68 73.39 0.07 OUTLIER Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.268 -0.423 . . . . 75.43 112.059 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -160.82 -44.1 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.471 0.708 . . . . 64.34 110.369 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 88.14 -151.81 23.13 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 115.553 -0.748 . . . . 61.21 111.599 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 44.2 p -79.05 102.06 8.18 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 118.022 0.911 . . . . 72.55 109.182 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -67.03 149.36 50.72 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.953 -0.758 . . . . 74.31 108.953 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.82 102.04 0.09 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.626 0.77 . . . . 73.02 111.327 -173.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -85.55 150.97 24.29 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.627 -0.715 . . . . 74.43 109.637 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -83.31 -176.83 6.51 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.683 0.793 . . . . 73.15 110.233 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.89 -40.8 91.9 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.565 0.746 . . . . 42.21 110.251 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 124.783 1.233 . . . . 74.44 111.046 178.049 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.265 -0.643 . . . . 71.52 109.265 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 57.7 m -70.86 82.83 0.65 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.33 0.652 . . . . 71.54 110.017 172.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -67.35 124.4 23.06 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.25 -0.886 . . . . 72.41 111.111 -173.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -69.34 89.31 0.48 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.051 -1.462 . . . . 72.21 107.051 162.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -66.5 161.22 23.37 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.896 -0.593 . . . . 71.33 110.469 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -53.69 150.9 6.66 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.166 0.986 . . . . 62.43 112.513 -172.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 42.5 p -76.97 9.64 2.82 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.355 1.062 . . . . 75.34 113.017 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -68.93 89.69 0.42 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.888 0.875 . . . . 71.23 109.45 171.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.0 ttp -33.63 125.86 0.41 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.409 1.484 . . . . 71.55 113.336 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 90.0 m -133.05 143.26 49.25 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.003 0.921 . . . . 72.21 108.79 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -159.95 90.13 0.9 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.56 -1.274 . . . . 72.33 107.56 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -118.78 116.91 27.53 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.24 -1.022 . . . . 72.33 108.24 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.444 HG21 HD11 ' D' ' 16' ' ' ILE . 13.7 mt -73.2 109.97 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.091 -0.707 . . . . 75.41 109.091 177.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -80.65 -37.85 30.18 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.449 0.7 . . . . 74.23 111.846 -173.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -168.9 139.01 2.3 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 117.414 0.097 . . . . 64.53 111.126 -168.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.504 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.4 mp -117.82 135.04 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.144 -1.428 . . . . 75.03 107.144 169.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -160.53 150.29 17.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.434 0.635 . . . . 71.24 111.798 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 64.3 p -86.5 113.56 22.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.949 -1.023 . . . . 74.2 109.18 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -81.31 -22.04 38.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.298 0.639 . . . . 73.14 110.554 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.476 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.6 t70 -160.39 142.39 12.74 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.151 -0.931 . . . . 74.05 109.042 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.546 HG21 ' HE2' ' C' ' 117' ' ' MET . 85.5 mt -138.65 143.54 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.116 -1.068 . . . . 71.21 108.116 175.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -143.54 133.12 23.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.754 0.822 . . . . 72.13 108.916 171.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.4 t80 -134.77 131.85 38.03 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.328 -1.73 . . . . 71.3 106.328 166.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 25.4 mt-10 -133.09 130.41 39.28 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.91 0.884 . . . . 75.44 108.83 -173.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -138.65 78.34 31.59 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.048 -1.093 . . . . 54.52 108.048 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.52 -31.29 21.87 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.896 2.397 . . . . 72.14 112.388 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -99.84 -1.29 37.86 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.457 -1.247 . . . . 72.31 110.971 -173.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.513 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -29.93 -67.2 0.14 Allowed Pre-proline 0 C--N 1.36 1.058 0 C-N-CA 126.517 1.927 . . . . 75.15 116.134 -160.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.405 ' HB3' HD11 ' C' ' 83' ' ' ILE . 80.9 Cg_endo -71.62 -29.64 15.83 Favored 'Trans proline' 0 C--N 1.375 1.959 0 CA-C-N 122.63 1.975 . . . . 72.13 113.318 -170.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.454 ' HA ' HE21 ' D' ' 33' ' ' GLN . 5.8 p-80 -84.91 -23.44 28.87 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 117.678 0.217 . . . . 64.44 111.137 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.513 HG12 ' O ' ' D' ' 28' ' ' ALA . 8.9 p -80.6 -26.73 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 122.65 0.38 . . . . 74.34 110.444 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -61.71 -25.4 67.4 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.328 0.651 . . . . 74.13 112.436 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.454 HE21 ' HA ' ' D' ' 30' ' ' HIS . 74.3 mt-30 -53.21 -28.78 28.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.275 1.03 . . . . 75.23 111.509 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -84.1 101.52 11.87 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.139 0.975 . . . . 74.01 110.116 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.34 80.43 7.75 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.991 -1.004 . . . . 75.33 108.987 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.422 ' HD1' HD23 ' D' ' 68' ' ' LEU . 50.6 t-105 -142.98 156.47 44.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.85 1.26 . . . . 73.14 108.253 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -80.3 101.98 1.08 Allowed Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 108.066 -1.087 . . . . 61.12 108.066 174.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.92 119.72 6.5 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.084 2.523 . . . . 74.22 112.901 -167.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.84 112.86 2.73 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 123.957 0.785 . . . . 71.43 109.912 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' D' ' 66' ' ' ALA . 27.5 m -100.02 151.07 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.881 -1.054 . . . . 53.25 111.131 -172.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' H' ' 465' ' ' LYS . 23.5 tptp -118.08 117.96 30.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.118 -1.067 . . . . 73.13 108.118 173.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.0 tp -94.62 120.21 34.49 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.919 -0.771 . . . . 72.04 108.919 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.538 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.4 t70 -127.67 112.88 15.33 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.76 -1.2 . . . . 74.22 107.76 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 67.0 mt -96.16 129.08 43.56 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.003 0.521 . . . . 72.11 109.688 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.58 ' HA ' ' HG ' ' H' ' 460' ' ' LEU . 30.1 t70 -136.05 121.55 19.43 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.069 -0.715 . . . . 71.44 109.069 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.491 ' H ' HD21 ' H' ' 460' ' ' LEU . 10.1 t -105.84 168.28 9.22 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.519 0.675 . . . . 55.11 110.512 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -161.05 162.73 31.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.286 -1.325 . . . . 53.44 108.539 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 24.4 p -156.88 153.32 28.0 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.868 -0.79 . . . . 71.41 108.868 172.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 37.3 p -155.69 131.36 9.76 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.543 0.737 . . . . 73.42 109.544 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -73.6 127.96 34.2 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.928 0.491 . . . . 54.15 110.073 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' D' ' 57' ' ' GLU . 61.4 mt -92.64 -35.08 13.72 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.625 -0.509 . . . . 70.41 109.625 175.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.28 -178.48 3.63 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.359 1.063 . . . . 63.13 109.512 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -65.67 127.64 32.75 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.983 -0.747 . . . . 71.43 108.983 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.81 19.3 11.32 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.39 1.076 . . . . 73.44 112.105 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.97 124.28 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.846 0.858 . . . . 74.05 109.173 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.407 ' HD1' HD11 ' D' ' 86' ' ' ILE . 15.0 m-85 -133.57 131.7 40.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.485 0.714 . . . . 71.02 109.751 176.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.527 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.0 tt0 -92.43 120.12 32.62 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.19 -1.041 . . . . 64.2 108.19 167.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -100.9 140.3 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.929 -1.137 . . . . 70.4 107.929 170.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.525 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.8 t -122.76 129.18 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.468 -0.938 . . . . 62.42 108.468 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.45 116.68 32.27 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.163 -1.421 . . . . 63.45 107.163 170.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -104.94 101.86 11.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.942 -1.133 . . . . 73.34 107.942 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.28 137.66 21.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.663 -0.699 . . . . 61.15 109.156 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 32.6 m -117.93 142.16 47.65 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.516 0.727 . . . . 63.04 109.805 177.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.414 HG21 HG21 ' D' ' 114' ' ' ILE . 59.3 t -136.5 113.08 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.058 0.943 . . . . 71.32 109.457 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 89.9 m -106.56 108.92 20.67 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.507 -0.553 . . . . 64.14 109.507 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -106.54 158.45 16.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.185 0.594 . . . . 74.53 110.368 -176.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 4.8 p -153.73 140.73 19.3 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-O 121.438 0.637 . . . . 63.13 112.404 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.481 HD12 HG22 ' D' ' 31' ' ' VAL . 70.5 mt -111.57 116.25 30.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.799 1.24 . . . . 72.41 107.764 169.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.76 -120.78 8.29 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 123.563 0.539 . . . . 74.0 113.112 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -102.84 6.66 39.33 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.82 0.848 . . . . 65.34 111.408 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -135.21 162.13 33.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.83 0.452 . . . . 54.41 110.725 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 30.4 m -57.61 142.9 43.2 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.175 0.99 . . . . 71.03 111.45 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.37 -68.58 0.79 Allowed 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.049 -1.093 . . . . 45.01 108.049 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -141.15 149.17 41.15 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.963 -1.017 . . . . 71.14 109.472 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.6 mt -112.55 146.27 38.83 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.681 -1.229 . . . . 72.13 107.681 169.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.51 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.8 t -153.97 133.45 12.79 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.765 -0.458 . . . . 70.14 109.765 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -154.26 126.61 7.94 Favored 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.97 -0.381 . . . . 73.43 109.97 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 97.9 t -131.09 125.02 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.783 0.833 . . . . 71.55 110.16 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 37.7 mt-30 -87.71 86.33 7.17 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.795 -0.817 . . . . 73.24 108.795 168.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -81.43 92.15 6.4 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.234 -0.893 . . . . 75.44 109.503 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.96 162.59 27.58 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 111.951 -0.46 . . . . 72.31 111.951 178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.31 136.46 4.43 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.997 -0.441 . . . . 54.11 111.997 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.78 127.77 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.73 -0.841 . . . . 74.14 108.73 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.43 125.65 47.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.236 1.014 . . . . 60.34 108.915 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 6.4 t -87.98 97.16 10.8 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.086 -1.079 . . . . 52.13 108.086 176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.566 HD13 HG11 ' H' ' 452' ' ' VAL . 2.7 pp -111.32 139.03 37.3 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 C-N-CA 123.546 0.738 . . . . 73.12 110.154 -171.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -157.82 157.18 32.82 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.06 0.544 . . . . 72.53 109.643 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.03 17.99 77.49 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.329 0.393 . . . . 73.11 113.512 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.455 HD11 ' HB ' ' D' ' 86' ' ' ILE . 0.2 OUTLIER -126.68 134.41 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.817 0.847 . . . . 71.52 108.944 178.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.57 177.02 8.77 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.269 0.628 . . . . 64.4 111.136 -174.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.53 -111.36 2.06 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 124.284 0.99 . . . . 65.5 114.573 171.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.3 m -89.55 -27.05 20.52 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.712 0.805 . . . . 74.42 110.804 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -64.65 -41.03 96.4 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.314 0.645 . . . . 72.43 110.642 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.675 ' SD ' ' HA ' ' H' ' 452' ' ' VAL . 26.9 ptt? -69.21 -34.04 74.26 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 116.036 -0.529 . . . . 71.33 111.08 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.32 -32.29 64.49 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.286 0.634 . . . . 50.21 110.968 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -77.65 -34.93 52.96 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.427 1.091 . . . . 73.13 110.262 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.2 -51.68 11.6 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.859 -0.61 . . . . 51.42 111.091 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.489 HD23 ' SG ' ' D' ' 102' ' ' CYS . 83.8 mt -85.86 -24.29 26.76 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.948 0.499 . . . . 62.31 112.03 -172.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.84 -14.06 55.63 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.751 -0.472 . . . . 61.23 113.668 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.628 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -135.81 -59.2 0.76 Allowed 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 117.354 0.577 . . . . 21.14 111.89 -173.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -67.8 -41.19 83.55 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.098 0.559 . . . . 71.31 112.295 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.489 ' SG ' HD23 ' D' ' 98' ' ' LEU . 70.4 m -67.86 -45.77 43.41 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 118.483 -0.77 . . . . 75.24 112.321 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -56.5 -36.2 97.44 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.184 1.923 . . . . 51.21 112.909 168.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -65.36 -30.66 71.51 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.606 0.763 . . . . 72.22 111.558 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.422 HD13 HD11 ' D' ' 13' ' ' ILE . 80.0 mt -71.3 -39.27 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.192 0.997 . . . . 52.32 110.463 174.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -76.0 -19.51 58.62 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.441 -0.799 . . . . 52.12 111.527 -176.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -64.88 -43.56 69.05 Favored Pre-proline 0 CA--C 1.562 1.409 0 CA-C-O 117.987 -1.006 . . . . 74.01 113.603 -174.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -51.48 -43.8 47.72 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.241 1.961 . . . . 61.34 113.923 170.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -72.83 -37.52 67.42 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.33 0.652 . . . . 74.15 111.2 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.33 -48.26 80.6 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.44 0.696 . . . . 73.24 109.674 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -54.38 -49.57 69.54 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.875 1.359 . . . . 73.34 110.942 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.16 -45.62 92.61 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.24 0.963 . . . . 53.23 111.372 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.7 t -58.51 -44.87 89.63 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.873 0.733 . . . . 71.42 110.697 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.51 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.0 mt -60.04 -56.56 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.184 0.994 . . . . 73.12 110.743 175.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.7 m -55.21 -42.78 73.77 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.932 1.293 . . . . 74.35 111.561 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 36.8 t -66.18 -40.63 90.6 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 114.561 -1.2 . . . . 74.25 110.047 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.5 mtm -70.57 -30.79 67.59 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.961 0.505 . . . . 62.14 111.869 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.448 HG23 ' O ' ' D' ' 114' ' ' ILE . 73.8 t -64.05 -45.89 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.484 0.714 . . . . 53.55 109.947 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -74.97 -28.13 60.44 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.648 -0.706 . . . . 54.51 111.28 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -70.85 -34.01 71.21 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.236 -0.653 . . . . 60.23 109.236 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.66 11.09 62.63 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.924 0.765 . . . . 71.33 112.919 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.477 HG23 ' HB3' ' C' ' 17' ' ' TYR . 78.9 p 58.51 16.84 4.48 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 126.499 1.92 . . . . 73.4 114.606 175.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -80.16 146.88 63.8 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.096 -0.705 . . . . 73.04 109.096 171.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.53 133.2 25.92 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.291 2.661 . . . . 64.13 112.428 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -53.34 136.93 36.33 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.346 1.029 . . . . 72.33 112.589 -168.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.412 HD12 HD12 ' H' ' 468' ' ' LEU . 51.6 tp -108.37 107.33 17.86 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.488 -0.778 . . . . 72.44 109.74 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.453 HD22 HD12 ' B' ' 16' ' ' ILE . 11.6 m120 -101.23 96.22 7.05 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.4 -0.963 . . . . 72.01 108.4 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.37 122.22 15.68 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.851 0.46 . . . . 71.25 110.05 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.71 123.06 80.18 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 122.993 0.517 . . . . 53.34 109.844 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.89 122.84 11.83 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.626 2.217 . . . . 65.05 112.031 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 75.0 t -106.78 123.27 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.854 -0.795 . . . . 73.22 108.854 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -80.29 93.32 5.89 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.019 -0.734 . . . . 75.1 109.019 174.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -60.81 -28.07 68.51 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.545 0.738 . . . . 73.45 111.292 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.628 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 6.0 t70 -62.8 -50.08 72.42 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.423 1.089 . . . . 73.13 111.265 -173.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.66 -45.26 87.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.556 0.743 . . . . 65.2 111.408 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.66 -26.05 66.01 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.603 0.761 . . . . 71.11 111.603 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -67.27 -39.53 86.06 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.608 0.763 . . . . 71.14 110.447 175.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 31.0 mtt -61.28 -39.11 89.17 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.517 0.727 . . . . 74.41 109.821 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.462 ' HA ' ' HG3' ' D' ' 142' ' ' GLN . 19.3 m120 -63.9 -46.86 82.97 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.129 0.893 . . . . 74.35 111.052 175.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -54.57 -38.47 66.72 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.095 0.958 . . . . 73.11 111.256 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.9 mp -74.55 -39.85 62.06 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.203 0.601 . . . . 63.32 111.622 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.462 ' HG3' ' HA ' ' D' ' 139' ' ' ASN . 0.0 OUTLIER -86.33 11.4 12.33 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.093 0.775 . . . . 71.03 113.093 -174.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -118.99 87.83 2.81 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.469 0.652 . . . . 44.4 110.256 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -162.23 168.29 22.64 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.452 -1.249 . . . . 50.53 109.114 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.85 82.23 2.15 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.057 0.543 . . . . 63.52 110.151 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.34 65.72 3.78 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 115.687 -0.688 . . . . 60.04 111.707 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -157.63 -149.03 0.22 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.761 0.825 . . . . 60.42 109.298 -171.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -47.25 109.51 0.43 Allowed Glycine 0 C--N 1.364 2.123 0 C-N-CA 123.723 0.678 . . . . 73.51 113.529 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 17.5 m -73.78 87.06 1.72 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.68 1.192 . . . . 75.01 110.55 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -161.55 -168.45 1.99 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.209 1.004 . . . . 73.32 108.982 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.23 71.69 1.71 Allowed 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 121.914 0.864 . . . . 74.54 110.53 174.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -72.31 98.17 2.15 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.311 -0.859 . . . . 61.11 109.407 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -75.98 141.11 42.28 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 116.037 -0.529 . . . . 73.44 110.237 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -174.47 162.52 3.51 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.199 1.399 . . . . 74.15 108.517 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 N-CA-C 108.784 -0.821 . . . . 73.03 108.784 178.41 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 110.175 -0.305 . . . . 62.24 110.175 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . 0.434 HG13 HG23 ' E' ' 452' ' ' VAL . 9.8 p -75.61 163.37 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 C-N-CA 123.354 0.661 . . . . 64.41 111.278 -172.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . 0.563 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 88.4 t 75.15 -76.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.837 0 C-N-CA 125.768 1.627 . . . . 74.23 111.398 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 60.81 46.67 94.06 Favored Glycine 0 C--N 1.343 0.951 0 O-C-N 123.19 0.306 . . . . 53.14 112.804 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.26 151.11 48.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.356 0.662 . . . . 73.1 111.708 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 14.1 p -113.97 -33.71 5.65 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.943 0.897 . . . . 62.11 109.577 168.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 26.1 t70 68.45 154.17 0.1 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.758 1.223 . . . . 74.41 112.154 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -124.16 -11.83 7.47 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.989 0.916 . . . . 62.13 111.549 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 30.7 m 58.62 88.01 0.07 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 124.533 1.133 . . . . 74.33 109.859 -173.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -161.65 137.05 7.56 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 116.311 -0.404 . . . . 75.12 110.301 -171.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 45.5 mt -138.91 177.37 7.94 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.772 0.829 . . . . 54.54 110.533 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.75 50.55 2.23 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.776 1.23 . . . . 74.1 110.419 -171.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -82.68 144.38 30.29 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.695 -0.684 . . . . 74.4 110.93 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 4.9 m -138.38 49.54 1.91 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 108.272 -1.01 . . . . 63.45 108.272 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 26.2 ptm -163.89 170.78 16.29 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.685 -1.143 . . . . 72.42 109.828 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . 0.641 ' HG2' ' H ' ' E' ' 466' ' ' ALA . 0.0 OUTLIER -127.5 -95.96 0.42 Allowed 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 108.698 -0.853 . . . . 65.31 108.698 167.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . 0.641 ' H ' ' HG2' ' E' ' 465' ' ' LYS . . . -163.79 164.36 23.65 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.767 0.827 . . . . 75.32 109.637 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -164.37 87.96 0.49 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.135 -1.061 . . . . 44.35 108.135 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 50.0 mt -93.41 -68.64 0.79 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.477 0.711 . . . . 74.4 110.568 -170.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 134.19 42.69 0.14 Allowed Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.404 -0.816 . . . . 61.24 111.326 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 43.1 mt -87.43 19.61 3.22 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.384 0.673 . . . . 71.13 111.985 -176.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? . . . . . 0 CA--C 1.555 1.172 0 N-CA-C 107.301 -1.37 . . . . 72.53 107.301 -178.413 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.081 -0.711 . . . . 63.43 109.081 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . 0.613 HG21 ' HA ' ' B' ' 54' ' ' ASP . 14.8 p -158.2 143.12 7.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 C-N-CA 122.86 0.464 . . . . 74.4 110.395 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 12.1 p -173.03 166.34 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.69 1.196 . . . . 73.34 108.075 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . 0.722 ' HA3' HD13 ' B' ' 98' ' ' LEU . . . -104.23 -90.64 2.18 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.046 -0.822 . . . . 73.25 111.046 168.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 2.9 pp -160.17 -174.57 4.6 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.149 0.979 . . . . 54.54 109.726 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 12.1 t -145.0 30.22 1.17 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.987 0.899 . . . . 70.24 108.698 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -112.45 130.13 56.09 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.832 -1.076 . . . . 71.31 110.071 -169.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -161.28 29.81 0.14 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.129 0.972 . . . . 55.3 108.803 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 85.4 m -63.02 -44.98 94.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.167 0.987 . . . . 72.35 111.225 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -159.51 135.81 9.0 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.549 0.74 . . . . 74.5 109.491 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.54 123.69 27.81 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.414 0.685 . . . . 74.12 110.218 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' B' ' 136' ' ' LEU . 6.3 p90 -62.35 114.37 3.45 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.653 -1.158 . . . . 71.44 110.518 175.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -135.4 106.66 6.77 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.123 -0.695 . . . . 73.34 109.123 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 74.9 m -148.45 112.14 5.07 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.797 -1.186 . . . . 73.24 107.797 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 46.8 ttp -147.16 142.29 27.16 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.258 -0.645 . . . . 71.41 109.258 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -73.82 -17.79 61.03 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.21 1.004 . . . . 74.25 112.07 -170.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -126.55 167.63 15.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.971 0.908 . . . . 71.35 109.38 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -81.94 -40.4 22.32 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.678 0.391 . . . . 60.12 111.313 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . 0.485 HD13 HG21 ' B' ' 40' ' ' VAL . 21.3 tp -155.64 -45.73 0.08 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.983 0.513 . . . . 70.24 111.463 -174.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 95.71 41.92 3.74 Favored Glycine 0 N--CA 1.472 1.092 0 N-CA-C 110.599 -1.0 . . . . 64.41 110.599 -166.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' B' ' 37' ' ' GLN . 10.4 tt -78.51 -47.86 16.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.351 1.06 . . . . 71.34 109.811 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt . . . . . 0 C--O 1.252 1.232 0 N-CA-C 107.3 -1.37 . . . . 71.11 107.3 177.524 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 109.561 -0.533 . . . . 53.31 109.561 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 6.1 p -70.13 101.39 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 CA-C-O 121.835 0.826 . . . . 74.24 111.05 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 24.0 m -136.25 162.98 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.375 1.07 . . . . 71.44 110.5 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 148.55 69.65 0.01 OUTLIER Glycine 0 C--N 1.356 1.674 0 O-C-N 123.054 0.221 . . . . 74.15 113.167 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' C' ' 98' ' ' LEU . 94.4 mt -131.84 170.96 14.12 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.675 0.79 . . . . 71.23 111.06 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 9.9 t -70.28 137.6 50.87 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 116.194 -0.457 . . . . 61.11 110.444 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -89.29 49.95 1.85 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.957 0.903 . . . . 72.44 109.973 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 71.04 112.52 0.06 Allowed 'General case' 0 C--N 1.363 1.167 0 C-N-CA 125.903 1.681 . . . . 63.01 109.973 -174.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 15.3 t -141.15 -47.26 0.39 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.443 0.697 . . . . 70.35 109.897 168.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -175.27 166.78 3.41 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.245 1.018 . . . . 74.31 110.12 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -137.7 135.59 36.59 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.219 -1.03 . . . . 75.11 108.219 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -58.42 113.09 1.81 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.489 1.116 . . . . 61.35 111.408 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . 0.452 ' HE1' HG21 ' C' ' 131' ' ' VAL . 54.0 t80 -158.2 110.39 2.3 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.956 -0.386 . . . . 73.21 109.956 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . 0.466 ' HA ' ' HE2' ' G' ' 465' ' ' LYS . 38.1 p -133.65 82.71 2.0 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.835 0.854 . . . . 53.31 110.748 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 31.5 mtm -135.99 -64.05 0.63 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.869 -0.789 . . . . 73.24 108.869 168.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . 0.481 ' HA ' ' H ' ' C' ' 42' ' ' LEU . 0.0 OUTLIER 64.92 -79.08 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.907 1.283 . . . . 74.44 111.368 -177.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -72.99 86.37 1.31 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.763 -0.458 . . . . 31.45 109.763 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -151.21 31.19 0.61 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.26 0.624 . . . . 71.5 111.811 -171.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . 0.673 ' HB2' HG11 ' C' ' 40' ' ' VAL . 4.7 tt -97.98 -66.8 0.88 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.222 -1.029 . . . . 73.41 108.222 175.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 132.19 2.2 4.23 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.495 -0.775 . . . . 75.41 113.048 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . 0.436 ' HG ' HD22 ' G' ' 468' ' ' LEU . 80.9 mt -69.0 133.04 47.62 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.589 0.694 . . . . 75.02 110.044 174.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 26.0 tptp . . . . . 0 C--O 1.249 1.072 0 C-N-CA 123.629 0.772 . . . . 70.13 109.059 -175.609 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.742 -0.466 . . . . 74.1 109.742 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 96.4 t -75.08 -67.82 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 107.348 -1.353 . . . . 61.42 107.348 168.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . 0.675 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 16.7 m -100.73 144.94 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 115.364 -0.834 . . . . 72.23 110.052 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -176.25 81.33 0.07 OUTLIER Glycine 0 C--N 1.34 0.804 0 O-C-N 123.478 0.486 . . . . 75.44 111.897 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . 0.426 HD21 HD12 ' D' ' 98' ' ' LEU . 1.5 pt? -147.64 133.7 19.28 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.929 0.892 . . . . 61.52 109.005 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 14.8 t -133.69 -1.52 3.07 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.875 0.47 . . . . 63.14 111.028 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -82.68 142.85 31.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.264 0.626 . . . . 64.42 110.099 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -74.88 -20.61 59.66 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.36 0.664 . . . . 63.43 111.376 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 27.8 m 72.62 128.76 0.04 OUTLIER 'General case' 0 C--N 1.364 1.23 0 C-N-CA 125.296 1.439 . . . . 75.11 111.045 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.88 121.19 14.51 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 122.756 0.422 . . . . 74.4 109.89 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . 0.58 ' HG ' ' HA ' ' D' ' 45' ' ' ASP . 4.5 mm? -65.23 149.4 50.0 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.164 0.983 . . . . 51.25 111.981 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -135.27 136.76 41.92 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 113.618 -1.628 . . . . 71.24 108.553 -172.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 90.2 t80 69.38 134.39 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.945 1.298 . . . . 72.11 112.176 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 14.3 t -156.11 133.03 10.48 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 108.783 -0.821 . . . . 75.53 108.783 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -134.59 159.86 39.88 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.783 0.433 . . . . 70.01 111.437 -170.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' D' ' 41' ' ' LYS . 4.3 ttmp? -83.16 -66.28 0.91 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.504 0.722 . . . . 72.04 109.702 173.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -69.5 90.49 0.54 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.596 0.758 . . . . 62.13 111.976 -171.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -102.83 33.49 3.2 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 114.798 -1.092 . . . . 75.5 109.876 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . 0.412 HD12 HD12 ' D' ' 126' ' ' LEU . 6.6 tt -166.98 -52.56 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 106.978 -1.49 . . . . 74.21 106.978 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.13 -30.83 3.8 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 114.418 -1.265 . . . . 65.2 110.443 -173.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 59.27 81.01 0.18 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 124.917 1.287 . . . . 73.12 110.815 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 94.6 mttt . . . . . 0 C--O 1.248 1.015 0 CA-C-N 115.247 -0.888 . . . . 60.54 109.676 -179.381 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 110.53 -0.174 . . . . 61.22 110.53 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m 57.81 37.81 27.13 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.26 1.024 . . . . 73.35 111.434 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 66.25 90.73 0.09 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.078 1.351 . . . . 71.45 111.204 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.02 134.55 40.96 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 107.499 -1.297 . . . . 74.52 107.499 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 73.29 117.38 0.05 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.183 1.393 . . . . 75.24 109.977 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -61.93 -64.95 0.77 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.442 0.697 . . . . 54.2 109.795 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 p -144.34 168.26 20.5 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.485 1.114 . . . . 43.21 109.409 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -157.04 133.01 9.54 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.328 -0.99 . . . . 62.32 108.328 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 83.7 mtp -145.24 137.91 26.1 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.264 1.026 . . . . 75.14 109.356 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 92.3 m -147.15 120.02 8.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.784 0.834 . . . . 55.32 108.845 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.58 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 13.7 t80 -137.93 126.83 24.01 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.958 0.503 . . . . 65.21 109.713 177.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -138.16 132.5 32.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.418 -1.327 . . . . 62.55 107.418 172.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.527 HG12 ' HD2' ' A' ' 84' ' ' PHE . 46.9 mt -92.76 116.82 34.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.188 -0.671 . . . . 71.41 109.188 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.6 -43.4 59.79 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 124.256 0.973 . . . . 70.11 108.909 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -173.71 129.73 0.42 Allowed 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.243 0.34 . . . . 73.43 111.007 -172.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.492 HD11 HD13 ' A' ' 13' ' ' ILE . 77.1 mt -113.87 139.74 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.954 0.902 . . . . 55.12 109.097 172.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -168.97 -179.78 3.79 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 124.537 1.148 . . . . 72.42 110.495 -170.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -110.15 126.38 54.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.42 -0.809 . . . . 65.23 109.466 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -80.54 -48.8 12.22 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.338 -0.615 . . . . 74.11 109.338 171.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 19.3 t70 -135.58 132.27 36.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.652 -0.704 . . . . 72.44 109.481 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.3 mt -123.21 141.66 42.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.239 -1.393 . . . . 54.03 107.239 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.0 t -144.64 139.07 27.8 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 123.576 0.547 . . . . 74.01 109.586 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.452 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.6 t80 -146.36 126.3 13.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.632 -1.618 . . . . 74.42 106.632 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 22.5 mt-10 -129.6 127.75 41.27 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.438 0.695 . . . . 61.32 109.511 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -137.95 73.93 44.97 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.976 -1.12 . . . . 74.12 107.976 170.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.3 -16.19 13.85 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.664 2.243 . . . . 73.25 110.795 176.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -105.35 13.54 30.2 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.973 1.309 . . . . 62.02 108.96 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -53.12 -47.93 93.98 Favored Pre-proline 0 CA--C 1.566 1.589 0 C-N-CA 124.935 1.294 . . . . 53.13 113.568 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 37.5 Cg_exo -64.17 -24.39 65.94 Favored 'Trans proline' 0 C--N 1.397 3.107 0 C-N-CA 122.131 1.887 . . . . 71.4 113.608 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -74.07 -42.44 60.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.172 0.589 . . . . 71.1 110.597 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.428 HG21 ' HE1' ' A' ' 123' ' ' PHE . 90.3 t -50.37 -33.54 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 124.735 1.214 . . . . 74.42 112.356 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -58.02 -39.9 79.51 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.427 1.091 . . . . 74.0 111.694 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -91.67 -23.21 19.88 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.244 1.018 . . . . 74.21 111.628 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 32.0 mmmt -80.4 147.59 30.94 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.402 0.681 . . . . 52.34 111.654 -175.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.34 129.0 35.97 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.404 -0.961 . . . . 65.24 108.404 170.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.509 ' HE1' ' HB3' ' E' ' 470' ' ' LEU . 69.8 t-105 -76.21 96.38 3.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.0 0.52 . . . . 74.44 110.85 -172.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -148.07 67.17 9.89 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 109.339 -0.615 . . . . 65.21 109.339 170.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -84.26 152.87 12.35 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.762 2.308 . . . . 74.1 111.589 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -97.0 106.44 18.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.452 -1.314 . . . . 73.52 107.452 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.07 98.19 4.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 116.016 -0.538 . . . . 63.44 109.984 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -78.73 113.45 16.8 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.09 -0.959 . . . . 73.52 108.478 170.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' E' ' 467' ' ' ALA . 46.1 tp -100.22 142.87 31.11 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.794 -1.188 . . . . 74.55 107.794 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.54 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 38.8 t70 -145.44 150.26 36.18 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.061 0.545 . . . . 74.23 109.834 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.2 mt -130.53 126.54 37.05 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.479 0.711 . . . . 71.25 110.49 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.673 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 10.5 m-20 -124.72 141.22 52.26 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.328 1.051 . . . . 64.34 109.499 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.441 ' HB ' HD23 ' E' ' 460' ' ' LEU . 87.5 m -134.8 131.12 37.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.008 0.523 . . . . 63.54 110.366 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.01 152.48 50.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.082 0.953 . . . . 55.04 109.383 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.425 ' HB2' HD11 ' A' ' 98' ' ' LEU . 22.4 t -123.45 153.92 39.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.452 0.701 . . . . 43.54 110.424 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.7 t -149.33 119.62 7.32 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.34 1.056 . . . . 72.33 108.695 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -78.42 106.59 10.46 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.482 -0.562 . . . . 44.34 109.482 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 57' ' ' GLU . 42.3 mt -82.0 -35.81 28.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.595 0.758 . . . . 55.41 110.224 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -164.48 -174.36 3.43 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.06 -0.973 . . . . 74.04 109.86 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.84 126.12 28.71 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.264 -1.013 . . . . 65.23 108.264 172.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 85' ' ' SER . 4.8 m-20 65.04 14.63 9.49 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.171 0.989 . . . . 74.23 111.4 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.9 t -128.64 104.88 12.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.58 0 N-CA-C 107.8 -1.185 . . . . 63.35 107.8 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.95 126.52 36.27 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.644 -0.707 . . . . 74.22 109.711 -170.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' HB2' HD11 ' A' ' 51' ' ' LEU . 21.0 tp10 -86.98 128.72 35.07 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 124.438 1.095 . . . . 70.24 109.225 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -128.02 120.32 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.379 -1.341 . . . . 65.44 107.379 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.5 t -110.97 118.51 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.778 0.831 . . . . 73.31 109.146 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.6 tp -100.06 108.11 20.2 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.88 -0.785 . . . . 74.12 108.88 172.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.673 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 27.5 ttp180 -87.18 104.98 16.88 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.543 -0.54 . . . . 75.31 109.543 173.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.1 t -94.39 104.75 16.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.119 -1.067 . . . . 74.31 108.119 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 30.7 m -96.27 135.87 37.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.728 0.811 . . . . 62.3 110.298 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.535 HG21 HG21 ' A' ' 114' ' ' ILE . 74.6 t -128.51 116.79 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.227 1.411 . . . . 62.25 108.544 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -120.95 123.36 42.27 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.209 -1.034 . . . . 55.53 108.209 172.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.84 113.78 21.1 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.839 -1.171 . . . . 52.33 107.839 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.6 t -144.76 143.85 30.88 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.902 0.481 . . . . 73.5 110.173 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -119.33 84.68 2.24 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.013 1.325 . . . . 74.21 108.961 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.14 -119.57 5.22 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.238 -0.892 . . . . 72.12 112.645 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -87.83 -18.98 28.09 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.435 0.694 . . . . 74.45 110.967 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.41 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 1.5 tp10 -94.07 120.27 34.09 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.468 -0.938 . . . . 70.32 108.468 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.3 m -87.35 143.5 27.22 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.114 0.415 . . . . 70.54 110.211 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.71 -66.41 0.89 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.356 -0.609 . . . . 72.12 109.356 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -161.49 174.23 13.71 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.199 -0.91 . . . . 75.42 110.985 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 64' ' ' VAL . 58.2 tp -137.81 137.41 38.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.852 1.261 . . . . 70.34 108.113 175.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.447 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 56.7 m -141.32 130.62 23.61 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.857 -1.164 . . . . 74.3 107.857 175.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -146.7 120.5 9.26 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.603 0.638 . . . . 73.53 109.739 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.84 113.39 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.36 0.664 . . . . 63.4 110.623 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -82.99 87.1 6.89 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.413 -0.958 . . . . 63.32 108.413 166.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.46 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.1 tp-100 -77.19 102.71 6.75 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.304 -0.999 . . . . 62.54 108.304 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.07 143.58 17.1 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.603 -0.599 . . . . 71.34 111.603 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.93 121.89 1.56 Allowed Glycine 0 N--CA 1.451 -0.336 0 N-CA-C 111.041 -0.824 . . . . 72.1 111.041 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.5 mt -82.02 122.26 36.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 108.107 -1.071 . . . . 43.3 108.107 171.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.58 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.6 m-85 -127.64 119.59 26.24 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.993 0.917 . . . . 73.4 108.962 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 74.4 m -81.07 91.63 6.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.584 0.754 . . . . 71.41 109.692 169.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.5 tt -96.61 135.64 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 114.555 -1.202 . . . . 74.54 109.232 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -161.05 163.56 31.47 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.091 0.956 . . . . 75.1 110.109 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.42 -33.61 5.71 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 116.259 -0.428 . . . . 64.31 113.879 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.553 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.58 155.16 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.928 0.491 . . . . 74.45 111.043 -174.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.96 175.36 13.04 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.73 -1.123 . . . . 74.43 110.169 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.36 -142.49 34.15 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 116.022 -0.535 . . . . 71.54 111.892 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.1 p -70.17 -15.86 63.01 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.338 0.655 . . . . 73.33 111.581 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -75.18 -37.39 61.27 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.738 0.815 . . . . 64.22 111.137 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.626 ' SD ' HD23 ' E' ' 454' ' ' LEU . 0.0 OUTLIER -75.67 -28.64 58.79 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 110.132 -0.321 . . . . 74.21 110.132 173.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.92 -24.97 62.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.09 0.556 . . . . 72.41 110.458 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -68.17 -38.68 82.34 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 122.908 0.483 . . . . 71.22 109.847 171.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 68.8 m -65.86 -39.56 90.84 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.462 -0.335 . . . . 75.21 110.279 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.517 HD22 HD22 ' E' ' 454' ' ' LEU . 36.0 tp -66.69 -51.44 55.99 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.914 0.886 . . . . 73.15 111.91 -175.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.11 -26.84 10.76 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.558 -0.746 . . . . 70.22 114.075 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -111.41 -66.22 1.1 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.204 0.502 . . . . 53.03 112.034 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.622 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 72.2 t80 -68.77 -61.11 1.95 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.264 1.026 . . . . 74.04 112.766 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 94.2 m -67.6 -36.68 10.51 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 113.916 1.08 . . . . 70.41 113.916 -174.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.54 -31.34 50.92 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 121.548 1.499 . . . . 73.42 112.506 167.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.21 -28.47 68.77 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.521 0.328 . . . . 62.33 110.633 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.481 HG21 ' CD1' ' A' ' 13' ' ' ILE . 50.1 mm -62.53 -45.28 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.765 0.826 . . . . 73.11 109.86 171.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.46 HD22 ' HG3' ' A' ' 80' ' ' GLN . 80.0 mt -72.29 -27.0 62.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.977 0.911 . . . . 71.43 112.256 -175.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -57.7 -45.68 99.81 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 114.142 1.164 . . . . 73.03 114.142 -168.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -62.11 -38.81 53.67 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 121.978 1.785 . . . . 71.44 112.915 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -67.13 -39.38 86.59 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.302 0.641 . . . . 53.01 111.075 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.93 -43.49 71.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.31 0.644 . . . . 74.23 110.448 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -52.05 -48.07 64.8 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 124.421 1.075 . . . . 72.33 110.2 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.08 -47.94 75.5 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 124.089 0.868 . . . . 75.04 111.342 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.45 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.5 t -58.25 -27.68 64.21 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.833 0.708 . . . . 60.34 111.22 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.535 HG21 HG21 ' A' ' 64' ' ' VAL . 86.6 mt -77.46 -58.58 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.592 1.157 . . . . 63.51 110.287 174.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.7 m -57.36 -33.72 68.06 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 124.667 1.187 . . . . 74.54 111.344 -173.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -63.67 -49.02 74.81 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.848 0.859 . . . . 61.34 109.977 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.452 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 69.3 mtm -63.56 -34.12 77.1 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.389 0.676 . . . . 73.14 111.459 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -66.46 -46.0 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.196 0.998 . . . . 75.12 110.461 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.2 m -70.22 -28.67 65.46 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.442 0.697 . . . . 74.43 111.388 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -73.35 -31.69 64.1 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.428 0.691 . . . . 72.22 109.782 174.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.06 2.78 86.31 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.88 0.738 . . . . 75.0 112.735 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.5 m 68.5 16.73 9.13 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.918 1.287 . . . . 42.24 111.552 173.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.428 ' HE1' HG21 ' A' ' 31' ' ' VAL . 96.9 m-85 -78.85 156.29 77.44 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 109.011 -0.737 . . . . 74.03 109.011 171.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.73 163.8 17.75 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.486 2.124 . . . . 75.45 112.531 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -60.36 121.61 12.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.062 0.945 . . . . 75.52 110.998 -172.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.524 HD21 HG11 ' A' ' 64' ' ' VAL . 53.0 tp -106.16 93.92 4.88 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.743 -0.836 . . . . 61.04 108.743 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.481 HD21 ' N ' ' C' ' 16' ' ' ILE . 71.4 m-20 -107.1 85.27 2.11 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.889 -1.152 . . . . 73.15 107.889 173.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.429 ' HB2' HD22 ' A' ' 42' ' ' LEU . 4.0 pp -60.11 137.52 58.08 Favored 'General case' 0 C--O 1.251 1.178 0 CA-C-N 114.447 -1.251 . . . . 61.51 109.246 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.63 143.91 85.79 Favored Pre-proline 0 C--O 1.243 0.758 0 C-N-CA 123.162 0.585 . . . . 72.1 110.948 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.05 161.61 45.46 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 121.702 1.601 . . . . 75.33 110.214 170.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.86 130.22 18.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.675 -0.861 . . . . 73.04 108.675 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.461 ' HB2' ' HG3' ' C' ' 147' ' ' GLU . 37.4 t-20 -75.07 92.03 2.6 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.888 -0.596 . . . . 62.13 110.071 -174.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.558 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 83.9 m-85 -58.09 -35.51 71.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.86 0.864 . . . . 73.11 111.91 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -60.46 -50.73 72.41 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.531 0.733 . . . . 54.24 110.302 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.47 94.43 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.135 0.897 . . . . 71.33 111.434 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 139' ' ' ASN . 91.6 mt -65.72 -41.91 91.7 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.859 -0.61 . . . . 54.43 111.15 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -68.37 -32.26 72.22 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.029 -0.532 . . . . 54.43 109.578 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.4 ' SD ' HD23 ' A' ' 141' ' ' LEU . 15.9 mmt -59.55 -41.78 90.87 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.667 0.605 . . . . 52.31 110.835 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.423 HD22 ' HA ' ' A' ' 136' ' ' LEU . 65.5 m-80 -56.34 -38.67 71.67 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 123.667 0.605 . . . . 73.11 111.134 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -75.38 -40.1 58.41 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.73 0.812 . . . . 73.24 111.036 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.4 HD23 ' SD ' ' A' ' 138' ' ' MET . 55.8 tp -70.05 -51.28 33.35 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.491 1.116 . . . . 64.0 112.805 -168.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -168.83 2.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.873 -0.603 . . . . 74.34 111.616 -169.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 59.51 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.696 1.598 . . . . 75.53 111.806 -168.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 145' ' ' ALA . 43.7 tt0 -152.9 179.07 9.0 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.135 0.974 . . . . 72.43 108.42 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.401 ' H ' ' HG2' ' A' ' 144' ' ' GLN . . . 67.61 11.72 8.51 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.505 1.122 . . . . 74.03 113.114 170.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.37 -10.17 86.22 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 112.652 -0.179 . . . . 61.24 112.652 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.31 114.64 6.94 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.845 0.858 . . . . 74.44 108.722 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -148.02 38.34 1.05 Allowed Glycine 0 C--N 1.343 0.933 0 N-CA-C 112.107 -0.397 . . . . 65.21 112.107 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.6 m -84.64 87.43 7.28 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.794 -0.817 . . . . 74.2 108.794 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -80.27 93.8 5.97 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.432 -0.804 . . . . 61.31 109.56 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.46 -22.21 65.5 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.008 0.923 . . . . 55.44 110.532 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -64.77 99.54 0.34 Allowed 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.87 0.868 . . . . 53.41 110.053 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -122.71 18.84 10.31 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.374 1.07 . . . . 54.11 110.153 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -143.67 124.15 13.97 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.062 0.545 . . . . 71.1 109.998 -174.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 N-CA-C 108.228 -1.027 . . . . 64.34 108.228 174.29 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.7 mtm . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 108.788 -0.819 . . . . 64.45 108.788 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 23.3 p -157.31 76.26 0.83 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.702 0.801 . . . . 73.31 108.849 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.61 ' HA ' ' HB1' ' B' ' 87' ' ' ALA . 4.5 mp0 -84.4 78.07 9.88 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.982 -1.008 . . . . 72.01 110.154 -176.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.673 HE22 ' HB3' ' B' ' 6' ' ' ASN . 0.2 OUTLIER -93.33 103.14 15.39 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.65 -1.241 . . . . 74.51 107.65 177.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . 0.504 ' HA ' ' HA2' ' B' ' 88' ' ' GLY . 3.6 p-10 -67.48 -30.54 70.27 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 113.687 0.995 . . . . 64.3 113.687 -166.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.673 ' HB3' HE22 ' B' ' 4' ' ' GLN . 46.3 t-20 -65.25 152.33 43.97 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.163 0.585 . . . . 71.14 109.471 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 43.4 m -60.25 80.68 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.481 1.112 . . . . 74.42 111.93 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -147.15 -41.22 0.18 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.796 1.638 . . . . 74.45 106.807 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.525 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 23.2 ptm 54.92 170.5 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 127.342 2.257 . . . . 72.42 114.583 172.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.5 m -159.13 133.48 7.8 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.169 -0.923 . . . . 63.55 108.63 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.93 156.71 48.35 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.533 -0.543 . . . . 71.41 109.533 157.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -124.24 137.52 54.5 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 107.442 -1.318 . . . . 65.01 107.442 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.489 HD11 HD13 ' B' ' 105' ' ' ILE . 27.4 mt -78.92 117.45 24.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 107.708 -1.219 . . . . 73.01 107.708 176.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -78.23 -42.47 31.13 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.874 -0.787 . . . . 75.45 108.874 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -164.9 135.71 4.01 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.022 -0.99 . . . . 74.1 110.155 -170.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 85.5 mt -114.46 139.15 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 106.619 -1.623 . . . . 62.2 106.619 167.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -166.98 150.65 6.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.241 0.543 . . . . 75.03 111.524 -176.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 75.9 m -78.24 128.98 34.53 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.935 -1.029 . . . . 63.14 109.084 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 20.9 mttp -91.4 -46.24 8.12 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.661 0.784 . . . . 71.12 110.616 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 22.5 t70 -144.41 133.25 22.49 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.217 -0.447 . . . . 63.2 110.687 -165.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.8 mm -130.82 142.15 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.157 0.983 . . . . 74.12 109.114 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 81.5 p -139.2 144.45 38.52 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.376 -0.972 . . . . 72.33 108.376 170.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.1 t80 -145.81 134.13 21.81 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.971 -1.492 . . . . 73.44 106.971 163.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.645 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 36.7 mt-10 -136.89 127.24 26.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.518 -0.919 . . . . 63.02 108.518 -175.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.561 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -124.55 84.94 56.75 Favored Pre-proline 0 C--O 1.24 0.571 0 N-CA-C 107.69 -1.226 . . . . 72.22 107.69 171.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.71 -32.93 46.13 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.701 2.268 . . . . 52.34 111.394 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -104.45 10.71 35.12 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 117.873 -1.06 . . . . 71.43 110.793 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.617 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -29.64 -68.7 0.11 Allowed Pre-proline 0 N--CA 1.5 2.06 0 C-N-CA 125.355 1.462 . . . . 73.21 114.869 -170.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 11.6 Cg_exo -67.49 -21.21 46.83 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 122.199 1.933 . . . . 73.23 113.042 -171.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -96.81 -32.68 11.99 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.296 1.039 . . . . 71.15 112.434 -172.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.565 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.8 p -82.69 -19.7 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 122.683 0.393 . . . . 72.31 111.327 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -62.43 -25.41 67.95 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 113.976 1.102 . . . . 72.21 113.976 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -56.56 -25.62 52.83 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.081 0.552 . . . . 75.31 111.198 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.528 ' HB2' HD13 ' B' ' 68' ' ' LEU . 87.5 mttt -88.45 92.94 9.37 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.268 1.027 . . . . 74.14 109.435 176.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.24 91.25 6.17 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.099 -0.704 . . . . 63.02 109.099 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -163.32 156.82 19.4 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.837 0.855 . . . . 74.13 109.497 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.591 ' HB2' HD21 ' F' ' 470' ' ' LEU . 38.4 mt-30 -76.45 104.65 1.7 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.026 0.93 . . . . 70.41 108.649 171.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.607 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.2 Cg_endo -63.44 153.07 76.96 Favored 'Trans proline' 0 C--N 1.366 1.46 0 C-N-CA 123.137 2.558 . . . . 73.25 113.238 -176.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.8 118.6 7.38 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 123.778 0.674 . . . . 74.3 109.37 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.574 HG21 HD11 ' F' ' 468' ' ' LEU . 29.9 m -87.46 161.06 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 114.977 -1.011 . . . . 65.02 111.569 -176.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -149.26 107.77 3.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.521 -1.659 . . . . 75.14 106.521 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 mp -100.27 148.69 24.37 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.164 0.585 . . . . 74.43 110.313 -171.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -131.74 113.44 13.54 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.708 -1.219 . . . . 65.31 107.708 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.2 127.25 45.14 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 106.02 -1.844 . . . . 74.02 106.02 176.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.581 ' HA ' ' HG ' ' F' ' 460' ' ' LEU . 24.8 t70 -144.99 148.64 33.99 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.797 0.839 . . . . 72.02 109.364 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 37.0 p -134.91 118.55 17.04 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.23 0.612 . . . . 65.4 109.995 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.48 153.31 31.36 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.766 1.226 . . . . 73.32 108.325 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 77.6 p -143.75 166.14 25.71 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.183 0.447 . . . . 50.5 111.34 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.0 p -152.33 149.97 29.22 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.25 1.02 . . . . 73.34 109.22 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -93.8 124.6 37.91 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.546 -0.539 . . . . 64.43 109.546 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.29 -52.42 5.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.128 -0.693 . . . . 73.31 109.128 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.41 -175.59 4.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.206 1.003 . . . . 62.2 109.646 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.46 116.33 8.09 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.577 -0.738 . . . . 75.42 109.218 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 83.0 m-20 74.08 -3.37 2.54 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.27 1.428 . . . . 74.4 112.887 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 48.4 t -106.04 110.41 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.521 -0.918 . . . . 72.05 108.521 176.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.488 ' HE2' ' HB ' ' B' ' 86' ' ' ILE . 1.3 p90 -119.97 173.34 7.13 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.88 0.872 . . . . 73.34 109.65 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -143.08 110.97 5.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.047 -1.094 . . . . 72.14 108.047 -174.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 55.8 t -91.52 145.28 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.184 0.994 . . . . 62.13 109.817 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.5 t -129.33 115.13 34.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.263 -1.014 . . . . 73.42 108.263 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.4 OUTLIER -97.09 110.71 23.2 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.623 -0.88 . . . . 70.44 108.623 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -95.18 118.67 32.37 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.661 0.785 . . . . 63.05 110.746 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.484 ' HB ' HD11 ' B' ' 114' ' ' ILE . 26.3 t -116.54 103.19 14.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.53 -1.285 . . . . 74.02 107.53 168.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.567 HG23 ' HB2' ' B' ' 77' ' ' GLU . 2.8 m -99.6 131.3 45.69 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.222 -0.659 . . . . 64.13 109.222 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 96.5 t -125.21 116.99 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.342 0.657 . . . . 64.52 109.944 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.6 m -99.53 142.98 30.3 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.762 0.825 . . . . 60.21 108.957 167.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.404 ' HB1' ' HG2' ' B' ' 38' ' ' PRO . . . -149.22 147.04 27.93 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.033 0.533 . . . . 70.32 110.36 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.445 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 23.8 p -146.93 130.6 16.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.702 0.401 . . . . 72.41 111.93 -174.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.607 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 25.2 mt -95.84 118.85 33.27 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.679 1.191 . . . . 74.34 109.772 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.73 -108.8 2.6 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 123.742 0.651 . . . . 72.5 112.307 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -118.63 1.59 11.66 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.211 1.004 . . . . 74.24 110.384 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -122.51 155.2 36.69 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.993 0.517 . . . . 74.55 109.936 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.1 m -63.37 134.98 56.66 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.82 0.7 . . . . 72.33 110.842 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.565 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.4 -64.84 1.06 Allowed 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.492 -1.299 . . . . 65.22 107.492 174.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -148.75 157.92 43.79 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.203 -0.908 . . . . 73.14 111.012 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.645 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 69.3 mt -130.18 143.57 50.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.589 -1.634 . . . . 62.52 106.589 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 41.9 t -155.28 156.67 35.96 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.644 -0.502 . . . . 71.02 109.644 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.567 ' HB2' HG23 ' B' ' 63' ' ' THR . 34.7 tt0 -160.27 136.17 8.46 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.123 -1.065 . . . . 71.12 108.123 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 93.4 t -124.06 141.53 43.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.622 -0.881 . . . . 73.44 108.622 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -120.57 89.6 3.16 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.581 -0.896 . . . . 73.52 108.581 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.563 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.6 tp-100 -83.3 99.09 9.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.678 -1.146 . . . . 72.2 108.821 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.84 169.95 35.9 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 116.19 -0.459 . . . . 53.51 111.968 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.36 129.86 1.97 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.68 -0.568 . . . . 61.12 111.68 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.3 mt -85.21 129.35 37.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.597 0.759 . . . . 71.52 109.227 172.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -131.92 139.76 48.82 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.947 -1.131 . . . . 74.23 107.947 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.3 m -112.71 97.87 6.85 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.867 -0.79 . . . . 73.45 108.867 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.498 HG21 HG13 ' F' ' 452' ' ' VAL . 17.4 tt -96.54 147.02 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.697 0.799 . . . . 72.21 111.097 -166.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.61 ' HB1' ' HA ' ' B' ' 3' ' ' GLU . . . -148.97 141.34 24.17 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.326 0.65 . . . . 65.33 110.396 -174.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' B' ' 5' ' ' ASN . . . 99.57 -63.2 0.69 Allowed Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.617 -0.719 . . . . 24.41 114.488 169.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.525 ' HB ' ' HB3' ' B' ' 9' ' ' MET . 17.2 tt -66.49 163.68 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.369 0 C-N-CA 124.042 0.937 . . . . 74.25 111.126 -173.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -158.91 175.47 13.53 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.085 0.402 . . . . 74.34 110.689 -172.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' B' ' 94' ' ' MET . . . 66.91 -132.2 31.26 Favored Glycine 0 C--N 1.355 1.59 0 C-N-CA 123.656 0.646 . . . . 34.33 114.446 169.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 46.3 m -75.9 -27.41 57.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.666 0.787 . . . . 72.42 110.947 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.486 ' HB3' HD11 ' B' ' 89' ' ' ILE . 52.1 mt-30 -68.63 -33.66 74.4 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.853 -0.612 . . . . 73.23 111.437 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.501 ' SD ' ' HA ' ' F' ' 452' ' ' VAL . 0.0 OUTLIER -71.26 -24.66 62.21 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.378 0.271 . . . . 54.32 110.734 176.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.52 78.28 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.114 0.566 . . . . 64.44 110.834 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -63.1 -29.95 71.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.3 -0.863 . . . . 75.44 110.976 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.481 ' SG ' HD12 ' B' ' 86' ' ' ILE . 49.2 t -74.67 -62.11 1.65 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.411 -0.359 . . . . 60.55 110.771 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.523 HD12 ' N ' ' B' ' 99' ' ' GLY . 3.0 pp -63.49 -32.79 74.34 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.126 0.788 . . . . 75.35 113.126 -173.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.523 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -92.25 -36.36 6.3 Favored Glycine 0 C--N 1.345 1.056 0 O-C-N 123.482 0.488 . . . . 50.3 113.273 -172.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.0 -53.76 2.15 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.615 0.598 . . . . 64.31 112.615 -167.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 51.7 t80 -72.03 -45.05 62.31 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.862 0.865 . . . . 75.1 111.617 -168.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.492 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 70.8 m -66.11 -49.68 54.86 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 123.6 0.76 . . . . 61.34 111.253 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 80.4 Cg_exo -53.63 -36.42 81.04 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 122.479 2.12 . . . . 71.32 114.203 168.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -57.44 -38.85 75.1 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 123.399 0.679 . . . . 72.2 110.709 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.489 HD13 HD11 ' B' ' 13' ' ' ILE . 80.5 mt -64.99 -43.4 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.117 0.967 . . . . 44.12 110.633 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 52.5 mt -83.23 -15.17 51.42 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.978 0.911 . . . . 75.22 112.043 -172.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -61.28 -49.32 88.46 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.023 -0.989 . . . . 70.42 113.558 -170.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.01 -31.01 83.85 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 121.729 1.619 . . . . 74.24 112.97 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.563 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 86.7 m-85 -67.92 -50.02 58.5 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.889 0.476 . . . . 71.11 110.207 176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.41 -40.51 78.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.831 0.852 . . . . 74.3 110.582 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.749 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 30.8 ttt180 -58.08 -56.67 19.05 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.39 1.476 . . . . 72.52 111.065 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -63.54 -34.81 78.61 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.937 0.773 . . . . 73.45 110.51 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.7 t -69.88 -40.32 75.75 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.209 0.603 . . . . 72.44 111.417 -176.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.484 HD11 ' HB ' ' B' ' 62' ' ' VAL . 70.5 mt -62.22 -53.54 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 109.563 -0.532 . . . . 54.43 109.563 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.414 HG21 ' OG ' ' C' ' 119' ' ' SER . 12.0 m -60.07 -30.08 68.99 Favored 'General case' 0 CA--C 1.554 1.124 0 O-C-N 124.539 1.149 . . . . 41.21 111.403 -175.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.7 t -64.66 -54.09 37.18 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.555 0.742 . . . . 61.31 110.022 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.4 mmt -67.26 -34.59 77.75 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.411 0.684 . . . . 75.32 111.991 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.96 -38.31 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.134 0.974 . . . . 61.15 110.463 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.421 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 11.8 t -78.07 -20.64 51.92 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.886 -0.597 . . . . 42.55 111.139 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.45 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 92.7 mtt-85 -69.24 -33.79 73.81 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.422 -0.584 . . . . 74.54 109.422 171.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.29 11.3 58.63 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.595 0.559 . . . . 71.52 112.698 168.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.7 p 58.98 31.44 21.36 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.637 1.975 . . . . 62.3 114.18 170.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -84.81 157.93 59.89 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.133 0.573 . . . . 74.44 110.133 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.38 -175.29 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.994 2.463 . . . . 75.42 113.349 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -61.7 114.41 3.28 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.3 -0.864 . . . . 73.3 112.149 -170.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 35.9 tp -110.23 84.76 1.98 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.331 -0.989 . . . . 71.44 108.331 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.23 93.79 8.43 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.284 -0.636 . . . . 71.31 109.284 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.749 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 22.7 tp -57.68 127.77 33.69 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.737 0.815 . . . . 70.13 111.421 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.57 153.77 94.79 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 124.509 1.124 . . . . 74.32 111.813 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.19 100.56 0.46 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.836 2.357 . . . . 61.32 112.162 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.92 108.93 20.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.073 -1.084 . . . . 61.24 108.073 172.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 60.9 t30 -94.08 95.21 8.86 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 107.686 -1.227 . . . . 53.2 107.686 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.78 -42.74 89.69 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 124.081 0.863 . . . . 65.41 109.501 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.36 -39.09 69.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.191 1.397 . . . . 73.54 112.843 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.423 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -63.92 -50.33 69.13 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.717 0.807 . . . . 54.54 111.304 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 82.6 mt -79.11 -28.91 43.01 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.254 -0.885 . . . . 61.43 111.305 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.518 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 78.5 t80 -69.88 -35.66 74.83 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.756 0.822 . . . . 74.42 109.947 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 14.4 tmm? -59.23 -34.11 71.81 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.073 0.949 . . . . 64.51 110.742 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -75.42 -35.58 60.96 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.612 0.765 . . . . 73.32 110.931 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -60.48 -29.41 69.04 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.594 1.158 . . . . 75.53 111.932 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 22.9 mt -85.16 -9.29 58.01 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.859 0.464 . . . . 65.34 111.781 -174.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -124.04 103.86 8.55 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.79 0.836 . . . . 75.14 108.94 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -83.83 58.37 4.62 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.142 0.973 . . . . 73.41 110.09 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -154.7 165.35 36.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.099 -0.955 . . . . 71.31 109.818 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.56 121.52 35.01 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.539 0.735 . . . . 73.24 110.432 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.65 173.7 53.93 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 123.393 0.433 . . . . 54.13 112.996 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -89.67 122.8 33.12 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.516 0.726 . . . . 64.0 110.55 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.27 111.33 0.52 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.887 -0.885 . . . . 61.03 110.887 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 12.1 t -113.86 -179.0 3.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.528 0.731 . . . . 64.42 110.632 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -111.3 124.1 51.55 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.101 -1.074 . . . . 55.42 108.101 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -74.78 146.51 42.05 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.513 -0.551 . . . . 73.5 109.513 174.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -65.6 87.99 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.124 0.97 . . . . 65.02 109.074 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -73.69 96.04 2.44 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.681 0.792 . . . . 74.11 109.852 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -117.46 144.51 44.96 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.744 0.817 . . . . 75.23 109.454 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.855 0 C-N-CA 123.909 0.884 . . . . 54.44 108.869 178.415 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 109.402 -0.592 . . . . 63.44 109.402 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 43.0 t -148.59 129.04 13.92 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.739 0.816 . . . . 55.12 108.989 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -149.34 146.44 27.52 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.062 0.545 . . . . 73.34 109.707 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -138.23 144.8 40.77 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.502 1.121 . . . . 74.22 108.344 175.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -88.89 -57.99 2.71 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.796 -0.446 . . . . 64.35 109.796 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -166.91 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.096 0.558 . . . . 73.12 110.54 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 28.7 m -73.91 84.13 1.71 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.304 0.642 . . . . 72.34 110.19 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -78.79 -59.91 2.59 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.743 -0.662 . . . . 64.31 109.289 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.514 ' SD ' ' HA ' ' C' ' 147' ' ' GLU . 53.7 ttm 61.44 116.02 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.729 1.611 . . . . 52.13 112.602 -178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m -127.43 97.06 4.75 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.336 -1.727 . . . . 71.13 106.336 172.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.45 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 9.0 t80 -124.64 117.48 24.37 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.013 0.525 . . . . 74.43 110.893 -175.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.483 ' HB2' ' HG3' ' C' ' 153' ' ' GLN . 49.5 tp60 -137.27 133.2 34.76 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.21 -1.404 . . . . 71.43 107.21 173.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.413 HD13 HG21 ' C' ' 105' ' ' ILE . 45.5 mt -74.36 118.57 20.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.567 -0.901 . . . . 72.31 108.567 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.511 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 1.4 mt-30 -77.09 -40.92 44.26 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.131 0.894 . . . . 73.3 109.892 -176.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -170.56 147.65 2.94 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 116.045 -0.525 . . . . 74.21 110.077 -173.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.481 ' N ' HD21 ' A' ' 127' ' ' ASN . 96.6 mt -135.46 137.4 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.791 -1.188 . . . . 63.11 107.791 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.474 ' HB3' HG23 ' D' ' 122' ' ' THR . 29.8 p90 -176.01 173.78 2.2 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.903 0.752 . . . . 75.35 111.228 -171.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -100.03 123.82 44.71 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.615 0.766 . . . . 62.51 109.594 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.425 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.0 mmtp -70.67 -48.94 52.28 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.821 -1.177 . . . . 75.44 107.821 168.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -135.37 143.12 45.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 113.863 -1.517 . . . . 53.41 110.283 -172.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.0 mt -137.89 146.97 26.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 126.077 1.751 . . . . 73.31 106.359 174.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -162.21 149.95 14.31 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.423 0.63 . . . . 54.25 110.405 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.449 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 93.7 t80 -140.35 139.19 35.32 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.661 -1.237 . . . . 64.43 107.661 171.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -136.23 128.83 30.61 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.509 0.724 . . . . 71.13 110.061 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.92 82.65 11.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 106.838 -1.541 . . . . 61.22 106.838 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.85 -26.1 38.53 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.974 2.449 . . . . 63.43 112.268 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -112.28 27.23 9.83 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 114.822 -1.081 . . . . 75.21 109.641 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.415 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -50.19 -58.62 9.08 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 114.449 1.277 . . . . 71.43 114.449 -170.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.57 -31.49 79.82 Favored 'Trans proline' 0 C--N 1.388 2.624 0 CA-C-N 121.891 1.711 . . . . 65.42 112.092 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -69.75 -43.06 73.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.354 1.062 . . . . 73.12 112.031 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.67 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.7 p -77.81 -24.87 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 123.04 0.536 . . . . 55.32 111.644 -173.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.0 -29.11 70.29 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.354 0.262 . . . . 54.32 111.664 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -104.78 36.18 2.52 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.202 0.601 . . . . 74.33 110.615 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -111.07 169.46 8.76 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.235 1.014 . . . . 71.23 109.969 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -68.42 130.57 43.28 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.03 0.532 . . . . 63.23 110.147 173.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -73.99 93.37 2.22 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.324 1.049 . . . . 70.34 109.224 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -150.24 59.25 3.54 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.302 0.641 . . . . 70.14 109.712 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.4 110.28 3.03 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.643 2.229 . . . . 74.12 111.768 -175.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -86.52 108.51 18.58 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.522 -0.918 . . . . 45.12 108.522 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.405 HG11 ' H ' ' G' ' 468' ' ' LEU . 7.4 p -84.53 142.33 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.308 1.043 . . . . 71.03 111.257 -171.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -130.57 119.45 22.55 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.875 -1.528 . . . . 74.21 106.875 174.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 30.1 tp -101.38 124.79 47.63 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 109.635 -0.506 . . . . 54.03 109.635 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.475 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 13.7 t70 -117.24 112.2 20.47 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.258 -1.016 . . . . 74.42 108.258 -176.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.438 HD13 ' HE1' ' C' ' 133' ' ' PHE . 79.9 mt -110.86 111.1 22.01 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.963 -0.754 . . . . 64.53 108.963 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -122.63 139.78 53.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.34 1.056 . . . . 75.12 108.674 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 m -126.8 126.37 43.28 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.511 0.672 . . . . 34.24 110.258 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.76 154.91 25.46 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.108 -1.406 . . . . 53.53 107.975 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.524 ' HB2' ' HE1' ' C' ' 56' ' ' TYR . 13.4 p -149.5 142.71 25.07 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.87 0.468 . . . . 72.32 109.871 -177.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.7 t -149.74 146.65 27.32 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.896 0.878 . . . . 75.31 110.162 -171.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -82.95 133.82 35.09 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.486 -0.561 . . . . 74.31 109.486 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.556 HD11 HD12 ' C' ' 83' ' ' ILE . 43.7 mt -106.53 -41.29 5.31 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.052 -0.722 . . . . 71.4 109.052 173.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.01 -175.65 5.54 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.731 -1.122 . . . . 34.41 109.963 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -67.22 119.08 11.52 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 114.973 -1.012 . . . . 64.44 109.679 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 65.34 8.21 4.79 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.017 1.327 . . . . 75.23 112.584 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -113.18 96.96 5.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 107.657 -1.238 . . . . 72.02 107.657 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.524 ' HE1' ' HB2' ' C' ' 48' ' ' SER . 1.6 t80 -114.87 129.51 56.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.652 -0.704 . . . . 71.05 109.597 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.504 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.7 tt0 -88.77 135.02 33.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.983 -1.008 . . . . 62.53 110.218 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.85 141.59 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.704 -1.221 . . . . 70.11 107.704 166.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -128.66 123.43 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.614 -1.254 . . . . 72.55 107.614 173.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.97 102.83 12.23 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.424 -1.325 . . . . 64.44 107.424 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 -85.86 122.85 30.51 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.947 -1.478 . . . . 75.12 108.443 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.6 t -117.73 126.04 74.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 107.735 -1.209 . . . . 73.43 107.735 169.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 13.0 m -126.75 115.88 20.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.61 -0.885 . . . . 72.5 108.61 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.534 HG11 HD11 ' C' ' 126' ' ' LEU . 65.2 t -102.67 120.57 52.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 109.012 -0.736 . . . . 61.13 109.012 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 16.3 m -103.52 142.83 33.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.382 -0.97 . . . . 52.33 108.382 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.44 118.25 13.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.545 -1.28 . . . . 64.43 107.545 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -132.29 134.01 44.75 Favored 'General case' 0 C--O 1.224 -0.262 0 O-C-N 123.855 0.722 . . . . 65.2 109.575 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 12.1 mt -86.2 28.01 0.87 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.809 1.243 . . . . 75.14 111.081 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.7 -104.84 1.53 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 110.453 -1.059 . . . . 32.34 110.453 -169.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -90.57 -30.89 16.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.908 0.883 . . . . 70.32 110.587 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -75.45 124.3 26.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.284 1.034 . . . . 72.33 110.206 172.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 18.0 m -80.68 125.61 30.25 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.789 -0.819 . . . . 44.21 108.789 167.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.67 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.82 -61.22 2.07 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.374 -0.602 . . . . 45.25 109.374 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -151.34 156.83 41.57 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.475 0.655 . . . . 73.42 111.237 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.447 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -127.79 142.2 51.37 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 106.75 -1.574 . . . . 61.45 106.75 172.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.447 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.4 t -148.07 141.07 24.87 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.597 -0.89 . . . . 74.31 108.597 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -147.35 133.72 19.62 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.123 -0.695 . . . . 74.41 109.123 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' C' ' 110' ' ' ALA . 59.8 t -135.97 113.75 14.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.569 1.147 . . . . 74.34 108.145 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -95.5 89.11 5.28 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.769 -0.826 . . . . 72.12 108.769 174.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -79.78 98.77 7.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.268 -0.878 . . . . 64.11 110.144 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.65 144.82 17.99 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-O 121.177 0.321 . . . . 52.53 112.45 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.58 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -146.2 128.17 2.98 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.346 -1.102 . . . . 73.52 110.346 -176.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.556 HD12 HD11 ' C' ' 51' ' ' LEU . 11.0 mm -88.32 122.68 40.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.36 -0.978 . . . . 71.45 108.36 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.45 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 62.0 m-85 -127.24 119.51 26.54 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.108 -0.701 . . . . 64.31 109.108 -175.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 31.2 p -82.96 109.64 17.25 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.797 -0.816 . . . . 61.51 108.797 176.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.578 HD13 HD21 ' C' ' 98' ' ' LEU . 32.9 pt -116.12 102.53 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-O 122.151 0.976 . . . . 61.54 110.276 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.16 158.65 30.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.106 0.962 . . . . 31.14 108.9 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.11 -18.67 34.96 Favored Glycine 0 C--N 1.344 0.986 0 N-CA-C 114.06 0.384 . . . . 62.52 114.06 173.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.19 158.74 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.381 1.072 . . . . 70.13 110.608 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -161.25 -177.26 5.91 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.119 0.567 . . . . 63.11 110.94 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.45 -116.19 8.83 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-N 115.308 -0.86 . . . . 73.02 113.78 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.6 p -70.23 -34.49 72.94 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.096 0.959 . . . . 74.44 111.24 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -70.25 -38.72 75.22 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.68 -0.691 . . . . 72.2 111.207 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 22.0 ptm -78.97 -25.55 43.44 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 119.588 -0.244 . . . . 72.54 110.697 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.47 85.53 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.646 -0.502 . . . . 63.23 109.646 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -75.73 -34.66 60.34 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.394 0.434 . . . . 64.45 111.673 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 40.3 t -59.0 -35.89 74.0 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.654 0.596 . . . . 71.04 110.661 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.578 HD21 HD13 ' C' ' 86' ' ' ILE . 51.3 mt -100.49 -16.3 17.59 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.273 0.629 . . . . 74.52 111.308 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.79 -30.5 57.72 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 114.491 0.556 . . . . 74.22 114.491 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.18 -39.09 0.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.861 0.464 . . . . 31.43 110.866 -168.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -66.07 -48.95 69.3 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.143 1.777 . . . . 64.54 112.718 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 51.0 m -73.12 -45.65 8.17 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 118.57 -0.728 . . . . 32.03 112.133 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -53.37 -30.78 54.24 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 122.602 2.201 . . . . 65.35 113.528 170.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -64.82 -40.69 95.61 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.862 0.865 . . . . 70.51 110.364 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.413 HG21 HD13 ' C' ' 13' ' ' ILE . 47.9 mm -60.71 -44.15 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.056 0.542 . . . . 74.53 109.795 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.58 HD21 ' HA3' ' C' ' 82' ' ' GLY . 88.0 mt -80.08 -26.81 39.46 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.907 -1.042 . . . . 75.43 112.764 -170.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -57.36 -48.55 97.12 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 117.575 -1.203 . . . . 72.13 113.534 -172.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.74 -37.96 94.92 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.356 2.037 . . . . 74.42 113.732 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -68.27 -44.68 75.03 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.844 0.458 . . . . 70.44 110.587 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.411 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -64.64 -38.3 90.53 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.803 -0.635 . . . . 62.54 110.78 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -57.16 -48.58 78.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.477 1.511 . . . . 72.13 110.834 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.35 -34.59 68.13 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.398 0.679 . . . . 62.12 110.69 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.5 t -69.11 -30.71 69.05 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.031 0.532 . . . . 45.42 111.287 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.517 HD11 ' HB ' ' C' ' 62' ' ' VAL . 97.7 mt -68.47 -51.36 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.439 0.696 . . . . 71.21 109.541 173.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.415 HG21 ' OG ' ' B' ' 119' ' ' SER . 10.5 m -60.25 -31.95 70.69 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.166 0.916 . . . . 71.43 111.104 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.9 t -64.51 -54.78 27.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.722 0.809 . . . . 55.03 109.465 174.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.449 ' HB3' ' HB2' ' C' ' 23' ' ' PHE . 0.0 OUTLIER -57.56 -42.52 83.19 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.741 1.216 . . . . 71.21 112.84 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' C' ' 123' ' ' PHE . 58.3 t -66.27 -41.74 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.105 0.962 . . . . 74.12 110.422 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.414 ' OG ' HG21 ' B' ' 115' ' ' THR . 32.7 t -70.64 -26.51 63.5 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.954 -0.567 . . . . 74.15 111.011 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.5 mtt-85 -70.93 -40.45 72.07 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.211 0.605 . . . . 73.54 109.439 175.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' C' ' 23' ' ' PHE . . . -82.57 1.26 88.22 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.87 0.731 . . . . 33.35 112.934 173.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 16.5 p 66.1 24.83 10.89 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.479 1.912 . . . . 50.34 113.931 170.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.477 ' HB2' HG13 ' C' ' 118' ' ' VAL . 79.7 m-85 -85.27 163.76 43.83 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.018 0.927 . . . . 62.41 110.056 172.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -54.67 124.18 15.54 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.979 2.453 . . . . 55.42 112.721 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.421 ' NE2' ' HB2' ' B' ' 119' ' ' SER . 47.1 mt-30 -60.49 137.89 58.09 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.074 0.549 . . . . 74.52 110.855 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.534 HD11 HG11 ' C' ' 64' ' ' VAL . 2.5 pt? -130.22 127.52 39.8 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.895 -0.593 . . . . 71.33 110.049 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -110.1 110.24 21.05 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.267 -1.012 . . . . 75.54 108.267 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.31 134.53 56.62 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 124.134 0.896 . . . . 71.44 110.99 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -70.81 147.07 94.05 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 123.857 0.723 . . . . 73.42 111.499 -175.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.456 ' HG3' HD12 ' A' ' 16' ' ' ILE . 9.7 Cg_exo -69.4 109.7 2.3 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.601 2.201 . . . . 72.41 111.905 176.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.494 HG11 ' SD ' ' G' ' 464' ' ' MET . 26.3 m -106.07 138.95 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.756 -0.831 . . . . 74.02 108.756 170.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -75.85 88.34 2.86 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.91 0.484 . . . . 75.12 110.204 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.438 ' HE1' HD13 ' C' ' 44' ' ' LEU . 98.5 m-85 -62.05 -48.32 80.76 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.664 -0.698 . . . . 75.31 110.429 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.12 -44.64 68.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.667 -1.151 . . . . 70.13 112.455 -170.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.65 87.85 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.242 0.964 . . . . 75.01 111.307 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 -50.4 70.92 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 124.439 1.087 . . . . 73.35 109.852 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -72.92 -24.58 60.84 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.834 -0.621 . . . . 74.2 110.282 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 26.6 ttt -75.35 -43.26 51.43 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.317 0.647 . . . . 72.1 111.124 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -69.15 -36.93 77.95 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.603 -0.517 . . . . 73.13 109.603 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -64.91 -84.58 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.78 1.232 . . . . 74.23 110.917 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -99.17 102.05 13.59 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.091 0.956 . . . . 74.32 108.933 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 66.0 108.87 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.594 1.558 . . . . 75.32 112.88 175.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -75.12 79.74 2.27 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.709 0.804 . . . . 65.34 109.049 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -163.1 141.61 8.27 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.513 0.725 . . . . 61.51 110.672 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.35 175.05 11.78 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.641 1.176 . . . . 55.22 108.719 172.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.19 99.97 1.08 Allowed Glycine 0 C--N 1.343 0.918 0 N-CA-C 112.001 -0.44 . . . . 72.14 112.001 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . 0.514 ' HA ' ' SD ' ' C' ' 9' ' ' MET . 7.0 pt-20 -72.0 144.53 48.8 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.76 0.824 . . . . 71.33 111.464 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -102.92 42.03 1.99 Allowed Glycine 0 C--N 1.348 1.228 0 CA-C-N 115.753 -0.658 . . . . 65.03 112.589 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 40.3 p -75.8 131.78 39.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.227 0.611 . . . . 73.04 109.942 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -135.38 96.76 3.53 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.795 0.438 . . . . 72.13 111.732 -170.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 59.87 -87.48 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.524 1.53 . . . . 63.51 111.544 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -80.97 -42.17 21.66 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.106 0.562 . . . . 72.11 110.606 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.483 ' HG3' ' HB2' ' C' ' 12' ' ' GLN . 22.6 tp60 62.78 58.84 1.5 Allowed 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 122.462 1.125 . . . . 74.21 108.9 -171.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 65.83 14.27 9.46 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 113.501 -1.681 . . . . 53.54 112.658 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 C-N-CA 123.267 0.627 . . . . 38.17 109.835 178.559 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.472 -0.566 . . . . 73.22 109.472 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 69.4 p -149.96 118.26 6.42 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.917 -0.771 . . . . 65.23 108.917 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.62 162.73 40.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.525 0.73 . . . . 74.24 110.046 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -141.87 99.23 3.49 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.17 0.588 . . . . 70.31 110.032 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -112.62 81.61 1.51 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.086 -1.079 . . . . 73.04 108.086 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -89.12 30.34 0.97 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.636 -0.711 . . . . 71.0 111.039 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.1 t -67.54 -18.53 65.06 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.591 0.756 . . . . 74.3 111.121 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -79.06 -23.48 44.2 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.741 1.216 . . . . 75.32 111.617 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.542 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 11.8 tpt -27.63 125.07 0.09 Allowed 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 126.302 1.841 . . . . 74.22 115.18 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.6 m -146.26 144.33 29.79 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.007 0.923 . . . . 71.42 109.8 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -152.5 113.29 4.15 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.115 -1.069 . . . . 73.04 108.115 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -131.57 121.48 24.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.871 0.868 . . . . 63.34 108.751 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 23.7 mt -75.35 121.29 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.544 -0.91 . . . . 55.03 108.544 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.432 HE22 HG22 ' D' ' 55' ' ' VAL . 54.3 mt-30 -88.57 -31.49 18.61 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.188 0.595 . . . . 52.24 111.584 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -169.08 142.63 2.86 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 120.587 0.232 . . . . 73.23 111.526 -174.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.4 132.85 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 107.188 -1.412 . . . . 74.32 107.188 169.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.463 ' HE1' HG13 ' D' ' 83' ' ' ILE . 36.9 p90 -161.15 152.28 18.69 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.925 0.869 . . . . 75.22 111.438 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -88.47 116.13 26.48 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.428 -1.26 . . . . 74.42 108.975 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -83.56 -26.42 30.1 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.407 -0.59 . . . . 63.32 109.407 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -154.31 139.97 17.97 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.967 -1.015 . . . . 61.33 109.352 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.448 HG21 ' HE2' ' C' ' 117' ' ' MET . 38.5 mt -137.33 147.31 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.865 1.266 . . . . 71.24 107.851 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -156.27 143.29 18.91 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.348 0.595 . . . . 73.3 110.068 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.9 t80 -138.05 133.58 33.71 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.401 -1.703 . . . . 73.02 106.401 170.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.2 mt-10 -129.2 141.13 51.24 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.887 0.875 . . . . 73.13 109.061 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.98 81.27 39.86 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.166 -1.42 . . . . 70.41 107.166 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.79 -36.15 8.51 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.006 2.471 . . . . 73.25 113.012 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -104.84 17.66 23.74 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.709 0.804 . . . . 75.22 110.793 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -32.49 -64.79 0.23 Allowed Pre-proline 0 CA--C 1.564 1.488 0 N-CA-C 116.11 1.892 . . . . 65.05 116.11 -164.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.415 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 68.8 Cg_endo -77.91 -20.88 11.41 Favored 'Trans proline' 0 C--N 1.382 2.295 0 CA-C-N 122.896 2.07 . . . . 61.34 113.732 -176.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -72.9 -40.09 65.84 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.759 1.223 . . . . 72.2 109.884 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.769 HG21 ' HA ' ' D' ' 73' ' ' ALA . 14.6 p -83.59 -14.54 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.485 -0.78 . . . . 71.04 111.807 -175.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 20.0 m-85 -68.15 -15.99 63.81 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.666 -0.646 . . . . 73.12 111.862 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -67.29 -19.16 65.44 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.74 0.816 . . . . 64.55 110.971 173.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.497 ' HB2' HD13 ' D' ' 68' ' ' LEU . 28.3 mmtp -84.96 87.61 7.37 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.034 0.934 . . . . 64.0 108.847 174.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.54 68.06 10.3 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.737 0.78 . . . . 71.44 108.919 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 48.3 t-105 -142.19 158.46 43.71 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.984 0.913 . . . . 62.31 109.251 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -72.95 111.1 10.07 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.676 1.19 . . . . 54.3 110.031 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.83 141.73 55.07 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.927 2.418 . . . . 54.02 112.33 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.59 ' HB2' ' HB2' ' H' ' 470' ' ' LEU . 35.9 tt0 -75.67 124.72 27.71 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.153 -0.684 . . . . 75.45 109.153 173.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.663 HG13 HG13 ' D' ' 64' ' ' VAL . 59.2 t -97.93 107.67 20.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.831 -0.803 . . . . 41.13 108.831 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -95.28 118.5 32.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.433 -1.321 . . . . 72.31 107.433 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.608 HD23 ' SD ' ' H' ' 464' ' ' MET . 3.2 mm? -97.57 143.2 28.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.238 0.615 . . . . 64.21 110.326 -175.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.726 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.7 m-20 -127.45 112.36 14.88 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.576 -1.268 . . . . 70.23 107.576 169.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 88.2 mt -99.72 130.2 45.91 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.433 0.693 . . . . 70.54 110.114 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.447 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.2 t0 -144.87 149.76 35.9 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.51 1.124 . . . . 63.31 108.373 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -125.12 159.65 30.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.519 0.676 . . . . 55.41 110.257 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.496 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.96 154.28 37.99 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.818 -1.549 . . . . 72.23 106.818 172.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.7 p -167.64 152.97 7.13 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.853 0.297 . . . . 62.14 111.223 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.7 p -163.74 142.47 7.82 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.91 0.884 . . . . 65.51 109.707 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -75.92 121.05 22.11 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.231 -0.655 . . . . 55.14 109.231 176.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 49.4 mt -89.93 -38.61 13.55 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.855 0.36 . . . . 75.44 110.436 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.42 -176.07 5.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.053 -0.522 . . . . 73.22 110.438 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -69.49 118.51 12.45 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.229 0.611 . . . . 64.12 109.594 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 67.99 9.2 7.0 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.907 1.283 . . . . 63.01 111.856 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.432 HG22 HE22 ' D' ' 14' ' ' GLN . 66.2 t -113.44 119.1 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.327 0.651 . . . . 63.42 109.693 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -128.41 129.56 46.36 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.009 0.924 . . . . 75.24 108.79 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -96.53 138.96 33.33 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.953 0.901 . . . . 73.42 109.072 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -126.42 122.76 61.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 N-CA-C 108.113 -1.069 . . . . 64.15 108.113 173.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.559 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 23.6 t -99.11 137.62 26.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 123.693 0.797 . . . . 75.01 108.903 171.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.41 123.32 44.95 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.67 -0.863 . . . . 71.5 108.67 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.447 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.4 ttm-85 -98.6 113.67 25.82 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 109.086 -0.709 . . . . 74.42 109.086 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.8 t -112.74 113.35 43.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.778 -1.193 . . . . 65.15 107.778 170.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.726 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 48.5 m -111.74 136.8 50.51 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.817 0.847 . . . . 70.55 109.141 -177.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.663 HG13 HG13 ' D' ' 40' ' ' VAL . 78.0 t -130.13 108.34 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.419 1.088 . . . . 64.41 109.635 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 38.1 m -107.58 114.67 28.81 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.371 -0.974 . . . . 64.03 108.371 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.4 145.13 48.22 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.328 0.651 . . . . 72.32 110.533 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 50.6 p -129.67 147.76 51.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.972 0.909 . . . . 75.34 109.246 173.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' D' ' 34' ' ' LYS . 25.6 mt -118.5 108.75 15.38 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.389 1.076 . . . . 72.53 108.243 171.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . 0.443 ' H ' HD21 ' H' ' 470' ' ' LEU . . . 70.42 -126.11 15.18 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 123.686 0.617 . . . . 61.5 112.447 -176.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -90.61 2.36 55.92 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.31 0.644 . . . . 73.41 112.602 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -134.06 158.98 42.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.551 0.34 . . . . 70.33 111.354 -166.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.7 m -65.17 124.35 21.92 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.17 -0.923 . . . . 61.01 109.651 174.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.769 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -80.81 -72.8 0.4 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.158 -1.052 . . . . 52.33 108.158 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -155.45 139.48 16.41 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.477 -0.783 . . . . 52.01 110.036 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 37.0 mt -105.47 150.76 25.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.326 -1.306 . . . . 54.42 107.795 176.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.1 t -158.38 147.63 19.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.909 -0.404 . . . . 63.01 109.909 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.01 134.13 10.39 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.917 -0.771 . . . . 73.3 108.917 172.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.2 t -128.46 137.23 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.406 -0.961 . . . . 64.24 108.406 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -117.86 81.55 1.68 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.73 -1.211 . . . . 64.42 107.73 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -80.06 96.48 6.49 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 112.961 -1.927 . . . . 64.34 109.802 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.63 143.17 17.58 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.676 -0.569 . . . . 62.33 111.676 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.66 130.81 5.38 Favored Glycine 0 C--O 1.228 -0.243 0 N-CA-C 111.214 -0.755 . . . . 74.1 111.214 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.463 HG13 ' HE1' ' D' ' 17' ' ' TYR . 70.8 mt -90.3 122.74 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.95 -1.13 . . . . 73.23 107.95 172.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -124.15 149.54 46.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.035 0.934 . . . . 70.32 109.049 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t -115.01 102.7 10.2 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.981 -1.118 . . . . 64.5 107.981 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.569 HG23 HD12 ' D' ' 89' ' ' ILE . 46.1 mt -108.81 128.03 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.988 0.915 . . . . 71.31 110.443 -171.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.18 157.31 42.51 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.961 0.905 . . . . 72.22 110.272 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.87 11.96 81.03 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.331 -0.395 . . . . 62.1 113.933 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.569 HD12 HG23 ' D' ' 86' ' ' ILE . 15.8 mt -111.42 127.65 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.062 0.945 . . . . 72.51 110.443 -173.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.04 164.1 34.12 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.228 1.011 . . . . 73.54 111.039 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.18 -131.57 11.34 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.54 -0.754 . . . . 31.24 113.569 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -75.79 -24.43 55.97 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.813 0.845 . . . . 75.12 111.487 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -65.15 -26.37 68.15 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.44 0.696 . . . . 73.43 110.724 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 54.3 mtp -54.31 -55.15 31.24 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.489 1.116 . . . . 73.12 110.831 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.71 -41.43 83.57 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.952 -1.022 . . . . 65.21 110.648 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.402 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 28.4 t-80 -65.9 -24.89 66.93 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.88 0.872 . . . . 60.12 111.742 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -80.38 -48.85 12.3 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.832 -0.432 . . . . 52.12 109.832 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.562 ' HB2' HG11 ' H' ' 452' ' ' VAL . 28.5 tp -67.72 -56.01 10.95 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.729 0.812 . . . . 75.14 112.452 -171.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.88 -0.1 51.98 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 114.654 0.621 . . . . 41.23 114.654 -168.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -124.84 -66.07 0.99 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.673 0.737 . . . . 43.43 110.88 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -65.88 -54.21 29.59 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.536 0.734 . . . . 75.43 111.763 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.2 m -62.69 -46.35 88.52 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.305 -0.855 . . . . 64.13 112.387 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.32 -36.6 97.21 Favored 'Trans proline' 0 C--N 1.393 2.909 0 C-N-CA 122.523 2.149 . . . . 70.32 113.378 168.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' D' ' 133' ' ' PHE . 64.3 t30 -71.09 -23.86 62.19 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.213 0.605 . . . . 73.54 110.77 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 29.7 mm -76.68 -36.51 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.961 0.904 . . . . 75.2 110.252 171.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.88 -18.62 53.63 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.31 0.644 . . . . 70.32 111.862 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -71.34 -37.94 6.2 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 113.901 1.074 . . . . 63.44 113.901 -173.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.99 -45.63 37.52 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 121.883 1.722 . . . . 71.21 112.281 168.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -70.61 -33.49 71.1 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.32 -0.855 . . . . 60.34 111.764 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.85 -51.48 54.99 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.301 0.64 . . . . 62.3 110.084 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -51.2 -52.32 45.52 Favored 'General case' 0 C--N 1.358 0.942 0 O-C-N 124.797 1.311 . . . . 73.43 110.309 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.38 -46.23 91.06 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.383 1.052 . . . . 73.45 111.839 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.6 t -58.97 -41.9 88.62 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.863 0.727 . . . . 64.44 110.659 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.477 HG23 ' SG ' ' D' ' 76' ' ' CYS . 80.4 mt -64.33 -56.08 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 123.996 0.81 . . . . 73.2 110.411 174.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 61.4 m -51.89 -44.55 63.79 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.816 1.247 . . . . 43.34 111.574 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.5 t -65.29 -42.0 93.58 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.912 -1.04 . . . . 71.3 110.201 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.4 mtm -68.58 -34.25 75.48 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.028 0.531 . . . . 65.4 111.772 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -66.99 -40.85 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.002 0.921 . . . . 55.41 110.099 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 77.7 p -76.66 -28.47 55.99 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.979 0.512 . . . . 74.35 111.012 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -73.68 -28.53 61.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.222 0.609 . . . . 72.41 109.633 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.18 3.64 86.66 Favored Glycine 0 C--N 1.351 1.381 0 O-C-N 123.837 0.71 . . . . 71.3 112.378 172.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.474 HG23 ' HB3' ' C' ' 17' ' ' TYR . 45.2 p 60.09 20.0 9.23 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 126.845 2.058 . . . . 64.31 114.181 175.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -79.61 157.23 74.9 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 123.13 0.572 . . . . 74.23 109.853 171.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.53 126.34 17.69 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.946 2.431 . . . . 73.54 112.367 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -56.05 138.99 48.3 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.425 1.09 . . . . 73.43 112.041 -174.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 32.5 mt -107.92 101.41 10.68 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.557 -0.535 . . . . 74.23 109.557 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -100.65 84.83 2.8 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.615 -1.254 . . . . 74.14 107.615 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -59.18 115.68 3.36 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 114.775 -1.102 . . . . 71.42 109.991 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.79 136.06 86.87 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 124.189 0.931 . . . . 45.11 110.191 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 24.3 Cg_exo -61.7 114.31 2.21 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.802 2.335 . . . . 62.01 112.55 -172.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.1 m -108.02 128.38 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.483 0.713 . . . . 75.01 109.243 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -85.84 103.98 15.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.632 0.773 . . . . 41.34 110.544 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' D' ' 104' ' ' ASN . 63.9 m-85 -66.5 -25.63 66.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.205 0.602 . . . . 70.44 112.041 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.468 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 2.5 m-20 -57.42 -58.67 7.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.892 0.877 . . . . 71.31 111.258 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.17 90.19 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.815 0.846 . . . . 62.0 111.713 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.88 -29.76 68.95 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.181 -0.918 . . . . 74.12 112.067 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -72.92 -34.94 66.91 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.537 0.735 . . . . 73.3 110.66 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 45.2 mtt -60.83 -39.77 90.28 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.528 -0.545 . . . . 74.43 109.528 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.495 ' HA ' HE21 ' D' ' 142' ' ' GLN . 84.7 m-20 -64.92 -43.26 93.38 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.172 0.92 . . . . 62.3 110.843 175.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -55.38 -31.87 62.16 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.141 0.976 . . . . 73.11 111.398 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.95 -47.19 12.03 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.82 0.848 . . . . 53.32 111.969 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.495 HE21 ' HA ' ' D' ' 139' ' ' ASN . 5.0 pp0? -89.89 9.09 28.94 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.698 0.629 . . . . 74.24 112.698 -171.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -117.87 87.25 2.68 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.545 -0.909 . . . . 65.22 108.545 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.35 157.61 17.75 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 113.795 -1.548 . . . . 75.44 108.596 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.64 -35.82 77.13 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.472 0.709 . . . . 70.45 111.637 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.0 158.88 9.56 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.955 -0.566 . . . . 70.01 112.009 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.72 118.13 26.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.94 0.896 . . . . 74.22 108.797 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.29 83.65 0.16 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.953 -0.859 . . . . 52.44 110.953 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 41.0 m -73.37 99.1 2.85 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.368 0.667 . . . . 74.01 110.499 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.12 131.3 44.76 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.739 0.816 . . . . 71.34 109.87 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -125.5 150.47 47.37 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.712 0.805 . . . . 70.14 110.903 -171.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 74.85 88.63 0.09 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.442 1.497 . . . . 52.52 111.496 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -139.04 27.71 2.36 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.27 -1.381 . . . . 64.23 107.27 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.78 95.42 0.67 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.667 1.187 . . . . 64.31 110.84 -167.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 124.053 0.941 . . . . 38.17 109.088 -177.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 108.861 -0.792 . . . . 71.14 108.861 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . 0.539 HG13 ' HA ' ' A' ' 87' ' ' ALA . 48.0 t -120.96 89.86 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.178 0.591 . . . . 75.45 110.764 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 59.3 t 65.53 133.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.443 1.097 . . . . 62.11 113.775 163.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -146.17 58.16 0.5 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.825 -0.51 . . . . 74.13 111.825 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . 0.626 HD23 ' SD ' ' A' ' 94' ' ' MET . 4.5 pp -117.06 155.65 28.9 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.395 0.678 . . . . 62.1 110.97 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 2.0 p -147.97 -48.66 0.16 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.797 1.239 . . . . 51.03 108.725 167.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.41 137.11 50.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.993 0.517 . . . . 74.41 110.8 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -157.94 97.41 1.54 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.914 0.886 . . . . 64.44 108.89 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 59.8 p -72.49 -67.47 0.55 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.667 -0.697 . . . . 70.25 111.265 -175.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -167.74 159.17 11.56 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.079 0.951 . . . . 72.11 109.045 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . 0.441 HD23 ' HB ' ' A' ' 46' ' ' THR . 1.4 tm? -68.39 122.96 19.49 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 108.787 -0.82 . . . . 70.31 108.787 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -44.04 -32.73 1.25 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 126.194 1.798 . . . . 71.43 115.123 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -136.86 111.58 8.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.311 0.645 . . . . 65.42 109.728 175.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 40.8 p -72.87 124.62 25.76 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.23 -1.026 . . . . 70.5 108.23 167.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 12.4 tpt -62.6 161.11 12.67 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.423 -0.584 . . . . 71.34 109.423 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.45 -65.44 0.68 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.227 -0.657 . . . . 74.01 109.227 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -86.62 174.48 8.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.19 0.596 . . . . 52.34 111.293 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -154.81 -56.7 0.1 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.547 0.739 . . . . 72.25 109.707 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -171.64 160.89 5.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.696 0.798 . . . . 74.15 109.839 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -99.54 82.6 0.56 Allowed Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.703 -0.559 . . . . 70.35 111.703 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . 0.509 ' HB3' ' HE1' ' A' ' 36' ' ' TRP . 35.2 mt -70.49 106.32 3.4 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.76 0.424 . . . . 72.13 110.313 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt . . . . . 0 C--O 1.25 1.091 0 N-CA-C 108.118 -1.067 . . . . 72.21 108.118 179.747 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 110.004 -0.369 . . . . 74.21 110.004 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . 0.469 HG13 ' O ' ' B' ' 89' ' ' ILE . 40.9 t -67.9 -62.43 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 109.41 -0.589 . . . . 73.3 109.41 172.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . 0.501 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 19.2 m -83.26 156.98 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.083 -0.962 . . . . 75.34 111.671 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -164.58 56.99 0.27 Allowed Glycine 0 C--N 1.344 1.002 0 CA-C-N 115.846 -0.615 . . . . 61.43 112.939 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . 0.447 ' HB2' HD22 ' B' ' 98' ' ' LEU . 4.9 tt -72.17 111.97 7.85 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.665 -1.235 . . . . 75.44 107.665 172.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 43.0 m -147.06 -47.52 0.18 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.548 0.739 . . . . 70.11 109.622 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -115.45 173.11 6.69 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.655 0.782 . . . . 75.5 111.781 -173.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 58.58 26.48 14.45 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.415 1.486 . . . . 64.03 111.455 174.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 27.9 m -79.11 86.24 4.95 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.477 0.711 . . . . 74.13 110.053 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -125.84 113.68 17.56 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.151 -0.932 . . . . 54.14 108.814 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . 0.581 ' HG ' ' HA ' ' B' ' 45' ' ' ASP . 3.7 mm? -87.28 120.42 28.54 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.808 0.843 . . . . 72.41 108.804 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -88.66 44.82 1.23 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.069 1.347 . . . . 72.34 111.18 -173.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.63 112.31 18.29 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.666 0.786 . . . . 73.44 111.61 -173.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 18.9 p -139.34 105.97 5.35 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 107.047 -1.464 . . . . 73.43 107.047 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 26.6 ptm -141.68 153.42 44.68 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.03 0.443 . . . . 74.43 111.919 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -134.8 -75.14 0.46 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.641 1.176 . . . . 60.44 109.19 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . 0.686 ' HB1' ' HA ' ' F' ' 471' ' ' LYS . . . -91.58 112.06 23.82 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.07 0.948 . . . . 71.12 110.82 -171.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -164.41 -53.85 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.217 0.607 . . . . 70.23 111.946 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . 0.574 HD11 HG21 ' B' ' 40' ' ' VAL . 0.7 OUTLIER -85.16 63.94 8.39 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.935 0.874 . . . . 73.03 112.899 -167.052 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 90.61 -57.11 3.43 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.417 -1.073 . . . . 54.25 110.417 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' B' ' 37' ' ' GLN . 95.1 mt -65.43 113.07 3.86 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.06 -0.719 . . . . 74.12 109.06 169.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . 0.686 ' HA ' ' HB1' ' F' ' 466' ' ' ALA . 86.9 tttt . . . . . 0 C--O 1.25 1.098 0 C-N-CA 123.233 0.613 . . . . 63.55 109.467 -175.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.409 -0.589 . . . . 74.34 109.409 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 8.2 p -71.45 144.81 12.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 C-N-CA 123.148 0.579 . . . . 71.51 109.631 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 73.3 t 68.3 85.68 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 124.038 0.935 . . . . 55.22 109.851 -173.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 174.4 99.37 0.12 Allowed Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.288 -0.869 . . . . 44.05 111.837 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 5.9 mp -82.31 148.02 28.55 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.087 -0.708 . . . . 64.35 109.087 174.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 13.3 t -82.07 -28.77 32.19 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.765 0.426 . . . . 72.12 110.557 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -170.01 161.49 8.74 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.263 1.025 . . . . 65.43 109.374 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -97.44 -50.48 4.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.611 0.765 . . . . 74.21 112.008 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 23.3 m 66.86 157.86 0.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.636 1.174 . . . . 74.21 111.397 -171.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -74.92 73.15 2.14 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.241 -0.652 . . . . 74.05 109.241 173.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 22.7 tp 55.62 -93.82 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.866 1.266 . . . . 72.44 109.544 -168.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 33.5 p90 173.55 -27.25 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.503 1.521 . . . . 73.21 109.259 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -142.34 159.23 42.64 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.664 0.786 . . . . 54.13 110.33 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 12.3 t -151.65 164.49 36.8 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.666 1.186 . . . . 73.41 108.297 171.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . 0.494 ' SD ' HG11 ' C' ' 131' ' ' VAL . 24.2 ptm -156.67 148.69 22.98 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.426 0.69 . . . . 72.11 109.612 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -102.82 -64.49 1.07 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.103 -0.703 . . . . 71.21 109.103 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -75.19 82.41 2.35 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.781 -1.099 . . . . 53.41 110.955 -173.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -77.32 -37.29 52.91 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.489 -0.778 . . . . 74.42 110.042 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . 0.405 ' H ' HG11 ' C' ' 40' ' ' VAL . 93.9 mt -140.19 169.35 17.84 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.498 1.119 . . . . 71.2 109.955 177.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -137.05 110.61 0.79 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 109.454 -1.458 . . . . 53.01 109.454 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . 0.417 ' H ' HD23 ' G' ' 470' ' ' LEU . 2.3 pt? -137.45 148.9 46.46 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.007 0.523 . . . . 60.41 111.225 -169.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? . . . . . 0 C--O 1.251 1.176 0 N-CA-C 107.04 -1.467 . . . . 71.53 107.04 179.073 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 109.727 -0.471 . . . . 75.12 109.727 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.11 -35.7 29.26 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 N-CA-C 109.546 -0.539 . . . . 73.24 109.546 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . 0.562 HG11 ' HB2' ' D' ' 98' ' ' LEU . 35.4 m -133.75 143.32 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 122.004 -0.435 . . . . 64.14 110.341 175.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -86.43 -14.26 66.37 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.371 -0.832 . . . . 55.14 112.939 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 91.6 mt 58.52 -144.99 0.57 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.004 0.922 . . . . 73.0 110.841 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 11.0 m 65.5 25.39 11.83 Favored 'General case' 0 C--N 1.364 1.199 0 CA-C-O 122.293 1.044 . . . . 62.51 110.056 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.57 -177.57 4.83 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.045 -0.979 . . . . 74.01 110.434 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -110.6 157.95 19.11 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.296 0.639 . . . . 75.31 111.493 -171.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 27.0 m -82.6 71.36 9.68 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.077 -0.965 . . . . 34.54 109.963 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 35.5 t70 179.46 127.85 0.07 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.531 -1.213 . . . . 65.13 109.336 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.52 -104.42 0.06 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.66 -0.496 . . . . 75.12 109.66 170.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -176.85 179.94 1.02 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.963 1.305 . . . . 74.13 108.108 -166.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 30.4 t80 58.2 78.09 0.26 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.352 1.061 . . . . 64.4 111.306 175.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 29.9 m -60.52 -26.36 66.81 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.185 -0.916 . . . . 32.03 110.545 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . 0.608 ' SD ' HD23 ' D' ' 42' ' ' LEU . 17.2 ttt 75.07 151.68 0.12 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 125.879 1.671 . . . . 72.4 110.937 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' H' ' 465' ' ' LYS . 0.2 OUTLIER -88.51 28.89 1.05 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.356 1.062 . . . . 72.32 110.493 -173.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . 64.51 102.67 0.04 OUTLIER 'General case' 0 C--N 1.363 1.173 0 C-N-CA 125.399 1.48 . . . . 64.34 111.055 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . 0.588 ' HB3' ' HB ' ' D' ' 40' ' ' VAL . . . -65.66 138.34 57.92 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.326 0.65 . . . . 75.24 110.947 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . 0.463 HD12 HG23 ' D' ' 40' ' ' VAL . 70.5 mt 76.53 -59.48 0.5 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.539 1.535 . . . . 52.25 112.053 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 91.56 119.88 2.43 Favored Glycine 0 C--N 1.344 0.988 0 N-CA-C 112.402 -0.279 . . . . 74.14 112.402 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . 0.59 ' HB2' ' HB2' ' D' ' 39' ' ' GLU . 13.0 tp -89.82 101.18 13.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.156 0.583 . . . . 72.54 110.379 -175.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt . . . . . 0 C--O 1.252 1.226 0 N-CA-C 108.227 -1.027 . . . . 74.1 108.227 170.309 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.027 0 CA-C-O 121.477 0.656 . . . . 65.55 109.935 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 t -174.15 -54.07 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.904 0.881 . . . . 72.14 109.958 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -150.59 156.9 42.28 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.125 -0.943 . . . . 75.45 109.943 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -81.22 104.02 11.4 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 107.667 -1.235 . . . . 64.21 107.667 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -67.37 90.88 0.24 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.239 0.615 . . . . 72.32 110.244 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -101.43 -45.9 5.17 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.155 0.582 . . . . 62.12 109.708 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -76.18 93.84 3.43 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 109.309 -0.626 . . . . 53.11 109.309 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -63.13 -29.44 70.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.218 1.007 . . . . 74.12 110.191 174.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.0 ttp -73.64 134.07 43.57 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 114.86 -1.064 . . . . 74.31 110.348 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.9 m -150.79 125.82 9.87 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.904 0.882 . . . . 53.31 108.704 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.691 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 11.5 t80 -123.09 124.71 43.7 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.329 -0.989 . . . . 74.24 108.329 170.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -141.7 112.07 6.99 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.73 -0.668 . . . . 41.45 109.851 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.594 HG12 ' HD2' ' A' ' 84' ' ' PHE . 52.7 mt -83.05 113.87 22.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.804 -0.813 . . . . 72.3 108.804 173.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -81.34 -31.97 33.21 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.792 -0.64 . . . . 63.03 109.843 -177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -171.53 143.54 1.78 Allowed 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.008 0.193 . . . . 64.43 111.108 -173.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.86 126.92 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 124.251 1.02 . . . . 65.31 108.384 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -160.54 168.71 24.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.028 0.931 . . . . 75.12 110.698 -170.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.6 p -93.39 121.06 34.39 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.083 -0.71 . . . . 72.55 109.083 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -85.76 -26.07 26.03 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.037 -0.529 . . . . 72.11 109.675 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.2 t70 -152.77 142.59 22.06 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.934 -1.03 . . . . 72.13 110.197 -175.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.599 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 88.2 mt -146.19 141.72 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.728 1.611 . . . . 72.55 107.057 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -151.82 132.14 13.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.579 -0.526 . . . . 74.45 109.579 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 82.9 t80 -130.99 122.6 27.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.74 -1.578 . . . . 63.41 106.74 175.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -129.99 118.42 21.59 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.36 -0.607 . . . . 73.15 109.36 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.12 79.03 70.11 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.826 -1.175 . . . . 75.11 107.826 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.26 -33.05 40.61 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.052 2.501 . . . . 55.3 111.686 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.429 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 47.5 m-80 -107.03 36.73 2.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.779 -1.1 . . . . 60.14 109.631 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.536 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -60.39 -44.58 96.28 Favored Pre-proline 0 CA--C 1.57 1.743 0 C-N-CA 124.537 1.135 . . . . 61.22 113.967 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.88 -20.85 11.46 Favored 'Trans proline' 0 C--N 1.385 2.468 0 CA-C-N 121.522 1.579 . . . . 74.13 112.876 172.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 61.7 m170 -77.67 -38.97 46.47 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.143 0.577 . . . . 72.14 110.876 -176.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.649 HG23 HD12 ' A' ' 68' ' ' LEU . 10.6 p -63.48 -27.7 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.989 0.916 . . . . 51.4 110.998 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.602 ' HD1' HH11 ' B' ' 15' ' ' ARG . 91.7 t80 -62.44 -35.57 79.7 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.315 1.046 . . . . 42.21 110.907 174.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -93.03 -25.43 17.95 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.641 0.776 . . . . 63.44 111.264 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HE2' HD22 ' A' ' 68' ' ' LEU . 53.9 mtpt -82.87 165.31 19.89 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.463 0.705 . . . . 72.45 111.489 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.472 ' O ' HD21 ' A' ' 68' ' ' LEU . 10.3 m-20 -80.77 128.66 33.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.178 0.991 . . . . 72.14 108.919 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -69.28 85.92 0.4 Allowed 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.37 0.605 . . . . 75.24 111.245 -177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -127.25 82.28 68.47 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.543 1.137 . . . . 74.32 108.647 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -85.11 152.52 10.95 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.418 2.079 . . . . 64.0 113.117 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' HB3' ' NZ ' ' A' ' 41' ' ' LYS . 63.1 mm-40 -105.6 85.49 2.25 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.865 -1.161 . . . . 70.25 107.865 176.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG22 ' HE3' ' E' ' 471' ' ' LYS . 27.6 m -82.5 93.83 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 122.323 1.059 . . . . 62.42 111.357 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 39' ' ' GLU . 13.7 mptt -98.17 136.05 38.94 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.912 -1.04 . . . . 72.0 108.61 169.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.476 ' HB2' ' HG ' ' E' ' 468' ' ' LEU . 37.2 tp -119.57 114.8 22.79 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.009 -0.737 . . . . 70.4 109.009 172.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -102.67 128.55 49.32 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.028 -1.101 . . . . 70.25 108.028 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' HB2' ' HG ' ' E' ' 460' ' ' LEU . 91.1 mt -107.35 143.03 36.22 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.625 -0.88 . . . . 62.53 108.625 175.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 26.2 t70 -143.29 130.46 20.79 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.987 -0.746 . . . . 64.34 108.987 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -105.77 131.09 53.54 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.065 -0.717 . . . . 74.33 109.065 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.6 127.37 38.86 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.658 0.783 . . . . 72.22 109.664 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.1 p -94.83 153.22 17.83 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.143 0.977 . . . . 55.44 110.214 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.9 t -150.39 127.39 11.15 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.872 -0.788 . . . . 62.34 108.872 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -103.01 106.7 17.27 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.282 -0.636 . . . . 75.3 109.282 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.584 HD11 ' HB2' ' A' ' 57' ' ' GLU . 65.6 mt -83.37 -30.47 27.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.047 0.539 . . . . 70.34 110.505 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -163.73 -177.98 5.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.12 -0.946 . . . . 53.44 109.748 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.43 126.27 28.76 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.518 -1.29 . . . . 62.54 107.518 164.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.429 ' HA ' HG12 ' E' ' 451' ' ' VAL . 0.8 OUTLIER 74.19 -3.85 2.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.272 1.029 . . . . 74.55 112.85 175.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 50.5 t -115.64 111.4 35.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 107.403 -1.332 . . . . 63.53 107.403 177.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -130.99 123.73 29.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.39 -0.596 . . . . 52.41 109.39 -172.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.584 ' HB2' HD11 ' A' ' 51' ' ' LEU . 45.3 tt0 -93.95 140.34 29.82 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.762 0.825 . . . . 73.15 109.404 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -119.29 143.43 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.483 -1.302 . . . . 54.24 107.483 170.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.03 117.74 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.967 -1.123 . . . . 72.54 107.967 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -99.54 106.8 18.84 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.215 -1.031 . . . . 73.22 108.215 178.221 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.569 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 62.9 ttt180 -84.34 105.89 15.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.063 0.945 . . . . 72.4 109.29 176.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.536 HG22 HD12 ' A' ' 60' ' ' LEU . 15.9 t -104.71 115.84 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.869 0.868 . . . . 61.53 109.003 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.3 m -110.71 112.71 24.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.091 0.957 . . . . 74.43 110.511 -175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 114' ' ' ILE . 53.0 t -102.89 107.35 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.888 0.875 . . . . 74.43 109.176 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.1 m -105.13 109.91 22.08 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.531 -0.915 . . . . 74.45 108.531 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.71 104.1 9.96 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.611 -0.885 . . . . 24.2 108.611 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.8 m -107.76 127.15 53.44 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.563 0.745 . . . . 71.1 109.13 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.649 HD12 HG23 ' A' ' 31' ' ' VAL . 2.2 tt -86.62 87.14 7.38 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 106.781 -1.563 . . . . 43.13 106.781 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.86 -98.7 1.32 Allowed Glycine 0 C--N 1.343 0.926 0 CA-C-N 114.51 -1.223 . . . . 70.44 110.632 -172.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -115.5 -12.54 11.65 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.124 0.97 . . . . 73.15 110.443 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.408 ' HB2' ' HZ3' ' A' ' 34' ' ' LYS . 11.1 mp0 -99.48 119.5 38.12 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.227 1.011 . . . . 70.43 109.671 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.3 m -61.82 122.44 15.39 Favored 'General case' 0 C--O 1.242 0.676 0 O-C-N 123.459 0.474 . . . . 75.42 111.409 -178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.93 -55.67 5.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.045 -1.095 . . . . 75.13 108.045 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.511 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 51.7 p90 -158.95 150.43 20.56 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.854 -1.066 . . . . 71.32 110.601 175.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 64' ' ' VAL . 47.0 tp -131.1 107.57 9.14 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 107.741 -1.207 . . . . 54.14 107.741 176.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.511 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 60.4 m -109.74 99.78 8.89 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.659 0.784 . . . . 62.32 109.715 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -119.71 116.04 25.14 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.636 -0.876 . . . . 54.34 108.636 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.4 t -128.24 132.3 68.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 123.992 0.917 . . . . 64.55 109.29 -173.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 44.9 mt-30 -104.55 101.13 10.79 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 109.232 -0.655 . . . . 62.51 109.232 168.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -86.82 105.4 16.99 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.107 -1.072 . . . . 74.4 108.107 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.44 144.6 17.15 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 111.756 -0.538 . . . . 73.35 111.756 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.485 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.23 137.09 7.89 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.078 -0.809 . . . . 63.33 111.078 177.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.4 mt -89.08 123.58 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 108.844 -0.799 . . . . 62.41 108.844 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.691 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 34.8 m-85 -128.18 133.59 48.93 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.264 0.626 . . . . 74.32 109.654 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.3 t -100.89 114.31 28.05 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.67 -0.863 . . . . 74.24 108.67 176.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.31 142.31 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.831 0.852 . . . . 72.32 109.25 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HA ' HG21 ' E' ' 451' ' ' VAL . . . -160.49 152.35 19.97 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.088 0.955 . . . . 54.52 109.792 173.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.2 -17.19 57.82 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.558 0.536 . . . . 54.01 114.398 173.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.544 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -132.18 152.95 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.483 0.713 . . . . 73.31 109.874 178.586 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.492 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 17.9 tt0 -150.27 -179.05 6.88 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.845 0.858 . . . . 54.55 108.866 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 71.9 -135.58 23.2 Favored Glycine 0 C--N 1.35 1.359 0 C-N-CA 123.003 0.335 . . . . 71.1 113.888 176.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.2 p -79.32 -15.13 58.43 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.075 0.55 . . . . 73.12 110.918 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -74.96 -36.84 62.07 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.151 0.98 . . . . 74.42 110.532 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.625 ' SD ' ' HA ' ' E' ' 452' ' ' VAL . 12.9 ptt? -74.94 -25.13 58.67 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 110.259 -0.274 . . . . 64.32 110.259 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.45 -26.53 62.76 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.294 0.637 . . . . 73.2 110.26 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.484 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 27.5 t-80 -71.88 -34.56 69.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.069 0.548 . . . . 73.45 110.494 171.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.544 ' SG ' HG13 ' A' ' 89' ' ' ILE . 79.3 m -69.58 -61.27 1.85 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.454 0.302 . . . . 73.22 110.769 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' E' ' 454' ' ' LEU . 1.1 pp -76.21 -24.23 54.65 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.676 0.39 . . . . 70.33 111.194 -173.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.0 3.75 38.53 Favored Glycine 0 N--CA 1.476 1.325 0 CA-C-O 119.762 -0.466 . . . . 73.35 114.251 -171.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -147.49 -59.0 0.26 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 117.375 0.588 . . . . 24.34 111.755 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.424 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 84.6 t80 -70.74 -51.05 29.74 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.776 0.831 . . . . 75.35 112.511 -173.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.437 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 74.5 m -76.18 -34.2 1.38 Allowed Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 113.876 1.065 . . . . 75.14 113.876 -173.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.455 ' HB2' HD23 ' A' ' 60' ' ' LEU . 42.8 Cg_endo -69.12 -22.38 35.08 Favored 'Trans proline' 0 C--N 1.379 2.143 0 CA-C-N 121.596 1.606 . . . . 61.52 112.92 167.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -70.35 -31.36 68.6 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.389 0.676 . . . . 73.22 109.721 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 35.9 mm -57.08 -39.09 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.185 0.994 . . . . 74.12 110.962 171.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.485 HD21 ' HA3' ' A' ' 82' ' ' GLY . 54.0 mt -86.23 -16.99 35.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.788 0.835 . . . . 73.32 112.748 -172.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -64.79 -43.14 68.17 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 113.453 0.909 . . . . 73.15 113.453 -175.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.46 -36.25 78.44 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.058 1.839 . . . . 44.15 113.243 173.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -70.5 -40.06 73.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.347 0.659 . . . . 74.42 111.223 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.11 -40.55 86.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.299 0.64 . . . . 71.2 110.149 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.523 ' NH1' HD12 ' C' ' 105' ' ' ILE . 36.9 ttm180 -51.56 -55.52 18.68 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 124.334 1.021 . . . . 65.41 110.143 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.37 -47.31 86.41 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 124.367 1.042 . . . . 52.43 111.537 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.4 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 37.3 t -55.14 -45.01 75.6 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.93 0.769 . . . . 65.33 110.987 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.475 HG21 HG21 ' A' ' 64' ' ' VAL . 83.9 mt -64.69 -55.68 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 114.773 -1.103 . . . . 73.04 110.758 176.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -55.58 -37.35 67.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.985 0.914 . . . . 52.24 111.799 -175.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -66.79 -49.89 64.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.88 -1.055 . . . . 44.41 109.912 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 38.8 mtp -58.44 -37.18 74.89 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.773 0.829 . . . . 62.12 111.847 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 114' ' ' ILE . 98.2 t -65.69 -47.86 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.851 0.86 . . . . 73.14 110.263 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.9 p -74.98 -21.61 59.05 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.18 0.592 . . . . 72.04 111.876 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -73.0 -34.27 66.29 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.519 0.728 . . . . 72.51 109.362 172.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.82 0.66 76.95 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.894 0.746 . . . . 42.35 113.1 172.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.4 m 69.25 19.63 7.76 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 124.648 1.179 . . . . 75.31 111.141 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -86.97 150.46 50.08 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.627 0.771 . . . . 72.1 109.987 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.48 152.6 15.61 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.722 2.948 . . . . 71.32 114.374 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -57.67 140.92 50.05 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.238 1.015 . . . . 73.14 112.413 -172.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' E' ' 468' ' ' LEU . 16.8 tp -127.14 113.36 16.28 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.853 0.461 . . . . 45.24 110.558 -176.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -122.41 86.7 2.62 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.387 0.675 . . . . 71.25 109.206 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.69 ' H ' HD23 ' A' ' 128' ' ' LEU . 0.5 OUTLIER -65.61 131.06 45.44 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.278 0.631 . . . . 52.03 110.028 175.22 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.657 ' HB3' ' HB1' ' E' ' 466' ' ' ALA . . . -75.38 146.39 81.09 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 123.756 0.822 . . . . 71.21 111.847 -170.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.51 121.99 7.9 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 122.942 2.428 . . . . 75.21 112.548 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -108.39 134.73 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 109.217 -0.661 . . . . 71.25 109.217 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.403 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 52.5 t-20 -80.76 101.94 9.64 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.701 0.8 . . . . 72.12 109.355 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -66.9 -27.15 67.27 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.275 0.63 . . . . 62.4 111.596 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.538 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 5.1 m-20 -67.87 -37.49 81.88 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.836 0.855 . . . . 65.52 110.816 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.48 -37.24 84.66 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.893 0.746 . . . . 44.0 110.589 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 132' ' ' ASN . 84.3 mt -67.07 -45.14 78.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.655 0.782 . . . . 71.44 111.396 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -64.0 -39.49 94.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.507 -0.769 . . . . 73.2 109.322 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.418 ' SD ' HD23 ' A' ' 141' ' ' LEU . 13.7 tpt -64.39 -31.65 72.94 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 124.211 0.944 . . . . 63.41 110.668 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.641 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 88.8 m-20 -60.24 -42.36 95.12 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.316 0.646 . . . . 75.21 110.995 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -70.74 -39.24 73.44 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.632 -0.713 . . . . 74.1 110.998 174.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.418 HD23 ' SD ' ' A' ' 138' ' ' MET . 28.3 tp -68.56 -48.51 64.07 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.109 0.964 . . . . 75.33 111.99 -170.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -167.71 10.02 0.02 OUTLIER 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 123.581 0.752 . . . . 70.41 110.937 -170.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.641 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 96.1 mt-30 61.76 -171.88 0.15 Allowed 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 124.411 1.084 . . . . 75.03 110.855 -167.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -67.12 95.05 0.38 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.03 -0.73 . . . . 75.53 109.03 174.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.6 123.08 41.08 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.452 -0.944 . . . . 72.34 108.452 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.96 106.28 0.64 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.344 -0.702 . . . . 62.12 111.344 -173.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -109.41 121.05 44.32 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.545 -0.909 . . . . 64.23 108.545 173.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -142.89 142.0 11.1 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.677 -0.569 . . . . 52.25 111.677 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -149.79 156.79 42.42 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.747 0.819 . . . . 53.1 109.881 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -128.21 110.74 12.71 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.521 0.677 . . . . 64.33 111.015 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -131.28 77.6 1.79 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 106.907 -1.516 . . . . 73.2 106.907 175.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -121.21 62.42 0.89 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.65 0.738 . . . . 74.23 109.775 -177.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -169.5 124.71 0.84 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 113.791 -1.549 . . . . 72.02 108.694 171.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -94.89 106.85 18.86 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.281 -1.378 . . . . 72.13 107.281 167.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.432 0 O-C-N 123.815 0.697 . . . . 61.41 110.785 -175.252 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.132 0.492 . . . . 54.31 110.838 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 51.1 p -131.92 147.06 52.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.459 1.104 . . . . 62.31 108.448 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.73 132.52 49.58 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.864 -0.791 . . . . 75.23 108.864 -172.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -138.1 116.27 11.79 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.66 0.384 . . . . 74.2 110.624 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -140.02 133.71 30.4 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.444 1.098 . . . . 72.44 108.444 170.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -90.09 14.8 11.48 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.404 0.682 . . . . 60.53 111.11 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 28.3 m -55.1 116.23 2.67 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.276 1.031 . . . . 70.23 110.326 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.06 87.16 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 124.357 1.036 . . . . 74.02 111.082 178.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.402 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 14.3 ptm 60.71 170.21 0.09 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.333 2.253 . . . . 55.1 114.87 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 95.5 m -158.05 127.92 6.02 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.28 1.832 . . . . 74.33 106.608 175.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -133.49 132.83 41.48 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.686 0.395 . . . . 74.41 110.317 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -140.09 142.08 36.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.34 0.656 . . . . 75.12 109.732 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.449 HD11 HD13 ' B' ' 105' ' ' ILE . 32.1 mt -95.64 120.68 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 107.989 -1.115 . . . . 73.35 107.989 170.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -85.2 -50.86 7.04 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.334 -0.617 . . . . 63.44 109.334 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.602 HH11 ' HD1' ' A' ' 32' ' ' PHE . 46.0 ttt180 -162.03 137.99 7.68 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.364 -0.834 . . . . 75.42 109.508 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 91.4 mt -114.99 145.46 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 106.77 -1.567 . . . . 74.33 106.77 171.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -165.61 141.24 5.1 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.931 0.396 . . . . 74.2 111.416 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 59.0 m -72.92 120.92 19.21 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.108 -1.071 . . . . 74.45 108.108 171.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.536 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 46.8 mtpt -92.67 -32.42 14.76 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.221 0.608 . . . . 73.53 111.267 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.9 t70 -153.93 137.8 16.25 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.064 0.228 . . . . 73.55 110.689 -171.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 47.8 mm -134.87 141.3 43.47 Favored 'Isoleucine or valine' 0 C--N 1.348 0.533 0 C-N-CA 124.834 1.254 . . . . 64.32 108.223 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.3 t -139.16 127.07 22.2 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.526 -1.286 . . . . 74.23 107.526 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.599 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.0 t80 -143.39 114.35 7.74 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.478 -0.934 . . . . 64.1 108.478 173.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -119.48 137.94 53.47 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.031 0.933 . . . . 65.35 108.817 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.01 81.04 71.17 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.461 -1.311 . . . . 74.54 107.461 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.87 -44.39 16.61 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.25 2.633 . . . . 71.33 113.356 -166.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.53 ' HB2' ' HB ' ' B' ' 31' ' ' VAL . 33.5 m-80 -100.25 15.49 27.41 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 117.905 -1.045 . . . . 72.4 110.792 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.424 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -30.17 -72.26 0.06 OUTLIER Pre-proline 0 N--CA 1.511 2.59 0 C-N-CA 125.927 1.691 . . . . 64.12 115.048 -165.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 33.9 Cg_endo -66.3 -21.61 54.25 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.462 2.108 . . . . 64.01 113.166 -172.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -83.11 -49.53 9.42 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.383 -0.826 . . . . 71.11 111.308 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.658 HG22 HD12 ' B' ' 68' ' ' LEU . 8.1 p -64.37 -19.61 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.133 0.973 . . . . 31.14 112.056 -166.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -61.37 -11.77 11.49 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 123.821 0.848 . . . . 75.35 112.319 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.607 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 24.7 pt20 -55.34 -40.27 71.03 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.08 1.352 . . . . 51.41 111.574 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.607 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 90.0 mttt -94.54 89.65 5.89 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.622 0.769 . . . . 65.43 108.925 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.32 86.91 2.51 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.388 -0.824 . . . . 64.25 109.641 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -154.16 155.15 34.81 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.087 1.355 . . . . 73.34 107.377 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -76.2 102.91 0.87 Allowed Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.559 -0.904 . . . . 63.53 108.559 170.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.524 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 34.6 Cg_endo -60.06 142.06 97.59 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 123.136 2.558 . . . . 62.53 113.098 -170.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.41 121.58 13.57 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 123.701 0.625 . . . . 74.41 109.441 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' B' ' 65' ' ' THR . 18.3 m -104.05 135.5 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.587 -0.733 . . . . 65.25 112.314 -171.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.592 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 54.1 tttp -106.1 103.48 12.97 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.597 -1.26 . . . . 63.54 107.597 170.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.644 ' H ' HD23 ' B' ' 42' ' ' LEU . 2.2 pt? -95.81 132.31 41.19 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.81 -0.811 . . . . 73.03 108.81 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 19.5 t70 -131.77 146.96 52.44 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.14 1.376 . . . . 73.32 109.123 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 tp -125.04 131.4 53.38 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.106 0.962 . . . . 75.45 109.724 -172.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -148.87 155.89 41.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.643 1.177 . . . . 71.13 108.822 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.5 p -134.93 130.41 35.81 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.452 0.701 . . . . 62.11 109.753 173.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.79 122.71 46.26 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.97 -1.122 . . . . 74.52 107.97 174.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.3 m -124.8 160.79 27.89 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 122.915 0.486 . . . . 74.11 109.865 -175.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 94.6 p -152.35 139.82 19.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.493 0.717 . . . . 73.13 110.064 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -82.19 105.26 13.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.27 0.628 . . . . 63.04 110.067 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 78.4 mt -72.23 -42.77 65.32 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.62 0.724 . . . . 74.11 109.603 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.37 -179.16 7.92 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.269 -1.332 . . . . 63.13 108.782 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.25 123.12 22.28 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.291 -1.003 . . . . 65.31 108.291 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 72.82 -5.4 1.89 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.517 1.527 . . . . 62.45 113.288 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -111.49 109.83 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 107.59 -1.263 . . . . 75.32 107.59 173.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.72 140.5 52.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.183 -0.673 . . . . 74.34 109.183 -173.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -99.7 133.65 43.74 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.149 -1.056 . . . . 74.31 108.149 172.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -115.69 139.58 41.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.2 -1.037 . . . . 75.41 108.2 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 33.0 t -126.54 120.83 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.62 -0.881 . . . . 64.04 108.62 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.66 113.13 25.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.125 -1.065 . . . . 63.04 108.125 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -100.65 122.43 43.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.806 0.442 . . . . 73.14 110.315 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -116.09 114.61 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 107.783 -1.192 . . . . 63.34 107.783 171.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 48.7 m -96.4 137.72 35.06 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.474 -0.935 . . . . 51.51 108.474 173.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 85.5 t -131.99 133.08 61.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.998 -0.742 . . . . 72.11 108.998 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 91.4 m -120.09 148.88 43.05 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.767 1.227 . . . . 72.23 107.721 175.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.45 134.65 21.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 122.858 0.463 . . . . 64.13 110.077 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.6 p -132.62 126.69 33.28 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.308 0.643 . . . . 61.33 110.751 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.658 HD12 HG22 ' B' ' 31' ' ' VAL . 41.2 mt -95.13 103.15 15.0 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 108.149 -1.056 . . . . 74.2 108.149 170.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.48 -109.78 3.1 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.008 -0.996 . . . . 73.34 111.206 -170.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -117.37 5.15 12.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.928 0.891 . . . . 64.23 111.583 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -116.17 149.21 39.44 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.185 -0.672 . . . . 75.4 109.185 175.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 65.7 m -72.89 134.0 44.63 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.192 0.308 . . . . 65.53 111.097 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.495 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -82.97 -68.21 0.72 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.249 -1.019 . . . . 64.4 108.249 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -144.25 158.94 43.46 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.811 -1.086 . . . . 63.21 110.395 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 94.8 mt -131.2 120.82 23.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.08 -1.822 . . . . 64.12 106.08 174.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 36.9 t -132.35 145.24 51.11 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.194 -0.669 . . . . 74.41 109.194 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -160.19 133.96 7.11 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.865 -0.791 . . . . 71.53 108.865 -175.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -128.01 146.39 33.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.87 0.868 . . . . 74.02 108.918 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 17.6 mt-30 -124.96 93.32 3.85 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.233 -1.025 . . . . 72.33 108.233 170.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.531 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -85.57 101.0 12.32 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.845 -1.071 . . . . 71.53 109.155 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.07 160.26 29.52 Favored Glycine 0 C--N 1.339 0.748 0 O-C-N 123.435 0.459 . . . . 65.11 112.047 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.18 130.42 2.34 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 119.952 -0.36 . . . . 73.11 112.22 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -84.54 126.09 40.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 108.806 -0.813 . . . . 74.24 108.806 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -132.37 134.18 44.86 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.282 1.033 . . . . 73.55 108.972 -176.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.6 m -102.06 103.08 13.65 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.822 0.849 . . . . 74.13 109.51 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.672 ' HB ' HD11 ' B' ' 89' ' ' ILE . 46.2 pt -103.92 135.33 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.496 0.719 . . . . 74.21 109.794 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -146.69 151.81 37.81 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.863 -0.792 . . . . 41.12 108.863 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 88.93 -62.16 3.66 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 112.109 -0.396 . . . . 61.11 112.109 -176.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.672 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -62.12 142.07 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.679 0.392 . . . . 72.44 111.781 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.84 167.73 26.61 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.969 0.907 . . . . 71.1 109.526 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.07 -113.62 5.28 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.794 0.684 . . . . 74.15 113.042 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 2.2 m -87.17 -17.49 32.57 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.609 -0.348 . . . . 44.32 111.26 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -65.61 -46.75 78.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.982 0.513 . . . . 65.23 110.262 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -24.42 57.03 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 116.058 -0.519 . . . . 74.44 110.529 177.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.94 -40.77 98.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.33 0.586 . . . . 44.32 109.918 169.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -70.25 -30.91 68.08 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.31 1.044 . . . . 73.21 111.203 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.484 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 69.2 m -70.76 -67.68 0.49 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 110.247 -0.279 . . . . 63.32 110.247 174.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 59.3 mt -74.34 -21.93 59.46 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.585 0.587 . . . . 74.21 112.585 -168.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.95 3.09 41.2 Favored Glycine 0 N--CA 1.474 1.205 0 CA-C-O 119.522 -0.599 . . . . 60.54 114.302 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.48 -62.85 0.2 Allowed 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.789 0.795 . . . . 70.41 111.909 -177.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 89.4 t80 -68.18 -39.18 82.61 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.915 0.886 . . . . 72.14 112.372 -172.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.411 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 91.3 m -73.08 -46.36 8.22 Favored Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 123.693 0.797 . . . . 64.24 111.103 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.411 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 78.5 Cg_exo -55.87 -34.05 90.39 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.025 1.817 . . . . 53.31 113.727 167.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -59.6 -38.77 82.13 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.231 0.613 . . . . 72.24 110.799 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.449 HD13 HD11 ' B' ' 13' ' ' ILE . 70.4 mt -64.12 -42.99 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.06 0.944 . . . . 74.14 110.836 175.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 80' ' ' GLN . 74.1 mt -79.03 -19.73 50.73 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.657 -1.156 . . . . 71.33 112.399 -173.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -59.7 -47.41 97.59 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.179 1.177 . . . . 71.42 114.179 -171.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.96 -42.78 61.84 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.373 2.048 . . . . 73.13 113.788 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.531 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 82.5 m-85 -66.27 -48.63 69.81 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.839 -0.619 . . . . 64.43 110.421 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.96 -42.12 84.33 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.742 0.817 . . . . 63.54 110.908 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 49.5 ttt180 -61.86 -54.71 38.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.245 1.418 . . . . 64.41 110.995 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -67.17 -34.16 76.95 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 123.998 0.811 . . . . 73.24 110.147 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.6 t -68.18 -33.93 75.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.71 0.404 . . . . 74.24 111.088 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 70.9 mt -65.28 -52.01 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.415 -0.587 . . . . 65.34 109.415 171.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.0 m -60.01 -30.62 69.27 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 123.979 0.8 . . . . 75.53 111.543 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.2 t -63.63 -51.86 63.36 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 123.454 0.702 . . . . 52.23 109.858 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -68.59 -34.91 76.6 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.148 0.579 . . . . 64.11 110.985 -174.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.05 -43.04 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.736 0.815 . . . . 64.03 110.312 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.3 t -68.75 -30.19 68.75 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.393 -0.821 . . . . 52.24 111.598 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.8 mtt-85 -69.59 -43.4 72.88 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.547 -0.751 . . . . 75.54 109.612 176.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.21 -3.09 64.24 Favored Glycine 0 C--N 1.357 1.708 0 O-C-N 124.072 0.857 . . . . 55.45 112.924 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 28.2 p 62.18 25.87 15.5 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 126.506 1.922 . . . . 71.23 112.86 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -80.34 161.51 64.64 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 123.837 0.855 . . . . 54.43 110.729 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -49.41 157.86 1.95 Allowed 'Trans proline' 0 C--N 1.387 2.581 0 C-N-CA 123.742 2.961 . . . . 71.41 115.178 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -59.61 114.17 2.6 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.226 1.01 . . . . 52.31 111.306 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -119.1 108.97 15.35 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.657 -0.868 . . . . 65.35 108.657 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -124.02 134.44 53.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.511 -0.922 . . . . 75.22 108.511 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.429 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.3 mm? -77.02 147.42 36.78 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.299 0.639 . . . . 74.02 109.848 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.23 147.23 53.04 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 123.092 0.557 . . . . 62.52 109.667 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.33 110.78 0.85 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.151 2.568 . . . . 73.23 112.322 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.0 t -90.11 112.63 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.435 -0.95 . . . . 72.22 108.435 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -82.08 83.83 7.2 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.968 -1.123 . . . . 74.22 107.968 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -54.41 -42.26 70.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.288 1.035 . . . . 64.42 111.302 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.73 -43.09 80.79 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.408 1.083 . . . . 71.32 111.888 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.52 -54.25 45.64 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.316 0.646 . . . . 74.2 110.271 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.4 -29.37 70.43 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.613 -1.176 . . . . 54.2 111.47 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.457 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 75.2 t80 -65.54 -43.21 90.67 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.151 0.58 . . . . 54.14 110.433 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 60.4 mtt -64.83 -36.2 83.55 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.888 0.475 . . . . 54.04 110.674 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -82.96 -4.61 58.45 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.767 0.827 . . . . 71.21 111.464 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -83.12 -34.27 26.12 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.081 0.552 . . . . 74.12 109.668 173.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 12.7 mt -77.68 -6.27 53.33 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.621 -0.718 . . . . 75.35 111.38 -172.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -144.35 132.75 21.99 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.464 1.106 . . . . 54.41 108.153 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -79.44 68.75 5.54 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.713 0.768 . . . . 71.42 109.709 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -143.29 177.19 8.59 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.198 1.399 . . . . 72.03 108.541 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.38 97.59 2.88 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.014 0.526 . . . . 75.42 110.647 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.97 149.88 21.13 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 111.764 -0.534 . . . . 54.4 111.764 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -160.85 165.65 29.84 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.671 0.789 . . . . 62.22 110.412 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.31 85.45 0.14 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 111.393 -0.683 . . . . 63.43 111.393 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.6 p -85.15 110.44 19.0 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.164 0.586 . . . . 75.3 109.616 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -137.41 144.73 42.54 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.122 -1.807 . . . . 75.32 106.122 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -169.44 125.53 0.88 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.086 0.554 . . . . 75.44 109.75 -176.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -168.9 94.57 0.33 Allowed 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.54 0.736 . . . . 71.5 111.501 174.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.21 61.99 2.1 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 106.759 -1.571 . . . . 73.11 106.759 163.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.48 117.66 18.37 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.481 -1.236 . . . . 74.51 109.722 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 C-N-CA 123.733 0.813 . . . . 72.22 108.946 -178.648 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.844 -0.428 . . . . 74.24 109.844 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -139.08 -176.54 4.54 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 108.075 -1.083 . . . . 75.12 108.075 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.73 77.33 3.36 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.199 0.6 . . . . 54.25 109.691 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 57.15 68.7 0.82 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.083 1.353 . . . . 71.02 111.777 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -74.77 80.84 2.08 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.688 -0.856 . . . . 74.34 108.688 172.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -172.71 123.68 0.45 Allowed 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.769 -1.197 . . . . 61.21 107.769 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 45.8 p -72.68 -67.87 0.52 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.24 -0.652 . . . . 62.42 109.24 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 56.72 65.31 1.43 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.061 1.344 . . . . 74.24 111.896 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.475 ' HG3' HD12 ' C' ' 89' ' ' ILE . 54.4 ttm 57.33 113.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.817 1.647 . . . . 74.31 113.352 177.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 31.4 m -87.81 80.49 7.84 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.368 -0.975 . . . . 74.01 108.368 173.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.56 122.93 33.8 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.79 -1.095 . . . . 61.32 109.155 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.483 ' HA ' HE21 ' C' ' 12' ' ' GLN . 0.1 OUTLIER -137.21 108.41 6.81 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.593 -1.262 . . . . 74.22 107.593 168.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.9 118.62 6.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.071 -1.085 . . . . 74.45 108.071 172.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.478 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.1 mm-40 -82.74 -48.84 10.4 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.705 0.628 . . . . 41.24 109.415 -178.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -170.19 124.46 0.74 Allowed 'General case' 0 C--N 1.354 0.78 0 CA-C-N 115.947 -0.569 . . . . 62.34 110.677 -172.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.1 mt -112.35 139.27 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 107.736 -1.209 . . . . 63.11 107.736 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -173.5 153.12 2.26 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.094 0.474 . . . . 74.45 110.435 -168.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.9 p -82.32 116.64 21.91 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.96 -0.755 . . . . 71.42 108.96 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.43 ' HG3' ' HA3' ' C' ' 81' ' ' GLY . 15.2 mtmt -83.58 -29.79 27.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.09 0.472 . . . . 75.53 109.947 176.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 27.4 t70 -144.37 138.68 27.97 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.132 -0.94 . . . . 75.42 109.354 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 87.0 mt -136.51 140.24 43.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.924 -1.509 . . . . 74.44 106.924 171.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -157.05 141.23 16.39 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.842 0.353 . . . . 72.31 110.155 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 86.8 t80 -136.44 148.2 47.62 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.489 -1.3 . . . . 75.42 107.489 171.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -145.08 118.12 8.84 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.0 0.92 . . . . 74.33 110.062 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.83 83.78 51.7 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 107.222 -1.399 . . . . 15.4 107.222 163.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.01 -27.89 19.94 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.331 2.021 . . . . 72.33 111.394 175.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -92.25 12.2 23.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.579 1.151 . . . . 74.22 110.747 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.81 -58.76 7.63 Favored Pre-proline 0 C--N 1.37 1.463 0 N-CA-C 114.698 1.37 . . . . 63.12 114.698 -165.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -62.98 -39.77 38.44 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 121.503 1.468 . . . . 51.14 112.171 -174.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -70.3 -34.96 73.36 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.787 -1.097 . . . . 71.33 112.233 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.692 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.3 p -80.6 -26.06 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 112.906 0.706 . . . . 72.32 112.906 -170.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -64.77 -20.48 66.39 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 113.29 0.848 . . . . 73.02 113.29 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -99.11 12.07 37.18 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.302 0.641 . . . . 73.11 111.286 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.726 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -88.06 146.32 25.52 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.276 -0.638 . . . . 61.35 109.276 172.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -57.98 119.18 6.3 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.116 -0.698 . . . . 73.44 109.116 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.7 t90 -67.8 93.17 0.38 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.803 0.841 . . . . 71.2 111.283 -173.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -148.99 69.1 9.81 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 124.839 1.255 . . . . 73.41 108.251 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -80.16 133.27 9.78 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.573 2.182 . . . . 73.44 111.152 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.09 105.11 15.59 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.107 -1.072 . . . . 74.42 108.107 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.55 113.56 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 115.36 -0.836 . . . . 70.21 110.329 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -111.17 110.7 21.34 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.183 -1.414 . . . . 72.41 107.183 170.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 40.4 tp -91.28 142.26 27.9 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.124 0.569 . . . . 71.31 109.7 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.42 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 20.1 t70 -131.95 117.75 18.86 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.823 -1.177 . . . . 73.31 107.823 175.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.6 mt -108.72 151.67 25.87 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.607 0.763 . . . . 63.33 109.953 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 30.0 t70 -157.6 150.19 22.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.198 0.599 . . . . 55.44 109.949 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 3.0 m -144.45 123.36 12.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.629 0.772 . . . . 54.22 110.117 176.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.78 135.11 54.44 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.619 -0.882 . . . . 73.14 108.619 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.4 p -131.2 142.31 50.17 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.239 0.616 . . . . 74.42 109.623 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 29.6 t -145.79 150.8 36.88 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.137 0.975 . . . . 73.13 109.532 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.54 ' NE2' HG11 ' G' ' 452' ' ' VAL . 55.2 tt0 -75.75 138.77 41.46 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.957 -0.565 . . . . 74.44 109.829 174.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.632 HD11 HD12 ' C' ' 83' ' ' ILE . 62.6 mt -106.22 -43.26 4.85 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.681 -0.859 . . . . 74.34 108.681 169.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.66 -176.34 5.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.63 -1.168 . . . . 60.02 109.525 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . 0.479 ' HB3' ' HA ' ' G' ' 450' ' ' ASN . 12.2 m-20 -66.18 126.1 27.63 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.511 -0.768 . . . . 62.23 109.684 176.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 72.2 -1.82 2.78 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.31 1.444 . . . . 73.35 112.032 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -114.89 114.12 45.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 C-N-CA 123.264 0.625 . . . . 55.11 109.418 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -124.84 135.3 52.78 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.063 0.945 . . . . 74.34 109.192 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.562 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.8 tt0 -92.6 123.97 36.29 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 124.154 0.909 . . . . 70.23 108.877 168.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 85.3 t -103.79 136.95 34.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.293 -1.003 . . . . 62.5 108.293 168.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -121.17 130.58 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.303 -1.369 . . . . 75.5 107.303 174.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.26 104.26 11.64 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.818 -1.178 . . . . 52.1 107.818 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.575 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 30.4 ttm-85 -88.39 126.19 35.09 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.241 -1.345 . . . . 74.22 108.297 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.597 ' HB ' HD11 ' C' ' 114' ' ' ILE . 21.5 t -123.58 128.22 74.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.583 -1.266 . . . . 64.41 107.583 173.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 9.8 m -128.37 112.0 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.746 -0.835 . . . . 71.44 108.746 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.455 HG21 HG21 ' C' ' 114' ' ' ILE . 51.7 t -104.84 116.02 47.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.92 -1.036 . . . . 71.25 108.788 -173.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.9 m -105.8 141.37 37.34 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.07 -0.715 . . . . 72.41 109.07 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.15 115.15 8.74 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.85 -1.167 . . . . 73.13 107.85 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.9 m -137.17 134.25 36.11 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.483 0.49 . . . . 54.53 109.833 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.726 HD13 ' HG2' ' C' ' 34' ' ' LYS . 0.5 OUTLIER -87.88 42.03 1.03 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.936 1.294 . . . . 61.22 108.596 177.135 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.27 -112.62 4.17 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.209 -0.756 . . . . 70.54 111.209 -171.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.56 -30.71 19.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.326 0.65 . . . . 71.25 109.485 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.15 110.53 3.02 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 115.222 -0.899 . . . . 64.44 109.032 173.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -77.95 125.49 29.42 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 109.001 -0.74 . . . . 74.05 109.001 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.692 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.85 -57.87 3.75 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.421 -1.325 . . . . 62.23 107.421 171.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -167.4 169.23 12.45 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 121.885 0.85 . . . . 71.13 111.939 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -133.77 141.63 47.57 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 105.947 -1.872 . . . . 72.11 105.947 170.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 47.4 t -151.34 113.44 4.53 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.963 -0.384 . . . . 44.32 109.963 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -117.02 127.62 54.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.478 0.311 . . . . 73.21 110.309 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.5 t -118.24 138.33 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.953 -1.129 . . . . 74.33 107.953 167.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.6 mt-30 -116.05 94.96 4.88 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 108.68 -0.859 . . . . 72.12 108.68 173.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.478 ' HG3' HD22 ' C' ' 106' ' ' LEU . 9.4 tp-100 -79.79 102.64 9.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.954 -1.021 . . . . 62.33 109.903 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.43 ' HA3' ' HG3' ' C' ' 19' ' ' LYS . . . -85.58 151.85 25.75 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 111.759 -0.536 . . . . 72.51 111.759 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.59 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.37 118.47 0.86 Allowed Glycine 0 CA--C 1.506 -0.475 0 N-CA-C 111.697 -0.561 . . . . 71.34 111.697 -177.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.632 HD12 HD11 ' C' ' 51' ' ' LEU . 8.8 mm -84.71 125.91 40.29 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 N-CA-C 108.764 -0.828 . . . . 70.51 108.764 173.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -134.24 120.08 19.55 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.673 -0.862 . . . . 73.22 108.673 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 61.1 p -91.07 118.82 30.71 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.189 -0.671 . . . . 71.44 109.189 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.749 HG21 ' SG ' ' C' ' 97' ' ' CYS . 1.8 pp -125.61 141.13 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.594 1.158 . . . . 72.43 111.356 -174.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.657 ' HA ' HG21 ' G' ' 451' ' ' VAL . . . -149.53 167.46 26.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.333 0.653 . . . . 75.43 110.326 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.64 -54.41 3.78 Favored Glycine 0 N--CA 1.475 1.269 0 N-CA-C 112.43 -0.268 . . . . 55.0 112.43 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.475 HD12 ' HG3' ' C' ' 9' ' ' MET . 0.2 OUTLIER -81.42 157.54 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.254 0.622 . . . . 75.12 110.564 177.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -161.79 178.63 8.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.851 0.46 . . . . 73.34 110.418 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.54 -114.1 5.58 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.718 0.637 . . . . 64.25 113.533 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -82.55 -20.08 37.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.672 0.789 . . . . 64.5 112.087 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.56 -42.92 61.01 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.513 -0.551 . . . . 73.15 109.513 177.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 23.9 ptm -74.23 -30.11 62.02 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 110.248 -0.278 . . . . 73.22 110.248 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.553 ' HA ' HD22 ' G' ' 454' ' ' LEU . . . -59.59 -43.69 93.59 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 123.489 0.493 . . . . 75.15 110.118 175.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -74.72 -35.83 62.67 Favored 'General case' 0 C--O 1.245 0.832 0 O-C-N 123.477 0.485 . . . . 72.43 111.78 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.749 ' SG ' HG21 ' C' ' 86' ' ' ILE . 53.3 t -56.6 -36.37 69.32 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.644 0.59 . . . . 70.41 110.558 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 24.4 mt -98.31 -18.06 18.56 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.856 0.862 . . . . 75.33 111.18 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.43 -29.62 55.44 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 115.015 0.766 . . . . 51.1 115.015 -172.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.94 -36.0 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.654 0.382 . . . . 63.14 111.081 -170.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -67.61 -45.8 74.39 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.216 1.406 . . . . 74.42 112.677 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.0 m -79.79 -40.41 1.37 Allowed Pre-proline 0 CA--C 1.557 1.247 0 CA-C-O 118.475 -0.774 . . . . 61.12 112.481 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -54.0 -27.58 45.92 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 122.249 1.966 . . . . 70.05 114.078 166.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -68.28 -37.9 81.14 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.679 0.792 . . . . 74.15 109.768 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.523 HD12 ' NH1' ' A' ' 111' ' ' ARG . 43.8 mm -68.94 -34.01 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.008 0.523 . . . . 73.11 109.983 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.59 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.4 mt -81.34 -27.3 35.01 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.917 0.887 . . . . 75.35 112.756 -177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -57.8 -48.52 97.03 Favored Pre-proline 0 CA--C 1.559 1.31 0 N-CA-C 113.959 1.096 . . . . 73.4 113.959 -174.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.94 -37.15 79.29 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 121.992 1.795 . . . . 74.42 113.056 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -66.69 -42.46 86.43 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.103 0.561 . . . . 61.11 110.895 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.56 99.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.539 0.736 . . . . 61.0 110.461 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.598 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 35.9 ttt180 -54.12 -56.47 17.85 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.464 1.506 . . . . 63.5 111.412 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.23 -35.43 77.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.733 0.413 . . . . 73.21 110.543 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 20.0 t -64.75 -33.58 76.32 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.957 0.503 . . . . 73.11 111.973 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.597 HD11 ' HB ' ' C' ' 62' ' ' VAL . 75.4 mt -76.75 -52.7 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.585 0.754 . . . . 74.4 110.231 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -60.94 -28.67 69.12 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.356 0.662 . . . . 71.03 111.38 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.2 t -67.31 -52.07 44.86 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.779 0.832 . . . . 51.4 109.156 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.547 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.37 -36.84 78.97 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.226 1.011 . . . . 71.25 112.338 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.498 HG11 HD13 ' C' ' 126' ' ' LEU . 78.3 t -66.53 -44.84 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.633 0.773 . . . . 72.33 109.904 175.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 40.4 t -69.2 -22.92 63.86 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.262 -0.881 . . . . 71.11 111.645 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.3 mtt-85 -75.65 -41.05 55.13 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.49 0.716 . . . . 75.15 109.082 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.01 -2.87 62.89 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 123.83 0.706 . . . . 63.44 112.498 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p 67.03 27.76 8.62 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.88 2.072 . . . . 74.12 113.611 169.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -83.8 153.45 64.13 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 108.813 -0.81 . . . . 73.53 108.813 168.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -60.67 178.49 0.47 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.149 2.566 . . . . 74.24 114.75 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -60.8 114.33 2.98 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 114.171 1.174 . . . . 54.21 114.171 -174.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.498 HD13 HG11 ' C' ' 118' ' ' VAL . 7.2 mp -112.2 89.49 3.08 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.81 -0.811 . . . . 73.41 108.81 163.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -91.32 112.68 24.69 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.513 -0.921 . . . . 53.54 108.513 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.598 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -65.0 126.29 27.55 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.618 0.767 . . . . 61.32 110.587 -177.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.21 149.18 81.82 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 124.423 1.089 . . . . 72.4 111.887 -173.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.07 105.3 0.32 Allowed 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.11 2.54 . . . . 73.32 113.212 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.6 111.33 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.707 -0.849 . . . . 73.54 108.707 171.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -87.22 90.31 8.31 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 108.622 -0.881 . . . . 65.11 108.622 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -60.36 -29.95 69.24 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.251 1.021 . . . . 63.22 111.261 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.56 -43.93 68.88 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.415 1.486 . . . . 75.01 112.915 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.61 82.97 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.348 1.03 . . . . 74.24 110.604 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 20.6 tp -71.72 -29.31 64.41 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.142 -0.935 . . . . 74.13 111.152 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -74.21 -26.13 60.08 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.639 0.375 . . . . 72.04 110.344 177.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 91.5 mtp -71.97 -32.28 67.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.582 0.353 . . . . 73.31 110.5 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -71.22 -46.51 61.0 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.882 0.473 . . . . 53.44 109.967 174.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -56.51 -82.87 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 124.651 1.18 . . . . 74.3 110.743 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' C' ' 145' ' ' ALA . 17.9 tp 64.52 -81.98 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.759 1.624 . . . . 50.51 108.997 -174.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 11.7 tm0? 179.3 -57.63 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.227 1.411 . . . . 73.01 107.397 166.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -93.53 -76.02 0.48 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.399 -0.819 . . . . 70.42 109.395 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -176.71 160.72 1.98 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.846 0.858 . . . . 74.53 110.45 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.502 ' HB2' HD22 ' C' ' 141' ' ' LEU . . . -126.15 153.5 44.51 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.058 0.943 . . . . 73.44 109.567 175.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.31 43.21 0.52 Allowed Glycine 0 C--N 1.347 1.163 0 O-C-N 123.043 0.215 . . . . 35.14 113.2 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -156.71 147.42 21.67 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.812 0.445 . . . . 55.13 110.48 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -142.67 -177.09 17.37 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 110.754 -0.938 . . . . 64.21 110.754 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 92.6 m -113.42 -96.69 0.44 Allowed 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.111 -0.7 . . . . 72.22 109.111 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 38.84 69.22 0.28 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.559 1.543 . . . . 71.54 113.608 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -93.4 142.88 26.83 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.119 -1.067 . . . . 75.14 108.119 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . 0.415 ' HD2' HD21 ' A' ' 141' ' ' LEU . 36.8 t-80 -150.12 117.25 5.99 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.597 0.359 . . . . 71.51 111.127 -170.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -95.5 129.37 42.69 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.505 -0.924 . . . . 71.11 108.505 160.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -79.47 74.43 6.1 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.826 0.822 . . . . 75.12 109.206 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-N 114.605 -1.18 . . . . 72.2 108.783 -178.18 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.423 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 109.99 -0.374 . . . . 73.42 109.99 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 18.0 m -91.92 -179.38 5.28 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.512 1.125 . . . . 64.15 110.941 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -78.1 83.23 4.4 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.409 0.624 . . . . 72.02 109.418 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' D' ' 5' ' ' ASN . 15.7 tp60 -149.82 -175.36 5.0 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 106.819 -1.549 . . . . 73.22 106.819 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . 0.417 ' H ' ' HG3' ' D' ' 4' ' ' GLN . 25.5 p-10 -64.2 -28.23 69.6 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 118.922 0.783 . . . . 74.05 109.687 167.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.594 HD22 ' HB3' ' D' ' 9' ' ' MET . 4.3 t30 70.13 103.17 0.06 Allowed 'General case' 0 C--N 1.36 1.05 0 C-N-CA 125.979 1.712 . . . . 63.41 109.66 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -72.93 146.26 46.23 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.501 -0.772 . . . . 74.54 110.46 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 73.21 -1.73 2.96 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.797 1.239 . . . . 74.14 113.318 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.594 ' HB3' HD22 ' D' ' 6' ' ' ASN . 6.1 ptm -36.46 153.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.313 1.227 . . . . 74.34 114.313 165.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 21.0 m -117.27 143.55 45.78 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.592 0.757 . . . . 75.04 110.905 177.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.545 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 71.1 t80 -162.58 97.7 0.98 Allowed 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.063 -1.458 . . . . 73.33 107.063 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -112.22 115.01 28.11 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.394 -1.336 . . . . 75.24 107.394 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.474 HD11 HD12 ' D' ' 105' ' ' ILE . 59.7 mt -73.59 119.31 20.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.384 -0.969 . . . . 75.43 108.384 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.46 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 9.5 mm100 -85.34 -41.77 15.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.693 -0.685 . . . . 75.24 109.219 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -174.67 144.27 0.83 Allowed 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.251 0.345 . . . . 64.42 111.164 -167.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.469 HD11 HG21 ' D' ' 13' ' ' ILE . 4.1 mp -120.66 142.39 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.112 -1.44 . . . . 72.11 107.112 170.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -164.87 160.44 19.4 Favored 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.405 0.682 . . . . 75.54 111.121 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.8 p -93.15 116.48 29.07 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.325 -0.621 . . . . 72.13 109.325 173.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -85.38 -19.88 30.73 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.965 0.506 . . . . 75.42 110.105 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.1 t70 -160.31 140.03 11.15 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.782 0.833 . . . . 75.15 109.261 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.547 HG21 ' HE2' ' C' ' 117' ' ' MET . 98.6 mt -137.95 142.86 34.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 124.859 1.263 . . . . 74.21 107.701 175.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -141.6 136.23 30.81 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.957 0.903 . . . . 75.43 108.807 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.505 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 82.4 t80 -143.53 124.87 14.66 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.587 -1.634 . . . . 64.12 106.587 168.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 27.0 mt-10 -135.13 118.02 16.25 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.612 -0.884 . . . . 63.45 108.612 -173.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.59 82.39 9.97 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.729 -1.212 . . . . 65.23 107.729 174.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.47 -33.74 10.45 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.681 2.254 . . . . 64.13 113.183 -170.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -103.52 11.06 36.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.542 0.737 . . . . 65.53 110.666 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.441 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -30.66 -70.57 0.09 OUTLIER Pre-proline 0 CA--C 1.565 1.521 0 N-CA-C 116.276 1.954 . . . . 55.11 116.276 -160.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.46 -15.42 19.77 Favored 'Trans proline' 0 C--N 1.375 1.946 0 CA-C-N 123.55 2.304 . . . . 72.12 113.829 -173.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -79.79 -41.1 27.21 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.485 1.114 . . . . 52.34 110.044 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.5 p -79.96 -23.46 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 116.235 -0.439 . . . . 72.25 111.34 -173.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -63.19 -19.81 64.85 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.127 0.417 . . . . 72.33 112.127 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -61.47 -17.1 52.94 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.877 0.871 . . . . 75.32 111.947 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.419 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 37.6 mtmt -99.83 110.75 23.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.772 0.829 . . . . 61.5 111.09 174.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.49 93.85 9.47 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.576 -0.738 . . . . 62.13 109.722 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -157.39 157.07 33.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.432 1.093 . . . . 64.35 108.235 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.464 ' HG3' HD13 ' H' ' 470' ' ' LEU . 30.3 tp60 -76.44 106.38 3.24 Favored Pre-proline 0 N--CA 1.477 0.908 0 N-CA-C 107.374 -1.343 . . . . 71.32 107.374 171.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.58 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 24.5 Cg_exo -63.21 137.31 60.5 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.796 2.331 . . . . 74.22 112.452 -167.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 7.4 mm-40 -56.93 109.72 0.69 Allowed 'General case' 0 C--N 1.361 1.075 0 O-C-N 124.082 0.864 . . . . 73.41 109.692 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.609 HG23 HG13 ' D' ' 64' ' ' VAL . 2.1 p -99.63 111.71 29.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 115.198 -0.91 . . . . 53.15 110.586 -171.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -86.49 111.86 20.97 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.366 -1.346 . . . . 72.21 107.366 169.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -95.79 151.86 19.0 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 108.961 -0.755 . . . . 73.44 108.961 173.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -151.44 154.12 35.99 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.438 -0.949 . . . . 70.0 108.438 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.682 ' HB2' HD13 ' H' ' 460' ' ' LEU . 89.6 mt -131.14 144.04 51.09 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.725 0.81 . . . . 72.4 109.711 -176.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.672 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.8 t70 -141.41 125.48 17.29 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.61 1.164 . . . . 64.43 108.234 175.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -104.66 145.38 30.42 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 109.215 -0.661 . . . . 71.15 109.215 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.99 142.69 24.61 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.158 -1.053 . . . . 74.44 108.158 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 47.6 p -141.94 159.92 41.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.602 0.637 . . . . 65.32 111.35 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -163.39 125.91 2.59 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.893 0.877 . . . . 64.53 109.668 -173.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -74.99 121.87 22.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.576 -0.528 . . . . 72.55 109.576 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' D' ' 57' ' ' GLU . 55.9 mt -96.36 -29.65 13.84 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.139 0.576 . . . . 74.14 111.283 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.21 -173.01 3.43 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.391 0.677 . . . . 41.0 110.45 -177.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.89 120.84 18.06 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.968 -1.014 . . . . 75.44 110.762 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 65.05 3.74 2.26 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.487 1.115 . . . . 74.21 112.005 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 51.5 t -117.0 124.2 72.73 Favored 'Isoleucine or valine' 0 C--N 1.349 0.575 0 C-N-CA 123.369 0.668 . . . . 64.51 109.572 -173.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -120.81 173.13 7.41 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.957 1.303 . . . . 74.2 109.99 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.538 ' HB2' HD11 ' D' ' 51' ' ' LEU . 33.4 tt0 -131.3 133.84 45.77 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.733 -1.576 . . . . 61.41 107.008 168.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.6 t -120.63 141.77 39.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.004 -1.11 . . . . 64.13 108.004 168.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 39.8 t -120.77 131.32 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.718 -1.216 . . . . 65.05 107.718 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.419 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -115.16 119.75 37.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.464 -0.939 . . . . 72.2 108.464 178.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.672 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.2 ttm180 -104.77 102.37 11.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.129 -1.063 . . . . 72.32 108.129 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.2 t -94.48 102.51 13.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.693 -1.225 . . . . 72.45 107.693 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 28.4 m -100.32 140.0 35.2 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.544 -0.753 . . . . 74.54 109.588 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.76 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 52.0 t -132.35 133.68 59.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.628 1.571 . . . . 54.43 108.6 -172.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.0 m -134.66 100.77 4.72 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.117 -1.068 . . . . 51.41 108.117 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -104.2 153.14 21.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.644 0.778 . . . . 62.24 110.868 -176.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 65.1 p -146.08 137.96 25.06 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.29 0.567 . . . . 70.13 111.909 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.509 HD12 HG22 ' D' ' 31' ' ' VAL . 53.3 mt -105.69 125.7 51.29 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.586 1.154 . . . . 72.21 108.131 170.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.03 -113.29 5.5 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.454 0.471 . . . . 75.23 112.728 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.96 5.32 13.94 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.346 0.659 . . . . 75.24 110.706 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.419 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 12.4 pt-20 -127.11 159.9 32.81 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.151 0.58 . . . . 73.22 110.276 -174.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -68.92 130.72 43.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.598 0.759 . . . . 61.15 111.95 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.525 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.99 -77.46 0.3 Allowed 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.82 -0.807 . . . . 74.32 108.82 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -141.33 147.57 38.32 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 121.227 0.537 . . . . 72.45 110.859 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 55.8 mt -117.85 140.03 50.27 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.805 -1.183 . . . . 61.15 107.805 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.76 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 33.0 m -141.21 144.7 34.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.118 0.967 . . . . 70.43 109.035 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -156.94 118.07 3.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.16 -1.052 . . . . 74.01 108.16 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.83 113.05 25.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 109.361 -0.607 . . . . 73.11 109.361 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -89.73 85.88 6.54 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.649 -0.871 . . . . 74.23 108.649 172.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -79.09 94.66 5.38 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.618 -1.174 . . . . 73.42 108.509 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.83 145.95 21.12 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.781 -0.528 . . . . 55.03 111.781 177.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.474 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -145.67 131.41 4.15 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.445 -0.662 . . . . 52.54 111.445 -176.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 43.6 mt -89.0 128.73 40.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 N-CA-C 108.248 -1.019 . . . . 73.42 108.248 176.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -135.08 123.9 23.91 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.175 0.59 . . . . 73.4 110.1 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 57.8 m -74.19 108.46 7.0 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.081 -0.711 . . . . 53.25 109.081 166.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.54 HD13 HD23 ' D' ' 98' ' ' LEU . 45.1 pt -105.22 138.29 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.355 0.662 . . . . 71.11 109.271 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.537 ' HA ' HG21 ' H' ' 451' ' ' VAL . . . -167.76 170.43 10.86 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.377 1.071 . . . . 73.23 108.934 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.19 -15.1 29.93 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-O 119.899 -0.39 . . . . 63.32 112.718 -177.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.401 HD11 ' HB ' ' D' ' 86' ' ' ILE . 1.5 pp -128.49 134.97 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.401 1.08 . . . . 72.42 109.631 -174.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -132.42 158.36 42.21 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.851 0.861 . . . . 73.43 109.726 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.08 -127.05 39.87 Favored Glycine 0 C--N 1.355 1.587 0 O-C-N 124.366 1.041 . . . . 41.12 114.426 172.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 75.1 p -63.17 -39.86 95.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.699 0.8 . . . . 73.31 111.257 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -73.76 -27.11 60.99 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.578 -0.737 . . . . 71.12 111.623 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.5 ' HG3' ' O ' ' H' ' 451' ' ' VAL . 18.3 tmm? -70.93 -44.72 65.54 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 109.516 -0.549 . . . . 70.5 109.516 172.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.04 -25.04 66.63 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.519 0.728 . . . . 44.24 111.462 174.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.2 t-160 -78.67 -38.51 39.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.785 0.834 . . . . 71.1 110.713 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -73.69 -27.29 61.14 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.258 0.623 . . . . 63.43 111.506 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.54 HD23 HD13 ' D' ' 86' ' ' ILE . 2.3 tm? -100.1 -54.01 2.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.311 1.044 . . . . 72.31 109.819 -170.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.9 14.42 58.72 Favored Glycine 0 N--CA 1.472 1.065 0 CA-C-O 119.557 -0.579 . . . . 52.2 114.433 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.508 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -149.74 -55.44 0.17 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.574 0.687 . . . . 75.41 112.016 -178.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -72.6 -37.85 68.0 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 112.233 0.457 . . . . 74.13 112.233 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.545 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 96.6 m -61.94 -46.93 92.28 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 118.687 -0.673 . . . . 64.54 112.392 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.419 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 82.4 Cg_exo -52.06 -35.29 61.13 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.285 1.99 . . . . 74.41 114.325 167.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -68.67 -25.34 64.76 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 122.909 0.484 . . . . 60.43 112.079 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.474 HD12 HD11 ' D' ' 13' ' ' ILE . 23.8 mm -73.01 -40.05 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.706 0.765 . . . . 70.41 109.813 171.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.474 HD21 ' HA3' ' D' ' 82' ' ' GLY . 91.8 mt -77.27 -26.8 52.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.776 -1.102 . . . . 64.53 112.839 -173.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -62.83 -43.5 83.08 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 113.725 1.009 . . . . 72.33 113.725 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.42 -45.87 34.86 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.051 1.834 . . . . 74.31 113.949 171.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -72.26 -37.15 69.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.584 0.754 . . . . 73.0 111.342 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.41 90.2 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.906 0.882 . . . . 72.42 110.43 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.476 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 29.4 ttp180 -55.22 -52.71 62.48 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 114.523 -1.217 . . . . 75.22 110.181 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -60.16 -43.41 95.79 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.295 0.997 . . . . 73.34 111.629 -174.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.2 t -59.41 -43.97 92.93 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.512 0.508 . . . . 73.31 110.771 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.473 HG23 ' SG ' ' D' ' 76' ' ' CYS . 80.6 mt -64.8 -49.68 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.918 0.887 . . . . 74.22 110.987 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 23.2 m -56.31 -40.82 74.99 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.414 1.086 . . . . 61.15 111.192 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 14.4 t -66.59 -44.24 82.71 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 114.447 -1.251 . . . . 64.32 110.045 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.505 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.1 mtm -67.87 -32.01 72.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.904 0.482 . . . . 73.43 111.82 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' D' ' 114' ' ' ILE . 61.9 t -67.65 -42.7 86.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.681 0.793 . . . . 72.44 110.216 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.2 p -74.87 -29.95 61.17 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.829 0.451 . . . . 75.13 111.181 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 -72.3 -36.73 69.02 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.622 0.769 . . . . 52.25 109.893 174.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.96 2.7 79.65 Favored Glycine 0 C--N 1.356 1.657 0 O-C-N 123.696 0.622 . . . . 74.24 112.427 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.3 p 62.28 23.26 13.75 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.819 2.048 . . . . 73.22 113.964 171.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.54 155.85 65.62 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 109.029 -0.73 . . . . 70.35 109.029 167.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.413 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 27.8 Cg_endo -60.79 142.24 97.15 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 122.39 2.06 . . . . 64.1 111.405 176.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -51.6 147.67 6.14 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.256 1.422 . . . . 72.2 113.669 -167.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.584 ' HA ' HD11 ' H' ' 468' ' ' LEU . 23.2 tp -122.61 98.82 6.09 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.003 0.521 . . . . 74.11 110.477 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -101.73 92.18 4.73 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.696 0.798 . . . . 71.24 109.849 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.476 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -64.38 118.52 8.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.453 0.701 . . . . 61.42 110.397 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -60.57 132.9 91.26 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 123.466 0.707 . . . . 70.11 111.021 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 4.7 Cg_exo -73.09 117.59 5.18 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.795 2.33 . . . . 71.43 111.287 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.61 145.36 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.016 0.526 . . . . 71.22 110.926 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -89.27 97.9 11.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.019 0.928 . . . . 51.05 109.946 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.504 ' HA ' HD12 ' D' ' 136' ' ' LEU . 7.5 t80 -76.19 -16.97 59.74 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.263 0.625 . . . . 65.32 111.183 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.508 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 13.1 m-20 -62.65 -49.23 75.96 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.325 0.65 . . . . 74.11 110.924 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.92 -45.87 89.29 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.643 0.59 . . . . 72.02 110.597 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' D' ' 133' ' ' PHE . 82.4 mt -58.56 -42.18 87.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.629 -1.169 . . . . 74.54 111.925 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -67.69 -43.76 79.38 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.649 0.78 . . . . 71.13 110.973 -178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 73.7 mtm -65.94 -27.83 68.46 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.591 0.356 . . . . 73.25 110.76 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -74.22 -34.12 63.59 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.044 -0.525 . . . . 73.12 110.779 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -66.13 -36.85 84.22 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.105 0.562 . . . . 74.52 111.095 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.6 mp -70.31 -30.4 67.38 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.065 0.546 . . . . 54.11 111.765 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.417 ' NE2' ' HA2' ' D' ' 148' ' ' GLY . 13.3 pt20 -91.3 10.06 28.87 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.753 0.421 . . . . 75.33 112.07 174.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -120.2 89.87 3.21 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.964 0.888 . . . . 74.14 110.069 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -144.86 -62.79 0.36 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 106.238 -1.764 . . . . 63.42 106.238 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.9 -14.61 25.85 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.242 1.017 . . . . 54.02 110.913 171.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.15 97.86 1.46 Allowed Glycine 0 C--N 1.352 1.435 0 O-C-N 123.532 0.52 . . . . 50.32 111.837 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.32 -179.82 5.87 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.08 0.952 . . . . 43.44 110.651 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . 0.417 ' HA2' ' NE2' ' D' ' 142' ' ' GLN . . . -146.5 124.76 2.07 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-O 119.879 -0.4 . . . . 61.22 112.341 -176.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 12.9 t -70.56 -20.15 62.81 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.591 0.756 . . . . 71.13 111.864 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 66.36 101.42 0.04 OUTLIER 'General case' 0 C--N 1.358 0.969 0 C-N-CA 125.425 1.49 . . . . 73.33 111.449 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.13 87.46 1.08 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.947 -0.76 . . . . 74.45 108.947 171.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -150.89 155.63 39.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 108.498 -0.927 . . . . 70.35 108.498 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 72.28 142.01 0.06 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.081 1.352 . . . . 75.53 110.159 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -69.98 81.33 0.48 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.509 -0.552 . . . . 71.11 109.509 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.864 0 C-N-CA 124.139 0.975 . . . . 65.53 109.741 -176.249 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.257 -0.275 . . . . 73.42 110.257 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . 0.469 HG21 ' HA ' ' A' ' 87' ' ' ALA . 7.9 p -176.92 -22.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 124.909 1.284 . . . . 71.51 109.573 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . 0.625 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 12.5 p -147.05 147.48 17.6 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 123.818 0.847 . . . . 62.0 109.951 -171.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 175.81 145.86 5.67 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.052 -0.522 . . . . 64.35 112.616 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . 0.484 ' HB3' HD11 ' A' ' 98' ' ' LEU . 9.6 tt -162.01 108.43 1.31 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 106.414 -1.698 . . . . 64.43 106.414 173.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 4.8 m -104.97 -10.41 17.26 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.603 0.761 . . . . 63.53 110.16 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -94.45 62.04 2.82 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.114 0.966 . . . . 74.12 110.244 -177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -86.84 -163.33 0.89 Allowed 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 115.33 -0.85 . . . . 61.15 110.644 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 11.3 m 69.23 52.0 0.49 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.765 1.226 . . . . 75.21 111.109 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -161.65 134.47 6.1 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.95 -1.477 . . . . 74.53 107.946 171.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -113.56 107.53 15.92 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 106.397 -1.705 . . . . 62.4 106.397 169.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -81.49 44.43 0.8 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.685 1.194 . . . . 73.44 111.912 -175.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . 0.483 ' HE2' ' SD ' ' E' ' 464' ' ' MET . 29.5 t80 -162.98 128.79 3.26 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.996 0.918 . . . . 74.04 109.205 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 1.7 t -80.45 110.42 15.9 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.255 -1.017 . . . . 74.13 108.255 171.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . 0.496 ' HG3' ' HA ' ' E' ' 467' ' ' ALA . 12.8 tpt -65.87 87.23 0.09 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 121.986 0.898 . . . . 70.12 110.812 -173.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -77.79 -43.74 29.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.046 -1.434 . . . . 64.52 110.813 -174.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . 0.657 ' HB1' ' HB3' ' A' ' 129' ' ' ALA . . . -61.52 -43.25 99.2 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.124 -0.944 . . . . 42.23 110.226 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . 0.496 ' HA ' ' HG3' ' E' ' 464' ' ' MET . . . 49.76 -103.03 0.11 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.572 1.549 . . . . 54.41 113.303 177.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . 0.599 ' HB3' HD11 ' A' ' 126' ' ' LEU . 95.3 mt -134.69 119.97 18.93 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.596 0.758 . . . . 73.54 109.439 -166.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -83.52 92.26 1.66 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 111.45 -0.66 . . . . 52.5 111.45 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 6.4 tt -138.48 -59.77 0.62 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.557 -0.905 . . . . 71.2 108.557 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . 0.485 ' HE3' HG22 ' A' ' 40' ' ' VAL . 7.8 mtmp? . . . . . 0 C--O 1.256 1.404 0 C-N-CA 123.789 0.836 . . . . 73.21 110.022 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.657 -0.127 . . . . 74.43 110.657 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.75 -29.64 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 122.983 0.513 . . . . 75.12 111.334 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . 0.571 HG12 HD11 ' B' ' 86' ' ' ILE . 34.1 m -74.91 174.66 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.207 1.003 . . . . 74.11 113.425 -173.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 176.05 -94.67 0.1 OUTLIER Glycine 0 C--N 1.35 1.344 0 CA-C-O 119.368 -0.684 . . . . 75.51 111.713 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 64.89 98.44 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 124.976 1.31 . . . . 72.03 112.029 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 23.8 m -116.24 90.73 3.4 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.363 -0.606 . . . . 64.41 109.363 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -102.07 159.31 15.49 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.823 0.849 . . . . 70.22 110.572 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -167.96 150.59 5.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.504 1.122 . . . . 74.01 108.635 176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 18.7 m 74.56 161.89 0.25 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.633 1.173 . . . . 53.42 110.385 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -56.52 137.2 53.8 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.482 0.713 . . . . 71.32 110.395 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 74.3 mt -74.65 165.75 24.7 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.057 0.543 . . . . 74.1 111.662 -175.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -52.18 138.72 25.29 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.262 -1.335 . . . . 65.2 111.272 171.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.9 -56.19 0.77 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 109.106 -0.702 . . . . 73.32 109.106 175.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 14.7 m 73.18 -40.96 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.272 1.429 . . . . 75.21 113.617 172.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . 0.418 ' SD ' ' O ' ' F' ' 464' ' ' MET . 3.0 ppp? -74.79 82.47 2.12 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 122.333 1.064 . . . . 61.45 111.366 -174.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.14 -23.05 62.0 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.8 -1.091 . . . . 74.11 109.109 171.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -78.03 83.1 4.34 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.277 -1.009 . . . . 73.44 108.277 165.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -86.81 -146.0 0.12 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.411 1.084 . . . . 71.31 110.255 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 6.3 tt -53.16 -43.42 67.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.758 0.823 . . . . 60.52 109.824 174.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 99.62 -21.11 46.7 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 115.825 -0.625 . . . . 74.43 112.74 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 61.73 -84.96 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.021 1.328 . . . . 72.44 110.715 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.16 0 N-CA-C 108.36 -0.978 . . . . 65.12 108.36 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . 0.479 ' HA ' ' HB3' ' C' ' 53' ' ' ASP . 16.2 p-10 . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 118.722 -0.656 . . . . 62.31 110.268 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . 0.657 HG21 ' HA ' ' C' ' 87' ' ' ALA . 62.2 t 26.18 75.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 126.622 1.969 . . . . 73.13 114.455 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . 0.54 HG11 ' NE2' ' C' ' 50' ' ' GLN . 17.2 m -137.15 153.45 29.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 113.871 -1.513 . . . . 73.22 109.053 176.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 169.96 -49.07 0.2 Allowed Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.918 -0.473 . . . . 51.54 111.918 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . 0.553 HD22 ' HA ' ' C' ' 95' ' ' ALA . 49.6 tp -68.94 105.61 2.44 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 122.769 0.428 . . . . 73.35 109.942 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 2.9 m -126.5 28.57 5.92 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.46 1.104 . . . . 74.22 109.52 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.81 141.71 50.8 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.934 0.894 . . . . 73.13 108.825 173.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -85.35 -36.95 20.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.001 0.921 . . . . 40.23 109.895 -177.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 32.6 m 68.19 0.04 2.31 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.87 1.268 . . . . 74.41 111.248 -171.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 55.09 -85.4 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.921 1.288 . . . . 71.13 109.273 -164.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 56.7 tp -177.31 130.64 0.16 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.535 -1.654 . . . . 71.21 106.535 165.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -87.66 29.82 0.87 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.077 0.951 . . . . 65.51 111.008 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -144.13 104.44 4.12 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.877 -0.786 . . . . 74.5 108.877 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 53.3 p -63.39 -38.27 90.51 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 124.255 0.972 . . . . 74.32 110.189 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . 0.433 ' SD ' ' HB2' ' G' ' 466' ' ' ALA . 0.3 OUTLIER 78.97 -43.14 0.32 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.59 1.956 . . . . 64.24 111.091 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 58.6 tttp 76.09 -70.26 0.15 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.964 1.706 . . . . 74.23 110.331 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . 0.433 ' HB2' ' SD ' ' G' ' 464' ' ' MET . . . 63.83 146.86 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.543 1.537 . . . . 74.2 112.704 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -159.74 89.9 0.9 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.516 -1.661 . . . . 71.32 106.516 170.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.67 147.86 47.06 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.582 -0.525 . . . . 74.41 109.582 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -80.64 61.11 4.53 Favored Glycine 0 C--N 1.346 1.086 0 O-C-N 123.536 0.523 . . . . 62.52 112.289 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . 0.442 HD11 ' HG ' ' C' ' 126' ' ' LEU . 60.2 mt -92.96 54.31 2.15 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.174 0.99 . . . . 74.14 108.776 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? . . . . . 0 C--O 1.249 1.04 0 N-CA-C 107.941 -1.133 . . . . 64.24 107.941 -169.33 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 . . . . . 0 N--CA 1.486 1.325 0 N-CA-C 108.856 -0.794 . . . . 73.54 108.856 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . 0.66 HG13 HG13 ' H' ' 452' ' ' VAL . 9.7 p -77.51 -41.76 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 122.311 0.244 . . . . 72.31 111.136 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . 0.66 HG13 HG13 ' H' ' 451' ' ' VAL . 25.1 m -94.5 -177.03 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 122.818 0.447 . . . . 70.42 111.988 -174.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 101.46 79.94 1.45 Allowed Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.661 -0.699 . . . . 72.25 112.623 169.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 1.4 pp -148.22 172.56 14.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.699 0.762 . . . . 74.3 111.845 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 19.8 p -139.51 143.21 37.35 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.376 1.87 . . . . 73.53 106.443 168.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.5 -57.98 10.42 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.176 0.591 . . . . 60.11 109.873 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 59.01 19.95 7.74 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.856 1.262 . . . . 73.52 112.653 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 15.2 t -144.92 158.1 43.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.973 0.509 . . . . 70.03 110.427 -175.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -111.66 -70.32 0.82 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.793 0.837 . . . . 72.35 109.253 -175.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' D' ' 44' ' ' LEU . 42.7 tp -161.92 146.47 12.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.39 1.076 . . . . 71.54 108.904 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -142.13 43.59 1.67 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.497 1.119 . . . . 75.22 109.29 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . 0.487 ' HB3' HD11 ' H' ' 460' ' ' LEU . 54.2 t80 -150.88 145.67 25.8 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.946 -1.024 . . . . 75.12 110.2 -175.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 90.5 m -140.9 139.48 34.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.198 0.999 . . . . 53.14 109.465 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 60.0 ttp -154.92 -46.32 0.08 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.63 0.772 . . . . 75.52 109.705 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . 0.615 ' HG2' ' H ' ' H' ' 466' ' ' ALA . 14.9 ttpt 68.98 -174.05 0.19 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.95 1.3 . . . . 71.5 108.568 -171.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . 0.615 ' H ' ' HG2' ' H' ' 465' ' ' LYS . . . 71.02 -170.77 0.16 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.819 0.848 . . . . 70.53 112.333 168.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . 0.406 ' HB3' HD12 ' H' ' 468' ' ' LEU . . . -167.15 -67.17 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.66 0.784 . . . . 74.31 109.743 177.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . 0.584 HD11 ' HA ' ' D' ' 126' ' ' LEU . 2.9 mp -88.3 -45.05 10.36 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.812 -0.631 . . . . 52.21 109.874 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 154.65 -23.46 0.64 Allowed Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.242 -0.89 . . . . 33.23 112.292 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . 0.464 HD13 ' HG3' ' D' ' 37' ' ' GLN . 3.1 mm? 63.15 63.71 0.9 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.348 1.059 . . . . 72.52 109.657 176.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp . . . . . 0 C--O 1.253 1.267 0 CA-C-N 114.9 -1.046 . . . . 65.41 109.153 -174.7 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 121.12 0.486 . . . . 73.32 109.809 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -147.88 144.96 28.46 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.879 1.271 . . . . 74.32 108.063 175.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.611 ' HG2' ' H ' ' A' ' 4' ' ' GLN . 33.6 tt0 65.88 -171.3 0.19 Allowed 'General case' 0 CA--C 1.567 1.602 0 O-C-N 124.242 0.964 . . . . 74.24 109.231 -176.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.611 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 24.3 tt0 -59.15 93.1 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.946 0.899 . . . . 61.03 110.014 170.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.02 -51.39 2.12 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.158 0.983 . . . . 64.25 108.921 -175.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -78.8 85.15 4.82 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.19 -0.67 . . . . 32.42 109.19 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.9 m -143.96 106.39 4.41 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.707 -1.22 . . . . 70.42 107.707 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -63.78 88.94 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 O-C-N 123.828 0.705 . . . . 62.43 109.859 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 mpt? 65.16 154.97 0.07 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.016 1.327 . . . . 73.3 111.824 -176.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.4 m -145.61 123.43 11.94 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.13 -1.063 . . . . 62.43 108.13 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.633 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.6 t80 -138.48 129.88 27.45 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.826 0.346 . . . . 71.4 110.472 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -153.23 108.64 3.24 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 107.811 -1.181 . . . . 75.24 107.811 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.427 HG12 ' HD2' ' A' ' 84' ' ' PHE . 52.8 mt -74.51 116.32 16.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.815 -0.439 . . . . 74.43 109.815 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -74.13 -42.11 60.52 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 124.072 0.858 . . . . 74.23 110.781 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -178.31 121.39 0.1 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.162 0.289 . . . . 70.34 110.734 -169.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 82.4 mt -106.96 129.56 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.717 0.807 . . . . 75.32 108.878 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.423 ' HB3' HG23 ' B' ' 122' ' ' THR . 34.0 p90 -163.06 148.39 11.7 Favored 'General case' 0 C--N 1.346 0.418 0 O-C-N 123.646 0.591 . . . . 74.21 111.653 -174.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.1 p -75.02 112.39 11.2 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.863 -0.608 . . . . 60.35 109.406 175.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 35.7 mtpt -80.79 -23.78 39.03 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.421 -0.354 . . . . 71.52 110.192 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.2 t70 -153.24 142.08 21.11 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.964 0.906 . . . . 75.51 110.393 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.6 mt -135.03 141.73 42.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 125.64 1.576 . . . . 72.12 107.574 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.7 t -145.72 112.42 5.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.141 0.576 . . . . 65.01 110.026 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 87.5 t80 -125.83 119.92 29.15 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.3 -1.0 . . . . 72.54 108.3 174.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -118.42 136.2 53.91 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.927 -0.768 . . . . 61.31 108.927 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.726 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -148.67 78.78 8.97 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 107.813 -1.18 . . . . 74.31 107.813 170.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.35 -29.93 5.76 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.698 2.265 . . . . 75.43 111.253 175.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -102.7 23.55 11.88 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.943 1.297 . . . . 73.55 109.909 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.726 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -58.82 -45.06 99.64 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 125.26 1.424 . . . . 75.01 112.327 176.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -64.81 -34.11 50.82 Favored 'Trans proline' 0 C--N 1.399 3.217 0 CA-C-N 120.995 1.391 . . . . 70.42 112.713 172.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.422 ' HA ' ' OE1' ' A' ' 33' ' ' GLN . 30.4 m170 -68.76 -16.23 63.74 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.527 0.731 . . . . 75.2 112.616 -171.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 28' ' ' ALA . 9.3 p -72.73 -19.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 122.438 0.295 . . . . 73.22 110.665 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -78.5 -29.03 46.41 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 108.412 -0.959 . . . . 53.12 108.412 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.422 ' OE1' ' HA ' ' A' ' 30' ' ' HIS . 1.0 OUTLIER -80.95 -54.78 5.27 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.931 -1.031 . . . . 63.31 110.737 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 30' ' ' HIS . 54.5 mtmt -84.78 171.43 12.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.093 0.957 . . . . 62.24 112.577 -173.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.29 153.2 21.08 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.848 0.859 . . . . 64.44 109.819 172.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.642 ' HE1' ' HB3' ' E' ' 470' ' ' LEU . 66.3 t-105 -85.2 94.05 8.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.42 0.688 . . . . 62.24 110.756 -173.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -127.37 83.56 65.71 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.175 0.99 . . . . 74.21 108.868 172.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -86.54 149.75 8.84 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.61 2.207 . . . . 73.23 112.72 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -99.09 91.66 5.11 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.613 -1.254 . . . . 54.4 107.613 168.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -66.34 99.06 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 CA-C-O 121.701 0.762 . . . . 65.1 110.388 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -108.16 113.35 26.42 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.531 -0.914 . . . . 54.25 108.531 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.0 tp -107.06 145.23 32.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.54 0.736 . . . . 63.44 109.059 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -139.42 133.21 30.69 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.498 1.119 . . . . 54.53 108.484 174.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -119.48 123.15 43.32 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 109.059 -0.719 . . . . 73.13 109.059 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 24.3 m-20 -119.81 121.7 39.71 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.764 -0.828 . . . . 60.44 108.764 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.59 ' HB ' HD21 ' E' ' 460' ' ' LEU . 31.4 m -106.95 122.87 47.28 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.767 -0.827 . . . . 74.43 108.767 175.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.68 151.33 49.15 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.945 0.898 . . . . 41.24 108.66 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.5 m -132.8 155.87 48.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.178 -0.675 . . . . 75.23 109.178 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -148.03 128.96 14.41 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.78 0.432 . . . . 74.3 110.378 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -73.7 107.7 6.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.91 0.884 . . . . 72.42 109.839 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.1 mt -78.37 -41.26 33.88 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.751 -0.659 . . . . 70.12 109.512 175.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.65 -179.18 7.86 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.647 1.179 . . . . 53.23 108.752 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -61.98 113.26 2.71 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.672 0.389 . . . . 70.3 110.243 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 68.39 12.23 8.65 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.89 1.276 . . . . 64.12 112.28 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.48 110.7 33.16 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 N-CA-C 107.485 -1.302 . . . . 72.22 107.485 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -126.24 152.88 45.51 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.812 -0.81 . . . . 75.01 108.812 -174.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -117.84 153.58 33.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.658 -0.867 . . . . 73.42 108.658 167.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.5 t -117.98 125.24 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.24 -1.392 . . . . 75.05 107.24 167.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.86 107.61 22.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 124.099 0.96 . . . . 61.23 108.681 174.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.7 tp -99.78 101.85 13.13 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.871 -0.788 . . . . 74.03 108.871 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 14.4 ttm180 -84.42 102.75 13.01 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.187 -0.672 . . . . 64.32 109.187 175.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.8 t -95.32 102.33 13.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 108.279 -1.008 . . . . 74.15 108.279 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.4 m -98.25 119.46 36.95 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.047 0.939 . . . . 72.03 110.322 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.535 ' O ' HD12 ' A' ' 75' ' ' LEU . 97.9 t -115.51 123.84 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.926 0.89 . . . . 62.12 108.874 175.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 t -132.2 126.63 34.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.516 -0.92 . . . . 52.12 108.516 169.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -124.13 107.13 10.93 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.633 -0.877 . . . . 71.05 108.633 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.6 p -113.85 143.02 45.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.653 0.781 . . . . 40.12 111.021 -175.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 68' ' ' LEU . 1.3 pt? -110.61 85.87 2.2 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.103 -1.073 . . . . 62.32 108.103 171.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.89 -125.57 8.03 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 114.66 -1.155 . . . . 71.54 110.932 -173.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -87.72 -26.87 22.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.593 0.697 . . . . 63.02 109.621 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -76.23 118.97 19.5 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 123.006 0.522 . . . . 53.23 110.779 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.7 m -77.19 132.42 38.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.192 -0.67 . . . . 63.24 109.192 171.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.03 -57.08 3.99 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.616 -0.883 . . . . 61.03 108.616 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.406 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 47.8 p90 -149.39 152.59 36.02 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.88 -1.055 . . . . 73.41 111.223 175.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.535 HD12 ' O ' ' A' ' 64' ' ' VAL . 40.9 tp -114.3 135.19 54.35 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.147 -1.427 . . . . 63.51 107.147 166.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.406 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 76.1 m -135.96 98.1 3.8 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.481 -0.933 . . . . 72.23 108.481 170.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -125.11 116.04 21.43 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.717 1.207 . . . . 75.43 108.379 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.4 t -128.73 115.69 38.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.765 0.826 . . . . 61.02 109.466 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 72.0 mt-30 -85.51 84.98 7.46 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 107.973 -1.121 . . . . 75.13 107.973 170.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.456 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.4 tp-100 -76.47 99.58 4.96 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.715 -1.13 . . . . 71.32 108.186 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.86 155.79 29.37 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 110.683 -0.967 . . . . 73.22 110.683 176.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.34 120.63 0.98 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.351 -1.1 . . . . 35.41 110.351 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.9 mt -81.5 122.22 36.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 108.109 -1.071 . . . . 71.04 108.109 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.633 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 43.8 m-85 -123.46 118.15 26.78 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.834 -1.173 . . . . 74.22 107.834 -176.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.0 t -84.69 104.0 14.28 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.52 -1.289 . . . . 64.23 107.52 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.85 139.97 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 116.118 -0.492 . . . . 63.41 110.874 -170.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.736 ' HA ' HG21 ' E' ' 451' ' ' VAL . . . -156.82 176.05 13.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.357 1.063 . . . . 52.13 110.239 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.02 -7.11 62.41 Favored Glycine 0 N--CA 1.475 1.235 0 N-CA-C 114.961 0.744 . . . . 71.23 114.961 172.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.574 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -138.75 158.21 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 117.885 0.843 . . . . 73.42 110.859 -177.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.37 174.48 14.8 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.965 0.506 . . . . 75.25 109.989 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.34 -127.52 26.72 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 114.528 0.571 . . . . 72.04 114.528 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.565 HG23 ' HB2' ' C' ' 153' ' ' GLN . 16.5 p -68.78 -20.89 64.36 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.196 0.598 . . . . 72.03 111.234 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -75.9 -42.99 47.41 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.659 0.784 . . . . 71.35 109.893 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' E' ' 452' ' ' VAL . 25.6 ptt? -72.97 -27.94 62.11 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 110.038 -0.356 . . . . 72.53 110.038 175.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.12 -27.71 65.81 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 115.803 -0.635 . . . . 72.02 110.269 173.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -78.31 -30.14 48.12 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.218 0.607 . . . . 74.03 111.125 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.574 ' SG ' HG13 ' A' ' 89' ' ' ILE . 70.9 m -61.86 -46.59 88.8 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.875 -0.602 . . . . 62.52 111.09 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -81.26 -24.57 37.23 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.096 -0.502 . . . . 73.0 110.605 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.24 -33.21 49.84 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 114.772 0.669 . . . . 75.35 114.772 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.53 -45.75 0.17 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.379 0.589 . . . . 71.03 112.091 -169.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 55.1 t80 -62.54 -64.47 0.91 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.512 1.125 . . . . 72.45 112.035 -168.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 92.7 m -78.6 -33.61 0.93 Allowed Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.428 1.27 . . . . 73.53 114.428 -174.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 35.4 Cg_endo -64.18 -30.77 64.91 Favored 'Trans proline' 0 C--N 1.394 2.959 0 CA-C-N 122.23 1.832 . . . . 73.11 112.841 171.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -69.29 -26.57 64.81 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.677 0.391 . . . . 71.42 110.882 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.61 -40.9 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 64.12 110.125 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.456 HD22 ' HG3' ' A' ' 80' ' ' GLN . 79.7 mt -80.6 -21.82 41.22 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.067 0.947 . . . . 71.15 112.613 -174.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -63.57 -44.27 80.58 Favored Pre-proline 0 CA--C 1.567 1.605 0 CA-C-O 117.64 -1.171 . . . . 74.54 113.229 -172.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.4 -34.48 76.55 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.112 1.874 . . . . 62.22 113.474 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -72.97 -41.25 64.58 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.211 0.605 . . . . 74.44 111.329 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.45 -38.2 74.47 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.994 0.518 . . . . 71.35 110.182 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.559 ' HA ' HD23 ' A' ' 128' ' ' LEU . 29.7 ttm180 -54.44 -51.15 65.86 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.203 1.001 . . . . 72.43 109.888 174.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.63 -48.39 77.49 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.485 1.116 . . . . 75.25 111.361 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.413 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.1 t -55.91 -44.58 78.41 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.047 0.842 . . . . 34.45 110.538 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 118' ' ' VAL . 74.5 mt -65.22 -50.5 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.526 1.13 . . . . 71.24 110.747 176.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.492 HG23 ' HG3' ' A' ' 125' ' ' GLN . 95.0 m -53.17 -46.07 68.77 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.835 0.854 . . . . 75.22 110.322 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -65.13 -46.23 81.84 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.922 -1.49 . . . . 65.1 109.527 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 37.5 mtp -59.43 -41.18 88.96 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.696 0.798 . . . . 64.54 111.865 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 114' ' ' ILE . 93.4 t -62.94 -45.61 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.912 0.885 . . . . 50.45 110.236 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.3 m -72.58 -27.45 62.19 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.447 -0.797 . . . . 32.31 111.831 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.605 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.9 mtt-85 -75.12 -31.72 61.18 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.492 0.717 . . . . 73.12 109.723 175.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.13 -0.7 86.62 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.58 -0.736 . . . . 64.11 112.878 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m 69.53 20.12 7.24 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.763 1.225 . . . . 54.34 111.047 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -89.67 146.87 36.44 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 123.45 0.7 . . . . 75.11 109.657 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.64 133.09 31.98 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.52 2.813 . . . . 71.24 113.517 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.492 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.6 tt0 -54.93 137.44 45.71 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.238 1.015 . . . . 63.22 113.24 -170.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.439 ' CD2' HG11 ' A' ' 64' ' ' VAL . 27.7 tp -119.82 102.4 8.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.859 1.264 . . . . 64.13 109.349 177.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -99.34 114.65 27.64 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.213 -1.403 . . . . 64.04 107.213 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 111' ' ' ARG . 3.7 mm? -62.53 132.9 54.0 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.099 0.559 . . . . 64.11 110.476 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.8 146.01 91.47 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.213 0.605 . . . . 62.54 110.776 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.562 ' HG3' ' HD2' ' C' ' 11' ' ' PHE . 34.2 Cg_endo -60.74 112.16 1.26 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.382 2.054 . . . . 64.13 111.323 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 80.6 t -99.92 113.91 36.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 108.473 -0.936 . . . . 50.31 108.473 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -78.79 85.95 4.75 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 108.767 -0.827 . . . . 74.42 108.767 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -64.02 -27.82 69.38 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.649 -0.705 . . . . 74.01 111.144 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.07 -48.45 76.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.801 0.84 . . . . 62.43 110.224 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.43 -57.01 12.8 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.003 -0.999 . . . . 65.33 110.463 175.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.2 mt -58.05 -36.73 73.19 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.562 1.145 . . . . 74.13 112.812 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.579 ' CE1' HD22 ' A' ' 141' ' ' LEU . 42.6 t80 -61.62 -50.81 71.08 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.772 0.67 . . . . 61.3 110.381 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 95.2 mmm -68.33 -26.39 65.58 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.909 -0.587 . . . . 62.2 110.612 -174.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.61 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 55.3 m-80 -63.07 -42.7 99.71 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.288 0.635 . . . . 62.34 110.659 170.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.626 ' HB2' ' HB3' ' E' ' 461' ' ' PHE . 0.1 OUTLIER -61.32 -46.23 91.13 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.147 0.979 . . . . 75.44 110.524 174.194 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 137' ' ' PHE . 19.9 tp -70.21 -50.25 41.88 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.37 -1.286 . . . . 75.34 112.926 -165.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.23 9.94 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.383 0.427 . . . . 63.11 110.162 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.61 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 75.5 mt-30 58.85 -171.83 0.11 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.312 1.045 . . . . 74.23 112.432 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.8 -174.03 4.66 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.594 1.158 . . . . 70.42 108.883 171.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.37 -59.95 0.09 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.321 0.648 . . . . 71.32 109.559 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.26 125.63 0.79 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 111.341 -0.703 . . . . 73.32 111.341 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -113.58 -29.44 7.16 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.081 0.953 . . . . 73.34 110.784 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.25 -104.14 3.12 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-O 119.058 -0.857 . . . . 41.0 112.012 -176.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.5 m 70.18 128.88 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.068 1.347 . . . . 64.13 109.735 -169.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -58.52 5.98 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 109.345 -0.613 . . . . 73.54 109.345 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.14 110.71 21.99 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.467 -0.938 . . . . 65.41 108.467 -177.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -164.92 172.11 13.23 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.482 1.113 . . . . 73.34 109.309 -176.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -81.28 -42.43 20.65 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.066 0.546 . . . . 71.13 110.666 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -73.93 170.88 14.49 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.937 0.895 . . . . 60.12 111.387 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.059 0 C-N-CA 123.581 0.752 . . . . 51.45 111.47 -173.477 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 95.0 mmm . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.267 -0.272 . . . . 70.21 110.267 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 44.3 p -75.5 78.68 2.53 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.54 -0.911 . . . . 60.13 108.54 170.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -166.34 140.78 4.33 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.692 -1.14 . . . . 75.41 109.465 -166.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -146.92 163.73 35.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.686 0.794 . . . . 63.4 109.094 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -115.31 171.85 7.44 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.348 0.659 . . . . 74.15 110.482 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -129.25 136.17 49.74 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.158 -1.053 . . . . 63.33 108.158 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -154.7 170.72 20.9 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.231 0.612 . . . . 73.5 110.294 -172.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.45 137.32 54.38 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.948 -0.76 . . . . 73.2 108.948 167.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.68 ' HE3' HD12 ' B' ' 89' ' ' ILE . 21.3 ptm 48.86 -174.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 126.823 2.049 . . . . 70.52 114.364 -177.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 66.2 m -136.81 114.33 11.01 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.932 -0.766 . . . . 74.24 108.932 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -136.11 137.35 40.94 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.712 -0.847 . . . . 64.34 108.712 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -148.5 140.8 24.16 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.562 0.745 . . . . 72.44 109.258 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.5 mt -90.32 113.55 26.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.434 -1.321 . . . . 73.24 107.434 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -76.22 -43.57 41.63 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.446 -0.576 . . . . 64.23 109.446 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -164.78 139.63 5.36 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.719 -0.673 . . . . 73.42 110.071 -175.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 88.2 mt -115.7 144.12 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 106.212 -1.773 . . . . 70.34 106.212 168.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.522 ' HE1' HG13 ' B' ' 83' ' ' ILE . 32.5 p90 -170.08 149.36 3.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.449 0.642 . . . . 75.11 111.648 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -77.81 125.71 29.76 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.872 -1.058 . . . . 64.52 109.347 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.451 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.3 mtpt -99.4 -21.51 15.96 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.872 0.869 . . . . 72.52 111.57 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -160.78 133.41 6.25 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.495 0.318 . . . . 64.0 110.441 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 40.8 mm -126.33 137.91 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.273 -1.01 . . . . 73.3 108.273 168.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 37.2 t -139.48 134.21 31.98 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.746 -1.205 . . . . 72.11 107.746 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -150.32 109.48 3.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.895 -1.15 . . . . 63.14 107.895 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -119.71 115.0 23.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.278 1.031 . . . . 74.02 108.895 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.45 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -109.39 86.64 4.44 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 108.486 -0.931 . . . . 60.15 108.486 172.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.41 -32.45 8.02 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.742 2.295 . . . . 73.15 113.011 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -104.2 14.68 29.93 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.713 0.805 . . . . 50.34 110.403 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.49 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -38.39 -60.79 0.97 Allowed Pre-proline 0 CA--C 1.562 1.437 0 N-CA-C 114.758 1.392 . . . . 62.23 114.758 -165.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 20.4 Cg_exo -63.24 -35.28 64.2 Favored 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 122.101 1.867 . . . . 74.15 112.504 -175.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -78.84 -47.01 17.43 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.168 -0.923 . . . . 71.21 111.593 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.673 HG22 HD12 ' B' ' 68' ' ' LEU . 9.1 p -62.4 -22.4 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.583 0.753 . . . . 72.44 112.332 -167.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -63.34 -13.95 44.64 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.988 0.915 . . . . 73.12 112.993 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.542 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 25.6 pt20 -60.36 -33.14 72.01 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.422 1.089 . . . . 72.42 111.585 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.542 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.3 mttt -96.18 86.18 4.18 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.585 0.754 . . . . 74.0 108.993 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -74.22 97.36 2.95 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 115.806 -0.634 . . . . 71.12 110.902 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -163.43 157.3 19.69 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.32 1.448 . . . . 74.25 108.179 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.489 HE21 ' HA ' ' F' ' 470' ' ' LEU . 14.4 mt-30 -72.85 108.74 4.85 Favored Pre-proline 0 C--N 1.356 0.861 0 N-CA-C 107.827 -1.175 . . . . 74.04 107.827 169.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.412 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.0 Cg_endo -60.18 147.06 94.85 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.796 2.331 . . . . 64.44 113.702 -167.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 11.3 tp10 -53.31 109.33 0.42 Allowed 'General case' 0 N--CA 1.484 1.246 0 O-C-N 124.349 1.031 . . . . 75.14 110.42 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.569 HG12 HD21 ' F' ' 470' ' ' LEU . 14.9 p -88.87 131.03 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 O-C-N 123.7 0.625 . . . . 73.12 110.625 -172.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -121.23 121.75 38.45 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.597 -1.26 . . . . 63.41 107.597 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -106.05 124.88 50.28 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.763 -0.828 . . . . 73.52 108.763 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.515 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.5 m-20 -122.16 111.33 16.84 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 106.398 -1.705 . . . . 64.02 106.398 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 87.3 mt -101.38 127.21 48.13 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.157 -1.053 . . . . 75.34 108.157 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -140.02 136.5 33.77 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.384 -1.339 . . . . 53.24 107.384 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.5 p -128.96 115.85 18.46 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.827 -0.434 . . . . 54.25 109.827 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.7 134.82 54.65 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.443 -1.317 . . . . 72.22 107.443 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.0 m -138.89 162.88 33.74 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.316 0.507 . . . . 62.3 111.312 -172.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.0 p -157.8 143.3 17.06 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.744 0.818 . . . . 75.1 110.888 -172.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -83.4 135.21 34.78 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.711 0.804 . . . . 75.03 109.77 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 mt -99.26 -40.88 7.72 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.205 0.526 . . . . 75.34 109.891 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.85 -178.45 7.32 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.906 -1.043 . . . . 73.35 109.997 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -71.63 122.28 20.28 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 115.468 -0.787 . . . . 74.32 109.289 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 74.0 -4.76 2.19 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 125.765 1.626 . . . . 75.3 112.04 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.3 110.16 30.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.51 -0.922 . . . . 51.04 108.51 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -125.25 140.22 53.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.617 -0.883 . . . . 72.5 108.617 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -122.78 115.05 21.37 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.243 -1.021 . . . . 71.33 108.243 -171.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 83.5 t -99.37 141.98 15.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 123.815 0.846 . . . . 70.33 109.617 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.15 119.34 58.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 109.046 -0.724 . . . . 64.51 109.046 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.94 129.42 40.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.013 -1.476 . . . . 74.11 107.013 175.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -121.75 109.9 15.27 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.818 0.847 . . . . 64.14 109.04 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 56.0 t -104.76 102.81 14.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.257 -1.386 . . . . 74.34 107.257 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 24.4 m -97.86 126.06 43.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.886 -0.783 . . . . 74.31 108.886 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.604 HG21 HG21 ' B' ' 114' ' ' ILE . 70.2 t -116.31 121.9 68.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 124.792 1.237 . . . . 63.44 108.27 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 62.9 m -113.29 137.1 52.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.815 -0.809 . . . . 72.45 108.815 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -144.03 146.15 32.68 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 122.628 0.371 . . . . 71.21 110.602 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.52 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 76.0 p -150.32 140.63 22.28 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.656 0.598 . . . . 64.34 111.306 -174.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.673 HD12 HG22 ' B' ' 31' ' ' VAL . 76.5 mt -102.51 109.66 21.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.198 -1.038 . . . . 64.01 108.198 170.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.75 -131.61 37.22 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 116.001 -0.545 . . . . 74.15 112.389 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -95.92 14.7 22.65 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.477 0.547 . . . . 72.02 112.477 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.508 ' HG3' HG23 ' B' ' 31' ' ' VAL . 12.6 pt-20 -126.7 141.0 51.98 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.961 0.505 . . . . 73.45 109.915 178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 48.2 m -70.51 127.51 32.95 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 123.289 0.635 . . . . 71.3 111.233 -175.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.562 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -80.28 -67.36 0.77 Allowed 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.454 -0.943 . . . . 61.42 108.454 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.496 ' HZ ' HD13 ' B' ' 126' ' ' LEU . 51.5 p90 -150.25 155.37 39.58 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-O 121.619 0.723 . . . . 72.51 111.869 178.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 33.7 mt -122.86 109.52 14.27 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.124 -1.806 . . . . 64.44 106.124 172.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' B' ' 114' ' ' ILE . 37.6 t -120.75 115.39 23.22 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.449 -0.574 . . . . 72.23 109.449 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -121.36 123.84 43.09 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.645 -1.242 . . . . 64.11 107.645 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.51 143.42 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.667 -0.864 . . . . 54.02 108.667 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -124.66 100.65 6.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.312 -0.858 . . . . 53.0 108.813 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.454 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.7 tp-100 -90.25 105.81 18.06 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.224 -0.658 . . . . 72.43 109.224 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.451 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.13 164.74 26.17 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 111.799 -0.521 . . . . 63.43 111.799 175.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.67 128.3 1.92 Allowed Glycine 0 CA--C 1.52 0.365 0 CA-C-O 120.024 -0.32 . . . . 72.44 112.497 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.522 HG13 ' HE1' ' B' ' 17' ' ' TYR . 48.5 mt -84.37 123.83 39.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.966 -0.753 . . . . 71.05 108.966 172.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -133.12 136.55 45.88 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.015 . . . . 65.24 108.795 -175.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.9 m -103.51 108.57 19.89 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.346 0.659 . . . . 72.42 110.047 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.623 HD13 HD21 ' B' ' 98' ' ' LEU . 41.0 pt -100.11 132.03 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.251 1.02 . . . . 74.13 109.912 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.47 144.12 20.45 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 122.721 0.409 . . . . 55.31 110.057 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.75 -55.06 1.66 Allowed Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.808 -0.633 . . . . 74.31 112.164 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.68 HD12 ' HE3' ' B' ' 9' ' ' MET . 0.2 OUTLIER -72.57 155.06 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 75.45 111.255 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.27 167.37 28.85 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.127 -0.942 . . . . 73.11 109.502 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.07 -121.74 27.13 Favored Glycine 0 C--N 1.346 1.09 0 O-C-N 124.103 0.877 . . . . 70.33 114.589 172.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . 0.419 HG23 HD13 ' B' ' 141' ' ' LEU . 89.8 m -71.89 -35.05 69.63 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.399 1.079 . . . . 70.35 111.784 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -70.51 -31.88 69.14 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 120.986 0.422 . . . . 54.34 110.373 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' F' ' 452' ' ' VAL . 49.3 ttp -74.08 -34.22 63.91 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.637 -0.71 . . . . 63.4 110.382 173.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.428 ' HA ' HD11 ' F' ' 454' ' ' LEU . . . -60.03 -41.93 93.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.198 0.599 . . . . 52.32 110.25 174.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -64.17 -25.36 68.05 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.578 1.151 . . . . 71.34 111.39 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -78.83 -59.2 2.88 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.993 0.517 . . . . 44.35 110.282 174.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.623 HD21 HD13 ' B' ' 86' ' ' ILE . 66.3 mt -72.63 -40.53 66.35 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.856 0.688 . . . . 72.52 112.856 -167.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.32 3.97 61.98 Favored Glycine 0 N--CA 1.469 0.859 0 CA-C-O 119.728 -0.484 . . . . 64.4 114.073 -173.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.608 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -143.37 -69.65 0.33 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.33 0.565 . . . . 62.21 111.386 -175.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.34 -43.49 96.42 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.702 1.201 . . . . 62.33 112.049 -172.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.423 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 94.4 m -66.39 -50.43 48.28 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 124.206 1.003 . . . . 74.31 111.562 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 78.1 Cg_exo -55.18 -35.17 90.27 Favored 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.187 1.925 . . . . 71.43 113.995 169.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.403 HD21 ' N ' ' B' ' 134' ' ' ASP . 63.4 m-80 -63.27 -33.59 75.84 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 118.159 0.436 . . . . 74.44 111.825 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 77.4 mt -66.06 -40.94 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.362 0.665 . . . . 74.05 110.408 175.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.7 mt -82.61 -20.82 35.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.192 0.997 . . . . 72.02 112.851 -172.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.2 -47.98 97.24 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-O 117.864 -1.065 . . . . 75.04 113.822 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.36 -32.78 89.7 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 121.993 1.796 . . . . 73.4 113.166 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.454 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 91.7 m-85 -70.37 -48.96 53.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.842 0.457 . . . . 72.21 110.133 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.62 -43.35 72.15 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.95 0.9 . . . . 71.11 110.251 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.545 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 35.9 ttt-85 -59.97 -55.03 39.1 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.322 1.449 . . . . 73.32 111.824 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.56 -33.81 76.78 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.766 0.827 . . . . 72.31 110.065 -175.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.605 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.1 t -72.16 -43.3 64.83 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.8 -0.636 . . . . 75.12 111.355 -176.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.604 HG21 HG21 ' B' ' 64' ' ' VAL . 99.1 mt -60.0 -53.59 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 109.819 -0.437 . . . . 72.1 109.819 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 86.8 m -59.32 -32.82 70.42 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 124.084 0.865 . . . . 74.12 111.41 -176.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.3 t -61.98 -47.42 84.89 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.297 0.639 . . . . 50.11 109.674 174.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.8 mmt -69.24 -34.42 74.77 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.17 0.588 . . . . 74.23 111.368 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 114' ' ' ILE . 92.4 t -60.83 -43.15 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.148 0.979 . . . . 71.03 109.924 174.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.0 t -68.22 -33.77 75.02 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.634 -1.166 . . . . 72.42 111.471 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.1 mtt-85 -66.95 -35.93 81.09 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.518 0.727 . . . . 71.41 110.152 177.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.09 9.51 60.44 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-O 119.483 -0.62 . . . . 61.24 113.361 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 17' ' ' TYR . 70.4 p 57.06 22.14 7.07 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 126.158 1.783 . . . . 74.01 113.72 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -78.79 149.26 73.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.796 -0.446 . . . . 61.14 109.796 175.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.462 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 28.7 Cg_endo -59.57 171.57 2.56 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.306 2.67 . . . . 63.12 113.672 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.429 ' NE2' HD21 ' B' ' 127' ' ' ASN . 51.9 tp60 -62.91 114.77 3.85 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.038 -0.983 . . . . 63.43 111.88 -167.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.496 HD13 ' HZ ' ' B' ' 74' ' ' PHE . 8.6 tt -135.78 106.64 6.62 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.961 -0.755 . . . . 61.02 108.961 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.429 HD21 ' NE2' ' B' ' 125' ' ' GLN . 12.9 m120 -114.26 135.14 54.39 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.847 0.859 . . . . 75.12 109.843 -178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.545 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.5 mm? -72.24 124.73 25.66 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.198 -0.667 . . . . 74.35 109.198 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.611 ' HB3' ' SD ' ' F' ' 464' ' ' MET . . . -73.72 152.25 89.21 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.296 0.639 . . . . 73.42 110.962 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.17 110.1 1.28 Allowed 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 122.402 2.068 . . . . 61.33 112.947 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 31.2 t -100.71 111.0 29.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.106 -1.072 . . . . 72.24 108.106 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.409 ' O ' HD13 ' B' ' 136' ' ' LEU . 43.6 t-20 -85.05 90.29 7.81 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.459 -0.941 . . . . 63.12 108.459 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -57.04 -31.53 65.27 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.45 0.7 . . . . 74.31 111.321 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.608 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 11.7 t70 -73.11 -44.92 59.68 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.259 1.024 . . . . 72.31 111.054 -173.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.53 -39.0 93.27 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.075 0.95 . . . . 44.13 111.48 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' F' ' 461' ' ' PHE . 8.5 mp -75.1 -33.54 61.63 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.105 -0.952 . . . . 62.23 110.866 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.451 ' CZ ' HD21 ' B' ' 141' ' ' LEU . 69.3 t80 -64.82 -30.02 71.0 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.05 0.94 . . . . 53.25 111.645 -177.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 56.7 mtt -56.35 -36.43 68.76 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.693 0.797 . . . . 64.41 111.229 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -88.79 -19.04 26.51 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.218 1.007 . . . . 62.04 110.876 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -73.03 -19.79 61.13 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.609 0.764 . . . . 74.44 111.195 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.451 HD21 ' CZ ' ' B' ' 137' ' ' PHE . 40.0 mt -92.85 -8.3 43.84 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.886 0.699 . . . . 75.14 112.886 -172.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.413 HE22 ' HG3' ' B' ' 144' ' ' GLN . 0.0 OUTLIER -167.54 130.15 1.64 Allowed 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.445 -0.946 . . . . 71.31 108.445 -179.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -57.38 -40.05 77.36 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.195 0.998 . . . . 64.14 112.64 -172.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.413 ' HG3' HE22 ' B' ' 142' ' ' GLN . 25.5 pt20 -116.01 86.79 2.55 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.753 0.787 . . . . 74.54 110.19 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.62 139.94 47.7 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.836 -0.62 . . . . 64.32 110.196 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.46 160.6 54.09 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 114.993 0.757 . . . . 34.25 114.993 -170.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -73.93 171.82 12.74 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.607 1.163 . . . . 71.24 112.318 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.15 110.19 1.06 Allowed Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.289 -0.869 . . . . 72.31 111.179 177.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 71.4 p -110.29 127.53 55.06 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.814 0.846 . . . . 64.04 109.776 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -160.52 160.11 31.52 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.988 0.915 . . . . 63.42 109.004 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.31 111.88 1.93 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.956 0.502 . . . . 74.11 110.775 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . 0.571 ' HA ' ' HG2' ' D' ' 90' ' ' GLU . 28.8 p80 -142.96 114.01 7.71 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.022 -0.536 . . . . 63.41 110.698 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -160.49 76.76 0.6 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.425 1.49 . . . . 74.22 107.661 168.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -93.01 -179.76 5.2 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.241 -0.891 . . . . 71.11 109.291 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 C-N-CA 123.75 0.82 . . . . 37.62 109.191 -179.159 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 46.7 ttm . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.768 -0.456 . . . . 73.31 109.768 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 48.5 t -74.86 104.48 5.49 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.336 0.654 . . . . 74.04 110.529 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.0 100.18 0.3 Allowed 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.798 -0.637 . . . . 45.14 110.09 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -67.13 82.06 0.13 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.856 0.862 . . . . 64.04 109.048 172.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -91.21 151.5 20.91 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.337 -0.847 . . . . 64.2 109.618 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -66.45 149.06 50.98 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.285 0.634 . . . . 60.11 110.327 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 14.4 m -50.66 130.78 25.01 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.654 1.181 . . . . 64.43 110.94 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -55.86 97.03 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.845 0.858 . . . . 72.22 110.441 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 52.1 ttm 64.94 149.49 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 125.384 1.473 . . . . 73.14 112.281 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 51.6 m -127.11 89.93 3.06 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.062 -1.088 . . . . 62.23 108.062 171.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.562 ' HD2' ' HG3' ' A' ' 130' ' ' PRO . 64.4 t80 -107.81 122.95 47.81 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.354 -0.98 . . . . 72.21 108.354 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -139.1 117.85 12.3 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.382 0.673 . . . . 74.33 109.644 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.2 mt -73.22 127.11 34.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 108.856 -0.794 . . . . 53.1 108.856 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.599 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.3 mm-40 -94.0 -46.22 7.24 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.466 -0.568 . . . . 72.03 109.466 173.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -170.97 141.32 1.69 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.602 -0.726 . . . . 75.34 109.418 -167.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.0 mt -136.13 130.25 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.295 -1.372 . . . . 72.14 107.295 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -166.34 157.81 13.34 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.154 0.502 . . . . 73.12 110.611 -164.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.8 p -88.56 117.29 27.41 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.45 -0.796 . . . . 74.3 109.047 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -86.88 -37.6 17.54 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.144 0.497 . . . . 71.24 109.893 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -138.35 127.72 24.59 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.13 -0.941 . . . . 75.44 109.137 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.5 mt -129.8 139.5 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.398 -1.334 . . . . 72.13 107.398 175.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -147.71 145.38 28.85 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.529 0.731 . . . . 74.01 109.678 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -143.12 134.44 26.05 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.469 -1.308 . . . . 74.02 107.469 168.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.4 mt-10 -129.11 126.98 40.53 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 124.326 1.05 . . . . 73.15 108.421 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.76 81.04 23.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 106.664 -1.606 . . . . 70.44 106.664 169.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -64.29 -31.58 62.96 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.966 2.444 . . . . 75.25 112.233 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -105.7 19.28 20.81 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.232 -0.895 . . . . 63.4 111.215 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.419 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -41.28 -62.15 1.14 Allowed Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 117.598 -1.191 . . . . 74.32 114.199 -167.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.0 -44.1 26.52 Favored 'Trans proline' 0 C--N 1.391 2.788 0 CA-C-N 121.977 1.742 . . . . 71.34 111.628 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -68.81 -31.71 70.91 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.016 0.926 . . . . 61.14 112.514 -174.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.709 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.5 p -80.5 -16.59 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 C-N-CA 122.731 0.413 . . . . 73.11 111.322 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -75.39 -22.55 57.39 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.563 0.345 . . . . 75.43 111.683 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -95.74 4.49 52.9 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.452 0.301 . . . . 62.31 111.113 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -91.5 151.64 20.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.444 0.697 . . . . 74.44 110.337 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -56.87 124.33 18.19 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 124.092 0.87 . . . . 51.02 110.303 175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.9 t90 -84.58 93.39 8.35 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.784 -0.644 . . . . 62.43 110.273 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -145.24 76.98 13.12 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.182 -1.044 . . . . 50.24 108.182 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.8 128.88 6.09 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.687 2.258 . . . . 75.14 112.867 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -85.28 109.43 18.35 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.072 -1.455 . . . . 71.34 107.072 161.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 m -96.48 113.27 30.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.045 0.938 . . . . 75.13 110.571 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -119.65 112.41 19.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.892 1.277 . . . . 73.53 108.186 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.06 168.62 12.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.424 0.69 . . . . 63.13 111.632 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 29.5 t70 -145.5 105.52 4.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.19 0.596 . . . . 72.14 109.976 173.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.42 130.36 55.5 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.576 1.15 . . . . 73.13 109.38 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -156.49 153.88 29.48 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.461 0.705 . . . . 74.33 109.946 171.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -129.81 152.46 49.27 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.947 0.899 . . . . 70.41 110.239 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.7 167.43 22.57 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.257 1.023 . . . . 71.22 108.84 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.468 ' HB3' HG22 ' C' ' 58' ' ' VAL . 93.1 p -148.15 152.75 37.81 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.046 0.538 . . . . 65.51 109.912 174.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 27.4 p -143.87 135.05 25.67 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.493 0.717 . . . . 62.53 109.545 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -64.91 116.25 6.18 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.941 0.775 . . . . 71.22 109.59 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.634 HD11 HD12 ' C' ' 83' ' ' ILE . 94.5 mt -84.38 -39.72 18.71 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.349 0.595 . . . . 74.42 109.44 174.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.18 -174.84 5.02 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.291 -1.322 . . . . 72.15 109.663 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.84 113.75 2.67 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.986 -1.006 . . . . 71.45 109.954 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.4 ' HA ' HG13 ' G' ' 452' ' ' VAL . 4.3 m-20 69.97 4.43 4.79 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.94 1.296 . . . . 75.24 112.975 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -105.86 123.0 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.04 0.936 . . . . 65.11 109.444 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -111.91 161.43 16.41 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.694 0.759 . . . . 70.45 110.37 172.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.547 ' HB2' HD11 ' C' ' 51' ' ' LEU . 32.9 tt0 -123.67 111.82 16.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.949 -1.5 . . . . 65.13 106.949 166.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' C' ' 48' ' ' SER . 74.0 t -94.07 121.29 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.026 -1.102 . . . . 72.13 108.026 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.33 133.51 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.502 -0.925 . . . . 72.54 108.502 173.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -119.45 109.06 15.3 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.247 -1.02 . . . . 75.33 108.247 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -99.77 112.97 25.17 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.685 0.794 . . . . 73.3 109.784 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.3 t -106.4 130.93 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.259 1.024 . . . . 70.32 108.357 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 4.9 m -125.31 146.42 49.57 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.725 -0.843 . . . . 71.11 108.725 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 62.6 t -136.35 109.46 8.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 124.506 1.122 . . . . 75.31 108.644 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 22.1 m -99.25 140.83 32.83 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.512 -0.921 . . . . 74.2 108.512 171.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.11 105.71 5.83 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.825 -1.176 . . . . 71.45 107.825 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 52.3 m -119.67 133.17 55.75 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.698 -0.852 . . . . 53.55 108.698 177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 mt -82.68 51.34 1.86 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.263 1.425 . . . . 74.31 110.303 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.81 -76.68 0.31 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.504 -1.038 . . . . 64.14 110.504 -175.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.99 -31.7 2.12 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.701 1.2 . . . . 61.52 109.809 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -70.88 100.32 1.92 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.344 1.057 . . . . 75.14 110.257 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 49.8 m -66.64 125.13 24.82 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 118.007 0.367 . . . . 72.15 110.273 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.709 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -82.0 -55.02 4.84 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 114.982 -1.008 . . . . 31.42 109.161 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -161.14 176.08 11.69 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.259 1.028 . . . . 72.41 112.448 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.2 tm? -137.88 146.53 43.48 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 113.001 -1.909 . . . . 74.1 106.212 172.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.458 ' N ' HD13 ' C' ' 75' ' ' LEU . 44.1 t -148.3 143.39 26.89 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.614 -0.884 . . . . 74.41 108.614 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -155.89 137.12 13.84 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.718 0.294 . . . . 74.0 110.345 -177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.9 t -135.62 137.84 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.466 1.106 . . . . 72.34 108.751 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -115.31 94.55 4.77 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.329 -0.989 . . . . 51.53 108.329 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -79.44 98.55 6.82 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.489 -0.778 . . . . 74.5 109.452 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.24 143.4 22.87 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.208 -1.157 . . . . 70.22 110.208 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.488 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.84 117.23 0.88 Allowed Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 111.53 -0.628 . . . . 32.23 111.53 -174.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.634 HD12 HD11 ' C' ' 51' ' ' LEU . 6.4 mm -82.61 128.79 38.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 108.638 -0.875 . . . . 62.42 108.638 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -135.85 122.03 20.3 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.43 0.457 . . . . 72.03 110.109 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 22.1 m -79.48 107.55 12.33 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.059 -1.089 . . . . 70.35 108.059 169.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.68 143.83 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.069 0.547 . . . . 72.11 110.637 -175.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -158.5 166.28 32.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.314 1.046 . . . . 73.12 109.652 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.46 -34.58 4.4 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.984 -0.553 . . . . 75.4 112.896 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.17 140.42 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.731 0.813 . . . . 71.42 110.531 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -148.3 156.65 42.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.585 0.754 . . . . 75.4 109.712 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.81 -117.54 8.21 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 116.209 -0.45 . . . . 34.14 113.248 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 5.2 m -70.6 -33.53 71.16 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.036 0.934 . . . . 72.42 110.501 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -67.14 -39.9 86.66 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.732 -1.122 . . . . 73.4 110.085 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 39.6 ttp -78.11 -24.64 47.41 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.272 -0.876 . . . . 63.13 110.741 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.39 95.65 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 122.752 0.421 . . . . 71.1 110.435 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -75.94 -41.19 52.42 Favored 'General case' 0 C--O 1.248 0.979 0 N-CA-C 111.927 0.343 . . . . 75.32 111.927 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -55.61 -48.89 74.16 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.069 0.856 . . . . 73.41 110.543 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.449 HD23 ' SG ' ' C' ' 102' ' ' CYS . 34.9 mt -92.88 -14.26 27.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.277 0.631 . . . . 43.02 111.076 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.93 -29.39 65.07 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 123.329 0.49 . . . . 73.42 113.835 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -156.5 -39.83 0.08 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 113.13 0.789 . . . . 72.43 113.13 -166.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -66.04 -55.82 14.68 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.453 0.471 . . . . 72.54 111.184 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.545 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 37.8 m -64.52 -46.28 77.35 Favored Pre-proline 0 CA--C 1.563 1.478 0 C-N-CA 123.643 0.777 . . . . 42.32 112.943 -177.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.56 -19.81 54.15 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 121.967 1.778 . . . . 74.54 113.967 174.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' C' ' 100' ' ' ALA . 0.2 OUTLIER -71.98 -28.41 63.4 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.714 -0.476 . . . . 71.31 109.714 176.189 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.71 -43.21 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.673 0.789 . . . . 73.31 109.67 171.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.488 HD21 ' HA3' ' C' ' 82' ' ' GLY . 66.0 mt -74.95 -28.2 60.49 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 114.886 -1.052 . . . . 52.22 112.133 -172.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -56.7 -50.2 89.31 Favored Pre-proline 0 CA--C 1.566 1.578 0 CA-C-O 117.34 -1.314 . . . . 74.43 114.243 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.54 -39.14 55.58 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 122.4 2.067 . . . . 72.11 113.367 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.472 ' HE2' HG21 ' A' ' 115' ' ' THR . 20.1 m-85 -67.94 -48.34 66.19 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.781 0.832 . . . . 72.51 110.405 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.15 -34.84 75.66 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.011 -0.995 . . . . 54.25 110.843 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -61.33 -56.53 19.42 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 124.12 0.968 . . . . 73.53 109.988 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.01 -30.33 71.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 123.724 0.64 . . . . 71.1 110.717 -175.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.5 t -73.91 -31.24 63.0 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.142 0.577 . . . . 73.32 110.884 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 58.7 mt -74.0 -50.33 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.945 0.498 . . . . 63.31 109.724 173.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 5.2 m -62.62 -30.27 71.23 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.013 0.925 . . . . 45.45 110.887 -175.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.3 t -65.5 -51.75 57.75 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.999 -0.741 . . . . 61.21 108.999 172.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.627 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.59 -36.65 76.67 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.541 1.136 . . . . 71.44 112.926 -179.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.708 HG11 HD23 ' C' ' 126' ' ' LEU . 95.0 t -71.72 -39.36 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.473 0.709 . . . . 74.23 109.775 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.5 t -70.77 -26.45 63.36 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.655 0.782 . . . . 51.24 111.234 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 78.2 mtt-85 -72.93 -42.49 63.41 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.744 -0.836 . . . . 75.43 108.744 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.1 -4.17 82.93 Favored Glycine 0 C--N 1.356 1.649 0 O-C-N 123.706 0.629 . . . . 70.33 112.942 173.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 23.4 p 66.83 25.84 9.48 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.633 1.973 . . . . 72.3 113.62 171.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.506 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 98.6 m-85 -86.49 166.08 29.7 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 123.841 0.857 . . . . 74.14 109.115 169.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 51.3 Cg_endo -62.67 178.31 1.01 Allowed 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 123.139 2.559 . . . . 51.31 114.708 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -59.67 112.22 1.73 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.877 1.271 . . . . 72.42 111.742 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.708 HD23 HG11 ' C' ' 118' ' ' VAL . 4.1 mm? -106.62 96.78 6.69 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.211 -0.663 . . . . 72.3 109.211 172.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -124.79 122.48 37.54 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.708 1.203 . . . . 74.01 108.539 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 14.8 tp -79.96 135.4 36.39 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.932 -0.395 . . . . 75.43 109.932 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.13 140.44 78.14 Favored Pre-proline 0 CA--C 1.547 0.849 0 O-C-N 124.45 1.094 . . . . 64.02 110.304 173.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.84 102.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.582 2.188 . . . . 51.23 112.676 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 50.0 t -95.74 111.17 25.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 106.675 -1.602 . . . . 53.25 106.675 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -76.24 83.22 3.03 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.633 -1.247 . . . . 74.53 107.633 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -56.43 -36.64 69.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.731 0.812 . . . . 62.12 110.825 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.7 -43.13 99.45 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 114.857 -1.065 . . . . 64.44 111.213 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.02 91.53 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.637 0.586 . . . . 62.52 110.952 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.1 mp -57.48 -50.66 72.33 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 123.97 0.794 . . . . 75.35 111.409 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.433 ' HA ' ' HB3' ' C' ' 140' ' ' TYR . 8.0 t80 -74.93 -20.82 59.53 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.347 0.659 . . . . 73.04 110.396 -177.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.415 ' O ' ' HB3' ' C' ' 142' ' ' GLN . 52.3 ttm -68.42 -55.4 12.03 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 122.806 0.442 . . . . 72.14 110.017 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -65.22 -35.06 79.89 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 122.443 0.297 . . . . 55.12 111.27 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.433 ' HB3' ' HA ' ' C' ' 137' ' ' PHE . 61.5 t80 -54.91 -83.67 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.807 1.243 . . . . 65.3 111.063 174.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 10.0 tp -98.67 87.3 3.75 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 109.546 -0.539 . . . . 74.32 109.546 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' C' ' 138' ' ' MET . 11.3 pt20 -133.63 133.9 42.53 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.646 0.778 . . . . 70.31 111.241 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -143.57 -56.37 0.39 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.389 -1.338 . . . . 52.44 107.389 169.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -79.5 104.32 10.02 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.963 -1.017 . . . . 41.21 109.382 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.31 -162.0 1.04 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.648 0.779 . . . . 72.44 111.007 -173.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.48 -143.04 3.83 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 110.556 -1.018 . . . . 70.52 110.556 175.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.54 147.56 27.61 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.6 -0.889 . . . . 74.45 108.6 175.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.87 121.84 17.77 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 123.745 0.653 . . . . 71.42 112.799 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 60.8 m -101.55 93.97 5.64 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.781 0.832 . . . . 41.34 110.53 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -87.55 160.57 18.17 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.551 0.74 . . . . 55.54 109.726 172.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -102.55 -174.87 2.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.266 0.626 . . . . 71.44 110.116 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -123.36 115.37 21.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.066 1.346 . . . . 75.22 108.714 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.565 ' HB2' HG23 ' A' ' 92' ' ' THR . 8.6 tt0 -83.17 140.5 32.55 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.965 0.506 . . . . 62.41 110.567 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -148.83 135.33 19.53 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.045 -1.095 . . . . 65.21 108.045 171.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.383 0 N-CA-C 108.921 -0.77 . . . . 71.21 108.921 -176.797 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 109.283 -0.636 . . . . 74.25 109.283 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 32.8 t -74.75 85.38 2.16 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.014 -0.736 . . . . 75.14 109.014 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.65 178.68 7.86 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.231 -0.895 . . . . 73.4 111.307 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -117.67 75.73 1.01 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.951 0.882 . . . . 73.31 110.715 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -68.37 104.74 1.95 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.325 -0.852 . . . . 74.42 109.056 171.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -71.05 115.54 10.31 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.638 0.733 . . . . 62.02 109.987 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -99.1 -164.36 1.12 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.165 0.986 . . . . 62.54 108.712 172.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -72.3 165.77 23.8 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 109.056 -0.72 . . . . 53.32 109.056 167.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.565 ' HG3' HG23 ' D' ' 89' ' ' ILE . 4.9 ttp -32.26 123.56 0.32 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.132 0.973 . . . . 73.0 112.235 173.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 45.1 m -112.14 141.6 45.62 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.277 0.631 . . . . 73.44 109.737 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -175.13 102.01 0.08 Allowed 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.458 -2.053 . . . . 74.21 105.458 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -144.2 134.47 24.39 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.243 -0.89 . . . . 64.44 108.799 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.3 mt -84.25 122.6 38.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 115.203 -0.908 . . . . 72.13 109.182 -176.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -90.07 -39.8 12.69 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 122.617 0.367 . . . . 74.13 111.315 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -166.56 127.79 1.71 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 111.755 0.28 . . . . 65.35 111.755 -167.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.75 136.13 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.343 -1.354 . . . . 72.11 107.343 167.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.41 ' HE1' HG13 ' D' ' 83' ' ' ILE . 25.1 p90 -156.51 164.38 38.29 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.771 0.796 . . . . 73.22 111.334 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 65.3 p -100.15 123.27 44.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.043 -0.981 . . . . 75.14 108.839 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -87.24 -36.01 18.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.67 0.748 . . . . 60.52 109.132 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 2.6 t70 -142.07 138.88 32.05 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.233 -1.349 . . . . 61.22 108.942 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.627 HG21 ' HE2' ' C' ' 117' ' ' MET . 82.3 mt -134.25 145.89 32.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.63 -1.248 . . . . 63.53 107.63 169.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -148.11 137.87 22.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.886 -0.783 . . . . 65.1 108.886 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.422 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.5 t80 -146.12 124.06 12.03 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.239 -1.393 . . . . 74.31 107.239 170.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -121.75 148.49 44.57 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.079 -0.711 . . . . 75.4 109.079 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.78 84.19 27.27 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 106.738 -1.578 . . . . 64.51 106.738 171.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.4 -46.08 6.16 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.198 2.598 . . . . 74.23 113.586 -167.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -104.95 28.0 7.6 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.703 0.801 . . . . 50.12 109.591 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.27 -66.72 0.34 Allowed Pre-proline 0 CA--C 1.565 1.528 0 N-CA-C 114.908 1.447 . . . . 75.31 114.908 -161.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.451 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.7 Cg_endo -73.8 -20.13 20.24 Favored 'Trans proline' 0 C--N 1.382 2.324 0 CA-C-N 122.533 1.94 . . . . 75.15 113.3 -174.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -73.88 -40.44 63.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.595 1.158 . . . . 62.14 110.328 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.463 HG21 ' HA ' ' D' ' 73' ' ' ALA . 4.0 p -85.54 -23.95 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 123.341 0.657 . . . . 64.11 111.803 -171.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -60.64 -22.09 63.46 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 123.286 0.634 . . . . 74.01 112.428 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -68.17 -10.3 53.19 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.579 0.752 . . . . 73.34 111.052 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -100.95 107.73 19.29 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.737 1.215 . . . . 73.24 110.246 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -93.27 91.87 7.44 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.293 0.637 . . . . 72.31 110.423 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.548 ' HZ3' ' H ' ' D' ' 69' ' ' GLY . 22.0 t90 -161.62 158.41 26.13 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.937 1.295 . . . . 63.41 108.127 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.443 HE21 ' HD2' ' D' ' 38' ' ' PRO . 29.1 tp60 -69.31 108.03 2.74 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 107.999 -1.111 . . . . 74.03 107.999 169.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.443 ' HD2' HE21 ' D' ' 37' ' ' GLN . 51.2 Cg_exo -56.74 124.23 15.75 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.967 2.444 . . . . 63.31 112.495 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.617 ' HA ' ' HG ' ' H' ' 470' ' ' LEU . 44.5 tt0 -57.28 110.98 0.94 Allowed 'General case' 0 C--N 1.359 0.996 0 O-C-N 124.442 1.088 . . . . 70.32 110.244 -174.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.742 HG12 HD11 ' H' ' 470' ' ' LEU . 2.8 p -101.68 112.39 34.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 115.283 -0.871 . . . . 75.32 110.269 -172.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.55 109.82 18.79 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 104.908 -2.256 . . . . 74.34 104.908 165.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.454 HD21 HD11 ' D' ' 128' ' ' LEU . 5.4 tt -95.49 127.9 41.91 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.36 -1.348 . . . . 70.25 107.36 -170.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.523 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 10.0 t70 -130.17 147.0 51.85 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 123.542 0.527 . . . . 72.31 109.915 -176.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -127.99 153.02 47.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.584 0.753 . . . . 73.21 109.682 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -157.69 147.78 20.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.055 0.942 . . . . 73.2 108.828 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -127.73 160.85 30.42 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.409 -0.589 . . . . 72.33 109.409 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.477 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.05 166.77 31.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.755 -1.112 . . . . 63.52 108.661 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.408 ' O ' HG22 ' H' ' 455' ' ' THR . 21.8 p -165.72 161.31 18.01 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.609 0.764 . . . . 55.42 109.557 178.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.2 p -151.98 160.47 43.47 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.282 1.033 . . . . 72.45 109.238 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -98.81 120.65 39.6 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.995 -0.742 . . . . 72.35 108.995 171.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' D' ' 57' ' ' GLU . 59.2 mt -91.0 -41.3 11.18 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.124 0.488 . . . . 73.02 110.198 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -153.51 -172.44 4.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.754 0.822 . . . . 43.44 110.896 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.37 105.96 1.59 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 114.968 -1.015 . . . . 70.33 109.53 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 64.11 18.59 11.33 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.517 1.127 . . . . 74.23 112.404 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 98.1 t -117.83 120.44 64.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.587 0 N-CA-C 107.843 -1.169 . . . . 74.41 107.843 169.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -125.46 163.8 21.86 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.671 0.788 . . . . 73.35 109.411 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.523 ' HB2' HD11 ' D' ' 51' ' ' LEU . 22.2 tt0 -121.52 148.38 44.55 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 124.746 1.218 . . . . 72.51 107.714 169.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.1 t -129.75 119.28 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 106.896 -1.52 . . . . 75.31 106.896 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.522 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 41.4 t -99.38 125.29 52.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.987 -0.746 . . . . 73.4 108.987 176.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.64 124.86 49.61 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.702 -1.221 . . . . 64.3 107.702 175.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -118.98 95.66 4.91 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.987 -0.746 . . . . 74.42 108.987 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -91.24 123.1 43.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.078 -1.082 . . . . 75.4 108.078 174.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 24.0 m -111.15 144.06 40.9 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.25 0.548 . . . . 72.14 110.041 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.458 HG13 HG23 ' D' ' 40' ' ' VAL . 93.9 t -137.44 120.28 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.111 0.964 . . . . 74.22 109.503 -175.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 100.0 m -113.39 121.03 43.12 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 107.912 -1.144 . . . . 74.54 107.912 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.88 145.49 48.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.333 0.653 . . . . 51.3 110.319 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.456 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.8 m -146.83 129.96 16.48 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 123.526 0.516 . . . . 72.2 111.129 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 mt -92.86 92.6 7.98 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.945 -1.132 . . . . 74.31 107.945 173.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . 0.548 ' H ' ' HZ3' ' D' ' 36' ' ' TRP . . . 70.22 -114.77 5.67 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 114.571 -1.195 . . . . 54.31 113.382 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.15 6.37 40.36 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.299 0.852 . . . . 74.15 113.299 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.91 156.94 43.02 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.11 0.414 . . . . 54.33 110.222 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.5 m -67.29 136.89 55.59 Favored 'General case' 0 C--O 1.242 0.697 0 O-C-N 123.633 0.583 . . . . 65.44 110.694 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.463 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.34 -69.57 0.71 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.252 -1.34 . . . . 75.44 108.522 175.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -145.58 157.46 43.98 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 121.319 0.58 . . . . 72.22 109.958 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -131.96 144.58 50.91 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.255 -1.387 . . . . 72.33 107.255 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.563 ' SG ' HG12 ' D' ' 114' ' ' ILE . 43.6 t -158.22 136.68 11.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.336 0.254 . . . . 65.3 110.589 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -154.07 128.35 9.1 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.387 0.675 . . . . 73.21 109.32 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.2 118.39 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.382 0.673 . . . . 54.13 109.905 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.626 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.6 mt-30 -89.77 82.97 6.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.34 0.656 . . . . 61.33 109.307 169.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -80.37 91.86 5.73 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.963 1.305 . . . . 63.31 109.359 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.25 142.18 17.98 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.713 -0.555 . . . . 65.13 111.713 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.93 132.31 5.5 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 119.716 -0.491 . . . . 70.43 112.064 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.41 HG13 ' HE1' ' D' ' 17' ' ' TYR . 61.9 mt -89.17 131.23 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.379 0.672 . . . . 70.55 109.99 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -131.22 124.55 30.81 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.886 0.875 . . . . 70.31 109.341 175.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 71.5 m -83.75 111.7 19.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.088 -1.078 . . . . 73.12 108.088 168.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.461 HD12 ' SG ' ' D' ' 97' ' ' CYS . 5.5 tt -138.06 127.99 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 122.902 0.481 . . . . 63.01 111.117 -172.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.68 167.66 27.86 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.398 1.479 . . . . 54.25 109.099 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.05 11.51 63.11 Favored Glycine 0 N--CA 1.473 1.128 0 CA-C-O 119.463 -0.632 . . . . 75.42 113.66 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.565 HG23 ' HG3' ' D' ' 9' ' ' MET . 0.2 OUTLIER -141.8 169.22 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 125.079 1.352 . . . . 74.25 109.661 171.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.571 ' HG2' ' HA ' ' B' ' 152' ' ' HIS . 3.8 pt-20 -153.91 175.82 12.91 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.723 0.409 . . . . 63.24 111.912 -173.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.89 -107.42 0.71 Allowed Glycine 0 C--N 1.36 1.868 0 O-C-N 124.757 1.285 . . . . 64.31 115.263 164.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.0 p -66.04 -41.54 90.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.816 0.847 . . . . 72.13 110.974 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -74.72 -38.03 62.41 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.344 0.657 . . . . 65.21 111.685 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.608 ' SD ' ' HB ' ' H' ' 452' ' ' VAL . 23.9 ptt? -66.63 -34.46 77.92 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.867 0.365 . . . . 75.24 110.671 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.98 -42.65 69.4 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.907 -0.588 . . . . 73.22 109.646 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.408 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 49.8 t-80 -66.25 -26.41 67.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.421 1.088 . . . . 70.53 111.817 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . 0.461 ' SG ' HD12 ' D' ' 86' ' ' ILE . 25.3 t -91.12 -54.14 4.07 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.844 -0.122 . . . . 73.33 110.864 -176.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -72.31 -29.77 64.16 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.391 0.276 . . . . 72.42 111.494 -176.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.5 12.91 27.98 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.122 -0.821 . . . . 73.01 114.532 -172.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -154.46 -59.65 0.12 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.983 0.891 . . . . 62.41 112.207 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -68.59 -50.41 51.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.006 0.523 . . . . 73.43 111.499 -173.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 83.7 m -62.6 -45.71 88.78 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.11 0.964 . . . . 72.41 112.243 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -52.56 -40.79 71.58 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.203 1.935 . . . . 71.5 112.967 167.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -66.07 -29.87 70.28 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.256 0.622 . . . . 75.54 111.328 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.7 mm -69.59 -42.4 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.894 0.878 . . . . 61.52 110.436 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 62.8 mt -74.83 -16.28 60.7 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.224 -0.898 . . . . 61.23 111.67 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.423 ' HE2' ' HA ' ' D' ' 130' ' ' PRO . 27.6 t80 -68.07 -40.37 21.73 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.916 -1.04 . . . . 75.24 113.74 -169.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -53.39 -44.84 45.6 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.011 1.807 . . . . 45.23 112.895 167.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -69.24 -36.64 77.37 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.692 0.797 . . . . 73.12 111.783 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.07 -49.46 69.95 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.241 0.616 . . . . 64.42 109.717 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.492 HH12 ' HB3' ' D' ' 130' ' ' PRO . 26.5 ttp180 -55.99 -47.62 77.37 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 124.357 1.036 . . . . 73.03 110.946 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -62.13 -49.03 77.49 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.073 0.858 . . . . 65.22 111.534 -174.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.0 -41.86 83.98 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.053 0.846 . . . . 72.44 110.636 -178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.563 HG12 ' SG ' ' D' ' 76' ' ' CYS . 81.1 mt -60.4 -56.51 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 O-C-N 124.293 0.996 . . . . 70.55 110.79 173.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -58.21 -37.55 75.04 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.588 1.155 . . . . 75.52 111.372 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -66.78 -42.15 86.5 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.155 -0.93 . . . . 75.45 110.079 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.4 mtm -72.52 -27.11 62.04 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.809 0.444 . . . . 65.53 111.766 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.408 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.0 t -67.97 -42.14 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.458 0.703 . . . . 64.11 110.078 173.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.6 p -75.62 -29.44 59.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.813 0.445 . . . . 71.3 111.108 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -74.26 -33.84 63.41 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.245 0.618 . . . . 73.42 109.599 174.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.68 -2.25 90.62 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-N 115.746 -0.661 . . . . 53.02 112.237 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p 66.57 21.3 10.73 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.876 2.07 . . . . 44.43 113.904 170.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -82.62 156.77 67.95 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.452 0.701 . . . . 75.12 110.348 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.97 137.23 44.23 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.298 2.666 . . . . 63.14 112.138 173.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -54.66 136.77 45.18 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.359 1.037 . . . . 74.33 111.929 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -113.44 102.32 10.2 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.568 -0.901 . . . . 74.02 108.568 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -98.29 95.08 7.13 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.221 -1.4 . . . . 42.31 107.221 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.454 HD11 HD21 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -57.11 113.89 1.9 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.566 -1.197 . . . . 65.24 108.273 -176.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.88 122.65 70.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 123.963 0.789 . . . . 75.53 110.632 -171.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.492 ' HB3' HH12 ' D' ' 111' ' ' ARG . 59.1 Cg_endo -72.64 112.52 3.5 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.944 1.763 . . . . 63.51 111.427 -176.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.0 m -105.81 138.52 30.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 N-CA-C 108.317 -0.994 . . . . 70.11 108.317 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -79.25 77.11 5.78 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.872 0.844 . . . . 62.01 109.726 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.608 ' HE2' HD11 ' H' ' 460' ' ' LEU . 86.5 t80 -56.71 -29.39 62.39 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.623 1.569 . . . . 70.3 111.64 -178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.658 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 21.7 t70 -60.51 -45.1 95.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.13 1.372 . . . . 75.54 110.747 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.07 -37.84 57.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.807 0.843 . . . . 63.31 111.329 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' H' ' 462' ' ' TYR . 9.8 mp -58.93 -31.23 68.48 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.33 0.652 . . . . 65.54 111.043 174.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -69.53 -41.77 75.52 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.986 0.914 . . . . 71.51 110.8 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 30.8 mtt -62.79 -36.28 82.61 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.393 0.677 . . . . 60.33 109.89 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.404 ' HA ' HE21 ' D' ' 142' ' ' GLN . 27.9 t-20 -68.28 -36.15 78.95 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.938 -1.028 . . . . 74.24 111.176 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -68.5 -40.47 80.86 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.777 0.831 . . . . 75.41 111.748 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.88 -36.33 80.95 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.313 0.645 . . . . 72.33 111.537 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.404 HE21 ' HA ' ' D' ' 139' ' ' ASN . 23.4 pt20 -89.47 37.55 0.87 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.074 0.549 . . . . 72.35 111.28 177.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -127.03 84.8 2.3 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.436 1.094 . . . . 52.25 109.641 172.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -143.07 13.71 1.85 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.47 1.108 . . . . 74.52 109.531 170.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.89 -58.68 0.32 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.797 0.839 . . . . 72.04 110.368 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 129.57 120.01 2.2 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-O 119.947 -0.363 . . . . 34.54 112.358 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -141.51 126.66 18.47 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.445 0.698 . . . . 74.3 110.176 -177.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.0 -84.83 0.07 OUTLIER Glycine 0 C--N 1.35 1.331 0 O-C-N 124.322 1.014 . . . . 64.43 112.804 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 4.4 t -69.76 97.69 1.12 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.133 0.973 . . . . 60.12 110.461 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -126.38 -37.92 2.16 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.653 1.181 . . . . 71.13 109.116 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -81.69 119.34 23.71 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.928 0.891 . . . . 64.2 109.138 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -82.83 95.86 8.05 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.043 -0.725 . . . . 72.24 109.043 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -63.71 88.93 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.83 1.252 . . . . 62.52 111.221 -176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -142.88 111.41 6.25 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.407 -0.96 . . . . 75.34 108.407 -176.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 N-CA-C 109.541 -0.54 . . . . 65.32 109.541 -174.463 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.444 -0.576 . . . . 71.25 109.444 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 87' ' ' ALA . 3.9 p -119.07 -63.1 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.113 0.565 . . . . 75.22 111.492 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . 0.462 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 43.3 t -92.11 89.8 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.256 -1.016 . . . . 55.34 108.256 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -80.29 60.08 4.53 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.367 -0.833 . . . . 74.34 113.197 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 65.2 tp -82.2 122.52 28.0 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 109.442 -0.577 . . . . 52.41 109.442 176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 44.6 m -139.65 136.11 33.96 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.243 -1.021 . . . . 53.41 108.243 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 10.7 t70 76.21 163.16 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.37 1.468 . . . . 74.41 111.501 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -83.96 161.86 20.65 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.948 0.899 . . . . 60.55 112.209 -174.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 51.2 m -147.51 141.16 25.57 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.227 1.011 . . . . 63.11 109.446 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.3 142.64 58.31 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.703 0.801 . . . . 71.4 111.026 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . 0.59 HD21 ' HB ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -89.0 144.51 26.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.698 0.761 . . . . 70.22 109.932 -177.116 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . 0.626 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 18.9 p90 -92.79 13.36 20.53 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.0 1.32 . . . . 65.13 112.956 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -66.19 108.15 2.19 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 120.744 0.307 . . . . 74.45 110.857 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 10.0 t -153.96 117.94 4.75 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.405 -0.816 . . . . 74.13 109.664 173.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -158.07 149.94 21.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.014 0.926 . . . . 75.24 109.352 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -85.23 80.91 9.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.695 -0.854 . . . . 71.22 108.695 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -80.34 152.73 28.79 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.343 -0.844 . . . . 55.22 111.549 -176.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -155.83 166.61 32.99 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.723 0.809 . . . . 71.04 110.049 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . 0.508 HD22 ' HG ' ' E' ' 470' ' ' LEU . 2.0 tt -157.67 -61.18 0.09 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 108.586 -0.894 . . . . 63.42 108.586 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 121.26 -107.61 1.25 Allowed Glycine 0 C--N 1.341 0.822 0 N-CA-C 110.043 -1.223 . . . . 73.42 110.043 -172.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . 0.642 ' HB3' ' HE1' ' A' ' 36' ' ' TRP . 75.8 mt 53.7 72.32 0.45 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 124.619 1.168 . . . . 75.25 110.456 -176.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? . . . . . 0 C--O 1.253 1.255 0 N-CA-C 107.94 -1.134 . . . . 75.03 107.94 -174.748 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 108.899 -0.778 . . . . 75.0 108.899 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . 0.423 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 28.2 m -97.94 165.37 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 122.781 0.432 . . . . 70.32 110.603 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . 0.47 ' N ' ' SD ' ' B' ' 94' ' ' MET . 56.7 t 66.84 136.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 124.782 1.233 . . . . 63.44 111.251 -176.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -178.04 -157.68 19.3 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 111.678 -0.569 . . . . 32.35 111.678 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . 0.428 HD11 ' HA ' ' B' ' 95' ' ' ALA . 6.6 mp 64.93 -173.21 0.18 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.211 1.004 . . . . 63.52 111.248 178.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 11.7 t -157.3 179.32 9.37 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.707 0.403 . . . . 74.1 110.089 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -68.4 107.38 2.84 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.583 -0.895 . . . . 75.44 108.583 175.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -110.09 126.46 54.05 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.02 0.528 . . . . 65.01 110.654 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 16.7 p -92.19 -45.38 8.28 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.361 1.064 . . . . 52.51 110.797 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -75.39 80.68 2.45 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.33 0.586 . . . . 71.23 109.706 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 85.5 mt -97.1 157.58 15.85 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.356 -0.838 . . . . 70.43 111.001 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . 0.429 ' HB2' ' HB3' ' B' ' 136' ' ' LEU . 6.0 p90 -59.06 139.04 57.27 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 113.477 -1.692 . . . . 63.01 110.83 165.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -160.16 107.97 1.65 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.59 0.756 . . . . 72.31 109.043 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 4.3 t -151.37 66.85 0.89 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 122.866 1.317 . . . . 64.34 108.19 174.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . 0.611 ' SD ' ' HB3' ' B' ' 129' ' ' ALA . 54.0 ttp -76.73 92.82 3.59 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.041 -1.436 . . . . 72.21 109.138 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -66.94 -32.55 73.88 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.07 0.948 . . . . 75.11 111.561 -176.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -66.47 -59.74 3.38 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.427 0.691 . . . . 63.24 110.869 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . 0.51 ' H ' ' HG2' ' F' ' 464' ' ' MET . . . 56.58 -170.29 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.821 1.248 . . . . 54.22 112.089 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -132.65 134.86 45.39 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.503 -0.554 . . . . 61.22 109.503 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . -81.91 119.12 4.78 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.587 -0.733 . . . . 71.3 112.005 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . 0.569 HD21 HG12 ' B' ' 40' ' ' VAL . 3.2 mm? -76.95 85.82 3.49 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.135 -0.691 . . . . 74.04 109.135 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . 0.458 ' H ' ' NE2' ' B' ' 37' ' ' GLN . 19.2 tptp . . . . . 0 CA--C 1.561 1.376 0 C-N-CA 125.767 1.627 . . . . 55.13 110.012 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . 0.492 ' HB3' HG22 ' G' ' 452' ' ' VAL . 86.6 m-20 . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.849 -0.426 . . . . 72.25 109.849 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 4.0 p -73.89 -10.69 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.561 0.744 . . . . 72.52 111.554 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . 0.492 HG22 ' HB3' ' G' ' 450' ' ' ASN . 35.2 m -67.86 -179.33 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 124.136 0.974 . . . . 73.04 111.786 173.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 98.47 68.62 0.92 Allowed Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.421 -0.809 . . . . 62.3 112.082 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . 0.454 HD13 ' HB2' ' G' ' 457' ' ' GLN . 4.1 pp -87.44 138.17 31.71 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.333 -0.988 . . . . 74.13 108.333 169.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 63.0 m -83.56 -60.47 2.12 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 110.36 -0.237 . . . . 73.53 110.36 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -107.31 140.91 39.48 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.337 0.655 . . . . 64.3 111.473 -174.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . 0.598 ' HG2' ' H ' ' G' ' 458' ' ' THR . 31.6 tt0 -174.87 -175.88 0.93 Allowed 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 124.986 1.315 . . . . 74.54 108.098 175.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . 0.598 ' H ' ' HG2' ' G' ' 457' ' ' GLN . 62.6 p 69.03 158.39 0.16 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 126.763 2.025 . . . . 73.03 112.147 -176.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 30.2 t70 59.11 76.19 0.36 Allowed 'General case' 0 C--N 1.355 0.831 0 C-N-CA 124.134 0.974 . . . . 73.32 108.869 -170.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.64 114.24 6.1 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.341 -1.355 . . . . 72.11 107.341 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -41.3 -48.14 3.57 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.913 1.285 . . . . 74.23 112.49 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 58.3 t80 48.91 81.17 0.05 Allowed 'General case' 0 C--N 1.362 1.11 0 C-N-CA 125.351 1.46 . . . . 75.23 111.672 175.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 14.8 t -86.19 -0.28 55.37 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.803 -0.635 . . . . 53.14 111.652 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 13.2 tpt -61.34 119.25 8.14 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.274 1.029 . . . . 71.04 110.299 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.23 -63.08 1.35 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.194 0.998 . . . . 65.13 110.634 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -61.52 109.71 1.26 Allowed 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.512 0.725 . . . . 70.42 110.287 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -69.6 -82.83 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 O-C-N 124.049 0.843 . . . . 72.13 109.842 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . 0.429 HD13 HD12 ' C' ' 126' ' ' LEU . 50.5 mt -141.58 178.24 7.59 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.195 0.998 . . . . 72.53 108.838 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -146.51 129.7 3.42 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-O 119.325 -0.708 . . . . 34.3 111.797 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . 0.499 HD21 HD22 ' C' ' 126' ' ' LEU . 24.0 mt -124.55 114.45 19.43 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 117.328 0.564 . . . . 73.22 110.605 177.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 N-CA-C 106.853 -1.536 . . . . 75.12 106.853 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 42.6 t30 . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.115 -0.698 . . . . 62.25 109.115 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 46.5 t -55.46 -57.81 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.943 0.897 . . . . 62.32 111.808 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . 0.608 ' HB ' ' SD ' ' D' ' 94' ' ' MET . 2.1 p -143.04 -80.93 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 122.89 0.476 . . . . 63.21 112.046 -174.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . 0.528 ' H ' HG13 ' H' ' 452' ' ' VAL . . . 79.73 100.33 0.27 Allowed Glycine 0 C--N 1.35 1.35 0 N-CA-C 111.598 -0.601 . . . . 61.54 111.598 -168.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -140.83 144.03 35.13 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.33 0.565 . . . . 64.21 110.402 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . 0.408 HG22 ' O ' ' D' ' 48' ' ' SER . 26.8 p -140.84 99.52 3.63 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.111 1.364 . . . . 63.44 108.852 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -147.89 133.79 19.11 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.549 0.34 . . . . 73.43 110.168 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -134.8 36.32 3.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.272 1.029 . . . . 64.04 109.651 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 21.4 m -80.98 87.43 5.99 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 122.176 -0.328 . . . . 72.21 110.259 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 12.7 t70 62.53 -171.5 0.16 Allowed 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 124.887 1.275 . . . . 71.12 110.463 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . 0.608 HD11 ' HE2' ' D' ' 133' ' ' PHE . 0.4 OUTLIER -139.41 137.73 35.9 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.828 -0.805 . . . . 54.03 108.828 175.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . 0.433 ' N ' HD13 ' H' ' 460' ' ' LEU . 19.9 p90 -87.04 18.67 3.45 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.116 1.366 . . . . 72.13 113.269 -172.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . 0.455 ' HA ' HD23 ' D' ' 136' ' ' LEU . 6.0 p90 -77.11 139.91 40.1 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 118.031 0.378 . . . . 72.45 110.444 -177.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 33.4 p -127.75 124.62 38.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.521 0.729 . . . . 64.41 109.756 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . 0.425 ' HE2' ' HB3' ' H' ' 464' ' ' MET . 40.4 ttp -160.96 -81.74 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.585 0.754 . . . . 74.43 109.853 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? 58.04 75.75 0.37 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.048 0.939 . . . . 64.12 111.05 -172.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -167.87 -51.33 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.785 0.834 . . . . 54.23 109.553 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . 66.1 -80.9 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.389 1.476 . . . . 64.55 112.251 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 95.6 mt -133.51 -9.66 2.84 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.472 0.709 . . . . 61.22 112.132 -175.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.19 -37.36 3.41 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 111.785 -0.526 . . . . 50.54 111.785 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . 0.742 HD11 HG12 ' D' ' 40' ' ' VAL . 3.6 mm? 69.35 84.34 0.15 Allowed 'General case' 0 C--N 1.355 0.817 0 C-N-CA 125.497 1.519 . . . . 72.14 112.466 169.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . 0.4 ' HB3' ' NZ ' ' H' ' 471' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.126 0 N-CA-C 106.801 -1.555 . . . . 73.34 106.801 175.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.429 ' HB3' ' HB3' ' A' ' 6' ' ' ASN . 1.7 mpt? . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.78 0.324 . . . . 74.14 110.391 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 m -72.93 91.45 1.54 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.597 0.759 . . . . 72.44 109.007 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 64.76 -164.97 0.24 Allowed 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 124.522 1.129 . . . . 71.34 111.345 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 67.41 -81.26 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.613 1.565 . . . . 72.43 111.425 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -126.72 92.03 3.47 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.422 -0.955 . . . . 71.34 108.422 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.452 ' HB2' ' HG3' ' A' ' 8' ' ' GLU . 25.9 p-10 -155.36 -50.68 0.09 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.006 0.522 . . . . 74.44 110.176 176.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m 52.12 29.97 7.07 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.882 1.273 . . . . 52.14 111.902 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' A' ' 6' ' ' ASN . 42.7 mt-10 -65.05 -38.59 91.34 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.895 0.878 . . . . 74.32 111.103 -172.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.3 mtm -84.51 143.44 29.35 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.66 -0.7 . . . . 65.33 109.233 172.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.1 m -146.62 132.02 18.6 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.614 0.765 . . . . 61.12 109.865 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.651 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.4 t80 -133.25 132.87 41.96 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.647 -0.872 . . . . 65.52 108.647 173.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -147.39 116.64 6.94 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.682 -0.858 . . . . 74.52 108.682 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.463 HG12 ' HD2' ' A' ' 84' ' ' PHE . 50.7 mt -81.19 117.4 27.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.87 -0.789 . . . . 71.12 108.87 176.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -86.34 -40.37 15.52 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 123.742 0.651 . . . . 74.42 110.757 -175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -168.12 137.46 2.48 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 122.969 0.168 . . . . 74.55 110.744 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.593 HD12 ' HG3' ' C' ' 130' ' ' PRO . 88.6 mt -125.44 133.48 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.378 1.071 . . . . 72.52 108.584 177.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' HB3' HG23 ' B' ' 122' ' ' THR . 41.4 p90 -168.97 177.32 4.99 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 123.97 0.794 . . . . 75.44 111.355 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -102.2 122.96 45.19 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.05 -0.977 . . . . 74.3 108.749 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 31.3 mtpt -88.07 -45.21 10.36 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.316 -0.624 . . . . 65.43 109.316 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.3 t70 -134.34 125.67 28.08 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.507 -1.224 . . . . 72.02 108.288 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 58.9 mt -124.91 140.39 48.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.696 -1.594 . . . . 64.21 106.696 173.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -156.09 121.12 4.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.17 0.509 . . . . 74.53 109.727 171.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.474 ' H ' ' HB ' ' B' ' 21' ' ' ILE . 86.8 t80 -116.3 118.54 33.05 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 106.36 -1.718 . . . . 72.42 106.36 173.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -119.56 126.48 51.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.058 0.39 . . . . 51.43 110.145 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.17 75.64 23.15 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.685 -1.228 . . . . 54.33 107.685 169.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.56 -28.68 25.91 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.26 1.974 . . . . 62.42 110.405 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.454 ' O ' HG23 ' A' ' 31' ' ' VAL . 43.1 m-20 -93.33 12.41 24.81 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.196 -1.365 . . . . 71.13 110.898 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.73 -46.88 80.19 Favored Pre-proline 0 CA--C 1.571 1.752 0 C-N-CA 124.185 0.994 . . . . 70.4 113.607 -176.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.13 -21.77 20.05 Favored 'Trans proline' 0 C--N 1.396 3.073 0 C-N-CA 122.082 1.855 . . . . 75.31 113.651 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -71.65 -47.57 53.53 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.623 -0.51 . . . . 70.02 109.623 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.614 HG22 HD21 ' A' ' 68' ' ' LEU . 88.1 t -60.91 -33.88 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.738 1.215 . . . . 72.3 110.936 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.446 ' HD1' HH11 ' B' ' 15' ' ' ARG . 90.9 t80 -56.46 -39.52 73.3 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.643 1.177 . . . . 74.41 111.918 176.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -96.43 -35.15 11.26 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.652 0.781 . . . . 60.21 111.87 -172.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -83.15 170.63 14.54 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.596 0.758 . . . . 74.55 112.88 -172.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.63 115.86 9.36 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.825 0.85 . . . . 43.52 111.101 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -79.63 92.65 5.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.022 0.929 . . . . 71.42 109.966 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -140.51 75.83 26.09 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 107.38 -1.341 . . . . 72.2 107.38 172.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 67' ' ' SER . 24.6 Cg_endo -90.52 163.85 4.35 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.095 2.53 . . . . 72.4 113.98 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -126.32 118.39 24.97 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.04 -0.982 . . . . 64.33 108.534 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.69 110.05 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.602 0.761 . . . . 74.32 110.831 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -103.24 140.07 37.86 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.679 -0.86 . . . . 74.25 108.679 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.541 HD23 ' SD ' ' E' ' 464' ' ' MET . 64.7 tp -132.09 124.76 29.83 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.491 0.716 . . . . 73.1 109.701 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.452 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 64.4 m-20 -102.95 124.33 48.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.152 -1.055 . . . . 71.31 108.152 175.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.35 115.21 29.82 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.788 -1.56 . . . . 72.3 106.788 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 12.0 m-20 -132.07 124.6 29.53 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.096 -1.075 . . . . 62.32 108.096 -177.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.541 ' HB ' HD21 ' E' ' 460' ' ' LEU . 53.9 m -115.35 121.94 44.36 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.404 -0.591 . . . . 71.23 109.404 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.76 140.86 48.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.182 0.993 . . . . 71.22 108.614 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.563 ' HB3' ' H ' ' E' ' 454' ' ' LEU . 37.0 t -130.59 163.92 26.06 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.358 0.599 . . . . 65.31 111.628 -173.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.2 t -148.91 121.62 8.64 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.198 -1.365 . . . . 74.44 108.256 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -71.67 107.89 4.74 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.822 0.849 . . . . 70.45 109.279 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.9 mt -78.52 -34.51 47.24 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.221 0.608 . . . . 71.34 110.281 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.54 -177.71 6.59 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.939 0.895 . . . . 72.25 109.878 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.72 119.44 14.86 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.412 -0.588 . . . . 75.33 109.412 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.748 ' HA ' ' HB ' ' E' ' 451' ' ' VAL . 42.7 m-20 67.34 20.15 10.04 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.084 1.354 . . . . 73.41 112.151 -174.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.12 124.05 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.414 1.086 . . . . 75.31 108.35 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.499 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -142.43 169.22 17.99 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.337 -0.616 . . . . 73.54 109.337 174.337 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -128.75 130.51 47.17 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.498 -0.927 . . . . 74.3 108.498 174.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.8 m -102.42 132.06 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.586 -0.894 . . . . 62.12 108.586 169.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.51 106.92 21.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 125.194 1.397 . . . . 73.41 107.68 177.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.7 tp -87.57 99.14 11.82 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.693 -0.685 . . . . 71.12 109.155 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.709 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 52.6 ttt-85 -84.38 105.24 15.06 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.805 -0.813 . . . . 75.14 108.805 174.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.507 HG21 ' HB1' ' A' ' 110' ' ' ALA . 1.7 m -112.95 106.58 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 108.37 -0.974 . . . . 62.23 108.37 175.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 25.6 m -109.83 112.01 23.79 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.451 1.1 . . . . 74.32 110.716 -167.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 78.2 t -101.74 110.97 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.52 0.728 . . . . 74.42 109.656 -178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -115.44 108.29 16.29 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.735 -0.839 . . . . 70.25 108.735 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.79 133.49 53.08 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.312 -0.995 . . . . 61.11 108.312 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 39.4 t -140.27 134.38 30.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.905 0.482 . . . . 71.11 110.595 -176.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.657 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -94.78 80.17 3.74 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.432 1.093 . . . . 74.43 108.436 172.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.06 -118.86 5.48 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.311 -0.858 . . . . 74.44 112.593 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -89.41 5.97 42.82 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.61 0.764 . . . . 73.3 111.368 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.439 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . 6.3 tp10 -116.84 112.92 21.77 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.636 -0.876 . . . . 73.23 108.636 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.0 m -73.75 130.08 39.24 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.541 0.609 . . . . 72.25 109.864 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.533 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.81 -59.96 2.53 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.433 0.693 . . . . 74.21 109.789 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -159.28 163.35 35.85 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 115.157 -0.928 . . . . 71.33 110.782 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 34.6 tp -135.68 106.38 6.55 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.751 -1.113 . . . . 74.23 108.172 175.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 118' ' ' VAL . 57.2 m -107.69 97.36 7.1 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.241 -0.651 . . . . 73.43 109.241 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -113.06 117.16 31.23 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.671 -1.233 . . . . 74.53 107.671 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.4 t -126.3 109.55 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.492 -0.776 . . . . 73.0 109.119 -175.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.579 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.3 mt-30 -90.34 86.23 6.42 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.866 -1.061 . . . . 63.35 108.608 171.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.49 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.1 tp-100 -76.42 109.05 9.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.156 -1.384 . . . . 65.03 108.104 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.37 144.83 17.53 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.429 -0.668 . . . . 61.41 111.429 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.418 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -148.59 122.46 1.49 Allowed Glycine 0 CA--C 1.502 -0.746 0 N-CA-C 110.869 -0.892 . . . . 72.43 110.869 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.9 mt -80.93 121.77 35.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 108.406 -0.961 . . . . 75.25 108.406 175.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.651 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.2 m-85 -130.37 135.53 48.13 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.511 -0.922 . . . . 74.02 108.511 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.4 p -112.62 98.02 6.96 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.325 -0.62 . . . . 61.33 109.325 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.44 HD12 HD11 ' A' ' 89' ' ' ILE . 39.3 pt -99.52 149.8 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 115.733 -0.667 . . . . 73.33 109.469 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.58 147.73 14.02 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.413 0.685 . . . . 74.13 110.121 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.24 9.75 64.93 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 114.873 0.709 . . . . 62.41 114.873 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -123.39 153.36 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.748 0.819 . . . . 72.24 110.085 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 14.2 tt0 -160.78 179.4 8.55 Favored 'General case' 0 CA--C 1.557 1.228 0 O-C-N 123.251 0.345 . . . . 74.43 111.085 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.457 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 73.61 -133.62 17.85 Favored Glycine 0 C--N 1.351 1.38 0 C-N-CA 123.907 0.765 . . . . 71.32 113.838 177.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.0 p -64.86 -35.25 80.51 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.934 0.894 . . . . 72.44 110.961 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -64.96 -35.58 81.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.994 0.918 . . . . 75.04 110.846 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.571 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 28.1 ttt -62.37 -47.06 85.82 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.635 0.774 . . . . 75.1 110.904 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.71 -39.24 91.02 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.777 -0.647 . . . . 71.0 110.865 175.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -67.24 -31.86 72.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.287 1.035 . . . . 71.14 111.633 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 24.6 t -69.95 -29.27 66.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.991 0.424 . . . . 74.42 110.899 -175.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.593 HD13 ' HG ' ' E' ' 454' ' ' LEU . 1.8 tt -95.09 -32.68 12.99 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.75 -0.659 . . . . 63.42 110.235 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.2 -1.93 66.51 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-O 119.578 -0.568 . . . . 74.2 113.942 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -147.82 -64.54 0.26 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 117.827 0.813 . . . . 75.31 111.967 -176.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.435 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 51.1 t80 -56.22 -70.83 0.1 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.252 1.421 . . . . 73.33 113.607 -169.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.424 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 86.6 m -72.35 -35.64 3.4 Favored Pre-proline 0 CA--C 1.565 1.541 0 N-CA-C 114.894 1.442 . . . . 73.31 114.894 -173.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 37.8 Cg_endo -64.65 -26.12 61.38 Favored 'Trans proline' 0 C--N 1.392 2.866 0 CA-C-N 121.99 1.746 . . . . 72.15 113.103 173.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -72.53 -23.1 60.95 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.847 0.459 . . . . 74.21 111.217 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.3 mm -61.91 -40.58 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.092 0.472 . . . . 74.2 109.759 171.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.49 HD22 ' HG3' ' A' ' 80' ' ' GLN . 83.7 mt -82.82 -13.45 56.18 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.298 -0.864 . . . . 73.54 112.507 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.415 ' HE2' ' HA ' ' A' ' 130' ' ' PRO . 49.2 t80 -63.94 -43.23 74.73 Favored Pre-proline 0 CA--C 1.567 1.613 0 C-N-CA 123.709 0.804 . . . . 75.23 113.101 -174.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.56 -35.77 57.59 Favored 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 122.215 1.943 . . . . 60.55 113.904 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.2 -40.54 64.66 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.918 0.487 . . . . 74.11 110.79 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.507 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -69.81 -36.12 75.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.528 -0.76 . . . . 65.44 110.514 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.467 ' NH1' HD12 ' C' ' 105' ' ' ILE . 36.5 ttm180 -52.95 -53.07 55.09 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.292 0.995 . . . . 74.42 109.66 171.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -62.75 -44.61 95.74 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 124.385 1.053 . . . . 72.42 111.701 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 17.1 t -62.2 -45.3 93.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.474 0.71 . . . . 61.42 110.555 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.3 mt -60.97 -54.66 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.799 0.84 . . . . 74.22 110.016 175.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.586 HG23 ' HG3' ' A' ' 125' ' ' GLN . 85.0 m -48.55 -48.0 38.92 Favored 'General case' 0 C--O 1.248 1.024 0 C-N-CA 124.515 1.126 . . . . 64.43 111.585 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -64.31 -47.69 78.48 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.272 -1.331 . . . . 62.43 110.034 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 39.0 mtp -61.07 -41.04 95.9 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.183 0.993 . . . . 73.2 112.32 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 114' ' ' ILE . 98.3 t -62.2 -45.94 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.691 0.796 . . . . 73.25 109.954 177.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.0 m -70.68 -27.77 64.27 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.386 -0.825 . . . . 50.32 111.978 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -72.55 -30.14 64.17 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.505 0.722 . . . . 72.05 110.186 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.82 7.07 75.9 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.541 0.525 . . . . 40.12 112.981 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.1 m 69.41 12.23 8.24 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.772 1.229 . . . . 74.11 111.791 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.533 ' HE1' HG11 ' A' ' 31' ' ' VAL . 89.3 m-85 -81.1 152.35 71.14 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.177 0.591 . . . . 72.32 109.792 173.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.4 138.16 79.31 Favored 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 123.162 2.575 . . . . 71.44 112.224 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.586 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.5 tt0 -55.39 129.48 38.78 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 123.875 0.734 . . . . 75.23 111.654 -176.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.4 tp -110.4 116.76 32.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.945 -1.025 . . . . 71.02 109.566 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -118.84 101.87 8.38 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.723 -1.214 . . . . 63.42 107.723 172.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 pp -64.4 134.24 54.16 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 109.8 -0.445 . . . . 63.21 109.8 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.28 146.9 94.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.058 0.543 . . . . 62.04 110.46 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.415 ' HA ' ' HE2' ' A' ' 107' ' ' PHE . 36.3 Cg_exo -61.83 115.18 2.64 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.54 2.16 . . . . 54.23 111.38 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.35 121.08 48.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.986 -1.116 . . . . 75.01 107.986 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -71.98 95.81 1.63 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.801 -0.815 . . . . 73.34 108.801 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 94.3 m-85 -60.51 -31.61 70.66 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.67 0.788 . . . . 71.43 111.996 -177.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.66 -50.74 70.02 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.911 0.757 . . . . 61.03 109.921 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.11 90.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.574 0.75 . . . . 62.44 111.064 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.41 -34.18 77.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.738 0.815 . . . . 73.33 111.42 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -73.19 -34.6 66.07 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.187 0.595 . . . . 74.01 110.036 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.456 ' SD ' ' HA3' ' A' ' 146' ' ' GLY . 24.1 mmt -74.68 -23.73 58.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.041 0.536 . . . . 72.22 111.306 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 143' ' ' GLN . 82.4 m-20 -66.95 -31.12 71.48 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.26 0.624 . . . . 61.13 110.061 171.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -85.76 -45.11 11.93 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.312 -0.858 . . . . 71.44 110.474 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.4 tp -69.14 -45.96 68.79 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.617 1.167 . . . . 70.23 111.575 -170.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -146.77 12.37 1.13 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 120.968 0.413 . . . . 71.34 111.335 -172.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 2.1 mp0 69.04 -75.97 0.06 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.489 1.516 . . . . 53.2 112.689 176.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -128.95 65.75 1.44 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.47 0.652 . . . . 65.23 109.819 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -165.45 -160.73 0.48 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.572 -1.194 . . . . 60.13 109.704 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.456 ' HA3' ' SD ' ' A' ' 138' ' ' MET . . . 89.65 8.2 68.01 Favored Glycine 0 C--N 1.355 1.633 0 O-C-N 122.943 0.152 . . . . 71.22 113.316 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.402 ' O ' ' HB ' ' C' ' 149' ' ' THR . 11.2 pt-20 -81.57 134.44 35.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.246 1.018 . . . . 62.01 111.141 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.58 -147.62 25.56 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 116.31 -0.405 . . . . 72.33 112.667 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.1 m -139.71 160.32 40.14 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.921 0.888 . . . . 75.13 109.396 -176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -82.2 -159.05 0.28 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.926 0.891 . . . . 55.43 110.618 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 65.22 83.87 0.16 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.565 1.146 . . . . 64.14 110.438 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -141.03 32.17 1.76 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.311 -1.313 . . . . 74.42 108.524 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -83.2 72.36 10.16 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 108.371 -0.974 . . . . 73.44 108.371 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -66.11 -64.54 0.84 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.458 0.703 . . . . 63.42 111.337 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.048 0 CA-C-O 118.15 -0.928 . . . . 61.02 109.095 -179.597 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.54 ' SD ' ' HA ' ' F' ' 452' ' ' VAL . 90.5 mtp . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.192 -0.67 . . . . 62.54 109.192 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 42.4 t -163.17 -64.74 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.202 1.001 . . . . 72.32 108.969 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -166.42 133.73 2.65 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.132 -1.062 . . . . 73.52 108.132 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -75.13 87.56 2.42 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.536 1.16 . . . . 72.11 110.796 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -110.14 -32.64 6.93 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.154 -0.93 . . . . 64.21 110.903 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -77.68 90.9 4.0 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.16 -0.682 . . . . 74.21 109.16 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 17.4 m -75.77 -37.64 59.06 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.514 -1.221 . . . . 71.23 110.674 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -76.54 -20.62 56.69 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.742 -1.117 . . . . 73.35 111.089 -174.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 22.9 ptm 51.67 -168.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 126.507 1.923 . . . . 73.31 113.353 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 87.7 m -141.62 121.26 13.37 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.663 -1.236 . . . . 75.13 107.663 174.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.455 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 30.8 t80 -139.32 138.96 37.13 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.546 -0.909 . . . . 55.22 108.546 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -158.93 141.12 13.88 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.215 0.606 . . . . 73.31 109.674 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.418 HD13 HD11 ' B' ' 16' ' ' ILE . 54.1 mt -83.69 121.98 37.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.989 -1.115 . . . . 64.04 107.989 172.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -94.11 -43.8 8.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.204 0.602 . . . . 61.31 109.401 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.446 HH11 ' HD1' ' A' ' 32' ' ' PHE . 50.0 ttt180 -163.89 132.69 3.77 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.515 -0.766 . . . . 73.31 109.314 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.418 HD11 HD13 ' B' ' 13' ' ' ILE . 96.0 mt -115.02 141.29 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.237 -1.394 . . . . 63.35 107.237 169.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.428 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 33.1 p90 -164.73 157.27 16.44 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.837 0.711 . . . . 74.21 110.735 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.502 HG21 HD11 ' B' ' 21' ' ' ILE . 22.6 m -83.72 122.92 29.29 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.635 -1.246 . . . . 72.15 107.635 168.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.414 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 19.4 mtpp -84.15 -52.82 5.96 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.917 -0.772 . . . . 75.34 108.917 176.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 28.9 t70 -134.96 149.43 50.22 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.687 -0.688 . . . . 63.25 111.256 -170.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.502 HD11 HG21 ' B' ' 18' ' ' THR . 25.7 mm -139.81 144.74 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.528 1.531 . . . . 74.53 108.575 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -147.73 110.99 4.88 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.098 0.873 . . . . 75.44 108.667 166.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.477 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 85.7 t80 -119.81 113.06 20.03 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.204 -1.406 . . . . 72.3 107.204 170.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -122.95 124.23 42.72 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.611 0.764 . . . . 72.41 109.203 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.49 85.0 12.78 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.162 -1.421 . . . . 71.02 107.162 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.44 -36.83 19.02 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.886 2.39 . . . . 71.01 112.811 -169.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -105.5 17.26 24.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.887 0.875 . . . . 61.44 110.378 -176.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.435 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -41.59 -61.97 1.25 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 115.349 1.611 . . . . 63.52 115.349 -164.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.3 Cg_exo -66.97 -16.06 48.61 Favored 'Trans proline' 0 C--N 1.4 3.287 0 C-N-CA 122.314 2.01 . . . . 55.14 112.372 -170.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -97.73 -49.04 4.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.19 0.996 . . . . 74.11 111.408 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.516 HG22 HD12 ' B' ' 68' ' ' LEU . 9.8 p -64.38 -20.49 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.563 0.745 . . . . 51.23 112.333 -166.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -65.04 -17.76 64.73 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.45 0.908 . . . . 72.23 113.45 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -59.3 -25.52 64.21 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.114 0.566 . . . . 71.34 110.901 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -94.46 80.11 3.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.512 1.125 . . . . 65.35 108.674 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.3 93.25 3.4 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.294 0.569 . . . . 72.02 109.59 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -161.74 158.26 25.56 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.752 1.221 . . . . 70.35 107.988 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -60.43 106.15 0.71 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.903 0.881 . . . . 72.05 110.032 169.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.546 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 35.5 Cg_endo -64.35 124.71 13.79 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.872 1.714 . . . . 73.03 110.497 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -58.15 107.23 0.45 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 123.724 0.64 . . . . 61.42 110.126 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.569 HG22 HD21 ' F' ' 470' ' ' LEU . 28.5 m -96.68 150.52 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.744 0.783 . . . . 74.33 112.535 -173.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -119.42 115.12 23.44 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.253 -1.34 . . . . 64.23 107.657 170.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.544 HD21 HD23 ' F' ' 468' ' ' LEU . 3.9 mp -85.15 132.22 34.33 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.421 -1.326 . . . . 71.22 107.421 176.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 14.4 t70 -147.38 110.96 4.95 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 110.135 -0.32 . . . . 75.3 110.135 -177.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 mp -100.57 163.79 12.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.995 0.426 . . . . 72.31 110.211 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 17.7 t70 -158.43 139.25 12.91 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.712 1.205 . . . . 52.4 108.397 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 47.8 p -133.6 117.73 17.4 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.938 0.495 . . . . 71.53 110.452 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.64 162.8 17.44 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.632 1.173 . . . . 50.24 108.662 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.434 ' HB2' ' HD2' ' B' ' 56' ' ' TYR . 64.1 p -143.22 160.93 39.54 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.184 -0.672 . . . . 71.31 109.184 170.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.0 p -152.16 135.6 16.02 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.509 0.724 . . . . 64.33 109.426 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.33 124.95 29.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.08 0.552 . . . . 43.42 110.215 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 64.6 mt -86.96 -44.68 11.44 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.672 -0.492 . . . . 74.43 109.672 172.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.96 -175.63 5.47 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.675 -0.693 . . . . 62.24 111.098 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.48 124.32 21.02 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.524 -1.216 . . . . 73.04 109.443 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.427 ' H ' ' HB ' ' F' ' 451' ' ' VAL . 7.2 m-20 67.29 19.59 10.2 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.563 1.145 . . . . 72.13 111.663 178.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -131.27 125.82 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.166 0.986 . . . . 72.22 109.464 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.434 ' HD2' ' HB2' ' B' ' 48' ' ' SER . 0.2 OUTLIER -131.81 140.51 49.18 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.977 -0.749 . . . . 74.34 108.977 174.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -112.41 106.67 15.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.982 -1.488 . . . . 73.43 106.982 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.4 t -93.74 140.66 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.921 0.488 . . . . 62.21 109.924 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.3 t -116.77 135.34 57.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 124.41 1.084 . . . . 72.3 109.062 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.07 109.87 16.41 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.82 -1.178 . . . . 74.23 107.82 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.501 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.2 ttt180 -95.38 123.64 39.01 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.813 0.845 . . . . 75.12 109.727 173.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.514 ' HB ' HD11 ' B' ' 114' ' ' ILE . 15.2 t -118.34 123.85 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.347 -0.982 . . . . 64.54 108.347 171.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 39.6 m -107.85 140.78 40.43 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.676 1.19 . . . . 72.42 109.455 -178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.463 HG21 HG21 ' B' ' 114' ' ' ILE . 97.8 t -133.13 100.59 3.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 124.155 0.982 . . . . 64.11 108.715 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 70.8 m -84.0 138.88 32.88 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.023 -1.102 . . . . 52.31 108.023 167.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.554 ' HB2' HG12 ' B' ' 40' ' ' VAL . . . -147.69 149.39 32.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.985 0.357 . . . . 61.14 110.459 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 62.5 p -152.11 135.91 16.3 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.834 0.709 . . . . 70.51 111.541 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.546 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 43.6 mt -103.21 117.35 34.34 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.182 0.993 . . . . 75.12 108.942 173.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.04 -112.69 5.13 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.244 -0.889 . . . . 65.03 112.189 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -115.88 4.21 13.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.691 0.796 . . . . 75.31 111.703 -175.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -118.96 158.72 25.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.591 0.756 . . . . 73.25 110.012 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.5 m -64.56 138.25 58.3 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.615 0.572 . . . . 74.34 110.792 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.448 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -96.71 -65.11 0.99 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.337 -0.847 . . . . 72.21 108.811 171.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -149.82 155.29 39.83 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.368 -0.833 . . . . 74.05 109.721 -177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 41.4 mt -131.98 108.56 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.232 -1.766 . . . . 64.35 106.232 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.444 ' SG ' HG23 ' B' ' 114' ' ' ILE . 49.4 t -118.82 139.46 51.57 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.693 -0.854 . . . . 44.04 108.693 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -159.69 133.78 7.47 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.29 -0.633 . . . . 65.11 109.29 -173.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.7 t -124.62 146.48 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.126 -0.943 . . . . 73.33 109.019 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 29.1 mt-30 -122.3 84.12 2.21 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.076 -1.083 . . . . 71.15 108.076 171.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -81.75 101.06 9.88 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.721 -1.127 . . . . 73.31 109.473 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -92.2 167.78 30.58 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 111.9 -0.48 . . . . 44.35 111.9 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.87 126.81 1.66 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.109 -0.796 . . . . 54.12 111.109 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 65.6 mt -84.83 127.78 39.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.605 -0.887 . . . . 72.24 108.605 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -134.87 146.36 49.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.153 0.981 . . . . 72.04 108.618 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -99.94 106.9 18.76 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.883 -0.784 . . . . 63.3 108.883 170.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.661 ' HB ' HD11 ' B' ' 89' ' ' ILE . 48.4 pt -116.06 130.41 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.171 0.588 . . . . 62.51 110.239 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -149.52 159.9 43.92 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.559 0.744 . . . . 34.05 110.304 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.99 -54.32 4.73 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.741 -0.663 . . . . 55.41 112.692 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.661 HD11 ' HB ' ' B' ' 86' ' ' ILE . 17.6 pt -54.23 138.56 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.736 1.214 . . . . 65.52 112.798 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -162.8 172.5 15.11 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.793 -1.094 . . . . 71.43 109.749 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.42 -109.93 2.94 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.994 -0.548 . . . . 44.24 112.282 -173.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.2 m -89.61 -26.62 20.68 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.481 0.712 . . . . 63.44 110.946 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.511 ' HB3' HG22 ' B' ' 89' ' ' ILE . 48.5 mt-30 -58.52 -46.08 87.51 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.394 0.616 . . . . 71.02 110.049 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.552 ' HB2' HG21 ' F' ' 452' ' ' VAL . 0.0 OUTLIER -70.32 -35.29 73.55 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.584 -1.189 . . . . 65.05 110.507 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.72 -47.85 84.03 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 124.119 0.887 . . . . 62.42 109.954 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -62.24 -27.8 69.25 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.263 -1.335 . . . . 74.21 111.306 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 t -76.06 -66.93 0.73 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.008 0.523 . . . . 72.13 110.888 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 94' ' ' MET . 1.5 pp -71.83 -22.54 61.53 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 112.92 0.711 . . . . 64.41 112.92 -173.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.6 -1.21 53.04 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.553 -0.582 . . . . 33.43 114.058 -175.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.98 -64.43 0.19 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.608 0.704 . . . . 73.01 111.755 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -59.91 -55.03 39.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.314 1.045 . . . . 75.33 112.021 -168.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.482 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 92.1 m -59.52 -52.09 76.6 Favored Pre-proline 0 CA--C 1.568 1.665 0 C-N-CA 124.397 1.079 . . . . 72.05 112.097 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 71.1 Cg_exo -54.92 -40.5 85.23 Favored 'Trans proline' 0 C--N 1.404 3.485 0 C-N-CA 122.433 2.089 . . . . 72.45 114.393 172.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -63.89 -24.18 67.64 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.888 0.699 . . . . 73.43 112.888 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.53 -43.98 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.603 -0.517 . . . . 52.23 109.603 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 60.8 mt -76.71 -21.99 54.53 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.55 -1.205 . . . . 71.31 112.015 -173.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -60.57 -48.38 93.58 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 118.073 -0.965 . . . . 72.01 113.283 -171.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.28 -39.5 86.54 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.987 1.791 . . . . 63.24 113.277 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -66.57 -45.83 78.03 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.193 0.597 . . . . 75.32 110.684 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.88 -34.75 78.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.278 0.631 . . . . 64.2 111.045 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.721 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 39.1 ttt180 -63.62 -54.33 37.55 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.143 1.377 . . . . 64.11 111.178 -177.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.39 -33.9 76.74 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.716 0.635 . . . . 73.53 109.821 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.499 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.4 t -66.73 -31.52 72.23 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.146 0.578 . . . . 72.3 111.907 -177.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.582 HD12 HD22 ' B' ' 128' ' ' LEU . 80.5 mt -70.45 -58.66 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 109.033 -0.729 . . . . 75.51 109.033 172.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.6 m -59.02 -26.63 64.72 Favored 'General case' 0 CA--C 1.554 1.103 0 O-C-N 124.29 0.994 . . . . 51.42 111.825 -173.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 36.3 t -60.52 -56.6 19.36 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.205 1.002 . . . . 64.54 109.268 173.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.3 mmt -67.48 -34.21 76.69 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.655 0.782 . . . . 75.31 111.375 -173.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 114' ' ' ILE . 94.0 t -59.71 -49.69 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.958 0.903 . . . . 62.45 110.121 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.7 t -66.31 -34.75 78.7 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.651 -1.158 . . . . 60.45 111.363 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.403 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.6 mtt-85 -65.46 -35.84 82.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.388 0.675 . . . . 62.23 110.337 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.52 15.07 53.13 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 123.923 0.764 . . . . 51.12 112.96 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.503 HG23 ' HB3' ' A' ' 17' ' ' TYR . 69.3 p 54.37 26.78 7.33 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.959 1.704 . . . . 73.44 113.608 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -85.3 151.16 56.11 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.357 0.663 . . . . 63.22 110.906 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.61 167.71 1.34 Allowed 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 124.049 3.166 . . . . 64.12 115.315 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -63.85 114.83 4.31 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.036 -0.984 . . . . 65.2 112.548 -167.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 17.0 tp -116.28 98.49 6.62 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 115.432 -0.804 . . . . 64.12 109.501 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -97.37 95.96 8.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.25 -1.018 . . . . 75.43 108.25 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.721 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 31.8 tp -55.18 116.87 3.04 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.352 0.661 . . . . 73.53 110.69 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.62 146.18 88.17 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.886 0.874 . . . . 55.22 111.582 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -76.61 110.71 3.1 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.328 2.685 . . . . 75.5 111.923 -173.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.2 t -90.82 111.0 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 108.576 -0.898 . . . . 74.24 108.576 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -78.75 110.81 14.25 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.68 -0.859 . . . . 60.34 108.68 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -69.5 -48.66 59.86 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.581 0.55 . . . . 71.21 110.619 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -56.95 -40.78 77.08 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.187 0.995 . . . . 73.54 112.442 -171.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.43 -53.84 53.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.211 1.004 . . . . 70.12 111.384 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' F' ' 462' ' ' TYR . 6.5 mp -84.64 -11.98 54.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.493 -0.776 . . . . 74.1 111.664 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.404 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 66.7 t80 -71.38 -33.1 69.21 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.16 0.584 . . . . 53.44 110.272 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 59.9 mtm -63.47 -35.38 80.25 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.957 -0.565 . . . . 62.2 109.518 172.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.448 ' N ' HD22 ' B' ' 139' ' ' ASN . 0.7 OUTLIER -74.59 -16.44 60.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.774 0.83 . . . . 61.23 110.661 176.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -82.46 -34.97 27.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.263 0.625 . . . . 70.01 111.056 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 75.4 mt -81.86 -12.27 58.55 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 111.983 0.364 . . . . 74.53 111.983 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -156.94 130.51 8.1 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.317 1.047 . . . . 63.52 108.387 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -64.74 90.53 0.08 Allowed 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 121.903 0.858 . . . . 75.23 109.494 172.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -171.83 134.0 0.77 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.387 -1.278 . . . . 72.44 107.83 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.09 142.64 27.52 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.966 0.506 . . . . 54.52 110.596 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.01 46.24 1.2 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 110.871 -0.892 . . . . 70.44 110.871 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -65.46 149.1 50.6 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.51 1.124 . . . . 53.11 112.018 -176.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -122.68 147.34 16.83 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 110.759 -0.937 . . . . 72.42 110.759 174.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 67.1 p -71.86 93.55 1.34 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.19 -0.67 . . . . 61.42 109.19 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.54 71.23 2.45 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.375 1.083 . . . . 74.25 110.667 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -88.02 173.45 8.87 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 114.751 -1.113 . . . . 74.22 111.13 -175.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -150.2 104.43 3.26 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.648 -0.705 . . . . 73.12 109.617 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -111.48 115.39 29.15 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.63 -0.878 . . . . 75.13 108.63 174.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.18 163.48 28.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.767 0.827 . . . . 52.43 110.856 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.26 0 C-N-CA 123.805 0.842 . . . . 62.11 110.032 177.524 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttp . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.508 -0.553 . . . . 62.1 109.508 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 45.6 m 62.38 82.85 0.17 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.797 1.239 . . . . 65.02 111.265 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.93 34.92 0.51 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.268 1.027 . . . . 74.41 111.858 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -70.6 2.42 4.08 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.405 1.082 . . . . 65.43 112.446 174.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 65.0 t30 70.04 23.93 5.22 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.355 1.462 . . . . 71.13 110.939 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -83.71 -14.09 52.5 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.418 -0.81 . . . . 71.52 110.415 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 14.9 t -78.69 159.8 27.8 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 123.417 0.687 . . . . 73.42 110.382 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -99.4 72.78 1.83 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.411 0.684 . . . . 70.31 109.342 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 24.1 ttt 65.36 145.62 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.011 1.324 . . . . 73.52 112.949 175.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 32.4 m -85.56 95.9 9.47 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.029 -0.73 . . . . 73.31 109.029 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.546 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 3.5 t80 -121.14 124.2 44.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.487 0.715 . . . . 74.1 109.896 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.425 HE21 HE22 ' C' ' 14' ' ' GLN . 27.3 tt0 -140.61 140.16 35.03 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.165 -1.05 . . . . 55.33 108.165 170.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 68.0 mt -85.96 129.74 37.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.159 -0.682 . . . . 74.05 109.159 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.486 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.1 mm-40 -87.94 -45.43 10.24 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.64 0.776 . . . . 75.35 109.727 178.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -169.7 148.21 3.59 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.024 -0.534 . . . . 72.44 109.667 -172.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.4 mt -137.58 136.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.747 -1.205 . . . . 73.03 107.747 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.464 ' HB3' HG23 ' D' ' 122' ' ' THR . 28.9 p90 -169.74 161.03 9.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.007 0.432 . . . . 73.13 111.838 -172.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.9 p -80.39 108.06 13.7 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.095 -0.705 . . . . 54.3 109.095 170.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -68.34 -37.3 80.39 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.445 -0.576 . . . . 73.14 109.445 172.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 12.8 t70 -149.78 150.27 31.78 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.49 -0.777 . . . . 65.14 109.83 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.5 mt -141.63 146.94 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.34 1.456 . . . . 61.32 107.62 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -152.19 142.37 22.35 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.484 0.714 . . . . 73.12 109.563 173.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -142.9 137.86 29.8 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.618 -1.253 . . . . 75.45 107.618 170.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -130.08 121.68 26.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.365 1.066 . . . . 74.33 109.293 -172.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.34 69.11 13.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 106.12 -1.807 . . . . 74.41 106.12 165.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.22 -10.35 27.09 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.555 2.17 . . . . 34.4 112.178 -174.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -123.23 26.38 8.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.664 1.585 . . . . 70.35 109.774 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.61 -58.12 4.06 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 114.64 1.348 . . . . 72.31 114.64 -169.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.57 -33.32 46.18 Favored 'Trans proline' 0 C--N 1.388 2.609 0 CA-C-N 121.844 1.694 . . . . 73.03 112.362 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -69.41 -37.53 77.51 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.846 0.859 . . . . 75.11 111.575 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.876 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -79.31 -26.33 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 N-CA-C 112.513 0.56 . . . . 74.5 112.513 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.25 -31.87 73.24 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 112.212 0.449 . . . . 64.04 112.212 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -85.79 9.55 16.23 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.542 0.337 . . . . 72.04 111.881 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.62 166.1 11.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.484 0.714 . . . . 54.55 111.037 -175.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -58.2 127.53 32.58 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.003 0.921 . . . . 55.33 110.018 170.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.46 ' NE1' ' HG2' ' C' ' 124' ' ' PRO . 32.9 t90 -84.95 93.24 8.51 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.613 0.765 . . . . 73.21 109.831 177.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -150.47 78.73 7.59 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 108.51 -0.922 . . . . 74.23 108.51 164.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.501 ' HB3' ' HB1' ' C' ' 66' ' ' ALA . 16.6 Cg_exo -68.56 136.95 37.85 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.681 2.254 . . . . 41.43 112.183 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -86.21 93.43 9.04 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 105.359 -2.089 . . . . 61.21 105.359 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.406 HG23 ' HB1' ' G' ' 466' ' ' ALA . 17.0 m -68.6 131.41 33.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 115.368 -0.833 . . . . 60.1 109.755 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 tptt -134.9 129.62 34.64 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.526 -1.657 . . . . 74.13 106.526 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.579 HD12 ' SD ' ' G' ' 464' ' ' MET . 2.8 tm? -116.32 139.68 50.13 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.508 -0.923 . . . . 70.23 108.508 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.549 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.2 t70 -134.4 141.2 46.76 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.453 1.101 . . . . 55.32 108.971 -177.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 79.6 mt -132.11 137.15 47.61 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.309 1.044 . . . . 64.42 108.917 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.509 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 27.3 t70 -144.81 155.23 43.39 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.11 0.964 . . . . 71.13 109.201 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.659 ' H ' HD21 ' G' ' 460' ' ' LEU . 5.1 m -151.1 138.55 19.51 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.29 1.036 . . . . 62.43 109.577 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.67 173.92 10.17 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.742 1.217 . . . . 62.12 108.926 175.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -159.95 153.95 23.18 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.65 0.78 . . . . 71.14 110.039 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.8 p -155.3 137.54 14.8 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.258 0.623 . . . . 65.54 109.434 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.438 ' NE2' HG21 ' G' ' 452' ' ' VAL . 58.3 tt0 -77.32 118.8 20.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.053 -0.721 . . . . 71.42 109.053 174.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.575 HD11 HD12 ' C' ' 83' ' ' ILE . 54.1 mt -93.35 -43.16 8.92 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.348 -0.612 . . . . 72.33 109.348 176.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -148.79 -177.89 6.05 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.227 -0.897 . . . . 75.12 110.919 -177.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.91 123.8 21.21 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.722 -1.126 . . . . 73.54 109.101 175.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 61.27 18.81 9.55 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.444 1.098 . . . . 65.01 112.056 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 77.4 t -127.88 103.67 10.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 124.351 1.06 . . . . 64.12 109.238 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.503 ' HD1' HD11 ' C' ' 86' ' ' ILE . 24.7 m-85 -102.3 146.49 27.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.489 -0.778 . . . . 72.25 108.986 169.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.55 ' HB2' HD11 ' C' ' 51' ' ' LEU . 35.0 tt0 -94.35 129.07 41.18 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.408 -1.33 . . . . 70.42 107.408 160.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.408 HG11 ' HD3' ' C' ' 103' ' ' PRO . 42.4 t -106.27 143.4 17.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.993 -1.114 . . . . 74.3 107.993 165.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.0 t -121.28 140.66 44.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 107.931 -1.137 . . . . 75.25 107.931 172.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -129.71 106.97 9.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.553 -1.277 . . . . 72.15 107.553 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.509 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 58.7 ttt-85 -95.41 122.64 38.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.993 -1.458 . . . . 74.23 108.83 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.9 t -117.27 132.35 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.013 -1.106 . . . . 64.5 108.013 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.8 m -134.12 128.95 35.18 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.3 0.64 . . . . 74.22 109.715 -174.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.624 HG23 HD13 ' C' ' 114' ' ' ILE . 61.6 t -115.64 121.03 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.839 0.856 . . . . 74.54 109.712 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.7 m -100.81 145.36 28.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.476 0.71 . . . . 74.53 109.179 170.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' C' ' 38' ' ' PRO . . . -136.98 131.37 32.85 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.792 -1.188 . . . . 62.01 107.792 169.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.7 m -139.95 129.17 23.83 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 123.598 0.561 . . . . 72.11 110.266 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 37.1 mt -85.22 41.5 0.89 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.319 1.048 . . . . 64.01 109.704 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.73 -104.17 2.54 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 110.053 -1.219 . . . . 54.04 110.053 -170.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -93.8 -29.72 15.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.263 1.025 . . . . 65.52 110.003 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -73.14 120.17 18.4 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.823 0.849 . . . . 71.14 110.268 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 35.7 m -75.88 129.64 37.29 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.568 -0.53 . . . . 51.11 109.568 173.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.876 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.27 -60.95 2.07 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.398 -0.964 . . . . 73.22 108.398 170.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -158.09 173.77 16.23 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 114.417 -1.265 . . . . 63.34 111.436 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -138.89 130.04 26.79 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.572 -1.64 . . . . 70.23 106.572 162.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 46.0 t -128.35 138.73 52.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.946 -1.131 . . . . 74.43 107.946 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . 0.415 ' HG2' ' OE1' ' C' ' 79' ' ' GLN . 28.7 tt0 -154.54 129.07 9.19 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.522 -0.548 . . . . 75.52 109.522 -170.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' C' ' 61' ' ' ARG . 97.2 t -135.03 114.3 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.689 0.796 . . . . 54.41 109.921 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.415 ' OE1' ' HG2' ' C' ' 77' ' ' GLU . 1.7 mp0 -90.08 87.84 7.04 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.531 -0.915 . . . . 71.31 108.531 174.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -83.21 98.77 9.55 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.308 -0.86 . . . . 35.34 109.662 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.42 159.49 38.86 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.441 -0.664 . . . . 52.44 111.441 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.582 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -161.25 118.83 0.85 Allowed Glycine 0 CA--C 1.504 -0.614 0 N-CA-C 111.047 -0.821 . . . . 74.31 111.047 -177.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.575 HD12 HD11 ' C' ' 51' ' ' LEU . 6.9 mm -84.1 121.13 36.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.334 -0.987 . . . . 74.2 108.334 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.546 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 57.6 m-85 -126.58 118.46 24.89 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.421 -0.955 . . . . 75.32 108.421 -177.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 54.5 p -87.95 105.87 17.74 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.688 -0.856 . . . . 64.0 108.688 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.608 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -116.97 125.9 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.038 0.935 . . . . 73.22 109.341 -176.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.96 163.93 32.05 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.473 0.709 . . . . 43.51 110.697 -172.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.04 -41.99 2.88 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 115.519 -0.764 . . . . 71.14 113.111 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 46.9 mm -122.73 150.4 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.901 0.88 . . . . 70.41 110.421 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.433 ' HB3' ' HB ' ' G' ' 451' ' ' VAL . 12.5 pt-20 -145.52 -174.22 4.34 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.179 0.992 . . . . 73.41 111.544 -168.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.64 -138.17 25.62 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 115.414 -0.812 . . . . 74.13 113.778 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' C' ' 141' ' ' LEU . 53.5 p -61.87 -29.12 69.98 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.152 0.981 . . . . 71.54 111.113 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -70.04 -44.71 68.66 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.471 -1.24 . . . . 75.35 111.326 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -73.7 -30.45 62.88 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 110.17 -0.307 . . . . 64.23 110.17 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.4 81.11 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.134 0.574 . . . . 63.11 109.615 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -72.17 -41.05 67.49 Favored 'General case' 0 C--O 1.241 0.636 0 O-C-N 123.464 0.478 . . . . 71.14 110.935 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -59.5 -38.18 80.23 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.272 0.983 . . . . 70.13 111.119 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 37.4 mt -101.13 -23.48 14.46 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.356 0.662 . . . . 54.55 112.417 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.78 -23.74 57.2 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 116.138 -0.483 . . . . 61.52 114.107 -170.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.64 -43.47 0.1 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.148 0.499 . . . . 62.44 111.034 -171.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -66.34 -42.79 87.61 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.425 1.49 . . . . 75.11 112.729 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 33.8 m -73.76 -43.48 6.61 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-O 118.832 -0.604 . . . . 51.13 112.277 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.408 ' HD3' HG11 ' C' ' 58' ' ' VAL . 84.8 Cg_exo -51.22 -31.83 38.2 Favored 'Trans proline' 0 C--N 1.393 2.873 0 C-N-CA 122.361 2.041 . . . . 73.13 114.201 167.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' C' ' 134' ' ' ASP . 74.7 m-20 -64.17 -35.18 79.95 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.854 0.862 . . . . 74.42 111.712 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.467 HD12 ' NH1' ' A' ' 111' ' ' ARG . 50.8 mm -68.43 -38.69 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.281 0.563 . . . . 53.24 109.723 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.582 HD21 ' HA3' ' C' ' 82' ' ' GLY . 90.9 mt -80.56 -22.71 40.53 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.725 -1.125 . . . . 73.55 112.736 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.49 ' HZ ' HD22 ' C' ' 128' ' ' LEU . 45.7 t80 -59.48 -49.73 90.84 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-O 117.75 -1.119 . . . . 75.14 113.631 -173.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -53.02 -36.68 76.91 Favored 'Trans proline' 0 C--N 1.392 2.831 0 C-N-CA 122.44 2.094 . . . . 72.42 114.006 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -69.3 -52.88 23.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.763 0.825 . . . . 71.32 110.763 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.28 -36.3 81.66 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.148 -0.933 . . . . 62.21 111.142 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -59.11 -54.96 41.05 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.657 1.583 . . . . 72.51 110.814 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -67.75 -33.72 75.4 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.554 0.742 . . . . 75.41 110.251 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 28.1 t -68.58 -31.84 71.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.03 0.532 . . . . 74.11 111.496 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.624 HD13 HG23 ' C' ' 64' ' ' VAL . 64.2 mt -68.92 -52.44 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.129 -0.487 . . . . 65.14 109.993 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 3.6 m -65.49 -28.83 69.48 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 123.741 0.651 . . . . 72.42 111.24 -174.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 46.3 t -66.53 -49.31 66.92 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 123.771 0.828 . . . . 51.4 109.413 171.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.619 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.09 -40.72 86.16 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.804 1.242 . . . . 65.41 112.917 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.542 HG13 ' HB2' ' C' ' 123' ' ' PHE . 39.2 t -67.75 -42.48 86.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.323 1.049 . . . . 64.45 110.351 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.0 t -70.0 -27.22 64.51 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.716 -0.675 . . . . 51.2 111.154 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.481 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.1 mtt-85 -68.38 -36.85 79.78 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.807 0.843 . . . . 74.33 108.93 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.39 9.26 67.98 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 124.052 0.845 . . . . 51.23 112.834 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 57.0 p 55.52 36.61 27.5 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.614 1.565 . . . . 54.21 113.759 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.542 ' HB2' HG13 ' C' ' 118' ' ' VAL . 97.0 m-85 -96.64 158.03 34.32 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.916 0.887 . . . . 63.42 109.243 172.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.46 ' HG2' ' NE1' ' C' ' 36' ' ' TRP . 34.6 Cg_exo -61.52 157.7 40.21 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 122.993 2.462 . . . . 70.34 113.882 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -60.18 141.24 56.25 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.448 1.099 . . . . 73.23 113.184 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.626 ' HB3' ' HB2' ' G' ' 470' ' ' LEU . 0.5 OUTLIER -134.72 96.7 3.6 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.961 -1.018 . . . . 75.3 109.816 170.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -90.65 95.62 10.24 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.288 -1.005 . . . . 75.53 108.288 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.55 HD11 HD21 ' C' ' 42' ' ' LEU . 1.3 tt -60.49 129.36 41.21 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.498 1.119 . . . . 73.03 110.628 -172.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.86 148.72 98.44 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.373 0.669 . . . . 72.54 111.284 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.593 ' HG3' HD12 ' A' ' 16' ' ' ILE . 50.1 Cg_exo -54.29 117.56 4.06 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.783 2.322 . . . . 53.14 112.693 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.35 118.21 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.822 -0.807 . . . . 73.01 108.822 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.91 88.56 4.71 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.089 0.556 . . . . 73.44 109.935 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -73.82 -45.25 52.49 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.072 -0.714 . . . . 73.14 109.072 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.513 ' HB2' ' ND2' ' C' ' 104' ' ' ASN . 20.6 t70 -66.98 -41.64 86.44 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.277 -1.328 . . . . 72.45 111.707 -168.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.86 94.19 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.755 -1.111 . . . . 63.12 112.075 -177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.31 -26.44 46.93 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 116.035 -0.53 . . . . 62.55 112.378 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -68.92 -25.51 64.62 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.717 0.407 . . . . 71.04 110.742 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 65.7 mtt -59.72 -41.61 91.24 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.336 0.655 . . . . 71.52 110.46 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -60.79 -37.3 81.46 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.655 0.782 . . . . 72.22 111.13 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -66.15 -85.06 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.306 1.043 . . . . 73.32 110.052 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.458 ' HB3' ' HB ' ' C' ' 92' ' ' THR . 72.2 mt -131.83 134.52 45.86 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.238 0.615 . . . . 74.54 110.25 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -160.43 163.55 32.97 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.547 1.139 . . . . 64.32 109.265 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -95.26 102.07 13.85 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.979 -0.749 . . . . 72.23 108.979 171.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -76.17 101.56 5.42 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.161 -1.051 . . . . 61.21 108.161 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -174.63 144.56 0.86 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.65 1.18 . . . . 72.03 109.007 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -165.75 142.11 7.46 Favored Glycine 0 C--N 1.343 0.972 0 O-C-N 123.407 0.442 . . . . 45.23 112.477 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -78.74 -178.41 5.94 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.563 0.745 . . . . 64.04 111.618 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -102.13 133.76 11.5 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 111.205 -0.758 . . . . 73.53 111.205 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 147' ' ' GLU . 12.6 t -135.81 175.23 9.79 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.732 0.813 . . . . 74.34 108.986 173.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -134.4 146.19 49.64 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 109.359 -0.608 . . . . 74.32 109.359 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.64 126.67 28.28 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.754 0.822 . . . . 72.02 109.066 171.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -141.36 86.75 2.03 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.387 -0.968 . . . . 74.34 108.387 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -71.8 104.76 3.53 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.241 -0.651 . . . . 74.41 109.241 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -151.23 132.41 14.44 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.258 1.023 . . . . 71.01 108.512 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 C-N-CA 123.711 0.805 . . . . 54.31 108.997 -178.848 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 120.767 0.317 . . . . 73.34 110.499 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 19.0 m -90.63 76.69 6.48 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.793 0.837 . . . . 71.11 109.672 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.93 104.68 11.6 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.644 -0.707 . . . . 74.4 109.889 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -73.68 -178.92 3.34 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.414 1.085 . . . . 70.44 111.733 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -136.68 145.61 44.95 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.754 0.822 . . . . 63.32 110.008 170.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -83.07 96.99 8.54 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-O 121.596 0.712 . . . . 75.34 110.454 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 98.2 m -145.0 146.84 32.09 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.533 1.133 . . . . 74.12 109.107 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -66.08 108.87 2.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.331 -1.359 . . . . 74.4 107.331 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 4.0 ttp -29.15 120.49 0.14 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 125.653 1.846 . . . . 75.41 112.907 -168.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 57.5 m -121.37 139.82 52.93 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.669 0.787 . . . . 72.13 109.371 -176.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -157.46 96.21 1.52 Allowed 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.879 -1.156 . . . . 70.25 107.879 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -113.67 130.15 56.45 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.292 -1.373 . . . . 63.22 107.292 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.511 HG21 HD11 ' D' ' 16' ' ' ILE . 39.9 mt -73.21 119.28 19.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.503 -0.925 . . . . 71.55 108.503 176.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -87.06 -30.97 20.76 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.462 0.476 . . . . 63.44 110.651 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -176.55 139.59 0.33 Allowed 'General case' 0 C--N 1.369 1.443 0 C-N-CA 122.483 0.313 . . . . 75.53 110.53 -170.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.511 HD11 HG21 ' D' ' 13' ' ' ILE . 3.1 mp -120.89 134.58 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 107.76 -1.2 . . . . 71.22 107.76 172.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -161.3 172.42 16.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.948 0.88 . . . . 71.0 111.919 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 45.7 p -104.34 124.3 48.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.758 -1.11 . . . . 72.21 109.221 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -94.55 -20.04 19.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.334 0.654 . . . . 73.43 110.186 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.721 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 3.7 t70 -158.66 135.18 9.39 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.139 -1.06 . . . . 34.42 108.139 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.619 HG21 ' HE2' ' C' ' 117' ' ' MET . 72.6 mt -135.9 145.33 31.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.068 -1.086 . . . . 73.33 108.068 175.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -151.21 144.1 24.51 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.897 0.748 . . . . 73.33 109.325 172.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.0 t80 -145.13 115.61 7.62 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 105.939 -1.875 . . . . 73.55 105.939 168.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 22.9 mt-10 -119.86 110.65 16.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.934 -0.765 . . . . 50.21 108.934 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.52 88.36 4.1 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 107.842 -1.17 . . . . 42.42 107.842 172.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.88 -28.78 7.48 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.744 2.296 . . . . 52.42 112.754 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -114.67 17.97 16.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.517 1.127 . . . . 73.13 109.96 -171.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.63 -67.53 0.33 Allowed Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 114.85 1.426 . . . . 50.31 114.85 -160.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.82 -15.62 23.81 Favored 'Trans proline' 0 C--N 1.39 2.722 0 CA-C-N 122.426 1.902 . . . . 54.1 113.54 -173.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -78.45 -45.2 22.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.45 1.1 . . . . 60.04 110.736 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.04 -24.59 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 CA-C-N 115.986 -0.552 . . . . 71.55 111.617 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -52.87 -31.27 38.61 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 123.797 0.839 . . . . 73.41 113.004 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -53.01 -24.28 9.21 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.627 1.171 . . . . 72.42 111.916 -176.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -83.41 96.38 8.53 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.441 1.096 . . . . 53.33 110.066 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -74.88 83.54 2.19 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.52 0.676 . . . . 63.41 110.078 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 -155.89 156.94 35.5 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.017 1.327 . . . . 73.05 107.915 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.425 ' O ' HD12 ' H' ' 470' ' ' LEU . 1.2 mp0 -82.21 112.2 34.02 Favored Pre-proline 0 N--CA 1.483 1.198 0 N-CA-C 109.147 -0.686 . . . . 71.32 109.147 173.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.1 124.85 16.87 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 123.416 2.744 . . . . 73.54 113.917 -173.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.683 ' HA ' ' HG ' ' H' ' 470' ' ' LEU . 38.5 mt-10 -62.1 120.36 10.73 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.021 1.329 . . . . 74.35 110.894 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.543 HG23 HG13 ' D' ' 64' ' ' VAL . 7.2 p -95.43 127.44 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.466 0.65 . . . . 70.14 110.882 -170.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -119.61 106.78 12.51 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 105.988 -1.856 . . . . 72.54 105.988 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.539 ' H ' HD23 ' D' ' 42' ' ' LEU . 1.3 pt? -110.72 134.44 52.47 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.945 0.498 . . . . 71.13 110.612 -170.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -108.72 126.4 52.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.455 0.702 . . . . 74.3 109.198 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -100.81 137.09 39.67 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.162 0.985 . . . . 74.51 109.75 -175.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.542 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.9 t70 -153.9 139.13 17.49 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.437 -0.949 . . . . 70.24 108.437 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.7 t -117.24 155.65 29.09 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.094 0.473 . . . . 71.12 110.095 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.54 176.22 11.54 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.42 1.088 . . . . 75.43 108.866 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.5 p -174.21 161.36 3.51 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.82 0.448 . . . . 43.14 111.989 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 28.4 t -157.04 124.04 5.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.605 1.162 . . . . 63.03 109.806 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -78.73 123.72 27.46 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.454 -0.573 . . . . 74.14 109.454 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 38.5 mt -94.08 -32.8 13.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.16 0.584 . . . . 71.11 109.954 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.62 -176.73 4.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.775 1.23 . . . . 52.03 108.922 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.71 135.05 36.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.093 -1.077 . . . . 54.42 108.093 171.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 74.28 -0.19 3.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.412 1.485 . . . . 63.44 111.605 -174.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.0 t -129.79 118.54 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.125 0.97 . . . . 72.51 108.782 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -141.86 128.55 20.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.702 -0.481 . . . . 73.12 109.702 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -94.23 140.26 30.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.893 0.877 . . . . 75.25 109.316 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 63.0 t -122.75 138.56 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.971 -1.122 . . . . 73.45 107.971 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.6 t -111.55 143.19 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.541 1.136 . . . . 65.03 108.388 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.51 123.58 41.58 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.506 -0.924 . . . . 71.02 108.506 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.542 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.4 ttm-85 -102.57 96.0 6.61 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.108 -1.071 . . . . 54.32 108.108 176.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 78.2 t -99.47 128.94 50.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.327 -0.99 . . . . 71.24 108.327 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 3.6 m -120.93 144.06 48.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.226 -1.027 . . . . 73.42 108.226 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.543 HG13 HG23 ' D' ' 40' ' ' VAL . 53.3 t -136.66 101.83 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.443 -1.317 . . . . 73.45 107.443 -174.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 88.5 m -107.33 97.69 7.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.17 0.988 . . . . 72.23 108.571 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.08 152.83 18.38 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.817 -0.628 . . . . 75.12 110.958 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.7 m -144.05 130.68 20.11 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.715 -0.675 . . . . 73.41 110.518 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 32.5 mt -91.82 101.09 13.68 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.833 -1.543 . . . . 73.13 106.833 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.71 -128.64 12.74 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.625 0.578 . . . . 61.44 112.383 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.3 5.73 43.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.826 0.85 . . . . 61.44 111.804 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -123.88 140.94 52.49 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.592 0.757 . . . . 73.34 110.604 -171.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.2 m -58.16 125.73 24.44 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.106 0.962 . . . . 71.12 110.721 175.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.476 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.14 -74.72 0.43 Allowed 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.908 -1.145 . . . . 75.35 107.908 175.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . 0.499 ' HZ ' HD22 ' D' ' 126' ' ' LEU . 54.4 p90 -140.86 154.3 46.12 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-O 121.543 0.687 . . . . 72.04 110.221 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 39.7 mt -115.86 147.25 41.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.352 -1.722 . . . . 71.4 106.352 172.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.525 ' SG ' HG12 ' D' ' 114' ' ' ILE . 23.5 t -160.25 127.79 4.53 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 109.681 -0.488 . . . . 71.41 109.681 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -142.27 124.14 15.21 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.623 -0.51 . . . . 73.45 109.623 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.19 122.7 62.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 C-N-CA 123.464 0.706 . . . . 72.43 109.641 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.721 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 21.1 mt-30 -88.12 88.92 7.79 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.159 -1.052 . . . . 71.54 108.159 164.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.13 101.0 8.52 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.406 -1.27 . . . . 72.33 108.903 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.74 148.25 20.3 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.853 -0.499 . . . . 53.42 111.853 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.481 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -147.54 128.99 3.07 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 111.371 -0.692 . . . . 62.11 111.371 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.9 mt -91.76 141.75 14.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.547 -0.909 . . . . 71.43 108.547 174.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -139.43 129.47 25.07 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.459 0.703 . . . . 44.11 110.09 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -74.24 99.12 3.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.145 0.578 . . . . 65.45 109.687 168.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 9.4 tt -122.02 118.63 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-O 121.364 0.602 . . . . 44.52 110.9 -174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.0 167.92 21.03 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.454 1.102 . . . . 54.44 109.31 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.4 24.94 66.88 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-O 119.906 -0.386 . . . . 74.1 113.439 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.28 156.41 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.981 0.912 . . . . 74.25 111.682 -175.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.28 171.73 4.71 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.412 1.085 . . . . 72.32 110.717 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.21 -118.65 12.9 Favored Glycine 0 C--N 1.355 1.629 0 N-CA-C 114.894 0.718 . . . . 74.03 114.894 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.2 m -82.64 -28.96 30.37 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.234 0.614 . . . . 74.02 110.599 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -66.76 -42.36 86.29 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.269 0.628 . . . . 64.42 111.335 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.578 ' SD ' ' HA ' ' H' ' 452' ' ' VAL . 25.9 ptt? -62.5 -39.45 93.52 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.878 -0.601 . . . . 53.11 110.244 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.77 74.53 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.543 0.737 . . . . 51.32 110.954 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -67.08 -30.36 70.38 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.76 0.824 . . . . 74.21 110.9 -176.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -79.92 -47.09 15.6 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.717 -0.674 . . . . 62.12 110.304 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' D' ' 94' ' ' MET . 4.7 tt -69.58 -55.25 10.63 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.29 1.036 . . . . 72.25 111.575 -168.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.97 10.82 73.65 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.964 -0.562 . . . . 64.32 114.09 -171.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.689 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -140.14 -65.85 0.45 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 117.346 0.573 . . . . 71.45 111.306 -175.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -70.8 -43.86 67.77 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.376 -0.829 . . . . 72.42 111.776 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -63.51 -50.02 75.11 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 124.012 0.925 . . . . 71.05 112.614 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.21 -21.9 30.78 Favored 'Trans proline' 0 C--N 1.397 3.114 0 C-N-CA 121.865 1.71 . . . . 75.13 112.907 174.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' D' ' 100' ' ' ALA . 0.2 OUTLIER -68.53 -32.8 73.0 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.989 0.516 . . . . 72.51 110.21 178.279 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 57.6 mt -67.6 -36.76 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 124.324 1.05 . . . . 62.12 110.643 173.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.481 HD21 ' HA3' ' D' ' 82' ' ' GLY . 89.2 mt -76.11 -18.17 59.28 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.126 -0.943 . . . . 75.33 112.392 -176.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -68.21 -45.36 39.35 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 113.662 0.986 . . . . 74.43 113.662 -173.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -53.24 -38.87 82.1 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 122.324 2.016 . . . . 71.53 113.702 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -77.99 -33.35 51.4 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.703 0.801 . . . . 71.22 111.935 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.08 64.58 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.067 -0.716 . . . . 73.42 109.067 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -53.7 -48.08 69.9 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 124.813 1.321 . . . . 72.12 110.602 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.49 -52.13 66.52 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.329 0.652 . . . . 72.52 111.305 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.76 -44.33 77.55 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 124.081 0.863 . . . . 75.24 110.99 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.525 HG12 ' SG ' ' D' ' 76' ' ' CYS . 32.7 mt -62.26 -60.12 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.929 0.892 . . . . 70.01 110.855 174.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 93.7 m -51.67 -39.55 58.44 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.113 1.365 . . . . 75.11 112.214 -173.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 48.4 t -67.08 -44.49 79.92 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.018 -0.992 . . . . 51.0 110.022 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.41 ' HB2' ' HE3' ' D' ' 117' ' ' MET . 72.9 mtm -68.02 -26.41 65.88 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.174 0.59 . . . . 74.3 112.184 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' D' ' 114' ' ' ILE . 80.0 t -67.81 -45.59 83.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.75 0.82 . . . . 73.21 109.784 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.9 p -73.84 -26.85 60.79 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.843 -0.617 . . . . 74.12 111.054 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -70.16 -37.16 75.14 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.613 0.765 . . . . 74.1 109.481 173.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.48 11.2 61.92 Favored Glycine 0 C--N 1.357 1.704 0 O-C-N 123.986 0.804 . . . . 74.24 112.732 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.464 HG23 ' HB3' ' C' ' 17' ' ' TYR . 67.5 p 58.17 16.93 4.21 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 126.815 2.046 . . . . 72.54 115.093 174.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -79.49 146.98 66.97 Favored Pre-proline 0 C--O 1.243 0.719 0 N-CA-C 107.961 -1.125 . . . . 73.42 107.961 166.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -46.67 138.43 14.67 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 123.534 2.823 . . . . 74.35 112.757 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -64.68 120.04 11.68 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 123.767 0.667 . . . . 65.31 110.49 -174.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.499 HD22 ' HZ ' ' D' ' 74' ' ' PHE . 4.8 mp -104.63 101.96 11.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.959 -0.756 . . . . 72.33 108.959 -176.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -100.64 93.51 5.62 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.437 -0.949 . . . . 74.15 108.437 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.29 133.48 47.03 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.914 0.886 . . . . 71.31 110.23 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.693 ' HB3' ' HB1' ' H' ' 467' ' ' ALA . . . -66.3 137.65 95.6 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.885 0.474 . . . . 43.32 110.657 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.79 130.04 17.45 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.841 2.361 . . . . 64.21 112.339 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.71 140.74 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.423 0.689 . . . . 73.21 110.268 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -97.01 108.37 21.09 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.095 0.958 . . . . 75.33 109.73 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -76.51 -21.11 56.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.371 0.668 . . . . 64.35 111.401 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.689 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 9.9 t70 -65.81 -49.91 66.53 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.527 0.731 . . . . 75.12 111.744 -171.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.1 89.87 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.842 0.714 . . . . 74.41 111.372 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.7 mp -81.01 -17.19 51.15 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.535 -1.212 . . . . 75.41 111.732 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -77.19 -43.98 31.76 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.439 -0.578 . . . . 74.42 109.439 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 73.8 mtm -64.37 -32.31 73.87 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.79 -0.641 . . . . 72.43 110.775 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -71.49 -42.68 67.75 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.955 0.902 . . . . 74.21 109.54 172.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -59.49 -41.88 90.85 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.717 0.807 . . . . 74.22 112.296 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.71 -35.02 79.56 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.437 0.695 . . . . 62.3 112.02 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -88.3 10.8 18.5 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.792 0.437 . . . . 73.31 111.26 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -120.29 85.04 2.32 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.721 0.809 . . . . 74.34 109.346 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -162.18 134.17 5.52 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.112 1.365 . . . . 71.43 108.218 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.71 91.09 1.87 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 122.978 0.511 . . . . 72.11 109.759 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.7 176.79 45.98 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.28 -0.873 . . . . 54.43 113.248 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -171.52 136.35 0.98 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.081 0.953 . . . . 70.44 109.465 177.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -134.24 162.64 24.57 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.706 -0.558 . . . . 74.03 111.706 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 14.8 t -158.95 153.1 23.7 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.759 0.824 . . . . 72.52 109.362 176.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -155.81 116.89 3.87 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.519 0.327 . . . . 62.12 110.591 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -80.22 65.23 5.31 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.604 1.162 . . . . 74.2 110.234 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -68.23 113.19 5.64 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.586 1.154 . . . . 74.3 110.897 -174.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -119.75 114.39 22.08 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.324 0.65 . . . . 61.0 110.988 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -84.14 83.48 7.95 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.329 0.651 . . . . 53.52 111.231 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.295 0 C-N-CA 124.547 1.139 . . . . 73.43 108.797 175.342 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 55.8 t30 . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 109.753 -0.462 . . . . 74.24 109.753 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . 0.748 ' HB ' ' HA ' ' A' ' 54' ' ' ASP . 8.4 p -115.44 160.38 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.398 1.079 . . . . 73.12 108.94 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . 0.531 HG13 HD12 ' A' ' 98' ' ' LEU . 6.9 p -111.25 153.59 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.592 0.757 . . . . 64.13 110.468 -174.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -152.5 112.8 0.55 Allowed Glycine 0 C--N 1.357 1.703 0 CA-C-O 119.902 -0.388 . . . . 71.52 112.279 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . 0.593 ' HG ' HD13 ' A' ' 98' ' ' LEU . 73.0 mt -85.08 84.47 7.69 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 117.385 0.592 . . . . 73.13 109.612 173.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 8.9 m -77.43 -17.73 57.84 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-N 115.344 -0.844 . . . . 64.24 109.917 172.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -74.92 152.1 38.86 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.2 1.0 . . . . 75.41 110.563 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.07 91.64 3.55 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.631 0.772 . . . . 74.24 110.824 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 19.9 p -140.23 173.81 11.14 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.589 1.155 . . . . 61.42 108.998 170.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -68.99 152.57 45.1 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.086 -0.709 . . . . 62.33 109.086 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . 0.541 HD21 ' HB ' ' A' ' 46' ' ' THR . 79.2 mt -76.39 -62.83 1.49 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.192 0.52 . . . . 64.42 110.302 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . 0.402 ' H ' ' H ' ' E' ' 462' ' ' TYR . 0.9 OUTLIER -173.04 -9.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 114.952 -1.022 . . . . 73.11 112.241 -169.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . 0.402 ' H ' ' H ' ' E' ' 461' ' ' PHE . 88.8 t80 -168.34 122.24 0.9 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.125 0.421 . . . . 73.24 111.066 -168.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 31.8 m -97.18 131.32 44.04 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 107.816 -1.179 . . . . 54.34 107.816 165.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . 0.541 ' SD ' HD23 ' A' ' 42' ' ' LEU . 28.4 ttt -96.45 114.26 25.91 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.922 0.489 . . . . 72.33 111.665 -171.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -96.82 110.74 23.16 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.393 -0.966 . . . . 61.41 108.393 167.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -83.31 -48.57 10.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.164 0.586 . . . . 45.4 110.929 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . 68.84 -63.03 0.37 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.821 1.648 . . . . 71.33 111.966 -173.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 2.0 tt 75.6 -64.98 0.34 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.212 1.805 . . . . 72.35 109.823 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 96.78 53.3 1.42 Allowed Glycine 0 C--N 1.342 0.876 0 N-CA-C 111.205 -0.758 . . . . 43.02 111.205 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.44 135.69 45.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.232 0.613 . . . . 71.23 110.424 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 59.7 pttt . . . . . 0 CA--C 1.565 1.546 0 C-N-CA 124.346 1.058 . . . . 75.3 109.26 177.929 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 14.6 m120 . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.718 0.294 . . . . 73.45 111.099 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . 0.427 ' HB ' ' H ' ' B' ' 54' ' ' ASP . 11.8 p -133.5 160.9 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.822 0.849 . . . . 74.04 109.194 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . 0.552 HG21 ' HB2' ' B' ' 94' ' ' MET . 32.1 m -67.64 173.86 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.466 1.106 . . . . 63.14 112.597 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -115.54 154.24 17.06 Favored Glycine 0 C--N 1.345 1.034 0 N-CA-C 111.495 -0.642 . . . . 62.24 111.495 173.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 67.2 tp -88.59 139.66 30.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.97 0.508 . . . . 74.22 109.812 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 17.6 p -76.8 159.03 30.43 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.257 1.023 . . . . 73.35 111.548 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.92 146.44 46.11 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.973 -1.012 . . . . 72.53 109.957 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . 0.462 ' HG2' ' HB2' ' F' ' 459' ' ' ASP . 35.0 tt0 59.2 87.7 0.08 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.088 1.355 . . . . 62.42 110.936 -175.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 32.0 p -66.55 -47.1 73.93 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.945 -0.57 . . . . 74.14 110.085 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . 0.462 ' HB2' ' HG2' ' F' ' 457' ' ' GLN . 34.8 t70 51.88 93.94 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 O-C-N 125.076 1.485 . . . . 75.13 112.15 169.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.12 108.89 2.82 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 122.427 1.108 . . . . 73.5 109.887 -174.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -67.35 0.67 2.71 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.396 2.278 . . . . 73.34 114.396 -175.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . 0.565 ' HA ' HD22 ' B' ' 136' ' ' LEU . 4.5 p90 -68.34 129.49 40.08 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-N 118.565 0.62 . . . . 72.2 110.2 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 33.8 m -96.48 -55.25 2.98 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.84 -1.17 . . . . 74.35 107.84 170.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 26.3 ttt 58.37 99.06 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.792 1.637 . . . . 75.5 112.595 173.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -79.57 -15.1 58.28 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.586 0.755 . . . . 70.33 112.708 -173.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -112.79 160.36 18.06 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.574 0.749 . . . . 62.14 110.223 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -96.62 -86.93 0.31 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.241 -0.652 . . . . 71.24 109.241 175.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . 0.544 HD23 HD21 ' B' ' 42' ' ' LEU . 2.3 pp -172.28 -30.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.627 0.771 . . . . 73.21 112.138 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 148.97 80.52 0.03 OUTLIER Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.518 -0.633 . . . . 43.23 111.518 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . 0.569 HD21 HG22 ' B' ' 40' ' ' VAL . 4.0 mm? -102.0 -65.7 0.97 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.175 0.59 . . . . 65.12 109.711 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 21.2 tptm . . . . . 0 CA--C 1.551 1.006 0 C-N-CA 123.2 0.6 . . . . 71.32 109.446 -176.86 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 43.1 t30 . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 121.221 0.534 . . . . 63.02 110.704 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' C' ' 90' ' ' GLU . 20.8 m -110.44 -12.44 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.702 1.201 . . . . 52.11 108.409 160.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . 0.438 HG21 ' NE2' ' C' ' 50' ' ' GLN . 18.2 m -68.22 163.56 3.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 C-N-CA 124.886 1.274 . . . . 63.45 112.035 -174.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 139.21 70.1 0.04 OUTLIER Glycine 0 C--N 1.342 0.899 0 CA-C-N 116.015 -0.539 . . . . 73.43 112.232 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 4.0 pp -134.66 154.21 51.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.711 0.805 . . . . 73.42 109.273 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 8.7 t -90.73 135.61 33.6 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 109.311 -0.625 . . . . 74.13 109.311 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -78.19 97.33 5.46 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.835 -0.802 . . . . 41.43 108.835 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . 0.429 ' HG2' ' H ' ' G' ' 458' ' ' THR . 32.5 tt0 -159.19 179.55 8.91 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.218 1.007 . . . . 71.01 108.708 -172.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . 0.429 ' H ' ' HG2' ' G' ' 457' ' ' GLN . 21.8 m 80.12 118.58 0.05 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.131 1.772 . . . . 75.51 109.134 -175.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -84.8 46.9 1.31 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.135 0.974 . . . . 71.24 111.269 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . 0.659 HD21 ' H ' ' C' ' 46' ' ' THR . 3.3 mm? 71.51 179.45 0.24 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.781 1.233 . . . . 75.13 112.745 174.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -142.73 178.15 7.84 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 125.638 1.575 . . . . 72.41 107.969 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 92.7 t80 67.14 102.32 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.358 1.063 . . . . 61.41 111.838 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 83.0 m -84.2 109.91 18.12 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.97 -1.122 . . . . 52.53 107.97 168.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . 0.579 ' SD ' HD12 ' C' ' 42' ' ' LEU . 24.5 ttt -71.83 142.33 49.62 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.323 -0.621 . . . . 71.14 109.323 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -82.49 11.77 5.28 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.742 0.817 . . . . 61.41 111.738 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . 0.406 ' HB1' HG23 ' C' ' 40' ' ' VAL . . . 61.79 81.67 0.19 Allowed 'General case' 0 C--N 1.36 1.043 0 C-N-CA 124.907 1.283 . . . . 62.42 111.189 178.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -147.66 83.36 1.53 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.853 -0.795 . . . . 61.32 108.853 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . 0.508 HD23 ' HB2' ' C' ' 42' ' ' LEU . 1.2 pp -124.62 17.95 8.79 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.009 0.924 . . . . 61.24 112.53 -170.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 101.95 -40.54 2.39 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-O 120.002 -0.332 . . . . 64.23 113.92 173.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . 0.626 ' HB2' ' HB3' ' C' ' 126' ' ' LEU . 61.5 tp -67.85 140.92 56.58 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.07 0.548 . . . . 72.24 110.567 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt . . . . . 0 C--O 1.251 1.153 0 C-N-CA 124.142 0.977 . . . . 75.5 110.174 -174.808 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 46.4 t30 . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.876 -0.416 . . . . 62.5 109.876 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . 0.494 HG23 HG13 ' H' ' 452' ' ' VAL . 17.5 m -108.95 -26.32 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.921 0.889 . . . . 75.32 110.966 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . 0.578 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 23.7 m -103.79 174.2 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.441 0.696 . . . . 70.51 112.073 -174.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -143.37 110.17 0.58 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 110.707 -0.957 . . . . 74.33 110.707 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.45 94.21 6.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.641 0.776 . . . . 73.42 110.134 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 5.8 t -91.82 61.9 4.24 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.499 1.142 . . . . 62.34 109.11 173.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.93 -127.41 0.05 Allowed 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 114.424 -1.262 . . . . 63.41 109.82 -177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 58.58 14.66 3.18 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 126.522 1.929 . . . . 72.24 114.047 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 19.5 p -107.39 -81.35 0.56 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.481 0.712 . . . . 72.23 111.054 -174.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -173.81 -174.38 0.94 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.236 1.015 . . . . 60.42 109.836 -176.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . 0.539 ' HG ' ' HA ' ' D' ' 45' ' ' ASP . 2.5 tm? -120.78 110.38 16.29 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.655 -1.239 . . . . 63.24 107.655 175.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . 0.414 ' O ' HD13 ' H' ' 460' ' ' LEU . 53.1 p90 -64.83 162.03 17.0 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.009 0.924 . . . . 71.01 111.578 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 18.2 t80 68.4 92.5 0.08 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.293 1.037 . . . . 73.13 110.295 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 23.4 m -72.02 -42.25 66.6 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.342 -0.845 . . . . 74.04 110.557 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . 0.482 ' HE2' HD11 ' D' ' 42' ' ' LEU . 11.2 tpt 72.18 149.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.687 1.195 . . . . 65.41 112.871 170.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -140.61 -66.79 0.43 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.932 0.893 . . . . 73.53 110.463 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -133.47 153.98 51.17 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.139 0.576 . . . . 62.02 111.699 -173.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . 0.693 ' HB1' ' HB3' ' D' ' 129' ' ' ALA . . . -148.15 -49.81 0.17 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.764 1.226 . . . . 73.44 108.357 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . 0.449 HD23 ' N ' ' H' ' 469' ' ' GLY . 5.0 tt -74.15 142.9 45.47 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.08 -1.418 . . . . 52.34 107.35 169.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . 0.449 ' N ' HD23 ' H' ' 468' ' ' LEU . . . -81.52 81.83 1.62 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-O 120.006 -0.33 . . . . 61.51 112.619 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . 0.683 ' HG ' ' HA ' ' D' ' 39' ' ' GLU . 3.2 mm? -78.68 72.72 5.22 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.897 -0.779 . . . . 54.42 108.897 173.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt . . . . . 0 CA--C 1.549 0.919 0 CA-C-N 114.914 -1.039 . . . . 70.12 109.071 -173.336 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tpt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.77 0.319 . . . . 75.45 111.003 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.6 p -143.22 54.67 1.36 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.643 -0.873 . . . . 72.53 108.643 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.33 84.89 5.21 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.752 -1.113 . . . . 75.13 108.802 -168.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -131.09 -177.68 4.49 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.202 1.001 . . . . 75.44 110.113 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 63.03 43.75 6.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.187 0.995 . . . . 74.21 110.343 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -106.48 87.77 2.62 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.255 -0.884 . . . . 74.12 109.219 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 t -158.81 -50.22 0.06 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 116.088 -0.505 . . . . 64.21 111.742 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.33 -59.98 2.17 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.468 -0.938 . . . . 65.05 108.468 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.8 ttt -131.61 152.56 50.72 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.662 1.185 . . . . 75.2 107.982 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.7 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 31.3 m -140.48 127.99 21.42 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.848 0.859 . . . . 74.13 108.711 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.436 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 16.8 t80 -133.68 121.23 21.66 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.898 -1.149 . . . . 73.05 107.898 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -136.97 112.59 9.4 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.037 -0.727 . . . . 72.35 109.037 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.538 HG12 ' HD2' ' A' ' 84' ' ' PHE . 46.3 mt -81.98 114.96 23.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.42 -0.955 . . . . 72.4 108.42 171.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -80.34 -39.26 28.97 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.475 -0.784 . . . . 72.44 109.686 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -168.16 133.16 1.77 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 116.236 -0.438 . . . . 72.12 111.035 -167.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.449 HD11 HD13 ' A' ' 13' ' ' ILE . 91.5 mt -119.47 132.13 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.289 1.036 . . . . 54.14 108.304 173.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.402 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 24.7 p90 -164.22 176.72 8.94 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.709 0.766 . . . . 73.15 111.427 -171.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.6 p -109.3 118.07 35.72 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.978 -1.01 . . . . 51.14 109.112 177.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 36.9 mtpt -84.87 -26.69 27.18 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.441 -0.345 . . . . 75.41 110.328 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -152.28 132.33 13.45 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.507 -0.769 . . . . 65.25 109.083 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 62.7 mt -128.93 141.81 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.505 -1.294 . . . . 74.13 107.505 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.4 t -151.79 144.21 24.12 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 123.494 0.496 . . . . 72.33 110.831 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.477 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 59.1 t80 -144.6 128.83 17.75 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 106.712 -1.588 . . . . 74.11 106.712 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -135.83 110.72 8.78 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.638 -0.875 . . . . 63.33 108.638 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.84 85.97 8.33 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.99 -1.115 . . . . 63.42 107.99 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.67 -25.76 20.31 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.562 2.175 . . . . 64.33 111.939 -174.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -107.91 31.09 5.77 Favored 'General case' 0 C--O 1.206 -1.2 0 C-N-CA 123.784 0.834 . . . . 71.34 109.846 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -50.95 -53.98 42.12 Favored Pre-proline 0 CA--C 1.577 2.015 0 N-CA-C 113.64 0.978 . . . . 65.23 113.64 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 2.6 Cg_exo -79.58 -20.54 9.31 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.004 1.803 . . . . 75.41 113.106 173.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -88.0 -29.96 20.35 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.786 0.834 . . . . 72.14 112.131 -167.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.43 HG11 ' HE1' ' A' ' 123' ' ' PHE . 9.2 p -76.52 -13.83 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 124.101 0.96 . . . . 72.44 110.404 -175.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.49 -37.52 75.7 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.104 0.962 . . . . 74.25 110.857 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -73.54 -27.8 61.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.484 -0.78 . . . . 75.42 111.715 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -81.98 151.89 26.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.418 0.687 . . . . 64.12 112.219 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -64.04 140.48 58.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.617 0.767 . . . . 74.23 109.157 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.541 ' NE1' ' HB3' ' E' ' 470' ' ' LEU . 57.8 t-105 -80.28 80.66 6.68 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.74 0.781 . . . . 64.32 109.474 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -132.84 72.9 76.64 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.862 -1.063 . . . . 73.23 108.716 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -89.67 149.0 5.07 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.535 2.157 . . . . 70.23 112.002 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -96.41 117.73 31.47 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.259 -1.386 . . . . 73.53 107.259 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.79 112.33 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 123.423 0.689 . . . . 75.43 110.376 -173.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 43' ' ' ASP . 25.7 ttpt -114.23 130.78 56.63 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.662 -0.866 . . . . 71.45 108.662 172.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.434 HD22 HD22 ' A' ' 128' ' ' LEU . 69.2 tp -96.46 109.98 22.43 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.663 -1.236 . . . . 73.52 107.663 173.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.446 ' HB2' ' HE3' ' A' ' 41' ' ' LYS . 21.9 t70 -102.99 107.71 18.61 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.086 -1.079 . . . . 62.13 108.086 -177.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -96.64 161.36 13.92 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.675 -0.491 . . . . 75.33 109.675 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.728 ' HA ' HD21 ' E' ' 460' ' ' LEU . 8.9 t0 -153.34 127.11 8.84 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.141 -0.689 . . . . 63.12 109.141 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -105.74 120.45 41.73 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.868 -0.79 . . . . 73.11 108.868 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.17 153.31 51.91 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.052 0.941 . . . . 43.12 108.759 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.0 m -127.2 156.9 41.11 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.856 0.462 . . . . 72.02 110.874 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 38.1 t -149.23 133.17 17.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.317 0.647 . . . . 72.4 110.139 -171.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -88.05 117.45 26.94 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.83 -0.433 . . . . 63.21 109.83 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 57' ' ' GLU . 48.8 mt -95.57 -36.19 11.36 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.373 0.669 . . . . 73.24 110.89 -176.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.76 -168.0 0.73 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.984 0.913 . . . . 51.42 111.016 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.26 112.83 3.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.504 1.122 . . . . 74.51 110.856 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 65.39 3.77 2.44 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 124.817 1.247 . . . . 74.1 112.792 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.7 t -104.44 115.28 46.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.051 -1.092 . . . . 53.42 108.051 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.07 168.15 12.73 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.445 -0.946 . . . . 73.11 108.445 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.524 ' HB2' HD11 ' A' ' 51' ' ' LEU . 44.7 tt0 -132.04 147.38 52.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.059 -0.973 . . . . 70.24 108.885 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.433 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 65.4 t -120.87 125.52 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.006 -1.479 . . . . 73.33 107.006 164.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.86 114.62 47.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.123 -1.066 . . . . 75.34 108.123 175.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.606 HD22 HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -96.69 109.5 22.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.377 -0.972 . . . . 74.33 108.377 178.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 66.1 ttp85 -83.17 103.86 12.9 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.592 -0.892 . . . . 62.04 108.592 172.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.707 HG21 ' HB1' ' A' ' 110' ' ' ALA . 2.5 m -103.5 103.81 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.631 0.729 . . . . 55.11 109.228 174.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 m -103.12 117.05 33.68 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.449 1.1 . . . . 63.23 110.096 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 56.1 t -101.09 109.44 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.834 0.854 . . . . 54.22 109.629 176.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.1 m -103.28 108.49 19.73 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.321 -0.622 . . . . 65.45 109.321 175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.47 106.91 14.51 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.017 0.927 . . . . 64.35 108.763 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 m -140.92 148.33 40.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.939 0.496 . . . . 72.31 110.519 -175.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.15 85.68 2.45 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.982 0.896 . . . . 63.3 109.083 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.14 -106.58 2.4 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 114.421 -1.263 . . . . 62.2 112.424 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -96.4 -26.08 15.47 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.331 1.052 . . . . 72.41 110.6 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -92.73 109.17 20.59 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.821 0.849 . . . . 75.13 109.682 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.8 m -72.7 123.88 24.19 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.323 -0.621 . . . . 70.33 109.323 171.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -58.33 5.7 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.065 0.853 . . . . 74.23 108.8 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -158.85 155.77 28.41 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.233 -1.349 . . . . 75.33 109.721 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.468 HD12 ' O ' ' A' ' 64' ' ' VAL . 64.0 tp -126.92 138.21 53.26 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.789 -1.189 . . . . 52.41 107.789 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.565 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 73.7 m -134.43 139.99 45.94 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.095 -1.076 . . . . 73.34 108.095 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -149.35 125.59 10.78 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 117.818 0.281 . . . . 63.55 110.251 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.88 112.0 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.771 0.829 . . . . 72.21 109.819 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.409 ' OE1' ' HG3' ' A' ' 61' ' ' ARG . 2.4 mp0 -87.29 84.32 7.24 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.473 -0.936 . . . . 73.33 108.473 173.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.414 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.2 tp-100 -76.65 95.31 3.94 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 114.629 -1.169 . . . . 73.11 108.678 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.28 143.92 17.21 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.073 -0.811 . . . . 60.51 111.073 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.54 130.87 4.25 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.115 -0.794 . . . . 62.23 111.115 -177.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.0 mt -81.93 123.36 38.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.73 -0.841 . . . . 74.12 108.73 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.538 ' HD2' HG12 ' A' ' 13' ' ' ILE . 32.1 m-85 -130.81 137.38 49.4 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.852 -0.796 . . . . 74.15 108.852 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 m -97.19 116.46 29.44 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.037 -0.727 . . . . 75.33 109.037 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.78 135.15 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.062 -1.088 . . . . 74.42 108.062 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.7 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -164.0 136.72 5.1 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.001 0.921 . . . . 61.5 109.182 169.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.65 -16.38 60.89 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 114.664 0.626 . . . . 33.03 114.664 173.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.512 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -114.03 135.4 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 117.645 0.722 . . . . 72.3 109.734 178.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -140.53 172.47 12.68 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.104 0.962 . . . . 73.01 109.998 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.69 -123.78 33.1 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.036 0.835 . . . . 64.2 114.57 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.425 ' HB ' HD11 ' A' ' 141' ' ' LEU . 51.1 p -78.35 -27.59 47.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.216 1.007 . . . . 63.35 111.583 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.432 HE21 ' HA ' ' A' ' 89' ' ' ILE . 29.3 tt0 -68.34 -36.57 79.46 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.813 0.845 . . . . 75.3 109.97 175.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 48.3 ttm -69.44 -41.98 75.55 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 116.056 -0.52 . . . . 71.02 110.203 171.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.54 -30.12 69.56 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.988 0.515 . . . . 73.02 111.421 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -71.63 -36.43 70.75 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.244 0.618 . . . . 75.3 110.97 173.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.562 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 99.6 m -67.12 -63.09 1.13 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.815 0.446 . . . . 70.11 111.59 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.15 -17.92 61.33 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.273 0.471 . . . . 73.1 112.273 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.01 -11.96 38.23 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.262 -0.743 . . . . 63.11 114.415 -175.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.04 -52.56 0.19 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.153 0.976 . . . . 74.43 112.965 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.562 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 28.2 t80 -63.37 -56.37 16.9 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.752 1.221 . . . . 74.24 111.491 -172.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.8 m -77.67 -35.41 1.27 Allowed Pre-proline 0 CA--C 1.565 1.555 0 N-CA-C 113.245 0.832 . . . . 62.33 113.245 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.83 -39.73 57.85 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.364 2.043 . . . . 74.11 113.19 163.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -64.06 -35.16 79.82 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.073 0.549 . . . . 74.22 111.376 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.53 HG21 ' CD1' ' A' ' 13' ' ' ILE . 51.0 mm -63.25 -42.24 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.787 0.835 . . . . 72.04 110.645 176.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.414 HD22 ' HG3' ' A' ' 80' ' ' GLN . 85.5 mt -72.57 -30.06 64.09 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.08 -0.964 . . . . 72.21 112.068 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -58.36 -44.21 98.94 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 114.6 1.334 . . . . 63.14 114.6 -170.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.68 -39.84 84.5 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.191 1.927 . . . . 62.3 114.115 173.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -72.88 -40.0 65.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.231 0.613 . . . . 74.42 111.228 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.707 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.68 -40.1 88.4 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.525 -0.761 . . . . 74.43 110.489 176.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.435 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.3 ttm180 -54.15 -50.66 66.44 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.554 1.159 . . . . 75.21 110.292 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -66.86 -42.69 85.26 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.14 0.9 . . . . 72.41 111.559 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.579 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.2 t -61.46 -24.66 66.71 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.228 0.611 . . . . 74.01 111.622 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.434 HG21 HG21 ' A' ' 64' ' ' VAL . 96.7 mt -87.29 -44.19 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.4 1.08 . . . . 71.03 110.897 174.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 125' ' ' GLN . 87.7 m -62.64 -40.58 97.45 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.451 0.643 . . . . 74.23 111.244 -174.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.0 t -70.72 -41.01 72.46 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.191 -0.913 . . . . 73.53 109.595 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.477 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.2 ttm -58.4 -48.94 79.05 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.598 1.159 . . . . 73.35 112.079 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.73 -33.78 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.523 0.729 . . . . 64.31 110.734 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.4 t -72.71 -28.44 62.67 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.755 0.822 . . . . 71.5 111.191 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.1 mtt-85 -75.17 -30.24 60.66 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.545 0.738 . . . . 72.1 110.138 175.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.54 -2.17 79.27 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.794 0.684 . . . . 43.14 112.703 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.9 m 69.4 14.67 8.44 Favored 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 125.057 1.343 . . . . 54.43 111.596 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.43 ' HE1' HG11 ' A' ' 31' ' ' VAL . 94.0 m-85 -82.35 152.59 67.75 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 108.572 -0.899 . . . . 61.35 108.572 169.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -50.12 150.1 10.96 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.266 2.644 . . . . 74.25 114.064 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.7 tt0 -61.37 136.46 58.05 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.763 -0.653 . . . . 51.53 111.438 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.8 tp -117.01 102.02 8.99 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.824 -1.08 . . . . 73.24 108.857 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -97.96 104.33 16.35 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.948 -1.131 . . . . 74.1 107.948 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.434 HD22 HD22 ' A' ' 42' ' ' LEU . 89.8 mt -64.08 130.29 43.39 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.575 0.547 . . . . 62.32 109.797 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.28 138.53 97.18 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 119.086 -0.483 . . . . 74.05 110.268 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.07 115.52 2.55 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.472 2.115 . . . . 54.44 112.403 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.65 113.21 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.671 -1.233 . . . . 71.41 107.671 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.491 ' ND2' ' H ' ' A' ' 135' ' ' ALA . 5.4 t30 -88.97 85.25 6.68 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.677 -0.86 . . . . 73.42 108.677 -175.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.509 ' HA ' HD12 ' A' ' 136' ' ' LEU . 93.1 m-85 -58.57 -32.64 69.11 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.52 1.128 . . . . 74.42 112.607 -174.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -63.41 -47.75 80.68 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.455 -0.793 . . . . 51.22 111.319 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.491 ' H ' ' ND2' ' A' ' 132' ' ' ASN . . . -59.06 -49.46 77.78 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.636 0.585 . . . . 50.35 109.997 176.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 133' ' ' PHE . 76.2 mt -54.95 -41.14 70.74 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 124.731 1.269 . . . . 75.35 112.238 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.449 ' HE2' HD22 ' A' ' 141' ' ' LEU . 44.5 t80 -74.78 -34.64 62.49 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.99 -0.55 . . . . 64.15 110.437 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 8.5 mmt -67.65 -32.96 74.01 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.567 0.347 . . . . 52.53 110.49 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -65.69 -26.53 67.82 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.59 0.756 . . . . 54.51 111.141 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -85.48 -57.66 2.98 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.799 0.44 . . . . 63.1 110.064 172.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.449 HD22 ' HE2' ' A' ' 137' ' ' PHE . 36.7 tp -63.63 -33.32 75.36 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.266 1.026 . . . . 64.3 112.546 -165.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.93 -6.06 0.6 Allowed 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 109.557 -0.534 . . . . 65.41 109.557 -164.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 67.72 -70.68 0.12 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.734 1.614 . . . . 73.22 111.263 -174.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -165.1 -69.33 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.695 0.398 . . . . 65.41 110.179 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 48.35 -155.41 0.08 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.637 1.175 . . . . 53.2 111.606 -170.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 123.19 95.41 1.2 Allowed Glycine 0 C--N 1.34 0.779 0 O-C-N 122.175 -0.328 . . . . 54.0 113.031 172.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -93.12 139.87 30.1 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 106.815 -1.55 . . . . 75.0 106.815 167.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.31 47.88 0.62 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 114.941 0.736 . . . . 72.23 114.941 -171.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.0 p -87.39 136.95 32.74 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.613 -0.884 . . . . 75.22 108.613 164.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.22 120.74 17.23 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.531 -0.914 . . . . 64.21 108.531 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -80.63 -70.57 0.52 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.678 0.391 . . . . 71.21 111.367 -174.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -59.58 97.48 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.02 0.825 . . . . 73.22 112.277 -166.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -68.91 119.11 12.72 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 115.634 -0.712 . . . . 63.32 109.631 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.29 94.63 0.11 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.834 0.854 . . . . 73.14 110.675 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 N-CA-C 108.485 -0.931 . . . . 62.34 108.485 174.073 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 108.69 -0.856 . . . . 54.43 108.69 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t -66.57 95.81 0.35 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.363 0.665 . . . . 74.15 111.329 -172.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -84.03 -64.22 1.2 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.205 0.602 . . . . 72.34 110.226 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -91.6 83.72 5.39 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.045 0.45 . . . . 74.44 110.256 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -87.97 25.88 1.47 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.297 0.639 . . . . 55.32 110.53 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -130.5 117.98 20.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.753 0.821 . . . . 72.24 108.838 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -167.52 158.51 11.46 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.104 0.962 . . . . 74.23 110.0 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -74.31 -30.16 61.93 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.747 0.819 . . . . 52.24 109.731 173.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 12.4 ptm 56.19 172.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 126.843 2.057 . . . . 71.2 113.67 -173.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 87.7 m -151.22 135.14 16.56 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.054 -1.091 . . . . 74.42 108.054 175.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -144.76 135.36 24.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.012 0.525 . . . . 73.13 109.939 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -154.45 125.46 7.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.819 0.848 . . . . 75.24 109.053 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.511 HD11 HD13 ' B' ' 105' ' ' ILE . 17.9 mt -77.97 118.4 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.606 -0.887 . . . . 43.52 108.606 171.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -91.49 -39.52 11.9 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.868 -0.419 . . . . 50.2 109.868 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -166.88 138.29 3.32 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.756 0.66 . . . . 72.33 109.731 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.416 HD11 HD13 ' B' ' 13' ' ' ILE . 96.7 mt -115.73 145.24 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 106.878 -1.527 . . . . 64.22 106.878 169.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -169.52 168.24 9.41 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.578 0.704 . . . . 64.3 111.578 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 86.4 m -96.51 131.92 42.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.251 -0.886 . . . . 62.41 108.668 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.424 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.8 mtpt -96.58 -36.31 10.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.497 0.719 . . . . 74.22 109.979 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -152.48 145.25 24.33 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.024 -0.534 . . . . 71.2 110.91 -172.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 41.3 mm -134.46 145.18 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.755 1.222 . . . . 73.0 109.104 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 23.0 t -145.94 134.63 22.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.128 -0.942 . . . . 73.43 108.896 172.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.457 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.4 t80 -149.3 109.77 4.21 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.885 -1.154 . . . . 74.1 107.885 170.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -117.3 114.77 24.07 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.542 -0.91 . . . . 71.02 108.542 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.7 87.61 2.92 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 107.848 -1.167 . . . . 74.54 107.848 169.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.65 -51.76 4.63 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.905 2.403 . . . . 65.04 112.462 -171.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.497 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 72.3 m-20 -98.2 23.17 8.57 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.578 0.751 . . . . 53.1 110.957 -176.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -33.17 -67.06 0.2 Allowed Pre-proline 0 N--CA 1.498 1.925 0 C-N-CA 125.327 1.451 . . . . 73.45 114.64 -168.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.93 -20.78 57.75 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.348 2.032 . . . . 50.42 113.013 -172.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -96.57 -28.47 14.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.889 0.876 . . . . 73.2 112.16 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' B' ' 73' ' ' ALA . 10.7 p -83.22 -18.35 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 122.633 0.373 . . . . 71.44 111.117 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -66.39 -15.34 63.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.102 0.779 . . . . 72.31 113.102 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.483 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -62.64 -24.52 67.65 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 120.935 0.398 . . . . 70.13 110.753 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.59 ' HB2' HD13 ' B' ' 68' ' ' LEU . 89.8 mttt -96.17 101.39 13.03 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.477 1.111 . . . . 75.33 109.498 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.61 80.9 5.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.498 0.719 . . . . 71.41 109.692 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -154.17 158.91 41.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.113 -0.949 . . . . 75.54 108.682 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -75.79 108.5 6.03 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 124.081 0.952 . . . . 64.13 109.929 174.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.598 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 43.3 Cg_endo -66.72 150.02 83.61 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.918 2.412 . . . . 74.33 112.778 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -58.66 108.11 0.6 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.686 0.616 . . . . 73.23 110.771 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.598 ' H ' HD21 ' F' ' 470' ' ' LEU . 81.4 t -89.86 120.99 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.975 -1.011 . . . . 51.24 110.28 -176.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' F' ' 466' ' ' ALA . 29.9 ttpt -108.07 128.95 55.13 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.703 -1.221 . . . . 70.21 107.703 168.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.761 ' HB2' ' HB2' ' F' ' 467' ' ' ALA . 40.5 tp -90.7 148.44 22.6 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.831 -0.433 . . . . 73.12 109.831 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -148.11 141.11 24.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.393 1.077 . . . . 74.35 108.167 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 96.0 mt -135.42 142.74 45.68 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.484 0.714 . . . . 74.25 109.783 -175.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 6.2 m-20 -132.08 110.29 10.6 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.898 -1.149 . . . . 73.31 107.898 165.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 23.6 p -109.84 100.07 9.11 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.767 -0.827 . . . . 74.51 108.767 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.63 116.36 23.7 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.473 0.709 . . . . 51.13 109.28 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.408 ' HB3' HG22 ' B' ' 58' ' ' VAL . 20.2 p -100.84 162.78 12.67 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.949 0.9 . . . . 75.01 109.282 176.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.5 p -150.11 170.63 18.46 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.504 0.721 . . . . 61.31 109.641 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -113.45 107.67 16.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.499 0.72 . . . . 61.12 109.719 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.97 -38.15 64.28 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.955 0.502 . . . . 71.35 110.06 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -161.69 177.78 9.63 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.66 -1.154 . . . . 32.31 109.991 -174.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -63.48 119.21 9.32 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.704 -0.48 . . . . 63.13 109.704 174.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 71.99 -3.01 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.854 1.262 . . . . 73.34 112.779 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 97.8 t -105.09 112.5 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.812 -0.81 . . . . 71.33 108.812 175.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -126.94 139.64 52.91 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.151 0.58 . . . . 74.43 109.748 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -120.53 106.94 12.27 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.867 -0.79 . . . . 71.01 108.867 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' B' ' 48' ' ' SER . 96.7 t -92.91 122.44 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.656 1.182 . . . . 74.13 111.028 -177.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.83 115.03 45.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.726 -0.472 . . . . 74.03 109.726 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.22 120.27 37.27 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.579 -1.267 . . . . 72.55 107.579 174.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.447 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 13.4 ttm180 -109.0 127.74 54.34 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.23 -0.655 . . . . 71.44 109.23 172.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.49 103.73 14.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.038 -1.097 . . . . 71.45 108.038 174.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -102.61 130.81 49.6 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.393 -0.595 . . . . 63.04 109.393 176.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.613 HG11 HD21 ' B' ' 126' ' ' LEU . 92.1 t -122.37 112.48 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.359 1.063 . . . . 72.34 109.241 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.2 m -92.8 138.15 31.74 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.568 0.747 . . . . 32.43 109.361 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.76 142.88 24.09 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.813 0.445 . . . . 71.0 111.249 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.489 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 21.5 p -153.36 133.69 13.5 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.571 0.582 . . . . 73.13 112.571 -174.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.598 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 52.8 mt -100.12 122.4 42.92 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.531 1.132 . . . . 64.23 111.183 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.25 -110.84 3.72 Favored Glycine 0 C--N 1.342 0.892 0 O-C-N 123.906 0.754 . . . . 62.24 113.042 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.09 5.27 20.04 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.616 0.766 . . . . 73.05 111.551 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.497 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.9 pt-20 -129.13 159.25 36.59 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.851 0.46 . . . . 64.31 110.74 -175.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 61.9 m -75.38 138.26 41.6 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.131 0.491 . . . . 72.13 110.706 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.589 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.57 -71.46 0.65 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.114 -1.069 . . . . 72.12 108.114 176.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -146.4 144.39 29.69 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.761 -0.654 . . . . 74.14 110.203 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.9 mt -123.41 112.46 17.57 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 106.656 -1.609 . . . . 73.31 106.656 174.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.497 ' SG ' HG23 ' B' ' 114' ' ' ILE . 35.6 t -116.93 154.95 29.94 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.071 -0.715 . . . . 74.34 109.071 -178.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.7 tt0 -163.97 137.22 5.31 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.012 -0.736 . . . . 63.3 109.012 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 75.4 t -133.71 146.01 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.267 1.027 . . . . 73.25 108.744 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -122.2 95.8 4.79 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.905 -0.776 . . . . 75.14 108.905 170.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -85.56 98.98 10.95 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.92 -0.771 . . . . 74.14 108.92 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.424 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -93.08 143.1 16.28 Favored Glycine 0 C--N 1.343 0.952 0 N-CA-C 111.187 -0.765 . . . . 72.32 111.187 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.417 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -143.52 127.0 2.93 Favored Glycine 0 C--N 1.331 0.305 0 N-CA-C 112.165 -0.374 . . . . 61.24 112.165 -173.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 51.3 mt -85.93 127.91 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 109.11 -0.7 . . . . 74.44 109.11 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.33 157.21 47.49 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.818 1.247 . . . . 64.25 108.465 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 68.5 m -117.75 100.36 7.55 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.392 0.677 . . . . 71.34 109.41 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.536 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.5 pp -111.11 137.36 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.862 0.465 . . . . 53.21 110.001 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.55 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -154.53 166.91 31.82 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.015 0.926 . . . . 54.55 110.12 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.27 -59.27 4.81 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 111.46 -0.656 . . . . 75.33 111.46 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.536 HD11 ' HB ' ' B' ' 86' ' ' ILE . 15.4 pt -63.2 139.45 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 124.428 1.091 . . . . 42.12 110.892 171.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.499 ' HG3' ' HA ' ' F' ' 451' ' ' VAL . 32.2 tt0 -152.14 151.41 31.01 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.315 0.646 . . . . 73.3 110.2 -177.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.65 -111.86 4.11 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.959 -0.456 . . . . 25.54 111.959 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -80.53 -25.01 38.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.379 0.672 . . . . 70.24 110.812 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -68.79 -35.64 77.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.765 -0.652 . . . . 74.13 110.133 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -85.92 -23.57 26.94 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.598 -0.728 . . . . 65.35 110.598 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.02 77.19 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.967 0.413 . . . . 72.01 110.769 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 30.4 t-80 -68.3 -27.05 65.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.33 0.652 . . . . 74.35 110.823 176.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.437 ' SG ' HG21 ' B' ' 86' ' ' ILE . 18.9 t -81.19 -68.5 0.68 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.479 -0.563 . . . . 71.11 109.479 176.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.534 HD21 HG12 ' B' ' 86' ' ' ILE . 23.9 mt -69.57 -22.44 63.54 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.888 0.699 . . . . 73.01 112.888 -171.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.89 -11.17 47.41 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-O 119.53 -0.594 . . . . 44.44 113.772 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -138.37 -58.86 0.64 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.659 0.73 . . . . 43.44 112.317 -173.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -72.51 -41.69 65.63 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.941 0.496 . . . . 74.14 111.935 -172.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 86.3 m -68.66 -47.65 33.43 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.066 0.947 . . . . 72.14 111.489 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -56.78 -31.33 87.94 Favored 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 122.143 1.895 . . . . 70.42 113.582 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -62.34 -38.74 90.65 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 123.373 0.669 . . . . 73.22 110.673 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.511 HD13 HD11 ' B' ' 13' ' ' ILE . 68.0 mt -69.34 -44.11 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.789 0.836 . . . . 73.23 110.617 175.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.417 HD21 ' HA3' ' B' ' 82' ' ' GLY . 59.5 mt -73.64 -20.17 60.65 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.327 -0.851 . . . . 74.34 111.776 -176.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -62.33 -49.44 84.04 Favored Pre-proline 0 N--CA 1.481 1.105 0 N-CA-C 114.748 1.388 . . . . 71.51 114.748 -169.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.27 -32.19 82.07 Favored 'Trans proline' 0 C--N 1.377 2.077 0 CA-C-N 121.384 1.53 . . . . 73.3 112.474 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -66.58 -48.49 69.43 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.069 0.548 . . . . 72.13 110.363 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.05 -41.15 87.19 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.203 -0.908 . . . . 74.54 110.747 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -60.35 -56.29 23.22 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.487 1.115 . . . . 75.35 111.102 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.88 -35.29 80.67 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.032 0.533 . . . . 74.43 110.266 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.6 t -66.87 -37.44 84.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.879 0.472 . . . . 63.54 111.209 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.497 HG23 ' SG ' ' B' ' 76' ' ' CYS . 50.3 mt -63.22 -52.32 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 122.879 0.472 . . . . 74.13 110.05 172.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.451 HG21 ' OG ' ' C' ' 119' ' ' SER . 21.0 m -59.83 -31.94 70.2 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.885 0.874 . . . . 74.32 111.591 -177.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.8 t -64.8 -49.13 71.86 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.406 -0.816 . . . . 72.45 109.766 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -68.88 -31.77 70.94 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.078 0.551 . . . . 74.41 111.342 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.52 -43.71 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.776 0.83 . . . . 65.25 110.065 172.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.1 t -68.45 -31.91 71.56 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.642 -0.708 . . . . 71.24 111.499 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.579 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 76.1 mtt-85 -68.03 -41.85 81.47 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.894 -0.593 . . . . 71.23 109.728 176.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.62 1.24 86.55 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.704 0.627 . . . . 73.15 113.12 173.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 26.4 p 60.87 26.64 16.5 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.404 1.882 . . . . 71.42 113.822 171.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -80.09 162.3 62.41 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 123.819 0.848 . . . . 73.55 111.443 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -55.22 158.51 11.86 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 123.263 2.642 . . . . 72.34 113.242 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.451 HE21 ' ND2' ' B' ' 127' ' ' ASN . 66.2 tp60 -58.81 134.51 56.94 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.148 -0.933 . . . . 64.43 112.528 -171.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.613 HD21 HG11 ' B' ' 64' ' ' VAL . 30.9 tp -130.2 109.99 11.23 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.314 -0.857 . . . . 65.12 108.976 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.451 ' ND2' HE21 ' B' ' 125' ' ' GLN . 64.8 m-80 -122.11 120.05 33.13 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.303 -0.999 . . . . 74.54 108.303 171.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.575 HD11 HD22 ' B' ' 42' ' ' LEU . 39.6 tp -84.72 136.22 33.81 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.71 0.404 . . . . 74.42 109.975 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.35 145.08 84.95 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.885 0.874 . . . . 60.42 111.462 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.77 130.16 35.6 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.159 2.573 . . . . 74.54 113.064 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -95.15 113.16 28.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 114.807 -1.088 . . . . 55.33 108.381 172.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -74.47 79.83 1.93 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.163 -1.421 . . . . 72.32 107.163 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -54.7 -38.59 67.22 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.481 0.713 . . . . 74.04 111.24 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.94 -43.13 77.12 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.354 1.062 . . . . 75.52 111.742 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.97 38.83 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.935 0.894 . . . . 75.5 111.437 -176.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.541 ' HB2' ' HD2' ' F' ' 461' ' ' PHE . 1.5 mm? -79.54 -22.28 44.08 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 116.4 -0.364 . . . . 73.52 111.203 -174.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.473 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 73.1 t80 -65.11 -36.68 85.05 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.943 -0.392 . . . . 70.12 109.943 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 71.0 mtm -60.4 -36.04 77.17 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.416 0.448 . . . . 71.24 110.833 175.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -85.62 -18.62 32.77 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.644 0.778 . . . . 75.25 111.457 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -68.01 -32.8 73.43 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.285 1.034 . . . . 73.42 111.189 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 12.8 mt -89.37 9.26 26.83 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.034 -0.985 . . . . 75.03 111.232 -172.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -160.24 -159.36 0.7 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.837 1.255 . . . . 62.23 108.16 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -136.44 88.52 2.38 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 121.29 0.567 . . . . 63.22 109.546 167.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -135.54 174.87 10.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.056 0.942 . . . . 71.34 108.952 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -141.8 147.37 37.17 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.2 0.6 . . . . 71.21 110.548 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.55 177.4 45.31 Favored Glycine 0 C--N 1.35 1.319 0 O-C-N 123.593 0.558 . . . . 65.44 112.366 175.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -160.36 -179.04 7.36 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.63 0.772 . . . . 54.24 110.327 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.54 107.61 0.24 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.805 -0.442 . . . . 54.14 113.113 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 28.0 m -69.34 99.77 1.25 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.314 0.646 . . . . 62.44 109.821 171.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . 0.544 ' HG2' HG21 ' D' ' 10' ' ' THR . 47.6 mt-10 -78.45 87.34 4.45 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.578 -0.737 . . . . 74.24 110.808 -176.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -71.1 126.45 29.63 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.613 -0.721 . . . . 74.25 110.302 171.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -170.48 137.36 1.39 Allowed 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.671 1.188 . . . . 63.23 108.573 -177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.71 168.77 18.41 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.932 0.893 . . . . 73.42 110.355 178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -83.57 92.04 7.55 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.232 -0.655 . . . . 73.41 109.232 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-N 115.321 -0.854 . . . . 74.32 110.948 179.023 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 109.374 -0.602 . . . . 74.22 109.374 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 55.9 m -144.88 93.46 2.41 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.586 0.754 . . . . 64.34 110.26 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -120.91 124.97 46.26 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.306 -0.998 . . . . 75.54 108.306 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -80.24 107.18 12.83 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.477 -0.934 . . . . 72.0 108.477 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -69.92 -39.74 75.97 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.292 1.037 . . . . 65.25 110.675 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -78.3 87.6 4.35 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.399 -0.819 . . . . 73.55 108.932 174.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 6.8 t -148.61 116.95 6.49 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.85 0.86 . . . . 74.51 109.59 -175.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -81.46 132.41 35.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.044 0.538 . . . . 65.1 111.117 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.6 ttt 63.6 110.98 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.436 1.494 . . . . 74.34 111.756 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.615 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 89.5 m -101.29 101.32 11.97 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.125 -1.065 . . . . 60.53 108.125 171.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.497 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.5 t80 -108.6 122.87 47.99 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.735 -0.839 . . . . 75.04 108.735 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -136.67 128.28 28.74 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.493 -0.929 . . . . 75.04 108.493 172.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.454 HD13 HD11 ' C' ' 16' ' ' ILE . 61.1 mt -71.64 124.45 28.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.645 -0.872 . . . . 74.02 108.645 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -88.84 -46.42 8.96 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.098 0.559 . . . . 73.53 109.558 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -172.31 125.57 0.52 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.95 -0.568 . . . . 72.2 110.329 -171.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.454 HD11 HD13 ' C' ' 13' ' ' ILE . 91.3 mt -109.93 141.37 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 107.946 -1.131 . . . . 72.24 107.946 176.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.506 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 25.8 p90 -175.71 174.99 2.12 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.421 0.629 . . . . 71.31 110.775 -171.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -104.09 124.97 50.02 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.569 -0.741 . . . . 72.25 109.065 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.506 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 27.4 mmtp -69.88 -49.72 49.52 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.755 -1.202 . . . . 73.13 107.755 168.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -139.2 142.46 37.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 113.253 -1.794 . . . . 72.14 109.172 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.579 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.6 mt -138.79 142.67 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.292 -1.373 . . . . 41.03 107.292 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.1 t -156.81 150.44 24.54 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.459 0.647 . . . . 63.24 110.624 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.434 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 89.4 t80 -141.75 124.94 16.37 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.433 -1.321 . . . . 74.51 107.433 172.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 39.3 mt-10 -122.21 111.74 17.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.664 0.786 . . . . 65.12 109.516 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.92 82.04 69.18 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 107.641 -1.244 . . . . 71.45 107.641 170.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.1 -29.55 11.64 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.388 2.059 . . . . 73.41 111.824 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -99.38 19.41 15.59 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.842 0.857 . . . . 73.3 110.04 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.443 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -47.84 -55.16 18.62 Favored Pre-proline 0 CA--C 1.561 1.366 0 N-CA-C 113.793 1.034 . . . . 63.43 113.793 -171.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.513 ' HB3' HD13 ' D' ' 51' ' ' LEU . 36.3 Cg_exo -60.62 -43.39 32.94 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 121.644 1.562 . . . . 64.2 112.284 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -69.84 -30.09 67.5 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 113.861 -1.518 . . . . 73.34 112.663 -174.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.732 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.6 p -82.0 -22.06 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 112.282 0.475 . . . . 61.23 112.282 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -71.44 -23.94 61.93 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 122.246 -0.284 . . . . 73.35 111.706 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -87.19 10.58 16.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.33 0.652 . . . . 72.11 110.946 174.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.702 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -106.56 159.93 15.81 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.929 0.892 . . . . 51.21 109.818 176.081 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -73.11 121.24 19.9 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.503 0.721 . . . . 74.53 109.479 167.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -84.87 95.84 9.14 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.019 0.528 . . . . 73.11 110.171 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -142.74 75.98 17.85 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 108.162 -1.051 . . . . 71.44 108.162 166.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -87.24 156.18 8.19 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.898 2.398 . . . . 70.13 113.569 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.37 118.89 27.11 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 113.731 -1.577 . . . . 73.41 108.386 173.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.41 101.59 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 122.934 0.494 . . . . 62.54 110.003 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.476 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 2.3 mptp? -91.39 102.69 15.38 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 106.427 -1.694 . . . . 74.45 106.427 169.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' G' ' 464' ' ' MET . 50.1 tp -97.26 126.22 42.33 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.112 0.565 . . . . 73.32 110.086 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -120.38 136.13 54.81 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.366 1.066 . . . . 62.41 108.963 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.78 132.28 54.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.048 0.939 . . . . 72.45 108.657 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -130.76 151.65 50.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.176 0.991 . . . . 75.33 108.852 169.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.428 HG22 HD11 ' G' ' 460' ' ' LEU . 6.7 t -149.89 144.14 25.73 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.073 -0.714 . . . . 72.13 109.073 169.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.55 149.05 43.42 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.617 0.767 . . . . 73.04 108.939 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 28.5 p -127.21 142.78 51.4 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.346 0.658 . . . . 73.21 110.397 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.7 t -145.2 128.06 16.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.955 0.902 . . . . 72.31 109.369 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -70.34 119.68 14.89 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.522 0.729 . . . . 53.22 109.728 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.576 HD11 HD12 ' C' ' 83' ' ' ILE . 51.1 mt -92.3 -29.9 16.13 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.999 0.519 . . . . 61.14 109.753 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.35 179.22 7.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.429 1.092 . . . . 64.25 110.097 176.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.68 123.32 17.62 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.597 -0.729 . . . . 64.45 109.292 175.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.99 19.42 11.85 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.177 0.923 . . . . 74.04 111.706 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.69 115.31 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.695 -0.854 . . . . 74.35 108.695 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.504 ' HD2' HD11 ' C' ' 86' ' ' ILE . 1.0 OUTLIER -115.38 157.94 23.17 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.578 0.751 . . . . 72.21 109.057 175.182 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' C' ' 48' ' ' SER . 22.5 tt0 -116.34 120.45 38.91 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.334 -1.303 . . . . 54.31 107.506 170.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.4 t -107.75 135.22 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.606 -0.887 . . . . 62.03 108.606 170.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.57 108.45 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.918 -0.771 . . . . 73.01 108.918 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.57 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -86.45 108.7 18.63 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.519 -1.289 . . . . 75.4 107.519 175.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.5 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 24.0 ttm180 -95.94 119.64 34.8 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.435 -0.95 . . . . 74.24 108.435 173.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.497 ' HB ' HD11 ' C' ' 114' ' ' ILE . 29.1 t -111.94 130.95 64.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.01 -1.107 . . . . 72.43 108.01 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 13.3 m -126.92 121.73 32.58 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.654 -0.869 . . . . 71.43 108.654 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.688 HG11 HD21 ' C' ' 126' ' ' LEU . 22.1 t -112.19 116.7 53.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.244 -0.65 . . . . 64.42 109.244 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 3.5 m -102.1 137.32 40.52 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.543 -0.91 . . . . 74.24 108.543 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.1 118.62 21.78 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.307 -0.997 . . . . 64.32 108.307 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 13.3 m -133.58 130.64 38.67 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.521 0.513 . . . . 74.34 110.664 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.702 HD13 ' HG2' ' C' ' 34' ' ' LYS . 25.6 mt -86.81 45.63 1.28 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.238 1.415 . . . . 61.23 109.796 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.09 -85.21 0.49 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 110.476 -1.05 . . . . 65.25 110.476 -171.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.42 -29.13 5.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.486 0.715 . . . . 51.05 110.496 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 8.2 tp10 -63.17 118.72 8.33 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.072 0.949 . . . . 73.11 109.918 175.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -74.31 117.72 16.44 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.532 -0.914 . . . . 71.44 108.532 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.732 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.68 -55.05 7.4 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.333 -0.988 . . . . 74.23 108.333 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -164.99 163.46 20.76 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.91 -1.041 . . . . 74.34 110.288 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -130.31 142.43 50.54 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 105.803 -1.925 . . . . 74.21 105.803 172.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.481 ' SG ' HG23 ' C' ' 114' ' ' ILE . 50.1 t -144.63 142.91 30.47 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.316 -0.994 . . . . 73.12 108.316 174.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -150.29 127.82 11.53 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.433 -0.58 . . . . 74.23 109.433 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 74.8 t -127.73 136.23 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.559 1.144 . . . . 60.01 108.267 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.5 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 69.7 mt-30 -109.59 87.35 2.48 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.121 -1.066 . . . . 74.33 108.121 174.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -78.21 96.9 5.33 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.341 -0.845 . . . . 52.51 109.251 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.2 146.45 21.09 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.327 -0.851 . . . . 73.2 112.399 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.493 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.27 118.11 0.9 Allowed Glycine 0 C--O 1.238 0.373 0 N-CA-C 110.958 -0.857 . . . . 63.3 110.958 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.576 HD12 HD11 ' C' ' 51' ' ' LEU . 15.5 mm -82.22 131.29 34.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.725 -0.843 . . . . 62.04 108.725 176.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -134.75 120.06 18.98 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 123.615 0.572 . . . . 72.14 110.083 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.0 p -79.72 106.16 11.54 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.153 -1.055 . . . . 62.52 108.153 170.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.504 HD11 ' HD2' ' C' ' 56' ' ' TYR . 2.3 pp -116.11 142.82 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.178 0.991 . . . . 71.3 109.98 -172.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -149.88 158.21 43.94 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.884 0.474 . . . . 53.42 110.607 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.55 -29.01 6.46 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.218 -0.447 . . . . 63.12 113.963 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.639 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -84.67 164.68 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.123 0.569 . . . . 73.41 111.401 -176.306 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -164.55 148.48 9.28 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.879 0.872 . . . . 72.42 109.205 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.88 -115.07 7.43 Favored Glycine 0 C--N 1.351 1.389 0 O-C-N 123.79 0.681 . . . . 73.13 114.516 170.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 70.4 p -79.88 -26.99 40.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.783 0.833 . . . . 54.11 110.906 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -67.34 -38.8 85.45 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.455 0.702 . . . . 73.22 109.746 173.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.442 ' SD ' ' O ' ' G' ' 451' ' ' VAL . 40.4 ttp -73.11 -38.99 66.14 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.811 -0.632 . . . . 65.3 110.464 174.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 -40.69 85.51 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 123.776 0.672 . . . . 52.41 110.588 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.407 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 12.7 t-80 -79.1 -34.1 43.83 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 123.576 0.548 . . . . 72.13 112.029 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -53.96 -41.76 68.16 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 123.634 0.584 . . . . 74.21 110.533 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.99 -14.65 17.76 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.309 -0.859 . . . . 51.33 110.954 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.16 -21.9 64.25 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 114.086 0.395 . . . . 62.12 114.086 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.27 -45.03 0.09 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.489 0.552 . . . . 63.24 112.489 -171.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -67.54 -48.99 65.4 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.315 0.385 . . . . 72.33 111.439 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.497 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 94.5 m -64.58 -49.56 69.95 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 118.714 -0.66 . . . . 53.04 111.895 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.57 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 75.1 Cg_exo -56.55 -30.22 81.93 Favored 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 122.259 1.973 . . . . 63.24 114.309 170.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -64.64 -41.03 96.42 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.594 0.758 . . . . 62.53 110.589 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.435 HD12 ' NH1' ' A' ' 111' ' ' ARG . 39.3 mm -61.08 -45.23 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.557 -0.747 . . . . 71.04 110.173 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.493 HD21 ' HA3' ' C' ' 82' ' ' GLY . 71.8 mt -79.23 -16.6 56.26 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.193 -0.912 . . . . 74.22 112.418 -172.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -62.68 -48.32 86.12 Favored Pre-proline 0 CA--C 1.561 1.372 0 N-CA-C 114.194 1.183 . . . . 73.0 114.194 -172.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -59.06 -34.72 99.0 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 121.833 1.689 . . . . 52.33 112.94 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -71.2 -44.95 64.42 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.504 0.721 . . . . 75.25 110.831 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.14 -44.7 87.98 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.333 -0.848 . . . . 61.11 109.925 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -54.1 -54.62 36.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.705 1.202 . . . . 74.52 111.305 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.62 -29.39 68.7 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.269 0.628 . . . . 71.22 110.872 -174.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.1 t -73.9 -37.0 64.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.998 0.519 . . . . 72.44 110.973 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.497 HD11 ' HB ' ' C' ' 62' ' ' VAL . 89.4 mt -67.81 -51.72 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.342 -0.614 . . . . 71.01 109.342 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 14.5 m -58.36 -31.84 67.99 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.613 0.765 . . . . 70.32 111.404 -177.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -62.42 -57.73 10.22 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.328 0.651 . . . . 75.1 109.599 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.569 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.77 -41.89 61.98 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.715 1.206 . . . . 52.54 112.843 177.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' C' ' 114' ' ' ILE . 95.7 t -67.48 -46.26 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.067 0.947 . . . . 62.44 110.758 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.451 ' OG ' HG21 ' B' ' 115' ' ' THR . 39.5 t -69.72 -26.42 64.32 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.556 -0.747 . . . . 72.35 111.281 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' D' ' 17' ' ' TYR . 78.1 mtt-85 -71.63 -42.11 68.02 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.467 0.707 . . . . 74.13 109.339 174.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.03 -3.11 67.6 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 123.759 0.662 . . . . 62.23 112.852 170.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p 65.5 30.82 10.56 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.828 2.051 . . . . 71.31 113.506 171.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -88.79 142.18 30.43 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 108.078 -1.082 . . . . 55.05 108.078 167.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -55.49 172.39 0.48 Allowed 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 123.213 2.609 . . . . 73.53 115.732 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -46.19 135.0 8.16 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.746 1.619 . . . . 75.43 114.83 -169.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.688 HD21 HG11 ' C' ' 64' ' ' VAL . 43.7 tp -137.15 86.86 2.23 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.183 -1.371 . . . . 61.15 108.631 176.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -116.21 114.94 25.12 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.004 0.922 . . . . 71.42 109.105 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.09 137.3 38.15 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 122.588 0.355 . . . . 42.44 110.562 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.66 157.98 88.72 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 124.744 1.217 . . . . 74.33 111.272 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.73 111.67 0.65 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.233 2.622 . . . . 72.23 112.835 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.5 t -97.52 112.07 28.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.193 -0.669 . . . . 73.44 109.193 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.64 77.94 7.42 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.392 0.677 . . . . 55.04 109.744 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -60.14 -38.96 84.68 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.689 -0.687 . . . . 64.24 109.414 171.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -57.46 -35.28 69.95 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 114.095 -1.411 . . . . 64.12 112.745 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.64 -51.98 67.08 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 124.122 0.889 . . . . 74.35 111.134 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.8 mp -74.83 -35.01 62.43 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.836 -0.62 . . . . 63.45 111.435 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.407 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . 2.2 t80 -75.5 -28.39 59.14 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 122.678 0.391 . . . . 73.31 110.566 -177.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -73.63 -31.39 63.5 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.455 0.702 . . . . 60.13 110.23 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -60.79 -38.39 85.16 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.081 0.552 . . . . 71.22 110.646 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -70.36 -87.21 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.699 -0.682 . . . . 74.4 109.399 169.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.5 ' HG ' ' HG2' ' C' ' 142' ' ' GLN . 56.4 tp 49.49 -89.63 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.862 1.265 . . . . 60.24 110.873 -171.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.5 ' HG2' ' HG ' ' C' ' 141' ' ' LEU . 30.0 pt20 179.99 167.69 1.27 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.969 1.308 . . . . 74.15 108.645 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -79.3 113.53 17.51 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.381 -0.599 . . . . 72.24 109.381 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -158.88 152.2 22.68 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.621 0.368 . . . . 44.52 111.531 -176.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.6 143.73 32.67 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.617 0.767 . . . . 61.01 109.915 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -119.26 179.37 16.7 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.336 0.397 . . . . 63.4 112.42 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.5 168.28 20.21 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.049 0.939 . . . . 70.1 109.403 177.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.9 107.66 0.48 Allowed Glycine 0 C--N 1.339 0.706 0 N-CA-C 111.13 -0.788 . . . . 61.11 111.13 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 82.2 m -149.66 91.45 1.81 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.446 1.099 . . . . 74.51 108.262 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.06 114.22 20.47 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.281 0.562 . . . . 73.25 109.967 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.49 103.98 16.15 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 106.728 -1.582 . . . . 72.1 106.728 168.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -108.74 85.8 2.17 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.311 0.577 . . . . 72.14 110.673 -175.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -81.69 148.56 28.93 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.645 -0.707 . . . . 75.14 109.096 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -158.2 126.11 5.25 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.866 -0.79 . . . . 74.41 108.866 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 C-N-CA 123.803 0.841 . . . . 52.32 109.502 -174.049 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.482 ' SD ' ' N ' ' D' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 110.518 -0.178 . . . . 43.35 110.518 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 37.2 t -161.21 179.29 8.48 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.046 0.938 . . . . 65.25 108.857 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.84 100.09 7.84 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.533 -0.914 . . . . 64.13 108.533 172.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -135.47 14.99 3.44 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.026 -0.988 . . . . 72.34 110.926 -171.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -112.31 19.88 17.26 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.989 0.915 . . . . 74.2 110.151 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -59.14 -44.21 92.05 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.32 1.048 . . . . 61.3 111.561 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.592 HG23 ' H ' ' D' ' 9' ' ' MET . 9.4 t -160.62 -166.23 1.59 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.375 1.07 . . . . 75.05 108.652 -176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -76.0 14.81 0.63 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.623 0.769 . . . . 74.35 111.562 176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.592 ' H ' HG23 ' D' ' 7' ' ' THR . 5.3 ttp -30.16 136.41 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.745 1.618 . . . . 62.3 113.25 165.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.544 HG21 ' HG2' ' B' ' 150' ' ' GLU . 5.2 m -105.62 143.55 33.61 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.089 0.556 . . . . 43.35 109.652 176.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -148.53 96.46 2.6 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.306 -1.368 . . . . 72.23 107.306 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -119.25 122.42 41.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.378 -0.971 . . . . 64.14 108.378 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.446 HD11 HD13 ' D' ' 105' ' ' ILE . 41.2 mt -78.49 114.66 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.841 -1.17 . . . . 74.44 107.841 169.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -84.86 -38.73 19.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.356 0.262 . . . . 74.43 111.504 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -169.3 127.22 0.96 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 119.757 -0.163 . . . . 75.24 111.248 -166.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.41 HD11 HG21 ' D' ' 13' ' ' ILE . 2.4 mp -105.33 134.59 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.144 -1.428 . . . . 73.45 107.144 164.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 36.2 p90 -154.87 165.45 36.63 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.975 0.893 . . . . 64.32 111.033 174.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -98.54 117.97 34.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.337 -1.301 . . . . 65.22 109.46 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.44 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 33.2 mtpt -82.25 -33.68 29.12 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.729 -0.841 . . . . 74.21 108.729 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -143.95 144.53 31.74 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 114.535 -1.211 . . . . 51.15 109.398 173.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.569 HD13 ' HE3' ' C' ' 117' ' ' MET . 47.2 mt -133.73 141.25 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.41 -1.33 . . . . 62.31 107.41 172.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -144.1 137.1 27.3 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.955 0.902 . . . . 70.04 108.917 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.579 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.0 t80 -152.33 128.66 10.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.237 -1.764 . . . . 74.23 106.237 172.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -138.41 125.66 21.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.67 0.788 . . . . 74.33 109.354 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.29 83.8 60.59 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.257 -1.016 . . . . 73.03 108.257 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.42 -23.55 20.25 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.692 2.262 . . . . 53.14 112.62 -173.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 -106.84 1.69 24.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.569 0.748 . . . . 65.55 111.075 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.404 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -27.27 -66.64 0.11 Allowed Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 116.702 2.112 . . . . 53.21 116.702 -161.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.75 -22.29 9.12 Favored 'Trans proline' 0 C--N 1.38 2.229 0 CA-C-N 123.544 2.301 . . . . 72.14 113.718 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -70.73 -38.09 73.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.213 1.005 . . . . 73.22 109.291 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.515 HG22 HD12 ' D' ' 68' ' ' LEU . 9.9 p -84.92 -21.86 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 115.801 -0.636 . . . . 64.23 111.738 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -65.95 -20.36 66.18 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 112.418 0.525 . . . . 72.42 112.418 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.54 -22.15 64.89 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.296 0.638 . . . . 74.1 110.439 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -88.6 83.52 6.77 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.43 1.092 . . . . 70.12 108.396 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.23 93.2 5.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.552 -0.749 . . . . 44.42 110.099 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -160.36 158.28 29.36 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.3 1.04 . . . . 75.53 109.102 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.85 ' HG3' HD11 ' H' ' 470' ' ' LEU . 67.9 tp60 -65.92 107.42 1.53 Allowed Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 124.007 0.923 . . . . 62.43 109.548 171.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.92 117.29 4.3 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 122.964 2.443 . . . . 73.44 112.867 -167.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.492 ' HA ' HD13 ' H' ' 470' ' ' LEU . 0.4 OUTLIER -73.84 121.61 21.16 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.103 -0.703 . . . . 64.24 109.103 -175.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' D' ' 66' ' ' ALA . 14.5 m -107.86 151.05 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.492 0.717 . . . . 70.5 112.309 -168.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -109.37 125.3 52.23 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.709 -1.219 . . . . 75.24 107.709 164.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.565 ' HB2' ' SD ' ' H' ' 464' ' ' MET . 65.4 mt -97.03 133.89 41.11 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.796 -0.446 . . . . 74.31 109.796 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -145.65 128.45 16.31 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.452 -1.314 . . . . 51.23 107.452 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.85 159.18 42.21 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.418 0.627 . . . . 72.31 111.071 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.0 t70 -136.48 128.96 30.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.479 1.512 . . . . 61.22 108.304 -170.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.6 t -106.06 146.77 29.71 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.28 -0.637 . . . . 72.22 109.28 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.99 170.48 19.77 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.709 0.804 . . . . 72.55 109.032 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 88.9 p -162.9 155.2 18.59 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 123.163 0.289 . . . . 65.24 110.83 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 22.2 t -153.44 153.88 33.34 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.489 1.116 . . . . 72.23 109.726 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.96 136.99 32.72 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 109.542 -0.54 . . . . 64.41 109.542 172.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' C' ' 29' ' ' PRO . 26.7 mt -109.5 -34.64 6.45 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.156 0.583 . . . . 75.54 110.138 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -157.01 -178.62 7.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.937 0.895 . . . . 71.43 110.243 176.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.72 118.62 10.52 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.474 -0.785 . . . . 74.33 110.082 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 56.79 17.22 3.09 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 124.998 1.319 . . . . 73.31 113.036 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 77.9 t -118.51 110.29 29.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 106.696 -1.594 . . . . 73.4 106.696 171.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.477 ' HB2' HD11 ' D' ' 86' ' ' ILE . 6.0 t80 -120.7 161.26 21.72 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.431 -0.952 . . . . 64.5 108.431 -170.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -129.74 145.42 51.54 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.306 -0.861 . . . . 63.3 109.516 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.71 125.05 66.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.064 -1.458 . . . . 61.23 107.064 172.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 43.6 t -103.26 133.2 47.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.935 -0.765 . . . . 64.42 108.935 176.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.57 118.42 31.62 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.665 -0.865 . . . . 73.24 108.665 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.469 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.2 ttm-85 -104.27 96.05 6.37 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.253 -1.018 . . . . 74.41 108.253 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.35 125.21 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.874 -0.787 . . . . 51.43 108.874 174.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 5.9 m -118.07 134.01 55.38 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 123.633 0.583 . . . . 73.04 109.669 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.407 HG21 HG21 ' D' ' 114' ' ' ILE . 64.4 t -119.58 117.66 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.305 1.042 . . . . 72.24 108.914 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 31.9 m -105.91 94.1 5.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.885 0.874 . . . . 72.2 108.652 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -96.2 151.31 19.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.013 0.525 . . . . 61.4 111.337 -172.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.424 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 56.7 p -147.0 135.62 22.02 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.35 -0.841 . . . . 74.34 111.449 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.515 HD12 HG22 ' D' ' 31' ' ' VAL . 22.6 mt -96.56 94.42 7.35 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.518 -1.29 . . . . 74.32 107.518 167.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.77 -117.01 8.76 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.313 -0.858 . . . . 74.2 112.577 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -93.69 4.77 53.42 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.851 0.86 . . . . 74.15 111.914 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -118.9 140.29 50.22 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.013 0.525 . . . . 74.45 110.183 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.6 m -63.57 116.15 5.36 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 123.456 0.472 . . . . 52.31 110.255 174.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.488 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -77.24 -72.12 0.37 Allowed 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.949 -0.759 . . . . 51.21 108.949 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -142.03 153.42 44.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.573 -0.739 . . . . 74.52 109.935 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 79.2 mt -115.48 148.52 39.35 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.935 -1.506 . . . . 72.23 106.935 169.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.528 ' SG ' HG12 ' D' ' 114' ' ' ILE . 47.4 t -155.1 143.12 20.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.27 -0.641 . . . . 74.21 109.27 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -155.8 127.28 7.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.61 -0.515 . . . . 74.14 109.61 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.31 120.52 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 122.863 0.465 . . . . 74.24 110.125 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -89.48 83.57 6.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.977 -0.749 . . . . 72.3 108.977 171.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -79.7 91.55 5.28 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.789 -1.096 . . . . 71.43 108.78 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.84 143.23 18.92 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 110.96 -0.856 . . . . 75.12 110.96 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.517 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -135.31 130.77 5.54 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 112.059 -0.416 . . . . 74.25 112.059 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.44 HG13 ' HE1' ' D' ' 17' ' ' TYR . 43.5 mt -89.44 126.15 42.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 124.028 0.931 . . . . 71.21 109.026 174.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -127.76 125.57 40.15 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.532 -0.914 . . . . 64.11 108.532 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.5 t -86.45 111.17 20.29 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.652 -1.24 . . . . 65.13 107.652 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' D' ' 56' ' ' TYR . 0.9 OUTLIER -130.24 136.7 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.288 0.566 . . . . 74.02 110.538 -173.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.4 156.3 40.4 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.8 1.24 . . . . 74.4 107.882 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.28 20.92 79.46 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 121.117 -0.564 . . . . 62.4 112.322 -175.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 45.5 pt -109.8 152.35 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.057 0.943 . . . . 60.23 109.24 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -163.16 146.04 10.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.903 0.481 . . . . 72.33 110.912 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.91 -120.81 11.41 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 115.17 0.828 . . . . 51.02 115.17 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 24.2 p -70.08 -24.06 63.16 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.482 1.113 . . . . 73.51 112.272 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -64.19 -36.11 82.99 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.443 0.697 . . . . 62.33 110.211 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.667 ' SD ' ' HA ' ' H' ' 452' ' ' VAL . 19.4 mtm -68.25 -51.88 40.19 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.52 0.513 . . . . 72.3 110.318 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.33 70.92 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.067 0.547 . . . . 71.11 111.915 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 28.9 t-80 -72.68 -32.17 65.6 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.887 0.875 . . . . 75.23 111.161 176.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.4 t -78.31 -53.52 7.21 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.491 0.316 . . . . 63.41 111.258 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' D' ' 94' ' ' MET . 4.6 pp -95.3 -18.98 20.36 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.308 0.643 . . . . 74.31 112.163 -169.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.4 13.23 56.95 Favored Glycine 0 N--CA 1.473 1.152 0 CA-C-O 120.051 -0.305 . . . . 52.23 112.693 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.685 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -152.63 -71.03 0.15 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 111.969 0.359 . . . . 73.25 111.969 -176.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -73.11 -32.74 65.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 112.378 0.51 . . . . 73.33 112.378 -171.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -71.71 -43.89 11.73 Favored Pre-proline 0 CA--C 1.561 1.365 0 CA-C-O 118.48 -0.771 . . . . 74.34 111.791 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -52.95 -36.1 73.92 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.194 1.929 . . . . 75.14 113.287 164.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -67.84 -22.31 65.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.517 0.727 . . . . 74.31 111.586 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.446 HD13 HD11 ' D' ' 13' ' ' ILE . 87.1 mt -81.1 -40.24 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 124.415 1.086 . . . . 71.41 110.463 172.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.517 HD21 ' HA3' ' D' ' 82' ' ' GLY . 93.9 mt -73.03 -22.75 60.58 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.246 -0.888 . . . . 71.33 111.82 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -71.68 -40.34 8.31 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 124.263 1.025 . . . . 75.31 113.308 -171.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -52.58 -42.66 60.57 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.292 1.994 . . . . 74.51 114.243 166.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -74.82 -35.72 62.43 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.167 0.587 . . . . 71.13 111.482 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.65 -42.42 86.71 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.562 -0.533 . . . . 54.04 109.562 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.637 HH12 ' HB3' ' D' ' 130' ' ' PRO . 21.2 ttp180 -51.49 -56.71 11.85 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 124.805 1.316 . . . . 72.25 110.708 173.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -67.17 -37.76 84.27 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.346 1.028 . . . . 73.34 111.584 -171.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -60.39 -45.25 94.22 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.467 0.479 . . . . 74.01 110.445 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.528 HG12 ' SG ' ' D' ' 76' ' ' CYS . 96.6 mt -61.8 -53.64 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.036 -0.984 . . . . 71.2 110.706 174.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -56.39 -40.35 74.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.305 1.042 . . . . 53.24 111.525 -172.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.4 t -66.48 -43.4 85.51 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 114.783 -1.099 . . . . 61.42 110.6 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.3 mtm -70.17 -26.24 63.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.705 0.402 . . . . 61.22 111.66 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' D' ' 114' ' ' ILE . 69.2 t -68.06 -45.23 83.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 123.566 0.746 . . . . 73.44 110.019 173.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.9 p -74.84 -26.21 59.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.816 0.446 . . . . 64.24 111.473 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -75.65 -34.71 60.52 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.204 0.601 . . . . 74.11 109.646 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.36 1.65 84.68 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.651 0.595 . . . . 73.02 112.303 171.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 44.6 p 61.04 21.23 11.62 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 127.073 2.149 . . . . 60.43 114.458 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -78.44 142.7 62.83 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 107.86 -1.163 . . . . 73.3 107.86 168.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -50.18 137.74 37.52 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.245 2.63 . . . . 71.21 113.192 176.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -50.22 135.49 21.19 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.842 1.257 . . . . 71.01 114.04 -164.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 18.7 tp -108.84 102.0 11.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.196 0.599 . . . . 50.3 110.675 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -100.35 96.91 7.75 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.368 0.604 . . . . 74.34 109.931 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.94 123.2 19.18 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.122 1.369 . . . . 50.21 111.357 -175.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.07 122.84 88.14 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.396 0.679 . . . . 73.13 110.385 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.637 ' HB3' HH12 ' D' ' 111' ' ' ARG . 74.2 Cg_endo -80.87 128.85 6.81 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.304 2.003 . . . . 62.11 112.674 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.39 146.1 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.497 0.719 . . . . 72.33 109.807 176.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -85.6 89.83 7.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.029 0.532 . . . . 75.13 109.566 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -59.21 -24.08 62.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.61 0.764 . . . . 71.12 112.344 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.685 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 9.8 t70 -60.23 -52.47 65.16 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.075 0.95 . . . . 71.34 110.7 -176.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.77 -40.04 69.55 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.127 -0.942 . . . . 71.12 111.359 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 91.4 mt -58.17 -34.5 70.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.627 0.771 . . . . 63.33 112.111 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -71.97 -49.06 40.47 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.377 0.671 . . . . 74.1 110.57 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 74.5 mtm -63.21 -34.53 77.84 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.76 0.424 . . . . 61.0 110.869 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -70.7 -35.96 73.01 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.964 0.506 . . . . 71.51 111.017 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -61.73 -42.88 99.54 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.702 0.401 . . . . 73.12 110.8 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.39 -30.22 71.27 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.563 0.745 . . . . 75.22 112.248 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -93.0 20.23 6.95 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.045 0.538 . . . . 74.44 112.328 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -122.2 81.65 1.86 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.025 0.53 . . . . 74.23 111.598 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -145.43 84.73 1.7 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.983 1.313 . . . . 75.44 108.278 166.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.82 137.04 9.56 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.356 0.663 . . . . 43.41 110.454 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.86 -14.79 82.22 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 111.779 -0.528 . . . . 73.35 111.779 170.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.27 138.2 41.71 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.125 0.97 . . . . 75.51 109.184 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.58 -178.65 29.98 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.669 0.605 . . . . 54.1 113.896 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 12.5 t -148.91 -152.07 0.42 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.502 -0.925 . . . . 73.4 108.502 -173.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -54.76 147.17 15.38 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.557 0.743 . . . . 64.52 110.758 172.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -77.61 78.15 4.12 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.485 0.659 . . . . 63.54 109.811 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -149.65 140.17 22.47 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.973 -1.012 . . . . 74.33 109.019 174.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -160.52 133.89 6.76 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.668 -0.864 . . . . 75.32 108.668 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -109.93 138.89 45.67 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.693 0.797 . . . . 72.23 109.332 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.919 0 C-N-CA 123.337 0.655 . . . . 71.44 111.506 -172.248 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 58.6 t30 . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.618 -0.512 . . . . 64.44 109.618 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . 0.682 HG11 ' HA ' ' A' ' 87' ' ' ALA . 11.5 p -113.12 -23.65 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.118 0.967 . . . . 71.11 109.899 176.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 18.9 m -63.08 150.12 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.706 1.202 . . . . 71.24 114.066 -167.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -168.75 -174.79 37.7 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.193 -0.912 . . . . 52.21 112.127 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -160.78 102.96 1.33 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 106.679 -1.6 . . . . 72.35 106.679 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 6.4 t -130.32 59.68 1.64 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 122.09 0.948 . . . . 73.12 110.223 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -160.13 129.79 5.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.987 -1.006 . . . . 74.11 109.608 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -131.37 106.47 8.28 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.353 -0.98 . . . . 74.12 108.353 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 15.3 t -148.33 150.35 33.44 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.456 -0.572 . . . . 75.32 109.456 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -85.01 66.01 9.54 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.601 -0.888 . . . . 71.32 108.601 174.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . 0.728 HD21 ' HA ' ' A' ' 45' ' ' ASP . 3.5 mm? 61.95 -171.55 0.16 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.753 1.221 . . . . 71.14 111.671 -176.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . 0.455 ' HD1' ' HB3' ' A' ' 136' ' ' LEU . 6.0 p90 -157.36 8.32 0.17 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.446 0.698 . . . . 71.4 111.04 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . 0.44 ' OH ' ' HA ' ' A' ' 43' ' ' ASP . 34.2 p90 -84.78 172.83 11.15 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.152 0.501 . . . . 64.23 110.856 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 9.9 t -121.43 -22.33 5.99 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.806 0.842 . . . . 62.33 110.262 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.07 -79.53 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.717 1.607 . . . . 75.13 109.129 -171.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 87.2 tttt 74.66 -24.55 0.21 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.608 1.563 . . . . 65.13 113.753 167.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -81.54 85.24 6.54 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.138 0.494 . . . . 61.33 110.201 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -73.66 120.41 19.22 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.457 -0.792 . . . . 71.55 109.401 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . 0.423 ' HB3' HD22 ' E' ' 470' ' ' LEU . 4.1 tt -69.89 -43.15 72.35 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.562 -0.903 . . . . 73.53 108.562 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.29 -48.14 2.64 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.826 -0.624 . . . . 52.03 112.027 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . 0.541 ' HB3' ' NE1' ' A' ' 36' ' ' TRP . 4.0 mm? 70.92 102.94 0.06 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.219 1.407 . . . . 60.14 110.86 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 96.2 mttt . . . . . 0 C--O 1.251 1.163 0 C-N-CA 124.702 1.201 . . . . 74.05 108.881 -177.832 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 14.2 m120 . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 108.626 -0.879 . . . . 73.35 108.626 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . 0.499 ' HA ' ' HG3' ' B' ' 90' ' ' GLU . 88.0 t -64.35 -46.01 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.39 0.676 . . . . 74.45 111.309 -173.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 15.5 m -52.44 134.03 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 113.916 1.08 . . . . 71.25 113.916 -173.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -163.93 47.16 0.31 Allowed Glycine 0 C--N 1.341 0.818 0 CA-C-N 115.046 -0.979 . . . . 72.4 110.858 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.15 124.01 26.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.401 0.68 . . . . 74.13 109.801 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 18.5 m -68.67 125.34 26.24 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 109.208 -0.664 . . . . 73.53 109.208 172.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -58.44 143.9 43.87 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.957 0.903 . . . . 61.31 112.529 -173.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -70.31 88.57 0.64 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.305 1.042 . . . . 70.34 111.881 -171.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 41.0 p -102.52 -144.43 0.36 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.165 0.986 . . . . 73.33 108.867 172.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.17 85.09 0.05 Allowed 'General case' 0 C--N 1.358 0.94 0 N-CA-C 108.962 -0.755 . . . . 71.43 108.962 170.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . 0.52 ' H ' HD23 ' F' ' 460' ' ' LEU . 2.2 pt? -75.65 127.62 33.46 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.803 -0.635 . . . . 74.21 110.708 -174.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . 0.541 ' HD2' ' HB2' ' B' ' 136' ' ' LEU . 93.7 m-85 69.09 -77.33 0.05 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.917 1.287 . . . . 73.42 113.289 170.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -132.54 173.01 11.76 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.551 0.691 . . . . 62.03 111.366 -171.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 12.0 m -132.57 54.44 1.95 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 107.659 -1.237 . . . . 73.24 107.659 171.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 53.1 mtm -70.7 -21.31 62.58 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.215 -0.902 . . . . 71.42 110.753 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 48.8 tttp 70.59 -76.08 0.07 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.557 1.143 . . . . 72.52 110.486 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' B' ' 41' ' ' LYS . . . -86.34 164.79 16.87 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.873 0.869 . . . . 72.33 110.746 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . 0.761 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -121.18 160.26 24.16 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.505 0.722 . . . . 73.22 109.834 174.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 7.3 mp 66.89 -76.4 0.05 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.667 1.187 . . . . 72.1 110.013 -173.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 132.41 -18.14 4.69 Favored Glycine 0 N--CA 1.476 1.35 0 N-CA-C 111.813 -0.515 . . . . 52.51 111.813 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . 0.598 HD21 ' H ' ' B' ' 40' ' ' VAL . 3.2 mm? 60.93 32.24 19.99 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.028 1.331 . . . . 74.43 111.063 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 C--O 1.252 1.195 0 C-N-CA 124.968 1.307 . . . . 53.42 107.77 -179.239 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 121.603 0.716 . . . . 63.15 109.246 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . 0.442 ' O ' ' SD ' ' C' ' 94' ' ' MET . 8.9 p -72.56 -11.66 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 114.695 -1.139 . . . . 74.14 111.423 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . 0.482 ' HA ' ' HE2' ' C' ' 56' ' ' TYR . 33.6 m -126.73 173.06 13.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 124.531 1.132 . . . . 72.53 110.001 174.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 109.76 79.31 1.08 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.735 -0.546 . . . . 62.44 111.735 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 79.8 mt -124.96 126.38 45.38 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.321 1.048 . . . . 72.42 108.232 169.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 58.5 p -78.85 -60.73 2.26 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 122.805 0.442 . . . . 70.03 111.162 -175.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -164.64 154.8 14.13 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.095 0.558 . . . . 73.42 110.172 -175.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -153.4 52.54 0.73 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.472 -0.936 . . . . 62.15 108.472 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 14.5 t -72.55 142.43 48.46 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.308 -0.86 . . . . 61.2 110.177 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 21.4 t70 66.11 108.11 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.383 1.073 . . . . 53.5 111.243 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . 0.428 HD11 HG22 ' C' ' 46' ' ' THR . 56.7 mt -93.48 166.59 12.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.277 0.561 . . . . 35.22 111.128 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -77.28 177.39 7.95 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.956 -1.02 . . . . 64.44 110.17 168.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 70.2 t80 64.23 76.57 0.34 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.215 1.006 . . . . 63.01 110.467 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 16.6 p -94.0 88.72 5.79 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.719 -0.845 . . . . 54.43 108.719 169.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . 0.631 ' HB3' ' HB3' ' C' ' 42' ' ' LEU . 39.7 tpp -72.19 132.17 43.76 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.505 -0.771 . . . . 63.51 110.262 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -124.81 12.85 8.53 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.94 0.896 . . . . 73.21 111.378 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -144.69 -67.36 0.32 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.109 0.564 . . . . 54.24 110.474 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . 60.93 -79.93 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.228 1.411 . . . . 34.44 111.866 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . 0.434 HD12 HD12 ' C' ' 126' ' ' LEU . 84.3 mt -110.94 125.04 53.27 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.123 0.969 . . . . 73.22 109.654 -177.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -76.84 74.78 1.76 Allowed Glycine 0 C--N 1.345 1.057 0 N-CA-C 110.785 -0.926 . . . . 55.24 110.785 170.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 85.2 mt -73.29 90.66 1.65 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.978 0.911 . . . . 73.23 109.913 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.055 -0.974 . . . . 64.14 108.813 -178.229 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.533 0.206 . . . . 75.34 111.027 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . . . . . . . . . 11.8 p -96.5 -29.21 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 109.472 -0.566 . . . . 72.11 109.472 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . 0.667 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 11.0 p -82.04 147.8 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.524 0.73 . . . . 64.13 110.741 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 147.34 114.66 0.82 Allowed Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.843 -0.42 . . . . 35.12 112.621 174.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . 0.587 ' HG ' ' H ' ' H' ' 455' ' ' THR . 0.3 OUTLIER -123.13 -84.55 0.66 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.245 0.618 . . . . 72.42 109.365 174.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . 0.587 ' H ' ' HG ' ' H' ' 454' ' ' LEU . 14.1 t 174.2 175.69 0.15 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.579 1.152 . . . . 73.24 109.275 -172.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -72.37 136.78 46.21 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.815 -0.809 . . . . 74.24 108.815 167.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 15.3 pm0 -136.33 39.1 2.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.738 0.415 . . . . 74.52 110.336 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 10.9 p -50.02 96.64 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.887 0.875 . . . . 74.34 112.242 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -176.62 174.52 1.84 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.166 1.786 . . . . 64.1 107.325 -174.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 14.8 tp -149.19 156.82 42.74 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.424 0.63 . . . . 74.4 110.843 173.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -101.59 -158.97 0.7 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.019 1.328 . . . . 74.13 108.911 167.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 28.3 t80 70.07 151.4 0.09 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.602 0.761 . . . . 74.23 112.555 169.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 51.4 m -131.66 125.28 31.74 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.743 0.817 . . . . 74.23 109.971 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . 0.565 ' SD ' ' HB2' ' D' ' 42' ' ' LEU . 5.8 ptp -129.15 109.75 11.43 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.666 0.786 . . . . 64.2 110.016 175.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . 0.442 ' O ' ' HE2' ' H' ' 471' ' ' LYS . 30.9 ttmt -73.66 -46.7 44.97 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 107.319 -1.363 . . . . 72.43 107.319 164.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -72.18 160.87 31.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.195 -1.366 . . . . 74.43 111.837 -178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -118.08 -85.61 0.64 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.161 0.584 . . . . 74.3 111.303 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -163.02 56.14 0.19 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.876 0.846 . . . . 74.42 111.213 -167.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 96.04 -52.8 1.65 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.235 -1.146 . . . . 74.31 110.235 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . 0.85 HD11 ' HG3' ' D' ' 37' ' ' GLN . 83.8 mt -69.92 112.82 6.6 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 108.235 -1.024 . . . . 70.35 108.235 167.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' H' ' 465' ' ' LYS . 5.1 ttpm? . . . . . 0 CA--C 1.56 1.364 0 O-C-N 124.255 0.972 . . . . 73.14 110.68 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.897 -0.409 . . . . 65.34 109.897 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 m 64.6 -80.82 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.91 1.284 . . . . 52.23 111.364 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -102.43 93.17 5.02 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.813 -0.81 . . . . 64.13 108.813 172.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -84.3 -41.74 16.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.198 -1.038 . . . . 73.14 108.198 167.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -80.92 85.37 6.23 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 124.183 0.993 . . . . 72.42 109.113 174.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -78.99 132.8 36.79 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.968 -0.56 . . . . 72.44 109.772 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -141.61 155.36 45.74 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.181 0.992 . . . . 61.14 109.137 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -67.55 175.47 2.84 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.293 0.637 . . . . 74.21 109.907 171.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.4 mtt -61.64 129.15 39.67 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.633 -0.506 . . . . 61.12 109.633 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' C' ' 150' ' ' GLU . 75.6 m -141.42 121.09 13.4 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.482 0.713 . . . . 72.23 109.137 -170.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.522 ' HD1' HG22 ' C' ' 149' ' ' THR . 21.6 t80 -134.28 125.0 26.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.7 0.8 . . . . 74.05 109.32 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -137.93 135.71 36.33 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.145 -1.057 . . . . 75.11 108.145 175.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.594 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.5 mt -92.83 118.31 38.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.22 -1.03 . . . . 75.52 108.22 174.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -88.83 -30.21 19.12 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 124.003 0.814 . . . . 64.44 110.272 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -171.28 147.61 2.51 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 123.275 0.359 . . . . 74.15 110.721 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 84.6 mt -137.05 134.16 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.503 1.121 . . . . 75.34 108.058 173.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.542 ' HB3' HG23 ' B' ' 122' ' ' THR . 25.1 p90 -166.54 169.2 13.97 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.773 0.797 . . . . 74.12 112.193 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -89.36 122.75 32.89 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.303 -0.862 . . . . 72.12 108.778 170.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.461 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.6 mtpt -87.7 -18.65 29.03 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.926 -0.398 . . . . 74.22 109.926 173.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.1 t70 -161.73 144.73 12.09 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.102 0.961 . . . . 75.21 109.297 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.613 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 82.0 mt -140.49 142.52 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.813 1.645 . . . . 62.41 107.172 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -146.32 139.99 26.1 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.176 0.513 . . . . 61.02 110.147 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 89.1 t80 -141.44 127.15 19.1 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.204 -1.406 . . . . 71.22 107.204 173.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -133.87 122.43 23.18 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.734 -0.469 . . . . 74.41 109.734 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.02 74.53 79.72 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.278 -1.378 . . . . 74.34 107.278 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.57 -22.09 51.66 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.662 2.241 . . . . 70.25 112.543 -173.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 42.6 m-80 -120.01 34.81 5.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.124 0.97 . . . . 73.33 109.314 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.45 -54.21 37.39 Favored Pre-proline 0 CA--C 1.565 1.522 0 CA-C-O 118.128 -0.939 . . . . 44.32 113.4 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.97 -22.02 31.68 Favored 'Trans proline' 0 C--N 1.387 2.599 0 CA-C-N 121.607 1.609 . . . . 70.51 113.147 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 6.0 t-160 -82.03 -38.83 24.41 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.99 0.916 . . . . 63.13 110.885 -171.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 73' ' ' ALA . 34.2 m -69.43 -25.92 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.311 0.644 . . . . 74.24 111.957 -175.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -72.43 -24.51 61.23 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.192 0.597 . . . . 71.5 111.004 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -77.09 -49.07 16.12 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.687 0.795 . . . . 71.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -75.36 172.77 11.89 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.372 0.669 . . . . 75.12 111.779 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.56 116.96 4.74 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 123.444 0.698 . . . . 75.25 110.525 176.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -73.65 90.41 1.8 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.455 -0.793 . . . . 70.24 109.549 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -131.4 72.0 81.13 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.092 -1.077 . . . . 74.54 108.092 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.57 116.77 2.96 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.396 2.064 . . . . 62.32 111.245 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -94.78 111.46 23.24 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.658 -1.238 . . . . 63.13 107.658 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 m -85.71 127.82 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-N 114.458 -1.246 . . . . 50.32 112.013 -170.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -122.01 114.54 21.1 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.334 1.453 . . . . 75.02 107.805 177.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.578 ' HB3' ' HB3' ' E' ' 464' ' ' MET . 22.6 tp -110.44 113.73 26.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.032 0.533 . . . . 52.01 109.823 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -113.11 110.05 19.8 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.744 0.818 . . . . 64.11 108.902 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mp -97.88 155.35 17.1 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.179 -0.674 . . . . 75.03 109.179 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.9 t70 -148.83 146.76 28.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.432 1.093 . . . . 73.23 108.437 -174.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.2 m -141.89 134.44 28.25 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.614 0.765 . . . . 74.14 110.175 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.2 140.51 46.55 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.807 0.843 . . . . 74.32 110.61 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.464 ' HB3' HD21 ' A' ' 98' ' ' LEU . 39.5 p -92.16 152.97 19.62 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.029 0.932 . . . . 63.12 109.834 176.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -151.85 145.25 24.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.946 0.898 . . . . 61.12 109.178 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -113.44 137.76 51.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.976 -0.75 . . . . 63.23 108.976 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.3 mt -110.96 -36.42 5.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.496 0.718 . . . . 74.25 110.469 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -160.45 -176.85 5.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.388 0.675 . . . . 74.11 110.828 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.28 120.54 12.95 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.166 -1.05 . . . . 74.32 108.166 170.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 72.46 -5.91 1.71 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.778 1.231 . . . . 63.42 112.702 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 52.3 t -109.25 116.38 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.081 0.952 . . . . 65.22 108.832 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.78 162.56 28.17 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.26 0.624 . . . . 72.41 109.549 -176.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -134.88 145.74 48.55 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.063 0.945 . . . . 72.54 109.732 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -131.6 147.57 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.5 -0.926 . . . . 75.1 108.5 166.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.13 117.3 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.728 0.811 . . . . 72.4 109.382 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.7 tp -97.91 103.28 15.2 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.874 -0.787 . . . . 51.32 108.874 173.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.612 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 27.3 ttp180 -88.26 112.99 23.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.3 0.64 . . . . 70.11 109.673 172.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.85 123.2 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.598 -0.89 . . . . 55.21 108.598 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -115.77 120.65 39.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.748 0.819 . . . . 70.4 110.061 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.446 ' O ' HD12 ' A' ' 75' ' ' LEU . 86.0 t -111.39 113.46 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.992 0.917 . . . . 51.04 110.007 -178.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.2 m -112.06 105.6 14.03 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.82 -0.807 . . . . 64.13 108.82 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -111.38 105.36 13.97 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.198 -1.038 . . . . 70.55 108.198 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.3 p -128.85 131.29 47.67 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.49 0.716 . . . . 60.35 110.753 -174.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.715 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -91.83 87.15 6.14 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.564 -0.902 . . . . 71.4 108.564 175.371 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.15 -102.88 2.32 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 114.981 -1.009 . . . . 72.23 111.902 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.43 -26.12 12.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.994 0.517 . . . . 72.2 110.327 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -91.68 127.4 37.12 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.894 0.878 . . . . 52.42 109.159 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.7 m -87.4 134.56 33.56 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 122.643 0.377 . . . . 75.34 110.751 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.648 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -76.48 -61.09 2.07 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 124.283 0.989 . . . . 74.5 108.668 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -152.88 153.79 33.76 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.554 -1.203 . . . . 62.22 110.725 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 58.6 tp -122.18 136.73 54.95 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.849 -1.537 . . . . 71.31 106.849 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 85.8 m -140.05 103.39 4.61 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.187 0.595 . . . . 72.55 109.445 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.22 117.68 24.37 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.216 -0.661 . . . . 74.13 109.216 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -126.11 113.79 35.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 123.862 0.865 . . . . 74.34 109.683 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.612 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 50.0 mt-30 -85.38 84.86 7.51 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.65 -0.871 . . . . 73.12 108.65 170.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.403 ' O ' HD13 ' A' ' 106' ' ' LEU . 8.1 tp-100 -79.84 100.87 8.21 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.367 -0.975 . . . . 72.33 108.367 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.12 144.79 17.36 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 111.335 -0.706 . . . . 71.42 111.335 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.535 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.02 128.43 4.22 Favored Glycine 0 CA--C 1.504 -0.639 0 N-CA-C 111.369 -0.692 . . . . 70.11 111.369 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.0 mt -82.22 119.63 32.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.406 -0.961 . . . . 74.23 108.406 172.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.594 ' HD2' HG12 ' A' ' 13' ' ' ILE . 26.9 m-85 -130.31 117.73 20.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.954 -1.128 . . . . 70.03 107.954 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 p -78.75 108.42 12.16 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.973 -1.121 . . . . 73.25 107.973 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.538 ' HB ' HD11 ' A' ' 89' ' ' ILE . 42.9 pt -119.19 139.45 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.361 0.664 . . . . 63.5 109.943 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.32 159.68 28.75 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.478 1.111 . . . . 73.11 109.522 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.54 4.0 89.05 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.926 -0.375 . . . . 40.34 113.879 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -120.46 136.58 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.284 -1.006 . . . . 72.22 108.284 172.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -141.22 173.6 11.33 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.34 1.056 . . . . 74.13 109.659 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.83 -133.14 51.33 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 123.948 0.78 . . . . 72.12 114.198 174.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.646 ' HB ' HD11 ' A' ' 141' ' ' LEU . 55.5 p -71.55 -24.82 62.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.01 0.924 . . . . 73.11 111.854 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -68.82 -44.11 74.18 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.582 0.753 . . . . 71.33 110.17 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 52.3 ttp -63.33 -48.4 78.18 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.956 -0.387 . . . . 62.42 109.956 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.9 -31.6 68.76 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.171 0.919 . . . . 55.23 112.034 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -73.98 -45.08 52.26 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.95 0.5 . . . . 70.41 110.62 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 78.7 m -66.55 -25.04 66.46 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.177 0.591 . . . . 40.14 111.575 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 48' ' ' SER . 6.0 tt -95.72 -42.5 8.34 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.459 1.103 . . . . 74.44 110.159 -173.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.77 4.31 53.3 Favored Glycine 0 N--CA 1.472 1.045 0 CA-C-N 115.945 -0.57 . . . . 74.24 113.681 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.6 -57.79 0.32 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.224 0.512 . . . . 74.42 111.772 -176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.496 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.2 t80 -70.68 -62.43 1.4 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.118 0.567 . . . . 75.11 112.395 -170.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.3 m -68.71 -33.09 4.06 Favored Pre-proline 0 CA--C 1.567 1.618 0 N-CA-C 114.369 1.248 . . . . 73.34 114.369 -173.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.02 -24.77 44.93 Favored 'Trans proline' 0 C--N 1.39 2.742 0 CA-C-N 121.725 1.652 . . . . 63.43 112.776 167.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -73.41 -26.56 61.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.776 -0.453 . . . . 73.34 109.776 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.5 mm -63.63 -36.52 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.466 0.707 . . . . 73.03 109.818 169.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.535 HD21 ' HA3' ' A' ' 82' ' ' GLY . 76.5 mt -79.97 -17.61 52.5 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.899 0.88 . . . . 63.32 111.932 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -64.69 -46.17 76.17 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 117.755 -1.117 . . . . 65.14 113.684 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.47 -33.88 67.24 Favored 'Trans proline' 0 C--N 1.389 2.675 0 CA-C-N 122.071 1.776 . . . . 74.14 112.838 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -70.53 -41.16 72.91 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.37 0.668 . . . . 70.21 111.239 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.98 -39.68 79.28 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.925 0.49 . . . . 75.21 110.405 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.474 ' NH1' HG23 ' C' ' 105' ' ' ILE . 36.5 ttm180 -53.2 -51.54 61.76 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 124.402 1.064 . . . . 54.22 109.611 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -66.59 -44.21 82.81 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.023 -0.989 . . . . 75.31 111.653 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.418 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.9 t -62.2 -33.99 75.6 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.174 0.59 . . . . 75.14 111.306 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 118' ' ' VAL . 83.3 mt -70.63 -55.97 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.112 0.965 . . . . 64.35 110.092 173.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.8 m -51.67 -43.43 62.69 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.697 1.199 . . . . 62.35 111.466 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -63.37 -47.07 83.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.906 -1.497 . . . . 54.41 110.268 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.429 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 69.0 mtm -63.13 -36.96 85.34 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.053 0.541 . . . . 62.31 111.722 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 114' ' ' ILE . 86.1 t -62.83 -47.2 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 123.507 0.723 . . . . 72.35 110.298 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.4 p -76.75 -20.25 56.71 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.153 0.581 . . . . 52.33 112.089 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -75.59 -34.89 60.66 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.005 -0.739 . . . . 72.31 109.005 172.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.43 -0.88 80.35 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.457 -0.792 . . . . 73.43 112.291 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.8 m 70.92 14.22 6.94 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 125.246 1.418 . . . . 25.24 111.578 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -77.91 157.43 79.02 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 123.619 0.767 . . . . 74.52 110.027 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.63 131.19 44.35 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.214 2.609 . . . . 71.05 111.897 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -55.24 126.41 24.78 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 124.414 1.071 . . . . 70.33 112.148 -170.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.8 tp -106.16 97.63 7.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.553 -0.748 . . . . 74.01 109.295 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.466 ' H ' ' HA3' ' E' ' 469' ' ' GLY . 80.4 m-20 -95.78 107.63 19.88 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.389 -1.337 . . . . 71.43 107.389 174.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.441 ' HB3' ' HG3' ' A' ' 111' ' ' ARG . 30.5 tp -72.03 126.81 30.71 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.441 -0.799 . . . . 64.22 110.213 -176.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.1 139.02 92.5 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.401 0.68 . . . . 41.01 110.441 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.58 128.46 28.36 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.906 2.404 . . . . 74.14 113.192 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 96.8 t -100.22 120.88 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.858 -0.793 . . . . 72.5 108.858 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.478 HD22 ' HB3' ' A' ' 135' ' ' ALA . 1.3 p-10 -76.7 74.01 3.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.515 1.126 . . . . 65.03 110.932 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -56.36 -39.54 73.05 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.406 0.682 . . . . 74.34 111.862 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.8 -33.35 72.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.509 1.124 . . . . 73.22 111.864 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.478 ' HB3' HD22 ' A' ' 132' ' ' ASN . . . -75.46 -43.01 51.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.158 0.583 . . . . 65.42 110.168 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.5 -38.19 90.15 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.333 -0.849 . . . . 74.44 110.131 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -69.22 -38.62 78.64 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.294 -0.866 . . . . 72.02 109.949 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -41.06 85.87 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.213 1.005 . . . . 61.34 110.599 176.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.527 ' HA ' ' HB2' ' A' ' 143' ' ' GLN . 82.4 m-20 -66.76 -23.8 66.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.21 1.004 . . . . 72.42 112.048 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -91.9 -34.86 14.33 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.166 0.987 . . . . 73.34 110.896 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.646 HD11 ' HB ' ' A' ' 92' ' ' THR . 41.7 tp -67.93 -48.64 65.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.58 1.152 . . . . 55.11 112.829 -165.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -146.97 4.07 0.83 Allowed 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.225 0.328 . . . . 74.13 111.029 -174.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.527 ' HB2' ' HA ' ' A' ' 139' ' ' ASN . 21.1 mm-40 -107.39 175.74 5.39 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.736 0.814 . . . . 53.33 109.841 173.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -144.93 -32.9 0.39 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.349 -0.842 . . . . 71.12 109.516 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 68.55 -175.23 0.2 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.931 1.292 . . . . 72.11 111.398 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 72.97 -97.04 0.8 Allowed Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.73 -0.548 . . . . 73.24 111.73 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.59 81.88 5.32 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 122.355 1.074 . . . . 54.24 109.838 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.4 134.69 3.37 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 114.922 -1.035 . . . . 53.24 111.309 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 46.6 m -136.14 124.14 22.85 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.864 0.866 . . . . 75.43 108.956 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 70.07 151.37 0.09 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.615 1.166 . . . . 73.01 111.744 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.25 110.85 3.54 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.962 -1.125 . . . . 65.25 107.962 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -54.74 112.14 0.97 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.873 0.869 . . . . 64.44 111.428 -177.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -123.36 125.76 45.58 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.945 0.898 . . . . 73.32 108.752 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -142.45 120.58 12.17 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.242 1.017 . . . . 65.21 108.658 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.025 0 C-N-CA 123.51 0.724 . . . . 62.13 110.279 -177.561 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 110.23 -0.285 . . . . 75.32 110.23 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.4 p -90.21 110.18 21.23 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.322 -0.621 . . . . 62.23 109.322 175.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.64 107.45 2.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.252 0.621 . . . . 41.21 109.896 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -71.08 134.39 47.0 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.97 0.908 . . . . 63.03 111.304 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -98.31 145.65 26.46 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.545 -1.28 . . . . 61.21 107.545 171.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -64.33 116.28 5.89 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.946 0.499 . . . . 60.54 110.433 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -113.56 152.93 29.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.068 0.947 . . . . 51.32 110.236 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.7 -29.43 58.97 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.936 0.894 . . . . 73.31 110.503 171.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 6.0 ptm 50.76 168.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 127.692 2.397 . . . . 74.32 114.379 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 58.3 m -162.04 143.41 10.84 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.278 1.031 . . . . 74.23 108.367 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -148.27 157.05 43.26 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.444 0.64 . . . . 72.23 111.389 161.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -124.1 133.33 53.63 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.116 -1.439 . . . . 70.14 107.116 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.465 HD11 HD13 ' B' ' 105' ' ' ILE . 27.7 mt -77.0 123.96 34.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.902 -0.777 . . . . 52.24 108.902 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -83.01 -45.48 14.01 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.818 0.698 . . . . 70.45 109.911 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -170.32 130.98 0.94 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.931 -0.577 . . . . 63.53 110.279 -171.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.432 HD11 HD13 ' B' ' 13' ' ' ILE . 77.6 mt -113.91 139.47 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 107.408 -1.33 . . . . 75.35 107.408 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -161.93 152.73 17.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.576 0.703 . . . . 65.24 111.762 -174.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 81.7 m -77.47 121.36 23.74 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.165 -1.379 . . . . 73.13 108.195 171.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.587 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.1 mtpt -93.62 -29.53 15.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.528 0.731 . . . . 71.22 110.453 -178.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -160.69 139.25 10.1 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.363 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.515 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.6 mm -133.21 142.01 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.867 1.267 . . . . 52.22 108.802 174.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -138.56 129.99 27.41 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.493 -1.299 . . . . 75.41 107.493 171.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.613 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.7 t80 -142.78 132.4 23.84 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.294 -1.373 . . . . 64.4 107.294 170.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -133.29 148.43 51.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.686 -0.857 . . . . 73.45 108.686 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.789 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -142.85 77.67 16.25 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 107.538 -1.282 . . . . 74.23 107.538 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.83 -36.83 17.27 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.928 2.419 . . . . 72.33 112.265 -171.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -100.37 -0.94 37.27 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.598 0.759 . . . . 72.32 111.346 -174.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.789 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -36.67 -66.08 0.29 Allowed Pre-proline 0 N--CA 1.494 1.728 0 C-N-CA 125.834 1.653 . . . . 61.34 115.013 -165.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.09 -24.42 73.32 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.332 2.021 . . . . 73.42 113.305 -170.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -93.12 -32.21 14.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.367 0.667 . . . . 71.24 111.262 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.612 HG22 HD12 ' B' ' 68' ' ' LEU . 1.5 p -75.56 -20.81 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 122.895 0.478 . . . . 74.34 110.922 -172.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -66.4 -10.11 40.45 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.633 0.773 . . . . 74.23 112.952 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -61.73 -28.72 69.63 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.231 0.612 . . . . 72.34 110.266 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -90.44 96.84 10.85 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 124.34 1.056 . . . . 72.42 109.536 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.08 94.99 1.97 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.507 -0.923 . . . . 64.31 108.507 171.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.439 ' HZ3' ' H ' ' B' ' 69' ' ' GLY . 26.9 t90 -169.35 154.96 6.05 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.372 1.069 . . . . 74.45 108.844 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.416 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 0.1 OUTLIER -87.07 110.59 34.35 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 108.046 -1.094 . . . . 64.35 108.046 170.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.422 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 53.8 Cg_endo -68.69 143.24 55.52 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.817 2.345 . . . . 63.43 113.407 -170.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -60.5 107.96 0.75 Allowed 'General case' 0 C--O 1.242 0.663 0 O-C-N 124.281 0.988 . . . . 73.03 110.066 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.5 m -86.34 161.2 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.207 -0.906 . . . . 75.35 110.972 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.482 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 60.3 tttp -134.16 104.29 6.14 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.612 -1.255 . . . . 72.04 107.612 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.49 HD22 ' HG3' ' F' ' 464' ' ' MET . 5.5 mp -85.17 124.22 31.58 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.523 -0.917 . . . . 73.1 108.523 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -140.81 109.82 6.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.214 -1.402 . . . . 64.42 107.214 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.61 155.09 17.78 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.876 -0.787 . . . . 75.31 108.876 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -155.71 149.89 25.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.452 -1.249 . . . . 72.44 108.374 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -140.65 143.12 34.98 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.352 0.596 . . . . 72.34 111.099 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.43 148.48 37.85 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.942 1.297 . . . . 63.14 107.915 172.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 72.4 p -145.03 162.92 35.76 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.114 0.416 . . . . 74.1 111.456 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -151.84 147.82 27.08 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.906 0.882 . . . . 44.53 109.833 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.474 ' HB2' HG11 ' F' ' 452' ' ' VAL . 58.1 tt0 -84.04 131.36 34.82 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.331 0.652 . . . . 74.22 109.566 172.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 43.3 mt -93.66 -44.31 8.24 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.333 0.653 . . . . 73.22 109.509 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.62 -176.35 5.89 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.369 1.068 . . . . 74.05 110.177 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -69.47 120.35 15.13 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.713 -1.131 . . . . 64.3 109.346 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.77 16.75 10.62 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.3 1.04 . . . . 73.2 112.072 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 67.1 t -130.15 104.06 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.221 -1.029 . . . . 74.41 108.221 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -112.55 167.25 10.61 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.922 -1.14 . . . . 74.31 107.922 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -143.38 121.37 12.07 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.202 -1.036 . . . . 63.34 108.202 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -106.5 143.29 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.173 0.989 . . . . 61.32 109.39 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.508 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 35.6 t -116.78 144.53 24.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.977 -0.749 . . . . 64.35 108.977 176.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -127.71 110.06 12.28 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.143 -1.058 . . . . 72.32 108.143 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 36.1 ttm180 -94.36 122.3 36.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.841 0.856 . . . . 72.03 110.162 171.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 47.7 t -116.44 103.43 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.387 -1.338 . . . . 65.23 107.387 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.2 m -98.9 131.7 44.78 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.302 0.641 . . . . 73.11 109.542 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 91.5 t -123.49 130.02 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.023 0.929 . . . . 61.01 109.631 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.5 m -119.25 136.88 54.01 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 108.85 -0.796 . . . . 73.32 108.85 172.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.49 151.95 43.76 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.057 0.389 . . . . 65.42 110.917 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.5 p -152.22 132.77 13.87 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.175 0.922 . . . . 75.1 111.515 -173.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.612 HD12 HG22 ' B' ' 31' ' ' VAL . 77.4 mt -93.51 104.17 16.32 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.682 -1.229 . . . . 62.21 107.682 175.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.439 ' H ' ' HZ3' ' B' ' 36' ' ' TRP . . . 85.57 -110.7 3.47 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.462 -0.655 . . . . 54.03 111.462 -174.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.77 1.17 9.93 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.888 0.875 . . . . 73.52 110.419 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -113.55 150.87 32.36 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.034 -0.728 . . . . 70.13 109.034 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -62.16 139.11 58.48 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.822 0.702 . . . . 73.13 110.908 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.465 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -97.4 -67.78 0.83 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.545 -1.279 . . . . 65.24 107.545 170.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -145.18 160.61 41.18 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.005 -0.998 . . . . 74.54 109.993 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -135.0 138.64 44.16 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.471 -1.677 . . . . 63.03 106.471 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -150.04 157.87 43.58 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.876 0.369 . . . . 74.14 110.084 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -164.62 135.55 4.18 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.03 -1.1 . . . . 33.44 108.03 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.44 HG22 HD12 ' B' ' 21' ' ' ILE . 95.8 t -126.2 145.88 32.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.572 -0.899 . . . . 75.12 108.572 172.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.424 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 45.3 mt-30 -123.29 86.69 2.62 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.739 -0.837 . . . . 75.45 108.739 171.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.6 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.0 tp-100 -83.26 101.43 11.25 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.955 -1.021 . . . . 73.43 109.424 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.587 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.55 169.9 34.74 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.894 -0.482 . . . . 55.42 111.894 175.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.26 137.12 4.57 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 111.304 -0.718 . . . . 43.45 111.304 -176.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.3 mt -96.87 125.91 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.044 0.938 . . . . 70.11 108.529 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -128.3 131.26 48.67 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.662 -1.236 . . . . 72.11 107.662 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 45.0 m -97.96 89.82 4.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.463 -0.569 . . . . 72.21 109.463 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.467 ' HB ' HD12 ' B' ' 89' ' ' ILE . 1.6 pp -94.42 139.67 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.424 0.69 . . . . 74.42 111.527 -166.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.29 138.49 21.43 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.37 1.068 . . . . 75.42 109.294 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.4 -35.87 4.02 Favored Glycine 0 C--N 1.345 1.033 0 O-C-N 123.642 0.589 . . . . 62.41 113.307 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.467 HD12 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -54.64 137.48 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 C-N-CA 124.805 1.242 . . . . 71.41 112.752 -175.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -158.9 142.34 14.89 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.563 0.345 . . . . 75.44 111.282 175.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' B' ' 94' ' ' MET . . . 67.04 -121.92 17.57 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 114.573 0.589 . . . . 72.04 114.573 173.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 84.8 m -65.66 -33.21 75.36 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.645 0.778 . . . . 75.03 110.193 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -68.29 -39.26 82.14 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.34 -0.845 . . . . 74.41 110.202 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.638 ' HE2' HD22 ' F' ' 454' ' ' LEU . 17.5 ptm -78.79 -28.9 44.68 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 116.314 -0.403 . . . . 64.02 110.72 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.91 -30.55 62.65 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.2 0.6 . . . . 70.33 110.916 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -79.61 -33.48 41.48 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.092 0.957 . . . . 72.53 109.994 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.6 t -71.37 -65.15 0.79 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.587 0.755 . . . . 61.42 110.298 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.436 HD21 HG21 ' B' ' 86' ' ' ILE . 50.6 mt -80.45 -20.24 44.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.823 0.849 . . . . 71.23 112.395 -171.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.65 -13.16 41.75 Favored Glycine 0 N--CA 1.477 1.383 0 CA-C-O 119.646 -0.53 . . . . 71.12 114.363 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.93 -52.86 0.52 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 117.612 0.706 . . . . 74.32 111.688 -172.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -73.58 -38.47 65.14 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.047 0.539 . . . . 73.14 111.601 -173.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.41 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.4 m -70.43 -48.23 18.1 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-O 118.655 -0.688 . . . . 74.13 111.246 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.43 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 53.5 Cg_exo -55.86 -33.26 87.97 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.107 1.872 . . . . 70.4 113.701 168.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -59.52 -39.21 83.16 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.332 0.653 . . . . 72.12 111.644 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.465 HD13 HD11 ' B' ' 13' ' ' ILE . 79.8 mt -66.11 -41.06 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.09 0.956 . . . . 62.14 110.844 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 52.6 mt -80.13 -16.04 55.78 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.404 -0.817 . . . . 70.32 111.887 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -60.21 -48.8 93.26 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.198 0.999 . . . . 73.02 113.589 -172.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.553 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 33.3 Cg_endo -61.34 -34.08 88.0 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.141 1.894 . . . . 72.32 113.498 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.6 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 94.3 m-85 -67.39 -46.86 72.01 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.692 0.397 . . . . 75.3 110.234 177.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.45 86.08 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.47 -0.786 . . . . 41.21 111.112 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.568 ' HA ' HD23 ' B' ' 128' ' ' LEU . 29.0 mtp-105 -55.16 -61.39 2.35 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.376 1.07 . . . . 71.22 111.36 175.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.37 -27.85 69.29 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.07 0.856 . . . . 74.44 110.781 -173.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.515 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.5 t -73.32 -37.94 65.97 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.108 0.563 . . . . 73.02 111.048 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 71.2 mt -64.89 -51.86 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.449 -0.574 . . . . 73.44 109.449 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.537 HG21 ' OG ' ' C' ' 119' ' ' SER . 14.4 m -58.19 -34.63 70.56 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 124.406 1.067 . . . . 71.42 111.902 -176.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 25.7 t -58.86 -52.25 66.55 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 124.028 0.83 . . . . 74.53 109.46 175.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.2 mmt -69.28 -33.46 73.24 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.496 0.719 . . . . 75.32 111.417 -174.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.04 -44.33 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.974 0.91 . . . . 53.32 110.496 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -69.48 -32.17 70.9 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.178 -0.919 . . . . 61.45 111.209 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.1 mtt-85 -67.7 -37.97 83.02 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 115.393 -0.821 . . . . 72.32 109.357 175.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.43 4.14 64.86 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 124.161 0.913 . . . . 52.22 113.237 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.542 HG23 ' HB3' ' A' ' 17' ' ' TYR . 82.1 p 58.8 32.07 21.85 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.169 1.787 . . . . 70.54 113.12 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -95.47 154.25 39.36 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 124.203 1.001 . . . . 71.44 110.972 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.416 ' HG2' ' HA ' ' B' ' 37' ' ' GLN . 81.2 Cg_exo -49.92 158.77 1.97 Allowed 'Trans proline' 0 C--N 1.39 2.731 0 C-N-CA 124.299 3.333 . . . . 64.42 115.652 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.515 HE21 ' ND2' ' B' ' 127' ' ' ASN . 67.6 tp60 -63.94 130.75 45.34 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 114.636 -1.166 . . . . 72.45 112.251 -172.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 68.6 tp -141.53 123.77 15.63 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.938 0.895 . . . . 52.44 109.709 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.515 ' ND2' HE21 ' B' ' 125' ' ' GLN . 51.0 m-80 -130.49 136.36 48.9 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.209 -1.034 . . . . 74.43 108.209 168.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.568 HD23 ' HA ' ' B' ' 111' ' ' ARG . 1.9 mm? -82.93 119.66 24.7 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.457 -0.942 . . . . 64.21 108.457 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.02 150.37 71.64 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.183 0.593 . . . . 61.12 111.054 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.09 140.58 41.78 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.061 2.508 . . . . 75.14 112.817 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.575 HG21 ' HA ' ' F' ' 464' ' ' MET . 61.6 t -127.38 145.6 34.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.446 -1.316 . . . . 71.44 107.446 167.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -66.61 101.51 0.79 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.605 0.762 . . . . 61.45 110.902 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -61.11 -32.58 72.26 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.004 0.521 . . . . 75.11 110.126 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -69.78 -52.61 23.75 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.407 1.083 . . . . 60.13 111.193 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.19 -44.4 95.12 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 123.707 0.63 . . . . 52.2 111.184 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 66.7 mt -61.2 -37.48 83.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.959 0.504 . . . . 64.51 111.44 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.409 ' O ' ' HB3' ' B' ' 140' ' ' TYR . 72.4 t80 -68.17 -46.35 70.99 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.53 0.519 . . . . 73.43 110.733 -176.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 26.0 ptm -69.51 -25.42 64.03 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 117.772 0.26 . . . . 63.35 110.953 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.414 ' ND2' ' HG2' ' B' ' 144' ' ' GLN . 0.9 OUTLIER -74.84 -29.26 61.0 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.63 0.772 . . . . 72.33 110.621 175.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' B' ' 137' ' ' PHE . 24.0 t80 -62.63 -38.24 89.49 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.445 0.698 . . . . 73.54 109.893 171.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 8.1 mt -81.21 -2.45 48.76 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.189 -0.914 . . . . 74.23 110.929 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 71.52 6.67 5.8 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.645 1.578 . . . . 62.3 111.89 -177.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -89.48 87.83 7.22 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.962 -0.755 . . . . 75.42 108.962 176.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.414 ' HG2' ' ND2' ' B' ' 139' ' ' ASN . 5.0 tm0? -120.11 98.35 6.03 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.802 -1.185 . . . . 71.23 107.802 -176.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.86 86.68 2.95 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.859 0.463 . . . . 64.31 110.163 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . 0.552 ' HA3' ' HG2' ' D' ' 8' ' ' GLU . . . 85.46 132.99 2.9 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.716 -0.675 . . . . 51.21 113.2 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -102.19 153.78 19.64 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.455 0.702 . . . . 73.4 109.948 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -73.48 109.6 2.85 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.968 -0.56 . . . . 32.42 112.053 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.1 t -80.79 172.0 14.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.943 0.897 . . . . 74.33 110.424 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -145.41 80.01 1.59 Allowed 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.694 0.759 . . . . 70.03 112.813 -170.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -75.01 84.1 2.26 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.629 0.771 . . . . 73.33 109.919 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -80.74 94.0 6.31 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.598 -0.728 . . . . 63.34 109.106 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . 0.682 ' HG3' ' HB3' ' D' ' 1' ' ' MET . 22.8 tm0? -66.47 130.96 44.96 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.475 -0.935 . . . . 74.12 108.475 173.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.95 111.31 6.24 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.062 0.545 . . . . 53.53 110.102 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 C-N-CA 124.022 0.929 . . . . 55.21 109.143 -177.012 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.343 0.592 . . . . 71.44 109.423 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -163.96 106.28 0.93 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.338 1.055 . . . . 71.22 108.631 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -151.57 -44.06 0.11 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.585 0.754 . . . . 61.24 109.988 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -119.69 21.08 12.17 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.229 1.012 . . . . 51.1 109.24 175.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -71.17 104.09 2.97 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.418 1.087 . . . . 60.23 110.3 -172.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 t30 65.72 95.65 0.06 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.861 0.865 . . . . 72.32 109.742 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 29.5 m -126.19 101.04 6.58 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.362 0.665 . . . . 74.23 110.622 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -71.79 105.97 3.97 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.241 -0.651 . . . . 73.31 109.241 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.432 ' SD ' HD13 ' C' ' 89' ' ' ILE . 60.6 ttp 64.75 113.82 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.214 1.406 . . . . 72.54 111.453 -172.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.596 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 43.6 m -93.28 91.38 7.21 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.84 -0.8 . . . . 73.04 108.84 173.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.562 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 6.0 t80 -110.03 124.81 52.11 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.827 -0.805 . . . . 74.22 108.827 174.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -145.83 134.19 21.87 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.601 0.76 . . . . 72.15 109.162 171.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 67.2 mt -78.17 122.44 33.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.323 -0.991 . . . . 73.31 108.323 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.622 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 82.4 mm-40 -89.77 -42.19 11.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.217 -0.901 . . . . 73.41 110.639 -175.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.401 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 17.6 ttt180 -175.6 129.82 0.26 Allowed 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.384 0.427 . . . . 74.01 110.214 -168.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 66.5 mt -121.77 131.8 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.636 -0.876 . . . . 62.54 108.636 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.502 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 32.6 p90 -171.36 173.09 4.96 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.706 0.765 . . . . 73.44 111.311 -169.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.3 p -95.88 119.58 34.64 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.32 -0.855 . . . . 63.34 109.572 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.502 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 21.8 mmtp -65.32 -47.74 75.49 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 107.581 -1.266 . . . . 70.55 107.581 169.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 21.9 t70 -144.04 143.84 31.36 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 113.352 -1.749 . . . . 70.32 109.936 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.3 mt -129.96 144.36 38.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.475 -1.676 . . . . 73.4 106.475 172.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -152.53 147.25 25.98 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.35 0.595 . . . . 63.53 109.712 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -144.55 137.06 26.53 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.451 -1.314 . . . . 75.23 107.451 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -135.22 131.43 36.67 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.858 0.863 . . . . 74.51 109.352 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -154.28 76.63 5.65 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 106.799 -1.556 . . . . 61.3 106.799 172.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.66 -42.0 5.38 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.229 1.953 . . . . 75.31 111.429 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -96.96 29.04 3.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.525 1.13 . . . . 74.12 110.595 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.569 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -51.63 -55.87 25.97 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.201 -0.904 . . . . 42.52 113.408 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.5 -32.9 70.18 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 121.723 1.615 . . . . 73.34 112.684 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -67.99 -44.48 76.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.081 0.553 . . . . 54.14 110.859 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.753 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.8 p -77.17 -22.65 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 112.708 0.632 . . . . 72.22 112.708 -173.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -63.72 -33.6 76.02 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.22 0.452 . . . . 74.42 112.22 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -85.79 11.18 11.68 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.471 0.308 . . . . 60.12 111.572 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.799 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -89.95 158.51 17.36 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.505 0.722 . . . . 74.43 109.978 175.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -65.17 129.0 38.11 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.942 0.897 . . . . 73.53 109.791 165.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 58.9 t90 -82.03 94.16 7.12 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.386 0.674 . . . . 65.11 111.312 -172.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -141.39 76.15 21.65 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.644 0.778 . . . . 74.12 108.934 172.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -83.54 126.98 4.25 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.118 2.545 . . . . 51.43 113.252 -175.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -84.37 103.38 13.49 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.271 -1.381 . . . . 62.15 107.271 168.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 19.6 m -88.33 103.56 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 122.155 0.979 . . . . 61.42 110.855 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.541 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 82.7 tttt -93.87 104.11 16.19 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.802 -1.09 . . . . 74.33 108.644 177.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.13 136.72 32.82 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.351 -0.981 . . . . 74.21 108.351 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -130.88 105.34 7.7 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.927 -0.768 . . . . 54.12 108.927 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mp -103.19 135.02 45.63 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.239 -1.023 . . . . 52.2 108.239 -173.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.424 ' HA ' ' HG ' ' G' ' 460' ' ' LEU . 24.6 t70 -151.44 155.48 38.67 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.515 0.726 . . . . 60.15 110.061 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -139.04 146.72 41.16 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.128 0.571 . . . . 75.34 109.719 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.84 146.66 43.71 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.153 0.981 . . . . 71.22 108.949 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.1 p -137.0 151.78 49.38 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.111 0.564 . . . . 53.45 110.297 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 86.4 p -149.41 157.94 43.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.854 0.862 . . . . 72.33 109.76 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -89.36 118.77 29.27 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.982 -0.747 . . . . 74.5 108.982 174.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.567 HD11 HD12 ' C' ' 83' ' ' ILE . 57.5 mt -90.8 -40.3 11.87 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.299 0.571 . . . . 55.54 109.779 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.71 177.82 10.28 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 114.395 -1.275 . . . . 62.12 108.95 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.64 119.56 14.06 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 109.264 -0.643 . . . . 63.15 109.264 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 66.92 21.81 10.27 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.545 1.138 . . . . 74.4 111.15 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 65.9 t -126.69 101.61 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.855 1.262 . . . . 73.14 108.158 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.58 ' HB2' HD11 ' C' ' 86' ' ' ILE . 0.2 OUTLIER -104.23 138.04 41.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.173 -0.677 . . . . 72.32 109.173 177.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.432 ' HB2' HD11 ' C' ' 51' ' ' LEU . 29.1 tt0 -85.57 137.75 32.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.577 -1.192 . . . . 70.35 108.667 166.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 23.8 t -122.18 139.54 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.682 -1.229 . . . . 64.41 107.682 167.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 49.6 t -131.79 131.94 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 108.545 -0.909 . . . . 73.54 108.545 175.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.21 109.35 21.01 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.802 -1.555 . . . . 65.2 106.802 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.443 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 5.8 tmm_? -99.5 105.73 17.67 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.748 -1.204 . . . . 64.42 107.748 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.466 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.3 t -107.77 138.37 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.478 -0.934 . . . . 64.21 108.478 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 35.7 m -134.04 121.22 21.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.35 -0.611 . . . . 74.03 109.35 171.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.594 HG11 HD13 ' C' ' 126' ' ' LEU . 59.7 t -106.35 111.72 36.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-N 114.885 -1.052 . . . . 73.45 109.014 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 7.0 m -103.36 142.72 33.74 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.213 -0.903 . . . . 72.11 109.42 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.88 120.71 19.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.716 -1.216 . . . . 74.32 107.716 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.6 m -140.44 128.0 21.5 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.565 0.541 . . . . 71.34 110.816 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.799 HD13 ' HG2' ' C' ' 34' ' ' LYS . 8.5 mt -89.27 31.63 0.89 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.174 1.39 . . . . 62.33 110.813 -176.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.67 -105.42 0.95 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 109.808 -1.317 . . . . 44.4 109.808 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.13 -18.08 17.87 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.981 0.913 . . . . 55.01 110.053 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.515 ' HG2' ' NZ ' ' C' ' 34' ' ' LYS . 5.7 tp10 -76.37 119.17 19.88 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.898 0.879 . . . . 73.22 109.515 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 44.8 m -76.98 128.42 34.48 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.261 -0.644 . . . . 74.24 109.261 172.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.753 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -78.39 -56.39 4.49 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.287 -1.005 . . . . 71.44 108.287 170.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . 0.549 ' HZ ' HD11 ' C' ' 126' ' ' LEU . 41.5 p90 -163.83 174.31 11.71 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.359 0.663 . . . . 71.24 110.716 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.12 107.68 5.07 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.37 -1.344 . . . . 72.23 107.37 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -110.58 143.43 41.0 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.827 -0.805 . . . . 62.3 108.827 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -151.81 134.39 15.44 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.348 0.659 . . . . 63.24 109.646 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.1 t -135.89 119.54 24.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 124.281 1.032 . . . . 64.01 109.19 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.443 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 54.3 mt-30 -92.17 88.27 6.43 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.58 -0.896 . . . . 72.3 108.58 170.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -79.64 99.49 7.39 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.736 -0.665 . . . . 44.52 109.785 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.22 144.2 16.97 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 116.416 -0.356 . . . . 71.52 112.518 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.569 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.23 135.4 5.35 Favored Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 110.536 -1.026 . . . . 41.34 110.536 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 8.8 mm -94.8 127.01 47.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.429 -0.952 . . . . 72.22 108.429 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.562 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 47.0 m-85 -134.22 118.38 17.55 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.251 -0.648 . . . . 71.41 109.251 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 53.8 m -75.7 132.92 40.84 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.219 -0.66 . . . . 73.04 109.219 175.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' C' ' 56' ' ' TYR . 1.1 pp -134.38 107.23 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.189 0.996 . . . . 74.35 109.219 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.596 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -130.25 157.71 41.75 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.898 -0.779 . . . . 72.42 108.898 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.22 -42.8 3.02 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 123.15 0.281 . . . . 53.44 113.22 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.432 HD13 ' SD ' ' C' ' 9' ' ' MET . 46.4 pt -93.26 169.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.544 0.738 . . . . 71.54 110.445 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -170.47 171.88 6.29 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 124.012 0.82 . . . . 73.33 109.622 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.87 -123.64 7.53 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.777 -0.457 . . . . 64.21 112.755 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 69.1 p -68.44 -29.24 67.84 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.418 0.687 . . . . 52.1 111.234 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -64.16 -51.23 64.85 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.244 1.017 . . . . 62.52 110.645 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 21.2 ptm -74.01 -28.18 61.32 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.284 0.365 . . . . 72.4 110.564 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.522 ' HA ' HD21 ' G' ' 454' ' ' LEU . . . -58.11 -43.98 87.45 Favored 'General case' 0 C--N 1.362 1.135 0 O-C-N 123.682 0.614 . . . . 41.4 109.594 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -77.61 -42.05 36.38 Favored 'General case' 0 C--O 1.245 0.863 0 O-C-N 123.562 0.539 . . . . 64.34 111.809 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -61.79 -39.03 90.25 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.058 0.849 . . . . 61.4 110.693 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.488 HD11 HG12 ' C' ' 86' ' ' ILE . 33.5 mt -101.3 -17.01 16.75 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 122.888 0.475 . . . . 65.14 111.74 -177.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' C' ' 137' ' ' PHE . . . -77.2 -29.2 56.9 Favored Glycine 0 C--N 1.354 1.583 0 N-CA-C 114.558 0.583 . . . . 55.21 114.558 -175.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.12 -36.09 0.09 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 120.805 0.336 . . . . 63.14 111.736 -169.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.53 -45.88 74.43 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.267 1.427 . . . . 75.31 112.125 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 55.5 m -76.68 -42.56 2.98 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 118.625 -0.702 . . . . 71.01 112.734 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.31 -27.35 57.03 Favored 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 122.194 1.929 . . . . 65.12 113.832 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -66.74 -36.92 83.6 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.519 0.727 . . . . 64.01 110.845 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.474 HG23 ' NH1' ' A' ' 111' ' ' ARG . 44.2 mm -63.18 -38.28 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.352 0.661 . . . . 62.01 109.617 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.569 HD21 ' HA3' ' C' ' 82' ' ' GLY . 90.9 mt -81.83 -18.12 45.04 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.808 -1.087 . . . . 71.02 112.765 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -60.49 -48.67 92.99 Favored Pre-proline 0 CA--C 1.561 1.371 0 N-CA-C 114.133 1.16 . . . . 74.24 114.133 -172.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -62.85 -34.11 73.26 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.845 1.697 . . . . 63.23 112.7 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -70.05 -45.64 66.67 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.47 0.708 . . . . 72.4 111.013 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.38 95.79 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 115.834 -0.621 . . . . 71.11 109.613 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.533 ' HG3' HD23 ' C' ' 128' ' ' LEU . 65.3 ttt180 -57.45 -52.85 63.73 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 124.599 1.187 . . . . 62.21 111.341 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.43 -31.33 71.44 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.921 0.488 . . . . 65.43 110.584 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.8 t -73.06 -34.5 66.3 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.965 0.506 . . . . 71.44 111.132 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.466 HD11 ' HB ' ' C' ' 62' ' ' VAL . 83.8 mt -68.59 -53.71 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.261 0.624 . . . . 52.12 109.591 174.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.3 m -63.19 -28.27 69.93 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.205 1.002 . . . . 71.21 111.389 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.8 t -64.05 -51.93 61.79 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.359 0.663 . . . . 72.15 109.417 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.575 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.55 -32.13 73.04 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.3 1.04 . . . . 70.21 112.766 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.574 HG21 HD12 ' C' ' 126' ' ' LEU . 71.7 t -67.02 -46.59 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.664 0.786 . . . . 54.44 110.095 174.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.537 ' OG ' HG21 ' B' ' 115' ' ' THR . 36.9 t -63.51 -34.86 78.71 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.045 -0.979 . . . . 74.54 111.445 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -69.29 -43.57 73.57 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.305 -0.861 . . . . 71.11 109.355 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.75 -4.87 72.41 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.783 0.677 . . . . 60.53 112.802 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.5 p 61.9 34.83 16.7 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.776 2.03 . . . . 55.34 113.138 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.426 ' HB2' HG13 ' C' ' 118' ' ' VAL . 83.5 m-85 -88.09 159.74 47.56 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.397 1.079 . . . . 73.22 109.704 171.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.1 164.34 8.53 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 123.373 2.715 . . . . 71.41 114.639 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -55.32 133.22 49.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.871 1.268 . . . . 61.23 113.001 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.594 HD13 HG11 ' C' ' 64' ' ' VAL . 36.2 mt -117.38 108.77 15.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.794 0.837 . . . . 65.34 109.607 170.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.7 110.97 22.52 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.491 -0.929 . . . . 70.14 108.491 174.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.533 HD23 ' HG3' ' C' ' 111' ' ' ARG . 3.7 mm? -76.6 133.14 39.74 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.627 -0.509 . . . . 75.41 109.627 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.08 139.6 82.45 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 124.054 0.846 . . . . 74.12 111.133 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.58 96.43 0.42 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.647 2.231 . . . . 73.31 111.99 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.23 116.05 39.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.482 -1.303 . . . . 70.2 107.482 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -78.19 79.28 4.65 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.584 -0.895 . . . . 61.22 108.584 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -55.8 -34.22 65.12 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.867 0.867 . . . . 73.53 110.814 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -60.48 -51.29 70.09 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.854 1.262 . . . . 62.24 111.451 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.1 -38.8 92.39 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.046 0.539 . . . . 31.15 111.088 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.35 -27.8 67.43 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.374 -0.83 . . . . 55.04 111.338 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.411 ' CE2' ' HA3' ' C' ' 99' ' ' GLY . 3.4 t80 -81.93 -31.28 31.41 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.283 0.633 . . . . 71.2 110.179 176.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 26.1 ttt -71.22 -39.59 71.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.384 0.674 . . . . 51.44 110.61 -173.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -73.1 -35.93 66.68 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.637 -0.711 . . . . 60.53 110.818 171.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -63.2 -85.13 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.816 1.246 . . . . 75.0 111.089 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -119.58 81.89 1.79 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.753 0.821 . . . . 74.25 109.146 -177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -166.54 -91.56 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 107.832 -1.173 . . . . 64.21 107.832 169.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -138.91 -78.3 0.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.036 -0.728 . . . . 74.52 109.036 169.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -149.83 158.62 44.34 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.522 0.729 . . . . 75.21 110.237 -171.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -163.5 -177.4 5.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.656 0.782 . . . . 73.43 110.76 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.24 29.37 45.65 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 115.669 -0.696 . . . . 54.24 112.828 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.25 -66.82 0.68 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.111 0.964 . . . . 74.12 111.361 -173.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.25 19.2 44.55 Favored Glycine 0 C--N 1.355 1.594 0 CA-C-N 116.648 -0.251 . . . . 71.3 113.121 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.522 HG22 ' HD1' ' A' ' 11' ' ' PHE . 59.1 p -126.2 160.65 29.68 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.055 0.942 . . . . 71.11 110.01 -177.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 8.5 tp10 -153.88 128.32 9.22 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.335 -0.987 . . . . 73.11 108.335 173.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.13 101.95 0.96 Allowed 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.24 -1.022 . . . . 45.4 108.24 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -70.71 88.31 0.71 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.521 -0.918 . . . . 71.44 108.521 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -140.72 83.11 1.88 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.296 -2.113 . . . . 72.11 105.296 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -69.53 137.78 52.75 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.039 -0.982 . . . . 72.44 110.364 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 C-N-CA 123.345 0.658 . . . . 70.42 110.157 -176.384 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.682 ' HB3' ' HG3' ' B' ' 153' ' ' GLN . 12.0 tpt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 108.591 -0.892 . . . . 74.04 108.591 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -78.77 80.82 5.11 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.777 0.831 . . . . 63.34 110.335 -176.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.63 99.63 1.7 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 107.485 -1.302 . . . . 63.0 107.485 174.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -56.17 99.03 0.03 OUTLIER 'General case' 0 C--N 1.359 0.995 0 C-N-CA 124.098 0.959 . . . . 63.1 111.984 -168.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -67.7 101.59 1.07 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.732 -1.122 . . . . 73.22 109.032 173.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -79.06 70.97 5.5 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.593 0.757 . . . . 72.23 109.509 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -171.87 -156.46 0.1 Allowed 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.723 1.209 . . . . 65.11 107.992 -169.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.552 ' HG2' ' HA3' ' B' ' 146' ' ' GLY . 9.2 mp0 -77.08 131.68 38.49 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.007 0.923 . . . . 63.22 109.87 175.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.554 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 20.9 ptm -33.59 147.72 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.392 1.477 . . . . 72.12 114.476 168.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 86.5 m -118.15 141.83 48.08 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.365 0.666 . . . . 65.54 110.207 175.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -156.25 103.83 2.2 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.355 -1.35 . . . . 64.35 107.355 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -125.86 147.28 49.5 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.417 -0.957 . . . . 74.52 108.417 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.503 HG21 HD11 ' D' ' 16' ' ' ILE . 8.7 mt -95.85 129.51 45.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.71 -0.848 . . . . 74.21 108.71 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -87.08 -37.35 17.5 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.457 0.703 . . . . 73.12 111.711 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -167.82 124.71 1.12 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.004 0.372 . . . . 72.0 112.004 -170.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.503 HD11 HG21 ' D' ' 13' ' ' ILE . 2.0 mp -104.15 132.49 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.133 -1.432 . . . . 63.51 107.133 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.439 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 21.6 p90 -162.91 153.21 16.32 Favored 'General case' 0 C--N 1.337 0.061 0 O-C-N 123.652 0.595 . . . . 75.43 110.908 178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -84.32 123.33 30.06 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.874 -0.787 . . . . 62.12 108.874 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.439 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.8 mtpt -92.25 -22.91 19.51 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.46 -0.57 . . . . 73.31 109.46 175.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.3 t70 -152.52 140.24 19.9 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.612 0.765 . . . . 74.45 109.496 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.575 HG21 ' HE2' ' C' ' 117' ' ' MET . 78.0 mt -139.83 145.6 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.805 -1.183 . . . . 74.24 107.805 174.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 58.6 m -148.5 121.45 8.78 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.431 1.093 . . . . 72.51 109.718 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.542 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 92.6 t80 -124.13 117.68 25.18 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.296 -1.742 . . . . 72.43 106.296 166.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.578 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 31.6 mt-10 -127.92 109.29 11.45 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.62 -0.511 . . . . 64.14 109.62 -174.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.41 85.91 17.04 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 108.099 -1.075 . . . . 62.05 108.099 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.83 -26.93 15.19 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.502 2.134 . . . . 75.34 112.092 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -104.24 8.37 36.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.884 0.874 . . . . 74.31 110.259 -174.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.428 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -32.99 -68.68 0.15 Allowed Pre-proline 0 CA--C 1.567 1.617 0 N-CA-C 116.32 1.97 . . . . 72.45 116.32 -165.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.459 ' HB3' HD11 ' C' ' 83' ' ' ILE . 75.7 Cg_endo -73.06 -21.49 20.55 Favored 'Trans proline' 0 C--N 1.384 2.423 0 CA-C-N 123.598 2.321 . . . . 65.44 113.699 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -74.47 -39.84 62.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.823 1.249 . . . . 72.12 110.004 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.4 p -83.67 -24.74 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.076 0.55 . . . . 64.11 112.274 -170.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.92 -19.03 63.84 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 122.867 0.467 . . . . 73.5 112.157 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -69.03 0.06 5.07 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.348 1.059 . . . . 73.14 111.933 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -110.72 100.85 9.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.881 1.272 . . . . 74.21 109.949 168.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.31 90.01 4.96 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.341 0.591 . . . . 74.44 109.598 171.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' D' ' 39' ' ' GLU . 19.7 t90 -154.32 156.11 36.34 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.1 -1.444 . . . . 64.14 107.1 174.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -70.58 107.88 2.98 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.398 -1.334 . . . . 75.41 107.398 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.458 ' O ' HG13 ' D' ' 40' ' ' VAL . 50.6 Cg_exo -55.21 125.55 19.53 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.89 2.394 . . . . 62.11 111.473 -171.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.464 ' HB2' ' CH2' ' D' ' 36' ' ' TRP . 34.1 tt0 -58.48 110.66 1.02 Allowed 'General case' 0 C--N 1.353 0.756 0 O-C-N 124.172 0.92 . . . . 74.43 109.667 -177.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.585 HG22 HD11 ' H' ' 470' ' ' LEU . 16.2 m -98.25 122.36 49.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 121.607 0.717 . . . . 74.23 110.455 -171.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.421 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 53.3 tttm -86.27 132.28 34.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 106.392 -1.707 . . . . 63.22 106.392 165.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.601 HD22 ' SD ' ' H' ' 464' ' ' MET . 0.4 OUTLIER -126.21 109.15 12.0 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.326 -0.99 . . . . 54.03 108.326 -169.008 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -127.41 149.75 49.94 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.387 1.075 . . . . 64.04 108.387 -176.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.51 HD21 HD21 ' D' ' 60' ' ' LEU . 8.4 tt -139.43 139.25 37.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.076 -0.713 . . . . 73.21 109.076 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -133.54 139.7 46.75 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.384 1.474 . . . . 61.11 107.31 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -105.82 164.73 11.71 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.074 -0.713 . . . . 74.1 109.074 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.54 160.55 40.61 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.879 0.872 . . . . 73.11 108.899 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -159.15 151.22 20.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.053 0.541 . . . . 70.1 110.046 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.2 p -160.64 129.84 4.88 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.053 0.941 . . . . 74.33 109.167 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -73.93 133.64 43.09 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.19 0.596 . . . . 62.32 110.251 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 54.2 mt -100.76 -34.5 9.81 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.248 0.619 . . . . 42.22 110.717 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.96 -176.24 5.38 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.807 0.843 . . . . 54.54 109.974 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.85 121.62 14.48 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.108 -0.951 . . . . 74.31 109.933 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 65.61 2.93 2.23 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.886 1.275 . . . . 75.22 113.101 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.0 t -112.67 116.41 52.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.327 -0.99 . . . . 72.34 108.327 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -133.53 130.48 38.53 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.091 -1.077 . . . . 74.42 108.091 -171.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -98.65 143.81 28.62 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.923 0.889 . . . . 74.52 109.48 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 54.8 t -120.04 137.66 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.78 -1.193 . . . . 63.22 107.78 166.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.476 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.3 t -116.0 126.58 73.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.788 -1.19 . . . . 71.25 107.788 175.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.51 HD21 HD21 ' D' ' 44' ' ' LEU . 0.0 OUTLIER -104.17 117.41 34.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.619 -0.882 . . . . 60.11 108.619 -177.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 22.1 ttm-85 -102.84 96.35 6.78 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.66 -0.867 . . . . 72.43 108.66 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 50.7 t -96.31 130.22 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.21 -1.033 . . . . 55.03 108.21 170.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 19.2 m -128.9 132.99 47.73 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.273 0.629 . . . . 43.11 110.446 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 69.1 t -126.29 112.39 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.736 1.214 . . . . 74.43 109.555 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 30.7 m -103.1 96.04 6.52 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.493 0.717 . . . . 44.32 109.301 176.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.13 153.83 17.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.95 0.5 . . . . 71.22 111.2 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.444 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.6 p -152.37 127.63 9.86 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.925 -0.579 . . . . 71.03 111.276 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.412 HD12 HG22 ' D' ' 31' ' ' VAL . 25.2 mt -95.76 101.71 13.43 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.967 -1.123 . . . . 73.41 107.967 170.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . 0.442 ' H ' ' HZ3' ' D' ' 36' ' ' TRP . . . 68.14 -118.6 9.63 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 123.63 0.581 . . . . 42.14 113.797 177.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.76 5.3 46.63 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.629 0.771 . . . . 71.34 113.053 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.21 164.49 32.11 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 120.89 0.376 . . . . 75.14 110.791 -174.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.1 m -68.15 132.03 46.47 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.045 -0.98 . . . . 73.13 110.697 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -86.74 -71.98 0.53 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.711 -1.218 . . . . 75.33 107.711 174.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -141.43 151.37 43.35 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 121.318 0.58 . . . . 73.35 110.436 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 72.2 mt -111.41 146.37 37.29 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.565 -1.272 . . . . 71.03 107.565 171.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.511 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.2 m -146.69 132.46 18.97 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.876 0.87 . . . . 74.31 108.686 -174.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -155.7 126.24 6.81 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.138 -1.06 . . . . 73.03 108.138 170.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.1 t -131.15 115.28 29.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 108.911 -0.774 . . . . 75.34 108.911 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 70.7 mt-30 -93.1 85.59 5.12 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.966 -0.753 . . . . 71.11 108.966 173.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.09 97.11 6.71 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.516 -1.22 . . . . 64.33 109.022 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.7 144.03 20.22 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.862 -0.495 . . . . 71.23 111.862 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.416 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -140.06 130.04 4.5 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 111.037 -0.825 . . . . 41.43 111.037 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.409 HG13 ' HE1' ' D' ' 17' ' ' TYR . 54.5 mt -90.54 123.95 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 107.989 -1.115 . . . . 71.04 107.989 177.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -123.95 136.06 54.07 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.638 0.775 . . . . 75.35 110.13 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 20.8 m -93.3 112.08 23.91 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.442 -0.947 . . . . 73.42 108.442 171.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 31.4 pt -108.19 122.27 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-O 121.19 0.519 . . . . 73.24 110.211 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -147.47 154.41 40.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.529 1.132 . . . . 51.32 109.072 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 81.23 -19.63 7.98 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 114.054 0.382 . . . . 61.4 114.054 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -127.3 154.49 37.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 124.448 1.099 . . . . 72.13 109.332 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' H' ' 450' ' ' ASN . 0.0 OUTLIER -163.49 159.39 22.03 Favored 'General case' 0 C--O 1.242 0.687 0 O-C-N 123.632 0.582 . . . . 75.34 110.695 -174.013 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.61 -99.16 0.08 OUTLIER Glycine 0 C--N 1.355 1.597 0 O-C-N 124.218 0.949 . . . . 71.35 114.763 170.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 25.6 m -68.42 -44.38 75.12 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.246 1.018 . . . . 54.03 111.453 -174.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.581 HE21 ' HB2' ' D' ' 152' ' ' HIS . 7.2 tp-100 -72.61 -29.54 63.58 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.056 -0.52 . . . . 73.34 110.563 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.442 ' SD ' ' HA ' ' H' ' 452' ' ' VAL . 35.1 ttp -60.25 -34.97 74.45 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 123.662 0.601 . . . . 75.03 110.35 174.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.16 82.07 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 122.306 -0.247 . . . . 31.14 111.438 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -80.08 -43.94 20.9 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.284 0.634 . . . . 61.42 111.945 -178.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 43.8 t -74.29 -42.57 59.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.361 0.664 . . . . 74.44 110.703 -172.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.542 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 15.0 tp -87.93 -33.84 18.32 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.362 1.065 . . . . 70.15 110.45 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.22 -26.09 29.37 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-N 116.356 -0.383 . . . . 72.23 113.948 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.18 -57.88 2.04 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 117.186 0.493 . . . . 70.55 111.389 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -70.13 -33.83 72.3 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.553 0.575 . . . . 64.45 112.553 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 69.4 m -67.36 -49.55 42.49 Favored Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 118.477 -0.773 . . . . 52.32 111.825 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.38 -30.06 90.13 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 121.864 1.71 . . . . 62.41 113.727 168.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -64.78 -37.98 89.44 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.516 0.726 . . . . 73.0 110.118 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.4 HG21 HD13 ' D' ' 13' ' ' ILE . 30.5 mm -62.94 -45.48 98.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.722 0.809 . . . . 64.12 110.873 173.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.416 HD21 ' HA3' ' D' ' 82' ' ' GLY . 83.2 mt -77.25 -18.18 57.82 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.926 -1.034 . . . . 71.22 112.399 -170.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -69.69 -42.12 18.15 Favored Pre-proline 0 N--CA 1.486 1.329 0 N-CA-C 113.914 1.079 . . . . 70.01 113.914 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.69 -41.75 60.12 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.033 1.822 . . . . 52.23 113.107 169.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -75.36 -35.15 61.17 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.975 0.91 . . . . 73.41 111.6 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.24 -46.55 67.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.01 0.524 . . . . 64.34 110.192 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -53.67 -49.12 68.67 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.751 1.282 . . . . 65.41 110.73 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.72 -45.77 92.54 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.308 1.005 . . . . 75.33 111.977 -175.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.4 t -63.15 -39.57 95.06 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.63 0.581 . . . . 54.22 111.231 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.457 ' O ' HG23 ' D' ' 118' ' ' VAL . 86.2 mt -59.76 -55.49 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.554 0.741 . . . . 62.05 110.093 172.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 38.3 m -56.68 -40.16 75.08 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.804 1.242 . . . . 74.41 112.005 -174.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -68.35 -40.62 81.48 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.06 -0.973 . . . . 74.33 110.561 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 68.5 mtm -68.33 -33.2 73.88 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.611 0.365 . . . . 71.21 111.524 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.8 t -63.65 -43.46 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.601 0.761 . . . . 64.34 110.36 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.89 -30.93 61.45 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 116.178 -0.464 . . . . 65.31 111.206 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -74.18 -26.15 60.12 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.205 0.602 . . . . 73.11 110.32 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.44 7.96 74.94 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.646 0.591 . . . . 63.2 112.404 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.447 HG23 ' HB3' ' C' ' 17' ' ' TYR . 44.3 p 61.11 17.21 7.84 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.514 1.926 . . . . 62.32 114.81 174.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.09 150.97 72.44 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 109.558 -0.534 . . . . 72.44 109.558 172.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.6 127.87 22.04 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.116 2.544 . . . . 53.01 111.448 171.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -51.65 145.31 9.39 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.676 1.235 . . . . 74.41 113.007 -171.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.427 HD13 HG11 ' D' ' 40' ' ' VAL . 56.8 tp -117.05 106.19 13.11 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.692 -0.686 . . . . 73.44 109.538 -175.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -101.95 104.19 14.87 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.037 -0.727 . . . . 74.41 109.037 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.82 118.35 13.5 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.156 -0.683 . . . . 65.45 109.156 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 135.76 89.24 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.214 0.605 . . . . 75.31 110.137 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.84 119.34 6.35 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.63 2.22 . . . . 72.32 112.314 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 82.8 t -108.85 115.55 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.083 0.953 . . . . 74.32 108.916 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -77.79 113.2 15.42 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.943 0.497 . . . . 54.24 110.037 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -72.22 -35.88 68.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.684 0.793 . . . . 72.24 111.509 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.47 -50.35 74.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.412 1.085 . . . . 71.11 111.739 -175.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.31 71.51 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.156 0.582 . . . . 54.23 110.636 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 34.4 mt -63.3 -23.76 67.56 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.41 0.684 . . . . 43.3 112.571 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -69.11 -39.45 78.93 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.654 0.782 . . . . 71.13 110.238 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 32.2 mtt -65.84 -28.9 69.32 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.135 -0.939 . . . . 72.3 110.131 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -70.31 -38.46 74.94 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.345 0.658 . . . . 60.12 110.662 174.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -62.36 -41.31 98.5 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.354 0.662 . . . . 70.35 111.288 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.9 mp -74.88 -29.02 60.88 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.552 0.741 . . . . 72.13 112.243 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -83.49 0.72 45.16 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 117.61 0.186 . . . . 74.22 111.19 177.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -121.23 46.91 1.94 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.13 0.572 . . . . 71.34 109.787 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -167.59 145.31 4.55 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.707 0.803 . . . . 74.24 109.859 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.39 78.38 5.91 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.508 0.67 . . . . 64.52 109.48 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.51 57.16 0.06 OUTLIER Glycine 0 C--N 1.344 1.026 0 CA-C-N 114.868 -1.06 . . . . 54.52 110.778 -177.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -73.82 90.23 1.87 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 121.879 0.847 . . . . 74.35 110.983 -178.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -121.53 79.9 0.34 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.1 -1.2 . . . . 71.12 110.1 172.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 76.1 p -108.53 151.91 25.46 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.582 0.753 . . . . 73.52 110.133 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -144.12 154.12 42.86 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.794 0.838 . . . . 71.24 108.85 174.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.37 -87.6 0.3 Allowed 'General case' 0 CA--C 1.558 1.266 0 CA-C-O 118.17 -0.919 . . . . 62.11 111.114 -175.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . 0.581 ' HB2' HE21 ' D' ' 93' ' ' GLN . 57.0 m170 43.45 67.58 0.63 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.282 1.433 . . . . 75.21 112.983 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.26 14.09 0.99 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.674 -0.693 . . . . 71.01 111.385 -175.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -64.6 102.95 0.61 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.697 0.799 . . . . 75.55 110.659 -172.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 C-N-CA 124.291 1.036 . . . . 75.23 108.209 -176.38 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 109.123 -0.695 . . . . 65.11 109.123 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 62.0 t -140.21 -48.58 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.561 1.144 . . . . 74.34 108.571 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.4 150.53 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.401 1.08 . . . . 73.5 109.486 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -153.65 -71.82 0.01 OUTLIER Glycine 0 C--N 1.339 0.704 0 N-CA-C 110.494 -1.042 . . . . 73.25 110.494 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 10.6 mp 67.88 146.02 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.543 1.537 . . . . 73.21 112.145 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 61.6 p -70.44 110.46 5.36 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.265 -0.879 . . . . 51.24 108.694 170.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.69 178.29 5.53 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.218 0.607 . . . . 75.4 110.138 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 62.59 16.69 9.02 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 124.292 1.037 . . . . 70.33 112.221 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 48.6 m -90.13 -33.44 16.25 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.957 0.903 . . . . 74.12 110.539 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.47 -163.86 0.26 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.408 1.083 . . . . 74.52 110.355 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 53.6 tp -80.26 141.84 35.16 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.123 -1.066 . . . . 74.31 108.123 165.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -85.27 35.27 0.59 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.433 1.093 . . . . 74.42 111.229 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -168.73 143.89 3.36 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.967 0.907 . . . . 61.15 109.698 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 27.1 p -132.27 127.65 36.14 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.314 1.046 . . . . 75.14 108.232 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . 0.578 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 52.8 tpp -80.16 136.46 36.51 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.858 0.463 . . . . 63.3 111.158 -174.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -142.47 86.54 1.96 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.262 -1.385 . . . . 72.0 107.262 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -159.29 169.51 23.9 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.296 -0.866 . . . . 72.2 110.241 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . -67.42 113.21 5.1 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.789 0.835 . . . . 71.41 110.985 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 79.0 mt -94.9 -175.42 3.55 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.265 1.026 . . . . 74.32 109.691 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . 0.466 ' HA3' ' H ' ' A' ' 127' ' ' ASN . . . -48.35 -83.62 0.03 OUTLIER Glycine 0 N--CA 1.483 1.814 0 N-CA-C 115.429 0.932 . . . . 74.22 115.429 -173.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 58.14 20.14 6.73 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.371 1.069 . . . . 75.35 112.486 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 25.3 pttm . . . . . 0 C--O 1.262 1.734 0 C-N-CA 124.584 1.154 . . . . 74.14 109.427 179.595 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 109.853 -0.425 . . . . 74.04 109.853 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 33.4 m -82.04 -24.16 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 122.98 0.512 . . . . 64.13 110.063 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' B' ' 50' ' ' GLN . 86.1 t -92.39 133.12 34.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.998 0.919 . . . . 74.55 109.534 174.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 171.72 62.44 0.04 OUTLIER Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.362 -0.695 . . . . 74.14 111.362 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . 0.638 HD22 ' HE2' ' B' ' 94' ' ' MET . 2.4 pt? -148.6 155.39 41.02 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.324 0.65 . . . . 71.04 109.755 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 41.7 p -108.87 122.65 47.63 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.969 -1.123 . . . . 74.14 107.969 171.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -73.42 151.03 41.28 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.491 0.317 . . . . 71.21 110.291 176.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -92.77 122.76 35.49 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 109.166 -0.679 . . . . 51.54 109.166 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 28.8 m -86.84 54.43 3.17 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.457 1.122 . . . . 75.25 108.638 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -168.96 90.1 0.22 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.183 -1.371 . . . . 64.44 107.943 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . 0.707 HD12 ' HB2' ' F' ' 462' ' ' TYR . 0.2 OUTLIER -77.57 121.96 24.62 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.725 -1.213 . . . . 55.55 107.725 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -81.04 48.05 1.07 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.907 1.283 . . . . 71.33 110.662 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . 0.707 ' HB2' HD12 ' F' ' 460' ' ' LEU . 7.2 t80 -85.3 94.55 8.96 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.94 -1.133 . . . . 74.32 107.94 -175.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 37.0 p -59.29 -57.96 10.72 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.979 0.8 . . . . 54.42 110.593 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . 0.575 ' HA ' HG21 ' B' ' 131' ' ' VAL . 0.0 OUTLIER 67.88 111.03 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.198 1.399 . . . . 74.25 111.474 174.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -113.82 -25.18 8.75 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.275 0.63 . . . . 74.11 111.796 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -84.14 67.54 9.77 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.405 0.622 . . . . 75.44 111.475 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -72.88 151.2 42.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.467 0.707 . . . . 54.22 110.158 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . 0.601 ' H ' HD23 ' F' ' 468' ' ' LEU . 1.9 pt? -73.29 -1.9 19.8 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.008 0.523 . . . . 73.11 111.731 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 96.64 -41.09 2.43 Favored Glycine 0 C--N 1.357 1.744 0 C-N-CA 123.053 0.359 . . . . 75.43 113.134 171.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 61.13 29.82 19.05 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.66 1.184 . . . . 75.53 111.95 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.078 0 N-CA-C 107.862 -1.162 . . . . 71.52 107.862 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 110.195 -0.298 . . . . 71.13 110.195 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 4.4 t 58.45 71.07 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.997 0 C-N-CA 124.806 1.242 . . . . 74.54 110.352 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.32 147.9 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.459 1.103 . . . . 74.24 110.387 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 141.01 32.79 0.14 Allowed Glycine 0 C--N 1.354 1.535 0 N-CA-C 114.462 0.545 . . . . 62.01 114.462 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' C' ' 95' ' ' ALA . 8.4 mp -110.0 165.18 11.93 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 117.565 0.683 . . . . 71.31 111.403 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 9.7 m 53.41 51.64 14.97 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.12 1.368 . . . . 72.1 110.411 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -93.47 -34.41 13.42 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 114.763 -1.108 . . . . 73.44 108.589 172.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -116.25 129.52 56.33 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.495 1.118 . . . . 74.43 108.306 166.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 89.2 m -84.0 95.93 8.7 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.275 0.63 . . . . 62.1 109.51 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -139.26 118.71 12.91 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.749 0.82 . . . . 75.52 109.028 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . 0.424 ' HG ' ' HA ' ' C' ' 45' ' ' ASP . 1.0 OUTLIER -118.51 110.82 17.85 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.08 -1.452 . . . . 75.21 107.08 176.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -76.69 140.48 40.89 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.761 0.824 . . . . 75.41 110.085 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 72.5 t80 72.77 143.19 0.06 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.885 1.274 . . . . 74.01 112.571 172.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 12.8 t -157.7 170.57 22.08 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.255 1.022 . . . . 75.21 109.219 172.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 71.2 mtm -121.18 120.04 34.08 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.658 0.783 . . . . 62.23 110.43 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -113.39 124.26 52.03 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.537 -1.283 . . . . 73.52 107.537 172.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . 71.55 -17.14 0.35 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 124.882 1.273 . . . . 74.11 113.425 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -92.43 95.4 9.63 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.587 0.755 . . . . 53.44 110.817 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 1.4 tt -156.26 144.2 19.6 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 107.23 -1.396 . . . . 71.33 107.23 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -62.56 82.92 0.03 OUTLIER Glycine 0 C--N 1.35 1.332 0 O-C-N 123.581 0.55 . . . . 51.11 111.867 170.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 4.5 tt -158.93 -48.86 0.06 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.782 1.633 . . . . 70.4 107.323 -175.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 63.3 tttp . . . . . 0 C--O 1.247 0.966 0 C-N-CA 124.687 1.195 . . . . 72.1 107.995 179.545 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' D' ' 90' ' ' GLU . 53.8 t-20 . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 109.143 -0.688 . . . . 73.14 109.143 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . 0.588 HG13 HG13 ' H' ' 452' ' ' VAL . 14.3 p -60.57 -32.32 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.716 1.206 . . . . 64.34 111.028 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . 0.588 HG13 HG13 ' H' ' 451' ' ' VAL . 32.1 m -113.79 158.84 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.321 1.048 . . . . 74.31 110.56 177.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 160.09 10.83 0.04 OUTLIER Glycine 0 N--CA 1.471 0.988 0 CA-C-N 115.821 -0.627 . . . . 61.43 112.966 -176.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' H' ' 456' ' ' ASP . 56.3 tp -91.55 128.87 37.55 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.787 0.835 . . . . 70.43 108.83 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 35.5 p -85.6 28.25 0.78 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.945 0.898 . . . . 54.23 111.334 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . 0.401 ' H ' ' HG ' ' H' ' 454' ' ' LEU . 19.1 t70 66.91 154.94 0.09 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.309 1.444 . . . . 71.31 112.153 -176.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -108.11 114.48 28.42 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.502 0.721 . . . . 72.44 109.569 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 20.7 p -90.5 152.08 21.09 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 123.918 0.887 . . . . 75.32 108.913 172.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 23.4 t70 67.31 174.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.224 0.952 . . . . 73.1 109.435 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.72 144.48 20.44 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.809 -0.812 . . . . 55.53 108.809 169.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -80.08 40.1 0.46 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 126.803 2.041 . . . . 70.42 111.737 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -72.14 90.34 1.2 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.004 0.922 . . . . 72.52 110.613 -170.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 24.0 m -102.15 82.67 2.24 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.204 1.001 . . . . 71.32 109.165 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . 0.601 ' SD ' HD22 ' D' ' 42' ' ' LEU . 27.4 ttt -84.71 99.48 10.87 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.696 -0.853 . . . . 51.35 108.696 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -72.1 -32.3 66.87 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.955 0.902 . . . . 72.33 112.161 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -130.14 139.11 50.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.198 0.599 . . . . 73.34 110.273 -178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -118.04 175.3 5.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.803 1.241 . . . . 63.32 108.369 173.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -58.19 -28.21 64.58 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.837 0.855 . . . . 73.51 112.588 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 108.07 115.19 3.87 Favored Glycine 0 C--N 1.354 1.556 0 N-CA-C 110.831 -0.907 . . . . 30.44 110.831 -176.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . 0.585 HD11 HG22 ' D' ' 40' ' ' VAL . 3.5 mm? -88.66 74.33 8.43 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.403 0.681 . . . . 75.33 111.074 -174.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 124.602 1.161 . . . . 54.01 108.199 173.604 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.432 ' N ' ' HA ' ' C' ' 150' ' ' GLU . 66.0 mtt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.211 -0.292 . . . . 73.14 110.211 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 p -162.57 -47.72 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.906 0.482 . . . . 75.21 112.036 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 67.97 29.72 6.35 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.483 1.113 . . . . 62.34 110.431 -162.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -101.77 99.58 9.83 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.472 0.709 . . . . 73.53 110.015 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -86.54 160.71 18.87 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 108.125 -1.065 . . . . 53.45 108.125 170.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.25 -38.26 88.57 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.457 0.703 . . . . 73.5 111.112 -175.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 9' ' ' MET . 13.4 m 70.68 156.74 0.16 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.358 1.463 . . . . 52.33 111.791 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.56 -27.54 68.7 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.278 0.631 . . . . 71.22 111.024 173.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.568 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -110.79 168.12 9.72 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.845 0.858 . . . . 71.52 109.501 170.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.7 m -145.69 139.79 26.8 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.0 0.52 . . . . 72.04 109.82 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.695 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 17.3 t80 -127.14 131.07 50.86 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.303 1.041 . . . . 64.01 109.191 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 26.5 tp60 -147.79 107.34 3.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.276 0.631 . . . . 71.45 110.052 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.598 HG12 ' HD2' ' A' ' 84' ' ' PHE . 60.7 mt -75.02 120.58 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.586 -0.524 . . . . 71.02 109.586 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -89.63 -36.99 14.96 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 124.079 0.862 . . . . 73.04 110.027 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -169.15 146.0 3.52 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 110.454 -0.202 . . . . 73.01 110.454 -171.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 97.6 mt -137.9 128.37 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 124.544 1.138 . . . . 73.35 108.058 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.465 ' HB3' HG23 ' B' ' 122' ' ' THR . 44.3 p90 -167.83 154.63 8.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.716 0.806 . . . . 73.12 111.205 -172.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.7 p -75.14 112.82 11.79 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.238 -0.652 . . . . 73.22 109.238 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HG3' ' HA3' ' A' ' 81' ' ' GLY . 32.6 mtpt -71.61 -34.35 69.78 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.251 -0.431 . . . . 63.42 110.481 174.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -153.79 148.65 26.57 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.056 -0.974 . . . . 73.4 109.111 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 80.9 mt -138.19 148.77 24.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 C-N-CA 124.947 1.299 . . . . 63.31 108.043 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 17.9 t -147.14 142.3 27.19 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.892 0.877 . . . . 74.42 109.93 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.544 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.3 t80 -153.06 132.88 13.2 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.625 1.17 . . . . 71.41 107.859 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -139.85 135.1 32.59 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.499 1.119 . . . . 72.0 108.34 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.06 87.46 48.39 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 108.32 -0.993 . . . . 74.13 108.32 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.458 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 37.3 Cg_exo -64.09 -48.65 4.7 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.608 2.872 . . . . 74.1 113.107 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -91.96 24.43 3.24 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.784 0.834 . . . . 74.13 111.169 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.571 ' HB1' ' HE2' ' B' ' 17' ' ' TYR . . . -53.07 -48.91 90.23 Favored Pre-proline 0 CA--C 1.568 1.638 0 N-CA-C 114.837 1.421 . . . . 65.14 114.837 -173.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.47 -19.73 16.62 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 121.742 1.628 . . . . 75.3 111.94 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -100.64 -13.42 18.56 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.074 -0.966 . . . . 75.1 112.29 -170.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.56 -26.04 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.798 0.839 . . . . 51.15 112.055 -169.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -78.9 -33.77 45.28 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.988 -1.006 . . . . 52.41 110.413 176.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -82.43 -32.19 29.14 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.917 0.887 . . . . 74.34 111.568 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.97 161.1 26.89 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.299 -0.63 . . . . 73.23 109.299 175.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.36 134.67 56.16 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.145 0.578 . . . . 74.53 110.059 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -95.69 85.88 4.26 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.343 0.657 . . . . 63.3 110.715 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.55 ' H ' HD12 ' A' ' 68' ' ' LEU . 79.7 mt-30 -135.58 68.53 66.74 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 123.648 0.779 . . . . 75.24 109.005 169.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -78.72 159.21 28.18 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.169 1.913 . . . . 74.24 111.867 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -106.73 105.69 15.85 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.042 -1.095 . . . . 61.3 108.042 173.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 p -74.62 93.35 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-O 122.363 1.078 . . . . 73.13 110.274 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 49.4 mtpt -85.82 115.56 23.54 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.347 -1.297 . . . . 53.51 108.279 172.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.541 HD23 ' HG3' ' E' ' 464' ' ' MET . 67.3 tp -116.05 134.8 54.56 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.146 -0.687 . . . . 75.22 109.146 174.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.662 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 32.4 t70 -128.62 146.68 50.79 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.301 1.04 . . . . 72.32 109.168 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.2 mt -128.45 125.09 37.79 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.184 0.994 . . . . 74.55 108.496 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 21.8 t0 -129.2 148.97 51.18 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.101 0.96 . . . . 55.22 109.413 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.565 ' HB ' HD21 ' E' ' 460' ' ' LEU . 59.0 m -144.14 138.42 28.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.252 1.021 . . . . 72.53 109.923 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.9 138.59 18.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.02 0.928 . . . . 64.34 109.324 169.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.6 m -90.36 162.42 15.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.138 0.575 . . . . 73.45 110.199 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.8 t -148.8 119.61 7.58 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.384 1.073 . . . . 63.42 108.231 -174.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -78.65 120.31 23.15 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.808 -0.442 . . . . 70.0 109.808 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.0 mt -92.17 -44.99 8.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.738 -0.838 . . . . 54.12 108.738 171.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.12 -178.88 6.75 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.157 -1.383 . . . . 71.44 108.88 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -74.57 133.34 42.24 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.897 -1.149 . . . . 73.31 107.897 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 70.27 -8.66 0.83 Allowed 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 125.489 1.516 . . . . 72.21 112.871 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.7 t -110.76 106.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 N-CA-C 108.863 -0.791 . . . . 74.23 108.863 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -130.36 121.65 26.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.732 0.777 . . . . 74.51 109.202 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -93.37 121.83 35.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 124.903 1.281 . . . . 64.12 109.396 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.07 132.97 45.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.898 -1.149 . . . . 52.14 107.898 176.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.6 t -120.1 115.59 47.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.585 -0.895 . . . . 42.52 108.585 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 tt -94.33 116.64 29.05 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.277 -1.008 . . . . 62.1 108.277 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.744 ' HG3' ' HG3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -93.01 102.13 14.48 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.816 -0.809 . . . . 74.13 108.816 172.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.514 HG11 ' HB1' ' A' ' 110' ' ' ALA . 2.4 p -99.61 110.17 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 108.998 -0.742 . . . . 74.14 108.998 176.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.662 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 33.8 m -95.99 133.58 40.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.282 1.033 . . . . 71.2 109.055 -176.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.4 t -130.99 115.72 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 107.981 -1.118 . . . . 74.32 107.981 -174.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 16.8 m -127.39 108.24 10.67 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.732 -0.84 . . . . 74.32 108.732 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.61 103.44 14.26 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 106.828 -1.545 . . . . 75.24 106.828 171.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.4 p -136.71 127.4 27.14 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.181 0.592 . . . . 75.41 110.39 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.55 HD12 ' H ' ' A' ' 37' ' ' GLN . 6.4 tt -89.71 88.22 7.3 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 106.844 -1.539 . . . . 73.34 106.844 173.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.29 -83.86 0.97 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.257 -0.737 . . . . 62.41 111.257 178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -119.84 -26.25 5.68 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.87 0.868 . . . . 52.33 110.866 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -82.26 101.65 10.65 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.372 0.269 . . . . 72.44 111.016 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 26' ' ' PRO . 61.6 m -70.35 112.8 6.93 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.334 0.654 . . . . 64.23 109.842 173.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.61 -59.4 4.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.174 0.989 . . . . 71.13 109.476 171.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -149.16 160.92 42.93 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.997 -1.002 . . . . 73.24 111.029 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 64' ' ' VAL . 49.1 tp -141.33 133.66 28.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.548 1.539 . . . . 63.11 107.3 -175.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.55 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 35.0 m -147.28 120.29 8.79 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 118.807 0.73 . . . . 55.14 110.381 -171.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 9.5 mp0 -128.09 128.8 45.56 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.012 -1.107 . . . . 72.44 108.012 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.7 t -131.24 110.67 18.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.34 -0.615 . . . . 73.31 109.34 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.744 ' HG3' ' HG3' ' A' ' 61' ' ' ARG . 15.5 mp0 -85.04 79.43 9.63 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.474 -1.306 . . . . 75.22 107.474 174.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.44 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.4 tp-100 -78.21 97.27 5.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.801 -1.185 . . . . 63.41 107.801 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 19' ' ' LYS . . . -93.91 147.2 18.49 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.041 -0.823 . . . . 34.14 111.041 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.41 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -148.78 126.87 2.37 Favored Glycine 0 CA--C 1.499 -0.929 0 N-CA-C 110.264 -1.134 . . . . 64.32 110.264 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 60.6 mt -82.38 114.28 23.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.653 -0.869 . . . . 72.23 108.653 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.695 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.6 m-85 -122.46 119.14 30.08 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.66 -0.867 . . . . 75.32 108.66 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 23.1 t -84.63 91.13 7.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.064 -0.717 . . . . 73.13 109.064 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -100.39 128.48 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.502 0.668 . . . . 55.32 109.23 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.89 154.75 44.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.939 1.296 . . . . 55.14 108.496 -175.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 84.19 9.54 81.93 Favored Glycine 0 N--CA 1.48 1.618 0 C-N-CA 121.673 -0.299 . . . . 41.31 113.715 172.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.533 HG22 ' HB3' ' A' ' 93' ' ' GLN . 0.9 OUTLIER -127.17 138.2 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.269 1.028 . . . . 61.51 110.772 -174.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -142.43 173.26 11.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.226 1.011 . . . . 73.01 109.707 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.92 -117.16 10.67 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.703 -0.681 . . . . 55.01 113.524 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.643 ' HB ' HD11 ' A' ' 141' ' ' LEU . 29.3 p -86.64 -26.63 24.27 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.702 0.801 . . . . 71.35 112.365 175.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.533 ' HB3' HG22 ' A' ' 89' ' ' ILE . 16.5 mm100 -60.09 -43.97 95.15 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.44 0.696 . . . . 73.31 110.512 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.537 ' SD ' ' HB ' ' E' ' 452' ' ' VAL . 24.7 ptt? -62.85 -40.37 97.24 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.249 -0.887 . . . . 74.13 110.888 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.7 -26.04 62.34 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.616 0.766 . . . . 65.41 110.568 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -78.09 -30.47 49.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.243 0.617 . . . . 73.31 110.514 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.478 ' SG ' HG21 ' A' ' 89' ' ' ILE . 72.0 m -70.74 -64.84 0.82 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.48 -0.327 . . . . 61.42 110.531 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -88.51 -9.19 53.26 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.206 0.817 . . . . 71.32 113.206 -171.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.6 3.53 32.49 Favored Glycine 0 N--CA 1.48 1.631 0 CA-C-O 119.791 -0.449 . . . . 74.11 113.635 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.65 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.25 -64.05 0.31 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.287 0.543 . . . . 75.14 111.414 -176.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.471 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 84.2 t80 -70.5 -51.65 27.44 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.244 -0.889 . . . . 62.44 111.588 -172.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.4 m -72.9 -36.11 3.26 Favored Pre-proline 0 CA--C 1.566 1.564 0 N-CA-C 113.859 1.059 . . . . 63.04 113.859 -172.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.495 ' HA ' HD12 ' A' ' 106' ' ' LEU . 30.4 Cg_endo -65.39 -26.9 55.24 Favored 'Trans proline' 0 C--N 1.39 2.727 0 CA-C-N 121.732 1.654 . . . . 73.05 112.507 167.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.548 HD21 ' HA ' ' A' ' 132' ' ' ASN . 25.8 t-20 -71.84 -25.86 62.14 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.505 0.322 . . . . 64.52 110.252 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -62.84 -36.49 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.467 0.707 . . . . 71.22 109.926 170.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 103' ' ' PRO . 65.5 mt -78.11 -23.23 47.96 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.298 1.039 . . . . 70.1 112.36 -178.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -61.81 -43.48 87.59 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 117.797 -1.097 . . . . 73.33 113.672 -172.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.56 -38.75 60.08 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.124 1.883 . . . . 74.35 113.076 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -69.44 -41.45 76.29 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.374 0.669 . . . . 75.14 111.057 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.514 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -67.61 -42.41 82.42 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.499 0.719 . . . . 73.14 110.128 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.589 ' HA ' HD23 ' A' ' 128' ' ' LEU . 29.8 ttm180 -51.17 -53.33 35.77 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.833 1.333 . . . . 55.0 110.256 175.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -66.16 -42.33 89.13 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.436 1.085 . . . . 73.12 111.214 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.4 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.9 t -60.88 -34.77 75.15 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.249 0.619 . . . . 74.42 111.398 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 81.0 mt -73.75 -51.66 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.815 0.846 . . . . 51.23 109.837 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.564 HG23 ' HG3' ' A' ' 125' ' ' GLN . 95.4 m -52.35 -51.28 59.71 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.334 1.054 . . . . 52.12 111.359 -174.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -65.42 -44.0 88.75 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.117 -1.401 . . . . 73.01 110.461 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.544 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 43.0 ttp -67.2 -35.45 79.64 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.03 0.932 . . . . 64.1 111.9 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.91 -40.39 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.246 1.018 . . . . 71.34 110.037 174.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -71.71 -25.42 62.07 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.952 0.901 . . . . 73.53 111.304 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -76.29 -25.92 55.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.756 0.822 . . . . 74.0 109.605 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.04 0.12 88.95 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.826 0.704 . . . . 75.23 112.712 171.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.3 m 67.88 15.98 9.61 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.848 1.259 . . . . 74.15 111.679 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.96 156.71 69.62 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.373 0.669 . . . . 73.13 109.365 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.85 141.96 92.76 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.476 2.117 . . . . 71.12 111.554 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.564 ' HG3' HG23 ' A' ' 115' ' ' THR . 29.7 tt0 -55.03 134.77 49.25 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.192 0.933 . . . . 72.43 111.78 -175.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.7 tp -118.69 98.97 6.49 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.492 -0.776 . . . . 74.34 110.287 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -100.18 113.21 25.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.379 -1.341 . . . . 64.12 107.379 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.589 HD23 ' HA ' ' A' ' 111' ' ' ARG . 2.6 mm? -72.85 128.41 35.43 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.149 0.58 . . . . 71.2 109.522 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -56.03 135.48 73.92 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.632 0.773 . . . . 50.4 111.235 -178.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.534 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 42.8 Cg_exo -58.08 98.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.727 2.285 . . . . 74.15 112.762 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 129' ' ' ALA . 95.3 t -100.18 113.99 37.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.371 -0.974 . . . . 73.24 108.371 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.548 ' HA ' HD21 ' A' ' 104' ' ' ASN . 53.6 t30 -84.74 102.4 12.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.671 0.388 . . . . 73.43 110.045 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -63.67 -25.28 68.14 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.927 0.891 . . . . 70.21 111.468 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.65 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 7.2 t70 -65.96 -48.71 70.42 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.111 0.882 . . . . 74.52 110.432 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.37 -39.57 94.89 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.61 0.764 . . . . 70.52 111.334 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.94 -40.73 83.22 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.15 -0.932 . . . . 74.04 111.081 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -68.0 -38.45 82.65 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.191 -0.913 . . . . 72.32 109.5 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.77 -39.58 74.31 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 124.228 0.955 . . . . 73.32 110.624 177.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 88.7 m-20 -59.24 -52.24 66.55 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.684 0.794 . . . . 73.53 111.08 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -64.83 -36.36 84.07 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.778 0.831 . . . . 73.53 111.416 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.643 HD11 ' HB ' ' A' ' 92' ' ' THR . 48.7 tp -69.93 -50.91 37.4 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.593 1.157 . . . . 64.25 111.888 -171.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -162.96 -3.14 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.312 0.645 . . . . 62.14 110.776 -169.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 36.1 tt0 69.94 133.56 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.623 1.569 . . . . 72.23 110.378 -165.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.83 178.5 8.15 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 122.043 -0.41 . . . . 64.24 111.27 176.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.63 143.89 26.06 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.417 0.687 . . . . 52.32 109.993 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.99 79.94 0.37 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.647 -0.581 . . . . 54.31 111.647 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -79.7 135.78 36.62 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.801 0.84 . . . . 73.52 111.517 -171.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.76 105.3 0.27 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 110.068 -1.213 . . . . 51.12 110.068 175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -98.47 131.19 44.92 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.0 0.52 . . . . 73.22 110.829 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -80.29 154.37 27.87 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.528 0.731 . . . . 64.0 110.817 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' C' ' 90' ' ' GLU . 5.0 tp10 -176.03 139.2 0.37 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.997 1.319 . . . . 72.24 108.698 176.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -155.42 124.5 6.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.947 0.403 . . . . 75.02 111.447 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -115.92 -158.02 0.67 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.161 1.385 . . . . 61.33 108.399 173.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -143.63 114.93 7.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.159 0.584 . . . . 53.21 109.579 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 C-N-CA 123.906 0.882 . . . . 65.23 110.665 -178.566 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 44.9 ttm . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.568 -0.531 . . . . 74.32 109.568 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 34.5 t -73.39 130.69 40.69 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.237 -0.653 . . . . 64.5 109.237 174.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -76.68 128.53 34.85 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.682 -0.488 . . . . 74.15 109.682 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -78.17 143.66 37.04 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.554 -0.536 . . . . 72.24 109.554 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -70.59 148.82 47.73 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.732 0.813 . . . . 65.03 110.766 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' B' ' 88' ' ' GLY . 4.1 m-20 -63.34 123.59 19.1 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.561 1.144 . . . . 74.03 110.305 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -126.4 160.28 30.9 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.576 0.75 . . . . 75.24 110.429 -174.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 82.39 -59.65 0.18 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 126.387 1.875 . . . . 75.52 112.41 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.514 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 8.8 ptm 59.11 168.93 0.06 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 127.064 2.146 . . . . 70.44 113.471 -171.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m -159.01 138.16 11.34 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.439 1.096 . . . . 72.52 108.579 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.97 157.42 43.41 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.485 0.66 . . . . 74.44 110.21 160.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -125.45 139.11 53.92 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 107.757 -1.201 . . . . 72.11 107.757 172.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.496 HD11 HD13 ' B' ' 105' ' ' ILE . 50.4 mt -76.66 120.41 26.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.482 -0.932 . . . . 62.11 108.482 173.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -83.5 -39.61 20.25 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.075 -0.713 . . . . 75.01 109.075 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -165.73 135.78 3.51 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.597 -0.729 . . . . 74.34 110.277 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.479 HD11 HD13 ' B' ' 13' ' ' ILE . 79.9 mt -114.96 140.73 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 106.411 -1.7 . . . . 73.52 106.411 168.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.571 ' HE2' ' HB1' ' A' ' 28' ' ' ALA . 36.4 p90 -171.49 170.62 5.74 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.597 0.713 . . . . 73.15 112.041 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.684 HG21 HD11 ' B' ' 21' ' ' ILE . 24.8 m -98.11 130.72 44.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.546 -1.206 . . . . 71.3 108.792 174.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -96.26 -34.47 11.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.875 0.87 . . . . 73.11 110.407 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -148.98 136.34 20.19 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.792 -0.64 . . . . 71.02 110.555 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.684 HD11 HG21 ' B' ' 18' ' ' THR . 47.0 mm -127.98 138.62 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.222 1.009 . . . . 65.43 108.915 171.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 39.8 t -135.66 129.55 32.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.228 1.411 . . . . 71.12 107.217 174.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.4 t80 -139.7 119.79 13.65 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 107.155 -1.424 . . . . 54.04 107.155 168.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.52 113.83 19.26 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.249 -0.648 . . . . 72.2 109.249 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.644 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.59 84.55 1.95 Allowed Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 107.556 -1.276 . . . . 74.11 107.556 166.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.19 -22.83 18.66 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.748 2.299 . . . . 60.22 111.385 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.413 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 89.2 m-20 -116.55 7.81 13.78 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.664 1.186 . . . . 62.23 110.898 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.644 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -29.02 -62.62 0.21 Allowed Pre-proline 0 N--CA 1.491 1.576 0 C-N-CA 126.244 1.817 . . . . 71.25 115.186 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 21.2 Cg_exo -61.9 -49.47 6.69 Favored 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 122.183 1.922 . . . . 75.2 112.122 -170.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 77.4 m80 -88.92 -11.9 43.19 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.052 -0.977 . . . . 73.31 112.251 -171.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.718 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.4 p -81.08 -23.36 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 CA-C-N 118.303 0.501 . . . . 72.05 110.525 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -64.77 -18.96 65.53 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.929 0.892 . . . . 64.24 113.331 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.9 pt20 -66.21 -23.3 66.41 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.882 0.473 . . . . 63.42 111.043 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -83.98 95.67 8.61 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.295 0.638 . . . . 55.44 109.589 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.38 83.32 1.93 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.922 0.889 . . . . 75.12 109.352 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.414 ' HZ3' ' H ' ' B' ' 69' ' ' GLY . 28.3 t90 -159.08 155.93 28.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.947 -1.024 . . . . 71.33 109.156 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -83.03 108.31 12.22 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.057 0.943 . . . . 73.0 108.502 169.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.556 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 55.6 Cg_endo -68.66 129.53 18.97 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.418 2.079 . . . . 72.32 112.294 -173.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.89 123.48 18.14 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 123.897 0.748 . . . . 73.4 110.164 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.517 HG11 HD21 ' B' ' 126' ' ' LEU . 33.0 m -104.0 150.68 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.463 0.705 . . . . 75.3 111.785 -169.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -133.57 119.85 20.0 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.542 -0.91 . . . . 74.42 108.542 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.22 144.26 25.47 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.782 0.833 . . . . 73.4 109.625 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.665 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 10.2 m-20 -136.08 115.32 12.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.716 1.207 . . . . 55.15 108.368 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.9 149.47 23.37 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.415 -0.587 . . . . 74.11 109.415 177.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.9 t70 -155.62 114.23 3.48 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.353 -0.98 . . . . 74.12 108.353 177.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.0 p -113.7 103.85 11.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.23 0.612 . . . . 71.22 109.656 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.24 118.46 32.35 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.638 0.775 . . . . 62.34 109.281 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 14.0 p -102.82 162.28 13.05 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.983 0.513 . . . . 63.54 110.755 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -151.82 136.84 17.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.057 0.943 . . . . 73.52 109.33 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -80.87 112.25 18.08 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.358 0.663 . . . . 75.12 109.721 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' B' ' 57' ' ' GLU . 75.3 mt -81.39 -54.06 5.78 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.31 0.576 . . . . 44.44 111.023 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.409 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -144.34 -163.74 1.75 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.372 1.069 . . . . 74.3 109.362 -176.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.42 100.95 0.53 Allowed 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.966 0.791 . . . . 74.04 109.432 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 22.1 m-20 62.13 15.7 7.65 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.582 1.153 . . . . 55.44 112.839 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 95.5 t -104.39 123.89 58.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 106.085 -1.82 . . . . 73.03 106.085 169.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.91 167.22 21.61 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.944 -0.761 . . . . 74.12 108.944 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.528 ' HB2' HD11 ' B' ' 51' ' ' LEU . 12.1 tt0 -124.38 120.7 32.87 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.608 -0.886 . . . . 71.51 108.608 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.1 t -88.19 137.72 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.714 -0.847 . . . . 62.23 108.714 170.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 56.3 t -120.88 110.39 28.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.484 -0.932 . . . . 71.32 108.484 175.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.05 99.08 11.45 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.712 -1.218 . . . . 74.24 107.712 177.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.485 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 13.2 ttm180 -87.27 113.11 22.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.595 -0.729 . . . . 64.1 109.429 170.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.54 123.84 63.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.764 -1.198 . . . . 73.13 107.764 170.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.665 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 6.9 m -118.55 134.75 54.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.926 -0.768 . . . . 54.44 108.926 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.464 HG23 HD13 ' B' ' 114' ' ' ILE . 88.1 t -122.45 127.92 75.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 123.964 0.906 . . . . 72.33 108.636 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.5 m -112.22 147.57 35.92 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 124.265 1.026 . . . . 60.21 108.739 172.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.23 147.21 33.29 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.439 0.696 . . . . 74.45 109.831 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.1 p -137.48 125.99 23.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.408 0.683 . . . . 72.11 110.381 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.653 HD12 HG22 ' B' ' 31' ' ' VAL . 42.2 mt -93.18 99.88 12.37 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 106.979 -1.489 . . . . 75.53 106.979 171.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.414 ' H ' ' HZ3' ' B' ' 36' ' ' TRP . . . 77.58 -118.55 5.06 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.492 -0.776 . . . . 72.45 112.651 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -103.33 14.77 30.77 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.128 0.971 . . . . 74.14 111.076 -171.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.413 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.9 pt-20 -147.84 156.49 42.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.721 0.808 . . . . 74.43 110.209 -173.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 86.7 m -66.26 135.83 55.0 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.698 0.624 . . . . 50.11 110.755 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.718 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -89.68 -62.57 1.44 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.584 -0.895 . . . . 73.43 108.584 174.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -150.92 157.88 43.46 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.095 -1.411 . . . . 54.4 109.96 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -132.34 138.63 47.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.766 -1.568 . . . . 61.31 106.766 175.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.424 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 49.8 t -142.65 151.01 40.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.467 -0.938 . . . . 42.04 108.467 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 44.8 tt0 -161.96 126.91 3.4 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.717 -0.845 . . . . 72.54 108.717 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.68 144.07 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 123.84 0.856 . . . . 61.24 108.934 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -115.16 91.2 3.54 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.36 -0.978 . . . . 73.53 108.36 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -81.19 97.63 7.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.545 -0.909 . . . . 73.03 108.545 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.96 142.7 16.14 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.129 -0.788 . . . . 74.25 111.129 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.85 128.86 3.58 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.123 -0.791 . . . . 74.33 111.123 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.7 mt -87.98 126.86 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.843 0.857 . . . . 63.24 109.837 175.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -134.47 134.6 41.72 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.501 -1.296 . . . . 72.33 107.501 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -109.38 93.02 4.29 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.036 0.535 . . . . 74.13 110.205 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 30.0 pt -94.38 144.85 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.327 0.584 . . . . 73.01 112.445 -167.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.79 146.86 19.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.915 1.286 . . . . 75.45 107.926 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 102.4 -25.85 26.21 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-O 119.884 -0.398 . . . . 64.41 113.761 176.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' B' ' 94' ' ' MET . 5.4 pt -84.31 165.56 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 117.48 0.64 . . . . 71.44 111.664 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -171.8 175.32 3.96 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.047 1.339 . . . . 74.41 108.726 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.21 -125.6 8.25 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.931 -0.468 . . . . 54.24 111.931 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.2 m -103.32 -13.14 16.81 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.511 0.724 . . . . 71.24 109.434 170.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -62.34 -27.78 69.29 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.148 0.979 . . . . 74.01 109.971 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.702 ' SD ' HG12 ' F' ' 451' ' ' VAL . 25.4 ptt? -71.06 -37.39 72.49 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.54 -0.754 . . . . 75.23 110.789 171.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.04 -21.24 59.17 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 115.451 -0.795 . . . . 74.02 110.766 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -76.99 -28.43 55.08 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.12 0.568 . . . . 71.22 111.425 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.24 -37.69 75.39 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.834 0.709 . . . . 72.15 110.052 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -102.8 -9.12 20.23 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.736 0.814 . . . . 74.52 111.819 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.32 -25.39 57.26 Favored Glycine 0 N--CA 1.475 1.265 0 C-N-CA 123.677 0.656 . . . . 75.12 112.728 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.47 -56.52 0.11 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.096 -0.552 . . . . 71.14 110.975 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -55.24 -54.81 38.7 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.604 1.162 . . . . 73.21 112.187 -168.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 78.9 m -69.62 -48.74 23.23 Favored Pre-proline 0 CA--C 1.562 1.405 0 CA-C-O 118.191 -0.909 . . . . 62.25 112.032 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -50.81 -35.79 49.83 Favored 'Trans proline' 0 C--N 1.399 3.195 0 C-N-CA 122.61 2.207 . . . . 73.22 113.929 170.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -75.15 -23.87 57.87 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.531 0.732 . . . . 72.1 111.701 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.496 HD13 HD11 ' B' ' 13' ' ' ILE . 83.2 mt -70.01 -44.14 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.089 -0.708 . . . . 63.32 109.089 168.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -80.6 -21.46 41.57 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.831 -1.077 . . . . 74.11 112.448 -173.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -62.48 -46.11 89.49 Favored Pre-proline 0 N--CA 1.487 1.394 0 N-CA-C 113.754 1.02 . . . . 62.22 113.754 -169.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.83 -35.71 98.17 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.859 1.706 . . . . 74.52 112.817 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -68.66 -45.31 72.11 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.991 0.517 . . . . 74.43 110.066 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.52 -37.53 78.56 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.689 0.796 . . . . 54.13 110.487 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -62.33 -57.88 9.71 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 124.29 1.036 . . . . 71.52 110.694 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -65.34 -28.88 69.61 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.988 0.805 . . . . 70.11 110.655 -173.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.488 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.3 t -75.09 -36.05 61.74 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.903 0.481 . . . . 74.42 111.377 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.464 HD13 HG23 ' B' ' 64' ' ' VAL . 81.7 mt -66.96 -52.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 109.671 -0.492 . . . . 61.11 109.671 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.458 HG21 ' OG ' ' C' ' 119' ' ' SER . 28.6 m -58.24 -33.56 69.49 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 124.339 1.024 . . . . 75.41 111.568 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 22.7 t -58.49 -53.94 52.62 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 123.813 0.696 . . . . 63.33 109.85 175.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.6 mmt -69.64 -35.22 75.03 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.493 0.717 . . . . 73.53 111.723 -171.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.98 -45.58 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.635 0.774 . . . . 71.22 110.428 174.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.41 ' OG ' HG21 ' C' ' 115' ' ' THR . 47.0 t -68.6 -32.58 72.56 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.969 -1.014 . . . . 65.42 111.357 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.7 mtt-85 -65.62 -37.2 85.93 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.552 -0.749 . . . . 74.0 109.389 175.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.37 5.0 65.2 Favored Glycine 0 C--N 1.357 1.72 0 O-C-N 124.213 0.946 . . . . 63.15 113.511 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.465 HG23 ' HB3' ' A' ' 17' ' ' TYR . 82.3 p 57.28 35.63 26.34 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.827 1.651 . . . . 72.34 112.96 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -95.26 162.53 24.43 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.83 0.852 . . . . 73.3 110.214 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.24 159.84 7.37 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 123.717 2.944 . . . . 72.32 114.19 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.515 HE21 ' ND2' ' B' ' 127' ' ' ASN . 67.9 tp60 -66.4 117.39 8.57 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.058 -0.973 . . . . 72.54 111.757 -176.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.517 HD21 HG11 ' B' ' 40' ' ' VAL . 10.2 mp -120.13 127.42 52.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.146 0.978 . . . . 73.15 109.455 173.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.515 ' ND2' HE21 ' B' ' 125' ' ' GLN . 50.7 m-80 -123.75 134.8 53.61 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.539 -0.911 . . . . 44.33 108.539 168.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.08 125.72 27.57 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.004 0.922 . . . . 75.31 109.892 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.28 151.14 87.75 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 124.011 0.924 . . . . 70.41 111.5 -176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.23 120.33 7.47 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.008 2.472 . . . . 71.44 112.431 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.9 t -118.33 112.7 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.941 -1.133 . . . . 54.11 107.941 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -79.13 84.86 5.07 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.838 -0.801 . . . . 63.55 108.838 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.72 -23.55 67.22 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.571 0.748 . . . . 75.02 111.83 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.07 -48.66 62.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.771 0.828 . . . . 71.11 110.696 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.43 95.39 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.683 -1.144 . . . . 75.3 110.306 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 71.4 mt -71.53 -31.21 66.79 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.254 -1.339 . . . . 74.54 111.868 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.615 ' CE1' HD11 ' B' ' 141' ' ' LEU . 51.4 t80 -69.77 -23.03 63.3 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.717 0.407 . . . . 74.21 110.723 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 82.8 mtp -71.69 -35.81 70.39 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.089 0.471 . . . . 74.12 110.09 174.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.8 -15.55 59.7 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.805 0.842 . . . . 63.11 110.882 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -67.54 -32.83 73.88 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.561 1.145 . . . . 62.2 110.724 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.615 HD11 ' CE1' ' B' ' 137' ' ' PHE . 24.4 mt -111.66 -6.26 14.38 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.912 0.885 . . . . 64.53 112.71 -163.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -154.18 170.01 22.23 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.489 -0.93 . . . . 74.03 108.489 -172.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -48.37 119.94 3.32 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.175 0.99 . . . . 75.41 110.295 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -49.96 99.5 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.963 1.305 . . . . 64.44 111.691 -172.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.51 40.42 1.16 Allowed 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.116 0.967 . . . . 64.31 109.844 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.94 57.45 5.07 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.751 -0.659 . . . . 31.14 111.463 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -76.29 89.31 3.14 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.965 0.906 . . . . 73.13 108.991 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.32 69.1 2.83 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 114.756 -1.111 . . . . 45.12 110.833 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 19.3 m -70.5 83.11 0.59 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.776 -0.824 . . . . 64.0 108.776 175.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -80.34 83.77 6.12 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.965 -1.016 . . . . 51.51 109.764 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -87.49 120.5 28.86 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.675 -1.232 . . . . 74.42 107.675 170.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -83.68 -9.38 58.9 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.78 0.432 . . . . 74.44 111.63 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 57.43 -168.7 0.11 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.423 1.089 . . . . 65.41 110.851 -174.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -139.79 92.96 2.6 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.55 -0.908 . . . . 62.4 108.55 171.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.907 0 C-N-CA 124.623 1.169 . . . . 64.54 110.751 -174.997 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 109.99 -0.374 . . . . 50.34 109.99 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 63.0 m -150.91 101.23 2.88 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.47 1.108 . . . . 75.1 108.456 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.76 135.84 41.73 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.966 0.506 . . . . 63.41 109.684 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -102.16 105.72 16.46 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.443 0.697 . . . . 72.03 109.993 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -152.27 142.49 22.39 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.055 0.942 . . . . 53.54 108.902 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -146.71 9.93 1.04 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.668 0.787 . . . . 75.52 110.173 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 77.3 p -74.71 -16.12 60.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.542 0.737 . . . . 72.14 111.366 -176.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.64 60.15 6.05 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 108.199 -1.037 . . . . 73.05 108.199 175.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 58.3 ttp 53.95 113.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 126.09 1.756 . . . . 74.3 113.351 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 10.6 m -92.55 108.35 19.91 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.943 -1.132 . . . . 62.34 107.943 167.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.933 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 62.5 t80 -123.41 121.33 35.48 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.655 -1.239 . . . . 64.41 107.655 174.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -137.21 122.76 19.69 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.168 -0.679 . . . . 63.42 109.168 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.04 125.35 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.807 -0.812 . . . . 73.05 108.807 172.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.564 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 29.3 mm-40 -91.97 -42.85 9.78 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.695 0.798 . . . . 71.31 109.306 175.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -175.61 138.58 0.39 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.63 -0.878 . . . . 64.22 108.63 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -127.91 141.67 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.862 -1.162 . . . . 60.14 107.862 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -170.57 161.18 7.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.714 0.768 . . . . 74.1 111.582 -171.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.457 HG21 ' SG ' ' C' ' 113' ' ' CYS . 68.3 p -83.95 107.47 16.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.753 -1.112 . . . . 71.3 108.338 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -68.81 -41.67 78.31 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.309 -0.996 . . . . 72.51 108.309 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 26.8 t70 -139.27 142.32 37.76 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 114.381 -1.282 . . . . 74.01 109.555 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.617 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.4 mt -135.99 145.35 31.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.548 1.539 . . . . 72.02 106.911 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -154.28 149.36 26.87 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.463 0.705 . . . . 73.42 109.504 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -155.82 109.01 2.71 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.2 -1.037 . . . . 74.21 108.2 174.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -119.3 111.9 18.78 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.266 0.626 . . . . 72.51 110.352 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -110.64 87.64 6.85 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 106.732 -1.581 . . . . 65.34 106.732 169.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.15 -23.65 24.39 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.698 2.266 . . . . 71.3 112.299 -170.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -121.39 29.71 7.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.367 1.067 . . . . 51.44 109.546 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.479 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -49.68 -53.54 40.54 Favored Pre-proline 0 CA--C 1.562 1.426 0 N-CA-C 114.031 1.123 . . . . 53.12 114.031 -171.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.468 ' HB3' HD13 ' D' ' 51' ' ' LEU . 26.3 Cg_exo -60.52 -48.72 10.55 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 121.671 1.581 . . . . 74.33 112.091 -176.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -69.99 -27.08 64.42 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.244 -1.344 . . . . 63.3 112.27 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.767 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -79.54 -26.95 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 112.557 0.577 . . . . 72.53 112.557 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -68.19 -27.39 66.35 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.01 0.374 . . . . 73.21 112.01 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -89.9 9.62 26.95 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.441 0.696 . . . . 62.24 111.797 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.6 176.57 5.97 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.585 0.754 . . . . 65.31 110.065 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -76.93 124.37 27.65 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.47 0.708 . . . . 74.51 109.367 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.48 ' HE1' HD12 ' G' ' 470' ' ' LEU . 50.7 t90 -85.15 84.84 7.56 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.711 0.804 . . . . 75.14 111.157 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -142.56 79.92 14.88 Favored Pre-proline 0 N--CA 1.478 0.943 0 N-CA-C 107.334 -1.358 . . . . 74.54 107.334 164.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.42 139.95 14.9 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.678 2.252 . . . . 75.51 112.922 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -83.73 104.92 14.23 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 106.19 -1.781 . . . . 63.24 106.19 165.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.507 ' HB ' HD12 ' G' ' 468' ' ' LEU . 5.8 m -93.46 102.74 13.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.197 -1.365 . . . . 73.24 110.791 -169.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.546 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 54.4 mttp -91.84 111.13 22.54 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.489 -0.778 . . . . 75.23 109.005 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.547 ' HB3' ' HG ' ' G' ' 468' ' ' LEU . 3.5 pp -86.41 157.22 19.89 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.515 -0.55 . . . . 75.55 109.515 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.641 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.6 t70 -151.75 137.32 17.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.044 -1.095 . . . . 55.13 108.044 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.417 HD22 HD12 ' G' ' 460' ' ' LEU . 6.2 tt -137.97 137.2 37.7 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.556 -0.905 . . . . 73.32 108.556 177.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -148.21 125.58 11.6 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.973 1.309 . . . . 71.22 108.596 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m -114.22 126.35 54.95 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.431 0.634 . . . . 74.44 110.342 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.23 141.05 52.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.862 1.265 . . . . 73.25 107.805 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -152.24 143.68 23.39 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.851 0.46 . . . . 73.15 110.46 -170.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 80.5 p -148.43 151.93 36.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.211 0.605 . . . . 60.51 111.23 -171.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -79.22 136.89 37.2 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.466 0.706 . . . . 73.15 110.269 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.607 HD11 ' HB2' ' C' ' 57' ' ' GLU . 29.8 mt -110.12 -34.42 6.39 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.53 0.732 . . . . 71.04 110.245 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -154.47 179.82 8.66 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.36 0.664 . . . . 54.45 110.242 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -58.46 112.93 1.75 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.719 0.808 . . . . 64.51 109.907 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 64.12 9.82 5.0 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.672 1.189 . . . . 63.15 113.473 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 94.2 t -105.59 116.25 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.558 -1.275 . . . . 50.13 107.558 172.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.423 ' HB2' HD11 ' C' ' 86' ' ' ILE . 39.8 t80 -134.09 124.21 25.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.013 -0.736 . . . . 73.53 109.013 -175.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.607 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.3 tt0 -83.42 139.01 33.23 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.92 0.888 . . . . 74.41 109.635 175.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.403 HG11 ' HD3' ' C' ' 103' ' ' PRO . 42.0 t -120.05 135.33 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 124.185 0.994 . . . . 64.55 108.496 166.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.578 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 59.1 t -115.84 144.55 23.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.543 -0.91 . . . . 64.25 108.543 175.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.4 104.64 8.56 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.197 -1.038 . . . . 75.02 108.197 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -88.16 117.46 27.07 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 107.79 -1.189 . . . . 63.4 107.79 175.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.483 HG11 HD21 ' C' ' 128' ' ' LEU . 21.4 t -118.88 118.85 59.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.741 -1.207 . . . . 71.23 107.741 175.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.641 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.9 m -122.3 122.32 38.81 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.579 0.752 . . . . 71.35 109.54 -173.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.751 HG13 HD13 ' G' ' 468' ' ' LEU . 99.5 t -110.36 122.16 64.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.083 1.353 . . . . 71.23 109.258 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.6 m -117.55 144.17 45.38 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.446 -0.946 . . . . 71.24 108.446 175.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.28 128.47 19.81 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.482 -0.933 . . . . 65.15 108.482 176.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 21.4 m -142.91 129.3 20.03 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.092 0.557 . . . . 54.32 110.586 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 49.0 mt -87.67 32.95 0.71 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.174 1.39 . . . . 74.54 111.334 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 -100.72 1.41 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.41 -1.076 . . . . 74.55 110.41 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.64 -31.09 17.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.808 0.843 . . . . 71.04 109.953 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -76.62 120.23 21.53 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.276 1.03 . . . . 74.14 110.092 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.2 m -78.14 126.18 30.44 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.561 -0.903 . . . . 71.51 108.561 168.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.767 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -60.98 2.06 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.589 -0.893 . . . . 74.21 108.589 173.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -163.61 172.49 14.25 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.068 0.937 . . . . 74.24 111.83 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.407 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.6 tm? -135.8 145.57 46.65 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 105.863 -1.902 . . . . 74.44 105.863 172.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.415 ' SG ' HG23 ' C' ' 114' ' ' ILE . 41.8 t -147.98 150.42 33.96 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.059 -1.089 . . . . 74.32 108.059 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.99 132.83 8.5 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.759 -0.46 . . . . 74.25 109.759 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -132.52 114.1 22.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.263 -1.014 . . . . 62.53 108.263 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 68.4 mt-30 -94.15 85.12 4.59 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.401 -0.963 . . . . 62.32 108.401 173.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -78.33 97.4 5.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.053 -1.431 . . . . 72.14 110.324 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -89.37 161.13 29.81 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 116.465 -0.334 . . . . 71.01 112.382 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.513 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -163.16 123.06 1.15 Allowed Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 111.058 -0.817 . . . . 73.24 111.058 -175.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.58 HD12 HD11 ' C' ' 51' ' ' LEU . 6.2 mm -82.26 125.92 39.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.532 -0.914 . . . . 74.42 108.532 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -131.6 119.74 21.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.166 0.587 . . . . 70.45 110.257 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 71.9 m -80.66 111.89 17.52 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.934 -0.765 . . . . 52.25 108.934 170.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.74 HG12 HD21 ' C' ' 98' ' ' LEU . 1.2 pp -117.06 139.31 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.225 1.01 . . . . 63.5 110.317 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.07 172.68 13.46 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.409 1.084 . . . . 73.23 110.514 -172.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.93 -59.67 3.55 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 116.179 -0.464 . . . . 71.24 112.086 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.81 157.57 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.756 0.823 . . . . 75.11 109.475 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.595 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 13.3 pt-20 -145.53 -170.8 3.54 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.0 0.52 . . . . 74.42 109.925 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.82 -121.73 24.26 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 114.621 0.608 . . . . 72.15 114.621 174.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 62.6 p -73.33 -34.27 65.58 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.792 0.837 . . . . 73.51 110.555 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -70.14 -32.7 70.81 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.243 1.017 . . . . 64.25 109.981 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.595 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 39.4 ttp -79.61 -33.13 41.8 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.836 -1.074 . . . . 61.42 110.838 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.45 84.17 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.369 0.604 . . . . 40.43 109.913 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 49.2 t-80 -65.42 -29.21 69.88 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.562 -1.199 . . . . 72.23 111.478 175.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.3 -60.81 2.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.057 0.543 . . . . 72.22 110.448 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.74 HD21 HG12 ' C' ' 86' ' ' ILE . 92.9 mt -74.16 -33.81 63.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.074 0.95 . . . . 54.22 112.696 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.35 8.79 77.08 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-O 119.475 -0.625 . . . . 72.04 113.551 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -156.87 -66.23 0.1 Allowed 'General case' 0 C--N 1.357 0.916 0 CA-C-N 117.724 0.762 . . . . 52.44 112.874 -172.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' C' ' 104' ' ' ASN . 87.9 t80 -63.89 -34.8 78.76 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.286 0.634 . . . . 75.42 112.328 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.933 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 56.2 m -72.75 -46.28 9.18 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.69 -0.671 . . . . 74.04 111.148 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 83.2 Cg_exo -52.99 -32.95 60.25 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.312 2.008 . . . . 75.54 113.791 164.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' C' ' 101' ' ' TYR . 5.1 m-20 -60.09 -39.83 87.49 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 123.158 0.583 . . . . 62.32 110.911 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.447 HD12 ' NH1' ' A' ' 111' ' ' ARG . 40.2 mm -66.5 -45.22 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 115.954 -0.567 . . . . 64.51 110.198 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.513 HD21 ' HA3' ' C' ' 82' ' ' GLY . 42.3 mt -75.88 -16.39 60.06 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.433 -0.803 . . . . 74.53 111.986 -174.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -59.92 -52.7 71.76 Favored Pre-proline 0 CA--C 1.566 1.583 0 C-N-CA 125.035 1.334 . . . . 60.12 113.811 -172.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.18 -31.38 64.34 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 121.948 1.765 . . . . 62.51 112.784 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.514 ' HE2' HG21 ' A' ' 115' ' ' THR . 90.3 m-85 -69.09 -47.6 64.78 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.188 0.595 . . . . 74.33 110.546 178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.37 -41.85 85.66 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.179 -0.918 . . . . 71.13 109.925 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -56.08 -57.72 10.97 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 124.437 1.086 . . . . 71.34 111.126 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -66.93 -30.93 71.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.181 0.593 . . . . 54.44 111.036 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.457 ' SG ' HG21 ' C' ' 18' ' ' THR . 9.6 t -70.5 -34.1 71.95 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.779 0.432 . . . . 72.34 110.971 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.564 HG21 HG21 ' C' ' 64' ' ' VAL . 88.4 mt -69.34 -51.24 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.277 -0.638 . . . . 52.31 109.277 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.41 HG21 ' OG ' ' B' ' 119' ' ' SER . 13.7 m -58.43 -33.53 69.79 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.05 0.94 . . . . 72.12 111.286 -174.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 28.3 t -62.9 -54.85 32.32 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.834 -1.075 . . . . 52.24 109.13 173.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.523 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.96 -40.05 72.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.91 1.284 . . . . 74.32 112.639 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.3 t -63.34 -47.72 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.956 0.902 . . . . 73.45 109.691 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.458 ' OG ' HG21 ' B' ' 115' ' ' THR . 48.4 t -69.95 -27.98 65.19 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.238 -0.892 . . . . 63.02 111.93 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' C' ' 116' ' ' SER . 84.3 mtt-85 -70.65 -43.68 68.67 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.688 0.795 . . . . 75.42 109.29 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.15 5.86 65.39 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.955 -1.02 . . . . 65.3 112.522 172.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 64.8 p 61.66 29.76 18.28 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.175 1.79 . . . . 65.51 113.757 168.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.408 ' HB2' HG13 ' C' ' 118' ' ' VAL . 95.6 m-85 -86.62 152.53 54.56 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 108.981 -0.748 . . . . 75.31 108.981 169.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.43 173.26 3.58 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.258 2.639 . . . . 71.32 114.649 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -50.79 130.92 25.75 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.308 1.443 . . . . 75.31 114.043 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' G' ' 468' ' ' LEU . 3.1 tm? -133.88 112.6 11.43 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 107.388 -1.338 . . . . 71.0 107.388 177.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -133.16 132.15 41.26 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.497 0.719 . . . . 73.21 109.99 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.483 HD21 HG11 ' C' ' 62' ' ' VAL . 6.8 mp -86.07 125.93 33.81 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.765 0.826 . . . . 74.41 110.11 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.45 ' HB3' ' SD ' ' G' ' 464' ' ' MET . . . -79.86 155.67 75.32 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 124.75 1.22 . . . . 61.34 111.18 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.03 113.93 1.79 Allowed 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 123.361 2.708 . . . . 74.32 113.522 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.39 113.38 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.786 0.834 . . . . 74.22 109.279 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -76.38 91.05 3.25 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.689 0.795 . . . . 74.32 110.473 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -68.55 -33.06 73.43 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 110.062 -0.348 . . . . 72.55 110.062 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.511 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 12.7 p-10 -65.02 -45.83 83.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.527 1.131 . . . . 74.52 111.447 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.53 -37.09 71.18 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.372 0.669 . . . . 73.53 110.897 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.26 -18.45 55.32 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.23 -0.895 . . . . 70.35 112.347 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -59.84 -17.78 39.05 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.096 0.558 . . . . 71.33 111.626 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 22.3 mmt -51.25 -42.27 60.91 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.688 0.795 . . . . 73.44 111.185 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -66.83 -36.39 82.25 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.153 0.581 . . . . 73.2 111.43 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -68.87 -86.52 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.827 0.851 . . . . 71.33 110.69 174.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.489 HD13 HE21 ' C' ' 144' ' ' GLN . 88.3 mt 56.1 -84.7 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.588 1.155 . . . . 62.44 110.861 -172.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -167.11 -83.39 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.727 -0.842 . . . . 72.14 108.727 176.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.45 -50.6 3.11 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 107.521 -1.288 . . . . 73.33 107.521 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.489 HE21 HD13 ' C' ' 141' ' ' LEU . 17.9 pt20 -55.58 124.09 16.18 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.249 -1.341 . . . . 70.32 110.636 172.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.3 108.6 21.18 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.571 0.748 . . . . 52.13 109.96 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.3 93.0 1.2 Allowed Glycine 0 C--N 1.337 0.639 0 N-CA-C 110.239 -1.144 . . . . 75.13 110.239 171.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.04 142.95 32.91 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.073 0.549 . . . . 74.53 109.764 -175.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.1 -33.15 0.1 OUTLIER Glycine 0 C--N 1.347 1.163 0 CA-C-N 115.943 -0.571 . . . . 74.4 112.463 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 28.3 p -133.19 108.77 9.0 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.771 0.828 . . . . 65.22 109.779 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.432 ' HA ' ' N ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -89.78 126.66 35.76 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 109.278 -0.638 . . . . 64.34 109.278 178.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.58 13.01 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.06 1.344 . . . . 73.24 110.855 -172.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.01 142.02 35.54 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.627 0.771 . . . . 72.15 111.003 -172.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -78.92 89.76 4.73 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.345 1.058 . . . . 71.44 109.872 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -129.88 123.0 29.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.306 1.042 . . . . 75.41 108.917 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 N-CA-C 109.54 -0.541 . . . . 63.23 109.54 -177.261 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.74 0.305 . . . . 63.53 110.563 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 47.3 t -129.72 94.17 3.68 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.414 0.685 . . . . 54.41 109.241 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -86.85 114.52 23.56 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.151 -0.685 . . . . 73.2 109.151 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -89.31 83.13 6.43 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.248 -1.019 . . . . 73.44 108.248 175.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -65.33 114.3 4.68 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.026 -0.988 . . . . 74.4 110.125 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -74.06 79.27 1.72 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 122.348 1.07 . . . . 62.41 110.509 -176.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 33.4 m -108.04 140.94 40.47 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.824 -1.08 . . . . 72.43 109.355 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -70.88 109.11 4.84 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.116 -1.068 . . . . 72.21 108.116 170.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.8 ttp -30.41 123.93 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 125.325 1.641 . . . . 74.24 113.783 -173.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 22.5 m -114.16 142.36 46.34 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.072 -1.085 . . . . 75.11 108.072 171.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -157.19 91.28 1.17 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.951 -1.5 . . . . 72.4 106.951 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -113.43 114.71 26.96 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.341 -0.985 . . . . 65.21 108.341 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.475 HG21 HD11 ' D' ' 16' ' ' ILE . 12.6 mt -75.27 114.76 15.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.014 -1.106 . . . . 63.0 108.014 174.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -89.96 -32.27 16.88 Favored 'General case' 0 C--O 1.242 0.705 0 O-C-N 123.423 0.452 . . . . 71.0 111.096 -178.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -172.76 146.42 1.61 Allowed 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.062 0.226 . . . . 74.22 111.555 -170.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.475 HD11 HG21 ' D' ' 13' ' ' ILE . 2.9 mp -126.56 132.27 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 105.79 -1.929 . . . . 71.1 105.79 170.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.409 ' HE1' HG13 ' D' ' 83' ' ' ILE . 28.8 p90 -158.53 150.92 21.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.203 1.001 . . . . 74.44 111.03 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -84.23 119.22 24.78 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.222 -1.808 . . . . 55.31 108.487 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -95.08 -28.53 15.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.34 -0.615 . . . . 63.44 109.34 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.1 t70 -145.16 128.74 17.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.583 -1.189 . . . . 73.03 108.232 175.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.523 HG21 ' HE2' ' C' ' 117' ' ' MET . 73.4 mt -129.92 137.72 55.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.401 -1.333 . . . . 74.24 107.401 172.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -138.24 139.42 39.22 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.438 1.095 . . . . 75.24 108.312 176.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.617 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -150.61 129.45 12.46 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.093 -1.447 . . . . 74.21 107.093 170.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.7 mt-10 -131.26 150.98 51.92 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.895 0.878 . . . . 75.31 109.178 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.23 78.21 19.2 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 106.946 -1.501 . . . . 44.12 106.946 173.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.8 -22.88 17.18 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.78 2.32 . . . . 74.13 113.596 -170.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -108.15 16.34 23.39 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.102 0.561 . . . . 73.13 110.256 176.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.1 -66.92 0.29 Allowed Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 115.581 1.697 . . . . 53.54 115.581 -160.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.437 ' HB3' HD11 ' C' ' 83' ' ' ILE . 96.2 Cg_endo -74.15 -20.51 18.93 Favored 'Trans proline' 0 C--N 1.387 2.568 0 CA-C-N 122.435 1.905 . . . . 73.14 112.717 -173.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -74.26 -41.05 61.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.148 1.379 . . . . 72.11 110.445 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' D' ' 73' ' ' ALA . 3.6 p -84.04 -20.92 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 115.883 -0.599 . . . . 63.54 111.066 -170.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -62.74 -22.08 66.29 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.076 0.551 . . . . 74.42 112.433 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -65.75 -18.0 65.02 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.489 0.715 . . . . 64.52 111.06 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -84.09 102.55 12.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.489 1.115 . . . . 65.13 108.972 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -84.56 89.42 7.44 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.373 -0.603 . . . . 52.32 109.373 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.442 ' HZ2' ' H ' ' H' ' 471' ' ' LYS . 39.1 t-105 -168.5 158.85 9.84 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.618 1.167 . . . . 71.43 109.368 176.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -72.13 109.8 6.56 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 108.315 -0.994 . . . . 71.41 108.315 169.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.52 125.91 20.07 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.307 2.671 . . . . 64.34 113.329 -173.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.02 115.66 2.75 Favored 'General case' 0 C--N 1.361 1.101 0 O-C-N 124.484 1.115 . . . . 70.04 109.61 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.597 HG23 HG13 ' D' ' 64' ' ' VAL . 3.0 p -96.66 112.76 29.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-O 121.86 0.838 . . . . 64.31 110.562 -170.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -101.91 151.24 22.34 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.846 -1.07 . . . . 65.44 108.258 167.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.45 HD21 HD12 ' D' ' 128' ' ' LEU . 5.3 mp -131.49 136.12 47.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.771 0.428 . . . . 73.42 110.637 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.652 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 30.4 m-20 -107.79 150.28 27.19 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 107.376 -1.342 . . . . 74.55 107.376 165.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.456 HD22 ' CD1' ' H' ' 462' ' ' TYR . 18.8 tp -137.36 131.27 31.87 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.584 0.23 . . . . 70.33 110.993 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 34.3 m-20 -138.87 158.42 44.24 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.61 1.164 . . . . 73.21 108.711 170.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.0 t -124.48 175.35 7.2 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.601 0.761 . . . . 72.34 109.189 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -161.34 163.99 30.38 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.9 0.88 . . . . 74.44 109.448 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 71.9 p -150.26 153.0 35.42 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.617 0.767 . . . . 73.4 109.264 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.7 p -156.62 140.41 16.11 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.485 0.714 . . . . 72.11 110.262 -174.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . 0.716 HE22 HG11 ' H' ' 452' ' ' VAL . 45.9 tp60 -91.56 116.43 28.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.511 0.724 . . . . 64.52 109.064 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' C' ' 29' ' ' PRO . 26.8 mt -98.5 -42.17 7.43 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.093 0.473 . . . . 71.23 110.297 -173.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.16 176.02 10.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.431 1.093 . . . . 55.33 108.097 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.08 130.61 41.33 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.581 -0.526 . . . . 71.14 109.581 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 61.42 11.0 3.45 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 124.425 1.09 . . . . 64.24 112.813 -171.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.67 114.37 43.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 108.211 -1.033 . . . . 75.22 108.211 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.46 ' HE2' ' H ' ' H' ' 453' ' ' GLY . 0.1 OUTLIER -111.12 164.66 12.61 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.175 -1.046 . . . . 73.04 108.175 -175.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.437 ' HB2' HD11 ' D' ' 51' ' ' LEU . 62.3 tt0 -131.04 150.89 51.94 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.838 -0.801 . . . . 73.24 108.838 169.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.61 141.87 42.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.795 1.238 . . . . 61.21 107.874 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 47.2 t -128.1 126.41 66.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.778 -1.194 . . . . 64.24 107.778 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.08 120.9 43.35 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.074 -1.084 . . . . 63.31 108.074 -175.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.417 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 22.3 ttm-85 -100.99 97.63 8.18 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.583 -0.895 . . . . 64.4 108.583 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.19 123.93 47.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.619 -1.252 . . . . 74.4 107.619 167.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.652 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 12.9 m -118.74 130.37 55.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.959 -0.756 . . . . 72.43 108.959 177.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.597 HG13 HG23 ' D' ' 40' ' ' VAL . 94.2 t -117.48 121.1 66.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.106 0.962 . . . . 61.11 109.157 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.1 m -116.01 104.0 11.15 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.083 -1.08 . . . . 62.22 108.083 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.27 150.57 24.32 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.641 -0.709 . . . . 64.24 110.493 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 55.1 p -143.96 142.19 30.6 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.705 0.628 . . . . 73.03 111.053 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 21.4 mt -110.32 104.37 13.15 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 124.633 1.173 . . . . 62.55 109.191 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.03 -112.9 3.55 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.443 -0.663 . . . . 71.31 111.443 -177.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -117.52 14.32 14.53 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.249 0.619 . . . . 72.41 111.488 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.58 156.04 45.52 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.071 0.548 . . . . 74.4 110.59 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.5 m -63.4 127.28 30.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.09 0.956 . . . . 63.24 111.502 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.504 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -86.03 -75.78 0.36 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.842 -0.799 . . . . 73.2 108.842 174.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.29 139.46 35.5 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-O 121.349 0.595 . . . . 75.55 110.03 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 80.6 mt -103.54 147.37 27.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.912 -1.144 . . . . 74.03 107.912 171.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.548 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.6 t -158.02 146.66 19.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 122.914 0.486 . . . . 71.22 109.859 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -156.2 134.28 11.29 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 108.858 -0.793 . . . . 51.41 108.858 171.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.32 114.75 24.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 109.104 -0.702 . . . . 75.12 109.104 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.452 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 72.3 mt-30 -89.08 83.23 6.54 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.295 -1.002 . . . . 53.14 108.295 171.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -80.96 99.22 8.29 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.457 -1.702 . . . . 75.25 109.946 -175.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.08 163.62 29.3 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 116.441 -0.345 . . . . 73.44 112.483 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.467 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -161.96 132.87 2.94 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 111.883 -0.487 . . . . 73.13 111.883 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.409 HG13 ' HE1' ' D' ' 17' ' ' TYR . 43.7 mt -88.93 130.41 38.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 123.822 0.849 . . . . 71.12 109.311 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -133.85 124.23 26.13 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.356 0.662 . . . . 73.52 110.04 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -83.41 105.5 14.41 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.594 -0.891 . . . . 64.52 108.594 170.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.434 HD13 HD13 ' D' ' 98' ' ' LEU . 47.8 pt -109.78 141.93 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 122.985 0.514 . . . . 75.35 110.855 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.467 ' HA ' HG21 ' H' ' 451' ' ' VAL . . . -154.35 159.88 41.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.309 1.044 . . . . 52.24 109.354 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.04 10.59 81.16 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 115.009 0.764 . . . . 54.43 115.009 173.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 24.0 pt -124.06 135.07 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.596 0.758 . . . . 71.22 109.549 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.73 164.9 28.95 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.517 0.727 . . . . 73.14 110.682 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.14 -121.9 25.57 Favored Glycine 0 C--N 1.353 1.481 0 O-C-N 124.091 0.87 . . . . 75.24 114.393 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 12.5 t -72.04 -32.4 67.07 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.691 0.796 . . . . 53.4 111.44 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -71.62 -35.28 70.39 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.167 0.587 . . . . 73.01 110.706 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.445 ' HE1' ' HB2' ' H' ' 454' ' ' LEU . 1.6 tmt? -66.56 -47.48 72.66 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.295 -0.866 . . . . 73.35 110.154 175.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.54 -28.37 69.89 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.21 -0.905 . . . . 63.43 111.479 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -76.47 -46.51 26.5 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.939 0.896 . . . . 71.31 110.869 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -69.71 -42.48 73.97 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.013 -0.54 . . . . 75.23 111.296 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.548 HD23 HD22 ' H' ' 454' ' ' LEU . 12.4 tp -84.51 -36.21 22.38 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 122.68 0.392 . . . . 73.23 111.195 -173.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.0 -23.09 42.65 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.036 -0.529 . . . . 55.25 113.705 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.572 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -122.17 -56.34 1.83 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.23 0.515 . . . . 70.53 111.949 -175.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . 0.413 ' O ' HG12 ' D' ' 105' ' ' ILE . 63.7 t80 -66.76 -43.36 84.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 111.841 0.312 . . . . 74.32 111.841 -173.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 98.8 m -65.85 -47.83 63.88 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.053 -0.975 . . . . 72.14 112.912 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.463 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.3 Cg_exo -57.0 -36.22 99.25 Favored 'Trans proline' 0 C--N 1.4 3.263 0 C-N-CA 121.847 1.698 . . . . 72.31 112.7 170.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -65.1 -31.22 72.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.851 0.86 . . . . 71.34 111.119 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.413 HG12 ' O ' ' D' ' 101' ' ' TYR . 46.3 mm -68.25 -40.89 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.502 0.721 . . . . 75.32 110.164 173.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.467 HD21 ' HA3' ' D' ' 82' ' ' GLY . 63.3 mt -77.96 -21.82 50.4 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.252 -0.886 . . . . 75.2 111.856 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -64.27 -41.29 59.44 Favored Pre-proline 0 CA--C 1.566 1.562 0 N-CA-C 114.098 1.147 . . . . 71.31 114.098 -172.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -51.19 -43.38 49.05 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 122.263 1.975 . . . . 71.02 113.56 170.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -72.51 -37.89 68.26 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.57 -0.741 . . . . 72.13 111.03 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.22 -45.11 93.16 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.498 0.719 . . . . 71.23 110.528 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -57.28 -51.85 67.71 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.416 1.072 . . . . 74.01 110.395 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.02 -44.65 96.25 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.175 0.922 . . . . 72.13 112.009 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -54.59 -48.14 72.5 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.91 0.756 . . . . 70.44 110.359 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.548 HG12 ' SG ' ' D' ' 76' ' ' CYS . 82.2 mt -60.4 -54.85 29.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 CA-C-N 114.502 -1.226 . . . . 60.41 110.38 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.0 m -55.39 -39.92 70.75 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.301 1.04 . . . . 73.3 111.806 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -68.05 -41.93 81.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.005 -0.998 . . . . 73.21 110.566 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -70.01 -29.19 66.19 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.8 0.44 . . . . 72.42 111.828 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' D' ' 114' ' ' ILE . 65.9 t -66.12 -45.1 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 123.961 0.904 . . . . 72.44 109.834 175.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.0 p -74.49 -28.93 61.22 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.992 -0.549 . . . . 72.35 111.251 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 -72.86 -33.5 66.14 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.429 0.692 . . . . 73.21 109.809 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.47 2.01 86.28 Favored Glycine 0 C--N 1.355 1.603 0 CA-C-N 115.769 -0.65 . . . . 53.31 112.165 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.8 p 64.37 18.98 11.62 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 127.142 2.177 . . . . 63.23 113.984 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -80.02 147.38 65.57 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 108.587 -0.894 . . . . 70.41 108.587 168.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.87 148.8 91.19 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.083 1.855 . . . . 63.41 111.463 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -57.8 139.84 53.09 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.723 1.209 . . . . 32.41 113.883 -165.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.487 HD11 HG21 ' D' ' 40' ' ' VAL . 42.2 tp -109.09 102.59 11.55 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.055 -0.975 . . . . 74.02 109.678 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -100.91 104.39 15.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.266 0.626 . . . . 74.11 109.385 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.45 HD12 HD21 ' D' ' 42' ' ' LEU . 3.0 mm? -74.56 118.62 17.72 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.16 0.584 . . . . 65.42 109.441 175.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.9 136.35 72.89 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.691 0.796 . . . . 72.4 111.368 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.83 118.97 5.81 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.217 1.945 . . . . 75.14 110.76 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.5 p -107.38 136.75 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.521 0.728 . . . . 53.43 110.028 -173.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 55.0 t30 -76.73 76.27 3.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.688 -1.227 . . . . 73.44 107.688 169.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.442 ' HE2' HD21 ' D' ' 44' ' ' LEU . 87.4 t80 -59.98 -33.15 71.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.075 -1.421 . . . . 74.41 112.006 -172.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.572 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 17.4 t70 -60.27 -34.8 74.24 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.656 1.182 . . . . 63.45 111.392 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.486 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -67.18 -37.92 84.53 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.16 -0.927 . . . . 44.21 111.716 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.6 mp -64.21 -33.34 75.58 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.707 0.803 . . . . 42.25 110.956 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.45 ' HD1' ' HZ ' ' H' ' 461' ' ' PHE . 61.3 t80 -65.9 -30.73 71.37 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.121 0.969 . . . . 75.34 111.808 -178.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 49.6 mtt -60.71 -23.82 65.19 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.826 0.85 . . . . 51.32 112.136 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.42 ' HA ' HE21 ' D' ' 142' ' ' GLN . 64.0 t30 -75.59 -42.13 52.82 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.266 0.626 . . . . 72.33 110.847 176.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -58.66 -38.06 77.34 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.026 0.93 . . . . 74.33 111.329 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.429 HD11 ' CE2' ' D' ' 137' ' ' PHE . 5.2 mp -60.4 -31.05 70.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.97 0.908 . . . . 75.04 111.767 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.42 HE21 ' HA ' ' D' ' 139' ' ' ASN . 39.0 mt-30 -89.21 1.32 55.85 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.554 0.741 . . . . 64.22 111.586 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -138.15 77.19 1.62 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.057 0.943 . . . . 53.11 109.574 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -162.05 139.52 8.55 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.613 0.765 . . . . 64.45 110.015 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.88 178.33 8.42 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.543 0.737 . . . . 75.04 110.232 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 98.72 175.61 32.34 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 116.01 -0.541 . . . . 71.54 111.965 -174.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -166.53 152.04 8.22 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.278 0.631 . . . . 65.35 111.155 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -92.94 85.65 1.15 Allowed Glycine 0 C--N 1.342 0.915 0 N-CA-C 110.524 -1.03 . . . . 61.02 110.524 172.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 11.4 m -76.27 79.44 3.05 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.358 0.599 . . . . 73.42 110.303 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -86.88 104.06 15.86 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.7 -0.682 . . . . 72.21 109.308 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -82.92 72.78 9.99 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.845 -1.169 . . . . 63.24 107.845 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -78.4 80.13 4.81 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.379 -0.828 . . . . 63.32 109.831 -171.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -96.66 102.62 14.43 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.924 -0.769 . . . . 71.01 108.924 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -65.85 140.34 58.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.632 0.773 . . . . 75.12 109.645 173.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 C-N-CA 123.455 0.702 . . . . 63.44 109.786 -174.382 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.172 -0.677 . . . . 70.43 109.172 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 28.3 m -82.23 -35.21 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 122.943 0.497 . . . . 73.44 111.333 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . 0.537 ' HB ' ' SD ' ' A' ' 94' ' ' MET . 5.2 m -137.34 149.39 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.223 0.609 . . . . 73.43 109.748 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -130.84 83.45 0.31 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.038 -0.825 . . . . 72.43 111.038 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 2.4 pp -131.99 141.59 49.33 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.684 0.794 . . . . 65.43 110.279 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 40.6 p -131.16 66.99 1.52 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.084 0.954 . . . . 71.03 109.669 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -78.62 134.78 37.15 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.431 -0.804 . . . . 74.31 109.201 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -108.93 -70.19 0.82 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.553 0.741 . . . . 75.42 111.174 -173.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 52.6 m -148.97 162.01 40.76 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.095 0.958 . . . . 73.34 110.088 -175.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 87.98 142.38 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 127.193 2.197 . . . . 63.31 111.481 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . 0.565 HD21 ' HB ' ' A' ' 46' ' ' THR . 49.5 mt -126.08 175.64 7.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.219 1.008 . . . . 72.21 109.199 168.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -95.37 24.54 5.01 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.884 1.274 . . . . 74.13 110.79 -177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -141.58 135.58 30.21 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.099 0.56 . . . . 75.02 110.265 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 10.2 t -125.05 146.95 49.2 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.705 1.202 . . . . 75.22 108.251 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . 0.541 ' HG3' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -99.54 105.26 17.13 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.358 -0.608 . . . . 74.34 109.358 -176.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -115.33 -2.12 12.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.267 1.027 . . . . 73.01 111.133 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.03 72.07 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.495 0.718 . . . . 64.53 111.541 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . 62.42 178.69 0.13 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.542 1.137 . . . . 72.13 112.517 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 90.1 mt -133.61 -50.76 0.85 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.436 0.694 . . . . 63.32 110.2 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 79.25 63.5 2.04 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 110.882 -0.887 . . . . 51.52 110.882 -172.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.8 122.71 17.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.692 0.797 . . . . 65.32 110.978 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.556 1.18 0 N-CA-C 108.131 -1.063 . . . . 73.12 108.131 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 108.958 -0.756 . . . . 72.41 108.958 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . 0.702 HG12 ' SD ' ' B' ' 94' ' ' MET . 59.0 t -67.96 -61.49 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 122.876 0.47 . . . . 73.41 110.862 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 29.9 m -72.18 157.53 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.269 0.628 . . . . 55.34 111.338 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -147.02 -66.06 0.01 OUTLIER Glycine 0 C--N 1.353 1.514 0 N-CA-C 111.594 -0.602 . . . . 62.23 111.594 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 11.0 mp 69.6 -178.52 0.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 125.112 1.365 . . . . 54.41 113.953 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . 0.41 HG23 HE21 ' F' ' 457' ' ' GLN . 9.7 t -154.02 164.63 38.13 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 113.952 -1.476 . . . . 52.32 108.885 176.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.42 113.55 5.38 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.042 0.937 . . . . 71.01 110.678 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . 0.41 HE21 HG23 ' F' ' 455' ' ' THR . 86.9 mm-40 -129.71 137.9 50.84 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.985 0.914 . . . . 73.44 109.97 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 47.2 m -102.97 124.54 48.67 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.988 0.915 . . . . 62.25 109.779 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 69.87 146.33 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.083 1.353 . . . . 73.25 111.967 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 91.2 mt -128.76 -61.9 1.04 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.275 -1.009 . . . . 70.23 108.275 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -176.52 161.38 2.16 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.27 1.428 . . . . 72.21 109.534 -173.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.21 -71.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.85 -0.796 . . . . 74.35 108.85 172.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 5.6 m 57.77 39.31 27.22 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.405 1.082 . . . . 60.2 110.723 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 41.7 ttm -73.16 110.21 7.28 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.137 -0.938 . . . . 72.35 109.458 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -69.53 -51.6 34.17 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.084 0.954 . . . . 71.44 111.489 -171.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -127.4 164.94 20.74 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.871 0.868 . . . . 73.41 109.155 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -59.27 168.63 1.39 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.111 0.964 . . . . 41.12 113.551 -172.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . 0.474 HD12 ' N ' ' F' ' 469' ' ' GLY . 2.2 pp -55.94 -25.15 42.07 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.931 0.892 . . . . 75.14 112.254 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . 0.474 ' N ' HD12 ' F' ' 468' ' ' LEU . . . -168.77 -80.9 0.05 OUTLIER Glycine 0 C--N 1.344 0.979 0 N-CA-C 109.862 -1.295 . . . . 72.21 109.862 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 19.0 tp 59.56 73.02 0.5 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.536 1.135 . . . . 64.0 110.517 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 62.2 tttp . . . . . 0 C--O 1.254 1.303 0 C-N-CA 123.14 0.576 . . . . 74.32 109.95 -173.692 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 121.679 0.752 . . . . 64.41 109.46 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . 0.539 HG23 HG23 ' G' ' 452' ' ' VAL . 7.9 m -153.78 -165.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.775 1.23 . . . . 62.54 109.97 -173.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . 0.539 HG23 HG23 ' G' ' 451' ' ' VAL . 60.4 t 67.69 116.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.28 0 C-N-CA 126.219 1.807 . . . . 75.15 111.124 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 162.7 63.55 0.02 OUTLIER Glycine 0 C--N 1.345 1.066 0 N-CA-C 111.67 -0.572 . . . . 60.42 111.67 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 7.1 mp -95.5 109.76 21.92 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.21 -1.033 . . . . 42.21 108.21 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 23.0 p -58.92 -48.62 80.8 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.622 0.769 . . . . 64.33 111.693 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -119.4 156.29 30.41 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.17 0.588 . . . . 74.25 110.598 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -122.22 2.99 9.82 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.951 1.3 . . . . 74.02 109.952 168.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 20.5 m -76.33 140.96 41.69 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.27 1.028 . . . . 75.02 110.817 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 70.77 131.4 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.663 1.585 . . . . 75.42 111.931 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . 0.417 HD12 HD22 ' C' ' 44' ' ' LEU . 0.1 OUTLIER -151.19 101.41 2.85 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 106.833 -1.543 . . . . 74.35 106.833 166.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.85 154.1 12.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.152 1.381 . . . . 72.14 113.312 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -149.55 87.29 1.5 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.458 -1.312 . . . . 74.31 107.458 171.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 11.9 t -85.43 14.32 5.61 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.854 0.861 . . . . 73.13 112.363 -168.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . 0.45 ' SD ' ' HB3' ' C' ' 129' ' ' ALA . 55.4 ttp -66.75 95.4 0.35 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.482 -0.562 . . . . 43.13 109.482 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -66.07 -20.82 66.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.638 1.175 . . . . 75.14 111.372 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -59.02 -21.4 59.01 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 124.026 0.931 . . . . 74.41 111.519 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . 0.412 ' HA ' HD23 ' C' ' 42' ' ' LEU . . . 53.71 83.01 0.08 Allowed 'General case' 0 C--N 1.364 1.207 0 C-N-CA 125.189 1.395 . . . . 72.1 111.506 173.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . 0.751 HD13 HG13 ' C' ' 64' ' ' VAL . 96.1 mt 56.75 -83.02 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.462 1.105 . . . . 73.33 112.54 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.72 -148.14 11.61 Favored Glycine 0 C--O 1.239 0.41 0 N-CA-C 109.653 -1.379 . . . . 44.44 109.653 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . 0.48 HD12 ' HE1' ' C' ' 36' ' ' TRP . 2.6 mm? 70.36 -21.56 0.18 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 125.289 1.436 . . . . 72.21 114.009 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 125.369 1.468 . . . . 72.24 112.108 171.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 7.7 p30 . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 121.345 0.593 . . . . 72.23 109.929 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' D' ' 87' ' ' ALA . 69.6 t -99.49 -13.27 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.729 0.811 . . . . 73.31 109.4 170.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . 0.716 HG11 HE22 ' D' ' 50' ' ' GLN . 25.3 m -112.17 159.0 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.505 0.722 . . . . 72.4 111.126 -176.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . 0.46 ' H ' ' HE2' ' D' ' 56' ' ' TYR . . . 116.22 50.89 0.41 Allowed Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.706 -0.679 . . . . 70.52 112.294 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . 0.548 HD22 HD23 ' D' ' 98' ' ' LEU . 59.9 tp -73.38 142.43 47.0 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.917 0.487 . . . . 61.15 110.341 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 22.5 p -73.04 82.77 1.25 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.849 -0.797 . . . . 65.22 108.849 168.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.35 131.13 47.27 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.442 -0.799 . . . . 42.24 110.918 -176.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.98 128.31 11.3 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.119 -1.437 . . . . 70.03 107.119 -175.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 47.7 p -73.31 -54.1 9.19 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.922 0.489 . . . . 64.31 111.417 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.85 117.55 5.15 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.017 0.927 . . . . 55.11 110.757 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.99 128.1 35.64 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.09 0.472 . . . . 75.32 110.075 -170.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . 0.45 ' HZ ' ' HD1' ' D' ' 137' ' ' PHE . 21.3 p90 -51.82 144.39 11.44 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.256 1.823 . . . . 70.53 112.23 173.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . 0.456 ' CD1' HD22 ' D' ' 44' ' ' LEU . 14.8 t80 -147.94 63.14 1.12 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.368 -0.975 . . . . 72.22 108.368 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 42.8 p -77.56 80.93 4.03 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.752 -1.113 . . . . 71.52 109.778 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 59.8 mtp -126.98 153.47 45.84 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.99 0.916 . . . . 74.24 110.396 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -131.44 174.89 9.62 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 114.249 -1.341 . . . . 75.32 108.626 174.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . 64.49 -77.19 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.568 1.147 . . . . 75.23 110.9 -173.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . 70.78 -64.48 0.37 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.516 1.526 . . . . 63.24 111.777 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . 0.523 ' HB3' HD22 ' H' ' 470' ' ' LEU . 7.2 tt -147.49 147.58 30.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 106.364 -1.717 . . . . 62.44 106.364 171.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . 0.464 ' N ' HD23 ' H' ' 468' ' ' LEU . . . -76.47 75.05 1.65 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 123.073 0.233 . . . . 72.14 113.127 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' H' ' 468' ' ' LEU . 1.7 pt? -146.33 150.62 36.08 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.582 0.753 . . . . 65.02 110.065 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . 0.442 ' H ' ' HZ2' ' D' ' 36' ' ' TRP . 10.0 mtmp? . . . . . 0 C--O 1.253 1.266 0 N-CA-C 107.02 -1.474 . . . . 70.31 107.02 168.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.399 -0.593 . . . . 64.34 109.399 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.4 m -84.66 15.24 3.95 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.481 0.919 . . . . 64.54 113.481 -168.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -72.18 90.53 1.22 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.662 -0.496 . . . . 75.34 109.662 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -89.46 161.36 16.3 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.404 -0.816 . . . . 75.44 109.696 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -72.98 -70.9 0.33 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.275 -1.009 . . . . 72.22 108.275 171.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 61.35 -65.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.856 1.662 . . . . 74.51 114.028 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 m -39.43 125.64 1.72 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.055 1.742 . . . . 71.32 112.491 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -61.63 -37.38 83.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.449 1.1 . . . . 72.43 110.435 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.411 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.4 mpt? -74.58 164.0 27.09 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.549 -1.205 . . . . 73.41 109.921 171.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m -140.21 127.7 21.46 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.985 -1.117 . . . . 52.11 107.985 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -137.81 134.92 35.76 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.529 -0.915 . . . . 73.34 108.529 172.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -149.96 110.96 4.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.215 -1.032 . . . . 65.42 108.215 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.443 HG21 ' HG2' ' C' ' 130' ' ' PRO . 32.7 mt -78.14 110.38 13.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.59 -0.892 . . . . 73.55 108.59 176.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -80.08 -32.62 39.26 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.957 -1.02 . . . . 74.0 110.175 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -177.44 126.25 0.14 Allowed 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.375 0.422 . . . . 74.14 110.415 -172.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.435 HD12 ' HG3' ' C' ' 130' ' ' PRO . 93.8 mt -113.52 130.99 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.424 -0.954 . . . . 72.15 108.424 169.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -160.18 154.31 23.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.334 1.054 . . . . 54.1 109.561 -172.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.5 p -79.84 120.27 23.86 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.937 -0.764 . . . . 74.01 108.937 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -81.0 -31.23 34.74 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.04 0.448 . . . . 65.21 109.855 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -153.26 143.57 22.41 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.774 -1.103 . . . . 64.11 109.537 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -133.86 145.1 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.852 1.261 . . . . 72.32 108.122 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -144.82 134.38 23.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.346 0.593 . . . . 73.21 109.471 171.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -134.56 131.13 37.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.184 -1.784 . . . . 75.1 106.184 162.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -134.33 142.07 47.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.974 -0.75 . . . . 63.45 108.974 171.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.45 79.08 55.39 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 106.459 -1.682 . . . . 62.53 106.459 169.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.2 -15.23 35.39 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.486 2.124 . . . . 52.13 110.329 174.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -112.44 28.01 9.15 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.848 1.259 . . . . 74.15 111.139 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.663 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -60.12 -54.54 54.27 Favored Pre-proline 0 CA--C 1.575 1.907 0 CA-C-O 118.933 -0.556 . . . . 72.43 111.344 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.663 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 11.6 Cg_exo -76.48 -14.93 17.85 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 122.192 1.928 . . . . 74.34 113.373 173.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -69.88 -53.28 18.75 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 109.633 -0.506 . . . . 73.53 109.633 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.567 HG11 ' HE1' ' A' ' 123' ' ' PHE . 12.1 p -64.44 -23.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.783 0.833 . . . . 62.01 111.424 -175.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -58.09 -40.4 81.03 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.607 0.763 . . . . 64.43 110.4 171.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -90.64 -30.3 17.24 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.327 1.051 . . . . 72.02 111.021 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 14.1 mmmm -84.0 172.16 12.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.275 1.03 . . . . 71.11 111.38 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.23 148.59 23.52 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.675 0.79 . . . . 71.54 109.818 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.404 ' CZ2' ' HG3' ' A' ' 38' ' ' PRO . 68.8 t-105 -79.59 90.94 5.15 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.234 0.614 . . . . 74.42 109.761 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.704 HE21 ' HE3' ' E' ' 471' ' ' LYS . 50.6 mt-30 -132.37 42.03 0.81 Allowed Pre-proline 0 CA--C 1.574 1.869 0 C-N-CA 123.313 0.645 . . . . 74.54 112.69 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.487 ' HG2' ' HB2' ' E' ' 470' ' ' LEU . 45.0 Cg_endo -81.47 140.03 11.76 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.308 2.006 . . . . 72.4 113.564 -171.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -98.69 99.96 11.13 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.764 -1.199 . . . . 65.23 107.764 168.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' E' ' 467' ' ' ALA . 48.8 t -83.13 93.33 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 115.619 -0.719 . . . . 64.53 109.999 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -78.4 153.03 31.91 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.869 0.366 . . . . 74.25 110.375 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.1 tp -122.2 130.2 52.98 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.387 -0.824 . . . . 60.1 109.969 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -130.98 146.84 52.51 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.562 1.145 . . . . 64.34 107.916 172.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.552 HD22 HD21 ' A' ' 60' ' ' LEU . 85.2 mt -129.53 148.53 51.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.468 0.707 . . . . 62.32 109.845 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.713 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 14.9 m-20 -132.48 140.14 48.25 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.183 0.993 . . . . 71.44 109.1 172.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.735 ' H ' HD21 ' E' ' 460' ' ' LEU . 24.0 m -108.22 126.2 52.53 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.062 1.345 . . . . 54.43 108.488 174.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.16 146.16 51.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.593 0.757 . . . . 54.45 109.163 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.5 m -134.45 158.51 43.72 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.847 0.459 . . . . 70.11 111.045 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 40.2 t -154.44 129.49 9.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.451 1.1 . . . . 71.31 108.605 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -84.48 107.75 16.9 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.15 -0.685 . . . . 51.13 109.15 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.0 mt -79.57 -38.43 34.1 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.986 0.515 . . . . 55.44 110.372 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.19 -177.03 6.25 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.495 -0.775 . . . . 74.22 110.315 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.13 111.82 2.37 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.875 0.87 . . . . 64.45 109.95 174.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 65.28 17.23 10.92 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.053 1.341 . . . . 75.11 112.873 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.79 116.7 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.223 -1.029 . . . . 71.02 108.223 169.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -110.7 167.57 10.13 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.603 1.192 . . . . 71.45 111.501 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 9.6 tp10 -128.78 126.43 39.92 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 112.393 -2.185 . . . . 50.11 105.661 169.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.24 131.27 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 107.482 -1.303 . . . . 62.32 107.482 173.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 21.9 t -119.49 115.52 47.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 124.128 0.971 . . . . 54.23 108.656 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.552 HD21 HD22 ' A' ' 44' ' ' LEU . 3.7 tt -88.19 98.01 11.32 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.322 -1.733 . . . . 64.31 106.322 167.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.713 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 46.8 ttt-85 -85.61 101.97 13.16 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.952 -1.129 . . . . 65.41 107.952 174.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.486 HG11 ' HB1' ' A' ' 110' ' ' ALA . 2.3 p -105.02 124.26 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.294 0.637 . . . . 41.22 110.291 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.0 m -108.13 130.84 55.09 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 123.846 0.858 . . . . 74.32 109.593 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.41 ' O ' HD12 ' A' ' 75' ' ' LEU . 45.9 t -126.32 122.65 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.02 1.328 . . . . 74.13 107.973 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 t -128.88 120.59 26.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.018 0.527 . . . . 71.54 109.68 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -105.15 110.18 22.45 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.589 -0.893 . . . . 41.54 108.589 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.3 p -124.88 126.89 46.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.862 0.465 . . . . 74.14 111.403 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.521 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -104.62 84.78 2.22 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.806 -1.183 . . . . 52.23 107.806 166.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.94 -117.32 5.08 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.386 -0.824 . . . . 23.02 111.846 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -87.94 -23.22 23.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.056 0.542 . . . . 71.23 109.889 175.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.53 134.87 35.57 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.026 0.93 . . . . 74.22 110.725 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.3 m -83.15 154.37 24.33 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.072 0.949 . . . . 73.5 109.148 168.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.9 -61.18 1.4 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.197 -1.038 . . . . 51.31 108.197 164.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -151.07 170.36 19.58 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.53 -1.214 . . . . 73.51 110.722 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 64' ' ' VAL . 51.2 tp -138.83 129.22 25.77 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.043 1.337 . . . . 64.45 107.729 177.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.3 m -136.07 117.6 14.83 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.809 0.844 . . . . 74.15 108.761 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -138.79 115.38 10.59 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.274 -0.639 . . . . 61.33 109.274 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.7 t -123.99 115.72 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.202 1.001 . . . . 62.41 109.498 -171.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.631 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 17.3 mt-30 -87.85 82.43 7.3 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.156 -1.053 . . . . 73.44 108.156 169.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.4 115.5 16.2 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.022 -1.103 . . . . 73.2 108.022 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.14 170.85 13.59 Favored Glycine 0 C--O 1.242 0.618 0 CA-C-O 121.227 0.348 . . . . 64.1 112.255 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.51 136.05 3.97 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.144 -0.528 . . . . 74.33 112.0 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.5 mt -81.1 122.84 36.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 108.131 -1.063 . . . . 72.43 108.131 169.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.496 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.3 m-85 -130.95 118.49 20.74 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.717 -0.846 . . . . 71.12 108.717 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.5 p -94.98 118.11 31.27 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.896 -0.779 . . . . 74.24 108.896 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.416 ' HB ' HD11 ' A' ' 89' ' ' ILE . 2.8 pp -128.55 157.11 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.137 0.975 . . . . 31.2 110.624 -174.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.48 154.01 13.71 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.975 0.91 . . . . 74.32 109.947 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.4 9.63 61.51 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 113.752 0.261 . . . . 73.32 113.752 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.629 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -133.19 145.09 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.937 0.895 . . . . 65.21 109.934 178.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.534 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.6 tt0 -156.13 174.13 15.82 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.15 0.58 . . . . 65.41 109.819 177.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.534 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 60.07 -116.94 9.81 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.678 0.656 . . . . 65.34 113.444 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.4 p -71.55 -27.01 62.87 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.745 0.818 . . . . 75.41 110.934 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -71.02 -36.2 72.3 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.762 0.825 . . . . 61.5 110.432 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.414 ' HA ' ' SG ' ' A' ' 97' ' ' CYS . 49.3 ttm -73.11 -37.17 66.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.068 0.547 . . . . 72.43 110.09 175.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 -24.69 66.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.792 -0.64 . . . . 71.43 110.231 172.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.528 ' NE2' ' HB3' ' A' ' 100' ' ' ALA . 9.8 t-160 -83.38 -25.95 30.91 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.562 0.745 . . . . 44.21 111.204 176.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.629 ' SG ' HG13 ' A' ' 89' ' ' ILE . 74.0 m -56.86 -43.21 80.98 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.004 0.431 . . . . 73.44 110.492 175.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -90.73 -20.74 22.09 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.567 -0.742 . . . . 70.24 111.268 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -38.56 41.8 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 114.071 0.388 . . . . 74.11 114.071 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.528 ' HB3' ' NE2' ' A' ' 96' ' ' HIS . . . -150.88 -47.12 0.12 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 117.508 0.654 . . . . 52.23 112.004 -175.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.413 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 31.2 t80 -45.08 -70.24 0.11 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 126.053 1.741 . . . . 74.42 112.865 -175.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.1 m -81.29 -34.53 0.73 Allowed Pre-proline 0 CA--C 1.572 1.79 0 N-CA-C 115.462 1.653 . . . . 64.24 115.462 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.447 ' O ' HD12 ' A' ' 60' ' ' LEU . 37.4 Cg_endo -63.88 -34.74 59.27 Favored 'Trans proline' 0 C--N 1.399 3.231 0 CA-C-N 122.701 2.0 . . . . 61.32 112.619 175.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -66.56 -26.62 67.21 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 120.716 0.293 . . . . 60.22 111.299 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.06 -43.44 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.67 0.788 . . . . 75.53 110.18 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.9 mt -78.03 -14.66 59.42 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.061 0.944 . . . . 74.34 112.479 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.16 -49.38 84.93 Favored Pre-proline 0 CA--C 1.565 1.555 0 N-CA-C 113.486 0.921 . . . . 74.44 113.486 -171.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.1 -32.3 75.09 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 121.929 1.753 . . . . 71.34 112.572 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -74.48 -37.63 63.13 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.694 0.798 . . . . 71.02 111.58 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.486 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -70.26 -45.15 67.02 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.843 0.457 . . . . 54.34 110.099 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.41 ' NH1' HD12 ' C' ' 105' ' ' ILE . 31.9 ttm180 -54.2 -47.73 71.79 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.365 1.041 . . . . 64.12 110.342 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.27 -46.38 89.06 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.139 0.9 . . . . 74.02 111.725 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 117' ' ' MET . 37.1 t -59.81 -38.39 81.82 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.408 0.683 . . . . 72.44 110.537 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.2 mt -70.82 -47.84 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.034 0.934 . . . . 73.35 110.896 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -54.41 -38.16 65.91 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.791 0.836 . . . . 74.1 110.343 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.6 t -65.86 -47.01 76.34 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.325 -1.307 . . . . 75.53 110.253 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 34.0 mmt -57.18 -48.21 79.32 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.159 0.583 . . . . 71.32 111.246 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 114' ' ' ILE . 58.6 t -64.27 -48.63 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.443 1.097 . . . . 72.03 111.046 -175.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 51.1 m -69.97 -29.57 66.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.33 0.652 . . . . 74.23 112.209 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -71.11 -28.33 64.23 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.832 0.453 . . . . 75.4 110.255 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.48 7.97 66.65 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-O 119.755 -0.469 . . . . 55.34 113.126 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.492 ' HB ' HH21 ' B' ' 15' ' ' ARG . 15.7 m 68.28 15.01 9.3 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.776 1.231 . . . . 72.14 111.245 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.567 ' HE1' HG11 ' A' ' 31' ' ' VAL . 63.6 m-85 -89.54 144.5 32.12 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.451 -0.944 . . . . 72.12 108.451 173.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.37 142.89 88.12 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.822 2.348 . . . . 65.34 111.898 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.25 138.45 16.47 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.391 1.076 . . . . 70.31 112.486 -175.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.1 tp -115.6 103.03 10.31 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.732 -1.122 . . . . 60.33 110.062 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.432 HD21 ' HB ' ' C' ' 16' ' ' ILE . 79.1 m-20 -111.47 96.85 6.35 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.044 -1.095 . . . . 73.3 108.044 168.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.9 151.28 47.86 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.422 -0.808 . . . . 73.5 110.056 176.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.69 145.72 95.21 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.745 0.818 . . . . 74.3 111.73 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -57.68 127.62 26.0 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.832 2.355 . . . . 73.44 112.657 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 93.8 t -102.04 115.97 44.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 124.457 1.103 . . . . 71.14 109.243 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -84.86 93.62 8.55 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.521 -0.918 . . . . 72.53 108.521 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -65.06 -27.36 68.73 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.657 0.783 . . . . 73.02 111.801 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -66.72 -47.15 73.21 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.935 0.494 . . . . 72.43 110.175 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.04 -50.88 71.92 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 124.114 0.884 . . . . 73.24 109.912 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.479 ' HB3' ' CD1' ' E' ' 461' ' ' PHE . 52.2 mt -62.29 -38.42 89.3 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.647 -1.16 . . . . 72.41 112.343 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.564 ' CE1' HD22 ' A' ' 141' ' ' LEU . 30.2 t80 -65.82 -46.78 77.33 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.361 0.665 . . . . 74.41 110.472 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.404 ' SD ' HD23 ' A' ' 141' ' ' LEU . 94.2 mmm -70.62 -26.76 63.63 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.913 -0.585 . . . . 71.03 110.624 -175.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 93.4 m-20 -58.57 -38.9 78.86 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.719 0.808 . . . . 73.52 111.014 171.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.567 ' HB2' ' HB3' ' E' ' 461' ' ' PHE . 0.4 OUTLIER -70.61 -48.01 57.27 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.522 1.129 . . . . 73.42 111.048 173.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.564 HD22 ' CE1' ' A' ' 137' ' ' PHE . 23.0 tp -70.13 -38.89 75.65 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 113.941 -1.481 . . . . 64.22 113.626 -166.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.481 ' NE2' ' HB3' ' C' ' 150' ' ' GLU . 11.8 pt20 -158.24 5.02 0.12 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.442 0.697 . . . . 74.24 111.442 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 28.6 tt0 62.92 -153.29 0.34 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.222 1.009 . . . . 75.45 108.957 -165.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.496 ' H ' ' HG2' ' A' ' 143' ' ' GLN . 13.8 mt-30 65.49 82.98 0.17 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.823 0.849 . . . . 74.42 111.221 171.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.22 62.91 7.71 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 122.172 0.987 . . . . 72.34 109.135 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.33 -163.56 31.66 Favored Glycine 0 C--O 1.243 0.69 0 CA-C-N 114.307 -1.315 . . . . 73.13 111.322 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 56.53 -90.7 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.502 1.121 . . . . 72.21 109.813 -170.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 55.92 27.6 51.08 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 115.047 0.779 . . . . 64.45 115.047 172.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -147.19 160.57 42.31 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.383 0.673 . . . . 63.32 110.185 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -152.29 138.52 18.37 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.807 0.843 . . . . 73.22 109.251 175.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -107.09 139.93 40.73 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.994 0.918 . . . . 62.4 109.163 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -132.02 21.95 4.52 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.829 0.852 . . . . 73.01 112.081 -169.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -84.51 55.39 3.37 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.546 0.689 . . . . 71.41 112.042 -177.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.81 104.37 2.88 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.037 0.535 . . . . 64.24 109.95 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.274 0 C-N-CA 123.942 0.897 . . . . 60.01 110.414 179.224 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 109.873 -0.417 . . . . 72.51 109.873 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.9 m -146.66 -171.31 3.72 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.537 1.135 . . . . 60.13 109.702 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' B' ' 4' ' ' GLN . 14.6 tt0 -138.9 172.15 13.28 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.643 0.777 . . . . 61.23 109.058 175.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.481 ' H ' ' HG2' ' B' ' 3' ' ' GLU . 37.0 mt-30 -81.24 -23.69 37.88 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.446 0.698 . . . . 73.23 109.949 175.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 17.8 m120 70.38 95.3 0.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.559 1.544 . . . . 55.32 113.1 172.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -77.09 86.64 3.58 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.294 0.638 . . . . 72.4 109.505 172.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 14.4 t -161.7 176.7 10.67 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.677 0.791 . . . . 73.13 109.898 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.7 123.11 17.04 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.192 -1.04 . . . . 63.35 108.192 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.6 ptm 46.74 -168.46 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.548 1.539 . . . . 75.44 112.784 -171.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 56.0 m -147.57 129.09 14.98 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.875 -1.157 . . . . 72.34 107.875 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -147.37 140.97 25.54 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.801 -0.814 . . . . 72.3 108.801 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -153.0 141.21 20.5 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.17 -0.678 . . . . 62.11 109.17 175.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 mt -85.86 121.26 37.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.179 -1.045 . . . . 71.34 108.179 174.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -88.08 -42.45 12.38 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.527 0.517 . . . . 63.52 109.931 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.492 HH21 ' HB ' ' A' ' 122' ' ' THR . 65.5 ttt180 -167.8 133.76 2.01 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.765 -0.652 . . . . 74.21 109.695 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.0 mt -115.15 140.48 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.025 -1.472 . . . . 60.2 107.025 168.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.497 ' CE2' ' HB1' ' A' ' 28' ' ' ALA . 34.8 p90 -164.25 158.34 18.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.881 0.848 . . . . 74.24 111.544 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 96.9 m -83.6 120.84 26.45 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.43 -1.259 . . . . 74.24 108.545 171.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.412 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 35.8 mtpt -88.43 -33.38 17.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.44 0.696 . . . . 74.32 110.423 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.5 t70 -150.82 135.94 17.62 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.739 -0.664 . . . . 72.3 110.826 -171.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.42 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.2 mm -127.98 139.79 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.617 1.167 . . . . 74.12 108.678 166.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 43.5 t -140.93 131.34 25.21 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.077 -1.083 . . . . 72.54 108.077 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -141.89 115.4 9.01 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.861 -1.163 . . . . 54.13 107.861 170.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 36.5 mt-10 -118.26 112.54 20.22 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.902 -1.148 . . . . 60.24 107.902 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.487 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.83 83.23 1.22 Allowed Pre-proline 0 C--O 1.24 0.575 0 N-CA-C 106.311 -1.737 . . . . 72.1 106.311 164.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.91 -13.74 29.25 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 122.459 2.106 . . . . 74.23 112.139 -171.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -123.59 12.48 9.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.075 0.95 . . . . 61.42 110.774 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.512 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -34.86 -62.7 0.4 Allowed Pre-proline 0 N--CA 1.501 2.096 0 N-CA-C 114.456 1.28 . . . . 74.1 114.456 -170.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 25.9 Cg_exo -61.18 -36.3 81.35 Favored 'Trans proline' 0 C--N 1.396 3.067 0 C-N-CA 122.154 1.903 . . . . 61.32 113.429 -174.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -92.1 -18.8 23.06 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.891 0.7 . . . . 74.4 112.891 -173.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.717 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.6 p -83.12 -19.91 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 118.69 0.677 . . . . 72.14 111.422 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -67.91 -14.38 62.92 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 112.94 0.719 . . . . 72.33 112.94 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.489 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.8 pt20 -60.49 -26.32 66.73 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.125 0.488 . . . . 41.41 110.371 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.489 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 88.2 mttt -101.66 87.65 3.21 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.535 1.134 . . . . 73.51 108.728 175.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -79.54 101.98 8.57 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.315 -0.624 . . . . 71.33 109.315 174.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -172.66 158.01 3.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.48 1.112 . . . . 74.11 108.877 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.533 ' HG2' ' HB2' ' B' ' 124' ' ' PRO . 47.6 mt-30 -64.65 107.59 1.47 Allowed Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.948 0.899 . . . . 74.14 109.123 168.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.61 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.7 Cg_endo -59.14 160.86 17.67 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 123.351 2.7 . . . . 71.55 113.653 -176.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -59.81 103.02 0.18 Allowed 'General case' 0 C--N 1.35 0.614 0 N-CA-C 107.722 -1.214 . . . . 71.32 107.722 169.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.0 m -91.55 161.22 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.3 -0.864 . . . . 65.04 110.509 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -135.71 113.75 11.27 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.398 -1.334 . . . . 75.12 107.398 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.592 HD12 ' HB3' ' F' ' 468' ' ' LEU . 4.1 tt -85.2 126.2 33.46 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.692 -1.595 . . . . 73.33 106.692 173.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.72 144.79 26.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.942 -1.132 . . . . 52.35 107.942 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -146.63 160.02 42.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.061 0.544 . . . . 52.35 110.145 174.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -143.65 150.17 38.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.037 0.935 . . . . 63.3 109.335 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -125.52 115.26 19.93 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.007 0.923 . . . . 73.51 109.85 -174.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.02 161.66 19.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.479 1.112 . . . . 60.11 108.501 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 77.4 p -145.37 162.84 36.3 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.538 0.335 . . . . 64.11 110.351 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -154.49 136.19 14.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.684 0.794 . . . . 75.24 109.543 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -89.89 116.06 27.68 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.924 -0.398 . . . . 73.13 109.924 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 24.5 mt -80.25 -52.15 8.07 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.146 0.978 . . . . 72.54 110.741 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.32 -168.53 2.56 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.42 1.088 . . . . 73.42 109.013 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -63.05 100.8 0.23 Allowed 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.492 0.495 . . . . 73.12 110.205 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 63.62 16.16 9.47 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.064 1.345 . . . . 75.25 113.227 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 69.1 t -103.44 101.12 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 105.065 -2.198 . . . . 62.05 105.065 167.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -118.97 168.93 10.34 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.388 -0.967 . . . . 73.3 108.388 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -144.9 111.86 5.91 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.433 -0.951 . . . . 62.31 108.433 -171.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -96.27 137.78 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 O-C-N 124.029 0.831 . . . . 61.32 109.471 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 37.3 t -113.48 117.64 56.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.808 0.843 . . . . 64.35 109.274 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.39 110.73 23.23 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.317 -1.364 . . . . 75.31 107.317 173.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -100.31 128.85 46.28 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.794 -0.817 . . . . 74.13 108.794 173.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.52 ' HB ' HD11 ' B' ' 114' ' ' ILE . 11.4 t -126.91 123.7 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.024 -1.102 . . . . 65.12 108.024 172.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -118.81 134.52 55.1 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.704 0.802 . . . . 72.1 110.807 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.432 HG21 HG21 ' B' ' 114' ' ' ILE . 66.8 t -120.26 101.77 11.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.488 1.515 . . . . 74.22 108.452 177.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 90.5 m -84.65 135.28 34.24 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.883 -1.155 . . . . 70.21 107.883 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.22 141.48 26.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.935 0.334 . . . . 63.1 111.325 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.469 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 58.2 p -148.84 135.3 19.49 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.226 0.61 . . . . 65.31 111.341 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.61 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 24.1 mt -96.67 115.3 27.21 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 124.395 1.078 . . . . 73.23 109.995 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.32 -108.44 2.36 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 115.477 -0.783 . . . . 61.51 112.492 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -116.19 2.1 13.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.404 0.681 . . . . 52.21 110.982 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -116.2 145.28 43.23 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.438 -0.578 . . . . 71.32 109.438 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 51.2 m -64.74 135.91 56.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.972 0.509 . . . . 63.35 110.778 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.717 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -92.29 -64.26 1.13 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.339 -0.986 . . . . 55.22 108.339 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -154.11 154.7 34.07 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.79 -1.096 . . . . 62.42 109.827 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.41 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 41.6 mt -131.95 108.7 9.55 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.917 -1.883 . . . . 73.54 105.917 176.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.4 t -118.26 143.38 46.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.48 -0.933 . . . . 74.2 108.48 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -157.14 129.31 7.29 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.627 -0.879 . . . . 72.43 108.627 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' B' ' 113' ' ' CYS . 81.1 t -123.42 146.35 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.638 0.775 . . . . 65.11 109.148 176.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.2 mt-30 -123.58 96.17 4.87 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.405 -0.961 . . . . 64.21 108.405 169.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.0 tp-100 -86.47 99.52 11.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.503 -0.925 . . . . 74.15 108.503 174.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.23 167.96 33.34 Favored Glycine 0 C--O 1.244 0.734 0 N-CA-C 110.906 -0.877 . . . . 42.44 110.906 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.19 125.46 1.42 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 112.299 -0.32 . . . . 74.11 112.299 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 53.0 mt -85.85 128.91 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.02 0.928 . . . . 70.52 108.982 172.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -134.62 158.87 42.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.617 1.167 . . . . 74.42 108.366 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.6 m -131.83 129.26 40.23 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.854 -0.795 . . . . 63.41 108.854 171.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 13.9 tt -139.9 145.54 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.093 0.557 . . . . 55.11 110.686 -175.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.17 164.24 34.54 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.45 1.1 . . . . 70.21 109.162 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.21 -25.23 15.3 Favored Glycine 0 N--CA 1.475 1.264 0 CA-C-O 121.039 0.244 . . . . 15.11 112.502 -175.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 17.3 tt -88.91 133.03 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.722 1.209 . . . . 72.34 111.849 -167.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -149.6 -176.47 5.42 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.193 1.397 . . . . 65.01 109.219 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.05 -134.11 27.01 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 114.897 -1.047 . . . . 61.32 113.162 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 61.0 m -73.39 -29.19 62.44 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.175 0.99 . . . . 74.25 111.417 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -57.96 -33.34 68.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.562 0.745 . . . . 64.11 111.863 -171.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 22.9 ptm -60.4 -39.84 88.78 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.705 0.802 . . . . 73.21 111.194 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.81 -32.45 59.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.834 0.854 . . . . 54.23 110.319 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -68.57 -28.3 66.84 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.014 -0.994 . . . . 72.55 111.303 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.498 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 48.9 t -75.4 -66.61 0.75 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.089 0.555 . . . . 74.2 110.162 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.95 -26.42 65.05 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.123 0.569 . . . . 73.3 111.967 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.87 -9.8 62.1 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-O 119.489 -0.617 . . . . 60.03 114.462 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.59 -56.21 0.13 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.818 0.809 . . . . 60.21 113.177 -167.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 92.7 t80 -67.6 -49.48 62.91 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.366 0.667 . . . . 72.32 111.899 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.486 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.1 m -61.96 -51.51 74.66 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.646 0.779 . . . . 74.2 111.604 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 89.0 Cg_exo -53.5 -35.34 75.97 Favored 'Trans proline' 0 C--N 1.4 3.262 0 C-N-CA 122.547 2.165 . . . . 64.4 114.332 172.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -58.63 -43.87 89.83 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 123.359 0.664 . . . . 63.23 110.612 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mt -59.71 -41.0 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.167 0.987 . . . . 73.31 110.912 177.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 46.9 mt -84.5 -17.05 40.29 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.236 1.014 . . . . 73.45 112.207 -172.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -58.83 -50.07 89.97 Favored Pre-proline 0 CA--C 1.556 1.182 0 N-CA-C 114.02 1.119 . . . . 73.35 114.02 -170.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.49 -34.33 92.95 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.03 1.82 . . . . 62.44 113.12 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.504 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 74.4 m-85 -65.69 -50.45 64.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.001 0.52 . . . . 74.4 110.091 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.16 81.47 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.818 0.847 . . . . 70.13 111.197 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.414 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 36.0 ttt180 -63.89 -53.5 49.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.409 1.483 . . . . 73.03 111.18 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.92 -38.43 90.96 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 123.874 0.734 . . . . 75.12 109.71 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.454 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.2 t -66.63 -36.66 83.11 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.511 -0.768 . . . . 71.32 111.958 -174.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.52 HD11 ' HB ' ' B' ' 62' ' ' VAL . 66.3 mt -62.11 -56.59 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 109.104 -0.702 . . . . 71.41 109.104 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.8 m -60.85 -25.61 66.78 Favored 'General case' 0 CA--C 1.556 1.21 0 O-C-N 124.334 1.021 . . . . 70.04 111.648 -173.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.9 t -68.3 -46.19 70.98 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.7 0.8 . . . . 75.11 110.261 175.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 7.9 mmt -72.54 -34.65 67.69 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.89 0.476 . . . . 74.12 111.063 -177.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 114' ' ' ILE . 93.8 t -57.53 -44.22 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.231 1.013 . . . . 73.42 109.567 171.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.5 t -70.74 -30.88 67.53 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.427 -1.26 . . . . 72.51 112.07 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' B' ' 116' ' ' SER . 89.1 mtt-85 -69.8 -36.03 75.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.983 0.513 . . . . 63.1 110.036 177.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.64 1.95 84.34 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.592 0.558 . . . . 54.52 112.559 171.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 26.7 p 62.18 30.77 17.75 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.687 1.995 . . . . 73.24 113.0 172.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -85.16 155.05 60.63 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.667 0.787 . . . . 74.2 110.095 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.533 ' HB2' ' HG2' ' B' ' 37' ' ' GLN . 48.0 Cg_exo -57.15 168.82 2.38 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.231 2.621 . . . . 74.1 114.537 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.417 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 63.9 tp60 -56.85 133.42 54.44 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.573 1.149 . . . . 75.14 112.065 -172.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.47 102.48 6.65 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.269 -1.012 . . . . 53.13 108.269 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.53 101.31 12.21 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.611 0.764 . . . . 74.5 109.553 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.414 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 0.2 OUTLIER -61.28 129.35 40.83 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 109.259 -0.645 . . . . 71.23 109.259 179.451 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.684 ' HB3' ' SD ' ' F' ' 464' ' ' MET . . . -77.64 152.13 80.47 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 123.625 0.77 . . . . 64.55 111.941 -173.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.426 ' HG2' ' HB ' ' D' ' 13' ' ' ILE . 6.2 Cg_endo -81.26 109.69 2.16 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.25 2.633 . . . . 50.23 112.137 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 t -115.06 112.4 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.19 -0.67 . . . . 61.01 109.19 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' B' ' 136' ' ' LEU . 56.2 t-20 -85.24 112.85 21.12 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.905 -0.776 . . . . 74.4 108.905 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -89.86 -27.47 19.9 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.01 0.744 . . . . 72.21 113.01 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -73.77 -42.71 60.68 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 118.602 0.637 . . . . 73.42 111.416 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.2 89.25 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.542 0.737 . . . . 60.15 110.307 172.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' B' ' 132' ' ' ASN . 0.9 OUTLIER -68.78 -33.5 73.98 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.079 0.951 . . . . 75.32 110.25 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.522 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 80.3 t80 -60.69 -35.57 76.61 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.429 0.692 . . . . 74.34 110.767 -175.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 23.4 mmt -62.24 -36.88 83.37 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.044 0.449 . . . . 75.52 111.242 176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -76.28 -29.43 57.4 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.79 0.836 . . . . 72.3 111.017 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -60.13 -32.1 70.69 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.39 1.076 . . . . 75.34 110.965 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 7.0 mt -89.02 11.19 19.0 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.9 0.88 . . . . 72.35 110.864 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 61.85 19.44 10.64 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.071 1.348 . . . . 74.11 111.953 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -85.46 135.09 33.99 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.966 0.507 . . . . 74.31 110.695 -176.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -116.4 105.13 12.17 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.478 -1.304 . . . . 70.12 107.478 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.11 123.91 14.08 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.691 1.196 . . . . 61.21 111.004 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.47 76.2 0.51 Allowed Glycine 0 C--N 1.351 1.385 0 O-C-N 123.958 0.786 . . . . 23.14 112.776 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -164.05 63.55 0.15 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.909 1.284 . . . . 74.14 108.999 -175.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.13 56.84 4.86 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.468 -0.787 . . . . 52.35 112.094 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 5.7 t -116.34 132.97 56.52 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.637 1.175 . . . . 55.42 108.564 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -169.34 158.96 8.42 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.273 -0.64 . . . . 74.33 109.273 -171.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.35 151.74 44.91 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.668 0.747 . . . . 73.35 110.595 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -126.94 4.84 6.54 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.657 -1.156 . . . . 72.32 108.691 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -162.78 149.96 13.25 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 125.034 1.334 . . . . 72.3 108.307 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -74.68 86.77 2.16 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.731 0.776 . . . . 75.15 109.713 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.854 0 CA-C-N 115.541 -0.754 . . . . 44.42 109.491 179.115 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 35.1 ttm . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 108.907 -0.775 . . . . 60.34 108.907 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.1 p -111.6 83.84 1.85 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 107.877 -1.157 . . . . 64.42 107.877 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -102.47 -27.23 12.91 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.849 -1.069 . . . . 73.34 111.719 -169.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -149.31 110.35 4.36 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.252 0.621 . . . . 74.2 109.632 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -152.37 146.63 25.49 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.452 1.101 . . . . 73.15 109.477 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 63.52 15.17 8.62 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.051 1.34 . . . . 73.33 112.837 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 32.2 p -74.31 100.07 3.65 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.605 0.762 . . . . 74.12 109.1 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.55 87.96 0.67 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.851 0.86 . . . . 63.14 111.018 -173.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 27.6 ttt 64.2 114.86 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.681 1.592 . . . . 71.51 112.648 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 90.9 m -101.88 99.67 9.9 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.93 -0.766 . . . . 72.12 108.93 171.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -94.31 140.83 29.29 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.535 -0.757 . . . . 74.35 109.387 175.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.63 136.05 15.92 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.536 -0.542 . . . . 65.11 109.536 172.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.14 127.84 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 108.517 -0.92 . . . . 74.51 108.517 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.497 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.8 mm-40 -89.8 -47.47 7.88 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.207 -0.664 . . . . 73.24 109.207 174.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -175.0 134.41 0.34 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.798 -0.637 . . . . 62.23 109.836 -170.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.432 ' HB ' HD21 ' A' ' 127' ' ' ASN . 84.8 mt -117.34 144.98 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.791 -1.189 . . . . 73.34 107.791 176.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.431 ' CE2' ' HG2' ' C' ' 19' ' ' LYS . 36.7 p90 -171.53 161.72 6.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.506 0.669 . . . . 73.24 111.301 -174.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.9 p -88.63 112.51 23.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.876 -1.157 . . . . 73.32 107.876 169.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' C' ' 17' ' ' TYR . 18.1 mttt -67.44 -48.97 65.67 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 122.24 1.019 . . . . 73.21 108.345 171.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.34 133.37 36.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 113.599 -1.637 . . . . 74.13 109.045 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 79.6 mt -124.49 141.31 45.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.692 -1.596 . . . . 60.53 106.692 172.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -153.92 147.61 25.27 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.398 0.618 . . . . 53.34 110.997 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 81.7 t80 -146.37 132.12 18.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 106.899 -1.519 . . . . 71.42 106.899 169.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -132.54 124.93 29.4 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.729 0.811 . . . . 73.14 109.35 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.41 79.87 29.03 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.06 -1.459 . . . . 54.31 107.06 172.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.72 -26.74 19.05 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.748 2.299 . . . . 71.14 111.569 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -102.43 17.6 23.16 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.283 1.033 . . . . 73.41 110.218 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.419 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -47.96 -59.63 5.53 Favored Pre-proline 0 C--N 1.371 1.512 0 N-CA-C 114.774 1.398 . . . . 62.4 114.774 -166.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 23.7 Cg_exo -61.14 -42.36 36.53 Favored 'Trans proline' 0 C--N 1.393 2.917 0 CA-C-N 121.834 1.691 . . . . 55.04 111.919 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -69.73 -33.16 72.1 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.402 -1.272 . . . . 71.13 112.232 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.699 HG21 ' HA ' ' C' ' 73' ' ' ALA . 5.0 p -79.43 -21.6 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 O-C-N 122.094 -0.379 . . . . 63.13 111.867 -176.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -69.83 -22.18 63.31 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.762 0.425 . . . . 61.14 111.742 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -97.29 19.46 13.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.671 0.388 . . . . 74.14 111.295 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.761 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.76 149.83 21.41 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.902 -0.777 . . . . 75.33 108.902 170.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -69.41 129.7 40.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.88 -0.785 . . . . 70.45 108.88 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.401 ' HZ2' HD22 ' G' ' 470' ' ' LEU . 82.6 t90 -68.51 109.72 3.85 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.165 0.586 . . . . 73.34 111.418 -172.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -163.08 70.19 1.93 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.948 0.899 . . . . 54.41 108.879 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -88.52 128.5 2.12 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.94 2.427 . . . . 62.3 112.818 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.442 ' HB3' ' HE2' ' C' ' 41' ' ' LYS . 26.4 mt-10 -84.68 94.96 8.76 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.381 -0.97 . . . . 74.11 108.381 168.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 m -74.7 99.17 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-N 114.419 -1.264 . . . . 64.53 110.314 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' C' ' 39' ' ' GLU . 73.4 mmtt -92.76 103.35 15.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.76 -1.109 . . . . 72.14 108.497 177.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.498 HD21 HG13 ' C' ' 62' ' ' VAL . 7.3 tt -95.04 136.71 35.03 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.913 -0.773 . . . . 74.22 108.913 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -118.4 112.73 20.37 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.253 1.421 . . . . 73.2 107.739 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.571 HD23 HD12 ' G' ' 460' ' ' LEU . 14.7 tp -104.14 133.96 48.2 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.926 -0.768 . . . . 75.11 108.926 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.4 t70 -140.47 149.33 42.4 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.045 0.938 . . . . 70.24 109.153 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.524 ' O ' ' HB3' ' G' ' 457' ' ' GLN . 7.9 m -132.57 130.36 40.21 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 123.505 0.722 . . . . 64.22 109.301 169.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.37 153.23 26.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.933 1.293 . . . . 71.22 108.241 175.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 17.8 p -149.85 140.92 22.97 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.711 -0.477 . . . . 74.4 109.711 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -161.16 150.81 16.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.878 0.871 . . . . 73.31 109.453 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -86.08 132.7 33.98 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.936 -0.394 . . . . 73.1 109.936 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.559 HD11 HD12 ' C' ' 83' ' ' ILE . 50.0 mt -98.88 -38.41 9.04 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.426 0.69 . . . . 74.32 109.269 173.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.63 178.0 10.77 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.229 1.012 . . . . 70.52 109.635 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.89 123.17 17.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.94 0.496 . . . . 73.34 109.891 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 71.38 -8.77 0.98 Allowed 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 126.316 1.846 . . . . 72.05 113.311 -173.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -95.27 97.5 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.77 -0.826 . . . . 61.53 108.77 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.611 ' HE1' ' HA ' ' G' ' 452' ' ' VAL . 0.2 OUTLIER -105.66 124.54 49.72 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.132 -0.692 . . . . 72.41 109.132 -179.227 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.43 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.4 tt0 -90.16 135.4 33.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.163 0.585 . . . . 74.1 109.715 173.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.34 141.34 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.502 1.121 . . . . 73.35 107.979 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.7 t -127.49 129.27 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 107.662 -1.236 . . . . 74.21 107.662 172.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.17 102.81 11.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.575 -1.269 . . . . 73.01 107.575 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -84.22 127.83 34.19 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.037 -0.983 . . . . 74.41 108.388 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.498 HG13 HD21 ' C' ' 42' ' ' LEU . 40.9 t -124.45 121.06 60.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 107.123 -1.436 . . . . 75.23 107.123 168.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 9.5 m -124.98 115.36 20.44 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.479 -0.563 . . . . 71.14 109.479 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.413 HG23 HD13 ' C' ' 114' ' ' ILE . 81.2 t -99.92 107.96 21.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.298 -1.001 . . . . 62.33 108.298 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 55.6 m -96.18 139.82 31.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.276 -1.75 . . . . 73.54 106.276 169.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.75 116.19 11.99 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.527 -1.286 . . . . 63.12 107.527 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.6 m -127.08 168.39 14.67 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.031 -0.729 . . . . 70.53 109.031 175.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.761 HD13 ' HG2' ' C' ' 34' ' ' LYS . 5.6 mt -123.47 21.41 9.43 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.535 1.134 . . . . 53.3 109.004 -174.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.72 -99.76 1.0 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.66 -1.376 . . . . 64.42 109.66 -166.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -90.89 -31.62 16.35 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.418 0.687 . . . . 74.15 110.64 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -85.36 120.17 26.54 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.059 0.943 . . . . 63.53 110.875 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 40.5 m -73.55 125.78 28.76 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.744 -0.465 . . . . 63.54 109.744 170.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.699 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.0 -61.86 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.091 0.869 . . . . 41.23 109.003 171.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . 0.476 ' HZ ' HD21 ' C' ' 126' ' ' LEU . 54.6 p90 -164.86 176.08 9.03 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.708 0.766 . . . . 71.23 111.739 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -130.41 144.77 51.6 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 106.508 -1.664 . . . . 74.24 106.508 168.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.456 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.8 t -152.47 111.65 3.86 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.085 -0.709 . . . . 64.42 109.085 174.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.69 133.86 55.5 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.822 -0.436 . . . . 62.35 109.822 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 56.1 t -124.95 135.05 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.735 0.814 . . . . 63.2 108.846 168.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -111.99 90.4 3.33 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.835 -1.172 . . . . 64.15 107.835 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.05 96.59 6.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.427 -0.806 . . . . 65.41 109.403 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.63 146.8 20.92 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.218 -0.753 . . . . 73.05 111.218 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.527 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.36 117.5 0.85 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.312 -1.115 . . . . 72.22 110.312 -175.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.559 HD12 HD11 ' C' ' 51' ' ' LEU . 10.7 mm -82.88 126.54 40.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 107.714 -1.217 . . . . 72.42 107.714 176.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -133.13 121.28 22.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.481 0.713 . . . . 74.44 109.378 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.6 p -85.24 111.07 19.51 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.204 -0.665 . . . . 63.15 109.204 174.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 49.4 pt -114.68 141.17 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.088 0.955 . . . . 71.4 108.975 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -144.95 164.42 31.19 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.399 0.68 . . . . 24.23 110.004 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.75 -55.8 0.72 Allowed Glycine 0 C--N 1.341 0.82 0 O-C-N 123.512 0.508 . . . . 60.11 113.137 172.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.48 170.52 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 112.577 0.584 . . . . 72.43 112.577 -173.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.484 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 17.1 pt-20 -151.97 -172.64 4.28 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.941 0.897 . . . . 70.55 109.819 172.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.49 -137.92 16.96 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-O 119.338 -0.701 . . . . 42.13 113.231 172.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 25.3 p -63.49 -33.58 75.89 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.895 0.878 . . . . 53.22 111.402 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -59.65 -48.53 81.32 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.242 1.017 . . . . 71.04 110.064 176.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.484 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 35.8 ttp -72.97 -30.09 63.57 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.613 -1.176 . . . . 74.31 110.845 176.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.58 -35.13 73.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.912 0.485 . . . . 74.12 110.23 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -78.67 -33.16 47.26 Favored 'General case' 0 C--O 1.242 0.702 0 O-C-N 123.693 0.621 . . . . 63.33 111.827 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 39.8 t -57.23 -39.28 75.18 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.412 0.445 . . . . 31.2 110.442 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.8 mt -95.21 -19.54 19.96 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.794 0.837 . . . . 71.13 110.348 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.99 -29.4 54.32 Favored Glycine 0 C--N 1.349 1.252 0 C-N-CA 123.559 0.6 . . . . 73.42 114.036 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.03 -41.94 0.08 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.601 0.593 . . . . 55.34 112.601 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -61.85 -57.54 11.4 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.222 0.609 . . . . 72.11 111.961 -173.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 97.0 m -66.64 -46.6 57.35 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.927 0.891 . . . . 54.12 112.45 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.58 -35.92 69.14 Favored 'Trans proline' 0 C--N 1.401 3.328 0 C-N-CA 122.428 2.085 . . . . 75.53 113.388 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -67.75 -35.65 79.09 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.763 0.825 . . . . 64.42 110.463 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.41 HD12 ' NH1' ' A' ' 111' ' ' ARG . 46.8 mm -63.73 -39.5 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 122.863 0.465 . . . . 70.4 109.995 174.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.527 HD21 ' HA3' ' C' ' 82' ' ' GLY . 83.2 mt -85.78 -22.82 27.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.098 0.959 . . . . 74.43 112.847 -173.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -60.29 -46.59 97.69 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 124.984 1.314 . . . . 74.52 113.787 -172.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.614 ' HA ' ' HD3' ' C' ' 111' ' ' ARG . 35.2 Cg_exo -63.55 -34.53 63.95 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 122.307 2.005 . . . . 73.31 113.463 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -67.49 -44.59 78.15 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.752 0.421 . . . . 75.43 110.142 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.37 78.49 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 115.285 -0.871 . . . . 61.24 110.891 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.744 ' HG2' ' HG ' ' C' ' 128' ' ' LEU . 21.3 mtp-105 -56.88 -62.32 1.82 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.784 0.833 . . . . 65.42 110.707 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -64.51 -30.13 71.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.243 0.617 . . . . 71.43 111.286 -172.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.5 t -74.07 -32.85 63.46 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.073 0.549 . . . . 64.31 111.502 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.44 HG23 ' SG ' ' C' ' 76' ' ' CYS . 66.4 mt -73.71 -49.81 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.274 0.63 . . . . 74.22 109.846 172.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 90.6 m -57.26 -37.79 72.88 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.343 1.057 . . . . 75.34 111.407 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -63.72 -48.07 78.54 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.34 -0.846 . . . . 75.21 109.622 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.674 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.59 -37.89 88.0 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.617 1.167 . . . . 65.13 112.991 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.445 HG21 HD11 ' C' ' 126' ' ' LEU . 78.5 t -68.36 -43.28 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.657 0.783 . . . . 72.44 110.611 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -66.19 -30.42 70.89 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 115.018 -0.992 . . . . 72.34 110.604 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -71.86 -34.29 69.1 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 123.69 0.796 . . . . 63.31 109.455 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.69 5.58 77.8 Favored Glycine 0 C--N 1.353 1.484 0 O-C-N 123.73 0.644 . . . . 74.12 113.04 174.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.451 HG23 ' HB3' ' D' ' 17' ' ' TYR . 75.5 p 60.62 23.36 13.13 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.524 1.93 . . . . 72.21 113.974 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.444 ' HB2' HG13 ' C' ' 118' ' ' VAL . 90.1 m-85 -85.06 156.56 60.41 Favored Pre-proline 0 CA--C 1.555 1.145 0 N-CA-C 108.739 -0.837 . . . . 64.02 108.739 170.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.11 155.35 40.05 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.195 2.597 . . . . 53.2 113.129 -176.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.417 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 52.3 mm-40 -60.13 131.39 50.68 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.978 0.911 . . . . 75.12 112.017 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.523 ' HB3' ' HG ' ' G' ' 470' ' ' LEU . 2.9 pp -144.67 126.82 15.63 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.819 0.848 . . . . 71.34 108.809 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -127.7 124.88 38.95 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.537 -1.653 . . . . 63.32 106.537 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.744 ' HG ' ' HG2' ' C' ' 111' ' ' ARG . 0.0 OUTLIER -75.82 130.12 38.08 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.475 -0.565 . . . . 71.5 109.475 -171.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.57 154.39 93.31 Favored Pre-proline 0 CA--C 1.551 1.001 0 O-C-N 124.726 1.266 . . . . 72.31 112.589 -170.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.443 ' HG2' HG21 ' A' ' 13' ' ' ILE . 7.6 Cg_exo -68.79 115.2 3.83 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.372 2.048 . . . . 73.01 111.749 175.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 51.0 t -99.12 134.28 38.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.084 -1.45 . . . . 62.21 107.084 168.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -73.65 73.34 1.49 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.219 0.608 . . . . 65.23 110.358 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -60.75 -39.63 89.45 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.448 0.699 . . . . 74.21 110.656 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' C' ' 138' ' ' MET . 10.7 m-20 -61.61 -49.36 76.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.299 -0.864 . . . . 71.14 111.606 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.49 87.67 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.88 0.737 . . . . 54.2 111.183 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.434 ' HB2' ' HE1' ' G' ' 461' ' ' PHE . 93.8 mt -67.71 -34.8 77.6 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.543 -0.753 . . . . 74.41 111.894 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -79.72 -22.01 43.86 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.663 0.385 . . . . 61.04 110.677 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 66.1 mtt -65.54 -26.54 67.93 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.361 0.664 . . . . 74.21 110.921 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -63.45 -37.79 88.66 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.53 0.732 . . . . 54.21 111.177 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -56.02 -81.0 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.025 0.93 . . . . 74.11 110.674 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 2.3 pp -67.8 -179.6 1.19 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.385 0.674 . . . . 64.52 111.668 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.86 159.3 37.0 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.969 0.508 . . . . 73.11 110.227 176.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.68 -179.73 7.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.884 0.874 . . . . 73.43 110.312 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -146.05 156.17 43.29 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.102 0.961 . . . . 73.24 108.967 171.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.99 147.8 11.55 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.635 0.774 . . . . 63.5 110.015 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.0 60.49 0.48 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.94 -0.464 . . . . 60.43 111.94 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.04 135.54 47.31 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.265 -1.013 . . . . 71.13 108.265 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 169.5 43.13 0.03 OUTLIER Glycine 0 C--N 1.338 0.679 0 N-CA-C 111.066 -0.814 . . . . 72.41 111.066 176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.1 t -139.94 132.95 29.46 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.165 0.586 . . . . 71.52 109.969 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.481 ' HB3' ' NE2' ' A' ' 142' ' ' GLN . 0.1 OUTLIER -158.29 -172.04 3.72 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.355 1.062 . . . . 62.32 109.498 178.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -157.71 112.88 2.72 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.046 -0.724 . . . . 73.24 109.046 172.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -73.57 86.98 1.61 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.974 -0.75 . . . . 71.04 108.974 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -107.69 101.18 10.5 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.331 -0.618 . . . . 74.41 109.331 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -149.51 104.97 3.41 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.46 -0.941 . . . . 64.32 108.46 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 C-N-CA 123.892 0.877 . . . . 74.35 110.011 -179.156 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.823 -0.436 . . . . 74.23 109.823 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 42.0 p -167.95 112.79 0.66 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.31 1.044 . . . . 64.43 109.631 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -66.4 114.78 5.68 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.473 -0.566 . . . . 54.21 109.473 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -172.33 -76.91 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.012 0.925 . . . . 74.21 108.59 -173.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . 0.415 ' H ' ' H ' ' D' ' 6' ' ' ASN . 2.5 p-10 -168.96 0.91 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.12 1.768 . . . . 61.43 108.744 173.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.415 ' H ' ' H ' ' D' ' 5' ' ' ASN . 5.4 t30 -61.41 152.26 30.19 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 124.249 1.02 . . . . 71.11 108.948 167.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 19.2 m -65.38 88.34 0.08 Allowed 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 121.442 0.639 . . . . 71.35 112.285 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -98.29 -13.66 20.64 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.501 1.12 . . . . 65.3 108.394 166.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.9 tpt -28.44 126.42 0.09 Allowed 'General case' 0 C--N 1.37 1.472 0 C-N-CA 127.318 2.247 . . . . 71.24 113.663 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 61.6 m -129.23 138.79 51.89 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.676 0.79 . . . . 62.52 111.066 -173.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -154.47 93.01 1.55 Allowed 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.579 -1.637 . . . . 74.51 106.579 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -113.23 126.87 55.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.177 -0.675 . . . . 71.42 109.177 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.426 ' HB ' ' HG2' ' B' ' 130' ' ' PRO . 10.2 mt -87.56 119.87 35.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.062 -1.088 . . . . 74.3 108.062 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -85.62 -28.52 24.72 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 123.643 0.589 . . . . 60.43 111.125 -175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -172.4 121.03 0.42 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 110.399 -0.223 . . . . 52.23 110.399 -166.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.4 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.2 mp -106.02 133.49 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 107.328 -1.36 . . . . 74.05 107.328 169.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.451 ' HB3' HG23 ' C' ' 122' ' ' THR . 42.6 p90 -162.63 174.18 12.93 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 122.007 0.908 . . . . 75.44 112.045 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . 0.511 HG21 HD11 ' D' ' 21' ' ' ILE . 74.9 p -104.57 124.18 48.86 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.188 -1.369 . . . . 65.43 109.188 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 36.4 mtpt -93.86 -18.49 21.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.418 0.687 . . . . 53.24 109.559 177.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.7 t70 -162.12 135.17 6.06 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 124.377 1.071 . . . . 73.52 108.989 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.674 HD13 ' HE3' ' C' ' 117' ' ' MET . 86.8 mt -136.16 133.86 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.602 1.161 . . . . 64.22 108.076 176.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 57.8 m -137.59 113.46 9.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.413 1.085 . . . . 64.4 109.655 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.521 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 83.8 t80 -116.82 117.12 28.86 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.353 -1.721 . . . . 72.35 106.353 163.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.4 mt-10 -126.3 111.33 14.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.422 0.689 . . . . 72.01 109.357 -175.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.17 87.31 7.17 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.272 -1.01 . . . . 71.25 108.272 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -75.54 -32.61 4.67 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.7 2.267 . . . . 72.31 113.01 -171.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 44.6 m-20 -100.42 9.09 43.11 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.557 0.743 . . . . 71.43 110.161 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.434 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -28.06 -69.79 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 116.18 1.919 . . . . 72.12 116.18 -161.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.405 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 68.4 Cg_endo -77.41 -19.6 13.08 Favored 'Trans proline' 0 C--N 1.383 2.353 0 CA-C-N 123.558 2.306 . . . . 70.22 113.765 -174.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.504 ' HA ' HE21 ' D' ' 33' ' ' GLN . 5.9 t-160 -70.18 -43.07 71.54 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.366 1.066 . . . . 52.34 109.13 173.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.567 HG21 ' HA ' ' D' ' 73' ' ' ALA . 6.3 p -84.28 -15.65 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.81 0.844 . . . . 71.32 111.398 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.405 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.8 m-85 -70.4 -19.69 62.99 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 120.784 0.325 . . . . 54.34 111.38 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.504 HE21 ' HA ' ' D' ' 30' ' ' HIS . 43.1 mt-30 -72.66 -12.44 61.04 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.413 -0.812 . . . . 71.31 111.069 176.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -83.26 84.51 7.47 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.208 1.003 . . . . 64.01 108.885 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -77.46 80.43 3.95 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.457 0.646 . . . . 71.21 109.282 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -156.23 163.8 39.12 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.501 -1.227 . . . . 73.24 108.842 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.474 ' NE2' HD21 ' D' ' 126' ' ' LEU . 23.7 tp60 -89.99 108.18 24.23 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.204 1.002 . . . . 74.12 109.65 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.419 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 34.8 Cg_exo -59.85 158.09 30.51 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 123.329 2.686 . . . . 73.34 114.302 -174.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.581 ' HB2' ' HB3' ' H' ' 470' ' ' LEU . 8.7 tp10 -79.82 157.31 27.06 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.356 1.062 . . . . 74.45 110.736 177.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.83 118.47 57.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.178 -0.675 . . . . 73.22 109.178 172.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -117.65 114.04 22.79 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.819 0.847 . . . . 51.03 108.832 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.35 126.33 43.82 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.113 0.565 . . . . 72.41 111.034 -172.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -124.97 120.09 30.6 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.959 1.304 . . . . 65.52 107.654 170.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt -110.95 146.03 37.33 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.728 0.411 . . . . 73.33 110.093 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 34.5 t70 -147.82 151.5 36.07 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.651 1.18 . . . . 75.51 108.342 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -132.16 163.73 27.88 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.735 0.414 . . . . 75.3 110.432 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.673 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.93 175.21 13.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.371 1.068 . . . . 60.1 109.512 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.578 ' HB3' HD21 ' D' ' 98' ' ' LEU . 50.5 p -168.5 157.25 8.69 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.81 0.844 . . . . 61.33 110.573 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 88.5 p -153.2 154.56 34.95 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.962 0.905 . . . . 72.11 109.038 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -94.59 116.97 29.4 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.728 -0.842 . . . . 75.22 108.728 170.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 42.7 mt -93.38 -30.01 15.32 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 110.02 -0.363 . . . . 73.44 110.02 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.83 -174.84 4.1 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.444 0.698 . . . . 72.42 111.2 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -67.09 116.47 7.94 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.661 -1.154 . . . . 71.44 109.455 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 66.02 5.5 3.56 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.867 1.267 . . . . 73.12 112.567 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 78.8 t -110.18 120.05 60.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 108.545 -0.909 . . . . 75.35 108.545 176.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -135.26 131.27 36.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.752 -0.833 . . . . 73.52 108.752 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -89.81 148.01 23.46 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.698 0.799 . . . . 63.35 109.355 173.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.8 t -125.49 139.87 50.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 124.737 1.215 . . . . 74.23 107.867 170.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.673 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 77.8 t -118.69 135.37 59.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.282 -1.007 . . . . 73.32 108.282 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 121.01 39.39 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.785 -0.82 . . . . 74.54 108.785 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 24.8 ttm-85 -103.38 96.0 6.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.048 -1.093 . . . . 64.22 108.048 176.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 74.5 t -97.81 119.0 45.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.295 -1.002 . . . . 52.11 108.295 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 14.2 m -119.77 129.87 54.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.846 -1.07 . . . . 55.33 108.541 -172.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 67.2 t -122.47 128.97 75.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 124.837 1.255 . . . . 73.24 108.261 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 95.9 m -122.34 120.63 34.58 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.199 -1.037 . . . . 63.21 108.199 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.71 151.94 39.95 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.472 -0.785 . . . . 75.31 110.08 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.463 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 19.7 p -149.6 125.37 10.47 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.293 -0.867 . . . . 65.41 109.368 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 12.0 mt -92.83 114.21 26.7 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.221 1.008 . . . . 74.31 108.931 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.92 -110.1 2.94 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.966 -0.854 . . . . 75.01 110.966 -174.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 5.94 8.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.013 0.925 . . . . 74.42 110.844 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -123.02 155.41 36.91 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.539 0.736 . . . . 74.32 109.788 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -60.51 129.98 44.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.851 0.86 . . . . 75.41 111.979 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.567 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.96 -72.74 0.55 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.756 -1.201 . . . . 72.04 107.756 176.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -145.57 146.36 31.36 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.216 -0.902 . . . . 73.4 110.217 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.7 mt -114.34 143.58 44.65 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.534 1.134 . . . . 73.45 108.134 175.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.551 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 23.7 m -142.09 137.49 31.03 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.832 0.853 . . . . 72.23 109.232 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -154.41 121.0 5.45 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.799 -1.186 . . . . 72.44 107.799 170.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.7 t -130.8 115.23 29.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.684 -0.858 . . . . 63.02 108.684 -175.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -88.49 85.37 6.84 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.431 -0.952 . . . . 72.21 108.431 172.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -78.61 96.77 5.58 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.248 -1.342 . . . . 62.24 108.771 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.85 143.12 17.4 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 115.827 -0.624 . . . . 74.43 111.867 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -140.75 129.64 4.22 Favored Glycine 0 C--N 1.329 0.187 0 N-CA-C 110.685 -0.966 . . . . 72.53 110.685 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.0 mt -90.15 129.43 41.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.321 -0.992 . . . . 73.14 108.321 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -128.92 153.46 47.49 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.71 0.404 . . . . 74.15 111.06 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -114.88 105.65 13.25 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.806 1.242 . . . . 65.23 108.097 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.35 122.76 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.125 0.57 . . . . 52.31 110.305 -175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.08 141.94 24.67 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.316 1.046 . . . . 34.42 108.48 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.94 -20.13 29.35 Favored Glycine 0 N--CA 1.468 0.825 0 O-C-N 123.116 0.26 . . . . 60.02 112.59 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 32.9 pt -131.95 147.0 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.414 0.686 . . . . 74.44 109.17 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.07 163.48 33.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.807 0.843 . . . . 73.51 111.317 -176.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.64 -127.52 31.37 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.173 -0.921 . . . . 65.14 114.264 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.1 m -74.32 -30.63 62.14 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.192 0.997 . . . . 74.12 111.135 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -65.46 -34.83 79.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.32 0.648 . . . . 75.34 109.977 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.676 ' HG3' HG12 ' H' ' 451' ' ' VAL . 1.2 tmt? -83.62 -26.17 30.18 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.534 -0.757 . . . . 71.12 110.817 175.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.08 -23.16 67.09 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.86 0.362 . . . . 52.02 110.612 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -70.48 -43.6 69.42 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.672 0.789 . . . . 72.34 110.557 168.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -63.59 -46.83 84.03 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.933 0.493 . . . . 63.14 110.966 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' D' ' 48' ' ' SER . 7.3 tt -77.2 -46.26 23.88 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.838 0.855 . . . . 72.21 109.785 -175.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.37 -12.69 83.58 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.83 -0.623 . . . . 71.34 114.149 -172.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.49 -61.03 0.65 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.424 0.612 . . . . 74.4 112.546 -172.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -67.06 -39.7 86.95 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 112.639 0.607 . . . . 75.14 112.639 -172.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.445 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 97.7 m -68.91 -48.94 28.15 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 118.547 -0.739 . . . . 71.25 111.086 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 71.0 Cg_exo -55.74 -35.11 92.81 Favored 'Trans proline' 0 C--N 1.399 3.209 0 C-N-CA 122.413 2.075 . . . . 65.5 113.169 168.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -63.36 -37.37 87.02 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.338 0.655 . . . . 74.25 110.276 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.5 mm -67.58 -43.42 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.664 0.786 . . . . 64.35 110.703 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' D' ' 82' ' ' GLY . 95.1 mt -75.08 -16.71 60.55 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.382 -0.826 . . . . 72.24 111.809 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -69.64 -43.08 21.07 Favored Pre-proline 0 CA--C 1.56 1.334 0 CA-C-O 118.209 -0.9 . . . . 73.43 113.274 -170.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -53.15 -44.74 46.37 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.2 1.934 . . . . 74.52 112.964 168.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.49 -36.09 76.19 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.665 0.786 . . . . 71.05 111.817 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.94 -54.66 31.11 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.49 0.716 . . . . 55.14 109.678 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -49.56 -49.46 46.28 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 125.068 1.48 . . . . 65.44 111.038 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -64.79 -44.0 91.39 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 124.132 0.895 . . . . 55.21 111.608 -173.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 37.0 t -60.33 -43.7 96.18 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.511 0.507 . . . . 75.44 110.717 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.493 HG21 HG21 ' D' ' 64' ' ' VAL . 77.3 mt -59.42 -56.97 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.399 1.08 . . . . 74.02 110.057 173.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.3 m -59.07 -35.35 73.22 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.205 1.402 . . . . 61.12 112.053 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -69.27 -43.85 73.06 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.643 -0.708 . . . . 72.44 109.753 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 72.3 mtm -67.38 -31.82 72.3 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.974 0.51 . . . . 64.05 111.875 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.477 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.6 t -62.69 -45.37 98.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.976 0.91 . . . . 72.53 110.334 175.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.8 p -73.59 -32.08 63.93 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 116.126 -0.488 . . . . 44.05 111.136 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -70.67 -31.78 68.82 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.633 0.773 . . . . 72.55 110.509 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.06 8.84 76.96 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-N 115.491 -0.777 . . . . 73.42 112.419 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 28.3 p 63.94 18.45 11.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.494 1.918 . . . . 74.54 114.231 171.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.82 147.69 49.28 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.198 0.599 . . . . 74.01 109.446 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.42 124.07 13.43 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.358 2.705 . . . . 72.42 112.932 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -61.86 130.09 44.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.955 1.302 . . . . 61.23 112.092 -173.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.474 HD21 ' NE2' ' D' ' 37' ' ' GLN . 71.2 mt -119.09 112.5 19.62 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.015 0.926 . . . . 60.04 109.12 -176.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -100.79 103.06 14.27 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.749 -0.834 . . . . 70.12 108.749 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 29.2 tp -68.91 135.85 51.67 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.679 -1.146 . . . . 70.33 112.053 -169.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.31 135.9 93.46 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 122.989 0.516 . . . . 61.24 110.428 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -64.04 136.41 52.23 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.719 2.279 . . . . 75.44 111.925 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.85 123.19 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.563 0.745 . . . . 64.34 109.211 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -82.66 92.59 7.19 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.954 -0.758 . . . . 43.12 108.954 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -67.23 -35.76 80.26 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.982 -0.554 . . . . 70.23 110.555 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.62 -53.51 57.25 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.575 1.15 . . . . 71.41 112.789 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.82 93.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.116 0.566 . . . . 35.42 110.973 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' D' ' 139' ' ' ASN . 33.4 tp -76.2 -17.77 59.37 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.592 -0.731 . . . . 64.54 111.951 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.428 ' O ' HD13 ' D' ' 141' ' ' LEU . 89.8 t80 -64.48 -40.42 95.64 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.398 -0.593 . . . . 74.14 109.398 171.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 30.8 mtt -68.39 -37.01 79.99 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.999 -1.0 . . . . 75.13 109.981 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.421 ' HB2' HD12 ' D' ' 136' ' ' LEU . 2.5 m-20 -69.64 -34.17 73.64 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.36 -0.836 . . . . 71.34 110.661 176.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -69.22 -40.66 77.83 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.412 0.685 . . . . 71.22 111.059 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.428 HD13 ' O ' ' D' ' 137' ' ' PHE . 6.4 mp -63.73 -30.86 71.91 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.399 0.68 . . . . 75.1 111.911 -177.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -91.67 18.09 7.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.926 0.49 . . . . 75.43 111.841 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 30.6 mm-40 -119.01 90.5 3.35 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.9 0.88 . . . . 74.32 109.114 176.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.5 113.07 6.29 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 106.112 -1.81 . . . . 75.02 106.112 175.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.5 87.45 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.092 0.957 . . . . 51.03 111.397 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.44 -171.34 23.77 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 111.014 -0.834 . . . . 65.21 111.014 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -166.76 117.88 0.94 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.032 0.533 . . . . 72.25 110.037 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.54 152.27 37.26 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.647 0.592 . . . . 45.13 111.851 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 35.9 p -66.93 154.35 41.28 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.874 0.87 . . . . 73.5 111.553 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -57.05 136.73 56.33 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.646 1.179 . . . . 72.14 112.373 -175.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -110.29 66.59 0.63 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.625 0.77 . . . . 74.1 109.632 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -66.74 97.75 0.48 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.538 -0.755 . . . . 72.43 109.756 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.48 179.39 5.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.978 0.911 . . . . 71.43 109.596 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -134.71 84.03 2.07 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.664 -0.865 . . . . 73.3 108.664 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.887 0 C-N-CA 123.993 0.917 . . . . 44.51 109.26 -179.658 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 53.0 t30 . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 108.993 -0.743 . . . . 73.11 108.993 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 65.5 t -90.91 -31.3 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 115.351 -0.84 . . . . 75.42 109.396 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 31.3 m -54.53 144.97 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.203 1.001 . . . . 74.21 113.229 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -140.86 -40.9 0.08 OUTLIER Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.171 -0.922 . . . . 71.13 111.378 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 1.5 tt 66.01 99.33 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.062 1.345 . . . . 74.42 109.861 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 71.8 p -75.98 168.62 19.7 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.277 0.631 . . . . 74.34 110.162 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -58.88 115.66 3.26 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.24 0.616 . . . . 65.31 109.514 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -63.04 100.77 0.23 Allowed 'General case' 0 C--N 1.353 0.723 0 CA-C-O 121.598 0.713 . . . . 74.12 109.412 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 21.7 m -61.35 148.74 40.42 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 114.812 -1.085 . . . . 72.54 110.32 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -51.13 147.65 5.19 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.504 0.722 . . . . 70.14 109.972 174.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . 0.735 HD21 ' H ' ' A' ' 46' ' ' THR . 4.0 mm? -65.05 126.04 26.79 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.972 0.891 . . . . 72.42 112.849 -166.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . 0.567 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 3.2 p90 -70.58 -3.97 20.8 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.308 -1.769 . . . . 73.14 112.165 170.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -60.45 98.0 0.06 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 124.029 0.932 . . . . 75.01 109.722 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 14.7 p -121.14 61.35 0.91 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.018 1.327 . . . . 63.21 109.372 -176.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 50.9 ttp -154.01 105.58 2.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.514 -1.221 . . . . 62.44 108.72 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -82.63 84.7 7.19 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.407 -0.96 . . . . 74.05 108.407 172.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -77.7 72.34 4.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.754 0.822 . . . . 65.2 109.858 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 40' ' ' VAL . . . -96.69 115.27 27.15 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.328 -0.851 . . . . 60.01 109.048 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.91 -38.25 90.21 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.656 0.598 . . . . 70.5 110.938 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . 64.92 65.52 2.91 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.451 -0.795 . . . . 72.42 111.852 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . 0.487 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . 90.8 mt -64.01 113.91 3.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.553 0.741 . . . . 63.25 109.465 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . 0.704 ' HE3' HE21 ' A' ' 37' ' ' GLN . 23.3 tptm . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.439 -0.791 . . . . 73.41 109.394 -170.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.219 0.533 . . . . 60.15 109.843 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.29 -3.78 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.656 1.183 . . . . 74.45 111.602 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 35.5 m -101.83 165.55 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.054 0.942 . . . . 63.03 111.383 -177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 151.67 173.28 21.29 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 116.22 -0.446 . . . . 74.41 111.986 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 92.2 mt -122.77 165.39 16.66 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.943 0.897 . . . . 62.43 110.843 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 40.9 p -71.09 -57.08 4.87 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.663 -0.699 . . . . 73.15 109.427 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 26.6 t70 171.49 -41.91 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.201 1.8 . . . . 54.55 108.056 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.29 78.44 0.21 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.561 1.545 . . . . 74.21 109.161 -176.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 25.2 m -93.39 118.94 31.92 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.344 1.058 . . . . 73.42 108.842 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 64.92 104.92 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.431 1.092 . . . . 70.24 110.721 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.3 108.98 0.77 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.28 0.632 . . . . 74.44 111.476 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . 0.431 ' HB2' HD22 ' B' ' 136' ' ' LEU . 14.2 p90 -61.11 108.09 0.84 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.961 -1.018 . . . . 73.04 109.319 172.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -146.58 107.34 4.12 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.834 -0.621 . . . . 73.25 109.329 -172.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 47.0 p -124.8 87.27 2.69 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.806 0.843 . . . . 73.14 109.396 176.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . 0.684 ' SD ' ' HB3' ' B' ' 129' ' ' ALA . 64.0 ttp -102.68 112.12 24.74 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.344 -0.984 . . . . 73.04 108.344 175.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -70.13 -50.28 42.2 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.886 0.875 . . . . 64.44 110.434 -172.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -89.85 170.72 10.16 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.147 0.579 . . . . 74.14 111.039 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -86.77 169.37 12.67 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.903 0.481 . . . . 63.04 110.08 173.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . 0.68 ' H ' HD23 ' F' ' 468' ' ' LEU . 1.3 pt? -84.79 71.45 10.85 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.753 0.787 . . . . 74.22 110.872 -176.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 79.55 -56.03 4.45 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.255 -0.884 . . . . 71.21 112.805 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 4.6 tt -62.62 107.43 0.95 Allowed 'General case' 0 C--N 1.348 0.513 0 N-CA-C 107.825 -1.176 . . . . 72.5 107.825 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 53.8 pttt . . . . . 0 C--O 1.249 1.029 0 C-N-CA 124.268 1.027 . . . . 74.14 109.528 176.514 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 59.8 t30 . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.998 -0.371 . . . . 74.53 109.998 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . 0.441 ' O ' ' SD ' ' C' ' 94' ' ' MET . 8.9 p -157.64 13.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 122.608 0.363 . . . . 74.31 110.542 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . 0.611 ' HA ' ' HE1' ' C' ' 56' ' ' TYR . 27.4 m -130.01 154.02 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 113.098 0.777 . . . . 64.42 113.098 -174.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . -168.2 -147.37 5.31 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 113.938 -1.483 . . . . 54.12 110.108 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 7.7 mp 53.87 90.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.474 1.11 . . . . 73.44 112.642 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 42.9 p -108.63 8.7 27.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.138 0.975 . . . . 61.42 110.471 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.92 96.37 2.92 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.013 0.925 . . . . 71.01 108.912 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . 0.524 ' HB3' ' O ' ' C' ' 46' ' ' THR . 23.0 mp0 -113.13 61.47 0.64 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.793 0.837 . . . . 72.21 108.943 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 73.0 p -117.83 136.12 53.63 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.256 0.622 . . . . 70.54 110.182 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 53.74 80.95 0.1 Allowed 'General case' 0 C--O 1.243 0.741 0 C-N-CA 125.02 1.328 . . . . 72.3 111.78 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . 0.571 HD12 HD23 ' C' ' 44' ' ' LEU . 1.5 tm? -71.9 120.65 17.79 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.984 -1.488 . . . . 63.13 106.984 174.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . 0.434 ' HE1' ' HB2' ' C' ' 136' ' ' LEU . 15.1 p90 -51.65 116.08 1.94 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.851 1.26 . . . . 62.35 110.943 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -141.18 95.36 2.82 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.84 -1.17 . . . . 70.01 107.84 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 42.6 m -121.88 115.41 22.55 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.651 0.78 . . . . 73.15 109.998 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . . . . . . . . . 52.1 mtt -111.19 -175.01 2.6 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.239 1.016 . . . . 74.31 109.295 170.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -81.18 -6.57 59.0 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.444 -0.798 . . . . 74.11 111.39 174.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -142.32 -77.05 0.26 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.434 0.694 . . . . 52.54 109.777 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -171.34 -55.45 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.449 1.1 . . . . 73.34 108.607 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 tt -148.46 -64.36 0.24 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 106.445 -1.687 . . . . 71.12 106.445 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 97.9 -178.91 32.47 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.018 -0.992 . . . . 74.12 111.804 -174.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . 0.523 ' HG ' ' HB3' ' C' ' 126' ' ' LEU . 6.0 tt -167.13 -61.02 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 106.833 -1.543 . . . . 62.11 106.833 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.554 1.097 0 N-CA-C 106.562 -1.644 . . . . 71.24 106.562 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 . . . . . 0 C--O 1.243 0.715 0 N-CA-C 110.226 -0.287 . . . . 61.01 110.226 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . 0.676 HG12 ' HG3' ' D' ' 94' ' ' MET . 40.1 t -60.33 -53.86 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.219 0.949 . . . . 75.32 109.442 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . . . . . . . . . 18.2 m -71.93 154.96 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 115.973 -0.558 . . . . 62.33 111.625 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -150.96 57.42 0.45 Allowed Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.023 -0.535 . . . . 72.05 111.998 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . 0.543 HD11 HD22 ' D' ' 98' ' ' LEU . 2.4 mm? -77.29 107.59 9.81 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.399 -0.593 . . . . 65.23 109.399 177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 14.8 m -66.45 -54.83 19.74 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 123.793 0.683 . . . . 70.42 110.644 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -174.93 149.1 1.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.062 0.945 . . . . 72.24 109.91 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -81.84 77.9 8.61 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.625 0.726 . . . . 74.33 109.388 173.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 13.8 p -76.34 -66.78 0.76 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.8 -1.091 . . . . 63.24 111.291 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -164.66 149.46 9.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.646 0.779 . . . . 75.34 109.931 -171.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . 0.498 ' HG ' ' HA ' ' D' ' 45' ' ' ASP . 4.4 mm? -87.6 100.07 12.52 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 123.559 0.744 . . . . 71.01 109.656 175.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -59.42 108.6 0.73 Allowed 'General case' 0 CA--C 1.559 1.309 0 CA-C-N 114.813 -1.085 . . . . 62.44 110.024 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -159.16 126.0 4.66 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.44 -0.948 . . . . 72.51 108.44 168.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 23.6 m -83.35 -69.96 0.6 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.407 -1.331 . . . . 74.43 107.407 171.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' H' ' 465' ' ' LYS . 0.0 OUTLIER 65.61 138.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.079 1.352 . . . . 73.11 112.132 172.833 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . 0.411 ' N ' ' SD ' ' H' ' 464' ' ' MET . 39.4 ttpt -159.89 105.96 1.6 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.716 0.407 . . . . 71.01 110.593 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -164.01 32.64 0.08 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.779 0.831 . . . . 63.42 110.816 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -68.34 140.61 55.91 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.009 0.524 . . . . 62.25 110.163 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . . . . . . . . . 4.2 mp -83.89 -6.96 59.53 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.443 0.697 . . . . 71.43 112.04 -174.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 76.01 39.87 31.63 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.132 0.27 . . . . 63.33 113.186 173.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . 0.581 ' HB3' ' HB2' ' D' ' 39' ' ' GLU . 7.7 tt -73.0 -54.28 9.0 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.307 -0.997 . . . . 72.01 108.307 168.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' H' ' 471' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-N 114.15 -1.386 . . . . 75.43 108.999 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptm . . . . . 0 C--O 1.24 0.568 0 CA-C-O 121.429 0.633 . . . . 71.22 110.126 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m -146.43 155.46 42.58 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.217 1.007 . . . . 63.44 109.271 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.02 145.29 26.33 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.872 0.869 . . . . 61.22 109.695 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -73.8 109.06 7.01 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.943 0.497 . . . . 62.35 109.844 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -77.14 153.46 34.19 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.347 -0.612 . . . . 53.23 109.347 172.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -68.42 -20.54 64.66 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.603 0.761 . . . . 71.02 111.261 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 p -86.78 7.38 27.13 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.865 0.866 . . . . 70.45 112.584 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.583 ' HG3' ' HG3' ' A' ' 9' ' ' MET . 10.2 pt-20 -54.94 -39.52 68.95 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.888 0.875 . . . . 44.24 112.722 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.583 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 58.0 mtt -84.72 137.61 33.12 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.7 0.8 . . . . 53.51 109.718 -177.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 68.9 m -143.43 132.81 23.37 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.655 0.782 . . . . 74.55 109.388 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.68 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.6 t80 -136.44 131.63 34.33 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.745 1.218 . . . . 62.44 108.951 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.536 HE22 ' HB2' ' C' ' 151' ' ' GLU . 43.9 tp60 -138.93 117.93 12.5 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.013 0.925 . . . . 73.34 108.652 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.532 HG12 ' HD2' ' A' ' 84' ' ' PHE . 39.1 mt -84.19 110.91 19.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.549 -0.908 . . . . 74.15 108.549 172.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -78.07 -40.03 39.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.991 0.807 . . . . 73.11 110.132 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -169.84 143.77 2.68 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 121.137 -0.225 . . . . 65.44 111.125 -171.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.533 HD12 ' HG3' ' C' ' 130' ' ' PRO . 94.2 mt -135.71 128.31 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.121 -1.066 . . . . 63.03 108.121 175.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' HB3' HG23 ' B' ' 122' ' ' THR . 28.7 p90 -165.62 150.21 8.57 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.177 0.991 . . . . 70.31 110.37 -169.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -75.32 114.91 14.4 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.978 -0.749 . . . . 52.01 108.978 173.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 37.5 mtpt -81.74 -28.36 33.39 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.297 -0.631 . . . . 71.12 109.297 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.1 t70 -149.08 138.52 21.67 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.235 -0.893 . . . . 74.23 109.723 174.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.9 mt -131.11 150.43 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 107.257 -1.386 . . . . 74.15 107.257 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.0 t -158.23 146.4 18.62 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.387 0.429 . . . . 63.45 109.972 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 82.4 t80 -137.72 141.07 41.02 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.262 -1.384 . . . . 75.51 107.262 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 50.7 mt-10 -139.13 133.55 31.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.374 0.67 . . . . 74.02 109.39 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -147.32 73.39 11.88 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 107.235 -1.394 . . . . 63.33 107.235 171.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.51 -22.25 18.57 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.63 2.22 . . . . 74.44 111.779 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.408 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 94.2 m-20 -112.27 32.8 5.29 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.019 1.328 . . . . 42.35 109.367 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -60.47 -46.75 97.44 Favored Pre-proline 0 CA--C 1.571 1.763 0 N-CA-C 113.054 0.761 . . . . 70.4 113.054 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 25.4 Cg_exo -66.61 -19.28 54.26 Favored 'Trans proline' 0 C--N 1.393 2.909 0 C-N-CA 122.002 1.801 . . . . 72.31 113.216 172.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -79.93 -48.86 12.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.398 0.679 . . . . 71.25 110.892 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 7.8 p -68.43 -18.93 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.963 0.505 . . . . 54.34 110.71 -178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -62.2 -39.63 93.39 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.108 0.963 . . . . 73.15 111.29 175.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -95.06 -13.14 25.44 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.591 0.756 . . . . 71.54 111.552 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 31.9 mmtp -83.19 167.93 17.26 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.24 0.616 . . . . 72.54 111.928 177.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -83.85 137.27 33.77 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.92 0.888 . . . . 71.04 109.819 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -77.68 86.77 3.96 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.469 0.652 . . . . 72.53 109.86 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -138.34 73.77 42.63 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 107.652 -1.24 . . . . 75.04 107.652 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 37.2 Cg_endo -91.05 166.06 3.75 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.48 2.12 . . . . 72.22 113.506 -174.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -99.58 105.51 17.39 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.06 -1.459 . . . . 74.54 107.06 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' E' ' 467' ' ' ALA . 16.4 m -73.13 90.87 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-O 122.728 1.251 . . . . 70.02 110.78 -178.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 65' ' ' THR . 29.8 mmmt -94.91 118.09 31.21 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.899 -1.046 . . . . 71.43 108.887 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.9 tp -116.77 127.2 54.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.25 -1.389 . . . . 72.04 107.25 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HB2' HG22 ' A' ' 63' ' ' THR . 6.7 m-20 -123.54 122.91 39.41 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.334 -1.358 . . . . 71.3 107.334 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.412 ' HG ' HG22 ' A' ' 62' ' ' VAL . 6.3 tt -128.75 136.46 50.59 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.75 -0.833 . . . . 75.42 108.75 -169.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 28.8 t70 -143.75 145.35 32.33 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.993 1.317 . . . . 73.03 108.431 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.0 m -114.35 133.77 55.45 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.262 -1.014 . . . . 73.2 108.262 171.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.96 143.15 50.65 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.881 -0.785 . . . . 71.15 108.881 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.8 m -127.8 152.54 47.66 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.077 0.551 . . . . 72.14 111.017 -170.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.6 p -159.44 140.36 12.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.724 0.64 . . . . 72.11 110.123 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -87.18 109.22 19.32 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.304 -0.628 . . . . 74.31 109.304 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 57' ' ' GLU . 82.7 mt -78.95 -41.63 28.87 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.229 0.538 . . . . 52.54 109.984 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.454 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -150.99 176.86 10.72 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.228 -1.027 . . . . 73.31 108.228 177.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -60.58 117.54 5.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.13 -0.693 . . . . 63.52 109.13 171.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 72.58 13.1 5.39 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.731 1.212 . . . . 72.45 112.317 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.454 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 49.1 t -118.93 125.17 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.395 -0.965 . . . . 60.44 108.395 176.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.404 ' HE1' HG12 ' E' ' 452' ' ' VAL . 5.5 m-85 -123.55 153.34 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.549 0.69 . . . . 73.54 111.582 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' A' ' 51' ' ' LEU . 8.4 tp10 -118.05 114.15 22.69 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.186 -1.783 . . . . 73.22 106.186 166.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.74 122.37 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 107.782 -1.192 . . . . 75.43 107.782 169.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -99.31 123.21 51.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.175 -1.046 . . . . 61.04 108.175 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 tp -86.74 96.83 10.3 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 106.754 -1.572 . . . . 60.42 106.754 173.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.597 ' HG2' ' HG3' ' A' ' 79' ' ' GLN . 0.8 OUTLIER -85.77 101.95 13.23 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.526 -1.216 . . . . 65.34 107.908 -175.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.412 HG22 ' HG ' ' A' ' 44' ' ' LEU . 62.1 t -125.08 137.97 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.067 0.547 . . . . 73.04 109.689 -174.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.428 HG22 ' HB2' ' A' ' 43' ' ' ASP . 7.5 t -138.53 145.63 40.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.348 0.659 . . . . 73.12 110.003 172.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 93.2 t -120.11 111.57 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.915 0.886 . . . . 70.41 108.614 177.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 20.7 m -105.52 107.91 19.15 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.199 -0.667 . . . . 74.41 109.199 173.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.64 104.64 15.02 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.736 -1.209 . . . . 53.33 107.736 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 25.0 m -117.27 123.53 46.81 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.954 -0.387 . . . . 73.13 109.954 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.72 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -90.26 86.33 6.48 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.049 0.928 . . . . 74.14 108.895 -178.372 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.29 -95.94 1.8 Allowed Glycine 0 C--N 1.339 0.741 0 CA-C-N 114.434 -1.257 . . . . 62.51 110.853 -174.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -114.73 -25.78 8.12 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.277 0.631 . . . . 73.31 111.455 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.408 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 29.8 tt0 -87.72 134.07 33.73 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.772 0.829 . . . . 65.24 110.693 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 49.4 m -84.96 135.07 34.2 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 120.923 0.392 . . . . 71.05 110.74 174.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.21 -61.61 1.85 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.83 1.252 . . . . 71.44 109.425 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -147.07 165.16 30.75 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.888 -1.051 . . . . 73.24 111.456 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 61.6 tp -135.65 108.79 7.71 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.028 -1.442 . . . . 72.31 107.561 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.429 ' SG ' HG22 ' A' ' 118' ' ' VAL . 90.0 m -108.35 104.38 13.74 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.269 0.628 . . . . 62.15 109.596 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.47 ' HG2' HE22 ' A' ' 79' ' ' GLN . 37.9 tt0 -124.13 117.28 24.29 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.171 0.988 . . . . 73.44 110.269 -169.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.1 t -133.69 112.83 17.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 123.7 0.8 . . . . 72.1 109.808 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.597 ' HG3' ' HG2' ' A' ' 61' ' ' ARG . 2.7 mp0 -89.68 84.22 6.3 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.657 1.183 . . . . 72.33 107.953 173.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -82.68 100.85 10.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.754 -1.112 . . . . 63.11 109.387 -175.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.13 151.91 20.99 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.45 0.469 . . . . 73.34 112.33 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.531 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -146.3 125.49 2.26 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.657 -0.577 . . . . 44.44 111.657 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.8 mt -81.45 118.13 28.68 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.252 -1.018 . . . . 72.34 108.252 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.68 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 41.1 m-85 -131.27 126.97 36.79 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.793 0.837 . . . . 74.3 108.971 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.3 m -83.75 115.64 22.31 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.379 1.072 . . . . 60.41 109.878 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 94' ' ' MET . 6.0 tt -97.14 136.68 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.246 1.019 . . . . 74.32 109.063 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -160.72 137.56 8.91 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.359 0.264 . . . . 62.14 111.368 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.97 -32.2 6.51 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.86 -0.609 . . . . 64.33 114.515 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -133.15 148.03 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 116.931 0.366 . . . . 70.41 111.693 -165.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 9.5 tt0 -134.99 -176.8 4.37 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.042 0.937 . . . . 72.25 109.18 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.501 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.94 -130.67 36.22 Favored Glycine 0 C--N 1.353 1.501 0 C-N-CA 123.178 0.418 . . . . 73.05 113.951 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.0 p -74.08 -21.71 59.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.537 0.735 . . . . 54.42 111.472 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.24 -49.68 47.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.446 0.698 . . . . 73.43 109.841 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.474 ' HB2' HD11 ' A' ' 86' ' ' ILE . 25.7 ptm -65.71 -32.13 73.52 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 116.189 -0.46 . . . . 41.13 110.269 177.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.624 ' HA ' HD12 ' E' ' 454' ' ' LEU . . . -63.68 -37.79 88.66 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 124.044 0.84 . . . . 62.33 111.388 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 51.9 t-80 -69.43 -36.53 76.74 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.562 0.745 . . . . 75.24 111.301 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.8 m -73.27 -43.49 60.98 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.213 0.53 . . . . 70.25 111.008 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.489 HD22 HD13 ' E' ' 454' ' ' LEU . 6.9 tt -83.05 -38.38 22.63 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.337 1.055 . . . . 62.31 110.495 -169.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.97 3.78 52.31 Favored Glycine 0 N--CA 1.473 1.12 0 CA-C-N 116.111 -0.495 . . . . 74.43 114.259 -171.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.543 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -139.76 -62.77 0.51 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 117.452 0.626 . . . . 32.43 111.573 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.479 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 83.5 t80 -68.38 -55.28 12.51 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.977 0.911 . . . . 75.44 112.508 -170.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 76.0 m -72.05 -36.35 4.1 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 114.605 1.335 . . . . 52.41 114.605 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.56 -21.34 46.23 Favored 'Trans proline' 0 C--N 1.386 2.536 0 CA-C-N 121.787 1.674 . . . . 74.44 112.921 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -75.1 -28.64 60.33 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.069 0.548 . . . . 72.0 110.658 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.7 mm -59.9 -37.53 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.566 0.747 . . . . 74.15 109.9 172.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.531 HD21 ' HA3' ' A' ' 82' ' ' GLY . 83.5 mt -78.35 -21.19 49.88 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.308 1.043 . . . . 74.04 112.527 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -61.22 -45.62 95.5 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.936 -1.03 . . . . 75.3 113.636 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.99 -34.57 80.48 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 121.929 1.753 . . . . 73.32 113.27 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.42 -43.4 66.82 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.573 0.749 . . . . 71.24 111.193 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.9 -41.08 75.18 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.095 0.558 . . . . 73.51 110.333 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.473 ' NH1' HG23 ' C' ' 105' ' ' ILE . 30.8 ttm180 -52.38 -52.81 51.55 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.158 0.983 . . . . 64.44 109.494 174.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.15 -52.52 65.37 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 124.637 1.211 . . . . 75.1 111.471 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 117' ' ' MET . 40.4 t -55.82 -50.09 71.48 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 124.38 1.05 . . . . 71.03 110.621 -176.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.4 mt -58.77 -50.64 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 124.07 0.948 . . . . 72.24 110.985 177.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.41 HG23 ' HG3' ' A' ' 125' ' ' GLN . 86.5 m -51.92 -46.06 64.52 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.814 0.846 . . . . 54.4 110.65 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -64.09 -41.51 97.28 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 113.967 -1.469 . . . . 74.15 109.579 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 113' ' ' CYS . 64.4 mmm -61.4 -42.5 98.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.182 0.593 . . . . 64.45 111.1 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 114' ' ' ILE . 57.8 t -62.05 -48.69 87.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.807 0.843 . . . . 64.52 110.091 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.0 p -71.75 -26.51 62.48 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.342 0.657 . . . . 45.5 111.956 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -70.76 -32.36 69.48 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.158 0.583 . . . . 72.12 109.996 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.75 -0.44 87.97 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.543 0.527 . . . . 34.53 112.987 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m 69.36 19.42 7.7 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 125.207 1.403 . . . . 71.42 111.217 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -86.06 150.8 53.33 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.542 -0.91 . . . . 73.1 108.542 171.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.91 143.12 92.78 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.721 2.281 . . . . 63.42 111.482 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.41 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.1 tt0 -57.63 136.67 56.83 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.469 0.708 . . . . 72.34 112.398 -171.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.638 HD13 ' HG ' ' E' ' 470' ' ' LEU . 29.1 tp -120.42 99.93 6.85 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.656 1.182 . . . . 73.23 109.335 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -99.8 101.47 12.63 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.606 -0.887 . . . . 73.04 108.606 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.17 117.72 5.91 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.057 -0.72 . . . . 72.04 109.057 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.23 142.58 86.01 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.373 0.669 . . . . 73.4 110.744 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.68 119.22 6.34 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.85 2.366 . . . . 74.15 112.826 -174.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.2 t -99.21 112.76 32.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 107.626 -1.25 . . . . 64.13 107.626 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -83.39 91.34 7.32 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 108.339 -0.985 . . . . 74.15 108.339 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -64.93 -24.58 67.57 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.659 -0.7 . . . . 74.34 111.489 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.543 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 8.6 t70 -69.7 -50.29 45.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.73 0.812 . . . . 72.41 110.066 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.16 -45.68 93.65 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.541 1.136 . . . . 64.01 110.87 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.6 mt -68.24 -30.89 70.04 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.925 -1.034 . . . . 64.02 111.919 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -70.66 -35.43 72.86 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 123.366 0.416 . . . . 73.53 109.914 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 32.4 tpp -63.1 -38.94 93.18 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 123.719 0.637 . . . . 70.55 110.492 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -63.87 -33.46 75.74 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.163 -0.926 . . . . 71.44 110.906 175.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -81.65 -32.99 31.6 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.197 0.999 . . . . 71.31 111.113 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 42.9 tp -67.24 -49.52 64.16 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.916 0.886 . . . . 74.32 111.969 -164.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.41 ' HG2' ' HA ' ' A' ' 147' ' ' GLU . 27.2 tt0 -159.07 5.08 0.1 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.678 0.621 . . . . 74.04 112.678 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -73.95 -17.51 61.0 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 109.152 -0.685 . . . . 73.45 109.152 168.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -59.23 164.06 3.41 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 125.162 1.385 . . . . 53.2 110.853 169.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.19 -24.08 25.21 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.358 1.063 . . . . 63.31 112.705 176.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.04 67.86 2.93 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-N 116.075 -0.511 . . . . 70.02 112.348 172.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.41 ' HA ' ' HG2' ' A' ' 142' ' ' GLN . 12.4 pt-20 -76.78 -172.86 2.42 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.321 1.048 . . . . 72.33 110.717 177.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 148.87 91.79 0.1 OUTLIER Glycine 0 C--N 1.344 1.023 0 C-N-CA 121.215 -0.517 . . . . 60.13 113.649 174.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.6 m -133.02 -91.42 0.38 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 107.657 -1.238 . . . . 71.14 107.657 171.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 165.69 -70.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 126.044 1.738 . . . . 72.14 107.61 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -171.59 -154.59 0.09 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 106.877 -1.527 . . . . 72.34 106.877 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -124.51 86.06 2.51 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.431 -0.952 . . . . 74.2 108.431 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -81.32 105.48 12.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.784 0.834 . . . . 64.0 109.562 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -83.49 -54.66 4.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.2 0.6 . . . . 74.44 111.008 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.239 0 CA-C-O 118.329 -0.843 . . . . 43.41 109.226 179.642 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.608 -0.516 . . . . 72.04 109.608 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 23.8 t -166.34 159.11 14.49 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.581 0.752 . . . . 65.01 109.645 176.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.515 ' HG3' ' H ' ' B' ' 4' ' ' GLN . 4.1 pt-20 -153.46 -92.6 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.81 0.844 . . . . 71.04 109.883 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.515 ' H ' ' HG3' ' B' ' 3' ' ' GLU . 26.9 tp60 57.15 90.98 0.04 OUTLIER 'General case' 0 C--N 1.364 1.202 0 C-N-CA 125.216 1.407 . . . . 74.04 111.771 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -79.3 163.87 24.56 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.957 -0.565 . . . . 74.41 109.716 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -68.28 106.07 2.34 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.212 -1.033 . . . . 70.13 108.212 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -132.81 156.33 47.33 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 123.905 0.882 . . . . 60.22 109.451 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -72.18 -41.06 67.44 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.197 -0.91 . . . . 70.53 109.238 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.437 ' HB2' HD12 ' B' ' 89' ' ' ILE . 18.3 ptm 50.85 -177.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 126.287 1.835 . . . . 51.44 112.384 -170.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 89.6 m -155.54 117.37 4.06 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 119.169 -0.443 . . . . 71.05 110.011 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . 0.266 0.3 OUTLIER -154.96 155.29 33.96 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.265 0.353 . . . . 61.43 110.951 147.246 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -126.88 140.86 52.03 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 107.702 -1.222 . . . . 70.1 107.702 170.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.533 HD11 HD13 ' B' ' 105' ' ' ILE . 30.4 mt -78.47 122.85 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.618 -0.719 . . . . 65.32 109.32 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -86.42 -49.92 7.26 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.883 0.74 . . . . 71.34 109.69 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -158.53 129.88 6.47 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.605 -0.725 . . . . 75.21 110.074 -171.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.468 HD11 HD13 ' B' ' 13' ' ' ILE . 94.8 mt -116.45 119.15 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 106.807 -1.553 . . . . 72.32 106.807 172.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -151.89 143.54 23.59 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.246 0.546 . . . . 74.2 110.942 -168.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -72.46 124.62 25.55 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.937 -1.029 . . . . 60.22 108.714 172.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.502 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.7 mtpt -95.01 -36.76 11.43 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.533 0.733 . . . . 70.32 110.319 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.0 t70 -157.07 141.08 16.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.602 -0.272 . . . . 72.52 110.984 -167.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' B' ' 78' ' ' VAL . 40.7 mm -141.13 148.08 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.118 1.367 . . . . 75.42 108.866 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 41.6 t -144.42 139.15 28.2 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.555 1.142 . . . . 64.34 108.13 170.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -145.01 114.21 7.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.665 -1.606 . . . . 70.11 106.665 170.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -124.85 112.51 16.74 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.825 0.45 . . . . 75.23 109.893 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.35 86.65 8.31 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 108.225 -1.028 . . . . 70.0 108.225 172.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.1 -35.29 11.92 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.916 2.41 . . . . 74.24 113.033 -173.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -102.87 19.33 19.57 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.587 0.755 . . . . 72.34 110.611 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.592 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -40.31 -65.48 0.44 Allowed Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 125.183 1.393 . . . . 75.25 113.836 -166.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 52.6 Cg_exo -53.54 -38.56 83.73 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.838 2.359 . . . . 75.24 114.018 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.412 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 52.8 m80 -87.48 -35.77 18.04 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.317 -0.856 . . . . 74.34 112.406 -170.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.576 HG22 HD12 ' B' ' 68' ' ' LEU . 11.1 p -69.99 -17.44 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.699 0.4 . . . . 64.42 111.425 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -68.7 -10.73 58.07 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 113.512 0.93 . . . . 62.12 113.512 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.7 pt20 -66.52 -25.13 66.53 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 122.811 0.444 . . . . 71.42 110.843 174.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -91.81 88.97 6.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.161 0.984 . . . . 70.1 108.747 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.51 76.79 6.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.823 0.849 . . . . 73.51 109.712 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -154.39 160.9 41.92 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.556 1.142 . . . . 70.13 108.37 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -75.15 107.41 3.93 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 124.833 1.253 . . . . 65.34 109.634 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.598 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 12.5 Cg_endo -59.95 133.71 52.19 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.103 2.536 . . . . 72.14 112.834 -175.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -57.7 114.59 2.34 Favored 'General case' 0 C--N 1.361 1.091 0 O-C-N 124.138 0.899 . . . . 74.22 111.051 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.23 156.75 3.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 114.775 -1.102 . . . . 63.1 111.485 -173.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -145.87 121.49 10.45 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.943 -1.503 . . . . 73.12 106.943 169.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.2 mp -86.22 155.39 20.73 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.11 -0.7 . . . . 61.32 109.11 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 27.2 t70 -144.6 145.2 31.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.981 -1.489 . . . . 75.44 106.981 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.89 135.85 29.89 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.146 -0.687 . . . . 75.3 109.146 -169.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.0 t70 -145.69 140.0 26.95 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.2 1.4 . . . . 70.15 108.254 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 74.8 p -134.26 141.31 46.94 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.987 -0.746 . . . . 63.52 108.987 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.44 120.68 4.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.41 0.684 . . . . 71.04 109.881 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 57.3 p -99.4 168.75 9.8 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.981 0.513 . . . . 74.54 109.911 176.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 86.5 p -151.15 135.87 17.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.06 0.544 . . . . 73.33 109.927 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -82.5 103.44 12.04 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.297 -0.631 . . . . 71.03 109.297 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' B' ' 57' ' ' GLU . 58.8 mt -75.02 -53.79 8.3 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.418 0.628 . . . . 62.33 110.629 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.88 -170.61 3.57 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.754 -1.112 . . . . 72.3 109.375 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -64.73 109.84 2.18 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.815 0.697 . . . . 51.32 109.72 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 13.3 m-20 71.97 1.55 3.96 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.123 1.369 . . . . 72.04 112.667 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.9 t -104.69 122.63 57.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.08 -1.081 . . . . 54.51 108.08 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.492 ' HE2' ' HB3' ' B' ' 98' ' ' LEU . 0.1 OUTLIER -135.98 154.64 51.02 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.034 -0.728 . . . . 71.45 109.034 178.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.672 ' HB2' HD11 ' B' ' 51' ' ' LEU . 12.5 tm-20 -123.29 110.53 15.31 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.672 -1.233 . . . . 75.43 107.672 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 95.0 t -89.81 141.35 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 O-C-N 123.777 0.673 . . . . 73.15 109.446 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.5 t -117.22 145.45 22.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 108.675 -0.861 . . . . 74.02 108.675 176.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.458 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -128.66 104.72 7.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.619 -1.252 . . . . 73.01 107.619 178.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.456 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 33.1 ttt180 -94.03 113.47 25.45 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.582 0.753 . . . . 64.34 110.596 173.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.19 104.36 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.258 -1.016 . . . . 65.31 108.258 171.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 41.3 m -96.34 142.0 28.99 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.534 -0.913 . . . . 63.44 108.534 175.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.455 HG11 HD21 ' B' ' 126' ' ' LEU . 90.4 t -136.5 136.01 48.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.507 -0.923 . . . . 75.4 108.507 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 74.6 m -122.48 137.7 54.79 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.599 -0.889 . . . . 73.41 108.599 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -141.64 141.83 33.4 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.617 0.767 . . . . 64.3 109.684 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.508 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 57.5 p -145.03 133.5 21.91 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.959 -0.564 . . . . 62.55 111.908 -173.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.598 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.1 mt -94.06 106.89 18.85 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.17 0.988 . . . . 74.14 109.033 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.49 -111.8 4.34 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 114.887 -1.051 . . . . 65.52 111.909 -173.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -107.64 5.36 26.8 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.81 0.844 . . . . 73.52 111.813 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -124.72 144.8 50.03 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.039 0.382 . . . . 61.14 111.237 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 99.8 m -64.72 119.92 11.48 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 123.817 0.698 . . . . 74.43 110.524 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.543 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -81.55 -65.63 0.99 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.712 -1.131 . . . . 72.43 108.02 176.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -144.2 150.75 38.49 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-O 121.723 0.773 . . . . 74.13 111.457 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 74.7 mt -115.03 142.19 46.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.086 -1.82 . . . . 73.1 106.086 166.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.541 ' SG ' HG23 ' B' ' 114' ' ' ILE . 49.7 t -147.55 146.8 29.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.804 -0.813 . . . . 73.01 108.804 176.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -160.7 136.39 8.14 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.512 -0.551 . . . . 74.01 109.512 -173.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.435 ' HA ' HD13 ' B' ' 21' ' ' ILE . 98.1 t -131.23 145.15 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 123.863 0.865 . . . . 73.43 109.203 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 42.2 mt-30 -122.71 88.49 2.94 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.076 -1.083 . . . . 74.54 108.076 171.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.4 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 11.2 tp-100 -81.24 101.62 9.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.783 -1.099 . . . . 61.13 109.157 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.502 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -95.75 163.06 23.44 Favored Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.677 -0.569 . . . . 73.44 111.677 176.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.74 127.41 1.9 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.114 -0.795 . . . . 74.14 111.114 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.89 127.2 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 109.045 -0.724 . . . . 73.23 109.045 172.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.421 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 24.0 m-85 -132.02 153.93 49.88 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 107.227 -1.397 . . . . 61.15 107.227 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 59.0 m -122.48 91.21 3.45 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.825 0.45 . . . . 72.14 110.41 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.429 HD11 HD11 ' B' ' 89' ' ' ILE . 15.4 tt -94.82 145.81 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.844 0.858 . . . . 73.43 112.474 -166.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.47 161.14 40.07 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 124.709 1.204 . . . . 65.21 108.999 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.06 -68.17 0.39 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.095 -0.502 . . . . 52.42 113.207 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.65 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -90.38 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 121.418 0.628 . . . . 71.33 112.03 -173.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.453 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 33.2 tt0 -156.94 179.38 9.35 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.826 1.25 . . . . 54.15 108.26 -176.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.453 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 72.4 -123.55 9.27 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 117.676 0.217 . . . . 61.42 112.621 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 32.2 m -93.41 -18.16 22.67 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.323 0.649 . . . . 70.11 111.436 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -68.08 -33.87 75.35 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 122.081 -0.387 . . . . 74.34 110.289 173.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' F' ' 452' ' ' VAL . 0.0 OUTLIER -77.56 -29.31 52.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.26 0.224 . . . . 75.33 110.477 173.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.471 ' HB1' ' HZ ' ' B' ' 137' ' ' PHE . . . -60.14 -40.78 91.01 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-O 121.403 0.621 . . . . 62.41 109.922 176.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 40.6 t-80 -64.12 -29.51 70.63 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.713 -1.13 . . . . 74.31 111.395 175.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.408 ' SG ' HD12 ' B' ' 86' ' ' ILE . 37.9 t -70.83 -66.11 0.65 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 110.312 -0.255 . . . . 75.41 110.312 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.691 HD23 ' HB ' ' F' ' 452' ' ' VAL . 0.4 OUTLIER -72.23 -23.83 61.29 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.56 0.948 . . . . 62.31 113.56 -174.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.92 1.07 56.45 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 119.651 -0.527 . . . . 61.11 113.346 -174.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.595 ' HA ' ' HB3' ' B' ' 133' ' ' PHE . . . -152.06 -62.43 0.17 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.413 0.523 . . . . 61.4 112.413 -175.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -66.65 -42.52 86.52 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.187 0.995 . . . . 75.13 111.89 -170.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.492 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 73.2 m -71.25 -50.58 11.07 Favored Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 124.332 1.053 . . . . 70.43 111.069 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 65.3 Cg_exo -57.16 -30.86 88.7 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.115 1.876 . . . . 73.01 114.014 170.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -59.13 -43.01 91.98 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 123.65 0.78 . . . . 75.33 110.298 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.533 HD13 HD11 ' B' ' 13' ' ' ILE . 73.8 mt -62.9 -41.37 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 115.09 -0.959 . . . . 53.55 110.889 176.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.15 -22.93 38.62 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.953 -1.022 . . . . 70.1 112.314 -172.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -58.72 -49.03 95.66 Favored Pre-proline 0 N--CA 1.486 1.333 0 N-CA-C 114.205 1.187 . . . . 71.32 114.205 -170.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -55.95 -36.82 96.36 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.029 1.819 . . . . 60.31 113.937 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.4 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 78.7 m-85 -67.43 -46.59 72.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.158 0.583 . . . . 73.51 110.601 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.54 88.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.686 0.794 . . . . 71.23 110.856 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.659 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 34.6 ttt180 -61.21 -54.69 41.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.632 1.573 . . . . 75.23 111.014 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -38.12 89.9 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.36 0.664 . . . . 61.31 110.021 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.475 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.8 t -66.63 -33.89 76.66 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 116.18 -0.464 . . . . 73.3 111.535 -176.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.541 HG23 ' SG ' ' B' ' 76' ' ' CYS . 62.6 mt -66.46 -52.05 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 109.896 -0.409 . . . . 75.31 109.896 175.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.45 HG21 ' OG ' ' C' ' 119' ' ' SER . 5.1 m -62.5 -30.57 71.37 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.732 0.645 . . . . 50.12 111.487 -176.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.5 t -61.3 -49.92 75.09 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.449 0.7 . . . . 74.23 109.376 174.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.0 mmt -58.44 -44.87 89.33 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.637 0.775 . . . . 63.42 111.03 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.11 -45.49 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.291 1.036 . . . . 64.54 111.269 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.0 t -63.45 -37.48 87.44 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.307 -0.86 . . . . 42.22 111.476 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.5 mtt-85 -66.16 -36.19 82.46 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.751 -1.113 . . . . 72.21 109.949 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.43 9.74 66.52 Favored Glycine 0 C--N 1.356 1.678 0 O-C-N 123.93 0.769 . . . . 65.31 113.898 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.445 HG23 ' HB3' ' A' ' 17' ' ' TYR . 72.4 p 54.76 35.38 23.89 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.781 1.632 . . . . 75.41 113.222 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -99.31 153.58 37.71 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.171 0.588 . . . . 70.22 110.342 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -50.82 158.6 2.89 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 123.868 3.046 . . . . 72.42 115.187 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -63.33 119.66 10.09 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.655 1.182 . . . . 71.51 112.699 -170.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.455 HD21 HG11 ' B' ' 64' ' ' VAL . 55.9 tp -108.54 102.75 11.8 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.064 -0.717 . . . . 74.53 109.064 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -100.21 105.29 16.86 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.22 -0.659 . . . . 70.41 109.22 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.659 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -73.33 113.0 9.92 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.037 -0.727 . . . . 71.53 109.037 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.09 149.94 96.18 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.922 0.889 . . . . 74.31 110.752 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.488 ' HG3' HD11 ' D' ' 16' ' ' ILE . 55.6 Cg_endo -66.37 123.35 11.04 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.441 2.094 . . . . 31.42 112.383 -175.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.8 111.61 24.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.306 -1.368 . . . . 73.43 107.306 172.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -76.97 86.56 3.5 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.63 -1.248 . . . . 73.51 107.63 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.595 ' HB3' ' HA ' ' B' ' 100' ' ' ALA . 97.7 m-85 -55.37 -42.65 74.22 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.895 0.878 . . . . 74.23 111.529 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.72 -42.43 97.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.361 1.064 . . . . 74.44 111.696 -174.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.04 -52.81 31.14 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.586 0.754 . . . . 74.33 110.283 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.25 -18.62 61.8 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.112 -0.949 . . . . 63.24 112.282 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.494 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 72.1 t80 -70.75 -40.52 72.66 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.329 0.651 . . . . 62.55 109.757 174.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 65.6 mtt -65.84 -26.44 67.66 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.739 0.416 . . . . 71.05 110.571 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.464 ' N ' HD22 ' B' ' 139' ' ' ASN . 0.7 OUTLIER -73.75 -29.18 62.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.835 0.854 . . . . 62.14 109.529 176.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.418 ' HD1' ' HB3' ' F' ' 461' ' ' PHE . 47.5 t80 -71.94 -32.63 67.51 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.421 1.088 . . . . 73.11 110.874 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 32.4 mt -80.08 0.1 33.42 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.73 0.812 . . . . 72.11 112.546 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -151.67 -168.41 3.07 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.415 -0.957 . . . . 65.31 108.415 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -123.95 22.01 8.91 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.104 0.562 . . . . 64.55 110.675 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -142.41 147.95 37.02 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.186 0.594 . . . . 45.32 110.666 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -173.43 -170.59 0.62 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.129 1.371 . . . . 75.24 108.991 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.83 -178.04 20.9 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 112.701 -0.16 . . . . 44.24 112.701 174.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.99 129.41 27.83 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.364 1.066 . . . . 72.02 108.964 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.16 100.83 0.52 Allowed Glycine 0 C--N 1.338 0.658 0 N-CA-C 111.004 -0.838 . . . . 64.02 111.004 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 14.4 t -148.48 157.02 43.2 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.145 0.578 . . . . 54.21 109.838 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -94.08 122.85 37.03 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.861 -0.609 . . . . 75.42 109.394 174.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -70.96 83.27 0.67 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 107.573 -1.269 . . . . 72.41 107.573 167.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -94.48 128.73 41.25 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.644 -0.707 . . . . 72.13 110.379 -173.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.49 -178.25 4.17 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.165 0.986 . . . . 52.11 110.018 174.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.06 -76.82 0.6 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.921 0.888 . . . . 54.3 109.044 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 C-N-CA 124.476 1.11 . . . . 44.12 108.487 -176.766 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.473 -0.566 . . . . 72.42 109.473 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 26.9 t -159.57 78.49 0.71 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.217 -1.031 . . . . 73.0 108.217 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -90.14 58.72 4.21 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.812 0.845 . . . . 60.01 109.496 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 63.97 -79.36 0.03 OUTLIER 'General case' 0 C--N 1.357 0.893 0 C-N-CA 125.212 1.405 . . . . 61.43 110.727 -176.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -159.92 -56.09 0.06 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.742 -1.207 . . . . 63.13 107.742 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 63.29 -163.94 0.26 Allowed 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 124.776 1.23 . . . . 72.2 109.394 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.432 HG22 ' HG3' ' C' ' 8' ' ' GLU . 54.2 m 69.29 151.1 0.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.467 1.107 . . . . 72.04 111.677 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.432 ' HG3' HG22 ' C' ' 7' ' ' THR . 49.6 mt-10 73.84 173.33 0.28 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.071 1.348 . . . . 71.31 111.798 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 28.0 ttt 63.67 112.25 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.183 1.393 . . . . 73.31 110.149 -171.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 40.2 m -126.3 105.16 8.61 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.711 -1.218 . . . . 73.1 107.711 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.522 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 3.2 t80 -116.14 119.85 37.12 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.127 -0.942 . . . . 74.21 108.578 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -136.47 131.9 34.64 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 107.981 -1.118 . . . . 61.22 107.981 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 63.8 mt -76.59 120.33 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.556 -0.905 . . . . 71.03 108.556 173.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.654 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.6 mm-40 -82.71 -42.31 18.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.075 -0.966 . . . . 63.02 109.106 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -170.94 149.31 2.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.639 -0.71 . . . . 73.33 109.703 -170.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.5 mt -138.3 133.77 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.645 -1.243 . . . . 65.11 107.645 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.423 ' HB3' HG23 ' D' ' 122' ' ' THR . 31.5 p90 -169.77 172.04 6.98 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.847 0.832 . . . . 74.01 111.77 -172.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -97.27 123.14 40.98 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.094 -0.957 . . . . 71.02 109.101 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.416 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 24.9 mmtp -71.21 -50.46 32.85 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 122.755 1.264 . . . . 73.5 107.631 168.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -134.92 141.88 46.41 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 112.517 -2.129 . . . . 71.23 108.889 -168.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 74.2 mt -137.95 142.03 36.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 106.024 -1.843 . . . . 55.34 106.024 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -155.99 150.15 25.49 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.316 0.579 . . . . 74.54 110.439 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -150.87 134.95 16.77 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.526 -1.287 . . . . 64.32 107.526 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -138.69 124.27 19.58 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.737 0.815 . . . . 75.34 109.499 -171.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.62 79.02 7.37 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 107.517 -1.29 . . . . 71.45 107.517 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.93 -42.71 61.5 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.026 2.484 . . . . 64.14 111.494 174.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -91.53 29.76 1.44 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.11 -1.404 . . . . 71.54 110.362 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.94 -58.91 8.71 Favored Pre-proline 0 N--CA 1.487 1.405 0 CA-C-O 118.084 -0.96 . . . . 74.41 113.046 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.33 -33.41 58.97 Favored 'Trans proline' 0 C--N 1.388 2.62 0 CA-C-N 121.735 1.655 . . . . 71.21 111.898 -178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -68.48 -37.63 80.3 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.202 1.401 . . . . 64.41 112.496 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.813 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.9 p -82.02 -23.51 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.372 0.269 . . . . 65.33 111.68 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -68.07 -35.83 78.85 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.877 0.37 . . . . 73.43 110.561 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -89.37 12.38 16.42 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.815 0.846 . . . . 71.43 111.062 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -101.27 160.51 14.35 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.154 0.982 . . . . 72.32 109.621 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.48 114.19 9.29 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.461 0.704 . . . . 60.42 109.91 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -78.84 100.95 7.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.879 0.872 . . . . 73.33 111.155 -174.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.545 ' H ' HD22 ' C' ' 68' ' ' LEU . 10.8 pt20 -149.9 78.42 8.14 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 124.107 0.963 . . . . 75.0 109.535 171.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -87.3 128.31 2.6 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.351 2.034 . . . . 73.31 112.571 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -86.27 91.5 8.49 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 106.075 -1.824 . . . . 65.25 106.075 165.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 18.0 m -72.49 131.81 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.737 -1.119 . . . . 64.22 111.831 -171.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -113.77 102.89 10.66 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.548 -1.279 . . . . 50.33 107.548 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -87.98 152.49 22.01 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.167 -0.679 . . . . 64.43 109.167 170.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.568 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.5 t70 -137.45 104.65 5.42 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.584 -0.895 . . . . 75.44 108.584 177.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 85.6 mt -92.65 113.09 25.28 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.839 -1.171 . . . . 63.12 107.839 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.3 t70 -122.27 153.7 38.55 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.856 1.262 . . . . 71.5 109.399 178.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.439 HG22 HD21 ' G' ' 460' ' ' LEU . 5.3 t -143.87 154.2 43.12 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.119 -0.697 . . . . 73.22 109.119 173.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' G' ' 457' ' ' GLN . . . -153.12 135.93 15.37 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.16 0.984 . . . . 51.24 109.097 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.459 ' HB3' HG22 ' C' ' 58' ' ' VAL . 29.6 p -125.71 142.18 51.64 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.363 0.665 . . . . 72.4 109.665 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.7 p -153.43 140.33 19.16 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.393 0.677 . . . . 73.14 110.766 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -72.18 127.14 31.62 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.955 0.902 . . . . 64.43 111.104 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' C' ' 57' ' ' GLU . 55.7 mt -96.06 -44.3 7.39 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.018 0.927 . . . . 72.22 109.708 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.25 -176.57 5.28 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.771 -1.104 . . . . 60.34 109.807 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.73 108.07 0.93 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.689 0.796 . . . . 72.2 110.369 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 70.63 1.6 3.76 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.745 1.618 . . . . 73.43 112.974 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 68.5 t -98.16 118.43 44.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.86 -0.793 . . . . 73.24 108.86 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -108.83 158.74 17.38 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 122.182 0.992 . . . . 73.04 110.28 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.586 ' HB2' HD11 ' C' ' 51' ' ' LEU . 24.6 tt0 -119.41 130.81 55.48 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 112.884 -1.962 . . . . 73.34 107.285 169.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.459 HG22 ' HB3' ' C' ' 48' ' ' SER . 76.0 t -115.28 126.4 72.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.877 -0.786 . . . . 60.24 108.877 170.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.486 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 88.0 t -105.79 130.36 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 107.788 -1.19 . . . . 73.01 107.788 171.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.41 103.75 10.43 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.837 -1.542 . . . . 54.22 106.837 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.423 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.9 ttm-85 -84.27 123.18 29.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.15 -1.386 . . . . 71.44 108.47 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -116.46 118.58 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.973 -1.121 . . . . 73.21 107.973 169.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 42.3 m -110.72 141.81 43.5 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.087 0.955 . . . . 63.24 108.628 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.706 HG11 HD11 ' C' ' 126' ' ' LEU . 55.8 t -126.1 127.65 71.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 108.663 -0.866 . . . . 24.44 108.663 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -115.81 137.37 52.15 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.22 -1.4 . . . . 74.44 107.22 167.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.51 114.39 14.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.187 -1.412 . . . . 62.42 107.187 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.6 m -134.75 134.08 40.6 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 123.562 0.539 . . . . 55.51 110.027 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.545 HD22 ' H ' ' C' ' 37' ' ' GLN . 12.5 mt -90.91 23.04 3.33 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 126.005 1.722 . . . . 73.14 110.133 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.39 -87.8 0.51 Allowed Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.024 -0.83 . . . . 65.53 111.024 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.2 -30.51 18.49 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.572 0.749 . . . . 71.31 110.326 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -92.97 118.36 31.07 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.455 0.702 . . . . 55.33 110.429 -173.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -77.44 122.4 25.14 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.614 -0.884 . . . . 71.13 108.614 169.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.813 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.5 -54.24 7.91 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.298 -0.865 . . . . 73.21 109.461 176.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -167.24 157.05 10.8 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.283 -0.871 . . . . 75.04 110.909 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.419 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -118.0 144.99 45.08 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 106.365 -1.717 . . . . 64.4 106.365 168.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.43 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.8 t -148.78 149.45 31.4 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.504 -0.924 . . . . 63.14 108.504 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -159.22 130.25 6.08 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.374 0.421 . . . . 54.32 110.073 175.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.5 t -125.54 131.6 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.891 0.876 . . . . 72.52 108.646 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -109.32 87.53 2.52 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.605 -1.257 . . . . 70.14 107.605 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.407 ' HG3' HD22 ' C' ' 106' ' ' LEU . 8.8 tp-100 -79.42 96.77 6.14 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.483 -0.78 . . . . 64.3 110.357 -175.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -97.7 143.23 16.58 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 112.306 -0.317 . . . . 61.22 112.306 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.99 140.62 8.53 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 110.357 -1.097 . . . . 71.1 110.357 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.654 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.7 mm -91.39 122.7 43.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.553 -0.906 . . . . 62.42 108.553 -178.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.522 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 63.8 m-85 -127.46 119.33 25.85 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.201 -1.037 . . . . 64.12 108.201 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 39.9 p -84.46 125.49 32.41 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.066 0.546 . . . . 75.33 109.563 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.624 HD13 HD11 ' C' ' 98' ' ' LEU . 39.0 pt -116.51 135.33 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.214 0.606 . . . . 70.11 109.776 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -153.45 151.29 29.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.947 0.899 . . . . 74.14 109.321 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.15 -57.74 4.26 Favored Glycine 0 N--CA 1.474 1.188 0 N-CA-C 112.243 -0.343 . . . . 72.43 112.243 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -85.48 156.15 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.869 0.868 . . . . 73.41 111.834 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.549 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 11.9 pt-20 -161.42 -175.74 4.97 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.416 -0.811 . . . . 74.34 110.421 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.1 -119.75 18.43 Favored Glycine 0 C--N 1.352 1.47 0 O-C-N 123.902 0.751 . . . . 61.44 113.845 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.482 ' HB ' HD11 ' C' ' 141' ' ' LEU . 47.3 p -72.94 -33.32 65.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.246 1.019 . . . . 72.51 111.171 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -67.9 -34.9 77.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.736 0.815 . . . . 72.04 110.903 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.549 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 55.3 ttp -75.35 -41.77 55.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.837 0.855 . . . . 72.34 110.396 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.37 -41.04 75.54 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.076 0.86 . . . . 50.04 110.086 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' C' ' 137' ' ' PHE . 18.7 t-160 -76.39 -43.2 41.68 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 124.05 0.844 . . . . 74.24 111.811 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -55.68 -40.25 72.06 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 123.956 0.785 . . . . 72.55 110.648 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.624 HD11 HD13 ' C' ' 86' ' ' ILE . 22.0 mt -101.71 -14.9 17.17 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.748 0.819 . . . . 71.51 111.632 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . 0.623 ' HA2' HG21 ' G' ' 458' ' ' THR . . . -76.87 -30.89 55.24 Favored Glycine 0 C--N 1.355 1.615 0 N-CA-C 114.77 0.668 . . . . 55.33 114.77 -176.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.2 -36.32 0.06 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.07 0.396 . . . . 62.41 112.07 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -59.2 -49.59 77.29 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 125.231 1.412 . . . . 71.14 112.535 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 88.1 m -77.94 -41.99 2.17 Favored Pre-proline 0 CA--C 1.563 1.464 0 CA-C-O 118.727 -0.654 . . . . 63.21 112.575 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.08 -33.44 34.98 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.449 2.099 . . . . 74.44 114.558 168.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.33 -26.68 63.87 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.581 0.752 . . . . 71.23 110.458 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.473 HG23 ' NH1' ' A' ' 111' ' ' ARG . 48.0 mm -68.71 -39.36 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.829 0.852 . . . . 62.35 109.725 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.407 HD22 ' HG3' ' C' ' 80' ' ' GLN . 35.8 mt -80.64 -23.82 39.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.668 1.187 . . . . 74.4 112.597 -174.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -57.3 -49.25 94.95 Favored Pre-proline 0 CA--C 1.563 1.45 0 N-CA-C 114.212 1.19 . . . . 75.12 114.212 -173.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.41 -37.64 96.82 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 121.945 1.764 . . . . 62.11 113.223 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -66.36 -49.01 68.34 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.837 0.855 . . . . 73.43 111.178 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.09 -38.97 84.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.289 -0.868 . . . . 65.43 110.628 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -58.54 -55.71 31.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.564 1.146 . . . . 74.42 110.8 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.29 -33.08 75.13 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.852 0.461 . . . . 75.13 110.39 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 33.4 t -71.16 -31.4 67.64 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.009 0.524 . . . . 64.55 111.48 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.43 HG23 ' SG ' ' C' ' 76' ' ' CYS . 76.9 mt -73.2 -54.04 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.523 -0.547 . . . . 75.21 109.523 172.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 4.7 m -62.46 -27.82 69.39 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.166 0.587 . . . . 73.34 111.271 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.6 t -61.33 -53.66 53.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.626 0.771 . . . . 54.12 109.094 169.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.57 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.28 -35.23 75.06 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.791 1.236 . . . . 73.44 112.46 179.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' C' ' 123' ' ' PHE . 75.0 t -65.67 -45.27 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.683 0.793 . . . . 73.5 109.622 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.45 ' OG ' HG21 ' B' ' 115' ' ' THR . 42.3 t -68.69 -28.55 66.95 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 124.001 0.813 . . . . 32.45 111.449 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.469 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 82.7 mtt-85 -70.74 -43.11 69.52 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.503 0.721 . . . . 72.21 109.211 176.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.09 -3.79 82.13 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 124.287 0.992 . . . . 51.52 112.24 172.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 65.82 26.55 11.18 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 127.026 2.13 . . . . 74.44 113.588 170.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.411 ' HB2' HG13 ' C' ' 118' ' ' VAL . 92.1 m-85 -82.8 156.62 67.56 Favored Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 109.021 -0.733 . . . . 73.25 109.021 171.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.14 175.1 2.72 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.909 2.406 . . . . 73.25 114.285 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -56.84 137.56 54.78 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.784 1.031 . . . . 74.22 113.784 -171.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.706 HD11 HG11 ' C' ' 64' ' ' VAL . 3.0 tt -126.9 87.03 2.59 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.662 -1.154 . . . . 70.55 108.278 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -107.89 109.66 21.23 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.21 0.604 . . . . 73.4 109.846 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -74.73 135.63 41.79 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 122.918 0.487 . . . . 73.1 110.762 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.26 151.38 87.86 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.894 0.877 . . . . 74.1 110.241 174.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.533 ' HG3' HD12 ' A' ' 16' ' ' ILE . 24.6 Cg_exo -60.93 103.34 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.816 2.344 . . . . 53.23 112.794 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.416 HG12 ' HG3' ' G' ' 464' ' ' MET . 17.9 m -98.46 111.13 27.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.244 -1.021 . . . . 61.44 108.244 168.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -75.72 84.57 2.72 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.32 -0.854 . . . . 74.41 109.196 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -54.39 -44.82 72.61 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.752 0.658 . . . . 75.55 110.121 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -59.74 -47.53 85.29 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.574 -1.194 . . . . 61.52 111.682 -174.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.27 87.01 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.345 0.658 . . . . 55.4 111.209 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' G' ' 462' ' ' TYR . 87.5 mt -62.96 -42.49 99.84 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.776 -0.647 . . . . 64.53 111.422 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.621 ' HA ' ' HB3' ' C' ' 140' ' ' TYR . 10.1 t80 -71.89 -26.48 62.34 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.935 0.494 . . . . 74.14 110.807 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 25.3 ttt -60.09 -45.77 91.83 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 122.769 0.428 . . . . 61.33 109.943 174.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -72.04 -35.61 69.4 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.974 0.91 . . . . 73.02 111.474 175.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.621 ' HB3' ' HA ' ' C' ' 137' ' ' PHE . 84.8 t80 -66.32 -84.81 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.082 0.953 . . . . 74.54 109.801 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.482 HD11 ' HB ' ' C' ' 92' ' ' THR . 23.2 tp 70.09 -76.4 0.06 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.697 1.599 . . . . 70.15 109.696 -175.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -138.05 2.04 2.31 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 124.067 0.947 . . . . 64.43 110.859 170.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -117.83 169.0 9.96 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.639 1.176 . . . . 71.34 109.067 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -52.75 148.48 7.33 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.171 0.989 . . . . 74.14 112.892 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' C' ' 140' ' ' TYR . . . -115.22 127.61 55.62 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.331 1.052 . . . . 44.01 109.999 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -155.72 70.08 0.28 Allowed Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.956 -0.458 . . . . 72.41 111.956 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -147.91 123.13 10.21 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.468 0.707 . . . . 73.43 109.708 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.32 147.3 5.16 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.391 0.432 . . . . 54.4 112.715 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 18.0 p -89.65 172.09 9.19 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.119 0.968 . . . . 72.0 110.657 177.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -119.49 159.07 25.0 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.796 0.838 . . . . 44.33 111.796 -170.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . 0.536 ' HB2' HE22 ' A' ' 12' ' ' GLN . 13.9 tp10 -145.24 146.57 31.75 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.925 0.49 . . . . 72.14 110.888 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -119.78 27.35 8.76 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.434 1.094 . . . . 70.04 112.25 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -64.92 132.69 50.03 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 118.192 0.451 . . . . 43.3 111.066 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -92.0 114.17 26.63 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.461 0.704 . . . . 71.01 109.332 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . 0.534 ' H ' ' HA3' ' G' ' 469' ' ' GLY . . . . . . . . 0 CA--C 1.562 1.418 0 C-N-CA 124.339 1.055 . . . . 55.23 109.096 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 109.108 -0.701 . . . . 64.12 109.108 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 23.4 m -119.88 147.74 44.34 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.044 0.937 . . . . 72.14 110.006 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -131.05 106.64 8.52 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.533 0.733 . . . . 63.34 109.374 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -94.18 80.98 4.03 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.739 -0.837 . . . . 64.12 108.739 171.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -158.46 147.33 18.93 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.723 -1.214 . . . . 45.44 107.723 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -71.92 84.21 0.95 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.537 0.684 . . . . 74.5 109.739 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -118.16 -170.63 1.92 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.952 1.301 . . . . 65.42 108.119 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -68.08 -14.87 63.31 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.169 0.803 . . . . 71.31 113.169 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 10.4 tpt -34.31 123.79 0.5 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.714 0.805 . . . . 52.12 111.46 159.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 37.1 m -133.55 142.34 48.13 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.088 0.555 . . . . 75.42 110.024 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -158.14 97.01 1.49 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.87 -1.529 . . . . 74.12 106.87 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -134.46 149.82 50.77 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.828 -0.805 . . . . 70.23 108.828 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.464 HD11 HG21 ' D' ' 105' ' ' ILE . 4.5 mt -92.87 130.48 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.404 -0.591 . . . . 70.32 109.404 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -86.73 -35.22 19.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.055 0.542 . . . . 52.23 110.5 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -174.54 130.56 0.35 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.488 0.315 . . . . 65.2 111.091 -172.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.488 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.5 mp -107.47 140.78 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.747 -1.205 . . . . 74.13 107.747 172.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -162.65 158.62 23.44 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.733 0.646 . . . . 71.15 111.679 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.8 p -93.59 118.85 31.89 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.169 -0.923 . . . . 72.55 109.56 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -90.28 -20.59 22.76 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 116.045 -0.525 . . . . 75.41 109.923 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.1 t70 -157.02 132.36 9.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.517 -0.765 . . . . 75.3 109.821 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.57 HG21 ' HE2' ' C' ' 117' ' ' MET . 60.4 mt -135.9 147.06 28.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 124.548 1.139 . . . . 41.31 107.982 171.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 42.0 t -153.52 115.68 4.35 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.82 0.7 . . . . 53.1 110.142 171.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -110.21 134.22 52.44 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.487 -1.671 . . . . 72.33 106.487 166.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.718 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 31.4 mt-10 -140.0 120.21 13.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.777 0.831 . . . . 72.02 108.959 -173.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.05 89.43 50.75 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.845 -1.169 . . . . 75.34 107.845 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.3 -46.8 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.103 2.536 . . . . 73.13 111.795 -174.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 26.3 m-20 -98.2 34.93 1.85 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.256 1.023 . . . . 71.14 109.01 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.8 -66.86 0.53 Allowed Pre-proline 0 CA--C 1.567 1.614 0 N-CA-C 114.101 1.149 . . . . 70.14 114.101 -162.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.428 ' HB3' HD11 ' C' ' 83' ' ' ILE . 95.1 Cg_endo -76.03 -20.28 15.04 Favored 'Trans proline' 0 C--N 1.384 2.447 0 CA-C-N 122.705 2.002 . . . . 75.34 113.02 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.413 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 6.6 t-160 -64.49 -47.65 78.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.575 1.55 . . . . 73.51 109.746 176.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.707 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.1 p -85.26 -23.94 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 CA-C-N 114.821 -1.081 . . . . 73.01 112.194 -168.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -60.79 -30.45 70.05 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 123.355 0.662 . . . . 73.31 112.765 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -60.08 -24.06 64.3 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.931 -1.031 . . . . 62.03 111.166 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -86.84 85.14 7.25 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.365 1.066 . . . . 75.44 108.775 173.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.15 82.08 3.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.419 0.628 . . . . 72.22 110.414 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -142.17 157.88 44.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.012 1.325 . . . . 53.45 107.759 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -68.22 107.69 2.15 Favored Pre-proline 0 CA--C 1.555 1.139 0 N-CA-C 108.635 -0.876 . . . . 71.32 108.635 172.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.412 ' O ' HG13 ' D' ' 40' ' ' VAL . 35.8 Cg_exo -59.93 120.96 9.06 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.122 2.548 . . . . 73.41 112.157 -168.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.47 ' HA ' ' HG ' ' H' ' 470' ' ' LEU . 46.9 mt-10 -67.15 111.78 4.1 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 123.943 0.777 . . . . 51.34 109.983 -175.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.608 HG12 ' HB2' ' D' ' 66' ' ' ALA . 35.9 m -104.5 142.49 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.109 -0.951 . . . . 75.23 110.745 -173.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.49 136.93 40.51 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.912 -1.144 . . . . 72.05 107.912 162.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.4 112.42 24.35 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.168 -1.049 . . . . 71.12 108.168 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -127.54 123.13 35.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.331 -0.989 . . . . 73.1 108.331 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.406 ' H ' HD22 ' H' ' 460' ' ' LEU . 6.0 mp -116.05 160.81 19.79 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.446 0.641 . . . . 71.34 110.047 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -149.73 151.6 33.92 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.202 -1.407 . . . . 64.23 107.202 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -128.37 154.18 46.26 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.464 -0.569 . . . . 71.3 109.464 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.69 157.75 43.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.983 0.913 . . . . 72.51 109.402 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.4 m -149.01 153.44 37.91 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.332 0.653 . . . . 50.52 109.968 175.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.8 t -152.67 126.01 8.69 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.669 0.788 . . . . 73.13 109.757 -169.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -78.01 118.33 20.19 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.78 0.432 . . . . 75.32 109.842 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.472 HD11 ' HB2' ' D' ' 57' ' ' GLU . 67.0 mt -91.72 -42.09 10.34 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.579 -0.526 . . . . 54.2 109.579 176.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.62 -174.95 5.09 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.872 -1.058 . . . . 73.32 110.05 -176.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.11 117.86 9.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.924 -1.035 . . . . 64.24 110.031 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 64.39 18.01 11.09 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.501 1.126 . . . . 71.01 111.68 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.98 119.25 59.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 124.228 1.011 . . . . 64.25 108.356 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.403 ' CD1' HD11 ' D' ' 86' ' ' ILE . 14.6 m-85 -132.44 127.33 35.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.501 -0.926 . . . . 74.11 108.501 175.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.472 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.1 tt0 -90.21 121.65 32.43 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.656 1.183 . . . . 72.4 108.897 169.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 74.3 t -102.27 142.37 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.542 -0.91 . . . . 64.41 108.542 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.455 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.6 t -121.91 130.76 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.463 -0.94 . . . . 65.41 108.463 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -110.59 119.85 40.52 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.442 -1.318 . . . . 71.1 107.442 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -98.02 96.6 8.26 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.034 -1.099 . . . . 74.42 108.034 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.9 t -93.44 120.01 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.012 -1.107 . . . . 74.55 108.012 171.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -119.18 140.87 49.46 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.432 0.693 . . . . 75.51 109.601 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.49 HG11 HD11 ' D' ' 126' ' ' LEU . 91.5 t -136.51 122.26 28.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 125.031 1.333 . . . . 55.44 108.276 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 93.3 m -119.51 112.63 19.6 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.743 -0.836 . . . . 55.21 108.743 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -111.02 154.82 23.64 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.855 0.862 . . . . 52.3 110.293 -172.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 34.0 p -149.8 134.14 17.35 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.783 0.677 . . . . 63.43 111.415 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.455 ' HB2' HG22 ' D' ' 31' ' ' VAL . 48.1 mt -113.19 122.62 48.04 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.933 1.293 . . . . 71.14 107.855 171.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.4 -112.46 3.48 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.999 -0.44 . . . . 63.32 111.999 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 4.08 9.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.118 0.967 . . . . 73.52 110.036 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -126.15 163.0 24.08 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.64 0.776 . . . . 70.24 110.392 -170.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.0 m -61.91 125.41 23.76 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 124.22 0.95 . . . . 74.03 111.801 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.707 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -81.13 -72.87 0.4 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.339 -0.985 . . . . 44.12 108.339 171.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . 0.525 ' HZ ' HD12 ' D' ' 126' ' ' LEU . 48.1 p90 -144.7 160.45 41.18 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.559 0.695 . . . . 65.41 110.311 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.718 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 64.8 mt -122.58 141.4 51.74 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 106.451 -1.685 . . . . 74.15 106.451 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.579 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.8 t -153.49 136.66 15.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.782 -0.451 . . . . 64.21 109.782 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -153.8 130.82 11.02 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.619 0.768 . . . . 74.23 108.936 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.8 t -129.44 114.19 30.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.532 -0.914 . . . . 74.13 108.532 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.0 mt-30 -89.9 84.75 6.24 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 122.045 0.926 . . . . 73.53 109.07 171.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.86 101.41 8.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 113.474 -1.694 . . . . 75.0 110.146 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.87 161.37 29.36 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.957 -0.457 . . . . 71.01 111.957 175.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.22 134.92 3.58 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.942 -0.863 . . . . 43.03 110.942 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.1 mt -87.33 128.51 39.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 124.101 0.96 . . . . 51.34 108.93 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -128.12 126.59 41.42 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.237 0.615 . . . . 63.3 110.175 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.4 m -81.13 102.45 10.28 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.984 -0.747 . . . . 73.4 108.984 169.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.538 HD13 HD11 ' D' ' 98' ' ' LEU . 44.7 pt -109.7 140.99 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.195 0.998 . . . . 70.23 110.689 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.9 159.16 34.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.836 0.854 . . . . 65.34 109.448 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.98 -0.36 89.08 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 114.349 0.499 . . . . 32.21 114.349 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.521 HD11 HD12 ' D' ' 86' ' ' ILE . 29.0 pt -105.37 147.86 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.473 0.709 . . . . 74.04 110.389 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.1 146.65 28.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.117 0.567 . . . . 73.21 111.588 -176.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.65 -113.5 2.78 Favored Glycine 0 C--N 1.355 1.605 0 C-N-CA 124.254 0.931 . . . . 74.35 115.143 175.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.9 p -64.43 -33.22 75.36 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.693 1.197 . . . . 64.04 111.6 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -65.64 -31.11 71.96 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.486 0.715 . . . . 75.05 111.032 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.683 ' HB3' HD23 ' H' ' 454' ' ' LEU . 55.9 mtm -67.97 -45.79 73.19 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.614 0.365 . . . . 70.31 110.128 174.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.12 -37.36 82.53 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.074 0.55 . . . . 74.42 111.317 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -71.15 -38.8 72.2 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.86 0.864 . . . . 44.43 111.078 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -72.75 -51.11 20.47 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.377 -0.374 . . . . 45.33 111.632 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.596 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.2 mm? -86.06 -28.52 24.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.422 0.689 . . . . 74.11 111.041 -174.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.95 -22.97 47.35 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 114.242 0.457 . . . . 71.51 114.242 -176.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -129.04 -56.6 1.18 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.983 0.513 . . . . 75.23 111.479 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . 0.548 ' HA ' HD22 ' D' ' 104' ' ' ASN . 63.2 t80 -70.63 -34.88 72.57 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 112.839 0.681 . . . . 73.13 112.839 -172.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.596 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 75.7 m -69.57 -49.45 21.77 Favored Pre-proline 0 CA--C 1.569 1.679 0 CA-C-O 118.562 -0.732 . . . . 63.12 111.625 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 84.1 Cg_exo -55.25 -30.3 71.14 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 122.565 2.176 . . . . 52.34 114.48 170.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . 0.548 HD22 ' HA ' ' D' ' 101' ' ' TYR . 72.9 m-20 -53.96 -40.26 66.69 Favored 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 123.584 0.754 . . . . 75.24 111.857 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.464 HG21 HD11 ' D' ' 13' ' ' ILE . 36.2 mt -78.69 -40.65 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.899 0.88 . . . . 63.41 110.761 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.2 mt -72.36 -20.82 61.39 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.506 -0.77 . . . . 73.11 111.973 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -68.22 -45.3 39.23 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.035 0.934 . . . . 73.24 113.119 -173.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -50.05 -45.77 31.4 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.591 2.194 . . . . 72.12 114.415 169.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.16 -41.57 77.07 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.446 0.698 . . . . 64.44 111.32 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.34 95.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.723 0.809 . . . . 73.23 110.51 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.461 ' HA ' HD23 ' D' ' 128' ' ' LEU . 29.5 ttp180 -59.72 -51.23 70.68 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.41 -1.268 . . . . 74.54 110.385 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.64 -45.81 92.45 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 124.528 1.143 . . . . 75.53 111.154 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.55 -41.34 80.77 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.01 0.819 . . . . 73.45 110.856 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.579 HG12 ' SG ' ' D' ' 76' ' ' CYS . 76.3 mt -63.05 -56.34 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 123.74 0.65 . . . . 64.5 110.262 173.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.3 m -53.7 -39.38 65.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.409 1.083 . . . . 33.42 111.682 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -66.15 -46.28 78.01 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.83 -1.077 . . . . 64.33 109.867 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.3 mtm -69.34 -30.21 68.19 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.002 0.521 . . . . 73.23 112.317 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.49 HG13 ' HB2' ' D' ' 123' ' ' PHE . 72.7 t -66.02 -45.32 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.461 0.704 . . . . 71.52 109.209 175.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -71.51 -33.03 68.87 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 123.391 0.432 . . . . 72.13 110.822 -178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -69.97 -33.03 71.54 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.927 0.891 . . . . 74.22 110.089 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.8 3.28 86.08 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 123.884 0.74 . . . . 73.53 112.463 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.423 HG23 ' HB3' ' C' ' 17' ' ' TYR . 36.4 p 63.1 23.77 14.11 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 126.721 2.008 . . . . 33.24 114.446 171.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.49 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.6 m-85 -86.74 151.5 52.68 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 108.924 -0.769 . . . . 73.01 108.924 170.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.07 145.92 31.97 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.352 2.701 . . . . 71.01 113.792 174.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -54.76 140.19 36.95 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.352 1.061 . . . . 72.22 113.668 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.532 ' HA ' HD11 ' H' ' 468' ' ' LEU . 4.8 tt -119.75 106.69 12.36 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.482 -0.932 . . . . 71.32 108.482 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -108.95 111.57 23.31 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.843 -0.799 . . . . 55.21 108.843 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' D' ' 111' ' ' ARG . 3.1 mm? -73.69 120.28 19.06 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.97 -0.752 . . . . 75.13 108.97 171.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.43 ' H ' ' HA ' ' H' ' 467' ' ' ALA . . . -67.28 137.93 94.14 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 109.812 -0.44 . . . . 64.12 109.812 175.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.85 115.03 3.26 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.385 2.056 . . . . 43.42 111.548 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.7 m -108.04 152.8 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.436 0.694 . . . . 75.32 110.09 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -81.51 96.18 7.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.399 -0.819 . . . . 73.02 109.121 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -63.49 -31.64 72.86 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.653 0.381 . . . . 74.23 111.22 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.429 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 54.9 m-20 -62.09 -57.82 10.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.531 0.732 . . . . 74.11 111.564 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.61 96.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.642 0.777 . . . . 64.44 111.17 -176.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.51 ' HA ' HD22 ' D' ' 139' ' ' ASN . 5.0 mp -67.23 -28.18 67.85 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.16 -0.927 . . . . 73.24 111.797 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -68.72 -34.4 75.56 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.004 0.922 . . . . 74.05 111.333 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 44.4 mtt -68.1 -26.18 65.69 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.169 0.588 . . . . 62.22 110.852 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.51 HD22 ' HA ' ' D' ' 136' ' ' LEU . 46.7 m-80 -73.99 -19.78 60.54 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.093 0.557 . . . . 73.44 111.674 176.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . 0.484 ' HB2' ' HB2' ' H' ' 461' ' ' PHE . 68.8 t80 -80.81 -40.03 25.66 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.047 0.539 . . . . 65.14 111.56 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.0 -27.95 69.18 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.223 1.009 . . . . 63.34 111.554 -177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -90.23 17.47 7.06 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 123.876 0.87 . . . . 62.35 112.105 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 53.4 mt-30 -119.23 88.59 2.96 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.839 0.856 . . . . 54.12 108.76 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -165.3 103.12 0.74 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.269 -0.878 . . . . 73.2 109.292 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 64.5 -74.25 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.79 1.636 . . . . 62.55 113.157 175.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.8 -140.57 2.96 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 111.852 -0.499 . . . . 74.23 111.852 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -143.88 172.15 13.24 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.737 0.815 . . . . 73.53 110.829 -175.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.05 -135.14 2.48 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.871 -0.604 . . . . 73.4 111.706 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.2 m -99.17 25.87 6.43 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.547 0.739 . . . . 74.34 109.864 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 56.43 77.58 0.24 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.715 1.206 . . . . 52.22 111.21 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.82 79.39 0.87 Allowed 'General case' 0 CA--C 1.549 0.942 0 CA-C-O 122.696 1.236 . . . . 50.15 108.737 171.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -80.75 97.1 7.16 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.059 -1.428 . . . . 73.42 109.578 -171.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -72.3 126.73 30.53 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.333 -0.988 . . . . 73.25 108.333 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -121.26 150.35 41.49 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.521 0.728 . . . . 71.43 110.532 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.834 0 C-N-CA 124.06 0.944 . . . . 55.2 108.483 -179.264 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 109.343 -0.614 . . . . 62.14 109.343 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 13.1 m -114.7 86.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-O 122.326 1.06 . . . . 70.04 108.773 171.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . 0.404 HG12 ' HE1' ' A' ' 56' ' ' TYR . 34.3 m -125.03 144.25 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 115.096 -0.956 . . . . 52.54 110.255 -172.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . 163.25 -169.23 38.29 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 115.602 -0.727 . . . . 54.2 111.639 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 95' ' ' ALA . 2.7 tt 65.66 66.31 0.52 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.969 1.307 . . . . 65.2 109.975 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 85.3 m -157.58 110.05 2.41 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.417 1.087 . . . . 65.14 108.834 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -158.22 -54.97 0.07 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.239 -1.022 . . . . 72.03 108.239 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -150.1 129.08 12.59 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.563 -0.902 . . . . 71.14 108.563 173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 76.3 p -92.56 27.27 2.35 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.087 0.955 . . . . 55.31 111.948 -174.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -70.39 106.84 3.54 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.55 0.74 . . . . 70.35 109.205 178.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . 0.559 ' H ' HD23 ' E' ' 460' ' ' LEU . 2.6 pt? -120.35 -178.61 3.73 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.602 0.715 . . . . 74.01 111.744 -167.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -86.13 158.05 19.88 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.164 1.386 . . . . 72.14 111.119 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -166.45 134.46 2.78 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.463 1.105 . . . . 74.54 109.147 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 28.8 p -132.96 -77.95 0.49 Allowed 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 123.126 0.571 . . . . 61.21 111.267 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . . . . . . . . . 94.8 mmm 66.66 -75.41 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.515 1.526 . . . . 61.44 111.501 -171.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 61.21 41.97 12.73 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.626 1.17 . . . . 64.34 111.269 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . -151.68 176.87 10.95 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.705 0.802 . . . . 44.33 110.359 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' A' ' 40' ' ' VAL . . . -81.02 17.42 1.23 Allowed 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.892 0.877 . . . . 72.34 112.106 177.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . . . . . . . . . 53.1 mt 68.37 -71.67 0.11 Allowed 'General case' 0 C--N 1.368 1.397 0 C-N-CA 126.413 1.885 . . . . 65.02 110.568 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -171.54 26.15 0.09 OUTLIER Glycine 0 C--N 1.341 0.828 0 O-C-N 123.922 0.764 . . . . 64.31 112.053 175.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . 0.638 ' HG ' HD13 ' A' ' 126' ' ' LEU . 70.4 mt -105.72 139.02 40.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.779 0.832 . . . . 70.2 109.936 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 58.4 pttt . . . . . 0 C--O 1.256 1.409 0 C-N-CA 123.526 0.73 . . . . 74.21 109.416 171.347 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 108.944 -0.762 . . . . 73.25 108.944 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . 0.445 HG13 HG22 ' F' ' 452' ' ' VAL . 14.5 p -60.36 -24.38 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.604 0.762 . . . . 74.11 112.248 -173.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . 0.691 ' HB ' HD23 ' B' ' 98' ' ' LEU . 2.8 m -148.67 159.08 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.107 0.963 . . . . 75.23 111.371 176.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . 0.525 ' H ' HD21 ' B' ' 98' ' ' LEU . . . 179.03 91.96 0.08 OUTLIER Glycine 0 C--N 1.357 1.736 0 CA-C-N 115.342 -0.844 . . . . 54.21 112.187 176.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . 0.484 ' HB2' HD22 ' B' ' 98' ' ' LEU . 30.0 tp -88.16 132.14 34.45 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.45 0.7 . . . . 45.52 110.418 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 41.0 m -149.52 144.54 26.33 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.193 0.997 . . . . 75.31 108.467 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -100.01 143.65 29.97 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.34 0.656 . . . . 72.3 110.309 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -72.37 -39.75 67.82 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.589 0.756 . . . . 44.14 110.263 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 19.6 p -145.86 -59.09 0.32 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.401 1.08 . . . . 72.13 109.015 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -151.75 165.94 32.89 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.534 1.134 . . . . 71.0 108.49 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.85 140.16 39.34 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.177 -0.675 . . . . 71.04 109.177 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . 0.418 ' HB3' ' HD1' ' B' ' 140' ' ' TYR . 48.7 p90 -67.19 135.75 53.97 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.534 0.734 . . . . 70.4 112.06 -174.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -141.33 119.49 12.08 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.869 -1.16 . . . . 63.35 107.869 172.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . . . . . . . . . 22.3 p -134.8 -41.04 0.76 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.007 0.923 . . . . 41.23 108.901 173.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 25.8 ttt 69.54 -78.75 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.443 1.497 . . . . 51.24 110.181 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -172.66 -58.92 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.872 1.269 . . . . 65.3 108.153 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -163.19 -63.38 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.827 0.851 . . . . 75.3 108.873 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -155.71 -178.27 7.17 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.845 1.258 . . . . 62.43 109.059 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 5.8 tt -80.34 -47.52 14.36 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.175 -0.676 . . . . 75.02 109.175 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.61 72.41 1.21 Allowed Glycine 0 C--N 1.341 0.832 0 N-CA-C 110.799 -0.92 . . . . 64.25 110.799 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . . . . . . . . . 88.4 mt -80.95 96.73 7.17 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.25 0.62 . . . . 72.44 109.623 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? . . . . . 0 CA--C 1.56 1.337 0 C-N-CA 125.048 1.339 . . . . 63.31 108.924 -177.028 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 16.5 m120 . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 109.935 -0.394 . . . . 65.21 109.935 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . 0.401 HG22 ' HB3' ' C' ' 90' ' ' GLU . 45.5 t -70.43 160.14 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 N-CA-C 108.287 -1.005 . . . . 60.51 108.287 171.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . 0.422 ' N ' ' SD ' ' C' ' 94' ' ' MET . 60.8 t 71.3 120.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.207 1.403 . . . . 65.41 111.603 -174.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 139.74 80.33 0.07 OUTLIER Glycine 0 C--N 1.35 1.352 0 N-CA-C 112.382 -0.287 . . . . 60.02 112.382 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' C' ' 98' ' ' LEU . 8.6 mp -102.0 -175.96 2.99 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.99 0.916 . . . . 54.34 110.774 177.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 22.3 p -80.58 156.67 26.33 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.714 1.206 . . . . 72.15 110.431 175.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -58.91 122.41 13.57 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.568 0.747 . . . . 75.2 111.166 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' C' ' 47' ' ' ALA . 61.3 tp60 78.19 -48.02 0.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.44 1.896 . . . . 74.32 112.744 176.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . 0.623 HG21 ' HA2' ' C' ' 99' ' ' GLY . 27.6 m 68.31 89.22 0.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.713 1.205 . . . . 75.34 108.829 -163.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.24 156.5 37.17 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.283 -0.872 . . . . 61.42 111.233 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . 0.495 ' HB3' ' HD1' ' G' ' 462' ' ' TYR . 4.2 mm? -100.37 168.67 9.61 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.872 0.844 . . . . 74.52 111.197 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -164.0 26.37 0.08 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 113.958 -1.474 . . . . 73.32 109.06 -162.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . 0.515 ' HA ' HD13 ' C' ' 136' ' ' LEU . 19.0 p90 -74.37 83.75 1.94 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.335 1.064 . . . . 75.21 110.96 -170.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 36.0 p -85.01 85.12 7.52 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.24 -0.891 . . . . 63.42 109.797 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . 0.416 ' HG3' HG12 ' C' ' 131' ' ' VAL . 16.3 tmm? -121.84 147.27 46.19 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.939 -0.763 . . . . 74.2 108.939 177.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . 0.444 ' HA ' ' HE3' ' G' ' 465' ' ' LYS . 1.4 tpmt? -58.48 -60.87 3.12 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.712 1.205 . . . . 72.25 112.981 -168.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -110.64 -147.05 0.41 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.784 0.834 . . . . 63.32 110.447 -171.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -150.33 -55.86 0.17 Allowed 'General case' 0 C--O 1.242 0.685 0 N-CA-C 107.961 -1.126 . . . . 70.52 107.961 175.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -167.58 -164.23 0.56 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.807 -1.542 . . . . 50.54 108.494 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . 0.534 ' HA3' ' H ' ' C' ' 155' ' ' ALA . . . -83.76 -97.62 0.59 Allowed Glycine 0 C--N 1.349 1.297 0 CA-C-O 119.587 -0.563 . . . . 61.32 112.333 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . . . . . . . . . 60.8 mt 55.8 77.06 0.25 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.94 1.296 . . . . 53.22 112.187 -173.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.35 0 CA-C-O 118.532 -0.747 . . . . 63.1 109.452 172.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . 0.476 ' ND2' HG13 ' H' ' 451' ' ' VAL . 1.7 t30 . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 109.972 -0.381 . . . . 71.55 109.972 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . 0.669 HG23 HG23 ' H' ' 452' ' ' VAL . 27.7 m -114.78 -179.87 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 123.005 0.522 . . . . 72.42 111.175 175.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . 0.669 HG23 HG23 ' H' ' 451' ' ' VAL . 22.4 t 74.01 132.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.388 1.875 . . . . 34.2 112.114 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . -161.82 95.36 0.13 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.185 -1.166 . . . . 31.01 110.185 174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . 0.683 HD23 ' HB3' ' D' ' 94' ' ' MET . 3.1 pp -127.72 170.13 13.06 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.311 0.577 . . . . 75.21 111.083 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 40.1 p -97.35 162.86 13.14 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.556 -1.202 . . . . 72.43 109.439 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.57 81.46 1.09 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.182 0.993 . . . . 60.01 111.386 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 51.38 -150.94 0.26 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.882 1.273 . . . . 72.2 113.445 168.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 4.4 t -158.84 -54.31 0.06 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.543 0.337 . . . . 72.42 111.422 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -175.56 166.61 3.24 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.597 0.759 . . . . 65.41 109.674 -171.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . 0.406 HD22 ' H ' ' D' ' 44' ' ' LEU . 39.1 tp -66.99 151.48 47.57 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.13 0.572 . . . . 64.22 109.847 172.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . 0.484 ' HB2' ' HB2' ' D' ' 140' ' ' TYR . 17.2 p90 -124.27 16.38 9.07 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.373 0.879 . . . . 73.32 113.373 -168.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . 0.427 ' HE2' ' SD ' ' H' ' 464' ' ' MET . 21.3 p90 -165.65 156.77 13.88 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 120.807 0.337 . . . . 73.31 111.323 178.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 56.8 m -91.59 103.66 16.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.588 0.755 . . . . 70.5 109.343 173.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . 0.427 ' SD ' ' HE2' ' H' ' 462' ' ' TYR . 14.2 tpt -77.44 105.56 8.65 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.359 0.663 . . . . 73.12 110.073 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -117.42 -50.72 2.53 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.587 1.155 . . . . 54.3 109.252 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -72.6 98.24 2.29 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 114.339 -1.301 . . . . 75.11 110.177 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . 0.43 ' HA ' ' H ' ' D' ' 129' ' ' ALA . . . -153.72 -67.48 0.14 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.536 -0.757 . . . . 73.14 109.594 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . 0.532 HD11 ' HA ' ' D' ' 126' ' ' LEU . 3.4 mm? -99.37 -53.24 3.28 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.125 0.97 . . . . 75.25 109.584 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . 92.04 -36.08 3.79 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.551 -0.749 . . . . 71.05 112.66 -174.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' D' ' 39' ' ' GLU . 2.8 mm? 58.5 39.96 24.43 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.213 1.405 . . . . 62.32 110.562 -178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? . . . . . 0 CA--C 1.555 1.173 0 CA-C-N 114.401 -1.272 . . . . 73.25 110.366 -177.356 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.5 mtp . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 109.386 -0.598 . . . . 44.5 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.0 p -150.84 113.15 4.61 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.297 -1.001 . . . . 73.4 108.297 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.85 157.0 34.16 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.806 0.842 . . . . 75.33 111.402 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -138.86 136.53 35.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.416 0.686 . . . . 74.44 109.749 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -135.39 -7.94 2.24 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.607 0.763 . . . . 73.23 111.184 -169.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -70.85 88.43 0.74 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.217 0.532 . . . . 74.45 110.457 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -81.87 -38.07 25.96 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.859 0.863 . . . . 54.33 109.597 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -73.27 139.07 45.89 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.063 -0.971 . . . . 71.45 110.154 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.492 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 4.5 ppp? -72.33 158.59 35.52 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.658 -0.701 . . . . 74.14 111.614 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.3 m -143.99 136.76 27.16 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.896 0.879 . . . . 72.22 109.071 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.623 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.6 t80 -136.21 129.71 32.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.062 -0.718 . . . . 71.42 109.062 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 48.1 tp60 -149.87 109.6 4.05 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.947 0.899 . . . . 73.53 109.04 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.539 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.4 mt -78.59 112.53 16.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.408 -0.96 . . . . 61.13 108.408 174.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.9 -41.83 25.35 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.825 -0.625 . . . . 61.23 109.317 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -171.19 123.57 0.59 Allowed 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.157 0.286 . . . . 75.31 111.185 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.615 HD12 ' HG3' ' C' ' 130' ' ' PRO . 72.2 mt -111.95 136.26 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 123.74 0.816 . . . . 64.32 109.166 174.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 24.9 p90 -166.52 177.8 6.45 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.204 0.94 . . . . 70.01 110.928 -171.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -103.08 120.23 40.3 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.459 -0.791 . . . . 61.22 109.01 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 27.2 mtpt -84.77 -38.42 19.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.404 -0.591 . . . . 73.2 109.404 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.719 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.7 t70 -138.97 136.28 35.22 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.063 -0.971 . . . . 74.31 109.534 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 49.7 mt -133.55 146.68 31.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.116 -1.438 . . . . 74.11 107.116 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.1 t -155.16 145.71 22.17 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.636 0.585 . . . . 54.23 109.811 172.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.449 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.6 t80 -145.89 131.72 19.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.926 -1.509 . . . . 73.22 106.926 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -138.72 129.96 27.05 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.721 -0.844 . . . . 72.41 108.721 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -129.43 81.41 70.1 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.316 -0.994 . . . . 74.51 108.316 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.26 -25.91 25.8 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.024 2.482 . . . . 70.22 112.986 -172.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 31' ' ' VAL . 51.4 m-80 -114.67 24.11 12.1 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.411 0.685 . . . . 64.15 110.445 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -52.1 -49.31 85.13 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 113.705 1.002 . . . . 73.24 113.705 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.54 -21.83 18.99 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 121.982 1.788 . . . . 74.22 111.964 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -80.1 -23.04 41.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.98 -1.009 . . . . 74.21 111.006 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 86.2 t -59.96 -24.65 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.637 0.775 . . . . 74.15 111.3 177.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -56.96 -38.85 73.54 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.852 0.861 . . . . 63.21 111.188 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -93.11 -20.92 20.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.497 0.719 . . . . 72.44 110.921 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.533 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 30.7 mmmt -79.86 143.41 34.34 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.62 0.768 . . . . 73.24 111.468 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.27 121.12 20.8 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 108.34 -0.985 . . . . 72.03 108.34 168.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -68.88 89.91 0.42 Allowed 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.472 0.482 . . . . 71.52 110.689 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -144.13 81.55 11.48 Favored Pre-proline 0 C--O 1.245 0.834 0 N-CA-C 107.519 -1.289 . . . . 74.5 107.519 167.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 95.5 Cg_endo -81.94 157.66 18.13 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.693 2.262 . . . . 73.43 112.798 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.413 ' HB3' ' HE3' ' A' ' 41' ' ' LYS . 16.6 mm-40 -95.74 99.97 11.74 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.084 -1.08 . . . . 75.55 108.084 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.2 m -71.21 94.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-O 122.292 1.044 . . . . 72.21 110.776 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 39' ' ' GLU . 97.6 mttt -110.03 135.63 50.56 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.753 -1.112 . . . . 74.12 109.443 -177.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.523 ' HB3' ' H ' ' E' ' 466' ' ' ALA . 39.5 tp -136.15 126.6 26.8 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.076 0.55 . . . . 65.42 110.737 -175.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.412 ' HA ' ' OH ' ' E' ' 462' ' ' TYR . 16.7 m-20 -126.42 131.29 51.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.83 0.852 . . . . 62.33 109.397 173.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.64 HD22 HG12 ' A' ' 62' ' ' VAL . 54.5 mt -119.69 134.33 55.27 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.413 0.685 . . . . 61.03 110.518 -175.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 8.2 m-20 -125.8 141.15 52.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.799 1.24 . . . . 74.43 108.188 173.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.5 m -126.32 129.85 49.66 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.006 -0.739 . . . . 73.31 109.006 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.58 153.95 50.5 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.438 1.095 . . . . 63.45 108.491 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB3' HD12 ' E' ' 454' ' ' LEU . 26.7 t -126.72 152.95 46.14 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 120.911 0.386 . . . . 53.24 110.17 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.5 t -149.45 121.41 8.22 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.386 1.074 . . . . 63.5 108.766 -176.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -74.28 125.85 29.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.092 0.557 . . . . 73.31 109.69 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.5 mt -95.49 -34.42 12.08 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.316 0.646 . . . . 75.12 110.421 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.0 177.36 10.83 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.08 0.952 . . . . 74.33 109.268 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -66.22 125.75 26.53 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.287 -0.634 . . . . 73.35 109.287 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 70.82 3.59 4.67 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.056 1.343 . . . . 73.42 112.142 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.75 115.0 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.251 1.021 . . . . 63.4 108.621 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -126.77 156.29 41.46 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.59 0.756 . . . . 74.1 109.604 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -130.19 142.85 50.54 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.266 -1.013 . . . . 62.4 108.266 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.51 139.91 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 108.241 -1.022 . . . . 75.31 108.241 165.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -112.41 107.34 22.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 107.824 -1.176 . . . . 65.24 107.824 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.8 tp -88.94 100.76 13.45 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.332 -0.849 . . . . 61.12 109.11 178.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 14.0 ttm-85 -84.46 107.89 16.96 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.65 -0.704 . . . . 62.22 109.155 175.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.64 HG12 HD22 ' A' ' 44' ' ' LEU . 19.8 m -103.96 130.22 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 123.857 0.863 . . . . 70.13 109.559 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.1 m -121.26 116.36 24.74 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.641 0.777 . . . . 72.24 110.075 -176.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.3 t -116.14 121.45 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.486 1.114 . . . . 64.41 108.83 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.6 m -126.71 124.9 40.85 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.347 -0.983 . . . . 63.44 108.347 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -125.56 105.24 8.89 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.163 -0.68 . . . . 72.32 109.163 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 42.4 t -116.73 128.86 55.73 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.377 0.671 . . . . 73.41 111.207 -173.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' A' ' 73' ' ' ALA . 5.1 mp -89.92 86.37 6.6 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.223 -1.399 . . . . 75.3 107.223 175.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.08 -104.88 2.07 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.512 -1.035 . . . . 73.41 110.512 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -109.23 -14.02 14.55 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.179 0.592 . . . . 75.34 110.534 174.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -85.48 95.97 9.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.934 0.894 . . . . 75.43 110.118 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 26.5 m -67.44 125.46 26.21 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 123.441 0.463 . . . . 43.24 110.535 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.491 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -78.01 -54.06 6.72 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.318 -0.856 . . . . 61.01 109.003 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -146.59 155.47 42.5 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.429 -1.26 . . . . 63.44 110.878 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.7 tp -133.48 132.07 40.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.527 -1.657 . . . . 54.33 106.527 176.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 85.1 m -133.92 110.44 9.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.342 -0.614 . . . . 74.22 109.342 -174.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -124.38 117.07 23.63 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.044 0.938 . . . . 71.35 109.118 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.4 ' O ' HG22 ' A' ' 62' ' ' VAL . 75.3 t -132.91 111.33 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.221 0.608 . . . . 74.21 109.817 -173.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.719 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 26.3 mt-30 -87.81 87.12 7.27 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 108.609 -0.886 . . . . 75.4 108.609 167.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.408 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.9 tp-100 -76.91 116.63 17.75 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.919 -1.037 . . . . 63.43 108.448 176.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.84 144.25 18.35 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.56 -0.616 . . . . 71.2 111.56 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.477 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.99 134.22 6.06 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 111.167 -0.773 . . . . 74.51 111.167 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.3 mt -82.89 115.43 25.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.645 -0.872 . . . . 52.31 108.645 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.623 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.4 m-85 -122.29 117.7 26.74 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.857 0.863 . . . . 74.23 108.937 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 12.6 m -90.81 89.94 7.7 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.321 -0.992 . . . . 52.24 108.321 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.7 pt -109.74 139.72 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.347 -0.842 . . . . 62.51 110.766 -172.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.8 168.95 25.56 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.846 -1.07 . . . . 64.11 109.695 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 81.11 9.61 85.93 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.606 0.566 . . . . 74.05 114.039 174.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.15 153.69 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.126 0.57 . . . . 64.24 110.603 -176.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -160.43 -172.48 3.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.669 0.788 . . . . 73.23 110.506 -171.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.1 -143.34 48.47 Favored Glycine 0 C--N 1.359 1.824 0 O-C-N 123.537 0.523 . . . . 43.41 112.636 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.9 t -86.44 -11.24 52.39 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 122.866 0.466 . . . . 74.45 111.038 166.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -33.99 74.83 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.925 0.89 . . . . 73.24 109.827 177.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -31.71 70.8 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.375 0.27 . . . . 63.45 110.966 173.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.68 -28.18 55.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.65 0.78 . . . . 61.21 110.826 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 43.8 t-80 -69.73 -29.36 66.71 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.136 0.574 . . . . 64.5 110.313 170.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 78.0 m -69.69 -49.34 54.39 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.489 0.316 . . . . 71.32 110.928 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 pp -85.16 -18.93 32.65 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.017 0.527 . . . . 52.14 112.339 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.69 3.87 27.63 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-O 119.782 -0.455 . . . . 63.11 114.117 -173.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -148.09 -63.57 0.26 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.33 0.565 . . . . 74.45 111.378 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -61.66 -66.0 0.6 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.367 1.467 . . . . 72.11 112.826 -168.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.401 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 95.9 m -73.9 -37.98 3.6 Favored Pre-proline 0 CA--C 1.569 1.675 0 N-CA-C 114.701 1.371 . . . . 44.13 114.701 -175.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 35.8 Cg_endo -64.55 -24.53 63.18 Favored 'Trans proline' 0 C--N 1.388 2.626 0 CA-C-N 121.837 1.692 . . . . 71.34 113.369 173.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -69.43 -29.78 67.57 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.017 0.527 . . . . 72.55 110.13 177.656 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.4 mm -62.66 -40.66 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.443 0.697 . . . . 53.15 110.184 176.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.477 HD21 ' HA3' ' A' ' 82' ' ' GLY . 96.3 mt -79.53 -19.24 50.06 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.166 0.986 . . . . 74.13 112.967 -175.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -59.4 -47.74 97.38 Favored Pre-proline 0 CA--C 1.569 1.693 0 N-CA-C 113.584 0.957 . . . . 74.44 113.584 -172.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.9 -37.05 57.08 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.061 1.841 . . . . 74.33 113.096 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -67.31 -40.22 85.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.319 0.648 . . . . 74.12 111.153 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.474 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.59 -42.65 86.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.151 0.58 . . . . 64.44 110.137 177.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -50.31 -53.68 26.92 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.475 1.11 . . . . 75.42 110.506 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -68.65 -38.05 80.14 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.394 -0.821 . . . . 63.2 111.433 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.37 -34.18 74.89 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.107 0.48 . . . . 74.14 111.095 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 118' ' ' VAL . 60.7 mt -69.49 -57.25 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.132 -0.94 . . . . 71.22 109.624 172.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -55.35 -37.07 67.01 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.869 1.268 . . . . 74.21 111.923 -172.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.4 t -65.38 -50.3 66.05 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.117 -0.947 . . . . 73.51 109.903 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.449 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 67.6 mtm -62.27 -37.84 87.04 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.173 0.589 . . . . 74.34 111.454 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 114' ' ' ILE . 99.3 t -59.57 -49.12 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.676 0.79 . . . . 75.41 110.062 176.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 30.3 m -69.74 -29.78 67.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.537 -0.756 . . . . 72.54 111.615 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -72.8 -26.96 61.7 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.638 0.775 . . . . 72.21 110.126 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.87 6.64 77.84 Favored Glycine 0 C--N 1.354 1.563 0 O-C-N 123.685 0.616 . . . . 34.24 112.913 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.478 ' HB ' HH21 ' B' ' 15' ' ' ARG . 22.9 m 67.66 15.48 9.72 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 124.534 1.134 . . . . 71.01 111.175 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.463 ' HE1' HG21 ' A' ' 31' ' ' VAL . 63.6 m-85 -87.82 140.93 31.36 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 108.546 -0.909 . . . . 62.12 108.546 174.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -49.45 148.23 11.4 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.267 2.645 . . . . 75.32 113.25 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -59.63 129.46 42.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.5 0.72 . . . . 73.11 112.236 -173.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.51 HD13 ' HB2' ' E' ' 470' ' ' LEU . 41.8 tp -110.18 101.55 10.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.121 0.968 . . . . 65.21 109.844 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -102.25 103.79 14.3 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.142 -1.059 . . . . 71.31 108.142 171.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.61 154.58 41.31 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.661 0.384 . . . . 73.32 110.575 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.418 ' HB3' ' SD ' ' E' ' 464' ' ' MET . . . -69.56 142.84 92.17 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.363 0.665 . . . . 54.44 111.079 -175.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.33 127.91 13.14 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.343 2.029 . . . . 72.44 112.771 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' E' ' 464' ' ' MET . 76.8 t -102.28 115.06 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.856 0.862 . . . . 75.03 108.878 175.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -92.14 85.91 5.62 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.671 -1.233 . . . . 70.23 107.671 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 91.8 m-85 -59.05 -31.6 69.01 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.745 -1.116 . . . . 52.43 113.203 -169.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.12 -36.67 83.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.351 0.26 . . . . 74.34 111.419 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.62 -38.17 89.19 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.109 0.563 . . . . 73.34 110.895 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.586 HD13 ' HA ' ' E' ' 462' ' ' TYR . 97.6 mt -66.5 -39.38 88.69 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.211 -0.904 . . . . 64.1 111.311 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -68.61 -25.91 65.09 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.998 -0.546 . . . . 73.35 110.833 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 17.0 mmt -60.71 -34.3 74.18 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.04 0.536 . . . . 50.31 111.665 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -66.32 -24.09 66.47 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.841 0.856 . . . . 61.22 111.612 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -91.84 -44.64 8.83 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.837 0.855 . . . . 73.14 110.78 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.4 tp -68.18 -46.08 71.67 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.484 1.114 . . . . 70.44 112.361 -171.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.549 ' HB3' ' HG2' ' A' ' 144' ' ' GLN . 1.4 mm-40 -145.62 4.06 1.0 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.949 0.499 . . . . 74.54 110.555 -172.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 62.68 20.63 12.19 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.654 1.181 . . . . 71.25 111.567 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.549 ' HG2' ' HB3' ' A' ' 142' ' ' GLN . 73.0 mm-40 -95.19 163.45 13.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.211 0.604 . . . . 75.13 110.18 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.41 33.55 1.23 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.023 0.929 . . . . 72.14 110.817 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.2 -61.49 4.71 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 116.027 -0.533 . . . . 71.43 111.921 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 62.57 97.36 0.03 OUTLIER 'General case' 0 C--N 1.357 0.907 0 C-N-CA 125.251 1.42 . . . . 75.43 110.773 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -108.05 113.69 3.95 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.095 -0.802 . . . . 72.34 111.095 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.9 m -68.15 101.91 1.25 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.146 0.578 . . . . 72.41 110.23 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -82.74 133.15 35.16 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.145 -0.934 . . . . 74.42 109.478 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.411 ' HB3' ' NE2' ' C' ' 142' ' ' GLN . 39.0 tt0 -144.57 139.63 28.26 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.53 -1.285 . . . . 75.4 107.53 171.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -71.3 87.68 0.84 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.621 0.768 . . . . 72.12 111.824 -170.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' C' ' 141' ' ' LEU . 59.6 tp60 -84.76 105.45 15.56 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.5 -1.296 . . . . 74.21 107.5 163.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -78.36 84.91 4.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.175 0.59 . . . . 72.31 109.601 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.289 0 CA-C-N 115.443 -0.799 . . . . 71.21 109.585 178.603 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.7 mtt . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.575 -0.528 . . . . 73.43 109.575 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 44.8 m -140.74 -49.13 0.43 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.471 0.708 . . . . 75.42 110.233 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.18 135.32 54.35 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 109.866 -0.42 . . . . 72.21 109.866 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -150.36 103.18 3.12 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.979 0.419 . . . . 63.22 110.64 -177.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -104.59 163.63 12.34 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.95 1.3 . . . . 73.42 108.65 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -148.61 172.72 14.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.836 0.854 . . . . 60.1 109.743 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 69.8 m -82.55 84.97 7.05 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.346 -0.983 . . . . 73.22 108.346 167.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -74.59 -66.9 0.68 Allowed 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.241 -0.891 . . . . 74.14 108.863 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.546 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 23.2 ptm 42.55 -165.14 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.989 1.715 . . . . 73.41 112.663 -171.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 81.0 m -153.78 137.88 16.45 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.415 -1.328 . . . . 73.42 107.415 173.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -150.79 142.14 23.33 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.991 -0.374 . . . . 71.2 109.991 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -159.11 141.94 14.28 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 123.919 0.762 . . . . 63.43 109.644 169.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.545 HD13 HD11 ' B' ' 16' ' ' ILE . 45.8 mt -80.26 125.39 39.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.877 -0.786 . . . . 65.45 108.877 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -96.3 -35.52 11.2 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.343 0.657 . . . . 74.45 109.609 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.478 HH21 ' HB ' ' A' ' 122' ' ' THR . 56.6 ttt180 -170.66 131.92 0.91 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.529 -0.76 . . . . 72.33 109.557 -176.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.545 HD11 HD13 ' B' ' 13' ' ' ILE . 87.2 mt -114.89 136.33 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 106.641 -1.614 . . . . 64.31 106.641 168.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -166.48 162.97 17.17 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.695 0.622 . . . . 61.14 111.306 -174.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.646 HG21 HD11 ' B' ' 21' ' ' ILE . 27.5 m -98.32 127.4 44.24 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.444 -0.947 . . . . 71.13 108.444 176.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -98.05 -23.72 15.64 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.745 0.818 . . . . 73.45 111.018 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 9.3 t70 -158.78 139.33 12.55 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.142 0.276 . . . . 70.3 111.188 -170.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.646 HD11 HG21 ' B' ' 18' ' ' THR . 40.8 mm -135.79 149.15 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.598 1.159 . . . . 74.04 108.754 175.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 17.7 m -146.89 143.62 28.67 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.524 1.13 . . . . 73.23 109.082 165.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -152.2 108.77 3.45 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.662 -1.236 . . . . 72.33 107.662 169.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -122.08 118.18 28.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.262 1.025 . . . . 72.12 108.399 -174.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -116.45 84.22 14.41 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.264 1.026 . . . . 72.11 108.549 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.23 -40.49 19.34 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.872 2.381 . . . . 62.43 112.585 -174.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 87.3 m-20 -96.67 13.8 27.09 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.987 -1.006 . . . . 70.11 111.078 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.44 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -40.29 -62.75 0.85 Allowed Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 115.086 1.513 . . . . 71.42 115.086 -164.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 6.7 Cg_exo -69.4 -25.58 30.13 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 121.721 1.614 . . . . 61.13 112.204 -171.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 69.7 m80 -95.44 -25.43 16.25 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.865 -1.061 . . . . 73.32 111.731 -170.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.672 HG22 HD12 ' B' ' 68' ' ' LEU . 8.7 p -83.9 -18.25 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.995 0.518 . . . . 64.03 110.981 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -61.11 -30.91 70.64 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.309 0.855 . . . . 73.34 113.309 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 28.7 pt20 -61.27 -18.12 56.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.831 0.452 . . . . 72.12 111.608 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -92.29 82.87 4.97 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.146 0.978 . . . . 71.15 108.865 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -86.52 90.83 8.36 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.281 -0.637 . . . . 72.53 109.281 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.7 t-105 -158.15 156.12 30.32 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.898 1.279 . . . . 71.11 107.988 174.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.553 ' HB3' HD22 ' F' ' 470' ' ' LEU . 20.9 mm-40 -59.79 104.76 0.47 Allowed Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.991 1.316 . . . . 71.11 111.295 173.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.616 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 60.9 Cg_endo -74.45 128.17 11.71 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.689 2.26 . . . . 64.01 112.415 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.88 125.74 24.81 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 123.565 0.541 . . . . 74.12 109.911 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.592 HG12 ' HB2' ' B' ' 66' ' ' ALA . 25.2 m -104.67 153.32 6.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.848 -0.615 . . . . 70.5 111.014 -176.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.462 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 79.4 tttt -108.71 117.98 35.59 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.789 -1.189 . . . . 75.33 107.789 169.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.501 HD21 ' HB1' ' F' ' 467' ' ' ALA . 0.6 OUTLIER -96.38 140.67 30.7 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.877 0.471 . . . . 74.21 110.23 176.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.558 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 6.1 t70 -145.42 155.85 43.4 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.616 -0.883 . . . . 74.23 108.616 -177.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' F' ' 461' ' ' PHE . 1.5 pt? -115.51 163.12 16.22 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.596 0.712 . . . . 75.34 110.771 -175.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.581 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.0 t70 -163.64 111.3 1.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.19 -1.411 . . . . 74.31 107.19 167.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.6 p -128.73 125.34 37.74 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.167 0.587 . . . . 71.54 110.239 -172.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.66 159.47 41.89 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.034 0.934 . . . . 41.23 109.932 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.9 p -133.29 159.24 40.84 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.138 0.575 . . . . 73.41 109.678 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 98.1 p -153.1 140.75 19.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.173 0.589 . . . . 71.34 109.582 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -89.01 115.84 26.86 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.882 0.473 . . . . 70.01 109.996 176.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.96 -39.91 17.56 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.682 0.793 . . . . 64.23 109.207 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.43 -176.51 5.83 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.594 1.158 . . . . 74.12 109.717 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -67.43 126.15 28.37 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.851 -0.613 . . . . 62.32 110.033 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' B' ' 85' ' ' SER . 7.2 m-20 69.02 -9.95 0.55 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.093 1.757 . . . . 74.34 112.487 -173.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.9 t -105.63 104.13 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.789 -0.819 . . . . 62.4 108.789 -172.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -115.18 168.08 10.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.413 -1.267 . . . . 74.4 108.979 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -143.64 117.43 9.3 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.848 -1.168 . . . . 74.14 107.848 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.88 144.71 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.591 1.156 . . . . 75.54 109.247 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.5 t -127.82 119.82 52.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.088 -0.708 . . . . 62.13 109.088 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -98.28 114.7 27.08 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.642 -1.614 . . . . 71.54 106.642 172.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.581 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 3.7 ttt180 -111.56 125.89 54.4 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.409 -0.589 . . . . 73.34 109.409 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 49.5 t -114.3 116.21 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.681 1.192 . . . . 74.22 108.429 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.8 m -97.61 137.03 37.14 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.18 -0.674 . . . . 75.44 109.18 173.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 76.9 t -133.02 126.22 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.859 0.864 . . . . 60.24 109.529 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 91.9 m -124.66 107.16 10.7 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.373 0.669 . . . . 75.11 110.236 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.592 ' HB2' HG12 ' B' ' 40' ' ' VAL . . . -106.5 151.83 24.47 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.217 0.607 . . . . 75.23 110.992 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 57.0 p -153.24 139.86 18.85 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.051 -0.977 . . . . 73.24 110.497 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.672 HD12 HG22 ' B' ' 31' ' ' VAL . 48.5 mt -107.87 102.33 11.54 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.28 1.032 . . . . 74.23 109.201 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.08 -110.18 3.2 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.609 -0.723 . . . . 72.12 112.733 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.94 2.81 46.81 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.637 0.775 . . . . 71.31 111.138 -169.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.41 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.1 pt-20 -144.07 158.13 43.9 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.967 0.507 . . . . 75.11 110.875 -170.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -65.82 143.71 57.31 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.955 0.785 . . . . 75.12 111.171 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.471 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -96.18 -70.22 0.72 Allowed 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.508 -0.923 . . . . 71.02 108.508 169.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -148.6 153.03 37.77 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.167 -0.924 . . . . 70.45 109.466 -173.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 23.4 mt -131.12 109.44 10.46 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.538 -1.282 . . . . 52.14 107.538 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.0 t -119.96 147.32 44.9 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.816 -0.439 . . . . 63.44 109.816 -175.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -157.6 133.69 9.47 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 109.486 -0.561 . . . . 63.44 109.486 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 89.6 t -129.62 148.52 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.4 0.68 . . . . 73.11 109.474 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.0 mt-30 -118.33 98.9 6.51 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.75 -1.204 . . . . 73.53 107.75 166.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -85.89 99.55 11.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.1 -1.074 . . . . 74.1 108.1 171.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.68 169.81 35.98 Favored Glycine 0 C--O 1.242 0.626 0 N-CA-C 111.228 -0.749 . . . . 62.15 111.228 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.42 127.74 1.59 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 112.111 -0.396 . . . . 73.22 112.111 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 46.8 mt -84.53 120.78 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 107.727 -1.212 . . . . 71.15 107.727 171.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -128.41 135.11 49.06 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.84 0.856 . . . . 75.35 109.211 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 67.5 m -93.91 117.25 29.84 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 110.045 -0.354 . . . . 54.32 110.045 172.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.597 HD13 HD21 ' B' ' 98' ' ' LEU . 45.3 pt -117.11 146.81 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.821 1.248 . . . . 70.21 110.025 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.637 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -152.69 161.37 42.65 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.391 1.077 . . . . 75.55 108.62 170.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 84.86 -28.76 4.38 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 113.794 0.278 . . . . 62.13 113.794 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.89 140.06 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 124.608 1.163 . . . . 71.0 112.209 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.539 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 36.0 tt0 -162.71 144.81 10.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.25 0.62 . . . . 65.22 110.175 -177.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.39 -113.3 5.58 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.578 0.548 . . . . 61.24 113.768 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 88.4 m -82.14 -24.32 35.13 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.609 0.764 . . . . 73.35 111.17 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.539 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 44.2 mt-30 -60.52 -43.87 96.66 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.044 0.537 . . . . 61.24 111.271 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -65.02 -36.49 84.55 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.41 0.444 . . . . 54.44 110.269 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.67 -37.35 86.26 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.229 1.012 . . . . 75.13 111.157 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -82.68 -29.36 29.99 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.234 0.614 . . . . 73.03 110.858 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -67.09 -64.39 0.86 Allowed 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.661 0.601 . . . . 74.51 110.177 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.597 HD21 HD13 ' B' ' 86' ' ' ILE . 60.2 mt -81.76 -18.57 43.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.837 0.455 . . . . 71.03 111.173 -176.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.46 -35.53 11.85 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.427 0.454 . . . . 55.24 113.955 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.451 ' HB1' ' HD1' ' B' ' 133' ' ' PHE . . . -134.99 -41.16 0.75 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.033 0.753 . . . . 65.4 113.033 -167.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -77.44 -48.61 16.73 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.659 0.784 . . . . 74.43 111.277 -170.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.48 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 86.5 m -64.88 -48.0 73.17 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.684 0.794 . . . . 71.53 110.859 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 53.4 Cg_exo -58.05 -30.29 89.69 Favored 'Trans proline' 0 C--N 1.397 3.105 0 C-N-CA 122.085 1.856 . . . . 74.51 114.339 170.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -61.06 -42.17 97.98 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 123.084 0.554 . . . . 64.24 110.856 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.88 -40.94 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 115.357 -0.838 . . . . 24.33 110.105 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.3 mt -77.65 -20.99 52.89 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.729 -1.123 . . . . 73.2 112.125 -174.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -59.71 -50.65 85.8 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 114.269 1.211 . . . . 73.34 114.269 -171.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.87 -31.74 95.96 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 121.755 1.637 . . . . 72.54 113.087 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -73.32 -47.21 44.4 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.462 0.705 . . . . 73.33 110.965 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.99 -43.07 81.34 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.287 0.635 . . . . 60.42 110.291 175.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt-85 -60.08 -51.2 70.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.371 1.468 . . . . 75.14 111.204 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.82 -34.91 79.24 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.12 0.568 . . . . 62.42 109.794 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.8 t -70.71 -34.85 72.37 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.962 0.505 . . . . 73.33 111.665 -177.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.476 ' O ' HG23 ' B' ' 118' ' ' VAL . 58.8 mt -65.34 -55.87 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 109.178 -0.675 . . . . 71.51 109.178 173.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 15.5 m -59.76 -27.5 66.58 Favored 'General case' 0 CA--C 1.552 1.043 0 O-C-N 124.001 0.813 . . . . 71.0 111.557 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -64.07 -51.02 66.05 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.341 0.657 . . . . 64.21 109.77 174.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -69.24 -35.04 75.72 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.082 0.553 . . . . 63.11 111.125 -175.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.9 t -59.16 -46.75 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.554 0.741 . . . . 61.3 109.697 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.4 t -67.12 -30.83 70.94 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.749 -1.114 . . . . 62.42 111.811 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.449 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -70.21 -38.65 75.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.834 -0.621 . . . . 55.31 110.12 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.06 1.88 83.17 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.85 0.719 . . . . 70.51 112.695 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 27.1 p 61.84 25.47 15.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.69 1.996 . . . . 51.35 113.302 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -80.51 155.01 74.09 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 123.568 0.747 . . . . 65.13 110.953 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -50.48 158.6 2.57 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.809 3.006 . . . . 65.11 115.042 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.407 ' HG3' HD21 ' B' ' 127' ' ' ASN . 60.7 tp60 -61.16 119.58 8.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.536 1.134 . . . . 75.21 112.531 -168.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.4 tp -110.18 127.15 54.77 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.269 0.628 . . . . 62.54 109.854 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.407 HD21 ' HG3' ' B' ' 125' ' ' GLN . 40.6 m-80 -129.06 126.13 38.76 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.587 0.755 . . . . 61.01 109.093 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.9 131.1 34.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.419 -0.585 . . . . 70.45 109.419 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.62 152.02 96.37 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.748 0.819 . . . . 75.3 111.365 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.09 109.12 0.87 Allowed 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.621 2.214 . . . . 44.4 111.464 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 24.1 t -91.21 115.53 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.39 -0.596 . . . . 53.52 109.39 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.451 ' O ' HD13 ' B' ' 136' ' ' LEU . 57.4 t-20 -72.7 90.72 1.41 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.198 0.599 . . . . 74.02 109.561 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.451 ' HD1' ' HB1' ' B' ' 100' ' ' ALA . 33.1 p90 -57.22 -32.93 67.01 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.97 0.908 . . . . 73.02 112.708 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -82.87 -41.31 19.13 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.389 0.676 . . . . 72.42 112.387 -168.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.33 61.99 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.125 0.57 . . . . 73.33 110.944 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.665 ' HG ' ' HB ' ' F' ' 463' ' ' THR . 6.7 mp -74.92 -30.67 61.32 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.672 -0.695 . . . . 73.12 109.868 172.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.625 ' CE1' HD11 ' B' ' 141' ' ' LEU . 59.6 t80 -70.79 -25.93 63.1 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.46 -0.791 . . . . 72.44 110.159 173.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 18.5 ttt -65.19 -36.51 84.43 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.939 0.496 . . . . 73.44 110.283 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -73.07 -32.22 64.88 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.729 -0.669 . . . . 75.54 110.502 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.506 ' HE1' ' HB2' ' F' ' 457' ' ' GLN . 81.4 t80 -56.57 -34.24 66.94 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.367 1.067 . . . . 73.35 111.23 176.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.625 HD11 ' CE1' ' B' ' 137' ' ' PHE . 7.8 mt -105.81 -11.19 16.34 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.528 0.566 . . . . 74.3 112.528 -173.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.01 141.41 18.69 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.602 -0.518 . . . . 72.24 109.602 -169.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.31 -48.67 69.58 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.107 1.363 . . . . 74.25 111.448 -170.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -114.71 92.59 4.0 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.826 0.851 . . . . 70.23 110.328 -171.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.19 137.63 36.71 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.193 -0.669 . . . . 51.44 109.193 170.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.14 74.43 1.22 Allowed Glycine 0 C--N 1.35 1.359 0 O-C-N 123.495 0.497 . . . . 73.11 112.54 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -73.22 155.5 39.49 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.688 0.795 . . . . 72.43 110.919 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 158.09 177.46 31.2 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 116.199 -0.455 . . . . 65.21 113.263 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 2.6 t -145.96 88.2 1.8 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.324 1.049 . . . . 75.51 108.509 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -94.56 99.27 11.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.506 -0.77 . . . . 72.32 109.655 -177.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.443 ' HA ' ' OG1' ' D' ' 10' ' ' THR . 48.1 mt-10 -89.47 121.4 31.67 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.295 -0.866 . . . . 65.33 109.664 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -123.5 83.05 2.08 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.335 0.654 . . . . 64.13 111.239 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -80.08 118.43 21.79 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.307 -0.86 . . . . 74.35 108.965 169.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -129.97 145.0 51.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.621 0.769 . . . . 54.31 109.079 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 C-N-CA 124.278 1.031 . . . . 70.23 108.969 179.248 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 60.4 mtt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.185 -0.672 . . . . 54.25 109.185 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -105.87 73.26 0.99 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.69 -0.855 . . . . 73.13 108.69 176.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -88.86 103.59 16.14 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.29 -0.868 . . . . 75.22 110.609 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 61.22 91.03 0.06 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.751 1.22 . . . . 63.15 112.287 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -93.07 -76.59 0.47 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.005 -1.109 . . . . 74.1 108.005 170.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.06 35.84 17.3 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.048 1.339 . . . . 72.23 111.268 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 23.9 m -80.87 80.53 7.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.633 0.773 . . . . 75.34 109.743 -175.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -102.86 82.39 2.11 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.096 -0.957 . . . . 71.52 108.595 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 26.4 ttt 62.11 111.0 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.512 1.525 . . . . 71.43 111.459 -173.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 27.0 m -111.35 84.09 1.88 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.9 -1.148 . . . . 60.4 107.9 174.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -93.55 118.64 31.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.16 -0.927 . . . . 74.25 108.637 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -138.12 135.37 35.68 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.48 -1.304 . . . . 72.4 107.48 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.2 mt -74.81 121.17 25.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.401 -0.963 . . . . 64.02 108.401 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.514 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 19.6 mm-40 -83.68 -44.05 14.9 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 123.888 0.743 . . . . 71.2 109.051 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -177.42 137.52 0.21 Allowed 'General case' 0 C--N 1.359 1.001 0 CA-C-N 115.491 -0.777 . . . . 73.1 109.72 -173.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.3 mt -124.46 143.8 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.008 -1.108 . . . . 75.04 108.008 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.476 ' OH ' HD11 ' C' ' 83' ' ' ILE . 30.7 p90 -171.43 165.13 7.02 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.36 0.6 . . . . 64.43 111.923 -172.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -92.64 107.67 19.39 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.967 -1.015 . . . . 73.04 109.191 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -68.38 -39.97 81.56 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.672 0.749 . . . . 54.14 109.548 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.471 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 19.3 t70 -143.28 139.36 30.12 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 113.918 -1.492 . . . . 75.5 109.192 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 96.4 mt -137.05 143.13 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 106.704 -1.591 . . . . 65.11 106.704 172.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -149.44 147.84 28.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.096 0.474 . . . . 54.23 110.001 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -147.46 135.32 21.18 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.45 -1.315 . . . . 72.2 107.45 169.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.596 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 33.7 mt-10 -138.13 111.3 7.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.561 0.745 . . . . 73.04 109.742 -170.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.11 74.02 11.0 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.445 -1.316 . . . . 73.32 107.445 166.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.46 -28.72 21.51 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.58 2.187 . . . . 73.42 111.163 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -88.22 14.49 9.25 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.957 -1.474 . . . . 72.43 111.787 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -44.83 -54.49 12.95 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 114.184 1.179 . . . . 63.42 114.184 -174.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.23 -37.08 85.55 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 121.916 1.744 . . . . 54.23 113.175 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -69.05 -45.1 71.26 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.836 0.854 . . . . 71.43 111.818 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.756 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -76.53 -22.28 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 113.156 0.798 . . . . 74.25 113.156 -174.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -65.49 -31.53 72.65 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 112.58 0.585 . . . . 72.24 112.58 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -94.84 11.55 31.19 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.355 0.662 . . . . 73.34 111.667 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -85.14 160.55 19.91 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.981 0.912 . . . . 73.42 110.688 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.92 115.38 3.37 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.339 0.656 . . . . 71.23 109.372 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -84.72 91.75 8.03 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.355 0.597 . . . . 54.25 110.01 -177.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -143.46 79.95 13.49 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 106.756 -1.572 . . . . 72.22 106.756 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' C' ' 67' ' ' SER . 6.4 Cg_exo -80.35 149.92 19.48 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 123.029 2.486 . . . . 62.54 113.619 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -108.03 110.79 22.58 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 107.064 -1.458 . . . . 64.11 107.064 169.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 m -80.43 124.11 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.334 0.588 . . . . 73.22 110.292 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 1.8 tmtp? -125.03 102.52 7.55 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.376 -1.713 . . . . 74.21 106.376 171.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.707 ' HB3' ' HB2' ' G' ' 464' ' ' MET . 4.2 tt -108.44 121.71 45.52 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.968 -1.864 . . . . 71.11 105.968 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -122.72 117.06 24.83 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.88 -0.415 . . . . 74.41 109.88 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.556 ' HB3' HD23 ' G' ' 460' ' ' LEU . 89.4 mt -92.23 150.93 20.61 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.677 0.791 . . . . 72.3 109.322 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 12.7 t70 -151.32 142.77 23.48 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.235 -1.024 . . . . 61.34 108.235 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -126.75 139.51 53.07 Favored 'General case' 0 C--O 1.249 1.072 0 N-CA-C 108.607 -0.886 . . . . 75.15 108.607 172.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.91 141.92 21.27 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.896 -1.149 . . . . 54.32 107.896 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 16.5 p -148.1 156.8 43.03 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 120.853 0.359 . . . . 64.33 110.844 -171.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 95.5 p -144.12 158.64 43.6 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.723 0.809 . . . . 63.22 110.014 -172.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -94.46 130.91 40.65 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.797 -0.816 . . . . 75.5 108.797 172.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.649 HD11 HD12 ' C' ' 83' ' ' ILE . 39.1 mt -99.79 -42.6 6.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.335 0.654 . . . . 43.1 110.489 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -152.67 -172.25 4.18 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.322 -0.853 . . . . 74.51 110.245 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.67 105.87 1.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.013 -0.994 . . . . 70.1 109.826 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 70.06 3.69 4.48 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.01 1.324 . . . . 71.23 113.13 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 56.1 t -100.76 122.78 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.109 -1.071 . . . . 55.53 108.109 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -138.25 124.39 20.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.01 -0.541 . . . . 61.35 109.736 -166.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' C' ' 51' ' ' LEU . 41.1 tt0 -84.83 137.8 32.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.561 0.745 . . . . 73.53 109.496 174.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.51 129.57 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.791 -1.189 . . . . 73.4 107.791 170.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.4 148.24 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.693 0.797 . . . . 73.14 109.109 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.09 111.92 14.02 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.481 -1.303 . . . . 60.24 107.481 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.6 tmm_? -98.42 107.13 19.52 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 107.731 -1.211 . . . . 75.43 107.731 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 t -103.62 123.11 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.186 -1.042 . . . . 74.11 108.186 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -111.83 141.55 45.32 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.021 -0.733 . . . . 65.11 109.021 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.625 HG21 HG21 ' C' ' 114' ' ' ILE . 91.1 t -131.84 123.21 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.515 1.126 . . . . 75.1 108.146 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 12.8 m -124.69 141.84 51.82 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.795 0.838 . . . . 65.13 108.764 177.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.69 123.98 16.72 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.235 -1.394 . . . . 61.12 107.235 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 60.4 m -133.3 158.22 43.49 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.6 0.714 . . . . 71.34 111.312 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 mt -121.35 39.85 3.73 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.356 1.463 . . . . 64.01 107.338 -171.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.29 -111.6 3.88 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 109.507 -1.437 . . . . 75.35 109.507 -166.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -90.48 -31.08 16.93 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.105 0.562 . . . . 72.21 110.389 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -70.67 106.91 3.69 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.026 0.93 . . . . 71.32 109.911 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.7 m -72.83 126.73 30.61 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.94 -0.763 . . . . 61.43 108.94 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.756 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.92 -58.23 4.1 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.029 -0.73 . . . . 63.04 109.029 178.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -159.43 163.8 35.1 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-N 115.536 -0.756 . . . . 74.41 110.897 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -128.27 144.84 51.16 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 106.517 -1.66 . . . . 72.13 106.517 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.46 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.3 t -149.42 147.11 27.87 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.334 -0.987 . . . . 75.02 108.334 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -157.43 135.28 10.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.72 0.295 . . . . 74.14 110.48 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' C' ' 110' ' ' ALA . 50.4 t -135.33 114.77 17.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 124.332 1.053 . . . . 74.33 108.704 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 65.4 mt-30 -97.35 89.9 4.89 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.143 -0.688 . . . . 54.53 109.143 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.1 tp-100 -79.39 102.47 8.72 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.053 -0.976 . . . . 52.33 110.498 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.96 157.14 31.89 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 116.202 -0.454 . . . . 51.31 112.035 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.589 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -160.81 116.64 0.73 Allowed Glycine 0 CA--C 1.508 -0.369 0 N-CA-C 111.72 -0.552 . . . . 74.24 111.72 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.649 HD12 HD11 ' C' ' 51' ' ' LEU . 7.4 mm -82.7 127.28 39.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.727 -0.842 . . . . 62.3 108.727 177.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -132.12 141.05 49.01 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.758 0.823 . . . . 64.24 109.082 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 13.5 p -83.73 122.92 29.29 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.142 -0.688 . . . . 65.3 109.142 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 46.6 pt -120.86 133.14 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.602 0.761 . . . . 63.11 109.804 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -163.63 159.68 21.99 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.302 1.041 . . . . 35.43 108.704 176.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.33 -57.6 4.22 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 112.713 -0.155 . . . . 70.54 112.713 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.407 ' H ' HG13 ' C' ' 89' ' ' ILE . 2.7 pp -88.57 163.76 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.184 0.594 . . . . 71.0 111.687 -177.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -165.85 163.21 18.71 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.673 0.789 . . . . 51.42 110.392 -173.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.92 -114.96 7.03 Favored Glycine 0 C--N 1.355 1.594 0 C-N-CA 123.44 0.543 . . . . 43.12 113.703 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -63.34 -40.47 97.37 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.731 0.812 . . . . 63.31 111.574 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -76.59 -32.1 57.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.675 0.39 . . . . 74.15 110.861 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 41.5 ttm -76.99 -28.71 55.19 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.274 0.358 . . . . 65.53 110.817 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.63 91.64 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.441 -0.577 . . . . 51.14 109.441 174.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -77.33 -25.22 50.92 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.308 0.38 . . . . 62.14 111.718 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.05 -52.18 66.47 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.542 0.526 . . . . 74.31 109.733 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 pp -81.99 -20.53 38.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.931 0.492 . . . . 74.34 110.882 176.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.27 -29.19 56.74 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 114.482 0.553 . . . . 75.24 114.482 -173.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.14 -43.52 0.06 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.918 0.71 . . . . 73.32 112.918 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -59.42 -46.08 89.73 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.477 0.711 . . . . 74.24 112.309 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.411 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 81.1 m -78.92 -46.87 1.74 Allowed Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.699 0.8 . . . . 71.31 111.396 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.411 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 53.0 Cg_exo -55.86 -26.3 56.92 Favored 'Trans proline' 0 C--N 1.399 3.185 0 C-N-CA 122.402 2.068 . . . . 74.3 113.831 169.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.33 -43.37 97.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.561 1.145 . . . . 73.32 109.936 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.0 mm -64.05 -45.21 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 114.84 -1.073 . . . . 71.22 109.789 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.589 HD21 ' HA3' ' C' ' 82' ' ' GLY . 86.4 mt -75.72 -25.18 56.39 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.149 -0.932 . . . . 72.0 112.812 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -56.22 -53.42 63.87 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 113.78 1.029 . . . . 71.21 113.78 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.69 -29.63 88.77 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 121.725 1.617 . . . . 75.52 113.387 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -68.94 -48.71 62.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.781 0.433 . . . . 63.13 110.478 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.23 -31.11 72.17 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.461 -0.791 . . . . 71.31 110.773 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.674 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 46.6 ttt180 -63.42 -58.86 5.71 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.472 1.509 . . . . 54.21 111.146 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -31.91 73.36 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.686 0.394 . . . . 74.21 110.262 -177.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -65.29 -31.34 72.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.141 0.576 . . . . 62.11 111.579 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.625 HG21 HG21 ' C' ' 64' ' ' VAL . 84.8 mt -74.89 -56.61 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 116.154 -0.475 . . . . 71.54 109.933 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 3.3 m -62.7 -27.72 69.45 Favored 'General case' 0 CA--C 1.553 1.066 0 O-C-N 123.688 0.617 . . . . 61.4 111.412 -172.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -62.39 -51.34 67.98 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.349 0.66 . . . . 74.32 109.304 170.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.668 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.79 -39.61 89.53 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.333 1.053 . . . . 61.33 112.435 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' C' ' 114' ' ' ILE . 60.4 t -59.91 -47.88 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.436 0.694 . . . . 73.52 109.422 176.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -66.31 -32.42 73.81 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.494 -1.23 . . . . 65.43 111.755 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.6 mtt-85 -67.8 -35.02 77.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.31 0.644 . . . . 74.21 109.879 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.39 10.84 69.91 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.928 0.767 . . . . 41.21 112.888 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.45 HG23 ' HB3' ' D' ' 17' ' ' TYR . 46.6 p 54.84 37.26 28.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.058 1.743 . . . . 73.34 113.752 177.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -95.65 153.48 39.41 Favored Pre-proline 0 N--CA 1.477 0.911 0 N-CA-C 108.196 -1.038 . . . . 71.4 108.196 168.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -64.76 168.9 12.47 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.5 2.134 . . . . 75.12 112.688 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -54.44 113.33 1.24 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.353 1.061 . . . . 73.35 113.412 -174.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.721 HD12 HD11 ' G' ' 470' ' ' LEU . 5.5 tt -113.87 87.03 2.53 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.307 -1.368 . . . . 64.22 107.307 167.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -95.47 127.47 41.54 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.23 -1.026 . . . . 73.34 108.23 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.68 HD12 HD11 ' C' ' 42' ' ' LEU . 2.3 mm? -73.62 132.15 42.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.552 0.741 . . . . 75.2 109.546 -174.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.62 153.47 75.91 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.518 0.727 . . . . 42.3 110.606 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.615 ' HG3' HD12 ' A' ' 16' ' ' ILE . 50.2 Cg_exo -51.58 115.68 2.25 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.771 2.314 . . . . 52.13 112.73 173.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.464 HG21 HD11 ' C' ' 44' ' ' LEU . 85.0 t -97.95 122.58 49.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.199 -0.667 . . . . 63.41 109.199 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -83.88 76.11 10.05 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.17 0.588 . . . . 75.11 109.497 174.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -60.51 -44.67 95.77 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 122.116 0.96 . . . . 72.32 109.038 170.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -65.09 -50.0 67.81 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 113.184 -1.825 . . . . 75.23 112.366 -172.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.33 -43.67 88.32 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.814 0.696 . . . . 43.24 111.825 -174.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -42.93 74.38 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.762 -1.108 . . . . 70.34 109.82 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.47 -23.92 61.12 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.739 0.416 . . . . 75.03 111.285 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 67.4 mtt -70.63 -46.84 62.57 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.049 -0.722 . . . . 73.23 109.049 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -57.71 -37.62 73.83 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.871 0.868 . . . . 73.23 111.117 175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -53.5 -77.44 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.39 1.476 . . . . 71.41 109.96 172.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.547 ' HA ' ' HG2' ' A' ' 153' ' ' GLN . 96.4 mt -49.63 -88.29 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.411 1.084 . . . . 43.31 113.007 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.411 ' NE2' ' HB3' ' A' ' 151' ' ' GLU . 20.3 pt20 -176.48 21.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.361 1.065 . . . . 75.24 110.101 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 59.58 88.24 0.07 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.702 1.601 . . . . 73.24 112.293 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -85.23 101.25 12.35 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.871 0.868 . . . . 73.04 108.677 175.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.55 116.49 14.19 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.996 0.518 . . . . 72.55 110.56 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.67 78.89 1.45 Allowed Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.453 -0.659 . . . . 74.44 111.453 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -74.97 145.37 42.6 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.166 0.586 . . . . 62.25 111.009 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -122.16 123.13 5.33 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 111.111 -0.796 . . . . 74.4 111.111 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 40.9 p -66.06 126.03 27.33 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.313 0.645 . . . . 61.52 110.251 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -84.93 145.62 27.67 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.453 0.644 . . . . 71.34 110.858 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -136.1 153.65 51.24 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 107.16 -1.422 . . . . 72.33 107.16 165.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -78.84 75.74 5.34 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.337 0.589 . . . . 74.22 109.541 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -139.39 142.24 37.53 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.916 1.286 . . . . 74.2 108.689 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -141.45 154.58 45.65 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.859 0.864 . . . . 55.31 108.828 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.374 0 N-CA-C 109.321 -0.622 . . . . 71.24 109.321 179.26 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 CA--C 1.551 0.991 0 CA-C-O 121.54 0.686 . . . . 74.51 111.321 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -89.84 109.39 20.4 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.408 -0.96 . . . . 74.24 108.408 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -159.76 -58.89 0.06 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.063 0.545 . . . . 64.15 110.32 -174.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -76.88 103.26 6.73 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.543 -0.753 . . . . 70.32 110.817 -172.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -147.74 138.7 23.4 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.12 0.968 . . . . 63.34 108.893 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.608 ' HB2' ' HB2' ' D' ' 9' ' ' MET . 28.3 p-10 -133.84 99.59 4.5 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.879 0.847 . . . . 71.15 110.545 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -120.05 -22.83 6.53 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.926 0.89 . . . . 74.43 109.417 170.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -91.32 -25.86 19.22 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.323 1.049 . . . . 71.24 111.285 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.608 ' HB2' ' HB2' ' D' ' 6' ' ' ASN . 8.1 ttp -31.84 130.56 0.14 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.579 1.952 . . . . 73.24 114.187 175.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.443 ' OG1' ' HA ' ' B' ' 151' ' ' GLU . 24.6 m -120.79 119.98 34.3 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.232 1.013 . . . . 75.55 108.733 172.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -148.23 102.21 3.34 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.506 -1.294 . . . . 71.35 107.506 172.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -126.1 115.91 20.56 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.763 -1.199 . . . . 73.02 107.763 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.436 HD13 HG21 ' D' ' 105' ' ' ILE . 13.7 mt -72.33 115.76 13.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 N-CA-C 108.247 -1.02 . . . . 75.41 108.247 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -88.01 -29.53 20.65 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.722 -0.672 . . . . 75.0 110.783 -169.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -179.54 141.13 0.15 Allowed 'General case' 0 C--N 1.366 1.315 0 C-N-CA 122.34 0.256 . . . . 74.22 110.411 -170.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.409 HD11 HG21 ' D' ' 13' ' ' ILE . 3.7 mp -122.46 135.79 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.256 -1.387 . . . . 53.41 107.256 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.45 ' HB3' HG23 ' C' ' 122' ' ' THR . 34.7 p90 -165.86 174.02 10.0 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-O 121.654 0.74 . . . . 75.13 112.258 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -105.06 120.17 40.84 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.735 -1.12 . . . . 62.41 108.912 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -89.91 -21.47 22.47 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.307 0.643 . . . . 73.4 109.805 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.673 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.0 t70 -155.37 139.36 16.37 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.081 -0.963 . . . . 71.03 108.856 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.668 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.3 mt -137.53 142.77 35.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.56 -1.274 . . . . 74.43 107.56 172.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.8 t -149.07 130.09 14.39 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.543 -0.91 . . . . 73.11 108.543 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.411 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 85.5 t80 -136.78 126.23 25.09 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.992 -1.484 . . . . 75.11 106.992 170.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.5 mt-10 -130.82 138.3 49.82 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.74 -0.837 . . . . 74.34 108.74 -175.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.77 82.86 67.81 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 106.97 -1.492 . . . . 74.51 106.97 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.08 -32.4 27.92 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.196 2.597 . . . . 61.43 113.034 -169.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -111.77 26.53 10.53 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.308 0.643 . . . . 75.52 109.385 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.04 -70.09 0.16 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 114.746 1.387 . . . . 50.41 114.746 -161.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.536 ' HB3' HD11 ' C' ' 83' ' ' ILE . 65.2 Cg_endo -77.04 -16.35 15.91 Favored 'Trans proline' 0 C--N 1.38 2.198 0 CA-C-N 122.401 1.893 . . . . 71.13 113.612 -172.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -76.13 -41.71 49.2 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.597 1.159 . . . . 74.45 110.327 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.48 HG22 HD12 ' D' ' 68' ' ' LEU . 6.6 p -82.66 -25.29 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 115.649 -0.705 . . . . 73.22 111.138 -170.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -61.5 -20.78 63.59 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.761 0.824 . . . . 75.34 113.004 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -60.86 -26.29 67.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.425 0.69 . . . . 75.01 110.945 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -91.72 86.4 5.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.941 0.897 . . . . 70.15 109.113 168.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -76.91 88.73 3.48 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.664 -0.698 . . . . 74.33 109.631 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -155.78 158.34 37.98 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.515 1.126 . . . . 75.44 108.489 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.559 ' HG3' HD12 ' H' ' 470' ' ' LEU . 29.8 tp60 -69.09 106.1 1.32 Allowed Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.891 0.876 . . . . 65.32 108.966 174.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.571 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 35.4 Cg_exo -63.17 141.15 81.6 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.664 2.243 . . . . 60.0 113.287 -171.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 8.5 mm-40 -58.73 111.35 1.24 Allowed 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.051 0.844 . . . . 70.51 110.2 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.498 HG13 ' O ' ' D' ' 38' ' ' PRO . 16.1 m -101.4 128.02 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.656 0.741 . . . . 75.33 111.83 -170.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -106.55 112.76 25.9 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.821 1.248 . . . . 72.01 107.913 171.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.64 ' H ' HD23 ' D' ' 42' ' ' LEU . 1.8 pt? -95.98 112.92 24.52 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.039 -1.097 . . . . 73.35 108.039 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -114.84 113.21 23.91 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.667 -1.235 . . . . 71.23 107.667 174.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.646 HD13 ' H ' ' D' ' 44' ' ' LEU . 0.0 OUTLIER -110.34 155.48 22.06 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.904 0.882 . . . . 74.02 109.247 -176.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.589 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -158.64 152.65 23.7 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.528 0.731 . . . . 64.11 109.983 -177.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -109.87 167.59 10.05 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.617 -0.512 . . . . 64.41 109.617 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.47 160.52 36.85 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.795 0.838 . . . . 71.55 108.866 173.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -146.4 151.52 37.59 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.656 0.382 . . . . 72.12 110.736 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.7 t -165.55 122.13 1.42 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.582 0.753 . . . . 53.03 109.873 -171.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -82.42 117.71 22.67 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.809 -0.441 . . . . 61.55 109.809 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.2 mt -97.63 -24.98 15.28 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.162 0.585 . . . . 72.24 110.71 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.62 -178.54 6.27 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.482 0.713 . . . . 54.13 111.037 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.51 114.3 4.78 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.475 -1.239 . . . . 33.14 109.791 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.14 21.18 11.62 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.302 1.041 . . . . 63.3 111.795 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 66.3 t -118.82 128.72 75.65 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 N-CA-C 108.159 -1.052 . . . . 72.11 108.159 170.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.443 ' HB2' HD11 ' D' ' 86' ' ' ILE . 0.4 OUTLIER -122.27 172.7 8.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.054 0.93 . . . . 65.11 110.287 174.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.9 tt0 -132.31 138.54 47.86 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.255 -1.793 . . . . 74.11 107.577 169.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.27 138.63 47.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.513 -1.292 . . . . 72.12 107.513 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 47.6 t -119.57 128.67 75.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.077 -1.083 . . . . 53.03 108.077 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.416 HD23 ' O ' ' D' ' 45' ' ' ASP . 0.1 OUTLIER -99.1 116.45 31.35 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.25 -1.019 . . . . 63.21 108.25 175.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.618 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 2.4 tmm_? -99.71 96.29 7.51 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.652 -1.61 . . . . 75.44 106.652 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.579 HG21 ' HB1' ' D' ' 110' ' ' ALA . 37.0 t -107.96 125.63 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.599 -0.889 . . . . 74.44 108.599 -177.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 20.8 m -130.26 135.29 47.96 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.366 0.667 . . . . 52.04 109.398 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 63.9 t -122.3 109.33 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.858 0.863 . . . . 65.33 109.257 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.1 m -95.39 111.54 23.4 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.832 -0.803 . . . . 44.14 108.832 170.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -115.28 149.84 37.18 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.48 0.712 . . . . 71.43 110.771 -173.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.404 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.1 m -149.32 132.28 16.17 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 123.778 0.674 . . . . 55.31 111.603 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.48 HD12 HG22 ' D' ' 31' ' ' VAL . 30.5 mt -96.24 109.35 21.84 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.554 -0.906 . . . . 61.45 108.554 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.38 -114.57 4.99 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 123.678 0.612 . . . . 54.05 113.02 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.57 16.53 20.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.57 0.748 . . . . 52.45 111.386 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -137.23 161.22 36.78 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.219 0.607 . . . . 74.31 109.785 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 19.5 m -69.62 138.9 53.47 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.561 0.538 . . . . 74.22 111.239 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.469 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -95.72 -70.64 0.7 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.955 0.902 . . . . 73.24 109.375 173.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -144.72 138.45 27.23 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 121.136 0.493 . . . . 73.2 110.286 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.7 mt -111.37 109.83 20.0 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.027 -1.101 . . . . 74.23 108.027 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.542 ' SG ' HG23 ' D' ' 114' ' ' ILE . 53.3 t -118.78 140.64 49.62 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.473 0.709 . . . . 65.34 109.406 -177.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -155.57 134.5 12.06 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.28 0.632 . . . . 72.42 109.629 175.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.18 119.06 18.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.929 0.892 . . . . 51.24 108.873 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.673 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.7 83.71 6.26 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.2 -1.037 . . . . 73.44 108.2 168.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.31 94.35 5.46 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.29 -1.323 . . . . 74.52 109.0 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.9 142.67 16.67 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.985 -0.446 . . . . 64.14 111.985 -178.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.523 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.15 130.02 4.14 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.542 -1.023 . . . . 62.21 110.542 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 39.0 mt -90.82 136.75 23.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.422 -0.955 . . . . 74.23 108.422 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -138.86 131.83 29.51 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.26 0.624 . . . . 64.13 109.84 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -80.17 109.31 14.51 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.772 -0.825 . . . . 54.21 108.772 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.537 HD13 HG12 ' H' ' 451' ' ' VAL . 1.6 pp -119.83 133.88 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.648 0.779 . . . . 74.34 111.81 -171.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.24 169.0 9.49 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.434 1.094 . . . . 72.42 109.207 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.18 11.46 84.89 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 115.368 0.907 . . . . 74.5 115.368 169.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.42 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -119.81 143.35 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 117.837 0.819 . . . . 73.52 110.059 177.117 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.2 -174.42 4.37 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.717 0.807 . . . . 73.41 111.072 -176.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.93 -120.85 14.86 Favored Glycine 0 C--N 1.357 1.728 0 O-C-N 123.455 0.472 . . . . 40.31 113.0 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 29.7 m -88.82 -28.65 20.28 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.213 0.605 . . . . 74.13 110.333 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -62.85 -30.23 71.35 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.273 1.029 . . . . 73.03 111.857 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 12.1 ptm -68.65 -29.39 67.87 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.079 0.552 . . . . 74.51 111.574 177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.54 -36.26 24.15 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.586 0.754 . . . . 73.35 110.651 174.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -70.02 -41.32 74.46 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.214 1.005 . . . . 74.22 111.61 -174.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.6 t -65.94 -50.33 64.76 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.099 0.56 . . . . 74.52 110.66 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 18.2 tp -76.95 -31.36 56.53 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 115.715 -0.675 . . . . 73.04 111.104 -173.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.28 -26.94 10.47 Favored Glycine 0 C--N 1.354 1.541 0 N-CA-C 114.931 0.732 . . . . 51.5 114.931 -170.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.37 -49.63 1.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 117.609 0.704 . . . . 53.2 112.118 -171.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -69.95 -48.29 58.96 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.26 0.624 . . . . 72.2 111.932 -173.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 92.6 m -61.44 -48.18 91.5 Favored Pre-proline 0 CA--C 1.564 1.502 0 CA-C-O 118.509 -0.758 . . . . 72.52 112.15 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.3 -35.68 91.96 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.113 1.875 . . . . 70.11 113.765 170.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -63.85 -39.74 94.93 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.993 0.517 . . . . 73.55 110.424 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.436 HG21 HD13 ' D' ' 13' ' ' ILE . 49.0 mm -60.51 -40.64 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.568 0.699 . . . . 61.42 110.544 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.523 HD21 ' HA3' ' D' ' 82' ' ' GLY . 96.1 mt -76.34 -19.17 58.47 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.84 -1.073 . . . . 74.51 112.061 -175.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -65.33 -43.8 65.68 Favored Pre-proline 0 CA--C 1.564 1.498 0 N-CA-C 114.189 1.181 . . . . 72.22 114.189 -170.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.63 -42.06 71.77 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 122.1 1.867 . . . . 52.34 113.432 172.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -73.68 -35.2 65.17 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.742 0.817 . . . . 65.55 111.808 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.579 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -61.51 -51.03 70.33 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.519 0.728 . . . . 44.42 109.592 176.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 31.4 ttp180 -54.92 -52.22 63.63 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 113.891 -1.504 . . . . 75.42 110.586 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.84 -48.0 81.05 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 124.023 0.827 . . . . 74.34 111.703 -174.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.9 t -59.9 -42.56 94.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.898 0.479 . . . . 54.25 111.169 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.542 HG23 ' SG ' ' D' ' 76' ' ' CYS . 70.3 mt -60.5 -52.53 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.927 0.891 . . . . 54.11 110.528 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 39.5 m -56.55 -44.88 81.33 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 125.063 1.345 . . . . 73.01 111.573 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 25.7 t -64.54 -41.36 96.4 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.696 -1.138 . . . . 51.41 110.457 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.427 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 71.8 mtm -70.56 -34.02 71.76 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.698 0.399 . . . . 64.22 111.749 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.425 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.7 t -63.12 -43.62 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.304 0.642 . . . . 64.43 110.044 176.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.4 p -72.45 -31.17 65.22 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 116.054 -0.521 . . . . 74.41 111.196 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.3 mtt-85 -71.46 -32.56 68.46 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.494 0.718 . . . . 73.33 110.411 175.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.29 7.22 79.42 Favored Glycine 0 C--N 1.351 1.405 0 O-C-N 123.67 0.606 . . . . 55.35 112.072 175.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 66.2 p 63.08 13.59 6.91 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.88 2.072 . . . . 73.12 114.309 173.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -79.26 149.82 73.21 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 108.543 -0.91 . . . . 75.24 108.543 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -48.25 122.08 7.05 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.075 2.517 . . . . 73.44 112.755 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -49.49 135.87 17.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.395 1.478 . . . . 62.41 112.345 -171.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 29.5 tp -108.16 95.9 5.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.941 0.496 . . . . 64.41 110.736 -169.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.634 ' H ' HD21 ' H' ' 468' ' ' LEU . 85.6 m-20 -103.4 87.74 2.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.674 0.79 . . . . 71.52 109.062 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.421 HD11 HD13 ' D' ' 42' ' ' LEU . 39.1 tp -71.68 133.63 45.77 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.014 -0.993 . . . . 63.15 110.549 -176.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.05 141.07 98.01 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 123.131 0.573 . . . . 73.33 110.892 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -61.4 130.98 33.98 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.666 2.244 . . . . 64.44 111.868 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 80.0 t -108.58 120.84 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.424 0.689 . . . . 41.53 109.77 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -82.99 91.37 7.15 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.591 -0.892 . . . . 73.41 108.591 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -66.72 -35.1 79.33 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.798 -0.637 . . . . 70.12 110.632 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' D' ' 138' ' ' MET . 6.0 m-20 -52.39 -52.14 55.24 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.201 1.4 . . . . 52.51 112.743 -173.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.68 75.26 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.19 0.596 . . . . 44.54 111.518 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -68.46 -28.5 67.1 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.569 -0.741 . . . . 64.43 111.19 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.467 ' O ' HD13 ' D' ' 141' ' ' LEU . 90.4 t80 -62.17 -42.76 99.57 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.968 0.907 . . . . 73.33 110.555 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 37.5 mtt -66.55 -40.49 89.09 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.118 0.567 . . . . 72.22 110.87 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 63.8 t30 -72.88 -33.08 65.84 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.897 -0.592 . . . . 72.31 110.523 177.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -62.65 -38.13 89.06 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.208 1.003 . . . . 64.2 111.764 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.467 HD13 ' O ' ' D' ' 137' ' ' PHE . 8.1 mp -70.93 -37.09 72.86 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.365 0.666 . . . . 74.34 111.997 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -87.39 39.64 0.88 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.185 0.594 . . . . 63.12 112.002 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 87.1 mm-40 -118.66 87.67 2.77 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.676 0.79 . . . . 72.2 109.578 -175.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -172.58 162.82 5.24 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.184 0.994 . . . . 70.15 110.093 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.21 139.96 58.14 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.898 0.479 . . . . 61.44 111.028 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 153.83 59.91 0.01 OUTLIER Glycine 0 C--N 1.345 1.046 0 CA-C-N 116.353 -0.385 . . . . 53.21 112.16 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.25 144.14 30.85 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.015 0.526 . . . . 51.51 110.538 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -93.71 48.56 2.3 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.173 -0.467 . . . . 63.13 112.081 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 48.1 p -95.63 87.09 4.6 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.49 0.716 . . . . 42.34 109.48 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.41 159.38 42.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.366 -0.833 . . . . 71.13 110.346 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -167.64 -64.13 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.866 -1.161 . . . . 72.54 107.866 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -178.1 143.38 0.3 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.496 1.518 . . . . 70.22 107.736 174.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -107.82 -72.58 0.72 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 106.327 -1.731 . . . . 63.31 106.327 169.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 41.92 70.14 0.3 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.748 1.619 . . . . 64.35 113.675 163.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.207 0 C-N-CA 122.724 0.41 . . . . 74.2 109.968 -177.51 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 111.594 0.22 . . . . 71.54 111.594 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.0 -57.82 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.367 0.667 . . . . 73.42 110.794 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 29.2 m -113.86 112.93 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-O 121.374 0.607 . . . . 74.15 111.675 -171.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -87.3 65.78 3.59 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 116.238 -0.437 . . . . 44.11 112.274 -176.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 48' ' ' SER . 75.4 mt -72.5 114.1 10.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.035 0.534 . . . . 71.44 109.942 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 8.9 t -138.87 -40.94 0.48 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.302 0.641 . . . . 74.01 110.055 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -91.08 -24.96 19.86 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.985 0.914 . . . . 73.4 111.3 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -56.9 114.72 2.22 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.317 1.047 . . . . 74.53 110.352 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . . . . . . . . . 85.0 m -139.82 -51.43 0.51 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.399 1.08 . . . . 73.44 109.886 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.11 132.1 35.12 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.487 0.715 . . . . 72.44 111.002 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -105.9 122.74 46.75 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.764 -1.198 . . . . 65.12 107.764 172.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -88.5 136.7 32.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.415 0.686 . . . . 73.3 109.741 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . 0.586 ' HA ' HD13 ' A' ' 136' ' ' LEU . 13.6 p90 -163.29 120.21 1.84 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.074 0.95 . . . . 70.21 108.586 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 36.3 m -69.52 -45.83 67.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.026 0.53 . . . . 71.12 110.797 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . 0.565 ' HB3' HG22 ' A' ' 131' ' ' VAL . 5.2 tmm? -72.89 96.77 2.15 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.472 -0.936 . . . . 74.34 108.472 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -130.02 131.0 45.67 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.856 -1.164 . . . . 73.3 107.856 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . 0.523 ' H ' ' HB3' ' A' ' 42' ' ' LEU . . . 61.11 -158.12 0.33 Allowed 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.344 1.028 . . . . 71.34 110.169 -174.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . 58.68 31.31 21.0 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.499 0.72 . . . . 34.3 111.219 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . 0.503 HD21 HD22 ' A' ' 42' ' ' LEU . 38.1 mt -67.46 148.77 51.1 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.06 -0.973 . . . . 74.41 109.566 -177.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -52.21 -84.81 0.02 OUTLIER Glycine 0 C--N 1.354 1.543 0 O-C-N 124.551 1.157 . . . . 52.3 113.444 -173.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . 0.51 ' HB2' HD13 ' A' ' 126' ' ' LEU . 24.9 tp 63.82 150.64 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.974 1.309 . . . . 74.01 112.219 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? . . . . . 0 CA--C 1.554 1.119 0 N-CA-C 107.499 -1.297 . . . . 71.53 107.499 173.887 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 110.387 -0.227 . . . . 71.31 110.387 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.56 -69.06 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.44 0.696 . . . . 74.22 109.201 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . . . . . . . . . 35.0 m -128.49 157.61 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.844 1.257 . . . . 73.12 108.603 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . -98.95 -49.64 1.59 Allowed Glycine 0 N--CA 1.468 0.785 0 N-CA-C 111.164 -0.774 . . . . 72.43 111.164 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 25.5 tp 48.27 62.42 2.53 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.662 1.585 . . . . 75.4 111.415 -173.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 46.3 p -102.34 35.23 2.48 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.543 -1.208 . . . . 74.35 109.461 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.7 -156.33 0.13 Allowed 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.359 1.064 . . . . 44.23 109.07 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . 0.506 ' HB2' ' HE1' ' B' ' 140' ' ' TYR . 23.1 mt-30 -62.31 -56.34 19.4 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.167 0.587 . . . . 72.45 109.803 174.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 12.8 m 62.26 8.92 2.95 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.83 1.252 . . . . 72.24 111.166 -172.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.27 103.65 16.3 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 124.534 1.134 . . . . 75.35 109.461 -173.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' B' ' 100' ' ' ALA . 1.6 pp -167.6 103.16 0.5 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.981 0.912 . . . . 72.11 108.8 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' B' ' 44' ' ' LEU . 3.2 m-85 179.01 154.56 0.43 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.52 1.528 . . . . 65.34 109.577 170.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . 0.445 ' HB3' HD13 ' B' ' 42' ' ' LEU . 59.3 m-85 64.15 10.2 5.31 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.335 1.454 . . . . 63.43 113.155 173.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . 0.665 ' HB ' ' HG ' ' B' ' 136' ' ' LEU . 9.0 m -76.65 72.4 3.3 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.178 -1.045 . . . . 72.03 108.178 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -151.83 163.21 39.68 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.932 -1.031 . . . . 75.41 109.779 -168.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -115.55 145.44 42.64 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.131 0.972 . . . . 63.21 108.462 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . 58.95 69.96 0.69 Allowed 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.125 0.89 . . . . 74.0 109.179 -168.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . 0.501 ' HB1' HD21 ' B' ' 42' ' ' LEU . . . -66.3 -16.36 63.98 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.749 -1.114 . . . . 71.11 113.389 -169.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 2.7 tt -154.28 -71.78 0.13 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.927 -0.768 . . . . 70.2 108.927 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 87.99 66.73 1.31 Allowed Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.589 -0.604 . . . . 63.04 111.589 -174.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . 0.553 HD22 ' HB3' ' B' ' 37' ' ' GLN . 91.3 mt -67.59 98.0 0.65 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.801 0.84 . . . . 75.54 110.824 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 62.1 tttm . . . . . 0 C--O 1.252 1.217 0 N-CA-C 108.579 -0.897 . . . . 70.5 108.579 -175.942 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 37.7 t30 . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 109.083 -0.71 . . . . 74.15 109.083 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.46 -59.94 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.273 0.629 . . . . 74.02 109.645 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . . . . . . . . . 11.3 p -157.87 149.24 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 115.821 -0.627 . . . . 73.43 110.597 -171.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . -119.71 111.4 2.02 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 109.039 -1.624 . . . . 74.33 109.039 169.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 38.6 tp -75.12 130.53 39.4 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.485 0.642 . . . . 70.54 111.322 -172.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 37.7 m -67.82 149.41 49.92 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.696 0.799 . . . . 60.54 109.576 170.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -61.35 87.49 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.011 0.524 . . . . 70.52 110.93 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.61 -60.07 2.52 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.476 -0.935 . . . . 73.42 108.476 175.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 29.7 m 58.86 79.43 0.22 Allowed 'General case' 0 C--O 1.247 0.957 0 O-C-N 124.525 1.141 . . . . 65.43 110.739 174.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -171.13 151.03 3.11 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.706 -1.133 . . . . 75.5 109.438 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' C' ' 44' ' ' LEU . 24.9 tp -153.8 123.83 6.88 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.493 -0.928 . . . . 72.24 108.493 169.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -52.91 -28.51 23.65 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.679 1.591 . . . . 64.24 113.87 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -85.09 89.18 7.56 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 122.743 0.417 . . . . 75.44 110.663 -171.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 86.0 m -99.57 127.8 45.67 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.569 -0.9 . . . . 62.34 108.569 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . 0.707 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . 63.4 mtp -107.05 126.83 52.86 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.012 0.925 . . . . 73.34 110.296 -173.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -112.5 -8.32 13.86 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 108.494 -0.928 . . . . 75.44 108.494 162.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -117.06 129.57 56.08 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.202 1.001 . . . . 72.34 109.291 175.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -160.66 -47.25 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.088 0.955 . . . . 74.44 109.606 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.64 -49.35 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 116.08 -0.509 . . . . 75.24 110.956 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . 105.95 -33.9 6.15 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 119.495 -0.614 . . . . 71.01 114.084 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . 0.721 HD11 HD12 ' C' ' 126' ' ' LEU . 88.2 mt 67.59 9.23 6.91 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 124.848 1.259 . . . . 74.11 112.053 -174.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 94.7 mttt . . . . . 0 C--O 1.254 1.317 0 C-N-CA 124.056 0.942 . . . . 61.52 109.193 -176.647 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 108.579 -0.897 . . . . 71.12 108.579 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . 0.537 HG12 HD13 ' D' ' 86' ' ' ILE . 21.2 t -61.73 -45.81 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 124.153 0.981 . . . . 73.15 109.68 175.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . 0.415 ' HA ' ' CE1' ' D' ' 56' ' ' TYR . 2.6 p -133.31 141.93 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 114.309 -1.314 . . . . 71.43 110.338 -173.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 112.11 -7.01 27.11 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.894 -0.594 . . . . 73.41 112.932 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . . . . . . . . . 39.3 tp -94.21 131.92 39.3 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.203 -0.666 . . . . 73.13 109.203 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 13.5 t -139.35 10.86 2.54 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.023 0.44 . . . . 54.15 110.496 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -147.02 163.92 34.69 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.002 0.521 . . . . 51.33 109.939 -169.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.99 120.06 41.13 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.759 1.224 . . . . 75.54 109.067 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 25.5 p -69.72 -69.17 0.36 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.987 0.515 . . . . 72.15 110.635 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -169.94 150.67 3.9 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.484 0.713 . . . . 73.43 110.11 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.54 -169.47 2.65 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.272 1.029 . . . . 74.11 111.029 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -159.16 7.46 0.11 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.47 0.708 . . . . 74.23 112.305 -171.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -119.12 134.84 54.96 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.886 0.766 . . . . 63.41 112.182 -175.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 30.4 p -138.75 153.85 48.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.728 1.611 . . . . 72.32 108.224 174.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . 0.486 ' HB3' HD21 ' D' ' 42' ' ' LEU . 55.6 ttp -155.94 141.77 18.01 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.621 -0.511 . . . . 72.43 109.621 173.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -67.73 -58.65 4.28 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.607 0.763 . . . . 75.43 111.633 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -151.43 167.05 29.17 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.084 0.554 . . . . 74.3 110.726 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . -129.43 166.9 18.66 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.17 0.988 . . . . 41.33 110.157 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . 0.634 HD21 ' H ' ' D' ' 127' ' ' ASN . 6.0 mp 59.27 -157.71 0.32 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.375 1.07 . . . . 62.42 111.206 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . -80.79 27.83 2.91 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 113.607 0.203 . . . . 73.22 113.607 173.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . 0.559 HD12 ' HG3' ' D' ' 37' ' ' GLN . 4.8 tt -89.92 101.16 13.86 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 107.882 -1.155 . . . . 74.45 107.882 177.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? . . . . . 0 C--O 1.253 1.266 0 N-CA-C 107.324 -1.361 . . . . 63.13 107.324 171.323 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptm . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 111.093 0.034 . . . . 75.2 111.093 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 t 178.66 115.23 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.088 1.355 . . . . 74.03 107.546 164.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.61 88.16 2.28 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.87 -1.159 . . . . 73.34 107.87 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -145.18 103.68 3.88 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.871 1.268 . . . . 72.01 108.197 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -121.13 170.54 9.45 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.863 0.865 . . . . 73.31 110.469 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -153.26 21.45 0.56 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.912 0.863 . . . . 62.41 109.411 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.8 p -78.88 82.86 5.04 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.264 -0.88 . . . . 74.24 110.892 -175.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.26 130.84 44.58 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.083 -0.962 . . . . 65.31 109.867 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.57 ' HG2' HD12 ' A' ' 89' ' ' ILE . 80.3 mtp -134.39 171.31 14.46 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.809 0.814 . . . . 64.14 111.651 -174.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.7 m -139.26 102.16 4.43 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 106.125 -1.806 . . . . 75.43 106.125 164.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.611 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.6 t80 -114.49 129.96 56.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.001 -1.0 . . . . 75.42 109.213 -171.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -140.99 108.84 5.67 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.36 -0.978 . . . . 75.11 108.36 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.551 HG12 ' HD2' ' A' ' 84' ' ' PHE . 55.0 mt -81.16 116.94 26.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.971 -0.751 . . . . 71.43 108.971 173.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.486 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -73.82 -40.77 63.11 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.634 -0.712 . . . . 75.24 109.301 -178.683 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -173.64 122.96 0.35 Allowed 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.299 0.374 . . . . 62.52 111.384 -171.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.561 HD12 ' HG3' ' C' ' 130' ' ' PRO . 71.3 mt -106.43 133.83 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.067 -0.716 . . . . 74.42 109.067 173.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB3' HG23 ' B' ' 122' ' ' THR . 33.2 p90 -163.76 178.86 7.53 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.882 0.873 . . . . 41.44 110.901 -173.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.9 p -106.2 116.26 31.63 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.951 -0.759 . . . . 74.11 108.951 176.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 22.7 mtpt -81.26 -29.71 34.31 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.422 -0.585 . . . . 73.13 109.422 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.3 t70 -146.84 141.75 26.95 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.719 -1.128 . . . . 45.25 109.697 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 88.0 mt -139.05 141.26 36.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 125.616 1.566 . . . . 74.32 106.807 171.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -147.96 136.85 21.94 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.184 0.516 . . . . 62.43 109.986 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.592 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.4 t80 -135.26 126.23 27.69 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.682 -1.229 . . . . 75.45 107.682 171.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.81 119.88 24.1 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.885 0.474 . . . . 74.14 110.159 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -132.93 80.4 60.71 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 107.367 -1.345 . . . . 62.24 107.367 170.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.66 -19.38 12.87 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.68 2.253 . . . . 74.34 111.192 175.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.496 ' O ' HG23 ' A' ' 31' ' ' VAL . 91.0 m-20 -103.94 16.98 25.08 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.294 1.038 . . . . 62.34 110.56 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.583 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -55.25 -46.6 99.66 Favored Pre-proline 0 CA--C 1.57 1.725 0 C-N-CA 123.54 0.736 . . . . 52.12 112.277 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.52 6.1 4.69 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 122.318 2.012 . . . . 72.43 113.383 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -100.78 -40.25 7.42 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.125 0.57 . . . . 75.2 109.8 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 27' ' ' ASN . 98.6 t -66.78 -34.39 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.716 0.806 . . . . 62.23 111.34 -175.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.457 ' CE1' ' HG3' ' A' ' 33' ' ' GLN . 1.1 p90 -65.82 -26.14 67.54 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 120.898 0.38 . . . . 75.12 111.029 -177.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.457 ' HG3' ' CE1' ' A' ' 32' ' ' PHE . 49.2 mt-30 -87.08 -44.11 11.79 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.372 0.669 . . . . 62.13 111.068 177.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HE3' HD11 ' A' ' 68' ' ' LEU . 53.4 mtmt -82.86 168.55 17.0 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.086 0.47 . . . . 73.54 112.251 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.24 131.96 41.69 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.009 -0.996 . . . . 61.15 110.535 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -77.44 98.62 5.35 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.589 1.156 . . . . 73.1 110.256 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -139.01 75.66 34.78 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 108.879 -0.786 . . . . 75.45 108.879 172.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -84.96 152.81 11.19 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.554 2.169 . . . . 72.54 112.863 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -118.33 108.76 15.48 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.603 -1.258 . . . . 73.05 107.603 172.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.523 HG21 ' HG ' ' E' ' 468' ' ' LEU . 22.6 m -82.54 135.41 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.609 0.764 . . . . 74.24 111.649 -171.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -123.28 113.28 18.67 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.895 -1.15 . . . . 73.14 107.895 174.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.421 HD23 ' HB3' ' E' ' 464' ' ' MET . 64.7 tp -110.46 116.72 31.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.045 0.538 . . . . 75.51 110.078 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.497 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 31.5 t70 -103.15 132.93 49.04 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 109.029 -0.73 . . . . 75.14 109.029 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' E' ' 464' ' ' MET . 85.5 mt -110.47 132.4 54.21 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.459 -0.941 . . . . 73.33 108.459 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.749 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 16.9 t70 -145.39 153.17 40.92 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 122.907 0.483 . . . . 62.2 110.068 177.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.447 ' O ' HG22 ' E' ' 458' ' ' THR . 26.6 m -127.71 139.39 52.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.667 1.187 . . . . 71.21 108.659 177.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.57 123.69 25.58 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.491 -0.559 . . . . 45.2 109.491 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.457 ' HB2' ' HA ' ' E' ' 456' ' ' ASP . 17.6 m -88.11 152.21 22.17 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.333 -0.617 . . . . 24.25 109.333 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -160.42 122.52 3.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.368 0.667 . . . . 73.21 109.819 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -81.04 139.12 35.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.026 0.53 . . . . 73.43 110.239 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.448 HD12 HG23 ' A' ' 83' ' ' ILE . 83.7 mt -117.49 -28.76 5.99 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.522 0.729 . . . . 61.22 110.138 176.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.2 -177.35 4.92 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.08 0.952 . . . . 62.24 109.374 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.18 128.22 35.57 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.269 -0.641 . . . . 54.22 109.269 173.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 69.38 2.42 3.7 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.204 1.402 . . . . 74.33 112.309 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.87 116.43 52.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 123.923 0.889 . . . . 71.23 109.389 -177.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.16 125.59 23.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.987 0.915 . . . . 74.24 108.678 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -93.83 145.39 24.64 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.632 -0.877 . . . . 63.22 108.632 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -111.58 138.26 40.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.995 -1.113 . . . . 54.4 107.995 172.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -114.73 106.78 21.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.021 -1.103 . . . . 72.4 108.021 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.7 tp -88.09 105.91 17.81 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.656 -0.868 . . . . 74.35 108.656 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.749 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 59.1 mtt85 -83.75 121.94 27.98 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.838 -0.801 . . . . 64.42 108.838 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.627 HG21 ' HB1' ' A' ' 110' ' ' ALA . 2.1 m -127.61 101.52 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.644 -0.873 . . . . 75.03 108.644 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 86.6 m -98.13 108.54 21.27 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.344 1.057 . . . . 72.13 109.87 -175.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.424 HG21 HG21 ' A' ' 114' ' ' ILE . 85.0 t -103.03 113.65 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.42 -0.585 . . . . 34.15 109.42 176.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.9 m -123.6 107.05 11.09 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.071 -0.714 . . . . 72.1 109.071 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.25 125.1 53.79 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.977 -0.749 . . . . 64.43 108.977 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.4 p -120.95 130.38 53.83 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.535 0.734 . . . . 70.44 110.161 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 68' ' ' LEU . 2.7 pt? -90.4 48.31 1.54 Allowed 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 122.278 1.037 . . . . 64.41 109.661 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.78 -125.34 6.36 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 114.915 -1.039 . . . . 22.11 111.071 -170.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.27 -28.34 23.83 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 117.48 0.64 . . . . 75.31 109.73 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -86.12 134.5 33.81 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.85 0.86 . . . . 74.12 110.571 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.2 m -74.72 133.4 42.04 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.649 0.593 . . . . 62.33 109.869 172.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.83 -51.88 9.1 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.891 0.877 . . . . 71.3 108.963 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -155.92 157.08 35.7 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.447 -1.252 . . . . 52.22 111.551 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 62.8 tp -121.97 109.76 14.99 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.403 -1.332 . . . . 70.32 107.403 166.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 80.1 m -107.28 97.36 7.13 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.939 -1.134 . . . . 72.33 107.939 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -122.13 115.8 23.08 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.36 -0.978 . . . . 52.41 108.36 -173.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.7 t -126.22 136.11 61.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.49 -0.777 . . . . 73.13 109.184 -172.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 24.5 mt-30 -110.28 91.17 3.55 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.826 -0.805 . . . . 64.24 108.826 167.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -77.18 113.17 14.63 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.867 -1.16 . . . . 63.15 107.867 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.72 142.19 16.12 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 112.198 -0.361 . . . . 22.32 112.198 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.41 141.54 10.86 Favored Glycine 0 CA--C 1.505 -0.557 0 N-CA-C 110.743 -0.943 . . . . 75.02 110.743 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 14' ' ' GLN . 36.2 mt -88.63 124.45 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 108.868 -0.79 . . . . 74.44 108.868 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.611 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 39.0 m-85 -129.3 128.97 44.27 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.706 0.802 . . . . 74.04 109.522 -171.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.2 t -89.05 120.84 30.82 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.912 -0.774 . . . . 61.25 108.912 174.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.1 pt -95.84 129.24 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.437 0.695 . . . . 74.23 109.898 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.03 158.9 7.34 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.934 0.894 . . . . 71.41 111.164 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 103.18 -33.38 6.63 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-N 115.771 -0.649 . . . . 61.15 113.494 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.57 HD12 ' HG2' ' A' ' 9' ' ' MET . 0.2 OUTLIER -137.62 170.7 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.837 0.855 . . . . 71.13 109.905 -177.25 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.95 173.33 11.61 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.524 0.73 . . . . 70.14 109.449 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.28 -145.09 43.81 Favored Glycine 0 C--N 1.351 1.387 0 C-N-CA 122.648 0.166 . . . . 53.41 113.498 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.549 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 23.3 p -72.64 -14.85 61.69 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.802 0.841 . . . . 73.15 111.921 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -68.07 -38.36 82.3 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.968 -0.753 . . . . 61.42 108.968 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.451 ' SD ' HG22 ' E' ' 451' ' ' VAL . 38.1 ttp -82.93 -35.49 26.02 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.485 0.714 . . . . 70.15 111.054 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.549 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -63.21 -26.5 68.83 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.942 0.497 . . . . 73.51 110.631 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.401 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 18.4 t-80 -66.38 -50.35 63.78 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.502 1.121 . . . . 74.31 110.506 169.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 71.0 m -67.2 -27.31 67.15 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.852 0.461 . . . . 73.03 112.1 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.88 -41.82 12.95 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.14 0.976 . . . . 74.02 109.589 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.84 2.18 56.9 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-O 119.469 -0.628 . . . . 75.43 114.585 -171.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.447 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -138.37 -62.06 0.58 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.608 0.704 . . . . 70.1 111.262 -177.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.44 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 80.6 t80 -62.75 -49.72 73.91 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.729 0.812 . . . . 71.41 111.736 -175.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 89.6 m -71.1 -39.64 8.49 Favored Pre-proline 0 CA--C 1.571 1.76 0 N-CA-C 114.101 1.148 . . . . 45.23 114.101 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.38 -24.4 50.09 Favored 'Trans proline' 0 C--N 1.387 2.571 0 CA-C-N 121.742 1.658 . . . . 63.41 112.826 167.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -27.57 61.76 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.907 -0.405 . . . . 75.05 109.907 177.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.8 mm -60.25 -40.7 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.911 0.884 . . . . 73.44 109.818 170.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.5 mt -80.07 -17.22 53.25 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.066 0.947 . . . . 62.32 112.338 -175.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -63.75 -45.22 81.78 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 113.916 1.08 . . . . 71.44 113.916 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.46 -39.51 65.36 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 121.596 1.53 . . . . 73.34 112.701 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -69.47 -38.48 77.73 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.379 0.672 . . . . 75.14 111.085 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.627 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.85 -41.73 86.87 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.816 -0.629 . . . . 63.24 110.39 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.581 ' HA ' HD21 ' A' ' 128' ' ' LEU . 40.9 ttm180 -54.78 -50.47 68.41 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 124.7 1.25 . . . . 74.13 110.29 177.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -63.65 -42.69 98.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.485 1.116 . . . . 72.23 111.397 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 117' ' ' MET . 27.6 t -60.93 -37.4 82.18 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 123.695 0.622 . . . . 45.34 110.61 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.424 HG21 HG21 ' A' ' 64' ' ' VAL . 78.5 mt -71.61 -43.05 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.483 1.113 . . . . 73.34 110.561 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.406 HG23 ' HG3' ' A' ' 125' ' ' GLN . 24.0 m -61.6 -33.99 74.86 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.731 0.776 . . . . 64.44 109.94 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.7 t -70.93 -40.09 72.27 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.712 -1.131 . . . . 74.33 109.864 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.592 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 18.4 mmt -59.08 -48.38 81.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.308 0.643 . . . . 65.35 111.626 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.1 m -68.13 -42.14 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 O-C-N 123.448 0.467 . . . . 74.24 111.43 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 56.9 m -69.01 -35.71 76.97 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.054 0.541 . . . . 72.22 111.692 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.515 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 95.2 mtt-85 -70.55 -35.19 72.98 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.896 0.479 . . . . 72.13 110.029 175.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.14 19.72 20.65 Favored Glycine 0 C--N 1.354 1.57 0 CA-C-O 119.14 -0.811 . . . . 75.05 114.32 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' B' ' 17' ' ' TYR . 2.4 t 61.4 10.73 3.3 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 127.16 2.184 . . . . 63.44 114.311 176.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -86.52 150.54 51.5 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 108.542 -0.91 . . . . 72.21 108.542 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.55 159.03 21.29 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.395 2.063 . . . . 62.52 112.2 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.406 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.1 tt0 -60.83 142.97 55.65 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.071 0.549 . . . . 72.03 112.308 -177.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.3 tp -128.15 121.8 30.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.117 0.967 . . . . 73.41 109.938 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -124.7 109.66 13.4 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.681 -0.859 . . . . 71.12 108.681 173.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.757 ' H ' HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -73.23 126.34 29.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 109.101 -0.703 . . . . 70.23 109.101 173.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.13 151.22 27.1 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 124.895 1.278 . . . . 61.21 112.715 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 110.23 0.65 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.805 2.337 . . . . 73.14 112.54 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 81.7 t -99.37 113.09 33.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.072 -1.084 . . . . 70.42 108.072 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -85.27 81.65 8.7 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.433 -0.951 . . . . 73.5 108.433 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -56.27 -31.9 64.02 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.456 0.702 . . . . 72.3 111.407 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.447 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 9.8 t70 -63.31 -48.3 78.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.546 1.138 . . . . 73.3 110.706 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.69 92.61 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.994 0.918 . . . . 44.31 111.445 176.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.7 mt -69.53 -34.6 74.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.731 0.812 . . . . 70.02 111.878 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.96 -38.48 79.44 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.652 -0.87 . . . . 63.31 108.652 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 10.4 mmt -60.35 -43.58 96.37 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 124.109 0.881 . . . . 62.34 111.195 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -58.47 -36.96 74.52 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.279 0.632 . . . . 72.31 110.853 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -77.87 -33.25 52.18 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.652 1.181 . . . . 71.4 111.216 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.6 -52.17 28.5 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.556 1.143 . . . . 74.14 111.6 -173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 172.12 -15.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.747 1.219 . . . . 72.44 110.899 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -69.92 159.65 33.31 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 122.032 0.92 . . . . 73.44 111.771 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -147.69 -32.7 0.27 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 113.837 -1.529 . . . . 72.12 108.811 -173.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.77 -42.54 33.69 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.451 -1.25 . . . . 61.13 112.081 -173.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.28 -133.27 2.85 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.974 -0.348 . . . . 70.03 113.092 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -65.64 -43.99 87.78 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.155 0.982 . . . . 65.35 110.332 -176.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.74 151.52 12.58 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 114.635 -1.166 . . . . 54.54 111.138 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.1 m -125.26 9.89 7.99 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 121.489 0.661 . . . . 73.44 109.281 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -80.25 151.7 29.47 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.844 0.858 . . . . 75.33 111.007 -170.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 71.53 178.5 0.25 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.066 1.346 . . . . 75.42 113.326 -175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -141.65 177.89 7.84 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.647 -1.615 . . . . 61.22 108.403 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -75.01 85.64 2.3 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.896 -1.15 . . . . 71.14 107.896 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.28 -48.2 44.22 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.594 -0.73 . . . . 70.23 109.759 -177.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-N 115.205 -0.907 . . . . 72.04 108.942 170.495 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.479 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.556 0.217 . . . . 74.22 110.594 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.7 t -120.01 128.22 53.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.457 0.703 . . . . 42.44 109.679 176.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.6 ' HG3' HE21 ' B' ' 4' ' ' GLN . 11.7 pt-20 -57.0 -25.96 59.38 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.469 1.108 . . . . 72.45 112.479 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.6 HE21 ' HG3' ' B' ' 3' ' ' GLU . 31.4 mm-40 -70.93 -24.67 62.49 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.992 0.917 . . . . 70.55 112.336 -176.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 32.99 78.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 125.923 1.689 . . . . 73.41 113.679 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -72.6 -171.63 0.85 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.069 1.347 . . . . 75.44 109.528 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -77.26 63.41 2.48 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 123.27 1.51 . . . . 70.2 109.162 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -110.13 -149.65 0.45 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.874 -1.512 . . . . 54.35 108.763 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.597 ' HB3' HG23 ' B' ' 89' ' ' ILE . 23.2 ptm 57.18 -173.73 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 125.594 1.558 . . . . 75.45 114.396 170.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 85.0 m -135.4 108.62 7.75 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.544 -0.91 . . . . 64.21 108.544 172.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -114.42 143.25 45.22 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.215 0.606 . . . . 63.44 109.848 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -149.72 140.81 22.99 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.289 0.636 . . . . 72.4 109.749 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.64 123.49 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.75 -1.204 . . . . 65.22 107.75 172.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.414 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 14.0 mm100 -86.23 -50.65 6.81 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.233 -0.654 . . . . 75.31 109.233 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -170.12 133.24 1.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.508 -0.769 . . . . 74.51 109.704 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.04 138.76 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 107.87 -1.159 . . . . 74.32 107.87 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.446 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 33.7 p90 -165.11 164.65 20.27 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 122.304 1.049 . . . . 73.03 112.379 -177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 74.3 m -87.73 130.08 34.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.938 -1.483 . . . . 73.41 108.063 169.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.405 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 40.5 mtpt -98.02 -36.62 10.06 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.381 0.672 . . . . 64.2 110.302 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -149.99 132.21 15.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.814 -0.63 . . . . 55.44 110.545 -170.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.454 HD12 HG22 ' B' ' 78' ' ' VAL . 48.8 mm -128.3 141.97 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.116 0.966 . . . . 75.43 108.553 171.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -142.34 130.67 22.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.227 -1.397 . . . . 73.12 107.227 173.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.417 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.0 t80 -144.99 109.85 5.06 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.585 -1.265 . . . . 71.12 107.585 170.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -120.89 123.42 42.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.54 -0.911 . . . . 72.03 108.54 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.96 87.16 2.25 Favored Pre-proline 0 C--O 1.242 0.68 0 N-CA-C 106.722 -1.584 . . . . 51.5 106.722 171.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.85 -36.1 19.26 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.639 2.226 . . . . 74.02 112.735 -165.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -110.83 22.25 15.57 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.86 0.864 . . . . 61.25 110.423 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -36.29 -64.93 0.34 Allowed Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 115.195 1.554 . . . . 42.33 115.195 -162.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.7 Cg_exo -66.21 -30.28 46.28 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 121.828 1.685 . . . . 53.12 112.682 -173.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.419 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 65.8 m80 -93.32 -15.87 25.29 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.373 -0.831 . . . . 74.42 112.284 -174.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.732 HG21 ' HA ' ' B' ' 73' ' ' ALA . 7.5 p -85.93 -30.12 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 117.93 0.332 . . . . 73.55 110.529 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -61.2 -19.54 61.73 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.742 0.817 . . . . 75.12 113.081 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.1 pt20 -64.85 -15.7 62.22 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.99 0.516 . . . . 75.23 111.594 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -99.57 97.58 8.55 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.109 0.964 . . . . 50.41 109.024 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -79.65 91.72 5.28 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.281 0.563 . . . . 74.05 109.796 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -164.36 159.81 20.13 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.322 1.049 . . . . 72.43 108.993 -174.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.8 pm0 -82.52 109.74 17.93 Favored Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 109.217 -0.661 . . . . 72.21 109.217 173.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.483 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 35.3 Cg_endo -62.41 127.38 20.75 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.815 2.343 . . . . 53.42 113.074 -171.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -56.73 120.16 7.37 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.294 0.996 . . . . 73.31 110.969 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.481 HG11 HD11 ' B' ' 126' ' ' LEU . 29.6 m -96.18 163.03 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.159 -0.928 . . . . 43.43 113.19 -168.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.549 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 81.8 tttt -148.88 137.46 21.19 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.982 1.713 . . . . 72.2 107.512 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.412 ' HB3' HD11 ' B' ' 44' ' ' LEU . 2.6 mm? -105.25 131.41 52.74 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.119 -0.697 . . . . 71.32 109.119 176.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.8 t70 -124.29 110.71 14.95 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 106.697 -1.594 . . . . 73.43 106.697 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.426 ' HB2' HD21 ' F' ' 460' ' ' LEU . 0.5 OUTLIER -114.98 129.26 56.68 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.832 -0.803 . . . . 74.04 108.832 -165.422 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 20.7 m-20 -130.65 112.79 13.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.035 0.534 . . . . 73.12 109.841 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 28.6 p -107.15 102.27 11.61 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.217 -1.031 . . . . 51.41 108.217 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.19 119.15 26.74 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.241 1.016 . . . . 73.23 109.321 -174.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.524 ' HB3' HG22 ' B' ' 58' ' ' VAL . 16.6 p -100.3 161.62 13.49 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.615 0.766 . . . . 73.01 109.931 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 81.2 p -151.07 137.21 18.35 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.5 0.72 . . . . 64.11 109.355 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -81.9 118.35 22.87 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.206 0.602 . . . . 74.42 109.788 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.17 -43.72 15.86 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.959 -0.756 . . . . 73.15 108.959 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.64 177.37 11.3 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.186 -1.37 . . . . 60.54 108.923 174.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.92 130.78 43.76 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.895 -0.78 . . . . 65.22 108.895 178.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 75.28 -4.45 2.37 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 125.056 1.343 . . . . 71.54 112.424 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -117.56 109.18 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.759 0.824 . . . . 65.05 109.332 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -125.56 138.61 53.96 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.401 -0.592 . . . . 71.32 109.401 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -119.07 107.09 13.07 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.092 -1.077 . . . . 72.32 108.092 -172.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' B' ' 48' ' ' SER . 85.8 t -94.3 135.13 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.991 0.916 . . . . 74.21 110.617 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.15 130.08 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.385 -0.969 . . . . 72.33 108.385 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.84 112.81 23.34 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.112 -1.07 . . . . 70.53 108.112 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.406 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 36.8 ttm180 -99.83 127.49 45.99 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.412 0.685 . . . . 73.12 109.829 173.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' B' ' 114' ' ' ILE . 46.0 t -123.12 102.64 11.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 106.67 -1.604 . . . . 74.34 106.67 167.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.5 m -99.44 126.25 45.32 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.346 -0.613 . . . . 75.32 109.346 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.522 HG11 HD21 ' B' ' 126' ' ' LEU . 60.3 t -108.94 105.43 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 123.298 0.639 . . . . 70.31 109.721 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 42.0 m -84.02 137.42 33.61 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.966 -1.124 . . . . 62.22 107.966 167.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.442 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -149.02 143.43 26.09 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.51 0.324 . . . . 44.23 110.182 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 49.4 p -146.0 134.23 21.7 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.579 0.549 . . . . 52.2 111.373 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.659 HD12 HG22 ' B' ' 31' ' ' VAL . 39.2 mt -93.35 109.94 21.49 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.511 -0.922 . . . . 62.21 108.511 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.67 -108.8 2.6 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.866 -1.061 . . . . 71.03 111.713 -170.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.95 3.97 10.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.045 0.938 . . . . 75.53 111.905 -175.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -115.03 149.78 36.92 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.436 -0.579 . . . . 72.41 109.436 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.2 m -67.31 133.26 49.33 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.936 0.398 . . . . 54.35 111.161 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.732 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -90.46 -64.07 1.19 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.962 -1.017 . . . . 74.53 109.234 176.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -150.02 154.68 38.6 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.316 -0.856 . . . . 73.34 110.393 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.0 mt -128.79 110.77 12.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.669 -1.604 . . . . 74.45 106.669 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.9 t -117.57 155.69 29.38 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.856 -0.794 . . . . 75.22 108.856 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -163.55 130.67 3.39 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.836 -0.801 . . . . 74.54 108.836 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.454 HG22 HD12 ' B' ' 21' ' ' ILE . 88.3 t -124.07 141.32 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.593 -0.891 . . . . 73.32 108.593 172.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -123.04 88.42 2.92 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.89 -0.782 . . . . 44.22 108.89 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.405 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -79.76 100.82 8.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.141 -0.936 . . . . 72.13 109.102 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.31 143.69 16.88 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.744 -0.542 . . . . 74.42 111.744 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.534 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -145.81 127.13 2.72 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.135 -0.786 . . . . 70.51 111.135 -172.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 14.3 mt -91.2 129.68 41.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 123.918 0.887 . . . . 62.43 108.617 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -137.71 133.68 34.47 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.889 -0.782 . . . . 53.21 108.889 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.8 m -93.42 109.19 20.77 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.953 -0.758 . . . . 70.32 108.953 172.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 pt -112.92 117.83 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.228 1.011 . . . . 71.22 109.118 -174.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -129.84 152.72 49.02 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.18 0.592 . . . . 61.21 110.791 -175.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.43 -60.22 4.32 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.824 0.702 . . . . 63.0 112.522 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.597 HG23 ' HB3' ' B' ' 9' ' ' MET . 2.8 pp -67.12 145.29 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.351 0.661 . . . . 60.25 112.391 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -166.32 174.51 9.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.186 0.595 . . . . 74.54 109.561 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.6 -112.29 3.91 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 112.217 -0.353 . . . . 75.55 112.217 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' B' ' 95' ' ' ALA . 31.6 m -78.13 -29.53 48.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.142 0.496 . . . . 74.4 110.742 176.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -69.99 -33.81 72.53 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.34 -0.391 . . . . 74.02 110.575 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.524 ' HB2' HG13 ' F' ' 452' ' ' VAL . 0.0 OUTLIER -74.86 -30.81 61.46 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.957 -0.565 . . . . 62.45 110.212 178.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' B' ' 92' ' ' THR . . . -59.83 -38.45 82.05 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.45 0.7 . . . . 64.22 110.032 171.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -76.08 -36.31 59.01 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.284 1.034 . . . . 71.05 111.608 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.64 -57.36 6.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 123.593 0.558 . . . . 65.13 109.846 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.3 mp -79.62 -15.83 56.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.94 0.496 . . . . 65.45 111.521 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.39 -15.02 48.98 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.41 0.524 . . . . 65.24 114.41 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.35 -56.74 0.32 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 117.341 0.57 . . . . 52.34 111.879 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -68.5 -52.56 30.97 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.835 0.854 . . . . 62.13 112.001 -167.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.452 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 92.2 m -63.04 -49.07 83.05 Favored Pre-proline 0 CA--C 1.565 1.542 0 C-N-CA 124.319 1.047 . . . . 74.31 112.13 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.0 Cg_exo -58.49 -34.07 98.48 Favored 'Trans proline' 0 C--N 1.398 3.15 0 C-N-CA 122.095 1.864 . . . . 74.33 113.559 171.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.24 -37.62 83.72 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.374 0.67 . . . . 75.25 111.747 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 45.4 mt -63.9 -41.72 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.843 0.857 . . . . 72.34 110.759 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.534 HD21 ' HA3' ' B' ' 82' ' ' GLY . 51.2 mt -80.19 -19.91 45.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.348 1.059 . . . . 54.32 112.311 -173.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -59.7 -49.38 92.1 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.278 1.214 . . . . 75.51 114.278 -171.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -61.67 -33.7 85.58 Favored 'Trans proline' 0 C--N 1.381 2.258 0 CA-C-N 121.452 1.554 . . . . 73.34 112.618 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.405 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 84.5 m-85 -68.06 -46.0 72.3 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 123.662 0.601 . . . . 63.51 110.087 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.25 -47.1 84.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.521 0.729 . . . . 73.24 110.22 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -54.26 -55.36 28.97 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.129 1.372 . . . . 75.32 111.581 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.02 -35.04 79.48 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.854 0.721 . . . . 75.01 110.389 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.515 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 6.8 t -69.03 -37.63 78.73 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.95 -0.568 . . . . 74.32 111.227 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.522 HD11 ' HB ' ' B' ' 62' ' ' VAL . 58.5 mt -63.2 -55.33 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.715 -0.476 . . . . 74.14 109.715 174.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.533 HG21 ' OG ' ' C' ' 119' ' ' SER . 18.9 m -59.0 -34.01 71.36 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 124.468 1.105 . . . . 74.42 111.404 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.5 t -57.98 -52.21 66.46 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.423 -0.808 . . . . 64.43 109.503 174.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 9.9 mmt -66.83 -38.19 85.95 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.333 0.653 . . . . 74.44 111.748 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.421 HG23 ' O ' ' B' ' 114' ' ' ILE . 91.2 t -58.9 -46.12 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.087 0.955 . . . . 73.32 110.303 176.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 45.3 t -70.99 -33.06 70.05 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.605 -1.18 . . . . 74.23 111.433 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' B' ' 116' ' ' SER . 90.8 mtt-85 -63.84 -36.84 85.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.106 0.563 . . . . 74.44 110.089 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.1 14.32 53.94 Favored Glycine 0 C--N 1.352 1.452 0 CA-C-O 119.43 -0.65 . . . . 53.44 113.322 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.45 HG23 ' HB3' ' A' ' 17' ' ' TYR . 82.5 p 55.93 26.9 10.35 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.917 1.687 . . . . 71.45 113.636 176.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -87.06 153.01 54.07 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 123.609 0.764 . . . . 74.22 110.55 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 161.06 2.16 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 124.17 3.247 . . . . 72.44 115.271 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.51 HE21 ' ND2' ' B' ' 127' ' ' ASN . 63.7 tp60 -63.05 140.56 58.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.925 0.89 . . . . 74.53 111.982 -171.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.522 HD21 HG11 ' B' ' 64' ' ' VAL . 13.7 tp -146.05 117.67 8.07 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.906 -0.588 . . . . 72.3 109.433 -173.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.51 ' ND2' HE21 ' B' ' 125' ' ' GLN . 26.4 m-80 -130.98 135.12 47.34 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.422 0.689 . . . . 74.35 110.06 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.73 130.87 34.31 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.825 0.85 . . . . 72.13 110.012 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.75 152.53 59.89 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.247 1.019 . . . . 63.54 111.285 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.804 ' HG2' HD13 ' D' ' 16' ' ' ILE . 20.5 Cg_exo -65.94 133.58 34.09 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.701 2.267 . . . . 74.01 112.81 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.415 HG21 ' N ' ' F' ' 464' ' ' MET . 16.1 t -121.22 115.12 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.126 -1.064 . . . . 73.34 108.126 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -80.45 82.23 6.53 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 109.684 -0.487 . . . . 75.12 109.684 -178.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -60.15 -27.24 66.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.882 0.873 . . . . 74.31 111.325 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -54.6 -47.74 73.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.986 1.314 . . . . 72.44 111.365 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.87 -37.95 85.41 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.706 -0.679 . . . . 64.21 111.274 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 9.2 mp -74.19 -19.06 60.67 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.551 0.74 . . . . 74.35 111.317 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.665 ' CE1' HD11 ' B' ' 141' ' ' LEU . 66.3 t80 -67.16 -26.4 66.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.932 0.493 . . . . 73.33 111.51 -176.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 26.2 mmt -63.08 -35.96 81.99 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.348 0.594 . . . . 61.2 110.248 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.478 ' N ' HD22 ' B' ' 139' ' ' ASN . 0.7 OUTLIER -79.06 -17.43 55.25 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.129 -0.941 . . . . 71.35 110.717 -178.352 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.578 ' HB2' ' HE1' ' F' ' 461' ' ' PHE . 46.2 t80 -68.43 -25.94 65.27 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.841 0.856 . . . . 75.4 111.496 174.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.665 HD11 ' CE1' ' B' ' 137' ' ' PHE . 15.3 mt -110.66 -6.58 14.8 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.97 0.908 . . . . 75.32 111.771 -168.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -155.61 137.09 14.09 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 123.415 0.447 . . . . 72.2 109.809 -173.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -70.48 80.72 0.57 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.794 0.807 . . . . 63.43 109.807 175.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -144.38 179.01 7.52 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.587 0.755 . . . . 72.35 110.647 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.42 151.82 29.45 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.335 -0.848 . . . . 74.23 109.719 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.07 174.63 51.15 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 116.084 -0.507 . . . . 61.15 112.197 171.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -100.82 152.79 20.09 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.448 0.699 . . . . 73.3 110.259 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.34 -163.47 34.67 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.099 -0.5 . . . . 65.52 113.445 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 58.6 m -140.03 -60.02 0.54 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.444 -0.947 . . . . 64.41 108.444 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 68.05 -65.16 0.26 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.713 1.605 . . . . 75.02 112.378 174.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -70.17 132.83 46.38 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.562 0.745 . . . . 73.24 110.105 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -130.16 151.79 50.3 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.266 0.626 . . . . 72.31 109.454 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -76.08 92.66 3.22 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.433 0.635 . . . . 71.32 109.762 177.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -81.72 92.89 6.69 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.769 -1.105 . . . . 61.35 109.675 -175.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 C-N-CA 123.896 0.879 . . . . 73.13 108.988 -177.603 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.632 -0.507 . . . . 71.5 109.632 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m -145.32 121.82 11.03 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.877 0.871 . . . . 73.02 109.158 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.03 33.46 0.91 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.377 0.671 . . . . 53.11 109.795 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.428 ' HB2' ' HA ' ' C' ' 7' ' ' THR . 42.3 mt-30 69.67 -165.77 0.17 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.979 1.312 . . . . 75.22 110.633 -172.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -101.07 -72.06 0.69 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.37 0.668 . . . . 72.34 109.4 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -86.51 -12.83 47.75 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.457 0.703 . . . . 43.01 110.512 175.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.428 ' HA ' ' HB2' ' C' ' 4' ' ' GLN . 2.7 m 63.22 32.92 14.67 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 124.569 1.148 . . . . 62.31 112.359 173.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.06 26.57 9.41 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.618 0.767 . . . . 61.54 112.112 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 55.4 ttp 66.39 136.63 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.823 1.249 . . . . 74.24 113.252 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -86.96 99.7 12.07 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 108.268 -1.012 . . . . 52.13 108.268 170.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.487 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.7 t80 -118.77 126.69 52.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.413 0.685 . . . . 64.43 109.743 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -146.59 133.58 20.28 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 109.111 -0.7 . . . . 73.4 109.111 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 82.1 mt -71.95 118.73 17.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.351 -0.981 . . . . 44.44 108.351 170.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.615 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 29.8 mm-40 -83.49 -49.22 9.49 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.415 0.447 . . . . 55.21 109.969 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -169.51 127.15 0.93 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 116.382 -0.372 . . . . 75.52 110.524 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -107.85 148.76 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 107.867 -1.161 . . . . 65.12 107.867 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' C' ' 19' ' ' LYS . 32.1 p90 -174.53 167.8 3.85 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.401 0.619 . . . . 74.44 111.223 -174.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.1 p -96.55 111.62 23.68 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.135 -1.061 . . . . 64.14 108.135 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' C' ' 17' ' ' TYR . 19.0 mttt -68.77 -47.6 65.79 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.812 -1.181 . . . . 61.13 107.812 170.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.2 t70 -133.55 139.68 46.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 113.558 -1.655 . . . . 65.23 109.69 -169.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.6 mt -140.97 143.78 27.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 105.898 -1.89 . . . . 64.11 105.898 174.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.0 t -158.09 148.46 20.42 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.278 -0.638 . . . . 54.22 109.278 173.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -147.64 130.95 16.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.122 -1.436 . . . . 62.31 107.122 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -133.47 126.47 31.2 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.001 0.52 . . . . 64.34 109.731 -176.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.39 80.86 18.56 Favored Pre-proline 0 C--O 1.242 0.705 0 N-CA-C 106.683 -1.599 . . . . 74.42 106.683 168.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.48 -12.49 29.5 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.73 2.286 . . . . 51.22 112.083 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -121.11 25.0 9.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.474 1.51 . . . . 71.21 109.628 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -46.38 -55.78 12.94 Favored Pre-proline 0 CA--C 1.563 1.46 0 N-CA-C 114.093 1.146 . . . . 71.44 114.093 -168.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 51.4 Cg_exo -56.67 -41.24 77.87 Favored 'Trans proline' 0 C--N 1.385 2.485 0 CA-C-N 121.829 1.689 . . . . 74.1 112.888 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -69.3 -33.76 73.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.082 -0.508 . . . . 71.41 112.091 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.87 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.4 p -79.03 -24.52 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 112.716 0.636 . . . . 71.1 112.716 176.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -67.34 -30.64 70.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.877 -0.514 . . . . 74.55 112.278 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -87.5 34.11 0.7 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.245 0.618 . . . . 61.53 111.071 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.54 153.8 41.56 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.568 0.747 . . . . 65.22 111.534 -172.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.5 118.06 13.84 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.709 -0.849 . . . . 73.55 108.709 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.526 ' HE1' ' HB3' ' G' ' 470' ' ' LEU . 74.9 t-105 -77.8 99.15 5.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.438 0.695 . . . . 72.22 110.681 -176.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -156.21 74.6 4.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.851 -0.796 . . . . 62.44 108.851 171.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -92.36 161.76 3.04 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.882 2.388 . . . . 63.44 114.029 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.37 95.38 10.18 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.766 -1.198 . . . . 61.32 107.766 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.4 t -80.26 98.48 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 115.358 -0.837 . . . . 74.15 109.841 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -106.77 110.11 22.19 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.405 -0.961 . . . . 74.22 108.405 174.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 mp -85.77 144.65 27.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.249 -1.76 . . . . 74.12 106.249 167.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -123.88 111.94 16.66 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.708 -0.849 . . . . 73.22 108.708 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 90.8 mt -93.88 142.01 27.86 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.082 0.553 . . . . 72.0 110.032 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.2 t70 -157.79 161.14 38.4 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.65 1.18 . . . . 71.21 108.343 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.1 t -146.57 135.0 21.95 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.028 0.442 . . . . 72.42 110.491 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.83 156.25 32.33 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.221 1.008 . . . . 64.33 108.738 172.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.452 ' HB2' ' CE2' ' C' ' 56' ' ' TYR . 63.8 p -160.74 151.99 19.1 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.334 0.253 . . . . 74.44 111.563 -173.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -161.21 142.66 11.7 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.847 0.859 . . . . 73.34 110.307 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.24 136.34 39.68 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.776 -0.453 . . . . 72.54 109.776 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.492 HD11 HD12 ' C' ' 83' ' ' ILE . 39.8 mt -108.95 -44.97 3.87 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.346 0.658 . . . . 74.32 109.701 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.41 -173.07 3.84 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.669 -0.696 . . . . 71.11 111.045 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -67.86 108.59 3.05 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.136 -0.938 . . . . 70.21 110.392 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 63.42 24.65 14.24 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.792 1.237 . . . . 61.25 111.512 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.29 114.47 45.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.361 -0.977 . . . . 74.23 108.361 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.452 ' CE2' ' HB2' ' C' ' 48' ' ' SER . 35.5 t80 -126.22 124.99 41.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.564 -0.902 . . . . 74.12 108.564 -176.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.466 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.9 tt0 -82.09 141.64 32.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.027 -0.988 . . . . 71.15 109.929 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.28 142.22 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.487 1.115 . . . . 65.41 108.196 169.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.08 133.33 60.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.836 -0.801 . . . . 53.54 108.836 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.43 114.88 29.33 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.911 -1.144 . . . . 75.34 107.911 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.557 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 41.5 ttm-85 -99.29 117.53 33.94 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.033 -0.729 . . . . 74.42 109.033 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.582 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.4 t -118.57 133.57 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.299 -1.001 . . . . 74.11 108.299 172.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 14.8 m -131.55 114.85 15.36 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.258 -0.645 . . . . 72.43 109.258 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.597 HG11 HD21 ' C' ' 126' ' ' LEU . 21.8 t -99.51 128.84 50.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.847 -0.798 . . . . 73.45 108.847 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.1 m -122.87 140.4 53.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.803 -1.184 . . . . 74.53 107.803 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' C' ' 73' ' ' ALA . . . -132.03 113.13 13.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.763 -1.199 . . . . 64.43 107.763 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.2 m -113.69 122.58 47.57 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.356 0.598 . . . . 63.44 110.173 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 mt -92.1 24.63 3.2 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.042 1.337 . . . . 73.24 109.52 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.1 -108.52 2.6 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 110.569 -1.012 . . . . 71.43 110.569 -170.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.63 -27.37 20.22 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.587 0.755 . . . . 73.33 110.276 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -79.42 119.26 22.19 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.685 0.794 . . . . 74.13 109.331 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 39.4 m -87.53 130.81 34.59 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.159 -0.682 . . . . 64.35 109.159 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.87 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.79 -61.61 1.75 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.249 0.619 . . . . 70.32 110.613 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -156.92 170.52 22.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.54 -0.755 . . . . 74.35 110.858 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -142.47 116.82 9.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.216 -1.401 . . . . 64.21 107.216 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.423 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -124.78 119.35 28.64 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.079 0.552 . . . . 64.12 109.751 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -121.94 125.67 46.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.684 0.394 . . . . 71.04 110.019 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.87 137.19 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.01 0.924 . . . . 63.5 108.817 172.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.9 mt-30 -115.56 95.41 5.14 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.635 -0.876 . . . . 65.0 108.635 172.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -79.71 100.25 7.8 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.626 -1.17 . . . . 74.21 110.081 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.45 149.34 27.32 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 116.194 -0.457 . . . . 75.55 112.071 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.553 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -157.03 122.2 1.15 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 111.713 -0.555 . . . . 34.43 111.713 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.615 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.9 mm -88.99 124.52 41.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.788 -0.819 . . . . 72.13 108.788 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.487 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 53.0 m-85 -131.44 118.82 20.75 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.074 0.549 . . . . 71.2 109.945 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 66.8 m -80.9 118.72 22.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.777 -0.823 . . . . 71.33 108.777 171.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 pp -135.05 141.32 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.849 0.86 . . . . 53.12 110.119 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.0 142.87 17.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.176 0.59 . . . . 51.13 110.522 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.94 -23.43 35.65 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.506 0.504 . . . . 75.23 114.264 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.568 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -89.82 153.55 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.451 0.7 . . . . 63.32 110.813 178.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -160.06 -179.07 7.46 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.344 -0.844 . . . . 71.42 110.221 174.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.85 -112.44 3.81 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.864 0.728 . . . . 41.12 114.249 177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.451 HG23 ' HB3' ' C' ' 145' ' ' ALA . 21.2 p -68.89 -43.02 76.14 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.178 0.991 . . . . 72.3 111.292 178.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.47 -37.44 85.13 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.856 -0.611 . . . . 64.33 111.418 -174.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -72.86 -39.96 66.07 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 110.364 -0.235 . . . . 73.21 110.364 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.13 -44.27 92.04 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 123.533 0.52 . . . . 74.44 110.81 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -80.39 -34.05 36.61 Favored 'General case' 0 C--O 1.245 0.864 0 O-C-N 123.411 0.444 . . . . 73.54 112.128 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.442 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 42.4 t -59.3 -37.16 77.03 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 123.425 0.453 . . . . 72.53 110.101 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 32.1 mt -93.94 -22.83 18.34 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.866 0.866 . . . . 75.11 111.033 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -31.65 57.98 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 115.077 0.791 . . . . 54.51 115.077 -172.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.65 -35.43 0.05 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.217 0.451 . . . . 32.01 112.217 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.442 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 45.5 t80 -60.18 -50.96 71.61 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.442 1.497 . . . . 62.3 112.567 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 61.4 m -75.41 -44.24 4.37 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-O 118.319 -0.848 . . . . 52.2 112.258 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -53.91 -26.71 41.13 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 122.001 1.801 . . . . 62.14 113.66 170.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -68.33 -34.91 76.97 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.514 0.725 . . . . 74.23 111.166 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -64.01 -36.51 77.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 123.356 0.662 . . . . 64.21 109.983 175.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.553 HD21 ' HA3' ' C' ' 82' ' ' GLY . 63.4 mt -84.94 -15.3 44.85 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.058 . . . . 71.52 112.265 -176.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -61.33 -48.57 90.88 Favored Pre-proline 0 CA--C 1.56 1.36 0 N-CA-C 114.115 1.154 . . . . 52.41 114.115 -173.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.82 -33.13 76.89 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 121.877 1.718 . . . . 61.34 112.767 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -71.5 -46.69 59.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.612 -0.722 . . . . 71.21 110.327 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.23 -41.9 76.43 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 115.321 -0.854 . . . . 63.31 109.847 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -56.21 -60.34 3.64 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.47 1.106 . . . . 71.33 111.718 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.02 -29.08 68.79 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.941 0.496 . . . . 70.04 111.237 -173.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 24.3 t -69.95 -35.87 74.84 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.009 0.524 . . . . 75.31 111.219 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.582 HD11 ' HB ' ' C' ' 62' ' ' VAL . 94.9 mt -72.92 -47.24 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.631 0.772 . . . . 70.13 110.036 174.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.0 m -61.0 -34.58 75.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.022 0.929 . . . . 75.54 111.125 -177.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -62.49 -51.72 66.32 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 115.351 -0.84 . . . . 52.25 109.59 174.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.549 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.46 -35.56 76.16 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.626 1.17 . . . . 72.32 112.867 -179.074 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.525 HG13 ' HB2' ' C' ' 123' ' ' PHE . 68.3 t -67.1 -44.99 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.548 0.739 . . . . 53.22 110.465 176.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.533 ' OG ' HG21 ' B' ' 115' ' ' THR . 47.3 t -66.8 -31.35 71.92 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.733 -0.667 . . . . 63.01 111.186 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' D' ' 17' ' ' TYR . 83.3 mtt-85 -67.29 -46.06 74.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.414 0.686 . . . . 74.31 109.391 176.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.21 -0.8 67.13 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.683 0.614 . . . . 62.11 113.24 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 34.2 p 64.6 27.96 13.27 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.742 2.017 . . . . 74.32 114.19 170.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.525 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.7 m-85 -83.73 155.67 65.04 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.529 0.731 . . . . 75.53 109.737 172.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -53.16 173.58 0.15 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 124.072 3.181 . . . . 75.5 115.573 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -55.6 132.97 50.13 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.728 1.211 . . . . 61.34 112.851 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.597 HD21 HG11 ' C' ' 64' ' ' VAL . 17.4 tp -135.14 102.48 5.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.929 -1.137 . . . . 73.04 107.929 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -123.42 126.81 47.46 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.105 0.562 . . . . 45.21 110.221 -175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mp -77.01 117.11 18.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.312 0.645 . . . . 71.52 109.379 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.79 162.36 58.82 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.507 1.123 . . . . 75.12 111.506 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.561 ' HG3' HD12 ' A' ' 16' ' ' ILE . 51.2 Cg_exo -55.19 103.61 0.11 Allowed 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.407 2.071 . . . . 45.13 112.152 169.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 89.0 t -97.99 113.24 32.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.57 0.748 . . . . 75.35 109.533 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -90.68 59.81 4.32 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.669 0.747 . . . . 63.03 110.025 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.484 ' HD1' ' H ' ' C' ' 133' ' ' PHE . 1.2 p90 -78.44 -14.21 59.48 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.214 -0.903 . . . . 64.41 110.066 175.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -75.47 -49.04 20.03 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.642 0.777 . . . . 71.45 109.818 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.66 74.17 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.524 -0.762 . . . . 73.32 110.622 174.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.481 ' HA ' ' ND2' ' C' ' 139' ' ' ASN . 1.2 tt -67.17 -42.8 83.65 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.311 -0.859 . . . . 62.41 110.415 176.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -64.97 -31.45 72.7 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.488 0.315 . . . . 65.25 110.81 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -49.38 65.56 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 122.876 0.471 . . . . 72.41 110.195 -177.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . 0.481 ' ND2' ' HA ' ' C' ' 136' ' ' LEU . 10.4 p30 -71.99 -33.67 68.29 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 122.672 0.389 . . . . 71.33 111.697 177.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -51.41 -80.8 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.318 1.047 . . . . 73.12 109.515 169.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.471 ' HG ' ' H ' ' C' ' 143' ' ' GLN . 27.4 tp 68.66 158.47 0.16 Allowed 'General case' 0 C--N 1.36 1.039 0 C-N-CA 124.889 1.276 . . . . 74.44 111.048 177.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -152.11 20.54 0.67 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.286 0.565 . . . . 71.35 109.975 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.471 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 9.1 tp-100 -161.86 110.87 1.5 Allowed 'General case' 0 C--N 1.35 0.602 0 CA-C-N 115.621 -0.718 . . . . 75.24 109.675 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -74.94 97.05 3.26 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-O 121.687 0.756 . . . . 70.43 110.04 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.451 ' HB3' HG23 ' C' ' 92' ' ' THR . . . -158.71 -172.63 3.9 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.334 -0.848 . . . . 63.5 110.531 -172.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 122.43 6.26 8.17 Favored Glycine 0 N--CA 1.474 1.21 0 C-N-CA 123.207 0.432 . . . . 73.42 112.478 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -75.62 94.39 3.19 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.401 0.68 . . . . 53.41 109.411 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 167.5 95.79 0.1 Allowed Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.762 -0.654 . . . . 63.21 111.903 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 84.8 m -141.15 107.16 5.17 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.141 0.976 . . . . 73.12 109.118 176.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -149.31 135.18 18.83 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 122.928 0.491 . . . . 71.25 109.835 175.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.61 101.64 2.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.464 1.106 . . . . 74.44 110.669 -170.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -127.31 116.57 20.74 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.784 0.834 . . . . 71.21 109.241 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -165.26 102.74 0.74 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 106.726 -1.583 . . . . 62.34 106.726 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -104.43 -0.24 28.22 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.957 0.903 . . . . 64.31 110.96 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 C-N-CA 125.468 1.507 . . . . 74.22 111.365 -178.976 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.603 -0.518 . . . . 62.42 109.603 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -173.63 75.65 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.93 -1.137 . . . . 73.32 107.93 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -80.45 119.11 22.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.749 -0.66 . . . . 71.24 110.412 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -135.37 116.21 14.06 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.961 0.905 . . . . 70.33 108.695 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -146.03 137.8 25.02 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.532 0.733 . . . . 62.33 109.702 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -126.8 120.07 28.42 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.232 -1.025 . . . . 52.34 108.232 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -66.51 -28.11 68.3 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.33 0.652 . . . . 73.15 111.322 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.02 1.93 11.79 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.089 0.956 . . . . 70.01 111.199 -178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.52 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.3 tpt -33.26 124.94 0.39 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.549 1.14 . . . . 75.2 112.698 163.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 94.3 m -148.86 140.88 23.84 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.844 0.857 . . . . 71.3 109.749 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.415 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 47.7 t80 -151.81 88.21 1.39 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.297 -1.372 . . . . 73.23 107.297 174.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -114.05 121.84 45.08 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.103 -1.073 . . . . 72.32 108.103 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.518 HD13 HG21 ' D' ' 105' ' ' ILE . 9.4 mt -86.98 128.47 39.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 116.213 -0.449 . . . . 65.12 110.117 -171.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.425 ' NE2' HG22 ' D' ' 83' ' ' ILE . 51.0 mt-30 -90.79 -39.74 12.2 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.437 0.695 . . . . 62.42 112.096 -173.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -175.08 122.19 0.22 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 112.219 0.452 . . . . 71.21 112.219 -167.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.804 HD13 ' HG2' ' B' ' 130' ' ' PRO . 1.5 mp -108.9 134.23 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.708 -0.849 . . . . 71.14 108.708 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.51 ' HE1' HG13 ' D' ' 83' ' ' ILE . 27.8 p90 -159.65 159.43 33.05 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 124.16 0.912 . . . . 74.35 110.487 -172.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -94.78 114.24 26.11 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.638 -0.71 . . . . 71.11 109.552 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.462 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 3.8 mtpp -77.84 -26.71 49.63 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.23 -0.656 . . . . 64.44 109.23 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.56 ' HB3' HE21 ' D' ' 79' ' ' GLN . 20.2 t70 -160.74 144.74 13.71 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.847 -1.069 . . . . 74.15 109.864 177.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.549 HG21 ' HE2' ' C' ' 117' ' ' MET . 68.0 mt -140.16 148.62 22.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 125.549 1.54 . . . . 55.43 107.388 174.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 26.9 t -156.08 119.44 4.3 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.226 0.61 . . . . 71.4 109.612 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.417 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.6 t80 -125.63 118.38 25.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.849 1.26 . . . . 74.31 107.879 173.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -124.16 135.96 53.86 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.124 -0.695 . . . . 74.12 109.124 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.48 86.36 39.21 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.442 -1.318 . . . . 63.54 107.442 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -66.61 -39.04 16.84 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.803 2.336 . . . . 62.42 113.115 -170.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 82.1 m-20 -101.3 17.33 22.86 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.869 0.868 . . . . 72.23 110.732 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.24 -70.81 0.12 Allowed Pre-proline 0 CA--C 1.562 1.424 0 N-CA-C 115.69 1.737 . . . . 61.43 115.69 -162.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.69 -18.79 14.96 Favored 'Trans proline' 0 C--N 1.382 2.328 0 CA-C-N 123.531 2.297 . . . . 60.44 113.198 -172.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.447 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 11.2 t-160 -68.1 -47.64 67.65 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.794 1.238 . . . . 73.21 109.347 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.6 p -83.17 -20.21 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.241 1.016 . . . . 63.2 111.838 -172.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -63.52 -32.19 73.57 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.175 0.512 . . . . 62.21 111.431 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -67.42 -10.48 51.75 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.969 -1.014 . . . . 71.32 111.544 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -96.17 84.74 3.84 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.119 0.967 . . . . 73.44 109.17 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.89 82.79 5.91 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.679 0.792 . . . . 64.32 109.866 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.4 t-105 -147.46 163.1 37.59 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.821 0.848 . . . . 74.43 109.665 -175.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -70.95 109.26 4.86 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.474 1.11 . . . . 75.05 110.438 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.39 144.04 25.44 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.795 2.33 . . . . 74.01 112.242 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' H' ' 470' ' ' LEU . 44.5 tt0 -90.03 135.62 33.54 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.874 -0.787 . . . . 65.21 108.874 171.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.52 ' HB ' HG13 ' D' ' 64' ' ' VAL . 32.9 m -105.78 127.67 60.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 123.045 0.538 . . . . 75.34 109.555 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -87.42 114.03 23.66 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.923 -1.51 . . . . 61.41 106.923 172.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.472 ' O ' HD12 ' D' ' 42' ' ' LEU . 2.9 pp -94.75 117.81 30.73 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.011 0.91 . . . . 72.02 109.28 -174.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -122.96 112.54 17.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.726 -1.583 . . . . 73.41 106.726 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.93 152.34 22.09 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.159 0.584 . . . . 51.32 109.712 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.0 t70 -151.02 156.28 40.81 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.756 1.222 . . . . 74.24 108.367 174.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -138.95 156.71 47.03 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.372 0.669 . . . . 73.2 109.464 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.409 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.47 177.86 10.78 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.283 0.633 . . . . 72.21 110.282 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.6 p -163.19 164.82 25.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.485 0.714 . . . . 53.22 111.2 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 91.1 p -156.36 132.71 10.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.402 1.081 . . . . 54.32 108.744 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -86.37 117.99 25.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.404 -0.591 . . . . 62.4 109.404 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.08 -25.42 16.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.084 0.554 . . . . 72.32 110.629 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.49 -178.68 5.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.392 1.077 . . . . 50.41 109.496 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.49 137.05 49.92 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.88 -0.785 . . . . 73.42 108.88 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.704 ' HA ' HG11 ' H' ' 451' ' ' VAL . 17.4 m-20 61.2 10.8 3.16 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.095 0.958 . . . . 72.23 112.772 -177.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -123.78 124.79 70.03 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 C-N-CA 124.63 1.172 . . . . 61.23 108.47 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.576 ' HD2' HD11 ' D' ' 86' ' ' ILE . 8.1 m-85 -128.29 158.59 37.76 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.399 -0.963 . . . . 75.43 108.399 171.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -125.9 128.04 46.95 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 105.729 -1.952 . . . . 72.55 105.729 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.45 141.23 31.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.598 -0.89 . . . . 65.11 108.598 -174.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 48.2 t -121.3 134.04 65.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 O-C-N 123.852 0.72 . . . . 64.23 109.136 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -117.49 121.89 42.23 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.18 -1.415 . . . . 74.35 107.18 174.139 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 15.7 ttm-85 -105.6 102.65 12.1 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.765 -0.828 . . . . 73.04 108.765 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 71.9 t -99.76 113.39 34.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.549 -0.908 . . . . 63.14 108.549 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 11.8 m -114.61 134.36 55.11 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.263 0.625 . . . . 73.03 109.377 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 78.8 t -131.67 102.44 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.344 1.457 . . . . 72.51 108.623 -171.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 96.5 m -103.36 95.8 6.33 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.323 -0.991 . . . . 74.23 108.323 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.56 159.94 14.62 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.059 0.456 . . . . 63.13 111.843 -172.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 53.3 p -145.47 142.93 29.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.135 -0.939 . . . . 72.12 110.912 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.472 ' HA ' HD11 ' H' ' 470' ' ' LEU . 14.9 mt -113.09 114.59 27.06 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.597 1.159 . . . . 64.41 108.711 169.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.96 -112.39 4.55 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.672 0.608 . . . . 61.24 112.857 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -106.94 3.75 26.49 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.289 0.636 . . . . 74.34 112.092 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -135.81 167.6 20.86 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.654 0.381 . . . . 74.43 110.677 -172.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.0 m -70.06 132.18 45.47 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.608 -0.724 . . . . 74.2 110.942 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.579 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -90.32 -76.46 0.43 Allowed 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.913 -1.143 . . . . 63.34 107.913 174.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -142.22 136.84 30.28 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 121.242 0.544 . . . . 62.41 111.641 -176.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 63.3 mt -104.34 140.29 38.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.124 1.369 . . . . 71.52 107.63 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.679 ' SG ' HG12 ' D' ' 114' ' ' ILE . 50.5 t -154.15 143.09 21.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.038 0.535 . . . . 43.43 109.615 -175.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -155.89 131.84 9.91 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.262 -1.014 . . . . 74.34 108.262 172.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.0 t -131.94 114.78 25.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.248 -0.649 . . . . 73.15 109.248 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.56 HE21 ' HB3' ' D' ' 20' ' ' ASP . 5.0 mt-30 -88.17 82.48 7.12 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.094 -1.076 . . . . 64.35 108.094 169.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -79.86 96.43 6.34 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.694 -1.594 . . . . 71.14 108.744 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.11 164.24 25.92 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.132 -0.486 . . . . 55.35 112.075 177.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.2 135.06 3.71 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 112.562 -0.215 . . . . 64.12 112.562 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.51 HG13 ' HE1' ' D' ' 17' ' ' TYR . 45.3 mt -89.79 129.66 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.343 1.057 . . . . 72.43 108.875 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -129.84 147.21 51.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.395 1.078 . . . . 75.4 110.321 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.1 m -108.01 109.78 21.33 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.555 -0.906 . . . . 74.22 108.555 171.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.576 HD11 ' HD2' ' D' ' 56' ' ' TYR . 19.2 pt -115.94 136.64 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.529 0.732 . . . . 71.52 110.942 -173.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -154.54 159.54 40.99 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.195 0.998 . . . . 75.34 109.115 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 80.01 -12.37 30.78 Favored Glycine 0 N--CA 1.478 1.457 0 N-CA-C 114.257 0.463 . . . . 75.14 114.257 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.466 ' O ' HG23 ' H' ' 451' ' ' VAL . 10.6 pt -123.09 142.1 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.424 1.089 . . . . 74.41 109.165 -178.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.585 ' HB3' ' HA ' ' H' ' 451' ' ' VAL . 6.3 pt-20 -165.83 164.55 18.66 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.506 0.722 . . . . 74.51 110.781 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.89 -114.72 7.11 Favored Glycine 0 C--N 1.354 1.56 0 O-C-N 123.851 0.719 . . . . 75.4 112.254 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.9 m -67.85 -37.79 82.3 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.492 0.717 . . . . 73.34 110.421 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -70.22 -28.78 65.54 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.602 0.761 . . . . 64.51 112.572 -177.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.557 ' HE1' HD22 ' H' ' 454' ' ' LEU . 18.5 tmm? -83.54 -32.03 26.08 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.25 -0.278 . . . . 73.04 110.25 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 -33.92 76.92 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.276 0.56 . . . . 71.42 110.379 169.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.429 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.1 t-80 -73.58 -20.28 60.66 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.994 1.317 . . . . 74.12 111.14 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -88.01 -53.83 4.54 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.435 0.294 . . . . 64.33 110.712 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.444 HD22 ' SD ' ' D' ' 94' ' ' MET . 9.8 mp -74.57 -32.92 62.55 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.659 0.783 . . . . 73.22 111.77 -173.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.19 14.54 61.13 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 119.072 -0.849 . . . . 74.44 113.311 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -157.58 -69.66 0.1 Allowed 'General case' 0 C--N 1.356 0.871 0 CA-C-N 118.212 1.006 . . . . 65.11 112.846 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -68.14 -39.61 82.62 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.818 0.447 . . . . 65.53 112.057 -171.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.415 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 74.8 m -69.5 -46.3 26.73 Favored Pre-proline 0 CA--C 1.557 1.242 0 CA-C-O 118.372 -0.823 . . . . 73.52 111.516 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.463 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 97.9 Cg_exo -51.29 -36.97 58.94 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 122.314 2.01 . . . . 75.22 113.373 165.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -65.83 -29.81 70.33 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.025 0.53 . . . . 64.54 111.792 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.518 HG21 HD13 ' D' ' 13' ' ' ILE . 46.2 mm -68.96 -44.81 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.521 -0.548 . . . . 73.33 109.521 171.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -77.05 -14.98 59.75 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.99 -1.005 . . . . 72.05 112.021 -173.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -73.73 -40.1 4.94 Favored Pre-proline 0 CA--C 1.561 1.395 0 N-CA-C 113.924 1.083 . . . . 61.45 113.924 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.7 -39.35 88.38 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 121.742 1.628 . . . . 73.24 112.782 169.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -72.67 -35.33 67.68 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.612 0.765 . . . . 73.31 110.985 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.1 -51.46 67.81 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.657 -0.701 . . . . 73.42 109.359 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 29.7 ttp-105 -54.34 -50.24 67.87 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.794 1.309 . . . . 53.51 110.874 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -64.11 -46.04 85.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.861 0.865 . . . . 71.45 111.898 -173.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.7 t -59.47 -40.42 86.86 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.994 0.809 . . . . 54.32 110.507 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.679 HG12 ' SG ' ' D' ' 76' ' ' CYS . 95.4 mt -63.01 -56.06 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.111 0.964 . . . . 61.21 110.35 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -55.36 -37.01 66.95 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.574 1.15 . . . . 64.11 111.376 -174.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.4 t -68.73 -46.23 69.43 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.009 -0.996 . . . . 61.24 110.144 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.8 mtm -68.21 -29.24 68.03 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.783 0.433 . . . . 62.41 111.897 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' D' ' 123' ' ' PHE . 54.7 t -68.7 -41.75 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.788 0.835 . . . . 63.54 110.266 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.6 p -74.88 -32.11 61.77 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.615 0.366 . . . . 63.12 110.909 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -70.43 -34.8 72.88 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.469 0.708 . . . . 63.42 109.82 174.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.51 5.61 82.89 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 115.345 -0.843 . . . . 54.32 112.537 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 26.6 p 63.04 16.32 9.2 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.407 1.883 . . . . 63.0 114.84 171.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.426 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.8 m-85 -80.71 153.82 73.22 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.462 0.705 . . . . 51.35 109.292 170.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.02 141.83 94.08 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.73 2.287 . . . . 62.04 113.083 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.76 134.92 47.85 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.865 1.266 . . . . 74.24 112.555 -174.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -110.01 107.13 16.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.109 -1.071 . . . . 42.03 108.109 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -99.22 89.06 4.1 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.911 -0.774 . . . . 72.44 108.911 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.49 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 44.0 tp -70.53 115.83 10.15 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.936 -1.029 . . . . 75.11 109.787 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.96 133.44 87.14 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 123.459 0.704 . . . . 70.4 111.396 -176.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 16.7 Cg_exo -66.71 113.35 2.71 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.626 2.217 . . . . 63.43 111.161 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 61.1 t -106.43 128.11 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.532 0.733 . . . . 71.23 109.045 -175.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -78.29 98.23 5.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.529 0.732 . . . . 73.42 109.713 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -63.46 -22.42 66.88 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.169 0.588 . . . . 72.4 111.855 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.426 ' O ' ' HG3' ' D' ' 138' ' ' MET . 10.9 m-20 -61.87 -48.56 79.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.321 0.648 . . . . 63.11 111.689 177.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.41 -45.77 89.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.551 0.74 . . . . 72.4 111.702 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.49 -31.8 72.19 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.934 -0.575 . . . . 74.25 111.128 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.418 ' O ' HD13 ' D' ' 141' ' ' LEU . 89.4 t80 -65.29 -43.19 91.92 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.248 0.619 . . . . 75.21 110.179 176.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 35.2 mtt -63.59 -40.4 96.84 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.278 0.631 . . . . 55.43 110.1 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.36 -40.59 96.93 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 124.026 0.829 . . . . 74.4 110.842 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -63.16 -40.08 96.53 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.337 0.655 . . . . 75.44 111.507 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.418 HD13 ' O ' ' D' ' 137' ' ' PHE . 7.1 mp -66.22 -36.26 82.58 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.541 0.736 . . . . 72.14 111.6 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -89.55 9.14 27.79 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.107 0.563 . . . . 73.34 111.307 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -121.22 87.51 2.77 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.207 1.003 . . . . 73.4 109.513 -176.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -148.39 23.68 1.02 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.76 0.791 . . . . 44.12 109.746 174.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.91 -44.04 0.07 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.084 1.354 . . . . 62.13 107.603 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -163.92 176.22 39.97 Favored Glycine 0 C--O 1.241 0.564 0 CA-C-N 113.716 -1.583 . . . . 71.34 109.528 169.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.64 100.65 0.92 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.582 -0.525 . . . . 71.15 109.582 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.51 158.04 46.88 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.631 -0.713 . . . . 73.02 112.777 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 24.3 m -129.44 80.25 1.95 Allowed 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.852 -0.795 . . . . 60.41 108.852 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.03 137.17 24.61 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.77 -1.105 . . . . 75.41 108.664 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -155.87 111.12 2.96 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.604 -1.628 . . . . 60.4 106.604 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -147.24 72.85 1.27 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.782 -1.192 . . . . 53.25 107.782 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -84.04 9.0 13.55 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.083 -0.962 . . . . 72.3 111.181 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -52.9 107.99 0.28 Allowed 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.513 1.125 . . . . 41.42 110.633 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.868 0.867 . . . . 75.21 109.787 -173.527 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' 450' ' ' ASN . . . . . . . . . . . . . 67.0 t30 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.974 0.416 . . . . 74.54 110.074 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' 451' ' ' VAL . . . . . 0.451 HG22 ' SD ' ' A' ' 94' ' ' MET . 8.1 p -67.62 121.13 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 121.521 0.677 . . . . 70.3 109.819 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 452' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.72 142.79 19.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 C-N-CA 124.822 1.249 . . . . 71.55 108.96 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 453' ' ' GLY . . . . . . . . . . . . . . . -157.11 172.33 34.61 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.562 -1.015 . . . . 73.33 110.562 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 454' ' ' LEU . . . . . . . . . . . . . 35.8 tp 64.24 113.4 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.672 1.189 . . . . 63.3 110.784 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 455' ' ' THR . . . . . . . . . . . . . 5.7 m -63.45 142.38 58.41 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.863 0.465 . . . . 73.15 110.262 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 456' ' ' ASP . . . . . 0.457 ' HA ' ' HB2' ' A' ' 48' ' ' SER . 6.9 m-20 -61.94 153.12 30.21 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.906 0.482 . . . . 71.42 110.336 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 457' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 71.13 166.75 0.3 Allowed 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.727 1.211 . . . . 64.34 110.227 -164.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 458' ' ' THR . . . . . 0.591 HG23 HD22 ' E' ' 460' ' ' LEU . 12.5 t -158.87 154.45 26.06 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.239 0.543 . . . . 74.42 111.13 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 459' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -99.82 7.69 44.78 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 124.318 1.047 . . . . 74.04 109.507 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 460' ' ' LEU . . . . . 0.591 HD22 HG23 ' E' ' 458' ' ' THR . 4.1 mm? 67.02 -176.33 0.2 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.255 1.422 . . . . 54.41 112.407 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 461' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -137.46 -13.49 1.53 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.853 1.261 . . . . 75.13 110.174 176.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 462' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -167.79 137.89 2.73 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 124.012 0.925 . . . . 74.24 109.73 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 463' ' ' THR . . . . . . . . . . . . . 80.6 p -116.01 134.96 54.41 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.229 -1.397 . . . . 64.35 107.229 169.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 464' ' ' MET . . . . . 0.478 ' HB2' HD11 ' A' ' 44' ' ' LEU . 7.2 tmm? -72.41 -75.43 0.14 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.597 -0.89 . . . . 75.41 108.597 -178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 465' ' ' LYS . . . . . . . . . . . . . 42.6 tttm 47.52 -87.42 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.332 1.453 . . . . 73.31 113.147 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 466' ' ' ALA . . . . . . . . . . . . . . . 49.66 -87.98 0.01 OUTLIER 'General case' 0 C--N 1.363 1.185 0 C-N-CA 125.058 1.343 . . . . 74.55 112.738 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 467' ' ' ALA . . . . . . . . . . . . . . . 171.5 152.74 0.06 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.431 1.892 . . . . 73.43 108.57 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 468' ' ' LEU . . . . . 0.523 ' HG ' HG21 ' A' ' 40' ' ' VAL . 4.4 pp -168.09 168.2 11.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.007 0.923 . . . . 74.03 109.344 168.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 469' ' ' GLY . . . . . . . . . . . . . . . -126.18 140.22 11.94 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.769 -0.65 . . . . 75.13 111.553 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 470' ' ' LEU . . . . . . . . . . . . . 5.3 mp -78.42 -62.16 1.77 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.306 -1.368 . . . . 72.43 107.306 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 471' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' E' ' 471' ' ' LYS . 33.3 mmtt . . . . . 0 C--O 1.252 1.219 0 C-N-CA 128.469 2.708 . . . . 72.5 106.367 163.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 450' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.796 -0.446 . . . . 73.04 109.796 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' F' F ' 451' ' ' VAL . . . . . . . . . . . . . 50.6 t 58.75 90.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 124.421 1.076 . . . . 62.05 108.992 -170.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 452' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' B' ' 94' ' ' MET . 60.0 t 73.52 165.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.767 1.227 . . . . 72.22 109.569 -169.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 453' ' ' GLY . . . . . . . . . . . . . . . 170.4 149.79 6.59 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 121.916 -0.49 . . . . 73.55 113.625 171.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 454' ' ' LEU . . . . . . . . . . . . . 3.9 pp -167.04 155.61 9.98 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.931 1.293 . . . . 75.3 109.312 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 455' ' ' THR . . . . . . . . . . . . . 14.1 m -99.68 -67.42 0.85 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 122.893 0.477 . . . . 63.02 109.781 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 456' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -167.58 96.44 0.46 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.327 -0.852 . . . . 73.25 110.633 -170.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 457' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 178.89 63.2 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.572 1.549 . . . . 61.42 107.488 166.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 458' ' ' THR . . . . . . . . . . . . . 60.4 p -118.36 106.08 12.38 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.2 -0.909 . . . . 75.24 110.251 -174.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 459' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -143.18 130.4 20.86 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.165 -1.05 . . . . 74.34 108.165 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 460' ' ' LEU . . . . . 0.485 ' H ' HD23 ' F' ' 460' ' ' LEU . 2.6 pt? -80.37 -173.0 3.81 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.616 0.766 . . . . 72.03 110.588 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 461' ' ' PHE . . . . . 0.578 ' HE1' ' HB2' ' B' ' 140' ' ' TYR . 8.2 m-85 -72.34 -72.41 0.24 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.786 0.834 . . . . 74.02 108.944 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 462' ' ' TYR . . . . . . . . . . . . . 15.0 t80 178.18 134.55 0.08 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.03 1.332 . . . . 41.43 107.42 176.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 463' ' ' THR . . . . . 0.405 ' H ' ' HG ' ' B' ' 44' ' ' LEU . 17.9 m -91.34 74.01 6.12 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.342 0.591 . . . . 64.1 110.346 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 464' ' ' MET . . . . . 0.415 ' N ' HG21 ' B' ' 131' ' ' VAL . 33.7 tpp -177.24 152.26 0.85 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.025 1.33 . . . . 62.43 109.018 168.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 465' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -64.79 -56.67 12.09 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.573 0.749 . . . . 74.24 109.846 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 466' ' ' ALA . . . . . . . . . . . . . . . -152.06 -66.82 0.17 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.432 -0.951 . . . . 72.31 108.432 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 467' ' ' ALA . . . . . . . . . . . . . . . -118.35 160.05 22.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.241 1.016 . . . . 34.44 108.67 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 468' ' ' LEU . . . . . . . . . . . . . 7.2 tt -66.96 -35.17 79.38 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.153 0.581 . . . . 73.42 110.34 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.19 -55.77 0.35 Allowed Glycine 0 CA--C 1.507 -0.413 0 N-CA-C 110.051 -1.22 . . . . 74.3 110.051 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 470' ' ' LEU . . . . . 0.644 ' H ' HD23 ' F' ' 470' ' ' LEU . 1.3 pt? -76.81 100.11 5.38 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.664 -0.768 . . . . 51.25 110.219 176.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 471' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.244 0.809 0 N-CA-C 107.07 -1.455 . . . . 73.35 107.07 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 450' ' ' ASN . . . . . . . . . . . . . 34.4 t30 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 110.124 -0.324 . . . . 70.05 110.124 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' G' G ' 451' ' ' VAL . . . . . 0.412 HG13 HG22 ' G' ' 452' ' ' VAL . 9.2 p -71.17 -40.99 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 123.419 0.688 . . . . 71.12 111.69 -174.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 452' ' ' VAL . . . . . 0.412 HG22 HG13 ' G' ' 451' ' ' VAL . 27.6 m -144.28 144.8 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.211 0.605 . . . . 72.43 111.046 -175.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 453' ' ' GLY . . . . . . . . . . . . . . . 144.27 77.08 0.03 OUTLIER Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.638 -0.585 . . . . 74.04 111.638 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 454' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.14 123.72 29.23 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.229 0.612 . . . . 63.54 110.441 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 455' ' ' THR . . . . . . . . . . . . . 17.6 p -82.68 -61.01 1.99 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.823 0.849 . . . . 74.03 110.036 175.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 456' ' ' ASP . . . . . . . . . . . . . 18.2 t70 68.02 120.52 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.13 1.372 . . . . 61.32 113.149 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 457' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -140.12 23.5 2.38 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.507 1.123 . . . . 71.14 110.711 175.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 458' ' ' THR . . . . . . . . . . . . . 87.1 m -144.03 136.01 26.37 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.07 0.548 . . . . 70.3 110.176 -174.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 459' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.47 171.17 7.79 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.995 0.518 . . . . 75.11 110.266 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 460' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.17 122.08 17.04 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.65 -0.87 . . . . 64.45 108.65 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 461' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -68.07 4.01 1.39 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.762 1.225 . . . . 75.44 114.097 -175.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 462' ' ' TYR . . . . . 0.414 ' CE2' ' HB2' ' G' ' 464' ' ' MET . 21.5 t80 -148.36 122.94 9.8 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.139 -0.689 . . . . 74.32 109.139 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 463' ' ' THR . . . . . . . . . . . . . 8.9 t -104.61 -43.66 5.09 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.336 0.655 . . . . 53.32 109.701 177.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 464' ' ' MET . . . . . 0.414 ' HB2' ' CE2' ' G' ' 462' ' ' TYR . 53.4 ttp 68.53 93.78 0.08 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.078 1.351 . . . . 53.33 111.753 -174.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 465' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -106.54 -51.53 2.93 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.598 -0.89 . . . . 74.44 108.598 170.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 466' ' ' ALA . . . . . . . . . . . . . . . -73.0 83.7 1.25 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.326 -0.852 . . . . 40.22 110.447 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 467' ' ' ALA . . . . . . . . . . . . . . . -159.33 -63.05 0.07 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.124 0.97 . . . . 55.43 108.827 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 468' ' ' LEU . . . . . . . . . . . . . 77.5 mt -101.26 110.79 22.86 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.576 -1.193 . . . . 74.14 108.555 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 469' ' ' GLY . . . . . . . . . . . . . . . -74.68 -51.51 8.03 Favored Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.365 -0.694 . . . . 73.43 111.365 175.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 470' ' ' LEU . . . . . 0.526 ' HB3' ' HE1' ' C' ' 36' ' ' TRP . 30.2 mt 57.69 103.69 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.89 1.676 . . . . 63.4 111.593 -176.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.376 -0.829 . . . . 64.4 111.064 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 450' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 108.2 -1.037 . . . . 74.33 108.2 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' H' H ' 451' ' ' VAL . . . . . 0.704 HG11 ' HA ' ' D' ' 54' ' ' ASP . 11.3 p -59.07 -38.24 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.1 0.96 . . . . 72.22 111.292 -177.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 452' ' ' VAL . . . . . . . . . . . . . 33.3 m -67.78 163.28 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.578 1.151 . . . . 73.5 112.526 -175.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 453' ' ' GLY . . . . . . . . . . . . . . . 94.78 97.92 1.67 Allowed Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.623 -0.717 . . . . 42.03 112.64 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 454' ' ' LEU . . . . . 0.557 HD22 ' HE1' ' D' ' 94' ' ' MET . 2.5 pt? -137.34 170.26 16.38 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.807 0.843 . . . . 73.12 109.403 173.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 455' ' ' THR . . . . . . . . . . . . . 26.9 m -70.47 144.96 51.26 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 109.443 -0.577 . . . . 75.44 109.443 172.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 456' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -58.47 103.82 0.18 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.67 -0.492 . . . . 65.12 109.67 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 457' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -69.83 83.74 0.47 Allowed 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 122.504 1.145 . . . . 74.43 110.833 -176.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 458' ' ' THR . . . . . . . . . . . . . 31.4 p -116.04 12.23 15.56 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 113.908 -1.497 . . . . 54.21 109.681 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 459' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -111.54 108.22 17.66 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.088 0.955 . . . . 74.33 109.629 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 460' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.16 84.89 6.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.201 1.0 . . . . 55.02 109.793 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 461' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -57.03 -19.9 21.34 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 113.42 -1.718 . . . . 74.04 112.217 169.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 462' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -65.67 101.7 0.65 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.185 -1.043 . . . . 74.45 108.185 171.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 463' ' ' THR . . . . . . . . . . . . . 4.8 t -140.35 76.23 1.55 Allowed 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 122.046 0.927 . . . . 65.35 110.048 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 464' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.47 166.43 33.3 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.266 -0.879 . . . . 75.45 110.002 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 465' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -160.32 134.49 7.29 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.003 -1.11 . . . . 74.24 108.003 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 466' ' ' ALA . . . . . . . . . . . . . . . -161.39 -159.42 0.64 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.509 0.724 . . . . 52.03 110.395 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 467' ' ' ALA . . . . . . . . . . . . . . . 78.05 -77.05 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.425 1.49 . . . . 63.34 112.131 172.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 468' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' D' ' 39' ' ' GLU . 0.6 OUTLIER -131.46 136.68 48.14 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.343 0.657 . . . . 73.55 110.451 -174.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' H' H ' 469' ' ' GLY . . . . . . . . . . . . . . . -127.18 19.07 6.08 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.44 -0.645 . . . . 62.32 114.254 -173.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 470' ' ' LEU . . . . . 0.56 ' HB2' ' HB2' ' D' ' 39' ' ' GLU . 12.7 tp 63.14 18.16 10.73 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 124.795 1.238 . . . . 71.13 111.337 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 471' ' ' LYS . . . . . . . . . . . . . 23.4 tptm . . . . . 0 C--O 1.248 1.006 0 N-CA-C 107.527 -1.286 . . . . 74.22 107.527 -170.567 . . . . . . . . 0 0 . 1 stop_ save_